PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Lopez-Martinez, LM; Santacruz-Ortega, H; Navarro, RE; Sotelo-Mundo, RR; Gonzalez-Aguilar, GA				Lopez-Martinez, Luis M.; Santacruz-Ortega, Hisila; Navarro, Rosa-Elena; Sotelo-Mundo, Rogerio R.; Gonzalez-Aguilar, Gustavo A.			A H-1 NMR Investigation of the Interaction between Phenolic Acids Found in Mango (Manguifera indica cv Ataulfo) and Papaya (Carica papaya cv Maradol) and 1,1-diphenyl-2-picrylhydrazyl (DPPH) Free Radicals	PLOS ONE			English	Article							NMR ANALYTICAL APPROACH; ANTIOXIDANT ACTIVITY; ANTAGONISM; SYNERGISM; PROFILES; EXTRACTS; CLARIFY; L.	The benefits of phenolic acids on human health are very often ascribed to their potential to counteract free radicals to provide antioxidant protection. This potential has been attributed to their acidic chemical structure, which possesses hydroxyl groups in different positions. Phenolic acids can interact between themselves and exhibit an additive, antagonistic or synergistic effect. In this paper, we used H-1 NMR to analyze the interactions and mechanisms that are present in major phenolic acids found in mango (gallic, protocatechuic, chlorogenic and vanillic acids) and papaya (caffeic, ferulic and p-coumaric acids), and the DPPH radical was used to evaluate the effect of the antioxidant mixtures. The interactions were found to occur via hydrogen bonds between the -OH and -COOH groups. Moreover, the phenolic acids exhibit two types of mechanisms for the neutralization of the DPPH radical. According to the results, these two mechanisms are Hydrogen Atom Transfer (HAT) and Single Electron Transfer (SET). The ability of the phenolic acid to neutralize the DPPH radical decreases in the following order in mango: gallic > chlorogenic > protocatechuic > vanillic. Moreover, within the acids found in papaya, the order was as follows: caffeic > p-coumaric > ferulic.	[Lopez-Martinez, Luis M.; Santacruz-Ortega, Hisila; Navarro, Rosa-Elena; Sotelo-Mundo, Rogerio R.; Gonzalez-Aguilar, Gustavo A.] Univ Sonora, DIPM, Hermosillo 83000, Sonora, Mexico; [Sotelo-Mundo, Rogerio R.; Gonzalez-Aguilar, Gustavo A.] CIAD, Hermosillo 83000, Sonora, Mexico	Universidad de Sonora; CIAD - Centro de Investigacion en Alimentacion y Desarrollo	Santacruz-Ortega, H (corresponding author), Univ Sonora, DIPM, Calle Rosales & Blvd Luis Encinas S-N, Hermosillo 83000, Sonora, Mexico.	hisila@polimeros.uson.mx; gustavo@ciad.mx	Sotelo-Mundo, Rogerio/A-6097-2011	Sotelo-Mundo, Rogerio/0000-0001-5543-6889	Mexican National Council CONACYT; University of Sonora; CIAD; Secretaria de Educacion Publica, Mexico (SES-SEP) [P/PIFI 2010-01]; project "Nutrigenomica e interacciones moleculares de fenoles y fibra dietaria del mango "Ataulfo" (Mangifera indica L.) en un sistema murino" [179574CB2012-01]	Mexican National Council CONACYT; University of Sonora; CIAD; Secretaria de Educacion Publica, Mexico (SES-SEP); project "Nutrigenomica e interacciones moleculares de fenoles y fibra dietaria del mango "Ataulfo" (Mangifera indica L.) en un sistema murino"	This study was financed by the Mexican National Council CONACYT, University of Sonora and CIAD. The NMR spectrometer is operated under the support of the Secretaria de Educacion Publica, Mexico (SES-SEP, programs No. P/PIFI 2010-01.) This work is part of the project "Nutrigenomica e interacciones moleculares de fenoles y fibra dietaria del mango "Ataulfo" (Mangifera indica L.) en un sistema murino" Project 179574CB2012-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbo M. O., 2014, Journal of Natural Products (India), V7, P48; Benavente-Garcia O, 2000, FOOD CHEM, V68, P457, DOI 10.1016/S0308-8146(99)00221-6; Borgert CJ, 2005, THROMB RES, V117, P123, DOI 10.1016/j.thromres.2005.06.008; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Chanda S, 2013, TURK J BIOL, V37, P81, DOI 10.3906/biy-1203-41; Charisiadis P, 2014, MOLECULES, V19, P13643, DOI 10.3390/molecules190913643; Charisiadis P, 2011, J NAT PROD, V74, P2462, DOI 10.1021/np200329a; Hidalgo M, 2010, FOOD CHEM, V121, P691, DOI 10.1016/j.foodchem.2009.12.097; Jain DP, 2011, J ADV PHARM TECHNOL, V2, P177, DOI 10.4103/2231-4040.85538; Kawabata J, 2002, J AGR FOOD CHEM, V50, P5468, DOI 10.1021/jf020347g; Kim KH, 2006, FOOD CHEM, V95, P466, DOI 10.1016/j.foodchem.2005.01.032; Palafox-Carlos H, 2012, MOLECULES, V17, P12657, DOI 10.3390/molecules171112657; Pekkarinen SS, 1999, J AGR FOOD CHEM, V47, P3036, DOI 10.1021/jf9813236; Rivera-Pastrana DM, 2010, J SCI FOOD AGR, V90, P2358, DOI 10.1002/jsfa.4092; Romano CS, 2009, FOOD CHEM, V115, P456, DOI 10.1016/j.foodchem.2008.12.029; Saito S, 2005, TETRAHEDRON, V61, P8101, DOI 10.1016/j.tet.2005.06.040; Sawai Y, 2005, J AGR FOOD CHEM, V53, P3598, DOI 10.1021/jf040423a; Sawai Y, 1998, J AGR FOOD CHEM, V46, P111, DOI 10.1021/jf970342x; Sawai Y, 2000, J AGR FOOD CHEM, V48, P6247, DOI 10.1021/jf000500b; Siquet C, 2006, FREE RADICAL RES, V40, P433, DOI 10.1080/10715760500540442; Tazaki H, 2001, BIOSCI BIOTECH BIOCH, V65, P2613, DOI 10.1271/bbb.65.2613; Villano D, 2005, ANAL CHIM ACTA, V538, P391, DOI 10.1016/j.aca.2005.02.016; Yin J, 2012, FOOD CHEM, V135, P2195, DOI 10.1016/j.foodchem.2012.07.025; Zhang M, 2013, MOLECULES, V18, P14096, DOI 10.3390/molecules181114096	24	55	58	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0140242	10.1371/journal.pone.0140242	http://dx.doi.org/10.1371/journal.pone.0140242			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559189	gold, Green Published, Green Submitted			2022-12-27	WOS:000364433100004
J	Shirima, DD; Pfeifer, M; Platts, PJ; Totland, O; Moe, SR				Shirima, Deo D.; Pfeifer, Marion; Platts, Philip J.; Totland, Orjan; Moe, Stein R.			Interactions between Canopy Structure and Herbaceous Biomass along Environmental Gradients in Moist Forest and Dry Miombo Woodland of Tanzania	PLOS ONE			English	Article							LEAF-AREA INDEX; TREE-GRASS INTERACTIONS; EASTERN ARC MOUNTAINS; ABOVEGROUND BIOMASS; TROPICAL FOREST; DIVERSITY; CARBON; HYPOTHESIS; ALLOMETRY; ALTITUDE	We have limited understanding of how tropical canopy foliage varies along environmental gradients, and how this may in turn affect forest processes and functions. Here, we analyse the relationships between canopy leaf area index (LAI) and above ground herbaceous biomass (AGBH) along environmental gradients in a moist forest and miombo woodland in Tanzania. We recorded canopy structure and herbaceous biomass in 100 permanent vegetation plots (20 m x 40 m), stratified by elevation. We quantified tree species richness, evenness, Shannon diversity and predominant height as measures of structural variability, and disturbance (tree stumps), soil nutrients and elevation as indicators of environmental variability. Moist forest and miombo woodland differed substantially with respect to nearly all variables tested. Both structural and environmental variables were found to affect LAI and AGBH, the latter being additionally dependent on LAI in moist forest but not in miombo, where other factors are limiting. Combining structural and environmental predictors yielded the most powerful models. In moist forest, they explained 76% and 25% of deviance in LAI and AGBH, respectively. In miombo woodland, they explained 82% and 45% of deviance in LAI and AGBH. In moist forest, LAI increased non-linearly with predominant height and linearly with tree richness, and decreased with soil nitrogen except under high disturbance. Miombo woodland LAI increased linearly with stem density, soil phosphorous and nitrogen, and decreased linearly with tree species evenness. AGBH in moist forest decreased with LAI at lower elevations whilst increasing slightly at higher elevations. AGBH in miombo woodland increased linearly with soil nitrogen and soil pH. Overall, moist forest plots had denser canopies and lower AGBH compared with miombo plots. Further field studies are encouraged, to disentangle the direct influence of LAI on AGBH from complex interrelationships between stand structure, environmental gradients and disturbance in African forests and woodlands.	[Shirima, Deo D.; Totland, Orjan; Moe, Stein R.] Norwegian Univ Life Sci, Dept Ecol & Nat Resource Management, N-1432 As, Norway; [Shirima, Deo D.] Sokoine Univ Agr, Fac Forestry & Nat Conservat, Dept Forest Biol, Morogoro, Tanzania; [Pfeifer, Marion] Imperial Coll London, Dept Life Sci, Ascot SL5 7PY, Berks, England; [Platts, Philip J.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England	Norwegian University of Life Sciences; Sokoine University of Agriculture; Imperial College London; University of York - UK	Shirima, DD (corresponding author), Norwegian Univ Life Sci, Dept Ecol & Nat Resource Management, POB 5003, N-1432 As, Norway.	dshirima2@gmail.com	Moe, Stein R./G-1507-2011; Platts, Philip J./C-2002-2009	Moe, Stein R./0000-0003-1005-3192; Platts, Philip J./0000-0002-0153-0121; Pfeifer, Marion/0000-0002-6775-3141	Norwegian State Education Loan Fund; Norwegian Government through the Climate Change Impacts, Adaptation and Mitigation programme at Sokoine University of Agriculture in Tanzania; European Research Council [281986]; Ministry for Foreign Affairs of Finland through the CHIESA project	Norwegian State Education Loan Fund; Norwegian Government through the Climate Change Impacts, Adaptation and Mitigation programme at Sokoine University of Agriculture in Tanzania; European Research Council(European Research Council (ERC)European Commission); Ministry for Foreign Affairs of Finland through the CHIESA project	The Norwegian State Education Loan Fund (http://www.lanekassen.no/) and Norwegian Government through the Climate Change Impacts, Adaptation and Mitigation programme at Sokoine University of Agriculture in Tanzania (http://www.drpgs.suanet.ac.tz/) funded DDS. MP is funded by European Research Council under the Project number 281986 and PJP was funded by the Ministry for Foreign Affairs of Finland through the CHIESA project (http://chiesa.icipe.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Breda NJJ, 2003, J EXP BOT, V54, P2403, DOI 10.1093/jxb/erg263; Callaway RM, 2007, INTERACTION COMPETIT; Campbell B., 1996, MIOMBO TRANSITION WO; Campbell B.M.B.M., 2007, CIFOR; Canty A, 2014, PACKAGE BOOT; Coomes DA, 2007, J ECOL, V95, P1084, DOI 10.1111/j.1365-2745.2007.01280.x; Crawley M. J., 2012, R BOOK, DOI DOI 10.1111/j.1365-294X.2008.03806.x; Crawley MJ, 2009, MIXED EFFECTS MODEL; DeRose RJ, 2010, CAN J FOREST RES, V40, P629, DOI 10.1139/X10-018; Dewees P.A., 2010, J NAT RESOUR POLICY, V2, P57, DOI DOI 10.1080/19390450903350846; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; FAO, 2010, GLOB FOR RES ASS ROM; Fischer R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123300; Fournier RA, 1996, AGR FOREST METEOROL, V82, P47, DOI 10.1016/0168-1923(96)02345-3; Frost P., 1996, MIOMBO TRANSITION WO, P11; Gatti RC, 2015, ECOL RES, V30, P119, DOI 10.1007/s11284-014-1217-3; Gibbs HK, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/4/045023; Gilliam FS, 2007, BIOSCIENCE, V57, P845, DOI 10.1641/B571007; Gilliam Frank S., 2003, P198; Gonsamo Gosa A, 2009, REMOTE SENSING LEAF; Hardwick SR, 2015, AGR FOREST METEOROL, V201, P187, DOI 10.1016/j.agrformet.2014.11.010; Hoang VS, 2011, J TROP FOR SCI, V23, P328; Ishii H, 2013, ECOL RES, V28, P191, DOI 10.1007/s11284-012-1025-6; James G, 2013, SPRINGER TEXTS STAT, V103, P303, DOI 10.1007/978-1-4614-7138-7_8; Jonckheere I, 2004, AGR FOREST METEOROL, V121, P19, DOI 10.1016/j.agrformet.2003.08.027; Jonckheere I, 2005, TREE PHYSIOL, V25, P723, DOI 10.1093/treephys/25.6.723; Kissinger G, 2012, DRIVERS DEFORESTATIO; KOHYAMA T, 1993, J ECOL, V81, P131, DOI 10.2307/2261230; Lovett JC, 1993, ASSESSMENT CONDITION; Ludwig F, 2001, J VEG SCI, V12, P579, DOI 10.2307/3237009; Malkinson D, 2010, OIKOS, V119, P1546, DOI 10.1111/j.1600-0706.2010.18375.x; Marshall AR, 2012, BIOL CONSERV, V154, P20, DOI 10.1016/j.biocon.2012.03.017; Mograbi PJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127093; Munishi PKT, 2004, J TROP FOR SCI, V16, P78; MURPHY PG, 1986, ANNU REV ECOL SYST, V17, P67, DOI 10.1146/annurev.es.17.110186.000435; Murtaugh PA, 2009, ECOL LETT, V12, P1061, DOI 10.1111/j.1461-0248.2009.01361.x; Pfeifer M, 2014, REMOTE SENS-BASEL, V6, P1973, DOI 10.3390/rs6031973; Pfeifer M, 2012, REMOTE SENS ENVIRON, V118, P103, DOI 10.1016/j.rse.2011.11.009; PIELOU E C, 1969, P286; Platts PJ, 2015, AFR J ECOL, V53, P103, DOI 10.1111/aje.12180; Price MF, 2013, MOUNTAIN GEOGRAPHY: PHYSICAL AND HUMAN DIMENSIONS, P1; Quinn GP, 2003, EXPT DESIGN DATA ANA; Reich PB, 2012, P ROY SOC B-BIOL SCI, V279, P2128, DOI 10.1098/rspb.2011.2270; Ribeiro NS, 2015, MIOMBO WOODLANDS RES; Runyan CW, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001841; Sagar R., 2012, Environmentalist, V32, P485, DOI 10.1007/s10669-012-9414-5; Scholes RJ, 1997, ANNU REV ECOL SYST, V28, P517, DOI 10.1146/annurev.ecolsys.28.1.517; Scholes RJ, 1996, J GEOPHYS RES-ATMOS, V101, P23667, DOI 10.1029/96JD01623; Shannon C.E, 1949, MATH THEORY COMMUNIC, V1st; Shirima DD, 2011, AFR J ECOL, V49, P332, DOI 10.1111/j.1365-2028.2011.01269.x; Tanzania URo, 1998, NAT FOR POL; Thomas PA, 2007, ECOLOGY OF WOODLANDS AND FORESTS: DESCRIPTION, DYNAMICS AND DIVERSITY, P1, DOI 10.1017/CBO9780511805578; Turner I.M., 2001, CAM TROP B, DOI 10.1017/CBO9780511542206; Unger M, 2013, TROP ECOL, V54, P33; van Laar A, 2007, FOREST MENSURATION M; Veenendaal EM, 2015, BIOGEOSCIENCES, V12, P2927, DOI 10.5194/bg-12-2927-2015; Weiss M, 2000, AGRONOMIE, V20, P3, DOI 10.1051/agro:2000105; WEISS M., 2014, CAN EYE V6 313 USER; West P. W., 2009, TREE FOREST MEASUREM, DOI [DOI 10.1007/978-3-540-95966-3, 10.1007/978-3-540-95966-3]; Willcock Simon, 2014, Carbon Balance Manag, V9, P2, DOI 10.1186/1750-0680-9-2; Williams M, 2008, FOREST ECOL MANAG, V254, P145, DOI 10.1016/j.foreco.2007.07.033; Yuan Y, 2013, ADV METEOROL, V2013, P6, DOI [DOI 10.1155/2013/964323, DOI 10.1155/2013/908307]; Zuur A, 2009, MIXED EFFECTS MODELS; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	65	13	15	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142784	10.1371/journal.pone.0142784	http://dx.doi.org/10.1371/journal.pone.0142784			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559410	Green Published, Green Accepted, gold			2022-12-27	WOS:000364433100124
J	Zhao, SR; Xi, L; Zhang, BH				Zhao, Shanrong; Xi, Li; Zhang, Baohong			Union Exon Based Approach for RNA-Seq Gene Quantification: To Be or Not to Be?	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; HUMAN GENOME ANNOTATION; TRANSCRIPTOME; ABUNDANCE; ALIGNMENT; ENSEMBL; REFSEQ; READS	In recent years, RNA-seq is emerging as a powerful technology in estimation of gene and/or transcript expression, and RPKM (Reads Per Kilobase per Million reads) is widely used to represent the relative abundance of mRNAs for a gene. In general, the methods for gene quantification can be largely divided into two categories: transcript-based approach and 'union exon'-based approach. Transcript-based approach is intrinsically more difficult because different isoforms of the gene typically have a high proportion of genomic overlap. On the other hand, 'union exon'-based approach method is much simpler and thus widely used in RNA-seq gene quantification. Biologically, a gene is expressed in one or more transcript isoforms. Therefore, transcript-based approach is logistically more meaningful than 'union exon'-based approach. Despite the fact that gene quantification is a fundamental task in most RNA-seq studies, however, it remains unclear whether 'union exon'-based approach for RNA-seq gene quantification is a good practice or not. In this paper, we carried out a side-by-side comparison of 'union exon'-based approach and transcript-based method in RNA-seq gene quantification. It was found that the gene expression levels are significantly underestimated by 'union exon'-based approach, and the average of RPKM from 'union exons'-based method is less than 50% of the mean expression obtained from transcript-based approach. The difference between the two approaches is primarily affected by the number of transcripts in a gene. We performed differential analysis at both gene and transcript levels, respectively, and found more insights, such as isoform switches, are gained from isoform differential analysis. The accuracy of isoform quantification would improve if the read coverage pattern and exon-exon spanning reads are taken into account and incorporated into EM (Expectation Maximization) algorithm. Our investigation discourages the use of 'union exons'-based approach in gene quantification despite its simplicity.	[Zhao, Shanrong; Xi, Li; Zhang, Baohong] Pfizer Worldwide Res & Dev, Clin Genet & Bioinformat, Cambridge, MA 02139 USA	Pfizer	Zhao, SR (corresponding author), Pfizer Worldwide Res & Dev, Clin Genet & Bioinformat, Cambridge, MA 02139 USA.	Shanrong.Zhao@pfizer.com			Pfizer	Pfizer(Pfizer)	The authors received no specific funding for this work. The authors are employed by a commercial company: Pfizer. Pfizer provided support in the form of salaries for authors SZ, LX and BZ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Angelini C, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-135; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Bai Y, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S2-S9; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Borozan I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076935; Choudhury R, 2009, J BIOL CHEM, V284, P9965, DOI 10.1074/jbc.M807442200; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Engstrom PG, 2013, NAT METHODS, V10, P1185, DOI [10.1038/NMETH.2722, 10.1038/nmeth.2722]; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/nmeth.1613, 10.1038/NMETH.1613]; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kanitz A, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0702-5; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li B, 2010, BIOINFORMATICS, V26, P493, DOI 10.1093/bioinformatics/btp692; Li HD, 2014, TRENDS GENET, V30, P340, DOI 10.1016/j.tig.2014.05.005; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Mele M, 2015, SCIENCE, V348, P660, DOI 10.1126/science.aaa0355; Mills JD, 2013, CURR GENOMICS, V14, P173, DOI 10.2174/1389202911314030003; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mutz KO, 2013, CURR OPIN BIOTECH, V24, P22, DOI 10.1016/j.copbio.2012.09.004; Nicolae M, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-9; Oldmeadow C, 2014, J PSYCHIATR RES, V52, P44, DOI 10.1016/j.jpsychires.2014.01.011; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sigurgeirsson B, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-631; Soneson C, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-91; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wagner GP, 2012, THEOR BIOSCI, V131, P281, DOI 10.1007/s12064-012-0162-3; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq622; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wu PY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S11-S8; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Zhao SR, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1876-7; Zhao SR, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1308-8; Zhao SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101374; Zhao SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0078644	43	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0141910	10.1371/journal.pone.0141910	http://dx.doi.org/10.1371/journal.pone.0141910			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559532	Green Published, gold, Green Submitted			2022-12-27	WOS:000364433100045
J	Batista, BG; Estrella, JC; Ferreira, CHG; Leite, DM; Nakamura, LHV; Reiff-Marganiec, S; Santana, MJ; Santana, RHC				Batista, Bruno Guazzelli; Estrella, Julio Cezar; Gomes Ferreira, Carlos Henrique; Leite Filho, Dionisio Machado; Vasconcelos Nakamura, Luis Hideo; Reiff-Marganiec, Stephan; Santana, Marcos Jose; Carlucci Santana, Regina Helena			Performance Evaluation of Resource Management in Cloud Computing Environments	PLOS ONE			English	Article							ALLOCATION	Cloud computing is a computational model in which resource providers can offer on-demand services to clients in a transparent way. However, to be able to guarantee quality of service without limiting the number of accepted requests, providers must be able to dynamically manage the available resources so that they can be optimized. This dynamic resource management is not a trivial task, since it involves meeting several challenges related to workload modeling, virtualization, performance modeling, deployment and monitoring of applications on virtualized resources. This paper carries out a performance evaluation of a module for resource management in a cloud environment that includes handling available resources during execution time and ensuring the quality of service defined in the service level agreement. An analysis was conducted of different resource configurations to define which dimension of resource scaling has a real influence on client requests. The results were used to model and implement a simulated cloud system, in which the allocated resource can be changed on-the-fly, with a corresponding change in price. In this way, the proposed module seeks to satisfy both the client by ensuring quality of service, and the provider by ensuring the best use of resources at a fair price.	[Batista, Bruno Guazzelli; Estrella, Julio Cezar; Gomes Ferreira, Carlos Henrique; Leite Filho, Dionisio Machado; Vasconcelos Nakamura, Luis Hideo; Santana, Marcos Jose; Carlucci Santana, Regina Helena] Univ Sao Paulo, ICMC, BR-13560 Sao Carlos, SP, Brazil; [Reiff-Marganiec, Stephan] Univ Leicester, Dept Comp Sci, Leicester, Leics, England	Universidade de Sao Paulo; University of Leicester	Batista, BG (corresponding author), Univ Sao Paulo, ICMC, BR-13560 Sao Carlos, SP, Brazil.	batista@icmc.usp.br	Gomes Ferreira, Carlos Henrique/AGZ-6553-2022; Ferreira, Carlos Henrique Gomes/AAF-7938-2020; Estrella, Julio Cezar/AAP-4484-2020	Gomes Ferreira, Carlos Henrique/0000-0001-9107-6884; Estrella, Julio Cezar/0000-0003-0524-3274; Reiff-Marganiec, Stephan/0000-0001-6456-7063	Sao Paulo Research Foundation - FAPESP [2011/17201-3]	Sao Paulo Research Foundation - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Sao Paulo Research Foundation - FAPESP, process number 2011/17201-3, http://fapesp.br/en/ (BGB received the funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Sharkh M, 2013, IEEE COMMUN MAG, V51, P46, DOI 10.1109/MCOM.2013.6658651; Anuradha V.P., 2014, INT C INF COMM EMB S, P1, DOI DOI 10.1109/ICICES.2014.7033931; Calheiros RN, 2011, VIRTUAL MACHINE PROV, P295, DOI [10. 1109/icpp. 2011. 17, DOI 10.1109/ICPP.2011.17]; Calheiros RN, 2011, SOFTWARE PRACT EXPER, V41, P23, DOI 10.1002/spe.995; Caron E, 2012, RR7857 INRIA; Cherkasova Ludmila, 2007, Performance Evaluation Review, V35, P42, DOI 10.1145/1330555.1330556; Ding S, 2014, APPL MATH COMPUT, V247, P941, DOI 10.1016/j.amc.2014.09.058; Ding S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097762; Ding S, 2014, KNOWL-BASED SYST, V56, P216, DOI 10.1016/j.knosys.2013.11.014; Ferguson P, 1998, QUALITY SERVICE DELI, V1, P1; Hussain H, 2013, PARALLEL COMPUT, V39, P709, DOI 10.1016/j.parco.2013.09.009; Iqbal W., 2010, EL ENG EL COMP TEL I, P317; Jain R, 1991, ART COMPUTER SYSTEMS, V182, P274; Linlin Wu, 2011, 2011 Proceedings of 11th IEEE/ACM International Symposium on Cluster, Cloud and Grid Computing (CCGrid 2011), P195, DOI 10.1109/CCGrid.2011.51; Manvi SS, 2014, J NETW COMPUT APPL, V41, P424, DOI 10.1016/j.jnca.2013.10.004; Mell P., 2011, NIST DEFINITION CLOU, V800, P7, DOI DOI 10.1136/emj.2010.096966; Morikawa T., 2011, P 4 IFIP INT C NEW T, V5, P1; Tram Truong Huu, 2010, Proceedings 2010 10th IEEE/ACM International Conference on Cluster, Cloud and Grid Computing (CCGrid), P612, DOI 10.1109/CCGRID.2010.23; Vegesna S, 2001, IP QUALITY SERVICE, V1, P1	19	21	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0141914	10.1371/journal.pone.0141914	http://dx.doi.org/10.1371/journal.pone.0141914			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555730	Green Published, Green Submitted, gold			2022-12-27	WOS:000364430700045
J	Cuadros, J; Perez-Tanoira, R; Prieto-Perez, L; Martin-Martin, I; Berzosa, P; Gonzalez, V; Tisiano, G; Balcha, S; Ramos, JM; Gorgolas, M				Cuadros, Juan; Perez-Tanoira, Ramon; Prieto-Perez, Laura; Martin-Martin, Ines; Berzosa, Pedro; Gonzalez, Vicenta; Tisiano, Gebre; Balcha, Seble; Manuel Ramos, Jose; Gorgolas, Miguel			Field Evaluation of Malaria Microscopy, Rapid Malaria Tests and Loop-Mediated Isothermal Amplification in a Rural Hospital in South Western Ethiopia	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; DIAGNOSIS; PARASITES; POINT; VIVAX; ASSAY; LAMP; KIT	Background In up to one third of the hospitals in some rural areas of Africa, laboratory services in malaria diagnosis are limited to microscopy by thin film, as no capability to perform thick film exists (gold standard in terms of sensitivity for malaria diagnosis). A new rapid molecular malaria diagnostic test called Loop-mediated isothermal DNA amplification (LAMP) has been recently validated in clinical trials showing exceptional sensitivity and specificity features. It could be a reliable diagnostic tool to be implemented without special equipment or training. Objective The objective of this proof of concept study was to confirm the feasibility of using LAMP technique for diagnosis of malaria in a rural Ethiopian hospital with limited resources. Methodology/Principal Findings This study was carried out in Gambo General Hospital, West Arsi Province (Ethiopia), from November 1st to December 31st 2013. A total of 162 patients with a non-focal febrile syndrome were investigated. The diagnostic capability (sensitivity, specificity, positive predictive and negative predictive values) of rapid malaria tests and microscopy by thin film was evaluated in comparison with LAMP. Eleven (6.79%) out of the 162 patients with fever and suspected malaria, tested positive for LAMP, 3 (1.85%) for rapid malaria tests and none of the eleven cases was detected by thin film microscopy. Conclusions/Significance LAMP can be performed in basic rural laboratories without the need for specialized infrastructure and it may set a reliable tool for malaria control to detect a low level parasitemia.	[Cuadros, Juan] Univ Hosp Principe Asturias, Dept Microbiol, Madrid, Spain; [Perez-Tanoira, Ramon; Prieto-Perez, Laura; Martin-Martin, Ines; Tisiano, Gebre; Balcha, Seble; Manuel Ramos, Jose; Gorgolas, Miguel] Gambo Rural Gen Hosp, Dept Med & Lab, West Arsi, Gambo, Ethiopia; [Perez-Tanoira, Ramon; Prieto-Perez, Laura; Gorgolas, Miguel] Fdn Jimenez Diaz, Div Infect Dis, E-28040 Madrid, Spain; [Perez-Tanoira, Ramon; Prieto-Perez, Laura; Gorgolas, Miguel] Univ Autonoma Madrid, Dept Med, Madrid, Spain; [Perez-Tanoira, Ramon] Univ Helsinki, Dept Otorhinolaryngol Head & Neck Surg, Helsinki, Finland; [Perez-Tanoira, Ramon] Helsinki Univ Hosp, Helsinki, Finland; [Martin-Martin, Ines] Hlth Inst Carlos III, Med Entomol Unit, Dept Parasitol, Natl Ctr Microbiol, Madrid, Spain; [Berzosa, Pedro; Gonzalez, Vicenta] Hlth Insitute Carlos III, Natl Ctr Trop Med, Madrid, Spain; [Manuel Ramos, Jose] Miguel Hernandez Univ, Hosp Gen Univ Alicante, Dept Internal Med, Alicante, Spain	Prince of Asturias University Hospital; Autonomous University of Madrid; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Instituto de Salud Carlos III; Centro Nacional de Medicina Tropical (CNMT); General University Hospital of Alicante; Universidad Miguel Hernandez de Elche	Perez-Tanoira, R (corresponding author), Gambo Rural Gen Hosp, Dept Med & Lab, West Arsi, Gambo, Ethiopia.	ramontanoira@hotmail.com	Gonzalez, Juan Cuadros/E-8697-2015; Ramos, Jose M./B-6420-2018; Tanoira, Ramón Pérez/K-4898-2014; Martin Martin, Ines/I-9358-2012	Gonzalez, Juan Cuadros/0000-0003-4098-4377; Ramos, Jose M./0000-0002-6501-9867; Tanoira, Ramón Pérez/0000-0002-9816-3208; Martin Martin, Ines/0000-0002-0956-7324; Berzosa, Pedro/0000-0002-8768-717X	Master of Tropical diseases of Department of Medicine; Universidad Autonoma de Madrid; Rural Gambo Hospital, Ethiopia; Master of Tropical Diseases and International Health of the Department of Medicine	Master of Tropical diseases of Department of Medicine; Universidad Autonoma de Madrid; Rural Gambo Hospital, Ethiopia; Master of Tropical Diseases and International Health of the Department of Medicine	The study was funded by the Master of Tropical diseases of Department of Medicine, Universidad Autonoma de Madrid and Rural Gambo Hospital, Ethiopia. The RDTs were provided by the government of Ethiopia. Special thanks to Francisco Reyes, the managing director of Gambo Hospital and Iveth Gonzalez, of FIND diagnostics for her help in obtaining the reagents.; We thank all the members of the laboratory and clinical staff of Gambo General Rural Hospital. The study was funded by the Master of Tropical Diseases and International Health of the Department of Medicine, held by the Universidad Autonoma of Madrid. RDTs were provided by the government of Ethiopia. Special mention to Dr. Francisco Reyes, the managing director of Gambo Hospital and Iveth Gonzalez, of FIND diagnostics for her invaluable help in obtaining the reactives.	Abeku TA, 2003, ACTA TROP, V87, P331, DOI 10.1016/S0001-706X(03)00123-2; Abreha T, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-292; Aydin-Schmidt B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103905; Biadglegne F, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0529-x; Cook J, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0573-y; Hopkins H, 2013, J INFECT DIS, V208, P645, DOI 10.1093/infdis/jit184; Hsiang MS, 2014, J INFECT DIS, V210, P1167, DOI 10.1093/infdis/jiu253; Institute of Medicine (US) Committee on the Economics of Antimalarial Drugs, 2004, SAVING LIVES BUYING; Lee PW, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-408; Mukadi P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-308; Najafabadi ZG, 2014, ACTA TROP, V136, P44, DOI 10.1016/j.actatropica.2014.03.029; Oriero EC, 2015, J ANTIMICROB CHEMOTH, V70, P2, DOI 10.1093/jac/dku343; Patel JC, 2014, J INFECT DIS, V210, P1180, DOI 10.1093/infdis/jiu252; Patel JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054986; Polley SD, 2013, J INFECT DIS, V208, P637, DOI 10.1093/infdis/jit183; Port JR, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-454; Shillcutt S, 2008, B WORLD HEALTH ORGAN, V86, P101, DOI 10.2471/BLT.07.042259; WHO, 2013, MAL RAP DIAGN TEST P; World Health Organization, 2010, BAS MAL MICR 1; Woyessa A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-218; Yongkiettrakul S, 2014, PARASITOL INT, V63, P777, DOI 10.1016/j.parint.2014.06.004; Zimmerman PA, 2015, CURR OPIN INFECT DIS, V28, P446, DOI 10.1097/QCO.0000000000000191	22	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142842	10.1371/journal.pone.0142842	http://dx.doi.org/10.1371/journal.pone.0142842			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555068	Green Published, Green Submitted, gold			2022-12-27	WOS:000364430700179
J	Garcia-Segura, L; Abreu-Goodger, C; Hernandez-Mendoza, A; Dinkova, TDD; Padilla-Noriega, L; Perez-Andrade, ME; Miranda-Rios, J				Garcia-Segura, Laura; Abreu-Goodger, Cei; Hernandez-Mendoza, Armando; Dimitrova Dinkova, Tzvetanka D.; Padilla-Noriega, Luis; Elva Perez-Andrade, Martha; Miranda-Rios, Juan			High-Throughput Profiling of Caenorhabditis elegans Starvation-Responsive microRNAs	PLOS ONE			English	Article							GERMLINE STEM-CELLS; LIFE-SPAN; C. ELEGANS; MESSENGER-RNA; MAMMALIAN MICRORNAS; GENE-EXPRESSION; DAUER FORMATION; LET-7 MICRORNA; RT-PCR; PROTEIN	MicroRNAs (miRNAs) are non-coding RNAs of -22 nucleotides in length that regulate gene expression by interfering with the stability and translation of mRNAs. Their expression is regulated during development, under a wide variety of stress conditions and in several pathological processes. In nature, animals often face feast or famine conditions. We observed that subjecting early L4 larvae from Caenorhabditis elegans to a 12-hr starvation period produced worms that are thinner and shorter than well-fed animals, with a decreased lipid accumulation, diminished progeny, reduced gonad size, and an increased lifespan. Our objective was to identify which of the 302 known miRNAs of C. elegans changed their expression under starvation conditions as compared to well-fed worms by means of deep sequencing in early L4 larvae. Our results indicate that 13 miRNAs (miR-34-3p, the family of miR-35-3p to miR-41-3p, miR-39-5p, miR-41-5p, miR-240-5p, miR-246-3p and miR-48135p) were upregulated, while 2 miRNAs (let-7-3p and miR-85-5p) were downregulated in 12hr starved vs. well-fed early L4 larvae. Some of the predicted targets of the miRNAs that changed their expression in starvation conditions are involved in metabolic or developmental process. In particular, miRNAs of the miR-35 family were upregulated 6-20 fold upon starvation. Additionally, we showed that the expression of gld-1, important in oogenesis, a validated target of miR-35-3p, was downregulated when the expression of miR-35-3p was upregulated. The expression of another reported target, the cell cycle regulator lin-23, was unchanged during starvation. This study represents a starting point for a more comprehensive understanding of the role of miRNAs during starvation in C. elegans.	[Garcia-Segura, Laura] Univ Nacl Autonoma Mexico, Programa Doctorado Ciencias Biomed, Mexico City, DF, Mexico; [Garcia-Segura, Laura; Elva Perez-Andrade, Martha; Miranda-Rios, Juan] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Biol Mol & Biotecnol, Unidad Genet Nutr, Mexico City, DF, Mexico; [Garcia-Segura, Laura; Elva Perez-Andrade, Martha; Miranda-Rios, Juan] Inst Nacl Pediat, Mexico City, DF, Mexico; [Abreu-Goodger, Cei] CINVESTAV, Unidad Genom Avanzada Langebio, Guanajuato, Mexico; [Hernandez-Mendoza, Armando] Univ Autonoma Edo Morelos, Ctr Invest Dinam Celular, Cuernavaca, Morelos, Mexico; [Dimitrova Dinkova, Tzvetanka D.] Univ Nacl Autonoma Mexico, Fac Quim, Dept Bioquim, Mexico City 04510, DF, Mexico; [Padilla-Noriega, Luis] Univ Nacl Autonoma Mexico, Fac Med, Dept Virol, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Universidad Autonoma del Estado de Morelos; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Miranda-Rios, J (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Biol Mol & Biotecnol, Unidad Genet Nutr, Mexico City, DF, Mexico.	riosjuanm@biomedicas.unam.mx	Abreu-Goodger, Cei/A-1268-2010; Dinkova, Tzvetanka/L-5678-2019; Miranda Ríos, Juan/ABB-7767-2021; Dinkova, Tzvetanka/AAE-6073-2020; Hernandez-Mendoza, Armando/A-8557-2018	Abreu-Goodger, Cei/0000-0001-8302-9893; Dinkova, Tzvetanka/0000-0001-7971-525X; Hernandez-Mendoza, Armando/0000-0002-7809-6888; Padilla-Noriega, Luis/0000-0002-1121-144X	Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT); Direccion General de Asuntos del Personal Academico (DGAPA), Universidad Nacional Autonoma de Mexico [IN209310-3, IN203514]; Fondos Federales Instituto Nacional de Pediatria [036/2015]; Consejo Nacional de Ciencia y Tecnologia (CONACYT), Mexico [384014]	Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)); Direccion General de Asuntos del Personal Academico (DGAPA), Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); Fondos Federales Instituto Nacional de Pediatria; Consejo Nacional de Ciencia y Tecnologia (CONACYT), Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Funding was provided by Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT), Direccion General de Asuntos del Personal Academico (DGAPA), Universidad Nacional Autonoma de Mexico, grants IN209310-3 and IN203514, dgapa.unam.mx, and Fondos Federales Instituto Nacional de Pediatria, grant 036/2015. This paper presents part of the PhD thesis of Laura Garcia-Segura, who is a doctoral student from Programa de Doctorado en Ciencias Biomedicas, Universidad Nacional Autonoma de Mexico (UNAM), and received fellowship 384014 from Consejo Nacional de Ciencia y Tecnologia (CONACYT), Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Saavedra E, 2010, CURR BIOL, V20, P367, DOI 10.1016/j.cub.2009.12.051; Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; Angelo G, 2009, SCIENCE, V326, P954, DOI 10.1126/science.1178343; AUSTIN J, 1987, CELL, V51, P589, DOI 10.1016/0092-8674(87)90128-0; AVERY L, 1993, GENETICS, V133, P897; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berry LW, 1997, DEVELOPMENT, V124, P925; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Boulias K, 2012, CELL METAB, V15, P439, DOI 10.1016/j.cmet.2012.02.014; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Christodoulou F, 2010, NATURE, V463, P1084, DOI 10.1038/nature08744; Czech B, 2009, MOL CELL, V36, P445, DOI 10.1016/j.molcel.2009.09.028; Davis MPA, 2013, METHODS, V63, P41, DOI 10.1016/j.ymeth.2013.06.027; de Lencastre A, 2010, CURR BIOL, V20, P2159, DOI 10.1016/j.cub.2010.11.015; Dealy MJ, 1999, NAT GENET, V23, P245, DOI 10.1038/13886; Eichhorn SW, 2014, MOL CELL, V56, P104, DOI 10.1016/j.molcel.2014.08.028; FRANCIS R, 1995, GENETICS, V139, P579; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garcia-Segura L, 2013, J NUTRIGENET NUTRIGE, V6, P16, DOI 10.1159/000345826; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghildiyal M, 2010, RNA, V16, P43, DOI 10.1261/rna.1972910; Gong GY, 2015, MAR BIOTECHNOL, V17, P338, DOI 10.1007/s10126-015-9623-2; Grad Y, 2003, MOL CELL, V11, P1253, DOI 10.1016/S1097-2765(03)00153-9; Grosshans H, 2005, DEV CELL, V8, P321, DOI 10.1016/j.devcel.2004.12.019; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hackenberg M, 2009, NUCLEIC ACIDS RES, V37, pW68, DOI 10.1093/nar/gkp347; Hammell CM, 2009, P NATL ACAD SCI USA, V106, P18668, DOI 10.1073/pnas.0908131106; Hansen M, 2013, CELL METAB, V17, P10, DOI 10.1016/j.cmet.2012.12.003; Hebeisen M, 2008, DEVELOPMENT, V135, P1259, DOI 10.1242/dev.014969; HOLLIDAY R, 1989, BIOESSAYS, V10, P125, DOI 10.1002/bies.950100408; Hope IA, 2002, C ELEGANS PRACTICAL, Vxxi; Jan CH, 2011, NATURE, V469, P97, DOI 10.1038/nature09616; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; JOHNSON TE, 1984, MECH AGEING DEV, V28, P23, DOI 10.1016/0047-6374(84)90150-7; Jones AR, 1996, DEV BIOL, V180, P165, DOI 10.1006/dbio.1996.0293; Jovanovic M, 2010, NAT METHODS, V7, P837, DOI [10.1038/NMETH.1504, 10.1038/nmeth.1504]; Kaeberlein TL, 2006, AGING CELL, V5, P487, DOI 10.1111/j.1474-9726.2006.00238.x; Karp X, 2011, GENETICS, V187, P345, DOI 10.1534/genetics.110.123992; Kato M, 2009, ONCOGENE, V28, P2419, DOI 10.1038/onc.2009.106; Kato M, 2013, AGEING RES REV, V12, P429, DOI 10.1016/j.arr.2012.03.012; Kato M, 2011, RNA, V17, P1804, DOI 10.1261/rna.2714411; Kato M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r54; Kipreos ET, 2000, DEVELOPMENT, V127, P5071; Kipreos ET, 1996, CELL, V85, P829, DOI 10.1016/S0092-8674(00)81267-2; KLASS MR, 1977, MECH AGEING DEV, V6, P413, DOI 10.1016/0047-6374(77)90043-4; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larance M, 2015, MOL CELL PROTEOMICS, V14, P1989, DOI 10.1074/mcp.M114.044289; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Leaman D, 2005, CELL, V121, P1097, DOI 10.1016/j.cell.2005.04.016; Lee MH, 2010, ADV EXP MED BIOL, V693, P106; Lehmann R, 2012, CELL STEM CELL, V10, P729, DOI 10.1016/j.stem.2012.05.016; Leung AKL, 2007, CELL, V130, P581, DOI 10.1016/j.cell.2007.08.010; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Li X, 2009, CELL, V137, P273, DOI 10.1016/j.cell.2009.01.058; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Liu M, 2011, CELL RES, V21, P1605, DOI 10.1038/cr.2011.102; Londin E, 2015, P NATL ACAD SCI USA, V112, pE1106, DOI 10.1073/pnas.1420955112; Lu XW, 1998, CELL, V95, P981, DOI 10.1016/S0092-8674(00)81722-5; Lu YC, 2009, RNA, V15, P1483, DOI 10.1261/rna.1702009; Lukowski SW, 2015, GENOMICS, V106, P107, DOI 10.1016/j.ygeno.2015.05.001; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Massirer KB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002536; McJunkin K, 2014, G3-GENES GENOM GENET, V4, P1747, DOI 10.1534/g3.114.011973; MENEELY PM, 1979, GENETICS, V92, P99; Minasaki R, 2014, RNA BIOL, V11, P111, DOI 10.4161/rna.27992; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Miska EA, 2007, PLOS GENET, V3, P2395, DOI 10.1371/journal.pgen.0030215; Mondol V, 2012, CURR TOP DEV BIOL, V99, P1, DOI 10.1016/B978-0-12-387038-4.00001-X; Motola DL, 2006, CELL, V124, P1209, DOI 10.1016/j.cell.2006.01.037; Okamura K, 2013, GENE DEV, V27, P778, DOI 10.1101/gad.211698.112; Okamura K, 2009, MOL CELL, V36, P431, DOI 10.1016/j.molcel.2009.09.027; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Pandit A, 2014, AGING-US, V6, P835, DOI 10.18632/aging.100697; Paradis S, 1999, GENE DEV, V13, P1438, DOI 10.1101/gad.13.11.1438; Parrish JZ, 2009, NEURON, V63, P788, DOI 10.1016/j.neuron.2009.08.006; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pincus Z, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002306; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roth LW, 2012, MATURITAS, V71, P315, DOI 10.1016/j.maturitas.2011.12.017; Roush SF, 2009, DEV BIOL, V334, P523, DOI 10.1016/j.ydbio.2009.07.012; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Schmid M, 2009, GENE DEV, V23, P824, DOI 10.1101/gad.494009; Seidel HS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028074; Shen YD, 2012, SCIENCE, V338, P1472, DOI 10.1126/science.1228967; Shi Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075475; Simon DJ, 2008, CELL, V133, P903, DOI 10.1016/j.cell.2008.04.035; Smith-Vikos T, 2014, CURR BIOL, V24, P2238, DOI 10.1016/j.cub.2014.08.013; Sokol NS, 2005, GENE DEV, V19, P2343, DOI 10.1101/gad.1356105; Song YQ, 2012, GENE DEV, V26, P1612, DOI 10.1101/gad.193243.112; Srinivasan S, 2015, ANNU REV PHYSIOL, V77, P161, DOI 10.1146/annurev-physiol-021014-071704; Suh N, 2009, GENETICS, V181, P1249, DOI 10.1534/genetics.108.099440; Than Minh, 2013, Worm, V2, pe26894, DOI 10.4161/worm.26894; Thondamal M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5879; Van Gilst MR, 2005, P NATL ACAD SCI USA, V102, P13496, DOI 10.1073/pnas.0506234102; Van Wynsberghe PM, 2011, NAT STRUCT MOL BIOL, V18, P302, DOI 10.1038/nsmb.1986; Vanfleteren JR, 1999, NEUROBIOL AGING, V20, P487, DOI 10.1016/S0197-4580(99)00087-1; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Wang JB, 2011, GENOME RES, V21, P1462, DOI 10.1101/gr.121426.111; Wang YS, 1999, CURR BIOL, V9, P1191, DOI 10.1016/S0960-9822(00)80024-X; Wen JY, 2015, NUCLEIC ACIDS RES, V43, P6207, DOI 10.1093/nar/gkv603; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Winter J, 2013, NUCLEIC ACIDS RES, V41, P5503, DOI 10.1093/nar/gkt251; Wood WB, 1988, NEMATODE CAENORHABDI, Vxiii; Yang JS, 2011, RNA, V17, P312, DOI 10.1261/rna.2537911; Yook K, 2012, NUCLEIC ACIDS RES, V40, pD735, DOI 10.1093/nar/gkr954; Zhang PC, 2013, CELL METAB, V17, P85, DOI 10.1016/j.cmet.2012.12.013; Zhang XC, 2011, P NATL ACAD SCI USA, V108, P17997, DOI 10.1073/pnas.1105982108; Zisoulis DG, 2011, METHODS MOL BIOL, V732, P169, DOI 10.1007/978-1-61779-083-6_13	116	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142262	10.1371/journal.pone.0142262	http://dx.doi.org/10.1371/journal.pone.0142262			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26554708	gold, Green Published, Green Submitted			2022-12-27	WOS:000364430700076
J	Hoare, S; Morris, ZS; Kelly, MP; Kuhn, I; Barclay, S				Hoare, Sarah; Morris, Zoe Slote; Kelly, Michael P.; Kuhn, Isla; Barclay, Stephen			Do Patients Want to Die at Home? A Systematic Review of the UK Literature, Focused on Missing Preferences for Place of Death	PLOS ONE			English	Article							SPECIALIST PALLIATIVE CARE; PREFERRED PLACE; GLOBAL BURDEN; END; CANCER; ENGLAND; DISEASE; LIFE	Background End-of-life care policy has a focus on enabling patients to die in their preferred place; this is believed for most to be home. This review assesses patient preferences for place of death examining: the extent of unreported preferences, the importance of patient factors (place of care and health diagnosis) and who reports preferences. Methods and Findings Systematic literature review of 7 electronic databases, grey literature, backwards citations from included studies and Palliative Medicine hand search. Included studies published between 2000-2015, reporting original, quantifiable results of adult UK preferences for place of death. Of 10826 articles reviewed, 61 met the inclusion criteria. Summary charts present preferences for place of death by health diagnosis, where patients were asked and who reported the preference. These charts are recalculated to include 'missing data,' the views of those whose preferences were not asked, expressed or reported or absent in studies. Missing data were common. Across all health conditions when missing data were excluded the majority preference was for home: when missing data were included, it was not known what proportion of patients with cancer, non-cancer or multiple conditions preferred home. Patients, family proxies and public all expressed a majority preference for home when missing data were excluded: when included, it was not known what proportion of patients or family proxies preferred home. Where patients wished to die was related to where they were asked their preference. Missing data calculations are limited to 'reported' data. Conclusions It is unknown what proportion of patients prefers to die at home or elsewhere. Reported preferences for place of death often exclude the views of those with no preference or not asked: when 'missing data' are included, they supress the proportion of preferences for all locations. Caution should be exercised if asserting that most patients prefer to die at home.	[Hoare, Sarah; Morris, Zoe Slote; Kelly, Michael P.; Barclay, Stephen] Univ Cambridge, Sch Clin Med, Dept Publ Hlth & Primary Care, Primary Care Unit,Cambridge Inst Publ Hlth, Forvie Site,Cambridge Biomedical Campus, Cambridge, England; [Kuhn, Isla] Univ Cambridge, Med Lib, Sch Clin Med, Cambridge, England	University of Cambridge; University of Cambridge	Hoare, S (corresponding author), Univ Cambridge, Sch Clin Med, Dept Publ Hlth & Primary Care, Primary Care Unit,Cambridge Inst Publ Hlth, Forvie Site,Cambridge Biomedical Campus, Cambridge, England.	seh91@medschl.cam.ac.uk	Hoare, Sarah/AAE-4153-2019; Kuhn, Isla L/J-6753-2012	Hoare, Sarah/0000-0002-8933-217X; Kuhn, Isla/0000-0002-2879-4020	National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research AMP; Care (CLAHRC) East of England, at Cambridgeshire; Peterborough NHS Foundation Trust [RG74481]	National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research AMP; Care (CLAHRC) East of England, at Cambridgeshire(National Institute for Health Research (NIHR)); Peterborough NHS Foundation Trust	This research was funded by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research & Care (CLAHRC) East of England, at Cambridgeshire and Peterborough NHS Foundation Trust, grant number RG74481 http://www.clahrc-eoe.nihr.ac.uk/ for SB. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The NIHR had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addington-Hall J, 2001, J PAIN SYMPTOM MANAG, V22, P784, DOI 10.1016/S0885-3924(01)00330-X; [Anonymous], 2010, GOOD DEATH TIM THINK; Ashton S, 2013, JDC, V21, P28; Bajwah S, 2012, LUNG, V190, P215, DOI 10.1007/s00408-011-9355-7; Barclay S, 2010, BMJ, P341, DOI 10.1136/bmjspcare-2012-000338; Barclay S, 2010, BMJ, V341; Barclay S, 2009, BRIT J GEN PRACT, V59, P642, DOI 10.3399/bjgp09X454052; Bruni C, 2010, 8 PALL CAR C 10 12 M, P226; Capel M, 2012, BMJ SUPPORT PALLIAT, V2, P43, DOI 10.1136/bmjspcare-2011-000097; Cox K, 2011, BMC PALLIAT CARE, V10, DOI 10.1186/1472-684X-10-18; Department of Health, 2012, END LIF CAR STRAT 4; Department of Health, 2012, 1 NAT VOICES SURV BE; Department of Health, 2013, NHS OUTC FRAM 2014 1; Department of Health, 2008, END LIF CAR STRAT PR; Evans R, 2014, INT J PALLIAT NURS, V20, P579, DOI 10.12968/ijpn.2014.20.12.579; Gandy R, 2010, J CARE SERV MANAG, V4, P321, DOI [10.1179/175016810X12773688140464, DOI 10.1179/175016810X12773688140464]; Gerrard R, 2011, PALLIATIVE MED, V25, P333, DOI 10.1177/0269216310387459; Gomes B, 2012, ANN ONCOL, V23, P2006, DOI 10.1093/annonc/mdr602; Gomes B., 2011, LOCAL PREFERENCES PL; Gomes B, 2013, BMC PALLIAT CARE, V12, DOI 10.1186/1472-684X-12-7; Gott M, 2004, PALLIATIVE MED, V18, P460, DOI 10.1191/0269216304pm889oa; Gough D., 2007, RES PAP EDUC, V22, P213; Hanratty B, 2012, J PAIN SYMPTOM MANAG, V44, P74, DOI 10.1016/j.jpainsymman.2011.08.006; Higginson I J, 2000, J Palliat Med, V3, P287, DOI 10.1089/jpm.2000.3.287; Higginson IJ, 2010, 6 RES C EAPC JUN 10, pS188; Higginson IJ, 2003, PRIORITIES PREFERENC; Higginson IJ, 2010, PALLIATIVE MED, V24, P352, DOI 10.1177/0269216309360489; Holdsworth L, 2010, INT J PALLIAT NURS, V16, P424, DOI 10.12968/ijpn.2010.16.9.78634; Hunt KJ, 2014, J PALLIAT MED, V17, P176, DOI 10.1089/jpm.2013.0385; Johnson M, 2012, BR J CARDIOL, V19, P71, DOI DOI 10.5837/BJC.2012.014; Johnson S, 2010, PREFERRED PRIORITIES; King G, 2000, Int J Palliat Nurs, V6, P280; Lehman R, 2012, BRIT MED J, V344, DOI 10.1136/bmj.d8158; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; McCall K, 2005, INT J PALLIAT NURS, V11, P541, DOI 10.12968/ijpn.2005.11.10.19983; McKeown A, 2008, INT J PALLIAT NURS, V14, P454, DOI 10.12968/ijpn.2008.14.9.31126; Munday D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2391; National Institute for Health and Clinical Excellence (NICE), 2011, GUID COMM END LIF CA; Newton J, REPORT PREFERRED PLA; Office for National Statistics, 2012, NAT BER SURV VOICES; Oxenham David, 2013, BMJ Qual Improv Rep, V2, DOI 10.1136/bmjquality.u201375.w897; Pollock K, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4855; Shipman C, 2008, BMJ; Thomas C, 2004, SOC SCI MED, V58, P2431, DOI 10.1016/j.socscimed.2003.09.005; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Waghorn Melanie, 2011, BMJ Support Palliat Care, V1, P310, DOI 10.1136/bmjspcare-2011-000041; Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X; Wood CD., 2013, TIME PLACE WHAT PEOP	48	79	80	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142723	10.1371/journal.pone.0142723	http://dx.doi.org/10.1371/journal.pone.0142723			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555077	Green Published, gold, Green Submitted			2022-12-27	WOS:000364430700159
J	Katsaros, KM; Speidl, WS; Demyanets, S; Kastl, SP; Krychtiuk, KA; Wonnerth, A; Zorn, G; Tentzeris, L; Farhan, S; Maurer, G; Wojta, J; Huber, K				Katsaros, Katharina M.; Speidl, Walter S.; Demyanets, Svitlana; Kastl, Stefan P.; Krychtiuk, Konstantin A.; Wonnerth, Anna; Zorn, Gerlinde; Tentzeris, Loannis; Farhan, Serdar; Maurer, Gerald; Wojta, Johann; Huber, Kurt			G-CSF Predicts Cardiovascular Events in Patients with Stable Coronary Artery Disease	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; SMOOTH-MUSCLE-CELLS; NEOINTIMAL FORMATION; STEM-CELLS; PACLITAXEL; ATHEROSCLEROSIS; INFLAMMATION; NEUTROPHILS; ARREST	Granulocyte-colony-stimulating-factor (G-CSF) induces mobilization of progenitor cells but may also exert pro-inflammatory and pro-thrombotic effects. Treatment with recombinant G-CSF after acute myocardial infarction is currently under examination and has been associated with in-stent restenosis. However, it is not known whether plasma levels of endogenous G-CSF are also associated with an increased cardiovascular risk. Therefore we included 280 patients with angiographically proven stable coronary artery disease. G-CSF was measured by specific ELISA and patients were followed for a median of 30 months for the occurrence of major adverse cardiovascular events (MACE: death, myocardial infarction, re-hospitalization). Those with cardiac events during follow-up showed significant higher G-CSF levels (32.3 pg/mL IQR 21.4-40.5 pg/mL vs. 24.6 pg/mL IQR 16.4-34.9 pg/mL; p<0.05) at baseline. Patients with G-CSF plasma levels above the median had a 2-fold increased risk for MACE (p< 0.05). This was independent from established cardiovascular risk factors. In addition, G-CSF above the median was a predictor of clinical in-stent restenosis after implantation of bare-metal stents (6.6% vs. 19.4%; p< 0.05) but not of drug-eluting stents (7.7% vs. 7.6%; p = 0.98). This data suggests that endogenous plasma levels of G-CSF predict cardiovascular events independently from established cardiac risk factors and are associated with increased in-stent restenosis rates after implantation of bare metal stents.	[Katsaros, Katharina M.; Speidl, Walter S.; Demyanets, Svitlana; Kastl, Stefan P.; Krychtiuk, Konstantin A.; Wonnerth, Anna; Zorn, Gerlinde; Maurer, Gerald; Wojta, Johann] Med Univ Vienna, Dept Internal Med 2, Vienna, Austria; [Katsaros, Katharina M.; Kastl, Stefan P.; Krychtiuk, Konstantin A.; Wojta, Johann] Ludwig Boltzmann Cluster Cardiovasc Res, Vienna, Austria; [Tentzeris, Loannis; Farhan, Serdar; Huber, Kurt] Wilhelminenhosp, Cardiol & Intens Care Med, Dept Med 3, Vienna, Austria	Medical University of Vienna; Ludwig Boltzmann Institute; Wilhelminenspital	Wojta, J (corresponding author), Med Univ Vienna, Dept Internal Med 2, Vienna, Austria.	johann.wojta@meduniwien.ac.at	Speidl, Walter S./AAU-8830-2020; Kastl, Stefan P/B-2695-2009; Wojta, Johann/AAC-8433-2020	Speidl, Walter S./0000-0002-7267-3138; Kastl, Stefan P/0000-0002-9682-0200; Wojta, Johann/0000-0002-1282-9276; Krychtiuk, Konstantin/0000-0001-7792-2837; Maurer, Gerald/0000-0002-9043-7657	Ludwig Boltzmann Cluster for Cardiovascular Research; Association for the Promotion of Research in Arteriosclerosis, Thrombosis and Vascular Biology	Ludwig Boltzmann Cluster for Cardiovascular Research; Association for the Promotion of Research in Arteriosclerosis, Thrombosis and Vascular Biology	Funding: KMK, SPK, MK, and JW received funding from the Ludwig Boltzmann Cluster for Cardiovascular Research; KMK, SPK, and MK received funding from the Association for the Promotion of Research in Arteriosclerosis, Thrombosis and Vascular Biology.	Baetta R, 2010, ATHEROSCLEROSIS, V210, P1, DOI 10.1016/j.atherosclerosis.2009.10.028; Blagosklonny MV, 2006, CELL CYCLE, V5, P1574, DOI 10.4161/cc.5.14.3113; Blagosklonny MV, 2004, CELL CYCLE, V3, P1050; Chen X, 2004, ARTERIOSCL THROM VAS, V24, P1217, DOI 10.1161/01.ATV.0000130024.50058.de; Clever YP, 2011, EUROINTERVENTION, V7, pK32, DOI 10.4244/EIJV7SKA6; Deshpande D, 2008, PHARM RES-DORDR, V25, P1936, DOI 10.1007/s11095-008-9614-3; Di Gregoli K, 2012, CURR OPIN LIPIDOL, V23, P412, DOI 10.1097/MOL.0b013e328357ca6e; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; Falanga A, 1999, BLOOD, V93, P2506, DOI 10.1182/blood.V93.8.2506.408k31_2506_2514; Guasti L, 2011, THROMB HAEMOSTASIS, V106, P591, DOI 10.1160/TH11-02-0096; Haghighat A, 2007, CIRCULATION, V115, P2049, DOI 10.1161/CIRCULATIONAHA.106.665570; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Hasegawa H, 2006, BIOCHEM BIOPH RES CO, V344, P370, DOI 10.1016/j.bbrc.2006.03.081; Kang HJ, 2004, LANCET, V363, P751, DOI 10.1016/S0140-6736(04)15689-4; Krychtiuk KA, 2013, HAMOSTASEOLOGIE, V33, P269, DOI 10.5482/HAMO-13-07-0039; Mansour S, 2006, J AM COLL CARDIOL, V47, P1727, DOI 10.1016/j.jacc.2006.01.039; Marino F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124565; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; Steinwender C, 2006, AM HEART J, V151, DOI 10.1016/j.ahj.2006.03.012; Thygesen K, 2012, EUR HEART J, V33, P2551, DOI 10.1093/eurheartj/ehs184; Uchiyama R, 2012, J MOL CELL CARDIOL, V52, P1038, DOI 10.1016/j.yjmcc.2011.12.016; Yoshioka T, 2006, CARDIOVASC RES, V70, P61, DOI 10.1016/j.cardiores.2005.12.013; Zohlnhofer D, 2008, J AM COLL CARDIOL, V51, P1429, DOI 10.1016/j.jacc.2007.11.073	23	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142532	10.1371/journal.pone.0142532	http://dx.doi.org/10.1371/journal.pone.0142532			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555480	Green Published, Green Submitted, gold			2022-12-27	WOS:000364430700123
J	Lee, JH; Park, KM; Han, DJ; Bang, NY; Kim, DH; Na, H; Lim, S; Kim, TB; Kim, DG; Kim, HJ; Chung, Y; Sung, SH; Surh, YJ; Kim, S; Han, BW				Lee, Ji-Hyun; Park, Kyoung Mii; Han, Dong-Jin; Bang, Nam Young; Kim, Do-Hee; Na, Hyeongjin; Lim, Semi; Kim, Tae Bum; Kim, Dae Gyu; Kim, Hyun-Jung; Chung, Yeonseok; Sung, Sang Hyun; Surh, Young-Joon; Kim, Sunghoon; Han, Byung Woo			PharmDB-K: Integrated Bio-Pharmacological Network Database for Traditional Korean Medicine	PLOS ONE			English	Article							NF-KAPPA-B; COX-2 EXPRESSION; CHINESE MEDICINE; INFORMATION; UPDATE; SCHIZANDRIN; MECHANISM; RESOURCE; CANCER; CELLS	Despite the growing attention given to Traditional Medicine (TM) worldwide, there is no wellknown, publicly available, integrated bio-pharmacological Traditional Korean Medicine (TKM) database for researchers in drug discovery. In this study, we have constructed PharmDB-K, which offers comprehensive information relating to TKM-associated drugs (compound), disease indication, and protein relationships. To explore the underlying molecular interaction of TKM, we integrated fourteen different databases, six Pharmacopoeias, and literature, and established a massive bio-pharmacological network for TKM and experimentally validated some cases predicted from the PharmDB-K analyses. Currently, PharmDB-K contains information about 262 TKMs, 7,815 drugs, 3,721 diseases, 32,373 proteins, and 1,887 side effects. One of the unique sets of information in PharmDB-K includes 400 indicator compounds used for standardization of herbal medicine. Furthermore, we are operating PharmDB-K via phExplorer (a network visualization software) and BioMart (a data federation framework) for convenient search and analysis of the TKM network. Database URL: http://pharmdb-k.org, http://biomart.i-pharm.org.	[Lee, Ji-Hyun; Han, Dong-Jin; Bang, Nam Young; Lim, Semi; Kim, Dae Gyu; Kim, Sunghoon] Seoul Natl Univ, Med Bioconvergence Res Ctr, Seoul 152742, South Korea; [Lee, Ji-Hyun; Park, Kyoung Mii; Kim, Do-Hee; Na, Hyeongjin; Kim, Tae Bum; Chung, Yeonseok; Sung, Sang Hyun; Surh, Young-Joon; Han, Byung Woo] Seoul Natl Univ, Pharmaceut Sci Res Inst, Coll Pharm, Seoul 151742, South Korea; [Lee, Ji-Hyun; Park, Kyoung Mii; Han, Byung Woo] Seoul Natl Univ, Informat Ctr Biopharmacol Network, Suwon 443270, South Korea; [Han, Dong-Jin; Bang, Nam Young; Kim, Sunghoon] Seoul Natl Univ, Dept Mol Med & Biopharmaceut Sci, Seoul 151742, South Korea; [Kim, Hyun-Jung] Chung Ang Univ, Coll Pharm, Seoul 156756, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Chung Ang University	Han, BW (corresponding author), Seoul Natl Univ, Pharmaceut Sci Res Inst, Coll Pharm, Seoul 151742, South Korea.	bwhan@snu.ac.kr	Kim, Sunghoon/AAE-8314-2020	kim, sunghoon/0000-0002-1570-3230	Basic Science Research Program - Ministry of Education; Ministry of Science, ICT and Future Planning through the National Research Foundation of Korea [NRF-2013R1A1A2058353, NRF-2013M3A6A4043695]	Basic Science Research Program - Ministry of Education; Ministry of Science, ICT and Future Planning through the National Research Foundation of Korea	This research was supported by the Basic Science Research Program funded by the Ministry of Education [JL] and Global Frontier Project funded by the Ministry of Science, ICT and Future Planning through the National Research Foundation of Korea [BH] (NRF-2013R1A1A2058353 and NRF-2013M3A6A4043695). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Administration KFaD, 2012, KOR PHARM; Administration KFaD, 2012, KOR HERB PHARM; [Anonymous], 2014, DEF DICT MED HERBS; [Anonymous], 2014, KOR TRAD KNOWL PORT; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Bolton E., 2008, PUBCHEM INTEGRATED P; Brown GR, 2015, NUCLEIC ACIDS RES, V43, pD36, DOI 10.1093/nar/gku1055; Chen CYC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015939; Chen X, 2006, BRIT J PHARMACOL, V149, P1092, DOI 10.1038/sj.bjp.0706945; Chung MH, 2014, MUTAT RES-FUND MOL M, V768, P74, DOI [10.1016/j.mrfmmm.2014.04.003, 1]; Commission CP, 2011, PHARMACOPOEIA PEOPLE; Commission DPsRoKP, 2011, PHARM DEM PEOPL REP; Davis AP, 2015, NUCLEIC ACIDS RES, V43, pD914, DOI 10.1093/nar/gku935; Fang XL, 2005, J MED CHEM, V48, P1481, DOI 10.1021/jm049838d; Fang YC, 2008, BMC COMPLEM ALTERN M, V8, DOI 10.1186/1472-6882-8-58; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Gunther S, 2008, NUCLEIC ACIDS RES, V36, pD919, DOI 10.1093/nar/gkm862; Jang ES, 2007, KOREAN J OREINTAL ME, V13, P143; Kanphaet TKW, 2009, HERBAL PHARMACOPOEIA; Kasprzyk A, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar049; Khan AQ, 2012, FOOD CHEM TOXICOL, V50, P175, DOI 10.1016/j.fct.2011.10.043; Kim HY, 2011, TOXICOLOGY, V282, P104, DOI 10.1016/j.tox.2011.01.017; Kim SJ, 2010, PHYTOTHER RES, V24, P193, DOI 10.1002/ptr.2907; Kuhn M, 2014, NUCLEIC ACIDS RES, V42, pD401, DOI 10.1093/nar/gkt1207; Kuhn M, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2009.98; Law V, 2014, NUCLEIC ACIDS RES, V42, pD1091, DOI 10.1093/nar/gkt1068; Lee B, 2007, BIOL PHARM BULL, V30, P1153, DOI 10.1248/bpb.30.1153; Lee HS, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-80; Lim E, 2010, NUCLEIC ACIDS RES, V38, pD781, DOI 10.1093/nar/gkp934; Liu YB, 2010, BIOINFORMATICS, V26, P587, DOI 10.1093/bioinformatics/btp697; Maglott D, 2011, NUCLEIC ACIDS RES, V39, pD52, DOI 10.1093/nar/gkq1237; Medicine M-NIoG, 2014, ONLINE MENDELIAN INH; Pharmaceutical Japan mdrsso, 2012, JAP PHARM ENGL VERS; Rahman S, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep076; ROGERS FB, 1963, B MED LIBR ASSOC, V51, P114; Ru JL, 2014, J CHEMINFORMATICS, V6, DOI 10.1186/1758-2946-6-13; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Shen JH, 2003, CURR MED CHEM, V10, P2327, DOI 10.2174/0929867033456729; Sohn SH, 2009, NEUROTOXICOLOGY, V30, P368, DOI 10.1016/j.neuro.2009.02.006; Xue RC, 2013, NUCLEIC ACIDS RES, V41, pD1089, DOI 10.1093/nar/gks1100; Yu R, 2006, J INT MED RES, V34, P231, DOI 10.1177/147323000603400301; Zanzoni A, 2002, FEBS LETT, V513, P135, DOI 10.1016/S0014-5793(01)03293-8; Zhu F, 2012, NUCLEIC ACIDS RES, V40, pD1128, DOI 10.1093/nar/gkr797	43	9	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142624	10.1371/journal.pone.0142624	http://dx.doi.org/10.1371/journal.pone.0142624			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555441	gold, Green Published, Green Submitted			2022-12-27	WOS:000364430700143
J	Robinson, JE; St John, FAV; Griffiths, RA; Roberts, DL				Robinson, Janine E.; St John, Freya A. V.; Griffiths, Richard A.; Roberts, David L.			Captive Reptile Mortality Rates in the Home and Implications for the Wildlife Trade	PLOS ONE			English	Article							TORTOISES TESTUDO-GRAECA; RANDOMIZED-RESPONSE; UNITED-KINGDOM; LIFE-HISTORY; GLOBAL TRADE; CONSERVATION; MADAGASCAR; BIAS; CONSUMPTION; POPULATION	The trade in wildlife and keeping of exotic pets is subject to varying levels of national and international regulation and is a topic often attracting controversy. Reptiles are popular exotic pets and comprise a substantial component of the live animal trade. High mortality of traded animals raises welfare concerns, and also has implications for conservation if collection from the wild is required to meet demand. Mortality of reptiles can occur at any stage of the trade chain from collector to consumer. However, there is limited information on mortality rates of reptiles across trade chains, particularly amongst final consumers in the home. We investigated mortality rates of reptiles amongst consumers using a specialised technique for asking sensitive questions, additive Randomised Response Technique (aRRT), as well as direct questioning (DQ). Overall, 3.6% of snakes, chelonians and lizards died within one year of acquisition. Boas and pythons had the lowest reported mortality rates of 1.9% and chameleons had the highest at 28.2%. More than 97% of snakes, 87% of lizards and 69% of chelonians acquired by respondents over five years were reported to be captive bred and results suggest that mortality rates may be lowest for captive bred individuals. Estimates of mortality from aRRT and DQ did not differ significantly which is in line with our findings that respondents did not find questions about reptile mortality to be sensitive. This research suggests that captive reptile mortality in the home is rather low, and identifies those taxa where further effort could be made to reduce mortality rates.	[Robinson, Janine E.; St John, Freya A. V.; Griffiths, Richard A.; Roberts, David L.] Univ Kent, Durrell Inst Conservat & Ecol, Sch Anthropol & Conservat, Canterbury CT2 7NR, Kent, England	University of Kent	Robinson, JE (corresponding author), Univ Kent, Durrell Inst Conservat & Ecol, Sch Anthropol & Conservat, Canterbury CT2 7NR, Kent, England.	jr418@kent.ac.uk; D.L.Roberts@kent.ac.uk	Robinson, Janine/AAM-6714-2021	Roberts, David/0000-0001-6788-2691; Robinson, Janine/0000-0002-1207-0001	University of Kent	University of Kent	JER was funded through a University of Kent 50th Anniversary Scholarship. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. FAVSJ, RAG and DLR received no specific funding for this work.	Anderson L, 2013, NORWAY SAYS NO WAY P; Andreone F, 2005, TROP ZOOL, V18, P209, DOI 10.1080/03946975.2005.10531221; Ashley S, 2014, J APPL ANIM WELF SCI, V17, P308, DOI 10.1080/10888705.2014.918511; Auliya M., 2003, HOT TRADE COOL CREAT; Baker SE, 2013, BIOSCIENCE, V63, P928, DOI 10.1525/bio.2013.63.12.6; Bartlett RD, 2006, BARRONS ED SERIES; BBC, 2015, EX PET RUL BE REV SC; BBC, 2014, 100S DEAD AN FOUND S; Bustard R, 1989, BRIT HERPETOLOGICAL, P27; CABI, 2014, NORW RET BAN REPT AM; Check E, 2004, NATURE, V427, P277, DOI 10.1038/427277a; Chomel BB, 2007, EMERG INFECT DIS, V13, P6, DOI 10.3201/eid1301.060480; CITES, 2013, CONV INT TRAD END SP; Clark B., 2013, REPORT LOOKING REPTI; de Volder S, 2013, ANAL NATL LEGISLATIO; Engler M., 2007, OPPORTUNITY THREAT R; EUARK, 2012, REPT AMPH COMP AN; Europe GN, 2014, 100S REPT FOUND DEAD; Gordon I., 2003, Journal of Environment & Development, V12, P82, DOI 10.1177/1070496502250439; Gupta S, 2013, AM J MATH MANAGEMENT, V22, P369; Hailey A, 2000, ANIM CONSERV, V3, P185, DOI 10.1111/j.1469-1795.2000.tb00102.x; Herrel A, 2014, HERPETOL J, V24, P103; Hoover C, 1998, US ROLE INT LIVE REP; Hutton J, 2003, TRADE IN WILDLIFE: REGULATION FOR CONSERVATION, P108; John FAVS, 2010, BIOL CONSERV, V143, P1025, DOI 10.1016/j.biocon.2010.01.018; Karsten KB, 2008, P NATL ACAD SCI USA, V105, P8980, DOI 10.1073/pnas.0802468105; Katz EM, HERPETOLOGICAL J, V23, P179; King MF, 2000, PSYCHOL MARKET, V17, P79, DOI 10.1002/(SICI)1520-6793(200002)17:2<79::AID-MAR2>3.0.CO;2-0; Lahaut VMHCJ, 2002, ALCOHOL ALCOHOLISM, V37, P256, DOI 10.1093/alcalc/37.3.256; LAWRENCE K, 1987, BRIT VET J, V143, P432, DOI 10.1016/0007-1935(87)90020-0; LAWRENCE K, 1988, BRIT VET J, V144, P187, DOI 10.1016/0007-1935(88)90052-8; LAWRENCE K, 1987, BRIT VET J, V143, P567, DOI 10.1016/0007-1935(87)90048-0; Lensvelt-Mulders GJLM, 2005, SOCIOL METHOD RES, V33, P319, DOI 10.1177/0049124104268664; Lyons JA, 2011, BIOL CONSERV, V144, P3073, DOI 10.1016/j.biocon.2011.10.002; Masin S, 2014, BIOL INVASIONS, V16, P217, DOI 10.1007/s10530-013-0515-y; New John C. Jr, 2004, Journal of Applied Animal Welfare Science, V7, P229, DOI 10.1207/s15327604jaws0704_1; Nuno A, 2015, BIOL CONSERV, V189, P5, DOI 10.1016/j.biocon.2014.09.047; O'Brien S, 2003, ORYX, V37, P338, DOI 10.1017/S0030605303000590; Pike DA, 2008, ECOLOGY, V89, P607, DOI 10.1890/06-2162.1; POLLOCK KH, 1976, J AM STAT ASSOC, V71, P884, DOI 10.2307/2286855; Prance G, 2011, CONDUCTING RESEARCH IN CONSERVATION: SOCIAL SCIENCE METHODS AND PRACTICE, P65; Razafimanahaka JH, 2012, ORYX, V46, P584, DOI 10.1017/S0030605312000579; Robinson JE, 2015, BIOL CONSERV, V184, P42, DOI 10.1016/j.biocon.2014.12.019; Scharf I, 2015, GLOBAL ECOL BIOGEOGR, V24, P396, DOI 10.1111/geb.12244; Schutz C, 2003, BFN SKRIPTEN, P90; Shi HT, 2007, CONSERV BIOL, V21, P5, DOI 10.1111/j.1523-1739.2006.00622_2.x; Smart AC, 1993, UK TRADE LIVE REPTIL; Tacutu R, 2013, NUCLEIC ACIDS RES, V41, pD1027, DOI 10.1093/nar/gks1155; Toland E, 2012, BIOLOGIST, V59, P14; U.S. Fish and Wildlife Service (USFWS), 2012, FED REG, V77; WARNER SL, 1965, J AM STAT ASSOC, V60, P63, DOI 10.2307/2283137; Warwick C., 2014, Journal of Animal Ethics, V4, P74, DOI 10.5406/janimalethics.4.1.0074; Webb JK, 2002, ORYX, V36, P170, DOI 10.1017/S0030605302000248	53	26	26	1	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0141460	10.1371/journal.pone.0141460	http://dx.doi.org/10.1371/journal.pone.0141460			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556237	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000364430700029
J	Yang, XL; Liu, L; Shi, YY; Li, YS; Tan, XY; Hu, XM; Sun, XM				Yang, Xiao-li; Liu, Li; Shi, Yuan-yuan; Li, Yong-shuai; Tan, Xuyun; Hu, Xiao-meng; Sun, Xiao-min			The Relationship between Cultural Anxiety and Ethnic Essentialism: The Mediating Role of an Endorsement of Multicultural Ideology	PLoS One			English	Article							PSYCHOLOGICAL ESSENTIALISM; IDENTIFICATION	Many studies have explored the social consequences of ethnic essentialism in recent decades. In addition, a few studies have focused on the impact of perceived cultural context on ethnic essentialism. However, it is not clear why perceived cultural context can lead to changes in ethnic essentialism. In the present study, we hypothesized that the cultural anxiety of ethnic minorities may trigger a strong endorsement of and support for a multicultural ideology, thereby affecting beliefs about ethnic groups. To address the issue, 226 Tibetan and 102 Hui college students from Mainland China completed our questionnaires. The results across the two samples showed that (1) cultural anxiety was positively associated with both the endorsement of a multicultural ideology and ethnic essentialism, (2) cultural anxiety and the endorsement of a multicultural ideology positively predicted ethnic essentialism after controlling for demographic variables, and (3) cultural anxiety had both a direct effect on ethnic essentialism and an indirect effect on ethnic essentialism through the endorsement of a multicultural ideology. Our findings suggest that when ethnic minorities experience cultural anxiety, they might endorse a multicultural ideology and adopt essentialism to affirm their ethnic identities.	[Yang, Xiao-li] Northwest Normal Univ, Res Ctr Educ Dev Minor, Sch Psychol, Lanzhou, Peoples R China; [Liu, Li; Shi, Yuan-yuan; Li, Yong-shuai; Tan, Xuyun; Sun, Xiao-min] Beijing Normal Univ, Sch Psychol, Beijing 100875, Peoples R China; [Hu, Xiao-meng] Rutgers State Univ, Dept Psychol, New Brunswick, NJ 08903 USA	Northwest Normal University - China; Beijing Normal University; Rutgers State University New Brunswick	Yang, XL (corresponding author), Northwest Normal Univ, Res Ctr Educ Dev Minor, Sch Psychol, Lanzhou, Peoples R China.	yangxiaolianny@126.com; l.liu@bnu.edu.cn	Liu, Li/T-6645-2017	Liu, Li/0000-0002-4898-3013; Tan, Xuyun/0000-0001-5734-2878	National Social Science Foundation of China [14CSH037]; Humanities and Social Science Foundation of Ministry of Education of China [13JYC190027]; Planning Projects for Education Science of Gansu Province [GS[2014]GHBZ015]; National Natural Science Foundation of China [71071021]	National Social Science Foundation of China; Humanities and Social Science Foundation of Ministry of Education of China(Ministry of Education, China); Planning Projects for Education Science of Gansu Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Social Science Foundation of China (14CSH037), Humanities and Social Science Foundation of Ministry of Education of China (13JYC190027), and the Planning Projects for Education Science of Gansu Province (GS[2014]GHBZ015) awarded to Xiao-li Yang, and by the National Natural Science Foundation of China (71071021) awarded to Li Liu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew JH, 2011, PERSONALITY INDIVIDU, V50, P95; Bastian B, 2006, J EXP SOC PSYCHOL, V42, P228, DOI 10.1016/j.jesp.2005.03.003; Bastian B, 2007, J SOC PSYCHOL, V147, P531, DOI 10.3200/SOCP.147.5.531-542; BERRY JW, 1995, CAN J BEHAV SCI, V27, P301, DOI 10.1037/0008-400X.27.3.301; Chen SX, 2008, J PERS, V76, P804; [高承海 Gao Chenghai], 2013, [心理学报, Acta Psychologica Sinica], V45, P231; GAO GE, 1990, INT J INTERCULT REL, V14, P301, DOI 10.1016/0147-1767(90)90017-Q; Greenberg J, 1997, ADV EXP SOC PSYCHOL, V29, P61, DOI 10.1016/S0065-2601(08)60016-7; Grillo R.D., 2003, ANTHROPOL THEOR, V3, P157, DOI DOI 10.1177/1463499603003002002; Gudykunst BW, 1986, THEORIES INTERCULTUR, P123; Haslam N, 2006, GROUP PROCESS INTERG, V9, P63, DOI 10.1177/1368430206059861; Haslam N, 2000, BRIT J SOC PSYCHOL, V39, P113, DOI 10.1348/014466600164363; Keller J, 2005, J PERS SOC PSYCHOL, V88, P686, DOI 10.1037/0022-3514.88.4.686; MEDIN D, 1989, SIMILARITY AND ANALOGICAL REASONING, P179, DOI 10.1017/CBO9780511529863.009; Meng Y, 2013, CONT ED CULTURE, V5, P26; Morton TA, 2009, PERS SOC PSYCHOL B, V35, P656, DOI 10.1177/0146167208331254; No S, 2008, J PERS SOC PSYCHOL, V95, P91; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Rothbart M., 1992, LANGUAGE INTERACTION, P11; Sidanius J, 2004, POLIT PSYCHOL, V25, P845, DOI 10.1111/j.1467-9221.2004.00401.x; Tafel H, 1986, PSYCHOL INTERGROUP R, P7; Verkuyten M, 2004, EUR J SOC PSYCHOL, V34, P647, DOI 10.1002/ejsp.222; Verkuyten M, 2003, BRIT J SOC PSYCHOL, V42, P371, DOI 10.1348/014466603322438215; Verkuyten M, 2009, SOC JUSTICE RES, V22, P31, DOI 10.1007/s11211-008-0087-7; Williams MJ, 2008, J PERS SOC PSYCHOL, V94, P1033, DOI 10.1037/0022-3514.94.6.1033; Zhou GH, 2009, ETHNIC ARTS Q, V1, P88	26	3	3	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0141875	10.1371/journal.pone.0141875	http://dx.doi.org/10.1371/journal.pone.0141875			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7CT	26555505	Green Published, gold, Green Submitted			2022-12-27	WOS:000364430700043
J	Lin, CL; Fesi, BD; Marquis, M; Bosak, NP; Theodorides, ML; Avigdor, M; McDaniel, AH; Duke, FF; Lysenko, A; Khoshnevisan, A; Gantick, BR; Arayata, CJ; Nelson, TM; Bachmanov, AA; Reed, DR				Lin, Cailu; Fesi, Brad D.; Marquis, Michael; Bosak, Natalia P.; Theodorides, Maria L.; Avigdor, Mauricio; McDaniel, Amanda H.; Duke, Fujiko F.; Lysenko, Anna; Khoshnevisan, Amin; Gantick, Brian R.; Arayata, Charles J.; Nelson, Theodore M.; Bachmanov, Alexander A.; Reed, Danielle R.			Body Composition QTLs Identified in Intercross Populations Are Reproducible in Consomic Mouse Strains	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; GENOME-WIDE SET; GENETIC ARCHITECTURE; POSITIONAL CLONING; CANDIDATE GENES; COMPLEX TRAITS; OBESITY QTLS; C57BL/6J; MICE; ADIPOSITY	Genetic variation contributes to individual differences in obesity, but defining the exact relationships between naturally occurring genotypes and their effects on fatness remains elusive. As a step toward positional cloning of previously identified body composition quantitative trait loci (QTLs) from F-2 crosses of mice from the C57BL/6ByJ and 129P3/J inbred strains, we sought to recapture them on a homogenous genetic background of consomic (chromosome substitution) strains. Male and female mice from reciprocal consomic strains originating from the C57BL/6ByJ and 129P3/J strains were bred and measured for body weight, length, and adiposity. Chromosomes 2, 7, and 9 were selected for substitution because previous F2 intercross studies revealed body composition QTLs on these chromosomes. We considered a QTL confirmed if one or both sexes of one or both reciprocal consomic strains differed significantly from the host strain in the expected direction after correction for multiple testing. Using these criteria, we confirmed two of two QTLs for body weight (Bwq5-6), three of three QTLs for body length (Bdln3-5), and three of three QTLs for adiposity (Adip20, Adip26 and Adip27). Overall, this study shows that despite the biological complexity of body size and composition, most QTLs for these traits are preserved when transferred to consomic strains; in addition, studying reciprocal consomic strains of both sexes is useful in assessing the robustness of a particular QTL.	[Lin, Cailu; Fesi, Brad D.; Marquis, Michael; Bosak, Natalia P.; Theodorides, Maria L.; Avigdor, Mauricio; McDaniel, Amanda H.; Duke, Fujiko F.; Lysenko, Anna; Khoshnevisan, Amin; Gantick, Brian R.; Arayata, Charles J.; Nelson, Theodore M.; Bachmanov, Alexander A.; Reed, Danielle R.] Monell Chem Senses Ctr, Philadelphia, PA 19104 USA	Monell Chemical Senses Center	Reed, DR (corresponding author), Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA.	reed@monell.org	Bachmanov, Alexander A./AAH-8857-2020; Lin, Cailu/E-5316-2011	Bachmanov, Alexander A./0000-0002-2861-3322; Lin, Cailu/0000-0001-8909-7758	National Institutes of Health [DK094759, DK058797, AA011028, DC000882]; Monell Institutional Funds; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK094759, R01DK058797] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA011028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000882] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Monell Institutional Funds; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Funding: These studies were funded by the National Institutes of Health, DK094759, DK058797, AA011028, DC000882 and Monell Institutional Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; Bachmanov AA, 2001, PHYSIOL BEHAV, V72, P603, DOI 10.1016/S0031-9384(01)00412-7; Bachmanov AA, 2001, CHEM SENSES, V26, P925, DOI 10.1093/chemse/26.7.925; Bogue MA, 2004, GENETICA, V122, P71, DOI 10.1007/s10709-004-1438-4; Brockmann GA, 2000, GENOME RES, V10, P1941, DOI 10.1101/gr.GR1499R; Buchner DA, 2008, PHYSIOL GENOMICS, V35, P116, DOI 10.1152/physiolgenomics.00033.2008; Casellas J, 2009, MAMM GENOME, V20, P269, DOI 10.1007/s00335-009-9182-9; Cheverud JM, 2001, MAMM GENOME, V12, P3, DOI 10.1007/s003350010218; Collins FS, 2014, NATURE, V505, P612, DOI 10.1038/505612a; Crabbe JC, 1999, SCIENCE, V284, P1670, DOI 10.1126/science.284.5420.1670; Davis RC, 2005, GENOMICS, V86, P259, DOI 10.1016/j.ygeno.2005.05.010; Davis RC, 2007, GENOMICS, V90, P306, DOI 10.1016/j.ygeno.2007.05.009; Eppig JT, 2005, NUCLEIC ACIDS RES, V33, pD471, DOI 10.1093/nar/gki113; Farber CR, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2146-7-102; Fawcett GL, 2008, OBESITY, V16, P1861, DOI 10.1038/oby.2008.300; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; GODFREY P, 1993, NAT GENET, V4, P227, DOI 10.1038/ng0793-227; Gregorova S, 2008, GENOME RES, V18, P509, DOI 10.1101/gr.7160508; Gularte-Merida R, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-014-1191-8; Ishikawa A, 2007, MAMM GENOME, V18, P229, DOI 10.1007/s00335-007-9009-5; Ishimori N, 2006, J BONE MINER RES, V21, P105, DOI 10.1359/JBMR.050902; Ishimori N, 2004, J LIPID RES, V45, P1624, DOI 10.1194/jlr.M400098-JLR200; Jerez-Timaure NC, 2005, PHYSIOL GENOMICS, V21, P411, DOI 10.1152/physiolgenomics.00256.2004; Lin CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068776; Markel P, 1997, NAT GENET, V17, P280, DOI 10.1038/ng1197-280; McDaniel AH, 2006, MAMM GENOME, V17, P1078, DOI 10.1007/s00335-006-0055-1; Mollah MBR, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-84; Nadeau JH, 2000, NAT GENET, V24, P221, DOI 10.1038/73427; Reed DR, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-4; Reed DR, 2008, OBESITY, V16, P483, DOI 10.1038/oby.2007.26; Reed DR, 2007, PHYSIOL BEHAV, V91, P593, DOI 10.1016/j.physbeh.2007.03.026; Reed DR, 2006, MAMM GENOME, V17, P1065, DOI 10.1007/s00335-006-0054-2; Reed DR, 2011, PHYSIOL BEHAV, V103, P523, DOI 10.1016/j.physbeh.2011.04.006; Reed DR, 2003, MAMM GENOME, V14, P302, DOI 10.1007/s00335-002-2170-y; Shao HF, 2010, MAMM GENOME, V21, P276, DOI 10.1007/s00335-010-9267-5; Shao HF, 2008, P NATL ACAD SCI USA, V105, P19910, DOI 10.1073/pnas.0810388105; Silver Lee M., 1995; Singer JB, 2004, SCIENCE, V304, P445, DOI 10.1126/science.1093139; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; SNELL GD, 1948, J GENET, V49, P87, DOI 10.1007/BF02986826; Su Z, 2008, INT J OBESITY, V32, P1180, DOI 10.1038/ijo.2008.56; Su ZG, 2009, J LIPID RES, V50, P116, DOI 10.1194/jlr.M800411-JLR200; Takada T, 2008, GENOME RES, V18, P500, DOI 10.1101/gr.7175308; Taylor BA, 1999, MAMM GENOME, V10, P963, DOI 10.1007/s003359901141; Taylor BA, 1997, GENOMICS, V43, P249, DOI 10.1006/geno.1997.4835; Ussar S, 2015, CELL METAB, V22, P516, DOI 10.1016/j.cmet.2015.07.007; Wakeland E, 1997, IMMUNOL TODAY, V18, P472, DOI 10.1016/S0167-5699(97)01126-2; White JK, 2013, CELL, V154, P452, DOI 10.1016/j.cell.2013.06.022; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	49	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2015	10	11							e0141494	10.1371/journal.pone.0141494	http://dx.doi.org/10.1371/journal.pone.0141494			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7AC	26551037	Green Published, gold, Green Submitted			2022-12-27	WOS:000364422800005
J	Benavente, JN; Seeb, LW; Seeb, JE; Arismendi, I; Hernandez, CE; Gajardo, G; Galleguillos, R; Cadiz, MI; Musleh, SS; Gomez-Uchida, D				Benavente, Javiera N.; Seeb, Lisa W.; Seeb, James E.; Arismendi, Ivan; Hernandez, Cristian E.; Gajardo, Gonzalo; Galleguillos, Ricardo; Cadiz, Maria I.; Musleh, Selim S.; Gomez-Uchida, Daniel			Temporal Genetic Variance and Propagule-Driven Genetic Structure Characterize Naturalized Rainbow Trout (Oncorhynchus mykiss) from a Patagonian Lake Impacted by Trout Farming	PLOS ONE			English	Article							EFFECTIVE POPULATION-SIZE; SOUTHERN CHILE; LINKAGE DISEQUILIBRIUM; INVASIVE SALMONIDS; SOCKEYE-SALMON; NATIVE FISHES; DIVERSITY; PATTERNS; STABILITY; EVOLUTION	Knowledge about the genetic underpinnings of invasions-a theme addressed by invasion genetics as a discipline-is still scarce amid well documented ecological impacts of non-native species on ecosystems of Patagonia in South America. One of the most invasive species in Patagonia's freshwater systems and elsewhere is rainbow trout (Oncorhynchus mykiss). This species was introduced to Chile during the early twentieth century for stocking and promoting recreational fishing; during the late twentieth century was reintroduced for farming purposes and is now naturalized. We used population-and individual-based inference from single nucleotide polymorphisms (SNPs) to illuminate three objectives related to the establishment and naturalization of Rainbow Trout in Lake Llanquihue. This lake has been intensively used for trout farming during the last three decades. Our results emanate from samples collected from five inlet streams over two seasons, winter and spring. First, we found that significant intra- population (temporal) genetic variance was greater than inter-population (spatial) genetic variance, downplaying the importance of spatial divergence during the process of naturalization. Allele frequency differences between cohorts, consistent with variation in fish length between spring and winter collections, might explain temporal genetic differences. Second, individual-based Bayesian clustering suggested that genetic structure within Lake Llanquihue was largely driven by putative farm propagules found at one single stream during spring, but not in winter. This suggests that farm brood-stock might migrate upstream to breed during spring at that particular stream. It is unclear whether interbreeding has occurred between "pure" naturalized and farm trout in this and other streams. Third, estimates of the annual number of breeders (N-b) were below 73 in half of the collections, suggestive of genetically small and recently founded populations that might experience substantial genetic drift. Our results reinforce the notion that naturalized trout originated recently from a small yet genetically diverse source and that farm propagules might have played a significant role in the invasion of Rainbow Trout within a single lake with intensive trout farming. Our results also argue for proficient mitigation measures that include management of escapes and strategies to minimize unintentional releases from farm facilities.	[Benavente, Javiera N.; Hernandez, Cristian E.; Cadiz, Maria I.; Musleh, Selim S.; Gomez-Uchida, Daniel] Univ Concepcion, Dept Zool, Concepcion, Chile; [Seeb, Lisa W.; Seeb, James E.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Arismendi, Ivan] Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA; [Gajardo, Gonzalo] Univ Los Lagos, Lab Genet Acuicultura & Biodiversidad, Osorno, Chile; [Galleguillos, Ricardo; Musleh, Selim S.] Univ Concepcion, Dept Oceanog, Concepcion, Chile; [Cadiz, Maria I.; Gomez-Uchida, Daniel] Univ Concepcion, Interdisciplinary Ctr Aquaculture Res INCAR, Concepcion, Chile	Universidad de Concepcion; University of Washington; University of Washington Seattle; Oregon State University; Universidad de Los Lagos; Universidad de Concepcion; Universidad de Concepcion	Gomez-Uchida, D (corresponding author), Univ Concepcion, Dept Zool, Casilla 160-C, Concepcion, Chile.	dgomezu@udec.cl	G., Gonzalo Gajardo/H-6104-2019; Hernández, Cristián E./GLS-1111-2022; Arismendi, Ivan/B-3144-2010; Gajardo, Gonzalo/AAN-3507-2020; Seeb, Lisa W/GSN-3076-2022; Gomez-Uchida, Daniel/AAB-7043-2019; Hernández, Cristián E./AAS-1286-2020	Hernández, Cristián E./0000-0002-9811-2881; Arismendi, Ivan/0000-0002-8774-9350; Gajardo, Gonzalo/0000-0001-8634-141X; Gomez-Uchida, Daniel/0000-0002-5150-2030; Hernández, Cristián E./0000-0002-9811-2881; Benavente, Javiera/0000-0001-7045-1171	Fondo de Desarrollo Cientifico y Tecnologico, FONDECYT [1130807]; Fondo de Desarrollo de Areas Prioritarias, FONDAP [15110027]; Direccion de Investigacion Universidad de Concepcion, DIUC [212.113.082-1.0]	Fondo de Desarrollo Cientifico y Tecnologico, FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Fondo de Desarrollo de Areas Prioritarias, FONDAP(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP); Direccion de Investigacion Universidad de Concepcion, DIUC	This work was supported by the Fondo de Desarrollo Cientifico y Tecnologico, FONDECYT 1130807, Fondo de Desarrollo de Areas Prioritarias, FONDAP 15110027, and Direccion de Investigacion Universidad de Concepcion, DIUC 212.113.082-1.0.	Allendorf FW, 2003, CONSERV BIOL, V17, P24, DOI 10.1046/j.1523-1739.2003.02365.x; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 2015, BBC NEWS; Arismendi I, 2014, REV FISH BIOL FISHER, V24, P919, DOI 10.1007/s11160-014-9351-0; Arismendi I, 2011, ANN LIMNOL-INT J LIM, V47, P133, DOI 10.1051/limn/2011012; Arismendi I, 2009, FRESHWATER BIOL, V54, P1135, DOI 10.1111/j.1365-2427.2008.02157.x; Barrett SCH, 2015, MOL ECOL, V24, P1927, DOI 10.1111/mec.13014; Basulto S., 2003, LARGO VIAJE SALMONES; Becker LA, 2007, CONSERV BIOL, V21, P1347, DOI 10.1111/j.1523-1739.2007.00761.x; Berthelot C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4657; Blankenship SM, 2009, T AM FISH SOC, V138, P1052, DOI 10.1577/T08-165.1; Buschmann AH, 2009, OCEAN COAST MANAGE, V52, P243, DOI 10.1016/j.ocecoaman.2009.03.002; Campos H, 1988, ARCH HYDROBIOL S, V81, P37; Consuegra S, 2011, EVOL APPL, V4, P660, DOI 10.1111/j.1752-4571.2011.00189.x; Correa C, 2012, ECOL APPL, V22, P828, DOI 10.1890/11-1174.1; De Leaniz CG, 2010, SYST BIODIVERS, V8, P447, DOI 10.1080/14772000.2010.537706; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Falush D, 2003, GENETICS, V164, P1567; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Frankham R, 2010, BIOL CONSERV, V143, P1919, DOI 10.1016/j.biocon.2010.05.011; Fraser EJ, 2013, BIOL CONSERV, V167, P35, DOI 10.1016/j.biocon.2013.07.011; Garcia Alvarado M., 2008, BASES TECNICAS PARAE; Garcia-Berthou E, 2007, J FISH BIOL, V71, P33, DOI 10.1111/j.1095-8649.2007.01668.x; Glover KA, 2010, AQUACULT ENV INTERAC, V1, P1, DOI 10.3354/aei00002; Gomez-Uchida D, 2012, CAN J FISH AQUAT SCI, V69, P916, DOI 10.1139/F2012-029; Gomez-Uchida D, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-48; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Habit E, 2012, DIVERS DISTRIB, V18, P1153, DOI 10.1111/j.1472-4642.2012.00906.x; Habit E, 2010, GLOBAL ECOL BIOGEOGR, V19, P697, DOI 10.1111/j.1466-8238.2010.00541.x; Hanfling B, 2007, J FISH BIOL, V71, P115, DOI 10.1111/j.1095-8649.2007.01685.x; Hansen MM, 2002, MOL ECOL, V11, P2523, DOI 10.1046/j.1365-294X.2002.01634.x; Heath DD, 2002, MOL ECOL, V11, P197, DOI 10.1046/j.1365-294X.2002.01434.x; Helyar SJ, 2011, MOL ECOL RESOUR, V11, P123, DOI 10.1111/j.1755-0998.2010.02943.x; Hendry AP, 2000, SCIENCE, V290, P516, DOI 10.1126/science.290.5491.516; Hendry AP, 2003, EVOLUTION ILLUMINATED: SALMON AND THEIR RELATIVES, P52; Herborg LM, 2007, MOL ECOL, V16, P231, DOI 10.1111/j.1365-294X.2006.03133.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jones MH, 2015, T AM FISH SOC, V144, P977, DOI 10.1080/00028487.2015.1057346; Keller SR, 2010, J EVOLUTION BIOL, V23, P1720, DOI 10.1111/j.1420-9101.2010.02037.x; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; LEBERG PL, 1992, EVOLUTION, V46, P477, DOI 10.1111/j.1558-5646.1992.tb02053.x; Leon-Munoz J, 2007, SALMON FARMING LAKES; Limborg MT, 2012, ECOL EVOL, V2, P1, DOI 10.1002/ece3.59; Lowe S., 2000, ENCY BIOL INVASIONS; Luikart G, 1998, CONSERV BIOL, V12, P228, DOI 10.1046/j.1523-1739.1998.96388.x; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Marchetti MP, 2004, FRESHWATER BIOL, V49, P646, DOI 10.1111/j.1365-2427.2004.01202.x; McGlauflin MT, 2010, T AM FISH SOC, V139, P676, DOI 10.1577/T09-103.1; Monzon-Arguello C, 2014, IMMUNOGENETICS, V66, P393, DOI 10.1007/s00251-014-0771-8; Monzon-Arguello C, 2014, EVOL APPL, V7, P921, DOI 10.1111/eva.12188; Monzon-Arguello C, 2013, ECOL EVOL, V3, P3359, DOI 10.1002/ece3.701; Ostberg CO, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-570; Ozerov MY, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-88; Palstra FP, 2012, ECOL EVOL, V2, P2357, DOI 10.1002/ece3.329; Palstra FP, 2010, CAN J FISH AQUAT SCI, V67, P225, DOI 10.1139/F09-176; Pascual MA, 2007, AQUAT ECOSYST HEALTH, V10, P212, DOI 10.1080/14634980701351361; Pascual MA, 2009, FRONT ECOL ENVIRON, V7, P533, DOI 10.1890/070127; Perez C, 2014, SKRETTING PARTICIPA; Praebel K, 2013, ECOL EVOL, V3, P1400, DOI 10.1002/ece3.552; Pritchard JK, 2000, GENETICS, V155, P945; Pysek P, 2010, ANNU REV ENV RESOUR, V35, P25, DOI 10.1146/annurev-environ-033009-095548; Quinn T. P, 2018, BEHAV ECOLOGY PACIFI; Rossi CMR, 2012, GENETICA, V140, P439, DOI 10.1007/s10709-012-9692-3; Rollins LA, 2013, ECOL EVOL, V3, P4501, DOI 10.1002/ece3.824; Roman J, 2007, TRENDS ECOL EVOL, V22, P454, DOI 10.1016/j.tree.2007.07.002; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Ryman N, 2006, MOL ECOL NOTES, V6, P285, DOI 10.1111/j.1471-8286.2005.01146.x; Schroder V, 2011, BIOL INVASIONS, V13, P203, DOI 10.1007/s10530-010-9802-z; Seeb JE, 2009, SNP GENOTYPING 5 NUC; Seeb LW, 2000, T AM FISH SOC, V129, P1223, DOI 10.1577/1548-8659(2000)129&lt;1223:GDOSSO&gt;2.0.CO;2; Sepulveda M, 2013, AQUACULT ENV INTERAC, V4, P273, DOI 10.3354/aei00089; Simberloff D, 2009, ANNU REV ECOL EVOL S, V40, P81, DOI 10.1146/annurev.ecolsys.110308.120304; Smith MJ, 2011, MOL ECOL RESOUR, V11, P268, DOI 10.1111/j.1755-0998.2010.02965.x; Soto D, 2006, REV CHIL HIST NAT, V79, P97; Soto D, 2001, ECOL APPL, V11, P1750, DOI 10.2307/3061093; Thorstad EB., 2008, NINA SPECIAL REP, V36; Vargas PV, 2010, REV BIOL MAR OCEANOG, V45, P285; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Waples RS, 2007, GENETICS, V175, P219, DOI 10.1534/genetics.106.065300; Waples RS, 2011, GENETICS, V189, P633, DOI 10.1534/genetics.111.132233; Waples RS, 2010, EVOL APPL, V3, P244, DOI 10.1111/j.1752-4571.2009.00104.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Whitlock MC, 1999, HEREDITY, V82, P117, DOI 10.1038/sj.hdy.6884960	86	3	4	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142040	10.1371/journal.pone.0142040	http://dx.doi.org/10.1371/journal.pone.0142040			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544983	Green Submitted, gold, Green Published			2022-12-27	WOS:000364398700074
J	Martinez-Garcia, C; Izquierdo-Lahuerta, A; Vivas, Y; Velasco, I; Yeo, TK; Chen, S; Medina-Gomez, G				Martinez-Garcia, Cristina; Izquierdo-Lahuerta, Adriana; Vivas, Yurena; Velasco, Ismael; Yeo, Tet-Kin; Chen, Sheldon; Medina-Gomez, Gema			Renal Lipotoxicity-Associated Inflammation and Insulin Resistance Affects Actin Cytoskeleton Organization in Podocytes	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; TGF-BETA; FILAMENT ORGANIZATION; FOOT PROCESSES; ER-STRESS; CELLS; PROTEIN; INJURY; SENSITIVITY; INHIBITION	In the last few decades a change in lifestyle has led to an alarming increase in the prevalence of obesity and obesity-associated complications. Obese patients are at increased risk of developing hypertension, heart disease, insulin resistance (IR), dyslipidemia, type 2 diabetes and renal disease. The excess calories are stored as triglycerides in adipose tissue, but also may accumulate ectopically in other organs, including the kidney, which contributes to the damage through a toxic process named lipotoxicity. Recently, the evidence suggests that renal lipid accumulation leads to glomerular damage and, more specifically, produces dysfunction in podocytes, key cells that compose and maintain the glomerular filtration barrier. Our aim was to analyze the early mechanisms underlying the development of renal disease associated with the process of lipotoxicity in podocytes. Our results show that treatment of podocytes with palmitic acid produced intracellular accumulation of lipid droplets and abnormal glucose and lipid metabolism. This was accompanied by the development of inflammation, oxidative stress and endoplasmic reticulum stress and insulin resistance. We found specific rearrangements of the actin cytoskeleton and slit diaphragm proteins (Nephrin, P-Cadherin, Vimentin) associated with this insulin resistance in palmitic-treated podocytes. We conclude that lipotoxicity accelerates glomerular disease through lipid accumulation and inflammation. Moreover, saturated fatty acids specifically promote insulin resistance by disturbing the cytoarchitecture of podocytes. These data suggest that renal lipid metabolism and cytoskeleton rearrangements may serve as a target for specific therapies aimed at slowing the progression of podocyte failure during metabolic syndrome.	[Martinez-Garcia, Cristina; Izquierdo-Lahuerta, Adriana; Vivas, Yurena; Velasco, Ismael; Medina-Gomez, Gema] Univ Rey Juan Carlos, Dept Ciencias Basicas Salud, Area Bioquim & Genet Mol, Madrid, Spain; [Yeo, Tet-Kin; Chen, Sheldon] Northwestern Univ, Div Nephrol Hypertens, Chicago, IL 60611 USA	Universidad Rey Juan Carlos; Northwestern University	Medina-Gomez, G (corresponding author), Univ Rey Juan Carlos, Dept Ciencias Basicas Salud, Area Bioquim & Genet Mol, Avda Atenas S-N, Madrid, Spain.	gema.medina@urjc.es	Medina-Gomez, Gema/CAI-1063-2022; Medina-Gomez, Gema/F-5667-2016; Medina-Gomez, Gema/CAF-4668-2022	Medina-Gomez, Gema/0000-0001-8169-681X; Medina-Gomez, Gema/0000-0001-8169-681X; Medina-Gomez, Gema/0000-0001-8169-681X; Vivas-Garcia, Yurena/0000-0002-0230-4521; Chen, Sheldon/0000-0002-5427-4969	Programa de Ramon y Cajal, Ministerio de Ciencia e Innovacion [RYC-2008-02068]; Ministerio de economia y competitividad [BFU2012- 33594, BFU2013-47384-R]; Comunidad de Madrid [S2010/BMD-2423]; Ayudas a la Movilidad, Universidad Rey Juan Carlos	Programa de Ramon y Cajal, Ministerio de Ciencia e Innovacion; Ministerio de economia y competitividad(Spanish Government); Comunidad de Madrid(Comunidad de Madrid); Ayudas a la Movilidad, Universidad Rey Juan Carlos	This work was supported by RYC-2008-02068, Programa de Ramon y Cajal, Ministerio de Ciencia e Innovacion, http://www.idi.mineco.gob.es/portal/site/MICINN/, GMG; BFU2012- 33594, Ministerio de economia y competitividad, http://www.mineco.gob.es/portal/site/mineco/idi, GMG; BFU2013-47384-R, Ministerio de economia y competitividad, http://www.mineco.gob.es/portal/site/mineco/idi, GMG; S2010/BMD-2423, Comunidad de Madrid, http://www.madrid.org/cs/Satellite? pagename=ComunidadMadrid/Home, GMG; Ayudas a la Movilidad 2012, Universidad Rey Juan Carlos, http://www.urjc.es, CMG.	Ariyama H, 2010, J BIOL CHEM, V285, P22027, DOI 10.1074/jbc.M110.126870; Bijian K, 2005, AM J PHYSL RENAL PHY; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braissant O, 1998, ENDOCRINOLOGY, V139, P2748, DOI 10.1210/en.139.6.2748; Brown EJ, 2010, NAT GENET, V42, P72, DOI 10.1038/ng.505; Carobbio S, 2011, CURR OPIN CLIN NUTR, V14, P520, DOI 10.1097/MCO.0b013e32834ad966; Chavez-Tapia NC, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-20; Chuang PY, 2009, NEPHRON PHYSIOL, V111, P9, DOI 10.1159/000191075; Coward RJM, 2005, J AM SOC NEPHROL, V16, P629, DOI 10.1681/ASN.2004030172; Coward RJM, 2005, DIABETES; Crean JKG, 2002, J BIOL CHEM, V277, P44187, DOI 10.1074/jbc.M203715200; Fornoni A, 2014, FRONTIERS ENDOCRINOL, DOI [10.3339/fendo.2014.00127, DOI 10.3339/FENDO.2014.00127]; Fornoni A, 2014, NAT REV NEPHROL, V10, P379, DOI 10.1038/nrneph.2014.87; Frieden C, 1986, ACTIN POLYM, P15974; Gao D, 2010, J BIOL CHEM, V285, P29965, DOI 10.1074/jbc.M110.128694; Gao ZG, 2004, MOL ENDOCRINOL, V18, P2024, DOI 10.1210/me.2003-0383; Gonzalez-rodriguez A, 2013, NIH PUBLIC ACCESS, V11, P284, DOI [10.1111/j.1474-9726.2011.00786.x.ESSENTIAL, DOI 10.1111/J.1474-9726.2011.00786.X.ESSENTIAL]; Ha TS, 2015, DIABETES-METAB RES, V31, P50, DOI 10.1002/dmrr.2562; Haffner SM, 2006, AM J MED, V119, p3S, DOI 10.1016/j.amjmed.2006.01.008; Hagen RM, 2010, FEBS LETT, V584, P2689, DOI 10.1016/j.febslet.2010.04.004; Hale LJ, 2013, AM J PHYSIOL-RENAL, V305, pF182, DOI 10.1152/ajprenal.00548.2012; Hivert MF, 2008, J CLIN ENDOCR METAB, V93, P3165, DOI 10.1210/jc.2008-0425; Ichimura K, 2003, J HISTOCHEM CYTOCHEM, V51, P1589, DOI 10.1177/002215540305101203; Ichimura K, 2007, CELL TISSUE RES, V329, P541, DOI 10.1007/s00441-007-0440-4; Ijaz A, 2009, KIDNEY INT, V75, P381, DOI 10.1038/ki.2008.559; JAT PS, 1991, P NATL ACAD SCI USA, V88, P5096, DOI 10.1073/pnas.88.12.5096; Jimenez-Altayo F, 2006, J PHARMACOL EXP THER, V316, P42, DOI 10.1124/jpet.105.088435; Joles JA, 2000, J AM SOC NEPHROL, V11, P669, DOI 10.1681/ASN.V114669; Kamata H, 2005, ARCH BIOCHEM BIOPHYS, V434, P16, DOI 10.1016/j.abb.2004.07.036; KEANE WF, 1994, KIDNEY INT, V46, P910, DOI 10.1038/ki.1994.349; Kume S, 2007, J AM SOC NEPHROL, V18, P2715, DOI 10.1681/ASN.2007010089; Kwoh C, 2006, ANNU REV PATHOL-MECH, V1, P349, DOI 10.1146/annurev.pathol.1.110304.100119; Lavin PJ, 2008, CURR OPIN NEPHROL HY, V17, P386, DOI 10.1097/MNH.0b013e32830464f4; Lee EY, 2009, AM J PHYSIOL-RENAL, V297, pF85, DOI 10.1152/ajprenal.90642.2008; Lee HS, 1999, AM J PHYSIOL-RENAL, V277, pF369, DOI 10.1152/ajprenal.1999.277.3.F369; Lennon R, 2009, NEPHROL DIAL TRANSPL; Li XJ, 2014, INT J MOL SCI, V15, P6657, DOI 10.3390/ijms15046657; Macconi D, 2006, AM J PATHOL, V168, P1073, DOI 10.2353/ajpath.2006.050701; MACHUCA E, 2009, HUM MOL GENET, V18, P185; Madhusudhan T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7496; Martinez-Garcia C, 2012, DIS MODELS MECH; Moorhead JF, 2015, LANCET ELSEVIER, V320, P1309, DOI DOI 10.1016/S0140-6736(82)91513-6; Morino K, 2014, MUSCLE SPECIFIC IRS, V57, DOI [10.2337/db06-0454.K.M, DOI 10.2337/DB06-0454.K.M]; Muller-Krebs S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080340; Mundel P, 2002, J AM SOC NEPHROL, V13, P3005, DOI 10.1097/01.ASN.0000039661.06947.FD; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Nam BY, 2012, APOPTOSIS, V17, P1, DOI 10.1007/s10495-011-0661-6; Nemeth ZH, 2004, J CELL PHYSIOL, V200, P71, DOI 10.1002/jcp.10477; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Rotter V, 2003, J BIOL CHEM, V278, P45777, DOI 10.1074/jbc.M301977200; Ruan XZ, 2004, BIOCHEM SOC T, V32, P88, DOI 10.1042/BST0320088; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Schmitz-Peiffer C, 1999, J BIOL CHEM, V274, P24202, DOI 10.1074/jbc.274.34.24202; Senn JJ, 2006, J BIOL CHEM, V281, P26865, DOI 10.1074/jbc.M513304200; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; THOMAS ME, 1993, KIDNEY INT, V44, P1124, DOI 10.1038/ki.1993.358; Thomas ME, 2002, AM J PHYSIOL-RENAL, V283, pF640, DOI 10.1152/ajprenal.00001.2002; THOMAS ME, 1995, AM J PHYSIOL-RENAL, V268, pF1177, DOI 10.1152/ajprenal.1995.268.6.F1177; Thorn K, 2010, J CELL BIOCHEM, V111, P497, DOI 10.1002/jcb.22734; Valverde Angela M., 2011, Archives of Physiology and Biochemistry, V117, P105, DOI 10.3109/13813455.2011.557386; Vivas Y, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-86; Welsh GI, 2012, NAT REV NEPHROL, V8, P14, DOI 10.1038/nrneph.2011.151; Welsh GI, 2010, CELL METAB, V12, P329, DOI 10.1016/j.cmet.2010.08.015; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Xaus J, 2001, BLOOD, V98, P2124, DOI 10.1182/blood.V98.7.2124; Ziyadeh FN, 2004, J AM SOC NEPHROL, V15, pS55, DOI 10.1097/01.ASN.0000093460.24823.5B	67	55	56	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142291	10.1371/journal.pone.0142291	http://dx.doi.org/10.1371/journal.pone.0142291			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26545114	gold, Green Published, Green Submitted			2022-12-27	WOS:000364398700107
J	Prill, K; Reid, PW; Wohlgemuth, SL; Pilgrim, DB				Prill, Kendal; Reid, Pamela Windsor; Wohlgemuth, Serene L.; Pilgrim, David B.			Still Heart Encodes a Structural HMT, SMYD1b, with Chaperone-Like Function during Fast Muscle Sarcomere Assembly	PLOS ONE			English	Article							MYOFIBRIL ORGANIZATION; SKELETAL-MUSCLES; ZEBRAFISH; UNC-45; HSP90A; METHYLTRANSFERASE; MUTATIONS; INTERACTS; COMPONENT; PROTEINS	The vertebrate sarcomere is a complex and highly organized contractile structure whose assembly and function requires the coordination of hundreds of proteins. Proteins require proper folding and inco rporation into the sarcomere by assembly factors, and they must also be maintained and replaced due to the constant physical stress of muscle contraction. Zebrafish mutants affecting muscle assembly and maintenance have proven to be an ideal tool for identification and analysis of factors necessary for these processes. The still heart mutant was identified due to motility defects and a nonfunctional heart. The cognate gene for the mutant was shown to be smyd1b and the still heart mutation results in an early nonsense codon. SMYD1 mutants show a lack of heart looping and chamber definition due to a lack of expression of heart morphogenesis factors gata4, gata5 and hand2. On a cellular level, fast muscle fibers in homozygous mutants do not form mature sarcomeres due to the lack of fast muscle myosin incorporation by SMYD1b when sarcomeres are first being assembled (19hpf), supporting SMYD1b as an assembly protein during sarcomere formation.	[Prill, Kendal; Reid, Pamela Windsor; Wohlgemuth, Serene L.; Pilgrim, David B.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	University of Alberta	Pilgrim, DB (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	dpilgrim@ualberta.ca		Wohlgemuth, Serene/0000-0001-7287-0935	Canadian Institutes of health Research [126606]; Natural Sciences and Engineering Research Council [105466]	Canadian Institutes of health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Canadian Institutes of health Research, www.cihr.ca, #126606; and the Natural Sciences and Engineering Research Council, www.nserc-crsng.gc.ca, #105466. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao WY, 2000, J CELL BIOL, V148, P375, DOI 10.1083/jcb.148.2.375; Bernick EP, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-70; Bonnemann CG, 2004, CURR OPIN NEUROL, V17, P529; Brown MA, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-26; Bryson-Richardson R, 2005, DEV DYNAM, V233, P1018, DOI 10.1002/dvdy.20380; Clark KA, 2002, ANNU REV CELL DEV BI, V18, P637, DOI 10.1146/annurev.cellbio.18.012502.105840; Codina M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008416; Donlin LT, 2012, GENE DEV, V26, P114, DOI 10.1101/gad.177758.111; Du SJ, 2008, P NATL ACAD SCI USA, V105, P554, DOI 10.1073/pnas.0707330105; Etard C, 2008, J CELL BIOL, V180, P1163, DOI 10.1083/jcb.200709128; Etard C, 2007, DEV BIOL, V308, P133, DOI 10.1016/j.ydbio.2007.05.014; Ferrante MI, 2011, J CELL SCI, V124, P565, DOI 10.1242/jcs.071274; Frumkin A, 2014, FRONT MOL BIOSCI, V1; Geach TJ, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-75; Gongal PA, 2008, HUM MOL GENET, V17, P525, DOI 10.1093/hmg/ddm328; Gottlieb PD, 2002, NAT GENET, V31, P25, DOI 10.1038/ng866; Granato M, 1996, DEVELOPMENT, V123, P399; Hawkins TA, 2008, DEVELOPMENT, V135, P1147, DOI 10.1242/dev.018150; Johnson SL, 1999, METHOD CELL BIOL, V60, P357; Just S, 2011, J CELL SCI, V124, P3127, DOI 10.1242/jcs.084772; Li H, 2011, ZOOKEYS, P1, DOI 10.3897/zookeys.96.1495; Li HQ, 2013, MOL BIOL CELL, V24, P3511, DOI 10.1091/mbc.E13-06-0352; Maves L, 2007, DEVELOPMENT, V134, P3371, DOI 10.1242/dev.003905; Melkani GC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022579; Melkani GC, 2010, BIOCHEM BIOPH RES CO, V396, P317, DOI 10.1016/j.bbrc.2010.04.090; Myhre J, 2014, DEV BIOL; Myhre JL, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/712315; Phan D, 2005, DEVELOPMENT, V132, P2669, DOI 10.1242/dev.01849; POSTLETHWAIT JH, 1994, SCIENCE, V264, P699, DOI 10.1126/science.8171321; Price MG, 2002, J CELL SCI, V115, P4013, DOI 10.1242/jcs.00108; Rottbauer W, 2006, CIRC RES, V99, P323, DOI 10.1161/01.RES.0000234807.16034.fe; Sato Y, 2010, J BIOL CHEM, V285, P7111, DOI 10.1074/jbc.M109.052977; Sparrow JC, 2009, NAT REV MOL CELL BIO, V10, P293, DOI 10.1038/nrm2634; Stainier DYR, 1996, DEVELOPMENT, V123, P285; STREISINGER G, 1981, NATURE, V291, P293, DOI 10.1038/291293a0; Tan XG, 2006, P NATL ACAD SCI USA, V103, P2713, DOI 10.1073/pnas.0509503103; Westerfield M., 2000, THE ZEBRAFISH BOOK A; Wohlgemuth SL, 2007, DEV BIOL, V303, P483, DOI 10.1016/j.ydbio.2006.11.027; Yu Q, 2003, CURR BIOL, V13, pR525, DOI 10.1016/S0960-9822(03)00447-0	39	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142528	10.1371/journal.pone.0142528	http://dx.doi.org/10.1371/journal.pone.0142528			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544721	Green Published, Green Submitted, gold			2022-12-27	WOS:000364398700152
J	Driller, C; Merker, S; Perwitasari-Farajallah, D; Sinaga, W; Anggraeni, N; Zischler, H				Driller, Christine; Merker, Stefan; Perwitasari-Farajallah, Dyah; Sinaga, Walberto; Anggraeni, Novita; Zischler, Hans			Stop and Go - Waves of Tarsier Dispersal Mirror the Genesis of Sulawesi Island	PLOS ONE			English	Article							MOLECULAR PHYLOGENETICS; SPECIES TREES; MITOCHONDRIAL; EVOLUTION; DIVERSIFICATION; BIODIVERSITY; BIOGEOGRAPHY; PATTERNS; NUCLEAR; RECONSTRUCTIONS	The Indonesian island of Sulawesi harbors a highly endemic and diverse fauna sparking fascination since long before Wallace's contemplation of biogeographical patterns in the region. Allopatric diversification driven by geological or climatic processes has been identified as the main mechanism shaping present faunal distribution on the island. There is both consensus and conflict among range patterns of terrestrial species pointing to the different effects of vicariant events on once co-distributed taxa. Tarsiers, small nocturnal primates with possible evidence of an Eocene fossil record on the Asian mainland, are at present exclusively found in insular Southeast Asia. Sulawesi is hotspot of tarsier diversity, whereby island colonization and subsequent radiation of this old endemic primate lineage remained largely enigmatic. To resolve the phylogeographic history of Sulawesi tarsiers we analyzed an island-wide sample for a set of five approved autosomal phylogenetic markers (ABCA1, ADORA3, AXIN1, RAG1, and TTR) and the paternally inherited SRY gene. We constructed ML and Bayesian phylogenetic trees and estimated divergence times between tarsier populations. We found that their arrival at the Proto-Sulawesi archipelago coincided with initial Miocene tectonic uplift and hypothesize that tarsiers dispersed over the region in distinct waves. Intra-island diversification was spurred by land emergence and a rapid succession of glacial cycles during the Plio-Pleistocene. Some tarsier range boundaries concur with spatial limits in other taxa backing the notion of centers of faunal endemism on Sulawesi. This congruence, however, has partially been superimposed by taxon-specific dispersal patterns.	[Driller, Christine; Zischler, Hans] Johannes Gutenberg Univ Mainz, Inst Anthropol, D-55122 Mainz, Germany; [Merker, Stefan] State Museum Nat Hist Stuttgart, Dept Zool, Stuttgart, Germany; [Perwitasari-Farajallah, Dyah; Sinaga, Walberto] Bogor Agr Univ, Primate Res Ctr, Bogor, Indonesia; [Perwitasari-Farajallah, Dyah] Bogor Agr Univ, Dept Biol, Bogor, Indonesia; [Anggraeni, Novita] Bogor Agr Univ, Sch Grad Studies, Bogor, Indonesia	Johannes Gutenberg University of Mainz; Bogor Agricultural University; Bogor Agricultural University; Bogor Agricultural University	Driller, C (corresponding author), Johannes Gutenberg Univ Mainz, Inst Anthropol, D-55122 Mainz, Germany.	driller@uni-mainz.de	Driller, Christine/AAW-2151-2020; Perwitasari-Farajallah, Dyah/CAE-9260-2022	Driller, Christine/0000-0003-2000-4095; Perwitasari-Farajallah, Dyah/0000-0001-6206-1675; Zischler, Hans/0000-0002-3440-8376; Merker, Stefan/0000-0003-3142-7720	Deutsche Forschungsgemeinschaft (DFG) [ZI568/6-1, ZI568/6-2]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft (DFG, http://www.dfg.de). Grants ZI568/6-1 and ZI568/6-2 were allocated to HZ. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEARD KC, 1994, NATURE, V368, P604, DOI 10.1038/368604a0; Bohonak AJ, 1999, Q REV BIOL, V74, P21, DOI 10.1086/392950; Brandon-Jones D, 2004, INT J PRIMATOL, V25, P97, DOI 10.1023/B:IJOP.0000014647.18720.32; Bridle JR, 2004, EVOLUTION, V58, P1394; Bridle JR, 2001, BIOL J LINN SOC, V72, P373, DOI 10.1111/j.1095-8312.2001.tb01324.x; Burton JA, 2010, INT J PRIMATOL, V31, P1123, DOI 10.1007/s10764-010-9449-8; Butlin RK, 1998, BIOGEOGRAPHY GEOLOGI, P355; Campbell P, 2007, MOL PHYLOGENET EVOL, V44, P474, DOI 10.1016/j.ympev.2007.02.013; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chaimanee Y, 2010, P R SOC B, V278, P1956; Clement M., 2002, P 16 INT PARALLEL DI, P7; Clements B, 2009, PETROL GEOSCI, V15, P159, DOI 10.1144/1354-079309-831; Dagosto M, TARSIERS PRESENT FUT, P237; Driller C, 2009, INT J PRIMATOL, V30, P267, DOI 10.1007/s10764-009-9341-6; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Esselstyn JA, 2009, EVOLUTION, V63, P2595, DOI 10.1111/j.1558-5646.2009.00743.x; Evans Ben J., 2012, Systematics Association Special Volume Series, V82, P270; Evans BJ, 2003, EVOLUTION, V57, P1931; Evans BJ, 2003, EVOLUTION, V57, P1436; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Groves C, 2010, INT J PRIMATOL, V31, P1071, DOI 10.1007/s10764-010-9443-1; Grow N, 2010, INT J PRIMATOL, V31, P1174, DOI 10.1007/s10764-010-9456-9; Hall R, 2002, J ASIAN EARTH SCI, V20, P353, DOI 10.1016/S1367-9120(01)00069-4; Hall R, 2001, FAUNAL AND FLORAL MIGRATIONS AND EVOLUTION IN SE ASIA-AUSTRALASIA, P35; Hall R, 2009, BLUMEA, V54, P148, DOI 10.3767/000651909X475941; Hall R, 2013, J LIMNOL, V72, P1, DOI 10.4081/jlimnol.2013.s2.e1; Hall R, 2012, TECTONOPHYSICS, V570, P1, DOI 10.1016/j.tecto.2012.04.021; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HAQ BU, 1987, SCIENCE, V235, P1156, DOI 10.1126/science.235.4793.1156; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hope G, 2001, PALAEOGEOGR PALAEOCL, V171, P129, DOI 10.1016/S0031-0182(01)00243-7; Horvath JE, 2008, GENOME RES, V18, P489, DOI 10.1101/gr.7265208; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Knowles LL, 2009, SYST BIOL, V58, P463, DOI 10.1093/sysbio/syp061; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; Lohman DJ, 2011, ANNU REV ECOL EVOL S, V42, P205, DOI 10.1146/annurev-ecolsys-102710-145001; Lyrholm T, 1999, P ROY SOC B-BIOL SCI, V266, P347, DOI 10.1098/rspb.1999.0644; McGuire JA, 2007, HERPETOL MONOGR, V21, P179, DOI 10.1655/07-012.1; MELNICK DJ, 1992, INT J PRIMATOL, V13, P379, DOI 10.1007/BF02547824; Merker S, 2014, J MOL EVOL, V79, P40, DOI 10.1007/s00239-014-9631-2; Merker S, 2010, INT J PRIMATOL, V31, P1107, DOI 10.1007/s10764-010-9452-0; Merker S, 2009, P NATL ACAD SCI USA, V106, P8459, DOI 10.1073/pnas.0900319106; Michaux B, 2010, BIOL J LINN SOC, V101, P193, DOI 10.1111/j.1095-8312.2010.01473.x; Moen D, 2014, TRENDS ECOL EVOL, V29, P190, DOI 10.1016/j.tree.2014.01.010; Moss Steve J., 1998, P133; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Natus I.R, 2005, THESIS; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; Rambaut A., 2007, TRACER V1 5; Ronquist F, 2011, MRBAYES VER IN PRESS; Ruedi M, 1998, MOL PHYLOGENET EVOL, V9, P567, DOI 10.1006/mpev.1998.0487; Sanders KL, 2014, BIOL CONSERV, V171, P200, DOI 10.1016/j.biocon.2014.01.013; Schmitz J, 2001, GENETICS, V157, P777; Seehausen O, 2008, MOL ECOL, V17, P30, DOI 10.1111/j.1365-294X.2007.03529.x; Setiadi MI, 2011, AM NAT, V178, P221, DOI 10.1086/660830; Shaul S, 2002, GENE, V300, P59, DOI 10.1016/S0378-1119(02)00851-X; Shekelle M, 2010, INT J PRIMATOL, V31, P1083, DOI 10.1007/s10764-010-9457-8; Shekelle Myron, 2008, Primate Conservation, V23, P55, DOI 10.1896/052.023.0106; Springer MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049521; Stelbrink B, 2012, EVOLUTION, V66, P2252, DOI 10.1111/j.1558-5646.2012.01588.x; van den Bergh GD, 2001, PALAEOGEOGR PALAEOCL, V171, P385, DOI 10.1016/S0031-0182(01)00255-3; VAWTER L, 1986, SCIENCE, V234, P194, DOI 10.1126/science.3018931; von Rintelen T, 2007, HYDROBIOLOGIA, V592, P11, DOI 10.1007/s10750-007-0765-8; von Rintelen T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098917; Whitten T, 2002, ECOLOGY SULAWESI; Zheng YC, 2011, MOL BIOL EVOL, V28, P2521, DOI 10.1093/molbev/msr072; Zwickl D. J, 2006, GENETIC ALGORITHM AP	69	16	16	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0141212	10.1371/journal.pone.0141212	http://dx.doi.org/10.1371/journal.pone.0141212			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559527	gold, Green Published, Green Submitted			2022-12-27	WOS:000364433100025
J	Greenaway, C; Ma, AT; Kloda, LA; Klein, M; Cnossen, S; Schwarzer, G; Shrier, I				Greenaway, Christina; Ma, Ann Thu; Kloda, Lorie A.; Klein, Marina; Cnossen, Sonya; Schwarzer, Guido; Shrier, Ian			The Seroprevalence of Hepatitis C Antibodies in Immigrants and Refugees from Intermediate and High Endemic Countries: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							VIRUS-INFECTION; PREGNANT-WOMEN; COST-EFFECTIVENESS; GENERAL-POPULATION; AFRICAN IMMIGRANTS; ALBANIAN REFUGEES; HIV-INFECTIONS; HCV INFECTION; VIRAL MARKERS; BLOOD-DONORS	Background & Aims Hepatitis C virus (HCV) infection is a significant global health issue that leads to 350,000 preventable deaths annually due to associated cirrhosis and hepatocellular carcinoma (HCC). Immigrants and refugees (migrants) originating from intermediate/high HCV endemic countries are likely at increased risk for HCV infection due to HCV exposure in their countries of origin. The aim of this study was to estimate the HCV seroprevalence of the migrant population living in low HCV prevalence countries. Methods Four electronic databases were searched from database inception until June 17, 2014 for studies reporting the prevalence of HCV antibodies among migrants. Seroprevalence estimates were pooled with a random-effect model and were stratified by age group, region of origin and migration status and a meta-regression was modeled to explore heterogeneity. Results Data from 50 studies representing 38,635 migrants from all world regions were included. The overall anti-HCV prevalence (representing previous and current infections) was 1.9% (95% CI, 1.4-2.7%, I-2 96.1). Older age and region of origin, particularly Sub-Saharan Africa, Asia, and Eastern Europe were the strongest predictors of HCV seroprevalence. The estimated HCV seroprevalence of migrants from these regions was >2% and is higher than that reported for most host populations. Conclusion Adult migrants originating from Asia, Sub-Saharan Africa and Eastern Europe are at increased risk for HCV and may benefit from targeted HCV screening.	[Greenaway, Christina] McGill Univ, Jewish Gen Hosp, Div Infect Dis, Montreal, PQ H3T 1E2, Canada; [Greenaway, Christina; Cnossen, Sonya] McGill Univ, Jewish Gen Hosp, Lady Davis Res Inst Med Res, Ctr Clin Epidemiol, Montreal, PQ H3T 1E2, Canada; [Greenaway, Christina; Shrier, Ian] McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada; [Ma, Ann Thu] Ctr Hosp Univ Montreal, Dept Internal Med, Montreal, PQ, Canada; [Kloda, Lorie A.] McGill Univ, Lib, Montreal, PQ, Canada; [Klein, Marina] McGill Univ, Ctr Hlth, Div Infect Dis, Montreal, PQ, Canada; [Schwarzer, Guido] Univ Freiburg, Med Ctr, Inst Med Biometry & Stat, Freiburg, Germany	McGill University; McGill University; McGill University; Universite de Montreal; McGill University; McGill University; University of Freiburg	Greenaway, C (corresponding author), McGill Univ, Jewish Gen Hosp, Div Infect Dis, Montreal, PQ H3T 1E2, Canada.	ca.greenaway@mcgill.ca	Kloda, Lorie A./H-3221-2019; Schwarzer, Guido/A-8168-2009; Shrier, Ian/AAI-6502-2020	Kloda, Lorie A./0000-0003-1429-1497; Schwarzer, Guido/0000-0001-6214-9087; Shrier, Ian/0000-0001-9914-3498; Klein, Marina/0000-0002-3063-8430				Almog R, 1999, INFECTION, V27, P212, DOI 10.1007/BF02561531; Alter MJ, 2007, WORLD J GASTROENTERO, V13, P2436, DOI 10.3748/wjg.v13.i17.2436; [Anonymous], 1999, Wkly Epidemiol Rec, V74, P425; [Anonymous], 2010, HEP B C EU NEIGHB PR; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Asselah T, 2014, LIVER INT, V34, P1447, DOI 10.1111/liv.12599; AUSSEL L, 1991, PATHOL BIOL, V39, P991; Australian Bureau of Statistics, 2007, 2006 CENS POP HOUS C; Barendregt JJ, 2013, J EPIDEMIOL COMMUN H, V67, P974, DOI 10.1136/jech-2013-203104; Bates D., 2012, IME4 LINEAR MIXED EF; Beggio M, 2007, G Ital Med Lav Ergon, V29, P745; Belgium Statistics, 2011, POP NAT SEX GROUP CL; Bottecchia M, 2011, J ANTIMICROB CHEMOTH, V66, P641, DOI 10.1093/jac/dkq484; Caritas Italiana, 2010, DOSS STAT IMM CAR MI; Chiaramonte M, 1998, EPIDEMIOL INFECT, V121, P179, DOI 10.1017/S0950268898001034; Chironna M, 2000, EPIDEMIOL INFECT, V125, P163, DOI 10.1017/S0950268899004215; Chironna M, 2001, Int J Infect Dis, V5, P209, DOI 10.1016/S1201-9712(01)90073-6; Chironna M, 2003, INFECTION, V31, P70, DOI 10.1007/s15010-002-3100-3; Coffin PO, 2012, CLIN INFECT DIS, V54, P1259, DOI 10.1093/cid/cis011; Cornberg M, 2011, LIVER INT, V31, P30, DOI 10.1111/j.1478-3231.2011.02539.x; Czech Statistical Office, 2010, FOR CZECH REP 2010; DALEKOS GN, 1995, EUR J GASTROEN HEPAT, V7, P553; Denburg A, 2007, Can Commun Dis Rep, V33, P16; El Khoury Antoine C, 2012, J Med Econ, V15, P887, DOI 10.3111/13696998.2012.681332; Estadistica INd, 2008, NAT IMM SURV REV PAD; FAUSTINI A, 1994, J PUBLIC HEALTH MED, V16, P71, DOI 10.1093/oxfordjournals.pubmed.a042938; Feeney ER, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g3308; FLATAU E, 1993, ISRAEL J MED SCI, V29, P387; Fleiss J L, 1993, Stat Methods Med Res, V2, P121, DOI 10.1177/096228029300200202; GARCIASAMANIEGO J, 1994, AM J GASTROENTEROL, V89, P1918; Gimeno LA, 2006, ENF EMERG, V8, P40; Glikberg F, 1997, J CLIN GASTROENTEROL, V24, P30, DOI 10.1097/00004836-199701000-00006; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Greenaway C, 2007, ANN INTERN MED, V146, P20, DOI 10.7326/0003-4819-146-1-200701020-00005; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.03.017, 10.1016/j.jclinepi.2011.06.004]; Hagan LM, 2014, HEPATOLOGY, V60, P37, DOI 10.1002/hep.27151; Hajarizadeh B, 2013, NAT REV GASTRO HEPAT, V10, P553, DOI 10.1038/nrgastro.2013.107; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hatzakis A, 2013, J VIRAL HEPATITIS, V20, P1, DOI 10.1111/jvh.12120; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Huerga H, 2002, PEDIATR INFECT DIS J, V21, P830, DOI 10.1097/00006454-200209000-00009; Hunter JP, 2014, J CLIN EPIDEMIOL, V67, P897, DOI 10.1016/j.jclinepi.2014.03.003; Institut national de la statistique et des etudes economiques, 2006, REC POP ETR SEL SEX; Iorio A, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h870; Ireland CSO, 2006, POP US RES PRES US R; Israel Central Bureau of Statistics, 2008, 2008 CENS MAL FEM BO; JOHANSSON PJH, 1990, SCAND J INFECT DIS, V22, P619; Johnson D, 2007, RATES INFECT DIS NUT; Kershenobich D, 2011, LIVER INT, V31, P18, DOI 10.1111/j.1478-3231.2011.02538.x; King K, 2001, MED J AUSTRALIA, V175, P600, DOI 10.5694/j.1326-5377.2001.tb143742.x; Lam BP, 2015, THER ADV GASTROENTER, V8, P298, DOI 10.1177/1756283X15587481; Lavanchy D, 2011, CLIN MICROBIOL INFEC, V17, P107, DOI 10.1111/j.1469-0691.2010.03432.x; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lopez-Velez R, 1997, J CLIN GASTROENTEROL, V25, P650, DOI 10.1097/00004836-199712000-00020; Madhava V, 2002, LANCET INFECT DIS, V2, P293, DOI 10.1016/S1473-3099(02)00264-5; MalamitsiPuchner A, 1996, EUR J EPIDEMIOL, V12, P297, DOI 10.1007/BF00145420; Manzardo Christian, 2008, Travel Med Infect Dis, V6, P4, DOI 10.1016/j.tmaid.2007.11.002; MARCELLIN P, 1993, DIGEST DIS SCI, V38, P2151, DOI 10.1007/BF01299888; Martin Ibanez I, 2006, An Pediatr (Barc), V64, P550; Aliberch RMM, 2010, GAC SANIT, V24, P288, DOI 10.1016/j.gaceta.2009.10.013; Milionis C, 2010, EUR J GEN PRACT, V16, P236, DOI 10.3109/13814788.2010.525631; Miller LC, 2000, PEDIATRICS, V105, part. no., DOI 10.1542/peds.105.6.e76; Mitrovic N, 2015, DIGEST LIVER DIS, V47, P572, DOI 10.1016/j.dld.2015.03.019; Moyer VA, 2013, ANN INTERN MED, V159, P349, DOI 10.7326/0003-4819-159-5-201309030-00672; Murphy EL, 2010, J INFECT DIS, V202, P576, DOI 10.1086/654882; National Institute for Health and Clinical Excellence, HEP B C WAYS PROM OF; Nordenstedt H, 2010, DIGEST LIVER DIS, V42, pS206, DOI 10.1016/S1590-8658(10)60507-5; Observatory MM, 2004, DAT IMM GREEC CENS 2; Ouimet MJ, 2008, CAN J PUBLIC HEALTH, V99, P499, DOI 10.1007/BF03403785; Panagopoulos P, 2004, J Matern Fetal Neonatal Med, V16, P106; Paxton GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038194; Pedemonte P, 2002, ITAL J PEDIATR, V28, P392; Pepin J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099677; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Pho MT, 2014, HEPATOLOGY, V60, P12, DOI 10.1002/hep.27220; Pottie K, 2011, CAN MED ASSOC J, V183, pE824, DOI 10.1503/cmaj.090313; Ramos JM, 2003, ENFERM INFEC MICR CL, V21, P540, DOI 10.1157/13054545; Raptopoulou-Gigi M, 2001, EUR J EPIDEMIOL, V17, P263, DOI 10.1023/A:1017951605272; Razavi H, 2014, J VIRAL HEPATITIS, V21, P34, DOI 10.1111/jvh.12248; Rein DB, 2012, ANN INTERN MED, V156, P263, DOI 10.7326/0003-4819-156-4-201202210-00378; Remis RS., 2004, STUDY CHARACTERIZE E; Remis RS, 2007, MODELLING INCIDENCE, P46; Rivas P, 2013, AM J TROP MED HYG, V88, P789, DOI 10.4269/ajtmh.12-0319; ROUDOTTHORAVAL F, 1992, GASTROEN CLIN BIOL, V16, P255; Roussos A, 2003, WORLD J GASTROENTERO, V9, P993; Rucker G, 2009, STAT MED, V28, P721, DOI 10.1002/sim.3511; Saiman L, 2001, PEDIATRICS, V108, P608, DOI 10.1542/peds.108.3.608; SANTANTONIO T, 1993, EUR J EPIDEMIOL, V9, P537, DOI 10.1007/BF00209532; Santiago B, 2012, ENFERM INFEC MICR CL, V30, P64, DOI 10.1016/j.eimc.2011.07.010; Sanz-Pelaez O, 2007, ENFERM INFEC MICR CL, V25, P604, DOI 10.1157/13111191; Schwarzer G., META METAANALYSIS R; Servico de Estrangeiros e Fronteiras, 2010, REL IM FRONT AS SERV; Sievert W, 2011, LIVER INT, V31, P61, DOI 10.1111/j.1478-3231.2011.02540.x; Slot E, 2015, TRANSFUSION; Smith BD, 2012, ANN INTERN MED; Sonego M, 2002, MED CLIN-BARCELONA, V119, P489, DOI 10.1016/S0025-7753(02)73471-4; Statistics Canada, 2006, IMM STAT PER IMM PLA; Statistics Denmark, 2009, POP ANC REG TIM CIT; Statistics Finland, 2011, COUNTR BIRTH ACC AG; Statistics Netherlands, 2011, POP NETH 1 JAN 2011; Statistics New Zealand, 2006, 2006 CENS POP HOUS Q; Statistics Norway, 2011, FOR BORN SEX COUNTR; Statistics Sweden, 2011, FOR BORN PERS SWED C; Statistik Austria, 2010, BEV 2010 POP CIT; Statistisches Bundesamt, 2010, STAT YB 2010; Swiss Federal Institute of Statistics, 2010, POP RES SEL NAT PAYS; Tafuri S, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-213; The World Bank, 2014, COUNTR EC 2014; Toro C, 2006, J MED VIROL, V78, P1599, DOI 10.1002/jmv.20744; Tramuto F, 2012, J COMMUN HEALTH, V37, P547, DOI 10.1007/s10900-011-9477-0; TRAUTWEIN C, 1995, J MED VIROL, V45, P429, DOI 10.1002/jmv.1890450413; Trubnikov M, 2014, Can Commun Dis Rep, V40, P429; U.S. Census Bureau. American Community Survey, 2009, SEL CHAR FOR BORN PO; Urbanus AT, 2011, J HEPATOL, V55, P1207, DOI 10.1016/j.jhep.2011.02.028; Valerio LI, 2008, REV CLIN ESP, V208, P426, DOI 10.1157/13127602; van Schaik R, 2009, EUR J PEDIATR, V168, P1101, DOI 10.1007/s00431-008-0895-7; Viviano, 2007, ITAL J PEDIATR, V33, P92; Wedemeyer H, 2014, J VIRAL HEPATITIS, V21, P60, DOI 10.1111/jvh.12249	118	54	54	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0141715	10.1371/journal.pone.0141715	http://dx.doi.org/10.1371/journal.pone.0141715			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7DR	26558905	Green Submitted, Green Published, gold			2022-12-27	WOS:000364433100041
J	Priori, R; Casadei, L; Valerio, M; Scrivo, R; Valesini, G; Manetti, C				Priori, Roberta; Casadei, Luca; Valerio, Mariacristina; Scrivo, Rossana; Valesini, Guido; Manetti, Cesare			H-1-NMR-Based Metabolomic Study for Identifying Serum Profiles Associated with the Response to Etanercept in Patients with Rheumatoid Arthritis	PLOS ONE			English	Article							ANTITUMOR NECROSIS FACTOR; ERYTHROCYTE SEDIMENTATION-RATE; COBRA COMBINATION THERAPY; C-REACTIVE PROTEIN; CONCOMITANT METHOTREXATE; MONOCLONAL-ANTIBODY; DISEASE-ACTIVITY; JOINT DAMAGE; FOLLOW-UP; ADALIMUMAB	Objective A considerable proportion of patients with rheumatoid arthritis (RA) do not have a satisfactory response to biological therapies. We investigated the use of metabolomics approach to identify biomarkers able to anticipate the response to biologics in RA patients. Methods Due to gender differences in metabolomic profiling, the analysis was restricted to female patients starting etanercept as the first biological treatment and having a minimum of six months' follow-up. Each patient was evaluated by the same rheumatologist before and after six months of treatment. At this time, the clinical response (good, moderate, none) was determined according to the EUropean League Against Rheumatism (EULAR) criteria, based on both erythrocyte sedimentation rate (EULAR-ESR) and C-reactive protein (EULAR-CRP). Sera collected prior and after six months of etanercept were analyzed by H-1-nuclear magnetic resonance (NMR) spectroscopy in combination with multivariate data analysis. Results Twenty-seven patients were enrolled: 18 had a good/moderate response and 9 were non responders according to both EULAR-ESR and EULAR-CRP after six months of etanercept. Metabolomic analysis at baseline was able to discriminate good, moderate, and non-responders with a very good predictivity (Q(2) = 0.68) and an excellent sensitivity, specificity, and accuracy (100%). In good responders, we found an increase in isoleucine, leucine, valine, alanine, glutamine, tyrosine, and glucose levels and a decrease in 3-hydroxybutyrate levels after six months of treatment with etanercept with respect to baseline. Conclusion Our study confirms the potential of metabolomic analysis to predict the response to biological agents. Changes in metabolic profiles during treatment may help elucidate their mechanism of action.	[Priori, Roberta; Scrivo, Rossana; Valesini, Guido] Univ Roma La Sapienza, Dept Internal Med & Med Specialties, Rheumatol Unit, I-00185 Rome, Italy; [Casadei, Luca; Valerio, Mariacristina; Manetti, Cesare] Univ Roma La Sapienza, Dept Chem, I-00185 Rome, Italy	Sapienza University Rome; Sapienza University Rome	Valesini, G (corresponding author), Univ Roma La Sapienza, Dept Internal Med & Med Specialties, Rheumatol Unit, I-00185 Rome, Italy.	guido.valesini@uniroma1.it	priori, roberta/Z-6259-2019	priori, roberta/0000-0002-6695-1445; Valesini, Guido/0000-0002-7757-8092; Casadei, Luca/0000-0002-6977-5010; Valerio, Mariacristina/0000-0001-7740-9945	Progetti d'Ateneo (Sapienza Universita di Roma)	Progetti d'Ateneo (Sapienza Universita di Roma)	This work was supported by Progetti d'Ateneo (Sapienza Universita di Roma) 2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SB, 2012, OSTEOARTHR CARTILAGE, V20, P64, DOI 10.1016/j.joca.2011.10.010; Aletaha D, 2005, NAT CLIN PRACT RHEUM, V1, P62, DOI 10.1038/ncprheum0050; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bathon JM, 2000, NEW ENGL J MED, V343, P1586, DOI 10.1056/NEJM200011303432201; BENIGNI R, 1994, AM J PHYSIOL, V266, pR1697, DOI 10.1152/ajpregu.1994.266.5.R1697; Boers M, 1997, LANCET, V350, P309, DOI 10.1016/S0140-6736(97)01300-7; Choy EH, 2013, NAT REV RHEUMATOL, V9, P154, DOI 10.1038/nrrheum.2013.8; Clair EWS, 2004, ARTHRITIS RHEUM-US, V50, P3432, DOI 10.1002/art.20568; Claxson A, 1999, BBA-MOL BASIS DIS, V1454, P57, DOI 10.1016/S0925-4439(99)00020-4; EGSMOSE C, 1995, J RHEUMATOL, V22, P2208; Fages A, 2014, INVESTIGATING SOURCE; Finckh A, 2006, ARTHRIT RHEUM-ARTHR, V55, P864, DOI 10.1002/art.22353; FRIES JF, 1980, ARTHRITIS RHEUM, V23, P137, DOI 10.1002/art.1780230202; Goodacre R, 2007, METABOLOMICS, V3, P231, DOI 10.1007/s11306-007-0081-3; Kapoor SR, 2013, ARTHRITIS RHEUM-US, V65, P1448, DOI 10.1002/art.37921; Kawasaki Y, 2013, MOD RHEUMATOL, V23, P1192, DOI [10.3109/s10165-012-0822-7, 10.1007/s10165-012-0822-7]; Keystone EC, 2004, ARTHRITIS RHEUM, V50, P1400, DOI 10.1002/art.20217; Klaasen R, 2011, RHEUMATOLOGY, V50, P1487, DOI 10.1093/rheumatology/ker010; Krieckaert CL, 2012, ANN RHEUM DIS, V71, P1914, DOI 10.1136/annrheumdis-2012-201544; Landewe RBM, 2002, ARTHRITIS RHEUM-US, V46, P347, DOI 10.1002/art.10083; Lauridsen MB, 2010, J PROTEOME RES, V9, P4545, DOI 10.1021/pr1002774; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; Madsen RK, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3243; Matsui T, 2007, ANN RHEUM DIS, V66, P1221, DOI 10.1136/ard.2006.063834; Meshitsuka S, 1999, CLIN CHIM ACTA, V281, P163, DOI 10.1016/S0009-8981(98)00200-9; Mittelstrass K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002215; NAUGHTON D, 1993, FEBS LETT, V317, P135, DOI 10.1016/0014-5793(93)81508-W; Nicholson JK, 2008, NATURE, V455, P1054, DOI 10.1038/4551054a; Ouyang X, 2011, LUPUS, V20, P1411, DOI 10.1177/0961203311418707; Potter C, 2009, ANN RHEUM DIS, V68, P69, DOI 10.1136/ard.2007.084715; Priori R, 2013, AUTOIMMUN REV, V12, P1022, DOI 10.1016/j.autrev.2013.04.002; RANTAPAADAHLQVIST S, 1991, ANN RHEUM DIS, V50, P366, DOI 10.1136/ard.50.6.366; Scrivo R, 2014, CURR ALLERGY ASTHM R, V14, DOI 10.1007/s11882-014-0445-5; Sellam J, 2014, ARTHRITIS RHEUMATOL, V66, P2015, DOI 10.1002/art.38671; Semerano L, 2015, ANN RHEUM DIS, V74, P1325, DOI 10.1136/annrheumdis-2014-206618; Siemons L, 2014, CLIN RHEUMATOL, V33, P783, DOI 10.1007/s10067-014-2538-x; Singh JA, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007848.pub2; Slupsky CM, 2007, ANAL CHEM, V79, P6995, DOI 10.1021/ac0708588; Smolen JS, 2010, ANN RHEUM DIS, V69, P964, DOI 10.1136/ard.2009.126532; Tsakonas E, 2000, J RHEUMATOL, V27, P623; van den Broek M, 2012, ANN RHEUM DIS, V71, P245, DOI 10.1136/annrheumdis-2011-200379; van Gestel AM, 1998, ARTHRITIS RHEUM-US, V41, P1845, DOI 10.1002/1529-0131(199810)41:10<1845::AID-ART17>3.3.CO;2-B; van Tuyl LHD, 2010, ANN RHEUM DIS, V69, P807, DOI 10.1136/ard.2009.108027; vanderHeide A, 1996, ANN INTERN MED, V124, P699, DOI 10.7326/0003-4819-124-8-199604150-00001; Wang ZG, 2012, EXP THER MED, V4, P165, DOI 10.3892/etm.2012.567; Weinblatt ME, 1999, NEW ENGL J MED, V340, P253, DOI 10.1056/NEJM199901283400401; Weinblatt ME, 2003, ARTHRITIS RHEUM-US, V48, P35, DOI 10.1002/art.10697; Weljie AM, 2007, J PROTEOME RES, V6, P3456, DOI 10.1021/pr070123j; Wu TF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037210; Yazici Y, 2011, CLIN EXP RHEUMATOL, V29, P494; Young SP, 2013, ARTHRITIS RHEUM-US, V65, P2015, DOI 10.1002/art.38021	51	34	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0138537	10.1371/journal.pone.0138537	http://dx.doi.org/10.1371/journal.pone.0138537			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26558759	Green Published, gold, Green Submitted			2022-12-27	WOS:000364433100001
J	Tran, BX; Nguyen, LH; Phan, HTT; Latkin, CA				Bach Xuan Tran; Long Hoang Nguyen; Huong Thu Thi Phan; Latkin, Carl A.			Patient Satisfaction with Methadone Maintenance Treatment in Vietnam: A Comparison of Different Integrative-Service Delivery Models	PLOS ONE			English	Article							QUALITY-OF-LIFE; INTRAVENOUS-DRUG-USERS; COST-EFFECTIVENESS; PRIMARY-CARE; CLIENT SATISFACTION; ABUSE TREATMENT; INJECT DRUGS; HEALTH-CARE; HIV; HIV/AIDS	Background Patient satisfaction is an important component of quality in healthcare delivery. To inform the expansion of Methadone Maintenance Treatment (MMT) services in Vietnam, we examined the satisfaction of patients with regards to different services delivery models and identified its associated factors. Methods We interviewed 1,016 MMT patients at 5 clinics in Hanoi and Nam Dinh province. The modified SATIS instrument, a 10-item scale, was used to measure three dimensions: "Services quality and convenience", "Health workers' capacity and responsiveness" and "Inter-professional care". Results The average score was high across three SATIS dimensions. However, only one third of patients completely satisfied with general health services and treatment outcomes. Older age, higher education, having any problem in self-care and anxiety/depression were negatively associated with patient's satisfaction. Meanwhile, patients receiving MMT at clinics, where more comprehensive HIV and general health care services were available, were more likely to report a complete satisfaction. Conclusion Patients were highly satisfied with MMT services in Vietnam. However, treatment for drug users should go beyond methadone maintenance to address complicated health demands of drug users. Integrating MMT with comprehensive HIV and general health services together with improving the capacity of health workers and efficiency of services organisation to provide interconnected health care for drug users are critical for improving the outcomes of the MMT program.	[Bach Xuan Tran; Long Hoang Nguyen] Hanoi Med Univ, Inst Prevent Med & Publ Hlth, Hanoi 100803, Vietnam; [Bach Xuan Tran; Latkin, Carl A.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Long Hoang Nguyen] Vietnam Natl Univ, Sch Med & Pharm, Hanoi, Vietnam; [Huong Thu Thi Phan] Minist Hlth, Author HIV AIDS Control, Hanoi, Vietnam	Hanoi Medical University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Vietnam National University Hanoi	Tran, BX (corresponding author), Hanoi Med Univ, Inst Prevent Med & Publ Hlth, Hanoi 100803, Vietnam.	bach@hma.edu.vn	Nguyen, Long/E-6145-2015	Nguyen, Long/0000-0003-1658-2394	Vietnam Authority of HIV/AIDS Control World Bank supported HIV Project; International AIDS Society; US National Institute of Drug Abuse; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189] Funding Source: NIH RePORTER	Vietnam Authority of HIV/AIDS Control World Bank supported HIV Project; International AIDS Society; US National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by the Vietnam Authority of HIV/AIDS Control World Bank supported HIV Project. Dr. Bach Tran received a fellowship from the International AIDS Society and US National Institute of Drug Abuse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz Z, 2015, J SUBST ABUSE TREAT, V53, P47, DOI 10.1016/j.jsat.2014.12.008; Tran BX, 2015, HARM REDUCT J, V12, DOI 10.1186/s12954-015-0063-0; Tran BX, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-014-0640-z; Tran BX, 2013, B WORLD HEALTH ORGAN, V91, P475, DOI 10.2471/BLT.12.115147; Tran BX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051569; Tran BX, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-132; Tran BX, 2012, GLOB PUBLIC HEALTH, V7, P1080, DOI 10.1080/17441692.2012.736259; Tran BX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046680; Tran BX, 2012, QUAL LIFE RES, V21, P613, DOI 10.1007/s11136-011-9963-y; Tran BX, 2012, AIDS CARE, V24, P283, DOI 10.1080/09540121.2011.608420; Tran BX, 2011, AIDS CARE, V23, P1236, DOI 10.1080/09540121.2011.555749; Chow MYK, 2012, ASIA-PAC J PUBLIC HE, V24, P406, DOI 10.1177/1010539510384843; Control VAoHA, 2015, ANN REV HIV AIDS CON; Crow R, 2002, Health Technol Assess, V6, P1; de los Cobos JP, 2005, DRUG ALCOHOL DEPEN, V79, P405, DOI 10.1016/j.drugalcdep.2005.03.021; de los Cobos JP, 2004, DRUG ALCOHOL DEPEN, V73, P307, DOI 10.1016/j.drugalcdep.2003.11.001; DONOGHOE MC, 1992, BRIT J ADDICT, V87, P405; EQOL G, 2011, EQ 5D 5L US GUID BAS; Herman M, 1997, J ADDICT DIS, V16, P91, DOI 10.1300/J069v16n01_06; Hogan Beth, 2007, Health Mark Q, V24, P93, DOI 10.1080/07359680802125923; Jardine M, 2012, HARM REDUCT J, V9, DOI 10.1186/1477-7517-9-26; Kelly SM, 2010, AM J DRUG ALCOHOL AB, V36, P150, DOI 10.3109/00952991003736371; Madden A, 2008, DRUG ALCOHOL REV, V27, P671, DOI 10.1080/09595230801935706; Marchand K, 2015, J ADDICT MED, V9, P391, DOI 10.1097/ADM.0000000000000145; Marchand KI, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-174; McLellan AT, 1996, MILBANK Q, V74, P51, DOI 10.2307/3350433; Mitike G, 2002, ETHIOPIAN MED J, V40, P387; Nguyen Tam T M, 2012, Adv Prev Med, V2012, P732484, DOI 10.1155/2012/732484; OCONNOR PG, 1992, AM J MED, V93, P382, DOI 10.1016/0002-9343(92)90166-9; Olowookere Samuel Anu, 2012, J Int Assoc Physicians AIDS Care (Chic), V11, P188, DOI 10.1177/1545109711402214; SAMET JH, 1995, SUBST ABUS, V16, P131, DOI DOI 10.1080/08897079509444716; SELWYN PA, 1993, PUBLIC HEALTH REP, V108, P492; Simpson DD, 1997, J SUBST ABUSE TREAT, V14, P565, DOI 10.1016/S0740-5472(97)00181-5; Smith P., 2008, EUROPEAN OBSERVATORY; Stein MD, 2002, ADDICT BEHAV, V27, P727, DOI 10.1016/S0306-4603(01)00205-2; Tran BX, 2012, DRUG ALCOHOL DEPEN, V125, P260, DOI 10.1016/j.drugalcdep.2012.02.021; Trujols J, 2012, DRUG ALCOHOL DEPEN, V123, P41, DOI 10.1016/j.drugalcdep.2011.10.014; Trujols J, 2010, J CLIN PSYCHOPHARM, V30, P95, DOI 10.1097/JCP.0b013e3181c8b439; UMBRICHTSCHNEITER A, 1994, AM J PUBLIC HEALTH, V84, P207, DOI 10.2105/AJPH.84.2.207; van Beek I, 2007, INT J DRUG POLICY, V18, P329, DOI 10.1016/j.drugpo.2006.11.005; Doubova SV, 2009, SALUD PUBLICA MEXICO, V51, P231, DOI 10.1590/S0036-36342009000300014; World Health Organization Department of Mental Health and Substance Abuse Management of Substance Abuse, 2006, TREATM INJ DRUG US H; Zhang L, 2015, EUR J GASTROEN HEPAT, V27, P550, DOI 10.1097/MEG.0000000000000321; Zhang ZW, 2008, J HEALTH PSYCHOL, V13, P388, DOI 10.1177/1359105307088142	44	20	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142644	10.1371/journal.pone.0142644	http://dx.doi.org/10.1371/journal.pone.0142644			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7CT	26556036	Green Submitted, Green Published, gold			2022-12-27	WOS:000364430700148
J	Hao, SX; Hou, X; Wei, L; Li, J; Li, ZH; Wang, XT				Hao, Shixin; Hou, Xin; Wei, Lei; Li, Jian; Li, Zhonghu; Wang, Xiaotong			Extraction and Identification of the Pigment in the Adductor Muscle Scar of Pacific Oyster Crassostrea gigas	PLOS ONE			English	Article							MELANIN; BIOSYNTHESIS; MELANOGENESIS; PURIFICATION	In this study, UV (ultraviolet) and IR (infrared radiation) spectral analysis were integrated to identify the pigment in the adductor muscle scar of the Pacific oyster Crassostrea gigas. The pigment was extracted from the adductor muscle scars of cleaned oyster shells that were pulverized, hydrolyzed in hot hydrochloric acid, purified with diethyl ether, and dissolved in 0.01 mL/L NaOH. The maximum absorption of the pigment in the UV absorption spectrum within the range of 190-500 nm was observed between 210-220 nm. The UV absorbance decreased with increasing wavelength which was consistent with the UV spectral absorption characteristics of melanin. In addition, Fourier transform infrared spectroscopy scanning revealed characteristic absorption peaks that emerged near 3440 cm(-1) and 1630 cm(-1), which was consistent with infrared scanning features of eumelanin (a type of melanin). This study has demonstrated for the first time that the pigment in the adductor muscle scar of the Pacific oyster is melanin, hinting that the adductor muscle could be another organ pigmenting the mollusc shell with melanin other than mantle.	[Hao, Shixin; Wei, Lei; Li, Jian; Li, Zhonghu; Wang, Xiaotong] Ludong Univ, Sch Agr, Yantai, Shandong, Peoples R China; [Hou, Xin] Ludong Univ, Sch Life Sci, Yantai, Shandong, Peoples R China	Ludong University; Ludong University	Wang, XT (corresponding author), Ludong Univ, Sch Agr, Yantai, Shandong, Peoples R China.	wangxiaotong999@163.com						Aghajanyan AE, 2005, PIGM CELL RES, V18, P130, DOI 10.1111/j.1600-0749.2005.00211.x; Ahmed B, 2017, TRANSBOUND EMERG DIS, V64, P167, DOI 10.1111/tbed.12358; Araujo M, 2012, STRUCT CHEM, V23, P115, DOI 10.1007/s11224-011-9843-7; BELL AA, 1986, ANNU REV PHYTOPATHOL, V24, P411, DOI 10.1146/annurev.py.24.090186.002211; Deng WD, 2008, MOL BIOL REP, V35, P379, DOI 10.1007/s11033-007-9097-z; Deng WD, 2006, ANIM GENET, V37, P586, DOI 10.1111/j.1365-2052.2006.01530.x; Dubey S, 2014, PIGM CELL MELANOMA R, V27, P327, DOI 10.1111/pcmr.12231; El Bassam S, 2002, CAN J MICROBIOL, V48, P349, DOI 10.1139/w02-030; KOLLIAS N, 1991, J PHOTOCH PHOTOBIO B, V9, P135, DOI 10.1016/1011-1344(91)80147-A; Kumar R, 2015, FISH PHYSIOL BIOCHEM, V41, P761, DOI 10.1007/s10695-015-0044-y; Langfelder K, 2003, FUNGAL GENET BIOL, V38, P143, DOI 10.1016/S1087-1845(02)00526-1; Li N, 2010, FOOD CHEM, V118, P616, DOI 10.1016/j.foodchem.2009.05.043; Lu Y, 2014, APPL BIOCHEM BIOTECH, V174, P762, DOI 10.1007/s12010-014-1110-0; Magarelli M., 2010, Revista CES Medicina Veterinaria y Zootecnia, V5, P18; NICOLAUS RA, 1964, TETRAHEDRON, V20, P1163, DOI 10.1016/S0040-4020(01)98983-5; PROTA G, 1980, J INVEST DERMATOL, V75, P122, DOI 10.1111/1523-1747.ep12521344; Sharma S, 2002, PIGM CELL RES, V15, P127, DOI 10.1034/j.1600-0749.2002.1o076.x; Vrolijk MF, 2015, REDOX BIOL, V4, P272, DOI 10.1016/j.redox.2014.12.017; Wakamatsu K, 2002, PIGM CELL RES, V15, P174, DOI 10.1034/j.1600-0749.2002.02017.x; Yuan WL, 2007, PHYSIOL PLANTARUM, V131, P180, DOI 10.1111/j.1399-3054.2007.00948.x; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413	21	17	18	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142439	10.1371/journal.pone.0142439	http://dx.doi.org/10.1371/journal.pone.0142439			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555720	Green Published, gold, Green Submitted			2022-12-27	WOS:000364430700105
J	Lim, MCY; Wang, YF; Huang, SW; Yang, JY; Wang, JR				Lim, Matthew C. Y.; Wang, Ya-Fang; Huang, Sheng-Wen; Yang, Jyh-Yuan; Wang, Jen-Ren			High Incidence of Mammalian Orthoreovirus Identified by Environmental Surveillance in Taiwan	PLOS ONE			English	Article							HUMAN ADENOVIRUS; CELL-CULTURE; WASTE-WATER; RESPIRATORY ADENOVIRUS; ACUTE GASTROENTERITIS; POLIOVIRUS DETECTION; REOVIRUS; SEWAGE; ENTEROVIRUSES; TYPE-3	Wild poliovirus (WPV) persists in diverse locales worldwide, spreading outward from endemic areas. In response to the international threat of WPV transmission and changes in the national vaccination policy, we established an environmental surveillance system to monitor the circulation of wild and vaccine-related poliovirus in Taiwan. From July 2012 to December 2013, we collected sewage specimens every month from 10 sewage treatment plants located throughout Taiwan. The specimens were concentrated by the two-phase separation method and then inoculated into L20B, RD, and A549 cells for virus isolation. Viral isolates were identified and serotyped by immunofluorescence assay or molecular analysis. A total of 300 sewage samples were collected, and the results showed 163 samples (54.3%) were positive for virus, and 268 isolates were identified. Among these, 75 samples (25%) were positive for enterovirus (EV), but no poliovirus was found. In addition, 92 isolates were identified as enteroviruses and the most common serotypes were coxsackie-virus B4, coxsackievirus B3, and coxsackievirus B2. Interestingly, 102 (34%) and 82 (27.3%) specimens were positive for mammalian orthoreovirus (MRV) and adenovirus, respectively. This study confirmed that sewage surveillance can be a useful additional modality for monitoring the possible presence of wild-type or vaccine-derived poliovirus in wastewater, and can indicate the current types of viruses circulating in the population. Furthermore, since MRV was found in children with acute necrotizing encephalopathy and meningitis, the high incidence of MRV detected by environmental surveillance warrants further investigation.	[Lim, Matthew C. Y.; Wang, Jen-Ren] Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan 70101, Taiwan; [Huang, Sheng-Wen; Wang, Jen-Ren] Natl Cheng Kung Univ, Ctr Infect Dis & Signaling Res, Tainan 70101, Taiwan; [Wang, Jen-Ren] Natl Cheng Kung Univ Hosp, Dept Pathol, Tainan 70428, Taiwan; [Yang, Jyh-Yuan] Minist Hlth & Welf, Ctr Dis Control, Ctr Res Diagnost & Vaccine Dev, Taipei, Taiwan; [Wang, Ya-Fang; Wang, Jen-Ren] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Tainan, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; Centers For Disease Control - Taiwan; National Health Research Institutes - Taiwan	Wang, JR (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan 70101, Taiwan.	jrwang@mail.ncku.edu.tw	Wang, Jen-Ren/F-5254-2011	Wang, Jen-Ren/0000-0002-4127-4046	Centers for Disease Control, Taiwan [DOH102-DC-1106]; Ministry of Science and Technology (MOST) [MOST 104-2321-B006-002]; National Health Research Institutes [04A1-IVPP11-014]	Centers for Disease Control, Taiwan; Ministry of Science and Technology (MOST)(Ministry of Science and Technology, China); National Health Research Institutes(National Health Research Institutes, Japan)	This study was funded by the Centers for Disease Control, Taiwan (grant no. DOH102-DC-1106), Ministry of Science and Technology (MOST) (grant no. MOST 104-2321-B006-002), and National Health Research Institutes (grant no. 04A1-IVPP11-014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams T, 2000, B WORLD HEALTH ORGAN, V78, P1375; Andre M, 2013, MMWR-MORBID MORTAL W, V62, P768; Anis E, 2013, EURO SURVEILL, V18; Antona D, 2007, EUR J CLIN MICROBIOL, V26, P403, DOI 10.1007/s10096-007-0306-4; Aslan A, 2011, J APPL MICROBIOL, V111, P1250, DOI 10.1111/j.1365-2672.2011.05130.x; AWWA. (American Water Works Association), 1999, AWWA MAN WAT PRACT M; Battistone A, 2014, APPL ENVIRON MICROB, V80, P4491, DOI 10.1128/AEM.00108-14; Biologicals DoVa, 2003, GUID ENV SURV POL CI; Blasiole DA, 2004, J CLIN MICROBIOL, V42, P1686, DOI 10.1128/JCM.42.4.1686-1693.2004; Cardemil CV, 2014, EPIDEMIOL INFECT, V142, P163, DOI 10.1017/S0950268813000800; Centers for Disease Control and Prevention (CDC), 2013, MMWR Morb Mortal Wkly Rep, V62, P484; Chang SY, 2008, J MED VIROL, V80, P102, DOI 10.1002/jmv.21045; Chua KB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003803; Costan-Longares A, 2008, J APPL MICROBIOL, V105, P1945, DOI 10.1111/j.1365-2672.2008.03954.x; DAHLING DR, 1989, APPL ENVIRON MICROB, V55, P503, DOI 10.1128/AEM.55.2.503-506.1989; Day JM, 2009, INFECT GENET EVOL, V9, P390, DOI 10.1016/j.meegid.2009.01.011; Duncan R, 1999, VIROLOGY, V260, P316, DOI 10.1006/viro.1999.9832; Fraenkel-Conrat H, 1988, VIROLOGY; Gallagher EM, 2007, J VIROL METHODS, V139, P195, DOI 10.1016/j.jviromet.2006.10.001; Global Polio Eradication Initiative, WHO S E AS REG DECL; Griffin DW, 2003, CLIN MICROBIOL REV, V16, P129, DOI 10.1128/CMR.16.1.129-143.2003; Hermann L, 2004, PEDIATR INFECT DIS J, V23, P373, DOI 10.1097/00006454-200404000-00026; Hewitt J, 2013, WATER RES, V47, P6750, DOI 10.1016/j.watres.2013.09.001; Hovi T, 2012, EPIDEMIOL INFECT, V140, P1, DOI 10.1017/S095026881000316X; Jiang J, 2006, VIRUS GENES, V33, P193, DOI 10.1007/s11262-005-0046-4; Johansson PJH, 1996, SCAND J INFECT DIS, V28, P117, DOI 10.3109/00365549609049060; Kajon AE, 2010, J INFECT DIS, V202, P93, DOI 10.1086/653083; Kaneko H, 2011, BRIT J OPHTHALMOL, V95, P32, DOI 10.1136/bjo.2009.178772; Kaneko H, 2009, J GEN VIROL, V90, P1471, DOI 10.1099/vir.0.009225-0; Kew OM, 2005, ANNU REV MICROBIOL, V59, P587, DOI 10.1146/annurev.micro.58.030603.123625; Kim YJ, 2003, J CLIN MICROBIOL, V41, P4594, DOI 10.1128/JCM.41.10.4594-4599.2003; Lago PM, 2003, INT J EPIDEMIOL, V32, P772, DOI 10.1093/ije/dyg185; Lelli D, 2013, ZOONOSES PUBLIC HLTH, V60, P84, DOI 10.1111/zph.12001; LERNER AM, 1962, PHYS REV, V126, P947, DOI 10.1056/NEJM196211082671901; Lin KH, 2004, J MED VIROL, V73, P274, DOI 10.1002/jmv.20087; Lodder WJ, 2012, APPL ENVIRON MICROB, V78, P3800, DOI 10.1128/AEM.07972-11; Lowther SA, 2013, RISK ANAL, V33, P664, DOI 10.1111/risa.12032; Manor Y, 1999, J CLIN MICROBIOL, V37, P1670, DOI 10.1128/JCM.37.6.1670-1675.1999; MATSUURA K, 1993, MICROBIOL IMMUNOL, V37, P305, DOI 10.1111/j.1348-0421.1993.tb03214.x; Melnick JL, 1990, VIROLOGY, P549; METCALF TG, 1995, ANNU REV MICROBIOL, V49, P461, DOI 10.1146/annurev.micro.49.1.461; Metzgar D, 2005, J CLIN MICROBIOL, V43, P5743, DOI 10.1128/JCM.43.11.5743-5752.2005; Moturi EK, 2014, MMWR-MORBID MORTAL W, V30, P468; Nix WA, 2006, J CLIN MICROBIOL, V44, P2698, DOI 10.1128/JCM.00542-06; Ouattara LA, 2011, EMERG INFECT DIS, V17, P1436, DOI 10.3201/eid1708.101528; Paduch DA, 2007, CURR UROL REP, V8, P324, DOI 10.1007/s11934-007-0080-y; Piqueur MAC, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-95; RIDINGER DN, 1982, APPL ENVIRON MICROB, V43, P740, DOI 10.1128/AEM.43.4.740-746.1982; Rodriguez RA, 2013, WATER RES, V47, P3183, DOI 10.1016/j.watres.2013.03.022; ROSEN L, 1960, AM J HYG, V71, P242, DOI 10.1093/oxfordjournals.aje.a120107; SABIN AB, 1959, SCIENCE, V130, P1387, DOI 10.1126/science.130.3386.1387; Sherry B, 1998, CURR TOP MICROBIOL, V233, P51; Spinner ML, 2001, APPL ENVIRON MICROB, V67, P3016, DOI 10.1128/AEM.67.7.3016-3020.2001; Steyer A, 2013, J CLIN MICROBIOL, V51, P3818, DOI 10.1128/JCM.01531-13; Tansuphasiri Unchalee, 2000, Southeast Asian Journal of Tropical Medicine and Public Health, V31, P47; Tyler KL, 2004, J INFECT DIS, V189, P1664, DOI 10.1086/383129; Tyler KL, 1998, CURR TOP MICROBIOL, V233, P93; UHNOO I, 1984, J CLIN MICROBIOL, V20, P365, DOI 10.1128/JCM.20.3.365-372.1984; Wang SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075208; Watkins RE, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-162; Wen N, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-113; Wong MVM, 2013, J WATER HEALTH, V11, P659, DOI 10.2166/wh.2013.322; Wood DJ, 1999, J MED VIROL, V58, P188, DOI 10.1002/(SICI)1096-9071(199906)58:2<188::AID-JMV15>3.3.CO;2-8; Zheng HY, 2013, APPL ENVIRON MICROB, V79, P7679, DOI 10.1128/AEM.02058-13	64	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142745	10.1371/journal.pone.0142745	http://dx.doi.org/10.1371/journal.pone.0142745			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555962	Green Published, Green Submitted, gold			2022-12-27	WOS:000364430700167
J	Liu, HC; Zhu, DY; Wang, C; Guan, HG; Li, SL; Hu, C; Chen, ZC; Hu, YY; Lin, H; Lian, QQ; Ge, RS				Liu, Hua-Cheng; Zhu, Danyan; Wang, Chan; Guan, Hongguo; Li, Senlin; Hu, Cong; Chen, Zhichuan; Hu, Yuanyuan; Lin, Han; Lian, Qing-Quan; Ge, Ren-Shan			Effects of Etomidate on the Steroidogenesis of Rat Immature Leydig Cells	PLOS ONE			English	Article							BETA-HYDROXYSTEROID DEHYDROGENASE; ANESTHETIC ETOMIDATE; ADRENODOXIN; INHIBITORS; RECEPTORS	Background Etomidate is a rapid hypnotic intravenous anesthetic agent. The major side effect of etomidate is the reduced plasma concentration of corticosteroids, leading to the abnormal reaction of adrenals. Cortisol and testosterone biosynthesis has similar biosynthetic pathway, and shares several common steroidogenic enzymes, such as P450 side chain cleavage enzyme (CYP11A1) and 3 beta-hydroxysteroid dehydrogenase 1 (HSD3B1). The effect of etomidate on Leydig cell steroidogenesis during the cell maturation process is not well established. Methodology Immature Leydig cells isolated from 35 day-old rats were cultured with 30 mu M etomidate for 3 hours in combination with LH, 8Br-cAMP, 25R-OH-cholesterol, pregnenolone, progesterone, androstenedione, testosterone and dihydrotestosterone, respectively. The concentrations of 5a-androstanediol and testosterone in the media were measured by radioimmunoassay. Leydig cells were cultured with various concentrations of etomidate (0.3-30 mu M) for 3 hours, and total RNAs were extracted. Q-PCR was used to measure the mRNA levels of following genes: Lhcgr, Scarb1, Star, Cyp11a1, Hsd3b1, Cyp17a1, Hsd17b3, Srd5a1, and Akr1c14. The testis mitochondria and microsomes from 35-day-old rat testes were prepared and used to detect the direct action of etomidate on CYP11A1 and HSD3B1 activity. Results and Conclusions In intact Leydig cells, 30 mu M etomidate significantly inhibited androgen synthesis. Further studies showed that etomidate also inhibited the LH-stimulated androgen production. On purified testicular mitochondria and ER fractions, etomidate competitively inhibited both CYP11A1 and HSD3B1 activities, with the half maximal inhibitory concentration (IC50) values of 12.62 and 2.75 mu M, respectively. In addition, etomidate inhibited steroidogenesis-related gene expression. At about 0.3 mu M, etomidate significantly inhibited the expression of Akr1C14. At the higher concentration (30 mu M), it also reduced the expression levels of Cyp11a1, Hsd17b3 and Srd5a1. In conclusion, etomidate directly inhibits the activities of CYP11A1 and HSD3B1, and the expression levels of Cyp11a1 and Hsd17b3, leading to the lower production of androgen by Leydig cells.	[Liu, Hua-Cheng; Zhu, Danyan; Wang, Chan; Li, Senlin; Hu, Cong; Chen, Zhichuan; Hu, Yuanyuan; Lin, Han; Lian, Qing-Quan; Ge, Ren-Shan] Wenzhou Med Univ, Dept Anesthiol, Affiliated Hosp 2, Wenzhou 325027, Zhejiang, Peoples R China; [Liu, Hua-Cheng; Zhu, Danyan; Wang, Chan; Li, Senlin; Hu, Cong; Chen, Zhichuan; Hu, Yuanyuan; Lin, Han; Lian, Qing-Quan; Ge, Ren-Shan] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou 325027, Zhejiang, Peoples R China; [Guan, Hongguo] Wenzhou Med Univ, Sch Pharm, Wenzhou 325035, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Lian, QQ (corresponding author), Wenzhou Med Univ, Dept Anesthiol, Affiliated Hosp 2, Wenzhou 325027, Zhejiang, Peoples R China.	lianqingquanmz@163.com; r_ge@yahoo.com	Lin, Han/GRF-1081-2022	Chen, Zhichuan/0000-0002-4244-9469; Hu, Cong/0000-0001-9778-3141	Health Bureau of Zhejiang Province [WKJ2011-2-012, 2013ZDA017, 11-CX29]; National Natural Science Foundation [81471448]	Health Bureau of Zhejiang Province; National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was partially supported by the Health Bureau of Zhejiang Province (WKJ2011-2-012, 2013ZDA017 & 11-CX29), and the National Natural Science Foundation (No.81471448). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	DIAGO MC, 1988, ANAESTHESIA, V43, P644, DOI 10.1111/j.1365-2044.1988.tb04148.x; Doenicke A, 1974, Acta Anaesthesiol Belg, V25, P307; Forman SA, 2011, ANESTHESIOLOGY, V114, P695, DOI 10.1097/ALN.0b013e3181ff72b5; Ge RS, 1998, ENDOCRINOLOGY, V139, P3787, DOI 10.1210/en.139.9.3787; Ge RS, 1997, ENDOCRINOLOGY, V138, P2435, DOI 10.1210/en.138.6.2435; GOODING JM, 1976, ANESTH ANALG, V55, P286; Guo JJ, 2013, REPRODUCTION, V145, P371, DOI 10.1530/REP-12-0465; HANUKOGLU I, 1987, EUR J BIOCHEM, V169, P449, DOI 10.1111/j.1432-1033.1987.tb13632.x; HANUKOGLU I, 1980, J BIOL CHEM, V255, P3057, DOI 10.1016/S0021-9258(19)85851-9; HEYTENS L, 1987, HUM REPROD, V2, P85, DOI 10.1093/oxfordjournals.humrep.a136506; Hu GX, 2009, J STEROID BIOCHEM, V115, P14, DOI 10.1016/j.jsbmb.2009.02.004; Husain SS, 2003, J MED CHEM, V46, P1257, DOI 10.1021/jm020465v; LAMBERT A, 1987, J ENDOCRINOL, V113, P457, DOI 10.1677/joe.0.1130457; Ledingham IM, 1983, LANCET, V321; Lin H, 2008, P NATL ACAD SCI USA, V105, P7218, DOI 10.1073/pnas.0709260105; PAYNE AH, 1980, J BIOL CHEM, V255, P7118; Payne AH, 1997, STEROIDS, V62, P169, DOI 10.1016/S0039-128X(96)00177-8; Rijk JCW, 2012, CHEM RES TOXICOL, V25, P1720, DOI 10.1021/tx3001779; SCHULTE HM, 1990, J CLIN ENDOCR METAB, V70, P1426, DOI 10.1210/jcem-70-5-1426; Tomlin SL, 1998, ANESTHESIOLOGY, V88, P708, DOI 10.1097/00000542-199803000-00022; WAGNER RL, 1984, NEW ENGL J MED, V310, P1415, DOI 10.1056/NEJM198405313102202; WAGNER RL, 1984, ANESTHESIOLOGY, V61, P647, DOI 10.1097/00000542-198412000-00003; Ye LP, 2011, MOLECULES, V16, P9983, DOI 10.3390/molecules16129983; Zolle IM, 2008, J MED CHEM, V51, P2244, DOI 10.1021/jm800012w	24	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0139311	10.1371/journal.pone.0139311	http://dx.doi.org/10.1371/journal.pone.0139311			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555702	Green Published, gold, Green Submitted			2022-12-27	WOS:000364430700005
J	Valcour, VG; Spudich, SS; Sailasuta, N; Phanuphak, N; Lerdlum, S; Fletcher, JLK; Kroon, EDMB; Jagodzinskr, LL; Allen, IE; Adams, CL; Prueksakaew, P; Slike, BM; Hellmuth, JM; Kim, JH; Ananworanich, J				Valcour, Victor G.; Spudich, Serena S.; Sailasuta, Napapon; Phanuphak, Nittaya; Lerdlum, Sukalaya; Fletcher, James L. K.; Kroon, Eugene D. M. B.; Jagodzinskr, Linda L.; Allen, Isabel E.; Adams, Collin L.; Prueksakaew, Peeriya; Slike, Bonnie M.; Hellmuth, Joanna M.; Kim, Jerome H.; Ananworanich, Jintanat		SEARCH 010-RV 254 Study Grp	Neurological Response to cART vs. cART plus Integrase Inhibitor and CCR5 Antagonist Initiated during Acute HIV	PLoS One			English	Article							CEREBROSPINAL-FLUID; TREATMENT INTENSIFICATION; INFECTION; RALTEGRAVIR; MARAVIROC; REPLICATION; PERFORMANCE; ABNORMALITIES; MONOCYTES; DYNAMICS	Objective To compare central nervous system (CNS) outcomes in participants treated during acute HIV infection with standard combination antiretroviral therapy (cART) vs. cART plus integrase inhibitor and CCR5 antagonist (cART+). Design 24-week randomized open-label prospective evaluation. Method Participants were evaluated then randomized to initiate cART (efavirenz, tenofovir, and either emtricitabine or lamivudine) vs. cART+ (cART plus raltegravir and maraviroc) during acute HIV and re-evaluated at 4, 12 and 24 weeks. We examined plasma and CSF cytokines, HIV RNA levels, neurological and neuropsychological findings, and brain MRS across groups and compared to healthy controls. Results At baseline, 62 participants were in Fiebig stages I-V. Randomized groups were similar for mean age (27 vs. 25, p = 0.137), gender (each 94% male), plasma log(10) HIV RNA (5.4 vs. 5.6, p = 0.382), CSF log(10) HIV RNA (2.35 vs. 3.31, p = 0.561), and estimated duration of HIV (18 vs. 17 days, p = 0.546). Randomized arms did not differ at 24 weeks by any CNS outcome. Combining arms, all measures concurrent with antiretroviral treatment improved, for example, neuropsychological testing (mean NPZ-4 of -0.408 vs. 0.245, p<0.001) and inflammatory markers by MRS (e.g. mean frontal white matter (FWM) choline of 2.92 vs. 2.84, p = 0.045) at baseline and week 24, respectively. Plasma neopterin (p<0.001) and interferon gamma-induced protein 10 (IP-10) (p = 0.007) remained elevated in participants compared to controls but no statistically significant differences were seen in CSF cytokines compared to controls, despite individual variability among the HIV-infected group. Conclusions A 24-week course of cART+ improved CNS related outcomes, but was not associated with measurable differences compared to standard cART.	[Valcour, Victor G.; Adams, Collin L.; Hellmuth, Joanna M.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Spudich, Serena S.] Yale Univ, Dept Neurol, New Haven, CT USA; [Sailasuta, Napapon] Huntington Med Res Inst, Pasadena, CA USA; [Phanuphak, Nittaya; Fletcher, James L. K.; Kroon, Eugene D. M. B.; Prueksakaew, Peeriya; SEARCH 010-RV 254 Study Grp] Thai Red Cross AIDS Res Ctr, South East Asia Res Collaborat Hawaii, Bangkok, Thailand; [Lerdlum, Sukalaya; Ananworanich, Jintanat] Chulalongkorn Univ, Fac Med, Bangkok 10330, Thailand; [Kroon, Eugene D. M. B.] Armed Forces Res Inst Med Sci, Dept Retrovirol, US Component, Bangkok 10400, Thailand; [Jagodzinskr, Linda L.; Slike, Bonnie M.; Kim, Jerome H.; Ananworanich, Jintanat] Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD USA; [Allen, Isabel E.] Univ Calif San Francisco, Dept Biostat & Epidemiol, San Francisco, CA 94143 USA; [Slike, Bonnie M.; Ananworanich, Jintanat] Henry M Jackson Fdn Advancement Mil Med, Bethesda, MD USA	University of California System; University of California San Francisco; Yale University; Huntington Medical Research Institutes; Thai Red Cross Society; Chulalongkorn University; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); University of California System; University of California San Francisco; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc	Valcour, VG (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.	vvalcour@memory.ucsf.edu	Ananworanich, Jintanat/AAC-6348-2021; Phanuphak, Nittaya/AAA-8579-2019; Maldarelli, Frank/O-2428-2016	Ananworanich, Jintanat/0000-0003-1369-3224; Ratto-Kim, Silvia/0000-0003-2025-6399	National Institutes of Health [R21MH086341, R01MH095613]; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. [W81XWH-07-2-0067]; U.S. Department of Defense (DoD) from the National Institutes of Mental Health; Intramural research programs of the National Institute of Allergy and Infectious Diseases; Vaccine and Gene Therapy Institute; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH086341, R01MH095613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG023481] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.; U.S. Department of Defense (DoD) from the National Institutes of Mental Health; Intramural research programs of the National Institute of Allergy and Infectious Diseases; Vaccine and Gene Therapy Institute; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work is supported by R21MH086341 from the National Institutes of Health (VV), R01MH095613 from the National Institutes of Health (VV & SS), and a cooperative agreement (W81XWH-07-2-0067) between the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., and the U.S. Department of Defense (DoD) which includes support from the National Institutes of Mental Health. The views expressed are those of the authors and should not be construed to represent the positions of the US Army or the Department of Defense or views of the National Institutes of Health. The authors received additional funding from the Intramural research programs of the National Institute of Allergy and Infectious Diseases and of the Vaccine and Gene Therapy Institute. The Thai Government Pharmaceutical Organization (tenofovir, lamivudine, efavirenz), Gilead (Truvada, Atripla), Merck ( Sustiva, Isentress), and ViiV Healthcare (Selzentry) provided antiretroviral therapy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananworanich J, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-56; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Buzon MJ, 2010, NAT MED, V16, P460, DOI 10.1038/nm.2111; Croteau D, 2010, ANTIMICROB AGENTS CH, V54, P5156, DOI 10.1128/AAC.00507-10; Dahl V, 2011, J INFECT DIS, V204, P1936, DOI 10.1093/infdis/jir667; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Gonzalez-Scarano F, 2005, NAT REV IMMUNOL, V5, P69, DOI 10.1038/nri1527; Hazuda DJ, 2000, SCIENCE, V287, P646, DOI 10.1126/science.287.5453.646; Heaps J, 2013, J CLIN EXP NEUROPSYC, V35, P1, DOI 10.1080/13803395.2012.733682; Kelly KM, 2013, AIDS, V27, pF21, DOI 10.1097/QAD.0000000000000074; Letendre Scott L, 2010, Top HIV Med, V18, P45; Llibre JM, 2012, ANTIVIR THER, V17, P355, DOI 10.3851/IMP1917; Madeddu G, 2012, AIDS, V26, P2412, DOI 10.1097/QAD.0b013e32835aa141; Melica G, 2010, AIDS, V24, P2130, DOI 10.1097/QAD.0b013e32833c9353; Michael NL, 1999, J CLIN MICROBIOL, V37, P2557, DOI 10.1128/JCM.37.8.2557-2563.1999; Ndhlovu LC, 2014, J NEUROVIROL, V20, P571, DOI 10.1007/s13365-014-0279-x; Peluso M, 2014, C RETR OPP INF CROI; Peluso MJ, 2013, J INFECT DIS, V207, P1703, DOI 10.1093/infdis/jit088; Peluso MJ, 2015, C RETR OPP INF CROI; Rossi R, 2011, CLIN EXP IMMUNOL, V166, P184, DOI 10.1111/j.1365-2249.2011.04409.x; Sailasuta N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049272; Spudich S, 2011, J INFECT DIS, V204, P753, DOI 10.1093/infdis/jir387; Valcour VG, 2007, NEUROLOGY, V68, P525, DOI 10.1212/01.wnl.0000253196.78193.c7; Valcour V, 2012, J INFECT DIS, V206, P275, DOI 10.1093/infdis/jis326; Valcour VG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070164; Yilmaz A, 2010, JAIDS-J ACQ IMM DEF, V55, P590, DOI 10.1097/QAI.0b013e3181f5b3d1	26	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142600	10.1371/journal.pone.0142600	http://dx.doi.org/10.1371/journal.pone.0142600			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555069	Green Published, gold, Green Submitted			2022-12-27	WOS:000364430700139
J	Gul, A; Khan, I; Shafie, S; Khalid, A; Khan, A				Gul, Aaiza; Khan, Ilyas; Shafie, Sharidan; Khalid, Asma; Khan, Arshad			Heat Transfer in MHD Mixed Convection Flow of a Ferrofluid along a Vertical Channel	PLOS ONE			English	Article							TEMPERATURE-DEPENDENT VISCOSITY; NANOFLUID	This study investigated heat transfer in magnetohydrodynamic (MHD) mixed convection flow of ferrofluid along a vertical channel. The channel with non-uniform wall temperatures was taken in a vertical direction with transverse magnetic field. Water with nanoparticles of magnetite (Fe3O4) was selected as a conventional base fluid. In addition, non-magnetic (Al2O3) aluminium oxide nanoparticles were also used. Comparison between magnetic and magnetite nanoparticles were also conducted. Fluid motion was originated due to buoyancy force together with applied pressure gradient. The problem was modelled in terms of partial differential equations with physical boundary conditions. Analytical solutions were obtained for velocity and temperature. Graphical results were plotted and discussed. It was found that temperature and velocity of ferrofluids depend strongly on viscosity and thermal conductivity together with magnetic field. The results of the present study when compared concurred with published work.	[Gul, Aaiza; Shafie, Sharidan; Khalid, Asma; Khan, Arshad] Univ Teknol Malaysia, Fac Sci, Dept Math Sci, Utm Skudai, Johor, Malaysia; [Khan, Ilyas] Majmaah Univ, Coll Engn, Majmaah, Saudi Arabia; [Khalid, Asma] Sardar Bahadur Khan Womens Univ, Quetta, Pakistan	Universiti Teknologi Malaysia; Majmaah University	Khan, I (corresponding author), Majmaah Univ, Coll Engn, Majmaah, Saudi Arabia.	ilyaskhanqau@yahoo.com; sharidan@utm.my	Khan, Ilyas/C-8770-2019	Khan, Ilyas/0000-0002-2056-9371				Abareshi M, 2010, J MAGN MAGN MATER, V322, P3895, DOI 10.1016/j.jmmm.2010.08.016; Akbar NS, 2014, CURR NANOSCI, V10, P807, DOI 10.2174/1573413710666140718175012; Akbar NS, 2014, CURR NANOSCI, V10, P432, DOI 10.2174/15734137113096660125; Borglin SE, 2000, TRANSPORT POROUS MED, V41, P61, DOI 10.1023/A:1006676931721; BRINKMAN HC, 1952, J CHEM PHYS, V20, P571, DOI 10.1063/1.1700493; Chen RX, 2015, REV MAT, V19, P325; Choi, 1995, DEV APPL NONNEWTONIA, V66; Colla L, 2012, ADV MECH ENG, DOI 10.1155/2012/674947; Das SK, 2008, NANOFLUIDS: SCIENCE AND TECHNOLOGY, P1; Ellahi R, 2013, APPL MATH MODEL, V37, P1451, DOI 10.1016/j.apm.2012.04.004; Ellahi R, 2012, MATH COMPUT MODEL, V55, P1876, DOI 10.1016/j.mcm.2011.11.043; He JH, 2012, THERM SCI, V16, P7; He JH, 2012, THERM SCI, V16, P1263, DOI 10.2298/TSCI1205263H; Herisanu N, 2012, Z NATURFORSCH A, V67, P509, DOI 10.5560/ZNA.2012-0047; Idrees M, 2012, MATH COMPUT MODEL, V55, P1324, DOI 10.1016/j.mcm.2011.10.010; Khalid A, 2015, EUR PHYS J PLUS, V130, DOI 10.1140/epjp/i2015-15057-9; Khan U, 2015, PROPULS POWER RES, V4, P40, DOI 10.1016/j.jppr.2015.02.004; Khan ZH, 2014, IEEE T NANOTECHNOL, V13, P35, DOI 10.1109/TNANO.2013.2286991; Makinde O. D., 2005, Romanian Journal of Physics, V50, P931; Makinde OD, 2013, INT J HEAT MASS TRAN, V62, P526, DOI 10.1016/j.ijheatmasstransfer.2013.03.049; Mansur S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117733; Maxwell JC., 1873, TREATISE ELECT MAGNE; Ozerinc S, 2010, MICROFLUID NANOFLUID, V8, P145, DOI 10.1007/s10404-009-0524-4; Qasim M, 2014, PLOS ONE, V9; Ram P, 2014, FLUID DYN MATER PROC, V10, P179; Scherer C, 2005, BRAZ J PHYS, V35, P718, DOI 10.1590/S0103-97332005000400018; Sheikholeslami M, 2014, ENERGY, V75, P400, DOI 10.1016/j.energy.2014.07.089; Turkyilmazoglu M., 2014, J HEAT TRANSFER, V136; Ul Haq R, 2015, PHYSICA B, V457, P40, DOI 10.1016/j.physb.2014.09.031; Zawrah MF, 2015, STABILITY ELECT COND, P1687	30	80	81	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2015	10	11							e0141213	10.1371/journal.pone.0141213	http://dx.doi.org/10.1371/journal.pone.0141213			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7AC	26550837	Green Published, gold, Green Submitted			2022-12-27	WOS:000364422800002
J	Ramsey, NB; Andersen, OS				Ramsey, Nicole B.; Andersen, Olaf S.			Bilayer Effects of Antimalarial Compounds	PLOS ONE			English	Article							MODULATE CHANNEL FUNCTION; ACCESS MALARIA BOX; NMR-SPECTROSCOPY; SODIUM-CHANNELS; MEMBRANE; DRUGS; IDENTIFICATION; AMPHIPHILES; ANESTHETICS; INHIBITORS	Because of the perpetual development of resistance to current therapies for malaria, the Medicines for Malaria Venture developed the Malaria Box to facilitate the drug development process. We tested the 80 most potent compounds from the box for bilayer-mediated effects on membrane protein conformational changes (a measure of likely toxicity) in a gramicidin-based stopped flow fluorescence assay. Among the Malaria Box compounds tested, four compounds altered membrane properties (p< 0.05); MMV007384 stood out as a potent bilayer-perturbing compound that is toxic in many cell-based assays, suggesting that testing for membrane perturbation could help identify toxic compounds. In any case, MMV007384 should be approached with caution, if at all.	[Ramsey, Nicole B.] Weill Cornell Rockefeller Sloan Kettering Triinst, New York, NY USA; [Ramsey, Nicole B.] Weill Cornell Grad Sch Med Sci, Grad Program Pharmacol, New York, NY USA; [Andersen, Olaf S.] Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY 10065 USA	Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Cornell University	Andersen, OS (corresponding author), Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY 10065 USA.	sparre@med.cornell.edu			National Institute of General Medical Sciences of the National Institutes of Health [GM021342, T32GM007739]; UNCF/Merck Science Initiative fellowship; NIH [GM021342]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021342, T32GM007739] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); UNCF/Merck Science Initiative fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding: This work was supported by the National Institute of General Medical Sciences of the National Institutes of Health (http://www.nigms.nih.gov) grant GM021342 (OSA); NBR was supported by a Medical Scientist Training Program grant from the National Institute of General Medical Sciences of the National Institutes of Health (http://www.nigms.nih.gov) under award number T32GM007739 to the Weill Cornell/Rockefeller/Sloan-Kettering Tri-Institutional MD-PhD Program (PD: OSA), and by a UNCF/Merck Science Initiative fellowship (http://umsi.uncf.org/).; This work was supported by NIH grant GM021342 (OSA); NBR was supported by a Medical Scientist Training Program grant from the National Institute of General Medical Sciences of the National Institutes of Health under award number T32GM007739 to the Weill Cornell/Rockefeller/Sloan-Kettering Tri-Institutional MD-PhD Program, and by a UNCF/Merck Science Initiative fellowship; the Malaria Box compounds were a gift from the Medicines for Malaria Venture. We thank J. Fraser Glickman, Radda Rusinova, and R. Lea Sanford for advice and stimulating discussions.	Alejo JL, 2013, BIOPHYS J, V104, P2410, DOI 10.1016/j.bpj.2013.04.039; Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000402; Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Barry J, 2009, J AM CHEM SOC, V131, P4490, DOI 10.1021/ja809217u; Basore K, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00091; Berberan-Santos MN, 2005, CHEM PHYS, V315, P171, DOI 10.1016/j.chemphys.2005.04.006; Bickerton GR, 2012, NAT CHEM, V4, P90, DOI [10.1038/nchem.1243, 10.1038/NCHEM.1243]; Boyom FF, 2014, ANTIMICROB AGENTS CH, V58, P5848, DOI 10.1128/AAC.02541-14; Bruno MJ, 2007, P NATL ACAD SCI USA, V104, P9638, DOI 10.1073/pnas.0701015104; Bruno MJ, 2013, FARADAY DISCUSS, V161, P461, DOI 10.1039/c2fd20092a; Dandapani S, 2012, FUTURE MED CHEM, V4, P2279, DOI [10.4155/FMC.12.178, 10.4155/fmc.12.178]; Darby CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068942; Desai SA, 2012, CELL MICROBIOL, V14, P1003, DOI 10.1111/j.1462-5822.2012.01790.x; Finkelstein A, 1987, THEORY AND REALITY; Fletcher S, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-343; Hain AUP, 2014, J MED CHEM, V57, P4521, DOI 10.1021/jm401675a; Herold KF, 2014, J GEN PHYSIOL, V144, P545, DOI 10.1085/jgp.201411172; HUANG HW, 1986, BIOPHYS J, V50, P1061, DOI 10.1016/S0006-3495(86)83550-0; Hwang TC, 2003, BIOCHEMISTRY-US, V42, P13646, DOI 10.1021/bi034887y; Ingolfsson HI, 2007, BIOCHEMISTRY-US, V46, P10384, DOI 10.1021/bi701013n; Ingolfsson HI, 2014, ACS CHEM BIOL, V9, P1788, DOI 10.1021/cb500086e; Ingolfsson Helgi I, 2010, J Vis Exp, DOI 10.3791/2131; Ingolfsson HI, 2010, ASSAY DRUG DEV TECHN, V8, P427, DOI 10.1089/adt.2009.0250; Kaiser M, 2015, J BIOMOL SCREEN, V20, P634, DOI 10.1177/1087057115569155; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Lucantoni L, 2013, ANTIMICROB AGENTS CH, V57, P6050, DOI 10.1128/AAC.00870-13; Lundb&AELIG;k JA, 2012, CHOLESTEROL REGULATI; Lundbaek JA, 2005, MOL PHARMACOL, V68, P680, DOI 10.1124/mol.105.013573; Lundbaek JA, 2004, J GEN PHYSIOL, V123, P599, DOI 10.1085/jgp.200308996; LUNDBAEK JA, 1994, J GEN PHYSIOL, V104, P645, DOI 10.1085/jgp.104.4.645; Lundbaek JA, 2008, J GEN PHYSIOL, V131, P421, DOI 10.1085/jgp.200709948; Lundbaek JA, 2010, J R SOC INTERFACE, V7, P373, DOI 10.1098/rsif.2009.0443; Momo F, 2005, BIOPHYS CHEM, V118, P15, DOI 10.1016/j.bpc.2005.06.006; Nielsen C, 2000, BIOPHYS J, V79, P2583, DOI 10.1016/S0006-3495(00)76498-8; Njuguna JT, 2014, BIOORGAN MED CHEM, V22, P4338, DOI 10.1016/j.bmc.2014.05.007; Paiardini A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115859; Paul SM, 2010, NAT REV DRUG DISCOV, V9, P203, DOI 10.1038/nrd3078; Phyo AP, 2012, LANCET, V379, P1960, DOI 10.1016/S0140-6736(12)60484-X; Porcelli F, 2013, METHODS MOL BIOL, V1063, P159, DOI 10.1007/978-1-62703-583-5_9; Resto YA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111051; Rusinova R, 2011, J GEN PHYSIOL, V138, P249, DOI 10.1085/jgp.201010529; Sanford RLC-G J., 2015, BIOPHYS J, P108; Santos JS, 2004, MAGN RESON CHEM, V42, P105, DOI 10.1002/mrc.1327; SAWYER DB, 1989, BIOCHEMISTRY-US, V28, P6571, DOI 10.1021/bi00442a007; SAWYER DB, 1989, BIOCHIM BIOPHYS ACTA, V987, P129, DOI 10.1016/0005-2736(89)90464-1; SEEMAN P, 1972, PHARMACOL REV, V24, P583; Sogaard R, 2006, BIOCHEMISTRY-US, V45, P13118, DOI 10.1021/bi060734+; Spangenberg T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062906; Thennarasu S, 2010, BIOPHYS J, V98, P248, DOI 10.1016/j.bpj.2009.09.060; Torrecillas A, 2015, ACS CHEM NEUROSCI, V6, P1741, DOI 10.1021/acschemneuro.5b00168; VISWANADHAN VN, 1989, J CHEM INF COMP SCI, V29, P163, DOI 10.1021/ci00063a006; Walters WP, 2003, NAT REV DRUG DISCOV, V2, P259, DOI 10.1038/nrd1063; Wiese M, 2002, DRUG MEMBRANE INTERA; World Health Organization, WHO WORLD MALARIA RE; Zepik HH, 2008, CRIT REV TOXICOL, V38, P1, DOI 10.1080/10408440701524519	55	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2015	10	11							e0142401	10.1371/journal.pone.0142401	http://dx.doi.org/10.1371/journal.pone.0142401			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7AC	26551613	Green Submitted, Green Published, gold			2022-12-27	WOS:000364422800026
J	Gomez, CE; Perdiguero, B; Garcia-Arriaza, J; Cepeda, V; Sanchez-Sorzano, CO; Mothe, B; Jimenez, JL; Munoz-Fernandez, MA; Gatell, JM; de Quiros, JCLB; Brander, C; Garcia, F; Esteban, M				Elena Gomez, Carmen; Perdiguero, Beatriz; Garcia-Arriaza, Juan; Cepeda, Victoria; Oscar Sanchez-Sorzano, Carlos; Mothe, Beatriz; Luis Jimenez, Jose; Angeles Munoz-Fernandez, Maria; Gatell, Jose M.; Bernaldo de Quiros, Juan Carlos Lopez; Brander, Christian; Garcia, Felipe; Esteban, Mariano			A Phase I Randomized Therapeutic MVA-B Vaccination Improves the Magnitude and Quality of the T Cell Immune Responses in HIV-1-Infected Subjects on HAART	PLOS ONE			English	Article							VIRAL LOAD; HIV-1; SAFETY; IMMUNOGENICITY; GAG; IMMUNIZATION; VACCINES; CD4(+); REPLICATION; EFFICACY	Trial Design Previous studies suggested that poxvirus-based vaccines might be instrumental in the therapeutic HIV field. A phase I clinical trial was conducted in HIV-1-infected patients on highly active antiretroviral therapy (HAART), with CD4 T cell counts above 450 cells/mm3 and undetectable viremia. Thirty participants were randomized (2: 1) to receive either 3 intramuscular injections of MVA-B vaccine (coding for clade B HIV-1 Env, Gag, Pol and Nef antigens) or placebo, followed by interruption of HAART. Methods The magnitude, breadth, quality and phenotype of the HIV-1-specific T cell response were assayed by intracellular cytokine staining (ICS) in 22 volunteers pre-and post-vaccination. Results MVA-B vaccine induced newly detected HIV-1-specific CD4 T cell responses and expanded pre-existing responses (mostly against Gag, Pol and Nef antigens) that were high in magnitude, broadly directed and showed an enhanced polyfunctionality with a T effector memory (TEM) phenotype, while maintaining the magnitude and quality of the pre-existing HIV-1-specific CD8 T cell responses. In addition, vaccination also triggered preferential CD8(+) T cell polyfunctional responses to the MVA vector antigens that increase in magnitude after two and three booster doses. Conclusion MVA-B vaccination represents a feasible strategy to improve T cell responses in individuals with pre-existing HIV-1-specific immunity.	[Elena Gomez, Carmen; Perdiguero, Beatriz; Garcia-Arriaza, Juan; Cepeda, Victoria; Oscar Sanchez-Sorzano, Carlos; Esteban, Mariano] CSIC, Ctr Nacl Biotecnol, Dept Mol & Cellular Biol, Madrid, Spain; [Mothe, Beatriz; Brander, Christian] Autonomous Univ Barcelona, Hosp Univ Germans Trias & Pujol, IrsiCaixa HIVACAT, Badalona, Spain; [Luis Jimenez, Jose; Angeles Munoz-Fernandez, Maria; Bernaldo de Quiros, Juan Carlos Lopez] Hosp Univ Gregorio Maranon, Madrid, Spain; [Gatell, Jose M.; Garcia, Felipe] IDIBAPS, Hosp Clin HIVACAT, Barcelona, Spain; [Brander, Christian] ICREA, Barcelona, Spain; [Brander, Christian] Univ Vic & Cent Catalonia, Vic, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Autonomous University of Barcelona; Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa; General University Gregorio Maranon Hospital; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; ICREA; Universitat de Vic - Universitat Central de Catalunya (UVic-UCC)	Esteban, M (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Mol & Cellular Biol, Madrid, Spain.	mesteban@cnb.csic.es	GARCIA-ARRIAZA, JUAN/Q-6243-2017; Jiménez, José Luis/AAK-6193-2020; Gatell, Jose M/ABC-3607-2020; Sorzano, Carlos Oscar S S./F-2639-2016; , Felipe/F-4242-2014; S. Sorzano, Carlos Oscar/ABE-4884-2021; Gomez, Carmen Elena/K-1940-2014; Esteban, Mariano/ABG-5375-2020; Perdiguero, Beatriz/K-6587-2017	GARCIA-ARRIAZA, JUAN/0000-0002-5167-5724; Jiménez, José Luis/0000-0001-6187-6223; Sorzano, Carlos Oscar S S./0000-0002-9473-283X; , Felipe/0000-0001-7658-5832; S. Sorzano, Carlos Oscar/0000-0002-9473-283X; Gomez, Carmen Elena/0000-0002-5414-7935; Esteban, Mariano/0000-0003-0846-2827; Perdiguero, Beatriz/0000-0001-6276-7766; Munoz-Fernandez/0000-0002-0813-4500; Mothe, Beatriz/0000-0001-9975-407X	Spanish government [SAF2008-02036, FIPSE-360731/09, SAF2012-39075, EC10-153, TRA-094, FIS PS09/01297]; Red SIDA [RD12-0017-0037, RD12-0017-0038]; HIVACAT program; ICREA Funding Source: Custom	Spanish government(Spanish GovernmentEuropean Commission); Red SIDA; HIVACAT program; ICREA(ICREA)	This work was supported by the Spanish government (SAF2008-02036, FIPSE-360731/09, SAF2012-39075, EC10-153, TRA-094, FIS PS09/01297), Red SIDA (RD12-0017-0037 and RD12-0017-0038) and the HIVACAT program.	Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Betts MR, 2001, J VIROL, V75, P11983, DOI 10.1128/JVI.75.24.11983-11991.2001; Carcelain G, 2013, IMMUNOL REV, V254, P355, DOI 10.1111/imr.12083; Caskey M, 2015, NATURE, V522, P487, DOI 10.1038/nature14411; Dahabieh MS, 2015, ANNU REV MED, V66, P407, DOI 10.1146/annurev-med-092112-152941; De Crignis E, 2014, VIRUSES-BASEL, V6, P4581, DOI 10.3390/v6114581; Dorrell L, 2007, VACCINE, V25, P3277, DOI 10.1016/j.vaccine.2007.01.005; Dorrell L, 2006, J VIROL, V80, P4705, DOI 10.1128/JVI.80.10.4705-4716.2006; Gomez CE, 2013, EXPERT REV VACCINES, V12, P1395, DOI 10.1586/14760584.2013.845531; Gomez CE, 2011, J VIROL, V85, P11468, DOI 10.1128/JVI.05165-11; Emery S, 2007, HUM VACCINES, V3, P260, DOI 10.4161/hv.4627; Emery S, 2005, HUM VACCINES, V1, P232, DOI 10.4161/hv.1.6.2342; Garcia F, 2012, HUM VACC IMMUNOTHER, V8, P569, DOI 10.4161/hv.19555; Garcia F, 2011, VACCINE, V29, P8309, DOI 10.1016/j.vaccine.2011.08.098; Garcia-Arriaza J, 2012, VIRUS RES, V167, P391, DOI 10.1016/j.virusres.2012.05.020; Garcia-Arriaza J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012395; Garcia-Merino I, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-27; Gomez CE, 2007, VACCINE, V25, P2863, DOI 10.1016/j.vaccine.2006.09.090; Greenough TC, 2008, VACCINE, V26, P6883, DOI 10.1016/j.vaccine.2008.09.084; Harari A, 2012, EUR J IMMUNOL, V42, P3038, DOI 10.1002/eji.201242696; Harrer E, 2005, ANTIVIR THER, V10, P285; Hashimoto C, 2011, EXPERT OPIN DRUG DIS, V6, P1067, DOI 10.1517/17460441.2011.611129; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Howles S, 2010, VACCINE, V28, P7306, DOI 10.1016/j.vaccine.2010.08.077; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Kilby JM, 2006, J INFECT DIS, V194, P1672, DOI 10.1086/509508; Kutscher S, 2010, GENE THER, V17, P1372, DOI 10.1038/gt.2010.90; Levy Y, 2005, AIDS, V19, P279; Lu S, 2009, CURR OPIN IMMUNOL, V21, P346, DOI 10.1016/j.coi.2009.05.016; Najera JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011406; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; Mothe B, 2015, J ANTIMICROB CHEMOTH, V70, P1833, DOI 10.1093/jac/dkv046; Noe A, 2005, J ANTIMICROB CHEMOTH, V55, P410, DOI 10.1093/jac/dki038; Ondondo BO, 2006, EUR J IMMUNOL, V36, P2585, DOI 10.1002/eji.200636508; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Pantaleo G, 2013, CURR OPIN HIV AIDS, V8, P236, DOI 10.1097/COH.0b013e32835fd5cd; Ramirez LA, 2013, EXPERT OPIN BIOL TH, V13, P563, DOI 10.1517/14712598.2013.758709; Rasmussen TA, 2013, HUM VACC IMMUNOTHER, V9, P790, DOI 10.4161/hv.23202; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Sahu GK, 2015, AIDS RES HUM RETROV, V31, P25, DOI [10.1089/aid.2014.0194, 10.1089/AID.2014.0194]; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Streeck H, 2013, NAT MED, V19, P143, DOI 10.1038/nm.3054; Vanham G, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-72; Zuniga R, 2006, J VIROL, V80, P3122, DOI 10.1128/JVI.80.6.3122-3125.2006	46	16	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141456	10.1371/journal.pone.0141456	http://dx.doi.org/10.1371/journal.pone.0141456			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544853	Green Published, gold, Green Submitted			2022-12-27	WOS:000364398700025
J	Hargreaves, CE; Iriyama, C; Rose-Zerilli, MJJ; Nagelkerke, SQ; Hussain, K; Ganderton, R; Lee, C; Machado, LR; Hollox, EJ; Parker, H; Latham, KV; Kuijpers, TW; Potter, KN; Coupland, SE; Davies, A; Stackpole, M; Oates, M; Pettitt, AR; Glennie, MJ; Cragg, MS; Strefford, JC				Hargreaves, Chantal E.; Iriyama, Chisako; Rose-Zerilli, Matthew J. J.; Nagelkerke, Sietse Q.; Hussain, Khiyam; Ganderton, Rosalind; Lee, Charlotte; Machado, Lee R.; Hollox, Edward J.; Parker, Helen; Latham, Kate V.; Kuijpers, Taco W.; Potter, Kathleen N.; Coupland, Sarah E.; Davies, Andrew; Stackpole, Michael; Oates, Melanie; Pettitt, Andrew R.; Glennie, Martin J.; Cragg, Mark S.; Strefford, Jonathan C.			Evaluation of High-Throughput Genomic Assays for the Fc Gamma Receptor Locus	PLOS ONE			English	Article							DEPENDENT PROBE AMPLIFICATION; COPY NUMBER VARIATION; POLYMORPHISMS; ASSOCIATION; IGG; IMMUNOGLOBULIN; DISEASE; RIIB; RNA	Cancer immunotherapy has been revolutionised by the use monoclonal antibodies (mAb) that function through their interaction with Fc gamma receptors (Fc gamma Rs). The low-affinity Fc gamma R genes are highly homologous, map to a complex locus at 1p23 and harbour single nucleotide polymorphisms (SNPs) and copy number variation (CNV) that can impact on receptor function and response to therapeutic mAbs. This complexity can hinder accurate characterisation of the locus. We therefore evaluated and optimised a suite of assays for the genomic analysis of the Fc gamma R locus amenable to peripheral blood mononuclear cells and formalin-fixed paraffin-embedded (FFPE) material that can be employed in a high-throughput manner. Assessment of TaqMan genotyping for FCGR2A-131H/R, FCGR3A-158F/V and FCGR2B-232I/T SNPs demonstrated the need for additional methods to discriminate genotypes for the FCGR3A-158F/V and FCGR2B-232I/T SNPs due to sequence homology and CNV in the region. A multiplex ligation-dependent probe amplification assay provided high quality SNP and CNV data in PBMC cases, but there was greater data variability in FFPE material in a manner that was predicted by the BIOMED-2 multiplex PCR protocol. In conclusion, we have evaluated a suite of assays for the genomic analysis of the Fc gamma R locus that are scalable for application in large clinical trials of mAb therapy. These assays will ultimately help establish the importance of Fc gamma R genetics in predicting response to antibody therapeutics.	[Hargreaves, Chantal E.; Iriyama, Chisako; Rose-Zerilli, Matthew J. J.; Hussain, Khiyam; Parker, Helen; Latham, Kate V.; Potter, Kathleen N.; Davies, Andrew; Glennie, Martin J.; Cragg, Mark S.; Strefford, Jonathan C.] Univ Southampton, Fac Med, Canc Sci, Southampton SO16 6YD, Hants, England; [Iriyama, Chisako] Nagoya Univ, Dept Hematol & Oncol, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Nagelkerke, Sietse Q.; Kuijpers, Taco W.] Univ Amsterdam, Acad Med Ctr, Dept Blood Cell Res, Sanquin Res & Landsteiner Lab, NL-1066 CX Amsterdam, Netherlands; [Ganderton, Rosalind; Lee, Charlotte] Univ Hosp Southampton NHS Fdn Trust, Mol Pathol, Southampton SO16 6YD, Hants, England; [Machado, Lee R.; Hollox, Edward J.] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; [Machado, Lee R.] Univ Northampton, Sch Hlth, Northampton NN2 7AL, England; [Kuijpers, Taco W.] Univ Amsterdam, Acad Med Ctr, Dept Pediat Hematol Immunol & Infect Dis, Emma Childrens Hosp, NL-1105 AZ Amsterdam, Netherlands; [Coupland, Sarah E.; Stackpole, Michael; Oates, Melanie; Pettitt, Andrew R.] Univ Liverpool, Dept Mol & Clin Canc Med, Inst Translat Med, Liverpool L69 3GA, Merseyside, England	University of Southampton; Nagoya University; University of Amsterdam; Academic Medical Center Amsterdam; University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Leicester; University of Northampton; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Liverpool	Strefford, JC (corresponding author), Univ Southampton, Fac Med, Canc Sci, Southampton SO16 6YD, Hants, England.	jcs@soton.ac.uk	Nagelkerke, Sietse/GZL-6725-2022; Cragg, Mark S/E-5965-2010; Strefford, Jonathan/B-2826-2009; Hargreaves, Chantal/AAH-2556-2020; Iriyama, Chisako/P-9811-2015	Cragg, Mark S/0000-0003-2077-089X; Strefford, Jonathan/0000-0002-0972-2881; Hargreaves, Chantal/0000-0003-1177-0003; Coupland, Sarah/0000-0002-1464-2069; Hollox, Edward/0000-0002-0115-2298; Davies, Andrew/0000-0002-7517-6938; Machado, Lee/0000-0001-7974-2178; Rose-Zerilli, Matthew/0000-0002-1064-5350	Uehara Memorial Foundation; Leukaemia and Lymphoma Research [11052, 12050]; National Centre for the Replacement, Refinement and Reduction of Animals in Research [NC/C011204/1]; Cancer Research UK [C328/A2738, C328/A2737]; EJH Wellcome Trust [087663]; Kay Kendall Leukaemia Fund [KKL584]; Experimental Cancer Medicine Centre (ECMC) [12009]; The Francis Crick Institute [10015] Funding Source: researchfish; National Centre for the Replacement [NC/C011204/1] Funding Source: researchfish	Uehara Memorial Foundation(Uehara Memorial Foundation); Leukaemia and Lymphoma Research; National Centre for the Replacement, Refinement and Reduction of Animals in Research(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs)); Cancer Research UK(Cancer Research UK); EJH Wellcome Trust(Wellcome Trust); Kay Kendall Leukaemia Fund; Experimental Cancer Medicine Centre (ECMC); The Francis Crick Institute; National Centre for the Replacement	CI was supported by The Uehara Memorial Foundation, http://www.ueharazaidan.or.jp/; MSC was supported by Leukaemia and Lymphoma Research (11052, 12050), https://leukaemialymphomaresearch.org.uk/; MJG was supported by National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC/C011204/1), https://www.nc3rs.org.uk/; and Cancer Research UK (C328/A2738 and C328/A2737), www.cancerresearchuk.org/; and EJH Wellcome Trust (087663), www.wellcome.ac.uk/; JCS was supported by Kay Kendall Leukaemia Fund (KKL584), Search Results, www.kklf.org.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Experimental Cancer Medicine Centre (ECMC)-funded University of Southampton, Faculty of Medicine Human Tissue Bank (Human Tissue Authority licence 12009) for sample storage.	Bibeau F, 2009, J CLIN ONCOL, V27, P1122, DOI 10.1200/JCO.2008.18.0463; Blank MC, 2005, HUM GENET, V117, P220, DOI 10.1007/s00439-005-1302-3; Breunis WB, 2009, HUM MUTAT, V30, pE640, DOI 10.1002/humu.20997; Breunis WB, 2008, BLOOD, V111, P1029, DOI 10.1182/blood-2007-03-079913; Cartron G, 2002, BLOOD, V99, P754, DOI 10.1182/blood.V99.3.754; Chen JY, 2014, ARTHRITIS RHEUMATOL, V66, P3113, DOI 10.1002/art.38813; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Floto RA, 2005, NAT MED, V11, P1056, DOI 10.1038/nm1288; Glennie MJ, 2007, MOL IMMUNOL, V44, P3823, DOI 10.1016/j.molimm.2007.06.151; Hargreaves CE, 2015, IMMUNOLOGIC IN PRESS, V268; Hollox EJ, 2009, HUM MUTAT, V30, P477, DOI 10.1002/humu.20911; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Kokkat TJ, 2013, BIOPRESERV BIOBANK, V11, P101, DOI 10.1089/bio.2012.0052; Lake SL, 2012, INVEST OPHTH VIS SCI, V53, P2647, DOI 10.1167/iovs.12-9584; Li SYS, 2014, J CLIN INVEST, V124, P3879, DOI 10.1172/JCI75539; Machado LR, 2012, AM J HUM GENET, V90, P973, DOI 10.1016/j.ajhg.2012.04.018; Machado LR, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0078165, DOI 10.1371/J0URNAL.P0NE.0078165]; Niederer HA, 2010, HUM MOL GENET, V19, P3282, DOI 10.1093/hmg/ddq216; Niederer HA, 2010, ANN NY ACAD SCI, V1183, P69, DOI 10.1111/j.1749-6632.2009.05132.x; Nimmerjahn F, 2011, CURR TOP MICROBIOL, V350, P105, DOI 10.1007/82_2010_86; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Tamura K, 2011, ANN ONCOL, V22, P1302, DOI 10.1093/annonc/mdq585; van der Heijden J, 2012, J IMMUNOL, V188, P1318, DOI 10.4049/jimmunol.1003945; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; van Mirre E, 2006, BLOOD, V108, P584, DOI 10.1182/blood-2005-12-4997; Veal CD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-455; Weng WK, 2003, J CLIN ONCOL, V21, P3940, DOI 10.1200/JCO.2003.05.013	28	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142379	10.1371/journal.pone.0142379	http://dx.doi.org/10.1371/journal.pone.0142379			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26545243	gold, Green Published, Green Accepted			2022-12-27	WOS:000364398700124
J	Huang, J; Han, SS; Qin, DD; Wu, LH; Song, Y; Yu, F; Wang, SX; Liu, G; Zhao, MH				Huang, Jing; Han, Sha-sha; Qin, Dan-dan; Wu, Li-hua; Song, Yan; Yu, Feng; Wang, Su-xia; Liu, Gang; Zhao, Ming-hui			Renal Interstitial Arteriosclerotic Lesions in Lupus Nephritis Patients: A Cohort Study from China	PLOS ONE			English	Article							VASCULAR-LESIONS; AMERICAN-COLLEGE; IMMUNE-COMPLEXES; DISEASE-ACTIVITY; ERYTHEMATOSUS; ATHEROSCLEROSIS; MORTALITY; GLOMERULONEPHRITIS; CYCLOPHOSPHAMIDE; CLASSIFICATION	Objective The aim of this study was to evaluate renal arteriosclerotic lesions in patients with lupus nephritis and investigate their associations with clinical and pathological characteristics, especially cardio-vascular features. Design A retrospective cohort study. Participants Seventy-nine patients with renal biopsy-proven lupus nephritis, diagnosed between January 2000 and June 2008 from Peking University First Hospital. Results In clinico-pathological data, patients with arteriosclerosis had higher ratio of hypertension and more severe renal injury indices compared with patients with no renal vascular lesions. More importantly, patients with renal arteriosclerosis had worse cardiac structure and function under transthoracic echocardiographic examination. Patients with renal arteriosclerosis tend to have higher ratios of combined endpoints compared with those of no renal vascular lesions, although the difference didn't reach statistical meanings (P = 0.104). Conclusion Renal arteriosclerotic lesion was common and associated with vascular immune complex deposits in lupus nephritis. It might have a certain degree of association with poor outcomes and cardiovascular events, which needs further explorations.	[Huang, Jing; Han, Sha-sha; Yu, Feng; Wang, Su-xia; Liu, Gang; Zhao, Ming-hui] Peking Univ, Hosp 1, Dept Med, Div Renal, Beijing 100034, Peoples R China; [Huang, Jing; Han, Sha-sha; Yu, Feng; Wang, Su-xia; Liu, Gang; Zhao, Ming-hui] Peking Univ, Inst Nephrol, Beijing 100034, Peoples R China; [Huang, Jing; Han, Sha-sha; Yu, Feng; Wang, Su-xia; Liu, Gang; Zhao, Ming-hui] Minist Hlth China, Key Lab Renal Dis, Beijing 100034, Peoples R China; [Huang, Jing; Han, Sha-sha; Yu, Feng; Wang, Su-xia; Liu, Gang; Zhao, Ming-hui] Minist Educ China, Key Lab CKD Prevent & Treatment, Beijing 100034, Peoples R China; [Qin, Dan-dan] Harbin Med Univ, Affiliated Hosp 2, Dept Nephrol, Harbin 150000, Heilongjiang, Peoples R China; [Wu, Li-hua] Ningxia Med Univ, Gen Hosp, Dept Nephrol, Yinchuan 750004, Ningxia, Peoples R China; [Song, Yan] Chinese Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Dept Nephrol, Beijing 100048, Peoples R China; [Zhao, Ming-hui] Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China	Peking University; Peking University; Ministry of Education, China; Harbin Medical University; Ningxia Medical University; Chinese People's Liberation Army General Hospital	Song, Y (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Dept Nephrol, 51 Fucheng Rd, Beijing 100048, Peoples R China.	songyan0209@163.com; yufengevert1@sina.com			Chinese 973 project [2012CB517702]; National Natural Science Foundation of China [81321064, 81470932]	Chinese 973 project(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by (1) a grant of Chinese 973 project (No. 2012CB517702), Ming-hui Zhao designed and directed the study; (2) National Natural Science Foundation of China to Innovation Research Group (No. 81321064), http://www.nsfc.gov.cn/, Ming-hui Zhao designed and directed the study; (3) National Natural Science Foundation of China (No. 81470932), http://www.nsfc.gov.cn/, Feng Yu recruited patients, collected samples and clinical data of patients, designed and directed the study.	Andreoli L, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0343-1; APPEL GB, 1994, J AM SOC NEPHROL, V4, P1499; Asanuma Y, 2003, NEW ENGL J MED, V349, P2407, DOI 10.1056/NEJMoa035611; AUSTIN HA, 1994, KIDNEY INT, V45, P544, DOI 10.1038/ki.1994.70; AUSTIN HA, 1984, KIDNEY INT, V25, P689, DOI 10.1038/ki.1984.75; BANFI G, 1991, AM J KIDNEY DIS, V18, P240, DOI 10.1016/S0272-6386(12)80885-7; Berden JHM, 1997, KIDNEY INT, V52, P538, DOI 10.1038/ki.1997.365; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Cervera R, 2006, AUTOIMMUN REV, V5, P180, DOI 10.1016/j.autrev.2005.06.004; Cervera R, 2003, MEDICINE, V82, P299, DOI 10.1097/01.md.0000091181.93122.55; Cervera R, 2006, AUTOIMMUN REV, V5, P549, DOI 10.1016/j.autrev.2006.02.015; Chan TM, 2005, LUPUS, V14, P265, DOI 10.1191/0961203305lu2081oa; Cheitlin MD, 2003, CIRCULATION, V108, P1146, DOI 10.1161/01.CIR.0000073597.57414.A9; Contreras G, 2004, NEW ENGL J MED, V350, P971, DOI 10.1056/NEJMoa031855; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; de Leeuw K, 2009, ATHEROSCLEROSIS, V206, P546, DOI 10.1016/j.atherosclerosis.2009.03.018; Descombes E, 1997, MEDICINE, V76, P355, DOI 10.1097/00005792-199709000-00003; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Griffin B, 2013, LUPUS, V22, P1267, DOI 10.1177/0961203313505927; GRISHMAN E, 1988, MODERN PATHOL, V1, P235; Grootscholten C, 2006, KIDNEY INT, V70, P732, DOI 10.1038/sj.ki.5001630; Hallan SI, 2012, JAMA-J AM MED ASSOC, V308, P2349, DOI 10.1001/jama.2012.16817; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Inoue T, 2012, THER APHER DIAL, V16, P134, DOI 10.1111/j.1744-9987.2011.01048.x; JONSSON H, 1989, MEDICINE, V68, P141, DOI 10.1097/00005792-198905000-00002; LEONG KH, 1994, J RHEUMATOL, V21, P1264; Lewis MJ, 2012, ARTHRITIS RHEUM-US, V64, P2707, DOI 10.1002/art.34451; LIANG MH, 1989, ARTHRITIS RHEUM, V32, P1107, DOI 10.1002/anr.1780320909; Mak A, 2007, LUPUS, V16, P28, DOI 10.1177/0961203306074469; Mattos P, 2011, CLIN RHEUMATOL, V30, P165, DOI 10.1007/s10067-010-1662-5; McMahon M, 2007, CURR OPIN IMMUNOL, V19, P633, DOI 10.1016/j.coi.2007.11.001; Mustafa A, 2000, CIRCULATION, V102, P2576; Narshi CB, 2011, LUPUS, V20, P5, DOI 10.1177/0961203310382429; ROSNER S, 1982, ARTHRITIS RHEUM, V25, P612, DOI 10.1002/art.1780250602; Sun WP, 2013, LAB INVEST, V93, P626, DOI 10.1038/labinvest.2013.61; Thacker SG, 2012, ARTHRITIS RHEUM-US, V64, P2975, DOI 10.1002/art.34504; UROWITZ MB, 1976, AM J MED, V60, P221, DOI 10.1016/0002-9343(76)90431-9; Wang HY, 2008, LUPUS, V17, P638, DOI 10.1177/0961203308089408; Wang J, 2007, LUPUS, V16, P707, DOI 10.1177/0961203307081340; Weening JJ, 2004, KIDNEY INT, V65, P521, DOI 10.1111/j.1523-1755.2004.00443.x; Wu LH, 2013, KIDNEY INT, V83, P715, DOI 10.1038/ki.2012.409; Zhang JJ, 2008, NEPHROLOGY, V13, P712, DOI 10.1111/j.1440-1797.2008.00983.x	42	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141547	10.1371/journal.pone.0141547	http://dx.doi.org/10.1371/journal.pone.0141547			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544865	gold, Green Published, Green Submitted			2022-12-27	WOS:000364398700033
J	Prieto, C; Destouni, G				Prieto, Carmen; Destouni, Georgia			Climate-Driven Phenological Change: Developing Robust Spatiotemporal Modeling and Projection Capability	PLoS One			English	Article							BUTTERFLIES; TEMPERATURE; INSOLATION	Our possibility to appropriately detect, interpret and respond to climate-driven phenological changes depends on our ability to model and predict the changes. This ability may be hampered by non-linearity in climate-phenological relations, and by spatiotemporal variability and scale mismatches of climate and phenological data. A modeling methodology capable of handling such complexities can be a powerful tool for phenological change projection. Here we develop such a methodology using citizen scientists' observations of first flight dates for orange tip butterflies (Anthocharis cardamines) in three areas extending along a steep climate gradient. The developed methodology links point data of first flight observations to calculated cumulative degree-days until first flight based on gridded temperature data. Using this methodology we identify and quantify a first flight model that is consistent across different regions, data support scales and assumptions of subgrid variability and observation bias. Model application to observed warming over the past 60 years demonstrates the model usefulness for assessment of climate-driven first flight change. The cross-regional consistency of the model implies predictive capability for future changes, and calls for further application and testing of analogous modeling approaches to other species, phenological variables and parts of the world.	[Prieto, Carmen; Destouni, Georgia] Stockholm Univ, Bolin Ctr Climate Res, Dept Phys Geog, S-10691 Stockholm, Sweden	Stockholm University	Prieto, C (corresponding author), Stockholm Univ, Bolin Ctr Climate Res, Dept Phys Geog, S-10691 Stockholm, Sweden.	carmen.prieto@natgeo.su.se	Destouni, Georgia/AAS-5375-2020; Destouni, Georgia/M-9662-2016	Destouni, Georgia/0000-0001-9408-4425; Destouni, Georgia/0000-0001-9408-4425	strategic program Ekoklim at Stockholm University	strategic program Ekoklim at Stockholm University	The authors acknowledge financial funding for this research from the strategic program Ekoklim at Stockholm University (http://www.zoologi.su.se/ekoklim/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CIBSE, 2006, DEGREE DAYS THEORY A; Forister ML, 2003, GLOBAL CHANGE BIOL, V9, P1130, DOI 10.1046/j.1365-2486.2003.00643.x; Gienapp P, 2005, GLOBAL CHANGE BIOL, V11, P600, DOI 10.1111/j.1365-2486.2005.00925.x; Haylock MR, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD010201; Hodgson JA, 2011, GLOBAL CHANGE BIOL, V17, P1289, DOI 10.1111/j.1365-2486.2010.02308.x; Karlsson B, 2014, INT J BIOMETEOROL, V58, P691, DOI 10.1007/s00484-013-0649-8; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Posledovich D, 2014, BIOL J LINN SOC, V113, P981, DOI 10.1111/bij.12371; Roy DB, 2000, GLOB CHANGE BIOL, V6, P407, DOI 10.1046/j.1365-2486.2000.00322.x; Stefanescu C, 2003, GLOBAL CHANGE BIOL, V9, P1494, DOI 10.1046/j.1365-2486.2003.00682.x; [Swedish Environmental Protection Agency Swedish Species Information Centre], 2012, ARTP; Vercauteren N, 2014, J APPL METEOROL CLIM, V53, P323, DOI 10.1175/JAMC-D-13-0217.1; Vercauteren N, 2013, J APPL METEOROL CLIM, V52, P1208, DOI 10.1175/JAMC-D-12-0115.1; Westwood AR, 2010, ENVIRON ENTOMOL, V39, P1122, DOI 10.1603/EN09143	14	2	2	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141207	10.1371/journal.pone.0141207	http://dx.doi.org/10.1371/journal.pone.0141207			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26545112	Green Published, gold, Green Submitted			2022-12-27	WOS:000364398700019
J	Qin, L; Zhang, LF; Zhang, YQ; Shi, XC; Zhang, Y; Liu, XQ				Qin, Ling; Zhang, Lifan; Zhang, Yueqiu; Shi, Xiaochun; Zhang, Yao; Liu, Xiaoqing			Diagnostic Value of T-Cell Interferon-gamma Release Assays on Cerebrospinal Fluid for Tuberculous Meningitis	PLOS ONE			English	Article							RAPID DIAGNOSIS; SKIN-TEST; INFECTION; ENUMERATION; DISEASE	Diagnosis of tuberculous meningitis (TBM) remains a challenge. This study aimed to evaluate the performance of T-SPOT. TB test on cerebrospinal fluid mononuclear cells (CSFMCs) for suspected TBM patients. 43 consecutive patients with suspected TBM were enrolled in the study from June 2011 to September 2014. T-SPOT. TB was performed on both CSFMCs and peripheral blood mononuclear cells (PBMCs). The final diagnosis of TBM was independent of the T-SPOT. TB result. The diagnostic sensitivity, specificity, predictive value, and likelihood ratio of T-SPOT. TB on CSFMCs and PBMCs were analyzed. Of the 43 patients, 12 (27.9%) were finally diagnosed with TBM, 28 (65.1%) with non-TBM, and 3 (7.0%) with indeterminate diagnoses. Of 40 cases with definite diagnoses, the sensitivity and specificity were 92.0% and 96.0% for T-SPOT. TB on CSFMCs, and 83.0% and 82.0% for T-SPOT. TB on PBMCs, respectively. The positive predictive value (PPV) and negative predictive value (NPV) of T-SPOT. TB on CSFMCs were 85.0% and 96.0%, respectively. The PPV and NPV were 67.0% and 92.0% for T-SPOT. TB on PBMCs. The difference of T-SPOT. TB between CSFMCs and PBMCs was not significant so far as sensitivity, specificity, PPV, and NPV were concerned (P>0.05 for each). However, T-SPOT. TB on CSFMC and CSFMC: PBMC in TBM cases seemed higher than that in non-TBM cases. Our study further showed that T-SPOT. TB on CSFMCs might be a rapid and accurate diagnostic test for TBM. CSFMC: PBMC T-SPOT. TB ratio might be useful for the early diagnosis of TBM.	[Qin, Ling; Zhang, Lifan; Zhang, Yueqiu; Shi, Xiaochun; Liu, Xiaoqing] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Infect Dis, Beijing 100730, Peoples R China; [Qin, Ling; Zhang, Lifan; Zhang, Yueqiu; Shi, Xiaochun; Liu, Xiaoqing] Peking Union Med Coll, Beijing 100730, Peoples R China; [Zhang, Lifan; Zhang, Yao; Liu, Xiaoqing] Peking Union Med Coll, Clin Epidemiol Unit, Int Clin Epidemiol Network, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Liu, XQ (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Infect Dis, Beijing 100730, Peoples R China.	liuxqpumch@126.com			National Major Science and Technology Research Projects for the Control and Prevention of Major Infectious Diseases of China [2014ZX10003003]; Health Research & Special Projects [201402001]	National Major Science and Technology Research Projects for the Control and Prevention of Major Infectious Diseases of China; Health Research & Special Projects	This study was supported by grants from the National Major Science and Technology Research Projects for the Control and Prevention of Major Infectious Diseases of China (2014ZX10003003; http://www.nmp.gov.cn/zxjs/crb/201012/t20101208_2127.htm), and the Health Research & Special Projects (201402001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babu GN, 2008, NEUROSCI LETT, V436, P48, DOI 10.1016/j.neulet.2008.02.060; Bidstrup C, 2002, SCAND J INFECT DIS, V34, P811, DOI 10.1080/0036554021000026938; Ewer K, 2003, LANCET, V361, P1168, DOI 10.1016/S0140-6736(03)12950-9; Karam F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001441; Lalvani A, 2001, LANCET, V357, P2017, DOI 10.1016/S0140-6736(00)05115-1; Lee YM, 2013, INFECTION, V41, P1089, DOI 10.1007/s15010-013-0478-z; Pai M, 2003, LANCET INFECT DIS, V3, P633, DOI 10.1016/S1473-3099(03)00772-2; Park KH, 2012, EUR RESPIR J, V39, P768, DOI 10.1183/09031936.00098111; Patel VB, 2010, AM J RESP CRIT CARE, V182, P569, DOI 10.1164/rccm.200912-1931OC; Philip N, 2015, MALAYS J PATHOL, V37, P1; Rock RB, 2008, CLIN MICROBIOL REV, V21, P243, DOI 10.1128/CMR.00042-07; Takahashi Teruyuki, 2012, Tuberc Res Treat, V2012, P831292, DOI 10.1155/2012/831292; Thomas MM, 2008, INT J TUBERC LUNG D, V12, P651; Wilkinson KA, 2005, CLIN INFECT DIS, V40, P184, DOI 10.1086/426139; Zhang LF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0099946, 10.1371/journal.pone.0084950]	15	9	12	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141814	10.1371/journal.pone.0141814	http://dx.doi.org/10.1371/journal.pone.0141814			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26545256	gold, Green Published, Green Submitted			2022-12-27	WOS:000364398700052
J	Zhao, W; Zhang, WZ; Yang, ZY; Liu, AQ; Zhang, LX; Yang, FK; Wang, RJ; Ling, H				Zhao, Wei; Zhang, Weizhe; Yang, Ziyin; Liu, Aiqin; Zhang, Longxian; Yang, Fengkun; Wang, Rongjun; Ling, Hong			Genotyping of Enterocytozoon bieneusi in Farmed Blue Foxes (Alopex lagopus) and Raccoon Dogs (Nyctereutes procyonoides) in China	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; GIARDIA-DUODENALIS; GENETIC DIVERSITY; NORTHEAST CHINA; MICROSPORIDIOSIS; PREVALENCE; CRYPTOSPORIDIUM; INFECTION; SPECIFICITY; CATTLE	Enterocytozoon bieneusi is the most common species of microsporidia found both in humans and animals. Farmed animals, particularly closely associated to humans, may play an important role of zoonotic reservoir in transmitting this disease to humans. The fur industry is a major economic component in some parts of China. To understand the prevalence, genotype variety and zoonotic risk of E. bieneusi in farmed foxes and raccoon dogs, two species of fur animals, fecal specimens of 110 blue foxes and 49 raccoon dogs from Heilongjiang and Jilin provinces in China were examined by internal transcribed spacer (ITS)-based PCR. E. bieneusi was detected in 16.4% (18/110) blue foxes and 4.1%(2/49) raccoon dogs. Altogether, four genotypes of E. bieneusi were identified, including two known genotypes D (n = 13) and EbpC (n = 5), and two novel genotypes named as CHN-F1 (n = 1) in a fox and CHN-R1 (n = 1) in a raccoon dog. Phylogenetic analysis revealed that all the four genotypes were the members of zoonotic group 1. Genotypes D and EbpC were found in humans previously. The findings of zoonotic genotypes of E. bieneusi in the foxes and raccoon dogs suggest these animals infected with E. bieneusi may pose a threat to human health.	[Zhao, Wei; Zhang, Weizhe; Yang, Ziyin; Liu, Aiqin; Yang, Fengkun; Ling, Hong] Harbin Med Univ China, Dept Parasitol, Harbin 150081, Heilongjiang, Peoples R China; [Zhao, Wei; Zhang, Weizhe; Yang, Ziyin; Liu, Aiqin; Yang, Fengkun; Ling, Hong] Harbin Med Univ, Heilongjiang Prov Key Lab Infect & Immun, Harbin 150081, Heilongjiang, Peoples R China; [Zhao, Wei; Zhang, Weizhe; Yang, Ziyin; Liu, Aiqin; Yang, Fengkun; Ling, Hong] Heilongjiang Key Lab Pathogen Biol, Harbin 150081, Heilongjiang, Peoples R China; [Zhang, Longxian; Wang, Rongjun] Henan Agr Univ, Coll Anim Sci & Vet Med, Zhengzhou 450002, Henan, Peoples R China	Harbin Medical University; Harbin Medical University; Henan Agricultural University	Liu, AQ (corresponding author), Harbin Med Univ China, Dept Parasitol, Harbin 150081, Heilongjiang, Peoples R China.	liuaiqin1128@126.com; Lingh@ems.hrbmu.edu.cn	Zhang, Longxian/R-7799-2019; Zhang, Longxian/I-9223-2019; Zhang, Longxian/HGE-1918-2022	Zhang, Longxian/0000-0002-5706-131X; ling, hong/0000-0002-1886-1242	State Key Program of the National Natural Science Foundation of China [31330079]; Heilongjiang Province Education Bureau [12531266]	State Key Program of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Heilongjiang Province Education Bureau	The study was supported partially by the State Key Program of the National Natural Science Foundation of China (grant 31330079) (Longxian Zhang) and the Heilongjiang Province Education Bureau of No. 12531266 (Aiqin Liu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben Ayed L, 2012, J WATER HEALTH, V10, P431, DOI 10.2166/wh.2012.204; Buckholt MA, 2002, APPL ENVIRON MICROB, V68, P2595, DOI 10.1128/AEM.68.5.2595-2599.2002; Cheng HWA, 2011, PARASITOL RES, V109, P595, DOI 10.1007/s00436-011-2291-x; Decraene V, 2012, EPIDEMIOL INFECT, V140, P519, DOI 10.1017/S095026881100077X; Didier ES, 2006, CURR OPIN INFECT DIS, V19, P485, DOI 10.1097/01.qco.0000244055.46382.23; Didier ES, 2011, CURR OPIN INFECT DIS, V24, P490, DOI 10.1097/QCO.0b013e32834aa152; Didier ES, 2005, ACTA TROP, V94, P61, DOI 10.1016/j.actatropica.2005.01.010; Fayer R, 2014, MICROSPORIDIA: PATHOGENS OF OPPORTUNITY, 1ST EDITION, P135; Guo YQ, 2014, APPL ENVIRON MICROB, V80, P218, DOI 10.1128/AEM.02997-13; Henriques-Gil N, 2010, APPL ENVIRON MICROB, V76, P3333, DOI 10.1128/AEM.03026-09; Hu Y, 2014, ENVIRON SCI TECHNOL, V48, P14219, DOI 10.1021/es504464t; Jiang YX, 2015, APPL ENVIRON MICROB, V81, P3326, DOI 10.1128/AEM.00328-15; Karim MR, 2014, PARASITOL RES, V113, P3041, DOI 10.1007/s00436-014-3967-9; Karim MR, 2014, APPL ENVIRON MICROB, V80, P1893, DOI 10.1128/AEM.03845-13; Keeling P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000489; Li N, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001809; Li W, 2015, VET PARASITOL, V208, P125, DOI 10.1016/j.vetpar.2015.01.014; Li W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108279; Galvan-Diaz AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092289; Matos Olga, 2012, J Parasitol Res, V2012, P981424, DOI 10.1155/2012/981424; Mori H, 2013, VET PARASITOL, V197, P696, DOI 10.1016/j.vetpar.2013.07.025; Santin M, 2011, RES VET SCI, V90, P363, DOI 10.1016/j.rvsc.2010.07.014; Santin M, 2009, J EUKARYOT MICROBIOL, V56, P34, DOI 10.1111/j.1550-7408.2008.00380.x; Sulaiman IM, 2003, APPL ENVIRON MICROB, V69, P4495, DOI 10.1128/AEM.69.8.4495-4501.2003; Widmer G, 2010, INFECT GENET EVOL, V10, P122, DOI 10.1016/j.meegid.2009.11.009; Yang JP, 2014, J CLIN MICROBIOL, V52, P4363, DOI 10.1128/JCM.02295-14; Ye JB, 2012, EMERG INFECT DIS, V18, P1640, DOI 10.3201/eid1810.120653; Zhao W, 2015, J EUKARYOT MICROBIOL, V62, P553, DOI 10.1111/jeu.12210; Zhao W, 2015, INFECT GENET EVOL, V32, P265, DOI 10.1016/j.meegid.2015.03.026; Zhao W, 2014, PARASITOL RES, V113, P4243, DOI 10.1007/s00436-014-4100-9; Zhao W, 2014, APPL ENVIRON MICROB, V80, P3699, DOI 10.1128/AEM.00807-14	31	29	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142611	10.1371/journal.pone.0142611	http://dx.doi.org/10.1371/journal.pone.0142611			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544711	Green Published, gold			2022-12-27	WOS:000364398700160
J	Bujakowska, KM; White, J; Place, E; Consugar, M; Comander, J				Bujakowska, Kinga M.; White, Joseph; Place, Emily; Consugar, Mark; Comander, Jason			Efficient In Silico Identification of a Common Insertion in the MAK Gene which Causes Retinitis Pigmentosa	PLOS ONE			English	Article							GENERATION; ELEMENTS; MUTATIONS; IDENTIFY	Background Next generation sequencing (NGS) offers a rapid and comprehensive method of screening for mutations associated with retinitis pigmentosa and related disorders. However, certain sequence alterations such as large insertions or deletions may remain undetected using standard NGS pipelines. One such mutation is a recently-identified Alu insertion into the Male Germ Cell-Associated Kinase (MAK) gene, which is missed by standard NGS-based variant callers. Here, we developed an in silico method of searching NGS raw sequence reads to detect this mutation, without the need to recalculate sequence alignments or to screen every sample by PCR. Methods The Linux program grep was used to search for a 23 bp "probe" sequence containing the known junction sequence of the insert. A corresponding search was performed with the wildtype sequence. The matching reads were counted and further compared to the known sequences of the full wildtype and mutant genomic loci. (See https://github.com/MEEIBioinformaticsCenter/grepsearch.) Results In a test sample set consisting of eleven previously published homozygous mutants, detection of the MAK-Alu insertion was validated with 100% sensitivity and specificity. As a discovery cohort, raw NGS reads from 1,847 samples (including custom and whole exome selective capture) were searched in similar to 1 hour on a local computer cluster, yielding an additional five samples with MAK-Alu insertions and solving two previously unsolved pedigrees. Of these, one patient was homozygous for the insertion, one compound heterozygous with a missense change on the other allele (c. 46G>A; p. Gly16Arg), and three were heterozygous carriers. Conclusions Using the MAK-Alu grep program proved to be a rapid and effective method of finding a known, disease-causing Alu insertion in a large cohort of patients with NGS data. This simple approach avoids wet-lab assays or computationally expensive algorithms, and could also be used for other known disease-causing insertions and deletions.	[Bujakowska, Kinga M.; White, Joseph; Place, Emily; Consugar, Mark; Comander, Jason] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Ocular Genom Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary	Comander, J (corresponding author), Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Ocular Genom Inst, Boston, MA 02115 USA.	Jason_comander@meei.harvard.edu	Bujakowska, Kinga Maria/AGL-1293-2022	Bujakowska, Kinga/0000-0001-6809-9818; Comander, Jason/0000-0002-4257-7145	Fleming Family Foundation; NEI [K12 EY016335]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [K12EY016335] Funding Source: NIH RePORTER	Fleming Family Foundation; NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	KMB was supported by a fellowship with the Fleming Family Foundation. JC was supported by NEI K12 EY016335 and a Career Development Award from Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; Audo I, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-8; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Berger W, 2010, PROG RETIN EYE RES, V29, P335, DOI 10.1016/j.preteyeres.2010.03.004; Braun TA, 2013, HUM MOL GENET, V22, P5136, DOI 10.1093/hmg/ddt367; Bujakowska KM, 2014, INVEST OPHTH VIS SCI, V55, P8488, DOI 10.1167/iovs.14-15169; Choi YH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039927, 10.1371/journal.pone.0046688]; Consugar MB, 2015, GENET MED, V17, P253, DOI 10.1038/gim.2014.172; den Hollander AI, 2006, AM J HUM GENET, V79, P556, DOI 10.1086/507318; Erwin JA, 2014, NAT REV NEUROSCI, V15, P497, DOI 10.1038/nrn3730; Fields RR, 2002, AM J HUM GENET, V71, P607, DOI 10.1086/342098; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Jiang Y, 2012, BIOINFORMATICS, V28, P2576, DOI 10.1093/bioinformatics/bts484; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Li ST, 2013, GENOME RES, V23, P195, DOI 10.1101/gr.132480.111; Neidhardt J, 2007, HUM MUTAT, V28, P797, DOI 10.1002/humu.20521; Neveling K, 2013, HUM MUTAT, V34, P1721, DOI 10.1002/humu.22450; Neveling K, 2012, HUM MUTAT, V33, P963, DOI 10.1002/humu.22045; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nord AS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-184; Ozgul RK, 2011, AM J HUM GENET, V89, P253, DOI 10.1016/j.ajhg.2011.07.005; Price AL, 2004, GENOME RES, V14, P2245, DOI 10.1101/gr.2693004; Ratan A, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0483-6; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Tucker BA, 2011, P NATL ACAD SCI USA, V108, pE569, DOI 10.1073/pnas.1108918108; Venturini G, 2015, GENET MED, V17, P285, DOI 10.1038/gim.2014.132; Webb TR, 2012, HUM MOL GENET, V21, P3647, DOI 10.1093/hmg/dds194; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394	30	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142614	10.1371/journal.pone.0142614	http://dx.doi.org/10.1371/journal.pone.0142614			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26558903	gold, Green Published, Green Submitted			2022-12-27	WOS:000364433100101
J	Cui, HB; Zhai, JJ; Ma, C				Cui, Haibo; Zhai, Jingjing; Ma, Chuang			miRLocator: Machine Learning-Based Prediction of Mature MicroRNAs within Plant Pre-miRNA Sequences	PLOS ONE			English	Article							IDENTIFICATION	MicroRNAs (miRNAs) are a class of short, non-coding RNA that play regulatory roles in a wide variety of biological processes, such as plant growth and abiotic stress responses. Although several computational tools have been developed to identify primary miRNAs and precursor miRNAs (pre-miRNAs), very few provide the functionality of locating mature miRNAs within plant pre-miRNAs. This manuscript introduces a novel algorithm for predicting miRNAs named miRLocator, which isbased on machine learning techniques and sequence and structural features extracted from miRNA: miRNA* duplexes. To address the class imbalance problem (few real miRNAs and a large number of pseudo miRNAs), the prediction models in miRLocator were optimized by considering critical (and often ignored) factors that can markedly affect the prediction accuracy of mature miRNAs, including the machine learning algorithm and the ratio between training positive and negative samples. Ten-fold cross-validation on 5854 experimentally validated miRNAs from 19 plant species showed that miRLocator performed better than the state-of-art miRNA predictor miRdup in locating mature miRNAs within plant pre-miRNAs. miRLocator will aid researchers interested in discovering miRNAs from model and non-model plant species.	[Cui, Haibo] Hubei Univ, Sch Comp Sci & Informat Engn, Wuhan 430070, Peoples R China; [Zhai, Jingjing; Ma, Chuang] Northwest A&F Univ, Ctr Bioinformat, Coll Life Sci, Yangling 712100, Peoples R China; [Ma, Chuang] Northwest A&F Univ, Biomass Energy Ctr Arid & Semiarid Lands, Yangling 712100, Shaanxi, Peoples R China	Hubei University; Northwest A&F University - China; Northwest A&F University - China	Cui, HB (corresponding author), Hubei Univ, Sch Comp Sci & Informat Engn, Wuhan 430070, Peoples R China.	child@hubu.edu.cn; cma@nwafu.edu.cn		Zhai, Jingjing/0000-0002-1535-3103	Fund of Northwest AF University [Z111021403]; National Natural Science Foundation of China [31570371]	Fund of Northwest AF University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Fund of Northwest A&F University (Z111021403) and the National Natural Science Foundation of China (31570371). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allmer Jens, 2012, Frontiers in Genetics, V3, P209, DOI 10.3389/fgene.2012.00209; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Calle M Luz, 2011, Brief Bioinform, V12, P86, DOI 10.1093/bib/bbq011; Gkirtzou K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011843; He CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051673; Jensen LJ, 2011, BIOINFORMATICS, V27, P3331, DOI 10.1093/bioinformatics/btr585; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Karathanasis N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126151; Leclercq M, 2013, NUCLEIC ACIDS RES, V41, P7200, DOI 10.1093/nar/gkt466; Leung YY, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt426; Li F, 2012, P NATL ACAD SCI USA, V109, P1790, DOI 10.1073/pnas.1118282109; Luo Y, 2013, DEV BIOL, V380, P133, DOI 10.1016/j.ydbio.2013.05.009; Meng J, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0423-x; Nam JW, 2005, NUCLEIC ACIDS RES, V33, P3570, DOI 10.1093/nar/gki668; Rogers K, 2013, PLANT CELL, V25, P2383, DOI 10.1105/tpc.113.113159; Sunkar R, 2012, TRENDS PLANT SCI, V17, P196, DOI 10.1016/j.tplants.2012.01.010; Tempel S, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks146; Wang XW, 2005, BIOINFORMATICS, V21, P3610, DOI 10.1093/bioinformatics/bti562; Wu YG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-107; Xuan P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027422	20	17	17	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142753	10.1371/journal.pone.0142753	http://dx.doi.org/10.1371/journal.pone.0142753			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26558614	Green Published, gold, Green Submitted			2022-12-27	WOS:000364433100119
J	Hansen, TA; Fridholm, H; Froslev, TG; Kjartansdottir, KR; Willerslev, E; Nielsen, LP; Hansen, AJ				Hansen, Thomas Arn; Fridholm, Helena; Froslev, Tobias Guldberg; Kjartansdottir, Kristin Ros; Willerslev, Eske; Nielsen, Lars Peter; Hansen, Anders Johannes			New Type of Papillomavirus and Novel Circular Single Stranded DNA Virus Discovered in Urban Rattus norvegicus Using Circular DNA Enrichment and Metagenomics	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; PHYLOGENETIC ANALYSIS; HIGH-THROUGHPUT; IDENTIFICATION; CLASSIFICATION; ACCURACY; RATS	Rattus norvegicus (R. norvegicus) are ubiquitous and their presence has several effects on the human populations in our urban areas on a global scale. Both historically and presently, this close interaction has facilitated the dissemination of many pathogens to humans, making screening for potentially zoonotic and emerging viruses in rats highly relevant. We have investigated faecal samples from R. norvegicus collected from urban areas using a protocol based on metagenomic enrichment of circular DNA genomes and subsequent sequencing. We found a new type of papillomavirus, with a L1 region 82% identical to that of the known R. norvegicus Papillomavirus 2. Additionally, we found 20 different circular replication associated protein (Rep)-encoding single stranded DNA (CRESS-DNA) virus-like genomes, one of which has homology to the replication-associated gene of Beak and feather disease virus. Papillomaviruses are a group of viruses known for their carcinogenic potential, and although they are known to infect several different vertebrates, they are mainly studied and characterised in humans. CRESS-DNA viruses are found in many different environments and tissue types. Both papillomaviruses and CRESS-DNA viruses are known to have pathogenic potential and screening for novel and known viruses in R. norvegicus could help identify viruses with pathogenic potential.	[Hansen, Thomas Arn; Fridholm, Helena; Froslev, Tobias Guldberg; Kjartansdottir, Kristin Ros; Willerslev, Eske; Hansen, Anders Johannes] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, DK-1350 Copenhagen, Denmark; [Nielsen, Lars Peter] Statens Serum Inst, Dept Autoimmunol & Biomarkers, DK-2300 Copenhagen S, Denmark	University of Copenhagen; Statens Serum Institut	Hansen, AJ (corresponding author), Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, DK-1350 Copenhagen, Denmark.	ajhansen@snm.ku.dk	Willerslev, Eske/A-9619-2011; Willerslev, Eske/AAA-5686-2019; Hansen, Anders Johannes/A-5608-2013; Froslev, Tobias Guldberg/D-4940-2017	Willerslev, Eske/0000-0002-7081-6748; Hansen, Anders Johannes/0000-0002-1890-2702; Froslev, Tobias Guldberg/0000-0002-3530-013X	Innovation Fund Denmark (The GenomeDenmark platform) [019-2011-2]; VILLUM foundation (Biowide) [VKR-023343]	Innovation Fund Denmark (The GenomeDenmark platform); VILLUM foundation (Biowide)	This work was supported by the Innovation Fund Denmark (The GenomeDenmark platform, grant no. 019-2011-2) and a grant from VILLUM foundation (Biowide, VKR-023343).	Boisvert S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r122; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chandriani S, 2013, P NATL ACAD SCI USA, V110, pE1407, DOI 10.1073/pnas.1219217110; Cheung AK, 2014, AM SOC MICROBIOLOGY, V2, DOI [10.1128/genomeA.00347-14, DOI 10.1128/GENOMEA.00347-14]; Cheung AK, 2015, ARCH VIROL, V160, P353, DOI 10.1007/s00705-014-2234-9; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; de Villiers EM, 2013, VIROLOGY, V445, P2, DOI 10.1016/j.virol.2013.04.023; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eriksson A, 1988, Virus Genes, V1, P123, DOI 10.1007/BF00555932; Firth C, 2014, MBIO, V5, DOI 10.1128/mBio.01933-14; Grard G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002924; Himsworth CG, 2013, VECTOR-BORNE ZOONOT, V13, P349, DOI 10.1089/vbz.2012.1195; Jorgensen TS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087924; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lindgreen Stinus, 2012, BMC Res Notes, V5, P337, DOI 10.1186/1756-0500-5-337; Muhire BM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108277; ORTH G, 1977, J VIROL, V24, P108, DOI 10.1128/JVI.24.1.108-120.1977; PATEL KR, 1987, J GEN VIROL, V68, P2117, DOI 10.1099/0022-1317-68-8-2117; Rector A, 2013, VIROLOGY, V445, P213, DOI 10.1016/j.virol.2013.05.007; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rombel IT, 2002, GENE, V282, P33, DOI 10.1016/S0378-1119(01)00819-8; Rosario K, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00696; Rosario K, 2012, J GEN VIROL, V93, P2668, DOI 10.1099/vir.0.045948-0; Rosario K, 2012, ARCH VIROL, V157, P1851, DOI 10.1007/s00705-012-1391-y; RUDOLPH RL, 1981, J COMP PATHOL, V91, P123, DOI 10.1016/0021-9975(81)90052-9; Sachsenroder J, 2014, J GEN VIROL, V95, P2734, DOI 10.1099/vir.0.070029-0; Schafer K, 2011, J GEN VIROL, V92, P383, DOI 10.1099/vir.0.023515-0; Schulz E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047164; Schulz E, 2009, J GEN VIROL, V90, P2609, DOI 10.1099/vir.0.012583-0; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Vinzon SE, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003924; Wilson D. E., 2005, MAMMAL SPECIES WORLD; Zhu W, 2012, ARCH VIROL, V157, P85, DOI 10.1007/s00705-011-1140-7; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	35	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0141952	10.1371/journal.pone.0141952	http://dx.doi.org/10.1371/journal.pone.0141952			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559957	Green Submitted, gold, Green Published			2022-12-27	WOS:000364433100048
J	Athreya, V; Srivathsa, A; Puri, M; Karanth, KK; Kumar, NS; Karanth, KU				Athreya, Vidya; Srivathsa, Arjun; Puri, Mahi; Karanth, Krithi K.; Kumar, N. Samba; Karanth, K. Ullas			Spotted in the News: Using Media Reports to Examine Leopard Distribution, Depredation, and Management Practices outside Protected Areas in Southern India	PLOS ONE			English	Article							HUMAN-CARNIVORE CONFLICT; PANTHERA-PARDUS; NATIONAL-PARK; OCCUPANCY ESTIMATION; SPECIES OCCURRENCE; MULTIPLE STATES; WESTERN-GHATS; PATTERNS; CONSERVATION; LANDSCAPE	There is increasing evidence of large carnivore presence outside protected areas, globally. Although this spells conservation success through population recoveries, it makes carnivore persistence in human-use landscapes tenuous. The widespread distribution of leopards in certain regions of India typifies this problem. We obtained information on leopard- human interactions at a regional scale in Karnataka State, India, based on systematic surveys of local media reports. We applied an innovative occupancy modelling approach to map their distribution patterns and identify hotspots of livestock/human depredation. We also evaluated management responses like removals of 'problem' leopards through capture and translocations. Leopards occupied around 84,000 km(2) or 47% of the State's geographic area, outside designated national parks and wildlife sanctuaries. Their presence was facilitated by extent of vegetative cover-including irrigated croplands, rocky escarpments, and prey base in the form of feral and free-ranging dogs. Higher probabilities of livestock/human attacks by leopards were associated with similar ecological features as well as with capture/removals of leopards. Of the 56 cases of leopard removals reported, 91% did not involve human attacks, but followed livestock predation or only leopard sightings. The lack of knowledge on leopard ecology in human-use areas has resulted in unscientific interventions, which could aggravate the problem rather than mitigating it. Our results establish the presence of resident, breeding leopards in human-use areas. We therefore propose a shift in management focus, from current reactive practices like removal and translocation of leopards, to proactive measures that ensure safety of human lives and livelihoods.	[Athreya, Vidya; Srivathsa, Arjun; Puri, Mahi; Kumar, N. Samba] India Program, Wildlife Conservat Soc, Bengaluru, Karnataka, India; [Srivathsa, Arjun; Puri, Mahi; Karanth, Krithi K.; Kumar, N. Samba; Karanth, K. Ullas] Ctr Wildlife Studies, Bengaluru, Karnataka, India; [Karanth, Krithi K.; Karanth, K. Ullas] Global Conservat Program, Wildlife Conservat Soc, Bronx, NY USA; [Karanth, Krithi K.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA	Wildlife Conservation Society; Duke University	Athreya, V (corresponding author), India Program, Wildlife Conservat Soc, Bengaluru, Karnataka, India.	vidye.athreya@gmail.com	Kumar, Samba/ADR-7829-2022	Kumar, Samba/0000-0002-1226-8552; Srivathsa, Arjun/0000-0003-2935-3857				Agarwala M, 2010, BIOL CONSERV, V143, P2945, DOI 10.1016/j.biocon.2010.05.003; [Anonymous], HUNTER AND HUNTED; Athreya V, 2014, ORYX; Athreya V, 2013, PRELIMINARY AS UNPUB; Athreya V, 2014, TROP CONSERV SCI, V7, P75, DOI 10.1177/194008291400700111; Athreya V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057872; Athreya V, 2011, CONSERV BIOL, V25, P133, DOI 10.1111/j.1523-1739.2010.01599.x; Banerjee K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049457; Barua M, 2013, BIOL CONSERV, V157, P309, DOI 10.1016/j.biocon.2012.07.014; Bateman PW, 2012, J ZOOL, V287, P1, DOI 10.1111/j.1469-7998.2011.00887.x; Bradley EH, 2005, CONSERV BIOL, V19, P1498, DOI 10.1111/j.1523-1739.2005.00102.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Butler JRA, 2004, BIOL CONSERV, V115, P369, DOI 10.1016/S0006-3207(03)00152-6; Carter NH, 2012, P NATL ACAD SCI USA, V109, P15360, DOI 10.1073/pnas.1210490109; Chapron G, 2014, SCIENCE, V346, P1517, DOI 10.1126/science.1257553; Chapron G, 2014, SCIENCE, V343, P1199, DOI 10.1126/science.343.6176.1199-b; Crooks KR, 2011, PHILOS T R SOC B, V366, P2642, DOI 10.1098/rstb.2011.0120; Dalerum F, 2008, BIODIVERS CONSERV, V17, P2939, DOI 10.1007/s10531-008-9406-4; Dar NI, 2009, BIOL CONSERV, V142, P2076, DOI 10.1016/j.biocon.2009.04.003; Das A, 2006, BIOL CONSERV, V133, P16, DOI 10.1016/j.biocon.2006.05.023; De Angelo C, 2013, BIOL CONSERV, V159, P422, DOI 10.1016/j.biocon.2012.12.021; De Angelo C, 2011, DIVERS DISTRIB, V17, P422, DOI 10.1111/j.1472-4642.2011.00746.x; Dickman AJ, 2014, BIOL CONSERV, V178, P19, DOI 10.1016/j.biocon.2014.07.011; Edgaonkar A, 2002, MAMMALIA, V66, P353, DOI 10.1515/mamm.2002.66.3.353; Fonturbel FE, 2011, WILDLIFE BIOL, V17, P217, DOI 10.2981/10-091; Gehrt SD., 2010, URBAN CARNIVORES ECO; Ghosal S, 2015, SOC NATUR RESOUR, V28, P1092, DOI 10.1080/08941920.2015.1014597; Ghosal S, 2013, BIODIVERS CONSERV, V22, P2665, DOI 10.1007/s10531-013-0549-6; Gilroy JJ, 2015, SCIENCE, V347, P381, DOI 10.1126/science.347.6220.382-a; Goswami VR, 2015, CONSERV BIOL, V29, P1100, DOI 10.1111/cobi.12475; Goswami VR, 2014, BIOL CONSERV, V177, P74, DOI 10.1016/j.biocon.2014.06.013; Goswami VR, 2013, PNAS, V110, P385; Gubbi Sanjay, 2014, Cat News, V60, P30; Henschel P., 2008, PANTHERA PARDUS IUCN; Hiby LR, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-46; Hines JE., 2006, PRESENCESOFTWARE EST; Holmern T, 2007, BIOL CONSERV, V135, P518, DOI 10.1016/j.biocon.2006.10.049; Inskip C, 2009, ORYX, V43, P18, DOI 10.1017/S003060530899030X; Jathanna D, 2015, BIOL CONSERV, V187, P212, DOI 10.1016/j.biocon.2015.04.030; Joshi AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044372; KARANTH K U, 1986, Journal of the Bombay Natural History Society, V83, P166; Karanth KU, 2013, P NATL ACAD SCI USA, V110, pE110, DOI 10.1073/pnas.1216623110; Karanth KK, 2013, BIOL CONSERV, V166, P175, DOI 10.1016/j.biocon.2013.06.027; Karanth KK, 2009, J APPL ECOL, V46, P1189, DOI 10.1111/j.1365-2664.2009.01710.x; Karanth KU, 2004, P NATL ACAD SCI USA, V101, P4854, DOI 10.1073/pnas.0306210101; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Mackenzie DI, 2009, ECOLOGY, V90, P823, DOI 10.1890/08-0141.1; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Madden F, 2014, BIOL CONSERV, V178, P97, DOI 10.1016/j.biocon.2014.07.015; Madhusudan M.D., 2003, P31; Marker LL, 2005, S AFR J WILDL RES, V35, P105; Mech D., 2003, WOLVES BEHAV ECOLOGY; Meena V, 2014, BIOL CONSERV, V174, P120, DOI 10.1016/j.biocon.2014.03.025; Miller B, 1999, ANIM CONSERV, V2, P59, DOI 10.1111/j.1469-1795.1999.tb00049.x; Miller JRB, 2015, ECOL EVOL, V5, P1354, DOI 10.1002/ece3.1440; Ministry of Environment and Forests, 2011, GUID HUM LEOP CONFL; Navya R, 2014, CURR SCI INDIA, V107, P1381; Nichols JD, 2007, ECOLOGY, V88, P1395, DOI 10.1890/06-1474; Odden M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112044; Patil N, 2011, ORYX, V45, P472, DOI 10.1017/S0030605311001591; Puri M, 2015, DIVERS DISTRIB; Raza R. H., 2012, ILLUMINATING BLIND S; Rota CT, 2009, J APPL ECOL, V46, P1173, DOI 10.1111/j.1365-2664.2009.01734.x; Roy PS, 2015, INT J APPL EARTH OBS, V39, P142, DOI 10.1016/j.jag.2015.03.003; Schuette P, 2013, BIOL CONSERV, V158, P301, DOI 10.1016/j.biocon.2012.08.008; Shehzad W, 2015, ORYX, V49, P248, DOI 10.1017/S0030605313001026; Srivathsa A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098803; Stahl P, 2001, BIOL CONSERV, V101, P15, DOI 10.1016/S0006-3207(01)00054-4; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Treves Adrian, 2006, Human Dimensions of Wildlife, V11, P383, DOI 10.1080/10871200600984265; Treves A, 2011, BIOSCIENCE, V61, P451, DOI 10.1525/bio.2011.61.6.7; Lopez-Bao JV, 2015, SCIENCE, V348, P871, DOI 10.1126/science.348.6237.871-b; Vynne C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028939; Weilenmann M, 2010, WILDLIFE RES, V37, P702, DOI 10.1071/WR10013; Weise FJ, 2015, BIODIVERS CONSERV, V24, P1755, DOI 10.1007/s10531-015-0895-7; Weise FJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105042; Wielgus RB, 2013, BIOL CONSERV, V167, P69, DOI 10.1016/j.biocon.2013.07.008; Woodroffe R, 2000, ANIM CONSERV, V3, P165, DOI 10.1111/j.1469-1795.2000.tb00241.x; Woodroffe R., 2005, CONSERV BIOL; Yirga G, 2013, MAMM BIOL, V78, P193, DOI 10.1016/j.mambio.2012.09.001; Yirga G, 2013, AFR J ECOL, V51, P78, DOI 10.1111/aje.12008; Zarco-Gonzalez MM, 2013, BIOL CONSERV, V159, P80, DOI 10.1016/j.biocon.2012.11.007	82	34	36	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142647	10.1371/journal.pone.0142647	http://dx.doi.org/10.1371/journal.pone.0142647			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556229	Green Published, Green Submitted, gold			2022-12-27	WOS:000364430700149
J	Chatrou, MLL; Cleutjens, JP; van der Vusse, GJ; Roijers, RB; Mutsaers, PHA; Schurgers, LJ				Chatrou, Martijn L. L.; Cleutjens, Jack P.; van der Vusse, Ger J.; Roijers, Ruben B.; Mutsaers, Peter H. A.; Schurgers, Leon J.			Intra-Section Analysis of Human Coronary Arteries Reveals a Potential Role for Micro-Calcifications in Macrophage Recruitment in the Early Stage of Atherosclerosis	PLoS One			English	Article							MATRIX GLA-PROTEIN; SMOOTH-MUSCLE-CELL; CALCIUM-PHOSPHATE CRYSTALS; VASCULAR CALCIFICATION; IN-VITRO; LESIONS; INFLAMMATION; INHIBITION; APOPTOSIS; CLASSIFICATION	Background Vascular calcification is associated with poor cardiovascular outcome. Histochemical analysis of calcification and the expression of proteins involved in mineralization are usually based on whole section analysis, thereby often ignoring regional differences in atherosclerotic lesions. At present, limited information is available about factors involved in the initiation and progression of atherosclerosis. Aim of This Study This study investigates the intra-section association of micro-calcifications with markers for atherosclerosis in randomly chosen section areas of human coronary arteries. Moreover, the possible causal relationship between calcifying vascular smooth muscle cells and inflammation was explored in vitro. Technical Approach To gain insights into the pathogenesis of atherosclerosis, we performed analysis of the distribution of micro-calcifications using a 3-MeV proton microbeam. Additionally, we performed systematic analyses of 30 to 40 regions of 12 coronary sections obtained from 6 patients including histology and immuno-histochemistry. Section areas were classified according to CD68 positivity. In vitro experiments using human vascular smooth muscle cells (hVSMCs) were performed to evaluate causal relationships between calcification and inflammation. Results From each section multiple areas were randomly chosen and subsequently analyzed. Depositions of calcium crystals at the micrometer scale were already observed in areas with early pre-atheroma type I lesions. Micro-calcifications were initiated at the elastica interna concomitantly with upregulation of the uncarboxylated form of matrix Gla-protein (ucMGP). Both the amount of calcium crystals and ucMGP staining increased from type I to IV atherosclerotic lesions. Osteochondrogenic markers BMP-2 and osteocalcin were only significantly increased in type IV atheroma lesions, and at this stage correlated with the degree of calcification. From atheroma area type III onwards a considerable number of CD68 positive cells were observed in combination with calcification, suggesting a pro-inflammatory effect of micro-calcifications. In vitro, invasion assays revealed chemoattractant properties of cell-culture medium of calcifying vascular smooth muscle cells towards THP-1 cells, which implies pro-inflammatory effect of calcium deposits. Additionally, calcifying hVSMCs revealed a pro-inflammatory profile as compared to non-calcifying hVSMCs. Conclusion Our data indicate that calcification of VSMCs is one of the earliest events in the genesis of atherosclerosis, which strongly correlates with ucMGP staining. Our findings suggest that loss of calcification inhibitors and/or failure of inhibitory capacity is causative for the early precipitation of calcium, with concomitant increased inflammation followed by osteochondrogenic transdifferentiation of VSMCs.	[Chatrou, Martijn L. L.; Schurgers, Leon J.] Maastricht Univ, Dept Biochem, Cardiovasc Res Inst Maastricht, NL-6200 MD Maastricht, Netherlands; [Cleutjens, Jack P.] Maastricht Univ, Dept Pathol, Cardiovasc Res Inst Maastricht, NL-6200 MD Maastricht, Netherlands; [van der Vusse, Ger J.] Maastricht Univ, Dept Physiol, Cardiovasc Res Inst Maastricht, NL-6200 MD Maastricht, Netherlands; [Roijers, Ruben B.; Mutsaers, Peter H. A.] Eindhoven Univ Technol, Dept Appl Phys, Cyclotron Lab, NL-5600 MB Eindhoven, Netherlands	Maastricht University; Maastricht University; Maastricht University; Eindhoven University of Technology	Schurgers, LJ (corresponding author), Maastricht Univ, Dept Biochem, Cardiovasc Res Inst Maastricht, NL-6200 MD Maastricht, Netherlands.	l.schurgers@maastrichtuniversity.nl	Schurgers, Leon/AAT-7100-2021; Cleutjens, Jack P.M./F-6242-2012	Cleutjens, Jack P.M./0000-0002-4346-1785; Schurgers, Leon/0000-0001-7867-6957				Ahmad PJ, 2009, AM J PATHOL, V175, P2686, DOI 10.2353/ajpath.2009.080734; Aikawa E, 2007, CIRCULATION, V116, P2841, DOI 10.1161/CIRCULATIONAHA.107.732867; Chatrou MLL, 2012, BLOOD REV, V26, P155, DOI 10.1016/j.blre.2012.03.002; Chung JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029100; Clarke MCH, 2008, CIRC RES, V102, P1529, DOI 10.1161/CIRCRESAHA.108.175976; Clarke MCH, 2010, CIRC RES, V106, P363, DOI 10.1161/CIRCRESAHA.109.208389; Ewence AE, 2008, CIRC RES, V103, pE28, DOI 10.1161/CIRCRESAHA.108.181305; Ikeda K, 2012, BIOCHEM BIOPH RES CO, V425, P39, DOI 10.1016/j.bbrc.2012.07.045; Johnson RC, 2006, CIRC RES, V99, P1044, DOI 10.1161/01.RES.0000249379.55535.21; Joshi NV, 2014, LANCET, V383, P705, DOI 10.1016/S0140-6736(13)61754-7; Kapustin AN, 2015, CIRC RES, V116, P1312, DOI 10.1161/CIRCRESAHA.116.305012; Kapustin AN, 2011, CIRC RES, V109, pE1, DOI 10.1161/CIRCRESAHA.110.238808; Mous DJW, 1997, NUCL INSTRUM METH B, V130, P31, DOI 10.1016/S0168-583X(97)00186-9; Nadra I, 2005, CIRC RES, V96, P1248, DOI 10.1161/01.RES.0000171451.88616.c2; O'Young J, 2011, J AM CHEM SOC, V133, P18406, DOI 10.1021/ja207628k; Otsuka F, 2014, ARTERIOSCL THROM VAS, V34, P724, DOI 10.1161/ATVBAHA.113.302642; Pazar B, 2011, J IMMUNOL, V186, P2495, DOI 10.4049/jimmunol.1001284; Price PA, 1998, ARTERIOSCL THROM VAS, V18, P1400, DOI 10.1161/01.ATV.18.9.1400; Proudfoot D, 2000, CIRC RES, V87, P1055, DOI 10.1161/01.RES.87.11.1055; Proudfoot D, 1998, ARTERIOSCL THROM VAS, V18, P379, DOI 10.1161/01.ATV.18.3.379; Raggi P, 2004, J AM COLL CARDIOL, V43, P1663, DOI 10.1016/j.jacc.2003.09.068; Raggi P, 2004, ARTERIOSCL THROM VAS, V24, P1272, DOI 10.1161/01.ATV.0000127024.40516.ef; Roijers RB, 2008, ANAL CHEM, V80, P55, DOI 10.1021/ac0706628; Roijers RB, 2011, AM J PATHOL, V178, P2879, DOI 10.1016/j.ajpath.2011.02.004; Rosenhek R, 2000, NEW ENGL J MED, V343, P611, DOI 10.1056/NEJM200008313430903; ROSS R, 1973, SCIENCE, V180, P1332, DOI 10.1126/science.180.4093.1332; Schurgers LJ, 2007, J THROMB HAEMOST, V5, P2503, DOI 10.1111/j.1538-7836.2007.02758.x; Schurgers LJ, 2013, TRENDS MOL MED, V19, P217, DOI 10.1016/j.molmed.2012.12.008; Schurgers LJ, 2005, ARTERIOSCL THROM VAS, V25, P1629, DOI 10.1161/01.ATV.0000173313.46222.43; Shanahan CM, 2011, CIRC RES, V109, P697, DOI 10.1161/CIRCRESAHA.110.234914; SHANAHAN CM, 1994, J CLIN INVEST, V93, P2393, DOI 10.1172/JCI117246; Speer MY, 2009, CIRC RES, V104, P733, DOI 10.1161/CIRCRESAHA.108.183053; Spronk HMH, 2001, BIOCHEM BIOPH RES CO, V289, P485, DOI 10.1006/bbrc.2001.5996; Stary HC, 2000, ARTERIOSCL THROM VAS, V20, P1177, DOI 10.1161/01.ATV.20.5.1177; STARY HC, 1994, ARTERIOSCLER THROMB, V14, P840, DOI 10.1161/01.ATV.14.5.840; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; Wallin R, 2000, THROMB HAEMOSTASIS, V84, P1039; Yao YC, 2010, CIRC RES, V107, P485, DOI 10.1161/CIRCRESAHA.110.219071	38	36	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142335	10.1371/journal.pone.0142335	http://dx.doi.org/10.1371/journal.pone.0142335			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555788	Green Published, Green Submitted, gold			2022-12-27	WOS:000364430700086
J	Chen, JHC; Wong, G; Chapman, JR; Lim, WH				Chen, Jenny H. C.; Wong, Germaine; Chapman, Jeremy R.; Lim, Wai H.			Cumulative Doses of T-Cell Depleting Antibody and Cancer Risk after Kidney Transplantation	PLOS ONE			English	Article							ANTITHYMOCYTE GLOBULINS; RENAL-TRANSPLANTATION; ACUTE REJECTION; RECIPIENTS; IMMUNOSUPPRESSION; MECHANISMS; THERAPY	T-cell depleting antibody is associated with an increased risk of cancer after kidney transplantation, but a dose-dependent relationship has not been established. This study aimed to determine the association between cumulative doses of T-cell depleting antibody and the risk of cancer after kidney transplantation. Using data from the Australian and New Zealand Dialysis and Transplant Registry between 1997-2012, we assessed the risk of incident cancer and cumulative doses of T-cell depleting antibody using adjusted Cox regression models. Of the 503 kidney transplant recipients with 2835 person-years of follow-up, 276 (55%), 209 (41%) and 18 (4%) patients received T-cell depleting antibody for induction, rejection or induction and rejection respectively. The overall cancer incidence rate was 1,118 cancers per 100,000 patient-years, with 975, 1093 and 1377 cancers per 100,000 patient-years among those who had received 1-5 doses, 6-10 doses and >10 doses, respectively. There was no association between cumulative doses of T cell depleting antibody and risk of incident cancer (1-5: referent, 6-10: adjusted hazard ratio (HR) 1.19, 95% CI 0.48-2.95, >10: HR 1.42, 95% CI 0.50-4.02, p = 0.801). This lack of association is contradictory to our hypothesis and is likely attributed to the low event rates resulting in insufficient power to detect significant differences.	[Chen, Jenny H. C.] Prince Wales Hosp, Dept Renal Med, Sydney, NSW, Australia; [Wong, Germaine; Chapman, Jeremy R.] Westmead Hosp, Ctr Transplant & Renal Res, Sydney, NSW, Australia; [Wong, Germaine] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia; [Wong, Germaine] Childrens Hosp Westmead, Ctr Kidney Res, Westmead, NSW, Australia; [Lim, Wai H.] Sir Charles Gairdner Hosp, Perth, WA, Australia	University of Sydney; University of Sydney; University of Sydney; University of Western Australia	Lim, WH (corresponding author), Sir Charles Gairdner Hosp, Perth, WA, Australia.	wai.lim@health.wa.gov.au		Wong, Germaine/0000-0001-8422-7269				Bustami RT, 2004, AM J TRANSPLANT, V4, P87, DOI 10.1046/j.1600-6135.2003.00274.x; Cherikh WS, 2003, TRANSPLANTATION, V76, P1289, DOI 10.1097/01.TP.0000100826.58738.2B; Djamali A, 2000, TRANSPLANTATION, V69, P799; Halloran PF, 2004, NEW ENGL J MED, V351, P2715, DOI 10.1056/NEJMra033540; Hardinger KL, 2006, PHARMACOTHERAPY, V26, P1771, DOI 10.1592/phco.26.12.1771; Hung K, 1998, J EXP MED, V188, P2357, DOI 10.1084/jem.188.12.2357; Knutson KL, 2007, CANCER IMMUNOL IMMUN, V56, P271, DOI 10.1007/s00262-006-0194-y; Lim WH, 2014, TRANSPLANTATION, V97, P817, DOI 10.1097/01.TP.0000442773.38510.32; Midtvedt K, 2003, CLIN TRANSPLANT, V17, P69, DOI 10.1034/j.1399-0012.2003.02105.x; Mougiakakos D, 2010, ADV CANCER RES, V107, P57, DOI 10.1016/S0065-230X(10)07003-X; Nankivell BJ, 2010, NEW ENGL J MED, V363, P1451, DOI 10.1056/NEJMra0902927; Opelz G, 2006, TRANSPLANTATION, V81, P1227, DOI 10.1097/01.tp.0000219817.18049.36; Preville X, 2001, TRANSPLANTATION, V71, P460, DOI 10.1097/00007890-200102150-00021; Webster AC, 2006, TRANSPLANTATION, V81, P953, DOI 10.1097/01.tp.0000215178.72344.9d; Webster AC, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003897.pub3; Webster AC, 2010, NEPHROLOGY, V15, P491, DOI 10.1111/j.1440-1797.2010.01297.x; Zand MS, 2006, TRANSPLANTATION, V82, P1387, DOI 10.1097/01.tp.0000244063.05338.27	17	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0139479	10.1371/journal.pone.0139479	http://dx.doi.org/10.1371/journal.pone.0139479			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555791	gold, Green Published, Green Submitted			2022-12-27	WOS:000364430700006
J	Kaneko, T; Mashimo, T				Kaneko, Takehito; Mashimo, Tomoji			Simple Genome Editing of Rodent Intact Embryos by Electroporation	PLoS One			English	Article							ZINC-FINGER NUCLEASES; ENGINEERED ENDONUCLEASES; ZONA PELLUCIDA; KNOCKOUT RATS; MOUSE; GENE; MODELS; MICROINJECTION; GENERATION; PROGRESS	The clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated (Cas) system is a powerful tool for genome editing in animals. Recently, new technology has been developed to genetically modify animals without using highly skilled techniques, such as pronuclear microinjection of endonucleases. Technique for animal knockout system by electroporation (TAKE) method is a simple and effective technology that produces knockout rats by introducing endonuclease mRNAs into intact embryos using electroporation. Using TAKE method and CRISPR/Cas system, the present study successfully produced knockout and knock-in mice and rats. The mice and rats derived from embryos electroporated with Cas9 mRNA, gRNA and single-stranded oligodeoxynucleotide (ssODN) comprised the edited targeted gene as a knockout (67% of mice and 88% of rats) or knock-in (both 33%). The TAKE method could be widely used as a powerful tool to produce genetically modified animals by genome editing.	[Kaneko, Takehito] Kyoto Univ, Grad Sch Med, Inst Lab Anim, Kyoto 6068501, Japan; [Mashimo, Tomoji] Osaka Univ, Fac Med, Inst Expt Anim Sci, Suita, Osaka 5650871, Japan	Kyoto University; Osaka University	Kaneko, T (corresponding author), Kyoto Univ, Grad Sch Med, Inst Lab Anim, Kyoto 6068501, Japan.	tkaneko@anim.med.kyoto-u.ac.jp			Japan Society for the Promotion of Science [26290033]; Grants-in-Aid for Scientific Research [26290033] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research from Japan Society for the Promotion of Science (No. 26290033).	Aitman TJ, 2008, NAT GENET, V40, P516, DOI 10.1038/ng.147; Bedell MA, 1997, GENE DEV, V11, P11, DOI 10.1101/gad.11.1.11; BRONSON RA, 1970, J REPROD FERTIL, V22, P129, DOI 10.1530/jrf.0.0220129; Carbery ID, 2010, GENETICS, V186, P451, DOI 10.1534/genetics.110.117002; Charreau B, 1996, TRANSGENIC RES, V5, P223, DOI 10.1007/BF01972876; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Grabarek JB, 2002, GENESIS, V32, P269, DOI 10.1002/gene.10076; Jacob HJ, 1999, GENOME RES, V9, P1013, DOI 10.1101/gr.9.11.1013; JAENISCH R, 1988, SCIENCE, V240, P1468, DOI 10.1126/science.3287623; Kaneko T, 2015, METHODS MOL BIOL, V1239, P307, DOI 10.1007/978-1-4939-1862-1_18; Kaneko T, 2014, SCI REP-UK, V4, DOI 10.1038/srep06382; Li DL, 2013, NAT BIOTECHNOL, V31, P681, DOI 10.1038/nbt.2661; Li W, 2013, NAT BIOTECHNOL, V31, P684, DOI 10.1038/nbt.2652; Mashimo T, 2012, CELL REP, V2, P685, DOI 10.1016/j.celrep.2012.08.009; MODLINSKI JA, 1970, J EMBRYOL EXP MORPH, V23, P539; MULLINS JJ, 1990, NATURE, V344, P541, DOI 10.1038/344541a0; Nagy A., 2003, MANIPULATING MOUSE E; Nakanishi Satoshi, 2009, Laboratory Animal Research, V25, P75; Peng H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043748; Russell WMS., 1959, MED J AUSTRALIA; Sakuma T, 2013, SCI REP-UK, V3, DOI 10.1038/srep03379; Sung YH, 2013, NAT BIOTECHNOL, V31, P23, DOI 10.1038/nbt.2477; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940	23	73	74	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142755	10.1371/journal.pone.0142755	http://dx.doi.org/10.1371/journal.pone.0142755			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556280	Green Submitted, Green Published, gold			2022-12-27	WOS:000364430700169
J	Matias, MG; Arenas, F; Rubal, M; Pinto, IS				Matias, Miguel G.; Arenas, Francisco; Rubal, Marcos; Pinto, Isabel S.			Macroalgal Composition Determines the Structure of Benthic Assemblages Colonizing Fragmented Habitats	PLOS ONE			English	Article							LANDSCAPE ECOLOGY; EPIFAUNAL ASSEMBLAGES; BIODIVERSITY PATTERNS; ARTIFICIAL SEAGRASS; SPECIES RICHNESS; MARINE HABITATS; MATRIX MATTERS; NEW-ZEALAND; PATCH SIZE; ROCK POOLS	Understanding the consequences of fragmentation of coastal habitats is an important topic of discussion in marine ecology. Research on the effects of fragmentation has revealed complex and context-dependent biotic responses, which prevent generalizations across different habitats or study organisms. The effects of fragmentation in marine environments have been rarely investigated across heterogeneous habitats, since most studies have focused on a single type of habitat or patch. In this study, we assessed the effects of different levels of fragmentation (i.e. decreasing size of patches without overall habitat loss). We measured these effects using assemblages of macro-invertebrates colonizing representative morphological groups of intertidal macroalgae (e.g. encrusting, turf and canopy-forming algae). For this purpose, we constructed artificial assemblages with different combinations of morphological groups and increasing levels of fragmentation by manipulating the amount of bare rock or the spatial arrangement of different species in mixed assemblages. In general, our results showed that 1) fragmentation did not significantly affect the assemblages of macroinvertebrates; 2) at greater levels of fragmentation, there were greater numbers of species in mixed algal assemblages, suggesting that higher habitat complexity promotes species colonization. Our results suggest that predicting the consequences of fragmentation in heterogeneous habitats is dependent on the type and diversity of morphological groups making up those habitats.	[Matias, Miguel G.] Univ London Imperial Coll Sci Technol & Med, Ascot SL5 7PY, Berks, England; [Arenas, Francisco] Univ Porto, Aquat Ecol & Evolut Grp, Ctr Marine & Environm Res CIIMAR, P-4050123 Oporto, Portugal; [Rubal, Marcos; Pinto, Isabel S.] Univ Porto, Coastal Biodivers Grp, Ctr Marine & Environm Res CIIMAR, P-4050123 Oporto, Portugal; [Pinto, Isabel S.] Univ Porto, Dept Biol, Fac Sci, P-4150181 Oporto, Portugal	Imperial College London; Universidade do Porto; Universidade do Porto; Universidade do Porto	Matias, MG (corresponding author), Univ London Imperial Coll Sci Technol & Med, Silwood Pk Campus,Buckhurst Rd, Ascot SL5 7PY, Berks, England.	m.matias@imperial.ac.uk	Matias, Miguel G/D-4294-2019; Rubal, Marcos/B-1859-2017; Pinto, Isabel Sousa/W-1591-2019; Arenas, Francisco/M-7095-2015	Matias, Miguel G/0000-0001-9198-2051; Pinto, Isabel Sousa/0000-0002-9231-0553; Arenas, Francisco/0000-0001-6925-3805; Rubal, Marcos/0000-0002-1106-6035	Fundacao para a Ciencia e Tecnologia (FCT) [SFRH/BD/27506/2006]; Marie Curie Intra-European Fellowship within the 7th European Community Framework Programme (FORECOMM); European Regional Development Fund (ERDF) through the 'Programa Operacional Factores de Competitividade (POFC-COMPETE) within the 'Quadro de Referencia Estrategico Nacional (OREN)); ERDF through the COMPETE Program [PEst-C/MAR/LA0015/2011]; national FCT funds	Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Marie Curie Intra-European Fellowship within the 7th European Community Framework Programme (FORECOMM); European Regional Development Fund (ERDF) through the 'Programa Operacional Factores de Competitividade (POFC-COMPETE) within the 'Quadro de Referencia Estrategico Nacional (OREN)); ERDF through the COMPETE Program; national FCT funds(Portuguese Foundation for Science and Technology)	MGM was supported by funds from the Fundacao para a Ciencia e Tecnologia (FCT) SFRH/BD/27506/2006 and a Marie Curie Intra-European Fellowship within the 7th European Community Framework Programme (FORECOMM). FA, MR and ISP were funded by the European Regional Development Fund (ERDF) through the 'Programa Operacional Factores de Competitividade (POFC-COMPETE) within the 'Quadro de Referencia Estrategico Nacional (OREN)) and PEst-C/MAR/LA0015/2011 (by ERDF through the COMPETE Program and national FCT funds.	Airoldi L, 1997, J EXP MAR BIOL ECOL, V215, P269, DOI 10.1016/S0022-0981(96)02770-0; Airoldi L, 2007, OCEANOGR MAR BIOL, V45, P345; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Araujo R, 2006, ACTA OECOL, V30, P192, DOI 10.1016/j.actao.2006.04.002; Archambault P, 1996, MAR ECOL PROG SER, V136, P111, DOI 10.3354/meps136111; Arenas F, 2006, ECOLOGY, V87, P2851, DOI 10.1890/0012-9658(2006)87[2851:TIOMAA]2.0.CO;2; Arenas F, 2009, MAR ECOL PROG SER, V381, P99, DOI 10.3354/meps07950; Attrill MJ, 2000, ECOGRAPHY, V23, P114, DOI 10.1034/j.1600-0587.2000.230112.x; Beesley PL, 1998, MOLLUSCA SO SYNTHE B; Bell SS, 2001, BIOL CONSERV, V100, P115, DOI 10.1016/S0006-3207(00)00212-3; BenedettiCecchi L, 1996, MAR ECOL PROG SER, V135, P145, DOI 10.3354/meps135145; Best RJ, 2014, ECOLOGY, V95, P1308, DOI 10.1890/13-1480.1; Bowden DA, 2001, J EXP MAR BIOL ECOL, V259, P133, DOI 10.1016/S0022-0981(01)00236-2; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Brown PJ, 1999, J EXP MAR BIOL ECOL, V235, P45, DOI 10.1016/S0022-0981(98)00186-5; Bulleri F, 2012, OIKOS, V121, P1801, DOI 10.1111/j.1600-0706.2011.19967.x; Cacabelos E, 2010, ESTUAR COAST SHELF S, V89, P43, DOI 10.1016/j.ecss.2010.05.012; Carr MH, 2003, ECOL APPL, V13, pS90; Clarke KR, 2006, J EXP MAR BIOL ECOL, V330, P55, DOI 10.1016/j.jembe.2005.12.017; Collinge SK, 1996, LANDSCAPE URBAN PLAN, V36, P59, DOI 10.1016/S0169-2046(96)00341-6; Crowe T, 1996, J EXP MAR BIOL ECOL, V206, P83, DOI 10.1016/S0022-0981(96)02615-9; Crowe T. P., 2000, Journal of Aquatic Ecosystem Stress and Recovery, V7, P273, DOI 10.1023/A:1009911928100; Debinski DM, 2006, J BIOGEOGR, V33, P1791, DOI 10.1111/j.1365-2699.2006.01596.x; Downing J.A., 1991, Ecological Studies, P160; Eggleston DB, 1999, J EXP MAR BIOL ECOL, V236, P107, DOI 10.1016/S0022-0981(98)00192-0; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Goodsell PJ, 2008, MAR BIOL, V154, P117, DOI 10.1007/s00227-008-0906-2; Goodsell PJ, 2009, MAR ECOL PROG SER, V384, P23, DOI 10.3354/meps08037; Goodsell PJ, 2002, MAR ECOL PROG SER, V239, P37, DOI 10.3354/meps239037; Gray JS, 1997, BIODIVERS CONSERV, V6, P153, DOI 10.1023/A:1018335901847; GUNNILL FC, 1982, MAR BIOL, V69, P263, DOI 10.1007/BF00397492; HACKER SD, 1990, ECOLOGY, V71, P2269, DOI 10.2307/1938638; Holmquist JG, 1998, OIKOS, V81, P558, DOI 10.2307/3546776; Irving AD, 2007, J EXP MAR BIOL ECOL, V340, P40, DOI 10.1016/j.jembe.2006.08.010; KELAHER B, 2001, J MAR BIOL ASSOC UK, V81, P1; Keough MJ, 1998, ECOL APPL, V8, P141, DOI 10.1890/1051-0761(1998)008[0141:EOPDFT]2.0.CO;2; KOTLIAR NB, 1990, OIKOS, V59, P253, DOI 10.2307/3545542; LEVIN SA, 1974, P NATL ACAD SCI USA, V71, P2744, DOI 10.1073/pnas.71.7.2744; Lindenmayer DB, 2007, TRENDS ECOL EVOL, V22, P127, DOI 10.1016/j.tree.2006.11.006; Macreadie PI, 2009, CONSERV BIOL, V23, P644, DOI 10.1111/j.1523-1739.2008.01130.x; MARTEL A, 1991, J EXP MAR BIOL ECOL, V150, P131, DOI 10.1016/0022-0981(91)90111-9; Matias MG, 2010, AUSTRAL ECOL, V35, P743, DOI 10.1111/j.1442-9993.2009.02081.x; Matias MG, 2007, J ANIM ECOL, V76, P986, DOI 10.1111/j.1365-2656.2007.01277.x; Matias MG, 2013, MAR BIOL, V160, P493, DOI 10.1007/s00227-012-2155-7; Matias MG, 2011, MAR ECOL PROG SER, V437, P135, DOI 10.3354/meps09273; Matias MG, 2010, ECOLOGY, V91, P1908, DOI 10.1890/09-1083.1; Olabarria C, 2002, OECOLOGIA, V132, P159, DOI 10.1007/s00442-002-0940-6; Olabarria C, 2002, J EXP MAR BIOL ECOL, V269, P85, DOI 10.1016/S0022-0981(01)00394-X; Palmer MA, 2000, LANDSCAPE ECOL, V15, P563, DOI 10.1023/A:1008194130695; Parker JD, 2001, MAR ECOL PROG SER, V224, P55, DOI 10.3354/meps224055; Pereira SG, 2006, HYDROBIOLOGIA, V555, P185, DOI 10.1007/s10750-005-1115-3; Petchey OL, 2003, OIKOS, V101, P323, DOI 10.1034/j.1600-0706.2003.11828.x; Pickett S. T. A., 1985, ECOLOGY NATURAL DIST; RAY GC, 1991, BIOSCIENCE, V41, P490, DOI 10.2307/1311807; Ricketts TH, 2001, AM NAT, V158, P87, DOI 10.1086/320863; ROBBINS BD, 1994, TRENDS ECOL EVOL, V9, P301, DOI 10.1016/0169-5347(94)90041-8; Roberts CM, 1997, SCIENCE, V278, P1454, DOI 10.1126/science.278.5342.1454; Roberts DA, 2006, BIOL CONSERV, V127, P18, DOI 10.1016/j.biocon.2005.07.010; SANTELICES B, 1990, OCEANOGR MAR BIOL, V28, P177; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; Schiel DR, 1999, J EXP MAR BIOL ECOL, V235, P213, DOI 10.1016/S0022-0981(98)00170-1; SCHROEDER RE, 1987, B MAR SCI, V41, P441; Skilleter GA, 2005, MAR BIOL, V147, P353, DOI 10.1007/s00227-005-1580-2; STEELE JH, 1991, ECOL RES, V6, P175, DOI 10.1007/BF02347160; SUCHANEK TH, 1994, AM ZOOL, V34, P100; Tanner JE, 2006, ESTUAR COAST SHELF S, V68, P404, DOI 10.1016/j.ecss.2006.01.029; Thompson RC, 2002, ENVIRON CONSERV, V29, P168, DOI 10.1017/S0376892902000115; Turner MG, 2005, ANNU REV ECOL EVOL S, V36, P319, DOI 10.1146/annurev.ecolsys.36.102003.152614; TURNER MG, 1989, ANNU REV ECOL SYST, V20, P171, DOI 10.1146/annurev.es.20.110189.001131; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; Underwood AJ, 2006, J EXP MAR BIOL ECOL, V330, P221, DOI 10.1016/j.jembe.2005.12.029; VIRNSTEIN RW, 1986, MAR ECOL PROG SER, V29, P279, DOI 10.3354/meps029279; Warner RR, 2002, B MAR SCI, V70, P245; Warry FY, 2009, OECOLOGIA, V159, P883, DOI 10.1007/s00442-008-1258-9; WHITTAKER RH, 1977, THEOR POPUL BIOL, V12, P117, DOI 10.1016/0040-5809(77)90039-9; Wiens JA, 2002, FRESHWATER BIOL, V47, P501, DOI 10.1046/j.1365-2427.2002.00887.x; Wilcove D.S., 1986, P237; Williamson JE, 1996, NEW ZEAL J MAR FRESH, V30, P221	79	13	13	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142289	10.1371/journal.pone.0142289	http://dx.doi.org/10.1371/journal.pone.0142289			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26554924	Green Published, Green Submitted, gold			2022-12-27	WOS:000364430700078
J	Miller, NP; Amouzou, A; Hazel, E; Degefie, T; Legesse, H; Tafesse, M; Pearson, L; Black, RE; Bryce, J				Miller, Nathan P.; Amouzou, Agbessi; Hazel, Elizabeth; Degefie, Tedbabe; Legesse, Hailemariam; Tafesse, Mengistu; Pearson, Luwei; Black, Robert E.; Bryce, Jennifer			Assessing the Quality of Sick Child Care Provided by Community Health Workers	PLoS One			English	Article							CASE-MANAGEMENT; OF-CARE; PERFORMANCE; ETHIOPIA	Background As community case management of childhood illness expands in low-income countries, there is a need to assess the quality of care provided by community health workers. This study had the following objectives: 1) examine methods of recruitment of sick children for assessment of quality of care, 2) assess the validity of register review (RR) and direct observation only (DO) compared to direct observation with re-examination (DO+RE), and 3) assess the effect of observation on community health worker performance. Methods We conducted a survey to assess the quality of care provided by Ethiopian Health Extension Workers (HEWs). The sample of children was obtained through spontaneous consultation, HEW mobilization, or recruitment by the survey team. We assessed patient characteristics by recruitment method. Estimates of indicators of quality of care obtained using RR and DO were compared to gold standard estimates obtained through DO+RE. Sensitivity, specificity, and the area under receiver operator characteristic curve (AUC) were calculated to assess the validity of RR and DO. To assess the Hawthorne effect, we compared estimates from RR for children who were observed by the survey team to estimates from RR for children who were not observed by the survey team. Results Participants included 137 HEWs and 257 sick children in 103 health posts, plus 544 children from patient registers. Children mobilized by HEWs had the highest proportion of severe illness (27%). Indicators of quality of care from RR and DO had high sensitivity for most indicators, but specificity was low. The AUC for different indicators from RR ranged from 0.47 to 0.76, with only one indicator above 0.75. The AUC of indicators from DO ranged from 0.54 to 1.0, with three indicators above 0.75. The differences between estimates of correct care for observed versus not observed children were small. Conclusions Mobilization by HEWs and recruitment by the survey teams were feasible, but potentially biased, methods of obtaining sick children. Register review and DO underestimated performance errors. Our data suggest that being observed had only a small positive effect on the performance of HEWs.	[Miller, Nathan P.; Amouzou, Agbessi; Hazel, Elizabeth; Black, Robert E.; Bryce, Jennifer] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Inst Int Programs, Baltimore, MD 21205 USA; [Degefie, Tedbabe; Legesse, Hailemariam; Pearson, Luwei] United Nations Childrens Fund UNICEF, Ethiopia Country Off, Addis Ababa, Ethiopia; [Tafesse, Mengistu] ABH Serv PLC, Addis Ababa, Ethiopia	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Miller, NP (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Inst Int Programs, Baltimore, MD 21205 USA.	nmille33@jhu.edu		Amouzou, Agbessi/0000-0002-6262-3866; Hazel, Elizabeth A./0000-0002-9176-3278	United Nations Children's Fund [1000017212]; Government of Canada [7056791]; United States National Institutes of Health Training Grant for Maternal and Child Health [HD046405]; ABH Services, PLC; Oromia Regional Health Bureau; Ethiopian Federal Ministry of Health; JSI Research and Training Institute, Inc./Last 10 Kilometers Project [JSI/L10K]	United Nations Children's Fund; Government of Canada(CGIAR); United States National Institutes of Health Training Grant for Maternal and Child Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ABH Services, PLC; Oromia Regional Health Bureau; Ethiopian Federal Ministry of Health; JSI Research and Training Institute, Inc./Last 10 Kilometers Project	Funding: This work was supported by The United Nations Children's Fund (award 1000017212, http://www.unicef.org) and the Government of Canada (award 7056791,http://www.international.gc.ca/international/index.aspx?lang = eng). NPM received funding from the United States National Institutes of Health Training Grant for Maternal and Child Health (HD046405, http://www.nih.gov). Co-author Mengistu Tafesse is employed by ABH Services, PLC. ABH Services, PLC, provided support in the form of salaries for author MT and managed data collection. The specific role of this author is articulated in the 'author contributions' section.; The authors thank the Oromia Regional Health Bureau and the Ethiopian Federal Ministry of Health for their strong support of this research. Thanks to ABH Services, PLC for implementation of the survey. We also thank the JSI Research and Training Institute, Inc./Last 10 Kilometers Project (JSI/L10K) and the Integrated Family Health Program (JSI/IFHP).	Ashwell H. E. S., 1995, Papua New Guinea Medical Journal, V38, P198; Bank TW, 2011, WORLD DEV IND; CAMPBELL JP, 1995, ANN EMERG MED, V26, P590, DOI 10.1016/S0196-0644(95)70009-9; Cardemil CV, 2012, AM J TROP MED HYG, V87, P127, DOI 10.4269/ajtmh.2012.12-0389; Cochran WG., 1963, SAMPLING TECHNIQUES; Degefie T, 2009, ETHIOP J HEALTH DEV, V23, P120; Franco LM, 2002, INT J QUAL HEALTH C, V14, P17, DOI 10.1093/intqhc/14.suppl_1.17; Gilroy KE, 2013, HEALTH POLICY PLANN, V28, P573, DOI 10.1093/heapol/czs095; Haines A, 2007, LANCET, V369, P2121, DOI 10.1016/S0140-6736(07)60325-0; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hartung C., 2010, 4 ACM IEEE INT C INF 4 ACM IEEE INT C INF; Hermida J, 1999, INT J QUAL HEALTH C, V11, P429, DOI 10.1093/intqhc/11.5.429; Hrisos S, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-37; Leonard K, 2006, SOC SCI MED, V63, P2330, DOI 10.1016/j.socscimed.2006.06.003; Mehnaz Aisha, 1997, JPMA (Journal of the Pakistan Medical Association), V47, P42; Miller NP, 2014, AM J TROP MED HYG, V91, P424, DOI 10.4269/ajtmh.13-0751; Office of the Population and Housing Census Commission, 2011, SUMM STAT REP 2007 P; Rowe AK, 2005, LANCET, V366, P1026, DOI 10.1016/S0140-6736(05)67028-6; Rowe AK, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-95; Rowe SY, 2007, TROP MED INT HEALTH, V12, P651, DOI 10.1111/j.1365-3156.2007.01824.x; Rowe SY, 2006, INT J QUAL HEALTH C, V18, P299, DOI 10.1093/intqhc/mzl009; StataCorp, 2011, STAT STAT SOFTW REL, P173; WHO, 2003, HLTH FAC SURV TOOL E; WINCH PJ, 2003, IMPROVING PERFORMANC; World Health Organization, 2007, COMM HLTH WORK WHAT; Zhou X.H., 2002, STAT METHODS DIAGNOS, DOI 10.1002/9780470317082	26	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2015	10	11							e0142010	10.1371/journal.pone.0142010	http://dx.doi.org/10.1371/journal.pone.0142010			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7AC	26551035	Green Submitted, gold, Green Published			2022-12-27	WOS:000364422800014
J	Chiang, CY; Yu, MC; Yang, SL; Yen, MY; Bai, KJ				Chiang, Chen-Yuan; Yu, Ming-Chih; Yang, Shiang-Lin; Yen, Muh-Yong; Bai, Kuan-Jen			Surveillance of Tuberculosis in Taipei: The Influence of Nontuberculous Mycobacteria	PLOS ONE			English	Article							HUMAN TRANSMISSION; CYSTIC-FIBROSIS; LUNG-DISEASE; ABSCESSUS	Background Notification of tuberculosis (TB) but not nontuberculous mycobacteria (NTM) is mandatory in Taiwan. Partly due to the strict regulation on TB notification, several patients infected with NTM were notified as TB cases. Notification of patients infected with NTM as TB cases can trigger public health actions and impose additional burdens on the public health system. We conducted a study to assess the influence of NTM infection on surveillance of TB in Taipei. Methodology/Principal Findings The study population included all individuals with a positive culture for Mycobacterium who were citizens of Taipei City and notified as TB cases in the calendar years 2007-2010. Of the 4216 notified culture-positive tuberculosis (TB) cases, 894 (21.2%) were infected with NTM. The average annual reported case rate of infection with NTM was 8.6 (95% confidence interval 7.7-9.4) per 100,000 people. The reported case rate of NTM increased with age in both males and females. The proportion of reported TB cases infected with NTM was significantly higher in females than in males (27.6% vs 17.8%, adjusted OR (adjOR) 1.93, 95% confidence interval (CI) 1.63-2.28); in smear-positive than in smear-negative (23.1% vs 19.2%, adjOR 1.26, 95% CI 1.08-1.47); and in previously treated cases than in new cases (35.7% vs 19.1%, adjOR 2.30, 95% CI 1.88-2.82). The most frequent species was M. avium complex (32.4%), followed by M. chelonae complex (17.6%), M. fortuitum complex (17.0%) and M. kansasii (9.8%). Of the 890 notified NTM cases assessed, 703 (79.0%) were treated with anti-TB drugs, and 730 (82.0%) were de-notified. Conclusions/Significance The influence of NTM on surveillance of TB in Taipei was substantial. Health authorities should take action to ensure that nucleic acid amplification tests are performed in all smear-positive cases in a timely manner to reduce the misdiagnosis of patients infected with NTM as TB cases.	[Chiang, Chen-Yuan] Int Union TB & Lung Dis, Paris, France; [Chiang, Chen-Yuan; Yu, Ming-Chih; Bai, Kuan-Jen] Taipei Med Univ, Wan Fang Hosp, Dept Internal Med, Div Pulm Med, Taipei, Taiwan; [Chiang, Chen-Yuan] Taipei Med Univ, Coll Med, Sch Med, Dept Internal Med, Taipei, Taiwan; [Yu, Ming-Chih; Bai, Kuan-Jen] Taipei Med Univ, Coll Med, Sch Resp Therapy, Taipei, Taiwan; [Yang, Shiang-Lin] Ctr Dis Control, Dept Hlth, Taipei, Taiwan; [Yen, Muh-Yong] Taipei City Govt, Taipei City Hosp, Dept Dis Control & Prevent, Taipei, Taiwan	Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Medical University; Centers For Disease Control - Taiwan; Taipei City Hospital	Bai, KJ (corresponding author), Taipei Med Univ, Wan Fang Hosp, Dept Internal Med, Div Pulm Med, Taipei, Taiwan.	kjbai@w.tmu.edu.tw						Adjemian J, 2012, AM J RESP CRIT CARE, V185, P881, DOI 10.1164/rccm.201111-2016OC; Aitken ML, 2012, AM J RESP CRIT CARE, V185, P231, DOI 10.1164/ajrccm.185.2.231; Anonymous, 2009, Morbidity and Mortality Weekly Report, V58, P7; Brode SK, 2014, INT J TUBERC LUNG D, V18, P1370, DOI 10.5588/ijtld.14.0120; Bryant JM, 2013, LANCET, V381, P1551, DOI 10.1016/S0140-6736(13)60632-7; Canadian Thoracic Society, 2013, CAN RESP J SA, V20, p1A; Chiang CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044133; Chiang CY, 2002, INT J TUBERC LUNG D, V6, P974; Daley CL, 2010, INT J TUBERC LUNG D, V14, P665; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Hoefsloot W, 2013, EUR RESPIR J, V42, P1604, DOI 10.1183/09031936.00149212; Hoefsloot W, 2012, EUR RESPIR J, V40, P1576, DOI 10.1183/09031936.00096312; Kendall BA, 2011, EMERG INFECT DIS, V17, P506, DOI 10.3201/eid1703.101164; Khan K, 2007, AM J RESP CRIT CARE, V176, P306, DOI 10.1164/rccm.200702-201OC; Kim YK, 2014, INT J TUBERC LUNG D, V18, P725, DOI 10.5588/ijtld.13.0871; Lai CC, 2010, EMERG INFECT DIS, V16, P294, DOI 10.3201/eid1602.090675; Lo HY, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-915; Maiga M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036902; Marras TK, 2013, EMERG INFECT DIS, V19, P1889, DOI 10.3201/eid1911.130737; Moore JE, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-612; Philley JV, 2013, SEMIN RESP CRIT CARE, V34, P135, DOI 10.1055/s-0033-1333575; Ricketts WM, 2014, EUR RESPIR J, V44, P1085, DOI 10.1183/09031936.00066614; Ringshausen FC, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-231; Stanford J, 2012, INT J MYCOBACT, V1, P3, DOI 10.1016/j.ijmyco.2012.01.001; Thomson RM, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-89; van der Werf MJ, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-62; van Ingen J, 2012, EUR RESPIR MONOGR, P25, DOI 10.1183/1025448x.10022511; Wu J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109736; Xu KJ, 2014, EMERG INFECT DIS, V20, P1060, DOI 10.3201/eid2006.130700	29	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142324	10.1371/journal.pone.0142324	http://dx.doi.org/10.1371/journal.pone.0142324			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544554	Green Published, Green Submitted, gold			2022-12-27	WOS:000364398700111
J	Geisler, M; Allwood, CM				Geisler, Martin; Allwood, Carl Martin			Competence and Quality in Real-Life Decision Making	PLOS ONE			English	Article							TRAIT EMOTIONAL INTELLIGENCE; INDIVIDUAL-DIFFERENCES; TIME PERSPECTIVE; STYLES; PROCRASTINATION; RATIONALITY; PERSONALITY; VALIDATION; COGNITION; JUDGMENT	What distinguishes a competent decision maker and how should the issue of decision quality be approached in a real-life context? These questions were explored in three studies. In Study 1, using a web-based questionnaire and targeting a community sample, we investigated the relationships between objective and subjective indicators of real-life decision-making success. In Study 2 and 3, targeting two different samples of professionals, we explored if the prevalent cognitively oriented definition of decision-making competence could be beneficially expanded by adding aspects of competence in terms of social skills and time-approach. The predictive power for each of these three aspects of decision-making competence was explored for different indicators of real-life decision-making success. Overall, our results suggest that research on decision-making competence would benefit by expanding the definition of competence, by including decision-related abilities in terms of social skills and time-approach. Finally, the results also indicate that individual differences in real-life decision-making success profitably can be approached and measured by different criteria.	[Geisler, Martin; Allwood, Carl Martin] Univ Gothenburg, Dept Psychol, S-40020 Gothenburg, Sweden	University of Gothenburg	Geisler, M (corresponding author), Univ Gothenburg, Dept Psychol, Box 14158, S-40020 Gothenburg, Sweden.	martin.geisler@psy.gu.se			Swedish Research Council for Health, Working Life and Welfare, FORTE [2010-0430]	Swedish Research Council for Health, Working Life and Welfare, FORTE	This research was funded by a grant from the Swedish Research Council for Health, Working Life and Welfare, FORTE. dnr: 2010-0430 to CMA (http://www.forte.se/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARON J, 1994, BEHAV BRAIN SCI, V17, P1, DOI 10.1017/S0140525X0003301X; Baron J, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00577; Bechara A, 2005, GAME ECON BEHAV, V52, P336, DOI 10.1016/j.geb.2004.06.010; Carelli MG, 2011, EUR J PSYCHOL ASSESS, V27, P220, DOI 10.1027/1015-5759/a000076; Carnevale JJ, 2011, PERS INDIV DIFFER, V51, P274, DOI 10.1016/j.paid.2010.07.002; Day DV, 2002, J APPL PSYCHOL, V87, P390, DOI 10.1037//0021-9010.87.2.390; de Bruin WB, 2016, J BEHAV DECIS MAKING, V29, P363, DOI 10.1002/bdm.1882; De Bruin WB, 2012, J BEHAV DECIS MAKING, V25, P329, DOI 10.1002/bdm.753; de Bruin WB, 2007, J PERS SOC PSYCHOL, V92, P938, DOI 10.1037/0022-3514.92.5.938; Del Missier F, 2012, J BEHAV DECIS MAKING, V25, P331, DOI 10.1002/bdm.731; Dewberry C, 2013, PERS INDIV DIFFER, V55, P783, DOI 10.1016/j.paid.2013.06.012; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Diener E, 2002, PSYCHOL SCI, V13, P81, DOI 10.1111/1467-9280.00415; Drake L, 2008, TIME SOC, V17, P47, DOI 10.1177/0961463X07086304; Fischhoff B., 1980, COGNITIVE PROCESS, P117; Fischhoff B, 2010, WIRES COGN SCI, V1, P724, DOI 10.1002/wcs.65; Flynn FJ, 2006, J PERS SOC PSYCHOL, V91, P1123, DOI 10.1037/0022-3514.91.6.1123; Frederick S., 2003, TIME DECISION EC PSY, P13; FRISCH D, 1994, PSYCHOL BULL, V116, P46, DOI 10.1037/0033-2909.116.1.46; Frith CD, 2008, PHILOS T R SOC B, V363, P3875, DOI 10.1098/rstb.2008.0156; Gangestad SW, 2000, PSYCHOL BULL, V126, P530, DOI 10.1037//0033-2909.126.4.530; Gosling SD, 2004, AM PSYCHOL, V59, P93, DOI 10.1037/0003-066X.59.2.93; Gupta R, 2012, CURR PSYCHOL, V31, P195, DOI 10.1007/s12144-012-9136-3; Higgins ET, 2000, AM PSYCHOL, V55, P1217, DOI 10.1037/0003-066X.55.11.1217; Hsee CK, 2006, TRENDS COGN SCI, V10, P31, DOI 10.1016/j.tics.2005.11.007; Kahneman D, 1997, Q J ECON, V112, P375, DOI 10.1162/003355397555235; Kahneman D, 2000, CHOICES VALUES FRAME; Keren G., 2003, THINKING PSYCHOL PER, P347, DOI [10.1002/047001332X.ch16, DOI 10.1002/047001332X.CH16]; Keys DJ, 2007, PERSPECT PSYCHOL SCI, V2, P162, DOI 10.1111/j.1745-6916.2007.00035.x; KLINE B. R., 2005, PRINCIPLES PRACTICE, V2nd; KOHN PM, 1992, J BEHAV MED, V15, P221, DOI 10.1007/BF00848327; LAY CH, 1986, J RES PERS, V20, P474, DOI 10.1016/0092-6566(86)90127-3; LENNOX RD, 1984, J PERS SOC PSYCHOL, V46, P1349, DOI 10.1037/0022-3514.46.6.1349; Lerner JS, 1999, PSYCHOL BULL, V125, P255, DOI 10.1037/0033-2909.125.2.255; Loewenstein G., TIME DECISION EC PSY; Marklund M., 2008, TECHNICAL REPORT; Quevedo RJM, 2011, PERS INDIV DIFFER, V50, P206, DOI 10.1016/j.paid.2010.09.030; Mikolajczak M, 2012, PERS INDIV DIFFER, V52, P537, DOI 10.1016/j.paid.2011.12.001; Parker AM, 2005, J BEHAV DECIS MAKING, V18, P1, DOI 10.1002/bdm.481; Parker AM, 2007, JUDGM DECIS MAK, V2, P342; Parker AM, 2012, J BEHAV DECIS MAKING, V25, P382, DOI 10.1002/bdm.745; Pavot W, 2009, SOC INDIC RES SER, V39, P101, DOI 10.1007/978-90-481-2354-4_5; Perez J. C., 2005, INT HDB TRAIT EMOTIO, P88; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Petrides KV, 2007, BRIT J PSYCHOL, V98, P273, DOI 10.1348/000712606X120618; Petrides KV, 2006, J APPL SOC PSYCHOL, V36, P552, DOI 10.1111/j.0021-9029.2006.00019.x; Petrides KV, 2001, EUR J PERSONALITY, V15, P425, DOI 10.1002/per.416; Rilling JK, 2011, ANNU REV PSYCHOL, V62, P23, DOI 10.1146/annurev.psych.121208.131647; Ritov I., 1990, Journal of Behavioral Decision Making, V3, P263, DOI 10.1002/bdm.3960030404; Sanfey AG, 2007, SCIENCE, V318, P598, DOI 10.1126/science.1142996; Schwartz B, 2011, J THEOR SOC BEHAV, V41, P209, DOI 10.1111/j.1468-5914.2010.00450.x; Sevdalis N, 2007, PERS INDIV DIFFER, V42, P1347, DOI 10.1016/j.paid.2006.10.012; Slovic P, 2002, HEURISTICS BIASES PS, P397, DOI [DOI 10.1017/CBO9780511808098.025, 10.1017/CBO9780511808098.025]; SNYDER M, 1974, J PERS SOC PSYCHOL, V30, P526, DOI 10.1037/h0037039; Stanovich KE, 2000, BEHAV BRAIN SCI, V23, P645, DOI 10.1017/S0140525X00003435; Stanovich KE, 2013, THINK REASONING, V19, P1, DOI 10.1080/13546783.2012.713178; Steel P, 2007, PSYCHOL BULL, V133, P65, DOI 10.1037/0033-2909.133.1.65; STRATHMAN A, 1994, J PERS SOC PSYCHOL, V66, P742, DOI 10.1037/0022-3514.66.4.742; Strough J, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00783; Strough J, 2014, J BEHAV DECIS MAKING, V27, P78, DOI 10.1002/bdm.1781; Telle NT, 2011, PERS INDIV DIFFER, V50, P523, DOI 10.1016/j.paid.2010.11.010; Tetlock P. E., 1985, RES ORGAN BEHAV, V1, P297; Tetlock PE, 2002, PSYCHOL REV, V109, P451, DOI 10.1037//0033-295X.109.3.451; Tice DM, 1997, PSYCHOL SCI, V8, P454, DOI 10.1111/j.1467-9280.1997.tb00460.x; Usunier JC, 2007, TIME SOC, V16, P333, DOI 10.1177/0961463X07080272; Vohs KD, 2005, J PERS SOC PSYCHOL, V88, P632, DOI 10.1037/0022-3514.88.4.632; Weiss JW, 2012, SYNTHESE, V189, P759, DOI 10.1007/s11229-012-0112-0; Weller JA, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00540; Weller JA, 2015, J BEHAV DECIS MAKING, V28, P76, DOI 10.1002/bdm.1822; Weller JA, 2012, J BEHAV DECIS MAKING, V25, P414, DOI 10.1002/bdm.744; Wilson TD, 2005, CURR DIR PSYCHOL SCI, V14, P131, DOI 10.1111/j.0963-7214.2005.00355.x; Wittmann M, 2008, TRENDS COGN SCI, V12, P7, DOI 10.1016/j.tics.2007.10.004; Wood NL, 2014, PERS INDIV DIFFER, V70, P224, DOI 10.1016/j.paid.2014.06.036; Yates JF, 2001, EXP RES APPL, P9; Zimbardo PG, 1999, J PERS SOC PSYCHOL, V77, P1271, DOI 10.1037/0022-3514.77.6.1271	75	7	7	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142178	10.1371/journal.pone.0142178	http://dx.doi.org/10.1371/journal.pone.0142178			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV6RT	26545239	Green Published, gold, Green Submitted			2022-12-27	WOS:000364398700092
J	Moffa, EB; Machado, MAAM; Mussi, MCM; Xiao, YZ; Garrido, SS; Giampaolo, ET; Siqueira, WL				Moffa, Eduardo B.; Machado, Maria A. A. M.; Mussi, Maria C. M.; Xiao, Yizhi; Garrido, Saulo S.; Giampaolo, Eunice T.; Siqueira, Walter L.			In Vitro Identification of Histatin 5 Salivary Complexes	PLOS ONE			English	Article							PROLINE-RICH PROTEINS; WHOLE SALIVA; PROTEOME; STATHERIN; PEPTIDE; LACTOFERRIN; DOMAINS; AMYLASE; BINDING; MG2	With recent progress in the analysis of the salivary proteome, the number of salivary proteins identified has increased dramatically. However, the physiological functions of many of the newly discovered proteins remain unclear. Closely related to the study of a protein's function is the identification of its interaction partners. Although in saliva some proteins may act primarily as single monomeric units, a significant percentage of all salivary proteins, if not the majority, appear to act in complexes with partners to execute their diverse functions. Coimmunoprecipitation (Co-IP) and pull-down assays were used to identify the heterotypic complexes between histatin 5, a potent natural antifungal protein, and other salivary proteins in saliva. Classical protein-protein interaction methods in combination with high-throughput mass spectrometric techniques were carried out. Co-IP using protein G magnetic Sepharose TM beads suspension was able to capture salivary complexes formed between histatin 5 and its salivary protein partners. Pull-down assay was used to confirm histatin 5 protein partners. A total of 52 different proteins were identified to interact with histatin 5. The present study used proteomic approaches in conjunction with classical biochemical methods to investigate protein-protein interaction in human saliva. Our study demonstrated that when histatin 5 is complexed with salivary amylase, one of the 52 proteins identified as a histatin 5 partner, the antifungal activity of histatin 5 is reduced. We expected that our proteomic approach could serve as a basis for future studies on the mechanism and structural-characterization of those salivary protein interactions to understand their clinical significance.	[Moffa, Eduardo B.; Mussi, Maria C. M.; Xiao, Yizhi; Siqueira, Walter L.] Univ Western Ontario, Dept Dent & Biochem, Schulich Sch Med & Dent, London, ON, Canada; [Moffa, Eduardo B.; Giampaolo, Eunice T.] UNESP Univ Estadual Paulista, Araraquara Dent Sch, Dept Dent Mat & Prosthodont, Sao Paulo, Brazil; [Moffa, Eduardo B.] CEUMA Univ, Dept Prosthodont, Sao Luis, MA, Brazil; [Moffa, Eduardo B.; Machado, Maria A. A. M.] Univ Sao Paulo, Bauru Dent Sch, Dept Pediat Dent Orthodont & Publ Hlth, Bauru, SP, Brazil; [Mussi, Maria C. M.] Univ Sao Paulo, Sch Dent, Sao Paulo, SP, Brazil; [Garrido, Saulo S.] UNESP Univ Estadual Paulista, Inst Chem, Dept Biochem & Technol Chem, Sao Paulo, Brazil	Western University (University of Western Ontario); Universidade Estadual Paulista; Universidade Ceuma; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual Paulista	Siqueira, WL (corresponding author), Univ Western Ontario, Dept Dent & Biochem, Schulich Sch Med & Dent, London, ON, Canada.	walter.siqueira@uwo.ca	Siqueira, Walter/ABE-8924-2020; Moffa, Eduardo B/N-4260-2015; Machado, Maria Aparecida Andrade Moreira/D-8224-2012; Garrido, Saulo S Santesso/D-4267-2012; Mussi, Maria Carolina Martins/AAE-3128-2021; Siqueira, Walter/ABE-4069-2021	Siqueira, Walter/0000-0003-1921-3658; Moffa, Eduardo B/0000-0002-0372-6830; Machado, Maria Aparecida Andrade Moreira/0000-0003-3778-7444; Garrido, Saulo S Santesso/0000-0001-7122-1132; 	FAPESP [2011/23540-5, 2011/23543-4, 2012/01528-6, 2013/15412-2]; NSERC [371813]; CIHR [106657, 97577]; Canada Foundation for Innovation [25116]; CIHR New Investigator Award [113166]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); CIHR New Investigator Award(Canadian Institutes of Health Research (CIHR))	Support was provided by FAPESP Grants 2011/23540-5, 2011/23543-4, 2012/01528-6 and 2013/15412-2, NSERC grant#371813, CIHR grants #106657/#97577, and Canada Foundation for Innovation grant #25116. WLS is recipient of a CIHR New Investigator Award grant#113166.	Alberts B, 1998, CELL, V92, P291, DOI 10.1016/S0092-8674(00)80922-8; BAUM BJ, 1977, J DENT RES, V56, P1115, DOI 10.1177/00220345770560091801; BENNICK A, 1971, BIOCHEM J, V123, P455, DOI 10.1042/bj1230455; Bruno LS, 2005, BBA-MOL CELL RES, V1746, P65, DOI 10.1016/j.bbamcr.2005.08.007; Castagnola M, 2004, J BIOL CHEM, V279, P41436, DOI 10.1074/jbc.M404322200; Castagnola M, 2012, J MATERN-FETAL NEO M, V25, P27, DOI 10.3109/14767058.2012.714647; Castagnola M, 2012, EXPERT REV PROTEOMIC, V9, P33, DOI [10.1586/EPR.11.77, 10.1586/epr.11.77]; CSERHATI T, 1995, PEPTIDES, V16, P165, DOI 10.1016/0196-9781(94)00134-R; DAWES C, 1972, J PHYSIOL-LONDON, V220, P529, DOI 10.1113/jphysiol.1972.sp009721; Denny P, 2008, J PROTEOME RES, V7, P1994, DOI 10.1021/pr700764j; DICKINSON DP, 1987, BIOCHEM BIOPH RES CO, V149, P784, DOI 10.1016/0006-291X(87)90436-0; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gibbins HL, 2014, ORAL DIS, V20, P707, DOI 10.1111/odi.12194; Gibbins HL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119677; Gyurko C, 2001, ANTON LEEUW INT J G, V79, P297, DOI 10.1023/A:1012070600340; Helmerhorst EJ, 2006, ARCH ORAL BIOL, V51, P1061, DOI 10.1016/j.archoralbio.2006.06.005; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Iontcheva I, 1997, J DENT RES, V76, P734, DOI 10.1177/00220345970760030501; Iontcheva I, 2000, J DENT RES, V79, P732; KELLER PJ, 1971, BIOCHEMISTRY-US, V10, P4867, DOI 10.1021/bi00802a006; KOUSVELARI EE, 1979, BIOCHIM BIOPHYS ACTA, V578, P76, DOI 10.1016/0005-2795(79)90115-6; McDonald EE, 2011, J DENT RES, V90, P268, DOI 10.1177/0022034510388653; OPPENHEIM FG, 1988, J BIOL CHEM, V263, P7472; OPPENHEIM FG, 1971, BIOCHEMISTRY-US, V10, P4233, DOI 10.1021/bi00799a013; Oppenheim FG, 2007, ANN NY ACAD SCI, V1098, P22, DOI 10.1196/annals.1384.030; PLOS ONE Staff, 2015, PLoS One, V10, pe0126887, DOI 10.1371/journal.pone.0126887; POLLOCK JJ, 1984, INFECT IMMUN, V44, P702, DOI 10.1128/IAI.44.3.702-707.1984; RAJ PA, 1990, J BIOL CHEM, V265, P3898; Ramani AK, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-R40; Ruhl S, 2005, J DENT RES, V84, P29, DOI 10.1177/154405910508400104; Ruhl S, 2012, EXPERT REV PROTEOMIC, V9, P85, DOI [10.1586/epr.11.80, 10.1586/EPR.11.80]; Salih E, 2010, ANAL BIOCHEM, V407, P19, DOI 10.1016/j.ab.2010.07.012; SCHLESINGER DH, 1977, J BIOL CHEM, V252, P1689; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Siqueira WL, 2008, J DENT RES, V87, P445, DOI 10.1177/154405910808700508; Siqueira WL, 2007, ANN NY ACAD SCI, V1098, P504, DOI 10.1196/annals.1384.023; Siqueira WL, 2010, J DENT RES, V89, P626, DOI 10.1177/0022034510363384; Siqueira WL, 2012, PROTEOMICS, V12, P3426, DOI 10.1002/pmic.201100665; Siqueira WL, 2004, ORAL SURG ORAL MED O, V98, P76, DOI 10.1016/j.tripleo.2004.04.007; Soares RV, 2004, ARCH ORAL BIOL, V49, P337, DOI 10.1016/j.archoralbio.2003.11.007; Soares RV, 2003, J DENT RES, V82, P471, DOI 10.1177/154405910308200613; Sun XL, 2009, FASEB J, V23, P2691, DOI 10.1096/fj.09-131045; Vitorino R, 2012, J PROTEOMICS, V75, P5140, DOI 10.1016/j.jprot.2012.05.045; Wang GS, 2014, PHARMACEUTICALS-BASE, V7, P545, DOI 10.3390/ph7050545; XU T, 1991, INFECT IMMUN, V59, P2549, DOI 10.1128/IAI.59.8.2549-2554.1991	46	12	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142517	10.1371/journal.pone.0142517	http://dx.doi.org/10.1371/journal.pone.0142517			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544073	Green Published, Green Submitted, gold			2022-12-27	WOS:000364398700149
J	Paredes, VEB; Buchholz, HG; Gartenschlager, M; Breimhorst, M; Schreckenberger, M; Werhahn, KJ				Paredes, Viviane E. Bernedo; Buchholz, Hans-Georg; Gartenschlaeger, Martin; Breimhorst, Markus; Schreckenberger, Mathias; Werhahn, Konrad J.			Reduced D2/D3 Receptor Binding of Extrastriatal and Striatal Regions in Temporal Lobe Epilepsy	PLOS ONE			English	Article							BASAL GANGLIA; DOPAMINE TRANSPORTER; PET; AVAILABILITY; MODEL; ABNORMALITIES; ASSOCIATION; INVOLVEMENT; DEPENDENCE; BRAIN	Objective Dopamine is an endogenous neuromodulator in cortical circuits and the basal ganglia. In animal models of temporal lobe epilepsy (TLE), seizure threshold is modulated to some extent by dopamine, with D1-receptors having a pro- and D2-receptors an anticonvulsant effect. We aimed to extend our previously reported results on decreased D2/D3 receptor binding in the lateral epileptogenic temporal lobe and to correlate them with demographic and seizure variables to gain a more comprehensive understanding of the underlying involvement of the dopaminergic system in the epileptogenesis of TLE. Methods To quantify D2/D3 receptor binding, we studied 21 patients with TLE and hippocampal sclerosis (13 left- and eight right-sided) and 18 controls using PET with the high-affinity dopamine D2/D3-receptor ligand F-18-Fallypride to image striatal and extrastriatal binding. TLE was defined by interictal and ictal video-EEG, MRI and F-18-Fluorodeoxyglucose PET. Voxel-based statistical and regions-of-interest analyses were performed. Results F-18-Fallypride binding potential was significantly reduced in the affected temporal lobe and bilateral putamen. A positive correlation between age at onset of epilepsy and [F-18] FP BPnd (binding potential non-displaceable) in temporal regions on the epileptogenic side was found, as well as a negative correlation between epilepsy duration and [F-18] FP BPnd in the temporal pole on the epileptogenic side and a positive correlation between the estimated number of lifetime GTCS and [F-18] FP BPnd in the hippocampus on the epileptogenic side. Significance The areas of reduced D2/D3 receptor availability correspond to "the irritative zone" surrounding the epileptogenic area. Moreover, reduced D2/D3 receptor availability was detectable in the basal ganglia, which are suspected to be involved in a control circuit for epileptic seizures. The correlational analysis additionally suggests that increased epilepsy duration leads to increasing impairment of the dopaminergic system.	[Paredes, Viviane E. Bernedo; Breimhorst, Markus; Werhahn, Konrad J.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Neurol, D-55122 Mainz, Germany; [Buchholz, Hans-Georg; Gartenschlaeger, Martin; Schreckenberger, Mathias] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Nucl Med, D-55122 Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Paredes, VEB (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Neurol, D-55122 Mainz, Germany.	bernedo@uni-mainz.de			H.W. & J. Hector Foundation, Mannheim (Medizinprojekt M46)	H.W. & J. Hector Foundation, Mannheim (Medizinprojekt M46)	The experiments were supported by a scientific grant of the H.W. & J. Hector Foundation (URL:http://www.hector-stiftung.de/), Mannheim (Medizinprojekt M46). MS and KJW received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMEC RE, 1990, BIOL PSYCHIAT, V27, P249, DOI 10.1016/0006-3223(90)90001-I; ALTAJIR G, 1991, NEUROSCIENCE, V43, P51, DOI 10.1016/0306-4522(91)90416-L; ALTAJIR G, 1991, PHARMACOL BIOCHEM BE, V39, P109, DOI 10.1016/0091-3057(91)90405-Q; Ashburner J, 1997, NEUROIMAGE, V6, P209, DOI 10.1006/nimg.1997.0290; Bartenstein P, 2002, EUR J NUCL MED MOL I, V29, pBP43; Biraben A, 2004, NEUROLOGY, V63, P73, DOI 10.1212/01.WNL.0000132840.40838.13; Bouilleret V, 2008, NEUROLOGY, V70, P177, DOI 10.1212/01.wnl.0000297514.47695.48; Bouilleret V, 2005, J NUCL MED, V46, P540; Bozzi Y, 2000, J NEUROSCI, V20, P8643, DOI 10.1523/JNEUROSCI.20-22-08643.2000; Bozzi Y, 2006, TRENDS NEUROSCI, V29, P167, DOI 10.1016/j.tins.2006.01.002; Bozzi Y, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00157; Brown AK, 2012, INT J NEUROPSYCHOPH, V15, P989, DOI 10.1017/S1461145711001957; Carne RP, 2004, BRAIN, V127, P2276, DOI 10.1093/brain/awh257; Ciumas C, 2008, NEUROLOGY, V71, P788, DOI 10.1212/01.wnl.0000316120.70504.d5; Ciumas C, 2010, NEUROIMAGE, V51, P606, DOI 10.1016/j.neuroimage.2010.02.051; CSERNANSKY JG, 1988, BIOL PSYCHIAT, V23, P285, DOI 10.1016/0006-3223(88)90039-X; Deransart C, 2002, EPILEPTIC DISORD, V4, pS61; Fedi M, 2008, NEUROLOGY, V71, P795, DOI 10.1212/01.wnl.0000316192.52731.77; Fehr C, 2008, AM J PSYCHIAT, V165, P507, DOI 10.1176/appi.ajp.2007.07020352; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; Kim JH, 2011, EUR NEUROPSYCHOPHARM, V21, P885, DOI 10.1016/j.euroneuro.2011.03.009; Lammertsma AA, 1996, NEUROIMAGE, V4, P153, DOI 10.1006/nimg.1996.0066; Landvogt C, 2010, EPILEPSIA, V51, P1699, DOI 10.1111/j.1528-1167.2010.02569.x; McIntosh AM, 2004, BRAIN, V127, P2018, DOI 10.1093/brain/awh221; Merlet I, 2004, BRAIN, V127, P900, DOI 10.1093/brain/awh109; Norwood BA, 2010, J COMP NEUROL, V518, P3381, DOI 10.1002/cne.22406; Odano I, 2012, NEUROIMAGE, V59, P3582, DOI 10.1016/j.neuroimage.2011.10.067; RING HA, 1994, BIOL PSYCHIAT, V35, P375, DOI 10.1016/0006-3223(94)90003-5; Rocha L, 2012, NEUROBIOL DIS, V45, P499, DOI 10.1016/j.nbd.2011.09.006; Seidenberg M, 2005, EPILEPSIA, V46, P420, DOI 10.1111/j.0013-9580.2005.27004.x; Siessmeier T, 2005, J NUCL MED, V46, P964; Starr MS, 1996, SYNAPSE, V22, P159, DOI 10.1002/(SICI)1098-2396(199602)22:2<159::AID-SYN8>3.0.CO;2-C; TURSKI L, 1988, J NEUROSCI, V8, P4027; WAHNSCHAFFE U, 1991, BRAIN RES, V553, P181, DOI 10.1016/0006-8993(91)90822-D; Werhahn KJ, 2006, EPILEPSIA, V47, P1392, DOI 10.1111/j.1528-1167.2006.00561.x; WIENHARD K, 1992, J COMPUT ASSIST TOMO, V16, P804, DOI 10.1097/00004728-199209000-00024; Willmann O, 2007, SEIZURE-EUR J EPILEP, V16, P509, DOI 10.1016/j.seizure.2007.04.001; WONG DF, 1988, ANN NY ACAD SCI, V515, P203, DOI 10.1111/j.1749-6632.1988.tb32986.x; Yakushev IY, 2010, EPILEPSIA, V51, P415, DOI 10.1111/j.1528-1167.2009.02272.x	39	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141098	10.1371/journal.pone.0141098	http://dx.doi.org/10.1371/journal.pone.0141098			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544593	Green Published, gold, Green Submitted			2022-12-27	WOS:000364398700015
J	Berry, MS; Repke, MA; Nickerson, NP; Conway, LG; Odum, AL; Jordan, KE				Berry, Meredith S.; Repke, Meredith A.; Nickerson, Norma P.; Conway, Lucian G., III; Odum, Amy L.; Jordan, Kerry E.			Making Time for Nature: Visual Exposure to Natural Environments Lengthens Subjective Time Perception and Reduces Impulsivity	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; EPISODIC FUTURE THINKING; PATHOLOGICAL GAMBLERS; DELAY; REWARDS; ATTENTION; CHOICE; MONEY; PROBABILITY; MONETARY	Impulsivity in delay discounting is associated with maladaptive behaviors such as overeating and drug and alcohol abuse. Researchers have recently noted that delay discounting, even when measured by a brief laboratory task, may be the best predictor of human health related behaviors (e.g., exercise) currently available. Identifying techniques to decrease impulsivity in delay discounting, therefore, could help improve decision-making on a global scale. Visual exposure to natural environments is one recent approach shown to decrease impulsive decision-making in a delay discounting task, although the mechanism driving this result is currently unknown. The present experiment was thus designed to evaluate not only whether visual exposure to natural (mountains, lakes) relative to built (buildings, cities) environments resulted in less impulsivity, but also whether this exposure influenced time perception. Participants were randomly assigned to either a natural environment condition or a built environment condition. Participants viewed photographs of either natural scenes or built scenes before and during a delay discounting task in which they made choices about receiving immediate or delayed hypothetical monetary outcomes. Participants also completed an interval bisection task in which natural or built stimuli were judged as relatively longer or shorter presentation durations. Following the delay discounting and interval bisection tasks, additional measures of time perception were administered, including how many minutes participants thought had passed during the session and a scale measurement of whether time "flew" or "dragged" during the session. Participants exposed to natural as opposed to built scenes were less impulsive and also reported longer subjective session times, although no differences across groups were revealed with the interval bisection task. These results are the first to suggest that decreased impulsivity from exposure to natural as opposed to built environments may be related to lengthened time perception.	[Berry, Meredith S.; Nickerson, Norma P.] Univ Montana, Dept Soc & Conservat, Missoula, MT 59812 USA; [Repke, Meredith A.; Conway, Lucian G., III] Univ Montana, Dept Psychol, Missoula, MT 59812 USA; [Berry, Meredith S.; Odum, Amy L.; Jordan, Kerry E.] Utah State Univ, Dept Psychol, Logan, UT 84322 USA	University of Montana System; University of Montana; University of Montana System; University of Montana; Utah System of Higher Education; Utah State University	Berry, MS (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA.	mberry13@jhmi.edu						Anderson K, 2011, PHILOS T R SOC A, V369, P20, DOI 10.1098/rsta.2010.0290; Anokhin AP, 2011, BEHAV GENET, V41, P175, DOI 10.1007/s10519-010-9384-7; Arbuthnott KD, 2010, ANAL SOC ISS PUB POL, V10, P4, DOI 10.1111/j.1530-2415.2009.01196.x; Barkley RA, 2001, J ABNORM CHILD PSYCH, V29, P541, DOI 10.1023/A:1012233310098; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Baumann AA, 2012, BEHAV PROCESS, V90, P408, DOI 10.1016/j.beproc.2012.04.005; Berry MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097915; Berto R, 2005, J ENVIRON PSYCHOL, V25, P249, DOI 10.1016/j.jenvp.2005.07.001; Black AC, 2011, ADDICT BEHAV, V36, P125, DOI 10.1016/j.addbeh.2010.08.014; Blasing T. J., 2011, RECORD HIGH 2010 GLO; Bowler Diana E, 2010, BMC Public Health, V10, P456, DOI 10.1186/1471-2458-10-456; Centers for Disease Control and Prevention, 2014, AD OB FACTS; Chabris CF, 2008, J RISK UNCERTAINTY, V37, P237, DOI 10.1007/s11166-008-9053-x; Chivian E., 2008, SUSTAINING LIFE HUMA, pXI; Conway LG, 2004, J EXP SOC PSYCHOL, V40, P113, DOI 10.1016/S0022-1031(03)00089-1; Daniel TO, 2013, PSYCHOL SCI, V24, P2339, DOI 10.1177/0956797613488780; de Wit H, 2009, ADDICT BIOL, V14, P22, DOI 10.1111/j.1369-1600.2008.00129.x; Dixon MR, 2006, J APPL BEHAV ANAL, V39, P413, DOI 10.1901/jaba.2006.173-05; Dixon MR, 2003, J APPL BEHAV ANAL, V36, P449, DOI 10.1901/jaba.2003.36-449; Droit-Volet S, 2007, TRENDS COGN SCI, V11, P504, DOI 10.1016/j.tics.2007.09.008; Droit-Volet S, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00033; Friedel JE, 2014, PSYCHOPHARMACOLOGY, V231, P4517, DOI 10.1007/s00213-014-3597-z; Gilman JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101570; Green L, 2004, PSYCHOL BULL, V130, P769, DOI 10.1037/0033-2909.130.5.769; Hardisty DJ, 2009, J EXP PSYCHOL GEN, V138, P329, DOI 10.1037/a0016433; Hepburn C, 2010, ENVIRON RESOUR ECON, V46, P189, DOI 10.1007/s10640-010-9354-9; Johnson MW, 2008, EXP CLIN PSYCHOPHARM, V16, P264, DOI 10.1037/1064-1297.16.3.264; Johnson PS, 2015, J EXP ANAL BEHAV, V103, P87, DOI 10.1002/jeab.110; Kangas BD, 2009, BEHAV PROCESS, V82, P164, DOI 10.1016/j.beproc.2009.06.004; Kaplan BA, 2014, PSYCHOL REC, V64, P261, DOI 10.1007/s40732-014-0041-z; Koffarnus MN, 2013, J EXP ANAL BEHAV, V99, P32, DOI 10.1002/jeab.2; Lagorio CH, 2005, BEHAV PROCESS, V69, P173, DOI 10.1016/j.beproc.2005.02.003; Madden G.J., 2010, IMPULSIVITY BEHAV NE, P3; Mazur J.E., 1987, QUANTITATIVE ANAL BE, P55; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Myerson J, 2001, J EXP ANAL BEHAV, V76, P235, DOI 10.1901/jeab.2001.76-235; National Institutes on Drug Abuse, 2014, TRENDS STAT; Odum AL, 2011, J EXP ANAL BEHAV, V96, P427, DOI 10.1901/jeab.2011.96-423; Odum AL, 2011, BEHAV PROCESS, V87, P1, DOI 10.1016/j.beproc.2011.02.007; Peper JS, 2013, CEREB CORTEX, V23, P1695, DOI 10.1093/cercor/bhs163; Peters J, 2010, NEURON, V66, P138, DOI 10.1016/j.neuron.2010.03.026; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; Rachlin H, 2006, J EXP ANAL BEHAV, V85, P425, DOI 10.1901/jeab.2006.85-05; RACHLIN H, 1991, J EXP ANAL BEHAV, V55, P233, DOI 10.1901/jeab.1991.55-233; Radu PT, 2011, J EXP ANAL BEHAV, V96, P363, DOI 10.1901/jeab.2011.96-363; Reed SC, 2012, EXP CLIN PSYCHOPHARM, V20, P454, DOI 10.1037/a0029087; Rodzon K, 2011, BEHAV PROCESS, V86, P164, DOI 10.1016/j.beproc.2010.09.007; Rubia K, 2009, PHILOS T R SOC B, V364, P1919, DOI 10.1098/rstb.2009.0014; Rudd M, 2012, PSYCHOL SCI, V23, P1130, DOI 10.1177/0956797612438731; Rung JM, 2015, J EXP ANAL BEHAV, V103, P108, DOI 10.1002/jeab.132; Sheffer CE, 2014, ADDICT BEHAV, V39, P1682, DOI 10.1016/j.addbeh.2014.04.019; Takahashi T, 2007, PHYSICA A, V385, P637, DOI 10.1016/j.physa.2007.07.020; Thompson CW, 2012, LANDSCAPE URBAN PLAN, V105, P221, DOI 10.1016/j.landurbplan.2011.12.015; ULRICH RS, 1981, ENVIRON BEHAV, V13, P523, DOI 10.1177/0013916581135001; Ungemach C, 2011, PSYCHOL SCI, V22, P253, DOI 10.1177/0956797610396225; van der Wal AJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2295; Weller RE, 2008, APPETITE, V51, P563, DOI 10.1016/j.appet.2008.04.010; White MP, 2013, PSYCHOL SCI, V24, P920, DOI 10.1177/0956797612464659; Wittmann M., 2009, J NEUROSCIENCE PSYCH, V2, P1, DOI [10.1037/a0015460, DOI 10.1037/A0015460]; Wittmann M, 2007, DRUG ALCOHOL DEPEN, V90, P183, DOI 10.1016/j.drugalcdep.2007.03.005; Wittmann M, 2011, BRAIN RES, V1406, P43, DOI 10.1016/j.brainres.2011.06.048	61	38	38	5	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0141030	10.1371/journal.pone.0141030	http://dx.doi.org/10.1371/journal.pone.0141030			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7DR	26558610	Green Published, Green Submitted, gold			2022-12-27	WOS:000364433100019
J	Cunha, HA; de Castro, RL; Secchi, ER; Crespo, EA; Lailson-Brito, J; Azevedo, AF; Lazoski, C; Sole-Cava, AM				Cunha, Haydee A.; de Castro, Rocio Loizaga; Secchi, Eduardo R.; Crespo, Enrique A.; Lailson-Brito, Jose; Azevedo, Alexandre F.; Lazoski, Cristiano; Sole-Cava, Antonio M.			Molecular and Morphological Differentiation of Common Dolphins (Delphinus sp.) in the Southwestern Atlantic: Testing the Two Species Hypothesis in Sympatry	PLOS ONE			English	Article							POPULATION GENETIC-STRUCTURE; PHYLOGENETIC-RELATIONSHIPS; TAXONOMIC STATUS; MITOCHONDRIAL; CETACEANS; BIOGEOGRAPHY; ABUNDANCE; SOFTWARE; INSIGHTS; DENSITY	The taxonomy of common dolphins (Delphinus sp.) has always been controversial, with over twenty described species since the original description of the type species of the genus (Delphinus delphis Linnaeus, 1758). Two species and four subspecies are currently accepted, but recent molecular data have challenged this view. In this study we investigated the molecular taxonomy of common dolphins through analyses of cytochrome b sequences of 297 individuals from most of their distribution. We included 37 novel sequences from the Southwestern Atlantic Ocean, a region where the short-and long-beaked morphotypes occur in sympatry, but which had not been well sampled before. Skulls of individuals from the Southwestern Atlantic were measured to test the validity of the rostral index as a diagnostic character and confirmed the presence of the two morphotypes in our genetic sample. Our genetic results show that all common dolphins in the Atlantic Ocean belong to a single species, Delphinus delphis. According to genetic data, the species Delphinus capensis is invalid. Long-beaked common dolphins from the Northeastern Pacific Ocean may constitute a different species. Our conclusions prompt the need for revision of currently accepted common dolphin species and subspecies and of Delphinus delphis distribution.	[Cunha, Haydee A.; Lailson-Brito, Jose; Azevedo, Alexandre F.] Univ Estado Rio de Janeiro, Lab Mamiferos Aquat & Bioindicadores MAOUA, Fac Oceanog, BR-20550011 Rio De Janeiro, RJ, Brazil; [de Castro, Rocio Loizaga; Crespo, Enrique A.] Ctr Nacl Patagon CONICET, Lab Mamiferos Marinos, Puerto Madryn, Chubut, Argentina; [Secchi, Eduardo R.] Fundacao Univ Rio Grande, Inst Oceanog, Lab Ecol Conservacao Megafauna Marinh EcoMega, Rio Grande, RS, Brazil; [Cunha, Haydee A.; Lazoski, Cristiano; Sole-Cava, Antonio M.] Univ Fed Rio de Janeiro, Inst Biol, Lab Biodiversidade Mol, Rio De Janeiro, RJ, Brazil	Universidade do Estado do Rio de Janeiro; Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidade Federal do Rio Grande; Universidade Federal do Rio de Janeiro	Cunha, HA (corresponding author), Univ Estado Rio de Janeiro, Lab Mamiferos Aquat & Bioindicadores MAOUA, Fac Oceanog, BR-20550011 Rio De Janeiro, RJ, Brazil.	haydeecunha@yahoo.com.br	AZEVEDO, ALEXANDRE/HII-5648-2022; Azevedo, Alexandre/B-9660-2013; Cunha, Haydee/O-1940-2017; Secchi, Eduardo R./ABF-1191-2020; Sole-Cava, Antonio M/G-4209-2011; Brito, Jose Lailson/B-3572-2013; Lazoski, Cristiano/H-6192-2013; Lazoski, Cristiano/U-5549-2019	Azevedo, Alexandre/0000-0002-3754-9035; Secchi, Eduardo R./0000-0001-9087-9909; Sole-Cava, Antonio M/0000-0003-0363-5821; Brito, Jose Lailson/0000-0001-8366-458X; Lazoski, Cristiano/0000-0002-6322-4672	UERJ; FAPERJ; CENPAT; Cetacean Society International; Cetacean Specialist Group (IUCN); MEC-ICI (Agencia Espanola de Cooperacion Internacional); Center for Marine Conservation; MCTI/CNPq; UERJ ("Prociencia" Program); CNPq [305303/2010-4, 304826/2008-1, 305515/2009-8, 307843/2011-4]; FAPERJ (JCNE) [101.449/2010]	UERJ; FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CENPAT; Cetacean Society International; Cetacean Specialist Group (IUCN); MEC-ICI (Agencia Espanola de Cooperacion Internacional); Center for Marine Conservation; MCTI/CNPq; UERJ ("Prociencia" Program); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ (JCNE)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	Samples from Rio de Janeiro were collected from stranded specimens by the MAQUA (Laboratorio de Mamiferos Aquaticos e Bioindicadores/UERJ) team, with the financial support of UERJ and FAPERJ. Argentine samples were collected from incidentally caught individuals with partial funding by CENPAT, Cetacean Society International, Cetacean Specialist Group (IUCN), MEC- ICI (Agencia Espanola de Cooperacion Internacional) and the Center for Marine Conservation. Thanks are also given to Bill Rossiter, Randy Reeves, Toni Raga and Mary McLean for their continuous and encouraging help and support to CENPAT. Samples from Rio Grande do Sul were collected from stranded carcasses and through biopsy darting, by the EcoMega (Laboratorio de Ecologia e Conservacao da Megafauna Marinha/FURG) team. We are also grateful to Juliana Marigo, Carolina Bertozzi and Projeto Biopesca for the sample from Sao Paulo, and to two anonymous referees, for their suggestions to the manuscript. Molecular analyses were performed in the Laboratorio de Biodiversidade Molecular, UFRJ, and were funded by MCTI/CNPq. JLB has a research grant from UERJ ("Prociencia" Program), CNPq (grant #305303/2010-4) and FAPERJ (JCNE). AFA has a research grant from CNPq (grant #304826/2008-1), FAPERJ (JCNE #101.449/2010) and UERJ ("Prociencia" Program). AMSC and ERS have research grants from CNPq (grant #s 305515/2009-8 and 307843/2011-4, respectively).	Amaha A, 1994, GEOGRAPHIC VARIATION; Amaral AR, 2007, MAR BIOL, V151, P1967, DOI 10.1007/s00227-007-0635-y; Amaral AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083645; Amaral AR, 2012, MOL ECOL, V21, P4854, DOI 10.1111/j.1365-294X.2012.05728.x; Amos W, 1990, INDIVIDUAL RECOGNITI; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Artedi P, 1736, POSTH, V76; Avise John C., 1994, pi; BANKS RC, 1969, J MAMMAL, V50, P262, DOI 10.2307/1378342; Barabash I. I., 1935, Bulletin de la Societe des Naturalistes de Moscou Sect Biol, V44, P246; Barlow J, 2007, FISH B-NOAA, V105, P509; Bell Catherine H., 2002, Australian Mammalogy, V24, P1; Carretta J V, 2003, MAR FISH REV, V66, P21; Charland KM, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017207, 10.1371/journal.pone.0024047]; COCKCROFT VG, 1990, S AFR J MARINE SCI, V9, P371; Cunha HA, 2005, MAR BIOL, V148, P449, DOI 10.1007/s00227-005-0078-2; Dall WH, 1873, ANN MAG NAT HIST, V11, P316; de Boer MN, 2010, J MAR BIOL ASSOC UK, V90, P1613, DOI 10.1017/S0025315410001165; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Duchene S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027138; Evans W., 1994, HDB MARINE MAMMALS, V5, P191; Filby NE, 2010, AQUAT MAMM, V36, P33, DOI 10.1578/AM.36.1.2010.33; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Gonzalez P., 2002, CRECIMIENTO DESARROL; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hammond PS, 2008, DELPHINUS DELPHIS; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hershkovitz P., 1966, Bulletin United States National Museum, VNo. 246, P1; Heyning John E., 1994, Contributions in Science (Los Angeles), V442, P1; Jefferson T.A., 2015, COMPREHENSIVE GUIDE; Jefferson TA, 2002, MAR MAMMAL SCI, V18, P787, DOI 10.1111/j.1748-7692.2002.tb01074.x; Jefferson TA, 2009, MAR BIOL, V156, P1109, DOI 10.1007/s00227-009-1152-y; Kingston SE, 2004, J HERED, V95, P1, DOI 10.1093/jhered/esh010; LeDuc RG, 1999, MAR MAMMAL SCI, V15, P619, DOI 10.1111/j.1748-7692.1999.tb00833.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Linnaeus C, 1767, SYSTEMA NATURAE REGN, VI, DOI 10.5962/bhl.title.542; Miller G. S., 1936, Proceedings of the Biological Society of Washington, V49, P145; Morin PA, 2010, GENOME RES, V20, P908, DOI 10.1101/gr.102954.109; Moura AE, 2014, HEREDITY EDINB, V114, P1; Murphy S, 2006, MAR MAMMAL SCI, V22, P573, DOI 10.1111/j.1748-7692.2006.00037.x; Natoli A, 2006, J EVOLUTION BIOL, V19, P943, DOI 10.1111/j.1420-9101.2005.01033.x; Natoli A, 2008, CONSERV GENET, V9, P627, DOI 10.1007/s10592-007-9379-y; Perrin W., 2017, ENCY MARINE MAMMALS, P245; Perrin WF, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P255; Pinela AM, 2011, J ZOOL, V284, P239, DOI 10.1111/j.1469-7998.2011.00798.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; RICE DW, 1998, MARINE MAMMALS WORLD; ROSEL PE, 1994, MAR BIOL, V119, P159, DOI 10.1007/BF00349552; Samaai T, 2005, AFR J MAR SCI, V27, P449, DOI 10.2989/18142320509504103; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; Silva MA, 2014, MAR BIOL RES, V10, P123, DOI 10.1080/17451000.2013.793814; Stockin KA, 2014, MAR MAMMAL SCI, V30, P44, DOI 10.1111/mms.12027; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tavares M, 2010, MAMMAL REV, V40, P40, DOI 10.1111/j.1365-2907.2009.00154.x; Thompson Finlay N, 2013, PLoS One, V8, pe64438, DOI 10.1371/journal.pone.0064438; Toews DPL, 2012, MOL ECOL, V21, P3907, DOI 10.1111/j.1365-294X.2012.05664.x; True FW., 1889, B US NATL MUSEUM, V36, P1; Van Bree P. J. H., 1971, Mammalia, V35, P345; VANBREE PJH, 1972, J MAMMAL, V53, P372, DOI 10.2307/1379178; Westgate AJ, 2007, J MAMMAL, V88, P678, DOI 10.1644/06-MAMM-A-177R.1; Xiong Y, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-20	61	28	30	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0140251	10.1371/journal.pone.0140251	http://dx.doi.org/10.1371/journal.pone.0140251			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559411	Green Submitted, Green Published, gold			2022-12-27	WOS:000364433100005
J	Fang, HW; Fazeli, M; Cheng, W; Huang, L; Hu, HY				Fang, Hongwei; Fazeli, Mehdi; Cheng, Wei; Huang, Lei; Hu, Hongying			Biostabilization and Transport of Cohesive Sediment Deposits in the Three Gorges Reservoir	PLOS ONE			English	Article							STABILITY; STABILIZATION; ERODIBILITY; MORPHOLOGY; VELOCITY; EROSION	Cohesive sediment deposits in the Three Gorges Reservoir, China, were used to investigate physical and geochemical properties, biofilm mass, and erosion and deposition characteristics. Biofilm cultivation was performed in a recirculating flume for three different periods (5, 10 and 15 days) under ambient temperature and with sufficient nutrients supply. Three groups of size-fractionated sediment were sequentially used, including 0-0.02 mm, 0.02-0.05 mm and 0.05-0.10 mm. Desired conditions for erosion and deposition were designed by managing high bed shear stress at the narrow part of upstream flume and low shear stress at the wide part of downstream flume. Biostabilization and transport characteristics of the biofilm coated sediment (bio-sediment) were strongly influenced by the cultivation period, and the results were compared with clean sediment. The bio-sediment was more resistant to erosion, and the mean shear stress was increased by factors of 2.65, 2.73 and 5.01 for sediment with 5, 10 and 15 days of biofilm growth compared with clean sediment, resulting in less sediment being eroded from the bed. Simultaneously, the settling velocity was smaller for bio-sediment due to higher organic content and porosity (i.e., lower density). Additionally, there was a smaller probability of deposition for sediment with a longer cultivation period after erosion, resulting in more retention time in aquatic systems. These results will benefit water management in natural rivers.	[Fang, Hongwei; Fazeli, Mehdi; Cheng, Wei; Huang, Lei] Tsinghua Univ, Dept Hydraul Engn, State Key Lab Hydrosci & Engn, Beijing 100084, Peoples R China; [Fazeli, Mehdi] Univ Yasuj, Dept Civil Engn, Yasuj, Iran; [Hu, Hongying] Tsinghua Univ, Sch Environm, Beijing 100084, Peoples R China	Tsinghua University; Yasouj University; Tsinghua University	Huang, L (corresponding author), Tsinghua Univ, Dept Hydraul Engn, State Key Lab Hydrosci & Engn, Beijing 100084, Peoples R China.	huangl05@mails.tsinghua.edu.cn	Fazeli, Mehdi/AAV-5695-2020	Fazeli, Mehdi/0000-0002-2787-3368	National Natural Science Foundation of China [51139003, 11372161]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (No. 51139003 and 11372161). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos CL, 2004, J MARINE SYST, V51, P211, DOI 10.1016/j.jmarsys.2004.05.013; Black KS, 2002, J HYDRAUL ENG, V128, P2, DOI 10.1061/(ASCE)0733-9429(2002)128:1(2); Chen MH, 2013, OCEAN DYNAM, V63, P1113, DOI 10.1007/s10236-013-0641-1; de Brouwer JFC, 2005, MICROB ECOL, V49, P501, DOI 10.1007/s00248-004-0020-z; Droppo IG, 2009, MAR FRESHWATER RES, V60, P690, DOI 10.1071/MF08019; Droppo IG, 2001, J SEDIMENT RES, V71, P717, DOI 10.1306/2DC40963-0E47-11D7-8643000102C1865D; Fang H. W., 2009, SURFACE CHARACTERIST; Fang HW, 2013, INT J SEDIMENT RES, V28, P246, DOI 10.1016/S1001-6279(13)60035-9; Fang HW, 2014, J HYDRO-ENVIRON RES, V8, P186, DOI 10.1016/j.jher.2014.04.003; Fang HW, 2014, SEDIMENTOLOGY, V61, P648, DOI 10.1111/sed.12065; Fang HW, 2000, J HYDRAUL ENG-ASCE, V126, P578, DOI 10.1061/(ASCE)0733-9429(2000)126:8(578); Fang HW, 2003, J HYDRAUL RES, V41, P379, DOI 10.1080/00221680309499983; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Friend PL, 2003, CONT SHELF RES, V23, P1899, DOI 10.1016/j.csr.2002.12.001; Gerbersdorf SU, 2008, GEOBIOLOGY, V6, P57, DOI 10.1111/j.1472-4669.2007.00120.x; GIBBS RJ, 1983, ENVIRON SCI TECHNOL, V17, P237, DOI 10.1021/es00110a011; Grabowski RC, 2011, EARTH-SCI REV, V105, P101, DOI 10.1016/j.earscirev.2011.01.008; Hagadorn JW, 2012, SEDIMENTOLOGY, V59, P795, DOI 10.1111/j.1365-3091.2011.01278.x; Headley JV, 1998, ENVIRON SCI TECHNOL, V32, P3968, DOI 10.1021/es980499l; Huang L, 2015, CHEMOSPHERE, V134, P374, DOI 10.1016/j.chemosphere.2015.05.009; Koster M, 2007, SEDIMENT DYNAMICS PO; Kuang Qi-jun, 2005, Acta Hydrobiologica Sinica, V29, P353; Liu C, 2013, INT J SEDIMENT RES, V28, P486, DOI 10.1016/S1001-6279(14)60007-X; Liu YY, 2009, PLANT SOIL, V317, P213, DOI 10.1007/s11104-008-9803-1; Neu TR., 1994, BIOSTABILIZATION; Samaras AG, 2014, INT J SEDIMENT RES, V29, P304, DOI 10.1016/S1001-6279(14)60046-9; Shang QQ, 2014, INT J SEDIMENT RES, V29, P471, DOI 10.1016/S1001-6279(14)60060-3; Stone M, 2011, WATER RES, V45, P521, DOI 10.1016/j.watres.2010.09.016; Sutherland TF, 1998, LIMNOL OCEANOGR, V43, P225, DOI 10.4319/lo.1998.43.2.0225; Underwood GJC, 2003, ADV BOT RES, V40, P183, DOI 10.1016/S0065-2296(05)40005-1; Viparelli E, 2015, SEDIMENTOLOGY, V62, P1384, DOI 10.1111/sed.12187; Watanabe R, 2008, P 4 INT C SCOUR ER T; Wingender J., 1999, MICROBIAL EXTRACELLU; [吴志超 Wu Zhichao], 2005, [环境污染与防治, Environmental Pollution & Control], V27, P177; Yao QZ, 2009, APPL GEOCHEM, V24, P2186, DOI 10.1016/j.apgeochem.2009.09.023; Zhao HM., 2009, 33 IAHR C WAT ENG SU; Zhao HM, 2011, SCANNING, V33, P437, DOI 10.1002/sca.20247	37	15	16	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142673	10.1371/journal.pone.0142673	http://dx.doi.org/10.1371/journal.pone.0142673			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26560122	gold, Green Submitted, Green Published			2022-12-27	WOS:000364433100109
J	Pasotti, F; Saravia, LA; De Troch, M; Tarantelli, MS; Sahade, R; Vanreusel, A				Pasotti, Francesca; Ariel Saravia, Leonardo; De Troch, Marleen; Soledad Tarantelli, Maria; Sahade, Ricardo; Vanreusel, Ann			Benthic Trophic Interactions in an Antarctic Shallow Water Ecosystem Affected by Recent Glacier Retreat	PLOS ONE			English	Article							KING-GEORGE ISLAND; STABLE-ISOTOPE RATIOS; POTTER COVE; SIGNY ISLAND; PRIAPULUS-CAUDATUS; FEEDING ECOLOGY; COASTAL WATERS; ORGANIC-MATTER; MARTEL INLET; FOOD-WEB	The western Antarctic Peninsula is experiencing strong environmental changes as a consequence of ongoing regional warming. Glaciers in the area are retreating rapidly and increased sediment-laden meltwater runoff threatens the benthic biodiversity at shallow depths. We identified three sites with a distinct glacier-retreat related history and different levels of glacial influence in the inner part of Potter Cove (King George Island, South Shetland Islands), a fjord-like embayment impacted since the 1950s by a tidewater glacier retreat. We compared the soft sediment meio- and macrofauna isotopic niche widths (delta C-13 and delta N-15 stable isotope analysis) at the three sites to investigate possible glacier retreat-related influences on benthic trophic interactions. The isotopic niches were locally shaped by the different degrees of glacier retreat-related disturbance within the Cove. Wider isotopic niche widths were found at the site that has become ice-free most recently, and narrower niches at the older ice-free sites. At an intermediate state of glacier retreat-related disturbance (e.g. via ice-growler scouring) species with different strategies could settle. The site at the earliest stage of post-retreat development was characterized by an assemblage with lower trophic redundancy. Generally, the isotopic niche widths increased with increasing size spectra of organisms within the community, excepting the youngest assemblage, where the pioneer colonizer meiofauna size class displayed the highest isotopic niche width. Meiofauna at all sites generally occupied positions in the isotopic space that suggested a detrital-pool food source and/or the presence of predatory taxa. In general ice scour and glacial impact appeared to play a two-fold role within the Cove: i) either stimulating trophic diversity by allowing continuous re-colonization of meiofaunal species or, ii) over time driving the benthic assemblages into a more compact trophic structure with increased connectedness and resource recycling.	[Pasotti, Francesca; De Troch, Marleen; Vanreusel, Ann] Univ Ghent, Marine Biol Lab, B-9000 Ghent, Belgium; [Ariel Saravia, Leonardo] Natl Univ Gen Sarmiento, Inst Sci, RA-1613 Buenos Aires, DF, Argentina; [Soledad Tarantelli, Maria; Sahade, Ricardo] Univ Nacl Cordoba, CONICET, Inst Anim Div & Ecol, Fac Cs EF & Nat, RA-5000 Cordoba, Argentina	Ghent University; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Pasotti, F (corresponding author), Univ Ghent, Marine Biol Lab, Krijgslaan 281-S8, B-9000 Ghent, Belgium.	Francesca.pasotti@ugent.be	Saravia, Leonardo A./AAM-3461-2021; De Troch, Marleen/AAB-9809-2019	Saravia, Leonardo A./0000-0002-7911-4398; De Troch, Marleen/0000-0002-6800-0299; Sahade, Ricardo/0000-0001-5650-8135	Belgian Science Policy Office (BELSPO) [BR/132/A1/vERSO]; EU project Imconet (FP7 IRSES) [319718]	Belgian Science Policy Office (BELSPO)(Belgian Federal Science Policy Office); EU project Imconet (FP7 IRSES)	The authors acknowledge the vERSO project (www.versoproject.be, funded by the Belgian Science Policy Office (BELSPO, contract no BR/132/A1/vERSO) and the EU project Imconet (FP7 IRSES, action no. 319718) for financial and networking support. We acknowledge the vERSO project (www.versoproject.be), funded by the Belgian Science Policy Office (BELSPO, contract no BR/132/A1/vERSO) and the EU project Imconet (FP7 IRSES, action no. 319718) for financial and networking support. We would like to thank all the military and scientific staff at Carlini base for their valuable assistance during the sampling process. A special thank goes to Oscar Gonzales and Doris Abele for their logistic support.	Abram NJ, 2013, NAT GEOSCI, V6, P404, DOI [10.1038/ngeo1787, 10.1038/NGEO1787]; Anisimov O.A., 2001, CLIMATE CHANGE 2001, P85; Barnes DKA, 2008, CLIM RES, V37, P149, DOI 10.3354/cr00760; Barnes DKA, 2011, NAT CLIM CHANGE, V1, P365, DOI 10.1038/NCLIMATE1232; Barrett JE, 2008, GLOBAL CHANGE BIOL, V14, P2249, DOI 10.1111/j.1365-2486.2008.01641.x; Batschelet E, 1981, CIRCULAR STAT BIOL; BEST BA, 1988, BIOL BULL-US, V175, P332, DOI 10.2307/1541723; Bick A, 2013, POLAR BIOL, V36, P673, DOI 10.1007/s00300-013-1293-9; Blazewicz-Paszkowycz M, 2002, ANTARCT SCI, V14, P11, DOI 10.1017/S0954102002000524; Bromberg S, 2000, B MAR SCI, V67, P175; Brown KM, 2004, OECOLOGIA, V141, P121, DOI 10.1007/s00442-004-1648-6; Brown LE, 2012, GLOBAL CHANGE BIOL, V18, P2195, DOI 10.1111/j.1365-2486.2012.02675.x; Convey P, 2009, ANTARCT SCI, V21, P541, DOI 10.1017/S0954102009990642; Convey P, 2011, POLAR BIOL, V34, P1629, DOI 10.1007/s00300-011-1068-0; Cook A. J., 2009, CRYOSPHERE DISCUSSIO, V3, P579; Cook AJ, 2005, SCIENCE, V308, P541, DOI 10.1126/science.1104235; Corbisier TN, 2004, POLAR BIOL, V27, P75, DOI 10.1007/s00300-003-0567-z; DAVENPORT J, 1988, PROC R SOC SER B-BIO, V232, P431, DOI 10.1098/rspb.1988.0005; De Troch M, 2005, AQUAT MICROB ECOL, V39, P135, DOI 10.3354/ame039135; Denny M, 2011, BIOL BULL-US, V221, P155, DOI 10.1086/BBLv221n2p155; Dierssen HM, 2002, P NATL ACAD SCI USA, V99, P1790, DOI 10.1073/pnas.032206999; Eraso A., 2007, KARST CRYOKARST STUD, V45, P111; Fauchald K., 1979, Oceanography and Marine Biology an Annual Review, V17, P193; Favero-Longo SE, 2012, ANTARCT SCI, V24, P323, DOI 10.1017/S0954102012000120; Gillies CL, 2013, MAR ECOL PROG SER, V478, P27, DOI 10.3354/meps10214; Gillies CL, 2012, ESTUAR COAST SHELF S, V97, P44, DOI 10.1016/j.ecss.2011.11.003; Gillies CL, 2012, THESIS; Grange LJ, 2013, PLOS ONE, V32, P20040; Gryziak G, 2009, PESQUI AGROPECU BRAS, V44, P891, DOI 10.1590/S0100-204X2009000800013; Guerra-Garcia JM, 2014, J SEA RES, V85, P508, DOI 10.1016/j.seares.2013.08.006; Gutt J, 2001, POLAR BIOL, V24, P553, DOI 10.1007/s003000100262; Gutt J, 2011, DEEP-SEA RES PT II, V58, P74, DOI 10.1016/j.dsr2.2010.05.024; Halliday N, 1939, J BIOL CHEM, V129, P65; HEIP C, 1974, MAR BIOL, V28, P79, DOI 10.1007/BF00389120; HEIP C, 1985, OCEANOGR MAR BIOL, V23, P399; Higgins R. P., 1988, INTRO STUDY MEIOFAUN; Husmann G, 2012, ESTUAR COAST SHELF S, V111, P48, DOI 10.1016/j.ecss.2012.06.003; Ilieva-Makulec K, 2009, POL J ECOL, V57, P811; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; JENSEN P, 1987, MAR ECOL PROG SER, V35, P187, DOI 10.3354/meps035187; Kaehler S, 2001, MAR ECOL PROG SER, V219, P299, DOI 10.3354/meps219299; Kaehler S, 2000, MAR ECOL PROG SER, V208, P13, DOI 10.3354/meps208013; KLOSER H, 1994, ESTUAR COAST SHELF S, V38, P523, DOI 10.1006/ecss.1994.1036; Kozloff E. N, 1990, INVERTEBRATES; Layman CA, 2007, ECOLOGY, V88, P42, DOI 10.1890/0012-9658(2007)88[42:CSIRPF]2.0.CO;2; Ledger ME, 2008, OECOLOGIA, V155, P809, DOI 10.1007/s00442-007-0950-5; Lee HJ, 2001, POLAR BIOL, V24, P926; Lee HJ, 2001, POLAR BIOL, V24, P918, DOI 10.1007/s003000100300; Lehmann MF, 2002, GEOCHIM COSMOCHIM AC, V66, P3573, DOI 10.1016/S0016-7037(02)00968-7; Quartino ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058223; Lindeman RL, 1942, ECOLOGY, V23, P399, DOI 10.2307/1930126; MACARTHUR RH, 1972, ECOLOGY, V53, P330, DOI 10.2307/1934090; Maddi P, THESIS, P1; McCarthy MA, 2007, BAYESIAN METHODS FOR ECOLOGY, P1, DOI 10.1017/CBO9780511802454; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; Moens T, 2002, MAR ECOL PROG SER, V234, P127, DOI 10.3354/meps234127; Nyssen F, 2005, ROLE BENTHIC AMPHIPO; Pasotti F, 2015, MAR ECOL-EVOL PERSP, V36, P716, DOI 10.1111/maec.12179; Pasotti F, 2012, POLAR BIOL, V35, P1629, DOI 10.1007/s00300-012-1203-6; Peck LS, 1999, MAR ECOL PROG SER, V186, P1, DOI 10.3354/meps186001; PECK LS, 1993, MAR BIOL, V117, P235, DOI 10.1007/BF00345668; Philipp EER, 2011, ANTARCT SCI, V23, P127, DOI 10.1017/S0954102010000970; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Pritchard HD, 2012, NATURE, V484, P502, DOI 10.1038/nature10968; Pugh PJA, 1997, J EXP MAR BIOL ECOL, V210, P1, DOI 10.1016/S0022-0981(96)02711-6; Quartino ML, 2008, POLAR BIOL, V31, P281, DOI 10.1007/s00300-007-0356-1; Raes M, 2010, GLOBAL CHANGE BIOL, V16, P1618, DOI 10.1111/j.1365-2486.2009.02137.x; Rennie MD, 2012, CAN J ZOOL, V90, P1320, DOI 10.1139/z2012-101; Ruckamp M, 2011, GLOBAL PLANET CHANGE, V79, P99, DOI 10.1016/j.gloplacha.2011.06.009; Ruppert EE, 1994, INVERTEBRATE ZOOLOGY; Sahade R, 1998, POLAR BIOL, V19, P85, DOI 10.1007/s003000050218; Sahade Ricardo, 2008, Berichte zur Polar- und Meeresforschung, V571, P331; Sahade Ricardo, 1998, Berichte zur Polarforschung, V299, P123; Sancho LG, 2011, POLAR BIOL, V34, P813, DOI 10.1007/s00300-010-0935-4; Sarakinos HC, 2002, CAN J ZOOL, V80, P381, DOI 10.1139/z02-007; Scambos TA, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020670; Schloss IR, 2014, LIMNOL OCEANOGR, V59, P195, DOI 10.4319/lo.2014.59.1.0195; Schloss IR, 2002, J MARINE SYST, V36, P129, DOI 10.1016/S0924-7963(02)00183-5; Schratzberger M, 1999, MAR ECOL PROG SER, V181, P227, DOI 10.3354/meps181227; Servetto N, 2013, POLAR RES, V32, DOI 10.3402/polar.v32i0.20040; SHIRLEY TC, 1990, B MAR SCI, V47, P149; Slattery M, 1997, POLAR BIOL, V18, P172, DOI 10.1007/s003000050174; Smale DA, 2008, SCIENCE, V349, P89; Smale DA, 2008, ECOGRAPHY, V31, P289, DOI 10.1111/j.0906-7590.2008.05456.x; Smale DA, 2008, MAR ECOL PROG SER, V355, P85, DOI 10.3354/meps07311; Smale DA, 2007, MAR ECOL PROG SER, V349, P89, DOI 10.3354/meps07104; Steig EJ, 2013, NAT GEOSCI, V6, P372, DOI [10.1038/ngeo1778, 10.1038/NGEO1778]; Syvaranta J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056094; Tatian M, 2004, ANTARCT SCI, V16, P123, DOI 10.1017/S0954102004001890; Tatian M, 2008, BERICHTE POLAR MEERE, P571; Tation M, 2008, POLAR BIOL, V31, P509, DOI 10.1007/s00300-007-0379-7; Tatian Marcos, 2008, Berichte zur Polar- und Meeresforschung, V571, P118; Thomas ER, 2013, GEOPHYS RES LETT, V40, P5492, DOI 10.1002/2013GL057782; Thrush S. F., 2011, MAR ECOL, V2011, P1; Torre L, 2014, MAR ENVIRON RES, V99, P179, DOI 10.1016/j.marenvres.2014.05.014; Torre L, 2012, POLAR BIOL, V35, P1743, DOI 10.1007/s00300-012-1208-1; Townsend CR, 1997, LIMNOL OCEANOGR, V42, P938, DOI 10.4319/lo.1997.42.5.0938; Trott TJ, 1998, MAR FRESHW BEHAV PHY, V31, P251, DOI 10.1080/10236249809387076; USTACH JF, 1982, J EXP MAR BIOL ECOL, V64, P203, DOI 10.1016/0022-0981(82)90010-7; Vander Zanden MJ, 2001, LIMNOL OCEANOGR, V46, P2061; Vaughan DG, 2003, CLIMATIC CHANGE, V60, P243, DOI 10.1023/A:1026021217991; Veit-Kohler G, 2008, J EXP MAR BIOL ECOL, V363, P58, DOI 10.1016/j.jembe.2008.06.018; Walkusz W, 2007, OCEANOLOGIA, V49, P369; WARWICK RM, 1990, J EXP MAR BIOL ECOL, V138, P119, DOI 10.1016/0022-0981(90)90180-K; Wittmann KJ, 1996, BIOSYST ECOL SER, P221; Wolfl AC, 2014, GEO-MAR LETT, V34, P435, DOI 10.1007/s00367-014-0375-1	106	35	36	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0141742	10.1371/journal.pone.0141742	http://dx.doi.org/10.1371/journal.pone.0141742			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559062	Green Published, Green Submitted, gold			2022-12-27	WOS:000364433100042
J	Tamosaityte, S; Galli, R; Uckermann, O; Sitoci-Ficici, KH; Later, R; Beiermeister, R; Doberenz, F; Gelinsky, M; Leipnitz, E; Schackert, G; Koch, E; Sablinskas, V; Steiner, G; Kirsch, M				Tamosaityte, Sandra; Galli, Roberta; Uckermann, Ortrud; Sitoci-Ficici, Kerim H.; Later, Robert; Beiermeister, Rudolf; Doberenz, Falko; Gelinsky, Michael; Leipnitz, Elke; Schackert, Gabriele; Koch, Edmund; Sablinskas, Valdas; Steiner, Gerald; Kirsch, Matthias			Biochemical Monitoring of Spinal Cord Injury by FT-IR Spectroscopy-Effects of Therapeutic Alginate Implant in Rat Models	PLOS ONE			English	Article							PROMOTES FUNCTIONAL RECOVERY; CENTRAL-NERVOUS-SYSTEM; OF-THE-ART; ENHANCES ELONGATION; REPAIR STRATEGIES; HUMAN TISSUES; STEM-CELLS; ADULT-RATS; HYDROGEL; GROWTH	Spinal cord injury (SCI) induces complex biochemical changes, which result in inhibition of nervous tissue regeneration abilities. In this study, Fourier-transform infrared (FT-IR) spectroscopy was applied to assess the outcomes of implants made of a novel type of non-functionalized soft calcium alginate hydrogel in a rat model of spinal cord hemisection (n = 28). Using FT-IR spectroscopic imaging, we evaluated the stability of the implants and the effects on morphology and biochemistry of the injured tissue one and six months after injury. A semi-quantitative evaluation of the distribution of lipids and collagen showed that alginate significantly reduced injury-induced demyelination of the contralateral white matter and fibrotic scarring in the chronic state after SCI. The spectral information enabled to detect and localize the alginate hydrogel at the lesion site and proved its long-term persistence in vivo. These findings demonstrate a positive impact of alginate hydrogel on recovery after SCI and prove FT-IR spectroscopic imaging as alternative method to evaluate and optimize future SCI repair strategies.	[Tamosaityte, Sandra; Galli, Roberta; Koch, Edmund; Steiner, Gerald] Tech Univ Dresden, Fac Med, Dept Anesthesiol & Intens Care Med, Clin Sensoring & Monitoring, Dresden, Germany; [Tamosaityte, Sandra; Sablinskas, Valdas; Steiner, Gerald] Vilnius State Univ, Fac Phys, Dept Gen Phys & Spect, Vilnius, Lithuania; [Uckermann, Ortrud; Sitoci-Ficici, Kerim H.; Later, Robert; Leipnitz, Elke; Schackert, Gabriele; Kirsch, Matthias] Tech Univ Dresden, Carl Gustav Carus Univ Hosp, Neurosurg, Dresden, Germany; [Beiermeister, Rudolf; Doberenz, Falko; Gelinsky, Michael] Tech Univ Dresden, Ctr Translat Bone Joint & Soft Tissue Res, Dresden, Germany; [Kirsch, Matthias] Tech Univ Dresden, Cluster Excellence, CRTD DFG Ctr Regenerat Therapies Dresden, Dresden, Germany	Technische Universitat Dresden; Vilnius University; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Technische Universitat Dresden	Galli, R (corresponding author), Tech Univ Dresden, Fac Med, Dept Anesthesiol & Intens Care Med, Clin Sensoring & Monitoring, Dresden, Germany.	roberta.galli@tu-dresden.de; matthias.kirsch@uniklinikum-dresden.de	Gelinsky, Michael/A-9680-2012	Gelinsky, Michael/0000-0001-9075-5121; Koch, Edmund/0000-0003-0554-2178	German Federal Ministry of Education and Research (MediCARS project) [A.Z. 13N10777]; Medical Faculty of the TU Dresden (Habilitationsforderung fur Frauen); Saxon Development Bank (SAB)	German Federal Ministry of Education and Research (MediCARS project); Medical Faculty of the TU Dresden (Habilitationsforderung fur Frauen); Saxon Development Bank (SAB)	This research was partly funded by the German Federal Ministry of Education and Research (MediCARS project, A.Z. 13N10777). Moreover OU is recipient of a fellowship from the Medical Faculty of the TU Dresden (Habilitationsforderung fur Frauen) and RB is recipient of a scholarship from the Saxon Development Bank (SAB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansorena E, 2013, INT J PHARMACEUT, V455, P148, DOI 10.1016/j.ijpharm.2013.07.045; Arvanian VL, 2009, EXP NEUROL, V216, P471, DOI 10.1016/j.expneurol.2009.01.004; Awad BI, 2015, WORLD NEUROSURG, V83, P120, DOI 10.1016/j.wneu.2013.01.042; Belbachir K, 2009, ANAL BIOANAL CHEM, V395, P829, DOI 10.1007/s00216-009-3019-y; Boyce Vanessa S, 2014, Handb Exp Pharmacol, V220, P443, DOI 10.1007/978-3-642-45106-5_16; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Bradbury EJ, 2006, NAT REV NEUROSCI, V7, P644, DOI 10.1038/nrn1964; Bregman BS, 1997, EXP NEUROL, V148, P475, DOI 10.1006/exnr.1997.6705; Chanimov M, 2006, MED SCI MONITOR, V12, pBR63; Cheheltani R, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.5.056014; Christie SD, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E5; Daemi H, 2012, SCI IRAN, V19, P2023, DOI 10.1016/j.scient.2012.10.005; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; Dhoot NO, 2004, J BIOMED MATER RES A, V71A, P191, DOI 10.1002/jbm.a.30103; Diem M, 2013, J BIOPHOTONICS, V6, P855, DOI 10.1002/jbio.201300131; Estrada V, 2014, NEUROBIOL DIS, V67, P165, DOI 10.1016/j.nbd.2014.03.018; Fajardo AR, 2012, RSC ADV, V2, P11095, DOI 10.1039/c2ra20785k; Galli R, 2012, ANAL CHEM, V84, P8707, DOI 10.1021/ac301938m; Hagg T, 2006, J NEUROTRAUM, V23, P264, DOI 10.1089/neu.2006.23.263; Hunanyan AS, 2011, J NEUROPHYSIOL, V105, P1033, DOI 10.1152/jn.00810.2010; Hurlbert RJ, 2013, NEUROSURGERY, V72, P93, DOI 10.1227/NEU.0b013e31827765c6; Kataoka K, 2004, TISSUE ENG, V10, P493, DOI 10.1089/107632704323061852; Kataoka K, 2001, J BIOMED MATER RES, V54, P373, DOI 10.1002/1097-4636(20010305)54:3<373::AID-JBM90>3.3.CO;2-H; Klapka N, 2006, J NEUROTRAUM, V23, P422, DOI 10.1089/neu.2006.23.422; Kong HJ, 2004, BIOMACROMOLECULES, V5, P1720, DOI 10.1021/bm049879r; Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003; Levin IW, 2005, ANNU REV PHYS CHEM, V56, P429, DOI 10.1146/annurev.physchem.56.092503.141205; Liu KZ, 2002, CLIN CHEM, V48, P499; Madigan NN, 2009, RESP PHYSIOL NEUROBI, V169, P183, DOI 10.1016/j.resp.2009.08.015; Martinon S, 2008, MINI-REV MED CHEM, V8, P222; Matyash M, 2014, TISSUE ENG PART C-ME, V20, P401, DOI [10.1089/ten.tec.2013.0252, 10.1089/ten.TEC.2013.0252]; Matyash M, 2012, TISSUE ENG PT A, V18, P55, DOI [10.1089/ten.tea.2011.0097, 10.1089/ten.TEA.2011.0097]; McKay CA, 2014, ACS APPL MATER INTER, V6, P1424, DOI 10.1021/am4027423; Meier RJ, 2005, CHEM SOC REV, V34, P743, DOI 10.1039/b503880d; Muse ED, 2001, J NEUROCHEM, V76, P77, DOI 10.1046/j.1471-4159.2001.00015.x; Novikov LN, 2002, BIOMATERIALS, V23, P3369, DOI 10.1016/S0142-9612(02)00037-6; Novikova LN, 2003, CURR OPIN NEUROL, V16, P711, DOI 10.1097/00019052-200312000-00011; Olsztynska-Janus S, 2012, ACTA BIOENG BIOMECH, V14, P121, DOI 10.5277/abb120414; Olsztynska-Janus S, 2012, ACTA BIOENG BIOMECH, V14, P101, DOI 10.5277/abb120314; Pakulska MM, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/2/024101; Perale G, 2008, J APPL BIOMATER BIOM, V6, P1; Perale G, 2011, ACS CHEM NEUROSCI, V2, P336, DOI 10.1021/cn200030w; Prang P, 2006, BIOMATERIALS, V27, P3560, DOI 10.1016/j.biomaterials.2006.01.053; Profyris C, 2004, NEUROBIOL DIS, V15, P415, DOI 10.1016/j.nbd.2003.11.015; 최기환, 2006, [Tissue Engineering and Regenerative Medicine, 조직공학과 재생의학], V3, P472; Sarker B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107952; Saxena T, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3549700; Shearer MC, 2001, CELL TISSUE RES, V305, P267, DOI 10.1007/s004410100384; Shoichet MS, 1996, BIOTECHNOL BIOENG, V50, P374, DOI 10.1002/(SICI)1097-0290(19960520)50:4<374::AID-BIT4>3.0.CO;2-I; Smith GM, 2011, BRAIN RES BULL, V84, P300, DOI 10.1016/j.brainresbull.2010.05.013; Storer PD, 2003, J NEUROSCI RES, V74, P502, DOI 10.1002/jnr.10787; Straley KS, 2010, J NEUROTRAUM, V27, P1, DOI 10.1089/neu.2009.0948; Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899; Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955; Tobias CA, 2005, J NEUROTRAUM, V22, P138, DOI 10.1089/neu.2005.22.138	55	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142660	10.1371/journal.pone.0142660	http://dx.doi.org/10.1371/journal.pone.0142660			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559822	Green Published, gold			2022-12-27	WOS:000364433100107
J	Convertino, M; Samoshkin, A; Viet, CT; Gauthier, J; Li Fraine, SP; Sharif-Naeini, R; Schmidt, BL; Maixner, W; Diatchenko, L; Dokholyan, NV				Convertino, Marino; Samoshkin, Alexander; Viet, Chi T.; Gauthier, Josee; Li Fraine, Steven P.; Sharif-Naeini, Reza; Schmidt, Brian L.; Maixner, William; Diatchenko, Luda; Dokholyan, Nikolay V.			Differential Regulation of 6-and 7-Transmembrane Helix Variants of mu-Opioid Receptor in Response to Morphine Stimulation	PLOS ONE			English	Article							DISCRETE MOLECULAR-DYNAMICS; MOR-1 SPLICE VARIANTS; OPIATE RECEPTOR; FORCE-FIELD; CRYSTAL-STRUCTURE; ACTIVATION; GENE; SIMULATIONS; BINDING; DESENSITIZATION	The pharmacological effect of opioids originates, at the cellular level, by their interaction with the mu-opioid receptor (mOR) resulting in the regulation of voltage-gated Ca2+ channels and inwardly rectifying K+ channels that ultimately modulate the synaptic transmission. Recently, an alternative six trans-membrane helix isoform of mOR, (6TM-mOR) has been identified, but its function and signaling are still largely unknown. Here, we present the structural and functional mechanisms of 6TM-mOR signaling activity upon binding to morphine. Our data suggest that despite the similarity of binding modes of the alternative 6TM-mOR and the dominant seven trans-membrane helix variant (7TM-mOR), the interaction with morphine generates different dynamic responses in the two receptors, thus, promoting the activation of different mOR-specific signaling pathways. We characterize a series of 6TM-mOR-specific cellular responses, and observed that they are significantly different from those for 7TM-mOR. Morphine stimulation of 6TM-mOR does not promote a cellular cAMP response, while it increases the intracellular Ca2+ concentration and reduces the cellular K+ conductance. Our findings indicate that 6TM-mOR has a unique contribution to the cellular opioid responses. Therefore, it should be considered as a relevant target for the development of novel pharmacological tools and medical protocols involving the use of opioids.	[Convertino, Marino; Dokholyan, Nikolay V.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Samoshkin, Alexander; Diatchenko, Luda] McGill Univ, Alan Edwards Ctr Res Pain, Montreal, PQ H3A 0G1, Canada; [Viet, Chi T.; Schmidt, Brian L.] NYU, Bluestone Ctr Clin Res, New York, NY 10010 USA; [Gauthier, Josee; Maixner, William; Dokholyan, Nikolay V.] Univ N Carolina, Ctr Pain Res & Innovat, 385 S Columbia St, Chapel Hill, NC 27599 USA; [Li Fraine, Steven P.; Sharif-Naeini, Reza] McGill Univ, Dept Physiol & Cell Informat Syst, Montreal, PQ H3G 0B1, Canada	University of North Carolina; University of North Carolina Chapel Hill; McGill University; New York University; University of North Carolina; University of North Carolina Chapel Hill; McGill University	Maixner, W (corresponding author), Univ N Carolina, Ctr Pain Res & Innovat, 385 S Columbia St, Chapel Hill, NC 27599 USA.	bill_maixner@dentistry.unc.edu; luda.diatchenko@mcgill.ca; dokh@unc.edu	Dokholyan, Nikolay/D-8081-2018	Dokholyan, Nikolay/0000-0002-8225-4025; Li Fraine, Steven/0000-0003-0333-4391; Samoshkin, Alexander/0000-0001-6296-2254	National Institutes of Health [P01 NS045685/NS/NINDS, STTR 1R41DA032293-01, R01DE019796]; Oral and Maxillofacial Surgery Research Support Grant; Canadian Institute of Health Research [G237818/CERC32151/CIHR]; Louise and Alan Edwards Foundation; Pfizer Canada Professorship in Pain Research; National Institutes of Health T90 training grant [1T90DE021986-01]; NIH [P01 NS045685/NS/NINDS, STTR 1R41DA032293-01, R01DE019796]; T90 training grant [1T90DE021986-01]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T90DE021986, R01DE019796] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS045685] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R41DA032293] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oral and Maxillofacial Surgery Research Support Grant; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Louise and Alan Edwards Foundation; Pfizer Canada Professorship in Pain Research; National Institutes of Health T90 training grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); T90 training grant; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by National Institutes of Health grants P01 NS045685/NS/NINDS (LD, WM), STTR 1R41DA032293-01 (LD, NVD, WM and Algynomics Inc.) and R01DE019796 (BLS), Oral and Maxillofacial Surgery Research Support Grant (BLS, CTV), Canadian Institute of Health Research G237818/CERC32151/CIHR (LD), the Louise and Alan Edwards Foundation, and Pfizer Canada Professorship in Pain Research (LD), National Institutes of Health T90 training grant 1T90DE021986-01 (AS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work was supported in part by NIH grants P01 NS045685/NS/NINDS (LD, WM), STTR 1R41DA032293-01 (LD, NVD, WM and Algynomics Inc.) and R01DE019796 (BLS), Oral and Maxillofacial Surgery Research Support Grant (BLS, CTV), G237818/CERC32151/CIHR (LD), the Louise and Alan Edwards Foundation, and Pfizer Canada Professorship in Pain Research (LD), T90 training grant 1T90DE021986-01 (AS).	ANDERSEN HC, 1980, J CHEM PHYS, V72, P2384, DOI 10.1063/1.439486; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bohn LM, 2004, MOL PHARMACOL, V66, P106, DOI 10.1124/mol.66.1.106; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Convertino M, 2014, PROG NEUROPSYCHOPHAR, VS0278-5846, P00235; Crain SM, 2000, PAIN, V84, P121, DOI 10.1016/S0304-3959(99)00223-7; Darden T, 1999, STRUCT FOLD DES, V7, pR55, DOI 10.1016/S0969-2126(99)80033-1; Ding F, 2013, J CHEM INF MODEL, V53, P1871, DOI 10.1021/ci300478y; Ding F, 2010, J CHEM INF MODEL, V50, P1623, DOI 10.1021/ci100218t; Dokholyan NV, 1998, FOLD DES, V3, P577, DOI 10.1016/S1359-0278(98)00072-8; Dror RO, 2011, P NATL ACAD SCI USA, V108, P18684, DOI 10.1073/pnas.1110499108; Eadie W.T., 1971, STAT METHODS EXPT PH; Eckhardt K, 2000, FEBS LETT, V470, P309, DOI 10.1016/S0014-5793(00)01329-6; Gharagozlou Parham, 2003, BMC Pharmacol, V3, P1, DOI 10.1186/1471-2210-3-1; Gris P, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-33; Groer CE, 2011, J BIOL CHEM, V286, P31731, DOI 10.1074/jbc.M111.248310; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Inturrisi CE, 2002, CLIN J PAIN, V18, pS3, DOI 10.1097/00002508-200207001-00002; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Kleywegt GJ, 2004, ACTA CRYSTALLOGR D, V60, P2240, DOI 10.1107/S0907444904013253; Kota P, 2011, BIOINFORMATICS, V27, P2209, DOI 10.1093/bioinformatics/btr374; LAMBERT DG, 1993, BIOCHEM PHARMACOL, V46, P1145, DOI 10.1016/0006-2952(93)90462-6; Lazaridis T, 2000, CURR OPIN STRUC BIOL, V10, P139, DOI 10.1016/S0959-440X(00)00063-4; Majumdar S, 2012, J MED CHEM, V55, P6352, DOI 10.1021/jm300305c; Majumdar S, 2011, P NATL ACAD SCI USA, V108, P19778, DOI 10.1073/pnas.1115231108; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Matthes HWD, 1996, NATURE, V383, P819, DOI 10.1038/383819a0; Miao YL, 2013, P NATL ACAD SCI USA, V110, P10982, DOI 10.1073/pnas.1309755110; MIGNAT C, 1995, LIFE SCI, V56, P793, DOI 10.1016/0024-3205(95)00010-4; Mihara S, 2012, BMC PHARM, V88, P315; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Reisine T, 1996, GOODMAN GILMANS PHAR, P521; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Rowlingson JC, 2000, ANESTHESIA, P7351; Samoshkin A, 2014, INT NARC RES C 2014; Samoshkin A, 2015, SCI REPORTS UNPUB; SCHROEDER JE, 1993, J NEUROSCI, V13, P867; Serohijos AWR, 2011, STRUCTURE, V19, P1683, DOI 10.1016/j.str.2011.08.003; Shabalina SA, 2009, HUM MOL GENET, V18, P1037, DOI 10.1093/hmg/ddn439; Shim J, 2013, J PHYS CHEM B, V117, P7907, DOI 10.1021/jp404238n; Shirvanyants D, 2012, J PHYS CHEM B, V116, P8375, DOI 10.1021/jp2114576; Sora I, 2001, NEUROPSYCHOPHARMACOL, V25, P41, DOI 10.1016/S0893-133X(00)00252-9; Uhl GR, 1999, P NATL ACAD SCI USA, V96, P7752, DOI 10.1073/pnas.96.14.7752; Waldhoer M, 2004, ANNU REV BIOCHEM, V73, P953, DOI 10.1146/annurev.biochem.73.011303.073940; Whistler JL, 1998, P NATL ACAD SCI USA, V95, P9914, DOI 10.1073/pnas.95.17.9914; Yin S, 2008, J CHEM INF MODEL, V48, P1656, DOI 10.1021/ci8001167; Zhang J, 1998, P NATL ACAD SCI USA, V95, P7157, DOI 10.1073/pnas.95.12.7157; Zoete V, 2011, J COMPUT CHEM, V32, P2359, DOI 10.1002/jcc.21816	54	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142826	10.1371/journal.pone.0142826	http://dx.doi.org/10.1371/journal.pone.0142826			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26554831	Green Published, Green Submitted, gold			2022-12-27	WOS:000364430700177
J	Hau, SJ; Sun, JS; Davies, PR; Frana, TS; Nicholson, TL				Hau, Samantha J.; Sun, Jisun; Davies, Peter R.; Frana, Timothy S.; Nicholson, Tracy L.			Comparative Prevalence of Immune Evasion Complex Genes Associated with beta-Hemolysin Converting Bacteriophages in MRSA ST5 Isolates from Swine, Swine Facilities, Humans with Swine Contact, and Humans with No Swine Contact	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; CHEMOTAXIS INHIBITORY PROTEIN; UNITED-STATES; MOLECULAR CHARACTERIZATION; COLONIZATION; STRAINS; HOST; EPIDEMIOLOGY; CLONES; ST398	Livestock associated methicillin-resistant Staphylococcus aureus (LA-MRSA) draws concern from the public health community because in some countries these organisms may represent the largest reservoir of MRSA outside hospital settings. Recent studies indicate LA-MRSA strains from swine are more genetically diverse than the first reported sequence type ST398. In the US, a diverse population of LA-MRSA is found including organisms of the ST398, ST9, and ST5 lineages. Occurrence of ST5 MRSA in swine is of particular concern since ST5 is among the most prevalent lineages causing clinical infections in humans. The prominence of ST5 in clinical disease is believed to result from acquisition of bacterio-phages containing virulence or host-adapted genes including the immune-evasion cluster (IEC) genes carried by beta-hemolysin converting bacteriophages, whose absence in LAMRSA ST398 is thought to contribute to reduced rates of human infection and transmission associated with this lineage. The goal of this study was to investigate the prevalence of IEC genes associated with beta-hemolysin converting bacteriophages in MRSA ST5 isolates obtained from agricultural sources, including swine, swine facilities, and humans with shortor long-term swine exposure. To gain a broader perspective, the prevalence of these genes in LA-MRSA ST5 strains was compared to the prevalence in clinical MRSA ST5 strains from humans with no known exposure to swine. IEC genes were not present in any of the tested MRSA ST5 strains from agricultural sources and the beta-hemolysin gene was intact in these strains, indicating the bacteriophage's absence. In contrast, the prevalence of the beta-hemolysin converting bacteriophage in MRSA ST5 strains from humans with no exposure to swine was 90.4%. The absence of beta-hemolysin converting bacteriophage in LA-MRSA ST5 isolates is consistent with previous reports evaluating ST398 strains and provides genetic evidence indicating LA-MRSA ST5 isolates may harbor a reduced capacity to cause severe disease in immunocompetent humans.	[Hau, Samantha J.; Frana, Timothy S.] Iowa State Univ, Coll Vet Med, Dept Vet Diagnost & Prod Anim Med, Ames, IA USA; [Sun, Jisun; Davies, Peter R.] Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA; [Nicholson, Tracy L.] ARS, Natl Anim Dis Ctr, USDA, Ames, IA USA	Iowa State University; University of Minnesota System; University of Minnesota Twin Cities; United States Department of Agriculture (USDA)	Nicholson, TL (corresponding author), ARS, Natl Anim Dis Ctr, USDA, Ames, IA USA.	tracy.nicholson@ars.usda.gov			National Pork Board [14-124]; United States Department of Agriculture, Agriculture Research Service [5030-32000-109-00D]; Centers for Disease Control and Prevention [U54OH010170]; Lora and Russ Talbot Graduate Fellowship; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [U54OH010170] Funding Source: NIH RePORTER	National Pork Board; United States Department of Agriculture, Agriculture Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Lora and Russ Talbot Graduate Fellowship; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH))	Funding, wholly or in part, was provided by The National Pork Board (#14-124) and by the United States Department of Agriculture, Agriculture Research Service (Project#5030-32000-109-00D). Isolates from swine veterinarians were obtained with funding under cooperative agreement award U54OH010170 (Upper Midwest Agricultural Safety and Health Center) from the Centers for Disease Control and Prevention. SJH is supported by the Lora and Russ Talbot Graduate Fellowship. The funders of the work did not influence study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Balaban N, 2000, INT J FOOD MICROBIOL, V61, P1, DOI 10.1016/S0168-1605(00)00377-9; Bootsma MCJ, 2011, J R SOC INTERFACE, V8, P578, DOI 10.1098/rsif.2010.0349; Cuny C, 2015, VET MICROBIOL, V177, P219, DOI 10.1016/j.vetmic.2015.02.031; de Haas CJC, 2004, J EXP MED, V199, P687, DOI 10.1084/jem.20031636; Diep BA, 2006, J INFECT DIS, V193, P1495, DOI 10.1086/503777; European Food Safety Authority (EFSA), 2009, EFSA J, V993, P1, DOI [10.2903/j.efsa.2009.993, DOI 10.2903/J.EFSA.2009.993]; Frana TS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053738; Franco A, 2011, J ANTIMICROB CHEMOTH, V66, P1231, DOI 10.1093/jac/dkr115; Fridkin SK, 2005, NEW ENGL J MED, V352, P1436, DOI 10.1056/NEJMoa043252; Gladysheva IP, 2003, P NATL ACAD SCI USA, V100, P9168, DOI 10.1073/pnas.1631716100; Gorwitz RJ, 2008, J INFECT DIS, V197, P1226, DOI 10.1086/533494; Graveland H, 2011, INT J MED MICROBIOL, V301, P630, DOI 10.1016/j.ijmm.2011.09.004; Hudson LO, 2013, J CLIN MICROBIOL, V51, P3788, DOI 10.1128/JCM.01708-13; Jarraud S, 2002, INFECT IMMUN, V70, P631, DOI 10.1128/IAI.70.2.631-641.2002; JEVONS MP, 1961, BRIT MED J, V1, P124, DOI 10.1136/bmj.1.5219.124-a; Jin T, 2004, J IMMUNOL, V172, P1169, DOI 10.4049/jimmunol.172.2.1169; Khanna T, 2008, VET MICROBIOL, V128, P298, DOI 10.1016/j.vetmic.2007.10.006; Klein EY, 2013, AM J EPIDEMIOL, V177, P666, DOI 10.1093/aje/kws273; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Linhares LL, 2015, J VET DIAGN INVEST, V27, P55, DOI 10.1177/1040638714559598; Lowder BV, 2009, P NATL ACAD SCI USA, V106, P19545, DOI 10.1073/pnas.0909285106; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; McCarthy AJ, 2011, GENOME BIOL EVOL, V3, P1164, DOI 10.1093/gbe/evr092; Miko BA, 2013, J CLIN MICROBIOL, V51, P874, DOI 10.1128/JCM.00923-12; Molla B, 2012, J CLIN MICROBIOL, V50, P3687, DOI 10.1128/JCM.01971-12; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; Moodley A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049344; Omland O, 2012, ANN AGR ENV MED, V19, P637; Price LB, 2012, MBIO, V3, DOI 10.1128/mBio.00305-11; Redziniak DE, 2009, INT J SPORTS MED, V30, P557, DOI 10.1055/s-0029-1214382; Rooijakkers SHM, 2005, NAT IMMUNOL, V6, P920, DOI 10.1038/ni1235; Rooijakkers SHM, 2005, MICROBES INFECT, V7, P476, DOI 10.1016/j.micinf.2004.12.014; Sivaraman K, 2009, FUTURE MICROBIOL, V4, P999, DOI 10.2217/FMB.09.79; Sun J, 2015, PLOS ONE; Sung JML, 2008, MICROBIOL-SGM, V154, P1949, DOI 10.1099/mic.0.2007/015289-0; Tonn K, 2013, J ENVIRON HEALTH, V75, P44; Uhlemann AC, 2012, MBIO, V3, DOI 10.1128/mBio.00027-12; van Wamel WJB, 2006, J BACTERIOL, V188, P1310, DOI 10.1128/JB.188.4.1310-1315.2006; Voss A, 2005, EMERG INFECT DIS, V11, P1965, DOI 10.3201/eid1112.050428; Wagenaar JA, 2009, VET MICROBIOL, V139, P405, DOI 10.1016/j.vetmic.2009.06.014; Weese JS, 2010, LETT APPL MICROBIOL, V51, P338, DOI 10.1111/j.1472-765X.2010.02901.x; Wulf MWH, 2012, EUR J CLIN MICROBIOL, V31, P61, DOI 10.1007/s10096-011-1269-z; Xu SX, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00052	43	24	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142832	10.1371/journal.pone.0142832	http://dx.doi.org/10.1371/journal.pone.0142832			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26554919	Green Published, Green Submitted, gold			2022-12-27	WOS:000364430700178
J	Nichols, BE; Gotz, HM; van Gorp, ECM; Verbon, A; Rokx, C; Boucher, CAB; van de Vijver, DAMC				Nichols, Brooke E.; Gotz, Hannelore M.; van Gorp, Eric C. M.; Verbon, Annelies; Rokx, Casper; Boucher, Charles A. B.; van de Vijver, David A. M. C.			Partner Notification for Reduction of HIV-1 Transmission and Related Costs among Men Who Have Sex with Men: A Mathematical Modeling Study	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIRETROVIRAL THERAPY; SAN-FRANCISCO; UNITED-STATES; INFECTION; OUTCOMES; RISK; ELIGIBILITY; POPULATION; DIAGNOSIS	Background Earlier antiretroviral treatment initiation prevents new HIV infections. A key problem in HIV prevention and care is the high number of patients diagnosed late, as these undiagnosed patients can continue forward HIV transmission. We modeled the impact on the Dutch men-who- have-sex-with-men (MSM) HIV epidemic and cost-effectiveness of an existing partner notification process for earlier identification of HIV-infected individuals to reduce HIV transmission. Methods Reduction in new infections and cost-effectiveness ratios were obtained for the use of partner notification to identify 5% of all new diagnoses (Scenario 1) and 20% of all new diagnoses (Scenario 2), versus no partner notification. Costs and quality adjusted life years (QALYs) were assigned to each disease state and calculated over 5 year increments for a 20 year period. Results Partner notification is predicted to avert 18-69 infections (interquartile range [IQR] 13-24; 51-93) over the course of 5 years countrywide to 221-830 (IQR 140-299; 530-1,127) over 20 years for Scenario 1 and 2 respectively. Partner notification was considered cost-effective in the short term, with increasing cost-effectiveness over time: from (sic)41,476-(sic)41, 736 (IQR (sic)40,529-(sic)42,147; (sic)40,791-(sic)42,397) to (sic)5,773 -(sic)5,887 ((sic)5,134-(sic)7,196; (sic)5,411(sic) 6,552) per QALY gained over a 5 and 20 year period, respectively. The full monetary benefits of partner notification by preventing new HIV infections become more apparent over time. Conclusions Partner notification will not lead to the end of the HIV epidemic, but will prevent new infections and be increasingly cost-effectiveness over time.	[Nichols, Brooke E.; van Gorp, Eric C. M.; Boucher, Charles A. B.; van de Vijver, David A. M. C.] Erasmus MC, Dept Virosci, Rotterdam, Netherlands; [Gotz, Hannelore M.] Publ Hlth Serv Rotterdam Rijnmond, Dept Infect Dis Control, Rotterdam, Netherlands; [Gotz, Hannelore M.] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [van Gorp, Eric C. M.; Verbon, Annelies; Rokx, Casper] Erasmus MC, Dept Internal Med & Infect Dis, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Nichols, BE (corresponding author), Erasmus MC, Dept Virosci, Rotterdam, Netherlands.	b.nichols@erasmusmc.nl	Nichols, Brooke E./V-5496-2019; Rokx, Casper/ABG-2016-2021	Nichols, Brooke E./0000-0003-4682-4999; Gotz, Hannelore Martha/0000-0002-1236-6224; van de Vijver, David/0000-0001-5877-8526	Aids Fonds Netherlands [2010-035]; European Union: FP7 CHAIN [223131]; European Union: FP7 DynaNets [233847]	Aids Fonds Netherlands; European Union: FP7 CHAIN; European Union: FP7 DynaNets	This work was supported by Aids Fonds Netherlands (2010-035), http://doodzonde.aidsfonds.nl/, to BN; European Union: FP7 CHAIN (No. 223131), http://ec.europa.eu/research/fp7/index_en. cfm, to DvdV; and European Union: FP7 DynaNets (No. 233847), http://ec.europa.eu/research/fp7/index_en. cfm, to DvdV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens K, 2007, JAIDS-J ACQ IMM DEF, V46, P479, DOI 10.1097/QAI.0b013e3181594c61; [Anonymous], 2014, GAP REP; Bellan SE, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001801; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Braithwaite RS, 2008, MED CARE, V46, P349, DOI 10.1097/MLR.0b013e31815c31a7; Brinkhof MWG, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000066; Brown LB, 2011, JAIDS-J ACQ IMM DEF, V56, P437, DOI 10.1097/QAI.0b013e318202bf7d; Cain LE, 2011, ANN INTERN MED, V154, P509, DOI 10.7326/0003-4819-154-8-201104190-00001; Champenois K, 2012, BMJ OPEN, V2, DOI [10.1136/bmjopen-2011-000693, DOI 10.1136/bmjopen-2011-000693]; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Colfax GN, 2002, AIDS, V16, P1529, DOI 10.1097/00002030-200207260-00010; de la Fuente L, 2009, AIDS PATIENT CARE ST, V23, P625, DOI 10.1089/apc.2009.0019; Donker G, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001834; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Eaton JW, 2014, LANCET GLOB HEALTH, V2, pE23, DOI 10.1016/S2214-109X(13)70172-4; Edelman EJ, 2014, AIDS BEHAV, V18, P1898, DOI 10.1007/s10461-014-0799-7; de Olalla PG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121536; Golden MR, 2004, SEX TRANSM DIS, V31, P709, DOI 10.1097/01.olq.0000145847.65523.43; Gotz HM, 2014, SEX TRANSM INFECT, V90, P195, DOI 10.1136/sextrans-2013-051254; Govindasamy D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080017; Hall HI, 2012, AIDS, V26, P893, DOI 10.1097/QAD.0b013e328351f73f; Hogben M, 2007, AM J PREV MED, V33, pS89, DOI 10.1016/j.amepre.2007.04.015; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Insurance FfH, 2006, GUID PHARM RES UPD V; Kall MM, 2012, EUR J GEN PRACT, V18, P181, DOI 10.3109/13814788.2012.685069; Lima VD, 2008, J INFECT DIS, V198, P59, DOI 10.1086/588673; Lipsitz MC, 2014, INT J STD AIDS, V25, P325, DOI 10.1177/0956462413507443; Lodi S, 2011, CLIN INFECT DIS, V53, P817, DOI 10.1093/cid/cir494; Long EF, 2010, ANN INTERN MED, V153, P778, DOI 10.7326/0003-4819-153-12-201012210-00004; Mabuto T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102267; Marcus JL, 2009, AIDS, V23, P1024, DOI 10.1097/QAD.0b013e32832921a7; Marcus U, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-919; Mattson CL, 2014, AIDS, V28, P1203, DOI 10.1097/QAD.0000000000000273; Mocroft A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001510; Muessig KE, 2012, AIDS, V26, P2267, DOI 10.1097/QAD.0b013e328355713d; Nakagawa F, 2012, AIDS, V26, P335, DOI 10.1097/QAD.0b013e32834dcec9; Neumann PJ, 2014, NEW ENGL J MED, V371, P796, DOI 10.1056/NEJMp1405158; Nichols BE, 2014, AIDS, V28, P73, DOI 10.1097/01.aids.0000433239.01611.52; Nichols BE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059549; NVHB, 2014, NVHB 2 1 WANN BEG; Pilcher CD, 2007, AIDS, V21, P1723, DOI 10.1097/QAD.0b013e3281532c82; ROSE KA, 1991, J FORECASTING, V10, P117, DOI 10.1002/for.3980100108; Rothenberg R, 2002, CLIN INFECT DIS, V35, pS138, DOI 10.1086/342101; Sood N, 2013, CLIN INFECT DIS, V56, P1789, DOI 10.1093/cid/cit158; Sorensen SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029098; Tan SS, 2012, INT J TECHNOL ASSESS, V28, P152, DOI 10.1017/S0266462312000062; The World Bank, 2014, NETH WORLD DEV IND 2; Therneau TM., 2015, INTRO RECURSIVE PART; van Aar F, 2015, INT J STD AIDS, V26, P565, DOI 10.1177/0956462414547398; van Bergen JEAM, 2012, EUR J GEN PRACT, V18, P133, DOI 10.3109/13814788.2012.704361; van Sighem A, 2014, MON REP 2014 HUM IMM; van Sighem A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044819; Varghese B, 1999, AIDS, V13, P1745, DOI 10.1097/00002030-199909100-00019; Venables WN, 2002, MODERN APPL STAT S, V4th, P211, DOI [10.1007/978-0-387-21706-2_8, DOI 10.1007/978-0-387-21706-2]; Walensky RP, 2013, ANN INTERN MED, V158, P84, DOI 10.7326/0003-4819-158-2-201301150-00002; Walensky RP, 2010, CLIN INFECT DIS, V51, P392, DOI 10.1086/655130; World Health Organization, GLOB HLTH OBS DAT RE; Zorginstituut Nederland, 2014, GIPEILINGEN 2013 ONT, P35	58	10	11	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142576	10.1371/journal.pone.0142576	http://dx.doi.org/10.1371/journal.pone.0142576			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26554586	Green Published, Green Submitted, gold			2022-12-27	WOS:000364430700135
J	Sosa-Garcia, B; Vazquez-Rivera, V; Gonzalez-Flores, JN; Engel, BE; Cress, WD; Santiago-Cardona, PG				Sosa-Garcia, Bernadette; Vazquez-Rivera, Viviana; Gonzalez-Flores, Jonathan N.; Engel, Brienne E.; Cress, W. Douglas; Santiago-Cardona, Pedro G.			The Retinoblastoma Tumor Suppressor Transcriptionally Represses Pak1 in Osteoblasts	PLOS ONE			English	Article							E-CADHERIN; LUNG CARCINOMAS; PROTEIN-KINASES; BONE; EXPRESSION; CELLS; E2F; CANCER; DIFFERENTIATION; OSTEOSARCOMA	We previously characterized the retinoblastoma tumor suppressor protein (Rb) as a regulator of adherens junction assembly and cell-to-cell adhesion in osteoblasts. This is a novel function since Rb is predominantly known as a cell cycle repressor. Herein, we characterized the molecular mechanisms by which Rb performs this function, hypothesizing that Rb controls the activity of known regulators of adherens junction assembly. We found that Rb represses the expression of the p21-activated protein kinase (Pak1), an effector of the small Rho GTPase Rac1. Rac1 is a well-known regulator of adherens junction assembly whose increased activity in cancer is linked to perturbations of intercellular adhesion. Using nuclear run-on and luciferase reporter transcription assays, we found that Pak1 repression by Rb is transcriptional, without affecting Pak1 mRNA and protein stability. Pak1 promoter bioinformatics showed multiple E2F1 binding sites within 155 base pairs of the transcriptional start site, and a Pak1-promoter region containing these E2F sites is susceptible to transcriptional inhibition by Rb. Chromatin immunoprecipitations showed that an Rb-E2F complex binds to the region of the Pak1 promoter containing the E2F1 binding sites, suggesting that Pak1 is an E2F target and that the repressive effect of Rb on Pak1 involves blocking the trans-activating capacity of E2F. A bioinformatics analysis showed elevated Pak1 expression in several solid tumors relative to adjacent normal tissue, with both Pak1 and E2F increased relative to normal tissue in breast cancer, supporting a cancer etiology for Pak1 up-regulation. Therefore, we propose that by repressing Pak1 expression, Rb prevents Rac1 hyperactivity usually associated with cancer and related to cytoskeletal derangements that disrupt cell adhesion, consequently enhancing cancer cell migratory capacity. This de-regulation of cell adhesion due to Rb loss could be part of the molecular events associated with cancer progression and metastasis.	[Sosa-Garcia, Bernadette; Vazquez-Rivera, Viviana; Gonzalez-Flores, Jonathan N.; Santiago-Cardona, Pedro G.] Ponce Hlth Sci Univ, Div Biochem, Dept Basic Sci, Ponce, PR 00716 USA; [Engel, Brienne E.; Cress, W. Douglas] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA; [Engel, Brienne E.; Cress, W. Douglas] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Thorac Oncol Dept, Tampa, FL 33612 USA	Ponce Health Sciences University; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Santiago-Cardona, PG (corresponding author), Ponce Hlth Sci Univ, Div Biochem, Dept Basic Sci, Ponce, PR 00716 USA.	psantiago@psm.edu			Ponce Health Sciences University (PHSU) RCMI Molecular and Genomics Core Grant [RR003050/MD007579]; National Cancer Institute, National Institute of Health [1U54CA163071-01A1]; NATIONAL CANCER INSTITUTE [U54CA163068, U54CA163071] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003050] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007579] Funding Source: NIH RePORTER	Ponce Health Sciences University (PHSU) RCMI Molecular and Genomics Core Grant; National Cancer Institute, National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Funding: We acknowledge the support with instrumentation and services of the Ponce Health Sciences University (PHSU) RCMI Molecular and Genomics Core (Grant RR003050/MD007579). This work was funded by National Cancer Institute, National Institute of Health (http://www.cancer.gov), grant 1U54CA163071-01A1, to WDC and PGSC.	ARAKI N, 1991, CLIN ORTHOP RELAT R, P271; Arima Y, 2008, CANCER RES, V68, P5104, DOI 10.1158/0008-5472.CAN-07-5680; Arima Y, 2012, J BIOL CHEM, V287, P7896, DOI 10.1074/jbc.M111.313759; Attwooll C, 2004, EMBO J, V23, P4709, DOI 10.1038/sj.emboj.7600481; Batsche E, 1998, MOL CELL BIOL, V18, P3647, DOI 10.1128/MCB.18.7.3647; Berman SD, 2008, MOL CANCER RES, V6, P1440, DOI 10.1158/1541-7786.MCR-08-0176; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Braga VMM, 2000, MOL BIOL CELL, V11, P3703, DOI 10.1091/mbc.11.11.3703; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Chen PL, 1996, GENE DEV, V10, P2794, DOI 10.1101/gad.10.21.2794; Cheng SL, 2000, J BONE MINER RES, V15, P2362, DOI 10.1359/jbmr.2000.15.12.2362; DAHLIN DC, 1975, CLIN ORTHOP RELAT R, P23; Diehl JA, 2002, CANCER BIOL THER, V1, P226, DOI 10.4161/cbt.72; Dummler B, 2009, CANCER METAST REV, V28, P51, DOI 10.1007/s10555-008-9168-1; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Engel BE, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.461; GU W, 1993, CELL, V72, P309, DOI 10.1016/0092-8674(93)90110-C; Gutierrez GM, 2008, P NATL ACAD SCI USA, V105, P18402, DOI 10.1073/pnas.0805925105; Han K, 2014, CELL BIOL INT, V38, P1394, DOI 10.1002/cbin.10351; Hay E, 2000, J CELL PHYSIOL, V183, P117, DOI 10.1002/(SICI)1097-4652(200004)183:1<117::AID-JCP14>3.0.CO;2-#; Hou J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010312; HYNES RO, 1992, CELL, V68, P303, DOI 10.1016/0092-8674(92)90472-O; Johnson JL, 2012, CANCER RES, V72, P516, DOI 10.1158/0008-5472.CAN-11-2647; Kashima T, 1999, AM J PATHOL, V155, P1549, DOI 10.1016/S0002-9440(10)65471-5; Kaye FJ, 2002, ONCOGENE, V21, P6908, DOI 10.1038/sj.onc.1205834; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Knudsen ES, 2006, EXP BIOL MED, V231, P1271; Lallemand D, 2003, GENE DEV, V17, P1090, DOI 10.1101/gad.1054603; Lozano E, 2003, BIOESSAYS, V25, P452, DOI 10.1002/bies.10262; Lozano E, 2008, J CELL SCI, V121, P933, DOI 10.1242/jcs.016121; LUDLOW JW, 1993, MOL CELL BIOL, V13, P367, DOI 10.1128/MCB.13.1.367; LUEDER GT, 1986, ARCH OPHTHALMOL-CHIC, V104, P372; Marie PJ, 2002, J CELL PHYSIOL, V190, P297, DOI 10.1002/jcp.10073; McClatchey AI, 2005, GENE DEV, V19, P2265, DOI 10.1101/gad.1335605; Mirabello L, 2009, CANCER-AM CANCER SOC, V115, P1531, DOI 10.1002/cncr.24121; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; Nola S, 2011, J CELL BIOL, V195, P855, DOI 10.1083/jcb.201107162; OTTERSON GA, 1994, ONCOGENE, V9, P3375; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Rodriguez-Salas N, 2001, HISTOL HISTOPATHOL, V16, P353, DOI 10.14670/HH-16.353; Ross JF, 1999, MOL CELL, V3, P195, DOI 10.1016/S1097-2765(00)80310-X; Sandberg AA, 2003, CANCER GENET CYTOGEN, V145, P1, DOI 10.1016/S0165-4608(03)00105-5; Sharova LV, 2009, DNA RES, V16, P45, DOI 10.1093/dnares/dsn030; Sosa-Garcia B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013954; Stains Joseph P, 2005, Birth Defects Res C Embryo Today, V75, P72, DOI 10.1002/bdrc.20034; Stearman RS, 2005, AM J PATHOL, V167, P1763, DOI 10.1016/S0002-9440(10)61257-6; Tang Y, 1998, P NATL ACAD SCI USA, V95, P5139, DOI 10.1073/pnas.95.9.5139; Thomas DM, 2001, MOL CELL, V8, P303, DOI 10.1016/S1097-2765(01)00327-6; Thomas DM, 2003, CANCER BIOL THER, V2, P2; TOKURAKU M, 1995, INT J CANCER, V64, P355, DOI 10.1002/ijc.2910640513; Tsukita Shoichiro, 1992, Current Opinion in Cell Biology, V4, P834, DOI 10.1016/0955-0674(92)90108-O; Van Aken EH, 2002, INVEST OPHTH VIS SCI, V43, P595; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; WEINTRAUB SJ, 1992, NATURE, V358, P259, DOI 10.1038/358259a0; WEINTRAUB SJ, 1995, NATURE, V375, P812, DOI 10.1038/375812a0; Yoon JH, 2002, CANCER RES, V62, P6500	56	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142406	10.1371/journal.pone.0142406	http://dx.doi.org/10.1371/journal.pone.0142406			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555075	Green Published, Green Submitted, gold			2022-12-27	WOS:000364430700099
J	Stankiewicz, AM; Goscik, J; Majewska, A; Swiergiel, AH; Juszczak, GR				Stankiewicz, Adrian M.; Goscik, Joanna; Majewska, Alicja; Swiergiel, Artur H.; Juszczak, Grzegorz R.			The Effect of Acute and Chronic Social Stress on the Hippocampal Transcriptome in Mice	PLOS ONE			English	Article							CHRONIC MILD STRESS; REAL-TIME PCR; GENE-EXPRESSION; MICROARRAY DATA; MOLECULAR CHARACTERIZATION; ARGININE-VASOPRESSIN; PREFRONTAL CORTEX; CHOROID-PLEXUS; MESSENGER-RNA; TISSUE-REPAIR	Psychogenic stress contributes to the formation of brain pathology. Using gene expression microarrays, we analyzed the hippocampal transcriptome of mice subjected to acute and chronic social stress of different duration. The longest period of social stress altered the expression of the highest number of genes and most of the stress-induced changes in transcription were reversible after 5 days of rest. Chronic stress affected genes involved in the functioning of the vascular system (Alas2, Hbb-b1, Hba-a2, Hba-a1), injury response (Vwf, Mgp, Cfh, Fbln5, Col3a1, Ctgf) and inflammation (S100a8, S100a9, Ctla2a, Ctla2b, Lcn2, Lrg1, Rsad2, Isg20). The results suggest that stress may affect brain functions through the stress-induced dysfunction of the vascular system. An important issue raised in our work is also the risk of the contamination of brain tissue samples with choroid plexus. Such contamination would result in a consistent up-or down-regulation of genes, such as Ttr, Igf2, Igfbp2, Prlr, Enpp2, Sostdc1, 1500015O10RIK (Ecrg4), Kl, Clic6, Kcne2, F5, Slc4a5, and Aqp1. Our study suggests that some of the previously reported, supposedly specific changes in hippocampal gene expression, may be a result of the inclusion of choroid plexus in the hippocampal samples.	[Stankiewicz, Adrian M.; Juszczak, Grzegorz R.] Polish Acad Sci, Inst Genet & Anim Breeding, Dept Anim Behav, Jastrzebiec, Poland; [Goscik, Joanna] Bialystok Tech Univ, Software Dept, Fac Comp Sci, Bialystok, Poland; [Majewska, Alicja] Warsaw Univ Life Sci, Dept Physiol Sci, Fac Vet Med, Warsaw, Poland; [Swiergiel, Artur H.] Univ Gdansk, Inst Biol, Dept Human & Anim Physiol, PL-80952 Gdansk, Poland; [Swiergiel, Artur H.] Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol Toxicol & Neurosci, Shreveport, LA 71105 USA	Institute of Genetics & Animal Biotechnology, Polish Academy of Sciences; Polish Academy of Sciences; Bialystok University of Technology; Warsaw University of Life Sciences; Fahrenheit Universities; University of Gdansk; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Juszczak, GR (corresponding author), Polish Acad Sci, Inst Genet & Anim Breeding, Dept Anim Behav, Jastrzebiec, Poland.	g.juszczak@ighz.pl	Juszczak, Grzegorz R/A-1339-2008; Stankiewicz, Adrian/AAD-1363-2021; Goscik, Joanna/S-6541-2018	Stankiewicz, Adrian/0000-0002-2719-6205; Goscik, Joanna/0000-0003-0433-6145; , Alicja/0000-0002-9815-7844; Swiergiel, Artur/0000-0001-7945-3325; Juszczak, Grzegorz/0000-0002-0976-6905	Ministerstwo Nauki i Szkolnictwa Wyzszego [N N311 604938, N N519 657940]; Narodowe Centrum Nauki [2011/03 N/NZ29/05222]	Ministerstwo Nauki i Szkolnictwa Wyzszego(Ministry of Science and Higher Education, Poland); Narodowe Centrum Nauki(National Science Centre, Poland)	This work was supported by the following grants: Grant N N311 604938, Ministerstwo Nauki i Szkolnictwa Wyzszego (PL; http://www.nauka.gov.pl/) to GRJ; Grant 2011/03 N/NZ29/05222, Narodowe Centrum Nauki (http://www.ncn.gov.pl/) to AMS; and Grant N N519 657940, Ministerstwo Nauki i Szkolnictwa Wyzszego (PL; http://www.nauka.gov.pl/) to JG. Funders of the study were not involved in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberini Cristina M, 2010, Cerebrum, V2010, P21; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Andrus BM, 2012, MOL PSYCHIATR, V17, P49, DOI 10.1038/mp.2010.119; Aso E, 2011, EUR NEUROPSYCHOPHARM, V21, P11, DOI 10.1016/j.euroneuro.2010.06.007; Barnes P, 2012, HIPPOCAMPUS, V22, P149, DOI 10.1002/hipo.20879; Barreto GE, 2012, EXP NEUROL, V238, P284, DOI 10.1016/j.expneurol.2012.08.015; Barro-Soria R, 2010, PFLUG ARCH EUR J PHY, V459, P485, DOI 10.1007/s00424-009-0745-0; Benatti C, 2012, J NEUROSCI RES, V90, P2103, DOI 10.1002/jnr.23100; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergstrom A, 2007, J MOL NEUROSCI, V33, P201, DOI 10.1007/s12031-007-0065-9; Bhatia V, 2005, J GASTROEN HEPATOL, V20, P332, DOI 10.1111/j.1440-1746.2004.03508.x; BLANCHARD DC, 1993, BEHAV BRAIN RES, V58, P113, DOI 10.1016/0166-4328(93)90096-9; Camors E, 2012, J MOL CELL CARDIOL, V52, P1240, DOI 10.1016/j.yjmcc.2012.02.010; Chen J, 2010, J NEUROENDOCRINOL, V22, P1072, DOI 10.1111/j.1365-2826.2010.02054.x; Chen Z, 2003, J IMMUNOL, V171, P3627, DOI 10.4049/jimmunol.171.7.3627; Choi YG, 2011, GENE, V481, P7, DOI 10.1016/j.gene.2011.03.006; Cox-Limpens KEM, 2014, BRAIN RES, V1564, P85, DOI 10.1016/j.brainres.2014.04.001; Curtin NM, 2009, BRAIN BEHAV IMMUN, V23, P535, DOI 10.1016/j.bbi.2009.02.003; Datson NA, 2012, HIPPOCAMPUS, V22, P359, DOI 10.1002/hipo.20905; de Cordoba SR, 2008, CLIN EXP IMMUNOL, V151, P1, DOI 10.1111/j.1365-2249.2007.03574.x; Denhardt DT, 2001, ANNU REV PHARMACOL, V41, P723, DOI 10.1146/annurev.pharmtox.41.1.723; DeVito LM, 2009, J NEUROSCI, V29, P2676, DOI 10.1523/JNEUROSCI.5488-08.2009; Diaz A, 1997, INT J BIOCHEM CELL B, V29, P251, DOI 10.1016/S1357-2725(96)00112-4; Diaz-Moran S, 2013, BEHAV BRAIN RES, V257, P129, DOI 10.1016/j.bbr.2013.09.041; Duncan MR, 1999, FASEB J, V13, P1774, DOI 10.1096/fasebj.13.13.1774; Dunn AJ, 2008, EUR J PHARMACOL, V583, P186, DOI 10.1016/j.ejphar.2007.11.069; Elloumi F, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-54; Engin E, 2008, NEUROPEPTIDES, V42, P411, DOI 10.1016/j.npep.2008.04.004; Engler H, 2008, PSYCHONEUROENDOCRINO, V33, P108, DOI 10.1016/j.psyneuen.2007.10.007; Farzaneh-Far A, 2000, BIOCHEM BIOPH RES CO, V277, P736, DOI 10.1006/bbrc.2000.3747; Frank SPC, 2011, MOL IMMUNOL, V49, P353, DOI 10.1016/j.molimm.2011.09.011; Golden SA, 2011, NAT PROTOC, V6, P1183, DOI 10.1038/nprot.2011.361; Gonzalez AM, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-6; Gray JD, 2014, MOL PSYCHIATR, V19, P1171, DOI 10.1038/mp.2013.175; Guadall A, 2011, J BIOL CHEM, V286, P7093, DOI 10.1074/jbc.M110.162917; He YD, 2010, TRANSL STROKE RES, V1, P48, DOI 10.1007/s12975-009-0004-x; He YD, 2009, J CEREBR BLOOD F MET, V29, P596, DOI 10.1038/jcbfm.2008.145; Hlavacova N, 2012, INT J NEUROPSYCHOPH, V15, P247, DOI 10.1017/S1461145711000368; Hohoff C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058880; Hori M, 2012, DIS MODEL MECH, V5, P270, DOI 10.1242/dmm.008276; Howerton CL, 2008, APPL ANIM BEHAV SCI, V115, P90, DOI 10.1016/j.applanim.2008.05.004; Ishida H, 2003, BIOL PHARM BULL, V26, P170, DOI 10.1248/bpb.26.170; Iwanaga Y, 2008, NEUROPATH APPL NEURO, V34, P145, DOI 10.1111/j.1365-2990.2007.00877.x; Iwayama Y, 2010, AM J MED GENET B, V153B, P484, DOI 10.1002/ajmg.b.31004; Jain M, 2012, EXP CELL RES, V318, P753, DOI 10.1016/j.yexcr.2012.01.016; Jolly RA, 2005, PHYSIOL GENOMICS, V22, P346, DOI 10.1152/physiolgenomics.00260.2004; Jorstad TS, 2007, TRENDS PLANT SCI, V12, P46, DOI 10.1016/j.tplants.2007.01.001; Jungke P, 2011, PSYCHOPHARMACOLOGY, V213, P757, DOI 10.1007/s00213-010-2032-3; Kendziorski C, 2005, P NATL ACAD SCI USA, V102, P4252, DOI 10.1073/pnas.0500607102; Kim JJ, 2002, NAT REV NEUROSCI, V3, P453, DOI 10.1038/nrn849; Klamp T, 2003, J IMMUNOL, V171, P1255, DOI 10.4049/jimmunol.171.3.1255; Kreipke CW, 2006, MICROVASC RES, V71, P197, DOI 10.1016/j.mvr.2006.02.002; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Kudryavtseva NN, 2000, AGGRESSIVE BEHAV, V26; LaCroix-Fralish ML, 2011, PAIN, V152, P1888, DOI 10.1016/j.pain.2011.04.014; Lauridsen JB, 2011, NEUROSCI RES, V70, P269, DOI 10.1016/j.neures.2011.03.011; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Li XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057621; Lisowski P, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-144; Lisowski P, 2011, EUR NEUROPSYCHOPHARM, V21, P45, DOI 10.1016/j.euroneuro.2010.08.004; Liu YY, 2010, CELL MOL NEUROBIOL, V30, P1035, DOI 10.1007/s10571-010-9534-8; Marques F, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-10; Masana M, 2014, PSYCHONEUROENDOCRINO, V48, P98, DOI 10.1016/j.psyneuen.2014.06.009; Matsumata M, 2012, STEM CELLS, V30, P1532, DOI 10.1002/stem.1124; Mengod G, 2011, RECEPT SER, P17, DOI 10.1007/978-1-60761-941-3_2; MICHENER CD, 1957, EVOLUTION, V11, P130, DOI 10.2307/2406046; Midwood KS, 2004, INT J BIOCHEM CELL B, V36, P1031, DOI 10.1016/j.biocel.2003.12.003; MILLER C H, 1991, Neurological Research, V13, P117; Mitchell K, 2008, PAIN, V134, P216, DOI 10.1016/j.pain.2007.10.024; Morey JS, 2006, BIOL PROCED ONLINE, V8, P175, DOI 10.1251/bpo126; Nakase S, 1998, LIFE SCI, V63, P23, DOI 10.1016/S0024-3205(98)00232-X; Newton SS, 2013, CELL MOL LIFE SCI, V70, P1739, DOI 10.1007/s00018-013-1281-9; Noda K, 2013, P NATL ACAD SCI USA, V110, P2852, DOI 10.1073/pnas.1215779110; Nolz JC, 2014, J CLIN INVEST, V124, P1013, DOI 10.1172/JCI72039; O'Donnell LC, 2002, J LEUKOCYTE BIOL, V72, P478; Okaty BW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016493; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pickering T G, 2001, Curr Hypertens Rep, V3, P249, DOI 10.1007/s11906-001-0047-1; Poh KW, 2012, J NEUROSCI, V32, P35, DOI 10.1523/JNEUROSCI.2389-11.2012; Poh KW, 2009, PAIN, V142, P133, DOI 10.1016/j.pain.2008.12.029; Ramos-Cejudo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052121; Reiche EMV, 2004, LANCET ONCOL, V5, P617, DOI 10.1016/S1470-2045(04)01597-9; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Reimand J, 2011, NUCLEIC ACIDS RES, V39, pW307, DOI 10.1093/nar/gkr378; Reininger AJ, 2008, HAEMOPHILIA, V14, P11, DOI 10.1111/j.1365-2516.2008.01848.x; Richter F, 2009, J COMP NEUROL, V515, P538, DOI 10.1002/cne.22062; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Roepke TK, 2011, FASEB J, V25, P4264, DOI 10.1096/fj.11-187609; Roet KCD, 2013, J NEUROSCI, V33, P11116, DOI 10.1523/JNEUROSCI.1002-13.2013; Rosell A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016750; Rosensteel SM, 2010, EXP MOL PATHOL, V89, P307, DOI 10.1016/j.yexmp.2010.07.003; Rozanski A, 1999, CIRCULATION, V99, P2192, DOI 10.1161/01.CIR.99.16.2192; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sanda C, 2006, J INTERF CYTOK RES, V26, P462, DOI 10.1089/jir.2006.26.462; Sarlus H, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-99; Sathyanesan M, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.64; Schelshorn DW, 2009, J CEREBR BLOOD F MET, V29, P585, DOI 10.1038/jcbfm.2008.152; Schmidt MV, 2011, P NATL ACAD SCI USA, V108, P17213, DOI 10.1073/pnas.1103318108; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Schroll A, 2012, EUR J IMMUNOL, V42, P3346, DOI 10.1002/eji.201142351; Sharifi K, 2011, HISTOCHEM CELL BIOL, V136, P501, DOI 10.1007/s00418-011-0865-4; Shenoy AR, 2007, IMMUNOBIOLOGY, V212, P771, DOI 10.1016/j.imbio.2007.09.018; Shi-Wen X, 2008, CYTOKINE GROWTH F R, V19, P133, DOI 10.1016/j.cytogfr.2008.01.002; Shih JH, 2004, BIOINFORMATICS, V20, P3318, DOI 10.1093/bioinformatics/bth391; Sinha R, 2008, ANN NY ACAD SCI, V1141, P105, DOI 10.1196/annals.1441.030; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Smyth GK, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-165; Sousa JC, 2007, NEUROBIOL AGING, V28, P713, DOI 10.1016/j.neurobiolaging.2006.03.015; Stankiewicz AM, 2014, BMC NEUROSCI, V15, DOI 10.1186/s12868-014-0130-6; Stepniak P, 2013, ACTA BIOCHIM POL, V60, P647; STRANG CJ, 1988, J EXP MED, V168, P1685, DOI 10.1084/jem.168.5.1685; SVANE PC, 1995, FEBS LETT, V373, P35, DOI 10.1016/0014-5793(95)01008-3; Takagi Y, 2014, NEUROL MED-CHIR, V54, P163, DOI 10.2176/nmc.oa2012-0422; Taylor GA, 2004, NAT REV IMMUNOL, V4, P100, DOI 10.1038/nri1270; Templin JS, 2012, BRAIN RES, V1457, P1, DOI 10.1016/j.brainres.2012.03.066; van der Staay FJ, 2010, PHYSIOL BEHAV, V100, P154, DOI 10.1016/j.physbeh.2010.02.020; Vandal K, 2003, J IMMUNOL, V171, P2602, DOI 10.4049/jimmunol.171.5.2602; Wang XK, 1998, J NEUROSCI, V18, P2075; Watanabe A, 2007, PLOS BIOL, V5, P2469, DOI 10.1371/journal.pbio.0050297; Weinberg A, 2000, LANCET, V355, P533, DOI 10.1016/S0140-6736(99)07366-3; Wohleb ES, 2013, J NEUROSCI, V33, P13820, DOI 10.1523/JNEUROSCI.1671-13.2013; Wolburg H, 2010, ACTA NEUROPATHOL, V119, P75, DOI 10.1007/s00401-009-0627-8; Yamada A, 2005, J IMMUNOL, V175, P5708, DOI 10.4049/jimmunol.175.9.5708; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zhang L, 2013, NEUROSCIENCE, V228, P139, DOI 10.1016/j.neuroscience.2012.10.010; Zhang SQ, 2009, ANN ALLERG ASTHMA IM, V103, P525, DOI 10.1016/S1081-1206(10)60270-0	127	73	74	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142195	10.1371/journal.pone.0142195	http://dx.doi.org/10.1371/journal.pone.0142195			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556046	Green Published, gold, Green Submitted			2022-12-27	WOS:000364430700068
J	van Lettow, M; Bedell, R; Maosa, S; Phiri, K; Chan, AK; Mwinjiwa, E; Kwekwesa, A; Kawonga, H; Joshua, M; Harries, AD; van Oosterhout, JJ				van Lettow, Monique; Bedell, Richard; Maosa, Sonia; Phiri, Kenneth; Chan, Adrienne K.; Mwinjiwa, Edson; Kwekwesa, Aunex; Kawonga, Harry; Joshua, Martias; Harries, Anthony D.; van Oosterhout, Joep J.			Outcomes and Diagnostic Processes in Outpatients with Presumptive Tuberculosis in Zomba District, Malawi	PLOS ONE			English	Article							ANTIRETROVIRAL TREATMENT; HIV; CARE; RESISTANCE; SUSPECTS; AFRICA	Background In Malawi, outpatients who have presumptive tuberculosis (TB), i.e. fever, night sweats, weight loss and/or any-duration cough (HIV-infected) or cough of at least 2 weeks (HIV-uninfected), are registered in chronic cough registers. They should receive a diagnostic work-up with first-step provider-initiated HIV testing and sputum testing which includes XpertMTB/RIF, following a national algorithm introduced in 2012. Methods An operational study, in which we prospectively studied 6-month outcomes of adult outpatients who were registered in chronic cough registers in Zomba Central Hospital and Matawale peri-urban Health Center, between February and September 2013. We recorded implementation of the diagnostic protocol and outcomes at 6 months from registration. Results Of 348 patients enrolled, 165(47%) were male, median age was 40 years, 72(21%) had previous TB. At registration 154(44%) were known HIV-positive, 34(10%) HIV-negative (26 unconfirmed) and 160(46%) had unknown HIV status; 104(56%) patients with unknown/unconfirmed HIV status underwent HIV testing. At 6 months 191(55%) were HIV-positive, 87(25%) HIV-negative (26 unconfirmed) and 70(20%) still had unknown HIV status. Higher age and registration in Matawale were independently associated with remaining unknown HIV status after 6 months. 62% of patients had sputum tested, including XpertMTB/RIF, according to the algorithm. TB was diagnosed in 54(15%) patients. This was based on XpertMTB/RIF results in 8(15%) diagnosed cases. In 26(48%) TB was diagnosed on clinical grounds. Coverage of ART in HIV-positive patients was 89%. At 6 months, 236(68%) were asymptomatic, 48(14%) symptomatic, 25(7%) had been lost-to-follow-up and 39(11%) had died. Mortality among those HIV-positive, HIV-negative and with unknown HIV-status was 15%, 2% and 10%, respectively. Male gender, being HIV-positive-not-on-ART and not receiving antibiotics were independent risk factors for mortality. Conclusion HIV prevalence among patients with presumptive TB was high (55%). One quarter was not HIV tested and mortality in this group was substantial (10%). The impact of XpertMTB/RIF on TB diagnosis was limited.	[van Lettow, Monique; Bedell, Richard; Maosa, Sonia; Phiri, Kenneth; Chan, Adrienne K.; Mwinjiwa, Edson; Kwekwesa, Aunex; Kawonga, Harry; van Oosterhout, Joep J.] Dignitas Int, Zomba, Malawi; [van Lettow, Monique; Chan, Adrienne K.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Chan, Adrienne K.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Div Infect Dis, Toronto, ON, Canada; [Joshua, Martias] Zomba Cent Hosp, Minist Hlth, Zomba, Malawi; [Harries, Anthony D.] Int Union TB & Lung Dis, Paris, France; [Harries, Anthony D.] London Sch Hyg & Trop Med, London WC1, England; [van Oosterhout, Joep J.] Univ Malawi, Dept Med, Coll Med, Blantyre, Malawi	University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of London; London School of Hygiene & Tropical Medicine; University of Malawi	van Lettow, M (corresponding author), Dignitas Int, Zomba, Malawi.	m.vanlettow@dignitasinternational.org	Bedell, Richard/AAC-2595-2020	Bedell, Richard/0000-0002-5687-8053; Phiri, Kamija/0000-0003-1753-2727	International Union Against Tuberculosis and Lung Disease (The Union); United States Agency for International Development (USAID); Zomba District Health Management Team; Dignitas Data Department	International Union Against Tuberculosis and Lung Disease (The Union); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); Zomba District Health Management Team; Dignitas Data Department	This study was made possible with the financial assistance of the International Union Against Tuberculosis and Lung Disease (The Union) and the United States Agency for International Development (USAID). The contents of this document are the sole responsibility of the authors and can under no circumstances be regarded as reflecting the positions of The Union or reflect the views of the USAID or the United States Government.; The authors thank Maxwell Maximus for his diligence with data collection and following up patients at their place of residence, the Zomba District Health Management Team and the Dignitas Data Department for their support.	Abouyannis M, 2014, B WORLD HEALTH ORGAN, V92, P798, DOI 10.2471/BLT.13.126532; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Chikovore J, 2015, GLOBAL HEALTH ACTION, V8, P1, DOI 10.3402/gha.v8.26292; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Cox HS, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001760; Deribew A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018614; Gawa LG, 2011, PUBLIC HEALTH ACTION, V1, P2, DOI 10.5588/pha.11.0007; Government of Malawi Ministry of Health, 2015, INT HIV PROGR REP JU; Hargreaves NJ, 2002, MALAWI MED J, V13, P20; Harries AD, 2011, INT J TUBERC LUNG D, V15, P427, DOI 10.5588/ijtld.11.0051; Havlir DV, 2008, JAMA-J AM MED ASSOC, V300, P423, DOI 10.1001/jama.300.4.423; Houben RMGJ, 2012, AIDS, V26, P2233, DOI 10.1097/QAD.0b013e32835958ed; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; Kennedy CE, 2013, AIDS BEHAV, V17, P1571, DOI 10.1007/s10461-012-0241-y; Kerkhoff AD, 2011, AIDS; Lawn SD, 2011, SAMJ S AFR MED J, V101, P258, DOI 10.7196/SAMJ.4392; Malawi Ministry of Health, 2014, CLIN MAN HIV CHILDR; Malawi Ministry of Health, 2012, NAT TB CONTR PROGR O; Munthali L, 2006, INT J TUBERC LUNG D, V10, P199; Musheke M, 2013, BMC PUBLIC HEALTH, V13, DOI [10.1186/1471-2458-13-220, 10.1186/1472-6963-13-97]; Odhiambo J, 2008, INT J TUBERC LUNG D, V12, pS63; Theron G, 2014, LANCET, V383, P424, DOI 10.1016/S0140-6736(13)62073-5; UNAIDS, 2014, HIV AIDS EST; van Lettow M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048856; World Health Organization, 2012, WHO POL COLL TB HIV; Yoon C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048599	26	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0141414	10.1371/journal.pone.0141414	http://dx.doi.org/10.1371/journal.pone.0141414			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556045	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000364430700028
J	Wilson, H; Miles, AF; Daane, KM; Altieri, MA				Wilson, Houston; Miles, Albie F.; Daane, Kent M.; Altieri, Miguel A.			Landscape Diversity and Crop Vigor Influence Biological Control of the Western Grape Leafhopper (E. elegantula Osborn) in Vineyards	PLOS ONE			English	Article							HOMALODISCA-COAGULATA; POPULATION-DYNAMICS; OKANAGAN VALLEY; NATURAL ENEMIES; AMINO-ACIDS; ROOTSTOCKS; PERFORMANCE; HYMENOPTERA; HOMOPTERA; ABUNDANCE	This study evaluated how the proportional area of natural habitat surrounding a vineyard (i.e. landscape diversity) worked in conjunction with crop vigor, cultivar and rootstock selection to influence biological control of the western grape leafhopper (Erythroneura elegantula Osborn). The key natural enemies of E. elegantula are Anagrus erythroneurae S. Trjapitzin & Chiappini and A. daanei Triapitsyn, both of which are likely impacted by changes in landscape diversity due to their reliance on non-crop habitat to successfully overwinter. Additionally, E. elegantula is sensitive to changes in host plant quality which may influence densities on specific cultivars, rootstocks and/or vines with increased vigor. From 20102013, data were collected on natural enemy and leafhopper densities, pest parasitism rates and vine vigor from multiple vineyards that represented a continuum of landscape diversity. Early in the season, vineyards in more diverse landscapes had higher Anagrus spp. densities and lower E. elegantula densities, which led to increased parasitism of E. elegantula. Although late season densities of E. elegantula tended to be lower in vineyards with higher early season parasitism rates and lower total petiole nitrogen content, they were also affected by rootstock and cultivar. While diverse landscapes can support higher natural enemy populations, which can lead to increased biological control, leafhopper densities also appear to be mediated by cultivar, rootstock and vine vigor.	[Wilson, Houston; Miles, Albie F.; Daane, Kent M.; Altieri, Miguel A.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Wilson, H (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	houston@berkeley.edu	Wilson, Houston/AAY-1091-2020		Robert Van den Bosch Memorial Scholarship	Robert Van den Bosch Memorial Scholarship	This work was supported by grants to HW from the Robert Van den Bosch Memorial Scholarship.	Awmack CS, 2002, ANNU REV ENTOMOL, V47, P817, DOI 10.1146/annurev.ento.47.091201.145300; Barbosa P., 2012, INSECT OUTBREAKS REV; Bellota E, 2013, ENTOMOL EXP APPL, V149, P185, DOI 10.1111/eea.12122; Bentley W, 2015, UN ANR PUBLICATION, V3448; Berenbaum MR, 2012, HERBIVORES THEIR INT; Bettiga LJ, 2003, UC ANR PUBLICATION, V3419; Bianchi FJJA, 2006, P ROY SOC B-BIOL SCI, V273, P1715, DOI 10.1098/rspb.2006.3530; BRODBECK BV, 1990, OECOLOGIA, V83, P338, DOI 10.1007/BF00317557; Chaplin-Kramer R, 2011, ECOL LETT, V14, P922, DOI 10.1111/j.1461-0248.2011.01642.x; CLARIDGE DW, 1986, ECOL ENTOMOL, V11, P31, DOI 10.1111/j.1365-2311.1986.tb00277.x; Cooper M, 2014, CALIF AGR, V68, P125, DOI 10.3733/ca.v068n04p125; Costello MJ, 1999, J ARACHNOL, V27, P531; Coyle DR, 2010, AGR FOREST ENTOMOL, V12, P89, DOI 10.1111/j.1461-9563.2009.00456.x; D'Alberto CF, 2012, BIOCONTROL, V57, P541, DOI 10.1007/s10526-011-9435-x; Daane K. M., 1998, California Agriculture, V52, P27, DOI 10.3733/ca.v052n05p27; Daane K.M., 2013, GRAPE PEST MANAGEMEN, V3rd ed., P202; de Valpine P, 2010, ECOL APPL, V20, P1926, DOI 10.1890/09-0468.1; DOUTT R L, 1973, Environmental Entomology, V2, P381, DOI 10.1093/ee/2.3.381; DOUTT RL, 1965, J ECON ENTOMOL, V58, P586, DOI 10.1093/jee/58.3.586; DUKE SO, 1994, INT J PLANT SCI, V155, P617, DOI 10.1086/297200; Eilers EJ, 2009, BIOL CONTROL, V51, P388, DOI 10.1016/j.biocontrol.2009.07.010; GOONEWARDENE HF, 1989, J ECON ENTOMOL, V82, P1426, DOI 10.1093/jee/82.5.1426; GOULD AB, 1991, PLANT DIS, V75, P767, DOI 10.1094/PD-75-0767; Hanley ME, 2007, PERSPECT PLANT ECOL, V8, P157, DOI 10.1016/j.ppees.2007.01.001; Hanna R, 2003, ENTOMOL EXP APPL, V107, P177, DOI 10.1046/j.1570-7458.2003.00051.x; HAWTHORNE DJ, 1994, ENTOMOL EXP APPL, V70, P63, DOI 10.1007/BF02380632; Hogg BN, 2015, ECOL ENTOMOL, V40, P69, DOI 10.1111/een.12162; Hogg BN, 2013, DIVERS DISTRIB, V19, P281, DOI 10.1111/j.1472-4642.2012.00935.x; Hogg BN, 2011, ECOL APPL, V21, P565, DOI 10.1890/10-0496.1; Hogg BN, 2010, AGR ECOSYST ENVIRON, V135, P260, DOI 10.1016/j.agee.2009.10.004; HOU RF, 1978, EXPERIENTIA, V34, P465, DOI 10.1007/BF01935929; Ibacache A, 2009, CHIL J AGR RES, V69, P503, DOI 10.4067/S0718-58392009000400004; Isaia M, 2006, ENVIRON ENTOMOL, V35, P297, DOI 10.1603/0046-225X-35.2.297; Jones JB, 2012, PLANT NUTRITION AND SOIL FERTILITY MANUAL, 2ND EDITION, P1, DOI 10.1201/b11577; Kidd N.A.C., 2005, P435, DOI 10.1007/1-4020-2625-0_7; Landis DA, 2000, ANNU REV ENTOMOL, V45, P175, DOI 10.1146/annurev.ento.45.1.175; Lowery D. Thomas, 2007, Journal of the Entomological Society of British Columbia, V104, P9; MATTSON WJ, 1987, BIOSCIENCE, V37, P110, DOI 10.2307/1310365; MCKENZIE LM, 1972, CAN ENTOMOL, V104, P1229, DOI 10.4039/Ent1041229-8; Munoz ST, 2008, INTEGRATED CONTROL C, V38, P197; Murphy BC, 1998, ENTOMOL EXP APPL, V87, P225, DOI 10.1023/A:1003294222162; Nicholls C. I., 2000, Agricultural and Forest Entomology, V2, P107, DOI 10.1046/j.1461-9563.2000.00054.x; Nicholls CI, 2001, LANDSCAPE ECOL, V16, P133, DOI 10.1023/A:1011128222867; Omer AD, 1999, J APPL ENTOMOL, V123, P341, DOI 10.1046/j.1439-0418.1999.00394.x; PILLEMER EA, 1978, ENTOMOL EXP APPL, V24, P83, DOI 10.1007/BF00334175; Powell G, 2006, ANNU REV ENTOMOL, V51, P309, DOI 10.1146/annurev.ento.51.110104.151107; PRICE PW, 1991, OIKOS, V62, P244, DOI 10.2307/3545270; Reisenauer HM, 1978, BULLETIN, V1879; Reynolds AG, 2001, HORTTECHNOLOGY, V11, P419, DOI 10.21273/HORTTECH.11.3.419; Rhoades D.F., 1979, HERBIVORES THEIR INT; Robinson TL, 2011, ACTA HORTIC, V903, P249, DOI 10.17660/ActaHortic.2011.903.31; RUHL EH, 1989, AUST J EXP AGR, V29, P707, DOI 10.1071/EA9890707; Saif Ullah, 2012, Journal of Agricultural Research (Lahore), V50, P217; SAKAI T, 1976, Applied Entomology and Zoology, V11, P82; Sandanayaka WRM, 2003, ENTOMOL EXP APPL, V109, P63, DOI 10.1046/j.1570-7458.2003.00095.x; Schoonhoven L. M., 2005, Insect-plant biology; Settle W. H., 1986, California Agriculture, V40, P30; Shiflet T. N., 1994, RANGELAND COVER TYPE; Smith MW, 2004, SCI HORTIC-AMSTERDAM, V102, P75, DOI 10.1016/j.scienta.2003.12.004; SOUTHEY J M, 1991, South African Journal for Enology and Viticulture, V12, P32; Thies C, 2005, P ROY SOC B-BIOL SCI, V272, P203, DOI 10.1098/rspb.2004.2902; Thomson LJ, 2013, BIOL CONTROL, V64, P57, DOI 10.1016/j.biocontrol.2012.09.019; Thomson LJ, 2010, BIOL CONTROL, V54, P248, DOI 10.1016/j.biocontrol.2010.05.018; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Triapitsyn SV, 1998, T AM ENTOMOL SOC, V124, P77; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Tscharntke T, 2002, ECOL RES, V17, P229, DOI 10.1046/j.1440-1703.2002.00482.x; Tscharntke T, 2004, ANNU REV ENTOMOL, V49, P405, DOI 10.1146/annurev.ento.49.061802.123339; Webster AD, 1995, NEW ZEAL J CROP HORT, V23, P373, DOI 10.1080/01140671.1995.9513913; WHITE TCR, 1984, OECOLOGIA, V63, P90, DOI 10.1007/BF00379790; WILLIAMS DW, 1984, HILGARDIA, V52, P1; Williams L, 2000, BIOL CONTROL, V18, P136, DOI 10.1006/bcon.2000.0817; Williams T, 2003, BIOCONTROL SCI TECHN, V13, P459, DOI 10.1080/0958315031000140956; Wilson H, 2015, DRYAD DIGITAL REPOSI; Wilson H, 2015, AGR ECOSYST ENVIRON, V211, P43, DOI 10.1016/j.agee.2015.04.021; Wolpert JA, 2005, AM J ENOL VITICULT, V56, P163	76	11	12	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0141752	10.1371/journal.pone.0141752	http://dx.doi.org/10.1371/journal.pone.0141752			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555074	Green Published, gold, Green Submitted			2022-12-27	WOS:000364430700039
J	Zhu, FQ; Chen, T; Zhang, YQ; Sun, HX; Cao, H; Lu, JX; Zhao, LS; Li, G				Zhu, Fengqin; Chen, Tian; Zhang, Yeqiong; Sun, Haixia; Cao, Hong; Lu, Jianxi; Zhao, Linshan; Li, Gang			A Novel Adeno-Associated Virus-Based Genetic Vaccine Encoding the Hepatitis C Virus NS3/4 Protein Exhibits Immunogenic Properties in Mice Superior to Those of an NS3-Protein-Based Vaccine	PLOS ONE			English	Article							GENOTYPE 1 INFECTION; T-CELL RESPONSES; IN-VIVO; IMMUNE-RESPONSES; HCV INFECTION; NONSTRUCTURAL PROTEIN-3; LYMPHOCYTE RESPONSE; RHESUS-MONKEYS; PROGRESS; VECTORS	More than 170 million individuals worldwide are infected with hepatitis C virus (HCV), and up to an estimated 30% of chronically infected individuals will go on to develop progressive liver disease. Despite the recent advances in antiviral treatment of HCV infection, it remains a major public health problem. Thus, development of an effective vaccine is urgently required. In this study, we constructed novel adeno-associated virus (AAV) vectors expressing the full-length NS3 or NS3/4 protein of HCV genotype 1b. The expression of the NS3 or NS3/4 protein in HepG2 cells was confirmed by western blotting. C57BL/6 mice were intramuscularly immunised with a single injection of AAV vectors, and the resultant immune response was investigated. The AAV2/rh32.33. NS3/4 vaccine induced stronger humoral and cellular responses than did the AAV2/rh32.33. NS3 vaccine. Our results demonstrate that AAV-based vaccines exhibit considerable potential for the development of an effective anti-HCV vaccine.	[Zhu, Fengqin; Chen, Tian; Zhang, Yeqiong; Sun, Haixia; Cao, Hong; Lu, Jianxi; Zhao, Linshan; Li, Gang] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Infect Dis, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Li, G (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Infect Dis, Guangzhou 510275, Guangdong, Peoples R China.	lg3195@gmail.com	Chen, Tianfeng/AAG-6123-2019		Science and Technology Planning Project of Guangdong Province, China [2010B060900041]	Science and Technology Planning Project of Guangdong Province, China	This study was supported by grants from the Science and Technology Planning Project of Guangdong Province, China (Grant No: 2010B060900041, GL.	Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; Barefoot B, 2008, VACCINE, V26, P6108, DOI 10.1016/j.vaccine.2008.09.007; Casimiro DR, 2003, J VIROL, V77, P6305, DOI 10.1128/JVI.77.11.6305-6313.2003; CERNY A, 1995, J CLIN INVEST, V95, P521, DOI 10.1172/JCI117694; Diepolder HM, 1997, J VIROL, V71, P6011, DOI 10.1128/JVI.71.8.6011-6019.1997; DIEPOLDER HM, 1995, LANCET, V346, P1006, DOI 10.1016/S0140-6736(95)91691-1; Dismuke DJ, 2013, CURR GENE THER, V13, P434; Draper SJ, 2010, NAT REV MICROBIOL, V8, P62, DOI 10.1038/nrmicro2240; Eisenstein M, 2011, NATURE, V474, pS16, DOI 10.1038/474S16a; Fournillier A, 2007, VACCINE, V25, P7339, DOI 10.1016/j.vaccine.2007.08.020; Fournillier A, 2006, VACCINE, V24, P3153, DOI 10.1016/j.vaccine.2006.01.039; Frelin L, 2003, GENE THER, V10, P686, DOI 10.1038/sj.gt.3301933; Gao GP, 2002, P NATL ACAD SCI USA, V99, P11854, DOI 10.1073/pnas.182412299; Gerlach JT, 2005, J VIROL, V79, P12425, DOI 10.1128/JVI.79.19.12425-12433.2005; GRAKOUI A, 1993, J VIROL, V67, P1385, DOI 10.1128/JVI.67.3.1385-1395.1993; Habersetzer F, 2011, GASTROENTEROLOGY, V141, P890, DOI 10.1053/j.gastro.2011.06.009; Habersetzer F, 2009, CURR OPIN MOL THER, V11, P456; Huang Y, 2001, BIOCHEM BIOPH RES CO, V281, P732, DOI 10.1006/bbrc.2001.4424; Hugle T, 2001, VIROLOGY, V284, P70, DOI 10.1006/viro.2001.0873; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Lang KA, 2008, VACCINE, V26, P6225, DOI 10.1016/j.vaccine.2008.07.052; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Law LMJ, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.79; Li JA, 1997, J VIROL, V71, P5236, DOI 10.1128/JVI.71.7.5236-5243.1997; Li XL, 2012, MICROBES INFECT, V14, P1000, DOI 10.1016/j.micinf.2012.05.002; Liang TJ, 2013, NAT MED, V19, P869, DOI 10.1038/nm.3183; Lin JP, 2009, J VIROL, V83, P12738, DOI 10.1128/JVI.01441-09; Livingston BD, 2001, VACCINE, V19, P4652, DOI 10.1016/S0264-410X(01)00233-X; Logan GJ, 2010, IMMUNOL CELL BIOL, V88, P228, DOI 10.1038/icb.2009.92; Mingozzi F, 2011, NAT REV GENET, V12, P341, DOI 10.1038/nrg2988; Missale G, 1996, J CLIN INVEST, V98, P706, DOI 10.1172/JCI118842; Nieto K, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00005; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Reed KE, 2000, CURR TOP MICROBIOL, V242, P55; Rehermann B, 2009, J CLIN INVEST, V119, P1745, DOI 10.1172/JCI39133; Roohvand F, 2012, EXPERT OPIN THER PAT, V22, P391, DOI 10.1517/13543776.2012.673589; Simmonds P, 2013, CURR TOP MICROBIOL, V369, P1, DOI 10.1007/978-3-642-27340-7_1; Swadling L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009185; Tang HL, 2009, CLIN SCI, V117, P49, DOI 10.1042/CS20080631; TANJI Y, 1995, J VIROL, V69, P1575, DOI 10.1128/JVI.69.3.1575-1581.1995; Thammanichanond D, 2008, CLIN IMMUNOL, V128, P329, DOI 10.1016/j.clim.2008.04.002; Timm J, 2004, J EXP MED, V200, P1593, DOI 10.1084/jem.20041006; Torresi J, 2011, J HEPATOL, V54, P1273, DOI 10.1016/j.jhep.2010.09.040; Vandenberghe LH, 2009, GENE THER, V16, P1416, DOI 10.1038/gt.2009.101; Wedemeyer H, 2009, VACCINE, V27, P5142, DOI 10.1016/j.vaccine.2009.06.027; Weiland O, 2013, MOL THER, V21, P1796, DOI 10.1038/mt.2013.119; Xiao XA, 1996, J VIROL, V70, P8098, DOI 10.1128/JVI.70.11.8098-8108.1996	48	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142349	10.1371/journal.pone.0142349	http://dx.doi.org/10.1371/journal.pone.0142349			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556235	gold, Green Submitted, Green Published			2022-12-27	WOS:000364430700089
J	Chen, YC; Ho, WM; Lee, YS; Chen, HW; Chen, CM				Chen, Yi Chun; Ho, Wei Min; Lee, Yun Shien; Chen, Huei Wen; Chen, Chiung-Mei			Polymorphisms in the Promoters of the MMP-2 and TIMP-2 Genes Are Associated with Spontaneous Deep Intracerebral Hemorrhage in the Taiwan Population	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; CHINESE HAN POPULATION; SMOOTH-MUSCLE-CELLS; MATRIX METALLOPROTEINASES; CEREBRAL ANEURYSMS; STROKE; RISK; EXPRESSION; INHIBITORS; GUIDELINES	Background Spontaneous intracerebral hemorrhage (ICH) is a devastating stroke subtype. Matrix metalloproteinases (MMPs) function in the degradation of extracellular matrix and the activities of MMPs are modulated by their endogenous inhibitors, tissue inhibitors of metalloproteinases (TIMPs). This study aimed to discuss relationship of MMP-2 and TIMP-2 to spontaneous deep ICH (SDICH) susceptibility and hematoma size. Methods Associations were tested by logistic regression and general linear models (GLM) where appropriate, adjusting with covariables of age, sex, hypertension, diabetes mellitus, smoking, and alcohol consumption. Association analyses were performed first by stratification of genders and then by the age of 65 years old (y/o). Elder population was defined as subjects who were older than 65 y/o. Results There were 396 SDICH patients and 376 control subjects in this study. In the elder group, rs7503607 C>A variant in TIMP-2 was associated with SDICH in male and overall patients (OR = 3.49, 95% CI 1.45 to 8.40, P = 0.005 and OR = 2.45, 95% CI 1.37 to 4.38, P = 0.003, respectively) in additive genetic model. In recessive genetic model, rs2285053 TT genotype in MMP-2 was correlated to SDICH in male patients and overall elder group (OR = 7.30, 95% CI 1.3 to 40, P = 0.02 and OR = 2.91, 95% CI 1.02 to 8.31, P = 0.046, respectively), and rs7503726 AA genotype in TIMP-2 was associated with SDICH in female patients (OR = 0.29, 95% CI 0.1 to 0.84, P = 0.02). In younger male and overall younger patients, SDICH patients who had supratentorial hemorrhage had significantly lower frequency of AA genotypes in rs7503726 than those with infratentorial hemorrhage (OR = 0.36, 95% CI 0.17 to 0.75, P = 0.006 and OR = 0.43, 95% CI 0.22 to 0.84, P = 0.014, respectively). Hemorrhage size increased by 9.7 (95% CI 2.1 to 43, P = 0.004) cm(3) per minor allele (A) of the rs7503607 variant in the elder female patients and increased by 4.3 (95% CI 1.4 to 12.9, P = 0.009) cm(3) per minor allele (A) in all elder patients. In younger patients, the hemorrhage size decreased by 3.3 (95% CI 1.2 to 9.5, P = 0.03) cm(3) per minor allele of the s7503726 variant in the female patients. Conclusions This study showed a significant association between the variants of MMP-2 and TIMP-2 promoters and SDICH susceptibility with significant age and gender differences. Hemorrhage location and size might be affected by TIMP-2 promoter variants in the SDICH patients.	[Chen, Yi Chun; Ho, Wei Min; Chen, Huei Wen; Chen, Chiung-Mei] Chang Gung Mem Hosp, Linkou Med Ctr, Dept Neurol, Taoyuan, Taiwan; [Chen, Yi Chun; Ho, Wei Min; Chen, Huei Wen; Chen, Chiung-Mei] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Lee, Yun Shien] Ming Chuan Univ, Dept Biotechnol, Taoyuan, Taiwan; [Lee, Yun Shien] Chang Gung Mem Hosp, Genom Med Res Core Lab, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Ming Chuan University; Chang Gung Memorial Hospital	Chen, CM (corresponding author), Chang Gung Mem Hosp, Linkou Med Ctr, Dept Neurol, Taoyuan, Taiwan.	cmchen@adm.cgmh.org.tw	Chen, Chiung-Mei/AAL-6260-2020	Chen, Yi-Chun/0000-0001-9435-8596	National Science Council in Taiwan [NSC 101-2314-B-182A-064, 103-2314-B-182A-027]; Chang Gung Memorial Hospital, Taiwan [CMRPG3A0291, CMRPG3C174]	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital, Taiwan(Chang Gung Memorial Hospital)	Funding: This study was supported by National Science Council in Taiwan (NSC 101-2314-B-182A-064, 103-2314-B-182A-027) and by Chang Gung Memorial Hospital, Taiwan (CMRPG3A0291 and CMRPG3C174): YCC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Alvarez-Sabin J, 2004, STROKE, V35, P1316, DOI 10.1161/01.STR.0000126827.69286.90; Aoki T, 2007, STROKE, V38, P2337, DOI 10.1161/STROKEAHA.107.481838; Baird AE, 2010, J AM COLL CARDIOL, V56, P245, DOI 10.1016/j.jacc.2010.02.051; BRODERICK JP, 1993, STROKE, V24, P987, DOI 10.1161/01.STR.24.7.987; Castellazzi M, 2010, ACTA NEUROCHIR SUPPL, V106, P137, DOI 10.1007/978-3-211-98811-4_24; Castoldi G, 2007, CLIN EXP PHARMACOL P, V34, P205, DOI 10.1111/j.1440-1681.2007.04573.x; Chen CM, 2008, EUR J NEUROL, V15, P1206, DOI 10.1111/j.1468-1331.2008.02294.x; Chen YC, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-41; Davis SM, 2006, NEUROLOGY, V66, P1175, DOI 10.1212/01.wnl.0000208408.98482.99; Florczak-Rzepka M, 2012, CEREBROVASC DIS, V34, P249, DOI 10.1159/000341686; Gauderman WJ, 2002, AM J EPIDEMIOL, V155, P478, DOI 10.1093/aje/155.5.478; Hadler-Olsen E, 2011, FEBS J, V278, P28, DOI 10.1111/j.1742-4658.2010.07920.x; Hernandez-Guillamon M, 2010, THE JOURNAL OF BIOLO, V285, P27144, DOI [10.1074/jbc.M110.135228, DOI 10.1074/JBC.M110.135228]; Hernandez-Guillamon M, 2012, BRAIN PATHOL, V22, P133, DOI 10.1111/j.1750-3639.2011.00512.x; Ho WM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125397; Hopps E, 2015, EUR REV MED PHARMACO, V19, P2583; Hsieh FI, 2010, CIRCULATION, V122, P1116, DOI 10.1161/CIRCULATIONAHA.110.936526; Huang Y, 2014, J RENIN-ANGIO-ALDO S, V15, P32, DOI 10.1177/1470320313481838; Kim SK, 2012, J INTERF CYTOK RES, V32, P81, DOI 10.1089/jir.2011.0022; Limpert E, 2001, BIOSCIENCE, V51, P341, DOI 10.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;2; Miyazaki S, 2010, CIRC J, V74, P1158, DOI 10.1253/circj.CJ-09-0412; Mun-Bryce S, 1998, J CEREBR BLOOD F MET, V18, P1163, DOI 10.1097/00004647-199811000-00001; Onal IK, 2009, EUR J INTERN MED, V20, P369, DOI 10.1016/j.ejim.2008.10.003; Qin HJ, 2013, NEUROL RES, V35, P545, DOI 10.1179/1743132813Y.0000000184; Qin HW, 1999, J BIOL CHEM, V274, P29130, DOI 10.1074/jbc.274.41.29130; Qureshi AI, 2009, LANCET, V373, P1632, DOI 10.1016/S0140-6736(09)60371-8; Reuter B, 2009, CEREBROVASC DIS, V28, P558, DOI 10.1159/000247599; Rosenberg GA, 1998, STROKE, V29, P2189, DOI 10.1161/01.STR.29.10.2189; Rost NS, 2008, STROKE, V39, P2166, DOI 10.1161/STROKEAHA.107.501650; Schoenborn CA, 2005, VITAL HLTH STAT, V10, P1; Sessa M, 2008, NEUROL SCI, V29, pS258, DOI 10.1007/s10072-008-0956-8; Steiner T, 2014, INT J STROKE, V9, P840, DOI 10.1111/ijs.12309; Sulter G, 1999, STROKE, V30, P1538, DOI 10.1161/01.STR.30.8.1538; Sun YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067402; Sutherland GR, 2006, J CLIN NEUROSCI, V13, P511, DOI 10.1016/j.jocn.2004.12.012; Todor DR, 1998, STROKE, V29, P1580, DOI 10.1161/01.STR.29.8.1580; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Vukasovic I, 2006, CLIN CHEM LAB MED, V44, P428, DOI 10.1515/CCLM.2006.079; Wang HX, 2014, INT J NEUROSCI, V124, P61, DOI 10.3109/00207454.2013.823604; Wingrove CS, 1998, BBA-MOL BASIS DIS, V1406, P169, DOI 10.1016/S0925-4439(97)00097-5; Woo D, 2002, STROKE, V33, P1190, DOI 10.1161/01.STR.0000014774.88027.22; Yan CH, 2007, J CELL PHYSIOL, V211, P19, DOI 10.1002/jcp.20948; Yang J, 2014, J NEUROL SCI, V341, P55, DOI 10.1016/j.jns.2014.03.049; Yi YC, 2009, CLIN CHIM ACTA, V409, P127, DOI 10.1016/j.cca.2009.09.015; Yokota T, 2010, HEART VESSELS, V25, P460, DOI 10.1007/s00380-010-0013-4; Yu CY, 2004, CANCER RES, V64, P7622, DOI 10.1158/0008-5472.CAN-04-1521	47	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2015	10	11							e0142482	10.1371/journal.pone.0142482	http://dx.doi.org/10.1371/journal.pone.0142482			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7AC	26551785	Green Published, gold, Green Submitted			2022-12-27	WOS:000364422800027
J	Kissine, M; Cano-Chervel, J; Carlier, S; De Brabanter, P; Ducenne, L; Pairon, MC; Deconinck, N; Delvenne, V; Leybaert, J				Kissine, Mikhail; Cano-Chervel, Julie; Carlier, Sophie; De Brabanter, Philippe; Ducenne, Lesley; Pairon, Marie-Charlotte; Deconinck, Nicolas; Delvenne, Veronique; Leybaert, Jacqueline			Children with Autism Understand Indirect Speech Acts: Evidence from a Semi-Structured Act-Out Task	PLOS ONE			English	Article							FALSE BELIEF; PRAGMATIC IMPAIRMENTS; ACTION ANTICIPATION; INDIRECT REQUESTS; MIND; LANGUAGE; ADULTS; COMPREHENSION; ATTRIBUTION; EXPLORATION	Children with Autism Spectrum Disorder are often said to present a global pragmatic impairment. However, there is some observational evidence that context-based comprehension of indirect requests may be preserved in autism. In order to provide experimental confirmation to this hypothesis, indirect speech act comprehension was tested in a group of 15 children with autism between 7 and 12 years and a group of 20 typically developing children between 2:7 and 3:6 years. The aim of the study was to determine whether children with autism can display genuinely contextual understanding of indirect requests. The experiment consisted of a three-pronged semi-structured task involving Mr Potato Head. In the first phase a declarative sentence was uttered by one adult as an instruction to put a garment on a Mr Potato Head toy; in the second the same sentence was uttered as a comment on a picture by another speaker; in the third phase the same sentence was uttered as a comment on a picture by the first speaker. Children with autism complied with the indirect request in the first phase and demonstrated the capacity to inhibit the directive interpretation in phases 2 and 3. TD children had some difficulty in understanding the indirect instruction in phase 1. These results call for a more nuanced view of pragmatic dysfunction in autism.	[Kissine, Mikhail; Carlier, Sophie; De Brabanter, Philippe; Deconinck, Nicolas; Delvenne, Veronique; Leybaert, Jacqueline] Univ Libre Bruxelles, Brussels, Belgium; [Cano-Chervel, Julie; Carlier, Sophie; Ducenne, Lesley; Pairon, Marie-Charlotte; Deconinck, Nicolas; Delvenne, Veronique] Univ Libre Bruxelles Autrement, Hop Univ Enfants Reine Fabiola, Ctr Ressource Autisme, Brussels, Belgium	Universite Libre de Bruxelles	Kissine, M (corresponding author), Univ Libre Bruxelles, Brussels, Belgium.	mkissine@ulb.ac.be	Kissine, Mikhail/AAE-9184-2020	Kissine, Mikhail/0000-0001-6693-9772	F.R.S.-FNRS [F.4502.15]; ARC	F.R.S.-FNRS(Fonds de la Recherche Scientifique - FNRS); ARC(Australian Research Council)	Funding: Work reported in this paper benefited from the Research Incentive Grant F.4502.15 (F.R.S.-FNRS) and a ARC-Consolidator Grant to Mikhail Kissine.	Baltaxe C., 1977, J PEDIATR PSYCHOL, V2, P176, DOI [10.1093/jpepsy/2.4.176, DOI 10.1093/JPEPSY/2.4.176]; Baron-Cohen S., 2000, UNDERSTANDING OTHER, V2, P102, DOI DOI 10.1093/ACPROF:OSO/9780199692972.001.0001; Bloom P, 2000, COGNITION, V77, pB25, DOI 10.1016/S0010-0277(00)00096-2; Capps L., 1998, AUTISM, V2, P325, DOI [10.1177/1362361398024002, DOI 10.1177/1362361398024002]; CARRELL PL, 1981, J CHILD LANG, V8, P329, DOI 10.1017/S0305000900003226; Carston, 2002, THOUGHTS UTTERANCES; Chevallier C, 2010, J AUTISM DEV DISORD, V40, P1104, DOI 10.1007/s10803-010-0960-8; CLARK HH, 1975, J VERB LEARN VERB BE, V14, P56, DOI 10.1016/S0022-5371(75)80006-5; CLEMENTS WA, 1994, COGNITIVE DEV, V9, P377, DOI 10.1016/0885-2014(94)90012-4; Cole Peter, 1975, SYNTAX SEMANTICSVOL, P59, DOI DOI 10.1017/CBO9780511609213.004; EALES MJ, 1993, J AUTISM DEV DISORD, V23, P593, DOI 10.1007/BF01046104; Gernsbacher MA, 2012, METAPHOR SYMBOL, V27, P93, DOI 10.1080/10926488.2012.656255; GIBBS RW, 1986, ACTA PSYCHOL, V62, P41, DOI 10.1016/0001-6918(86)90004-1; Giora R, 2012, METAPHOR SYMBOL, V27, P22, DOI 10.1080/10926488.2012.638823; Grice P., 1989, STUDIES WAY WORDS; HAPPE FGE, 1995, CHILD DEV, V66, P843, DOI 10.2307/1131954; Helloin M-C, 2006, BATTERIE INFORMATISE; Irwin JR, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00397; Jary M, 2014, KEY TOP SEMANT PRAGM, P1, DOI 10.1017/CBO9780511998126; Kissine M, 2013, FROM UTTERANCES TO SPEECH ACTS, P1, DOI 10.1017/CBO9780511842191; Kissine M, 2012, AUTISM, V16, P523, DOI 10.1177/1362361311406296; Kissine M, 2012, MIND LANG, V27, P1, DOI 10.1111/j.1468-0017.2011.01433.x; MacKay G, 2005, CHILD LANG TEACH THE, V20, P13; Morgan J.L., 1978, SYNTAX SEMANTICS VOL, P261; Nichols Shaun, 2003, MINDREADING INTEGRAT; Norbury CF, 2005, BRIT J DEV PSYCHOL, V23, P383, DOI 10.1348/026151005X26732; Onishi KH, 2005, SCIENCE, V308, P255, DOI 10.1126/science.1107621; Ozonoff S, 1996, BRAIN LANG, V52, P411, DOI 10.1006/brln.1996.0022; PAUL R, 1985, J SPEECH HEAR RES, V28, P475, DOI 10.1044/jshr.2804.475; Perkins, 2007, PRAGMATIC IMPAIRMENT; PERNER J, 1989, CHILD DEV, V60, P689, DOI 10.2307/1130734; Pijnacker J, 2009, J AUTISM DEV DISORD, V39, P607, DOI 10.1007/s10803-008-0661-8; Recanati Francois, 2004, LITERAL MEANING; REEDER K, 1980, J CHILD LANG, V7, P13, DOI 10.1017/S0305000900007005; Ruytenbeek N., DRAWING LINE PERSPEC; Schulze C, 2015, COGNITION, V136, P91, DOI 10.1016/j.cognition.2014.11.036; Senju A, 2010, DEV PSYCHOPATHOL, V22, P353, DOI 10.1017/S0954579410000106; SHATZ M, 1978, COGNITIVE PSYCHOL, V10, P271, DOI 10.1016/0010-0285(78)90001-4; Shintel H, 2009, TOP COGN SCI, V1, P260, DOI 10.1111/j.1756-8765.2009.01018.x; Southgate V, 2007, PSYCHOL SCI, V18, P587, DOI 10.1111/j.1467-9280.2007.01944.x; Sperber D, 2002, MIND LANG, V17, P3, DOI 10.1111/1468-0017.00186; Sperber Dan, 1986, RELEVANCE COMMUNICAT, V142; Surian L, 1996, Cogn Neuropsychiatry, V1, P55, DOI 10.1080/135468096396703; TAGERFLUSBERG H, 1991, J CHILD PSYCHOL PSYC, V32, P1123, DOI 10.1111/j.1469-7610.1991.tb00353.x; Terkourafi M, 2009, CURR RES SEMANT PRAG, V20, P27; Tomasello M, 2008, JEAN NICOD LECT, P1; Yirmiya N, 1998, PSYCHOL BULL, V124, P283, DOI 10.1037/0033-2909.124.3.283	47	19	19	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2015	10	11							e0142191	10.1371/journal.pone.0142191	http://dx.doi.org/10.1371/journal.pone.0142191			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7AC	26551648	Green Submitted, gold, Green Published			2022-12-27	WOS:000364422800018
J	Brotnow, L; Reiss, D; Stover, CS; Ganiban, J; Leve, LD; Neiderhiser, JM; Shaw, DS; Stevens, HE				Brotnow, Line; Reiss, David; Stover, Carla S.; Ganiban, Jody; Leve, Leslie D.; Neiderhiser, Jenae M.; Shaw, Daniel S.; Stevens, Hanna E.			Expectant Mothers Maximizing Opportunities: Maternal Characteristics Moderate Multifactorial Prenatal Stress in the Prediction of Birth Weight in a Sample of Children Adopted at Birth	PLOS ONE			English	Article							RISK-FACTORS; PSYCHOSOCIAL STRESS; SOCIAL SUPPORT; EMOTIONAL DISTRESS; GENETIC INFLUENCES; PRETERM BIRTH; PARTNER ABUSE; EARLY GROWTH; LIFE EVENTS; PREGNANCY	Background Mothers' stress in pregnancy is considered an environmental risk factor in child development. Multiple stressors may combine to increase risk, and maternal personal characteristics may offset the effects of stress. This study aimed to test the effect of 1) multifactorial prenatal stress, integrating objective "stressors" and subjective "distress" and 2) the moderating effects of maternal characteristics (perceived social support, self-esteem and specific personality traits) on infant birthweight. Method Hierarchical regression modeling was used to examine cross-sectional data on 403 birth mothers and their newborns from an adoption study. Results Distress during pregnancy showed a statistically significant association with birthweight (R-2 = 0.032, F-(2,F- 398) = 6.782, p = .001). The hierarchical regression model revealed an almost two-fold increase in variance of birthweight predicted by stressors as compared with distress measures (R-2 Delta = 0.049, F-(4,F- 394) = 5.339, p <.001). Further, maternal characteristics moderated this association (R-2 Delta = 0.031, F-(4,F- 389) = 3.413, p = .009). Specifically, the expected benefit to birthweight as a function of higher SES was observed only for mothers with lower levels of harm-avoidance and higher levels of perceived social support. Importantly, the results were not better explained by prematurity, pregnancy complications, exposure to drugs, alcohol or environmental toxins. Conclusions The findings support multidimensional theoretical models of prenatal stress. Although both objective stressors and subjectively measured distress predict birthweight, they should be considered distinct and cumulative components of stress. This study further highlights that jointly considering risk factors and protective factors in pregnancy improves the ability to predict birthweight.	[Brotnow, Line; Stevens, Hanna E.] Univ Iowa, Coll Med, Dept Psychiat, Iowa City, IA 52242 USA; [Brotnow, Line; Reiss, David; Stevens, Hanna E.] Yale Univ, Sch Med, Yale Child Study Ctr, New Haven, CT USA; [Stover, Carla S.] Univ S Florida, Dept Mental Hlth Law & Policy, Tampa, FL USA; [Ganiban, Jody] George Washington Univ, Dept Psychol, Washington, DC 20052 USA; [Leve, Leslie D.] Univ Oregon, Dept Counseling Psychol & Human Serv, Eugene, OR 97403 USA; [Neiderhiser, Jenae M.] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA; [Shaw, Daniel S.] Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA	University of Iowa; Yale University; State University System of Florida; University of South Florida; George Washington University; University of Oregon; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Stevens, HE (corresponding author), Univ Iowa, Coll Med, Dept Psychiat, Iowa City, IA 52242 USA.	hanna-stevens@uiowa.edu	Stevens, Hanna/M-4104-2016	Stevens, Hanna/0000-0002-3906-0786	Klingenstein Third Generation Foundation; National Center for Advancing Translational Science [CTSA UL1 TR000142]; National Institute of Child Health and Human Development [R01 HD042608]; National Institute on Drug Abuse, NIH, U.S. PHS; National Institute on Drug Abuse [R01 DA020585]; National Institute of Mental Health and OBSSR, NIH, U.S. PHS; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R56HD042608] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042608] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH077823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020585] Funding Source: NIH RePORTER	Klingenstein Third Generation Foundation(Klingenstein Philanthropies); National Center for Advancing Translational Science; National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Drug Abuse, NIH, U.S. PHS; National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Mental Health and OBSSR, NIH, U.S. PHS; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This project was supported by the Klingenstein Third Generation Foundation Fellowship in ADHD (P.I.: Hanna Stevens, M.D., Ph.D), support to Hanna Stevens from CTSA UL1 TR000142 from the National Center for Advancing Translational Science, R01 HD042608 from the National Institute of Child Health and Human Development and the National Institute on Drug Abuse, NIH, U.S. PHS (PI Years 1-5: David Reiss, M.D.; PI Years 6-10: Leslie Leve, PhD) and grant R01 DA020585 from the National Institute on Drug Abuse, the National Institute of Mental Health and OBSSR, NIH, U.S. PHS (PI: Jenae Neiderhiser, Ph.D.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the Eunice Kennedy Shriver National Institute of Child Health and Human Development or the National Institutes of Health.	Alderdice F, 2012, J PSYCHOSOM OBST GYN, V33, P62, DOI 10.3109/0167482X.2012.673040; Aldwin C., 2007, STRESS COPING DEV IN; ANDREASEN NC, 1977, ARCH GEN PSYCHIAT, V34, P1229; Bale TL, 2010, BIOL PSYCHIAT, V68, P314, DOI 10.1016/j.biopsych.2010.05.028; Barker DJP, 1997, NUTRITION, V13, P807, DOI 10.1016/S0899-9007(97)00193-7; Beck A, 1993, MANUAL BECK DEPRESSI; Beck A.T., 1990, BECK SCALE SUICIDE I; Bell S, 2012, SOC SCI MED, V74, P1324, DOI 10.1016/j.socscimed.2012.01.019; BELSKY J, 1984, CHILD DEV, V55, P83, DOI 10.2307/1129836; Betts KS, 2014, DEPRESS ANXIETY, V31, P9, DOI 10.1002/da.22210; Beydoun H, 2008, PAEDIATR PERINAT EP, V22, P438, DOI 10.1111/j.1365-3016.2008.00951.x; Bolten MI, 2012, J PEDIATR-US, V161, P104, DOI 10.1016/j.jpeds.2011.12.044; Borcherding K, 2005, J FAM NURS, V11, P289, DOI 10.1177/1074840705278582; Boulet SL, 2011, MATERN CHILD HLTH J, V15, P836, DOI 10.1007/s10995-009-0538-2; BRONFENBRENNER U, 1994, PSYCHOL REV, V101, P568, DOI 10.1037/0033-295X.101.4.568; Brown SJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-196; Campbell J, 1999, AM J EPIDEMIOL, V150, P714; Campos B, 2008, CULT DIVERS ETHN MIN, V14, P155, DOI 10.1037/1099-9809.14.2.155; Caspi A, 1996, INT J METHOD PSYCH, V6, P101, DOI 10.1002/(SICI)1234-988X(199607)6:2<101::AID-MPR156>3.3.CO;2-E; Chen MJ, 2011, AM J OBSTET GYNECOL, V205, P402, DOI 10.1016/j.ajog.2011.05.003; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; Cohen J., 2003, APPL MULTIPLE REGRES; CONGER RD, 1994, CHILD DEV, V65, P541, DOI 10.1111/j.1467-8624.1994.tb00768.x; Costello EJ, 2007, ARCH GEN PSYCHIAT, V64, P338, DOI 10.1001/archpsyc.64.3.338; DOHRENWEND BS, 1978, J HEALTH SOC BEHAV, V19, P205, DOI 10.2307/2136536; Dunkel Schetter C, 2013, HLTH PSYCHOL REV, P1; Dyer JM, 2011, J IMMIGR MINOR HEALT, V13, P487, DOI 10.1007/s10903-010-9331-y; Entringer S, 2010, CURR OPIN ENDOCRINOL, V17, P507, DOI 10.1097/MED.0b013e3283405921; Entringer S, 2009, HORM BEHAV, V55, P292, DOI 10.1016/j.yhbeh.2008.11.006; Feldman PJ, 2000, PSYCHOSOM MED, V62, P715, DOI 10.1097/00006842-200009000-00016; Field T, 2011, INFANT BEHAV DEV, V34, P1, DOI 10.1016/j.infbeh.2010.09.008; Glazier RH, 2004, J PSYCHOSOM OBST GYN, V25, P247, DOI 10.1080/01674820400024406; Gofin R, 2000, PUBLIC HEALTH, V114, P161, DOI 10.1016/S0033-3506(00)00328-0; Graignic-Philippe R, 2014, NEUROSCI BIOBEHAV R, V43, P137, DOI 10.1016/j.neubiorev.2014.03.022; Grote NK, 2010, ARCH GEN PSYCHIAT, V67, P1012, DOI 10.1001/archgenpsychiatry.2010.111; Hamilton JG, 2008, J PSYCHOSOM OBST GYN, V29, P97, DOI 10.1080/01674820701690624; Harden KP, 2007, BEHAV GENET, V37, P273, DOI 10.1007/s10519-006-9113-4; Harris A, 2011, HORM BEHAV, V59, P279, DOI 10.1016/j.yhbeh.2010.06.007; Hayes AF, 2009, BEHAV RES METHODS, V41, P924, DOI 10.3758/BRM.41.3.924; Hobel CJ, 2008, CLIN OBSTET GYNECOL, V51, P333, DOI 10.1097/GRF.0b013e31816f2709; Kendler KS, 2007, PSYCHOL MED, V37, P615, DOI 10.1017/S0033291706009524; Kendler KS, 2008, ARCH GEN PSYCHIAT; Kenny LC, 2014, RES PERSPECT END INT, V12, P41, DOI 10.1007/978-3-319-02591-9_4; Khashan AS, 2008, ARCH GEN PSYCHIAT, V65, P146, DOI 10.1001/archgenpsychiatry.2007.20; King S, 2012, BIRTH DEFECTS RES C, V96, P273, DOI 10.1002/bdrc.21026; Lazarus R.S., 1984, EMOTION ADAPTATION; Lazarus RS., 2006, STRESS EMOTION NEW S; Lazinski M, 2008, ARCH WOMEN MENT HLTH, V11, P363, DOI 10.1007/s00737-008-0035-4; LeCuyer-Maus EA, 2003, PUBLIC HEALTH NURS, V20, P132, DOI 10.1046/j.1525-1446.2003.20207.x; Leve LD, 2007, TWIN RES HUM GENET, V10, P84, DOI 10.1375/twin.10.1.84; Leve LD, 2013, TWIN RES HUM GENET, V16, P412, DOI 10.1017/thg.2012.126; Levy-Shiff R, 1998, DEV PSYCHOL, V34, P1417, DOI 10.1037/0012-1649.34.6.1417; Lobel M, 2000, HEALTH PSYCHOL, V19, P544, DOI 10.1037/0278-6133.19.6.544; LOBEL M, 1994, J BEHAV MED, V17, P225, DOI 10.1007/BF01857952; LOBEL M, 1992, HEALTH PSYCHOL, V11, P32, DOI 10.1037/0278-6133.11.1.32; Lucassen PJ, 2013, TRENDS NEUROSCI, V36, P621, DOI 10.1016/j.tins.2013.08.002; Marceau K, 2013, INT J BEHAV DEV, V37, P366, DOI 10.1177/0165025413489378; McFarlane J, 1996, NURS RES, V45, P37, DOI 10.1097/00006199-199601000-00007; McKelvey LM, 2002, INFANT MENT HEALTH J, V23, P164, DOI 10.1002/imhj.10010; Messer B., 1986, MANUAL ADULT SELF PE; Monk C, 2013, J CHILD PSYCHOL PSYC, V54, P115, DOI 10.1111/jcpp.12000; Nast I, 2013, PEDIAT PERINATAL EPI; Nylen KJ, 2012, J BEHAV MED; Pettersson E, 2014, J CHILD PSYCHOL PSYC; Pluess M, 2010, BIOL PSYCHOL, V83, P169, DOI 10.1016/j.biopsycho.2009.12.005; Raphael-Left J, 2005, PSYCHOL PROCESSES CH; Rice F, 2010, PSYCHOL MED, V40, P335, DOI 10.1017/S0033291709005911; Rini CK, 1999, HEALTH PSYCHOL, V18, P333, DOI 10.1037/0278-6133.18.4.333; Rogers E, 2009, NEOREVIEWS, V3, P100; Roy-Matton N, 2011, OBSTET GYNECOL SURV, V66, P475, DOI 10.1097/OGX.0b013e31822954c0; Schetter CD, 2011, ANNU REV PSYCHOL, V62, P531, DOI 10.1146/annurev.psych.031809.130727; Schofield TJ, 2012, MERRILL PALMER QUART, V58, P255, DOI 10.1353/mpq.2012.0008; Swickert RJ, 2010, PERS INDIV DIFFER, V48, P736, DOI 10.1016/j.paid.2010.01.018; Thapar A, 2009, BRIT J PSYCHIAT, V195, P100, DOI 10.1192/bjp.bp.109.062828; Valladares E, 2002, OBSTET GYNECOL, V100, P700, DOI 10.1016/S0029-7844(02)02093-8; van den Oord EJCG, 2003, J CHILD PSYCHOL PSYC, V44, P180; Wadhwa PD, 2005, PSYCHONEUROENDOCRINO, V30, P724, DOI 10.1016/j.psyneuen.2005.02.004; Wainstock T, 2013, J MATERN-FETAL NEO M, P1; Weinstock M, 2008, NEUROSCI BIOBEHAV R, V32, P1073, DOI 10.1016/j.neubiorev.2008.03.002; Yali AM, 1999, J PSYCHOSOM OBST GYN, V20, P39, DOI 10.3109/01674829909075575; Zhu P, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.02.023	81	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141881	10.1371/journal.pone.0141881	http://dx.doi.org/10.1371/journal.pone.0141881			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV6RT	26544958	Green Published, gold, Green Accepted			2022-12-27	WOS:000364398700058
J	Brown, TA; Tkachuk, AN; Clayton, DA				Brown, Timothy A.; Tkachuk, Ariana N.; Clayton, David A.			Mitochondrial Transcription Factor A (TFAM) Binds to RNA Containing 4-Way Junctions and Mitochondrial tRNA	PLOS ONE			English	Article							DNA COPY NUMBER; MOBILITY GROUP BOX; PROTEIN; POLYMERASE; INNATE; IDENTIFICATION; REPLICATION; NUCLEOIDS; DEGRADATION; BIOGENESIS	Mitochondrial DNA (mtDNA) is maintained within nucleoprotein complexes known as nucleoids. These structures are highly condensed by the DNA packaging protein, mitochondrial Transcription Factor A (TFAM). Nucleoids also include RNA, RNA: DNA hybrids, and are associated with proteins involved with RNA processing and mitochondrial ribosome biogenesis. Here we characterize the ability of TFAM to bind various RNA containing substrates in order to determine their role in TFAM distribution and function within the nucleoid. We find that TFAM binds to RNA-containing 4-way junctions but does not bind appreciably to RNA hairpins, internal loops, or linear RNA: DNA hybrids. Therefore the RNA within nucleoids largely excludes TFAM, and its distribution is not grossly altered with removal of RNA. Within the cell, TFAM binds to mitochondrial tRNAs, consistent with our RNA 4-way junction data. Kinetic binding assays and RNase-insensitive TFAM distribution indicate that DNA remains the preferred substrate within the nucleoid. However, TFAM binds to tRNA with nanomolar affinity and these complexes are not rare. TFAM-immunoprecipitated tRNAs have processed ends, suggesting that binding is not specific to RNA precursors. The amount of each immunoprecipitated tRNA is not well correlated with tRNA celluar abundance, indicating unequal TFAM binding preferences. TFAM-mt-tRNA interaction suggests potentially new functions for this protein.	[Brown, Timothy A.; Tkachuk, Ariana N.; Clayton, David A.] Howard Hughes Med Inst, Ashburn, VA 20147 USA	Howard Hughes Medical Institute	Brown, TA (corresponding author), Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA.	brownt@janelia.hhmi.org		Tkachuk, Ariana/0000-0001-8991-9643; Brown, Timothy/0000-0001-8941-7678	Howard Hughes Medical Institute; Janelia Research Campus	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Janelia Research Campus	This work was funded entirely by the Howard Hughes Medical Institute through full and direct support of the Janelia Research Campus (www.janelia.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonicka H, 2013, CELL METAB, V17, P386, DOI 10.1016/j.cmet.2013.02.006; Arnoult D, 2011, EMBO REP, V12, P901, DOI 10.1038/embor.2011.157; Balandina A, 2002, J BIOL CHEM, V277, P27622, DOI 10.1074/jbc.M201978200; Bell AJ, 2008, BIOCHEM BIOPH RES CO, V377, P262, DOI 10.1016/j.bbrc.2008.09.131; Bianchi ME, 2007, IMMUNOL REV, V220, P35, DOI 10.1111/j.1600-065X.2007.00574.x; Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200; Bogenhagen DF, 2014, CELL METAB, V19, P618, DOI 10.1016/j.cmet.2014.03.013; BONNEFOY E, 1994, J MOL BIOL, V242, P116, DOI 10.1006/jmbi.1994.1563; Brown A, 2014, SCIENCE, V346, P718, DOI 10.1126/science.1258026; Brown TA, 2002, NUCLEIC ACIDS RES, V30, P2004, DOI 10.1093/nar/30.9.2004; Brown TA, 2011, MOL CELL BIOL, V31, P4994, DOI 10.1128/MCB.05694-11; Brown TA, 2008, J BIOL CHEM, V283, P36743, DOI 10.1074/jbc.M806174200; Brzezniak LK, 2011, RNA BIOL, V8, P616, DOI 10.4161/rna.8.4.15393; Cotney J, 2007, NUCLEIC ACIDS RES, V35, P4042, DOI 10.1093/nar/gkm424; Damas J, 2012, NUCLEIC ACIDS RES, V40, P7606, DOI 10.1093/nar/gks500; Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909; Farge G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2001; Fender A, 2012, BIOCHIMIE, V94, P1090, DOI 10.1016/j.biochi.2012.02.030; Fernandez-Vizarra E, 2002, METHODS, V26, P292, DOI 10.1016/S1046-2023(02)00034-8; FISHER RP, 1988, MOL CELL BIOL, V8, P3496, DOI 10.1128/MCB.8.8.3496; FISHER RP, 1989, GENE DEV, V3, P2202, DOI 10.1101/gad.3.12b.2202; Gangelhoff TA, 2009, NUCLEIC ACIDS RES, V37, P3153, DOI 10.1093/nar/gkp157; Gilbert SL, 2000, J BIOL CHEM, V275, P36491, DOI 10.1074/jbc.C000409200; He J, 2012, NUCLEIC ACIDS RES, V40, P6109, DOI 10.1093/nar/gks266; He J, 2012, NUCLEIC ACIDS RES, V40, P6097, DOI 10.1093/nar/gks257; Holzmann J, 2008, CELL, V135, P462, DOI 10.1016/j.cell.2008.09.013; Hue THD, 2014, EMBO MOL MED, V6, P183, DOI 10.1002/emmm.201303202; Hunter SE, 2004, MITOCHONDRION, V4, P21, DOI 10.1016/j.mito.2004.04.003; Iborra FJ, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-9; Jourdain AA, 2013, CELL METAB, V17, P399, DOI 10.1016/j.cmet.2013.02.005; Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404; KING MP, 1993, J BIOL CHEM, V268, P10228; Kolesar JE, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1324; Kukat C, 2011, P NATL ACAD SCI USA, V108, P13534, DOI 10.1073/pnas.1109263108; Lee KW, 2013, J BIOL CHEM, V288, P31386, DOI 10.1074/jbc.M113.515692; Lu B, 2013, MOL CELL, V49, P121, DOI 10.1016/j.molcel.2012.10.023; Malarkey CS, 2012, TRENDS BIOCHEM SCI, V37, P553, DOI 10.1016/j.tibs.2012.09.003; Malarkey CS, 2012, NUCLEIC ACIDS RES, V40, P614, DOI 10.1093/nar/gkr787; Markov DA, 2009, YEAST, V26, P423, DOI 10.1002/yea.1672; Matsushima Y, 2010, P NATL ACAD SCI USA, V107, P18410, DOI 10.1073/pnas.1008924107; Mei YD, 2010, MOL CELL, V37, P668, DOI 10.1016/j.molcel.2010.01.023; Nagaike T, 2001, J BIOL CHEM, V276, P40041, DOI 10.1074/jbc.M106202200; Ngo Huu B, 2014, Nat Commun, V5, P3077, DOI 10.1038/ncomms4077; Ohno T, 2000, BIOCHEM BIOPH RES CO, V271, P492, DOI 10.1006/bbrc.2000.2656; OJALA D, 1980, CELL, V22, P393, DOI 10.1016/0092-8674(80)90350-5; Ozawa T, 2007, NAT METHODS, V4, P413, DOI 10.1038/NMETH1030; Perli E, 2014, EMBO MOL MED, V6, P169, DOI 10.1002/emmm.201303198; Pohjoismaki JLO, 2006, NUCLEIC ACIDS RES, V34, P5815, DOI 10.1093/nar/gkl703; Pohjoismaki JLO, 2010, J MOL BIOL, V397, P1144, DOI 10.1016/j.jmb.2010.02.029; Rodeheffer MS, 2003, J BIOL CHEM, V278, P18695, DOI 10.1074/jbc.M301399200; Rorbach J, 2008, NUCLEIC ACIDS RES, V36, P5787, DOI 10.1093/nar/gkn576; Shi YH, 2012, P NATL ACAD SCI USA, V109, P16510, DOI 10.1073/pnas.1119738109; Surovtseva YV, 2013, NUCLEIC ACIDS RES, V41, P2479, DOI 10.1093/nar/gks1447; Surovtseva YV, 2011, P NATL ACAD SCI USA, V108, P17921, DOI 10.1073/pnas.1108852108; Suzuki T, 2007, METHOD ENZYMOL, V425, P231, DOI 10.1016/S0076-6879(07)25010-4; Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258; WANG Y, 2013, PLOS ONE, V2013; Wang YS, 2006, J BIOL CHEM, V281, P25791, DOI 10.1074/jbc.M604501200; West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156; Yanai H, 2011, J INTERN MED, V270, P301, DOI 10.1111/j.1365-2796.2011.02433.x; Ylikallio E, 2010, HUM MOL GENET, V19, P2695, DOI 10.1093/hmg/ddq163	61	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142436	10.1371/journal.pone.0142436	http://dx.doi.org/10.1371/journal.pone.0142436			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26545237	Green Submitted, Green Published, gold			2022-12-27	WOS:000364398700140
J	Fu, J; Sharma, P; Spicer, V; Krokhin, OV; Zhang, XL; Fristensky, B; Cicek, N; Sparling, R; Levin, DB				Fu, Jilagamazhi; Sharma, Parveen; Spicer, Vic; Krokhin, Oleg V.; Zhang, Xiangli; Fristensky, Brian; Cicek, Nazim; Sparling, Richard; Levin, David. B.			Quantitative 'Omics Analyses of Medium Chain Length Polyhydroxyalkanaote Metabolism in Pseudomonas putida LS46 Cultured with Waste Glycerol and Waste Fatty Acids	PLOS ONE			English	Article							ENHANCED PRODUCTION; TREHALOSE SYNTHASE; ESCHERICHIA-COLI; BIOSYNTHESIS; AERUGINOSA; EXPRESSION; GENOME; KT2440; GROWTH; POLY(3-HYDROXYBUTYRATE-CO-3-HYDROXYHEXANOATE)	Transcriptomes and proteomes of Pseudomonas putida LS46 cultured with biodiesel-derived waste glycerol or waste free fatty acids, as sole carbon sources, were compared under conditions that were either permissive or non-permissive for synthesis of medium chain length polyhydroxyalkanoates (mcl-PHA). The objectives of this study were to elucidate mechanisms that influence activation of biopolymer synthesis, intra-cellular accumulation, and monomer composition, and determine if these were physiologically specific to the carbon sources used for growth of P. putida LS46. Active mcl-PHA synthesis by P. putida LS46 was associated with high expression levels of key mcl-PHA biosynthesis genes and/or gene products including monomer-supplying proteins, PHA synthases, and granule-associated proteins. 'Omics data suggested that expression of these genes were regulated by different genetic mechanisms in P. putida LS46 cells in different physiological states, when cultured on the two waste carbon sources. Optimal polymer production by P. putida LS46 was primarily limited by less efficient glycerol metabolism during mcl-PHA synthesis on waste glycerol. Mapping the 'Omics data to the mcl-PHA biosynthetic pathway revealed significant variations in gene expression, primarily involved in: 1) glycerol transportation; 2) enzymatic reactions that recycle reducing equivalents and produce key mcl-PHA biosynthesis pathway intermediates (e.g. NADH/NADPH, acetyl-CoA). Active synthesis of mcl-PHAs was observed during exponential phase in cultures with waste free fatty acids, and was associated with the fatty acid beta-oxidation pathway. A putative Thioesterase in the beta-oxidation pathway that may regulate the level of fatty acid beta-oxidation intermediates, and thus carbon flux to mcl-PHA biosynthesis, was highly up-regulated. Finally, the data suggested that differences in expression of selected fatty acid metabolism and mcl-PHA monomer-supplying enzymes may play a role in determining the monomer composition of mcl-PHA polymers. Understanding the relationships between genome content, gene and gene product expression, and how these factors influence polymer synthesis, will aid in optimization of mcl-PHA production by P. putida LS46 using biodiesel waste streams.	[Fu, Jilagamazhi; Sharma, Parveen; Cicek, Nazim; Levin, David. B.] Univ Manitoba, Dept Biosyst Engn, Winnipeg, MB, Canada; [Spicer, Vic; Krokhin, Oleg V.] Univ Manitoba, Dept Internal Med, Winnipeg, MB, Canada; [Spicer, Vic; Krokhin, Oleg V.] Univ Manitoba, Manitoba Ctr Prote & Syst Biol, Winnipeg, MB, Canada; [Zhang, Xiangli; Fristensky, Brian] Univ Manitoba, Dept Plant Sci, Winnipeg, MB R3T 2N2, Canada; [Sparling, Richard] Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2N2, Canada	University of Manitoba; University of Manitoba; University of Manitoba; University of Manitoba; University of Manitoba	Levin, DB (corresponding author), Univ Manitoba, Dept Biosyst Engn, Winnipeg, MB, Canada.	david.levin@umanitoba.ca		Cicek, Nazim/0000-0002-3929-2536; Fristensky, Brian/0000-0002-1554-3492	Genome Canada, through the Applied Genomics Research in Bioproducts or Crops (ABC) program; government of the Province of Manitoba through the Manitoba Research Innovation Fund (MRIF); Manitoba Rural Adaptation Council (MRAC)	Genome Canada, through the Applied Genomics Research in Bioproducts or Crops (ABC) program; government of the Province of Manitoba through the Manitoba Research Innovation Fund (MRIF); Manitoba Rural Adaptation Council (MRAC)	This work was funded by Genome Canada, through the Applied Genomics Research in Bioproducts or Crops (ABC) program for the grant titled, "Microbial Genomics for Biofuels and Co-Products from Biorefining Processes", and by the government of the Province of Manitoba through the Manitoba Research Innovation Fund (MRIF) and the Manitoba Rural Adaptation Council (MRAC).	Akaraonye E, 2010, J CHEM TECHNOL BIOT, V85, P732, DOI 10.1002/jctb.2392; Borrero-de Acuna JM, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-88; Cavalheiro JMBT, 2009, PROCESS BIOCHEM, V44, P509, DOI 10.1016/j.procbio.2009.01.008; Cerrate S, 2006, INT J POULT SCI, V11, P1001, DOI [10.3923/ijps.2006.1001.1007, DOI 10.3923/IJPS.2006.1001.1007]; Deziel E, 2003, MICROBIOL-SGM, V149, P2005, DOI 10.1099/mic.0.26154-0; Escapa IF, 2013, ENVIRON MICROBIOL, V15, P93, DOI 10.1111/j.1462-2920.2012.02790.x; Escapa IF, 2012, ENVIRON MICROBIOL, V14, P1049, DOI 10.1111/j.1462-2920.2011.02684.x; Follonier S, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-25; Freeman BC, 2010, ENVIRON MICROBIOL, V12, P1486, DOI 10.1111/j.1462-2920.2010.02171.x; Fu J, 2014, CAN J MICROBIOL, V60, P461, DOI 10.1139/cjm-2014-0108; Fukui T, 1998, J BACTERIOL, V180, P667, DOI 10.1128/JB.180.3.667-673.1998; Galan B, 2011, MOL MICROBIOL, V79, P402, DOI 10.1111/j.1365-2958.2010.07450.x; Gungormusler-Yilmaz M, 2014, AMB EXPRESS, V4, DOI 10.1186/s13568-014-0063-6; Guzik MW, 2014, MICROBIOL-SGM, V160, P1760, DOI 10.1099/mic.0.078758-0; Hoang TT, 1997, J BACTERIOL, V179, P5326, DOI 10.1128/jb.179.17.5326-5332.1997; Hoffmann N, 2004, FEMS MICROBIOL LETT, V237, P1, DOI 10.1111/j.1574-6968.2004.tb09671.x; Hunt MC, 2002, PROG LIPID RES, V41, P99, DOI 10.1016/S0163-7827(01)00017-0; de Eugenio LI, 2010, ENVIRON MICROBIOL, V12, P207, DOI [10.1111/j.1462-2920.2009.02061.x, 10.1111/j.1462-2920.2010.02199.x]; Javidpour P, 2014, APPL ENVIRON MICROB, V80, P497, DOI 10.1128/AEM.03194-13; Joyce AR, 2006, NAT REV MOL CELL BIO, V7, P198, DOI 10.1038/nrm1857; Kang Y, 2008, MICROBIOL-SGM, V154, P1584, DOI 10.1099/mic.0.2008/018135-0; Karine L, 2008, MOL MICROBIOL, V67, P241; Kenny ST, 2012, APPL MICROBIOL BIOT, V95, P623, DOI 10.1007/s00253-012-4058-4; Kim J, 2013, ENV MICROBIOL REP, V5, P883, DOI 10.1111/1758-2229.12090; Kimber MS, 2004, J BIOL CHEM, V279, P52593, DOI 10.1074/jbc.M408105200; Koller M, 2005, BIOMACROMOLECULES, V6, P561, DOI 10.1021/bm049478b; La Rosa R, 2014, ENVIRON MICROBIOL, V16, P278, DOI 10.1111/1462-2920.12303; Lee IY, 1996, BIOTECHNOL BIOENG, V52, P707, DOI 10.1002/(SICI)1097-0290(19961220)52:6<707::AID-BIT8>3.0.CO;2-S; LEE IY, 1995, FEMS MICROBIOL LETT, V131, P35, DOI 10.1111/j.1574-6968.1995.tb07750.x; Li C, 2013, ENERGIES, V6, P4739, DOI 10.3390/en6094739; Lu XY, 2003, FEMS MICROBIOL LETT, V221, P97, DOI 10.1016/S0378-1097(03)00173-3; Ma Y, 2006, J FOOD ENG, V77, P342, DOI 10.1016/j.jfoodeng.2005.06.042; MALOY SR, 1980, J BACTERIOL, V143, P720, DOI 10.1128/JB.143.2.720-725.1980; McMahon B, 2007, FEMS MICROBIOL LETT, V273, P50, DOI 10.1111/j.1574-6968.2007.00780.x; Nelson KE, 2002, ENVIRON MICROBIOL, V4, P799, DOI 10.1046/j.1462-2920.2002.00366.x; Nikel PI, 2014, ENVIRON MICROBIOL, V16, P239, DOI 10.1111/1462-2920.12224; Poblete-Castro I, 2013, METAB ENG, V15, P113, DOI 10.1016/j.ymben.2012.10.004; Poblete-Castro I, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-34; Qiu YZ, 2005, BIOTECHNOL LETT, V27, P1381, DOI 10.1007/s10529-005-3685-6; Regine HA, 1991, J BACTERIOL, V173, P7918; Rehm BHA, 2001, APPL ENVIRON MICROB, V67, P3102, DOI 10.1128/AEM.67.7.3102-3109.2001; Ren Q, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-254; Ren Q, 2009, BIOMACROMOLECULES, V10, P916, DOI 10.1021/bm801431c; Roca A, 2013, ENVIRON MICROBIOL, V15, P780, DOI 10.1111/1462-2920.12037; Ryan WJ, 2013, APPL ENVIRON MICROB, V79, P1795, DOI 10.1128/AEM.02962-12; Sabirova JS, 2006, J BACTERIOL, V188, P8452, DOI 10.1128/JB.01321-06; Sato S, 2011, APPL MICROBIOL BIOT, V90, P951, DOI 10.1007/s00253-011-3150-5; Schweizer HP, 1997, MICROBIOL-SGM, V143, P1287, DOI 10.1099/00221287-143-4-1287; Sharma PK, 2012, CAN J MICROBIOL, V58, P982, DOI [10.1139/w2012-074, 10.1139/W2012-074]; Simon O, 2014, J PROTEOMICS, V109, P212, DOI 10.1016/j.jprot.2014.07.006; Singh R, 2007, J BACTERIOL, V189, P6665, DOI 10.1128/JB.00555-07; SPENCER AK, 1978, J BIOL CHEM, V253, P5922; Su J, 2014, BIOTECHNOL LETT, V36, P1009, DOI 10.1007/s10529-013-1450-9; Sun ZY, 2007, APPL MICROBIOL BIOT, V74, P69, DOI 10.1007/s00253-006-0655-4; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Trotschel C, 2013, MICROB BIOTECHNOL, V6, P708, DOI 10.1111/1751-7915.12035; Tuleva BK, 2002, Z NATURFORSCH C, V57, P356; Verbeke TJ, 2014, APPL ENVIRON MICROB, V80, P1602, DOI 10.1128/AEM.03555-13; Verhoef S, 2014, NEW BIOTECHNOL, V31, P114, DOI 10.1016/j.nbt.2013.08.006; Wang P, 2015, SCI REP-UK, V5, DOI 10.1038/srep09150; Wang Q, 2012, APPL ENVIRON MICROB, V78, P519, DOI 10.1128/AEM.07020-11; Wang TF, 2014, CAN J MICROBIOL, V60, P599, DOI 10.1139/cjm-2014-0330; Yang FX, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-13	63	17	17	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142322	10.1371/journal.pone.0142322	http://dx.doi.org/10.1371/journal.pone.0142322			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544181	Green Published, Green Submitted, gold			2022-12-27	WOS:000364398700110
J	Gu, QY; Zhang, J; Hu, HF; Tan, YE; Shi, SM; Nian, YY				Gu, Qiaoyan; Zhang, Jun; Hu, Haifeng; Tan, Yu-e; Shi, Shengmei; Nian, Yuanyuan			Clinical Significance of MiR-137 Expression in Patients with Gastric Cancer After Radical Gastrectomy	PLOS ONE			English	Article							PROMOTER; PATHOGENESIS; MIRNAS	The dysregulation of miR-137 plays vital roles in the oncogenesis and progression of various types of cancer, but its role in prognosis of gastric cancer patients remains unknown. This study was designed to investigate the expression and prognostic significance of miR-137 in gastric cancer patients after radical gastrectomy. Quantitative real-time PCR (qRT-PCR) was performed to evaluate the expression of miR-137 in human gastric cancer cell lines and tissues in patients with gastric adenocarcinoma. Results were assessed for association with clinical factors and overall survival by using Kaplan-Meier analysis. Prognostic values of miR-137 expression and clinical outcomes were evaluated by Cox regression analysis. The results exhibited that the expression level of miR-137 was decreased in human gastric cancer cell lines and tissues, and down-regulated expression of miR-137 was associated with tumor cell differentiation, N stage, and TNM stage. Decreased miR-137 expression in gastric cancer tissues was positively correlated with poor overall survival of gastric cancer patients. Further multivariate Cox regression analysis suggested that miR-137 expression was an independent prognostic indicator for gastric cancer except for TNM stage. Applying the prognostic value of miR-137 expression to TNM stage III group showed a better risk stratification for overall survival. In conclusion, the results reinforced the critical role for the down-regulated miR-137 expression in gastric cancer and suggested that miR-137 expression could be a prognostic indicator for this disease. In addition, these patients with TNM stage III gastric cancer and low miR-137 expression might need more aggressive postoperative treatment and closer follow-up.	[Gu, Qiaoyan; Zhang, Jun; Nian, Yuanyuan] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Gastroenterol, Xian 710049, Peoples R China; [Gu, Qiaoyan; Hu, Haifeng; Tan, Yu-e; Shi, Shengmei] Yanan Univ, Affiliated Hosp, Dept Gastroenterol, Yanan, Peoples R China	Xi'an Jiaotong University; Yanan University	Zhang, J (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Gastroenterol, Xian 710049, Peoples R China.	zhangjun_2016@sina.com						Chakrabarti M, 2015, GENE, V573, P141, DOI 10.1016/j.gene.2015.07.034; Chen DL, 2013, CARCINOGENESIS, V34, P803, DOI 10.1093/carcin/bgs400; Chen WQ, 2014, CHIN J CANCER, V33, P402, DOI 10.5732/cjc.014.10084; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Figueiredo C, 2013, HELICOBACTER, V18, P28, DOI 10.1111/hel.12083; Guo JL, 2013, BIOCHEM BIOPH RES CO, V441, P357, DOI 10.1016/j.bbrc.2013.10.052; Kang N, 2015, LUNG CANCER, V89, P99, DOI 10.1016/j.lungcan.2015.05.011; Langevin SM, 2010, CARCINOGENESIS, V31, P864, DOI 10.1093/carcin/bgq051; Liu M, 2011, INT J CANCER, V128, P1269, DOI 10.1002/ijc.25452; Liu S, 2014, TUMOR BIOL, V35, P9131, DOI 10.1007/s13277-014-2177-5; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Stadtlander CTKH, 1999, CARCINOGENESIS, V20, P2195, DOI 10.1093/carcin/20.12.2195; Stanitz E, 2013, ANTICANCER RES, V33, P3195; Steponaitiene R, 2016, MOL CARCINOGEN, V55, P376, DOI 10.1002/mc.22287; Thrumurthy SG, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6367; Washington K, 2010, ANN SURG ONCOL, V17, P3077, DOI 10.1245/s10434-010-1362-z; Wu LP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130124; Yang L, 2006, WORLD J GASTROENTERO, V12, P17, DOI 10.3748/wjg.v12.i1.17; Yang YJ, 2015, CLIN CANCER RES, V21, P2399, DOI 10.1158/1078-0432.CCR-14-1437; Yao Y, 2009, MOL MED REP, V2, P963, DOI 10.3892/mmr_00000199; Zhao YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039102; Zheng XS, 2015, J CANCER RES CLIN, V141, P785, DOI 10.1007/s00432-014-1847-4	23	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142377	10.1371/journal.pone.0142377	http://dx.doi.org/10.1371/journal.pone.0142377			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26545111	Green Submitted, Green Published, gold			2022-12-27	WOS:000364398700123
J	Lopez-Rull, I; Hornero-Mendez, D; Frias, O; Blanco, G				Lopez-Rull, Isabel; Hornero-Mendez, Damaso; Frias, Oscar; Blanco, Guillermo			Age-Related Relationships between Innate Immunity and Plasma Carotenoids in an Obligate Avian Scavenger	PLOS ONE			English	Article							VULTURES GYPS-FULVUS; COLONIAL GRIFFON VULTURES; LIFE-HISTORY; TRADE-OFFS; ACQUIRED-IMMUNITY; SEXUAL SIGNALS; TREE SWALLOWS; BIRDS; NESTLINGS; DEFENSE	Variation in immunity is influenced by allocation trade-offs that are expected to change between age-classes as a result of the different environmental and physiological conditions that individuals encounter over their lifetime. One such trade-off occurs with carotenoids, which must be acquired with food and are involved in a variety of physiological functions. Nonetheless, relationships between immunity and carotenoids in species where these micronutrients are scarce due to diet are poorly studied. Among birds, vultures show the lowest concentrations of plasma carotenoids due to a diet based on carrion. Here, we investigated variations in the relationships between innate immunity (hemagglutination by natural antibodies and hemolysis by complement proteins), pathogen infection and plasma carotenoids in nestling and adult griffon vultures (Gyps fulvus) in the wild. Nestlings showed lower hemolysis, higher total carotenoid concentration and higher pathogen infection than adults. Hemolysis was negatively related to carotenoid concentration only in nestlings. A differential carotenoid allocation to immunity due to the incomplete development of the immune system of nestlings compared with adults is suggested linked to, or regardless of, potential differences in parasite infection, which requires experimental testing. We also found that individuals with more severe pathogen infections showed lower hemagglutination than those with a lower intensity infection irrespective of their age and carotenoid level. These results are consistent with the idea that intraspecific relationships between innate immunity and carotenoids may change across ontogeny, even in species lacking carotenoid-based coloration. Thus, even low concentrations of plasma carotenoids due to a scavenger diet can be essential to the development and activation of the immune system in growing birds.	[Lopez-Rull, Isabel; Frias, Oscar; Blanco, Guillermo] CSIC, Museo Nacl Ciencias Nat, Dept Ecol Evolut, E-28006 Madrid, Spain; [Hornero-Mendez, Damaso] CSIC, Inst Grasa, Dept Biotecnol Alimentos, E-41080 Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de la Grasa (IG)	Lopez-Rull, I (corresponding author), CSIC, Museo Nacl Ciencias Nat, Dept Ecol Evolut, E-28006 Madrid, Spain.	isalorull@gmail.com	Blanco, Guillermo/L-3170-2014; Hornero-Mendez, Damaso/H-2507-2012; Lopez-Rull, Isabel/AAB-1097-2019	Blanco, Guillermo/0000-0001-5742-4929; Hornero-Mendez, Damaso/0000-0002-1781-5703; Lopez-Rull, Isabel/0000-0002-3255-0459	Spanish Ministerio of Economia y Competitividad [CGL2009-12753-C02-01/BOS, CGL2010-15726]; CYTED [112RT0445]	Spanish Ministerio of Economia y Competitividad(Spanish Government); CYTED	Funds were provided by the projects CGL2009-12753-C02-01/BOS and CGL2010-15726 of Spanish Ministerio of Economia y Competitividad. DHM is member of the IBERCAROT Network, funded by CYTED (ref. 112RT0445).	Aguilera E, 2007, NATURWISSENSCHAFTEN, V94, P895, DOI 10.1007/s00114-007-0268-5; Alonso-Alvarez C, 2004, AM NAT, V164, P651, DOI 10.1086/424971; [Anonymous], 1993, LOS BUITRES IBERICOS; Apanius V, 1998, AVIAN GROWTH DEV EVO, V8, P203; Baeta R, 2008, P ROY SOC B-BIOL SCI, V275, P427, DOI 10.1098/rspb.2007.1383; Biard C, 2009, J EXP BIOL, V212, P1336, DOI 10.1242/jeb.028449; Biard C, 2006, J EXP BIOL, V209, P1004, DOI 10.1242/jeb.02089; Blanco G, 1997, IBIS, V139, P180, DOI 10.1111/j.1474-919X.1997.tb04522.x; Blanco G, 2005, P ROY SOC B-BIOL SCI, V272, P1893, DOI 10.1098/rspb.2005.3157; Blanco G, 1996, AUK, V113, P247, DOI 10.2307/4088957; Blanco G, 2006, BIOL J LINN SOC, V88, P383, DOI 10.1111/j.1095-8312.2006.00625.x; Blanco G, 2014, POPUL ECOL, V56, P593, DOI 10.1007/s10144-014-0445-2; Blanco G, 2014, POPUL ECOL, V56, P203, DOI 10.1007/s10144-013-0404-3; Blanco G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065562; Blount JD, 2003, OIKOS, V102, P340, DOI 10.1034/j.1600-0706.2003.12413.x; Blount JD, 2003, SCIENCE, V300, P125, DOI 10.1126/science.1082142; Bonneaud C, 2003, AM NAT, V161, P367, DOI 10.1086/346134; Bortolotti GR, 2002, J ANIM ECOL, V71, P333, DOI 10.1046/j.1365-2656.2002.00602.x; Butler MW, 2012, FUNCT ECOL, V26, P406, DOI 10.1111/j.1365-2435.2011.01942.x; Chew BP, 2009, CAROTENOIDS SER, V5, P363, DOI 10.1007/978-3-7643-7501-0_17; Chew BP, 2004, J NUTR, V134, p257S, DOI 10.1093/jn/134.1.257S; Cucco M, 2006, BEHAV PROCESS, V73, P325, DOI 10.1016/j.beproc.2006.08.002; De Coster G, 2010, J EXP BIOL, V213, P3012, DOI 10.1242/jeb.042721; DONAZAR JA, 1989, ARDEA, V77, P217; Elosegui I., 1989, ACTA BIOL MONTANA, V3; Fellah JS, 2008, AVIAN IMMUNOLOGY, P51, DOI 10.1016/B978-012370634-8.50006-8; Fenoglio S, 2002, ETHOL ECOL EVOL, V14, P149; Fitze PS, 2007, AM NAT, V169, pS137, DOI 10.1086/510094; Friend M., 1999, FIELD MANUAL WILDLIF; Goodwin TW, 1984, BIOCH CAROTENOIDS, VII; Hill GE, 2012, AM NAT, V180, pE127, DOI 10.1086/667861; Killpack TL, 2013, J AVIAN BIOL, V44, P513, DOI 10.1111/j.1600-048X.2013.00239.x; Killpack TL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047294; Klasing Kirk C., 2004, Acta Zoologica Sinica, V50, P961; Koutsos EA, 2003, COMP BIOCHEM PHYS A, V135, P635, DOI 10.1016/S1095-6433(03)00158-2; Leclaire S, 2015, BEHAV ECOL SOCIOBIOL; Lee KA, 2008, J ANIM ECOL, V77, P356, DOI 10.1111/j.1365-2656.2007.01347.x; Lee KA, 2006, INTEGR COMP BIOL, V46, P1000, DOI 10.1093/icb/icl049; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Lopez-Rull I, 2015, NESTS, EGGS, AND INCUBATION: NEW IDEAS ABOUT AVIAN REPRODUCTION, P82; LOZANO GA, 1994, OIKOS, V70, P309, DOI 10.2307/3545643; Lucas A, 2014, J EXP BIOL, V217, P1253, DOI 10.1242/jeb.098004; Martinez F, 1997, J FIELD ORNITHOL, V68, P392; Martinez F, 1998, ORNIS FENNICA, V75, P145; Matson KD, 2005, DEV COMP IMMUNOL, V29, P275, DOI 10.1016/j.dci.2004.07.006; Mauck RA, 2005, FUNCT ECOL, V19, P1001, DOI 10.1111/j.1365-2435.2005.01060.x; McGraw KJ, 2011, BIOL J LINN SOC, V102, P560, DOI 10.1111/j.1095-8312.2010.01594.x; McGraw KJ, 2003, AM NAT, V162, P704, DOI 10.1086/378904; MINGUEZMOSQUERA MI, 1993, J AGR FOOD CHEM, V41, P1616, DOI 10.1021/jf00034a018; Negro JJ, 2002, NATURE, V416, P807, DOI 10.1038/416807a; Norris K, 2000, BEHAV ECOL, V11, P19, DOI 10.1093/beheco/11.1.19; Noziere P, 2006, ANIM FEED SCI TECH, V131, P418, DOI 10.1016/j.anifeedsci.2006.06.018; Ochsenbein AF, 2000, IMMUNOL TODAY, V21, P624, DOI 10.1016/S0167-5699(00)01754-0; Olson VA, 1998, TRENDS ECOL EVOL, V13, P510, DOI 10.1016/S0169-5347(98)01484-0; Palacios MG, 2009, DEV COMP IMMUNOL, V33, P456, DOI 10.1016/j.dci.2008.09.006; Parejo D, 2007, J AVIAN BIOL, V38, P717, DOI 10.1111/j.2007.0908-8857.04081.x; Parejo D, 2009, NATURWISSENSCHAFTEN, V96, P1193, DOI 10.1007/s00114-009-0584-z; Peig J, 2010, FUNCT ECOL, V24, P1323, DOI 10.1111/j.1365-2435.2010.01751.x; Perez-Rodriguez L, 2008, J EXP BIOL, V211, P2155, DOI 10.1242/jeb.017178; Peters A, 2004, AM NAT, V164, P51, DOI 10.1086/421302; Peters A, 2011, OECOLOGIA, V166, P35, DOI 10.1007/s00442-011-1921-4; Ritchie V.W., 1994, AVIAN MED PRINCIPLES; Saino N, 2003, P ROY SOC B-BIOL SCI, V270, P2485, DOI 10.1098/rspb.2003.2534; Sandland GJ, 2003, TRENDS PARASITOL, V19, P571, DOI 10.1016/j.pt.2003.10.006; Simons MJP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043088; Smits JEG, 2008, COMP BIOCHEM PHYS A, V151, P711, DOI 10.1016/j.cbpa.2008.08.025; Stambaugh T, 2011, WILSON J ORNITHOL, V123, P779, DOI 10.1676/10-197.1; Surai PF, 2011, J POULT SCI, V38, P1; Wink M, 1998, MOL ECOL, V7, P779, DOI 10.1046/j.1365-294x.1998.00377.x	69	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141759	10.1371/journal.pone.0141759	http://dx.doi.org/10.1371/journal.pone.0141759			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544885	Green Submitted, gold, Green Published			2022-12-27	WOS:000364398700041
J	Regmi, SC; Park, SY; Kim, SJ; Banskota, S; Shah, S; Kim, DH; Kim, JA				Regmi, Sushil C.; Park, Su Young; Kim, Seung Joo; Banskota, Suhrid; Shah, Sajita; Kim, Dong-Hee; Kim, Jung-Ae			The Anti-Tumor Activity of Succinyl Macrolactin A Is Mediated through the beta-Catenin Destruction Complex via the Suppression of Tankyrase and PI3K/Akt	PLOS ONE			English	Article							CANCER STEM-CELLS; COLORECTAL-CANCER; COLON-CANCER; WNT PATHWAY; INHIBITION; PROLIFERATION; MUTATIONS; PROGRESSION; MACROLIDES; GROWTH	Accumulated gene mutations in cancer suggest that multi-targeted suppression of affected signaling networks is a promising strategy for cancer treatment. In the present study, we report that 7-O-succinyl macrolactin A (SMA) suppresses tumor growth by stabilizing the beta-catenin destruction complex, which was achieved through inhibition of regulatory components associated with the complex. SMA significantly reduced the activities of PI3K/Akt, which corresponded with a decrease in GSK3 beta phosphorylation, an increase in beta-catenin phosphorylation, and a reduction in nuclear beta-catenin content in HT29 human colon cancer cells. At the same time, the activity of tankyrase, which inhibits the beta-catenin destruction complex by destabilizing the axin level, was suppressed by SMA. Despite the low potency of SMA against tankyrase activity (IC50 of 50.1 mu M and 15.5 mu M for tankyrase 1 and 2, respectively) compared to XAV939 (IC50 of 11 nM for tankyrase 1), a selective and potent tankyrase inhibitor, SMA had strong inhibitory effects on beta-catenin-dependent TCF/LEF1 transcriptional activity (IC50 of 39.8 nM), which were similar to that of XAV939 (IC50 of 28.1 nM). In addition to suppressing the colony forming ability of colon cancer cells in vitro, SMA significantly inhibited tumor growth in CT26 syngenic and HT29 xenograft mouse tumor models. Furthermore, treating mice with SMA in combination with 5-FU in a colon cancer xenograft model or with cisplatin in an A549 lung cancer xenograft model resulted in greater anti-tumor activity than did treatment with the drugs alone. In the xenograft tumor tissues, SMA dose-dependently inhibited nuclear beta-catenin along with reductions in GSK3 beta phosphorylation and increases in axin levels. These results suggest that SMA is a possible candidate as an effective anti-cancer agent alone or in combination with cytotoxic chemotherapeutic drugs, such as 5-FU and cisplatin, and that the mode of action for SMA involves stabilization of the beta-catenin destruction complex through inhibition of tankyrase and the PI3K/Akt signaling pathway.	[Regmi, Sushil C.; Park, Su Young; Kim, Seung Joo; Banskota, Suhrid; Shah, Sajita; Kim, Jung-Ae] Yeungnam Univ, Coll Pharm, Gyongsan, South Korea; [Kim, Dong-Hee] Daewoo Pharm Co Ltd, Ctr Res & Dev, Busan, South Korea	Yeungnam University	Kim, JA (corresponding author), Yeungnam Univ, Coll Pharm, Gyongsan, South Korea.	jakim@yu.ac.kr	Banskota, Suhrid/AAF-2315-2020; Banskota, Suhrid/Q-8485-2016; Regmi, Sushil/M-6385-2017	Banskota, Suhrid/0000-0003-3183-6268; Banskota, Suhrid/0000-0003-3183-6268; 	Yeungnam University Research Grant; Daewoo Pharmaceutical Co., Ltd	Yeungnam University Research Grant; Daewoo Pharmaceutical Co., Ltd	This work was supported by a Yeungnam University Research Grant (2014). Daewoo Pharmaceutical Co., Ltd provided the material, SMA, and support in the form of salary for author DHK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinleye A, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-88; Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Casas-Selves M, 2012, CANCER RES, V72, P4154, DOI 10.1158/0008-5472.CAN-11-2848; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Ewan K, 2010, CANCER RES, V70, P5963, DOI 10.1158/0008-5472.CAN-10-1028; Gelmini S, 2004, CANCER LETT, V216, P81, DOI 10.1016/j.canlet.2004.05.010; Gelmini S, 2006, ONCOL REP, V16, P1261; GUSTAFSON K, 1989, J AM CHEM SOC, V111, P7519, DOI 10.1021/ja00201a036; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Ihle NT, 2009, CANCER RES, V69, P143, DOI 10.1158/0008-5472.CAN-07-6656; Ishibe S, 2006, MOL CELL BIOL, V26, P9232, DOI 10.1128/MCB.01312-06; Kang Y, 2015, ARCH PHARM RES, V38, P249, DOI 10.1007/s12272-014-0535-x; Kanoh S, 2010, CLIN MICROBIOL REV, V23, P590, DOI 10.1128/CMR.00078-09; Kolligs FT, 2002, DIGESTION, V66, P131, DOI 10.1159/000066755; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Li XQ, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-114; McNeill H, 2010, NAT REV MOL CELL BIO, V11, P404, DOI 10.1038/nrm2902; Nakashima T, 2008, ONCOL REP, V19, P203; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Ng SW, 2009, J BIOL CHEM, V284, P24767, DOI 10.1074/jbc.M109.011692; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; Park S, 2014, EUR J PHARMACOL, V735, P184, DOI 10.1016/j.ejphar.2014.04.024; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; RISIO M, 1991, CANCER RES, V51, P1917; RISIO M, 1992, J CELL BIOCHEM, P79; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Shebzukhov YV, 2008, CANCER IMMUNOL IMMUN, V57, P871, DOI 10.1007/s00262-007-0423-z; Stewart DJ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt356; Stewart DJ, 2010, CRIT REV ONCOL HEMAT, V75, P173, DOI 10.1016/j.critrevonc.2009.11.006; Teng Y, 2010, BIOCHEM BIOPH RES CO, V392, P373, DOI 10.1016/j.bbrc.2010.01.028; Tian XH, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-100; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Voskas Daniel, 2010, F1000 Biol Rep, V2, P82, DOI 10.3410/B2-82; Zhang J, 2011, GASTROENTEROLOGY, V141, P50, DOI 10.1053/j.gastro.2011.05.010	40	17	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141753	10.1371/journal.pone.0141753	http://dx.doi.org/10.1371/journal.pone.0141753			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544726	Green Published, gold, Green Submitted			2022-12-27	WOS:000364398700040
J	Roy, S; Basu, S; Dasgupta, D; Bhattacharyya, D; Banerjee, R				Roy, Sourav; Basu, Sankar; Dasgupta, Dipak; Bhattacharyya, Dhananjay; Banerjee, Rahul			The Unfolding MD Simulations of Cyclophilin: Analyzed by Surface Contact Networks and Their Associated Metrics	PLOS ONE			English	Article							TRANSFER-RNA SYNTHETASE; FREE-ENERGY LANDSCAPE; MOLECULAR-DYNAMICS; LEISHMANIA-DONOVANI; PROTEIN STRUCTURES; MOLTEN GLOBULES; RIBONUCLEASE-A; KEY RESIDUES; PACKING; COMPLEMENTARITY	Currently, considerable interest exists with regard to the dissociation of close packed aminoacids within proteins, in the course of unfolding, which could result in either wet or dry moltenglobules. The progressive disjuncture of residues constituting the hydrophobic core ofcyclophilin from L. donovani (LdCyp) has been studied during the thermal unfolding of the molecule, by molecular dynamics simulations. LdCyp has been represented as a surface contactnetwork (SCN) based on the surface complementarity (S-m) of interacting residues within themolecular interior. The application of Sm to side chain packing within proteins make it a very sensitive indicator of subtle perturbations in packing, in the thermal unfolding of the protein. Network based metrics have been defined to track the sequential changes in the disintegration ofthe SCN spanning the hydrophobic core of LdCyp and these metrics prove to be highly sensitive compared to traditional metrics in indicating the increased conformational (and dynamical) flexibility in the network. These metrics have been applied to suggest criteria distinguishing DMG, WMG and transition state ensembles and to identify key residues involved in crucial conformational/topological events during the unfolding process.	[Roy, Sourav; Basu, Sankar; Dasgupta, Dipak; Bhattacharyya, Dhananjay; Banerjee, Rahul] Saha Inst Nucl Phys, Kolkata 700064, India	Saha Institute of Nuclear Physics	Bhattacharyya, D (corresponding author), Saha Inst Nucl Phys, Sect 1,Block AF, Kolkata 700064, India.	dhananjay.bhattacharyya@saha.ac.in; rahul.banerjee@saha.ac.in	Basu, Sankar/AAD-7202-2019; ROY, SOURAV/ABE-1206-2020	Basu, Sankar/0000-0003-1393-1982; ROY, SOURAV/0000-0001-5354-3824	Department of Atomic Energy (Government of India) [XII-RD-SIN-5.04-0102, XII-RD-SIN-5.04-0103]	Department of Atomic Energy (Government of India)(Department of Atomic Energy (DAE))	This project was funded by Department of Atomic Energy (Government of India) Projects of SINP: MSACR [XII-R&D-SIN-5.04-0102] and BARD -[XII-R&D-SIN-5.04-0103].	Amitai G, 2004, J MOL BIOL, V344, P1135, DOI 10.1016/j.jmb.2004.10.055; Atilgan AR, 2004, BIOPHYS J, V86, P85, DOI 10.1016/S0006-3495(04)74086-2; Baldwin RL, 2013, PROTEIN-STRUCT FUNCT, V78, P2725; Baldwin RL, 2013, CURR OPIN STRUC BIOL, V23, P4, DOI 10.1016/j.sbi.2012.11.004; Banerjee R, 2003, J MOL BIOL, V333, P211, DOI 10.1016/j.jmb.2003.08.013; Basu S, 2014, INDIAN J BIOCHEM BIO, V51, P188; Basu S, 2012, BIOPHYS J, V102, P2605, DOI 10.1016/j.bpj.2012.04.029; Basu S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-195; BEHE MJ, 1991, P NATL ACAD SCI USA, V88, P4195, DOI 10.1073/pnas.88.10.4195; Bhattacharyya M, 2013, PROTEIN SCI, V22, P1399, DOI 10.1002/pro.2333; Bhattacharyya M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051676; Bhattacharyya M, 2011, BIOCHEMISTRY-US, V50, P6225, DOI 10.1021/bi200306u; Bhattacharyya M, 2010, PROTEINS, V78, P506, DOI 10.1002/prot.22573; Bhattacharyya S, 2013, CURR OPIN STRUC BIOL, V23, P11, DOI 10.1016/j.sbi.2012.10.010; Borg I, 2010, MODERN MULTIDIMENSIO; Brinda KV, 2005, BIOPHYS J, V89, P4159, DOI 10.1529/biophysj.105.064485; BROCCHIERI L, 1994, P NATL ACAD SCI USA, V91, P9297, DOI 10.1073/pnas.91.20.9297; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; Dasgupta A, 2014, J PHYS CHEM B, V118, P6380, DOI 10.1021/jp410019f; Dokholyan NV, 2002, P NATL ACAD SCI USA, V99, P8637, DOI 10.1073/pnas.122076099; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Gao M, 2010, J PHYS CHEM B, V114, P15687, DOI 10.1021/jp1052453; Ghosh A, 2007, P NATL ACAD SCI USA, V104, P15711, DOI 10.1073/pnas.0704459104; Ghosh A, 2007, BIOPHYS J, V92, P2523, DOI 10.1529/biophysj.106.099903; Glassner NC, 1996, P NATL ACAD SCI USA, V93, P12155; Greene LH, 2003, J MOL BIOL, V334, P781, DOI 10.1016/j.jmb.2003.08.061; HOELTZLI SD, 1995, P NATL ACAD SCI USA, V92, P9318, DOI 10.1073/pnas.92.20.9318; Hua L, 2008, P NATL ACAD SCI USA, V105, P16928, DOI 10.1073/pnas.0808427105; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jacobs DJ, 2001, PROTEINS, V44, P150, DOI 10.1002/prot.1081; Jakalian A, 2002, J COMPUT CHEM, V23, P1623, DOI 10.1002/jcc.10128; Jha SK, 2009, P NATL ACAD SCI USA, V106, P12289, DOI 10.1073/pnas.0905744106; Joo H, 2014, PROTEINS, V82, P2128, DOI 10.1002/prot.24569; Joo H, 2012, J MOL BIOL, V419, P234, DOI 10.1016/j.jmb.2012.03.004; Juneja J, 2002, BIOCHEMISTRY-US, V41, P2641, DOI 10.1021/bi011480p; Jung JW, 2005, PROTEINS, V58, P389, DOI 10.1002/prot.20324; KIEFHABER T, 1995, NATURE, V375, P513, DOI 10.1038/375513a0; KIEFHABER T, 1995, P NATL ACAD SCI USA, V92, P2657, DOI 10.1073/pnas.92.7.2657; Krishnan A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002149; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Mitchell JBO, 1999, PROTEIN-STRUCT FUNCT, V29, P359; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Prajapati RS, 2007, BIOCHEMISTRY-US, V46, P10339, DOI 10.1021/bi700577m; Rami BR, 2002, BIOCHEMISTRY-US, V41, P1710, DOI 10.1021/bi0120300; Reiner A, 2010, P NATL ACAD SCI USA, V107, P4955, DOI 10.1073/pnas.0910001107; Roy S, 2014, INT J BIOL MACROMOL, V69, P353, DOI 10.1016/j.ijbiomac.2014.05.063; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Salimi NL, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000689; Samanta U, 1999, ACTA CRYSTALLOGR D, V55, P1421, DOI 10.1107/S090744499900726X; SHAKHNOVICH EI, 1989, BIOPOLYMERS, V28, P1667, DOI 10.1002/bip.360281003; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; SINGH J, 1985, FEBS LETT, V191, P1, DOI 10.1016/0014-5793(85)80982-0; Sukhwal A, 2011, ACTA CRYSTALLOGR D, V67, P429, DOI 10.1107/S0907444911007062; Thorpe MF, 2001, J MOL GRAPH MODEL, V19, P60, DOI 10.1016/S1093-3263(00)00122-4; Vendruscolo M, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.061910; Vendruscolo M, 2001, NATURE, V409, P641, DOI 10.1038/35054591; Venugopal V, 2007, ACTA CRYSTALLOGR F, V63, P60, DOI 10.1107/S1744309106056351; Vishveshwara S., 2002, J THEOR COMPUT CHEM, V1, P187, DOI DOI 10.1142/S0219633602000117; Zhou RH, 2003, P NATL ACAD SCI USA, V100, P13280, DOI 10.1073/pnas.2233312100; Zhou RH, 2001, P NATL ACAD SCI USA, V98, P14931, DOI 10.1073/pnas.201543998	61	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142173	10.1371/journal.pone.0142173	http://dx.doi.org/10.1371/journal.pone.0142173			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26545107	Green Submitted, Green Published, gold			2022-12-27	WOS:000364398700091
J	Zhang, K; Yun, SD; Shah, NJ				Zhang, Ke; Yun, Seong Dae; Shah, N. Jon			Tripled Readout Slices in Multi Time-Point pCASL Using Multiband Look-Locker EPI	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; WHOLE-BRAIN; ARTERIAL; PERFUSION; VOLUME; MODEL	Multi time-point pseudo-continuous arterial spin labelling (pCASL) with a Look-Locker EPI readout can sample the signal curve of blood kinetics at multiple time points after the labelling pulse. However, due to signal relaxation of labelled blood, the number of readout slices is limited. The aim of this study is to employ a multiband excitation technique to triple the number of readout slices in multi time-point pCASL. The multiband technique, along with 2fold in-plane parallel imaging, was incorporated into the Look-Locker EPI for the multi timepoint sampling of blood kinetic behaviour following the pCASL labelling scheme. The performance evaluation of the multiband and the single-band techniques were performed on four healthy subjects using a 32-channel head RF coil at 3T. Quantitative perfusion maps were analysed using a combination of labelling with and without flow suppression gradients. The perfusion maps provided by the multiband accelerated multi time-point pCASL were in good agreement with the conventional single-band technique. Multiband acceleration caused SNR loss but offered quantitative perfusion maps in 6.23 min with 18 slices compared with 6 slices within the same time period for the single-band method. As conclusion, the multiband technique can successfully triple the number of readout slices while achieving comparable perfusion data in the same measurement time as the conventional single-band readout.	[Zhang, Ke; Yun, Seong Dae; Shah, N. Jon] Forschungszentrum Julich, Med Imaging Phys, Inst Neurosci & Med 4, D-52425 Julich, Germany; [Shah, N. Jon] Rhein Westfal TH Aachen, JARA, Fac Med, Dept Neurol, Aachen, Germany	Helmholtz Association; Research Center Julich; RWTH Aachen University	Shah, NJ (corresponding author), Forschungszentrum Julich, Med Imaging Phys, Inst Neurosci & Med 4, D-52425 Julich, Germany.	n.j.shah@fz-juelich.de	Shah, N. Jon/H-5849-2013	Shah, N. Jon/0000-0002-8151-6169; Yun, Seong Dae/0000-0001-7398-1899				Alsop DC, 1996, J CEREBR BLOOD F MET, V16, P1236, DOI 10.1097/00004647-199611000-00019; Blaimer Martin, 2004, Top Magn Reson Imaging, V15, P223, DOI 10.1097/01.rmr.0000136558.09801.dd; Brookes MJ, 2007, MAGN RESON MED, V58, P41, DOI 10.1002/mrm.21199; Buxton RB, 1998, MAGNET RESON MED, V40, P383, DOI 10.1002/mrm.1910400308; Chappell MA, 2010, MAGN RESON MED, V63, P1357, DOI 10.1002/mrm.22320; Chen YF, 2012, MAGN RESON MATER PHY, V25, P135, DOI 10.1007/s10334-011-0276-5; Dai WY, 2013, MAGN RESON MED, V69, P1014, DOI 10.1002/mrm.24335; Dai WY, 2008, MAGN RESON MED, V60, P1488, DOI 10.1002/mrm.21790; DETRE JA, 1992, MAGNET RESON MED, V23, P37, DOI 10.1002/mrm.1910230106; Feinberg DA, 2013, MAGN RESON MED, V70, P1500, DOI 10.1002/mrm.24994; Feinberg DA, 2013, J MAGN RESON, V229, P90, DOI 10.1016/j.jmr.2013.02.002; Feinberg DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015710; Gunther M, 2005, MAGN RESON MED, V54, P491, DOI 10.1002/mrm.20580; Gunther M, 2001, MAGNET RESON MED, V46, P974, DOI 10.1002/mrm.1284; Gunther M., 2007, P 15 ANN M ISMRM, V15, P380; Hendrikse J, 2003, MAGNET RESON MED, V50, P429, DOI 10.1002/mrm.10525; HERSCOVITCH P, 1985, J CEREBR BLOOD F MET, V5, P65, DOI 10.1038/jcbfm.1985.9; Kim T, 2013, MAGN RESON MED, V70, P1653, DOI 10.1002/mrm.24880; Koopmans PJ, 2012, NEUROIMAGE, V62, P1939, DOI 10.1016/j.neuroimage.2012.05.080; Larkman DJ, 2001, J MAGN RESON IMAGING, V13, P313, DOI 10.1002/1522-2586(200102)13:2<313::AID-JMRI1045>3.0.CO;2-W; LEENDERS KL, 1990, BRAIN, V113, P27, DOI 10.1093/brain/113.1.27; Moeller S, 2010, MAGN RESON MED, V63, P1144, DOI 10.1002/mrm.22361; Ostergaard L, 1996, MAGN RESON MED, V36, P715, DOI 10.1002/mrm.1910360510; Ozyurt O., 2010, P 18 ANN M ISMRM, V18, P4065; Paling D, 2014, J CEREBR BLOOD F MET, V34, P34, DOI 10.1038/jcbfm.2013.161; Petersen ET, 2010, NEUROIMAGE, V49, P104, DOI 10.1016/j.neuroimage.2009.07.068; Petersen ET, 2006, MAGN RESON MED, V55, P219, DOI 10.1002/mrm.20784; Setsompop K, 2012, MAGN RESON MED, V67, P1210, DOI 10.1002/mrm.23097; Lawrence KS, 2012, MAGN RESON MED, V67, P1275, DOI 10.1002/mrm.23104; Teeuwisse WM, 2014, MAGN RESON MED, V72, P1712, DOI 10.1002/mrm.25083; Wu WC, 2007, MAGN RESON MED, V58, P1020, DOI 10.1002/mrm.21403; Zhang K, 2014, J CEREBR BLOOD F MET, V34, P1373, DOI 10.1038/jcbfm.2014.92	32	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141108	10.1371/journal.pone.0141108	http://dx.doi.org/10.1371/journal.pone.0141108			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544715	Green Published, gold			2022-12-27	WOS:000364398700016
J	Bandyopadhyay, S; Mahapatra, SK; Chowdhury, BP; Jha, MK; Das, S; Halder, K; Majumdar, SB; Saha, B; Majumdar, S				Bandyopadhyay, Syamdas; Mahapatra, Santanu Kar; Chowdhury, Bidisha Paul; Jha, Mukesh Kumar; Das, Shibali; Halder, Kuntal; Majumdar, Suchandra Bhattacharyya; Saha, Bhaskar; Majumdar, Subrata			Toll-Like Receptor 2 Targeted Rectification of Impaired CD8(+) T Cell Functions in Experimental Leishmania donovani Infection Reinstates Host Protection	PLOS ONE			English	Article							INTERFERON-GAMMA; RESPONSES; ACTIVATION; VACCINE; CD4(+); IL-12; IFN	Leishmania donovani, a protozoan parasite, causes the disease visceral leishmanisis (VL), characterized by inappropriate CD8(+) T-cell activation. Therefore, we examined whether the Toll-like Receptor 2 (TLR2) ligand Ara-LAM, a cell wall glycolipid from non-pathogenic Mycobacterium smegmatis, would restore CD8(+) T-cell function during VL. We observed that by efficient upregulation of TLR2 signaling-mediated NF-kappa B translocation and MAPK signaling in CD8(+) T-cells (CD25(+) CD28(+) IL-12R(+) IFN-gamma R+), Ara-LAM triggered signaling resulted in the activation of T-bet, which in turn, induced transcription favourable histone modification at the IFN-gamma, perforin, granzyme-B promoter regions in CD8(+) T-cells. Thus, we conclude that Ara-LAM induced efficient activation of effector CD8(+) T-cells by upregulating the expression of IFN-gamma, perforin and granzyme-B in an NF-kappa B and MAPK induced T-bet dependent manner in VL.	[Bandyopadhyay, Syamdas; Mahapatra, Santanu Kar; Chowdhury, Bidisha Paul; Das, Shibali; Halder, Kuntal; Majumdar, Suchandra Bhattacharyya; Majumdar, Subrata] Bose Inst, Div Mol Med, Kolkata, India; [Jha, Mukesh Kumar; Saha, Bhaskar] Natl Ctr Cell Sci, Pune, Maharashtra, India	Department of Science & Technology (India); Bose Institute; Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS)	Majumdar, S (corresponding author), Bose Inst, Div Mol Med, Kolkata, India.	subrata@jcbose.ac.in	Das, Shibali/AAA-2683-2021; Mahapatra, Santanu Kar/AAC-2594-2021	Das, Shibali/0000-0003-1263-8178; Mahapatra, Santanu Kar/0000-0002-2257-8538	Department of Biotechnology, Ministry of Science and technology [BT/PR14435/MED/29/201/2010]	Department of Biotechnology, Ministry of Science and technology	Funding was provided by the Department of Biotechnology, Ministry of Science and technology (IN), http://www.dbtindia.nic.in/, BT/PR14435/MED/29/201/2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal P, 2009, J IMMUNOL, V183, P1695, DOI 10.4049/jimmunol.0900592; Ahmed S, 2003, INFECT IMMUN, V71, P401, DOI 10.1128/IAI.71.1.401-410.2003; Alexander J, 2005, IMMUNOL LETT, V99, P17, DOI 10.1016/j.imlet.2005.01.009; Bhattacharjee S, 2012, J ANTIMICROB CHEMOTH, V67, P1905, DOI 10.1093/jac/dks159; Bhattacharya P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024141; Bhattacharya P, 2010, J INFECT DIS, V202, P145, DOI 10.1086/653210; Bodas M, 2006, J IMMUNOL, V177, P4636, DOI 10.4049/jimmunol.177.7.4636; Colmenares M, 2003, INFECT IMMUN, V71, P3172, DOI 10.1128/IAI.71.6.3172-3182.2003; Das G, 1999, SCAND J IMMUNOL, V49, P307, DOI 10.1046/j.1365-3083.1999.00486.x; Das S, 2014, IMMUNE SUBVERSION MY, V9; Das S, 2015, TUBERCULOSIS, V95, P208, DOI 10.1016/j.tube.2014.11.007; Elloso MM, 2001, EUR J IMMUNOL, V31, P384, DOI 10.1002/1521-4141(200102)31:2<384::AID-IMMU384>3.0.CO;2-9; Ghosh S, 2002, INFECT IMMUN, V70, P6828, DOI 10.1128/IAI.70.12.6828-6838.2002; Gigley JP, 2012, TRENDS PARASITOL, V28, P377, DOI 10.1016/j.pt.2012.07.001; Gozalbo D, 2014, FRONT BIOSCI-LANDMRK, V19, P1279, DOI 10.2741/4281; Halder K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091656; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kang JY, 2009, IMMUNITY, V31, P873, DOI 10.1016/j.immuni.2009.09.018; Kared H, 2014, CURR OPIN IMMUNOL, V29, P79, DOI 10.1016/j.coi.2014.05.003; Kaushal H, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0653-6; Kumar R, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00251; MAJUMDAR S, 1993, BIOCHIM BIOPHYS ACTA, V1176, P276, DOI 10.1016/0167-4889(93)90056-U; Majumder N, 2006, GLYCOCONJUGATE J, V23, P675, DOI 10.1007/s10719-006-9017-9; Pandey SP, 2014, J IMMUNOL, V193, P3632, DOI 10.4049/jimmunol.1400672; Quigley M, 2009, BLOOD, V113, P2256, DOI 10.1182/blood-2008-03-148809; Rub A, 2009, NAT IMMUNOL, V10, P273, DOI 10.1038/ni.1705; Russ BE, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00371; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Sullivan BM, 2003, P NATL ACAD SCI USA, V100, P15818, DOI 10.1073/pnas.2636938100; Sutherland APR, 2013, J IMMUNOL, V190, P3977, DOI 10.4049/jimmunol.1201730; Tian S, 2007, J IMMUNOL, V179, P2952, DOI 10.4049/jimmunol.179.5.2952; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Wakil AE, 1998, J EXP MED, V188, P1651, DOI 10.1084/jem.188.9.1651; Whitmire JK, 2005, J EXP MED, V201, P1053, DOI 10.1084/jem.20041463	34	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142800	10.1371/journal.pone.0142800	http://dx.doi.org/10.1371/journal.pone.0142800			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559815	Green Published, gold, Green Submitted			2022-12-27	WOS:000364433100127
J	Garcia-Seco, D; Zhang, Y; Gutierrez-Manero, FJ; Martin, C; Ramos-Solano, B				Garcia-Seco, Daniel; Zhang, Yang; Gutierrez-Manero, Francisco J.; Martin, Cathie; Ramos-Solano, Beatriz			Application of Pseudomonas fluorescens to Blackberry under Field Conditions Improves Fruit Quality by Modifying Flavonoid Metabolism	PLOS ONE			English	Article							GROWTH PROMOTING RHIZOBACTERIA; PATHOGENESIS-RELATED-PROTEIN; TRANSCRIPTION FACTOR; SYSTEMIC RESISTANCE; ANTHOCYANIN BIOSYNTHESIS; ISOFLAVONE METABOLISM; GENE-EXPRESSION; ABSCISIC-ACID; GRAPE BERRIES; ARABIDOPSIS	Application of a plant growth promoting rhizobacterium (PGPR), Pseudomonas fluorescens N21.4, to roots of blackberries (Rubus sp.) is part of an optimised cultivation practice to improve yields and quality of fruit throughout the year in this important fruit crop. Blackberries are especially rich in flavonoids and therefore offer potential benefits for human health in prevention or amelioration of chronic diseases. However, the phenylpropanoid pathway and its regulation during ripening have not been studied in detail, in this species. PGPR may trigger flavonoid biosynthesis as part of an induced systemic response (ISR) given the important role of this pathway in plant defence, to cause increased levels of flavonoids in the fruit. We have identified structural genes encoding enzymes of the phenylpropanoid and flavonoid biosynthetic pathways catalysing the conversion of phenylalanine to the final products including flavonols, anthocyanins and catechins from blackberry, and regulatory genes likely involved in controlling the activity of pathway branches. We have also measured the major flavonols, anthocyanins and catechins at three stages during ripening. Our results demonstrate the coordinated expression of flavonoid biosynthetic genes with the accumulation of anthocyanins, catechins, and flavonols in developing fruits of blackberry. Elicitation of blackberry plants by treatment of roots with P. fluorescens N21.4, caused increased expression of some flavonoid biosynthetic genes and an accompanying increase in the concentration of selected flavonoids in fruits. Our data demonstrate the physiological mechanisms involved in the improvement of fruit quality by PGPR under field conditions, and highlight some of the genetic targets of elicitation by beneficial bacteria.	[Garcia-Seco, Daniel; Gutierrez-Manero, Francisco J.; Ramos-Solano, Beatriz] Univ CEU San Pablo, Fac Farm, Madrid, Spain; [Zhang, Yang; Martin, Cathie] John Innes Ctr, Norwich, Norfolk, England	San Pablo CEU University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Garcia-Seco, D (corresponding author), Univ CEU San Pablo, Fac Farm, Ctra Boadilla del Monte Km 5-3, Madrid, Spain.	danielgsh@hotmail.com	Gutierrez-Mañero, Francisco Javier/C-1110-2016; Garcia-Seco, Daniel/AAC-7796-2020; Ramos-Solano, Beatriz/I-6545-2015	Gutierrez-Mañero, Francisco Javier/0000-0001-5230-6798; Garcia-Seco, Daniel/0000-0002-4560-4110; Ramos-Solano, Beatriz/0000-0003-0280-5198	Ministerio de Ciencia e Innovacion [BES-2010-038057]; Institute Strategic Program Understanding and Exploiting Plant and Microbial Secondary Metabolism from the BBSRC [BB/J004596/1]; European Union [245121]; John Innes Foundation;  [AGL 2009-08324];  [AGL 2013 45189-R]; Biotechnology and Biological Sciences Research Council [BBS/E/J/00000153, BBS/E/J/000CA535] Funding Source: researchfish; BBSRC [BBS/E/J/000CA535] Funding Source: UKRI	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Institute Strategic Program Understanding and Exploiting Plant and Microbial Secondary Metabolism from the BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union(European Commission); John Innes Foundation; ; ; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	DGS, BR and FJG were supported by Ministerio de Ciencia e Innovacion (BES-2010-038057) and projects AGL 2009-08324 and AGL 2013 45189-R. YZ and CM were supported by the Institute Strategic Program Understanding and Exploiting Plant and Microbial Secondary Metabolism (BB/J004596/1) from the BBSRC and by the European Union FP7 ATHENA collaborative project (Grant Agreement 245121). YZ was also supported by a Rotation Studentship from the John Innes Foundation.	Algar E, 2014, PLANT PHYSIOL BIOCH, V82, P9, DOI 10.1016/j.plaphy.2014.05.001; Bassolino L, 2013, NEW PHYTOL, V200, P650, DOI 10.1111/nph.12524; Baudry A, 2004, PLANT J, V39, P366, DOI 10.1111/j.1365-313X.2004.02138.x; Bohm B, 1998, INTRO FLAVONOIDS CHE; Boss PK, 1996, PLANT PHYSIOL, V111, P1059, DOI 10.1104/pp.111.4.1059; Boue S M, 2008, J Food Sci, V73, pH43, DOI 10.1111/j.1750-3841.2008.00707.x; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Butelli E, 2008, NAT BIOTECHNOL, V26, P1301, DOI 10.1038/nbt.1506; Capanoglu E, 2010, TRENDS FOOD SCI TECH, V21, P399, DOI 10.1016/j.tifs.2010.05.001; Chen A, 2013, FOOD CHEM; Choudhary DK, 2009, MICROBIOL RES, V164, P493, DOI 10.1016/j.micres.2008.08.007; Choudhury S, 2010, PLANT CELL REP; Conrath U, 2011, TRENDS PLANT SCI, V16, P524, DOI 10.1016/j.tplants.2011.06.004; Cuevas-Rodriguez EO, 2010, J AGR FOOD CHEM, V58, P7458, DOI 10.1021/jf101485r; Dakora FD, 1996, PHYSIOL MOL PLANT P, V49, P1, DOI 10.1006/pmpp.1996.0035; Dangl J, 2006, NATURE, V444; Ding CK, 2002, PLANTA, V214, P895, DOI 10.1007/s00425-001-0698-9; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Domenech J, 2007, PLANT SOIL, V290, P43, DOI 10.1007/s11104-006-9089-0; Dornenburg H, 2004, PROCESS BIOCHEM, V39, P1369, DOI 10.1016/S0032-9592(03)00262-0; Elomaa P, 2003, PLANT PHYSIOL, V133, P1831, DOI 10.1104/pp.103.026039; Fraga CG, 2011, FREE RADICAL BIO MED, V51, P813, DOI 10.1016/j.freeradbiomed.2011.06.002; Garcia-Seco D, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-014-1198-1; Garcia-Seco D, 2013, AGRON SUSTAIN DEV, V33, P385, DOI 10.1007/s13593-012-0103-z; Genty B, 1989, BIOCH BIOPHYS ACTA B; Giusti M. M., 2001, CURR PROTOC FOOD ANA, V00, DOI DOI 10.1002/0471142913.FAF0102S00; Gonzalez A, 2008, PLANT J; Gonzalez A, 2009, DEV BIOL, V325, P412, DOI 10.1016/j.ydbio.2008.10.005; Hammerschmidt R, 1999, ANNU REV PHYTOPATHOL, V37, P285, DOI 10.1146/annurev.phyto.37.1.285; Harborne JB, 2000, PHYTOCHEMISTRY, V55, P481, DOI 10.1016/S0031-9422(00)00235-1; Hassimotto NMA, 2011, J SCI FOOD AGR, V91, P523, DOI 10.1002/jsfa.4216; Hemm MR, 2001, TRENDS PLANT SCI, V6, P135, DOI 10.1016/S1360-1385(01)01915-X; Hoffmann-Sommergruber K, 2002, BIOCHEM SOC T, V30, P930, DOI 10.1042/BST0300930; HOLTON TA, 1995, PLANT CELL, V7, P1071, DOI 10.1105/tpc.7.7.1071; Hummer K, 2010, HORTSCIENCE; Iriti M, 2009, PLANT SIGNAL BEHAV, V4, P66, DOI 10.4161/psb.4.1.7408; Jaakola L, 2002, PLANT PHYSIOL, V130, P729, DOI 10.1104/pp.006957; Jackson D, 1992, PLANT J; Jia Z, 1999, FOOD CHEM, V64, P555, DOI 10.1016/S0308-8146(98)00102-2; Jin HL, 2000, EMBO J, V19, P6150, DOI 10.1093/emboj/19.22.6150; Kesari R, 2010, POSTHARVEST BIOL TEC, V56, P64, DOI 10.1016/j.postharvbio.2009.11.012; Kumar A, 2003, PHYTOCHEMISTRY, V62, P513, DOI 10.1016/S0031-9422(02)00572-1; Kumar D, 2013, P NATL A SCI INDIA B, V83, P1, DOI 10.1007/s40011-012-0059-4; Lakshmanan V, 2012, PLANT PHYSIOL, V160, P1642, DOI 10.1104/pp.112.200386; Lattanzio V., 2013, NATURAL PRODUCTS, P1543; Li XW, 2013, GENE, V532, P72, DOI 10.1016/j.gene.2013.09.015; Lin-Wang Kui, 2010, BMC Plant Biol, V10, P50, DOI 10.1186/1471-2229-10-50; Lucas Garcia J, 2004, PLANT SOIL, V39, P366; Martin C, 1997, TRENDS GENET, V13, P67, DOI 10.1016/S0168-9525(96)10049-4; Martin C, 2013, ANNU REV PLANT BIOL, V64, P19, DOI 10.1146/annurev-arplant-050312-120142; Medina-Puche L, 2014, J EXP BOT, V65, P401, DOI 10.1093/jxb/ert377; Mehrtens F, 2005, PLANT PHYSIOL, V138, P1083, DOI 10.1104/pp.104.058032; Nesi N, 2001, PLANT CELL, V13, P2099, DOI 10.1105/tpc.13.9.2099; Park KS, 2000, BIOL CONTROL, V18, P2, DOI 10.1006/bcon.2000.0815; QUATTROCCHIO F, 1993, PLANT CELL, V5, P1497, DOI 10.1105/tpc.5.11.1497; Ramamoorthy V, 2002, PLANT SOIL, V239, P55, DOI 10.1023/A:1014904815352; Ramirez V, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003445; Ramos-Solano B, 2014, PLANT PHYSIOL BIOCH, V74, P1, DOI 10.1016/j.plaphy.2013.10.029; Ramos-Solano B, 2015, LWT-FOOD SCI TECHNOL, V61, P437, DOI 10.1016/j.lwt.2014.11.051; Ramos-Solano B, 2010, J AGR FOOD CHEM, V58, P1484, DOI 10.1021/jf903299a; Rezzonico E, 1998, PLANT PHYSIOL, V117, P585, DOI 10.1104/pp.117.2.585; Robinson SP, 1997, PLANT PHYSIOL, V114, P771, DOI 10.1104/pp.114.3.771; Ruijters EJB, 2014, PHARMACOL RES, V79, P28, DOI 10.1016/j.phrs.2013.11.004; Salzman RA, 1998, PLANT PHYSIOL, V117, P465, DOI 10.1104/pp.117.2.465; Schiliro E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048646; Seeram NP, 2012, J AGR FOOD CHEM, V60, P5685, DOI 10.1021/jf203455z; Singh R, 2010, COMPR REV FOOD SCI F, V9, P398, DOI 10.1111/j.1541-4337.2010.00116.x; SOKAL RR, 1981, SYST ZOOL, V30, P309, DOI 10.2307/2413252; Solano BR, 2008, PHYTOPATHOLOGY, V98, P451, DOI 10.1094/PHYTO-98-4-0451; STAFFORD HA, 1991, PLANT PHYSIOL, V96, P680, DOI 10.1104/pp.96.3.680; Tahara S, 2007, BIOSCI BIOTECH BIOCH, V71, P1387, DOI 10.1271/bbb.70028; Uimari A, 1998, MOL GEN GENET, V257, P198, DOI 10.1007/s004380050639; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Vaaje-Kolstad G, 2005, J BIOL; WEIDENBORNER M, 1990, PHYTOCHEMISTRY, V29, P1103, DOI 10.1016/0031-9422(90)85412-9; Xu BJ, 2007, J FOOD SCI, V72, pS159, DOI 10.1111/j.1750-3841.2006.00260.x; Zamioudis C, 2012, MOL PLANT MICROBE IN, V25, P139, DOI 10.1094/MPMI-06-11-0179; Zhang HM, 2008, PLANT J, V56, P264, DOI 10.1111/j.1365-313X.2008.03593.x; Zhang Y, 2013, CURR BIOL, V23, P1094, DOI 10.1016/j.cub.2013.04.072; Zhao JF, 2007, PLANT CELL, V19, P3805, DOI 10.1105/tpc.106.048900	80	58	60	6	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142639	10.1371/journal.pone.0142639	http://dx.doi.org/10.1371/journal.pone.0142639			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559418	Green Published, gold, Green Submitted			2022-12-27	WOS:000364433100104
J	Asgari, E; Mofrad, MRK				Asgari, Ehsaneddin; Mofrad, Mohammad R. K.			Continuous Distributed Representation of Biological Sequences for Deep Proteomics and Genomics	PLOS ONE			English	Article							PROTEIN; LANGUAGE; CLASSIFICATION; VISUALIZATION; DATABASE	We introduce a new representation and feature extraction method for biological sequences. Named bio-vectors (BioVec) to refer to biological sequences in general with protein-vectors (ProtVec) for proteins (amino-acid sequences) and gene-vectors (GeneVec) for gene sequences, this representation can be widely used in applications of deep learning in proteomics and genomics. In the present paper, we focus on protein-vectors that can be utilized in a wide array of bioinformatics investigations such as family classification, protein visualization, structure prediction, disordered protein identification, and protein-protein interaction prediction. In this method, we adopt artificial neural network approaches and represent a protein sequence with a single dense n-dimensional vector. To evaluate this method, we apply it in classification of 324,018 protein sequences obtained from Swiss-Prot belonging to 7,027 protein families, where an average family classification accuracy of 93% +/- 0.06% is obtained, outperforming existing family classification methods. In addition, we use ProtVec representation to predict disordered proteins from structured proteins. Two databases of disordered sequences are used: the DisProt database as well as a database featuring the disordered regions of nucleoporins rich with phenylalanine-glycine repeats (FG-Nups). Using support vector machine classifiers, FG-Nup sequences are distinguished from structured protein sequences found in Protein Data Bank (PDB) with a 99.8% accuracy, and unstructured DisProt sequences are differentiated from structured DisProt sequences with 100.0% accuracy. These results indicate that by only providing sequence data for various proteins into this model, accurate information about protein structure can be determined. Importantly, this model needs to be trained only once and can then be applied to extract a comprehensive set of information regarding proteins of interest. Moreover, this representation can be considered as pre-training for various applications of deep learning in bioinformatics. The related data is available at Life Language Processing Website: http://llp.berkeley.edu and Harvard Dataverse: http://dx.doi.org/10.7910/DVN/JMFHTN.	[Asgari, Ehsaneddin; Mofrad, Mohammad R. K.] Univ Calif Berkeley, Mol Cell Biomech Lab, Dept Bioengn, Berkeley, CA 94720 USA; [Asgari, Ehsaneddin; Mofrad, Mohammad R. K.] Univ Calif Berkeley, Mol Cell Biomech Lab, Dept Mech Engn, Berkeley, CA 94720 USA; [Mofrad, Mohammad R. K.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Mofrad, MRK (corresponding author), Univ Calif Berkeley, Mol Cell Biomech Lab, Dept Bioengn, Berkeley, CA 94720 USA.	mofrad@berkeley.edu	Asgari, Ehsaneddin/AAJ-3680-2021		National Science Foundation through CAREER Award [CBET-0955291]	National Science Foundation through CAREER Award	Financial support from National Science Foundation through a CAREER Award (CBET-0955291) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073831; Aragues R, 2007, PLOS COMPUT BIOL, V3, P1761, DOI 10.1371/journal.pcbi.0030178; Azimi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081741; Bork P, 1998, J MOL BIOL, V283, P707, DOI 10.1006/jmbi.1998.2144; Cai CZ, 2003, NUCLEIC ACIDS RES, V31, P3692, DOI 10.1093/nar/gkg600; Cai YZ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000529; Collobert R, 2011, J MACH LEARN RES, V12, P2493; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Ganapathiraju M., 2002, P 2 INT C HUM LANG T, P76; Goldberg Y., 2014, WORD2VEC EXPLAINED D, V1402, P3722; He B, 2009, CELL RES, V19, P929, DOI 10.1038/cr.2009.87; Huynen M, 2000, GENOME RES, V10, P1204, DOI 10.1101/gr.10.8.1204; Jamali T, 2011, INT REV CEL MOL BIO, V287, P233, DOI 10.1016/B978-0-12-386043-9.00006-2; Lasko TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066341; LESLIE C, 2002, P PSB, V7, P566; McGregor E, 2004, J PROTEOME RES, V3, P694, DOI [10.1021/pr040022a, DOI 10.1021/PR040022A]; Mikolov T., 2013, COMPUTING RES REPOSI, V1301, P3781; Mikolov Tomas, 2013, P ADV NEUR INF PROC, P3111, DOI DOI 10.1162/JMLR.2003.3.4-5.951; Mistry J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt263; Motomura K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050039; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Peyro M, 2015, SCI REPORTS IN PRESS; Platzer A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056883; Procter JB, 2010, NAT METHODS, V7, pS16, DOI [10.1038/NMETH.1434, 10.1038/nmeth.1434]; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; Rose PW, 2013, NUCLEIC ACIDS RES, V41, pD475, DOI 10.1093/nar/gks1200; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Searls DB, 2002, NATURE, V420, P211, DOI 10.1038/nature01255; Sickmeier M, 2007, NUCLEIC ACIDS RES, V35, pD786, DOI 10.1093/nar/gkl893; Srinivasan SM, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-96; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Suykens JAK, 1999, NEURAL PROCESS LETT, V9, P293, DOI 10.1023/A:1018628609742; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Vries JK, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-72; Xiong HY, 2015, SCIENCE, V347, DOI 10.1126/science.1254806; Yandell MD, 2002, NAT REV GENET, V3, P601, DOI 10.1038/nrg861	39	336	340	8	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0141287	10.1371/journal.pone.0141287	http://dx.doi.org/10.1371/journal.pone.0141287			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555596	Green Submitted, Green Published, gold			2022-12-27	WOS:000364430700024
J	Bao, L; Messer, K; Schwab, R; Harismendy, O; Pu, MY; Crain, B; Yost, S; Frazer, KA; Rana, B; Hasteh, F; Wallace, A; Parker, BA				Bao, Lei; Messer, Karen; Schwab, Richard; Harismendy, Olivier; Pu, Minya; Crain, Brian; Yost, Shawn; Frazer, Kelly A.; Rana, Brinda; Hasteh, Farnaz; Wallace, Anne; Parker, Barbara A.			Mutational Profiling Can Establish Clonal or Independent Origin in Synchronous Bilateral Breast and Other Tumors	PLoS One			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; CARCINOMA IN-SITU; CANCER; RELATEDNESS; HETEROGENEITY; PROGRESSION; METASTASIS; DISEASE; LESIONS; TESTS	Background Synchronous tumors can be independent primary tumors or a primary-metastatic (clonal) pair, which may have clinical implications. Mutational profiling of tumor DNA is increasingly common in the clinic. We investigated whether mutational profiling can distinguish independent from clonal tumors in breast and other cancers, using a carefully defined test based on the Clonal Likelihood Score (CLS = 100 x # shared high confidence (HC) mutations/ # total HC mutations). Methods Statistical properties of a formal test using the CLS were investigated. A high CLS is evidence in favor of clonality; the test is implemented as a one-sided binomial test of proportions. Test parameters were empirically determined using 16,422 independent breast tumor pairs and 15 primary-metastatic tumor pairs from 10 cancer types using The Cancer Genome Atlas. Results We validated performance of the test with its established parameters, using five published data sets comprising 15,758 known independent tumor pairs (maximum CLS = 4.1%, minimum p-value = 0.48) and 283 known tumor clonal pairs (minimum CLS 13%, maximum p-value < 0.01), across renal cell, testicular, and colorectal cancer. The CLS test correctly classified all validation samples but one, which it appears may have been incorrectly classified in the published data. As proof-of-concept we then applied the CLS test to two new cases of invasive synchronous bilateral breast cancer at our institution, each with one hormone receptor positive (ER+/PR+/HER2-) lobular and one triple negative ductal carcinoma. High confidence mutations were identified by exome sequencing and results were validated using deep targeted sequencing. The first tumor pair had CLS of 81% (p-value < 10-15), supporting clonality. In the second pair, no common mutations of 184 variants were validated (p-value >0.99), supporting independence. A plausible molecular mechanism for the shift from hormone receptor positive to triple negative was identified in the clonal pair. Conclusion We have developed the statistical properties of a carefully defined Clonal Likelihood Score test from mutational profiling of tumor DNA. Under identified conditions, the test appears to reliably distinguish between synchronous tumors of clonal and of independent origin in several cancer types. This approach may have scientific and clinical utility.	[Bao, Lei; Messer, Karen; Pu, Minya; Crain, Brian; Yost, Shawn] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Messer, Karen] Univ Calif San Diego, Dept Family Med & Publ Hlth, Div Biostat, La Jolla, CA 92093 USA; [Schwab, Richard; Parker, Barbara A.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Harismendy, Olivier; Frazer, Kelly A.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Rana, Brinda] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Hasteh, Farnaz] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Wallace, Anne] Univ Calif San Diego, Dept Surg, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Messer, K (corresponding author), Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA.	kmesser@ucsd.edu	Harismendy, Olivier/AAM-2072-2021; Schwab, Richard/AAX-9262-2020	Harismendy, Olivier/0000-0002-8098-9888; Yost, Shawn/0000-0001-6653-1056; Frazer, Kelly/0000-0002-6060-8902	Breast Cancer Research Foundation; National Cancer Institute [5R01CA166293]; NATIONAL CANCER INSTITUTE [R01CA166293, P30CA023100] Funding Source: NIH RePORTER	Breast Cancer Research Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding: This study is supported by a Breast Cancer Research Foundation grant (Parker, PI) and by 5R01CA166293 from the National Cancer Institute.	Agresti A, 2013, CATEGORICAL DATA ANA; Andrade VP, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3222; Balko JM, 2014, CANCER DISCOV, V4, P232, DOI 10.1158/2159-8290.CD-13-0286; Banelli B, 2010, ANN ONCOL, V21, P1237, DOI 10.1093/annonc/mdp470; Bao L, 2014, BIOINFORMATICS; Begg CB, 2007, BIOMETRICS, V63, P522, DOI 10.1111/j.1541-0420.2006.00681.x; Brennan ME, 2009, J CLIN ONCOL, V27, P5640, DOI 10.1200/JCO.2008.21.5756; Chunder N, 2004, PATHOL RES PRACT, V200, P735, DOI 10.1016/j.prp.2004.09.001; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; De Mattos-Arruda L, 2014, MOL ONCOL, V8, P150, DOI 10.1016/j.molonc.2013.10.006; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Gerlinger M, 2014, NAT GENET, V46, P225, DOI 10.1038/ng.2891; Hernandez L, 2012, J PATHOL, V227, P42, DOI 10.1002/path.3990; Heselmeyer-Haddad K, 2012, AM J PATHOL, V181, P1807, DOI 10.1016/j.ajpath.2012.07.012; Hu N, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-576; Imyanitov EN, 2002, INT J CANCER, V100, P557, DOI 10.1002/ijc.10530; Janschek E, 2001, BREAST CANCER RES TR, V67, P1, DOI 10.1023/A:1010661514306; Lee SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090459; LEIS HP, 1978, SURG CLIN N AM, V58, P833; Nemes S, 2013, GENE CHROMOSOME CANC, V52, P1007, DOI 10.1002/gcc.22096; Nichol AM, 2011, J CLIN ONCOL, V29, P4763, DOI 10.1200/JCO.2011.35.0165; Nilsen G, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-591; Ostrovnaya I, 2011, BIOINFORMATICS, V27, P1698, DOI 10.1093/bioinformatics/btr267; Ostrovnaya I, 2010, STAT MED, V29, P1608, DOI 10.1002/sim.3866; Ostrovnaya I, 2010, CLIN CANCER RES, V16, P1358, DOI 10.1158/1078-0432.CCR-09-2398; Ostrovnaya I, 2008, BIOMETRICS, V64, P1018, DOI 10.1111/j.1541-0420.2008.00988.x; Poplawski AB, 2010, EUR J HUM GENET, V18, P560, DOI 10.1038/ejhg.2009.230; Saad RS, 2008, MODERN PATHOL, V21, P1200, DOI 10.1038/modpathol.2008.35; Schmid SM, 2011, EJSO-EUR J SURG ONC, V37, P623, DOI 10.1016/j.ejso.2011.05.006; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Soria JC, 2014, ANN ONCOL, V25, P2244, DOI 10.1093/annonc/mdu390; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Teixeira MR, 2004, BRIT J CANCER, V91, P775, DOI 10.1038/sj.bjc.6602021; Wagner PL, 2009, AM J CLIN PATHOL, V132, P871, DOI 10.1309/AJCP7AK1VWFNMCSW; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764	35	14	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142487	10.1371/journal.pone.0142487	http://dx.doi.org/10.1371/journal.pone.0142487			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26554380	Green Published, gold			2022-12-27	WOS:000364430700114
J	De Gaetano, A; Gaz, C; Palumbo, P; Panunzi, S				De Gaetano, Andrea; Gaz, Claudio; Palumbo, Pasquale; Panunzi, Simona			A Unifying Organ Model of Pancreatic Insulin Secretion	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; BETA-CELL DYSFUNCTION; PLASMA-GLUCOSE; SUSTAINED OSCILLATIONS; MOUSE ISLETS; PULSATILE; SENSITIVITY; RESISTANCE; ENTRAINMENT; GLUCAGON	The secretion of insulin by the pancreas has been the object of much attention over the past several decades. Insulin is known to be secreted by pancreatic beta-cells in response to hyperglycemia: its blood concentrations however exhibit both high-frequency (period approx. 10 minutes) and low-frequency oscillations (period approx. 1.5 hours). Furthermore, characteristic insulin secretory response to challenge maneuvers have been described, such as frequency entrainment upon sinusoidal glycemic stimulation; substantial insulin peaks following minimal glucose administration; progressively strengthened insulin secretion response after repeated administration of the same amount of glucose; insulin and glucose characteristic curves after Intra-Venous administration of glucose boli in healthy and prediabetic subjects as well as in Type 2 Diabetes Mellitus. Previous modeling of beta-cell physiology has been mainly directed to the intracellular chain of events giving rise to single-cell or cell-cluster hormone release oscillations, but the large size, long period and complex morphology of the diverse responses to whole-body glucose stimuli has not yet been coherently explained. Starting with the seminal work of Grodsky it was hypothesized that the population of pancreatic beta-cells, possibly functionally aggregated in islets of Langerhans, could be viewed as a set of independent, similar, but not identical controllers (firing units) with distributed functional parameters. The present work shows how a single model based on a population of independent islet controllers can reproduce very closely a diverse array of actually observed experimental results, with the same set of working parameters. The model's success in reproducing a diverse array of experiments implies that, in order to understand the macroscopic behaviour of the endocrine pancreas in regulating glycemia, there is no need to hypothesize intrapancreatic pacemakers, influences between different islets of Langerhans, glycolitic-induced oscillations or beta-cell sensitivity to the rate of change of glycemia.	[De Gaetano, Andrea; Gaz, Claudio; Palumbo, Pasquale; Panunzi, Simona] UCSC, CNR IASI BioMatLab, Inst Anal Syst & Comp Sci, Italian Natl Res Council,Biomath Lab, I-00168 Rome, Italy; [Gaz, Claudio] Univ Roma La Sapienza, Dept Comp Control & Management Engn DIAG, I-00185 Rome, Italy	Catholic University of the Sacred Heart; Consiglio Nazionale delle Ricerche (CNR); Istituto di Analisi dei Sistemi ed Informatica "Antonio Ruberti" (IASI-CNR); Sapienza University Rome	Gaz, C (corresponding author), UCSC, CNR IASI BioMatLab, Inst Anal Syst & Comp Sci, Italian Natl Res Council,Biomath Lab, Largo A Gemelli 8, I-00168 Rome, Italy.	claudior.gaz@biomatematica.it	De Gaetano, Andrea/AAC-4805-2021; Panunzi, Simona/AAK-9337-2020	PALUMBO, PASQUALE/0000-0002-9371-2802; Panunzi, Simona/0000-0003-0956-8578; De Gaetano, Andrea/0000-0001-7712-056X; GAZ, CLAUDIO ROBERTO/0000-0003-4659-5831				Abdul-Ghani MA, 2006, DIABETES CARE, V29, P1130, DOI 10.2337/dc05-2179; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; ANDERSON GE, 1967, METABOLISM, V16, P586, DOI 10.1016/0026-0495(67)90002-9; Bennett DL, 2004, APPL MATH COMPUT, V151, P189, DOI 10.1016/S0096-3003(03)00332-1; Bergman RN, 2002, EUR J CLIN INVEST, V32, P35, DOI 10.1046/j.1365-2362.32.s3.5.x; BERGMAN RN, 1979, AM J PHYSIOL, V236, pE667, DOI 10.1152/ajpendo.1979.236.6.E667; BERGSTEN P, 1993, DIABETES, V42, P670, DOI 10.2337/diabetes.42.5.670; Bertram R, 2004, BIOPHYS J, V87, P3074, DOI 10.1529/biophysj.104.049262; Bertram R, 2004, B MATH BIOL, V66, P1313, DOI 10.1016/j.bulm.2003.12.005; Bertuzzi A, 2007, AM J PHYSIOL-ENDOC M, V293, pE396, DOI 10.1152/ajpendo.00647.2006; Bugianesi E, 2005, HEPATOLOGY, V42, P987, DOI 10.1002/hep.20920; Cavaghan MK, 1997, J CLIN INVEST, V100, P530, DOI 10.1172/JCI119562; Chen YD, 2008, BIOPHYS J, V95, P2226, DOI 10.1529/biophysj.107.124990; CHOU HF, 1991, LIFE SCI, V48, P1463, DOI 10.1016/0024-3205(91)90183-C; CHOU HF, 1990, DIABETES, V39, P112, DOI 10.2337/diabetes.39.1.112; De Gaetano A, 2000, J MATH BIOL, V40, P136, DOI 10.1007/s002850050007; De Gaetano A, 2013, IEEE DECIS CONTR P, P3355, DOI 10.1109/CDC.2013.6760396; De Gaetano A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070875; DEFRONZO RA, 1988, DIABETES, V37, P667, DOI 10.2337/diab.37.6.667; DIAMOND MP, 1995, J SOC GYNECOL INVEST, V2, P708, DOI 10.1016/1071-5576(95)00023-8; DOUGLAS WW, 1968, BRIT J PHARMACOL, V34, P451, DOI 10.1111/j.1476-5381.1968.tb08474.x; EDDLESTONE GT, 1984, J MEMBRANE BIOL, V77, P1, DOI 10.1007/BF01871095; EHRMANN DA, 1995, J CLIN INVEST, V96, P520, DOI 10.1172/JCI118064; Engelborghs K, 2001, J MATH BIOL, V42, P361, DOI 10.1007/s002850000072; Faerch K, 2008, DIABETOLOGIA, V51, P853, DOI 10.1007/s00125-008-0951-x; Festa A, 2004, DIABETES, V53, P1549, DOI 10.2337/diabetes.53.6.1549; GOODNER CJ, 1982, SCIENCE, V215, P1257, DOI 10.1126/science.7036347; GOODNER CJ, 1991, AM J PHYSIOL, V260, pE422, DOI 10.1152/ajpendo.1991.260.3.E422; GOODNER CJ, 1977, SCIENCE, V195, P177, DOI 10.1126/science.401543; GRODSKY GM, 1972, J CLIN INVEST, V51, P2047, DOI 10.1172/JCI107011; Gutenkunst RN, 2007, PLOS COMPUT BIOL, V3, P1871, DOI 10.1371/journal.pcbi.0030189; Hansen KM, 1923, ACTA ENDOCRINOL COPE; Hollingdal M, 2000, DIABETES, V49, P1334, DOI 10.2337/diabetes.49.8.1334; Juhl C, 2002, DIABETES, V51, pS255, DOI 10.2337/diabetes.51.2007.S255; KAHN SE, 1993, DIABETES, V42, P1663, DOI 10.2337/diabetes.42.11.1663; KOERKER DJ, 1978, ENDOCRINOLOGY, V102, P1649, DOI 10.1210/endo-102-5-1649; LANG DA, 1982, DIABETES, V31, P22, DOI 10.2337/diabetes.31.1.22; LANG DA, 1979, NEW ENGL J MED, V301, P1023, DOI 10.1056/NEJM197911083011903; Larsen MO, 2002, DIABETOLOGIA, V45, P1389, DOI 10.1007/s00125-002-0928-0; Li JX, 2006, J THEOR BIOL, V242, P722, DOI 10.1016/j.jtbi.2006.04.002; Low JT, 2013, DIABETOLOGIA, V56, P2629, DOI 10.1007/s00125-013-3019-5; Man CD, 2007, IEEE T BIO-MED ENG, V54, P1740, DOI 10.1109/TBME.2007.893506; Mao CS, 2004, AM J PHYSIOL-ENDOC M, V287, pE50, DOI 10.1152/ajpendo.00555.2003; Mao CS, 1999, DIABETES, V48, P714, DOI 10.2337/diabetes.48.4.714; Mari A, 2002, DIABETES, V51, pS221, DOI 10.2337/diabetes.51.2007.S221; MATTHEWS DR, 1987, ENDOCRINOLOGY, V120, P2272, DOI 10.1210/endo-120-6-2272; Meda P, 2013, DIABETOLOGIA, V56, P2552, DOI 10.1007/s00125-013-3073-z; MEISSNER HP, 1976, NATURE, V262, P502, DOI 10.1038/262502a0; MILLSAPS K, 1975, Mathematical Biosciences, V23, P237, DOI 10.1016/0025-5564(75)90038-3; OMEARA NM, 1993, J CLIN INVEST, V92, P262, DOI 10.1172/JCI116560; Osei K, 1997, DIABETES CARE, V20, P396, DOI 10.2337/diacare.20.3.396; Overgaard RV, 2006, ANN BIOMED ENG, V34, P1343, DOI 10.1007/s10439-006-9154-0; Palumbo P, 2007, DISCRETE CONT DYN-B, V7, P399; Palumbo P, 2010, J MATH BIOL, V61, P171, DOI 10.1007/s00285-009-0297-0; Panunzi S, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-35; Pedersen MG, 2005, BIOPHYS J, V89, P107, DOI 10.1529/biophysj.104.055681; Pedersen MG, 2014, INTERFACE FOCUS; Pedersen MG, 2008, PHILOS T R SOC A, V366, P3525, DOI 10.1098/rsta.2008.0120; Pedersen MG, 2011, IEEE T BIO-MED ENG, V58, P3020, DOI 10.1109/TBME.2011.2164918; Pedersen MG, 2010, AM J PHYSIOL-ENDOC M, V298, pE597, DOI 10.1152/ajpendo.00670.2009; Pedersen MG, 2009, P NATL ACAD SCI USA, V106, P7432, DOI 10.1073/pnas.0901202106; PIPELEERS D, 1994, DIABETOLOGIA, V37, pS57, DOI 10.1007/BF00400827; POLONSKY KS, 1988, J CLIN INVEST, V81, P442, DOI 10.1172/JCI113339; Porksen N, 1997, AM J PHYSIOL-ENDOC M, V273, pE908; PORKSEN N, 1994, J CLIN INVEST, V94, P219, DOI 10.1172/JCI117310; PORKSEN N, 1995, AM J PHYSIOL-ENDOC M, V269, pE478, DOI 10.1152/ajpendo.1995.269.3.E478; Porksen N., 2000, AM J PHYSL ENDOCRINO, V278; Pratley RE, 2001, DIABETOLOGIA, V44, P929, DOI 10.1007/s001250100580; ROSSETTI L, 1990, DIABETES CARE, V13, P610, DOI 10.2337/diacare.13.6.610; SALOMON D, 1986, EXP CELL RES, V162, P507, DOI 10.1016/0014-4827(86)90354-X; SANDOW A, 1952, YALE J BIOL MED, V25, P176; SCHUIT FC, 1988, P NATL ACAD SCI USA, V85, P3865, DOI 10.1073/pnas.85.11.3865; SCOTT AM, 1981, DIABETOLOGIA, V21, P470; SHAPIRO ET, 1988, J CLIN ENDOCR METAB, V67, P307, DOI 10.1210/jcem-67-2-307; SIMON C, 1987, J CLIN ENDOCR METAB, V64, P669, DOI 10.1210/jcem-64-4-669; Simon C, 2000, AM J PHYSIOL-ENDOC M, V278, pE413, DOI 10.1152/ajpendo.2000.278.3.E413; Simon C, 2002, DIABETES, V51, pS258, DOI 10.2337/diabetes.51.2007.S258; SMOLEN P, 1995, J THEOR BIOL, V174, P137, DOI 10.1006/jtbi.1995.0087; STAGNER JI, 1985, AM J PHYSIOL, V248, pE522, DOI 10.1152/ajpendo.1985.248.5.E522; STAGNER JI, 1980, J CLIN INVEST, V65, P939, DOI 10.1172/JCI109750; STAGNER JI, 1985, AM J PHYSIOL, V248, pE516, DOI 10.1152/ajpendo.1985.248.5.E516; Stamper IJ, 2013, J THEOR BIOL, V318, P210, DOI 10.1016/j.jtbi.2012.11.002; STURIS J, 1994, AM J PHYSIOL, V267, pE250, DOI 10.1152/ajpendo.1994.267.2.E250; STURIS J, 1991, J CLIN INVEST, V87, P439, DOI 10.1172/JCI115015; TOFFOLO G, 1980, DIABETES, V29, P979, DOI 10.2337/diabetes.29.12.979; Toschi E, 2002, DIABETES, V51, pS130, DOI 10.2337/diabetes.51.2007.S130; Watson EM, 2011, COMPUT METH PROG BIO, V102, P119, DOI 10.1016/j.cmpb.2010.08.013; Weyer C, 1999, DIABETES, V48, P2197, DOI 10.2337/diabetes.48.11.2197	88	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142344	10.1371/journal.pone.0142344	http://dx.doi.org/10.1371/journal.pone.0142344			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555895	Green Published, Green Submitted, gold			2022-12-27	WOS:000364430700087
J	Ni, HB; Liu, HX; Gao, R				Ni, Haibo; Liu, Huixiang; Gao, Rong			Serum Lipids and Breast Cancer Risk: A Meta-Analysis of Prospective Cohort Studies	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; METABOLIC SYNDROME; TREND ESTIMATION; BLOOD-LIPIDS; DYSLIPIDEMIA; POPULATION; WEIGHT; LEVEL; WOMEN; SCALE	Purpose Epidemiologic studies exploring causal associations between serum lipids and breast cancer risk have reported contradictory results. We conducted a meta-analysis of prospective cohort studies to evaluate these associations. Methods Relevant studies were identified by searching PubMed and EMBASE through April 2015. We included prospective cohort studies that reported relative risk (RR) estimates with 95% confidence intervals (CIs) for the associations of specific lipid components (i.e., total cholesterol [TC], high-density lipoprotein cholesterol [HDL-C], low-density lipoprotein cholesterol [LDL-C], and triglycerides [TG]) with breast cancer risk. Either a fixed-or a random-effects model was used to calculate pooled RRs. Results Fifteen prospective cohort studies involving 1,189,635 participants and 23,369 breast cancer cases were included in the meta-analysis. The pooled RRs of breast cancer for the highest versus lowest categories were 0.96 (95% CI: 0.86-1.07) for TC, 0.92 (95% CI: 0.73-1.16) for HDL-C, 0.90 (95% CI: 0.77-1.06) for LDL-C, and 0.93 (95% CI: 0.86-1.00) for TG. Notably, for HDL-C, a significant reduction of breast cancer risk was observed among postmenopausal women (RR = 0.77, 95% CI: 0.64-0.93) but not among premenopausal women. Similar trends of the associations were observed in the dose-response analysis. Conclusions Our findings suggest that serum levels of TG but not TC and LDL-C may be inversely associated with breast cancer risk. Serum HDL-C may also protect against breast carcinogenesis among postmenopausal women.	[Ni, Haibo; Liu, Huixiang; Gao, Rong] First Peoples Hosp Zhangjiagang City, Dept Neurosurg, Suzhou, Jiangsu, Peoples R China		Gao, R (corresponding author), First Peoples Hosp Zhangjiagang City, Dept Neurosurg, Suzhou, Jiangsu, Peoples R China.	tsong@vip.sina.com						Abdelsalam KEA, 2012, J RES MED SCI, V17, P562; Agnoli C, 2010, NUTR METAB CARDIOVAS, V20, P41, DOI 10.1016/j.numecd.2009.02.006; Araujo F, 2014, EUR J PREV CARDIOL, V21, P1004, DOI 10.1177/2047487313497864; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; BERNSTEIN L, 1993, EPIDEMIOL REV, V15, P48, DOI 10.1093/oxfordjournals.epirev.a036116; Bjorge T, 2010, CANCER EPIDEM BIOMAR, V19, P1737, DOI 10.1158/1055-9965.EPI-10-0230; Borena W, 2011, CANCER CAUSE CONTROL, V22, P291, DOI 10.1007/s10552-010-9697-0; Bosco JLF, 2012, BREAST CANCER RES TR, V134, P1247, DOI 10.1007/s10549-012-2131-4; BOYD NF, 1991, FREE RADICAL BIO MED, V10, P185, DOI 10.1016/0891-5849(91)90074-D; Capasso I, 2010, CANCER BIOL THER, V10, P1240, DOI 10.4161/cbt.10.12.13473; Danilo C, 2012, CURR OPIN PHARMACOL, V12, P677, DOI 10.1016/j.coph.2012.07.009; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eliassen AH, 2008, ADV EXP MED BIOL, V630, P148; Eliassen AH, 2005, ARCH INTERN MED, V165, P2264, DOI 10.1001/archinte.165.19.2264; Esposito K, 2013, MENOPAUSE, V20, P1301, DOI [10.1097/GME.0b013e31828ce95d, 10.1097/gme.0b013e31828ce95d]; Esteve E, 2005, CLIN NUTR, V24, P16, DOI 10.1016/j.clnu.2004.08.004; Fagherazzi G, 2010, EUR J CANCER PREV, V19, P120, DOI 10.1097/CEJ.0b013e3283354918; Furberg AS, 2004, J NATL CANCER I, V96, P1152, DOI 10.1093/jnci/djh216; GAARD M, 1994, CANCER CAUSE CONTROL, V5, P501, DOI 10.1007/BF01831377; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237; Ha M, 2009, CANCER CAUSE CONTROL, V20, P1055, DOI 10.1007/s10552-009-9301-7; Hamling J, 2008, STAT MED, V27, P954, DOI 10.1002/sim.3013; HIATT RA, 1982, J NATL CANCER I, V68, P885; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; His M, 2014, EUR J EPIDEMIOL, V29, P119, DOI 10.1007/s10654-014-9884-5; Hokanson J E, 1996, J Cardiovasc Risk, V3, P213, DOI 10.1097/00043798-199604000-00014; HOYER AP, 1992, CANCER CAUSE CONTROL, V3, P403, DOI 10.1007/BF00051352; Inoue M, 2009, EUR J CANCER PREV, V18, P240, DOI 10.1097/CEJ.0b013e3283240460; Iso H, 2009, INT J CANCER, V125, P2679, DOI 10.1002/ijc.24668; Kabat GC, 2009, CANCER EPIDEM BIOMAR, V18, P2046, DOI 10.1158/1055-9965.EPI-09-0235; Kelley GA, 2012, CLIN NUTR, V31, P156, DOI 10.1016/j.clnu.2011.11.011; Kitahara CM, 2011, J CLIN ONCOL, V29, P1592, DOI 10.1200/JCO.2010.31.5200; Kucharska-Newton AM, 2008, ANN EPIDEMIOL, V18, P671, DOI 10.1016/j.annepidem.2008.06.006; Langsenlehner U, 2005, BREAST CANCER RES TR, V90, P113, DOI 10.1007/s10549-004-3607-7; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Mainous AG, 2005, AM J EPIDEMIOL, V161, P1115, DOI 10.1093/aje/kwi131; Manjer J, 2001, EUR J CANCER PREV, V10, P281, DOI 10.1097/00008469-200106000-00013; Manjer J, 2001, EUR J CANCER PREV, V10, P33, DOI 10.1097/00008469-200102000-00004; Melvin JC, 2012, CANCER EPIDEM BIOMAR, V21, P1381, DOI 10.1158/1055-9965.EPI-12-0188; Moorman PG, 1998, CANCER EPIDEM BIOMAR, V7, P483; Nelson ER, 2014, TRENDS ENDOCRIN MET, V25, P649, DOI 10.1016/j.tem.2014.10.001; Orsini N, 2006, STATA J, V6, P40, DOI 10.1177/1536867X0600600103; Osaki Y, 2012, CANCER EPIDEMIOL, V36, P141, DOI 10.1016/j.canep.2011.03.007; Ray G, 2001, CLIN BIOCHEM, V34, P71, DOI 10.1016/S0009-9120(00)00200-9; Reeves KW, 2012, CANCER CAUSE CONTROL, V23, P1241, DOI 10.1007/s10552-012-0002-2; Rossi RE, 2014, ANTICANCER RES, V34, P6861; Sarrel PM, 1998, SEMIN REPROD ENDOCR, V16, P121, DOI 10.1055/s-2007-1016262; Schernhammer ES, 2005, CANCER EPIDEM BIOMAR, V14, P699, DOI 10.1158/1055-9965.EPI-04-0561; Smith DG, 2007, AM J MANAG CARE, V13, pS68; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Strohmaier S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054242; TORNBERG SA, 1988, ACTA ONCOL, V27, P31; Tulinius H, 1997, CANCER EPIDEM BIOMAR, V6, P863; Undela K, 2012, BREAST CANCER RES TR, V135, P261, DOI 10.1007/s10549-012-2154-x; VATTEN LJ, 1990, CANCER RES, V50, P2341	55	69	71	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142669	10.1371/journal.pone.0142669	http://dx.doi.org/10.1371/journal.pone.0142669			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26554382	gold, Green Published, Green Submitted			2022-12-27	WOS:000364430700154
J	Niziolek, PJ; Bullock, W; Warman, ML; Robling, AG				Niziolek, Paul J.; Bullock, Whitney; Warman, Matthew L.; Robling, Alexander G.			Missense Mutations in LRP5 Associated with High Bone Mass Protect the Mouse Skeleton from Disuse- and Ovariectomy-Induced Osteopenia	PLOS ONE			English	Article							WNT SIGNALING PATHWAY; SCLEROSTIN; RECEPTOR; OSTEOBLASTS; INHIBITION; DENSITY; OSTEOPOROSIS; INCREASES; MUSCLE; LIGAND	The low density lipoprotein receptor-related protein-5 (LRP5), a co-receptor in the Wnt signaling pathway, modulates bone mass in humans and in mice. Lrp5 knock-out mice have severely impaired responsiveness to mechanical stimulation whereas Lrp5 gain-of-function knock-in and transgenic mice have enhanced responsiveness to mechanical stimulation. Those observations highlight the importance of Lrp5 protein in bone cell mechanotransduction. It is unclear if and how high bone mass-causing (HBM) point mutations in Lrp5 alter the bone-wasting effects of mechanical disuse. To address this issue we explored the skeletal effects of mechanical disuse using two models, tail suspension and Botulinum toxin-induced muscle paralysis, in two different Lrp5 HBM knock-in mouse models. A separate experiment employing estrogen withdrawal-induced bone loss by ovariectomy was also conducted as a control. Both disuse stimuli induced significant bone loss in WT mice, but Lrp5 A214V and G171V were partially or fully protected from the bone loss that normally results from disuse. Trabecular bone parameters among HBM mice were significantly affected by disuse in both models, but these data are consistent with DEXA data showing a failure to continue growing in HBM mice, rather than a loss of pre-existing bone. Ovariectomy in Lrp5 HBM mice resulted in similar protection from catabolism as was observed for the disuse experiments. In conclusion, the Lrp5 HBM alleles offer significant protection from the resorptive effects of disuse and from estrogen withdrawal, and consequently, present a potential mechanism to mimic with pharmaceutical intervention to protect against various bone-wasting stimuli.	[Niziolek, Paul J.; Bullock, Whitney; Robling, Alexander G.] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA; [Niziolek, Paul J.] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Warman, Matthew L.] Childrens Hosp, Dept Orthopaed Surg, Boston, MA 02115 USA; [Warman, Matthew L.] Harvard Univ, Howard Hughes Med Inst, Sch Med, Dept Genet, Cambridge, MA 02138 USA; [Robling, Alexander G.] Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46202 USA; [Robling, Alexander G.] Richard L Roudebush VA Med Ctr, Indianapolis, IN USA	Indiana University System; Indiana University Bloomington; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Harvard University; Boston Children's Hospital; Harvard University; Howard Hughes Medical Institute; Indiana University System; Indiana University-Purdue University Indianapolis; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center	Robling, AG (corresponding author), Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA.	arobling@iupui.edu		Bullock, Whitney/0000-0001-9008-8314	PHS (NCCR) [5TL1RR025759-02]; NIH [AR53237]; VA [BX001478]; Howard Hughes Medical Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR025759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053237] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001478] Funding Source: NIH RePORTER	PHS (NCCR)(Swiss National Science Foundation (SNSF)United States Department of Health & Human ServicesUnited States Public Health Service); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA(US Department of Veterans Affairs); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by PHS (NCCR) grant 5TL1RR025759-02 (A. Shekhar, PI; trainee recipient is PJN), NIH grant AR53237 and VA grant BX001478 (to AGR), and the Howard Hughes Medical Institute (to MLW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai M, 2005, MOL CELL BIOL, V25, P4946, DOI 10.1128/MCB.25.12.4946-4955.2005; Atti E, 2008, J BONE MINER RES, V23, pS362; Balemans W, 2006, BONE, V38, pS6, DOI 10.1016/j.bone.2005.01.064; Balemans W, 2008, CALCIFIED TISSUE INT, V82, P445, DOI 10.1007/s00223-008-9130-9; Bauman WA, 2015, PM&R, V7, P188, DOI 10.1016/j.pmrj.2014.08.948; Bex F, 2003, J BONE MINER RES, V18, pS60; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Choi HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007930; Cui Y, 2010, LRP5 FUNCTIONS BONE; Cui YJ, 2011, NAT MED, V17, P684, DOI 10.1038/nm.2388; Ellies DL, 2006, J BONE MINER RES, V21, P1738, DOI 10.1359/JBMR.060810; Ellies DL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096257; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Hens JR, 2005, J BONE MINER RES, V20, P1103, DOI 10.1359/JBMR.050210; Johnson ML, 2006, REV ENDOCR METAB DIS, V7, P41, DOI 10.1007/s1154-006-9003-3; Kang KS, 2015, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00246; Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785; Koay MA, 2005, TRENDS MOL MED, V11, P129, DOI 10.1016/j.molmed.2005.01.004; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Levasseur R, 2005, JOINT BONE SPINE, V72, P207, DOI 10.1016/j.jbspin.2004.10.008; Li J, 2006, BONE, V39, P754, DOI 10.1016/j.bone.2006.03.017; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; Lin CW, 2009, J BONE MINER RES, V24, P1651, DOI [10.1359/JBMR.090411, 10.1359/jbmr.090411]; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Manske SL, 2010, BONE, V46, P24, DOI 10.1016/j.bone.2009.10.016; Minisola S, 2014, EXPERT OPIN BIOL TH, V14, P1225, DOI 10.1517/14712598.2014.920815; Mulder E, 2015, EUR J APPL PHYSIOL, V115, P727, DOI 10.1007/s00421-014-3045-0; Nagaraja MP, 2013, J CELL BIOCHEM, V114, P1001, DOI 10.1002/jcb.24454; Nevill AM, 2003, BONE, V32, P62, DOI 10.1016/S8756-3282(02)00927-4; Niziolek PJ, 2015, J BONE MINER RES, V30, P1822, DOI 10.1002/jbmr.2514; Niziolek PJ, 2011, BONE, V49, P1010, DOI 10.1016/j.bone.2011.07.034; Oliver L., 2009, J BONE MINER RES, V24, pS77; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; Sawakami K, 2006, J BIOL CHEM, V281, P23698, DOI 10.1074/jbc.M601000200; Saxon LK, 2011, BONE, V49, P184, DOI 10.1016/j.bone.2011.03.683; Semenov M, 2005, J BIOL CHEM, V280, P26770, DOI 10.1074/jbc.M504308200; Seynnes OR, 2010, J MUSCULOSKEL NEURON, V10, P124; Shackelford LC, 2004, J APPL PHYSIOL, V97, P119, DOI 10.1152/japplphysiol.00741.2003; Shah AD, 2015, INT J WOMENS HEALTH, V7, P565, DOI 10.2147/IJWH.S73244; Spatz JM, 2013, J BONE MINER RES, V28, P865, DOI 10.1002/jbmr.1807; Tian XY, 2011, BONE, V48, P197, DOI 10.1016/j.bone.2010.09.009; Tu X, 2010, ASBMR; Warner SE, 2006, BONE, V38, P257, DOI 10.1016/j.bone.2005.08.009; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Williams BO, 2009, J BONE MINER RES, V24, P171, DOI [10.1359/JBMR.081235, 10.1359/jbmr.081235]; Xiong L, 2015, P NATL ACAD SCI USA, V112, P3487, DOI 10.1073/pnas.1419714112; Zehnder Y, 2004, OSTEOPOROSIS INT, V15, P180, DOI 10.1007/s00198-003-1529-6	47	18	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0140775	10.1371/journal.pone.0140775	http://dx.doi.org/10.1371/journal.pone.0140775			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26554834	Green Published, gold			2022-12-27	WOS:000364430700017
J	Wang, R; Chen, L; Fan, L; Gao, DW; Liang, ZR; He, J; Gong, WQ; Gao, LG				Wang, Rong; Chen, Lei; Fan, Li; Gao, Dewei; Liang, Zhiru; He, Jing; Gong, Weiqin; Gao, Linggen			Incidence and Effects of Polypharmacy on Clinical Outcome among Patients Aged 80(+): A Five-Year Follow-Up Study	PLOS ONE			English	Article							ADVERSE DRUG EVENTS; OLDER-ADULTS; POTENTIALLY INAPPROPRIATE; ELDERLY-PATIENTS; MEDICATION USE; HIP FRACTURE; RISK-FACTOR; FALL-RISK; MORTALITY; FRAILTY	Objectives Polypharmacy is a problem of growing interest in geriatrics with the increase in drug consumption in recent years, is defined according to the WHO criteria as the, "concurrent use of five or more different prescription medication". We investigated the clinical characteristics of polypharmacy and identified the effects of polypharmacy on clinical outcome among patients aged 80+ admitted to Chinese PLA general hospital. Methods Older men aged >= 80 years (n = 1562) were included in this study. The included participants attended a structured clinical examination and an interview carried out by a geriatrician and trained nurses. A follow-up survey in 2014 was carried out on survivors in the same way as in 2009. The clinical outcome measured were adverse drug reactions, falls, frailty, disability, cognitive impairment, mortality. The association between polypharmacy and clinical outcome was assessed by logistic regression. Results The mean (range) age of the included participants was 85.2 (80-104) years. Medication exposure was reported by 100% of the population. Mean number of medications reported in this population was 9.56 +/- 5.68. The prevalence of polypharmacy (>= 6 medications) in the present study was 70%. At the time of the follow-up survey, an increase in the number of taken medicines had occurred among half of the survivors. The risk of different outcomes in relation to number of medications rises significantly, the odds ratios were 1.21 (95% confidence interval [CI] 1.17-1.28) for adverse drug reactions, 1.18 (95% CI 1.10-1.26) for falls, 1.16 (95% CI 1.09-1.24) for disability, and 1.19 (95% CI 1.12-1.23) for mortality. There was no association between increasing number of medications and cognitive impairment. Conclusions Our study demonstrates that polypharmacy is very common in the very old patients, and observed that number of medications was a factor associated with difference clinical outcome independently of the age, type of medications prescribed and accompanied comorbidities.	[Wang, Rong; Gao, Dewei; Liang, Zhiru; He, Jing; Gong, Weiqin; Gao, Linggen] Gen Hosp Chinese Peoples Liberat Army, Dept Comprehens Surg, Beijing, Peoples R China; [Chen, Lei] Gen Hosp Chinese Peoples Liberat Army, Dept Thorac Surg, Beijing, Peoples R China; [Fan, Li] Gen Hosp Chinese Peoples Liberat Army, Dept Geriatr Cardiol, Beijing, Peoples R China		Fan, L (corresponding author), Gen Hosp Chinese Peoples Liberat Army, Dept Geriatr Cardiol, Beijing, Peoples R China.	fanlighcpl@gmail.com; gaodeweigdw@163.com			China Postdoctoral Science Foundation [2012T50865]; Military Healthcare Fund [12BJZ39]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Military Healthcare Fund	This work was supported by a general financial grant from the China Postdoctoral Science Foundation (2012T50865, to L.Gao.) and a grant from the Military Healthcare Fund 12BJZ39 (to L. Fan).	Aparasu RR, 2000, ANN PHARMACOTHER, V34, P338, DOI 10.1345/aph.19006; Bergman H, 2007, J GERONTOL A-BIOL, V62, P731, DOI 10.1093/gerona/62.7.731; Bourgeois FT, 2010, PHARMACOEPIDEM DR S, V19, P901, DOI 10.1002/pds.1984; Caselli G., 2002, GENUS, P9; Damian J, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-6; Edwards IR, 2000, LANCET, V356, P1255, DOI 10.1016/S0140-6736(00)02799-9; Espino DV, 2006, J GERONTOL A-BIOL, V61, P170, DOI 10.1093/gerona/61.2.170; Fialova D, 2005, JAMA-J AM MED ASSOC, V293, P1348, DOI 10.1001/jama.293.11.1348; Field TS, 2004, J AM GERIATR SOC, V52, P1349, DOI 10.1111/j.1532-5415.2004.52367.x; Fletcher Paula C, 2009, J Patient Saf, V5, P61, DOI 10.1097/PTS.0b013e3181a551ed; Frazier Susan C, 2005, J Gerontol Nurs, V31, P4; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Fried LP, 2004, J GERONTOL A-BIOL, V59, P255; Fulton Maryann M, 2005, J Am Acad Nurse Pract, V17, P123, DOI 10.1111/j.1041-2972.2005.0020.x; Gandhi TK, 2003, NEW ENGL J MED, V348, P1556, DOI 10.1056/NEJMsa020703; Haider SI, 2007, INT J CLIN PHARM TH, V45, P643; Haleem S, 2008, INJURY, V39, P1157, DOI 10.1016/j.injury.2008.03.022; Harper K, 2010, INT J ENV RES PUB HE, V7, P675, DOI 10.3390/ijerph7020675; Hilmer SN, 2009, CLIN PHARMACOL THER, V85, P86, DOI 10.1038/clpt.2008.224; Hilmer SN, 2012, J GERONTOL A-BIOL, V67, P181, DOI 10.1093/gerona/glr066; Jyrkka J, 2009, DRUG AGING, V26, P493, DOI 10.2165/00002512-200926060-00006; KATZ S, 1970, GERONTOLOGIST, V10, P20, DOI 10.1093/geront/10.1_Part_1.20; Kojima T, 2011, GERIATR GERONTOL INT, V11, P438, DOI 10.1111/j.1447-0594.2011.00703.x; Lai SW, 2010, MEDICINE, V89, P295, DOI 10.1097/MD.0b013e3181f15efc; Lau DT, 2005, ARCH INTERN MED, V165, P68, DOI 10.1001/archinte.165.1.68; Lee CY, 2011, NEUROUROL URODYNAM, V30, P1286, DOI 10.1002/nau.21044; Maher RL, 2014, EXPERT OPIN DRUG SAF, V13, P57, DOI 10.1517/14740338.2013.827660; Mansur N, 2008, ANN PHARMACOTHER, V42, P783, DOI 10.1345/aph.1L070; Pozzi C, 2010, PHARMACOEPIDEM DR S, V19, P954, DOI 10.1002/pds.1997; Schafer I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015941; Tromp AM, 2001, J CLIN EPIDEMIOL, V54, P837, DOI 10.1016/S0895-4356(01)00349-3; United Nations, 2002, WORLD POP AG; US General Accounting Office, 1995, PUBL GAO HEHS; Ziere G, 2006, BRIT J CLIN PHARMACO, V61, P218, DOI 10.1111/j.1365-2125.2005.02543.x	34	46	46	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142123	10.1371/journal.pone.0142123	http://dx.doi.org/10.1371/journal.pone.0142123			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7CT	26554710	Green Published, gold, Green Submitted			2022-12-27	WOS:000364430700056
J	Dean, GS; Clifford, D; Whelan, AO; Tchilian, EZ; Beverley, PCL; Salguero, FJ; Xing, Z; Vordermeier, HM; Villarreal-Ramos, B				Dean, Gillian S.; Clifford, Derek; Whelan, Adam O.; Tchilian, Elma Z.; Beverley, Peter C. L.; Salguero, Francisco J.; Xing, Zhou; Vordermeier, Hans M.; Villarreal-Ramos, Bernardo			Protection Induced by Simultaneous Subcutaneous and Endobronchial Vaccination with BCG/BCG and BCG/Adenovirus Expressing Antigen 85A against Mycobacterium bovis in Cattle	PLOS ONE			English	Article							BCG; TUBERCULOSIS; IMMUNIZATION; RESPONSES; VACCINES; MUCOSAL	The incidence of bovine tuberculosis (bTB) in the GB has been increasing since the 1980s. Immunisation, alongside current control measures, has been proposed as a sustainable measure to control bTB. Immunisation with Mycobacterium bovis bacillus Calmette-Guerin (BCG) has been shown to protect against bTB. Furthermore, much experimental data indicates that pulmonary local immunity is important for protection against respiratory infections including Mycobacterium tuberculosis and that pulmonary immunisation is highly effective. Here, we evaluated protection against M. bovis, the main causative agent of bTB, conferred by BCG delivered subcutaneously, endobronchially or by the new strategy of simultaneous immunisation by both routes. We also tested simultaneous subcutaneous immunisation with BCG and endobronchial delivery of a recombinant type 5 adenovirus expressing mycobacterial antigen 85A. There was significantly reduced visible pathology in animals receiving the simultaneous BCG/BCG or BCG/Ad85 treatment compared to naive controls. Furthermore, there were significantly fewer advanced microscopic granulomata in animals receiving BCG/Ad85A compared to naive controls. Thus, combining local and systemic immunisation limits the development of pathology, which in turn could decrease bTB transmission.	[Dean, Gillian S.; Clifford, Derek; Whelan, Adam O.; Salguero, Francisco J.; Vordermeier, Hans M.; Villarreal-Ramos, Bernardo] APHA Weybridge, TB Res Grp, New Haw KT15 3NB, Surrey, England; [Xing, Zhou] McMaster Univ, McMaster Immunol Res Ctr, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Tchilian, Elma Z.; Beverley, Peter C. L.] Univ Oxford, Peter Medawar Bldg Pathogen Res, Oxford, England	McMaster University; University of Oxford	Villarreal-Ramos, B (corresponding author), APHA Weybridge, TB Res Grp, Woodham Lane, New Haw KT15 3NB, Surrey, England.	Bernardo.Villarreal-Ramos@apha.gsi.gov.uk	Tchilian, Elma Z/Q-5976-2017; Salguero, Francisco J/A-7336-2010; Vordermeier, H Martin/C-6936-2011	Tchilian, Elma Z/0000-0002-4869-5118; Beverley, Peter/0000-0003-0481-2180; Salguero, Francisco Javier/0000-0002-5315-3882	 [SE3266];  [60701235]; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001932] Funding Source: researchfish; Medical Research Council [G1100085, G0701235] Funding Source: researchfish; BBSRC [BBS/E/I/00001932] Funding Source: UKRI; MRC [G1100085, G0701235] Funding Source: UKRI	; ; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	SE3266 (https://www.gov.uk/government/organisations/department-for-environment-food-ruralaffairs) HMV BVR AOW GSD DC FJS, 60701235 (http://www.mrc.ac.uk/) EZT PCLB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranday-Cortes E, 2012, TRANSBOUND EMERG DIS, DOI [10.1111/tbed.12035, DOI 10.1111/TBED.12035]; Calmette A, 1931, Proc R Soc Med, V24, P1481; Dean G, 2014, VACCINE, V32, P1304, DOI 10.1016/j.vaccine.2013.11.045; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; Forbes EK, 2008, J IMMUNOL, V181, P4955, DOI 10.4049/jimmunol.181.7.4955; Griffin JFT, 2001, TUBERCULOSIS, V81, P133, DOI 10.1054/tube.2000.0271; Krebs J., 1997, PB3423 HMSO; Lightbody KA, 1998, VET REC, V142, P295, DOI 10.1136/vr.142.12.295; Ronan EO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008235; Santosuosso M, 2006, INFECT IMMUN, V74, P4634, DOI 10.1128/IAI.00517-06; Smaill F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006843; Tchilian EZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027477; Villarreal-Ramos B, 2006, VACCINE, V24, P6850, DOI 10.1016/j.vaccine.2006.06.034; Vordermeier HM, 2009, INFECT IMMUN, V77, P3364, DOI 10.1128/IAI.00287-09; Vordermeier HM, 2004, IMMUNOLOGY, V112, P461, DOI 10.1111/j.1365-2567.2004.01903.x; Vordermeier HM, 2002, INFECT IMMUN, V70, P3026, DOI 10.1128/IAI.70.6.3026-3032.2002; Vordermeier HM, 2006, VET J, V171, P229, DOI 10.1016/j.tvjl.2004.11.001; Wang J, 2004, J IMMUNOL, V173, P6357, DOI 10.4049/jimmunol.173.10.6357; Wangoo A, 2005, J COMP PATHOL, V133, P223, DOI 10.1016/j.jcpa.2005.05.001; Whelan A, 2012, VACCINE, V30, P6294, DOI 10.1016/j.vaccine.2012.07.086; Wood PR, 2001, TUBERCULOSIS, V81, P147, DOI 10.1054/tube.2000.0272; Xing Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005856	22	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142270	10.1371/journal.pone.0142270	http://dx.doi.org/10.1371/journal.pone.0142270			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544594	Green Published, Green Submitted, gold			2022-12-27	WOS:000364398700103
J	Natarelli, L; Ranaldi, G; Leoni, G; Roselli, M; Guantario, B; Comitato, R; Ambra, R; Cimino, F; Speciale, A; Virgili, F; Canali, R				Natarelli, Lucia; Ranaldi, Giulia; Leoni, Guido; Roselli, Marianna; Guantario, Barbara; Comitato, Raffaella; Ambra, Roberto; Cimino, Francesco; Speciale, Antonio; Virgili, Fabio; Canali, Raffaella			Nanomolar Caffeic Acid Decreases Glucose Uptake and the Effects of High Glucose in Endothelial Cells	PLOS ONE			English	Article							NF-KAPPA-B; NATURAL PROTECTIVE MECHANISM; INDUCED APOPTOSIS; COFFEE CONSUMPTION; HYPERGLYCEMIA; INHIBITION; PATHWAY; DEATH; RISK; PHOSPHORYLATION	Epidemiological studies suggest that moderate and prolonged consumption of coffee is associated with a reduced risk of developing type 2 diabetes but the molecular mechanisms underlying this effect are not known. In this study, we report the effects of physiological concentrations of caffeic acid, easily achievable by normal dietary habits, in endothelial cells cultured in 25 mM of glucose (high glucose, HG). In HG, the presence of 10 nM caffeic acid was associated with a decrease of glucose uptake but not to changes of GLUT-1 membrane localization or mRNA levels. Moreover, caffeic acid countered HG-induced loss of barrier integrity, reducing actin rearrangement and FITC-dextran passage. The decreased flux of glucose associated to caffeic acid affected HG induced apoptosis by down-regulating the expression of initiator (caspase 8 and 9) and effector caspases (caspase 7 and 3) and by increasing the levels of phosphorylated Bcl-2. We also observed that caffeic acid in HG condition was associated to a reduction of p65 subunit nuclear levels with respect to HG alone. NF-kappa B activation has been shown to lead to apoptosis in HG treated cells and the analysis of the expression of a panel of about 90 genes related to NF-kappa B signaling pathway revealed that caffeic acid significantly influenced gene expression changes induced by HG. In conclusion, our results suggest that caffeic acid, decreasing the metabolic stress induced by HG, allows the activation of survival mechanisms mediated by a different modulation of NF-kappa B-related signaling pathways and to the activation of anti-apoptotic proteins.	[Natarelli, Lucia; Ranaldi, Giulia; Roselli, Marianna; Guantario, Barbara; Comitato, Raffaella; Ambra, Roberto; Virgili, Fabio; Canali, Raffaella] Council Agr Res & Econ, Food & Nutr Res Ctr, Rome, Italy; [Leoni, Guido] Univ Roma La Sapienza, Dept Phys, I-00185 Rome, Italy; [Cimino, Francesco; Speciale, Antonio] Univ Messina, Dept Drug Sci & Hlth Prod, Messina, Italy	Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Sapienza University Rome; University of Messina	Canali, R (corresponding author), Council Agr Res & Econ, Food & Nutr Res Ctr, Rome, Italy.	raffaella.canali@entecra.it	Roselli, Marianna/L-6501-2019; Ranaldi, Giulia/ABC-4934-2020; Speciale, Antonio/C-2846-2011; Natarelli, Lucia/AAY-6449-2020; Canali, Raffaella/AAA-3965-2020; Leoni, Guido/AAX-6544-2020	Roselli, Marianna/0000-0003-2355-3241; Speciale, Antonio/0000-0002-6135-3892; Canali, Raffaella/0000-0003-0012-4831; Leoni, Guido/0000-0003-0502-1962; Ambra, Roberto/0000-0002-1120-3976; Natarelli, Lucia/0000-0002-9725-6576; RANALDI, GIULIA/0000-0002-6889-144X; Guantario, Barbara/0000-0002-1759-5253; Virgili, Fabio/0000-0002-9691-8742	Italian Ministry of Agricultural and Nutritional Policies and Forestry	Italian Ministry of Agricultural and Nutritional Policies and Forestry	This work was supported by the Italian Ministry of Agricultural and Nutritional Policies and Forestry (Special Research Projects MiPAAF - NUME and MiPAAF - MEDITO). The authors are grateful to the Epigenomics Flagship Project-EPIGEN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliprantis AO, 2000, EMBO J, V19, P3325, DOI 10.1093/emboj/19.13.3325; Alpert E, 2005, DIABETOLOGIA, V48, P752, DOI 10.1007/s00125-005-1681-y; Alpert E, 2002, BIOCHEM J, V362, P413, DOI 10.1042/0264-6021:3620413; BAUER J, 1992, J CELL PHYSIOL, V153, P437, DOI 10.1002/jcp.1041530302; BAUMGARTNERPARZER SM, 1995, DIABETES, V44, P1323, DOI 10.2337/diabetes.44.11.1323; Bhupathiraju SN, 2013, AM J CLIN NUTR, V97, P155, DOI 10.3945/ajcn.112.048603; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Busik JV, 2002, INVEST OPHTH VIS SCI, V43, P2356; Cerami EG, 2011, NUCLEIC ACIDS RES, V39, pD685, DOI 10.1093/nar/gkq1039; Chang WC, 2010, TAIWAN J OBSTET GYNE, V49, P419, DOI 10.1016/S1028-4559(10)60092-7; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Cohen G., 2007, Archives of Physiology and Biochemistry, V113, P259, DOI 10.1080/13813450701783513; Davidson SM, 2006, AM J PHYSIOL-HEART C, V291, pH1486, DOI 10.1152/ajpheart.00301.2006; de Jongh RT, 2004, CIRCULATION, V109, P2529, DOI 10.1161/01.CIR.0000129772.26647.6F; Duffy A, 2006, ENDOTHELIUM-J ENDOTH, V13, P9, DOI 10.1080/10623320600659997; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Frustaci A, 2000, CIRC RES, V87, P1123, DOI 10.1161/01.RES.87.12.1123; Goldin A, 2006, CIRCULATION, V114, P597, DOI 10.1161/CIRCULATIONAHA.106.621854; Handa P, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-16; Hempel A, 1997, CIRC RES, V81, P363, DOI 10.1161/01.RES.81.3.363; Hindley A, 2002, J CELL SCI, V115, P1575; Ho FM, 2006, CELL SIGNAL, V18, P391, DOI 10.1016/j.cellsig.2005.05.009; Huang DW, 2009, J AGR FOOD CHEM, V57, P7687, DOI 10.1021/jf901376x; KAISER N, 1993, DIABETES, V42, P80, DOI 10.2337/diabetes.42.1.80; Kaiser WJ, 2004, J IMMUNOL, V172, P1699, DOI 10.4049/jimmunol.172.3.1699; Kang NJ, 2009, CARCINOGENESIS, V30, P321, DOI 10.1093/carcin/bgn282; Kishimoto Y, 2013, EUR J CLIN NUTR, V67, P532, DOI 10.1038/ejcn.2013.29; Lee HZ, 2004, LIFE SCI, V74, P2085, DOI 10.1016/j.lfs.2003.06.046; McIlwain DR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008656; Miele C, 2007, J BIOL CHEM, V282, P31835, DOI 10.1074/jbc.M702481200; Munshi N, 2002, J IMMUNOL, V168, P5860, DOI 10.4049/jimmunol.168.11.5860; Nakagami H, 2001, DIABETES, V50, P1472, DOI 10.2337/diabetes.50.6.1472; Nardini M, 2002, J AGR FOOD CHEM, V50, P5735, DOI 10.1021/jf0257547; Natella F, 2012, NUTR REV, V70, P207, DOI 10.1111/j.1753-4887.2012.00470.x; Nobe K, 2006, J PHARMACOL EXP THER, V318, P530, DOI 10.1124/jpet.106.105015; Nourbakhsh M, 1999, EMBO J, V18, P6415, DOI 10.1093/emboj/18.22.6415; Ranaldi G, 2013, J NUTR BIOCHEM, V24, P967, DOI 10.1016/j.jnutbio.2012.06.020; Riahi Y, 2010, DIABETES, V59, P808, DOI 10.2337/db09-1207; Ruvolo PP, 2001, LEUKEMIA, V15, P515, DOI 10.1038/sj.leu.2402090; Salameh A, 1997, J CARDIOVASC PHARM, V30, P182, DOI 10.1097/00005344-199708000-00006; Salaun B, 2007, EUR J IMMUNOL, V37, P3311, DOI 10.1002/eji.200737744; Sheu ML, 2005, ARTERIOSCL THROM VAS, V25, P539, DOI 10.1161/01.ATV.0000155462.24263.e4; Sprick MR, 2004, BBA-MOL CELL RES, V1644, P125, DOI 10.1016/j.bbamcr.2003.11.002; Sun RL, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.178798; Swanton E, 1999, ONCOGENE, V18, P1781, DOI 10.1038/sj.onc.1202490; Tobin NP, 2008, AM J PHYSIOL-HEART C, V295, pH1403, DOI 10.1152/ajpheart.00240.2008; Tunnicliffe JM, 2008, APPL PHYSIOL NUTR ME, V33, P1290, DOI 10.1139/H08-123; Vacaresse N, 2001, BRIT J PHARMACOL, V132, P1777, DOI 10.1038/sj.bjp.0703981; van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97; Van Dam RM, 2004, DIABETES CARE, V27, P2990, DOI 10.2337/diacare.27.12.2990; Vauzour D, 2010, NUTRIENTS, V2, P1106, DOI 10.3390/nu2111106; Wegener Elmar, 2007, Sci STKE, V2007, ppe21, DOI 10.1126/stke.3842007pe21; WELSCH CA, 1989, J NUTR, V119, P1698, DOI 10.1093/jn/119.11.1698; Yochum L, 1999, AM J EPIDEMIOL, V149, P943, DOI 10.1093/oxfordjournals.aje.a009738	54	10	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142421	10.1371/journal.pone.0142421	http://dx.doi.org/10.1371/journal.pone.0142421			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544184	Green Submitted, Green Published, gold			2022-12-27	WOS:000364398700134
J	Park, SJ; Ahn, HS; Kim, JS; Lee, C				Park, Seong-Jun; Ahn, Hee-Sung; Kim, Jun Seok; Lee, Cheolju			Evaluation of Multi-tRNA Synthetase Complex by Multiple Reaction Monitoring Mass Spectrometry Coupled with Size Exclusion Chromatography	PLoS One			English	Article							PROTEIN-PROTEIN INTERACTIONS; ELONGATION FACTOR-I; MACROMOLECULAR ASSEMBLAGE; CANCER; PURIFICATION; CELLS; QUANTIFICATION; TRANSLATION; DISSECTION; PROTEOMICS	Eight aminoacyl-tRNA synthetases (M, K, Q, D, R, I, EP and LARS) and three auxiliary proteins (AIMP1, 2 and 3) are known to form a multi-tRNA synthetase complex (MSC) in mammalian cells. We combined size exclusion chromatography (SEC) with reversed-phase liquid chromatography multiple reaction monitoring mass spectrometry (RPLC-MRM-MS) to characterize MSC components and free ARS proteins in human embryonic kidney (HEK 293T) cells. Crude cell extract and affinity-purified proteins were fractionated by SEC in non-denaturing state and ARSs were monitored in each fraction by MRM-MS. The eleven MSC components appeared mostly in earlier SEC fractions demonstrating their participation in complex formation. TARSL2 and AIMP2-DX2, despite their low abundance, were co-purified with KARS and detected in the SEC fractions, where MSC appeared. Moreover, other large complex-forming ARS proteins, such as VARS and FARS, were detected in earlier fractions. The MRM-MS results were further confirmed by western blot analysis. Our study demonstrates usefulness of combined SEC-MRM analysis for the characterization of protein complexes and in understanding the behavior of minor isoforms or variant proteins.	[Park, Seong-Jun; Ahn, Hee-Sung; Kim, Jun Seok; Lee, Cheolju] Korea Inst Sci & Technol, Biomed Res Inst, Ctr Theragnosis, Seoul 136791, South Korea; [Ahn, Hee-Sung; Lee, Cheolju] Univ Sci & Technol, Dept Biol Chem, Daejeon 305333, South Korea	Korea Institute of Science & Technology (KIST); University of Science & Technology (UST)	Lee, C (corresponding author), Korea Inst Sci & Technol, Biomed Res Inst, Ctr Theragnosis, Seoul 136791, South Korea.	clee270@kist.re.kr		Ahn, Hee-Sung/0000-0003-2241-6536	National Research Foundation - Korean Ministry of Science, ICT and Future Planning [2013M3A9B6076414]; Korea Health Industry Development Institute - Korean Ministry of Health Welfare [HI14C3484]; National Research Council of Science and Technology; intramural program of the Korea Institute of Science and Technology	National Research Foundation - Korean Ministry of Science, ICT and Future Planning; Korea Health Industry Development Institute - Korean Ministry of Health Welfare; National Research Council of Science and Technology; intramural program of the Korea Institute of Science and Technology	The study was supported by a grant from the National Research Foundation (Next-Generation Applied Omics program: 2013M3A9B6076414) funded by the Korean Ministry of Science, ICT and Future Planning, a grant from the Korea Health Industry Development Institute (Research Hospital program: HI14C3484) funded by the Korean Ministry of Health & Welfare, and a grant for the Joint Research Project funded by National Research Council of Science and Technology. The study was also supported by an intramural program of the Korea Institute of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEC G, 1989, J BIOL CHEM, V264, P21131; Choi JW, 2012, J MOL CELL BIOL, V4, P164, DOI 10.1093/jmcb/mjs018; Choi JW, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001351; Dias J, 2013, J BIOL CHEM, V288, P23979, DOI 10.1074/jbc.M113.489922; Fu YY, 2014, P NATL ACAD SCI USA, V111, P15084, DOI 10.1073/pnas.1408836111; Guo M, 2013, NAT CHEM BIOL, V9, P145, DOI [10.1038/nchembio.1158, 10.1038/NCHEMBIO.1158]; Havugimana PC, 2012, CELL, V150, P1068, DOI 10.1016/j.cell.2012.08.011; Hooper J, 1997, J ROY SOC MED, V90, P706; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Kaminska M, 2009, J BIOL CHEM, V284, P6053, DOI 10.1074/jbc.M809636200; Keefe AD, 2001, PROTEIN EXPRES PURIF, V23, P440, DOI 10.1006/prep.2001.1515; Kennedy JJ, 2014, NAT METHODS, V11, P149, DOI [10.1038/NMETH.2763, 10.1038/nmeth.2763]; Kim JS, 2014, ANAL CHIM ACTA, V840, P1, DOI 10.1016/j.aca.2014.06.024; Kim JS, 2013, J PROTEOME RES, V12, P2582, DOI 10.1021/pr3011414; Kim JY, 2002, P NATL ACAD SCI USA, V99, P7912, DOI 10.1073/pnas.122110199; Kim K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081734; Kirkwood KJ, 2013, MOL CELL PROTEOMICS, V12, P3851, DOI 10.1074/mcp.M113.032367; Kristensen AR, 2012, NAT METHODS, V9, P907, DOI 10.1038/nmeth.2131; Kuzyk MA, 2009, MOL CELL PROTEOMICS, V8, P1860, DOI 10.1074/mcp.M800540-MCP200; Lee SW, 2004, J CELL SCI, V117, P3725, DOI 10.1242/jcs.01342; Liu XQ, 2013, METHODS, V61, P304, DOI 10.1016/j.ymeth.2013.03.006; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Martinez-Aguilar J, 2013, J PROTEOME RES, V12, P3679, DOI 10.1021/pr400251t; MOSYAK L, 1995, NAT STRUCT BIOL, V2, P537, DOI 10.1038/nsb0795-537; MOTORIN YA, 1991, EUR J BIOCHEM, V201, P325, DOI 10.1111/j.1432-1033.1991.tb16289.x; Nathanson L, 2000, J BIOL CHEM, V275, P31559, DOI 10.1074/jbc.C000385200; Negrutskii BS, 1999, J BIOL CHEM, V274, P4545, DOI 10.1074/jbc.274.8.4545; Olinares PDB, 2010, MOL CELL PROTEOMICS, V9, P1594, DOI 10.1074/mcp.M000038-MCP201; Pan S, 2012, J PROTEOME RES, V11, P1937, DOI 10.1021/pr201117w; Pardo M, 2012, J PROTEOME RES, V11, P1462, DOI 10.1021/pr2011632; Park SG, 2005, TRENDS BIOCHEM SCI, V30, P569, DOI 10.1016/j.tibs.2005.08.004; Quevillon S, 1999, J MOL BIOL, V285, P183, DOI 10.1006/jmbi.1998.2316; Rho SB, 1999, P NATL ACAD SCI USA, V96, P4488, DOI 10.1073/pnas.96.8.4488; Robinson JC, 2000, J MOL BIOL, V304, P983, DOI 10.1006/jmbi.2000.4242; Rodova M, 1999, BIOCHEM BIOPH RES CO, V255, P765, DOI 10.1006/bbrc.1999.0141; Schimmel P, 2008, PROTEIN SCI, V17, P1643, DOI 10.1110/ps.037242.108; Trinkle-Mulcahy L, 2008, J CELL BIOL, V183, P223, DOI 10.1083/jcb.200805092; Yao P, 2013, EMBO MOL MED, V5, P332, DOI 10.1002/emmm.201100626	38	12	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142253	10.1371/journal.pone.0142253	http://dx.doi.org/10.1371/journal.pone.0142253			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544075	Green Submitted, gold, Green Published			2022-12-27	WOS:000364398700101
J	Reid, JP; Schnitzer, SA; Powers, JS				Reid, Joseph Pignatello; Schnitzer, Stefan A.; Powers, Jennifer S.			Short and Long-Term Soil Moisture Effects of Liana Removal in a Seasonally Moist Tropical Forest	PLOS ONE			English	Article							TREE REGENERATION; SECONDARY FOREST; GROWTH; DYNAMICS; PATTERNS; ABUNDANCE; DROUGHT; WATER; ECOLOGY; BIOMASS	Lianas (woody vines) are particularly abundant in tropical forests, and their abundance is increasing in the neotropics. Lianas can compete intensely with trees for above-and below-ground resources, including water. As tropical forests experience longer and more intense dry seasons, competition for water is likely to intensify. However, we lack an understanding of how liana abundance affects soil moisture and hence competition with trees for water in tropical forests. To address this critical knowledge gap, we conducted a large-scale liana removal experiment in a seasonal tropical moist forest in central Panama. We monitored shallow and deep soil moisture over the course of three years to assess the effects of lianas in eight 0.64 ha removal plots and eight control plots. Liana removal caused short-term effects in surface soils. Surface soils (10 cm depth) in removal plots dried more slowly during dry periods and accumulated water more slowly after rainfall events. These effects disappeared within four months of the removal treatment. In deeper soils (40 cm depth), liana removal resulted in a multi-year trend towards 5-25% higher soil moisture during the dry seasons with the largest significant effects occurring in the dry season of the third year following treatment. Liana removal did not affect surface soil temperature. Multiple and mutually occurring mechanisms may be responsible for the effects of liana removal on soil moisture, including competition with trees, and altered microclimate, and soil structure. These results indicate that lianas influence hydrologic processes, which may affect tree community dynamics and forest carbon cycling.	[Reid, Joseph Pignatello; Powers, Jennifer S.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Schnitzer, Stefan A.] Marquette Univ, Dept Biol Sci, Milwaukee, WI 53201 USA; [Schnitzer, Stefan A.; Powers, Jennifer S.] Smithsonian Trop Res Inst, Balboa, Panama; [Powers, Jennifer S.] Univ Minnesota, Dept Plant Biol, St Paul, MN USA	University of Minnesota System; University of Minnesota Twin Cities; Marquette University; Smithsonian Institution; Smithsonian Tropical Research Institute; University of Minnesota System; University of Minnesota Twin Cities	Powers, JS (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA.	powers@umn.edu	Reid, Joseph/I-3292-2012	Reid, Joseph/0000-0001-6905-5235	National Science Foundation [DEB 0845071]; NSF [DEB 1019436, DEB 1019441]; Direct For Biological Sciences [1019436] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was made possible by National Science Foundation Grants DEB 0845071 and NSF DEB 1019436 to S.A.S, and NSF DEB 1019441 to J.S.P. The website for the US National Science Foundation is: http://www.nsf.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Cansino L, 2015, ECOLOGY, V96, P39, DOI 10.1890/14-1002.1; Andrade JL, 2005, TREES-STRUCT FUNCT, V19, P282, DOI 10.1007/s00468-004-0388-x; Asner GP, 2012, ECOL LETT, V15, P1001, DOI 10.1111/j.1461-0248.2012.01821.x; Barry KE, BIOTROPICA IN PRESS; Bruno RD, 2006, HYDROL PROCESS, V20, P2477, DOI 10.1002/hyp.6211; Cai ZQ, 2009, OECOLOGIA, V161, P25, DOI 10.1007/s00442-009-1355-4; Carnpanello PI, 2007, FOREST ECOL MANAG, V252, P108, DOI 10.1016/j.foreco.2007.06.032; Chen LJ, 2015, IEEE SYST J, V9, P1091, DOI 10.1109/JSYST.2013.2296979; Coenders-Gerrits AMJ, 2013, HYDROL EARTH SYST SC, V17, P1749, DOI 10.5194/hess-17-1749-2013; DeWalt SJ, 2004, BIOTROPICA, V36, P7, DOI 10.1646/02115; Duran SM, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0301; EWERS FW, 1990, OECOLOGIA, V84, P544, DOI 10.1007/BF00328172; Ewers FW, 1997, OECOLOGIA, V110, P191, DOI 10.1007/s004420050149; Fu R, 2013, P NATL ACAD SCI USA, V110, P18110, DOI 10.1073/pnas.1302584110; GENTRY A H, 1983, Tropical Ecology, V24, P63; Grauel WT, 2004, FOREST ECOL MANAG, V190, P99, DOI 10.1016/j.foreco.2003.10.009; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoffman MD, 2014, J MACH LEARN RES, V15, P1593; Jacobsen AL, 2012, AM J BOT, V99, P1583, DOI 10.3732/ajb.1200140; Laurance WF, 2014, ECOLOGY, V95, P1604, DOI 10.1890/13-1571.1; Lewis SL, 2009, ANNU REV ECOL EVOL S, V40, P529, DOI 10.1146/annurev.ecolsys.39.110707.173345; da Costa ACL, 2010, NEW PHYTOL, V187, P579, DOI 10.1111/j.1469-8137.2010.03309.x; Perez-Salicrup DR, 2000, OECOLOGIA, V124, P469, DOI 10.1007/PL00008872; Perez-Salicrup DR, 2001, ECOLOGY, V82, P389, DOI 10.1890/0012-9658(2001)082[0389:EOLCOT]2.0.CO;2; Phillips OL, 2002, NATURE, V418, P770, DOI 10.1038/nature00926; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Powers JS, 2005, NEW PHYTOL, V165, P913, DOI 10.1111/j.1469-8137.2004.01279.x; Powers JS, 2014, ECOLOGY OF LIANAS; R Core Team, 2021, R LANGUAGE ENV STAT; Restom TG, 2004, FOREST ECOL MANAG, V190, P109, DOI 10.1016/j.foreco.2003.10.010; Restom TG, 2001, PLANT SOIL, V236, P155, DOI 10.1023/A:1012776532147; Schnitzer SA, 2002, TRENDS ECOL EVOL, V17, P223, DOI 10.1016/S0169-5347(02)02491-6; Schnitzer SA, 2005, AM NAT, V166, P262, DOI 10.1086/431250; Schnitzer SA, 2015, ECOLOGY OF LIANAS, P451; Schnitzer SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052114; Schnitzer SA, 2011, ECOL LETT, V14, P397, DOI 10.1111/j.1461-0248.2011.01590.x; Schnitzer SA, 2010, ECOL LETT, V13, P849, DOI 10.1111/j.1461-0248.2010.01480.x; Team SD, 2013, STAN MODELING LANGUA; Team SD, 2013, STAN A C LIB PROBABI; Tobin MF, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00322.1; Townsend AR, 2011, FRONT ECOL ENVIRON, V9, P9, DOI 10.1890/100047; van der Heijden GM, 2013, BIOTROPICA, V45, P682, DOI 10.1111/btp.12060; van der Heijden GMF, 2015, P NATL ACAD SCI USA, V112, P13267, DOI 10.1073/pnas.1504869112; van der Sande MT, 2013, OECOLOGIA, V172, P961, DOI 10.1007/s00442-012-2563-x; Wyka TP, 2013, ANN BOT-LONDON, V112, P1667, DOI 10.1093/aob/mct236; Yavitt JB, 2009, AUST J SOIL RES, V47, P674, DOI 10.1071/SR08258; Yavitt JB, 2008, J TROP ECOL, V24, P19, DOI 10.1017/S0266467407004713; Zhu SD, 2009, PLANT ECOL, V204, P295, DOI 10.1007/s11258-009-9592-5	48	17	18	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141891	10.1371/journal.pone.0141891	http://dx.doi.org/10.1371/journal.pone.0141891			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26545205	Green Submitted, Green Published, gold			2022-12-27	WOS:000364398700060
J	Zhang, J; Chen, BB; Wu, T; Wang, Q; Zhuang, L; Zhu, C; Fan, N; Qing, WJ; Ma, Y; Xu, XP				Zhang, Jing; Chen, Bobin; Wu, Ting; Wang, Qian; Zhuang, Lin; Zhu, Chen; Fan, Ni; Qing, Wenjiao; Ma, Yan; Xu, Xiaoping			Synergistic Effect and Molecular Mechanism of Homoharringtonine and Bortezomib on SKM-1 Cell Apoptosis	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; NF-KAPPA-B; RISK MYELODYSPLASTIC SYNDROME; LOW-DOSE CYTARABINE; INTENSIVE CHEMOTHERAPY; IN-VITRO; CANCER; COMBINATION; MICRORNAS; REGIMENS	Background Myelodysplastic syndromes (MDS) are clonal marrow stem-cell disorders with a high risk of progression to acute myeloid leukemia (AML). Treatment options are limited and targeted therapies are not available for MDS. In the present study, we investigated the cytotoxicity and the molecular mechanism of Homoharringtonine (HHT) and Bortezomib towards highrisk MDS cell line SKM-1 in vitro and the role of miR-3151 was first evaluated in SKM-1 cells. Methods SKM-1 cells were treated with different concentrations of HHT or Bortezomib, and cell viability was analyzed with CCK-8 assay. The influence on cell proliferation, cell cycle distribution and the percentage of apoptosis cells were analyzed by flow cytometry. Calcusyn software was used to calculate combination index (CI) values. Western blot was used to analysis phosphorylation of Akt and nuclear NF-kappa B protein expression in SKM-1 cells. Mature miR-3151 level and p53 protein level were detected after HHT or Bortezomib treatment. The cell proliferation and p53 protein level were reassessed in SKM-1 cells infected with lentivirus to overexpress miR-3151. Results Simultaneous exposure to HHT and Bortezomib (10.4: 1) resulted in a significant reduction of cell proliferation in SKM-1 cells (P < 0.05). Cell cycle arrest at G0/ G1 and G2/M phase was observed (P < 0.05). HHT and Bortezomib synergistically induced cell apoptosis by regulating members of caspase 9, caspase 3 and Bcl-2 family (P < 0.01). The mechanisms of the synergy involved Akt and NF-kappa B signaling pathway inhibition, downregulation of mature miR-3151 and increment of downstream p53 protein level. Overexpression of miR-3151 promoted cell proliferation and inhibited p53 protein expression in SKM-1 (P < 0.01). Conclusions HHT and Bortezomib synergistically inhibit SKM-1 cell proliferation and induce apoptosis in vitro. Inhibition of Akt and NF-kappa B pathway signaling contribute to molecular mechanism of HHT and Bortezomib. miR-3151 abundance is implicated in SKM-1 cell viability, cell proliferation and p53 protein expression.	[Zhang, Jing; Chen, Bobin; Wu, Ting; Wang, Qian; Zhuang, Lin; Zhu, Chen; Fan, Ni; Qing, Wenjiao; Ma, Yan; Xu, Xiaoping] Fudan Univ, Huashan Hosp, Shanghai Med Coll, Dept Hematol, Shanghai 200433, Peoples R China	Fudan University	Xu, XP (corresponding author), Fudan Univ, Huashan Hosp, Shanghai Med Coll, Dept Hematol, Shanghai 200433, Peoples R China.	xpxu1111@163.com	MA, YAN/HHN-2912-2022		National Natural Science Foundation of China [81070404]; Sub-topic of National Science and Technology Major Project [2012ZX0903004-001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sub-topic of National Science and Technology Major Project	The study was supported by the National Natural Science Foundation of China (Grant No. 81070404) and the Sub-topic of National Science and Technology Major Project (Grant No. 2012ZX0903004-001). The funder conceived and designed the experiments.	Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Braun T, 2006, BLOOD, V107, P1156; CHEN JYZDL, 1990, CANCER RES, V50, P2031; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Crawford LJ, 2013, BLOOD REV, V27, P297, DOI 10.1016/j.blre.2013.10.002; Dlugosz PJ, 2006, EMBO J, V25, P2287, DOI 10.1038/sj.emboj.7601126; Eisfeld AK, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004762; Eisfeld AK, 2012, BLOOD, V120, P249, DOI 10.1182/blood-2012-02-408492; He L, 2007, NAT REV CANCER, V7, P819, DOI 10.1038/nrc2232; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hermeking H, 2007, CANCER CELL, V12, P414, DOI 10.1016/j.ccr.2007.10.028; Huang J, 2011, INT J HEMATOL, V93, P482, DOI 10.1007/s12185-011-0821-z; Jin J, 2006, LEUKEMIA, V20, P1361, DOI 10.1038/sj.leu.2404287; Jin J, 2013, LANCET ONCOL, V14, P599, DOI 10.1016/S1470-2045(13)70152-9; Kantarjian H, 2006, CANCER-AM CANCER SOC, V106, P1099, DOI 10.1002/cncr.21699; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Knipp S, 2007, CANCER-AM CANCER SOC, V110, P345, DOI 10.1002/cncr.22779; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Li S, 2013, ZHEJIANG MED J, V35, P105; Meng HT, 2008, LEUKEMIA LYMPHOMA, V49, P1954, DOI 10.1080/10428190802320368; Nyakern M, 2006, LEUKEMIA, V20, P230, DOI 10.1038/sj.leu.2404057; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Riccioni R, 2007, BRIT J HAEMATOL, V139, P194, DOI 10.1111/j.1365-2141.2007.06757.x; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Ryningen A, 2006, LEUKEMIA RES, V30, P1531, DOI 10.1016/j.leukres.2006.02.014; Shu HE, 2007, ZHONGGUO WU ZHEN XUE, V7, P331; Su Ji-Ying, 2009, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V17, P459; Wu LY, 2011, J CANCER RES CLIN, V137, P1563, DOI 10.1007/s00432-011-1020-2; Wu LY, 2009, LEUKEMIA LYMPHOMA, V50, P1461, DOI 10.1080/10428190903096719; XU B, 1981, AM J CHINESE MED, V9, P268, DOI 10.1142/S0192415X81000354; XU B, 1981, TRENDS PHARMACOL SCI, V2, P271, DOI 10.1016/0165-6147(81)90337-0; Yao Y, 1999, ACTA ACAD MED XUZHOU, V19, P221	34	3	4	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142422	10.1371/journal.pone.0142422	http://dx.doi.org/10.1371/journal.pone.0142422			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544558	Green Published, Green Submitted, gold			2022-12-27	WOS:000364398700135
J	Colquhoun, JM; Wozniak, RAF; Dunman, PM				Colquhoun, Jennifer M.; Wozniak, Rachel A. F.; Dunman, Paul M.			Clinically Relevant Growth Conditions Alter Acinetobacter baumannii Antibiotic Susceptibility and Promote Identification of Novel Antibacterial Agents	PLOS ONE			English	Article							IN-VITRO; RESISTANCE; OUTCOMES	Biological processes that govern bacterial proliferation and survival in the host-environment (s) are likely to be vastly different from those that are required for viability in nutrient-rich laboratory media. Consequently, growth-based antimicrobial screens performed in conditions modeling aspects of bacterial disease states have the potential to identify new classes of antimicrobials that would be missed by screens performed in conventional laboratory media. Accordingly, we performed screens of the Selleck library of 853 FDA approved drugs for agents that exhibit antimicrobial activity toward the Gram-negative bacterial pathogen Acinetobacter baumannii during growth in human serum, lung surfactant, and/or the organism in the biofilm state and compared those results to that of conventional laboratory medium. Results revealed that a total of 90 compounds representing 73 antibiotics and 17 agents that were developed for alternative therapeutic indications displayed antimicrobial properties toward the test strain in at least one screening condition. Of the active library antibiotics only four agents, rifampin, rifaximin, ciprofloxacin and tetracycline, exhibited antimicrobial activity toward the organism during all screening conditions, whereas the remainder were inactive in >= 1 condition; 56 antibiotics were inactive during serum growth, 25 and 38 were inactive toward lung surfactant grown and biofilm-associated cells, respectively, suggesting that subsets of antibiotics may outperform others in differing infection settings. Moreover, 9 antibiotics that are predominantly used for the treatment Gram-positive pathogens and 10 non-antibiotics lacked detectable antimicrobial activity toward A. baumannii grown in conventional medium but were active during >= 1 alternative growth condition( s). Such agents may represent promising anti-Acinetobacter agents that would have likely been overlooked by antimicrobial whole cell screening assays performed in traditional laboratory screening media.	[Colquhoun, Jennifer M.; Dunman, Paul M.] Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Wozniak, Rachel A. F.] Univ Rochester, Sch Med & Dent, Dept Ophthalmol, Flaum Eye Inst, Rochester, NY USA	University of Rochester; University of Rochester	Dunman, PM (corresponding author), Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA.	paul_dunman@urmc.rochester.edu	Wozniak, Rachel A F/Y-9717-2019	Wozniak, Rachel A F/0000-0002-2693-1394; Colquhoun, Jennifer/0000-0002-2659-2919	National Institute of Allergy and Infectious Diseases (NIAID) [AI103507, GM068411-11]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI118689, R01AI103507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM068411] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of Allergy and Infectious Diseases (NIAID) (http://www.niaid.nih.gov/researchfunding/Pages/default.aspx) Grant number AI103507 awarded to PMD and (https://researchtraining.nih.gov/programs/training-grants?CFID=5926611&CFTOKEN=10dd7bed435a38d1-3D3CA4AB-5056-9439-7EC3989DDD4F9913) Grant number GM068411-11 awarded to JMC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhady W, 2013, ANTIMICROB AGENTS CH, V57, P1447, DOI 10.1128/AAC.02073-12; Antoszczak M, 2014, EUR J MED CHEM, V76, P435, DOI 10.1016/j.ejmech.2014.02.031; Blanchard C, 2014, ANTIMICROB AGENTS CH, V58, P6360, DOI 10.1128/AAC.03535-14; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Burnett BP, 2008, CUTIS, V82, P273; Bush K, 2011, NAT REV MICROBIOL, V9, P894, DOI 10.1038/nrmicro2693; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; del Pozo JL, 2007, CLIN PHARMACOL THER, V82, P204, DOI 10.1038/sj.clpt.6100247; Doi Y, 2009, EMERG INFECT DIS, V15, P980, DOI 10.3201/eid1506.081006; Fahnoe KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051732; FERGUSON CA, 1979, CAN J MICROBIOL, V25, P545, DOI 10.1139/m79-080; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Gajadeera C, 2015, J ANTIBIOT, V68, P153, DOI 10.1038/ja.2014.131; Garcia LG, 2013, J ANTIMICROB CHEMOTH, V68, P1455, DOI 10.1093/jac/dkt072; GILLASPY AF, 1995, INFECT IMMUN, V63, P3373, DOI 10.1128/IAI.63.9.3373-3380.1995; HOLLOWAY BW, 1986, ANNU REV MICROBIOL, V40, P79, DOI 10.1146/annurev.mi.40.100186.000455; Hood MI, 2010, ANTIMICROB AGENTS CH, V54, P1029, DOI 10.1128/AAC.00963-09; Jacobs AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085729; Jacobs AC, 2013, ANTIMICROB AGENTS CH, V57, P26, DOI 10.1128/AAC.01640-12; Jacobs AC, 2012, FEMS IMMUNOL MED MIC, V64, P403, DOI 10.1111/j.1574-695X.2011.00926.x; Jacobs AC, 2010, INFECT IMMUN, V78, P1952, DOI 10.1128/IAI.00889-09; Kruszewska Hanna, 2002, Acta Pol Pharm, V59, P436; Lee SA, 2015, P NATL ACAD SCI USA, V112, P5189, DOI 10.1073/pnas.1422186112; Mathur H, 2014, GUT MICROBES, V5, P696, DOI 10.4161/19490976.2014.983768; McGann P, 2014, MBIO, V5, DOI 10.1128/mBio.00915-14; MILLER AK, 1971, APPL MICROBIOL, V22, P480, DOI 10.1128/AEM.22.3.480-481.1971; Mizutani Y, 1997, ONCOL REP, V4, P909; Ng TM, 2014, INFECT CONT HOSP EP, V35, P49, DOI 10.1086/674387; Niederman MS, 2001, CRIT CARE MED, V29, pN114, DOI 10.1097/00003246-200104001-00011; Pomakova DK, 2012, EUR J CLIN MICROBIOL, V31, P981, DOI 10.1007/s10096-011-1396-6; Queenan AM, 2012, DIAGN MICR INFEC DIS, V73, P267, DOI 10.1016/j.diagmicrobio.2012.04.002; Rangel-Vega A, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00282; Rice LB, 2008, J INFECT DIS, V197, P1079, DOI 10.1086/533452; Schmitz FJ, 1997, EUR J EPIDEMIOL, V13, P709, DOI 10.1023/A:1007338906923; Sievert DM, 2013, INFECT CONT HOSP EP, V34, P1, DOI 10.1086/668770; Silver LL, 2011, CLIN MICROBIOL REV, V24, P71, DOI 10.1128/CMR.00030-10; Silverman JA, 2005, J INFECT DIS, V191, P2149, DOI 10.1086/430352; Umland TC, 2012, MBIO, V3, DOI 10.1128/mBio.00113-12; Yang HF, 2015, INFECT DIS-NOR, V47, P433, DOI 10.3109/00365548.2014.997284	39	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0143033	10.1371/journal.pone.0143033	http://dx.doi.org/10.1371/journal.pone.0143033			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26558753	Green Published, Green Submitted, gold			2022-12-27	WOS:000364433100140
J	Golosio, B; Cangelosi, A; Gamotina, O; Masala, GL				Golosio, Bruno; Cangelosi, Angelo; Gamotina, Olesya; Masala, Giovanni Luca			A Cognitive Neural Architecture Able to Learn and Communicate through Natural Language	PLOS ONE			English	Article							DEVELOPMENT SURVEY LDS; LARGE-SCALE MODEL; WORKING-MEMORY; INTEGRATION; KNOWLEDGE; NETWORKS	Communicative interactions involve a kind of procedural knowledge that is used by the human brain for processing verbal and nonverbal inputs and for language production. Although considerable work has been done on modeling human language abilities, it has been difficult to bring them together to a comprehensive tabula rasa system compatible with current knowledge of how verbal information is processed in the brain. This work presents a cognitive system, entirely based on a large-scale neural architecture, which was developed to shed light on the procedural knowledge involved in language elaboration. The main component of this system is the central executive, which is a supervising system that coordinates the other components of the working memory. In our model, the central executive is a neural network that takes as input the neural activation states of the short-term memory and yields as output mental actions, which control the flow of information among the working memory components through neural gating mechanisms. The proposed system is capable of learning to communicate through natural language starting from tabula rasa, without any a priori knowledge of the structure of phrases, meaning of words, role of the different classes of words, only by interacting with a human through a text-based interface, using an open-ended incremental learning process. It is able to learn nouns, verbs, adjectives, pronouns and other word classes, and to use them in expressive language. The model was validated on a corpus of 1587 input sentences, based on literature on early language assessment, at the level of about 4-years old child, and produced 521 output sentences, expressing a broad range of language processing functionalities.	[Golosio, Bruno; Gamotina, Olesya; Masala, Giovanni Luca] Univ Sassari, POLCOMING Dept, Sect Engn & Informat Technol, I-07100 Sassari, Italy; [Cangelosi, Angelo] Univ Plymouth, Sch Comp & Math, Ctr Robot & Neural Syst, Plymouth PL4 8AA, Devon, England	University of Sassari; University of Plymouth	Golosio, B (corresponding author), Univ Sassari, POLCOMING Dept, Sect Engn & Informat Technol, I-07100 Sassari, Italy.	golosio@uniss.it	Cangelosi, Angelo/D-6784-2011	Cangelosi, Angelo/0000-0002-4709-2243; masala, giovanni/0000-0001-6734-9424; Golosio, Bruno/0000-0001-5144-6932	Regione Autonoma della Sardegna [O. P. FSE 2007-2012 L.R.7/2007]; United Kingdom, Engineering and Physical Sciences Research Council, BABEL project; European Community, Seventh Framework Programme, POETICON++ project; EPSRC [EP/J004561/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/J004561/1] Funding Source: researchfish	Regione Autonoma della Sardegna(Regione Sardegna); United Kingdom, Engineering and Physical Sciences Research Council, BABEL project; European Community, Seventh Framework Programme, POETICON++ project; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This study was supported by Regione Autonoma della Sardegna, O. P. FSE 2007-2012 L.R.7/2007, BG, GLM; United Kingdom, Engineering and Physical Sciences Research Council, BABEL project, AC; European Community, Seventh Framework Programme, POETICON++ project, AC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananthanarayanan R., 2007, P 2007 ACM IEEE C SU, P1, DOI DOI 10.1145/1362622.1362627; [Anonymous], 2013, P C EMP METH NAT LAN; [Anonymous], 1998, NEURAL NETWORKS COMP; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Baddeley A, 2012, ANNU REV PSYCHOL, V63, P1, DOI 10.1146/annurev-psych-120710-100422; Bookheimer S, 2002, ANNU REV NEUROSCI, V25, P151, DOI 10.1146/annurev.neuro.25.112701.142946; Bryck RL, 2005, MEM COGNITION, V33, P611, DOI 10.3758/BF03195328; Cangelosi A., 2015, DEV ROBOTICS BABIES; Cangelosi A, 2010, IEEE T AUTON MENT DE, V2, P167, DOI 10.1109/TAMD.2010.2053034; CAPLAN D, 1985, COGNITION, V21, P117, DOI 10.1016/0010-0277(85)90048-4; Chomsky Noam, 1959, INFORM CONTR, V2, DOI [10.1016/S0019-9958(59)90362-6, DOI 10.1016/S0019-9958(59)90362-6]; Cowan N., 1995, ATTENTION MEMORY INT; Deryugina OV, 2010, SCI TECH INF PROCESS, V37, P143, DOI 10.3103/S0147688210020097; Devlin JT, 2003, J COGNITIVE NEUROSCI, V15, P71, DOI 10.1162/089892903321107837; Dominey PE, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00500; Dominey PF, 2005, ARTIF INTELL, V167, P31, DOI 10.1016/j.artint.2005.06.007; Duch W, 2008, FRONT ARTIF INTEL AP, V171, P122; Eliasmith C, 2012, SCIENCE, V338, P1202, DOI 10.1126/science.1225266; ELMAN JL, 1991, MACH LEARN, V7, P195, DOI 10.1007/BF00114844; Fidelman P, 2005, P 27 ANN M COGN SCI; Fodor J. A., 1975, LANGUAGE THOUGHT; Fodor J. A., 2010, LOT2 LANGUAGE THOUGH; Friederici AD, 2002, TRENDS COGN SCI, V6, P78, DOI 10.1016/S1364-6613(00)01839-8; Gisiger T, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00001; Hagoort P, 2004, SCIENCE, V304, P438, DOI 10.1126/science.1095455; Hagoort P, 2005, TRENDS COGN SCI, V9, P416, DOI 10.1016/j.tics.2005.07.004; Hebb Donald O., 1949, ORG BEHAV; Hinaut X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052946; Izhikevich EM, 2008, P NATL ACAD SCI USA, V105, P3593, DOI 10.1073/pnas.0712231105; Jurafsky D., 2009, SPEECH LANGUAGE PROC; Kieras DE, 1997, HUM-COMPUT INTERACT, V12, P391, DOI 10.1207/s15327051hci1204_4; LAIRD JE, 1987, ARTIF INTELL, V33, P1, DOI 10.1016/0004-3702(87)90050-6; LANGLEY P, 2005, 2005 IEEEW INT C, P18; Langley P, 2009, COGN SYST RES, V10, P141, DOI 10.1016/j.cogsys.2006.07.004; MacWhinney B., 2000, CHILDES PROJECT, V2; McClelland J. L., 1986, PARALLEL DISTRIBUTED, V2; McElree B, 2001, J EXP PSYCHOL LEARN, V27, P817, DOI 10.1037/0278-7393.27.3.817; MIIKKULAINEN R, 1995, APPL INTELL, V5, P137, DOI 10.1007/BF00877229; Miikkulainen R, 1993, SUBSYMBOLIC NATURAL; Mikolov T, 2012, IEEE W SP LANG TECH, P234, DOI 10.1109/SLT.2012.6424228; Morse AF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116012; Newell A., 1990, UNIFIED THEORIES COG; O'reilly R.C., 2000, COMPUTATIONAL EXPLOR; Oberauer K, 2002, J EXP PSYCHOL LEARN, V28, P411, DOI 10.1037//0278-7393.28.3.411; Rescorla L, 2002, J SPEECH LANG HEAR R, V45, DOI 10.1044/1092-4388(2002/059); Rescorla L, 2001, J SPEECH LANG HEAR R, V44, P434, DOI 10.1044/1092-4388(2001/035); Roy D, 2005, ARTIF INTELL, V167, P1, DOI 10.1016/j.artint.2005.06.002; Socher R., 2013, P 51 ANN M ASS COMP, P455; Socher R, 2011, INT C MACHINE LEARNI; Sutskever I, 2014, ADV NEUR IN, V27; Vandierendonck A, 2012, PSYCHOL BELG, V52, P229, DOI 10.5334/pb-52-2-3-229; Warren-Leubecker A., 1982, THESIS; WARRENLEUBECKER A, 1984, CHILD DEV, V55, P1379, DOI 10.2307/1130007	54	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0140866	10.1371/journal.pone.0140866	http://dx.doi.org/10.1371/journal.pone.0140866			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7DR	26560154	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000364433100011
J	Graziani, C; Luzzi, I; Owczarek, S; Dionisi, AM; Busani, L				Graziani, Caterina; Luzzi, Ida; Owczarek, Slawomir; Dionisi, Anna Maria; Busani, Luca			Salmonella enterica Serovar Napoli Infection in Italy from 2000 to 2013: Spatial and Spatio-Temporal Analysis of Cases Distribution and the Effect of Human and Animal Density on the Risk of Infection	PLOS ONE			English	Article								Background Salmonella Napoli is uncommon in Europe. In Italy however, it has been growing in importance since 2000. To date, no risk factors have been identified to account for its rise. This study aims at describing the epidemiology, spatial and spatio-temporal patterns of S. Napoli in Italy from 2000 to 2013, and to explore the role of several environmental correlates, namely urbanization, altitude and number of livestock farms, on the risk of S. Napoli infection among humans. Method Data were obtained from Enter-Net Italy, a network of diagnostic laboratories. The data were aggregated at the municipality level. Descriptive epidemiology, multivariate regression models, spatial and spatio-temporal analyses were performed on the number of cases and incidence rates. Results S. Napoli showed an expanding trend at the national level, and an increasing number of cases. Compared to the other main serovars in Italy, the risk of S. Napoli infection was higher in the age group <1 year, and lower in the other age groups. Although urbanization and the number of farms were associated with the risk of S. Napoli infection to some extent, their role in the epidemiology of the disease remains inconclusive. S. Napoli cases showed a positive global spatial autocorrelation as well as a significant spatio-temporal interaction. Twenty-four spatial and spatio-temporal clusters were identified, seven purely spatial and 17 spatio-temporal, mainly in north-western Italy. Most of the clusters were in areas characterized by urban and industrial settlements surrounded by agricultural land and an abundance of freshwater bodies. Conclusions Our results point to the presence, in a number of areas in Italy, of a Salmonella of public health concern originating in the environment. This highlights the increasing relevance of environmental, non-food-related sources of human exposure to enteric pathogens.	[Graziani, Caterina; Busani, Luca] Ist Super Sanita, Dept Vet Publ Hlth & Food Safety, I-00161 Rome, Italy; [Luzzi, Ida; Owczarek, Slawomir; Dionisi, Anna Maria] Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, I-00161 Rome, Italy	Istituto Superiore di Sanita (ISS); IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); Istituto Superiore di Sanita (ISS)	Busani, L (corresponding author), Ist Super Sanita, Dept Vet Publ Hlth & Food Safety, Viale Regina Elena 299, I-00161 Rome, Italy.	luca.busani@iss.it	Dionisi, Anna Maria/B-8722-2016; Busani, Luca/J-9253-2012; LUZZI, IDA/B-8715-2016	Dionisi, Anna Maria/0000-0002-4492-8498; Busani, Luca/0000-0002-6081-2794; LUZZI, IDA/0000-0002-7614-601X	Centro Nazionale per la Prevenzione e il Controllo delle Malattie - Italian Ministry of Health [5M10-1616-2014, 8977-2014]	Centro Nazionale per la Prevenzione e il Controllo delle Malattie - Italian Ministry of Health	The study was supported by Grant Number 5M10-1616-2014 and Grant Number 8977-2014 from the Centro Nazionale per la Prevenzione e il Controllo delle Malattie - Italian Ministry of Health (www.ccm-network.it). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akil L, 2014, FOODBORNE PATHOG DIS, V11, P974, DOI 10.1089/fpd.2014.1802; Andreoletti O, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1826; Chiari M, 2014, ACTA VET SCAND, V56, DOI 10.1186/s13028-014-0086-7; Chiari M, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-42; David JM, 2014, EPIDEMIOL INFECT, V142, P28, DOI 10.1017/S0950268813000770; Domingues AR, 2014, EPIDEMIOL INFECT, V142, P1614, DOI 10.1017/S095026881300215X; European Food Safety Authority, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3547; Fischer M.M., 2010, HDB APPL SPATIAL ANA, DOI [10.1007/978-3-642-03647-7, DOI 10.1007/978-3-642-03647-7]; Fisher IST, 2009, FOODBORNE PATHOG DIS, V6, P613, DOI 10.1089/fpd.2008.0206; Graziani C, 2013, EURO SURVEILL B EUR, V18; Graziani C, 2011, FOODBORNE PATHOG DIS, V8, P997, DOI 10.1089/fpd.2010.0833; Greene SK, 2008, FOODBORNE PATHOG DIS, V5, P669, DOI 10.1089/fpd.2008.0111; KNOX EG, 1964, ROY STAT SOC C-APP, V13, P25; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Levallois P, 2014, ZOONOSES PUBLIC HLTH, V61, P28, DOI 10.1111/zph.12039; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Moore DA, 1999, EPIDEMIOL REV, V21, P143, DOI 10.1093/oxfordjournals.epirev.a017993; Mughini-Gras L, 2012, EURO SURVEILL B EUR, V17; Mughini-Gras L, 2013, EPIDEMIOL INFECT, P1; Oggioni C, 2010, Ann Ig, V22, P327; Pardhan-Ali A, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-17; Pires SM, 2010, FOODBORNE PATHOG DIS, V7, P1351, DOI 10.1089/fpd.2010.0564; Rizzoli A, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00251; Robardet E, 2011, INT J PARASITOL, V41, P145, DOI 10.1016/j.ijpara.2010.08.007	24	20	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142419	10.1371/journal.pone.0142419	http://dx.doi.org/10.1371/journal.pone.0142419			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26558381	Green Submitted, gold, Green Published			2022-12-27	WOS:000364433100078
J	Parraguez, VH; Mamani, S; Cofre, E; Castellaro, G; Urquieta, B; De los Reyes, M; Astiz, S; Gonzalez-Bulnes, A				Parraguez, Victor H.; Mamani, Sandra; Cofre, Eileen; Castellaro, Giorgio; Urquieta, Bessie; De los Reyes, Monica; Astiz, Susana; Gonzalez-Bulnes, Antonio			Disturbances in Maternal Steroidogenesis and Appearance of Intrauterine Growth Retardation at High-Altitude Environments Are Established from Early Pregnancy. Effects of Treatment with Antioxidant Vitamins	PLOS ONE			English	Article							FETAL CARDIOVASCULAR DEFENSE; BIRTH-WEIGHT; PROGESTERONE CONCENTRATIONS; OXIDATIVE STRESS; BLOOD-PLASMA; HYPOXIA; SHEEP; RESTRICTION; MODEL; PREECLAMPSIA	Pregnancies at high-altitudes are influenced by hypoxia and oxidative stress and frequently affected by IUGR. However, a common thought is that early pregnant women visiting altitude have no major complications for gestation development, since IUGR is developed during the second half of pregnancy. Thus, using a well-characterized sheep-model, we aimed to determine whether long-and/or short-term exposure to high-altitude may affect maternal steroidogenesis and therefore embryo-fetal growth from conception. The second aim was to differentiate the relative role of hypoxia and oxidative stress by assessing the effects of supplementation with antioxidant agents during this early-pregnancy stage, which were previously found to be useful to prevent IUGR. The results indicate that both long-and short-term exposure to high-altitude causes disturbances in maternal ovarian steroidogenesis and negatively affects embryo-fetal growth already during the very early stages of gestation, with the consequences being even worsened in newcomers to high-altitude. The supply of antioxidant during this period only showed discrete effects for preventing IUGR. In conclusion, the present study gives a warning for clinicians about the risks for early-pregnant women when visiting high-altitude regions and suggests the need for further studies on the effects of the length of exposure and on the interaction of the exposure with the pregnancy stage.	[Parraguez, Victor H.; Cofre, Eileen; Urquieta, Bessie; De los Reyes, Monica] Univ Chile, Fac Vet Sci, Santiago, Chile; [Parraguez, Victor H.; Mamani, Sandra; Castellaro, Giorgio] Univ Chile, Fac Agr Sci, Santiago, Chile; [Parraguez, Victor H.] Univ Chile, Int Ctr Andean Studies, Santiago, Chile; [Astiz, Susana; Gonzalez-Bulnes, Antonio] SGIT INIA, Comparat Physiol Lab, Madrid 28040, Spain; [Gonzalez-Bulnes, Antonio] Univ Sassari, Dept Vet Med, I-07100 Sassari, Italy	Universidad de Chile; Universidad de Chile; Universidad de Chile; University of Sassari	Parraguez, VH (corresponding author), Univ Chile, Fac Vet Sci, Casilla 2,Correo 15, Santiago, Chile.	vparragu@uchile.cl	Gonzalez-Bulnes, Antonio/K-7691-2015; Astiz, Susana/AAN-8769-2021; Parraguez, Victor/I-5415-2013	Gonzalez-Bulnes, Antonio/0000-0002-0917-4475; Parraguez, Victor/0000-0002-3621-2705	FONDECYT from CONICYT, Chile [1100189]; Spanish Agency for International Cooperation and Development (AECID) [A/023494/09, A/030536/10]	FONDECYT from CONICYT, Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Spanish Agency for International Cooperation and Development (AECID)	The experimental work was supported by grant FONDECYT 1100189 from CONICYT, Chile and the Spanish Agency for International Cooperation and Development (AECID; Technical Cooperation Projects A/023494/09 and A/030536/10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry JS, 2008, THERIOGENOLOGY, V69, P55, DOI 10.1016/j.theriogenology.2007.09.021; Barry JS, 2008, SEMIN PERINATOL, V32, P225, DOI 10.1053/j.semperi.2007.11.004; BASSETT JM, 1969, J ENDOCRINOL, V45, P449, DOI 10.1677/joe.0.0450449; Bazer FW, 2013, REPROD FERT DEVELOP, V25, P129, DOI 10.1071/RD12266; Bazer FW, 2012, J ANIM SCI BIOTECHNO, V3, DOI 10.1186/2049-1891-3-23; Charles SM, 2014, J CLIN ENDOCR METAB, V99, P2908, DOI 10.1210/jc.2013-4102; de Bulnes AG, 1998, SMALL RUMINANT RES, V27, P243, DOI 10.1016/S0921-4488(97)00062-X; FISCHER B, 1993, J REPROD FERTIL, V99, P673, DOI 10.1530/jrf.0.0990673; GAGIOTI S, 1996, J BRAZ ASS ADV, V48, P37; Garrel C, 2010, J ENDOCRINOL, V205, P107, DOI 10.1677/JOE-09-0362; Ghidini A, 1996, Obstet Gynecol Surv, V51, P376, DOI 10.1097/00006254-199606000-00023; Giussani DA, 2001, PEDIATR RES, V49, P490, DOI 10.1203/00006450-200104000-00009; Giussani DA, 2014, ADV EXP MED BIOL, V814, P77, DOI 10.1007/978-1-4939-1031-1_7; Gonzalez-Bulnes A, 2010, REPROD DOMEST ANIM, V45, P9, DOI 10.1111/j.1439-0531.2010.01640.x; Hancock SN, 2012, J PHYSIOL-LONDON, V590, P1273, DOI 10.1113/jphysiol.2011.220699; Hartinger S, 2006, INT J GYNECOL OBSTET, V93, P275, DOI 10.1016/j.ijgo.2006.02.023; Herrera EA, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00149; Huddleston B. A, 2003, 10 FOOD AGR ORG UN; Igwebuike UM, 2010, ANIM REPROD SCI, V121, P189, DOI 10.1016/j.anireprosci.2010.04.007; Jauniaux E, 2006, HUM REPROD UPDATE, V12, P747, DOI 10.1093/humupd/dml016; Jensen GM, 1997, AM J PUBLIC HEALTH, V87, P1003, DOI 10.2105/AJPH.87.6.1003; Jiang B, 2000, MOL ENDOCRINOL, V14, P1661, DOI 10.1210/me.14.10.1661; Julian CG, 2007, ARCH DIS CHILD-FETAL, V92, P372, DOI 10.1136/adc.2006.109579; Kane AD, 2014, J PHYSIOL-LONDON, V592, P475, DOI 10.1113/jphysiol.2013.264275; Keyes LE, 2003, PEDIATR RES, V54, P20, DOI 10.1203/01.PDR.0000069846.64389.DC; Krampl E, 2000, ULTRASOUND OBST GYN, V16, P9, DOI 10.1046/j.1469-0705.2000.00156.x; Krebs C, 1996, AM J OBSTET GYNECOL, V175, P1534, DOI 10.1016/S0002-9378(96)70103-5; Larstad M, 2002, J CHROMATOGR B, V766, P107, DOI 10.1016/S0378-4347(01)00437-6; Lemley CO, 2010, J ENDOCRINOL, V205, P233, DOI 10.1677/JOE-10-0042; LISSI E, 1992, FREE RADICAL RES COM, V17, P299, DOI 10.3109/10715769209079523; MONGE C, 1991, PHYSIOL REV, V71, P1135, DOI 10.1152/physrev.1991.71.4.1135; Moore LG, 1998, YEARB PHYS ANTHROPOL, V41, P25; Moore LG, 2004, PLACENTA, V25, pS60, DOI 10.1016/j.placenta.2004.01.008; Moore LG, 2001, AM J HUM BIOL, V13, P635, DOI 10.1002/ajhb.1102; Moore LG, 2011, RESP PHYSIOL NEUROBI, V178, P181, DOI 10.1016/j.resp.2011.04.017; MOORE NW, 1972, J ENDOCRINOL, V53, P187, DOI 10.1677/joe.0.0530187; Morrison JL, 2008, CLIN EXP PHARMACOL P, V35, P730, DOI 10.1111/j.1440-1681.2008.04975.x; Mortola JP, 2000, J PEDIATR-US, V136, P324, DOI 10.1067/mpd.2000.103507; Muhlhausler BS, 2011, PEDIATR RES, V70, P117, DOI 10.1203/PDR.0b013e31821f6cfd; Murphy VE, 2006, ENDOCR REV, V27, P141, DOI 10.1210/er.2005-0011; National Research Council, 1985, NUTR REQ SHEEP; Okazaki KM, 2006, REGEN MED, V1, P71, DOI 10.2217/17460751.1.1.71; Parraguez VH, 2014, REPROD DOMEST ANIM, V49, P977, DOI 10.1111/rda.12417; Parraguez VH, 2005, REPROD FERT DEVELOP, V17, P497, DOI 10.1071/RD04060; Parraguez VH, 2006, ANIM REPROD SCI, V95, P151, DOI 10.1016/j.anireprosci.2005.11.003; Parraguez VH, 2013, REPROD FERT DEVELOP, V25, P639, DOI 10.1071/RD12020; Parraguez VH, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-24; Parraguez VH, 2011, REPROD FERT DEVELOP, V23, P285, DOI 10.1071/RD10016; PAVIA CS, 1983, J INFECT DIS, V147, P1006, DOI 10.1093/infdis/147.6.1006; Poore KR, 2010, J PHYSIOL-LONDON, V588, P2219, DOI 10.1113/jphysiol.2010.187682; Redmer DA, 2004, DOMEST ANIM ENDOCRIN, V27, P199, DOI 10.1016/j.domaniend.2004.06.006; Reynolds LP, 2010, J ANIM SCI, V88, pE61, DOI 10.2527/jas.2009-2359; REZNICK AZ, 1994, METHOD ENZYMOL, V233, P357; Rogers PAW, 2009, REPROD SCI, V16, P147, DOI 10.1177/1933719108325509; Salas SP, 2006, HYPERTENSION, V47, P203, DOI 10.1161/01.HYP.0000200042.64517.19; SCHILESINGER M, 1975, FERTIL STERIL, V18, P95; Sharma RK, 2013, SMALL RUMINANT RES, V115, P67, DOI 10.1016/j.smallrumres.2013.08.003; Thakor AS, 2015, J PINEAL RES, V59, P80, DOI 10.1111/jpi.12242; Thakor AS, 2010, J PINEAL RES, V49, P399, DOI 10.1111/j.1600-079X.2010.00813.x; WATSON AJ, 1994, BIOL REPROD, V50, P725, DOI 10.1095/biolreprod50.4.725; WAYNER DDM, 1985, FEBS LETT, V187, P33, DOI 10.1016/0014-5793(85)81208-4; ZAMUDIO S, 1994, J SOC GYNECOL INVEST, V1, P197, DOI 10.1177/107155769400100304	62	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0140902	10.1371/journal.pone.0140902	http://dx.doi.org/10.1371/journal.pone.0140902			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26560325	Green Submitted, Green Published, gold			2022-12-27	WOS:000364433100012
J	Chiu, RYT; Thach, AV; Wu, CM; Wu, BM; Kamei, DT				Chiu, Ricky Y. T.; Thach, Alison V.; Wu, Chloe M.; Wu, Benjamin M.; Kamei, Daniel T.			An Aqueous Two-Phase System for the Concentration and Extraction of Proteins from the Interface for Detection Using the Lateral-Flow Immunoassay	PLoS One			English	Article							PARTICLE-SIZE; PAPER; CHROMATOGRAPHY; SENSITIVITY	The paper-based immunoassay for point-of-care diagnostics is widely used due to its low cost and portability over traditional lab-based assays. Lateral-flow immunoassay (LFA) is the most well-established paper-based assay since it is rapid and easy to use. However, the disadvantage of LFA is its lack of sensitivity in some cases where a large sample volume is required, limiting its use as a diagnostic tool. To improve the sensitivity of LFA, we previously reported on the concentration of analytes into one of the two bulk phases of an aqueous two-phase system (ATPS) prior to detection. In this study, we preserved the advantages of LFA while significantly improving upon our previous proof-of-concept studies by employing a novel approach of concentrating gold nanoparticles, a common LFA colori-metric indicator. By conjugating specific antibodies and polymers to the surfaces of the particles, these gold nanoprobes (GNPs) were able to capture target proteins in the sample and subsequently be concentrated within 10 min at the interface of an ATPS solution comprised of polyethylene glycol, potassium phosphate, and phosphate-buffered saline. These GNPs were then extracted and applied directly to LFA. By combining this prior ATPS interface extraction with LFA, the detection limit of LFA for a model protein was improved by 100-fold from 1 ng/mu L to 0.01 ng/mu L. Additionally, we examined the behavior of the ATPS system in fetal bovine serum and synthetic urine to more closely approach real-world applications. Despite using more complex matrices, ATPS interface extraction still improved the detection limit by 100-fold within 15 to 25 min, demonstrating the system's potential to be applied to patient samples.	[Chiu, Ricky Y. T.; Thach, Alison V.; Wu, Chloe M.; Wu, Benjamin M.; Kamei, Daniel T.] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA; [Wu, Benjamin M.] Univ Calif Los Angeles, Sch Dent, Div Adv Prosthodont, Los Angeles, CA 90024 USA; [Wu, Benjamin M.] Univ Calif Los Angeles, Sch Dent, Weintraub Ctr Reconstruct Biotechnol, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Kamei, DT (corresponding author), Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA.	kamei@seas.ucla.edu		Wu, Benjamin/0000-0001-5236-8534	UCLA School of Dentistry; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023057] Funding Source: NIH RePORTER	UCLA School of Dentistry; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by a grant from the UCLA School of Dentistry. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertsson, 1986, PARTITION CELL PARTI; Cassano CL, 2013, MICROFLUID NANOFLUID, V15, P173, DOI 10.1007/s10404-013-1140-x; Champluvier B, 1992, Bioseparation, V2, P343; Chiu RY, 2014, ANN BIOMED ENG; Ellerbee AK, 2009, ANAL CHEM, V81, P8447, DOI 10.1021/ac901307q; FRENS G, 1972, KOLLOID Z Z POLYM, V250, P736, DOI 10.1007/BF01498565; FRENS G, 1973, NATURE-PHYS SCI, V241, P20, DOI 10.1038/physci241020a0; Fu E, 2011, ANAL CHEM, V83, P7941, DOI 10.1021/ac201950g; Jokerst JV, 2011, NANOMEDICINE-UK, V6, P715, DOI [10.2217/NNM.11.19, 10.2217/nnm.11.19]; Jue E, 2014, BIOTECHNOL BIOENG; LINDBLOM H, 1983, J CHROMATOGR, V266, P187, DOI 10.1016/S0021-9673(01)90892-1; Martinez AW, 2007, ANGEW CHEM INT EDIT, V46, P1318, DOI 10.1002/anie.200603817; Mashayekhi F, 2012, ANAL BIOANAL CHEM, V404, P2057, DOI 10.1007/s00216-012-6278-y; Mashayekhi F, 2010, ANAL BIOANAL CHEM, V398, P2955, DOI 10.1007/s00216-010-4213-7; Old J, 2012, J FORENSIC SCI, V57, P489, DOI 10.1111/j.1556-4029.2011.01968.x; Peruski AH, 2003, CLIN DIAGN LAB IMMUN, V10, P506, DOI 10.1128/CDLI.10.4.506-513.2003; Posthuma-Trumpie GA, 2009, ANAL BIOANAL CHEM, V393, P569, DOI 10.1007/s00216-008-2287-2; Schubert-Ullrich P, 2009, ANAL BIOANAL CHEM, V395, P69, DOI 10.1007/s00216-009-2715-y; Stevens DY, 2008, LAB CHIP, V8, P2038, DOI 10.1039/b811158h; Uyeki TM, 2009, CLIN INFECT DIS, V48, pE89, DOI 10.1086/597828; Warsinke A, 2009, ANAL BIOANAL CHEM, V393, P1393, DOI 10.1007/s00216-008-2572-0; ZUK RF, 1985, CLIN CHEM, V31, P1144	22	13	19	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142654	10.1371/journal.pone.0142654	http://dx.doi.org/10.1371/journal.pone.0142654			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556593	gold, Green Published, Green Submitted			2022-12-27	WOS:000364430700151
J	Civardi, C; Schubert, M; Fey, A; Wick, P; Schwarze, FWMR				Civardi, Chiara; Schubert, Mark; Fey, Angelika; Wick, Peter; Schwarze, Francis W. M. R.			Micronized Copper Wood Preservatives: Efficacy of Ion, Nano, and Bulk Copper against the Brown Rot Fungus Rhodonia placenta	PLOS ONE			English	Article							ENGINEERED NANOPARTICLES; IN-VITRO; TOLERANCE; TOXICITY; LACCASE; OXIDE; TETRATHIOMOLYBDATE; CHEMISTRY; STRAIN; GROWTH	Recently introduced micronized copper (MC) formulations, consisting of a nanosized fraction of basic copper (Cu) carbonate (CuCO3 center dot Cu(OH)(2)) nanoparticles (NPs), were introduced to the market for wood protection. Cu NPs may presumably be more effective against wood-destroying fungi than bulk or ionic Cu compounds. In particular, Cu-tolerant wood-destroying fungi may not recognize NPs, which may penetrate into fungal cell walls and membranes and exert their impact. The objective of this study was to assess if MC wood preservative formulations have a superior efficacy against Cu-tolerant wood-destroying fungi due to nano effects than conventional Cu biocides. After screening a range of wood-destroying fungi for their resistance to Cu, we investigated fungal growth of the Cu-tolerant fungus Rhodonia placenta in solid and liquid media and on wood treated with MC azole (MCA). In liquid cultures we evaluated the fungal response to ion, nano and bulk Cu distinguishing the ionic and particle effects by means of the Cu2+ chelator ammonium tetrathiomolybdate (TTM) and measuring fungal biomass, oxalic acid production and laccase activity of R. placenta. Our results do not support the presence of particular nano effects of MCA against R. placenta that would account for an increased antifungal efficacy, but provide evidence that attribute the main effectiveness of MCA to azoles.	[Civardi, Chiara; Schubert, Mark; Fey, Angelika; Schwarze, Francis W. M. R.] Empa, Appl Wood Mat, St Gallen, Switzerland; [Civardi, Chiara] ETH, Inst Bldg Mat, Zurich, Switzerland; [Wick, Peter] Empa, Particles Biol Interact, St Gallen, Switzerland	Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA); Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA)	Civardi, C (corresponding author), Empa, Appl Wood Mat, St Gallen, Switzerland.	chiara.civardi@empa.ch; francis.schwarze@empa.ch	Schwarze, Francis/Y-2157-2018	Schwarze, Francis/0000-0003-3306-8303; Schubert, Mark/0000-0002-6900-0370	Swiss National Research Foundation [NRP 64, 406440_141618]	Swiss National Research Foundation(Swiss National Science Foundation (SNSF))	The study was financially supported by the Swiss National Research Foundation (NRP 64, Grant No. 406440_141618). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanese A, 2012, ANNU REV BIOMED ENG, V14, P1, DOI [10.1146/annurev-bioeng-071811-150124, 10.1146/annurev.bioeng-071811-150124]; Arantes V, 2011, J IND MICROBIOL BIOT, V38, P541, DOI 10.1007/s10295-010-0798-2; Bondarenko O, 2013, ARCH TOXICOL, V87, P1181, DOI 10.1007/s00204-013-1079-4; Brewer GJ, 2009, TRANSL RES, V154, P70, DOI 10.1016/j.trsl.2009.05.002; Brewer GJ, 2005, CURR CANCER DRUG TAR, V5, P195, DOI 10.2174/1568009053765807; Buerki-Thurnherr T, 2013, NANOTOXICOLOGY, V7, P402, DOI 10.3109/17435390.2012.666575; Bulcke F, 2014, NANOTOXICOLOGY, V8, P775, DOI 10.3109/17435390.2013.829591; Choi O, 2008, WATER RES, V42, P3066, DOI 10.1016/j.watres.2008.02.021; Civardi C, 2015, ENVIRON POLLUT, V200, P126, DOI 10.1016/j.envpol.2015.02.018; Cookson LJ, 2010, FOREST PROD J, V60, P6, DOI 10.13073/0015-7473-60.1.6; Dhyani S, 2012, WOOD SCI TECHNOL, V46, P1203, DOI 10.1007/s00226-012-0475-x; ENGLANDER CM, 1971, APPL MICROBIOL, V22, P1012, DOI 10.1128/AEM.22.6.1012-1016.1971; European Committee for Standardization, 1997, 113 EN EUR COMM STAN; European Committee for Standardization, 1992, 275 EN EUR COMM STAN; Fischer-Parton S, 2000, J MICROSC-OXFORD, V198, P246, DOI 10.1046/j.1365-2818.2000.00708.x; FLEMMING CA, 1989, WATER AIR SOIL POLL, V44, P143, DOI 10.1007/BF00228784; Gil-Allue C, 2015, ENVIRON SCI TECHNOL, V49, P1165, DOI 10.1021/es5050166; Goodell B, 2003, ACS SYM SER, V845, P97; Green F, 2003, INT BIODETER BIODEGR, V51, P145, DOI 10.1016/S0964-8305(02)00099-9; Habicht J, 2010, MIKRONISIERTES KUPFE, P161; Herpoel I, 2002, J PULP PAP SCI, V28, P67; Hughes A, 2006, ENV OPTIMISATION WOO; HUMPHRIES WR, 1986, VET REC, V119, P596; Jin L., 2010, 41st Annual Meeting of the International Research Group on Wood Protection, Biarritz, France, 9-13 May 2010, pIRG; JOSEPHHORNE T, 1995, FEBS LETT, V374, P174, DOI 10.1016/0014-5793(95)01102-K; Kim JH, 2000, ARCH BIOCHEM BIOPHYS, V382, P72, DOI 10.1006/abbi.2000.1996; Krumova EZ, 2009, PROCESS BIOCHEM, V44, P288, DOI 10.1016/j.procbio.2008.10.023; Kumar A., 1999, Acta Phytopathologica et Entomologica Hungarica, V34, P27; Limbach LK, 2007, ENVIRON SCI TECHNOL, V41, P4158, DOI 10.1021/es062629t; Lomascolo A, 2003, J APPL MICROBIOL, V94, P618, DOI 10.1046/j.1365-2672.2003.01879.x; MCCALLAN SEA, 1949, BOT REV, V15, P629, DOI 10.1007/BF02861716; McIntyre CR, 2010, P 105 ANN M AM WOOD, V105, P114; MCQUAID A, 1991, J INORG BIOCHEM, V41, P87, DOI 10.1016/0162-0134(91)80002-Y; Midander K, 2009, SMALL, V5, P389, DOI 10.1002/smll.200801220; Montag J, 2006, J PHYTOPATHOL, V154, P474, DOI 10.1111/j.1439-0434.2006.01132.x; Navarro E, 2008, ECOTOXICOLOGY, V17, P372, DOI 10.1007/s10646-008-0214-0; Obanda DN, 2008, THESIS; OHSUMI Y, 1988, J BACTERIOL, V170, P2676, DOI 10.1128/jb.170.6.2676-2682.1988; Park KH, 2005, BBA-GEN SUBJECTS, V1726, P115, DOI 10.1016/j.bbagen.2005.06.010; Platten WE, 2014, EPA600R14365; Ray M, 2010, P IRG ANN M 2010 MAY; SAGRIPANTI JL, 1991, TOXICOL APPL PHARM, V110, P477, DOI 10.1016/0041-008X(91)90048-J; Sharma SS, 2009, TRENDS PLANT SCI, V14, P43, DOI 10.1016/j.tplants.2008.10.007; Stirling R, 2010, P IRG ANN M 2010 MAY; Studer AM, 2010, TOXICOL LETT, V197, P169, DOI 10.1016/j.toxlet.2010.05.012; Sun FL, 2012, J WOOD SCI, V58, P51, DOI 10.1007/s10086-011-1223-9; SUTTER HP, 1983, MATER ORGANISMEN, V18, P241; Tang JD, 2013, APPL ENVIRON MICROB, V79, P1523, DOI 10.1128/AEM.02916-12; Watanabe T, 1998, J BIOTECHNOL, V62, P221, DOI 10.1016/S0168-1656(98)00063-7; WAZNY J, 1986, HOLZFORSCHUNG, V40, P383, DOI 10.1515/hfsg.1986.40.6.383; Wei DS, 2010, APPL ENVIRON MICROB, V76, P2091, DOI 10.1128/AEM.02929-09; WESSELS JGH, 1993, NEW PHYTOL, V123, P397, DOI 10.1111/j.1469-8137.1993.tb03751.x; Woo C, 2010, INT BIODETER BIODEGR, V64, P403, DOI 10.1016/j.ibiod.2010.01.009; Xue W, 2014, P IRG ANN M 2014 MAY; Xue W, 2013, HOLZFORSCHUNG, V67, P815, DOI 10.1515/hf-2012-0136; Xue W, 2012, HOLZFORSCHUNG, V66, P889, DOI 10.1515/HF.2011.188; Zhang J, 2009, CANADIAN WOOD PRESER, P69	57	30	30	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142578	10.1371/journal.pone.0142578	http://dx.doi.org/10.1371/journal.pone.0142578			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26554706	gold, Green Published, Green Submitted			2022-12-27	WOS:000364430700136
J	Giordano, C; Vinet, J; Curia, G; Biagini, G				Giordano, Carmela; Vinet, Jonathan; Curia, Giulia; Biagini, Giuseppe			Repeated 6-Hz Corneal Stimulation Progressively Increases FosB/Delta FosB Levels in the Lateral Amygdala and Induces Seizure Generalization to the Hippocampus	PLOS ONE			English	Article							ACCESSORY BASAL NUCLEI; DELTA-FOSB; GLUTAMATE-DECARBOXYLASE; ANTIEPILEPTIC DRUGS; STATUS EPILEPTICUS; POSTICTAL STATE; KETOGENIC DIET; EPILEPSY; EFFICACY; DAMAGE	Exposure to repetitive seizures is known to promote convulsions which depend on specific patterns of network activity. We aimed at evaluating the changes in seizure phenotype and neuronal network activation caused by a modified 6-Hz corneal stimulation model of psychomotor seizures. Mice received up to 4 sessions of 6-Hz corneal stimulation with fixed current amplitude of 32 mA and inter-stimulation interval of 72 h. Video-electroencephalography showed that evoked seizures were characterized by a motor component and a non-motor component. Seizures always appeared in frontal cortex, but only at the fourth stimulation they involved the hippocampus, suggesting the establishment of an epileptogenic process. Duration of seizure non-motor component progressively decreased after the second session, whereas convulsive seizures remained unchanged. In addition, a more severe seizure phenotype, consisting of tonic-clonic generalized convulsions, was predominant after the second session. Immunohistochemistry and double immunofluorescence experiments revealed a significant increase in neuronal activity occurring in the lateral amygdala after the fourth session, most likely due to activity of principal cells. These findings indicate a predominant role of amygdala in promoting progressively more severe convulsions as well as the late recruitment of the hippocampus in the seizure spread. We propose that the repeated 6-Hz corneal stimulation model may be used to investigate some mechanisms of epileptogenesis and to test putative antiepileptogenic drugs.	[Giordano, Carmela; Vinet, Jonathan; Curia, Giulia; Biagini, Giuseppe] Univ Modena & Reggio Emilia, Dept Biomed Metab & Neural Sci, Lab Expt Epileptol, Modena, Italy; [Biagini, Giuseppe] NOCSAE Hosp, AUSL Modena, Dept Neurosci, Modena, Italy	Universita di Modena e Reggio Emilia	Biagini, G (corresponding author), Univ Modena & Reggio Emilia, Dept Biomed Metab & Neural Sci, Lab Expt Epileptol, Modena, Italy.	gbiagini@unimore.it	Biagini, Giuseppe/I-3227-2013; Curia, Giulia/A-8863-2008; Vinet, Jonathan/O-2934-2015	Biagini, Giuseppe/0000-0002-7130-2511; Curia, Giulia/0000-0002-8472-350X; Vinet, Jonathan/0000-0001-9011-6207	Italian Ministry of Health [RF-2010-2309921]; Marie Sklodowska-Curie Fellowship [326651]	Italian Ministry of Health(Ministry of Health, Italy); Marie Sklodowska-Curie Fellowship	This study was supported by the Italian Ministry of Health (grant RF-2010-2309921 to GB). JV is recipient of a Marie Sklodowska-Curie Fellowship (FP7-PEOPLE-2012-IEF, #326651). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre V, 2000, NEUROSCIENCE, V99, P469, DOI 10.1016/S0306-4522(00)00209-8; Aroniadou-Anderjaska V, 2008, EPILEPSY RES, V78, P102, DOI 10.1016/j.eplepsyres.2007.11.011; Bankstahl M, 2013, EPILEPSY RES, V107, P205, DOI 10.1016/j.eplepsyres.2013.09.014; Barton ME, 2001, EPILEPSY RES, V47, P217, DOI 10.1016/S0920-1211(01)00302-3; Biagini G, 2005, NEUROMOL MED, V7, P325, DOI 10.1385/NMM:7:4:325; Biagini G, 2008, J NEUROPATH EXP NEUR, V67, P687, DOI 10.1097/NEN.0b013e318181b8ae; BROWN WC, 1953, J PHARMACOL EXP THER, V107, P273; CALDECOTTHAZARD S, 1987, PROG NEURO-PSYCHOPH, V11, P389, DOI 10.1016/0278-5846(87)90014-5; CHEN JS, 1995, MOL PHARMACOL, V48, P880; Curia G, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00046; Duncan GE, 2005, EPILEPSY RES, V67, P81, DOI 10.1016/j.eplepsyres.2005.08.009; Fisher RS, 2010, EPILEPSY BEHAV, V19, P100, DOI 10.1016/j.yebeh.2010.06.038; Fisher RS, 2000, EPILEPSY BEHAV, V1, P52, DOI 10.1006/ebeh.2000.0023; FRENK H, 1979, BRAIN RES, V167, P435, DOI 10.1016/0006-8993(79)90842-4; Giordano C, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00063; Gualtieri F, 2012, NEUROSCIENCE, V218, P278, DOI 10.1016/j.neuroscience.2012.05.018; Harris GC, 2007, NEUROSCIENCE, V147, P583, DOI 10.1016/j.neuroscience.2007.04.050; Hartman AL, 2008, EPILEPSIA, V49, P334, DOI 10.1111/j.1528-1167.2007.01430.x; Kaminski RM, 2004, EPILEPSIA, V45, P864, DOI 10.1111/j.0013-9580.2004.04504.x; KAUFMAN DL, 1991, J NEUROCHEM, V56, P720, DOI 10.1111/j.1471-4159.1991.tb08211.x; KAUFMAN DL, 1986, SCIENCE, V232, P1138, DOI 10.1126/science.3518061; KELLY ME, 1994, BRAIN RES, V634, P245, DOI 10.1016/0006-8993(94)91927-5; Kelz MB, 2000, CURR OPIN NEUROL, V13, P715, DOI 10.1097/00019052-200012000-00017; Kemppainen S, 2004, NEUROSCIENCE, V126, P485, DOI 10.1016/j.neuroscience.2004.03.015; Krishnan GP, 2011, J NEUROSCI, V31, P8870, DOI 10.1523/JNEUROSCI.6200-10.2011; Leclercq K, 2014, EPILEPSY RES, V108, P675, DOI 10.1016/j.eplepsyres.2014.02.013; Liu XB, 1996, P NATL ACAD SCI USA, V93, P7332, DOI 10.1073/pnas.93.14.7332; Lucchi C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072716; Madsen TM, 2006, CELL MOL NEUROBIOL, V26, P87, DOI 10.1007/s10571-006-9202-1; Mares P, 2015, NEUROPHARMACOLOGY, V88, P99, DOI 10.1016/j.neuropharm.2014.09.007; Matagne A, 1998, EPILEPSY RES, V31, P59, DOI 10.1016/S0920-1211(98)00016-3; Mohapel P, 2001, EUR J NEUROSCI, V13, P1501, DOI 10.1046/j.0953-816x.2001.01532.x; Morimoto K, 2004, PROG NEUROBIOL, V73, P1, DOI 10.1016/j.pneurobio.2004.03.009; Morris TA, 2000, MOL BRAIN RES, V79, P138, DOI 10.1016/S0169-328X(00)00112-1; Neal EG, 2008, LANCET NEUROL, V7, P500, DOI 10.1016/S1474-4422(08)70092-9; Pikkarainen M, 1999, J COMP NEUROL, V403, P229; Rowley NM, 2010, EPILEPSY RES, V92, P163, DOI 10.1016/j.eplepsyres.2010.09.002; SANGDEE P, 1982, EPILEPSIA, V23, P471, DOI 10.1111/j.1528-1157.1982.tb05435.x; Savander V, 1997, NEUROSCIENCE, V77, P767, DOI 10.1016/S0306-4522(96)00513-1; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; VELISEK L, 1992, EPILEPSY RES, V12, P37, DOI 10.1016/0920-1211(92)90089-C; White SH., 2002, ANTIEPILEPTIC DRUGS, V5, P36	42	32	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0141221	10.1371/journal.pone.0141221	http://dx.doi.org/10.1371/journal.pone.0141221			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555229	gold, Green Published, Green Submitted			2022-12-27	WOS:000364430700021
J	Huang, YT; Ko, WC; Chan, YJ; Lu, JJ; Tsai, HY; Liao, CH; Sheng, WH; Teng, LJ; Hsueh, PR				Huang, Yu-Tsung; Ko, Wen-Chien; Chan, Yu-Jiun; Lu, Jang-Jih; Tsai, Hsih-Yeh; Liao, Chun-Hsing; Sheng, Wang-Huei; Teng, Lee-Jene; Hsueh, Po-Ren			Disease Burden of Invasive Listeriosis and Molecular Characterization of Clinical Isolates in Taiwan, 2000-2013	PLoS One			English	Article							MONOCYTOGENES; CLONES; EPIDEMIOLOGY; PCR	The information about disease burden and epidemiology of invasive listeriosis in Asia is scarce. From 2000 to 2013, a total of 338 patients with invasive listeriosis (bacteremia, meningitis, and peritonitis) were treated at four medical centers in Taiwan. The incidence (per 10,000 admissions) of invasive listeriosis increased significantly during the 14-year period among the four centers (0.15 in 2000 and >1.25 during 2010-2012) and at each of the four medical centers. Among these patients, 45.9% were elderly (>65 years old) and 3.3% were less than one year of age. More than one-third (36.7%) of the patients acquired invasive listeriosis in the spring (April to June). Among the 132 preserved Listeria monocytogenes isolates analyzed, the most frequently isolated PCR serogroup-sequence type (ST) was IIb-ST87 (23.5%), followed by IIa-ST378 (19.7%) and IIa-ST155 (12.1%). Isolation of PCR serogroups IIb and IVb increased significantly with year, with a predominance of IIb-ST87 isolates (23.5%) and IIb-ST 228 isolates emerging in 2013. A total of 12 different randomly amplified polymorphic DNA (RAPD) patterns (Patterns I to XII) were identified among the 112 L. monocytogenes isolates belonging to eight main PCR serogroup-STs. Identical RAPD patterns were found among the isolates exhibiting the same PCR serogroup-ST. In conclusion, our study revealed that during 2000-2013, listeriosis at four medical centers in Taiwan was caused by heterogeneous strains and that the upsurge in incidence beginning in 2005 was caused by at least two predominant clones.	[Huang, Yu-Tsung; Tsai, Hsih-Yeh; Liao, Chun-Hsing] Far Eastern Mem Hosp, Dept Internal Med, New Taipei, Taiwan; [Ko, Wen-Chien] Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan 70428, Taiwan; [Ko, Wen-Chien] Natl Cheng Kung Univ, Coll Med, Tainan 70101, Taiwan; [Lu, Jang-Jih] Chang Gung Mem Hosp, Dept Lab Med, Taoyuan, Taiwan; [Chan, Yu-Jiun] Taipei Vet Gen Hosp, Dept Lab Med, Taipei, Taiwan; [Chan, Yu-Jiun] Natl Yang Ming Univ, Taipei 112, Taiwan; [Huang, Yu-Tsung; Teng, Lee-Jene] Natl Taiwan Univ, Grad Inst Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan; [Huang, Yu-Tsung; Sheng, Wang-Huei; Hsueh, Po-Ren] Natl Taiwan Univ, Dept Lab Med, Natl Taiwan Univ Hosp, Coll Med, Taipei 10764, Taiwan; [Hsueh, Po-Ren] Natl Taiwan Univ, Coll Med, Dept Internal Med, Natl Taiwan Univ Hosp, Taipei, Taiwan	Far Eastern Memorial Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; Chang Gung Memorial Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Hsueh, PR (corresponding author), Natl Taiwan Univ, Dept Lab Med, Natl Taiwan Univ Hosp, Coll Med, Taipei 10764, Taiwan.	hsporen@ntu.edu.tw	Ko, Wen-Chien/ABG-4316-2020; Hsueh, Po-Ren/ABE-1594-2021	Ko, Wen-Chien/0000-0001-7497-149X; Liao, Chun-Hsing/0000-0002-4099-3487; SHENG, WANG-HUEI/0000-0002-5605-7853; HSUEH, PO-REN/0000-0002-7502-9225; Huang, Yu-tsung/0000-0002-7805-4178; TENG, LEE-JENE/0000-0003-0104-741X	Ministry of Science and Technology [MOST 103-2300-B-002-054]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was financially supported by a grant from Ministry of Science and Technology (MOST 103-2300-B-002-054). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cantinelli T, 2013, J CLIN MICROBIOL, V51, P3770, DOI 10.1128/JCM.01874-13; Charlier C, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000105; Chenal-Francisque V, 2011, EMERG INFECT DIS, V17, P1110, DOI [10.3201/eid/1706.101778, 10.3201/eid1706.101778]; de Noordhout CM, 2014, LANCET INFECT DIS, V14, P1073, DOI 10.1016/S1473-3099(14)70870-9; Doumith M, 2004, J CLIN MICROBIOL, V42, P3819, DOI 10.1128/JCM.42.8.3819-3822.2004; Goulet V, 2008, EMERG INFECT DIS, V14, P734, DOI 10.3201/eid1405.071395; Guevara RE, 2009, CLIN INFECT DIS, V48, P1507, DOI 10.1086/598935; Haase JK, 2014, ENVIRON MICROBIOL, V16, P405, DOI 10.1111/1462-2920.12342; Hsieh WS, 2009, INT J INFECT DIS, V13, P193, DOI 10.1016/j.ijid.2008.06.006; Huang SL, 2010, J MICROBIOL IMMUNOL, V43, P485, DOI 10.1016/S1684-1182(10)60075-8; Huang YT, 2011, EMERG INFECT DIS, V17, P1731, DOI 10.3201/eid1709.110093; Kerouanton A, 2010, J MICROBIOL METH, V80, P134, DOI 10.1016/j.mimet.2009.11.008; Lado BH, 2003, APPL ENVIRON MICROB, V69, P2223, DOI 10.1128/AEM.69.4.2223-2229.2003; Louie M, 1996, J CLIN MICROBIOL, V34, P15, DOI 10.1128/JCM.34.1.15-19.1996; McCollum JT, 2013, NEW ENGL J MED, V369, P944, DOI 10.1056/NEJMoa1215837; Okutani A, 2004, EPIDEMIOL INFECT, V132, P769, DOI 10.1017/S0950268804001967; Ragon M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000146; Silk BJ, 2012, CLIN INFECT DIS, V54, pS396, DOI 10.1093/cid/cis268; Swaminathan B, 2007, MICROBES INFECT, V9, P1236, DOI 10.1016/j.micinf.2007.05.011; Wang HL, 2013, CLIN INFECT DIS, V56, P666, DOI 10.1093/cid/cis943; Wang JP, 2013, J FOOD PROTECT, V76, P1046, DOI 10.4315/0362-028X.JFP-12-448; Wang Y, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-119; WONG HC, 1990, APPL ENVIRON MICROB, V56, P3101, DOI 10.1128/AEM.56.10.3101-3104.1990; Yeh KS, 2005, J FOOD PROTECT, V68, P458, DOI 10.4315/0362-028X-68.3.458	24	36	38	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0141241	10.1371/journal.pone.0141241	http://dx.doi.org/10.1371/journal.pone.0141241			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555445	gold, Green Published, Green Submitted			2022-12-27	WOS:000364430700023
J	Kegler, P; Baum, G; Indriana, LF; Wild, C; Kunzmann, A				Kegler, Pia; Baum, Gunilla; Indriana, Lisa F.; Wild, Christian; Kunzmann, Andreas			Physiological Response of the Hard Coral Pocillopora verrucosa from Lombok, Indonesia, to Two Common Pollutants in Combination with High Temperature	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; WATER-SOLUBLE FRACTION; SCLERACTINIAN CORALS; CLIMATE-CHANGE; RISK-ASSESSMENT; REEF ECOSYSTEM; FLORIDA-KEYS; PHOTOSYNTHESIS; OIL; SURFACTANTS	Knowledge on interactive effects of global (e.g. ocean warming) and local stressors (e.g. pollution) is needed to develop appropriate management strategies for coral reefs. Surfactants and diesel are common coastal pollutants, but knowledge of their effects on hard corals as key reef ecosystem engineers is scarce. This study thus investigated the physiological reaction of Pocillopora verrucosa from Lombok, Indonesia, to exposure with a) the water-soluble fraction of diesel (determined by total polycyclic aromatic hydrocarbons (PAH); 0.69 +/- 0.14 mg L-1), b) the surfactant linear alkylbenzene sulfonate (LAS; 0.95 +/- 0.02 mg L-1) and c) combinations of each pollutant with high temperature (+3 degrees C). To determine effects on metabolism, respiration, photosynthetic efficiency and coral tissue health were measured. Findings revealed no significant effects of diesel, while LAS resulted in severe coral tissue losses (16-95% after 84 h). High temperature led to an increase in photosynthetic yield of corals after 48 h compared to the control treatment, but no difference was detected thereafter. In combination, diesel and high temperature significantly increased coral dark respiration, whereas LAS and high temperature caused higher tissue losses (81-100% after 84 h) and indicated a severe decline in maximum quantum yield. These results confirm the hypothesized combined effects of high temperature with either of the two investigated pollutants. Our study demonstrates the importance of reducing import of these pollutants in coastal areas in future adaptive reef management, particularly in the context of ocean warming.	[Kegler, Pia; Baum, Gunilla; Kunzmann, Andreas] Leibniz Ctr Trop Marine Ecol, Dept Ecol, Bremen, Germany; [Indriana, Lisa F.] Indonesian Inst Sci, Res Ctr Oceanog, Mataram Marine Bio Ind Tech Implementat Unit, Pemenang, Indonesia; [Wild, Christian] Univ Bremen, Fac Biol & Chem, D-28359 Bremen, Germany	Leibniz Zentrum fur Marine Tropenforschung (ZMT); Indonesian Institute of Sciences; University of Bremen	Kegler, P (corresponding author), Leibniz Ctr Trop Marine Ecol, Dept Ecol, Bremen, Germany.	piakegler@gmx.de	Kunzmann, Andreas/O-1345-2013; Kunzmann, Andreas/O-5459-2019	Kunzmann, Andreas/0000-0002-9500-4332; Kunzmann, Andreas/0000-0002-9500-4332	AiF Projekt GmbH [2665803MD3]; German Federal Ministry of Education and Research [03F0641A]; A Kunzmann	AiF Projekt GmbH; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); A Kunzmann	This project was funded partly through AiF Projekt GmbH (www.aif-projekt-gmbh.de, project ILAR no. 2665803MD3) and through the German Federal Ministry of Education and Research (www.bmbf.de, project SPICE, grant no. 03F0641A) in the frame of the Indonesian German collaboration in marine research. Both grants were received through A Kunzmann. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL PD, 1974, J FISH BIOL, V6, P279, DOI 10.1111/j.1095-8649.1974.tb04545.x; Al-Dahash LM, 2013, MAR POLLUT BULL, V72, P364, DOI 10.1016/j.marpolbul.2012.08.029; Al-Horani FA, 2003, MAR BIOL, V142, P419, DOI 10.1007/s00227-002-0981-8; [Anonymous], SCI INPUT OIL SPILL; [Anonymous], 2003, OIL SEA; Baskett ML, 2010, GLOBAL CHANGE BIOL, V16, P1229, DOI 10.1111/j.1365-2486.2009.02062.x; Beer S, 1998, MAR BIOL, V131, P607, DOI 10.1007/s002270050352; Beyer J, 2014, MAR ENVIRON RES, V96, P81, DOI 10.1016/j.marenvres.2013.10.008; Bhagooli R, 2004, COMP BIOCHEM PHYS A, V137, P547, DOI 10.1016/j.cbpb.2003.11.008; Bourne DG, 2009, TRENDS MICROBIOL, V17, P554, DOI 10.1016/j.tim.2009.09.004; Braga J.K., 2014, AM J ANAL CHEM, V5, P8, DOI DOI 10.4236/AJAC.2014.51002; Brown BE, 1997, CORAL REEFS, V16, pS129, DOI 10.1007/s003380050249; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Burke L, 2012, REEFS RISK REVISITED; Chupa J, 2007, KENT RIEGELS HDB IND, P1694; Clara M, 2007, WATER RES, V41, P4339, DOI 10.1016/j.watres.2007.06.027; COLES SL, 1977, MAR BIOL, V43, P209, DOI 10.1007/BF00402313; Cserhati T, 2002, ENVIRON INT, V28, P337, DOI 10.1016/S0160-4120(02)00032-6; DAVIES PS, 1984, CORAL REEFS, V2, P181; DeLeo DM, 2016, DEEP-SEA RES PT II, V129, P137, DOI 10.1016/j.dsr2.2015.02.028; Falahudin D., 2012, COAST MAR SCI, V35, P112; Fournie JW, 2012, DIS AQUAT ORGAN, V99, P85, DOI 10.3354/dao02459; George AL, 1999, ENVIRON TOXICOL CHEM, V18, P2232, DOI 10.1002/etc.5620181016; Guppy M, 1999, BIOL REV, V74, P1, DOI 10.1017/S0006323198005258; Haapkyla J, 2007, VIE MILIEU, V57, P95; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Isobe T, 2007, ENVIRON MONIT ASSESS, V135, P423, DOI 10.1007/s10661-007-9661-y; Ivankovic T, 2010, ARH HIG RADA TOKSIKO, V61, P95, DOI 10.2478/10004-1254-61-2010-1943; Johnson LL, 2002, AQUAT CONSERV, V12, P517, DOI 10.1002/aqc.522; Jones RJ, 1999, MAR POLLUT BULL, V38, P864, DOI 10.1016/S0025-326X(98)90160-6; Kaniewska P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034659; Kemp DW, 2011, GLOBAL CHANGE BIOL, V17, P3468, DOI 10.1111/j.1365-2486.2011.02487.x; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; Ko FC, 2014, ENVIRON POLLUT, V185, P35, DOI 10.1016/j.envpol.2013.10.025; Lara-Martin PA, 2008, TRAC-TREND ANAL CHEM, V27, P684, DOI 10.1016/j.trac.2008.05.005; Lesser MP, 2013, CORAL REEFS, V32, P25, DOI 10.1007/s00338-012-0993-x; Logan DT, 2007, HUM ECOL RISK ASSESS, V13, P302, DOI 10.1080/10807030701226749; Maina J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023064; Maltby L, 1999, ECOL APPL, V9, P431, DOI 10.1890/1051-0761(1999)009[0431:SSTIOO]2.0.CO;2; MARSH J A JR, 1970, Ecology (Washington D C), V51, P255, DOI 10.2307/1933661; Masson-Delmotte V., 2018, GLOBAL WARMING 15 C; Mercurio P, 2004, ENVIRON POLLUT, V129, P183, DOI 10.1016/j.envpol.2003.11.008; Ministry of environment lands and parks Province of British Columbia, 1993, AMB WAT QUAL CRIT PO; MUSCATINE L, 1984, PROC R SOC SER B-BIO, V222, P181, DOI 10.1098/rspb.1984.0058; Negri AP, 2000, MAR POLLUT BULL, V41, P420, DOI 10.1016/S0025-326X(00)00139-9; Pampanin DM., 2013, HYDROCARBON, V5, P83, DOI [10.5772/48176, DOI 10.5772/48176]; Philipp E, 2003, J EXP MAR BIOL ECOL, V287, P57, DOI 10.1016/S0022-0981(02)00495-1; Portner HO, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P411; Porter JW, 1999, LIMNOL OCEANOGR, V44, P941, DOI 10.4319/lo.1999.44.3_part_2.0941; Redman AD, 2015, MAR POLLUT BULL, V98, P156, DOI 10.1016/j.marpolbul.2015.06.053; Reynaud S, 2003, GLOBAL CHANGE BIOL, V9, P1660, DOI 10.1046/j.1365-2486.2003.00678.x; RINKEVICH B, 1979, MAR POLLUT BULL, V10, P328, DOI 10.1016/0025-326X(79)90402-8; Risk MJ, 2001, B MAR SCI, V69, P443; Rohwer F, 2002, MAR ECOL PROG SER, V243, P1, DOI 10.3354/meps243001; Santos CA, 2013, NEOTROP ICHTHYOL, V11, P193, DOI 10.1590/S1679-62252013000100022; Santos CA, 2010, ZOOLOGIA-CURITIBA, V27, P956, DOI 10.1590/S1984-46702010000600017; Shafir S, 2014, WATER AIR SOIL POLL, V225, DOI 10.1007/s11270-014-1890-4; Simonato JD, 2008, ECOTOX ENVIRON SAFE, V69, P112, DOI 10.1016/j.ecoenv.2007.01.012; Singer MM, 2000, MAR POLLUT BULL, V40, P1007, DOI 10.1016/S0025-326X(00)00045-X; Temara A, 2001, MAR POLLUT BULL, V42, P635, DOI 10.1016/S0025-326X(01)00061-3; U. S. Energy Information Administration, INT EN STAT; Ulstrup KE, 2011, AQUAT BIOL, V12, P241, DOI 10.3354/ab00338; Van Dam J., 2011, ECOL IMPACTS TOXIC C, P187, DOI DOI 10.2174/978160805121211101010187; Vanzella TP, 2007, MUTAT RES-GEN TOX EN, V631, P36, DOI 10.1016/j.mrgentox.2007.04.004; Walz H., 1998, SUBMERSIBLE PHOTOSYN; Whitall D, 2014, MAR POLLUT BULL, V80, P293, DOI 10.1016/j.marpolbul.2013.12.053; Wild C, 2011, MAR FRESHWATER RES, V62, P205, DOI 10.1071/MF10254; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x	70	13	13	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142744	10.1371/journal.pone.0142744	http://dx.doi.org/10.1371/journal.pone.0142744			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555818	gold, Green Published, Green Submitted			2022-12-27	WOS:000364430700166
J	Shelburne, SA; Ajami, NJ; Chibucos, MC; Beird, HC; Tarrand, J; Galloway-Pena, J; Albert, N; Chemaly, RF; Ghantoji, SS; Marsh, L; Pemmaraju, N; Andreeff, M; Shpall, EJ; Wargo, JA; Rezvani, K; Alousi, A; Bruno, VM; Futreal, PA; Petrosino, JF; Kontoyiannis, DP				Shelburne, Samuel A.; Ajami, Nadim J.; Chibucos, Marcus C.; Beird, Hannah C.; Tarrand, Jeffrey; Galloway-Pena, Jessica; Albert, Nathan; Chemaly, Roy F.; Ghantoji, Shashank S.; Marsh, Lisa; Pemmaraju, Naveen; Andreeff, Michael; Shpall, Elizabeth J.; Wargo, Jennifer A.; Rezvani, Katayoun; Alousi, Amin; Bruno, Vincent M.; Futreal, Phillip A.; Petrosino, Joseph F.; Kontoyiannis, Dimitrios P.			Implementation of a Pan-Genomic Approach to Investigate Holobiont-Infecting Microbe Interaction: A Case Report of a Leukemic Patient with Invasive Mucormycosis	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; PATHOGEN COEVOLUTION; HIGH-THROUGHPUT; DISEASE; HOST; ASPERGILLOSIS; MUTATION; FUNGAL; MUCOR; SUSCEPTIBILITY	Disease can be conceptualized as the result of interactions between infecting microbe and holobiont, the combination of a host and its microbial communities. It is likely that genomic variation in the host, infecting microbe, and commensal microbiota are key determinants of infectious disease clinical outcomes. However, until recently, simultaneous, multiomic investigation of infecting microbe and holobiont components has rarely been explored. Herein, we characterized the infecting microbe, host, micro-and mycobiomes leading up to infection onset in a leukemia patient that developed invasive mucormycosis. We discovered that the patient was infected with a strain of the recently described Mucor velutinosus species which we determined was hypervirulent in a Drosophila challenge model and has a predisposition for skin dissemination. After completing the infecting M. velutinosus genome and genomes from four other Mucor species, comparative pathogenomics was performed and assisted in identifying 66 M. velutinosus-specific putatively secreted proteins, including multiple novel secreted aspartyl proteinases which may contribute to the unique clinical presentation of skin dissemination. Whole exome sequencing of the patient revealed multiple non-synonymous polymorphisms in genes critical to control of fungal proliferation, such as TLR6 and PTX3. Moreover, the patient had a non-synonymous polymorphism in the NOD2 gene and a missense mutation in FUT2, which have been linked to microbial dysbiosis and microbiome diversity maintenance during physiologic stress, respectively. In concert with host genetic polymorphism data, the micro- and mycobiome analyses revealed that the infection developed amid a dysbiotic microbiome with low alpha-diversity, dominated by staphylococci. Additionally, longitudinal mycobiome data showed that M. velutinosus DNA was detectable in oral samples preceding disease onset. Our genome-level study of the host-infecting microbe-commensal triad extends the concept of personalized genomic medicine to the holobiont-infecting microbe interface thereby offering novel opportunities for using synergistic genetic methods to increase understanding of infectious diseases pathogenesis and clinical outcomes.	[Shelburne, Samuel A.; Galloway-Pena, Jessica; Albert, Nathan; Chemaly, Roy F.; Ghantoji, Shashank S.; Marsh, Lisa] Univ Texas MD Anderson Canc Ctr, Dept Infect Dis, Houston, TX 77030 USA; [Shelburne, Samuel A.; Beird, Hannah C.; Wargo, Jennifer A.; Futreal, Phillip A.; Kontoyiannis, Dimitrios P.] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA; [Ajami, Nadim J.; Bruno, Vincent M.; Petrosino, Joseph F.] Baylor Coll Med, Alkek Ctr Metagen & Microbiome Res, Houston, TX 77030 USA; [Ajami, Nadim J.; Bruno, Vincent M.; Petrosino, Joseph F.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Chibucos, Marcus C.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Chibucos, Marcus C.] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Tarrand, Jeffrey] Univ Texas MD Anderson Canc Ctr, Dept Lab Med, Houston, TX 77030 USA; [Pemmaraju, Naveen; Andreeff, Michael] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Shpall, Elizabeth J.; Rezvani, Katayoun; Alousi, Amin] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA; [Wargo, Jennifer A.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; Baylor College of Medicine; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Kontoyiannis, DP (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA.	dkontoyi@mdanderson.org	Petrosino, Joseph F./AAF-1621-2019; Galloway-Pena, Jessica/J-5496-2019; Chibucos, Marcus/B-1506-2015	Galloway-Pena, Jessica/0000-0003-1081-254X; Chibucos, Marcus/0000-0001-9586-0780; Beird, Hannah/0000-0002-5078-534X	National Institutes of Allergy and Infectious Diseases at the National Institutes of Health [R01AI089891, U19AI110820]; Chapman Foundation; MD Anderson Cancer Center Support Grant [P30 CA016672]; MDACC Odyssey Fellowship; MDACC Moon Shot GAP Proposal; Frances King Black Endowment for Cancer Research; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA061508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089891, U19AI110820] Funding Source: NIH RePORTER	National Institutes of Allergy and Infectious Diseases at the National Institutes of Health; Chapman Foundation; MD Anderson Cancer Center Support Grant; MDACC Odyssey Fellowship; MDACC Moon Shot GAP Proposal; Frances King Black Endowment for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Allergy and Infectious Diseases at the National Institutes of Health [R01AI089891 to SAS, U19AI110820 to MCC and VMB, and HHSN272200900009C to VMB], the Chapman Foundation and MD Anderson Cancer Center Support Grant P30 CA016672 (the Bioinformatics Shared Resource), the CFP Foundation supported MDACC Odyssey Fellowship (JGP), the MDACC Moon Shot GAP Proposal (DPK), and the Frances King Black Endowment for Cancer Research (DPK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler J, 2011, AM J GASTROENTEROL, V106, P699, DOI 10.1038/ajg.2011.19; Al-Samarrai TH, 2000, LETT APPL MICROBIOL, V30, P53, DOI 10.1046/j.1472-765x.2000.00664.x; Alexeyenko A, 2006, BIOINFORMATICS, V22, pE9, DOI 10.1093/bioinformatics/btl213; Alvarez E, 2009, J CLIN MICROBIOL, V47, P1650, DOI 10.1128/JCM.00036-09; Alvarez E, 2011, MED MYCOL, V49, P62, DOI 10.3109/13693786.2010.499521; Buffie CG, 2015, NATURE, V517, P205, DOI 10.1038/nature13828; Camargo JF, 2014, CLIN INFECT DIS, V59, P569, DOI 10.1093/cid/ciu337; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carlsson B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005593; Casadevall A, 2015, INFECT IMMUN, V83, P2, DOI 10.1128/IAI.02627-14; Chamilos G, 2008, P NATL ACAD SCI USA, V105, P9367, DOI 10.1073/pnas.0709578105; Cunha C, 2014, NEW ENGL J MED, V370, P421, DOI 10.1056/NEJMoa1211161; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Findley K, 2013, NATURE, V498, P367, DOI 10.1038/nature12171; Flores AR, 2015, P NATL ACAD SCI USA, V112, P6431, DOI 10.1073/pnas.1504725112; Gagneux S, 2012, PHILOS T R SOC B, V367, P850, DOI 10.1098/rstb.2011.0316; Ghannoum MA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000713; Ghorban K, 2013, INFLAMMATION, V36, P633, DOI 10.1007/s10753-012-9585-8; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Henriet S, 2013, ADV EXP MED BIOL, V764, P27, DOI 10.1007/978-1-4614-4726-9_3; Hermet A, 2012, FUNGAL BIOL-UK, V116, P692, DOI 10.1016/j.funbio.2012.04.002; Hu JZ, 2010, J IMMUNOL, V185, P424, DOI 10.4049/jimmunol.0903291; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Joichi Yumiko, 2014, Med Mycol J, V55, pE43, DOI 10.3314/mmj.55.E43; Kesh S, 2005, ANN NY ACAD SCI, V1062, P95, DOI 10.1196/annals.1358.012; Khor CC, 2010, NEW ENGL J MED, V362, P2092, DOI 10.1056/NEJMoa0905606; Kodaman N, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00290; Koljalg U, 2013, MOL ECOL, V22, P5271, DOI 10.1111/mec.12481; Kolwijck E, 2014, EUR J IMMUNOL, V44, P3156, DOI 10.1002/eji.201344404; Kontoyiannis DP, 2014, MYCOSES, V57, P240, DOI 10.1111/myc.12149; Kumar N, 2014, J ALLERGY CLIN IMMUN, V134, P236, DOI 10.1016/j.jaci.2014.02.037; Lee SC, 2014, MBIO, V5, DOI 10.1128/mBio.01390-14; Lewis RE, 2011, ANTIMICROB AGENTS CH, V55, P411, DOI 10.1128/AAC.00792-10; Lionakis MS, 2014, MED MYCOL, V52, P555, DOI 10.1093/mmy/myu029; Lipinski S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00479; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Ma LJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000549; Merker M, 2015, NAT GENET, V47, P242, DOI 10.1038/ng.3195; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Naglik JR, 2003, MICROBIOL MOL BIOL R, V67, P400, DOI 10.1128/MMBR.67.3.400-428.2003; Olsen RJ, 2012, ARCH PATHOL LAB MED, V136, P1414, DOI 10.5858/arpa.2012-0025-RA; Ostlund G, 2010, NUCLEIC ACIDS RES, V38, pD196, DOI 10.1093/nar/gkp931; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pickard JM, 2014, NATURE, V514, P638, DOI 10.1038/nature13823; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rimmer A, 2014, NAT GENET, V46, P912, DOI 10.1038/ng.3036; Roden MM, 2005, CLIN INFECT DIS, V41, P634, DOI 10.1086/432579; Shelburne SA, 2014, EMERG INFECT DIS, V20, P762, DOI 10.3201/eid2005.130953; Sugui JA, 2011, J CLIN MICROBIOL, V49, P2728, DOI 10.1128/JCM.00387-11; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; ten Oever J, 2014, EUR J IMMUNOL, V44, P3182, DOI 10.1002/eji.201344405; Tieri P, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00059; White TJ, 1990, FUNGAL PHYLOGENETICS; Wojtowicz A, 2015, CLIN INFECT DIS, V61, P619, DOI 10.1093/cid/civ386; Zelante T, 2013, IMMUNITY, V39, P372, DOI 10.1016/j.immuni.2013.08.003; Zhang JJ, 2014, SCIENCE, V346, P256, DOI 10.1126/science.1256930; Zimin AV, 2013, BIOINFORMATICS, V29, P2669, DOI 10.1093/bioinformatics/btt476	60	37	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0139851	10.1371/journal.pone.0139851	http://dx.doi.org/10.1371/journal.pone.0139851			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556047	Green Published, gold, Green Submitted			2022-12-27	WOS:000364430700008
J	von Loga, K; Kohlhaussen, J; Burkhardt, L; Simon, R; Steurer, S; Burdak-Rothkamm, S; Jacobsen, F; Sauter, G; Krech, T				von Loga, Katharina; Kohlhaussen, Jule; Burkhardt, Lia; Simon, Ronald; Steurer, Stefan; Burdak-Rothkamm, Susanne; Jacobsen, Frank; Sauter, Guido; Krech, Till			FGFR1 Amplification Is Often Homogeneous and Strongly Linked to the Squamous Cell Carcinoma Subtype in Esophageal Carcinoma	PLoS One			English	Article							TISSUE MICROARRAY ANALYSIS; ENDOTHELIAL GROWTH-FACTOR; RECEPTOR TYROSINE KINASE; 1 GENE AMPLIFICATION; LUNG-CANCER; BREAST-CANCER; TARGETED THERAPIES; SELECTIVE INHIBITOR; CIGARETTE-SMOKING; POOR-PROGNOSIS	Background and Aims Amplification of the fibroblast growth factor receptor 1 (FGFR1) is believed to predict response to multi-kinase inhibitors targeting FGFR1. Esophageal cancer is an aggressive disease, for which novel targeted therapies are highly warranted. Methods This study was designed to investigate the prevalence and clinical significance of FGFR1 amplification in a tissue microarray containing 346 adenocarcinomas and 254 squamous cell carcinomas of the esophagus, using dual-labeling fluorescence in situ hybridization (FISH) analysis. Results FGFR1 amplification, defined as a ratio of FGFR1: centromere 8 copy numbers >= 2.0, was more frequently seen in squamous cell carcinoma (8.9% of 202 interpretable cases) than in adenocarcinoma (1.6% of 308; p<0.0001). There was no association between FGFR1 amplification and tumor phenotype or clinical outcome. To study potential heterogeneity of FGFR1 amplification, all available tumor blocks from 23 FGFR1 amplified tumors were analyzed on conventional large sections. This analysis revealed complete homogeneity of FGFR1 amplification in 20 (86.9%) primary tumors and in all available lymph node metastases. Remarkably, FGFR1 amplification was also seen in dysplasia adjacent to tumor in 6 of 9 patients with FGFR1 amplified primary cancers. Conclusions In conclusion, FGFR1 amplification occurs in a relevant subgroup of carcinomas of the esophagus and may play a particular role for development of squamous cell cancers. The high homogeneity of FGFR1 amplification suggests that patients with FGFR1 amplified esophageal cancers may particularly benefit from anti-FGFR1 therapies and prompt for clinical studies in this tumor type.	[von Loga, Katharina; Kohlhaussen, Jule; Burkhardt, Lia; Simon, Ronald; Steurer, Stefan; Burdak-Rothkamm, Susanne; Jacobsen, Frank; Sauter, Guido; Krech, Till] Univ Med Ctr Hamburg Eppendorf, Dept Pathol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	von Loga, K (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Pathol, Hamburg, Germany.	kvonloga@uke.de	Burdak-Rothkamm, Susanne/I-2553-2012	Burdak-Rothkamm, Susanne/0000-0002-3840-2844				Al-Kuraya K, 2005, MODERN PATHOL, V18, P891, DOI 10.1038/modpathol.3800408; Arnold M, 2015, GUT, V64, P381, DOI 10.1136/gutjnl-2014-308124; Ashman LK, 2013, EXPERT OPIN INV DRUG, V22, P103, DOI 10.1517/13543784.2013.740010; Bandla S, 2012, ANN THORAC SURG, V93, P1101, DOI 10.1016/j.athoracsur.2012.01.064; Barlund M, 2000, J NATL CANCER I, V92, P1252, DOI 10.1093/jnci/92.15.1252; Bosman F., 2010, WHO CLASSIFICATION T, V4th; Brady NJ, 2013, EXPERT REV ENDOCRINO, V8, P391, DOI 10.1586/17446651.2013.811910; Brunello E, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-103; Chang JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105524; Cihoric N, 2014, BRIT J CANCER, V110, P2914, DOI 10.1038/bjc.2014.229; Courjal F, 1997, CANCER RES, V57, P4360; Delaney C, 2015, CHIN J CANCER, V34, DOI 10.1186/s40880-015-0007-9; Dienstmann R, 2014, ANN ONCOL, V25, P552, DOI 10.1093/annonc/mdt419; Ellis LM, 2008, CLIN CANCER RES, V14, P6371, DOI 10.1158/1078-0432.CCR-07-5287; Farrell J, 2013, INT J MOL SCI, V14, P15510, DOI 10.3390/ijms140815510; Ferrara N, 2004, ONCOLOGIST, V9, P2, DOI 10.1634/theoncologist.9-suppl_1-2; Freier K, 2007, ORAL ONCOL, V43, P60, DOI 10.1016/j.oraloncology.2006.01.005; Gavine PR, 2012, CANCER RES, V72, P2045, DOI 10.1158/0008-5472.CAN-11-3034; Goke F, 2012, CHEST, V142, P1020, DOI 10.1378/chest.11-2943; Goke F, 2015, CLIN CANC RES; Grob TJ, 2013, LUNG CANCER, V79, P221, DOI 10.1016/j.lungcan.2012.11.009; Guagnano V, 2012, CANCER DISCOV, V2, P1118, DOI 10.1158/2159-8290.CD-12-0210; Guagnano V, 2011, J MED CHEM, V54, P7066, DOI 10.1021/jm2006222; Heist RS, 2012, J THORAC ONCOL, V7, P1775, DOI 10.1097/JTO.0b013e31826aed28; Ishizuka T, 2002, BIOCHEM BIOPH RES CO, V296, P152, DOI 10.1016/S0006-291X(02)00836-7; Jiang T, 2015, LUNG CANCER, V87, P1, DOI 10.1016/j.lungcan.2014.11.009; Kim HR, 2013, J CLIN ONCOL, V31, P731, DOI 10.1200/JCO.2012.43.8622; Kim HS, 2015, ONCOTARGET, V6, P2562, DOI 10.18632/oncotarget.2944; Krishnaswamy S, 2009, CLIN CANCER RES, V15, P5714, DOI 10.1158/1078-0432.CCR-09-0070; Lin L, 2000, CANCER RES, V60, P1341; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lubin JH, 2012, CANCER EPIDEMIOL, V36, P306, DOI 10.1016/j.canep.2012.03.001; Medical Advisory Secretariat, 2010, Ont Health Technol Assess Ser, V10, P1; Mirlacher M, 2010, METHODS MOL BIOL, V664, P37, DOI 10.1007/978-1-60761-806-5_4; Moch H, 1999, AM J PATHOL, V154, P981, DOI 10.1016/S0002-9440(10)65349-7; Murphy CG, 2012, ANTI-CANCER DRUG, V23, P765, DOI 10.1097/CAD.0b013e328352d292; Nocito A, 2001, J PATHOL, V194, P349, DOI 10.1002/1096-9896(200107)194:3<349::AID-PATH887>3.0.CO;2-D; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165; Preusser M, 2014, LUNG CANCER, V83, P83, DOI 10.1016/j.lungcan.2013.10.004; Reichelt U, 2007, MODERN PATHOL, V20, P120, DOI 10.1038/modpathol.3800712; Reis JS, 2006, CLIN CANCER RES, V12, P6652, DOI 10.1158/1078-0432.CCR-06-1164; Ruiz C, 2006, INT J CANCER, V118, P2190, DOI 10.1002/ijc.21581; Saito S, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1065-8; Schildhaus HU, 2012, MODERN PATHOL, V25, P1473, DOI 10.1038/modpathol.2012.102; Seo AN, 2014, VIRCHOWS ARCH, V465, P547, DOI 10.1007/s00428-014-1634-2; Simon R, 2001, J NATL CANCER I, V93, P1141, DOI 10.1093/jnci/93.15.1141; Sobin LH, 2010, TNM CLASSIFICATION M; Sugiura K, 2007, ONCOL REP, V17, P557; Tennstedt P, 2012, INT J ONCOL, V40, P261, DOI 10.3892/ijo.2011.1216; Torhorst J, 2001, AM J PATHOL, V159, P2249, DOI 10.1016/S0002-9440(10)63075-1; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Weiss J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001451; Welm BE, 2002, J CELL BIOL, V157, P703, DOI 10.1083/jcb.200107119; Worni M, 2014, DIS ESOPHAGUS, V27, P662, DOI 10.1111/dote.12123; Yu QY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127404; Zhang JC, 2012, CLIN CANCER RES, V18, P6658, DOI 10.1158/1078-0432.CCR-12-2694; Zhang YW, 2013, WORLD J GASTROENTERO, V19, P5598, DOI 10.3748/wjg.v19.i34.5598	58	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0141867	10.1371/journal.pone.0141867	http://dx.doi.org/10.1371/journal.pone.0141867			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555375	Green Published, gold, Green Submitted			2022-12-27	WOS:000364430700042
J	Weaver, JR; Nadler, JL; Taylor-Fishwick, DA				Weaver, Jessica R.; Nadler, Jerry L.; Taylor-Fishwick, David A.			Interleukin-12 (IL-12)/STAT4 Axis Is an Important Element for beta-Cell Dysfunction Induced by Inflammatory Cytokines	PLoS One			English	Article							NONOBESE DIABETIC MICE; NOD MICE; DOUBLE-BLIND; MONOCLONAL-ANTIBODY; INSULIN-RESISTANCE; IL-12/IL-23 INHIBITOR; STAT4-DEFICIENT MICE; PANCREATIC-ISLETS; IFN-GAMMA; IL-12	Pathology driving beta-cell loss in diabetes is poorly defined. Chronic subclinical inflammation is associated with beta-cell dysfunction. Acute in vitro exposure of islets and beta-cells to an inflammatory cytokine cocktail ( IL-1 beta/TNF-alpha/IFN-gamma) results in loss of cell function and viability. The contribution of each cytokine alone or in combination has been evaluated in homogeneous mouse beta-cell lines and primary mouse islets. Cytokine cooperation is required for beta-cell apoptosis with the most potent combinations including IL-1 beta. Single cytokine exposure did not induce beta-cell apoptosis. Expression of endogenous interleukin-12 in beta-cells correlated with inflammatory cytokine combinations that induced beta-cell apoptosis. Uncoupling of the IL-12 axis by a block of IL-12 production, inhibition of IL-12 receptor/ligand interaction or disruption of IL-12 receptor signaling conferred protection to beta-cells from apoptosis induced by inflammatory cytokine stimulation. Signaling through STAT4 is indicated since disruption of IL-12 concomitantly reduced inflammatory cytokine stimulation of endogenous IFN-gamma expression. Primary mouse islets isolated from mice deficient in STAT4 show resistance to inflammatory-cytokine-induced cell death when compared to islets isolated from wild type mice. Collectively, the data identify IL-12 as an important mediator of inflammation induced beta-cell apoptosis. Modulation of IL-12/STAT4 signaling may be a valuable therapeutic strategy to preserve islet/beta-cell viability in established diabetes.	[Weaver, Jessica R.; Taylor-Fishwick, David A.] Eastern Virginia Med Sch, Dept Microbiol & Mol Cell Biol, Norfolk, VA 23501 USA; [Nadler, Jerry L.; Taylor-Fishwick, David A.] Eastern Virginia Med Sch, Dept Internal Med, Norfolk, VA 23501 USA; [Nadler, Jerry L.; Taylor-Fishwick, David A.] Eastern Virginia Med Sch, Strelitz Diabet Ctr, Norfolk, VA 23501 USA	Eastern Virginia Medical School; Eastern Virginia Medical School; Eastern Virginia Medical School	Taylor-Fishwick, DA (corresponding author), Eastern Virginia Med Sch, Dept Microbiol & Mol Cell Biol, Norfolk, VA 23501 USA.	taylord@evms.edu	Taylor, David/S-5508-2019	Taylor, David/0000-0002-6720-7482	 [47-2013-519];  [W81XWH-10-1-0148];  [HL112605]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112605] Funding Source: NIH RePORTER	; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Support was provided by 47-2013-519 (jdrf.org), W81XWH-10-1-0148 (cdmrp.org), and HL112605 (NIH.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Maskari M, 2010, IRAN J IMMUNOL, V7, P124, DOI IJIv7i2A8; Altinova AE, 2010, J ENDOCRINOL INVEST, V33, P451, DOI [10.3275/6766, 10.1007/BF03346623]; Billich A, 2007, IDRUGS, V10, P53; Boyton RJ, 2005, INT IMMUNOL, V17, P1157, DOI 10.1093/intimm/dxh293; Burakoff R, 2006, INFLAMM BOWEL DIS, V12, P558, DOI 10.1097/01.ibd.0000225337.14356.31; Catalan V, 2007, OBES SURG, V17, P1464, DOI 10.1007/s11695-008-9424-z; Chen M, 2005, DIABETOLOGIA, V48, P486, DOI 10.1007/s00125-005-1673-y; Cieslak M, 2015, ACTA BIOCHIM POL, V62, P15; Coon ME, 1999, J IMMUNOL, V163, P6567; Donath MY, 2014, NAT REV DRUG DISCOV, V13, P465, DOI 10.1038/nrd4275; Ehses JA, 2009, P NATL ACAD SCI USA, V106, P13998, DOI 10.1073/pnas.0810087106; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; Gandhi M, 2010, SEMIN CUTAN MED SURG, V29, P48, DOI 10.1016/j.sder.2010.02.001; GILLESSEN S, 1995, EUR J IMMUNOL, V25, P200, DOI 10.1002/eji.1830250133; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Holz A, 2001, J CLIN INVEST, V108, P1749; Hultgren B, 1996, DIABETES, V45, P812, DOI 10.2337/diabetes.45.6.812; HUNTER CA, 1995, J IMMUNOL, V155, P4347; Igoillo-Esteve M, 2010, DIABETOLOGIA, V53, P1395, DOI 10.1007/s00125-010-1707-y; Imai Y, 2013, DIABETES OBES METAB, V15, P117, DOI 10.1111/dom.12161; Imai Y., 2015, ISLETS LANGERHANS, P989; Jorns A, 2005, DIABETES, V54, P2041, DOI 10.2337/diabetes.54.7.2041; Kang YS, 2010, DIABETES RES CLIN PR, V89, P141, DOI 10.1016/j.diabres.2010.03.020; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; KATZ JD, 1995, SCIENCE, V268, P1185, DOI 10.1126/science.7761837; Keino H, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2530; Kimball AB, 2008, ARCH DERMATOL, V144, P200, DOI 10.1001/archdermatol.2007.63; Korman BD, 2008, GENES IMMUN, V9, P267, DOI 10.1038/gene.2008.1; Korman BD, 2008, CURR ALLERGY ASTHM R, V8, P398, DOI 10.1007/s11882-008-0077-8; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Lee HS, 2008, ANN NY ACAD SCI, V1150, P93, DOI 10.1196/annals.1447.013; Leonardi CL, 2008, LANCET, V371, P1665, DOI 10.1016/S0140-6736(08)60725-4; Marzorati S, 2006, AM J TRANSPLANT, V6, P2791, DOI 10.1111/j.1600-6143.2006.01512.x; Morahan G, 2009, GENES IMMUN, V10, pS64, DOI 10.1038/gene.2009.94; Morahan G, 2001, NAT GENET, V27, P218, DOI 10.1038/84872; Moran A, 2013, LANCET, V381, P1905, DOI 10.1016/S0140-6736(13)60023-9; Papp KA, 2008, LANCET, V371, P1675, DOI 10.1016/S0140-6736(08)60726-6; Rabinovitch A, 1996, J AUTOIMMUN, V9, P645, DOI 10.1006/jaut.1996.0084; Rothe H, 1997, DIABETOLOGIA, V40, P641, DOI 10.1007/s001250050728; Serreze DV, 2000, DIABETES, V49, P2007, DOI 10.2337/diabetes.49.12.2007; Sloan-Lancaster J, 2013, DIABETES CARE, V36, P2239, DOI 10.2337/dc12-1835; Soleimanpour SA, 2013, TRENDS ENDOCRIN MET, V24, P324, DOI 10.1016/j.tem.2013.03.005; Steinberg GR, 2007, CELL CYCLE, V6, P888, DOI 10.4161/cc.6.8.4135; Su SC, 2011, ACTA DIABETOL, V48, P113, DOI 10.1007/s00592-009-0171-y; Taylor-Fishwick DA, 2013, DIABETOLOGIA, V56, P126, DOI 10.1007/s00125-012-2732-9; Taylor-Fishwick DA, 2010, DIABETES S1, V59; Tilg H, 2008, MOL MED, V14, P222, DOI 10.2119/2007-00119.Tilg; Tisch R, 1996, CELL, V85, P291, DOI 10.1016/S0092-8674(00)81106-X; Trembleau S, 1999, J IMMUNOL, V163, P2960; Trembleau S, 1997, EUR J IMMUNOL, V27, P2330, DOI 10.1002/eji.1830270930; TREMBLEAU S, 1995, J EXP MED, V181, P817, DOI 10.1084/jem.181.2.817; Wada Y, 2007, BLOOD, V109, P1156, DOI 10.1182/blood-2006-04-019398; Weaver JR, 2013, MOL CELL ENDOCRINOL, V369, P35, DOI 10.1016/j.mce.2013.01.011; Weaver JR, 2012, MOL CELL ENDOCRINOL, V358, P88, DOI 10.1016/j.mce.2012.03.004; Weaver JR, 2015, ISLETS LANGERHANS, P923; Westwell-Roper C, 2014, DIABETOLOGIA, V57, P447, DOI 10.1007/s00125-013-3151-2; Yang ZD, 2004, J AUTOIMMUN, V22, P191, DOI 10.1016/j.jaut.2003.08.006; Yang ZD, 2002, DIABETOLOGIA, V45, P1307, DOI 10.1007/s00125-002-0901-y; Zervou MI, 2008, HUM IMMUNOL, V69, P647, DOI 10.1016/j.humimm.2008.07.004; Zipris D, 1996, J IMMUNOL, V156, P1315	60	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142735	10.1371/journal.pone.0142735	http://dx.doi.org/10.1371/journal.pone.0142735			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555476	Green Published, Green Submitted, gold			2022-12-27	WOS:000364430700163
J	Darzi, S; Islam, MT; Tiong, SK; Kibria, S; Singh, M				Darzi, Soodabeh; Islam, Mohammad Tariqul; Tiong, Sieh Kiong; Kibria, Salehin; Singh, Mandeep			Stochastic Leader Gravitational Search Algorithm for Enhanced Adaptive Beamforming Technique	PLOS ONE			English	Article								In this paper, stochastic leader gravitational search algorithm (SL-GSA) based on randomized k is proposed. Standard GSA (SGSA) utilizes the best agents without any randomization, thus it is more prone to converge at suboptimal results. Initially, the new approach randomly choses k agents from the set of all agents to improve the global search ability. Gradually, the set of agents is reduced by eliminating the agents with the poorest performances to allow rapid convergence. The performance of the SL-GSA was analyzed for six well-known benchmark functions, and the results are compared with SGSA and some of its variants. Furthermore, the SL-GSA is applied to minimum variance distortionless response (MVDR) beamforming technique to ensure compatibility with real world optimization problems. The proposed algorithm demonstrates superior convergence rate and quality of solution for both real world problems and benchmark functions compared to original algorithm and other recent variants of SGSA.	[Darzi, Soodabeh] Univ Kebangsaan Malaysia, Ctr Space Sci ANGKASA, Bangi, Malaysia; [Islam, Mohammad Tariqul; Kibria, Salehin; Singh, Mandeep] Univ Kebangsaan Malaysia, Dept Elect Elect & Syst Engn, Bangi, Malaysia; [Tiong, Sieh Kiong] Univ Tenaga Nas, Coll Engn, Ctr Syst & Machine Intelligence, Selangor, Malaysia	Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia; Universiti Tenaga Nasional	Islam, MT (corresponding author), Univ Kebangsaan Malaysia, Dept Elect Elect & Syst Engn, Bangi, Malaysia.	titareq@gmail.com	Singh, Mandeep/AAC-8680-2020; Tiong, Sieh Kiong/GLR-1734-2022; Islam, Mohammad Tariqul/M-7377-2016; singh, mandeep/W-7242-2019; Islam, Mohammad Tariqul/E-6380-2012	Islam, Mohammad Tariqul/0000-0002-4929-3209; Islam, Mohammad Tariqul/0000-0002-4929-3209	University Research Grant [DIP-2014-029]	University Research Grant	Funding: This work was supported by University Research Grant with project code DIP-2014-029. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CAPON J, 1969, P IEEE, V57, P1408, DOI 10.1109/PROC.1969.7278; Dahrouj H, 2010, IEEE T WIREL COMMUN, V9, P1748, DOI 10.1109/TWC.2010.05.090936; Darzi S, 2014, SCI WORLD J, DOI 10.1155/2014/724639; Gu BJ, 2013, INT J INNOV COMPUT I, V9, P4531; Khajehzadeh M, 2013, STRUCT ENG MECH, V45, P111, DOI 10.12989/sem.2013.45.1.111; Khajehzadeh M, 2012, ENG APPL ARTIF INTEL, V25, P1589, DOI 10.1016/j.engappai.2012.01.011; Khodier MM, 2005, IEEE T ANTENN PROPAG, V53, P2674, DOI 10.1109/TAP.2005.851762; Liu F. L., 2011, Progress In Electromagnetics Research C, V20, P239; Omar O. Kaid, 2012, Progress In Electromagnetics Research C, V32, P65; Rashedi E, 2009, INFORM SCIENCES, V179, P2232, DOI 10.1016/j.ins.2009.03.004; Tiong S. K., 2014, SCI WORLD J; Zaharis ZD, 2011, PROG ELECTROMAGN RES, V117, P165, DOI 10.2528/PIER11041904	13	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2015	10	11							e0140526	10.1371/journal.pone.0140526	http://dx.doi.org/10.1371/journal.pone.0140526			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7AC	26552032	Green Submitted, Green Published, gold			2022-12-27	WOS:000364422800001
J	Kutuzov, N; Gulin, A; Lyaskovskiy, V; Nadtochenko, V; Maksimov, G				Kutuzov, Nikolay; Gulin, Alexander; Lyaskovskiy, Vladimir; Nadtochenko, Victor; Maksimov, Georgy			ATP-Mediated Compositional Change in Peripheral Myelin Membranes: A Comparative Raman Spectroscopy and Time-Of-Flight Secondary Ion Mass Spectrometry Study	PLOS ONE			English	Article							NERVOUS-SYSTEM; ADENOSINE; LIPIDS; VISUALIZATION; ENHANCEMENT; RECEPTOR	In the present paper we addressed a mechanism of the myelin reorganization initiated by extracellular ATP and adenosine in sciatic nerves of the frog Rana temporaria. In combination with Raman microspectroscopy, allowing noninvasive live-cell measurements, we employed time-of-flight secondary ion mass spectrometry (TOF-SIMS) to follow the underlying changes in chemical composition of myelin membranes triggered by the purinergic agents. The simultaneous increase in lipid ordering degree, decrease in membrane fluidity and the degree of fatty acid unsaturation were induced by both ATP and adenosine. Mass spectrometry measurements revealed that ATP administration also led to the marked elevation of membrane cholesterol and decrease of phosphotidylcholine amounts. Vesicular lipid transport pathways are considered as possible mechanisms of compositional and structural changes of myelin.	[Kutuzov, Nikolay; Maksimov, Georgy] Moscow MV Lomonosov State Univ, Fac Biol, Dept Biophys, Moscow 119991, Russia; [Gulin, Alexander; Nadtochenko, Victor] RAS, NN Semenov Chem Phys Inst, Moscow 119991, Russia; [Gulin, Alexander; Nadtochenko, Victor] Moscow MV Lomonosov State Univ, Fac Chem, Moscow 119991, Russia; [Lyaskovskiy, Vladimir] All Russian Res Inst Opt & Phys Measurements, Moscow 119361, Russia; [Nadtochenko, Victor] Moscow Inst Phys & Technol, Dolgoprudnyi 141700, Moscow Region, Russia; [Nadtochenko, Victor] Inst Problems Chem Phys RAS, Chernogolovka 142432, Moscow Region, Russia	Lomonosov Moscow State University; Russian Academy of Sciences; N.N. Semenov Federal Research Centre for Chemical Physics, Russian Academy of Sciences; Lomonosov Moscow State University; Moscow Institute of Physics & Technology; Russian Academy of Sciences	Kutuzov, N (corresponding author), Moscow MV Lomonosov State Univ, Fac Biol, Dept Biophys, Leninskie Gory 1-12, Moscow 119991, Russia.	kutuzovnp@gmail.com	, nadtochenko/M-3080-2013; Maksimov, Georgy V/B-4396-2016; NADTOCHENKO, VICTOR/AAO-5334-2021; Gulin, Alexander/J-3311-2016	Maksimov, Georgy V/0000-0002-7377-0773; NADTOCHENKO, VICTOR/0000-0002-6645-692X; Kutuzov, Nikolay/0000-0003-3737-165X; Gulin, Alexander/0000-0001-7117-4276	Russian Foundation for Basic Research [14-04-31883-mol-a, 14-14-00856]; Presidium of the Russian Academy of Sciences, program "Basic sciences for medicine"	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Presidium of the Russian Academy of Sciences, program "Basic sciences for medicine"	The authors acknowledge financial support from Russian Foundation for Basic Research for young researchers, grant 14-04-31883-mol-a, and Presidium of the Russian Academy of Sciences, program "Basic sciences for medicine". The TOF-SIMS measurements were carried out with partial support from the Russian Foundation for basic research grant 14-14-00856.	Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Boison D, 2010, CELL DEATH DIFFER, V17, P1071, DOI 10.1038/cdd.2009.131; Brunelle A, 2005, J MASS SPECTROM, V40, P985, DOI 10.1002/jms.902; BUNOW MR, 1977, BIOCHIM BIOPHYS ACTA, V487, P388, DOI 10.1016/0005-2760(77)90015-7; Burnstock G, 2006, BRIT J PHARMACOL, V147, pS172, DOI 10.1038/sj.bjp.0706429; Burnstock G, 2009, BRAZ J MED BIOL RES, V42, P3, DOI 10.1590/S0100-879X2008005000037; Chrast R, 2011, J LIPID RES, V52, P419, DOI 10.1194/jlr.R009761; Cunha Rodrigo A, 2005, Purinergic Signal, V1, P111, DOI 10.1007/s11302-005-0649-1; Fletcher JS, 2013, ANAL CHEM, V85, P610, DOI 10.1021/ac303088m; Gomes CV, 2011, BBA-BIOMEMBRANES, V1808, P1380, DOI 10.1016/j.bbamem.2010.12.001; Goto-Inoue N, 2011, BBA-MOL CELL BIOL L, V1811, P961, DOI 10.1016/j.bbalip.2011.03.004; Grafe P, 2006, Purinergic Signal, V2, P527, DOI 10.1007/s11302-006-9018-y; Guan XL, 2006, FASEB J, V20, P1152, DOI 10.1096/fj.05-5362com; Gulin A, 2014, APPL SURF SCI, V316, P36, DOI 10.1016/j.apsusc.2014.07.102; Gulin AA, 2015, BIOCHEM MOSC SUPPL S, V9, P202, DOI 10.1134/S1990747815020154; Janfelt C, 2012, FASEB J, V26, P2667, DOI 10.1096/fj.11-201152; Jones EA, 2007, J AM SOC MASS SPECTR, V18, P1559, DOI 10.1016/j.jasms.2007.05.014; Kasukurthi R, 2009, J NEUROSCI METH, V184, P303, DOI 10.1016/j.jneumeth.2009.08.019; Kutuzov NP, 2013, LASER PHYS LETT, V10, DOI 10.1088/1612-2011/10/7/075606; Kutuzov NP, 2014, BIOPHYS J, V107, P891, DOI 10.1016/j.bpj.2014.07.002; Latini S, 2001, J NEUROCHEM, V79, P463, DOI 10.1046/j.1471-4159.2001.00607.x; Lazar AN, 2013, ACTA NEUROPATHOL, V125, P133, DOI 10.1007/s00401-012-1041-1; Maekawa S, 1999, J BIOL CHEM, V274, P21369, DOI 10.1074/jbc.274.30.21369; Maksimov G. V., 2014, Biophysics, V59, P81, DOI 10.1134/S0006350914010072; Maxfield FR, 2002, J CLIN INVEST, V110, P891, DOI 10.1172/JCI200216500; MYERS DB, 1977, ACTA NEUROPATHOL, V37, P7, DOI 10.1007/BF00684533; PEZOLET M, 1985, BIOPHYS J, V47, P367, DOI 10.1016/S0006-3495(85)83927-8; Rittiner JE, 2012, J BIOL CHEM, V287, P5301, DOI 10.1074/jbc.M111.291666; Robson Simon C, 2006, Purinergic Signal, V2, P409, DOI 10.1007/s11302-006-9003-5; Rodionova N. N., 2014, Biofizika, V59, P108, DOI 10.1134/S0006350914010163; Shin YH, 2014, CELL MOL NEUROBIOL, V34, P361, DOI 10.1007/s10571-013-0020-y; Soccio RE, 2004, ARTERIOSCL THROM VAS, V24, P1150, DOI 10.1161/01.ATV.0000131264.66417.d5; Stevens B, 2002, NEURON, V36, P855, DOI 10.1016/S0896-6273(02)01067-X; SZALONTAI B, 1977, BIOCHEM BIOPH RES CO, V76, P660, DOI 10.1016/0006-291X(77)91551-0; Takenouchi Takato, 2014, Results Immunol, V4, P62, DOI 10.1016/j.rinim.2014.07.002; Touboul D, 2011, CURR OPIN CHEM BIOL, V15, P725, DOI 10.1016/j.cbpa.2011.04.017; Tuck Elizabeth, 2010, Commun Integr Biol, V3, P209; Wewers MD, 2009, PURINERG SIGNAL, V5, P189, DOI 10.1007/s11302-009-9131-9; Wu HW, 2011, P NATL ACAD SCI USA, V108, P3809, DOI 10.1073/pnas.1009043108; ZIMMERMANN H, 1994, TRENDS NEUROSCI, V17, P420, DOI 10.1016/0166-2236(94)90016-7	40	9	9	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142084	10.1371/journal.pone.0142084	http://dx.doi.org/10.1371/journal.pone.0142084			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544552	Green Submitted, Green Published, gold			2022-12-27	WOS:000364398700079
J	Nikitin, N; Trifonova, E; Evtushenko, E; Kirpichnikov, M; Atabekov, J; Karpova, O				Nikitin, Nikolai; Trifonova, Ekaterina; Evtushenko, Evgeniy; Kirpichnikov, Mikhail; Atabekov, Joseph; Karpova, Olga			Comparative Study of Non-Enveloped Icosahedral Viruses Size	PLoS One			English	Article							CAULIFLOWER MOSAIC-VIRUS; BIOPHYSICAL PROPERTIES; PARTICLES; NANOPARTICLES; PURIFICATION; MORPHOLOGY; RESOLUTION; TRACKING; VIRIONS; PROTEIN	Now, as before, transmission electron microscopy (TEM) is a widely used technique for the determination of virions size. In some studies, dynamic light scattering (DLS) has also been applied for this purpose. Data obtained by different authors and using different methods could vary significantly. The process of TEM sample preparation involves drying on the substrate, which can cause virions to undergo morphology changes. Therefore, other techniques should be used for measurements of virions size in liquid, (i. e. under conditions closer to native). DLS and nanoparticle tracking analysis (NTA) provide supplementary data about the virions hydrodynamic diameter and aggregation state in liquid. In contrast to DLS, NTA data have a higher resolution and also are less sensitive to minor admixtures. In the present work, the size of non- enveloped icosahedral viruses of different nature was analyzed by TEM, DLS and NTA: the viruses used were the encephalomyocarditis virus (animal virus), and cauliflower mosaic virus, brome mosaic virus and bean mild mosaic virus (plant viruses). The same, freshly purified, samples of each virus were used for analysis using the different techniques. The results were compared with earlier published data and description databases. DLS data about the hydrodynamic diameter of bean mild mosaic virus, and NTA data for all examined viruses, were obtained for the first time. For all virus samples, the values of size obtained by TEM were less than virions sizes determined by DLS and NTA. The contribution of the electrical double layer (EDL) in virions hydrodynamic diameter was evaluated. DLS and NTA data adjusted for EDL thickness were in better agreement with TEM results.	[Nikitin, Nikolai; Trifonova, Ekaterina; Evtushenko, Evgeniy; Kirpichnikov, Mikhail; Atabekov, Joseph; Karpova, Olga] Moscow MV Lomonosov State Univ, Moscow, Russia	Lomonosov Moscow State University	Nikitin, N (corresponding author), Moscow MV Lomonosov State Univ, Moscow, Russia.	nikitin@mail.bio.msu.ru	Evtushenko, Evgeniy G/O-1565-2014; Karpova, Olga V/H-2475-2013; Atabekov, Joseph/J-3264-2013; Evtushenko, Ekaterina A./H-6989-2013; Nikitin, Nikolai/D-6520-2013	Evtushenko, Evgeniy G/0000-0003-1264-4770; Karpova, Olga V/0000-0002-0605-9033; Evtushenko, Ekaterina A./0000-0002-0679-6818; Nikitin, Nikolai/0000-0001-9626-2336	Russian Science Foundation [14-24-00007]; Russian Foundation for Basic Research [14-04-31449 mol_a]	Russian Science Foundation(Russian Science Foundation (RSF)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This work was supported by The Russian Science Foundation (grant. 14-24-00007 to NN ET JA OK) and the Russian Foundation for Basic Research (Grant No. 14-04-31449 mol_a TO NN ET).; We thank Dr. Sergey Chirkov and Dr. Anatoly Gmyl for providing viruses. Experiments with cauliflower mosaic virus, brome mosaic virus and bean mild mosaic virus were funded by the Russian Science Foundation (Grant No. 14-24-00007). Encephalomyocarditis virus analysis by TEM, DLS and NTA were supported by the Russian Foundation for Basic Research (Grant No. 14- 04- 31449 mol_a).	Aljabali AAA, 2011, INTEGR BIOL-UK, V3, P119, DOI 10.1039/c0ib00056f; [Anonymous], 2012, E2834 ASTM; [Anonymous], [No title captured]; Azizi A, 2012, ANAL CHEM, V84, P9585, DOI 10.1021/ac302525y; Berne B. J., 2000, DYNAMIC LIGHT SCATTE; BOCKSTAHLER LE, 1962, BIOPHYS J, V2, P1, DOI 10.1016/S0006-3495(62)86836-2; Bromley KM, 2008, J MATER CHEM, V18, P4796, DOI 10.1039/b809585j; BURNESS ATH, 1970, J GEN VIROL, V6, P381, DOI 10.1099/0022-1317-6-3-381; Chen C, 2008, J PHYS CHEM A, V112, P9405, DOI 10.1021/jp802498z; CHENG RH, 1992, VIROLOGY, V186, P655, DOI 10.1016/0042-6822(92)90032-K; DOBOS P, 1977, J VIROL, V22, P150, DOI 10.1128/JVI.22.1.150-159.1977; Du Sh, 2010, J CHEM TECHNOL BIOT, V85, P1223; FLOYD R, 1979, APPL ENVIRON MICROB, V38, P395, DOI 10.1128/AEM.38.3.395-401.1979; FUJISAWA I, 1967, PHYTOPATHOLOGY, V57, P1130; HILLS GJ, 1968, J ULTRA MOL STRUCT R, V24, P134, DOI 10.1016/S0022-5320(68)80022-X; HINZ RW, 1962, EXP CELL RES, V26, P571, DOI 10.1016/0014-4827(62)90163-5; HULL R, 1976, J GEN VIROL, V31, P93, DOI 10.1099/0022-1317-31-1-93; ITOH T, 1969, VIROLOGY, V39, P367, DOI 10.1016/0042-6822(69)90084-1; Kapur N, 2012, J VIRAL HEPATITIS, V19, P436, DOI 10.1111/j.1365-2893.2011.01559.x; KARASEV AV, 1989, INTERVIROLOGY, V30, P285, DOI 10.1159/000150104; KARPOVA OV, 1989, J GEN VIROL, V70, P2287, DOI 10.1099/0022-1317-70-9-2287; Kendall K, 2010, J ADHESION, V86, P1029, DOI 10.1080/00218464.2010.515479; Lorber B, 2012, BIOCHEM MOL BIOL EDU, V40, P372, DOI 10.1002/bmb.20644; LUO M, 1987, SCIENCE, V235, P182, DOI 10.1126/science.3026048; Michen B, 2010, J APPL MICROBIOL, V109, P388, DOI 10.1111/j.1365-2672.2010.04663.x; Ni P, 2014, J MOL BIOL, V426, P1061, DOI 10.1016/j.jmb.2013.09.007; Nikitin N, 2013, MICROSC MICROANAL, V19, P808, DOI 10.1017/S1431927613000597; Petrova EK, 2015, BIOCHIMIE, V115, P116, DOI 10.1016/j.biochi.2015.05.012; Petrova EK, 2013, BIOCHIMIE, V95, P2415, DOI 10.1016/j.biochi.2013.09.004; PIRONE TP, 1961, PHYTOPATHOLOGY, V51, P541; Raicu V., 2008, INTEGRATED MOL CELLU; SCHOELZ J, 1986, MOL CELL BIOL, V6, P2632, DOI 10.1128/MCB.6.7.2632; Shah SN, 2009, DALTON T, P8479, DOI 10.1039/b906847c; SPEIR JA, 1995, STRUCTURE, V3, P63, DOI 10.1016/S0969-2126(01)00135-6; Steinmetz NF, 2009, SMALL, V5, P813, DOI 10.1002/smll.200801348; Trifonova E, 2014, J BIOMOL STRUCT DYN, V32, P1193, DOI 10.1080/07391102.2013.816868; Wang Z, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5808; WATERWORTH HE, 1977, PHYTOPATHOLOGY, V67, P169, DOI 10.1094/Phyto-67-169; Zhang X, 2008, P NATL ACAD SCI USA, V105, P1867, DOI 10.1073/pnas.0711623105; Zhou JC, 2012, J NANOBIOTECHNOL, V10, DOI 10.1186/1477-3155-10-18	40	25	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142415	10.1371/journal.pone.0142415	http://dx.doi.org/10.1371/journal.pone.0142415			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26545232	Green Published, Green Submitted, gold			2022-12-27	WOS:000364398700132
J	Rybaczek, D; Musialek, MW; Balcerczyk, A				Rybaczek, Dorota; Musialek, Marcelina Weronika; Balcerczyk, Aneta			Caffeine-Induced Premature Chromosome Condensation Results in the Apoptosis-Like Programmed Cell Death in Root Meristems of Vicia faba	PLOS ONE			English	Article							MITOTIC CATASTROPHE; DNA FRAGMENTATION; MINOR SEEDLINGS; H2AX HISTONES; PISUM-SATIVUM; CYCLE PHASE; PLANT; INDUCTION; STRESS; PHOSPHORYLATION	We have demonstrated that the activation of apoptosis-like programmed cell death (ALPCD) was a secondary result of caffeine (CF) induced premature chromosome condensation (PCC) in hydroxyurea-synchronized Vicia faba root meristem cells. Initiation of the apoptotic-like cell degradation pathway seemed to be the result of DNA damage generated by treatment with hydroxyurea (HU) [double-stranded breaks (DSBs) mostly] and co-treatment with HU/CF [single-stranded breaks (SSBs) mainly]. A single chromosome comet assay was successfully used to study different types of DNA damage (neutral variant-DSBs versus alkaline-DSBs or SSBs). The immunocytochemical detection of H2AXS139Ph and PARP-2 were used as markers for DSBs and SSBs, respectively. Acridine orange and ethidium bromide (AO/EB) were applied for quantitative immunofluorescence measurements of dead, dying and living cells. Apoptotic-type DNA fragmentation and positive TUNEL reaction finally proved that CF triggers AL-PCD in stressed V. faba root meristem cells. In addition, the results obtained under transmission electron microscopy (TEM) further revealed apoptotic-like features at the ultrastructural level of PCC-type cells: (i) extensive vacuolization; (ii) abnormal chromatin condensation, its marginalization and concomitant degradation; (iii) formation of autophagy-like vesicles (iv) protoplast shrinkage (v) fragmentation of cell nuclei and (vi) extensive degeneration of the cells. The results obtained have been discussed with respect to the vacuolar/autolytic type of plant-specific AL-PCD.	[Rybaczek, Dorota; Musialek, Marcelina Weronika] Univ Lodz, Dept Cytophysiol, Inst Expt Biol, Fac Biol & Environm Protect, PL-90131 Lodz, Poland; [Balcerczyk, Aneta] Univ Lodz, Dept Mol Biophys, Fac Biol & Environm Protect, PL-90131 Lodz, Poland	University of Lodz; University of Lodz	Rybaczek, D (corresponding author), Univ Lodz, Dept Cytophysiol, Inst Expt Biol, Fac Biol & Environm Protect, PL-90131 Lodz, Poland.	dorota.rybaczek@gmail.com	Rybaczek, Dorota/ABC-7091-2020	Rybaczek, Dorota/0000-0002-9020-3391; Balcerczyk, Aneta/0000-0001-8544-5778; Musialek, Marcelina/0000-0003-4014-7915	Foundation for Polish Science [POMOST/2011-4/8]	Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission)	The work was funded by 'POMOST' fellowship from the Foundation for Polish Science (contract no. POMOST/2011-4/8).; The work was funded by 'POMOST' fellowship from the Foundation for Polish Science (grant number: POMOST/2011-4/8; DR: author who received the funding); this funding source had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Affenzeller MJ, 2009, J EXP BOT, V60, P939, DOI 10.1093/jxb/ern348; Babula P, 2009, ENVIRON EXP BOT, V65, P330, DOI 10.1016/j.envexpbot.2008.11.007; Banfalvi G, 2005, APOPTOSIS, V10, P631, DOI 10.1007/s10495-005-1897-9; Barciszewski J, 2007, INT J BIOL MACROMOL, V40, P182, DOI 10.1016/j.ijbiomac.2006.06.024; Borek S, 2009, J EXP BOT, V60, P3453, DOI 10.1093/jxb/erp186; Brown EJ, 2000, GENE DEV, V14, P397; BRUNI A, 1976, HISTOCHEMISTRY, V48, P269, DOI 10.1007/BF00499244; Byczkowska A, 2013, PROTOPLASMA, V250, P121, DOI 10.1007/s00709-012-0383-9; Carimi F, 2003, PLANTA, V216, P413, DOI 10.1007/s00425-002-0862-x; Cassab GI, 1992, TISSUE PRINTING, P23; Collazo C., 2006, BIOTECNOL APL, V23, P1; Della Mea M, 2007, AMINO ACIDS, V33, P395, DOI 10.1007/s00726-007-0530-3; Diaz-Tielas C, 2012, PLANT CELL ENVIRON, V35, P1500, DOI 10.1111/j.1365-3040.2012.02506.x; Dominguez F, 2004, J BIOL CHEM, V279, P11530, DOI 10.1074/jbc.M308082200; Dominguez F, 2001, PLANTA, V213, P352, DOI 10.1007/s004250000517; Dominguez F, 2006, BIOCHEM J, V397, P529, DOI 10.1042/BJ20051809; Dominguez F, 2012, PLANT SCI, V197, P114, DOI 10.1016/j.plantsci.2012.09.009; Doniak M, 2014, PLANT CELL REP, V33, P2063, DOI 10.1007/s00299-014-1681-9; Dunn SR, 2004, CELL DEATH DIFFER, V11, P1213, DOI 10.1038/sj.cdd.4401484; El-Maarouf-Bouteau H, 2011, J EXP BOT, V62, P5003, DOI 10.1093/jxb/err198; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Fragkos M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022946; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Gladish DK, 2006, ANN BOT-LONDON, V97, P895, DOI 10.1093/aob/mcl040; Gohring F, 1997, EMBO J, V16, P7361, DOI 10.1093/emboj/16.24.7361; Groover A, 1999, PLANT PHYSIOL, V119, P375, DOI 10.1104/pp.119.2.375; Huang XA, 2006, CYTOM PART A, V69A, P222, DOI 10.1002/cyto.a.20257; Hubner B, 2009, EUR BIOPHYS J BIOPHY, V38, P729, DOI 10.1007/s00249-009-0496-z; Iglesias-Guimarais V, 2013, J BIOL CHEM, V288, P9200, DOI 10.1074/jbc.M112.411371; Jones A, 2000, TRENDS PLANT SCI, V5, P225, DOI 10.1016/S1360-1385(00)01605-8; Jones AM, 2001, METHOD CELL BIOL, V66, P437; Kobori S, 2007, PLANT BIOTECHNOL-NAR, V24, P375, DOI 10.5511/plantbiotechnology.24.375; Kolodziejek I, 2007, PROTOPLASMA, V232, P97, DOI 10.1007/s00709-007-0271-x; Kontek R, 2014, TOXICOL IN VITRO, V28, P282, DOI 10.1016/j.tiv.2013.11.007; Krantic S, 2005, TRENDS NEUROSCI, V28, P670, DOI 10.1016/j.tins.2005.09.011; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Kunikowska A, 2013, PROTOPLASMA, V250, P851, DOI 10.1007/s00709-012-0466-7; Kuthanova A, 2008, PLANT CELL ENVIRON, V31, P1634, DOI 10.1111/j.1365-3040.2008.01876.x; Lang FF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129196; Lockshin RA, 2004, INT J BIOCHEM CELL B, V36, P2405, DOI 10.1016/j.biocel.2004.04.011; Mazurczyk M, 2015, BIOCHIMIE, V108, P25, DOI 10.1016/j.biochi.2014.10.026; MEIKRANTZ W, 1994, P NATL ACAD SCI USA, V91, P3754, DOI 10.1073/pnas.91.9.3754; Minina EA, 2013, J CELL BIOL, V203, P917, DOI 10.1083/jcb.201307082; Nishawar Jan, 2008, Biotechnology and Molecular Biology Reviews, V3, P111; OLIVE MR, 1990, PLANT MOL BIOL, V15, P593, DOI 10.1007/BF00017834; Ovejero-Benito MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064890; Potocki L, 2014, BIOCHIMIE, V97, P163, DOI 10.1016/j.biochi.2013.10.010; Reape TJ, 2008, J EXP BOT, V59, P435, DOI 10.1093/jxb/erm258; Reape TJ, 2010, APOPTOSIS, V15, P249, DOI 10.1007/s10495-009-0447-2; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Ribble D, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-12; Rybaczek D, 2007, BIOL PLANTARUM, V51, P443, DOI 10.1007/s10535-007-0094-9; Rybaczek D, 2002, FOLIA HISTOCHEM CYTO, V40, P51; Rybaczek D, 2011, DNA REPAIR, P185; Rybaczek D, 2013, NEW RES DIRECTIONS D, P231, DOI [10.5772/54020, DOI 10.5772/54020]; Rybaczek D, 2008, ACTA PHYSIOL PLANT, V30, P663, DOI 10.1007/s11738-008-0163-5; Rybaczek D, 2007, HISTOCHEM CELL BIOL, V128, P227, DOI 10.1007/s00418-007-0311-9; Rybaczek D, 2007, PROTOPLASMA, V230, P31, DOI 10.1007/s00709-006-0192-0; Rybaczek D, 2014, PLANT CELL REP, V33, P1547, DOI 10.1007/s00299-014-1637-0; Rybaczek D, 2011, HISTOCHEM CELL BIOL, V135, P263, DOI 10.1007/s00418-011-0793-3; SCHLEGEL R, 1986, SCIENCE, V232, P1264, DOI 10.1126/science.2422760; Serafini-Fracassini D, 2010, PLANT PHYSIOL BIOCH, V48, P602, DOI 10.1016/j.plaphy.2010.03.005; Smetana O, 2012, J EXP BOT, V63, P2631, DOI 10.1093/jxb/err439; Tegeder M, 1995, PLANT CELL REP, V15, P164, DOI 10.1007/BF00193712; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Vakifahmetoglu H, 2008, CELL DEATH DIFFER, V15, P1153, DOI 10.1038/cdd.2008.47; van Doorn WG, 2011, CELL DEATH DIFFER, V18, P1241, DOI 10.1038/cdd.2011.36; van Doorn WG, 2005, TRENDS PLANT SCI, V10, P478, DOI 10.1016/j.tplants.2005.08.003; van Doorn WG, 2005, TRENDS PLANT SCI, V10, P117, DOI 10.1016/j.tplants.2005.01.006; van Doorn WG, 2011, J EXP BOT, V62, P4749, DOI 10.1093/jxb/err196; Vanyushin BF, 2004, INT REV CYTOL, V233, P135, DOI 10.1016/S0074-7696(04)33004-4; VAUX DL, 1994, CELL, V76, P777, DOI 10.1016/0092-8674(94)90350-6; Vitale I, 2011, NAT REV MOL CELL BIO, V12, P384, DOI 10.1038/nrm3115; Wang JH, 2013, TRENDS PLANT SCI, V18, P133, DOI 10.1016/j.tplants.2012.09.004; Yamada T, 2006, J EXP BOT, V57, P3543, DOI 10.1093/jxb/erl100; Yoshida M, 1997, EXP CELL RES, V232, P225, DOI 10.1006/excr.1997.3538	77	14	15	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142307	10.1371/journal.pone.0142307	http://dx.doi.org/10.1371/journal.pone.0142307			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26545248	gold, Green Submitted, Green Published			2022-12-27	WOS:000364398700108
J	Urayama, A; Dohgu, S; Robinson, SM; Sly, WS; Grubb, JH; Banks, WA				Urayama, Akihiko; Dohgu, Shinya; Robinson, Sandra M.; Sly, William S.; Grubb, Jeffery H.; Banks, William A.			Alpha Adrenergic Induction of Transport of Lysosomal Enzyme across the Blood-Brain Barrier	PLoS One			English	Article							MANNOSE 6-PHOSPHATE RECEPTOR; MEDIATED TRANSPORT; INTERNALIZATION; SUBTYPES; STORAGE; VII	The impermeability of the adult blood-brain barrier (BBB) to lysosomal enzymes impedes the ability to treat the central nervous system manifestations of lysosomal storage diseases. Here, we found that simultaneous stimulation of the alpha1 and alpha2 adrenoreceptor restores in adult mice the high rate of transport for the lysosomal enzyme P-GUS that is seen in neonates but lost with development. Beta adrenergics, other monoamines, and acetylcholine did not restore this transport. A high dose (500 microg/mouse) of clonidine, a strong alpha2 and weak alpha1 agonist, was able to act as monotherapy in the stimulation of P-GUS transport. Neither use of alpha1 plus alpha2 agonists nor the high dose clonidine disrupted the BBB to albumin. In situ brain perfusion and immunohistochemistry studies indicated that adrengerics act on transporters already at the luminal surface of brain endothelial cells. These results show that adrenergic stimulation, including monotherapy with clonidine, could be key for CNS enzyme replacement therapy.	[Urayama, Akihiko] Univ Texas Med Sch Houston, Dept Neurol, Houston, TX USA; [Dohgu, Shinya] Fac Pharmaceut Sci, Dept Pharmaceut Care & Hlth Sci, Fukuoka, Japan; [Robinson, Sandra M.] St Louis Univ, Div Geriatr Med, Dept Internal Med, St Louis, MO 63103 USA; [Sly, William S.; Grubb, Jeffery H.] St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO USA; [Banks, William A.] Vet Affairs Puget Sound Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Seattle, WA 98493 USA; [Banks, William A.] Univ Washington, Sch Med, Dept Med, Div Gerontol & Geriatr Med, Seattle, WA 98195 USA	University of Texas System; University of Texas Health Science Center Houston; Saint Louis University; Saint Louis University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle	Banks, WA (corresponding author), Vet Affairs Puget Sound Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Seattle, WA 98493 USA.	wabanks1@uw.edu	Dohgu, Shinya/AAK-9992-2020; Banks, William A/K-1330-2017	Banks, William A/0000-0002-0496-3619	National Institutes of Health [Ro1 NS081134]; Veterans Affairs; Shire; NIH [R01 NS081134]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs); Shire; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	National Institutes of Health (WAB) Ro1 NS081134, Veterans Affairs (WAB) (no number), Shire (WAB; WSS) (no number). The funders had no role in the study, design, data collection and analysis, decision to publish, or preparation of the manuscript.; Supported by Veterans Affairs (WAB), Shire, and NIH R01 NS081134 (WAB). The contents do not represent the views of the US Department of Veterans Affairs or the United States Government.	Banks WA, 2001, BRAIN RES, V899, P209, DOI 10.1016/S0006-8993(01)02242-9; BANKS WA, 1986, J PHARMACOL EXP THER, V239, P668; BANKS WA, 1988, J PHARMACOL EXP THER, V244, P579; Begley DJ, 2008, CURR PHARM DESIGN, V14, P1566, DOI 10.2174/138161208784705504; BLASBERG RG, 1983, J CEREBR BLOOD F MET, V3, P8, DOI 10.1038/jcbfm.1983.2; Calias P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030341; Dohgu S, 2008, EXP NEUROL, V210, P740, DOI 10.1016/j.expneurol.2007.12.028; Georgieva JV, 2011, MOL THER, V19, P318, DOI 10.1038/mt.2010.236; Grubb JH, 2008, P NATL ACAD SCI USA, V105, P2616, DOI 10.1073/pnas.0712147105; KALARIA RN, 1989, NEUROSCI LETT, V106, P233, DOI 10.1016/0304-3940(89)90231-0; LOSSINSKY AS, 1983, ACTA NEUROPATHOL, V61, P239, DOI 10.1007/BF00691992; MURPHY VA, 1985, J CEREBR BLOOD F MET, V5, P401, DOI 10.1038/jcbfm.1985.55; PATLAK CS, 1983, J CEREBR BLOOD F MET, V3, P1, DOI 10.1038/jcbfm.1983.1; Perez-Aso M, 2013, BBA-MOL CELL RES, V1833, P2322, DOI 10.1016/j.bbamcr.2013.06.013; Preston Jane E, 2014, Adv Pharmacol, V71, P147, DOI 10.1016/bs.apha.2014.06.001; REESE TS, 1967, J CELL BIOL, V34, P207, DOI 10.1083/jcb.34.1.207; SANDS MS, 1994, J CLIN INVEST, V93, P2324, DOI 10.1172/JCI117237; Shi T, 2006, MOL PHARMACOL, V70, P129, DOI 10.1124/mol.105.020735; Stanasila L, 2008, MOL PHARMACOL, V74, P562, DOI 10.1124/mol.107.043422; Tomatsu S, 2007, HUMAN MOL GENETICS; Urayama A, 2004, P NATL ACAD SCI USA, V101, P12658, DOI 10.1073/pnas.0405042101; Urayama A, 2008, MOL THER, V16, P1261, DOI 10.1038/mt.2008.84; Urayama A, 2007, P NATL ACAD SCI USA, V104, P12873, DOI 10.1073/pnas.0705611104; VANDEURS B, 1978, MICROVASC RES, V16, P280, DOI 10.1016/0026-2862(78)90061-4; Wheway J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052586	25	5	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142347	10.1371/journal.pone.0142347	http://dx.doi.org/10.1371/journal.pone.0142347			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26545208	gold, Green Published, Green Submitted			2022-12-27	WOS:000364398700116
J	Nanri, A; Nakagawa, T; Kuwahara, K; Yamamoto, S; Honda, T; Okazaki, H; Uehara, A; Yamamoto, M; Miyamoto, T; Kochi, T; Eguchi, M; Murakami, T; Shimizu, C; Shimizu, M; Tomita, K; Nagahama, S; Imai, T; Nishihara, A; Sasaki, N; Hori, A; Sakamoto, N; Nishiura, C; Totsuzaki, T; Kato, N; Fukasawa, K; Hu, HH; Akter, S; Kurotani, K; Kabe, I; Mizoue, T; Sone, T; Dohi, S				Nanri, Akiko; Nakagawa, Tohru; Kuwahara, Keisuke; Yamamoto, Shuichiro; Honda, Toru; Okazaki, Hiroko; Uehara, Akihiko; Yamamoto, Makoto; Miyamoto, Toshiaki; Kochi, Takeshi; Eguchi, Masafumi; Murakami, Taizo; Shimizu, Chii; Shimizu, Makiko; Tomita, Kentaro; Nagahama, Satsue; Imai, Teppei; Nishihara, Akiko; Sasaki, Naoko; Hori, Ai; Sakamoto, Nobuaki; Nishiura, Chihiro; Totsuzaki, Takafumi; Kato, Noritada; Fukasawa, Kenji; Hu Huanhuan; Akter, Shamima; Kurotani, Kayo; Kabe, Isamu; Mizoue, Tetsuya; Sone, Tomofumi; Dohi, Seitaro		Japan Epidemiology Collaboration O	Development of Risk Score for Predicting 3-Year Incidence of Type 2 Diabetes: Japan Epidemiology Collaboration on Occupational Health Study	PLOS ONE			English	Article							FAMILY-HISTORY; MODELS; POPULATION	Objective Risk models and scores have been developed to predict incidence of type 2 diabetes in Western populations, but their performance may differ when applied to non-Western populations. We developed and validated a risk score for predicting 3-year incidence of type 2 diabetes in a Japanese population. Methods Participants were 37,416 men and women, aged 30 or older, who received periodic health checkup in 2008-2009 in eight companies. Diabetes was defined as fasting plasma glucose (FPG) >= 126 mg/dl, random plasma glucose >= 200 mg/dl, glycated hemoglobin (HbA1c) >= 6.5%, or receiving medical treatment for diabetes. Risk scores on non-invasive and invasive models including FPG and HbA1c were developed using logistic regression in a derivation cohort and validated in the remaining cohort. Results The area under the curve (AUC) for the non-invasive model including age, sex, body mass index, waist circumference, hypertension, and smoking status was 0.717 (95% CI, 0.703-0.731). In the invasive model in which both FPG and HbA1c were added to the non-invasive model, AUC was increased to 0.893 (95% CI, 0.883-0.902). When the risk scores were applied to the validation cohort, AUCs (95% CI) for the non-invasive and invasive model were 0.734 (0.715-0.753) and 0.882 (0.868-0.895), respectively. Participants with a non-invasive score of >= 15 and invasive score of >= 19 were projected to have >20% and >50% risk, respectively, of developing type 2 diabetes within 3 years. Conclusions The simple risk score of the non-invasive model might be useful for predicting incident type 2 diabetes, and its predictive performance may be markedly improved by incorporating FPG and HbA1c.	[Nanri, Akiko; Kuwahara, Keisuke; Hu Huanhuan; Akter, Shamima; Kurotani, Kayo; Mizoue, Tetsuya] Natl Ctr Global Hlth & Med, Dept Epidemiol & Prevent, Ctr Clin Sci, Tokyo, Japan; [Nakagawa, Tohru; Yamamoto, Shuichiro; Honda, Toru] Hitachi Ltd, Ibaraki, Japan; [Kuwahara, Keisuke] Teikyo Univ, Grad Sch Publ Hlth, Tokyo 173, Japan; [Okazaki, Hiroko; Dohi, Seitaro] Mitsui Chem Inc, Tokyo, Japan; [Uehara, Akihiko; Yamamoto, Makoto] YAMAHA CORP, Shizuoka, Japan; [Miyamoto, Toshiaki] Nippon Steel & Sumitomo Met Corp Kimitsu Works, Chiba, Japan; [Kochi, Takeshi; Eguchi, Masafumi; Kabe, Isamu] Furukawa Elect Corp Ltd, Tokyo, Japan; [Murakami, Taizo; Shimizu, Chii; Shimizu, Makiko] Keihin Occupat Hlth Ctr, Mizue Med Clin, Mizue, Kanagawa, Japan; [Tomita, Kentaro] Mitsubishi Plast Inc, Tokyo, Japan; [Nagahama, Satsue] All Japan Labour Welf Fdn, Tokyo, Japan; [Imai, Teppei; Nishihara, Akiko] Azbil Corp, Tokyo, Japan; [Sasaki, Naoko] Mitsubishi Fuso Truck & Bus Corp, Kawasaki, Kanagawa, Japan; [Hori, Ai; Nishiura, Chihiro] Tokyo Gas Co Ltd, Dept Safety & Hlth, Tokyo, Japan; [Sakamoto, Nobuaki] Hlth Design Inc, Tokyo, Japan; [Totsuzaki, Takafumi] Mizuho Hlth Insurance Soc, Tokyo, Japan; [Kato, Noritada] Fuji Elect Co Ltd, Kawasaki, Kanagawa, Japan; [Fukasawa, Kenji] ADVANTAGE Risk Management Co Ltd, Tokyo, Japan; [Sone, Tomofumi] Natl Inst Publ Hlth, Saitama, Japan	National Center for Global Health & Medicine - Japan; Hitachi Limited; Teikyo University; Mitsui Chemicals; Yamaha; Nippon Steel & Sumitomo Metal Corporation; Furukawa Electric; Daimler AG; Fuji Electric Co., LTD.; National Institute of Public Health - Japan	Nanri, A (corresponding author), Natl Ctr Global Hlth & Med, Dept Epidemiol & Prevent, Ctr Clin Sci, Tokyo, Japan.	nanri@ri.ncgm.go.jp	Nishiura, Chihiro/C-4132-2017; Nishiura, Chihiro/Q-7938-2019; Hori, Ai/G-5277-2019	Nishiura, Chihiro/0000-0002-8850-5446; Nishiura, Chihiro/0000-0002-8850-5446; Hori, Ai/0000-0002-0191-5996; Kochi, Takeshi/0000-0002-3411-1070; Kuwahara, Keisuke/0000-0002-7503-1333	Industrial Health Foundation; Japan Society for the Promotion of Science [25293146]	Industrial Health Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by a grant from the Industrial Health Foundation and Grant-in-Aid for Scientific Research (B) (25293146) from the Japan Society for the Promotion of Science.	Aekplakorn W, 2006, DIABETES CARE, V29, P1872, DOI 10.2337/dc05-2141; Beagley J, 2014, DIABETES RES CLIN PR, V103, P150, DOI 10.1016/j.diabres.2013.11.001; Bianco A, 2014, ACTA DIABETOL, V51, P79, DOI 10.1007/s00592-013-0502-x; Chien K, 2009, DIABETOLOGIA, V52, P443, DOI 10.1007/s00125-008-1232-4; Chuang SY, 2011, DIABETES RES CLIN PR, V92, P128, DOI 10.1016/j.diabres.2010.12.022; Collins GS, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-103; Das Mithun, 2012, J Cardiovasc Dis Res, V3, P104, DOI 10.4103/0975-3583.95362; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Doi Y, 2012, DIABETIC MED, V29, P107, DOI 10.1111/j.1464-5491.2011.03376.x; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Guasch-Ferre M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033437; He S, 2012, DIABETES RES CLIN PR, V95, P291, DOI 10.1016/j.diabres.2011.10.039; Heianza Y, 2012, DIABETOLOGIA, V55, P3213, DOI 10.1007/s00125-012-2712-0; Kashiwagi A, 2012, DIABETOL INT, V3, P8, DOI 10.1007/s13340-012-0069-8; Lim NK, 2012, CIRC J, V76, P1904, DOI 10.1253/circj.CJ-11-1236; Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725; Liu M, 2011, DIABETES TECHNOL THE, V13, P501, DOI 10.1089/dia.2010.0106; Ministry of Health Labour and Walfare, 2012, NAT HLTH NUTR SURV J; Ministry of Health Labour and Welfare Japan, 2010, NAT HLTH NUTR SURV J; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Noble D, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7163; Pomara F, 2006, Minerva Med, V97, P379; Ramachandran A, 2010, LANCET, V375, P408, DOI 10.1016/S0140-6736(09)60937-5; Sasai Hiroyuki, 2008, Nihon Koshu Eisei Zasshi, V55, P287; Schulze MB, 2009, DIABETES CARE, V32, P2116, DOI 10.2337/dc09-0197; Sullivan LM, 2004, STAT MED, V23, P1631, DOI 10.1002/sim.1742; Sun F, 2009, DIABETES RES CLIN PR, V85, P228, DOI 10.1016/j.diabres.2009.05.005; Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9; Zamora-Ginez I, 2012, ANN HUM BIOL, V39, P102, DOI 10.3109/03014460.2011.645507; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	31	41	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142779	10.1371/journal.pone.0142779	http://dx.doi.org/10.1371/journal.pone.0142779			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26558900	Green Submitted, gold, Green Published			2022-12-27	WOS:000364433100121
J	Thomas, R; Galanakis, C; Vezina, S; Longpre, D; Boissonnault, M; Huchet, E; Charest, L; Murphy, D; Trottier, B; Machouf, N				Thomas, Rejean; Galanakis, Chrissi; Vezina, Sylvie; Longpre, Daniele; Boissonnault, Michel; Huchet, Emmanuelle; Charest, Louise; Murphy, Daniel; Trottier, Benoit; Machouf, Nima			Adherence to Post-Exposure Prophylaxis (PEP) and Incidence of HIV Seroconversion in a Major North American Cohort	PLOS ONE			English	Article							COMMUNITY-HEALTH CENTER; SEXUAL EXPOSURE; RETROSPECTIVE ANALYSIS; EMERGENCY-DEPARTMENT; TRANSMISSION RISK; TENOFOVIR DF; MEN; EMTRICITABINE; METAANALYSIS; TOLERABILITY	Background There is limited evidence on the efficacy of post-exposure prophylaxis (PEP) for sexual exposures. We sought to determine the factors associated with adherence to treatment and describe the incidence of PEP failures in a Montreal clinic. Methods We prospectively assessed all patients consulting for PEP following sexual exposures from October 2000 to July 2014. Patients were followed at 4 and 16 weeks after starting PEP. Treatment adherence was determined by self-report at week 4. Multivariable logistic regression was used to estimate the factors predicting adherence to treatment. Results 3547 PEP consults were included. Patients were mainly male (92%), MSM (83%) and sought PEP for anal intercourse (72%). Seventy-eight percent (n = 2772) of patients received a prescription for PEP, consisting of Tenofovir/Emtracitabine (TVD) + Lopinavir/Ritonavir (LPV) in 74% of cases, followed by Zidovudine/Lamivudine (CBV) + LPV (10%) and TVD + Raltegravir (RAL) (8%). Seventy percent of patients were adherent to treatment. Compared to TVD + LPV, patients taking CBV + LPV were less likely to adhere to treatment (OR 0.58, 95% CI 0.44-0.75), while no difference was observed for patients taking TVD + RAL (OR 1.15, 95% CI 0.83-1.59). First-time PEP consults, older and male patients were also more adherent to treatment. Ten treated patients seroconverted (0.37%) during the study period, yet only 1 case can be attributed to PEP failure (failure rate = 0.04%). Conclusion PEP regimen was associated with treatment adherence. Patients were more likely to be adherent to TVD-based regimens. Ten patients seroconverted after taking PEP; however, only 1 case was a PEP failure as the remaining patients continued to engage in high-risk behavior during follow-up. One month PEP is an effective preventive measure to avoid HIV infection.	[Thomas, Rejean; Galanakis, Chrissi; Vezina, Sylvie; Longpre, Daniele; Boissonnault, Michel; Huchet, Emmanuelle; Charest, Louise; Murphy, Daniel; Trottier, Benoit; Machouf, Nima] Clin Med Actuel, Montreal, PQ, Canada		Machouf, N (corresponding author), Clin Med Actuel, Montreal, PQ, Canada.	nima.machouf@lactuel.ca			Abbvie	Abbvie(AbbVie)	The authors would like to thank Abbvie (www.abbvie.ca) for funding the creation of the PEP database. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arribas JR, 2008, JAIDS-J ACQ IMM DEF, V47, P74, DOI 10.1097/QAI.0b013e31815acab8; Baggaley RF, 2010, INT J EPIDEMIOL, V39, P1048, DOI 10.1093/ije/dyq057; Barber TJ, 2010, CURR OPIN HIV AIDS, V5, P322, DOI 10.1097/COH.0b013e32833a5e6c; Benn P, 2011, INT J STD AIDS, V22, P695, DOI 10.1258/ijsa.2011.171011; Bogoch II, 2014, CLIN INFECT DIS, V58, P1618, DOI 10.1093/cid/ciu118; Bryant J, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13140; Cai J, 2014, CHINESE MED J-PEKING, V127, P2632, DOI 10.3760/cma.j.issn.0366-6999.20140538; Cardo DM, 1997, NEW ENGL J MED, V337, P1485, DOI 10.1056/NEJM199711203372101; Casalino E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104350; Chan ACH, 2013, INT J STD AIDS, V24, P393, DOI 10.1177/0956462412472826; Dilley JW, 2007, JAIDS-J ACQ IMM DEF, V44, P569, DOI 10.1097/QAI.0b013e318033ffbd; Fernandez-Balbuena S, 2013, HIV MED, V14, P252, DOI 10.1111/j.1468-1293.2012.01056.x; Ford N, 2014, AIDS, V28, P2721, DOI 10.1097/QAD.0000000000000505; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Gulholm T, 2013, SEX HEALTH, V10, P438, DOI 10.1071/SH13018; Heuker J, 2012, AIDS, V26, P505, DOI 10.1097/QAD.0b013e32834f32d8; Irvine C, 2015, CLIN INFECT DIS, V60, pS165, DOI 10.1093/cid/civ069; Jain S, 2015, AIDS PATIENT CARE ST, V29, P20, DOI 10.1089/apc.2014.0154; Jain S, 2015, JAIDS-J ACQ IMM DEF, V68, P97, DOI 10.1097/QAI.0000000000000403; Jin FY, 2010, AIDS, V24, P907, DOI 10.1097/QAD.0b013e3283372d90; Joshi M, 2014, INT J STD AIDS, V25, P67, DOI 10.1177/0956462413491734; Krause KH, 2014, WOMEN HEALTH ISS, V24, pE407, DOI 10.1016/j.whi.2014.04.003; Landovitz RJ, 2012, AIDS PATIENT CARE ST, V26, P320, DOI 10.1089/apc.2011.0432; Lunding S, 2007, 4 INT AIDS SOC C HIV; Mayer KH, 2012, JAIDS-J ACQ IMM DEF, V59, P354, DOI 10.1097/QAI.0b013e31824a03b8; McAllister J, 2014, HIV MED, V15, P13, DOI 10.1111/hiv.12075; McCarty EJ, 2011, INT J STD AIDS, V22, P407, DOI 10.1258/ijsa.2009.009463; McDougal SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105030; Mehta SA, 2011, SEX TRANSM INFECT, V87, P344, DOI 10.1136/sti.2010.046284; Oldenburg CE, 2014, AIDS BEHAV, V18, P217, DOI 10.1007/s10461-013-0567-0; Patel P, 2014, AIDS, V28, P1509, DOI 10.1097/QAD.0000000000000298; Rodriguez AE, 2013, JAIDS-J ACQ IMM DEF, V64, pS68, DOI 10.1097/QAI.0b013e3182a901a2; Roland ME, 2005, CLIN INFECT DIS, V41, P1507, DOI 10.1086/497268; Sultan B, 2014, HIV AIDS-RES PALLIAT, V6, P147, DOI 10.2147/HIV.S46585; Tissot F, 2010, HIV MED, V11, P584, DOI 10.1111/j.1468-1293.2010.00826.x; Tosini W, 2010, AIDS, V24, P2375, DOI 10.1097/QAD.0b013e32833dfad1; Vives N, 2008, ENFERM INFEC MICR CL, V26, P546, DOI 10.1157/13128270	37	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142534	10.1371/journal.pone.0142534	http://dx.doi.org/10.1371/journal.pone.0142534			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7DR	26559816	Green Published, gold, Green Submitted			2022-12-27	WOS:000364433100087
J	Clancy, AK; Woods, K; McMahon, A; Probst, Y				Clancy, Annabel K.; Woods, Kaitlyn; McMahon, Anne; Probst, Yasmine			Food Composition Database Format and Structure: A User Focused Approach	PLOS ONE			English	Article							NUTRITION; NEEDS	This study aimed to investigate the needs of Australian food composition database user's regarding database format and relate this to the format of databases available globally. Three semi structured synchronous online focus groups (M = 3, F = 11) and n = 6 female key informant interviews were recorded. Beliefs surrounding the use, training, understanding, benefits and limitations of food composition data and databases were explored. Verbatim transcriptions underwent preliminary coding followed by thematic analysis with NVivo qualitative analysis software to extract the final themes. Schematic analysis was applied to the final themes related to database format. Desktop analysis also examined the format of six key globally available databases. 24 dominant themes were established, of which five related to format; database use, food classification, framework, accessibility and availability, and data derivation. Desktop analysis revealed that food classification systems varied considerably between databases. Microsoft Excel was a common file format used in all databases, and available software varied between countries. User's also recognised that food composition databases format should ideally be designed specifically for the intended use, have a user-friendly food classification system, incorporate accurate data with clear explanation of data derivation and feature user input. However, such databases are limited by data availability and resources. Further exploration of data sharing options should be considered. Furthermore, user's understanding of food composition data and databases limitations is inherent to the correct application of non-specific databases. Therefore, further exploration of user FCDB training should also be considered.	[Clancy, Annabel K.; Woods, Kaitlyn; McMahon, Anne; Probst, Yasmine] Univ Wollongong, Sch Med, Wollongong, NSW 2500, Australia	University of Wollongong	Clancy, AK (corresponding author), Univ Wollongong, Sch Med, Wollongong, NSW 2500, Australia.	akc834@uowmail.edu.au	Clancy, Annabel/AAF-3037-2020; Probst, Yasmine/A-1342-2008	Clancy, Annabel/0000-0001-7589-1766; Probst, Yasmine/0000-0002-1971-173X; McMahon, Anne-Therese/0000-0001-9657-6001	National Health and Medical Research Council Translating Research into Practice Fellowship [APP1072484]	National Health and Medical Research Council Translating Research into Practice Fellowship	This research contributed to a National Health and Medical Research Council Translating Research into Practice Fellowship, #APP1072484, YP, https://www.nhmrc.gov.au/grants-funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Charrondiere UR, 2007, J FOOD COMPOS ANAL, V20, P713, DOI 10.1016/j.jfca.2007.06.004; Charrondiere UR, 2011, J FOOD COMPOS ANAL, V24, P711, DOI 10.1016/j.jfca.2010.09.006; Draper A, 2011, J HUM NUTR DIET, V24, P3, DOI 10.1111/j.1365-277X.2010.01117.x; Egan B, 2011, EUR J CLIN NUTR, V65, P757, DOI 10.1038/ejcn.2011.24; Egan MB, 2007, EUR J CLIN NUTR, V61, P813, DOI 10.1038/sj.ejcn.1602823; Egan MB, 2009, FOOD CHEM, V113, P804, DOI 10.1016/j.foodchem.2008.05.039; Finglas PM, 2014, ADV NUTR, V5, p608S, DOI 10.3945/an.113.005470; Food Standards Agency, 2010, COMPOSITION FOODS; Food Standards Australia and New Zealand, 2013, MON NUTR OUR FOOD SU; Glaser B., 1992, BASICS GROUNDED THEO; Green J., 2018, QUALITATIVE METHODS, VFourth; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Harrison GG, 2004, J FOOD COMPOS ANAL, V17, P259, DOI 10.1016/j.jfca.2004.03.014; Haytowitz DB, 2009, J FOOD COMPOS ANAL, V22, P433, DOI 10.1016/j.jfca.2009.01.003; Health Canada, 2010, FOOD NUTR NUTR DAT; Ireland J, 2013, PROC FOOD SCI, V2, P195, DOI 10.1016/j.profoo.2013.04.028; Ireland Jayne D., 2000, Journal of Food Composition and Analysis, V13, P529, DOI 10.1006/jfca.2000.0921; Kenny AJ, 2005, J ADV NURS, V49, P414, DOI 10.1111/j.1365-2648.2004.03305.x; Krueger R.A., 2015, FOCUS GROUPS PRACTIC; Machackova M, 2013, FOOD CHEM, V140, P533, DOI 10.1016/j.foodchem.2013.01.095; McCabe-Sellers BJ, 2008, J FOOD COMPOS ANAL, V21, pS27, DOI 10.1016/j.jfca.2007.07.002; New Zealand Institute for Plant and Food Research Ltd & Ministry of Health, 2014, NZ FOOD COMP DAT; Oxford Dictionary, 2014, FORM; Pakkala H, 2010, EUR J CLIN NUTR, V64, pS58, DOI 10.1038/ejcn.2010.212; Pennington JAT, 2007, J AM DIET ASSOC, V107, P2105, DOI 10.1016/j.jada.2007.09.004; Pennington JAT, 2008, J FOOD COMPOS ANAL, V21, pS3, DOI 10.1016/j.jfca.2007.02.005; Probst YC, 2015, TRENDS FOOD SCI TECH, V42, P173, DOI 10.1016/j.tifs.2014.12.005; Probst YC, 2005, J NUTR EDUC BEHAV, V37, P20, DOI 10.1016/S1499-4046(06)60255-8; Schakel SF, 2001, J FOOD COMPOS ANAL, V14, P315, DOI 10.1006/jfca.2001.0992; Sobolewski R, 2010, NUTR DIET, V67, P37, DOI 10.1111/j.1747-0080.2010.01393.x; Stumbo PJ, 2008, J FOOD COMPOS ANAL, V21, pS13, DOI 10.1016/j.jfca.2007.07.011; Stumbo PJ, 2001, J FOOD COMPOS ANAL, V14, P323, DOI 10.1006/jfca.2001.0996; Swift JA, 2010, J HUM NUTR DIET, V23, P559, DOI 10.1111/j.1365-277X.2010.01116.x; Tony Ng K W Jr, 2010, Malays J Nutr, V16, P125; U.S. Department of Agriculture Agriculture Research Service, 2014, USDA NAT NUTR DAT ST; Unwin ID, 2002, J FOOD COMPOS ANAL, V15, P491, DOI 10.1006/jfca.2002.1086; Watson M, 2006, INT J THER REHABIL, V13, P551, DOI 10.12968/ijtr.2006.13.12.22471; Whitehead LC, 2007, SOC SCI MED, V65, P782, DOI 10.1016/j.socscimed.2007.03.005	38	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142137	10.1371/journal.pone.0142137	http://dx.doi.org/10.1371/journal.pone.0142137			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26554836	gold, Green Published, Green Submitted			2022-12-27	WOS:000364430700057
J	Elovaara, H; Huusko, T; Maksimow, M; Elima, K; Yegutkin, GG; Skurnik, M; Dobrindt, U; Siitonen, A; McPherson, MJ; Salmi, M; Jalkanen, S				Elovaara, Heli; Huusko, Teija; Maksimow, Mikael; Elima, Kati; Yegutkin, Gennady G.; Skurnik, Mikael; Dobrindt, Ulrich; Siitonen, Anja; McPherson, Michael J.; Salmi, Marko; Jalkanen, Sirpa			Primary Amine Oxidase of Escherichia coli Is a Metabolic Enzyme that Can Use a Human Leukocyte Molecule as a Substrate	PLOS ONE			English	Article							VASCULAR ADHESION PROTEIN-1; PROPIONATE CATABOLIC GENES; ACTIVE-SITE BASE; MONOAMINE-OXIDASE; CATALYTIC MECHANISM; 2-HYDRAZINOPYRIDINE ADDUCT; ARTHROBACTER-GLOBIFORMIS; YERSINIA-ENTEROCOLITICA; DEGRADATION PATHWAY; MUTATIONAL VARIANTS	Escherichia coli amine oxidase (ECAO), encoded by the tynA gene, catalyzes the oxidative deamination of aromatic amines into aldehydes through a well-established mechanism, but its exact biological role is unknown. We investigated the role of ECAO by screening environmental and human isolates for tynA and characterizing a tynA-deletion strain using microarray analysis and biochemical studies. The presence of tynA did not correlate with pathogenicity. In tynA+ Escherichia coli strains, ECAO enabled bacterial growth in phenylethylamine, and the resultant H2O2 was released into the growth medium. Some aminoglycoside antibiotics inhibited the enzymatic activity of ECAO, which could affect the growth of tynA+ bacteria. Our results suggest that tynA is a reserve gene used under stringent environmental conditions in which ECAO may, due to its production of H2O2, provide a growth advantage over other bacteria that are unable to manage high levels of this oxidant. In addition, ECAO, which resembles the human homolog hAOC3, is able to process an unknown substrate on human leukocytes.	[Elovaara, Heli; Huusko, Teija; Maksimow, Mikael; Elima, Kati; Yegutkin, Gennady G.; Salmi, Marko; Jalkanen, Sirpa] Univ Turku, MediCity Res Lab, Turku, Finland; [Elovaara, Heli; Huusko, Teija; Yegutkin, Gennady G.; Salmi, Marko; Jalkanen, Sirpa] Univ Turku, Dept Med Microbiol & Immunol, Turku, Finland; [Huusko, Teija] Turku Grad Sch Biomed Sci, Turku, Finland; [Elima, Kati] Univ Turku, Dept Med Biochem & Genet, Turku, Finland; [Skurnik, Mikael] Univ Helsinki, Dept Bacteriol & Immunol, Res Programs Unit, Medicum,Immunobiol, Helsinki, Finland; [Skurnik, Mikael] Helsinki Univ Cent Hosp Lab Diagnost, Helsinki, Finland; [Dobrindt, Ulrich] Univ Munster, Inst Hyg, D-48149 Munster, Germany; [Siitonen, Anja] Natl Inst Hlth & Welf, Dept Infect Dis Surveillance & Control, Bacteriol Unit, Helsinki, Finland; [McPherson, Michael J.] Univ Leeds, Inst Mol & Cellular Biol, Fac Biol Sci, Astbury Ctr Struct Mol Biol, Leeds, W Yorkshire, England	University of Turku; University of Turku; University of Turku; University of Turku; University of Helsinki; University of Munster; Finland National Institute for Health & Welfare; University of Leeds	Salmi, M (corresponding author), Univ Turku, MediCity Res Lab, Turku, Finland.	marko.salmi@utu.fi; sirjal@utu.fi	Yegutkin, Gennady G./K-3815-2014; Dobrindt, Ulrich/AEU-2378-2022; Skurnik, Mikael/I-8477-2019	Yegutkin, Gennady G./0000-0001-6684-7982; Dobrindt, Ulrich/0000-0001-9949-1898; Skurnik, Mikael/0000-0001-8791-9260; McPherson, Michael/0000-0002-0719-6427	Academy of Finland [132701, 141136]; Turku Graduate School of Biomedical Sciences; University of Turku foundation; Maud Kuistila foundation	Academy of Finland(Academy of Finland); Turku Graduate School of Biomedical Sciences; University of Turku foundation; Maud Kuistila foundation	This work was supported by the Academy of Finland (www.aka.fi) #132701 (to HE), by the Academy of Finland (www.aka.fi) #141136 (to MS and SJ), by the Turku Graduate School of Biomedical Sciences (www.tubs.utu.fi, to TH), by the University of Turku foundation (https://www.utu.fi/fi/yksikot/yliopistosaatio/en/Sivut/home.aspx, to HE), and by the Maud Kuistila foundation (http://www.maudkuistilanmuistosaatio.fi/index.php?lang=en, to HE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalto K, 2011, BLOOD, V118, P3725, DOI 10.1182/blood-2010-09-311076; AZAKAMI H, 1994, J FERMENT BIOENG, V77, P315, DOI 10.1016/0922-338X(94)90241-0; Bertani G, 2004, J BACTERIOL, V186, P595, DOI 10.1128/JB.186.3.595-600.2004; BLASCO F, 1992, MOL MICROBIOL, V6, P221, DOI 10.1111/j.1365-2958.1992.tb02003.x; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Brock M, 2002, EUR J BIOCHEM, V269, P6184, DOI 10.1046/j.1432-1033.2002.03336.x; Bunch PK, 1997, MICROBIOL-UK, V143, P187, DOI 10.1099/00221287-143-1-187; CAI DY, 1994, J BIOL CHEM, V269, P32039; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Chiang SM, 2012, ARCH BIOCHEM BIOPHYS, V525, P161, DOI 10.1016/j.abb.2012.02.007; CHOI YH, 1995, J BIOL CHEM, V270, P4712, DOI 10.1074/jbc.270.9.4712; DELORENZO V, 1994, METHOD ENZYMOL, V235, P386; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; EDWARDS CQ, 1976, ANTIMICROB AGENTS CH, V9, P925, DOI 10.1128/AAC.9.6.925; Fernandez C, 2014, ENV MICROBIOL REP, V6, P239, DOI 10.1111/1758-2229.12117; Ferrandez A, 2000, J BIOL CHEM, V275, P12214, DOI 10.1074/jbc.275.16.12214; Fic E, 2009, J MOL MICROB BIOTECH, V17, P1, DOI 10.1159/000178014; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Hacisalihoglu A, 1997, MICROBIOL-UK, V143, P505, DOI 10.1099/00221287-143-2-505; Hanahan D., 1985, DNA CLONING PRACTICA, V1, P109; Hara-Kudo Y, 2000, APPL ENVIRON MICROB, V66, P5540, DOI 10.1128/AEM.66.12.5540-5543.2000; Ho KK, 2005, J BACTERIOL, V187, P1067, DOI 10.1128/JB.187.3.1067-1073.2005; Holt A, 1997, ANAL BIOCHEM, V244, P384, DOI 10.1006/abio.1996.9911; Hovatta I, 2006, DNA MICROARRAY DATA; Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032; Janion C, 2008, INT J BIOL SCI, V4, P338; Jansen WTM, 2002, INFECT IMMUN, V70, P5202, DOI 10.1128/IAI.70.9.5202-5207.2002; Jia WJ, 2009, BIOCHEM J, V417, P297, DOI 10.1042/BJ20080746; Jiang H, 2006, BIOTECHNOL LETT, V28, P1241, DOI 10.1007/s10529-006-9080-0; Kehres DG, 2002, J BACTERIOL, V184, P3151, DOI 10.1128/JB.184.12.3151-3158.2002; Kivi E, 2009, BLOOD, V114, P5385, DOI 10.1182/blood-2009-04-219253; KLINMAN JP, 1994, ANNU REV BIOCHEM, V63, P299, DOI 10.1146/annurev.bi.63.070194.001503; Koskinen K, 2004, BLOOD, V103, P3388, DOI 10.1182/blood-2003-09-3275; Kumar SR, 2013, J BACTERIOL, V195, P4569, DOI 10.1128/JB.00737-13; Kurtis CRP, 2011, J NEURAL TRANSM, V118, P1043, DOI 10.1007/s00702-011-0620-y; Layer G, 2005, BIOL CHEM, V386, P971, DOI 10.1515/BC.2005.113; Lee SK, 2005, J BACTERIOL, V187, P2793, DOI 10.1128/JB.187.8.2793-2800.2005; Lyles GA, 1995, PROG BRAIN RES, V106, P293; Lynnes T, 2014, MEAT SCI, V96, P165, DOI 10.1016/j.meatsci.2013.06.030; Maniatis T., 1982, MOL CLONING; Marttila-Ichihara F, 2006, ARTHRITIS RHEUM-US, V54, P2852, DOI 10.1002/art.22061; MILLER VL, 1988, INFECT IMMUN, V56, P1242, DOI 10.1128/IAI.56.5.1242-1248.1988; MORGAN RW, 1986, P NATL ACAD SCI USA, V83, P8059, DOI 10.1073/pnas.83.21.8059; MU D, 1994, J BIOL CHEM, V269, P9926; Mure M, 2005, BIOCHEMISTRY-US, V44, P1583, DOI 10.1021/bi0479860; Mure M, 2005, BIOCHEMISTRY-US, V44, P1568, DOI 10.1021/bi047988k; MUROOKA Y, 1978, J BACTERIOL, V136, P714, DOI 10.1128/JB.136.2.714-722.1978; Murray JM, 1999, BIOCHEMISTRY-US, V38, P8217, DOI 10.1021/bi9900469; Murray JM, 2001, BIOCHEMISTRY-US, V40, P12808, DOI 10.1021/bi011187p; O'Reilly EK, 2004, J BACTERIOL, V186, P7149, DOI 10.1128/JB.186.21.7149-7160.2004; Olivieri A, 2012, BBA-GEN SUBJECTS, V1820, P482, DOI 10.1016/j.bbagen.2011.12.009; Park JM, 2012, GENE, V504, P116, DOI 10.1016/j.gene.2012.04.074; PARSONS MR, 1995, STRUCTURE, V3, P1171, DOI 10.1016/S0969-2126(01)00253-2; Peter C, 2008, EUKARYOT CELL, V7, P1781, DOI 10.1128/EC.00230-08; Pomposiello PJ, 2001, TRENDS BIOTECHNOL, V19, P109, DOI 10.1016/S0167-7799(00)01542-0; R Development Core Team, 2006, R LANG ENV STAT COMP; Rahimpour M, 2013, BIOCHEM J, V452, P559, DOI 10.1042/BJ20130154; Rankin LD, 2008, J BACTERIOL, V190, P6170, DOI 10.1128/JB.00508-08; Reitzer L, 2001, MICROBIOL MOL BIOL R, V65, P422, DOI 10.1128/MMBR.65.3.422-444.2001; ROH JH, 1994, BIOSCI BIOTECH BIOCH, V58, P1652, DOI 10.1271/bbb.58.1652; Salmi M, 2005, NAT REV IMMUNOL, V5, P760, DOI 10.1038/nri1705; Salmi M, 2001, IMMUNITY, V14, P265, DOI 10.1016/S1074-7613(01)00108-X; Salmi M, 2014, SEMIN IMMUNOPATHOL, V36, P163, DOI 10.1007/s00281-014-0417-9; Salmi M, 2012, EUR J IMMUNOL, V42, P284, DOI 10.1002/eji.201142223; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Saysell CG, 2002, BIOCHEM J, V365, P809, DOI 10.1042/BJ20011435; Selva L, 2009, P NATL ACAD SCI USA, V106, P1234, DOI 10.1073/pnas.0809600106; Shimada T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020081; SHIMIZU E, 1990, AGR BIOL CHEM TOKYO, V54, P851, DOI 10.1080/00021369.1990.10870020; SKURNIK M, 1995, MOL MICROBIOL, V17, P575, DOI 10.1111/j.1365-2958.1995.mmi_17030575.x; Smith D, 2003, CHEM ABSTR, V138, P57890; Song F, 2006, J BIOL CHEM, V281, P11028, DOI 10.1074/jbc.M513896200; Stolen CM, 2005, IMMUNITY, V22, P105, DOI 10.1016/j.immuni.2004.12.006; SUGINO H, 1992, J BACTERIOL, V174, P2485, DOI 10.1128/jb.174.8.2485-2492.1992; Tao K, 1997, J BACTERIOL, V179, P5967, DOI 10.1128/jb.179.18.5967-5970.1997; Teufel R, 2010, P NATL ACAD SCI USA, V107, P14390, DOI 10.1073/pnas.1005399107; Wang GD, 1998, J FOOD PROTECT, V61, P662, DOI 10.4315/0362-028X-61.6.662; Wilmot CM, 1999, SCIENCE, V286, P1724, DOI 10.1126/science.286.5445.1724; Wilmot CM, 1997, BIOCHEMISTRY-US, V36, P1608, DOI 10.1021/bi962205j; Zeng J, 2013, J BACTERIOL, V195, P5141, DOI 10.1128/JB.00837-13; ZHANG XP, 1993, J BACTERIOL, V175, P5617, DOI 10.1128/JB.175.17.5617-5627.1993; Zimmer DP, 2000, P NATL ACAD SCI USA, V97, P14674, DOI 10.1073/pnas.97.26.14674	83	15	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142367	10.1371/journal.pone.0142367	http://dx.doi.org/10.1371/journal.pone.0142367			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556595	Green Published, gold			2022-12-27	WOS:000364430700091
J	Hamel, DL; Deloire, M; Ruet, A; Charre-Morin, J; Saubusse, A; Ouallet, JC; Brochet, B				Hamel, Delphine Lamargue; Deloire, Mathilde; Ruet, Aurelie; Charre-Morin, Julie; Saubusse, Aurore; Ouallet, Jean-Christophe; Brochet, Bruno			Deciphering Depressive Mood in Relapsing-Remitting and Progressive Multiple Sclerosis and Its Consequence on Quality of Life	PLOS ONE			English	Article							DIAGNOSTIC-CRITERIA; IMPAIRMENT; DISABILITY	Background Depressive mood and other emotional symptoms are common in multiple sclerosis (MS). The patient-reported outcome version of the "Echelle d'Humeur Depressive" (EHD-PRO) aims to differentiate between two dimensions of depressive mood in people living with MS (PwMS). Objectives First, to compare EHD-PRO assessment and its two dimensions, lack of emotional control and emotional blunting, between a large sample of healthy controls (HCs) and two samples of PwMS, relapsing-remitting MS (RRMS) and primary progressive MS (PPMS); and second, to analyse the relationships between EHD-PRO scores with neurological disability, cognitive function, fatigue and health-related quality of life (HR-QOL). Results Regardless of their phenotype, PwMS had significantly higher EHD-PRO scores than HCs. EHD-PRO scores did not differ between the two MS groups. EHD-PRO scores did not correlate with disability and fatigue scores, disease duration or cognitive z scores. In RRMS, the lack of emotional control was independently associated with a decrease in HR-QOL. Conclusion The EHD-PRO is able to easily detect depressive mood and to differentiate between two clinical dimensions, emotional blunting and lack of emotional control. The scale is sensitive and seems robust to confounding factors. Lack of emotional control seems to contribute significantly to altered HR-QOL in RRMS.	[Hamel, Delphine Lamargue; Ruet, Aurelie; Brochet, Bruno] Univ Bordeaux, INSERM, U862, Neuroctr Magendie, Bordeaux, France; [Deloire, Mathilde; Ruet, Aurelie; Charre-Morin, Julie; Saubusse, Aurore; Ouallet, Jean-Christophe; Brochet, Bruno] CHU Bordeaux, INSERM CHU CIC P 0005, F-33076 Bordeaux, France; [Deloire, Mathilde; Ruet, Aurelie; Charre-Morin, Julie; Saubusse, Aurore; Ouallet, Jean-Christophe; Brochet, Bruno] CHU Bordeaux, Serv Neurol, F-33076 Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Bordeaux	Brochet, B (corresponding author), Univ Bordeaux, INSERM, U862, Neuroctr Magendie, Bordeaux, France.	bruna.brochet@chubbordeaux.fr		Lamargue, Delphine/0000-0001-8415-889X; OUALLET, Jean-Christophe/0000-0003-3231-6416	Bayer Health Care, France	Bayer Health Care, France	The study was supported in part by Bayer Health Care, France. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no other funding source.	Beck AT, 1996, PSYCHOL ASSESS; Benedict RHB, 2003, MULT SCLER J, V9, P393, DOI 10.1191/1352458503ms902oa; Brochet B, 2009, REV NEUROL-FRANCE, V165, pS173, DOI 10.1016/S0035-3787(09)72131-9; Bungener C, 1996, J AM GERIATR SOC, V44, P1066, DOI 10.1111/j.1532-5415.1996.tb02939.x; Dulau C, 2015, NEUROPSYCH SYMP NEUR, P213, DOI 10.1007/978-3-319-18464-7_15; Feinstein A, 2001, J AFFECT DISORDERS, V66, P193, DOI 10.1016/S0165-0327(00)00298-6; Feinstein A, 2011, MULT SCLER J, V17, P1276, DOI 10.1177/1352458511417835; JOUVENT R, 1988, Psychiatrie and Psychobiologie, V3, P245; JOUVENT R, 1991, ROY SOC MED INT CONG, V183, P35; Lobentanz IS, 2004, ACTA NEUROL SCAND, V110, P6, DOI 10.1111/j.1600-0404.2004.00257.x; Patten SB, 2003, NEUROLOGY, V61, P1524, DOI 10.1212/01.WNL.0000095964.34294.B4; Perneger, 2001, QUESTIONNAIRE MOS SF; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Radat F, 2007, ENCEPHALE, V33, P49; Rao S, 1990, MANUAL BRIEF REPEATA; Ruet A, 2013, MULT SCLER J, V19, P1665, DOI 10.1177/1352458513480251; Ruet A, 2013, NEUROLOGY, V80, P1501, DOI 10.1212/WNL.0b013e31828cf82f; Ruet A, 2013, J NEUROL, V260, P776, DOI 10.1007/s00415-012-6705-1; Sharrack B, 1999, MULT SCLER, V5, P223, DOI 10.1191/135245899678846131; Spielberger C. D., 1973, MANUAL STATE TRAIT I; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zimmermann P, 2009, TESTS EVALUATION ATT	23	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142152	10.1371/journal.pone.0142152	http://dx.doi.org/10.1371/journal.pone.0142152			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555230	Green Submitted, Green Published, gold			2022-12-27	WOS:000364430700061
J	Jenkins, T; Delhaye, J; Christe, P				Jenkins, Tania; Delhaye, Jessica; Christe, Philippe			Testing Local Adaptation in a Natural Great Tit-Malaria System: An Experimental Approach	PLOS ONE			English	Article							AVIAN BLOOD PARASITES; PLASMODIUM-RELICTUM; OXIDATIVE STRESS; MODEL SELECTION; PRACTICAL GUIDE; METABOLIC-RATE; BLUE TITS; HOST SEX; WILD; HAEMOPROTEUS	Finding out whether Plasmodium spp. are coevolving with their vertebrate hosts is of both theoretical and applied interest and can influence our understanding of the effects and dynamics of malaria infection. In this study, we tested for local adaptation as a signature of coevolution between malaria blood parasites, Plasmodium spp. and its host, the great tit, Parus major. We conducted a reciprocal transplant experiment of birds in the field, where we exposed birds from two populations to Plasmodium parasites. This experimental set-up also provided a unique opportunity to study the natural history of malaria infection in the wild and to assess the effects of primary malaria infection on juvenile birds. We present three main findings: i) there was no support for local adaptation; ii) there was a male-biased infection rate; iii) infection occurred towards the end of the summer and differed between sites. There were also site-specific effects of malaria infection on the hosts. Taken together, we present one of the few experimental studies of parasite-host local adaptation in a natural malaria system, and our results shed light on the effects of avian malaria infection in the wild.	[Jenkins, Tania; Delhaye, Jessica; Christe, Philippe] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland	University of Lausanne	Jenkins, T (corresponding author), Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland.	tania.jenkins@unil.ch	; Christe, Philippe/X-4493-2018	Jenkins, Tania/0000-0002-6816-3848; Christe, Philippe/0000-0002-8605-7002	Swiss National Science Foundation [138187]; Herbette Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Herbette Foundation	Support was provided to PC by the Swiss National Science Foundation grant, number 138187 [http://www.snf.ch/en/Pages/default.aspx] and by the Herbette Foundation [http://www.unil.ch/herbette/fr/home.html].	[Anonymous], 1877, DIFFERENT FORMS FLOW; APPLEGATE J E, 1971, Journal of Wildlife Diseases, V7, P91; Atkinson CT, 2000, J WILDLIFE DIS, V36, P197, DOI 10.7589/0090-3558-36.2.197; ATKINSON CT, 1988, J MED ENTOMOL, V25, P45, DOI 10.1093/jmedent/25.1.45; Barton K., 2014, MUMIN MULTIMODEL INF; Bates D, LME4 LINEAR MIXED EF; Bensch S, 2000, P ROY SOC B-BIOL SCI, V267, P1583, DOI 10.1098/rspb.2000.1181; Bensch S, 2009, MOL ECOL RESOUR, V9, P1353, DOI 10.1111/j.1755-0998.2009.02692.x; Bize P, 2008, ECOLOGY, V89, P2584, DOI 10.1890/07-1135.1; Blanquart F, 2013, ECOL LETT, V16, P1195, DOI 10.1111/ele.12150; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bonneaud C, 2006, EVOLUTION, V60, P383, DOI 10.1111/j.0014-3820.2006.tb01114.x; Brockhurst MA, 2013, TRENDS ECOL EVOL, V28, P367, DOI 10.1016/j.tree.2013.02.009; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Buchanan KL, 2001, P ROY SOC B-BIOL SCI, V268, P1337, DOI 10.1098/rspb.2001.1669; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Cellier-Holzem E, 2010, INT J PARASITOL, V40, P1447, DOI 10.1016/j.ijpara.2010.04.014; Christe P, 2007, J ANIM ECOL, V76, P703, DOI 10.1111/j.1365-2656.2007.01255.x; Christe P, 2012, P ROY SOC B-BIOL SCI, V279, P1142, DOI 10.1098/rspb.2011.1546; CRAN, 2012, R LANG ENV STAT COMP; DAVIDAR P, 1993, AUK, V110, P109; Dawson RD, 2000, AUK, V117, P373, DOI 10.1642/0004-8038(2000)117[0373:EOHPOC]2.0.CO;2; Del Hoyo J., 2007, HDB BIRDS WORLD, V12; Dietrich M, 2014, J ANIM ECOL, V83, P576, DOI 10.1111/1365-2656.12170; Duneau D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001271; Dybdahl MF, 2003, TRENDS ECOL EVOL, V18, P523, DOI 10.1016/S0169-5347(03)00223-4; EBERT D, 1994, SCIENCE, V265, P1084, DOI 10.1126/science.265.5175.1084; Ejiri H, 2011, J MED ENTOMOL, V48, P904, DOI 10.1603/ME11053; Galipaud M, 2014, METHODS ECOL EVOL, V5, P983, DOI 10.1111/2041-210X.12251; Gandon S, 2002, ECOL LETT, V5, P246, DOI 10.1046/j.1461-0248.2002.00305.x; Gandon S, 1996, P ROY SOC B-BIOL SCI, V263, P1003, DOI 10.1098/rspb.1996.0148; Garnham PCC., 1966, MALARIA PARASITES OT; Gelman A., 2014, ARM DATA ANAL USING; Glaizot O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034964; Graham AL, 2005, ANNU REV ECOL EVOL S, V36, P373, DOI 10.1146/annurev.ecolsys.36.102003.152622; Greischar MA, 2007, ECOL LETT, V10, P418, DOI 10.1111/j.1461-0248.2007.01028.x; Grueber CE, 2011, J EVOLUTION BIOL, V24, P699, DOI 10.1111/j.1420-9101.2010.02210.x; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; HAYWORTH AM, 1987, J PARASITOL, V73, P850, DOI 10.2307/3282431; Hedrick PW, 2011, HEREDITY, V107, P283, DOI 10.1038/hdy.2011.16; Hellgren O, 2004, J PARASITOL, V90, P797, DOI 10.1645/GE-184R1; Hoeksema JD, 2008, AM NAT, V171, P275, DOI 10.1086/527496; Holt RD, 1997, AM NAT, V149, P563, DOI 10.1086/286005; Ishtiaq F, 2010, J BIOGEOGR, V37, P120, DOI 10.1111/j.1365-2699.2009.02189.x; Jenkins T, 2011, MOL ECOL, V20, P3910, DOI 10.1111/j.1365-294X.2011.05221.x; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Joy DA, 2008, MOL BIOL EVOL, V25, P1245, DOI 10.1093/molbev/msn073; Kaltz O, 1999, EVOLUTION, V53, P395, DOI [10.1111/j.1558-5646.1999.tb03775.x, 10.2307/2640776]; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Kim KS, 2010, MOL ECOL, V19, P5545, DOI 10.1111/j.1365-294X.2010.04897.x; Kimura M, 2006, J PARASITOL, V92, P1043, DOI 10.1645/GE-639R.1; Knowles SCL, 2010, J EVOLUTION BIOL, V23, P557, DOI 10.1111/j.1420-9101.2009.01920.x; Knowles SCL, 2014, J ANIM ECOL, V83, P429, DOI 10.1111/1365-2656.12154; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; Lachish S, 2011, J ANIM ECOL, V80, P1196, DOI 10.1111/j.1365-2656.2011.01836.x; Laine AL, 2005, J EVOLUTION BIOL, V18, P930, DOI 10.1111/j.1420-9101.2005.00933.x; Lajeunesse MJ, 2002, P ROY SOC B-BIOL SCI, V269, P703, DOI 10.1098/rspb.2001.1943; Lalubin F, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-307; Lemoine M, 2012, AM NAT, V179, P270, DOI 10.1086/663699; Lively CM, 1999, AM NAT, V153, pS34, DOI 10.1086/303210; Lively CM, 2004, AM NAT, V164, pS6, DOI 10.1086/424605; Loiseau C, 2011, P ROY SOC B-BIOL SCI, V278, P1264, DOI 10.1098/rspb.2010.1968; Mackinnon MJ, 2004, PHILOS T R SOC B, V359, P965, DOI 10.1098/rstb.2003.1414; McCoy KD, 2002, EVOL ECOL RES, V4, P441; Merino S, 2000, P ROY SOC B-BIOL SCI, V267, P2507, DOI 10.1098/rspb.2000.1312; Moore SL, 2002, SCIENCE, V297, P2015, DOI 10.1126/science.1074196; Morgan AD, 2005, NATURE, V437, P253, DOI 10.1038/nature03913; Oppliger A, 1999, J EVOLUTION BIOL, V12, P951, DOI 10.1046/j.1420-9101.1999.00101.x; Palinauskas V, 2008, EXP PARASITOL, V120, P372, DOI 10.1016/j.exppara.2008.09.001; Peig J, 2009, OIKOS, V118, P1883, DOI 10.1111/j.1600-0706.2009.17643.x; Perrins C.M., 1979, BRIT TITS; Poulin R, 1996, AM NAT, V147, P287, DOI 10.1086/285851; Py I, 2006, EVOL ECOL RES, V8, P483; Ricklefs RE, 2004, SYST BIOL, V53, P111, DOI 10.1080/10635150490264987; ROST R, 1990, J ORNITHOL, V131, P403, DOI 10.1007/BF01639816; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; Sepil I, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0134; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Sorci G, 2013, PARASITE IMMUNOL, V35, P350, DOI 10.1111/pim.12047; Sorci G, 2009, PHILOS T R SOC B, V364, P71, DOI 10.1098/rstb.2008.0151; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; Thompson J. N., 2005, INTERSPEC INTERACT; Tschirren B, 2003, J ANIM ECOL, V72, P839, DOI 10.1046/j.1365-2656.2003.00755.x; Valkinas G., 2005, AVIAN MALARIA PARASI; Valkiunas G, 2006, J PARASITOL, V92, P1123, DOI 10.1645/GE-3564-RN.1; van Rooyen J., 2013, CHARACTERISING AVIAN; van Rooyen J, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-139; WARNER RE, 1968, CONDOR, V70, P101, DOI 10.2307/1365954; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Williams RB, 2005, AVIAN PATHOL, V34, P29, DOI 10.1080/03079450400025430; Wood MJ, 2007, MOL ECOL, V16, P3263, DOI 10.1111/j.1365-294X.2007.03362.x; Woolhouse MEJ, 2002, NAT GENET, V32, P569, DOI 10.1038/ng1202-569; Zuk M, 1996, INT J PARASITOL, V26, P1009, DOI [10.1016/S0020-7519(96)00086-0, 10.1016/S0020-7519(96)80001-4]	94	14	14	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0141391	10.1371/journal.pone.0141391	http://dx.doi.org/10.1371/journal.pone.0141391			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555892	Green Published, Green Submitted, gold			2022-12-27	WOS:000364430700027
J	Liu, YC; Liu, YY; Yip, PK; Akanuma, K; Meguro, K				Liu, Yi-Chien; Liu, Yen-Ying; Yip, Ping-Keung; Akanuma, Kyoko; Meguro, Kenichi			More Delusions May Be Observed in Low-Proficient Multilingual Alzheimer's Disease Patients	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; LANGUAGE; DEMENTIA; SYMPTOMS; CONFABULATIONS; DECLINE; IMPACT; MEMORY; CARE	Background Language impairment and behavioral symptoms are both common phenomena in dementia patients. In this study, we investigated the behavioral symptoms in dementia patients with different language backgrounds. Through this, we aimed to propose a possible connection between language and delusion. Methods We recruited 21 patients with Alzheimer's disease (AD), according to the DSM-IV and NINCDS-ADRDA criteria, from the memory clinic of the Cardinal Tien Hospital in Taipei, Taiwan. They were classified into two groups: 11 multilinguals who could speak Japanese, Taiwanese and Mandarin Chinese, and 10 bilinguals who only spoke Taiwanese and Mandarin Chinese. There were no differences between age, education, disease duration, disease severity, environment and medical care between these two groups. Comprehensive neuropsychological examinations, including Clinical Dementia Rating (CDR), Mini-Mental Status Examination (MMSE), Cognitive Abilities Screening Instrument (CASI), Verbal fluency, Chinese version of the Boston naming test (BNT) and the Behavioral Pathology in Alzheimer's Disease Rating Scale (BEHAVE-AD), were administered. Results The multilingual group showed worse results on the Boston naming test. Other neuropsychological tests, including the MMSE, CASI and Verbal fluency, were not significantly different. More delusions were noted in the multilingual group. Three pairs of subjects were identified for further examination of their differences. These three cases presented the typical scenario of how language misunderstanding may cause delusions in multilingual dementia patients. Consequently, more emotion and distorted ideas may be induced in the multilinguals compared with the MMSE-matched controls. Conclusion Inappropriate mixing of language or conflict between cognition and emotion may cause more delusions in these multilingual patients. This reminds us that delusion is not a pure biological outcome of brain degeneration. Although the cognitive performance was not significantly different between our groups, language may still affect their delusion.	[Liu, Yi-Chien; Akanuma, Kyoko; Meguro, Kenichi] Tohoku Univ, Div Geriatr Behav Neurol, CYRIC, Sendai, Miyagi 980, Japan; [Liu, Yi-Chien; Yip, Ping-Keung] Fu Jen Catholic Univ, Sch Med, Taipei, Taiwan; [Liu, Yi-Chien; Liu, Yen-Ying; Yip, Ping-Keung] Cardinal Tien Hosp, Neurol Ctr, Taipei, Taiwan	Tohoku University; Fu Jen Catholic University	Meguro, K (corresponding author), Tohoku Univ, Div Geriatr Behav Neurol, CYRIC, Sendai, Miyagi 980, Japan.	k-meg@umin.ac.jp						Apostolova LG, 2014, DEMENT GERIATR COGN, V37, P315, DOI 10.1159/000351009; Bencini GML, 2011, J NEUROLINGUIST, V24, P25, DOI 10.1016/j.jneuroling.2010.07.004; Boughtwood D, 2013, DEMENTIA-LONDON, V12, P7, DOI 10.1177/1471301211416173; Cheung RW, 2004, J INT NEUROPSYCH SOC, V10, P46, DOI 10.1017/S1355617704101069; Farber NB, 2000, ARCH GEN PSYCHIAT, V57, P1165, DOI 10.1001/archpsyc.57.12.1165; Ferris SH, 2013, CLIN INTERV AGING, V8, P1007, DOI 10.2147/CIA.S39959; Fotopoulou A, 2010, COGN NEUROPSYCHIATRY, V15, P38, DOI 10.1080/13546800903250949; Friedland D, 1999, APHASIOLOGY, V13, P427, DOI 10.1080/026870399402163; Gollan TH, 2010, NEUROPSYCHOLOGIA, V48, P1356, DOI 10.1016/j.neuropsychologia.2009.12.038; Grimby A., 1998, J CLIN GEROPSYCHOLOG, V4, P65; Hart B D, 1997, Clin Nurse Spec, V11, P20, DOI 10.1097/00002800-199701000-00015; Hong GRS, 2009, J CLIN NURS, V18, P1365, DOI 10.1111/j.1365-2702.2008.02566.x; Ivanova I, 2014, J INT NEUROPSYCH SOC, V20, P534, DOI 10.1017/S1355617714000228; Johnson M.K., 2000, HDB NEUROPSYCHOLOGY, V2, P383; Korf ESC, 2004, NEUROLOGY, V63, P94, DOI 10.1212/01.WNL.0000133114.92694.93; Kowoll M. E., 2015, J ALZHEIMERS DIS JAD; Lam LCW, 2001, INT J GERIATR PSYCH, V16, P368, DOI 10.1002/gps.345; Lee E, 2007, ARCH CLIN NEUROPSYCH, V22, P949, DOI 10.1016/j.acn.2007.07.003; Lee E, 2009, COGN BEHAV NEUROL, V22, P81, DOI 10.1097/WNN.0b013e3181a7226c; Lindquist KA, 2013, EMOT REV, V5, P66, DOI 10.1177/1754073912451351; Garcia-Alberca JM, 2011, ARCH GERONTOL GERIAT, V52, P264, DOI 10.1016/j.archger.2010.05.004; Meguro K., 2003, PSYCHOGERIATRICS, V3, P63; Meguro K, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-83; Nakatsuka M, 2014, DEMENT GERIATR COGN, V38, P46, DOI 10.1159/000357837; Paradis M, 2008, J NEUROLINGUIST, V21, P199, DOI 10.1016/j.jneuroling.2007.09.002; Perquin M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062030; Potkins D, 2003, INT J GERIATR PSYCH, V18, P1002, DOI 10.1002/gps.1002; Querbes O, 2009, BRAIN, V132, P2036, DOI 10.1093/brain/awp105; Scarmeas N, 2005, ARCH NEUROL-CHICAGO, V62, P1601, DOI 10.1001/archneur.62.10.1601; Sultzer DL, 2003, AM J PSYCHIAT, V160, P341, DOI 10.1176/appi.ajp.160.2.341; Taler V, 2008, J CLIN EXP NEUROPSYC, V30, P501, DOI 10.1080/13803390701550128; Venneri A, 2000, NEUROPSYCHOLOGIA, V38, P213, DOI 10.1016/S0028-3932(99)00061-5; Yi-Chien Liu, 2012, PREVALENCE DEMENTIA, pP3	33	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0140714	10.1371/journal.pone.0140714	http://dx.doi.org/10.1371/journal.pone.0140714			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7CT	26554588	Green Submitted, gold, Green Published			2022-12-27	WOS:000364430700015
J	Zhang, SB; Chen, WY; Huang, JL; Bi, YF; Yang, XF				Zhang, Shi-Bao; Chen, Wen-Yun; Huang, Jia-Lin; Bi, Ying-Feng; Yang, Xue-Fei			Orchid Species Richness along Elevational and Environmental Gradients in Yunnan, China	PLOS ONE			English	Article							GEOMETRIC CONSTRAINTS; VASCULAR EPIPHYTES; RAPOPORTS RULE; DIVERSITY PATTERNS; ENDEMIC RICHNESS; PLANT DIVERSITY; AREA; CONSERVATION; CLIMATE; DETERMINANTS	The family Orchidaceae is not only one of the most diverse families of flowering plants, but also one of the most endangered plant taxa. Therefore, understanding how its species richness varies along geographical and environmental gradients is essential for conservation efforts. However, such knowledge is rarely available, especially on a large scale. We used a database extracted from herbarium records to investigate the relationships between orchid species richness and elevation, and to examine how elevational diversity in Yunnan Province, China, might be explained by mid-domain effect (MDE), species-area relationship (SAR), water-energy dynamics (WED), Rapoport's Rule, and climatic variables. This particular location was selected because it is one of the primary centers of distribution for orchids. We recorded 691 species that span 127 genera and account for 88.59% of all confirmed orchid species in Yunnan. Species richness, estimated at 200-m intervals along a slope, was closely correlated with elevation, peaking at 1395 to 1723 m. The elevational pattern of orchid richness was considerably shaped by MDE, SAR, WED, and climate. Among those four predictors, climate was the strongest while MDE was the weakest for predicting the elevational pattern of orchid richness. Species richness showed parabolic responses to mean annual temperature (MAT) and mean annual precipitation (MAP), with maximum richness values recorded at 13.7 to 17.7 degrees C for MAT and 1237 to 1414 mm for MAP. Rapoport's Rule also helped to explain the elevational pattern of species richness in Yunnan, but those influences were not entirely uniform across all methods. These results suggested that the elevational pattern of orchid species richness in Yunnan is collectively shaped by several mechanisms related to geometric constraints, size of the land area, and environments. Because of the dominant role of climate in determining orchid richness, our findings may contribute to a better understanding of the potential effects of climate change on orchid diversity, and the development of conservation strategies for orchids.	[Zhang, Shi-Bao; Huang, Jia-Lin; Bi, Ying-Feng; Yang, Xue-Fei] Chinese Acad Sci, Key Lab Econ Plants & Biotechnol, Kunming Inst Bot, Kunming, Peoples R China; [Zhang, Shi-Bao; Huang, Jia-Lin; Bi, Ying-Feng; Yang, Xue-Fei] Yunnan Key Lab Wild Plant Resources, Kunming, Peoples R China; [Chen, Wen-Yun] Chinese Acad Sci, Key Lab Plant Diversity & Biogeog East Asia, Kunming Inst Bot, Kunming, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS	Zhang, SB (corresponding author), Chinese Acad Sci, Key Lab Econ Plants & Biotechnol, Kunming Inst Bot, Kunming, Peoples R China.	sbzhang@mail.kib.ac.cn	Chen, Wen-yun/AAS-4433-2021; Yang, Xuefei/G-5656-2012; Bi, Yingfeng/AAO-8544-2020	Yang, Xuefei/0000-0002-0986-2745; Chen, Wen-Yun/0000-0001-5560-407X	National Natural Science Foundation of China [31170315, 31370362]; Natural Science Foundation of Yunnan Province [2013FA044]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Yunnan Province(Natural Science Foundation of Yunnan Province)	This work is financially supported by the National Natural Science Foundation of China (31170315, 31370362) and the Natural Science Foundation of Yunnan Province (2013FA044).	Acharya KP, 2011, J BIOGEOGR, V38, P1821, DOI 10.1111/j.1365-2699.2011.02511.x; Allen R. G., 1998, FAO Irrigation and Drainage Paper; Arrhenius O, 1921, J ECOL, V9, P95, DOI 10.2307/2255763; Bachman S, 2004, ECOGRAPHY, V27, P299, DOI 10.1111/j.0906-7590.2004.03759.x; Baldi A, 2008, J BIOGEOGR, V35, P675, DOI 10.1111/j.1365-2699.2007.01825.x; Barthlott W, 2001, PLANT ECOL, V152, P145, DOI 10.1023/A:1011483901452; Benzing D., 1990, J TROP ECOL, V8, P55, DOI [10.1017/S0266467400006088, DOI 10.1017/S0266467400006088]; Bhattarai KR, 2006, DIVERS DISTRIB, V12, P373, DOI 10.1111/j.1366-9516.2006.00244.x; Bhattarai KR, 2004, J BIOGEOGR, V31, P389, DOI 10.1046/j.0305-0270.2003.01013.x; Bhattarai KR, 2003, GLOBAL ECOL BIOGEOGR, V12, P327, DOI 10.1046/j.1466-822X.2003.00044.x; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Bowden JJ, 2010, ECOSCIENCE, V17, P287, DOI 10.2980/17-3-3308; Cardelus CL, 2006, J ECOL, V94, P144, DOI 10.1111/j.1365-2745.2005.01052.x; Carpenter C, 2005, J BIOGEOGR, V32, P999, DOI 10.1111/j.1365-2699.2005.01249.x; Chen SB, 2015, BIODIVERS CONSERV, V24, P593, DOI 10.1007/s10531-014-0838-8; Chi Xiu-Lian, 2011, Chinese Journal of Plant Ecology, V35, P362, DOI 10.3724/SP.J.1258.2011.00362; Colwell RK, 2008, ECOGRAPHY, V31, P4, DOI 10.1111/j.2008.0906-7590.05347.x; Crain BJ, 2014, DIVERS DISTRIB, V20, P652, DOI 10.1111/ddi.12179; Crain BJ., 2012, LANKESTERIANA, V12, P13; Currie DJ, 2008, ECOL MONOGR, V78, P3, DOI 10.1890/06-1302.1; Dorazio RM, 2011, BIODIVERSITY LOSS IN A CHANGING PLANET, P277; Drakare S, 2006, ECOL LETT, V9, P215, DOI 10.1111/j.1461-0248.2005.00848.x; Fan ZX, 2013, CLIMATIC CHANGE, V116, P309, DOI 10.1007/s10584-012-0479-4; Fan ZX, 2011, INT J CLIMATOL, V31, P2078, DOI 10.1002/joc.2214; Fay MF, 2009, ANN BOT-LONDON, V104, P359, DOI [10.1093/aob/mcp190, 10.1093/aob/mcp195]; Moreira ASP, 2008, BRAZ ARCH BIOL TECHN, V51, P83, DOI 10.1590/S1516-89132008000100011; Fu CZ, 2006, ECOGRAPHY, V29, P919, DOI 10.1111/j.2006.0906-7590.04802.x; Gotelli NJ, 2004, ECOSIM NULL MODELS S; Gravendeel B, 2004, PHILOS T ROY SOC B, V359, P1523, DOI 10.1098/rstb.2004.1529; Grytnes JA, 2002, AM NAT, V159, P294, DOI 10.1086/338542; Grytnes JA, 2006, J BIOGEOGR, V33, P1838, DOI 10.1111/j.1365-2699.2006.01554.x; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Jacquemyn H, 2005, J BIOGEOGR, V32, P1751, DOI 10.1111/j.1365-2699.2005.01307.x; Jalal Jeewan Singh, 2012, International Journal of Plant Biology, V3, pe5, DOI 10.4081/pb.2012.e5; Kluge J, 2006, GLOBAL ECOL BIOGEOGR, V15, P358, DOI [10.1111/j.1466-822X.2006.00223.x, 10.1111/j.1466-822x.2006.00223.x]; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Kreft H, 2007, P NATL ACAD SCI USA, V104, P5925, DOI 10.1073/pnas.0608361104; Kromer T, 2005, J BIOGEOGR, V32, P1799, DOI 10.1111/j.1365-2699.2005.01318.x; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; LETCHER AJ, 1994, AM NAT, V144, P30, DOI 10.1086/285659; Li H, 2003, FLORA YUNNANICA, V14; Li Z., 2015, STUDY CLIMATE CHANGE; Liu Q, 2015, CONSERV BIOL, V29, P1563, DOI 10.1111/cobi.12584; [刘仲健 LIU Zhong-Jian], 2009, [生态学报, Acta Ecologica Sinica], V29, P3443; Lobo JM, 2008, BIODIVERS CONSERV, V17, P873, DOI 10.1007/s10531-008-9333-4; Lomolino MV, 2001, GLOBAL ECOL BIOGEOGR, V10, P3, DOI 10.1046/j.1466-822x.2001.00229.x; Luo ZH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027975; McCain CM, 2007, GLOBAL ECOL BIOGEOGR, V16, P1, DOI 10.1111/j.1466-8238.2006.00263.x; Moreno RA, 2008, GLOBAL ECOL BIOGEOGR, V17, P415, DOI 10.1111/j.1466-8238.2007.00372.x; Myers Norman, 2000, Nature (London), V403, P853, DOI 10.1038/35002501; Nogues-Bravo D, 2008, NATURE, V453, P216, DOI 10.1038/nature06812; O'Brien EM, 1998, J BIOGEOGR, V25, P379, DOI 10.1046/j.1365-2699.1998.252166.x; PAGEL MD, 1991, AM NAT, V137, P791, DOI 10.1086/285194; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; R Core Team, 2014, R FDN STAT COMP; RAHBEK C, 1995, ECOGRAPHY, V18, P200, DOI 10.1111/j.1600-0587.1995.tb00341.x; ROHDE K, 1993, AM NAT, V142, P1, DOI 10.1086/285526; ROSENZWEIG ML, 1992, J MAMMAL, V73, P715, DOI 10.2307/1382191; Schickhoff U, 2015, EARTH SYST DYNAM, V6, P245, DOI 10.5194/esd-6-245-2015; Soberon J, 2009, P NATL ACAD SCI USA, V106, P19644, DOI 10.1073/pnas.0901637106; Solow AR, 2006, DIVERS DISTRIB, V12, P423, DOI 10.1111/j.1366-9516.2006.00259.x; STEVENS GC, 1992, AM NAT, V140, P893, DOI 10.1086/285447; Swarts ND, 2009, ANN BOT-LONDON, V104, P543, DOI 10.1093/aob/mcp025; Telwala Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057103; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Tian Huaizhen, 2008, Shengwu Duoyangxing, V16, P75, DOI 10.3724/SP.J.1003.2008.07081; Triantis KA, 2003, J BIOGEOGR, V30, P19, DOI 10.1046/j.1365-2699.2003.00805.x; Trigas P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059425; Vetaas OR, 2002, GLOBAL ECOL BIOGEOGR, V11, P291, DOI 10.1046/j.1466-822X.2002.00297.x; Wang JJ, 2013, NAT HAZARDS, V67, P431, DOI 10.1007/s11069-013-0572-7; Wang ZH, 2007, DIVERS DISTRIB, V13, P845, DOI 10.1111/j.1472-4642.2007.00335.x; Wang ZH, 2011, P ROY SOC B-BIOL SCI, V278, P2122, DOI 10.1098/rspb.2010.1897; Watkins JE, 2006, AM J BOT, V93, P73, DOI 10.3732/ajb.93.1.73; Wolf JHD, 2003, J BIOGEOGR, V30, P1689, DOI 10.1046/j.1365-2699.2003.00902.x; Wu YJ, 2013, J BIOGEOGR, V40, P2310, DOI 10.1111/jbi.12177; Zhang SB, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00260; Zhang SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040080; Zhang ZJ, 2015, BIOL CONSERV, V181, P64, DOI 10.1016/j.biocon.2014.10.026; ZHAO M, 2015, CHINA PLOS ONE, V0010; Zhao SQ, 2006, GLOBAL ECOL BIOGEOGR, V15, P386, DOI 10.1111/j.1466-822x.2006.00236.x	81	59	62	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142621	10.1371/journal.pone.0142621	http://dx.doi.org/10.1371/journal.pone.0142621			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555336	Green Published, Green Submitted, gold			2022-12-27	WOS:000364430700142
J	Hulland, KRS; Chase, RP; Caruso, BA; Swain, R; Biswal, B; Sahoo, KC; Panigrahi, P; Dreibelbis, R				Hulland, Kristyna R. S.; Chase, Rachel P.; Caruso, Bethany A.; Swain, Rojalin; Biswal, Bismita; Sahoo, Krushna Chandra; Panigrahi, Pinaki; Dreibelbis, Robert			Sanitation, Stress, and Life Stage: A Systematic Data Collection Study among Women in Odisha, India	PLoS One			English	Article							LOCAL PERCEPTIONS; WATER INSECURITY; QUALITATIVE DATA; ACCESS; HEALTH; MANAGEMENT; DISTRESS; RANKING; AFRICA; GENDER	Emerging evidence demonstrates how inadequate access to water and sanitation is linked to psychosocial stress, especially among women, forcing them to navigate social and physical barriers during their daily sanitation routines. We examine sanitation-related psychosocial stress (SRPS) across women's reproductive lives in three distinct geographic sites (urban slums, rural villages, and rural tribal villages) in Odisha, India. We explored daily sanitation practices of adolescent, newly married, pregnant, and established adult women (n = 60) and identified stressors encountered during sanitation. Responding to structured data collection methods, women ranked seven sanitation activities (defecation, urination, menstruation, bathing, post-defecation cleaning, carrying water, and changing clothes) based on stress (high to low) and level of freedom (associated with greatest freedom to having the most restrictions). Women then identified common stressors they encountered when practicing sanitation and sorted stressors in constrained piles based on frequency and severity of each issue. The constellation of factors influencing SRPS varies by life stage and location. Overall, sanitation behaviors that were most restricted (i.e., menstruation) were the most stressful. Women in different sites encountered different stressors, and the level of perceived severity varied based on site and life stage. Understanding the influence of place and life stage on SRPS provides a nuanced understanding of sanitation, and may help identify areas for intervention.	[Hulland, Kristyna R. S.] Univ Chicago, Ctr Global Hlth, Chicago, IL 60637 USA; [Chase, Rachel P.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Caruso, Bethany A.] Emory Univ, Rollins Sch Publ Hlth, Ctr Global Safe Water, Dept Behav Sci & Hlth Educ, Atlanta, GA 30322 USA; [Swain, Rojalin; Biswal, Bismita; Sahoo, Krushna Chandra] Asian Inst Publ Hlth, Bhubaneswar, Orissa, India; [Panigrahi, Pinaki] Univ Nebraska Med Ctr, Coll Publ Hlth, Epidemiol & Pediat, Omaha, NE USA; [Panigrahi, Pinaki] Univ Nebraska Med Ctr, Coll Publ Hlth, Ctr Global Hlth & Dev, Omaha, NE USA; [Dreibelbis, Robert] Univ Oklahoma, Ctr Appl Social Res, Norman, OK 73019 USA	University of Chicago; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Emory University; Rollins School Public Health; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Oklahoma System; University of Oklahoma - Norman	Dreibelbis, R (corresponding author), Univ Oklahoma, Ctr Appl Social Res, Norman, OK 73019 USA.	rdreibe@ou.edu	Kuang, Jinyi/L-8488-2017; Sahoo, Krushna Chandra/AAF-2813-2020	Kuang, Jinyi/0000-0003-4173-3246; Dreibelbis, Robert/0000-0002-9716-0419; Chase, Rachel/0000-0002-1503-4954	Department for International Development (DfID) as part of the SHARE research programme; Water Supply and Sanitation Council (WSSCC)	Department for International Development (DfID) as part of the SHARE research programme; Water Supply and Sanitation Council (WSSCC)	Funding: This work was made possible with UK aid from the Department for International Development (DfID), as part of the SHARE research programme, and support from the Water Supply and Sanitation Council (WSSCC). However, the views expressed do not necessarily reflect DfID's official policies or the policies of WSSCC. The funding agencies had no involvement in study design, data collection, data analysis, and data interpretation.	Abrahams N, 2006, TROP MED INT HEALTH, V11, P751, DOI 10.1111/j.1365-3156.2006.01600.x; [Anonymous], RES GUID MAINSTR GEN; Biswas Soutik, BBC NEWS; Bolton P, 2001, J NERV MENT DIS, V189, P243, DOI 10.1097/00005053-200104000-00006; Bourey C, 2012, GLOB PUBLIC HEALTH, V7, P995, DOI 10.1080/17441692.2012.709259; Bradley EH, 2007, HEALTH SERV RES, V42, P1758, DOI 10.1111/j.1475-6773.2006.00684.x; Census Organization of India, 2011, OR POP CENS DAT; Crow B, 2002, SOC NATUR RESOUR, V15, P709, DOI 10.1080/08941920290069308; DeJordy R, 2007, FIELD METHOD, V19, P239, DOI 10.1177/1525822X07302104; Dohn MN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101007; Fisher Julie, 2006, WATER SANITATION HYG; Garg S, 2001, REPROD HEALTH MATTER, V9, P16, DOI 10.1016/S0968-8080(01)90004-7; Gruebner O, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-36; Hamal M, 2014, INT J HLTH SCI RES I, V4, P28; Hargreaves JR, 2007, WORLD DEV, V35, P212, DOI 10.1016/j.worlddev.2005.10.021; Henley P, 2014, CAN J PHYSIOL PHARM, V92, P725, DOI 10.1139/cjpp-2014-0035; Hossain Anushay, 2014, HUFFINGTON POST; Hueso A, 2013, WATER POLICY, V15, P1001, DOI 10.2166/wp.2013.032; KOLENDA PM, 1964, J ASIAN STUD, V23, P71, DOI 10.2307/2050622; Lennon S., 2011, FEAR ANGER PERCEPTIO; Massey K., 2011, INSECURITY SHAME EXP; McMahon SA, 2011, BMC INT HEALTH HUM R, V11, DOI 10.1186/1472-698X-11-7; McPeak JG, 2009, J DEV STUD, V45, P1663, DOI 10.1080/00220380902890219; Nallari A., 2015, ENV URBANIZATION; Nord M., 2014, INTRO ITEM RESPONSE; Nyamongo IK, 1999, TROP MED INT HEALTH, V4, P736, DOI 10.1046/j.1365-3156.1999.00484.x; Panda SM, 2007, GEND TECHNOL DEV, V11, P321, DOI 10.1177/097185240701100302; ROMNEY AK, 1964, AM ANTHROPOL, V66, P146; Sahoo KC, 2015, SOC SCI MED, V139, P80, DOI 10.1016/j.socscimed.2015.06.031; Schmidt M., 2002, EARLY CHILD DEV CARE, V172, P451, DOI [DOI 10.1080/03004430214550, 10.1080/03004430214550]; Singh N, 2006, GEND TECHNOL DEV, V10, P61, DOI 10.1177/097185240501000104; Sommer M, 2013, COMPARE, V43, P323, DOI 10.1080/03057925.2012.693280; Sorenson SB, 2011, SOC SCI MED, V72, P1522, DOI 10.1016/j.socscimed.2011.03.010; Stevenson EGJ, 2012, SOC SCI MED, V75, P392, DOI 10.1016/j.socscimed.2012.03.022; Stopnitzky Y, 2012, SSRN ELECT J, DOI [10.2139/ssrn.2031273, DOI 10.2139/SSRN.2031273]; Sultana F, 2011, GEOFORUM, V42, P163, DOI 10.1016/j.geoforum.2010.12.002; Sumpter C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062004; Tewary A., 2013, BBC NEWS; VANCAMPENHOUT B, 2006, J AFRICAN EC, V16, P406, DOI DOI 10.1093/JAE/EJL041; WELLER SC, 1988, SYSTEMATIC DATA COLL; World Health Organization & UNICEF, 2015, PROGR SAN DRINK WAT; Wutich A, 2008, SOC SCI MED, V67, P2116, DOI 10.1016/j.socscimed.2008.09.042	42	56	56	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2015	10	11							e0141883	10.1371/journal.pone.0141883	http://dx.doi.org/10.1371/journal.pone.0141883			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7AC	26551866	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000364422800010
J	Chen, CH; Liao, WC; Wu, BR; Chen, CY; Chen, WC; Hsia, TC; Cheng, WC; Tu, CY; Hsu, WH				Chen, Chia-Hung; Liao, Wei-Chih; Wu, Biing-Ru; Chen, Chih-Yu; Chen, Wei-Chun; Hsia, Te-Chun; Cheng, Wen-Chien; Tu, Chih-Yen; Hsu, Wu-Huei			Endobronchial Ultrasound Changed the World of Lung Cancer Patients: A 11-Year Institutional Experience	PLOS ONE			English	Article							TRANSBRONCHIAL NEEDLE ASPIRATION; PERIPHERAL PULMONARY-LESIONS; GUIDE-SHEATH; DIAGNOSIS; CT; BRONCHOSCOPY; BIOPSY; ULTRASONOGRAPHY; PNEUMOTHORAX; METAANALYSIS	Objectives The role of advanced bronchoscopic diagnostic techniques in the detection and staging of lung cancer has increased sharply in recent years. The development of endobronchial ultrasound (EBUS) improved minimally invasive mediastinal staging and diagnosis of peripheral lung lesions (PLLs). We investigated the impact of using EBUS as a diagnostic method for tissue acquisition in lung cancer patients. Methods In a single center observational retrospective study, 3712 subjects were diagnosed with lung cancer from 2003 to 2013 (EBUS was introduced in 2008). Thus, we divided the data into two periods: the conventional bronchoscopy period (2003 to 2007) and the EBUS period (2008 to 2013). Results A total of 3712 patients were included in the analysis. Comparing the conventional bronchoscopy period with the EBUS period data, there has been a significant reduction in the use of diagnostic modalities: CT-guided biopsy (P < 0.0001) and pleural effusion cytology (P < 0.0001). The proportion of subjects diagnosed using bronchoscopy significantly increased from 39.4% in the conventional period to 47.4% in the EBUS period (P < 0.0001). In the EBUS period, there has also been a significant increase in the proportion of patients proceeding directly to diagnostic surgery (P < 0.0001). Compared to bronchoscopy, the incidence of complications was higher in those who underwent CT guide biopsy. The incidence of iatrogenic pneumothorax significantly decreased in the EBUS period. Conclusions Advanced bronchoscopic techniques are widely used in the diagnosis of lung cancer. At our institution, the increasing use of EBUS for providing lung cancer diagnosis has led to a significant reduction in other diagnostic modalities, namely CT-guided biopsy and pleural effusion cytology. These changes in practice also led to a reduction in the incidence of complications.	[Chen, Chia-Hung; Liao, Wei-Chih; Wu, Biing-Ru; Chen, Chih-Yu; Chen, Wei-Chun; Hsia, Te-Chun; Cheng, Wen-Chien; Tu, Chih-Yen; Hsu, Wu-Huei] China Med Univ Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Taichung, Taiwan; [Wu, Biing-Ru; Chen, Chih-Yu; Chen, Wei-Chun; Cheng, Wen-Chien; Tu, Chih-Yen; Hsu, Wu-Huei] China Med Univ, Sch Med, Taichung, Taiwan; [Tu, Chih-Yen] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Chen, Chia-Hung; Hsia, Te-Chun] China Med Univ, Dept Resp Therapy, Taichung, Taiwan; [Chen, Chia-Hung; Liao, Wei-Chih] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Liao, Wei-Chih; Chen, Wei-Chun; Hsia, Te-Chun; Cheng, Wen-Chien] China Med Univ, Hyperbar Oxygen Therapy Ctr, Dept Internal Med, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; National Chung Hsing University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan	Cheng, WC (corresponding author), China Med Univ Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Taichung, Taiwan.	chesttu@gmail.com; wcchengdr@gmail.com						Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Alberts WM, 2013, CHEST, V143, p38S, DOI 10.1378/chest.12-2342; Asano F, 2012, RESPIROLOGY, V17, P478, DOI 10.1111/j.1440-1843.2011.02123.x; Baaklini WA, 2000, CHEST, V117, P1049, DOI 10.1378/chest.117.4.1049; Cancer Care Ontario, 2013, CANCER FACT LUNG CAN; Chen Alexander, 2014, Ann Am Thorac Soc, V11, P578, DOI 10.1513/AnnalsATS.201311-384OC; Figueiredo VR, 2013, J BRAS PNEUMOL, V39, P226, DOI 10.1590/S1806-37132013000200015; Gu P, 2009, EUR J CANCER, V45, P1389, DOI 10.1016/j.ejca.2008.11.043; Herth FJF, 2009, J THORAC ONCOL, V4, P1060, DOI 10.1097/JTO.0b013e3181b24100; Holty JEC, 2005, THORAX, V60, P949, DOI 10.1136/thx.2005.041525; Izumo T, 2013, J THORAC DIS, V5, P745, DOI 10.3978/j.issn.2072-1439.2013.11.30; Kikuchi E, 2004, EUR RESPIR J, V24, P533, DOI 10.1183/09031936.04.00138603; Lam B, 2006, EUR RESPIR J, V28, P915, DOI 10.1183/09031936.06.00131405; Navani N, 2012, AM J RESP CRIT CARE, V185, P1316, DOI 10.1164/rccm.201202-0294OC; Navani N, 2011, THORAX, V66, P352, DOI 10.1136/thx.2010.146407; NICE (National Institute for Health and Care Excellence), 2011, LUNG CANC DIAGN MAN; Rivera MP, 2007, CHEST, V132, p131S, DOI 10.1378/chest.07-1357; Roth Kjetil, 2008, BMC Pulm Med, V8, P2, DOI 10.1186/1471-2466-8-2; Saji H, 2002, CHEST, V121, P1521, DOI 10.1378/chest.121.5.1521; Sakairi Y, 2013, GEN THORAC CARDIOVAS, V61, P522, DOI 10.1007/s11748-013-0263-z; Seidelman JL, 2013, CANCER IMAGING, V13, P365, DOI 10.1102/1470-7330.2013.9025; Sharma C P, 2002, Indian J Chest Dis Allied Sci, V44, P25; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Steinfort DP, 2011, EUR RESPIR J, V37, P902, DOI 10.1183/09031936.00075310; Steinfort DP, 2013, EUR RESPIR J, V41, P539, DOI 10.1183/09031936.00044612; Steinfort DP, 2011, RESP MED, V105, P1704, DOI 10.1016/j.rmed.2011.08.008; Steinfort DP, 2010, RESP CARE, V55, P702; Tournoy KG, 2009, LUNG CANCER, V63, P45, DOI 10.1016/j.lungcan.2008.04.004; Varela-Lema L, 2009, EUR RESPIR J, V33, P1156, DOI 10.1183/09031936.00097908; Verma A, 2013, YONSEI MED J, V54, P672, DOI 10.3349/ymj.2013.54.3.672; Yasufuku K, 2006, CHEST, V130, P710, DOI 10.1378/chest.130.3.710; Yasufuku K, 2011, J THORAC CARDIOV SUR, V142, P1393, DOI 10.1016/j.jtcvs.2011.08.037; Yeow KM, 2004, CHEST, V126, P748, DOI 10.1378/chest.126.3.748; Zaric B, 2013, J THORAC DIS, V5, pS359, DOI 10.3978/j.issn.2072-1439.2013.05.15	34	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142336	10.1371/journal.pone.0142336	http://dx.doi.org/10.1371/journal.pone.0142336			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26545094	gold, Green Published, Green Submitted			2022-12-27	WOS:000364398700115
J	Gobl, CS; Bozkurt, L; Tura, A; Pacini, G; Kautzky-Willer, A; Mittlbock, M				Goebl, Christian S.; Bozkurt, Latife; Tura, Andrea; Pacini, Giovanni; Kautzky-Willer, Alexandra; Mittlboeck, Martina			Application of Penalized Regression Techniques in Modelling Insulin Sensitivity by Correlated Metabolic Parameters	PLOS ONE			English	Article							VARIABLE SELECTION; PROGNOSTIC MODELS; IDENTIFICATION; PREDICTORS; SHRINKAGE; LASSO	This paper aims to introduce penalized estimation techniques in clinical investigations of diabetes, as well as to assess their possible advantages and limitations. Data from a previous study was used to carry out the simulations to assess: a) which procedure results in the lowest prediction error of the final model in the setting of a large number of predictor variables with high multicollinearity (of importance if insulin sensitivity should be predicted) and b) which procedure achieves the most accurate estimate of regression coefficients in the setting of fewer predictors with small unidirectional effects and moderate correlation between explanatory variables (of importance if the specific relation between an independent variable and insulin sensitivity should be examined). Moreover a special focus is on the correct direction of estimated parameter effects, a non-negligible source of error and misinterpretation of study results. The simulations were performed for varying sample size to evaluate the performance of LASSO, Ridge as well as different algorithms for Elastic Net. These methods were also compared with automatic variable selection procedures (i. e. optimizing AIC or BIC). We were not able to identify one method achieving superior performance in all situations. However, the improved accuracy of estimated effects underlines the importance of using penalized regression techniques in our example (e.g. if a researcher aims to compare relations of several correlated parameters with insulin sensitivity). However, the decision which procedure should be used depends on the specific context of a study (accuracy versus complexity) and moreover should involve clinical prior knowledge.	[Goebl, Christian S.] Med Univ Vienna, Div Feto Maternal Med, Dept Gynecol & Obstet, Vienna, Austria; [Bozkurt, Latife; Kautzky-Willer, Alexandra] Med Univ Vienna, Div Endocrinol & Metab, Dept Internal Med 3, Unit Gender Med, Vienna, Austria; [Tura, Andrea; Pacini, Giovanni] CNR, Inst Neurosci, Metab Unit, Padua, Italy; [Mittlboeck, Martina] Med Univ Vienna, Sect Clin Biometr, Ctr Med Stat Informat & Intelligent Syst, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Consiglio Nazionale delle Ricerche (CNR); Medical University of Vienna	Mittlbock, M (corresponding author), Med Univ Vienna, Sect Clin Biometr, Ctr Med Stat Informat & Intelligent Syst, Vienna, Austria.	martina.mittlboeck@meduniwien.ac.at		Kautzky-Willer, Alexandra/0000-0002-3520-4105; Mittlboeck, Martina/0000-0003-1097-4047	Austrian Science Fund [P14515 MED]	Austrian Science Fund(Austrian Science Fund (FWF))	The study was supported by the Austrian Science Fund (P14515 MED) to AKW.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Ambler G, 2012, STAT MED, V31, P1150, DOI 10.1002/sim.4371; Bi J, 2012, J SENS STUD, V27, P87, DOI 10.1111/j.1745-459X.2012.00370.x; Borai A, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-158; Efron B, 2004, J AM STAT ASSOC, V99, P619, DOI 10.1198/016214504000000692; Gobi CS, 2013, AM J PHYSIOL-ENDOC M, V304, pE524, DOI [10.1152/ajpendo.00461.2012, DOI 10.1152/AJPEND0.00461.2012]; Gobl CS, 2015, AM J PHYSIOL-REG I, V309, pR13, DOI 10.1152/ajpregu.00059.2015; Goeman J., 2018, PENALIZED L1 LASO FU; Goeman JJ, 2010, BIOMETRICAL J, V52, P70, DOI 10.1002/bimj.200900028; Hammami D, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD017864; Hastie T., 2009, UNSUPERVISED LEARNIN; Hocking RR., 2003, METHODS APPL LINEAR, DOI 10.1002/0471434159; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; LECESSIE S, 1992, J R STAT SOC C-APPL, V41, P191, DOI DOI 10.2307/2347628; LILLIOJA S, 1993, NEW ENGL J MED, V329, P1988, DOI 10.1056/NEJM199312303292703; Pacini G, 1998, AM J PHYSIOL-ENDOC M, V274, pE592, DOI 10.1152/ajpendo.1998.274.4.E592; Porzelius C, 2010, STAT COMPUT, V20, P151, DOI 10.1007/s11222-009-9155-6; Sauerbrei W, 1999, J ROY STAT SOC C-APP, V48, P313, DOI 10.1111/1467-9876.00155; Sauerbrei W, 2007, STAT MED, V26, P5512, DOI 10.1002/sim.3148; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Steyerberg E., 2009, CLIN PREDICTION MODE; Steyerberg EW, 2000, STAT MED, V19, P1059, DOI 10.1002/(SICI)1097-0258(20000430)19:8<1059::AID-SIM412>3.0.CO;2-0; Tibshirani R, 1997, STAT MED, V16, P385, DOI 10.1002/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tura A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050419; Vach K, 2001, STAT NEERL, V55, P53, DOI 10.1111/1467-9574.00156; Van Houwelingen H. C., 2013, OPEN J STAT, V3, P79, DOI DOI 10.4236/OJS.2013.32011; Venables WN., 2002, MODERN APPL STAT S 4; Vidaurre D, 2013, INT STAT REV, V81, P361, DOI 10.1111/insr.12023; Waldron L, 2011, BIOINFORMATICS, V27, P3399, DOI 10.1093/bioinformatics/btr591; WYATT JC, 1995, BMJ-BRIT MED J, V311, P1539, DOI 10.1136/bmj.311.7019.1539; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	32	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141524	10.1371/journal.pone.0141524	http://dx.doi.org/10.1371/journal.pone.0141524			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544569	Green Published, Green Submitted, gold			2022-12-27	WOS:000364398700031
J	Gonzalez-Bulnes, A; Torres-Rovira, L; Astiz, S; Ovilo, C; Sanchez-Sanchez, R; Gomez-Fidalgo, E; Perez-Solana, M; Martin-Lluch, M; Garcia-Contreras, C; Vazquez-Gomez, M				Gonzalez-Bulnes, Antonio; Torres-Rovira, Laura; Astiz, Susana; Ovilo, Cristina; Sanchez-Sanchez, Raul; Gomez-Fidalgo, Ernesto; Perez-Solana, Mariluz; Martin-Lluch, Mercedes; Garcia-Contreras, Consuelo; Vazquez-Gomez, Marta			Fetal Sex Modulates Developmental Response to Maternal Malnutrition	PLOS ONE			English	Article							INTRAUTERINE GROWTH-RETARDATION; ANIMAL-MODELS; GESTATIONAL-AGE; BLOOD-PRESSURE; BIRTH-WEIGHT; SWINE; RESTRICTION; PIG; CHOLESTEROL; OBESITY	The incidence of obesity and metabolic diseases is dramatically high in rapidly developing countries. Causes have been related to intrinsic ethnic features with development of a thrifty genotype for adapting to food scarcity, prenatal programming by undernutrition, and postnatal exposure to obesogenic lifestyle. Observational studies in humans and experimental studies in animal models evidence that the adaptive responses of the offspring may be modulated by their sex. In the contemporary context of world globalization, the new question arising is the existence and extent of sex-related differences in developmental and metabolic traits in case of mixed-race. Hence, in the current study, using a swine model, we compared male and female fetuses that were crossbred from mothers with thrifty genotype and fathers without thrifty genotype. Female conceptuses evidence stronger protective strategies for their adequate growth and postnatal survival. In brief, both male and female fetuses developed a brain-sparing effect but female fetuses were still able to maintain the development of other viscerae than the brain (mainly liver, intestine and kidneys) at the expense of carcass development. Furthermore, these morphometric differences were reinforced by differences in nutrient availability (glucose and cholesterol) favoring female fetuses with severe developmental predicament. These findings set the basis for further studies aiming to increase the knowledge on the interaction between genetic and environmental factors in the determination of adult phenotype	[Gonzalez-Bulnes, Antonio; Astiz, Susana; Ovilo, Cristina; Sanchez-Sanchez, Raul; Gomez-Fidalgo, Ernesto; Perez-Solana, Mariluz; Martin-Lluch, Mercedes; Garcia-Contreras, Consuelo] INIA, Madrid, Spain; [Gonzalez-Bulnes, Antonio; Torres-Rovira, Laura] Univ Sassari, I-07100 Sassari, Italy; [Vazquez-Gomez, Marta] UCM, Fac Vet, Madrid, Spain	University of Sassari; Complutense University of Madrid	Gonzalez-Bulnes, A (corresponding author), INIA, Madrid, Spain.	bulnes@inia.es	Garcia Contreras, Consolacion/AAX-2057-2021; Astiz, Susana/AAN-8769-2021; Garcia-Contreras, Consolacion/GSE-0766-2022; Ovilo, Cristina/N-9931-2014; Vázquez-Gómez, Marta/L-7054-2014; Gonzalez-Bulnes, Antonio/K-7691-2015; Sánchez, Raúl Sánchez/M-8694-2019	Garcia-Contreras, Consolacion/0000-0003-4624-2585; Ovilo, Cristina/0000-0002-5738-8435; Vázquez-Gómez, Marta/0000-0002-8916-2086; Gonzalez-Bulnes, Antonio/0000-0002-0917-4475; Sánchez, Raúl Sánchez/0000-0002-2987-5906; Torres-Rovira, Laura/0000-0003-1467-7533; Martin, Mercedes/0000-0003-4734-4196	Ministry of Science and Innovation [AGL2010-21991-C03-03]; Ministry of Economy and Competitiveness [AGL2013-48121-C3-2-R]; FEDER	Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministry of Economy and Competitiveness; FEDER(European Commission)	The experimental work was supported by funds from the Ministry of Science and Innovation (project AGL2010-21991-C03-03) and the Ministry of Economy and Competitiveness (project AGL2013-48121-C3-2-R to AGB), co-funded by FEDER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken CE, 2013, REPRODUCTION, V145, pR1, DOI 10.1530/REP-11-0489; Antipatis C, 2000, BRIT J NUTR, V84, P125; Bahr A, 2012, REPROD DOMEST ANIM, V47, P59, DOI 10.1111/j.1439-0531.2012.02056.x; Barbaux S, 2015, PLACENTA, V36, pS5, DOI 10.1016/j.placenta.2015.01.196; Barbero A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078424; Bauer R, 2000, AM J PHYSIOL-REG I, V279, pR1010, DOI 10.1152/ajpregu.2000.279.3.R1010; Bavdekar A, 1999, DIABETES, V48, P2422, DOI 10.2337/diabetes.48.12.2422; Bee G, 2004, J ANIM SCI, V82, P826; British Society of Animal Science, 2003, NUTR REQ STAND PIGS; D'Inca R, 2010, J NUTR, V140, P925, DOI 10.3945/jn.109.116822; DAWKINS MJR, 1966, BRIT MED BULL, V22, P27, DOI 10.1093/oxfordjournals.bmb.a070432; DOUGLAS WR, 1972, SPACE LIFE SCI, V3, P226, DOI 10.1007/BF00928167; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Gonzalez-Bulnes A, 2012, REPRODUCTION, V144, P269, DOI 10.1530/REP-12-0105; Gonzalez-Bulnes A, 2012, GEN COMP ENDOCR, V176, P94, DOI 10.1016/j.ygcen.2011.12.038; Guilloteau P, 2010, NUTR RES REV, V23, P4, DOI 10.1017/S0954422410000077; Haugen G, 2005, CIRC RES, V96, P12, DOI 10.1161/01.RES.0000152391.45273.A2; HOUPT KA, 1979, YALE J BIOL MED, V52, P307; HUHN RG, 1969, LAB ANIM CARE, V19, P403; Kong APS, 2013, NAT REV ENDOCRINOL, V9, P537, DOI 10.1038/nrendo.2013.102; Krishnaveni GV, 2014, CLIN ENDOCRINOL, V80, P73, DOI 10.1111/cen.12143; Kuhn G, 2002, FLEISCHWIRTSCHAFT, V82, P128; Kurome M, 2015, METHODS MOL BIOL, V1222, P37, DOI 10.1007/978-1-4939-1594-1_4; Latini G, 2004, ACTA PAEDIATR, V93, P1635, DOI 10.1080/08035250410023106; Lesage J, 2001, ENDOCRINOLOGY, V142, P1692, DOI 10.1210/en.142.5.1692; Lunney JK, 2007, INT J BIOL SCI, V3, P179, DOI 10.7150/ijbs.3.179; Metges CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031390; MOHAN M, 1990, Indian Pediatrics, V27, P43; Myatt L, 2006, J PHYSIOL-LONDON, V572, P25, DOI 10.1113/jphysiol.2006.104968; Nijland MJ, 2010, J PHYSIOL-LONDON, V588, P1349, DOI 10.1113/jphysiol.2009.184168; Ovilo C, 2005, GENET RES, V85, P57, DOI 10.1017/S0016672305007330; Ovilo C, 2014, BRIT J NUTR, V111, P735, DOI 10.1017/S0007114513002948; Paixao AD, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.111823; Palinski W, 2009, CIRC RES, V104, P569, DOI 10.1161/CIRCRESAHA.109.194191; Pandey A, 2015, IUBMB LIFE, V67, P506, DOI 10.1002/iub.1396; Perry B, 2002, BRAIN MIND, V3, P79, DOI DOI 10.1023/A:1016557824657; Prentice Andrew M, 2014, Nestle Nutr Inst Workshop Ser, V78, P155, DOI 10.1159/000354957; Prentice AM, 2009, NESTLE NUTR WORKS SE, V63, P47, DOI 10.1159/000209972; Quiniou N, 2002, LIVEST PROD SCI, V78, P63, DOI 10.1016/S0301-6226(02)00181-1; RANDALL GCB, 1983, BIOL REPROD, V29, P1077, DOI 10.1095/biolreprod29.5.1077; Rehfeldt C, 2006, J Anim Sci, V84 Suppl, pE113; Rexhepaj R, 2008, AM J PHYSIOL-REG I, V294, pR2008, DOI 10.1152/ajpregu.00737.2007; Ritz E, 2011, NAT REV NEPHROL, V7, P137, DOI 10.1038/nrneph.2011.1; RUDOLPH AM, 1984, J DEV PHYSIOL, V6, P11; Schmidt W, 1992, Adv Anat Embryol Cell Biol, V127, P1; Scully Tony, 2012, Nature, V485, pS2; SHELLEY HJ, 1975, BRIT MED BULL, V31, P37, DOI 10.1093/oxfordjournals.bmb.a071239; SHELLEY HJ, 1961, BRIT MED BULL, V17, P137, DOI 10.1093/oxfordjournals.bmb.a069888; Shetty P, 2012, NATURE, V485, pS14, DOI 10.1038/485S14a; Spurlock ME, 2008, J NUTR, V138, P397, DOI 10.1093/jn/138.2.397; Thomas Nihal, 2012, Indian J Endocrinol Metab, V16, pS142, DOI 10.4103/2230-8210.104024; Torres-Rovira L, 2012, SCI WORLD J, DOI 10.1100/2012/510149; Torres-Rovira L, 2013, ENDOCR METAB IMMUNE, V13, P143, DOI 10.2174/1871530311313020002; Torres-Rovira L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066728; Trahair J F, 1997, Equine Vet J Suppl, P40; Vuguin PM, 2007, HORM RES, V68, P113, DOI 10.1159/000100545; Wells JCK, 2009, INT J EPIDEMIOL, V38, P63, DOI 10.1093/ije/dyn183; Wise T, 1997, J ANIM SCI, V75, P2197; WISE T, 1993, J ANIM SCI, V71, P2732, DOI 10.2527/1993.71102732x; Wolf E, 2014, TRANSGENIC RES, V23, P27, DOI 10.1007/s11248-013-9755-y; Woollett LA, 2001, CURR OPIN LIPIDOL, V12, P305, DOI 10.1097/00041433-200106000-00010; Wu G, 2006, J ANIM SCI, V84, P2316, DOI 10.2527/jas.2006-156	62	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142158	10.1371/journal.pone.0142158	http://dx.doi.org/10.1371/journal.pone.0142158			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544862	Green Published, gold, Green Submitted			2022-12-27	WOS:000364398700089
J	Hudson, BD; Hum, NR; Thomas, CB; Kohlgruber, A; Sebastian, A; Collette, NM; Coleman, MA; Christiansen, BA; Loots, GG				Hudson, Bryan D.; Hum, Nicholas R.; Thomas, Cynthia B.; Kohlgruber, Ayano; Sebastian, Aimy; Collette, Nicole M.; Coleman, Matthew A.; Christiansen, Blaine A.; Loots, Gabriela G.			SOST Inhibits Prostate Cancer Invasion	PLOS ONE			English	Article							RECEPTOR-RELATED PROTEIN-5; SECRETED WNT ANTAGONIST; VAN-BUCHEM-DISEASE; IN-VITRO; BETA-CATENIN; SIGNALING PATHWAY; BONE METASTASIS; COLON-CANCER; CELL-GROWTH; GENE	Inhibitors of Wnt signaling have been shown to be involved in prostate cancer (PC) metastasis; however the role of Sclerostin (Sost) has not yet been explored. Here we show that elevated Wnt signaling derived from Sost deficient osteoblasts promotes PC invasion, while rhSOST has an inhibitory effect. In contrast, rhDKK1 promotes PC elongation and filopodia formation, morphological changes characteristic of an invasive phenotype. Furthermore, rhDKK1 was found to activate canonical Wnt signaling in PC3 cells, suggesting that SOST and DKK1 have opposing roles on Wnt signaling in this context. Gene expression analysis of PC3 cells co-cultured with OBs exhibiting varying amounts of Wnt signaling identified CRIM1 as one of the transcripts upregulated under highly invasive conditions. We found CRIM1 overexpression to also promote cell-invasion. These findings suggest that bonederived Wnt signaling may enhance PC tropism by promoting CRIM1 expression and facilitating cancer cell invasion and adhesion to bone. We concluded that SOST and DKK1 have opposing effects on PC3 cell invasion and that bone-derived Wnt signaling positively contributes to the invasive phenotypes of PC3 cells by activating CRIM1 expression and facilitating PC-OB physical interaction. As such, we investigated the effects of high concentrations of SOST in vivo. We found that PC3-cells overexpressing SOST injected via the tail vein in NSG mice did not readily metastasize, and those injected intrafemorally had significantly reduced osteolysis, suggesting that targeting the molecular bone environment may influence bone metastatic prognosis in clinical settings.	[Hudson, Bryan D.; Hum, Nicholas R.; Thomas, Cynthia B.; Kohlgruber, Ayano; Sebastian, Aimy; Collette, Nicole M.; Coleman, Matthew A.; Loots, Gabriela G.] Lawrence Livermore Natl Lab, Phys & Life Sci Directorate, Biol & Biotechnol Div, Livermore, CA 94550 USA; [Sebastian, Aimy; Loots, Gabriela G.] Univ Calif Merced, Sch Nat Sci, Merced, CA USA; [Coleman, Matthew A.] Univ Calif Davis, Med Ctr, Dept Radiat Oncol, Sacramento, CA 95817 USA; [Christiansen, Blaine A.] Univ Calif Davis, Med Ctr, Dept Orthopaed Surg, Sacramento, CA 95817 USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; University of California Merced; University of California System; University of California Davis; University of California System; University of California Davis	Loots, GG (corresponding author), Lawrence Livermore Natl Lab, Phys & Life Sci Directorate, Biol & Biotechnol Div, Livermore, CA 94550 USA.	loots1@llnl.gov	Sebastian, Aimy/S-5230-2017; Loots, Gabriela G/AGA-4868-2022	Sebastian, Aimy/0000-0002-7822-7040; Loots, Gabriela G/0000-0001-9546-5561; Coleman, Matthew/0000-0003-1389-4018; Christiansen, Blaine/0000-0002-0105-6458; Hum, Nicholas/0000-0003-1605-3193; Collette, Nicole/0000-0002-9068-8712	National Institute of Health [DK075730, P41MI03483]; Lawrence Livermore National Laboratory [LDRD-10-ERD-020]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103483] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of Health Grant No. DK075730 and P41MI03483 Lawrence Livermore National Laboratory Grant No. LDRD-10-ERD-020. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arjonen A, 2014, J CLIN INVEST, V124, P1069, DOI 10.1172/JCI67280; Balemans W, 2002, J MED GENET, V39, P91, DOI 10.1136/jmg.39.2.91; Balemans W, 2001, HUM MOL GENET, V10, P537, DOI 10.1093/hmg/10.5.537; BELLOWS CG, 1986, J CELL BIOCHEM, V31, P153, DOI 10.1002/jcb.240310207; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Brunkow ME, 2001, AM J HUM GENET, V68, P577, DOI 10.1086/318811; Chesire DR, 2002, ONCOGENE, V21, P2679, DOI 10.1038/sj.onc.1205352; Chung LWK, 2005, J UROLOGY, V173, P10, DOI 10.1097/01.ju.0000141582.15218.10; Collette NM, 2012, P NATL ACAD SCI USA, V109, P14092, DOI 10.1073/pnas.1207188109; Collette NM, 2013, DEV BIOL, DOI [10.1016/j.ydbio.2013.08.015, DOI 10.1016/J.YDBI0.2013.08.015]; Cruciat CM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a015081; Daimon E, 2013, ARCH DERMATOL RES, V305, P571, DOI 10.1007/s00403-013-1343-8; Dhar S, 2011, P NATL ACAD SCI USA, V108, P1850, DOI 10.1073/pnas.1011379108; Festuccia C, 2000, INT J CANCER, V85, P407, DOI 10.1002/(SICI)1097-0215(20000201)85:3<407::AID-IJC18>3.0.CO;2-8; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Gonzalex-Sancho JM, 2005, ONCOGENE, V24, P1098, DOI 10.1038/sj.onc.1208303; Guo Y, 2008, CANCER RES, V68, P3350, DOI 10.1158/0008-5472.CAN-07-3220; HODGES GM, 1970, EUR J CANCER, V6, P235, DOI 10.1016/0014-2964(70)90026-5; Holmen SL, 2004, J BONE MINER RES, V19, P2033, DOI 10.1359/JBMR.040907; Jenkins ZA, 2009, NAT GENET, V41, P95, DOI 10.1038/ng.270; Jung K, 2014, BBA-REV CANCER, V1846, P425, DOI 10.1016/j.bbcan.2014.09.001; Kapinas K, 2012, MATRIX BIOL, V31, P299, DOI 10.1016/j.matbio.2012.03.002; Keil R, 2013, BIOL CHEM, V394, P1005, DOI 10.1515/hsz-2013-0114; Khaja ASS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026539; Kim H, 2013, INT J ONCOL, V43, P1319, DOI 10.3892/ijo.2013.2036; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Li SJ, 2011, J MOL HISTOL, V42, P491, DOI 10.1007/s10735-011-9347-1; Li XQ, 2015, CANCER RES, V75, P3302, DOI 10.1158/0008-5472.CAN-15-0240; Lu Y, 2007, INT J CANCER, V121, P724, DOI 10.1002/ijc.22704; Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370; Matsuura I, 2010, BIOCHEM J, V426, P327, DOI 10.1042/BJ20090990; Mencej-Bedrac S, 2009, CALCIFIED TISSUE INT, V85, P501, DOI 10.1007/s00223-009-9306-y; Meyer M, 2012, J CELL SCI, V125, P5690, DOI 10.1242/jcs.108167; Nagaoka T, 2013, CELL SIGNAL, V25, P178, DOI 10.1016/j.cellsig.2012.09.024; Ongkeko WM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085803; Perdu B, 2010, J BONE MINER RES, V25, P82, DOI 10.1359/jbmr.090707; Polakis P, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008052; Ponferrada VG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032635; Qi LS, 2012, CANCER SCI, V103, P828, DOI 10.1111/j.1349-7006.2012.02222.x; Rivadeneira F, 2009, NAT GENET, V41, P1199, DOI 10.1038/ng.446; Sarahrudi K, 2012, J ORTHOP RES, V30, P1549, DOI 10.1002/jor.22129; Sato N, 2010, CANCER RES, V70, P5326, DOI 10.1158/0008-5472.CAN-09-3879; Scatton O, 2006, ONCOGENE, V25, P4067, DOI 10.1038/sj.onc.1209430; Shindo A, 2014, SCIENCE, V343, P649, DOI 10.1126/science.1243126; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sims AM, 2008, J BONE MINER RES, V23, P499, DOI 10.1359/JBMR.071113; Staehling-Hampton K, 2002, AM J MED GENET, V110, P144, DOI 10.1002/ajmg.10401; Tang YX, 2009, MOL CANCER THER, V8, P458, DOI 10.1158/1535-7163.MCT-08-0885; Tao YM, 2013, DIGEST LIVER DIS, V45, P251, DOI 10.1016/j.dld.2012.10.020; Uysal-Onganer P, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-55; Verras M, 2006, CANCER LETT, V237, P22, DOI 10.1016/j.canlet.2005.06.004; Wang BE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002186; Wang YK, 1999, GENOMICS, V57, P235, DOI 10.1006/geno.1999.5773; Yee DS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-162; Yu B, 2009, J HEPATOL, V50, P948, DOI 10.1016/j.jhep.2008.11.020; Zi XL, 2005, CANCER RES, V65, P9762, DOI 10.1158/0008-5472.CAN-05-0103	56	21	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142058	10.1371/journal.pone.0142058	http://dx.doi.org/10.1371/journal.pone.0142058			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26545120	Green Published, Green Submitted, gold			2022-12-27	WOS:000364398700075
J	Liu, B; Taioli, E				Liu, Bian; Taioli, Emanuela			Seasonal Variations of Complete Blood Count and Inflammatory Biomarkers in the US Population - Analysis of NHANES Data	PLOS ONE			English	Article							C-REACTIVE PROTEIN; MYOCARDIAL-INFARCTION; PHYSICAL-ACTIVITY; RISK-FACTORS; AIR-TEMPERATURE; HEART-FAILURE; PLATELET; DISEASE; MECHANISMS; FIBRINOGEN	Background Recent studies reported seasonal differences in gene expression in white blood cells, adipose tissue, and inflammatory biomarkers of the immune system. There is no data on the seasonal variations of these biomarkers in the US general population of both children and adults. Then aim of this study is to explore the seasonal trends in complete blood count (CBC), and C-reactive protein (CRP) in a large non- institutionalized US population. Methods Seven cross-sectional data collected in the National Health and Nutrition Examination Survey (NHANES) during 1999-2012 were aggregated; participants reporting recent use of prescribed steroids, chemotherapy, immunomodulators and antibiotics were excluded. Linear regression models were used to compare levels of CBC and CRP between winter-spring (November-April) and summer-fall (May-October), adjusting for demographics, personal behavioral factors, and chronic disease conditions. Results A total of 27,478 children and 36,644 adults (>= 18 years) were included in the study. Levels of neutrophils, white blood cell count (WBC), and CRP were higher in winter-spring than summer-fall (p <= 0.05). Red blood cell components were lower in winter-spring than in summer-fall, while the opposite was seen for platelets. Conclusions This large population-based study found notable seasonal variations in blood cell composition and inflammatory biomarkers, with a more pro-inflammatory immune system seen in winter-spring than summer-fall. The red blood cell patterns could have implications for the observed cardio-vascular seasonality.	[Taioli, Emanuela] Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, New York, NY 10029 USA; Inst Translat Epidemiol, New York, NY USA	Icahn School of Medicine at Mount Sinai	Taioli, E (corresponding author), Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, New York, NY 10029 USA.	emanuela.taioli@mountsinai.org		Liu, Bian/0000-0001-9166-693X				Abramson JL, 2002, ARCH INTERN MED, V162, P1286, DOI 10.1001/archinte.162.11.1286; Anand IS, 2006, EUR HEART J, V27, P485; Anand IS, 2008, HEART FAIL REV, V13, P379, DOI 10.1007/s10741-008-9088-8; Azab B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112361; Braga ALF, 2002, ENVIRON HEALTH PERSP, V110, P859, DOI 10.1289/ehp.02110859; Crawford VLS, 2000, QJM-MON J ASSOC PHYS, V93, P745, DOI 10.1093/qjmed/93.11.745; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; De Jong S, 2014, HUM MOL GENET, V23, P2721, DOI 10.1093/hmg/ddt665; Dopico XC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8000; ELWOOD PC, 1993, BRIT HEART J, V70, P520; Fares Auda, 2013, N Am J Med Sci, V5, P266, DOI 10.4103/1947-2714.110430; Ferreira RC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003444; Gallerani M, 1999, RHEUMATOLOGY, V38, P1003, DOI 10.1093/rheumatology/38.10.1003; Gallerani M, 2013, EUR J MED RES, V18, DOI 10.1186/2047-783X-18-31; Gasparyan AY, 2011, RHEUMATOL INT, V31, P153, DOI 10.1007/s00296-010-1446-x; Goldinger A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126995; KEATINGE WR, 1984, BMJ-BRIT MED J, V289, P1405, DOI 10.1136/bmj.289.6456.1405; Khera A, 2009, J CLIN ENDOCR METAB, V94, P3251, DOI 10.1210/jc.2008-2406; KRISTALBONEH E, 1993, BRIT J HAEMATOL, V85, P603; Lewington S, 2012, J HYPERTENS, V30, P1383, DOI 10.1097/HJH.0b013e32835465b5; Marti-Soler H, 2014, HEART, V100, P1517, DOI 10.1136/heartjnl-2014-305623; Matthews CE, 2001, AM J EPIDEMIOL, V153, P172, DOI 10.1093/aje/153.2.172; Mavri A, 2001, BLOOD COAGUL FIBRIN, V12, P359, DOI 10.1097/00001721-200107000-00004; NCHS, 2013, SPEC WEIGHT PAR; Newman MA, 2009, MED SCI SPORT EXER, V41, P322, DOI 10.1249/MSS.0b013e3181864c05; Ornato JP, 1996, J AM COLL CARDIOL, V28, P1684, DOI 10.1016/S0735-1097(96)00411-1; ROSENTHAL NE, 1984, ARCH GEN PSYCHIAT, V41, P72; Rudnicka AR, 2007, CIRCULATION, V115, P996, DOI 10.1161/CIRCULATIONAHA.106.635169; Schneider A, 2008, EPIDEMIOLOGY, V19, P391, DOI 10.1097/EDE.0b013e31816a4325; Sung KC, 2006, INT J CARDIOL, V107, P338, DOI 10.1016/j.ijcard.2005.03.045; Thirup P, 2003, SPORTS MED, V33, P231, DOI 10.2165/00007256-200333030-00005; Wolf K, 2009, CIRCULATION, V120, P735, DOI 10.1161/CIRCULATIONAHA.108.815860; Woloshin S, 2005, NEW ENGL J MED, V352, P1611, DOI 10.1056/NEJM200504143521525; Zipf G, 2013, NATL CTR HLTH STAT V, V1	34	36	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142382	10.1371/journal.pone.0142382	http://dx.doi.org/10.1371/journal.pone.0142382			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544180	Green Published, gold, Green Submitted			2022-12-27	WOS:000364398700126
J	Hansen, SM; Haider, H; Eichler, A; Godau, C; Frensch, PA; Gaschler, R				Hansen, Sonja Maria; Haider, Hilde; Eichler, Alexandra; Godau, Claudia; Frensch, Peter A.; Gaschler, Robert			Fostering Formal Commutativity Knowledge with Approximate Arithmetic	PLOS ONE			English	Article							PROCEDURAL KNOWLEDGE; CONCEPTUAL KNOWLEDGE; NUMBER; INSTRUCTION; MATHEMATICS; REPRESENTATIONS; FLEXIBILITY; STRATEGIES	How can we enhance the understanding of abstract mathematical principles in elementary school? Different studies found out that nonsymbolic estimation could foster subsequent exact number processing and simple arithmetic. Taking the commutativity principle as a test case, we investigated if the approximate calculation of symbolic commutative quantities can also alter the access to procedural and conceptual knowledge of a more abstract arithmetic principle. Experiment 1 tested first graders who had not been instructed about commutativity in school yet. Approximate calculation with symbolic quantities positively influenced the use of commutativity-based shortcuts in formal arithmetic. We replicated this finding with older first graders (Experiment 2) and third graders (Experiment 3). Despite the positive effect of approximation on the spontaneous application of commutativity-based shortcuts in arithmetic problems, we found no comparable impact on the application of conceptual knowledge of the commutativity principle. Overall, our results show that the usage of a specific arithmetic principle can benefit from approximation. However, the findings also suggest that the correct use of certain procedures does not always imply conceptual understanding. Rather, the conceptual understanding of commutativity seems to lag behind procedural proficiency during elementary school.	[Hansen, Sonja Maria; Haider, Hilde; Eichler, Alexandra] Univ Cologne, Dept Psychol, D-50931 Cologne, Germany; [Godau, Claudia; Frensch, Peter A.; Gaschler, Robert] Humboldt Univ, Exzellenzcluster Bild Wissen Gestaltung, D-10099 Berlin, Germany; [Gaschler, Robert] Fernuniv, Dept Psychol, Hagen, Germany	University of Cologne; Humboldt University of Berlin; Fern University Hagen	Hansen, SM (corresponding author), Univ Cologne, Dept Psychol, D-50931 Cologne, Germany.	sonja.hansen@uni-koeln.de			German Research Foundation (Deutsche Forschungsgemeinschaft DFG) [HA-5447/6-1/6-2]	German Research Foundation (Deutsche Forschungsgemeinschaft DFG)(German Research Foundation (DFG))	This research was supported by the German Research Foundation (Deutsche Forschungsgemeinschaft DFG; grant number HA-5447/6-1/6-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAROODY AJ, 1987, J RES MATH EDUC, V18, P141, DOI 10.2307/749248; Baroody AJ, 2003, STUD MATH TH LEARN, P1; Baroody AJ, 1999, J EXP CHILD PSYCHOL, V74, P157, DOI 10.1006/jecp.1999.2524; Baroody AJ., 1983, J RES MATH EDUC, V14, P156, DOI [10.2307/748379, DOI 10.2307/748379]; BAROODY AJ, 1984, COGNITION INSTRUCT, V1, P321, DOI [DOI 10.1207/S1532690XCI0103_3, DOI 10.1207/S1532690XCI0103_]; Baroody AJ, 2007, J RES MATH EDUC, V38, P115, DOI 10.2307/30034952; Barth H, 2005, P NATL ACAD SCI USA, V102, P14116, DOI 10.1073/pnas.0505512102; Bermejo V., 1993, LEARN INSTR, V3, P55; Bonig D., 2001, GRUNDSCHULZEITSCHRIF, V15, P43; Burr DC, 2010, J VISION, V10, DOI 10.1167/10.6.20; Canobi K., 2002, ED PSYCHOL, V22, P513, DOI DOI 10.1080/0144341022000023608; Canobi KH, 2005, J EXP CHILD PSYCHOL, V92, P220, DOI 10.1016/j.jecp.2005.06.001; Canobi KH, 1998, DEV PSYCHOL, V34, P882, DOI 10.1037/0012-1649.34.5.882; Cantlon JF, 2009, TRENDS COGN SCI, V13, P83, DOI 10.1016/j.tics.2008.11.007; Charras P, 2012, ATTEN PERCEPT PSYCHO, V74, P163, DOI 10.3758/s13414-011-0217-4; Cowan R, 2003, STUD MATH TH LEARN, P35; De Smedt B, 2009, J EXP CHILD PSYCHOL, V103, P469, DOI 10.1016/j.jecp.2009.01.010; Dean D, 2007, SCI EDUC, V91, P384, DOI 10.1002/sce.20194; DeCaro MS, 2012, J EXP CHILD PSYCHOL, V113, P552, DOI 10.1016/j.jecp.2012.06.009; Dehaene S., 2004, MONKEY BRAIN HUMAN B, P133; DGPs, 2004, REV FORSCH BEZ ETH R; Dowker A., 2012, INDIVIDUAL DIFFERENC; Dowker A., 2014, FRONT HUM NEUROSCI, P7; Dowker A, 2009, COGNITIVE DEV, V24, P401, DOI 10.1016/j.cogdev.2009.09.005; Feigenson L, 2004, TRENDS COGN SCI, V8, P307, DOI 10.1016/j.tics.2004.05.002; Flavell J.H., 1976, NATURE INTELLIGENCE, P231, DOI DOI 10.1038/HDY.1976.85; Fyfe ER, 2012, J EDUC PSYCHOL, V104, P1094, DOI 10.1037/a0028389; GALLISTEL CR, 1992, COGNITION, V44, P43, DOI 10.1016/0010-0277(92)90050-R; Gaschler R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074972; GEARY DC, 1995, AM PSYCHOL, V50, P24, DOI 10.1037/0003-066X.50.1.24; Gilmore CK, 2008, COGNITION, V107, P932, DOI 10.1016/j.cognition.2007.12.007; Gilmore CK, 2007, NATURE, V447, P589, DOI 10.1038/nature05850; Gilmore CK, 2010, COGNITION, V115, P394, DOI 10.1016/j.cognition.2010.02.002; Godau C, 2014, PSYCHOLOGY, V5, P127, DOI DOI 10.4236/PSYCH.2014.52020; Haider H., 2014, FRONT LEARN RES, V2, P1, DOI [10.14786/flr.v2i1.37, DOI 10.14786/FLR.V2I1.37]; Hannula MM, 2010, J EXP CHILD PSYCHOL, V107, P394, DOI 10.1016/j.jecp.2010.06.004; Hannula MM, 2005, LEARN INSTR, V15, P237, DOI 10.1016/j.learninstruc.2005.04.005; Hansen SM, 2013, C EXP PSYCH TEAP 201; HATANO G, 1988, NEW DIR CHILD ADOLES, V41, P55, DOI DOI 10.1002/CD.23219884105; Hiebert J, 1996, COGNITION INSTRUCT, V14, P251, DOI 10.1207/s1532690xci1403_1; Hiebert J, 1986, CONCEPTUAL PROCEDURA, V1- 27, p[xiii, 309]; Hyde DC, 2014, COGNITION, V131, P92, DOI 10.1016/j.cognition.2013.12.007; Knops A, 2009, ATTEN PERCEPT PSYCHO, V71, P803, DOI 10.3758/APP.71.4.803; LEFEVRE JA, 1993, COGNITION INSTRUCT, V11, P95, DOI 10.1207/s1532690xci1102_1; LeFevre JA, 2006, J EXP CHILD PSYCHOL, V93, P285, DOI 10.1016/j.jecp.2005.11.002; LOFTUS GR, 1994, PSYCHON B REV, V1, P476, DOI 10.3758/BF03210951; Matthews P, 2009, J EXP CHILD PSYCHOL, V104, P1, DOI 10.1016/j.jecp.2008.08.004; Mazzocco MMM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023749; McMullen JA, 2011, PME CONFERENCE PROCE, P217; McNeil NM, 2000, J EDUC PSYCHOL, V92, P734, DOI 10.1037/0022-0663.92.4.734; Obersteiner A, 2013, LEARN INSTR, V23, P125, DOI 10.1016/j.learninstruc.2012.08.004; Piazza M, 2010, TRENDS COGN SCI, V14, P542, DOI 10.1016/j.tics.2010.09.008; Prather RW, 2009, DEV REV, V29, P221, DOI 10.1016/j.dr.2009.09.001; Renton M., 1996, EDUC PSYCHOL, V16, P407, DOI [DOI 10.1080/0144341960160405, 10.1080/0144341960160405]; Resnick L. B., 1992, ANAL ARITHMETIC MATH, P373; RESNICK LB, 1989, AM PSYCHOL, V44, P162, DOI 10.1037/0003-066X.44.2.162; Rittle-Johnson B, 2006, CHILD DEV, V77, P1, DOI 10.1111/j.1467-8624.2006.00852.x; Rittle-Johnson B, 2001, J EDUC PSYCHOL, V93, P346, DOI 10.1037/0022-0663.93.2.346; Schneider M, 2011, DEV PSYCHOL, V47, P1525, DOI 10.1037/a0024997; Schneider M, 2010, DEV PSYCHOL, V46, P178, DOI 10.1037/a0016701; Sherman J, 2009, J EDUC PSYCHOL, V101, P88, DOI 10.1037/a0013156; Siegler R., 1989, CHILDREN DISCOVER NE; Siegler R.S., 2005, HDB MATH COGNITION P, P197; Siegler RS, 1998, J EXP PSYCHOL GEN, V127, P377, DOI 10.1037/0096-3445.127.4.377; Siegler RS, 2000, CURR DIR PSYCHOL SCI, V9, P79, DOI 10.1111/1467-8721.00065; SOPHIAN C, 1995, COGNITION INSTRUCT, V13, P253, DOI 10.1207/s1532690xci1302_4; Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704; Verschaffel L., 1994, LEARN INSTR, V4, P273, DOI DOI 10.1016/0959-4752(94)90002-7; WYNN K, 1992, NATURE, V358, P749, DOI 10.1038/358749a0; Xu F, 2000, COGNITION, V74, pB1, DOI 10.1016/S0010-0277(99)00066-9	70	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142551	10.1371/journal.pone.0142551	http://dx.doi.org/10.1371/journal.pone.0142551			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26560311	Green Submitted, Green Published, gold			2022-12-27	WOS:000364433100091
J	Stiglic, G; Pajnkihar, M				Stiglic, Gregor; Pajnkihar, Majda			Evaluation of Major Online Diabetes Risk Calculators and Computerized Predictive Models	PLOS ONE			English	Article							CAROTID ATHEROSCLEROSIS; ASSESSMENT SCORE; LIFE-STYLE; VALIDATION; AUSTRALIA	Classical paper-and-pencil based risk assessment questionnaires are often accompanied by the online versions of the questionnaire to reach a wider population. This study focuses on the loss, especially in risk estimation performance, that can be inflicted by direct transformation from the paper to online versions of risk estimation calculators by ignoring the possibilities of more complex and accurate calculations that can be performed using the online calculators. We empirically compare the risk estimation performance between four major diabetes risk calculators and two, more advanced, predictive models. National Health and Nutrition Examination Survey (NHANES) data from 1999-2012 was used to evaluate the performance of detecting diabetes and pre-diabetes. American Diabetes Association risk test achieved the best predictive performance in category of classical paper-and-pencil based tests with an Area Under the ROC Curve (AUC) of 0.699 for undiagnosed diabetes (0.662 for pre-diabetes) and 47% (47% for pre-diabetes) persons selected for screening. Our results demonstrate a significant difference in performance with additional benefits for a lower number of persons selected for screening when statistical methods are used. The best AUC overall was obtained in diabetes risk prediction using logistic regression with AUC of 0.775 (0.734) and an average 34% (48%) persons selected for screening. However, generalized boosted regression models might be a better option from the economical point of view as the number of selected persons for screening of 30%(47%) lies significantly lower for diabetes risk assessment in comparison to logistic regression (p < 0.001), with a significantly higher AUC (p < 0.001) of 0.774 (0.740) for the pre-diabetes group. Our results demonstrate a serious lack of predictive performance in four major online diabetes risk calculators. Therefore, one should take great care and consider optimizing the online versions of questionnaires that were primarily developed as classical paper questionnaires.	[Stiglic, Gregor; Pajnkihar, Majda] Univ Maribor, Fac Hlth Sci, SLO-2000 Maribor, Slovenia; [Stiglic, Gregor] Univ Maribor, Fac Elect Engn & Comp Sci, SLO-2000 Maribor, Slovenia	University of Maribor; University of Maribor	Stiglic, G (corresponding author), Univ Maribor, Fac Hlth Sci, SLO-2000 Maribor, Slovenia.	gregor.stiglic@um.si	Stiglic, Gregor/E-5286-2011	Stiglic, Gregor/0000-0002-0183-8679; Pajnkihar, Majda/0000-0002-6298-045X	Swiss National Science Foundation through a SCOPES Joint Research Projects [IZ73Z0_152415]	Swiss National Science Foundation through a SCOPES Joint Research Projects	Both authors of this study were supported by the Swiss National Science Foundation through a SCOPES 2013 Joint Research Projects grant IZ73Z0_152415 (http://www.snf.ch/en/funding/programmes/scopes/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi A, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5900; [Anonymous], 2014, ADA DIABETES RISK TE; Bang HJ, 2009, ANN INTERN MED, V151, P775, DOI 10.7326/0003-4819-151-11-200912010-00005; Buijsse B, 2011, EPIDEMIOL REV; Cameron AJ, 2003, MED J AUSTRALIA, V178, P427, DOI 10.5694/j.1326-5377.2003.tb05283.x; Centers for Disease Control and Prevention National Health and Nutrition Examination Survey (NHANES), 1999, NAT HLTH NUTR EX SUR; Chen L, 2010, MED J AUSTRALIA, V192, P197, DOI 10.5694/j.1326-5377.2010.tb03478.x; Chomutare T, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1874; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; Collins GS, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-40; Collins GS, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-103; Cook AJ, 2004, PAIN, V110, P310, DOI 10.1016/j.pain.2004.04.012; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Grant Janet F, 2006, Epidemiol Perspect Innov, V3, P4, DOI 10.1186/1742-5573-3-4; Gray LJ, 2013, DIABETIC MED, V30, P758, DOI 10.1111/dme.12115; Gray LJ, 2010, DIABETIC MED, V27, P887, DOI 10.1111/j.1464-5491.2010.03037.x; Hwang SJ, 1997, CIRCULATION, V96, P4219; Kaczorowski J, 2009, CAN J DIABETES, V33, P381, DOI 10.1016/S1499-2671(09)34008-3; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; MITCHELL P, 1995, OPHTHALMOLOGY, V102, P1450; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; OLEARY DH, 1991, STROKE, V22, P1155, DOI 10.1161/01.STR.22.9.1155; Shortliffe EH, 2014, J BIOMED INFORM, V48, P1, DOI 10.1016/j.jbi.2014.02.016; Penn L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057143; R Core Team, 2021, R LANGUAGE ENV STAT; Ridgeway G., 2013, GBM GEN BOOST REGR M; Robinson CA, 2011, CHRON DIS INJ CAN, V32, P19; Stiglic G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033812; Varma S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-91; Yu W, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-16	30	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142827	10.1371/journal.pone.0142827	http://dx.doi.org/10.1371/journal.pone.0142827			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26560153	Green Submitted, Green Published, gold			2022-12-27	WOS:000364433100130
J	Bian, SZ; Jin, J; Zhang, JH; Li, QN; Yu, J; Yu, SY; Chen, JF; Yu, XJ; Qin, J; Huang, L				Bian, Shi-Zhu; Jin, Jun; Zhang, Ji-Hang; Li, Qian-Ning; Yu, Jie; Yu, Shi-Yong; Chen, Jian-Fei; Yu, Xue-Jun; Qin, Jun; Huang, Lan			Principal Component Analysis and Risk Factors for Acute Mountain Sickness upon Acute Exposure at 3700 m	PLOS ONE			English	Article							HIGH-ALTITUDE EXPOSURE; HEART-RATE-VARIABILITY; ANXIETY DISORDERS; HEADACHE; DEPRESSION; HYPOXIA; SYMPTOMS	Objective We aimed to describe the heterogeneity in the clinical presentation of acute mountain sickness (AMS) and to identify its primary risk factors. Methods The participants (n = 163) received case report form questionnaires, and their heart rate (HR), oxygen saturation (SpO(2)), echocardiographic and transcranial Doppler variables, ability to perform mental and physical work, mood and psychological factors were assessed within 18 to 22 hours after arriving at 3700 m from sea level (500 m) by plane. First, we examined the differences in all variables between the AMS-positive and the AMS-negative groups. Second, an adjusted regression analysis was performed after correlation and principal component analyses. Results The AMS patients had a higher diastolic vertebral artery velocity (V-d; p = 0.018), a higher HR (p = 0.006) and a lower SpO(2). The AMS subjects also experienced poorer sleep quality, as quantified using the Athens Insomnia Scale (AIS). Moreover, the AMS population exhibited more negative mood states, including anxiety, depression, hostility, fatigue and confusion. Five principal components focused on diverse aspects were also found to be significant. Additionally, more advanced age (p = 0.007), a higher HR (p = 0.034), a higher Vd (p = 0.014), a higher AIS score (p = 0.030), a decreased pursuit aiming capacity (p = 0.035) and decreased vigor (p = 0.015) were risk factors for AMS. Conclusions Mood states play critical roles in the development of AMS. Furthermore, an elevated HR and V-d, advanced age, elevated AIS sores, insufficient vigor and decreased mental work capacity are independent risk factors for AMS.	[Bian, Shi-Zhu; Jin, Jun; Zhang, Ji-Hang; Yu, Jie; Yu, Shi-Yong; Chen, Jian-Fei; Yu, Xue-Jun; Qin, Jun; Huang, Lan] Third Mil Med Univ, Inst Cardiovasc Dis PLA, Xingiao Hosp, Chongqing, Peoples R China; [Bian, Shi-Zhu; Jin, Jun; Zhang, Ji-Hang; Yu, Jie; Yu, Shi-Yong; Chen, Jian-Fei; Yu, Xue-Jun; Qin, Jun; Huang, Lan] Third Mil Med Univ, Dept Cardiol, Xingiao Hosp, Chongqing, Peoples R China; [Li, Qian-Ning] Third Mil Med Univ, Dept Neurol, Xingiao Hosp, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University	Huang, L (corresponding author), Third Mil Med Univ, Inst Cardiovasc Dis PLA, Xingiao Hosp, Chongqing, Peoples R China.	huanglan260@126.com		Huang, Lan/0000-0001-9594-4722	Ministry of Health of P.R. China [201002012]; Peoples Liberation Army P.R.C. grant [BWS14J040]	Ministry of Health of P.R. China; Peoples Liberation Army P.R.C. grant	Funding: This work was supported by the Special Health Research Project, Ministry of Health of P.R. China (grant No. 201002012) and Peoples Liberation Army P.R.C. (grant No. BWS14J040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1966, AEROSPACE MED, V37, P163; Bartsch P, 2013, NEW ENGL J MED, V369, P1666, DOI 10.1056/NEJMc1309747; Bailey DM, 2009, CELL MOL LIFE SCI, V66, P3583, DOI 10.1007/s00018-009-0145-9; Basnyat B, 2003, LANCET, V361, P1967, DOI 10.1016/S0140-6736(03)13591-X; Baumgartner RW, 1999, J APPL PHYSIOL, V86, P1578, DOI 10.1152/jappl.1999.86.5.1578; Bian SZ, 2015, J HEADACHE PAIN, V16, DOI 10.1186/s10194-015-0527-3; Bian SZ, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-35; Bian SZ, 2014, EUROPEAN J APPL PHYS; Blaauw BA, 2014, J HEADACHE PAIN, V15, DOI 10.1186/1129-2377-15-38; BONNON M, 1995, AVIAT SPACE ENVIR MD, V66, P330; Campbell MC, 2013, NEUROLOGY, V81, P520, DOI 10.1212/WNL.0b013e31829e6f94; Carod-Artal FJ, 2012, NEUROLOGIA; Das BB, 2004, ARCH PEDIAT ADOL MED, V158, P1170, DOI 10.1001/archpedi.158.12.1170; Dong JQ, 2013, PHYSIOL BEHAV, V112, P23, DOI 10.1016/j.physbeh.2013.02.001; Fabris C, 2014, DIABETES TECHNOL THE; Fagenholz PJ, 2007, WILD ENVIRON MED, V18, P312, DOI 10.1580/07-WEME-BR-102R1.1; Fukuda T, 2010, INT HEART J, V51, P170, DOI 10.1536/ihj.51.170; Huang HH, 2010, CLIN J SPORT MED, V20, P58, DOI 10.1097/JSM.0b013e3181cae6ba; Imray C, 2010, PROG CARDIOVASC DIS, V52, P467, DOI 10.1016/j.pcad.2010.02.003; Karinen HM, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00336; Koehle MS, 2010, EUR J EMERG MED, V17, P119, DOI 10.1097/MEJ.0b013e32832fa099; Lemos VD, 2012, PSYCHOPHYSIOLOGY, V49, P1298, DOI 10.1111/j.1469-8986.2012.01411.x; Li X, 2011, ASIA PAC J PUBLIC HL; MISSOUM G, 1992, INT J SPORTS MED, V13, pS37, DOI 10.1055/s-2007-1024587; Naeije R, 2010, PROG CARDIOVASC DIS, V52, P456, DOI 10.1016/j.pcad.2010.03.004; Norcliffe LJ, 2005, J PHYSIOL-LONDON, V566, P287, DOI 10.1113/jphysiol.2005.086629; Oliver SJ, 2012, J TRAVEL MED, V19, P210, DOI 10.1111/j.1708-8305.2012.00609.x; Pasha MAQ, 2010, CHEST, V137, p13S, DOI 10.1378/chest.09-2445; REGARD M, 1991, AVIAT SPACE ENVIR MD, V62, P291; Roth WT, 2002, DEPRESS ANXIETY, V16, P51, DOI 10.1002/da.10059; Seifert CL, 2011, J NEUROL, V258, P123, DOI 10.1007/s00415-010-5704-3; Van Osta A, 2005, STROKE, V36, P557, DOI 10.1161/01.STR.0000155735.85888.13; Vigo DE, 2010, WILD ENVIRON MED, V21, P4, DOI 10.1016/j.wem.2009.12.022; WHITE AJ, 1984, AVIAT SPACE ENVIR MD, V55, P598; White KS, 2006, J PEDIATR PSYCHOL, V31, P582, DOI 10.1093/jpepsy/jsj050; Wu TY, 2012, CHINESE MED J-PEKING, V125, P1393, DOI 10.3760/cma.j.issn.0366-6999.2012.08.006; Zwart JA, 2003, EUR J NEUROL, V10, P147, DOI 10.1046/j.1468-1331.2003.00551.x	37	11	15	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142375	10.1371/journal.pone.0142375	http://dx.doi.org/10.1371/journal.pone.0142375			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26554385	gold, Green Published, Green Submitted			2022-12-27	WOS:000364430700094
J	Egli, N; Zajonz, A; Burger, MT; Schweighoffer, T				Egli, Nicole; Zajonz, Alexandra; Burger, Matthew T.; Schweighoffer, Tamas			Human CD180 Transmits Signals via the PIM-1L Kinase	PLoS One			English	Article							PROSTATE-CANCER CELLS; B-CELLS; RP105; ACTIVATION; RECEPTOR; GROWTH; APOPTOSIS; PROLIFERATION; EXPRESSION; MOLECULE	Toll-like receptors (TLRs) are important sensors of the innate immune system that recognize conserved structural motifs and activate cells via a downstream signaling cascade. The CD180/MD1 molecular complex is an unusual member of the TLR family, since it lacks the components that are normally required for signal transduction by other TLRs. Therefore the CD180/MD 1 complex has been considered of being incapable of independently initiating cellular signals. Using chemogenetic approaches we identified specifically the membrane bound long form of PIM-1 kinase, PIM-1L as the mediator of CD180-dependent signaling. A dominant negative isoform of PIM-1L, but not of other PIM kinases, inhibited signaling elicited by cross-linking of CD180, and this effect was phenocopied by PIM inhibitors. PIM-1L was directed to the cell membrane by its N-terminal extension, where it colocalized and physically associated with CD180. Triggering CD180 also induced increased phosphorylation of the anti-apoptotic protein BAD in a PIM kinase-dependent fashion. Also in primary human B cells, which are the main cells expressing CD180 in man, cross-linking of CD180 by monoclonal antibodies stimulated cell survival and proliferation that was abrogated by specific inhibitors. By associating with PIM-1L, CD180 can thus obtain autonomous signaling capabilities, and this complex is then channeling inflammatory signals into B cell survival programs. Pharmacological inhibition of PIM-1 should therefore provide novel therapeutic options in diseases that respond to innate immune stimulation with subsequently increased B cell activity, such as lupus erythematosus or myasthenia gravis.	[Egli, Nicole; Zajonz, Alexandra; Schweighoffer, Tamas] Novartis Inst Biomed Res, Autoimmune Transplantat & Inflammatory Dis Area, Basel, Switzerland; [Burger, Matthew T.] Novartis Inst Biomed Res, Global Discovery Chem, Cambridge, MA USA	Novartis; Novartis	Schweighoffer, T (corresponding author), Novartis Inst Biomed Res, Autoimmune Transplantat & Inflammatory Dis Area, Basel, Switzerland.	tamas.schweighoffer@novartis.com			Novartis	Novartis(Novartis)	The authors are employees of Novartis and received no specific funding for this work. Novartis provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bhattacharya N, 2002, CHROMOSOMA, V111, P80, DOI 10.1007/s00412-002-0192-6; Blumenthal A, 2009, CELL HOST MICROBE, V5, P35, DOI 10.1016/j.chom.2008.12.002; Burger MT, 2013, ACS MED CHEM LETT, V4, P1193, DOI 10.1021/ml400307j; Chaplin JW, 2013, J EXP MED, V210, P2135, DOI 10.1084/jem.20130188; Chaplin JW, 2011, J IMMUNOL, V187, P4199, DOI 10.4049/jimmunol.1100198; Divanovic S, 2005, NAT IMMUNOL, V6, P571, DOI 10.1038/ni1198; Hammerman PS, 2004, CANCER RES, V64, P8341, DOI 10.1158/0008-5472.CAN-04-2284; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Hu XF, 2009, J CLIN INVEST, V119, P362, DOI 10.1172/JCI33216; Kim JH, 2010, CELL SIGNAL, V22, P1858, DOI 10.1016/j.cellsig.2010.07.013; Mikkers H, 2004, MOL CELL BIOL, V24, P6104, DOI 10.1128/MCB.24.13.6104-6115.2004; MIYAKE K, 1995, J IMMUNOL, V154, P3333; MIYAKE K, 1994, J EXP MED, V180, P1217, DOI 10.1084/jem.180.4.1217; Nagai Y, 2013, ADIPOCYTE, V2, P61, DOI 10.4161/adip.22929; Nagai Y, 2012, INT IMMUNOL, V24, P389, DOI 10.1093/intimm/dxs040; Ogata H, 2000, J EXP MED, V192, P23, DOI 10.1084/jem.192.1.23; Peltola K, 2009, NEOPLASIA, V11, P629, DOI 10.1593/neo.81038; Porakishvili N, 2011, BRIT J HAEMATOL, V153, P486, DOI 10.1111/j.1365-2141.2011.08605.x; SARIS CJM, 1991, EMBO J, V10, P655, DOI 10.1002/j.1460-2075.1991.tb07994.x; Tao ZF, 2009, J MED CHEM, V52, P6621, DOI 10.1021/jm900943h; VALENTINE MA, 1988, J IMMUNOL, V140, P4071; Xie Y, 2006, ONCOGENE, V25, P70, DOI 10.1038/sj.onc.1209058; Xie Y, 2008, J BIOL CHEM, V283, P3349, DOI 10.1074/jbc.M707773200; Xu DP, 2011, CARCINOGENESIS, V32, P488, DOI 10.1093/carcin/bgr007; Yang J, 2010, IMMUNOLOGY; Yazawa N, 2003, BLOOD, V102, P1374, DOI 10.1182/blood-2002-11-3573; Yoon SI, 2011, NAT STRUCT MOL BIOL, V18, P1028, DOI 10.1038/nsmb.2106; Zhu N, 2002, J IMMUNOL, V168, P744, DOI 10.4049/jimmunol.168.2.744	28	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142741	10.1371/journal.pone.0142741	http://dx.doi.org/10.1371/journal.pone.0142741			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555723	Green Published, Green Submitted, gold			2022-12-27	WOS:000364430700165
J	Hahn, K; Rohdin, C; Jagannathan, V; Wohlsein, P; Baumgartner, W; Seehusen, F; Spitzbarth, I; Grandon, R; Drogemuller, C; Jaderlund, KH				Hahn, Kerstin; Rohdin, Cecilia; Jagannathan, Vidhya; Wohlsein, Peter; Baumgaertner, Wolfgang; Seehusen, Frauke; Spitzbarth, Ingo; Grandon, Rodrigo; Droegemueller, Cord; Jaderlund, Karin Hultin			TECPR2 Associated Neuroaxonal Dystrophy in Spanish Water Dogs	PLOS ONE			English	Article							BRAIN IRON ACCUMULATION; HEREDITARY SPASTIC PARAPARESIS; NEURODEGENERATIVE DISORDERS; AXONAL DEGENERATION; PHOSPHOLIPASE A(2); MOUSE MODEL; AUTOPHAGY; DISEASE; MUTATIONS; PROTEIN	Clinical, pathological and genetic examination revealed an as yet uncharacterized juvenile-onset neuroaxonal dystrophy (NAD) in Spanish water dogs. Affected dogs presented with various neurological deficits including gait abnormalities and behavioral deficits. Histopathology demonstrated spheroid formation accentuated in the grey matter of the cerebral hemispheres, the cerebellum, the brain stem and in the sensory pathways of the spinal cord. Iron accumulation was absent. Ultrastructurally spheroids contained predominantly closely packed vesicles with a double-layered membrane, which were characterized as autophagosomes using immunohistochemistry. The family history of the four affected dogs suggested an autosomal recessive inheritance. SNP genotyping showed a single genomic region of extended homozygosity of 4.5 Mb in the four cases on CFA 8. Linkage analysis revealed a maximal parametric LOD score of 2.5 at this region. By whole genome re-sequencing of one affected dog, a perfectly associated, single, non-synonymous coding variant in the canine tectonin beta-propeller repeat-containing protein 2 (TECPR2) gene affecting a highly conserved region was detected (c.4009C>T or p.R1337W). This canine NAD form displays etiologic parallels to an inherited TECPR2 associated type of human hereditary spastic paraparesis (HSP). In contrast to the canine NAD, the spinal cord lesions in most types of human HSP involve the sensory and the motor pathways. Furthermore, the canine NAD form reveals similarities to cases of human NAD defined by widespread spheroid formation without iron accumulation in the basal ganglia. Thus TECPR2 should also be considered as candidate gene for human NAD. Immunohistochemistry and the ultrastructural findings further support the assumption, that TECPR2 regulates autophagosome accumulation in the autophagic pathways. Consequently, this report provides the first genetic characterization of juvenile canine NAD, describes the histopathological features associated with the TECPR2 mutation and provides evidence to emphasize the association between failure of autophagy and neurodegeneration.	[Hahn, Kerstin; Wohlsein, Peter; Baumgaertner, Wolfgang; Seehusen, Frauke; Spitzbarth, Ingo] Univ Vet Med Hannover, Dept Pathol, Hannover, Germany; [Rohdin, Cecilia] Swedish Univ Agr Sci, Univ Anim Hosp, Uppsala, Sweden; [Jagannathan, Vidhya; Droegemueller, Cord] Univ Bern, Inst Genet, Vetsuisse Fac, Bern, Switzerland; [Grandon, Rodrigo] Swedish Univ Agr Sci, Dept Biomed Sci & Vet Publ Hlth, Div Pathol Pharmacol & Toxicol, Uppsala, Sweden; [Jaderlund, Karin Hultin] Norwegian Univ Life Sci, Dept Compan Anim Clin Sci, Oslo, Norway; [Baumgaertner, Wolfgang] Ctr Syst Neurosci, Hannover, Germany; [Rohdin, Cecilia] Albano Small Anim Hosp, Anicura, Danderyd, Sweden	University of Veterinary Medicine Hannover, Foundation; Swedish University of Agricultural Sciences; University of Bern; Swedish University of Agricultural Sciences; Norwegian University of Life Sciences	Drogemuller, C (corresponding author), Univ Bern, Inst Genet, Vetsuisse Fac, Bern, Switzerland.	Cord.Droegemueller@vetsuisse.unibe.ch	Jagannathan, Vidhya/P-1055-2019; Rohdin, Cecilia/E-5590-2016; Jäderlund, Karin Hultin/AAL-8211-2020; Seehusen, Frauke/Q-8192-2018	Jagannathan, Vidhya/0000-0002-8155-0041; Rohdin, Cecilia/0000-0002-7698-550X; Seehusen, Frauke/0000-0001-6701-7868; Drogemuller, Cord/0000-0001-9773-522X				Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Bouley DM, 2006, J COMP PATHOL, V134, P161, DOI 10.1016/j.jcpa.2005.10.002; Chang J, 2014, J CLIN INVEST, V124, P5249, DOI 10.1172/JCI77598; Chen DD, 2012, MOL CELL, V45, P629, DOI 10.1016/j.molcel.2011.12.036; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Colombelli C, 2015, J INHERIT METAB DIS, V38, P123, DOI 10.1007/s10545-014-9770-z; COWEN D, 1963, J NEUROPATH EXP NEUR, V22, P175, DOI 10.1097/00005072-196304000-00001; Deegan S, 2013, CELL MOL LIFE SCI, V70, P2425, DOI 10.1007/s00018-012-1173-4; Dehouck Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-151; Filomeni G, 2015, CELL DEATH DIFFER, V22, P377, DOI 10.1038/cdd.2014.150; Fink JK, 2013, ACTA NEUROPATHOL, V126, P307, DOI 10.1007/s00401-013-1115-8; Fyfe JC, 2011, NEUROGENETICS, V12, P223, DOI 10.1007/s10048-011-0285-6; Gregory A., 2008, GENEREVIEWS; Haack TB, 2012, AM J HUM GENET, V91, P1144, DOI 10.1016/j.ajhg.2012.10.019; Halliday GM, 2011, ACTA NEUROPATHOL, V122, P187, DOI 10.1007/s00401-011-0852-9; Hartig MB, 2011, AM J HUM GENET, V89, P543, DOI 10.1016/j.ajhg.2011.09.007; Hayflick SJ, 2013, BRAIN, V136, P1708, DOI 10.1093/brain/awt095; Inoue M, 1996, ACTA NEUROPATHOL, V92, P555, DOI 10.1007/s004010050561; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Khundadze M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003988; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Komatsu M, 2007, P NATL ACAD SCI USA, V104, P14489, DOI 10.1073/pnas.0701311104; Kurian MA, 2008, NEUROLOGY, V70, P1623, DOI 10.1212/01.wnl.0000310986.48286.8e; Kyostila K, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005169; Lamb CA, 2013, BIOESSAYS, V35, P34, DOI 10.1002/bies.201200130; Lebrand C, 2002, EMBO J, V21, P1289, DOI 10.1093/emboj/21.6.1289; Lee S, 2011, J NEUROSCI, V31, P7817, DOI 10.1523/JNEUROSCI.6412-10.2011; Levi S, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00099; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lowe JS, 2002, GREENFIELDS NEUROPAT, P390; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Marangoni M, 2014, NEUROBIOL AGING, V35, P2382, DOI 10.1016/j.neurobiolaging.2014.04.024; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Morgan NV, 2006, NAT GENET, V38, P752, DOI 10.1038/ng1826; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Novarino G, 2014, SCIENCE, V343, P506, DOI 10.1126/science.1247363; Oz-Levi D, 2012, AM J HUM GENET, V91, P1065, DOI 10.1016/j.ajhg.2012.09.015; Petersen B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015079; Petersen B, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-51; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Saitsu H, 2013, NAT GENET, V45, P445, DOI 10.1038/ng.2562; Schneider SA, 2013, CURR NEUROPHARMACOL, V11, P59, DOI 10.2174/157015913804999469; Seehusen F, 2010, BRAIN PATHOL, V20, P551, DOI 10.1111/j.1750-3639.2009.00332.x; Settembre C, 2014, TRENDS CELL BIOL, V24, P743, DOI 10.1016/j.tcb.2014.06.006; Shinzawa K, 2008, J NEUROSCI, V28, P2212, DOI 10.1523/JNEUROSCI.4354-07.2008; Siso S, 2006, VET J, V171, P20, DOI 10.1016/j.tvjl.2004.08.015; Summers B, 1995, VET NEUROPATHOLOGY, P315; Ulrich R, 2008, NEUROPATH APPL NEURO, V34, P603, DOI 10.1111/j.1365-2990.2008.00956.x; Vantaggiato C, 2014, AUTOPHAGY, V10, P374, DOI 10.4161/auto.27173; Wada H, 2009, AM J PATHOL, V175, P2257, DOI 10.2353/ajpath.2009.090343; Wirths O, 2007, NEUROBIOL AGING, V28, P1689, DOI 10.1016/j.neurobiolaging.2006.07.021; Xiao SX, 2006, BBA-MOL BASIS DIS, V1762, P1001, DOI 10.1016/j.bbadis.2006.09.003; Zhou B, 2001, NAT GENET, V28, P345, DOI 10.1038/ng572	56	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0141824	10.1371/journal.pone.0141824	http://dx.doi.org/10.1371/journal.pone.0141824			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555167	gold, Green Published			2022-12-27	WOS:000364430700040
J	Li, KL; Wan, PJ; Wang, WX; Lai, FX; Fu, Q				Li, Kai-Long; Wan, Pin-Jun; Wang, Wei-Xia; Lai, Feng-Xiang; Fu, Qiang			Ran Involved in the Development and Reproduction Is a Potential Target for RNA-Interference-Based Pest Management in Nilaparvata lugens	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; HEMIPTERA DELPHACIDAE; BROWN PLANTHOPPER; CYTOCHROME-P450 CYP6AY1; INSECTICIDE RESISTANCE; ECDYSONE RECEPTOR; TRANSPORT FACTOR; NUCLEAR IMPORT; WING-MORPHS; GENE	Ran (RanGTPase) in insects participates in the 20-hydroxyecdysone signal transduction pathway in which downstream genes, FTZ-F1, Krupp-molog 1 (Kr-h1) and vitellogenin, are involved. A putative Ran gene (NlRan) was cloned from Nilaparvata lugens, a destructive phloem-feeding pest of rice. NlRan has the typical Ran primary structure features that are conserved in insects. NlRan showed higher mRNA abundance immediately after molting and peaked in newly emerged female adults. Among the examined tissues ovary had the highest transcript level, followed by fat body, midgut and integument, and legs. Three days after dsNlRan injection the NlRan mRNA abundance in the third-, fourth-, and fifth-instar nymphs was decreased by 94.3%, 98.4% and 97.0%, respectively. NlFTZ-F1 expression levels in treated third-and fourth-instar nymphs were reduced by 89.3% and 23.8%, respectively. In contrast, NlKr-h1 mRNA levels were up-regulated by 67.5 and 1.5 folds, respectively. NlRan knockdown significantly decreased the body weights, delayed development, and killed >85% of the nymphs at day seven. Two apparent phenotypic defects were observed: (1) Extended body form, and failed to molt; (2) The cuticle at the notum was split open but cannot completely shed off. The newly emerged female adults from dsNlRan injected fifth-instar nymphs showed lower levels of NlRan and vitellogenin, lower weight gain and honeydew excretion comparing with the blank control, and no offspring. Those results suggest that NlRan encodes a functional protein that was involved in development and reproduction. The study established proof of concept that NlRan could serve as a target for dsRNA-based pesticides for N. lugens control.	[Li, Kai-Long; Wan, Pin-Jun; Wang, Wei-Xia; Lai, Feng-Xiang; Fu, Qiang] China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou 310006, Zhejiang, Peoples R China	Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS	Fu, Q (corresponding author), China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou 310006, Zhejiang, Peoples R China.	fuqiang@caas.cn	Li, Kailong/AGZ-1532-2022	Li, Kailong/0000-0003-2386-6897	Zhejiang Provincial Natural Science Foundation of China [LY15C140004]; National Natural Science Foundation of China [31201512, 31371939, 31501637]; National Rice Industrial Technology System [CARS-1-18]; China National Rice Institute; Agricultural Science and Technology Innovation Program (ASTIP) of Chinese Academy of Agricultural Sciences	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Rice Industrial Technology System; China National Rice Institute; Agricultural Science and Technology Innovation Program (ASTIP) of Chinese Academy of Agricultural Sciences	This research was supported by grants of the Zhejiang Provincial Natural Science Foundation of China (LY15C140004), the National Natural Science Foundation of China (31201512 and 31371939), and the National Rice Industrial Technology System (CARS-1-18). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors confirm that China National Rice Institute provided support in the form of salaries for authors Kai-Long Li, Pin-Jun Wan, Wei-Xia Wang, and Qiang Fu, but did not have any additional role in the study design, data collection and analysis and decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; This research was supported by grants of the Zhejiang Provincial Natural Science Foundation of China (LY15C140004), the National Natural Science Foundation of China (31501637), the Agricultural Science and Technology Innovation Program (ASTIP) of Chinese Academy of Agricultural Sciences and the National Rice Industrial Technology System (CARS-1-18). We thank Prof. Zhi-Tao Zhang from China National Rice Research Institute and Prof. Guo-Qing Li from Nanjing Agricultural University for their insightful discussions during the course of this research.	Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Belles X, 2014, INSECT BIOCHEM MOLEC, V52, P60, DOI 10.1016/j.ibmb.2014.06.009; Belles X, 2010, ANNU REV ENTOMOL, V55, P111, DOI 10.1146/annurev-ento-112408-085301; BISCHOFF FR, 1994, P NATL ACAD SCI USA, V91, P2587, DOI 10.1073/pnas.91.7.2587; Chen X N., 2003, BROWN PLANTHOPPER OC, P1; Cheng DJ, 2005, TISSUE CELL, V37, P37, DOI 10.1016/j.tice.2004.09.003; Cruz J, 2008, DEV DYNAM, V237, P3179, DOI 10.1002/dvdy.21728; Ding ZP, 2013, INSECT BIOCHEM MOLEC, V43, P1021, DOI 10.1016/j.ibmb.2013.08.005; Han F, 2007, FISH SHELLFISH IMMUN, V23, P937, DOI 10.1016/j.fsi.2007.01.022; Han F, 2012, GENE, V495, P65, DOI 10.1016/j.gene.2011.11.048; He HJ, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-1; Heong K.L., 2009, PLANTHOPPERS NEW THR; Hughes M, 1998, J CELL SCI, V111, P3017; Jindra M, 2013, ANNU REV ENTOMOL, V58, P181, DOI 10.1146/annurev-ento-120811-153700; Kalab P, 1999, CURR BIOL, V9, P481, DOI 10.1016/S0960-9822(99)80213-9; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu SH, 2010, INSECT BIOCHEM MOLEC, V40, P666, DOI 10.1016/j.ibmb.2010.06.007; Liu S, 2015, PEST MANAG SCI, V71, P32, DOI 10.1002/ps.3760; Liu XP, 2014, INSECT BIOCHEM MOLEC, V55, P51, DOI 10.1016/j.ibmb.2014.10.008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu K, 2015, J INSECT PHYSIOL, V73, P20, DOI 10.1016/j.jinsphys.2015.01.007; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; MELCHIOR F, 1993, J CELL BIOL, V123, P1649, DOI 10.1083/jcb.123.6.1649; Mello TRP, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00445; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; Pang R, 2014, INSECT MOL BIOL, V23, P768, DOI 10.1111/imb.12121; Ribbeck K, 1998, EMBO J, V17, P6587, DOI 10.1093/emboj/17.22.6587; Riddiford LM, 2012, GEN COMP ENDOCR, V179, P477, DOI 10.1016/j.ygcen.2012.06.001; Sanderson HS, 2006, CURR BIOL, V16, pR466, DOI 10.1016/j.cub.2006.05.032; Sinha VB, 2014, MOL BIOL REP, V41, P5989, DOI 10.1007/s11033-014-3476-z; Smith A, 1998, CURR BIOL, V8, P1403, DOI 10.1016/S0960-9822(98)00023-2; Smykal V, 2014, INSECT BIOCHEM MOLEC, V45, P69, DOI 10.1016/j.ibmb.2013.12.003; Song JS, 2014, INSECT BIOCHEM MOLEC, V52, P94, DOI 10.1016/j.ibmb.2014.07.001; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Tang QY, 2013, INSECT SCI, V20, P254, DOI 10.1111/j.1744-7917.2012.01519.x; Tufail M, 2010, INSECT MOL BIOL, V19, P787, DOI 10.1111/j.1365-2583.2010.01035.x; Tufail M, 2009, J INSECT PHYSIOL, V55, P87, DOI 10.1016/j.jinsphys.2008.11.007; Tufail M, 2008, J INSECT PHYSIOL, V54, P1447, DOI 10.1016/j.jinsphys.2008.08.007; Wan PJ, 2015, PEST MANAG SCI, V71, P1387, DOI 10.1002/ps.3941; Wan PJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127789; Wang WX, 2015, J INSECT SCI, V15, DOI 10.1093/jisesa/iev046; Wang Y, 2012, INSECT BIOCHEM MOLEC, V42, P637, DOI 10.1016/j.ibmb.2012.04.009; Wang ZX, 2011, ARCH INSECT BIOCHEM, V78, P30, DOI 10.1002/arch.20437; Wilkins MR, 1999, METH MOL B, V112, P531; Wu WJ, 2012, J INSECT PHYSIOL, V58, P420, DOI 10.1016/j.jinsphys.2012.01.012; Xia F, 2008, CANCER RES, V68, P1826, DOI 10.1158/0008-5472.CAN-07-5279; Xu HJ, 2015, NATURE, V519, P464, DOI 10.1038/nature14286; Xu PP, 2014, J EXP BOT, V65, P3277, DOI 10.1093/jxb/eru178; Xue J, 2013, INSECT BIOCHEM MOLEC, V43, P433, DOI 10.1016/j.ibmb.2013.02.006; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233; Yu R, 2014, INT J BIOL SCI, V10, P1171, DOI 10.7150/ijbs.9598; Yuan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086503; Yuen HF, 2012, CLIN CANCER RES, V18, P380, DOI 10.1158/1078-0432.CCR-11-2035; Zhang BX, 2015, J INSECT PHYSIOL, V79, P19, DOI 10.1016/j.jinsphys.2015.05.006; Zhou WW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056604	56	10	12	5	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142142	10.1371/journal.pone.0142142	http://dx.doi.org/10.1371/journal.pone.0142142			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26554926	Green Published, gold, Green Submitted			2022-12-27	WOS:000364430700058
J	Miller, M; Zorn, J; Brielmeier, M				Miller, Manuel; Zorn, Julia; Brielmeier, Markus			High-Resolution Melting Curve Analysis for Identification of Pasteurellaceae Species in Experimental Animal Facilities	PLOS ONE			English	Article							LABORATORY MICE; LISTERIA-MONOCYTOGENES; STAPHYLOCOCCUS-AUREUS; PNEUMOTROPICA; BACTERIA; RODENTS; RATS; HRM	Pasteurellaceae are among the most prevalent bacterial pathogens isolated from mice housed in experimental animal facilities. Reliable detection and differentiation of Pasteurellaceae are essential for high-quality health monitoring. In this study, we combined a realtime PCR assay amplifying a variable region in the 16S rRNA sequence with high-resolution melting curve analysis (HRM) to identify and differentiate among the commonly isolated species Pasteurella pneumotropica biotypes "Jawetz" and "Heyl", Actinobacillus muris, and Haemophilus influenzaemurium. We used a set of six reference strains for assay development, with the melting profiles of these strains clearly distinguishable due to DNA sequence variations in the amplicon. For evaluation, we used real-time PCR/HRM to test 25 unknown Pasteurellaceae isolates obtained from an external diagnostic laboratory and found the results to be consistent with those of partial 16S rRNA sequencing. The real-time PCR/HRM method provides a sensitive, rapid, and closed-tube approach for Pasteurellaceae species identification for health monitoring of laboratory mice.	[Miller, Manuel; Zorn, Julia; Brielmeier, Markus] German Res Ctr Environm Hlth, Res Unit Comparat Med, Neuherberg, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Miller, M (corresponding author), German Res Ctr Environm Hlth, Res Unit Comparat Med, Neuherberg, Germany.	manuel.miller@helmholtz-muenchen.de						Benga L, 2013, J MICROBIOL METH, V95, P256, DOI 10.1016/j.mimet.2013.09.005; Boot R, 2004, SCAND J LAB ANIM SCI, V31, P177; Bootz F, 1998, LAB ANIM SCI, V48, P542; Chen JHK, 2013, J MICROBIOL METH, V92, P99, DOI 10.1016/j.mimet.2012.11.006; Cheng JC, 2006, CLIN CHEM, V52, P1997, DOI 10.1373/clinchem.2006.069286; Council NR, 1991, INF DIS MIC RATS; Dole VS, 2010, COMPARATIVE MED, V60, P427; Hayashimoto N, 2005, EXP ANIM TOKYO, V54, P123, DOI 10.1538/expanim.54.123; Hayashimoto N, 2013, EXP ANIM TOKYO, V62, P41, DOI 10.1538/expanim.62.41; Iacumin L, 2015, FOOD MICROBIOL, V46, P357, DOI 10.1016/j.fm.2014.08.007; Kodjo A, 1999, LAB ANIM SCI, V49, P49; Mahler M, 2014, LAB ANIM-UK, V48, P178, DOI 10.1177/0023677213516312; Ohshima C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099223; Patten CC, 2010, COMPARATIVE MED, V60, P18; Pritchett-Corning KR, 2009, LAB ANIM-UK, V43, P165, DOI 10.1258/la.2008.008009; Rebelo AR, 2011, J VET DIAGN INVEST, V23, P932, DOI 10.1177/1040638711416846; Reed GH, 2007, PHARMACOGENOMICS, V8, P597, DOI 10.2217/14622416.8.6.597; Sakaridis I, 2014, BIOTECHNOL BIOTEC EQ, V28, P107, DOI 10.1080/13102818.2014.901681; Scharmann W, 2001, LAB ANIM-UK, V35, P163, DOI 10.1258/0023677011911543; Wang RF, 1996, LAB ANIM SCI, V46, P81; Wittwer CT, 2003, CLIN CHEM, V49, P853, DOI 10.1373/49.6.853; Xiao XL, 2014, FOOD ANAL METHOD, V7, P1960, DOI 10.1007/s12161-014-9875-x; Zahidi JM, 2015, DIAGN MICR INFEC DIS, V81, P227, DOI 10.1016/j.diagmicrobio.2014.12.012	23	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142560	10.1371/journal.pone.0142560	http://dx.doi.org/10.1371/journal.pone.0142560			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556281	Green Published, gold, Green Submitted			2022-12-27	WOS:000364430700129
J	Mounier, R; Lobo, D; Cook, F; Martin, M; Attias, A; Ait-Mamar, B; Gabriel, I; Bekaert, O; Bardon, J; Nebbad, B; Plaud, B; Dhonneur, G				Mounier, Roman; Lobo, David; Cook, Fabrice; Martin, Mathieu; Attias, Arie; Ait-Mamar, Bouziane; Gabriel, Inanna; Bekaert, Olivier; Bardon, Jean; Nebbad, Biba; Plaud, Benoit; Dhonneur, Gilles			From the Skin to the Brain: Pathophysiology of Colonization and Infection of External Ventricular Drain, a Prospective Observational Study	PLoS One			English	Article							CEREBROSPINAL-FLUID; RISK-FACTORS; NEUROSURGICAL PATIENTS; CLINICAL ARTICLE; EARLY-DIAGNOSIS; CARE PATIENTS; CATHETERS; MENINGITIS; DURATION; HYDROCEPHALUS	Ventriculostomy-related infection (VRI) is a serious complication of external ventricular drain (EVD) but its natural history is poorly studied. We prospectively tracked the bacteria pathways from skin towards ventricles to identify the infectious process resulting in ventriculostomy-related colonization (VRC), and VRI. We systematically sampled cerebrospinal fluid (CSF) on a daily basis and collected swabs from both the skin and stopcock every 3.0 days for microbiological analysis including in 101 neurosurgical patient. Risk factors for positive event defined as either VRC or VRI were recorded and related to our microbiological findings. A total of 1261 CSF samples, 473 skin swabs, and 450 stopcock swabs were collected. Skin site was more frequently colonized than stopcock (70 (60%) vs 34 (29%), p = 0.023), and earlier (14 +/- 1.4 vs 24 +/- 1.5 days, p<0.0001). Sixty-one (52%) and 32 (27%) skin and stopcock sites were colonized with commensal bacteria, 1 (1%) and 1 (1%) with pathogens, 8 (7%) and 1 (1%) with combined pathogens and commensal bacteria, respectively. Sixteen positive events were diagnosed; a cutaneous origin was identified in 69% of cases. The presence of a pathogen at skin site (6/16 vs 4/85, OR: 11.8, [2.5-56.8], p = 0.002) and CSF leakage (7/16 vs 6/85, OR 10 [2.4-41.2], p = 0.001)) were the two independent significant risk factors statistically linked to positive events occurrence. Our results suggest that VRC and VRI mainly results from an extra-luminal progression of pathogens initially colonizing the skin site where CSF leaks.	[Mounier, Roman; Lobo, David; Cook, Fabrice; Martin, Mathieu; Attias, Arie; Ait-Mamar, Bouziane; Gabriel, Inanna; Bardon, Jean; Dhonneur, Gilles] Henri Mondor Univ Hosp Paris, Paris Sch Med 12, Dept Anesthesia & Surg Intens Care, Creteil, France; [Bekaert, Olivier] Henri Mondor Univ Hosp Paris, Paris Sch Med 12, Dept Neurosurg, Creteil, France; [Nebbad, Biba] Henri Mondor Univ Hosp Paris, Paris Sch Med 12, Dept Microbiol, Creteil, France; [Plaud, Benoit] St Louis Univ Hosp Paris, Paris Sch Med 7, Dept Anesthesiol & Surg Intens Care, Paris, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	Mounier, R (corresponding author), Henri Mondor Univ Hosp Paris, Paris Sch Med 12, Dept Anesthesia & Surg Intens Care, Creteil, France.	roman.mounier@laposte.net		Lobo, David/0000-0002-7906-6023				Arabi Y, 2005, AM J INFECT CONTROL, V33, P137, DOI 10.1016/j.ajic.2004.11.008; Bayston R, 1997, J NEUROSURG, V87, P247, DOI 10.3171/jns.1997.87.2.0247; Beekmann S, 2010, INFECT CAUSED PERCUT, P3697; Beer R, 2008, J NEUROL, V255, P1617, DOI 10.1007/s00415-008-0059-8; BOGDAHN U, 1992, NEUROSURGERY, V31, P898, DOI 10.1227/00006123-199211000-00011; CLARK WC, 1989, NEUROSURGERY, V25, P20; FRIEDMAN WA, 1980, J NEUROSURG, V53, P662, DOI 10.3171/jns.1980.53.5.0662; Harrop JS, 2010, NEUROSURGERY, V67, P187, DOI 10.1227/01.NEU.0000370247.11479.B6; Hetem DJ, 2010, J NEUROSURG, V113, P1309, DOI 10.3171/2010.6.JNS10258; Hoefnagel D, 2008, ACTA NEUROCHIR, V150, P209, DOI 10.1007/s00701-007-1458-9; Holloway KL, 1996, J NEUROSURG, V85, P419, DOI 10.3171/jns.1996.85.3.0419; Huang CR, 2005, INFECTION, V33, P56, DOI 10.1007/s15010-005-4083-7; KANTER RK, 1984, NEW ENGL J MED, V311, P987; KHATIB R, 1995, J CLIN MICROBIOL, V33, P816, DOI 10.1128/JCM.33.4.816-820.1995; KIM DK, 1995, J NEUROL NEUROSUR PS, V58, P444, DOI 10.1136/jnnp.58.4.444; Korinek AM, 2005, ACTA NEUROCHIR, V147, P39, DOI 10.1007/s00701-004-0416-z; Leverstein-van Hall MA, 2010, J NEUROSURG, V112, P345, DOI 10.3171/2009.6.JNS09223; Lozier AP, 2002, NEUROSURGERY, V51, P170, DOI 10.1097/00006123-200207000-00024; Lyke KE, 2001, CLIN INFECT DIS, V33, P2028, DOI 10.1086/324492; Martinez R, 2002, INTENS CARE MED, V28, P208, DOI 10.1007/s00134-001-1176-3; MAYHALL CG, 1984, NEW ENGL J MED, V310, P553, DOI 10.1056/NEJM198403013100903; Meredith FT, 1997, J CLIN MICROBIOL, V35, P3109, DOI 10.1128/JCM.35.12.3109-3111.1997; Mounier R, 2015, ACTA NEUROCHIR, V157, P2209, DOI 10.1007/s00701-015-2574-6; Muttaiyah S, 2008, J MED MICROBIOL, V57, P207, DOI 10.1099/jmm.0.47518-0; OHRSTROM JK, 1989, ACTA NEUROCHIR, V100, P67, DOI 10.1007/BF01405277; PARAMORE CG, 1994, ACTA NEUROCHIR, V127, P79, DOI 10.1007/BF01808552; Pattavilakom A, 2006, NEUROSURGERY, V58, P930, DOI 10.1227/01.NEU.0000210155.65102.E7; Pfausler B, 2004, ACTA NEUROCHIR, V146, P477, DOI 10.1007/s00701-004-0258-8; Pfisterer W, 2003, J NEUROL NEUROSUR PS, V74, P929, DOI 10.1136/jnnp.74.7.929; Poon WS, 1998, ACT NEUR S, V71, P146; Raad I, 2007, LANCET INFECT DIS, V7, P645, DOI 10.1016/S1473-3099(07)70235-9; Schade RP, 2006, J NEUROSURG, V104, P101, DOI 10.3171/jns.2006.104.1.101; Sonabend AM, 2011, NEUROSURGERY, V68, P996, DOI 10.1227/NEU.0b013e3182096d84; STENAGER E, 1986, ACTA NEUROCHIR, V83, P20, DOI 10.1007/BF01420503; Tamburrini G, 2008, ACTA NEUROCHIR, V150, P1049, DOI 10.1007/s00701-008-0022-6; Walti LN, 2013, J INFECTION, V66, P424, DOI 10.1016/j.jinf.2012.12.010; WINFIELD JA, 1993, NEUROSURGERY, V33, P424; Winfield JA, 1993, NEUROSURGERY, V33, P430; WYLER AR, 1972, J NEUROSURG, V37, P185, DOI 10.3171/jns.1972.37.2.0185; Zabramski JM, 2003, J NEUROSURG, V98, P725, DOI 10.3171/jns.2003.98.4.0725	40	26	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142320	10.1371/journal.pone.0142320	http://dx.doi.org/10.1371/journal.pone.0142320			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555597	Green Submitted, Green Published, gold			2022-12-27	WOS:000364430700084
J	Xu, PJ; Li, ZG; Wang, H; Zhang, XC; Yang, Z				Xu, Pengjuan; Li, Zhigui; Wang, Hui; Zhang, Xiaochen; Yang, Zhuo			Triptolide Inhibited Cytotoxicity of Differentiated PC12 Cells Induced by Amyloid-Beta(25-35) via the Autophagy Pathway	PLOS ONE			English	Article							WILFORDII HOOK-F; NF-KAPPA-B; ALZHEIMERS-DISEASE; NEURONAL DEATH; AMYLOID-BETA; EXPRESSION; APOPTOSIS; LC3; NEURODEGENERATION; EPIDEMIOLOGY	Evidence shows that an abnormal deposition of amyloid beta-peptide(25-35) (A beta(25-35)) was the primary cause of the pathogenesis of Alzheimer's disease (AD). And the elimination of A beta(25-35) is considered an important target for the treatment of AD. Triptolide (TP), isolated from Tripterygium wilfordii Hook. f. (TWHF), has been shown to possess a broad spectrum of biological profiles, including neurotrophic and neuroprotective effects. In our study investigating the effect and potential mechanism of triptolide on cytotoxicity of differentiated rat pheochromocytoma cell line (the PC12 cell line is often used as a neuronal developmental model) induced by Amyloid-Beta(25-35) (A beta(25-35)), we used 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay, flow cytometry, Western blot, and acridine orange staining to detect whether triptolide could inhibit A beta(25-35)-induced cell apoptosis. We focused on the potential role of the autophagy pathway in A beta(25-35)-treated differentiated PC12 cells. Our experiments show that cell viability is significantly decreased, and the apoptosis increased in A beta(25-35)-treated differentiated PC12 cells. Meanwhile, A beta(25-35) treatment increased the expression of microtubule-associated protein light chain 3 II (LC3 II), which indicates an activation of autophagy. However, triptolide could protect differentiated PC12 cells against A beta(25-35)-induced cytotoxicity and attenuate A beta(25-35)-induced differentiated PC12 cell apoptosis. Triptolide could also suppress the level of autophagy. In order to assess the effect of autophagy on the protective effects of triptolide in differentiated PC12 cells treated with A beta(25-35), we used 3-Methyladenine (3-MA, an autophagy inhibitor) and rapamycin (an autophagy activator). MTT assay showed that 3-MA elevated cell viability compared with the A beta(25-35)-treated group and rapamycin inhibits the protection of triptolide. These results suggest that triptolide will repair the neurological damage in AD caused by deposition of A beta(25-35) via the autophagy pathway, all of which may provide an exciting view of the potential application of triptolide or TWHF as a future research for AD.	[Xu, Pengjuan] Tianjin Univ Tradit Chinese Med, Sch Integrat Med, Tianjin 300193, Peoples R China; [Li, Zhigui; Zhang, Xiaochen; Yang, Zhuo] Nankai Univ, Tianjin Key Lab Tumor Microenvironm & Neurovasc R, State Key Lab Med Chem Biol, Coll Med, Tianjin 300071, Peoples R China; [Wang, Hui] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China	Tianjin University of Traditional Chinese Medicine; Nankai University; Nankai University	Xu, PJ (corresponding author), Tianjin Univ Tradit Chinese Med, Sch Integrat Med, Tianjin 300193, Peoples R China.	pjxu1984@tjutcm.edu.cn	Li, Zhigui/I-9108-2019	Li, Zhigui/0000-0003-1317-8679				Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Adlard PA, 2009, DRUG TODAY, V45, P293, DOI [10.1358/dot.2009.045.004.1353853, 10.1358/dot.2009.45.4.1353853]; Banerjee R, 2010, TRENDS NEUROSCI, V33, P541, DOI 10.1016/j.tins.2010.09.001; Banerjee R, 2009, BBA-MOL BASIS DIS, V1792, P651, DOI 10.1016/j.bbadis.2008.11.007; Baregamian N, 2009, OXID MED CELL LONGEV, V2, P297, DOI 10.4161/oxim.2.5.9541; Bates KA, 2009, MOL PSYCHIATR, V14, P469, DOI 10.1038/mp.2008.96; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Brinker AM, 2007, PHYTOCHEMISTRY, V68, P732, DOI 10.1016/j.phytochem.2006.11.029; Caccamo A, 2010, J BIOL CHEM, V285, P13107, DOI 10.1074/jbc.M110.100420; Chen T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118645; Chen YQ, 2008, AUTOPHAGY, V4, P246, DOI 10.4161/auto.5432; Chen YQ, 2011, J CELL SCI, V124, P161, DOI 10.1242/jcs.064576; De Duve C, 1963, CIB FDN S LYS; Gao Jun-Peng, 2008, Neurosci Bull, V24, P133, DOI 10.1007/s12264-008-1225-9; Geng Y, 2012, PHYTOTHER RES, V26, P337, DOI 10.1002/ptr.3538; Ghavami S, 2014, PROG NEUROBIOL, V112, P24, DOI 10.1016/j.pneurobio.2013.10.004; Gu Ming, 2004, Shengli Xuebao, V56, P73; Hamaguchi T, 2006, CELL MOL LIFE SCI, V63, P1538, DOI 10.1007/s00018-005-5599-9; Han YG, 2013, J MOL NEUROSCI, V50, P577, DOI 10.1007/s12031-013-0004-x; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; He Qihua, 2003, Beijing Da Xue Xue Bao Yi Xue Ban, V35, P252; Huang D, 2007, AM J PHYSIOL-CELL PH, V292, pC1339, DOI 10.1152/ajpcell.00144.2006; Hung SY, 2009, AUTOPHAGY, V5, P502, DOI 10.4161/auto.5.4.8096; Jaeger PA, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-16; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kirkland RA, 2002, NEUROSCIENCE, V115, P587, DOI 10.1016/S0306-4522(02)00512-2; KUPCHAN SM, 1972, J AM CHEM SOC, V94, P7194, DOI 10.1021/ja00775a078; Lee EA, 2005, KIDNEY INT, V67, P1762, DOI 10.1111/j.1523-1755.2005.00274.x; Lin MH, 2010, ORAL ONCOL, V46, P822, DOI 10.1016/j.oraloncology.2010.08.002; Lin N, 2001, ARTHRITIS RHEUM-US, V44, P2193, DOI 10.1002/1529-0131(200109)44:9&lt;2193::AID-ART373&gt;3.0.CO;2-5; Luo TF, 2014, INT J MOL SCI, V15, P15426, DOI 10.3390/ijms150915426; Martinez-Vicente M, 2007, LANCET NEUROL, V6, P352, DOI 10.1016/S1474-4422(07)70076-5; Mielke MM, 2014, CLIN EPIDEMIOL, V6, P37, DOI 10.2147/CLEP.S37929; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nelson Michael P, 2013, Curr Pathobiol Rep, V1, P239; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Nixon RA, 2008, AUTOPHAGY, V4, P590, DOI 10.4161/auto.6259; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; Reitz C, 2011, NAT REV NEUROL, V7, P137, DOI [10.1038/nrneurol.2011.2, 10.1101/cshperspect.a006239]; Ristica B, 2014, EXP CELL RES, V326, P90, DOI 10.1016/j.yexcr.2014.05.021; Sawa A, 2005, NEUROBIOL DIS, V20, P267, DOI 10.1016/j.nbd.2005.02.013; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; Tao XL, 2000, RHEUM DIS CLIN N AM, V26, P29, DOI 10.1016/S0889-857X(05)70118-6; TAO XL, 1991, ARTHRITIS RHEUM, V34, P1274, DOI 10.1002/art.1780341011; TELLEZNAGEL I, 1974, J NEUROPATH EXP NEUR, V33, P308, DOI 10.1097/00005072-197404000-00008; Tischler AS, 2002, ANN NY ACAD SCI, V971, P366, DOI 10.1111/j.1749-6632.2002.tb04498.x; Tooze SA, 2008, CURR OPIN NEUROBIOL, V18, P504, DOI 10.1016/j.conb.2008.09.015; Ulamek-Koziol M, 2013, NEUROCHEM RES, V38, P1769, DOI 10.1007/s11064-013-1082-4; Wang H, 2015, LISS 2013, P1, DOI 10.1007/978-3-642-40660-7_1; Wei MM, 2014, MOL CELL BIOCHEM, V394, P261, DOI 10.1007/s11010-014-2102-7; Xu PJ, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-0906-5; Xu YN, 2011, J REPROD DEVELOP, V57, P143, DOI 10.1262/jrd.10-110H; Xue LZ, 1999, MOL CELL NEUROSCI, V14, P180, DOI 10.1006/mcne.1999.0780; Zhang R, 2013, CHINESE MED J-PEKING, V126, P1884, DOI 10.3760/cma.j.issn.0366-6999.20130095; Zheng Y, 2013, CNS NEUROSCI THER, V19, P76, DOI 10.1111/cns.12039	58	27	29	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142719	10.1371/journal.pone.0142719	http://dx.doi.org/10.1371/journal.pone.0142719			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26554937	Green Published, gold, Green Submitted			2022-12-27	WOS:000364430700158
J	El-Serafi, I; Afsharian, P; Moshfegh, A; Hassan, M; Terelius, Y				El-Serafi, Ibrahim; Afsharian, Parvaneh; Moshfegh, Ali; Hassan, Moustapha; Terelius, Ylva			Cytochrome P450 Oxidoreductase Influences CYP2B6 Activity in Cyclophosphamide Bioactivation	PLOS ONE			English	Article							P450 OXIDOREDUCTASE; INTERINDIVIDUAL VARIABILITY; ALLELE FREQUENCIES; GENE POLYMORPHISMS; IN-VITRO; METABOLISM; VARIANTS; 4-HYDROXYCYCLOPHOSPHAMIDE; PHARMACOKINETICS; EXPRESSION	Introduction Cyclophosphamide is commonly used as an important component in conditioning prior to hematopoietic stem cell transplantation, a curative treatment for several hematological diseases. Cyclophosphamide is a prodrug activated mainly by cytochrome P450 2B6 (CYP2B6) in the liver. A high degree of inter-and intra-individual variation in cyclophosphamide kinetics has been reported in several studies. Materials and Methods Hydroxylation of cyclophosphamide was investigated in vitro using three microsomal batches of CYP2B6*1 with different ratios of POR/CYP expression levels. Twenty patients undergoing hematopoietic stem cell transplantation were also included in the study. All patients received an i.v. infusion of cyclophosphamide (60 mg/kg/day, for two days) as a part of their conditioning. Blood samples were collected from each patient before cyclophosphamide infusion, 6 h after the first dose and before and 6 h after the second dose. POR gene expression was measured by mRNA analysis and the pharmacokinetics of cyclophosphamide and its active metabolite were determined. Results A strong correlation between the in vitro intrinsic clearance of cyclophosphamide and the POR/CYP ratio was found. The apparent K-m for CYP2B6.1 was almost constant (3-4 mM), while the CLint values were proportional to the POR/CYP ratio (3-34 mu L/min/nmol CYP). In patients, the average expression of the POR gene in blood was significantly (P < 0.001) up-regulated after cyclophosphamide infusion, with high inter-individual variations and significant correlation with the concentration ratio of the active metabolite 4-hydroxy-cyclophosphamide/cyclophosphamide. Nine patients were carriers for POR*28; four patients had relatively high POR expression. Conclusions This investigation shows for the first time that POR besides CYP2B6 can influence cyclophosphamide metabolism. Our results indicate that not only CYPs are important, but also POR expression and/or activity may influence cyclophosphamide bioactivation, affecting therapeutic efficacy and treatment related toxicity and hence on clinical outcome. Thus, both POR and CYP genotype and expression levels may have to be taken into account when personalizing treatment schedules to achieve optimal therapeutic drug plasma concentrations of cyclophosphamide.	[El-Serafi, Ibrahim; Afsharian, Parvaneh; Hassan, Moustapha] Karolinska Inst, Dept Lab Med, ECM, Stockholm, Sweden; [Moshfegh, Ali] Karolinska Inst, Dept Oncol Pathol, CCK, Stockholm, Sweden; [Hassan, Moustapha] Karolinska Univ Hosp Huddinge, Dept Clin Res Ctr, Stockholm, Sweden; [Terelius, Ylva] Medivir AB, Dept Discovery Res, Huddinge, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Medivir	Hassan, M (corresponding author), Karolinska Inst, Dept Lab Med, ECM, Stockholm, Sweden.	Moustapha.Hassan@ki.se	Hassan, Moustapha/H-9260-2015	Hassan, Moustapha/0000-0003-1927-5859; El-Serafi, Ibrahim/0000-0002-0463-1518	Swedish Childhood Cancer Society; Swedish Cancer Foundation; Karolinska Institute	Swedish Childhood Cancer Society; Swedish Cancer Foundation; Karolinska Institute(Karolinska Institutet)	The study was supported by grants from the Swedish Childhood Cancer Society, Swedish Cancer Foundation and The Karolinska Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Medivir provided support in the form of salary for author YT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Afsar NA, 2012, EUR J CLIN PHARMACOL, V68, P389, DOI 10.1007/s00228-011-1134-0; Afsharian P, 2005, EUR J HAEMATOL, V75, P206, DOI 10.1111/j.1600-0609.2005.00492.x; Agrawal V, 2008, PHARMACOGENET GENOM, V18, P569, DOI 10.1097/FPC.0b013e32830054ac; Ariyoshi N, 2001, BIOCHEM BIOPH RES CO, V281, P1256, DOI 10.1006/bbrc.2001.4524; Ariyoshi N, 2011, DRUG METAB DISPOS, V39, P2045, DOI 10.1124/dmd.111.039586; Binotto G, 2003, ONCOLOGY-BASEL, V65, P17, DOI 10.1159/000073353; Burt RK, 2008, JAMA-J AM MED ASSOC, V299, P925, DOI 10.1001/jama.299.8.925; CHANG TKH, 1993, CANCER RES, V53, P5629; Chen X, 2012, PLOS ONE, V7; Cho JY, 2004, DRUG METAB DISPOS, V32, P1341, DOI 10.1124/dmd.104.001107; de Jonge H, 2011, PHARMACOGENOMICS, V12, P1281, DOI [10.2217/PGS.11.77, 10.2217/pgs.11.77]; Fernandes BJD, 2011, CANCER CHEMOTH PHARM, V68, P897, DOI 10.1007/s00280-011-1554-7; El-Serafi I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086619; Fluck CE, 2004, NAT GENET, V36, P228, DOI 10.1038/ng1300; Gomes AM, 2009, PHARMACOGENOMICS, V10, P579, DOI [10.2217/pgs.09.7, 10.2217/PGS.09.7]; GORDON MY, 1985, LEUKEMIA RES, V9, P1017, DOI 10.1016/0145-2126(85)90072-4; Griskevicius L, 2002, THER DRUG MONIT, V24, P405, DOI 10.1097/00007691-200206000-00013; Hart SN, 2008, EXPERT OPIN DRUG MET, V4, P439, DOI [10.1517/17425255.4.4.439, 10.1517/17425255.4.4.439 ]; Hesse LM, 2004, PHARMACOGENETICS, V14, P225, DOI 10.1097/00008571-200404000-00002; Huang NW, 2005, AM J HUM GENET, V76, P729, DOI 10.1086/429417; Klein K, 2005, PHARMACOGENET GENOM, V15, P861, DOI 10.1097/01213011-200512000-00004; Lang T, 2004, J PHARMACOL EXP THER, V311, P34, DOI 10.1124/jpet.104.068973; Lang T, 2001, PHARMACOGENETICS, V11, P399, DOI 10.1097/00008571-200107000-00004; Merla G, 2006, AM J HUM GENET, V79, P332, DOI 10.1086/506371; Pandey AV, 2010, BIOCHEM BIOPH RES CO, V400, P374, DOI 10.1016/j.bbrc.2010.08.072; Raccor BS, 2012, DRUG METAB DISPOS, V40, P54, DOI 10.1124/dmd.111.039347; Ren S, 1997, CANCER RES, V57, P4229; REYNOLDS M, 1989, EUR J HAEMATOL, V43, P314; RODRIGUEZ G, 1994, INVEST NEW DRUG, V12, P75, DOI 10.1007/BF00874436; Rotger Margalida, 2005, Pharmacogenet Genomics, V15, P1, DOI 10.1097/01213011-200501000-00001; Sandee D, 2010, PHARMACOGENET GENOM, V20, P677, DOI 10.1097/FPC.0b013e32833f4f9b; SINGER CRJ, 1987, LEUKEMIA RES, V11, P953, DOI 10.1016/0145-2126(87)90112-3; SLADEK NE, 1988, PHARMACOL THERAPEUT, V37, P301, DOI 10.1016/0163-7258(88)90004-6; Subramanian M, 2012, PHARMACOGENET GENOM, V22, P590, DOI 10.1097/FPC.0b013e3283544062; Tsuchiya K, 2004, BIOCHEM BIOPH RES CO, V319, P1322, DOI 10.1016/j.bbrc.2004.05.116; Wang SL, 2007, DRUG METAB DISPOS, V35, P176, DOI 10.1124/dmd.106.011056; Wortham M, 2007, DRUG METAB DISPOS, V35, P1700, DOI 10.1124/dmd.107.016436; Xie HJ, 2006, EUR J PHARM SCI, V27, P54, DOI 10.1016/j.ejps.2005.08.008; Xie HJ, 2003, PHARMACOGENOMICS J, V3, P53, DOI 10.1038/sj.tpj.6500157; Xie HJ, 2003, BONE MARROW TRANSPL, V31, P197, DOI 10.1038/sj.bmt.1703815; Yao S, 2010, CLIN CANCER RES, V16, P6169, DOI 10.1158/1078-0432.CCR-10-0281; Zhang HM, 2011, J PHARMACOL EXP THER, V338, P803, DOI 10.1124/jpet.111.183111; Zhang JJ, 2012, EUR J CLIN PHARM	43	22	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141979	10.1371/journal.pone.0141979	http://dx.doi.org/10.1371/journal.pone.0141979			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544874	Green Submitted, gold, Green Published			2022-12-27	WOS:000364398700065
J	Giri, A; Wu, JM; Ward, RM; Hartmann, KE; Park, AJ; North, KE; Graff, M; Wallace, RB; Bareh, G; Qi, LH; O'Sullivan, MJ; Reiner, AP; Edwards, TL; Edwards, DRV				Giri, Ayush; Wu, Jennifer M.; Ward, Renee M.; Hartmann, Katherine E.; Park, Amy J.; North, Kari E.; Graff, Mariaelisa; Wallace, Robert B.; Bareh, Gihan; Qi, Lihong; O'Sullivan, Mary J.; Reiner, Alexander P.; Edwards, Todd L.; Edwards, Digna R. Velez			Genetic Determinants of Pelvic Organ Prolapse among African American and Hispanic Women in the Women's Health Initiative	PLOS ONE			English	Article							TIBIAL NERVE-STIMULATION; GENOME-WIDE ASSOCIATION; NATURAL-HISTORY; LAMININ GAMMA-1; FAMILY-HISTORY; RISK; DISORDERS; INCONTINENCE; METAANALYSIS; EXPRESSION	Current evidence suggests a multifactorial etiology to pelvic organ prolapse (POP), including genetic predisposition. We conducted a genome-wide association study of POP in African American (AA) and Hispanic (HP) women from the Women's Health Initiative Hormone Therapy study. Cases were defined as any POP (grades 1-3) or moderate/severe POP (grades 2-3), while controls had grade 0 POP. We performed race-specific multiple logistic regression analyses between SNPs imputed to 1000 genomes in relation to POP (grade 0 vs 1-3; grade 0 vs 2-3) adjusting for age at diagnosis, body mass index, parity, and genetic ancestry. There were 1274 controls and 1427 cases of any POP and 317 cases of moderate/severe POP. Although none of the analyses reached genome-wide significance (p < 5 x 10(-8)), we noted variants in several loci that met p < 10(-6). In race-specific analysis of grade 0 vs 2-3, intronic SNPs in the CPE gene (rs28573326, OR: 2.14; 95% CI 1.62-2.83; p = 1.0 x 10(-7)) were associated with POP in AAs, and SNPs in the gene AL132709.5 (rs1950626, OR: 2.96; 95% CI 1.96-4.48, p = 2.6 x 10(-7)) were associated with POP in HPs. Inverse variance fixed-effect meta-analysis of the race-specific results showed suggestive signals for SNPs in the DPP6 gene (rs11243354, OR: 1.36; p = 4.2 x 10(-7)) in the grade 0 vs 1-3 analyses and for SNPs around PGBD5 (rs740494, OR: 2.17; p = 8.6 x 10(-7)) and SHC3 (rs2209875, OR: 0.60; p = 9.3 x 10(-7)) in the grade 0 vs 2-3 analyses. While we did not identify genome-wide significant findings, we document several SNPs reaching suggestive statistical significance. Further interrogation of POP in larger minority samples is warranted.	[Giri, Ayush; Hartmann, Katherine E.; Reiner, Alexander P.; Edwards, Todd L.; Edwards, Digna R. Velez] Vanderbilt Univ, Vanderbilt Epidemiol Ctr, Inst Med & Publ Hlth, Nashville, TN 37235 USA; [Wu, Jennifer M.] Univ N Carolina, Ctr Womens Hlth Res, Dept Obstet & Gynecol, Chapel Hill, NC USA; [Ward, Renee M.; Hartmann, Katherine E.; Edwards, Digna R. Velez] Vanderbilt Univ, Med Ctr, Dept Obstet & Gynecol, Nashville, TN 37232 USA; [Hartmann, Katherine E.; Edwards, Todd L.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA; [Park, Amy J.] Georgetown Univ, Med Ctr, Dept Obstet & Gynecol & Urol, Washington, DC 20007 USA; [North, Kari E.; Graff, Mariaelisa] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Wallace, Robert B.] Univ Iowa, Dept Epidemiol, Iowa City, IA USA; [Bareh, Gihan] Loma Linda Univ, Dept Obstet & Gynecol, Loma Linda, CA 92350 USA; [Qi, Lihong] Univ Calif Davis, Dept Publ Hlth Sci, Davis, CA 95616 USA; [O'Sullivan, Mary J.] Univ Miami, Dept Obstet & Gynecol, Miami, FL USA; [Reiner, Alexander P.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Edwards, Todd L.; Edwards, Digna R. Velez] Vanderbilt Univ, Vanderbilt Genet Inst, Nashville, TN 37235 USA	Vanderbilt University; University of North Carolina; University of North Carolina Chapel Hill; Vanderbilt University; Vanderbilt University; Georgetown University; University of North Carolina; University of North Carolina Chapel Hill; University of Iowa; Loma Linda University; University of California System; University of California Davis; University of Miami; University of Washington; University of Washington Seattle; Vanderbilt University	Edwards, TL (corresponding author), Vanderbilt Univ, Vanderbilt Epidemiol Ctr, Inst Med & Publ Hlth, 221 Kirkland Hall, Nashville, TN 37235 USA.	todd.l.edwards@vanderbilt.edu; digna.r.velez.edwards@vanderbilt.edu	Wu, Jennifer/GRX-1831-2022; Qi, LI/AAF-3389-2019; Hartmann, Katherine Eubanks/AAV-5288-2020	Wu, Jennifer/0000-0002-4477-3932; Wu, Jennifer/0000-0002-3171-1054; Hartmann, Katherine/0000-0002-7051-8185	National Heart, Lung, and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services [N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, 44221]; NHLBI [N02-HL-64278]; Vanderbilt Clinical and Translational Research Scholar award [5KL2RR024975]; Building Interdisciplinary Research Careers in Women's Health career development program [5K12HD04383-11]; Eunice Kennedy Shriver National Institute of Child Health & Human Development [K23HD068404]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K23HD068404] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA015704] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064278] Funding Source: NIH RePORTER; WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH [N01WH042129, N01WH042107, N01WH032122, N01WH032100, N01WH032118, N01WH032111, N01WH032108, N01WH022110, N01WH032105, N01WH032115] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Vanderbilt Clinical and Translational Research Scholar award; Building Interdisciplinary Research Careers in Women's Health career development program; Eunice Kennedy Shriver National Institute of Child Health & Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The Women's Health Initiative program is funded by the National Heart, Lung, and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services through contracts N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, and 44221. Funding for Women's Health Initiative SHARe genotyping was provided by NHLBI Contract N02-HL-64278. This work was funded by Vanderbilt Clinical and Translational Research Scholar award (5KL2RR024975) to Todd Edwards and by the Building Interdisciplinary Research Careers in Women's Health career development program (5K12HD04383-11) to Digna R. Velez Edwards. Dr. Jennifer Wu is supported by K23HD068404, Eunice Kennedy Shriver National Institute of Child Health & Human Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen-Brady K, 2014, AM J OBSTET GYNECOLO; Allen-Brady K, 2011, OBSTET GYNECOL, V118, P1345, DOI 10.1097/AOG.0b013e318236f4b5; Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; Biemans JMAE, 2013, NEUROMODULATION, V16, P25, DOI 10.1111/j.1525-1403.2012.00504.x; Bortolini MAT, 2012, NEUROUROL URODYNAM, V31, P109, DOI 10.1002/nau.21175; Bradley CS, 2007, OBSTET GYNECOL, V109, P848, DOI 10.1097/01.AOG.0000255977.91296.5d; Buchsbaum GM, 2006, OBSTET GYNECOL, V108, P1388, DOI 10.1097/01.AOG.0000245784.31082.ed; Chen C, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.014; Chen H, 2001, HUM MUTAT, V18, P120, DOI 10.1002/humu.1161; Chen HY, 2010, EUR J OBSTET GYN R B, V149, P222, DOI 10.1016/j.ejogrb.2009.12.014; Chiaffarino F, 1999, EUR J OBSTET GYN R B, V82, P63, DOI 10.1016/S0301-2115(98)00175-4; Chu KF, 2013, POSTGRAD MED, V125, P53, DOI 10.3810/pgm.2013.07.2679; Cronin S, 2009, EUR J HUM GENET, V17, P213, DOI 10.1038/ejhg.2008.194; Cronin S, 2008, HUM MOL GENET, V17, P768, DOI 10.1093/hmg/ddm361; Curb JD, 2003, ANN EPIDEMIOL, V13, pS122, DOI 10.1016/S1047-2797(03)00048-6; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Edenfield AL, 2015, OBSTET GYNECOL SURV, V70, P329, DOI 10.1097/OGX.0000000000000171; Glazener C, 2013, BJOG-INT J OBSTET GY, V120, P161, DOI 10.1111/1471-0528.12075; Han B, 2011, AM J HUM GENET, V88, P586, DOI 10.1016/j.ajhg.2011.04.014; Hays J, 2003, ANN EPIDEMIOL, V13, pS18, DOI 10.1016/S1047-2797(03)00042-5; Hendrix SL, 2002, AM J OBSTET GYNECOL, V186, P1160, DOI 10.1067/mob.2002.123819; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Jackson RS, 1997, NAT GENET, V16, P303, DOI 10.1038/ng0797-303; Kluivers KB, 2009, INT UROGYNECOL J, V20, P1113, DOI 10.1007/s00192-009-0913-y; Koch WF, 2014, INNERVATION MATURE H, P337; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Kudish BI, 2009, OBSTET GYNECOL, V113, P81, DOI 10.1097/AOG.0b013e318190a0dd; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Low SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011824; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; McLennan MT, 2008, INT UROGYNECOL J, V19, P1063, DOI 10.1007/s00192-008-0591-1; Morris AP, 2011, GENET EPIDEMIOL, V35, P809, DOI 10.1002/gepi.20630; NAGGERT JK, 1995, NAT GENET, V10, P135, DOI 10.1038/ng0695-135; Nikolova G, 2007, HUM GENET, V120, P847, DOI 10.1007/s00439-006-0267-1; Norton PA, 2013, INT UROGYNECOL J, V24, P413, DOI 10.1007/s00192-012-1866-0; Nygaard I, 2008, JAMA-J AM MED ASSOC, V300, P1311, DOI 10.1001/jama.300.11.1311; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rortveit G, 2007, OBSTET GYNECOLOGY, V109; Tanaka S, 2013, PHARMACOGENOMICS J, V13, P27, DOI 10.1038/tpj.2011.36; van Balken MR, 2001, J UROLOGY, V166, P914, DOI 10.1016/S0022-5347(05)65863-6; van Es MA, 2008, NAT GENET, V40, P29, DOI 10.1038/ng.2007.52; Wang X, 2013, HUM MOL GENET; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Ward RM, 2014, AM J OBSTET GYNECOL, V211, P326, DOI 10.1016/j.ajog.2014.04.006; Whitcomb EL, 2009, OBSTET GYNECOL, V114, P1271, DOI 10.1097/AOG.0b013e3181bf9cc8; Wu JM, 2014, OBSTET GYNECOL, V123, P1201, DOI 10.1097/AOG.0000000000000286; Wu JM, 2013, AM J OBSTET GYNECOL, V208, P360, DOI 10.1016/j.ajog.2012.11.030; Wu JM, 2012, OBSTET GYNECOL, V120, P587, DOI 10.1097/AOG.0b013e318262234b; Wu JM, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.01.033	50	12	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141647	10.1371/journal.pone.0141647	http://dx.doi.org/10.1371/journal.pone.0141647			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26545240	Green Published, gold, Green Submitted			2022-12-27	WOS:000364398700036
J	Huang, JB; Yu, YH; Wei, CY; Qin, QH; Mo, QG; Yang, WP				Huang, Jinbo; Yu, Yinghua; Wei, Changyuan; Qin, Qinghong; Mo, Qinguo; Yang, Weiping			Harmonic Scalpel versus Electrocautery Dissection in Modified Radical Mastectomy for Breast Cancer: A Meta-Analysis	PLOS ONE			English	Article							SEROMA FORMATION; WOUND COMPLICATIONS; ULTRASONIC DISSECTION; SURGERY; TRIAL	Background Despite the common use of conventional electrocautery in modified radical mastectomy for breast cancer, the harmonic scalpel is recently emerging as a dominant surgical instrument for dissection and haemostasis, which is thought to reduce the morbidity, such as seroma and blood loss. But the results of published trials are inconsistent. So we made the metaanalysis to assess the intraoperative and postoperative endpoints among women undergoing modified radical mastectomy with harmonic scalpel or electrocautery. Methods A comprehensive literature search of case-control studies from PubMed, MEDLINE, EMBASE and Cochrane Library databases involving modified radical mastectomy with harmonic scalpel or electrocautery was performed. We carried out a meta-analysis of primary endpoints including postoperative drainage, seroma development, intraoperative blood loss and secondly endpoints including operative time and wound complications. We used odds ratios (ORs) with 95% confidence intervals (CIs) to evaluate the effect size for categorical outcomes and standardised mean differences (SMDs) for continuous outcomes. Results A total of 11 studies with 702 patients were included for this meta-analysis. There was significant difference in total postoperative drainage (SMD: -0.74 [95% CI: -1.31, -0.16]; P < 0.01), seroma development[OR: 0.49 (0.34, 0.70); P < 0.01], intraoperative blood loss (SMD: -1.14 [95% CI: -1.81,-0.47]; P < 0.01) and wound complications [OR: 0.38 (0.24, 0.59); P < 0.01] between harmonic scalpel dissection and standard electrocautery in modified radical mastectomy for breast cancer. No difference was found as for operative time between harmonic scalpel dissection and standard electrocautery (SMD: 0.04 [95% CI: -0.41, 0.50]; P = 0.85). Conclusion Compared to standard electrocautery, harmonic scalpel dissection presents significant advantages in decreasing postoperative drainage, seroma development, intraoperative blood loss and wound complications in modified radical mastectomy for breast cancer, without increasing operative time. Harmonic scalpel can be recommended as a preferential surgical instrument in modified radical mastectomy.	[Huang, Jinbo; Yu, Yinghua; Wei, Changyuan; Qin, Qinghong; Mo, Qinguo] Guangxi Med Univ, Affiliated Tumor Hosp, Dept Breast Surg, Nanning, Guangxi, Peoples R China; [Yang, Weiping] Guangxi Med Univ, Affiliated Tumor Hosp, Dept Ultrasound Diag, Nanning, Guangxi, Peoples R China	Guangxi Medical University; Guangxi Medical University	Yang, WP (corresponding author), Guangxi Med Univ, Affiliated Tumor Hosp, Dept Ultrasound Diag, Nanning, Guangxi, Peoples R China.	1358269512@qq.com	Yang, Wei/HIA-0360-2022					Adwani A, 2006, INT J CLIN PRACT, V60, P562, DOI 10.1111/j.1742-1241.2006.00689.x; Anlar B, 2013, EUR SURG, V45, P286, DOI 10.1007/s10353-013-0231-y; Carcoforo P, 2003, J AM COLL SURGEONS, V196, P365, DOI 10.1016/S1072-7515(02)01757-X; Chen S C, 1999, Changgeng Yi Xue Za Zhi, V22, P37; Currie A, 2012, EJSO-EUR J SURG ONC, V38, P897, DOI 10.1016/j.ejso.2012.05.006; Damani SR, 2013, J SURG PAKISTAN, V18, P2; Deo S. V. S., 2002, SMJ Singapore Medical Journal, V43, P226; Deo SVS, 2000, J SURG ONCOL, V74, P204, DOI 10.1002/1096-9098(200007)74:3<204::AID-JSO9>3.0.CO;2-U; Ribeiro GHFP, 2013, INT J SURG, V11, P496, DOI 10.1016/j.ijsu.2013.03.013; Galatius H, 2003, BREAST, V12, P338, DOI 10.1016/S0960-9776(03)00110-3; Gonzalez Ernest A, 2003, Breast J, V9, P385, DOI 10.1046/j.1524-4741.2003.09504.x; HAMBLEY R, 1988, J DERMATOL SURG ONC, V14, P1213, DOI 10.1111/j.1524-4725.1988.tb03478.x; HOEFER RA, 1990, J AM OSTEOPATH ASSOC, V90, P47; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Khan S, 2014, ANN SURG ONCOL, V21, P808, DOI 10.1245/s10434-013-3369-8; Kiyingi AK, 2015, ANZ J SURG, V85, P358, DOI 10.1111/ans.12594; Kontos M, 2008, J BUON, V13, P223; Kozomara D, 2010, COLLEGIUM ANTROPOL, V34, P105; Kumar S, 1995, J R Coll Surg Edinb, V40, P292; Kuroi K, 2006, JPN J CLIN ONCOL, V36, P197, DOI 10.1093/jjco/hyl019; Parker DJ, 2009, ANZ J SURG, V79, P476, DOI 10.1111/j.1445-2197.2009.04949.x; Perko Z, 2006, SURG ENDOSC, V20, P322, DOI 10.1007/s00464-005-0089-6; Porter KA, 1998, AM J SURG, V176, P8, DOI 10.1016/S0002-9610(98)00093-2; Rohaizak M, 2013, Med J Malaysia, V68, P204; Sajid MS, 2012, J SURG ONCOL, V106, P783, DOI 10.1002/jso.23140; Segura-Castillo Jose Luis, 2005, Cir Cir, V73, P345; Shamley DR, 2005, BREAST CANCER RES TR, V90, P263, DOI 10.1007/s10549-004-4727-9; SHEENCHEN SM, 1993, EUR J SURG, V159, P457; VANHEURN LWE, 1995, BRIT J SURG, V82, P931, DOI 10.1002/bjs.1800820725; Woodworth PA, 2000, AM SURGEON, V66, P444; Yilmaz KB, 2011, J BREAST CANCER, V14, P58, DOI 10.4048/jbc.2011.14.1.58; Yuan N, 2014, MOL CLIN ONCOL, V2, P245, DOI 10.3892/mco.2013.230	33	27	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142271	10.1371/journal.pone.0142271	http://dx.doi.org/10.1371/journal.pone.0142271			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544716	Green Submitted, Green Published, gold			2022-12-27	WOS:000364398700104
J	Vargas, CL; Espinoza, MA; Giglio, A; Soza, A				Vargas, Constanza L.; Espinoza, Manuel A.; Giglio, Andres; Soza, Alejandro			Cost Effectiveness of Daclatasvir/Asunaprevir Versus Peginterferon/Ribavirin and Protease Inhibitors for the Treatment of Hepatitis c Genotype 1b Naive Patients in Chile	PLOS ONE			English	Article							DACLATASVIR PLUS ASUNAPREVIR; HEPATOCELLULAR-CARCINOMA; NATURAL-HISTORY; LIVER-DISEASE; UNITED-STATES; CIRRHOSIS; THERAPY; TRANSPLANTATION; RIBAVIRIN; SURVIVAL	Introduction Daclatasvir and Asunaprevir (DCV/ASV) have recently been approved for the treatment of chronic hepatitis C virus infection. In association, they are more effective and safer than previous available treatments, but more expensive. It is unclear if paying for the additional costs is an efficient strategy considering limited resources. Methods A Markov model was built to estimate the expected costs in Chilean pesos (CL$) and converted to US dollars (US$) and benefits in quality adjusted life years (QALYs) in a hypothetic cohort of naive patients receiving DCV/ASV compared to protease inhibitors (PIs) and Peginterferon plus Ribavirin (PR). Efficacy was obtained from a mixed-treatment comparison study and costs were estimated from local sources. Utilities were obtained applying the EQ-5D survey to local patients and then valued with the Chilean tariff. A time horizon of 46 years and a discount rate of 3% for costs and outcomes was considered. The ICERs were estimated for a range of DCV/ASV prices. Deterministic and probabilistic sensitivity analyses were performed. Results PIs were extendedly dominated by DCV/ASV. The ICER of DCV/ASV compared to PR was US$ 16,635/QALY at a total treatment price of US$ 77,419; US$ 11,581/QALY at a price of US$ 58,065; US$ 6,375/QALY at a price of US$ 38,710; and US$ 1,364 /QALY at a price of US$ 19,355. The probability of cost-effectiveness at a price of US$ 38,710 was 91.6% while there is a 21.43% probability that DCV/ASV dominates PR if the total treatment price was US$ 19,355. Although the results are sensitive to certain parameters, the ICER did not increase above the suggested threshold of 1 GDP per capita. Conclusions DCV/ASV can be considered cost-effective at any price of the range studied. These results provide decision makers useful information about the value of incorporating these drugs into the public Chilean healthcare system.	[Vargas, Constanza L.; Espinoza, Manuel A.; Soza, Alejandro] Pontificia Univ Catolica Chile, Clin Res Ctr, Hlth Technol Assessment Unit, Santiago, Chile; [Espinoza, Manuel A.] Pontificia Univ Catolica Chile, Dept Publ Hlth, Santiago, Chile; [Giglio, Andres] Hosp Dr Sotero del Rio, Santiago, Chile; [Soza, Alejandro] Pontificia Univ Catolica Chile, Dept Gastroenterol, Santiago, Chile	Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Universidad de Chile; Pontificia Universidad Catolica de Chile	Espinoza, MA (corresponding author), Pontificia Univ Catolica Chile, Clin Res Ctr, Hlth Technol Assessment Unit, Alameda 340, Santiago, Chile.	maespinoza@med.puc.cl	Espinoza, Manuel/AAU-5178-2020	Espinoza, Manuel/0000-0001-9564-9512; Vargas, Constanza/0000-0002-8667-1926	Bristol Meyers Squib	Bristol Meyers Squib	Bristol Meyers Squib provided the funding of this study to the Centre for Clinical Research, Pontificia Universidad Catolica de Chile. The study was performed under strict clauses of independence of the authors regarding matters of study design, data collection, interpretation of data, analysis of the results and elaboration of the manuscript. This manuscript did not require the approval of BMS for its submission.	Abrarira G L, 2013, SANTIAGO COMPOSTELA; [Anonymous], 2015, HEPATOLOGY BALTIMORE; Benvegnu L, 2001, GUT, V48, P110, DOI 10.1136/gut.48.1.110; Booth J, 2001, CLIN GUIDELINES MANA; CANTOR SB, 1994, MED DECIS MAKING, V14, P259, DOI 10.1177/0272989X9401400308; Cardoso AC, 2010, J HEPATOL, V52, P652, DOI 10.1016/j.jhep.2009.12.028; CENABAST, 2014, INF COMP MERC TEL BO; Chhatwal J, 2015, ANN INTERN MED, V162, P397, DOI 10.7326/M14-1336; D'Amico G, 2006, J HEPATOL, V44, P217, DOI 10.1016/j.jhep.2005.10.013; Fattovich G, 1997, GASTROENTEROLOGY, V112, P463, DOI 10.1053/gast.1997.v112.pm9024300; FONASA, 2014, DECR LEY INF PREC 20; FONASA, 2014, AR FONASA MOD AT I M; Gao M, 2013, CURR OPIN VIROL, V3, P514, DOI 10.1016/j.coviro.2013.06.014; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; INE D, 2014, AN EST VIT 2012; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Kumada H, 2014, HEPATOLOGY, V59, P2083, DOI 10.1002/hep.27113; Lang K, 2009, J HEPATOL, V50, P89, DOI 10.1016/j.jhep.2008.07.029; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Leidner AJ, 2015, HEPATOLOGY BALTIMORE; Ltda BA, 2009, ESTUDIO VERIFICACION; Manns M, 2014, LANCET, V384, P1597, DOI 10.1016/S0140-6736(14)61059-X; Martin NK, 2012, HEPATOLOGY, V55, P49, DOI 10.1002/hep.24656; McEwan P, 2013, APPL HEALTH ECON HEA, V11, P53, DOI 10.1007/s40258-012-0002-0; McLernon DJ, 2008, MED DECIS MAKING, V28, P582, DOI 10.1177/0272989X08315240; McPhee F, 2012, ANTIMICROB AGENTS CH, V56, P5387, DOI 10.1128/AAC.01186-12; MINSAL, 2013, AN CAN VAL EST VER C; [MINSAL salud Edl], 2013, SAL EDL; [MINSAL Publica SdS], 2010, PUBL SDS; Najafzadeh M, 2015, ANN INTERN MED, V162, P407, DOI 10.7326/M14-1152; NICE, 2013, PEG ALF RIB TREATM M; Pawlotsky JM, 2015, J HEPATOL, V63, P199, DOI 10.1016/j.jhep.2015.03.025; Perez R, TRANSPLANTE HEPATICO; Planas R, 2004, J HEPATOL, V40, P823, DOI 10.1016/j.jhep.2004.01.005; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Ryder SD, 2015, CLIN MED, V15, P197, DOI 10.7861/clinmedicine.15-2-197; Saab S, 2010, LIVER TRANSPLANT, V16, P748, DOI 10.1002/lt.22072; Shepherd J, 2007, HEALTH TECHNOL ASSES, V11, P1; Signorovitch JE, 2015, J COMP EFFECT RES, P1; Soza Alejandro, 2004, Ann Hepatol, V3, P146; Thein HH, 2008, HEPATOLOGY, V48, P418, DOI 10.1002/hep.22375; Thuluvath PJ, 2010, AM J TRANSPLANT, V10, P1003, DOI 10.1111/j.1600-6143.2010.03037.x; Townsend R, 2011, VALUE HEALTH, V14, P1068, DOI 10.1016/j.jval.2011.06.006; WHO, 2014, GUID SCREEN CAR TREA; Wolfe RA, 2010, AM J TRANSPLANT, V10, P961, DOI 10.1111/j.1600-6143.2010.03021.x; Zarate V, 2011, VALUE HEALTH, V14, P1135, DOI 10.1016/j.jval.2011.09.002	46	8	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141660	10.1371/journal.pone.0141660	http://dx.doi.org/10.1371/journal.pone.0141660			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544203	Green Published, gold, Green Submitted			2022-12-27	WOS:000364398700038
J	Cai, Y; Kimura, S				Cai, Yan; Kimura, Shioko			Secretoglobin 3A2 Exhibits Anti-Fibrotic Activity in Bleomycin-Induced Pulmonary Fibrosis Model Mice	PLOS ONE			English	Article							SURFACTANT PROTEIN-A; UTEROGLOBIN-RELATED PROTEIN-1; LUNG; MOUSE; GENE; INFLAMMATION; EXPRESSION; MARKER	Objective Secretoglobin (SCGB) 3A2 is a novel lung-enriched cytokine, previously shown to exhibit anti-inflammatory, growth factor, and anti-fibrotic activities. The latter activity was demonstrated using exogenously-administered recombinant SCGB3A2 in the bleomycin (BLM)induced pulmonary fibrosis model. Whether SCGB3A2 exhibits anti-fibrotic activity in vivo is not known. Methods Mice null for the Scgb3a2 gene were subjected to the BLM-induced pulmonary fibrosis model, and the severity of pulmonary fibrosis determined using histological and biochemical methods. Results BLM treatment caused weight loss of both Scgb3a2-null and wild-type mice, however, the loss was far more pronounced in BLM-treated Scgb3a2-null than wild-type mice, and the weight of day 21 of BLM-treated Scgb3a2-null mice was about half of that of BLM-treated wild-type mice. Hematoxylin & Eosin, Masson Trichrome, and Sirius Red staining of lung sections, Ashcroft fibrosis scores, hydroxyproline contents, and the levels of mRNAs encoding various collagens demonstrated that BLM-treated Scgb3a2-null mouse lungs had more severe fibrosis than those of wild-type mouse lungs. Total and differential inflammatory cell numbers in bronchoalveolar lavage fluids, and levels of lung mRNAs including those encoding Th2 cytokines such as IL-4 and profibrotic cytokines such as TGF beta were higher in BLM-treated Scgb3a2-null mouse lungs as compared to those of wild-type mouse lungs. In contrast, mRNAs encoding surfactant proteins A, B, C, and D, and SCGB1A1 did not differ between BLM-treated Scgb3a2-null and wild-type mouse lungs. Conclusion The role of SCGB3A2 in fibrosis was revisited using Scgb3a2-null mice and littermate controls in the BLM-induced pulmonary fibrosis model. The pulmonary fibrosis in the Scgb3a2-null mice was more severe than the wild-type controls, thus establishing that SCGB3A2 has anti-fibrotic activity in vivo. Importantly, surfactant proteins and SCGB1A1 appear not to be involved in the susceptibility of Scgb3a2-null mice to BLM-induced pulmonary fibrosis.	[Cai, Yan; Kimura, Shioko] NCI, Lab Metab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Kimura, S (corresponding author), NCI, Lab Metab, NIH, Bethesda, MD 20892 USA.	kimuras@mail.nih.gov	Cai, Yan/P-4383-2015		Intramural Research Program of the National Cancer Institute [ZIABC010449]; NATIONAL CANCER INSTITUTE [ZIABC010449] Funding Source: NIH RePORTER	Intramural Research Program of the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding provided by ZIABC010449, Intramural Research Program of the National Cancer Institute, http://www.cancer.gov/, SK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano Y, 2001, ARTHRITIS RHEUM-US, V44, P1363, DOI 10.1002/1529-0131(200106)44:6<1363::AID-ART229>3.0.CO;2-5; ASHCROFT T, 1988, J CLIN PATHOL, V41, P467, DOI 10.1136/jcp.41.4.467; Cai Y, 2014, AM J PHYSIOL-LUNG C, V306, pL10, DOI 10.1152/ajplung.00037.2013; Chiba Y, 2006, AM J RESP CRIT CARE, V173, P958, DOI 10.1164/rccm.200503-456OC; Chiba Y, 2005, IMMUNOL LETT, V97, P123, DOI 10.1016/j.imlet.2004.10.013; Chiba Y, 2004, AM J PHYSIOL-LUNG C, V287, pL1193, DOI 10.1152/ajplung.00263.2004; Della Latta V, 2015, PHARMACOL RES, V97, P122, DOI 10.1016/j.phrs.2015.04.012; Fujita M, 2005, CYTOKINE, V31, P25, DOI 10.1016/j.cyto.2005.02.006; Guha A, 2012, P NATL ACAD SCI USA, V109, P12592, DOI 10.1073/pnas.1204710109; Harrod KS, 1998, AM J PHYSIOL-LUNG C, V275, pL924, DOI 10.1152/ajplung.1998.275.5.L924; Hasegawa M, 2011, J RHEUMATOL, V38, P877, DOI 10.3899/jrheum.100591; Jackson Brian C., 2011, Human Genomics, V5, P691; Kido T, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/216465; Kinder BW, 2009, CHEST, V135, P1557, DOI 10.1378/chest.08-2209; Kingma PS, 2006, CURR OPIN PHARMACOL, V6, P277, DOI 10.1016/j.coph.2006.02.003; Klug J, 2000, ANN NY ACAD SCI, V923, P348; Kurotani R, 2008, AM J RESP CRIT CARE, V178, P389, DOI 10.1164/rccm.200707-1104OC; Kurotani R, 2011, J BIOL CHEM, V286, P19682, DOI 10.1074/jbc.M111.239046; Kurotani R, 2011, LUNG CANCER, V71, P42, DOI 10.1016/j.lungcan.2010.04.001; Lawson WE, 2005, AM J PATHOL, V167, P1267, DOI 10.1016/S0002-9440(10)61214-X; Lee YC, 2006, FEBS LETT, V580, P4515, DOI 10.1016/j.febslet.2006.07.031; Liu W, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-101; Luzina I.G., 2014, CYTOKINE; Mandal AK, 2004, J EXP MED, V199, P1317, DOI 10.1084/jem.20031666; MCCORMAC FX, 1995, AM J RESP CRIT CARE, V152, P751, DOI 10.1164/ajrccm.152.2.7633738; Mukherjee AB, 2007, ENDOCR REV, V28, P707, DOI 10.1210/er.2007-0018; Mulugeta S, 2006, MICROBES INFECT, V8, P2317, DOI 10.1016/j.micinf.2006.04.009; Niimi T, 2001, MOL ENDOCRINOL, V15, P2021, DOI 10.1210/me.15.11.2021; Reynolds SD, 2002, AM J RESP CRIT CARE, V166, P1498, DOI 10.1164/rccm.200204-285OC; Saha A, 2010, J BIOL CHEM, V285, P10822, DOI 10.1074/jbc.M109.083550; Tachihara-Yoshikawa Motoko, 2008, Fukushima J Med Sci, V54, P61; Tomita T, 2008, J BIOL CHEM, V283, P25617, DOI 10.1074/jbc.M805140200; Whitsett Jeffrey A, 2005, Biol Neonate, V87, P283, DOI 10.1159/000084875; Yang YP, 2004, J BIOL CHEM, V279, P29336, DOI 10.1074/jbc.C400162200	34	14	16	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142497	10.1371/journal.pone.0142497	http://dx.doi.org/10.1371/journal.pone.0142497			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559674	gold, Green Published, Green Submitted			2022-12-27	WOS:000364433100086
J	Gupta, J; Pathak, M; Misra, S; Misra-Bhattacharya, S				Gupta, Jyoti; Pathak, Manisha; Misra, Sweta; Misra-Bhattacharya, Shailja			Immunogenicity and Protective Efficacy of Brugia malayi Heavy Chain Myosin as Homologous DNA, Protein and Heterologous DNA/Protein Prime Boost Vaccine in Rodent Model	PLOS ONE			English	Article							IMMUNE-RESPONSES; ONCHOCERCA-VOLVULUS; CLINICAL-TRIALS; HIGH-LEVEL; IMMUNIZATION; INDUCTION; INFECTIONS; EXPRESSION; CHALLENGE; VECTOR	We earlier demonstrated the immunoprophylactic efficacy of recombinant heavy chain myosin (Bm-Myo) of Brugia malayi (B. malayi) in rodent models. In the current study, further attempts have been made to improve this efficacy by employing alternate approaches such as homologous DNA (pcD-Myo) and heterologous DNA/protein prime boost (pcD-Myo+BmMyo) in BALB/c mouse model. The gene bm-myo was cloned in a mammalian expression vector pcDNA 3.1(+) and protein expression was confirmed in mammalian Vero cell line. A significant degree of protection (79.2%+/- 2.32) against L3 challenge in pcD-Myo+Bm-Myo immunized group was observed which was much higher than that exerted by Bm-Myo (66.6%+/- 2.23) and pcD-Myo (41.6%+/- 2.45). In the heterologous immunized group, the percentage of peritoneal leukocytes such as macrophages, neutrophils, B cells and T cells marginally increased and their population augmented further significantly following L3 challenge. pcD-Myo+Bm-Myo immunization elicited robust cellular and humoral immune responses as compared to pcD-Myo and Bm-Myo groups as evidenced by an increased accumulation of CD4+, CD8+T cells and CD19+B cells in the mouse spleen and activation of peritoneal macrophages. Though immunized animals produced antigen-specific IgG antibodies and isotypes, sera of mice receiving pcD-Myo+Bm-Myo or Bm-Myo developed much higher antibody levels than other groups and there was profound antibody-dependent cellular adhesion and cytotoxicity (ADCC) to B. malayi infective larvae (L3). pcD-Myo+Bm-Myo as well as BmMyo mice generated a mixed T helper cell phenotype as evidenced by the production of both pro-inflammatory (IL-2, IFN-gamma) and anti-inflammatory (IL-4, IL-10) cytokines. Mice receiving pcD-Myo on contrary displayed a polarized pro-inflammatory immune response. The findings suggest that the priming of animals with DNA followed by protein booster generates heightened and mixed pro-and anti-inflammatory immune responses that are capable of providing high degree of protection against filarial larval invasion.	[Gupta, Jyoti; Pathak, Manisha; Misra, Sweta; Misra-Bhattacharya, Shailja] CSIR, Cent Drug Res Inst, Div Parasitol, Lucknow 226031, Uttar Pradesh, India; [Gupta, Jyoti; Misra, Sweta; Misra-Bhattacharya, Shailja] Acad Sci & Innovat Res, New Delhi, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Academy of Scientific & Innovative Research (AcSIR)	Misra-Bhattacharya, S (corresponding author), CSIR, Cent Drug Res Inst, Div Parasitol, BS 10-1,Sect 10,Sitapur Rd, Lucknow 226031, Uttar Pradesh, India.	shailja_cdri@rediffmail.com			Council of Scientific and Industrial Research (CSIR); Indian Council of Medical Research (ICMR), New Delhi	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Indian Council of Medical Research (ICMR), New Delhi(Indian Council of Medical Research (ICMR))	The authors thank the Council of Scientific and Industrial Research (CSIR) and Indian Council of Medical Research (ICMR), New Delhi for financial support in the form of research fellowships to JG, SM and MP and CSIR Network project SPlenDID. The funders have no role in study design, data collection, analysis and decision to publish or preparation of the manuscript.	Anuradha R, 2014, CLIN VACCINE IMMUNOL, V21, P1620, DOI 10.1128/CVI.00598-14; Babayan SA, 2006, INT J PARASITOL, V36, P903, DOI 10.1016/j.ijpara.2006.04.013; Babu S, 2000, INFECT IMMUN, V68, P3034, DOI 10.1128/IAI.68.5.3034-3035.2000; Babu S, 2006, J IMMUNOL, V176, P3885, DOI 10.4049/jimmunol.176.7.3885; Balazs DA, 2011, J DRUG DELIV, V2011, DOI 10.1155/2011/326497; Bennuru S, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000410; Bourguinat C, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000072; Cao SN, 2013, ACTA PARASITOL, V58, P619, DOI 10.2478/s11686-013-0183-1; Catmull J, 1999, VACCINE, V17, P31, DOI 10.1016/S0264-410X(98)00147-9; Dakshinamoorthy G, 2013, VACCINE, V31, P1616, DOI 10.1016/j.vaccine.2012.09.055; Dakshinamoorthy G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034077; Darquet AM, 1997, GENE THER, V4, P1341, DOI 10.1038/sj.gt.3300540; Davtyan H, 2010, GENE THER, V17, P261, DOI 10.1038/gt.2009.140; De Filette M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087837; Eberl G, 2000, EUR J IMMUNOL, V30, P985, DOI 10.1002/(SICI)1521-4141(200004)30:4<985::AID-IMMU985>3.0.CO;2-E; Feng GZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061135; Galioto AM, 2006, INFECT IMMUN, V74, P5730, DOI 10.1128/IAI.01958-05; Gil A, 2013, HUM VACC IMMUNOTHER, V9, P2120, DOI 10.4161/hv.25750; Goyal R, 2012, NANOMED-NANOTECHNOL, V8, P167, DOI 10.1016/j.nano.2011.06.001; Harrison RA, 1999, VACCINE, V18, P647, DOI 10.1016/S0264-410X(99)00274-1; Hartikka J, 1996, HUM GENE THER, V7, P1205, DOI 10.1089/hum.1996.7.10-1205; Irvine KR, 1996, J IMMUNOL, V156, P238; Jones S, 2009, VACCINE, V27, P2506, DOI 10.1016/j.vaccine.2009.02.061; Klencke B, 2002, CLIN CANCER RES, V8, P1028; Kushwaha S, 2012, PARASITE IMMUNOL, V34, P199, DOI 10.1111/j.1365-3024.2012.01352.x; Kushwaha S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072585; Kushwaha S, 2012, MICROBES INFECT, V14, P1330, DOI 10.1016/j.micinf.2012.08.006; Law M, 2007, J VIROL, V81, P4272, DOI 10.1128/JVI.02536-06; Li BW, 1999, VACCINE, V18, P76, DOI 10.1016/S0264-410X(99)00182-6; Li L, 2012, J BIOTECHNOL, V162, P171, DOI 10.1016/j.jbiotec.2012.08.012; Li YH, 2010, VACCINE, V28, P5370, DOI 10.1016/j.vaccine.2010.04.067; Liu MA, 2005, ADV GENET, V55, P25, DOI 10.1016/S0065-2660(05)55002-8; Lustigman S, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000076; Madhumathi J, 2010, VACCINE, V28, P5038, DOI 10.1016/j.vaccine.2010.05.012; Mazumder S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014644; Mellstedt H, 1999, Curr Opin Hematol, V6, P169, DOI 10.1097/00062752-199905000-00008; Min J, 2012, VACCINE, V30, P5631, DOI 10.1016/j.vaccine.2012.06.081; Murray J, 2001, MOL BIOCHEM PARASIT, V118, P89, DOI 10.1016/S0166-6851(01)00374-7; Nag JK, 2013, COMP IMMUNOL MICROB, V36, P25, DOI 10.1016/j.cimid.2012.09.004; Nishimura T, 2000, INT IMMUNOL, V12, P987, DOI 10.1093/intimm/12.7.987; Nolan T, 2014, J INFECT DIS, V210, P1800, DOI 10.1093/infdis/jiu359; Obwaller A, 2001, PARASITOL RES, V87, P383, DOI 10.1007/s004360000352; Pertmer TM, 1996, J VIROL, V70, P6119, DOI 10.1128/JVI.70.9.6119-6125.1996; Pokharel DR, 2006, VACCINE, V24, P6208, DOI 10.1016/j.vaccine.2006.05.103; Ramachandran S, 2004, MICROBIOL IMMUNOL, V48, P945, DOI 10.1111/j.1348-0421.2004.tb03624.x; Ramalingam T, 2003, EXP PARASITOL, V105, P131, DOI 10.1016/j.exppara.2003.09.001; Ramalingam T, 2003, INFECT IMMUN, V71, P4361, DOI 10.1128/IAI.71.8.4361-4367.2003; Ramesh M, 2007, PARASITE IMMUNOL, V29, P395, DOI 10.1111/j.1365-3024.2007.00954.x; Ramshaw IA, 2000, IMMUNOL TODAY, V21, P163, DOI 10.1016/S0167-5699(00)01612-1; Sahu BR, 2008, J INFECT DIS, V198, P434, DOI 10.1086/589881; Shrivastava N, 2013, COMP IMMUNOL MICROB, V36, P507, DOI 10.1016/j.cimid.2013.05.003; Simons JE, 2005, EUR J IMMUNOL, V35, P189, DOI 10.1002/eji.200425541; Smith LR, 2010, VACCINE, V28, P2565, DOI 10.1016/j.vaccine.2010.01.029; Thirugnanam S, 2007, EXP PARASITOL, V116, P483, DOI 10.1016/j.exppara.2007.02.017; Vedi S, 2008, VACCINE, V26, P5997, DOI 10.1016/j.vaccine.2008.08.073; Veerapathran A, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000457; Verma SK, 2008, PARASITOL RES, V102, P481, DOI 10.1007/s00436-007-0786-2; Wang S, 2008, VACCINE, V26, P1098, DOI 10.1016/j.vaccine.2007.12.024; Wolstenholme AJ, 2004, TRENDS PARASITOL, V20, P469, DOI 10.1016/j.pt.2004.07.010; Yan J, 2009, VACCINE, V27, P431, DOI 10.1016/j.vaccine.2008.10.078; Zheng C, 2006, VACCINE, V24, P4625, DOI 10.1016/j.vaccine.2005.08.046	61	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142548	10.1371/journal.pone.0142548	http://dx.doi.org/10.1371/journal.pone.0142548			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26560102	gold, Green Published, Green Submitted			2022-12-27	WOS:000364433100089
J	Kobayashi, M; Kim, SH; Nakamura, H; Kaneda, S; Fujii, T				Kobayashi, Marina; Kim, Soo Hyeon; Nakamura, Hiroko; Kaneda, Shohei; Fujii, Teruo			Cancer Cell Analyses at the Single Cell-Level Using Electroactive Microwell Array Device	PLOS ONE			English	Article							CIRCULATING TUMOR-CELLS; PROSTATE-CANCER; BLOOD; DIELECTROPHORESIS; ACOUSTOPHORESIS; CENTRIFUGATION; ENUMERATION; EXPRESSION; ENRICHMENT; SEPARATION	Circulating tumor cells (CTCs), shed from primary tumors and disseminated into peripheral blood, are playing a major role in metastasis. Even after isolation of CTCs from blood, the target cells are mixed with a population of other cell types. Here, we propose a new method for analyses of cell mixture at the single-cell level using a microfluidic device that contains arrayed electroactive microwells. Dielectrophoretic (DEP) force, induced by the electrodes patterned on the bottom surface of the microwells, allows efficient trapping and stable positioning of single cells for high-throughput biochemical analyses. We demonstrated that various on-chip analyses including immunostaining, viability/apoptosis assay and fluorescent in situ hybridization (FISH) at the single-cell level could be conducted just by applying specific reagents for each assay. Our simple method should greatly help discrimination and analysis of rare cancer cells among a population of blood cells.	[Kobayashi, Marina; Kim, Soo Hyeon; Nakamura, Hiroko; Kaneda, Shohei; Fujii, Teruo] Univ Tokyo, Inst Ind Sci, Tokyo, Japan; [Kaneda, Shohei; Fujii, Teruo] Univ Tokyo, LIMMS CNRS IIS UMI 2820, Tokyo, Japan; [Kobayashi, Marina; Kim, Soo Hyeon; Nakamura, Hiroko; Kaneda, Shohei; Fujii, Teruo] JST CREST, Tokyo, Japan	University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST)	Fujii, T (corresponding author), Univ Tokyo, Inst Ind Sci, Tokyo, Japan.	tfujii@iis.u-tokyo.ac.jp	Kim, Soo Hyeon/L-8991-2016	Kim, Soo Hyeon/0000-0001-9842-9523	Japan Science and Technology Agency for Core Research for Evolutional Science and Technology (CREST); Strategic International Research Cooperative Program (SICP)	Japan Science and Technology Agency for Core Research for Evolutional Science and Technology (CREST); Strategic International Research Cooperative Program (SICP)	This work was partially supported by the Japan Science and Technology Agency for Core Research for Evolutional Science and Technology (CREST) and for Strategic International Research Cooperative Program (SICP).	Albrecht DR, 2006, NAT METHODS, V3, P369, DOI 10.1038/NMETH873; Antfolk M, 2015, LAB CHIP, V15, P2102, DOI 10.1039/c5lc00078e; Asbury CL, 2002, ELECTROPHORESIS, V23, P2658, DOI 10.1002/1522-2683(200208)23:16<2658::AID-ELPS2658>3.0.CO;2-O; Augustsson P, 2012, ANAL CHEM, V84, P7954, DOI 10.1021/ac301723s; Chang CC, 1996, P NATL ACAD SCI USA, V93, P6947, DOI 10.1073/pnas.93.14.6947; de Bono JS, 2008, CLIN CANCER RES, V14, P6302, DOI 10.1158/1078-0432.CCR-08-0872; Dharmasiri U, 2009, ELECTROPHORESIS, V30, P3289, DOI 10.1002/elps.200900141; El-Ali J, 2006, NATURE, V442, P403, DOI 10.1038/nature05063; Gascoyne PRC, 2009, ELECTROPHORESIS, V30, P1388, DOI 10.1002/elps.200800373; Huang Y, 2003, BIOMED MICRODEVICES, V5, P217, DOI 10.1023/A:1025760209483; Karabacak NM, 2014, NAT PROTOC, V9, P694, DOI 10.1038/nprot.2014.044; Kim SH, 2014, LAB CHIP, V14, P730, DOI 10.1039/c3lc51086g; Kim SH, 2011, SMALL, V7, P3239, DOI 10.1002/smll.201101028; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Li P, 2015, P NATL ACAD SCI USA, V112, P4970, DOI 10.1073/pnas.1504484112; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Nordin M, 2012, LAB CHIP, V12, P4610, DOI 10.1039/c2lc40629b; Ozkumur E, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005616; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Tan SJ, 2009, BIOMED MICRODEVICES, V11, P883, DOI 10.1007/s10544-009-9305-9; WANG DIC, 1968, BIOTECHNOL BIOENG, V10, P641, DOI 10.1002/bit.260100509; Yang J, 2002, CLIN DIAGN LAB IMMUN, V9, P1142, DOI 10.1128/CDLI.9.5.1142-1143.2002; Zhang C, 2010, ANAL BIOANAL CHEM, V396, P401, DOI 10.1007/s00216-009-2922-6	23	21	22	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0139980	10.1371/journal.pone.0139980	http://dx.doi.org/10.1371/journal.pone.0139980			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26558904	gold, Green Published, Green Submitted			2022-12-27	WOS:000364433100002
J	Muller, HH; Englbrecht, M; Wiesener, MS; Titze, S; Heller, K; Groemer, TW; Schett, G; Eckardt, KU; Kornhuber, J; Maler, JM				Mueller, Helge H.; Englbrecht, Matthias; Wiesener, Michael S.; Titze, Stephanie; Heller, Katharina; Groemer, Teja W.; Schett, Georg; Eckardt, Kai-Uwe; Kornhuber, Johannes; Maler, Juan Manuel			Depression, Anxiety, Resilience and Coping Pre and Post Kidney Transplantation - Initial Findings from the Psychiatric Impairments in Kidney Transplantation (PI-KT)-Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; HEALTH-RELATED QUALITY; STAGE RENAL-DISEASE; PSYCHOSOCIAL FACTORS; RISK-FACTORS; GRAFT LOSS; 1ST YEAR; RECIPIENTS; HEMODIALYSIS; PREVALENCE	Purpose Depression/anxiety, impaired Health-Related Quality of Life (HRQoL) and coping and resilience structures, are associated with increased mortality/poor outcome in chronic kidney disease (CKD) patients before (CKD/pre-KT) and after kidney (CKD-T) transplantation. Less is known about prevalence rates of psychiatric symptoms and impaired HRQoL of non-transplanted compared with transplanted patients. Methods In a cross-sectional study comparing 101 CKD/pre-KT patients with 151 cadaveric-transplanted (CKD-T) patients, we examined prevalence of depression/anxiety (HADS questionnaire) and coping, resilience and HRQoL (SF-12, Resilience-Scale and FKV-questionnaire). Results The prevalence of both depressive and anxiety symptoms was not significantly different between different pre-/and CKD-T patient groups. In CKD-T no significant relations of coping strategies with kidney function were identified. Furthermore, the Resilience Scales for acceptance and competence did not suggest any differences between the CKD/pre-KT and CKD-T subgroup. In the CKD/pre-KT patients, significant correlations were identified between the acceptance subscale and partnership, as well as between the competence subscale and older age/partnership. Conclusions Both the CKD/pre-KT and CKD-T patients exhibited notable impairments in the HRQoL which which showed a comparable pattern of results. KT itself does not appear to be the main risk factor for the development of mental impairments.	[Mueller, Helge H.; Groemer, Teja W.; Kornhuber, Johannes; Maler, Juan Manuel] Univ Erlangen Nurnberg, Dept Psychiat & Psychotherapy, D-91054 Erlangen, Germany; [Englbrecht, Matthias; Schett, Georg] Univ Erlangen Nurnberg, Dept Internal Med Rheumatol & Immunol 3, D-91054 Erlangen, Germany; [Wiesener, Michael S.; Titze, Stephanie; Heller, Katharina; Eckardt, Kai-Uwe] Univ Erlangen Nurnberg, Dept Internal Med Nephrol & Hypertens 4, D-91054 Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Maler, JM (corresponding author), Univ Erlangen Nurnberg, Dept Psychiat & Psychotherapy, D-91054 Erlangen, Germany.	manuel.maler@uk-erlangen.de	Müller, Helge H.O./P-9524-2018; Kornhuber, Johannes/B-9613-2014	Kornhuber, Johannes/0000-0002-8096-3987	ELAN-Fonds (Erlanger Leistungsbezogene Anschubfinanzierung und Nachwuchsforderung)	ELAN-Fonds (Erlanger Leistungsbezogene Anschubfinanzierung und Nachwuchsforderung)	The study was supported by the ELAN-Fonds (Erlanger Leistungsbezogene Anschubfinanzierung und Nachwuchsforderung). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI [10.1056/NEJMra073096, 10.1038/nrdp.2016.65]; Bossola M, 2012, J NEPHROL, V25, P689, DOI 10.5301/jn.5000042; Bromet E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-90; Cabral JF, 2015, TRANSPL P, V47, P989, DOI 10.1016/j.transproceed.2015.03.036; Chiang HH, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-78; Chisholm-Burns MA, 2012, CLIN TRANSPLANT, V26, P411, DOI 10.1111/j.1399-0012.2011.01541.x; Christensen AJ, 2002, J CONSULT CLIN PSYCH, V70, P712, DOI 10.1037/0022-006X.70.3.712; Costa-Requena G, 2014, MED CLIN-BARCELONA, V142, P393, DOI 10.1016/j.medcli.2013.09.044; Cukor D, 2012, NEPHRON CLIN PRACT, V122, P139, DOI 10.1159/000349940; Czyzewski L, 2014, ANN TRANSPL, V19, P576, DOI 10.12659/AOT.891265; Dobbels F, 2007, ADV CHRONIC KIDNEY D, V14, P370, DOI 10.1053/j.ackd.2007.07.005; Earvolino-Ramirez M, 2007, NURS FORUM, V42, P73, DOI 10.1111/j.1744-6198.2007.00070.x; FA M, 1989, FREIB FRAG KRANKH TE; Fernandez-Jimenez E, 2013, TRANSPL P, V45, P3616, DOI 10.1016/j.transproceed.2013.10.027; Fiebiger Wolfgang, 2004, Health Qual Life Outcomes, V2, P2, DOI 10.1186/1477-7525-2-2; Forero CG, 2013, J CLIN EPIDEMIOL, V66, P790, DOI 10.1016/j.jclinepi.2013.02.007; Gandek B, 1998, J CLIN EPIDEMIOL, V51, P1171, DOI 10.1016/S0895-4356(98)00109-7; Garcia-Dia MJ, 2013, ARCH PSYCHIAT NURS, V27, P264, DOI 10.1016/j.apnu.2013.07.003; GILL TM, 1994, JAMA-J AM MED ASSOC, V272, P619, DOI 10.1001/jama.272.8.619; Gomez-Besteiro MI, 2004, AM J NEPHROL, V24, P346, DOI 10.1159/000079053; Halen NV, 2012, CURR PSYCHIAT REP, V14, P36, DOI 10.1007/s11920-011-0248-5; Health Quality Ontario, 2013, Ont Health Technol Assess Ser, V13, P1; Janowski K, 2014, STRESS HEALTH, V30, P34, DOI 10.1002/smi.2493; Janowski K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063920; Kaveh K, 2001, AM J KIDNEY DIS, V37, P244, DOI 10.1053/ajkd.2001.21286; Kimmel PL, 2001, KIDNEY INT, V59, P1599, DOI 10.1046/j.1523-1755.2001.0590041599.x; Kovacs AZ, 2011, NEPHROL DIAL TRANSPL, V26, P1058, DOI 10.1093/ndt/gfq476; Krebber AMH, 2014, PSYCHO-ONCOLOGY, V23, P121, DOI 10.1002/pon.3409; Kurpas D, 2013, ADV EXP MED BIOL, V788, P401, DOI 10.1007/978-94-007-6627-3_54; Kurpas D, 2013, RESP PHYSIOL NEUROBI, V187, P114, DOI 10.1016/j.resp.2013.02.009; Lazarus RS, 2006, J PERS, V74, P9, DOI 10.1111/j.1467-6494.2005.00368.x; Leppert K, 2005, PSYCHOTHER PSYCH MED, V55, P365, DOI 10.1055/s-2005-866873; Majernikova M, 2012, AM J NEPHROL, V36, P459, DOI 10.1159/000343884; Masten AS, 2001, AM PSYCHOL, V56, P227, DOI 10.1037/0003-066X.56.3.227; McKercher C, 2013, NEPHROLOGY, V18, P585, DOI 10.1111/nep.12138; Mehr ZP, 2011, INT J TRANSPLANT MED, V2, P178; Molnar-Varga M, 2011, AM J KIDNEY DIS, V58, P444, DOI 10.1053/j.ajkd.2011.03.028; Muller H, 2010, KIDNEY INT, V77, P833, DOI 10.1038/ki.2010.48; Muhammad S, 2012, J REN CARE, V38, P182, DOI 10.1111/j.1755-6686.2012.00324.x; Ogutmen B, 2006, TRANSPLANT P, V38, P419, DOI 10.1016/j.transproceed.2006.01.016; Ortega T, 2009, TRANSPL P, V41, P2265, DOI 10.1016/j.transproceed.2009.06.175; Ortiz F, 2014, TRANSPL INT, V27, P1143, DOI 10.1111/tri.12394; Ozcurumez G, 2004, TRANSPL P, V36, P114, DOI 10.1016/j.transproceed.2003.11.004; Palmer S, 2013, KIDNEY INT, V84, P179, DOI 10.1038/ki.2013.77; Palmer SC, 2013, AM J KIDNEY DIS, V62, P493, DOI 10.1053/j.ajkd.2013.02.369; Pascazio L, 2010, TRANSPL P, V42, P3586, DOI 10.1016/j.transproceed.2010.08.056; Perez-San-Gregorio MA, 2013, TRANSPL P, V45, P3656, DOI 10.1016/j.transproceed.2013.10.029; Poppe C, 2013, NEPHROL DIAL TRANSPL, V28, P116, DOI 10.1093/ndt/gfs151; Prihodova L, 2014, J ADV NURS, V70, P2871, DOI 10.1111/jan.12447; Prihodova L, 2014, TRANSPLANTATION, V97, P1139, DOI 10.1097/01.TP.0000441092.24593.1e; Reckert A, 2013, Z PSYCHOSOM MED PSYC, V59, P170, DOI 10.13109/zptm.2013.59.2.170; Resende L, 2009, TRANSPL P, V41, P846, DOI 10.1016/j.transproceed.2009.01.066; Resende L, 2009, TRANSPL P, V41, P837, DOI 10.1016/j.transproceed.2009.01.063; Revicki DA, 2000, QUAL LIFE RES, V9, P887, DOI 10.1023/A:1008996223999; Richardson GE, 2002, J CLIN PSYCHOL, V58, P307, DOI 10.1002/jclp.10020; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; Schweitzer J, 2003, TRANSPLANTATION, V76, P1464, DOI 10.1097/01.TP.0000084320.57817.32; SNAITH RP, 1986, BRIT MED J, V292, P344, DOI 10.1136/bmj.292.6516.344; Stomer U, 2013, ANN TRANSPL, V18, P635, DOI 10.12659/AOT.889124; Tanriverdi N, 2004, TRANSPL P, V36, P117, DOI 10.1016/j.transproceed.2003.11.003; Tonelli M, 2011, AM J TRANSPLANT, V11, P2093, DOI 10.1111/j.1600-6143.2011.03686.x; Tsunoda T, 2010, TRANSPL P, V42, P1679, DOI 10.1016/j.transproceed.2009.12.073; Wagnild G M, 1993, J Nurs Meas, V1, P165; Wagnild GM, 2009, J PSYCHOSOC NURS MEN, V47, P28, DOI 10.3928/02793695-20091103-01; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P945, DOI 10.1016/S0895-4356(98)00085-7; Wiesenthal JD, 2011, BJU INT, V107, P636, DOI 10.1111/j.1464-410X.2010.09571.x; Zalai D, 2012, SEMIN DIALYSIS, V25, P428, DOI 10.1111/j.1525-139X.2012.01100.x	67	27	30	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0140706	10.1371/journal.pone.0140706	http://dx.doi.org/10.1371/journal.pone.0140706			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7DR	26559531	Green Published, gold, Green Submitted			2022-12-27	WOS:000364433100006
J	Almuhayawi, M; Altun, O; Abdulmajeed, AD; Ullberg, M; Ozenci, V				Almuhayawi, Mohammed; Altun, Osman; Abdulmajeed, Adam Dilshad; Ullberg, Mans; Ozenci, Volkan			The Performance of the Four Anaerobic Blood Culture Bottles BacT/ALERT-FN, -FN Plus, BACTEC-Plus and -Lytic in Detection of Anaerobic Bacteria and Identification by Direct MALDI-TOF MS	PLoS One			English	Article							FLIGHT MASS-SPECTROMETRY; DESORPTION-IONIZATION-TIME; CLINICAL-SIGNIFICANCE; RAPID IDENTIFICATION; STREAM INFECTIONS; CANCER-PATIENTS; FA PLUS; MICROORGANISMS; MULTICENTER; BACTEROIDES	Detection and identification of anaerobic bacteria in blood cultures (BC) is a well-recognized challenge in clinical microbiology. We studied 100 clinical anaerobic BC isolates to evaluate the performance of BacT/ALERT-FN, -FN Plus (BioMerieux), BACTEC-Plus and -Lytic (Becton Dickinson BioSciences) BC bottles in detection and time to detection (TTD) of anaerobic bacteria. BACTEC Lytic had higher detection rate (94/100, 94%) than Bad/ALERT FN Plus (80/100, 80%) (p<0.01) in the studied material. There was no significant difference in detection of anaerobic bacteria among the remaining bottle types. The 67 anaerobic bacteria that signalled positive in all four bottle types were analyzed to compare the time to detection (TTD) and isolates were directly identified by MALDI-TOF MS. There was a significant difference in TTD among the four bottle types (p<0.0001). The shortest median TTD was 18 h in BACTEC Lytic followed by BacT/ALERT FN (23.5 h), BACTEC Plus (27 h) and finally BacT/ALERT FN Plus (38 h) bottles. In contrast, MALDI-TOF MS performed similarly in all bottle types with accurate identification in 51/67 (76%) BacT/ALERT FN, 51/67 (76%) BacT/ALERT FN Plus, 53/67 (79%) BACTEC Plus and 50/67 (75%) BACTEC Lytic bottles. In conclusion, BACTEC Lytic bottles have significantly better detection rates and shorter TTD compared to the three other bottle types. The anaerobic BC bottles are equally suitable for direct MALDI-TOF MS for rapid and reliable identification of common anaerobic bacteria. Further clinical studies are warranted to investigate the performance of anaerobic BC bottles in detection of anaerobic bacteria and identification by direct MALDI-TOF MS.	[Almuhayawi, Mohammed; Altun, Osman; Abdulmajeed, Adam Dilshad; Ullberg, Mans; Ozenci, Volkan] Karolinska Inst, Div Clin Microbiol F 72, Karolinska Univ Hosp, SE-14186 Stockholm, Sweden; [Almuhayawi, Mohammed] King Abdulaziz Univ, Dept Microbiol, Jeddah 21413, Saudi Arabia	Karolinska Institutet; Karolinska University Hospital; King Abdulaziz University	Ozenci, V (corresponding author), Karolinska Inst, Div Clin Microbiol F 72, Karolinska Univ Hosp, SE-14186 Stockholm, Sweden.	volkan.ozenci@karolinska.se	Özenci, Volkan/H-3116-2019; Almuhayawi, Mohammed/AAY-1778-2020	Özenci, Volkan/0000-0002-8069-4027; Almuhayawi, Mohammed/0000-0002-4792-066X				Angeletti S, 2015, NEW MICROBIOL, V38, P379; Awadel-Kariem FM, 2010, ANAEROBE, V16, P223, DOI 10.1016/j.anaerobe.2010.01.001; Brook I, 2010, ANAEROBE, V16, P183, DOI 10.1016/j.anaerobe.2009.12.001; Chen JHK, 2013, J CLIN MICROBIOL, V51, P1733, DOI 10.1128/JCM.03259-12; Christner M, 2010, J CLIN MICROBIOL, V48, P1584, DOI 10.1128/JCM.01831-09; Coltella L, 2013, EUR J CLIN MICROBIOL, V32, P1183, DOI 10.1007/s10096-013-1865-1; Farina C, 2015, NEW MICROBIOL, V38, P245; Fenner L, 2007, EMERG INFECT DIS, V13, P1260, DOI 10.3201/eid1308.060662; Fiori B, 2014, J CLIN MICROBIOL, V52, P3558, DOI 10.1128/JCM.01171-14; Goldstein EJC, 1996, CLIN INFECT DIS, V23, pS97, DOI 10.1093/clinids/23.Supplement_1.S97; Grohs P, 2007, J CLIN MICROBIOL, V45, P2711, DOI 10.1128/JCM.00059-07; Kirn TJ, 2014, J CLIN MICROBIOL, V52, P839, DOI 10.1128/JCM.03063-13; Lee DH, 2013, J CLIN MICROBIOL, V51, P4150, DOI 10.1128/JCM.01935-13; Leli C, 2013, INT J MED MICROBIOL, V303, P205, DOI 10.1016/j.ijmm.2013.03.002; Mirrett S, 2003, J CLIN MICROBIOL, V41, P2391, DOI 10.1128/JCM.41.6.2391-2394.2003; Moussaoui W, 2010, CLIN MICROBIOL INFEC, V16, P1631, DOI 10.1111/j.1469-0691.2010.03356.x; Nagy E, 2009, CLIN MICROBIOL INFEC, V15, P796, DOI 10.1111/j.1469-0691.2009.02788.x; Nagy E, 2014, FUTURE MICROBIOL, V9, P217, DOI 10.2217/fmb.13.150; Nguyen MH, 2000, CLIN INFECT DIS, V30, P870, DOI 10.1086/313805; NORIEGA LM, 1993, SUPPORT CARE CANCER, V1, P250, DOI 10.1007/BF00366044; PERAINO VA, 1993, CLIN INFECT DIS, V16, pS288, DOI 10.1093/clinids/16.Supplement_4.S288; ROHNER P, 1995, J CLIN MICROBIOL, V33, P313, DOI 10.1128/JCM.33.2.313-317.1995; Romero-Gomez MP, 2011, J INFECTION, V62, P251, DOI 10.1016/j.jinf.2010.12.008; Spanu T, 2012, J CLIN MICROBIOL, V50, P176, DOI 10.1128/JCM.05742-11; Stefani Stefania, 2009, Int J Antimicrob Agents, V34 Suppl 4, pS9, DOI 10.1016/S0924-8579(09)70558-8; Veloo AC, 2014, CLIN MICROBIOL INFEC; Wieser A, 2012, APPL MICROBIOL BIOT, V93, P965, DOI 10.1007/s00253-011-3783-4; WILSON ML, 1992, J CLIN MICROBIOL, V30, P63, DOI 10.1128/JCM.30.1.63-66.1992; Wuppenhorst N, 2012, EUR J CLIN MICROBIOL, V31, P2843, DOI 10.1007/s10096-012-1638-2; Zahar JR, 2005, CLIN MICROBIOL INFEC, V11, P724, DOI 10.1111/j.1469-0691.2005.01214.x	30	23	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142398	10.1371/journal.pone.0142398	http://dx.doi.org/10.1371/journal.pone.0142398			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26554930	gold, Green Published, Green Submitted			2022-12-27	WOS:000364430700098
J	Baniqued, PL; Allen, CM; Kranz, MB; Johnson, K; Sipolins, A; Dickens, C; Ward, N; Geyer, A; Kramer, AF				Baniqued, Pauline L.; Allen, Courtney M.; Kranz, Michael B.; Johnson, Kathryn; Sipolins, Aldis; Dickens, Charles; Ward, Nathan; Geyer, Alexandra; Kramer, Arthur F.			Working Memory, Reasoning, and Task Switching Training: Transfer Effects, Limitations, and Great Expectations?	PLOS ONE			English	Article							FLUID INTELLIGENCE; AGE-DIFFERENCES; COGNITIVE CONTROL; ATTENTION CONTROL; CAPACITY; CHILDREN; SPAN; PERFORMANCE; BRAIN; PLASTICITY	Although some studies have shown that cognitive training can produce improvements to untrained cognitive domains (far transfer), many others fail to show these effects, especially when it comes to improving fluid intelligence. The current study was designed to overcome several limitations of previous training studies by incorporating training expectancy assessments, an active control group, and "Mind Frontiers," a video game-based mobile program comprised of six adaptive, cognitively demanding training tasks that have been found to lead to increased scores in fluid intelligence (Gf) tests. We hypothesize that such integrated training may lead to broad improvements in cognitive abilities by targeting aspects of working memory, executive function, reasoning, and problem solving. Ninety participants completed 20 hour-and-a-half long training sessions over four to five weeks, 45 of whom played Mind Frontiers and 45 of whom completed visual search and change detection tasks (active control). After training, the Mind Frontiers group improved in working memory n-back tests, a composite measure of perceptual speed, and a composite measure of reaction time in reasoning tests. No training-related improvements were found in reasoning accuracy or other working memory tests, nor in composite measures of episodic memory, selective attention, divided attention, and multi-tasking. Perceived self-improvement in the tested abilities did not differ between groups. A general expectancy difference in problem-solving was observed between groups, but this perceived benefit did not correlate with training-related improvement. In summary, although these findings provide modest evidence regarding the efficacy of an integrated cognitive training program, more research is needed to determine the utility of Mind Frontiers as a cognitive training tool.	[Baniqued, Pauline L.; Allen, Courtney M.; Kranz, Michael B.; Johnson, Kathryn; Sipolins, Aldis; Ward, Nathan; Kramer, Arthur F.] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Baniqued, Pauline L.; Kranz, Michael B.; Sipolins, Aldis; Kramer, Arthur F.] Univ Illinois, Dept Psychol, Urbana, IL 61801 USA; [Dickens, Charles; Geyer, Alexandra] Aptima Inc, Woburn, MA USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Baniqued, PL (corresponding author), Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA.	banique1@illinois.edu	Ward, Nathan/AAB-5713-2021; Kramer, Arthur/AAB-2937-2019	Kramer, Arthur/0000-0001-5870-2724	Office of Naval Research [N00014-12-C-0360]; National Science Foundation Neuroengineering IGERT Fellowship [0903622]; Beckman Institute Graduate Fellowship; Beckman Institute Postdoctoral Fellowship; Aptima, Inc.	Office of Naval Research(Office of Naval Research); National Science Foundation Neuroengineering IGERT Fellowship; Beckman Institute Graduate Fellowship; Beckman Institute Postdoctoral Fellowship; Aptima, Inc.	This research was supported by the Office of Naval Research (N00014-12-C-0360 to AFK). PLB was supported by a National Science Foundation Neuroengineering IGERT Fellowship (grant no. 0903622) and a Beckman Institute Graduate Fellowship. NMW was supported by a Beckman Institute Postdoctoral Fellowship. Charles Dickens is employed by Aptima, Inc. and Alexandra Geyer was employed by Aptima, Inc. during the development and implementation of the current study. Aptima, Inc. provided support in the form of salaries for authors CD and AG, research materials to develop the Mind Frontiers game application (including the software used to record gameplay and the hardware used by the Mind Frontiers participants during the training sessions), and technical assistance for the Mind Frontiers training games (CD), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ackerman PL, 2010, PSYCHOL AGING, V25, P753, DOI 10.1037/a0019277; Au J, 2015, PSYCHON B REV, V22, P366, DOI 10.3758/s13423-014-0699-x; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Ball K, 2002, JAMA-J AM MED ASSOC, V288, P2271, DOI 10.1001/jama.288.18.2271; Baniqued PL, 2014, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.01010; Basak C, 2011, BRAIN COGNITION, V76, P407, DOI 10.1016/j.bandc.2011.03.017; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bavelier D, 2012, ANNU REV NEUROSCI, V35, P391, DOI 10.1146/annurev-neuro-060909-152832; Bennett GK., 1947, DIFFERENTIAL APTITUD; Boot Walter R, 2014, Cerebrum, V2014, P15; Boot WR, 2013, PERSPECT PSYCHOL SCI, V8, P445, DOI 10.1177/1745691613491271; Boot WR, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00226; Boot WR, 2010, ACTA PSYCHOL, V135, P349, DOI 10.1016/j.actpsy.2010.09.005; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brehmer Y, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00063; Broadway JM, 2010, BEHAV RES METHODS, V42, P563, DOI 10.3758/BRM.42.2.563; Bush G, 2003, MOL PSYCHIATR, V8, P60, DOI 10.1038/sj.mp.4001217; Buysse D J, 1989, Psychiatry Res, V28, P193; Chein JM, 2010, PSYCHON B REV, V17, P193, DOI 10.3758/PBR.17.2.193; Coderre EL, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01070; Colom R, 2007, PERS INDIV DIFFER, V42, P1503, DOI 10.1016/j.paid.2006.10.023; Costa R, 2012, J VISION, V12, P1032, DOI [10.1167/12.9.1032, DOI 10.1167/12.9.1032]; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Crone EA, 2009, DEVELOPMENTAL SCI, V12, P55, DOI 10.1111/j.1467-7687.2008.00743.x; Dahlin E, 2008, SCIENCE, V320, P1510, DOI 10.1126/science.1155466; Dahlin E, 2008, PSYCHOL AGING, V23, P720, DOI 10.1037/a0014296; DINGES DF, 1985, BEHAV RES METH INSTR, V17, P652, DOI 10.3758/BF03200977; Dougherty MR, 2015, PSYCHON B R IN PRESS; Duckworth AL, 2007, J PERS SOC PSYCHOL, V92, P1087, DOI 10.1037/0022-3514.92.6.1087; Dunning DL, 2013, DEVELOPMENTAL SCI, V16, P915, DOI 10.1111/desc.12068; EFRON B, 1987, J AM STAT ASSOC, V82, P171, DOI 10.2307/2289144; Ekstrom R., 1976, MANUAL KIT FACTOR RE; Erickson KI, 2010, CEREB CORTEX, V20, P2522, DOI 10.1093/cercor/bhp293; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Fitzgerald KD, 2010, NEUROIMAGE, V49, P3463, DOI 10.1016/j.neuroimage.2009.11.004; Gaspar JG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067781; Godin G., 1997, MED SCI SPORT EXER, V29, pS36, DOI DOI 10.1097/00005768-199706001-00009; Gottfredson LS, 1997, INTELLIGENCE, V24, P79, DOI 10.1016/S0160-2896(97)90014-3; Gray JR, 2004, NAT REV NEUROSCI, V5, P471, DOI 10.1038/nrn1405; Gray JR, 2003, NAT NEUROSCI, V6, P316, DOI 10.1038/nn1014; Green CS, 2008, PSYCHOL AGING, V23, P692, DOI 10.1037/a0014345; Halekoh U, 2014, J STAT SOFTW, V59, P1; HALLETT PE, 1978, VISION RES, V18, P1279, DOI 10.1016/0042-6989(78)90218-3; Harrison TL, 2013, PSYCHOL SCI, V24, P2409, DOI 10.1177/0956797613492984; Hertzog Christopher, 2008, Psychol Sci Public Interest, V9, P1, DOI 10.1111/j.1539-6053.2009.01034.x; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Holmes J, 2009, DEVELOPMENTAL SCI, V12, pF9, DOI 10.1111/j.1467-7687.2009.00848.x; HORN JL, 1967, ACTA PSYCHOL, V26, P107, DOI 10.1016/0001-6918(67)90011-X; Jaeggi SM, 2003, NEUROIMAGE, V19, P210, DOI 10.1016/S1053-8119(03)00098-3; Jaeggi SM, 2008, P NATL ACAD SCI USA, V105, P6829, DOI 10.1073/pnas.0801268105; Jaeggi SM, 2007, COGN AFFECT BEHAV NE, V7, P75, DOI 10.3758/CABN.7.2.75; Jaeggi SM, 2014, MEM COGNITION, V42, P464, DOI 10.3758/s13421-013-0364-z; Jaeggi SM, 2011, P NATL ACAD SCI USA, V108, P10081, DOI 10.1073/pnas.1103228108; Jaeggi SM, 2010, INTELLIGENCE, V38, P625, DOI 10.1016/j.intell.2010.09.001; JENSEN AR, 1969, HARVARD EDUC REV, V39, P1; John O.P., 1991, BIG 5 INVENTORY VERS; Jolles DD, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00076; Jurca R, 2005, AM J PREV MED, V29, P185, DOI 10.1016/j.amepre.2005.06.004; Kane MJ, 2007, J EXP PSYCHOL LEARN, V33, P615, DOI 10.1037/0278-7393.33.3.615; Kane MJ, 2006, J EXP PSYCHOL LEARN, V32, P749, DOI 10.1037/0278-7393.32.4.749; Kane MJ, 2001, J EXP PSYCHOL GEN, V130, P169, DOI 10.1037/0096-3445.130.2.169; Karbach J, 2014, PSYCHOL SCI, V25, P2027, DOI 10.1177/0956797614548725; Karbach J, 2009, DEVELOPMENTAL SCI, V12, P978, DOI 10.1111/j.1467-7687.2009.00846.x; KECKLUND G, 1992, J SLEEP RES, V1, P30, DOI 10.1111/j.1365-2869.1992.tb00005.x; Keshvari S, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002927; KIRCHNER WK, 1958, J EXP PSYCHOL, V55, P352, DOI 10.1037/h0043688; Kirk HE, 2015, RES DEV DISABIL, V38, P145, DOI 10.1016/j.ridd.2014.12.026; Klingberg T, 2002, J CLIN EXP NEUROPSYC, V24, P781, DOI 10.1076/jcen.24.6.781.8395; Klingberg T, 2005, J AM ACAD CHILD PSY, V44, P177, DOI 10.1097/00004583-200502000-00010; Klingberg T, 2010, TRENDS COGN SCI, V14, P317, DOI 10.1016/j.tics.2010.05.002; Kramer AF, 1999, NATURE, V400, P418, DOI 10.1038/22682; Kundu B, 2013, J NEUROSCI, V33, P8705, DOI 10.1523/JNEUROSCI.5565-12.2013; Lampit A, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001756; Lampit A, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00794; Lee H, 2012, ACTA PSYCHOL, V139, P146, DOI 10.1016/j.actpsy.2011.11.003; Loosli SV, 2012, CHILD NEUROPSYCHOL, V18, P62, DOI 10.1080/09297049.2011.575772; Lovden M, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00141; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; Mackey AP, 2011, DEVELOPMENTAL SCI, V14, P582, DOI 10.1111/j.1467-7687.2010.01005.x; Melby-Lervag M, 2014, PSYCHON B R IN PRESS, V2015; Monti JM, 2015, J COGNITIVE NEUROSCI, V27, P234, DOI 10.1162/jocn_a_00717; Moody DE, 2009, INTELLIGENCE, V37, P327, DOI 10.1016/j.intell.2009.04.005; Morrison AB, 2011, PSYCHON B REV, V18, P46, DOI 10.3758/s13423-010-0034-0; Novick JM, 2014, LANG COGN NEUROSCI, V29, P186, DOI 10.1080/01690965.2012.758297; Nutley SB, 2011, DEVELOPMENTAL SCI, V14, P591, DOI 10.1111/j.1467-7687.2010.01022.x; Oei AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058546; Olesen PJ, 2004, NAT NEUROSCI, V7, P75, DOI 10.1038/nn1165; Ophir E, 2009, P NATL ACAD SCI USA, V106, P15583, DOI 10.1073/pnas.0903620106; Owen AM, 2010, NATURE, V465, P775, DOI 10.1038/nature09042; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Poole BJ, 2009, Q J EXP PSYCHOL, V62, P1430, DOI 10.1080/17470210802479329; Raven J, 1998, SECTION 4 ADV PROGRE; Ravens J, 1962, ADV PROGR MATRICES; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; Redick TS, 2013, J EXP PSYCHOL GEN, V142, P359, DOI 10.1037/a0029082; Redick TS, 2012, J COGN PSYCHOL, V24, P844, DOI 10.1080/20445911.2012.704359; Redick TS, 2012, EUR J PSYCHOL ASSESS, V28, P164, DOI 10.1027/1015-5759/a000123; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rueda MR, 2012, DEV COGN NEUROS-NETH, V2, pS192, DOI 10.1016/j.dcn.2011.09.004; Rouder JN, 2009, PSYCHON B REV, V16, P225, DOI 10.3758/PBR.16.2.225; Rueda MR, 2005, P NATL ACAD SCI USA, V102, P14931, DOI 10.1073/pnas.0506897102; Salthouse TA, 2005, NEUROPSYCHOLOGY, V19, P532, DOI 10.1037/0894-4105.19.4.532; Salthouse TA, 1996, NEUROPSYCHOLOGY, V10, P272, DOI 10.1037/0894-4105.10.2.272; Salthouse TA, 2003, PSYCHOL AGING, V18, P91, DOI 10.1037/0882-7974.18.1.91; SALTHOUSE TA, 1991, DEV PSYCHOL, V27, P763, DOI 10.1037/0012-1649.27.5.763; Salthouse TA, 2008, INTELLIGENCE, V36, P464, DOI 10.1016/j.intell.2007.10.003; Salthouse TA, 2009, NEUROBIOL AGING, V30, P507, DOI 10.1016/j.neurobiolaging.2008.09.023; Schaie K Warner, 2005, Res Hum Dev, V2, P133, DOI 10.1207/s15427617rhd0203_4; Schmiedek F, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00027; Schneider W., 2002, E PRIME USERS GUIDE; Schubert T, 2015, ACTA PSYCHOL, V157, P200, DOI 10.1016/j.actpsy.2015.03.005; Schubert T, 2014, PSYCHOL RES-PSYCH FO, V78, P749, DOI 10.1007/s00426-014-0619-8; Schweizer S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024372; Shipstead Z, 2012, PSYCHOL BULL, V138, P628, DOI 10.1037/a0027473; Shipstead Z, 2012, Q J EXP PSYCHOL, V65, P401, DOI 10.1080/17470218.2012.655698; Sprenger AM, 2013, INTELLIGENCE, V41, P638, DOI 10.1016/j.intell.2013.07.013; Stephenson CL, 2013, INTELLIGENCE, V41, P341, DOI 10.1016/j.intell.2013.05.006; Stothart CR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109557; Studer-Luethi B, 2012, PERS INDIV DIFFER, V53, P44, DOI 10.1016/j.paid.2012.02.012; Thompson TW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063614; Thorell LB, 2009, DEVELOPMENTAL SCI, V12, P106, DOI 10.1111/j.1467-7687.2008.00745.x; TURNER ML, 1989, J MEM LANG, V28, P127, DOI 10.1016/0749-596X(89)90040-5; Unsworth N, 2005, BEHAV RES METHODS, V37, P498, DOI 10.3758/BF03192720; Unsworth N, 2010, J MEM LANG, V62, P392, DOI 10.1016/j.jml.2010.02.001; van Muijden J, 2012, FRONT HUM NEUROSCI, V6, P1, DOI 10.3389/fnhum.2012.00221; von Bastian CC, 2015, PSYCHOL RE IN PRESS; von Bastian CC, 2013, MEM COGNITION, V41, P611, DOI 10.3758/s13421-012-0280-7; Watson PD, 2013, HIPPOCAMPUS, V23, P570, DOI 10.1002/hipo.22115; Wechsler D., 2008, WECHSLER ADULT INTEL; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Willis S L, 1986, Psychol Aging, V1, P239, DOI 10.1037/0882-7974.1.3.239; Willis SL, 2006, JAMA-J AM MED ASSOC, V296, P2805, DOI 10.1001/jama.296.23.2805; Zachary R, 1986, SHIPLEY I LIVING SCA	133	28	28	3	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142169	10.1371/journal.pone.0142169	http://dx.doi.org/10.1371/journal.pone.0142169			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7CT	26555341	Green Published, gold, Green Submitted			2022-12-27	WOS:000364430700062
J	FitzGerald, JA; Allen, E; Wall, DM; Jackson, SA; Murphy, JD; Dobson, ADW				FitzGerald, Jamie A.; Allen, Eoin; Wall, David M.; Jackson, Stephen A.; Murphy, Jerry D.; Dobson, Alan D. W.			Methanosarcina Play an Important Role in Anaerobic Co-Digestion of the Seaweed Ulva lactuca: Taxonomy and Predicted Metabolism of Functional Microbial Communities	PLOS ONE			English	Article							METHANOGENIC POPULATION-DYNAMICS; RNA GENE DATABASE; SP-NOV.; FATTY-ACIDS; BACTERIAL; DIVERSITY; INHIBITION; SEQUENCES; ARCHAEAL; NICKEL	Macro-algae represent an ideal resource of third generation biofuels, but their use necessitates a refinement of commonly used anaerobic digestion processes. In a previous study, contrasting mixes of dairy slurry and the macro-alga Ulva lactuca were anaerobically digested in mesophilic continuously stirred tank reactors for 40 weeks. Higher proportions of U. lactuca in the feedstock led to inhibited digestion and rapid accumulation of volatile fatty acids, requiring a reduced organic loading rate. In this study, 16S pyrosequencing was employed to characterise the microbial communities of both the weakest (R1) and strongest (R6) performing reactors from the previous work as they developed over a 39 and 27-week period respectively. Comparing the reactor communities revealed clear differences in taxonomy, predicted metabolic orientation and mechanisms of inhibition, while constrained canonical analysis (CCA) showed ammonia and biogas yield to be the strongest factors differentiating the two reactor communities. Significant biomarker taxa and predicted metabolic activities were identified for viable and failing anaerobic digestion of U. lactuca. Acetoclastic methanogens were inhibited early in R1 operation, followed by a gradual decline of hydrogenotrophic methanogens. Near-total loss of methanogens led to an accumulation of acetic acid that reduced performance of R1, while a slow decline in biogas yield in R6 could be attributed to inhibition of acetogenic rather than methanogenic activity. The improved performance of R6 is likely to have been as a result of the large Methanosarcina population, which enabled rapid removal of acetic acid, providing favourable conditions for substrate degradation.	[FitzGerald, Jamie A.; Allen, Eoin; Wall, David M.; Jackson, Stephen A.; Murphy, Jerry D.; Dobson, Alan D. W.] Natl Univ Ireland Univ Coll Cork, Environm Res Inst, Cork, Ireland; [FitzGerald, Jamie A.; Jackson, Stephen A.; Dobson, Alan D. W.] Natl Univ Ireland Univ Coll Cork, Sch Microbiol, Cork, Ireland; [Allen, Eoin; Wall, David M.; Murphy, Jerry D.] Natl Univ Ireland Univ Coll Cork, Sch Engn, Cork, Ireland; [FitzGerald, Jamie A.; Allen, Eoin; Wall, David M.; Murphy, Jerry D.] Natl Univ Ireland Univ Coll Cork, Sci Fdn Ireland, MaREI Ctr, Cork, Ireland	University College Cork; University College Cork; University College Cork; University College Cork	Murphy, JD (corresponding author), Natl Univ Ireland Univ Coll Cork, Environm Res Inst, Lee Rd, Cork, Ireland.	jerry.murphy@ucc.ie; a.dobson@ucc.ie	Murphy, Jerry D/ABH-3038-2020; Dobson, Alan D W/M-7844-2017; Jackson, Stephen/J-4368-2019	Murphy, Jerry D/0000-0003-2120-1357; Dobson, Alan D W/0000-0002-7713-5574; Jackson, Stephen/0000-0001-7869-9032; Wall, David/0000-0001-5802-2884; FitzGerald, Jamie A/0000-0003-1060-816X	Science Foundation Ireland (SFI) [11/RFP.1/ENM/3213, 12/RC/2302]; Teagasc through a Walsh Fellowship; Beaufort Marine Research Award, part of the Sea Change Strategy; Strategy for Science Technology and Innovation; Marine Institute under the Marine Research Sub-Programme of the National Development Plan	Science Foundation Ireland (SFI)(Science Foundation Ireland); Teagasc through a Walsh Fellowship; Beaufort Marine Research Award, part of the Sea Change Strategy; Strategy for Science Technology and Innovation; Marine Institute under the Marine Research Sub-Programme of the National Development Plan	The work was supported by Science Foundation Ireland (SFI) under Grant Numbers 11/RFP.1/ENM/3213 and (12/RC/2302), and by Teagasc through a Walsh Fellowship and support by the Beaufort Marine Research Award, part of the Sea Change Strategy and the Strategy for Science Technology and Innovation (2006-2012), with the support of The Marine Institute under the Marine Research Sub-Programme of the National Development Plan 2007-2013. Although the funding bodies provided support in the form of salaries for authors JAF, EA, DMW and JDM, they did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abubucker S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002358; Allen E, 2013, WASTE MANAGE, V33, P2425, DOI 10.1016/j.wasman.2013.06.017; Allen E, 2014, BIORESOURCE TECHNOL, V170, P436, DOI 10.1016/j.biortech.2014.08.005; Baena S, 2000, INT J SYST EVOL MICR, V50, P259, DOI 10.1099/00207713-50-1-259; Baena S, 1998, ANAEROBE, V4, P241, DOI 10.1006/anae.1998.0170; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Blankenberg D, 2001, CURRENT PROTOCOLS IN; Bragg L, 2012, NAT METHODS, V9, P425, DOI 10.1038/nmeth.1990; Briand X, 1997, J APPL PHYCOL, V9, P511; Briones A, 2003, CURR OPIN BIOTECH, V14, P270, DOI 10.1016/S0958-1669(03)00065-X; Calli B, 2005, ENZYME MICROB TECH, V37, P448, DOI 10.1016/j.enzmictec.2005.03.013; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Carballa M, 2015, CURR OPIN BIOTECH, V33, P103, DOI 10.1016/j.copbio.2015.01.008; Chen SY, 2005, INT J SYST EVOL MICR, V55, P2257, DOI 10.1099/ijs.0.63807-0; Chen Y, 2008, BIORESOURCE TECHNOL, V99, P4044, DOI 10.1016/j.biortech.2007.01.057; Chumpitazi BP, 2015, ALIMENT PHARM THER, V42, P418, DOI 10.1111/apt.13286; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; Conklin A, 2006, WATER ENVIRON RES, V78, P486, DOI 10.2175/106143006X95393; Dave A, 2013, BIORESOURCE TECHNOL, V135, P120, DOI 10.1016/j.biortech.2013.01.005; De Vrieze J, 2012, BIORESOURCE TECHNOL, V112, P1, DOI 10.1016/j.biortech.2012.02.079; Delbes C, 2000, ENVIRON MICROBIOL, V2, P506, DOI 10.1046/j.1462-2920.2000.00132.x; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dridi B, 2012, INT J SYST EVOL MICR, V62, P1902, DOI 10.1099/ijs.0.033712-0; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; FEIJOO G, 1995, ENZYME MICROB TECH, V17, P180, DOI 10.1016/0141-0229(94)00011-F; Fernandez A, 1999, APPL ENVIRON MICROB, V65, P3697; Fotidis IA, 2013, FEMS MICROBIOL ECOL, V83, P38, DOI 10.1111/j.1574-6941.2012.01456.x; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gonzalez-Gil G, 1999, APPL ENVIRON MICROB, V65, P1789; Gottschalk G, 2001, BBA-BIOENERGETICS, V1505, P28, DOI 10.1016/S0005-2728(00)00274-7; Grabowski A, 2005, INT J SYST EVOL MICR, V55, P1113, DOI 10.1099/ijs.0.63426-0; Green SJ, 2015, PLOS ONE, V10; Griffin ME, 1998, BIOTECHNOL BIOENG, V57, P342, DOI 10.1002/(SICI)1097-0290(19980205)57:3<342::AID-BIT11>3.0.CO;2-I; Hinks J, 2013, BIORESOURCE TECHNOL, V143, P221, DOI 10.1016/j.biortech.2013.05.124; Hori T, 2006, APPL ENVIRON MICROB, V72, P1623, DOI 10.1128/AEM.72.2.1623-1630.2006; HUSER BA, 1982, ARCH MICROBIOL, V132, P1, DOI 10.1007/BF00690808; Jimenez DJ, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-92; Jumas-Bilak E, 2014, THE PROKARYTOES OTHE; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Karatan E, 2013, BIOTECHNOL LETT, V35, P1715, DOI 10.1007/s10529-013-1286-3; Koch C, 2014, CURR OPIN BIOTECH, V27, P65, DOI 10.1016/j.copbio.2013.11.006; Krober M, 2009, J BIOTECHNOL, V142, P38, DOI 10.1016/j.jbiotec.2009.02.010; Lee KCY, 2014, THE PROKARYOTES OTHE; Lee SH, 2013, BIORESOURCE TECHNOL, V145, P25, DOI 10.1016/j.biortech.2013.02.070; Li A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-3; Loudon AH, 2014, ISME J, V8, P830, DOI 10.1038/ismej.2013.200; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Martini M, 2014, THE PROKARYTOES FIRM; MCCARTY PL, 1961, J WATER POLLUT CON F, V33, P399; MCCARTY PL, 1961, J WATER POLLUT CON F, V33, P223; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Mhuantong W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128043; Morand P, 2005, J COASTAL RES, V21, P1009, DOI 10.2112/04-700A.1; MURRAY WD, 1981, APPL ENVIRON MICROB, V42, P502, DOI 10.1128/AEM.42.3.502-505.1981; Nelson MC, 2012, BIORESOURCE TECHNOL, V107, P135, DOI 10.1016/j.biortech.2011.12.070; Nordmann W., 1977, KA INFORMATIONEN FUR, V3; Nyonyo T, 2014, FEMS MICROBIOL ECOL, V88, P528, DOI 10.1111/1574-6941.12318; Ohkuma M, 1999, FEMS MICROBIOL LETT, V171, P147, DOI 10.1111/j.1574-6968.1999.tb13425.x; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Oren A., 2014, THE PROKARYOTES OTHE, P1028; Pelmenschikov V, 2002, J AM CHEM SOC, V124, P4039, DOI 10.1021/ja011664r; PERCIVAL E, 1979, BRIT PHYCOL J, V14, P103, DOI 10.1080/00071617900650121; Pope PB, 2013, 3 BIOTECH, V3, P407, DOI 10.1007/s13205-012-0097-x; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Pullammanappallil PC, 2001, BIORESOURCE TECHNOL, V78, P165, DOI 10.1016/S0960-8524(00)00187-5; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; R Core Team, 2021, R LANGUAGE ENV STAT; RINZEMA A, 1994, WATER ENVIRON RES, V66, P40, DOI 10.2175/WER.66.1.7; Rodriguez C, FUEL PROCESS TECHNOL; ROMESSER JA, 1979, ARCH MICROBIOL, V121, P147, DOI 10.1007/BF00689979; Santana RH, 2015, MICROB ECOL, V70, P545, DOI 10.1007/s00248-015-0581-z; Schluter A, 2008, J BIOTECHNOL, V136, P77, DOI 10.1016/j.jbiotec.2008.05.008; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Seppala M, 2013, FUEL, V107, P209, DOI 10.1016/j.fuel.2012.12.069; Solli L, 2014, BIOTECHNOL BIOFUELS, V14, DOI 10.1186/s13068-014-0146-2; SPROTT GD, 1986, SYST APPL MICROBIOL, V7, P358; SPROTT GD, 1984, J BIOL CHEM, V259, P2602; St-Pierre B, 2014, APPL MICROBIOL BIOT, V98, P2709, DOI 10.1007/s00253-013-5220-3; Sundberg C, 2013, FEMS MICROBIOL ECOL, V85, P612, DOI 10.1111/1574-6941.12148; Tauch A, 2014, THE PROKARYOTES ACTI; Teixiera LM, 2014, THE PROKARYTOES GAMM; Thauer RK, 2010, ANNU REV BIOCHEM, V79, P507, DOI 10.1146/annurev.biochem.030508.152103; Vanegas CH, 2013, ENVIRON TECHNOL, V34, P2277, DOI 10.1080/09593330.2013.765922; Vazquez-Baeza Y, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-16; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Werner JJ, 2011, P NATL ACAD SCI USA, V108, P4158, DOI 10.1073/pnas.1015676108; Whitford M F, 2001, BMC Microbiol, V1, P5, DOI 10.1186/1471-2180-1-5; Wijekoon KC, 2011, BIORESOURCE TECHNOL, V102, P5353, DOI 10.1016/j.biortech.2010.12.081; Wilkins D, 2015, APPL ENVIRON MICROB, V81, P604, DOI 10.1128/AEM.02566-14; Williams J, 2013, BIORESOURCE TECHNOL, V140, P234, DOI 10.1016/j.biortech.2013.04.089; Wirth R, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0243-x; Wong KH, 2000, FOOD CHEM, V71, P475, DOI 10.1016/S0308-8146(00)00175-8; Yamada T, 2006, INT J SYST EVOL MICR, V56, P1331, DOI 10.1099/ijs.0.64169-0; Yenigun O, 2013, PROCESS BIOCHEM, V48, P901, DOI 10.1016/j.procbio.2013.04.012; Zandvoort MH, 2006, ENG LIFE SCI, V6, P293, DOI 10.1002/elsc.200620129; Zhang JX, 2015, BIORESOURCE TECHNOL, V179, P43, DOI 10.1016/j.biortech.2014.11.102	98	25	25	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142603	10.1371/journal.pone.0142603	http://dx.doi.org/10.1371/journal.pone.0142603			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555136	gold, Green Submitted, Green Published			2022-12-27	WOS:000364430700140
J	Foulon, S; Greacen, T; Pasquet, B; Dugravier, R; Saias, T; Guedeney, N; Guedeney, A; Tubach, F				Foulon, Stephanie; Greacen, Tim; Pasquet, Blandine; Dugravier, Romain; Saias, Thomas; Guedeney, Nicole; Guedeney, Antoine; Tubach, Florence		CAPEDP Study Grp	Predictors of Study Attrition in a Randomized Controlled Trial Evaluating a Perinatal Home-Visiting Program with Mothers with Psychosocial Vulnerabilities	PLOS ONE			English	Article							CHILD HEALTH; ATTACHMENT STYLE; START PROGRAM; LOW-INCOME; VISITATION; RISK; INTERVENTION; ENGAGEMENT; DEPRESSION; STRATEGIES	Objective Randomised controlled trials evaluating perinatal home-visiting programs are frequently confronted with the problem of high attrition rates. The aim of the present study is to identify predictors of study attrition in a trial evaluating a perinatal home-visiting program in France. Materials and Methods CAPEDP is a French randomized trial comparing a perinatal home-visiting program using psychologists versus usual care (N = 440). The first assessment was at inclusion into the trial at the 27th week of pregnancy and the final assessment when the child reached the age of two. Attrition rates were calculated at 3 and 24 months postpartum. Stepwise logistic regression was used to identify predictors of early (between inclusion and 3 months postpartum) and later (between 3 and 24 months postpartum) attrition among social, psychological and parenting factors. Results Attrition rates were 17% and 63% at 3 and 24 months respectively. At 24 months, there was significantly more attrition in the control arm (70.6%) compared to the intervention arm (55.2%). Five independent predictors of early attrition were identified: having already had an abortion; having greater attachment insecurity as measured with the Vulnerable Attachment Style Questionnaire (VASQ); having lower global severity of psychiatric symptoms as assessed with the Symptom Check-List (SCL-90) at inclusion, being neither currently employed nor studying; and declaring no tobacco consumption during pregnancy. Being randomized into the control arm, having undergone early parental loss before age 11 and having lower global severity of psychiatric symptoms (SCL-90) at 3 months postpartum were the only variables associated with later attrition. Conclusion This study provides key information for identifying mothers who may require specific support to avoid study attrition in trials evaluating a home-visiting program.	[Foulon, Stephanie] Hop Bichat Claude Bernard, AP HP, Dept Epidemiol & Rech Clin, F-75877 Paris, France; [Greacen, Tim; Saias, Thomas] Etab Publ Sante Maison Blanche, Lab Rech, Paris, France; [Pasquet, Blandine; Tubach, Florence] Hop Bichat Claude Bernard, AP HP, Dept Epidemiol & Rech Clin, CIC EC 1425, F-75877 Paris, France; [Dugravier, Romain; Guedeney, Antoine] Hop Bichat Claude Bernard, AP HP, Serv Pedopsychiat, F-75877 Paris, France; [Dugravier, Romain; Guedeney, Antoine] Inst Natl Sante & Rech Med, PSIGIAM U669, Paris, France; [Saias, Thomas] Inst Natl Prevent & Educ Sante, St Denis, France; [Saias, Thomas] Univ Quebec, Dept Psychol, Montreal, PQ H3C 3P8, Canada; [Guedeney, Nicole] Inst Mutualiste Montsouris, Paris, France; [Tubach, Florence] INSERM, ECEVE, UMR 1123, CIC EC 11425, Paris, France; [Tubach, Florence] Univ Paris Diderot, ECEVE, UMR 1123, Sorbonne Paris Cite, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Quebec; University of Quebec Montreal; Institute Mutualiste Montsouris; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Foulon, S (corresponding author), Hop Bichat Claude Bernard, AP HP, Dept Epidemiol & Rech Clin, F-75877 Paris, France.	stephanie.foulon@gmail.com	; Purper-Ouakil, Diane/AAC-5024-2019	Guedeney, Antoine/0000-0002-2346-4495; Tereno, Susana/0000-0001-5258-7913; Purper-Ouakil, Diane/0000-0003-0454-1579; Foulon, Stephanie/0000-0002-0213-0736; Azria, Elie/0000-0002-6159-6253	French Ministry of Health Programme Hospitalier de Recherche Clinique [PHRC: AOM05056]; Institut National de Prevention et d'Education a la sante [INPES: DAS 08/2006 DAS 018/09 DAS 084/10]; Institut de Recherche en Sante Publique [IReSP: REV0702]	French Ministry of Health Programme Hospitalier de Recherche Clinique; Institut National de Prevention et d'Education a la sante; Institut de Recherche en Sante Publique	Funding: The CAPEDP study was supported by research grants from the French Ministry of Health Programme Hospitalier de Recherche Clinique (PHRC: AOM05056), the Institut National de Prevention et d'Education a la sante (INPES: DAS 08/2006 DAS 018/09 DAS 084/10), and the Institut de Recherche en Sante Publique (IReSP: REV0702). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abidin R R, 1989, Child Health Care, V18, P114, DOI 10.1207/s15326888chc1802_9; Ammerman RT, 2006, J FAM VIOLENCE, V21, P105, DOI 10.1007/s10896-005-9009-8; Armstrong KL, 2000, J PAEDIATR CHILD H, V36, P555, DOI 10.1046/j.1440-1754.2000.00591.x; Barlow J, 2007, ARCH DIS CHILD, V92, P229, DOI 10.1136/adc.2006.095117; Barnett J, 2012, CONTEMP CLIN TRIALS, V33, P925, DOI 10.1016/j.cct.2012.06.005; Bifulco A, 2003, PSYCHOL MED, V33, P1099, DOI 10.1017/S0033291703008237; BLUMENTHAL DS, 1995, HEALTH SERV RES, V30, P197; Boivin M, 2005, J CHILD PSYCHOL PSYC, V46, P612, DOI 10.1111/j.1469-7610.2004.00375.x; BRADLEY RH, 1979, AM J MENT DEF, V84, P235; Caldera D, 2007, CHILD ABUSE NEGLECT, V31, P829, DOI 10.1016/j.chiabu.2007.02.008; Coatsworth J Douglas, 2006, J Prim Prev, V27, P171, DOI 10.1007/s10935-005-0028-2; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Derogatis, 1994, ADM SCOR PROC MAN; Diener MJ, 2011, PSYCHOTHERAPY, V48, P237, DOI 10.1037/a0022425; Duggan A, 2000, PEDIATRICS, V105, P250; Duggan AK, 1999, FUTURE CHILD, V9, P66, DOI 10.2307/1602722; Duggan AK, 2009, J CONSULT CLIN PSYCH, V77, P788, DOI 10.1037/a0015709; Dugravier R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072216; Fergusson DM, 2005, PEDIATRICS, V116, pE803, DOI 10.1542/peds.2005-0948; Guedeney A, 2013, INFANT MENT HEALTH J, V34, P594, DOI 10.1002/imhj.21413; Guedeney N., 1995, DEVENIR, V7, P69; Gunning M, 2004, BRIT J PSYCHIAT, V184, pS38, DOI 10.1192/bjp.184.46.s38; GUTELIUS MF, 1977, PEDIATRICS, V60, P294; HARDY JB, 1989, J PEDIATR-US, V115, P927, DOI 10.1016/S0022-3476(89)80744-9; Holland ML, 2014, AM J PUBLIC HEALTH, V104, pE58, DOI 10.2105/AJPH.2014.302115; Holland ML, 2014, JOGNN-J OBST GYN NEO, V43, P61, DOI 10.1111/1552-6909.12263; Howe D, 2011, ATTACHMENT LIFECOURS; Jadad A. R., 2008, RANDOMIZED CONTROLLE, P29; JOHNSON Z, 1993, BRIT MED J, V306, P1449, DOI 10.1136/bmj.306.6890.1449; Katz KS, 2001, J COMMUN HEALTH, V26, P203, DOI 10.1023/A:1010373113060; Kemp L, 2011, ARCH DIS CHILD, V96, P533, DOI 10.1136/adc.2010.196279; Kitzman H, 1997, JAMA-J AM MED ASSOC, V278, P644, DOI 10.1001/jama.278.8.644; Koniak-Griffin D, 2003, NURS RES, V52, P127, DOI 10.1097/00006199-200303000-00009; Korfmacher J., 1997, APPL DEV SCI, V1, P43, DOI DOI 10.1207/S1532480XADS0101_5; LARSON CP, 1980, PEDIATRICS, V66, P191; Mallinckrodt B, 2009, ATTACHMENT APPROACH, P264; Mikulincer M., 2007, ATTACHMENT ADULTHOOD; Mytton J, 2014, HEALTH EDUC BEHAV, V41, P127, DOI 10.1177/1090198113485755; OLDS DL, 1986, PEDIATRICS, V78, P65; Raikes H, 2006, EARLY CHILD RES Q, V21, P2, DOI 10.1016/j.ecresq.2006.01.006; Robinson KA, 2007, J CLIN EPIDEMIOL, V60, P757, DOI 10.1016/j.jclinepi.2006.11.023; Sharps P, 2013, PEDIATRICS, V132, pS134, DOI 10.1542/peds.2013-1021L; St Pierre RG, 1999, FUTURE CHILD, V9, P134; Tough SC, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-148; Tubach F, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-648; Whittaker KA, 2012, CHILD SOC, V26, P138, DOI 10.1111/j.1099-0860.2010.00333.x	46	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142495	10.1371/journal.pone.0142495	http://dx.doi.org/10.1371/journal.pone.0142495			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7CT	26554839	Green Published, Green Submitted, gold			2022-12-27	WOS:000364430700117
J	Gan, L; O'Hanlon, TP; Lai, ZN; Fannin, R; Weller, ML; Rider, LG; Chiorini, JA; Miller, FW				Gan, Lu; O'Hanlon, Terrance P.; Lai, Zhennan; Fannin, Rick; Weller, Melodie L.; Rider, Lisa G.; Chiorini, John A.; Miller, Frederick W.			Gene Expression Profiles from Disease Discordant Twins Suggest Shared Antiviral Pathways and Viral Exposures among Multiple Systemic Autoimmune Diseases	PLOS ONE			English	Article							PERIPHERAL-BLOOD CELLS; I INTERFERON; LUPUS-ERYTHEMATOSUS; INFECTION; PATHOGENESIS; RECOGNITION; MECHANISMS; AGENTS	Viral agents are of interest as possible autoimmune triggers due to prior reported associations and widely studied molecular mechanisms of antiviral immune responses in autoimmunity. Here we examined new viral candidates for the initiation and/or promotion of systemic autoimmune diseases (SAID), as well as possible related signaling pathways shared in the pathogenesis of those disorders. RNA isolated from peripheral blood samples from 33 twins discordant for SAID and 33 matched, unrelated healthy controls was analyzed using a custom viral-human gene microarray. Paired comparisons were made among three study groups-probands with SAID, their unaffected twins, and matched, unrelated healthy controls-using statistical and molecular pathway analyses. Probands and unaffected twins differed significantly in the expression of 537 human genes, and 107 of those were associated with viral infections. These 537 differentially expressed human genes participate in overlapping networks of several canonical, biologic pathways relating to antiviral responses and inflammation. Moreover, certain viral genes were expressed at higher levels in probands compared to either unaffected twins or unrelated, healthy controls. Interestingly, viral gene expression levels in unaffected twins appeared intermediate between those of probands and the matched, unrelated healthy controls. Of the viruses with over-expressed viral genes, herpes simplex virus-2 (HSV-2) was the only human viral pathogen identified using four distinct oligonucleotide probes corresponding to three HSV-2 genes associated with different stages of viral infection. Although the effects from immunosuppressive therapy on viral gene expression remain unclear, this exploratory study suggests a new approach to evaluate shared viral agents and antiviral immune responses that may be involved in the development of SAID.	[Gan, Lu; O'Hanlon, Terrance P.; Rider, Lisa G.; Miller, Frederick W.] NIEHS, Environm Autoimmun Grp, Clin Res Branch, NIH, Bethesda, MD USA; [Lai, Zhennan; Weller, Melodie L.; Chiorini, John A.] Natl Inst Dent & Craniofacial Res, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD USA; [Fannin, Rick] NIEHS, Microarray Core, Lab Toxicol & Pharmacol, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Miller, FW (corresponding author), NIEHS, Environm Autoimmun Grp, Clin Res Branch, NIH, Bethesda, MD USA.	millerf@mail.nih.gov	Rider, Lisa G/C-7083-2018; Miller, Frederick/D-2431-2019	Rider, Lisa G/0000-0002-6912-2458; Miller, Frederick/0000-0003-2831-9593	Intramural Research Program of the NIH, National Institute of Environmental Health Sciences; National Institute of Dental and Craniofacial Research; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000695] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZICES102445, ZIAES101081, ZIAES101074] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding: This research was supported by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences (http://www.niehs.nih.gov/) and National Institute of Dental and Craniofacial Research (http://www.nider.nih.gov/). Funding was received by FWM and JAC.	AL-Zarzour N, 2011, J INFECT DEV COUNTR, V5, P890, DOI 10.3855/jidc.1757; Andersson U, 2010, BBA-GENE REGUL MECH, V1799, P141, DOI 10.1016/j.bbagrm.2009.11.003; Bach JF, 2005, J AUTOIMMUN, V25, P74, DOI 10.1016/j.jaut.2005.09.024; Bilgic H, 2009, ARTHRITIS RHEUM-US, V60, P3436, DOI 10.1002/art.24936; Borba EF, 2010, JCR-J CLIN RHEUMATOL, V16, P119, DOI 10.1097/RHU.0b013e3181d52ed7; Brinkworth JF, 2014, CURR OPIN IMMUNOL, V31, P66, DOI 10.1016/j.coi.2014.09.008; Chakravarty EF, 2008, ARTHRITIS RHEUM-US, V58, P2949, DOI 10.1002/art.23883; Crow MK, 2014, J IMMUNOL, V192, P5459, DOI 10.4049/jimmunol.1002795; Cusick MF, 2012, CLIN REV ALLERG IMMU, V42, P102, DOI [10.1007/s12016-011-8293-8, 10.1007/s12016-011-8294-7]; Draborg AH, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/535738; Esmaili N, 2010, INT J DERMATOL, V49, P1261, DOI 10.1111/j.1365-4632.2010.04515.x; Gan L, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-67; Gan L, 2011, CURR OPIN RHEUMATOL, V23, P585, DOI 10.1097/BOR.0b013e32834b5457; Gourley M, 2007, NAT CLIN PRACT RHEUM, V3, P172, DOI 10.1038/ncprheum0435; Higgs BW, 2011, ANN RHEUM DIS, V70, P2029, DOI 10.1136/ard.2011.150326; Ishii T, 2005, DNA RES, V12, P429, DOI 10.1093/dnares/dsi020; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kraan TCV, 2005, ARTHRITIS RHEUM-US, V52, pS421; Lee YC, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/427696; Magro CM, 2009, J CUTAN PATHOL, V36, P853, DOI 10.1111/j.1600-0560.2008.01171.x; Marcenaro E, 2012, ADV EXP MED BIOL, V946, P295, DOI 10.1007/978-1-4614-0106-3_17; Miller FW, 2011, ADV EXP MED BIOL, V711, P61; Moon UY, 2004, ARTHRITIS RES THER, V6, pR295, DOI 10.1186/ar1181; Moroncini Gianluca, 2013, Clin Exp Rheumatol, V31, P3; Mortensen PB, 2010, SCHIZOPHR RES, V122, P257, DOI 10.1016/j.schres.2010.06.010; Munz C, 2009, NAT REV IMMUNOL, V9, P246, DOI 10.1038/nri2527; O'Hanlon TP, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3330; Pierdominici M, 2011, CURR PHARM DESIGN, V17, P3888, DOI 10.2174/138161211798357809; Ram M, 2008, AUTOIMMUN REV, V7, P621, DOI 10.1016/j.autrev.2008.06.008; Rasmussen SB, 2007, J VIROL, V81, P13315, DOI 10.1128/JVI.01167-07; Selmi C, 2013, CLIN REV ALLERG IMMU, V45, P290, DOI 10.1007/s12016-013-8386-7; Selmi C, 2012, J AUTOIMMUN, V39, P272, DOI 10.1016/j.jaut.2012.05.007; Sevilla J, 2004, J PEDIAT HEMATOL ONC, V26, P831; Shao L, 2009, J EXP MED, V206, P1435, DOI 10.1084/jem.20082251; Tauriainen S, 2011, SEMIN IMMUNOPATHOL, V33, P45, DOI 10.1007/s00281-010-0207-y; Toonen EJM, 2011, PHARMACOGENOMICS, V12, P985, DOI [10.2217/pgs.11.34, 10.2217/PGS.11.34]; Wang D, 2002, P NATL ACAD SCI USA, V99, P15687, DOI 10.1073/pnas.242579699; Wang D, 2003, PLOS BIOL, V1, P257, DOI 10.1371/journal.pbio.0000002	39	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142486	10.1371/journal.pone.0142486	http://dx.doi.org/10.1371/journal.pone.0142486			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556803	Green Published, Green Submitted, gold			2022-12-27	WOS:000364430700113
J	Notch, EG; Goodale, BC; Barnaby, R; Coutermarsh, B; Berwin, B; Taylor, VF; Jackson, BP; Stanton, BA				Notch, Emily G.; Goodale, Britton C.; Barnaby, Roxanna; Coutermarsh, Bonita; Berwin, Brent; Taylor, Vivien F.; Jackson, Brian P.; Stanton, Bruce A.			Monomethylarsonous Acid (MMA(III)) Has an Adverse Effect on the Innate Immune Response of Human Bronchial Epithelial Cells to Pseudomonas aeruginosa	PLOS ONE			English	Article							UTERO ARSENIC EXPOSURE; IN-UTERO; DRINKING-WATER; KAPPA-B; TRIVALENT; RICE; METABOLISM; EXPRESSION; INFECTION; TOXICITY	Arsenic is the number one contaminant of concern with regard to human health according to the World Health Organization. Epidemiological studies on Asian and South American populations have linked arsenic exposure with an increased incidence of lung disease, including pneumonia, and chronic obstructive pulmonary disease, both of which are associated with bacterial infection. However, little is known about the effects of low dose arsenic exposure, or the contributions of organic arsenic to the innate immune response to bacterial infection. This study examined the effects on Pseudomonas aeruginosa (P. aeruginosa) induced cytokine secretion by human bronchial epithelial cells (HBEC) by inorganic sodium arsenite (iAs(III)) and two major metabolites, monomethylarsonous acid (MMA(III)) and dimethylarsenic acid (DMA(v)), at concentrations relevant to the U.S. population. Neither iAs(III) nor DMAv altered P. aeruginosa induced cytokine secretion. By contrast, MMAIII increased P. aeruginosa induced secretion of IL-8, IL-6 and CXCL2. A combination of iAs(III), MMAIII and DMAv (10 pbb total) reduced IL-8 and CXCL1 secretion. These data demonstrate for the first time that exposure to MMAIII alone, and a combination of iAs(III), MMAIII and DMAv at levels relevant to the U.S. may have negative effects on the innate immune response of human bronchial epithelial cells to P. aeruginosa.	[Notch, Emily G.; Goodale, Britton C.; Barnaby, Roxanna; Coutermarsh, Bonita; Berwin, Brent; Stanton, Bruce A.] Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Ctr Environm Hlth Sci, Hanover, NH 03755 USA; [Notch, Emily G.] Western New England Univ, Dept Phys & Biol Sci, Springfield, MA USA; [Taylor, Vivien F.; Jackson, Brian P.] Dartmouth Coll, Dept Earth Sci, Hanover, NH 03755 USA	Dartmouth College; Western New England University; Dartmouth College	Notch, EG (corresponding author), Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Ctr Environm Hlth Sci, Hanover, NH 03755 USA.	emily.notch@wne.edu		Berwin, Brent/0000-0001-9196-3256	National Institute of Environmental Health Sciences [P42 ES007373];  [R01 HL074175]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074175] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES007373] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding: This work was supported by grant P42 ES007373 from the National Institute of Environmental Health Sciences (http://www.niehs.nih.gov/) [B.A.S.; Superfund Research Program (SRP) Project 3]. E.G.N. was supported by a postdoctoral fellowship from P42 ES007373 (SRP, Training Core), and by grant R01 HL074175 (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander J, 2009, EFSA J, V7, DOI 10.2903/j.efsa.2009.1351; ATSDR, 2007, TOX PROF ARS; Bailey KA, 2014, TOXICOL SCI, V139, P328, DOI 10.1093/toxsci/kfu053; Bomberger JM, 2012, J BIOL CHEM, V287, P17130, DOI 10.1074/jbc.M111.338855; Burke SJ, 2014, AM J PHYSIOL-ENDOC M, V306, pE131, DOI 10.1152/ajpendo.00347.2013; Calatayud M, 2014, TOXICOL LETT, V224, P40, DOI 10.1016/j.toxlet.2013.09.016; Calatayud M, 2015, ARCH TOXICOL, V89, P555, DOI 10.1007/s00204-014-1271-1; Dangleben NL, 2013, ENV HLTH, V12; Dodmane PR, 2013, TOXICOLOGY, V312, P18, DOI 10.1016/j.tox.2013.07.008; Dubin Patricia J, 2007, Expert Rev Respir Med, V1, P121, DOI 10.1586/17476348.1.1.121; Escudero-Lourdes C, 2010, TOXICOL APPL PHARM, V244, P162, DOI 10.1016/j.taap.2009.12.029; Farzan SF, 2013, ENVIRON RES, V126, P24, DOI 10.1016/j.envres.2013.05.001; Fry RC, 2007, PLOS GENET, V3, P2180, DOI 10.1371/journal.pgen.0030207; Gosse JA, 2014, J APPL TOXICOL, V34, P498, DOI 10.1002/jat.2898; Guo L, 2014, TOXICOL APPL PHARM, V277, P21, DOI 10.1016/j.taap.2014.02.020; Hall M, 2007, ENVIRON HEALTH PERSP, V115, P1503, DOI 10.1289/ehp.9906; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Hughes MF, 2002, TOXICOL LETT, V133, P1, DOI 10.1016/S0378-4274(02)00084-X; Hughes MF, 2011, TOXICOL SCI, V123, P305, DOI 10.1093/toxsci/kfr184; Jackson BP, 2012, ENVIRON HEALTH PERSP, V120, P623, DOI 10.1289/ehp.1104619; Jackson BP, 2012, PURE APPL CHEM, V84, P215, DOI 10.1351/PAC-CON-11-09-17; Kozul CD, 2009, ENVIRON HEALTH PERSP, V117, P1441, DOI 10.1289/ehp.0900911; Kube D, 2001, AM J PHYSIOL-LUNG C, V280, pL493, DOI 10.1152/ajplung.2001.280.3.L493; Kurzius-Spencer M, 2013, J EXPOS SCI ENV EPID, V24, P156; LANTZ RC, 1994, ENVIRON RES, V67, P183, DOI 10.1006/enrs.1994.1073; Lavoie EG, 2011, MICROBES INFECT, V13, P1133, DOI 10.1016/j.micinf.2011.07.011; Lieberman David, 2003, Am J Respir Med, V2, P459; Lovewell RR, 2014, AM J PHYSIOL-LUNG C, V306, pL591, DOI 10.1152/ajplung.00335.2013; Mandal BK, 2002, TALANTA, V58, P201, DOI 10.1016/S0039-9140(02)00268-0; Mayer AK, 2007, J IMMUNOL, V178, P3134, DOI 10.4049/jimmunol.178.5.3134; Meharg AA, 2008, J ENVIRON MONITOR, V10, P428, DOI 10.1039/b800981c; MILLAR IT, 1960, INORG SYN, V6, P113, DOI 10.1002/9780470132371.ch36; Moreau-Marquis Sophie, 2010, J Vis Exp, DOI 10.3791/2186; Nadeau KC, 2014, CLIN IMMUNOL, V155, P188, DOI 10.1016/j.clim.2014.09.004; Nayak AS, 2007, TOXICOL SCI, V98, P118, DOI 10.1093/toxsci/kfm072; Nielsen MGL PJ, 2010, 201051992010 US GEOL; Parvez F, 2008, ENVIRON HEALTH PERSP, V116, P190, DOI 10.1289/ehp.9507; Ryu JH, 2010, MOL CELLS, V30, P173, DOI 10.1007/s10059-010-0146-4; Sanders AP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031354; Schwende H, 1996, J LEUKOCYTE BIOL, V59, P555, DOI 10.1002/jlb.59.4.555; Sherwood CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082970; Smith AH, 2006, ENVIRON HEALTH PERSP, V114, P1293, DOI 10.1289/ehp.8832; Styblo M, 1999, CHEM RES TOXICOL, V12, P560, DOI 10.1021/tx990050l; Styblo M, 2000, ARCH TOXICOL, V74, P289, DOI 10.1007/s002040000134; Welch AH, 1999, ARSENIC EXPOSURE AND HEALTH EFFECTS, P9, DOI 10.1016/B978-008043648-7/50004-2; Williams BJ, 2010, RESPIROLOGY, V15, P1037, DOI 10.1111/j.1440-1843.2010.01819.x; Zhao FJ, 2013, ENVIRON SCI TECHNOL, V47, P3957, DOI 10.1021/es304295n; Zhu YG, 2008, ENVIRON POLLUT, V154, P169, DOI 10.1016/j.envpol.2008.03.015	48	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142392	10.1371/journal.pone.0142392	http://dx.doi.org/10.1371/journal.pone.0142392			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26554712	Green Published, Green Submitted, gold			2022-12-27	WOS:000364430700096
J	Sun, HY; Liu, P; Nolan, LK; Lamont, SJ				Sun, Hongyan; Liu, Peng; Nolan, Lisa K.; Lamont, Susan J.			Novel Pathways Revealed in Bursa of Fabricius Transcriptome in Response to Extraintestinal Pathogenic Escherichia coli (ExPEC) Infection	PLOS ONE			English	Article							CELL-ADHESION; MOLECULAR-BASIS; CHICKEN; COLIBACILLOSIS; ACTIVATION; SYK; IMMUNOGLOBULIN; VIRULENCE; RECEPTOR; VIRUS	Extraintestinal pathogenic Escherichia coli (ExPEC) has major negative impacts on human and animal health. Recent research suggests food-borne links between human and animal ExPEC diseases with particular concern for poultry contaminated with avian pathogenic E. coli (APEC), the avian ExPEC. APEC is also a very important animal pathogen, causing colibacillosis, one of the world's most widespread bacterial diseases of poultry. Previous studies showed marked atrophy and lymphocytes depletion in the bursa during APEC infection. Thus, a more comprehensive understanding of the avian bursa response to APEC infection will facilitate genetic selection for disease resistance. Four-week-old commercial male broiler chickens were infected with APEC O1 or given saline as a control. Bursas were collected at 1 and 5 days post-infection (dpi). Based on lesion scores of liver, pericardium and air sacs, infected birds were classified as having mild or severe pathology, representing resistant and susceptible phenotypes, respectively. Twenty-two individual bursa RNA libraries were sequenced, each yielding an average of 27 million single-end, 100-bp reads. There were 2469 novel genes in the total of 16,603 detected. Large numbers of significantly differentially expressed (DE) genes were detected when comparing susceptible and resistant birds at 5 dpi, susceptible and non-infected birds at 5 dpi, and susceptible birds at 5 dpi and 1 dpi. The DE genes were associated with signal transduction, the immune response, cell growth and cell death pathways. These data provide considerable insight into potential mechanisms of resistance to ExPEC infection, thus paving the way to develop strategies for ExPEC prevention and treatment, as well as enhancing innate resistance by genetic selection in animals.	[Sun, Hongyan; Lamont, Susan J.] Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA; [Liu, Peng] Iowa State Univ, Dept Stat, Ames, IA 50011 USA; [Nolan, Lisa K.] Iowa State Univ, Dept Vet Microbiol & Prevent Med, Ames, IA 50011 USA	Iowa State University; Iowa State University; Iowa State University	Lamont, SJ (corresponding author), Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA.	sjlamont@iastate.edu			United States Department of Agriculture National Institute of Food and Agriculture [5357]; USDA National Institute of Food and Agriculture [2008-35604-18805]	United States Department of Agriculture National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	This work was supported by The United States Department of Agriculture National Institute of Food and Agriculture, Hatch Project number 5357 and Grant no. 2008-35604-18805 from the USDA National Institute of Food and Agriculture.	Antao EM, 2008, MICROB PATHOGENESIS, V45, P361, DOI 10.1016/j.micpath.2008.08.005; Baba Y, 2001, P NATL ACAD SCI USA, V98, P2582, DOI 10.1073/pnas.051626198; BARBU V, 1989, NUCLEIC ACIDS RES, V17, P7115, DOI 10.1093/nar/17.17.7115; Bastiani M, 2005, FEMS MICROBIOL LETT, V253, P133, DOI 10.1016/j.femsle.2005.09.024; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergmann A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3145re8; Davani D, 2014, J IMMUNOL, V192, P3207, DOI 10.4049/jimmunol.1302394; Di Agostino S, 2006, CANCER CELL, V10, P191, DOI 10.1016/j.ccr.2006.08.013; Dziva F, 2008, AVIAN PATHOL, V37, P355, DOI 10.1080/03079450802216652; Ewers C, 2007, INT J MED MICROBIOL, V297, P163, DOI 10.1016/j.ijmm.2007.01.003; Gao QX, 2012, VET MICROBIOL, V160, P395, DOI 10.1016/j.vetmic.2012.06.009; Ge XKZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112048; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; Harris TJC, 2010, NAT REV MOL CELL BIO, V11, P502, DOI 10.1038/nrm2927; Haupt S, 2003, J CELL SCI, V116, P4077, DOI 10.1242/jcs.00739; Horn F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041031; Ishiai M, 1999, IMMUNITY, V10, P117, DOI 10.1016/S1074-7613(00)80012-6; Johnson TJ, 2007, J BACTERIOL, V189, P3228, DOI 10.1128/JB.01726-06; Johnson TJ, 2009, FOODBORNE PATHOG DIS, V6, P657, DOI 10.1089/fpd.2009.0266; Kariyawasam S, 2004, AVIAN DIS, V48, P287, DOI 10.1637/7093; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Keshvara LM, 1998, J IMMUNOL, V161, P5276; La Ragione RM, 2002, RES VET SCI, V73, P27, DOI 10.1016/S0034-5288(02)00075-9; Lammers A, 2010, DEV COMP IMMUNOL, V34, P1254, DOI 10.1016/j.dci.2010.07.001; Li HL, 1997, J BIOL CHEM, V272, P18200, DOI 10.1074/jbc.272.29.18200; Luo HL, 2012, BIOMATERIALS, V33, P4277, DOI 10.1016/j.biomaterials.2012.02.042; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Masum MA, 2014, INT J VET SCI MED, V2, P103, DOI 10.1016/j.ijvsm.2014.06.001; Matthijs MGR, 2003, AVIAN PATHOL, V32, P473, DOI 10.1080/0307945031000154062; Matulova M, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-37; Matulova M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048101; Nair KS, 2005, J CLIN PATHOL, V58, P343, DOI 10.1136/jcp.2004.018036; NAKAMURA K, 1986, VET PATHOL, V23, P712, DOI 10.1177/030098588602300610; NAKAMURA K, 1985, VET PATHOL, V22, P592, DOI 10.1177/030098588502200614; Nikaido H, 2009, ANNU REV BIOCHEM, V78, P119, DOI 10.1146/annurev.biochem.78.082907.145923; Nolan LK., 2020, DIS POULTRY, P770, DOI 10.1002/9781119421481.ch18; Okegawa T, 2002, J UROLOGY, V167, P1836, DOI 10.1016/S0022-5347(05)65245-7; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Pan HP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125868; Peighambari SM, 2000, AVIAN DIS, V44, P759, DOI 10.2307/1593047; Pike KA, 2004, J IMMUNOL, V172, P2210, DOI 10.4049/jimmunol.172.4.2210; REYNAUD CA, 1987, CELL, V48, P379, DOI 10.1016/0092-8674(87)90189-9; Ricci M. Stacey, 2007, P31; Rodriguez-Siek KE, 2005, VET RES, V36, P241, DOI 10.1051/vetres:2004057; ROSENBERGER JK, 1985, AVIAN DIS, V29, P1108, DOI 10.2307/1590465; Rozen S, 2000, Methods Mol Biol, V132, P365; Salehi TZ, 2012, BRAZ J MICROBIOL, V43, P363, DOI [10.1590/S1517-838220120001000043, 10.1590/S1517-83822012000100043]; Samba-Louaka A, 2008, CELL MICROBIOL, V10, P2496, DOI 10.1111/j.1462-5822.2008.01224.x; Sandford Erin E, 2012, Results Immunol, V2, P44, DOI 10.1016/j.rinim.2012.02.003; Sandford EE, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-469; Sarson AJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-260; Sayegh CE, 1999, EMBO J, V18, P6319, DOI 10.1093/emboj/18.22.6319; Sayegh CE, 2000, IMMUNOL REV, V175, P187, DOI 10.1034/j.1600-065X.2000.017507.x; Shinohara Hisaaki, 2006, Subcell Biochem, V40, P145; Skyberg JA, 2006, INFECT IMMUN, V74, P6287, DOI 10.1128/IAI.00363-06; THOMPSON CB, 1987, CELL, V48, P369, DOI 10.1016/0092-8674(87)90188-7; Tivendale KA, 2010, INFECT IMMUN, V78, P3412, DOI 10.1128/IAI.00347-10; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Weber M, 2008, J EXP MED, V205, P853, DOI 10.1084/jem.20072619; Wei L, 2011, VIROLOGY, V420, P156, DOI 10.1016/j.virol.2011.08.027; Wieland WH, 2004, BIOCHEM J, V380, P669, DOI [10.1042/BJ20040200, 10.1042/bj20040200]; YOKOYAMA H, 1992, INFECT IMMUN, V60, P998, DOI 10.1128/IAI.60.3.998-1007.1992; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14	64	22	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142570	10.1371/journal.pone.0142570	http://dx.doi.org/10.1371/journal.pone.0142570			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556806	Green Published, Green Submitted, gold			2022-12-27	WOS:000364430700133
J	Wilson, CS; Chang, AJ; Greene, R; Machado, S; Parsons, MW; Takats, TA; Zambetti, LJ; Springer, AL				Wilson, Corinne S.; Chang, Alex J.; Greene, Rebecca; Machado, Sulynn; Parsons, Matthew W.; Takats, Taylor A.; Zambetti, Luke J.; Springer, Amy L.			Knockdown of Inner Arm Protein IC138 in Trypanosoma brucei Causes Defective Motility and Flagellar Detachment	PLOS ONE			English	Article							DYNEIN REGULATORY COMPLEX; AFRICAN TRYPANOSOMES; AXONEMAL DYNEIN; PARAFLAGELLAR ROD; I1 DYNEIN; CHLAMYDOMONAS-REINHARDTII; CRYOELECTRON TOMOGRAPHY; CELL MORPHOGENESIS; ATTACHMENT ZONE; TSETSE-FLY	Motility in the protozoan parasite Trypanosoma brucei is conferred by a single flagellum, attached alongside the cell, which moves the cell forward using a beat that is generated from tip-to-base. We are interested in characterizing components that regulate flagellar beating, in this study we extend the characterization of TbIC138, the ortholog of a dynein intermediate chain that regulates axonemal inner arm dynein f/I1. TbIC138 was tagged In situ-and shown to fractionate with the inner arm components of the flagellum. RNAi knockdown of TbIC138 resulted in significantly reduced protein levels, mild growth defect and significant motility defects. These cells tended to cluster, exhibited slow and abnormal motility and some cells had partially or fully detached flagella. Slight but significant increases were observed in the incidence of mis-localized or missing kinetoplasts. To document development of the TbIC138 knockdown phenotype over time, we performed a detailed analysis of flagellar detachment and motility changes over 108 hours following induction of RNAi. Abnormal motility, such as slow twitching or irregular beating, was observed early, and became progressively more severe such that by 72 hours-post-induction, approximately 80% of the cells were immotile. Progressively more cells exhibited flagellar detachment over time, but this phenotype was not as prevalent as immotility, affecting less than 60% of the population. Detached flagella had abnormal beating, but abnormal beating was also observed in cells with no flagellar detachment, suggesting that TbIC138 has a direct, or primary, effect on the flagellar beat, whereas detachment is a secondary phenotype of TbIC138 knockdown. Our results are consistent with the role of TbIC138 as a regulator of motility, and has a phenotype amenable to more extensive structure-function analyses to further elucidate its role in the control of flagellar beat in T. brucei.	[Wilson, Corinne S.; Takats, Taylor A.; Springer, Amy L.] Siena Coll, Dept Biol, Loudonville, NY 12211 USA; [Chang, Alex J.; Machado, Sulynn; Parsons, Matthew W.; Zambetti, Luke J.] Amherst Coll, Dept Biol, Amherst, MA 01002 USA; [Greene, Rebecca] Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA	Amherst College; University of Massachusetts System; University of Massachusetts Amherst	Springer, AL (corresponding author), Siena Coll, Dept Biol, Loudonville, NY 12211 USA.	aspringer@siena.edu		Parsons, Matthew/0000-0003-1543-5309	National Institutes of Health AREA Award [7R15AI101941-02]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI101941] Funding Source: NIH RePORTER	National Institutes of Health AREA Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by National Institutes of Health AREA Award No 7R15AI101941-02, (http://www.niaid.nih.gov) (ALS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absalon S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000437; Alsford S, 2011, GENOME RES, V21, P915, DOI 10.1101/gr.115089.110; Baker N, 2013, TRENDS PARASITOL, V29, P110, DOI 10.1016/j.pt.2012.12.005; Baron DM, 2007, J CELL SCI, V120, P478, DOI 10.1242/jcs.03352; Bastin P, 1999, MOL CELL BIOL, V19, P8191; Bastin P, 1999, J CELL SCI, V112, P3769; Bastin P, 1998, NATURE, V391, P548, DOI 10.1038/35300; Bayly PV, 2010, CYTOSKELETON, V67, P56, DOI 10.1002/cm.20424; Bower R, 2009, MOL BIOL CELL, V20, P3055, DOI 10.1091/mbc.E09-04-0277; Branche C, 2006, J CELL SCI, V119, P3443, DOI 10.1242/jcs.03078; Broadhead R, 2006, NATURE, V440, P224, DOI 10.1038/nature04541; BROKAW CJ, 1987, CELL MOTIL CYTOSKEL, V8, P68, DOI 10.1002/cm.970080110; BRUN R, 1979, ACTA TROP, V36, P289; Brun R, 2012, INFECT DIS CLIN N AM, V26, P261, DOI 10.1016/j.idc.2012.03.003; Bui KH, 2008, J CELL BIOL, V183, P923, DOI 10.1083/jcb.200808050; Chandler J, 2008, EUKARYOT CELL, V7, P2141, DOI 10.1128/EC.00199-08; Cnops J, 2014, PARASITOLOGY, P1, DOI DOI 10.1017/S0031182013001224; Davidge JA, 2006, J CELL SCI, V119, P3935, DOI 10.1242/jcs.03203; Engstler M, 2007, CELL, V131, P505, DOI 10.1016/j.cell.2007.08.046; Gadelha C, 2007, CELL MOTIL CYTOSKEL, V64, P629, DOI 10.1002/cm.20210; Habermacher G, 1997, J CELL BIOL, V136, P167, DOI 10.1083/jcb.136.1.167; Hammarton TC, 2007, CURR OPIN MICROBIOL, V10, P520, DOI 10.1016/j.mib.2007.10.005; Hayes P, 2014, J CELL BIOL, V206, P377, DOI 10.1083/jcb.201312067; Heddergott N, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003023; Hendrickson TW, 2013, BBA-MOL CELL RES, V1833, P3265, DOI 10.1016/j.bbamcr.2013.09.011; Hendrickson TW, 2004, MOL BIOL CELL, V15, P5431, DOI 10.1091/mbc.E04-08-0694; Heuser T, 2012, P NATL ACAD SCI USA, V109, pE2067, DOI 10.1073/pnas.1120690109; Heuser T, 2009, J CELL BIOL, V187, P921, DOI 10.1083/jcb.200908067; Hill KL, 2000, J BIOL CHEM, V275, P39369, DOI 10.1074/jbc.M006907200; Hoog JL, 2012, J STRUCT BIOL, V178, P189, DOI 10.1016/j.jsb.2012.01.009; Hughes LC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0025700; Hutchings NR, 2002, J CELL BIOL, V156, P867, DOI 10.1083/jcb.200201036; Ikeda KN, 2012, J CELL SCI, V125, P3173, DOI 10.1242/jcs.101162; Inaba K, 2007, ANN NY ACAD SCI, V1101, P506, DOI 10.1196/annals.1389.017; Ishikawa T, 2007, J MOL BIOL, V368, P1249, DOI 10.1016/j.jmb.2007.02.072; Kamiya R, 2014, ZOOL SCI, V31, P633, DOI 10.2108/zs140066; King SJ, 1997, J CELL BIOL, V136, P177, DOI 10.1083/jcb.136.1.177; King SM, 2012, J STRUCT BIOL, V179, P222, DOI 10.1016/j.jsb.2012.02.013; Kohl L, 2003, EMBO J, V22, P5336, DOI 10.1093/emboj/cdg518; Kohl L, 1999, J EUKARYOT MICROBIOL, V46, P105, DOI 10.1111/j.1550-7408.1999.tb04592.x; Kotani N, 2007, BIOPHYS J, V93, P886, DOI 10.1529/biophysj.106.101964; Koyfman AY, 2011, P NATL ACAD SCI USA, V108, P11105, DOI 10.1073/pnas.1103634108; LaCount DJ, 2000, MOL BIOCHEM PARASIT, V111, P67, DOI 10.1016/S0166-6851(00)00300-5; LaCount DJ, 2002, J BIOL CHEM, V277, P17580, DOI 10.1074/jbc.M200873200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Langousis G, 2014, NAT REV MICROBIOL, V12, P505, DOI 10.1038/nrmicro3274; Matthews KR, 2005, J CELL SCI, V118, P283, DOI 10.1242/jcs.01649; McDonald J.H., 2014, HDB BIOL STAT; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Nicastro D, 2006, SCIENCE, V313, P944, DOI 10.1126/science.1128618; Oberholzer M, 2006, MOL BIOCHEM PARASIT, V145, P117, DOI 10.1016/j.molbiopara.2005.09.002; Oberholzer M, 2009, METHOD CELL BIOL, V93, P21, DOI 10.1016/S0091-679X(08)93002-8; Oda T, 2014, J CELL BIOL, V204, P807, DOI 10.1083/jcb.201312014; Pays E, 2014, NAT REV MICROBIOL, V12, P575, DOI 10.1038/nrmicro3298; PIPERNO G, 1994, J CELL BIOL, V125, P1109, DOI 10.1083/jcb.125.5.1109; Porter ME, 2000, J CELL BIOL, V151, pF37, DOI 10.1083/jcb.151.5.F37; Ralston KS, 2011, EUKARYOT CELL, V10, P884, DOI 10.1128/EC.00298-10; Ralston KS, 2009, ANNU REV MICROBIOL, V63, P335, DOI 10.1146/annurev.micro.091208.073353; Ralston KS, 2006, EUKARYOT CELL, V5, P696, DOI 10.1128/EC.5.4.696-711.2006; Ralston KS, 2006, PLOS PATHOG, P2; ROBINSON D, 1991, METHOD ENZYMOL, V196, P285; Rocha GM, 2006, J STRUCT BIOL, V154, P89, DOI 10.1016/j.jsb.2005.11.008; Rodriguez JA, 2009, P NATL ACAD SCI USA, V106, P19322, DOI 10.1073/pnas.0907001106; Rotureau B, 2014, CELL MICROBIOL, V16, P425, DOI 10.1111/cmi.12230; Rotureau B, 2014, J CELL SCI, V127, P204, DOI 10.1242/jcs.136424; Rotureau B, 2011, CELL MICROBIOL, V13, P705, DOI 10.1111/j.1462-5822.2010.01566.x; Santrich C, 1997, MOL BIOCHEM PARASIT, V90, P95, DOI 10.1016/S0166-6851(97)00149-7; Selvapandiyan A, 2007, MOL BIOL CELL, V18, P3290, DOI 10.1091/mbc.E07-01-0022; SHERWIN T, 1989, PHILOS T R SOC B, V323, P573, DOI 10.1098/rstb.1989.0037; Shimizu Y, 2014, BIOPHYS J, V106, P2157, DOI 10.1016/j.bpj.2014.04.009; Simarro PP, 2013, RES REP TROP MED, V4, P1, DOI 10.2147/RRTM.S40157; Springer AL, 2011, MOL BIOCHEM PARASIT, V175, P68, DOI 10.1016/j.molbiopara.2010.09.005; Stellamanns E, 2014, SCI REP-UK, V4, DOI 10.1038/srep06515; SUMMERS KE, 1971, P NATL ACAD SCI USA, V68, P3092, DOI 10.1073/pnas.68.12.3092; Sun SY, 2013, J CELL SCI, V126, P520, DOI 10.1242/jcs.113621; Sunter JD, 2015, J CELL SCI, V128, P1580, DOI 10.1242/jcs.166447; Sunter JD, 2015, J CELL SCI; Ueno H, 2014, CYTOSKELETON, V71, P412, DOI 10.1002/cm.21180; Uppaluri S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002058; Van den Abbeele J, 1999, PARASITOLOGY, V118, P469, DOI 10.1017/S0031182099004217; VanderWaal KE, 2011, MOL BIOL CELL, V22, P2862, DOI 10.1091/mbc.E11-03-0270; Vaughan S, 2008, PROTIST, V159, P127, DOI 10.1016/j.protis.2007.08.005; VICKERMAN K, 1985, BRIT MED BULL, V41, P105, DOI 10.1093/oxfordjournals.bmb.a072036; VICKERMAN K, 1988, BIOL CELL, V64, P109, DOI 10.1016/0248-4900(88)90070-6; Vincensini L, 2011, BIOL CELL, V103, P109, DOI 10.1042/BC20100104; Viswanadha R, 2014, CYTOSKELETON, V71, P573, DOI 10.1002/cm.21192; Weisse S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037296; Wheeler RJ, 2013, MOL MICROBIOL, V90, P1339, DOI 10.1111/mmi.12436; Wheeler RJ, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-1; Wheeler RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079581; Wickstead B, 2007, TRAFFIC, V8, P1708, DOI 10.1111/j.1600-0854.2007.00646.x; Wirschell M, 2007, CELL MOTIL CYTOSKEL, V64, P569, DOI 10.1002/cm.20211; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Yamamoto R, 2013, J CELL BIOL, V201, P263, DOI 10.1083/jcb.201211048; Zhou Q, 2011, J CELL SCI, V124, P3848, DOI 10.1242/jcs.087676; Zukas R, 2012, BIOCELL, V36, P133	96	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0139579	10.1371/journal.pone.0139579	http://dx.doi.org/10.1371/journal.pone.0139579			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555902	gold, Green Published, Green Submitted			2022-12-27	WOS:000364430700007
J	Alonso, A; Yu, B; Qureshi, WT; Grams, ME; Selvin, E; Soliman, EZ; Loehr, LR; Chen, LY; Agarwal, SK; Alexander, D; Boerwinkle, E				Alonso, Alvaro; Yu, Bing; Qureshi, Waqas T.; Grams, Morgan E.; Selvin, Elizabeth; Soliman, Elsayed Z.; Loehr, Laura R.; Chen, Lin Y.; Agarwal, Sunil K.; Alexander, Danny; Boerwinkle, Eric			Metabolomics and Incidence of Atrial Fibrillation in African Americans: The Atherosclerosis Risk in Communities (ARIC) Study	PLOS ONE			English	Article							HEART-FAILURE; BILE-ACIDS	Background Atrial fibrillation (AF) is a common arrhythmia. Application of metabolomic approaches, which may identify novel pathways and biomarkers of disease risk, to a longitudinal epidemiologic study of AF has been limited. Methods We determined the prospective association of 118 serum metabolites identified through untargeted metabolomics profiling with the incidence of newly-diagnosed AF in 1919 African-American men and women from the Atherosclerosis Risk in Communities study without AF at baseline (1987-1989). Incident AF cases through 2011 were ascertained from study electrocardiograms, hospital discharge codes, and death certificates. Results During a median follow-up of 22 years, we identified 183 incident AF cases. In Cox proportional hazards models adjusted for age, sex, smoking, body mass index, systolic blood pressure, use of antihypertensive medication, diabetes, prevalent heart failure, prevalent coronary heart disease, and kidney function, two conjugated bile acids (glycolithocholate sulfate and glycocholenate sulfate) were significantly associated with AF risk after correcting for multiple comparisons (p<0.0004). Multivariable-adjusted hazard ratios (95% confidence intervals) of AF were 1.22 (1.12-1.32) for glycolithocholate sulfate and 1.22 (1.10-1.35) for glycocholenate sulfate per 1-standard deviation higher levels. Associations were not appreciably different after additional adjustment for alcohol consumption or concentrations of circulating albumin and liver enzymes. Conclusion We found an association of higher levels of two bile acids with an increased risk of AF, pointing to a potential novel pathway in AF pathogenesis. Replication of results in independent studies is warranted.	[Alonso, Alvaro] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA; [Yu, Bing; Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX 77030 USA; [Qureshi, Waqas T.] Wake Forest Univ, Bowman Gray Sch Med, Div Cardiovasc Med, Winston Salem, NC USA; [Grams, Morgan E.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Grams, Morgan E.; Selvin, Elizabeth] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Selvin, Elizabeth] Johns Hopkins Univ, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD USA; [Soliman, Elsayed Z.] Wake Forest Sch Med, Dept Epidemiol & Prevent, Epidemiol Cardiol Res Ctr EPICARE, Winston Salem, NC USA; [Soliman, Elsayed Z.] Wake Forest Sch Med, Dept Med Cardiol, Winston Salem, NC USA; [Loehr, Laura R.] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Chen, Lin Y.] Univ Minnesota, Sch Med, Dept Med, Div Cardiovasc, Minneapolis, MN 55455 USA; [Agarwal, Sunil K.] Mt Sinai Heart Hosp, New York, NY USA; [Alexander, Danny] Metabolon Inc, Durham, NC USA; [Boerwinkle, Eric] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Texas System; University of Texas Health Science Center Houston; Wake Forest University; Wake Forest Baptist Medical Center; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Wake Forest University; Wake Forest University; University of North Carolina; University of North Carolina Chapel Hill; University of Minnesota System; University of Minnesota Twin Cities; Metabolon; Baylor College of Medicine	Alonso, A (corresponding author), Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA.	alonso@umn.edu	Qureshi, Waqas/H-3498-2019; Alonso, Alvaro/A-4917-2010; Soliman, Elsayed Z/AAD-7135-2020	Qureshi, Waqas/0000-0002-5189-4417; Alonso, Alvaro/0000-0002-2225-8323; Soliman, Elsayed Z/0000-0001-5632-8150; Grams, Morgan/0000-0002-4430-6023; Loehr, Laura/0000-0002-9054-1825; Chen, Lin/0000-0002-0700-814X	National Heart, Lung, and Blood Institute [HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HSN268201100012C, RC1HL099452]; National Human Genome Research Institute [3U01HG004402-02S1]; National Institute of Diabetes and Digestive and Kidney Diseases [R01DK089174, K24DK106414]; Metabolon, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL099452] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK089174, K24DK106414] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Metabolon, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HSN268201100012C). The metabolomics research was sponsored by the National Human Genome Research Institute (3U01HG004402-02S1). This work was additionally supported by National Heart, Lung, and Blood Institute grant RC1HL099452 to Dr. Alonso and by National Institute of Diabetes and Digestive and Kidney Diseases grant R01DK089174 and K24DK106414 to Dr. Selvin. The metabolomics measurements were sponsored by National Human Genome Research Institute (3U01HG004402-02S1). Reagents for the ALT, AST, and GGT assays were donated by Roche Diagnostics. Author DA is employed by Metabolon, Inc., a commercial entity. Metabolon, Inc. provided support in the form of salaries for this author [DA], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contribution' section. Similarly, the remaining funders did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Inizi S, 2006, INT J GYNECOL OBSTET, V93, P53, DOI 10.1016/j.ijgo.2005.12.030; Alnouti Y, 2009, TOXICOL SCI, V108, P225, DOI 10.1093/toxsci/kfn268; Alonso Alvaro, 2014, J Am Heart Assoc, V3, pe001211, DOI 10.1161/JAHA.114.001211; Alonso A, 2014, HEART, V100, P1511, DOI 10.1136/heartjnl-2014-305756; Alonso A, 2009, AM HEART J, V158, P111, DOI 10.1016/j.ahj.2009.05.010; BINAH O, 1987, N-S ARCH PHARMACOL, V335, P160; De Souza AI, 2010, J MOL CELL CARDIOL, V49, P851, DOI 10.1016/j.yjmcc.2010.07.008; Gorelik J, 2004, BJOG-INT J OBSTET GY, V111, P867, DOI 10.1111/j.1471-0528.2004.00166.x; Harrell FE, 2001, REGRESSION MODELING; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Jensen PN, 2012, PHARMACOEPIDEM DR S, V21, P141, DOI 10.1002/pds.2317; Kobayashi N, 2002, STEROIDS, V67, P827, DOI 10.1016/S0039-128X(02)00036-3; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Loehr LR, 2008, AM J CARDIOL, V101, P1016, DOI 10.1016/j.amjcard.2007.11.061; Lopez FL, 2012, CIRC-ARRHYTHMIA ELEC, V5, P155, DOI 10.1161/CIRCEP.111.966804; Mayr M, 2008, J AM COLL CARDIOL, V51, P585, DOI 10.1016/j.jacc.2007.09.055; MINDER EI, 1979, J LIPID RES, V20, P986; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Rainer PP, 2013, HEART, V99, P1685, DOI 10.1136/heartjnl-2013-304163; Rienstra M, 2012, CIRCULATION, V125, pE941, DOI 10.1161/CIRCULATIONAHA.112.112920; Roberts LD, 2013, CELL METAB, V18, P43, DOI 10.1016/j.cmet.2013.05.009; Sankoh AJ, 1997, STAT MED, V16, P2529, DOI 10.1002/(SICI)1097-0258(19971130)16:22<2529::AID-SIM692>3.0.CO;2-J; Schaap FG, 2014, NAT REV GASTRO HEPAT, V11, P55, DOI 10.1038/nrgastro.2013.151; Sinner MF, 2013, AM J CARDIOL, V111, P219, DOI 10.1016/j.amjcard.2012.09.021; Soliman EZ, 2009, STROKE, V40, P1204, DOI 10.1161/STROKEAHA.108.534735; Van Wagoner DR, 2015, HEART RHYTHM, V12, pE5, DOI 10.1016/j.hrthm.2014.11.011; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Zheng Y, 2014, OMICS, V18, P364, DOI 10.1089/omi.2014.0019; Zheng Y, 2013, AM J EPIDEMIOL, V178, P534, DOI 10.1093/aje/kwt004	29	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142610	10.1371/journal.pone.0142610	http://dx.doi.org/10.1371/journal.pone.0142610			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544570	Green Published, Green Submitted, gold			2022-12-27	WOS:000364398700159
J	Dominguez, LJ; Bes-Rastrollo, M; Basterra-Gortari, FJ; Gea, A; Barbagallo, M; Martinez-Gonzalez, MA				Dominguez, Ligia J.; Bes-Rastrollo, Maira; Javier Basterra-Gortari, Francisco; Gea, Alfredo; Barbagallo, Mario; Martinez-Gonzalez, Miguel A.			Association of a Dietary Score with Incident Type 2 Diabetes: The Dietary-Based Diabetes-Risk Score (DDS)	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; LIFE-STYLE INTERVENTION; FOOD-FREQUENCY QUESTIONNAIRE; ACTIVITY PROMOTION PROGRAMS; MEDITERRANEAN DIET; FOLLOW-UP; PREVENTION; MORTALITY; ADHERENCE; DISEASE	Background Strong evidence supports that dietary modifications may decrease incident type 2 diabetes mellitus (T2DM). Numerous diabetes risk models/scores have been developed, but most do not rely specifically on dietary variables or do not fully capture the overall dietary pattern. We prospectively assessed the association of a dietary-based diabetes-risk score (DDS), which integrates optimal food patterns, with the risk of developing T2DM in the SUN ("Seguimiento Universidad de Navarra") longitudinal study. Methods We assessed 17,292 participants initially free of diabetes, followed-up for a mean of 9.2 years. A validated 136-item FFQ was administered at baseline. Taking into account previous literature, the DDS positively weighted vegetables, fruit, whole cereals, nuts, coffee, low-fat dairy, fiber, PUFA, and alcohol in moderate amounts; while it negatively weighted red meat, processed meats and sugar-sweetened beverages. Energy-adjusted quintiles of each item (with exception of moderate alcohol consumption that received either 0 or 5 points) were used to build the DDS (maximum: 60 points). Incident T2DM was confirmed through additional detailed questionnaires and review of medical records of participants. We used Cox proportional hazards models adjusted for socio-demographic and anthropometric parameters, health-related habits, and clinical variables to estimate hazard ratios (HR) of T2DM. Results We observed 143 T2DM confirmed cases during follow-up. Better baseline conformity with the DDS was associated with lower incidence of T2DM (multivariable-adjusted HR for intermediate (25-39 points) vs. low (11-24) category 0.43 [95% confidence interval (CI) 0.21, 0.89]; and for high (40-60) vs. low category 0.32 [95% CI: 0.14, 0.69]; p for linear trend: 0.019). Conclusions The DDS, a simple score exclusively based on dietary components, showed a strong inverse association with incident T2DM. This score may be applicable in clinical practice to improve dietary habits of subjects at high risk of T2DM and also as an educational tool for laypeople to help them in self-assessing their future risk for developing diabetes.	[Dominguez, Ligia J.; Barbagallo, Mario] Univ Palermo, Dept Internal Med & Geriatr, Geriatr Unit, Palermo, Italy; [Bes-Rastrollo, Maira; Javier Basterra-Gortari, Francisco; Gea, Alfredo; Martinez-Gonzalez, Miguel A.] Univ Navarra, IDISNA, Dept Prevent Med & Publ Hlth, E-31080 Pamplona, Spain; [Bes-Rastrollo, Maira; Javier Basterra-Gortari, Francisco; Gea, Alfredo; Martinez-Gonzalez, Miguel A.] Inst Salud Carlos III, CIBER Fisiopatol Obesidad Nutr CIBERobn, Madrid, Spain; [Javier Basterra-Gortari, Francisco] Osasunbidea IDISNA, Hosp Reina Sofia, Dept Internal Med Endocrinol, Tudela, Spain	University of Palermo; University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Servicio Navarro de Salud - Osasunbidea	Dominguez, LJ (corresponding author), Univ Palermo, Dept Internal Med & Geriatr, Geriatr Unit, Palermo, Italy.	ligia.dominguez@unipa.it	Bes-Rastrollo, Maira/A-1329-2009; Martinez-Gonzalez, Miguel A./AAE-7669-2019; BARBAGALLO, MARIO/K-4794-2017	Bes-Rastrollo, Maira/0000-0002-9139-4206; BARBAGALLO, MARIO/0000-0002-1349-6530; Gea, Alfredo/0000-0002-2229-4690	Spanish Ministry of Health and European Regional Development Fund (FEDER) [PI10/02993, PI10/02658, PI13/00615, PI14/01668, PI14/01798, PI14/1764, RD06/0045, G03/140]; Navarra Regional Government [45/2011, 122/2014]; FPU fellowship from the Spanish Government	Spanish Ministry of Health and European Regional Development Fund (FEDER); Navarra Regional Government; FPU fellowship from the Spanish Government(Spanish Government)	The Seguimiento Universidad de Navarra (SUN) study has received funding from the Spanish Ministry of Health and European Regional Development Fund (FEDER) (grants PI10/02993, PI10/02658, PI13/00615, PI14/01668, PI14/01798, PI14/1764, RD06/0045, G03/140), and the Navarra Regional Government (45/2011, 122/2014). AG is supported by a FPU fellowship from the Spanish Government.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Ardisson Korat Andres V, 2014, Curr Nutr Rep, V3, P345; Balk EM, 2015, ANN INTERN MED, V163, P437, DOI 10.7326/M15-0452; Bes-Rastrollo M., 2005, REV ESP OBES, V3, P352; Bhupathiraju SN, 2014, DIABETOLOGIA, V57, P1346, DOI 10.1007/s00125-014-3235-7; Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; Ciulla TA, 2003, DIABETES CARE, V26, P2653, DOI 10.2337/diacare.26.9.2653; COLDITZ GA, 1995, ANN INTERN MED, V122, P481, DOI 10.7326/0003-4819-122-7-199504010-00001; Cuadrado C., 2013, TABLAS COMPOSICION A, V16th; de la Fuente-Arrillaga C, 2010, PUBLIC HEALTH NUTR, V13, P1364, DOI 10.1017/S1368980009993065; DiPreta JA, 2014, MED CLIN N AM, V98, P353, DOI 10.1016/j.mcna.2013.10.010; Dominguez LJ, 2013, NUTR METAB CARDIOVAS, V23, P451, DOI 10.1016/j.numecd.2011.10.009; Donin AS, 2015, DIABETOLOGIA; Fernandez-Ballarth JD, 2010, BRIT J NUTR, V103, P1808, DOI 10.1017/S0007114509993837; Greenland S, 2008, MODERN EPIDEMIOLOGY, P303; Hu FB, 1999, AM J EPIDEMIOL, V149, P531, DOI 10.1093/oxfordjournals.aje.a009849; Hu FB, 2015, JAMA-J AM MED ASSOC, V313, P2319, DOI 10.1001/jama.2015.5287; Imamura F, 2015, LANCET GLOB HEALTH, V3, pE132, DOI 10.1016/S2214-109X(14)70381-X; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Joseph JJ, 2014, CURR OPIN ENDOCRINOL, V21, P109, DOI 10.1097/MED.0000000000000044; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kroger J, 2014, DIABETOLOGIA, V57, P321, DOI 10.1007/s00125-013-3092-9; Li GW, 2014, LANCET DIABETES ENDO, V2, P474, DOI 10.1016/S2213-8587(14)70057-9; Li R, 2015, ANN INTERN MED, V163, P452, DOI 10.7326/M15-0469; Lindstrom J, 2006, LANCET, V368, P1673, DOI 10.1016/S0140-6736(06)69701-8; Martinez-Gonzalez MA, 2008, BMJ-BRIT MED J, V336, P1348, DOI 10.1136/bmj.39561.501007.BE; Martinez-Gonzalez MA, 2005, PUBLIC HEALTH NUTR, V8, P920, DOI 10.1079/PHN2005745; Martinez-Gonzalez MA, 2002, NUTR NEUROSCI, V5, P65, DOI 10.1080/10284150290007047; MARTINMORENO JM, 1993, INT J EPIDEMIOL, V22, P512, DOI 10.1093/ije/22.3.512; Mataix Verdu J., 2009, TABLA COMPOSICION AL, V5th; Morley JE, 2013, J AM MED DIR ASSOC, V14, P392, DOI 10.1016/j.jamda.2013.03.022; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Noble D, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7163; Nowak C, 2015, LANCET DIABETES ENDO, V3, P166, DOI 10.1016/S2213-8587(14)70261-X; O'Connor LM, 2014, DIABETOLOGIA, V57, P909, DOI 10.1007/s00125-014-3176-1; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Phillips CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078950; Ramachandran A, 2006, DIABETOLOGIA, V49, P289, DOI 10.1007/s00125-005-0097-z; Schmid R, 2011, DIABETES CARE, V34, P1863, DOI 10.2337/dc11-0206; Schroder H, 2011, J NUTR, V141, P1140, DOI 10.3945/jn.110.135566; Seaquist ER, 2014, JAMA-J AM MED ASSOC, V311, P2267, DOI 10.1001/jama.2014.6451; Segui-Gomez M, 2006, INT J EPIDEMIOL, V35, P1417, DOI 10.1093/ije/dyl223; Sinclair A, 2015, LANCET DIABETES ENDO, V3, P275, DOI 10.1016/S2213-8587(14)70176-7; Tobias DK, 2014, NEW ENGL J MED, V370, P233, DOI 10.1056/NEJMoa1304501; Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Willet W., 1998, NUTR EPIDEMIOLOGY, P74, DOI DOI 10.1093/ACPROF:OSO/9780195122978.001.0001; Zimmet PZ, 2014, LANCET DIABETES ENDO, V2, P56, DOI 10.1016/S2213-8587(13)70112-8	48	14	14	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141760	10.1371/journal.pone.0141760	http://dx.doi.org/10.1371/journal.pone.0141760			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544985	gold, Green Published, Green Submitted			2022-12-27	WOS:000364398700042
J	Gaykalova, DA; Vatapalli, R; Wei, YY; Tsai, HL; Wang, H; Zhang, C; Hennessey, PT; Guo, T; Tan, M; Li, R; Ahn, J; Khan, Z; Westra, WH; Bishop, JA; Zaboli, D; Koch, WM; Khan, T; Ochs, MF; Califano, JA				Gaykalova, Daria A.; Vatapalli, Rajita; Wei, Yingying; Tsai, Hua-Ling; Wang, Hao; Zhang, Chi; Hennessey, Patrick T.; Guo, Theresa; Tan, Marietta; Li, Ryan; Ahn, Julie; Khan, Zubair; Westra, William H.; Bishop, Justin A.; Zaboli, David; Koch, Wayne M.; Khan, Tanbir; Ochs, Michael F.; Califano, Joseph A.			Outlier Analysis Defines Zinc Finger Gene Family DNA Methylation in Tumors and Saliva of Head and Neck Cancer Patients	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; PROMOTER HYPERMETHYLATION; GLOBAL HYPOMETHYLATION; PROTEIN; ACTIVATION; EXPRESSION; BIOMARKER; BIOLOGY; RINSES; EDNRB	Head and Neck Squamous Cell Carcinoma (HNSCC) is the fifth most common cancer, annually affecting over half a million people worldwide. Presently, there are no accepted biomarkers for clinical detection and surveillance of HNSCC. In this work, a comprehensive genome-wide analysis of epigenetic alterations in primary HNSCC tumors was employed in conjunction with cancer-specific outlier statistics to define novel biomarker genes which are differentially methylated in HNSCC. The 37 identified biomarker candidates were top-scoring outlier genes with prominent differential methylation in tumors, but with no signal in normal tissues. These putative candidates were validated in independent HNSCC cohorts from our institution and TCGA (The Cancer Genome Atlas). Using the top candidates, ZNF14, ZNF160, and ZNF420, an assay was developed for detection of HNSCC cancer in primary tissue and saliva samples with 100% specificity when compared to normal control samples. Given the high detection specificity, the analysis of ZNF DNA methylation in combination with other DNA methylation biomarkers may be useful in the clinical setting for HNSCC detection and surveillance, particularly in high-risk patients. Several additional candidates identified through this work can be further investigated toward future development of a multi-gene panel of biomarkers for the surveillance and detection of HNSCC.	[Gaykalova, Daria A.; Vatapalli, Rajita; Zhang, Chi; Hennessey, Patrick T.; Guo, Theresa; Tan, Marietta; Li, Ryan; Ahn, Julie; Khan, Zubair; Westra, William H.; Bishop, Justin A.; Zaboli, David; Koch, Wayne M.; Khan, Tanbir; Califano, Joseph A.] Johns Hopkins Med Inst, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA; [Vatapalli, Rajita] Northwestern Univ, Dept Urol, Chicago, IL 60611 USA; [Wei, Yingying; Tsai, Hua-Ling; Wang, Hao; Ochs, Michael F.] Johns Hopkins Med Inst, Dept Oncol, Div Oncol Biostat, Baltimore, MD 21205 USA; [Wei, Yingying] Chinese Univ Hong Kong, Dept Stat, Shatin, Hong Kong, Peoples R China; [Zhang, Chi] Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA; [Westra, William H.; Bishop, Justin A.] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA; [Ochs, Michael F.] Coll New Jersey, Dept Math & Stat, Ewing, NJ USA; [Califano, Joseph A.] Greater Baltimore Med Ctr, Milton J Dance Head & Neck Ctr, Baltimore, MD USA; [Califano, Joseph A.] Univ Calif San Diego, Dept Surg, Div Otolaryngol Head & Neck Surg, La Jolla, CA 92093 USA	Johns Hopkins University; Johns Hopkins Medicine; Northwestern University; Johns Hopkins University; Johns Hopkins Medicine; Chinese University of Hong Kong; University of Virginia; Johns Hopkins University; Johns Hopkins Medicine; College of New Jersey; Greater Baltimore Medical Center; University of California System; University of California San Diego	Califano, JA (corresponding author), Johns Hopkins Med Inst, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA.	jcalifano@ucsd.edu	Wei, Yingying/S-8001-2018; Vatapalli, Rajita/AAN-1397-2021; Guo, Theresa/AFU-3555-2022; Guo, Theresa/AAF-2216-2021	Wei, Yingying/0000-0003-3826-336X; Zhang, Chi/0000-0002-9297-0690; Ahn, Julie/0000-0001-5168-6717	National Institute of Dental and Craniofacial Research and National Institute of Health Challenge Grant [RC1DE020324]; National Institute of Dental and Craniofacial Research and National Cancer Institute grant [P50 DE 019032]; NATIONAL CANCER INSTITUTE [P50CA096784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [P50DE019032, R01DE023347] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RC1DE020324] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM011000] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research and National Institute of Health Challenge Grant; National Institute of Dental and Craniofacial Research and National Cancer Institute grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the National Institute of Dental and Craniofacial Research and National Institute of Health Challenge Grant (RC1DE020324); National Institute of Dental and Craniofacial Research and National Cancer Institute grant (P50 DE 019032 Head and Neck Cancer SPORE) to JAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Arantes LMRB, 2014, ORAL ONCOL, V50, P587, DOI 10.1016/j.oraloncology.2014.02.015; Belbin TJ, 2008, HEAD NECK PATHOL, V2, P243, DOI 10.1007/s12105-008-0071-4; Bhan S, 2011, CLIN CANCER RES, V17, P4267, DOI 10.1158/1078-0432.CCR-11-0653; Calmon MF, 2009, NEOPLASIA, V11, P1329, DOI 10.1593/neo.91110; Carvalho AL, 2008, CLIN CANCER RES, V14, P97, DOI 10.1158/1078-0432.CCR-07-0722; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; Demokan S, 2010, INT J CANCER, V127, P2351, DOI 10.1002/ijc.25248; Fertig EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078127; Gaykalova D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040389; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghosh Debashis, 2013, Methods Mol Biol, V972, P141, DOI 10.1007/978-1-60327-337-4_9; Ghosh D, 2010, J BIOPHARM STAT, V20, P193, DOI 10.1080/10543400903572704; Grimwood J, 2004, NATURE, V428, P529, DOI 10.1038/nature02399; Guerrero-Preston R, 2011, CANCER PREV RES, V4, P1061, DOI 10.1158/1940-6207.CAPR-11-0006; Guerrero-Preston R, 2014, EPIGENETICS, V9; Ha PK, 2006, LANCET ONCOL, V7, P77, DOI 10.1016/S1470-2045(05)70540-4; Hartmann S, 2012, J APPL GENET, V53, P167, DOI 10.1007/s13353-011-0079-4; Hayashi M, 2014, ANN SURG ONCOL, V21, P3124, DOI 10.1245/s10434-014-3661-2; He Q, 2011, ONCOL LETT, V2, P725, DOI 10.3892/ol.2011.297; Kim MS, 2006, CANCER RES, V66, P3409, DOI 10.1158/0008-5472.CAN-05-1608; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Li R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091263; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lleras RA, 2013, CLIN CANCER RES, V19, P5444, DOI 10.1158/1078-0432.CCR-12-3280; Lleras RA, 2011, AM J PATHOL, V178, P1965, DOI 10.1016/j.ajpath.2011.01.049; Carvalho AL, 2011, CLIN CANCER RES, V17, P4782, DOI 10.1158/1078-0432.CCR-11-0324; Lukic S, 2014, CELL DEATH DIFFER, V21, P381, DOI 10.1038/cdd.2013.150; MacDonald JW, 2006, BIOINFORMATICS, V22, P2950, DOI 10.1093/bioinformatics/btl433; Marur S, 2008, MAYO CLIN PROC, V83, P489, DOI 10.4065/83.4.489; Ochs MF, 2013, IEEE ACM T COMPUTATI; Ovchinnikov DA, 2012, TRANSL ONCOL, V5, P321, DOI 10.1593/tlo.12232; Pattani KM, 2010, CANCER PREV RES, V3, P1093, DOI 10.1158/1940-6207.CAPR-10-0115; Pepe M. S., 2003, STAT EVALUATION MED; Poage GM, 2011, CLIN CANCER RES, V17, P3579, DOI 10.1158/1078-0432.CCR-11-0044; Rathi KS, 2014, DRUG DEV RE IN PRESS; Schussel J, 2013, CLIN CANCER RES, V19, P3268, DOI 10.1158/1078-0432.CCR-12-3496; Shao CB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048582; Shao CB, 2011, ORAL ONCOL, V47, P251, DOI 10.1016/j.oraloncology.2011.01.008; Sharma R, 2010, ORAL DIS, V16, P668, DOI 10.1111/j.1601-0825.2010.01676.x; Shaw RJ, 2006, BRIT J CANCER, V94, P561, DOI 10.1038/sj.bjc.6602972; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Smith IM, 2007, INT J CANCER, V121, P1724, DOI 10.1002/ijc.22889; Sun WY, 2014, CANCER RES, V74, P1091, DOI 10.1158/0008-5472.CAN-13-1259; Sun WY, 2012, CLIN CANCER RES, V18, P1082, DOI 10.1158/1078-0432.CCR-11-2392; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Viet CT, 2008, CANCER EPIDEM BIOMAR, V17, P3603, DOI 10.1158/1055-9965.EPI-08-0507; Worsham MJ, 2013, OTOLARYNG HEAD NECK, V149, P409, DOI 10.1177/0194599813490895; Yang Jing, 2011, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V46, P308	50	29	29	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142148	10.1371/journal.pone.0142148	http://dx.doi.org/10.1371/journal.pone.0142148			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544568	Green Published, gold, Green Submitted			2022-12-27	WOS:000364398700087
J	Karnatak, R				Karnatak, Rajat			Linear Augmentation for Stabilizing Stationary Solutions: Potential Pitfalls and Their Application	PLOS ONE			English	Article							AMPLITUDE DEATH; POPULATION; PREDATOR; SYNCHRONIZATION; EXTINCTION; DYNAMICS; BEHAVIOR	Linear augmentation has recently been shown to be effective in targeting desired stationary solutions, suppressing bistablity, in regulating the dynamics of drive response systems and in controlling the dynamics of hidden attractors. The simplicity of the procedure is the main highlight of this scheme but questions related to its general applicability still need to be addressed. Focusing on the issue of targeting stationary solutions, this work demonstrates instances where the scheme fails to stabilize the required solutions and leads to other complicated dynamical scenarios. Examples from conservative as well as dissipative systems are presented in this regard and important applications in dissipative predator-prey systems are discussed, which include preventative measures to avoid potentially catastrophic dynamical transitions in these systems.	Max Planck Inst Phys Komplexer Syst, Nonlinear Dynam & Time Series Anal Res Grp, D-01187 Dresden, Germany	Max Planck Society	Karnatak, R (corresponding author), Max Planck Inst Phys Komplexer Syst, Nonlinear Dynam & Time Series Anal Res Grp, Nothnitzer Str 38, D-01187 Dresden, Germany.	rajat@pks.mpg.de						[Anonymous], 1999, OXFORD SERIES ECOLOG; Ansmann G, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.052911; ARONSON DG, 1990, PHYSICA D, V41, P403, DOI 10.1016/0167-2789(90)90007-C; Atay FM, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.094101; Balanov AG, 2004, PHYSICA D, V199, P1, DOI 10.1016/j.physd.2004.05.008; BARELI K, 1984, J PHYS CHEM-US, V88, P3616, DOI 10.1021/j150660a048; Boccaletti S, 1999, PHYS REV E, V59, P6574, DOI 10.1103/PhysRevE.59.6574; Ceballos G, 2002, SCIENCE, V296, P904, DOI 10.1126/science.1069349; Christensen V, 1996, REV FISH BIOL FISHER, V6, P417, DOI 10.1007/BF00164324; De Boer RJ, 1998, J THEOR BIOL, V190, P201, DOI 10.1006/jtbi.1997.0548; de Roos AM, 2013, MODELING POPULATION; ERMENTROUT GB, 1990, PHYSICA D, V41, P219, DOI 10.1016/0167-2789(90)90124-8; FAUCI AS, 1993, SCIENCE, V262, P1011, DOI 10.1126/science.8235617; Feudel U, 2008, INT J BIFURCAT CHAOS, V18, P1607, DOI 10.1142/S0218127408021233; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Hauschildt B, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.051906; Holling C. S., 1959, Canadian Entomologist, V91, P385; HOLLING C. S., 1959, CANADIAN ENT, V91, P293; HU G, 1994, PHYS REV LETT, V72, P68, DOI 10.1103/PhysRevLett.72.68; Hughes JB, 1997, SCIENCE, V278, P689, DOI 10.1126/science.278.5338.689; Javaloyes J, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.011108; Karnatak R., UNPUB; Karnatak R, 2014, CHAOS SOLITON FRACT, V68, P48, DOI 10.1016/j.chaos.2014.07.003; Karnatak R, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.022917; Karnatak R, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.035201; Konishi K, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.067202; Koseska A, 2013, PHYS REP, V531, P173, DOI 10.1016/j.physrep.2013.06.001; Kruse D, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.183601; LANDE R, 1993, AM NAT, V142, P911, DOI 10.1086/285580; Lotka AJ, 1910, J PHYS CHEM-US, V14, P271, DOI 10.1021/j150111a004; MIROLLO RE, 1990, J STAT PHYS, V60, P245, DOI 10.1007/BF01013676; Ngonghala CN, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.056206; Oncel SS, 2013, RENEW SUST ENERG REV, V26, P241, DOI 10.1016/j.rser.2013.05.059; OTT E, 1990, PHYS REV LETT, V64, P1196, DOI 10.1103/PhysRevLett.64.1196; PECORA LM, 1990, PHYS REV LETT, V64, P821, DOI 10.1103/PhysRevLett.64.821; Peng JH, 1996, PHYS REV LETT, V76, P904, DOI 10.1103/PhysRevLett.76.904; Pikovsky A, 2001, SYNCHRONIZATION UNIV; Pisarchik AN, 2014, PHYS REP, V540, P167, DOI 10.1016/j.physrep.2014.02.007; Prasad A, 2005, PRAMANA-J PHYS, V64, P513, DOI 10.1007/BF02706199; PYRAGAS K, 1992, PHYS LETT A, V170, P421, DOI 10.1016/0375-9601(92)90745-8; Reddy DVR, 1998, PHYS REV LETT, V80, P5109, DOI 10.1103/PhysRevLett.80.5109; Resmi V, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.046211; Resmi V, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.046216; ROSENZWEIG ML, 1963, AM NAT, V97, P209, DOI 10.1086/282272; Saxena G, 2012, PHYS REP, V521, P205, DOI 10.1016/j.physrep.2012.09.003; Scholl E., 2008, HDB CHAOS CONTROL; Scott SA, 2010, CURR OPIN BIOTECH, V21, P277, DOI 10.1016/j.copbio.2010.03.005; Sharma A, 2012, CHAOS, V22, DOI 10.1063/1.4729459; Sharma PR, 2015, INT J BIFURCAT CHAOS, V25, DOI 10.1142/S0218127415500613; Sharma PR, 2014, EUR PHYS J-SPEC TOP, V223, P1531, DOI 10.1140/epjst/e2014-02115-1; Sharma PR, 2013, PHYS LETT A, V377, P2329, DOI 10.1016/j.physleta.2013.07.002; Sharma PR, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.067201; SOLOMON ME, 1949, J ANIM ECOL, V18, P1, DOI 10.2307/1578; Toth R, 2006, J PHYS CHEM B, V110, P10170, DOI 10.1021/jp060732z; TRUSCOTT JE, 1994, PHILOS T R SOC A, V347, P703, DOI 10.1098/rsta.1994.0076; Volterra V, 1926, NATURE, V118, P558, DOI 10.1038/118558a0; WEISS RA, 1993, SCIENCE, V260, P1273, DOI 10.1126/science.8493571; YODZIS P, 1994, ECOL APPL, V4, P51, DOI 10.2307/1942114; Zhang W, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-S1-S13	60	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142238	10.1371/journal.pone.0142238	http://dx.doi.org/10.1371/journal.pone.0142238			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544879	Green Submitted, Green Published, gold			2022-12-27	WOS:000364398700097
J	King, DFL; McKay, PF; Mann, JFS; Jones, CB; Shattock, RJ				King, Deborah F. L.; McKay, Paul F.; Mann, Jamie F. S.; Jones, C. Bryn; Shattock, Robin J.			Plasmid DNA Vaccine Co-Immunisation Modulates Cellular and Humoral Immune Responses Induced by Intranasal Inoculation in Mice	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-1/SIV CHIMERIC VIRUS; EPITHELIAL TRANSCYTOSIS; ENVELOPE GLYCOPROTEIN; RHESUS MACAQUES; MUCOSAL; PROTEIN; PROTECTION; CELLS; INDUCTION	Background An effective HIV vaccine will likely require induction of both mucosal and systemic cellular and humoral immune responses. We investigated whether intramuscular (IM) delivery of electroporated plasmid DNA vaccine and simultaneous protein vaccinations by intranasal (IN) and IM routes could be combined to induce mucosal and systemic cellular and humoral immune responses to a model HIV-1 CN54 gp140 antigen in mice. Results Co-immunisation of DNA with intranasal protein successfully elicited both serum and vaginal IgG and IgA responses, whereas DNA and IM protein co-delivery did not induce systemic or mucosal IgA responses. Cellular IFN gamma responses were preserved in co-immunisation protocols compared to protein-only vaccination groups. The addition of DNA to IN protein vaccination reduced the strong Th2 bias observed with IN protein vaccination alone. Luminex analysis also revealed that co-immunisation with DNA and IN protein induced expression of cytokines that promote B-cell function, generation of T-FH cells and CCR5 ligands that can reduce HIV infectivity. Significance These data suggest that while IN inoculation alone elicits both cellular and humoral responses, co-administration with homologous DNA vaccination can tailor these towards a more balanced Th1/Th2 phenotype modulating the cellular cytokine profile while eliciting high-levels of antigen-specific antibody. This work provides insights on how to generate differential immune responses within the same vaccination visit, and supports co-immunisation with DNA and protein by a mucosal route as a potential delivery strategy for HIV vaccines.	[King, Deborah F. L.; McKay, Paul F.; Mann, Jamie F. S.; Jones, C. Bryn; Shattock, Robin J.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis, Div Med, Mucosal Infect & Immun Grp, London, England	Imperial College London	Shattock, RJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis, Div Med, Mucosal Infect & Immun Grp, London, England.	r.shattock@imperial.ac.uk		Mann, Jamie/0000-0001-7037-1286; McKay, Paul/0000-0001-5195-6254	Center for HIV/AIDS Vaccine Immunology (CHAVI) [U19 AI067854-05]; Dormeur Investment Service Ltd; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067854] Funding Source: NIH RePORTER	Center for HIV/AIDS Vaccine Immunology (CHAVI); Dormeur Investment Service Ltd; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	DFLK was supported by a grant to RJS by the Center for HIV/AIDS Vaccine Immunology (CHAVI) # U19 AI067854-05. The authors gratefully acknowledge Dormeur Investment Service Ltd for providing funds to purchase equipment used in these studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfsen A, 2001, J IMMUNOL, V166, P6257, DOI 10.4049/jimmunol.166.10.6257; Arias MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041144; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Belakova J, 2007, ARCH IMMUNOL THER EX, V55, P387, DOI 10.1007/s00005-007-0044-4; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Bixler SL, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/852418; Buffa V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050529; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; El-Kamary SS, 2010, J INFECT DIS, V202, P1649, DOI 10.1086/657087; Fischer JE, 1997, J VIROL, V71, P8672, DOI 10.1128/JVI.71.11.8672-8677.1997; Fu TM, 2007, AIDS RES HUM RETROV, V23, P67, DOI 10.1089/aid.2006.0114; Geng SA, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-27; GRAHAM MB, 1994, J EXP MED, V180, P1273, DOI 10.1084/jem.180.4.1273; Hersperger AR, 2011, BLOOD, V117, P3799, DOI 10.1182/blood-2010-12-322727; Hersperger AR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000917; Hessell AJ, 2010, J VIROL, V84, P1302, DOI 10.1128/JVI.01272-09; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; HSIEH CS, 1995, J EXP MED, V181, P713, DOI 10.1084/jem.181.2.713; Hutnick NA, 2011, CURR OPIN VIROL, V1, P233, DOI 10.1016/j.coviro.2011.08.003; Jalah R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091550; Jin HL, 2005, VIROLOGY, V337, P183, DOI 10.1016/j.virol.2005.03.029; Jin HL, 2008, J IMMUNOL, V180, P5360, DOI 10.4049/jimmunol.180.8.5360; Kang YM, 2007, BIOCHEM BIOPH RES CO, V353, P1034, DOI 10.1016/j.bbrc.2006.12.124; Klein K, 2013, J VIROLOGY; Li JY, 2013, VACCINE, V31, P3747, DOI 10.1016/j.vaccine.2013.04.037; Mann JFS, 2014, J VIROL, V88, P6959, DOI 10.1128/JVI.00183-14; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; McKay PF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084707; Milpied PJ, 2013, NAT IMMUNOL, V14, P313, DOI 10.1038/ni.2567; Mitsdoerffer M, 2010, P NATL ACAD SCI USA, V107, P14292, DOI 10.1073/pnas.1009234107; Moran TM, 1996, J VIROL, V70, P5230, DOI 10.1128/JVI.70.8.5230-5235.1996; Naz RK, 2012, J REPROD IMMUNOL, V93, P1, DOI 10.1016/j.jri.2011.09.005; Pal R, 2006, VIROLOGY, V348, P341, DOI 10.1016/j.virol.2005.12.029; Patel V, 2013, P NATL ACAD SCI USA, V110, P2975, DOI 10.1073/pnas.1215393110; Patel V, 2010, VACCINE, V28, P4827, DOI 10.1016/j.vaccine.2010.04.064; Pissani F, 2014, VACCINE, V32, P507, DOI 10.1016/j.vaccine.2013.11.022; REINER SL, 1995, ANNU REV IMMUNOL, V13, P151, DOI 10.1146/annurev.iy.13.040195.001055; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rodenburg CM, 2001, AIDS RES HUM RETROV, V17, P161, DOI 10.1089/08892220150217247; Rosati M, 2009, P NATL ACAD SCI USA, V106, P15831, DOI 10.1073/pnas.0902628106; Shibata R, 1999, NAT MED, V5, P204, DOI 10.1038/5568; Trumpfheller C, 1998, CLIN EXP IMMUNOL, V112, P92; Tudor D, 2009, MUCOSAL IMMUNOL, V2, P412, DOI 10.1038/mi.2009.89; Tudor D, 2012, P NATL ACAD SCI USA, V109, P12680, DOI 10.1073/pnas.1200024109; Walker Bruce D, 2007, Top HIV Med, V15, P134; Watkins JD, 2013, AIDS, V27, pF13, DOI 10.1097/QAD.0b013e328360eac6; Yin JM, 2011, VACCINE, V29, P6763, DOI 10.1016/j.vaccine.2010.12.055	49	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141557	10.1371/journal.pone.0141557	http://dx.doi.org/10.1371/journal.pone.0141557			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544970	Green Published, Green Submitted, gold			2022-12-27	WOS:000364398700034
J	Otsuka, M; Kurihara, T; Isaka, T				Otsuka, Mitsuo; Kurihara, Toshiyuki; Isaka, Tadao			Effect of a Wide Stance on Block Start Performance in Sprint Running	PLOS ONE			English	Article							JOINT COORDINATE SYSTEM; SQUAT; PHASE; KINEMATICS; KNEE; SIZE; HIP	This study aimed to clarify the effect of widened stance width at the set position during the block start phase in sprint running on kinematics and kinetics at the hip joint and block-induced power. Fourteen male sprinters volunteered to participate in this study. They performed three block-start trials with a normal stance width (25 +/- 1 cm, normal condition) and a widened stance width (45 +/- 2 cm, widened condition) at the set position. The block start movements were recorded at 250 Hz with high-speed cameras and the ground reaction forces at 1250 Hz with force plates. During the block phase in the widened condition, the hip abduction and external rotation angles in both legs were significantly larger and smaller, respectively, than those in the normal condition. The positive peak value of the hip power in the rear leg was significantly greater in the widened condition than that in the normal condition. However, no significant difference was seen in the normalized block-induced power between the widened and normal conditions. We conclude that a widened stance width at the set position affects the hip-joint kinematics and rear hip power generation during the block start phase, but no effect on the block-induced power when considering sprinting performance during the whole block start phase.	[Otsuka, Mitsuo; Kurihara, Toshiyuki; Isaka, Tadao] Ritsumeikan Univ, Fac Sport & Hlth Sci, Kusatsu, Shiga 5258577, Japan	Ritsumeikan University	Otsuka, M (corresponding author), Ritsumeikan Univ, Fac Sport & Hlth Sci, 1-1-1 Nojihigashi, Kusatsu, Shiga 5258577, Japan.	otsuka-a@st.ritsumei.ac.jp	Otsuka, Mitsuo/AAB-4120-2019	Otsuka, Mitsuo/0000-0003-1391-4939	Kozuki Foundation [2011-9-1]; Grants-in-Aid for Scientific Research [26560361] Funding Source: KAKEN	Kozuki Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Kozuki Foundation 2011-9-1 to MO (http://www.kozuki.or.jp/jigyou/spresearch/list2011_09_spres.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bezodis NE, 2010, SPORT BIOMECH, V9, P258, DOI 10.1080/14763141.2010.538713; Bezodis NE, 2015, EUR J SPORT SCI, V15, P118, DOI 10.1080/17461391.2014.928915; Bradshaw EJ, 2007, SPORT BIOMECH, V6, P246, DOI 10.1080/14763140701489660; Clark DR, 2012, J STRENGTH COND RES, V26, P1169, DOI 10.1519/JSC.0b013e31822d533d; Debaere S, 2013, J SPORT SCI, V31, P137, DOI 10.1080/02640414.2012.722225; DEMPSTER WT, 1967, AM J ANAT, V120, P33, DOI 10.1002/aja.1001200104; Demura S, 2010, J STRENGTH COND RES, V24, P2742, DOI 10.1519/JSC.0b013e3181e27386; GROOD ES, 1983, J BIOMECH ENG-T ASME, V105, P136, DOI 10.1115/1.3138397; GUISSARD N, 1992, MED SCI SPORT EXER, V24, P1257; HANAVAN E P Jr, 1964, AMRL TR, P1; Harland MJ, 1997, SPORTS MED, V23, P11, DOI 10.2165/00007256-199723010-00002; HOF AL, 1996, GAIT POSTURE, V4, P222; International Association of Athletic Federations, 2013, COMP RUL 2014 2015, P154; Lieberman DE, 2010, NATURE, V463, P531, DOI 10.1038/nature08723; McCaw ST, 1999, MED SCI SPORT EXER, V31, P428, DOI 10.1097/00005768-199903000-00012; Mendoza L, 1993, J SPORT SCI, V11, P25, DOI 10.1080/02640419308729959; Mero A, 2006, J SPORT SCI, V24, P165, DOI 10.1080/02640410500131753; Milanese C, 2014, BIOL SPORT, V31, P209, DOI 10.5604/20831862.1111848; Mirakhorlo M, 2014, J RES HEALTH SCI, V14, P23; Okkonen O, 2013, J STRENGTH COND RES, V27, P2662, DOI 10.1519/JSC.0b013e31829992b0; Otsuka M, 2014, J APPL BIOMECH, V30, P390, DOI 10.1123/jab.2013-0017; Paoli A, 2009, J STRENGTH COND RES, V23, P246, DOI 10.1519/JSC.0b013e3181876811; Slawinski J, 2012, INT J SPORTS MED, V33, P555, DOI 10.1055/s-0032-1304587; Slawinski J, 2013, J SPORT SCI, V31, P256, DOI 10.1080/02640414.2012.729076; Winter D., 2009, BIOMECHANICS MOTOR C, V4th; Wu G, 2002, J BIOMECH, V35, P543, DOI 10.1016/S0021-9290(01)00222-6	27	13	13	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142230	10.1371/journal.pone.0142230	http://dx.doi.org/10.1371/journal.pone.0142230			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544719	Green Published, Green Submitted, gold			2022-12-27	WOS:000364398700096
J	Faber-Hammond, J; Samanta, MP; Whitchurch, EA; Manning, D; Sisneros, JA; Coffin, AB				Faber-Hammond, Joshua; Samanta, Manoj P.; Whitchurch, Elizabeth A.; Manning, Dustin; Sisneros, Joseph A.; Coffin, Allison B.			Saccular Transcriptome Profiles of the Seasonal Breeding Plainfin Midshipman Fish (Porichthys notatus), a Teleost with Divergent Sexual Phenotypes	PLOS ONE			English	Article							SENSORY HAIR-CELLS; INNER-EAR; GENE-EXPRESSION; ACOUSTIC-SIGNALS; STEROID-LEVELS; HUMAN HOMOLOG; PLASTICITY; NOTCH; REGENERATION; SENSITIVITY	Acoustic communication is essential for the reproductive success of the plainfin midshipman fish (Porichthys notatus). During the breeding season, type I males use acoustic cues to advertise nest location to potential mates, creating an audible signal that attracts reproductive females. Type II (sneaker) males also likely use this social acoustic signal to find breeding pairs from which to steal fertilizations. Estrogen-induced changes in the auditory system of breeding females are thought to enhance neural encoding of the advertisement call, and recent anatomical data suggest the saccule (the main auditory end organ) as one possible target for this seasonal modulation. Here we describe saccular transcriptomes from all three sexual phenotypes (females, type I and II males) collected during the breeding season as a first step in understanding the mechanisms underlying sexual phenotype-specific and seasonal differences in auditory function. We used RNA-Seq on the Ion Torrent platform to create a combined transcriptome dataset containing over 79,000 assembled transcripts representing almost 9,000 unique annotated genes. These identified genes include several with known inner ear function and multiple steroid hormone receptors. Transcripts most closely matched to published genomes of nile tilapia and large yellow croaker, inconsistent with the phylogenetic relationship between these species but consistent with the importance of acoustic communication in their life-history strategies. We then compared the RNA-Seq results from the saccules of reproductive females with a separate transcriptome from the non-reproductive female phenotype and found over 700 differentially expressed transcripts, including members of the Wnt and Notch signaling pathways that mediate cell proliferation and hair cell addition in the inner ear. These data constitute a valuable resource for furthering our understanding of the molecular basis for peripheral auditory function as well as a range of future midshipman and cross-species comparative studies of the auditory periphery.	[Faber-Hammond, Joshua; Manning, Dustin; Coffin, Allison B.] Washington State Univ, Coll Arts & Sci, Vancouver, WA 98686 USA; [Samanta, Manoj P.] Systemix Inst, Redmond, WA USA; [Whitchurch, Elizabeth A.] Humboldt State Univ, Dept Biol Sci, Arcata, CA 95521 USA; [Sisneros, Joseph A.] Univ Washington, Dept Psychol, Seattle, WA 98195 USA; [Coffin, Allison B.] Washington State Univ, Dept Integrat Physiol & Neurosci, Vancouver, WA USA	Washington State University; California State University System; California State Polytechnic University, Humboldt; University of Washington; University of Washington Seattle; Washington State University	Coffin, AB (corresponding author), Washington State Univ, Coll Arts & Sci, Vancouver, WA 98686 USA.	Allison.coffin@wsu.edu	Sisneros, Joseph/AAU-9965-2020	Sisneros, Joseph/0000-0002-3114-773X	Capita Foundation; Washington State University Vancouver	Capita Foundation; Washington State University Vancouver	This work was funded by a Capita Foundation (http://www.capitafoundation.org/) grant and by start-up funds and a mini-grant from Washington State University Vancouver (http://www.vancouver.wsu.edu/), all to ABC. No grant numbers are available. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arch VS, 2009, HEARING RES, V252, P15, DOI 10.1016/j.heares.2009.01.001; Avraham KB, 1997, HUM MOL GENET, V6, P1225, DOI 10.1093/hmg/6.8.1225; Bass AH, 1999, DESIGN OF ANIMAL COMMUNICATION, P493; Bass AH, 2007, FISH PHYSL SENSORY S, V25; Bass AH, 2012, P NATL ACAD SCI USA, V109, P10677, DOI 10.1073/pnas.1201886109; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Betancur-R R, 2013, PLOS CURR-TREE LIFE, DOI 10.1371/currents.tol.53ba26640df0ccaee75bb165c8c26288; BRANTLEY RK, 1994, ETHOLOGY, V96, P213, DOI 10.1111/j.1439-0310.1994.tb01011.x; BRANTLEY RK, 1993, HORM BEHAV, V27, P332, DOI 10.1006/hbeh.1993.1025; Cai TT, 2015, J NEUROSCI, V35, P5870, DOI 10.1523/JNEUROSCI.5083-14.2015; Caras ML, 2012, J NEUROSCI, V32, P17597, DOI 10.1523/JNEUROSCI.3938-12.2012; Coffin AB, 2012, J NEUROSCI, V32, P1366, DOI 10.1523/JNEUROSCI.4928-11.2012; Ernest S, 2000, HUM MOL GENET, V9, P2189, DOI 10.1093/hmg/9.14.2189; Fan JZ, 2014, MOL CELL BIOCHEM, V392, P85, DOI 10.1007/s11010-014-2021-7; Feng NY, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1577-2; Fergus DJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1940-3; Forlano PM, 2010, J COMP NEUROL, V518, P493, DOI 10.1002/cne.22233; Forlano PM, SPRINGER HDB AUDITOR, V57; Fraser BA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-202; Haddon C, 1998, DEVELOPMENT, V125, P4637; Hertzano R, 2012, HEARING RES, V288, P77, DOI 10.1016/j.heares.2012.01.002; Jacques BE, 2014, DEV NEUROBIOL, V74, P438, DOI 10.1002/dneu.22134; Johnson J, 1999, DEV DYNAM, V216, P499, DOI 10.1002/(SICI)1097-0177(199912)216:4/5<499::AID-DVDY18>3.0.CO;2-S; Kang YJ, 2008, JARO-J ASSOC RES OTO, V9, P436, DOI 10.1007/s10162-008-0137-8; Kazmierczak P, 2012, TRENDS NEUROSCI, V35, P220, DOI 10.1016/j.tins.2011.10.007; Kouzmenko AP, 2004, J BIOL CHEM, V279, P40255, DOI 10.1074/jbc.C400331200; Li WY, 2015, P NATL ACAD SCI USA, V112, P166, DOI 10.1073/pnas.1415901112; Liang Y, 1999, GENOMICS, V61, P243, DOI 10.1006/geno.1999.5976; Longrie N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061467; Ma EY, 2008, J NEUROSCI, V28, P2261, DOI 10.1523/JNEUROSCI.4372-07.2008; MayerGostan N, 1997, CELL TISSUE RES, V289, P53, DOI 10.1007/s004410050851; McDermott BM, 2007, P NATL ACAD SCI USA, V104, P11820, DOI 10.1073/pnas.0704476104; McKibben JR, 1998, J ACOUST SOC AM, V104, P3520, DOI 10.1121/1.423938; McKibben JR, 2001, J COMP PHYSIOL A, V187, P271, DOI 10.1007/s003590100199; Melchionda S, 2001, AM J HUM GENET, V69, P635, DOI 10.1086/323156; Moeller G, 2009, MOL CELL ENDOCRINOL, V301, P7, DOI 10.1016/j.mce.2008.10.040; Mora C, 1999, SCAND J UROL NEPHROL, V33, P63; Murayama E, 2005, MECH DEVELOP, V122, P791, DOI 10.1016/j.mod.2005.03.002; Nelson JS., 2016, FISHES WORLD, DOI DOI 10.1002/9781119174844.FMATTER; Pan BF, 2013, NEURON, V79, P504, DOI 10.1016/j.neuron.2013.06.019; Patel M, 2013, NEUROSCIENCE, V248, P1, DOI 10.1016/j.neuroscience.2013.05.038; Payan P, 1997, J EXP BIOL, V200, P1905; Powers TR, 2012, BMC GENOMICS, V13, P1, DOI 10.1186/1471-2164-13-225; Ramcharttar J, 2006, T AM FISH SOC, V135, P1409, DOI 10.1577/T05-207.1; Rohmann KN, 2013, CURR BIOL, V23, P678, DOI 10.1016/j.cub.2013.03.014; Rohmann KN, 2011, J EXP BIOL, V214, P1931, DOI 10.1242/jeb.054114; Rohmann KN, 2009, MOL BIOL EVOL, V26, P1509, DOI 10.1093/molbev/msp060; Romero-Carvajal A, 2015, DEV CELL, V34, P267, DOI 10.1016/j.devcel.2015.05.025; Ruiz-Palmero I, 2011, J NEUROENDOCRINOL, V23, P355, DOI 10.1111/j.1365-2826.2011.02110.x; SAIDEL WM, 1990, HEARING RES, V47, P139, DOI 10.1016/0378-5955(90)90171-K; Scheffer DI, 2015, J NEUROSCI, V35, P6366, DOI 10.1523/JNEUROSCI.5126-14.2015; Schuck JB, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-88; Seiler C, 2004, DEV BIOL, V272, P328, DOI 10.1016/j.ydbio.2004.05.004; Sisneros JA, 2004, SCIENCE, V305, P404, DOI 10.1126/science.1097218; Sisneros JA, 2004, GEN COMP ENDOCR, V136, P101, DOI 10.1016/j.ygcen.2003.12.007; Sisneros JA, 2003, J NEUROSCI, V23, P1049; Sisneros JA, 2007, J COMP PHYSIOL A, V193, P413, DOI 10.1007/s00359-006-0195-5; Sisneros JA, 2009, J NEUROPHYSIOL, V102, P1121, DOI 10.1152/jn.00236.2009; Sollner C, 2004, NATURE, V428, P955, DOI 10.1038/nature02484; Steigelman KA, 2011, J NEUROSCI, V31, P12241, DOI 10.1523/JNEUROSCI.6531-10.2011; Stooke-Vaughan GA, 2015, DEVELOPMENT, V142, P1137, DOI 10.1242/dev.116632; Tomkins JL, 2002, ANIM BEHAV, V63, P1009, DOI 10.1006/anbe.2001.1994; Vahava O, 1998, SCIENCE, V279, P1950, DOI 10.1126/science.279.5358.1950; Varea O, 2010, STEROIDS, V75, P565, DOI 10.1016/j.steroids.2009.09.006; Wainwright PC, 2012, SYST BIOL, V61, P1001, DOI 10.1093/sysbio/sys060; Wang SZ, 2013, J NEUROSCI, V33, P12242, DOI 10.1523/JNEUROSCI.5736-12.2013; Woods C, 2004, NAT NEUROSCI, V7, P1310, DOI 10.1038/nn1349; Yin XH, 2015, EXP CELL RES, V335, P107, DOI 10.1016/j.yexcr.2015.04.020	69	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142814	10.1371/journal.pone.0142814	http://dx.doi.org/10.1371/journal.pone.0142814			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26560106	Green Published, gold, Green Submitted			2022-12-27	WOS:000364433100129
J	Kanda, R; Nagao, T; Tho, NV; Ogawa, E; Murakami, Y; Osawa, M; Saika, Y; Doi, K; Nakano, Y				Kanda, Rie; Nagao, Taishi; Nguyen Van Tho; Ogawa, Emiko; Murakami, Yoshitaka; Osawa, Makoto; Saika, Yoshinori; Doi, Kenji; Nakano, Yasutaka			Factors Affecting Time to Sputum Culture Conversion in Adults with Pulmonary Tuberculosis: A Historical Cohort Study without Censored Cases	PLOS ONE			English	Article							CIGARETTE-SMOKING; RELAPSE; SMEAR	Background In patients with pulmonary tuberculosis (TB), shortening the time to sputum culture conversion is desirable to reduce the likelihood of mycobacterial transmission. A persistent positive sputum culture after 2 months of treatment is reported to be associated with the presence of cavitation and the extent of disease on chest X-ray, high colony count, diabetes mellitus, and smoking. However, little is known about factors affecting the time to sputum culture conversion. This study was conducted to evaluate factors affecting the time to sputum culture conversion throughout the course of treatment in adults with pulmonary TB. Methods This study was performed using a database of the medical records of patients with active pulmonary TB who were treated at Hirakata Kohsai Hospital in Hirakata City, Osaka, Japan, from October 2000 to October 2002. Cox proportional-hazards analysis was used to evaluate factors affecting the time to sputum culture conversion after adjusting for potential confounders. Results The data of 86 patients with pulmonary TB were analyzed. The median time to sputum culture conversion was 39 days, and the maximum time was 116 days. The Cox proportional-hazards analysis showed that a higher smear grading (HR, 0.40; 95% CI, 0.23-0.71) and a history of ever smoking (HR, 0.48; 95% CI, 0.25-0.94) were associated with delayed sputum culture conversion. Conclusion High smear grading and smoking prolonged the time to sputum culture conversion in adults with pulmonary TB. To effectively control TB, measures to decrease the cigarette smoking rate should be implemented, in addition to early detection and timely anti-TB treatment.	[Kanda, Rie; Nagao, Taishi; Nguyen Van Tho; Nakano, Yasutaka] Shiga Univ Med Sci, Dept Med, Div Resp Med, Otsu, Shiga, Japan; [Ogawa, Emiko] Shiga Univ Med Sci, Hlth Adm Ctr, Otsu, Shiga, Japan; [Murakami, Yoshitaka] Shiga Univ Med Sci, Dept Med Stat, Otsu, Shiga, Japan; [Osawa, Makoto] Shiga Univ Med Sci Hosp, Div Infect Control & Prevent, Otsu, Shiga, Japan; [Saika, Yoshinori] Hirakata Kohsai Hosp, Dept Radiol, Osaka, Japan; [Doi, Kenji] Morinomiya Hosp, Dept Radiol, Osaka, Japan	Shiga University of Medical Science; Shiga University of Medical Science; Shiga University of Medical Science; Shiga University of Medical Science	Nakano, Y (corresponding author), Shiga Univ Med Sci, Dept Med, Div Resp Med, Otsu, Shiga, Japan.	nakano@belle.shiga-med.ac.jp		Nguyen, Tho/0000-0002-0198-6284				Mota PC, 2012, REV PORT PNEUMOL, V18, P72, DOI 10.1016/j.rppneu.2011.12.005; de Boer RN, 2014, TUBERCULOSIS, V94, P87, DOI 10.1016/j.tube.2013.10.005; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; Guler M, 2007, INT J CLIN PRACT, V61, P231, DOI 10.1111/j.1742-1241.2006.01131.x; Leung CC, 2015, EUR RESPIR J, V45, P738, DOI 10.1183/09031936.00114214; Maciel EL, 2013, INT J TUBERC LUNG D, V17, P225, DOI 10.5588/ijtld.12.0426; MITCHISON DA, 1993, AM REV RESPIR DIS, V147, P1062, DOI 10.1164/ajrccm/147.4.1062; O'Leary SM, 2014, AM J RESP CRIT CARE, V190, P1430, DOI 10.1164/rccm.201407-1385OC; Shaler CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059185; Shang SB, 2011, J INFECT DIS, V203, P1240, DOI 10.1093/infdis/jir009; Slam K, 2007, INT J TUBERC LUNG D, V11, P1049; The Committee for Classification of Tuberculosis, 1959, KEKKAKU, V34, P885; The Japanese Society for Tuberculosis, 1996, MAN MED CAR STAND TU; Visser ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029588; Wallis RS, 2009, LANCET INFECT DIS, V9, P162, DOI 10.1016/S1473-3099(09)70042-8; World Health Organization, 2014, FACT SHEET TUB	16	21	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142607	10.1371/journal.pone.0142607	http://dx.doi.org/10.1371/journal.pone.0142607			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26558764	Green Published, gold, Green Submitted			2022-12-27	WOS:000364433100100
J	Li, X; Li, X; Li, YX; Zhang, Y; Chen, D; Sun, MZ; Zhao, X; Chen, DY; Feng, XZ				Li, Xiang; Li, Xu; Li, Yi-Xiang; Zhang, Yuan; Chen, Di; Sun, Ming-Zhu; Zhao, Xin; Chen, Dong-Yan; Feng, Xi-Zeng			The Difference between Anxiolytic and Anxiogenic Effects Induced by Acute and Chronic Alcohol Exposure and Changes in Associative Learning and Memory Based on Color Preference and the Cause of Parkinson-Like Behaviors in Zebrafish	PLOS ONE			English	Article							DANIO-RERIO; LARVAL ZEBRAFISH; PREFERRING RATS; NATIONAL-SURVEY; ETHANOL; SENSITIVITY; RESPONSES; DISEASE; SYSTEM; FISH	We describe an interdisciplinary comparison of the effects of acute and chronic alcohol exposure in terms of their disturbance of light, dark and color preferences and the occurrence of Parkinson-like behavior in zebrafish through computer visual tracking, data mining, and behavioral and physiological analyses. We found that zebrafish in anxiolytic and anxious states, which are induced by acute and chronic repeated alcohol exposure, respectively, display distinct emotional reactions in light/dark preference tests as well as distinct learning and memory abilities in color-enhanced conditional place preference (CPP) tests. Additionally, compared with the chronic alcohol (1.0%) treatment, acute alcohol exposure had a significant, dose-dependent effect on anxiety, learning and memory (color preference) as well as locomotive activities. Acute exposure doses (0.5%, 1.0%, and 1.5%) generated an "inverted V" dose-dependent pattern in all of the behavioral parameters, with 1.0% having the greatest effect, while the chronic treatment had a moderate effect. Furthermore, by measuring locomotive activity, learning and memory performance, the number of dopaminergic neurons, tyrosine hydroxylase expression, and the change in the photo-receptors in the retina, we found that acute and chronic alcohol exposure induced varying degrees of Parkinson-like symptoms in zebrafish. Taken together, these results illuminated the behavioral and physiological mechanisms underlying the changes associated with learning and memory and the cause of potential Parkinson-like behaviors in zebrafish due to acute and chronic alcohol exposure.	[Li, Xiang; Li, Yi-Xiang; Zhang, Yuan; Feng, Xi-Zeng] Nankai Univ, Coll Life Sci, Minist Educ, State Key Lab Med Chem Biol,Key Lab Bioact Mat, Tianjin 300071, Peoples R China; [Chen, Di; Sun, Ming-Zhu; Zhao, Xin] Nankai Univ, Inst Robot & Automat Informat Syst, Tianjin 300071, Peoples R China; [Li, Xu; Chen, Dong-Yan] Nankai Univ, Sch Med, Dept Physiol, Key Lab Anim Models & Degenerat Dis, Tianjin 300071, Peoples R China	Nankai University; Nankai University; Nankai University	Zhao, X (corresponding author), Nankai Univ, Inst Robot & Automat Informat Syst, Tianjin 300071, Peoples R China.	zhaoxin@nankai.edu.cn; chendy@nankai.edu.cn; xzfeng@nankai.edu.cn	Li, Yixiang/J-9407-2019	xu, li/0000-0001-8051-9141	Special Fund for Basic Research on Scientific Instruments of the Chinese National Natural Science Foundation [61327802]; National Basic Research Program (973 program) of China "The fundamental and frontier studies of the new topology of molecular functional carbon materials" [2015CB856500]; Tianjin Science Technology Research Funds of China [10JCYBJC25300]; State Key Laboratory of Medicinal Chemical Biology [20130301]	Special Fund for Basic Research on Scientific Instruments of the Chinese National Natural Science Foundation; National Basic Research Program (973 program) of China "The fundamental and frontier studies of the new topology of molecular functional carbon materials"; Tianjin Science Technology Research Funds of China; State Key Laboratory of Medicinal Chemical Biology	This project was initiated in the State Key Laboratory of Medicinal Chemical Biology at Nankai University. X.Z., D.Y.C., and X.Z.F. were supported by the Special Fund for Basic Research on Scientific Instruments of the Chinese National Natural Science Foundation (grant no: 61327802). The work performed in the laboratory of X.Z.F. was supported by the National Basic Research Program (973 program) of China "The fundamental and frontier studies of the new topology of molecular functional carbon materials" (2015CB856500). The work performed by the group of D.Y.C. was supported by the Tianjin Science Technology Research Funds of China (grant no: 10JCYBJC25300) and the fund from the State Key Laboratory of Medicinal Chemical Biology (grant no: 20130301).	Al-Imari L, 2008, BEHAV BRAIN RES, V189, P216, DOI 10.1016/j.bbr.2007.12.007; [Anonymous], 2012, J VIS EXP, pii; Avdesh A, 2010, P MEAS BEHAV, V2010, P155; Avdesh A, 2012, J ALZHEIMERS DIS, V28, P459, DOI 10.3233/JAD-2011-110704; Best JD, 2008, NEUROPSYCHOPHARMACOL, V33, P1206, DOI 10.1038/sj.npp.1301489; Bretaud S, 2004, NEUROTOXICOL TERATOL, V26, P857, DOI 10.1016/j.ntt.2004.06.014; Brockerhoff SE, 2011, CELL MOL LIFE SCI, V68, P651, DOI 10.1007/s00018-010-0563-8; Cachat J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017597; Casu MA, 2002, BRAIN RES, V924, P242, DOI 10.1016/S0006-8993(01)03296-6; Chacon DM, 2014, PROG NEURO-PSYCHOPH, V53, P109, DOI 10.1016/j.pnpbp.2014.03.009; Chatterjee D, 2014, AMINO ACIDS, V46, P921, DOI 10.1007/s00726-013-1658-y; Chatterjee D, 2009, BEHAV BRAIN RES, V200, P208, DOI 10.1016/j.bbr.2009.01.016; Darland T, 2001, P NATL ACAD SCI USA, V98, P11691, DOI 10.1073/pnas.191380698; Deroche-Gamonet V, 2004, SCIENCE, V305, P1014, DOI 10.1126/science.1099020; Echevarria DJ, 2011, PROG NEURO-PSYCHOPH, V35, P1416, DOI 10.1016/j.pnpbp.2011.01.020; Echevarria DJ, 2011, REV NEUROSCIENCE, V22, P85, DOI 10.1515/RNS.2011.010; Gao HM, 2002, J NEUROCHEM, V81, P1285, DOI 10.1046/j.1471-4159.2002.00928.x; Gerlai R, 2009, GENES BRAIN BEHAV, V8, P586, DOI 10.1111/j.1601-183X.2009.00488.x; Gerlai R., 2012, USING ZEBRAFISH UNRA, P3; Gerlai R, 2008, ALCOHOL CLIN EXP RES, V32, P1763, DOI 10.1111/j.1530-0277.2008.00761.x; Gerlai R, 2011, METHOD CELL BIOL, V101, P249, DOI 10.1016/B978-0-12-387036-0.00012-8; Gerlai R, 2011, REV NEUROSCIENCE, V22, P3, DOI 10.1515/RNS.2011.002; Grella SL, 2010, INT J COMP PSYCHOL, V23; Guarnieri DJ, 2003, INT REV NEUROBIOL, V54, P54; GUO S, 2009, COMMUN INTEGR BIOL, V2, P512; Harwood HJ, 1998, RECENT DEV ALCOHOL, V14, P307, DOI 10.1007/0-306-47148-5_14; Howarth DL, 2011, ALCOHOL CLIN EXP RES, V35, P826, DOI 10.1111/j.1530-0277.2010.01407.x; Huang JTJ, 2008, MOL PSYCHIATR, V13, P1118, DOI 10.1038/sj.mp.4002108; Hughes A, 1998, VISUAL NEUROSCI, V15, P1029, DOI 10.1017/S095252389815602X; JAFFE JH, 1983, CLIN PHARMACOL THER, V34, P623, DOI 10.1038/clpt.1983.224; KUSHNER MG, 1990, AM J PSYCHIAT, V147, P685; Ladu F, 2014, ALCOHOLISM CLIN EXPT; Li X, 2014, SCI REP-UK, V4, DOI 10.1038/srep03810; Lockwood B, 2004, PHARMACOL BIOCHEM BE, V77, P647, DOI 10.1016/j.pbb.2004.01.003; Mathur P, 2011, BEHAV BRAIN RES, V219, P234, DOI 10.1016/j.bbr.2011.01.019; Maximino C, 2010, NAT PROTOC, V5, P209, DOI 10.1038/nprot.2009.225; Oliveira J., 2015, ZEBRAFISH; Pather S, 2009, BEHAV BRAIN RES, V196, P323, DOI 10.1016/j.bbr.2008.09.013; Reimers MJ, 2004, J BIOL CHEM, V279, P38303, DOI 10.1074/jbc.M401165200; Shannon W, 2003, PHARMACOGENOMICS, V4, P41, DOI 10.1517/phgs.4.1.41.22581; Shohat-Ophir G, 2012, SCIENCE, V335, P1351, DOI 10.1126/science.1215932; Sison M, 2010, BEHAV BRAIN RES, V207, P99, DOI 10.1016/j.bbr.2009.09.043; Spence R, 2008, ETHOLOGY, V114, P582, DOI 10.1111/j.1439-0310.2008.01515.x; Tran S, 2013, BEHAV BRAIN RES, V252, P204, DOI 10.1016/j.bbr.2013.05.065; Sun YP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035645; Teesson M, 2000, AUST NZ J PSYCHIAT, V34, P206, DOI 10.1080/j.1440-1614.2000.00715.x; Tropepe V, 2003, GENES BRAIN BEHAV, V2, P268, DOI 10.1034/j.1601-183X.2003.00038.x; Vengeliene V, 2008, BRIT J PHARMACOL, V154, P299, DOI 10.1038/bjp.2008.30; Ward A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005946; Weber DN, 2012, CURR TOP NEUROTOX, P335, DOI 10.1007/978-1-4614-2383-6_19; WECHSLER H, 1994, JAMA-J AM MED ASSOC, V272, P1672, DOI 10.1001/jama.272.21.1672; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wullimann MF, 1996, NEUROANATOMY ZEBRAFI, DOI 10.1007/978-3-0348-8979-7_6; Zandy SL, 2014, PSYCHOPHARMACOLOGY, P1; ZHOU FC, 1995, ALCOHOL, V12, P403, DOI 10.1016/0741-8329(95)00010-O; Zhu W, 2004, ALCOHOL ALCOHOLISM, V39, P53, DOI 10.1093/alcalc/agh023	56	15	15	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0141134	10.1371/journal.pone.0141134	http://dx.doi.org/10.1371/journal.pone.0141134			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26558894	Green Published, gold, Green Submitted			2022-12-27	WOS:000364433100021
J	Miura, Y; Hashii, N; Tsumoto, H; Takakura, D; Ohta, Y; Abe, Y; Arai, Y; Kawasaki, N; Hirose, N; Endo, T				Miura, Yuri; Hashii, Noritaka; Tsumoto, Hiroki; Takakura, Daisuke; Ohta, Yuki; Abe, Yukiko; Arai, Yasumichi; Kawasaki, Nana; Hirose, Nobuyoshi; Endo, Tamao		SONIC	Change in N-Glycosylation of Plasma Proteins in Japanese Semisupercentenarians	PLOS ONE			English	Article							LIQUID CHROMATOGRAPHY/MASS SPECTROMETRY; ALPHA-2-6-LINKED SIALIC ACIDS; GLYCANS; BIOMARKERS; CARCINOMA; PROFILES; IGG; AGE	An N-glycomic analysis of plasma proteins was performed in Japanese semisupercentenarians (SSCs) (mean 106.7 years), aged controls (mean 71.6 years), and young controls (mean 30.2 years) by liquid chromatography/mass spectrometry (LC/MS) using a graphitized carbon column. Characteristic N-glycans in SSCs were discriminated using a multivariate analysis; orthogonal projections to latent structures (O-PLS). The results obtained showed that multi-branched and highly sialylated N-glycans as well as agalacto-and/or bisecting N-glycans were increased in SSCs, while biantennary N-glycans were decreased. Since multi-branched and highly sialylated N-glycans have been implicated in anti-inflammatory activities, these changes may play a role in the enhanced chronic inflammation observed in SSCs. The levels of inflammatory proteins, such as CRP, adiponectin, IL-6, and TNF-a, were elevated in SSCs. These results suggested that responses to inflammation may play an important role in extreme longevity and healthy aging in humans. This is the first study to show that the N-glycans of plasma proteins were associated with extreme longevity and healthy aging in humans.	[Miura, Yuri; Tsumoto, Hiroki; Endo, Tamao] Tokyo Metropolitan Inst Gerontol, Res Team Mech Aging, Tokyo, Japan; [Hashii, Noritaka; Takakura, Daisuke; Ohta, Yuki; Kawasaki, Nana] Natl Inst Hlth Sci, Div Biol Chem & Biol, Tokyo, Japan; [Abe, Yukiko; Arai, Yasumichi; Hirose, Nobuyoshi] Keio Univ, Sch Med, Ctr Supercentenarian Res, Tokyo, Japan	Tokyo Metropolitan Institute of Gerontology; National Institute of Health Sciences - Japan; Keio University	Endo, T (corresponding author), Tokyo Metropolitan Inst Gerontol, Res Team Mech Aging, Tokyo, Japan.	endo@tmig.or.jp			Japan Society for the Promotion of Science [24659141]; Mitsui Sumitomo Insurance Welfare Foundation [18]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Mitsui Sumitomo Insurance Welfare Foundation(Mitsui Sumitomo Insurance Welfare Foundation)	The Japan Society for the Promotion of Science (No. 24659141 to TE) (http://www.jsps.go.jp/j-grantsinaid/index.html), and Mitsui Sumitomo Insurance Welfare Foundation (No. 18 to YM)(http://www.ms-ins.com/welfare/): The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldredge D, 2012, J PROTEOME RES, V11, P1958, DOI 10.1021/pr2011439; Arai Y, 2014, J GERONTOL A-BIOL, V69, P486, DOI 10.1093/gerona/glt146; Callewaert N, 2003, GLYCOBIOLOGY, V13, P367, DOI 10.1093/glycob/cwg040; Ding N, 2011, AGE AGEING, V40, P568, DOI 10.1093/ageing/afr084; Dutta M, 2015, J PROTEOMICS, V114, P182, DOI 10.1016/j.jprot.2014.10.021; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Freeze HH, 2005, CURR OPIN STRUC BIOL, V15, P490, DOI 10.1016/j.sbi.2005.08.010; Gagneux P, 2003, J BIOL CHEM, V278, P48245, DOI 10.1074/jbc.M309813200; Gierman HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112430; Hashii N, 2005, PROTEOMICS, V5, P4665, DOI 10.1002/pmic.200401330; Hashii N, 2014, RAPID COMMUN MASS SP, V28, P921, DOI 10.1002/rcm.6858; Hedlund M, 2008, CANCER RES, V68, P388, DOI 10.1158/0008-5472.CAN-07-1340; Holm T, 2014, ALLERGY, V69, P104, DOI 10.1111/all.12308; Huffman JE, 2011, HUM MOL GENET, V20, P5000, DOI 10.1093/hmg/ddr414; Itoh S, 2006, J CHROMATOGR A, V1103, P296, DOI 10.1016/j.chroma.2005.11.043; Kaneshiro N, 2009, RAPID COMMUN MASS SP, V23, P3720, DOI 10.1002/rcm.4315; Knezevic A, 2010, GLYCOBIOLOGY, V20, P959, DOI 10.1093/glycob/cwq051; Langereis MA, 2015, CELL REP, V11, P1966, DOI 10.1016/j.celrep.2015.05.044; Lauc G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003225; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Lu JP, 2011, J PROTEOME RES, V10, P4959, DOI 10.1021/pr2004067; Miura Y, 2011, EXP GERONTOL, V46, P81, DOI 10.1016/j.exger.2010.10.002; Miyahara K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074861; PAREKH R, 1988, J EXP MED, V167, P1731, DOI 10.1084/jem.167.5.1731; PAWLOWSKI T, 1986, Behring Institute Mitteilungen, P11; Ruhaak LR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073082; Ruhaak LR, 2012, ANAL CHEM, V84, P396, DOI 10.1021/ac202775t; Ruhaak LR, 2011, J PROTEOME RES, V10, P1667, DOI 10.1021/pr1009959; Saldova R, 2014, J PROTEOME RES, V13, P2314, DOI 10.1021/pr401092y; Sarrats A, 2010, PROTEOM CLIN APPL, V4, P432, DOI 10.1002/prca.200900150; Sato Y, 2010, GERIATR GERONTOL INT, V10, pS32, DOI 10.1111/j.1447-0594.2010.00602.x; Sebastiani P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029848; Taniguchi N, 2015, ADV CANCER RES, V126, P11, DOI 10.1016/bs.acr.2014.11.001; TSUCHIYA N, 1993, J IMMUNOL, V151, P1137; Tsutsui H, 2011, CLIN CHIM ACTA, V412, P861, DOI 10.1016/j.cca.2010.12.023; Vanhooren V, 2008, BIOGERONTOLOGY, V9, P351, DOI 10.1007/s10522-008-9140-z; Vanhooren V, 2007, REJUV RES, V10, P521, DOI 10.1089/rej.2007.0556; Vanhooren V, 2010, EXP GERONTOL, V45, P738, DOI 10.1016/j.exger.2010.08.009; Vanhooren V, 2009, MECH AGEING DEV, V130, P92, DOI 10.1016/j.mad.2008.11.008	39	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142645	10.1371/journal.pone.0142645	http://dx.doi.org/10.1371/journal.pone.0142645			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559536	Green Published, Green Submitted, gold			2022-12-27	WOS:000364433100105
J	Udroiu, I; Antoccia, A; Tanzarella, C; Giuliani, L; Pacchierotti, F; Cordelli, E; Eleuteri, P; Villani, P; Sgura, A				Udroiu, Ion; Antoccia, Antonio; Tanzarella, Caterina; Giuliani, Livio; Pacchierotti, Francesca; Cordelli, Eugenia; Eleuteri, Patrizia; Villani, Paola; Sgura, Antonella			Genotoxicity Induced by Foetal and Infant Exposure to Magnetic Fields and Modulation of Ionising Radiation Effects	PLOS ONE			English	Article							DNA-DAMAGE; TESTICULAR DEVELOPMENT; PERIPHERAL-BLOOD; 60 HZ; FREQUENCY; ADULT; MICRONUCLEI; MICE; SPERMATOGENESIS; CELLS	Background Few studies have investigated the toxicity and genotoxicity of extremely low frequency magnetic fields (ELF-MF) during prenatal and neonatal development. These phases of life are characterized by cell proliferation and differentiation, which might make them sensitive to environmental stressors. Although in vitro evidences suggest that ELF-MF may modify the effects of ionizing radiation, no research has been conducted so far in vivo on the genotoxic effects of ELF-MF combined with X-rays. Aim and methods Aim of this study was to investigate in somatic and germ cells the effects of chronic ELF-MF exposure from mid gestation until weaning, and any possible modulation produced by ELF-MF exposure on ionizing radiation-induced damage. Mice were exposed to 50 Hz, 65 mu T magnetic field, 24 hours/day, for a total of 30 days, starting from 12 days post-conception. Another group was irradiated with 1 Gy X-rays immediately before ELF-MF exposure, other groups were only X-irradiated or sham-exposed. Micronucleus test on blood erythrocytes was performed at multiple times from 1 to 140 days after birth. Additionally, 42 days after birth, genotoxic and cytotoxic effects on male germ cells were assessed by comet assay and flow cytometric analysis. Results ELF-MF exposure had no teratogenic effect and did not affect survival, growth and development. The micronucleus test indicated that ELF-MF induced a slight genotoxic damage only after the maximum exposure time and that this effect faded away in the months following the end of exposure. ELF-MF had no effects on ionizing radiation (IR)-induced genotoxicity in erythrocytes. Differently, ELF-MF appeared to modulate the response of male germ cells to X-rays with an impact on proliferation/differentiation processes. These results point to the importance of tissue specificity and development on the impact of ELF-MF on the early stages of life and indicate the need of further research on the molecular mechanisms underlying ELF-MF biological effects.	[Udroiu, Ion; Antoccia, Antonio; Tanzarella, Caterina; Sgura, Antonella] Univ Rome Roma Tre, Dept Sci, Rome, Italy; [Giuliani, Livio] INAIL, Res Ctr Monteporzio Catone, Rome, Italy; [Pacchierotti, Francesca; Cordelli, Eugenia; Eleuteri, Patrizia; Villani, Paola] ENEA, Tech Unit Radiat Biol & Human Hlth, Rome, Italy	Italfarmaco; Roma Tre University; Italian National Agency New Technical Energy & Sustainable Economics Development	Udroiu, I (corresponding author), Univ Rome Roma Tre, Dept Sci, Rome, Italy.	ion.udroiu@uniroma1.it	Sgura, Antonella/H-3274-2019		Istituto nazionale per l'assicurazione contro gli infortuni sul lavoro [B23/DIPIA/2009]	Istituto nazionale per l'assicurazione contro gli infortuni sul lavoro	This work was supported by "Istituto nazionale per l'assicurazione contro gli infortuni sul lavoro", grant number B23/DIPIA/2009 (www.inail.it). LG (INAIL).	Abramsson-Zetterberg L, 2001, BIOELECTROMAGNETICS, V22, P351, DOI 10.1002/bem.61; Alcaraz M, 2014, ELECTROMAGN BIOL MED, V33, P51, DOI 10.3109/15368378.2013.783851; BRENT RL, 1980, TERATOLOGY, V21, P281, DOI 10.1002/tera.1420210304; CHERNOFF N, 1992, TOXICOLOGY, V74, P91, DOI 10.1016/0300-483X(92)90132-X; Chung MK, 2005, ASIAN J ANDROL, V7, P189, DOI 10.1111/j.1745-7262.2005.00007.x; COLE RJ, 1981, MUTAT RES, V80, P141, DOI 10.1016/0027-5107(81)90184-6; Cordelli E, 2003, RADIAT RES, V160, P443, DOI 10.1667/RR3053; Cordelli E, 2012, ENVIRON MOL MUTAGEN, V53, P429, DOI 10.1002/em.21703; Duan WX, 2014, BIOELECTROMAGNETICS, V35, P58, DOI 10.1002/bem.21816; Ema H, 2000, BLOOD, V95, P2284, DOI 10.1182/blood.V95.7.2284.007k14_2284_2288; Erdal N, 2007, MUTAT RES-GEN TOX EN, V630, P69, DOI 10.1016/j.mrgentox.2007.03.001; Gharamaleki H, 2014, ACTA ENDOCRINOL-BUCH, V10, P577, DOI 10.4183/aeb.2014.577; Haines GA, 2002, BIOL REPROD, V67, P854, DOI 10.1095/biolreprod.102.004382; Haines GA, 2001, MUTAT RES-GEN TOX EN, V495, P21, DOI 10.1016/S1383-5718(01)00181-4; HINTENLANG DE, 1993, BIOELECTROMAGNETICS, V14, P545, DOI 10.1002/bem.2250140606; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2002, IARC Monogr Eval Carcinog Risks Hum, V80, P1; JANCA FC, 1986, BIOL REPROD, V34, P613, DOI 10.1095/biolreprod34.4.613; Karotki AV, 2012, CELL MOL LIFE SCI, V69, P3351, DOI 10.1007/s00018-012-1148-5; Kim AS, 2006, MUTAT RES-REV MUTAT, V613, P138, DOI 10.1016/j.mrrev.2006.09.001; Lee SK, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/567183; Li PZ, 2009, CANCER CAUSE CONTROL, V20, P945, DOI 10.1007/s10552-009-9311-5; Luukkonen J, 2014, MUTAT RES-FUND MOL M, V760, P33, DOI 10.1016/j.mrfmmm.2013.12.002; Marshall GM, 2014, NAT REV CANCER, V14, P277, DOI 10.1038/nrc3679; Mattsson MO, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00132; MCGIVERN RF, 1990, TERATOLOGY, V41, P1, DOI 10.1002/tera.1420410102; Miyakoshi J, 2000, J RADIAT RES, V41, P293, DOI 10.1269/jrr.41.293; Morita T, 1997, MUTAT RES-GEN TOX EN, V389, P3, DOI 10.1016/S1383-5718(96)00070-8; Neri M, 2005, ENVIRON HEALTH PERSP, V113, P1226, DOI 10.1289/ehp.7806; Okudan N, 2010, NEUROENDOCRINOL LETT, V31, P208; Paashuis-Lew YRM, 1998, MUTAGENESIS, V13, P613, DOI 10.1093/mutage/13.6.613; Pafkova Hana, 1994, Reviews on Environmental Health, V10, P235; Repacholi M, 2012, SCI TOTAL ENVIRON, V426, P454, DOI 10.1016/j.scitotenv.2012.03.030; Ryan BM, 1999, TERATOLOGY, V59, P156; SANDERSON BJS, 1993, MUTAT RES, V285, P27, DOI 10.1016/0027-5107(93)90048-K; Svedenstal BM, 1998, ELECTRO MAGNETOBIOL, V17, P127, DOI 10.3109/15368379809022558; Teepen JC, 2012, INT J CANCER, V131, P769, DOI 10.1002/ijc.27542; Tenorio BM, 2011, J APPL TOXICOL, V31, P223, DOI 10.1002/jat.1584; Udroiu I, 2006, INT J RADIAT BIOL, V82, P561, DOI 10.1080/09553000600876660; Udroiu I, 2010, NONTHERMAL EFFECTS M, P123; Udroiu I, 2006, ENVIRON MOL MUTAGEN, V47, P320, DOI 10.1002/em.20209; Udrou I, 2008, EUR J ONCOL, V13, P239; VERGOUWEN RPFA, 1991, J REPROD FERTIL, V93, P233, DOI 10.1530/jrf.0.0930233; VERGOUWEN RPFA, 1995, RADIAT RES, V141, P66, DOI 10.2307/3579091; WERTHEIMER N, 1979, AM J EPIDEMIOL, V109, P273, DOI 10.1093/oxfordjournals.aje.a112681; World Health Organization, 2007, ENV HLTH CRIT, V238; XI WG, 1994, IEEE T BIO-MED ENG, V41, P1018, DOI 10.1109/10.335839; Yoon HE, 2014, INT J RADIAT BIOL, V90, P291, DOI 10.3109/09553002.2014.887866; Zhang XJ, 2007, ELECTROMAGN BIOL MED, V26, P167, DOI 10.1080/15368370701580756; Zuniga-Gonzalez G, 1998, MUTAT RES-GEN TOX EN, V413, P187, DOI 10.1016/S1383-5718(97)00184-8	49	5	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142259	10.1371/journal.pone.0142259	http://dx.doi.org/10.1371/journal.pone.0142259			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559811	gold, Green Published, Green Submitted			2022-12-27	WOS:000364433100067
J	Baker, EC; Layden, MJ; van Rossum, DB; Kamel, B; Medina, M; Simpson, E; Jegla, T				Baker, Emma C.; Layden, Michael J.; van Rossum, Damian B.; Kamel, Bishoy; Medina, Monica; Simpson, Eboni; Jegla, Timothy			Functional Characterization of Cnidarian HCN Channels Points to an Early Evolution of I-h	PLOS ONE			English	Article							HYPERPOLARIZATION-ACTIVATED CHANNEL; VOLTAGE-SENSOR MOVEMENT; K+ CHANNELS; ION CHANNELS; POTASSIUM CHANNEL; MOLECULAR CHARACTERIZATION; DISTAL DENDRITES; TERMINAL REGION; CATION CHANNEL; SEA-ANEMONE	HCN channels play a unique role in bilaterian physiology as the only hyperpolarizationgated cation channels. Their voltage-gating is regulated by cyclic nucleotides and phosphatidylinositol 4,5-bisphosphate (PIP2). Activation of HCN channels provides the depolarizing current in response to hyperpolarization that is critical for intrinsic rhythmicity in neurons and the sinoatrial node. Additionally, HCN channels regulate dendritic excitability in a wide variety of neurons. Little is known about the early functional evolution of HCN channels, but the presence of HCN sequences in basal metazoan phyla and choanoflagellates, a protozoan sister group to the metazoans, indicate that the gene family predates metazoan emergence. We functionally characterized two HCN channel orthologs from Nematostella vectensis (Cnidaria, Anthozoa) to determine which properties of HCN channels were established prior to the emergence of bilaterians. We find Nematostella HCN channels share all the major functional features of bilaterian HCNs, including reversed voltage-dependence, activation by cAMP and PIP2, and block by extracellular Cs+. Thus bilaterian-like HCN channels were already present in the common parahoxozoan ancestor of bilaterians and cnidarians, at a time when the functional diversity of voltage-gated K+ channels was rapidly expanding. NvHCN1 and NvHCN2 are expressed broadly in planulae and in both the endoderm and ectoderm of juvenile polyps.	[Baker, Emma C.; van Rossum, Damian B.; Kamel, Bishoy; Medina, Monica; Jegla, Timothy] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Layden, Michael J.] Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA; [van Rossum, Damian B.; Jegla, Timothy] Huck Inst Life Sci, University Pk, PA USA; [Simpson, Eboni] Penn State Univ, Grad Sch, SROP, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Lehigh University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Jegla, T (corresponding author), Penn State Univ, Dept Biol, University Pk, PA 16802 USA.	tjj3@psu.edu	Kamel, Bishoy/H-6166-2019	Kamel, Bishoy/0000-0003-2934-3827; van Rossum, Damian/0000-0003-1011-2586; Jegla, Timothy/0000-0001-8616-2390	Eberly College of Science at Penn State University; Summer Research Opportunities Program (SROP)	Eberly College of Science at Penn State University; Summer Research Opportunities Program (SROP)	This study was funded by start-up funds provided by the Eberly College of Science at Penn State University to TJ. ES was funded by the Summer Research Opportunities Program (SROP) run by the Penn State University Graduate School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Baruscotti M, 2005, PHARMACOL THERAPEUT, V107, P59, DOI 10.1016/j.pharmthera.2005.01.005; Barzilai MG, 2012, CELL REP, V2, P242, DOI 10.1016/j.celrep.2012.06.016; Brams M, 2014, P NATL ACAD SCI USA, V111, P7855, DOI 10.1073/pnas.1401917111; Brelidze TI, 2013, P NATL ACAD SCI USA, V110, P11648, DOI 10.1073/pnas.1306887110; Brelidze TI, 2012, NATURE, V481, P530, DOI 10.1038/nature10735; Brelidze TI, 2009, J BIOL CHEM, V284, P27989, DOI 10.1074/jbc.M109.016337; Bright SR, 2007, MOL PHARMACOL, V71, P176, DOI 10.1124/mol.106.026401; Budde T, 2005, J NEUROSCI, V25, P9871, DOI 10.1523/JNEUROSCI.2590-05.2005; Cai XJ, 2012, GENOMICS, V99, P241, DOI 10.1016/j.ygeno.2012.01.007; Chapman JA, 2010, NATURE, V464, P592, DOI 10.1038/nature08830; Chen S, 2007, J GEN PHYSIOL, V129, P175, DOI 10.1085/jgp.200609585; Clancy SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006330; Craven KB, 2006, ANNU REV PHYSIOL, V68, P375, DOI 10.1146/annurev.physiol.68.040104.134728; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; DIFRANCESCO D, 1993, ANNU REV PHYSIOL, V55, P455, DOI 10.1146/annurev.physiol.55.1.455; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Er F, 2003, CIRCULATION, V107, P485, DOI 10.1161/01.CIR.0000045672.32920.CB; Flynn GE, 2011, J BIOL CHEM, V286, P15535, DOI 10.1074/jbc.M110.214650; Gauss R, 1998, NATURE, V393, P583, DOI 10.1038/31248; George MS, 2009, NAT NEUROSCI, V12, P577, DOI 10.1038/nn.2307; Gisselmann G, 2003, INSECT BIOCHEM MOLEC, V33, P1123, DOI 10.1016/S0965-1748(03)00132-2; Gustincich S, 2003, GENOME RES, V13, P1395, DOI 10.1101/gr.1135303; Haitin Y, 2013, NATURE, V501, P444, DOI 10.1038/nature12487; Halaszovich CR, 2009, J BIOL CHEM, V284, P2106, DOI 10.1074/jbc.M803543200; Hedrich R, 2012, PHYSIOL REV, V92, P1777, DOI 10.1152/physrev.00038.2011; Horwitz GC, 2011, J NEUROSCI, V31, P16814, DOI 10.1523/JNEUROSCI.3064-11.2011; Ishii TM, 1999, J BIOL CHEM, V274, P12835, DOI 10.1074/jbc.274.18.12835; Jackson HA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047590; Jegla T, 1995, J NEUROSCI, V15, P7989; JEGLA T, 1994, SOC GEN PHY, V49, P213; JEGLA T, 1995, RECEPTOR CHANNEL, V3, P51; Jegla T, 1997, J NEUROSCI, V17, P32, DOI 10.1523/JNEUROSCI.17-01-00032.1997; Jegla T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051366; Jegla TJ, 2009, COMB CHEM HIGH T SCR, V12, P2, DOI 10.2174/138620709787047957; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Kuo MMC, 2005, FEMS MICROBIOL REV, V29, P961, DOI 10.1016/j.femsre.2005.03.003; Layden MJ, 2014, EVODEVO, V5, DOI 10.1186/2041-9139-5-30; Layden MJ, 2012, DEVELOPMENT, V139, P1013, DOI 10.1242/dev.073221; Li X, 2015, P NATL ACAD SCI USA, V112, pE1010, DOI 10.1073/pnas.1422941112; Li XF, 2015, J EXP BIOL, V218, P526, DOI 10.1242/jeb.110080; Li Y, 2011, P NATL ACAD SCI USA, V108, P9095, DOI 10.1073/pnas.1100872108; Loukin SH, 2005, J GEN PHYSIOL, V125, P521, DOI 10.1085/jgp.200509261; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; MacKinnon R, 1998, SCIENCE, V280, P106, DOI 10.1126/science.280.5360.106; Mannikko R, 2002, NATURE, V419, P837, DOI 10.1038/nature01038; Marlow H, 2012, DEV BIOL, V362, P295, DOI 10.1016/j.ydbio.2011.11.012; Marlow HQ, 2009, DEV NEUROBIOL, V69, P235, DOI 10.1002/dneu.20698; Martinson AS, 2014, P NATL ACAD SCI USA, V111, P5712, DOI 10.1073/pnas.1321716111; Mistrik P, 2005, J BIOL CHEM, V280, P27056, DOI 10.1074/jbc.M502696200; Moran Y, 2015, J EXP BIOL, V218, P515, DOI 10.1242/jeb.110270; Moran Y, 2014, GENOME BIOL EVOL, V6, P2210, DOI 10.1093/gbe/evu177; Moroz LL, 2014, NATURE, V510, P109, DOI 10.1038/nature13400; Moya A, 2012, MOL ECOL, V21, P2440, DOI 10.1111/j.1365-294X.2012.05554.x; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; Nolan MF, 2004, CELL, V119, P719, DOI 10.1016/S0092-8674(04)01055-4; Ouyang Q, 2007, J NEUROPHYSIOL, V97, P3880, DOI 10.1152/jn.00246.2007; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Pian P, 2006, J GEN PHYSIOL, V128, P593, DOI 10.1085/jgp.200609648; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Renfer E, 2010, P NATL ACAD SCI USA, V107, P104, DOI 10.1073/pnas.0909148107; Riesgo A, 2014, MOL BIOL EVOL, V31, P1102, DOI 10.1093/molbev/msu057; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Rodriguez-Menchaca AA, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00170; Rodriguez-Menchaca AA, 2012, P NATL ACAD SCI USA, V109, pE2399, DOI 10.1073/pnas.1207901109; Ryan JF, 2013, SCIENCE, V342, P1336, DOI 10.1126/science.1242592; Ryan JF, 2010, EVODEVO, V1, DOI 10.1186/2041-9139-1-9; Salichos L, 2013, NATURE, V497, P327, DOI 10.1038/nature12130; Sand RM, 2011, J EXP BIOL, V214, P3124, DOI 10.1242/jeb.057000; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; SCHACHTMAN DP, 1992, SCIENCE, V258, P1654, DOI 10.1126/science.8966547; Seifert R, 1999, P NATL ACAD SCI USA, V96, P9391, DOI 10.1073/pnas.96.16.9391; SENTENAC H, 1992, SCIENCE, V256, P663, DOI 10.1126/science.1585180; Shinzato C, 2011, NATURE, V476, P320, DOI 10.1038/nature10249; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Stieber J, 2005, J BIOL CHEM, V280, P34635, DOI 10.1074/jbc.M502508200; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tsay D, 2007, NEURON, V56, P1076, DOI 10.1016/j.neuron.2007.11.015; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Whelan NV, 2015, P NATL ACAD SCI USA, V112, P5773, DOI 10.1073/pnas.1503453112; Ying SW, 2007, J NEUROSCI, V27, P8719, DOI 10.1523/JNEUROSCI.1630-07.2007; Yu Frank H, 2004, Sci STKE, V2004, pre15, DOI 10.1126/stke.2532004re15; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zaydman MA, 2013, P NATL ACAD SCI USA, V110, P13180, DOI 10.1073/pnas.1305167110; Zhainazarov AB, 2004, J MEMBRANE BIOL, V201, P51, DOI 10.1007/s00232-004-0707-4; Zolles G, 2006, NEURON, V52, P1027, DOI 10.1016/j.neuron.2006.12.005	90	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142730	10.1371/journal.pone.0142730	http://dx.doi.org/10.1371/journal.pone.0142730			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555239	Green Submitted, Green Published, gold			2022-12-27	WOS:000364430700161
J	Bellavia, D; Cataliotti, A; Clemenza, F; Baravoglia, CH; Luca, A; Traina, M; Gridelli, B; Bertani, T; Burnett, JC; Scardulla, C				Bellavia, Diego; Cataliotti, Alessandro; Clemenza, Francesco; Baravoglia, Cesar Hernandez; Luca, Angelo; Traina, Marcello; Gridelli, Bruno; Bertani, Tullio; Burnett, John C.; Scardulla, Cesare			Long-Term Structural and Functional Myocardial Adaptations in Healthy Living Kidney Donors: A Pilot Study	PLOS ONE			English	Article							SPECKLE-TRACKING ECHOCARDIOGRAPHY; CARDIOVASCULAR-DISEASE; DIASTOLIC DYSFUNCTION; TISSUE DOPPLER; ASSOCIATION; PROPEPTIDE; FIBROSIS; STIFFNESS; MARKERS; UTILITY	Background and Aims Compensatory renal hypertrophy following unilateral nephrectomy (UNX) occurs in the remaining kidney. However, the long-term cardiac adaptive process to UNX remains poorly defined in humans. Our goal was to characterize myocardial structure and function in living kidney donors (LKDs), approximately 12 years after UNX. Methods and Results Cardiac function and structure in 15 Italian LKDs, at least 5 years after UNX (median time from donation = 8.4 years) was investigated and compared to those of age and sex matched U.S. citizens healthy controls (n = 15). Standard and speckle tracking echocardiography (STE) was performed in both LKDs and controls. Plasma angiotensin II, aldosterone, atrial natriuretic peptide (ANP), N terminus pro B-type natriuretic peptide (NT-proBNP), cyclic guanylyl monophosphate (cGMP), and amino-terminal peptide of procollagen III (PIIINP) were also collected. Median follow-up was 11.9 years. In LKDs, LV geometry and function by STE were similar to controls, wall thickness and volumes were within normal limits also by CMR. In LKDs, CMR was negative for myocardial fibrosis, but apical rotation and LV torsion obtained by STE were impaired as compared to controls (21.4 +/- 7.8 vs 32.7 +/- 8.9 degrees, p = 0.04). Serum creatinine and PIIINP levels were increased [1.1 (0.9-1.3) mg/dL, and 5.8 (5.4-7.6)] mu g/L, respectively), while urinary cGMP was reduced [270 (250-355) vs 581 (437-698) pmol/mL] in LKDs. No LKD developed cardiovascular or renal events during follow-up. Conclusions Long-term kidney donors have no apparent structural myocardial abnormalities as assessed by contrast enhanced CMR. However, myocardial deformation of the apical segments, as well as apical rotation, and LV torsion are reduced. The concomitant increase in circulating PIIINP level is suggestive of fibrosis. Further studies, focused on US and EU patients are warranted to evaluate whether these early functional modifications will progress to a more compromised cardiac function and structure at a later time.	[Bellavia, Diego; Clemenza, Francesco; Baravoglia, Cesar Hernandez; Gridelli, Bruno; Scardulla, Cesare] Mediterranean Inst Transplantat & Adv Specialized, Div Cardiovasc Dis, Palermo, Italy; [Bellavia, Diego; Burnett, John C.] Mayo Clin, Cardiorenal Res Lab, Div Cardiovasc Dis, Rochester, MN USA; [Cataliotti, Alessandro] Univ Oslo, Inst Clin Med, Oslo, Norway; [Cataliotti, Alessandro] Univ Oslo, Expt Med Res Inst, Oslo, Norway; [Cataliotti, Alessandro] Oslo Univ Hosp, Oslo, Norway; [Luca, Angelo] Mediterranean Inst Transplantat & Adv Specialized, Dept Radiol, Palermo, Italy; [Traina, Marcello] Univ Palermo, Sport & Exercise Sci DISMOT Res Unit, Palermo, Italy; [Bertani, Tullio] Mediterranean Inst Transplantat & Adv Specialized, Div Nephrol, Palermo, Italy	IRCCS Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione (ISMETT); Mayo Clinic; University of Oslo; University of Oslo; University of Oslo; IRCCS Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione (ISMETT); University of Palermo; IRCCS Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione (ISMETT)	Bellavia, D (corresponding author), Mediterranean Inst Transplantat & Adv Specialized, Div Cardiovasc Dis, Palermo, Italy.	dbellavia@ismett.edu	traina, mario/A-1309-2012; Bellavia, Diego/K-3072-2018	Traina, Marcello/0000-0003-2373-3621; Bellavia, Diego/0000-0003-3808-2868	Doris Duke Charitable Foundation [2006064]	Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF))	This work was supported by the grant Clinical Scientific Development Award (CSDA) 2006064 (A.C.) from the Doris Duke Charitable Foundation.	Abraham TP, 2007, CIRCULATION, V116, P2597, DOI 10.1161/CIRCULATIONAHA.106.647172; Bellavia D, 2008, HEART; Bellavia D, 2010, HEART, V96, P440, DOI 10.1136/hrt.2009.182170; Cataliotti A, 2002, AM J PHYSIOL-RENAL, V283, pF464, DOI 10.1152/ajprenal.00372.2001; Chatzikyriakou SV, 2008, EUR J HEART FAIL, V10, P1181, DOI 10.1016/j.ejheart.2008.09.007; Cicoira M, 2004, J CARD FAIL, V10, P403, DOI 10.1016/j.cardfail.2004.01.010; Dellegrottaglie S, 2011, NEPHROL DIAL TRANSPL, V26, P2891, DOI 10.1093/ndt/gfr186; Diagnostica O. PIIINP RIA*. Intact N-terminal propeptide of type III procollagen, 2009, RADIOIMMUNOASSAY KIT; Ellims AH, 2014, CIRC-HEART FAIL, V7, P271, DOI 10.1161/CIRCHEARTFAILURE.113.000665; FehrmanEkholm I, 1997, TRANSPLANTATION, V64, P976, DOI 10.1097/00007890-199710150-00007; Garg AX, 2006, KIDNEY INT, V70, P1801, DOI 10.1038/sj.ki.5001819; Garg AX, 2012, BMJ-BRIT MED J, P344; Go A, 2013, HEAR DIS STROKE STAT, V127, pe1; Ibrahim HN, 2009, NEW ENGL J MED, V360, P459, DOI 10.1056/NEJMoa0804883; Kido R, 2009, AM J TRANSPLANT, V9, P2514, DOI 10.1111/j.1600-6143.2009.02795.x; Kottgen A, 2008, AM J KIDNEY DIS, V51, P385, DOI 10.1053/j.ajkd.2007.11.019; Kwon DH, 2008, INT J CARDIOVAS IMAG, V24, P617, DOI 10.1007/s10554-008-9292-6; Lang RM, 2015, J AM SOC ECHOCARDIOG, V28, P1, DOI 10.1016/j.echo.2014.10.003; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Martin FL, 2012, AM J PHYSIOL-REG I, V302, pR292, DOI 10.1152/ajpregu.00194.2011; Marwick TH, 2009, JACC-CARDIOVASC IMAG, V2, P80, DOI 10.1016/j.jcmg.2007.12.007; Mjoen G, 2014, KIDNEY INT, V86, P162, DOI 10.1038/ki.2013.460; Muzaale AD, 2014, JAMA-J AM MED ASSOC, V311, P579, DOI 10.1001/jama.2013.285141; Nichols M, 2013, EUR HEART J, V34, P3028, DOI 10.1093/eurheartj/eht356; OHYAMA K, 1990, BIOCHIM BIOPHYS ACTA, V1053, P173, DOI 10.1016/0167-4889(90)90010-B; Ommen SR, 2000, CIRCULATION, V102, P1788; Park SJ, 2008, J AM SOC ECHOCARDIOG, V21, P1129, DOI 10.1016/j.echo.2008.04.002; Reese PP, 2015, AM J TRANSPLANT, V15, P287, DOI 10.1111/ajt.13015; RISTELI J, 1988, CLIN CHEM, V34, P715; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Segev DL, 2010, JAMA-J AM MED ASSOC, V303, P959, DOI 10.1001/jama.2010.237; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Teppo AM, 2003, TRANSPLANTATION, V75, P2113, DOI 10.1097/01.TP.0000066809.60389.48; World Health Organization, 2022, GLOB HLTH OBS	34	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142103	10.1371/journal.pone.0142103	http://dx.doi.org/10.1371/journal.pone.0142103			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556804	Green Published, gold, Green Submitted			2022-12-27	WOS:000364430700053
J	Dickinson-Copeland, CM; Wilson, NO; Liu, ML; Driss, A; Salifu, H; Adjel, AA; Wilson, M; Gyan, B; Oduro, D; Badu, K; Botchway, F; Anderson, W; Bond, V; Bacanamwo, M; Singh, S; Stiles, JK				Dickinson-Copeland, Carmen M.; Wilson, Nana O.; Liu, Mingli; Driss, Adel; Salifu, Hassana; Adjel, Andrew A.; Wilson, Michael; Gyan, Ben; Oduro, Daniel; Badu, Kingsley; Botchway, Felix; Anderson, Winston; Bond, Vincent; Bacanamwo, Methode; Singh, Shailesh; Stiles, Jonathan K.			Heme-Mediated Induction of CXCL10 and Depletion of CD34+Progenitor Cells Is Toll-Like Receptor 4 Dependent	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; CEREBRAL MALARIA; PLASMODIUM-FALCIPARUM; OXYGENASE-1; ACTIVATION; EXPRESSION; PATHOGENESIS; NEOVASCULARIZATION; SUSCEPTIBILITY; MOBILIZATION	Plasmodium falciparum infection can cause microvascular dysfunction, cerebral encephalopathy and death if untreated. We have previously shown that high concentrations of free heme, and C-X-C motif chemokine 10 (CXCL10) in sera of malaria patients induce apoptosis in microvascular endothelial and neuronal cells contributing to vascular dysfunction, blood-brain barrier (BBB) damage and mortality. Endothelial progenitor cells (EPC) are microvascular endothelial cell precursors partly responsible for repair and regeneration of damaged BBB endothelium. Studies have shown that EPC's are depleted in severe malaria patients, but the mechanisms mediating this phenomenon are unknown. Toll-like receptors recognize a wide variety of pathogen-associated molecular patterns generated by pathogens such as bacteria and parasites. We tested the hypothesis that EPC depletion during malaria pathogenesis is a function of heme-induced apoptosis mediated by CXCL10 induction and toll-like receptor (TLR) activation. Heme and CXCL10 concentrations in plasma obtained from malaria patients were elevated compared with non-malaria subjects. EPC numbers were significantly decreased in malaria patients (P < 0.02) and TLR4 expression was significantly elevated in vivo. These findings were confirmed in EPC precursors in vitro; where it was determined that heme-induced apoptosis and CXCL10 expression was TLR4-mediated. We conclude that increased serum heme mediates depletion of EPC during malaria pathogenesis.	[Dickinson-Copeland, Carmen M.; Wilson, Nana O.; Liu, Mingli; Driss, Adel; Salifu, Hassana; Bond, Vincent; Singh, Shailesh; Stiles, Jonathan K.] Morehouse Sch Med, Dept Biochem & Immunol, Atlanta, GA 30310 USA; [Adjel, Andrew A.; Botchway, Felix] Univ Ghana, Sch Med, Korle Bu Teaching Hosp, Dept Pathol, Accra, Ghana; [Adjel, Andrew A.; Wilson, Michael; Gyan, Ben; Oduro, Daniel] Univ Ghana, Noguchi Mem Inst Med Res, Dept Parasitol, Accra, Ghana; [Badu, Kingsley] Univ Ghana, Noguchi Mem Inst Med Res, Dept Immunol, Accra, Ghana; [Anderson, Winston] Howard Univ, Dept Biol, Washington, DC 20059 USA; [Bacanamwo, Methode] Morehouse Sch Med, Cardiovasc Res Inst, Atlanta, GA 30310 USA	Morehouse School of Medicine; University of Ghana; University of Ghana; University of Ghana; Howard University; Morehouse School of Medicine	Dickinson-Copeland, CM (corresponding author), Morehouse Sch Med, Dept Biochem & Immunol, Atlanta, GA 30310 USA.	cdcopeland@msm.edu; jstiles@msm.edu	Stiles, Jonathan K./AFM-1940-2022; Driss, Adel/X-6772-2019; Driss, Adel/A-4151-2008; Badu, Kingsley/AAE-8418-2020	Badu, Kingsley/0000-0002-7886-5528; Adjei, Andrew Anthony/0000-0001-5109-2919; Stiles, Jonathan Kwamina/0000-0003-0829-1482	National Institute of Minority Health and Health Disparities (NIMHD) [8G12MD007602, 1R56NS091616-01]; T-32 Sleep/Cardiovascular Grant [5T32HL103104-02]; Clinical Research Education and Career Development (CRECD) Grant [2R25RR017694-06A1]; Minority Biomedical Research Support Program (NIH/NIGMS) Grant [2R25GM058268]; National Institutes of Health Fogarty International Center [1R25TW009340]; National Institute of Neurological Disorders and Stroke (NINDS) [R21TW006804]; American Society for Microbiology Robert D. Watkins Graduate Fellowship; FOGARTY INTERNATIONAL CENTER [R25TW009340, R21TW006804] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R25RR017694] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL103104] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM058268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS091616, R01NS091616] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD007588, T37MD008639, G12MD007602] Funding Source: NIH RePORTER	National Institute of Minority Health and Health Disparities (NIMHD); T-32 Sleep/Cardiovascular Grant; Clinical Research Education and Career Development (CRECD) Grant; Minority Biomedical Research Support Program (NIH/NIGMS) Grant; National Institutes of Health Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); American Society for Microbiology Robert D. Watkins Graduate Fellowship; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by Grants # 8G12MD007602 and 1R56NS091616-01 from the National Institute of Minority Health and Health Disparities (NIMHD), T-32 Sleep/Cardiovascular Grant # 5T32HL103104-02, Clinical Research Education and Career Development (CRECD) Grant # 2R25RR017694-06A1, Minority Biomedical Research Support Program (NIH/NIGMS) Grant # 2R25GM058268, National Institutes of Health Fogarty International Center #1R25TW009340, National Institute of Neurological Disorders and Stroke (NINDS) #R21TW006804, and the American Society for Microbiology Robert D. Watkins Graduate Fellowship. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIMHD or the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDALLA SH, 1990, BLOOD CELLS, V16, P401; Andrade BB, 2010, J IMMUNOL, V185, P1196, DOI 10.4049/jimmunol.0904179; Apinjohr TO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081071; Armah H, 2005, ANN TROP MED PARASIT, V99, P629, DOI 10.1179/136485905X51508; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Baldridge MT, 2011, TRENDS IMMUNOL, V32, P57, DOI 10.1016/j.it.2010.12.003; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Belcher JD, 2013, ISRN OXIDATIVE MED, V2013, P1; Belcher JD, 2014, BLOOD, V123, P377, DOI 10.1182/blood-2013-04-495887; Blann AD, 2006, ATHEROSCLEROSIS, V188, P12, DOI 10.1016/j.atherosclerosis.2005.12.024; Campos MA, 2001, J IMMUNOL, V167, P416, DOI 10.4049/jimmunol.167.1.416; Coban C, 2005, J EXP MED, V201, P19, DOI 10.1084/jem.20041836; Coban C, 2007, INT IMMUNOL, V19, P67, DOI 10.1093/intimm/dxl123; Couper KN, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000744; Crosby HA, 2009, J HEPATOL, V51, P734, DOI 10.1016/j.jhep.2009.06.021; Cunnington AJ, 2012, J IMMUNOL, V189, P5336, DOI 10.4049/jimmunol.1201028; Datta D, 2007, AM J PHYSIOL-RENAL, V293, pF1222, DOI 10.1152/ajprenal.00164.2007; Dey S, 2012, J BIOL CHEM, V287, P26630, DOI 10.1074/jbc.M112.341255; Dondorp AM, 2010, LANCET, V376, P1647, DOI 10.1016/S0140-6736(10)61924-1; DORMER P, 1983, BLUT, V46, P279, DOI 10.1007/BF00319868; Driss A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-271; Egan CG, 2008, DIABETOLOGIA, V51, P1296, DOI 10.1007/s00125-008-0939-6; Esamai F, 2003, J TROP PEDIATRICS, V49, P216, DOI 10.1093/tropej/49.4.216; Esplin BL, 2011, J IMMUNOL, V186, P5367, DOI 10.4049/jimmunol.1003438; Fadini GP, 2006, DIABETOLOGIA, V49, P3075, DOI 10.1007/s00125-006-0401-6; Fortes GB, 2012, BLOOD, V119, P2368, DOI 10.1182/blood-2011-08-375303; Gallagher KA, 2007, J CLIN INVEST, V117, P1249, DOI 10.1172/JCI29710; Gyan B, 2009, AM J TROP MED HYG, V80, P541, DOI 10.4269/ajtmh.2009.80.541; Herrmann M, 2014, STEM CELL RES, V13, P465, DOI 10.1016/j.scr.2014.10.005; Hunt NH, 2007, NAT MED, V13, P667, DOI 10.1038/nm0607-667; Hunt NH, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00113; Hwang SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101558; Idro Richard, 2010, BMC Res Notes, V3, P104, DOI 10.1186/1756-0500-3-104; Imaizumi T, 2013, NEUROSCI RES, V76, P195, DOI 10.1016/j.neures.2013.05.002; Ingram DA, 2005, BLOOD, V105, P2783, DOI 10.1182/blood-2004-08-3057; Jain V, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-83; Jain V, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-383; Jialal I, 2010, AM J CARDIOL, V106, P1606, DOI 10.1016/j.amjcard.2010.07.039; Krishnegowda G, 2005, J BIOL CHEM, V280, P8606, DOI 10.1074/jbc.M413541200; Lapergue B, 2007, PROG NEUROBIOL, V83, P349, DOI 10.1016/j.pneurobio.2007.08.001; Lin YW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084731; Liu ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071366; Liu ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034280; Liu ML, 2011, CYTOKINE GROWTH F R, V22, P121, DOI 10.1016/j.cytogfr.2011.06.001; Lucchi NW, 2011, DIS MARKERS, V31, P327, DOI [10.1155/2011/345706, 10.3233/DMA-2011-0854]; Maratheftis CI, 2007, CLIN CANCER RES, V13, P1154, DOI 10.1158/1078-0432.CCR-06-2108; May L, 2010, EUR J HUM GENET, V18, P490, DOI 10.1038/ejhg.2009.182; Mockenhaupt FP, 2006, P NATL ACAD SCI USA, V103, P177, DOI 10.1073/pnas.0506803102; Murayama T, 2002, EXP HEMATOL, V30, P967, DOI 10.1016/S0301-472X(02)00867-6; Pamplona A, 2007, NAT MED, V13, P703, DOI 10.1038/nm1586; Pamplona A, 2009, INT J BIOCHEM CELL B, V41, P711, DOI 10.1016/j.biocel.2008.09.020; Rodriguez S, 2009, BLOOD, V114, P4064, DOI 10.1182/blood-2009-04-214916; Schaer DJ, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00415; Schroder NW, 2005, LANCET INFECT DIS, V5, P156, DOI 10.1016/S1473-3099(05)70023-2; Seixas E, 2009, P NATL ACAD SCI USA, V106, P15837, DOI 10.1073/pnas.0903419106; Service GS, 2011, GHAN MULT IND CLUST; Shih RH, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-86; Takeda M, 2005, JPN J INFECT DIS, V58, P268; Tolosano E, 2010, ANTIOXID REDOX SIGN, V12, P305, DOI 10.1089/ars.2009.2787; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Vinchi F, 2008, AM J PATHOL, V173, P289, DOI 10.2353/ajpath.2008.071130; Vinchi F, 2013, CIRCULATION, V127, P1317, DOI 10.1161/CIRCULATIONAHA.112.130179; Wagener FADTG, 2003, PHARMACOL REV, V55, P551, DOI 10.1124/pr.55.3.5; White NJ, 1996, NEW ENGL J MED, V335, P800, DOI 10.1056/NEJM199609123351107; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Wilson N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081329; Wilson NO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060898; Wilson NO, 2011, AM J TROP MED HYG, V85, P12, DOI 10.4269/ajtmh.2011.10-0512; Yanagibashi T, 2015, IMMUNOL LETT, V163, P22, DOI 10.1016/j.imlet.2014.11.012; Young PP, 2007, PROG CARDIOVASC DIS, V49, P421, DOI 10.1016/j.pcad.2007.02.004	72	11	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142328	10.1371/journal.pone.0142328	http://dx.doi.org/10.1371/journal.pone.0142328			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555697	gold, Green Submitted, Green Published			2022-12-27	WOS:000364430700085
J	Fernandez-Lansac, V; Crespo, M				Fernandez-Lansac, Violeta; Crespo, Maria			Narrative Length and Speech Rate in Battered Women	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC MEMORIES; AUTOBIOGRAPHICAL MEMORY; LINGUISTIC PREDICTORS; SYMPTOMS; DEPRESSION; DISSOCIATION; ORGANIZATION; QUALITIES; PTSD	Narrative length and speech rate of traumatic recollections have been previously associated with different emotions and adjustment trajectories after trauma. However, the evidence is limited and the results are mixed. The present study aimed to evaluate length (i.e., word count) and speech rate (i.e., words per minute) in narratives of events with different valence (i.e., neutral, positive, and negative/traumatic) by 50 battered women (trauma group) and 50 non-traumatized women (controls). The results showed that traumatic narratives by the trauma group were longer than those by the control group. Moreover, they were inversely related to time since the event and anxiety during disclosure, whereas the speech rate was also inversely associated with anxiety, as well as with peritraumatic dissociation and avoidance. The shorter narratives for positive events and a decelerated speech pattern for traumatic experiences predicted psychological symptoms. Additionally, the individual's emotional state predicted narrative aspects, with bidirectional effects. Our findings showed that linguistic characteristics of traumatic narratives (but also of narratives of positive events) revealed information about how the victims elaborated autobiographical memories and coped with the trauma.	[Fernandez-Lansac, Violeta; Crespo, Maria] Univ Complutense Madrid, Fac Psicol, Madrid, Spain	Complutense University of Madrid	Crespo, M (corresponding author), Univ Complutense Madrid, Fac Psicol, Campus Somosaguas, Madrid, Spain.	mcrespo@psi.ucm.es	Fernández-Lansac, Violeta/P-3072-2016; CRESPO, MARIA/C-8623-2011	Fernández-Lansac, Violeta/0000-0002-5157-7083; CRESPO, MARIA/0000-0001-8762-7874	Spanish Ministry of Economy and Competitiveness Grant from the Complutense University at Madrid [PSI2012-31952]	Spanish Ministry of Economy and Competitiveness Grant from the Complutense University at Madrid	This work was supported by the Project PSI2012-31952 from the Spanish Ministry of Economy and Competitiveness Grant 2011/2015 from the Complutense University at Madrid (awarded to V. Fernandez-Lansac). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Conrad J, 2001, APPL COGNITIVE PSYCH, V15, pS159, DOI 10.1002/acp.839; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Beaudreau SA, 2006, PSYCINFO; Beaudreau SA, 2007, J TRAUMA STRESS, V20, P353, DOI 10.1002/jts.20206; Beck A.T., 1990, MANUAL BECK ANXIETY; Beck AT, 1996, BDI 2 BECK DEPRESSIO; Berntsen D, 2006, BEHAV RES THER, V44, P219, DOI 10.1016/j.brat.2005.01.009; Berntsen D, 2003, APPL COGNITIVE PSYCH, V17, P675, DOI 10.1002/acp.894; Brewin CR, 1996, PSYCHOL REV, V103, P670, DOI 10.1037/0033-295X.103.4.670; Brewin CR, 2003, CLIN PSYCHOL REV, V23, P339, DOI 10.1016/S0272-7358(03)00033-3; Crespo M., 2012, EGEP EVALUACION GLOB; Crespo M, 2016, PSYCHOL TRAUMA-US, V8, P149, DOI 10.1037/tra0000041; D'Andrea W, 2012, APPL COGNITIVE PSYCH, V26, P316, DOI 10.1002/acp.1830; Dekel S, 2013, PSYCHOL TRAUMA-US, V5, P26, DOI 10.1037/a0022750; Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0; Foa E. B., 1993, AM PSYCHIAT PRESS RE, V12, P273; FOA EB, 1995, J TRAUMA STRESS, V8, P675, DOI 10.1007/BF02102894; Freer BD, 2010, VIOLENCE VICTIMS, V25, P742, DOI 10.1891/0886-6708.25.6.742; Gray MJ, 2001, APPL COGNITIVE PSYCH, V15, pS171, DOI 10.1002/acp.840; Greenhoot AF, 2013, MEMORY, V21, P125, DOI 10.1080/09658211.2012.712975; Hashemi B, 2008, B MENNINGER CLIN, V72, P179, DOI 10.1521/bumc.2008.72.3.179; Jelinek L, 2009, J ABNORM PSYCHOL, V118, P288, DOI 10.1037/a0015633; Kensinger E.A., 2008, HDB EMOTIONS, V3rd ed., P601; KUYKEN W, 1995, BRIT J CLIN PSYCHOL, V34, P89, DOI 10.1111/j.2044-8260.1995.tb01441.x; Lindblom KM, 2010, APPL COGNITIVE PSYCH, V24, P1, DOI 10.1002/acp.1547; Marmar CR, 1998, PROG PSYCH, P229; Marmar CR, 2004, ASSESSING PSYCHOL TR, P144; O'Kearney R, 2006, J TRAUMA STRESS, V19, P81, DOI 10.1002/jts.20099; O'Kearney R, 2011, J TRAUMA STRESS, V24, P716, DOI 10.1002/jts.20690; Pennebaker J. W., 2001, LINGUISTIC INQUIRY W; Ramirez-Esparza N, 2007, REV MEX PSICOL, V24, P85; Romisch S, 2014, PSYCHOL TRAUMA-US, V6, P465, DOI 10.1037/a0035169; SIEGMAN AW, 1993, J ABNORM PSYCHOL, V102, P430, DOI 10.1037/0021-843X.102.3.430; VANDERKOLK BA, 1995, J TRAUMA STRESS, V8, P505, DOI 10.1002/jts.2490080402; Wechsler D., 1997, WECHSLER ADULT INTEL; WILLIAMS JMG, 1988, PSYCHOL MED, V18, P689, DOI 10.1017/S0033291700008370	36	12	12	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142651	10.1371/journal.pone.0142651	http://dx.doi.org/10.1371/journal.pone.0142651			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7CT	26556474	gold, Green Published, Green Submitted			2022-12-27	WOS:000364430700150
J	Fung, M; Kim, J; Marty, FM; Schwarzinger, M; Koo, S				Fung, Monica; Kim, Jane; Marty, Francisco M.; Schwarzinger, Michael; Koo, Sophia			Meta-Analysis and Cost Comparison of Empirical versus Pre-Emptive Antifungal Strategies in Hematologic Malignancy Patients with High-Risk Febrile Neutropenia	PLoS One			English	Article							RANDOMIZED CONTROLLED-TRIAL; INVASIVE FUNGAL DISEASE; CELL TRANSPLANT RECIPIENTS; IMMUNOCOMPROMISED PATIENTS; PULMONARY ASPERGILLOSIS; PROSPECTIVE FEASIBILITY; COMPUTED-TOMOGRAPHY; THERAPY; GALACTOMANNAN; INFECTIONS	Background Invasive fungal disease (IFD) causes significant morbidity and mortality in hematologic malignancy patients with high-risk febrile neutropenia (FN). These patients therefore often receive empirical antifungal therapy. Diagnostic test-guided pre-emptive antifungal therapy has been evaluated as an alternative treatment strategy in these patients. Methods We conducted an electronic search for literature comparing empirical versus pre-emptive antifungal strategies in FN among adult hematologic malignancy patients. We systematically reviewed 9 studies, including randomized-controlled trials, cohort studies, and feasibility studies. Random and fixed-effect models were used to generate pooled relative risk estimates of IFD detection, IFD-related mortality, overall mortality, and rates and duration of antifungal therapy. Heterogeneity was measured via Cochran's Q test, I-2 statistic, and between study tau(2). Incorporating these parameters and direct costs of drugs and diagnostic testing, we constructed a comparative costing model for the two strategies. We conducted probabilistic sensitivity analysis on pooled estimates and one-way sensitivity analyses on other key parameters with uncertain estimates. Results Nine published studies met inclusion criteria. Compared to empirical antifungal therapy, pre-emptive strategies were associated with significantly lower antifungal exposure (RR 0.48, 95% CI 0.27-0.85) and duration without an increase in IFD-related mortality (RR 0.82, 95% CI 0.36-1.87) or overall mortality (RR 0.95, 95% CI 0.46-1.99). The pre-emptive strategy cost $324 less (95% credible interval -$291.88 to $418.65 pre-emptive compared to empirical) than the empirical approach per FN episode. However, the cost difference was influenced by relatively small changes in costs of antifungal therapy and diagnostic testing. Conclusions Compared to empirical antifungal therapy, pre-emptive antifungal therapy in patients with high-risk FN may decrease antifungal use without increasing mortality. We demonstrate a state of economic equipoise between empirical and diagnostic-directed pre-emptive antifungal treatment strategies, influenced by small changes in cost of antifungal therapy and diagnostic testing, in the current literature. This work emphasizes the need for optimization of existing fungal diagnostic strategies, development of more efficient diagnostic strategies, and less toxic and more cost-effective antifungals.	[Fung, Monica] Beth Israel Deaconess Med Ctr, Dept Internal Med, Boston, MA 02215 USA; [Fung, Monica; Marty, Francisco M.; Koo, Sophia] Harvard Univ, Sch Med, Boston, MA USA; [Kim, Jane] Harvard Univ, Dept Hlth Policy & Management, TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Marty, Francisco M.; Koo, Sophia] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Marty, Francisco M.; Koo, Sophia] Dana Farber Canc Inst, Boston, MA 02115 USA; [Schwarzinger, Michael] Translat Hlth Econ Network, Paris, France; [Schwarzinger, Michael] INSERM, Decis Sci Infect Dis Prevent Control & Care, IAME, Paris, France; [Schwarzinger, Michael] Univ Paris Diderot, IAME, Paris, France	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Fung, M (corresponding author), Beth Israel Deaconess Med Ctr, Dept Internal Med, Boston, MA 02215 USA.	mfung@bidmc.harvard.edu	Schwarzinger, Michael/F-7367-2011; Marty, Francisco M./H-7088-2019	Schwarzinger, Michael/0000-0002-0573-6856; Marty, Francisco M./0000-0002-3708-8734; Koo, Sophia/0000-0002-4973-7439	National Institute of Allergy and Infectious Diseases [K23 AI097225]; Translational Health Economics Network; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI097225] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Translational Health Economics Network; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Sophia Koo is supported by K23 AI097225 from the National Institute of Allergy and Infectious Diseases (http://www.niaid.nih.gov/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Michael Schwarzinger is employed by the company Translational Health Economics Network. This funder provided support in the form of salary for Dr. Schwarzinger, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the author contributions section.	Aguilar-Guisado M, 2010, BONE MARROW TRANSPL, V45, P159, DOI 10.1038/bmt.2009.125; Barnes R, 2015, CLIN THER, V37, P1317, DOI 10.1016/j.clinthera.2015.03.021; Blennow O, 2010, BONE MARROW TRANSPL, V45, P1710, DOI 10.1038/bmt.2010.38; Caillot D, 2001, J CLIN ONCOL, V19, P253, DOI 10.1200/JCO.2001.19.1.253; Caillot D, 1997, J CLIN ONCOL, V15, P139, DOI 10.1200/JCO.1997.15.1.139; Ceesay MM, 2015, J ANTIMICROB CHEMOTH, V70, P1175, DOI 10.1093/jac/dku506; Cordonnier C, 2013, CLIN MICROBIOL IN S6, P27; Cordonnier C, 2009, CLIN INFECT DIS, V48, P1042, DOI 10.1086/597395; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Donnelly JP, 2013, LANCET INFECT DIS, V13, P470, DOI [10.1016/S1473-3099(13)70112-9, 10.1016/s1473-3099(13)70112-9]; Drgona L, 2014, EUR J CLIN MICROBIOL, V33, P7, DOI 10.1007/s10096-013-1944-3; Freemantle N, 2011, J ANTIMICROB CHEMOTH, V66, pi25, DOI 10.1093/jac/dkq439; Freifeld AG, 2011, CLIN INFECT DIS, V52, P427, DOI 10.1093/cid/ciq147; Girmenia C, 2010, J CLIN ONCOL, V28, P667, DOI 10.1200/JCO.2009.21.8032; Hebart H, 2009, BONE MARROW TRANSPL, V43, P553, DOI 10.1038/bmt.2008.355; Herbrecht R, 2008, CLIN INFECT DIS, V46, P886, DOI 10.1086/527383; Kawazu M, 2004, J CLIN MICROBIOL, V42, P2733, DOI 10.1128/JCM.42.6.2733-2741.2004; Kontoyiannis DP, 2010, CLIN INFECT DIS, V50, P1091, DOI 10.1086/651263; Koo S, 2009, CLIN INFECT DIS, V49, P1650, DOI 10.1086/647942; Lamoth F, 2012, CLIN INFECT DIS, V54, P633, DOI 10.1093/cid/cir897; Maertens J, 2005, CLIN INFECT DIS, V41, P1242, DOI 10.1086/496927; Maertens J, 2001, BLOOD, V97, P1604, DOI 10.1182/blood.V97.6.1604; Aguado JM, 2015, CLIN INFECT DIS, V60, P405, DOI 10.1093/cid/ciu833; Marr KA, 2015, ANN INTERN MED, V162, P81, DOI 10.7326/M13-2508; Martin-Pena A, 2013, ANTIMICROB AGENTS CH, V57, P4664, DOI 10.1128/AAC.00723-13; Mengoli C, 2009, LANCET INFECT DIS, V9, P89, DOI 10.1016/S1473-3099(09)70019-2; Morrissey CO, 2013, LANCET INFECT DIS, V13, P519, DOI 10.1016/S1473-3099(13)70076-8; Nivoix Y, 2008, CLIN INFECT DIS, V47, P1176, DOI 10.1086/592255; Oshima K, 2007, J ANTIMICROB CHEMOTH, V60, P350, DOI 10.1093/jac/dkm217; Pagano L, 2011, HAEMATOL-HEMATOL J, V96, P1366, DOI 10.3324/haematol.2011.042598; Pfeiffer CD, 2006, CLIN INFECT DIS, V42, P1417, DOI 10.1086/503427; Segal BH, 2009, NEW ENGL J MED, V360, P1870, DOI 10.1056/NEJMra0808853; Slobbe L, 2008, CLIN INFECT DIS, V47, P1507, DOI 10.1086/591531; Tan BH, 2011, INT J INFECT DIS, V15, pE350, DOI 10.1016/j.ijid.2011.01.011; Truven Health Analytics, RED BOOK ONL PHARM F; VARTIVARIAN SE, 1993, CLIN INFECT DIS, V17, pS487, DOI 10.1093/clinids/17.Supplement_2.S487; Walsh TJ, 2008, CLIN INFECT DIS, V46, P327, DOI 10.1086/525258; White PL, 2010, J CLIN MICROBIOL, V48, P3753, DOI 10.1128/JCM.01466-10; Wingard JR, 2000, CLIN INFECT DIS, V31, P1155, DOI 10.1086/317451	39	32	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0140930	10.1371/journal.pone.0140930	http://dx.doi.org/10.1371/journal.pone.0140930			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26554923	Green Submitted, Green Published, gold			2022-12-27	WOS:000364430700018
J	Huang, YW; Zhang, H; Li, XD; Hu, SX; Cai, L; Sun, QL; Li, WC; Deng, ZH; Xiang, XY; Zhang, HJ; Li, FC; Gao, LD				Huang, Yiwei; Zhang, Hong; Li, Xiaodan; Hu, Shixiong; Cai, Liang; Sun, Qianlai; Li, Wenchao; Deng, Zhihong; Xiang, Xingyu; Zhang, Hengjiao; Li, Fangcai; Gao, Lidong			Detection and Genetic Characteristics of H9N2 Avian Influenza Viruses from Live Poultry Markets in Hunan Province, China	PLOS ONE			English	Article							HUMAN INFECTION; A VIRUSES; INTERNAL GENES; BIRD MARKETS; H5N1; H7N9; TRANSMISSION; REPLICATION; EVOLUTION; CHICKENS	H9N2 avian influenza viruses (AIVs) are highly prevalent and of low pathogenicity in domestic poultry. These viruses show a high genetic compatibility with other subtypes of AIVs and have been involved in the genesis of H5N1, H7N9 and H10N8 viruses causing severe infection in humans. The first case of human infection with H9N2 viruses in Hunan province of China have been confirmed in November 2013 and identified that H9N2 viruses from live poultry markets (LPMs) near the patient's house could be the source of infection. However, the prevalence, distribution and genetic characteristics of H9N2 viruses in LPMs all over the province are not clear. We collected and tested 3943 environmental samples from 380 LPMs covering all 122 counties/districts of Hunan province from February to April, 2014. A total of 618 (15.7%) samples were H9 subtype positive and 200 (52.6%) markets in 98 (80.3%) counties/districts were contaminated with H9 subtype AIVs. We sequenced the entire coding sequences of the genomes of eleven H9N2 isolates from environmental samples. Phylogenetic analysis showed that the gene sequences of the H9N2 AIVs exhibited high homology (94.3%-100%). All eleven viruses were in a same branch in the phylogenetic trees and belonged to a same genotype. No gene reassortment had been found. Molecular analysis demonstrated that all the viruses had typical molecular characteristics of contemporary avian H9N2 influenza viruses. Continued surveillance of AIVs in LPMs is warranted for identification of further viral evolution and novel reassortants with pandemic potential.	[Huang, Yiwei; Zhang, Hong; Hu, Shixiong; Cai, Liang; Sun, Qianlai; Li, Wenchao; Deng, Zhihong; Xiang, Xingyu; Zhang, Hengjiao; Li, Fangcai; Gao, Lidong] Hunan Prov Ctr Dis Control & Prevent, Changsha, Hunan, Peoples R China; [Li, Xiaodan] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Gao, LD (corresponding author), Hunan Prov Ctr Dis Control & Prevent, Changsha, Hunan, Peoples R China.	810173358@qq.com			Hunan Provincial Health and Family Planning Commission, China [C2015-63]; National Science and Technology Key Project of China [2013ZX10004-202]	Hunan Provincial Health and Family Planning Commission, China; National Science and Technology Key Project of China	This work was supported by the grant from Hunan Provincial Health and Family Planning Commission, China (C2015-63), and by the National Science and Technology Key Project of China (2013ZX10004-202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DJ, 2007, VACCINE, V25, P5637, DOI 10.1016/j.vaccine.2006.10.051; BEAN WJ, 1989, J INFECT DIS, V159, P1050, DOI 10.1093/infdis/159.6.1050; Butt KM, 2005, J CLIN MICROBIOL, V43, P5760, DOI 10.1128/JCM.43.11.5760-5767.2005; Chen HY, 2014, LANCET, V383, P714, DOI 10.1016/S0140-6736(14)60111-2; Chen ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107266; Deng GH, 2013, J VIROL, V87, P9452, DOI 10.1128/JVI.00776-13; Dong GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017212; Fournie G, 2011, J R SOC INTERFACE, V8, P1079, DOI 10.1098/rsif.2010.0510; Fusaro A, 2011, J VIROL, V85, P8413, DOI 10.1128/JVI.00219-11; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Gu M, 2014, VET MICROBIOL, V174, P309, DOI 10.1016/j.vetmic.2014.09.029; Guan Y, 1999, P NATL ACAD SCI USA, V96, P9363, DOI 10.1073/pnas.96.16.9363; Guo YJ, 2000, VIROLOGY, V267, P279, DOI 10.1006/viro.1999.0115; Huang Yi-wei, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P709; Huang YW, 2015, J MED VIROL, V87, P1641, DOI 10.1002/jmv.24231; Hurt AC, 2009, DRUGS, V69, P2523, DOI 10.2165/11531450-000000000-00000; Indriani R, 2010, EMERG INFECT DIS, V16, P1889, DOI 10.3201/eid1612.100402; Kang M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126335; Ke CW, 2014, EMERG INFECT DIS, V20, P2034, DOI 10.3201/eid2012.140765; Lam TTY, 2013, NATURE, V502, P241, DOI 10.1038/nature12515; Li Q, 2014, NEW ENGL J MED, V370, P520, DOI 10.1056/NEJMoa1304617; Lin YP, 2000, P NATL ACAD SCI USA, V97, P9654, DOI 10.1073/pnas.160270697; Massin P, 2001, J VIROL, V75, P5398, DOI 10.1128/JVI.75.11.5398-5404.2001; Matrosovich M, 1999, J VIROL, V73, P1146, DOI 10.1128/JVI.73.2.1146-1155.1999; Matrosovich MN, 1997, VIROLOGY, V233, P224, DOI 10.1006/viro.1997.8580; Matrosovich MN, 2001, VIROLOGY, V281, P156, DOI 10.1006/viro.2000.0799; Ni XS, 2015, MICROBES INFECT, V17, P48, DOI 10.1016/j.micinf.2014.09.007; Nili H, 2002, AVIAN PATHOL, V31, P247, DOI 10.1080/03079450220136567; Peiris JSM, 2001, J VIROL, V75, P9679, DOI 10.1128/JVI.75.20.9679-9686.2001; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Ping JH, 2010, J VIROL, V84, P10606, DOI 10.1128/JVI.01187-10; Pu J, 2015, P NATL ACAD SCI USA, V112, P548, DOI 10.1073/pnas.1422456112; Tian J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038233; To KKW, 2013, LANCET INFECT DIS, V13, P809, DOI 10.1016/S1473-3099(13)70167-1; Wan HQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002923; Wang B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101287; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; World Health Organization (WHO), WHO INF MOL DIAGN IN; Yu HJ, 2006, LANCET, V367, P84, DOI 10.1016/S0140-6736(05)67894-4; Yu HJ, 2014, LANCET, V383, P541, DOI 10.1016/S0140-6736(13)61904-2; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9; Zhang PH, 2009, J VIROL, V83, P8428, DOI 10.1128/JVI.00659-09; Zhu Y, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-77	43	9	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142584	10.1371/journal.pone.0142584	http://dx.doi.org/10.1371/journal.pone.0142584			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26554921	gold, Green Submitted, Green Published			2022-12-27	WOS:000364430700138
J	Zhang, YD; Peng, WS; Ao, X; Dai, HY; Yuan, L; Huang, XZ; Zhou, QL				Zhang, Yide; Peng, Weisheng; Ao, Xiang; Dai, Houyong; Yuan, Li; Huang, Xinzhong; Zhou, Qiaoling			TAK-242, a Toll-Like Receptor 4 Antagonist, Protects against Aldosterone-Induced Cardiac and Renal Injury	PLoS One			English	Article							SPONTANEOUSLY HYPERTENSIVE-RATS; ACUTE KIDNEY INJURY; DIABETIC-NEPHROPATHY; BLOOD-PRESSURE; INFLAMMATION; FIBROSIS; DAMAGE; TLR4; EPLERENONE; EXPRESSION	Cardiovascular and renal inflammation induced by Aldosterone (Aldo) plays an important role in the pathogenesis of hypertension and renal fibrosis. Toll-like receptor 4 (TLR4) signaling contributes to inflammatory cardiovascular and renal diseases, but its role in Aldo-induced hypertension and renal damage is not clear. In the current study, rats were treated with Aldo-salt combined with TAK-242 (a TLR4 signaling antagonist) for 4 weeks. Hemodynamic, cardiac and renal parameters were assayed at the indicated time. We found that Aldosalt-treated rats present cardiac and renal hypertrophy and dysfunction. Cardiac and renal expression levels of TLR4 as well as levels of molecular markers attesting inflammation and fibrosis are increased by Aldo infusion, whereas the treatment of TAK-242 reverses these alterations. TAK-242 suppresses cardiac and renal inflammatory cytokines levels (TNF-a, IL-1 beta and MCP-1). Furthermore, TAK-242 inhibits hypertension, cardiac and renal fibrosis, and also attenuates the Aldo-induced Epithelial-Mesenchymal Transition (EMT). In experimental hyperaldosteronism, upregulation of TLR4 is correlated with cardiac and renal fibrosis and dysfunction, and a TLR4 signaling antagonist, TAK-242, can reverse these alterations. TAK-242 may be a therapeutic option for salt-sensitive hypertension and renal fibrosis.	[Zhang, Yide; Dai, Houyong; Yuan, Li; Huang, Xinzhong] Nantong Univ, Dept Nephrol, Affiliated Hosp, Nantong, Jiangsu, Peoples R China; [Peng, Weisheng; Ao, Xiang; Zhou, Qiaoling] Cent S Univ, Affiliated Xiangya Hosp, Dept Nephrol, Changsha, Hunan, Peoples R China	Nantong University; Central South University	Zhou, QL (corresponding author), Cent S Univ, Affiliated Xiangya Hosp, Dept Nephrol, Changsha, Hunan, Peoples R China.	zqling8315@163.com						Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Beg AA, 2002, TRENDS IMMUNOL, V23, P509, DOI 10.1016/S1471-4906(02)02317-7; Briet M, 2010, NAT REV NEPHROL, V6, P261, DOI 10.1038/nrneph.2010.30; Brown NJ, 2013, NAT REV NEPHROL, V9, P459, DOI 10.1038/nrneph.2013.110; Brown NJ, 2000, KIDNEY INT, V58, P1219, DOI 10.1046/j.1523-1755.2000.00277.x; Clemitson JR, 2002, HYPERTENSION, V40, P292, DOI 10.1161/01.HYP.0000029106.10586.4C; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Dange RB, 2014, CARDIOVASC RES, V103, P17, DOI 10.1093/cvr/cvu067; de las Hera N, 2007, J HYPERTENS, V25, P629, DOI 10.1097/HJH.0b013e3280112ce5; Devaraj S, 2011, ARTERIOSCL THROM VAS, V31, P1796, DOI 10.1161/ATVBAHA.111.228924; Devaraj S, 2011, METABOLISM, V60, P256, DOI 10.1016/j.metabol.2010.01.005; Doi T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093513; Echem C, 2015, INT J CARDIOL, V187, P243, DOI 10.1016/j.ijcard.2015.03.190; Eissler R, 2011, HYPERTENS RES, V34, P551, DOI 10.1038/hr.2010.270; Elmarakby AA, 2007, HYPERTENSION, V50, P1069, DOI 10.1161/HYPERTENSIONAHA.107.098806; Frangogiannis NG, 2014, NAT REV CARDIOL, V11, P255, DOI 10.1038/nrcardio.2014.28; Garate I, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-8; Ha TZ, 2005, CARDIOVASC RES, V68, P224, DOI 10.1016/j.cardiores.2005.05.025; Hernanz R., 2015, BR J PHARM; Irita J, 2011, AM J PHYSIOL-RENAL, V301, pF833, DOI 10.1152/ajprenal.00557.2010; Jenke A, 2013, CARDIOVASC RES, V99, P422, DOI 10.1093/cvr/cvt118; Jia LN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117757; Jialal I, 2014, J DIABETES COMPLICAT, V28, P755, DOI 10.1016/j.jdiacomp.2014.07.003; Kapinas K, 2010, J BIOL CHEM, V285, P25221, DOI 10.1074/jbc.M110.116137; Lee SB, 2010, KIDNEY INT, V78, pS22, DOI 10.1038/ki.2010.418; Li JJ, 2005, MED HYPOTHESES, V64, P925, DOI 10.1016/j.mehy.2004.10.016; Masola V, 2012, J BIOL CHEM, V287, P1478, DOI 10.1074/jbc.M111.279836; Matsuda S, 2015, J ATHEROSCLER THROMB; Meng XM, 2014, NAT REV NEPHROL, V10, P493, DOI 10.1038/nrneph.2014.114; Moreth K, 2014, MATRIX BIOL, V35, P143, DOI 10.1016/j.matbio.2014.01.010; Parissis JT, 2002, INT J CARDIOL, V83, P13, DOI 10.1016/S0167-5273(02)00021-9; Paulus P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094366; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Rafiq K, 2011, J PHARMACOL SCI, V115, P1, DOI 10.1254/jphs.10R07CR; Savoia C, 2006, CURR OPIN NEPHROL HY, V15, P152, DOI 10.1097/01.mnh.0000203189.57513.76; Sha T, 2007, EUR J PHARMACOL, V571, P231, DOI 10.1016/j.ejphar.2007.06.027; Sha T, 2011, SHOCK, V35, P205, DOI 10.1097/SHK.0b013e3181f48942; Shah N, 2013, LIVER INT, V33, P398, DOI 10.1111/liv.12047; Shirali AC, 2008, J AM SOC NEPHROL, V19, P1444, DOI 10.1681/ASN.2008010123; Stribos EGD, 2015, MOL IMMUNOL, V64, P82, DOI 10.1016/j.molimm.2014.11.003; Summers SA, 2010, AM J PATHOL, V177, P2234, DOI 10.2353/ajpath.2010.100153; Sun CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034026; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Tang SCW, 2015, J RENAL NUTR, V25, P230, DOI 10.1053/j.jrn.2014.10.020; White WB, 2003, HYPERTENSION, V41, P1021, DOI 10.1161/01.HYP.0000067463.13172.EA; Williams GH, 2004, AM J CARDIOL, V93, P990, DOI 10.1016/j.amjcard.2004.01.007; Yao LL, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-23; Zhang YD, 2013, CLIN NEPHROL, V80, P249, DOI 10.5414/CN107875	48	39	44	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142456	10.1371/journal.pone.0142456	http://dx.doi.org/10.1371/journal.pone.0142456			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556241	Green Submitted, gold, Green Published			2022-12-27	WOS:000364430700109
J	Brownley, RC; Agarwal, S; Loder, S; Eboda, O; Li, J; Peterson, J; Hwang, C; Breuler, C; Kaartinen, V; Zhou, B; Mishina, Y; Levi, B				Brownley, R. Cameron; Agarwal, Shailesh; Loder, Shawn; Eboda, Oluwatobi; Li, John; Peterson, Joshua; Hwang, Charles; Breuler, Christopher; Kaartinen, Vesa; Zhou, Bin; Mishina, Yuji; Levi, Benjamin			Characterization of Heterotopic Ossification Using Radiographic Imaging: Evidence for a Paradigm Shift	PLOS ONE			English	Article							BONE-FORMATION; CARTILAGE; MRI; INHIBITION; PREVENTION; MICROCT; RODENTS; INJURY; MOUSE; MODEL	Heterotopic ossification (HO) is the growth of extra- skeletal bone which occurs following trauma, burns, and in patients with genetic bone morphogenetic protein (BMP) receptor mutations. The clinical and laboratory evaluation of HO is dependent on radiographic imaging to identify and characterize these lesions. Here we show that despite its inadequacies, plain film radiography and single modality microCT continue to serve as a primary method of HO imaging in nearly 30% of published in vivo literature. Furthermore, we demonstrate that detailed microCT analysis is superior to plain film and single modality microCT radiography specifically in the evaluation of HO formed through three representative models due to its ability to 1) define structural relationships between growing extra- skeletal bone and normal, anatomic bone, 2) provide accurate quantification and growth rate based on volume of the space- occupying lesion, thereby facilitating assessments of therapeutic intervention, 3) identify HO at earlier times allowing for evaluation of early intervention, and 4) characterization of metrics of bone physiology including porosity, tissue mineral density, and cortical and trabecular volume. Examination of our trauma model using microCT demonstrated two separate areas of HO based on anatomic location and relationship with surrounding, normal bone structures. Additionally, microCT allows HO growth rate to be evaluated to characterize HO progression. Taken together, these data demonstrate the need for a paradigm shift in the evaluation of HO towards microCT as a standard tool for imaging.	[Brownley, R. Cameron; Agarwal, Shailesh; Loder, Shawn; Eboda, Oluwatobi; Li, John; Peterson, Joshua; Hwang, Charles; Breuler, Christopher; Levi, Benjamin] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Kaartinen, Vesa; Mishina, Yuji] Univ Michigan, Sch Dent, Ann Arbor, MI 48109 USA; [Zhou, Bin] Albert Einstein Coll Med, New York, NY USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Yeshiva University	Levi, B (corresponding author), Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA.	blevi@umich.edu	Kaartinen, Vesa/AAU-5396-2021		NIH/NIGMS [K08GM109105-0]; Plastic Surgery Foundation National Endowment Award; Association for Academic Surgery Roslyn Award; Research & Education Foundation Scholarship; American Association for the Surgery of Trauma Research & Education Foundation Scholarship [DOD: W81XWH-14- DMRDP-CRMRP- NMSIRA]; American Association of Plastic Surgery Research Fellowship; Coller Society Research Fellowship; NIH F32 Fellowship; Plastic Surgery Foundation; Howard Hughes Medical Institute (HHMI) Medical Fellows Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T35HL007690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K08GM109105] Funding Source: NIH RePORTER	NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Plastic Surgery Foundation National Endowment Award; Association for Academic Surgery Roslyn Award; Research & Education Foundation Scholarship; American Association for the Surgery of Trauma Research & Education Foundation Scholarship; American Association of Plastic Surgery Research Fellowship; Coller Society Research Fellowship; NIH F32 Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Plastic Surgery Foundation; Howard Hughes Medical Institute (HHMI) Medical Fellows Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	B.L. received funding from NIH/NIGMS -K08GM109105-0, Plastic Surgery Foundation National Endowment Award, the Association for Academic Surgery Roslyn Award, the Research & Education Foundation Scholarship, American Association for the Surgery of Trauma Research & Education Foundation Scholarship, DOD: W81XWH-14- DMRDP-CRMRP- NMSIRA, and American Association of Plastic Surgery Research Fellowship. S.A. was supported by the Coller Society Research Fellowship, NIH F32 Fellowship, and Plastic Surgery Foundation. S.L. was supported by the Howard Hughes Medical Institute (HHMI) Medical Fellows Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2015, DEV BIOL, V400, P202, DOI 10.1016/j.ydbio.2015.02.011; Baiker M, 2012, MOL IMAGING BIOL, V14, P420, DOI 10.1007/s11307-011-0522-2; Banovac K, 2001, SPINAL CORD, V39, P370, DOI 10.1038/sj.sc.3101166; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Buie HR, 2013, MED ENG PHYS, V35, P1645, DOI 10.1016/j.medengphy.2013.05.016; Cipriano C, 2009, ORTHOPEDICS, P32; Demontiero O, 2011, EXP GERONTOL, V46, P435, DOI 10.1016/j.exger.2011.01.001; Dijkstra AJ, 2010, CARTILAGE, V1, P328, DOI 10.1177/1947603510376819; Foldager CB, 2009, ACTA ORTHOP, V80, P737, DOI 10.3109/17453670903487040; Fransen M, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001160.PUB2; Fukuda T, 2009, J BIOL CHEM, V284, P7149, DOI 10.1074/jbc.M801681200; Imhof H, 2002, EUR RADIOL, V12, P2781, DOI 10.1007/s00330-001-1301-2; Lin L, 2010, BONE, V46, P425, DOI 10.1016/j.bone.2009.08.057; Mackie EJ, 2008, INT J BIOCHEM CELL B, V40, P46, DOI 10.1016/j.biocel.2007.06.009; Nishiyama KK, 2010, BONE, V46, P155, DOI 10.1016/j.bone.2009.09.023; Okagbare PI, 2012, ANALYST, V137, P77, DOI 10.1039/c1an15847c; Pavey GJ, 2015, CLIN ORTHOP RELAT R, V473, P2814, DOI 10.1007/s11999-015-4266-1; Peterson JR, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008810; Peterson JR, 2014, ANN SURG, V259, P993, DOI 10.1097/SLA.0b013e318291da85; Peterson JR, 2013, BONE, V54, P28, DOI 10.1016/j.bone.2013.01.002; Raghavan M, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3426310; Shimono K, 2011, NAT MED, V17, P454, DOI 10.1038/nm.2334; Shore EM, 2006, NAT GENET, V38, P525, DOI 10.1038/ng1783; Taha MA, 2013, J MAGN RESON IMAGING, V38, P231, DOI 10.1002/jmri.23876; Taiani JT, 2014, BONE, V64, P263, DOI 10.1016/j.bone.2014.04.019; Teo JCM, 2007, MAT SCI ENG C-BIO S, V27, P333, DOI 10.1016/j.msec.2006.05.003; THOMAS BJ, 1985, J BONE JOINT SURG AM, V67A, P400, DOI 10.2106/00004623-198567030-00008; van Kuijk AA, 2002, SPINAL CORD, V40, P313, DOI 10.1038/sj.sc.3101309; Yu PB, 2008, NAT MED, V14, P1363, DOI 10.1038/nm.1888	29	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141432	10.1371/journal.pone.0141432	http://dx.doi.org/10.1371/journal.pone.0141432			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544555	Green Published, gold, Green Submitted			2022-12-27	WOS:000364398700023
J	Goodbody-Gringley, G; Marchini, C; Chequer, AD; Goffredo, S				Goodbody-Gringley, Gretchen; Marchini, Chiara; Chequer, Alex D.; Goffredo, Stefano			Population Structure of Montastraea cavernosa on Shallow versus Mesophotic Reefs in Bermuda	PLOS ONE			English	Article							BUILDING CORALS; PARTIAL MORTALITY; SCLERACTINIAN CORALS; AGARICIA-AGARICITES; CLIMATE-CHANGE; GROWTH; DEPTH; DEEP; DISTRIBUTIONS; RESPIRATION	Mesophotic coral reef ecosystems remain largely unexplored with only limited information available on taxonomic composition, abundance and distribution. Yet, mesophotic reefs may serve as potential refugia for shallow-water species and thus understanding biodiversity, ecology and connectivity of deep reef communities is integral for resource management and conservation. The Caribbean coral, Montastraea cavernosa, is considered a depth generalist and is commonly found at mesophotic depths. We surveyed abundance and size-frequency of M. cavernosa populations at six shallow (10m) and six upper mesophotic (45m) sites in Bermuda and found population structure was depth dependent. The mean surface area of colonies at mesophotic sites was significantly smaller than at shallow sites, suggesting that growth rates and maximum colony surface area are limited on mesophotic reefs. Colony density was significantly higher at mesophotic sites, however, resulting in equal contributions to overall percent cover. Size-frequency distributions between shallow and mesophotic sites were also significantly different with populations at mesophotic reefs skewed towards smaller individuals. Overall, the results of this study provide valuable baseline data on population structure, which indicate that the mesophotic reefs of Bermuda support an established population of M. cavernosa.	[Goodbody-Gringley, Gretchen] Bermuda Inst Ocean Sci, St Georges GE 01, Bermuda; [Marchini, Chiara; Goffredo, Stefano] Univ Bologna, Marine Sci Grp, Dept Biol Geol & Environm Sci, I-40126 Bologna, Italy; [Chequer, Alex D.] Ocean Support Fdn, Hamilton HM 11, Bermuda	Bermuda Institute of Ocean Sciences; University of Bologna	Goodbody-Gringley, G (corresponding author), Bermuda Inst Ocean Sci, 17 Biol Lane, St Georges GE 01, Bermuda.	gretchen.ggringley@bios.edu		goffredo, stefano/0000-0002-5022-9503	BIOS; Marco Polo Award from UNIBO; Ocean Support Foundation	BIOS; Marco Polo Award from UNIBO; Ocean Support Foundation	Funding for this work was provided by a Grant-in-Aid from BIOS and a Marco Polo Award from UNIBO to support C. Marchini. In-kind support was also provided by the Ocean Support Foundation to cover technical diving costs and boat fees.	Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anthony KRN, 2003, FUNCT ECOL, V17, P246, DOI 10.1046/j.1365-2435.2003.00731.x; AVERY WE, 1997, P 8 INT COR REEF S, V2, P1179; Bak R.P.M., 1976, Netherlands J Sea Res, V10, P285, DOI 10.1016/0077-7579(76)90009-0; Bak RP, 2005, CORAL REEFS, V24, P475, DOI 10.1007/s00338-005-0009-1; Bak RPM, 1998, MAR ECOL PROG SER, V162, P301, DOI 10.3354/meps162301; Barnes D.J., 1990, P109; BENDEL RB, 1989, OECOLOGIA, V78, P394, DOI 10.1007/BF00379115; Bongaerts P, 2011, CORAL REEFS, V30, P335, DOI 10.1007/s00338-011-0725-7; Bongaerts P, 2010, CORAL REEFS, V29, P309, DOI 10.1007/s00338-009-0581-x; Bongaerts P, 2015, SCI REP-UK, V5, DOI 10.1038/srep07652; Bongaerts P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010871; Brazeau DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065845; Caroselli E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037848; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Chadwick-Furman NE, 2000, J EXP MAR BIOL ECOL, V249, P199, DOI 10.1016/S0022-0981(00)00204-5; Clarke GL, 1936, RAPP P V REUN CONS I, V101, P3; Crabbe MJC, 2009, MAR ENVIRON RES, V67, P189, DOI 10.1016/j.marenvres.2009.01.003; DAVIES PS, 1980, BIOL BULL, V158, P187, DOI 10.2307/1540930; Donner SD, 2005, GLOBAL CHANGE BIOL, V11, P2251, DOI 10.1111/j.1365-2486.2005.01073.x; Falkowski P.G., 1990, P89; FRICKE H, 1985, MAR BIOL, V88, P175, DOI 10.1007/BF00397165; FRICKE HW, 1987, OECOLOGIA, V73, P371, DOI 10.1007/BF00385253; Grigg RW, 2006, CORAL REEFS, V25, P77, DOI 10.1007/s00338-005-0073-6; Hinderstein LM, 2010, CORAL REEFS, V29, P247, DOI 10.1007/s00338-010-0614-5; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; HUGHES TP, 1985, ECOL MONOGR, V55, P141, DOI 10.2307/1942555; HUGHES TP, 1980, SCIENCE, V209, P713, DOI 10.1126/science.209.4457.713; HUSTON MA, 1985, ANNU REV ECOL SYST, V16, P149, DOI 10.1146/annurev.es.16.110185.001053; Jackson J, 2014, STATUS TRENDS CARIBB, DOI DOI 10.1111/1365-2664.12388; Kahng SE, 2010, CORAL REEFS, V29, P255, DOI 10.1007/s00338-010-0593-6; Kahng SE, 2006, CORAL REEFS, V25, P254, DOI 10.1007/s00338-006-0098-5; Kahng SE, 2014, J EXP MAR BIOL ECOL, V7, P71; KOBLUK DR, 1994, B MAR SCI, V54, P142; LASKER HR, 1981, BIOL BULL, V160, P292, DOI 10.2307/1540889; Lesser MP, 2011, BIOL INVASIONS, V13, P1855, DOI 10.1007/s10530-011-0005-z; Lesser MP, 2010, ECOLOGY, V91, P990, DOI 10.1890/09-0313.1; Lesser MP, 2009, J EXP MAR BIOL ECOL, V375, P1, DOI 10.1016/j.jembe.2009.05.009; Liddell W. D, 2000, P 10 INT COR REEF S, V1, P437; Lirman D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023047; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; MARAGOS JE, 1986, CORAL REEFS, V4, P141, DOI 10.1007/BF00427935; McClanahan TR, 2008, MAR BIOL, V153, P755, DOI 10.1007/s00227-007-0844-4; Meesters EH, 2001, MAR ECOL PROG SER, V209, P43, DOI 10.3354/meps209043; Meesters EH, 1997, J SEA RES, V37, P131, DOI 10.1016/S1385-1101(96)00004-4; Meesters EH, 1996, B MAR SCI, V58, P838; Menza C, 2007, CONT SHELF RES, V27, P2224, DOI 10.1016/j.csr.2007.05.017; Menza C, 2008, REV BIOL TROP, V56, P11; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Reed JK, 1985, P 5 INT COR REEF S, V6, P249; Riegl B, 2003, INT J EARTH SCI, V92, P520, DOI 10.1007/s00531-003-0328-9; Serrano X, 2014, MOL ECOL, V23, P4226, DOI 10.1111/mec.12861; SHAPIRO SS, 1972, J AM STAT ASSOC, V67, P215, DOI 10.2307/2284728; Sokal R. R, 1981, BIOMETRY; Sokal RR, 1994, BIOMETRY PRINCIPLES, V3rd; SZMANT AM, 1986, CORAL REEFS, V5, P43, DOI 10.1007/BF00302170; VANMOORSEL GWNM, 1985, MAR ECOL PROG SER, V24, P99, DOI 10.3354/meps024099; vanWoesik R, 1997, CORAL REEFS, V16, P103, DOI 10.1007/s003380050064; Venn AA, 2009, CORAL REEFS, V28, P135, DOI 10.1007/s00338-008-0435-y; Veron J.E.N., 2000, CORALS WORLD, V1-3; White KN, 2013, PEERJ, V1, DOI 10.7717/peerj.151; Wilkinson CR, 2003, P 7 INT COR REEF S G, V1, P11	63	20	20	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142427	10.1371/journal.pone.0142427	http://dx.doi.org/10.1371/journal.pone.0142427			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544963	Green Published, Green Submitted, gold			2022-12-27	WOS:000364398700138
J	Letouzey, V; Bastide, S; Ulrich, D; Beccera, L; Lomma, M; de Tayrac, R; Lavigne, JP				Letouzey, Vincent; Bastide, Sophie; Ulrich, Daniela; Beccera, Laurie; Lomma, Mariella; de Tayrac, Renaud; Lavigne, Jean Philippe			Impact of Bacterial Vaginosis on Perineal Tears during Delivery: A Prospective Cohort Study	PLOS ONE			English	Article							RISK-FACTORS; INFECTION; TRAUMA	Objective Long term effects of perineal tears pose a major worldwide health issue for women during delivery. Since bacterial vaginosis is related to major obstacles in obstetrics the aim of this study was to determine the relationship between bacterial vaginosis and the occurrence of perineal tears during vaginal delivery. Methods Between June 2013 and December 2013 pregnant women delivering after 37 weeks were recruited at one University hospital / tertiary care referral center in the course of this single-center, prospective cohort study. Bacterial vaginosis was assessed according to Nugent score method. Logistic-regression model was used to estimate odds ratios, adjusted for other risk factors to test the relationship between bacterial vaginosis and the occurrence of 1st to 4th degree perineal tears in women undergoing vaginal delivery. Results A total of 728 woman were included, 662 analyzed with a complete Nugent Score of the vaginal swab. The prevalence of 1st to 4th degree perineal tears was 35.8%(95% Confidence Interval (95% CI) = [32.2; 39.6]). The presence of BV was not significantly associated to the incidence of perineal tears neither in the univariate analysis (crude Odds Ratio = 1.43; 95% CI = [0.79; 2.60]; p = 0.235) nor in the multivariate analysis (adjusted Odds Ratio = 1.65; 95% CI = [0.81; 3.36]; p = 0.167). Instrumental delivery was the most important risk factor for perineal lacerations. Conclusions There is no evidence that vaginosis is a risk factor for vaginal tears.	[Letouzey, Vincent; Ulrich, Daniela; Beccera, Laurie; de Tayrac, Renaud] Univ Nimes Hosp, Dept Obstet & Gynaecol, F-30006 Nimes, France; [Bastide, Sophie; Lomma, Mariella] Univ Nimes Hosp, Dept Biostat Epidemiol Publ Hlth & Bioinformat, F-30006 Nimes, France; [Bastide, Sophie] Univ Montpellier I, EA2415, Montpellier, France; [Lavigne, Jean Philippe] Univ Nimes Hosp, Dept Microbiol, F-30006 Nimes, France; [Lavigne, Jean Philippe] Univ Montpellier, Natl Inst Hlth & Med Res, U1047, Nimes, France	Universite de Montpellier; CHU de Nimes; Universite de Montpellier; CHU de Nimes; Universite de Montpellier; Universite de Montpellier; CHU de Nimes; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Ulrich, D (corresponding author), Univ Nimes Hosp, Dept Obstet & Gynaecol, F-30006 Nimes, France.	daniela.ulrich@medunigraz.at	Gold, Daniela/ABE-4818-2020; Lavigne, Jean-Philippe/E-1756-2014	Gold, Daniela/0000-0002-7196-454X; Lavigne, Jean-Philippe/0000-0002-9484-0304				American College of Obstetricians-Gynecologists, 2006, OBSTET GYNECOL, V107, P956; Bretelle F, 2015, CLIN INFECT DIS, V60, P860, DOI 10.1093/cid/ciu966; Evers EC, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.06.055; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; GRAVETT MG, 1986, JAMA-J AM MED ASSOC, V256, P1899; Gurol-Urganci I, 2013, BJOG-INT J OBSTET GY, V120, P1516, DOI 10.1111/1471-0528.12363; Hauck YL, 2015, WOMEN BIRTH, V28, P16, DOI 10.1016/j.wombi.2014.10.007; Hillier SL, 1995, NEW ENGL J MED, V333, P1737, DOI 10.1056/NEJM199512283332604; MARTIUS J, 1990, ARCH GYNECOL OBSTET, V247, P1, DOI 10.1007/BF02390649; Menard JP, 2010, OBSTET GYNECOL, V115, P134, DOI 10.1097/AOG.0b013e3181c391d7; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Pergialiotis V, 2014, INT J GYNECOL OBSTET, V125, P6, DOI 10.1016/j.ijgo.2013.09.034; Priestley CJF, 1997, GENITOURIN MED, V73, P23; Samarasekera DN, 2008, COLORECTAL DIS, V10, P793, DOI 10.1111/j.1463-1318.2007.01445.x; Sharma H, 2014, SEMIN REPROD MED, V32, P43, DOI 10.1055/s-0033-1361822; Smith LA, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-59; SPIEGEL CA, 1991, CLIN MICROBIOL REV, V4, P485, DOI 10.1128/CMR.4.4.485-502.1991; Witkin SS, 2015, BJOG-INT J OBSTET GY, V122, P213, DOI 10.1111/1471-0528.13115; Witkin SS, 2007, BEST PRACT RES CL OB, V21, P347, DOI 10.1016/j.bpobgyn.2006.12.004	19	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0139334	10.1371/journal.pone.0139334	http://dx.doi.org/10.1371/journal.pone.0139334			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544959	Green Published, gold, Green Submitted			2022-12-27	WOS:000364398700002
J	Perkins, BA; Cherney, DZI; Soleymanlou, N; Lee, JA; Partridge, H; Tschirhart, H; Zinman, B; Mazze, R; Fagan, N; Kaspers, S; Woerle, HJ; Broedl, UC; Johansen, OE				Perkins, Bruce A.; Cherney, David Z. I.; Soleymanlou, Nima; Lee, Justin A.; Partridge, Helen; Tschirhart, Holly; Zinman, Bernard; Mazze, Roger; Fagan, Nora; Kaspers, Stefan; Woerle, Hans-Juergen; Broedl, Uli C.; Johansen, Odd Erik			Diurnal Glycemic Patterns during an 8-Week Open-Label Proof-of-Concept Trial of Empagliflozin in Type 1 Diabetes	PLOS ONE			English	Article							COTRANSPORTER 2 INHIBITION; SGLT2 INHIBITOR; DOUBLE-BLIND; ADD-ON; GLUCOSE; DAPAGLIFLOZIN; METFORMIN; INSULIN; CANAGLIFLOZIN; IPRAGLIFLOZIN	Background We recently reported improved glycemic control with reduced insulin dose in subjects with type 1 diabetes treated with the sodium glucose co-transporter-2 inhibitor empagliflozin. To further characterize the effects, we analyzed diurnal glycemic patterns by continuous glucose monitoring (CGM). Methods In an 8-week single-arm open-label pilot study of empagliflozin, we compared ambulatory glucose profiles produced from CGM data during 2-week intervals in a placebo run-in baseline period, end-of-treatment, and post-treatment. Change in glycemic exposure was evaluated by area under the median curve according to time of day (AUC(TOTAL) 12:00am-11:55pm; AUC(DAY) 7:05am-10:55pm, AUC(NIGHT) 11:00pm-7:00am), as well as glycemic variability, glycemic stability and time-in-target (>= 70 to <= 140mg/dL). Results The 40 patients (26 on insulin pump) were aged 24 +/- 5 years and BMI 24.5 +/- 3.2 kg/m(2). Consistent with the observed HbA1c decrease (8.0 +/- 0.9% to 7.6 +/- 0.9%, p<0.0001), normalized AUC(TOTAL) CGM decreased from 153.7 +/- 25.4 to 149.0 +/- 30.2mg/dL.h at end-of-treatment (p = 0.31), and significantly increased post-treatment (164.1 +/- 29.5mg/dL.h, p = 0.02). The numerical decrease in normalized AUC(NIGHT) (152.0 +/- 36.6 to 141.9 +/- 34.4mg/dL.h, p = 0.13) exceeded AUC(DAY) (154.5 +/- 24.5 to 152.6 +/- 30.4mg/dL.h, p = 0.65). Trends toward lower glycemic variability (83.1 +/- 18.9 to 75.6 +/- 28.6mg/dL, p = 0.06) and little change in glycemic stability (10.8 +/- 3.6 to 10.3 +/- 4.5mg/dL/h, p = 0.51) were observed. When empagliflozin was discontinued, these worsened relative to baseline (89.3 +/- 19.3mg/dL, p = 0.04 and 11.8 +/- 3.7mg/dL/hr, p = 0.08). Time-in-target numerically increased (40.2 +/- 11.9 to 43.1 +/- 13.5%, p = 0.69) at end-of-treatment but reversed post-treatment. Findings were similar on stratification of pump and MDI subjects. Conclusions We observed that empagliflozin was associated with patterns of improved nighttime glycemia more prominent than daytime.	[Perkins, Bruce A.; Lee, Justin A.; Partridge, Helen; Tschirhart, Holly; Zinman, Bernard] Univ Toronto, Dept Med, Div Endocrinol & Metab, Toronto, ON, Canada; [Cherney, David Z. I.] Univ Toronto, Toronto Gen Hosp, Univ Hlth Network, Dept Med,Div Nephrol, Toronto, ON M5G 1L7, Canada; [Soleymanlou, Nima] Boehringer Ingelheim Canada Ltd Ltee, Burlington, ON, Canada; [Perkins, Bruce A.; Zinman, Bernard] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Mazze, Roger] WHO, Collaborating Ctr, Minneapolis, MN USA; [Fagan, Nora] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT USA; [Kaspers, Stefan; Woerle, Hans-Juergen; Broedl, Uli C.] Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany; [Johansen, Odd Erik] Boehringer Ingelheim Norway KS, Asker, Norway	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; Boehringer Ingelheim; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; World Health Organization; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim	Perkins, BA (corresponding author), Univ Toronto, Dept Med, Div Endocrinol & Metab, Toronto, ON, Canada.	bperkins@mtsinai.on.ca	Zinman, Bernard/E-7266-2013; Perkins, Bruce A/L-3726-2017; Woerle, Hans/ABE-1013-2021		Boehringer Ingelheim; Eli Lilly	Boehringer Ingelheim(Boehringer Ingelheim); Eli Lilly(Eli Lilly)	This study was funded by Boehringer Ingelheim and Eli Lilly. Boehringer Ingelheim's involvement included study design, data collection and data analysis. Eli Lilly's involvement was limited to co-funding of the study.	Bergenstal RM, 2013, DIABETES TECHNOL THE, V15, P198, DOI 10.1089/dia.2013.0051; Brand T, 2012, ADV THER, V29, P889, DOI 10.1007/s12325-012-0055-3; Cherney DZI, 2014, CAN J DIABETES, V38, P356, DOI 10.1016/j.jcjd.2014.05.006; Cherney DZI, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-28; Cherney DZI, 2014, CIRCULATION, V129, P587, DOI 10.1161/CIRCULATIONAHA.113.005081; Cuypers J, 2013, ACTA CLIN BELG, V68, P287, DOI 10.2143/ACB.3349; DCCT Res Grp, 1988, DIABETES CARE, V11, P567; DeFronzo RA, 2012, DIABETES OBES METAB, V14, P5, DOI 10.1111/j.1463-1326.2011.01511.x; Gerstl EM, 2008, EUR J PEDIATR, V167, P447, DOI 10.1007/s00431-007-0586-9; Heise T, 2013, DIABETES OBES METAB, V15, P613, DOI 10.1111/dom.12073; Henry RR, 2012, INT J CLIN PRACT, V66, P446, DOI 10.1111/j.1742-1241.2012.02911.x; Henry RR, 2015, DIABETES CARE, V38, P412, DOI 10.2337/dc13-2955; Imran SA, 2013, CAN J DIABETES, V37, pS31, DOI 10.1016/j.jcjd.2013.01.016; Kurosaki E, 2013, PHARMACOL THERAPEUT, V139, P51, DOI 10.1016/j.pharmthera.2013.04.003; Luippold G, 2012, DIABETES OBES METAB, V14, P601, DOI 10.1111/j.1463-1326.2012.01569.x; Mazze R, 2008, DIABETES TECHNOL THE, V10, pS93, DOI 10.1089/dia.2008.0006; Mazze RS, 2008, DIABETES TECHNOL THE, V10, P149, DOI 10.1089/dia.2007.0293; Mudaliar S, 2012, DIABETES CARE, V35, P2198, DOI 10.2337/dc12-0508; Musso G, 2012, ANN MED, V44, P375, DOI 10.3109/07853890.2011.560181; Nauck MA, 2011, DIABETES CARE, V34, P2015, DOI 10.2337/dc11-0606; Perkins BA, 2014, DIABETES CARE, V37, P1480, DOI 10.2337/dc13-2338; Polidori D, 2013, DIABETES CARE, V36, P2154, DOI 10.2337/dc12-2391; Rosenstock J, 2012, DIABETES CARE, V35, P1473, DOI 10.2337/dc11-1693; Rosenstock J, 2012, DIABETES CARE, V35, P1232, DOI 10.2337/dc11-1926; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Skrtic M, 2014, DIABETOLOGIA, V57, P2599, DOI 10.1007/s00125-014-3396-4; Wilding JPH, 2013, DIABETES OBES METAB, V15, P403, DOI 10.1111/dom.12038; Wilding JPH, 2009, DIABETES CARE, V32, P1656, DOI 10.2337/dc09-0517; Wood JR, 2013, DIABETES CARE, V36, P2035, DOI 10.2337/dc12-1959	29	28	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141085	10.1371/journal.pone.0141085	http://dx.doi.org/10.1371/journal.pone.0141085			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544192	gold, Green Published, Green Submitted			2022-12-27	WOS:000364398700014
J	Stone, VN; Parikh, HI; El-rami, F; Ge, XC; Chen, WH; Zhang, Y; Kellogg, GE; Xu, P				Stone, Victoria N.; Parikh, Hardik I.; El-rami, Fadi; Ge, Xiuchun; Chen, Weihau; Zhang, Yan; Kellogg, Glen E.; Xu, Ping			Identification of Small-Molecule Inhibitors against Meso-2, 6-Diaminopimelate Dehydrogenase from Porphyromonas gingivalis	PLOS ONE			English	Article							DIAMINOPIMELIC ACID DAP; STRUCTURE-BASED DESIGN; LYSINE BIOSYNTHESIS; PROTEIN STRUCTURES; DRUG DISCOVERY; FREE-ENERGY; ANTIBIOTICS; MICROBIOTA; TARGET; PERIODONTITIS	Species-specific antimicrobial therapy has the potential to combat the increasing threat of antibiotic resistance and alteration of the human microbiome. We therefore set out to demonstrate the beginning of a pathogen-selective drug discovery method using the periodontal pathogen Porphyromonas gingivalis as a model. Through our knowledge of metabolic networks and essential genes we identified a "druggable" essential target, meso-diaminopimelate dehydrogenase, which is found in a limited number of species. We adopted a high-throughput virtual screen method on the ZINC chemical library to select a group of potential small-molecule inhibitors. Meso-diaminopimelate dehydrogenase from P. gingivalis was first expressed and purified in Escherichia coli then characterized for enzymatic inhibitor screening studies. Several inhibitors with similar structural scaffolds containing a sulfonamide core and aromatic substituents showed dose-dependent inhibition. These compounds were further assayed showing reasonable whole-cell activity and the inhibition mechanism was determined. We conclude that the establishment of this target and screening strategy provides a model for the future development of new antimicrobials.	[Stone, Victoria N.; El-rami, Fadi; Ge, Xiuchun; Chen, Weihau; Xu, Ping] Virginia Commonwealth Univ, Philips Inst Oral Hlth Res, Richmond, VA 23284 USA; [Stone, Victoria N.; El-rami, Fadi; Xu, Ping] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA; [Parikh, Hardik I.; Zhang, Yan; Kellogg, Glen E.] Virginia Commonwealth Univ, Dept Med Chem, Richmond, VA 23298 USA; [Kellogg, Glen E.; Xu, Ping] Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Xu, P (corresponding author), Virginia Commonwealth Univ, Philips Inst Oral Hlth Res, Richmond, VA 23284 USA.	pxu@vcu.edu	Parikh, Hardik/AAG-4963-2021	Kellogg, Glen/0000-0002-6282-6794; Parikh, Hardik/0000-0002-5621-7343	National Institutes of Health, US [R01DE018138, R01DE023078, F31DE024038]; NATIONAL CANCER INSTITUTE [P30CA016059] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023078, F31DE024038, R01DE018138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047463] Funding Source: NIH RePORTER	National Institutes of Health, US(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by the National Institutes of Health, US, grants R01DE018138 (PX), R01DE023078 (PX) and F31DE024038 (VS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT SD, 1994, J AM CHEM SOC, V116, P6513, DOI 10.1021/ja00094a004; Akita H, 2011, AMB EXPRESS, V1, DOI 10.1186/2191-0855-1-43; Amini S, 2011, CURR OPIN MICROBIOL, V14, P513, DOI 10.1016/j.mib.2011.07.017; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Avila M, 2009, DNA CELL BIOL, V28, P405, DOI 10.1089/dna.2009.0874; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bakheet TM, 2009, BIOINFORMATICS, V25, P451, DOI 10.1093/bioinformatics/btp002; Blount KF, 2007, NAT CHEM BIOL, V3, P44, DOI 10.1038/nchembio842; Burley SK, 2008, STRUCTURE, V16, P5, DOI 10.1016/j.str.2007.12.002; Cain R, 2014, BIOORG CHEM, V55, P69, DOI 10.1016/j.bioorg.2014.05.008; Chen T, 2010, DATABASE, V2010; Chen YY, 2011, MOL MICROBIOL, V79, P1380, DOI 10.1111/j.1365-2958.2010.07530.x; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; CLELAND WW, 1967, ADV ENZYMOL RAMB, V29, P1; Cozzini P, 2002, J MED CHEM, V45, P2469, DOI 10.1021/jm0200299; CREMER J, 1988, J GEN MICROBIOL, V134, P3221; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; Darveau RP, 1998, INFECT IMMUN, V66, P1660, DOI 10.1128/IAI.66.4.1660-1665.1998; DESJARLAIS RL, 1990, P NATL ACAD SCI USA, V87, P6644, DOI 10.1073/pnas.87.17.6644; Detert J, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3106; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; Eke PI, 2015, J PERIODONTOL, V86, P611, DOI 10.1902/jop.2015.140520; Perez-Cobas AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080201; Fazius F, 2013, APPL MICROBIOL BIOT, V97, P3763, DOI 10.1007/s00253-013-4805-1; FLETCHER HM, 1995, INFECT IMMUN, V63, P1521, DOI 10.1128/IAI.63.4.1521-1528.1995; Gabanyi Margaret J., 2011, Journal of Structural and Functional Genomics, V12, P45, DOI 10.1007/s10969-011-9106-2; Gleeson MP, 2008, J MED CHEM, V51, P817, DOI 10.1021/jm701122q; Griffen AL, 1998, J CLIN MICROBIOL, V36, P3239, DOI 10.1128/JCM.36.11.3239-3242.1998; Gwynn MN, 2010, ANN NY ACAD SCI, V1213, P5, DOI 10.1111/j.1749-6632.2010.05828.x; Hajishengallis G, 2011, CELL HOST MICROBE, V10, P497, DOI 10.1016/j.chom.2011.10.006; Hudson AO, 2011, BBA-PROTEINS PROTEOM, V1814, P1162, DOI 10.1016/j.bbapap.2011.04.019; HURST T, 1994, J CHEM INF COMP SCI, V34, P190, DOI 10.1021/ci00017a025; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Hutton CA, 2003, MINI-REV MED CHEM, V3, P115, DOI 10.2174/1389557033405359; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Ishiguro I, 2009, FEMS MICROBIOL LETT, V292, P261, DOI 10.1111/j.1574-6968.2009.01489.x; Jernberg C, 2010, MICROBIOL-SGM, V156, P3216, DOI 10.1099/mic.0.040618-0; Johnson CL, 2012, PEDIATRICS, V129, P950, DOI 10.1542/peds.2011-2736; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Jorgensen JH, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P1152; Kassebaum NJ, 2014, J DENT RES, V93, P1045, DOI 10.1177/0022034514552491; Keller TH, 2006, CURR OPIN CHEM BIOL, V10, P357, DOI 10.1016/j.cbpa.2006.06.014; Kellogg GE, 2000, EUR J MED CHEM, V35, P651, DOI 10.1016/S0223-5234(00)00167-7; KLAINER AS, 1974, ANTIMICROB AGENTS CH, V6, P216, DOI 10.1128/AAC.6.2.216; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Koul A, 2011, NATURE, V469, P483, DOI 10.1038/nature09657; Leekha S, 2011, MAYO CLIN PROC, V86, P156, DOI 10.4065/mcp.2010.0639; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; McGovern SL, 2002, J MED CHEM, V45, P1712, DOI 10.1021/jm010533y; MISONO H, 1979, J BACTERIOL, V137, P22, DOI 10.1128/JB.137.1.22-27.1979; MISONO H, 1980, J BIOL CHEM, V255, P599; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Noverr MC, 2004, TRENDS MICROBIOL, V12, P562, DOI 10.1016/j.tim.2004.10.008; Paiva AM, 2001, BBA-PROTEIN STRUCT M, V1545, P67, DOI 10.1016/S0167-4838(00)00262-4; Pavelka MS, 1996, J BACTERIOL, V178, P6496, DOI 10.1128/jb.178.22.6496-6507.1996; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Sakamoto S, 2001, J MOL CATAL B-ENZYM, V12, P85, DOI 10.1016/S1381-1177(00)00207-1; Scapin G, 1996, BIOCHEMISTRY-US, V35, P13540, DOI 10.1021/bi961628i; Schobel F, 2010, EUKARYOT CELL, V9, P878, DOI 10.1128/EC.00020-10; Seidler J, 2003, J MED CHEM, V46, P4477, DOI 10.1021/jm030191r; Song Jae-Hoon, 2008, V416, P401, DOI 10.1007/978-1-59745-321-9_28; Spyrakis F, 2007, EUR J MED CHEM, V42, P921, DOI 10.1016/j.ejmech.2006.12.037; Sullivan A, 2001, Lancet Infect Dis, V1, P101, DOI 10.1016/S1473-3099(01)00066-4; Sutherland A, 1999, CHEM COMMUN, P555, DOI 10.1039/a900297i; Tonetti MS, 2015, J CLIN PERIODONT S16, V42, pS5, DOI [10.1111/jcpe.12368, DOI 10.1111/JCPE.12368]; WHITE PJ, 1983, J GEN MICROBIOL, V129, P739; Xu P, 2011, SCI REP-UK, V1, DOI 10.1038/srep00125	67	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141126	10.1371/journal.pone.0141126	http://dx.doi.org/10.1371/journal.pone.0141126			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544875	Green Published, gold, Green Submitted			2022-12-27	WOS:000364398700017
J	Belletti, A; Musu, M; Silvetti, S; Saleh, O; Pasin, L; Monaco, F; Hajjar, LA; Fominskiy, E; Finco, G; Zangrillo, A; Landoni, G				Belletti, Alessandro; Musu, Mario; Silvetti, Simona; Saleh, Omar; Pasin, Laura; Monaco, Fabrizio; Hajjar, Ludhmila A.; Fominskiy, Evgeny; Finco, Gabriele; Zangrillo, Alberto; Landoni, Giovanni			Non-Adrenergic Vasopressors in Patients with or at Risk for Vasodilatory Shock. A Systematic Review and Meta-Analysis of Randomized Trials	PLOS ONE			English	Article							MEAN ARTERIAL-PRESSURE; HYPERDYNAMIC SEPTIC SHOCK; LOW-DOSE VASOPRESSIN; METHYLENE-BLUE; SEVERE SEPSIS; ARGININE-VASOPRESSIN; REDUCES MORTALITY; INFUSION; TERLIPRESSIN; NOREPINEPHRINE	Introduction Hypotensive state is frequently observed in several critical conditions. If an adequate mean arterial pressure is not promptly restored, insufficient tissue perfusion and organ dysfunction may develop. Fluids and catecholamines are the cornerstone of critical hypotensive states management. Catecholamines side effects such as increased myocardial oxygen consumption and development of arrhythmias are well known. Thus, in recent years, interest in catecholamine-sparing agents such as vasopressin, terlipressin and methylene blue has increased; however, few randomized trials, mostly with small sample sizes, have been performed. We therefore conducted a meta-analysis of randomized trials to investigate the effect of non-catecholaminergic vasopressors on mortality. Methods PubMed, BioMed Central and Embase were searched (update December 31st, 2014) by two independent investigators. Inclusion criteria were: random allocation to treatment, at least one group receiving a non-catecholaminergic vasopressor, patients with or at risk for vasodilatory shock. Exclusion criteria were: crossover studies, pediatric population, nonhuman studies, studies published as abstract only, lack of data on mortality. Studied drugs were vasopressin, terlipressin and methylene blue. Primary endpoint was mortality at the longest follow-up available. Results A total of 1,608 patients from 20 studies were included in our analysis. The studied settings were sepsis (10/20 studies [50%]), cardiac surgery (7/20 [35%]), vasodilatory shock due to any cause (2/20 [19%]), and acute traumatic injury (1/20 [5%]). Overall, pooled estimates showed that treatment with non-catecholaminergic agents improves survival (278/810 [34.3%] versus 309/798 [38.7%], risk ratio = 0.88, 95% confidence interval = 0.79 to 0.98, p = 0.02). None of the drugs was associated with significant reduction inmortality when analyzed independently. Results were not confirmed when analyzing studies with a low risk of bias. Conclusions Catecholamine-sparing agents in patients with or at risk for vasodilatory shock may improve survival. Further researches on this topic are needed to confirm the finding.	[Belletti, Alessandro; Silvetti, Simona; Saleh, Omar; Pasin, Laura; Monaco, Fabrizio; Zangrillo, Alberto; Landoni, Giovanni] IRCCS, San Raffaele Sci Inst, Dept Anaesthesia & Intens Care, Milan, Italy; [Musu, Mario; Finco, Gabriele] Univ Cagliari, Dept Med Sci M Aresu, Cagliari, Italy; [Hajjar, Ludhmila A.] Univ Sao Paulo, Dept Cardiopneumol, Surg Intens Care Unit, Sao Paulo, Brazil; [Fominskiy, Evgeny] Academician EN Meshalkin Novosibirsk State Budget, Dept Anaesthesiol & Intens Care, Novosibirsk, Russia; [Zangrillo, Alberto; Landoni, Giovanni] Univ Vita Salute San Raffaele, Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Cagliari; Universidade de Sao Paulo; Meshalkin National Medical Research Center; Vita-Salute San Raffaele University	Landoni, G (corresponding author), IRCCS, San Raffaele Sci Inst, Dept Anaesthesia & Intens Care, Milan, Italy.	landoni.giovanni@hsr.it	Finco, Gabriele/AAH-1697-2022; Zangrillo, Alberto/AAH-2037-2019; Finco, Gabriele/AFL-9587-2022; Giovanni, Landoni/AAH-1881-2019; Monaco, Fabrizio/GZA-9167-2022; silvetti, simona/AAB-1101-2020; Pasin, Laura/AAA-8188-2020; Belletti, Alessandro/I-1981-2019; Fominskiy, Evgeny/D-9118-2014	Finco, Gabriele/0000-0002-3059-9865; Zangrillo, Alberto/0000-0002-7687-7648; Finco, Gabriele/0000-0002-3059-9865; Giovanni, Landoni/0000-0002-8594-5980; Monaco, Fabrizio/0000-0001-5186-1976; Belletti, Alessandro/0000-0003-3131-0565; MUSU, MARIO/0000-0003-4882-2014; Pasin, Laura/0000-0001-5757-4791; Fominskiy, Evgeny/0000-0002-3198-4458; Saleh, Omar/0000-0003-2704-3759; Abrahao Hajjar, Ludhmila/0000-0001-5645-2055				Adhikari NKJ, 2010, LANCET, V376, P1339, DOI 10.1016/S0140-6736(10)60446-1; Albanese J, 2005, CRIT CARE MED, V33, P1897, DOI 10.1097/01.CCM.0000178182.37639.D6; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Barrett LK, 2007, CRIT CARE MED, V35, P33, DOI 10.1097/01.CCM.0000251127.45385.CD; Bassi E, 2013, CRIT CARE RES PRACT, V2013, DOI 10.1155/2013/654708; Biondi-Zoccai G, 2011, HEART LUNG VESSEL, V3, P161; Biondi-Zoccai G, 2011, HEART LUNG VESSEL, V3, P93; Biondi-Zoccai GGL, 2005, INT J EPIDEMIOL, V34, P224, DOI 10.1093/ije/dyh311; Bourgoin A, 2005, CRIT CARE MED, V33, P780, DOI 10.1097/01.CCM.0000157788.20591.23; Cohn SM, 2011, WORLD J SURG, V35, P430, DOI 10.1007/s00268-010-0875-8; De Backer D, 2010, NEW ENGL J MED, V362, P779, DOI 10.1056/NEJMoa0907118; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Dunser Martin W, 2009, J Intensive Care Med, V24, P293, DOI 10.1177/0885066609340519; Dunser MW, 2003, CIRCULATION, V107, P2313, DOI 10.1161/01.CIR.0000066692.71008.BB; Dunser MW, 2002, INTENS CARE MED, V28, P746, DOI 10.1007/s00134-002-1265-y; Egi M, 2007, ANN THORAC SURG, V83, P715, DOI 10.1016/j.athoracsur.2006.08.041; Gordon AC, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005866; Gordon AC, 2014, CRIT CARE MED, V42, P1325, DOI 10.1097/CCM.0000000000000212; Gordon AC, 2010, INTENS CARE MED, V36, P83, DOI 10.1007/s00134-009-1687-x; Greco T, 2013, HEART LUNG VESSEL, V5, P219; Hasija S, 2010, J CARDIOTHOR VASC AN, V24, P230, DOI 10.1053/j.jvca.2009.08.001; Hua F, 2013, J EMERG MED, V44, P434, DOI 10.1016/j.jemermed.2012.02.073; Ioannidis JP, 2009, PLOS MED, V6, pE; Jang DH, 2013, J MED TOXICOL, V9, P242, DOI 10.1007/s13181-013-0298-7; Kirov MY, 2001, CRIT CARE MED, V29, P1860, DOI 10.1097/00003246-200110000-00002; Landoni Giovanni, 2014, J Cardiothorac Vasc Anesth, V28, pe12, DOI 10.1053/j.jvca.2013.12.012; Landry DW, 2001, NEW ENGL J MED, V345, P588, DOI 10.1056/NEJMra002709; Lange M, 2008, INTENS CARE MED, V34, P821, DOI 10.1007/s00134-007-0946-y; Lauzier F, 2006, INTENS CARE MED, V32, P1782, DOI 10.1007/s00134-006-0378-0; Lavigne D, 2010, SEMIN CARDIOTHORAC V, V14, P186, DOI 10.1177/1089253210379271; Leone M, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0794-z; Levin RL, 2004, ANN THORAC SURG, V77, P496, DOI 10.1016/S0003-4975(03)01510-8; Levy B, 2010, INTENS CARE MED, V36, P2019, DOI 10.1007/s00134-010-2045-8; Luckner G, 2006, CRIT CARE, V10, DOI 10.1186/cc4845; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Malay MB, 1999, J TRAUMA, V47, P699, DOI 10.1097/00005373-199910000-00014; Martino EA, 2016, J CARDIOTHOR VASC AN, V30, P423, DOI 10.1053/j.jvca.2015.09.011; Maslow AD, 2006, ANESTH ANALG, V103, P2, DOI 10.1213/01.ane.0000221261.25310.fe; MAYER B, 1993, EUR HEART J, V14, P22; Mayr VD, 2006, CRIT CARE, V10, DOI 10.1186/cc5086; Memis D, 2002, ANAESTH INTENS CARE, V30, P755, DOI 10.1177/0310057X0203000606; Morales DLS, 2003, ANN THORAC SURG, V75, P926, DOI 10.1016/S0003-4975(02)04408-9; Morelli A, 2008, BRIT J ANAESTH, V100, P494, DOI 10.1093/bja/aen017; Morelli A, 2009, EXPERT OPIN PHARMACO, V10, P2569, DOI 10.1517/14656560903257808; Morelli A, 2009, CRIT CARE, V13, DOI 10.1186/cc7990; Okamoto Y, 2015, J CARDIOTHOR VASC AN, V29, P46, DOI 10.1053/j.jvca.2014.07.007; Omar S, 2015, AM J MED SCI, V349, P80, DOI 10.1097/MAJ.0000000000000341; Ozal E, 2005, ANN THORAC SURG, V79, P1615, DOI 10.1016/j.athoracsur.2004.10.038; Papadopoulos G, 2010, J CARDIOTHORAC SURG, V5, DOI 10.1186/1749-8090-5-17; Pasin L, 2013, CRIT CARE RESUSC, V15, P42; Polito A, 2012, INTENS CARE MED, V38, P9, DOI 10.1007/s00134-011-2407-x; Rehberg S, 2010, CRIT CARE MED, V38, P2016, DOI 10.1097/CCM.0b013e3181ef4694; Russell JA, 2008, NEW ENGL J MED, V358, P877, DOI 10.1056/NEJMoa067373; Russell JA, 2011, CRIT CARE, V15, DOI 10.1186/cc8224; Russell JA, 2009, CRIT CARE MED, V37, P811, DOI 10.1097/CCM.0b013e3181961ace; SAITO T, 1995, INTENS CARE MED, V21, P204, DOI 10.1007/BF01701473; Schmittinger CA, 2012, INTENS CARE MED, V38, P950, DOI 10.1007/s00134-012-2531-2; Neto AS, 2012, CRIT CARE, V16, DOI 10.1186/cc11469; Svoboda P, 2012, HEPATO-GASTROENTEROL, V59, P1043, DOI 10.5754/hge10550; Waechter J, 2014, CRIT CARE MED, V42, P2158, DOI 10.1097/CCM.0000000000000520; Walsh M, 2013, ANESTHESIOLOGY, V119, P507, DOI 10.1097/ALN.0b013e3182a10e26; Weiner MM, 2013, J CARDIOTHOR VASC AN, V27, P1233, DOI 10.1053/j.jvca.2013.02.026; Zangrillo A, 2015, J CRIT CARE, V30, P908, DOI 10.1016/j.jcrc.2015.05.017	63	38	38	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142605	10.1371/journal.pone.0142605	http://dx.doi.org/10.1371/journal.pone.0142605			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26558621	Green Published, Green Submitted, gold			2022-12-27	WOS:000364433100099
J	Huang, S; Lv, YJ; Peng, YJ; Zhang, LF; Xiu, LW				Huang, Shuai; Lv, Yuejun; Peng, Yanju; Zhang, Lifang; Xiu, Liwei			Effect of Different Groundwater Levels on Seismic Dynamic Response and Failure Mode of Sandy Slope	PLOS ONE			English	Article							STABILITY ANALYSIS; EMBANKMENT SLOPES; WATER; EARTHQUAKES; FREQUENCY; BEHAVIOR	Heavy seismic damage tends to occur in slopes when groundwater is present. The main objectives of this paper are to determine the dynamic response and failure mode of sandy slope subjected simultaneously to seismic forces and variable groundwater conditions. This paper applies the finite element method, which is a fast and efficient design tool in modern engineering analysis, to evaluate dynamic response of the slope subjected simultaneously to seismic forces and variable groundwater conditions. Shaking table test is conducted to analyze the failure mode and verify the accuracy of the finite element method results. The research results show that dynamic response values of the slope have different variation rules under near and far field earthquakes. And the damage location and pattern of the slope are different in varying groundwater conditions. The destruction starts at the top of the slope when the slope is in no groundwater, which shows that the slope appears obvious whipping effect under the earthquake. The destruction starts at the toe of the slope when the slope is in the high groundwater levels. Meanwhile, the top of the slope shows obvious seismic subsidence phenomenon after earthquake. Furthermore, the existence of the groundwater has a certain effect of damping.	[Huang, Shuai; Lv, Yuejun; Peng, Yanju; Zhang, Lifang; Xiu, Liwei] China Earthquake Adm, Inst Crustal Dynam, Beijing 100085, Peoples R China	China Earthquake Administration	Huang, S (corresponding author), China Earthquake Adm, Inst Crustal Dynam, Beijing 100085, Peoples R China.	huangshuai3395@163.com			National Key Technology Support Program of China [2011AA11A102]; Institute of Crustal Dynamics, China Earthquake Administration [ZDJ2015-03]	National Key Technology Support Program of China(National Key Technology R&D Program); Institute of Crustal Dynamics, China Earthquake Administration	This work is financially supported by the National Key Technology Support Program of China (2011AA11A102) and research grant from Institute of Crustal Dynamics, China Earthquake Administration (No. ZDJ2015-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ausilio E, 2000, SOIL DYN EARTHQ ENG, V19, P159, DOI 10.1016/S0267-7261(00)00005-1; Bi ZW, 2009, ROCK SOIL MECH, V30, P180; Cai D, 2015, RAILWAY ENG, V1, P56; [董建华 Dong Jianhua], 2011, [工程力学, Engineering Mechanics], V28, P101; Griffiths DV, 1999, GEOTECHNIQUE, V49, P387, DOI 10.1680/geot.1999.49.3.387; Jia GW, 2009, ENG GEOL, V106, P92, DOI 10.1016/j.enggeo.2009.03.003; Jibson RW, 2011, ENG GEOL, V122, P43, DOI 10.1016/j.enggeo.2010.09.017; [金艳丽 JIN Yanli], 2007, [工程地质学报, Journal of Engineering Geology], V15, P599; Katz O, 2006, EARTH PLANET SC LETT, V247, P280, DOI 10.1016/j.epsl.2006.05.009; Kim JM, 2013, SOIL DYN EARTHQ ENG, V44, P67, DOI 10.1016/j.soildyn.2012.09.001; Kokusho I, 2007, J GEOTECH GEOENVIRON, V133, P828, DOI 10.1061/(ASCE)1090-0241(2007)133:7(828); Lin Yu-Bang, 2012, Journal of Central South University (Science and Technology), V43, P3631; Lin YL, 2015, NAT HAZARDS, V76, P791, DOI 10.1007/s11069-014-1517-5; Lin YL, 2013, DISASTER ADV, V6, P69; Lin YL, 2013, NAT HAZARDS, V69, P219, DOI 10.1007/s11069-013-0701-3; Lin YL, 2013, DISASTER ADV, V6, P12; Lu L, 2015, ENG GEOL, V193, P288, DOI 10.1016/j.enggeo.2015.05.001; Ministry of Railways of the People's Republic of China, 2006, COD SEISM DES RAILW; Ng CWW, 2001, CAN GEOTECH J, V38, P1049, DOI 10.1139/cgj-38-5-1049; Shuai Huang, 2015, ELECT J GEOTECHNICAL, V20, P1; Srilatha N, 2013, GEOTEXT GEOMEMBRANES, V36, P27, DOI 10.1016/j.geotexmem.2012.10.004; Stamatopoulos CA, 2007, SOIL DYN EARTHQ ENG, V27, P1082, DOI 10.1016/j.soildyn.2007.01.012; Tong FG, 2008, ROCK SOIL MECH, V29, P1035; Viratjandr C, 2006, CAN GEOTECH J, V43, P802, DOI 10.1139/T06-042; Wang JX, 2007, ROCK SOIL MECH, V28, P213; Wright SG, 2003, PURE APPL GEOPHYS, V160, P1865, DOI 10.1007/s00024-003-2410-4; Ye HL, 2012, CHINA CIVIL ENG J, V45, P129; Zhang Luming, 2009, J RAILWAY ENG SOC, V07, P15; Zhao Lianheng, 2010, Journal of Highway and Transportation Research and Development, V27, P1	29	3	3	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142268	10.1371/journal.pone.0142268	http://dx.doi.org/10.1371/journal.pone.0142268			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26560103	Green Published, Green Submitted, gold			2022-12-27	WOS:000364433100069
J	Moulis, G; Palmaro, A; Sailler, L; Lapeyre-Mestre, M				Moulis, Guillaume; Palmaro, Aurore; Sailler, Laurent; Lapeyre-Mestre, Maryse			Corticosteroid Risk Function of Severe Infection in Primary Immune Thrombocytopenia Adults. A Nationwide Nested Case-Control Study	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; GLUCOCORTICOID THERAPY; CEREBRAL ASPERGILLOSIS; SERIOUS INFECTION; OLDER PATIENTS; SPLENECTOMY; RITUXIMAB; PURPURA; EFFICACY; PATIENT	Corticosteroid (CS)-related infection risk in immune thrombocytopenia (ITP) is unknown. The aim of this study was to assess the adjusted CS risk function of severe infection in persistent or chronic primary ITP adults. We designed a nested case-control study in the FAITH cohort. This cohort is built through the French national health insurance database named SNIIRAM and includes all treated incident persistent or chronic primary ITP adults in France (ENCePP no4574). Patients who entered the FAITH cohort between 2009 and 2012 were eligible (n = 1805). Cases were patients with infection as primary diagnosis code during hospitalization. Index date was the date of first hospitalization for infection. A 2: 1 matching was performed on age and entry date in the cohort. Various CS exposure time-windows were defined: current user, exposure during the 1/3/6 months preceding index date and from the entry date. CS doses were converted in prednisone equivalent (PEQ). The cumulative CS doses were averaged in each time-window to obtain daily PEQ dosages. Each CS exposure definition was assessed using multivariate conditional regression models. During the study period, 161 cases (9 opportunistic) occurred. The model with the best goodness of fit was CS exposure during the month before the index date (OR: 2.48, 95% CI: 1.613.83). The dose-effect relation showed that the risk existed from averaged daily doses >= 5 mg PEQ (vs. <5 mg: 2.09, 95% CI: 1.17-3.71). The risk of infection was mainly supported by current or recent exposure to CS, even with low doses.	[Moulis, Guillaume; Palmaro, Aurore; Sailler, Laurent; Lapeyre-Mestre, Maryse] Univ Toulouse 3, INSERM, Fac Med, UMR 1027, F-31062 Toulouse, France; [Moulis, Guillaume; Sailler, Laurent] Ctr Hosp Univ Toulouse, Serv Med Interne, Toulouse, France; [Moulis, Guillaume; Palmaro, Aurore; Sailler, Laurent; Lapeyre-Mestre, Maryse] Ctr Hosp Univ Toulouse, CIC 1436, Toulouse, France; [Lapeyre-Mestre, Maryse] Ctr Hosp Univ Toulouse, Serv Pharmacol Med & Clin, Fac Med, Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse	Moulis, G (corresponding author), Univ Toulouse 3, INSERM, Fac Med, UMR 1027, F-31062 Toulouse, France.	guillaume.moulis@univ-tlse3.fr	Lapeyre-Mestre, Maryse/C-8710-2012; Palmaro, Aurore/N-3112-2015	Lapeyre-Mestre, Maryse/0000-0002-5494-5873; Palmaro, Aurore/0000-0002-5660-9224				AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Apostolidis J, 2001, BLOOD, V98, P2875, DOI 10.1182/blood.V98.9.2875a; Arnold DM, 2007, ANN INTERN MED, V146, P25, DOI 10.7326/0003-4819-146-1-200701020-00006; Bannay A, 2013, REV DEPIDEMIOLOGIE S, VS9; Boyle S, 2013, BLOOD, V121, P4782, DOI 10.1182/blood-2012-12-467068; Collins AJ, 2009, AM J KIDNEY DIS, V53, pS27, DOI 10.1053/j.ajkd.2008.07.055; Cutolo M, 2008, AUTOIMMUN REV, V8, P153, DOI 10.1016/j.autrev.2008.07.010; de Stoppelaar SF, 2014, BLOOD, V124, P3781, DOI 10.1182/blood-2014-05-573915; Dixon WG, 2011, ANN RHEUM DIS, V70, P956, DOI 10.1136/ard.2010.144741; Dixon WG, 2012, ANN RHEUM DIS, V71, P1128, DOI 10.1136/annrheumdis-2011-200702; Fianchi L, 2007, ANN HEMATOL, V86, P225, DOI 10.1007/s00277-006-0206-1; Frederiksen H, 2014, BRIT J HAEMATOL, V166, P260, DOI 10.1111/bjh.12869; George JN, 1996, BLOOD, V88, P3, DOI 10.1182/blood.V88.1.3.3; Ghanima W, 2012, BLOOD, V120, P960, DOI 10.1182/blood-2011-12-309153; Godeau B, 2008, BLOOD, V112, P999, DOI 10.1182/blood-2008-01-131029; Gottenberg JE, 2010, ARTHRITIS RHEUM-US, V62, P2625, DOI 10.1002/art.27555; Grossi O, 2013, REV MED INTERNE, V34, P269, DOI 10.1016/j.revmed.2012.12.008; Hu MH, 2014, ANN HEMATOL, V93, P1023, DOI 10.1007/s00277-014-2014-3; Khellaf M, 2005, HAEMATOLOGICA, V90, P829; Khellaf M, 2014, BLOOD, V124, P3228, DOI 10.1182/blood-2014-06-582346; Kojouri K, 2004, BLOOD, V104, P2623, DOI 10.1182/blood-2004-03-1168; Kyaw MH, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.07.044; Listing J, 2013, RHEUMATOLOGY, V52, P53, DOI 10.1093/rheumatology/kes305; Lo E, 2014, AUTOIMMUN REV, V13, P577, DOI 10.1016/j.autrev.2014.01.026; Morrell CN, 2014, BLOOD, V123, P2759, DOI 10.1182/blood-2013-11-462432; Moulis G, 2015, REV MED INTERNE, V36, P411, DOI 10.1016/j.revmed.2014.11.009; Moulis G, 2015, AUTOIMMUN REV, V14, P168, DOI 10.1016/j.autrev.2014.10.017; Moulis G, 2014, BLOOD, V124, P3308, DOI 10.1182/blood-2014-05-578336; Moulis G, 2014, THERAPIE, V69, P437, DOI 10.2515/therapie/2014056; Moulis G, 2014, AM J HEMATOL, V89, P41, DOI 10.1002/ajh.23580; Nakano Takako, 2002, Nihon Kokyuki Gakkai Zasshi, V40, P945; Neunert C, 2011, BLOOD, V117, P4190, DOI 10.1182/blood-2010-08-302984; Nikkels AF, 1999, DERMATOLOGY, V199, P361, DOI 10.1159/000018292; Norgaard M, 2011, BLOOD, V117, P3514, DOI 10.1182/blood-2010-10-312819; Papadopoulos A, 2008, ANN HEMATOL, V87, P685, DOI 10.1007/s00277-008-0452-5; Portielje JEA, 2001, BLOOD, V97, P2549, DOI 10.1182/blood.V97.9.2549; Provan D, 2010, BLOOD, V115, P168, DOI 10.1182/blood-2009-06-225565; Rodeghiero F, 2009, BLOOD, V113, P2386, DOI 10.1182/blood-2008-07-162503; Schoonen WM, 2009, BRIT J HAEMATOL, V145, P235, DOI 10.1111/j.1365-2141.2009.07615.x; STASI R, 1995, AM J MED, V98, P436, DOI 10.1016/S0002-9343(99)80342-8; Stasi R, 2011, BRIT J HAEMATOL, V153, P437, DOI 10.1111/j.1365-2141.2010.08562.x; STUCK AE, 1989, REV INFECT DIS, V11, P954; Thomsen RW, 2009, ANN INTERN MED, V151, P546, DOI 10.7326/0003-4819-151-8-200910200-00008; Tsai Hung-Chin, 2006, J Chin Med Assoc, V69, P278, DOI 10.1016/S1726-4901(09)70257-6; Wu Q, 2015, CLIN APPL T IN PRESS	45	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142217	10.1371/journal.pone.0142217	http://dx.doi.org/10.1371/journal.pone.0142217			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559054	Green Published, gold, Green Submitted			2022-12-27	WOS:000364433100062
J	Axelsson, EP; Iason, GR; Julkunen-Tiitto, R; Whitham, TG				Axelsson, E. Petter; Iason, Glenn R.; Julkunen-Tiitto, Riitta; Whitham, Thomas G.			Host Genetics and Environment Drive Divergent Responses of Two Resource Sharing Gall-Formers on Norway Spruce: A Common Garden Analysis	PLOS ONE			English	Article							PICEA-ABIES CLONES; PLANT GENOTYPE; COMMUNITY STRUCTURE; ARTHROPOD COMMUNITY; HERBIVORE COMMUNITY; FOLIAR CHEMISTRY; LEAF-LITTER; RESISTANCE; GENES; APHID	A central issue in the field of community genetics is the expectation that trait variation among genotypes play a defining role in structuring associated species and in forming community phenotypes. Quantifying the existence of such community phenotypes in two common garden environments also has important consequences for our understanding of gene-by-environment interactions at the community level. The existence of community phenotypes has not been evaluated in the crowns of boreal forest trees. In this study we address the influence of tree genetics on needle chemistry and genetic x environment interactions on two gall-inducing adelgid aphids (Adelges spp. and Sacchiphantes spp.) that share the same elongating bud/shoot niche. We examine the hypothesis that the canopies of different genotypes of Norway spruce (Picea abies L.) support different community phenotypes. Three patterns emerged. First, the two gallers show clear differences in their response to host genetics and environment. Whereas genetics significantly affected the abundance of Adelges spp. galls, Sacchiphantes spp. was predominately affected by the environment suggesting that the genetic influence is stronger in Adelges spp. Second, the among family variation in genetically controlled resistance was large, i.e. fullsib families differed as much as 10 fold in susceptibility towards Adelges spp. (0.57 to 6.2 galls/branch). Also, the distribution of chemical profiles was continuous, showing both overlap as well as examples of significant differences among fullsib families. Third, despite the predicted effects of host chemistry on galls, principal component analyses using 31 different phenolic substances showed only limited association with galls and a similarity test showed that trees with similar phenolic chemical characteristics, did not host more similar communities of gallers. Nonetheless, the large genetic variation in trait expression and clear differences in how community members respond to host genetics supports our hypothesis that the canopies of Norway spruce differ in their community phenotypes.	[Axelsson, E. Petter] Swedish Univ Agr Sci, Dept Wildlife Fish & Environm Studies, S-90183 Umea, Sweden; [Iason, Glenn R.] James Hutton Inst, Aberdeen AB15 8QH, Scotland; [Julkunen-Tiitto, Riitta] Univ Eastern Finland, Dept Biol, Joensuu 80101, Finland; [Whitham, Thomas G.] No Arizona Univ, Merriam Powell Ctr Environm Res, Flagstaff, AZ 86011 USA; [Whitham, Thomas G.] No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA	Swedish University of Agricultural Sciences; James Hutton Institute; University of Eastern Finland; Northern Arizona University; Northern Arizona University	Axelsson, EP (corresponding author), Swedish Univ Agr Sci, Dept Wildlife Fish & Environm Studies, S-90183 Umea, Sweden.	petter.axelsson@slu.se	Julkunen-Tiitto, Riitta/GRR-9781-2022		King Carl XVI Gustaf's 50-Year Fund; Fonden for skogsvetenskaplig forskning; Scottish Government's Rural and Environment Science and Analytical Services; BBSRC [BB/L012227/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L012227/1] Funding Source: researchfish	King Carl XVI Gustaf's 50-Year Fund; Fonden for skogsvetenskaplig forskning; Scottish Government's Rural and Environment Science and Analytical Services; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by King Carl XVI Gustaf's 50-Year Fund and Fonden for skogsvetenskaplig forskning (EPA). GRI was funded by the Scottish Government's Rural and Environment Science and Analytical Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdala-Roberts L, 2013, OIKOS, V122, P1157, DOI 10.1111/j.1600-0706.2012.00159.x; Agrawal AA, 2015, ECOL LETT, V18, P985, DOI 10.1111/ele.12482; [Anonymous], 2014, SWED STAT YB FOR; Axelsson EP, 2011, J APPL ECOL, V48, P1472, DOI 10.1111/j.1365-2664.2011.02046.x; Axelsson EP, 2010, ECOSYSTEMS, V13, P1049, DOI 10.1007/s10021-010-9373-y; Bailey JK, 2006, ECOL LETT, V9, P78, DOI 10.1111/j.1461-0248.2005.00844.x; Bains B, 2009, CAN J FOREST RES, V39, P2536, DOI 10.1139/X09-164; Bangert RK, 2006, MOL ECOL, V15, P1379, DOI 10.1111/j.1365-294X.2005.02749.x; Bernhardsson C, 2013, ECOL LETT, V16, P791, DOI 10.1111/ele.12114; Bjorkman C, 2000, OECOLOGIA, V123, P223, DOI 10.1007/s004420051009; Busby PE, 2014, ECOLOGY; Carmona D, 2011, FUNCT ECOL, V25, P358, DOI 10.1111/j.1365-2435.2010.01794.x; Compson ZG, 2011, OECOLOGIA, V167, P711, DOI 10.1007/s00442-011-2033-x; Danielsson M, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-154; DENNO RF, 1995, ANNU REV ENTOMOL, V40, P297, DOI 10.1146/annurev.en.40.010195.001501; Evans LM, 2012, OECOLOGIA, V168, P483, DOI 10.1007/s00442-011-2108-8; Gehring C, 2014, MOL ECOL, V23, P1379, DOI 10.1111/mec.12503; Goslee SC, 2007, J STAT SOFTWARE, V22; Hartmann G, 2010, SKADOR SIUKDOMAR TRA; Hertel H, 1999, PHYTON AUSTRIA, V36, P65; Hjalten J, 2007, OIKOS, V116, P751, DOI [10.1111/j.2007.0030-1299.15365.x, 10.1111/j.0030-1299.2007.15365.x]; Holeski LM, 2009, ECOLOGY, V90, P2969, DOI 10.1890/08-2378.1; Iason GR, 2005, ECOL LETT, V8, P364, DOI 10.1111/j.1461-0248.2005.00732.x; Johnson MTJ, 2008, ECOLOGY, V89, P145, DOI 10.1890/07-0395.1; Johnson MTJ, 2005, ECOLOGY, V86, P874, DOI 10.1890/04-1068; Johnson MTJ, 2006, ECOL LETT, V9, P24, DOI 10.1111/j.1461-0248.2005.00833.x; Julkunen-Tiitto R, 2001, J CHEM ECOL, V27, P779, DOI 10.1023/A:1010358120482; Keith AR, 2010, ECOLOGY, V91, P3398, DOI 10.1890/09-1236.1; Khudr MS, 2014, ADV ECOLOGICAL RES, V50, P243; Korkama T, 2006, NEW PHYTOL, V171, P815, DOI 10.1111/j.1469-8137.2006.01786.x; Korkama-Rajala T, 2008, MICROB ECOL, V56, P76, DOI 10.1007/s00248-007-9326-y; Leimu R, 2006, AM NAT, V168, pE15, DOI 10.1086/505766; LeRoy CJ, 2007, J N AM BENTHOL SOC, V26, P426, DOI 10.1899/06-113.1; Leski T, 2010, MYCORRHIZA, V20, P473, DOI 10.1007/s00572-010-0298-2; MADDOX GD, 1990, ECOLOGY, V71, P2115, DOI 10.2307/1938625; Mattson WJ, 1998, BIOL GALL INDUCING A, V199, P304; McKinnon ML, 1999, FUNCT ECOL, V13, P859, DOI 10.1046/j.1365-2435.1999.00376.x; Pakeman RJ, 2006, ECOGRAPHY, V29, P451, DOI 10.1111/j.2006.0906-7590.04617.x; Payne R.W., 2009, GENSTAT WINDOWS, V12nd; Roche BM, 1997, EVOLUTION, V51, P1490, DOI 10.1111/j.1558-5646.1997.tb01472.x; Roder J, 2010, FOREST ECOL MANAG, V259, P1513, DOI 10.1016/j.foreco.2010.01.027; Savolainen O, 2013, NAT REV GENET, V14, P807, DOI 10.1038/nrg3522; Shuster SM, 2006, EVOLUTION, V60, P991, DOI 10.1111/j.0014-3820.2006.tb01177.x; Stenberg JA, 2011, ECOL ENTOMOL, V36, P442, DOI 10.1111/j.1365-2311.2011.01285.x; Tack AJM, 2012, OIKOS, V121, P481, DOI 10.1111/j.1600-0706.2011.19926.x; Tack AJM, 2010, ECOLOGY, V91, P2660, DOI 10.1890/09-1027.1; Taulavuori K, 2013, NAT PROD COMMUN, V8, P791; TJIA B, 1975, FOREST SCI, V21, P180; Velmala SM, 2013, MYCORRHIZA, V23, P21, DOI 10.1007/s00572-012-0446-y; Viswanathan DV, 2005, ECOLOGY, V86, P886, DOI 10.1890/04-0313; Wellendorf H, 2008, SILVAE GENET, V57, P312, DOI 10.1515/sg-2008-0047; WHITHAM TG, 1989, SCIENCE, V244, P1490, DOI 10.1126/science.244.4911.1490; Whitham TG, 2006, NAT REV GENET, V7, P510, DOI 10.1038/nrg1877; Whitham TG, 2012, TRENDS PLANT SCI, V17, P271, DOI 10.1016/j.tplants.2012.01.005; Wimp GM, 2004, ECOL LETT, V7, P776, DOI 10.1111/j.1461-0248.2004.00635.x; Zhao BG, 1998, ENVIRON ENTOMOL, V27, P984, DOI 10.1093/ee/27.4.984; Zytynska SE, 2010, ECOLOGY, V91, P1563, DOI 10.1890/09-2070.1	57	9	9	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142257	10.1371/journal.pone.0142257	http://dx.doi.org/10.1371/journal.pone.0142257			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26554587	gold, Green Published, Green Submitted			2022-12-27	WOS:000364430700075
J	Deng, X; Zhang, GL; Zhang, L; Feng, Y; Li, ZH; Wu, GM; Yue, YH; Li, GS; Cao, Y; Zhu, P				Deng, Xin; Zhang, Guoli; Zhang, Ling; Feng, Yan; Li, Zehong; Wu, GuangMou; Yue, Yuhuan; Li, Gensong; Cao, Yu; Zhu, Ping			Developing a Novel Gene-Delivery Vector System Using the Recombinant Fusion Protein of Pseudomonas Exotoxin A and Hyperthermophilic Archaeal Histone HPhA	PLoS One			English	Article							PYROCOCCUS-HORIKOSHII OT3; ARGININE-RICH PEPTIDES; X-RAY ANALYSIS; AERUGINOSA EXOTOXIN; DNA DELIVERY; EXPRESSION; CELLS; THERAPY; CANCER; COMPLEX	Non-viral gene delivery system with many advantages has a great potential for the future of gene therapy. One inherent obstacle of such approach is the uptake by endocytosis into vesicular compartments. Receptor-mediated gene delivery method holds promise to overcome this obstacle. In this study, we developed a receptor-mediated gene delivery system based on a combination of the Pseudomonas exotoxin A (PE), which has a receptor binding and membrane translocation domain, and the hyperthermophilic archaeal histone (HPhA), which has the DNA binding ability. First, we constructed and expressed the rPE-HPhA fusion protein. We then examined the cytotoxicity and the DNA binding ability of rPE-HPhA. We further assessed the efficiency of transfection of the pEGF-C1 plasmid DNA to CHO cells by the rPE-HPhA system, in comparison to the cationic liposome method. The results showed that the transfection efficiency of rPE-HPhA was higher than that of cationic liposomes. In addition, the rPE-HPhA gene delivery system is non-specific to DNA sequence, topology or targeted cell type. Thus, the rPE-HPhA system can be used for delivering genes of interest into mammalian cells and has great potential to be applied for gene therapy.	[Deng, Xin; Li, Gensong] China Med Univ, Basic Med Sci Res Coll, Expt Ctr Funct Subjects, Shenyang 110001, Liaoning, Peoples R China; [Zhang, Guoli; Zhang, Ling; Wu, GuangMou; Yue, Yuhuan; Zhu, Ping] PLA, Inst Vet Med, Acad Mil Med Sci, Changchun, Jilin, Peoples R China; [Feng, Yan] Jilin Univ, Key Lab Mol Enzymol, Changchun 130023, Jilin, Peoples R China; [Li, Zehong] Jilin Agr Univ, Dept Biol & Technol, Changchun, Jilin, Peoples R China; [Cao, Yu] China Med Univ, Dept Physiol, Shenyang 110001, Liaoning, Peoples R China	China Medical University; Academy of Military Medical Sciences - China; Jilin University; Jilin Agricultural University; China Medical University	Deng, X (corresponding author), China Med Univ, Basic Med Sci Res Coll, Expt Ctr Funct Subjects, Shenyang 110001, Liaoning, Peoples R China.	dengxin@mail.cmu.edu.cn; zhangguoli2001@126.com	Deng, Xin/GVU-4397-2022	Deng, Xin/0000-0001-7846-7389	National Nature Science Foundation of China [81370712, 31172165]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding: This work was supported by the National Nature Science Foundation of China (http://www.nsfc.gov.cn), Grant numbers: 81370712 (XD) and 31172165 (GLZ). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akutsu J, 2005, J BIOCHEM, V138, P159, DOI 10.1093/jb/mvi115; Arote RB, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/4/044102; Askou AL, 2015, MOL THER-METH CLIN D, V2, DOI 10.1038/mtm.2014.64; Boland EL, 2014, J MOL BIOL, V426, P645, DOI 10.1016/j.jmb.2013.11.002; Chen TY, 2000, APPL MICROBIOL BIOT, V53, P558, DOI 10.1007/s002530051657; Chen W, 2014, J CONTROL RELEASE, V190, P398, DOI 10.1016/j.jconrel.2014.05.023; Chung M, 2013, ANAL CHEM, V85, P7753, DOI 10.1021/ac401012j; Daddaoua A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039390; Davis ME, 2002, CURR OPIN BIOTECH, V13, P128, DOI 10.1016/S0958-1669(02)00294-X; Deng X, 2008, J DRUG TARGET, V16, P379, DOI [10.1080/10611860802102324, 10.1080/10611860802102324 ]; Du Toit A, 2015, NAT REV MOL CELL BIO, V16, DOI 10.1038/nrm3939; El-Aneed A, 2004, J CONTROL RELEASE, V94, P1, DOI 10.1016/j.jconrel.2003.09.013; Eshita Y, 2015, DRUG DELIV TRANSL RE, V5, P38, DOI 10.1007/s13346-014-0213-z; Felgner PL, 1997, HUM GENE THER, V8, P511, DOI 10.1089/hum.1997.8.5-511; Futaki S, 2001, J BIOL CHEM, V276, P5836, DOI 10.1074/jbc.M007540200; Harutyunyan S, 2014, J VIROL, V88, P6307, DOI 10.1128/JVI.00539-14; Hashida H, 2004, BRIT J CANCER, V90, P1252, DOI 10.1038/sj.bjc.6601680; Hung CF, 2001, CANCER RES, V61, P3698; Johnsen KB, 2014, BBA-REV CANCER, V1846, P75, DOI 10.1016/j.bbcan.2014.04.005; Jorgensen R, 2005, NATURE, V436, P979, DOI 10.1038/nature03871; Kang HJ, 2011, ACTA CRYSTALLOGR F, V67, P144, DOI 10.1107/S1744309110048426; Kanzawa T, 2003, J BIOMED BIOTECHNOL, P25; Kawarabayasi Y, 1998, DNA Res, V5, P55, DOI 10.1093/dnares/5.2.55; Khabou H, 2015, M S-MED SCI, V31, P529, DOI 10.1051/medsci/20153105015; Kreppel F, 2002, INVEST OPHTH VIS SCI, V43, P1965; Li AX, 2006, TALANTA, V70, P330, DOI 10.1016/j.talanta.2006.02.056; Li T, 2003, J MOL BIOL, V325, P1031, DOI 10.1016/S0022-2836(02)01285-8; Li T, 2002, ACTA CRYSTALLOGR D, V58, P870, DOI 10.1107/S0907444902005036; Lorenz C, 2011, RNA BIOL, V8, P627, DOI 10.4161/rna.8.4.15394; Mazor R, 2012, P NATL ACAD SCI USA, V109, pE3597, DOI 10.1073/pnas.1218138109; Miyoshi D, 2014, CHEMMEDCHEM, V9, P2156, DOI 10.1002/cmdc.201402157; Motioch LJ, 2015, EXPERT OPIN BIOL TH, V15, P803, DOI [10.1517/14712598.2015.1036734, DOI 10.1517/14712598.2015.1036734]; Paulsson M, 2015, J CYST FIBROS, V14, P600, DOI 10.1016/j.jcf.2015.05.005; Roe K, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-75; Sauer H, 2013, STEM CELLS DEV, V22, P1443, DOI 10.1089/scd.2012.0640; Suzuki T, 2002, J BIOL CHEM, V277, P2437, DOI 10.1074/jbc.M110017200; Tafesse FG, 2014, J BIOL CHEM, V289, P24005, DOI 10.1074/jbc.M114.589275; Tolmachov Oleg E, 2012, Med Hypotheses, V78, P632, DOI 10.1016/j.mehy.2012.01.042; WAGNER E, 1991, P NATL ACAD SCI USA, V88, P4255, DOI 10.1073/pnas.88.10.4255; Wedekind JE, 2001, J MOL BIOL, V314, P823, DOI 10.1006/jmbi.2001.5195; Weldon JE, 2011, FEBS J, V278, P4683, DOI 10.1111/j.1742-4658.2011.08182.x; Weng L, 2004, PROTEIN EXPRES PURIF, V33, P145, DOI 10.1016/j.pep.2003.09.004; Weng L, 2004, BIOCHIM BIOPHYS ACTA, V1720, P209; Yang N, 2012, INT J PHARM INVESTIG, V2, P97, DOI 10.4103/2230-973X.104388; Ye MP, 2014, INFECT IMMUN, V82, P1840, DOI 10.1128/IAI.00030-14	45	5	6	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142558	10.1371/journal.pone.0142558	http://dx.doi.org/10.1371/journal.pone.0142558			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556098	gold, Green Submitted, Green Published			2022-12-27	WOS:000364430700128
J	Hanusch, AL; de Oliveira, GR; de Saboia-Morais, SMT; Machado, RC; dos Anjos, MM; Chen, LC				Hanusch, Alex Lucas; de Oliveira, Guilherme Roberto; Teixeira de Saboia-Morais, Simone Maria; Machado, Rafael Cosme; dos Anjos, Murilo Machado; Chen, Lee Chen			Genotoxicity and Cytotoxicity Evaluation of the Neolignan Analogue 2-(4-Nitrophenoxy)-1 Phenylethanone and its Protective Effect Against DNA Damage	PLOS ONE			English	Article							IN-VITRO; MICRONUCLEUS TEST; COMET ASSAY; CELLS; EXTRACT; LIGNAN; (-)-HINOKININ; INHIBITION; BLOOD; SEEDS	Neolignans are secondary metabolites found in various groups of Angiosperms. They belong to a class of natural compounds with great diversity of chemical structures and pharmacological activities. These compounds are formed by linking two phenylpropanoid units. Several compounds that have ability to prevent genetic damage have been isolated from plants, and can be used to prevent or delay the development of tumor cells. Genetic toxicology evaluation is widely used in risk assessment of new drugs in preclinical screening tests. In this study, we evaluated the genotoxicity and cytotoxicity of the neolignan analogue 2-(4nitrophenoxy)-1-phenylethanone (4NF) and its protective effect against DNA damage using the mouse bone marrow micronucleus test and the comet assay in mouse peripheral blood. Our results showed that this neolignan analogue had no genotoxic activity and was able to reduce induced damage both in mouse bone marrow and peripheral blood. Although the neolignan analogue 4NF was cytotoxic, it reduced cyclophosphamide-induced cytotoxicity. In conclusion, it showed no genotoxic action, but exhibited cytotoxic, antigenotoxic, and anticytotoxic activities.	[Hanusch, Alex Lucas; Teixeira de Saboia-Morais, Simone Maria; Machado, Rafael Cosme; Chen, Lee Chen] Univ Fed Goias, Inst Ciencias Biol, Goiania, Go, Brazil; [de Oliveira, Guilherme Roberto; dos Anjos, Murilo Machado] Univ Fed Goias, Inst Quim, Goiania, Go, Brazil	Universidade Federal de Goias; Universidade Federal de Goias	Hanusch, AL (corresponding author), Univ Fed Goias, Inst Ciencias Biol, Goiania, Go, Brazil.	bioalh@hotmail.com	Sabóia-Morais, Simone M. T./M-8014-2017; Sabóia-Morais, Simone/AAL-8001-2021; Chen, Lee Chen/B-1668-2013; Chen-Chen, Lee/Q-9797-2019	Sabóia-Morais, Simone/0000-0001-7729-499X; Chen, Lee Chen/0000-0002-0386-247X; Chen-Chen, Lee/0000-0002-0386-247X; Cosme Machado, Rafael/0000-0002-2050-3487	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by grants from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) to ALH, RCM. http://www.capes.gov/br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de Rezende AAA, 2013, FOOD CHEM TOXICOL, V55, P645, DOI 10.1016/j.fct.2013.01.050; [Anonymous], BIOMED PREV NUTR; Antunes L. M. G., 2000, Revista de Nutricao, V13, P81, DOI 10.1590/S1415-52732000000200002; Aveniente M, 2007, BIOORGAN MED CHEM, V15, P7337, DOI 10.1016/j.bmc.2007.08.016; Barata LES, 2000, PHYTOCHEMISTRY, V55, P589, DOI 10.1016/S0031-9422(00)00240-5; Brambilla G, 2009, PHARMACOL RES, V60, P1, DOI 10.1016/j.phrs.2009.03.007; Cao GY, 2015, FOOD CHEM, V173, P231, DOI 10.1016/j.foodchem.2014.09.170; Collins AR, 2008, MUTAGENESIS, V23, P143, DOI 10.1093/mutage/gem051; Cordell J L, 1995, MLO Med Lab Obs, V27, P35; HEDDLE JA, 1973, MUTAT RES, V18, P187, DOI 10.1016/0027-5107(73)90035-3; Huang XX, 2013, BIOORG MED CHEM LETT, V23, P5599, DOI 10.1016/j.bmcl.2013.08.045; Jena G. B., 2002, Indian Journal of Pharmacology, V34, P86; Kahl VFS, 2012, MUTAT RES-GEN TOX EN, V744, P140, DOI 10.1016/j.mrgentox.2012.01.008; Kang K, 2011, NEOPLASIA, V13, P1043, DOI 10.1593/neo.11972; Konya K, 2001, PHYTOMEDICINE, V8, P454, DOI 10.1078/S0944-7113(04)70064-1; Kumar BS, 2014, BIOORGAN MED CHEM, V22, P1342, DOI 10.1016/j.bmc.2013.12.067; Lee JS, 2004, ARCH PHARM RES, V27, P1043, DOI 10.1007/BF02975429; Lee WS, 2004, BIOORG MED CHEM LETT, V14, P5623, DOI 10.1016/j.bmcl.2004.08.054; Li N, 2007, REGUL TOXICOL PHARM, V49, P154, DOI 10.1016/j.yrtph.2007.06.005; Lourenço J.A., 2010, Rev. bras. plantas med., V12, P414, DOI 10.1590/S1516-05722010000400003; Medola JF, 2007, FOOD CHEM TOXICOL, V45, P638, DOI 10.1016/j.fct.2006.10.012; Olfert E.D, 1993, GUIDE CARE USE EXPT, V1; Oliveira Junior LM, 2007, REV ELETRON FARM, V4, P82; Pinheiro AAC, 2004, J MOL STRUC-THEOCHEM, V672, P215, DOI 10.1016/j.theochem.2003.11.027; Resende FA, 2010, MUTAT RES-GEN TOX EN, V700, P62, DOI 10.1016/j.mrgentox.2010.04.023; Rhee CH, 2001, APPL ENVIRON MICROB, V67, P3445, DOI 10.1128/AEM.67.8.3445-3449.2001; Saeed M, 2014, PHYTOMEDICINE, V21, P689, DOI 10.1016/j.phymed.2014.01.006; Saito J, 2006, MUTAT RES-GEN TOX EN, V609, P68, DOI 10.1016/j.mrgentox.2006.06.021; Salto J, 2008, FOOD CHEM TOXICOL, V46, P694, DOI 10.1016/j.fct.2007.09.097; SCHMID W, 1975, MUTAT RES, V31, P9, DOI 10.1016/0165-1161(75)90058-8; Schnaider Taylor Brandão, 2003, Rev. Bras. Anestesiol., V53, P278, DOI 10.1590/S0034-70942003000200014; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Sinigaglia M, 2006, MUTAT RES-GEN TOX EN, V607, P225, DOI 10.1016/j.mrgentox.2006.04.012; Souza V. A., 2012, REV VIRTUAL QUIM, V4, P197; Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J; VONLEDEB.M, 1973, MUTAT RES, V19, P109, DOI 10.1016/0027-5107(73)90118-8; Yamamoto ML, 2013, MUTAT RES-FUND MOL M, V749, P58, DOI 10.1016/j.mrfmmm.2013.05.003; Yang Q, 2014, FOOD CHEM TOXICOL, V70, P40, DOI 10.1016/j.fct.2014.04.039	38	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142284	10.1371/journal.pone.0142284	http://dx.doi.org/10.1371/journal.pone.0142284			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26554835	Green Published, Green Submitted, gold			2022-12-27	WOS:000364430700077
J	Liebrenz, M; Schneider, M; Buadze, A; Gehring, MT; Dube, A; Caflisch, C				Liebrenz, Michael; Schneider, Marcel; Buadze, Anna; Gehring, Marie-Therese; Dube, Anish; Caflisch, Carlo			High-Dose Benzodiazepine Dependence: A Qualitative Study of Patients' Perceptions on Initiation, Reasons for Use, and Obtainment	PLOS ONE			English	Article							CASE REGISTER ANALYSIS; LONG-TERM USE; ESSENTIAL TREMOR; STANDARDS SUBCOMMITTEE; METHADONE PROGRAM; AMERICAN-ACADEMY; THERAPEUTIC-USE; ABUSE; DISCONTINUATION; PRESCRIPTION	Background High-dose benzodiazepine (BZD) dependence is associated with a wide variety of negative health consequences. Affected individuals are reported to suffer from severe mental disorders and are often unable to achieve long-term abstinence via recommended discontinuation strategies. Although it is increasingly understood that treatment interventions should take subjective experiences and beliefs into account, the perceptions of this group of individuals remain under-investigated. Methods We conducted an exploratory qualitative study with 41 adult subjects meeting criteria for (high-dose) BZD-dependence, as defined by ICD-10. One-on-one in-depth interviews allowed for an exploration of this group's views on the reasons behind their initial and then continued use of BZDs, as well as their procurement strategies. Mayring's qualitative content analysis was used to evaluate our data. Results In this sample, all participants had developed explanatory models for why they began using BZDs. We identified a multitude of reasons that we grouped into four broad categories, as explaining continued BZD use: (1) to cope with symptoms of psychological distress or mental disorder other than substance use, (2) to manage symptoms of physical or psychological discomfort associated with somatic disorder, (3) to alleviate symptoms of substance-related disorders, and (4) for recreational purposes, that is, sensation-seeking and other social reasons. Subjects often considered BZDs less dangerous than other substances and associated their use more often with harm reduction than as recreational. Specific obtainment strategies varied widely: the majority of participants oscillated between legal and illegal methods, often relying on the black market when faced with treatment termination. Conclusions Irrespective of comorbidity, participants expressed a clear preference for medically related explanatory models for their BZD use. We therefore suggest that clinicians consider patients' motives for long-term, high-dose BZD use when formulating treatment plans for this patient group, especially since it is known that individuals are more compliant with approaches they perceive to be manageable, tolerable, and effective.	[Liebrenz, Michael; Buadze, Anna; Caflisch, Carlo] Univ Zurich, Hosp Psychiat, Dept Psychiat Psychotherapy & Psychosomat, Zurich, Switzerland; [Liebrenz, Michael] Univ Bern, Inst Legal Med, Dept Forens Psychiat, Bern, Switzerland; [Schneider, Marcel] Univ Zurich Hosp, Dept Surg, Div Visceral & Transplantat Surg, CH-8091 Zurich, Switzerland; [Gehring, Marie-Therese] Ulmenhof, Sozialtherapie, Offenbach, Switzerland; [Dube, Anish] Univ Penn Hlth Syst, Philadelphia, PA USA	University of Zurich; University of Bern; University of Zurich; University Zurich Hospital; University of Pennsylvania	Liebrenz, M (corresponding author), Univ Zurich, Hosp Psychiat, Dept Psychiat Psychotherapy & Psychosomat, Zurich, Switzerland.	Michael.Liebrenz@fpd.unibe.ch	Schneider, Marcel André/AAW-9712-2020	Schneider, Marcel André/0000-0002-6723-8879; Buadze, Ana/0000-0002-8683-6807; Liebrenz, Michael/0000-0001-8040-2744	Prof. Dr. Max Cloetta foundation, Zurich, Switzerland; Uniscientia foundation, Vaduz, Principality of Liechtenstein	Prof. Dr. Max Cloetta foundation, Zurich, Switzerland; Uniscientia foundation, Vaduz, Principality of Liechtenstein	Michael Liebrenz was financially supported by the Prof. Dr. Max Cloetta foundation, Zurich, Switzerland, and the Uniscientia foundation, Vaduz, Principality of Liechtenstein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi-Severini Silvia, 2014, CMAJ Open, V2, pE208, DOI 10.9778/cmajo.20130076; Angermeyer MC, 1999, SOC PSYCH PSYCH EPID, V34, P202, DOI 10.1007/s001270050134; [Anonymous], QUALITATIVE INHALTSA; Ashton H, 2005, CURR OPIN PSYCHIATR, V18, P249, DOI 10.1097/01.yco.0000165594.60434.84; ASHTON H, 1994, DRUGS, V48, P25, DOI 10.2165/00003495-199448010-00004; Baandrup L, 2015, PHARM INTERVENTIONS; Barker MJ, 2004, CNS DRUGS, V18, P37, DOI 10.2165/00023210-200418010-00004; Benavides S, 2009, ANN PHARMACOTHER, V43, P85, DOI 10.1345/aph.1K612; Buadze A, 2010, HARM REDUCT J, V7, DOI 10.1186/1477-7517-7-22; Carter BL, 2008, J CLIN HYPERTENS, V10, P260, DOI 10.1111/j.1751-7176.2008.07434.x; Chebib M, 1999, CLIN EXP PHARMACOL P, V26, P937, DOI 10.1046/j.1440-1681.1999.03151.x; Chen KW, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-90; Clark RE, 2004, J CLIN PSYCHIAT, V65, P151; COLE JO, 1990, J PSYCHIAT RES, V24, P135, DOI 10.1016/0022-3956(90)90045-R; COSTA E, 1979, ANNU REV PHARMACOL, V19, P531, DOI 10.1146/annurev.pa.19.040179.002531; Costello Daniel J, 2007, J Intensive Care Med, V22, P319, DOI 10.1177/0885066607307506; Dearing RL, 2005, ADDICT BEHAV, V30, P1392, DOI 10.1016/j.addbeh.2005.02.002; Dell'osso B, 2013, EUR PSYCHIAT, V28, P7, DOI 10.1016/j.eurpsy.2011.11.003; Dilling H, 1994, INT KLASSIFIKATION P; Fang SY, 2009, DRUG ALCOHOL DEPEN, V104, P140, DOI 10.1016/j.drugalcdep.2009.04.017; Gallagher RM, 2012, ADV HEALTH SCI EDUC, V17, P247, DOI 10.1007/s10459-010-9260-5; HARRISON M, 1984, CLIN PHARMACOL THER, V36, P527, DOI 10.1038/clpt.1984.214; Heberlein A, 2009, FORTSCHR NEUROL PSYC, V77, P7, DOI 10.1055/s-0028-1100831; Jena AB, 2011, ANN INTERN MED, V155, P848, DOI 10.7326/0003-4819-155-12-201112200-00008; KING MB, 1990, BRIT J GEN PRACT, V40, P194; Klingemann HKH, 1996, ADDICTION, V91, P723, DOI 10.1046/j.1360-0443.1996.9157238.x; Lader M, 2014, BRIT J CLIN PHARMACO, V77, P295, DOI 10.1111/j.1365-2125.2012.04418.x; Ladewig D, 1996, SUCHT, V42, P167; Lagnaoui R, 2004, EUR J CLIN PHARMACOL, V60, P523, DOI 10.1007/s00228-004-0808-2; Lee JWY, 2010, J CLIN PSYCHOPHARM, V30, P3, DOI 10.1097/JCP.0b013e3181c9bfe6; Liebrenz M, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0493-y; Liebrenz M, 2014, HARM REDUCT J, V11, DOI 10.1186/1477-7517-11-23; Liebrenz M, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-141; Liebrenz M, 2010, ADDICTION, V105, P1870, DOI 10.1111/j.1360-0443.2010.02933.x; Louis ED, 2010, J NEUROL SCI, V289, P144, DOI 10.1016/j.jns.2009.08.029; Lyons KE, 2003, DRUG SAFETY, V26, P461, DOI 10.2165/00002018-200326070-00003; Maremmani AGI, 2013, CLONAZEPAM AGONIST S, V2013; Marlatt G A, 1997, NIDA Res Monogr, V165, P44; Mavring P, 2000, FORUM QUALITATIVE SO, P2; Mayring P., 2000, QUALITATIVE CONTENT; Nakao M, 2007, INT J CLIN PHARM TH, V45, P30; Newman Robert G, 2006, Harm Reduct J, V3, P20, DOI 10.1186/1477-7517-3-20; Nordt C, 2006, LANCET, V367, P1830, DOI 10.1016/S0140-6736(06)68804-1; O'Brien CP, 2005, J CLIN PSYCHIAT, V66, P28; Olfson M, 2015, JAMA PSYCHIAT, V72, P136, DOI 10.1001/jamapsychiatry.2014.1763; ONG LML, 1995, SOC SCI MED, V40, P903, DOI 10.1016/0277-9536(94)00155-M; Parr JM, 2009, ADDICTION, V104, P13, DOI 10.1111/j.1360-0443.2008.02364.x; Parr JM, 2006, SOC SCI MED, V62, P1237, DOI 10.1016/j.socscimed.2005.07.016; Patten SB, 2009, J AFFECT DISORDERS, V117, pS5, DOI 10.1016/j.jad.2009.06.044; Paulose-Ram R, 2007, PHARMACOEPIDEM DR S, V16, P560, DOI 10.1002/pds.1367; Petitjean S, 2007, INT CLIN PSYCHOPHARM, V22, P292, DOI 10.1097/YIC.0b013e328105e0f2; Quaglio G, 2012, PSYCHIAT RES, V198, P457, DOI 10.1016/j.psychres.2012.02.008; REVES JG, 1985, ANESTHESIOLOGY, V62, P310, DOI 10.1097/00000542-198503000-00017; Richards BL, 2012, J RHEUMATOL, V39, P34, DOI 10.3899/jrheum.120340; RICKELS K, 1990, ARCH GEN PSYCHIAT, V47, P899; RICKELS K, 1983, JAMA-J AM MED ASSOC, V250, P767, DOI 10.1001/jama.250.6.767; Rosenbaum JF, 2005, J CLIN PSYCHIAT, V66, P4; Roy-Byrne PP, 2005, J CLIN PSYCHIAT, V66, P14; Saari TI, 2011, PHARMACOL REV, V63, P243, DOI 10.1124/pr.110.002717; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Vermeire E, 2001, J CLIN PHARM THER, V26, P331, DOI 10.1046/j.1365-2710.2001.00363.x; Voshaar RCO, 2006, CAN J PSYCHIAT, V51, P445, DOI 10.1177/070674370605100706; Wild TC, 2006, ADDICT BEHAV, V31, P1858, DOI 10.1016/j.addbeh.2006.01.002; WOODY GE, 1975, J PSYCHEDEL DRUG, V7, P373, DOI 10.1080/02791072.1975.10471526; Zesiewicz TA, 2011, NEUROLOGY, V77, P1752, DOI 10.1212/WNL.0b013e318236f0fd; Zesiewicz TA, 2005, NEUROLOGY, V64, P2008, DOI 10.1212/01.WNL.0000163769.28552.CD	66	21	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142057	10.1371/journal.pone.0142057	http://dx.doi.org/10.1371/journal.pone.0142057			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7CT	26556055	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000364430700048
J	Rolls, DA; Wang, P; McBryde, E; Pattison, P; Robins, G				Rolls, David A.; Wang, Peng; McBryde, Emma; Pattison, Philippa; Robins, Garry			A Simulation Study Comparing Epidemic Dynamics on Exponential Random Graph and Edge-Triangle Configuration Type Contact Network Models	PLOS ONE			English	Article							P-ASTERISK MODELS; INFECTIOUS-DISEASE; SPREAD	We compare two broad types of empirically grounded random network models in terms of their abilities to capture both network features and simulated Susceptible-Infected-Recovered (SIR) epidemic dynamics. The types of network models are exponential random graph models (ERGMs) and extensions of the configuration model. We use three kinds of empirical contact networks, chosen to provide both variety and realistic patterns of human contact: a highly clustered network, a bipartite network and a snowball sampled network of a "hidden population". In the case of the snowball sampled network we present a novel method for fitting an edge-triangle model. In our results, ERGMs consistently capture clustering as well or better than configuration-type models, but the latter models better capture the node degree distribution. Despite the additional computational requirements to fit ERGMs to empirical networks, the use of ERGMs provides only a slight improvement in the ability of the models to recreate epidemic features of the empirical network in simulated SIR epidemics. Generally, SIR epidemic results from using configuration-type models fall between those from a random network model (i.e., an Erdos-Renyi model) and an ERGM. The addition of subgraphs of size four to edge-triangle type models does improve agreement with the empirical network for smaller densities in clustered networks. Additional subgraphs do not make a noticeable difference in our example, although we would expect the ability to model cliques to be helpful for contact networks exhibiting household structure.	[Rolls, David A.; Wang, Peng; Pattison, Philippa; Robins, Garry] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic 3010, Australia; [McBryde, Emma] Univ Melbourne, Dept Med RMH, Melbourne, Vic 3010, Australia	University of Melbourne; University of Melbourne	Rolls, DA (corresponding author), Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic 3010, Australia.	drolls@unimelb.edu.au	Wang, Peng/AAV-7760-2021; Rolls, David/C-2886-2012; McBryde, Emma/D-2220-2018	Wang, Peng/0000-0002-7701-561X; Rolls, David/0000-0003-0397-9923; McBryde, Emma/0000-0002-9570-9172; Pattison, Philippa/0000-0001-9626-2897; Robins, Garry/0000-0001-7538-5804	Australian Research Council [0987730]; University of Melbourne	Australian Research Council(Australian Research Council); University of Melbourne(University of Melbourne)	DAR was partly funded by the Australian Research Council (Discovery project grant 0987730, http://www.arc.gov.au/ncgp/dp/dp_default.htm) and partly by the University of Melbourne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bearman PS, 2004, AM J SOCIOL, V110, P44, DOI 10.1086/386272; Chatterjee S, 2011, ARXIV11022650V3; FRANK O, 1986, J AM STAT ASSOC, V81, P832, DOI 10.2307/2289017; GILBERT EN, 1959, ANN MATH STAT, V30, P1141, DOI 10.1214/aoms/1177706098; Gile KJ, 2010, SOCIOL METHODOL, V40, P285, DOI 10.1111/j.1467-9531.2010.01223.x; Goodman L.A., 1961, ANN MATH STAT, P148, DOI [10.1214/aoms/1177705148, DOI 10.1214/AOMS/1177705148]; Handcock MS, 2010, ANN APPL STAT, V4, P5, DOI 10.1214/08-AOAS221; Handcock Mark S., 2003, STATNET SOFTWARE TOO; Holme P, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003142; House Thomas, 2011, J R Soc Interface, V8, P67, DOI 10.1098/rsif.2010.0179; Hunter DR, 2007, SOC NETWORKS, V29, P216, DOI 10.1016/j.socnet.2006.08.005; Illenberger J, 2012, SOC NETWORKS, V34, P701, DOI 10.1016/j.socnet.2012.09.001; Isella L, 2011, J THEOR BIOL, V271, P166, DOI 10.1016/j.jtbi.2010.11.033; Karrer B, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.066118; Kenah E, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036113; Machens A, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-185; Mathworks Inc, 2012, MATLAB VERS 7 14 0 R; Meyers LA, 2007, B AM MATH SOC, V44, P63; Miller JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069162; Miller JC, 2012, J R SOC INTERFACE, V9, P890, DOI 10.1098/rsif.2011.0403; Miller JC, 2009, J R SOC INTERFACE, V6, P1121, DOI 10.1098/rsif.2008.0524; Miller JC, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.020901; MOLLOY M, 1995, RANDOM STRUCT ALGOR, V6, P161, DOI 10.1002/rsa.3240060204; Newman MEJ, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.058701; Newman MEJ, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.026121; Newman MEJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016128; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Pattison P, 2002, SOCIOL METHODOL, V32, P301, DOI 10.1111/1467-9531.00119; Pattison PE, 2013, J MATH PSYCHOL, V57, P284, DOI 10.1016/j.jmp.2013.05.004; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Robins G, 2007, SOC NETWORKS, V29, P192, DOI 10.1016/j.socnet.2006.08.003; Robins G, 2007, SOC NETWORKS, V29, P173, DOI 10.1016/j.socnet.2006.08.002; Rolls DA, 2013, SOC NETWORKS, V35, P699, DOI 10.1016/j.socnet.2013.06.003; Salathe M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002616; Salathe M, 2010, P NATL ACAD SCI USA, V107, P22020, DOI 10.1073/pnas.1009094108; Salganik MJ, 2004, SOCIOL METHODOL, V34, P193, DOI 10.1111/j.0081-1750.2004.00152.x; Skvoretz J, 1999, SOCIOL METHODOL, V29, P253, DOI 10.1111/0081-1750.00066; Smieszek T, 2009, THEORETICAL BIOL MED, V6; Snijders TAB, 1992, B SOCIOLOGICAL METHO, V36, P59, DOI DOI 10.1177/075910639203600104; Snijders TAB, 2006, SOCIOL METHODOL, V36, P99, DOI 10.1111/j.1467-9531.2006.00176.x; Stehle J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023176; Stehle J, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-87; Volz EM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002042; Wang P., 2006, PNET PROGRAM SIMULAT; Wang P, 2013, SOC NETWORKS, V35, P96, DOI 10.1016/j.socnet.2013.01.004; Wang P, 2013, SOC NETWORKS, V35, P211, DOI 10.1016/j.socnet.2011.12.004; Wang P, 2009, SOC NETWORKS, V31, P12, DOI 10.1016/j.socnet.2008.08.002; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Welch D, 2011, EPIDEMICS-NETH, V3, P38, DOI 10.1016/j.epidem.2011.01.002	51	4	4	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142181	10.1371/journal.pone.0142181	http://dx.doi.org/10.1371/journal.pone.0142181			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7CT	26555701	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000364430700065
J	Bhattacharjee, P; Bhattacharyya, D				Bhattacharjee, Payel; Bhattacharyya, Debasish			An Enzyme from Aristolochia indica Destabilizes Fibrin-beta Amyloid Co-Aggregate: Implication in Cerebrovascular Diseases	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR; FRAGMENT-D; BINDING; THROMBOSIS; VENOM	Fibrinogen and beta-amyloid (A beta) peptide independently form ordered aggregates but in combination, they form disordered structures which are resistant to fibrinolytic enzymes like plasmin and cause severity in cerebral amyloid angiopathy (CAA). A novel enzyme of 31.3 kDa has been isolated from the root of the medicinal plant Aristolochia indica that showed fibrinolytic as well as fibrin-A beta co-aggregate destabilizing properties. This enzyme is functionally distinct from plasmin. Thrombolytic action of the enzyme was demonstrated in rat model. The potency of the plant enzyme in degrading fibrin and fibrin-plasma protein (A beta, human serum albumin, lysozyme, transthyretin and fibronectin) co-aggregates was demonstrated by atomic force microscopy, scanning electron microscopy and confocal microscopy that showed better potency of the plant enzyme as compared to plasmin. Moreover, the plant enzyme inhibited localization of the co-aggregate inside SH-SY5Y human neuroblastoma cells and also co-aggregate induced cytotoxicity. Plasmin was inefficient in this respect. In the background of limited options for fragmentation of these co-aggregates, the plant enzyme may appear as a potential proteolytic enzyme.	[Bhattacharjee, Payel; Bhattacharyya, Debasish] Indian Inst Chem Biol, CSIR, Div Struct Biol & Bioinformat, Kolkata 700032, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Bhattacharjee, P (corresponding author), Indian Inst Chem Biol, CSIR, Div Struct Biol & Bioinformat, Kolkata 700032, India.	payel.iicb@gmail.com; debasish@iicb.res.in			CSIR-Net Work Project [miND BSC0115]; Department of Science and Technology, Cognition Science Initiative, Project [SR/CSI/07/2009(G)]; UGC-NET fellowship	CSIR-Net Work Project(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology, Cognition Science Initiative, Project; UGC-NET fellowship	This work is supported by CSIR-Net Work Project (miND BSC0115) and the Department of Science and Technology, Cognition Science Initiative, Project No. SR/CSI/07/2009(G). P.B. was supported by UGC-NET fellowship.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Adams RA, 2004, MOL INTERV, V4, P163; Ahn HJ, 2014, J EXP MED, V211, P1049, DOI 10.1084/jem.20131751; Ahn HJ, 2010, P NATL ACAD SCI USA, V107, P21812, DOI 10.1073/pnas.1010373107; ASTRUP T, 1952, ARCH BIOCHEM BIOPHYS, V40, P346, DOI 10.1016/0003-9861(52)90121-5; Bhattacharjee P, 2013, J BIOL CHEM, V288, P30559, DOI 10.1074/jbc.M113.511410; Bhattacharjee P, 2013, J ETHNOPHARMACOL, V145, P220, DOI 10.1016/j.jep.2012.10.056; Buchmann K, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00459; Charidimou A, 2012, J NEUROL NEUROSUR PS, V83, P124, DOI 10.1136/jnnp-2011-301308; Cortes-Canteli M, 2009, J THROMB HAEMOST, V7, P146, DOI 10.1111/j.1538-7836.2009.03376.x; Furie B, 2005, J CLIN INVEST, V115, P3355, DOI 10.1172/JCI26987; GOLDENBERG DP, 1984, ANAL BIOCHEM, V138, P1, DOI 10.1016/0003-2697(84)90761-9; Hawkes C, 2012, J ADDICT RES THER S, VS5, pe001; Hoffman R, 1998, J INVEST DERMATOL, V111, P1140, DOI 10.1046/j.1523-1747.1998.00429.x; Johnson SM, 2012, J MOL BIOL, V421, P185, DOI 10.1016/j.jmb.2011.12.060; KACZMAREK E, 1993, J BIOL CHEM, V268, P2474; Killer M, 2010, DRUG DISCOV TODAY, V15, P640, DOI 10.1016/j.drudis.2010.04.007; Kim SH, 1998, ANAL BIOCHEM, V263, P115, DOI 10.1006/abio.1998.2816; Kolev K., 2014, FIBRINOLYSIS THROMBO, P3, DOI [10.5772/57353., DOI 10.5772/57353]; Lai Aaron Y, 2010, Int J Alzheimers Dis, V2011, P548380, DOI 10.4061/2011/548380; Levi M, 2001, THROMB HAEMOSTASIS, V86, P1331; Liu RM, 2011, NEUROBIOL AGING, V32, P1079, DOI 10.1016/j.neurobiolaging.2009.06.003; Longstaff C, 2011, BLOOD, V117, P661, DOI 10.1182/blood-2010-06-290338; Lord ST, 2011, ARTERIOSCL THROM VAS, V31, P494, DOI 10.1161/ATVBAHA.110.213389; Maity G, 2011, TOXICON, V57, P747, DOI 10.1016/j.toxicon.2011.02.008; McCarty SM, 2013, ADV WOUND CARE, V2, P438, DOI 10.1089/wound.2012.0370; Oliveira SB, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-21; OPRANDY JJ, 1988, AM J TROP MED HYG, V38, P181, DOI 10.4269/ajtmh.1988.38.181; Pontes-Neto Octavio M, 2012, Eur Neurol Rev, V7, P134; PRINCEN HMG, 1985, THROMB HAEMOSTASIS, V53, P212; Rego ROM, 2005, INSECT BIOCHEM MOLEC, V35, P991, DOI 10.1016/j.ibmb.2005.04.001; Sakono M, 2010, FEBS J, V277, P1348, DOI 10.1111/j.1742-4658.2010.07568.x; SHEARMAN MS, 1995, J NEUROCHEM, V65, P218, DOI 10.1046/j.1471-4159.1995.65010218.x; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Simkhada JR, 2010, PROCESS BIOCHEM, V45, P88, DOI 10.1016/j.procbio.2009.08.010; Smith EE, 2009, STROKE, V40, P2601, DOI 10.1161/STROKEAHA.108.536839; Stoffels JMJ, 2013, BRAIN, V136, P116, DOI 10.1093/brain/aws313; Talens S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041966; Taylor D, 2012, DRUG TREATMENTS ALZH, P1; Tucker HM, 2000, J NEUROSCI, V20, P3937; van Rooden S, 2009, STROKE, V40, P3022, DOI 10.1161/STROKEAHA.109.554378; Vieira MNN, 2006, CELL BIOCHEM BIOPHYS, V44, P549, DOI 10.1385/CBB:44:3:549; WILCHEK M, 1984, METHOD ENZYMOL, V104, P3; Yakovlev S, 2000, BIOCHEMISTRY-US, V39, P15730, DOI 10.1021/bi001847a; Yang Z, 2002, BIOCHEMISTRY-US, V41, P10218, DOI 10.1021/bi020299t; Zamolodchikov D, 2012, BLOOD, V119, P3342, DOI 10.1182/blood-2011-11-389668; ZHANG Y, 1995, J BIOL CHEM, V270, P10246, DOI 10.1074/jbc.270.17.10246	47	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141986	10.1371/journal.pone.0141986	http://dx.doi.org/10.1371/journal.pone.0141986			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26545113	Green Submitted, Green Published, gold			2022-12-27	WOS:000364398700067
J	Christin, S; St-Laurent, MH; Berteaux, D				Christin, Sylvain; St-Laurent, Martin-Hugues; Berteaux, Dominique			Evaluation of Argos Telemetry Accuracy in the High-Arctic and Implications for the Estimation of Home-Range Size	PLoS One			English	Article							SMALL SATELLITE TRANSMITTERS; POSITIONING SYSTEM COLLARS; ANIMAL MOVEMENT DATA; STATE-SPACE METHODS; LOCATION ACCURACY; FORAGING ECOLOGY; ELEPHANT SEALS; BOREAL FOREST; TRACKING DATA; FIX INTERVAL	Animal tracking through Argos satellite telemetry has enormous potential to test hypotheses in animal behavior, evolutionary ecology, or conservation biology. Yet the applicability of this technique cannot be fully assessed because no clear picture exists as to the conditions influencing the accuracy of Argos locations. Latitude, type of environment, and transmitter movement are among the main candidate factors affecting accuracy. A posteriori data filtering can remove "bad" locations, but again testing is still needed to refine filters. First, we evaluate experimentally the accuracy of Argos locations in a polar terrestrial environment (Nunavut, Canada), with both static and mobile transmitters transported by humans and coupled to GPS transmitters. We report static errors among the lowest published. However, the 68th error percentiles of mobile transmitters were 1.7 to 3.8 times greater than those of static transmitters. Second, we test how different filtering methods influence the quality of Argos location datasets. Accuracy of location datasets was best improved when filtering in locations of the best classes (LC3 and 2), while the Douglas Argos filter and a homemade speed filter yielded similar performance while retaining more locations. All filters effectively reduced the 68th error percentiles. Finally, we assess how location error impacted, at six spatial scales, two common estimators of home-range size (a proxy of animal space use behavior synthetizing movements), the minimum convex polygon and the fixed kernel estimator. Location error led to a sometimes dramatic overestimation of home-range size, especially at very local scales. We conclude that Argos telemetry is appropriate to study medium-size terrestrial animals in polar environments, but recommend that location errors are always measured and evaluated against research hypotheses, and that data are always filtered before analysis. How movement speed of transmitters affects location error needs additional research.	[Christin, Sylvain; Berteaux, Dominique] Univ Quebec, Chaire Rech Canada Biodivers Nord, Rimouski, PQ G5L 3A1, Canada; [Christin, Sylvain; Berteaux, Dominique] Univ Quebec, Ctr Northern Studies, Rimouski, PQ G5L 3A1, Canada; [St-Laurent, Martin-Hugues] Univ Quebec, Ctr Northern Studies, Dept Biol Chim & Geog, Rimouski, PQ G5L 3A1, Canada; [St-Laurent, Martin-Hugues] Univ Quebec, Ctr Forest Res, Rimouski, PQ G5L 3A1, Canada	University of Quebec; University of Quebec; University of Quebec; University of Quebec	Berteaux, D (corresponding author), Univ Quebec, Chaire Rech Canada Biodivers Nord, Rimouski, PQ G5L 3A1, Canada.	dominique_berteaux@uqar.ca	Berteaux, Dominique/J-3276-2016; Christin, Sylvain/AAS-8910-2020	Berteaux, Dominique/0000-0003-2728-5985; Christin, Sylvain/0000-0001-5876-911X	Canada Foundation for Innovation [228343]; Canada Research Chairs Program; Kenneth M Molson Foundation; Natural Sciences and Engineering Research Council of Canada [227080-2009, 386661-2010]; Mittimatalik Hunters and Trappers Organization; Network of Centres of Excellence of Canada ArcticNet; Polar Continental Shelf Program (Natural Resources Canada); Universite du Quebec a Rimouski (UQAR); Parks Canada Agency	Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canada Research Chairs Program(Canada Research Chairs); Kenneth M Molson Foundation; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Mittimatalik Hunters and Trappers Organization; Network of Centres of Excellence of Canada ArcticNet; Polar Continental Shelf Program (Natural Resources Canada)(Natural Resources Canada); Universite du Quebec a Rimouski (UQAR); Parks Canada Agency	This study was supported by Canada Foundation for Innovation (grant 228343 to DB; http://www.innovation.ca/), Canada Research Chairs Program, Kenneth M Molson Foundation (grants 2011 and 2012 to DB; http://www.kennethmolsonfoundation.ca/), Natural Sciences and Engineering Research Council of Canada (grant 227080-2009 to DB and grant 386661-2010 to MHSL; http://www.nserc-crsng.gc.ca/), Mittimatalik Hunters and Trappers Organization, Network of Centres of Excellence of Canada ArcticNet (grant 2.9ArcticWildlife to DB; http://www.arcticnet.ulaval.ca/), Parks Canada Agency, Polar Continental Shelf Program (Natural Resources Canada), and Universite du Quebec a Rimouski (UQAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreassen HP, 1998, ECOLOGY, V79, P1223, DOI 10.1890/0012-9658(1998)079[1223:SURTHF]2.0.CO;2; Austin D, 2003, MAR MAMMAL SCI, V19, P371, DOI 10.1111/j.1748-7692.2003.tb01115.x; Beauchesne D, 2014, BIOL CONSERV, V172, P190, DOI 10.1016/j.biocon.2014.03.002; Beauchesne D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077514; Boyd IL, 1998, CAN J FISH AQUAT SCI, V55, P845, DOI 10.1139/cjfas-55-4-845; Boyd JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063051; Bradshaw CJA, 2007, ECOL APPL, V17, P628, DOI 10.1890/06-0964; Breed GA, 2012, ECOL MODEL, V235, P49, DOI 10.1016/j.ecolmodel.2012.03.021; Britten MW, 1999, J WILDLIFE MANAGE, V63, P1349, DOI 10.2307/3802854; Burgman MA, 2003, ANIM CONSERV, V6, P19, DOI 10.1017/S1367943003003044; Burns JM, 1998, MAR MAMMAL SCI, V14, P750, DOI 10.1111/j.1748-7692.1998.tb00760.x; Cain JW, 2005, WILDLIFE SOC B, V33, P926, DOI 10.2193/0091-7648(2005)33[926:IOTAGF]2.0.CO;2; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Cargnelutti B, 2007, J WILDLIFE MANAGE, V71, P1380, DOI 10.2193/2006-257; Christin S, 2015, DATA EVALUATION ARGO, DOI [http://dx.doi.org/10.5061/dryad.bt72k, DOI 10.5061/DRYAD.BT72K]; Costa DP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008677; D'Eon RG, 2002, WILDLIFE SOC B, V30, P430; Deutsch CJ, 1998, MAR TECHNOL SOC J, V32, P18; Douglas DC, 2012, METHODS ECOL EVOL, V3, P999, DOI 10.1111/j.2041-210X.2012.00245.x; Dubinin M, 2010, EUR J WILDLIFE RES, V56, P459, DOI 10.1007/s10344-009-0354-4; Dussault C, 1999, WILDLIFE SOC B, V27, P965; Frair JL, 2010, PHILOS T R SOC B, V365, P2187, DOI 10.1098/rstb.2010.0084; Frair JL, 2004, J APPL ECOL, V41, P201, DOI 10.1111/j.0021-8901.2004.00902.x; Freitas C, 2008, MAR MAMMAL SCI, V24, P315, DOI 10.1111/j.1748-7692.2007.00180.x; Georges JY, 1997, IBIS, V139, P403, DOI 10.1111/j.1474-919X.1997.tb04644.x; Gitzen RA, 2006, J WILDLIFE MANAGE, V70, P1334, DOI 10.2193/0022-541X(2006)70[1334:BSFFAO]2.0.CO;2; Grueter CC, 2009, PRIMATES, V50, P81, DOI 10.1007/s10329-008-0113-2; Harris R. B, 1990, TRACKING WILDLIFE SA; Hays GC, 2001, ANIM BEHAV, V61, P1035, DOI 10.1006/anbe.2001.1685; Hazel J, 2009, J EXP MAR BIOL ECOL, V374, P58, DOI 10.1016/j.jembe.2009.04.009; Heard DC, 2008, J WILDLIFE MANAGE, V72, P596, DOI 10.2193/2007-175; Hebblewhite M, 2007, J WILDLIFE MANAGE, V71, P2026, DOI 10.2193/2006-238; Hebblewhite M, 2010, PHILOS T R SOC B, V365, P2303, DOI 10.1098/rstb.2010.0087; Hemson G, 2005, J ANIM ECOL, V74, P455, DOI 10.1111/j.1365-2656.2005.00944.x; Hoenner X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040713; Ionides EL, 2006, P NATL ACAD SCI USA, V103, P18438, DOI 10.1073/pnas.0603181103; Jiang Z, 2008, ECOL RES, V23, P581, DOI 10.1007/s11284-007-0412-x; Jonsen ID, 2013, DEEP-SEA RES PT II, V88-89, P34, DOI 10.1016/j.dsr2.2012.07.008; Jonsen ID, 2007, MAR ECOL PROG SER, V337, P255, DOI 10.3354/meps337255; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; Jonsen ID, 2003, ECOLOGY, V84, P3055, DOI 10.1890/02-0670; Kaczensky Petra, 2010, Wildlife Biology in Practice, V6, P108; KEATING KA, 1991, J WILDLIFE MANAGE, V55, P160, DOI 10.2307/3809254; KEATING KA, 1994, J WILDLIFE MANAGE, V58, P414, DOI 10.2307/3809311; Le Boeuf BJ, 2000, ECOL MONOGR, V70, P353, DOI 10.1890/0012-9615(2000)070[0353:FEONES]2.0.CO;2; Lowry LF, 2001, MAR MAMMAL SCI, V17, P835, DOI 10.1111/j.1748-7692.2001.tb01301.x; Manly B.F.J., 2002, RESOURCE SELECTION A; MCCONNELL BJ, 1992, ANTARCT SCI, V4, P393, DOI 10.1017/S0954102092000580; McKeown A, 2012, AUSTRAL ECOL, V37, P295, DOI 10.1111/j.1442-9993.2011.02276.x; Mellone U, 2011, INT J BIOMETEOROL, V55, P463, DOI 10.1007/s00484-010-0368-3; Nicholls D. G., 2007, Notornis, V54, P137; Nicholls D. G., 2007, Notornis, V54, P121; Patterson TA, 2010, ECOLOGY, V91, P273, DOI 10.1890/08-1480.1; Pedersen MW, 2011, OIKOS, V120, P1281, DOI 10.1111/j.1600-0706.2011.19044.x; REMPEL RS, 1995, J WILDLIFE MANAGE, V59, P543, DOI 10.2307/3802461; Royer F, 2008, J EXP MAR BIOL ECOL, V359, P1, DOI 10.1016/j.jembe.2008.01.026; Sager-Fradkin KA, 2007, J WILDLIFE MANAGE, V71, P1298, DOI 10.2193/2006-367; Sauder JD, 2012, WILDLIFE SOC B, V36, P813, DOI 10.1002/wsb.157; Seaman DE, 1996, ECOLOGY, V77, P2075, DOI 10.2307/2265701; Soutullo A, 2007, J WILDLIFE MANAGE, V71, P1010, DOI 10.2193/2006-042; STEWART BS, 1989, MAR MAMMAL SCI, V5, P361, DOI 10.1111/j.1748-7692.1989.tb00348.x; Tarroux A, 2011, THESIS U QUEBEC RIMO; Tarroux A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042427; Tarroux A, 2010, POLAR BIOL, V33, P1021, DOI 10.1007/s00300-010-0780-5; Tougaard Jakob, 2008, Endangered Species Research, V4, P113, DOI 10.3354/esr00068; Urbano F, 2010, PHILOS T R SOC B, V365, P2177, DOI 10.1098/rstb.2010.0081; Vincent C, 2002, MAR MAMMAL SCI, V18, P156, DOI 10.1111/j.1748-7692.2002.tb01025.x; White NA, 2002, POLAR BIOL, V25, P629, DOI 10.1007/s00300-002-0385-8; Witt MJ, 2010, ANIM BEHAV, V80, P571, DOI 10.1016/j.anbehav.2010.05.022	69	10	10	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141999	10.1371/journal.pone.0141999	http://dx.doi.org/10.1371/journal.pone.0141999			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26545245	Green Published, Green Submitted, gold			2022-12-27	WOS:000364398700068
J	Fontinha, D; Lopes, FB; Marques, S; Simas, JP				Fontinha, Diana; Lopes, Filipa B.; Marques, Sofia; Pedro Simas, J.			Murid Gammaherpesvirus Latency-Associated Protein M2 Promotes the Formation of Conjugates between Transformed B Lymphoma Cells and T Helper Cells	PLoS One			English	Article							EPSTEIN-BARR-VIRUS; IMMUNOLOGICAL SYNAPSE; GERMINAL-CENTER; TARGET-CELLS; HIV-1 NEF; IN-VIVO; INFECTION; PATHOGENESIS; LYMPHOCYTES; ACTIVATION	Establishment of persistent infection in memory B cells by murid herpesvirus-4 (MuHV-4) depends on the proliferation of latently infected germinal center B cells, for which T cell help is essential. Whether the virus is capable of modulating B-T helper cell interaction for its own benefit is still unknown. Here, we investigate if the MuHV-4 latency associated M2 protein, which assembles multiprotein complexes with B cell signaling proteins, plays a role. We observed that M2 led to the upregulation of adhesion and co-stimulatory molecules in transduced B cell lines. In an MHC-II restricted OVA peptide-specific system, M2 polarized to the B-T helper contact zone. Furthermore, it promoted B cell polarization, as demonstrated by the increased proximity of the B cell microtubule organizing center to the interface. Consistent with these data, M2 promoted the formation of B-T helper cell conjugates. In an in vitro competition assay, this translated into a competitive advantage, as T cells preferentially conjugated with M2-expressing B cells. However, expression of M2 alone in B cells was not sufficient to lead to T cell activation, as it only occurred in the presence of specific peptide. Taken together, these findings support that M2 promotes the formation of B-T helper cell conjugates. In an in vivo context this may confer a competitive advantage to the infected B cell in acquisition of T cell help and initiation of a germinal center reaction, hence host colonization.	[Pedro Simas, J.] Univ Lisbon, Fac Med, Inst Mol Med, P-1699 Lisbon, Portugal; Univ Lisbon, Fac Med, Inst Microbiol, P-1699 Lisbon, Portugal	Universidade de Lisboa; Universidade de Lisboa	Simas, JP (corresponding author), Univ Lisbon, Fac Med, Inst Mol Med, P-1699 Lisbon, Portugal.	psimas@medicina.ulisboa.pt	Simas, J Pedro/M-5157-2013	Simas, J Pedro/0000-0001-6982-9253; Alenquer, Marta/0000-0003-3062-1222; Marques, Sofia/0000-0003-1467-1529; Fontinha, Diana/0000-0002-0046-648X	Fundacao para a Ciencia e a Tecnologia [PTDC/SAU-MII/099314/2008]	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	The authors received funding for this work from Fundacao para a Ciencia e a Tecnologia (PTDC/SAU-MII/099314/2008).	Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Barton E, 2011, ANNU REV IMMUNOL, V29, P351, DOI 10.1146/annurev-immunol-072710-081639; Cho NH, 2004, J EXP MED, V200, P681, DOI 10.1084/jem.20040924; Collins CM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004106; Collins CM, 2009, J VIROL, V83, P6484, DOI 10.1128/JVI.00297-09; Coscoy L, 2001, J CLIN INVEST, V107, P1599, DOI 10.1172/JCI12432; de Miranda MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001654; de Miranda MP, 2013, J BIOL CHEM, V288, P3858, DOI 10.1074/jbc.M112.439810; Decalf J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004269; Depoil D, 2005, IMMUNITY, V22, P185, DOI 10.1016/j.immuni.2004.12.010; Duchez S, 2011, J IMMUNOL, V187, P4571, DOI 10.4049/jimmunol.1100600; EHTISHAM S, 1993, J VIROL, V67, P5247, DOI 10.1128/JVI.67.9.5247-5252.1993; Evans AG, 2008, J EXP MED, V205, P669, DOI 10.1084/jem.20071135; Flano E, 2002, J EXP MED, V196, P1363, DOI 10.1084/jem.20020890; Frederico B, 2014, CELL HOST MICROBE, V15, P457, DOI 10.1016/j.chom.2014.03.010; Friedl P, 2005, NAT REV IMMUNOL, V5, P532, DOI 10.1038/nri1647; GEIGER B, 1982, J CELL BIOL, V95, P137, DOI 10.1083/jcb.95.1.137; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Haller C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001212; Haller C, 2006, J BIOL CHEM, V281, P19618, DOI 10.1074/jbc.M513802200; Huppa JB, 2003, NAT REV IMMUNOL, V3, P973, DOI 10.1038/nri1245; Jacoby MA, 2002, J VIROL, V76, P1790, DOI 10.1128/JVI.76.4.1790-1801.2002; Kim IJ, 2003, J IMMUNOL, V171, P886, DOI 10.4049/jimmunol.171.2.886; KUPFER A, 1986, P NATL ACAD SCI USA, V83, P6080, DOI 10.1073/pnas.83.16.6080; KUPFER A, 1984, J IMMUNOL, V133, P2762; Liang XZ, 2004, J VIROL, V78, P12416, DOI 10.1128/JVI.78.22.12416-12427.2004; Macrae AI, 2003, J VIROL, V77, P9700, DOI 10.1128/JVI.77.17.9700-9709.2003; Madureira PA, 2005, J BIOL CHEM, V280, P37310, DOI 10.1074/jbc.M507478200; Marques S, 2003, J VIROL, V77, P7308, DOI 10.1128/JVI.77.13.7308-7318.2003; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Rangaswamy US, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105197; Rangaswamy US, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003858; Robertson JM, 2000, J IMMUNOL, V164, P4706, DOI 10.4049/jimmunol.164.9.4706; Rodrigues L, 2006, J VIROL, V80, P6123, DOI 10.1128/JVI.02700-05; Roughan JE, 2009, J VIROL, V83, P3968, DOI 10.1128/JVI.02609-08; Saxena SK, 2012, FUTURE VIROL, V7, P609, DOI 10.2217/FVL.12.42; Siegel AM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000039; Simas JP, 2004, J GEN VIROL, V85, P2789, DOI 10.1099/vir.0.80138-0; Simas JP, 1998, TRENDS MICROBIOL, V6, P276; Stevenson PG, 1999, J VIROL, V73, P1075, DOI 10.1128/JVI.73.2.1075-1079.1999; Thorley-Lawson DA, 2013, CURR OPIN VIROL, V3, P227, DOI 10.1016/j.coviro.2013.04.005; Thoulouze MI, 2006, IMMUNITY, V24, P547, DOI 10.1016/j.immuni.2006.02.016; Usherwood EJ, 1996, J GEN VIROL, V77, P627, DOI 10.1099/0022-1317-77-4-627; VALITUTTI S, 1993, EUR J IMMUNOL, V23, P790, DOI 10.1002/eji.1830230403; Valitutti S, 2000, METH MOL B, V121, P305; Willer DO, 2003, J VIROL, V77, P8310, DOI 10.1128/JVI.77.15.8310-8321.2003	46	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142540	10.1371/journal.pone.0142540	http://dx.doi.org/10.1371/journal.pone.0142540			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544979	gold, Green Published, Green Submitted			2022-12-27	WOS:000364398700154
J	Gepner, AD; Colangelo, LA; Reilly, N; Korcarz, CE; Kaufman, JD; Stein, JH				Gepner, Adam D.; Colangelo, Laura A.; Reilly, Nicole; Korcarz, Claudia E.; Kaufman, Joel D.; Stein, James H.			Carotid Artery Longitudinal Displacement, Cardiovascular Disease and Risk Factors: The Multi-Ethnic Study of Atherosclerosis	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; BLOOD-PRESSURE; SHEAR STRAIN; WALL; ASSOCIATIONS; MOVEMENTS; DISTENSIBILITY; ELASTICITY; STIFFNESS	Background Associations between carotid artery longitudinal displacement, cardiovascular disease risk factors, and events were evaluated in a large, multi-ethnic cohort. Materials and Methods A novel, reproducible protocol was developed for measuring right common carotid artery longitudinal displacement using ultrasound speckle-tracking. Total longitudinal displacement was measured in 389 randomly selected participants from the Multi-Ethnic Study of Atherosclerosis that were free of cardiovascular disease at baseline. Univariate analyses and Pearson Correlations were used to define relationships between longitudinal displacement with traditional cardiovascular risk factors and traditional measures of arterial stiffness. Hazard ratios of longitudinal displacement for cardiovascular disease and coronary heart disease events were compared using Cox proportional hazards models. Results Participants were a mean (standard deviation) 59.0 (8.7) years old, 48% female, 39% White, 26% Black, 22% Hispanic, and 14% Chinese. They had 19 (4.9%) cardiovascular disease and 14 (3.6%) coronary heart disease events over a mean 9.5 years of follow-up. Less longitudinal displacement was associated with Chinese (beta = -0.11, p = 0.02) compared to White race/ethnicity and greater longitudinal displacement was associated with higher carotid intima-media thickness (beta = 0.26, p = 0.004). Longitudinal displacement was not associated with other cardiovascular disease risk factors or markers of arterial stiffness. After adjustment for age and sex, and heart rate, Chinese race/ethnicity (beta = -0.10, p = 0.04) and carotid intima-media thickness (beta = 0.30 p = 0.003) were associated independently with longitudinal displacement. Longitudinal displacement predicted coronary heart disease (Hazard ratio [HR] 3.3, 95% Confidence intervals [CI] 0.96-11.14, p = 0.06) and cardiovascular disease (HR 2.1, 95% CI 0.6-7.3, p = 0.23) events. Conclusions Less longitudinal displacement is associated with Chinese ethnicity and greater carotid artery longitudinal displacement is associated with thicker intima-media thickness. Longitudinal displacement may predict adverse coronary heart disease and cardiovascular disease events.	[Gepner, Adam D.; Reilly, Nicole; Korcarz, Claudia E.; Stein, James H.] Univ Wisconsin, Dept Med, Div Cardiovasc Med, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Colangelo, Laura A.] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Kaufman, Joel D.] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA	University of Wisconsin System; University of Wisconsin Madison; Northwestern University; Feinberg School of Medicine; University of Washington; University of Washington Seattle	Stein, JH (corresponding author), Univ Wisconsin, Dept Med, Div Cardiovasc Med, Sch Med & Publ Hlth, Madison, WI 53706 USA.	jhs@medicine.wisc.edu	Kaufman, Joel D/B-5761-2008; Korcarz, Claudia/A-5728-2018	Kaufman, Joel D/0000-0003-4174-9037; Stein, James/0000-0002-2770-8223; Korcarz, Claudia/0000-0001-9691-9027	National Heart, Lung, and Blood Institute [HC95159-HC95169, HL07936]; National Institute of Environmental Health Sciences [ES015915]; National Center for Research Resources [RR024156, RR025005]; Ruth L. Kirschstein National Research Service Award from the National Heart, Lung, and Blood Institute [HL07936]; Alpha Omega Alpha Postgraduate Award; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095162, N01HC095160, N01HC095163, N01HC095164, N01HC095169, N01HC095166, N01HC095161, N01HC095159, N01HC095168, N01HC095167, N01HC095165] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P50ES015915] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Ruth L. Kirschstein National Research Service Award from the National Heart, Lung, and Blood Institute; Alpha Omega Alpha Postgraduate Award; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Grants HC95159-HC95169 and HL07936 from the National Heart, Lung, and Blood Institute www.nhlbi.nih.gov, Grant ES015915 from the National Institute of Environmental Health Sciences www.niehs.nih.gov, Grants RR024156 and RR025005 from the National Center for Research Resources http://dnrc.nih.gov/reports/programs/ncrr.asp, Ruth L. Kirschstein National Research Service Award from the National Heart, Lung, and Blood Institute to the University of Wisconsin-Madison Cardiovascular Research Center (HL07936) http://www.nhlbi.nih.gov/research/training/programs/predoctoral/nrsa-parent-f31, Alpha Omega Alpha Postgraduate Award http://alphaomegaalpha.org/postgrad_award.html.	Ahlgren AR, 2009, CLIN PHYSIOL FUNCT I, V29, P353, DOI 10.1111/j.1475-097X.2009.00875.x; BRANDS PJ, 1995, ULTRASOUND MED BIOL, V21, P171, DOI 10.1016/S0301-5629(94)00111-1; Catalano M, 2011, EUR J ECHOCARDIOGR, V12, P528, DOI 10.1093/ejechocard/jer078; Cinthio M, 2006, AM J PHYSIOL-HEART C, V291, pH394, DOI 10.1152/ajpheart.00988.2005; Folsom AR, 2008, ARCH INTERN MED, V168, P1333, DOI 10.1001/archinte.168.12.1333; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gepner AD, 2014, STROKE, V45, P48, DOI 10.1161/STROKEAHA.113.002649; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Ma XJ, 2012, EUR J OBSTET GYN R B, V160, P30, DOI 10.1016/j.ejogrb.2011.09.038; Nichols W, 2011, THEORETICAL EXPT CLI; Oyre S, 1998, J AM COLL CARDIOL, V32, P128, DOI 10.1016/S0735-1097(98)00207-1; Pannier BM, 2002, AM J HYPERTENS, V15, P743, DOI 10.1016/S0895-7061(02)02962-X; Park HE, 2012, J ATHEROSCLER THROMB, V19, P349, DOI 10.5551/jat.10686; Persson M, 2003, CLIN PHYSIOL FUNCT I, V23, P247, DOI 10.1046/j.1475-097X.2003.00504.x; Reneman RS, 2005, EUR HEART J, V26, P960, DOI 10.1093/eurheartj/ehi177; Shimbo D, 2013, AM J HYPERTENS, V26, P896, DOI 10.1093/ajh/hpt040; Svedlund S, 2011, ARTERIOSCL THROM VAS, V31, P1668, DOI 10.1161/ATVBAHA.111.222901; Svedlund S, 2011, CLIN PHYSIOL FUNCT I, V31, P32, DOI 10.1111/j.1475-097X.2010.00976.x; Tattersall MC, 2014, STROKE, V45, P3257, DOI 10.1161/STROKEAHA.114.005669; Weber T, 2004, CIRCULATION, V109, P184, DOI 10.1161/01.CIR.0000105767.94169.E3; WEIZSACKER HW, 1983, J BIOMECH, V16, P703, DOI 10.1016/0021-9290(83)90080-5; Wilkins JT, 2012, AM J HYPERTENS, V25, P535, DOI 10.1038/ajh.2012.13; Yang WI, 2011, J HYPERTENS, V29, P2404, DOI 10.1097/HJH.0b013e32834c46dd; Zahnd G VD, 2012, LONGITUDINAL DISPLAC; Zahnd G, 2012, ULTRASOUND MED BIOL, V38, P1705, DOI 10.1016/j.ultrasmedbio.2012.05.004; Zhang L, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-39	26	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142138	10.1371/journal.pone.0142138	http://dx.doi.org/10.1371/journal.pone.0142138			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26545210	gold, Green Published, Green Submitted			2022-12-27	WOS:000364398700084
J	Gong, T; Shuai, L				Gong, Tao; Shuai, Lan			Modeling Coevolution between Language and Memory Capacity during Language Origin	PLOS ONE			English	Article							WORKING-MEMORY; EMERGENCE; EVOLUTION; COMMUNICATION; CHILDREN; IMPAIRMENT; SIMULATION; COMPONENT	Memory is essential to many cognitive tasks including language. Apart from empirical studies of memory effects on language acquisition and use, there lack sufficient evolutionary explorations on whether a high level of memory capacity is prerequisite for language and whether language origin could influence memory capacity. In line with evolutionary theories that natural selection refined language-related cognitive abilities, we advocated a coevolution scenario between language and memory capacity, which incorporated the genetic transmission of individual memory capacity, cultural transmission of idiolects, and natural and cultural selections on individual reproduction and language teaching. To illustrate the coevolution dynamics, we adopted a multi-agent computational model simulating the emergence of lexical items and simple syntax through iterated communications. Simulations showed that: along with the origin of a communal language, an initially-low memory capacity for acquired linguistic knowledge was boosted; and such coherent increase in linguistic understandability and memory capacities reflected a language-memory coevolution; and such coevolution stopped till memory capacities became sufficient for language communications. Statistical analyses revealed that the coevolution was realized mainly by natural selection based on individual communicative success in cultural transmissions. This work elaborated the biology-culture parallelism of language evolution, demonstrated the driving force of culturally-constituted factors for natural selection of individual cognitive abilities, and suggested that the degree difference in language-related cognitive abilities between humans and nonhuman animals could result from a coevolution with language.	[Gong, Tao; Shuai, Lan] Haskins Labs Inc, New Haven, CT 06511 USA	Yale University; Haskins Laboratories	Gong, T (corresponding author), Haskins Labs Inc, New Haven, CT 06511 USA.	gong@haskins.yale.edu			US NIH Grant [HD-071988]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD071988] Funding Source: NIH RePORTER	US NIH Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	T.G. acknowledges support by the US NIH Grant (HD-071988), but both authors received no specific funding for this particular work.	Arbib M, 2013, BRAIN GOT LANGUAGE M; Arbib MA, 2008, INTERACT STUD, V9, P154, DOI 10.1075/is.9.1.11arb; Arnon I, 2010, J MEM LANG, V62, P67, DOI 10.1016/j.jml.2009.09.005; Atkins PWB, 1998, APPL PSYCHOLINGUIST, V19, P537, DOI 10.1017/S0142716400010353; Atkinson R. C., 1968, PSYCHOL LEARNING MOT, V2, P89, DOI [DOI 10.1016/S0079-7421(08)60422-3, 10.1016/S0079-7421(08)60422-3]; Baddeley A, 1998, PSYCHOL REV, V105, P158, DOI 10.1037/0033-295X.105.1.158; Baddeley A, 2003, J COMMUN DISORD, V36, P189, DOI 10.1016/S0021-9924(03)00019-4; BADDELEY A, 1988, J MEM LANG, V27, P586, DOI 10.1016/0749-596X(88)90028-9; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Baronchelli A, 2006, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2006/06/P06014; Batali J., 1998, APPROACHES EVOLUTION, P405; Berwick RC, 2013, TRENDS COGN SCI, V17, P89, DOI 10.1016/j.tics.2012.12.002; Bishop DVM, 2001, PHILOS T R SOC B, V356, P369, DOI 10.1098/rstb.2000.0770; Bod R, 2009, COGNITIVE SCI, V33, P752, DOI 10.1111/j.1551-6709.2009.01031.x; Botha R, 2013, EVOLUTIONARY EMERGEN; Box G.E.P., 1987, WILEY SERIES PROBABI, P229; Bybee J, 2006, LANGUAGE, V82, P711, DOI 10.1353/lan.2006.0186; Chater N, 2009, P NATL ACAD SCI USA, V106, P1015, DOI 10.1073/pnas.0807191106; Chomsky N, 1995, MINIMALISM PROGRAM; Chomsky Noam, 2010, EVOLUTION HUMAN LANG, P45, DOI DOI 10.1017/CBO9780511817755.003; Christiansen MH, 1999, COGNITIVE SCI, V23, P157, DOI 10.1207/s15516709cog2302_2; Christiansen MH, 2008, BEHAV BRAIN SCI, V31, P489, DOI 10.1017/S0140525X08004998; Christiansen MH, 2011, HUM BIOL, V83, P247, DOI 10.3378/027.083.0206; Corballis MC, 2002, HAND MOUTH ORIGINS L; Deacon TW, 2010, P NATL ACAD SCI USA, V107, P9000, DOI 10.1073/pnas.0914624107; Deacon W. T., 1997, SYMBOLIC SPECIES COE; ELMAN JL, 1990, COGNITIVE SCI, V14, P179, DOI 10.1207/s15516709cog1402_1; Elman JL, 1996, RETHINKING INNATENES; Fagott J, 2006, P NATL ACAD SCI USA, V103, P17564, DOI 10.1073/pnas.0605184103; Feldman MW, 1996, TRENDS ECOL EVOL, V11, P453, DOI 10.1016/0169-5347(96)10052-5; Field A., 2009, DISCOVERING STAT USI, V3, DOI DOI 10.1080/1057610X.2016.1157408; Fitch WT, 2010, EVOLUTION OF LANGUAGE, PROCEEDINGS, P137; GATHERCOLE SE, 1990, J MEM LANG, V29, P336, DOI 10.1016/0749-596X(90)90004-J; Gelfand M., 2011, ADV CULTURE PSYCHOL, P5, DOI DOI 10.1093/ACPROF:OSO/9780195380392.001.0001; Gong t, 2015, LANGUAGE, V91, P256; Gong T., 2009, COMPUTATIONAL SIMULA; Gong T, 2013, LANG SCI, V40, P12, DOI 10.1016/j.langsci.2013.04.002; Gong T, 2013, LANG SCI, V37, P1, DOI 10.1016/j.langsci.2012.09.002; Gong T, 2012, P ROY SOC B-BIOL SCI, V279, P4643, DOI 10.1098/rspb.2012.1431; Gong T, 2011, INTERACT STUD, V12, P63, DOI 10.1075/is.12.1.03gon; Gong T, 2010, BIOLINGUISTICS, V4, P385; Gong T, 2010, ADAPT BEHAV, V18, P356, DOI 10.1177/1059712310377241; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; HULME C, 1991, J MEM LANG, V30, P685, DOI 10.1016/0749-596X(91)90032-F; Hurford J., 2012, ORIGINS GRAMMER; Hurford J.R., 2007, ORIGINS MEANING; HURFORD JR, 1989, LINGUA, V77, P187, DOI 10.1016/0024-3841(89)90015-6; Jenkins L, 2004, VARIATION UNIVERSALS, P379; Kendal J, 2011, PHILOS T R SOC B, V366, P785, DOI 10.1098/rstb.2010.0306; Kirby S., 1999, FUNCTION SELECTION I; Laland KN, 2010, NAT REV GENET, V11, P137, DOI 10.1038/nrg2734; Lefebvre C, 2013, NEW PERSPECTIVES ORI; Leonard LB, 2014, CHILD DEV PERSPECT, V8, P1, DOI 10.1111/cdep.12053; Levinson SC, 2013, STRUNGMANN FORUM REP, P219; Lum JAG, 2010, INT J LANG COMM DIS, V45, P96, DOI 10.3109/13682820902752285; Mesoudi A, 2011, HUM BIOL, V83, P141, DOI 10.3378/027.083.0201; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Nelson C, 2001, BEHAV BRAIN SCI, V24, P87; Odling-Smee J., 2003, MONOGRAPHS POPULATIO, V37; PINKER S, 1990, BEHAV BRAIN SCI, V13, P707, DOI 10.1017/S0140525X00081061; Puglisi A, 2008, P NATL ACAD SCI USA, V105, P7936, DOI 10.1073/pnas.0802485105; Richerson PJ, 2010, BIOLINGUISTICS, V4, P289; Richerson PJ., 2013, CULTURAL EVOLUTION S; Scholz J, 2009, NAT NEUROSCI, V12, P1370, DOI 10.1038/nn.2412; Scott-Phillips TC, 2012, P ROY SOC B-BIOL SCI, V279, P1943, DOI 10.1098/rspb.2011.2181; Scott-Phillips TC, 2009, COGNITION, V113, P226, DOI 10.1016/j.cognition.2009.08.009; Smith K, 2003, ARTIF LIFE, V9, P371, DOI 10.1162/106454603322694825; Sperber D, 2000, METAREPRESENTATIONS; Steels L, 2005, CONNECT SCI, V17, P213, DOI 10.1080/09540090500269088; Steels L., 2012, EXPT CULTURAL LANGUA; Steels L, 2011, PHYS LIFE REV, V8, P339, DOI 10.1016/j.plrev.2011.10.014; Stromswold K, 2001, LANGUAGE, V77, P647, DOI 10.1353/lan.2001.0247; Szamado S, 2013, OXFORD HDB LANGUAGE, P157; Tallerman M. M., 2013, OXFORD HDB LANGUAGE; Thompson JD., 1994, COEVOLUTIONARY PROCE; Tomasello M, 2005, BEHAV BRAIN SCI, V28, P675, DOI 10.1017/S0140525X05000129; Tomasello M, 2009, ORIGINS HUMAN COMMUN; Tomasello M., 2003, CONSTRUCTING LANGUAG; Tulving E., 1972, ORG MEMORY, P382, DOI DOI 10.1007/978-1-4419-0463-8_37; VANDERLELY HKJ, 1993, J SPEECH HEAR RES, V36, P1193, DOI 10.1044/jshr.3606.1193; Vosu E, 2008, TRAMES-J HUMANIT SOC, V12, P243, DOI 10.3176/tr.2008.3.01; Wagner K, 2003, ADAPT BEHAV, V11, P37, DOI 10.1177/10597123030111003; Watkins KE, 2002, BRAIN, V125, P452, DOI 10.1093/brain/awf058; Watumull J, 2014, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.01017; Wood R, 2012, ADAPT BEHAV, V20, P81, DOI 10.1177/1059712311421219; Wray A., 2008, FORMULAIC LANGUAGE P; Zhang MH, 2013, P NATL ACAD SCI USA, V110, P9698, DOI 10.1073/pnas.1303108110	89	5	5	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142281	10.1371/journal.pone.0142281	http://dx.doi.org/10.1371/journal.pone.0142281			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV6RT	26544876	gold, Green Submitted, Green Published			2022-12-27	WOS:000364398700105
J	Ismail, NA; Said, HM; Pinini, Z; Omar, SV; Beyers, N; Naidoo, P				Ismail, N. A.; Said, H. M.; Pinini, Z.; Omar, S. V.; Beyers, N.; Naidoo, P.			Optimizing Mycobacterial Culture in Smear-Negative, Human Immunodeficiency Virus-Infected Tuberculosis Cases	PLoS One			English	Article							PULMONARY TUBERCULOSIS; DIAGNOSIS; HIV; SPUTUM; YIELD; MICROSCOPY; SETTINGS; PROGRAM; PEOPLE; TIME	Introduction Tuberculosis (TB) is a significant public health problem and the diagnosis in human immunodeficiency virus (HIV)-infected individuals is challenging. The use of mycobacterial culture remains an important complementary tool and optimizing it has important benefits. We sought to determine the effect of an increase in the number of specimens evaluated, addition of nutritional supplementation to the culture medium, sputum appearance and volume on diagnostic yield and time to detection of pulmonary TB among smear-negative, HIV-infected adults. Methods In this prospective study conducted at the Tshwane District Hospital and Academic TB Laboratory, Pretoria, South Africa we collected three sputum specimens an hour apart from presumptive TB cases at an antiretroviral treatment site. We analysed specimens from 236 patients. Specimen appearance and volume were recorded. All specimens were processed for culture using both standard and supplemented media. Results A single specimen identified 79% of PTB cases using standard media; the second and third specimens added 12.5% and 8.3% respectively. Media supplementation, sputum appearance and specimen volume had no effect on culture yield or contamination rates. The mean time to detection was reduced from 19.8 days in standard cultures to 11.8 days in nutrient supplemented cultures (p = 0.002). For every 1 ml increase in sputum volume, time to detection was decreased by a factor of 0.797 (p = 0.011). Conclusion Use of an inexpensive culture supplement substantially reduced time to detection and could contribute to reducing treatment delay among HIV-infected cases.	[Ismail, N. A.] Univ Pretoria, Fac Hlth Sci, Dept Med Microbiol, ZA-0002 Pretoria, South Africa; [Ismail, N. A.; Said, H. M.; Omar, S. V.] Natl Inst Communicable Dis, Ctr TB, Johannesburg, South Africa; [Said, H. M.] Univ Free State, Dept Med Microbiol, Bloemfontein, South Africa; [Pinini, Z.] Gauteng Dept Hlth, TB HIV Directorate, Johannesburg, South Africa; [Beyers, N.; Naidoo, P.] Univ Stellenbosch, Dept Paediat & Child Hlth, Desmond Tutu TB Ctr, Cape Town, South Africa	University of Pretoria; National Institute for Communicable Diseases (NICD); University of the Free State; Stellenbosch University	Ismail, NA (corresponding author), Univ Pretoria, Fac Hlth Sci, Dept Med Microbiol, ZA-0002 Pretoria, South Africa.	naziri@nicd.ac.za	Omar, Shaheed Vally/AAB-5071-2020; Said, Halima/GWV-3962-2022	Omar, Shaheed Vally/0000-0001-6983-1636; Said, Halima/0000-0003-4843-9541	United States Agency for International Development (USAID) [GHN-A-00-08-00004-00]	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR)	This research was supported by a United States Agency for International Development (USAID) Cooperative Agreement (TREAT TB Agreement No. GHN-A-00-08-00004-00). The contents are the responsibility of the author(s) and do not necessarily reflect the views of USAID.	Brittle W, 2009, J CLIN MICROBIOL, V47, P1287, DOI 10.1128/JCM.02320-08; Cain KP, 2010, NEW ENGL J MED, V362, P707, DOI 10.1056/NEJMoa0907488; Getahun H, 2007, LANCET, V369, P2042, DOI 10.1016/S0140-6736(07)60284-0; Hargreaves NJ, 2001, INT J TUBERC LUNG D, V5, P847; Harries AD, 1999, T ROY SOC TROP MED H, V93, P443, DOI 10.1016/S0035-9203(99)90153-0; Havlir DV, 2008, JAMA-J AM MED ASSOC, V300, P423, DOI 10.1001/jama.300.4.423; Hopewell PC, 2006, LANCET INFECT DIS, V6, P710, DOI 10.1016/S1473-3099(06)70628-4; Kik SV, 2014, EUR RESPIR J, V43, P1793, DOI 10.1183/09031936.00217313; KUBICA GP, 1963, AM REV RESPIR DIS, V87, P775; Mase SR, 2007, INT J TUBERC LUNG D, V11, P485; Monkongdee P, 2009, AM J RESP CRIT CARE, V180, P903, DOI 10.1164/rccm.200905-0692OC; Padmapriyadarsini C, 2011, INDIAN J MED RES, V134, P850, DOI 10.4103/0971-5916.92630; Peter JG, 2014, EUR RESPIR J, V43, P185, DOI 10.1183/09031936.00198012; Peter JG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039966; Pheiffer C, 2008, INT J TUBERC LUNG D, V12, P792; Schoch OD, 2007, AM J RESP CRIT CARE, V175, P80, DOI 10.1164/rccm.200608-1092OC; STATSSA, 2013, MORT CAUS DEATH S AF; Steingart KR, 2006, LANCET INFECT DIS, V6, P664, DOI 10.1016/S1473-3099(06)70602-8; Steingart KR, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009593.pub2; WHO, 2012, WHO POL COLL TB HIV; World Health Organization, 2014, WHO MON XPERT MTB RI; World Health Organization, 2014, XPERT MTB RIF IMPL M	22	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141851	10.1371/journal.pone.0141851	http://dx.doi.org/10.1371/journal.pone.0141851			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544183	Green Published, gold			2022-12-27	WOS:000364398700054
J	Mansell, H; Soliman, M; Elmoselhi, H; Shoker, A				Mansell, Holly; Soliman, Mahmoud; Elmoselhi, Hamdi; Shoker, Ahmed			Elevated Circulating Interleukin 33 Levels in Stable Renal Transplant Recipients at High Risk for Cardiovascular Events	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; CORONARY-ARTERY-DISEASE; ACUTE REJECTION; HEART-DISEASE; IFN-GAMMA; IL-33; ATHEROSCLEROSIS; INFLAMMATION; SERUM; CYTOKINE	Background The Major Adverse Cardiovascular Events calculator (CRCRTR-MACE) estimates the burden of cardiovascular risk in renal transplant recipients (RTR). Our recent study of 95 RTR reported the 7-year median risk of cardiovascular events (CVE) to be 9.97%, ranging from 1.93 to 84.27%. Nearly a third (28.4%) of the cohort was above 20% risk for a CVE. Since interleukins (ILs) as part of the inflammatory response may play a role in the pathogenesis of cardiovascular disease (CVD), we extended this study to identify which ILs are associated with high cardiovascular risk in this population. Methods Twenty-two ILs were measured by multiplexed fluorescent bead-based immunoassay in 95 RTR and 56 normal controls. Stepwise analysis after multivariate determination of significant demographic and inflammatory variables was performed between the high and low-CVD risk groups (which were arbitrarily set at scores <10% and >= 20%, respectively). Normalized data was presented as mean +/- SD and non-normalized data as median (minimum-maximum). Significance was measured at <0.05. Results 27.5% of the low-risk and 31.3% of the high-risk groups had mean IL levels above the 95 percentile of the normal control levels. In the non-parametric analysis IL-6, 9, 16, 17 and 33 were significantly higher in the high-risk group compared to the control. Univariate analysis (UVA) of the high-risk group identified IL-33 as the only IL that remained significantly higher than the control and low-risk groups (p = 0.000). The percentage of patients with IL-33 levels above the 90 percentile of control value in the low and high-risk groups were 15.6% and 52.0%, respectively (p<0.002). UVA of factors significant to high IL-33 levels included estimated glomerular filtration rate (eGFR), while diabetes mellitus, serum phosphorus, microalbuminuria and age also remained significant in the multivariate analysis. Conclusion Circulating IL-33 level is positively associated with high CRCRTR-MACE score. Diminished eGFR, age, diabetes, serum phosphorus and microalbuminurea demonstrate significant relationship with elevated IL-33 levels, supporting the possible pathognomonic role of IL-33 in the cardiovascular burden in RTR.	[Mansell, Holly] Univ Saskatchewan, Coll Pharm & Nutr, Saskatoon, SK S7N 0W0, Canada; [Soliman, Mahmoud; Elmoselhi, Hamdi; Shoker, Ahmed] St Pauls Hosp, Saskatchewan Renal Transplant Program, Saskatoon, SK, Canada; [Shoker, Ahmed] Univ Saskatchewan, Dept Med, Saskatoon, SK S7N 0W0, Canada	University of Saskatchewan; St. Paul's Hospital; University of Saskatchewan; University of Saskatchewan	Shoker, A (corresponding author), St Pauls Hosp, Saskatchewan Renal Transplant Program, Saskatoon, SK, Canada.	ahmed.shoker@usask.ca			Astellas Pharma Canada	Astellas Pharma Canada(Astellas Pharmaceuticals)	http://www.astellas.ca/ Astellas Pharma Canada to A.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedini S, 2009, CLIN J AM SOC NEPHRO, V4, P1246, DOI 10.2215/CJN.00930209; Akcay A, 2011, J AM SOC NEPHROL, V22, P2057, DOI 10.1681/ASN.2010091011; Arnlov J, 2005, CIRCULATION, V112, P969, DOI 10.1161/CIRCULATIONAHA.105.538132; Bao YS, 2012, J CLIN IMMUNOL, V32, P587, DOI 10.1007/s10875-011-9622-7; Barbour M, 2014, EUR J IMMUNOL, V44, P3320, DOI 10.1002/eji.201444671; Brunner SM, 2011, TRANSPL INT, V24, P1027, DOI 10.1111/j.1432-2277.2011.01306.x; Calvo MS, 2013, AM J CLIN NUTR, V98, P6, DOI 10.3945/ajcn.112.053934; Cayrol C, 2014, CURR OPIN IMMUNOL, V31, P31, DOI 10.1016/j.coi.2014.09.004; Choi YS, 2009, BLOOD, V114, P3117, DOI 10.1182/blood-2009-02-203372; Cortez-Cooper M, 2013, VASC MED, V18, P282, DOI 10.1177/1358863X13508336; De Serres SA, 2012, CLIN J AM SOC NEPHRO, V7, P1018, DOI 10.2215/CJN.11051011; DECKERT T, 1989, DIABETOLOGIA, V32, P219, DOI 10.1007/BF00285287; Demyanets S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095055; Dhillon OS, 2013, INT J CARDIOL, V167, P2182, DOI 10.1016/j.ijcard.2012.05.073; Foley RN, 2009, J AM SOC NEPHROL, V20, P397, DOI 10.1681/ASN.2008020141; Fontes JA, 2015, CYTOKINE, V74, P62, DOI 10.1016/j.cyto.2014.12.024; Frostegard J, 1999, ATHEROSCLEROSIS, V145, P33, DOI 10.1016/S0021-9150(99)00011-8; Garg AX, 2002, KIDNEY INT, V61, P1486, DOI 10.1046/j.1523-1755.2002.00270.x; Gibson CM, 2006, AM J CARDIOL, V97, P1473, DOI 10.1016/j.amjcard.2005.12.037; Gregersen I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072769; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Hasan A, 2014, BMC IMMUNOL, V15, DOI 10.1186/1471-2172-15-19; Israni AK, 2010, AM J TRANSPLANT, V10, P338, DOI 10.1111/j.1600-6143.2009.02949.x; Jiang HR, 2012, EUR J IMMUNOL, V42, P1804, DOI 10.1002/eji.201141947; Kidd Parris, 2003, Altern Med Rev, V8, P223; Kritchevsky SB, 2005, CARDIOVASC RES, V66, P265, DOI 10.1016/j.cardiores.2004.12.026; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Libby P, 2010, CIRC J, V74, P213, DOI 10.1253/circj.CJ-09-0706; Lindmark E, 2001, JAMA-J AM MED ASSOC, V286, P2107, DOI 10.1001/jama.286.17.2107; Liu CL, 2014, CORONARY ARTERY DIS, V25, P498, DOI 10.1097/MCA.0000000000000117; Liu JY, 2014, J CLIN NEUROSCI, V21, P298, DOI 10.1016/j.jocn.2013.04.036; Liu Q, 2013, CYTOKINE, V62, P183, DOI 10.1016/j.cyto.2013.02.026; Lloyd-Jones DM, 2010, CIRCULATION, V121, P1768, DOI 10.1161/CIRCULATIONAHA.109.849166; Mansell H, 2015, AM J NEPHROL, V41, P147, DOI 10.1159/000377641; Mansell H, 2014, SCI WORLD J, DOI 10.1155/2014/750579; Mansell H, 2013, CLIN TRANSPLANT, V27, pE391, DOI 10.1111/ctr.12159; Matta BM, 2014, J IMMUNOL, V193, P4010, DOI 10.4049/jimmunol.1400481; McLaren JE, 2010, J IMMUNOL, V185, P1222, DOI 10.4049/jimmunol.1000520; Menon MC, 2013, ANN NY ACAD SCI, V1301, P21, DOI 10.1111/nyas.12283; Millan O, 2014, CLIN IMMUNOL, V154, P141, DOI 10.1016/j.clim.2014.07.007; Miller AM, 2008, J EXP MED, V205, P339, DOI 10.1084/jem.20071868; Miller AM, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-22; Milovanovic M, 2012, IMMUNOL RES, V52, P89, DOI 10.1007/s12026-012-8283-9; Murphy GEJ, 2010, ANN RHEUM DIS, V69, P43, DOI 10.1136/ard.2009.120113; Packard RRS, 2008, CLIN CHEM, V54, P24, DOI 10.1373/clinchem.2007.097360; Pomeshchik Y, 2015, BRAIN BEHAV IMMUN, V44, P68, DOI 10.1016/j.bbi.2014.08.002; Saini D, 2011, J HEART LUNG TRANSPL, V30, P624, DOI 10.1016/j.healun.2011.01.708; Salas A, 2013, GUT, V62, P1392, DOI 10.1136/gutjnl-2012-303920; Sanada S, 2007, J CLIN INVEST, V117, P1538, DOI 10.1172/JCI30634; Sanchez-Escuredo A, 2010, TRANSPL P, V42, P2905, DOI 10.1016/j.transproceed.2010.07.076; Schiffrin EL, 2007, CIRCULATION, V116, P85, DOI 10.1161/CIRCULATIONAHA.106.678342; Schuett H, 2009, THROMB HAEMOSTASIS, V102, P215, DOI 10.1160/TH09-05-0297; Shabgah AG, 2014, POSTEP DERM ALERGOL, V31, P256, DOI 10.5114/pdia.2014.40954; Shimpo M, 2004, CIRCULATION, V109, P2186, DOI 10.1161/01.CIR.0000127958.21003.5A; Shin WS, 2002, ATHEROSCLEROSIS, V160, P91, DOI 10.1016/S0021-9150(01)00571-8; Soveri I, 2012, TRANSPLANTATION, V94, P57, DOI 10.1097/TP.0b013e3182516cdc; Stenvinkel P, 2005, KIDNEY INT, V67, P1216, DOI 10.1111/j.1523-1755.2005.00200.x; Thierry A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088742; Tonelli M, 2005, CIRCULATION, V112, P2627, DOI 10.1161/CIRCULATIONAHA.105.553198; Tsimikas S, 2014, J AM COLL CARDIOL, V63, P1724, DOI 10.1016/j.jacc.2013.12.030; Yin H, 2010, TRANSPLANTATION, V89, P1189, DOI 10.1097/TP.0b013e3181d720af; Zhang K, 2013, CHINESE MED J-PEKING, V126, P3628, DOI 10.3760/cma.j.issn.0366-6999.20130145; Zhao Q, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/587376	64	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142141	10.1371/journal.pone.0142141	http://dx.doi.org/10.1371/journal.pone.0142141			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544186	Green Submitted, Green Published, gold			2022-12-27	WOS:000364398700086
J	Naidoo, K; Malindisa, ST; Otgaar, TC; Bernert, M; Dias, BD; Ferreira, E; Reusch, U; Knackmuss, S; Little, M; Weiss, SFT; Letsolo, BT				Naidoo, Kerrilyn; Malindisa, Sibusiso T.; Otgaar, Tyrone C.; Bernert, Martin; Dias, Bianca Da Costa; Ferreira, Eloise; Reusch, Uwe; Knackmuss, Stefan; Little, Melvyn; Weiss, Stefan F. T.; Letsolo, Boitelo T.			Knock-Down of the 37kDa/67kDa Laminin Receptor LRP/LR Impedes Telomerase Activity	PLOS ONE			English	Article							INFECTED NEURONAL CELLS; CELLULAR SENESCENCE; MAMMALIAN TELOMERES; ANTIBODY IGG1-IS18; PRPSC PROPAGATION; PRION PROTEIN; CANCER CELLS; ACTS; IMMORTALIZATION; SHELTERIN	Cancer has become a major problem worldwide due to its increasing incidence and mortality rates. Both the 37kDa/67kDa laminin receptor (LRP/LR) and telomerase are overexpressed in cancer cells. LRP/LR enhances the invasiveness of cancer cells thereby promoting metastasis, supporting angiogenesis and hampering apoptosis. An essential component of telomerase, hTERT is overexpressed in 85-90% of most cancers. hTERT expression and increased telomerase activity are associated with tumor progression. As LRP/LR and hTERT both play a role in cancer progression, we investigated a possible correlation between LRP/LR and telomerase. LRP/LR and hTERT co-localized in the perinuclear compartment of tumorigenic breast cancer (MDA_MB231) cells and non-tumorigenic human embryonic kidney (HEK293) cells. FLAG (R) Co-immunoprecipitation assays confirmed an interaction between LRP/LR and hTERT. In addition, flow cytometry revealed that both cell lines displayed high cell surface and intracellular LRP/LR and hTERT levels. Knock-down of LRP/LR by RNAi technology significantly reduced telomerase activity. These results suggest for the first time a novel function of LRP/LR in contributing to telomerase activity. siRNAs targeting LRP/LR may act as a potential alternative therapeutic tool for cancer treatment by (i) blocking metastasis (ii) promoting angiogenesis (iii) inducing apoptosis and (iv) impeding telomerase activity.	[Naidoo, Kerrilyn; Malindisa, Sibusiso T.; Otgaar, Tyrone C.; Bernert, Martin; Dias, Bianca Da Costa; Ferreira, Eloise; Weiss, Stefan F. T.; Letsolo, Boitelo T.] Univ Witwatersrand, Sch Mol & Cell Biol, ZA-2050 Johannesburg, South Africa; [Reusch, Uwe; Knackmuss, Stefan; Little, Melvyn] Affimed GmbH, D-69120 Heidelberg, Germany	University of Witwatersrand	Weiss, SFT (corresponding author), Univ Witwatersrand, Sch Mol & Cell Biol, Private Bag 3, ZA-2050 Johannesburg, South Africa.	Stefan.weiss@wits.ac.za; Boitelo.Letsolo@wits.ac.za	Malindisa, Sibusiso Tebogo/M-4359-2019; Malindisa, Sibusiso/GQQ-0761-2022; Malindisa, Sibusiso Tebogo T/G-5419-2019	Malindisa, Sibusiso Tebogo/0000-0002-9287-9408; Malindisa, Sibusiso Tebogo T/0000-0002-9287-9408; van der Merwe (nee Ferreira), Eloise/0000-0001-5985-4885	National Research Foundation; Republic of South Africa; South African Medical Research Council (SAMRC)	National Research Foundation; Republic of South Africa; South African Medical Research Council (SAMRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the National Research Foundation, the Republic of South Africa. Any opinions, findings and conclusions or recommendations expressed in this material are those of the authors, and therefore, the National Research Foundation does not accept any liability in this regard thereto. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. The research from which this publication emanated was co-funded by the South African Medical Research Council (SAMRC). The specific roles of these authors are articulated in the "author contributions" section.	ALLSOPP RC, 1995, EXP CELL RES, V220, P194, DOI 10.1006/excr.1995.1306; Baumer Y, 2010, CELL MOL LIFE SCI, V67, P2451, DOI 10.1007/s00018-010-0349-z; de Jesus BB, 2012, EMBO MOL MED, V4, P691, DOI 10.1002/emmm.201200245; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Capper R, 2007, GENE DEV, V21, P2495, DOI 10.1101/gad.439107; Chetty C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096268; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Dias BD, 2014, SCI REP-UK, V4, DOI 10.1038/srep05556; Dias BD, 2013, SCI REP-UK, V3, DOI 10.1038/srep02702; Gauczynski S, 2001, EMBO J, V20, P5863, DOI 10.1093/emboj/20.21.5863; Gauczynski S, 2006, J INFECT DIS, V194, P702, DOI 10.1086/505914; Greider CW, 1996, SCI AM, V274, P92, DOI 10.1038/scientificamerican0296-92; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; HARLEY CB, 1994, COLD SPRING HARB SYM, V59, P307, DOI 10.1101/SQB.1994.059.01.035; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HARLEY CB, 1992, EXP GERONTOL, V27, P375, DOI 10.1016/0531-5565(92)90068-B; Holt SE, 1996, MOL CELL BIOL, V16, P2932; Hundt C, 2001, EMBO J, V20, P5876, DOI 10.1093/emboj/20.21.5876; Jovanovic K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100373; Jovanovic K, 2013, SCI REP-UK, V3, DOI 10.1038/srep02699; Khumalo T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139584; Khumalo T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066297; Khusal R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058888; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Langlade-Demoyen P, 2010, Patent US, Patent No. [20140056932.2010, 20140056932]; Letsolo BT, 2010, NUCLEIC ACIDS RES, V38, P1841, DOI 10.1093/nar/gkp1183; Leucht C, 2003, EMBO REP, V4, P290, DOI 10.1038/sj.embor.embor768; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Lu LG, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2893; Mbazima V, 2010, FRONT BIOSCI-LANDMRK, V15, P1150, DOI 10.2741/3667; Moodley K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057409; Omar A, 2012, J MOL BIOL, V419, P102, DOI 10.1016/j.jmb.2012.02.035; Omar A, 2011, EXPERT OPIN THER PAT, V21, P35, DOI 10.1517/13543776.2011.539203; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Pinnock EC, 2016, J ALZHEIMERS DIS; Rieger R, 1997, NAT MED, V3, P1383, DOI 10.1038/nm1297-1383; Shay JW, 2005, CARCINOGENESIS, V26, P867, DOI 10.1093/carcin/bgh296; SHAY JW, 1991, EXP CELL RES, V196, P33, DOI 10.1016/0014-4827(91)90453-2; Tomas-Loba A, 2008, CELL, V135, P609, DOI 10.1016/j.cell.2008.09.034; Vana K, 2006, J MOL BIOL, V358, P57, DOI 10.1016/j.jmb.2006.02.011; WRIGHT WE, 1992, EXP GERONTOL, V27, P383, DOI 10.1016/0531-5565(92)90069-C; Zuber C, 2008, J MOL BIOL, V378, P530, DOI 10.1016/j.jmb.2008.02.004	42	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141618	10.1371/journal.pone.0141618	http://dx.doi.org/10.1371/journal.pone.0141618			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26545108	gold, Green Submitted, Green Published			2022-12-27	WOS:000364398700035
J	Ogura, Y; Miyake, N; Kou, I; Iida, A; Nakajima, M; Takeda, K; Fujibayashi, S; Shiina, M; Okada, E; Toyama, Y; Iwanami, A; Ishii, K; Ogata, K; Asahara, H; Matsumoto, N; Nakamura, M; Matsumoto, M; Ikegawa, S				Ogura, Yoji; Miyake, Noriko; Kou, Ikuyo; Iida, Aritoshi; Nakajima, Masahiro; Takeda, Kazuki; Fujibayashi, Shunsuke; Shiina, Masaaki; Okada, Eijiro; Toyama, Yoshiaki; Iwanami, Akio; Ishii, Ken; Ogata, Kazuhiro; Asahara, Hiroshi; Matsumoto, Naomichi; Nakamura, Masaya; Matsumoto, Morio; Ikegawa, Shiro			Identification of HOXD4 Mutations in Spinal Extradural Arachnoid Cyst	PLoS One			English	Article							LYMPHEDEMA-DISTICHIASIS SYNDROME; HOMEOBOX GENES; MFH-1; FAMILY	Spinal extradural arachnoid cyst (SEDAC) is a cyst in the spinal canal that protrudes into the epidural space from a defect in the dura mater and leads to neurological disturbances. We previously showed that familial SEDAC is caused by FOXC2 mutation; however, the causal gene of sporadic SEDAC has not been identified. To identify the causal gene of sporadic SEDAC, we performed whole exome sequencing for 12 subjects with sporadic SEDAC and identified heterozygous HOXD4 loss-of-function mutations in three subjects. HOXD4 haplo-insufficiency causes SEDAC and a transcriptional network containing HOXD4 and FOXC2 is involved in the development of the dura mater and the etiology of SEDAC.	[Ogura, Yoji; Kou, Ikuyo; Iida, Aritoshi; Nakajima, Masahiro; Takeda, Kazuki; Ikegawa, Shiro] RIKEN Ctr Integrat Med Sci, Lab Bone & Joint Dis, Tokyo 1088639, Japan; [Ogura, Yoji; Takeda, Kazuki; Toyama, Yoshiaki; Iwanami, Akio; Ishii, Ken; Nakamura, Masaya; Matsumoto, Morio] Keio Univ, Sch Med, Dept Orthopaed Surg, Tokyo 1608582, Japan; [Miyake, Noriko; Matsumoto, Naomichi] Yokohama City Univ, Dept Human Genet, Grad Sch Med, Yokohama, Kanagawa 2360004, Japan; [Fujibayashi, Shunsuke] Kyoto Univ, Dept Orthopaed Surg, Kyoto 6068507, Japan; [Shiina, Masaaki; Ogata, Kazuhiro] Yokohama City Univ, Grad Sch Med, Dept Biochem, Yokohama, Kanagawa 2360004, Japan; [Okada, Eijiro] Saiseikai Cent Hosp, Dept Orthopaed Surg, Tokyo 1080073, Japan; [Asahara, Hiroshi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Syst BioMed, Tokyo 1138510, Japan	RIKEN; Keio University; Yokohama City University; Kyoto University; Yokohama City University; Tokyo Saiseikai Central Hospital; Tokyo Medical & Dental University (TMDU)	Ikegawa, S (corresponding author), RIKEN Ctr Integrat Med Sci, Lab Bone & Joint Dis, Tokyo 1088639, Japan.	sikegawa@ims.u-tokyo.ac.jp	Ikegawa, Shiro/N-6895-2015; Iida, Aritoshi/CAA-1373-2022; Ogura, Yoji/V-2740-2019; Nakamura, Masaya/K-4111-2013	Ikegawa, Shiro/0000-0003-0316-2147; Iida, Aritoshi/0000-0001-7538-1651; 	Japan Agency For Medical Research and Development (AMED) [14525125]	Japan Agency For Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This study is supported by research grants from Japan Agency For Medical Research and Development (AMED) (contract No. 14525125). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang IC, 2004, PEDIATR NEUROSURG, V40, P70, DOI 10.1159/000078911; CILLUFFO JM, 1981, MAYO CLIN PROC, V56, P93; Fang JM, 2000, AM J HUM GENET, V67, P1382, DOI 10.1086/316915; Kaestner KH, 1996, DEVELOPMENT, V122, P1751; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Mark M, 1997, PEDIATR RES, V42, P421, DOI 10.1203/00006450-199710000-00001; MAVILIO F, 1986, NATURE, V324, P664, DOI 10.1038/324664a0; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; Miravet E, 2002, J CHILD NEUROL, V17, P770, DOI 10.1177/08830738020170101802; MIURA N, 1993, FEBS LETT, V326, P171, DOI 10.1016/0014-5793(93)81785-X; Ogura Y, 2012, PLOS ONE; Ogura Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080548; POPPERL H, 1992, EMBO J, V11, P3673, DOI 10.1002/j.1460-2075.1992.tb05452.x; Sanchez-Carpintero R, 2010, GENET MED, V12, P532, DOI 10.1097/GIM.0b013e3181e5c7ea; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Thim VV, 2005, HUM MUTAT, V25, P384, DOI 10.1002/humu.20155; Yabuki S, 2007, AM J MED GENET A, V143A, P884, DOI 10.1002/ajmg.a.31669	17	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142126	10.1371/journal.pone.0142126	http://dx.doi.org/10.1371/journal.pone.0142126			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26545093	Green Submitted, gold, Green Published			2022-12-27	WOS:000364398700083
J	Gerum, RC; Fabry, B; Metzner, C				Gerum, Richard Carl; Fabry, Ben; Metzner, Claus			Emergence of Asynchronous Local Clocks in Excitable Media	PLOS ONE			English	Article								Excitable media such as the myocardium or the brain consist of arrays of coupled excitable elements, in which the local excitation of a single element can propagate to its neighbors in the form of a non-linear autowave. Since each element has to pass through a refractory period immediately after excitation, the frequency of autowaves is self-limiting. In this work, we consider the case where each element is spontaneously excited at a fixed average rate and thereby initiates a new autowave. Although these spontaneous self-excitation events are modelled as independent Poisson point processes with exponentially distributed waiting times, the travelling autowaves lead collectively to a non-exponential, unimodal waiting time distribution for the individual elements. With increasing system size, a global 'clock' period T emerges as the most probable waiting time for each element, which fluctuates around T with an increasingly small but non-zero variance. This apparent synchronization between asynchronous, temporally uncorrelated point processes differs from synchronization effects between perfect oscillators interacting in a phase-aligning manner. Finally, we demonstrate that asynchronous local clocks also emerge in non-homogeneous systems in which the rates of self-excitation are different for all individuals, suggesting that this novel mechanism can occur in a wide range of excitable media.	[Gerum, Richard Carl; Fabry, Ben; Metzner, Claus] Univ Erlangen Nurnberg, Dept Phys, Erlangen, Germany	University of Erlangen Nuremberg	Gerum, RC (corresponding author), Univ Erlangen Nurnberg, Dept Phys, Erlangen, Germany.	rgerum@biomed.uni-erlangen.de	Gerum, Richard Carl/AAW-8732-2021; Fabry, Ben/AAT-5717-2020; Fabry, Ben/C-5496-2013; Metzner, Claus/D-9707-2013	Gerum, Richard Carl/0000-0001-5893-2650; Fabry, Ben/0000-0003-1737-0465; Fabry, Ben/0000-0003-1737-0465; 	Deutsche Forschungsgemeinschaft [FA 336/5-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (grant number FA 336/5-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALKAREY YI, 1991, P SOC PHOTO-OPT INS, V1621, P238, DOI 10.1117/12.50431; Belousov B. P., 1959, COMPILATION ABSTRACT; Christensen K, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.028104; DROSSEL B, 1992, PHYS REV LETT, V69, P1629, DOI 10.1103/PhysRevLett.69.1629; Durrett R, 1991, J THEORETICAL PROBAB, V4, P669, DOI 10.1007/BF01259549; Encinas LH, 2007, APPL MATH MODEL, V31, P1213, DOI 10.1016/j.apm.2006.04.001; Fisch R., 1993, ANN APPL PROBAB, V3, P935, DOI [10.1214/aoap/1177005268, DOI 10.1214/AOAP/1177005268]; FRISCH U, 1986, PHYS REV LETT, V56, P1505, DOI 10.1103/PhysRevLett.56.1505; Gerum RC, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/12/125022; GREENBERG JM, 1978, SIAM J APPL MATH, V34, P515, DOI 10.1137/0134040; Jalife J, 2000, ANNU REV PHYSIOL, V62, P25, DOI 10.1146/annurev.physiol.62.1.25; Kaneko T, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-21; Kuramoto Y., 1975, INT S MATH PROBL 197; Lu W, 2004, IEEE T CIRCUITS SY 1; Mainzer K., 2011, UNIVERSE AUTOMATON S; Min N, 2012, ABSTR APPL ANAL, DOI 10.1155/2012/948480; Sirakoulis G, 2000, ECOLOGICAL MODELLING, DOI [10.1016/S0304-3800(00)002945, DOI 10.1016/S0304-3800(00)002945]; Toffoli T, 1987, CELLULAR AUTOMATA MA; Vasiliev VA, 1987, MATH ITS APPL, V11; White SH, 2007, APPL MATH COMPUT, V186, P193, DOI 10.1016/j.amc.2006.06.126; Wu A, 2007, PHYS REV E; ZAIKIN AN, 1970, NATURE, V225, P535, DOI 10.1038/225535b0; Zhou DM, 2009, NEUROCOMPUTING, V72, P2331, DOI 10.1016/j.neucom.2008.12.008; Zitterbart DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020260	24	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142490	10.1371/journal.pone.0142490	http://dx.doi.org/10.1371/journal.pone.0142490			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559528	Green Submitted, Green Published, gold			2022-12-27	WOS:000364433100085
J	Khan, MU; Ahmad, A; Aqeel, T; Akbar, N; Salman, S; Idress, J				Khan, Muhammad Umair; Ahmad, Akram; Aqeel, Talieha; Akbar, Naila; Salman, Saad; Idress, Jawaria			A Cross-Sectional Survey of Healthcare Workers on the Knowledge and Attitudes towards Polio Vaccination in Pakistan	PLOS ONE			English	Article							IMMUNIZATION; PROGRAM; KARACHI	Introduction Pakistan accounts for 85.2% of the total polio cases reported worldwide. Healthcare workers (HCWs) are an integral part of immunization campaigns and source of education for the general public. This study aimed to assess the knowledge and attitudes towards polio vaccination among HCWs providing immunisation and education to general public in Quetta and Peshawar divisions of Pakistan. Methods A cross-sectional survey of 490 HCWs was conducted in two major referral public teaching hospitals of Quetta and Peshawar divisions. During February to April, 2015, a random sample of 490 HCWs was invited to participate in this study. Knowledge and attitudes were assessed by using self-administered, anonymous and pretested questionnaire. Descriptive and logistic regression analyses were used to express the results. Results A total of 468 participants responded to the questionnaire, giving a response rate of 95.5%. Overall, participants demonstrated good knowledge and positive attitudes towards polio vaccination. The mean knowledge score of HCWs about polio was 13.42 +/- 2.39 (based on 18 knowledge questions) while the mean attitude score was 28.75 +/- 5.5 (based on 9 attitudes statements). Knowledge gaps were identified about the incubation period of poliovirus (19.5%), management issues (31.9%), use of polio vaccine in mild illnesses (34.7%) and the consequences of the polio virus (36.9%). The majority of participants agreed that all children should be vaccinated for polio (95.1%), while reservations were noted about the need of a booster (38.9%), and sterility issues associated with polio vaccines (43.6%). Internet (n = 167, 37%) and Posters (n = 158, 35%) were the main sources used by HCWs to educate themselves about polio. Conclusion Participants in this study had good knowledge and positive attitudes towards polio vaccination. Although the data are indicative of gaps in the knowledge of HCWs, the findings may not be generalized to other hospitals in Pakistan.	[Khan, Muhammad Umair; Ahmad, Akram] UCSI Univ, Fac Pharmaceut Sci, Dept Clin Pharm, Kuala Lumpur, Malaysia; [Aqeel, Talieha; Akbar, Naila] Univ Baluchistan, Fac Pharm, Dept Pharm Practice, Quetta, Pakistan; [Salman, Saad] Univ Peshawar, Dept Pharm, Peshawar, Pakistan; [Idress, Jawaria] Post Grad Nursing Coll, Dept Integrated Sci, Peshawar, Pakistan	UCSI University; University of Balochistan; University of Peshawar	Ahmad, A (corresponding author), UCSI Univ, Fac Pharmaceut Sci, Dept Clin Pharm, Kuala Lumpur, Malaysia.	akrampharma67@gmail.com	Salman, Saad/C-8398-2016; Ahmad, PhD, Akram/P-7368-2015	Salman, Saad/0000-0001-6592-9812; Ahmad, PhD, Akram/0000-0002-9998-5860				Ahmad K, 2007, LANCET INFECT DIS, V7, P247, DOI 10.1016/S1473-3099(07)70066-X; Ahmad Nisar, 1999, JPMA (Journal of the Pakistan Medical Association), V49, P301; Ahmed I, 2015, THE TRIBUNE REV; Ahmed S I, 2001, J Pak Med Assoc, V51, P367; Anand S, 2004, LANCET, V364, P1603, DOI 10.1016/S0140-6736(04)17313-3; [Anonymous], 2010, POL AND PREV; April C, 2012, ERADICATING POLIO AF; Azira B, 2013, INT J COLLAB RES INT, V5, P157; Chhnang K, 2002, ATTITUDES IMMUNIZATI; Chumakov K, 2007, NAT REV MICROBIOL, V5, P952, DOI 10.1038/nrmicro1769; Hussain T, 2014, J PAK MED ASSOC, V64, P725; Jalal S, 2011, EUR J PUBLIC HEALTH, V21, P143, DOI 10.1093/eurpub/ckq199; Khowaja AR, 2012, B WORLD HEALTH ORGAN, V90, P822, DOI 10.2471/BLT.12.106260; Mangrio Nawab Khan, 2008, J Pak Med Assoc, V58, P64; Mushtaq MU, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-60; Naeem Mohammad, 2011, J Ayub Med Coll Abbottabad, V23, P98; Nishtar S, 2010, B WORLD HEALTH ORGAN, V88, P159, DOI 10.2471/BLT.09.066480; Obute JA, 2007, INT J HEALTH PROMOT, V45, P81, DOI 10.1080/14635240.2007.10708108; Owais A, 2013, VACCINE, V31, P3313, DOI 10.1016/j.vaccine.2013.05.015; Raosoft, 2008, ONL SAMPL SIZ CALC; Shah M, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-457; Shrivastava A, 2012, INDIAN J MED RES, V135, P520; World Health Organization, 2008, KNOWL ATT BEL STUD U; World Health Organization, 2014, POL; World Health Organization, 1999, GLOB ACT PLAN LAB CO; Yakum Martin Ndinakie, 2015, BMC Res Notes, V8, P145, DOI 10.1186/s13104-015-1109-9; Zeleke SA, 2000, LANCET, V356, pS21, DOI 10.1016/S0140-6736(00)92007-5	28	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142485	10.1371/journal.pone.0142485	http://dx.doi.org/10.1371/journal.pone.0142485			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559184	Green Submitted, gold, Green Published			2022-12-27	WOS:000364433100083
J	Nargis, N; Thompson, ME; Fong, GT; Driezen, P; Hussain, AKMG; Ruthbah, UH; Quah, ACK; Abdullah, AS				Nargis, Nigar; Thompson, Mary E.; Fong, Geoffrey T.; Driezen, Pete; Hussain, A. K. M. Ghulam; Ruthbah, Ummul H.; Quah, Anne C. K.; Abdullah, Abu S.			Prevalence and Patterns of Tobacco Use in Bangladesh from 2009 to 2012: Evidence from International Tobacco Control (ITC) Study	PLOS ONE			English	Article								Background Smoking and passive smoking are collectively the biggest preventable cause of death in Bangladesh, with major public health burden of morbidity, disability, mortality and community costs. The available studies of tobacco use in Bangladesh, however, do not necessarily employ nationally representative samples needed to monitor the problem at a national scale. This paper examines the prevalence and patterns of tobacco use among adults in Bangladesh and the changes over time using large nationally representative comparable surveys. Methods Using data from two enumerations of the International Tobacco Control (ITC) Bangladesh Project conducted in 2009 and 2012, prevalence estimates are obtained for all tobacco products by socio-economic determinants and sample types of over 90,000 individuals drawn from over 30,000 households. Household level sample weights are used to obtain nationally representative prevalence estimates and standard errors. Statistical tests of difference in the estimates between two time periods are based on a logistic regression model that accounts for the complex sampling design. Using a multinomial logit model, the time trend in tobacco use status is identified to capture the effects of macro level determinants including changes in tobacco control policies. Results Between 2009 and 2012, overall tobacco use went down from 42.4% to 36.3%. The decline is more pronounced with respect to smokeless tobacco use than smoking. The prevalence of exclusive cigarette smoking went up from 7.2% to 10.6%; exclusive bidi smoking remained stable at around 2%; while smoking both cigarette and bidi went down from 4.6% to 1.8%; exclusive smokeless tobacco use went down from 20.2% to 16.9%; and both smokeless tobacco use and smoking went down from 8.4% to 5.1%. In general, the prevalence of tobacco use is higher among men, increases from younger to older age groups, and is higher among poorer people. Smoking prevalence is the highest among the slum population, followed by the tribal population, the national population and the border area population, suggesting greater burden of tobacco use among the disadvantaged groups. Conclusions The overall decline in tobacco use can be viewed as a structural shift in the tobacco market in Bangladesh from low value products such as bidi and smokeless tobacco to high value cigarettes, which is expected with the growth in income and purchasing power of the general population. Despite the reduction in overall tobacco use, the male smoking prevalence in Bangladesh is still high at 37%. The world average of daily smoking among men is 31.1%. The Tobacco Control Act 2005 and the Amendment have yet to make a significant impact in curbing tobacco usage in Bangladesh. The findings in this paper further suggest that the tobacco control policies in Bangladesh need to include targeted interventions to restrain the use of particular types of tobacco products among specific demographic and socio-economic groups of the population, such as smoked tobacco among men, smokeless tobacco among women, and both smoked and smokeless tobacco among those living in rural areas, those in low socio-economic status and those belonging to the tribal and the slum population.	[Nargis, Nigar; Hussain, A. K. M. Ghulam; Ruthbah, Ummul H.] Univ Dhaka, Dhaka 1000, Bangladesh; [Thompson, Mary E.; Fong, Geoffrey T.; Driezen, Pete; Quah, Anne C. K.] Univ Waterloo, Waterloo, ON N2L 3G1, Canada; [Abdullah, Abu S.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Abdullah, Abu S.] Duke Kunshan Univ, Global Hlth Program, Suzhou, Jiangsu, Peoples R China	University of Dhaka; University of Waterloo; Boston University; Duke Kunshan University		nigar.nargis@cancer.org	Fong, Geoffrey T/H-2810-2014; Driezen, Pete/AAX-2804-2020; Nargis, Nigar/ABV-7173-2022; PAN, ZEQIANG/X-6341-2018	Fong, Geoffrey T/0000-0001-9098-6472; Driezen, Pete/0000-0003-2320-0999; Nargis, Nigar/0000-0003-4501-1398; Ruthbah, Ummul/0000-0002-5720-371X	International Development Research Centre (IDRC) [104831-002]; Canadian Institutes for Health Research [79551, 115016]; US National Cancer Institute [P01 CA138389]; Senior Investigator Award from Ontario Institute for Cancer Research; Prevention Scientist Award from the Canadian Cancer Research Institute; NATIONAL CANCER INSTITUTE [P01CA138389] Funding Source: NIH RePORTER	International Development Research Centre (IDRC); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Senior Investigator Award from Ontario Institute for Cancer Research; Prevention Scientist Award from the Canadian Cancer Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported by the International Development Research Centre (IDRC Grant 104831-002, http://www.idrc.ca) (funding to NN), Canadian Institutes for Health Research (Operating Grants 79551 and 115016, http://www.cihr-irsc.gc.ca) (funding to GTF), the US National Cancer Institute (P01 CA138389, http://www.cancer.gov/) (funding to GTF), and a Senior Investigator Award from Ontario Institute for Cancer Research (http://oicr.on.ca/) and a Prevention Scientist Award from the Canadian Cancer Research Institute (http://www.cancer.ca/research) to GTF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam DS, 2013, B WORLD HEALTH ORGAN, V91, P757, DOI 10.2471/BLT.13.120196; Efroymson D, 2001, TOB CONTROL, V10, P212, DOI 10.1136/tc.10.3.212; Esson K. M, 2004, MILLENNIUM DEV GOALS; Flora MS, 2009, TOB CONTROL, V18, P445, DOI 10.1136/tc.2008.028142; ITC Project, 2015, TECHNICAL REPORT; ITC Project, 2010, TECHNICAL REPORT; ITC Project, 2012, TOB PRIC TAX ITC CRO; Khan MMH, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-149; Marie N, 2014, JAMA-J AM MED ASSOC, V311, P183, DOI [10. 1001/ jama. 2013.284692, DOI 10.1001/JAMA.2013.284692]; Ministry of Health and Family Welfare, 2009, GLOBAL ADULT TOBACCO; Nargis N, 2014, INDIAN J CANC S1, V51; Sreeramareddy CT, 2014, POPUL HEALTH METR, V12, DOI 10.1186/s12963-014-0022-0; WHO, 2015, WHO GLOB REP TRENDS; World Bank, 2013, WORLD DEV IND DAT; World Bank, 2003, TOB CONTR POL STRAT; World Health Organization (WHO), 2010, NONC DIS RISK FACT S; World Health Organization (WHO), 2007, IMP TOB REL ILLN BAN	17	41	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0141135	10.1371/journal.pone.0141135	http://dx.doi.org/10.1371/journal.pone.0141135			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559051	gold, Green Published, Green Submitted			2022-12-27	WOS:000364433100022
J	Chen, F; Wang, TJ; Feng, CP; Lin, G; Zhu, YH; Wu, GY; Johnson, G; Wang, JJ				Chen, Fang; Wang, Taiji; Feng, Cuiping; Lin, Gang; Zhu, Yuhua; Wu, Guoyao; Johnson, Gregory; Wang, Junjun			Proteome Differences in Placenta and Endometrium between Normal and Intrauterine Growth Restricted Pig Fetuses	PLOS ONE			English	Article							MATERNAL NUTRITION; OXIDATIVE STRESS; IN-VIVO; FETAL; ANGIOGENESIS; PREGNANCY; TRANSPORT; CELLS; METABOLISM; EXPRESSION	Uteroplacental tissue plays a key role in substance exchanges between maternal and fetal circulation, and, therefore, in the growth and development of fetuses. In this study, proteomics and western blotting were applied to investigate the changes of proteome in the placenta and endometrium of normal and intrauterine growth restriction (IUGR) porcine fetuses during mid to late pregnancy (D60, 90, and 110 of gestation). Our results showed that proteins participating in cell structure, energy metabolism, stress response, cell turnover, as well as transport and metabolism of nutrients were differentially expressed in placenta and endometrium between normal and IUGR fetuses. Analysis of functions of these proteins suggests reductions in ATP production and nutrients transport, increases in oxidative stress and apoptosis, and impairment of cell metabolism in IUGR fetuses. Collectively, our findings aid in understanding of the mechanisms responsible for uteroplacental dysfunction in IUGR fetus, and are expected to provide new strategies to reduce fetal growth restriction in pigs and other mammals.	[Chen, Fang; Wang, Taiji; Lin, Gang; Zhu, Yuhua; Wu, Guoyao; Wang, Junjun] China Agr Univ, State Key Lab Anim Nutr, Coll Anim Sci & Technol, Alltech MAFIC Res Alliance, Beijing 100094, Peoples R China; [Chen, Fang] South China Agr Univ, Dept Anim Sci, Guangzhou, Guangdong, Peoples R China; [Feng, Cuiping] China Japan Friendship Hosp, Dept Obstet & Gynecol, Beijing, Peoples R China; [Wu, Guoyao] Texas A&M Univ, Dept Anim Sci, College Stn, TX 77843 USA; [Johnson, Gregory] Texas A&M Univ, Dept Vet Integrat Biosci, College Stn, TX USA	China Agricultural University; South China Agricultural University; China-Japan Friendship Hospital; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Wang, JJ (corresponding author), China Agr Univ, State Key Lab Anim Nutr, Coll Anim Sci & Technol, Alltech MAFIC Res Alliance, Beijing 100094, Peoples R China.	jkywjj@hotmail.com	Lin, Gang/AAH-6873-2020		National Natural Science Foundation of China [30810103902, 31272449, 31422052]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding: This study was supported by fundings from National Natural Science Foundation of China (no. 30810103902, 31272449, and 31422052). URL of National Natural Science Foundation of China: http://www.nsfc.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTOSIK D, 1987, AM J OBSTET GYNECOL, V156, P11, DOI 10.1016/0002-9378(87)90194-3; Bax BE, 1997, BBA-BIOENERGETICS, V1319, P283, DOI 10.1016/S0005-2728(96)00169-7; BAZER FW, 1992, P SOC EXP BIOL MED, V199, P373, DOI 10.3181/00379727-199-43371A; BISCHOF P, 1994, HUM REPROD, V9, P1652, DOI 10.1093/oxfordjournals.humrep.a138768; Burton Graham J, 2003, Reprod Biomed Online, V6, P84; Caraglia M, 2001, AMINO ACIDS, V20, P91, DOI 10.1007/s007260170050; Chen F, 2011, J ANIM SCI, V89, P743, DOI 10.2527/jas.2010-3146; Chiosis G, 2013, NAT STRUCT MOL BIOL, V20, P1, DOI 10.1038/nsmb.2481; Clarke L, 1998, BRIT J NUTR, V79, P359, DOI 10.1079/BJN19980060; FORD SP, 1995, J ANIM SCI, V73, P1852; Gandin V, 2008, NATURE, V455, P684, DOI 10.1038/nature07267; GODFREY KM, 1995, EUR J OBSTET GYN R B, V61, P15, DOI 10.1016/0028-2243(95)02148-L; Hempstock J, 2003, HUM PATHOL, V34, P1265, DOI 10.1016/j.humpath.2003.08.006; Jansson T, 1998, PEDIATR RES, V44, P532, DOI 10.1203/00006450-199810000-00011; Jauniaux E, 2006, HUM REPROD UPDATE, V12, P747, DOI 10.1093/humupd/dml016; Jiang PP, 2009, J PROTEOME RES, V8, P72, DOI 10.1021/pr800638w; Johansson S, 2001, BIOL REPROD, V64, P60, DOI 10.1095/biolreprod64.1.60; Kalis M, 2010, ISLETS, V2, P185, DOI 10.4161/isl.2.3.11654; KNIGHT JW, 1977, J ANIM SCI, V44, P620, DOI 10.2527/jas1977.444620x; Lachmann P J, 1979, Ciba Found Symp, P231; Lin G, 2012, J NUTR, V142, P990, DOI 10.3945/jn.111.153411; Liu C, 2012, J NUTR BIOCH, V24, P945; Magnusson AL, 2004, PLACENTA, V25, P337, DOI 10.1016/j.placenta.2003.08.021; Majumder S, 2014, NITRIC OXIDE-BIOL CH, V36, P76, DOI 10.1016/j.niox.2013.12.002; Marconi AM, 2008, SEMIN PERINATOL, V32, P178, DOI 10.1053/j.semperi.2008.02.007; Mateo RD, 2007, J NUTR, V137, P652, DOI 10.1093/jn/137.3.652; Matsuyama W, 2001, INTERNAL MED, V40, P1254, DOI 10.2169/internalmedicine.40.1254; McArdle HJ, 2008, J NEUROENDOCRINOL, V20, P427, DOI 10.1111/j.1365-2826.2008.01658.x; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; POTEMPA J, 1994, J BIOL CHEM, V269, P15957; Reynolds LP, 2002, INT J EXP PATHOL, V83, P151, DOI 10.1046/j.1365-2613.2002.00277.x; REYNOLDS LP, 1992, FASEB J, V6, P886, DOI 10.1096/fasebj.6.3.1371260; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Sahu A, 2001, IMMUNOL REV, V180, P35, DOI 10.1034/j.1600-065X.2001.1800103.x; Shibata E, 2001, PLACENTA, V22, P566, DOI 10.1053/plac.2001.0693; Szlosarek PW, 2006, CLIN CANCER RES, V12, P7126, DOI 10.1158/1078-0432.CCR-06-1101; Tavaria M, 1996, CELL STRESS CHAPERON, V1, P23, DOI 10.1379/1466-1268(1996)001<0023:AHSGTT>2.3.CO;2; Vourtsis D, 2013, EUR J PHARMACOL, V698, P122, DOI 10.1016/j.ejphar.2012.11.007; Wang JJ, 2008, J NUTR, V138, P60, DOI 10.1093/jn/138.1.60; Wang XQ, 2010, J PROTEOME RES, V9, P924, DOI 10.1021/pr900747d; Wu G, 2006, J ANIM SCI, V84, P2316, DOI 10.2527/jas.2006-156; Zamudio S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008551; Zhang S, 2015, NUTRIENTS, V7, P360, DOI 10.3390/nu7010360	43	29	35	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142396	10.1371/journal.pone.0142396	http://dx.doi.org/10.1371/journal.pone.0142396			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26554841	Green Published, Green Submitted, gold			2022-12-27	WOS:000364430700097
J	Dionne, MD; Deneux-Tharaux, C; Dupont, C; Basso, O; Rudigoz, RC; Bouvier-Colle, MH; Le Ray, C				Dionne, Marie-Danielle; Deneux-Tharaux, Catherine; Dupont, Corinne; Basso, Olga; Rudigoz, Rene-Charles; Bouvier-Colle, Marie-Helene; Le Ray, Camille			Duration of Expulsive Efforts and Risk of Postpartum Hemorrhage in Nulliparous Women: A Population-Based Study	PLOS ONE			English	Article							BLOOD-LOSS; 3RD STAGE; LABOR; 2ND-STAGE; MORBIDITY; INCREASE; LONG	Objective To assess the specific association between the duration of expulsive efforts and the risk of postpartum hemorrhage. Methods Population-based cohort-nested case-control study of nulliparous women delivering vaginally in 106 French maternity units between December 2004 and November 2006, including 3,852 women with PPH (blood loss >= 500 mL and/or peripartum Hb decrease >= 2 g/dL), 1,048 of them severe (peripartum Hb decrease >= 4 g/dL or transfusion of >= 2 units of red blood cells), and 762 controls from a representative sample of deliveries without hemorrhage in the same population. The association between duration of expulsive efforts and postpartum hemorrhage was estimated by multilevel logistic regression models adjusted for individual and hospital characteristics. Results Median duration of expulsive efforts was 18 minutes among controls, 20 minutes among postpartum hemorrhage and 23 minutes among severe postpartum hemorrhage (p<0.01). Duration of expulsive efforts was significantly, positively, and linearly associated with both postpartum hemorrhage and severe postpartum hemorrhage. After adjustment for other risk factors, every additional 10 minutes of expulsive efforts was associated with about a 10% increase in the risk of postpartum hemorrhage (aOR = 1.11 [1.02-1.21]) and severe postpartum hemorrhage (aOR = 1.14 [1.03-1.27]). Oxytocin during labor, duration of active phase of labor, forceps use, episiotomy, perineal tears, and birth weight were also independently associated with both risks. Conclusion Duration of expulsive efforts was independently associated with postpartum hemorrhage and severe postpartum hemorrhage. Interventions to shorten the duration of this stage, such as oxytocin, forceps, and episiotomy, are also associated with higher risks of postpartum hemorrhage. Beyond duration, other aspects of the management of active second stage should be evaluated as some might allow it to last longer with a minimal increase in postpartum hemorrhage risk.	[Dionne, Marie-Danielle; Deneux-Tharaux, Catherine; Bouvier-Colle, Marie-Helene; Le Ray, Camille] Paris Descartes Univ, Ctr Epidemiol & Stat Sorbonne Paris Cite, Obstet Perinatal & Pediat Epidemiol Res Team Epop, DHU Risks Pregnancy,Inserm,UMR 1153, Paris, France; [Dionne, Marie-Danielle; Basso, Olga] McGill Univ, Dept Obstet & Gynecol, Montreal, PQ H3A 2T5, Canada; [Dionne, Marie-Danielle] Univ Montreal, Ctr Hlth, Montreal, PQ, Canada; [Dupont, Corinne; Rudigoz, Rene-Charles] Univ Lyon 1, Hosp Civils Lyon, Hop Croix Rousse, Aurore Perinatal Network,EA 4129, F-69365 Lyon, France; [Basso, Olga] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Le Ray, Camille] Paris Descartes Univ, Cochin Broca Hotel Dieu Hosp, AP HP, Port Royal Matern, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; McGill University; Universite de Montreal; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; McGill University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite	Le Ray, C (corresponding author), Paris Descartes Univ, Ctr Epidemiol & Stat Sorbonne Paris Cite, Obstet Perinatal & Pediat Epidemiol Res Team Epop, DHU Risks Pregnancy,Inserm,UMR 1153, Paris, France.	camille.le-ray@cch.aphp.fr	Basso, Olga/E-5384-2010; DUPONT, Corinne/ABD-5045-2020; deneux-tharaux, catherine/R-1111-2016	Basso, Olga/0000-0001-9298-4921; deneux-tharaux, catherine/0000-0002-6561-3321; Le Ray, Camille/0000-0003-0891-1063	French Ministry of Health under its Clinical Research Hospital Program [27-35]; Caisse Nationale d'Assurance Maladie (CNAMTS); foundation of the Centre hospitalier universitaire de l'Universite de Montreal (CHUM); McGill University health centre (MUHC)	French Ministry of Health under its Clinical Research Hospital Program; Caisse Nationale d'Assurance Maladie (CNAMTS); foundation of the Centre hospitalier universitaire de l'Universite de Montreal (CHUM); McGill University health centre (MUHC)	The PITHAGORE6 project was funded by the French Ministry of Health under its Clinical Research Hospital Program (contract no.27-35) and the Caisse Nationale d'Assurance Maladie (CNAMTS). Marie-Danielle Dionne was financially supported by the foundation of the Centre hospitalier universitaire de l'Universite de Montreal (CHUM) and McGill University health centre (MUHC). These funders had no role in the design and conduct of the study, no role in the collection, analysis, or interpretation of the data, and no role in the writing of the manuscript or in the decision to submit for publication.	Al-Zirqi I, 2008, BJOG-INT J OBSTET GY, V115, P1265, DOI 10.1111/j.1471-0528.2008.01859.x; Bais JMJ, 2004, EUR J OBSTET GYN R B, V115, P166, DOI 10.1016/j.ejogrb.2003.12.008; Bateman BT, 2010, ANESTH ANALG, V110, P1368, DOI 10.1213/ANE.0b013e3181d74898; Belghiti J, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000514; Brace V, 2007, BJOG-INT J OBSTET GY, V114, P1388, DOI 10.1111/j.1471-0528.2007.01533.x; Buhimschi CS, 2002, AM J OBSTET GYNECOL, V186, P1339, DOI 10.1067/mob.2002.122402; Callaghan WM, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.011; Caughey AB, 2014, AM J OBSTET GYNECOL, V210, P179, DOI 10.1016/j.ajog.2014.01.026; Cheng YW, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.05.024; Cheng YW, 2004, AM J OBSTET GYNECOL, V191, P933, DOI 10.1016/j.ajog.2004.05.044; Deneux-Tharaux C, 2010, BJOG-INT J OBSTET GY, V117, P1278, DOI 10.1111/j.1471-0528.2010.02648.x; Ford JB, 2007, INT J GYNECOL OBSTET, V98, P237, DOI 10.1016/j.ijgo.2007.03.011; Joseph KS, 2007, BJOG-INT J OBSTET GY, V114, P751, DOI 10.1111/j.1471-0528.2007.01316.x; Kramer MS, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.07.007; Le Ray C, 2011, EUR J OBSTET GYN R B, V158, P167, DOI 10.1016/j.ejogrb.2011.04.035; Le Ray C, 2008, J GYNECOL OBST BIO R, V37, P325, DOI 10.1016/j.jgyn.2008.02.009; Le Ray C, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.08.002; Lutomski JE, 2012, BJOG-INT J OBSTET GY, V119, P306, DOI 10.1111/j.1471-0528.2011.03198.x; Mehrabadi A, 2013, BJOG-INT J OBSTET GY, V120, P853, DOI 10.1111/1471-0528.12149; Naime-Alix AF, 2008, J GYNECOL OBST BIO R, V37, P268, DOI 10.1016/j.jgyn.2007.12.010; Prasertcharoensuk W, 2000, INT J GYNECOL OBSTET, V71, P69, DOI 10.1016/S0020-7292(00)00294-0; Razvi K, 1996, AUST NZ J OBSTET GYN, V36, P152, DOI 10.1111/j.1479-828X.1996.tb03273.x; Schaal J-P, 2008, J Gynecol Obstet Biol Reprod (Paris), V37 Suppl 1, pS3, DOI 10.1016/j.jgyn.2007.11.004; Sheiner E, 2005, J MATERN-FETAL NEO M, V18, P149, DOI 10.1080/14767050500170088; Sosa CG, 2009, OBSTET GYNECOL, V113, P1313, DOI 10.1097/AOG.0b013e3181a66b05; Werkoff G, 2010, GYNECOL OBSTET FERTI, V38, P653, DOI 10.1016/j.gyobfe.2010.08.009; World Health Organization WHO, 2012, RECOMMENDATIONS PREV; Yeomans ER, 2010, OBSTET GYNECOL, V115, P645, DOI 10.1097/AOG.0b013e3181cfbefd; Zwart JJ, 2008, BJOG-INT J OBSTET GY, V115, P842, DOI 10.1111/j.1471-0528.2008.01713.x	29	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142171	10.1371/journal.pone.0142171	http://dx.doi.org/10.1371/journal.pone.0142171			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555447	gold, Green Submitted, Green Published			2022-12-27	WOS:000364430700063
J	Harkes, R; Keizer, VIP; Schaaf, MJM; Schmidt, T				Harkes, Rolf; Keizer, Veer I. P.; Schaaf, Marcel J. M.; Schmidt, Thomas			Depth-of-Focus Correction in Single-Molecule Data Allows Analysis of 3D Diffusion of the Glucocorticoid Receptor in the Nucleus	PLOS ONE			English	Article							TRANSCRIPTION FACTOR-BINDING; LIVING CELLS; PARTICLE TRACKING; PLASMA-MEMBRANE; HIGH-DENSITY; LIVE CELLS; MICROSCOPY; MICRODOMAINS; PROTEIN; DNA	Single-molecule imaging of proteins in a 2D environment like membranes has been frequently used to extract diffusive properties of multiple fractions of receptors. In a 3D environment the apparent fractions however change with observation time due to the movements of molecules out of the depth-of-field of the microscope. Here we developed a mathematical framework that allowed us to correct for the change in fraction size due to the limited detection volume in 3D single-molecule imaging. We applied our findings on the mobility of activated glucocorticoid receptors in the cell nucleus, and found a freely diffusing fraction of 0.49 +/- 0.02. Our analysis further showed that interchange between this mobile fraction and an immobile fraction does not occur on time scales shorter than 150 ms.	[Harkes, Rolf; Schmidt, Thomas] Leiden Univ, Phys Life Proc, Huygens Kamerlingh Onnes Lab, Leiden, Netherlands; [Keizer, Veer I. P.; Schaaf, Marcel J. M.] Leiden Univ, IBL, Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC	Schmidt, T (corresponding author), Leiden Univ, Phys Life Proc, Huygens Kamerlingh Onnes Lab, Leiden, Netherlands.	schmidt@physics.leidenuniv.nl	Schmidt, Thomas/B-6296-2009	Schmidt, Thomas/0000-0002-0045-1851; Schaaf, Marcel/0000-0002-5859-8936; Harkes, Rolf/0000-0001-6592-654X				Beato M, 2000, HUM REPROD UPDATE, V6, P225, DOI 10.1093/humupd/6.3.225; Becker M, 2002, EMBO REP, V3, P1188, DOI 10.1093/embo-reports/kvf244; Biddie SC, 2012, RHEUMATOLOGY, V51, P403, DOI 10.1093/rheumatology/ker215; Cambi A, 2007, NANO LETT, V7, P970, DOI 10.1021/nl0700503; Coppola S, 2012, SOFT MATTER, V8, P7919, DOI 10.1039/c2sm25532d; Courty S, 2006, NANO LETT, V6, P1491, DOI 10.1021/nl060921t; de Keijzer S, 2008, J CELL SCI, V121, P1750, DOI 10.1242/jcs.030692; Demtroder W., 1988, LASER SPECTROSCOPY; Dietrich C, 2002, BIOPHYS J, V82, P274, DOI 10.1016/S0006-3495(02)75393-9; FUNATSU T, 1995, NATURE, V374, P555, DOI 10.1038/374555a0; Gebhardt JCM, 2013, NAT METHODS, V10, P421, DOI [10.1038/NMETH.2411, 10.1038/nmeth.2411]; Giannone G, 2010, BIOPHYS J, V99, P1303, DOI 10.1016/j.bpj.2010.06.005; Groeneweg FL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090532; Hager GL, 2009, MOL CELL, V35, P741, DOI 10.1016/j.molcel.2009.09.005; Holtzer L, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2437066; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Kues T, 2001, BIOPHYS J, V80, P2954, DOI 10.1016/S0006-3495(01)76261-3; KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0; Lenne PF, 2006, EMBO J, V25, P3245, DOI 10.1038/sj.emboj.7601214; Lill Y, 2005, CHEMPHYSCHEM, V6, P1633, DOI 10.1002/cphc.200500111; Lommerse PHM, 2005, J CELL SCI, V118, P1799, DOI 10.1242/jcs.02300; Lu HP, 1998, SCIENCE, V282, P1877, DOI 10.1126/science.282.5395.1877; Mazza D, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks701; MCGHEE JD, 1974, J MOL BIOL, V86, P469, DOI 10.1016/0022-2836(74)90031-X; Morisaki T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5456; Pinaud F, 2009, TRAFFIC, V10, P691, DOI 10.1111/j.1600-0854.2009.00902.x; Sako Y, 2000, NAT CELL BIOL, V2, P168, DOI 10.1038/35004044; Schaaf MJM, 2009, BIOPHYS J, V97, P1206, DOI 10.1016/j.bpj.2009.05.044; Schmidt T, 1996, P NATL ACAD SCI USA, V93, P2926, DOI 10.1073/pnas.93.7.2926; Schutz GJ, 2000, EMBO J, V19, P892, DOI 10.1093/emboj/19.5.892; Schutz GJ, 1997, BIOPHYS J, V73, P1073, DOI 10.1016/S0006-3495(97)78139-6; Semrau S, 2007, BIOPHYS J, V92, P613, DOI 10.1529/biophysj.106.092577; Ueda M, 2001, SCIENCE, V294, P864, DOI 10.1126/science.1063951; Van Royen ME, 2014, J CELL SCI, V127, P1406, DOI 10.1242/jcs.135228; Wennmalm S, 1997, P NATL ACAD SCI USA, V94, P10641, DOI 10.1073/pnas.94.20.10641	35	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0141080	10.1371/journal.pone.0141080	http://dx.doi.org/10.1371/journal.pone.0141080			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555072	Green Submitted, gold, Green Published			2022-12-27	WOS:000364430700019
J	Kao, WL; Sun, CW				Kao, Wei-Lung; Sun, Chia-Wei			Gender-Related Effect in Oxygenation Dynamics by Using Far-Infrared Intervention with Near-Infrared Spectroscopy Measurement: A Gender Differences Controlled Trial	PLOS ONE			English	Article							NITRIC-OXIDE; CANCER-CELLS; MICROCIRCULATION	Many studies have indicated the microcirculation can directly respond to disease-related symptoms. However, the capacity of microcirculation would vary due to the gender differences. Near-infrared spectroscopy (NIRS) is a noninvasive technique to monitor tissue oxygenation dynamics. In this study, the far-infrared (FIR) source was used for physiological intervention of microcirculation. The experimental results show that the nature difference of oxygenation status exists between male and female during FIR irradiation. Therefore, we suggest the NIRS-based assessment should be calibrated with the gender-related effect for clinical diagnosis of peripheral arterial disease.	[Kao, Wei-Lung; Sun, Chia-Wei] Natl Chiao Tung Univ, Dept Photon, Hsinchu, Taiwan	National Yang Ming Chiao Tung University	Sun, CW (corresponding author), Natl Chiao Tung Univ, Dept Photon, Hsinchu, Taiwan.	chiaweisun@nctu.edu.tw			Taiwan National Science Council [NSC 101-2628-E-009-026-MY3, NSC 102-2321-B-009-002, NSC 102-2622-E-009-007-CC3, NSC 102-2627-E-010-001, NSC 102-3011-P-010-003]; Ministry of Education, Aim for the Top University Plan in National Chiao-Tung University [101W9866]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Education, Aim for the Top University Plan in National Chiao-Tung University	This work was supported in part by the Taiwan National Science Council under Grant Nos NSC 101-2628-E-009-026-MY3, NSC 102-2321-B-009-002, NSC 102-2622-E-009-007-CC3, NSC 102-2627-E-010-001, NSC 102-3011-P-010-003, and a grant from Ministry of Education, Aim for the Top University Plan in National Chiao-Tung University 101W9866, http://www.most.gov.tw/mp.aspx?mp=7	Capon A, 2003, AM J CLIN DERMATOL, V4, P1, DOI 10.2165/00128071-200304010-00001; Chambliss KL, 2002, ENDOCR REV, V23, P665, DOI 10.1210/er.2001-0045; Hamaoka T, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2805437; Ince C, 2005, CRIT CARE, V9, pS13, DOI 10.1186/cc3753; Ishibashi J, 2008, MED ONCOL, V25, P229, DOI 10.1007/s12032-007-9020-4; Leung TK, 2009, J MED BIOL ENG, V29, P15; Manfredini F, 2012, VASC ENDOVASC SURG, V46, P315, DOI 10.1177/1538574412443318; Mendelsohn ME, 2005, SCIENCE, V308, P1583, DOI 10.1126/science.1112062; Reckelhoff JF, 2001, HYPERTENSION, V37, P1199, DOI 10.1161/01.HYP.37.5.1199; Sader MA, 2002, CARDIOVASC RES, V53, P597, DOI 10.1016/S0008-6363(01)00473-4; Vatansever Fatma, 2012, Photonics Lasers Med, V4, P255; Wang CY, 2012, J BIOPHOTONICS, V5, P719, DOI 10.1002/jbio.201100108; Yu SY, 2006, PHOTODERMATOL PHOTO, V22, P78, DOI 10.1111/j.1600-0781.2006.00208.x	13	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0135166	10.1371/journal.pone.0135166	http://dx.doi.org/10.1371/journal.pone.0135166			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555225	Green Published, gold, Green Submitted			2022-12-27	WOS:000364430700001
J	LeClaire, LL; Fortwendel, JR				LeClaire, Lawrence L.; Fortwendel, Jarrod R.			Differential Support of Aspergillus fumigatus Morphogenesis by Yeast and Human Actins	PLoS One			English	Article							F-ACTIN; CANDIDA-ALBICANS; PHALLOIDIN BINDING; CRYPTOCOCCUS-NEOFORMANS; LATRUNCULIN-A; CELL POLARITY; TIP GROWTH; WILD-TYPE; CYTOSKELETON; NIDULANS	The actin cytoskeleton is highly conserved among eukaryotes and is essential for cellular processes regulating growth and differentiation. In fungi, filamentous actin (F-actin) orchestrates hyphal tip structure and extension via organization of exocytic and endocytic processes at the hyphal tip. Although highly conserved, there are key differences among actins of fungal species as well as between mammalian and fungal actins. For example, the F-actin stabilizing molecules, phalloidin and jasplakinolide, bind to actin structures in yeast and human cells, whereas phalloidin does not bind actin structures of Aspergillus. These discrepancies suggest structural differences between Aspergillus actin filaments and those of human and yeast cells. Additionally, fungal actin kinetics are much faster than those of humans, displaying 5-fold faster nucleation and 40-fold faster nucleotide exchange rates. Limited published studies suggest that these faster actin kinetics are required for normal growth and morphogenesis of yeast cells. In the current work, we show that replacement of Aspergillus actin with yeast actin generates a morphologically normal strain, suggesting that Aspergillus actin kinetics are similar to those of yeast. In contrast to wild type A. fumigatus, F-actin in this strain binds phalloidin, and pharmacological stabilization of these actin structures with jasplakinolide inhibits germination and alters morphogenesis in a dose-dependent manner. We also show that human beta-actin cannot support Aspergillus viability, even though the amino acid sequences of human and Aspergillus actins are 89.3% identical. Our findings show that minor differences in actin protein sequence account for loss of phalloidin and jasplakinolide sensitivity in Aspergillus species.	[LeClaire, Lawrence L.] Univ S Alabama, Coll Med, Dept Biochem & Mol Biol, Mobile, AL USA; [Fortwendel, Jarrod R.] Univ S Alabama, Coll Med, Dept Microbiol & Immunol, Mobile, AL 36688 USA	University of South Alabama; University of South Alabama	Fortwendel, JR (corresponding author), Univ S Alabama, Coll Med, Dept Microbiol & Immunol, Mobile, AL 36688 USA.	jfortwendel@southalabama.edu		Fortwendel, Jarrod/0000-0003-2301-4272	University of South Alabama; University of South Alabama Office of Research and Economic Development Research and Scholarly Development Award; University of South Alabama Faculty Development Council Grant	University of South Alabama; University of South Alabama Office of Research and Economic Development Research and Scholarly Development Award; University of South Alabama Faculty Development Council Grant	Funding: This project was funded by two University of South Alabama internal sources. They are: 1) The University of South Alabama Office of Research and Economic Development Research and Scholarly Development Award, and 2) The University of South Alabama Faculty Development Council Grant.	AKASHI T, 1994, MICROBIOL-SGM, V140, P271, DOI 10.1099/13500872-140-2-271; ANDERSON JM, 1986, J GEN MICROBIOL, V132, P2035; Ayscough KR, 1997, J CELL BIOL, V137, P399, DOI 10.1083/jcb.137.2.399; Ayscough KR, 1996, ANNU REV CELL DEV BI, V12, P129, DOI 10.1146/annurev.cellbio.12.1.129; Ayscough KR, 2000, CURR BIOL, V10, P1587, DOI 10.1016/S0960-9822(00)00859-9; Belmont LD, 1998, J CELL BIOL, V142, P1289, DOI 10.1083/jcb.142.5.1289; Berepiki A, 2011, NAT REV MICROBIOL, V9, P876, DOI 10.1038/nrmicro2666; Berepiki A, 2010, EUKARYOT CELL, V9, P547, DOI 10.1128/EC.00253-09; BROWN SS, 1981, J CELL BIOL, V88, P487, DOI 10.1083/jcb.88.3.487; BUBB MR, 1994, J BIOL CHEM, V269, P14869; Buzan J, 1999, P NATL ACAD SCI USA, V96, P2823, DOI 10.1073/pnas.96.6.2823; Buzan JM, 1996, P NATL ACAD SCI USA, V93, P91, DOI 10.1073/pnas.93.1.91; CANO ML, 1992, CELL MOTIL CYTOSKEL, V21, P147, DOI 10.1002/cm.970210208; COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473; COUE M, 1987, FEBS LETT, V213, P316, DOI 10.1016/0014-5793(87)81513-2; COVE DJ, 1966, BIOCHIM BIOPHYS ACTA, V113, P51, DOI 10.1016/S0926-6593(66)80120-0; De La Cruz EM, 1996, BIOCHEMISTRY-US, V35, P14054, DOI 10.1021/bi961047t; DE LA CRUZ EM, 1994, BIOCHEMISTRY-US, V33, P14387, DOI 10.1021/bi00252a003; Delgado-Alvarez DL, 2010, FUNGAL GENET BIOL, V47, P573, DOI 10.1016/j.fgb.2010.03.004; Fortwendel JR, 2008, EUKARYOT CELL, V7, P1530, DOI 10.1128/EC.00080-08; Fortwendel JR, 2012, EUKARYOT CELL, V11, P966, DOI 10.1128/EC.00091-12; Heath IB, 2003, FUNGAL GENET BIOL, V38, P85, DOI 10.1016/S1087-1845(02)00511-X; Juvvadi PR, 2011, MOL MICROBIOL, V82, P1235, DOI 10.1111/j.1365-2958.2011.07886.x; KARLSSON R, 1991, MOL CELL BIOL, V11, P213, DOI 10.1128/MCB.11.1.213; Knechtle P, 2003, MOL BIOL CELL, V14, P4140, DOI 10.1091/mbc.E03-03-0167; Kopecka M, 2001, EUR J CELL BIOL, V80, P303, DOI 10.1078/0171-9335-00157; Kopecka M, 2013, MICROSCOPY-JPN, V62, P295, DOI 10.1093/jmicro/dfs074; Kopecka M, 2009, CHEMOTHERAPY, V55, P278, DOI 10.1159/000224655; McKane M, 2006, J BIOL CHEM, V281, P29916, DOI 10.1074/jbc.M602251200; Moseley JB, 2006, MICROBIOL MOL BIOL R, V70, P605, DOI 10.1128/MMBR.00013-06; Murakoshi H, 2008, BRAIN CELL BIOL, V36, P31, DOI 10.1007/s11068-008-9024-9; Roca MG, 2010, EUKARYOT CELL, V9, P1171, DOI 10.1128/EC.00329-09; Scott RW, 2010, J CELL BIOL, V191, P169, DOI 10.1083/jcb.201002041; SCOTT VR, 1988, ANTIMICROB AGENTS CH, V32, P1154, DOI 10.1128/AAC.32.8.1154; Steinberg G, 2007, EUKARYOT CELL, V6, P351, DOI 10.1128/EC.00381-06; Taheri-Talesh N, 2008, MOL BIOL CELL, V19, P1439, DOI 10.1091/mbc.E07-05-0464; Ti SC, 2011, J BIOL CHEM, V286, P5784, DOI 10.1074/jbc.M110.199794; Toenjes KA, 2009, J MED MICROBIOL, V58, P779, DOI 10.1099/jmm.0.006841-0; Torralba S, 1998, MICROBIOL-SGM, V144, P45, DOI 10.1099/00221287-144-1-45; Upadhyay S, 2008, MOL MICROBIOL, V68, P690, DOI 10.1111/j.1365-2958.2008.06178.x; Wolkow TD, 1996, J CELL SCI, V109, P2179; Wolyniak MJ, 2007, EUKARYOT CELL, V6, P1824, DOI 10.1128/EC.00188-07	42	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142535	10.1371/journal.pone.0142535	http://dx.doi.org/10.1371/journal.pone.0142535			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555617	Green Submitted, Green Published, gold			2022-12-27	WOS:000364430700124
J	Lehmann, SJ; Scherberger, H				Lehmann, Sebastian J.; Scherberger, Hansjoerg			Spatial Representations in Local Field Potential Activity of Primate Anterior Intraparietal Cortex (AIP)	PLOS ONE			English	Article							POSTERIOR PARIETAL CORTEX; MACAQUE PARIETAL; MOTOR CORTEX; MOVEMENT DIRECTION; VISUAL GUIDANCE; HAND ACTION; MONKEY; PREMOTOR; GRASP; REACH	The execution of reach-to-grasp movements in order to interact with our environment is an important subset of the human movement repertoire. To coordinate such goal-directed movements, information about the relative spatial position of target and effector (in this case the hand) has to be continuously integrated and processed. Recently, we reported the existence of spatial representations in spiking-activity of the cortical fronto-parietal grasp network (Lehmann & Scherberger 2013), and in particular in the anterior intraparietal cortex (AIP). To further investigate the nature of these spatial representations, we explored in two rhesus monkeys (Macaca mulatta) how different frequency bands of the local field potential (LFP) in AIP are modulated by grip type, target position, and gaze position, during the planning and execution of reach-to-grasp movements. We systematically varied grasp type, spatial target, and gaze position and found that both spatial and grasp information were encoded in a variety of frequency bands (1-13Hz, 13-30Hz, 30-60Hz, and 60-100Hz, respectively). Whereas the representation of grasp type strongly increased towards and during movement execution, spatial information was represented throughout the task. Both spatial and grasp type representations could be readily decoded from all frequency bands. The fact that grasp type and spatial (reach) information was found not only in spiking activity, but also in various LFP frequency bands of AIP, might significantly contribute to the development of LFP-based neural interfaces for the control of upper limb prostheses.	[Lehmann, Sebastian J.; Scherberger, Hansjoerg] Deutsch Primatenzentrum GmbH, D-37077 Gottingen, Germany; [Lehmann, Sebastian J.; Scherberger, Hansjoerg] Univ Zurich, Inst Neuroinformat, CH-8057 Zurich, Switzerland; [Lehmann, Sebastian J.; Scherberger, Hansjoerg] Swiss Fed Inst Technol, CH-8057 Zurich, Switzerland; [Scherberger, Hansjoerg] Univ Gottingen, Dept Biol, D-37077 Gottingen, Germany; [Lehmann, Sebastian J.] Univ Western Ontario, Robarts Res Inst, Dept Physiol & Pharmacol, London, ON N6A 5B7, Canada	Deutsches Primatenzentrum (DPZ); University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Gottingen; Western University (University of Western Ontario)	Scherberger, H (corresponding author), Deutsch Primatenzentrum GmbH, D-37077 Gottingen, Germany.	hscherberger@dpz.eu			Swiss National Science Foundation [108323/1, 120652/1]; European Commission [13072]; University of Zurich [FK2004]; German Research Foundation [SCHE 1575/1-1, SCHE 1575/3-1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); University of Zurich; German Research Foundation(German Research Foundation (DFG))	This work was supported by the Swiss National Science Foundation (# 108323/1 and 120652/1), the European Commission (IRG # 13072 'NeuroGrasp'), the University of Zurich (Grant FK2004), and the German Research Foundation (SCHE 1575/1-1 & /3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agashe HA, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00121; Andersen RA, 2004, P ANN INT IEEE EMBS, V26, P5352; Asher I, 2007, J NEUROPHYSIOL, V97, P3684, DOI 10.1152/jn.00886.2006; Baker SN, 1997, J PHYSIOL-LONDON, V501, P225, DOI 10.1111/j.1469-7793.1997.225bo.x; Bansal AK, 2012, J NEUROPHYSIOL, V107, P1337, DOI 10.1152/jn.00781.2011; Batista AP, 1999, SCIENCE, V285, P257, DOI 10.1126/science.285.5425.257; Baumann MA, 2009, J NEUROSCI, V29, P6436, DOI 10.1523/JNEUROSCI.5479-08.2009; Bokil H, 2010, J NEUROSCI METH, V192, P146, DOI 10.1016/j.jneumeth.2010.06.020; Borra E, 2008, CEREB CORTEX, V18, P1094, DOI 10.1093/cercor/bhm146; Bremner LR, 2012, NEURON, V75, P342, DOI 10.1016/j.neuron.2012.03.041; Buneo CA, 2002, NATURE, V416, P632, DOI 10.1038/416632a; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Chang SWC, 2010, P NATL ACAD SCI USA, V107, P7951, DOI 10.1073/pnas.0913209107; Chang SWC, 2009, NEURON, V64, P744, DOI 10.1016/j.neuron.2009.11.005; Hwang EJ, 2009, J NEUROSCI, V29, P14363, DOI 10.1523/JNEUROSCI.2081-09.2009; Kilavik BE, 2012, CEREB CORTEX, V22, P2148, DOI 10.1093/cercor/bhr299; Lehmann SJ, 2013, J NEUROSCI, V33, P7038, DOI 10.1523/JNEUROSCI.5568-12.2013; Logothetis NK, 2002, PHILOS T R SOC B, V357, P1003, DOI 10.1098/rstb.2002.1114; Luppino G, 1999, EXP BRAIN RES, V128, P181, DOI 10.1007/s002210050833; Marzocchi N, 2008, EUR J NEUROSCI, V27, P775, DOI 10.1111/j.1460-9568.2008.06021.x; MATELLI M, 1986, J COMP NEUROL, V251, P281, DOI 10.1002/cne.902510302; Mehring C, 2004, J PHYSIOL-PARIS, V98, P498, DOI 10.1016/j.jphysparis.2005.09.016; Murata A, 2000, J NEUROPHYSIOL, V83, P2580, DOI 10.1152/jn.2000.83.5.2580; O'Leary JG, 2006, J NEUROPHYSIOL, V96, P1492, DOI 10.1152/jn.00106.2006; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; Rickert J, 2005, J NEUROSCI, V25, P8815, DOI 10.1523/JNEUROSCI.0816-05.2005; Rizzolatti G, 2001, NEURON, V31, P889, DOI 10.1016/S0896-6273(01)00423-8; Romero MC, 2014, J NEUROSCI, V34, P4006, DOI 10.1523/JNEUROSCI.4095-13.2014; Sakata H, 1997, TRENDS NEUROSCI, V20, P350, DOI 10.1016/S0166-2236(97)01067-9; SAKATA H, 1995, CEREB CORTEX, V5, P429, DOI 10.1093/cercor/5.5.429; Schaffelhofer S, 2015, J NEUROSCI, V35, P1068, DOI 10.1523/JNEUROSCI.3594-14.2015; Scherberger H, 2005, NEURON, V46, P347, DOI 10.1016/j.neuron.2005.03.004; Spinks RL, 2008, J NEUROSCI, V28, P10961, DOI 10.1523/JNEUROSCI.1956-08.2008; TAIRA M, 1990, EXP BRAIN RES, V83, P29; Tanne-Gariepy J, 2002, EXP BRAIN RES, V145, P91, DOI 10.1007/s00221-002-1078-9; Townsend BR, 2011, J NEUROSCI, V31, P14386, DOI 10.1523/JNEUROSCI.2451-11.2011; Zhuang J, 2010, IEEE T BIO-MED ENG, V57, P1774, DOI 10.1109/TBME.2010.2047015	38	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142679	10.1371/journal.pone.0142679	http://dx.doi.org/10.1371/journal.pone.0142679			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26554592	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000364430700155
J	Nnko, S; Bukenya, D; Kavishe, BB; Biraro, S; Peck, R; Kapiga, S; Grosskurth, H; Seeley, J				Nnko, Soori; Bukenya, Dominic; Kavishe, Bazil Balthazar; Biraro, Samuel; Peck, Robert; Kapiga, Saidi; Grosskurth, Heiner; Seeley, Janet			Chronic Diseases in North-West Tanzania and Southern Uganda. Public Perceptions of Terminologies, Aetiologies, Symptoms and Preferred Management	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; NONCOMMUNICABLE DISEASES; TRADITIONAL MEDICINE; HEALTH-SERVICES; HIV-INFECTION; EPILEPSY; STROKE; STIGMA; KNOWLEDGE; HIV/AIDS	Background Research has shown that health system utilization is low for chronic diseases (CDs) other than HIV. We describe the knowledge and perceptions of CDs identified from rural and urban communities in north-west Tanzania and southern Uganda. Methods Data were collected through a quantitative population survey, a quantitative health facility survey and focus group discussions (FGDs) and in-depth interviews (IDIs) in subgroups of population survey participants. The main focus of this paper is the findings from the FGDs and IDIs. Results We conducted 24 FGDs, involving approximately 180 adult participants and IDIs with 116 participants (>= 18 years). CDs studied included: asthma/chronic obstructive lung disease (COPD), diabetes, epilepsy, hypertension, cardiac failure and HIV-related disease. The understanding of most chronic conditions involved a combination of biomedical information, gleaned from health facility visits, local people who had suffered from a complaint or knew others who had and beliefs drawn from information shared in the community. The biomedical contribution shows some understanding of the aetiology of a condition and the management of that condition. However, local beliefs for certain conditions (such as epilepsy) suggest that biomedical treatment may be futile and therefore work counter to biomedical prescriptions for management. Conclusion Current perceptions of selected CDs may represent a barrier that prevents people from adopting efficacious health and treatment seeking behaviours. Interventions to improve this situation must include efforts to improve the quality of existing health services, so that people can access relevant, reliable and trustworthy services.	[Nnko, Soori] Natl Inst Med Res, Mwanza, Tanzania; [Bukenya, Dominic; Biraro, Samuel; Seeley, Janet] MRC UVRI Uganda Res Unit AIDS, Entebbe, Uganda; [Grosskurth, Heiner; Seeley, Janet] London Sch Hyg & Trop Med, London WC1, England; [Kavishe, Bazil Balthazar; Peck, Robert; Kapiga, Saidi] Mwanza Intervent Trials Unit, Mwanza, Tanzania; [Peck, Robert] Weill Buganda Sch Med, Mwanza, Tanzania; [Peck, Robert] Weill Cornell Med Coll, New York, NY USA	National Institute of Medical Research; University of London; London School of Hygiene & Tropical Medicine; Cornell University	Seeley, J (corresponding author), MRC UVRI Uganda Res Unit AIDS, POB 49, Entebbe, Uganda.	janet.seeley@mrcuganda.org	Kavishe, Bazil/H-4458-2017	Kavishe, Bazil/0000-0003-4839-4590; Kapiga, Saidi/0000-0003-1753-4060; Grosskurth, Heiner/0000-0001-9960-7280; Seeley, Janet/0000-0002-0583-5272; Peck, Robert/0000-0002-4526-2480	UK Government Medical Research Council (MRC UK) [99430]; Department for International Development (DFID) under the MRC/DFID Concordat agreement; Medical Research Council [G0901756, G1002650, MC_UP_A910_1112] Funding Source: researchfish; MRC [MC_UP_A910_1112, G0901756, G1002650] Funding Source: UKRI	UK Government Medical Research Council (MRC UK); Department for International Development (DFID) under the MRC/DFID Concordat agreement; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was funded by a grant from the UK Government Medical Research Council (MRC UK; grant id-nu 99430) provided with support from the Department for International Development (DFID) under the MRC/DFID Concordat agreement. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aalto AM, 2005, J PSYCHOSOM RES, V58, P393, DOI 10.1016/j.jpsychores.2005.03.001; Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Ahlberg BM, 2004, AFRICAN SOCIOLOGICAL, V7, P18; Aikins AD, 2012, ETHNIC HEALTH, V17, P551, DOI 10.1080/13557858.2012.782209; Aikins AD, 2010, GLOBALIZATION HEALTH, V6, DOI 10.1186/1744-8603-6-5; Akinyemi RO, 2009, EUR J NEUROL, V16, P998, DOI 10.1111/j.1468-1331.2009.02666.x; Amuri M, 2011, AIDS CARE, V23, P378, DOI 10.1080/09540121.2010.507739; Ayanniyi O, 2006, Afr J Med Med Sci, V35, P447; Backman G, 2008, LANCET, V372, P2047, DOI 10.1016/S0140-6736(08)61781-X; Baskind R, 2005, EPILEPSY BEHAV, V7, P68, DOI 10.1016/j.yebeh.2005.04.009; Baumann LC, 2010, DIABETES EDUCATOR, V36, P293, DOI 10.1177/0145721709358460; Benjamin LA, 2012, LANCET NEUROL, V11, P878, DOI 10.1016/S1474-4422(12)70205-3; Beune EJAJ, 2006, J HUM HYPERTENS, V20, P946, DOI 10.1038/sj.jhh.1002094; Boozary AS, 2014, JAMA-J AM MED ASSOC, V312, P1859, DOI 10.1001/jama.2014.14387; Boutayeb A, 2006, T ROY SOC TROP MED H, V100, P191, DOI 10.1016/j.trstmh.2005.07.021; BROWNER CH, 1988, CURR ANTHROPOL, V29, P681, DOI 10.1086/203688; Chan BT, 2015, AIDS, V29, P83, DOI 10.1097/QAD.0000000000000495; Cooper M, 2012, ETHNIC HEALTH, V17, P597, DOI 10.1080/13557858.2012.740003; Dalal S, 2011, INT J EPIDEMIOL, V40, P885, DOI 10.1093/ije/dyr050; Donkor ES, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-196; Dugbartey AT, 2013, ETHNIC DIS, V23, P1; Dzudie A, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001217; El Sharkawy G, 2006, EPILEPSY BEHAV, V8, P201, DOI 10.1016/j.yebeh.2005.09.011; Farmer P, 2004, CURR ANTHROPOL, V45, P305, DOI 10.1086/382250; Hjelm K, 2008, INT NURS REV, V55, P434, DOI 10.1111/j.1466-7657.2008.00665.x; Hnizdo E, 2001, CLIN EXP ALLERGY, V31, P32, DOI 10.1046/j.1365-2222.2001.00981.x; Hundt GL, 2004, J BIOSOC SCI, V36, P433, DOI 10.1017/S0021932004006662; Kalyango JN, 2008, AFRICAN HLTH SCI, V8; KAPLAN GA, 1993, CIRCULATION, V88, P1973, DOI 10.1161/01.CIR.88.4.1973; Katende D, 2015, TROP MED INT HEALTH, V20, P1385, DOI 10.1111/tmi.12560; Kavishe B, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0357-9; Keikelame MJ, 2013, EPILEPSY BEHAV, V28, P512, DOI 10.1016/j.yebeh.2013.05.025; Kiwanuka SN, 2008, T ROY SOC TROP MED H, V102, P1067, DOI 10.1016/j.trstmh.2008.04.023; KLEINMAN A, 1978, SOC SCI MED-MED ANTH, V12, P85, DOI 10.1016/0160-7987(78)90014-5; Kolapo KO, 2011, TROP MED INT HEALTH, V16, P707, DOI 10.1111/j.1365-3156.2011.02759.x; Komolafe M, 2011, AFRICAN J NEUROLOGIC, V30; Langwick S., 2011, BODIES POLITICS AFRI; Langwick SA, 2008, AM ETHNOL, V35, P428, DOI 10.1111/j.1548-1425.2008.00044.x; Legg C, 2013, APHASIOLOGY, V27, P126, DOI 10.1080/02687038.2012.684338; Leone T, 2012, GLOBALIZATION HEALTH, V8, DOI 10.1186/1744-8603-8-39; Levitt NS, 2011, AM J CLIN NUTR, V94, p1690S, DOI 10.3945/ajcn.111.019075; Mahajan AP, 2008, AIDS, V22, pS67, DOI 10.1097/01.aids.0000327438.13291.62; Maher D, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-355; Maiga Y, 2014, EPILEPSY BEHAV, V33, P115, DOI 10.1016/j.yebeh.2014.02.031; Marquez PV, 2013, CHALLENGE NONCOMMUNI; Marshall IJ, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e3953; Marsland R, 2012, MED ANTHROPOL Q, V26, P453, DOI 10.1111/maq.12001; Mayega RW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047632; Millogo A, 2004, ACTA NEUROL SCAND, V109, P250, DOI 10.1111/j.1600-0404.2004.00248.x; Mshana G, 2009, STROKE DISCOURSES RE; Mugumbate J, 2013, EPILEPSY BEHAV, V27, P144, DOI 10.1016/j.yebeh.2012.12.036; Mushi D, 2011, EPILEPSY BEHAV, V20, P338, DOI 10.1016/j.yebeh.2010.11.016; Musoke D, 2014, AFR HEALTH SCI, V14, DOI 10.4314/ahs.v14i4.36; Nakibuuka J, 2014, ISRN STROKE, V2014; Njamnshi AK, 2009, EPILEPSY BEHAV, V15, P179, DOI 10.1016/j.yebeh.2009.03.013; Nriagu J, 1999, EUR J EPIDEMIOL, V15, P747, DOI 10.1023/A:1007653709188; Nugent R, 2008, ANN NY ACAD SCI, V1136, P70, DOI 10.1196/annals.1425.027; Peck R, 2014, LANCET GLOB HEALTH, V2, pE285, DOI 10.1016/S2214-109X(14)70033-6; Prince R, 2012, MED ANTHROPOL Q, V26, P534, DOI 10.1111/maq.12006; Rabkin M, 2011, GLOB PUBLIC HEALTH, V6, P247, DOI 10.1080/17441692.2011.552068; Russell S, 2010, SOC SCI MED, V70, P375, DOI 10.1016/j.socscimed.2009.10.039; RWIZA HT, 1993, EPILEPSIA, V34, P1017, DOI 10.1111/j.1528-1157.1993.tb02127.x; Scholten F, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-886; Settumba SN, 2015, TROP MED INT HEALTH, V20, P781, DOI 10.1111/tmi.12487; Stoner B.P., 1986, MED ANTHROPOL Q, V17, P44, DOI DOI 10.1111/j.1937-6219.1986.tb01021.x; Strahl Hilde, 2003, Anthropol Med, V10, P309, DOI 10.1080/1364847032000133834; van Gemert F, 2011, PRIM CARE RESP J, V20, P240, DOI 10.4104/pcrj.2011.00027; Wang C, 2009, PREV MED, V48, P197, DOI 10.1016/j.ypmed.2008.11.008; Whyte SR, 2012, ANTHROPOL MED, V19, P63, DOI 10.1080/13648470.2012.660465; Young F, 2009, GLOBALIZATION HEALTH, V5, DOI 10.1186/1744-8603-5-9	70	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142194	10.1371/journal.pone.0142194	http://dx.doi.org/10.1371/journal.pone.0142194			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7CT	26555896	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000364430700067
J	Tellez, M; Merchant, M				Tellez, Marisa; Merchant, Mark			Biomonitoring Heavy Metal Pollution Using an Aquatic Apex Predator, the American Alligator, and Its Parasites	PLOS ONE			English	Article							MORELETS CROCODILE EGGS; FALSE DISCOVERY RATE; FOOD-WEB; ORGANOCHLORINE PESTICIDES; SMALL-INTESTINE; DANUBE RIVER; MERCURY; ZINC; METALLOTHIONEIN; TOXICITY	Monitoring the bioaccumulation of chemical elements within various organismal tissues has become a useful tool to survey current or chronic levels of heavy metal exposure within an environment. In this study, we compared the bioaccumulations of As, Cd, Cu, Fe, Pb, Se, and Zn between the American alligator, Alligator mississippiensis, and its parasites in order to establish their use as bioindicators of heavy metal pollution. Concomitant with these results, we were interested to determine if parasites were more sensitive bioindicators of heavy metals relative to alligators. We found parasites collectively accumulated higher levels of As, Cu, Se, and Zn in comparison to their alligator hosts, whereas Fe, Cd, and Pb concentrations were higher in alligators. Interestingly, Fe levels were significantly greater in intestinal trematodes than their alligator hosts when analyzed independently from other parasitic taxa. Further analyses showed alligator intestinal trematodes concentrated As, Cu, Fe, Se, and Zn at significantly higher levels than intestinal nematodes and parasites from other organs. However, pentastomids also employed the role as a good biomagnifier of As. Interestingly, parasitic abundance decreased as levels of As increased. Stomach and intestinal nematodes were the poorest bioaccumulators of metals, yet stomach nematodes showed their ability to concentrate Pb at orders of magnitude higher in comparison to other parasites. Conclusively, we suggest that parasites, particularly intestinal trematodes, are superior biomagnifiers of As, Cu, Se, and Zn, whereas alligators are likely good biological indicators of Fe, Cd, and Pb levels within the environment.	[Tellez, Marisa] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; [Merchant, Mark] McNeese State Univ, Dept Chem, Lake Charles, LA 70605 USA	University of California System; University of California Santa Barbara; University of Louisiana System; McNeese State University	Tellez, M (corresponding author), Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA.	marisatellez13@gmail.com		Merchant, Mark/0000-0001-6444-4012	NSF-Graduate Research Fellowship Program Award [DGE-0946816]; IUCN/Species Survival Committee-Crocodile Specialist Group; Chicago Herpetological Society; Sigma Xi Student Research-in-Aid Award	NSF-Graduate Research Fellowship Program Award; IUCN/Species Survival Committee-Crocodile Specialist Group; Chicago Herpetological Society; Sigma Xi Student Research-in-Aid Award	Funding: This study was funded by NSF-Graduate Research Fellowship Program Award No. DGE-0946816, https://www.nsfgrfp.org/, Funding assisted in data collecting and heavy metal analysis; IUCN/Species Survival Committee-Crocodile Specialist Group's Student Research Assistant Scheme, http://www.lucncsg.org/pages/General-Information.html, funding assisted in data collection and heavy metal analysis; Chicago Herpetological Society Graduate Student Research in Herpetology Award, http://www.chicagoherp.org/index.php?link=grants, funding assisted in data collection; Sigma Xi Student Research-in-Aid Award, https://www.sigmaxi.org/programs/grants-in-aid, funding assisted in data collection.	Abernathy CO, 2003, J NUTR, V133, p1536S, DOI 10.1093/jn/133.5.1536S; Altindag A, 2005, CHEMOSPHERE, V60, P552, DOI 10.1016/j.chemosphere.2005.01.009; BELL JU, 1985, COMP BIOCHEM PHYS C, V82, P123, DOI 10.1016/0742-8413(85)90218-X; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergey L, 2002, MAR POLLUT BULL, V44, P1046, DOI 10.1016/S0025-326X(02)00154-6; Brozova A, 2015, ENVIRON SCI POLLUT R, V22, P3175, DOI 10.1007/s11356-014-3733-7; Burger J, 2000, ARCH ENVIRON CON TOX, V38, P501, DOI 10.1007/s002449910066; Campbell Kym Rouse, 2003, Applied Herpetology, V1, P45, DOI 10.1163/157075403766451225; Campbell LM, 2005, SCI TOTAL ENVIRON, V351, P247, DOI 10.1016/j.scitotenv.2005.02.043; Chen CY, 2008, ENVIRON HEALTH PERSP, V116, P1706, DOI 10.1289/ehp.11211; Choong TSY, 2007, DESALINATION, V217, P139, DOI 10.1016/j.desal.2007.01.015; Coeurdassier M, 2010, ENVIRON POLLUT, V158, P2078, DOI 10.1016/j.envpol.2010.03.008; Crossgrove J, 2004, NMR BIOMED, V17, P544, DOI 10.1002/nbm.931; DIAMOND J, 1991, NEWS PHYSIOL SCI, V6, P92, DOI 10.1152/physiologyonline.1991.6.2.92; FAIRBROTHER A, 1994, J WILDLIFE DIS, V30, P222, DOI 10.7589/0090-3558-30.2.222; FLOS R, 1986, COMP BIOCHEM PHYS C, V83, P93, DOI 10.1016/0742-8413(86)90018-6; FRIEDEN E, 1973, NUTR REV, V31, P41; Garcia-Hernandez Jaqueline, 2007, Toxicological and Environmental Chemistry, V89, P507, DOI 10.1080/02772240601165594; Guillory G, 2011, INSTRUM SCI TECHNOL, V39, P368, DOI 10.1080/10739149.2011.585196; Halmetoja A, 2000, INT J PARASITOL, V30, P1437, DOI 10.1016/S0020-7519(00)00115-6; Hopkins WA, 2005, ENVIRON POLLUT, V134, P447, DOI 10.1016/j.envpol.2004.09.010; Ibs KH, 2003, J NUTR, V133, p1452S, DOI 10.1093/jn/133.5.1452S; Ikemoto T, 2004, ARCH ENVIRON CON TOX, V47, P402, DOI 10.1007/s00244-004-3188-9; Kannan K, 2006, CHEMOSPHERE, V65, P2160, DOI 10.1016/j.chemosphere.2006.06.003; Kelly EJ, 1996, J NUTR, V126, P1782; KLAASSEN CD, 1978, AM J PHYSIOL, V234, pE47, DOI 10.1152/ajpendo.1978.234.1.E47; Lafferty KD, 1999, LIMNOL OCEANOGR, V44, P925, DOI 10.4319/lo.1999.44.3_part_2.0925; Lafferty KD, 2004, PARASITISM ECOSYSTEM; Lafferty KD, 2006, P NATL ACAD SCI USA, V103, P11211, DOI 10.1073/pnas.0604755103; Lance VA, 2006, COMP BIOCHEM PHYS C, V142, P30, DOI 10.1016/j.cbpc.2005.09.008; Law K, 2006, ENVIRON TOXICOL CHEM, V25, P2177, DOI 10.1897/05-500R.1; Liu JH, 2005, MAR POLLUT BULL, V51, P857, DOI 10.1016/j.marpolbul.2005.04.014; LSUAg Center [Internet], SUMM AGR NAT RES; Martin PA, 2011, ECOTOXICOLOGY, V20, P1701, DOI 10.1007/s10646-011-0763-5; Moss JC, 2010, MICROCHEM J, V95, P5, DOI 10.1016/j.microc.2009.07.008; Nachev M, 2010, PARASITOLOGY, V137, P1239, DOI 10.1017/S0031182010000065; Nachev M, 2009, PARASITOLOGY, V136, P545, DOI 10.1017/S003118200900571X; Orescanin V, 2006, NUCL INSTRUM METH B, V245, P495, DOI 10.1016/j.nimb.2005.11.050; OTVOS JD, 1980, P NATL ACAD SCI-BIOL, V77, P7094, DOI 10.1073/pnas.77.12.7094; PAPPENHEIMER JR, 1987, J MEMBRANE BIOL, V100, P123, DOI 10.1007/BF02209145; Pepper CB, 2004, J WILDLIFE DIS, V40, P493, DOI 10.7589/0090-3558-40.3.493; Pietrock M, 2002, PARASITOL RES, V88, P225, DOI 10.1007/s00436-001-0529-8; R Development Core Team, 2012, R LANG ENV STAT COMP; Rabalais NN, 2009, ICES J MAR SCI, V66, P1528, DOI 10.1093/icesjms/fsp047; Rai PK, 2008, INT J PHYTOREMEDIAT, V10, P133, DOI 10.1080/15226510801913918; Rainwater TR, 2007, SCI TOTAL ENVIRON, V373, P146, DOI 10.1016/j.scitotenv.2006.11.010; Rainwater TR, 2002, ARCH ENVIRON CON TOX, V42, P319, DOI 10.1007/s00244-001-0020-7; Rink L, 2000, P NUTR SOC, V59, P541, DOI 10.1017/S0029665100000781; Salla V, 2011, MICROCHEM J, V97, P207, DOI 10.1016/j.microc.2010.09.005; SANDBERG AS, 1981, BRIT J NUTR, V45, P283, DOI 10.1079/BJN19810105; Sato M, 2002, TOHOKU J EXP MED, V196, P9, DOI 10.1620/tjem.196.9; Schludermann C, 2003, PARASITOLOGY, V126, pS61, DOI 10.1017/S0031182003003743; Seed, 2001, PARASITISM DIVERSITY; Siva PRM, 2010, INSTRUM SCI TECHNOL, V38, P448, DOI 10.1080/10739149.2010.511661; Sures B, 1998, INT J PARASITOL, V28, P1173, DOI 10.1016/S0020-7519(98)00105-2; Sures B, 1997, B ENVIRON CONTAM TOX, V59, P14, DOI 10.1007/s001289900437; Sures B, 1999, PARASITOL TODAY, V15, P16, DOI 10.1016/S0169-4758(98)01358-1; Sures B, 2004, TRENDS PARASITOL, V20, P170, DOI 10.1016/j.pt.2004.01.014; Sures B, 2003, ENVIRON POLLUT, V122, P401, DOI 10.1016/S0269-7491(02)00306-8; SURES B, 1995, ANAL CHIM ACTA, V311, P135, DOI 10.1016/0003-2670(95)00191-2; Sures Bernd, 2001, Aquatic Ecology, V35, P245, DOI 10.1023/A:1011422310314; Thielen F, 2004, ENVIRON POLLUT, V129, P421, DOI 10.1016/j.envpol.2003.11.011; THOMAS P, 1994, COMP BIOCHEM PHYS C, V107, P221, DOI 10.1016/1367-8280(94)90044-2; Wu TH, 2000, J AGR FOOD CHEM, V48, P6416, DOI 10.1021/jf000321u; Zhou QF, 2008, ANAL CHIM ACTA, V606, P135, DOI 10.1016/j.aca.2007.11.018	66	25	28	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142522	10.1371/journal.pone.0142522	http://dx.doi.org/10.1371/journal.pone.0142522			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555363	Green Submitted, gold, Green Published			2022-12-27	WOS:000364430700122
J	Srinivas, C; Ramaiah, MJ; Lavanya, A; Yerramsetty, S; Kishor, PBK; Basha, SA; Kamal, A; Bhadra, U; Bhadra, MP				Srinivas, Chatla; Ramaiah, M. Janaki; Lavanya, A.; Yerramsetty, Suresh; Kishor, P. B. Kavi; Basha, Shaik Anver; Kamal, Ahmed; Bhadra, Utpal; Bhadra, Manika-Pal			Novel Etoposide Analogue Modulates Expression of Angiogenesis Associated microRNAs and Regulates Cell Proliferation by Targeting STAT3 in Breast Cancer	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; TUMOR ANGIOGENESIS; THERAPEUTIC TARGET; SIGNAL TRANSDUCER; MIR-16 INDUCE; COLON-CANCER; IN-VITRO; VEGF; BCL-2; APOPTOSIS	Tumor microenvironment play role in angiogenesis and carcinogenesis. Etoposide, a known topoisomerase II inhibitor induces DNA damage resulting in cell cycle arrest. We developed a novel Etoposide analogue, Quinazolino-4 beta-amidopodophyllotoxin (C-10) that show better efficacy in regulating cell proliferation and angiogenesis. We evaluated its role on expression of microRNAs-15, 16, 17 and 221 and its targets Bcl-2, STAT3 and VEGF that dictate cell proliferation and angiogenesis. Docking studies clearly demonstrated the binding of Etoposide and C-10 to STAT3. We conclude that combination of Etoposide or C-10 with miR-15, 16, 17 and 221 as a new approach to induce apoptosis and control angiogenesis in breast cancer.	[Srinivas, Chatla; Ramaiah, M. Janaki; Lavanya, A.; Yerramsetty, Suresh; Bhadra, Manika-Pal] CSIR Indian Inst Chem Technol, Ctr Chem Biol, Hyderabad, Andhra Pradesh, India; [Ramaiah, M. Janaki] SASTRA Univ, Sch Chem & Biotechnol, Thanjavur, India; [Kishor, P. B. Kavi] Osmania Univ, Dept Genet, Hyderabad 500007, Andhra Pradesh, India; [Basha, Shaik Anver; Kamal, Ahmed] CSIR Indian Inst Chem Technol, Med Chem & Pharmacol, Hyderabad, Andhra Pradesh, India; [Bhadra, Utpal] CSIR Ctr Cellular & Mol Biol, Funct Genom & Gene Silencing Grp, Hyderabad, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT); Shanmugha Arts, Science, Technology & Research Academy (SASTRA); Osmania University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Bhadra, MP (corresponding author), CSIR Indian Inst Chem Technol, Ctr Chem Biol, Hyderabad, Andhra Pradesh, India.	manika@iict.res.in	Chatla, Srinivas/AAA-9299-2020; RAMAIAH, JANAKI/AAL-9074-2020	Chatla, Srinivas/0000-0002-8509-8494; Ramaiah, Janaki/0000-0003-1814-2819	CSIR [CSC-0111]	CSIR(Council of Scientific & Industrial Research (CSIR) - India)	Funding: The entire work was supported by CSIR 12th Five Year Plan, Project-SMILE (CSC-0111). CS and AL thank CSIR for their fellowship.	Aggarwal BB, 2009, ANN NY ACAD SCI, V1171, P59, DOI 10.1111/j.1749-6632.2009.04911.x; Albasanz-Puig A, 2012, BIOCHEM BIOPH RES CO, V428, P179, DOI 10.1016/j.bbrc.2012.10.037; Ando H, 2013, J GENE MED, V15, P20, DOI 10.1002/jgm.2690; Auyeung KKW, 2012, ONCOL REP, V28, P2188, DOI 10.3892/or.2012.2056; Becker S, 1998, NATURE, V394, P145, DOI 10.1038/28101; Bellou S, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-35; Bhattacharya R, 2009, CANCER RES, V69, P9090, DOI 10.1158/0008-5472.CAN-09-2552; Bid HK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035513; Bossung V, 2010, CURR OPIN OBSTET GYN, V22, P79, DOI 10.1097/GCO.0b013e328334e462; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Chen HX, 2009, NAT REV CLIN ONCOL, V6, P465, DOI 10.1038/nrclinonc.2009.94; Choi HJ, 2012, BBA-MOL CELL RES, V1823, P1082, DOI 10.1016/j.bbamcr.2012.03.015; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Claesson-Welsh L, 2013, J INTERN MED, V273, P114, DOI 10.1111/joim.12019; Cohen SM, 2006, GENE DEV, V20, P2769, DOI 10.1101/gad.1484606; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fossey SL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-81; Gerber HP, 1998, J BIOL CHEM, V273, P13313, DOI 10.1074/jbc.273.21.13313; Guo CJ, 2009, J HEPATOL, V50, P766, DOI 10.1016/j.jhep.2008.11.025; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Huang W, 2014, ACS CHEM BIOL, V9, P1188, DOI 10.1021/cb500071v; Ihle MA, 2015, MOL ONCOL, V9, P1421, DOI 10.1016/j.molonc.2015.03.013; Jain RK, 2006, NAT CLIN PRACT ONCOL, V3, P24, DOI 10.1038/ncponc0403; Kamal A, 2013, BIOORGAN MED CHEM, V21, P6414, DOI 10.1016/j.bmc.2013.08.051; Kaneko T, 2007, CANCER RES, V67, P9685, DOI 10.1158/0008-5472.CAN-07-1497; Key TJ, 2001, LANCET ONCOL, V2, P133, DOI 10.1016/S1470-2045(00)00254-0; Kim Y, 2002, PLANTA MED, V68, P271, DOI 10.1055/s-2002-23140; Kumar A, 2012, BIOINFORMATION, V8, P988, DOI 10.6026/97320630008988; Li Haoran, 2014, Oncoscience, V1, P531; Melo S, 2011, P NATL ACAD SCI USA, V108, P4394, DOI 10.1073/pnas.1014720108; Mueller MD, 2000, P NATL ACAD SCI USA, V97, P10972, DOI 10.1073/pnas.200377097; Nahar S, 2014, CHEM COMMUN, V50, P4639, DOI 10.1039/c3cc49337g; Nathwani SM, 2013, ONCOL REP, V29, P585, DOI 10.3892/or.2012.2181; Nicoli S, 2012, DEV CELL, V22, P418, DOI 10.1016/j.devcel.2012.01.008; Niu GL, 2002, ONCOGENE, V21, P2000, DOI 10.1038/sj.onc.1205260; Panigrahy D, 2010, EXP THER MED, V1, P739, DOI 10.3892/etm.2010.127; Pidgeon GP, 2001, BRIT J CANCER, V85, P273, DOI 10.1054/bjoc.2001.1876; Porcu E, 2013, ANGIOGENESIS, V16, P647, DOI 10.1007/s10456-013-9343-z; Prudent R, 2013, BRIT J PHARMACOL, V168, P673, DOI 10.1111/j.1476-5381.2012.02230.x; Regis G, 2008, SEMIN CELL DEV BIOL, V19, P351, DOI 10.1016/j.semcdb.2008.06.004; Ren XA, 2009, BRIT J PHARMACOL, V156, P1228, DOI 10.1111/j.1476-5381.2009.00112.x; Repovic P, 2003, ONCOGENE, V22, P8117, DOI 10.1038/sj.onc.1206922; Scherr M, 2014, LEUKEMIA, V28, P554, DOI 10.1038/leu.2013.361; Schneider BP, 2007, NAT CLIN PRACT ONCOL, V4, P181, DOI 10.1038/ncponc0740; Shan G, 2008, NAT BIOTECHNOL, V26, P933, DOI 10.1038/nbt.1481; Shen J, 2012, PANCREATOLOGY, V12, P91, DOI 10.1016/j.pan.2012.02.008; Shi M, 2010, CANCER METAST REV, V29, P785, DOI 10.1007/s10555-010-9265-9; Shi Q, 2001, CANCER RES, V61, P4143; Shinkaruk S., 2003, Current Medicinal Chemistry - Anti-Cancer Agents, V3, P95, DOI 10.2174/1568011033353452; Spinetti G, 2013, CIRC RES, V112, DOI 10.1161/CIRCRESAHA.111.300418; Sun CY, 2013, CARCINOGENESIS, V34, P426, DOI 10.1093/carcin/bgs333; Takahashi Y, 1997, ARCH SURG-CHICAGO, V132, P541; TISCHER E, 1991, J BIOL CHEM, V266, P11947; van Schooneveld E, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0526-y; Vangala JR, 2014, J BIOL CHEM, V289, P12612, DOI 10.1074/jbc.M113.542829; Wei DY, 2003, ONCOGENE, V22, P319, DOI 10.1038/sj.onc.1206122; Xia L, 2008, INT J CANCER, V123, P372, DOI 10.1002/ijc.23501; Zushi SI, 1998, INT J CANCER, V78, P326, DOI 10.1002/(SICI)1097-0215(19981029)78:3<326::AID-IJC12>3.0.CO;2-4	60	15	16	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2015	10	11							e0142006	10.1371/journal.pone.0142006	http://dx.doi.org/10.1371/journal.pone.0142006			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7AC	26551008	gold, Green Submitted, Green Published			2022-12-27	WOS:000364422800013
J	Harasti, D; Lee, KA; Gallen, C; Hughes, JM; Stewart, J				Harasti, David; Lee, Kate A.; Gallen, Christopher; Hughes, Julian M.; Stewart, John			Movements, Home Range and Site Fidelity of Snapper (Chrysophrys auratus) within a Temperate Marine Protected Area	PLOS ONE			English	Article							NEW-SOUTH-WALES; PAGRUS-AURATUS; HABITAT UTILIZATION; REEF FISH; TEMPORAL VARIATION; ACOUSTIC TRACKING; PATTERNS; RESERVES; SPARIDAE; BEHAVIOR	Understanding the movement dynamics of marine fish provides valuable information that can assist with species management, particularly regarding protection within marine protected areas (MPAs). We performed an acoustic tagging study implemented within the Port Stephens-Great Lakes Marine Park on the mid-north coast of New South Wales, Australia, to assess the movement patterns, home range and diel activity of snapper (Chrysophrys auratus; Sparidae); a species of significant recreational and commercial fishing importance in Australia. The study focused on C. auratus movements around Cabbage Tree Island, which is predominantly a no-take sanctuary zone (no fishing), with an array of acoustic stations deployed around the island and adjacent reefs and islands. Thirty C. auratus were tagged with internal acoustic tags in November 2010 with their movements recorded until September 2014. Both adult and juvenile C. auratus were observed to display strong site fidelity to Cabbage Tree Island with a mean 12-month residency index of 0.83 (range = 0 low to 1 high). Only three fish were detected on acoustic receivers away from Cabbage Tree Island, with one fish moving a considerable distance of similar to 290 kms over a short time frame (46 days). The longest period of residency recorded at the island was for three fish occurring regularly at the site for a period of 1249 days. Chrysophrys auratus displayed strong diurnal behaviour and detection frequency was significantly higher during the day than at night; however, there was no significant difference in detection frequency between different hours. This study demonstrates that even small-scale protected areas can benefit C. auratus during multiple life-history stages as it maintains a small home range and displays strong site fidelity over a period of 3 years.	[Harasti, David; Gallen, Christopher] NSW Dept Primary Ind, Fisheries Res, Nelson Bay, NSW 2315, Australia; [Lee, Kate A.] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia; [Hughes, Julian M.; Stewart, John] Sydney Inst Marine Sci, New South Wales Dept Primary Ind, Mosman, NSW 2088, Australia	NSW Department of Primary Industries; Macquarie University; NSW Department of Primary Industries; Sydney Institute of Marine Science	Harasti, D (corresponding author), NSW Dept Primary Ind, Fisheries Res, Nelson Bay, NSW 2315, Australia.	david.harasti@dpi.nsw.gov.au	Harasti, David/I-1266-2019; Stewart, John/N-7330-2016; Hughes, Julian/D-2695-2017	Harasti, David/0000-0002-2851-9838; Stewart, John/0000-0002-1435-0082; Hughes, Julian/0000-0002-0884-8386	NSW Recreational Fishing Trust [DPI60]	NSW Recreational Fishing Trust	This study was supported by NSW Recreational Fishing Trust (Project DPI60) (to JS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis D, 2012, J APPL ICHTHYOL, V28, P126, DOI 10.1111/j.1439-0426.2011.01795.x; Abecasis D, 2015, MAR ECOL PROG SER, V518, P255, DOI 10.3354/meps11054; Abecasis D, 2009, ESTUAR COAST SHELF S, V85, P525, DOI 10.1016/j.ecss.2009.09.001; Afonso P, 2008, MAR ECOL PROG SER, V359, P215, DOI 10.3354/meps07272; Afonso P, 2011, BIOL CONSERV, V144, P2739, DOI 10.1016/j.biocon.2011.07.028; Afonso P, 2009, MAR ECOL PROG SER, V381, P273, DOI 10.3354/meps07946; AGARDY MT, 1994, TRENDS ECOL EVOL, V9, P267, DOI 10.1016/0169-5347(94)90297-6; Alos J, 2011, MAR ECOL PROG SER, V427, P173, DOI 10.3354/meps09042; Babcock RC, 2010, P NATL ACAD SCI USA, V107, P18256, DOI 10.1073/pnas.0908012107; Banks SA, 2010, MAR POLICY, V34, P197, DOI 10.1016/j.marpol.2009.06.006; Barton K., 2012, MUMIN MULTIMODEL INF; Bates D., 2013, LME4 LINEAR MIXED EF; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Bond ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032983; Bruce BD, 2006, MAR BIOL, V150, P161, DOI 10.1007/s00227-006-0325-1; Bruce B. D., 2013, ACOUSTIC TRACKING AE; Bruce Barry D., 2012, P225; Bruce T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036687; Bryars S, 2012, MAR FRESHWATER RES, V63, P552, DOI 10.1071/MF12016; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Christie MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015715; Christie P, 2007, CORAL REEFS, V26, P1047, DOI 10.1007/s00338-007-0235-9; Coleman MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020168; CROSSLAND J, 1977, NEW ZEAL J MAR FRESH, V11, P37, DOI 10.1080/00288330.1977.9515660; Curley BG, 2013, REV FISH BIOL FISHER, V23, P435, DOI 10.1007/s11160-013-9309-7; Currey LM, 2014, MAR BIOL, V161, P2155, DOI 10.1007/s00227-014-2497-4; da Silva IM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0111774; Denny CM, 2004, MAR ECOL PROG SER, V272, P183, DOI 10.3354/meps272183; Di Franco A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031681; Edgar GJ, 2004, ENVIRON BIOL FISH, V70, P273, DOI 10.1023/B:EBFI.0000033342.89719.39; Edgar GJ, 2012, AUSTR MARINE LIFE; Edgar GJ, 2014, NATURE, V506, P216, DOI 10.1038/nature13022; Egli DP, 2004, ICES J MAR SCI, V61, P1137, DOI 10.1016/j.icesjms.2004.07.004; Ferguson AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065838; Ferrell D, 1996, ASSESSMENT FISHERY S; Francis M., 2012, COASTAL FISHES NZ; Gell FR, 2003, TRENDS ECOL EVOL, V18, P448, DOI 10.1016/S0169-5347(03)00189-7; Halpern BS, 2003, ECOL APPL, V13, pS117; HANSEN LP, 1993, ANIM BEHAV, V45, P927, DOI 10.1006/anbe.1993.1112; Harasti D, 2014, J APPL ICHTHYOL, V30, P1007, DOI 10.1111/jai.12446; Harasti D, 2014, J FISH BIOL, V85, P1413, DOI 10.1111/jfb.12492; Harasti D, 2015, J EXP MAR BIOL ECOL, V463, P173, DOI 10.1016/j.jembe.2014.12.003; Harrison HB, 2012, CURR BIOL, V22, P1023, DOI 10.1016/j.cub.2012.04.008; Hartill BW, 2003, MAR FRESHWATER RES, V54, P931, DOI 10.1071/MF02095; Heupel MR, 2006, MAR FRESHWATER RES, V57, P1, DOI 10.1071/MF05091; HILBORN R, 1990, CAN J FISH AQUAT SCI, V47, P635, DOI 10.1139/f90-071; HOLLAND KN, 1993, B MAR SCI, V52, P982; Hothorn T., 2010, MULTCOMP SIMULTANEOU; How JR, 2012, MAR FRESHWATER RES, V63, P312, DOI 10.1071/MF11194; Kelaher BP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085825; La Mesa G, 2013, HYDROBIOLOGIA, V720, P129, DOI 10.1007/s10750-013-1631-5; Lee KA, 2015, AQUAT CONSERV, V25, P174, DOI 10.1002/aqc.2431; Lester SE, 2008, MAR ECOL PROG SER, V367, P49, DOI 10.3354/meps07599; Lowe CG, 2003, MAR ECOL PROG SER, V256, P205, DOI 10.3354/meps256205; Lutcavage ME, 1999, CAN J FISH AQUAT SCI, V56, P173, DOI 10.1139/cjfas-56-2-173; Malcolm HA, 2007, MAR ECOL PROG SER, V350, P277, DOI 10.3354/meps07195; Malcolm HA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127616; Meyer CG, 2007, MAR ECOL PROG SER, V333, P13, DOI 10.3354/meps333013; Meyer CG, 2000, ENVIRON BIOL FISH, V59, P235, DOI 10.1023/A:1007664813814; Meyer CG, 2005, ENVIRON BIOL FISH, V73, P201, DOI 10.1007/s10641-005-0559-7; Molloy PP, 2009, J APPL ECOL, V46, P743, DOI 10.1111/j.1365-2664.2009.01662.x; Moran M, 2003, MAR FRESHWATER RES, V54, P913, DOI 10.1071/MF03012; Mumby PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008657; Nielsen JL, 2009, TAGGING TRACKING MAR; Norriss JV, 2012, MAR FRESHWATER RES, V63, P1191, DOI 10.1071/MF12077; Parsons DM, 2014, NEW ZEAL J MAR FRESH, V48, P256, DOI 10.1080/00288330.2014.892013; Parsons DM, 2011, CAN J FISH AQUAT SCI, V68, P632, DOI 10.1139/F11-005; Parsons DM, 2010, BIOL CONSERV, V143, P2039, DOI 10.1016/j.biocon.2010.05.009; Parsons DM, 2003, MAR ECOL PROG SER, V262, P253, DOI 10.3354/meps262253; Pastor J, 2009, CR BIOL, V332, P732, DOI 10.1016/j.crvi.2009.03.010; Pincock DG, 2011, FALSE DETECTIONS WHA; Pinheiro J, 2001, MIXED EFFECTS MODELS; Poulos DE, 2013, AQUAT CONSERV, V23, P838, DOI 10.1002/aqc.2362; R Core Development Team, 2009, R LANG ENV STAT COMP; Read AD, 2010, OCEAN COAST MANAGE, V53, P636, DOI 10.1016/j.ocecoaman.2010.08.003; Roberts C.M., 1991, Reviews in Fish Biology and Fisheries, V1, P65, DOI 10.1007/BF00042662; Roberts CM, 2001, SCIENCE, V294, P1920, DOI 10.1126/science.294.5548.1920; Russ GR, 2004, ECOL APPL, V14, P597, DOI 10.1890/03-5076; SCOTT SG, 1993, ENVIRON BIOL FISH, V36, P149, DOI 10.1007/BF00002794; Selig ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009278; Simpfendorfer CA, 2002, CAN J FISH AQUAT SCI, V59, P23, DOI 10.1139/F01-191; Smith ANH, 2014, MAR ECOL PROG SER, V499, P203, DOI 10.3354/meps10653; Squire Jr JL, 1974, REV CONTRIBUTED PA 2, P226; Stewart J, 2009, SIZE AGE SEXUAL MATU; Sumpton WD, 2003, MAR FRESHWATER RES, V54, P923, DOI 10.1071/MF02119; Terres MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136799; Topping DT, 2005, MAR BIOL, V147, P301, DOI 10.1007/s00227-005-1573-1; Villegas-Rios D, 2013, J SEA RES, V80, P61, DOI 10.1016/j.seares.2013.02.009; Wakefield CB, 2011, FISH RES, V109, P243, DOI 10.1016/j.fishres.2011.02.008; Willis TJ, 2001, NEW ZEAL J MAR FRESH, V35, P581, DOI 10.1080/00288330.2001.9517024; Zeller DC, 1998, CAN J FISH AQUAT SCI, V55, P917, DOI 10.1139/cjfas-55-4-917; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x; Zuur Alain F., 2009, P1	94	25	25	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142454	10.1371/journal.pone.0142454	http://dx.doi.org/10.1371/journal.pone.0142454			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544185	Green Submitted, Green Published, gold			2022-12-27	WOS:000364398700142
J	Manni, M; Gupta, S; Nixon, BG; Weaver, CT; Jessberger, R; Pernis, AB				Manni, Michela; Gupta, Sanjay; Nixon, Briana G.; Weaver, Casey T.; Jessberger, Rolf; Pernis, Alessandra B.			IRF4-Dependent and IRF4-Independent Pathways Contribute to DC Dysfunction in Lupus	PLOS ONE			English	Article							INTERFERON-REGULATORY FACTOR-4; HELPER-CELL-DIFFERENTIATION; DENDRITIC CELLS; TRANSCRIPTION-FACTOR; T-CELLS; B-CELLS; IRF4; AUTOIMMUNITY; SWAP-70; ERYTHEMATOSUS	Interferon Regulatory Factors (IRFs) play fundamental roles in dendritic cell (DC) differentiation and function. In particular, IRFs are critical transducers of TLR signaling and dysregulation in this family of factors is associated with the development of autoimmune disorders such as Systemic Lupus Erythematosus (SLE). While several IRFs are expressed in DCs their relative contribution to the aberrant phenotypic and functional characteristics that DCs acquire in autoimmune disease has not been fully delineated. Mice deficient in both DEF6 and SWAP-70 (= Double-knock-out or DKO mice), two members of a unique family of molecules that restrain IRF4 function, spontaneously develop a lupus-like disease. Although autoimmunity in DKO mice is accompanied by dysregulated IRF4 activity in both T and B cells, SWAP-70 is also known to regulate multiple aspects of DC biology leading us to directly evaluate DC development and function in these mice. By monitoring Blimp1 expression and IL-10 competency in DKO mice we demonstrate that DCs in these mice exhibit dysregulated IL-10 production, which is accompanied by aberrant Blimp1 expression in the spleen but not in the peripheral lymph nodes. We furthermore show that DCs from these mice are hyper-responsive to multiple TLR ligands and that IRF4 plays a differential role in in these responses by being required for the TLR4-mediated but not the TLR9-mediated upregulation of IL-10 expression. Thus, DC dysfunction in lupus-prone mice relies on both IRF4-dependent and IRF4-independent pathways.	[Manni, Michela; Gupta, Sanjay; Pernis, Alessandra B.] Hosp Special Surg, Autoimmun & Inflammat Program, New York, NY 10021 USA; [Nixon, Briana G.; Pernis, Alessandra B.] Weill Cornell Grad Sch Med Sci, Grad Program Immunol & Microbial Pathogenesis, New York, NY USA; [Weaver, Casey T.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Jessberger, Rolf] Tech Univ Dresden, Inst Physiol Chem, D-01062 Dresden, Germany; [Pernis, Alessandra B.] Cornell Univ, Weill Cornell Med Coll, Dept Med, New York, NY 10021 USA	Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; University of Alabama System; University of Alabama Birmingham; Technische Universitat Dresden; Cornell University	Pernis, AB (corresponding author), Hosp Special Surg, Autoimmun & Inflammat Program, 535 E 70th St, New York, NY 10021 USA.	pernisa@hss.edu		Nixon, Briana/0000-0001-7334-9404	National Institutes of Health [1R01AI083440, 1R01AR064883]; Alliance for Lupus Research; Peter Jay Sharp Foundation; David Z. Rosensweig Genomics Research Center; Kadmon Corporation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064883] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alliance for Lupus Research; Peter Jay Sharp Foundation; David Z. Rosensweig Genomics Research Center; Kadmon Corporation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institutes of Health 1R01AI083440 and 1R01AR064883, the Alliance for Lupus Research, the Peter Jay Sharp Foundation, and the David Z. Rosensweig Genomics Research Center (ABP). ABP also received funding from the Kadmon Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajana S, 2012, J IMMUNOL, V189, P3368, DOI 10.4049/jimmunol.1102613; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Biswas PS, 2012, J EXP MED, V209, P581, DOI 10.1084/jem.20111195; Biswas PS, 2010, J CLIN INVEST, V120, P3280, DOI 10.1172/JCI42856; Bollig N, 2012, P NATL ACAD SCI USA, V109, P8664, DOI 10.1073/pnas.1205834109; Boule MW, 2004, J EXP MED, V199, P1631, DOI 10.1084/jem.20031942; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Chen QZ, 2008, IMMUNITY, V29, P899, DOI 10.1016/j.immuni.2008.10.011; Cretney E, 2011, NAT IMMUNOL, V12, P304, DOI 10.1038/ni.2006; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; Feng YB, 2014, EXPERT OPIN THER PAT, V24, P295, DOI 10.1517/13543776.2014.863279; Gao Y, 2013, IMMUNITY, V39, P722, DOI 10.1016/j.immuni.2013.08.028; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Glasmacher E, 2012, SCIENCE, V338, P975, DOI 10.1126/science.1228309; Gotz A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060642; Groux H, 2003, J AUTOIMMUN, V20, P281, DOI 10.1016/S0896-8411(03)00044-1; Helft J, 2015, IMMUNITY, V42, P1197, DOI 10.1016/j.immuni.2015.05.018; Honma K, 2008, P NATL ACAD SCI USA, V105, P15890, DOI 10.1073/pnas.0803171105; Isgro J, 2013, ARTHRITIS RHEUM-US, V65, P1592, DOI 10.1002/art.37934; Kim SJ, 2011, J EXP MED, V208, P2193, DOI 10.1084/jem.20110658; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Lech M, 2011, J AM SOC NEPHROL, V22, P1443, DOI 10.1681/ASN.2010121260; Li P, 2012, NATURE, V490, P543, DOI 10.1038/nature11530; Lohoff M, 2005, NAT REV IMMUNOL, V5, P125, DOI 10.1038/nri1552; Lohoff M, 2002, P NATL ACAD SCI USA, V99, P11808, DOI 10.1073/pnas.182425099; Lugt BV, 2014, NAT IMMUNOL, V15, P161, DOI 10.1038/ni.2795; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Maynard CL, 2007, NAT IMMUNOL, V8, P931, DOI 10.1038/ni1504; Oberbanscheidt P, 2007, EUR J CELL BIOL, V86, P13, DOI 10.1016/j.ejcb.2006.08.005; Ocana-Morgner C, 2013, J IMMUNOL, V190, P5545, DOI 10.4049/jimmunol.1203095; Ocana-Morgner C, 2011, J IMMUNOL, V186, P5345, DOI 10.4049/jimmunol.1003461; Ocana-Morgner C, 2009, BLOOD, V113, P1474, DOI 10.1182/blood-2008-04-152587; Persson EK, 2013, IMMUNITY, V38, P958, DOI 10.1016/j.immuni.2013.03.009; Rengarajan J, 2002, J EXP MED, V195, P1003, DOI 10.1084/jem.20011128; Rogatsky I, 2014, AUTOIMMUNITY, V47, P242, DOI 10.3109/08916934.2013.853050; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Salloum R, 2011, TRANSL RES, V157, P326, DOI 10.1016/j.trsl.2011.01.006; Santana-de Anda K, 2011, AUTOIMMUN REV, V11, P98, DOI 10.1016/j.autrev.2011.08.006; Schlitzer A, 2013, IMMUNITY, V38, P970, DOI 10.1016/j.immuni.2013.04.011; Sciammas R, 2006, IMMUNITY, V25, P225, DOI 10.1016/j.immuni.2006.07.009; Sisirak V, 2014, J EXP MED, V211, P1969, DOI 10.1084/jem.20132522; Staudt V, 2010, IMMUNITY, V33, P192, DOI 10.1016/j.immuni.2010.07.014; Stirzaker RA, 2012, LUPUS, V21, P656, DOI 10.1177/0961203312436862; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Teichmann LL, 2015, IMMUNITY, V42, P552, DOI 10.1016/j.immuni.2015.02.015; Teichmann LL, 2012, J IMMUNOL, V188, P678, DOI 10.4049/jimmunol.1102456; Teichmann LL, 2010, IMMUNITY, V33, P967, DOI 10.1016/j.immuni.2010.11.025; Vistica BP, 2012, MOL VIS, V18, P1858; Watchmaker PB, 2014, NAT IMMUNOL, V15, P98, DOI 10.1038/ni.2768; Watkins AA, 2015, J IMMUNOL, V194, P1467, DOI 10.4049/jimmunol.1402807; Williams JW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3990; Yamamoto M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025812	53	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141927	10.1371/journal.pone.0141927	http://dx.doi.org/10.1371/journal.pone.0141927			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544714	Green Published, gold, Green Submitted			2022-12-27	WOS:000364398700064
J	Szigeti, A; Tatrai, E; Varga, BE; Szamosi, A; DeBuc, DC; Nagy, ZZ; Nemeth, J; Somfai, GM				Szigeti, Andrea; Tatrai, Erika; Varga, Boglarka Eniko; Szamosi, Anna; DeBuc, Delia Cabrera; Nagy, Zoltan Zsolt; Nemeth, Janos; Somfai, Gabor Mark			The Effect of Axial Length on the Thickness of Intraretinal Layers of the Macula	PLoS One			English	Article							OPTICAL COHERENCE TOMOGRAPHY; NERVE HEAD; CHOROIDAL THICKNESS; RETINAL THICKNESS; SEX; AGE; EYE; OCT; DETERMINANTS; PARAMETERS	Purpose The aim of this study was to evaluate the effect of axial length (AL) on the thickness of intraretinal layers in the macula using optical coherence tomography (OCT) image analysis. Methods Fifty three randomly selected eyes of 53 healthy subjects were recruited for this study. The median age of the participants was 29 years (range: 6 to 67 years). AL was measured for each eye using a Lenstar LS 900 device. OCT imaging of the macula was also performed by Stratus OCT. OCTRIMA software was used to process the raw OCT scans and to determine the weighted mean thickness of 6 intraretinal layers and the total retina. Partial correlation test was performed to assess the correlation between the AL and the thickness values. Results Total retinal thickness showed moderate negative correlation with AL (r = -0.378, p = 0.0007), while no correlation was observed between the thickness of the retinal nerve fiber layer (RNFL), ganglion cell layer (GCC), retinal pigment epithelium (RPE) and AL. Moderate negative correlation was observed also between the thickness of the ganglion cell layer and inner plexiform layer complex (GCL+ IPL), inner nuclear layer (INL), outer plexiform layer (OPL), outer nuclear layer (ONL) and AL which were more pronounced in the peripheral ring (r = -0.402, p = 0.004; r = -0.429, p = 0.002; r = -0.360, p = 0.01; r = -0.448, p = 0.001). Conclusions Our results have shown that the thickness of the nuclear layers and the total retina is correlated with AL. The reason underlying this could be the lateral stretching capability of these layers; however, further research is warranted to prove this theory. Our results suggest that the effect of AL on retinal layers should be taken into account in future studies.	[Szigeti, Andrea; Tatrai, Erika; Varga, Boglarka Eniko; Szamosi, Anna; Nagy, Zoltan Zsolt; Nemeth, Janos; Somfai, Gabor Mark] Semmelweis Univ, Dept Ophthalmol, H-1085 Budapest, Hungary; [DeBuc, Delia Cabrera; Somfai, Gabor Mark] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA	Semmelweis University; Bascom Palmer Eye Institute; University of Miami	Somfai, GM (corresponding author), Semmelweis Univ, Dept Ophthalmol, H-1085 Budapest, Hungary.	somfaigm@yahoo.com	Nagy, Zoltan Zsolt/T-6180-2017	Cabrera DeBuc, Delia/0000-0002-4726-894X; Somfai, Gabor Mark/0000-0001-6329-442X; Nemeth, Janos/0000-0001-8575-4888	Juvenile Diabetes Research Foundation Grant; NIH [NIH R01EY020607]; NIH Center [P30-EY014801]; Research to Prevent Blindness, Inc.; Helen Keller Foundation for Research and Education; Eotvos Scholarship of the Hungarian Scholarship Fund; Zsigmond Diabetes Fund of the Hungarian Academy of Sciences; NATIONAL EYE INSTITUTE [R01EY020607, P30EY014801] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation Grant(Juvenile Diabetes Research Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); Helen Keller Foundation for Research and Education; Eotvos Scholarship of the Hungarian Scholarship Fund; Zsigmond Diabetes Fund of the Hungarian Academy of Sciences; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported in part by a Juvenile Diabetes Research Foundation Grant, a NIH Grant No. NIH R01EY020607, a NIH Center Grant No. P30-EY014801, by an unrestricted grant to the University of Miami from Research to Prevent Blindness, Inc., by a research fellowship of the Helen Keller Foundation for Research and Education (GMS), the Eotvos Scholarship of the Hungarian Scholarship Fund, and by the Zsigmond Diabetes Fund of the Hungarian Academy of Sciences.	Abbott CJ, 2011, VISION RES, V51, P376, DOI 10.1016/j.visres.2010.12.005; ABDALLA MI, 1970, BRIT J OPHTHALMOL, V54, P122, DOI 10.1136/bjo.54.2.122; Amar Agarwal, 2012, PHACOEMULSIFICATION; ANDREASSEN TT, 1980, EXP EYE RES, V31, P435, DOI 10.1016/S0014-4835(80)80027-3; [Anonymous], 1991, OPHTHALMOL, V98, P741; Cheung CY, 2011, INVEST OPHTH VIS SCI, V52, P9629, DOI 10.1167/iovs.11-7481; Chou T, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/4/046001; DeBuc C., 2011, IMAGE SEG, V1, P15, DOI DOI 10.5772/628; Debuc DC, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3470116; DeBuc DC, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3268773; Demirkaya N, 2013, INVEST OPHTH VIS SCI, V54, P4934, DOI 10.1167/iovs.13-11913; Fernandez DC, 2005, OPT EXPRESS, V13, P10200, DOI 10.1364/OPEX.13.010200; Fledelius HC, 2014, ACTA OPHTHALMOL, V92, P259, DOI 10.1111/aos.12107; Franze K, 2011, SOFT MATTER, V7, P3147, DOI 10.1039/c0sm01017k; GUTHOFF R, 1984, OPHTHALMIC RES, V16, P289, DOI 10.1159/000265331; Huang D, 2012, INVEST OPHTH VIS SCI, V53, P4990, DOI 10.1167/iovs.11-8214; Huang JJ, 2011, OPHTHAL SURG LAS IM, V42, P216, DOI 10.3928/15428877-20110324-01; Ishikawa H, 2005, INVEST OPHTH VIS SCI, V46, P2012, DOI 10.1167/iovs.04-0335; Kashani AH, 2010, AM J OPHTHALMOL, V149, P496, DOI 10.1016/j.ajo.2009.09.025; Kelty PJ, 2008, INVEST OPHTH VIS SCI, V49, P2668, DOI 10.1167/iovs.07-1000; Knight OJ, 2012, ARCH OPHTHALMOL-CHIC, V130, P312, DOI 10.1001/archopthalmol.2011.1576; Koh VT, 2012, INVEST OPHTH VIS SCI, V53, P5853, DOI 10.1167/iovs.12-10414; Li XQ, 2011, INVEST OPHTH VIS SCI, V52, P8438, DOI 10.1167/iovs.11-8108; Massin P, 2001, ARCH OPHTHALMOL-CHIC, V119, P1135, DOI 10.1001/archopht.119.8.1135; Mwanza JC, 2011, INVEST OPHTH VIS SCI, V52, P7872, DOI 10.1167/iovs.11-7896; NEMETH J, 1992, ACTA OPHTHALMOL, V70, P353; Ooto S, 2011, INVEST OPHTH VIS SCI, V52, P8769, DOI 10.1167/iovs.11-8388; Puliafito Carmen A, 2010, Ophthalmic Surg Lasers Imaging, V41 Suppl, pS5, DOI 10.3928/15428877-20101031-20; Rao HL, 2011, INVEST OPHTH VIS SCI, V52, P1103, DOI 10.1167/iovs.10-5997; Read SA, 2011, OPTOMETRY VISION SCI, V88, P855, DOI 10.1097/OPX.0b013e3182186a36; Samarawickrama C, 2010, INVEST OPHTH VIS SCI, V51, P4471, DOI 10.1167/iovs.09-3892; Shahidi M, 2005, AM J OPHTHALMOL, V139, P1056, DOI 10.1016/j.ajo.2005.01.012; Silverman RH, 2009, CLIN EXP OPHTHALMOL, V37, P54, DOI 10.1111/j.1442-9071.2008.01892.x; Sogawa K, 2012, AM J OPHTHALMOL, V153, P1129, DOI 10.1016/j.ajo.2011.11.005; Somfai GM, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2774827; Song WK, 2010, INVEST OPHTH VIS SCI, V51, P3913, DOI 10.1167/iovs.09-4189; Tanna H, 2010, BRIT J OPHTHALMOL, V94, P372, DOI 10.1136/bjo.2009.163501; Tatrai E, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3573817; Tranquart F, 2003, J CLIN ULTRASOUND, V31, P258, DOI 10.1002/jcu.10169; Wagner-Schuman M, 2011, INVEST OPHTH VIS SCI, V52, P625, DOI 10.1167/iovs.10-5886; Wexler A, 2010, BMC OPHTHALMOL, V10, DOI 10.1186/1471-2415-10-13; Wolsley CJ, 2008, VISION RES, V48, P1554, DOI 10.1016/j.visres.2008.04.013; Wong ACM, 2005, EYE, V19, P292, DOI 10.1038/sj.eye.6701466	43	18	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142383	10.1371/journal.pone.0142383	http://dx.doi.org/10.1371/journal.pone.0142383			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544553	Green Published, gold, Green Submitted			2022-12-27	WOS:000364398700127
J	Fennis, BM; Andreassen, TW; Lervik-Olsen, L				Fennis, Bob M.; Andreassen, Tor W.; Lervik-Olsen, Line			Behavioral Disinhibition Can Foster Intentions to Healthy Lifestyle Change by Overcoming Commitment to Past Behavior	PLOS ONE			English	Article							IMPLEMENTATION INTENTIONS; SUBSTANCE USE; HABIT; INTERVENTIONS; METAANALYSIS; IMPULSIVITY; EFFICACY	To curb the trend towards obesity and unhealthy living, people may need to change their entire lifestyle to a healthier alternative, something that is frequently perceived to be problematic. The present research, using a large, representative community sample, hypothesized and found that a key factor responsible for why people do not intend to change lifestyles is a sense of commitment to past behavior. However we also found that the contribution of commitment was attenuated for individuals with a stronger tendency for behavioral disinhibition thus underscoring the "bright side" of this individual difference characteristic that traditionally has been mainly associated with impulsive and indulging behavior. Overall, the present findings add to our understanding of factors inhibiting and promoting healthy behavior change.	[Fennis, Bob M.] Univ Groningen, Groningen, Netherlands; [Andreassen, Tor W.] NHH, Bergen, Norway; [Lervik-Olsen, Line] Norwegian Business Sch, BI, Oslo, Norway; [Lervik-Olsen, Line] Ctr Serv Innovat, Oslo, Norway	University of Groningen; Norwegian School of Economics (NHH); BI Norwegian Business School	Fennis, BM (corresponding author), Univ Groningen, Groningen, Netherlands.	b.m.fennis@rug.nl		Fennis, Bob/0000-0003-4738-7524				Aarts H, 2000, J PERS SOC PSYCHOL, V78, P53, DOI 10.1037/0022-3514.78.1.53; Aiken L. S., 1991, MULTIPLE REGRESSION; AJZEN I, 1977, PSYCHOL BULL, V84, P888, DOI 10.1037/0033-2909.84.5.888; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Ajzen I., 2012, HDB THEORIES SOCIAL, VVolume 1, P438, DOI DOI 10.4135/9781446249215.N22; Ammerman AS, 2002, PREV MED, V35, P25, DOI 10.1006/pmed.2002.1028; [Anonymous], 2013, OB OV; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; Chen G, 2001, ORGAN RES METHODS, V4, P62, DOI 10.1177/109442810141004; Cialdini R.B., 2009, INFLUENCE SCI PRACTI, V5th ed.; CIALDINI RB, 1995, J PERS SOC PSYCHOL, V69, P318, DOI 10.1037/0022-3514.69.2.318; Cohen J., 2003, APPL MULTIPLE REGRES; Dawe S, 2004, NEUROSCI BIOBEHAV R, V28, P343, DOI 10.1016/j.neubiorev.2004.03.007; Dawes R.M., 1994, HOUSE CARDS PSYCHOL; de Vries P, 2011, ENVIRON BEHAV, V43, P612, DOI 10.1177/0013916510369630; de Wit H, 2009, ADDICT BIOL, V14, P22, DOI 10.1111/j.1369-1600.2008.00129.x; Fennis BM, 2011, J CONSUM PSYCHOL, V21, P302, DOI 10.1016/j.jcps.2010.12.003; Fennis BM, 2009, J CONSUM RES, V35, P906, DOI 10.1086/593291; FISHER RJ, 1992, J CONSUM RES, V19, P477, DOI 10.1086/209317; FOWLES DC, 1993, COMPREHENSIVE HDB PS, P57; Gigerenzer Gerd, 2006, HEURISTICS LAW, DOI DOI 10.1177/0011000005285875; Gollwitzer PM, 2006, ADV EXP SOC PSYCHOL, V38, P69, DOI 10.1016/S0065-2601(06)38002-1; GRAY JA, 1990, COGNITION EMOTION, V4, P269, DOI 10.1080/02699939008410799; Hamilton KR, 2014, ADDICT BEHAV, V39, P1565, DOI 10.1016/j.addbeh.2014.02.008; Hardcastle SJ, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-40; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Hirsh JB, 2011, PERSPECT PSYCHOL SCI, V6, P415, DOI 10.1177/1745691611416992; Johnson P. O., 1936, STAT RES MEMOIRS; Lee JS, 2015, J BEHAV DECIS MAKING, V28, P114, DOI 10.1002/bdm.1835; Loeber S, 2013, APPETITE, V71, P32, DOI 10.1016/j.appet.2013.07.008; Neal DT, 2011, PERS SOC PSYCHOL B, V37, P1428, DOI 10.1177/0146167211419863; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Orbell S, 2010, HEALTH PSYCHOL, V29, P374, DOI 10.1037/a0019596; Petty R. E., 1986, COMMUN PERSUATION, P1; Ridenour TA, 2013, AM J DRUG ALCOHOL AB, V39, P194, DOI 10.3109/00952990.2013.764884; Shore DA, 2014, J HEALTH COMMUN, V19, P275, DOI 10.1080/10810730.2014.888903; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Spiller SA, 2013, J MARKETING RES, V50, P277, DOI 10.1509/jmr.12.0420; Steyer R, 1999, EUR J PERSONALITY, V13, P389, DOI 10.1002/(SICI)1099-0984(199909/10)13:5<389::AID-PER361>3.3.CO;2-1; Stukas AA, 2014, EUR J SOC PSYCHOL, V44, P711, DOI 10.1002/ejsp.2019; Thaler R.H., 2021, NUDGE FINAL EDITION; Uitenbroek DG, 1996, SOC SCI MED, V43, P367, DOI 10.1016/0277-9536(95)00399-1; van den Bos K, 2009, J EXP SOC PSYCHOL, V45, P873, DOI 10.1016/j.jesp.2009.03.014; Verhoeven AAC, 2015, APPETITE, V84, P20, DOI 10.1016/j.appet.2014.09.013; Verhoeven AAC, 2014, PSYCHOL HEALTH, V29, P1476, DOI 10.1080/08870446.2014.950658; Verhoeven AAC, 2012, BRIT J HEALTH PSYCH, V17, P758, DOI 10.1111/j.2044-8287.2012.02070.x; Verplanken B, 2003, J APPL SOC PSYCHOL, V33, P1313, DOI 10.1111/j.1559-1816.2003.tb01951.x; Verplanken B, 2006, BRIT J SOC PSYCHOL, V45, P639, DOI 10.1348/014466605X49122; Wilson K, 2015, PSYCHOL BULL, V141, P474, DOI 10.1037/a0038295; Wood W, 2007, PSYCHOL REV, V114, P843, DOI 10.1037/0033-295X.114.4.843	50	6	6	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142489	10.1371/journal.pone.0142489	http://dx.doi.org/10.1371/journal.pone.0142489			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7DR	26559409	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000364433100084
J	Lubinga, SJ; Atukunda, EC; Wasswa-Ssalongo, G; Babigumira, JB				Lubinga, Solomon J.; Atukunda, Esther C.; Wasswa-Ssalongo, George; Babigumira, Joseph B.			Potential Cost-Effectiveness of Prenatal Distribution of Misoprostol for Prevention of Postpartum Hemorrhage in Uganda	PLOS ONE			English	Article							MATERNAL MORTALITY; ORAL MISOPROSTOL; UTERINE RUPTURE; SYSTEMATIC ANALYSIS; CONTROLLED-TRIAL; GLOBAL BURDEN; HOME BIRTHS; HEALTH; LABOR; INDUCTION	Background In settings where home birth rates are high, prenatal distribution of misoprostol has been advocated as a strategy to increase access to uterotonics during the third stage of labor to prevent postpartum hemorrhage (PPH). Our objective was to project the potential costeffectiveness of this strategy in Uganda from both governmental (the relevant payer) and modified societal perspectives. Methods and Findings To compare prenatal misoprostol distribution to status quo (no misoprostol distribution), we developed a decision analytic model that tracked the delivery pathways of a cohort of pregnant women from the prenatal period, labor to delivery without complications or delivery with PPH, and successful treatment or death. Delivery pathway parameters were derived from the Uganda Demographic and Health Survey. Incidence of PPH, treatment efficacy, adverse event and case fatality rates, access to misoprostol, and health resource use and cost data were obtained from published literature and supplemented with expert opinion where necessary. We computed the expected incidence of PPH, mortality, disability adjusted life years (DALYs), costs and incremental cost effectiveness ratios (ICERs). We conducted univariate and probabilistic sensitivity analyses to examine robustness of our results. In the base-case analysis, misoprostol distribution lowered the expected incidence of PPH by 1.0% (95% credibility interval (CrI): 0.55%, 1.95%), mortality by 0.08% (95% CrI: 0.04%, 0.13%) and DALYs by 0.02 (95% CrI: 0.01, 0.03). Mean costs were higher with prenatal misoprostol distribution from governmental by US$3.3 (95% CrI: 2.1, 4.2) and modified societal (by US$1.3; 95% CrI: -1.6, 2.8) perspectives. ICERs were US$191 (95% CrI: 82, 443) per DALY averted from a governmental perspective, and US$73 (95% CI: -86, 256) per DALY averted from a modified societal perspective. Conclusions Prenatal distribution of misoprostol is potentially cost-effective in Uganda and should be considered for national-level scale up for prevention of PPH.	[Lubinga, Solomon J.; Babigumira, Joseph B.] Univ Washington, Dept Pharm, Pharmaceut Outcomes Res & Policy Program, Seattle, WA 98195 USA; [Lubinga, Solomon J.; Babigumira, Joseph B.] Univ Washington, Dept Global Hlth, Global Med Program, Seattle, WA 98195 USA; [Atukunda, Esther C.] Mbarara Univ Sci & Technol, Dept Pharmacol, Mbarara, Uganda; [Wasswa-Ssalongo, George] Mbarara Reg Referral Hosp, Dept Obstet & Gynecol, Mbarara, Uganda	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Mbarara University of Science & Technology	Lubinga, SJ (corresponding author), Univ Washington, Dept Pharm, Pharmaceut Outcomes Res & Policy Program, Seattle, WA 98195 USA.	slubinga@uw.edu	Babigumira, Joseph/T-4208-2019; Lubinga, Solomon James/AAD-6637-2019; Lubinga, Solomon James/B-6590-2018	Lubinga, Solomon James/0000-0003-0539-9156; Lubinga, Solomon James/0000-0003-0539-9156				Abdel-Aleem H, 2010, INT J GYNECOL OBSTET, V111, P32, DOI 10.1016/j.ijgo.2010.04.036; Adam Taghreed, 2003, Cost Eff Resour Alloc, V1, P3, DOI 10.1186/1478-7547-1-3; Akhan S. E., 2001, Clinical and Experimental Obstetrics and Gynecology, V28, P118; Babigumira JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030735; Babigumira JB, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-904; Bank of Uganda, 2013, EXCH RAT; Begley CM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007412.pub2; Bradley SEK, 2007, INT J GYNECOL OBSTET, V97, P52, DOI 10.1016/j.ijgo.2006.12.005; Calvert C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041114; Chu CS, 2012, J ROY SOC MED, V105, P336, DOI 10.1258/jrsm.2012.120044; Derman RJ, 2006, LANCET, V368, P1248, DOI 10.1016/S0140-6736(06)69522-6; Ezegwui H U, 2006, J Obstet Gynaecol, V26, P160; Garrison LP, 2010, VALUE HEALTH, V13, P8, DOI 10.1111/j.1524-4733.2009.00660.x; Geller S, 2014, BJOG-INT J OBSTET GY, V121, P319, DOI 10.1111/1471-0528.12447; Geller SE, 2006, INT J GYNECOL OBSTET, V92, P202, DOI 10.1016/j.ijgo.2005.12.009; Gulmezoglu AM, 2001, LANCET, V358, P689, DOI 10.1016/S0140-6736(01)05835-4; Hoj L, 2005, BMJ-BRIT MED J, V331, P723, DOI 10.1136/bmj.331.7519.723; Hundley VA, 2013, BJOG-INT J OBSTET GY, V120, P277, DOI 10.1111/1471-0528.12049; Hutubessy Raymond, 2003, Cost Eff Resour Alloc, V1, P8, DOI 10.1186/1478-7547-1-8; Ifakara Health Institute Venture Strategies Innovations Bixby Center for Population Health and Sustainability PSI/Tanzania, 2011, PREV POSTP HEM HOM B; Joint Medical Stores, 2013, CAT PRIC IND; Kaye D, 2003, East Afr Med J, V80, P144; Khosla AH, 2002, AUST NZ J OBSTET GYN, V42, P412; Lara AM, 2007, J CLIN PATHOL, V60, P1117, DOI 10.1136/jcp.2006.042309; Levin A, 2003, INT J HEALTH PLAN M, V18, P3, DOI 10.1002/hpm.690; Majoko F, 2002, INT J GYNECOL OBSTET, V76, P77, DOI 10.1016/S0020-7292(01)00553-7; Management Sciences for Health, 2014, INT DRUG PRIC IND GU; Matsiko CW, 2003, HLTH POLICY DEV, V1, P15; Mazzone Michael E, 2006, WMJ, V105, P64; Mbonye AK, 2007, INT J GYNECOL OBSTET, V98, P285, DOI 10.1016/j.ijgo.2007.05.019; Mbonye AK, 2007, INT J GYNECOL OBSTET, V96, P220, DOI 10.1016/j.ijgo.2006.12.017; Mobeen N, 2011, BJOG-INT J OBSTET GY, V118, P353, DOI 10.1111/j.1471-0528.2010.02807.x; Mrisho M, 2007, TROP MED INT HEALTH, V12, P862, DOI 10.1111/j.1365-3156.2007.01855.x; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; National Medical Stores, 2010, PRIC IND; Ninci A, 2004, HLTH POLICY DEV, V2, P114; Oladapo OT, 2012, INT J GYNECOL OBSTET, V119, P105, DOI 10.1016/j.ijgo.2012.08.004; Pagel C, 2009, LANCET, V374, P1441, DOI 10.1016/S0140-6736(09)61566-X; Potts M, 2010, LANCET, V375, P1762, DOI 10.1016/S0140-6736(10)60750-7; Prata N, 2005, INT J GYNECOL OBSTET, V90, P51, DOI 10.1016/j.ijgo.2005.03.007; Rajasingham R, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001316; Rajbhandari S, 2010, INT J GYNECOL OBSTET, V108, P282, DOI 10.1016/j.ijgo.2009.11.006; Rutaremwa G, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0943-8; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Salomon JA, 2012, LANCET, V380, P2144, DOI 10.1016/S0140-6736(12)61690-0; Sanghvi H., 2004, PREVENTION POSTPARTU; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; Sempa J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-736; Smith JM, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-189; Stanton CK, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001524; Sutherland T, 2010, INT J GYNECOL OBSTET, V108, P289, DOI 10.1016/j.ijgo.2009.11.007; Sutherland T, 2009, INT J GYNECOL OBSTET, V104, P189, DOI 10.1016/j.ijgo.2008.10.011; Tang J, 2013, INT J GYNECOL OBSTET, V121, P186, DOI 10.1016/j.ijgo.2012.12.009; Thomas A, 2003, BJOG-INT J OBSTET GY, V110, P217, DOI 10.1016/S1470-0328(02)02605-8; Uganda Bureau of Statistics, 2013, CONS PRIC IND; Uganda Bureau of Statistics ICF International Inc, 2012, UG DEM HLTH SURV 201; Verguet S, 2015, HEALTH ECON, V24, P318, DOI 10.1002/hec.3019; Weeks AD, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0650-9; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; Weissman E, 1999, UGANDA SAFE MOTHERHO; Westhoff G, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001808.pub2; World Health Organization (WHO), 2012, REC PREV TREATM POST	62	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142550	10.1371/journal.pone.0142550	http://dx.doi.org/10.1371/journal.pone.0142550			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26560140	Green Published, gold, Green Submitted			2022-12-27	WOS:000364433100090
J	Garcia-Martin, JA; Clote, P				Garcia-Martin, Juan Antonio; Clote, Peter			RNA Thermodynamic Structural Entropy	PLOS ONE			English	Article							SECONDARY STRUCTURE PREDICTION; CONFIGURATIONAL ENTROPY; CONFORMATIONAL ENTROPY; PARTITION-FUNCTION; SEQUENCE LOGOS; WEB SERVER; INFORMATION; HYBRIDIZATION; ALIGNMENTS; ALGORITHM	Conformational entropy for atomic-level, three dimensional biomolecules is known experimentally to play an important role in protein-ligand discrimination, yet reliable computation of entropy remains a difficult problem. Here we describe the first two accurate and efficient algorithms to compute the conformational entropy for RNA secondary structures, with respect to the Turner energy model, where free energy parameters are determined from UV absorption experiments. An algorithm to compute the derivational entropy for RNA secondary structures had previously been introduced, using stochastic context free grammars (SCFGs). However, the numerical value of derivational entropy depends heavily on the chosen context free grammar and on the training set used to estimate rule probabilities. Using data from the Rfam database, we determine that both of our thermodynamic methods, which agree in numerical value, are substantially faster than the SCFG method. Thermodynamic structural entropy is much smaller than derivational entropy, and the correlation between length-normalized thermodynamic entropy and derivational entropy is moderately weak to poor. In applications, we plot the structural entropy as a function of temperature for known thermoswitches, such as the repression of heat shock gene expression (ROSE) element, we determine that the correlation between hammerhead ribozyme cleavage activity and total free energy is improved by including an additional free energy term arising from conformational entropy, and we plot the structural entropy of windows of the HIV-1 genome. Our software RNAentropy can compute structural entropy for any user-specified temperature, and supports both the Turner'99 and Turner'04 energy parameters. It follows that RNAentropy is state-of-the-art software to compute RNA secondary structure conformational entropy. Source code is available at https://github.com/clotelab/RNAentropy/; a full web server is available at http://bioinformatics.bc.edu/clotelab/RNAentropy, including source code and ancillary programs.	[Garcia-Martin, Juan Antonio; Clote, Peter] Boston Coll, Dept Biol, Chestnut Hill, MA 02467 USA	Boston College	Clote, P (corresponding author), Boston Coll, Dept Biol, Chestnut Hill, MA 02467 USA.	clote@bc.edu	Garcia-Martin, Juan Antonio/K-5956-2017; Garcia-Martin, Juan Antonio/HDN-5951-2022	Garcia-Martin, Juan Antonio/0000-0003-0993-4064; 	National Science Foundation [DBI-1262439]; Div Of Biological Infrastructure [1262439] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation DBI-1262439.	ALTSCHUL SF, 1985, MOL BIOL EVOL, V2, P526; Anderson JWJ, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-149; Bernhart SH, 2006, ALGORITHM MOL BIOL, V1, DOI 10.1186/1748-7188-1-3; Bindewald E, 2006, NUCLEIC ACIDS RES, V34, pW405, DOI 10.1093/nar/gkl269; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; Choi HMT, 2010, NAT BIOTECHNOL, V28, P1208, DOI 10.1038/nbt.1692; Clote P, 2005, RNA, V11, P578, DOI 10.1261/rna.7220505; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dill K.A., 2002, MOLECULAR DRIVING FO; Dimitrov RA, 2004, BIOPHYS J, V87, P215, DOI 10.1529/biophysj.103.020743; Ding Y, 2003, NUCLEIC ACIDS RES, V31, P7280, DOI 10.1093/nar/gkg938; Ding Y, 2004, NUCL ACIDS RES, V32, pW135, DOI 10.1093/nar/gkh449; Dirks RM, 2004, NUCLEIC ACIDS RES, V32, P1392, DOI 10.1093/nar/gkh291; Dotu I, 2014, NUCLEIC ACIDS RES, V42, P11752, DOI 10.1093/nar/gku740; Dowell RD, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-71; Fusy E, 2014, J MATH BIOL, V68, P341, DOI 10.1007/s00285-012-0631-9; Giegerich R, 1999, Pac Symp Biocomput, P126; Gorodkin J, 1997, COMPUT APPL BIOSCI, V13, P583; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hammell M, 2008, NAT METHODS, V5, P813, DOI 10.1038/NMETH.1247; Harpole KW, 2011, J PHYS CHEM B, V115, P9461, DOI 10.1021/jp111176x; Higgs PG, 2000, Q REV BIOPHYS, V33, P199, DOI 10.1017/S0033583500003620; Huynen M, 1997, J MOL BIOL, V267, P1104, DOI 10.1006/jmbi.1997.0889; Juhling F, 2009, NUCLEIC ACIDS RES, V37, pD159, DOI 10.1093/nar/gkn772; KARPLUS M, 1987, BIOPHYS J, V52, P1083, DOI 10.1016/S0006-3495(87)83303-9; Kazan H, 2013, NUCLEIC ACIDS RES, V41, pW180, DOI 10.1093/nar/gkt463; Kazan H, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000832; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Lorenz WA, 2008, J COMPUT BIOL, V15, P31, DOI 10.1089/cmb.2006.0153; Lu K, 2011, J MOL BIOL, V410, P609, DOI 10.1016/j.jmb.2011.04.029; Manzourolajdad A, 2013, J THEOR BIOL, V318, P140, DOI 10.1016/j.jtbi.2012.10.023; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; Marlow MS, 2010, NAT CHEM BIOL, V6, P352, DOI 10.1038/nchembio.347; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; Mathews DH, 2004, RNA, V10, P1178, DOI 10.1261/rna.7650904; MCCASKILL JS, 1990, BIOPOLYMERS, V29, P1105, DOI 10.1002/bip.360290621; Miklos I, 2005, B MATH BIOL, V67, P1031, DOI 10.1016/j.bulm.2004.12.003; Morgan SR, 1998, J PHYS A-MATH GEN, V31, P3153, DOI 10.1088/0305-4470/31/14/005; Nawrocki EP, 2015, NUCLEIC ACIDS RES, V43, pD130, DOI 10.1093/nar/gku1063; Nawrocki EP, 2013, BIOINFORMATICS, V29, P2933, DOI 10.1093/bioinformatics/btt509; Ng KLS, 2007, BIOINFORMATICS, V23, P1321, DOI 10.1093/bioinformatics/btm026; NUSSINOV R, 1980, P NATL ACAD SCI-BIOL, V77, P6309, DOI 10.1073/pnas.77.11.6309; Rivas E, 2000, BIOINFORMATICS, V16, P583, DOI 10.1093/bioinformatics/16.7.583; Rivas E, 2012, RNA, V18, P193, DOI 10.1261/rna.030049.111; Salari R, 2013, NUCLEIC ACIDS RES, V41, P44, DOI 10.1093/nar/gks1009; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Shao Y, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-469; Sukosd Z, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S2-S22; Sukosd Z, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-103; Tinoco Jr I., 2000, THERMODYNAMICS BIOL, P131; Turner DH, 2010, NUCLEIC ACIDS RES, V38, pD280, DOI 10.1093/nar/gkp892; Wand AJ, 2013, CURR OPIN STRUC BIOL, V23, P75, DOI 10.1016/j.sbi.2012.11.005; Wuchty S, 1999, BIOPOLYMERS, V49, P145, DOI 10.1002/(SICI)1097-0282(199902)49:2<145::AID-BIP4>3.3.CO;2-7; Zadeh JN, 2011, J COMPUT CHEM, V32, P439, DOI 10.1002/jcc.21633; Zarringhalam K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045160; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595; Zuker M, 1999, NATO ASI 3 HIGH TECH, V70, P11	58	16	17	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0137859	10.1371/journal.pone.0137859	http://dx.doi.org/10.1371/journal.pone.0137859			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555444	gold, Green Submitted, Green Published			2022-12-27	WOS:000364430700003
J	Langer, SM; Hopfensperger, K; Iyer, SS; Kreider, EF; Learn, GH; Lee, LH; Hahn, BH; Sauter, D				Langer, Simon M.; Hopfensperger, Kristina; Iyer, Shilpa S.; Kreider, Edward F.; Learn, Gerald H.; Lee, Lan-Hui; Hahn, Beatrice H.; Sauter, Daniel			A Naturally Occurring rev1-vpu Fusion Gene Does Not Confer a Fitness Advantage to HIV-1	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ACCESSORY PROTEIN VPU; MESSENGER-RNA; KAPPA-B; TRANSLATION INITIATION; CELL-SURFACE; ENV; EXPRESSION; REPLICATION; TAT	Background Pandemic strains of HIV-1 (group M) encode a total of nine structural (gag, pol, env), regulatory (rev, tat) and accessory (vif, vpr, vpu, nef) genes. However, some subtype A and C viruses exhibit an unusual gene arrangement in which the first exon of rev (rev1) and the vpu gene are placed in the same open reading frame. Although this rev1-vpu gene fusion is present in a considerable fraction of HIV-1 strains, its functional significance is unknown. Results Examining infectious molecular clones (IMCs) of HIV-1 that encode the rev1-vpu polymorphism, we show that a fusion protein is expressed in infected cells. Due to the splicing pattern of viral mRNA, however, these same IMCs also express a regular Vpu protein, which is produced at much higher levels. To investigate the function of the fusion gene, we characterized isogenic IMC pairs differing only in their ability to express a Rev1-Vpu protein. Analysis in transfected HEK293T and infected CD4+ T cells showed that all of these viruses were equally active in known Vpu functions, such as down-modulation of CD4 or counteraction of tetherin. Furthermore, the polymorphism did not affect Vpu-mediated inhibition of NF-kappa B activation or Rev-dependent nuclear export of incompletely spliced viral mRNAs. There was also no evidence for enhanced replication of Rev1-Vpu expressing viruses in primary PBMCs or ex vivo infected human lymphoid tissues. Finally, the frequency of HIV-1 quasis-pecies members that encoded a rev1-vpu fusion gene did not change in HIV-1 infected individuals over time. Conclusions Expression of a rev1-vpu fusion gene does not affect regular Rev and Vpu functions or alter HIV-1 replication in primary target cells. Since there is no evidence for increased replication fitness of rev1-vpu encoding viruses, this polymorphism likely emerged in the context of other mutations within and/or outside the rev1-vpu intergenic region, and may have a neutral phenotype.	[Langer, Simon M.; Hopfensperger, Kristina; Lee, Lan-Hui; Sauter, Daniel] Univ Ulm, Inst Mol Virol, Med Ctr, D-89081 Ulm, Germany; [Iyer, Shilpa S.; Kreider, Edward F.; Learn, Gerald H.; Hahn, Beatrice H.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Lee, Lan-Hui] Taipei City Hosp, Kunming Branch, Dept Lab, Taipei 10844, Taiwan	Ulm University; University of Pennsylvania; Pennsylvania Medicine; Taipei City Hospital	Sauter, D (corresponding author), Univ Ulm, Inst Mol Virol, Med Ctr, D-89081 Ulm, Germany.	daniel.sauter@uni-ulm.de	Learn, Jerry/E-3356-2012; Kreider, Edward/GSD-5998-2022	Kreider, Edward/0000-0003-2330-8430; Hahn, Beatrice/0000-0002-9400-9887; Hopfensperger, Kristina/0000-0002-6381-7988; Langer, Simon/0000-0002-9660-8058	Deutsche Forschungsgemeinschaft; EU; NIH (National Institutes of Health (US)) [UM1 AI 100645, P01 AI 088564, R01 AI 114266, R01 AI111789]; International Graduate School in Molecular Medicine Ulm; NIH [F30 AI112426-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F30AI112426, UM1AI100645, T32AI007632, P01AI088564, R01AI114266, R01AI111789, P30AI045008] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EU(European Commission); NIH (National Institutes of Health (US))(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Graduate School in Molecular Medicine Ulm; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the Deutsche Forschungsgemeinschaft (http://www.dfg.de/), the EU (http://erc.europa.eu/), and the NIH (National Institutes of Health (US)) (http://www.nih.gov/) (UM1 AI 100645, P01 AI 088564, R01 AI 114266 and R01 AI111789). SL was funded by the International Graduate School in Molecular Medicine Ulm (http://www.uni-ulm.de/einrichtungen/mm.html). EFK was supported by the NIH (F30 AI112426-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Akari H, 2001, J EXP MED, V194, P1299, DOI 10.1084/jem.194.9.1299; Anderson JL, 2007, J VIROL, V81, P4664, DOI 10.1128/JVI.01028-06; BENKO DM, 1990, J VIROL, V64, P2505, DOI 10.1128/JVI.64.6.2505-2518.1990; Bour S, 2001, J BIOL CHEM, V276, P15920, DOI 10.1074/jbc.M010533200; COHEN EA, 1990, J ACQ IMMUN DEF SYND, V3, P601; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Fouchier RAM, 1997, EMBO J, V16, P4531, DOI 10.1093/emboj/16.15.4531; FURTADO MR, 1991, VIROLOGY, V185, P258, DOI 10.1016/0042-6822(91)90773-5; GLUSHAKOVA S, 1995, NAT MED, V1, P1320, DOI 10.1038/nm1295-1320; GOTTLINGER HG, 1992, VIROLOGY, V189, P618, DOI 10.1016/0042-6822(92)90585-D; Guerrero S, 2015, VIRUSES-BASEL, V7, P199, DOI 10.3390/v7010199; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Kraus MH, 2010, VIROLOGY, V397, P346, DOI 10.1016/j.virol.2009.11.019; Krummheuer J, 2007, VIROLOGY, V363, P261, DOI 10.1016/j.virol.2007.01.022; Leulier F, 2003, EMBO REP, V4, P976, DOI 10.1038/sj.embor.embor936; Liu MKP, 2013, J CLIN INVEST, V123, P380, DOI 10.1172/JCI65330; MALIM MH, 1989, NATURE, V338, P254, DOI 10.1038/338254a0; Moll M, 2010, BLOOD, V116, P1876, DOI 10.1182/blood-2009-09-243667; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Ocwieja KE, 2012, NUCLEIC ACIDS RES, V40, P10345, DOI 10.1093/nar/gks753; Parrish NF, 2013, P NATL ACAD SCI USA, V110, P6626, DOI 10.1073/pnas.1304288110; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; PURCELL DFJ, 1993, J VIROL, V67, P6365, DOI 10.1128/JVI.67.11.6365-6378.1993; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; SALFELD J, 1990, EMBO J, V9, P965, DOI 10.1002/j.1460-2075.1990.tb08195.x; Sauter D, 2015, CELL REP, V10, P586, DOI 10.1016/j.celrep.2014.12.047; SCHWARTZ S, 1990, J VIROL, V64, P5448, DOI 10.1128/JVI.64.11.5448-5456.1990; SCHWARTZ S, 1992, MOL CELL BIOL, V12, P207, DOI 10.1128/MCB.12.1.207; Shah AH, 2010, CELL HOST MICROBE, V8, P397, DOI 10.1016/j.chom.2010.10.008; SHUGARS DC, 1993, J VIROL, V67, P4639, DOI 10.1128/JVI.67.8.4639-4650.1993; TANAKA M, 1990, CELL, V60, P375, DOI 10.1016/0092-8674(90)90589-7; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; WILLEY RL, 1992, J VIROL, V66, P7193, DOI 10.1128/JVI.66.12.7193-7200.1992; Wu YT, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-12; Yue L, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004565; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	37	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142118	10.1371/journal.pone.0142118	http://dx.doi.org/10.1371/journal.pone.0142118			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26554585	Green Published, Green Submitted, gold			2022-12-27	WOS:000364430700055
J	Ong, QK; Stellacci, F				Ong, Quy Khac; Stellacci, Francesco			Response to "Critical Assessment of the Evidence for Striped Nanoparticles"	PLOS ONE			English	Editorial Material							SCANNING-TUNNELING-MICROSCOPY; GOLD NANOPARTICLES; LIGAND-SHELL	Stirling et al., (10.1371/journal.pone.0108482) presented an analysis on some of our publications on the formation of stripe-like domains on mixed-ligand coated gold nanoparticles. The authors shed doubts on some of our results however no valid argument is provided against what we have shown since our first publication: scanning tunneling microscopy (STM) images of striped nanoparticles show stripe-like domains that are independent of imaging parameters and in particular of imaging speed. We have consistently ruled out the presence of artifacts by comparing sets of images acquired at different tip speeds, finding invariance of the stipe-like domains. Stirling and co-workers incorrectly analyzed this key control, using a different microscope and imaging conditions that do not compare to ours. We show here data proving that our approach is rigorous. Furthermore, we never solely relied on image analysis to draw our conclusions; we have always used the chemical nature of the particles to assess the veracity of our images. Stirling et al. do not provide any justification for the spacing of the features that we find on nanoparticles: similar to 1 nm for mixed ligand particles and similar to 0.5 nm for homoligand particles. Hence our two central arguments remain unmodified: independence from imaging parameters and dependence on ligand shell chemical composition. The paper report observations on our STM images; none is a sufficient condition to prove that our images are artifacts. We thoroughly addressed issues related to STM artifacts throughout our microscopy work. Stirling et al. provide guidelines for what they consider good STM images of nanoparticles, such images are indeed present in our literature. They conclude that the evidences we provided to date are insufficient, this is a departure from one of the authors' previous article which concluded that our images were composed of artifacts. Given that four independent laboratories have reproduced our measurements and that no scientifically rigorous argument is presented to invalidate our STM images, and also given that Stirling et al. do not contest the quality of our recent STM images, we re-affirm that specific binary mixture of ligands spontaneously form features in their ligand shell that we describe as stripe-like domains similar to 1 nm in width.	[Ong, Quy Khac; Stellacci, Francesco] Ecole Polytech Fed Lausanne, Inst Mat, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Stellacci, F (corresponding author), Ecole Polytech Fed Lausanne, Inst Mat, Lausanne, Switzerland.	francesco.stellacci@epfl.ch	Stellacci, Francesco/B-1990-2008	Stellacci, Francesco/0000-0003-4635-6080				Biscarini F, 2013, LANGMUIR, V29, P13723, DOI 10.1021/la403546c; Cesbron Y, 2012, SMALL, V8, P3714, DOI 10.1002/smll.201001465; Costelle L, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3548862; Edlund E, 2014, SOFT MATTER, V10, P2955, DOI 10.1039/c3sm52827h; Egorov SA, 2012, SOFT MATTER, V8, P3971, DOI 10.1039/c2sm07266a; Hembacher S, 2003, P NATL ACAD SCI USA, V100, P12539, DOI 10.1073/pnas.2134173100; Hu Y., 2009, J SCANNING PROBE MIC, V4, P24; Ionita P, 2008, ANAL CHEM, V80, P95, DOI 10.1021/ac071266s; Jackson AM, 2006, J AM CHEM SOC, V128, P11135, DOI 10.1021/ja061545h; Jackson AM, 2004, NAT MATER, V3, P330, DOI 10.1038/nmat1116; Kuna JJ, 2009, NAT MATER, V8, P837, DOI [10.1038/NMAT2534, 10.1038/nmat2534]; Kuznetsov YG, 2011, MICROBIOL MOL BIOL R, V75, P268, DOI 10.1128/MMBR.00041-10; Liu X, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2155; Mezour MA, 2014, ACS NANO, V8, P2214, DOI 10.1021/nn405357j; Miller WL, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3672104; Moglianetti M, 2014, CHEM SCI, V5, P1232, DOI 10.1039/c3sc52595c; Ong QK, 2014, CHEM COMMUN, V50, P10456, DOI 10.1039/c4cc04114c; Ong QK, 2013, ACS NANO, V7, P8529, DOI 10.1021/nn402414b; Rapino S, 2007, SMALL, V3, P386, DOI 10.1002/smll.200600456; Sarathy KV, 1997, J PHYS CHEM B, V101, P9876, DOI 10.1021/jp971544z; Singh C, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.226106; Stirling J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108482; Van Lehn RC, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3653937; Venema LC, 2000, PHYS REV B, V61, P2991, DOI 10.1103/PhysRevB.61.2991; Yu M, 2012, SMALL, V8, P3720, DOI 10.1002/smll.201202322	25	19	19	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0135594	10.1371/journal.pone.0135594	http://dx.doi.org/10.1371/journal.pone.0135594			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555337	gold, Green Submitted, Green Published			2022-12-27	WOS:000364430700002
J	Pahi, Z; Kiss, Z; Komonyi, O; Borsos, BN; Tora, L; Boros, IM; Pankotal, T				Pahi, Zoltan; Kiss, Zsuzsanna; Komonyi, Orban; Borsos, Barbara N.; Tora, Laszlo; Boros, Imre M.; Pankotal, Tibor			dTAF10-and dTAF10b-Containing Complexes Are Required for Ecdysone-Driven Larval-Pupal Morphogenesis in Drosophila melanogaster	PLOS ONE			English	Article							HISTONE H4 ACETYLATION; TRANSCRIPTIONAL ACTIVATION; GENE-EXPRESSION; HUMAN TAF(II)30; ADA2 HOMOLOGS; TFIID COMPLEX; P450 ENZYMES; DISTINCT; SAGA; METAMORPHOSIS	In eukaryotes the TFIID complex is required for preinitiation complex assembly which positions RNA polymerase II around transcription start sites. On the other hand, histone acetyltransferase complexes including SAGA and ATAC, modulate transcription at several steps through modification of specific core histone residues. In this study we investigated the function of Drosophila melanogaster proteins TAF10 and TAF10b, which are subunits of dTFIID and dSAGA, respectively. We generated a mutation which eliminated the production of both Drosophila TAF10 orthologues. The simultaneous deletion of both dTaf10 genes impaired the recruitment of the dTFIID subunit dTAF5 to polytene chromosomes, while binding of other TFIID subunits, dTAF1 and RNAPII was not affected. The lack of both dTAF10 proteins resulted in failures in the larval-pupal transition during metamorphosis and in transcriptional reprogramming at this developmental stage. Surprisingly, unlike dSAGA mutations, dATAC subunit mutations resulted in very similar changes in the steady state mRNA levels of approximately 5000 genes as did ablation of both dTaf10 genes, indicating that dTAF10 and/or dTAF10b-containing complexes and dATAC affect similar pathways. Importantly, the phenotype resulting from dTaf10+dTaf10b mutation could be rescued by ectopically added ecdysone, suggesting that dTAF10- and/or dTAF10b-containing complexes are involved in the expression of ecdysone biosynthetic genes. Indeed, in dTaf10+dTaf10b mutants, cytochrome genes, which regulate ecdysone synthesis in the ring gland, were underrepresented. Therefore our data support the idea that the presence of dTAF10 proteins in dTFIID and/or dSAGA is required only at specific developmental steps. We propose that distinct forms of dTFIID and/or dSAGA exist during Drosophila metamorphosis, wherein different TAF compositions serve to target RNAPII at different developmental stages and tissues.	[Pahi, Zoltan; Kiss, Zsuzsanna; Komonyi, Orban; Borsos, Barbara N.; Boros, Imre M.; Pankotal, Tibor] Univ Szeged, Dept Biochem & Mol Biol, Szeged, Hungary; [Boros, Imre M.; Pankotal, Tibor] Biol Res Ctr, Inst Biochem, H-6701 Szeged, Hungary; [Tora, Laszlo] Inst Genet & Biol Mol & Cellulaire, Illkirch Graffenstaden, France	Szeged University; Hungarian Academy of Sciences; Hungarian Biological Research Center; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Pankotal, T (corresponding author), Univ Szeged, Dept Biochem & Mol Biol, Szeged, Hungary.	pankotai@bio.u-szeged.hu	Pankotai, Tibor/A-5942-2015; Tora, Laszlo/E-9999-2018	Pankotai, Tibor/0000-0001-9810-5465; Tora, Laszlo/0000-0001-7398-2250; Boros, Imre/0000-0001-8504-9687; Borsos, Barbara Nikolett/0000-0002-5537-8612	European Union; State of Hungary; European Social Fund [TAMOP 4.2.4. A/2-11-1-2012-0001, HURO/1101/173/2.2.1]	European Union(European Commission); State of Hungary; European Social Fund(European Social Fund (ESF))	This research was supported by the European Union and the State of Hungary, co-financed by the European Social Fund in the framework of TAMOP 4.2.4. A/2-11-1-2012-0001 "National Excellence Program" and HURO/1101/173/2.2.1 Hungary-Romania Cross-Border Co-operation Program 2007-2013. The grants provided for the financial support for the reagents used in this study.	Baehrecke EH, 1996, ARCH INSECT BIOCHEM, V33, P231, DOI 10.1002/(SICI)1520-6327(1996)33:3/4&lt;231::AID-ARCH5&gt;3.0.CO;2-V; Beckstead RB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r99; Bieniossek C, 2013, NATURE, V493, P699, DOI 10.1038/nature11791; Burley SK, 1996, ANNU REV BIOCHEM, V65, P769, DOI 10.1146/annurev.bi.65.070196.004005; Ciurciu A, 2006, MOL CELL BIOL, V26, P9413, DOI 10.1128/MCB.01401-06; Demeny MA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000316; Durand A, 2013, J NANOBIOTECHNOL, V11, DOI 10.1186/1477-3155-11-S1-S4; Gegonne A, 2012, MOL CELL BIOL, V32, P1984, DOI 10.1128/MCB.06305-11; Georgieva S, 2000, MOL CELL BIOL, V20, P1639, DOI 10.1128/MCB.20.5.1639-1648.2000; Gilbert LI, 2004, MOL CELL ENDOCRINOL, V215, P1, DOI 10.1016/j.mce.2003.11.003; Grant PA, 1998, CELL, V94, P45, DOI 10.1016/S0092-8674(00)81220-9; GRUNSTEIN M, 1990, ANNU REV CELL BIOL, V6, P643, DOI 10.1146/annurev.cellbio.6.1.643; Indra AK, 2005, DEV BIOL, V285, P28, DOI 10.1016/j.ydbio.2005.05.043; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; JACQ X, 1994, CELL, V79, P107, DOI 10.1016/0092-8674(94)90404-9; Johnson CA, 1998, NUCLEIC ACIDS RES, V26, P994, DOI 10.1093/nar/26.4.994; Juven-Gershon T, 2010, DEV BIOL, V339, P225, DOI 10.1016/j.ydbio.2009.08.009; Kandiah E, 2014, CURR OPIN STRUC BIOL, V24, P91, DOI 10.1016/j.sbi.2013.12.005; Kaufmann J, 1998, MOL CELL BIOL, V18, P233, DOI 10.1128/MCB.18.1.233; Kirschner DB, 2002, MOL CELL BIOL, V22, P3178, DOI 10.1128/MCB.22.9.3178-3193.2002; Kusch T, 2003, MOL CELL BIOL, V23, P3305, DOI 10.1128/MCB.23.9.3305-3319.2003; Lebedeva LA, 2005, P NATL ACAD SCI USA, V102, P18087, DOI 10.1073/pnas.0509063102; Leurent C, 2002, EMBO J, V21, P3424, DOI 10.1093/emboj/cdf342; Martinez E, 1998, J BIOL CHEM, V273, P23781, DOI 10.1074/jbc.273.37.23781; Martinez E, 1998, MOL CELL BIOL, V18, P6571, DOI 10.1128/MCB.18.11.6571; Metzger D, 1999, EMBO J, V18, P4823, DOI 10.1093/emboj/18.17.4823; Mohan WS, 2003, MOL CELL BIOL, V23, P4307, DOI 10.1128/MCB.23.12.4307-4318.2003; Moriniere J, 2009, NATURE, V461, P664, DOI 10.1038/nature08397; Morse RH, 2007, J CELL BIOCHEM, V102, P560, DOI 10.1002/jcb.21493; Muratoglu S, 2003, MOL CELL BIOL, V23, P306, DOI 10.1128/MCB.23.1.306-321.2003; Ogryzko VV, 1998, CELL, V94, P35, DOI 10.1016/S0092-8674(00)81219-2; Pankotai T, 2005, MOL CELL BIOL, V25, P8215, DOI 10.1128/MCB.25.18.8215-8227.2005; Pankotai T, 2010, MOL CELL BIOL, V30, P4254, DOI 10.1128/MCB.00142-10; Rhee HS, 2012, NATURE, V483, P295, DOI 10.1038/nature10799; Sanders SL, 2002, MOL CELL BIOL, V22, P6000, DOI 10.1128/MCB.22.16.6000-6013.2002; Spedale G, 2012, GENE DEV, V26, P527, DOI 10.1101/gad.184705.111; Struhl Kevin, 1997, Genes and Function, V1, P5; Tatarakis A, 2008, MOL CELL, V31, P531, DOI 10.1016/j.molcel.2008.07.013; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; THUMMEL CS, 1995, CELL, V83, P871, DOI 10.1016/0092-8674(95)90203-1; Timmers HTM, 2005, TRENDS BIOCHEM SCI, V30, P7, DOI 10.1016/j.tibs.2004.11.007; Walker AK, 2001, EMBO J, V20, P5269, DOI 10.1093/emboj/20.18.5269; Wang YL, 2008, J BIOL CHEM, V283, P33808, DOI 10.1074/jbc.M806936200; Warren JT, 2002, P NATL ACAD SCI USA, V99, P11043, DOI 10.1073/pnas.162375799; Weake VM, 2009, GENE DEV, V23, P2818, DOI 10.1101/gad.1846409; White KP, 1999, SCIENCE, V286, P2179, DOI 10.1126/science.286.5447.2179; Wieczorek E, 1998, NATURE, V393, P187, DOI 10.1038/30283; Wright KJ, 2006, P NATL ACAD SCI USA, V103, P12347, DOI 10.1073/pnas.0605499103; Zsindely N, 2009, NUCLEIC ACIDS RES, V37, P6665, DOI 10.1093/nar/gkp722	49	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142226	10.1371/journal.pone.0142226	http://dx.doi.org/10.1371/journal.pone.0142226			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556600	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000364430700071
J	Quah, S; Breuker, CJ; Holland, PWH				Quah, Shan; Breuker, Casper J.; Holland, Peter W. H.			A Diversity of Conserved and Novel Ovarian MicroRNAs in the Speckled Wood (Pararge aegeria)	PLOS ONE			English	Article							MESSENGER-RNA; EVOLUTION; IDENTIFICATION; EXPRESSION; TRANSCRIPTION; TRANSITION; GENOMICS; MOSQUITO; RECEPTOR; HORMONE	microRNAs (miRNAs) are important regulators of animal development and other processes, and impart robustness to living systems through post-transcriptional regulation of specific mRNA transcripts. It is postulated that newly emergent miRNAs are generally expressed at low levels and with spatiotemporally restricted expression domains, thus minimising effects of spurious targeting on animal transcriptomes. Here we present ovarian miRNA transcriptome data for two geographically distinct populations of the Speckled Wood butterfly (Pararge aegeria). A total of 74 miRNAs were identified, including 11 newly discovered and evolutionarily-young miRNAs, bringing the total of miRNA genes known from P. aegeria up to 150. We find a positive correlation between miRNA age and expression level. A common set of 55 miRNAs are expressed in both populations. From this set, we identify seven that are consistently either ovary-specific or highly upregulated in ovaries relative to other tissues. This 'ovary set' includes miRNAs with known contributions to ovarian function in other insect species with similar ovaries and mode of oogenesis, including miR-989 and miR2763, plus new candidates for ovarian function. We also note that conserved miRNAs are overrepresented in the ovary relative to the whole body.	[Quah, Shan; Holland, Peter W. H.] Univ Oxford, Dept Zool, Oxford, England; [Breuker, Casper J.] Oxford Brookes Univ, Fac Hlth & Life Sci, Dept Biol & Med Sci, Evolutionary Dev Biol Res Grp, Oxford OX3 0BP, England	University of Oxford; Oxford Brookes University	Holland, PWH (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford, England.	peter.holland@zoo.ox.ac.uk	Breuker, Casper/N-6582-2013; Breuker, Casper/P-8270-2019	Breuker, Casper/0000-0001-7909-1950; Breuker, Casper/0000-0001-7909-1950; Holland, Peter/0000-0003-1533-9376	European Research Council under the European Union's Seventh Framework Programme (FP7)/ERC [268513]; A*STAR National Science PhD Scholarship	European Research Council under the European Union's Seventh Framework Programme (FP7)/ERC(European Research Council (ERC)); A*STAR National Science PhD Scholarship	This study was funded by the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant 268513 to PWHH and an A*STAR National Science PhD Scholarship to SQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ables ET, 2015, DEV BIOL, V400, P33, DOI 10.1016/j.ydbio.2015.01.013; Barckmann B, 2013, BBA-GENE REGUL MECH, V1829, P714, DOI 10.1016/j.bbagrm.2012.12.011; Bastock R, 2008, CURR BIOL, V18, pR1082, DOI 10.1016/j.cub.2008.09.011; Behura SK, 2007, INSECT BIOCHEM MOLEC, V37, P3, DOI 10.1016/j.ibmb.2006.10.006; Berezikov E, 2006, NAT GENET, V38, P1375, DOI 10.1038/ng1914; Berezikov E, 2011, NAT REV GENET, V12, P846, DOI 10.1038/nrg3079; Carter JM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-283; Charles JP, 1999, EUR J BIOCHEM, V266, P181, DOI 10.1046/j.1432-1327.1999.00842.x; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Chen W, 2013, MOL GENET GENOMICS, V288, P627, DOI 10.1007/s00438-013-0777-1; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cristino AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019350; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Ferguson L, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004698; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Gibbs M, 2010, PHYSIOL ENTOMOL, V35, P29, DOI 10.1111/j.1365-3032.2009.00706.x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Homma T, 2006, BIOCHEM BIOPH RES CO, V344, P386, DOI 10.1016/j.bbrc.2006.03.085; Jagadeeswaran G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-52; Jones CI, 2010, BIOCHEM SOC T, V38, P1137, DOI 10.1042/BST0381137; KADONOOKUDA K, 1994, ARCH INSECT BIOCHEM, V25, P121, DOI 10.1002/arch.940250205; Kenny NJ, 2013, GEN COMP ENDOCR, V188, P16, DOI 10.1016/j.ygcen.2013.02.013; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kloosterman WP, 2006, NAT METHODS, V3, P27, DOI 10.1038/NMETH843; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kugler JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067075; Lasko P, 2011, WIRES RNA, V2, P408, DOI 10.1002/wrna.70; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lozano J, 2015, P NATL ACAD SCI USA, V112, P3740, DOI 10.1073/pnas.1418522112; Lucas KJ, 2013, TRENDS PARASITOL, V29, P295, DOI 10.1016/j.pt.2013.04.003; Lyu Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004096; McBride D, 2012, REPRODUCTION, V144, P221, DOI 10.1530/REP-12-0025; McDonald JA, 2003, DEVELOPMENT, V130, P3469, DOI 10.1242/dev.00574; Mead EA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-244; Meunier J, 2013, GENOME RES, V23, P34, DOI 10.1101/gr.140269.112; Montell DJ, 2003, NAT REV MOL CELL BIO, V4, P13, DOI 10.1038/nrm1006; Mukherjee K, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-705; Ninova M, 2014, RNA, V20, P360, DOI 10.1261/rna.041657.113; Papantonis A, 2015, ANNU REV ENTOMOL, V60, P177, DOI 10.1146/annurev-ento-010814-020810; Pasquinelli AE, 2005, CURR OPIN GENET DEV, V15, P200, DOI 10.1016/j.gde.2005.01.002; Pinheiro EM, 2004, DEVELOPMENT, V131, P5243, DOI 10.1242/dev.01412; Preuss KM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-671; Quah S, 2015, MOL BIOL EVOL, V32, P1161, DOI 10.1093/molbev/msv004; Saunders C, 1999, MOL CELL, V3, P43, DOI 10.1016/S1097-2765(00)80173-2; Sokol NS, 2005, GENE DEV, V19, P2343, DOI 10.1101/gad.1356105; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Swevers L, 2003, INSECT BIOCHEM MOLEC, V33, P1285, DOI 10.1016/j.ibmb.2003.06.012; Tadros W, 2009, DEVELOPMENT, V136, P3033, DOI 10.1242/dev.033183; Wei J, 2004, DEV DYNAM, V230, P800, DOI 10.1002/dvdy.20108; Wheeler BM, 2009, EVOL DEV, V11, P50, DOI 10.1111/j.1525-142X.2008.00302.x; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Zhang XF, 2012, INSECT BIOCHEM MOLEC, V42, P381, DOI 10.1016/j.ibmb.2012.01.006	53	12	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142243	10.1371/journal.pone.0142243	http://dx.doi.org/10.1371/journal.pone.0142243			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556800	gold, Green Published, Green Submitted			2022-12-27	WOS:000364430700073
J	Wang, H; Luo, Y; Lin, Z; Lee, IW; Kwon, J; Cui, XS; Kim, NH				Wang, HaiYang; Luo, Yibo; Lin, Zili; Lee, In-Won; Kwon, Jeongwoo; Cui, Xiang-Shun; Kim, Nam-Hyung			Effect of ATM and HDAC Inhibition on Etoposide-Induced DNA Damage in Porcine Early Preimplantation Embryos	PLoS One			English	Article							DOUBLE-STRAND-BREAK; OOCYTE MEIOTIC MATURATION; IN-VITRO DEVELOPMENT; NUCLEAR TRANSFER; HISTONE H2AX; MAMMALIAN-CELLS; KINASE ATM; REPAIR; CAFFEINE; RECOMBINATION	Oocyte maturation and embryonic development are sensitive to DNA damage. Compared with somatic cells or oocytes, little is known about the response to DNA damage in early preimplantation embryos. In this study, we examined DNA damage checkpoints and DNA repair mechanisms in parthenogenetic preimplantation porcine embryos. We found that most of the etoposide-treated embryos showed delay in cleavage and ceased development before the blastocyst stage. In DNA-damaged embryos, the earliest positive TUNEL signals were detected on Day 5 of in vitro culture. Caffeine, which is an ATM (ataxia telangiectasia mutated) and ATR (ataxia telangiectasia and Rad3-related protein) kinase inhibitor, and KU55933, which is an ATM kinase inhibitor, were equally effective in rescuing the etoposide- induced cell-cycle blocks. This indicates that ATM plays a central role in the regulation of the checkpoint mechanisms. Treating the embryos with histone deacetylase inhibitors (HDACi) increased embryonic development and reduced etoposide-induced double-strand breaks (DSBs). The mRNA expression of genes involved in non-homologous end-joining (NHEJ) or homologous recombination (HR) pathways for DSB repair was reduced upon HDACi treatment in 5-day-old embryos. Furthermore, HDACi treatment increased the expression levels of pluripotency-related genes (OCT4, SOX2 and NANOG) and decreased the expression levels of apoptosis-related genes (CASP3 and BAX). These results indicate that early embryonic cleavage and development are disturbed by etoposide-induced DNA damage. ATMi (caffeine or KU55933) treatment bypasses the checkpoint while HDACi treatment improves the efficiency of DSB repair to increase the cleavage and blastocyst rate in porcine early preimplantation embryos.	[Wang, HaiYang; Luo, Yibo; Lin, Zili; Lee, In-Won; Kwon, Jeongwoo; Cui, Xiang-Shun; Kim, Nam-Hyung] Chungbuk Natl Univ, Dept Anim Sci, Cheongju 362763, Chungcheongbuk, South Korea	Chungbuk National University	Kim, NH (corresponding author), Chungbuk Natl Univ, Dept Anim Sci, Cheongju 362763, Chungcheongbuk, South Korea.	nhkim@chungbuk.ac.kr		WANG, HAIYANG/0000-0002-6362-6022	BioGreen 21 Program of the Rural Development Administration (RDA) of the Republic of Korea [PJ009594]	BioGreen 21 Program of the Rural Development Administration (RDA) of the Republic of Korea	Funding: This study was supported by a grant from the BioGreen 21 Program (No. PJ009594 to NK) of the Rural Development Administration (RDA) of the Republic of Korea.	Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Blasina A, 1999, CURR BIOL, V9, P1135, DOI 10.1016/S0960-9822(99)80486-2; Bohgaki Toshiyuki, 2010, Genome Integr, V1, P15, DOI 10.1186/2041-9414-1-15; Bohrer RC, 2014, CELL CYCLE, V13, P2138, DOI 10.4161/cc.29215; Brandsma Inger, 2012, Genome Integr, V3, P9, DOI 10.1186/2041-9414-3-9; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Cao SY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-4; Cortez D, 2003, J BIOL CHEM, V278, P37139, DOI 10.1074/jbc.M307088200; De Bont R, 2004, MUTAGENESIS, V19, P169, DOI 10.1093/mutage/geh025; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; Haber JE, 2000, TRENDS GENET, V16, P259, DOI 10.1016/S0168-9525(00)02022-9; Hao YH, 2003, BIOL REPROD, V69, P501, DOI 10.1095/biolreprod.103.016170; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Karran P, 2000, CURR OPIN GENET DEV, V10, P144, DOI 10.1016/S0959-437X(00)00069-1; Korwek Z, 2012, DNA REPAIR, V11, P864, DOI 10.1016/j.dnarep.2012.08.006; Lee HS, 2010, EMBO J, V29, P1434, DOI 10.1038/emboj.2010.27; Ma JY, 2013, CELL CYCLE, V12, P1233, DOI 10.4161/cc.24311; Marangos P, 2012, CURR BIOL, V22, P989, DOI 10.1016/j.cub.2012.03.063; McManus KJ, 2005, MOL BIOL CELL, V16, P5013, DOI 10.1091/mbc.E05-01-0065; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Mu XF, 2011, BIOL REPROD, V85, P524, DOI 10.1095/biolreprod.110.089334; Niemann H, 2008, REPRODUCTION, V135, P151, DOI 10.1530/REP-07-0397; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Sarkaria JN, 1999, CANCER RES, V59, P4375; Sharma GG, 2010, MOL CELL BIOL, V30, P3582, DOI 10.1128/MCB.01476-09; Smith J, 2010, ADV CANCER RES, V108, P73, DOI 10.1016/S0065.230X(10)08002.4; Soleimani R, 2011, AGING-US, V3, P782, DOI 10.18632/aging.100363; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Su GH, 2000, CANCER RES, V60, P3137; Tjeertes JV, 2009, EMBO J, V28, P1878, DOI 10.1038/emboj.2009.119; Turinetto V, 2015, NUCLEIC ACIDS RES, V43, P2489, DOI 10.1093/nar/gkv061; Van Thuan N, 2009, REPRODUCTION, V138, P309, DOI 10.1530/REP-08-0299; Wanczyk M, 2011, FRONT BIOSCI-LANDMRK, V16, P340, DOI 10.2741/3691; Wang LJ, 2011, CELL REPROGRAM, V13, P431, DOI 10.1089/cell.2011.0024; Wang ZW, 2013, CELL CYCLE, V12, P3336, DOI 10.4161/cc.26327; Wu CC, 2011, SCIENCE, V333, P459, DOI 10.1126/science.1204117; Xie AY, 2004, MOL CELL, V16, P1017, DOI 10.1016/j.molcel.2004.12.007; Yang MY, 2002, ANIM REPROD SCI, V70, P159, DOI 10.1016/S0378-4320(01)00186-5; Yang XH, 2013, J BIOL CHEM, V288, P18271, DOI 10.1074/jbc.M113.473199; Yukawa M, 2007, BIOCHEM BIOPH RES CO, V358, P578, DOI 10.1016/j.bbrc.2007.04.162; Zhang T, 2014, HISTOCHEM CELL BIOL, V142, P185, DOI 10.1007/s00418-014-1182-5	42	27	27	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142561	10.1371/journal.pone.0142561	http://dx.doi.org/10.1371/journal.pone.0142561			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556501	Green Submitted, Green Published, gold			2022-12-27	WOS:000364430700130
J	Ayele, HT; van Mourik, MSM; Debray, TPA; Bonten, MJM				Ayele, Henok Tadesse; van Mourik, Maaike S. M.; Debray, Thomas P. A.; Bonten, Marc J. M.			Isoniazid Prophylactic Therapy for the Prevention of Tuberculosis in HIV Infected Adults: A Systematic Review and Meta-Analysis of Randomized Trials	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; MYCOBACTERIUM-TUBERCULOSIS; SOUTH-AFRICA; RISK-FACTORS; REPLICATION; HAART; MACROPHAGES; IMPACT; INDUCTION; BURDEN	Background Infection with Human Immunodeficiency virus (HIV) is an important risk factor for Tuberculosis (TB). Anti-Retroviral Therapy (ART) has improved the prognosis of HIV and reduced the risk of TB infected patients. Isoniazid Preventive Therapy (IPT) aims to reduce the development of active TB in patients with latent TB. Objective Systematically review and synthesize effect estimates of IPT for TB prevention in adult HIV patients. Secondary objectives were to assess the effect of IPT on HIV disease progression, all-cause mortality and adverse drug reaction (ADR). Search Strategy Electronic databases were searched to identify relevant articles in English available by September 11th 2015. Selection Criteria Research articles comparing IPT to placebo or no treatment in HIV infected adults using randomized clinical trials. Data Analysis A qualitative review included study-level information on randomization and treatment allocation. Effect estimates were pooled using random-effects models to account for between study heterogeneity. Main Results This review assessed ten randomized clinical trials that assigned 7619 HIV patients to IPT or placebo. An overall 35% of TB risk reduction (RR = 0.65, 95% CI (0.51, 0.84)) was found in all participants, however, larger benefit of IPT was observed in Tuberculin Skin Test (TST) positive participants, with pooled relative risk reduction of 52% [RR = 0.48; 95% CI (0.29, 0.82)] and with a prediction interval ranging from 0.13 to 1.81. There was no statistically significant effect of IPT on TB occurrence in TST negative or unknown participants. IPT also reduced the risk of HIV disease progression in all participants (RR = 0.69; 95% CI (0.48, 0.99)) despite no benefits observed in TST strata. All-cause mortality was not affected by IPT although participants who had 12 months of IPT tend to have a reduced risk (RR = 0.65; 95% CI(0.47, 0.90)). IPT had an elevated, yet statistically non-significant, risk of adverse drug reaction [RR = 1.20; 95% CI (1.20, 1.71)]. Only a single study assessed the effect of IPT in combination with ART in preventing TB and occurrence of multi-drug resistant tuberculosis. Conclusions IPT use substantially contributes in preventing TB in persons with HIV in general and in TST positive individuals in particular. More evidence is needed to explain discrepancies in the protective effect of IPT in these individuals.	[Ayele, Henok Tadesse] Dilla Univ, Coll Hlth Sci, Dept Publ Hlth, Dilla, Gedeo Zone, Ethiopia; [Ayele, Henok Tadesse] Dilla Univ, Referral Hosp, Dilla, Gedeo Zone, Ethiopia; [Ayele, Henok Tadesse; Bonten, Marc J. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Dept Infect Dis Epidemiol, Utrecht, Netherlands; [Debray, Thomas P. A.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Dept Epidemiol, Utrecht, Netherlands; [van Mourik, Maaike S. M.; Bonten, Marc J. M.] Univ Med Ctr Utrecht, Dept Med Microbiol & Infect Control, Utrecht, Netherlands	Dilla University; Dilla University; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Ayele, HT (corresponding author), Dilla Univ, Coll Hlth Sci, Dept Publ Hlth, Dilla, Gedeo Zone, Ethiopia.	hennypho@yahoo.com	Debray, Thomas/J-7413-2012; Ayele, Henok Tadesse/AAA-5856-2019	Debray, Thomas/0000-0002-1790-2719; Ayele, Henok Tadesse/0000-0002-6117-0578; van Mourik, Maaike/0000-0003-2465-4132	Netherlands Fellowship Program (NUFFIC) [11169]	Netherlands Fellowship Program (NUFFIC)	Funding: The study was funded by the Netherlands Fellowship Program (NUFFIC grant number 11169). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akolo C, 2010, TREATMENT LATENT TUB; Akolo C, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000171.pub3; Andvord Kristian F., 2002, INT J TUBERC LUNG D, V6, P562; [Anonymous], METAANALYSIS FIXED E; Ayele HT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1089-3; Badri M, 2002, LANCET, V359, P2059, DOI 10.1016/S0140-6736(02)08904-3; Bucher HC, 1999, AIDS, V13, P501, DOI 10.1097/00002030-199903110-00009; Bucy RP, 2001, AIDS, V15, pS36, DOI 10.1097/00002030-200102002-00007; Churchyard GJ, 2014, NEW ENGL J MED, V370, P301, DOI [10.1056/NEJMoa1214289, 10.1056/NEJMc1402073]; Costagliola D, 2005, CLIN INFECT DIS, V41, P1772, DOI 10.1086/498315; Date AA, 2010, B WORLD HEALTH ORGAN, V88, P253, DOI 10.2471/BLT.09.066522; Debray TPA, 2015, RES SYN MET IN PRESS; Ferebee S, 1970, BIBL TUBERC, V26, P28; Fielding KL, 2011, CONTEMP CLIN TRIALS, V32, P382, DOI 10.1016/j.cct.2010.12.008; Galdston I., 1954, B MED LIB ASS, V42, P142; Girardi E, 2000, AIDS, V14, P1985, DOI 10.1097/00002030-200009080-00015; Goletti D, 1998, J INFECT DIS, V177, P1332, DOI 10.1086/515276; Goletti D, 2004, J INFECT DIS, V189, P624, DOI 10.1086/381554; Golub JE, 2007, AIDS, V21, P1441, DOI 10.1097/QAD.0b013e328216f441; Golub JE, 2009, AIDS, V23, P631, DOI 10.1097/QAD.0b013e328327964f; Gordin F, 2000, JAMA-J AM MED ASSOC, V283, P1445, DOI 10.1001/jama.283.11.1445; Graham N. M., 1996, EFFECT ISONIAZID CHE; Green S, 2011, COCHRANE HDB COCHRAN, V6, P3, DOI DOI 10.1002/9780470712184; GRIGG ERN, 1958, AM REV TUBERC PULM, V78, P426; GUELAR A, 1993, AIDS, V7, P1345, DOI 10.1097/00002030-199310000-00007; Gupta SS, 2012, J INT AIDS SOC, V15, P213; Hartung J, 2001, STAT MED, V20, P3875, DOI 10.1002/sim.1009; Hartung J, 1999, BIOMETRICAL J, V41, P901, DOI 10.1002/(SICI)1521-4036(199912)41:8<901::AID-BIMJ901>3.0.CO;2-W; Hoshino Y, 2002, J EXP MED, V195, P495, DOI 10.1084/jem.20011614; Hoshino Y, 2007, J INFECT DIS, V195, P1303, DOI 10.1086/513438; Jones JL, 2000, INT J TUBERC LUNG D, V4, P1026; Kerkhoff AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049928; Kwan CK, 2011, CLIN MICROBIOL REV, V24, P351, DOI 10.1128/CMR.00042-10; Lawn SD, 2005, AIDS, V19, P2109, DOI 10.1097/01.aids.0000194808.20035.c1; Lawn SD, 2005, AIDS, V19, P1113, DOI 10.1097/01.aids.0000176211.08581.5a; Lawn SD, 2006, AIDS, V20, P1605, DOI 10.1097/01.aids.0000238406.93249.cd; Lawn SD, 2010, LANCET INFECT DIS, V10, P489, DOI 10.1016/S1473-3099(10)70078-5; Lawn SD, 2009, AIDS, V23, P1717, DOI 10.1097/QAD.0b013e32832d3b6d; Mancino G, 1997, J INFECT DIS, V175, P1531, DOI 10.1086/516494; Merchant R. H., 2002, Indian Journal of Pediatrics, V69, P973, DOI 10.1007/BF02726017; Mesfin N, 2012, INT J STD AIDS, V23, P94, DOI 10.1258/ijsa.2011.011051; Mills HL, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005260; Miranda A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000826; Moreno S, 2008, INT J TUBERC LUNG D, V12, P1393; MORENO S, 1993, ANN INTERN MED, V119, P194, DOI 10.7326/0003-4819-119-3-199308010-00003; Muga R, 2007, AIDS, V21, P2521, DOI 10.1097/QAD.0b013e3282f1c933; NARAIN JP, 1992, TUBERCLE LUNG DIS, V73, P311, DOI 10.1016/0962-8479(92)90033-G; PAPE JW, 1993, LANCET, V342, P268, DOI 10.1016/0140-6736(93)91817-6; R Development Core Team, 2012, R LANG ENV STAT COMP; Ranjbar S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006116; Reed MB, 2004, NATURE, V431, P84, DOI 10.1038/nature02837; Riley RD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d549; Riley RD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c221; Samandari T, 2011, LANCET, V377, P1588, DOI 10.1016/S0140-6736(11)60204-3; Santoro-Lopes G, 2002, CLIN INFECT DIS, V34, P543, DOI 10.1086/338641; SELWYN PA, 1989, NEW ENGL J MED, V320, P545, DOI 10.1056/NEJM198903023200901; de Souza CTV, 2009, MEM I OSWALDO CRUZ, V104, P462, DOI 10.1590/S0074-02762009000300011; Wallace BC, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-80; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO Stop TB, 2004, INT POL COLL TB HIV; Wilkinson D, 1998, BRIT MED J, V317, P625, DOI 10.1136/bmj.317.7159.625; World Health Organization, 2015, GUID INT TUB CAS FIN; World Health Organization, 2013, GLOB TUB REP 2013, V375; Zumla A, 2013, NEW ENGL J MED, V368, P745, DOI 10.1056/NEJMra1200894	64	66	68	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2015	10	11							e0142290	10.1371/journal.pone.0142290	http://dx.doi.org/10.1371/journal.pone.0142290			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7AC	26551023	Green Published, Green Submitted, gold			2022-12-27	WOS:000364422800022
J	Capoferri, L; Verkade-Vreeker, MCA; Buitenhuis, D; Commandeur, JNM; Pastor, M; Vermeulen, NPE; Geerke, DP				Capoferri, Luigi; Verkade-Vreeker, Marlies C. A.; Buitenhuis, Danny; Commandeur, Jan N. M.; Pastor, Manuel; Vermeulen, Nico P. E.; Geerke, Daan P.			Linear Interaction Energy Based Prediction of Cytochrome P450 1A2 Binding Affinities with Reliability Estimation	PLOS ONE			English	Article							IN-VITRO INHIBITION; COMPUTATIONAL PREDICTION; DRUG-INTERACTIONS; MOLECULAR-DYNAMICS; LIVER-MICROSOMES; METABOLISM; ENZYMES; PROTEIN; QSAR; CYP1A2	Prediction of human Cytochrome P450 (CYP) binding affinities of small ligands, i.e., substrates and inhibitors, represents an important task for predicting drug-drug interactions. A quantitative assessment of the ligand binding affinity towards different CYPs can provide an estimate of inhibitory activity or an indication of isoforms prone to interact with the substrate of inhibitors. However, the accuracy of global quantitative models for CYP substrate binding or inhibition based on traditional molecular descriptors can be limited, because of the lack of information on the structure and flexibility of the catalytic site of CYPs. Here we describe the application of a method that combines protein-ligand docking, Molecular Dynamics (MD) simulations and Linear Interaction Energy (LIE) theory, to allow for quantitative CYP affinity prediction. Using this combined approach, a LIE model for human CYP 1A2 was developed and evaluated, based on a structurally diverse dataset for which the estimated experimental uncertainty was 3.3 kJ mol(-1). For the computed CYP 1A2 binding affinities, the model showed a root mean square error (RMSE) of 4.1 kJ mol(-1) and a standard error in prediction (SDEP) in cross-validation of 4.3 kJ mol(-1). A novel approach that includes information on both structural ligand description and protein-ligand interaction was developed for estimating the reliability of predictions, and was able to identify compounds from an external test set with a SDEP for the predicted affinities of 4.6 kJ mol(-1) (corresponding to 0.8 pKi units).	[Capoferri, Luigi; Verkade-Vreeker, Marlies C. A.; Buitenhuis, Danny; Commandeur, Jan N. M.; Vermeulen, Nico P. E.; Geerke, Daan P.] Vrije Univ Amsterdam, Dept Chem & Pharmaceut Sci, AIMMS Div Mol Toxicol, NL-1081 HV Amsterdam, Netherlands; [Pastor, Manuel] Univ Pompeu Fabra, Med Res Inst, IMIM Hosp del Mar, Res Programme Biomed Informat GRIB,Dept Expt & Hl, E-08003 Barcelona, Spain	Vrije Universiteit Amsterdam; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University	Geerke, DP (corresponding author), Vrije Univ Amsterdam, Dept Chem & Pharmaceut Sci, AIMMS Div Mol Toxicol, De Boelelaan 1083, NL-1081 HV Amsterdam, Netherlands.	d.p.geerke@vu.nl	Pastor, Manuel/A-1566-2010; Gasull, Martina/J-4076-2019	Pastor, Manuel/0000-0001-8850-1341; Vermeulen, Nico P.E./0000-0003-4194-6401; Geerke, Daan/0000-0002-5262-6166	Innovative Medicines Initiative Joint Undertaking (IMI-JU) [115002]; European Union; Netherlands Organisation for Scientific Research (NWO, VIDI) [723.012.105]	Innovative Medicines Initiative Joint Undertaking (IMI-JU); European Union(European Commission); Netherlands Organisation for Scientific Research (NWO, VIDI)(Netherlands Organization for Scientific Research (NWO))	Funding: The work was supported by Innovative Medicines Initiative Joint Undertaking (IMI-JU) under grant agreement no. 115002 (eTOX), resources of which are composed of financial contribution from the European Union Seventh Framework Programme (FP7/20072013) and EFPIA companies in kind contribution; www.etoxproject.eu. The work was also supported by The Netherlands Organisation for Scientific Research (NWO, VIDI grant 723.012.105); www.nwo.nl. Except for manuscript approval from the eTOX executive committee, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, MOL OP ENV MOE VERS; AQVIST J, 1994, PROTEIN ENG, V7, P385, DOI 10.1093/protein/7.3.385; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Breinholt VM, 2002, FOOD CHEM TOXICOL, V40, P609, DOI 10.1016/S0278-6915(01)00125-9; BURKE MD, 1983, CHEM-BIOL INTERACT, V45, P243; Busby WF, 1999, DRUG METAB DISPOS, V27, P246; CARLSON HA, 1995, J PHYS CHEM-US, V99, P10667, DOI 10.1021/j100026a034; Carrio P, 2014, J CHEM INF MODEL, V54, P1500, DOI 10.1021/ci500172z; Case D. A., 2012, AMBER 13; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Cho US, 2003, BBA-PROTEINS PROTEOM, V1648, P195, DOI 10.1016/S1570-9639(03)00148-1; Cohen LH, 2003, DRUG METAB DISPOS, V31, P1005, DOI 10.1124/dmd.31.8.1005; Correia M.A., 2005, CYTOCHROME P450 STRU, V3rd ed., P247, DOI DOI 10.1007/0-387-27447-2_7; De Maesschalck R, 2000, CHEMOMETR INTELL LAB, V50, P1, DOI 10.1016/S0169-7439(99)00047-7; Durant JL, 2002, J CHEM INF COMP SCI, V42, P1273, DOI 10.1021/ci010132r; Ekins S, 2001, DRUG METAB DISPOS, V29, P936; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Feenstra KA, 1999, J COMPUT CHEM, V20, P786, DOI 10.1002/(SICI)1096-987X(199906)20:8<786::AID-JCC5>3.0.CO;2-B; Gleeson MP, 2007, J COMPUT AID MOL DES, V21, P559, DOI 10.1007/s10822-007-9139-6; Guengerich FP, 2006, P NATL ACAD SCI USA, V103, P13565, DOI 10.1073/pnas.0606333103; Guengerich FP, 2006, AAPS J, V8, pE101, DOI 10.1208/aapsj080112; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X]; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hockney RW, 1970, POTENTIAL CALCULATIO; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hritz J, 2009, J PHYS CHEM B, V113, P12711, DOI 10.1021/jp902968m; Hubert M, 2005, TECHNOMETRICS, V47, P64, DOI 10.1198/004017004000000563; Iori F, 2005, BIOORGAN MED CHEM, V13, P4366, DOI 10.1016/j.bmc.2005.04.066; Jakalian A, 2000, J COMPUT CHEM, V21, P132, DOI 10.1002/(SICI)1096-987X(20000130)21:2<132::AID-JCC5>3.0.CO;2-P; JORGENSEN WL, 1983, J AM CHEM SOC, V105, P1407, DOI 10.1021/ja00344a001; Karjalainen MJ, 2008, BASIC CLIN PHARMACOL, V103, P157, DOI 10.1111/j.1742-7843.2008.00252.x; Katoh M, 2000, EUR J CLIN PHARMACOL, V55, P843, DOI 10.1007/s002280050706; Kazui M, 2010, DRUG METAB DISPOS, V38, P92, DOI 10.1124/dmd.109.029132; Kirchmair J, 2012, J CHEM INF MODEL, V52, P617, DOI 10.1021/ci200542m; Ko JW, 2000, BRIT J CLIN PHARMACO, V49, P343; Korb Oliver, 2007, Swarm Intelligence, V1, P115, DOI 10.1007/s11721-007-0006-9; Korb O, 2009, J CHEM INF MODEL, V49, P84, DOI 10.1021/ci800298z; Korhonen LE, 2005, J MED CHEM, V48, P3808, DOI 10.1021/jm0489713; Lautraite S, 2002, MUTAGENESIS, V17, P45, DOI 10.1093/mutage/17.1.45; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; Masimirembwa CM, 1999, DRUG METAB DISPOS, V27, P1117; MASUBUCHI Y, 1994, DRUG METAB DISPOS, V22, P909; Nikolova N, 2004, QSAR COMB SCI, V22, P1006, DOI 10.1002/qsar.200330831; Novotarskyi S, 2011, J CHEM INF MODEL, V51, P1271, DOI 10.1021/ci200091h; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Obach RS, 2006, J PHARMACOL EXP THER, V316, P336, DOI 10.1124/jpet.105.093229; Oldham HG, 1997, DRUG METAB DISPOS, V25, P970; OMURA T, 1964, J BIOL CHEM, V239, P2370; Peric-Hassler L, 2013, INT J MOL SCI, V14, P24514, DOI 10.3390/ijms141224514; Racha JK, 1998, BIOCHEMISTRY-US, V37, P7407, DOI 10.1021/bi973011m; Rendic S, 2002, DRUG METAB REV, V34, P83, DOI 10.1081/DMR-120001392; Roy K, 2008, CHEM BIOL DRUG DES, V72, P370, DOI 10.1111/j.1747-0285.2008.00717.x; Sahigara F, 2012, MOLECULES, V17, P4791, DOI 10.3390/molecules17054791; Sanderink GJ, 1997, J PHARMACOL EXP THER, V282, P1465; Sansen S, 2007, J BIOL CHEM, V282, P14348, DOI 10.1074/jbc.M611692200; Shahrokh K, 2012, J COMPUT CHEM, V33, P119, DOI 10.1002/jcc.21922; Smith DA, 1997, DRUG DISCOV TODAY, V2, P406, DOI 10.1016/S1359-6446(97)01081-7; Sousa da Silva Alan W, 2012, BMC Res Notes, V5, P367, DOI 10.1186/1756-0500-5-367; SPALDIN V, 1995, DRUG METAB DISPOS, V23, P929; Sridhar J, 2011, SAR QSAR ENVIRON RES, V22, P681, DOI 10.1080/1062936X.2011.623320; Sridhar J, 2012, MOLECULES, V17, P9283, DOI 10.3390/molecules17089283; Stjernschantz E, 2008, EXPERT OPIN DRUG MET, V4, P513, DOI 10.1517/17425255.4.5.513 ; Stjernschantz E, 2010, BIOPHYS J, V98, P2682, DOI 10.1016/j.bpj.2010.02.034; Vasanthanathan P, 2010, DRUG METAB DISPOS, V38, P1347, DOI 10.1124/dmd.110.032946; Vasanthanathan P, 2009, DRUG METAB DISPOS, V37, P658, DOI 10.1124/dmd.108.023507; Vosmeer CR, 2014, INT J MOL SCI, V15, P798, DOI 10.3390/ijms15010798; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wei XX, 1999, J PHARMACOL EXP THER, V289, P853; Wienkers LC, 2005, NAT REV DRUG DISCOV, V4, P825, DOI 10.1038/nrd1851; Yang YC, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0087749, 10.1371/journal.pone.0100677, 10.1371/journal.pone.0085863, 10.1371/journal.pone.0102942]; Yuan R, 2002, DRUG METAB DISPOS, V30, P1311, DOI 10.1124/dmd.30.12.1311	72	22	22	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2015	10	11							e0142232	10.1371/journal.pone.0142232	http://dx.doi.org/10.1371/journal.pone.0142232			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7AC	26551865	Green Published, Green Submitted, gold			2022-12-27	WOS:000364422800019
J	Gao, NN; Zhai, QX; Li, YY; Huang, K; Bian, DL; Wang, XM; Liu, CG; Xu, H; Zhang, T				Gao, Ningning; Zhai, Qixi; Li, Yinyan; Huang, Kun; Bian, Donglin; Wang, Xuemei; Liu, Caigang; Xu, Hong; Zhang, Teng			Clinical Implications of T beta RII Expression in Breast Cancer	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TGF-BETA; RECEPTOR-II; BONE METASTASIS; ESTROGEN; INVASIVENESS	Objective To explore the relationship between T beta RII [type II TGF beta (transforming growth factor beta) receptor] expression and clinicopathological characteristics, and to evaluate the prognostic significance of T beta RII expression in breast cancer. Methods Clinicopathological data and prognostic information of 108 patients with histologically confirmed breast cancer who were surgically treated at China Medical University between January 2007 and September 2008 were reviewed and the association between the clinicopathological characteristics and T beta RII expression was analyzed by chi-square test and multivariate analysis. The expression of T beta RII was assessed by immunohistochemistry. Results Of the 108 patients, 60 cases were T beta RII positive and 48 cases were negative. There was no significant association between T beta RII expression of the patients older than 40 years and that of the younger than 40 years (56.0% vs 50.0%; P = 0.742). The T beta RII expression rate was significantly increased in patients with lymph node metastasis compared to those without lymph node metastasis (67.40% vs 46.8%; P = 0.033). Statistically significant relationships were found between increasing tumor clinical stage and high T beta RII expression (P = 0.011). T beta RII expression was not associated with the expression of ER(estrogen receptor). PR, (progesterone receptor). Her-2 (human epidermal growth factor receptor 2) (P = 0.925, P = 0.861, and P = 0.840, respectively). Patients with high T beta RII expression showed poorer 5-year disease-free survival (DFS) compared to those with low expression (66.7% vs 45.6%; P = 0.028) by univariate analysis. Survival analysis demonstrated that T beta RII was associated with poor DFS (P = 0.011). Subgroup analysis revealed that T beta RII expression was associated with shorter DFS in patients with lymph node metastasis, ER-positive, PR-positive or Her-2-negative tumors (P = 0.006, P = 0.016, P = 0.022, and P = 0.033, respectively). Cox regression analysis revealed that high T beta RII expression was related to poor 5-year DFS, and it was an independent factor for predicting the poor outcome for breast cancer patients (P = 0.016). Conclusions High levels of T beta RII expression were associated with lymph node metastasis, increasing tumor clinical stage, and poorer 5-year DFS in patients with breast cancer. T beta RII may be a potential prognostic marker for breast cancer.	[Gao, Ningning; Zhai, Qixi; Li, Yinyan; Huang, Kun; Bian, Donglin; Wang, Xuemei] China Med Univ, Hosp 1, Ultrason Diag Dept, Shenyang 110001, Liaoning Provin, Peoples R China; [Liu, Caigang] Dalian Med Univ, Hosp 2, Dept Breast Surg, Dalian, Liaoning Provin, Peoples R China; [Xu, Hong; Zhang, Teng] Liaoning Prov Canc Hosp & Inst, Dept Breast Surg, Shenyang, Liaoning Provin, Peoples R China	China Medical University; Dalian Medical University	Wang, XM (corresponding author), China Med Univ, Hosp 1, Ultrason Diag Dept, Shenyang 110001, Liaoning Provin, Peoples R China.	wxmlmt@163.com	Wang, Xuemei/GXF-3702-2022; Liu, Caigang/C-7179-2018	Liu, Caigang/0000-0003-2083-235X				Arteaga CL, 1996, J MAMMARY GLAND BIOL, V1, P327, DOI 10.1007/BF02017388; Brattain MG, 1996, TYPE 2 TRANFORMING G, V8, P49; Buck MB, 2004, CLIN CANCER RES, V10, P491, DOI 10.1158/1078-0432.CCR-0320-03; Chen H, 2015, EXP THER MED, V9, P227, DOI 10.3892/etm.2014.2065; Chowdhury Sanjib, 2009, Mol Cell Pharmacol, V1, P57; de Kruijf EM, 2013, ANN ONCOL, V24, P384, DOI 10.1093/annonc/mds333; Deckers M, 2006, CANCER RES, V66, P2202, DOI 10.1158/0008-5472.CAN-05-3560; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Figueroa JD, 2010, BREAST CANCER RES TR, V121, P727, DOI 10.1007/s10549-009-0590-z; Gobbi H, 1999, J NATL CANCER I, V91, P2096, DOI 10.1093/jnci/91.24.2096; Gobbi H, 2000, HISTOPATHOLOGY, V36, P168; Goto N, 2014, J CANCER, V5, P336, DOI 10.7150/jca.7202; Goto N, 2011, CANCER SCI, V102, P1501, DOI 10.1111/j.1349-7006.2011.01977.x; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kang YB, 2005, P NATL ACAD SCI USA, V102, P13909, DOI 10.1073/pnas.0506517102; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Makris EA, 2011, BIOMATERIALS, V32, P7411, DOI 10.1016/j.biomaterials.2011.06.037; Mamiya T, 2010, LAB INVEST, V90, P1339, DOI 10.1038/labinvest.2010.105; Mishra S, 2014, ONCOGENE, V33, P4097, DOI 10.1038/onc.2013.374; Novitskiy SV, 2011, CANCER DISCOV, V1, P430, DOI 10.1158/2159-8290.CD-11-0100; Paiva CE, 2010, ANN ONCOL, V21, P734, DOI 10.1093/annonc/mdp518; Takanami I, 1997, J SURG ONCOL, V64, P262, DOI 10.1002/(SICI)1096-9098(199704)64:4<262::AID-JSO3>3.3.CO;2-0; Wakefield LM, 2002, CURR OPIN GENET DEV, V12, P22, DOI 10.1016/S0959-437X(01)00259-3; Wiercinska E, 2011, BREAST CANCER RES TR, V128, P657, DOI 10.1007/s10549-010-1147-x; Yu YJ, 2012, CARCINOGENESIS, V33, P68, DOI 10.1093/carcin/bgr246	26	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2015	10	11							e0141412	10.1371/journal.pone.0141412	http://dx.doi.org/10.1371/journal.pone.0141412			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7AC	26551005	gold, Green Submitted, Green Published			2022-12-27	WOS:000364422800004
J	Chantreau, V; Taddese, B; Munier, M; Gourdin, L; Henrion, D; Rodien, P; Chabbert, M				Chantreau, Vanessa; Taddese, Bruck; Munier, Mathilde; Gourdin, Louis; Henrion, Daniel; Rodien, Patrice; Chabbert, Marie			Molecular Insights into the Transmembrane Domain of the Thyrotropin Receptor	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; CRYSTAL-STRUCTURE; TSH RECEPTOR; ACTIVATION; DYNAMICS; HORMONE; COMPLEX; SWITCH; ANTAGONIST; MODULATION	The thyrotropin receptor (TSHR) is a G protein-coupled receptor (GPCR) that is member of the leucine-rich repeat subfamily (LGR). In the absence of crystal structure, the success of rational design of ligands targeting the receptor internal cavity depends on the quality of the TSHR models built. In this subfamily, transmembrane helices (TM) 2 and 5 are characterized by the absence of proline compared to most receptors, raising the question of the structural conformation of these helices. To gain insight into the structural properties of these helices, we carried out bioinformatics and experimental studies. Evolutionary analysis of the LGR family revealed a deletion in TM5 but provided no information on TM2. Wild type residues at positions 2.58, 2.59 or 2.60 in TM2 and/or at position 5.50 in TM5 were substituted to proline. Depending on the position of the proline substitution, different effects were observed on membrane expression, glycosylation, constitutive cAMP activity and responses to thyrotropin. Only proline substitution at position 2.59 maintained complex glycosylation and high membrane expression, supporting occurrence of a bulged TM2. The TSHR transmembrane domain was modeled by homology with the orexin 2 receptor, using a protocol that forced the deletion of one residue in the TM5 bulge of the template. The stability of the model was assessed by molecular dynamics simulations. TM5 straightened during the equilibration phase and was stable for the remainder of the simulations. Our data support a structural model of the TSHR transmembrane domain with a bulged TM2 and a straight TM5 that is specific of glycoprotein hormone receptors.	[Chantreau, Vanessa; Taddese, Bruck; Munier, Mathilde; Gourdin, Louis; Henrion, Daniel; Rodien, Patrice; Chabbert, Marie] Univ Angers, Lab Integrated Neurovasc & Mitochondrial Biol, INSERM 1083, UMR CNRS 6214, Angers, France; [Gourdin, Louis; Rodien, Patrice] CHU Angers, Dept Endocrinol, Reference Ctr Pathol Hormonal Recept, Angers, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Chabbert, M (corresponding author), Univ Angers, Lab Integrated Neurovasc & Mitochondrial Biol, INSERM 1083, UMR CNRS 6214, Angers, France.	marie.chabbert@univ-angers.fr	Henrion, Daniel/AAK-1995-2021; Henrion, Daniel/J-8141-2015; Rodien, Patrice/AAT-7909-2021; Henrion, Daniel/N-7023-2015; Munier, Mathilde/AAD-8239-2022; Munier, Mathilde/AAX-3770-2021	Henrion, Daniel/0000-0003-1094-0285; Henrion, Daniel/0000-0003-1094-0285; Henrion, Daniel/0000-0003-1094-0285; Munier, Mathilde/0000-0001-7194-6846; Taddese, Bruck/0000-0002-9884-4978	CNRS; INSERM; University of Angers; Conseil General de Maine-et-Loire; IBM; IFB; INRIA; SYSFERA	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University of Angers; Conseil General de Maine-et-Loire(Region Pays de la Loire); IBM(International Business Machines (IBM)); IFB; INRIA; SYSFERA	This work was supported by institutional grants from CNRS, INSERM and University of Angers. VC was supported by a fellowship from Conseil General de Maine-et-Loire. The authors thank NEC France SAS (Nanterre, France) for the kind provision of a multiprocessor server. The authors are grateful to CNRS, IBM, IFB, INRIA, and SYSFERA that provided access to the E-Biothon platform they are supporting. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti L, 2002, J CLIN ENDOCR METAB, V87, P2549, DOI 10.1210/jc.87.6.2549; Allen MD, 2011, FASEB J, V25, P3687, DOI 10.1096/fj.11-188961; Allen MD, 2011, THYROID, V21, P907, DOI 10.1089/thy.2011.0025; Biebermann H, 1998, FASEB J, V12, P1461, DOI 10.1096/fasebj.12.14.1461; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Cetani F, 1996, FEBS LETT, V378, P27, DOI 10.1016/0014-5793(95)01384-9; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Claus M, 2005, ENDOCRINOLOGY, V146, P5197, DOI 10.1210/en.2005-0713; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Davies TF, 2014, ENDOCRINOLOGY, V155, P1, DOI 10.1210/en.2013-2079; Derby MC, 2007, INT REV CYTOL, V261, P47, DOI 10.1016/S0074-7696(07)61002-X; Deupi X, 2010, PHYSIOLOGY, V25, P293, DOI 10.1152/physiol.00002.2010; Deville J, 2008, PROTEINS, V72, P115, DOI 10.1002/prot.21879; Deville J, 2009, J MOL EVOL, V68, P475, DOI 10.1007/s00239-009-9214-9; Fan QR, 2005, NATURE, V433, P269, DOI 10.1038/nature03206; Govaerts C, 2001, J BIOL CHEM, V276, P22991, DOI 10.1074/jbc.M102244200; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Jo S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000880; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Katritch V, 2012, TRENDS PHARMACOL SCI, V33, P17, DOI 10.1016/j.tips.2011.09.003; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Kleinau G, 2008, FASEB J, V22, P2798, DOI 10.1096/fj.07-104711; Kleinau Gunnar, 2014, Adv Pharmacol, V70, P81, DOI 10.1016/B978-0-12-417197-8.00003-1; Kleinau G, 2011, J BIOL CHEM, V286, P25859, DOI 10.1074/jbc.M110.196980; Kruse AC, 2013, NATURE, V504, P101, DOI 10.1038/nature12735; Kursawe R, 2007, TRENDS ENDOCRIN MET, V18, P199, DOI 10.1016/j.tem.2007.05.002; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Latif R, 2015, ENDOCRINOLOGY, V156, P488, DOI 10.1210/en.2014-1509; Laugwitz KL, 1996, P NATL ACAD SCI USA, V93, P116, DOI 10.1073/pnas.93.1.116; LAURENT E, 1987, MOL CELL ENDOCRINOL, V52, P273, DOI 10.1016/0303-7207(87)90055-4; Lee S, 2014, J PHYS CHEM B, V118, P547, DOI 10.1021/jp410344g; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mackerell AD, 2004, J COMPUT CHEM, V25, P1584, DOI 10.1002/jcc.20082; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Nagayama Y, 2000, J PHARMACOL EXP THER, V295, P404; Nagayama Y, 1998, J BIOL CHEM, V273, P33423, DOI 10.1074/jbc.273.50.33423; Neumann S, 2005, ENDOCRINOLOGY, V146, P477, DOI 10.1210/en.2004-1045; Neumann S, 2014, ENDOCRINOLOGY, V155, P310, DOI 10.1210/en.2013-1835; Neumann Susanne, 2009, Expert Rev Endocrinol Metab, V4, P669, DOI 10.1586/eem.09.36; Neumann S, 2008, ENDOCRINOLOGY, V149, P5945, DOI 10.1210/en.2008-0836; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pele J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019094; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rey J, 2010, J STRUCT BIOL, V171, P266, DOI 10.1016/j.jsb.2010.05.002; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanders J, 2007, THYROID, V17, P395, DOI 10.1089/thy.2007.0034; SEALFON SC, 1995, J BIOL CHEM, V270, P16683, DOI 10.1074/jbc.270.28.16683; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Urizar E, 2005, J BIOL CHEM, V280, P17135, DOI 10.1074/jbc.M414678200; van der Kant R, 2014, INT J MOL SCI, V15, P7841, DOI 10.3390/ijms15057841; VASSART G, 1992, ENDOCR REV, V13, P596, DOI 10.1210/er.13.3.596; Vassart G, 2004, TRENDS BIOCHEM SCI, V29, P119, DOI 10.1016/j.tibs.2004.01.006; Vlaeminck-Guillem V, 2002, MOL ENDOCRINOL, V16, P736, DOI 10.1210/me.16.4.736; Werry TD, 2003, BIOCHEM J, V374, P281, DOI 10.1042/BJ20030312; Wolf S, 2008, FEBS LETT, V582, P3335, DOI 10.1016/j.febslet.2008.08.022; Wolf S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123533; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Yin J, 2015, NATURE, V519, P247, DOI 10.1038/nature14035; Yohannan S, 2004, J MOL BIOL, V341, P1, DOI 10.1016/j.jmb.2004.06.025; Zhang DD, 2015, NATURE, V520, P317, DOI 10.1038/nature14287; Zhang KH, 2014, NATURE, V509, P115, DOI 10.1038/nature13083	66	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142250	10.1371/journal.pone.0142250	http://dx.doi.org/10.1371/journal.pone.0142250			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26545118	Green Submitted, Green Published, gold			2022-12-27	WOS:000364398700099
J	Kaminski, R; Kosinski, A; Brala, M; Piwko, G; Lewicka, E; Dabrowska-Kugacka, A; Raczak, G; Kozlowski, D; Grzybiak, M				Kaminski, Rafal; Kosinski, Adam; Brala, Mariola; Piwko, Grzegorz; Lewicka, Ewa; Dabrowska-Kugacka, Alicja; Raczak, Grzegorz; Kozlowski, Dariusz; Grzybiak, Marek			Variability of the Left Atrial Appendage in Human Hearts	PLOS ONE			English	Article							TRANSESOPHAGEAL ECHOCARDIOGRAPHY; RISK-FACTORS; FIBRILLATION; STROKE; ANTICOAGULATION; PREVALENCE; MORPHOLOGY; WARFARIN; ANATOMY; CLOSURE	Atrial fibrillation increases the risk of thrombus formation. It is commonly responsible for cerebral stroke whereas less frequently for pulmonary embolism. The aim of the study was to describe the morphology of the left atrial appendage in the human heart with respect to sex, age and weight. Macroscopic examination was carried out on 100 left appendages taken from the hearts of the patients aged 18-77, both sexes. All hearts preserved in 4% water solution of formaldehyde carried neither marks of coronary artery disease nor congenital abnormalities. Three axes of appendage orientation were performed. After the appendage had been cut off, morphological examination was performed in long and perpendicular axes. Measurements of the appendages were taken from anatomical specimens and their silicone casts. We classified the left atrial appendage into 4 morphological groups according to the number of lobes. Most left atrial appendages in female population were composed of 2 lobes. In the male group typically 2 or 3-lobed appendages were observed. The mean left atrial appendage orifice ranged from 12.0 to 16.0 mm and the most significant difference in the orifices between males and females was observed in LAA type 2 (about 3.3 mm). A smaller orifice and narrower, tubular shape of the LAA lobes could explain a higher risk of thrombus formation during nonvalvular atrial fibrillation in women. Knowledge of anatomical variability of the LAA helps diagnose some undefined echoes in the appendage during transesophageal echocardiographic examination.	[Kaminski, Rafal; Kosinski, Adam; Piwko, Grzegorz; Grzybiak, Marek] Med Univ Gdansk, Dept Clin Anat, Gdansk, Poland; [Brala, Mariola; Lewicka, Ewa; Dabrowska-Kugacka, Alicja; Raczak, Grzegorz; Kozlowski, Dariusz] Med Univ Gdansk, Dept Cardiol & Electrotherapy, Hosp Med, Gdansk, Poland	Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk	Kaminski, R (corresponding author), Med Univ Gdansk, Dept Clin Anat, Gdansk, Poland.	rafal.kaminski@gumed.edu.pl	Dabrowska-Kugacka, Alicja/ABE-2997-2020; Lewicka, Ewa/T-9676-2018; Kosiński, Adam/N-6300-2018	Dabrowska-Kugacka, Alicja/0000-0002-5546-7818; Lewicka, Ewa/0000-0002-0162-2659; Kosiński, Adam/0000-0001-7507-2285; Grzybiak, Marek/0000-0002-3119-160X				Al-Saady NM, 1999, HEART, V82, P547, DOI 10.1136/hrt.82.5.547; Anderson RH, 2007, EUROPACE, V9, P3, DOI 10.1093/europace/eum200; Cappellari M, 2013, J NEUROL, V260, P2681, DOI 10.1007/s00415-013-7064-2; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Di Biase L, 2012, J AM COLL CARDIOL, V6; ERNST G, 1995, ANAT REC, V242, P553, DOI 10.1002/ar.1092420411; Giralt-Steinhauer E, 2012, J NEUROL, V259, P745, DOI 10.1007/s00415-011-6259-7; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Go AS, 1999, ANN INTERN MED, V131, P927, DOI 10.7326/0003-4819-131-12-199912210-00004; Ho SY, 2002, PACE, V25, P342, DOI 10.1046/j.1460-9592.2002.00342.x; Kaminski R, 2015, KARDIOL POL, V73, P183, DOI 10.5603/KP.a2014.0170; Kleczynski P, 2012, KARDIOL POL, V70, P965; MANNING WJ, 1995, ANN INTERN MED, V123, P817, DOI 10.7326/0003-4819-123-11-199512010-00001; Mizuguchi KA, 2009, ANESTH ANALG, V108, P70, DOI 10.1213/ane.0b013e3181857e53; Nucifora G, 2011, CIRC-CARDIOVASC IMAG, V4, P514, DOI 10.1161/CIRCIMAGING.111.963892; Plewka M, 2011, KARDIOL POL, V69, P85; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Shariff N, 2012, J ATRIAL FIBR, V3, P79; Sievert H, 2002, CIRCULATION, V105, P1887, DOI 10.1161/01.CIR.0000015698.54752.6D; Stewart S, 2001, HEART, V86, P516, DOI 10.1136/heart.86.5.516; Su P, 2008, HEART, V94, P1166, DOI 10.1136/hrt.2006.111989; Ucerler H, 2013, ANATOL J CARDIOL, V13, P566, DOI 10.5152/akd.2013.181; Veinot JP, 1997, CIRCULATION, V96, P3112, DOI 10.1161/01.CIR.96.9.3112; WANG K, 1995, BRIT HEART J, V73, P559; Wang Y, 2010, J CARDIOVASC ELECTR, V21, P973, DOI 10.1111/j.1540-8167.2010.01814.x; WOLF PA, 1987, ARCH INTERN MED, V147, P1561, DOI 10.1001/archinte.147.9.1561	26	19	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141901	10.1371/journal.pone.0141901	http://dx.doi.org/10.1371/journal.pone.0141901			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544191	Green Published, Green Submitted, gold			2022-12-27	WOS:000364398700062
J	Li, K; Liu, Y; Wang, QX; Wu, YL; Song, SM; Sun, Y; Liu, TC; Wang, J; Li, Y; Du, SY				Li, Ke; Liu, Yi; Wang, Quanxin; Wu, Yalei; Song, Shimin; Sun, Yi; Liu, Tengchong; Wang, Jun; Li, Yang; Du, Shaoyi			A Spacecraft Electrical Characteristics Multi-Label Classification Method Based on Off-Line FCM Clustering and On-Line WPSVM	PLOS ONE			English	Article							FAULT-TOLERANT CONTROL; PARITY SPACE; SYSTEM	This paper proposes a novel multi-label classification method for resolving the spacecraft electrical characteristics problems which involve many unlabeled test data processing, high-dimensional features, long computing time and identification of slow rate. Firstly, both the fuzzy c-means (FCM) offline clustering and the principal component feature extraction algorithms are applied for the feature selection process. Secondly, the approximate weighted proximal support vector machine (WPSVM) online classification algorithms is used to reduce the feature dimension and further improve the rate of recognition for electrical characteristics spacecraft. Finally, the data capture contribution method by using thresholds is proposed to guarantee the validity and consistency of the data selection. The experimental results indicate that the method proposed can obtain better data features of the spacecraft electrical characteristics, improve the accuracy of identification and shorten the computing time effectively.	[Li, Ke; Liu, Yi; Wang, Quanxin; Wu, Yalei; Wang, Jun] Beihang Univ, Ergon & Environm Control Lab, Beijing 100191, Peoples R China; [Song, Shimin; Sun, Yi; Liu, Tengchong] China Acad Space Technol, Beijing, Peoples R China; [Li, Yang] Beihang Univ, Sch Automat Sci & Elect Engn, Beijing, Peoples R China; [Du, Shaoyi] Xi An Jiao Tong Univ, Inst Artificial Intelligence & Robot, Xian 710049, Shanxi, Peoples R China	Beihang University; Beihang University; Xi'an Jiaotong University	Li, Y (corresponding author), Beihang Univ, Ergon & Environm Control Lab, Beijing 100191, Peoples R China.	like@buaa.edu.cn	Li, Yang/AAJ-2985-2020; Li, Yang/K-8907-2012		Aeronautical Science Foundation of China [2012ZD51043]; Fanzhou Youth Scientific Funds [20100504]; Chinese Government Fundamental Research Funds for Central Universities [YWF-14-HKXY-017, YWF-13-HKXY-033]; National Natural Science Foundation of China [61403016]	Aeronautical Science Foundation of China; Fanzhou Youth Scientific Funds; Chinese Government Fundamental Research Funds for Central Universities; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors are supported by the Aeronautical Science Foundation of China (No. 2012ZD51043), Fanzhou Youth Scientific Funds (No. 20100504), Chinese Government Fundamental Research Funds for the Central Universities (No. YWF-14-HKXY-017, YWF-13-HKXY-033), and the National Natural Science Foundation of China (61403016).	Bonivento C, 2004, AUTOMATICA, V40, P355, DOI 10.1016/j.automatica.2003.10.003; Chen L, 2008, WORLD C; Chew HG, 2001, INT CONF ACOUST SPEE, P1269; Chidambaram B, 2005, AEROSP CONF PROC, P3532; Chien S., 2005, J AEROS COMP INF COM, V2, P196, DOI [10.2514/1.12923, DOI 10.2514/1.12923]; Cordon O, 1999, INT J APPROX REASON, V20, P21, DOI 10.1016/S0888-613X(98)10021-X; DAVID AK, 1991, IEEE T POWER SYST, V6, P59, DOI 10.1109/59.131092; Debeljkovic DL, 2004, DYNAM CONT DIS SER A, V11, P691; Dietterich TG, 2000, MACH LEARN, V40, P139, DOI 10.1023/A:1007607513941; Ding SX, 2007, FAULT DETECTION SUPE, P378; Ding X, 1999, IEEE T AUTOMAT CONTR, V44, P337, DOI 10.1109/9.746262; Du Lin, 2008, High Voltage Engineering, V34, P1589; Duan K, 2003, NEUROCOMPUTING, V51, P41, DOI 10.1016/S0925-2312(02)00601-X; Gao HJ, 2003, IEEE T AUTOMAT CONTR, V48, P1661, DOI 10.1109/TAC.2003.817012; Gao ZW, 2007, AUTOMATICA, V43, P912, DOI 10.1016/j.automatica.2006.11.018; Gu J, 2008, P REL MAINT S, P484; Hamdi H, 2009, FAULT DETECTION SUPE, P438; Huang JS, 2002, IEEE T POWER DELIVER, V17, P609, DOI 10.1109/61.997947; Jiang T, 2007, SYST MAN CYB 2007 IS, P3146; Keerthi SS, 2001, NEURAL COMPUT, V13, P637, DOI 10.1162/089976601300014493; Keller K, 2006, IEEE AER C; Kishore W., 2006, P IEEE INT C IND TEC, P1054; Kobayashi Y, 2007, IEEE T AUTOMAT CONTR, V52, P318, DOI 10.1109/TAC.2006.887897; Kulatunge A, 2002, NETWORK FAULT PREDIC; Li K, 2014, CHINESE J AERONAUT, V27, P1390, DOI 10.1016/j.cja.2014.10.005; Li K, 2013, CHINESE J AERONAUT, V26, P1360, DOI 10.1016/j.cja.2013.07.006; Li WH, 2000, J PROCESS CONTR, V10, P471, DOI 10.1016/S0959-1524(00)00022-6; Li ZY, 2014, INT CONF INFO SCI, P1, DOI 10.1109/ICIST.2014.6920318; Liu Y, 2014, INT CONF SIGN PROCES, P1413, DOI 10.1109/ICOSP.2014.7015232; Mika S, 1999, ADV NEUR IN, V11, P536; Nguang SK, 2006, INT J ROBUST NONLIN, V16, P913, DOI 10.1002/rnc.1116; PATTON RJ, 1994, J GUID CONTROL DYNAM, V17, P278, DOI 10.2514/3.21194; Shaw SR, 2000, MASSACHUSETTS I TECH, P213; Simani S., 2003, ADV IND CON, DOI 10.1007/978-1-59259-405-4; Swearingen K, 2007, AER C MAR; Tuchb BA, 2007, P 32 GOMACTECH C; Utgoff P. E., 1989, Machine Learning, V4, P161, DOI 10.1023/A:1022699900025; Utgoff P.E., 1994, P 11 INT C MACH LEAR, P318; Wang LA, 1996, IEEE T SYST MAN CY B, V26, P100, DOI 10.1109/3477.484441; Witten IH, 2011, BIOMEDICAL ENG ONLIN, V5, P95; Wu Hao, 2007, High Voltage Engineering, V33, P64; Wu Q, 2006, AM CONTR C; Yang H, 2003, PATTERN RECOGN, V36, P563, DOI 10.1016/S0031-3203(02)00048-1; Yang J, 2004, PATTERN ANAL MACHINE, P131; Zhang YM, 2001, J GUID CONTROL DYNAM, V24, P133, DOI 10.2514/2.4687; Zhang YM, 2008, ANNU REV CONTROL, V32, P229, DOI 10.1016/j.arcontrol.2008.03.008; Zhou ZH, 2002, KNOWL-BASED SYST, V15, P515, DOI 10.1016/S0950-7051(02)00038-2	47	6	6	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0140395	10.1371/journal.pone.0140395	http://dx.doi.org/10.1371/journal.pone.0140395			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544549	gold, Green Published, Green Submitted			2022-12-27	WOS:000364398700007
J	Park, H; Imoto, S; Miyano, S				Park, Heewon; Imoto, Seiya; Miyano, Satoru			Recursive Random Lasso (RRLasso) for Identifying Anti-Cancer Drug Targets	PLOS ONE			English	Article							HUMAN BREAST-CANCER; LUNG-CANCER; GASTRIC-CANCER; EXPRESSION; GENE; PROLIFERATION; INVASION; MARKER; GROWTH; CELLS	Uncovering driver genes is crucial for understanding heterogeneity in cancer. L-1-type regularization approaches have been widely used for uncovering cancer driver genes based on genome-scale data. Although the existing methods have been widely applied in the field of bioinformatics, they possess several drawbacks: subset size limitations, erroneous estimation results, multicollinearity, and heavy time consumption. We introduce a novel statistical strategy, called a Recursive Random Lasso (RRLasso), for high dimensional genomic data analysis and investigation of driver genes. For time-effective analysis, we consider a recursive bootstrap procedure in line with the random lasso. Furthermore, we introduce a parametric statistical test for driver gene selection based on bootstrap regression modeling results. The proposed RRLasso is not only rapid but performs well for high dimensional genomic data analysis. Monte Carlo simulations and analysis of the "Sanger Genomics of Drug Sensitivity in Cancer dataset from the Cancer Genome Project" show that the proposed RRLasso is an effective tool for high dimensional genomic data analysis. The proposed methods provide reliable and biologically relevant results for cancer driver gene selection.	[Park, Heewon; Imoto, Seiya; Miyano, Satoru] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Tokyo, Japan	University of Tokyo	Park, H (corresponding author), Yamaguchi Univ, Fac Global & Sci Studies, Yamaguchi, Yamaguchi, Japan.	hwpark@yamaguchi-u.ac.jp		Miyano, Satoru/0000-0002-1753-6616	RIKEN Advanced Institute for Computational Science through the HPCI System Research project [hp140230]	RIKEN Advanced Institute for Computational Science through the HPCI System Research project	This research used computational resources of the K computer provided by the RIKEN Advanced Institute for Computational Science through the HPCI System Research project (Project ID:hp140230) and the Super Computer System, Human Genome Center, Institute of Medical Science, University of Tokyo. The authors would like to thank the associate editor and anonymous reviewers for the constructive and valuable comments that improved the quality of the paper.	Abou-Sharieha Samah, 2009, Chinese Journal of Clinical Oncology, V6, P1, DOI 10.1007/s11805-009-0001-6; Akino K, 2007, CANCER SCI, V98, P88, DOI 10.1111/j.1349-7006.2006.00351.x; Amaia G, 2007, DRUG DISCOVERY TECHN; Berlato C, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2838; Bhushan L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022484; Bilecova-Rabajdova M, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/156034; Buess M, 2004, NEOPLASIA, V6, P813, DOI 10.1593/neo.04307; Chan CWM, 2009, P NATL ACAD SCI USA, V106, P1936, DOI 10.1073/pnas.0812904106; Chen QR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105393; Chen YL, 2013, BIOCHEM BIOPH RES CO, V442, P56, DOI 10.1016/j.bbrc.2013.10.165; Chen YZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091104; Chiang S. F., 2014, SURG SCI, V5, P418, DOI DOI 10.4236/SS.2014.510067; Cho H, 2014, ONCOTARGET, V5, P3482, DOI 10.18632/oncotarget.1947; Chorawala MR, 2012, INT J PHARM SCI DRUG, V4, P1, DOI DOI 10.7243/2050-120x-1-1; Chung FH, INTEGRATION NETWORK; Coghlin C, 2006, J PATHOL, V210, P351, DOI 10.1002/path.2056; Colombo J, 2013, BIOL PROCED ONLINE, V15, DOI 10.1186/1480-9222-15-10; Drayton RM, 2014, CLIN CANCER RES, V20, P1990, DOI 10.1158/1078-0432.CCR-13-2805; Dupouy S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004223; Edwards YJK, 2011, PLOS ONE, V8; Frezza C, 2014, GAUDE FREZZA CANC ME, V2; Gemma A, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-174; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Huang HC, 2010, TECHNOL CANCER RES T, V9, P219, DOI 10.1177/153303461000900301; Iwao-Koizumi K, 2005, J CLIN ONCOL, V23, P422, DOI 10.1200/JCO.2005.09.078; Jarzab M, 2005, BREAST CANCER RES, V7; Jin YJ, 2014, INT J CANCER, V134, P2294, DOI 10.1002/ijc.28568; Kashiwagi K, 2012, PATHOL INT, V62, P232, DOI 10.1111/j.1440-1827.2011.02781.x; Kato M, 2012, CANCER SCI, V103, P1363, DOI 10.1111/j.1349-7006.2012.02298.x; Katoh M, 2012, INT J ONCOL, V41, P1913, DOI 10.3892/ijo.2012.1669; Khin SS, 2009, INT J CANCER, V125, P328, DOI 10.1002/ijc.24318; Kim BY, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/584604; Kohn KW, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0035716, DOI 10.1371/J0URNAL.P0NE.0035716]; Kohno T, 2011, J THORAC ONCOL, V6, P813, DOI 10.1097/JTO.0b013e3181ee80ef; Kong CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022666; Kostianets O, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-161; Kundu J, 2012, INT J ONCOL, V41, P839, DOI 10.3892/ijo.2012.1517; Larriba Maria Jesus, 2013, Cancers (Basel), V5, P1242, DOI 10.3390/cancers5041242; Lee HJ, 2010, GASTROENTEROLOGY, V139, P213, DOI 10.1053/j.gastro.2010.04.008; Li CD, 2012, MOL CELL BIOCHEM, V370, P127, DOI 10.1007/s11010-012-1404-x; Lin H, 2012, CANCER GENE THER, V19, P845, DOI 10.1038/cgt.2012.70; Liu XX, 2011, FEBS LETT, V585, P1363, DOI 10.1016/j.febslet.2011.04.018; Llarena AM, 2009, J CLIN ONCOL, V27; Loberg RD, 2006, NEOPLASIA, V8, P69, DOI 10.1593/neo.05679; Miao LY, 2013, BIOCHEM BIOPH RES CO, V440, P792, DOI 10.1016/j.bbrc.2013.10.024; OKOCHI T, 1979, CANCER RES, V39, P1829; Ooe A, 2007, BREAST CANCER RES TR, V101, P305, DOI 10.1007/s10549-006-9293-x; Papapetropoulos S, 2006, GENE EXPRESSION, V13, P205, DOI 10.3727/000000006783991827; Pils D, 2010, GYNECOL ONCOL, V117, P189, DOI 10.1016/j.ygyno.2009.12.034; Samah NA, 2011, IIUM ENG J, V12, P213; Schulte Janin, 2011, BMC Med, V9, P137, DOI 10.1186/1741-7015-9-137; Sengupta D, 2014, BRIT J CANCER, V110, P2144, DOI 10.1038/bjc.2014.53; Shinojima T, 2012, EPIGENETICS-US, V7, P1279, DOI 10.4161/epi.22333; Spraggs CF, 2011, J CLIN ONCOL, V29, P667, DOI 10.1200/JCO.2010.31.3197; Stefanska B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068439; Sugiura T, 2007, CANCER BIOL THER, V6, P957, DOI 10.4161/cbt.6.6.4192; Suh KS, 2005, J INVEST DERM SYMP P, V10, P105, DOI 10.1111/j.1087-0024.2005.200402.x; Sun LG, 2014, CANCER GENET-NY, V207, P291, DOI 10.1016/j.cancergen.2014.07.003; TATA DB, 1993, ULTRASONICS, V31, P447, DOI 10.1016/0041-624X(93)90054-4; Tibshirani R, 2011, J R STAT SOC B, V73, P273, DOI 10.1111/j.1467-9868.2011.00771.x; Ummanni R, 2012, J PROTEOME RES, V11, P2452, DOI 10.1021/pr201172n; Velusamy T, 2013, P NATL ACAD SCI USA, V110, P3035, DOI 10.1073/pnas.1214326110; Wang SJ, 2011, ANN APPL STAT, V5, P468, DOI 10.1214/10-AOAS377; Wu GJ, 2006, CANCER RES, V66, P9829, DOI 10.1158/0008-5472.CAN-06-0506; Jiao Y, 2007, ACTA PHARMACOL SIN, V28, P1628, DOI 10.1111/j.1745-7254.2007.00647.x; Yao Q, 2009, ONCOL REP, V22, P541, DOI 10.3892/or_00000469; Yokomizo K, 2012, ANTICANCER RES, V32, P1319; Yun HM, 2014, FREE RADICAL BIO MED, V69, P367, DOI 10.1016/j.freeradbiomed.2014.02.001; Zhang J, 2011, MED ONCOL, V28, P494, DOI 10.1007/s12032-010-9489-0; Zhao Y, 2013, INT J MOL SCI, V14, P19670, DOI 10.3390/ijms141019670; Zhiying X, 2013, CENT EUR J IMMUNOL, V38, P416, DOI [10.5114/ceji.2013.39755, DOI 10.5114/CEJI.2013.39755]; Zhu R, 2013, ONCOL REP, V30, P2137, DOI 10.3892/or.2013.2697; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x; Zou H, 2009, ANN STAT, V37, P1733, DOI 10.1214/08-AOS625	74	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141869	10.1371/journal.pone.0141869	http://dx.doi.org/10.1371/journal.pone.0141869			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544691	gold, Green Published, Green Submitted			2022-12-27	WOS:000364398700056
J	Pokrzywa, M; Norum, M; Lengqvist, J; Ghobadpour, M; Abdul-Hussein, S; Moslemi, AR; Tajsharghi, H				Pokrzywa, Malgorzata; Norum, Michaela; Lengqvist, Johan; Ghobadpour, Mehrnaz; Abdul-Hussein, Saba; Moslemi, Ali-Reza; Tajsharghi, Homa			Developmental MYH3 Myopathy Associated with Expression of Mutant Protein and Reduced Expression Levels of Embryonic MyHC	PLOS ONE			English	Article							MYOSIN HEAVY-CHAIN; SKELETAL-MUSCLE; IIB-MYOSIN; IN-VIVO; GENE; MUTATIONS; HYPERTROPHY; ATROPHY; MOUSE; RING	Objective An essential role for embryonic MyHC in foetal development has been found from its association with distal arthrogryposis syndromes, a heterogeneous group of disorders characterised by congenital contractions. The latter probably result from severe myopathy during foetal development. Lack of embryonic muscle biopsy material and suitable animal models has hindered study of the pathomechanisms linking mutations in MYH3 to prenatal myopathy. Methods and Results We determined the pathomechanisms of developmental myopathy caused by recurrent p. Thr178Ile MYH3 heterozygosity, using patient-derived skeletal muscle cells in culture as an experimental disease model to emulate early embryonic development. These cultured cells were processed for discrimination and quantitative analysis of mutant and wild-type MYH3 alleles and MyHC transcripts, real-time RT-qPCR, sequence analysis, immunofluorescence microscopy, immunoblot, and proteomic assessments. Involvement of the ubiquitin proteasome system was investigated in patients with p. Thr178Ile mutations in MYH3 and MYH2. We found equal overall expression of mutant and wild-type MyHC mRNAs and proteins. Compared to the controls, however, expression of embryonic MyHC transcripts and proteins was reduced whereas expression of myosin-specific E3 ubiquitin ligase (MuRF1) was increased. We also found delayed myofibrillogenesis and atrophic myotubes but structured sarcomeres. Conclusion In conclusion, this study suggests that developmental p.Thr178Ile MYH3 myopathy is associated with a combined pathomechanism of insufficient dosage of functional embryonic MyHC and production of mutant protein.	[Pokrzywa, Malgorzata; Norum, Michaela; Ghobadpour, Mehrnaz; Tajsharghi, Homa] Univ Gothenburg, Dept Clin & Med Genet, Gothenburg, Sweden; [Lengqvist, Johan] Univ Gothenburg, Sahlgrenska Acad, Prote Core Facil, Gothenburg, Sweden; [Abdul-Hussein, Saba; Moslemi, Ali-Reza; Tajsharghi, Homa] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Pathol, Gothenburg, Sweden; [Tajsharghi, Homa] Univ Skovde, Sch Biomed, Syst Biol Res Ctr, Skovde, Sweden	University of Gothenburg; University of Gothenburg; University of Gothenburg; University of Skovde	Tajsharghi, H (corresponding author), Univ Gothenburg, Dept Clin & Med Genet, Gothenburg, Sweden.	homa.tajsharghi@gu.se	Pokrzywa, Małgorzata/GQA-6257-2022		Swedish Research Council; Swedish Society of Medicine; Ake Wiberg Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Society of Medicine; Ake Wiberg Foundation	This study was supported by research grants to HT from the Swedish Research Council, the Swedish Society of Medicine, and the Ake Wiberg Foundation. The funding bodies had no role in the design of the study, in data collection and analysis, in the decision to publish or in preparation of the manuscript.	Abdul-Hussein S, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-262; AcakpoSatchivi LJR, 1997, J CELL BIOL, V139, P1219, DOI 10.1083/jcb.139.5.1219; Allen DL, 2000, MICROSC RES TECHNIQ, V50, P492, DOI 10.1002/1097-0029(20000915)50:6<492::AID-JEMT6>3.3.CO;2-A; Allen DL, 2001, AM J PHYSIOL-CELL PH, V280, pC637, DOI 10.1152/ajpcell.2001.280.3.C637; Allen DL, 2001, DEV BIOL, V229, P383, DOI 10.1006/dbio.2000.9974; Alvarado DM, 2011, J BONE JOINT SURG AM, V93A, P1045, DOI 10.2106/JBJS.J.02004; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; FEGHALI R, 1989, J CELL BIOL, V108, P1791, DOI 10.1083/jcb.108.5.1791; Freemont PS, 2000, CURR BIOL, V10, pR84, DOI 10.1016/S0960-9822(00)00287-6; Glass D, 2010, ANN NY ACAD SCI, V1211, P25, DOI 10.1111/j.1749-6632.2010.05809.x; Glass DJ, 2003, NAT CELL BIOL, V5, P87, DOI 10.1038/ncb0203-87; KARSCHMIZRACHI I, 1989, NUCLEIC ACIDS RES, V17, P6167, DOI 10.1093/nar/17.15.6167; Mearini G, 2010, CARDIOVASC RES, V85, P357, DOI 10.1093/cvr/cvp348; Moslemi AR, 2010, NEW ENGL J MED, V362, P1203, DOI 10.1056/NEJMoa0900661; Oldfors A, 2012, ACTA NEUROPATHOLOGIC; Ruppel KM, 1996, MOL BIOL CELL, V7, P1123, DOI 10.1091/mbc.7.7.1123; Sartorius CA, 1998, J CELL BIOL, V141, P943, DOI 10.1083/jcb.141.4.943; Schiaffino S, 2010, ACTA PHYSIOL, V199, P451, DOI 10.1111/j.1748-1716.2010.02130.x; SCHIAFFINO S, 1994, J APPL PHYSIOL, V77, P493, DOI 10.1152/jappl.1994.77.2.493; Schiaffino S, 1996, PHYSIOL REV, V76, P371, DOI 10.1152/physrev.1996.76.2.371; SMERDU V, 1994, AM J PHYSIOL-CELL PH, V267, pC1723, DOI 10.1152/ajpcell.1994.267.6.C1723; Tajsharghi H, 2008, ARCH NEUROL-CHICAGO, V65, P1083, DOI 10.1001/archneur.65.8.1083; Tajsharghi H, 2014, EUR J HUM GENET, V22, P801, DOI 10.1038/ejhg.2013.250; Tajsharghi H, 2010, BRAIN, V133, P1451, DOI 10.1093/brain/awq083; Toydemir RM, 2006, NAT GENET, V38, P561, DOI 10.1038/ng1775; Weiss A, 1996, ANNU REV CELL DEV BI, V12, P417, DOI 10.1146/annurev.cellbio.12.1.417; Weiss A, 1999, P NATL ACAD SCI USA, V96, P2958, DOI 10.1073/pnas.96.6.2958; Willis MS, 2007, CIRC RES, V100, P456, DOI 10.1161/01.RES.0000259559.48597.32; Willis MS, 2009, AM J PHYSIOL-HEART C, V296, pH997, DOI 10.1152/ajpheart.00660.2008	29	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142094	10.1371/journal.pone.0142094	http://dx.doi.org/10.1371/journal.pone.0142094			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544689	Green Submitted, Green Published, gold			2022-12-27	WOS:000364398700080
J	Wiley, JA; Martin, JL; Herschkorn, SJ; Bond, J				Wiley, James A.; Martin, John Levi; Herschkorn, Stephen J.; Bond, Jason			A New Extension of the Binomial Error Model for Responses to Items of Varying Difficulty in Educational Testing and Attitude Surveys	PLoS One			English	Article							BAYESIAN INFORMATION CRITERION; LATENT TRAIT MODELS; MENTAL TEST-SCORES; GRADED RESPONSES; THEORETICAL DISTRIBUTION; FUNCTION MINIMIZATION; POLYTOMOUS RESPONSES; NONDICHOTOMIZATION; ADOLESCENCE; PRECISION	We put forward a new item response model which is an extension of the binomial error model first introduced by Keats and Lord. Like the binomial error model, the basic latent variable can be interpreted as a probability of responding in a certain way to an arbitrarily specified item. For a set of dichotomous items, this model gives predictions that are similar to other single parameter IRT models (such as the Rasch model) but has certain advantages in more complex cases. The first is that in specifying a flexible two-parameter Beta distribution for the latent variable, it is easy to formulate models for randomized experiments in which there is no reason to believe that either the latent variable or its distribution vary over randomly composed experimental groups. Second, the elementary response function is such that extensions to more complex cases (e. g., polychotomous responses, unfolding scales) are straightforward. Third, the probability metric of the latent trait allows tractable extensions to cover a wide variety of stochastic response processes.	[Wiley, James A.] Univ Calif San Francisco, Sch Med, Dept Family & Community Med, San Francisco, CA USA; [Wiley, James A.] Univ Calif San Francisco, Sch Med, Inst Hlth Policy Studies, San Francisco, CA 94143 USA; [Martin, John Levi] Univ Chicago, Dept Sociol, Chicago, IL 60637 USA; [Herschkorn, Stephen J.] CUNY Coll Staten Isl, Dept Math, New York, NY USA; [Bond, Jason] Alcohol Res Grp, Emeryville, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Chicago; City University of New York (CUNY) System; College of Staten Island (CUNY); Alcohol Research Group	Martin, JL (corresponding author), Univ Chicago, Dept Sociol, Chicago, IL 60637 USA.	jlmartin@uchicago.edu			NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA005595] Funding Source: NIH RePORTER; NIAAA NIH HHS [P50 AA005595] Funding Source: Medline	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		ANDRICH D, 1995, PSYCHOMETRIKA, V60, P37, DOI 10.1007/BF02294428; ANDRICH D, 1995, PSYCHOMETRIKA, V60, P7, DOI 10.1007/BF02294426; ANDRICH D, 1995, APPL PSYCH MEAS, V19, P101, DOI 10.1177/014662169501900111; Andrich D, 1996, BRIT J MATH STAT PSY, V49, P347, DOI 10.1111/j.2044-8317.1996.tb01093.x; ANDRICH D, 1993, APPL PSYCH MEAS, V17, P253, DOI 10.1177/014662169301700307; Bock RD, 1975, MULTIVARIATE STAT ME; Browning CR, 2005, AM SOCIOL REV, V70, P758, DOI 10.1177/000312240507000502; Brualdi R.A., 1977, INTRO COMBINATORICS; Coleman J. S., 1964, INTRO MATH SOCIOLOGY; Cox DR., 1970, ANAL BINARY DATA; Duncan OD, 1984, SURVEYING SUBJECTIVE, VIl, P367; EDWARDS AL, 1952, PSYCHOMETRIKA, V17, P169; FLETCHER R, 1964, COMPUT J, V7, P149, DOI 10.1093/comjnl/7.2.149; Greenfield TK, 2006, ALCOHOL CLIN EXP RES, V30, P1576, DOI 10.1111/j.1530-0277.2006.00189.x; Hagan J, 2001, AM SOCIOL REV, V66, P874, DOI 10.2307/3088877; HOUT M, 1987, AM SOCIOL REV, V52, P325, DOI 10.2307/2095353; HUYNH H, 1990, J EDUC STAT, V15, P39; JANSEN PGW, 1986, PSYCHOMETRIKA, V51, P69, DOI 10.1007/BF02294001; KEATS JA, 1962, PSYCHOMETRIKA, V27, P59, DOI 10.1007/BF02289665; KEATS JA, 1964, PSYCHOMETRIKA, V29, P215, DOI 10.1007/BF02289719; KELDERMAN H, 1989, PSYCHOMETRIKA, V54, P681, DOI 10.1007/BF02296403; KELDERMAN H, 1984, PSYCHOMETRIKA, V49, P223, DOI 10.1007/BF02294174; Lazarsfeld PF, 1966, READINGS MATH SOCIAL, V78-88; Lord RM, 1968, STAT THEORIES MENTAL; Luo GZ, 1998, J MATH PSYCHOL, V42, P400, DOI 10.1006/jmps.1998.1206; Luo GZ, 2001, J MATH PSYCHOL, V45, P224, DOI 10.1006/jmps.2000.1310; MacIntosh R, 1998, AM SOCIOL REV, V63, P452, DOI 10.2307/2657558; Maddala G.S., 1983, LTD DEPENDENT QUALIT, V3; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; OEGEMA D, 1994, AM SOCIOL REV, V59, P703, DOI 10.2307/2096444; POLAK E, 1969, REV FR INFORM RECH O, V3, P35; Raftery A, 1985, J ROYAL STAT SOC B, V48, P249; Raftery AE, 1999, SOCIOL METHOD RES, V27, P411, DOI 10.1177/0049124199027003005; Rasch G., 1960, PROBABILISTIC MODELS; Rasch G., 1966, READINGS MATH SOCIAL, P89; ROSKAM EE, 1995, PSYCHOMETRIKA, V60, P27, DOI 10.1007/BF02294427; Sniderman P, 1994, CODEBOOK 1994 SURVEY; Stouffer S. A., 1950, MEASUREMENT PREDICTI; THISSEN D, 1986, PSYCHOMETRIKA, V51, P567, DOI 10.1007/BF02295596; Wald A., 1950, STAT INFERENCE DYNAM, P305; Weakliem DL, 1999, SOCIOL METHOD RES, V27, P359, DOI 10.1177/0049124199027003002; Wilcox R. R., 1981, J ED STAT, V6, P3	43	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141981	10.1371/journal.pone.0141981	http://dx.doi.org/10.1371/journal.pone.0141981			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV6RT	26544974	Green Published, gold			2022-12-27	WOS:000364398700066
J	Wu, D; Kendrick, KM; Levitin, DJ; Li, CY; Yao, DZ				Wu, Dan; Kendrick, Keith M.; Levitin, Daniel J.; Li, Chaoyi; Yao, Dezhong			Bach Is the Father of Harmony: Revealed by a 1/f Fluctuation Analysis across Musical Genres	PLoS One			English	Article							BRAIN; SCALE; PREFERENCE; CONSONANCE; CLASSIFICATION; PERSPECTIVE; EVOLUTION; TOPOLOGY; GEOMETRY; EMOTION	Harmony is a fundamental attribute of music. Close connections exist between music and mathematics since both pursue harmony and unity. In music, the consonance of notes played simultaneously partly determines our perception of harmony; associates with aesthetic responses; and influences the emotion expression. The consonance could be considered as a window to understand and analyze harmony. Here for the first time we used a 1/f fluctuation analysis to investigate whether the consonance fluctuation structure in music with a wide range of composers and genres followed the scale free pattern that has been found for pitch, melody, rhythm, human body movements, brain activity, natural images and geographical features. We then used a network graph approach to investigate which composers were the most influential both within and across genres. Our results showed that patterns of consonance in music did follow scale-free characteristics, suggesting that this feature is a universally evolved one in both music and the living world. Furthermore, our network analysis revealed that Bach's harmony patterns were having the most influence on those used by other composers, followed closely by Mozart.	[Wu, Dan] Beijing Jiaotong Univ, Dept Biomed Engn, Sch Comp & Informat Technol, Beijing, Peoples R China; [Wu, Dan; Kendrick, Keith M.; Li, Chaoyi; Yao, Dezhong] Univ Elect Sci & Technol China, Key Lab NeuroInformat, Sch Life Sci & Technol, Minist Educ, Chengdu 610054, Peoples R China; [Levitin, Daniel J.] McGill Univ, Dept Psychol, Montreal, PQ, Canada; [Li, Chaoyi] Chinese Acad Sci, Ctr Life Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China	Beijing Jiaotong University; University of Electronic Science & Technology of China; McGill University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Yao, DZ (corresponding author), Univ Elect Sci & Technol China, Key Lab NeuroInformat, Sch Life Sci & Technol, Minist Educ, Chengdu 610054, Peoples R China.	dyao@uestc.edu.cn			National Natural Science Foundation of China [81201159, 91232725, 81330032]; China Postdoctoral Science Foundation [2014M550607]; Fundamental Research Funds for the Central Universities [2015JBM038]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	Funding was provided by National Natural Science Foundation of China, 81201159, http://www.nsfc.gov.cn/ to DW; China Postdoctoral Science Foundation, 2014M550607, http://jj.chinapostdoctor.org.cn/, to DW; Fundamental Research Funds for the Central Universities, 2015JBM038, to DW; National Natural Science Foundation of China, 91232725, 81330032, http://www.nsfc.gov.cn/ to DY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anglade A, 2010, J NEW MUSIC RES, V39, P349, DOI 10.1080/09298215.2010.525654; Bones O, 2014, NEUROPSYCHOLOGIA, V58, P23, DOI 10.1016/j.neuropsychologia.2014.03.011; Brothers HJ, 2009, FRACTALS, V17, P537, DOI 10.1142/S0218348X09004521; Burgoyne John Ashley, 2013, Mathematics and Computation in Music. 4th International Conference, MCM 2013. Proceedings: LNCS 7937, P52, DOI 10.1007/978-3-642-39357-0_4; Cano P, 2006, CHAOS, V16, DOI 10.1063/1.2137622; Das A, 2010, NONLINEAR ANAL-REAL, V11, P1790, DOI 10.1016/j.nonrwa.2009.04.004; Fitch WT, 2005, ANN NY ACAD SCI, V1060, P29, DOI 10.1196/annals.1360.004; Garcia-Lazaro JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022584; Good BH, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.046106; Hall RW, 2008, SCIENCE, V320, P328, DOI 10.1126/science.1155463; He BYJ, 2011, J NEUROSCI, V31, P13786, DOI 10.1523/JNEUROSCI.2111-11.2011; He BYJ, 2010, NEURON, V66, P353, DOI 10.1016/j.neuron.2010.04.020; Hedges T, 2014, J NEW MUSIC RES, V43, P276, DOI 10.1080/09298215.2014.925477; Helmholtz Hermann L. F., 2009, SENSATIONS TONE PHYS; Hennig H, 2014, P NATL ACAD SCI USA, V111, P12974, DOI 10.1073/pnas.1324142111; Hennig H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026457; HSU KJ, 1990, P NATL ACAD SCI USA, V87, P938, DOI 10.1073/pnas.87.3.938; HSU KJ, 1991, P NATL ACAD SCI USA, V88, P3507, DOI 10.1073/pnas.88.8.3507; Huron D., HUMDRUM KERN DATABAS; Kennedy M, OXFORD DICT MUSIC; Kepler Johannes, 1619, HARMONY WORLD; Kirkpatrick Ralph., 1953, DOMENICO SCARLATTI; Koelsch S, 2010, TRENDS COGN SCI, V14, P131, DOI 10.1016/j.tics.2010.01.002; Komeilipoor N, 2015, EXP BRAIN RES, V233, P1585, DOI 10.1007/s00221-015-4233-9; Kroll Mark, 2007, JN HUMMEL MUSICIANS; Krumhansl C.L., 1990, COGNITIVE FDN MUSICA, P77; Krummacher F, 1999, J BRAHMS QUELLEN TEX; Landon HCR., 1791, MOZARTS LAST YEAR; Lee JM, 2002, COMPUT BIOL MED, V32, P37, DOI 10.1016/S0010-4825(01)00031-2; Leicht EA, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.118703; Levitin D, 2011, THIS IS YOUR BRAIN M; Levitin DJ, 2012, P NATL ACAD SCI USA, V109, P3716, DOI 10.1073/pnas.1113828109; Levitin DJ, 2010, NATURE, V464, P834, DOI 10.1038/464834a; Liu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058710; Lu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049773; MacCallum RM, 2012, P NATL ACAD SCI USA, V109, P12081, DOI 10.1073/pnas.1203182109; Manaris B, 2005, COMPUT MUSIC J, V29, P55, DOI 10.1162/comj.2005.29.1.55; Mandelbrot B, 1983, FRACTAL GEOMETRY NAT; Masataka N, 2013, SCI REP-UK, V3, DOI 10.1038/srep02028; McDermott JH, 2010, CURR BIOL, V20, P1035, DOI 10.1016/j.cub.2010.04.019; Park JY, 2011, NEUROSCI LETT, V488, P101, DOI 10.1016/j.neulet.2010.11.011; Peretz I, 2006, COGNITION, V100, P1, DOI 10.1016/j.cognition.2005.11.004; Plantinga J, 2014, J EXP PSYCHOL HUMAN, V40, P40, DOI 10.1037/a0033471; Rankin SK, 2014, J ACOUST SOC AM, V136, pEL256, DOI 10.1121/1.4890198; Rodriguez FA, 2010, J NEUROSCI, V30, P15969, DOI 10.1523/JNEUROSCI.0966-10.2010; Ruiz MH, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01030; Schedl M, 2006, ASSIGNING VISUALIZIN, P260; Schoenberg Arnold, 1983, THEORY HARMONY; Sethares WA, 2014, J MATH MUSIC, V8, P73, DOI 10.1080/17459737.2013.850597; Sievers B, 2013, P NATL ACAD SCI USA, V110, P70, DOI 10.1073/pnas.1209023110; Smith RD, 2006, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2006/02/P02006; Sposobin I., 2000, HARMONY TXB; Steinbeis N, 2006, J COGNITIVE NEUROSCI, V18, P1380, DOI 10.1162/jocn.2006.18.8.1380; Teitelbaum T, 2008, CHAOS, V18, DOI 10.1063/1.2988285; Tramo MJ, 2001, ANN NY ACAD SCI, V930, P92, DOI 10.1111/j.1749-6632.2001.tb05727.x; Tymoczko D, 2006, SCIENCE, V313, P72, DOI 10.1126/science.1126287; VOSS RF, 1975, NATURE, V258, P317, DOI 10.1038/258317a0; Wan XG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112776; Wolff C., 1991, ESSAYS HIS LIFE MUSI; Wu D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005915; Yang B, 2010, SIGNAL PROCESS, V90, P1415, DOI 10.1016/j.sigpro.2009.09.009; Zentner Marcel, 2010, HDB MUSIC EMOTION TH, P187	62	12	12	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142431	10.1371/journal.pone.0142431	http://dx.doi.org/10.1371/journal.pone.0142431			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV6RT	26545104	gold, Green Published, Green Submitted			2022-12-27	WOS:000364398700139
J	Mageean, CJ; Griffiths, JR; Smith, DL; Clague, MJ; Prior, IA				Mageean, Craig J.; Griffiths, John R.; Smith, Duncan L.; Clague, Michael J.; Prior, Ian A.			Absolute Quantification of Endogenous Ras Isoform Abundance	PLOS ONE			English	Article							ALLELE-SPECIFIC IMBALANCE; COLORECTAL-CANCER; HIGH-SENSITIVITY; MUTANT PROTEINS; PLASMA-MEMBRANE; CELLS; LOCALIZATION; REPLACEMENT; ACTIVATION; MUTATIONS	Ras proteins are important signalling hubs situated near the top of networks controlling cell proliferation, differentiation and survival. Three almost identical isoforms, HRAS, KRAS and NRAS, are ubiquitously expressed yet have differing biological and oncogenic properties. In order to help understand the relative biological contributions of each isoform we have optimised a quantitative proteomics method for accurately measuring Ras isoform protein copy number per cell. The use of isotopic protein standards together with selected reaction monitoring for diagnostic peptides is sensitive, robust and suitable for application to sub-milligram quantities of lysates. We find that in a panel of isogenic SW48 colorectal cancer cells, endogenous Ras proteins are highly abundant with >= 260,000 total Ras protein copies per cell and the rank order of isoform abundance is KRAS>NRAS >= HRAS. A subset of oncogenic KRAS mutants exhibit increased total cellular Ras abundance and altered the ratio of mutant versus wild type KRAS protein. These data and methodology are significant because Ras protein copy number is required to parameterise models of signalling networks and informs interpretation of isoform-specific Ras functional data.	[Mageean, Craig J.; Clague, Michael J.; Prior, Ian A.] Univ Liverpool, Inst Translat Med, Div Cellular & Mol Physiol, Liverpool L69 3BX, Merseyside, England; [Griffiths, John R.; Smith, Duncan L.] Univ Manchester, Canc Res UK Manchester Inst, Manchester M20 4BX, Lancs, England	University of Liverpool; Cancer Research UK; University of Manchester	Prior, IA (corresponding author), Univ Liverpool, Inst Translat Med, Div Cellular & Mol Physiol, Liverpool L69 3BX, Merseyside, England.	iprior@liv.ac.uk	Clague, Michael J/A-7199-2008	Clague, Michael J/0000-0003-3355-9479; Prior, Ian/0000-0002-4055-5161	Wellcome Trust [WT089137]; European Union [259015]; Cancer Research UK [22308] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); European Union(European Commission); Cancer Research UK(Cancer Research UK)	This work was supported by funding from the Wellcome Trust (IAP; ref. WT089137) and by European Union Seventh Framework Programme funding (MJC; grant no. 259015 COLTHERES). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Brun V, 2009, J PROTEOMICS, V72, P740, DOI 10.1016/j.jprot.2009.03.007; BUDAY L, 1993, MOL CELL BIOL, V13, P1903, DOI 10.1128/MCB.13.3.1903; Buhrman G, 2007, STRUCTURE, V15, P1618, DOI 10.1016/j.str.2007.10.011; Chiosea SI, 2011, MODERN PATHOL, V24, P1571, DOI 10.1038/modpathol.2011.109; Cox AD, 2011, SMALL GTPASES, V1, P2; Das J, 2009, CELL, V136, P337, DOI 10.1016/j.cell.2008.11.051; Di Nicolantonio F, 2008, P NATL ACAD SCI USA, V105, P20864, DOI 10.1073/pnas.0808757105; Dupuis A, 2008, PROTEOMICS, V8, P4633, DOI 10.1002/pmic.200800326; Feng ZH, 2002, J NATL CANCER I, V94, P1527; FINNEY RE, 1993, SCIENCE, V260, P1524, DOI 10.1126/science.8502998; Halvey PJ, 2012, J PROTEOME RES, V11, P3908, DOI 10.1021/pr300161j; Henis YI, 2009, MOL MEMBR BIOL, V26, P80, DOI 10.1080/09687680802649582; Kulak NA, 2014, NAT METHODS, V11, P319, DOI [10.1038/NMETH.2834, 10.1038/nmeth.2834]; Lampson BL, 2013, CURR BIOL, V23, P70, DOI 10.1016/j.cub.2012.11.031; Laude AJ, 2008, J CELL SCI, V121, P421, DOI 10.1242/jcs.020107; LEON J, 1987, MOL CELL BIOL, V7, P1535, DOI 10.1128/MCB.7.4.1535; Lowenthal MS, 2014, ANAL CHEM, V86, P551, DOI 10.1021/ac4027274; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Markevich N. I., 2004, Systems Biology, V1, P104, DOI 10.1049/sb:20045003; Nagaraj N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.81; Omerovic J, 2008, ONCOGENE, V27, P2754, DOI 10.1038/sj.onc.1210925; Omerovic J, 2007, CELL MOL LIFE SCI, V64, P2575, DOI 10.1007/s00018-007-7133-8; Pershing NLK, 2015, J CLIN INVEST, V125, P222, DOI 10.1172/JCI77627; Plowman SJ, 2006, J EXP CLIN CANC RES, V25, P259; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; Prior IA, 2001, NAT CELL BIOL, V3, P368, DOI 10.1038/35070050; Prior IA, 2012, CANCER RES, V72, P2457, DOI 10.1158/0008-5472.CAN-11-2612; Pritchard C, 2014, ANAL CHEM, V86, P6525, DOI 10.1021/ac501032q; Quinlan MP, 2009, FUTURE ONCOL, V5, P105, DOI 10.2217/14796694.5.1.105; Ruppen-Canas I, 2012, PROTEOMICS, V12, P1319, DOI 10.1002/pmic.201100611; Sarkisian CJ, 2007, NAT CELL BIOL, V9, P493, DOI 10.1038/ncb1567; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; SEEBURG PH, 1984, NATURE, V312, P71, DOI 10.1038/312071a0; Soh J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007464; Stites EC, 2007, SCIENCE, V318, P463, DOI 10.1126/science.1144642; Stites EC, 2010, ADV EXP MED BIOL, V680, P661, DOI 10.1007/978-1-4419-5913-3_73; Tian TH, 2007, NAT CELL BIOL, V9, P905, DOI 10.1038/ncb1615; Tian TH, 2010, BIOPHYS J, V99, P534, DOI 10.1016/j.bpj.2010.04.055; To MD, 2008, NAT GENET, V40, P1240, DOI 10.1038/ng.211; Unwin RD, 2005, MOL CELL PROTEOMICS, V4, P1134, DOI 10.1074/mcp.M500113-MCP200; Valtorta E, 2013, INT J CANCER, V133, P1259, DOI 10.1002/ijc.28106; Wang Q, 2011, P NATL ACAD SCI USA, V108, P2444, DOI 10.1073/pnas.1019203108; Xu J, 2013, CANCER DISCOV, V3, P993, DOI 10.1158/2159-8290.CD-13-0096; Zhou Y, 2015, BBA-MOL CELL RES, V1853, P841, DOI 10.1016/j.bbamcr.2014.09.008	44	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142674	10.1371/journal.pone.0142674	http://dx.doi.org/10.1371/journal.pone.0142674			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26560143	gold, Green Published, Green Submitted			2022-12-27	WOS:000364433100110
J	Ulbrich, EJ; Fischer, MA; Manoliu, A; Marcon, M; Luechinger, R; Nanz, D; Reiner, CS				Ulbrich, Erika J.; Fischer, Michael A.; Manoliu, Andrei; Marcon, Magda; Luechinger, Roger; Nanz, Daniel; Reiner, Caecilia S.			Age- and Gender Dependent Liver Fat Content in a Healthy Normal BMI Population as Quantified by Fat-Water Separating DIXON MR Imaging	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; HEPATIC STEATOSIS; GRADIENT-ECHO; DISEASE; ACCURACY; PHASE; IDEAL; PREVALENCE; EXPERIENCE; BIOPSY	Objectives To establish age- and sex-dependent values of magnetic resonance (MR) liver fat-signal fraction (FSF) in healthy volunteers with normal body-mass index (BMI). Methods 2-point mDIXON sequences (repetition time/echo time, 4.2msec/1.2msec, 3.1msec) at 3.0 Tesla MR were acquired in 80 healthy volunteers with normal BMI (18.2 to 25.7 kg/m2) between 20 and 62 years (10 men/10 women per decade). FSF was measured in 5 liver segments (segment II, III, VI, VII, VIII) based on mean signal intensities in regions of interest placed on mDIXON-based water and fat images. Multivariate general linear models were used to test for significant differences between BMI-corrected FSF among age subgroups. Pearson and Spearman correlations between FSF and several body measures were calculated. Results Mean FSF (%) +/- standard deviations significantly differed between women (3.91 +/- 1.10) and men (4.69 +/- 1.38) and varied with age for women/men (p-value: 0.002/0.027): 3.05 +/- 0.49/3.74 +/- 0.60 (age group 20-29), 3.75 +/- 0.66/4.99 +/- 1.30 (30-39), 4.76 +/- 1.16/5.25 +/- 1.97 (40-49) and 4.09 +/- 1.26/4.79 +/- 0.93 (50-62). FSF differences among age subgroups were significant for women only (p = 0.003). Conclusions MR-based liver fat content is higher in men and peaks in the fifth decade for both genders.	[Ulbrich, Erika J.; Fischer, Michael A.; Manoliu, Andrei; Marcon, Magda; Nanz, Daniel; Reiner, Caecilia S.] Univ Zurich Hosp, Inst Diagnost & Intervent Radiol, CH-8091 Zurich, Switzerland; [Luechinger, Roger] Univ Zurich, Inst Biomed Engn, Zurich, Switzerland; [Luechinger, Roger] Swiss Fed Inst Technol, Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Ulbrich, EJ (corresponding author), Univ Zurich Hosp, Inst Diagnost & Intervent Radiol, CH-8091 Zurich, Switzerland.	erika.ulbrich@usz.ch	Manoliu, Andrei/AAN-1761-2021; Luechinger, Roger/AAD-5192-2019	Luechinger, Roger/0000-0002-7365-0421; Nanz, Daniel/0000-0003-4128-5201	University Zurich Research Program "Research Time for clinical research at the Medical Faculty of University Zurich" [RT-13-014]	University Zurich Research Program "Research Time for clinical research at the Medical Faculty of University Zurich"	This project is supported by the University Zurich Research Program "Research Time for clinical research at the Medical Faculty of University Zurich" (Grant number: RT-13-014) to EJU. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabousi A, 2011, J MAGN RESON IMAGING, V34, P474, DOI 10.1002/jmri.22603; Baffy G, 2012, J HEPATOL, V56, P1384, DOI 10.1016/j.jhep.2011.10.027; Bellentani S, 2004, EUR J GASTROEN HEPAT, V16, P1087, DOI 10.1097/00042737-200411000-00002; Borra RJH, 2009, RADIOLOGY, V250, P130, DOI 10.1148/radiol.2501071934; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; BUXTON RB, 1986, MAGNET RESON MED, V3, P881, DOI 10.1002/mrm.1910030609; Bydder M, 2008, MAGN RESON IMAGING, V26, P347, DOI 10.1016/j.mri.2007.08.012; Caldwell SH, 2004, J HEPATOL, V40, P578, DOI 10.1016/j.jhep.2004.02.013; Cassidy FH, 2009, RADIOGRAPHICS, V29, P231, DOI 10.1148/rg.291075123; Clavien P, 2007, NEW ENGL J MED, V356, P1545, DOI 10.1056/NEJMra065156; Conjeevaram HS, 2007, HEPATOLOGY, V45, P80, DOI 10.1002/hep.21455; Cotler SJ, 2007, J MAGN RESON IMAGING, V25, P743, DOI 10.1002/jmri.20865; Cowin GJ, 2008, J MAGN RESON IMAGING, V28, P937, DOI 10.1002/jmri.21542; d'Assignies G, 2009, EUR RADIOL, V19, P2033, DOI 10.1007/s00330-009-1351-4; Dixon JB, 2001, GASTROENTEROLOGY, V121, P91, DOI 10.1053/gast.2001.25540; Fischer MA, 2013, EUR RADIOL, V23, P408, DOI 10.1007/s00330-012-2614-z; Fischer MA, 2012, ACAD RADIOL, V19, P1208, DOI 10.1016/j.acra.2012.05.009; Fischer MA, 2010, INVEST RADIOL, V45, P465, DOI 10.1097/RLI.0b013e3181da1343; Gallagher D, 2000, AM J CLIN NUTR, V72, P694, DOI 10.1093/ajcn/72.3.694; Gan Lay, 2011, Curr Gerontol Geriatr Res, V2011, P831536, DOI 10.1155/2011/831536; Hall AR, 2013, LIVER INT, V33, P926, DOI 10.1111/liv.12162; Hamilton G, 2011, NMR BIOMED, V24, P784, DOI 10.1002/nbm.1622; Hines CDG, 2011, J MAGN RESON IMAGING, V33, P873, DOI 10.1002/jmri.22514; Hines CDG, 2010, RADIOLOGY, V254, P119, DOI [10.1148/radiol.09090131, 10.1148/radiol.2531090131]; Hussain HK, 2005, RADIOLOGY, V237, P1048, DOI 10.1148/radiol.2373041639; Kim H, 2008, MAGN RESON MED, V59, P521, DOI 10.1002/mrm.21561; Kundel HL, 2003, RADIOLOGY, V228, P303, DOI 10.1148/radiol.2282011860; Liu CY, 2007, MAGN RESON MED, V58, P354, DOI 10.1002/mrm.21301; LONGO R, 1995, JMRI-J MAGN RESON IM, V5, P281, DOI 10.1002/jmri.1880050311; Ma JF, 2008, J MAGN RESON IMAGING, V28, P543, DOI 10.1002/jmri.21492; Machann J, 2006, MAGN RESON MED, V55, P913, DOI 10.1002/mrm.20825; Mennesson N, 2009, J COMPUT ASSIST TOMO, V33, P672, DOI 10.1097/RCT.0b013e318199d883; Qayyum A, 2005, RADIOLOGY, V237, P507, DOI 10.1148/radiol.2372040539; Raptis DA, 2012, GUT, V61, P117, DOI 10.1136/gutjnl-2011-300155; Reeder SB, 2009, J MAGN RESON IMAGING, V29, P1332, DOI 10.1002/jmri.21751; Shin HJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117480; Stefan N, 2008, ENDOCR REV, V29, P939, DOI 10.1210/er.2008-0009; Szczepaniak LS, 2005, AM J PHYSIOL-ENDOC M, V288, pE462, DOI 10.1152/ajpendo.00064.2004; Tannapfel A, 2010, PATHOLOGE, V31, P225, DOI 10.1007/s00292-010-1274-5; THOMSEN C, 1994, MAGN RESON IMAGING, V12, P487, DOI 10.1016/0730-725X(94)92543-7; Westphalen ACA, 2007, RADIOLOGY, V242, P450, DOI 10.1148/radiol.2422052024; World Health Organization, 1997, OB PREV MAN GLOB EP; Yokoo T, 2009, RADIOLOGY, V251, P67, DOI 10.1148/radiol.2511080666; Yu HZ, 2007, J MAGN RESON IMAGING, V26, P1153, DOI 10.1002/jmri.21090	44	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0141691	10.1371/journal.pone.0141691	http://dx.doi.org/10.1371/journal.pone.0141691			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26554709	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000364430700036
J	Xiao, WQ; Jiang, WL; Shen, J; Yin, GJ; Fan, YT; Wu, DQ; Qiu, L; Yu, G; Xing, M; Hu, GY; Wang, XP; Wan, R				Xiao, Wenqin; Jiang, Weiliang; Shen, Jie; Yin, Guojian; Fan, Yuting; Wu, Deqing; Qiu, Lei; Yu, Ge; Xing, Miao; Hu, Guoyong; Wang, Xingpeng; Wan, Rong			Retinoic Acid Ameliorates Pancreatic Fibrosis and Inhibits the Activation of Pancreatic Stellate Cells in Mice with Experimental Chronic Pancreatitis via Suppressing the Wnt/beta-Catenin Signaling Pathway	PLOS ONE			English	Article							LIVER FIBROSIS; GENE-EXPRESSION; DUCTAL ADENOCARCINOMA; PULMONARY-FIBROSIS; BETA-CATENIN/TCF; BINDING-PROTEIN; DOWN-REGULATION; STEM-CELLS; IN-VITRO; WNT	Pancreatic fibrosis, a prominent feature of chronic pancreatitis (CP), induces persistent and permanent damage in the pancreas. Pancreatic stellate cells (PSCs) provide a major source of extracellular matrix (ECM) deposition during pancreatic injury, and persistent activation of PSCs plays a vital role in the progression of pancreatic fibrosis. Retinoic acid (RA), a retinoid, has a broad range of biological functions, including regulation of cell differentiation and proliferation, attenuating progressive fibrosis of multiple organs. In the present study, we investigated the effects of RA on fibrosis in experimental CP and cultured PSCs. CP was induced in mice by repetitive cerulein injection in vivo, and mouse PSCs were isolated and activated in vitro. Suppression of pancreatic fibrosis upon administration of RA was confirmed based on reduction of histological damage, a-smooth muscle actin (alpha-SMA) expression and mRNA levels of beta-catenin, platelet-derived growth factor (PDGF)-R beta transforming growth factor (TGF)-beta RII and collagen 1 alpha 1 in vivo. Wnt 2 and beta-catenin protein levels were markedly down-regulated, while Axin 2 expression level was up-regulated in the presence of RA, both in vivo and in vitro. Nuclear translation of beta-catenin was significantly decreased following RA treatment, compared with cerulein-induced CP in mice and activated PSCs. Furthermore, RA induced significant PSC apoptosis, inhibited proliferation, suppressed TCF/LEF-dependent transcriptional activity and ECM production of PSC via down-regulation of TGF beta RII, PDGFR beta and collagen 1 alpha 1 in vitro. These results indicate a critical role of the Wnt/beta-catenin signaling pathway in RA-induced effects on CP and PSC regulation and support the potential of RA as a suppressor of pancreatic fibrosis in mice.	[Xiao, Wenqin; Yin, Guojian; Fan, Yuting; Wu, Deqing; Qiu, Lei; Wan, Rong] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Gastroenterol, Shanghai 200092, Peoples R China; [Jiang, Weiliang; Yu, Ge; Xing, Miao; Hu, Guoyong; Wang, Xingpeng; Wan, Rong] Shanghai Jiao Tong Univ, Dept Gastroenterol, Shanghai Peoples Hosp 1, Sch Med, Shanghai 200030, Peoples R China; [Shen, Jie] Shanghai Second Mil Med Univ, Dept Gastroenterol, Shanghai Changzheng Hosp, Shanghai, Peoples R China	Tongji University; Shanghai Jiao Tong University; Naval Medical University	Wan, R (corresponding author), Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Gastroenterol, Shanghai 200092, Peoples R China.	wanrong1970@163.com			National Natural Science Foundation of China [81270543]; Shanghai Science and Technology Committee Foundation [12ZR1423100, XBR2013082]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Committee Foundation(Shanghai Science & Technology Committee)	This study was partly supported by National Natural Science Foundation of China (No. 81270543), and partly supported by Shanghai Science and Technology Committee Foundation (No. 12ZR1423100 and XBR2013082). The funder designed the study and decided to publish the manuscript.	Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Apte MV, 1999, GUT, V44, P534, DOI 10.1136/gut.44.4.534; Apte MV, 2004, DIGEST DIS, V22, P273, DOI 10.1159/000082799; Apte MV, 1998, GUT, V43, P128, DOI 10.1136/gut.43.1.128; Bachem MG, 1998, GASTROENTEROLOGY, V115, P421, DOI 10.1016/S0016-5085(98)70209-4; Cheng JH, 2008, AM J PHYSIOL-GASTR L, V294, pG39, DOI 10.1152/ajpgi.00263.2007; Cheng SL, 2010, CIRC RES, V107, P271, DOI 10.1161/CIRCRESAHA.110.219899; Cisternas P, 2014, CURR MOL MED, V14, P510, DOI 10.2174/1566524014666140414210346; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Detlefsen S, 2006, MODERN PATHOL, V19, P1019, DOI 10.1038/modpathol.3800613; Dey P, 2014, ONCOTARGET, V5, P4480, DOI 10.18632/oncotarget.2041; Erkan M, 2012, CURR MOL MED, V12, P288, DOI 10.2174/156652412799218921; Erkan M, 2012, GUT, V61, P172, DOI 10.1136/gutjnl-2011-301220; Froeling FEM, 2011, GASTROENTEROLOGY, V141, P1486, DOI 10.1053/j.gastro.2011.06.047; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Haber PS, 1999, AM J PATHOL, V155, P1087, DOI 10.1016/S0002-9440(10)65211-X; He H, 2011, HEPATOLOGY, V53, P548, DOI 10.1002/hep.24047; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Henderson WR, 2010, P NATL ACAD SCI USA, V107, P14309, DOI 10.1073/pnas.1001520107; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hisamori S, 2008, LIVER INT, V28, P1217, DOI 10.1111/j.1478-3231.2008.01745.x; Hu GY, 2011, GUT, V60, P820, DOI 10.1136/gut.2010.215178; Hu Q, 2009, NEPHROL DIAL TRANSPL, V24, P3033, DOI 10.1093/ndt/gfp245; Hu YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095145; Huang GC, 2000, WORLD J GASTROENTERO, V6, P819, DOI 10.3748/wjg.v6.i6.819; Huang GL, 2013, MOL CELL BIOL, V33, P3416, DOI 10.1128/MCB.00384-13; Jaster R, 2003, BIOCHEM PHARMACOL, V66, P633, DOI 10.1016/S0006-2952(03)00390-3; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Jiang F, 2006, J HEPATOL, V45, P401, DOI 10.1016/j.jhep.2006.03.016; Kim DM, 2013, BIOCHEM BIOPH RES CO, V434, P455, DOI 10.1016/j.bbrc.2013.03.095; Kobayashi H, 2002, GASTROENTEROLOGY, V123, P1331, DOI 10.1053/gast.2002.35949; Lim YC, 2012, EUR J CANCER, V48, P3310, DOI 10.1016/j.ejca.2012.04.013; Liu Y, 2014, INT J BIOCHEM CELL B, V47, P47, DOI 10.1016/j.biocel.2013.11.018; LONGNECKER DS, 1982, AM J PATHOL, V107, P103; LOTAN R, 1980, BIOCHIM BIOPHYS ACTA, V605, P33, DOI 10.1016/0304-419X(80)90021-9; Manolescu DC, 2014, APPL PHYSIOL NUTR ME, V39, P1127, DOI 10.1139/apnm-2014-0005; Masamune A, 2013, PANCREATOLOGY, V13, P102, DOI 10.1016/j.pan.2012.12.058; Masamune A, 2009, CLIN GASTROENTEROL H, V7, pS48, DOI 10.1016/j.cgh.2009.07.038; Masamune A, 2009, J GASTROENTEROL, V44, P249, DOI 10.1007/s00535-009-0013-2; Nagashio Y, 2004, LAB INVEST, V84, P1610, DOI 10.1038/labinvest.3700191; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Neuschwander-Tetri BA, 2000, LAB INVEST, V80, P143, DOI 10.1038/labinvest.3780018; Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470; Okuno M, 1997, HEPATOLOGY, V26, P913, DOI 10.1002/hep.510260417; Okuno M, 2002, FRONT BIOSCI-LANDMRK, V7, pD204, DOI 10.2741/okuno; Omary MB, 2007, J CLIN INVEST, V117, P50, DOI 10.1172/JCI30082; PINZANI M, 1992, J HEPATOL, V14, P211, DOI 10.1016/0168-8278(92)90160-Q; Puig-Divi V, 1999, DIGESTION, V60, P166, DOI 10.1159/000007643; Rennoll SA, 2014, BIOCHEM BIOPH RES CO, V443, P217, DOI 10.1016/j.bbrc.2013.11.089; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; RUSSELL RM, 1974, NEW ENGL J MED, V291, P435, DOI 10.1056/NEJM197408292910903; SATO T, 1995, EXP CELL RES, V217, P72, DOI 10.1006/excr.1995.1065; SOLOMON TE, 1984, AM J PHYSIOL, V247, pG105, DOI 10.1152/ajpgi.1984.247.1.G105; Tabata C, 2006, AM J RESP CRIT CARE, V174, P1352, DOI 10.1164/rccm.200606-862OC; VANLAETHEM JL, 1995, GASTROENTEROLOGY, V108, P1873, DOI 10.1016/0016-5085(95)90152-3; von Toerne C, 2012, AM J TRANSPLANT, V12, P55, DOI 10.1111/j.1600-6143.2011.03776.x; Wang Q, 2008, ONCOGENE, V27, P1527, DOI 10.1038/sj.onc.1210793; Wang Q, 2010, ONCOGENE, V29, P128, DOI 10.1038/onc.2009.302; Wehr AY, 2011, PANCREAS, V40, P557, DOI 10.1097/MPA.0b013e318214efaf; Xi YM, 2014, CANCER LETT, V353, P8, DOI 10.1016/j.canlet.2014.07.010; Yang LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031807; Ye B, 2013, CARDIOVASC PATHOL, V22, P54, DOI 10.1016/j.carpath.2012.03.004; Zhou TB, 2013, INT J MOL SCI, V14, P226, DOI 10.3390/ijms14010226; Zhou TB, 2012, INT J MOL SCI, V13, P2769, DOI 10.3390/ijms13032769	64	32	34	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0141462	10.1371/journal.pone.0141462	http://dx.doi.org/10.1371/journal.pone.0141462			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556479	gold, Green Published, Green Submitted			2022-12-27	WOS:000364430700030
J	Dumont, BL; Devlin, AA; Truempy, DM; Miller, JC; Singh, ND				Dumont, Beth L.; Devlin, Amy A.; Truempy, Dana M.; Miller, Jennifer C.; Singh, Nadia D.			No Evidence that Infection Alters Global Recombination Rate in House Mice	PLoS One			English	Article							CROSSING-OVER; DROSOPHILA-MELANOGASTER; MEIOTIC RECOMBINATION; ANTAGONISTIC COEVOLUTION; CHIASMA FREQUENCY; GENETIC-ANALYSIS; 3RD CHROMOSOME; HUMAN GENOME; RED QUEEN; TEMPERATURE	Recombination rate is a complex trait, with genetic and environmental factors shaping observed patterns of variation. Although recent studies have begun to unravel the genetic basis of recombination rate differences between organisms, less attention has focused on the environmental determinants of crossover rates. Here, we test the effect of one ubiquitous environmental pressure-bacterial infection-on global recombination frequency in mammals. We applied MLH1 mapping to assay global crossover rates in male mice infected with the pathogenic bacterium Borrelia burgdorferi, the causative agent of Lyme Disease, and uninfected control animals. Despite ample statistical power to identify biologically relevant differences between infected and uninfected animals, we find no evidence for a global recombination rate response to bacterial infection. Moreover, broad-scale patterns of crossover distribution, including the number of achiasmate bivalents, are not affected by infection status. Although pathogen exposure can plastically increase recombination in some species, our findings suggest that recombination rates in house mice may be resilient to at least some forms of infection stress. This negative result motivates future experiments with alternative house mouse pathogens to evaluate the generality of this conclusion.	[Dumont, Beth L.] N Carolina State Univ, Initiat Biol Complex, Raleigh, NC 27695 USA; [Dumont, Beth L.; Devlin, Amy A.; Truempy, Dana M.; Miller, Jennifer C.; Singh, Nadia D.] N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Dumont, BL (corresponding author), N Carolina State Univ, Initiat Biol Complex, Raleigh, NC 27695 USA.	bldumont@ncsu.edu; ndsingh@ncsu.edu			North Carolina State University (NCSU); Initiative in Biological Complexity at NCSU; National Institute of General Medical Sciences at the National Institutes of Health [1K99GM110332]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM110332] Funding Source: NIH RePORTER	North Carolina State University (NCSU); Initiative in Biological Complexity at NCSU; National Institute of General Medical Sciences at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding: This work was supported by startup funds provided by North Carolina State University (NCSU) to NDS and JCM. BLD is supported by a distinguished postdoctoral research fellowship with the Initiative in Biological Complexity at NCSU and a K99/R00 Pathway to Independence Award from the National Institute of General Medical Sciences at the National Institutes of Health (1K99GM110332; http://www.nigms.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by North Carolina State University (NCSU) start-up funds to NDS and JCM. BLD is supported by a distinguished postdoctoral research fellowship with the Initiative in Biological Complexity at NCSU and a K99/R00 Pathway to Independence Award from the National Institute of General Medical Sciences (1K99GM110332).	Abdullah MFF, 2001, P NATL ACAD SCI USA, V98, P14524, DOI 10.1073/pnas.201529598; Agrawal AF, 2005, GENETICS, V171, P803, DOI 10.1534/genetics.105.041301; Anderson LK, 1999, GENETICS, V151, P1569; Andronic L, 2012, CAN J PLANT SCI, V92, P1083, DOI [10.4141/CJPS2011-197, 10.4141/cjps2011-197]; Auton A, 2012, SCIENCE, V336, P193, DOI 10.1126/science.1216872; Barthold S.W., 1992, LYME DIS MOL IMMUNOL, P223; BARTHOLD SW, 1990, J INFECT DIS, V162, P133, DOI 10.1093/infdis/162.1.133; BARTHOLD SW, 1991, AM J PATHOL, V139, P263; Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Becker SD, 2007, LAB ANIM-UK, V41, P229, DOI 10.1258/002367707780378203; BELYAEV DK, 1982, BIOL ZBL, V101, P705; Borodin PM, 2008, GENETICS, V178, P621, DOI 10.1534/genetics.107.079665; Brick K, 2012, NATURE, V485, P642, DOI 10.1038/nature11089; Bridges CB, 1927, J GEN PHYSIOL, V8, P689, DOI 10.1085/jgp.8.6.689; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Busch JW, 2004, EVOLUTION, V58, P2584, DOI 10.1111/j.0014-3820.2004.tb00886.x; CHARLESWORTH B, 1985, HEREDITY, V54, P71, DOI 10.1038/hdy.1985.10; Cheng EY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000661; CHINNICI JP, 1971, GENETICS, V69, P85; Chowdhury R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000648; Coop G, 2008, SCIENCE, V319, P1395, DOI 10.1126/science.1151851; Coop G, 2007, NAT REV GENET, V8, P23, DOI 10.1038/nrg1947; DOWRICK G. J., 1957, HEREDITY, V11, P37, DOI 10.1038/hdy.1957.4; Dumont BL, 2008, EVOLUTION, V62, P276, DOI 10.1111/j.1558-5646.2007.00278.x; Dumont BL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002116; Dumont BL, 2011, GENETICS, V187, P643, DOI 10.1534/genetics.110.123851; Dumont BL, 2009, GENETICS, V182, P1345, DOI 10.1534/genetics.109.105114; Fledel-Alon A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020321; Fukuyama H, 2013, P NATL ACAD SCI USA, V110, P10717, DOI 10.1073/pnas.1304380110; HAMILTON WD, 1980, OIKOS, V35, P282, DOI 10.2307/3544435; HAMILTON WD, 1990, P NATL ACAD SCI USA, V87, P3566, DOI 10.1073/pnas.87.9.3566; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Hastey CJ, 2012, J IMMUNOL, V188, P5612, DOI 10.4049/jimmunol.1103735; HENDERSON SA, 1988, HEREDITY, V60, P387, DOI 10.1038/hdy.1988.57; HENDERSON SA, 1968, NATURE, V218, P22, DOI 10.1038/218022a0; HENDERSON SA, 1989, HEREDITY, V62, P77, DOI 10.1038/hdy.1989.10; Holloway JK, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000186; Hussin J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002251; Jaenlke J., 1978, EVOL THEORY, V94, P191; Jokela J, 2009, AM NAT, V174, pS43, DOI 10.1086/599080; Kauppi L, 2011, SCIENCE, V331, P916, DOI 10.1126/science.1195774; KIDWELL MG, 1972, GENETICS, V70, P419; Koehler KE, 2002, GENETICS, V162, P297; Kong A, 2004, NAT GENET, V36, P1203, DOI 10.1038/ng1445; Kong A, 2008, SCIENCE, V319, P1398, DOI 10.1126/science.1152422; Lucht JM, 2002, NAT GENET, V30, P311, DOI 10.1038/ng846; Lynch M, 2007, ORIGINS GENOME ARCHI; Ma Y, 1998, INFECT IMMUN, V66, P161, DOI 10.1128/IAI.66.1.161-168.1998; Miller JC, 2003, INFECT IMMUN, V71, P6943, DOI 10.1128/IAI.71.12.6943-6952.2003; Moro D, 2003, J WILDLIFE DIS, V39, P762, DOI 10.7589/0090-3558-39.4.762; Morran LT, 2011, SCIENCE, V333, P216, DOI 10.1126/science.1206360; Mostowy R, 2012, J EVOLUTION BIOL, V25, P2033, DOI 10.1111/j.1420-9101.2012.02584.x; Murdoch B, 2010, MAMM GENOME, V21, P550, DOI 10.1007/s00335-010-9303-5; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; Neel JV, 1941, GENETICS, V26, P506; PARSONS PA, 1988, BIOL J LINN SOC, V35, P49, DOI 10.1111/j.1095-8312.1988.tb00458.x; Parvanov ED, 2010, SCIENCE, V327, P835, DOI 10.1126/science.1181495; Peters AD, 1999, AM NAT, V154, P393, DOI 10.1086/303247; Peters AHFM, 1997, CHROMOSOME RES, V5, P66, DOI 10.1023/A:1018445520117; Phillips D, 2015, NEW PHYTOL, V208, P421, DOI 10.1111/nph.13548; Plough HH, 1917, J EXP ZOOL, V24, P147, DOI 10.1002/jez.1400240202; Plough HH, 1921, J EXP ZOOL, V32, P187, DOI 10.1002/jez.1400320202; POWELL JERREL B., 1963, CROP SCI, V3, P11, DOI 10.2135/cropsci1963.0011183X000300010005x; R Core Team, 2018, R LANG ENV STAT COMP; Radolf JD, 2012, NAT REV MICROBIOL, V10, P87, DOI 10.1038/nrmicro2714; SAGE RD, 1986, NATURE, V324, P60, DOI 10.1038/324060a0; Sandor C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002854; Schmid-Hempel P, 2002, AM NAT, V160, P403, DOI 10.1086/341517; Singh ND, 2015, SCIENCE, V349, P747, DOI 10.1126/science.aab1768; Smith HF, 1936, NATURE, V138, P329, DOI 10.1038/138329b0; Smukowski CS, 2011, HEREDITY, V107, P496, DOI 10.1038/hdy.2011.44; Song J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004226; Soper DM, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2013.1091; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Stern C, 1926, P NATL ACAD SCI USA, V12, P530, DOI 10.1073/pnas.12.8.530; Stevison LS, 2010, J MOL EVOL, V71, P332, DOI 10.1007/s00239-010-9388-1; Sun F, 2004, AM J HUM GENET, V74, P521, DOI 10.1086/382138; Susiarjo M, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030005; Tedman-Aucoin K, 2012, EVOLUTION, V66, P575, DOI 10.1111/j.1558-5646.2011.01450.x; Thomsen H, 2001, MAMM GENOME, V12, P724, DOI 10.1007/s00335-001-2068-0; Vrooman LA, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004949; Webb AJ, 2008, P NATL ACAD SCI USA, V105, P10471, DOI 10.1073/pnas.0804933105; Winckler W, 2005, SCIENCE, V308, P107, DOI 10.1126/science.1105322; Zuckert WR, 2005, CURR PROT MICROBIOL, V4	85	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2015	10	11							e0142266	10.1371/journal.pone.0142266	http://dx.doi.org/10.1371/journal.pone.0142266			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7AC	26550833	Green Submitted, gold, Green Published			2022-12-27	WOS:000364422800020
J	Javed, A; Leuchte, N; Neumann, B; Sopper, S; Sauermann, U				Javed, Aneela; Leuchte, Nicole; Neumann, Bent; Sopper, Sieghart; Sauermann, Ulrike			Noncytolytic CD8(+) Cell Mediated Antiviral Response Represents a Strong Element in the Immune Response of Simian Immunodeficiency Virus-Infected Long-Term Non-Progressing Rhesus Macaques	PLOS ONE			English	Article							CD8+ T-CELLS; CONTROL HIV-INFECTION; SOLUBLE FACTORS; POPULATION-LEVEL; CLINICAL STATE; IN-VITRO; REPLICATION; SUPPRESSION; LYMPHOCYTES; INHIBITION	The ability of long term non progressors to maintain very low levels of HIV/SIV and a healthy state, involves various host genetic and immunological factors. CD8+ non-cytolytic antiviral response (CNAR) most likely plays an important role in this regard. In order to gain a deeper insight into this unique phenomenon, the ability of CD8+ T cells to suppress viral replication in vitro was investigated in 16 uninfected, longitudinally in 23 SIV-infected long-term non-progressing (LTNPs), and 10 SIV-infected rhesus macaques with progressing disease. An acute infection assay utilizing CD4(+) cells from MHC-mismatched monkeys to avoid cytolytic responses was employed. The study has identified CNAR as a long-term stable activity that inversely correlated with plasma viral load. The activity was also detected in CD8(+) cells of uninfected macaques, which indicates that CNAR is not necessarily a virus specific response but increases after SIV-infection. Physical contact between CD4(+) and CD8(+) cells was mainly involved in mediating viral inhibition. Loss of this activity appeared to be due to a loss of CNAR-expressing CD8+ cells as well as a reduction of CNAR-responsive CD4+ cells. In contrast, in vitro viral replication did not differ in CD4+ cells from un-infected macaques, CNAR(+) and CNAR(-) LTNPs. A role for transitional memory cells in supporting CNAR in the macaque model of AIDS was questionable. CNAR appears to represent an important part of the immune response displayed by CD8+ T cells which might be underestimated up to now.	[Javed, Aneela] Natl Univ Sci & Technol, Atta Ur Rahman Sch Appl Biosci ASAB, Islamabad, Pakistan; [Javed, Aneela; Leuchte, Nicole; Neumann, Bent; Sauermann, Ulrike] Deutsch Primatenzentrum GmbH, Leibniz Inst Primatenforsch, Abt Infekt Modelle, Gottingen, Germany; [Sopper, Sieghart] Med Univ Innsbruck, Tumor Immunol Lab, Hematol & Oncol, A-6020 Innsbruck, Austria; [Sopper, Sieghart] Tyrolean Canc Res Inst, Innsbruck, Austria	National University of Sciences & Technology - Pakistan; Deutsches Primatenzentrum (DPZ); Medical University of Innsbruck	Sauermann, U (corresponding author), Deutsch Primatenzentrum GmbH, Leibniz Inst Primatenforsch, Abt Infekt Modelle, Gottingen, Germany.	usauerm@dpz.eu	javed, Aneela/ABE-8794-2021; Sopper, Sieghart/I-3155-2018	javed, Aneela/0000-0003-0280-0610; Sopper, Sieghart/0000-0003-2265-1974	EU [262443]; Higher Education commission of Pakistan	EU(European Commission); Higher Education commission of Pakistan(Higher Education Commission of Pakistan)	Funding: This work was funded by EU-grant no. 262443. AJ was recipient of a scholarship by Higher Education commission of Pakistan.	Abdelwahab SF, 2003, P NATL ACAD SCI USA, V100, P15006, DOI 10.1073/pnas.2035075100; al Basatena NKS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003656; Allers K, 2011, BLOOD, V117, P2791, DOI 10.1182/blood-2010-09-309591; Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Bailey JR, 2008, J VIROL, V82, P7395, DOI 10.1128/JVI.00800-08; Barker E, 1998, BLOOD, V92, P3105, DOI 10.1182/blood.V92.9.3105.421k46_3105_3114; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Blackbourn DJ, 1996, P NATL ACAD SCI USA, V93, P13125, DOI 10.1073/pnas.93.23.13125; Blackbourn DJ, 1997, AIDS, V11, P737, DOI 10.1097/00002030-199706000-00006; Boaz MJ, 2002, J IMMUNOL, V169, P6376, DOI 10.4049/jimmunol.169.11.6376; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Buckheit RW, 2012, J VIROL, V86, P13679, DOI 10.1128/JVI.02439-12; Buzon MJ, 2014, JAIDS-J ACQ IMM DEF, V65, P1, DOI 10.1097/QAI.0b013e3182a1bc81; Carlson JM, 2012, J VIROL, V86, P13202, DOI 10.1128/JVI.01998-12; Castelli JC, 2002, BLOOD, V99, P4225, DOI 10.1182/blood-2001-11-0078; CASTRO BA, 1991, CELL IMMUNOL, V132, P246, DOI 10.1016/0008-8749(91)90023-5; Chauhan NK, 2012, J MED VIROL, V84, P845, DOI 10.1002/jmv.23289; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Cocchi F, 2012, P NATL ACAD SCI USA, V109, P5411, DOI 10.1073/pnas.1202240109; Daza-Vamenta R, 2004, GENOME RES, V14, P1501, DOI 10.1101/gr.2134504; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; DeVico AL, 2004, NAT REV MICROBIOL, V2, P401, DOI 10.1038/nrmicro878; Dioszeghy V, 2006, J VIROL, V80, P236, DOI 10.1128/JVI.80.1.236-245.2006; ENNEN J, 1994, P NATL ACAD SCI USA, V91, P7207, DOI 10.1073/pnas.91.15.7207; Flynn JN, 2002, VET IMMUNOL IMMUNOP, V85, P159, DOI 10.1016/S0165-2427(01)00425-1; Freel SA, 2012, J VIROL, V86, P6835, DOI 10.1128/JVI.00437-12; Freel SA, 2010, J VIROL, V84, P4998, DOI 10.1128/JVI.00138-10; Guan Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003481; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hayden EC, 2013, NATURE, V504, P192; Hutter G, 2011, CLIN EXP IMMUNOL, V163, P284, DOI 10.1111/j.1365-2249.2010.04312.x; KANNAGI M, 1988, J IMMUNOL, V140, P2237; Kaur G, 2007, VIROLOGY, V369, P214, DOI 10.1016/j.virol.2007.07.031; Killian MS, 2013, J INTERF CYTOK RES, V33, P632, DOI 10.1089/jir.2012.0067; Killian MS, 2011, J VIROL, V85, P1696, DOI 10.1128/JVI.01120-10; Klatt NR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000747; Koga M, 2010, MICROBIOL IMMUNOL, V54, P196, DOI 10.1111/j.1348-0421.2010.00206.x; Le Borgne S, 2000, J VIROL, V74, P4456, DOI 10.1128/JVI.74.10.4456-4464.2000; Leslie A, 2010, J VIROL, V84, P9879, DOI 10.1128/JVI.00320-10; Levy JA, 2003, TRENDS IMMUNOL, V24, P628, DOI 10.1016/j.it.2003.10.005; Lu W, 2012, CELL REP, V2, P1736, DOI 10.1016/j.celrep.2012.11.016; Mackewicz CE, 2003, P NATL ACAD SCI USA, V100, P3433, DOI 10.1073/pnas.0630379100; MACKEWICZ CE, 1991, J CLIN INVEST, V87, P1462, DOI 10.1172/JCI115153; MACKEWICZ CE, 1994, CELL IMMUNOL, V153, P329, DOI 10.1006/cimm.1994.1032; Negri DRM, 2004, J GEN VIROL, V85, P1191, DOI 10.1099/vir.0.79794-0; O'Connor DH, 2004, J VIROL, V78, P14012, DOI 10.1128/JVI.78.24.14012-14022.2004; Ochieng W, 2009, JAIDS-J ACQ IMM DEF, V52, P162, DOI 10.1097/QAI.0b013e3181b22f4a; Pereyra F, 2008, J INFECT DIS, V197, P563, DOI 10.1086/526786; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; POWELL JD, 1993, CLIN EXP IMMUNOL, V91, P473; Raposo RAS, 2011, J IMMUNOL, V187, P748, DOI 10.4049/jimmunol.1003678; Sauermann U, 2008, GENES IMMUN, V9, P69, DOI 10.1038/sj.gene.6364448; Schultheiss T, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-24; SHEPPARD HW, 1993, AIDS, V7, P1159, DOI 10.1097/00002030-199309000-00002; Stephenson KE, 2012, J VIROL, V86, P9583, DOI 10.1128/JVI.00996-12; Tumne A, 2009, J VIROL, V83, P4354, DOI 10.1128/JVI.02629-08; Varadarajan N, 2011, J CLIN INVEST, V121, P4322, DOI 10.1172/JCI58653; Vella C., 2003, Current Drug Targets - Infectious Disorders, V3, P97, DOI 10.2174/1568005033481196; WALKER CM, 1991, CELL IMMUNOL, V137, P420, DOI 10.1016/0008-8749(91)90090-X; WALKER CM, 1986, SCIENCE, V234, P1563, DOI 10.1126/science.2431484; WALKER CM, 1991, J VIROL, V65, P5921, DOI 10.1128/JVI.65.11.5921-5927.1991; Wiseman RW, 2009, NAT MED, V15, P1322, DOI 10.1038/nm.2038; Wong JK, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000748; Yamamoto T, 2012, J VIROL, V86, P5877, DOI 10.1128/JVI.00315-12; Yang HB, 2012, J INFECT DIS, V206, P552, DOI 10.1093/infdis/jis379; Yuan L, 2009, CURR HIV RES, V7, P437, DOI 10.2174/157016209788680561	66	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2015	10	11							e0142086	10.1371/journal.pone.0142086	http://dx.doi.org/10.1371/journal.pone.0142086			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7AC	26551355	Green Submitted, Green Published, gold			2022-12-27	WOS:000364422800016
J	Cowell, WJ; Bellinger, DC; Coull, BA; Gennings, C; Wright, RO; Wright, RJ				Cowell, Whitney J.; Bellinger, David C.; Coull, Brent A.; Gennings, Chris; Wright, Robert O.; Wright, Rosalind J.			Associations between Prenatal Exposure to Black Carbon and Memory Domains in Urban Children: Modification by Sex and Prenatal Stress	PLOS ONE			English	Article							AIR-POLLUTION EXPOSURE; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; MATERNAL STRESS; DEVELOPMENTAL TOXICITY; PARTICULATE MATTER; POSTNATAL EXPOSURE; GENDER-DIFFERENCES; DEVELOPING BRAIN; BIRTH-WEIGHT; HEALTH	Background Whether fetal neurodevelopment is disrupted by traffic-related air pollution is uncertain. Animal studies suggest that chemical and non-chemical stressors interact to impact neurodevelopment, and that this association is further modified by sex. Objectives To examine associations between prenatal traffic-related black carbon exposure, prenatal stress, and sex with children's memory and learning. Methods Analyses included N = 258 mother-child dyads enrolled in a Boston, Massachusetts pregnancy cohort. Black carbon exposure was estimated using a validated spatiotemporal landuse regression model. Prenatal stress was measured using the Crisis in Family Systems-Revised survey of negative life events. The Wide Range Assessment of Memory and Learning (WRAML2) was administered at age 6 years; outcomes included the General Memory Index and its component indices [Verbal, Visual, and Attention Concentration]. Relationships between black carbon and WRAML2 index scores were examined using multivariable-adjusted linear regression including effect modification by stress and sex. Results Mothers were primarily minorities (60% Hispanic, 26% Black); 67% had <= 12 years of education. The main effect for black carbon was not significant for any WRAML2 index; however, in stratified analyses, among boys with high exposure to prenatal stress, Attention Concentration Index scores were on average 9.5 points lower for those with high compared to low prenatal black carbon exposure (P3-way interaction = 0.04). Conclusion The associations between prenatal exposure to black carbon and stress with children's memory scores were stronger in boys than in girls. Studies assessing complex interactions may more fully characterize health risks and, in particular, identify vulnerable subgroups.	[Cowell, Whitney J.] Columbia Univ, Mailman Sch Publ Hlth, Dept Environm Hlth Sci, New York, NY USA; [Bellinger, David C.] Childrens Hosp, Boston, MA 02115 USA; [Bellinger, David C.; Coull, Brent A.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Coull, Brent A.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Gennings, Chris; Wright, Robert O.] Icahn Sch Med Mt Sinai, Dept Prevent Med, New York, NY 10029 USA; [Wright, Robert O.; Wright, Rosalind J.] Icahn Sch Med Mt Sinai, Kravis Childrens Hosp, Dept Pediat, New York, NY 10029 USA; [Wright, Robert O.; Wright, Rosalind J.] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY 10029 USA	Columbia University; Harvard University; Boston Children's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Wright, RJ (corresponding author), Icahn Sch Med Mt Sinai, Kravis Childrens Hosp, Dept Pediat, New York, NY 10029 USA.	rosalind.wright@mssm.edu		Wright, Robert/0000-0003-1180-6459	National Institute of Environmental Health Science [R01ES010932, P30ES023515, P30ES000002, T32ES007322, R01ES013744]; National Heart, Lung and Blood Institute [U01HL072494, R01HL080674]; National Institute of Minority Health and Health Disparities [R01MD006086]; U.S. Environmental Protection Agency [RD-834798-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL072494, R01HL080674] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010932, P30ES023515, P30ES000002, T32ES007322] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD006086] Funding Source: NIH RePORTER	National Institute of Environmental Health Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); U.S. Environmental Protection Agency(United States Environmental Protection Agency); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	The Asthma Coalition on Community, Environment and Social Stress (ACCESS) project has been funded by grants R01ES010932 (National Institute of Environmental Health Science http://www.niehs.nih.gov/), U01HL072494, R01HL080674 (National Heart, Lung and Blood Institute http://www.nhlbi.nih.gov/), and R01MD006086 (National Institute of Minority Health and Health Disparities http://www.nimhd.nih.gov/) (RJW, PI). Phenotyping and biostatistical support was funded by P30ES023515 CG, ROW, RJW) and P30ES000002 (BAC) (National Institute of Environmental Health Science http://www.niehs.nih.gov/). During preparation of this manuscript, authors were supported by T32ES007322 (WJC) and R01ES013744 (ROW) (National Institute of Environmental Health Science http://www.niehs.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. CLEAN Air Center dedicated to air pollution estimates was funded by U.S. Environmental Protection Agency grant RD-834798-01 (http://www.epa.gov/). Its contents are solely the responsibility of the grantee and do not necessarily represent the official views of the USEPA. Further, USEPA does not endorse the purchase of any commercial products or services mentioned in the publication.	Adams W, 2008, ESSENTIALS WRAML2 TO; Aguiar A, 2010, ENVIRON HEALTH PERSP, V118, P1646, DOI 10.1289/ehp.1002326; Allen JL, 2014, ENVIRON HEALTH PERSP, V122, P939, DOI 10.1289/ehp.1307984; Arcangeli T, 2012, ULTRASOUND OBST GYN, V40, P267, DOI 10.1002/uog.11112; Berry CA, 2006, PSYCHOL REP, V98, P123, DOI 10.2466/PRO.98.1.123-132; Block ML, 2012, NEUROTOXICOLOGY, V33, P972, DOI 10.1016/j.neuro.2012.08.014; Bolton JL, 2014, BRAIN BEHAV IMMUN, V37, P30, DOI 10.1016/j.bbi.2013.10.029; Bolton JL, 2013, ENVIRON HEALTH PERSP, V121, P1075, DOI 10.1289/ehp.1306560; Bolton JL, 2012, FASEB J, V26, P4743, DOI 10.1096/fj.12-210989; Bowman RE, 2009, PHYSIOL BEHAV, V97, P21, DOI 10.1016/j.physbeh.2009.01.012; Bowman RE, 2005, J NEUROENDOCRINOL, V17, P526, DOI 10.1111/j.1365-2826.2005.01335.x; Bronson SL, 2014, ENDOCRINOLOGY, V155, P2635, DOI 10.1210/en.2014-1040; Chiu YHM, 2013, ENVIRON HEALTH PERSP, V121, P859, DOI 10.1289/ehp.1205940; Chiu YHM, 2012, AM J RESP CRIT CARE, V186, P147, DOI 10.1164/rccm.201201-0162OC; Clayton JA, 2014, NATURE, V509, P282, DOI 10.1038/509282a; Cordier S, 2002, ENVIRON RES, V89, P1, DOI 10.1006/enrs.2002.4349; Cory-Slechta DA, 2004, ENVIRON HEALTH PERSP, V112, P717, DOI 10.1289/ehp.6481; Cory-Slechta DA, 2008, BASIC CLIN PHARMACOL, V102, P218, DOI 10.1111/j.1742-7843.2007.00189.x; Davis EP, 2014, PSYCHONEUROENDOCRINO, V49, P11, DOI 10.1016/j.psyneuen.2014.06.014; Edwards SC, 2010, ENVIRON HEALTH PERSP, V118, P1326, DOI 10.1289/ehp.0901070; Ema M, 2013, REPROD TOXICOL, V42, P1, DOI 10.1016/j.reprotox.2013.06.074; Engel SM, 2010, ENVIRON HEALTH PERSP, V118, P565, DOI 10.1289/ehp.0901470; Erickson AC, 2014, J ENVIRON PUBLIC HEA, V2014, DOI 10.1155/2014/901017; Fougnie D., 2008, NEW RES SHORT TERM M, DOI 10.3389/conf.fnhum.2011.207.00576; Genc S, 2012, J TOXICOL-US, V2012, DOI 10.1155/2012/782462; Giedd JN, 1997, PROG NEURO-PSYCHOPH, V21, P1185, DOI 10.1016/S0278-5846(97)00158-9; Grahame TJ, 2014, J AIR WASTE MANAGE, V64, P620, DOI 10.1080/10962247.2014.912692; Grandjean P, 1997, NEUROTOXICOL TERATOL, V19, P417, DOI 10.1016/S0892-0362(97)00097-4; Green HF, 2014, NEUROSCI BIOBEHAV R, V40, P20, DOI 10.1016/j.neubiorev.2014.01.004; Gryparis A, 2007, J R STAT SOC C-APPL, V56, P183, DOI 10.1111/j.1467-9876.2007.00573.x; Gutteling BM, 2006, J ABNORM CHILD PSYCH, V34, P789, DOI 10.1007/s10802-006-9054-7; Guxens M, 2014, EPIDEMIOLOGY, V25, P636, DOI 10.1097/EDE.0000000000000133; Guxens M, 2012, ENVIRON HEALTH PERSP, V120, P144, DOI 10.1289/ehp.1103469; Hauser TU, 2014, JAMA PSYCHIAT, V71, P1165, DOI 10.1001/jamapsychiatry.2014.1093; Horton MK, 2012, NEUROTOXICOL TERATOL, V34, P534, DOI 10.1016/j.ntt.2012.07.004; Hougaard KS, 2007, NEUROTOXICOL TERATOL, V29, P425, DOI 10.1016/j.ntt.2007.02.003; Khandaker GM, 2013, PSYCHOL MED, V43, P239, DOI 10.1017/S0033291712000736; Kim E, 2014, SCI TOTAL ENVIRON, V481, P439, DOI 10.1016/j.scitotenv.2014.01.107; Knuesel I, 2014, NAT REV NEUROL, V10, P643, DOI 10.1038/nrneurol.2014.187; Lakshmanan A, 2015, ENVIRON RES, V137, P268, DOI 10.1016/j.envres.2014.10.035; Leal G, 2014, REGULATION HIPPOCAMP; Levesque S, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-105; Llop S, 2013, TOXICOLOGY, V311, P3, DOI 10.1016/j.tox.2013.04.015; Luine V, 2002, STRESS, V5, P205, DOI 10.1080/1025389021000010549; Maccari S, 2007, PSYCHONEUROENDOCRINO, V32, pS10, DOI 10.1016/j.psyneuen.2007.06.005; Mueller BR, 2007, PHYSIOL BEHAV, V91, P55, DOI 10.1016/j.physbeh.2007.01.017; Myers HF, 2009, J BEHAV MED, V32, P9, DOI 10.1007/s10865-008-9181-4; Newman NC, 2013, ENVIRON HEALTH PERSP, V121, P731, DOI 10.1289/ehp.1205555; Oken Emily, 2003, BMC Pediatr, V3, P6, DOI 10.1186/1471-2431-3-6; Pedersen M, 2013, LANCET RESP MED, V1, P695, DOI 10.1016/S2213-2600(13)70192-9; Perera F, 2012, ENVIRON HEALTH PERSP, V120, P1190, DOI 10.1289/ehp.1104492; Perera FP, 2012, ENVIRON HEALTH PERSP, V120, P921, DOI 10.1289/ehp.1104315; Perera FP, 2009, PEDIATRICS, V124, pE195, DOI 10.1542/peds.2008-3506; Ramirez-Amaya V, 2001, J NEUROSCI, V21, P7340; Sacher J, 2013, MAGN RESON IMAGING, V31, P366, DOI 10.1016/j.mri.2012.06.007; Sagiv SK, 2012, ARCH PEDIAT ADOL MED, V166, P1123, DOI 10.1001/archpediatrics.2012.1286; Sagiv SK, 2012, ENVIRON HEALTH PERSP, V120, P904, DOI 10.1289/ehp.1104372; Schneider ML, 2002, PSYCHONEUROENDOCRINO, V27, P285, DOI 10.1016/S0306-4530(01)00050-6; Schwarz JM, 2008, J NEUROCHEM, V105, P1561, DOI 10.1111/j.1471-4159.2008.05384.x; Semmler A, 2005, J CHEM NEUROANAT, V30, P144, DOI 10.1016/j.jchemneu.2005.07.003; Shalowitz MU, 1998, HEALTH SERV RES, V33, P1381; Sheslow D, 2003, WIDE RANGE ASSESSMEN; Shors TJ, 2004, TRENDS NEUROSCI, V27, P250, DOI 10.1016/j.tins.2004.03.007; Suglia SF, 2008, AM J EPIDEMIOL, V167, P280, DOI 10.1093/aje/kwm308; Tau GZ, 2010, NEUROPSYCHOPHARMACOL, V35, P147, DOI 10.1038/npp.2009.115; Vahter M, 2007, ENVIRON RES, V104, P70, DOI 10.1016/j.envres.2006.10.001; Volk HE, 2011, ENVIRON HEALTH PERSP, V119, P873, DOI 10.1289/ehp.1002835; Wang SQ, 2009, ENVIRON HEALTH PERSP, V117, P1612, DOI 10.1289/ehp.0800023; Weinstock M., 2015, ADV NEUROBIOLOGY, V10; Weston HI, 2014, NEUROTOXICOLOGY, V44, P169, DOI 10.1016/j.neuro.2014.06.013; Wright RJ, 2008, CIENC SAUDE COLETIVA, V13, P1729, DOI 10.1590/S1413-81232008000600008; Wright RJ, 2009, CURR OPIN PEDIATR, V21, P222, DOI 10.1097/MOP.0b013e3283292629; Zanchi ACT, 2010, INHAL TOXICOL, V22, P910, DOI 10.3109/08958378.2010.494313	74	40	41	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142492	10.1371/journal.pone.0142492	http://dx.doi.org/10.1371/journal.pone.0142492			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544967	Green Published, Green Submitted, gold			2022-12-27	WOS:000364398700146
J	Dai, XX; Duan, X; Cui, XS; Kim, NH; Xiong, B; Sun, SC				Dai, Xiao-Xin; Duan, Xing; Cui, Xiang-Shun; Kim, Nam-Hyung; Xiong, Bo; Sun, Shao-Chen			Melamine Induces Oxidative Stress in Mouse Ovary	PLOS ONE			English	Article							CYANURIC ACID; IN-VITRO; APOPTOSIS; DAMAGE; CELL; PROLIFERATION; REPRODUCTION; FERTILITY; FOLLICLES; TOXICITY	Melamine is a nitrogen heterocyclic triazine compound which is widely used as an industrial chemical. Although melamine is not considered to be acutely toxic with a high LD50 in animals, food contaminated with melamine expose risks to the human health. Melamine has been reported to be responsible for the renal impairment in mammals, its toxicity on the reproductive system, however, has not been adequately assessed. In the present study, we examined the effect of melamine on the follicle development and ovary formation. The data showed that melamine increased reactive oxygen species (ROS) levels, and induced granulosa cell apoptosis as well as follicle atresia. To further analyze the mechanism by which melamine induces oxidative stress, the expression and activities of two key antioxidant enzymes superoxide dismutase (SOD) and glutathi-one peroxidase (GPX) were analyzed, and the concentration of malondialdehyde (MDA) were compared between control and melamine-treated ovaries. The result revealed that melamine changed the expression and activities of SOD and GPX in the melamine-treated mice. Therefore, we demonstrate that melamine causes damage to the ovaries via oxidative stress pathway.	[Dai, Xiao-Xin; Duan, Xing; Xiong, Bo; Sun, Shao-Chen] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing 210095, Jiangsu, Peoples R China; [Cui, Xiang-Shun; Kim, Nam-Hyung] Chungbuk Natl Univ, Dept Anim Sci, Cheongju 361763, South Korea	Nanjing Agricultural University; Chungbuk National University	Sun, SC (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing 210095, Jiangsu, Peoples R China.	sunsc@njau.edu.cn			Natural Science Foundation of Jiangsu Province [BK20140030]; Biogreen 21 Program, RDA, Republic of Korea [PJ011126]	Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Biogreen 21 Program, RDA, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This work was supported by the Natural Science Foundation of Jiangsu Province (BK20140030) and the Biogreen 21 Program (PJ011126), RDA, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Natural Science Foundation of Jiangsu Province (BK20140030) and the Biogreen 21 Program (PJ011126), RDA, Republic of Korea.	Agarwal A, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-28; Agarwal A, 2008, ANTIOXID REDOX SIGN, V10, P1375, DOI 10.1089/ars.2007.1964; Agarwal A, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-49; Al-Gubory KH, 2010, INT J BIOCHEM CELL B, V42, P1634, DOI 10.1016/j.biocel.2010.06.001; BOCK M, 1957, BRIT J PHARM CHEMOTH, V12, P1; Borgeest C, 2002, TOXICOL SCI, V68, P473, DOI 10.1093/toxsci/68.2.473; Chiu J, 2012, TRENDS CELL BIOL, V22, P592, DOI 10.1016/j.tcb.2012.08.002; Cook HA, 2005, ELECTROPHORESIS, V26, P1576, DOI 10.1002/elps.200410058; Cooke MS, 2006, CLIN CHIM ACTA, V365, P30, DOI 10.1016/j.cca.2005.09.009; Corn CM, 2005, FERTIL STERIL, V84, P627, DOI 10.1016/j.fertnstert.2005.03.061; Duan X, 2015, HUM REPROD, V30, P1643, DOI 10.1093/humrep/dev091; El Mouatassim S, 1999, MOL HUM REPROD, V5, P720, DOI 10.1093/molehr/5.8.720; Galazyn-Sidorczuk M, 2009, CHEM-BIOL INTERACT, V180, P31, DOI 10.1016/j.cbi.2009.01.014; GENEROSO WM, 1988, MUTAT RES, V199, P175, DOI 10.1016/0027-5107(88)90243-6; Guo CZ, 2012, CELL BIOL INT, V36, P183, DOI 10.1042/CBI20110036; Han YG, 2011, CELL MOL NEUROBIOL, V31, P65, DOI 10.1007/s10571-010-9554-4; Hau AKC, 2009, J AM SOC NEPHROL, V20, P245, DOI 10.1681/ASN.2008101065; Ingelfinger JR, 2008, NEW ENGL J MED, V359, P2745, DOI 10.1056/NEJMp0808410; Jewgenow K, 1999, THERIOGENOLOGY, V51, P745, DOI 10.1016/S0093-691X(99)00023-0; Lam HS, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2991; Lu X, 2015, FISH SHELLFISH IMMUN, V42, P58, DOI 10.1016/j.fsi.2014.10.027; Mates JM, 2012, ARCH TOXICOL, V86, P1649, DOI 10.1007/s00204-012-0906-3; Momose-Sato Y, 2009, EUR J NEUROSCI, V29, P1, DOI 10.1111/j.1460-9568.2008.06568.x; Neerman MF, 2004, INT J PHARMACEUT, V281, P129, DOI 10.1016/j.ijpharm.2004.04.023; Parry J, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1802; Puschner B, 2011, CLIN LAB MED, V31, P181, DOI 10.1016/j.cll.2010.10.003; Rashid K, 2013, FOOD CHEM TOXICOL, V62, P584, DOI 10.1016/j.fct.2013.09.026; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Skinner CG, 2010, J MED TOXICOL, V6, P50, DOI 10.1007/s13181-010-0038-1; TILLY JL, 1995, ENDOCRINOLOGY, V136, P242, DOI 10.1210/en.136.1.242; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Wang W, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102467; Xue M, 2011, REGUL TOXICOL PHARM, V61, P93, DOI 10.1016/j.yrtph.2011.06.005; Yin RH, 2013, RES VET SCI, V94, P618, DOI 10.1016/j.rvsc.2012.11.010	34	16	16	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142564	10.1371/journal.pone.0142564	http://dx.doi.org/10.1371/journal.pone.0142564			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26545251	Green Submitted, Green Published, gold			2022-12-27	WOS:000364398700156
J	Golle, K; Muehlbauer, T; Wick, D; Granacher, U				Golle, Kathleen; Muehlbauer, Thomas; Wick, Ditmar; Granacher, Urs			Physical Fitness Percentiles of German Children Aged 9-12 Years: Findings from a Longitudinal Study	PLOS ONE			English	Article							CARDIORESPIRATORY FITNESS; METABOLIC RISK; FIELD-TESTS; LMS METHOD; VALUES; ADOLESCENTS; PERFORMANCE; STRENGTH; GROWTH; POWER	Background Generating percentile values is helpful for the identification of children with specific fitness characteristics (i. e., low or high fitness level) to set appropriate fitness goals (i. e., fitness/ health promotion and/or long-term youth athlete development). Thus, the aim of this longitudinal study was to assess physical fitness development in healthy children aged 9-12 years and to compute sex-and age-specific percentile values. Methods Two-hundred and forty children (88 girls, 152 boys) participated in this study and were tested for their physical fitness. Physical fitness was assessed using the 50-m sprint test (i. e., speed), the 1-kg ball push test, the triple hop test (i. e., upper-and lower-extremity muscular power), the stand-and-reach test (i. e., flexibility), the star run test (i. e., agility), and the 9-min run test (i. e., endurance). Age-and sex-specific percentile values (i. e., P-10 to P-90) were generated using the Lambda, Mu, and Sigma method. Adjusted (for change in body weight, height, and baseline performance) age-and sex-differences as well as the interactions thereof were expressed by calculating effect sizes (Cohen's d). Results Significant main effects of Age were detected for all physical fitness tests (d = 0.40-1.34), whereas significant main effects of Sex were found for upper-extremity muscular power (d = 0.55), flexibility (d = 0.81), agility (d = 0.44), and endurance (d = 0.32) only. Further, significant Sex by Age interactions were observed for upper-extremity muscular power (d = 0.36), flexibility (d = 0.61), and agility (d = 0.27) in favor of girls. Both, linear and curvilinear shaped curves were found for percentile values across the fitness tests. Accelerated (curvilinear) improvements were observed for upper-extremity muscular power (boys: 10-11 yrs; girls: 9-11 yrs), agility (boys: 9-10 yrs; girls: 9-11 yrs), and endurance (boys: 9-10 yrs; girls: 9-10 yrs). Tabulated percentiles for the 9-min run test indicated that running distances between 1,407-1,507 m, 1,479-1,597 m, 1,423-1,654 m, and 1,433-1,666 m in 9-to 12-year-old boys and 1,262-1,362 m, 1,329-1,434 m, 1,392-1,501 m, and 1,415-1,526 m in 9-to 12-year-old girls correspond to a "medium" fitness level (i. e., P-40 to P-60) in this population. Conclusions The observed differences in physical fitness development between boys and girls illustrate that age- and sex-specific maturational processes might have an impact on the fitness status of healthy children. Our statistical analyses revealed linear (e. g., lower-extremity muscular power) and curvilinear (e. g., agility) models of fitness improvement with age which is indicative of timed and capacity-specific fitness development pattern during childhood. Lastly, the provided age-and sex-specific percentile values can be used by coaches for talent identification and by teachers for rating/ grading of children's motor performance.	[Golle, Kathleen; Muehlbauer, Thomas; Granacher, Urs] Univ Potsdam, Res Focus Cognit Sci, Div Training & Movement Sci, Potsdam, Germany; [Wick, Ditmar] Univ Appl Sci Sport & Management, Potsdam, Germany	University of Potsdam	Golle, K (corresponding author), Univ Potsdam, Res Focus Cognit Sci, Div Training & Movement Sci, Potsdam, Germany.	kathleen.golle@uni-potsdam.de	Granacher, Urs/N-1963-2019; Granacher, Urs/GXM-3858-2022; Granacher, Urs/T-9900-2017	Granacher, Urs/0000-0002-7095-813X; Granacher, Urs/0000-0002-7095-813X; Granacher, Urs/0000-0002-7095-813X	Ministry of Education, Youth and Sport and the Sports Confederation of the federal state Brandenburg; Open Access Publication Fund of University of Potsdam	Ministry of Education, Youth and Sport and the Sports Confederation of the federal state Brandenburg; Open Access Publication Fund of University of Potsdam	The study was commissioned and supported by the Ministry of Education, Youth and Sport and the Sports Confederation of the federal state Brandenburg and by the Open Access Publication Fund of University of Potsdam." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN KL, 1976, EUR J APPL PHYSIOL O, V35, P49; Artero EG, 2011, PEDIATR DIABETES, V12, P704, DOI 10.1111/j.1399-5448.2011.00769.x; Balyi Istvan., 2013, LONG TERM ATHLETE DE; Bergmann GG, 2010, REV BRAS MED ESPORTE, V16, P339, DOI 10.1590/S1517-86922010000500004; Beunen G, 1988, Exerc Sport Sci Rev, V16, P503; Beunen G, 1997, INT J SPORTS MED, V18, pS171, DOI 10.1055/s-2007-972710; Beunen G, 2000, PEDIATR EXERC SCI, V12, P174, DOI 10.1123/pes.12.2.174; Bos K, 2009, DTSCH MOTORIK TEST 6; Bos K., 2009, BILD SPORT, P337, DOI [10.1007/978-3-531-94026-7_21, DOI 10.1007/978-3-531-94026-7_21]; CASPERSEN CJ, 1985, PUBLIC HEALTH REP, V0100; Castro-Pineiro J, 2011, NUTR HOSP, V26, P572, DOI [10.1590/S0212-16112011000300021, 10.3305/nh.2011.26.3.4597]; Castro-Pinero J, 2013, EUR J SPORT SCI, V13, P139, DOI 10.1080/17461391.2011.606833; Castro-Pinero J, 2009, J STRENGTH COND RES, V23, P2295, DOI 10.1519/JSC.0b013e3181b8d5c1; Catley MJ, 2013, BRIT J SPORT MED, V47, P98, DOI 10.1136/bjsports-2011-090218; Cohen J.E., 1988, STAT POWER ANAL BEHA; COLE TJ, 1990, EUR J CLIN NUTR, V44, P45; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; De Miguel-Etayo P, 2014, INT J OBESITY, V38, pS57, DOI 10.1038/ijo.2014.136; Dollman J, 2002, PEDIATR EXERC SCI, V14, P297, DOI 10.1123/pes.14.3.297; ERBAUGH SJ, 1990, PERCEPT MOTOR SKILL, V71, P1123, DOI 10.2466/PMS.71.7.1123-1128; Golle K, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-499; Haywood K., 2020, HUMAN KINETICS; JACKSON AS, 1976, RES QUART, V47, P86, DOI 10.1080/10671315.1976.10615344; Llorente-Cantarero FJ, 2012, GENDER MED, V9, P436, DOI 10.1016/j.genm.2012.08.006; Lloyd RS, 2012, STRENGTH COND J, V34, P61, DOI 10.1519/SSC.0b013e31825760ea; Lopes VP, 2011, SCAND J MED SCI SPOR, V21, P663, DOI 10.1111/j.1600-0838.2009.01027.x; Lopes VP, 2012, EUR J SPORT SCI, V12, P384, DOI 10.1080/17461391.2011.566368; Lundgren SS, 2011, ACTA PAEDIATR, V100, P1359, DOI 10.1111/j.1651-2227.2011.02322.x; Malina R. M., 2004, GROWTH MATURATION PH, DOI DOI 10.5040/9781492596837; Martin JC, 1998, PEDIATRIC ANAEROBIC PERFORMANCE, P45; Ministerium fur Landwirtschaft UuRdLBME, 2002, LAND; Moll C, 2012, NEUROMOTION AUFM AUT, P22; Ortega FB, 2008, INT J OBESITY, V32, P1, DOI 10.1038/sj.ijo.0803774; Pan H, 2004, STAT MED, V23, P1749, DOI 10.1002/sim.1692; Pan H, 1997, USERS GUIDE LMSCHART; Reyes MEP, 2003, AM J HUM BIOL, V15, P800, DOI 10.1002/ajhb.10218; Rodrigues LP, 2013, J SCI MED SPORT, V16, P118, DOI 10.1016/j.jsams.2012.06.008; De Oliveira MSR, 2014, J SPORT MED PHYS FIT, V54, P780; Safrit MJ, 1990, PEDIATRIC EXERCISE S, V2, P9, DOI DOI 10.1123/PES.2.1.9; Santos R, 2014, J SPORT SCI, V32, P1510, DOI 10.1080/02640414.2014.906046; Schulz S., 2013, RELIABILITAT S UNPUB; Smith JJ, 2014, SPORTS MED, V44, P1209, DOI 10.1007/s40279-014-0196-4; Stark G., 2000, JUGEND TRAINIERT OLY; Tambalis KD, 2016, EUR J SPORT SCI, V16, P736, DOI 10.1080/17461391.2015.1088577; TANNER JM, 1966, ARCH DIS CHILD, V41, P613, DOI 10.1136/adc.41.220.613; Twisk JWR, 2000, MED SCI SPORT EXER, V32, P1455, DOI 10.1097/00005768-200008000-00014; Van Praagh E, 2002, SPORTS MED, V32, P701, DOI 10.2165/00007256-200232110-00003; Viru A, 1998, BIOL SPORT, V15, P211; Viru A., 1999, EUR J PHYS ED, V4, P75, DOI DOI 10.1080/1740898990040106; Woll A, 2011, EUR J PEDIATR, V170, P1129, DOI 10.1007/s00431-010-1391-4	50	44	46	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142393	10.1371/journal.pone.0142393	http://dx.doi.org/10.1371/journal.pone.0142393			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544848	Green Submitted, gold, Green Published			2022-12-27	WOS:000364398700129
J	Hirano, S; Kanno, S				Hirano, Seishiro; Kanno, Sanae			Macrophage Receptor with Collagenous Structure (MARCO) Is Processed by either Macropinocytosis or Endocytosis-Autophagy Pathway	PLOS ONE			English	Article							RECYCLING ENDOSOMES; SCAVENGER RECEPTORS; PLASMA-MEMBRANE; PHAGOCYTOSIS; BINDING; CELLS; TRAFFICKING; EXPRESSION; MACHINERY; PARTICLES	The Macrophage Receptor with COllagenous structure (MARCO) protein is a plasma membrane receptor for un-opsonized or environmental particles on phagocytic cells. Here, we show that MARCO was internalized either by ruffling of plasma membrane followed by macropinocytosis or by endocytosis followed by fusion with autophagosome in CHO-K1 cells stably transfected with GFP-MARCO. The macropinocytic process generated large vesicles when the plasma membrane subsided. The endocytosis/autophagosome (amphisome) generated small fluorescent puncta which were visible in the presence of glutamine, chloroquine, bafilomycin, ammonia, and other amines. The small puncta, but not the large vesicles, co-localized with LC3B and lysosomes. The LC3-II/LC3-I ratio increased in the presence of glutamine, ammonia, and chloroquine in various cells. The small puncta trafficked between the peri-nuclear region and the distal ends of cells back and forth at rates of up to 2-3 mu m/sec; tubulin, but not actin, regulated the trafficking of the small puncta. Besides phagocytosis MARCO, an adhesive plasma membrane receptor, may play a role in incorporation of various extracellular materials into the cell via both macropinocytic and endocytic pathways.	[Hirano, Seishiro] Natl Inst Environm Studies, NanoTox, RCER, Tsukuba, Ibaraki 3058506, Japan; [Kanno, Sanae] St Marianna Univ, Sch Med, Legal Med, Miyamae Ku, Kawasaki, Kanagawa 2168511, Japan	National Institute for Environmental Studies - Japan; Saint Marianna University	Hirano, S (corresponding author), Natl Inst Environm Studies, NanoTox, RCER, 16-2 Onogawa, Tsukuba, Ibaraki 3058506, Japan.	seishiro@nies.go.jp			Japan Society for the Promotion of Science [26670341]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Funding for this work came from #26670341 Japan Society for the Promotion of Science, https://www.jsps.go.jp/english/index.html.	Bonilla DL, 2013, IMMUNITY, V39, P537, DOI 10.1016/j.immuni.2013.08.026; Boya P, 2013, NAT CELL BIOL, V15, P713, DOI 10.1038/ncb2788; Cheong H, 2011, P NATL ACAD SCI USA, V108, P11121, DOI 10.1073/pnas.1107969108; Cherra SJ, 2010, J CELL BIOL, V190, P533, DOI 10.1083/jcb.201002108; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; ELOMAA O, 1995, CELL, V80, P603, DOI 10.1016/0092-8674(95)90514-6; Eng CH, 2010, AUTOPHAGY, V6, P968, DOI 10.4161/auto.6.7.13082; Eng CH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000911; Ferguson TA, 2014, AUTOPHAGY, V10, P165, DOI 10.4161/auto.26735; Florey O, 2011, NAT CELL BIOL, V13, P1335, DOI 10.1038/ncb2363; Gump JM, 2014, NAT CELL BIOL, V16, P47, DOI 10.1038/ncb2886; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Hamasaki M, 2013, NATURE, V495, P389, DOI 10.1038/nature11910; Hirano S, 2012, TOXICOL APPL PHARM, V259, P96, DOI 10.1016/j.taap.2011.12.012; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Jahreiss L, 2008, TRAFFIC, V9, P574, DOI 10.1111/j.1600-0854.2008.00701.x; Kanno S, 2007, TOXICOL SCI, V97, P398, DOI 10.1093/toxsci/kfm050; Kerr MC, 2009, TRAFFIC, V10, P364, DOI 10.1111/j.1600-0854.2009.00878.x; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Klionsky DJ, 2005, J CELL SCI, V118, P7, DOI 10.1242/jcs.01620; Kobayashi S, 2010, AUTOPHAGY, V6, P36, DOI 10.4161/auto.6.1.10324; KOBZIK L, 1995, J IMMUNOL, V155, P367; Korolchuk VI, 2011, NAT CELL BIOL, V13, P453, DOI 10.1038/ncb2204; Kvell K, 2006, BIOCHEM BIOPH RES CO, V341, P1193, DOI 10.1016/j.bbrc.2006.01.083; Palecanda A, 1999, J EXP MED, V189, P1497, DOI 10.1084/jem.189.9.1497; Pous C, 2011, NAT CELL BIOL, V13, P342, DOI 10.1038/ncb0411-342; Puri C, 2014, AUTOPHAGY, V10, P182, DOI 10.4161/auto.27174; Puri C, 2013, CELL, V154, P1285, DOI 10.1016/j.cell.2013.08.044; Ravikumar B, 2010, NAT CELL BIOL, V12, P747, DOI 10.1038/ncb2078; Sakiyama T, 2009, GASTROENTEROLOGY, V136, P924, DOI 10.1053/j.gastro.2008.12.002; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Sou Y, 2006, J BIOL CHEM, V281, P3017, DOI 10.1074/jbc.M505888200; Stolz A, 2014, NAT CELL BIOL, V16, P495, DOI 10.1038/ncb2979; Thakur SA, 2009, TOXICOL SCI, V107, P238, DOI 10.1093/toxsci/kfn210; Tooze SA, 2010, NAT CELL BIOL, V12, P831, DOI 10.1038/ncb0910-831; van der Vos KE, 2012, NAT CELL BIOL, V14, P829, DOI 10.1038/ncb2536; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Zavodszky E, 2013, FEBS LETT, V587, P1988, DOI 10.1016/j.febslet.2013.04.025	40	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142062	10.1371/journal.pone.0142062	http://dx.doi.org/10.1371/journal.pone.0142062			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26545255	gold, Green Submitted, Green Published			2022-12-27	WOS:000364398700076
J	Mikulewicz, M; Kachniarz, K; Chojnacka, K				Mikulewicz, Marcin; Kachniarz, Krzysztof; Chojnacka, Katarzyna			Exposure of Cleft Lip and Palate Patients to Toxic Elements Released during Orthodontic Treatment in the Study of Non-Invasive Matrices	PLOS ONE			English	Article							HUMAN HAIR; ION RELEASE; NICKEL; APPLIANCES; MAGNESIUM; COPPER; SALIVA; IRON; ZINC; CORROSION	The Objective The aim of the study was evaluation of metal ions (nickel and chromium) released from orthodontic appliances in cleft lip and palate patients and the usefulness of non-invasive matrices (saliva and hair). Materials and Methods The material studied consisted of 100 individuals, including 59 females and 41 males of 5 to 16 years of age, which were divided into 3 groups: experimental-patients with cleft lip and palate (36 individuals, the average treatment time 5.74 years); control group-patients without cleft lip and palate, during orthodontic treatment (32 individuals, the average treatment time 1.78 years) and the control group patients without cleft lip and palate, without any orthodontic appliances (32 individuals). Samples (saliva, hair) were collected and subjects underwent a survey by questionnaire. Multi-elemental analyses of the composition of non-invasive matrices was conducted in an accredited laboratory by inductively coupled plasma spectrometry technique ICP-OES. The results were reported as mean contents of particular elements (Cd, Cr, Cu, Fe, Mn, Mo, Ni, Si) in hair and in saliva. Results The concentration of Cr, Ni, Fe and Cu ions in saliva of cleft lip and palate patients were several times higher as compared with not treated orthodontically control groups and higher than in the group with orthodontic appliances. Among the assessed matrices, hair of cleft lip and palate patients seem to be not a meaningful biomarker. Conclusion It was found that orthodontic appliances used in long-term treatment of cleft lip and palate patients do not release toxic levels of Cr and Ni ions.	[Mikulewicz, Marcin; Kachniarz, Krzysztof] Med Univ Wroclaw, Div Facial Abnormal, Dept Dentofacial Orthopaed & Orthodont, Wroclaw, Poland; [Chojnacka, Katarzyna] Wroclaw Univ Technol, Fac Chem, Dept Adv Mat Technol, PL-50370 Wroclaw, Poland	Wroclaw Medical University; Wroclaw University of Science & Technology	Mikulewicz, M (corresponding author), Med Univ Wroclaw, Div Facial Abnormal, Dept Dentofacial Orthopaed & Orthodont, Wroclaw, Poland.	mikulewicz.marcin@gmail.com		Mikulewicz, Marcin/0000-0001-5754-0284; Chojnacka, Katarzyna/0000-0001-6897-9882				Afridi HI, 2008, BIOL TRACE ELEM RES, V124, P206, DOI 10.1007/s12011-008-8142-7; Agaoglu G, 2001, ANGLE ORTHOD, V71, P375; Amini F, 2012, BIOL TRACE ELEM RES, V150, P31, DOI 10.1007/s12011-012-9478-6; Amini F, 2012, EUR J ORTHODONT, V34, P126, DOI 10.1093/ejo/cjq181; Angelieri F, 2011, AM J ORTHOD DENTOFAC, V139, DOI 10.1016/j.ajodo.2009.06.029; BENCKO V, 1995, TOXICOLOGY, V101, P29, DOI 10.1016/0300-483X(95)03018-B; Breme J., 1998, HDB BIOMATERIAL PROP; Chaturvedi T P, 2010, Indian J Dent Res, V21, P275, DOI 10.4103/0970-9290.66648; Chojnacka K, 2010, ENVIRON TOXICOL PHAR, V29, P314, DOI 10.1016/j.etap.2010.03.010; De Souza RM, 2008, ANGLE ORTHOD, V78, P345, DOI 10.2319/111806-466.1; Dongarra G, 2011, ENVIRON TOXICOL PHAR, V32, P27, DOI 10.1016/j.etap.2011.03.003; Eliades T, 2003, EUR J ORTHODONT, V25, P103, DOI 10.1093/ejo/25.1.103; Faccioni F, 2003, AM J ORTHOD DENTOFAC, V124, P687, DOI 10.1016/j.ajodo.2003.09.010; Fairbrother A, 2007, ECOTOX ENVIRON SAFE, V68, P145, DOI 10.1016/j.ecoenv.2007.03.015; Fors R, 2006, EUR J ORTHODONT, V28, P292, DOI 10.1093/ejo/cji091; Forte G, 2005, J TRACE ELEM MED BIO, V19, P195, DOI 10.1016/j.jtemb.2005.08.003; GAMMELGAARD B, 1990, ACTA DERM-VENEREOL, V70, P417; GJERDET NR, 1991, ACTA ODONTOL SCAND, V49, P73, DOI 10.3109/00016359109005889; House K, 2008, AM J ORTHOD DENTOFAC, V133, P584, DOI 10.1016/j.ajodo.2007.03.021; Joo NS, 2009, BIOL TRACE ELEM RES, V129, P28, DOI 10.1007/s12011-008-8281-x; Kabata-Pendias A, 2010, TRACE ELEMENTS SOILS, Vfourth, DOI [DOI 10.1201/B10158, 10.1201/9781420039900]; Kazi TG, 2011, BIOL TRACE ELEM RES, V143, P153, DOI 10.1007/s12011-010-8866-z; Kempson IM, 2011, CHEM SOC REV, V40, P3915, DOI 10.1039/c1cs15021a; Kerosuo H, 1997, AM J ORTHOD DENTOFAC, V111, P595, DOI 10.1016/S0889-5406(97)70310-X; Kobayashi GS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065677; Kocadereli I, 2000, ANGLE ORTHOD, V70, P431; Lech T, 2002, BIOL TRACE ELEM RES, V85, P111, DOI 10.1385/BTER:85:2:111; Levrini L, 2006, Minerva Stomatol, V55, P115; Lubkowska A, 2009, TRACE ELEM ELECTROLY, V26, P72; Matasa C G, 1995, J Clin Orthod, V29, P16; Mikulewicz M, 2015, BIOL TRACE ELEM RES, V163, P11, DOI 10.1007/s12011-014-0152-z; Mikulewicz M, 2011, ENVIRON TOXICOL PHAR, V32, P10, DOI 10.1016/j.etap.2011.02.009; Mossey P.A., 2001, GLOBAL REGISTRY DATA; Mossey PA, 2009, LANCET, V374, P1773, DOI 10.1016/S0140-6736(09)60695-4; Munksgaard E C, 1992, Adv Dent Res, V6, P17; Myers GJ, 2003, LANCET, V361, P1686, DOI 10.1016/S0140-6736(03)13371-5; Park SB, 2009, BIOL TRACE ELEM RES, V130, P218, DOI 10.1007/s12011-009-8336-7; Petoumeno E, 2008, J OROFAC ORTHOP, V69, P411, DOI 10.1007/s00056-008-0808-4; Rao KS, 2002, SPECTROCHIM ACTA B, V57, P1333; Schiff N, 2005, EUR J ORTHODONT, V27, P541, DOI 10.1093/ejo/cji050; Schmalz G., 2009, BASIC ASPECT BIOCOMP; Shamberger RJ, 2002, BIOL TRACE ELEM RES, V87, P1, DOI 10.1385/BTER:87:1-3:001; STAERKJAER L, 1990, EUR J ORTHODONT, V12, P284, DOI 10.1093/ejo/12.3.284; Staffolani N, 1999, J DENT, V27, P449, DOI 10.1016/S0300-5712(98)00073-6; Tobin J., 2005, HAIR EXPOSURE ENV PO, V7; ToumelinChemla F, 1996, J DENT, V24, P109, DOI 10.1016/0300-5712(95)00033-X; Unkiewicz-Winiarczyk A, 2009, BIOL TRACE ELEM RES, V128, P152, DOI 10.1007/s12011-008-8266-9; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; Wataha JC, 1999, J BIOMED MATER RES, V45, P251, DOI 10.1002/(SICI)1097-4636(19990605)45:3<251::AID-JBM13>3.0.CO;2-5; Williams DF, 1998, CONSENSUS DEFINITION; Winer B.J., 1962, STAT PRINCIPLES EXPT	52	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0140211	10.1371/journal.pone.0140211	http://dx.doi.org/10.1371/journal.pone.0140211			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544176	Green Published, Green Submitted, gold			2022-12-27	WOS:000364398700006
J	Saracco, F; Di Clemente, R; Gabrielli, A; Pietronero, L				Saracco, Fabio; Di Clemente, Riccardo; Gabrielli, Andrea; Pietronero, Luciano			From Innovation to Diversification: A Simple Competitive Model	PLOS ONE			English	Article							MUTUALISTIC NETWORKS; ECONOMIC COMPLEXITY; DISTRIBUTIONS; CAPABILITIES	Few attempts have been proposed in order to describe the statistical features and historical evolution of the export bipartite matrix countries/products. An important standpoint is the introduction of a products network, namely a hierarchical forest of products that models the formation and the evolution of commodities. In the present article, we propose a simple dynamical model where countries compete with each other to acquire the ability to produce and export new products. Countries will have two possibilities to expand their export: innovating, i.e. introducing new goods, namely new nodes in the product networks, or copying the productive process of others, i.e. occupying a node already present in the same network. In this way, the topology of the products network and the country-product matrix evolve simultaneously, driven by the countries push toward innovation.	[Saracco, Fabio; Di Clemente, Riccardo; Gabrielli, Andrea] Univ Roma, Dept Phys, ISC CNR UoS Sapienza, Ple Aldo Moro 5, I-00185 Rome, Italy; [Gabrielli, Andrea] Inst Adv Studies Lucca, IMT, I-55100 Lucca, Italy; [Pietronero, Luciano] Univ Roma La Sapienza, I-00185 Rome, Italy; [Pietronero, Luciano] London Inst Math Sci, London, England	Consiglio Nazionale delle Ricerche (CNR); Istituto dei Sistemi Complessi (ISC-CNR); Sapienza University Rome; University of Rome Tor Vergata; IMT School for Advanced Studies Lucca; Sapienza University Rome	Di Clemente, R (corresponding author), Univ Roma, Dept Phys, ISC CNR UoS Sapienza, Ple Aldo Moro 5, I-00185 Rome, Italy.	riccardo.diclemente@imtlucca.it	Di Clemente, Riccardo/N-9471-2014; Pietronero, Luciano/O-4473-2018; Saracco, Fabio/O-5295-2015; Gabrielli, Andrea/A-7175-2008	Di Clemente, Riccardo/0000-0001-8005-6351; Pietronero, Luciano/0000-0001-6424-8863; Saracco, Fabio/0000-0003-0812-5927; Gabrielli, Andrea/0000-0003-3705-7281				Aghion P., 1998, ENDOGENOUS GROWTH TH; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; BALASSA B, 1977, MANCH SCH ECON SOC, V45, P327, DOI 10.1111/j.1467-9957.1977.tb00701.x; Barbosa LA, 2009, THEOR BIOSCI, V128, P205, DOI 10.1007/s12064-009-0066-z; Barro R. J., 2003, EC GROWTH; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; Belmonte A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05301; Caldarelli G., 2007, SCALE FREE NETWORKS; Caldarelli G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047278; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Cristelli M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070726; Di Clemente R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112525; Feenstra RC, 2005, WORLD TRADE FLOWS 19; Hausmann R., 2007, CID WORKING PAPER SE, DOI [10.1111/j.1475-4932.1987.tb00650.x, DOI 10.1111/J.1475-4932.1987.TB00650.X]; Henisz W.J., 2000, ECON POLIT-OXFORD, V12, P1, DOI DOI 10.1111/1468-0343.00066; Hesse H, 2006, EXPORT DIVERSIFICATI; Hidalgo CA, 2007, SCIENCE, V317, P482, DOI 10.1126/science.1144581; Hidalgo CA, 2010, RWP10045 HKS; Hidalgo CA, 2009, P NATL ACAD SCI USA, V106, P10570, DOI 10.1073/pnas.0900943106; Johnson S, PREPRINT; Kauffman S., 1995, HOME UNIVERSE SEARCH; Krapivsky P, 2001, ORG GROWING RANDOM N; Maddison A., 2007, WORLD EC, V1; MURTHA TP, 1994, STRATEGIC MANAGE J, V15, P113; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Ostrom E., 1993, I INCENTIVES SUSTAIN; Pritchett L, 1997, J ECON PERSPECT, V11, P3, DOI 10.1257/jep.11.3.3; Pugliese E, 2016, EUR PHYS J-SPEC TOP, V225, P1893, DOI 10.1140/epjst/e2015-50118-1; Rogers Everett M., 2010, DIFFUSION INNOVATION; Saracco F, 2007, PREPRINT; Saracco F, 2015, SCI REP-UK, V5, DOI 10.1038/srep10595; STONE L, 1990, OECOLOGIA, V85, P74, DOI 10.1007/BF00317345; Suweis S, 2013, NATURE, V500, P449, DOI 10.1038/nature12438; Tacchella A, 2013, J ECON DYN CONTROL, V37, P1683, DOI 10.1016/j.jedc.2013.04.006; Tacchella A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00723; Tria F, 2014, SCI REP-UK, V4, DOI 10.1038/srep05890; Verona G, 2003, IND CORP CHANGE, V12, P577, DOI 10.1093/icc/12.3.577; Zaccaria A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113770	40	18	18	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0140420	10.1371/journal.pone.0140420	http://dx.doi.org/10.1371/journal.pone.0140420			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544685	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000364398700008
J	Thijs, W; Janssen, K; van Schadewijk, AM; Papapoulos, SE; le Cessie, S; Middeldorp, S; Melissant, CF; Rabe, KF; Hiemstra, PS				Thijs, Willemien; Janssen, Kirsten; van Schadewijk, Annemarie M.; Papapoulos, Socrates E.; le Cessie, Saskia; Middeldorp, Saskia; Melissant, Christian F.; Rabe, Klaus F.; Hiemstra, Pieter S.			Nasal Levels of Antimicrobial Peptides in Allergic Asthma Patients and Healthy Controls: Differences and Effect of a Short 1,25(OH)(2) Vitamin D3 Treatment	PLoS One			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; BRONCHIAL EPITHELIAL-CELLS; PNEUMOCOCCAL DISEASE; ATOPIC-DERMATITIS; CYSTIC-FIBROSIS; HOST-DEFENSE; CATHELICIDIN; EXPRESSION; INFLAMMATION; RISK	Background Allergy is often accompanied by infections and lower levels of antimicrobial peptides (AMPs). Vitamin D has been shown to increase expression of selected AMPs. In this study we investigated whether antimicrobial peptide levels in nasal secretions of allergic asthma patients are lower than in healthy controls, and whether administration of the active form of vitamin D (1,25(OH)(2)D3) affects these antimicrobial peptide levels. Methods The levels of antimicrobial peptides in nasal secretions were compared between 19 allergic asthma patients and 23 healthy controls. The effect of seven days daily oral treatment with 2 mu g 1,25(OH)(2)D3 on antimicrobial peptides in nasal secretions was assessed in a placebo-controlled cross-over clinical study. Results Levels of neutrophil alpha-defensins (human neutrophil peptides 1-3; HNP1-3) and lipocalin 2 (LCN2; also known as NGAL) were significantly lower in asthmatics, but no differences in LL-37 and SLPI were detected. Treatment with a short-term 1,25(OH)(2)D3 caused a small increase in HNP1-3, but not when the asthma and control groups were analyzed separately. LL-37, LCN2 and SLPI did not change after treatment with 1,25(OH)(2)D3. Conclusion Levels of the antimicrobial peptides HNP1-3 and LCN2 are lower in nasal secretions in asthmatics and are not substantially affected by a short-term treatment with active vitamin D.	[Thijs, Willemien; Janssen, Kirsten; van Schadewijk, Annemarie M.; Rabe, Klaus F.; Hiemstra, Pieter S.] Leiden Univ Med Ctr, Dept Pulmonol, Leiden, Netherlands; [Papapoulos, Socrates E.] Leiden Univ Med Ctr, Dept Endocrinol, Leiden, Netherlands; [le Cessie, Saskia] Leiden Univ Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands; [le Cessie, Saskia] Leiden Univ Med Ctr, Dept Med Stat, Leiden, Netherlands; [Middeldorp, Saskia] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Melissant, Christian F.] Spaame Hosp, Dept Pulmonol, Hoofddorp, Netherlands; [Rabe, Klaus F.] Lungen Clin Grosshansdorf, Dept Pulmonol & Thorac Surg, Grosshansdorf, Germany	Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC); University of Amsterdam; Academic Medical Center Amsterdam; Spaarne Hospital; Grosshansdorf Hospital	Thijs, W (corresponding author), Leiden Univ Med Ctr, Dept Pulmonol, Leiden, Netherlands.	willemienthijs@hotmail.com	Rabe, Klaus F./AAW-6296-2021; Middeldorp, Saskia/ABI-8197-2020; le+Cessie, Saskia/HGC-8966-2022	Rabe, Klaus F./0000-0002-7020-1401; Middeldorp, Saskia/0000-0002-1006-6420; le Cessie, Saskia/0000-0003-2154-4923				Beisswenger C, 2006, J IMMUNOL, V177, P1833, DOI 10.4049/jimmunol.177.3.1833; Bianchi ML, 1999, J BONE MINER RES, V14, P1789, DOI 10.1359/jbmr.1999.14.10.1789; Cole AM, 2000, J MICROBIOL METH, V41, P135, DOI 10.1016/S0167-7012(00)00140-8; Felgentreff K, 2006, PEPTIDES, V27, P3100, DOI 10.1016/j.peptides.2006.07.018; Global Initiative for Asthma (GINA), 2011, GLOB STRAT ASTHM MAN; Gombart AF, 2005, FASEB J, V19, P1067, DOI 10.1096/fj.04-3284com; Grossmann RE, 2012, EUR J CLIN NUTR, V66, P1072, DOI 10.1038/ejcn.2012.82; Hansdottir S, 2008, J IMMUNOL, V181, P7090, DOI 10.4049/jimmunol.181.10.7090; Hata TR, 2008, J ALLERGY CLIN IMMUN, V122, P829, DOI 10.1016/j.jaci.2008.08.020; Jeng L, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-28; Jung JA, 2010, J ALLERGY CLIN IMMUN, V125, P217, DOI 10.1016/j.jaci.2009.10.045; Kalfa VC, 2004, ANN ALLERG ASTHMA IM, V93, P288, DOI 10.1016/S1081-1206(10)61503-7; Kampe Mary, 2007, Clin Mol Allergy, V5, P4, DOI 10.1186/1476-7961-5-4; Keatings VM, 1997, AM J RESP CRIT CARE, V155, P449, DOI 10.1164/ajrccm.155.2.9032177; Lehouck A, 2012, ANN INTERN MED, V156, P105, DOI 10.7326/0003-4819-156-2-201201170-00004; Liu MC, 2012, CLIN EXP ALLERGY, V42, P383, DOI 10.1111/j.1365-2222.2011.03879.x; McCoy K, 2006, J ALLERGY CLIN IMMUN, V118, P1226, DOI 10.1016/j.jaci.2006.09.006; Misawa Y, 2009, INT J HEMATOL, V90, P561, DOI 10.1007/s12185-009-0452-9; Ong PY, 2002, NEW ENGL J MED, V347, P1151, DOI 10.1056/NEJMoa021481; PAPAPOULOS SE, 1982, CLIN SCI, V62, P427, DOI 10.1042/cs0620427; Rohde G, 2014, CLIN EXP ALLERGY; Schauber J, 2007, J CLIN INVEST, V117, P803, DOI 10.1172/JCI30142; Schrumpf JA, 2012, INFECT IMMUN, V80, P4485, DOI 10.1128/IAI.06224-11; Talbot TR, 2005, NEW ENGL J MED, V352, P2082, DOI 10.1056/NEJMoa044113; ten Brinke A, 2005, EUR RESPIR J, V26, P812, DOI 10.1183/09031936.05.00037905; Vahavihu K, 2010, BRIT J DERMATOL, V163, P321, DOI 10.1111/j.1365-2133.2010.09767.x; van Wetering S, 2000, J INVEST MED, V48, P359; VanWetering S, 1997, J LEUKOCYTE BIOL, V62, P217, DOI 10.1002/jlb.62.2.217; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; Xiao W, 2005, CHEST, V128, P2316, DOI 10.1378/chest.128.4.2316; Xystrakis E, 2006, J CLIN INVEST, V116, P146, DOI 10.1172/JCI21759; Zambrano JC, 2003, J ALLERGY CLIN IMMUN, V111, P1008, DOI 10.1067/mai.2003.1396; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	33	14	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0140986	10.1371/journal.pone.0140986	http://dx.doi.org/10.1371/journal.pone.0140986			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26545199	Green Submitted, Green Published, gold			2022-12-27	WOS:000364398700012
J	Lee, YK; Lee, PY; Cheong, AT; Ng, CJ; Abdullah, KL; Ong, TA; Razack, AHA				Lee, Yew Kong; Lee, Ping Yein; Cheong, Ai Theng; Ng, Chirk Jenn; Abdullah, Khatijah Lim; Ong, Teng Aik; Razack, Azad Hassan Abdul			To Share or Not to Share: Malaysian Healthcare Professionals' Views on Localized Prostate Cancer Treatment Decision Making Roles	PLOS ONE			English	Article							BREAST-CANCER; TREATMENT OPTIONS; PATIENT AUTONOMY; PREFERENCES; PARTICIPATION; CULTURES; DOCTORS; JAPAN; WOMEN	Aim To explore the views of Malaysian healthcare professionals (HCPs) on stakeholders' decision making roles in localized prostate cancer (PCa) treatment. Methods Qualitative interviews and focus groups were conducted with HCPs treating PCa. Data was analysed using a thematic approach. Four in-depth interviews and three focus group discussions were conducted between December 2012 and March 2013 using a topic guide. Interviews were audio-recorded, transcribed verbatim, and analysed thematically. Findings The participants comprised private urologists (n = 4), government urologists (n = 6), urology trainees (n = 6), government policy maker (n = 1) and oncologists (n = 3). HCP perceptions of the roles of the three parties involved (HCPs, patients, family) included: HCP as the main decision maker, HCP as a guide to patients' decision making, HCP as a facilitator to family involvement, patients as main decision maker and patient prefers HCP to decide. HCPs preferred to share the decision with patients due to equipoise between prostate treatment options. Family culture was important as family members often decided on the patient's treatment due to Malaysia's close-knit family culture. Conclusions A range of decision making roles were reported by HCPs. It is thus important that stake-holder roles are clarified during PCa treatment decisions. HCPs need to cultivate an awareness of sociocultural norms and family dynamics when supporting non-Western patients in making decisions about PCa.	[Lee, Yew Kong; Ng, Chirk Jenn] Univ Malaya, Dept Primary Care Med, Fac Med, Kuala Lumpur 50603, Malaysia; [Lee, Ping Yein; Cheong, Ai Theng] Univ Putra Malaysia, Dept Family Med, Serdang 43400, Selangor, Malaysia; [Abdullah, Khatijah Lim] Univ Malaya, Dept Nursing Sci, Fac Med, Kuala Lumpur 50603, Malaysia; [Ong, Teng Aik; Razack, Azad Hassan Abdul] Univ Malaya, Dept Surg, Fac Med, Kuala Lumpur 50603, Malaysia	Universiti Malaya; Universiti Putra Malaysia; Universiti Malaya; Universiti Malaya	Lee, PY (corresponding author), Univ Putra Malaysia, Dept Family Med, Serdang 43400, Selangor, Malaysia.	pylee02@gmail.com	NG, CHIRK JENN/C-1344-2010; Lee, Yew Kong/K-4339-2013; Cheong, Ai Theng/H-9884-2014; Ong, Teng Aik/B-5321-2010; Abdullah, Khatijah Lim/B-8782-2010; Razack, Azad HA/B-8152-2009; Lee, Ping Yein/C-1923-2012	Lee, Yew Kong/0000-0002-3034-8601; Cheong, Ai Theng/0000-0002-3895-530X; Ong, Teng Aik/0000-0002-0207-8966; Abdullah, Khatijah Lim/0000-0002-7185-6004; Razack, Azad HA/0000-0002-4237-6511; Lee, Ping Yein/0000-0002-0912-6043; Ng, Chirk Jenn/0000-0002-8320-1603	Universiti Putra Malaysia [04-02-12-2093RU]	Universiti Putra Malaysia	We thank Universiti Putra Malaysia for funding the study via PYL (Grant number 04-02-12-2093RU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alden DL, 2012, ASIA-PAC J PUBLIC HE, V24, P173, DOI 10.1177/1010539510365098; Aning JJ, 2012, CURR ONCOL, V19, pS37, DOI 10.3747/co.19.1287; Au AHY, 2011, HEALTH EXPECT, V14, P405, DOI 10.1111/j.1369-7625.2010.00655.x; Baider L, 2012, ANN ONCOL, V23, P62, DOI 10.1093/annonc/mds090; Bogdan R., 1975, INTRO QUALITATIVE RE; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Claramita M, 2013, ADV HEALTH SCI EDUC, V18, P15, DOI 10.1007/s10459-012-9352-5; Claramita M, 2011, PATIENT EDUC COUNS, V85, pE169, DOI 10.1016/j.pec.2011.02.002; Dai Qingkang, 2003, Med Law Int, V6, P53; Davison BJ, 2004, BJU INT, V93, P47, DOI 10.1111/j.1464-410X.2004.04553.x; Davison BJ, 2002, CANCER NURS, V25, P42, DOI 10.1097/00002820-200202000-00009; Gwede CK, 2005, CANCER-AM CANCER SOC, V104, P1381, DOI 10.1002/cncr.21330; Humayun Ayesha, 2008, BMC Med Ethics, V9, P14, DOI 10.1186/1472-6939-9-14; Ilic D, 2015, PSYCHO-ONCOLOGY, V24, P1303, DOI 10.1002/pon.3815; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Keyes M, 2013, CAN FAM PHYSICIAN, V59, P1269; KITZINGER J, 1995, BRIT MED J, V311, P299, DOI 10.1136/bmj.311.7000.299; Lam W, 2003, BREAST CANCER RES TR, V80, P171, DOI 10.1023/A:1024568732213; Lam WW, 2005, PSYCHO-ONCOLOGY, V14, P1, DOI 10.1002/pon.803; Lee YK, 2015, INT J NURS PRACT, V21, P125, DOI 10.1111/ijn.12355; Ministry of Health Malaysia, 2007, MAL CANC STAT DAT FI; Ng CJ, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-408; Nomura K, 2007, INTERNAL MED, V46, P1403, DOI 10.2169/internalmedicine.46.0141; O'Connor AM, 1998, PATIENT EDUC COUNS, V33, P267, DOI 10.1016/S0738-3991(98)00026-3; Obeidat RF, 2013, ONCOL NURS FORUM, V40, P454, DOI 10.1188/13.ONF.454-463; Patton M. Q., 1980, QUALITATIVE EVALUATI; Pickles T, 2004, CAN FAM PHYSICIAN, V50, P65; POPE C, 1995, BRIT MED J, V311, P42, DOI 10.1136/bmj.311.6996.42; Ruhnke GW, 2000, CHEST, V118, P1172, DOI 10.1378/chest.118.4.1172; Schouten BC, 2006, PATIENT EDUC COUNS, V64, P21, DOI 10.1016/j.pec.2005.11.014; Singh JA, 2010, AM J MANAG CARE, V16, P688; Tariman JD, 2010, ANN ONCOL, V21, P1145, DOI 10.1093/annonc/mdp534; Teh YC, 2014, ASIAN PAC J CANCER P, V15, P3163, DOI 10.7314/APJCP.2014.15.7.3163; Tong WT, 2014, ASIA-PAC J PUBLIC HE, V26, P536, DOI 10.1177/1010539513514434; Yousuf R. M., 2007, SMJ Singapore Medical Journal, V48, P559; Zhang YH, 2011, MED DECIS MAKING, V31, P245, DOI 10.1177/0272989X10375990	36	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142812	10.1371/journal.pone.0142812	http://dx.doi.org/10.1371/journal.pone.0142812			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7DR	26559947	gold, Green Published, Green Submitted			2022-12-27	WOS:000364433100128
J	Lendvai, AZ; Akcay, C; Ouyang, JQ; Dakin, R; Domalik, AD; St John, PS; Stanback, M; Moore, IT; Bonier, F				Lendvai, Adam Z.; Akcay, Caglar; Ouyang, Jenny Q.; Dakin, Roslyn; Domalik, Alice D.; St John, Prianka S.; Stanback, Mark; Moore, Ignacio T.; Bonier, Frances			Analysis of the Optimal Duration of Behavioral Observations Based on an Automated Continuous Monitoring System in Tree Swallows (Tachycineta bicolor): Is One Hour Good Enough?	PLOS ONE			English	Article							PARENTAL CARE; BROOD-SIZE; BLUE TITS; NEST; SEX; ALLOCATION; NESTLINGS; SPARROWS; PATTERNS; FITNESS	Studies of animal behavior often rely on human observation, which introduces a number of limitations on sampling. Recent developments in automated logging of behaviors make it possible to circumvent some of these problems. Once verified for efficacy and accuracy, these automated systems can be used to determine optimal sampling regimes for behavioral studies. Here, we used a radio-frequency identification (RFID) system to quantify parental effort in a bi-parental songbird species: the tree swallow (Tachycineta bicolor). We found that the accuracy of the RFID monitoring system was similar to that of video-recorded behavioral observations for quantifying parental visits. Using RFID monitoring, we also quantified the optimum duration of sampling periods for male and female parental effort by looking at the relationship between nest visit rates estimated from sampling periods with different durations and the total visit numbers for the day. The optimum sampling duration (the shortest observation time that explained the most variation in total daily visits per unit time) was 1h for both sexes. These results show that RFID and other automated technologies can be used to quantify behavior when human observation is constrained, and the information from these monitoring technologies can be useful for evaluating the efficacy of human observation methods.	[Lendvai, Adam Z.; Akcay, Caglar; Ouyang, Jenny Q.; Moore, Ignacio T.; Bonier, Frances] Virginia Tech, Dept Biol Sci, Blacksburg, VA USA; [Lendvai, Adam Z.] Univ Debrecen, Dept Evolutionary Zool & Human Biol, Debrecen, Hungary; [Ouyang, Jenny Q.] Netherlands Inst Ecol NIOO KNAW, Wageningen, Netherlands; [Dakin, Roslyn] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Dakin, Roslyn; Domalik, Alice D.; St John, Prianka S.; Bonier, Frances] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada; [Stanback, Mark] Davidson Coll, Dept Biol, Davidson, NC 28035 USA	Virginia Polytechnic Institute & State University; University of Debrecen; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); University of British Columbia; Queens University - Canada; Davidson College	Lendvai, AZ (corresponding author), Univ Debrecen, Dept Evolutionary Zool & Human Biol, Debrecen, Hungary.	lendvai@vt.edu	Akcay, Caglar/F-7145-2010; Akcay, Caglar/X-5112-2019; Lendvai, Adam Z/B-8546-2008; KNAW, NIOO-KNAW/A-4320-2012	Akcay, Caglar/0000-0003-0635-9586; Akcay, Caglar/0000-0003-0635-9586; Lendvai, Adam Z/0000-0002-8953-920X; Moore, Ignacio/0000-0001-8875-8913; KNAW, NIOO-KNAW/0000-0002-3835-159X	U.S. National Science Foundation (NSF) grant [IOS-1145625]; Natural Sciences and Engineering Research Council of Canada; Banting Postdoctoral Fellowship; Hungarian Scientific Research Fund [OTKA K113108]; NSF postdoctoral grant [DBI-1306025]; Direct For Biological Sciences [1145625] Funding Source: National Science Foundation	U.S. National Science Foundation (NSF) grant(National Science Foundation (NSF)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Banting Postdoctoral Fellowship; Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); NSF postdoctoral grant; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding was provided by a U.S. National Science Foundation (NSF) grant (FB, ITM, and MFH; IOS-1145625), the Natural Sciences and Engineering Research Council of Canada, and a Banting Postdoctoral Fellowship (FB). During the preparation of the manuscript, AZL was supported by a Hungarian Scientific Research Fund (OTKA K113108) and JQO by a NSF postdoctoral grant (DBI-1306025).	Ardia DR, 2007, CAN J ZOOL, V85, P847, DOI 10.1139/Z07-070; Ardia DR, 2006, CONDOR, V108, P601, DOI 10.1650/0010-5422(2006)108[601:gvittb]2.0.co;2; Bonier F, 2009, GEN COMP ENDOCR, V163, P208, DOI 10.1016/j.ygcen.2008.12.013; Bonter DN, 2011, J FIELD ORNITHOL, V82, P1, DOI 10.1111/j.1557-9263.2010.00302.x; Bortolotti LE, 2011, CAN J ZOOL, V89, P921, DOI 10.1139/Z11-068; Bridge ES, 2011, J FIELD ORNITHOL, V82, P52, DOI 10.1111/j.1557-9263.2010.00307.x; CAREY M, 1990, AUK, V107, P580; DeVries MS, 2013, ANIM BEHAV, V85, P957, DOI 10.1016/j.anbehav.2013.02.019; Froud R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114468; Garcia-Navas V, 2012, CONDOR, V114, P612, DOI 10.1525/cond.2012.110120; Gomez J, 2014, J ORNITHOL, V155, P37, DOI 10.1007/s10336-013-0984-x; Haccou P., 1992, STAT ANAL BEHAV DATA; Hogle NC, 2014, J ORNITHOL, V155, P91, DOI 10.1007/s10336-013-0991-y; Johnsen A, 2005, ANIM BEHAV, V70, P877, DOI 10.1016/j.anbehav.2005.01.005; Leonard M, 1996, BEHAV ECOL SOCIOBIOL, V38, P341, DOI 10.1007/s002650050250; McCarty JP, 2002, J FIELD ORNITHOL, V73, P9, DOI 10.1648/0273-8570-73.1.9; Murphy MT, 2015, J FIELD ORNITHOL, V86, P41, DOI 10.1111/jofo.12087; Niederhauser JM, 2014, J FIELD ORNITHOL, V85, P180, DOI 10.1111/jofo.12059; Ouyang JQ, 2013, HORM BEHAV, V63, P776, DOI 10.1016/j.yhbeh.2013.03.002; Pagani-Nunez E, 2013, ACTA ORNITHOL, V48, P194, DOI 10.3161/000164513X678847; R Core Team, 2014, LANG ENV STAT COMP; Ritz C, 2005, J STAT SOFTW, V12, P1; Rose AP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004111; Schwagmeyer PL, 1997, ANIM BEHAV, V54, P470, DOI 10.1006/anbe.1997.0483; Shutler D, 2012, AVIAN CONSERV ECOL, V7, DOI 10.5751/ACE-00517-070103; Tuyttens FAM, 2014, ANIM BEHAV, V90, P273, DOI 10.1016/j.anbehav.2014.02.007; Verspoor JJ, 2007, BEHAV ECOL, V18, P967, DOI 10.1093/beheco/arm089; WHEELWRIGHT NT, 1992, BEHAV ECOL SOCIOBIOL, V31, P279; Whittingham LA, 2003, ANIM BEHAV, V65, P1203, DOI 10.1006/anbe.2003.2178	29	21	22	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0141194	10.1371/journal.pone.0141194	http://dx.doi.org/10.1371/journal.pone.0141194			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559407	Green Published, Green Submitted, gold			2022-12-27	WOS:000364433100024
J	Low, LF; Fletcher, J; Goodenough, B; Jeon, YH; Etherton-Beer, C; MacAndrew, M; Beattie, E				Low, Lee-Fay; Fletcher, Jennifer; Goodenough, Belinda; Jeon, Yun-Hee; Etherton-Beer, Christopher; MacAndrew, Margaret; Beattie, Elizabeth			A Systematic Review of Interventions to Change Staff Care Practices in Order to Improve Resident Outcomes in Nursing Homes	PLOS ONE			English	Review							LONG-TERM-CARE; RANDOMIZED CONTROLLED-TRIAL; EMOTION-ORIENTED CARE; PERSON-CENTERED CARE; QUALITY-OF-LIFE; DEMENTIA-CARE; HEALTH-CARE; HIP PROTECTORS; ORAL-HEALTH; AGED CARE	Background We systematically reviewed interventions that attempted to change staff practice to improve long-term care resident outcomes. Methods Studies met criteria if they used a control group, included 6 or more nursing home units and quantitatively assessed staff behavior or resident outcomes. Intervention components were coded as including education material, training, audit and feedback, monitoring, champions, team meetings, policy or procedures and organizational restructure. Results Sixty-three unique studies were broadly grouped according to clinical domain-oral health (3 studies), hygiene and infection control (3 studies), nutrition (2 studies), nursing home acquired pneumonia (2 studies), depression (2 studies) appropriate prescribing (7 studies), reduction of physical restraints (3 studies), management of behavioral and psychological symptoms of dementia (6 studies), falls reduction and prevention (11 studies), quality improvement (9 studies), philosophy of care (10 studies) and other (5 studies). No single intervention component, combination of, or increased number of components was associated with greater likelihood of positive outcomes. Studies with positive outcomes for residents also tended to change staff behavior, however changing staff behavior did not necessarily improve resident outcomes. Studies targeting specific care tasks (e.g. oral care, physical restraints) were more likely to produce positive outcomes than those requiring global practice changes (e.g. care philosophy). Studies using intervention theories were more likely to be successful. Program logic was rarely articulated, so it was often unclear whether there was a coherent connection between the intervention components and measured outcomes. Many studies reported barriers relating to staff (e.g. turnover, high workload, attitudes) or organizational factors (e.g. funding, resources, logistics). Conclusion Changing staff practice in nursing homes is possible but complex. Interventionists should consider barriers and feasibility of program components to impact on each intended outcome.	[Low, Lee-Fay; Fletcher, Jennifer] Univ Sydney, Fac Hlth Sci, Sydney, NSW 2006, Australia; [Goodenough, Belinda] Univ New S Wales, Dementia Collaborat Res Ctr Assessment & Better C, Sydney, NSW 2052, Australia; [Goodenough, Belinda] Univ Wollongong, Dementia Study Training Ctr, Wollongong, NSW 2522, Australia; [Jeon, Yun-Hee] Univ Sydney, Sydney Nursing Sch, Sydney, NSW 2006, Australia; [Etherton-Beer, Christopher] Univ Western Australia, Sch Med & Pharmacol, Royal Perth Hosp Unit, Perth, WA 6009, Australia; [MacAndrew, Margaret; Beattie, Elizabeth] Queensland Univ Technol, Fac Hlth, Dementia Collaborat Res Ctr Carers & Consumers, Brisbane, Qld 4001, Australia	University of Sydney; University of New South Wales Sydney; University of Wollongong; University of Sydney; Royal Perth Hospital; University of Western Australia; Queensland University of Technology (QUT)	Low, LF (corresponding author), Univ Sydney, Fac Hlth Sci, Sydney, NSW 2006, Australia.	lee-fay.low@sydney.edu.au	Etherton-Beer, Christopher/B-2714-2014; Low, Lee-Fay/AAX-5302-2020	Etherton-Beer, Christopher/0000-0001-5148-0188; MacAndrew, Margaret/0000-0002-3724-9980; Goodenough, Belinda/0000-0003-0347-7915; Fletcher, Jennifer/0000-0002-9846-9354; jeon, yun-hee/0000-0003-2031-9134	Dementia Collaborative Research Centres at University of New South Wales; Queensland University of Technology; Australian National University	Dementia Collaborative Research Centres at University of New South Wales; Queensland University of Technology; Australian National University(Australian National University)	This work was supported by the Dementia Collaborative Research Centres at University of New South Wales, Queensland University of Technology, and Australian National University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamse W, 2005, J ENVIRON PSYCHOL, V25, P273, DOI 10.1016/j.jenvp.2005.08.002; Achterberg WP, 2001, J ADV NURS, V35, P268, DOI 10.1046/j.1365-2648.2001.01843.x; AVORN J, 1992, NEW ENGL J MED, V327, P168, DOI 10.1056/NEJM199207163270306; Baier RR, 2008, J AM MED DIR ASSOC, V9, P594, DOI 10.1016/j.jamda.2008.06.008; Baldwin NS, 2010, J HOSP INFECT, V76, P36, DOI 10.1016/j.jhin.2010.03.006; Baskerville NB, 2012, ANN FAM MED, V10, P63, DOI 10.1370/afm.1312; Bauman A., 2013, EVALUATION NUTSHELL; Becker C, 2003, J AM GERIATR SOC, V51, P306, DOI 10.1046/j.1532-5415.2003.51103.x; Becker C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024311; Beeckman D, 2013, INT J NURS STUD, V50, P475, DOI 10.1016/j.ijnurstu.2012.09.007; Benjamin K, 2014, J AGING PHYS ACTIV, V22, P154, DOI 10.1123/japa.2012-0139; Berkhout AAJMB, 2003, WORK STRESS, V17, P337, DOI 10.1080/02678370310001647645; Berkhout AJMB, 2004, J ADV NURS, V45, P621, DOI 10.1046/j.1365-2648.2003.02956.x; Berta W, 2013, CAN J AGING, V32, P73, DOI 10.1017/S0714980813000081; Boorsma M, 2011, CAN MED ASSOC J, V183, pE724, DOI 10.1503/cmaj.101498; Boumans N, 2005, SCAND J CARING SCI, V19, P240, DOI 10.1111/j.1471-6712.2005.00351.x; Bouwen A, 2008, AGE AGEING, V37, P306, DOI 10.1093/ageing/afn053; Bravo G, 2005, INT J QUAL HEALTH C, V17, P511, DOI 10.1093/intqhc/mzi064; Brownie S, 2013, CLIN INTERV AGING, V8, P1, DOI 10.2147/CIA.S38589; Burack OR, 2012, CLIN GERONTOLOGIST, V35, P390, DOI 10.1080/07317115.2012.702649; Burack OR, 2012, J AM MED DIR ASSOC, V13, P522, DOI 10.1016/j.jamda.2012.02.006; Burgio LD, 2001, GERONTOLOGIST, V41, P449, DOI 10.1093/geront/41.4.449; Chenoweth L, 2009, LANCET NEUROL, V8, P317, DOI 10.1016/S1474-4422(09)70045-6; Clare L, 2013, INT PSYCHOGERIATR, V25, P128, DOI 10.1017/S1041610212001226; Cochrane Effective Practice and Organisation of Care Review Group, 2013, DAT COLL CHECKL; Cooksy LJ, 2001, EVAL PROGRAM PLANN, V24, P119, DOI 10.1016/S0149-7189(01)00003-9; Cox H, 2008, AGE AGEING, V37, P167, DOI 10.1093/ageing/afm168; Crotty M, 2004, AGE AGEING, V33, P612, DOI 10.1093/ageing/afh213; Crotty M, 2004, BMC HEALTH SERV RES, V4, DOI 10.1186/1472-6963-4-6; Curran GM, 2012, MED CARE, V50, P217, DOI 10.1097/MLR.0b013e3182408812; Day A, 2009, J FAM VIOLENCE, V24, P203, DOI 10.1007/s10896-008-9221-4; De Visschere L, 2012, GERODONTOLOGY, V29, pE96, DOI 10.1111/j.1741-2358.2010.00418.x; Deudon A, 2009, INT J GERIATR PSYCH, V24, P1386, DOI 10.1002/gps.2275; Dwyer JJM, 1997, CAN J PUBLIC HEALTH, V88, P421, DOI 10.1007/BF03403919; Eccles M, 2005, J CLIN EPIDEMIOL, V58, P107, DOI 10.1016/j.jclinepi.2004.09.002; Eccles MP, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-18; Eisses AMH, 2005, BRIT J PSYCHIAT, V186, P404, DOI 10.1192/bjp.186.5.404; Finnema E, 2005, INT J GERIATR PSYCH, V20, P330, DOI 10.1002/gps.1286; Fossey J, 2006, BMJ-BRIT MED J, V332, P756, DOI 10.1136/bmj.38782.575868.7C; Frenkel H, 2001, COMMUNITY DENT ORAL, V29, P289, DOI 10.1034/j.1600-0528.2001.290408.x; Gaskill D, 2009, J NUTR HEALTH AGING, V13, P913, DOI 10.1007/s12603-009-0251-2; Grol R, 2004, MED J AUSTRALIA, V180, pS57, DOI 10.5694/j.1326-5377.2004.tb05948.x; Gulpers MJM, 2013, J AM GERIATR SOC, V61, P107, DOI 10.1111/jgs.12057; Gulpers MJM, 2011, J AM GERIATR SOC, V59, P2029, DOI 10.1111/j.1532-5415.2011.03662.x; Ho ML, 2012, INFECT CONT HOSP EP, V33, P761, DOI 10.1086/666740; Hoeffer B, 2006, GERONTOLOGIST, V46, P524, DOI 10.1093/geront/46.4.524; Huizing AR, 2009, J AM GERIATR SOC, V57, P1139, DOI 10.1111/j.1532-5415.2009.02309.x; Hutt E, 2011, J AM MED DIR ASSOC, V12, P499, DOI 10.1016/j.jamda.2010.03.011; Hutt E, 2010, J AM MED DIR ASSOC, V11, P365, DOI 10.1016/j.jamda.2009.09.017; Irvine AB, 2012, GERONTOLOGIST, V52, P13, DOI 10.1093/geront/gnr069; Jenkinson C, 2002, QUAL SAF HEALTH CARE, V11, P335, DOI 10.1136/qhc.11.4.335; Jeon YH, 2012, INT J NURS STUD, V49, P508, DOI 10.1016/j.ijnurstu.2011.10.020; Johnson CSJ, 2005, CAN J AGING, V24, P115, DOI 10.1353/cja.2005.0065; Jones Katherine R, 2004, Worldviews Evid Based Nurs, V1 Suppl 1, pS13, DOI 10.1111/j.1524-475X.2004.04045.x; Kerse N, 2004, J AM GERIATR SOC, V52, P524, DOI 10.1111/j.1532-5415.2004.52157.x; Kopke S, 2012, JAMA-J AM MED ASSOC, V307, P2177, DOI 10.1001/jama.2012.4517; Kuske B, 2007, INT PSYCHOGERIATR, V19, P818, DOI 10.1017/S1041610206004352; Leone E, 2013, INT J GERIATR PSYCH, V28, P383, DOI 10.1002/gps.3836; Leontjevas R, 2013, LANCET, V381, P2255, DOI 10.1016/S0140-6736(13)60590-5; Linnebur SA, 2011, AM J GERIATR PHARMAC, V9, P442, DOI 10.1016/j.amjopharm.2011.09.009; Makris AT, 2000, AM J INFECT CONTROL, V28, P3, DOI 10.1016/S0196-6553(00)90004-X; McCluskey Annie, 2005, BMC Med Educ, V5, P40, DOI 10.1186/1472-6920-5-40; Meador KG, 1997, J AM GERIATR SOC, V45, P207, DOI 10.1111/j.1532-5415.1997.tb04509.x; Meyer G, 2005, J AM GERIATR SOC, V53, P2153, DOI 10.1111/j.1532-5415.2005.00490.x; Meyer G, 2003, BRIT MED J, V326, P76, DOI 10.1136/bmj.326.7380.76; Michie S, 2005, QUAL SAF HEALTH CARE, V14, P26, DOI 10.1136/qshc.2004.011155; Miller Susan C, 2010, Med Care Res Rev, V67, p65S, DOI 10.1177/1077558710366862; Molloy DW, 2000, JAMA-J AM MED ASSOC, V283, P1437, DOI 10.1001/jama.283.11.1437; Naughton BJ, 2001, J AM GERIATR SOC, V49, P1020, DOI 10.1046/j.1532-5415.2001.49203.x; Nilsen P, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0242-0; Nilsen P, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-53; O'Halloran PD, 2004, AGE AGEING, V33, P582, DOI 10.1093/ageing/afh200; OXMAN AD, 1995, CAN MED ASSOC J, V153, P1423; Petticrew M, 2013, J CLIN EPIDEMIOL, V66, P1209, DOI 10.1016/j.jclinepi.2013.06.004; Pittet D, 2000, LANCET, V356, P1307, DOI 10.1016/S0140-6736(00)02814-2; Proctor R, 1999, LANCET, V354, P26, DOI 10.1016/S0140-6736(98)08237-3; Rahman AN, 2012, GERONTOLOGIST, V52, P597, DOI 10.1093/geront/gnr157; Rantz MJ, 2012, J AM MED DIR ASSOC, V13, P60, DOI 10.1016/j.jamda.2011.06.012; Rantz MJ, 2010, J AM MED DIR ASSOC, V11, P485, DOI 10.1016/j.jamda.2009.11.010; Rantz MJ, 2001, GERONTOLOGIST, V41, P525, DOI 10.1093/geront/41.4.525; Rapp K, 2010, J AM GERIATR SOC, V58, P70, DOI 10.1111/j.1532-5415.2009.02630.x; Rask K, 2007, J AM GERIATR SOC, V55, P342, DOI 10.1111/j.1532-5415.2007.01083.x; Ray WA, 2005, ARCH INTERN MED, V165, P2293, DOI 10.1001/archinte.165.19.2293; Scalzi Cynthia C, 2006, Nurs Adm Q, V30, P368; Schmidt I, 1998, J AM GERIATR SOC, V46, P77, DOI 10.1111/j.1532-5415.1998.tb01017.x; Schrijnemaekers V, 2002, INT J GERIATR PSYCH, V17, P926, DOI 10.1002/gps.681; Schrijnemaekers VJJ, 2003, J GERONTOL B-PSYCHOL, V58, pS50, DOI 10.1093/geronb/58.1.S50; Schrijnemaekers VJJ, 2002, J ADV NURS, V39, P182, DOI 10.1046/j.1365-2648.2002.02258.x; Scott SD, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-70; Scott Tim, 2003, J Health Serv Res Policy, V8, P105, DOI 10.1258/135581903321466085; Shier V, 2014, GERONTOLOGIST, V54, pS6, DOI 10.1093/geront/gnt147; Silva RB, 2013, J AM MED DIR ASSOC, V14, P685, DOI 10.1016/j.jamda.2013.05.015; Sloane PD, 2004, J AM GERIATR SOC, V52, P1795, DOI 10.1111/j.1532-5415.2004.52501.x; Smith M, 2013, ISSUES MENT HEALTH N, V34, P90, DOI 10.3109/01612840.2012.723798; Spector A, 2013, AGEING RES REV, V12, P354, DOI 10.1016/j.arr.2012.06.005; Stein CM, 2001, MED CARE, V39, P436; Teresi JA, 2013, INT J NURS STUD, V50, P644, DOI 10.1016/j.ijnurstu.2012.10.010; Teresi JA, 2013, INT J NURS STUD, V50, P448, DOI 10.1016/j.ijnurstu.2011.07.003; Testad I, 2014, INT PSYCHOGERIATR, V26, P1083, DOI 10.1017/S1041610214000131; Thompson DS, 2007, IMPLEMENT SCI, V2, DOI 10.1186/1748-5908-2-15; van de Ven G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067325; van der Putten GJ, 2013, CLIN ORAL INVEST, V17, P1143, DOI 10.1007/s00784-012-0793-2; van Gaal BGI, 2011, INT J NURS STUD, V48, P1040, DOI 10.1016/j.ijnurstu.2011.02.017; van Gaal BGI, 2010, INT J NURS STUD, V47, P1117, DOI 10.1016/j.ijnurstu.2010.02.001; van Weert JCM, 2006, J ADV NURS, V53, P656, DOI 10.1111/j.1365-2648.2006.03772.x; van Weert JCM, 2005, PATIENT EDUC COUNS, V58, P312, DOI 10.1016/j.pec.2004.07.013; van Weert JCM, 2004, INT J NURS STUD, V41, P397, DOI 10.1016/j.ijnurstu.2003.10.011; Vernooij-Dassen M, 2014, AGING MENT HEALTH, V18, P809, DOI 10.1080/13607863.2014.899977; Wagner C, 2001, QUAL HEALTH CARE, V10, P211, DOI 10.1136/qhc.0100211..; Wagner LM, 2005, GERONTOLOGIST, V45, P835, DOI 10.1093/geront/45.6.835; Westbury J, 2011, INT PSYCHOGERIATR, V23, P1260, DOI 10.1017/S1041610211000421; Westbury J, 2010, AUSTRALAS J AGEING, V29, P72, DOI 10.1111/j.1741-6612.2010.00409.x; Westbury J, 2010, INT PSYCHOGERIATR, V22, P26, DOI 10.1017/S1041610209991128; Westergren A, 2009, FOOD NUTR RES, V53; Westergren A, 2010, FOOD NUTR RES, V54, DOI 10.3402/fnr.v54i0.5402; Zimmerman S., 2010, ALZHEIMERS CARE TODA, V11, P83, DOI [10.1097/ACQ.0b013e3181dc1aad, DOI 10.1097/ACQ.0B013E3181DC1AAD]	116	81	82	2	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0140711	10.1371/journal.pone.0140711	http://dx.doi.org/10.1371/journal.pone.0140711			60	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7DR	26559675	gold, Green Published, Green Submitted			2022-12-27	WOS:000364433100007
J	Oprea, TI; Sklar, LA; Agola, JO; Guo, Y; Silberberg, M; Roxby, J; Vestling, A; Romero, E; Surviladze, Z; Murray-Krezan, C; Waller, A; Ursu, O; Hudson, LG; Wandinger-Ness, A				Oprea, Tudor I.; Sklar, Larry A.; Agola, Jacob O.; Guo, Yuna; Silberberg, Melina; Roxby, Joshua; Vestling, Anna; Romero, Elsa; Surviladze, Zurab; Murray-Krezan, Cristina; Waller, Anna; Ursu, Oleg; Hudson, Laurie G.; Wandinger-Ness, Angela			Novel Activities of Select NSAID R-Enantiomers against Rac1 and Cdc42 GTPases	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; SMALL-MOLECULE INHIBITOR; CHRONIC LYMPHOCYTIC-LEUKEMIA; NUCLEOTIDE EXCHANGE FACTORS; GROWTH-FACTOR RECEPTOR; FAMILY SMALL GTPASES; HUMAN BREAST-CANCER; RHO-GTPASES; FLOW-CYTOMETRY; OVARIAN-CANCER	Rho family GTPases (including Rac, Rho and Cdc42) collectively control cell proliferation, adhesion and migration and are of interest as functional therapeutic targets in numerous epithelial cancers. Based on high throughput screening of the Prestwick Chemical Library1 and cheminformatics we identified the R-enantiomers of two approved drugs (naproxen and ketorolac) as inhibitors of Rac1 and Cdc42. The corresponding S-enantiomers are considered the active component in racemic drug formulations, acting as non-steroidal anti-inflammatory drugs (NSAIDs) with selective activity against cyclooxygenases. Here, we show that the S-enantiomers of naproxen and ketorolac are inactive against the GTPases. Additionally, more than twenty other NSAIDs lacked inhibitory action against the GTPases, establishing the selectivity of the two identified NSAIDs. R-naproxen was first identified as a lead compound and tested in parallel with its S-enantiomer and the non-chiral 6-methoxy-naphthalene acetic acid (active metabolite of nabumetone, another NSAID) as a structural series. Cheminformatics-based substructure analyses-using the rotationally constrained carboxylate in R-naproxen-led to identification of racemic [R/S] ketorolac as a suitable FDA-approved candidate. Cell based measurement of GTPase activity (in animal and human cell lines) demonstrated that the R-enantiomers specifically inhibit epidermal growth factor stimulated Rac1 and Cdc42 activation. The GTPase inhibitory effects of the R-enantiomers in cells largely mimic those of established Rac1 (NSC23766) and Cdc42 (CID2950007/ML141) specific inhibitors. Docking predicts that rotational constraints position the carboxylate moieties of the R-enantiomers to preferentially coordinate the magnesium ion, thereby destabilizing nucleotide binding to Rac1 and Cdc42. The S-enantiomers can be docked but are less favorably positioned in proximity to the magnesium. R-naproxen and R-ketorolac have potential for rapid translation and efficacy in the treatment of several epithelial cancer types on account of established human toxicity profiles and novel activities against Rho-family GTPases.	[Oprea, Tudor I.; Sklar, Larry A.; Guo, Yuna; Surviladze, Zurab; Waller, Anna; Hudson, Laurie G.; Wandinger-Ness, Angela] Univ New Mexico, Hlth Sci Ctr, Ctr Comprehens Canc, Albuquerque, NM 87131 USA; [Oprea, Tudor I.; Ursu, Oleg] Univ New Mexico, Hlth Sci Ctr, Translat Informat Div, Dept Internal Med, Albuquerque, NM 87131 USA; [Sklar, Larry A.; Agola, Jacob O.; Guo, Yuna; Vestling, Anna; Romero, Elsa; Wandinger-Ness, Angela] Univ New Mexico, Hlth Sci Ctr, Dept Pathol, Albuquerque, NM 87131 USA; [Sklar, Larry A.; Surviladze, Zurab; Waller, Anna] Univ New Mexico, Hlth Sci Ctr, Ctr Mol Discovery, Albuquerque, NM 87131 USA; [Murray-Krezan, Cristina] Univ New Mexico, Hlth Sci Ctr, Div Epidemiol Biostat & Prevent Med, Dept Internal Med, Albuquerque, NM 87131 USA; [Silberberg, Melina; Roxby, Joshua; Hudson, Laurie G.] Univ New Mexico, Hlth Sci Ctr, Dept Pharmaceut Sci, Coll Pharm, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center	Wandinger-Ness, A (corresponding author), Univ New Mexico, Hlth Sci Ctr, Ctr Comprehens Canc, Albuquerque, NM 87131 USA.	wness@unm.edu	aubertin, rebeckah/O-9624-2015; Oprea, Tudor/A-5746-2011	aubertin, rebeckah/0000-0002-0558-7571; Oprea, Tudor/0000-0002-6195-6976	Department of Defense [OC093205, OC110514]; University of New Mexico Cancer Center [0990MD, 0990VW]; National Cancer Institute [R21 CA170375, P30 CA1181000, R25 CA153825]; National Institute of Mental Health [R03MH081231, U54 MH074425, U54 MH084690]; National Institute of Neurological Disorders and Stroke [R21 NS7740241]; National Science Foundation [MCB0956027]; National Institute of General Medical Sciences [R25 GM060201]; NATIONAL CANCER INSTITUTE [P30CA118100, R25CA153825, R21CA170375] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001449, UL1TR000041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM060201] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084690, U54MH074425, R03MH081231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077402] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); University of New Mexico Cancer Center; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Science Foundation(National Science Foundation (NSF)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the following sources of funding to: AWN LGH (Department of Defense [http://www.defense.gov] Concept Award OC093205 and Teal Expansion Award OC110514; University of New Mexico Cancer Center [http://cancer.unm.edu] Focus Interactive Group Awards 0990MD and 0990VW; National Cancer Institute [http://www.cancer.gov] R21 CA170375); AWN, ER and JOA (National Institute of Mental Health [http://www.nimh.nih.gov/index.shtml] R03MH081231 and National Institute of Neurological Disorders and Stroke [http://www.ninds.nih.gov] R21 NS7740241; National Science Foundation [http://www.nsf.gov/funding/] MCB0956027); AWN, LAS and TIO (National Cancer Institute [http://www.cancer.gov] P30 CA1181000); LAS, ZS, AW, OU, and TIO (National Institute of Mental Health [http://www.nimh.nih.gov/index.shtml] U54 MH074425 and U54 MH084690); AV (National Institute of General Medical Sciences [www.nigms.nih.gov] R25 GM060201); and YG (National Cancer Institute [http://www.cancer.gov] R25 CA153825). HeLaT4+ cells were obtained through the NIH AIDS Reagent Program [https://www.aidsreagent.org/reagentdetail.cfm?t=cell_lines&id=253], Division of AIDS, NIAID, originally deposited by Dr. Richard Axel.	Agola JO, 2012, ACS CHEM BIOL, V7, P1095, DOI 10.1021/cb3001099; ARIENS EJ, 1984, EUR J CLIN PHARMACOL, V26, P663, DOI 10.1007/BF00541922; BARNETT J, 1994, BBA-PROTEIN STRUCT M, V1209, P130, DOI 10.1016/0167-4838(94)90148-1; BAST RC, 1981, J CLIN INVEST, V68, P1331, DOI 10.1172/JCI110380; Baugher PJ, 2005, BREAST CANCER RES, V7, pR965, DOI 10.1186/bcr1329; Bid HK, 2013, MOL CANCER THER, V12, P1925, DOI 10.1158/1535-7163.MCT-13-0164; Blum R, 2008, RECENT PAT ANTI-CANC, V3, P31; Bologa CG, 2006, NAT CHEM BIOL, V2, P207, DOI 10.1038/nchembio775; Bosetti C, 2009, RECENT RESULTS CANC, V181, P231; Buchanan FG, 2003, J BIOL CHEM, V278, P35451, DOI 10.1074/jbc.M302474200; Buranda T, 2013, ANAL BIOCHEM, V442, P149, DOI 10.1016/j.ab.2013.07.039; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Caino MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031714; Carabaza A, 1996, J CLIN PHARMACOL, V36, P505, DOI 10.1002/j.1552-4604.1996.tb05040.x; Carter JH, 2004, CLIN CANCER RES, V10, P3448, DOI 10.1158/1078-0432.CCR-03-0210; Cherfils J, 2013, PHYSIOL REV, V93, P269, DOI 10.1152/physrev.00003.2012; Cook DR, 2014, ONCOGENE, V33, P4021, DOI 10.1038/onc.2013.362; CYaNMCCA Muller, 2012, AVAILABILITY EFFECT; Dahl KDC, 2007, MOL CANCER RES, V5, P413, DOI 10.1158/1541-7786.MCR-07-0019; Daugherty SE, 2011, AM J EPIDEMIOL, V173, P721, DOI 10.1093/aje/kwq437; Duggan KC, 2010, J BIOL CHEM, V285, P34950, DOI 10.1074/jbc.M110.162982; Durant JL, 2002, J CHEM INF COMP SCI, V42, P1273, DOI 10.1021/ci010132r; Ellenbroek SIJ, 2007, CLIN EXP METASTAS, V24, P657, DOI 10.1007/s10585-007-9119-1; Elwood PC, 2009, LANCET, V373, P1301, DOI 10.1016/S0140-6736(09)60243-9; Engers R, 2001, J BIOL CHEM, V276, P41889, DOI 10.1074/jbc.M105049200; Evans AM, 1996, J CLIN PHARMACOL, V36, pS7; Feng R, 2007, DRUG NEWS PERSPECT, V20, P431, DOI 10.1358/dnp.2007.20.7.1149631; Ferri N, 2009, J MED CHEM, V52, P4087, DOI 10.1021/jm8015987; Forget P, 2014, BRIT J ANAESTH, V113, P82, DOI 10.1093/bja/aet464; Forget P, 2013, MED HYPOTHESES, V81, P707, DOI 10.1016/j.mehy.2013.07.033; Fortin SP, 2012, MOL CANCER RES, V10, P958, DOI 10.1158/1541-7786.MCR-11-0616; Friesland A, 2013, P NATL ACAD SCI USA, V110, P1261, DOI 10.1073/pnas.1116051110; Fritz G, 2006, CURR CANCER DRUG TAR, V6, P1, DOI 10.2174/156800906775471752; Furmaniak-Kazmierczak E, 2007, CIRC RES, V100, P1328, DOI 10.1161/CIRCRESAHA.106.147744; FURST DE, 1987, ARTHRITIS RHEUM, V30, P1157, DOI 10.1002/art.1780301011; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Garcia-Mata R, 2007, TRENDS CELL BIOL, V17, P36, DOI 10.1016/j.tcb.2006.11.004; Gassmann P, 2009, NEOPLASIA, V11, P651, DOI 10.1593/neo.09272; Geerts H, 2007, IDRUGS, V10, P121; GLASER K, 1995, EUR J PHARMACOL, V281, P107, DOI 10.1016/0014-2999(95)00302-2; Gould CM, 2014, CELL ADHES MIGR, V8, P226, DOI 10.4161/cam.28346; Govek EE, 2011, DEV NEUROBIOL, V71, P528, DOI 10.1002/dneu.20850; Grant JA, 1996, J COMPUT CHEM, V17, P1653, DOI 10.1002/(SICI)1096-987X(19961115)17:14<1653::AID-JCC7>3.0.CO;2-K; Guo Y, 2015, CLIN CANCER RES, DOI [10.1158/1078-0432.CCR-15-0461, DOI 10.1158/1078-0432]; Guo YN, 2015, MOL CANCER THER, V14, P2215, DOI 10.1158/1535-7163.MCT-15-0419; Hales DB, 2008, ENDOCRINE, V33, P235, DOI 10.1007/s12020-008-9080-z; Hall A, 2012, BIOCHEM SOC T, V40, P1378, DOI 10.1042/BST20120103; Handley DA, 1998, J CLIN PHARMACOL, V38, p25S, DOI 10.1002/j.1552-4604.1998.tb04414.x; Hannibal CG, 2008, AM J EPIDEMIOL, V167, P1430, DOI 10.1093/aje/kwn082; Harman CA, 2007, J BIOL CHEM, V282, P28096, DOI 10.1074/jbc.M701335200; Hawkins PCD, 2007, J MED CHEM, V50, P74, DOI 10.1021/jm0603365; Hawkins PCD, 2012, J CHEM INF MODEL, V52, P2919, DOI 10.1021/ci300314k; Hawkins PCD, 2010, J CHEM INF MODEL, V50, P572, DOI 10.1021/ci100031x; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hong L, 2010, PROBE REPORTS NIH MO; Hong L, 2013, J BIOL CHEM, V288, P8531, DOI 10.1074/jbc.M112.435941; Horiguchi A, 2004, CLIN CANCER RES, V10, P8648, DOI 10.1158/1078-0432.CCR-04-1568; Huntjens DRH, 2006, BRIT J PHARMACOL, V148, P396, DOI 10.1038/sj.bjp.0706737; Inoue T, 2010, ONCOL REP, V24, P1487, DOI 10.3892/or_00001009; Janssen A, 2006, EUR J PHARMACOL, V540, P24, DOI 10.1016/j.ejphar.2006.04.030; Jett MF, 1999, J PHARMACOL EXP THER, V288, P1288; Kamai T, 2004, CLIN CANCER RES, V10, P4799, DOI 10.1158/1078-0432.CCR-0436-03; Karlsson R, 2009, BBA-REV CANCER, V1796, P91, DOI 10.1016/j.bbcan.2009.03.003; KEAN WF, 1989, J PHARM SCI, V78, P324, DOI 10.1002/jps.2600780413; KEAN WF, 1991, LANCET, V338, P1565, DOI 10.1016/0140-6736(91)92382-C; KENDALL MJ, 1989, EUR J CLIN PHARMACOL, V36, P299, DOI 10.1007/BF00558163; Kim HJ, 2014, BIOMOL THER, V22, P540, DOI 10.4062/biomolther.2014.081; Kolluri SK, 2005, P NATL ACAD SCI USA, V102, P2525, DOI 10.1073/pnas.0409721102; Kulkarni K, 2011, J BIOL CHEM, V286, P25341, DOI 10.1074/jbc.M111.236455; LANEUVILLE O, 1994, J PHARMACOL EXP THER, V271, P927; Lawson Campbell D, 2014, Small GTPases, V5, pe27958, DOI 10.4161/sgtp.27958; Lehmann FP., 1978, CHEM-BIOL INTERACT, V20, P239; Liggett JL, 2014, CANCER LETT, V346, P217, DOI 10.1016/j.canlet.2014.01.021; Lin Y, 2015, EXPERT OPIN DRUG DIS, V10, P991, DOI 10.1517/17460441.2015.1058775; Lindhagen E, 2007, CANCER CHEMOTH PHARM, V60, P545, DOI 10.1007/s00280-006-0400-9; Liu JK, 2012, J NEURO-ONCOL, V106, P561, DOI 10.1007/s11060-011-0712-4; Lu DS, 2004, P NATL ACAD SCI USA, V101, P3118, DOI 10.1073/pnas.0308648100; Machesky LM, 2008, FEBS LETT, V582, P2102, DOI 10.1016/j.febslet.2008.03.039; Mack NA, 2011, CELL CYCLE, V10, P1571, DOI 10.4161/cc.10.10.15612; MADDON PJ, 1986, CELL, V47, P333, DOI 10.1016/0092-8674(86)90590-8; Mills JEJ, 1996, J COMPUT AID MOL DES, V10, P607, DOI 10.1007/BF00134183; MITCHELL JA, 1993, P NATL ACAD SCI USA, V90, P11693, DOI 10.1073/pnas.90.24.11693; Montalvo-Ortiz BL, 2012, J BIOL CHEM, V287, P13228, DOI 10.1074/jbc.M111.334524; Mroszczak E, 1996, J CLIN PHARMACOL, V36, P521, DOI 10.1002/j.1552-4604.1996.tb05042.x; Muller O, 2004, ANGEW CHEM INT EDIT, V43, P450, DOI 10.1002/anie.200352587; Murray DW, 2014, BRIT J CANCER, V110, P1307, DOI 10.1038/bjc.2014.39; Nassar N, 2006, CURR TOP MED CHEM, V6, P1109, DOI 10.2174/156802606777812095; Ni SB, 2013, CANCER SCI, V104, P817, DOI 10.1111/cas.12157; Nicholls A, 2007, J MED CHEM, V50, P74; Onesto C, 2008, METHOD ENZYMOL, V439, P111, DOI 10.1016/S0076-6879(07)00409-0; OpenEye, 2014, OMEGA 2 4 6 SCI SOFT; OpenEye, 2014, ROCS 2 4 2 SCI SOFTW; Oprea Tudor I, 2011, Drug Discov Today Ther Strateg, V8, P61; Orgaz Jose L, 2014, Small GTPases, V5, pe29019, DOI 10.4161/sgtp.29019; Ortiz-Sanchez JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040809; Pinheiro SP, 2009, AM J EPIDEMIOL, V169, P1378, DOI 10.1093/aje/kwp062; Retsky M, 2013, CURR MED CHEM, V20, P4163; Retsky M, 2012, BREAST CANCER RES TR, V134, P881, DOI 10.1007/s10549-012-2094-5; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Robak P, 2008, LEUKEMIA LYMPHOMA, V49, P1452, DOI 10.1080/10428190802108854; Sahin IH, 2014, CANCER LETT, V345, P249, DOI 10.1016/j.canlet.2013.09.001; Schmitz K, 2014, EMBO MOL MED, V6, P1398, DOI 10.15252/emmm.201404168; Schnelzer A, 2000, ONCOGENE, V19, P3013, DOI 10.1038/sj.onc.1203621; Schwartz SL, 2008, ANAL BIOCHEM, V381, P258, DOI 10.1016/j.ab.2008.06.039; Shigemasa K, 2003, INT J ONCOL, V22, P99; Singh A, 2004, ONCOGENE, V23, P9369, DOI 10.1038/sj.onc.1208182; Skvortsov S, 2014, BRIT J CANCER, V110, P2677, DOI 10.1038/bjc.2014.221; Smith SW, 2009, TOXICOL SCI, V110, P4, DOI 10.1093/toxsci/kfp097; Spiering D, 2011, CELL ADHES MIGR, V5, P170, DOI 10.4161/cam.5.2.14403; Spuul P, 2014, SMALL GTPASES, V5, DOI [10.4161/sgtp.28713, DOI 10.4161/SGTP.28713]; Stengel K, 2011, CELL SIGNAL, V23, P1415, DOI 10.1016/j.cellsig.2011.04.001; Stolfi C, 2013, INT J MOL SCI, V14, P17972, DOI 10.3390/ijms140917972; SUESA N, 1993, CHIRALITY, V5, P589, DOI 10.1002/chir.530050805; Sun D, 2006, DRUG RESIST UPDATE, V9, P274, DOI 10.1016/j.drup.2006.12.001; Surviladze Z., 2010, PROBE REPORTS NIH MO; Surviladze Z, 2012, METHODS MOL BIOL, V827, P253, DOI 10.1007/978-1-61779-442-1_17; Surviladze Z, 2010, J BIOMOL SCREEN, V15, P10, DOI 10.1177/1087057109352240; TANIMOTO TT, 1961, T NEW YORK ACAD SCI, V23, P576, DOI 10.1111/j.2164-0947.1961.tb01390.x; Thomas EK, 2007, CANCER CELL, V12, P467, DOI 10.1016/j.ccr.2007.10.015; Thorat MA, 2013, CURR ONCOL REP, V15, P533, DOI 10.1007/s11912-013-0351-3; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Waldmann H, 2004, ANGEW CHEM INT EDIT, V43, P454, DOI 10.1002/anie.200353089; Warner TD, 1999, P NATL ACAD SCI USA, V96, P7563, DOI 10.1073/pnas.96.13.7563; Weaver AM, 2006, CLIN EXP METASTAS, V23, P97, DOI 10.1007/s10585-006-9014-1; WECHTER WJ, 1994, J CLIN PHARMACOL, V34, P1036, DOI 10.1002/j.1552-4604.1994.tb01977.x; Wiemer AJ, 2011, CLIN PHARMACOL THER, V90, P804, DOI 10.1038/clpt.2011.215; Wilson JC, 2011, CANCER CAUSE CONTROL, V22, P803, DOI 10.1007/s10552-011-9751-6; Yang J, 2009, SCIENCE, V325, P1398, DOI 10.1126/science.1174468; Yasui H, 2007, LEUKEMIA, V21, P535, DOI 10.1038/sj.leu.2404561; Yasui H, 2005, BLOOD, V106, P706, DOI 10.1182/blood-2005-02-0838; Zhou C, 2013, ONCOGENE, V32, P903, DOI 10.1038/onc.2012.99; Zins K, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-295; Zins K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074924	133	32	32	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142182	10.1371/journal.pone.0142182	http://dx.doi.org/10.1371/journal.pone.0142182			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26558612	gold, Green Submitted, Green Published			2022-12-27	WOS:000364433100059
J	Rao, M; Zuo, LD; Fang, F; Martin, K; Zheng, Y; Zhang, HP; Li, HG; Zhu, CH; Xiong, CL; Guan, HT				Rao, Meng; Zuo, Lian-Dong; Fang, Fang; Martin, Kuete; Zheng, Yi; Zhang, Hui-Ping; Li, Hong-Gang; Zhu, Chang-Hong; Xiong, Cheng-Liang; Guan, Huang-Tao			Association of Alcohol Consumption with Markers of Prostate Health and Reproductive Hormone Profiles: A Multi-Center Study of 4535 Men in China	PLOS ONE			English	Article							URINARY-TRACT SYMPTOMS; RISK-FACTORS; CIGARETTE-SMOKING; AMERICAN MEN; CANCER; HYPERPLASIA; POPULATION; PSA; TESTOSTERONE; ANTIGEN	Background The effect of alcohol consumption on prostate health and reproductive hormone profiles has long been investigated and currently, no consensus has been reached. Additionally, large studies focusing on this topic are relatively rare in China. Purpose To investigate the association of alcohol consumption with prostate measurements and reproductive hormone profiles in Chinese population; and to examine the relationship between hormone levels and prostate measurements. Methods This cross-sectional study included 4535 men from four representative provinces of China. Demographic details, family history of prostate disease, tobacco and alcohol consumption, as well as International Prostate Symptom Score (I-PSS) were collected through a questionnaire. Total prostate specific antingen (total PSA), free PSA, free PSA/total PSA ratio (f/tPSA), and reproductive hormones were measured in serum. Multi-variable regression models were used to test for association of alcohol consumption with markers of prostate health, used to test for association of alcohol consumption with reproductive hormones, and reproductive hormones with markers of prostate health. Results Alcohol consumption had no obvious impact on total PSA concentration and I-PSS. Current drinkers had lower level of free PSA (beta = -0.11, rho = 0.02) and f/tPSA (beta = -0.03, rho = 0.005), former drinkers also had lower level of free PSA (beta = -0.19, rho = 0.02) when compared with never drinkers. Lower Luteinizing hormone (LH) (beta = -1.05, rho = 0.01), sex hormone-binding globulin (SHBG) (beta = -4.71, rho = 0.01) and higher estradiol (beta = 7.81, rho = 0.01) was found in current drinkers than never drinkers, whereas higher LH (beta = 1.04, rho = 0.04) and free testosterone (FT) (beta = 0.03, rho = 0.02) was detected in former drinkers than never drinkers. Furthermore, LH was positively associated with f/tPSA (beta = 0.002, rho = 0.006), SHBG was also positively related with free PSA (beta = 0.003, rho = 0.003) and f/tPSA (beta = 0.0004, rho = 0.01). Both total testosterone (TT) and FT were inversely related with I-PSS (OR = 0.97, 95% CI, 0.95-0.98; OR = 0.23, 95% CI, 0.11-0.45, respectively). Conclusions Alcohol consumption could affect serum free PSA concentration and also f/tPSA ratio, and also acts as an endocrine disruptor on the male reproductive hormone profiles. LH and SHBG were positively related with fPSA and f/tPSA, and higher level of TT and FT may be helpful for improving participants' subjective symptoms.	[Rao, Meng; Fang, Fang; Martin, Kuete; Zhang, Hui-Ping; Li, Hong-Gang; Zhu, Chang-Hong; Xiong, Cheng-Liang; Guan, Huang-Tao] Huazhong Univ Sci & Technol, Tongji Med Coll, Family Planning Res Inst, Wuhan 430074, Peoples R China; [Zuo, Lian-Dong] Guangzhou Inst Populat & Family Planning, Guangzhou, Guangdong, Peoples R China; [Zheng, Yi] Wuhan Inst Dermatol & Venereol, Dept Venereol, Wuhan, Peoples R China; [Zhang, Hui-Ping; Li, Hong-Gang; Zhu, Chang-Hong; Xiong, Cheng-Liang; Guan, Huang-Tao] Huazhong Univ Sci & Technol, Tongji Med Coll, Reprod Med Ctr, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Guan, HT (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Family Planning Res Inst, Wuhan 430074, Peoples R China.	guanhtao@163.com	Zhang, Hui/HHN-8494-2022	Zheng, Yi/0000-0002-4953-6004	National Science and Technology Support Program of the Ministry of Science and Tec [2012BAI32B03]	National Science and Technology Support Program of the Ministry of Science and Tec	This work was supported by funds from the National Science and Technology Support Program of the Ministry of Science and Tec (Grant No. 2012BAI32B03, http://www.most.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benedetti A, 2009, CANCER DETECT PREV, V32, P352, DOI 10.1016/j.canep.2009.03.001; Bjelic MM, 2014, MOL CELL ENDOCRINOL, V396, P10, DOI 10.1016/j.mce.2014.08.007; Breslow RA, 1999, ANN EPIDEMIOL, V9, P254, DOI 10.1016/S1047-2797(98)00071-4; Breslow RA, 2013, AM J CLIN NUTR, V97, P1068, DOI 10.3945/ajcn.112.050161; Breslow RA, 2011, AM J EPIDEMIOL, V174, P1044, DOI 10.1093/aje/kwr210; Crawford ED, 2016, AM J MENS HEALTH, V10, P440, DOI 10.1177/1557988315590655; Dennis LK, 2000, PROSTATE, V42, P56; Nackauzi JDE, 2012, MED ONCOL, V29, P823, DOI 10.1007/s12032-011-9940-x; Fillmore KM, 2009, MOL NUTR FOOD RES, V53, P240, DOI 10.1002/mnfr.200800122; Fowler JE, 2000, J UROLOGY, V163, P1467, DOI 10.1016/S0022-5347(05)67644-6; Gao Y, 2012, UROLOGY, V79, P194, DOI 10.1016/j.urology.2011.07.1399; GORDON GG, 1976, NEW ENGL J MED, V295, P793, DOI 10.1056/NEJM197610072951501; Gray MA, 2004, ANTICANCER RES, V24, P2069; Guess HA, 2001, EPIDEMIOL REV, V23, P152, DOI 10.1093/oxfordjournals.epirev.a000782; Gumus E, 2005, UROL INT, V75, P50, DOI 10.1159/000085927; Herati AS, 2013, UROLOGY, V82, P1376, DOI 10.1016/j.urology.2013.07.015; JOSEPH DR, 1994, VITAM HORM, V49, P197; Joseph MA, 2003, AM J EPIDEMIOL, V157, P906, DOI 10.1093/aje/kwg051; Kang D, 2004, BJU INT, V93, P1241, DOI 10.1111/j.1464-410X.2004.04839.x; Levi F, 2003, PROSTATE, V56, P207, DOI 10.1002/pros.10250; Liang CZ, 2009, J UROLOGY, V182, P558, DOI 10.1016/j.juro.2009.04.011; Liu ZY, 2016, ASIAN J ANDROL, V18, P747, DOI 10.4103/1008-682X.160883; McGregor SE, 2013, CANCER CAUSE CONTROL, V24, P451, DOI 10.1007/s10552-012-0131-7; Meigs JB, 2001, J CLIN EPIDEMIOL, V54, P935, DOI 10.1016/S0895-4356(01)00351-1; Mettlin C, 1999, PROSTATE, V39, P153, DOI 10.1002/(SICI)1097-0045(19990515)39:3<153::AID-PROS2>3.0.CO;2-V; Oh MJ, 2012, J UROLOGY, V187, P1312, DOI 10.1016/j.juro.2011.11.085; Parsons JK, 2009, J UROLOGY, V182, P1463, DOI 10.1016/j.juro.2009.06.038; Peskoe SB, 2015, PROSTATE, V75, P1167, DOI 10.1002/pros.22998; Platz EA, 2004, AM J EPIDEMIOL, V159, P444, DOI 10.1093/aje/kwh062; Platz EA, 1999, AM J EPIDEMIOL, V149, P106, DOI 10.1093/oxfordjournals.aje.a009775; Putnam SD, 2000, ANN EPIDEMIOL, V10, P361, DOI 10.1016/S1047-2797(00)00057-0; Rizzo S, 2005, CELL PROLIFERAT, V38, P363, DOI 10.1111/j.1365-2184.2005.00356.x; Rohrmann S, 2005, BJU INT, V96, P77, DOI 10.1111/j.1464-410X.2005.05571.x; Sartorius G, 2009, ANN CLIN BIOCHEM, V46, P137, DOI 10.1258/acb.2008.008171; Schatzl G, 2000, UROLOGY, V55, P397, DOI 10.1016/S0090-4295(99)00473-2; Schiller Jeannine S, 2012, Vital Health Stat 10, P1; Seim A, 2005, BJU INT, V96, P88, DOI 10.1111/j.1464-410X.2005.05573.x; Xiong SG, 2015, PROSTATE, V75, P141, DOI 10.1002/pros.22899; YOUNG CYF, 1995, J ANDROL, V16, P97; Zuccolo L, 2013, INT J CANCER, V132, P2176, DOI 10.1002/ijc.27877	40	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142780	10.1371/journal.pone.0142780	http://dx.doi.org/10.1371/journal.pone.0142780			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559058	gold, Green Submitted, Green Published			2022-12-27	WOS:000364433100122
J	Sassa, A; Kamoshita, N; Kanemaru, Y; Honma, M; Yasui, M				Sassa, Akira; Kamoshita, Nagisa; Kanemaru, Yuki; Honma, Masamitsu; Yasui, Manabu			Xeroderma Pigmentosum Group A Suppresses Mutagenesis Caused by Clustered Oxidative DNA Adducts in the Human Genome	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; DOUBLE-STRAND BREAKS; IN-VITRO REPAIR; ESCHERICHIA-COLI; DAMAGE SITE; HUMAN-CELLS; IONIZING-RADIATION; TANDEM LESIONS; ABASIC SITE; BASE DAMAGE	Clustered DNA damage is defined as multiple sites of DNA damage within one or two helical turns of the duplex DNA. This complex damage is often formed by exposure of the genome to ionizing radiation and is difficult to repair. The mutagenic potential and repair mechanisms of clustered DNA damage in human cells remain to be elucidated. In this study, we investigated the involvement of nucleotide excision repair (NER) in clustered oxidative DNA adducts. To identify the in vivo protective roles of NER, we established a human cell line lacking the NER gene xeroderma pigmentosum group A (XPA). XPA knockout (KO) cells were generated from TSCER122 cells derived from the human lymphoblastoid TK6 cell line. To analyze the mutagenic events in DNA adducts in vivo, we previously employed a system of tracing DNA adducts in the targeted mutagenesis (TATAM), in which DNA adducts were sitespecifically introduced into intron 4 of thymidine kinase genes. Using the TATAM system, one or two tandem7,8-dihydro-8-oxoguanine (8-oxoG) adducts were introduced into the genomes of TSCER122 or XPA KO cells. In XPA KO cells, the proportion ofmutants induced by a single 8-oxoG (7.6%) was comparable with that in TSCER122 cells (8.1%). In contrast, the lack of XPA significantly enhanced the mutant proportion of tandem8-oxoG in the transcribed strand (12%) compared with that in TSCER122 cells (7.4%) but not in the non-transcribed strand (12% and 11% in XPA KO and TSCER122 cells, respectively). By sequencing the tandem 8-oxoG- integrated loci in the transcribed strand, we found that the proportion of tandem mutations was markedly increased in XPA KO cells. These results indicate that NER is involved in repairing clustered DNA adducts in the transcribed strand in vivo.	[Sassa, Akira; Kamoshita, Nagisa; Kanemaru, Yuki; Honma, Masamitsu; Yasui, Manabu] Natl Inst Hlth Sci, Div Genet & Mutagenesis, Setagaya Ku, Tokyo, Japan	National Institute of Health Sciences - Japan	Sassa, A (corresponding author), Natl Inst Hlth Sci, Div Genet & Mutagenesis, Setagaya Ku, Tokyo, Japan.	a-sassa@nihs.go.jp; m-yasui@nihs.go.jp		Sassa, Akira/0000-0003-2454-0223; Kanemaru, Yuki/0000-0001-9934-9488	Ministry of Education, Culture, Sports, Science and Technology in Japan [25281022]; Ministry of Health, Welfare and Labor in Japan	Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Welfare and Labor in Japan	The work was supported by the following: 25281022, Grant-in-Aid for Scientific Research (B) from the Ministry of Education, Culture, Sports, Science and Technology in Japan, MY, http://www.mext.go.jp/english/; and H27-food-general-002, Grant-in-Aid for Health Science Foundation from the Ministry of Health, Welfare and Labor in Japan, MH, http://www.mhlw.go.jp/english/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMES BN, 1991, MUTAT RES, V250, P3, DOI 10.1016/0027-5107(91)90157-J; Arakawa T, 2011, ANAL BIOCHEM, V416, P211, DOI 10.1016/j.ab.2011.05.017; Bellon S, 2009, NUCLEIC ACIDS RES, V37, P4430, DOI 10.1093/nar/gkp422; Budworth H, 2005, J MOL BIOL, V351, P1020, DOI 10.1016/j.jmb.2005.06.069; Cunniffe S, 2014, MUTAT RES-FUND MOL M, V762, P32, DOI 10.1016/j.mrfmmm.2014.02.005; Cunniffe SMT, 2007, DNA REPAIR, V6, P1839, DOI 10.1016/j.dnarep.2007.07.003; D'Errico M, 2006, EMBO J, V25, P4305, DOI 10.1038/sj.emboj.7601277; David-Cordonnier MH, 2001, BIOCHEMISTRY-US, V40, P11811, DOI 10.1021/bi0112356; de Waard H, 2003, DNA REPAIR, V2, P13, DOI 10.1016/S1568-7864(02)00188-X; Eccles LJ, 2010, NUCLEIC ACIDS RES, V38, P1123, DOI 10.1093/nar/gkp1070; Fujimoto H, 2005, J COMPUT CHEM, V26, P788, DOI 10.1002/jcc.20184; GROSOVSKY AJ, 1993, MUTAT RES, V289, P231, DOI 10.1016/0027-5107(93)90074-P; Guo J, 2013, NUCLEIC ACIDS RES, V41, P7700, DOI 10.1093/nar/gkt524; Harrison L, 1999, J MOL BIOL, V290, P667, DOI 10.1006/jmbi.1999.2892; Imoto S, 2008, BIOCHEMISTRY-US, V47, P4306, DOI 10.1021/bi7021427; Itoh M, 1999, BRAIN DEV-JPN, V21, P326, DOI 10.1016/S0387-7604(99)00033-9; Jiang Y, 2009, CHEM RES TOXICOL, V22, P574, DOI 10.1021/tx8003449; Kalam MA, 2005, CHEM RES TOXICOL, V18, P1187, DOI 10.1021/tx050119r; Kozmin SG, 2009, NUCLEIC ACIDS RES, V37, P1767, DOI 10.1093/nar/gkp010; Liu MM, 2013, MUTAT RES-FUND MOL M, V743, P4, DOI 10.1016/j.mrfmmm.2012.12.003; Maasho K, 2004, J IMMUNOL METHODS, V284, P133, DOI 10.1016/j.jim.2003.10.010; Malyarchuk S, 2004, NUCLEIC ACIDS RES, V32, P5721, DOI 10.1093/nar/gkh911; Malyarchuk S, 2009, DNA REPAIR, V8, P1343, DOI 10.1016/j.dnarep.2009.08.008; MICHAELS ML, 1992, BIOCHEMISTRY-US, V31, P10964, DOI 10.1021/bi00160a004; Nilsen H, 2001, CARCINOGENESIS, V22, P987, DOI 10.1093/carcin/22.7.987; Noguchi M, 2012, MUTAT RES-FUND MOL M, V732, P34, DOI 10.1016/j.mrfmmm.2011.12.009; ODA Y, 1991, NUCLEIC ACIDS RES, V19, P1407, DOI 10.1093/nar/19.7.1407; Parsons JL, 2005, NUCLEIC ACIDS RES, V33, P4849, DOI 10.1093/nar/gki816; Pearson CG, 2004, NUCLEIC ACIDS RES, V32, P263, DOI 10.1093/nar/gkh150; Reardon JT, 1997, P NATL ACAD SCI USA, V94, P9463, DOI 10.1073/pnas.94.17.9463; ROBINS P, 1991, EMBO J, V10, P3913, DOI 10.1002/j.1460-2075.1991.tb04961.x; Rosenquist TA, 1997, P NATL ACAD SCI USA, V94, P7429, DOI 10.1073/pnas.94.14.7429; Sassa A, 2014, J BIOL CHEM, V289, P13996, DOI 10.1074/jbc.M114.557769; Sassa A, 2012, J BIOL CHEM, V287, P36702, DOI 10.1074/jbc.M112.397786; SATOKATA I, 1993, GENE, V136, P345; SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0; Shikazono N, 2006, NUCLEIC ACIDS RES, V34, P3722, DOI 10.1093/nar/gkl503; Shikazono N, 2013, MUTAT RES-FUND MOL M, V749, P9, DOI 10.1016/j.mrfmmm.2013.07.010; Stevnsner T, 2002, ONCOGENE, V21, P8675, DOI 10.1038/sj.onc.1205994; Sutherland BM, 2002, RADIAT RES, V157, P611, DOI 10.1667/0033-7587(2002)157[0611:CDDIBX]2.0.CO;2; Sutherland BM, 2000, P NATL ACAD SCI USA, V97, P103, DOI 10.1073/pnas.97.1.103; Torres-Ramos CA, 2000, MOL CELL BIOL, V20, P3522, DOI 10.1128/MCB.20.10.3522-3528.2000; Yasui M, 2014, DNA REPAIR, V15, P11, DOI 10.1016/j.dnarep.2014.01.003; Yuan BF, 2010, CHEM RES TOXICOL, V23, P11, DOI 10.1021/tx9004264; Zhang Y, 2009, CURR GENOMICS, V10, P250, DOI 10.2174/138920209788488544	45	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142218	10.1371/journal.pone.0142218	http://dx.doi.org/10.1371/journal.pone.0142218			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559182	Green Published, Green Submitted, gold			2022-12-27	WOS:000364433100063
J	Bartsch, RP; Liu, KKL; Bashan, A; Ivanov, PC				Bartsch, Ronny P.; Liu, Kang K. L.; Bashan, Amir; Ivanov, Plamen Ch.			Network Physiology: How Organ Systems Dynamically Interact	PLOS ONE			English	Article							ENDOGENOUS CIRCADIAN-RHYTHM; CARDIAC DYNAMICS; SLEEP STAGES; HEARTBEAT; BEHAVIOR	We systematically study how diverse physiologic systems in the human organism dynamically interact and collectively behave to produce distinct physiologic states and functions. This is a fundamental question in the new interdisciplinary field of Network Physiology, and has not been previously explored. Introducing the novel concept of Time Delay Stability (TDS), we develop a computational approach to identify and quantify networks of physiologic interactions from long-term continuous, multi-channel physiological recordings. We also develop a physiologically-motivated visualization framework to map networks of dynamical organ interactions to graphical objects encoded with information about the coupling strength of network links quantified using the TDS measure. Applying a system-wide integrative approach, we identify distinct patterns in the network structure of organ interactions, as well as the frequency bands through which these interactions are mediated. We establish first maps representing physiologic organ network interactions and discover basic rules underlying the complex hierarchical reorganization in physiologic networks with transitions across physiologic states. Our findings demonstrate a direct association between network topology and physiologic function, and provide new insights into understanding how health and distinct physiologic states emerge from networked interactions among nonlinear multi-component complex systems. The presented here investigations are initial steps in building a first atlas of dynamic interactions among organ systems.	[Bartsch, Ronny P.] Bar Ilan Univ, Dept Phys, IL-52900 Ramat Gan, Israel; [Bartsch, Ronny P.; Liu, Kang K. L.; Ivanov, Plamen Ch.] Boston Univ, Dept Phys, Boston, MA 02215 USA; [Liu, Kang K. L.] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02115 USA; [Liu, Kang K. L.; Bashan, Amir; Ivanov, Plamen Ch.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Bashan, Amir] Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA; [Ivanov, Plamen Ch.] Brigham & Womens Hosp, Div Sleep Med, Boston, MA 02115 USA; [Ivanov, Plamen Ch.] Bulgarian Acad Sci, Inst Solid State Phys, BU-1784 Sofia, Bulgaria	Bar Ilan University; Boston University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Bulgarian Academy of Sciences	Ivanov, PC (corresponding author), Boston Univ, Dept Phys, 590 Commonwealth Ave, Boston, MA 02215 USA.	plamen@buphy.bu.edu	Liu, Kang/S-7993-2017; Bartsch, Ronny/E-7117-2012; Bashan, Amir/ABE-3163-2020; Ivanov, Plamen Ch./E-8004-2012	Liu, Kang/0000-0003-2019-7747; Bartsch, Ronny/0000-0001-8336-5141; Ivanov, Plamen Ch./0000-0001-7629-762X	W. M. Keck Foundation; National Institutes of Health [1R01-HL098437]; Office of Naval Research [000141010078]; US-Israel Binational Science Foundation [2012219]; EC-FP7 Marie Curie Fellowship [IIF 628159]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098437] Funding Source: NIH RePORTER	W. M. Keck Foundation(W.M. Keck Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Naval Research(Office of Naval Research); US-Israel Binational Science Foundation(US-Israel Binational Science Foundation); EC-FP7 Marie Curie Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by W. M. Keck Foundation (PI, KL); National Institutes of Health Grant 1R01-HL098437 (PI, KL, RB); Office of Naval Research Grant 000141010078 (PI, RB); US-Israel Binational Science Foundation Grant 2012219 (PI, KL, RB); and EC-FP7 Marie Curie Fellowship IIF 628159 (RB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arodz T, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/2/025002; Bartsch RP, 2014, COMPUT CARDIOL CONF, V41, P781; Bartsch RP, 2014, COMM COM INF SC, V438, P270; Bashan A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1705; Bunde A, 2000, PHYS REV LETT, V85, P3736, DOI 10.1103/PhysRevLett.85.3736; Faes L, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/10/105005; Fernandes HM, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/1/015001; Hegger R, 1998, PHYS REV LETT, V81, P558, DOI 10.1103/PhysRevLett.81.558; Hu K, 2004, P NATL ACAD SCI USA, V101, P18223, DOI 10.1073/pnas.0408243101; Ivanov PC, 1999, EUROPHYS LETT, V48, P594, DOI 10.1209/epl/i1999-00525-0; Ivanov PC, 2007, P NATL ACAD SCI USA, V104, P20702, DOI 10.1073/pnas.0709957104; Ivanov PC, 2007, IEEE ENG MED BIOL, V26, P33, DOI 10.1109/MEMB.2007.907093; Ivanov PC, 2014, UNDERST COMPLEX SYST, P203, DOI 10.1007/978-3-319-03518-5_10; Kantelhardt JW, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.051908; Kantelhardt JW, 2003, EUROPHYS LETT, V62, P147, DOI 10.1209/epl/i2003-00332-7; Karasik R, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.062902; Klosch G, 2001, IEEE ENG MED BIOL, V20, P51, DOI 10.1109/51.932725; Liu K, 2015, IOP C SER EARTH ENV, V26, DOI 10.1088/1755-1315/26/1/012013; Mosqueiro T, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/11/115010; Muller L, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/10/105004; Oliveira CLN, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/6/065022; Piper D, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/11/115012; Quill E., 2012, SCI NEWS, V182, P18, DOI [10.1002/scin.5591820619, DOI 10.1002/SCIN.5591820619]; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Rothkegel A, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/5/055006; Scala A, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/11/115017; Schmitt DT, 2009, IEEE T BIO-MED ENG, V56, P1564, DOI 10.1109/TBME.2009.2014819; Schumann AY, 2010, SLEEP, V33, P943, DOI 10.1093/sleep/33.7.943; Stankovski T, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/3/035002; Stramaglia S, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/10/105003; Traxl D, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/11/115009; West BJ, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/4/045009	32	159	160	5	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142143	10.1371/journal.pone.0142143	http://dx.doi.org/10.1371/journal.pone.0142143			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555073	Green Published, Green Submitted, gold			2022-12-27	WOS:000364430700059
J	Lopez-Rosenfeld, M; Carrillo, F; Garbulsky, G; Slezak, DF; Sigman, M				Lopez-Rosenfeld, Matias; Carrillo, Facundo; Garbulsky, Gerry; Fernandez Slezak, Diego; Sigman, Mariano			Quantitative Pedagogy: A Digital Two Player Game to Examine Communicative Competence	PLOS ONE			English	Article								Inner concepts are much richer than the words that describe them. Our general objective is to inquire what are the best procedures to communicate conceptual knowledge. We construct a simplified and controlled setup emulating important variables of pedagogy amenable to quantitative analysis. To this aim, we designed a game inspired in Chinese Whispers, to investigate which attributes of a description affect its capacity to faithfully convey an image. This is a two player game: an emitter and a receiver. The emitter was shown a simple geometric figure and was asked to describe it in words. He was informed that this description would be passed to the receiver who had to replicate the drawing from this description. We capitalized on vast data obtained from an android app to quantify the effect of different aspects of a description on communication precision. We show that descriptions more effectively communicate an image when they are coherent and when they are procedural. Instead, the creativity, the use of metaphors and the use of mathematical concepts do not affect its fidelity.	[Lopez-Rosenfeld, Matias; Carrillo, Facundo; Fernandez Slezak, Diego] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Computac, Lab Inteligencia Artificial Aplicada, RA-1428 Buenos Aires, DF, Argentina; [Garbulsky, Gerry] Mundo Ideas, Buenos Aires, DF, Argentina; [Lopez-Rosenfeld, Matias; Sigman, Mariano] Univ Torcuato Tella, Lab Neurociencia, Buenos Aires, DF, Argentina	Universidad Torcuato Di Tella	Sigman, M (corresponding author), Univ Torcuato Tella, Lab Neurociencia, Av Figueroa Alcorta 7350,C1428BCW, Buenos Aires, DF, Argentina.	msigman@utdt.edu	Slezak, Diego Fernandez/AAD-9543-2019		University of Buenos Aires, CONICET (Argentina); ANPCyT (Argentina); James McDonnell Foundation; Microsoft Faculty Fellowship	University of Buenos Aires, CONICET (Argentina)(University of Buenos AiresConsejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); ANPCyT (Argentina)(ANPCyT); James McDonnell Foundation; Microsoft Faculty Fellowship(Microsoft)	This research was supported by University of Buenos Aires, CONICET (Argentina) and ANPCyT (Argentina). MS is sponsored by James McDonnell Foundation 21st Century Science Initiative in Understanding Human Cognition. DFS is sponsored by Microsoft Faculty Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachman L. F, 1996, LANGUAGE TESTING PRA; Bachman L.F., 2004, STAT ANAL LANGUAGE A; Cameron L., 2003, METAPHOR ED DISCOURS; Canale M., 1980, APPL LINGUIS, V1, P1, DOI [10.1093/applin/i.1.1, DOI 10.1093/APPLIN/1.1.1, 10.1093/applin/1.1.1]; Chomsky N., 1965, ASPECTS THEORY SYNTA, V11; Csibra G, 2009, TRENDS COGN SCI, V13, P148, DOI 10.1016/j.tics.2009.01.005; Feigenson L, 2004, TRENDS COGN SCI, V8, P307, DOI 10.1016/j.tics.2004.05.002; Goldin-Meadow S, 2005, TRENDS COGN SCI, V9, P234, DOI 10.1016/j.tics.2005.03.006; Hoyles C., 1987, INT J MATH EDUC SCI, V18, P581, DOI [10.1080/0020739870180411, DOI 10.1080/0020739870180411, DOI 10.1080/0020739870180411LAPPAN]; Hymes D., 1966, SOCIOLINGUISTICS, P13156; Koch C., 1987, MATTERINTELLIGENCE, P115, DOI [10.1007/978-94-009-3833-5, DOI 10.1007/978-94-009-3833-5, DOI 10.1007/978-94-009-3833-5_5]; Littlejohn SW., 2010, THEORIES HUMAN COMMU; Lopez-Rosenfeld M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125772; Luoma Sari, 2004, ASSESSING SPEAKING; McNamara D.S., 2012, READING COMPREHENSIO; Mogg K, 1999, BEHAV RES THER, V37, P595, DOI 10.1016/S0005-7967(98)00158-2; NAFTULIN DH, 1973, J MED EDUC, V48, P630; Nusbaum HC, 2012, LANGUAGE COMMUNICATI; Ohman A, 2001, J EXP PSYCHOL GEN, V130, P466, DOI 10.1037/0096-3445.130.3.466; Shafto P., 2008, P 30 ANN C COGN SCI, P1632; Shafto P, 2014, COGNITIVE PSYCHOL, V71, P55, DOI 10.1016/j.cogpsych.2013.12.004; SPELKE E, 1994, COGNITION, V50, P431, DOI 10.1016/0010-0277(94)90039-6; Strauss S, 2014, TRENDS NEUROSCI EDUC, V3, P38, DOI 10.1016/j.tine.2014.05.001; von Ahn L, 2008, COMMUN ACM, V51, P58, DOI 10.1145/1378704.1378719	24	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142579	10.1371/journal.pone.0142579	http://dx.doi.org/10.1371/journal.pone.0142579			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7CT	26554833	gold, Green Submitted, Green Published			2022-12-27	WOS:000364430700137
J	Paulus, FM; Rademacher, L; Schafer, TAJ; Muller-Pinzler, L; Krach, S				Paulus, Frieder Michel; Rademacher, Lena; Schaefer, Theo Alexander Jose; Mueller-Pinzler, Laura; Krach, Soeren			Journal Impact Factor Shapes Scientists' Reward Signal in the Prospect of Publication	PLOS ONE			English	Article							NUCLEUS-ACCUMBENS; ANTICIPATION; BRAIN; DOPAMINE; MONETARY; WORK	The incentive structure of a scientist's life is increasingly mimicking economic principles. While intensely criticized, the journal impact factor (JIF) has taken a role as the new currency for scientists. Successful goal-directed behavior in academia thus requires knowledge about the JIF. Using functional neuroimaging we examined how the JIF, as a powerful incentive in academia, has shaped the behavior of scientists and the reward signal in the striatum. We demonstrate that the reward signal in the nucleus accumbens increases with higher JIF during the anticipation of a publication and found a positive correlation with the personal publication record (pJIF) supporting the notion that scientists have incorporated the predominant reward principle of the scientific community in their reward system. The implications of this behavioral adaptation within the ecological niche of the scientist's habitat remain unknown, but may also have effects which were not intended by the community.	[Paulus, Frieder Michel; Rademacher, Lena; Schaefer, Theo Alexander Jose; Mueller-Pinzler, Laura; Krach, Soeren] Med Univ Lubeck, Dept Psychiat & Psychotherapy, Social Neurosci Lab, D-23538 Lubeck, Germany	University of Lubeck	Paulus, FM (corresponding author), Med Univ Lubeck, Dept Psychiat & Psychotherapy, Social Neurosci Lab, D-23538 Lubeck, Germany.	paulus@snl.uni-luebeck.de; krach@snl.uni-luebeck.de		Krach, Soren/0000-0002-4834-8378; Schafer, Theo Alexander Jose/0000-0003-4102-559X				Alberts B, 2015, SCIENCE, V348, P1420, DOI 10.1126/science.aab3847; Alberts B, 2013, SCIENCE, V340, P787, DOI 10.1126/science.1240319; [Anonymous], 2005, NATURE, V435, P1003, DOI 10.1038/4351003a; Berridge K.C., 1999, WELL BEING FDN HEDON, P525; Brett M., 2002, 8 INT C FUNCT MAPP H, V16, P497; Bromberg-Martin ES, 2009, NEURON, V63, P119, DOI 10.1016/j.neuron.2009.06.009; Day JJ, 2010, BIOL PSYCHIAT, V68, P306, DOI 10.1016/j.biopsych.2010.03.026; Deci EL, 1999, PSYCHOL BULL, V125, P627, DOI 10.1037/0033-2909.125.6.627; Garfield E, 2006, JAMA-J AM MED ASSOC, V295, P90, DOI 10.1001/jama.295.1.90; Kirsch P, 2003, NEUROIMAGE, V20, P1086, DOI 10.1016/S1053-8119(03)00381-1; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Kroemer NB, 2014, NEUROIMAGE, V102, P510, DOI 10.1016/j.neuroimage.2014.07.060; Lehmann S, 2006, NATURE, V444, P1003, DOI 10.1038/4441003a; Morris G, 2006, NAT NEUROSCI, V9, P1057, DOI 10.1038/nn1743; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; Rademacher L, 2010, NEUROIMAGE, V49, P3276, DOI 10.1016/j.neuroimage.2009.10.089; Reich ES, 2013, NATURE, V502, P291, DOI 10.1038/502291a; Rolls ET, 2007, EUR J NEUROSCI, V26, P1067, DOI 10.1111/j.1460-9568.2007.05724.x; Salamone JD, 2012, NEURON, V76, P470, DOI 10.1016/j.neuron.2012.10.021; Schekman R., 2013, GUARDIAN; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; Sekercioglu CH, 2008, SCIENCE, V322, P371, DOI 10.1126/science.322.5900.371a; Sescousse G, 2015, SOC COGN AFFECT NEUR, V10, P467, DOI 10.1093/scan/nsu074; Simons K, 2008, SCIENCE, V322, P165, DOI 10.1126/science.1165316; Spreckelmeyer KN, 2009, SOC COGN AFFECT NEUR, V4, P158, DOI 10.1093/scan/nsn051; van Dijk D, 2014, CURR BIOL, V24, pR516, DOI 10.1016/j.cub.2014.04.039; Werner RF, 2015, FOCUS BIBLIOMETRICS; Yarkoni T, 2011, NAT METHODS, V8, P665, DOI [10.1038/NMETH.1635, 10.1038/nmeth.1635]	28	30	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142537	10.1371/journal.pone.0142537	http://dx.doi.org/10.1371/journal.pone.0142537			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555725	Green Published, Green Submitted, gold			2022-12-27	WOS:000364430700125
J	Xie, L; Altindal, T; Wu, XL				Xie, Li; Altindal, Tuba; Wu, Xiao-Lun			An Element of Determinism in a Stochastic Flagellar Motor Switch	PLOS ONE			English	Article							VIBRIO-ALGINOLYTICUS; CONFORMATIONAL SPREAD; ESCHERICHIA-COLI; PROTEINS; MECHANISM; CHEMOTAXIS; DIRECTION; BACTERIA; MODELS; POLAR	Marine bacterium Vibrio alginolyticus uses a single polar flagellum to navigate in an aqueous environment. Similar to Escherichia coli cells, the polar flagellar motor has two states; when the motor is counter-clockwise, the cell swims forward and when the motor is clockwise, the cell swims backward. V. alginolyticus also incorporates a direction randomization step at the start of the forward swimming interval by flicking its flagellum. To gain an understanding on how the polar flagellar motor switch is regulated, distributions of the forward Delta(f) and backward Delta(b) intervals are investigated herein. We found that the steady-state probability density functions, P(Delta(f)) and P(Delta(b)), of freely swimming bacteria are strongly peaked at a finite time, suggesting that the motor switch is not Poissonian. The short-time inhibition is sufficiently strong and long lasting, i.e., several hundred milliseconds for both intervals, which is readily observed and characterized. Treating motor reversal dynamics as a first-passage problem, which results from conformation fluctuations of the motor switch, we calculated P(Delta(f)) and P(Delta(b)) and found good agreement with the measurements.	[Xie, Li; Wu, Xiao-Lun] Univ Pittsburgh, Dept Phys & Astron, Pittsburgh, PA 15260 USA; [Altindal, Tuba] Simon Fraser Univ, Dept Phys, Burnaby, BC V5A 1S6, Canada	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Simon Fraser University	Xie, L (corresponding author), Univ Pittsburgh, Dept Phys & Astron, Pittsburgh, PA 15260 USA.	lix11@pitt.edu	Xie, Li/N-1724-2019	Xie, Li/0000-0003-3397-2407	National Science Fundation [DMR-1305006]; University of Pittsburgh; Direct For Mathematical & Physical Scien [1305006] Funding Source: National Science Foundation	National Science Fundation(National Science Foundation (NSF)); University of Pittsburgh(University of Pittsburgh); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	X-LW and TA are supported by the National Science Fundation grant No. DMR-1305006, received by X-LW (http://www.nsf.gov/). LX is supported by the Andrew Mellon Predoctoral Fellowship from the University of Pittsburgh (http www.asgraduate.pitt.edu/node/336). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER J, 1967, J GEN MICROBIOL, V46, P161, DOI 10.1099/00221287-46-2-161; Alexander RP, 2010, TRENDS MICROBIOL, V18, P494, DOI 10.1016/j.tim.2010.07.004; Altindal T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018231; [Anonymous], 1965, QUANTUM OPTICS ELECT; Bai F, 2010, SCIENCE, V327, P685, DOI 10.1126/science.1182105; BATCHELOR GK, 1959, J FLUID MECH, V5, P113, DOI 10.1017/S002211205900009X; Berg H C, 1974, Antibiot Chemother (1971), V19, P55; Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; Berry MJ, 1998, J NEUROSCI, V18, P2200; BLAKE PA, 1980, ANNU REV MICROBIOL, V34, P341, DOI 10.1146/annurev.mi.34.100180.002013; Bray D, 1998, NATURE, V393, P85, DOI 10.1038/30018; Chen SY, 2011, EMBO J, V30, P2972, DOI 10.1038/emboj.2011.186; Cluzel P, 2000, SCIENCE, V287, P1652, DOI 10.1126/science.287.5458.1652; COLQUHOUN D, 1981, PROC R SOC SER B-BIO, V211, P205, DOI 10.1098/rspb.1981.0003; Darling DA, 1953, 1 PASSAGE PROBLEM CO; Duke TAJ, 2001, J MOL BIOL, V308, P541, DOI 10.1006/jmbi.2001.4610; FIENBERG SE, 1974, BIOMETRICS, V30, P399, DOI 10.2307/2529198; Homma M, 1996, MICROBIOL-UK, V142, P2777, DOI 10.1099/13500872-142-10-2777; HOTANI H, 1982, J MOL BIOL, V156, P791, DOI 10.1016/0022-2836(82)90142-5; KAWAGISHI I, 1995, J BACTERIOL, V177, P5158, DOI 10.1128/jb.177.17.5158-5160.1995; Kojima M, 2007, MOL MICROBIOL, V64, P57, DOI 10.1111/j.1365-2958.2007.05623.x; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; KUO SC, 1989, J BACTERIOL, V171, P6279, DOI 10.1128/jb.171.11.6279-6287.1989; LEIFSON E, 1964, J BACTERIOL, V87, P652, DOI 10.1128/JB.87.3.652-666.1964; Li N, 2011, GENES CELLS, V16, P985, DOI 10.1111/j.1365-2443.2011.01545.x; Luchsinger RH, 1999, BIOPHYS J, V77, P2377, DOI 10.1016/S0006-3495(99)77075-X; MITCHELL JG, 1991, MICROBIAL ECOL, V22, P227, DOI 10.1007/BF02540225; Mochrie SGJ, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.031913; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Naber H, 1996, J THEOR BIOL, V181, P343, DOI 10.1006/jtbi.1996.0136; Paul K, 2011, P NATL ACAD SCI USA, V108, P17171, DOI 10.1073/pnas.1110111108; PURCELL EM, 1977, AM J PHYS, V45, P3, DOI 10.1119/1.10903; PURCELL EM, 1956, NATURE, V178, P1448; Scharf BE, 1998, P NATL ACAD SCI USA, V95, P201, DOI 10.1073/pnas.95.1.201; Schrodinger E, 1915, PHYS Z, V16, P289; Sen A, 2004, J ELECTRON MICROSC, V53, P305, DOI 10.1093/jmicro/53.3.305; Son K, 2013, NAT PHYS, V9, P494, DOI 10.1038/NPHYS2676; SPRINGER MS, 1979, NATURE, V280, P279, DOI 10.1038/280279a0; Takano Y, 2003, JSME INT J C-MECH SY, V46, P1241, DOI 10.1299/jsmec.46.1241; Terashima H, 2006, MOL MICROBIOL, V62, P1170, DOI 10.1111/j.1365-2958.2006.05435.x; Tu Y, 2008, P NATL ACAD SCI USA, V105, P11737, DOI 10.1073/pnas.0804641105; Tumer L, 1996, BIOPHYS J, V71, P2227, DOI 10.1016/S0006-3495(96)79425-0; Turner L, 2000, J BACTERIOL, V182, P2793, DOI 10.1128/JB.182.10.2793-2801.2000; Wang FB, 2014, P NATL ACAD SCI USA, V111, P15752, DOI 10.1073/pnas.1418548111; Xie L, 2015, BIOPHYS J, V108, P766, DOI 10.1016/j.bpj.2014.11.3479; Xie L, 2011, P NATL ACAD SCI USA, V108, P2246, DOI 10.1073/pnas.1011953108; YAMAMOTO K, 1990, J BACTERIOL, V172, P383, DOI 10.1128/JB.172.1.383-388.1990	47	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0141654	10.1371/journal.pone.0141654	http://dx.doi.org/10.1371/journal.pone.0141654			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26554590	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000364430700035
J	Brandmaier, P; Purz, S; Bremicker, K; Hockel, M; Barthel, H; Kluge, R; Kahn, T; Sabri, O; Stumpp, P				Brandmaier, P.; Purz, S.; Bremicker, K.; Hoeckel, M.; Barthel, H.; Kluge, R.; Kahn, T.; Sabri, O.; Stumpp, P.			Simultaneous [F-18]FDG-PET/MRI: Correlation of Apparent Diffusion Coefficient (ADC) and Standardized Uptake Value (SUV) in Primary and Recurrent Cervical Cancer	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; F-18 FLUORODEOXYGLUCOSE UPTAKE; NONMETASTATIC LYMPH-NODES; FDG PET/CT; THERAPY; DIFFERENTIATION; CARCINOMA; ACCURACY; MRI	Objectives Previous non simultaneous PET/MR studies have shown heterogeneous results about the correlation between standardized uptake values (SUVs) and apparent diffusion coefficients (ADCs). The aim of this study was to investigate correlations in patients with primary and recurrent tumors using a simultaneous PET/MRI system which could lead to a better understanding of tumor biology and might play a role in early response assessment. Methods We included 31 patients with histologically confirmed primary (n = 14) or recurrent cervical cancer (n = 17) who underwent simultaneous whole-body 18F-FDG-PET/MRI comprising DWI. Image analysis was performed by a radiologist and a nuclear physician who identified tumor margins and quantified ADC and SUV. Pearson correlations were calculated to investigate the association between ADC and SUV. Results 92 lesions were detected. We found a significant inverse correlation between SUVmax and ADCmia (r = -0.532, p = 0.05) in primary tumors as well as in primary metastases (r = -0.362, p = 0.05) and between SUVmean and ADCmin (r = -0.403,p = 0.03). In recurrent local tumors we found correlations for SUVmax and ADCmia (r = -0.747, p = 0.002) and SUVmean and ADCmia (r = -0.773, p = 0.001). Associations for recurrent metastases were not significant (p>0.05). Conclusions Our study demonstrates the feasibility of fast and reliable measurement of SUV and ADC with simultaneous PET/MRI. In patients with cervical cancer we found significant inverse correlations for SUV and ADC which could play a major role for further tumor characterization and therapy decisions.	[Brandmaier, P.; Bremicker, K.; Kahn, T.; Stumpp, P.] Univ Hosp Leipzig, Dept Diagnost & Intervent Radiol, Leipzig, Germany; [Purz, S.; Barthel, H.; Kluge, R.; Sabri, O.] Univ Hosp Leipzig, Dept Nucl Med, Leipzig, Germany; [Hoeckel, M.] Univ Hosp Leipzig, Dept Gynecol & Obstet, Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University	Brandmaier, P (corresponding author), Univ Hosp Leipzig, Dept Diagnost & Intervent Radiol, Leipzig, Germany.	philipe.brandmaier@medizin.uni-leipzig.de		Sabri, Osama/0000-0002-6425-3504				Baba S, 2014, J NUCL MED, V55, P736, DOI 10.2967/jnumed.113.129395; Cheson BD, 2007, J CLIN ONCOL, V25, P579, DOI 10.1200/JCO.2006.09.2403; Choi BB, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-126; Chung M. K., 2007, ENCY MEASUREMENT STA, V1, P189; Colombo N, 2012, ANN ONCOL, V23, P27, DOI 10.1093/annonc/mds268; Folpe AL, 2000, CLIN CANCER RES, V6, P1279; Furth C, 2009, J CLIN ONCOL, V27, P4385, DOI 10.1200/JCO.2008.19.7814; Grueneisen J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096751; Hagemann T, 2007, BRIT J CANCER, V96, P321, DOI 10.1038/sj.bjc.6603543; Heusch P, 2013, ROFO-FORTSCHR RONTG, V185, P1059, DOI 10.1055/s-0033-1350110; Ho KC, 2009, EUR J NUCL MED MOL I, V36, P200, DOI 10.1007/s00259-008-0936-5; Hoekstra CJ, 2005, J CLIN ONCOL, V23, P8362, DOI 10.1200/JCO.2005.01.1189; Horger M, 2014, EUR J RADIOL, V83, P1655, DOI 10.1016/j.ejrad.2014.05.027; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jung SH, 2012, J MAGN RESON IMAGING, V35, P110, DOI 10.1002/jmri.22749; Kidd EA, 2010, CANCER-AM CANCER SOC, V116, P1469, DOI 10.1002/cncr.24972; Kim JK, 2008, J MAGN RESON IMAGING, V28, P714, DOI 10.1002/jmri.21480; Kuang F, 2013, EUR RADIOL, V23, P1050, DOI 10.1007/s00330-012-2681-1; Le Bihan D, 1985, ANN M RSNA CHIC; Lee YY, 2009, GYNECOL ONCOL, V115, P65, DOI 10.1016/j.ygyno.2009.06.022; Levy A, 2011, GYNECOL ONCOL, V123, P110, DOI 10.1016/j.ygyno.2011.06.009; Liu Y, 2011, GYNECOL ONCOL, V122, P19, DOI 10.1016/j.ygyno.2011.03.023; Martin CM, 2006, EXPERT REV MOL DIAGN, V6, P217, DOI 10.1586/14737159.6.2.217; Martinez-Moller A, 2009, J NUCL MED, V50, P520, DOI 10.2967/jnumed.108.054726; Mori T, 2008, J THORAC ONCOL, V3, P358, DOI 10.1097/JTO.0b013e318168d9ed; Nakajo M, 2012, CLIN NUCL MED, V37, P475, DOI 10.1097/RLU.0b013e318248524a; Nakajo M, 2010, EUR J NUCL MED MOL I, V37, P2011, DOI 10.1007/s00259-010-1529-7; Pahk K, 2014, ANTICANCER RES, V34, P4447; Punwani S, 2013, EUR J NUCL MED MOL I, V40, P373, DOI 10.1007/s00259-012-2293-7; Rakheja R, 2013, AM J ROENTGENOL, V201, P1120, DOI 10.2214/AJR.13.11305; Rakheja R, 2012, AM J ROENTGENOL, V198, P1409, DOI 10.2214/AJR.11.7560; Schmidt H, 2013, INVEST RADIOL, V48, P247, DOI 10.1097/RLI.0b013e31828d56a1; Vanderhoek M, 2013, J NUCL MED, V54, P1188, DOI 10.2967/jnumed.112.113332; Varoquaux A, 2013, EUR J NUCL MED MOL I, V40, P842, DOI 10.1007/s00259-013-2351-9; Xue FY, 2006, GYNECOL ONCOL, V101, P147, DOI 10.1016/j.ygyno.2005.10.005; Xue HD, 2014, ARCH GYNECOL OBSTET, V290, P341, DOI 10.1007/s00404-014-3221-9; Yankeelov TE, 2012, MAGN RESON IMAGING, V30, P1342, DOI 10.1016/j.mri.2012.06.001; Zhang Jie, 2014, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V36, P73, DOI 10.3881/j.issn.1000-503X.2014.01.014	38	36	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2015	10	11							e0141684	10.1371/journal.pone.0141684	http://dx.doi.org/10.1371/journal.pone.0141684			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7AC	26551527	Green Published, Green Submitted, gold			2022-12-27	WOS:000364422800008
J	Abraham, A; Albulaihe, H; Alabdali, M; Qrimli, M; Breiner, A; Barnett, C; Katzberg, HD; Lovblom, LE; Perkins, BA; Bril, V				Abraham, Alon; Albulaihe, Hana; Alabdali, Majed; Qrimli, Mohammad; Breiner, Ari; Barnett, Carolina; Katzberg, Hans D.; Lovblom, Leif E.; Perkins, Bruce A.; Bril, Vera			Elevated Vibration Perception Thresholds in CIDP Patients Indicate More Severe Neuropathy and Lower Treatment Response Rates	PLOS ONE			English	Article							INFLAMMATORY DEMYELINATING POLYNEUROPATHY; PERIPHERAL NEUROPATHY; CRITERIA; POLYRADICULONEUROPATHY	Introduction Vibration perception threshold (VPT) examination using a neurothesiometer provides objective, sensitive and specific information, and has been utilized mainly in patients with diabetic polyneropathy. Objectives Explore the utility of VPT examination in CIDP patients. Methods CIDP subjects attending the Neuromuscular clinic between 01/2013 and 12/2014 were evaluated. Demographic data, clinical history, physical examination, VPT values, and electrophysiologic data from their charts were extracted. Results 70 charts were reviewed. 55 CIDP patients had elevated VPT, associated with higher frequency of abnormal sensory testing for various modalities (92.7% vs. 46.7%, p<0.0001), lower sensory and motor amplitudes and reduced conduction velocities on nerve conduction studies, and lower treatment response rates (54% vs. 93%, p = 0.01). Conclusion VPT examination is a simple tool, which is a reliable and sensitive measure not only for diabetic neuropathy, but also for CIDP. Moreover, in CIDP, elevated VPT values are also associated with lower treatment response rates.	[Abraham, Alon; Qrimli, Mohammad; Breiner, Ari; Barnett, Carolina; Katzberg, Hans D.; Bril, Vera] Univ Toronto, Univ Hlth Network, Div Neurol, Ellen & Martin Prosserman Ctr Neuromuscular Dis,D, Toronto, ON, Canada; [Albulaihe, Hana] King Saud Univ, King Khalid Univ Hosp, Dept Neurol, Riyadh, Saudi Arabia; [Alabdali, Majed] Univ Dammam, King Fahad Hosp Univ, Dept Neurol, Dammam, Saudi Arabia; [Lovblom, Leif E.; Perkins, Bruce A.] Mt Sinai Hosp, Dept Med, Div Endocrinol & Metab, Toronto, ON M5G 1X5, Canada; [Lovblom, Leif E.; Perkins, Bruce A.] Univ Toronto, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; King Saud University; King Khalid University Hospital; Imam Abdulrahman Bin Faisal University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Bril, V (corresponding author), Univ Toronto, Univ Hlth Network, Div Neurol, Ellen & Martin Prosserman Ctr Neuromuscular Dis,D, Toronto, ON, Canada.	vera.bril@utoronto.ca	Barnett, Carolina/AFM-9470-2022; Perkins, Bruce A/L-3726-2017; BRIL, vera/ABA-6509-2020; Abraham, Alon/H-9343-2019	Abraham, Alon/0000-0002-9020-2399; Lovblom, Leif Erik/0000-0002-6774-8924; Barnett, Carolina/0000-0001-5546-0221				Abraham A, 2015, EXPERT REV CLIN IMMU, V11, P537, DOI 10.1586/1744666X.2015.1018891; Amato A., 2008, NEUROMUSCULAR DISORD; Bolton CF, 2000, CANADIAN J NEUROLOGI, P288; Bril V, 2002, DIABETIC MED, V19, P661, DOI 10.1046/j.1464-5491.2002.00759.x; Bril V, 2010, MUSCLE NERVE, V42, P492, DOI 10.1002/mus.21733; Burns TM, 2002, J PERIPHER NERV SYST, V7, P112, DOI 10.1046/j.1529-8027.2002.02016.x; CLAUS D, 1993, MUSCLE NERVE, V16, P757, DOI 10.1002/mus.880160711; Cocito D, 2006, EUR J NEUROL, V13, P669, DOI 10.1111/j.1468-1331.2006.01259.x; Dimitrakoudis D, 2002, NEUROLOGY, V59, P611, DOI 10.1212/WNL.59.4.611; Dunnigan SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089344; Dyck PJ, 1999, MUSCLE NERVE, V22, P659, DOI 10.1002/(SICI)1097-4598(199906)22:6<659::AID-MUS1>3.0.CO;2-X; Hughes RAC, 2008, LANCET NEUROL, V7, P136, DOI 10.1016/S1474-4422(07)70329-0; Katz JS, 2000, NEUROLOGY, V54, P615, DOI 10.1212/WNL.54.3.615; Koski CL, 2009, J NEUROL SCI, V277, P1, DOI 10.1016/j.jns.2008.11.015; Kuwabara S, 2002, J NEUROL NEUROSUR PS, V72, P37, DOI 10.1136/jnnp.72.1.37; Magda P, 2003, ARCH NEUROL-CHICAGO, V60, P1755, DOI 10.1001/archneur.60.12.1755; Martin CL, 2010, DIABETES CARE, V33, P2635, DOI 10.2337/dc10-0616; Pestronk A, 2004, NEUROLOGY, V62, P461, DOI 10.1212/01.WNL.0000106939.41855.36; SIMMONS Z, 1993, NEUROLOGY, V43, P2202, DOI 10.1212/WNL.43.11.2202	19	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0139689	10.1371/journal.pone.0139689	http://dx.doi.org/10.1371/journal.pone.0139689			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26545096	Green Published, gold, Green Submitted			2022-12-27	WOS:000364398700003
J	Beretov, J; Wasinger, VC; Millar, EKA; Schwartz, P; Graham, PH; Li, Y				Beretov, Julia; Wasinger, Valerie C.; Millar, Ewan K. A.; Schwartz, Peter; Graham, Peter H.; Li, Yong			Proteomic Analysis of Urine to Identify Breast Cancer Biomarker Candidates Using a Label-Free LC-MS/MS Approach	PLOS ONE			English	Article							ANNEXIN A1 EXPRESSION; PROSTATE-SPECIFIC ANTIGEN; MATRIX PROTEIN-1 ECM1; SPARC-LIKE PROTEIN-1; NERVE GROWTH-FACTOR; SERUM BIOMARKERS; NASOPHARYNGEAL CARCINOMA; TUMOR-SUPPRESSOR; DUCTAL CARCINOMA; DRUG-RESISTANCE	Introduction Breast cancer is a complex heterogeneous disease and is a leading cause of death in women. Early diagnosis and monitoring progression of breast cancer are important for improving prognosis. The aim of this study was to identify protein biomarkers in urine for early screening detection and monitoring invasive breast cancer progression. Method We performed a comparative proteomic analysis using ion count relative quantification label free LC-MS/MS analysis of urine from breast cancer patients (n = 20) and healthy control women (n = 20). Results Unbiased label free LC-MS/MS-based proteomics was used to provide a profile of abundant proteins in the biological system of breast cancer patients. Data analysis revealed 59 urinary proteins that were significantly different in breast cancer patients compared to the normal control subjects (p< 0.05, fold change > 3). Thirty-six urinary proteins were exclusively found in specific breast cancer stages, with 24 increasing and 12 decreasing in their abundance. Amongst the 59 significant urinary proteins identified, a list of 13 novel up-regulated proteins were revealed that may be used to detect breast cancer. These include stage specific markers associated with pre-invasive breast cancer in the ductal carcinoma in-situ (DCIS) samples (Leucine LRC36, MAST4 and Uncharacterized protein CI131), early invasive breast cancer (DYH8, HBA, PEPA, uncharacterized protein C4orf14 (CD014), filaggrin and MMRN2) and metastatic breast cancer (AGRIN, NEGR1, FIBA and Keratin KIC10). Preliminary validation of 3 potential markers (ECM1, MAST4 and filaggrin) identified was performed in breast cancer cell lines by Western blotting. One potential marker MAST4 was further validated in human breast cancer tissues as well as individual human breast cancer urine samples with immunohistochemistry and Western blotting, respectively. Conclusions Our results indicate that urine is a useful non-invasive source of biomarkers and the profile patterns (biomarkers) identified, have potential for clinical use in the detection of BC. Validation with a larger independent cohort of patients is required in the following study.	[Beretov, Julia; Graham, Peter H.; Li, Yong] St George Hosp, Canc Care Ctr, Kogarah, NSW, Australia; [Beretov, Julia; Graham, Peter H.; Li, Yong] UNSW, Fac Med, St George & Sutherland Clin Sch, Kensington, NSW, Australia; [Beretov, Julia; Millar, Ewan K. A.] St George Hosp, Anat Pathol, SEALS, Kogarah, NSW, Australia; [Wasinger, Valerie C.] UNSW, Mark Wainwright Analyt Ctr, Bioanalyt Mass Spectrometry Facil, Kensington, NSW, Australia; [Wasinger, Valerie C.; Millar, Ewan K. A.] UNSW, Sch Med Sci, Kensington, NSW, Australia; [Millar, Ewan K. A.] Kinghorn Canc Ctr, Canc Res Program, Darlinghurst, NSW, Australia; [Millar, Ewan K. A.] St Vincents Hosp, Garvan Inst Med Res, Darlinghurst, NSW 2010, Australia; [Millar, Ewan K. A.] Univ Western Sydney, Sch Med & Hlth Sci, Campbelltown, NSW, Australia; [Schwartz, Peter] St George Private Hosp, Breast Surg, Kogarah, NSW, Australia	St George Hospital; University of New South Wales Sydney; St George Hospital; University of New South Wales Sydney; University of New South Wales Sydney; Garvan Institute of Medical Research; St Vincents Hospital Sydney; Western Sydney University	Li, Y (corresponding author), St George Hosp, Canc Care Ctr, Kogarah, NSW, Australia.	y.li@unsw.edu.au	Millar, Ewan/ABE-9127-2020; Wasinger, Valerie/AAC-5004-2021	Millar, Ewan/0000-0002-9778-3253; Wasinger, Valerie/0000-0001-5338-0869; Li, Yong/0000-0002-8910-9787; Beretov, Julia/0000-0001-5582-0020	St George Cancer Care Centre Research Trust Fund	St George Cancer Care Centre Research Trust Fund	Funding provided by St George Cancer Care Centre Research Trust Fund.	Aaboe M, 2003, BBA-MOL BASIS DIS, V1638, P72, DOI 10.1016/S0925-4439(03)00059-0; Abdullah-Soheimi SS, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-58; Adachi J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r80; Ahn WS, 2005, CANCER SCI, V96, P197, DOI 10.1111/j.1349-7006.2005.00029.x; Antalis CJ, 2011, CLIN EXP METASTAS, V28, P733, DOI 10.1007/s10585-011-9405-9; BELLAHCENE A, 1995, AM J PATHOL, V146, P95; Beretov Julia, 2014, Biomark Cancer, V6, P21, DOI 10.4137/BIC.S17991; Beretov J, 2014, ADV CLIN CHEM, V63, P123, DOI 10.1016/B978-0-12-800094-6.00004-2; Black MH, 2000, BREAST CANCER RES TR, V59, P1, DOI 10.1023/A:1006380306781; Candiano G, 2010, J PROTEOMICS, V73, P829, DOI 10.1016/j.jprot.2009.12.003; Cao Y, 2008, APPL IMMUNOHISTO M M, V16, P530, DOI 10.1097/PAI.0b013e31817432c3; Caruso Joseph A, 2011, Clin Exp Metastasis, V28, P529, DOI 10.1007/s10585-011-9389-5; Chang KP, 2010, PROTEOMICS, V10, P2644, DOI 10.1002/pmic.200900620; Chang L, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.407; Cho W, 2010, J PROTEOME RES, V9, P5960, DOI 10.1021/pr100747p; Coffelt SB, 2015, NATURE; Coffelt SB, 2015, TRENDS IMMUNOL, V36, P198, DOI 10.1016/j.it.2015.02.006; Custodio A, 2012, J CANCER RES CLIN, V138, P867, DOI 10.1007/s00432-012-1161-y; Deng M, 2013, ONCOGENE, V32, P4273, DOI 10.1038/onc.2012.434; Descamps S, 1998, J BIOL CHEM, V273, P16659, DOI 10.1074/jbc.273.27.16659; Dolle L, 2004, CURR CANCER DRUG TAR, V4, P463, DOI 10.2174/1568009043332853; dos Santos CR, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-16; Dowling P, 2012, INT J CANCER, V131, P911, DOI 10.1002/ijc.26462; Esposito I, 2007, NEOPLASIA, V9, P8, DOI 10.1593/neo.06646; Goncalves A, 2006, ONCOGENE, V25, P981, DOI 10.1038/sj.onc.1209131; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Han ZQ, 2001, FASEB J, V15, P988, DOI 10.1096/fj.99-0934com; Hao J, 2010, BRIT J CANCER, V103, P1008, DOI 10.1038/sj.bjc.6605839; Hassanein M, 2012, CANCER PREV RES, V5, P992, DOI 10.1158/1940-6207.CAPR-11-0441; He P, 2005, PROTEOMICS, V5, P3442, DOI 10.1002/pmic.200401301; Husi H, 2011, PROTEOM CLIN APPL, V5, P289, DOI 10.1002/prca.201000107; Kadowaki M, 2011, J CANCER RES CLIN, V137, P1105, DOI 10.1007/s00432-010-0974-9; Karp NA, 2007, MOL CELL PROTEOMICS, V6, P1354, DOI 10.1074/mcp.M600274-MCP200; Khurana A, 2013, CLIN EXP METASTAS, V30, P407, DOI 10.1007/s10585-012-9546-5; Kim BK, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2247; Klein-Scory S, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-70; Lakhani SR, 2012, WHO CLASSIFICATION T; Lal G, 2009, ANN SURG ONCOL, V16, P2280, DOI 10.1245/s10434-009-0533-2; Lee KM, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0479-6; Lei T, 2012, CLIN GENITOURINARY C; Leinonen T, 2007, J CLIN PATHOL, V60, P515, DOI 10.1136/jcp.2006.038711; Li JN, 2005, CLIN CHEM, V51, P2229, DOI 10.1373/clinchem.2005.052878; Linden M, 2012, PROTEOMICS, V12, P135, DOI 10.1002/pmic.201000810; Mohamed E, 2008, ELECTROPHORESIS, V29, P2645, DOI 10.1002/elps.200700828; Morimoto-Tomita M, 2005, NEOPLASIA, V7, P1001, DOI 10.1593/neo.05496; Myklebust MP, 2012, BRIT J CANCER, V106, P756, DOI 10.1038/bjc.2011.548; Nasim Faiz-Ul-Hassan, 2012, Biomark Cancer, V4, P19, DOI 10.4137/BIC.S10502; Nutter F, 2014, ENDOCR RELAT CANC; Opstal-van Winden AWJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-381; Pan S, 2011, MOL CELLULAR PROTEOM, V10; Parker BS, 2008, J PATHOL, V214, P337, DOI 10.1002/path.2265; Pavlova NN, 2013, ELIFE, V2, DOI 10.7554/eLife.00358; Peng L, 2013, EXP THER MED, V6, P1169, DOI 10.3892/etm.2013.1310; Profumo A, 2013, J PROTEOMICS, V85, P44, DOI 10.1016/j.jprot.2013.04.029; Provatopoulou X, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-390; Rho JH, 2008, J PROTEOME RES, V7, P2959, DOI 10.1021/pr8000892; Rittenhouse HG, 1998, CRIT REV CL LAB SCI, V35, P275, DOI 10.1080/10408369891234219; Robinson DR, 2011, NAT MED, V17, P1646, DOI 10.1038/nm.2580; Schulz DM, 2009, J PROTEOME RES, V8, P3430, DOI 10.1021/pr900071h; Semaan SM, 2012, J CANCER, V3, P269, DOI 10.7150/jca.4592; Shen DJ, 2005, BIOCHEM BIOPH RES CO, V326, P218, DOI 10.1016/j.bbrc.2004.10.214; Sloan KE, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-73; Solassol J, 2010, ONCOGENE, V29, P550, DOI 10.1038/onc.2009.341; Somiari RI, 2003, PROTEOMICS, V3, P1863, DOI 10.1002/pmic.200300560; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sun L, 2006, Mol Biol (Mosk), V40, P808; Takita J, 2011, CANCER SCI, V102, P1645, DOI 10.1111/j.1349-7006.2011.01995.x; Thongboonkerd V, 2002, KIDNEY INT, V62, P1461, DOI 10.1046/j.1523-1755.2002.00565.x; Turtoi A, 2012, J PROTEOME RES, V11, P5011, DOI 10.1021/pr3005698; Vafadar-Isfahani B, 2012, J ALZHEIMERS DIS, V28, P625, DOI 10.3233/JAD-2011-111505; VIZOSO F, 1995, J CLIN ONCOL, V13, P54, DOI 10.1200/JCO.1995.13.1.54; Wang LP, 2010, NEOPLASMA, V57, P253, DOI 10.4149/neo_2010_03_253; Wang LP, 2003, CANCER LETT, V200, P57, DOI 10.1016/S0304-3835(03)00350-1; Wenners AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045826; Whiteside TL, 2012, CLIN CANCER RES, V18, P2417, DOI 10.1158/1078-0432.CCR-12-0566; Wu QW, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-47; Yamanaka M, 2001, J UROLOGY, V166, P2495, DOI 10.1016/S0022-5347(05)65623-6; Yates JR, 2009, ANNU REV BIOMED ENG, V11, P49, DOI 10.1146/annurev-bioeng-061008-124934; Yi JK, 2009, CANCER EPIDEM BIOMAR, V18, P1357, DOI 10.1158/1055-9965.EPI-08-0696; Yin FQ, 2013, INT J ONCOL, V42, P1305, DOI 10.3892/ijo.2013.1819; Yom CK, 2011, J BREAST CANCER, V14, P262, DOI 10.4048/jbc.2011.14.4.262; Zeng Z, 2010, J CHROMATOGR A, V1217, P3307, DOI 10.1016/j.chroma.2009.09.029; Zhang Z, 2004, CANCER RES, V64, P5882, DOI 10.1158/0008-5472.CAN-04-0746; Zhu DJ, 2014, INT J CLIN EXP PATHO, V7, P1; Zoidakis J, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.009449	85	56	61	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141876	10.1371/journal.pone.0141876	http://dx.doi.org/10.1371/journal.pone.0141876			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544852	gold, Green Submitted, Green Published			2022-12-27	WOS:000364398700057
J	Blanton, C; He, ZC; Gottschall-Pass, KT; Sweeney, MI				Blanton, Cynthia; He, Zhengcheng; Gottschall-Pass, Katherine T.; Sweeney, Marva I.			Probiotics Blunt the Anti-Hypertensive Effect of Blueberry Feeding in Hypertensive Rats without Altering Hippuric Acid Production	PLOS ONE			English	Article							DIET VACCINIUM-ANGUSTIFOLIUM; INTESTINAL OXIDATIVE STRESS; BLOOD-PRESSURE; GUT MICROBIOTA; NITRIC-OXIDE; RISK-FACTORS; IN-VITRO; POLYPHENOLS; METABOLISM; CONSUMPTION	Previously we showed that feeding polyphenol-rich wild blueberries to hypertensive rats lowered systolic blood pressure. Since probiotic bacteria produce bioactive metabolites from berry polyphenols that enhance the health benefits of berry consumption, we hypothesized that adding probiotics to a blueberry-enriched diet would augment the anti-hypertensive effects of blueberry consumption. Groups (n = 8) of male spontaneously hypertensive rats were fed one of four AIN '93G-based diets for 8 weeks: Control (CON); 3% freeze-dried wild blueberry (BB); 1% probiotic bacteria (PRO); or 3% BB + 1% PRO (BB + PRO). Blood pressure was measured at weeks 0, 2, 4, 6, and 8 by the tail-cuff method, and urine was collected at weeks 4 and 8 to determine markers of oxidative stress (F2-isoprostanes), nitric oxide synthesis (nitrites), and polyphenol metabolism (hippuric acid). Data were analyzed using mixed models ANOVA with repeated measures. Diet had a significant main effect on diastolic blood pressure (p = 0.046), with significantly lower measurements in the BB-vs. CON-fed rats (p = 0.035). Systolic blood pressure showed a similar but less pronounced response to diet (p = 0.220), again with the largest difference between the BB and CON groups. Absolute increase in blood pressure between weeks 0 and 8 tended to be smaller in the BB and PRO vs. CON and BB + PRO groups (systolic increase, p = 0.074; diastolic increase, p = 0.185). Diet had a significant main effect on hippuric acid excretion (p < 0.0001), with 2- and similar to 1.5-fold higher levels at weeks 4 and 8, respectively, in the BB and BB + PRO vs. PRO and CON groups. Diet did not have a significant main effect on F2-iso-prostane (p = 0.159) or nitrite excretion (p = 0.670). Our findings show that adding probiotics to a blueberry-enriched diet does not enhance and actually may impair the anti-hypertensive effect of blueberry consumption. However, probiotic bacteria are not interfering with blueberry polyphenol metabolism into hippuric acid.	[Blanton, Cynthia] Idaho State Univ, Dept Nutr, Pocatello, ID 83209 USA; [He, Zhengcheng; Sweeney, Marva I.] Univ Prince Edward Isl, Dept Biol, Charlottetown, PE C1A 4P3, Canada; [Gottschall-Pass, Katherine T.] Univ Prince Edward Isl, Dept Appl Human Sci, Charlottetown, PE C1A 4P3, Canada	Idaho; Idaho State University; University of Prince Edward Island; University of Prince Edward Island	Blanton, C (corresponding author), Idaho State Univ, Dept Nutr, Pocatello, ID 83209 USA.	blancynt@isu.edu			Wild Blueberry Association of North America (WBANA)	Wild Blueberry Association of North America (WBANA)	The Wild Blueberry Association of North America (WBANA) provided $5000 USD to support this research. The financial support is not associated with a grant number. Marva Sweeney-Nixon has received funding from WBANA in the past and she was PI on this funding support (http://www.wildblueberries.com/health-research/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axling U, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-105; Basu A, 2010, J NUTR, V140, P1582, DOI 10.3945/jn.110.124701; Bohn T, 2015, MOL NUTR FOOD RES, V59, P1307, DOI 10.1002/mnfr.201400745; Borghi C, 2004, AM HEART J, V148, P285, DOI 10.1016/j.ahj.2004.02.003; Boto-Ordonez M, 2014, FOOD FUNCT, V5, P1932, DOI [10.1039/c4fo00029c, 10.1039/C4FO00029C]; Cassidy A, 2011, AM J CLIN NUTR, V93, P338, DOI 10.3945/ajcn.110.006783; Chen DW, 2015, J MICROBIOL BIOTECHN, V25, P687, DOI 10.4014/jmb.1409.09085; Chen HD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051001; Del Bo C, 2010, J AGR FOOD CHEM, V58, P2491, DOI 10.1021/jf903472x; Duda-Chodak A, 2015, EUR J NUTR, V54, P325, DOI 10.1007/s00394-015-0852-y; Elks CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024028; Erlund I, 2008, AM J CLIN NUTR, V87, P323, DOI 10.1093/ajcn/87.2.323; Esposito E, 2009, J NUTR, V139, P905, DOI 10.3945/jn.108.101808; Fortepiani LA, 2005, J HYPERTENS, V23, P801, DOI 10.1097/01.hjh.0000163149.05083.13; Gillespie C., 2011, Morbidity and Mortality Weekly Report, V60, P103; Haffner SM, 1996, ARCH INTERN MED, V156, P1994, DOI 10.1001/archinte.156.17.1994; Hakansson A, 2006, DIGEST DIS SCI, V51, P2094, DOI 10.1007/s10620-006-9170-9; Hakansson A, 2009, SCAND J GASTROENTERO, V44, P1213, DOI 10.1080/00365520903171268; Hidalgo M, 2012, J AGR FOOD CHEM, V60, P3882, DOI 10.1021/jf3002153; Hirata Y, 1996, HYPERTENSION, V27, P672, DOI 10.1161/01.HYP.27.3.672; HUANG PL, 1995, NATURE, V377, P239, DOI 10.1038/377239a0; Queipo-Ortuno MI, 2012, AM J CLIN NUTR, V95, P1323, DOI 10.3945/ajcn.111.027847; Jakesevic M, 2013, J AGR FOOD CHEM, V61, P3468, DOI 10.1021/jf400203h; Jakesevic M, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-8; Johnson SA, 2015, J ACAD NUTR DIET, V115, P369, DOI 10.1016/j.jand.2014.11.001; Jose PA, 2015, CURR OPIN NEPHROL HY, V24, P403, DOI 10.1097/MNH.0000000000000149; Kalea AZ, 2010, J NUTR BIOCHEM, V21, P14, DOI 10.1016/j.jnutbio.2008.09.005; Khalesi S, 2014, HYPERTENSION, V64, P897, DOI 10.1161/HYPERTENSIONAHA.114.03469; Kristo AS, 2010, J AGR FOOD CHEM, V58, P11600, DOI 10.1021/jf101839u; Lacombe A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067497; Landete JM, 2012, CRIT REV FOOD SCI, V52, P936, DOI 10.1080/10408398.2010.513779; Lopera YE, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/516727; Lye HS, 2009, INT J MOL SCI, V10, P3755, DOI 10.3390/ijms10093755; Mahboobi S, 2014, INT J PREVENTIVE MED, V5; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; Manning RD, 2003, ACTA PHYSIOL SCAND, V179, P243, DOI 10.1046/j.0001-6772.2003.01204.x; Molan AL, 2009, WORLD J MICROB BIOT, V25, P1243, DOI 10.1007/s11274-009-0011-9; Mulder TP, 2005, AM J CLIN NUTR, V81, p256S, DOI 10.1093/ajcn/81.1.256S; Nabha L, 2005, CLIN EXP HYPERTENS, V27, P71, DOI 10.1081/CEH-200044267; Nair AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111976; Okrozub VV, 2015, EPMA J, V6, DOI 10.1186/s13167-015-0035-1; PANZA JA, 1993, CIRCULATION, V87, P1468, DOI 10.1161/01.CIR.87.5.1468; Peluso I, 2014, INT J FOOD SCI NUTR, V65, P259, DOI 10.3109/09637486.2014.880670; Phipps FC, 1994, NIOSH MANUAL ANAL ME; Public Health Agency of Canada, HYPERTENSION; Rashid Sherzad K, 2014, PLoS One, V9, pe97458, DOI 10.1371/journal.pone.0097458; Riso P, 2013, EUR J NUTR, V52, P949, DOI 10.1007/s00394-012-0402-9; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Russell WR, 2008, NUTR CANCER, V60, P636, DOI 10.1080/01635580801987498; Russell WR, 2007, MOL NUTR FOOD RES, V51, P726, DOI 10.1002/mnfr.200700022; Sanchez-Patan F, 2012, J AGR FOOD CHEM, V60, P2136, DOI 10.1021/jf2040115; Selma MV, 2009, J AGR FOOD CHEM, V57, P6485, DOI 10.1021/jf902107d; Shaughnessy KS, 2009, NUTR RES, V29, P130, DOI 10.1016/j.nutres.2009.01.001; Sun J, 2015, ANN MED, V47, P430, DOI 10.3109/07853890.2015.1071872; Sweeney MI, 2002, NUTR NEUROSCI, V5, P427, DOI 10.1080/1028415021000055970; Tabasco R, 2011, FOOD MICROBIOL, V28, P1345, DOI 10.1016/j.fm.2011.06.005; Toromanovic J, 2008, BOSNIAN J BASIC MED, V8, P38, DOI 10.17305/bjbms.2008.2994; Tzounis X, 2011, AM J CLIN NUTR, V93, P62, DOI 10.3945/ajcn.110.000075; VALLANCE P, 1989, LANCET, V2, P997; Vendrame S, 2011, J AGR FOOD CHEM, V59, P12815, DOI 10.1021/jf2028686; Wallen WJ, 2002, J NUTR, V132, P2246, DOI 10.1093/jn/132.8.2246; Williamson G, 2010, BRIT J NUTR, V104, pS48, DOI 10.1017/S0007114510003946; Yang T, 2015, HYPERTENSION, V65, P1331, DOI 10.1161/HYPERTENSIONAHA.115.05315; Yang Y, 2015, INT J CLIN EXP PATHO, V8, P2700	64	8	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142036	10.1371/journal.pone.0142036	http://dx.doi.org/10.1371/journal.pone.0142036			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544724	gold, Green Published, Green Submitted			2022-12-27	WOS:000364398700072
J	McNamara, JM; Houston, AI; Higginson, AD				McNamara, John M.; Houston, Alasdair I.; Higginson, Andrew D.			Costs of Foraging Predispose Animals to Obesity-Related Mortality when Food Is Constantly Abundant	PLoS One			English	Article							PSYCHOSOCIAL STRESS; ENERGY-BALANCE; PREDATION RISK; TRADE-OFF; STARVATION; EPIDEMIC; WEIGHT; FAT; METAANALYSIS; PERSPECTIVE	Obesity is an important medical problem affecting humans and animals in the developed world, but the evolutionary origins of the behaviours that cause obesity are poorly understood. The potential role of occasional gluts of food in determining fat-storage strategies for avoiding mortality have been overlooked, even though animals experienced such conditions in the recent evolutionary past and may follow the same strategies in the modern environment. Humans, domestic, and captive animals in the developed world are exposed to a surplus of calorie-rich food, conditions characterised as 'constant-glut'. Here, we use a mathematical model to demonstrate that obesity-related mortality from poor health in a constant-glut environment should equal the average mortality rate in the 'pre-modern' environment when predation risk was more closely linked with foraging. It should therefore not be surprising that animals exposed to abundant food often over-eat to the point of ill-health. Our work suggests that individuals tend to defend a given excessive level of reserves because this level was adaptive when gluts were short-lived. The model predicts that mortality rate in constant-glut conditions can increase as the assumed health cost of being overweight decreases, meaning that any adaptation that reduced such health costs would have counter-intuitively led to an increase in mortality in the modern environment. Taken together, these results imply that efforts to reduce the incidence of obesity that are focussed on altering individual behaviour are likely to be ineffective because modern, constant-glut conditions trigger previously adaptive behavioural responses.	[McNamara, John M.] Univ Bristol, Sch Math, Bristol BS8 1TW, Avon, England; [Houston, Alasdair I.; Higginson, Andrew D.] Univ Bristol, Sch Biol Sci, Bristol BS8 1TQ, Avon, England; [Higginson, Andrew D.] Univ Exeter, Coll Life & Environm Sci, Exeter EX4 4QG, Devon, England	University of Bristol; University of Bristol; University of Exeter	Higginson, AD (corresponding author), Univ Bristol, Sch Biol Sci, Life Sci Bldg,24 Tyndall Ave, Bristol BS8 1TQ, Avon, England.	adhigginson@gmail.com			European Research Council [250209]; NERC Independent Research Fellowship [NE/L011921/1]; NERC [NE/L011921/1, NE/L011921/2] Funding Source: UKRI; Natural Environment Research Council [NE/L011921/1, NE/L011921/2] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); NERC Independent Research Fellowship(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the European Research Council (Advanced Grant 250209 to Alasdair Houston). An NERC Independent Research Fellowship (NE/L011921/1) was awarded to A.D.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JW, 2001, AM J CLIN NUTR, V74, P579; Barker DJP, 1997, NUTRITION, V13, P807, DOI 10.1016/S0899-9007(97)00193-7; Benyshek DC, 2006, AM J PHYS ANTHROPOL, V131, P120, DOI 10.1002/ajpa.20334; Brodin A, 2001, ANIM BEHAV, V62, P993, DOI 10.1006/anbe.2001.1844; Davis C, 2010, EAT BEHAV, V11, P301, DOI 10.1016/j.eatbeh.2010.07.004; Fawcett TW, 2014, TRENDS COGN SCI, V18, P153, DOI 10.1016/j.tics.2013.12.012; Frankenhuis WE, 2012, DEV PSYCHOL, V48, P628, DOI 10.1037/a0025629; Garaulet M, 2010, INT J OBESITY, V34, P1667, DOI 10.1038/ijo.2010.118; Gariepy G, 2010, INT J OBESITY, V34, P407, DOI 10.1038/ijo.2009.252; Gazzola A, 2005, J ZOOL, V266, P205, DOI 10.1017/S0952836905006801; GOSLER AG, 1995, NATURE, V377, P621, DOI 10.1038/377621a0; Hayward AD, 2012, P ROY SOC B-BIOL SCI, V279, P4165, DOI 10.1098/rspb.2012.1190; Heymsfield SB, 2007, AM J CLIN NUTR, V85, P346, DOI 10.1093/ajcn/85.2.346; Higginson AD, 2012, AM NAT, V179, P338, DOI 10.1086/664457; Hocken AG, 2000, NEW ZEAL J ZOOL, V27, P305, DOI 10.1080/03014223.2000.9518239; James PT, 2004, CLIN DERMATOL, V22, P276, DOI 10.1016/j.clindermatol.2004.01.010; Kirchengast S, 1998, ANN HUM BIOL, V25, P541, DOI 10.1080/03014469800006782; Klenov VE, 2014, CURR OPIN OBSTET GYN, V26, P455, DOI 10.1097/GCO.0000000000000113; LIMA SL, 1986, ECOLOGY, V67, P377, DOI 10.2307/1938580; Marik PE, 2012, OBES REV, V13, P902, DOI 10.1111/j.1467-789X.2012.01014.x; McCue MD, 2010, COMP BIOCHEM PHYS A, V156, P1, DOI 10.1016/j.cbpa.2010.01.002; MCNAMARA JM, 1990, ACTA BIOTHEOR, V38, P37, DOI 10.1007/BF00047272; MCNAMARA JM, 1990, ADV APPL PROBAB, V22, P295, DOI 10.2307/1427537; Milner JJ, 2012, P NUTR SOC, V71, P298, DOI 10.1017/S0029665112000158; Morrison CD, 2007, NUTR REV, V65, P517, DOI 10.1111/j.1753-4887.2007.tb00277.x; Mysterud A, 2008, J ZOOL, V275, P407, DOI 10.1111/j.1469-7998.2008.00453.x; NEEL JV, 1962, AM J HUM GENET, V14, P353; Nikolopoulou A, 2012, EXPERT REV CARDIOVAS, V10, P933, DOI [10.1586/erc.12.74, 10.1586/ERC.12.74]; Obesity Strubbe JH., 1994, FOOD INTAKE ENERGY E; ODEA K, 1992, DIABETES METAB REV, V8, P373, DOI 10.1002/dmr.5610080405; PASQUET P, 1992, AM J CLIN NUTR, V56, P483, DOI 10.1093/ajcn/56.3.483; Pereira JA, 2010, EUR J WILDLIFE RES, V56, P939, DOI 10.1007/s10344-010-0423-8; Pickering TR, 2005, EVOL ANTHROPOL, V14, P159, DOI 10.1002/evan.20070; Pollock N J, 1995, Asia Pac J Clin Nutr, V4, P357; Popkin BM, 2004, INT J OBESITY, V28, pS2, DOI [10.1038/sj.ijo.0802804, 10.1038/sj.ijo.0802557]; Putaala A, 2001, WILDL BIOL, V18, P291; Raj Manu, 2012, Indian J Endocrinol Metab, V16, P13, DOI 10.4103/2230-8210.91176; Rius B, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00257; Rogers PJ, 1999, P NUTR SOC, V58, P59, DOI 10.1079/PNS19990009; Rowland NE, 2008, PHYSIOL BEHAV, V93, P97, DOI 10.1016/j.physbeh.2007.08.003; Schekkerman H, 2009, J ORNITHOL, V150, P133, DOI 10.1007/s10336-008-0328-4; Scott KA, 2008, J PSYCHOSOM RES, V64, P97, DOI 10.1016/j.jpsychores.2007.09.006; Sermondade N, 2013, HUM REPROD UPDATE, V19, P221, DOI 10.1093/humupd/dms050; Siervo M, 2009, HORM METAB RES, V41, P261, DOI 10.1055/s-0028-1119377; Siervo M, 2008, OBES METAB-MILAN, V4, P131; Speakman JR, 2008, INT J OBESITY, V32, P1611, DOI 10.1038/ijo.2008.161; Speakman JR, 2013, ANNU REV NUTR, V33, P289, DOI 10.1146/annurev-nutr-071811-150711; Treves A, 1999, J HUM EVOL, V36, P275, DOI 10.1006/jhev.1998.0268; Troiano RP, 1996, INT J OBESITY, V20, P63; Wells JCK, 2011, EUR J CLIN NUTR, V65, P1173, DOI 10.1038/ejcn.2011.132; Wells JCK, 2009, INT J OBESITY, V33, P1331, DOI 10.1038/ijo.2009.175; Wells J. C. K., 2010, EVOLUTIONARY BIOL HU; Wells JCK, 2006, BIOL REV, V81, P183, DOI 10.1017/S1464793105006974; White CL, 2010, PHYSIOL BEHAV, V100, P408, DOI 10.1016/j.physbeh.2010.04.006; WITTER MS, 1993, PHILOS T R SOC B, V340, P73, DOI 10.1098/rstb.1993.0050; Zafon C, 2007, OBES REV, V8, P525, DOI 10.1111/j.1467-789X.2007.00377.x; Zimmer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022352	57	5	5	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141811	10.1371/journal.pone.0141811	http://dx.doi.org/10.1371/journal.pone.0141811			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26545121	Green Published, Green Submitted, gold			2022-12-27	WOS:000364398700051
J	Shuda, M; Guastafierro, A; Geng, XH; Shuda, Y; Ostrowski, SM; Lukianov, S; Jenkins, FJ; Honda, K; Maricich, SM; Moore, PS; Chang, Y				Shuda, Masahiro; Guastafierro, Anna; Geng, Xuehui; Shuda, Yoko; Ostrowski, Stephen M.; Lukianov, Stefan; Jenkins, Frank J.; Honda, Kord; Maricich, Stephen M.; Moore, Patrick S.; Chang, Yuan			Merkel Cell Polyomavirus Small T Antigen Induces Cancer and Embryonic Merkel Cell Proliferation in a Transgenic Mouse Model	PLOS ONE			English	Article							P53; CARCINOMA; EXPRESSION; MICE; RB; DIFFERENTIATION; TUMORIGENESIS; TRANSLATION; DEFICIENCY; VIRUSES	Merkel cell polyomavirus (MCV) causes the majority of human Merkel cell carcinomas (MCC) and encodes a small T (sT) antigen that transforms immortalized rodent fibroblasts in vitro. To develop a mouse model for MCV sT-induced carcinogenesis, we generated transgenic mice with a flox-stop-flox MCV sT sequence homologously recombined at the ROSA locus (ROSA(sT)), allowing Cre-mediated, conditional MCV sT expression. Standard tamoxifen (TMX) administration to adult Ubc(CreERT2); ROSA(sT) mice, in which Cre is ubiquitously expressed, resulted in MCV sT expression in multiple organs that was uniformly lethal within 5 days. Conversely, most adult UbcCreERT2; ROSAsT mice survived low-dose tamoxifen administration but developed ear lobe dermal hyperkeratosis and hypergranulosis. Simultaneous MCV sT expression and conditional homozygous p53 deletion generated multi-focal, poorly-differentiated, highly anaplastic tumors in the spleens and livers of mice after 60 days of TMX treatment. Mouse embryonic fibroblasts from these mice induced to express MCV sT exhibited anchorage-independent cell growth. To examine Merkel cell pathology, MCV sT expression was also induced during mid-embryogenesis in Merkel cells of Atoh1(CreERT2/+); ROSA(sT) mice, which lead to significantly increased Merkel cell numbers in touch domes at late embryonic ages that normalized postnatally. Tamoxifen administration to adult Atoh1(CreERT2/+); ROSA(sT) and Atoh1(CreERT2/+); ROSA(sT); p53(flox/flox) mice had no effects on Merkel cell numbers and did not induce tumor formation. Taken together, these results show that MCV sT stimulates progenitor Merkel cell proliferation in embryonic mice and is a bona fide viral oncoprotein that induces full cancer cell transformation in the p53-null setting.	[Shuda, Masahiro; Guastafierro, Anna; Shuda, Yoko; Lukianov, Stefan; Moore, Patrick S.; Chang, Yuan] Univ Pittsburgh, Inst Canc, Canc Virol Program, Pittsburgh, PA USA; [Geng, Xuehui; Maricich, Stephen M.] Univ Pittsburgh, Dept Pediat, Richard King Mellon Inst Pediat Res, Pittsburgh, PA 15260 USA; [Jenkins, Frank J.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA USA; [Ostrowski, Stephen M.; Honda, Kord] Case Western Reserve Univ, Sch Med, Dept Dermatol, Cleveland, OH USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Case Western Reserve University	Maricich, SM (corresponding author), Univ Pittsburgh, Dept Pediat, Richard King Mellon Inst Pediat Res, Pittsburgh, PA 15260 USA.	stephen.maricich@chp.edu; psm9@pitt.edu; yc70@pitt.edu	Chang, Yuan/F-4146-2011; SHUDA, MASAHIRO/F-5505-2011; Moore, Patrick/GVR-8294-2022; SHUDA, MASAHIRO/N-8239-2019; Moore, Patrick S./F-3960-2011	Chang, Yuan/0000-0003-1125-4041; SHUDA, MASAHIRO/0000-0003-0595-2572; SHUDA, MASAHIRO/0000-0003-0595-2572; Moore, Patrick S./0000-0002-8132-858X	NIH NCI [R01CA136806, CA136363, CA170354]; American Cancer Society Professorships; University of Pittsburgh Skin Cancer SPORE [CA12197305]; NIH NIAMS [R01AR05114, T32-AR007569]; Richard King Mellon Institute for Pediatric Research; Dermatology Foundation; University of Pittsburgh Cancer Institute [P30CA047904]; NATIONAL CANCER INSTITUTE [R01CA170354, R01CA136806, R01CA136363, P30CA047904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007569] Funding Source: NIH RePORTER	NIH NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society Professorships; University of Pittsburgh Skin Cancer SPORE(University of Pittsburgh); NIH NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Richard King Mellon Institute for Pediatric Research; Dermatology Foundation; University of Pittsburgh Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by NIH NCI R01CA136806, CA136363, CA170354, and American Cancer Society Professorships to PSM and YC. MS was supported in part by the University of Pittsburgh Skin Cancer SPORE CA12197305. SMM was supported by NIH NIAMS R01AR05114, Richard King Mellon Institute for Pediatric Research. SMO was supported by the Dermatology Foundation and NIH NIAMS T32-AR007569. This project used the University of Pittsburgh Cancer Institute core facilities that are supported in part by award P30CA047904.	Allan LA, 2000, MOL CELL BIOL, V20, P1291, DOI 10.1128/MCB.20.4.1291-1298.2000; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; BLYTH K, 1995, ONCOGENE, V10, P1717; Borchert S, 2014, J VIROL, V88, P3144, DOI 10.1128/JVI.02916-13; Borozan I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076935; Bossuyt W, 2009, PLOS BIOL, V7, P311, DOI 10.1371/journal.pbio.1000039; Cheng JW, 2013, J VIROL, V87, P6118, DOI 10.1128/JVI.00385-13; Choi J, 2010, AM J PATHOL, V177, P2645, DOI 10.2353/ajpath.2010.100306; DeCaprio JA, 2013, NAT REV MICROBIOL, V11, P264, DOI 10.1038/nrmicro2992; DONEHOWER LA, 1995, GENE DEV, V9, P882, DOI 10.1101/gad.9.7.882; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Feng HC, 2007, J VIROL, V81, P11332, DOI 10.1128/JVI.00875-07; Fujiyama T, 2009, DEVELOPMENT, V136, P2049, DOI 10.1242/dev.033480; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Houben R, 2012, INT J CANCER, V130, P847, DOI 10.1002/ijc.26076; Houben R, 2010, J VIROL, V84, P7064, DOI 10.1128/JVI.02400-09; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Kassem A, 2008, CANCER RES, V68, P5009, DOI 10.1158/0008-5472.CAN-08-0949; Khidr L, 2006, ONCOGENE, V25, P5210, DOI 10.1038/sj.onc.1209612; Kwun HJ, 2013, CELL HOST MICROBE, V14, P125, DOI 10.1016/j.chom.2013.06.008; Kwun HJ, 2009, J VIROL, V83, P12118, DOI 10.1128/JVI.01336-09; Maricich SM, 2009, SCIENCE, V324, P1580, DOI 10.1126/science.1172890; Moore PS, 2010, NAT REV CANCER, V10, P878, DOI 10.1038/nrc2961; Ostrowski SM, 2015, DEVELOPMENT ACCEPTED; Rodig SJ, 2012, J CLIN INVEST, V122, P4645, DOI 10.1172/JCI64116; Schmid M, 1997, VIRCHOWS ARCH, V430, P233, DOI 10.1007/BF01324807; Schmitt M, 2012, INT J CANCER, V131, P2863, DOI 10.1002/ijc.27607; SCHNEIDER JW, 1994, SCIENCE, V264, P1467, DOI 10.1126/science.8197461; Shuda M, 2008, P NATL ACAD SCI USA, V105, P16272, DOI 10.1073/pnas.0806526105; Shuda M, 2015, P NATL ACAD SCI USA, V112, P5875, DOI 10.1073/pnas.1505787112; Shuda M, 2014, J INVEST DERMATOL, V134, P1479, DOI 10.1038/jid.2013.483; Shuda M, 2011, J CLIN INVEST, V121, P3623, DOI 10.1172/JCI46323; Spurgeon ME, 2015, CANCER RES, V75, P1068, DOI 10.1158/0008-5472.CAN-14-2425; SYMONDS H, 1994, CELL, V78, P703, DOI 10.1016/0092-8674(94)90534-7; Verhaegen ME, 2014, THE JOURNAL OF INVES, DOI [10.1038/jid.2014.446, DOI 10.1038/JID.2014.446]; Wendzicki JA, 2015, CURR OPIN VIROL, V11, P38, DOI 10.1016/j.coviro.2015.01.009; Wright MC, 2015, J CELL BIOL, V208, P367, DOI 10.1083/jcb.201407101	37	58	59	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142329	10.1371/journal.pone.0142329	http://dx.doi.org/10.1371/journal.pone.0142329			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544690	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000364398700112
J	Valle, MS; Casabona, A; Cavallaro, C; Castorina, G; Cioni, M				Valle, Maria Stella; Casabona, Antonino; Cavallaro, Carlo; Castorina, Gabriele; Cioni, Matteo			Learning Upright Standing on a Multiaxial Balance Board	PLOS ONE			English	Article							POSTURAL CONTROL; APPROXIMATE ENTROPY; INTERNAL-MODELS; HEALTHY-YOUNG; MOTOR; SWAY; ADAPTATION; COORDINATION; MOVEMENTS; PERTURBATIONS	Upright stance on a balance board is a skill requiring complex rearrangement of the postural control. Despite the large use of these boards in training the standing posture, a comprehensive analysis of the learning process underlying the control of these devices is lacking. In this paper learning to maintain a stable stance on a multiaxial oscillating board was studied by analyzing performance changes over short and long periods. Healthy participants were asked to keep the board orientation as horizontal as possible for 20 sec, performing two sessions of 8 trials separated by 15-min pause. Memory consolidation was tested one week later. Amplitude and variability of the oscillations around horizontal plane and area and sway path of the board displacement decreased rapidly over the first session. The performance was stable during the second session, and retained after 1 week. A similar behavior was observed in the anterior-posterior and medial-lateral directions for amplitude and variability parameters, with less stable balance in the anterior-posterior direction. Approximate entropy and mean power frequency, assessing temporal dynamics and frequency content of oscillations, changed only in the anterior-posterior direction during the retention test. Overall, the ability to stand on a balance board is rapidly acquired, and retained for long time. The asymmetric stability between anterior-posterior and medial-lateral directions replicates a structure observed in other standing stances, suggesting a possible transfer from previous postural experiences. Conversely, changes in the temporal dynamics and the frequency content could be associated with new postural strategies developed later during memory consolidation.	[Valle, Maria Stella; Casabona, Antonino; Cioni, Matteo] Univ Catania, Dept Biomed & Biotechnol Sci, Catania, Italy; [Valle, Maria Stella; Casabona, Antonino; Cavallaro, Carlo; Castorina, Gabriele; Cioni, Matteo] Univ Catania, Gait & Posture Anal Lab, Catania, Italy; [Casabona, Antonino; Cavallaro, Carlo; Cioni, Matteo] Univ Catania, Phys Med & Rehabil Residency Program, Catania, Italy	University of Catania; University of Catania; University of Catania	Cioni, M (corresponding author), Univ Catania, Dept Biomed & Biotechnol Sci, Catania, Italy.	mcioni@unict.it		VALLE, Maria Stella/0000-0001-9728-3542; Casabona, Antonino/0000-0003-0180-4695	University of Catania	University of Catania	This work was supported by University of Catania.	Ahmed AA, 2007, J NEUROPHYSIOL, V97, P2439, DOI 10.1152/jn.00164.2006; Ahmed AA, 2009, J NEUROPHYSIOL, V102, P2816, DOI 10.1152/jn.00532.2009; Allum JHJ, 2003, IEEE ENG MED BIOL, V22, P37, DOI 10.1109/MEMB.2003.1195694; Almeida GL, 2006, GAIT POSTURE, V23, P17, DOI 10.1016/j.gaitpost.2004.11.020; ASSAIANTE C, 1995, HUM MOVEMENT SCI, V14, P13, DOI 10.1016/0167-9457(94)00048-J; Assaiante C, 2011, HUM MOVEMENT SCI, V30, P227, DOI 10.1016/j.humov.2010.05.007; Balasubramaniam R, 2000, GAIT POSTURE, V11, P12, DOI 10.1016/S0966-6362(99)00051-X; Bardy BG, 2007, J MOTOR BEHAV, V39, P326, DOI 10.3200/JMBR.39.4.326-336; Bloem BR, 2002, EXP BRAIN RES, V142, P91, DOI 10.1007/s00221-001-0926-3; Bottaro A, 2008, HUM MOVEMENT SCI, V27, P473, DOI 10.1016/j.humov.2007.11.005; Carpenter MG, 2001, EXP BRAIN RES, V138, P210, DOI 10.1007/s002210100681; Cavanaugh JT, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-42; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Chen CL, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-50; Chen FC, 2012, J EXP PSYCHOL-APPL, V18, P203, DOI 10.1037/a0026661; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cooper R L, 2005, Res Sports Med, V13, P163, DOI 10.1080/15438620590956197; Dettmer M, 2013, HUM MOVEMENT SCI, V32, P214, DOI 10.1016/j.humov.2012.12.002; Dougherty John, 2011, Mo Med, V108, P128; Doumas M, 2010, J NEUROPHYSIOL, V104, P1969, DOI 10.1152/jn.00345.2010; Duarte M, 2000, NEUROSCI LETT, V283, P173, DOI 10.1016/S0304-3940(00)00960-5; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Flanagan JR, 1997, J NEUROSCI, V17, P1519; Fransson PA, 1998, GAIT POSTURE, V7, P64, DOI 10.1016/S0966-6362(97)00030-1; Ganesan M, 2014, GAIT POSTURE, V39, P899, DOI 10.1016/j.gaitpost.2013.11.019; Genzel L, 2012, NEUROPSYCHOBIOLOGY, V66, P237, DOI 10.1159/000341878; Golomer E, 1999, NEUROSCI LETT, V267, P189, DOI 10.1016/S0304-3940(99)00356-0; Halicka Z, 2014, GAIT POSTURE, V39, P410, DOI 10.1016/j.gaitpost.2013.08.005; Haran F J, 2008, J Neurol Phys Ther, V32, P186, DOI 10.1097/NPT.0b013e31818dee39; HORAK FB, 1986, J NEUROPHYSIOL, V55, P1369, DOI 10.1152/jn.1986.55.6.1369; Hsu WL, 2007, J NEUROPHYSIOL, V97, P3024, DOI 10.1152/jn.01142.2006; Huisinga JM, 2012, NEUROSCI LETT, V524, P124, DOI 10.1016/j.neulet.2012.07.020; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; KESHNER EA, 1988, EXP BRAIN RES, V71, P455, DOI 10.1007/BF00248739; Krakauer JW, 2000, J NEUROSCI, V20, P8916, DOI 10.1523/jneurosci.20-23-08916.2000; Lakens Daniel, 2013, Front Psychol, V4, P863, DOI 10.3389/fpsyg.2013.00863; Latash ML, 2003, EXP BRAIN RES, V150, P314, DOI 10.1007/s00221-003-1419-3; Madureira MM, 2007, OSTEOPOROSIS INT, V18, P419, DOI 10.1007/s00198-006-0252-5; Mahboobin A, 2009, MED BIOL ENG COMPUT, V47, P921, DOI 10.1007/s11517-009-0477-5; MOORE SP, 1988, EXP BRAIN RES, V73, P648, DOI 10.1007/BF00406624; Morasso PG, 1999, NEURAL NETWORKS, V12, P1173, DOI 10.1016/S0893-6080(99)00058-1; Nagy E, 2004, EUR J APPL PHYSIOL, V92, P407, DOI 10.1007/s00421-004-1157-7; NASHNER LM, 1985, BEHAV BRAIN SCI, V8, P135, DOI 10.1017/S0140525X00020008; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; PINCUS SM, 1994, AM J PHYSIOL, V266, pH1643, DOI 10.1152/ajpheart.1994.266.4.H1643; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Podolski IYa, 1998, Membr Cell Biol, V11, P743; Prieto TE, 1996, IEEE T BIO-MED ENG, V43, P956, DOI 10.1109/10.532130; Prosperini L, 2010, MULT SCLER J, V16, P491, DOI 10.1177/1352458509359923; Rigoldi C, 2013, RES DEV DISABIL, V34, P840, DOI 10.1016/j.ridd.2012.11.007; Sabatini AM, 2000, MED BIOL ENG COMPUT, V38, P617, DOI 10.1007/BF02344866; Salaj S. S., 2007, KINESIOLOGY, V39, P131; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Shadmehr R, 1997, J NEUROSCI, V17, P409, DOI 10.1523/JNEUROSCI.17-01-00409.1997; Shea CH, 2000, HUM MOVEMENT SCI, V19, P737, DOI 10.1016/S0167-9457(00)00021-X; Stoffregen TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066949; Tjernstrom F, 2005, J VESTIBUL RES-EQUIL, V15, P31; Tjernstrom F, 2010, J VESTIBUL RES-EQUIL, V20, P407, DOI 10.3233/VES-2010-0391; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309; Torres-Oviedo G, 2007, J NEUROPHYSIOL, V98, P2144, DOI 10.1152/jn.01360.2006; Tseng YW, 2002, MOTOR CONTROL, V6, P183, DOI 10.1123/mcj.6.2.183; Wang Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085414; Wang Z, 2014, MOTOR CONTROL, V18, P165, DOI 10.1123/mc.2013-0064; Winter DA, 1996, J NEUROPHYSIOL, V75, P2334, DOI 10.1152/jn.1996.75.6.2334; Wolpert DM, 2011, NAT REV NEUROSCI, V12, P739, DOI 10.1038/nrn3112; Yaggie JA, 2006, J STRENGTH COND RES, V20, P422	66	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142423	10.1371/journal.pone.0142423	http://dx.doi.org/10.1371/journal.pone.0142423			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544694	Green Submitted, gold, Green Published			2022-12-27	WOS:000364398700136
J	Braz, SV; Monge-Fuentes, V; da Silva, JR; Tomaz, C; Tavares, MC; Garcia, MP; Bao, SN; Lozzi, SP; de Azevedo, RB				Braz, Shelida Vasconcelos; Monge-Fuentes, Victoria; da Silva, Jaqueline Rodrigues; Tomaz, Carlos; Tavares, Maria Clotilde; Garcia, Monica Pereira; Bao, Sonia Nair; Lozzi, Silene Paulino; de Azevedo, Ricardo Bentes			Morphological Analysis of Reticuloendothelial System in Capuchin Monkeys (Sapajus spp.) after Meso-2,3-Dimercaptosuccinic Acid (DMSA) Coated Magnetic Nanoparticles Administration	PLOS ONE			English	Article							IRON-OXIDE NANOPARTICLES; DRUG-DELIVERY; IN-VIVO; POLYMERIC NANOPARTICLES; MITOCHONDRIAL DYSFUNCTION; MAGHEMITE NANOPARTICLES; SURFACE MODIFICATION; OXIDATIVE INJURY; BLOCK-COPOLYMER; BIODISTRIBUTION	Magnetic nanoparticles can be used for numerous in vitro and in vivo applications. However, since uptake by the reticuloendothelial system represents an obstacle for the achievement of nanoparticle diagnostic and therapeutic goals, the aim of the present study was to evaluate the uptake of dimercaptosuccinic acid coated magnetic nanoparticles by reticulo-endothelial system phagocytic cells present in lymph nodes, spleen, and liver tissue and how the presence of these particles could have an impact on the morphology of these organs in capuchin monkeys (Sapajus spp.). Animals were intravenously injected with dimercaptosuccinic acid coated magnetic nanoparticles and euthanized 12 hours and 90 days post-injection. Organs were processed by transmission electron microscopy and histological techniques. Samples of spleen and lymph nodes showed no morphological changes. Nevertheless, liver samples collected 90 days post-administration showed slight morphological alteration in space of Disse. Moreover, morphometrical analysis of hepatic mitochondria was performed, suggesting a clear positive correlation between mitochondrial area and dimercaptosuccinic acid coated magnetic nanoparticles administration time. The present results are directly relevant to current safety considerations in clinical diagnostic and therapeutic uses of magnetic nanoparticles.	[Monge-Fuentes, Victoria; da Silva, Jaqueline Rodrigues; Garcia, Monica Pereira; de Azevedo, Ricardo Bentes] Univ Brasilia, Inst Biol Sci, Dept Genet & Morphol, Lab Nanobiotechnol, BR-70910900 Brasilia, DF, Brazil; [Braz, Shelida Vasconcelos; Lozzi, Silene Paulino] Univ Brasilia, Inst Biol Sci, Dept Genet & Morphol, BR-70910900 Brasilia, DF, Brazil; [Tomaz, Carlos; Tavares, Maria Clotilde] Univ Brasilia, Ctr Primate, BR-70910900 Brasilia, DF, Brazil; [Tomaz, Carlos; Tavares, Maria Clotilde] Univ Brasilia, Inst Biol, Dept Physiol Sci, Lab Neurosci & Behav, BR-70910900 Brasilia, DF, Brazil; [Bao, Sonia Nair] Univ Brasilia, Dept Cell Biol, Lab Electron Microscopy, BR-70919970 Brasilia, DF, Brazil; [Tomaz, Carlos] Univ CEUMA, Neurocience Grad Program, Sao Luis, MA, Brazil	Universidade de Brasilia; Universidade de Brasilia; Universidade de Brasilia; Universidade de Brasilia; Universidade de Brasilia; Universidade Ceuma	de Azevedo, RB (corresponding author), Univ Brasilia, Inst Biol Sci, Dept Genet & Morphol, Lab Nanobiotechnol, BR-70910900 Brasilia, DF, Brazil.	razevedo@unb.br	Tomaz, Carlos A B/F-8626-2012; Báo, Sônia/V-1214-2019	Azevedo, Ricardo/0000-0002-2137-9588; Bao, Sonia/0000-0002-9873-3098; Da Silva, Jaqueline R/0000-0002-6017-7057; Garcia, Monica/0000-0003-0114-5319	Brazilian agency: Ministerio da Ciencia, Tecnologia e Inovacao (MCTI); Brazilian agency: Financiadora de Estudos e Projetos (FINEP); Brazilian agency: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Brazilian agency: Instituto Nacional de Ciencia e Tecnologia-Nanobiotecnologia (INCT-Nanobiotechnology); Brazilian agency: Coordenacao de Aperfeicoamento de Pessoal do Nivel Superior (CAPES); CNPq; CAPES	Brazilian agency: Ministerio da Ciencia, Tecnologia e Inovacao (MCTI); Brazilian agency: Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep)); Brazilian agency: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian agency: Instituto Nacional de Ciencia e Tecnologia-Nanobiotecnologia (INCT-Nanobiotechnology); Brazilian agency: Coordenacao de Aperfeicoamento de Pessoal do Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the following Brazilian agencies: Ministerio da Ciencia, Tecnologia e Inovacao (MCTI); Financiadora de Estudos e Projetos (FINEP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Instituto Nacional de Ciencia e Tecnologia-Nanobiotecnologia (INCT-Nanobiotechnology); and Coordenacao de Aperfeicoamento de Pessoal do Nivel Superior (CAPES). The funders participated in the purchase of equipment and reagents used in this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Student scholarships were provided to VMF and JRS (CNPq) and SVB (CAPES).	Alexis F, 2008, MOL PHARMACEUT, V5, P505, DOI 10.1021/mp800051m; Allkemper T, 2002, RADIOLOGY, V223, P432, DOI 10.1148/radiol.2232010241; Andreas K, 2012, BIOMATERIALS, V33, P4515, DOI 10.1016/j.biomaterials.2012.02.064; Auffan M, 2006, ENVIRON SCI TECHNOL, V40, P4367, DOI 10.1021/es060691k; Brigger I, 2002, ADV DRUG DELIVER REV, V54, P631, DOI 10.1016/S0169-409X(02)00044-3; Britton RS, 2002, INT J HEMATOL, V76, P219, DOI 10.1007/BF02982791; Cai XH, 2014, J BIOMED NANOTECHNOL, V10, P251, DOI 10.1166/jbn.2014.1787; Cegnar M, 2004, EXP CELL RES, V301, P223, DOI 10.1016/j.yexcr.2004.07.021; Center SA, 1999, J SMALL ANIM PRACT, V40, P106, DOI 10.1111/j.1748-5827.1999.tb03050.x; Chang JM, 2006, INVEST RADIOL, V41, P168, DOI 10.1097/01.rli.0000192417.33989.7a; Chastellain A, 2004, J COLLOID INTERF SCI, V278, P353, DOI 10.1016/j.jcis.2004.06.025; Chaves SB, 2002, IEEE T MAGN, V38, P3231, DOI 10.1109/TMAG.2002.802495; Clement O, 1999, J COMPUT ASSIST TOMO, V23, pS45, DOI 10.1097/00004728-199911001-00007; Elloumi Hela, 2003, Tunis Med, V81, P763; Emerit J, 2001, BIOMED PHARMACOTHER, V55, P333, DOI 10.1016/S0753-3322(01)00068-3; Estevanato LLC, 2012, INT J NANOMED, V7, P5287, DOI 10.2147/IJN.S35279; Fauconnier N, 1999, J MOL LIQ, V83, P233, DOI 10.1016/S0167-7322(99)00088-4; Garcia MP, 2005, J MAGN MAGN MATER, V293, P277, DOI 10.1016/j.jmmm.2005.02.053; Gaucher G, 2009, BIOMACROMOLECULES, V10, P408, DOI 10.1021/bm801178f; Ge Y, 2010, COLLOID SURFACE B, V73, P294; Ghosh D, 2012, NAT NANOTECHNOL, V7, P677, DOI [10.1038/NNANO.2012.146, 10.1038/nnano.2012.146]; Green JBA, 2008, NAT CELL BIOL, V10, P375, DOI 10.1038/ncb0408-375; Hamid AA, 2011, RES CHEM INTERMEDIAT, V37, P791, DOI 10.1007/s11164-011-0317-8; Huh YM, 2005, J AM CHEM SOC, V127, P12387, DOI 10.1021/ja052337c; Jain TK, 2008, MOL PHARMACEUT, V5, P316, DOI 10.1021/mp7001285; Jun YW, 2005, J AM CHEM SOC, V127, P5732, DOI 10.1021/ja0422155; Kedziorek DA, 2010, MAGN RESON MED, V63, P1031, DOI 10.1002/mrm.22290; Khandhar AP, 2012, J BIOMED MATER RES A, V100A, P728, DOI 10.1002/jbm.a.34011; Kim JE, 2012, ARCH TOXICOL, V86, P685, DOI 10.1007/s00204-011-0773-3; Kulkarni SA, 2013, PHARM RES-DORDR, V30, P2512, DOI 10.1007/s11095-012-0958-3; Levy M, 2011, BIOMATERIALS, V32, P3988, DOI 10.1016/j.biomaterials.2011.02.031; Li SD, 2009, BBA-BIOMEMBRANES, V1788, P2259, DOI 10.1016/j.bbamem.2009.06.022; Liu YX, 2013, TOXICOL SCI, V131, P521, DOI 10.1093/toxsci/kfs300; Madrigal JLM, 2001, NEUROPSYCHOPHARMACOL, V24, P420, DOI 10.1016/S0893-133X(00)00208-6; Moghimi SM, 2001, PHARMACOL REV, V53, P283; Monge-Fuentes V, 2011, NANOMEDICINE-UK, V6, P1529, DOI [10.2217/NNM.11.47, 10.2217/nnm.11.47]; Owens DE, 2006, INT J PHARMACEUT, V307, P93, DOI 10.1016/j.ijpharm.2005.10.010; Pawelczyk E, 2006, NMR BIOMED, V19, P581, DOI 10.1002/nbm.1038; Prabakaran S, 2004, MOL PSYCHIATR, V9, P684, DOI 10.1038/sj.mp.4001511; Ramadori G, 2008, J PHYSIOL PHARMACOL, V59, P107; Rety F, 2000, J MAGN RESON IMAGING, V12, P734, DOI 10.1002/1522-2586(200011)12:5<734::AID-JMRI10>3.0.CO;2-R; Romberg B, 2008, PHARM RES, V25, P55, DOI 10.1007/s11095-007-9348-7; Saxena G, 2005, TOXICOLOGY, V214, P39, DOI 10.1016/j.tox.2005.05.026; Schladt TD, 2012, J MATER CHEM, V22, P9253, DOI 10.1039/c2jm15320c; Schulze F, 2014, SMALL, V10, P4340, DOI 10.1002/smll.201400707; Soler MAG, 2007, J NANOSCI NANOTECHNO, V7, P1069, DOI 10.1166/jnn.2007.423; STORM G, 1995, ADV DRUG DELIVER REV, V17, P31, DOI 10.1016/0169-409X(95)00039-A; Tietze R, 2013, NANOMED-NANOTECHNOL, V9, P961, DOI 10.1016/j.nano.2013.05.001; Unsoy G, 2014, EUR J PHARM SCI, V62, P243, DOI 10.1016/j.ejps.2014.05.021; Valois CRA, 2010, BIOMATERIALS, V31, P366, DOI 10.1016/j.biomaterials.2009.09.053; Wang N, 2013, J COLLOID INTERF SCI, V395, P50, DOI 10.1016/j.jcis.2012.11.062; Weissleder R, 1992, REV MAGN RESON MED, V4, P1; Wilhelm C, 2003, BIOMATERIALS, V24, P1001, DOI 10.1016/S0142-9612(02)00440-4; WISNER ER, 1995, ACAD RADIOL, V2, P405, DOI 10.1016/S1076-6332(05)80343-5; Wu QL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043729; Yamamoto Y, 2001, J CONTROL RELEASE, V77, P27, DOI 10.1016/S0168-3659(01)00451-5; Yin PT, 2014, SMALL, V10, P4106, DOI 10.1002/smll.201400963; Zborowski Maciej, 2005, Methods Mol Biol, V295, P291	58	4	4	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0140233	10.1371/journal.pone.0140233	http://dx.doi.org/10.1371/journal.pone.0140233			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559061	Green Published, gold, Green Submitted			2022-12-27	WOS:000364433100003
J	Watanabe, MTC; Hensold, N; Sano, PT				Coutinho Watanabe, Mauricio Takashi; Hensold, Nancy; Sano, Paulo Takeo			Syngonanthus androgynus, a Striking New Species from South America, its Phylogenetic Placement and Implications for Evolution of Bisexuality in Eriocaulaceae	PLOS ONE			English	Article							PAEPALANTHOIDEAE	In the present study, we describe and illustrate a remarkable new species of Syngonanthus from South America (Bolivia, Brazil and Peru). This new species is quickly distinguished from all species in the genus by trimerous and bisexual flowers, a unique set of characteristics in Syngonanthus. Complementary to this study, sequences of 33 species were down-loaded from GenBank and four species had sequences newly generated for this study. Molecular phylogenetic analyses based on nuclear ribosomal ITS and the plastid regions psbA-trnH and trnL-F were performed to determine its systematic position. The results have shown S. androgynus closely related to a well-supported clade that has been treated as Syngonanthus sect. Carphocephalus. Floral traits associated with this new plant also were surveyed. Character reconstruction suggests that the bisexual flowers originated independently more than once in the genus. However, trimerous flowers appear to be an ancestral condition of the whole genus.	[Coutinho Watanabe, Mauricio Takashi; Sano, Paulo Takeo] Univ Sao Paulo, Inst Biociencias, Dept Bot, Sao Paulo, SP, Brazil; [Hensold, Nancy] Field Museum Nat Hist, Keller Sci Act Ctr, Chicago, IL 60605 USA	Universidade de Sao Paulo; Field Museum of Natural History (Chicago)	Watanabe, MTC (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Bot, Sao Paulo, SP, Brazil.	mtcwatanabe@gmail.com	WATANABE, MAURICIO TAKASHI COUTINHO/S-4018-2019; WATANABE, MAURICIO T. C./R-1336-2018	WATANABE, MAURICIO TAKASHI COUTINHO/0000-0001-9690-5565; WATANABE, MAURICIO T. C./0000-0001-9690-5565	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [process 142172/2011-1]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [PDSE-0594/13-0]; Integrative Research Center Publication Fund	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Integrative Research Center Publication Fund	This project was funded by a scholarship at the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (granted to Mauricio Takashi Coutinho Watanabe, process 142172/2011-1) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (granted to Mauricio Takashi Coutinho Watanabe, process PDSE-0594/13-0). The Field Museum has offered support to Nancy Hensold for publications costs of this paper, through the Integrative Research Center Publication Fund (2015).	Bachman S, 2011, ZOOKEYS, P117, DOI 10.3897/zookeys.150.2109; Doyle J. J., 1987, PHYTOCHEM B, P11; Echternacht L, 2015, SYST BOT, V40, P136, DOI 10.1600/036364415X686431; Echternacht L, 2014, TAXON, V63, P47, DOI 10.12705/631.36; Echternacht L, 2011, BOT J LINN SOC, V167, P137, DOI 10.1111/j.1095-8339.2011.01170.x; Giulietti A.M., 1990, ACTA BOT BRAS, V4, P133, DOI [10.1590/S0102-33061990000100010, DOI 10.1590/S0102-33061990000100010]; Giulietti AM, 1997, THESIS; Giulietti AM, 1987, B BOT U SAO PAULO, V9, P1, DOI DOI 10.11606/ISSN.2316-9052.V9I0P1-151; Giulietti Ana M., 2012, Rodriguésia, V63, P001; Giulietti AM, 2012, PHYTOTAXA, V60, P50, DOI 10.11646/phytotaxa.60.1.7; Giulietti N., 1988, ACTA BOT BRAS, V1, P179; de Andrade MJG, 2010, TAXON, V59, P379, DOI 10.1002/tax.592004; HENSOLD N, 1991, ANN MO BOT GARD, V78, P424, DOI 10.2307/2399571; HENSOLD N, 1991, ANN MO BOT GARD, V78, P441, DOI 10.2307/2399572; IUCN, 2022, GUID US IUCN RED LIS; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Moldenke H., 1958, PHYTOLOGIA, V6, P329; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; Pagel M., 2014, BAYESTRAITS V 2 0; Parra L.R., 1997, WILLDENOWIA, V27, P227; Parra LR, 2010, TAXON, V59, P1135, DOI 10.1002/tax.594013; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A, 2013, TRACER VERSION 1 6; Remizowa MV, 2010, ANN MO BOT GARD, V97, P617, DOI 10.3417/2009142; Ricci CV, 1996, BIOCHEM SYST ECOL, V24, P577, DOI 10.1016/0305-1978(96)00056-7; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rosa MM, 2007, ANN BOT-LONDON, V99, P131, DOI 10.1093/aob/mcl231; Ruhland W., 1903, PFLANZENREICH 4, V30, P1, DOI DOI 10.11606/ISSN.2316-9052.V28I2P125-140; Sano PT, 2015, LISTA ESPECIES FLORA; Schmidt IB, 2007, ECON BOT, V61, P73, DOI 10.1663/0013-0001(2007)61[73:EAEOHO]2.0.CO;2; Stutzel T., 1998, FAMILIES GENERA VASC, P197; Trovo M, 2013, BOT J LINN SOC, V171, P225, DOI 10.1111/j.1095-8339.2012.01310.x; Watanabe MTC, 2015, PHYTOTAXA, V212, P271, DOI 10.11646/phytotaxa.212.4.3; Weiblen GD, 2000, AM NAT, V155, P46, DOI 10.1086/303303	34	9	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0141187	10.1371/journal.pone.0141187	http://dx.doi.org/10.1371/journal.pone.0141187			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559183	Green Published, Green Submitted, gold			2022-12-27	WOS:000364433100023
J	Lau, WH; Pandey, V; Kong, XJ; Wang, XN; Wu, ZS; Zhu, T; Lobie, PE				Lau, Wai-Hoe; Pandey, Vijay; Kong, Xiangjun; Wang, Xiao-Nan; Wu, ZhengSheng; Zhu, Tao; Lobie, Peter E.			Trefoil Factor-3 (TFF3) Stimulates De Novo Angiogenesis in Mammary Carcinoma both Directly and Indirectly via IL-8/CXCR2	PLOS ONE			English	Article							NEGATIVE BREAST-CANCER; GROWTH-HORMONE HGH; ENDOTHELIAL-CELLS; EPITHELIAL-CELLS; IN-VITRO; INTERLEUKIN-8 RECEPTORS; TUMOR-METASTASIS; BLADDER-CANCER; HUMAN-MELANOMA; EGF RECEPTOR	Mammary carcinoma cells produce pro-angiogenic factors to stimulate angiogenesis and tumor growth. Trefoil factor-3 (TFF3) is an oncogene secreted from mammary carcinoma cells and associated with poor prognosis. Herein, we demonstrate that TFF3 produced in mammary carcinoma cells functions as a promoter of tumor angiogenesis. Forced expression of TFF3 in mammary carcinoma cells promoted proliferation, survival, invasion and in vitro tubule formation of human umbilical vein endothelial cells (HUVEC). MCF7-TFF3 cells with forced expression of TFF3 generated tumors with enhanced microvessel density as compared to tumors formed by vector control cells. Depletion of TFF3 in mammary carcinoma cells by siRNA concordantly decreased the angiogenic behavior of HUVEC. Forced expression of TFF3 in mammary carcinoma cells stimulated IL-8 transcription and subsequently enhanced IL-8 expression in both mammary carcinoma cells and HUVEC. Depletion of IL-8 in mammary carcinoma cells with forced expression of TFF3, or antibody inhibition of IL-8, partially abrogated mammary carcinoma cell TFF3-stimulated HUVEC angiogenic behavior in vitro, as did inhibition of the IL-8 receptor, CXCR2. Depletion of STAT3 by siRNA in MCF-7 cells with forced expression of TFF3 partially diminished the angiogenic capability of TFF3 on stimulation of cellular processes of HUVEC. Exogenous recombinant hTFF3 also directly promoted the angiogenic behavior of HUVEC. Hence, TFF3 is a potent angiogenic factor and functions as a promoter of de novo angiogenesis in mammary carcinoma, which may co-coordinate with the growth promoting and metastatic actions of TFF3 in mammary carcinoma to enhance tumor progression.	[Lau, Wai-Hoe; Lobie, Peter E.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117595, Singapore; [Lau, Wai-Hoe; Pandey, Vijay; Lobie, Peter E.] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore; [Kong, Xiangjun; Zhu, Tao] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; [Kong, Xiangjun; Zhu, Tao] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Wang, Xiao-Nan; Wu, ZhengSheng] Anhui Med Univ, Dept Pathol, Hefei, Anhui, Peoples R China; [Wang, Xiao-Nan] Anhui Med Univ, Lab Pathogen Microbiol & Immunol, Hefei 230032, Anhui, Peoples R China; [Lobie, Peter E.] Natl Univ Singapore, Natl Hlth Syst, Natl Univ Canc Inst Singapore, Singapore 117548, Singapore	National University of Singapore; National University of Singapore; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Anhui Medical University; Anhui Medical University; National University of Singapore	Zhu, T (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China.	zhut@ustc.edu.cn; csipel@nus.edu.sg	Pandey, Vijay/P-2767-2016		Ministry of Education; National Research Foundation of Singapore; National Medical Research Council of Singapore [R-713-000-163-511]; National Key Scientific Program of China [2012CB934002, 2010CB912804]; National Natural Science Foundation of China [81272925, 31201022, 81302322]; Chinese Academy of Sciences President's International Fellowship Initiative (PIFI) [2015VBA031]	Ministry of Education; National Research Foundation of Singapore(National Research Foundation, Singapore); National Medical Research Council of Singapore(National Medical Research Council, Singapore); National Key Scientific Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences President's International Fellowship Initiative (PIFI)	This work was supported by the Cancer Science Institute of Singapore through grants from the Ministry of Education and the National Research Foundation of Singapore, by a grant from the National Medical Research Council of Singapore [R-713-000-163-511], the National Key Scientific Program of China (2012CB934002, 2010CB912804), National Natural Science Foundation of China (81272925, 31201022, 81302322). PEL was also supported by The Chinese Academy of Sciences President's International Fellowship Initiative (PIFI) (Grant No. 2015VBA031).	Addison CL, 2000, J IMMUNOL, V165, P5269, DOI 10.4049/jimmunol.165.9.5269; Ahmed ARH, 2012, AM J PATHOL, V180, P904, DOI 10.1016/j.ajpath.2011.11.022; Babyatsky M, 2009, CLIN EXP METASTAS, V26, P143, DOI 10.1007/s10585-008-9224-9; Baeriswyl V, 2009, SEMIN CANCER BIOL, V19, P329, DOI 10.1016/j.semcancer.2009.05.003; Bagley RG, 2003, CANCER RES, V63, P5866; Banerjee A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050098; Benoy IH, 2004, CLIN CANCER RES, V10, P7157, DOI 10.1158/1078-0432.CCR-04-0812; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Bouis Diane, 2001, Angiogenesis, V4, P91, DOI 10.1023/A:1012259529167; Brunet-Dunand SE, 2009, ENDOCRINOLOGY, V150, P1341, DOI 10.1210/en.2008-0608; Calnan DP, 1999, J PATHOL, V188, P312, DOI 10.1002/(SICI)1096-9896(199907)188:3<312::AID-PATH360>3.0.CO;2-P; Chan VYW, 2005, REGUL PEPTIDES, V127, P87, DOI 10.1016/j.regpep.2004.10.016; Chen YH, 2000, BIOCHEM BIOPH RES CO, V274, P576, DOI 10.1006/bbrc.2000.3176; Chen YZ, 2011, CANCER LETT, V302, P63, DOI 10.1016/j.canlet.2010.12.014; CHINERY R, 1995, PEPTIDES, V16, P749, DOI 10.1016/0196-9781(95)00045-L; Christine R, 2005, CANCER RES, V65, P195; Czabotar PE, 2009, CELL DEATH DIFFER, V16, P1187, DOI 10.1038/cdd.2009.83; De Larco JE, 2001, AM J PATHOL, V158, P639, DOI 10.1016/S0002-9440(10)64005-9; Devalaraja RM, 2000, J INVEST DERMATOL, V115, P234, DOI 10.1046/j.1523-1747.2000.00034.x; Dhar DK, 2005, CLIN CANCER RES, V11, P6472, DOI 10.1158/1078-0432.CCR-05-0671; Doane AS, 2006, ONCOGENE, V25, P3994, DOI 10.1038/sj.onc.1209415; Efstathiou JA, 1998, P NATL ACAD SCI USA, V95, P3122, DOI 10.1073/pnas.95.6.3122; Emami S, 2004, PEPTIDES, V25, P885, DOI 10.1016/j.peptides.2003.10.019; Emami S, 2001, FASEB J, V15, P351, DOI 10.1096/fj.00-0355com; Farmer P, 2005, ONCOGENE, V24, P4660, DOI 10.1038/sj.onc.1208561; Folkman J, 1992, Semin Cancer Biol, V3, P65; Fox SB, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1796; Gelao L, 2013, ECANCERMEDICALSCIENC, V7, DOI 10.3332/ecancer.2013.320; Gharavi NM, 2007, J BIOL CHEM, V282, P31460, DOI 10.1074/jbc.M704267200; Graness A, 2002, J BIOL CHEM, V277, P18440, DOI 10.1074/jbc.M200468200; Hayes E, 2011, FRONT BIOSCI-LANDMRK, V16, P838, DOI 10.2741/3723; Heidemann J, 2003, J BIOL CHEM, V278, P8508, DOI 10.1074/jbc.M208231200; Huang SY, 2002, AM J PATHOL, V161, P125, DOI 10.1016/S0002-9440(10)64164-8; Inoue K, 2000, CANCER RES, V60, P2290; Kahn HJ, 2002, LAB INVEST, V82, P1255, DOI 10.1097/01.LAB.0000028824.03032.AB; Kannan N, 2010, NEOPLASIA, V12, P1041, DOI 10.1593/neo.10916; Kaulsay KK, 2001, ENDOCRINOLOGY, V142, P767, DOI 10.1210/en.142.2.767; Kim SW, 2010, J AM COLL CARDIOL, V56, P593, DOI 10.1016/j.jacc.2010.01.070; Kinoshita K, 2000, MOL CELL BIOL, V20, P4680, DOI 10.1128/MCB.20.13.4680-4690.2000; Kitadai Y, 1998, AM J PATHOL, V152, P93; Lau WH, 2014, CANCER RES, V74, DOI 10.1158/1538-7445.AM2014-1020; Lee YS, 2012, BRIT J CANCER, V106, P1833, DOI 10.1038/bjc.2012.177; Li AH, 2003, J IMMUNOL, V170, P3369, DOI 10.4049/jimmunol.170.6.3369; Li Aihua, 2005, Angiogenesis, V8, P63, DOI 10.1007/s10456-005-5208-4; Li J, 2011, MOL BIOL REP, V38, P4787, DOI 10.1007/s11033-010-0616-y; Lin Y, 2004, INT J CANCER, V109, P507, DOI 10.1002/ijc.11724; Lubka M, 2009, J APPL GENET, V50, P167, DOI 10.1007/BF03195669; Madsen J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064441; May FEB, 1997, J PATHOL, V182, P404; McKenzie C, 1997, AM J PHYSIOL-GASTR L, V273, pG112, DOI 10.1152/ajpgi.1997.273.1.G112; Mertani HC, 2001, J BIOL CHEM, V276, P21464, DOI 10.1074/jbc.M100437200; Mian BM, 2003, CLIN CANCER RES, V9, P3167; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Miller LJ, 1998, ANTICANCER RES, V18, P77; Naderi A, 2008, NEOPLASIA, V10, P542, DOI 10.1593/neo.08274; Ning Y, 2011, INT J CANCER, V128, P2038, DOI 10.1002/ijc.25562; Oertel M, 2001, AM J RESP CELL MOL, V25, P418, DOI 10.1165/ajrcmb.25.4.4429; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Pandey V, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0429-3; Poulsom R, 1997, J PATHOL, V183, P30, DOI 10.1002/(SICI)1096-9896(199709)183:1<30::AID-PATH1085>3.0.CO;2-K; Prest SJ, 2002, FASEB J, V16, P592, DOI 10.1096/fj.01-0498fje; Richards BL, 1997, AM J SURG, V174, P507; Rodrigues S, 2003, FASEB J, V17, P7, DOI 10.1096/fj.02-0201com; Schneider BP, 2005, J CLIN ONCOL, V23, P1782, DOI 10.1200/JCO.2005.12.017; Scholz A, 2003, GASTROENTEROLOGY, V125, P891, DOI 10.1016/S0016-5085(03)01064-3; Schraufstatter IU, 2001, AM J PHYSIOL-LUNG C, V280, pL1094, DOI 10.1152/ajplung.2001.280.6.L1094; Singh S, 2010, FUTURE ONCOL, V6, P111, DOI 10.2217/FON.09.128; Singh S, 2009, CLIN CANCER RES, V15, P2380, DOI 10.1158/1078-0432.CCR-08-2387; Strieter RM, 2004, SEMIN CANCER BIOL, V14, P195, DOI 10.1016/j.semcancer.2003.10.006; Taupin D, 1999, J CLIN INVEST, V103, pR31, DOI 10.1172/JCI3304; Taupin DR, 2000, P NATL ACAD SCI USA, V97, P799, DOI 10.1073/pnas.97.2.799; Taylor KJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2593; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Varney ML, 2006, AM J CLIN PATHOL, V125, P209, DOI 10.1309/VPL5R.JR7F1D6V03; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Weigelt B, 2004, BRIT J CANCER, V90, P1531, DOI 10.1038/sj.bjc.6601659; Xu XM, 2011, BRAZ J MED BIOL RES, V44, P634, DOI [10.1590/S0100-879X2011007500070, 10.1590/S0100-879X2011000700004]; Yip KW, 2008, ONCOGENE, V27, P6398, DOI 10.1038/onc.2008.307; Youngs SJ, 1997, INT J CANCER, V71, P257, DOI 10.1002/(SICI)1097-0215(19970410)71:2<257::AID-IJC22>3.0.CO;2-D; Yu H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020334; Zhang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074669; zum Buschenfelde DM, 2004, PEPTIDES, V25, P873, DOI 10.1016/j.peptides.2003.11.024	82	32	32	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0141947	10.1371/journal.pone.0141947	http://dx.doi.org/10.1371/journal.pone.0141947			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559818	Green Published, gold, Green Submitted			2022-12-27	WOS:000364433100047
J	Raben, D; Mocroft, A; Rayment, M; Mitsura, VM; Hadziosmanovic, V; Sthoeger, ZM; Palfreeman, A; Morris, S; Kutsyna, G; Vassilenko, A; Minton, J; Necsoi, C; Estrada, VP; Grzeszczuk, A; Johansson, VS; Begovac, J; Ong, ELC; Cabie, A; Ajana, F; Celesia, BM; Maltez, F; Kitchen, M; Comi, L; Dragsted, UB; Clumeck, N; Gatell, J; Gazzard, B; Monforte, AD; Rockstroh, J; Yazdanpanah, Y; Champenois, K; Jakobsen, ML; Sullivan, A; Lundgren, JD				Raben, D.; Mocroft, A.; Rayment, M.; Mitsura, V. M.; Hadziosmanovic, V.; Sthoeger, Z. M.; Palfreeman, A.; Morris, S.; Kutsyna, G.; Vassilenko, A.; Minton, J.; Necsoi, C.; Estrada, V. P.; Grzeszczuk, A.; Johansson, V. Svedhem; Begovac, J.; Ong, E. L. C.; Cabie, A.; Ajana, F.; Celesia, B. M.; Maltez, F.; Kitchen, M.; Comi, L.; Dragsted, U. B.; Clumeck, N.; Gatell, J.; Gazzard, B.; Monforte, A. d'Arminio; Rockstroh, J.; Yazdanpanah, Y.; Champenois, K.; Jakobsen, M. L.; Sullivan, A.; Lundgren, J. D.		HIDES Audit Study Grp	Auditing HIV Testing Rates across Europe: Results from the HIDES 2 Study	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; MISSED OPPORTUNITIES; COST-EFFECTIVENESS	European guidelines recommend the routine offer of an HIV test in patients with a number of AIDS-defining and non-AIDS conditions believed to share an association with HIV; so called indicator conditions (IC). Adherence with this guidance across Europe is not known. We audited HIV testing behaviour in patients accessing care for a number of ICs. Participating centres reviewed the case notes of either 100 patients or of all consecutive patients in one year, presenting for each of the following ICs: tuberculosis, non-Hodgkins lymphoma, anal and cervical cancer, hepatitis B and C and oesophageal candidiasis. Observed HIV-positive rates were applied by region and IC to estimate the number of HIV diagnoses potentially missed. Outcomes examined were: HIV test rate (% of total patients with IC), HIV test accepted (% of tests performed/% of tests offered) and new HIV diagnosis rate (%). There were 49 audits from 23 centres, representing 7037 patients. The median test rate across audits was 72% (IQR 32-97), lowest in Northern Europe (median 44%, IQR 22-68%) and highest in Eastern Europe (median 99%, IQR 86-100). Uptake of testing was close to 100% in all regions. The median HIV+ rate was 0.9% (IQR 0.0-4.9), with 29 audits (60.4%) having an HIV+ rate >0.1%. After adjustment, there were no differences between regions of Europe in the proportion with >0.1% testing positive (global p = 0.14). A total of 113 patients tested HIV+. Applying the observed rates of testing HIV+ within individual ICs and regions to all persons presenting with an IC suggested that 105 diagnoses were potentially missed. Testing rates in well-established HIV ICs remained low across Europe, despite high prevalence rates, reflecting missed opportunities for earlier HIV diagnosis and care. Significant numbers may have had an opportunity for HIV diagnosis if all persons included in IC audits had been tested.	[Raben, D.; Jakobsen, M. L.; Lundgren, J. D.] Rigshosp, CHIP, DK-2100 Copenhagen, Denmark; [Mocroft, A.] UCL, London, England; [Rayment, M.; Gazzard, B.; Sullivan, A.] Chelsea & Westminster Hosp NHS Fdn Trust, London, England; [Mitsura, V. M.] Gomel State Med Univ, Gomel, BELARUS; [Hadziosmanovic, V.] Univ Sarajevo, Ctr Clin, Infect Dis Clin, Sarajevo 71000, Bosnia & Herceg; [Sthoeger, Z. M.] Ben Ari Inst Clin Immunol, Rehovot, Israel; [Palfreeman, A.] Univ Hosp Leicester NHS Trust, Leicester, Leics, England; [Morris, S.] Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, Scotland; [Kutsyna, G.] Luhansk AIDS Ctr, Lugansk, Ukraine; [Vassilenko, A.] Belarusian State Med Univ, Minsk, BELARUS; [Minton, J.] St James Univ Hosp, Leeds, W Yorkshire, England; [Necsoi, C.; Clumeck, N.] Hop Univ St Pierre, B-1000 Brussels, Belgium; [Estrada, V. P.] Hosp Univ San Carlos, Madrid, Spain; [Grzeszczuk, A.] Med Univ Bialystok, Dept Infect Dis & Hepatol, Bialystok, Poland; [Johansson, V. Svedhem] Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden; [Begovac, J.] Univ Hosp Infect Dis, Zagreb, Croatia; [Ong, E. L. C.] Newcastle Upon Tyne Hosp, Newcastle Upon Tyne, Tyne & Wear, England; [Cabie, A.] Ctr Hosp Univ Ft de France, Fort De France, Martinique, France; [Ajana, F.] Ctr Hosp Tourcoing, Tourcoing, France; [Celesia, B. M.] Univ Catania, Infect Dis Unit, ARNAS Garibaldi, Catania, Italy; [Maltez, F.] Hosp Curry Cabral, Lisbon, Portugal; [Kitchen, M.] Med Univ Innsbruck, A-6020 Innsbruck, Austria; [Comi, L.; Monforte, A. d'Arminio] San Paolo Hosp, Infect Dis Unit, Milan, Italy; [Dragsted, U. B.] Roskilde Hosp, Roskilde, Denmark; [Gatell, J.] Hosp Clin Barcelona, Barcelona, Spain; [Rockstroh, J.] Univ Bonn, Bonn, Germany; [Yazdanpanah, Y.] Univ Paris Diderot, UMR 1137, IAME, Sorbonne Paris Cite, Paris, France; [Yazdanpanah, Y.; Champenois, K.] INSERM, UMR 1137, IAME, Paris, France; [Yazdanpanah, Y.] Hop Bichat Claude Bernard, AP HP, Serv Biostat, Paris, France	Rigshospitalet; University of Copenhagen; University of London; University College London; Imperial College London; Gomel State Medical University; University of Sarajevo; University Hospitals of Leicester NHS Trust; University of Leicester; University of Edinburgh; Belarusian State Medical University; Saint James's University Hospital; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Medical University of Bialystok; Karolinska Institutet; Karolinska University Hospital; Newcastle University - UK; CHU Martinique; University of Catania; Medical University of Innsbruck; San Paolo-Polo Universitaria Hospital; University of Barcelona; Hospital Clinic de Barcelona; University of Bonn; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Raben, D (corresponding author), Rigshosp, CHIP, DK-2100 Copenhagen, Denmark.	dorthe.raben@regionh.dk	Gatell, Jose M/ABC-3607-2020; Estrada, Vicente/G-7518-2015; Vassilenko, Anna/AAB-4152-2021; Lundgren, Jens/AAE-6876-2019; Kitchen, Maria/AAN-4964-2020; Grzeszczuk, Anna/R-7844-2018; Begovac, Josip/AAI-5672-2021; Mitsura, Viktar/G-2457-2017; celesia, benedetto maurizio/E-4562-2017	Kitchen, Maria/0000-0003-1391-0532; Grzeszczuk, Anna/0000-0002-6420-5545; Begovac, Josip/0000-0003-2641-4327; Mitsura, Viktar/0000-0002-0449-5026; Estrada, Vicente/0000-0002-7795-5986; celesia, benedetto maurizio/0000-0002-6919-1955; Anna, Vassilenko/0000-0003-1907-2322; Ong, Edmund/0000-0002-6594-0509; Cabie, Andre/0000-0003-0117-3061	HIV in Europe initiative from Gilead Sciences; HIV in Europe initiative from Merck; HIV in Europe initiative from Tibotec; HIV in Europe initiative from Pfizer; HIV in Europe initiative from Schering-Plough; HIV in Europe initiative from Abbott; HIV in Europe initiative from BoehringerIngelheim; HIV in Europe initiative from Bristol-Myers Squibb; HIV in Europe initiative from GlaxoSmithKline; HIV in Europe initiative from ViiVHealthcare	HIV in Europe initiative from Gilead Sciences; HIV in Europe initiative from Merck; HIV in Europe initiative from Tibotec; HIV in Europe initiative from Pfizer; HIV in Europe initiative from Schering-Plough; HIV in Europe initiative from Abbott; HIV in Europe initiative from BoehringerIngelheim; HIV in Europe initiative from Bristol-Myers Squibb(Bristol-Myers Squibb); HIV in Europe initiative from GlaxoSmithKline; HIV in Europe initiative from ViiVHealthcare	The HIDES study was funded by the HIV in Europe initiative which has received funding from Gilead Sciences, Merck, Tibotec, Pfizer, Schering-Plough, Abbott, BoehringerIngelheim, Bristol-Myers Squibb, GlaxoSmithKline, ViiVHealthcare. The operational procedures within the initiative include the following in order to maintain the autonomy of the initiative. The Steering Committee is the governing body and sponsors do not have representation on the Steering Committee. Furthermore, data, records, reports, Intellectual Property Rights and Know How generated as result of the initiative shall be deemed vested in and the property of the Steering Committee, represented by AIDS Fonds Netherlands and CHIP, Rigshospitalet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antinori A, 2011, HIV MED, V12, P61, DOI 10.1111/j.1468-1293.2010.00857.x; Bander Dorota, 2009, Przegl Epidemiol, V63, P61; Bannister WP, 2006, JAIDS-J ACQ IMM DEF, V42, P229, DOI 10.1097/01.qai.0000214815.95786.31; Champenois K, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-200; Europaisches Zentrum fur die Pravention und die Kontrolle von Krankheiten, 2010, HIV TEST INCR UPT EF; European Centre for Disease Prevention and Control, 2011, HIV AIDS SURV EUR 20; Giraudon I, 2009, EUROSURVEILLANCE, V14; Helleberg M, 2012, SCAND J INFECT DIS, V44, P282, DOI 10.3109/00365548.2011.626440; HIV in Europe Initiative, 2012, HIV IND COND GUID IM; Mocroft A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001510; Nakagawa F, 2012, AIDS, V26, P335, DOI 10.1097/QAD.0b013e32834dcec9; Op de Coul ELM, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-185; Paltiel AD, 2005, NEW ENGL J MED, V352, P586, DOI 10.1056/NEJMsa042088; Pauly F, 2013, ARCH GYNECOLOGY OBST; Rayment M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039530; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; Schackman BR, 2002, ARCH INTERN MED, V162, P2478, DOI 10.1001/archinte.162.21.2478; Sullivan AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052845; Yazdanpanah Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013132	19	48	48	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0140845	10.1371/journal.pone.0140845	http://dx.doi.org/10.1371/journal.pone.0140845			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26560105	Green Accepted, gold, Green Published			2022-12-27	WOS:000364433100010
J	Besnier, F; Lenclume, V; Gerardin, P; Fianu, A; Martinez, J; Naty, N; Porcherat, S; Boussaid, K; Schneebeli, S; Jarlet, E; Hatia, S; Dalleau, G; Verkindt, C; Brun, JF; Gonthier, MP; Favier, F				Besnier, Florent; Lenclume, Victorine; Gerardin, Patrick; Fianu, Adrian; Martinez, Jeremy; Naty, Nadege; Porcherat, Sylvaine; Boussaid, Karim; Schneebeli, Stephane; Jarlet, Eric; Hatia, Sarah; Dalleau, Georges; Verkindt, Chantal; Brun, Jean-Frederic; Gonthier, Marie-Paule; Favier, Francois			Individualized Exercise Training at Maximal Fat Oxidation Combined with Fruit and Vegetable-Rich Diet in Overweight or Obese Women: The LIPOXmax-Reunion Randomized Controlled Trial	PLOS ONE			English	Article							INTENSITY INTERMITTENT EXERCISE; IMPAIRED GLUCOSE-TOLERANCE; TYPE-2 DIABETES-MELLITUS; CORONARY-HEART-DISEASE; LIPID OXIDATION; BODY-COMPOSITION; LIFE-STYLE; SUBSTRATE METABOLISM; WEIGHT-LOSS; ENDURANCE	Objectives Lifestyle combined interventions are a key strategy for preventing type-2 diabetes (T2DM) in overweight or obese subjects. In this framework, LIPOXmax individualized training, based on maximal fat oxidation [MFO], may be a promising intervention to promote fat mass (FM) reduction and prevent T2DM. Our primary objective was to compare three training programs of physical activity combined with a fruit-and vegetable-rich diet in reducing FM in overweight or obese women. Design and setting A five months non-blinded randomized controlled trial (RCT) with three parallel groups in La Reunion Island, a region where metabolic diseases are highly prevalent. Subjects One hundred and thirty-six non-diabetic obese (body mass index [BMI]: 27-40 kg/m(2)) young women (aged 20-40) were randomized (G1: MFO intensity; G2: 60% of VO2-peak intensity; G3: free moderate-intensity at-home exercise following good physical practices). Outcomes Anthropometry (BMI, bodyweight, FM, fat-free mass), glucose (fasting plasma glucose, insulin, HOMA-IR) and lipid (cholesterol and triglycerides) profiles, and MFO values were measured at month-0, month-3 and month-5. Results At month-5, among 109 women assessed on body composition, the three groups exhibited a significant FM reduction over time (G1: -4.1 +/- 0.54 kg; G2: -4.7 +/- 0.53 kg; G3: -3.5 +/- 0.78 kg, p<0.001, respectively) without inter-group differences (p = 0.135). All groups exhibited significant reductions in insulin levels or HOMA-IR index, and higher MFO values over time (p<0.001, respectively) but glucose control improvement was higher in G1 than in G3 while MFO values were higher in G1 than in G2 and G3. Changes in other outcome measures and inter-group differences were not significant. Conclusion In our RCT the LIPOXmax intervention did not show a superiority in reducing FM in overweight or obese women but is associated with higher MFO and better glucose control improvements. Other studies are required before proposing LIPOXmax training for the prevention of T2DM in overweight or obese women.	[Besnier, Florent; Lenclume, Victorine; Gerardin, Patrick; Fianu, Adrian; Martinez, Jeremy; Naty, Nadege; Porcherat, Sylvaine; Boussaid, Karim; Favier, Francois] INSERM, GIG 1410, F-97410 St Pierre, France; [Schneebeli, Stephane; Jarlet, Eric] Univ Hosp La Reunion, Unit Diabetol, Endocrinol, Metab Dis, St Pierre, Reunion, France; [Hatia, Sarah; Gonthier, Marie-Paule] Univ La Reunion, UMR DETROI, INSERM, U1188, St Clotilde, Reunion, France; [Dalleau, Georges; Verkindt, Chantal] Univ La Reunion, Intercultural Determinants Motr & Sports Performa, Le Tampon, Reunion, France; [Brun, Jean-Frederic] Univ Hosp Montpellier, Dept Clin Physiol, CERAMM, INSERM,U1046, Montpellier, France; [Brun, Jean-Frederic] Univ Montpellier, CNRS, UMR9214, Physiol & Expt Med Heart Muscles Heart Muscles, F-34059 Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Reunion; Institut National de la Sante et de la Recherche Medicale (Inserm); University of La Reunion; University of La Reunion; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Besnier, F (corresponding author), INSERM, GIG 1410, F-97410 St Pierre, France.	florent.besnier@hotmail.fr			Centre Hospitalier Universitaire of La Reunion; European Research and Development Fund (POCT FEDER); La Reunion island authorities (CPER)	Centre Hospitalier Universitaire of La Reunion; European Research and Development Fund (POCT FEDER); La Reunion island authorities (CPER)	The Centre Hospitalier Universitaire of La Reunion was the study sponsor. This research was supported by grants of La Reunion island authorities (CPER 2012) and by the European Research and Development Fund (POCT FEDER 2007-2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achten J, 2002, MED SCI SPORT EXER, V34, P92, DOI 10.1097/00005768-200201000-00015; Barwell ND, 2009, METABOLISM, V58, P1320, DOI 10.1016/j.metabol.2009.04.016; Ben Ounis O, 2009, SCI SPORT, V24, P178, DOI 10.1016/j.scispo.2008.10.002; Ben Ounis O, 2008, DIABETES METAB, V34, P595, DOI 10.1016/j.diabet.2008.05.011; Bordenave S, 2008, DIABETES METAB, V34, P162, DOI 10.1016/j.diabet.2007.11.006; Boutcher SH, 2011, J OBES, V2011, DOI 10.1155/2011/868305; Brandou F, 2003, DIABETES METAB, V29, P20, DOI 10.1016/S1262-3636(07)70003-4; BROOKS GA, 1994, J APPL PHYSIOL, V76, P2253, DOI 10.1152/jappl.1994.76.6.2253; Brun JF, 2012, J ENDOCRINOL INVEST, V35, P686, DOI 10.3275/8466; Brun JF, 2011, SCI SPORT, V26, P57, DOI 10.1016/j.scispo.2011.02.001; Canoy D, 2005, AM J CLIN NUTR, V82, P1203, DOI 10.1093/ajcn/82.6.1203; Carter Patrice, 2010, BMJ, V341, pc4229, DOI 10.1136/bmj.c4229; Cho JK, 2011, INT J SPORTS MED, V32, P468, DOI 10.1055/s-0031-1271789; DEBURGOS AM, 1992, EUR J CLIN NUTR, V46, P803; Donnelly JE, 2009, MED SCI SPORT EXER, V41, P459, DOI 10.1249/MSS.0b013e3181949333; Dumortier M, 2003, DIABETES METAB, V29, P509, DOI 10.1016/S1262-3636(07)70065-4; Elloumi M, 2009, ACTA PAEDIATR, V98, P1487, DOI 10.1111/j.1651-2227.2009.01365.x; Favier F, 2005, DIABETES RES CLIN PR, V67, P234, DOI 10.1016/j.diabres.2004.07.013; Favier F, 2002, COMPORTEMENTS ALIMEN; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Golay A, 2005, BEST PRACT RES CL EN, V19, P649, DOI 10.1016/j.beem.2005.07.010; Hansen D, 2007, SPORTS MED, V37, P31, DOI 10.2165/00007256-200737010-00003; Hofmann Peter, 2010, Cardiol Res Pract, V2011, P209302, DOI 10.4061/2011/209302; Hopkins M, 2010, OBES REV, V11, ps183; Houmard JA, 2008, AM J PHYSIOL-REG I, V294, pR1111, DOI 10.1152/ajpregu.00396.2007; Irving BA, 2008, MED SCI SPORT EXER, V40, P1863, DOI 10.1249/MSS.0b013e3181801d40; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lavault P, 2011, SCI SPORT, V26, P88, DOI 10.1016/j.scispo.2010.12.001; Lazzer S, 2011, J ENDOCRINOL INVEST, V34, P45, DOI [10.1007/BF03346694, 10.3275/7238]; MACRAE HSH, 1995, EUR J APPL PHYSIOL O, V71, P523, DOI 10.1007/BF00238555; Maskarinec G, 2000, J NUTR, V130, P3068, DOI 10.1093/jn/130.12.3068; Maurie J, 2011, SCI SPORT, V26, P92, DOI 10.1016/j.scispo.2010.12.002; Meyer T, 2005, INT J SPORTS MED, V26, pS38, DOI 10.1055/s-2004-830514; Nicklas BJ, 2009, AM J CLIN NUTR, V89, P1043, DOI 10.3945/ajcn.2008.26938; O'Donovan G, 2005, J APPL PHYSIOL, V98, P1619, DOI 10.1152/japplphysiol.01310.2004; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Perez-Martin A, 2001, DIABETES METAB, V27, P466; PERONNET F, 1991, CAN J SPORT SCI, V16, P23; Ramachandran A, 2006, DIABETOLOGIA, V49, P289, DOI 10.1007/s00125-005-0097-z; Rimm EB, 1996, JAMA-J AM MED ASSOC, V275, P447, DOI 10.1001/jama.275.6.447; Romain A J, 2012, J Nutr Metab, V2012, P285395, DOI 10.1155/2012/285395; Sahlin K, 2007, AM J PHYSIOL-ENDOC M, V292, pE223, DOI 10.1152/ajpendo.00266.2006; Salvadego D, 2010, AM J PHYSIOL-REG I, V299, pR1298, DOI 10.1152/ajpregu.00038.2010; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Tan SJ, 2012, J EXERC SCI FIT, V10, P64, DOI 10.1016/j.jesf.2012.10.002; Trapp EG, 2008, INT J OBESITY, V32, P684, DOI 10.1038/sj.ijo.0803781; TREMBLAY A, 1994, METABOLISM, V43, P814, DOI 10.1016/0026-0495(94)90259-3; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; van Aggel-Leijssen DP, 2002, METABOLISM, V51, P1003, DOI 10.1053/meta.2002.34028; van Aggel-Leijssen DP, 2001, OBES RES, V9, P86, DOI 10.1038/oby.2001.11; Venables MC, 2008, MED SCI SPORT EXER, V40, P495, DOI 10.1249/MSS.0b013e31815f256f; WHO, 2003, WHO TECH REP SER, V916, P1; Whyte LJ, 2010, METABOLISM, V59, P1421, DOI 10.1016/j.metabol.2010.01.002	53	29	30	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0139246	10.1371/journal.pone.0139246	http://dx.doi.org/10.1371/journal.pone.0139246			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555595	Green Submitted, Green Published, gold			2022-12-27	WOS:000364430700004
J	Bhat, ZY; Cadnapaphornchai, P; Ginsburg, K; Sivagnanam, M; Chopra, S; Treadway, CK; Lin, HS; Yoo, G; Sukari, A; Doshi, MD				Bhat, Zeenat Yousuf; Cadnapaphornchai, Pravit; Ginsburg, Kevin; Sivagnanam, Milani; Chopra, Shamit; Treadway, Corey K.; Lin, Ho-Sheng; Yoo, George; Sukari, Ammar; Doshi, Mona D.			Understanding the Risk Factors and Long-Term Consequences of Cisplatin-Associated Acute Kidney Injury: An Observational Cohort Study	PLoS One			English	Article							NEPHROTOXICITY; TOXICITY; CANCER	Acute kidney injury (AKI) is a well-known complication of cisplatin-based chemotherapy; however, its impact on long-term patient survival is unclear. We sought to determine the incidence and risk factors for development of cisplatin-associated AKI and its impact on long-term renal function and patient survival. We identified 233 patients who received 629 cycles of high-dose cisplatin (99 +/- 9mg/m(2)) for treatment of head and neck cancer between 2005 and 2011. These subjects were reviewed for development of AKI. Cisplatin nephrotoxicity (CN) was defined as persistent rise in serum creatinine, with a concomitant decline in serum magnesium and potassium, in absence of use of nephrotoxic agents and not reversed with hydration. All patients were hydrated per protocol and none had baseline glomerular filtration rate (GFR) via CKD-EPI<60mL/min/1.73m(2). The patients were grouped based on development of AKI and were staged for levels of injury, per KDIGO-AKI definition. Renal function was assessed via serum creatinine and estimated glomerular filtration rate (eGFR) via CKD-EPI at baseline, 6-and 12-months. Patients with AKI were screened for the absence of nephrotoxic medication use and a temporal decline in serum potassium and magnesium levels. Logistic regression models were constructed to determine risk factors for cisplatin-associated AKI. Twelve-month renal function was compared among groups using ANOVA. Kaplan-Maier curves and Cox proportional hazard models were constructed to study its impact on patient survival. Of 233 patients, 158(68%) developed AKI; 77 (49%) developed stage I, 55 (35%) developed stage II, and 26 (16%) developed stage III AKI. Their serum potassium and magnesium levels correlated negatively with level of injury (p<0.05). African American race was a significant risk factor for cisplatin-associated AKI, OR 2.8 (95% CI 1.3 to 6.3) and 2.8 (95% CI 1.2 to 6.7) patients with stage III AKI had the lowest eGFR value at 12 months (p = 0.05) and long-term patient survival (HR 2.1; p<0.01) than patients with no or lower grades of AKI. Most common causes of death were recurrent cancer (44%) or secondary malignancy elsewhere (40%). Cisplatin-associated severe AKI occurs in 20% of the patients and has a negative impact on long-term renal function and patient survival. PEG tube placement may be protective and should be considered in high risk-patients.	[Bhat, Zeenat Yousuf; Cadnapaphornchai, Pravit; Ginsburg, Kevin; Sivagnanam, Milani; Lin, Ho-Sheng; Yoo, George; Sukari, Ammar; Doshi, Mona D.] Wayne State Univ, Sch Med, Detroit, MI 48202 USA; [Chopra, Shamit] Patel Hosp, Civil Lines, Jalandhar City, Punjab, India; [Treadway, Corey K.] Cass St Ear Nose & Throat Associates, Traverse City, MI USA; [Lin, Ho-Sheng; Yoo, George; Sukari, Ammar] Karmanos Canc Inst, Detroit, MI USA	Wayne State University; Barbara Ann Karmanos Cancer Institute	Bhat, ZY (corresponding author), Wayne State Univ, Sch Med, Detroit, MI 48202 USA.	zbhat@med.wayne.edu	Bhat, Zeenat/AAA-8592-2021		NIDDK NIH HHS [T32 DK007202] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		de Jongh FE, 2003, BRIT J CANCER, V88, P1199, DOI 10.1038/sj.bjc.6600884; dos Santos NAG, 2012, ARCH TOXICOL, V86, P1233, DOI 10.1007/s00204-012-0821-7; Kidera Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101902; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; MADIAS NE, 1978, AM J MED, V65, P307, DOI 10.1016/0002-9343(78)90825-2; Mizuno T, 2013, ONCOLOGY-BASEL, V85, P364, DOI 10.1159/000356587; Morgan KP, 2014, ANN PHARMACOTHER, V48, P863, DOI 10.1177/1060028014533303; Pabla N, 2008, KIDNEY INT, V73, P994, DOI 10.1038/sj.ki.5002786; Shord SS, 2005, ANTICANCER RES, V25, P4165; Stewart DJ, 1997, CANCER CHEMOTH PHARM, V40, P293, DOI 10.1007/s002800050661; Vermorken JB, 2007, NEW ENGL J MED, V357, P1695, DOI 10.1056/NEJMoa071028	11	40	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142225	10.1371/journal.pone.0142225	http://dx.doi.org/10.1371/journal.pone.0142225			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556481	gold, Green Published, Green Submitted			2022-12-27	WOS:000364430700070
J	Kim, CS; Kim, IJ; Bae, EH; Ma, SK; Lee, J; Kim, SW				Kim, Chang Seong; Kim, In Jin; Bae, Eun Hui; Ma, Seong Kwon; Lee, JongUn; Kim, Soo Wan			Angiotensin-(1-7) Attenuates Kidney Injury Due to Obstructive Nephropathy in Rats	PLOS ONE			English	Article							UNILATERAL URETERAL OBSTRUCTION; PROXIMAL TUBULAR CELLS; GROWTH-FACTOR-BETA; RECEPTOR MAS; RENAL FIBROSIS; SYSTEM; DISEASE; INFLAMMATION; ACTIVATION; MODEL	Background Angiotensin-(1-7) [Ang-(1-7)] counteracts many actions of the renin-angiotensin-aldosterone system. Despite its renoprotective effects, extensive controversy exists regarding the role of Ang-(1-7) in obstructive nephropathy, which is characterized by renal tubulointerstitial fibrosis and apoptosis. Methods To examine the effects of Ang-(1-7) in unilateral ureteral obstruction (UUO), male Sprague-Dawley rats were divided into three groups: control, UUO, and Ang-(1-7)-treated UUO rats. Ang-(1-7) was continuously infused (24 mu g/[kg.h]) using osmotic pumps. We also treated NRK-52E cells in vitro with Ang II (1 mu M) in the presence or absence of Ang-(1-7) (1 mu M), Mas receptor antagonist A779 (1 mu M), and Mas receptor siRNA (50 nM) to examine the effects of Ang-(1-7) treatment on Ang II-stimulated renal injury via Mas receptor. Results Angiotensin II (Ang II) and angiotensin type 1 receptor (AT(1)R) protein expression was higher in UUO kidneys than in controls. Ang-(1-7) treatment also decreased proapoptotic protein expression in UUO kidneys. Ang-(1-7) also significantly ameliorated TUNEL positive cells in UUO kidneys. Additionally, Ang-(1-7) reduced profibrotic protein expression and decreased the increased tumor growth factor (TGF)-beta 1/Smad signaling present in UUO kidneys. In NRK-52E cells, Ang II induced the expression of TGF-beta 1/Smad signaling effectors and proapoptotic and fibrotic proteins, as well as cell cycle arrest, which were attenuated by Ang-(1-7) pretreatment. However, treatment with A779 and Mas receptor siRNA enhanced Ang II-induced apoptosis and fibrosis. Moreover, Ang II increased tumor necrosis factor-alpha converting enzyme (TACE) and decreased angiotensin-converting enzyme 2 (ACE2) expression in NRK-52E cells, while pretreatment with Ang-(1-7) or A779 significantly inhibited or enhanced these effects, respectively. Conclusion Ang-(1-7) prevents obstructive nephropathy by suppressing renal apoptosis and fibrosis, possibly by regulating TGF-beta 1/Smad signaling and cell cycle arrest via suppression of AT(1)R expression. In addition, Ang-(1-7) increased and decreased ACE2 and TACE expression, respectively, which could potentially mediate a positive feedback mechanism via the Mas receptor.	[Kim, Chang Seong; Bae, Eun Hui; Ma, Seong Kwon; Kim, Soo Wan] Chonnam Natl Univ, Sch Med, Dept Internal Med, Gwangju, South Korea; [Kim, In Jin; Lee, JongUn] Chonnam Natl Univ, Sch Med, Dept Physiol, Gwangju, South Korea	Chonnam National University; Chonnam National University	Kim, SW (corresponding author), Chonnam Natl Univ, Sch Med, Dept Internal Med, Gwangju, South Korea.	skanw@chonnam.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and future Planning [2013R1A2A2A01067611]; Pioneer Research Center Program through the National Research Foundation of Korea - Ministry of Science, ICT & Future Planning [2014M3C1A3053036]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI); Ministry of Health & Welfare, Republic of Korea [HI14C2084]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and future Planning(National Research Foundation of Korea); Pioneer Research Center Program through the National Research Foundation of Korea - Ministry of Science, ICT & Future Planning; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI)(Korea Health Industry Development Institute (KHIDI)); Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and future Planning (2013R1A2A2A01067611), by the Pioneer Research Center Program through the National Research Foundation of Korea funded by the Ministry of Science, ICT & Future Planning (2014M3C1A3053036), and by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI14C2084).	Bhaskaran M, 2003, AM J PHYSIOL-RENAL, V284, pF955, DOI 10.1152/ajprenal.00246.2002; Brosnihan KB, 1998, AM J CARDIOL, V82; Chappell MC, 2012, COMPR PHYSIOL, V2, P2733, DOI 10.1002/cphy.c120002; Dilauro M, 2010, AM J PHYSIOL-RENAL, V298, pF1523, DOI 10.1152/ajprenal.00426.2009; Esteban V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005406; Fraga-Silva RA, 2014, THROMB HAEMOSTASIS, V111, P736, DOI 10.1160/TH13-06-0448; Giani JF, 2012, AM J PHYSIOL-RENAL, V302, pF1606, DOI 10.1152/ajprenal.00063.2012; Hao PP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062788; Jawen J, 2012, J PHYSIOL PHARMACOL, V63, P77; Kim CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063186; Kim S, 2000, PHARMACOL REV, V52, P11; Kim SW, 2001, KIDNEY INT, V59, P1274, DOI 10.1046/j.1523-1755.2001.0590041274.x; KLAHR S, 1995, AM J KIDNEY DIS, V26, P141, DOI 10.1016/0272-6386(95)90167-1; Kostenis E, 2005, CIRCULATION, V111, P1806, DOI 10.1161/01.CIR.0000160867.23556.7D; Li P, 2013, HYPERTENSION, V61, P820, DOI 10.1161/HYPERTENSIONAHA.111.00191; Liu Z, 2012, AM J PHYSIOL-RENAL, V302, pF986, DOI 10.1152/ajprenal.00595.2011; Ma Seong Kwon, 2012, Chonnam Med J, V48, P150, DOI 10.4068/cmj.2012.48.3.150; Meng WX, 2014, AM J HYPERTENS, V27, P775, DOI 10.1093/ajh/hpt270; Mordwinkin NM, 2012, J PHARM SCI-US, V101, P373, DOI 10.1002/jps.22730; Park JW, 2010, KIDNEY INT, V77, P1076, DOI 10.1038/ki.2010.69; Patel VB, 2014, J MOL CELL CARDIOL, V66, P167, DOI 10.1016/j.yjmcc.2013.11.017; Pinheiro SVB, 2009, KIDNEY INT, V75, P1184, DOI 10.1038/ki.2009.61; Price PM, 2009, KIDNEY INT, V76, P604, DOI 10.1038/ki.2009.224; Robles NR, 2014, J CARDIOVASC PHARM T, V19, P14, DOI 10.1177/1074248413501018; Rocheville M, 2000, SCIENCE, V288, P154, DOI 10.1126/science.288.5463.154; Santos RAS, 2006, HYPERTENSION, V47, P996, DOI 10.1161/01.HYP.0000215289.51180.5c; Silveira KD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066082; van der Wouden EA, 2005, J RENIN-ANGIO-ALDO S, V6, P96, DOI 10.3317/jraas.2005.016; Velkoska E, 2011, CLIN SCI, V120, P335, DOI 10.1042/CS20100280; Wolf G, 2006, KIDNEY INT, V70, P1914, DOI 10.1038/sj.ki.5001846; WOLF G, 1993, J CLIN INVEST, V92, P1366, DOI 10.1172/JCI116710; Wu WP, 2010, AM J PHYSIOL-RENAL, V299, pF929, DOI 10.1152/ajprenal.00192.2010; Xu CY, 2013, NEPHROLOGY, V18, P761, DOI 10.1111/nep.12146; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144; Yoon HE, 2014, KOREAN J INTERN MED, V29, P291, DOI 10.3904/kjim.2014.29.3.291; Zhang JD, 2010, AM J PHYSIOL-RENAL, V298, pF579, DOI 10.1152/ajprenal.00548.2009; Zhang Y, 2010, J AM SOC NEPHROL, V21, P966, DOI 10.1681/ASN.2009080872; Zimmerman D, 2012, CLIN SCI, V123, P333, DOI 10.1042/CS20120111; Zimmerman DL, 2015, AM J PATHOL, V185, P729, DOI 10.1016/j.ajpath.2014.11.013	39	31	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142664	10.1371/journal.pone.0142664	http://dx.doi.org/10.1371/journal.pone.0142664			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556707	Green Published, Green Submitted, gold			2022-12-27	WOS:000364430700152
J	Kim, M; Piaia, A; Shenoy, N; Kagan, D; Gapp, B; Kueng, B; Weber, D; Dietrich, W; Ksiazek, I				Kim, Munkyung; Piaia, Alessandro; Shenoy, Neeta; Kagan, David; Gapp, Berangere; Kueng, Benjamin; Weber, Delphine; Dietrich, William; Ksiazek, Iwona			Progression of Alport Kidney Disease in Col4a3 Knock Out Mice Is Independent of Sex or Macrophage Depletion by Clodronate Treatment	PLOS ONE			English	Article							DELAYS RENAL-FAILURE; MOUSE MODEL; HEREDITARY NEPHROPATHY; IN-VIVO; COLLAGEN; FIBROSIS; INJURY; BLOCKADE; CELLS; MYOFIBROBLASTS	Alport syndrome is a genetic disease of collagen IV (alpha 3, 4, 5) resulting in renal failure. This study was designed to investigate sex-phenotype correlations and evaluate the contribution of macrophage infiltration to disease progression using Col4a3 knock out (Col4a3KO) mice, an established genetic model of autosomal recessive Alport syndrome. No sex differences in the evolution of body mass loss, renal pathology, biomarkers of tubular damage KIM-1 and NGAL, or deterioration of kidney function were observed during the life span of Col4a3KO mice. These findings confirm that, similar to human autosomal recessive Alport syndrome, female and male Col4a3KO mice develop renal failure at the same age and with similar severity. The specific contribution of macrophage infiltration to Alport disease, one of the prominent features of the disease in human and Col4a3KO mice, remains unknown. This study shows that depletion of kidney macrophages in Col4a3KO male mice by administration of clodronate liposomes, prior to clinical onset of disease and throughout the study period, does not protect the mice from renal failure and interstitial fibrosis, nor delay disease progression. These results suggest that therapy targeting macrophage recruitment to kidney is unlikely to be effective as treatment of Alport syndrome.	[Kim, Munkyung; Gapp, Berangere; Kueng, Benjamin; Weber, Delphine; Ksiazek, Iwona] Novartis Inst Biomed Res, Dev & Mol Pathways, Basel, Switzerland; [Piaia, Alessandro] Novartis Inst Biomed Res, Preclin Safety, Basel, Switzerland; [Shenoy, Neeta; Kagan, David] Novartis Inst Biomed Res, Preclin Safety, Cambridge, MA USA; [Dietrich, William] Novartis Inst Biomed Res, Dev & Mol Pathways, Cambridge, MA USA	Novartis; Novartis; Novartis; Novartis	Ksiazek, I (corresponding author), Novartis Inst Biomed Res, Dev & Mol Pathways, Basel, Switzerland.	iwona.ksiazek@novartis.ch			Novartis Institute of Biomedical Research (NIBR)	Novartis Institute of Biomedical Research (NIBR)	Funding for this work was provided by the Novartis Institute of Biomedical Research (NIBR). The funder provided support in the form of salaries and research materials for authors (MK, AP, NS, DK, BG, BK, DW, WD and IK), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; Clauss S, 2009, J PATHOL, V218, P40, DOI 10.1002/path.2505; Clayton A, 1997, J AM SOC NEPHROL, V8, P604; Cosgrove D, 1996, GENE DEV, V10, P2981, DOI 10.1101/gad.10.23.2981; Dennis J, 2010, AM J PATHOL, V177, P2527, DOI 10.2353/ajpath.2010.100017; Dudas J, 2007, CELL TISSUE RES, V329, P503, DOI 10.1007/s00441-007-0437-z; Flinter F, 1997, J MED GENET, V34, P326, DOI 10.1136/jmg.34.4.326; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gross O, 2003, KIDNEY INT, V63, P438, DOI 10.1046/j.1523-1755.2003.00779.x; Gross O, 2014, NEPHROL DIAL TRANSPL, V29, P124, DOI 10.1093/ndt/gfu028; Gross O, 2012, KIDNEY INT, V81, P494, DOI 10.1038/ki.2011.407; HASSTEDT SJ, 1983, AM J HUM GENET, V35, P1241; Hertz JM, 2012, EUR J HUM GENET, V20, DOI 10.1038/ejhg.2011.237; Ichimura T, 1998, J BIOL CHEM, V273, P4135, DOI 10.1074/jbc.273.7.4135; Jedlicka J, 2010, HUM PATHOL, V41, P582, DOI 10.1016/j.humpath.2009.08.024; Jo SK, 2006, NEPHROL DIAL TRANSPL, V21, P1231, DOI 10.1093/ndt/gfk047; Kalluri R, 2000, J BIOL CHEM, V275, P12719, DOI 10.1074/jbc.275.17.12719; Kitamoto K, 2009, J PHARMACOL SCI, V111, P285, DOI 10.1254/jphs.09227FP; Koepke ML, 2007, NEPHROL DIAL TRANSPL, V22, P1062, DOI 10.1093/ndt/gfl810; Korstanje R, 2014, KIDNEY INT, V85, P1461, DOI 10.1038/ki.2013.493; Kruegel J, 2013, NAT REV NEPHROL, V9, P170, DOI 10.1038/nrneph.2012.259; Kushiyama T, 2011, NEPHROLOGY, V16, P522, DOI 10.1111/j.1440-1797.2010.01439.x; LeBleu VS, 2008, LAB INVEST, V88, P284, DOI 10.1038/labinvest.3700715; Lee S, 2011, J AM SOC NEPHROL, V22, P317, DOI 10.1681/ASN.2009060615; Lin SL, 2009, J IMMUNOL, V183, P6733, DOI 10.4049/jimmunol.0901473; Mak RH, 2011, J CACHEXIA SARCOPENI, V2, P9, DOI 10.1007/s13539-011-0019-5; Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001; Miner JH, 1996, J CELL BIOL, V135, P1403, DOI 10.1083/jcb.135.5.1403; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; MOCHIZUKI T, 1994, NAT GENET, V8, P77, DOI 10.1038/ng0994-77; Nabity MB, 2012, J VET INTERN MED, V26, P282, DOI 10.1111/j.1939-1676.2012.00891.x; Ninichuk V, 2005, J AM SOC NEPHROL, V16, P977, DOI 10.1681/ASN.2004100871; Rheault MN, 2004, J AM SOC NEPHROL, V15, P1466, DOI 10.1097/01.ASN.0000130562.90255.8F; Ricardo SD, 2008, J CLIN INVEST, V118, P3522, DOI 10.1172/JCI36150; Rodgers KD, 2003, KIDNEY INT, V63, P1338, DOI 10.1046/j.1523-1755.2003.00871.x; Sampson NS, 2001, J BIOL CHEM, V276, P34182, DOI 10.1074/jbc.M102859200; Stubbs JR, 2012, J BONE MINER RES, V27, P38, DOI 10.1002/jbmr.516; Temme J, 2012, KIDNEY INT, V81, P779, DOI 10.1038/ki.2011.452; vanRooijen N, 1996, J IMMUNOL METHODS, V193, P93, DOI 10.1016/0022-1759(96)00056-7; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Wang YP, 2011, J AM SOC NEPHROL, V22, P21, DOI 10.1681/ASN.2010030269; WHALEN RE, 1961, AM J MED, V31, P171, DOI 10.1016/0002-9343(61)90107-3; Wu XS, 2014, J INVEST DERMATOL, V134, P2814, DOI 10.1038/jid.2014.206	43	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0141231	10.1371/journal.pone.0141231	http://dx.doi.org/10.1371/journal.pone.0141231			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555339	gold, Green Published, Green Submitted			2022-12-27	WOS:000364430700022
J	Sung, HH; Jeon, HG; Han, DH; Jeong, BC; Seo, SI; Lee, HM; Choi, HY; Jeon, SS				Sung, Hyun Hwan; Jeon, Hwang Gyun; Han, Deok Hyun; Jeong, Byong Chang; Seo, Seong Il; Lee, Hyun Moo; Choi, Han-Yong; Jeon, Seong Soo			Diagnostic Ureterorenoscopy Is Associated with Increased Intravesical Recurrence following Radical Nephroureterectomy in Upper Tract Urothelial Carcinoma	PLOS ONE			English	Article							UPPER URINARY-TRACT; TRANSITIONAL-CELL CARCINOMA; LAPAROSCOPIC NEPHROURETERECTOMY; ONCOLOGICAL OUTCOMES; BLADDER RECURRENCE; RENAL PELVIS; IMPACT; URETEROSCOPY; PREVENTION; GUIDELINES	Diagnostic ureterorenoscopy is powerful tool to confirm upper tract urothelial cancer (UTUC). However, URS and associated manipulation may be related to the risk of intravesical recurrence (IVR) following radical nephroureterectomy (RNU). We aimed to investigate whether preoperative ureterorenoscopy would increase IVR after RNU in patients with UTUC. We performed a retrospective analysis of 630 patients who had RNU with bladder cuff excision due to UTUC. Diagnostic URS was performed in 282 patients (44.7%). Patients were divided into two groups according to the URS. Survival analysis and multivariate Cox regression model were performed to address risk factors for the IVR. The interval from URS to RNU was measured. During URS, manipulation such as biopsy and resection was determined. The median age was 64 (IQR 56-72) years with follow-up duration of 34.3 (15.7-64.9) months. Median time from URS to RNU was 16 (0-38) days. The IVR developed in 42.5%(n = 268) patients at 8.2 (4.9-14.7) months. The five-year IVR-free survival rate was 42.6 +/- 8.0% and 63.6 +/- 6.9% in patients with and without preoperative URS, respectively (P < 0.001). In multivariate analysis, previous history of bladder tumour, extra-vesical excision of distal ureter, multifocal tumour, and URS (HR, 95% CI; 1.558, 1.204-2.016, P = 0.001) were independent predictors for higher IVR. The IVR rate in patients without manipulation during URS was not different to those with manipulation (P = 0.658). The duration from URS to RNU was not associated with IVR (P = 0.799). Diagnostic URS for UTUC increased IVR rate after RNU. However, the lessening of interval from URS to radical surgery or URS without any manipulation could not reduce the IVR rate.	[Sung, Hyun Hwan; Jeon, Hwang Gyun; Han, Deok Hyun; Jeong, Byong Chang; Seo, Seong Il; Lee, Hyun Moo; Choi, Han-Yong; Jeon, Seong Soo] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Urol,Samsung Biomed Res Inst, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center	Jeon, SS (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Urol,Samsung Biomed Res Inst, Seoul, South Korea.	seongsoo.jeon@samsung.com	sung, hh/O-6246-2014		Samsung Medical Center [CRS11115]	Samsung Medical Center(Samsung)	This study was supported by Samsung Medical Center, grant# CRS11115. The funder provided support in the form of salaries for authors [Jeon HH], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard CB, 2013, WORLD J UROL, V31, P175, DOI 10.1007/s00345-012-0915-0; Azemar MD, 2011, UROL ONCOL-SEMIN ORI, V29, P130, DOI 10.1016/j.urolonc.2009.06.003; Babjuk M, 2011, EUR UROL, V59, P997, DOI 10.1016/j.eururo.2011.03.017; Chromecki TF, 2012, EUR UROL, V61, P245, DOI 10.1016/j.eururo.2011.09.017; Hanna N, 2012, EUR UROL, V61, P715, DOI 10.1016/j.eururo.2011.12.026; Hattori R, 2006, UROLOGY, V67, P701, DOI 10.1016/j.urology.2005.10.022; Ishikawa S, 2010, J UROLOGY, V184, P883, DOI 10.1016/j.juro.2010.05.027; Ito A, 2013, J CLIN ONCOL, V31, P1422, DOI 10.1200/JCO.2012.45.2128; Kang CH, 2003, CANCER-AM CANCER SOC, V98, P1620, DOI 10.1002/cncr.11691; Kume H, 2006, J SURG ONCOL, V93, P318, DOI 10.1002/jso.20459; Li WM, 2010, EUR UROL, V57, P963, DOI 10.1016/j.eururo.2009.12.032; Liu YQ, 2014, UROL ONCOL-SEMIN ORI, V32, P146, DOI 10.1016/j.urolonc.2013.02.018; Lughezzani G, 2012, EUR UROL, V62, P100, DOI 10.1016/j.eururo.2012.02.030; Luo HL, 2013, ANN SURG ONCOL, V20, P3121, DOI 10.1245/s10434-013-3000-z; Margulis V, 2009, CANCER-AM CANCER SOC, V115, P1224, DOI 10.1002/cncr.24135; Ni SB, 2012, EUR UROL, V61, P1142, DOI 10.1016/j.eururo.2012.02.019; Nison L, 2013, WORLD J UROL, V31, P69, DOI 10.1007/s00345-012-0959-1; O'Brien T, 2011, EUR UROL, V60, P703, DOI 10.1016/j.eururo.2011.05.064; Pignot G, 2014, UROL ONCOL-SEMIN ORI, V32, DOI 10.1016/j.urolonc.2012.08.010; Raman JD, 2011, BJU INT, V107, P1059, DOI 10.1111/j.1464-410X.2010.09675.x; Ristau BT, 2012, UROLOGY, V79, P749, DOI 10.1016/j.urology.2011.12.024; Roupret M, 2013, EUR UROL, V63, P1059, DOI 10.1016/j.eururo.2013.03.032; Terakawa T, 2008, UROLOGY, V71, P123, DOI 10.1016/j.urology.2007.08.054; Wu WJ, 2010, J UROLOGY, V183, P56, DOI 10.1016/j.juro.2009.08.154; Xylinas E, 2014, EUR UROL, V65, P650, DOI 10.1016/j.eururo.2013.09.003; Xylinas E, 2014, EUR UROL, V65, P210, DOI 10.1016/j.eururo.2012.04.052; Xylinas E, 2013, WORLD J UROL, V31, P61, DOI 10.1007/s00345-012-0957-3; Zou LJ, 2014, WORLD J UROL, V32, P565, DOI 10.1007/s00345-013-1160-x	28	38	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0139976	10.1371/journal.pone.0139976	http://dx.doi.org/10.1371/journal.pone.0139976			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556239	Green Published, gold, Green Submitted			2022-12-27	WOS:000364430700009
J	Zhu, DH; Wang, P; Zhang, WZ; Yuan, Y; Li, B; Wang, J				Zhu, Dan H.; Wang, Ping; Zhang, Wei Z.; Yuan, Yue; Li, Bin; Wang, Jiang			Sampling and Complementarity Effects of Plant Diversity on Resource Use Increases the Invasion Resistance of Communities	PLoS One			English	Article							GRASSLAND COMMUNITIES; SPECIES-DIVERSITY; REDUCES INVASIBILITY; ECOSYSTEM FUNCTION; BIODIVERSITY; RICHNESS; IDENTITY; PATTERN; DYNAMICS; ABSENCE	Background Although plant diversity is postulated to resist invasion, studies have not provided consistent results, most of which were ascribed to the influences of other covariate environmental factors. Methodology/Principal Findings To explore the mechanisms by which plant diversity influences community invasibility, an experiment was conducted involving grassland sites varying in their species richness (one, two, four, eight, and sixteen species). Light interception efficiency and soil resources (total N, total P, and water content) were measured. The number of species, biomass, and the number of seedlings of the invading species decreased significantly with species richness. The presence of Patrinia scabiosaefolia Fisch. ex Trev. and Mosla dianthera (Buch.-Ham. ex Roxburgh) Maxim. significantly increased the resistance of the communities to invasion. A structural equation model showed that the richness of planted species had no direct and significant effect on invasion. Light interception efficiency had a negative effect on the invasion whereas soil water content had a positive effect. In monocultures, Antenoron filiforme (Thunb.) Rob. et Vaut. showed the highest light interception efficiency and P. scabiosaefolia recorded the lowest soil water content. With increased planted-species richness, a greater percentage of pots showed light use efficiency higher than that of A. filiforme and a lower soil water content than that in P. scabiosaefolia. Conclusions/Significance The results of this study suggest that plant diversity confers resistance to invasion, which is mainly ascribed to the sampling effect of particular species and the complementarity effect among species on resources use.	[Zhu, Dan H.; Wang, Ping; Zhang, Wei Z.; Yuan, Yue; Li, Bin; Wang, Jiang] Taizhou Univ, Dept Life Sci, Taizhou, Zhejiang, Peoples R China	Taizhou University	Wang, J (corresponding author), Taizhou Univ, Dept Life Sci, Taizhou, Zhejiang, Peoples R China.	wangjiang@tzc.edu.cn			national college students innovation and entrepreneurship training project [201410350007]; student project of Taizhou University [14XS24]; student project of life science department of Taizhou University [2014xszd01]; National Natural Science Foundation of China [31000256]; Natural Science Foundation of Zhejiang Province, China [LY13C030003]	national college students innovation and entrepreneurship training project; student project of Taizhou University; student project of life science department of Taizhou University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province, China(Natural Science Foundation of Zhejiang Province)	The Ecology Key Disciplines of Zhejiang Province in Taizhou University (EKD2013-04); The national college students innovation and entrepreneurship training project(201410350007), the student project of Taizhou University(14XS24) and the student project of life science department of Taizhou University(2014xszd01) support the experiment. The National Natural Science Foundation of China (Project 31000256) and the Natural Science Foundation of Zhejiang Province, China (LY13C030003) support the seeding collection and the work prepare for the experiment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SD, 2004, OECOLOGIA, V141, P612, DOI 10.1007/s00442-004-1679-z; [Anonymous], 2002, CAUSE CORRELATION BI; Byun C, 2013, J ECOL, V101, P128, DOI 10.1111/1365-2745.12016; Crawley MJ, 1999, ECOL LETT, V2, P140; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; Dimitrakopoulos PG, 2005, OECOLOGIA, V143, P428, DOI 10.1007/s00442-004-1808-8; Elton C. S., 1958, ECOLOGY INVASIONS AN; Emery SM, 2007, J ECOL, V95, P1027, DOI 10.1111/j.1365-2745.2007.01274.x; Emery SM, 2006, OIKOS, V115, P549, DOI 10.1111/j.2006.0030-1299.15172.x; Fargione JE, 2005, ECOL LETT, V8, P604, DOI 10.1111/j.1461-0248.2005.00753.x; Hector A, 2001, ECOL RES, V16, P819, DOI 10.1046/j.1440-1703.2001.00443.x; Hector A, 2002, ECOL LETT, V5, P502, DOI 10.1046/j.1461-0248.2002.00337.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Iriondo JM, 2003, BIOL CONSERV, V113, P367, DOI 10.1016/S0006-3207(03)00129-0; Kellner JB, 2009, CONSERV LETT, V2, P115, DOI 10.1111/j.1755-263X.2009.00056.x; Kennedy TA, 2002, NATURE, V417, P636, DOI 10.1038/nature00776; Knight KS, 2008, DIVERS DISTRIB, V14, P666, DOI 10.1111/j.1472-4642.2008.00468.x; Knops JMH, 1999, ECOL LETT, V2, P286, DOI 10.1046/j.1461-0248.1999.00083.x; Levine JM, 1999, OIKOS, V87, P15, DOI 10.2307/3546992; Levine JM, 2000, SCIENCE, V288, P852, DOI 10.1126/science.288.5467.852; Liao CZ, 2008, NEW PHYTOL, V177, P706, DOI 10.1111/j.1469-8137.2007.02290.x; Lonsdale WM, 1999, ECOLOGY, V80, P1522, DOI 10.2307/176544; Losure DA, 2007, OIKOS, V116, P87, DOI 10.1111/j.2006.0030-1299.15341.x; Lyons KG, 2001, ECOL LETT, V4, P358, DOI 10.1046/j.1461-0248.2001.00235.x; Maron J, 2007, ECOLOGY, V88, P2651, DOI 10.1890/06-1993.1; Mason TJ, 2012, J VEG SCI, V23, P657, DOI 10.1111/j.1654-1103.2012.01393.x; Meiners SJ, 2004, ECOL LETT, V7, P121, DOI 10.1111/j.1461-0248.2003.00563.x; Mwangi PN, 2007, J ECOL, V95, P65, DOI 10.1111/j.1365-2745.2006.01189.x; Naeem S, 2000, OIKOS, V91, P97, DOI 10.1034/j.1600-0706.2000.910108.x; Page AL, 1982, SOIL ANAL PART, V2, P595; Parker IM, 2000, ECOL APPL, V10, P726, DOI 10.1890/1051-0761(2000)010[0726:IDOCSA]2.0.CO;2; Reinhart KO, 2006, BIOL INVASIONS, V8, P231, DOI 10.1007/s10530-004-5163-9; Roscher C, 2009, J ECOL, V97, P32, DOI 10.1111/j.1365-2745.2008.01451.x; Schuster MJ, 2014, OIKOS, V123, P1101, DOI 10.1111/oik.01078; Shea K, 1998, ECOL APPL, V8, P824, DOI 10.1890/1051-0761(1998)008[0824:EBAIWM]2.0.CO;2; SILVERTOWN J, 1993, J ECOL, V81, P465, DOI 10.2307/2261525; Smith MD, 2004, OKIOS, V103, P253; Souza L, 2011, FUNCT ECOL, V25, P1106, DOI 10.1111/j.1365-2435.2011.01857.x; Stachowicz JJ, 2002, ECOLOGY, V83, P2575; Stohlgren TJ, 1999, ECOL MONOGR, V69, P25, DOI 10.1890/0012-9615(1999)069[0025:EPSIHS]2.0.CO;2; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; Van der Putten WH, 2000, OECOLOGIA, V124, P91, DOI 10.1007/s004420050028; van Ruijven J, 2003, ECOL LETT, V6, P910, DOI 10.1046/j.1461-0248.2003.00516.x; van Ruijven J, 2003, ECOL LETT, V6, P170, DOI 10.1046/j.1461-0248.2003.00427.x; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Wardle DA, 2001, OIKOS, V95, P161, DOI 10.1034/j.1600-0706.2001.950119.x	47	9	10	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0141559	10.1371/journal.pone.0141559	http://dx.doi.org/10.1371/journal.pone.0141559			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556713	Green Submitted, Green Published, gold			2022-12-27	WOS:000364430700032
J	Zhang, M; Zhang, SJ; Wen, YH; Wang, YH; Wei, YJ; Liu, HB; Zhang, DW; Su, JZ; Wang, F; Zhang, Y				Zhang, Min; Zhang, Shaojun; Wen, Yanhua; Wang, Yihan; Wei, Yanjun; Liu, Hongbo; Zhang, Dongwei; Su, Jianzhong; Wang, Fang; Zhang, Yan			DNA Methylation Patterns Can Estimate Nonequivalent Outcomes of Breast Cancer with the Same Receptor Subtypes	PLOS ONE			English	Article							PROMOTER HYPERMETHYLATION; EXPRESSION; BRCA1; HETEROGENEITY; EFFICACY; THERAPY; ALPHA; SERUM	Breast cancer has various molecular subtypes and displays high heterogeneity. Aberrant DNA methylation is involved in tumor origin, development and progression. Moreover, distinct DNA methylation patterns are associated with specific breast cancer subtypes. We explored DNA methylation patterns in association with gene expression to assess their impact on the prognosis of breast cancer based on Infinium 450K arrays (training set) from The Cancer Genome Atlas (TCGA). The DNA methylation patterns of 12 featured genes that had a high correlation with gene expression were identified through univariate and multivariable Cox proportional hazards models and used to define the methylation risk score (MRS). An improved ability to distinguish the power of the DNA methylation pattern from the 12 featured genes (p = 0.00103) was observed compared with the average methylation levels (p = 0.956) or gene expression (p = 0.909). Furthermore, MRS provided a good prognostic value for breast cancers even when the patients had the same receptor status. We found that ER-, PR-or Her2-samples with high-MRS had the worst 5-year survival rate and overall survival time. An independent test set including 28 patients with death as an outcome was used to test the validity of the MRS of the 12 featured genes; this analysis obtained a prognostic value equivalent to the training set. The predict power was validated through two independent datasets from the GEO database. The DNA methylation pattern is a powerful predictor of breast cancer survival, and can predict outcomes of the same breast cancer molecular subtypes.	[Zhang, Min; Zhang, Shaojun; Wen, Yanhua; Wang, Yihan; Wei, Yanjun; Liu, Hongbo; Su, Jianzhong; Wang, Fang; Zhang, Yan] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin 150081, Peoples R China; [Zhang, Dongwei] Harbin Med Univ, Affiliated Hosp 2, Dept Gen Surg, Harbin 150086, Peoples R China	Harbin Medical University; Harbin Medical University	Wang, F (corresponding author), Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin 150081, Peoples R China.	wangfang@ems.hrbmu.edu.cn; tyozhang@ems.hrbmu.edu.cn	Liu, Hongbo/M-2162-2015	Liu, Hongbo/0000-0002-0733-8616; Wang, Yihan/0000-0002-1163-4610	National Natural Science Foundation of China [61402139, 31401075, 31371334, 61403112, 61203262]; Natural Science Foundation of Heilongjiang Province [ZD2015003]; Natural Scientific Research Fund of Heilongjiang Provincial [QC2011C061]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province); Natural Scientific Research Fund of Heilongjiang Provincial	Funding: The authors thank the support of National Natural Science Foundation of China [grant number 61402139, 31401075, 31371334, 61403112, 61203262], the Natural Science Foundation of Heilongjiang Province [grant number ZD2015003] and the Natural Scientific Research Fund of Heilongjiang Provincial [grant number QC2011C061 to SZ].	Anderson WF, 2009, BREAST CANCER RES TR, V113, P189, DOI 10.1007/s10549-008-9918-3; Anderson WF, 2011, J NATL CANCER I, V103, P1397, DOI 10.1093/jnci/djr257; Anderson WF, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju165; Campan M, 2006, CURR TOP MICROBIOL, V310, P141; Cine N, 2014, ONCOL REP, V32, P1078, DOI 10.3892/or.2014.3277; Clare Stirzaker EZSJC, 2015, MOL CELLULAR ONCOLOG; DeSantis C, 2011, CA-CANCER J CLIN, V61, P409, DOI 10.3322/caac.20134; Dworkin AM, 2009, SEMIN CANCER BIOL, V19, P165, DOI 10.1016/j.semcancer.2009.02.007; Fiegl H, 2005, CANCER RES, V65, P1141, DOI 10.1158/0008-5472.CAN-04-2438; Gau DM, 2015, CELL CYCLE, V14, P1884, DOI 10.1080/15384101.2015.1036203; Honrado E, 2007, MODERN PATHOL, V20, P1298, DOI 10.1038/modpathol.3800969; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jiang WG, 2005, EUR J CANCER, V41, P1628, DOI 10.1016/j.ejca.2005.03.023; KOHLER BA, 2015, JNCI J NATL CANCER I, V107, DOI DOI 10.1093/JNCI/DJV048; Kurian AW, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2780; Lewis CM, 2005, CLIN CANCER RES, V11, P166; Lindstrom S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6303; Mirza S, 2007, LIFE SCI, V81, P280, DOI 10.1016/j.lfs.2007.05.012; Muller HM, 2003, CANCER RES, V63, P7641; Perez EA, 2011, ONCOLOGIST, V16, P20, DOI 10.1634/theoncologist.2011-S1-20; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Polyak K, 2011, J CLIN INVEST, V121, P3786, DOI 10.1172/JCI60534; Rudolph A, 2013, ENDOCR-RELAT CANCER, V20, P875, DOI 10.1530/ERC-13-0349; Schultz MD, 2015, NATURE; Silver DP, 2010, J CLIN ONCOL, V28, P1145, DOI 10.1200/JCO.2009.22.4725; Simon M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005097; Sofou K, 2015, MOL GENET GENOM MED, V3, P59, DOI 10.1002/mgg3.115; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stefansson OA, 2015, MOL ONCOL, V9, P555, DOI 10.1016/j.molonc.2014.10.012; Sui M, 2007, CANCER RES, V67, P5337, DOI 10.1158/0008-5472.CAN-06-4582; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Varelas X, 2014, GLYCOBIOLOGY, V24, P579, DOI 10.1093/glycob/cwu031; Veeck J, 2006, ONCOGENE, V25, P3479, DOI 10.1038/sj.onc.1209386; Vincent-Salomon A, 2007, CANCER RES, V67, P5134, DOI 10.1158/0008-5472.CAN-07-0465; Wajed SA, 2001, ANN SURG, V234, P10, DOI 10.1097/00000658-200107000-00003; Weisenberger DJ, 2015, TRANSL CANCER RES, V4, P219, DOI 10.3978/j.issn.2218-676X.2015.05.01	36	6	6	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2015	10	11							e0142279	10.1371/journal.pone.0142279	http://dx.doi.org/10.1371/journal.pone.0142279			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7AC	26550991	Green Published, gold, Green Submitted			2022-12-27	WOS:000364422800021
J	Ferrara, E; Yang, ZY				Ferrara, Emilio; Yang, Zeyao			Measuring Emotional Contagion in Social Media	PLOS ONE			English	Article							DIFFUSION; SENTIMENT; BEHAVIOR; SPREAD	Social media are used as main discussion channels by millions of individuals every day. The content individuals produce in daily social-media-based micro-communications, and the emotions therein expressed, may impact the emotional states of others. A recent experiment performed on Facebook hypothesized that emotions spread online, even in absence of non-verbal cues typical of in-person interactions, and that individuals are more likely to adopt positive or negative emotions if these are over-expressed in their social network. Experiments of this type, however, raise ethical concerns, as they require massive-scale content manipulation with unknown consequences for the individuals therein involved. Here, we study the dynamics of emotional contagion using a random sample of Twitter users, whose activity (and the stimuli they were exposed to) was observed during a week of September 2014. Rather than manipulating content, we devise a null model that discounts some confounding factors (including the effect of emotional contagion). We measure the emotional valence of content the users are exposed to before posting their own tweets. We determine that on average a negative post follows an over-exposure to 4.34% more negative content than baseline, while positive posts occur after an average over-exposure to 4.50% more positive contents. We highlight the presence of a linear relationship between the average emotional valence of the stimuli users are exposed to, and that of the responses they produce. We also identify two different classes of individuals: highly and scarcely susceptible to emotional contagion. Highly susceptible users are significantly less inclined to adopt negative emotions than the scarcely susceptible ones, but equally likely to adopt positive emotions. In general, the likelihood of adopting positive emotions is much greater than that of negative emotions.	[Ferrara, Emilio; Yang, Zeyao] Indiana Univ, Sch Informat & Comp, Bloomington, IN 47405 USA; [Ferrara, Emilio] Univ So Calif, Inst Informat Sci, Marina Del Rey, CA 90292 USA	Indiana University System; Indiana University Bloomington; University of Southern California	Ferrara, E (corresponding author), Indiana Univ, Sch Informat & Comp, Bloomington, IN 47405 USA.	ferrarae@isi.edu	Ferrara, Emilio/F-6136-2012	Ferrara, Emilio/0000-0002-1942-2831	NSF [IIS-0811994]; Direct For Computer & Info Scie & Enginr [1101743] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	ZY was partly supported by NSF grant no. IIS-0811994. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquisti A, 2014, J EC LIT; Akkaya Cem, 2009, P 2009 C EMP METH NA, P190; [Anonymous], 2011, SCIENCE, DOI [DOI 10.21055/0370-1069-2020-1-51-60, DOI 10.1016/j.jocs.2010.12.007]; Aral S, 2009, P NATL ACAD SCI USA, V106, P21544, DOI 10.1073/pnas.0908800106; Asur S., 2010, Proceedings 2010 IEEE/ACM International Conference on Web Intelligence-Intelligent Agent Technology (WI-IAT), P492, DOI 10.1109/WI-IAT.2010.63; Backstrom L., 2014, P 17 ACM C COMPUTER, P831, DOI DOI 10.1145/2531602.2531642; Bakshy E., 2012, P 21 INT C WORLD WID, P519, DOI [10.1145/2187836.2187907, DOI 10.1145/2187836.2187907]; Bo Pang, 2008, Foundations and Trends in Information Retrieval, V2, P1, DOI 10.1561/1500000001; Bollen J., 2011, ICWSM, P450; Bond RM, 2012, NATURE, V489, P295, DOI 10.1038/nature11421; Centola D, 2015, P NATL ACAD SCI USA, V112, P1989, DOI 10.1073/pnas.1418838112; Centola D, 2010, SCIENCE, V329, P1194, DOI 10.1126/science.1185231; Cheng J, 2014, WWW'14: PROCEEDINGS OF THE 23RD INTERNATIONAL CONFERENCE ON WORLD WIDE WEB, P925, DOI 10.1145/2566486.2567997; Choudhury MD, 2012, INT AAAI C WEBL SOC, P66; Conover MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064679; Conover MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055957; Coviello L, 2014, P IEEE, V102, P1911, DOI 10.1109/JPROC.2014.2366052; Coviello L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090315; De Meo P, 2014, COMMUN ACM, V57, P78, DOI 10.1145/2629438; Dimberg U, 2012, PSYCH J, V1, P118, DOI 10.1002/pchj.4; Ferrara E., 2013, P 1 ACM C ONL SOC NE, P213, DOI DOI 10.1145/2512938.2512956; Ferrara E, 2015, PEERJ COMPUT SCI, DOI 10.7717/peerj-cs.26; Ferrara E, 2012, EPJ DATA SCI, V1, DOI 10.1140/epjds9; Fiske ST, 2014, P NATL ACAD SCI USA, V111, P13675, DOI 10.1073/pnas.1414626111; Garcia D, 2012, EPJ DATA SCI, V1, DOI 10.1140/epjds3; Gilbert E, 2009, CHI2009: PROCEEDINGS OF THE 27TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P211; Golder SA, 2011, SCIENCE, V333, P1878, DOI 10.1126/science.1202775; Harris R.B., 2007, J APPL SCI RES, V3, P2081; Hatfield E., 1994, REV PERSONALITY SOCI; Hatfield E, 2009, SOCIAL NEUROSCIENCE OF EMPATHY, P19; Hodas NO, 2014, SCI REP-UK, V4, DOI 10.1038/srep04343; Hodas NO, 2012, PROCEEDINGS OF 2012 ASE/IEEE INTERNATIONAL CONFERENCE ON PRIVACY, SECURITY, RISK AND TRUST AND 2012 ASE/IEEE INTERNATIONAL CONFERENCE ON SOCIAL COMPUTING (SOCIALCOM/PASSAT 2012), P249, DOI 10.1109/SocialCom-PASSAT.2012.129; Hutto C., 2014, 8 INT C WEBL SOC MED, P1, DOI DOI 10.1093/A0BPLA/PLV053; Kang JH, 2013, P 24 ACM C HYP SOC M, P51; Kaplan AM, 2010, BUS HORIZONS, V53, P59, DOI 10.1016/j.bushor.2009.09.003; Kramer A. D., 2014, P NATL ACAD SCI USA; Kwak H., 2010, PROC 19 INT C WORLD, P591, DOI 10.1145/1772690.1772751; Lazer D, 2014, SCIENCE, V343, P1203, DOI 10.1126/science.1248506; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Le L, 2015, COSN 15 2015 ACM SGB; Mackie DM, 2015, EMERGING TRENDS SOCI; Mei Q., 2007, WWW, P171, DOI DOI 10.1145/1242572.1242596; Merchant RM, 2011, NEW ENGL J MED, V365, P289, DOI 10.1056/NEJMp1103591; Metaxas PT, 2012, SCIENCE, V338, P472, DOI 10.1126/science.1230456; Morstatter F, 2013, 7 INT AAAI C WEBL SO; Nematzadeh A, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.088701; Paltoglou G, 2010, ACL 2010: 48TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, P1386; Ratkiewicz J., 2011, ICWSM, P297; Rodriguez Manuel Gomez, 2013, P 6 ACM INT C WEB SE, P23, DOI DOI 10.1145/2433396.2433402; Sakaki T., 2010, P 19 INT C WORLD WID, P851, DOI [10.1145/1772690.1772777, DOI 10.1145/1772690.1772777, 10.1145/1772690.1772777.]; Shalizi CR, 2011, SOCIOL METHOD RES, V40, P211, DOI 10.1177/0049124111404820; Stieglitz S, 2013, J MANAGE INFORM SYST, V29, P217, DOI 10.2753/MIS0742-1222290408; Tang J., 2012, P 5 ACM INT C WEB SE, P743, DOI [http://doi.acm.org/10.1145/2124295.2124382, DOI 10.1145/2124295.2124382, 10.1145/2124295.2124382]; Thelwall M, 2011, J AM SOC INF SCI TEC, V62, P406, DOI 10.1002/asi.21462; Thelwall M, 2010, J AM SOC INF SCI TEC, V61, P2544, DOI 10.1002/asi.21416; Tsai Jason, 2012, Intelligent Virtual Agents. Proceedings 12th International Conference, IVA 2012, P81, DOI 10.1007/978-3-642-33197-8_8; Tufekci Zeynep, 2014, First Monday, V19, P152, DOI 10.5210/fm.v19i7.4901; VanderWeele TJ, 2011, SOCIOL METHOD RES, V40, P240, DOI 10.1177/0049124111404821; Varol O., 2014, P 2014 ACM C WEB SCI, P81, DOI DOI 10.1145/2615569; Vespignani A, 2009, SCIENCE, V325, P425, DOI 10.1126/science.1171990	62	170	171	24	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142390	10.1371/journal.pone.0142390	http://dx.doi.org/10.1371/journal.pone.0142390			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV6RT	26544688	gold, Green Published, Green Submitted			2022-12-27	WOS:000364398700128
J	Fusser, M; Kernstock, S; Aileni, VK; Egge-Jacobsen, W; Falnes, PO; Klungland, A				Fusser, Markus; Kernstock, Stefan; Aileni, Vinay Kumar; Egge-Jacobsen, Wolfgang; Falnes, Pal O.; Klungland, Arne			Lysine Methylation of the Valosin-Containing Protein (VCP) Is Dispensable for Development and Survival of Mice	PLOS ONE			English	Article							SKELETAL-MUSCLE; ATPASE ACTIVITY; AAA-ATPASE; METHYLTRANSFERASE; GLUT4; GENE; IDENTIFICATION; DOMAIN; TUG; DNA	Valosin-containing protein (VCP) is a homohexameric ATPase involved in a multitude cellular processes and it was recently shown that VCP is trimethylated at lysine 315 by the VCP lysine methyltransferase (VCPKMT). Here, we generated and validated a constitutive knockout mouse by targeting exon 1-4 of the Vcpkmt gene. We show that Vcpkmt is ubiquitously expressed in all tissues examined and confirm the sub-cellular localization to the cytoplasm. We show by (I) mass spectrometric analysis, (II) VCPKMT-mediated in vitro methylation of VCP in cell extracts and (III) immunostaining with a methylation specific antibody, that in Vcpkmt(-/-) mice the methylation of lysine 315 in VCP is completely abolished. In contrast, VCP is almost exclusively trimethylated in wild-type mice. Furthermore, we investigated the specificity of VCPKMT with in vitro methylation assays using as source of substrate protein extracts from Vcpkmt(-/-) mouse organs or three human Vcpkmt(-/-) cell lines. The results show that VCPKMT is a highly specific enzyme, and suggest that VCP is its sole substrate. The Vcpkmt(-/-) mice were viable, fertile and had no obvious pathological phenotype. Their body weight, life span and acute endurance capacity were comparable to wild-type controls. Overall the results show that VCPKMT is an enzyme required for methylation of K315 of VCP in vivo, but VCPKMT is not essential for development or survival under unstressed conditions.	[Fusser, Markus; Klungland, Arne] Oslo Univ Hosp, Rikshosp, Inst Med Microbiol, Oslo, Norway; [Kernstock, Stefan; Aileni, Vinay Kumar; Falnes, Pal O.] Univ Oslo, Fac Math & Nat Sci, Dept Biosci, Oslo, Norway; [Egge-Jacobsen, Wolfgang] Univ Oslo, Fac Math & Nat Sci, Dept Biosci, Glyconor Mass Spectrometry, Oslo, Norway; [Klungland, Arne] Univ Oslo, Inst Basic Med Sci, Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; University of Oslo	Klungland, A (corresponding author), Oslo Univ Hosp, Rikshosp, Inst Med Microbiol, Oslo, Norway.	arne.klungland@rr-research.no	Klungland, Arne/X-1233-2019; Falnes, Pål Ø./AAA-4581-2020	Klungland, Arne/0000-0001-7274-3661; Falnes, Pal/0000-0001-8114-6025	Norwegian Research Council [32198, 191749]; Health South East Region Norway [39429]; Norwegian Cancer Society [422102107744-PR-2007-0132]; Research Programme of the EEA/Norway Grants [POL/NOR/196258/2013]	Norwegian Research Council(Research Council of NorwayEuropean Commission); Health South East Region Norway; Norwegian Cancer Society(Norwegian Cancer Society); Research Programme of the EEA/Norway Grants	This study was funded by The Norwegian Research Council (http://www.forskningsradet.no/en/Home_page/1177315753906) (# 32198 to AK and #191749 to POF), Health South East Region Norway (http://www.helse-sorost.no/#39429toAK) and The Norwegian Cancer Society (https://kreftforeningen.no/#422102107744-PR-2007-0132toPOF). Funding for open access charge was provided by: Research Programme of the EEA/Norway Grants (grant numer POL/NOR/196258/2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hadid Q, 2014, MOL CELL BIOL, V34, P2903, DOI 10.1128/MCB.01634-13; Belman JP, 2014, REV ENDOCR METAB DIS, V15, P55, DOI 10.1007/s11154-013-9276-2; Bernkopf M, 2014, HUM MOL GENET, V23, P4015, DOI 10.1093/hmg/ddu115; BIRNBAUM MJ, 1989, CELL, V57, P305, DOI 10.1016/0092-8674(89)90968-9; Bogan JS, 2012, J BIOL CHEM, V287, P23932, DOI 10.1074/jbc.M112.339457; Bogan JS, 2003, NATURE, V425, P727, DOI 10.1038/nature01989; Campaner S, 2011, MOL CELL, V43, P681, DOI 10.1016/j.molcel.2011.08.007; Chapman E, 2011, MOL BIOSYST, V7, P700, DOI 10.1039/c0mb00176g; Clarke SG, 2013, TRENDS BIOCHEM SCI, V38, P243, DOI 10.1016/j.tibs.2013.02.004; Cloutier P, 2014, J PROTEOMICS, V100, P115, DOI 10.1016/j.jprot.2013.10.008; Cloutier P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003210; Davydova E, 2014, J BIOL CHEM, V289, P30499, DOI 10.1074/jbc.M114.601658; de Bot ST, 2012, BRAIN, V135, DOI 10.1093/brain/aws201; Diehl F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009748; Dzialo MC, 2014, J BIOL CHEM, V289, P30511, DOI 10.1074/jbc.M114.605527; Fueger PT, 2007, J PHYSIOL-LONDON, V582, P801, DOI 10.1113/jphysiol.2007.132902; Halawani D, 2009, MOL CELL BIOL, V29, P4484, DOI 10.1128/MCB.00252-09; Haziza S, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005388; Jakobsson ME, 2013, J BIOL CHEM, V288, P27752, DOI 10.1074/jbc.M113.483248; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Jones B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000190; Kernstock S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2041; Kooistra SM, 2012, NAT REV MOL CELL BIO, V13, P297, DOI 10.1038/nrm3327; Kurash JK, 2008, MOL CELL, V29, P392, DOI 10.1016/j.molcel.2007.12.025; Lanouette S, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.134974; Magen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052425; Magnani R, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1044; Malecki J, 2014, J BIOL CHEM; Meyer H, 2014, J CELL SCI, V127, P3877, DOI 10.1242/jcs.093831; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Mori-Konya C, 2009, GENES CELLS, V14, P483, DOI 10.1111/j.1365-2443.2009.01286.x; Muller JMM, 2007, BIOCHEM BIOPH RES CO, V354, P459, DOI 10.1016/j.bbrc.2006.12.206; Niwa H, 2012, J BIOL CHEM, V287, P8561, DOI 10.1074/jbc.M111.302778; Orme CM, 2012, J BIOL CHEM, V287, P6679, DOI 10.1074/jbc.M111.284232; Petrossian TC, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000976; Reiff RE, 2014, HUM MOL GENET, V23, P3456, DOI 10.1093/hmg/ddu054; Richter EA, 2013, PHYSIOL REV, V93, P993, DOI 10.1152/physrev.00038.2012; Ryder JW, 1999, FASEB J, V13, P2246, DOI 10.1096/fasebj.13.15.2246; Thiele W, 2011, J PATHOL, V225, P96, DOI 10.1002/path.2924; Tissier A, 1995, BIOCHIMIE, V77, P854, DOI 10.1016/0300-9084(95)90003-9; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Webb KJ, 2010, J BIOL CHEM, V285, P37598, DOI 10.1074/jbc.M110.170787; Yamanaka K, 2012, BBA-MOL CELL RES, V1823, P130, DOI 10.1016/j.bbamcr.2011.07.001; Zhang LL, 2014, BIOCHEM BIOPH RES CO, V451, P229, DOI 10.1016/j.bbrc.2014.07.110	45	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141472	10.1371/journal.pone.0141472	http://dx.doi.org/10.1371/journal.pone.0141472			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544960	Green Published, Green Submitted, gold			2022-12-27	WOS:000364398700026
J	Lemaitre, G; Heller, LM; Navolio, N; Zuniga-Penaranda, N				Lemaitre, Guillaume; Heller, Laurie M.; Navolio, Nicole; Zuniga-Penaranda, Nicolas			Priming Gestures with Sounds	PLOS ONE			English	Article							AUDITORY-PERCEPTION; EVENT FILES; REPRESENTATION; OBJECT; COMPATIBILITY; ASSOCIATIONS; KNOWLEDGE; SYSTEMS; STREAMS; DORSAL	We report a series of experiments about a little-studied type of compatibility effect between a stimulus and a response: the priming of manual gestures via sounds associated with these gestures. The goal was to investigate the plasticity of the gesture-sound associations mediating this type of priming. Five experiments used a primed choice-reaction task. Participants were cued by a stimulus to perform response gestures that produced response sounds; those sounds were also used as primes before the response cues. We compared arbitrary associations between gestures and sounds (key lifts and pure tones) created during the experiment (i.e. no pre-existing knowledge) with ecological associations corresponding to the structure of the world (tapping gestures and sounds, scraping gestures and sounds) learned through the entire life of the participant (thus existing prior to the experiment). Two results were found. First, the priming effect exists for ecological as well as arbitrary associations between gestures and sounds. Second, the priming effect is greatly reduced for ecologically existing associations and is eliminated for arbitrary associations when the response gesture stops producing the associated sounds. These results provide evidence that auditory-motor priming is mainly created by rapid learning of the association between sounds and the gestures that produce them. Auditory-motor priming is therefore mediated by short-term associations between gestures and sounds that can be readily reconfigured regardless of prior knowledge.	[Lemaitre, Guillaume; Heller, Laurie M.; Navolio, Nicole; Zuniga-Penaranda, Nicolas] Carnegie Mellon Univ, Dietrich Coll Humanities & Social Sci, Dept Psychol, Auditory Lab, Pittsburgh, PA 15213 USA	Carnegie Mellon University	Lemaitre, G (corresponding author), STMS IRCAM UPMC CNRS, Inst Rech & Coordinat Acoust Mus, Paris, France.	GuillaumeJLemaitre@gmail.com		Heller, Laurie/0000-0002-4735-5701	Carnegie Mellon University	Carnegie Mellon University	This work was supported by Carnegie Mellon University startup funds to L.M.H. and Carnegie Mellon University Summer Undergraduate Research Fellowship (SURF) to NZP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RB, 2002, NEUROIMAGE, V16, P361, DOI 10.1006/nimg.2002.1088; Alain C, 2001, P NATL ACAD SCI USA, V98, P12301, DOI 10.1073/pnas.211209098; Borst G, 2011, AM PSYCHOL, V66, P624, DOI 10.1037/a0024038; Bourquin NMP, 2013, BRAIN TOPOGR, V26, P152, DOI 10.1007/s10548-012-0260-z; Brass M, 2000, BRAIN COGNITION, V44, P124, DOI 10.1006/brcg.2000.1225; Brunel L, 2013, EXP PSYCHOL, V60, P100, DOI 10.1027/1618-3169/a000176; Bub DN, 2008, COGNITION, V106, P27, DOI 10.1016/j.cognition.2006.12.010; Bub DN, 2010, J EXP PSYCHOL HUMAN, V36, P341, DOI 10.1037/a0017606; Bub DN, 2003, PSYCHOL SCI, V14, P467, DOI 10.1111/1467-9280.02455; Carello C, 2005, MOVING IMAGE THEORY, P79; Castiello U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012240; Chao LL, 2000, NEUROIMAGE, V12, P478, DOI 10.1006/nimg.2000.0635; Chen CC, 2011, J HUMAN RESOURCE ADU, V9, P6; Elsner B, 2001, J EXP PSYCHOL HUMAN, V27, P229, DOI 10.1037/0096-1523.27.1.229; Engel LR, 2009, NEUROIMAGE, V47, P1778, DOI 10.1016/j.neuroimage.2009.05.041; Galati G, 2008, NEUROIMAGE, V40, P1274, DOI 10.1016/j.neuroimage.2007.12.044; Garofeanu C, 2004, EXP BRAIN RES, V159, P55, DOI 10.1007/s00221-004-1932-z; Gazzola V, 2006, CURR BIOL, V16, P1824, DOI 10.1016/j.cub.2006.07.072; Gillmeister H, 2008, BRAIN RES, V1217, P157, DOI 10.1016/j.brainres.2007.12.076; Goodale MA, 2011, VISION RES, V51, P1567, DOI 10.1016/j.visres.2010.07.027; Grassi M, 2013, ACTA PSYCHOL, V143, P96, DOI 10.1016/j.actpsy.2013.02.005; Hoeren M, 2013, EXP BRAIN RES, V229, P243, DOI 10.1007/s00221-013-3610-5; Hommel B, 2001, BEHAV BRAIN SCI, V24, P849, DOI 10.1017/S0140525X01000103; Hommel B, 2004, TRENDS COGN SCI, V8, P494, DOI 10.1016/j.tics.2004.08.007; Hommel B, 1996, PSYCHOL RES-PSYCH FO, V59, P176, DOI 10.1007/BF00425832; Howell DC., 2013, STAT METHODS PSYCHOL, V8; HOWELL P, 1988, PERCEPT PSYCHOPHYS, V43, P90, DOI 10.3758/BF03208978; International Standard Association, 2003, 2262003 ISO AM STAND; Klatzky RL, 2000, PRESENCE-TELEOP VIRT, V9, P399, DOI 10.1162/105474600566907; Kunde W, 2004, Q J EXP PSYCHOL-A, V57, P87, DOI 10.1080/02724980343000143; Kunde W, 2003, PSYCHOL RES-PSYCH FO, V67, P153, DOI 10.1007/s00426-002-0114-5; Kunde W, 2002, Q J EXP PSYCHOL-A, V55, P581, DOI 10.1080/02724980143000433; Kunde W, 2001, J EXP PSYCHOL HUMAN, V27, P387, DOI 10.1037//0096-1523.27.2.387; Lahav A, 2007, J NEUROSCI, V27, P308, DOI 10.1523/JNEUROSCI.4822-06.2007; Lakatos S, 1997, PERCEPT PSYCHOPHYS, V59, P1180, DOI 10.3758/BF03214206; Lemaitre G, 2013, EXP BRAIN RES, V226, P253, DOI 10.1007/s00221-013-3430-7; Lemaitre G, 2012, J ACOUST SOC AM, V131, P1337, DOI 10.1121/1.3675946; Lemaitre G, 2009, INT J HUM-COMPUT ST, V67, P976, DOI 10.1016/j.ijhcs.2009.07.002; Lewis JW, 2005, J NEUROSCI, V25, P5148, DOI 10.1523/JNEUROSCI.0419-05.2005; Lewis JW, 2004, CEREB CORTEX, V14, P1008, DOI 10.1093/cercor/bhh061; Lidji P, 2007, J EXP PSYCHOL HUMAN, V33, P1189, DOI 10.1037/0096-1523.33.5.1189; Liepelt R, 2008, J EXP PSYCHOL HUMAN, V34, P578, DOI 10.1037/0096-1523.34.3.578; Masson MEJ, 2011, J EXP PSYCHOL HUMAN, V37, P1470, DOI 10.1037/a0023509; McAdams S, 2010, J ACOUST SOC AM, V128, P1401, DOI 10.1121/1.3466867; McIntosh RD, 2009, NEUROPSYCHOLOGIA, V47, P1391, DOI 10.1016/j.neuropsychologia.2009.02.009; Memelink J, 2013, PSYCHOL RES-PSYCH FO, V77, P249, DOI 10.1007/s00426-012-0435-y; Olejnik S, 2003, PSYCHOL METHODS, V8, P434, DOI 10.1037/1082-989X.8.4.434; Pazzaglia M, 2008, CURR BIOL, V18, P1766, DOI 10.1016/j.cub.2008.09.061; Phillips JC, 2002, VIS COGN, V9, P540, DOI 10.1080/13506280143000575; Pizzamiglio L, 2005, NEUROIMAGE, V24, P852, DOI 10.1016/j.neuroimage.2004.09.025; Rauschecker JP, 2009, NAT NEUROSCI, V12, P718, DOI 10.1038/nn.2331; Saygin AP, 2003, BRAIN, V126, P928, DOI 10.1093/brain/awg082; Sedda A, 2011, EXP BRAIN RES, V209, P365, DOI 10.1007/s00221-011-2559-5; Shin YK, 2010, PSYCHOL BULL, V136, P943, DOI 10.1037/a0020541; SIMON JR, 1967, J APPL PSYCHOL, V51, P300, DOI 10.1037/h0020586; Tucker M, 2001, VIS COGN, V8, P769, DOI 10.1080/13506280042000144; Tucker M, 2004, ACTA PSYCHOL, V116, P185, DOI 10.1016/j.actpsy.2004.01.004; TULLER B, 1980, PERCEPT PSYCHOPHYS, V27, P277, DOI 10.3758/BF03206115; Vainio L, 2007, Q J EXP PSYCHOL, V60, P241, DOI 10.1080/17470210600625149; WARREN WH, 1984, J EXP PSYCHOL HUMAN, V10, P704, DOI 10.1037/0096-1523.10.5.704; Whyatt C, 2013, RES AUTISM SPECT DIS, V7, P613, DOI 10.1016/j.rasd.2013.01.003; Wiggett AJ, 2011, BRAIN COGNITION, V76, P87, DOI 10.1016/j.bandc.2011.02.014; ZATORRE RJ, 2004, THE JOURNAL OF NEURO, V24, P3637, DOI DOI 10.1523/JNEUR0SCI.5458-03.2004; Zatorre RJ, 2007, NAT REV NEUROSCI, V8, P547, DOI 10.1038/nrn2152; Zmigrod S, 2009, ATTEN PERCEPT PSYCHO, V71, P352, DOI 10.3758/APP.71.2.352	65	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141791	10.1371/journal.pone.0141791	http://dx.doi.org/10.1371/journal.pone.0141791			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV6RT	26544884	gold, Green Published, Green Submitted			2022-12-27	WOS:000364398700049
J	Park, SL; Hwang, B; Lee, SY; Kim, WT; Choi, YH; Chang, YC; Kim, WJ; Moon, SK				Park, Sung Lyea; Hwang, Byungdoo; Lee, Sun-Young; Kim, Won Tae; Choi, Yung Hyun; Chang, Young-Chae; Kim, Wun-Jae; Moon, Sung-Kwon			p21WAF1 Is Required for Interleukin-16-Induced Migration and Invasion of Vascular Smooth Muscle Cells via the p38MAPK/Sp-1/MMP-9 Pathway	PLOS ONE			English	Article							NF-KAPPA-B; DEPENDENT KINASE INHIBITOR; MATRIX-METALLOPROTEINASE-9 EXPRESSION; GROWTH-FACTOR; ARTERIAL INJURY; GENE-EXPRESSION; LYMPHOCYTE MIGRATION; UP-REGULATION; PROLIFERATION; ACTIVATION	Interleukin-16 (IL-16) is a lymphocyte chemoattractant factor well known for its role in immune responses, but its role in vascular disease is unknown. Here, we explored the novel physiological function of IL-16 in vascular smooth muscle cells (VSMCs). The expression of IL-16 and its receptor CD4 was observed in VSMCs. Treatment with IL-16 enhanced the migration and invasion by VSMCs without altering the proliferative potential. IL-16 induced MMP-9 expression via the binding activity of transcription factors NF-kappa B, AP-1, and Sp-1 motifs in VSMCs. Among the relevant signaling pathways examined, only p38MAPK phosphorylation was significantly stimulated in IL-16-treated VSMCs. Treatment with p38MAPK inhibitor SB203580 prevented the IL-16-induced migration and invasion of VSMCs. SB203580 treatment inhibited the MMP-9 expression and activation of Sp-1 binding in IL-16-treated VSMCs, and siRNA knockdown of CD4 expression blocked the induction of migration, invasion, p38MAPK phosphorylation, MMP-9 expression, and Sp-1 binding activation stimulated by IL-16. The IL-16 induced cell-cycle-inhibitor p21WAF1 expression in VSMCs, but had no effect on the expression levels of other cell-cycle negative regulators. Finally, blockage of p21WAF1 function with specific siRNA abolished the IL-16-induced elevation of migration, invasion, p38MAPK phosphorylation, MMP-9 expression, and Sp-1 binding activation in VSMCs. Taken together, p21WAF1 was required for the induction of p38MAPK-mediated MMP-9 expression via activation of the Sp-1 binding motif, which led to migration and invasion of VSMCs interacting with IL-16/CD4. These results could provide that IL-16 is a new target in the treatment of vascular diseases such as atherosclerosis and re-stenosis.	[Park, Sung Lyea; Hwang, Byungdoo; Lee, Sun-Young; Moon, Sung-Kwon] Chung Ang Univ, Dept Food & Nutr, Ansung 456756, South Korea; [Kim, Won Tae; Kim, Wun-Jae] Chungbuk Natl Univ, Dept Urol, Cheongju 361763, Chungbuk, South Korea; [Choi, Yung Hyun] Dong Eui Univ, Dept Biochem, Coll Oriental Med, Busan 614052, South Korea; [Chang, Young-Chae] Catholic Univ Daegu, Sch Med, Res Inst Biomed Engn, Daegu 705718, South Korea; [Chang, Young-Chae] Catholic Univ Daegu, Sch Med, Dept Med, Daegu 705718, South Korea	Chung Ang University; Chungbuk National University; Dong-Eui University; Catholic University of Daegu; Catholic University of Daegu	Moon, SK (corresponding author), Chung Ang Univ, Dept Food & Nutr, Ansung 456756, South Korea.	sumoon66@dreamwiz.com			National Research Foundation of Korea (NRF) grant - Korean government (MSIP) [2014007036]	National Research Foundation of Korea (NRF) grant - Korean government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP) (No. 2014007036).	BENDECK MP, 1994, CIRC RES, V75, P539, DOI 10.1161/01.RES.75.3.539; Bond M, 1998, FEBS LETT, V435, P29, DOI 10.1016/S0014-5793(98)01034-5; Bond M, 2001, CARDIOVASC RES, V50, P556, DOI 10.1016/S0008-6363(01)00220-6; CENTER DM, 1982, J IMMUNOL, V128, P2563; CHANG MW, 1995, J CLIN INVEST, V96, P2260, DOI 10.1172/JCI118281; Cho A, 2000, ARTERIOSCL THROM VAS, V20, P2527, DOI 10.1161/01.ATV.20.12.2527; Cho A, 2002, CIRC RES, V91, P845, DOI 10.1161/01.RES.0000040420.17366.2E; Cross DS, 2012, CURR MED RES OPIN, V28, P1819, DOI 10.1185/03007995.2012.742878; CRUIKSHANK WW, 1987, J IMMUNOL, V138, P3817; Galis ZS, 2002, CIRC RES, V91, P852, DOI 10.1161/01.RES.0000041036.86977.14; Gurjar MV, 2001, AM J PHYSIOL-HEART C, V281, pH2568, DOI 10.1152/ajpheart.2001.281.6.H2568; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Lee SJ, 2013, J BIOL CHEM, V288, P5539, DOI 10.1074/jbc.M112.410233; Lee SJ, 2008, INT IMMUNOPHARMACOL, V8, P1821, DOI 10.1016/j.intimp.2008.08.018; Lin CC, 2009, CELL SIGNAL, V21, P1652, DOI 10.1016/j.cellsig.2009.07.002; Liu C, 2007, CYTOKINE, V38, P145, DOI 10.1016/j.cyto.2007.05.016; Moon SK, 2004, J BIOL CHEM, V279, P33063, DOI 10.1074/jbc.M313462200; Moon SK, 2004, J CELL PHYSIOL, V198, P417, DOI 10.1002/jcp.10435; Nathe TJ, 2002, ARTERIOSCL THROM VAS, V22, P1293, DOI 10.1161/01.ATV.0000023428.69244.49; Newby AC, 2000, J PATHOL, V190, P300, DOI 10.1002/(SICI)1096-9896(200002)190:3<300::AID-PATH596>3.0.CO;2-I; Parada NA, 1996, CELL IMMUNOL, V168, P100, DOI 10.1006/cimm.1996.0054; Richmond J, 2014, J CELL PHYSIOL, V229, P139, DOI 10.1002/jcp.24441; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; RYAN TC, 1995, J BIOL CHEM, V270, P17081, DOI 10.1074/jbc.270.29.17081; SATO H, 1993, ONCOGENE, V8, P395; So MK, 2006, NAT PROTOC, V1, P1160, DOI 10.1038/nprot.2006.162; Weiss RH, 2000, J BIOL CHEM, V275, P10285, DOI 10.1074/jbc.275.14.10285; Yang ZY, 1996, P NATL ACAD SCI USA, V93, P7905, DOI 10.1073/pnas.93.15.7905; Yoon TJ, 2006, SMALL, V2, P209, DOI [10.1002/smll.200500360, 10.1002/511111.200500360]; Zhan YM, 2003, ARTERIOSCL THROM VAS, V23, P795, DOI 10.1161/01.ATV.0000066132.32063.F2	30	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142153	10.1371/journal.pone.0142153	http://dx.doi.org/10.1371/journal.pone.0142153			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544695	gold, Green Submitted, Green Published			2022-12-27	WOS:000364398700088
J	Kaushik, A; Bhatia, Y; Ali, S; Gupta, D				Kaushik, Abhinav; Bhatia, Yashuma; Ali, Shakir; Gupta, Dinesh			Gene Network Rewiring to Study Melanoma Stage Progression and Elements Essential for Driving Melanoma	PLOS ONE			English	Article							PATHWAY; EXPRESSION; WEB; INTERLEUKIN-8; ARRAYEXPRESS; INFORMATION; DATABASE; DATASETS; TARGETS; BIOLOGY	Metastatic melanoma patients have a poor prognosis, mainly attributable to the underlying heterogeneity in melanoma driver genes and altered gene expression profiles. These characteristics of melanoma also make the development of drugs and identification of novel drug targets for metastatic melanoma a daunting task. Systems biology offers an alternative approach to re-explore the genes or gene sets that display dysregulated behaviour without being differentially expressed. In this study, we have performed systems biology studies to enhance our knowledge about the conserved property of disease genes or gene sets among mutually exclusive datasets representing melanoma progression. We meta-analysed 642 microarray samples to generate melanoma reconstructed networks representing four different stages of melanoma progression to extract genes with altered molecular circuitry wiring as compared to a normal cellular state. Intriguingly, a majority of the melanoma network-rewired genes are not differentially expressed and the disease genes involved in melanoma progression consistently modulate its activity by rewiring network connections. We found that the shortlisted disease genes in the study show strong and abnormal network connectivity, which enhances with the disease progression. Moreover, the deviated network properties of the disease gene sets allow ranking/prioritization of different enriched, dysregulated and conserved pathway terms in metastatic melanoma, in agreement with previous findings. Our analysis also reveals presence of distinct network hubs in different stages of metastasizing tumor for the same set of pathways in the statistically conserved gene sets. The study results are also presented as a freely available database at http://bioinfo.icgeb.res.in/m3db/. The web-based database resource consists of results from the analysis presented here, integrated with cytoscape web and user-friendly tools for visualization, retrieval and further analysis.	[Kaushik, Abhinav; Bhatia, Yashuma; Gupta, Dinesh] Int Ctr Genet Engn & Biotechnol, Struct & Computat Biol Grp, Bioinformat Lab, New Delhi 110067, India; [Ali, Shakir] Jamia Hamdard, Fac Sci, Dept Biochem, New Delhi 110062, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Jamia Hamdard University	Gupta, D (corresponding author), Int Ctr Genet Engn & Biotechnol, Struct & Computat Biol Grp, Bioinformat Lab, New Delhi 110067, India.	dinesh@icgeb.res.in	Ali, Shakir/M-3679-2017; Gupta, Dinesh/C-1079-2009; Gupta, Dinesh/AAW-4243-2020	Ali, Shakir/0000-0002-4002-1231; Gupta, Dinesh/0000-0002-7548-8835; Gupta, Dinesh/0000-0002-7548-8835; kaushik, abhinav/0000-0001-5682-0209	Department of Biotechnology (DBT)-India [BT/BI/25/066/2012]; Council of Scientific and Industrial Research (CSIR)-India	Department of Biotechnology (DBT)-India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR)-India(Council of Scientific & Industrial Research (CSIR) - India)	DG conceived and received a grant from the Department of Biotechnology (DBT)-India grants (Grant no. BT/BI/25/066/2012). AK received research fellowship from Council of Scientific and Industrial Research (CSIR)-India.	Ahmed J, 2011, NUCLEIC ACIDS RES, V39, pD960, DOI 10.1093/nar/gkq910; Alstott J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085777; Anglani R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087075; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Bar-Eli M, 1999, PATHOBIOLOGY, V67, P12, DOI 10.1159/000028045; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barrett T, 2005, NUCLEIC ACIDS RES, V33, pD562; Bollobas B., 1985, N HOLLAND MATH STUDI, V118, P47, DOI [DOI 10.1016/S0304-0208(08)73612-0, 10.1016/S0304-0208(08)73612-0]; Brazma A, 2003, NUCLEIC ACIDS RES, V31, P68, DOI 10.1093/nar/gkg091; Busam KJ, 2000, MODERN PATHOL, V13, P459, DOI 10.1038/modpathol.3880078; Chen JS, 2013, BIOINFORMATICS, V29, P420, DOI 10.1093/bioinformatics/bts715; Chen YA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017844; Chen YA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099030; Cholewa BD, 2013, CANCER RES, V73, P6848, DOI 10.1158/0008-5472.CAN-13-2197; Chu JH, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-89; Collins K, 1997, P NATL ACAD SCI USA, V94, P2776, DOI 10.1073/pnas.94.7.2776; Conover William Jay, 1998, PRACTICAL NONPARAMET, V350; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Doig TN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-469; Edelman EJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040028; Feldman I, 2008, P NATL ACAD SCI USA, V105, P4323, DOI 10.1073/pnas.0701722105; Finger EC, 2014, ONCOGENE, V33, P1093, DOI 10.1038/onc.2013.47; Furlong LI, 2013, TRENDS GENET, V29, P150, DOI 10.1016/j.tig.2012.11.004; Gaiteri C, 2014, GENES BRAIN BEHAV, V13, P13, DOI 10.1111/gbb.12106; Griffith M, 2013, NAT METHODS, V10, P1209, DOI [10.1038/NMETH.2689, 10.1038/nmeth.2689]; Heider A, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-75; Homet B, 2014, J PATHOL, V232, P134, DOI 10.1002/path.4259; Horvath S, 2011, WEIGHTED NETWORK ANALYSIS: APPLICATIONS IN GENOMICS AND SYSTEMS BIOLOGY, P1, DOI 10.1007/978-1-4419-8819-5; Hou L, 2014, HUM MOL GENET, V23, P2780, DOI 10.1093/hmg/ddt668; Hudson NJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000382; Ideker T, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2011.99; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kauffmann A, 2009, BIOINFORMATICS, V25, P2092, DOI 10.1093/bioinformatics/btp354; Kim J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00900; Kotobuki Y, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12245; Kreeger PK, 2010, CARCINOGENESIS, V31, P2, DOI 10.1093/carcin/bgp261; Kumari S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050411; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Li J., 2009, BATCH EFFECTS NOISE, P141, DOI DOI 10.1002/9780470685983.CH12; Liu WD, 2013, 2013 INTERNATIONAL WORKSHOP ON MICROWAVE AND MILLIMETER WAVE CIRCUITS AND SYSTEM TECHNOLOGY (MMWCST), P1; Lopes CT, 2010, BIOINFORMATICS, V26, P2347, DOI 10.1093/bioinformatics/btq430; Lopez-Bergami P, 2007, CANCER CELL, V11, P447, DOI 10.1016/j.ccr.2007.03.009; Marchetti D, 1997, ADV ENZYME REGUL, V37, P111, DOI 10.1016/S0065-2571(96)00019-2; Markowetz F, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000655; McCarthy N, 2005, NAT REV CANCER, V5, P839, DOI 10.1038/nrc1747; Meek DW, 2012, CANCER LETT, V324, P126, DOI 10.1016/j.canlet.2012.05.011; Polanski R, 2014, CLIN CANCER RES, V20, P926, DOI 10.1158/1078-0432.CCR-13-2270; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Sean D, 2007, BIOINFORMATICS, V23, P1846, DOI 10.1093/bioinformatics/btm254; Shou C, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001050; Smith AP, 2005, CANCER BIOL THER, V4, P1018, DOI 10.4161/cbt.4.9.2165; Smyth G, 2005, LIMMA LINEAR MODELS; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Timar J, 2010, CLIN EXP METASTAS, V27, P371, DOI 10.1007/s10585-010-9307-2; Trevarton AJ, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00184; Wang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034247; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Zhao M, 2013, NUCLEIC ACIDS RES, V41, pD970, DOI 10.1093/nar/gks937	60	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142443	10.1371/journal.pone.0142443	http://dx.doi.org/10.1371/journal.pone.0142443			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26558755	gold, Green Submitted, Green Published			2022-12-27	WOS:000364433100080
J	El Sahili, A; Kwasiborski, A; Mothe, N; Velours, C; Legrand, P; Morera, S; Faure, D				El Sahili, Abbas; Kwasiborski, Anthony; Mothe, Nicolas; Velours, Christophe; Legrand, Pierre; Morera, Solange; Faure, Denis			Natural Guided Genome Engineering Reveals Transcriptional Regulators Controlling Quorum-Sensing Signal Degradation	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; RHODOCOCCUS-ERYTHROPOLIS; AGROBACTERIUM-TUMEFACIENS; QUENCHING BACTERIA; PLANT; LACTONASES; VIRULENCE; INTERFERENCE; SPECIFICITY; SOFTWARE	Quorum-quenching (QQ) are natural or engineered processes disrupting the quorum-sensing (QS) signalling which controls virulence and persistence (e.g. biofilm) in numerous bacteria. QQ involves different enzymes including lactonases, amidases, oxidases and reductases which degrade the QS molecules such as N-acylhomoserine lactones (NAHL). Rhodococcus erythropolis known to efficiently degrade NAHL is proposed as a biocontrol agent and a reservoir of QQ-enzymes for biotechnology. In R. erythropolis, regulation of QQ-enzymes remains unclear. In this work, we performed genome engineering on R. erythropolis, which is recalcitrant to reverse genetics, in order to investigate regulation of QQ-enzymes at a molecular and structural level with the aim to improve the QQ activity. Deep-sequencing of the R. erythropolis enhanced variants allowed identification of a punctual mutation in a key-transcriptional factor QsdR (Quorum sensing degradation Regulation) which regulates the sole QQ-lactonase QsdA identified so far. Using biophysical and structural studies on QsdR, we demonstrate that QQ activity can be improved by modifying the regulation of QQ-enzymes degrading QS signal. This modification requiring the change of only one amino-acid in a transcriptional factor leads to an enhanced R. erythropolis in which the QS-signal degradation pathway is strongly activated.	[El Sahili, Abbas; Kwasiborski, Anthony; Mothe, Nicolas; Velours, Christophe; Morera, Solange; Faure, Denis] Univ Paris Saclay, I2BC, Univ Paris 11, CNRS,CEA, F-91198 Gif Sur Yvette, France; [Legrand, Pierre] Synchrotron SOLEIL, F-91198 Gif Sur Yvette, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; SOLEIL Synchrotron	Morera, S (corresponding author), Univ Paris Saclay, I2BC, Univ Paris 11, CNRS,CEA, F-91198 Gif Sur Yvette, France.	solange.morera@i2bc.paris-saclay.fr; denis.faure@i2bc.paris-saclay.fr	LEGRAND, Pierre/G-7709-2011	LEGRAND, Pierre/0000-0003-2431-2255; El Sahili, Abbas/0000-0003-3973-686X; morera, solange/0000-0001-7781-0448	Agence Nationale de la Recherche; University Paris-Saclay [ED425]	Agence Nationale de la Recherche(French National Research Agency (ANR)); University Paris-Saclay	This work was supported by Agence Nationale de la Recherche (http://www.agence-nationale-recherche.fr/) to DF. AES was supported by a PhD-grant of the University Paris-Saclay (ED425). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afriat L, 2006, BIOCHEMISTRY-US, V45, P13677, DOI 10.1021/bi061268r; Agari Y, 2011, MICROBIOL-SGM, V157, P1589, DOI 10.1099/mic.0.048017-0; Aguilar C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-385; Barbey C, 2012, J PROTEOME RES, V11, P206, DOI 10.1021/pr200936q; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Cha C, 1998, MOL PLANT MICROBE IN, V11, P1119, DOI 10.1094/MPMI.1998.11.11.1119; CHILTON MD, 1974, P NATL ACAD SCI USA, V71, P3672, DOI 10.1073/pnas.71.9.3672; Chong HQ, 2014, BIOTECHNOL BIOENG, V111, P700, DOI 10.1002/bit.25134; Cirou A, 2007, ENVIRON MICROBIOL, V9, P1511, DOI 10.1111/j.1462-2920.2007.01270.x; Cirou A, 2012, APPL ENVIRON MICROB, V78, P481, DOI 10.1128/AEM.06159-11; Cirou A, 2011, RES MICROBIOL, V162, P945, DOI 10.1016/j.resmic.2011.01.010; Collins CH, 2006, NAT BIOTECHNOL, V24, P708, DOI 10.1038/nbt1209; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Dong YH, 2004, APPL ENVIRON MICROB, V70, P954, DOI 10.1128/AEM.70.2.954-960.2004; Dong YH, 2002, APPL ENVIRON MICROB, V68, P1754, DOI 10.1128/AEM.68.4.1754-1759.2002; Dong YH, 2001, NATURE, V411, P813, DOI 10.1038/35081101; Dong YH, 2007, PHILOS T R SOC B, V362, P1201, DOI 10.1098/rstb.2007.2045; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faure D, 2007, EUR J PLANT PATHOL, V119, P353, DOI 10.1007/s10658-007-9149-1; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; Gadakh B, 2015, CURR MED CHEM; Grandclement C, 2015, QUORUM QUENCHING ROL; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kambam PKR, 2008, BIOTECHNOL BIOENG, V101, P263, DOI 10.1002/bit.21901; Koch G, 2014, P NATL ACAD SCI USA, V111, P1568, DOI 10.1073/pnas.1311263111; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kwasiborski A, 2015, HEREDITY EDINB; Kwasiborski A, 2014, GENOME ANNOUNC, V2; Lade H, 2014, INT J BIOL SCI, V10, P547, DOI 10.7150/ijbs.9028; Lang JL, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00014; Latour X, 2013, AGRONOMY-BASEL, V3, P816, DOI 10.3390/agronomy3040816; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Oh HS, 2013, APPL MICROBIOL BIOT, V97, P10223, DOI 10.1007/s00253-013-4933-7; Oh HS, 2012, ENVIRON SCI TECHNOL, V46, P4877, DOI 10.1021/es204312u; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Tannieres M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065473; Tay SB, 2013, INT J MOL SCI, V14, P16570, DOI 10.3390/ijms140816570; Uroz S, 2005, MICROBIOL-SGM, V151, P3313, DOI 10.1099/mic.0.27961-0; Uroz S, 2003, MICROBIOL-SGM, V149, P1981, DOI 10.1099/mic.0.26375-0; Uroz S, 2008, APPL ENVIRON MICROB, V74, P1357, DOI 10.1128/AEM.02014-07; Uroz S, 2009, CHEMBIOCHEM, V10, P205, DOI 10.1002/cbic.200800521; Wahjudi M, 2011, MICROBIOL-SGM, V157, P2042, DOI 10.1099/mic.0.043935-0; Whitehead NA, 2001, FEMS MICROBIOL REV, V25, P365, DOI 10.1111/j.1574-6976.2001.tb00583.x; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Zhang FZ, 2012, METAB ENG, V14, P653, DOI 10.1016/j.ymben.2012.08.009; Zhang HB, 2002, P NATL ACAD SCI USA, V99, P4638, DOI 10.1073/pnas.022056699; Zhang LH, 2004, MOL MICROBIOL, V53, P1563, DOI 10.1111/j.1365-2958.2004.04234.x	48	4	4	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0141718	10.1371/journal.pone.0141718	http://dx.doi.org/10.1371/journal.pone.0141718			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26554837	Green Submitted, Green Published, gold			2022-12-27	WOS:000364430700037
J	Kim, KH; Liu, JG; Galvin, RJS; Dage, JL; Egeland, JA; Smith, RC; Merchant, KM; Paul, SM				Kim, Kwi Hye; Liu, Jiangang; Galvin, Rachelle J. Sells; Dage, Jeffrey L.; Egeland, Janice A.; Smith, Rosamund C.; Merchant, Kalpana M.; Paul, Steven M.			Transcriptomic Analysis of Induced Pluripotent Stem Cells Derived from Patients with Bipolar Disorder from an Old Order Amish Pedigree	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; GENOME-WIDE ASSOCIATION; GENE-EXPRESSION; RISK-FACTORS; IPS CELLS; SUICIDE; LITHIUM; IDENTIFICATION; PATHWAYS; TYROSINE	Fibroblasts from patients with Type I bipolar disorder (BPD) and their unaffected siblings were obtained from an Old Order Amish pedigree with a high incidence of BPD and reprogrammed to induced pluripotent stem cells (iPSCs). Established iPSCs were subsequently differentiated into neuroprogenitors (NPs) and then to neurons. Transcriptomic microarray analysis was conducted on RNA samples from iPSCs, NPs and neurons matured in culture for either 2 weeks (termed early neurons, E) or 4 weeks (termed late neurons, L). Global RNA profiling indicated that BPD and control iPSCs differentiated into NPs and neurons at a similar rate, enabling studies of differentially expressed genes in neurons from controls and BPD cases. Significant disease-associated differences in gene expression were observed only in L neurons. Specifically, 328 genes were differentially expressed between BPD and control L neurons including GAD1, glutamate decarboxylase 1 (2.5 fold) and SCN4B, the voltage gated type IV sodium channel beta subunit (-14.6 fold). Quantitative RT-PCR confirmed the up-regulation of GAD1 in BPD compared to control L neurons. Gene Ontology, GeneGo and Ingenuity Pathway Analysis of differentially regulated genes in L neurons suggest that alterations in RNA biosynthesis and metabolism, protein trafficking as well as receptor signaling pathways may play an important role in the pathophysiology of BPD.	[Kim, Kwi Hye; Liu, Jiangang; Galvin, Rachelle J. Sells; Dage, Jeffrey L.; Smith, Rosamund C.; Merchant, Kalpana M.] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA; [Egeland, Janice A.] Univ Miami, Miller Sch Med, Dept Psychiat & Behav Sci, Miami, FL 33136 USA; [Paul, Steven M.] Weill Cornell Med Coll, Mind & Brain Inst, New York, NY USA	Eli Lilly; University of Miami; Cornell University	Smith, RC (corresponding author), Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA.	smith_rosamund_c@lilly.com	Paul, Steve/ABE-5400-2020	Dage, Jeffrey/0000-0002-2192-1699	Eli Lilly and Company	Eli Lilly and Company(Eli Lilly)	Eli Lilly and Company fully funded this project. The funder provided support in the form of salaries for authors [KHK, JL, RJSG, JLD, RCS, KMM, SMP], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Akbarian S, 2006, BRAIN RES REV, V52, P293, DOI 10.1016/j.brainresrev.2006.04.001; Altar CA, 2009, NEUROPSYCHOPHARMACOL, V34, P18, DOI 10.1038/npp.2008.172; Bavamian S, 2015, MOL PSYCHIATR, V20, P573, DOI 10.1038/mp.2014.176; BEDDINGTON RSP, 1992, CIBA F SYMP, V165, P61; Benedetti F, 2005, NEUROSCI LETT, V376, P51, DOI 10.1016/j.neulet.2004.11.022; Brennand K, MOL PSYCHIAT, V20, P361; Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; Breunig JJ, 2008, P NATL ACAD SCI USA, V105, P13127, DOI 10.1073/pnas.0804558105; Cassidy F, 2011, SUICIDE LIFE-THREAT, V41, P6, DOI 10.1111/j.1943-278X.2010.00007.x; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Chen B, 2008, P NATL ACAD SCI USA, V105, P11382, DOI 10.1073/pnas.0804918105; Chen HM, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.12; Chen HM, 2013, BIPOLAR DISORD, V15, P177, DOI 10.1111/bdi.12039; Chung CY, 2013, SCIENCE, V342, P983, DOI 10.1126/science.1245296; Connolly KR, 2011, PRIMARY CARE COMPANI, V13; Conti L, 2010, NAT REV NEUROSCI, V11, P176, DOI 10.1038/nrn2761; Cooper O, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003985; Craddock N, 2013, LANCET, V381, P1654, DOI 10.1016/S0140-6736(13)60855-7; Dage JL, 2014, PSYCHOPHARMACOLOGY, V231, P1105, DOI 10.1007/s00213-013-3384-2; EGELAND JA, 1984, AM J PSYCHIAT, V141, P1049; EGELAND JA, 1987, NATURE, V325, P783, DOI 10.1038/325783a0; Egeland JA, 1994, GENETIC STUDIES AFFE, P70; Egeland Janice A., 1990, Psychiatric Genetics, V1, P5; Elashoff M, 2007, J MOL NEUROSCI, V31, P221, DOI 10.1385/JMN/31:03:221; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Fiorentino A, 2014, BIPOLAR DISORD, V16, P583, DOI 10.1111/bdi.12203; Georgi B, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004229; Ginns E.L., 2014, MOL PSYCHIATR, P1; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Guillozet-Bongaarts AL, 2014, MOL PSYCHIATR, V19, P478, DOI 10.1038/mp.2013.30; Hauser M, 2013, BIPOLAR DISORD, V15, P507, DOI 10.1111/bdi.12094; Hostetler JA, 1993, AMISH SOC, Vxi, P322; HUGHES K, 1993, EMBO J, V12, P803, DOI 10.1002/j.1460-2075.1993.tb05715.x; Katsetos CD, 2003, CELL MOTIL CYTOSKEL, V55, P77, DOI 10.1002/cm.10116; Kerner B, 2014, APPL CLIN GENET, V7, P33, DOI 10.2147/TACG.S39297; Kiskinis E, 2014, CELL STEM CELL, V14, P781, DOI 10.1016/j.stem.2014.03.004; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Konradi C, 2004, ARCH GEN PSYCHIAT, V61, P300, DOI 10.1001/archpsyc.61.3.300; Kwon GS, 2008, DEV CELL, V15, P509, DOI 10.1016/j.devcel.2008.07.017; MACCIONI RB, 1995, PHYSIOL REV, V75, P835, DOI 10.1152/physrev.1995.75.4.835; Madison JM, 2015, MOL PSYCHIATR, V20, P703, DOI 10.1038/mp.2015.7; Manuel MN, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-9; Muhleisen TW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4339; Odawara A, 2014, BIOCHEM BIOPH RES CO, V443, P1176, DOI 10.1016/j.bbrc.2013.12.142; Ogden CA, 2004, MOL PSYCHIATR, V9, P1007, DOI 10.1038/sj.mp.4001547; Pankratz MT, 2007, STEM CELLS, V25, P1511, DOI 10.1634/stemcells.2006-0707; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Patino GA, 2010, NEUROSCI LETT, V486, P53, DOI 10.1016/j.neulet.2010.06.050; PAULS DL, 1992, ARCH GEN PSYCHIAT, V49, P703; Post RM, 2010, J CLIN PSYCHIAT, V71, P864, DOI 10.4088/JCP.08m04994yel; Rallu M, 2002, DEVELOPMENT, V129, P4963; Ramaswami M, 2013, CELL, V154, P727, DOI 10.1016/j.cell.2013.07.038; Ryan MM, 2006, MOL PSYCHIATR, V11, P965, DOI 10.1038/sj.mp.4001875; Schlaeger TM, 2015, NAT BIOTECHNOL, V33, P58, DOI 10.1038/nbt.3070; Schubert KO, 2012, MOL PSYCHIATR, V17, P669, DOI 10.1038/mp.2011.123; Sibille E, 2004, NEUROPSYCHOPHARMACOL, V29, P351, DOI 10.1038/sj.npp.1300335; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Vitale AM, 2012, STEM CELL TRANSL MED, V1, P641, DOI 10.5966/sctm.2012-0043; WANG QM, 1994, J BIOL CHEM, V269, P14566	61	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142693	10.1371/journal.pone.0142693	http://dx.doi.org/10.1371/journal.pone.0142693			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26554713	Green Submitted, Green Published, gold			2022-12-27	WOS:000364430700156
J	Theunissen, MJ; Bosma, H; Verdonk, P; Feron, F				Theunissen, Marie-Jose; Bosma, Hans; Verdonk, Petra; Feron, Frans			Why Wait? Early Determinants of School Dropout in Preventive Pediatric Primary Care	PLoS One			English	Article							ASSERTIVE OUTREACH INTERVENTION; ADOLESCENT GIRLS; OUTCOMES; BEHAVIOR; NETHERLANDS; FAILURE; MOTHERS; GENDER; SCALE	Background To answer the question of what bio-psychosocial determinants in infancy, early and middle childhood, and adolescence predict school drop-out in young adulthood, we approached the complex process towards school dropout as a multidimensional, life-course phenomenon. The aim is to find signs of heightened risks of school dropout as early as possible which will eventually help public health workers in reducing these risks. Methods In a case-control design, we used data from both the Preventive Pediatric Primary Care (PPPC) files (that contain information from birth onwards) and additional questionnaires filled out by 529 youngsters, aged 18-23 years, and living in the South-east of the Netherlands. We first conducted univariate logistic regression analyses with school-dropout as the dependent variable. Backward and forward stepwise analyses with the significant variables were done with variables pertaining to the 0 to 4 year period. Remaining significant variables were forced into the next model and subsequently variables pertaining to respectively the 4 to 8, 8 to 12 and 12 to 16 year period were introduced in a stepwise analysis. All analyses were cross-validated in an exploratory and confirmatory random half of the sample. Results One parent families and families with a non-Western background less often attended the health examinations of the PPPC and such less attendance was related to school dropout. The birth of a sibling (OR 0.63, 95% CI 0.43-0.93) in infancy and self-efficacy (OR 0.53, 95% CI 0.38-0.74) in adolescence decreased the odds of school dropout; externalizing behavior (OR 2.81, 95% CI 1.53-5.14) in middle childhood and (sickness) absence (OR 5.62, 95% CI 2.18-14.52) in adolescence increased the risks. Conclusion To prevent school dropout, PPPC professionals should not wait until imminent dropout, but should identify and tackle risk factors as early as possible and actively approach youngsters who withdraw from public health care.	[Theunissen, Marie-Jose; Bosma, Hans; Feron, Frans] Maastricht Univ, Fac Hlth Med & Life Sci, Sch Publ Hlth & Primary Care CAPHRI, Dept Social Med, NL-6200 MD Maastricht, Netherlands; [Theunissen, Marie-Jose] Reg Publ Hlth Serv GGD Brabant Zuidoost, Youth Hlth Care Div, Eindhoven, Netherlands; [Verdonk, Petra] Vrije Univ Amsterdam Med Ctr, Sch Med Sci, EMGO Inst Hlth & Care Res, Dept Med Humanities, Amsterdam, Netherlands	Maastricht University; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Theunissen, MJ (corresponding author), Maastricht Univ, Fac Hlth Med & Life Sci, Sch Publ Hlth & Primary Care CAPHRI, Dept Social Med, NL-6200 MD Maastricht, Netherlands.	mj.theunissen@maastrichtuniversity.nl	Feron, Frans J.M./B-1748-2014; Bosma, Hans/A-6184-2013	Theunissen, Marie-Jose/0000-0001-6434-3334	Netherlands Organisation for Health Research and Development (ZonMw), as part of the project entitled Embedding and Expanding Academic Collaborative Centers for Public Health [20400.9003]	Netherlands Organisation for Health Research and Development (ZonMw), as part of the project entitled Embedding and Expanding Academic Collaborative Centers for Public Health	This study was supported by a grant from the Netherlands Organisation for Health Research and Development (ZonMw), as part of the project entitled Embedding and Expanding Academic Collaborative Centers for Public Health (project number 20400.9003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach TM., 2009, ACHENBACH SYSTEM EMP; Alatupa S., 2011, PSYCHOLOGY, V2, P542, DOI [DOI 10.4236/PSYCH.2011.26084, 10.4236/psych.2011.26084]; Archambault I, 2009, J SCHOOL HEALTH, V79, P408, DOI 10.1111/j.1746-1561.2009.00428.x; Bosma H, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1237; Bradshaw CP, 2010, J YOUTH ADOLESCENCE, V39, P953, DOI 10.1007/s10964-009-9442-8; Bradshaw CP, 2008, NEW DIR CHILD ADOLES, V122, P19, DOI 10.1002/cd.226; Breslau J., 2010, HLTH CHILDHOOD ADOLE; Brugman E, 2001, ARCH PEDIAT ADOL MED, V155, P462, DOI 10.1001/archpedi.155.4.462; Celio M, 2006, INT J CLIN PRACT, V60, P1254, DOI 10.1111/j.1742-1241.2006.00972.x; De Genna NM, 2011, J YOUTH ADOLESCENCE, V40, P1315, DOI 10.1007/s10964-010-9609-3; De Ridder KAA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-941; De Witte K, 2013, EDUC RES REV-NETH, V10, P13, DOI 10.1016/j.edurev.2013.05.002; Deardorff J, 2005, PEDIATRICS, V116, P1451, DOI 10.1542/peds.2005-0542; Department for Credential Evaluation SBB, 2012, DUTCH ED SYST; Dowrick P., 2005, HDB ADOLESCENT BEHAV, P589; Elgar FJ, 2015, LANCET; European Council, 2003, OFFICIAL J EUROPEAN, V46, P3; Fredriks AM, 2000, PEDIATR RES, V47, P316, DOI 10.1203/00006450-200003000-00006; Freudenberg N., 2007, PREVENTING CHRONIC D, V4, P1, DOI DOI 10.3410/F.1092087.545454; Herweijer L, 2008, GESTRUIKELD START SC; Howie LD, 2010, J SCHOOL HEALTH, V80, P119, DOI 10.1111/j.1746-1561.2009.00475.x; Jimerson S, 2000, J SCHOOL PSYCHOL, V38, P525, DOI 10.1016/S0022-4405(00)00051-0; Klabbers G, 2009, J HEALTH PSYCHOL, V14, P771, DOI 10.1177/1359105309338894; Kuo AA, 2006, PEDIATRICS, V118, P1692, DOI 10.1542/peds.2006-0620; Laurent Angulo M, 2005, ONTWIKKELINGSONDERZO; Law GR, 2012, MODERN METHODS EPIDE; Luteijn F, 2000, HANDLEIDING BIJ NPV; Mendle J, 2007, DEV REV, V27, P151, DOI 10.1016/j.dr.2006.11.001; NCJ [Dutch centre for Preventive Child and Youth Health care], 2014, APPL GUID PREV CHILD; Newcomb MD, 2002, J COUNS PSYCHOL, V49, P172, DOI 10.1037//0022-0167.49.2.172; O'Higgins N, 2007, GIORNALE EC, V66, P207; PEARLIN LI, 1978, J HEALTH SOC BEHAV, V19, P2, DOI 10.2307/2136319; Richiardi L, 2013, INT J EPIDEMIOL, V42, P1511, DOI 10.1093/ije/dyt127; RIVM, 2013, VOLKSGEZONDHEID TOEK; Rots-de Vries C, 2011, SCAND J CARING SCI, V25, P269, DOI 10.1111/j.1471-6712.2010.00822.x; Rots-de Vries C, 2011, SCAND J CARING SCI, V25, P211, DOI 10.1111/j.1471-6712.2010.00811.x; Sanderman R, 1995, EEN HANDLEIDING; Shavers VL, 2007, J NATL MED ASSOC, V99, P1013; SHERER M, 1982, PSYCHOL REP, V51, P663, DOI 10.2466/pr0.1982.51.2.663; Shrier I, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-70; Smeyers P, 2006, EDUC RES SER, V1, P95; Statistics Netherlands, 2012, DUTCH POP; Statistics Netherlands, 2006, KERNC POSTC 2004; Suhrcke M, 2011, IMPACT HLTH HLTH BEH; Tanner-Smith EE, 2013, PREV SCI, V14, P468, DOI 10.1007/s11121-012-0330-1; Theunissen MJ, 2015, EUR J PUBLIC HEALTH, V25, P57, DOI 10.1093/eurpub/cku097; Theunissen MJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1033; Traag T, 2011, IRISH EDUC STUD, V30, P45, DOI 10.1080/03323315.2011.535975; UNESCO, 2011, GEN C PAR UNESCO 36; Uzun AK, 2013, J MATERN-FETAL NEO M, V26, P454, DOI 10.3109/14767058.2012.733748; Visser GHA, 2009, EARLY HUM DEV, V85, P737, DOI 10.1016/j.earlhumdev.2009.09.008; WEITZMAN M, 1982, PEDIATRICS, V69, P739	52	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142315	10.1371/journal.pone.0142315	http://dx.doi.org/10.1371/journal.pone.0142315			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7CT	26555443	Green Published, Green Submitted, gold			2022-12-27	WOS:000364430700083
J	Xie, T; Musteanu, M; Lopez-Casas, PP; Shields, DJ; Olson, P; Rejto, PA; Hidalgo, M				Xie, Tao; Musteanu, Monica; Lopez-Casas, Pedro P.; Shields, David J.; Olson, Peter; Rejto, Paul A.; Hidalgo, Manuel			Whole Exome Sequencing of Rapid Autopsy Tumors and Xenograft Models Reveals Possible Driver Mutations Underlying Tumor Progression	PLOS ONE			English	Article							PANCREATIC DUCTAL ADENOCARCINOMA; ULTRACONSERVED ELEMENTS; SOMATIC ALTERATIONS; CANCER METASTASIS; MOUSE MODELS; GENOMES; PATTERNS; PATIENT; MUCINS; HETEROGENEITY	Pancreatic Ductal Adenocarcinoma (PDAC) is a highly lethal malignancy due to its propensity to invade and rapidly metastasize and remains very difficult to manage clinically. One major hindrance towards a better understanding of PDAC is the lack of molecular data sets and models representative of end stage disease. Moreover, it remains unclear how molecularly similar patient-derived xenograft (PDX) models are to the primary tumor from which they were derived. To identify potential molecular drivers in metastatic pancreatic cancer progression, we obtained matched primary tumor, metastases and normal (peripheral blood) samples under a rapid autopsy program and performed whole exome sequencing (WES) on tumor as well as normal samples. PDX models were also generated, sequenced and compared to tumors. Across the matched data sets generated for three patients, there were on average approximately 160 single-nucleotide mutations in each sample. The majority of mutations in each patient were shared among the primary and metastatic samples and, importantly, were largely retained in the xenograft models. Based on the mutation prevalence in the primary and metastatic sites, we proposed possible clonal evolution patterns marked by functional mutations affecting cancer genes such as KRAS, TP53 and SMAD4 that may play an important role in tumor initiation, progression and metastasis. These results add to our understanding of pancreatic tumor biology, and demonstrate that PDX models derived from advanced or end-stage likely closely approximate the genetics of the disease in the clinic and thus represent a biologically and clinically relevant pre-clinical platform that may enable the development of effective targeted therapies for PDAC.	[Xie, Tao; Shields, David J.; Olson, Peter; Rejto, Paul A.] Pfizer Worldwide Res & Dev, Oncol Res, San Diego, CA USA; [Musteanu, Monica; Lopez-Casas, Pedro P.; Hidalgo, Manuel] CNIO Spanish Natl Canc Res Ctr, E-28029 Madrid, Spain	Pfizer	Xie, T (corresponding author), Pfizer Worldwide Res & Dev, Oncol Res, San Diego, CA USA.	tao.xie@pfizer.com; mhidalgo@cnio.es	Rejto, Paul/M-4782-2019; Musteanu, Monica/R-5252-2018; Lopez-Casas, Pedro P./AAF-4146-2019; Lopez-Casas, Pedro P/S-8547-2017	Musteanu, Monica/0000-0002-1753-3765; Lopez-Casas, Pedro P./0000-0001-9866-7361; 	Pfizer Inc.	Pfizer Inc.(Pfizer)	This research was funded by Pfizer Inc. The funder provided support in the form of salaries for authors TX, DJS, PO, and PAR and/or research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aparicio S, 2015, NAT REV CANCER, V15, P311, DOI 10.1038/nrc3944; Azzoni C, 2006, VIRCHOWS ARCH, V448, P119, DOI 10.1007/s00428-005-0058-4; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chen SH, 2013, SCI REP-UK, V3, DOI 10.1038/srep01870; Christofori G, 2006, NATURE, V441, P444, DOI 10.1038/nature04872; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Conway T, 2012, BIOINFORMATICS, V28, pI172, DOI 10.1093/bioinformatics/bts236; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Eirew P, 2015, NATURE, V518, P422, DOI 10.1038/nature13952; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Gu Q, 2015, ONCOTARGET, DOI 10.18632/oncotarget.3969; Haridas D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026839; He YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079769; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Hidalgo M, 2012, CLIN CANCER RES, V18, P4249, DOI 10.1158/1078-0432.CCR-12-1327; Hirbe AC, 2015, CLIN CANCER RES, V21, P4201, DOI 10.1158/1078-0432.CCR-14-3049; Inaba T, 2003, P NATL ACAD SCI USA, V100, P2736, DOI 10.1073/pnas.0435410100; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jones FS, 2000, DEV DYNAM, V218, P235, DOI 10.1002/(SICI)1097-0177(200006)218:2<235::AID-DVDY2>3.3.CO;2-7; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kaur S, 2013, NAT REV GASTRO HEPAT, V10, P607, DOI 10.1038/nrgastro.2013.120; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Majumder B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7169; Mardis ER, 2012, NAT REV GASTRO HEPAT, V9, P477, DOI 10.1038/nrgastro.2012.126; Moniaux N, 2004, BRIT J CANCER, V91, P1633, DOI 10.1038/sj.bjc.6602163; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; Rossello FJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074432; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Setlur SR, 2012, CELL, V149, P959, DOI 10.1016/j.cell.2012.05.010; Shimizu A, 2012, CANCER SCI, V103, P739, DOI 10.1111/j.1349-7006.2012.02214.x; Siolas D, 2013, CANCER RES, V73, P5315, DOI 10.1158/0008-5472.CAN-13-1069; Smith BT, 2014, SYST BIOL, V63, P83, DOI 10.1093/sysbio/syt061; Vignot S, 2013, J CLIN ONCOL, V31, P2167, DOI 10.1200/JCO.2012.47.7737; Von Hoff DD, 2011, J CLIN ONCOL, V29, P4548, DOI 10.1200/JCO.2011.36.5742; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169; Winter JM, 2006, J GASTROINTEST SURG, V10, P1199, DOI 10.1016/j.gassur.2006.08.018; Xie T, 2014, GENOMICS, V104, P234, DOI 10.1016/j.ygeno.2014.07.012; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515	46	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142631	10.1371/journal.pone.0142631	http://dx.doi.org/10.1371/journal.pone.0142631			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555578	gold, Green Submitted, Green Published			2022-12-27	WOS:000364430700144
J	Boloori, A; Saghafian, S; Chakkera, HA; Cook, CB				Boloori, Alireza; Saghafian, Soroush; Chakkera, Harini A.; Cook, Curtiss B.			Characterization of Remitting and Relapsing Hyperglycemia in Post-Renal-Transplant Recipients	PLOS ONE			English	Article							POSTTRANSPLANT DIABETES-MELLITUS; COMPARING CYCLOSPORINE MICROEMULSION; HEPATITIS-C INFECTION; NEW-ONSET; RISK-FACTORS; METABOLIC SYNDROME; LIVER-TRANSPLANTATION; KIDNEY-TRANSPLANTATION; GLUCOSE-METABOLISM; SINGLE-CENTER	Background Hyperglycemia following solid organ transplant is common among patients without preexisting diabetes mellitus (DM). Post-transplant hyperglycemia can occur once or multiple times, which if continued, causes new-onset diabetes after transplantation (NODAT). Objective To study if the first and recurrent incidence of hyperglycemia are affected differently by immunosuppressive regimens, demographic and medical-related risk factors, and inpatient hyperglycemic conditions (i.e., an emphasis on the time course of post-transplant complications). Methods We conducted a retrospective analysis of 407 patients who underwent kidney transplantation at Mayo Clinic Arizona. Among these, there were 292 patients with no signs of DM prior to transplant. For this category of patients, we evaluated the impact of (1) immunosuppressive drugs (e.g., tacrolimus, sirolimus, and steroid), (2) demographic and medical-related risk factors, and (3) inpatient hyperglycemic conditions on the first and recurrent incidence of hyperglycemia in one year post-transplant. We employed two versions of Cox regression analyses: (1) a time-dependent model to analyze the recurrent cases of hyperglycemia and (2) a time-independent model to analyze the first incidence of hyperglycemia. Results Age (P = 0.018), HDL cholesterol (P = 0.010), and the average trough level of tacrolimus (P< 0.0001) are significant risk factors associated with the first incidence of hyperglycemia, while age (P< 0.0001), non-White race (P = 0.002), BMI (P = 0.002), HDL cholesterol (P = 0.003), uric acid (P = 0.012), and using steroid (P = 0.007) are the significant risk factors for the recurrent cases of hyperglycemia. Discussion This study draws attention to the importance of analyzing the risk factors associated with a disease (specially a chronic one) with respect to both its first and recurrent incidence, as well as carefully differentiating these two perspectives: a fact that is currently overlooked in the literature.	[Boloori, Alireza] Arizona State Univ, Dept Ind Engn, Sch Comp Informat & Decis Syst Engn, Tempe, AZ USA; [Saghafian, Soroush] Harvard Univ, Harvard Kennedy Sch, Cambridge, MA 02138 USA; [Chakkera, Harini A.] Mayo Clin, Sch Med, Div Nephrol & Transplantat, Scottsdale, AZ USA; [Cook, Curtiss B.] Mayo Clin, Sch Med, Div Endocrinol, Scottsdale, AZ USA	Arizona State University; Arizona State University-Tempe; Harvard University; Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic Phoenix	Saghafian, S (corresponding author), Harvard Univ, Harvard Kennedy Sch, Cambridge, MA 02138 USA.	Soroush_Saghafian@hks.harvard.edu		Chakkera, Harini/0000-0002-9456-0863; Saghafian, Soroush/0000-0002-9781-6561				Bayer ND, 2010, TRANSPLANTATION, V90, P861, DOI 10.1097/TP.0b013e3181f1543c; Bee YM, 2011, ANN ACAD MED SINGAP, V40, P160; BENDING JJ, 1987, BRIT MED J, V294, P401, DOI 10.1136/bmj.294.6569.401; Bloom Roy D, 2008, Transplant Rev (Orlando), V22, P39, DOI 10.1016/j.trre.2007.06.001; Borda B, 2011, TRANSPL P, V43, P1254, DOI 10.1016/j.transproceed.2011.03.091; Bulanowski M, 2012, ANN TRANSPL, V17, P61; Cardoso F, 2012, ANN ONCOL, V23, P11, DOI 10.1093/annonc/mds232; Carter SA, 2014, PEDIATR TRANSPLANT, V18, P698, DOI 10.1111/petr.12332; Chakkera HA, 2010, CLIN J AM SOC NEPHRO, V5, P1669, DOI 10.2215/CJN.09481209; Chakkera HA, 2009, CLIN J AM SOC NEPHRO, V4, P853, DOI 10.2215/CJN.05471008; Chien YS, 2008, TRANSPL P, V40, P2409, DOI 10.1016/j.transproceed.2008.06.034; Cohen EEW, 2012, CLIN CANCER RES, V18, P4785, DOI 10.1158/1078-0432.CCR-12-0110; Cosio FG, 2001, KIDNEY INT, V59, P732, DOI 10.1046/j.1523-1755.2001.059002732.x; Davidson JA, 2004, DIABETES CARE, V27, P805, DOI 10.2337/diacare.27.3.805; DRESNER LS, 1989, SURGERY, V106, P163; Duvoux C, 2013, TRANSPL INT, V26, P358, DOI 10.1111/tri.12065; Farris AB, 2010, VIRCHOWS ARCH, V457, P329, DOI 10.1007/s00428-010-0948-y; Furth S, 1996, PEDIATR NEPHROL, V10, P64, DOI 10.1007/BF00863448; Gaynor JJ, 2015, CLIN TRANSPLANT, V29, P301, DOI 10.1111/ctr.12510; Gelens MACJ, 2008, NEPHROL DIAL TRANSPL, V23, P701, DOI 10.1093/ndt/gfm544; Ghanta M, 2015, CARDIOL REV, V23, P109, DOI 10.1097/CRD.0000000000000044; Ghisdal L, 2012, DIABETES CARE, V35, P181, DOI 10.2337/dc11-1230; Herrero JI, 2003, TRANSPLANT P, V35, P1877, DOI 10.1016/S0041-1345(03)00644-4; Hjelmes&AELIG;th J, 2001, NEPHROL DIAL TRANSPL, V16, P374; Honda M, 2013, CLIN TRANSPLANT, V27, P426, DOI 10.1111/ctr.12103; HRICIK DE, 1991, TRANSPLANTATION, V51, P374, DOI 10.1097/00007890-199102000-00020; Johnston O, 2008, J AM SOC NEPHROL, V19, P1411, DOI 10.1681/ASN.2007111202; Kaposztas Z, 2011, TRANSPL P, V43, P1375, DOI 10.1016/j.transproceed.2011.04.008; Kappe C, 2015, CLIN SCI, V129, P405, DOI 10.1042/CS20140719; Kesiraju S, 2014, TRANSPL IMMUNOL, V30, P52, DOI 10.1016/j.trim.2013.10.006; Kuo HT, 2010, LIVER TRANSPLANT, V16, P1249, DOI 10.1002/lt.22139; Kurzawski M, 2012, EUR J CLIN PHARMACOL, V68, P1587, DOI 10.1007/s00228-012-1292-8; Lane JT, 2011, J CLIN ENDOCR METAB, V96, P3289, DOI 10.1210/jc.2011-0657; Levy G, 2004, TRANSPLANTATION, V77, P1632, DOI 10.1097/01.TP.0000129095.51031.42; Levy G, 2006, LIVER TRANSPLANT, V12, P1464, DOI 10.1002/lt.20802; Liu XX, 2014, ANN NUTR METAB, V65, P324, DOI 10.1159/000365892; Luan FL, 2010, CLIN TRANSPLANT, V24, P778, DOI 10.1111/j.1399-0012.2009.01194.x; Lv C, 2014, PLOS ONE; Marchetti P, 2004, J HEART LUNG TRANSPL, V23, pS194, DOI 10.1016/j.healun.2004.03.007; Matias P, 2008, TRANSPL P, V40, P3601, DOI 10.1016/j.transproceed.2008.07.138; Mecule A, 2010, TRANSPL P, V42, P1317, DOI 10.1016/j.transproceed.2010.03.123; Meerwein C, 2011, EUR J PHARMACOL, V671, P113, DOI 10.1016/j.ejphar.2011.09.166; Mohler JL, 2004, CLIN CANCER RES, V10, P440, DOI 10.1158/1078-0432.CCR-1146-03; Montero N, 2015, CURR DIABETES REV, V11, P144, DOI 10.2174/1573399811666150331160846; Mora PF, 2010, J INVEST MED, V58, P755, DOI 10.231/JIM.0b013e3181e61a64; Mozaffarian D, 2007, LANCET, V370, P667, DOI 10.1016/S0140-6736(07)61343-9; O'Grady JG, 2002, LANCET, V360, P1119, DOI 10.1016/S0140-6736(02)11196-2; Palepu S, 2015, WORLD J DIABETES, V6, P445, DOI 10.4239/wjd.v6.i3.445; Park SC, 2015, TRANSPL P, V47, P666, DOI 10.1016/j.transproceed.2014.11.053; Parvizi Z, 2014, MOL BIOL REP, V41, P6063, DOI 10.1007/s11033-014-3483-0; Pirsch JD, 2015, AM J TRANSPLANT, V15, P1982, DOI 10.1111/ajt.13247; Rakel A, 2011, DIABETES METAB, V37, P1, DOI 10.1016/j.diabet.2010.09.003; Rafacho A, 2014, J ENDOCRINOL, V223, pR49, DOI 10.1530/JOE-14-0373; Rajab A, 2007, TRANSPLANTATION, V84, P1131, DOI 10.1097/01.tp.0000287117.98785.54; Ramachandran R, 2014, NEPHROL DIAL TRANSPL, V29, P1918, DOI 10.1093/ndt/gfu097; Ramos-Cebrian M, 2007, TRANSPL P, V39, P2251, DOI 10.1016/j.transproceed.2007.06.035; Rodrigo E, 2006, J AM SOC NEPHROL, V17, pS291, DOI 10.1681/ASN.2006080929; Romagnoli J, 2006, TRANSPL P, V38, P1034, DOI 10.1016/j.transproceed.2006.03.072; Saliba F, 2007, LIVER TRANSPLANT, V13, P136, DOI 10.1002/lt.21010; Salifu Moro O, 2005, Curr Diab Rep, V5, P194, DOI 10.1007/s11892-005-0009-0; Sharif A, 2010, TRANSPLANTATION, V89, P327, DOI 10.1097/TP.0b013e3181bbf2c4; Soule JL, 2005, AM J SURG, V189, P552, DOI 10.1016/j.amjsurg.2005.01.033; Stevens RB, 2012, CLIN TRANSPLANT, V26, P123, DOI 10.1111/j.1399-0012.2011.01425.x; Taylor AL, 2005, CRIT REV ONCOL HEMAT, V56, P23, DOI 10.1016/j.critrevonc.2005.03.012; Taylor DO, 1999, J HEART LUNG TRANSPL, V18, P336, DOI 10.1016/S1053-2498(98)00060-6; Teutonico A, 2005, J AM SOC NEPHROL, V16, P3128, DOI 10.1681/ASN.2005050487; Tokodai K, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/436725; van Buuren S, 2011, J STAT SOFTW, V45, P1; van den Hoogen MWF, 2013, EXP CLIN TRANSPLANT, V11, P234, DOI 10.6002/ect.2012.0221; van Genugten RE, 2014, EUR J ENDOCRINOL, V170, P429, DOI 10.1530/EJE-13-0610; Van Laecke S, 2009, AM J TRANSPLANT, V9, P2140, DOI 10.1111/j.1600-6143.2009.02752.x; van Raalte DH, 2014, NETH J MED, V72, P62; Vodenik B, 2009, Transplant Proc, V41, pS31, DOI 10.1016/j.transproceed.2009.06.159; WAJNGOT A, 1992, P NATL ACAD SCI USA, V89, P6035, DOI 10.1073/pnas.89.13.6035; Wauters RP, 2012, TRANSPLANTATION, V94, P377, DOI 10.1097/TP.0b013e3182584831; WISE JK, 1973, J CLIN INVEST, V52, P2774, DOI 10.1172/JCI107473; Wissing KM, 2014, TRANSPLANT REV-ORLAN, V28, P37, DOI 10.1016/j.trre.2013.12.004; Wyzgal J, 2003, TRANSPLANT P, V35, P2216, DOI 10.1016/S0041-1345(03)00819-4; Yadav AD, 2013, J TRANSPLANT, V2013, DOI 10.1155/2013/269096	79	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2015	10	11							e0142363	10.1371/journal.pone.0142363	http://dx.doi.org/10.1371/journal.pone.0142363			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7AC	26551468	Green Submitted, Green Published, gold			2022-12-27	WOS:000364422800025
J	Tannetta, DS; Hunt, K; Jones, CI; Davidson, N; Coxon, CH; Ferguson, D; Redman, CW; Gibbins, JM; Sargent, IL; Tucker, KL				Tannetta, Dionne S.; Hunt, Kathryn; Jones, Chris I.; Davidson, Naomi; Coxon, Carmen H.; Ferguson, David; Redman, Christopher W.; Gibbins, Jonathan M.; Sargent, Ian L.; Tucker, Katherine L.			Syncytiotrophoblast Extracellular Vesicles from Pre-Eclampsia Placentas Differentially Affect Platelet Function	PLOS ONE			English	Article							AGGREGATION INHIBITING ACTIVITY; BORDER MEMBRANE-VESICLES; CARDIOVASCULAR-DISEASE; PREGNANCY; PATHOPHYSIOLOGY; MICROPARTICLES; MANAGEMENT; COLLAGEN	Pre-eclampsia (PE) complicates around 3% of all pregnancies and is one of the most common causes of maternal mortality worldwide. The pathophysiology of PE remains unclear however its underlying cause originates from the placenta and manifests as raised blood pressure, proteinuria, vascular or systemic inflammation and hypercoagulation in the mother. Women who develop PE are also at significantly higher risk of subsequently developing cardiovascular (CV) disease. In PE, the failing endoplasmic reticulum, oxidative and inflammatory stressed syncytiotrophoblast layer of the placenta sheds increased numbers of syncytiotrophoblast extracellular vesicles (STBEV) into the maternal circulation. Platelet reactivity, size and concentration are also known to be altered in some women who develop PE, although the underlying reasons for this have not been determined. In this study we show that STBEV from disease free placenta isolated ex vivo by dual placental perfusion associate rapidly with platelets. We provide evidence that STBEV isolated from normal placentas cause platelet activation and that this is increased with STBEV from PE pregnancies. Furthermore, treatment of platelets with aspirin, currently prescribed for women at high risk of PE to reduce platelet aggregation, also inhibits STBEV-induced reversible aggregation of washed platelets. Increased platelet reactivity as a result of exposure to PE placenta derived STBEVs correlates with increased thrombotic risk associated with PE. These observations establish a possible direct link between the clotting disturbances of PE and dysfunction of the placenta, as well as the known increased risk of thromboembolism associated with this condition.	[Tannetta, Dionne S.; Hunt, Kathryn; Davidson, Naomi; Redman, Christopher W.; Sargent, Ian L.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Obstet & Gynaecol, Womens Ctr, Oxford OX3 9DU, England; [Jones, Chris I.; Gibbins, Jonathan M.] Univ Reading, Sch Biol Sci, Inst Cardiovasc & Metab Res, Reading, Berks, England; [Coxon, Carmen H.] Univ Bristol, Sch Physiol & Pharmacol, Bristol, Avon, England; [Ferguson, David] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, Oxford OX3 9DU, England; [Tucker, Katherine L.] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England	University of Oxford; University of Reading; University of Bristol; University of Oxford; University of Oxford	Tucker, KL (corresponding author), Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England.	katherine.tucker@phc.ox.ac.uk		Jones, Chris/0000-0001-7537-1509; Gibbins, Jonathan/0000-0002-0372-5352	Medical Research Council [MR/J003360/1]; British Heart Foundation [RG/09/011/28094]; British Heart Foundation [RG/15/2/31224] Funding Source: researchfish; MRC [MR/J003360/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding: This work was funded by the Medical Research Council Programme grant MR/J003360/1 (DT) and the British Heart Foundation programme grant RG/09/011/28094. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselin J, 1997, BLOOD, V89, P1235, DOI 10.1182/blood.V89.4.1235; Baig S, 2014, CLIN PROTEOM, V11, DOI 10.1186/1559-0275-11-40; Bellamy L, 2007, BMJ-BRIT MED J, V335, P974, DOI 10.1136/bmj.39335.385301.BE; Chen Y, 2012, INT J GYNECOL OBSTET, V119, P234, DOI 10.1016/j.ijgo.2012.07.010; Dragovic RA, 2015, METHODS, V87, P64, DOI 10.1016/j.ymeth.2015.03.028; Dragovic RA, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.113266; Duley L, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004659.pub2; Duley L, 2006, BMJ-BRIT MED J, V332, P463, DOI 10.1136/bmj.332.7539.463; Erez O, 2008, J MATERN-FETAL NEO M, V21, P345, DOI 10.1080/14767050802034859; Fox KAA, 2004, HEART, V90, P698, DOI 10.1136/hrt.2003.020321; Gardiner C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026313; Germain SJ, 2007, J IMMUNOL, V178, P5949, DOI 10.4049/jimmunol.178.9.5949; Gibbins JM, 1998, J BIOL CHEM, V273, P34437, DOI 10.1074/jbc.273.51.34437; Gilbert JS, 2008, AM J PHYSIOL-HEART C, V294, pH541, DOI 10.1152/ajpheart.01113.2007; Hedlund M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016899; IIOKA H, 1994, PLACENTA, V15, P291, DOI 10.1016/0143-4004(94)90020-5; IIOKA H, 1993, PLACENTA, V14, P75, DOI 10.1016/S0143-4004(05)80250-4; JANES SL, 1994, CLIN SCI, V86, P731, DOI 10.1042/cs0860731; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Knight M, 1998, BRIT J OBSTET GYNAEC, V105, P632, DOI 10.1111/j.1471-0528.1998.tb10178.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lopez-Vilchez I, 2007, THROMB HAEMOSTASIS, V97, P202, DOI 10.1160/TH06-04-0216; Mincheva-Nilsson L, 2014, AM J REPROD IMMUNOL, V72, P440, DOI 10.1111/aji.12311; Morel O, 2011, SEMIN IMMUNOPATHOL, V33, P469, DOI 10.1007/s00281-010-0239-3; Powe CE, 2011, CIRCULATION, V123, P2856, DOI 10.1161/CIRCULATIONAHA.109.853127; Redman CWG, 2012, PLACENTA, V33, pS48, DOI 10.1016/j.placenta.2011.12.006; Schafer Andrew I., 1999, American Journal of Medicine, V106, p25S, DOI 10.1016/S0002-9343(99)00114-X; Shankar H, 2006, BLOOD, V108, P3027, DOI 10.1182/blood-2006-03-010330; Southcombe J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020245; Spyridon M, 2011, BLOOD, V117, P5751, DOI 10.1182/blood-2010-09-306142; Tannetta D, 2014, CELL MOL IMMUNOL, V11, P548, DOI 10.1038/cmi.2014.42; Tannetta D, 2013, CURR HYPERTENS REP, V15, P590, DOI 10.1007/s11906-013-0395-7; Tannetta DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056754; Tucker KL, 2012, METHODS MOL BIOL, V788, P101, DOI 10.1007/978-1-61779-307-3_8	34	48	52	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2015	10	11							e0142538	10.1371/journal.pone.0142538	http://dx.doi.org/10.1371/journal.pone.0142538			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7AC	26551971	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000364422800028
J	Chernov, AV; Reyes, L; Peterson, S; Strongin, AY				Chernov, Andrei V.; Reyes, Leticia; Peterson, Scott; Strongin, Alex Y.			Depletion of CG-Specific Methylation in Mycoplasma hyorhinis Genomic DNA after Host Cell Invasion	PLoS One			English	Article							MALIGNANT-TRANSFORMATION; ESCHERICHIA-COLI; INFECTION; CANCER; TOLL-LIKE-RECEPTOR-9; TRANSCRIPTION; GENITALIUM; ACTIVATION	Adaptation to the environment requires pathogenic bacteria to alter their gene expression in order to increase long-term survival in the host. Here, we present the first experimental evidence that bacterial DNA methylation affects the intracellular survival of pathogenic Mycoplasma hyorhinis. Using bisulfite sequencing, we identified that the M. hyorhinis DNA methylation landscape was distinct in free-livingM. hyorhinis relative to the internalized bacteria surviving in the infected human cells. We determined that genomic GATC sites were consistently highly methylated in the bacterial chromosome suggesting that the bacterial GATC-specific 5-methylcytosine DNA methyltransferase was fully functional both pre- and post-infection. In contrast, only the low CG methylation pattern was observed in the mycoplasma genome in the infective bacteria that invaded and then survived in the host cells. In turn, two distinct populations, with either high or low CG methylation, were detected in the M. hyorhinis cultures continually grown in the rich medium independently of host cells. We also identified that M. hyorhinis efficiently evaded endosomal degradation and uses exocytosis to exit infected human cells enabling re-infection of additional cells. The well-orchestrated changes in the chromosome methylation landscape play a major regulatory role in the mycoplasma life cycle.	[Chernov, Andrei V.; Peterson, Scott; Strongin, Alex Y.] Sanford Burnham Prebys Med Discovery Inst, Infect & Inflammatory Dis Ctr, La Jolla, CA 92037 USA; [Reyes, Leticia] Univ Florida, Coll Vet Med, Dept Infect Dis & Pathol, Gainesville, FL USA	Sanford Burnham Prebys Medical Discovery Institute; State University System of Florida; University of Florida	Chernov, AV (corresponding author), Sanford Burnham Prebys Med Discovery Inst, Infect & Inflammatory Dis Ctr, La Jolla, CA 92037 USA.	achernov@sbpdiscovery.org; strongin@sbpdiscovery.org	Reyes, Leticia/H-7338-2019; Chernov, Andrei/I-1623-2019; Strongin, Alex/R-6609-2019	Chernov, Andrei/0000-0002-3294-5418; Strongin, Alex/0000-0003-3765-3016	Institute of Predictive and Personalized Medicine of Cancer, Barcelona, Spain; National Cancer Institute at the National Institutes of Health [CA077470, CA083017, CA157328]; NATIONAL CANCER INSTITUTE [R01CA083017, R01CA157328, R01CA077470] Funding Source: NIH RePORTER	Institute of Predictive and Personalized Medicine of Cancer, Barcelona, Spain; National Cancer Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a Research Fellowship from the Institute of Predictive and Personalized Medicine of Cancer, Barcelona, Spain (to AVC)-http://www.imppc.org/, and the National Cancer Institute at the National Institutes of Health grants CA077470, CA083017 and CA157328 (to AYS)-http://www.cancer.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barykova YA, 2011, ONCOTARGET, V2, P289; Chernov AV, 2015, EPIGENETICS-US, V10, P303, DOI 10.1080/15592294.2015.1020000; Cimolai N, 2001, CAN J MICROBIOL, V47, P691, DOI 10.1139/cjm-47-8-691; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; FREY ML, 1968, AVIAN DIS, V12, P693, DOI 10.2307/1588456; Gong MM, 2008, MOL CANCER THER, V7, P530, DOI 10.1158/1535-7163.MCT-07-2191; Goodison S, 2013, GENOME ANNOUNC, V1, DOI [10.1128/genomeA.00036-13, DOI 10.1128/GENOMEA.00036-13]; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; Hackenberg M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-446; Huang S, 2001, WORLD J GASTROENTERO, V7, P266; Kahramanoglou C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1878; Kornspan JD, 2010, INFECT IMMUN, V78, P611, DOI 10.1128/IAI.01017-09; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Latz E, 2007, NAT IMMUNOL, V8, P772, DOI 10.1038/ni1479; Lipschutz JH, 2002, CURR BIOL, V12, pR212, DOI 10.1016/S0960-9822(02)00753-4; Lluch-Senar M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003191; Logunov DY, 2008, ONCOGENE, V27, P4521, DOI 10.1038/onc.2008.103; Masaki T, 2013, CELL, V152, P51, DOI 10.1016/j.cell.2012.12.014; Militello KT, 2012, FEMS MICROBIOL LETT, V328, P78, DOI 10.1111/j.1574-6968.2011.02482.x; Namiki K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006872; PETERSON SN, 1993, J BACTERIOL, V175, P7918, DOI 10.1128/JB.175.24.7918-7930.1993; Ramirez-Ortiz ZG, 2008, INFECT IMMUN, V76, P2123, DOI 10.1128/IAI.00047-08; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; Reyes L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074230; Rottem S, 2000, Subcell Biochem, V33, P199; Shell SS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003419; TSAI S, 1995, P NATL ACAD SCI USA, V92, P10197, DOI 10.1073/pnas.92.22.10197; Ueno PM, 2008, MICROBIOL-SGM, V154, P3033, DOI 10.1099/mic.0.2008/020735-0; Urbanek C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-233; Weber M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/243649; Wojciechowski M, 2013, P NATL ACAD SCI USA, V110, P105, DOI 10.1073/pnas.1207986110; Yang CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036138; Yang H, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-132	34	19	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142529	10.1371/journal.pone.0142529	http://dx.doi.org/10.1371/journal.pone.0142529			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544880	Green Submitted, Green Published, gold			2022-12-27	WOS:000364398700153
J	Hamilton, F; Graham, R; Luu, L; Peixoto, N				Hamilton, Franz; Graham, Robert; Luu, Lydia; Peixoto, Nathalia			Time-Dependent Increase in Network Response to Stimulation	PLoS One			English	Article							CORTICAL-NEURONS; DYNAMICS; CULTURES; CONNECTIVITY; ARRAYS; MEMORY	In vitro neuronal cultures have become a popular method with which to probe network-level neuronal dynamics and phenomena in controlled laboratory settings. One of the key dynamics of interest in these in vitro studies has been the extent to which cultured networks display properties indicative of learning. Here we demonstrate the effects of a high frequency electrical stimulation signal in training cultured networks of cortical neurons. Networks receiving this training signal displayed a time-dependent increase in the response to a low frequency probing stimulation, particularly in the time window of 20-50 ms after stimulation. This increase was found to be statistically significant as compared to control networks that did not receive training. The timing of this increase suggests potentiation of synaptic mechanisms. To further investigate this possibility, we leveraged the powerful Cox statistical connectivity method as previously investigated by our group. This method was used to identify and track changes in network connectivity strength.	[Hamilton, Franz; Peixoto, Nathalia] George Mason Univ, Dept Elect & Comp Engn, Fairfax, VA 22030 USA; [Graham, Robert; Luu, Lydia; Peixoto, Nathalia] George Mason Univ, Dept Bioengn, Fairfax, VA 22030 USA	George Mason University; George Mason University	Peixoto, N (corresponding author), George Mason Univ, Dept Elect & Comp Engn, Fairfax, VA 22030 USA.	npeixoto@gmu.edu		Luu, Lydia/0000-0001-6512-4686; Graham, Robert/0000-0002-9795-4614	National Science Foundation [CMMI-1300007]; George Mason University Libraries Open Access Publishing Fund	National Science Foundation(National Science Foundation (NSF)); George Mason University Libraries Open Access Publishing Fund	This work was funded by National Science Foundation grant CMMI-1300007 (NP received the funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Publication of this article was funded in part by the George Mason University Libraries Open Access Publishing Fund.	Anastassiou CA, 2011, NAT NEUROSCI, V14, P217, DOI 10.1038/nn.2727; Battaglia D, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002438; Berry T, 2012, J NEUROSCI METH, V209, P388, DOI 10.1016/j.jneumeth.2012.06.021; Bologna LL, 2010, NEUROSCIENCE, V165, P692, DOI 10.1016/j.neuroscience.2009.11.018; Chiappalone M, 2008, EUR J NEUROSCI, V28, P221, DOI 10.1111/j.1460-9568.2008.06259.x; Cox D, 2009, STOCHASTIC POINT PRO, V55, P6; Dranias MR, 2013, J NEUROSCI, V33, P1940, DOI 10.1523/JNEUROSCI.2718-12.2013; Eytan D, 2006, J NEUROSCI, V26, P8465, DOI 10.1523/JNEUROSCI.1627-06.2006; Frohlich F, 2010, NEURON, V67, P129, DOI 10.1016/j.neuron.2010.06.005; Gal A, 2010, J NEUROSCI, V30, P16332, DOI 10.1523/JNEUROSCI.4859-10.2010; Garofalo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006482; Hamilton F, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.052715; Ito SY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027431; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Jimbo Y, 1999, BIOPHYS J, V76, P670, DOI 10.1016/S0006-3495(99)77234-6; Kermany E, 2010, J NEUROSCI, V30, P9588, DOI 10.1523/JNEUROSCI.0661-10.2010; Knaack GL, 2013, NEUROTOXICOLOGY, V37, P19, DOI 10.1016/j.neuro.2013.03.002; le Feber J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008871; Li YL, 2007, BIOPHYS J, V93, P4151, DOI 10.1529/biophysj.107.111153; Li YL, 2007, BIOSENS BIOELECTRON, V22, P2976, DOI 10.1016/j.bios.2006.12.018; Marom S, 2005, PROG BRAIN RES, V147, P189, DOI 10.1016/S0079-6123(04)47014-9; Marom S, 2002, Q REV BIOPHYS, V35, P63, DOI 10.1017/S0033583501003742; Masud MS, 2011, J NEUROSCI METH, V196, P201, DOI 10.1016/j.jneumeth.2011.01.003; Ozen S, 2010, J NEUROSCI, V30, P11476, DOI 10.1523/JNEUROSCI.5252-09.2010; Ruaro ME, 2005, IEEE T BIO-MED ENG, V52, P371, DOI 10.1109/TBME.2004.842975; Shahaf G, 2001, J NEUROSCI, V21, P8782, DOI 10.1523/JNEUROSCI.21-22-08782.2001; Wagenaar DA, 2005, J NEUROSCI, V25, P680, DOI 10.1523/JNEUROSCI.4209-04.2005; Wagenaar DA, 2004, J NEUROSCI METH, V138, P27, DOI 10.1016/j.jneumeth.2004.03.005; Xiang GX, 2007, BIOSENS BIOELECTRON, V22, P2478, DOI 10.1016/j.bios.2006.09.026	29	5	6	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142399	10.1371/journal.pone.0142399	http://dx.doi.org/10.1371/journal.pone.0142399			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26545098	Green Published, gold, Green Submitted			2022-12-27	WOS:000364398700131
J	Kolokythas, A; Zhou, YL; Schwartz, JL; Adami, GR				Kolokythas, Antonia; Zhou, Yalu; Schwartz, Joel L.; Adami, Guy R.			Similar Squamous Cell Carcinoma Epithelium microRNA Expression in Never Smokers and Ever Smokers	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS HPV; NECK-CANCER; ORAL TONGUE; HEAD; PROLIFERATION; NONSMOKERS; SIGNATURES; DISCOVERY; PATTERNS; TOBACCO	The incidence of oral tumors in patients who never used mutagenic agents such as tobacco is increasing. In an effort to better understand these tumors we studied microRNA (miRNA) expression in tumor epithelium of never tobacco users, tumor epithelium of ever tobacco users, and nonpathological control oral epithelium. A comparison of levels among 372 miRNAs in 12 never tobacco users with oral squamous cell carcinoma (OSCC) versus 10 healthy controls was made using the reverse transcription quantitative polymerase chain reaction. A similar analysis was done with 8 ever tobacco users with OSCC. These comparisons revealed miR-10b-5p, miR-196a-5p, and miR-31-5p as enriched in the tumor epithelium in OSCC of both never and ever tobacco users. Examination of The Cancer Genome Atlas (TCGA) project miRNA data on 305 OSCCs and 30 controls revealed 100% of those miRNAs enriched in never smoker OSCCs in this patient group were also enriched in ever smoker OSCCs. Nonsupervised clustering of TCGA OSCCs was suggestive of two or four subgroups of tumors based on miRNA levels with limited evidence for differences in tobacco exposure among the groups. Results from both patient groups together stress the importance of miR196a-5p in OSCC malignancy in both never and ever smokers, and emphasize the overall similarity of miRNA expression in OSCCs in these two risk groups. It implies that there may be great similarity in etiology of OSCC in never and ever smokers and that classifying OSCC based on tobacco exposure may not be helpful in the clinic.	[Kolokythas, Antonia] Univ Illinois, Coll Dent, Dept Oral & Maxillofacial Surg, Chicago, IL 60610 USA; [Zhou, Yalu; Schwartz, Joel L.] Arphion Ltd, Chicago, IL 60612 USA; [Adami, Guy R.] Univ Illinois, Ctr Mol Biol Oral Dis, Dept Oral Med & Oral Diagnost, Chicago, IL 60610 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Adami, GR (corresponding author), Univ Illinois, Ctr Mol Biol Oral Dis, Dept Oral Med & Oral Diagnost, 801 South Paulina St, Chicago, IL 60610 USA.	gadami@uic.edu						Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Blenkiron C, 2007, HUM MOL GENET, V16, pR106, DOI 10.1093/hmg/ddm056; Braakhuis BJM, 2004, JNCI-J NATL CANCER I, V96, P998, DOI 10.1093/jnci/djh183; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen Dan, 2013, J Oral Maxillofac Res, V4, pe2, DOI 10.5037/jomr.2013.4102; Chung CH, 2004, CANCER CELL, V5, P489, DOI 10.1016/S1535-6108(04)00112-6; Corbetta S, 2010, ENDOCR-RELAT CANCER, V17, P135, DOI 10.1677/ERC-09-0134; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; De Sarkar N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104839; Di Leva G, 2014, ANNU REV PATHOL-MECH, V9, P287, DOI 10.1146/annurev-pathol-012513-104715; Durr ML, 2013, AM J OTOLARYNG, V34, P388, DOI 10.1016/j.amjoto.2013.01.017; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Farshadpour F, 2012, ORAL DIS, V18, P178, DOI 10.1111/j.1601-0825.2011.01861.x; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Heaton CM, 2014, LARYNGOSCOPE, V124, pE267, DOI 10.1002/lary.24595; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Hou T, 2014, BRIT J CANCER, V110, P1260, DOI 10.1038/bjc.2013.829; Hui ABY, 2010, CLIN CANCER RES, V16, P1129, DOI 10.1158/1078-0432.CCR-09-2166; Ide S, 2015, ANTICANCER RES, V35, P1447; John K, 2013, INT J DENT, V2013, DOI 10.1155/2013/650218; Kim YK, 2012, MOL CELL, V46, P893, DOI 10.1016/j.molcel.2012.05.036; Koch WM, 1999, LARYNGOSCOPE, V109, P1544, DOI 10.1097/00005537-199910000-00002; Kolokythas A, 2011, ORAL ONCOL, V47, P532, DOI 10.1016/j.oraloncology.2011.03.029; Kruger M, 2014, J CRANIO MAXILLO FAC; Laing Emma, 2010, BMC Res Notes, V3, P221, DOI 10.1186/1756-0500-3-221; Lawrence MS, 2015, NATURE, V517, P576, DOI 10.1038/nature14129; Li R, 2014, HEAD NECK-J SCI SPEC; Lingen MW, 2013, ORAL ONCOL, V49, P1, DOI 10.1016/j.oraloncology.2012.07.002; Liu CJ, 2013, ANN SURG ONCOL, V20, pS406, DOI 10.1245/s10434-012-2618-6; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu YC, 2012, CANCER PREV RES, V5, P665, DOI 10.1158/1940-6207.CAPR-11-0358; Lu ZM, 2014, ONCOTARGETS THER, V7, P525, DOI 10.2147/OTT.S59871; MacLellan SA, 2014, BMC CLIN PATHOL, V14, DOI 10.1186/1472-6890-14-27; Mendez E, 2012, CANCER RES, V72, P4896, DOI 10.1158/0008-5472.CAN-12-3285; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; Park YT, 2013, J OVARIAN RES, V6, DOI 10.1186/1757-2215-6-18; Pezzuto F, 2015, ONCOLOGY-BASEL, V89, P125, DOI 10.1159/000381717; Pickering CR, 2014, CLIN CANCER RES, V20, P3842, DOI 10.1158/1078-0432.CCR-14-0565; Poling JS, 2014, ORAL ONCOL, V50, P306, DOI 10.1016/j.oraloncology.2014.01.006; Pritchard CC, 2012, NAT REV GENET, V13, P358, DOI 10.1038/nrg3198; Rabinovics N, 2015, ORAL ONCOL, V51, pe23, DOI [10.1016/j.oraloncology.2015.02.004, DOI 10.1016/J.0RAL0NC0L0GY.2015.02.004]; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Rhodus Nelson L, 2014, Dent Clin North Am, V58, P315, DOI 10.1016/j.cden.2013.12.004; Saito K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071480; Schwartz JL, 2008, J ORAL PATHOL MED, V37, P70, DOI 10.1111/j.1600-0714.2007.00596.x; Sebastian P, 2014, J ORAL PATHOL MED, V43, P593, DOI 10.1111/jop.12175; Severino P, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-533; Simon R, 2007, CANCER INFORM, V3, P11; Tao K, 2014, AM J TRANSL RES, V6, P391; Tay FC, 2014, ADV DRUG DELIVERY RE; Tu HF, 2013, CURR OPIN OTOLARYNGO, V21, P104, DOI 10.1097/MOO.0b013e32835e1d6e; Varghese AM, 2014, J THORAC ONCOL, V9, P892, DOI 10.1097/JTO.0000000000000142; Villegas-Ruiz V, 2014, INT J CLIN EXP PATHO, V7, P1389; Walter V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056823; Westra WH, 2014, ORAL ONCOL, V50, P771, DOI 10.1016/j.oraloncology.2014.05.004; Wu BH, 2011, ORAL ONCOL, V47, P314, DOI 10.1016/j.oraloncology.2011.03.019; Xie ZJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057502; Zhang Huan, 2012, Cancer Biology Medicine, V9, P63, DOI 10.3969/j.issn.2095-3941.2012.01.012; Zhang J, 2013, BIOCHEM BIOPH RES CO, V440, P582, DOI 10.1016/j.bbrc.2013.09.142	61	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141695	10.1371/journal.pone.0141695	http://dx.doi.org/10.1371/journal.pone.0141695			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544609	Green Published, Green Submitted, gold			2022-12-27	WOS:000364398700039
J	Wolf, C; Pauly, A; Mayr, A; Gromer, T; Lenz, B; Kornhuber, J; Friedland, K				Wolf, Carolin; Pauly, Anne; Mayr, Andreas; Groemer, Teja; Lenz, Bernd; Kornhuber, Johannes; Friedland, Kristina			Pharmacist-Led Medication Reviews to Identify and Collaboratively Resolve Drug-Related Problems in Psychiatry - A Controlled, Clinical Trial	PLOS ONE			English	Article							APPROPRIATENESS INDEX; ERRORS; INTERVENTION; EVENTS; CARE; IDENTIFICATION; CLASSIFICATION; DOCUMENTATION; HOSPITALS; OUTCOMES	Aim of the study This prospective, controlled trial aimed to assess the effect of pharmacist-led medication reviews on the medication safety of psychiatric inpatients by the resolution of Drug-Related Problems (DRP). Both the therapy appropriateness measured with the Medication Appropriateness Index (MAI) and the number of unsolved DRP per patient were chosen as primary outcome measures. Methods Depending on their time of admission, 269 psychiatric patients that were admitted to a psychiatric university hospital were allocated in control (09/2012-03/2013) or intervention group (05/2013-12/2013). In both groups, DRP were identified by comprehensive medication reviews by clinical pharmacists at admission, during the hospital stay, and at discharge. In the intervention group, recommendations for identified DRP were compiled by the pharmacists and discussed with the therapeutic team. In the control group, recommendations were not provided except for serious or life threatening DRP. As a primary outcome measure, the changes in therapy appropriateness from admission to discharge as well as from admission to three months after discharge (follow-up) assessed with the MAI were compared between both groups. The second primary outcome was the number of unsolved DRP per patient after completing the study protocol. The DRP type, the relevance and the potential of drugs to cause DRP were also evaluated. Results The intervention led to a reduced MAI score by 1.4 points per patient (95% confidence interval [CI]: 0.8-2.0) at discharge and 1.3 points (95% CI: 0.7-1.9) at follow-up compared with controls. The number of unsolved DRP in the intervention group was 1.8 (95% CI: 1.5-2.1) less than in control. Conclusion The pharmaceutical medication reviews with interdisciplinary discussion of identified DRP appears to be a worthy strategy to improve medication safety in psychiatry as reflected by less unsolved DRP per patient and an enhanced appropriateness of therapy. The promising results of this trial likely warrant further research that evaluates direct clinical outcomes and health-related costs.	[Wolf, Carolin; Pauly, Anne; Friedland, Kristina] Univ Erlangen Nurnberg, Mol & Clin Pharm, D-91054 Erlangen, Germany; [Mayr, Andreas] Univ Erlangen Nurnberg, Dept Med Informat Biometry & Epidemiol, D-91054 Erlangen, Germany; [Groemer, Teja; Lenz, Bernd; Kornhuber, Johannes] Univ Erlangen Nurnberg, Dept Psychiat & Psychotherapy, D-91054 Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Friedland, K (corresponding author), Univ Erlangen Nurnberg, Mol & Clin Pharm, D-91054 Erlangen, Germany.	Kristina.leuner@fau.de	Kornhuber, Johannes/B-9613-2014; Friedland, Kristina/G-4651-2015	Kornhuber, Johannes/0000-0002-8096-3987; Mayr, Andreas/0000-0001-7106-9732; Friedland, Kristina/0000-0001-8603-5957; Lenz, Bernd/0000-0001-6086-0924	Forederinitiative Pharmazeutische Betreuung e.v	Forederinitiative Pharmazeutische Betreuung e.v	This work was supported by Forederinitiative Pharmazeutische Betreuung e.v, http://www.foerderinitiative.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderman CP, 1997, J CLIN PHARM THER, V22, P27, DOI 10.1046/j.1365-2710.1997.95975959.x; BATES DW, 1995, J GEN INTERN MED, V10, P199, DOI 10.1007/BF02600255; BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; Bondesson A, 2013, EUR J CLIN PHARMACOL, V69, P647, DOI 10.1007/s00228-012-1368-5; Brownlie K, 2014, INT J CLIN PHARM-NET, V36, P303, DOI 10.1007/s11096-013-9875-8; Burnett KM, 2009, AM J HEALTH-SYST PH, V66, P854, DOI 10.2146/ajhp080176; Campbell AR, 2011, AM J PHARM EDUC, V75; Dolder C, 2008, AM J HEALTH-SYST PH, V65, P1795, DOI 10.2146/ajhp060448; Fick DM, 2001, POTENTIALLY INAPPROP, V7; GANSO M, 2007, KRANKENHAUSPHARMAZIE, V28, P273; GANSO M, 2009, KRANKENHAUSPHARMAZIE, V30, P349; Gill-Banham S, 2003, PSYCHIAT B, V27, P208; Gillespie U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062401; Gillespie U, 2009, ARCH INTERN MED, V169, P894, DOI 10.1001/archinternmed.2009.71; Graabaek T, 2013, BASIC CLIN PHARMACOL, V112, P359, DOI 10.1111/bcpt.12062; Grasso B, 2007, J PHARM FINANC EC PO, V15, P73, DOI [10.1300/J371v15n0404, DOI 10.1300/J371V15N04_04]; Grasso BC, 2003, PSYCHIAT SERV, V54, P677, DOI 10.1176/appi.ps.54.5.677; Hanlon JT, 1996, AM J MED, V100, P428, DOI 10.1016/S0002-9343(97)89519-8; HANLON JT, 1992, J CLIN EPIDEMIOL, V45, P1045, DOI 10.1016/0895-4356(92)90144-C; Haynes RB, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000011.pub3; Hellstrom LM, 2011, EUR J CLIN PHARMACOL, V67, P741, DOI 10.1007/s00228-010-0982-3; Ito H, 2003, INT J QUAL HEALTH C, V15, P207, DOI 10.1093/intqhc/mzg038; Keers RN, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006084; Krahenbuhl-Melcher A, 2007, DRUG SAFETY, V30, P379; KUNKEL M, 2009, KRANKENHAUSPHARMAZIE, V30, P156; Mann K, 2008, WORLD J BIOL PSYCHIA, V9, P24, DOI 10.1080/15622970601178056; Muller F, 2014, EUR J CLIN PHARMACOL, V70, P727, DOI 10.1007/s00228-014-1665-2; National Coordinating Council for Medication Error Reporting and Prevention, WHAT IS MED ERR; Pharmaceutical Care Network Europe Foundation, PCNE CLASS V 6 2; Post TW, UPTODATE; Preston, STOCKLEYS DRUG INTER; Procyshyn RM, 2010, CNS DRUGS, V24, P595, DOI 10.2165/11533710-000000000-00000; Rothschild JM, 2007, GEN HOSP PSYCHIAT, V29, P156, DOI 10.1016/j.genhosppsych.2006.12.002; SAMSA GP, 1994, J CLIN EPIDEMIOL, V47, P891, DOI 10.1016/0895-4356(94)90192-9; Schaefer M, 2002, PHARM WORLD SCI, V24, P120, DOI 10.1023/A:1019543029936; SCHMADER K, 1994, J AM GERIATR SOC, V42, P1241; Schmader KE, 1997, ANN PHARMACOTHER, V31, P529, DOI 10.1177/106002809703100501; Senst BL, 2001, AM J HEALTH-SYST PH, V58, P1126, DOI 10.1093/ajhp/58.12.1126; Soerensen AL, 2013, RISK MANAG HEALTHC P, V6, P23, DOI 10.2147/RMHP.S47723; Spinewine A, 2006, J AM GERIATR SOC, V54, P720, DOI 10.1111/j.1532-5415.2006.00668_8.x; Spinewine A, 2007, J AM GERIATR SOC, V55, P658, DOI 10.1111/j.1532-5415.2007.01132.x; Stubbs J, 2004, HOSP PHARM, V11, P203; [Task Force on Patient Safety American Psychiatric Association], 2003, REC APA BOARD TRUST; van den Bemt PMLA, 2000, DRUG SAFETY, V22, P321, DOI 10.2165/00002018-200022040-00005; Viktil KK, 2008, BASIC CLIN PHARMACOL, V102, P275, DOI 10.1111/j.1742-7843.2007.00206.x; Viktil KK, 2006, PHARMACOEPIDEM DR S, V15, P667, DOI 10.1002/pds.1238	46	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142011	10.1371/journal.pone.0142011	http://dx.doi.org/10.1371/journal.pone.0142011			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV6RT	26544202	Green Submitted, Green Published, gold			2022-12-27	WOS:000364398700070
J	Zhang, CC; Wu, XJ; Lin, SB; Jia, ZX; Cao, J				Zhang, Congcong; Wu, Xinjuan; Lin, Songbai; Jia, Zhaoxia; Cao, Jing			Evaluation of Reliability and Validity of the Hendrich II Fall Risk Model in a Chinese Hospital Population	PLoS One			English	Article							STRATIFY; TOOL	To translate, validate and examine the reliability and validity of a Chinese version of the Hendrich II Fall risk Model (HFRM) in predicting falls in elderly inpatient. A sample of 989 Chinese elderly inpatients was recruited upon admission at the Peking Union Medical College Hospital. The inpatients were assessed for fall risk using the Chinese version of the HFRM at admission. The reliability of the Chinese version of the HFRM was determined using the internal consistency and test-rested methods. Validity was determined using construct validity and convergent validity. Receiver operating characteristic (ROC) curves were created to determine the sensitivity and specificity. The Chinese version of the HFRM showed excellent repeatability with an intra-class correlation coefficient (ICC) of 0.9950 (95% confidence interval (CI): 0.9923-0.9984). The inter-rater reliability was high with an ICC of 0.9950 (95% CI: 0.9923-0.9984). Cronbach's alpha coefficient was 0.366. Content validity was excellent, with a content validity ratio of 0.9333. The Chinese version of the HFRM had a sensitivity of 72% and a specificity of 69% when using a cut-off of 5 points on the scale. The area under the curve (AUC) was 0.815 (P< 0.001). The Chinese version of the HFRM showed good reliability and validity in assessing the risk of fall in Chinese elderly inpatients.	[Zhang, Congcong; Lin, Songbai] Beijing Union Med Coll Hosp, Int Med Serv, Beijing 100730, Peoples R China; [Wu, Xinjuan; Cao, Jing] Beijing Union Med Coll Hosp, Dept Nursing, Beijing 100730, Peoples R China; [Jia, Zhaoxia] Capital Med Univ, Beijing Maternal & Child Hlth Care Hosp, Beijing Obstet & Gynecol Hosp, Beijing 100026, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Capital Medical University	Wu, XJ (corresponding author), Beijing Union Med Coll Hosp, Dept Nursing, Beijing 100730, Peoples R China.	wuxinjuan@pumch.cn						Anderson C, 2015, CLIN NURS RES, V24, P269, DOI 10.1177/1054773814530758; Aranda-Gallardo M, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-122; Caldevilla MN, 2013, SCAND J CARING SCI, V27, P468, DOI 10.1111/j.1471-6712.2012.01031.x; Cigolle CT, 2015, JAMA INTERN MED, V175, P443, DOI 10.1001/jamainternmed.2014.7533; Cumbler EU, 2013, NEUROHOSPITALIST, V3, P203, DOI 10.1177/1941874412470666; Hendrich AL, 2003, APPL NURS RES, V16, P9, DOI 10.1053/apnr.2003.YAPNR2; Hendrich A, 2007, AM J NURS, V107, P50, DOI 10.1097/01.NAJ.0000298062.27349.8e; Ivziku D, 2011, INT J NURS STUD, V48, P468, DOI 10.1016/j.ijnurstu.2010.09.002; Kannus P, 2005, LANCET, V366, P1885, DOI 10.1016/S0140-6736(05)67604-0; Kim EAN, 2007, J ADV NURS, V60, P427, DOI 10.1111/j.1365-2648.2007.04419.x; Matarese M, 2015, J ADV NURS, V71, P1198, DOI 10.1111/jan.12542; Nassar N, 2014, J CLIN NURS, V23, P1620, DOI 10.1111/jocn.12278; Oliver D, 1997, BMJ-BRIT MED J, V315, P1049, DOI 10.1136/bmj.315.7115.1049; Oliver D, 2008, AGE AGEING, V37, P621, DOI 10.1093/ageing/afn203; Swartzell Kristen L, 2013, Medsurg Nurs, V22, P180; Thurman DJ, 2008, NEUROLOGY, V70, P473, DOI 10.1212/01.wnl.0000299085.18976.20	16	8	8	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142395	10.1371/journal.pone.0142395	http://dx.doi.org/10.1371/journal.pone.0142395			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV6RT	26544961	Green Published, gold, Green Submitted			2022-12-27	WOS:000364398700130
J	Avila-Rios, S; Garcia-Morales, C; Tapia-Trejo, D; Meza, RI; Nunez, SM; Parham, L; Flores, NA; Valladares, D; Pineda, LM; Flores, D; Motino, R; Umanzor, V; Carbajal, C; Murillo, W; Lorenzana, I; Palou, EY; Reyes-Teran, G				Avila-Rios, Santiago; Garcia-Morales, Claudia; Tapia-Trejo, Daniela; Meza, Rita I.; Nunez, Sandra M.; Parham, Leda; Flores, Norma A.; Valladares, Diana; Pineda, Luisa M.; Flores, Dixiana; Motino, Roxana; Umanzor, Victor; Carbajal, Candy; Murillo, Wendy; Lorenzana, Ivette; Palou, Elsa Y.; Reyes-Teran, Gustavo			HIV Drug Resistance Surveillance in Honduras after a Decade of Widespread Antiretroviral Therapy	PLOS ONE			English	Article							MUTATIONS; EPIDEMIOLOGY; TRANSMISSION; INDIVIDUALS	Introduction We assessed HIV drug resistance (DR) in individuals failing ART (acquired DR, ADR) and in ART-naive individuals (pre-ART DR, PDR) in Honduras, after 10 years of widespread availability of ART. Methods 365 HIV-infected, ART-naive, and 381 ART-experienced Honduran individuals were enrolled in 5 reference centres in Tegucigalpa, San Pedro Sula, La Ceiba, and Choluteca between April 2013 and April 2015. Plasma HIV protease-RT sequences were obtained. HIVDR was assessed using the WHO HIVDR mutation list and the Stanford algorithm. Recently infected (RI) individuals were identified using a multi-assay algorithm. Results PDR to any ARV drug was 11.5%(95% CI 8.4-15.2%). NNRTI PDR prevalence (8.2%) was higher than NRTI (2.2%) and PI (1.9%, p < 0.0001). No significant trends in time were observed when comparing 2013 and 2014, when using a moving average approach along the study period or when comparing individuals with > 500 vs. < 350 CD4+ T cells/mu L. PDR in recently infected individuals was 13.6%, showing no significant difference with PDR in individuals with longstanding infection (10.7%). The most prevalent PDR mutations were M46IL (1.4%), T215 revertants (0.5%), and K103NS (5.5%). The overall ADR prevalence in individuals with < 48 months on ART was 87.8% and for the >= 48 months on ART group 81.3%. ADR to three drug families increased in individuals with longer time on ART (p = 0.0343). M184V and K103N were the most frequent ADR mutations. PDR mutation frequency correlated with ADR mutation frequency for PI and NNRTI (p < 0.01), but not for NRTI. Clusters of viruses were observed suggesting transmission of HIVDR both from ART-experienced to ART-naive individuals and between ART-naive individuals. Conclusions The global PDR prevalence in Honduras remains at the intermediate level, after 10 years of widespread availability of ART. Evidence of ADR influencing the presence of PDR was observed by phylogenetic analyses and ADR/PDR mutation frequency correlations.	[Avila-Rios, Santiago; Garcia-Morales, Claudia; Tapia-Trejo, Daniela; Reyes-Teran, Gustavo] Natl Inst Resp Dis, Ctr Res Infect Dis, Mexico City, DF, Mexico; [Meza, Rita I.; Nunez, Sandra M.; Parham, Leda] Honduran Minist Hlth, HIV Natl Programme, Tegucigalpa, Honduras; [Meza, Rita I.; Nunez, Sandra M.; Parham, Leda] Honduran Minist Hlth, HIV Natl Lab, Tegucigalpa, Honduras; [Flores, Norma A.] Inst Nacl Cardio Pulm, Tegucigalpa, Honduras; [Valladares, Diana; Pineda, Luisa M.] Hosp Mario Catarino Rivas, San Pedro Sula, Honduras; [Flores, Dixiana; Motino, Roxana] Unidad Salud Metropolitana, Le Ceiba, Honduras; [Umanzor, Victor] Hosp Sur, Choluteca, Honduras; [Carbajal, Candy; Murillo, Wendy; Lorenzana, Ivette; Palou, Elsa Y.] Univ Nacl Autonoma Honduras, Tegucigalpa, Honduras; [Palou, Elsa Y.] Hosp Escuela Univ, Tegucigalpa, Honduras	Universidad Nacional Autonoma de Honduras	Lorenzana, I (corresponding author), Univ Nacl Autonoma Honduras, Tegucigalpa, Honduras.	ivettelorenzana@yahoo.com; palouey@yahoo.com.mx; gustavo.reyesteran@gmail.com	Avila-Rios, Santiago/AAB-4383-2020	Murillo, Wendy/0000-0002-8326-7223; Reyes-Teran, Gustavo/0000-0002-4115-4888; Lorenzana, Ivette/0000-0002-8128-8602	Mexican Government (Comision de Equidad y Genero de las Legislaturas LX-LXI y Comision de Igualdad de Genero de la Legislatura LXII de la H. Camara de Diputados de la Republica Mexicana); CONACYT [SALUD-2013-01-202475]	Mexican Government (Comision de Equidad y Genero de las Legislaturas LX-LXI y Comision de Igualdad de Genero de la Legislatura LXII de la H. Camara de Diputados de la Republica Mexicana); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by grants from the Mexican Government (Comision de Equidad y Genero de las Legislaturas LX-LXI y Comision de Igualdad de Genero de la Legislatura LXII de la H. Camara de Diputados de la Republica Mexicana), and CONACYT (SALUD-2013-01-202475). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], STANF HIV DRUG RES D; [Anonymous], RIP TOOL; [Anonymous], REGA HIV SUBT TOOL V; Avila-Rios S, 2015, AIDS RES HUM RETROV, V31, P401, DOI 10.1089/aid.2014.0057; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Frentz D, 2012, AIDS REV, V14, P17; Jain V, 2011, J INFECT DIS, V203, P1174, DOI 10.1093/infdis/jiq167; Laeyendecker O, 2013, J INFECT DIS, V207, P232, DOI 10.1093/infdis/jis659; Liu TF, 2006, CLIN INFECT DIS, V42, P1608, DOI 10.1086/503914; Lloyd B, 2008, AIDS RES HUM RETROV, V24, P529, DOI 10.1089/aid.2007.0172; Mourad R, 2015, AIDS, V29, P1917, DOI 10.1097/QAD.0000000000000768; Murillo W, 2010, HIV MED, V11, P95, DOI 10.1111/j.1468-1293.2009.00747.x; Murillo W, 2010, J CLIN VIROL, V49, P239, DOI 10.1016/j.jcv.2010.03.013; ONUSIDA, ONUSIDA HOND; Pineda-Pena AC, 2012, AIDS REV, V14, P256; Rhee SY, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001810; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P298, DOI 10.1093/nar/gkg100; Shafer RW, 2006, J INFECT DIS, V194, pS51, DOI 10.1086/505356; Strathdee SA, 2012, ANN EPIDEMIOL, V22, P426, DOI 10.1016/j.annepidem.2012.04.002; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; UNAIDS, 2014, 2014 PROGR REP SUBM; UNAIDS, UNAIDS GAP REP 2014; UNAIDS, UNAIDS HOND; UNDP, 2015, UN DEV PROGR REP; WHO, SURV HIV DRUG RES AD; WHO, WHO HIV DRUG RES STR; World Health Organization, WHO HIV DRUG RES REP; Yang WL, 2015, J INFECT DIS, V212, P28, DOI 10.1093/infdis/jiv012	28	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142604	10.1371/journal.pone.0142604	http://dx.doi.org/10.1371/journal.pone.0142604			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26558396	gold, Green Published, Green Submitted			2022-12-27	WOS:000364433100098
J	Lai, SH; Liao, SL; Yao, TC; Tsai, MH; Hua, MC; Yeh, KW; Huang, JL				Lai, Shen-Hao; Liao, Sui-Ling; Yao, Tsung-Chieh; Tsai, Ming-Han; Hua, Man-Chin; Yeh, Kuo-Wei; Huang, Jing-Long			Respiratory Function in Healthy Taiwanese Infants: Tidal Breathing Analysis, Passive Mechanics, and Tidal Forced Expiration	PLOS ONE			English	Article							LUNG-FUNCTION; AIRWAY FUNCTION; CHILDREN; FLOW; BIRTH; ETHNICITY; GENDER; GROWTH; AGE	Background Although infant lung function (ILF) testing is widely practiced in developed Western countries it is not typically performed in Eastern countries, and lung measurements are scarce for Asian infants. Therefore, this study aimed to establish normal reference values for Taiwanese infants. Materials and Methods Full-term infants without any chronic diseases and major anomalies were enrolled in the Prediction of Allergies in Taiwanese Children (PATCH) cohort study. Detailed medical data, such as body weight and length, birth history, and histories of previous illness and hospitalization were recorded. Lung function measurements such as analysis of tidal breathing, passive respiratory mechanics, and forced tidal expiratory flow-volume curves were obtained through Jaeger Masterscreen BabyBody Paediatrics System. Multiple linear analyses were performed to determine various parameters of the lung function tests. Results ILF test parameters were collected from 126 infants, and 189 tests were performed. The results revealed that the ratio of time to peak expiratory flow to total expiratory time, the ratio of volume to peak expiratory flow to total expiratory volume, and the ratio of inspiratory time to total respiratory time remained relatively constant despite differences in age. However, body length is the strongest independent variable influencing tidal volume, respiratory rate, resistance, compliance, and maximal expiratory flow at functional residual capacity. Conclusion According to our review of relevant literature, this is the first study to establish a reference data of ILF tests in the Asian population. This study provided reference values and regression equations for several variables of lung function measurements in healthy infants aged less than 2 years. With these race-specific reference data, ILF can more precisely and efficiently diagnose respiratory diseases in infants of Chinese ethnicity.	[Lai, Shen-Hao; Yao, Tsung-Chieh; Yeh, Kuo-Wei; Huang, Jing-Long] Chang Gung Univ, Chang Gung Mem Hosp, Dept Pediat, Taoyuan, Taiwan; [Lai, Shen-Hao; Liao, Sui-Ling; Yao, Tsung-Chieh; Tsai, Ming-Han; Hua, Man-Chin; Yeh, Kuo-Wei; Huang, Jing-Long] Chang Gung Univ, Dept Pediat, Taoyuan, Taiwan; [Liao, Sui-Ling; Tsai, Ming-Han; Hua, Man-Chin] Chang Gung Mem Hosp, Dept Pediat, Keelung, Taiwan; [Liao, Sui-Ling; Tsai, Ming-Han; Hua, Man-Chin] Chang Gung Univ, Keelung, Taiwan; [Lai, Shen-Hao; Liao, Sui-Ling; Yao, Tsung-Chieh; Tsai, Ming-Han; Hua, Man-Chin; Yeh, Kuo-Wei; Huang, Jing-Long] Predict Allergies Taiwanese Children PATCH Cohort, Keelung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Huang, JL (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Dept Pediat, Taoyuan, Taiwan.	hjlong0182@gmail.com	Yeh, Kuo-Wei/V-3725-2019	Huang, Jing-Long/0000-0001-9280-920X; Huang, Jing-Long/0000-0002-3530-7753	Chang Gung Medical Hospital [CMRPG2B0061, CMRPG2B0062, CMRPG2B0063, CMRPG3E1211]	Chang Gung Medical Hospital	This work was supported by Chang Gung Medical Hospital (CMRPG2B0061, CMRPG2B0062, CMRPG2B0063, and CMRPG3E1211).	American Thoracic Society, 2005, Am J Respir Crit Care Med, V172, P1463; Baraldi E, 2007, NEW ENGL J MED, V357, P1946, DOI 10.1056/NEJMra067279; Bates JHT, 2000, EUR RESPIR J, V16, P1180, DOI 10.1034/j.1399-3003.2000.16f26.x; Carlsen KCL, 1997, PEDIATR PULM, V24, P391, DOI 10.1002/(SICI)1099-0496(199712)24:6<391::AID-PPUL3>3.0.CO;2-K; CARLSEN KCL, 1994, EUR RESPIR J, V7, P1660, DOI 10.1183/09031936.94.07091660; CARLSEN KH, 1994, EUR RESPIR J, V7, P2154, DOI 10.1183/09031936.94.07122154; Cazzato S, 2013, PEDIATR PULM, V48, P830, DOI 10.1002/ppul.22676; Chavasse RJ, 2001, EUR RESPIR J, V18, P330, DOI 10.1183/09031936.01.00018401; Chen W, 2010, PEDIATR NEONATOL, V51, P69, DOI 10.1016/S1875-9572(10)60014-9; Colin AA, 2001, AM J RESP CRIT CARE, V163, P865, DOI 10.1164/ajrccm.163.4.9901040; Davis SD, 2010, AM J RESP CRIT CARE, V182, P1387, DOI 10.1164/rccm.200908-1236OC; Dezateux C, 2001, THORAX, V56, P680, DOI 10.1136/thorax.56.9.680; Ducharme FM, 2014, LANCET, V383, P1593, DOI 10.1016/S0140-6736(14)60615-2; Frey U, 2000, EUR RESPIR J, V16, P731, DOI 10.1034/j.1399-3003.2000.16d28.x; Frey U, 2001, J APPL PHYSIOL, V91, P1687, DOI 10.1152/jappl.2001.91.4.1687; Gappa M, 2001, EUR RESPIR J, V17, P141, DOI 10.1183/09031936.01.17101410; Hanrahan JP, 1996, AM J RESP CRIT CARE, V154, P670, DOI 10.1164/ajrccm.154.3.8810604; HANRAHAN JP, 1990, AM REV RESPIR DIS, V141, P1127, DOI 10.1164/ajrccm/141.5_Pt_1.1127; HATCH D, 1992, BRIT J ANAESTH, V68, P398, DOI 10.1093/bja/68.4.398; Hegde S, 2013, PEDIATR PULM, V48, P1148, DOI 10.1002/ppul.22799; Henschen M, 1999, AM J RESP CRIT CARE, V159, P480, DOI 10.1164/ajrccm.159.2.9801083; Hoo AF, 1998, AM J RESP CRIT CARE, V158, P700, DOI 10.1164/ajrccm.158.3.9711057; Hoo AF, 2002, AM J RESP CRIT CARE, V165, P1084, DOI 10.1164/ajrccm.165.8.2103035; Hoo AF, 2014, PEDIATR PULM, V49, P679, DOI 10.1002/ppul.22882; Katier N, 2006, PEDIATR PULM, V41, P1058, DOI 10.1002/ppul.20492; Liao SL, 2014, PEDIAT ALLERG IMM-UK, V25, P456, DOI 10.1111/pai.12247; Liao SL, 2013, EARLY HUM DEV, V89, P473, DOI 10.1016/j.earlhumdev.2013.03.013; Lum S, 2010, EUR RESPIR MONOGR, P46, DOI 10.1183/1025448x.00020909; Lum S, 2010, PEDIATR PULM, V45, P906, DOI 10.1002/ppul.21255; MASTERS IB, 1987, PEDIATR PULM, V3, P3, DOI 10.1002/ppul.1950030104; Shih SF, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-67; Sly PD, 2000, EUR RESPIR J, V16, P741, DOI 10.1034/j.1399-3003.2000.16d29.x; STOCKS J, 1994, AM J RESP CRIT CARE, V150, P1347, DOI 10.1164/ajrccm.150.5.7952563; Stocks J, 1997, AM J RESP CRIT CARE, V156, P1855, DOI 10.1164/ajrccm.156.6.9607056; Nguyen TTD, 2013, PEDIATR PULM, V48, P370, DOI 10.1002/ppul.22656; vanderEnt CK, 1996, AM J RESP CRIT CARE, V153, P1253, DOI 10.1164/ajrccm.153.4.8616550; Vilozni D, 2011, CHEST, V139, P1439, DOI 10.1378/chest.10-0625; Yao TC, 2014, J PEDIATR-US, V165, P1098, DOI 10.1016/j.jpeds.2014.08.048	38	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142797	10.1371/journal.pone.0142797	http://dx.doi.org/10.1371/journal.pone.0142797			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559673	Green Published, gold, Green Submitted			2022-12-27	WOS:000364433100126
J	Nakae, S; Sasaki, H; Hayashi, S; Hattori, N; Kumon, M; Nishiyama, Y; Adachi, K; Nagahisa, S; Hayashi, T; Inamasu, J; Abe, M; Hasegawa, M; Hirose, Y				Nakae, Shunsuke; Sasaki, Hikaru; Hayashi, Saeko; Hattori, Natsuki; Kumon, Masanobu; Nishiyama, Yuya; Adachi, Kazuhide; Nagahisa, Shinya; Hayashi, Takuro; Inamasu, Joji; Abe, Masato; Hasegawa, Mitsuhiro; Hirose, Yuichi			PCR-Based Simple Subgrouping Is Validated for Classification of Gliomas and Defines Negative Prognostic Copy Number Aberrations in IDH Mutant Gliomas	PLOS ONE			English	Article							TP53 MUTATIONS; SURVIVAL; OLIGODENDROGLIOMAS; MARKERS; 19Q	Genetic subgrouping of gliomas has been emphasized recently, particularly after the finding of isocitrate dehydrogenase 1 (IDH1) mutations. In a previous study, we investigated whole-chromosome copy number aberrations (CNAs) of gliomas and have described genetic subgrouping based on CNAs and IDH1 mutations. Subsequently, we classified gliomas using simple polymerase chain reaction (PCR)-based methods to improve the availability of genetic subgrouping. We selected IDH1/2 and TP53 as markers and analyzed 237 adult supratentorial gliomas using Sanger sequencing. Using these markers, we classified gliomas into three subgroups that were strongly associated with patient prognoses. These included IDH mutant gliomas without TP53 mutations, IDH mutant gliomas with TP53 mutations, and IDH wild-type gliomas. IDH mutant gliomas without TP53 mutations, which mostly corresponded to gliomas carrying 1p19q co-deletions, showed lower recurrence rates than the other 2 groups. In the other high-recurrence groups, the median progression- free survival (PFS) and overall survival (OS) of patients with IDH mutant gliomas with TP53 mutations were significantly longer than those of patients with IDH wild-type gliomas. Notably, most IDH mutant gliomas with TP53 mutations had at least one of the CNAs +7q, +8q, -9p, and -11p. Moreover, IDH mutant gliomas with at least one of these CNAs had a significantly worse prognosis than did other IDH mutant gliomas. PCR-based mutation analyses of IDH and TP53 were sufficient for simple genetic diagnosis of glioma that were strongly associated with prognosis of patients and enabled us to detect negative CNAs in IDH mutant gliomas.	[Nakae, Shunsuke; Hattori, Natsuki; Kumon, Masanobu; Nishiyama, Yuya; Adachi, Kazuhide; Nagahisa, Shinya; Hayashi, Takuro; Inamasu, Joji; Hasegawa, Mitsuhiro; Hirose, Yuichi] Fujita Hlth Univ, Dept Neurosurg, Toyoake, Aichi, Japan; [Sasaki, Hikaru; Hayashi, Saeko] Keio Univ, Dept Neurosurg, Tokyo, Japan; [Abe, Masato] Fujita Hlth Univ, Dept Pathol, Toyoake, Aichi, Japan	Fujita Health University; Keio University; Fujita Health University	Hirose, Y (corresponding author), Fujita Hlth Univ, Dept Neurosurg, Toyoake, Aichi, Japan.	yhirose@fujita-hu.ac.jp	Inamasu, Joji/R-7314-2019; Hirose, Yuichi/P-1731-2019	Hirose, Yuichi/0000-0002-1305-1830; ADACHI, KAZUHIDE/0000-0002-5275-8572; nishiyama, yuya/0000-0001-9715-6607	Grants-in-Aid for Scientific Research [25462278] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Alentorn A, 2014, NEURO-ONCOLOGY, V16, P400, DOI 10.1093/neuonc/not227; Cairncross JG, 1998, J NATL CANCER I, V90, P1473, DOI 10.1093/jnci/90.19.1473; de Carcer G, 2014, NAT CELL BIOL, V16, P504, DOI 10.1038/ncb2978; Hartmann C, 2013, CLIN CANCER RES, V19, P5146, DOI 10.1158/1078-0432.CCR-13-0017; Hirose Y, 2013, BRAIN TUMOR PATHOL, V30, P203, DOI 10.1007/s10014-013-0148-y; Hirose Y, 2011, NEUROSURGERY, V69, P376, DOI 10.1227/NEU.0b013e318212bcd8; Holstege H, 2009, CANCER RES, V69, P3625, DOI 10.1158/0008-5472.CAN-08-3426; Huse JT, 2014, CLIN CANCER RES, V20, P5601, DOI 10.1158/1078-0432.CCR-14-0831; Jiao YC, 2012, ONCOTARGET, V3, P709, DOI 10.18632/oncotarget.588; Killela PJ, 2014, ONCOTARGET, V5, P1515, DOI 10.18632/oncotarget.1765; Kitange G, 2005, GENE CHROMOSOME CANC, V42, P68, DOI 10.1002/gcc.20108; Koga Y, 2009, JPN J CLIN ONCOL, V39, P62, DOI 10.1093/jjco/hyn129; Leroy B, 2014, HUM MUTAT, V35, P672, DOI 10.1002/humu.22552; McLendon RE, 2005, CANCER, V104, P1693, DOI 10.1002/cncr.21362; Nam HJ, 2014, NAT CELL BIOL, V16, P535, DOI 10.1038/ncb2952; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Shatz M, 2012, CANCER RES, V72, P3948, DOI 10.1158/0008-5472.CAN-11-4134; Solis OE, 2011, J NEURO-ONCOL, V102, P477, DOI 10.1007/s11060-010-0335-1; Trost D, 2007, INT J CANCER, V120, P2368, DOI 10.1002/ijc.22574; Ueki K, 2002, CLIN CANCER RES, V8, P196; van Thuijl HF, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0471-6; Vegran F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055103; Walker DR, 1999, ONCOGENE, V18, P211, DOI 10.1038/sj.onc.1202298; Watanabe T, 2009, AM J PATHOL, V174, P1149, DOI 10.2353/ajpath.2009.080958; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yip S, 2012, J PATHOL, V226, P7, DOI 10.1002/path.2995	26	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142750	10.1371/journal.pone.0142750	http://dx.doi.org/10.1371/journal.pone.0142750			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26558387	gold, Green Published, Green Submitted			2022-12-27	WOS:000364433100118
J	Saokaew, S; Sugimoto, T; Kamae, I; Pratoomsoot, C; Chaiyakunapruk, N				Saokaew, Surasak; Sugimoto, Takashi; Kamae, Isao; Pratoomsoot, Chayanin; Chaiyakunapruk, Nathorn			Healthcare Databases in Thailand and Japan: Potential Sources for Health Technology Assessment Research	PLOS ONE			English	Article							SOUTH-KOREA; PHARMACOECONOMICS; TAIWAN	Background Health technology assessment (HTA) has been continuously used for value-based health-care decisions over the last decade. Healthcare databases represent an important source of information for HTA, which has seen a surge in use in Western countries. Although HTA agencies have been established in Asia-Pacific region, application and understanding of healthcare databases for HTA is rather limited. Thus, we reviewed existing databases to assess their potential for HTA in Thailand where HTA has been used officially and Japan where HTA is going to be officially introduced. Method Existing healthcare databases in Thailand and Japan were compiled and reviewed. Databases' characteristics e.g. name of database, host, scope/objective, time/sample size, design, data collection method, population/sample, and variables were described. Databases were assessed for its potential HTA use in terms of safety/efficacy/effectiveness, social/ethical, organization/professional, economic, and epidemiological domains. Request route for each database was also provided. Results Forty databases-20 from Thailand and 20 from Japan-were included. These comprised of national censuses, surveys, registries, administrative data, and claimed databases. All databases were potentially used for epidemiological studies. In addition, data on mortality, morbidity, disability, adverse events, quality of life, service/technology utilization, length of stay, and economics were also found in some databases. However, access to patientlevel data was limited since information about the databases was not available on public sources. Conclusion Our findings have shown that existing databases provided valuable information for HTA research with limitation on accessibility. Mutual dialogue on healthcare database development and usage for HTA among Asia-Pacific region is needed.	[Saokaew, Surasak] Univ Phayao, Sch Pharmaceut Sci, Ctr Hlth Outcomes Res & Therapeut Safety Cohorts, Phayao, Thailand; [Saokaew, Surasak; Kamae, Isao] Canon Inst Global Studies, Tokyo, Japan; [Saokaew, Surasak; Sugimoto, Takashi; Kamae, Isao] Univ Tokyo, Grad Sch Publ Policy, Tokyo, Japan; [Saokaew, Surasak; Kamae, Isao] Meiji Univ, Meiji Inst Global Affairs, Tokyo 101, Japan; [Saokaew, Surasak; Chaiyakunapruk, Nathorn] Naresuan Univ, Fac Pharmaceut Sci, CPOR, Phitsanulok, Thailand; [Pratoomsoot, Chayanin] Naresuan Univ, Fac Publ Hlth, Phitsanulok, Thailand; [Chaiyakunapruk, Nathorn] Monash Univ, Sch Pharm, Selangor, Malaysia; [Chaiyakunapruk, Nathorn] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Chaiyakunapruk, Nathorn] Univ Wisconsin, Sch Pharm, Madison, WI 53706 USA	University of Phayao; University of Tokyo; Meiji University; Naresuan University; Naresuan University; Monash University; Monash University Sunway; University of Queensland; University of Wisconsin System; University of Wisconsin Madison	Chaiyakunapruk, N (corresponding author), Naresuan Univ, Fac Pharmaceut Sci, CPOR, Phitsanulok, Thailand.	nathorn.chaiyakunapruk@monash.edu	Saokaew, Surasak/AAI-9804-2021	Saokaew, Surasak/0000-0002-1382-0660; Pratoomsoot, Chayanin/0000-0002-1073-5145				Aljunid SM, 2012, VALUE HEALTH, V15, pS132, DOI 10.1016/j.jval.2011.11.004; Busse R, 2002, INT J TECHNOL ASSESS, V18, P361, DOI 10.1017/S0266462302000284; Campbell B, 2012, APPL HEALTH ECON HEA, V10, P295, DOI 10.2165/11640550-000000000-00000; Claxton K, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16460; Dalal AA, 2012, AM J MANAG CARE, V18; Dionne PA, 2012, PSYCHIAT SERV; Draborg E, 2005, INT J TECHNOL ASSESS, V21, P89, DOI 10.1017/S0266462305050117; Ganesh SAP Research Unit, 2013, HLTH TECHN ASS INF; Garrison LP, 2007, VALUE HEALTH, V10, P326, DOI 10.1111/j.1524-4733.2007.00186.x; Gliklich RE, 2020, REGISTRIES EVALUATIN, V4th, DOI 10.23970/AHRQEPCREGISTRIES4; Hadley J, 2010, JNCI-J NATL CANCER I, V102, P1780, DOI 10.1093/jnci/djq393; Hisashige A, 2009, INT J TECHNOL ASSESS, V25, P210, DOI 10.1017/S0266462309090655; Hunger M, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-1; Husereau D, 2010, INT J TECHNOL ASSESS, V26, P341, DOI 10.1017/S0266462310000383; Joe Caputo, 2012, ACCESSPOINT, V2, P40; Kamae I, 2010, PHARMACOECONOMICS, V28, P831, DOI 10.2165/11538360-000000000-00000; Kapol Nattiya, 2008, J Med Assoc Thai, V91 Suppl 2, pS8; Kimura M, 2011, METHOD INFORM MED, V50, P131, DOI 10.3414/ME10-01-0015; Medical Research Foundation, 2011, DAT ARCH MAX UT SYST; Raftery J, 2005, HEALTH TECHNOL ASSES, V9, pIII; SALAR (SAoLAaR), 2007, NAT HEALTHC QUAL REG; Saokaew S, 2011, DRUG SAFETY, V34, P339, DOI 10.2165/11586590-000000000-00000; Simon GE, 2000, AM J PSYCHIAT, V157, P1731, DOI 10.1176/appi.ajp.157.11.1731; Stevens AJ, 2005, INT J TECHNOL ASSESS, V21, P96, DOI 10.1017/S0266462305050129; Stukel TA, 2007, JAMA-J AM MED ASSOC, V297, P278, DOI 10.1001/jama.297.3.278; Teerawattananon Y, 2009, INT J TECHNOL ASSESS, V25, P241, DOI 10.1017/S0266462309090709; Warren K, 1993, ANN NY ACAD SCI, V703, P341; Yang BM, 2009, VALUE HEALTH, V12, pS1, DOI 10.1111/j.1524-4733.2009.00618.x; [No title captured], DOI DOI 10.1002/14651858.CD001270	29	25	25	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0141993	10.1371/journal.pone.0141993	http://dx.doi.org/10.1371/journal.pone.0141993			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26560127	gold, Green Published, Green Submitted			2022-12-27	WOS:000364433100049
J	Pajarinen, J; Lin, TH; Sato, TS; Loi, F; Yao, ZY; Konttinen, YT; Goodman, SB				Pajarinen, Jukka; Lin, Tzu-hua; Sato, Taishi; Loi, Florence; Yao, Zhenyu; Konttinen, Yrjo T.; Goodman, Stuart B.			Establishment of Green Fluorescent Protein and Firefly Luciferase Expressing Mouse Primary Macrophages for In Vivo Bioluminescence Imaging	PLoS One			English	Article							UHMWPE PARTICLES; CELLS; ACTIVATION; INFUSION; CANCER	Macrophages play a key role in tissue homeostasis as well as in a range of pathological conditions including atherosclerosis, cancer, and autoimmunity. Many aspects of their in vivo behavior are, however, poorly understood. Bioluminescence imaging (BLI) with green fluorescent protein (GFP) and firefly luciferase (FLUC) labelled autologous reporter macrophages could potentially offer a powerful tool to study macrophage biology, but this approach has been hindered by the relative difficulty of efficient gene transfer into primary macrophages. Here we describe a straightforward method for producing large numbers of GFP/FLUC expressing mouse primary macrophages utilizing lentivirus vector, cyclosporine, and a double infection strategy. Using this method we achieved up to 60% of macrophages to express GFP with correspondingly high FLUC signal. When injected into the circulation using a mouse model of local biomaterial induced inflammation and osteolysis, macrophages were initially detectable within the lungs, followed by systemic homing to the local area of chronic inflammation in the distal femur. In addition, transduced macrophages maintained their ability to assume M1 and M2 phenotypes although the GFP/FLUC expression was altered by the polarizing signals. These reporter macrophages could prove to be valuable tools to study the role of macrophages in health and disease.	[Pajarinen, Jukka; Lin, Tzu-hua; Sato, Taishi; Loi, Florence; Yao, Zhenyu; Goodman, Stuart B.] Stanford Univ, Orthopaed Res Labs, Dept Orthopaed Surg, Sch Med, Stanford, CA 94305 USA; [Konttinen, Yrjo T.] Univ Helsinki, Dept Med, Inst Clin Med, Helsinki, Finland	Stanford University; University of Helsinki	Goodman, SB (corresponding author), Stanford Univ, Orthopaed Res Labs, Dept Orthopaed Surg, Sch Med, Stanford, CA 94305 USA.	goodbone@stanford.edu	Goodman, Stuart/AAZ-7499-2020	Goodman, Stuart/0000-0002-1919-3717	National Institutes of Health [2R01 AR055650, 1R01AR063717]; Ellenburg Chair in Surgery in Stanford University; Jane and Aatos Erkko foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063717, R01AR055650] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellenburg Chair in Surgery in Stanford University; Jane and Aatos Erkko foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The study was supported by National Institutes of Health grants 2R01 AR055650 and 1R01AR063717 (SBG), the Ellenburg Chair in Surgery in Stanford University (SBG), and Jane and Aatos Erkko foundation (JP) (http://www.jaes.fi/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama Yutaka, TFSEARCH SEARCHING T; Brown BN, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00510; Cao YA, 2005, TRANSPLANTATION, V80, P134, DOI 10.1097/01.TP.0000164347.50559.A3; Cao YA, 2004, P NATL ACAD SCI USA, V101, P221, DOI 10.1073/pnas.2637010100; Creusot RJ, 2009, BLOOD, V113, P6638, DOI 10.1182/blood-2009-02-204321; Escolano A, 2014, EMBO J, V33, P1117, DOI 10.1002/embj.201386369; Gibon E, 2012, J ORTHOP RES, V30, P547, DOI 10.1002/jor.21548; Goodman SB, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0962; Hoffman RM, 2005, NAT REV CANCER, V5, P796, DOI 10.1038/nrc1717; Hoffman RM, 2015, LAB INVEST, V95, P432, DOI 10.1038/labinvest.2014.154; Kang YJ, 2007, J IMMUNOL, V179, P4598, DOI 10.4049/jimmunol.179.7.4598; Ma T, 2008, BIOMATERIALS, V29, P3738, DOI 10.1016/j.biomaterials.2008.05.031; Martinez FO, 2013, BLOOD, V121, pE57, DOI 10.1182/blood-2012-06-436212; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nich C, 2013, J BIOMED MATER RES A, V101, P3033, DOI 10.1002/jbm.a.34599; Noser JA, 2006, J VIROL, V80, P7769, DOI 10.1128/JVI.02427-05; Pajarinen J, 2014, J MATER CHEM B, V2, P7094, DOI [10.1039/C4TB01005A, 10.1039/c4tb01005a]; Ren PG, 2011, CLIN ORTHOP RELAT R, V469, P113, DOI 10.1007/s11999-010-1645-5; Ruffell D, 2009, P NATL ACAD SCI USA, V106, P17475, DOI 10.1073/pnas.0908641106; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Weischenfeldt J, 2008, CSH PROTOC; Zhang Xia, 2009, V531, P123, DOI 10.1007/978-1-59745-396-7_9	23	25	26	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142736	10.1371/journal.pone.0142736	http://dx.doi.org/10.1371/journal.pone.0142736			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555613	Green Published, gold, Green Submitted			2022-12-27	WOS:000364430700164
J	Perez-Kohler, B; Garcia-Moreno, F; Brune, T; Pascual, G; Bellon, JM				Perez-Koehler, Barbara; Garcia-Moreno, Francisca; Brune, Thierry; Pascual, Gemma; Manuel Bellon, Juan			Preclinical Bioassay of a Polypropylene Mesh for Hernia Repair Pretreated with Antibacterial Solutions of Chlorhexidine and Allicin: An In Vivo Study	PLOS ONE			English	Article							INFECTIONS; VITRO; ANTIBIOTICS; RELEASE; SUTURE; RISK; CONTAMINATION; PREVENTION; MANAGEMENT; BIOFILMS	Introduction Prosthetic mesh infection constitutes one of the major complications following hernia repair. Antimicrobial, non-antibiotic biomaterials have the potential to reduce bacterial adhesion to the mesh surface and adjacent tissues while avoiding the development of novel antibiotic resistance. This study assesses the efficacy of presoaking reticular polypropylene meshes in chlorhexidine or a chlorhexidine and allicin combination (a natural antibacterial agent) for preventing bacterial infection in a short-time hernia-repair rabbit model. Methods Partial hernia defects (5 x 2 cm) were created on the lateral right side of the abdominal wall of New Zealand White rabbits (n = 21). The defects were inoculated with 0.5 mL of a 106 CFU/mL Staphylococcus aureus ATCC25923 strain and repaired with a DualMesh Plus antimicrobial mesh or a Surgipro mesh presoaked in either chlorhexidine (0.05%) or allicin-chlorhexidine (900 mu g/mL-0.05%). Fourteen days post-implant, mesh contraction was measured and tissue specimens were harvested to evaluate bacterial adhesion to the implant surface (via sonication, S. aureus immunolabeling), host-tissue incorporation (via staining, scanning electron microscopy) and macrophage response (via RAM-11 immunolabeling). Results The polypropylene mesh showed improved tissue integration relative to the DualMesh Plus. Both the DualMesh Plus and the chlorhexidine-soaked polypropylene meshes exhibited high bacterial clearance, with the latter material showing lower bacterial yields. The implants from the allicin-chlorhexidine group displayed a neoformed tissue containing differently sized abscesses and living bacteria, as well as a diminished macrophage response. The allicin-chlorhexidine coated implants exhibited the highest contraction. Conclusions The presoaking of reticular polypropylene materials with a low concentration of chlorhexidine provides the mesh with antibacterial activity without disrupting tissue integration. Due to the similarities found with the antimicrobial DualMesh Plus material, the chlorhexidine concentration tested could be utilized as a prophylactic treatment to resist infection by prosthetic mesh during hernia repair.	[Perez-Koehler, Barbara; Garcia-Moreno, Francisca; Manuel Bellon, Juan] Univ Alcala, Dept Surg Med & Social Sci, Fac Med & Hlth Sci, Madrid, Spain; [Brune, Thierry] Covidien Sofradim Prod, Trevoux, France; [Pascual, Gemma] Univ Alcala, Dept Med & Med Specialties, Fac Med & Hlth Sci, Madrid, Spain; [Perez-Koehler, Barbara; Garcia-Moreno, Francisca; Pascual, Gemma; Manuel Bellon, Juan] Networking Res Ctr Bioengn Biomat & Nanomed CIBER, Madrid, Spain	Universidad de Alcala; Covidien; Universidad de Alcala; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN	Bellon, JM (corresponding author), Univ Alcala, Dept Surg Med & Social Sci, Fac Med & Hlth Sci, Madrid, Spain.	juanm.bellon@uah.es	nisa, francisca f garcia-moreno/J-3906-2015; Köhler, Bárbara Pérez/M-1858-2019; PASCUAL, GEMMA/M-6564-2016	nisa, francisca f garcia-moreno/0000-0001-5360-0577; Köhler, Bárbara Pérez/0000-0002-5061-1526; garcia-moreno nisa, francisca/0000-0002-2194-4647; PASCUAL, GEMMA/0000-0002-1623-4384	Covidien - Sofradim Production	Covidien - Sofradim Production	Covidien - Sofradim Production provided support in the form of a financial research grant and salaries for TB, but the funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Agarwal A, 2012, BIOMATERIALS, V33, P6783, DOI 10.1016/j.biomaterials.2012.05.068; An YH, 1997, J MICROBIOL METH, V30, P141, DOI 10.1016/S0167-7012(97)00058-4; Ankri S, 1999, MICROBES INFECT, V1, P125, DOI 10.1016/S1286-4579(99)80003-3; Aydinuraz K, 2009, J SURG RES, V157, pE79, DOI 10.1016/j.jss.2009.04.008; Bellon JM, 2004, BRIT J SURG, V91, P489, DOI 10.1002/bjs.4451; Bellon JM, 2014, REV HISPANOAM HERNIA, V2, P49, DOI 10.1016/j.rehah.2014.02.002; Binnebosel M, 2011, SEMIN IMMUNOPATHOL, V33, P235, DOI 10.1007/s00281-010-0237-5; Burger JWA, 2004, ANN SURG, V240, P578; Carbonell AM, 2005, SURG ENDOSC, V19, P430, DOI 10.1007/s00464-004-8810-4; Cobb WS, 2009, AM SURGEON, V75, P762; Costerton JW, 2005, INT J ARTIF ORGANS, V28, P1062, DOI 10.1177/039139880502801103; Cruz-Villalon G, 2011, J APPL MICROBIOL, V110, P723, DOI 10.1111/j.1365-2672.2010.04929.x; Cutler RR, 2004, BRIT J BIOMED SCI, V61, P71, DOI 10.1080/09674845.2004.11732646; Deysine M, 1998, SURG CLIN N AM, V78, P1105, DOI 10.1016/S0039-6109(05)70372-8; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Edmiston CE, 2013, AM J INFECT CONTROL, V41, pS49, DOI 10.1016/j.ajic.2012.10.030; Engelsman AF, 2007, BIOMATERIALS, V28, P2314, DOI 10.1016/j.biomaterials.2007.01.028; Falagas ME, 2005, CLIN MICROBIOL INFEC, V11, P3, DOI 10.1111/j.1469-0691.2004.01014.x; Fernandez-Gutierrez M, 2013, ACTA BIOMATER, V9, P6006, DOI 10.1016/j.actbio.2012.12.012; Garcia-Pumarino R, 2014, J BIOMED MATER RES B, V102, P366, DOI 10.1002/jbm.b.33015; Giannelli M, 2008, TOXICOL IN VITRO, V22, P308, DOI 10.1016/j.tiv.2007.09.012; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; GRISTINA A G, 1988, Medical Progress Through Technology, V14, P205; Guillaume O, 2015, ADV HEALTHC MATER, V4, P1763, DOI 10.1002/adhm.201500201; Guillaume O, 2012, J CONTROL RELEASE, V162, P492, DOI 10.1016/j.jconrel.2012.08.003; Haase H, 2012, FOOD CHEM, V134, P141, DOI 10.1016/j.foodchem.2012.02.080; Harrell A G, 2006, Hernia, V10, P120, DOI 10.1007/s10029-005-0056-0; Harth KC, 2010, J SURG RES, V163, P337, DOI 10.1016/j.jss.2010.03.065; Hodge G, 2002, CYTOMETRY, V48, P209, DOI 10.1002/cyto.10133; Katsikogianni M, 2004, Eur Cell Mater, V8, P37; Keiss HP, 2003, J NUTR, V133, P2171, DOI 10.1093/jn/133.7.2171; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kockerling F, 2015, SURG ENDOSC; Lindsay D, 2006, J HOSP INFECT, V64, P313, DOI 10.1016/j.jhin.2006.06.028; Luijendijk RW, 2000, NEW ENGL J MED, V343, P392, DOI 10.1056/NEJM200008103430603; Mann TJ, 2001, ANAESTH INTENS CARE, V29, P600, DOI 10.1177/0310057X0102900606; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Perez-Kohler B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126711; Sanabria A, 2007, ANN SURG, V245, P392, DOI 10.1097/01.sla.0000250412.08210.8e; Sanchez-Manuel Francisco Javier, 2012, Cochrane Database Syst Rev, pCD003769, DOI 10.1002/14651858.CD003769.pub4; Sanders D, 2013, HERNIA, V17, P779, DOI 10.1007/s10029-013-1124-5; Sanders DL, 2013, SURG ENDOSC, V27, P978, DOI 10.1007/s00464-012-2545-4; Sistla SC, 2010, CHEMOTHERAPY, V56, P261, DOI 10.1159/000319901; Stoikes Nathaniel, 2013, Surg Technol Int, V23, P107; Tambe SM, 2001, J ANTIMICROB CHEMOTH, V47, P589, DOI 10.1093/jac/47.5.589; von Eiff C, 2005, DRUGS, V65, P179, DOI 10.2165/00003495-200565020-00003; Wiegering A, 2014, HERNIA, V18, P691, DOI 10.1007/s10029-014-1293-x; Yurko Y, 2012, SURG INNOV, V19, P20, DOI 10.1177/1553350611410716; Zhai HH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102760	49	24	25	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142768	10.1371/journal.pone.0142768	http://dx.doi.org/10.1371/journal.pone.0142768			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556805	Green Submitted, Green Published, gold			2022-12-27	WOS:000364430700173
J	Tie, CM; Gao, KL; Zhang, N; Zhang, SZ; Shen, JL; Xie, XJ; Wang, JA				Tie, Chunmiao; Gao, Kanglu; Zhang, Na; Zhang, Songzhao; Shen, Jiali; Xie, Xiaojie; Wang, Jian-an			Ezetimibe Attenuates Atherosclerosis Associated with Lipid Reduction and Inflammation Inhibition	PLoS One			English	Article							INTESTINAL CHOLESTEROL ABSORPTION; PLUS EZETIMIBE; DEFICIENT MICE; STATINS; SIMVASTATIN; ANEURYSMS	Background Ezetimibe, as a cholesterol absorption inhibitor, has been shown protecting against atherosclerosis when combined with statin. However, side by side comparison has not been made to evaluate the beneficial effects of ezetimibe alone versus statin. Herein, the study aimed to test whether ezetimibe alone would exhibit similar effects as statin and the combination therapy would be necessary in a moderate lesion size. Methods and Results ApoE-/-male mice that were fed a saturated-fat supplemented diet were randomly assigned to different therapeutic regimens: vehicle, ezetimibe alone (10 mg/kg/day), atorvastatin (20 mg/kg/day) or combination of ezetimibe and atorvastatin through the drinking water. On 28 days, mice were sacrificed and aorta and sera were collected to analyze the atherosclerotic lesion and blood lipid and cholesterol levels. As a result, ezetimibe alone exerted similar protective effects on atherosclerotic lesion sizes as atorvastatin, which was mediated by lowering serum cholesterol concentrations, inhibiting macrophage accumulation in the lesions and reducing circulatory inflammatory cytokines, such as monocyte chemoattractant protein (MCP-1) and tumor necrosis factor (TNF-alpha). In contrast to ezetimibe administration, atorvastatin alone attenuated atherosclerotic lesion which is dependent on its anti-inflammation effects. There were no significance differences in lesion areas and serum concentrations of cholesterol, oxidized LDL and inflammatory cytokines between combination therapy and monotherapy (either ezetimibe or atorvastatin). There were significant correlations between the lesion areas and serum concentrations of cholesterol, MCP-1 and TNF-alpha, respectively. However, there were no significant correlations between the lesion areas and serum concentrations of TGF-beta 1 and oxLDL. Conclusions Ezetimibe alone played the same protection against a moderate atherosclerotic lesion as atorvastatin, which was associated with lowering serum cholesterol, decreasing circulating inflammatory cytokines, and inhibiting macrophage accumulation in the lesions.	[Tie, Chunmiao; Gao, Kanglu; Zhang, Na; Shen, Jiali; Xie, Xiaojie; Wang, Jian-an] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Cardiol,Cardiovasc Key Lab Zhejiang Prov, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Songzhao] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Clin Lab, Hangzhou 310003, Zhejiang, Peoples R China; [Tie, Chunmiao] Shaoxing Univ, Dept Cardiol, Affiliated Boai Hosp, Shaoxing, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Shaoxing University	Xie, XJ (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Cardiol,Cardiovasc Key Lab Zhejiang Prov, Hangzhou 310003, Zhejiang, Peoples R China.	xiaojiexie@hotmail.com; jian_an_wang@yahoo.com	Shen, Jialie/AAX-6851-2020	Xie, Xiaojie/0000-0001-8421-2737	National Natural Science Foundation of China [31371475, 31171392, 81571932]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding: This work was supported by grants from the National Natural Science Foundation of China (31371475, 31171392 and 81571932). The funder had no role in the study design, data collection and analysis, decision to publish, or presentation of the manuscript.	Baigent C, 2011, LANCET, V377, P2181, DOI 10.1016/S0140-6736(11)60739-3; Bot I, 2011, ATHEROSCLEROSIS, V214, P295, DOI 10.1016/j.atherosclerosis.2010.11.008; Cannon CP, 2015, NEW ENGL J MED, V372, P2387, DOI 10.1056/NEJMoa1410489; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; Davis HR, 2011, ATHEROSCLEROSIS, V215, P266, DOI 10.1016/j.atherosclerosis.2011.02.010; Davis HR, 2001, ARTERIOSCL THROM VAS, V21, P2032, DOI 10.1161/hq1201.100260; Fleg JL, 2008, J AM COLL CARDIOL, V52, P2198, DOI 10.1016/j.jacc.2008.10.031; Gierman LM, 2014, ANN RHEUM DIS, V73, P921, DOI 10.1136/annrheumdis-2013-203248; Jia L, 2011, ANNU REV PHYSIOL, V73, P239, DOI 10.1146/annurev-physiol-012110-142233; Kastelein JJP, 2008, NEW ENGL J MED, V358, P1431, DOI 10.1056/NEJMoa0800742; Kouvelos GN, 2013, J CARDIOVASC PHARM T, V18, P5, DOI 10.1177/1074248412445506; Lin CF, 2011, CLIN THER, V33, P1120, DOI 10.1016/j.clinthera.2011.08.002; Lu H, 2013, CURR OPIN LIPIDOL, V24, P455, DOI 10.1097/MOL.0b013e3283654ef9; Meaney A, 2009, J CLIN PHARMACOL, V49, P838, DOI 10.1177/0091270009337011; Morrone D, 2012, ATHEROSCLEROSIS, V223, P251, DOI 10.1016/j.atherosclerosis.2012.02.016; Nakagami H, 2009, ATHEROSCLEROSIS, V203, P51, DOI 10.1016/j.atherosclerosis.2008.05.026; Rafieian-Kopaei M, 2014, INT J PREVENTIVE MED, V5, P927; Rodriguez-Vita J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003959; Stoletov K, 2009, CIRC RES, V104, P952, DOI 10.1161/CIRCRESAHA.108.189803; Sudhop T, 2002, CIRCULATION, V106, P1943, DOI 10.1161/01.CIR.0000034044.95911.DC; Umemoto T, 2012, J LIPID RES, V53, P2380, DOI 10.1194/jlr.M029264; Van Rooyen DM, 2013, J HEPATOL, V59, P144, DOI 10.1016/j.jhep.2013.02.024; Wang JA, 2011, ATHEROSCLEROSIS, V217, P90, DOI 10.1016/j.atherosclerosis.2011.03.005; Xie XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046411; Xie XJ, 2012, J NUTR BIOCHEM, V23, P549, DOI 10.1016/j.jnutbio.2011.02.011	25	27	29	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142430	10.1371/journal.pone.0142430	http://dx.doi.org/10.1371/journal.pone.0142430			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555472	Green Published, Green Submitted, gold			2022-12-27	WOS:000364430700103
J	Torres, GL; Cooper, WR; Horton, DR; Swisher, KD; Garczynski, SF; Munyaneza, JE; Barcenas, NM				Torres, Glenda L.; Cooper, W. Rodney; Horton, David R.; Swisher, Kylie D.; Garczynski, Stephen F.; Munyaneza, Joseph E.; Barcenas, Nina M.			Horizontal Transmission of "Candidatus Liberibacter solanacearum" by Bactericera cockerelli (Hemiptera: Triozidae) on Convolvulus and Ipomoea (Solanales: Convolvulaceae)	PLOS ONE			English	Article							UNITED-STATES; PCR ASSAY; POTATO; TOMATO; SULC; HAPLOTYPES; DISEASE; PLANTS; TIME	"Candidatus Liberibacter solanacearum" (Proteobacteria) is an important pathogen of solanaceous crops (Solanales: Solanaceae) in North America and New Zealand, and is the putative causal agent of zebra chip disease of potato. This phloem-limited pathogen is transmitted to potato and other solanaceous plants by the potato psyllid, Bactericera cockerelli (Hemiptera: Triozidae). While some plants in the Convolvulaceae (Solanales) are also known hosts for B. cockerelli, previous efforts to detect Liberibacter in Convolvulaceae have been unsuccessful. Moreover, studies to determine whether Liberibacter can be acquired from these plants by B. cockerelli are lacking. The goal of this study was to determine whether horizontal transmission of Liberibacter occurs among potato psyllids on two species of Convolvulaceae, sweet potato (Ipomoea batatas) and field bindweed (Convolvulus arvensis), which grows abundantly in potato growing regions of the United States. Results indicated that uninfected psyllids acquired Liberibacter from both I. batatas and C. arvensis if infected psyllids were present on plants concurrently with the uninfected psyllids. Uninfected psyllids did not acquire Liberibacter from plants if the infected psyllids were removed from the plants before the uninfected psyllids were allowed access. In contrast with previous reports, PCR did detect the presence of Liberibacter DNA in some plants. However, visible amplicons were faint and did not correspond with acquisition of the pathogen by uninfected psyllids. None of the plants exhibited disease symptoms. Results indicate that horizontal transmission of Liberibacter among potato psyllids can occur on Convolvulaceae, and that the association between Liberibacter and Convolvulaceae merits additional attention.	[Torres, Glenda L.; Barcenas, Nina M.] Heritage Univ, Dept Nat Sci, Toppenish, WA 98948 USA; [Cooper, W. Rodney; Horton, David R.; Swisher, Kylie D.; Garczynski, Stephen F.; Munyaneza, Joseph E.] ARS, USDA, Yakima Agr Res Lab, Wapato, WA 98951 USA	United States Department of Agriculture (USDA)	Cooper, WR (corresponding author), ARS, USDA, Yakima Agr Res Lab, Wapato, WA 98951 USA.	Rodney.Cooper@ars.usda.gov	Cooper, William/ABB-1389-2020	Cooper, William/0000-0001-7983-3627	National Science Foundation Research Experience for Undergraduates Award [DBI-1156603]; NSF-REU [DBI-1156603]	National Science Foundation Research Experience for Undergraduates Award; NSF-REU(National Science Foundation (NSF)NSF - Office of the Director (OD))	Glenda Torres was supported by National Science Foundation Research Experience for Undergraduates Award DBI-1156603 to NMB. (http://www.nsf.gov/funding/pgm_summ.jsp?pims_id=5517 NMB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Heather Headrick and Pauline Anderson provided technical assistance. Glenda Torres was supported by NSF-REU Award DBI-1156603 to Heritage University (PI Nina Barcenas). Mention of trade names or commercial products in this article is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the United States Department of Agriculture. USDA is an equal opportunity provider and employer.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bove JM, 2002, PLANT SCI, V163, P1083, DOI 10.1016/S0168-9452(02)00276-5; Cooper WR, 2015, AM J POTATO RES, V92, P91, DOI 10.1007/s12230-014-9416-6; Crosslin JM, 2011, SOUTHWEST ENTOMOL, V36, P125, DOI 10.3958/059.036.0202; Crosslin J. M., 2011, P 11 ANN ZEBR CHIP R, P17; Hansen AK, 2008, APPL ENVIRON MICROB, V74, P5862, DOI 10.1128/AEM.01268-08; Horton DR, 2015, AM ENTOMOLO IN PRESS; Jagoueix S, 1996, MOL CELL PROBE, V10, P43, DOI 10.1006/mcpr.1996.0006; JONES LD, 1987, SCIENCE, V237, P775, DOI 10.1126/science.3616608; KNOWLTON GEORGE F., 1934, JOUR ECON ENT, V27, P547, DOI 10.1093/jee/27.2.547; Levy J, 2011, PHYTOPATHOLOGY, V101, P1285, DOI 10.1094/PHYTO-04-11-0121; Lin H, 2012, EUR J PLANT PATHOL, V132, P297, DOI 10.1007/s10658-011-9874-3; Lin H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019135; List GM, 1939, J ECON ENTOMOL, V32, P30, DOI 10.1093/jee/32.1.30; Mann RS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029197; Munyaneza JE, 2012, AM J POTATO RES, V89, P329, DOI 10.1007/s12230-012-9262-3; Sengoda VG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093475; Sengoda VG, 2013, J ECON ENTOMOL, V106, P1964, DOI 10.1603/EC13129; Swisher KD, 2012, ENVIRON ENTOMOL, V41, P1019, DOI 10.1603/EN12066; Trivedi P, 2009, EUR J PLANT PATHOL, V124, P553, DOI 10.1007/s10658-009-9439-x; Wallis R. L., 1955, USDA TECHNICAL B, V1107; Wen AM, 2013, AM J POTATO RES, V90, P229, DOI 10.1007/s12230-012-9293-9; Zhang YP, 1998, J VIROL METHODS, V71, P45, DOI 10.1016/S0166-0934(97)00190-0	23	14	15	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142734	10.1371/journal.pone.0142734	http://dx.doi.org/10.1371/journal.pone.0142734			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555359	Green Submitted, Green Published, gold			2022-12-27	WOS:000364430700162
J	Collie, D; Glendinning, L; Govan, J; Wright, S; Thornton, E; Tennant, P; Doherty, C; McLachlan, G				Collie, David; Glendinning, Laura; Govan, John; Wright, Steven; Thornton, Elisabeth; Tennant, Peter; Doherty, Catherine; McLachlan, Gerry			Lung Microbiota Changes Associated with Chronic Pseudomonas aeruginosa Lung Infection and the Impact of Intravenous Colistimethate Sodium	PLOS ONE			English	Article							CYSTIC-FIBROSIS; COLISTIN METHANESULFONATE; PULMONARY EXACERBATIONS; SPUTUM; PHARMACOKINETICS; COMMUNITIES; DIVERSITY; DENSITY	Background Exacerbations associated with chronic lung infection with Pseudomonas aeruginosa are a major contributor to morbidity, mortality and premature death in cystic fibrosis. Such exacerbations are treated with antibiotics, which generally lead to an improvement in lung function and reduced sputum P. aeruginosa density. This potentially suggests a role for the latter in the pathogenesis of exacerbations. However, other data suggesting that changes in P. aeruginosa sputum culture status may not reliably predict an improvement in clinical status, and data indicating no significant changes in either total bacterial counts or in P. aeruginosa numbers in sputum samples collected prior to pulmonary exacerbation sheds doubt on this assumption. We used our recently developed lung segmental model of chronic Pseudomonas infection in sheep to investigate the lung microbiota changes associated with chronic P. aeruginosa lung infection and the impact of systemic therapy with colistimethate sodium (CMS). Methodology/Principal Findings We collected protected specimen brush (PSB) samples from sheep (n = 8) both prior to and 14 days after establishment of chronic local lung infection with P aeruginosa. Samples were taken from both directly infected lung segments (direct) and segments spatially remote to such sites (remote). Four sheep were treated with daily intravenous injections of CMS between days 7 and 14, and four were treated with a placebo. Necropsy examination at d14 confirmed the presence of chronic local lung infection and lung pathology in every direct lung segment. The predominant orders in lung microbiota communities before infection were Bacillales, Actinomycetales and Clostridiales. While lung microbiota samples were more likely to share similarities with other samples derived from the same lung, considerable within- and between-animal heterogeneity could be appreciated. Pseudomonadales joined the aforementioned list of predominant orders in lung microbiota communities after infection. Whilst treatment with CMS appeared to have little impact on microbial community composition after infection, or the change undergone by communities in reaching that state, when Gram negative organisms (excluding Pseudomonadales) were considered together as a group there was a significant decrease in their relative proportion that was only observed in the sheep treated with CMS. With only one exception the reduction was seen in both direct and remote lung segments. This reduction, coupled with generally increasing or stable levels of Pseudomonadales, meant that the proportion of the latter relative to total Gram negative bacteria increased in all bar one direct and one remote lung segment. Conclusions/Significance The proportional increase in Pseudomonadales relative to other Gram negative bacteria in the lungs of sheep treated with systemic CMS highlights the potential for such therapies to inadvertently select or create a niche for bacteria seeding from a persistent source of chronic infection.	[Collie, David; Glendinning, Laura; Wright, Steven; Thornton, Elisabeth; Tennant, Peter; McLachlan, Gerry] Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland; [Collie, David; Glendinning, Laura; Wright, Steven; Thornton, Elisabeth; Tennant, Peter; McLachlan, Gerry] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh EH9 1QH, Midlothian, Scotland; [Govan, John; Doherty, Catherine] Univ Edinburgh, Sch Med, Edinburgh, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; University of Edinburgh	Collie, D (corresponding author), Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland.	david.collie@ed.ac.uk		Glendinning, Laura/0000-0003-4789-6644; McLachlan, Gerry/0000-0001-5362-9804; Collie, David/0000-0001-9313-8137	Biological and Biotechnological Science Research Council (BBSRC) [BB/J004243/1]; NERC [R8/H10/56]; MRC [MR/K001744/1]; Biotechnology and Biological Sciences Research Council [1358257] Funding Source: researchfish; Medical Research Council [MR/K001744/1] Funding Source: researchfish	Biological and Biotechnological Science Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Biological and Biotechnological Science Research Council (BBSRC; www.bbsrc.ac.uk). Edinburgh Genomics is partly supported through core grants from NERC (R8/H10/56), MRC (MR/K001744/1) and BBSRC (BB/J004243/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, UK CYST FIBR REG ANN; Bekele AZ, 2010, FEMS MICROBIOL LETT, V305, P49, DOI 10.1111/j.1574-6968.2010.01911.x; Boisson M, 2014, ANTIMICROB AGENTS CH, V58, P7331, DOI 10.1128/AAC.03510-14; Burkett A, 2012, EUR J CLIN MICROBIOL, V31, P1603, DOI 10.1007/s10096-011-1483-8; Carmody Lisa A, 2013, Ann Am Thorac Soc, V10, P179, DOI 10.1513/AnnalsATS.201211-107OC; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Collie D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067677; Daniels TWV, 2013, J CYST FIBROS, V12, P22, DOI 10.1016/j.jcf.2012.05.008; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dickson RP, 2015, ANN AM THORAC SOC, V12, P821, DOI 10.1513/AnnalsATS.201501-029OC; Dickson RP, 2013, EXPERT REV RESP MED, V7, P245, DOI [10.1586/ers.13.24, 10.1586/ERS.13.24]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Goddard AF, 2012, P NATL ACAD SCI USA, V109, P13769, DOI 10.1073/pnas.1107435109; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; GOVAN JRW, 1978, J ANTIMICROB CHEMOTH, V4, P233, DOI 10.1093/jac/4.3.233; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Imberti R, 2010, CHEST, V138, P1333, DOI 10.1378/chest.10-0463; King PT, 2007, RESP MED, V101, P1633, DOI 10.1016/j.rmed.2007.03.009; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Le Gall F, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-143; Li J, 2003, ANTIMICROB AGENTS CH, V47, P1364, DOI 10.1128/AAC.47.4.1364-1370.2003; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Martinez-Solano L, 2008, CLIN INFECT DIS, V47, P1526, DOI 10.1086/593186; Nguyen T, 2013, J AEROSOL MED PULMON; Nicholas B, 2009, BIOCHEM SOC T, V37, P868, DOI 10.1042/BST0370868; Price KE, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-27; REGELMANN WE, 1990, AM REV RESPIR DIS, V141, P914, DOI 10.1164/ajrccm/141.4_Pt_1.914; Reid DW, 2013, J CYST FIBROS, V12, P688, DOI 10.1016/j.jcf.2013.03.008; Rogers GB, 2014, LANCET RESP MED, V2, P988, DOI 10.1016/S2213-2600(14)70213-9; Rogers Geraint B, 2014, Ann Am Thorac Soc, V11, P496, DOI 10.1513/AnnalsATS.201310-335OC; Sanders DB, 2011, PEDIATR PULM, V46, P393, DOI 10.1002/ppul.21374; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Segal LN, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-19; Stressmann FA, 2011, J CYST FIBROS, V10, P357, DOI 10.1016/j.jcf.2011.05.002	35	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142097	10.1371/journal.pone.0142097	http://dx.doi.org/10.1371/journal.pone.0142097			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544950	Green Submitted, Green Published, gold			2022-12-27	WOS:000364398700082
J	Watt, DG; Proctor, MJ; Park, JH; Horgan, PG; McMillan, DC				Watt, David G.; Proctor, Michael J.; Park, James H.; Horgan, Paul G.; McMillan, Donald C.			The Neutrophil-Platelet Score (NPS) Predicts Survival in Primary Operable Colorectal Cancer and a Variety of Common Cancers	PLOS ONE			English	Article							SYSTEMIC INFLAMMATORY RESPONSE; LYMPHOCYTE RATIO; POSTOPERATIVE SURVIVAL; PROGNOSTIC SCORE; COUNT; COMBINATION; SURGERY	Introduction Recent in-vitro studies have suggested that a critical checkpoint early in the inflammatory process involves the interaction between neutrophils and platelets. This confirms the importance of the innate immune system in the elaboration of the systemic inflammatory response. The aim of the present study was to examine whether a combination of the neutrophil and platelet counts were predictive of survival in patients with cancer. Methods Patients with histologically proven colorectal cancer who underwent potentially curative resection at a single centre between March 1999 and May 2013 (n = 796) and patients with cancer from the Glasgow Inflammation Outcome Study, who had a blood sample taken between January 2000 and December 2007 (n = 9649) were included in the analysis. Results In the colorectal cancer cohort, there were 173 cancer and 135 non-cancer deaths. In patients undergoing elective surgery, cancer-specific survival (CSS) at 5 years ranged from 97% in patients with TNM I disease and NPS = 0 to 57% in patients with TNM III disease and NPS = 2 (p = 0.019) and in patients undergoing elective surgery for node-negative colon cancer from 98% (TNM I, NPS = 0) to 65% (TNM II, NPS = 2) (p = 0.004). In those with a variety of common cancers there were 5218 cancer and 929 non-cancer deaths. On multivariate analysis, adjusting for age and sex and stratified by tumour site, incremental increase in the NPS was significantly associated with poorer CSS (p<0.001). Conclusion The neutrophil-platelet score predicted survival in a variety of common cancers and highlights the importance of the innate immune system in patients with cancer.	[Watt, David G.; Proctor, Michael J.; Park, James H.; Horgan, Paul G.; McMillan, Donald C.] Univ Glasgow, Glasgow Royal Infirm, Sch Med, Acad Surg Unit, Glasgow G31 2ER, Lanark, Scotland	University of Glasgow	Watt, DG (corresponding author), Univ Glasgow, Glasgow Royal Infirm, Sch Med, Acad Surg Unit, Glasgow G31 2ER, Lanark, Scotland.	davidwatt1@nhs.net		McMillan, Donald/0000-0003-4260-5334				Ardi VC, 2007, P NATL ACAD SCI USA, V104, P20262, DOI 10.1073/pnas.0706438104; Feng JF, 2014, TRANSL ONCOL, V7, P632, DOI 10.1016/j.tranon.2014.07.009; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Guthrie GJK, 2013, CRIT REV ONCOL HEMAT, V88, P218, DOI 10.1016/j.critrevonc.2013.03.010; Ishizuka M, 2013, BRIT J CANCER, V109, P401, DOI 10.1038/bjc.2013.350; Ishizuka M, 2014, J SURG ONCOL, V110, P935, DOI 10.1002/jso.23753; Jain S, 2010, ARTERIOSCL THROM VAS, V30, P2362, DOI 10.1161/ATVBAHA.110.207514; Kumar R, 2015, BRIT J CANCER, V112, P1157, DOI 10.1038/bjc.2015.67; Leitch EF, 2007, BRIT J CANCER, V97, P1266, DOI 10.1038/sj.bjc.6604027; Li MX, 2014, INT J CANCER, V134, P2403, DOI 10.1002/ijc.28536; McMillan DC, 2013, CANCER TREAT REV, V39, P534, DOI 10.1016/j.ctrv.2012.08.003; Oliphant R, 2013, BRIT J SURG, V100, P1388, DOI 10.1002/bjs.9227; Park JH, 2015, ANN SURG; Proctor MJ, 2010, BRIT J CANCER, V103, P870, DOI 10.1038/sj.bjc.6605855; Proctor MJ, 2013, CANCER-AM CANCER SOC, V119, P2325, DOI 10.1002/cncr.28018; Proctor MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116206; Roxburgh CSD, 2010, FUTURE ONCOL, V6, P149, DOI 10.2217/FON.09.136; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Sreeramkumar V, 2014, SCIENCE, V346, P1234, DOI 10.1126/science.1256478; Templeton AJ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju124; Ten Kate M, 2007, ANTICANCER RES, V27, P17; Wang SC, 2015, ANN SURG; Watt DG, 2015, AM J SURG, V210, P24, DOI 10.1016/j.amjsurg.2014.12.031	23	50	51	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142159	10.1371/journal.pone.0142159	http://dx.doi.org/10.1371/journal.pone.0142159			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544968	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000364398700090
J	Yu, Y; Liu, ZW; Hu, M; Liu, HM; Yang, JP; Zhou, L; Xiao, SY				Yu, Yu; Liu, Zi-wei; Hu, Mi; Liu, Hui-ming; Yang, Joyce P.; Zhou, Liang; Xiao, Shui-yuan			Mental Health Help-Seeking Intentions and Preferences of Rural Chinese Adults	PLOS ONE			English	Article							DISORDERS IDENTIFICATION TEST; GENERALIZED ANXIETY DISORDER; ILLNESS STIGMA; TEST AUDIT; DEPRESSION; ATTITUDES; PHQ-9; CARE; POPULATION; PREVALENCE	Purpose We aimed to investigate mental health help-seeking intentions and preferences of rural Chinese adults and determine predictors of the intentions. Methods A total of 2052 representative rural residents aged 18-60 completed a cross-sectional survey by face-to-face interviews. The survey included seven questions asking about respondents' help-seeking intentions and preferences, and a series of internationally validated instruments to assess self-perceived health status, depression, anxiety, alcohol abuse, mental health literacy, and attitudes towards mental illness. Results Nearly 80% of respondents were willing to seek psychological help if needed, and 72.4% preferred to get help from medical organizations, yet only 12% knew of any hospitals or clinics providing such help. A multivariate analysis of help-seeking intention revealed that being female, having lower education, higher social health, higher mental health knowledge, and physical causal attribution for depression were positive predictors of help-seeking intention. Conclusion A huge gap exists between the relatively higher intention for help-seeking and significantly lower knowledge of helpful resources. Predictors of help-seeking intention for mental problems in the current study are consistent with previous studies. Interventions to increase help-seeking for mental problems by Chinese rural adults may be best served by focusing on increasing public awareness of help sources, as well as improving residents' mental health literacy and social health, with special focus on males and those more educated.	[Yu, Yu; Liu, Zi-wei; Hu, Mi; Liu, Hui-ming; Zhou, Liang; Xiao, Shui-yuan] Cent S Univ, Sch Publ Hlth, Dept Social Med & Hlth Management, Changsha, Hunan, Peoples R China; [Yang, Joyce P.] Univ Washington, Dept Psychol, Seattle, WA 98195 USA	Central South University; University of Washington; University of Washington Seattle	Xiao, SY (corresponding author), Cent S Univ, Sch Publ Hlth, Dept Social Med & Hlth Management, Changsha, Hunan, Peoples R China.	xiaosy@csu.edu.cn	ZHOU, LIANG/AAG-7587-2020	ZHOU, LIANG/0000-0003-3207-7419	National Science and Technology Support Program, China [2009BAI77B01 2009BAI77B08]; Hunan Provincial Innovation Foundation for Postgraduate [CX2015B058]	National Science and Technology Support Program, China; Hunan Provincial Innovation Foundation for Postgraduate	This work was supported by the National Science and Technology Support Program, China (No. 2009BAI77B01 2009BAI77B08) and Hunan Provincial Innovation Foundation for Postgraduate, No. CX2015B058.	Alonso J, 2007, BRIT J PSYCHIAT, V190, P299, DOI 10.1192/bjp.bp.106.022004; Andrews G, 2001, BRIT J PSYCHIAT, V178, P145, DOI 10.1192/bjp.178.2.145; [Anonymous], 2010, RES 2009 NAT SURV DR; Baoliang Z, 2011, CHINESE J SCH HLTH, V32, P49; Boonstra N, 2012, SCHIZOPHR RES, V142, P12, DOI 10.1016/j.schres.2012.08.017; Boyd A, 2015, J AFFECT DISORDERS, V173, P245, DOI 10.1016/j.jad.2014.11.002; Boyd CP, 2011, RURAL REMOTE HEALTH, V11; Chen LY, 2013, PSYCHIAT SERV, V64, P863, DOI 10.1176/appi.ps.201200289; Chen SL, 2010, INT J GERIATR PSYCH, V25, P1127, DOI 10.1002/gps.2442; Chen TM, 2006, PSYCHIAT SERV, V57, P976, DOI 10.1176/appi.ps.57.7.976; Chew-Graham CA, 2003, MED EDUC, V37, P873, DOI 10.1046/j.1365-2923.2003.01627.x; Chin WY, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006730; Clement S, 2015, PSYCHOL MED, V45, P11, DOI 10.1017/S0033291714000129; Coles ME, 2014, J ANXIETY DISORD, V28, P737, DOI 10.1016/j.janxdis.2014.07.011; Coles ME, 2010, DEPRESS ANXIETY, V27, P63, DOI 10.1002/da.20620; Dell'Osso B, 2013, PSYCHOPATHOLOGY, V46, P14, DOI 10.1159/000338608; Eapen V, 2004, PSYCHOL REP, V94, P663; Eisenberg D, 2007, MED CARE, V45, P594, DOI 10.1097/MLR.0b013e31803bb4c1; Gulliver A, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-113; Henderson C, 2013, AM J PUBLIC HEALTH, V103, P777, DOI 10.2105/AJPH.2012.301056; Hines LA, 2014, PSYCHIAT SERV, V65, P98, DOI 10.1176/appi.ps.004972012; Hong S, 2014, ASIAN AM J PSYCHOL, V5, P353, DOI 10.1037/a0035680; Hu M., 2000, CHINESE J BEHAV MED, V9, P65; Jorm AF, 1997, MED J AUSTRALIA, V166, P182, DOI 10.5694/j.1326-5377.1997.tb140071.x; Judd F, 2008, AUST NZ J PSYCHIAT, V42, P24, DOI 10.1080/00048670701732681; Judd F, 2006, AUST NZ J PSYCHIAT, V40, P769, DOI 10.1111/j.1440-1614.2006.01882.x; Kessler RC, 2005, NEW ENGL J MED, V352, P2515, DOI 10.1056/NEJMsa043266; Knipscheer JW, 2005, INT J SOC PSYCHIATR, V51, P372, DOI 10.1177/0020764005060853; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kung WW, 2008, J NERV MENT DIS, V196, P46, DOI 10.1097/NMD.0b013e31815fa4f9; Li Q, 2011, ALCOHOL ALCOHOLISM, V46, P416, DOI 10.1093/alcalc/agr012; Lindsey MA, 2010, J BLACK PSYCHOL, V36, P458, DOI 10.1177/0095798409355796; Link BG, 2001, PSYCHIATR SERV, V52, P1621, DOI 10.1176/appi.ps.52.12.1621; LINK BG, 1987, AM J SOCIOL, V92, P1461, DOI 10.1086/228672; LINK BG, 1987, AM SOCIOL REV, V52, P96, DOI 10.2307/2095395; Mackenzie CS, 2006, AGING MENT HEALTH, V10, P574, DOI 10.1080/13607860600641200; Manea L, 2015, GEN HOSP PSYCHIAT, V37, P67, DOI 10.1016/j.genhosppsych.2014.09.009; Mo PKH, 2009, SOC PSYCH PSYCH EPID, V44, P675, DOI 10.1007/s00127-008-0484-0; Ng CH, 1997, AUST NZ J PSYCHIAT, V31, P382, DOI 10.3109/00048679709073848; O'Connor M, 2014, J MENT HEALTH, V23, P197, DOI 10.3109/09638237.2014.910646; Oliver MI, 2005, BRIT J PSYCHIAT, V186, P297, DOI 10.1192/bjp.186.4.297; Parker G, 2001, AM J PSYCHIAT, V158, P857, DOI 10.1176/appi.ajp.158.6.857; Peng Y, 2011, SHANGHAI ARCH PSYCHI, V23, P353; Perlick DA, 2001, PSYCHIAT SERV, V52, P1627, DOI 10.1176/appi.ps.52.12.1627; Pickard JG, 2011, SOC SERV REV, V85, P247, DOI 10.1086/660068; Qian JW, 2012, J MENT HEALTH POLICY, V15, P179; Reavley NJ, 2010, AUST NZ J PSYCHIAT, V44, P729, DOI 10.3109/00048671003705458; Reinert DF, 2007, ALCOHOL CLIN EXP RES, V31, P185, DOI 10.1111/j.1530-0277.2006.00295.x; Roh S, 2017, J APPL GERONTOL, V36, P94, DOI 10.1177/0733464814558875; Rusch N, 2014, EPIDEMIOL PSYCH SCI, V23, P177, DOI 10.1017/S204579601300036X; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schalet BD, 2014, J ANXIETY DISORD, V28, P88, DOI 10.1016/j.janxdis.2013.11.006; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; ten Have M, 2010, Tijdschr Psychiatr, V52, P205; Thikeo M, 2015, J IMMIGR MINOR HEALT, V17, P1679, DOI 10.1007/s10903-015-0171-7; Thornicroft G, 2007, LANCET, V370, P807, DOI 10.1016/S0140-6736(07)61392-0; Tieu Y, 2014, AGING MENT HEALTH, V18, P140, DOI 10.1080/13607863.2013.814104; TSENG WS, 1975, COMPR PSYCHIAT, V16, P237, DOI 10.1016/0010-440X(75)90050-4; Vaingankar JA, 2013, ANN ACAD MED SINGAP, V42, P514; Vega W A, 2001, J Immigr Health, V3, P133, DOI 10.1023/A:1011385004913; Wang Jingyi, 2013, Shanghai Arch Psychiatry, V25, P224, DOI 10.3969/j.issn.1002-0829.2013.04.004; Wang WZ, 2014, GEN HOSP PSYCHIAT, V36, P539, DOI 10.1016/j.genhosppsych.2014.05.021; WHO, 2001, WORLD HLTH REPORT 20; Wrigley S, 2005, AUST NZ J PSYCHIAT, V39, P514, DOI 10.1080/j.1440-1614.2005.01612.x; Wu CY, 2014, J FORMOS MED ASSOC, V113, P33, DOI 10.1016/j.jfma.2013.03.004; Xu J, CHINESE J HLTH STAT, V20, P272; Xu J, 2010, BMC PUBLIC HEALTH, V10, P9, DOI 10.1186/1471-2458-10-393; Yang J, AIDS BEHAV IN PRESS; Yang L. H., 2007, SMJ Singapore Medical Journal, V48, P977; Yang LH, 2007, SOC SCI MED, V64, P1524, DOI 10.1016/j.socscimed.2006.11.013; Yeap R, 2009, SINGAP MED J, V50, P1169; Yi X. U., 2003, CHIN J CLIN PSYCHOL, V3, P232; Ying DGC, 2010, POSTGRAD MED, V122, P32, DOI 10.3810/pgm.2010.07.2173	74	21	22	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141889	10.1371/journal.pone.0141889	http://dx.doi.org/10.1371/journal.pone.0141889			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV6RT	26545095	Green Submitted, gold, Green Published			2022-12-27	WOS:000364398700059
J	Clemente-Vicario, F; Alvarez, CE; Rowell, JL; Roy, S; London, CA; Kisseberth, WC; Lorch, G				Clemente-Vicario, Francisco; Alvarez, Carlos E.; Rowell, Jennie L.; Roy, Satavisha; London, Cheryl A.; Kisseberth, William C.; Lorch, Gwendolen			Human Genetic Relevance and Potent Antitumor Activity of Heat Shock Protein 90 Inhibition in Canine Lung Adenocarcinoma Cell Lines	PLOS ONE			English	Article							IN-VITRO; HSP90 INHIBITOR; STROMAL FIBROBLASTS; CHAPERONE HSP90; CANCER-CELLS; TUMOR-CELLS; DOGS; HSP70; CHEMOTHERAPY; GEMCITABINE	Background It has been an open question how similar human and canine lung cancers are. This has major implications in availability of human treatments for dogs and in establishing translational models to test new therapies in pet dogs. The prognosis for canine advanced lung cancer is poor and new treatments are needed. Heat shock protein 90 (HSP90) is an ATPase-dependent molecular chaperone ubiquitously expressed in eukaryotic cells. HSP90 is essential for posttranslational conformational maturation and stability of client proteins including protein kinases and transcription factors, many of which are important for the proliferation and survival of cancer cells. We investigated the activity of STA-1474, a HSP90 inhibitor, in two canine lung cancer cell lines, BACA and CLAC. Results Comparative genomic hybridization analysis of both cell lines revealed genetic relevance to human non-small cell lung cancer. STA-1474 inhibited growth and induced apoptosis of both cell lines in a dose-and time-dependent manner. The ICs50 after 72 h treatment with STA-1474 were 0.08 and 0.11 mu M for BACA and CLAC, respectively. When grown as spheroids, the IC50 of STA-1474 for BACA cells was approximately two-fold higher than when grown as a monolayer (0.348 mu M vs. 0.168 mu M), whereas CLAC spheroids were relatively drug resistant. Treatment of tumor-stromal fibroblasts with STA-1474 resulted in a dose-dependent decrease in their relative cell viability with a low IC50 of 0.28 mu M. Conclusions Here we first established that lung adenocarcinoma in people and dogs are genetically and biochemically similar. STA1474 demonstrated biological activity in both canine lung cancer cell lines and tumor-stromal fibroblasts. As significant decreases in relative cell viability can be achieved with nanomolar concentrations of STA-1474, investigation into the clinical efficacy of this drug in canine lung cancer patients is warranted.	[Clemente-Vicario, Francisco; Roy, Satavisha; Kisseberth, William C.; Lorch, Gwendolen] Ohio State Univ, Coll Vet Med, Dept Vet Clin Sci, Columbus, OH 43210 USA; [Alvarez, Carlos E.] Nationwide Childrens Hosp, Res Inst, Ctr Mol & Human Genet, Columbus, OH USA; [Rowell, Jennie L.] Ohio State Univ, Coll Nursing, Columbus, OH 43210 USA; [London, Cheryl A.] Ohio State Univ, Coll Vet Med, Dept Vet Biosci, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Lorch, G (corresponding author), Ohio State Univ, Coll Vet Med, Dept Vet Clin Sci, Columbus, OH 43210 USA.	lorch.2@osu.edu	Fiumefreddo, Andrea/T-2977-2019; London, Cheryl/E-6561-2012; Kisseberth, William/A-2587-2013; Roy, sashwati/E-3990-2011	Jaramillo Garcia, Luis Fernando/0000-0003-2909-9318	National Canine Cancer Foundation [GL15OH-005]; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001070] Funding Source: NIH RePORTER	National Canine Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	These studies were funded by the National Canine Cancer Foundation; Grant GL15OH-005 to GL (http://www.wearethecure.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams VJ, 2010, J SMALL ANIM PRACT, V51, P512, DOI 10.1111/j.1748-5827.2010.00974.x; Alvarez CE, 2014, ILAR J, V55, P16, DOI 10.1093/ilar/ilu010; Alvarez CE, 2012, MAMM GENOME, V23, P144, DOI 10.1007/s00335-011-9369-8; Barrott JJ, 2013, FEBS J, V280, P1381, DOI 10.1111/febs.12147; Berge EM, 2014, SEMIN ONCOL, V41, P110, DOI 10.1053/j.seminoncol.2013.12.006; Bettini G, 2009, VET COMP ONCOL, V7, P28, DOI 10.1111/j.1476-5829.2008.00166.x; Budman DR, 2002, ANTI-CANCER DRUG, V13, P1011, DOI 10.1097/00001813-200211000-00005; Chari R, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-32; Chatterjee M, 2013, HAEMATOLOGICA, V98, P1132, DOI 10.3324/haematol.2012.066175; Chen WK, 2009, GENOME RES, V19, P500, DOI 10.1101/gr.083741.108; CHOU TC, 1981, EUR J BIOCHEM, V115, P207, DOI 10.1111/j.1432-1033.1981.tb06218.x; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Davidson MR, 2013, J THORAC DIS, V5, pS463, DOI 10.3978/j.issn.2072-1439.2013.08.43; Davoli T, 2013, CELL, V155, P948, DOI 10.1016/j.cell.2013.10.011; De Luca A, 2004, ANTICANCER RES, V24, P2985; Dobson JM, 2002, J SMALL ANIM PRACT, V43, P240, DOI 10.1111/j.1748-5827.2002.tb00066.x; Ekert JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092248; Endo H, 2013, J THORAC ONCOL, V8, P131, DOI 10.1097/JTO.0b013e3182779ccf; Fleming JM, 2011, J VET INTERN MED, V25, P187, DOI 10.1111/j.1939-1676.2011.0695.x; Freise KJ, 2006, J VET PHARMACOL THER, V29, P137, DOI 10.1111/j.1365-2885.2006.00725.x; Garcia-Carbonero R, 2013, LANCET ONCOL, V14, pE358, DOI 10.1016/S1470-2045(13)70169-4; GAVER RC, 1988, CANCER CHEMOTH PHARM, V21, P197; Gorn M, 2008, ONKOLOGIE, V31, P185, DOI 10.1159/000118626; Griffey SM, 1998, CARCINOGENESIS, V19, P959, DOI 10.1093/carcin/19.6.959; Jung DW, 2011, CHEM BIOL, V18, P1581, DOI 10.1016/j.chembiol.2011.10.001; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; Kent MS, 2009, AM J VET RES, V70, P263, DOI 10.2460/ajvr.70.2.263; Kharaishvili G, 2014, CANCER CELL INT, V14, DOI 10.1186/1475-2867-14-41; KNAPP DW, 1995, AM J VET RES, V56, P801; Laederich MB, 2011, J BIOL CHEM, V286, P19597, DOI 10.1074/jbc.M110.206151; Lin TY, 2008, EXP HEMATOL, V36, P1266, DOI 10.1016/j.exphem.2008.05.001; London CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027018; Lotti F, 2013, J EXP MED, V210, P2851, DOI 10.1084/jem.20131195; Lwin Z, 2013, J THORAC DIS, V5, pS556, DOI 10.3978/j.issn.2072-1439.2013.08.47; Mariotti ET, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-19; McCleese JK, 2009, INT J CANCER, V125, P2792, DOI 10.1002/ijc.24660; McMahon MB, 2010, AM J VET RES, V71, P799, DOI 10.2460/ajvr.71.7.799; MOULTON JE, 1981, VET PATHOL, V18, P513, DOI 10.1177/030098588101800409; Nemoto Y, 2011, VET PATHOL, V48, P1029, DOI 10.1177/0300985810396106; O'Neill DG, 2013, VET J, V198, P638, DOI 10.1016/j.tvjl.2013.09.020; OGILVIE GK, 1989, J AM VET MED ASSOC, V195, P106; Park Young-Kyu, 2012, Genomics & Informatics, V10, P33, DOI 10.5808/GI.2012.10.1.33; Poirier VJ, 2004, J VET INTERN MED, V18, P536, DOI 10.1892/0891-6640(2004)18&lt;536:TDAEOV&gt;2.0.CO;2; Polton GA, 2008, J SMALL ANIM PRACT, V49, P66, DOI 10.1111/j.1748-5827.2007.00403.x; Powers MV, 2009, CELL CYCLE, V8, P518, DOI 10.4161/cc.8.4.7583; Proia DA, 2014, CANCER RES, V74, P1294, DOI 10.1158/0008-5472.CAN-13-3263; Qi Y, 2004, NATURE, V431, P712, DOI 10.1038/nature02958; Rathore K, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-465; Saibil H, 2013, NAT REV MOL CELL BIO, V14, P630, DOI 10.1038/nrm3658; Sakashita S, 2014, SEMIN ONCOL, V41, P28, DOI 10.1053/j.seminoncol.2013.12.008; Sang J, 2013, CANCER DISCOV, V3, P430, DOI 10.1158/2159-8290.CD-12-0440; Shimamura T, 2012, CLIN CANCER RES, V18, P4973, DOI 10.1158/1078-0432.CCR-11-2967; Shin HC, 2011, MOL PHARMACEUT, V8, P1257, DOI 10.1021/mp2000549; Simon D, 2001, AM J VET RES, V62, P1825, DOI 10.2460/ajvr.2001.62.1825; Socinski MA, 2013, CLIN CANCER RES, V19, P3068, DOI 10.1158/1078-0432.CCR-12-3381; Stokol T, 2011, AM J VET RES, V72, P1097, DOI 10.2460/ajvr.72.8.1097; SUPKO JG, 1995, CANCER CHEMOTH PHARM, V36, P305, DOI 10.1007/BF00689048; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Tripathi M, 2012, CELL ADHES MIGR, V6, P231, DOI 10.4161/cam.20419; Vail DM, 2004, SEMIN ONCOL, V31, P16, DOI 10.1053/j.seminoncol.2004.08.002; Vinci M, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-29; Wang Y, 2015, ORG BIOMOL CHEM, V13, P2108, DOI 10.1039/c4ob02531h; Ware Kathryn E, 2010, PLoS One, V5, pe14117, DOI 10.1371/journal.pone.0014117; Wen W, 2014, EXP BIOL MED, V239, P638, DOI 10.1177/1535370214527899; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Wu ZX, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.016675; Yamaguchi T, 2013, CANCER CELL, V23, P718, DOI 10.1016/j.ccr.2013.04.002	68	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142007	10.1371/journal.pone.0142007	http://dx.doi.org/10.1371/journal.pone.0142007			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26560147	gold, Green Published, Green Submitted			2022-12-27	WOS:000364433100050
J	Endlein, T; Federle, W				Endlein, Thomas; Federle, Walter			On Heels and Toes: How Ants Climb with Adhesive Pads and Tarsal Friction Hair Arrays	PLOS ONE			English	Article							EFFECTIVE ELASTIC-MODULUS; DIVISION-OF-LABOR; ATTACHMENT PADS; DETACHMENT; SMOOTH; BIOMECHANICS; COCKROACHES; HYMENOPTERA; MECHANISMS; INSECTS	Ants are able to climb effortlessly on vertical and inverted smooth surfaces. When climbing, their feet touch the substrate not only with their pretarsal adhesive pads but also with dense arrays of fine hairs on the ventral side of the 3rd and 4th tarsal segments. To understand what role these different attachment structures play during locomotion, we analysed leg kinematics and recorded single-leg ground reaction forces in Weaver ants (Oecophylla smaragdina) climbing vertically on a smooth glass substrate. We found that the ants engaged different attachment structures depending on whether their feet were above or below their Centre of Mass (CoM). Legs above the CoM pulled and engaged the arolia ('toes'), whereas legs below the CoM pushed with the 3rd and 4th tarsomeres ('heels') in surface contact. Legs above the CoM carried a significantly larger proportion of the body weight than legs below the CoM. Force measurements on individual ant tarsi showed that friction increased with normal load as a result of the bending and increasing side contact of the tarsal hairs. On a rough sandpaper substrate, the tarsal hairs generated higher friction forces in the pushing than in the pulling direction, whereas the reverse effect was found on the smooth substrate. When the tarsal hairs were pushed, buckling was observed for forces exceeding the shear forces found in climbing ants. Adhesion forces were small but not negligible, and higher on the smooth substrate. Our results indicate that the dense tarsal hair arrays produce friction forces when pressed against the substrate, and help the ants to push outwards during horizontal and vertical walking.	[Endlein, Thomas] Max Planck Inst Intelligent Syst, D-70569 Stuttgart, Germany; [Federle, Walter] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	Max Planck Society; University of Cambridge	Federle, W (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	wf222@cam.ac.uk			UK Biotechnology and Biological Sciences Research Council [BB/I008667/1]; Human Frontier Science Programme [RGP0034/2012]; German Research council [DFG FE 547/1-3]; BBSRC [BB/E004156/1, BB/I008667/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I008667/1, BB/E004156/1] Funding Source: researchfish	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Human Frontier Science Programme(Human Frontier Science Program); German Research council(German Research Foundation (DFG)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by research grants from the UK Biotechnology and Biological Sciences Research Council (BB/I008667/1, http://www.bbsrc.ac.uk/), the Human Frontier Science Programme (RGP0034/2012, http://www.hfsp.org/), and the German Research council (DFG FE 547/1-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Aziz Y. I., 1971, P ASP UI S CLOS RANG, P1, DOI [DOI 10.1080/10671188.1967.10616517, 10.14358/PERS.81.2.103]; Autumn K, 2006, J EXP BIOL, V209, P3558, DOI 10.1242/jeb.02469; Autumn K, 2000, NATURE, V405, P681, DOI 10.1038/35015073; Beutel RG, 2008, SYST ENTOMOL, V33, P501, DOI 10.1111/j.1365-3113.2008.00428.x; Bullock JMR, 2008, J EXP BIOL, V211, P3333, DOI 10.1242/jeb.020941; Bullock JMR, 2009, J EXP BIOL, V212, P1876, DOI 10.1242/jeb.030551; Clemente CJ, 2008, P ROY SOC B-BIOL SCI, V275, P1329, DOI 10.1098/rspb.2007.1660; Clemente CJ, 2009, J COMP PHYSIOL A, V195, P805, DOI 10.1007/s00359-009-0457-0; Drechsler P, 2006, J COMP PHYSIOL A, V192, P1213, DOI 10.1007/s00359-006-0150-5; Endlein T, 2008, J COMP PHYSIOL A, V194, P49, DOI 10.1007/s00359-007-0287-x; Federle W, 2004, ARTHROPOD STRUCT DEV, V33, P67, DOI 10.1016/j.asd.2003.11.001; Federle W, 2001, P NATL ACAD SCI USA, V98, P6215, DOI 10.1073/pnas.111139298; Frantsevich L, 2004, ARTHROPOD STRUCT DEV, V33, P77, DOI 10.1016/j.asd.2003.10.003; Goldman DI, 2006, J EXP BIOL, V209, P2990, DOI 10.1242/jeb.02322; Gorb S, 2000, J COMP PHYSIOL A, V186, P821, DOI 10.1007/s003590000135; Gorb SN, 2002, INTEGR COMP BIOL, V42, P1127, DOI 10.1093/icb/42.6.1127; Gravish N, 2008, J R SOC INTERFACE, V5, P339, DOI 10.1098/rsif.2007.1077; HANNA G, 1991, J EXP BIOL, V155, P103; HILL DE, 1977, ZOOL J LINN SOC-LOND, V60, P319, DOI 10.1111/j.1096-3642.1977.tb00838.x; KENDALL K, 1975, J PHYS D APPL PHYS, V8, P1449, DOI 10.1088/0022-3727/8/13/005; Labonte D, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0034; Labonte D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081943; Niederegger S, 2003, J INSECT PHYSIOL, V49, P611, DOI 10.1016/S0022-1910(03)00048-9; Niederegger S, 2006, J COMP PHYSIOL A, V192, P1223, DOI 10.1007/s00359-006-0157-y; Rivlin RS., 1944, COLLECTED PAPERS RS, V9, P215; ROTH LM, 1952, J EXP ZOOL, V119, P483, DOI 10.1002/jez.1401190307; Schulmeister S, 2003, ZOOL SCR, V32, P153, DOI 10.1046/j.1463-6409.2003.00118.x; Snodgrass R.E., 1956, ANATOMY HONEY BEE; Snodgrass RE, 1935, PRINCIPLES INSECT MO; Wolff JO, 2013, SCI REP-UK, V3, DOI 10.1038/srep01101; YOSHIZAWA H, 1993, J PHYS CHEM-US, V97, P4128, DOI 10.1021/j100118a033	31	32	32	5	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0141269	10.1371/journal.pone.0141269	http://dx.doi.org/10.1371/journal.pone.0141269			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559941	Green Published, gold, Green Submitted			2022-12-27	WOS:000364433100028
J	Hsieh, YH				Hsieh, Ying-Hen			Temporal Course of 2014 Ebola Virus Disease (EVD) Outbreak in West Africa Elucidated through Morbidity and Mortality Data: A Tale of Three Countries	PLOS ONE			English	Article							TRANSMISSION; DYNAMICS	The explosive outbreak of Ebola virus disease (EVD) in West Africa in 2014 appeared to have lessened in 2015, but potentially continues be a global public health threat. A simple mathematical model, the Richards model, is utilized to gauge the temporal variability in the spread of the Ebola virus disease (EVD) in West Africa in terms of its reproduction number R and its temporal changes via detection of epidemic waves and turning points during the 2014 outbreaks in the three most severely affected countries; namely, Guinea, Liberia, and Sierra Leone. The results reveal multiple waves of infection in each of these three countries, of varying lengths from a little more than one week to more than one month. All three countries exhibit marginally fluctuating reproduction numbers during June-October before gradually declining. Although high mobility continues between neighboring populations of these countries across the borders, outbreak in these three countries exhibits decidedly different temporal patterns. Guinea had the most waves but maintained consistently low transmissibility and hence has the smallest number of reported cases. Liberia had highest level of transmission before October, but has remained low since, with no detectable wave after the New Year. Sierra Leone has gradually declining waves since October, but still generated detectable waves up to mid-March 2015, and hence has cumulated the largest number of cases-exceeding that of Guinea and Liberia combined. Analysis indicates that, despite massive amount of international relief and intervention efforts, the outbreak is persisting in these regions in waves, albeit more sparsely and at a much lower level since the beginning of 2015.	[Hsieh, Ying-Hen] China Med Univ, Dept Publ Hlth, Taichung 40402, Taiwan; [Hsieh, Ying-Hen] China Med Univ, Ctr Infect Dis Educ & Res, Taichung 40402, Taiwan	China Medical University Taiwan; China Medical University Taiwan	Hsieh, YH (corresponding author), China Med Univ, Dept Publ Hlth, Taichung 40402, Taiwan.	hsieh@mail.cmu.edu.tw	Hsieh, Ying-Hen/E-9685-2010		Taiwan Ministry of Science and Technology (MOST) [103-2314-B-039-010-MY3, 103-2115-M-039-002-MY2]	Taiwan Ministry of Science and Technology (MOST)	YHH is funded by Taiwan Ministry of Science and Technology (MOST) grants (103-2314-B-039-010-MY3 and 103-2115-M-039-002-MY2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althaus Christian L, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.91afb5e0f279e7f29e7056095255b288; Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Camacho A, 2015, PLOS CURRENTS OUTBRE; Chowell G, 2014, PLOS CURRENTS OUTBRE; Chowell G, 2015, PLOS CURRENTS OUTBRE; Fisman D, 2014, PLOS CURRENTS OUTBRE; Getz WM, 2015, COMPUT MATH METHOD M, V2015, DOI 10.1155/2015/736507; Gomes MFC, 2014, PLOS CURRENTS OUTBRE; Hsieh YH, 2009, TROP MED INT HEALTH, V14, P628, DOI 10.1111/j.1365-3156.2009.02277.x; Hsieh YH, 2006, EMERG INFECT DIS, V12, P122, DOI 10.3201/eid1201.050396; Hsieh YH, 2004, EMERG INFECT DIS, V10, P1165, DOI 10.3201/eid1006.031023; Hsieh YH, 2013, INT J INFECT DIS, V17, pE838, DOI 10.1016/j.ijid.2013.01.002; Hsieh YH, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-332; Hsieh YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023853; Hsieh Ying-Hen, 2010, BMC Res Notes, V3, P283, DOI 10.1186/1756-0500-3-283; Hsieh YH, 2010, INFLUENZA OTHER RESP, V4, P187, DOI 10.1111/j.1750-2659.2010.00147.x; Lewnard JA, 2014, LANCET INFECT DIS, V14, P1189, DOI [10.1016/S1473-3099(14)70995-8, 10.1016/s1473-3099(14)70995-8]; Nishiura H, 2014, EUROSURVEILLANCE, V19, P5, DOI 10.2807/1560-7917.ES2014.19.36.20894; Pandey A, 2014, SCIENCE, V346, P991, DOI 10.1126/science.1260612; Plachouras D, 2014, EUROSURVEILLANCE, V19, P22, DOI 10.2807/1560-7917.ES2014.19.37.20907; RICHARDS FJ, 1959, J EXP BOT, V10, P290, DOI 10.1093/jxb/10.2.290; Rivers C. M., 2014, PLOS CURRENTS OUTBRE; Stadler Tanja, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.02bc6d927ecee7bbd33532ec8ba6a25f; Towers S., 2014, PLOS CURRENTS OUTBRE; Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754; Webb G, 2015, PLOS CURRENTS OUTBRE; World Health Organization, 2015, ON YEAR EB EP DEADL; World Health Organization (WHO), 2014, EB VIR DIS UPD W AF; World Health Organization (WHO), 2015, SIT REP; World Health Organization (WHO), 2015, SIT SUMM; Yamin D, 2015, ANN INTERN MED, V162, P11, DOI 10.7326/M14-2255	31	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0140810	10.1371/journal.pone.0140810	http://dx.doi.org/10.1371/journal.pone.0140810			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559945	Green Published, Green Submitted, gold			2022-12-27	WOS:000364433100009
J	Munar, E; Gomez-Puerto, G; Call, J; Nadal, M				Munar, Enric; Gomez-Puerto, Gerardo; Call, Josep; Nadal, Marcos			Common Visual Preference for Curved Contours in Humans and Great Apes	PLOS ONE			English	Article							CHIMPANZEES PAN-TROGLODYTES; TOP-DOWN FACILITATION; HOMO-SAPIENS; PERCEPTION; RECOGNITION; MONKEYS; COLOR; ATTRACTIVENESS; AESTHETICS; COGNITION	Among the visual preferences that guide many everyday activities and decisions, from consumer choices to social judgment, preference for curved over sharp-angled contours is commonly thought to have played an adaptive role throughout human evolution, favoring the avoidance of potentially harmful objects. However, because nonhuman primates also exhibit preferences for certain visual qualities, it is conceivable that humans' preference for curved contours is grounded on perceptual and cognitive mechanisms shared with extant nonhuman primate species. Here we aimed to determine whether nonhuman great apes and humans share a visual preference for curved over sharp-angled contours using a 2-alternative forced choice experimental paradigm under comparable conditions. Our results revealed that the human group and the great ape group indeed share a common preference for curved over sharp-angled contours, but that they differ in the manner and magnitude with which this preference is expressed behaviorally. These results suggest that humans' visual preference for curved objects evolved from earlier primate species' visual preferences, and that during this process it became stronger, but also more susceptible to the influence of higher cognitive processes and preference for other visual features.	[Munar, Enric; Gomez-Puerto, Gerardo] Univ Balearic Isl, CSIC, Human Evolut & Cognit Grp, Associated Grp IFISC, Palma De Mallorca, Balearic Island, Spain; [Call, Josep] Univ St Andrews, Sch Psychol & Neurosci, St Andrews, Fife, Scotland; [Call, Josep] Max Planck Inst Evolutionary Anthropol, Leipzig, Germany; [Nadal, Marcos] Univ Vienna, Dept Basic Psychol Res & Res Methods, Vienna, Austria	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat de les Illes Balears; University of St Andrews; Max Planck Society; University of Vienna	Munar, E (corresponding author), Fac Psychol, Campus Univ, Palma De Mallorca, Balearic Island, Spain.	enric.munar@uib.cat	Munar, Enric/C-7397-2011; Munar, Enric/AAK-4175-2021; Nadal, Marcos/A-5817-2009	Munar, Enric/0000-0001-7330-8389; Nadal, Marcos/0000-0002-9341-4688; Call Balaguer, Josep/0000-0002-8597-8336	Spanish Government Ministerio de Economia y Competitividad [FFI2010-20759, FFI2013-43270-P];  [BES-2011-047441]	Spanish Government Ministerio de Economia y Competitividad(Spanish Government); 	This study was funded by research grants FFI2010-20759 and FFI2013-43270-P from the Spanish Government Ministerio de Economia y Competitividad (http://www.mineco.gob.es). Gerardo Gomez-Puerto was supported by the grant BES-2011-047441. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 1999, NEUROPSYCHOLOGIA, V37, P1111, DOI 10.1016/S0028-3932(99)00039-1; Anderson JR, 2005, J EXP PSYCHOL-ANIM B, V31, P71, DOI 10.1037/0097-7403.31.1.71; Appleton J., 1975, EXPERIENCE LANDSCAPE; Aust U, 2015, J COMP PSYCHOL, V129, P1, DOI 10.1037/a0037691; BALLING JD, 1982, ENVIRON BEHAV, V14, P5, DOI 10.1177/0013916582141001; Bar M, 2003, J COGNITIVE NEUROSCI, V15, P600, DOI 10.1162/089892903321662976; Bar M, 2006, P NATL ACAD SCI USA, V103, P449, DOI 10.1073/pnas.0507062103; Bar M., 2008, J CONSUMER BEHAVIOUR, V7, P319, DOI [10.1002/cb.254, DOI 10.1002/CB.254]; Bar M, 2007, NEUROPSYCHOLOGIA, V45, P2191, DOI 10.1016/j.neuropsychologia.2007.03.008; Bar M, 2006, PSYCHOL SCI, V17, P645, DOI 10.1111/j.1467-9280.2006.01759.x; Carbon CC, 2010, ACTA PSYCHOL, V134, P233, DOI 10.1016/j.actpsy.2010.02.004; Deaner RO, 2005, CURR BIOL, V15, P543, DOI 10.1016/j.cub.2005.01.044; Fagot J, 1999, J COMP PSYCHOL, V113, P3, DOI 10.1037/0735-7036.113.1.3; Fagot J, 2000, PICTURE PERCEPTION A, P295; FANTZ RL, 1975, CHILD DEV, V46, P224, DOI 10.2307/1128853; Fillon CM, 1994, CURRENT PRIMATOLOGY, VII, P111; Fink B, 2006, EVOL HUM BEHAV, V27, P433, DOI 10.1016/j.evolhumbehav.2006.08.007; Fitch WT, 2004, SCIENCE, V303, P377, DOI 10.1126/science.1089401; Gomez-Puerto G, 2015, FRONTIERS H IN PRESS; GUTHRIE G, 1966, J PERS SOC PSYCHOL, V3, P619, DOI 10.1037/h0023197; HUMPHREY N, 1971, NATURE, V229, P615, DOI 10.1038/229615a0; Isbell LA, 2006, J HUM EVOL, V51, P1, DOI 10.1016/j.jhevol.2005.12.012; KAPLAN S, 1987, ENVIRON BEHAV, V19, P3, DOI 10.1177/0013916587191001; Kaplan Stephen., 1992, ADAPTED MIND EVOLUTI, P581; Killinger KM, 2004, J ANIM SCI, V82, P3288; Leder H, 2005, APPL COGNITIVE PSYCH, V19, P603, DOI 10.1002/acp.1088; Leder H, 2011, PERCEPTION, V40, P649, DOI 10.1068/p6845; Leder H, 2010, Q J EXP PSYCHOL, V63, P1858, DOI 10.1080/17470211003605142; Lobue V, 2014, EMOTION, V14, P701, DOI 10.1037/a0035898; MacLean EL, 2012, ANIM COGN, V15, P223, DOI 10.1007/s10071-011-0448-8; Matsuno T, 2008, PERCEPTION, V37, P1258, DOI 10.1068/p5859; Matsuno T, 2009, PRIMATES, V50, P121, DOI 10.1007/s10329-008-0128-8; Mende-Siedlecki P, 2013, SOC COGN AFFECT NEUR, V8, P285, DOI 10.1093/scan/nsr090; MIRANDA SB, 1973, CHILD DEV, V44, P555; Munar E, 2014, PHILOS HIST CULTURE, V34, P3; Orians GH, 1992, ADAPTED MIND EVOLUTI, P556; Palmer SE, 2013, ANNU REV PSYCHOL, V64, P77, DOI 10.1146/annurev-psych-120710-100504; Rosen LH, 2010, J SCHOOL PSYCHOL, V48, P313, DOI 10.1016/j.jsp.2010.03.001; Schaefer K., 2006, PSYCHOL SCI, V48, P187; Silvia P.J., 2009, EMPIR STUD ARTS, V27, P25, DOI [DOI 10.2190/EM.27.1.B, 10.2190/em.27.1.b]; Tanaka M, 2003, PRIMATES, V44, P157, DOI 10.1007/s10329-002-0022-8; Townsend C, 2014, J CONSUM RES, V40, P993, DOI 10.1086/673521; Ulrich RogerS., 1977, MAN ENV SYSTEMS, V7, P279; Vartanian O, 2013, P NATL ACAD SCI USA, V110, P10446, DOI 10.1073/pnas.1301227110; Westerman SJ, 2012, PSYCHOL MARKET, V29, P595, DOI 10.1002/mar.20546	45	49	49	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0141106	10.1371/journal.pone.0141106	http://dx.doi.org/10.1371/journal.pone.0141106			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7DR	26558754	Green Submitted, Green Published, gold			2022-12-27	WOS:000364433100020
J	Votavova, A; Tomcala, A; Kofronova, E; Kudzejova, M; Sobotnik, J; Jiros, P; Komzakova, O; Valterova, I				Votavova, Alena; Tomcala, Ales; Kofronova, Edita; Kudzejova, Michaela; Sobotnik, Jan; Jiros, Pavel; Komzakova, Olga; Valterova, Irena			Seasonal Dynamics in the Chemistry and Structure of the Fat Bodies of Bumblebee Queens	PLOS ONE			English	Article							MALE LABIAL GLAND; BOMBUS-TERRESTRIS; FUNCTIONAL-DIFFERENTIATION; PYRRHOCORIS-APTERUS; BODY; INSECT; TRIACYLGLYCEROLS; TEMPERATURE; METABOLISM; DIAPAUSE	Insects' fat bodies are responsible for nutrient storage and for a significant part of intermediary metabolism. Thus, it can be expected that the structure and content of the fat body will adaptively change, if an insect is going through different life stages. Bumblebee queens belong to such insects as they dramatically change their physiology several times over their lives in relation to their solitary overwintering, independent colony foundation stage, and during the colony life-cycle ending in the senescent stage. Here, we report on changes in the ultrastructure and lipid composition of the peripheral fat body of Bombus terrestris queens in relation to seasonal changes in the queens' activity. Six life stages are defined and evaluated in particular: pharate, callow, before and after hibernation, egg-laying, and senescence. Transmission electron microscopy revealed that the fat body contained two main cell types-adipocytes and oenocytes. Only adipocytes reveal important changes related to the life phase, and mostly the ration between inclusion and cytoplasm volume varies among particular stages. Both electron microscopy and chemical analyses of lipids highlighted seasonal variability in the quantity of the stored lipids, which peaked prior to hibernation. Triacylglycerols appeared to be the main energy source during hibernation, while the amount of glycogen before and after hibernation remained unchanged. In addition, we observed that the representation of some fatty acids within the triacylglycerols change during the queen's life. Last but not least, we show that fat body cell membranes do not undergo substantial changes concerning phospholipid composition in relation to overwintering. This finding supports the hypothesis that the cold-adaptation strategy of bumblebee queens is more likely to be based on polyol accumulation than on the restructuring of lipid membranes.	[Votavova, Alena; Komzakova, Olga] Agr Res Ltd, Troubsko, Czech Republic; [Tomcala, Ales; Kofronova, Edita; Kudzejova, Michaela; Jiros, Pavel; Valterova, Irena] Acad Sci Czech Republic, Inst Organ Chem & Biochem, Prague, Czech Republic; [Tomcala, Ales] Acad Sci Czech Republic, Ctr Biol, Inst Parasitol, Ceske Budejovice, Czech Republic; [Sobotnik, Jan] Czech Univ Life Sci, Fac Forestry & Wood Sci, Prague, Czech Republic	Research Institute for Fodder Crops, Ltd. Troubsko; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Czech University of Life Sciences Prague	Valterova, I (corresponding author), Acad Sci Czech Republic, Inst Organ Chem & Biochem, Prague, Czech Republic.	irena@uochb.cas.cz	Kofronova, Edita/H-7018-2014; Tomčala, Aleš/G-5717-2014	Tomčala, Aleš/0000-0002-5232-8441; Sobotnik, Jan/0000-0002-8581-637X; Valterova, Irena/0000-0001-5723-6143	Czech Science Foundation [14-04291S]; Institute of Organic Chemistry and Biochemistry [61388963]; Internal Grant Agency of Faculty of Forestry and Wood Sciences [20134359]; Agricultural Research, Ltd.	Czech Science Foundation(Grant Agency of the Czech Republic); Institute of Organic Chemistry and Biochemistry; Internal Grant Agency of Faculty of Forestry and Wood Sciences; Agricultural Research, Ltd.	This work was supported by the Czech Science Foundation (14-04291S); http://www.gacr.cz/; IV OK AV, Institute of Organic Chemistry and Biochemistry (61388963); http://www.uochb.cz/web/structure/31.html; IV AT EK MK PJ, Internal Grant Agency of Faculty of Forestry and Wood Sciences (20134359); http://www.fld.czu.cz/cs/; JS, and Agricultural Research, Ltd. The funder provided support in the form of salaries for authors [A.V., O.K.], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ALFORD D V, 1969, Journal of Apicultural Research, V8, P37; ALFORD DV, 1969, J ANIM ECOL, V38, P149, DOI 10.2307/2743; Banda H. J., 1991, Acta Horticulturae, P194; BEENAKKERS AMT, 1985, PROG LIPID RES, V24, P19; Benett VA, 1997, J COMP PHYSIOL B, V167, P249; BUCHMANN SL, 1978, J THEOR BIOL, V72, P639, DOI 10.1016/0022-5193(78)90277-1; Burmester T, 1999, EUR J ENTOMOL, V96, P213; Canavoso LE, 2001, ANNU REV NUTR, V21, P23, DOI 10.1146/annurev.nutr.21.1.23; Coppee A, 2011, CHEMOECOLOGY, V21, P75, DOI 10.1007/s00049-011-0070-x; Cvacka J, 2006, J CHROMATOGR A, V1101, P226, DOI 10.1016/j.chroma.2005.10.001; Cvacka J, 2008, LIPIDS, V43, P441, DOI 10.1007/s11745-008-3174-5; DANKS SM, 1979, J THERM BIOL, V4, P183, DOI 10.1016/0306-4565(79)90035-4; Downer GHR, 1978, BIOCH INSECTS, P58; DUCHATEAU MJ, 1988, BEHAVIOUR, V107, P186, DOI 10.1163/156853988X00340; Fliszkiewicz Monika, 2007, Journal of Apicultural Science, V51, P55; Hahn DA, 2011, ANNU REV ENTOMOL, V56, P103, DOI 10.1146/annurev-ento-112408-085436; HARWOOD JL, 1994, PORTL PR P, P107; HAUNERLAND NH, 1995, ANNU REV ENTOMOL, V40, P121, DOI 10.1146/annurev.en.40.010195.001005; HOLM S N, 1972, Entomologica Scandinavica, V3, P313; Jensen PV, 2000, ARTHROPOD STRUCT DEV, V29, P171, DOI 10.1016/S1467-8039(00)00021-9; Jiros P, 2011, LIPIDS, V46, P863, DOI 10.1007/s11745-011-3581-x; Kofronova E, 2009, EUR J LIPID SCI TECH, V111, P519, DOI 10.1002/ejlt.200800228; Kostal V, 2004, PHYSIOL ENTOMOL, V29, P344, DOI 10.1111/j.0307-6962.2004.00396.x; Kostal V, 2004, J INSECT PHYSIOL, V50, P303, DOI 10.1016/j.jinsphys.2004.01.006; Kostal V, 1998, J COMP PHYSIOL B, V168, P453, DOI 10.1007/s003600050165; Martin SJ, 2010, J CHEM ECOL, V36, P855, DOI 10.1007/s10886-010-9805-3; Ptacek V, 2010, ZAKLADY HROMADNEHO C, P34; ROSELER PF, 1986, INSECT BIOCHEM, V16, P501, DOI 10.1016/0020-1790(86)90027-2; Schmid-Hempel R, 2000, INSECT SOC, V47, P36, DOI 10.1007/s000400050006; Sladen FWL, 1912, THE BUMBLEBEE; Sobotnik J, 2008, J INSECT PHYSIOL, V54, P204, DOI 10.1016/j.jinsphys.2007.09.003; Sobotnik J, 2006, MICRON, V37, P648, DOI 10.1016/j.micron.2006.01.012; STANLEYSAMUELSON DW, 1988, ARCH INSECT BIOCHEM, V9, P1, DOI 10.1002/arch.940090102; STOREY JM, 1986, J INSECT PHYSIOL, V32, P549, DOI 10.1016/0022-1910(86)90070-3; Storey K.B., 1991, P64; Tomcala A, 2006, J EXP BIOL, V209, P4102, DOI 10.1242/jeb.02484; Tomcala A, 2010, COMP BIOCHEM PHYS B, V156, P26, DOI 10.1016/j.cbpb.2010.01.015; Vesterlund SR, 2014, INSECT SOC, V61, P265, DOI 10.1007/s00040-014-0351-9; Zacek P, 2009, J CHEM ECOL, V35, P698, DOI 10.1007/s10886-009-9650-4	39	16	16	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142261	10.1371/journal.pone.0142261	http://dx.doi.org/10.1371/journal.pone.0142261			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559946	Green Published, Green Submitted, gold			2022-12-27	WOS:000364433100068
J	Gross, AM; Kreisberg, JF; Ideker, T				Gross, Andrew M.; Kreisberg, Jason F.; Ideker, Trey			Analysis of Matched Tumor and Normal Profiles Reveals Common Transcriptional and Epigenetic Signals Shared across Cancer Types	PLOS ONE			English	Article							CELL-PROLIFERATION; GENE-EXPRESSION; SYSTEM; LANDSCAPE; PATHWAYS	To identify the transcriptional regulatory changes that are most widespread in solid tumors, we performed a pan-cancer analysis using over 600 pairs of tumors and adjacent normal tissues profiled in The Cancer Genome Atlas (TCGA). Frequency of upregulation was calculated across mRNA expression levels, microRNA expression levels and CpG methylation sites and is provided here as a resource. Frequent tumor-associated alterations were identified using a simple statistical approach. Many of the identified changes were consistent with the increased rate of cell division in cancer, such as the overexpression of cell cycle genes and hypermethylation of PRC2 binding sites. However, we also identified proliferation-independent alterations, which highlight novel pathways essential to tumor formation. Nearly all of the GABA receptors are frequently downregulated, with the gene encoding the delta subunit (GABRD) strongly upregulated as the notable exception. Metabolic genes are also frequently downregulated, particularly alcohol dehydrogenases and others consistent with the decreased role of oxidative phosphorylation in cancerous cells. Alterations in the composition of GABA receptors and metabolism may play a key role in the differentiation of cancer cells, independent of proliferation.	[Gross, Andrew M.; Ideker, Trey] Univ Calif San Diego, Bioinformat & Syst Biol Program, La Jolla, CA 92093 USA; [Kreisberg, Jason F.; Ideker, Trey] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Ideker, T (corresponding author), Univ Calif San Diego, Bioinformat & Syst Biol Program, La Jolla, CA 92093 USA.	tideker@ucsd.edu		Kreisberg, Jason/0000-0002-3616-079X; Ideker, Trey/0000-0002-1708-8454	US National Institute of General Medical Sciences [P50 GM085764, P41 GM103504-04]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM085764, P41GM103504] Funding Source: NIH RePORTER	US National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the US National Institute of General Medical Sciences, Grant # P50 GM085764 to TI and JFK and the US National Institute of General Medical Sciences, Grant # P41 GM103504-04 to TI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bottos A, 2009, P NATL ACAD SCI USA, V106, P20782, DOI 10.1073/pnas.0809510106; Broad Institute TCGA Genome Data Analysis Center, 2015, AN READ STAND TCGA D; Cheng WY, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002920; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Evan GI, 2001, NATURE, P411; Gardina PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-325; Geigerseder C, 2003, NEUROENDOCRINOLOGY, V77, P314, DOI 10.1159/000070897; Gentles AJ, 2015, NAT MED, V21, P938, DOI 10.1038/nm.3909; Hamfjord J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034150; Bueno MJ, 2008, CELL CYCLE, V7, P3143, DOI 10.4161/cc.7.20.6833; Kobayashi Y, 2011, GENOME RES, V21, P1017, DOI 10.1101/gr.119487.110; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Mele M, 2015, SCIENCE, V348, P660, DOI 10.1126/science.aaa0355; Notterman DA, 2001, CANCER RES, V61, P3124; NUSSER Z, 1995, J NEUROSCI, V15, P2948; Perez F, 2007, COMPUT SCI ENG, V9, P21, DOI 10.1109/MCSE.2007.53; Rahman M, 2015, BIOINFORMATICS, pbtv377; Schell JC, 2014, MOL CELL, V56, P400, DOI 10.1016/j.molcel.2014.09.026; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Seo JS, 2012, GENOME RES, V22, P2109, DOI 10.1101/gr.145144.112; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tamagnone L, 2012, CANCER CELL, V22, P145, DOI 10.1016/j.ccr.2012.06.031; Terunuma A, 2014, J CLIN INVEST, V124, P398, DOI 10.1172/JCI71180; Tian JD, 2004, J IMMUNOL, V173, P5298, DOI 10.4049/jimmunol.173.8.5298; Venet D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002240; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Wierstra I, 2007, BIOL CHEM, V388, P1257, DOI 10.1515/BC.2007.159; Young SZ, 2009, PHYSIOLOGY, V24, P171, DOI 10.1152/physiol.00002.2009	31	28	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142618	10.1371/journal.pone.0142618	http://dx.doi.org/10.1371/journal.pone.0142618			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555223	Green Published, Green Submitted, gold			2022-12-27	WOS:000364430700141
J	Huibers, MJH; Cohen, ZD; Lemmens, LHJM; Arntz, A; Peeters, FPML; Cuijpers, P; DeRubeis, RJ				Huibers, Marcus J. H.; Cohen, Zachary D.; Lemmens, Lotte H. J. M.; Arntz, Arnoud; Peeters, Frenk P. M. L.; Cuijpers, Pim; DeRubeis, Robert J.			Predicting Optimal Outcomes in Cognitive Therapy or Interpersonal Psychotherapy for Depressed Individuals Using the Personalized Advantage Index Approach	PLOS ONE			English	Article							COLLABORATIVE RESEARCH-PROGRAM; RANDOMIZED CLINICAL-TRIALS; MENTAL-HEALTH TREATMENT; BEHAVIORAL THERAPY; MAJOR DEPRESSION; NATIONAL-INSTITUTE; DISORDER; MEDICATION; PHARMACOTHERAPY; MODERATORS	Introduction Although psychotherapies for depression produce equivalent outcomes, individual patients respond differently to different therapies. Predictors of outcome have been identified in the context of randomized trials, but this information has not been used to predict which treatment works best for the depressed individual. In this paper, we aim to replicate a recently developed treatment selection method, using data from an RCT comparing the effects of cognitive therapy (CT) and interpersonal psychotherapy (IPT). Methods 134 depressed patients completed the pre- and post-treatment BDI-II assessment. First, we identified baseline predictors and moderators. Second, individual treatment recommendations were generated by combining the identified predictors and moderators in an algorithm that produces the Personalized Advantage Index (PAI), a measure of the predicted advantage in one therapy compared to the other, using standard regression analyses and the leave-one-out cross-validation approach. Results We found five predictors (gender, employment status, anxiety, personality disorder and quality of life) and six moderators (somatic complaints, cognitive problems, paranoid symptoms, interpersonal self-sacrificing, attributional style and number of life events) of treatment outcome. The mean average PAI value was 8.9 BDI points, and 63% of the sample was predicted to have a clinically meaningful advantage in one of the therapies. Those who were randomized to their predicted optimal treatment (either CT or IPT) had an observed mean end-BDI of 11.8, while those who received their predicted non-optimal treatment had an end-BDI of 17.8 (effect size for the difference = 0.51). Discussion Depressed patients who were randomized to their predicted optimal treatment fared much better than those randomized to their predicted non-optimal treatment. The PAI provides a great opportunity for formal decision-making to improve individual patient outcomes in depression. Although the utility of the PAI approach will need to be evaluated in prospective research, this study promotes the development of a treatment selection approach that can be used in regular mental health care, advancing the goals of personalized medicine.	[Huibers, Marcus J. H.; Cuijpers, Pim; DeRubeis, Robert J.] Vrije Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands; [Huibers, Marcus J. H.; Cohen, Zachary D.; DeRubeis, Robert J.] Univ Penn, Dept Psychol, Philadelphia, PA 19104 USA; [Lemmens, Lotte H. J. M.] Maastricht Univ, Dept Clin Psychol Sci, NL-6200 MD Maastricht, Netherlands; [Arntz, Arnoud] Univ Amsterdam, Dept Clin Psychol, NL-1018 WB Amsterdam, Netherlands; [Peeters, Frenk P. M. L.] Maastricht Univ, Dept Psychiat, NL-6200 MD Maastricht, Netherlands	Vrije Universiteit Amsterdam; University of Pennsylvania; Maastricht University; University of Amsterdam; Maastricht University	Huibers, MJH (corresponding author), Vrije Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands.	m.j.h.huibers@vu.nl	Arntz, Arnoud/M-3011-2013; Cuijpers, Pim/G-1703-2013; Cohen, Zachary/A-8946-2013	Arntz, Arnoud/0000-0002-7992-2272; Cohen, Zachary/0000-0002-4883-1028; Huibers, Marcus/0000-0002-9150-4049; Peeters, F/0000-0002-6167-8582; DeRubeis, Robert/0000-0003-3129-0277; Lemmens, Lotte/0000-0002-2037-1808	MQ: Transforming mental health [MQ14PM_27]; MQ: Transforming Mental Health [MQ14PM27] Funding Source: researchfish	MQ: Transforming mental health; MQ: Transforming Mental Health	Robert J. DeRubeis and Zachary D. Cohen are supported in part by a grant from MQ: Transforming mental health MQ14PM_27. The opinions and assertions contained in this article should not be construed as reflecting the views of the sponsor.	Barber JP, 1996, J CONSULT CLIN PSYCH, V64, P951, DOI 10.1037/0022-006X.64.5.951; Beck A, 1979, COGNITIVE THERAPY DE; Beck AT, 1996, PSYCHOL ASSESS; Bellino S, 2007, CAN J PSYCHIAT, V52, P718, DOI 10.1177/070674370705201106; Carter JD, 2011, J AFFECT DISORDERS, V128, P252, DOI 10.1016/j.jad.2010.07.002; Cuijpers P, 2012, DEPRESS ANXIETY, V29, P855, DOI 10.1002/da.21985; Cuijpers P, 2009, J CLIN PSYCHIAT, V70, P1219, DOI 10.4088/JCP.09r05021; DeRubeis RJ, 2005, ARCH GEN PSYCHIAT, V62, P409, DOI 10.1001/archpsyc.62.4.409; DeRubeis RJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083875; EFRON B, 1983, AM STAT, V37, P36, DOI 10.2307/2685844; ELKIN I, 1989, ARCH GEN PSYCHIAT, V46, P971; ELKIN I, 1995, J CONSULT CLIN PSYCH, V63, P841, DOI 10.1037/0022-006X.63.5.841; First M.B., 2014, STRUCTURED CLIN INTE; Fournier JC, 2008, BRIT J PSYCHIAT, V192, P124, DOI 10.1192/bjp.bp.107.037234; Fournier JC, 2009, J CONSULT CLIN PSYCH, V77, P775, DOI 10.1037/a0015401; Hamburg MA, 2010, NEW ENGL J MED, V363, P301, DOI 10.1056/NEJMp1006304; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hiroe T, 2005, PSYCHIAT RES, V135, P229, DOI 10.1016/j.psychres.2004.03.014; Huibers MJH, 2014, J AFFECT DISORDERS, V152, P146, DOI 10.1016/j.jad.2013.08.027; Jakobsen JC, 2012, PSYCHOL MED, V42, P1343, DOI 10.1017/S0033291711002236; Joyce PR, 2007, BRIT J PSYCHIAT, V190, P503, DOI 10.1192/bjp.bp.106.024737; Kazdin AE, 2007, ANNU REV CLIN PSYCHO, V3, P1, DOI 10.1146/annurev.clinpsy.3.022806.091432; Klerman GL, 1984, INTERPERSONAL PSYCHO; Kraemer HC, 2004, INT J METH PSYCH RES, V13, P141, DOI 10.1002/mpr.170; Kraemer HC, 2002, ARCH GEN PSYCHIAT, V59, P877, DOI 10.1001/archpsyc.59.10.877; Kraemer HC, 2013, STAT MED, V32, P1964, DOI 10.1002/sim.5734; Lemmens L. H. J. M., 2015, PSYCHOL MED, P1; Lemmens LHJM, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-150; Leykin Y, 2007, J CONSULT CLIN PSYCH, V75, P267, DOI 10.1037/0022-006X.75.2.267; Luty SE, 2007, BRIT J PSYCHIAT, V190, P496, DOI 10.1192/bjp.bp.106.024729; NEIMEYER RA, 1990, J COGNITIVE PSYCHOTH, V4, P23; Quilty LC, 2008, PSYCHOL MED, V38, P1531, DOI 10.1017/S0033291708003772; Simon GE, 2010, AM J PSYCHIAT; SOTSKY SM, 1991, AM J PSYCHIAT, V148, P997; van Schaik DJF, 2004, GEN HOSP PSYCHIAT, V26, P184, DOI 10.1016/j.genhosppsych.2003.12.001; Winter SE, 2013, PATIENT PREFER ADHER, V7, P1047, DOI 10.2147/PPA.S52746	36	92	93	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0140771	10.1371/journal.pone.0140771	http://dx.doi.org/10.1371/journal.pone.0140771			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7CT	26554707	Green Published, gold, Green Submitted			2022-12-27	WOS:000364430700016
J	Kraan, C; Dormann, CF; Greenfield, BL; Thrush, SF				Kraan, Casper; Dormann, Carsten F.; Greenfield, Barry L.; Thrush, Simon F.			Cross-Scale Variation in Biodiversity-Environment Links Illustrated by Coastal Sandflat Communities	PLOS ONE			English	Article							SPATIAL STRUCTURE; ECOLOGICAL DATA; SPECIES DISTRIBUTIONS; BIVALVES; AUTOCORRELATION; PATTERNS	Spatial variation in the composition of communities is the product of many biotic and environmental interactions. A neglected factor in the analysis of community distribution patterns is the multi-scale nature of the data, which has implications for understanding ecological processes and the development of conservation and environmental management practice. Drawing on recently established multivariate spatial analyses, we investigate whether including relationships between spatial structure and abiotic variables enable us to better discern patterns of species and communities across scales. Data comprised 1200 macro-zoobenthic samples collected over an array of distances (30 cm to 1 km) in three New Zealand harbours, as well as commonly used abiotic variables, such as sediment characteristics and chlorophyll a concentrations, measured at the same scales. Moran's eigenvector mapping was used to extract spatial scales at which communities were structured. Benthic communities, representing primarily bivalves, polychaetes and crustaceans, were spatially structured at four spatial scales, i.e. > 100 m, 50-100 m, 50-15 m, and < 15 m. A broad selection of abiotic variables contributed to the large-scale variation, whereas a more limited set explained part of the fine-scale community structure. Across all scales, less than 30% of the variation in spatial structure was captured by our analysis. The large number of species (48) making up the 10 highest species scores based on redundancy analyses illustrate the variability of species-scale associations. Our results emphasise that abiotic variables and biodiversity are related at all scales investigated and stress the importance of assessing the relationship between environmental variables and the abundance and distribution of biological assemblages across a range of different scales.	[Kraan, Casper; Greenfield, Barry L.; Thrush, Simon F.] Natl Inst Water & Atmospher Res, Hamilton, New Zealand; [Kraan, Casper; Dormann, Carsten F.] Univ Freiburg, Biometry & Environm Syst Anal, D-79106 Freiburg, Germany; [Thrush, Simon F.] Univ Auckland, Inst Marine Sci, Auckland 1, New Zealand	National Institute of Water & Atmospheric Research (NIWA) - New Zealand; University of Freiburg; University of Auckland	Kraan, C (corresponding author), Natl Inst Water & Atmospher Res, Hamilton, New Zealand.	casper.kraan@gmail.com		Thrush, Simon/0000-0002-4005-3882; Kraan, Casper/0000-0003-2062-6222; Dormann, Carsten/0000-0002-9835-1794	Marie-Curie International Outgoing Fellowship [298380]; Marsden fund of the Royal Society of New Zealand [NIW1102]	Marie-Curie International Outgoing Fellowship; Marsden fund of the Royal Society of New Zealand(Royal Society of New ZealandMarsden Fund (NZ))	Funding: CK was funded by a Marie-Curie International Outgoing Fellowship (298380). CK, CFD, BLG, and SFT were funded by the Marsden fund of the Royal Society of New Zealand (NIW1102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MB, 2007, GLOBAL ECOL BIOGEOGR, V16, P743, DOI 10.1111/j.1466-8238.2007.00359.x; Bellier E, 2007, ECOGRAPHY, V30, P385, DOI [10.1111/j.2007.0906-7590.04911.x, 10.1111/j.0906-7590.2007.04911.x]; Belmaker J, 2011, GLOBAL ECOL BIOGEOGR, V20, P464, DOI 10.1111/j.1466-8238.2010.00615.x; Benedetti-Cecchi L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012946; Blanchet FG, 2008, ECOLOGY, V89, P2623, DOI 10.1890/07-0986.1; Borcard D, 2002, ECOL MODEL, V153, P51, DOI 10.1016/S0304-3800(01)00501-4; Borcard D, 2004, ECOLOGY, V85, P1826, DOI 10.1890/03-3111; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Chapman MG, 2008, MAR ECOL PROG SER, V354, P147, DOI 10.3354/meps07205; Cressie NAC, 1993, SPATIAL STAT SPATIAL; Dormann CF, 2007, BASIC APPL ECOL, V8, P387, DOI 10.1016/j.baae.2006.11.001; Dray S, 2012, ECOL MONOGR, V82, P257, DOI 10.1890/11-1183.1; Dray S, 2006, ECOL MODEL, V196, P483, DOI 10.1016/j.ecolmodel.2006.02.015; Gray J.S., 2009, ECOLOGY MARINE SEDIM, Vsecond; Hewitt JE, 1997, J EXP MAR BIOL ECOL, V216, P77, DOI 10.1016/S0022-0981(97)00091-9; Jombart T, 2009, ECOGRAPHY, V32, P161, DOI 10.1111/j.1600-0587.2008.05567.x; Jones HFE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027065; Jones MM, 2011, GLOBAL ECOL BIOGEOGR, V20, P558, DOI 10.1111/j.1466-8238.2010.00627.x; Keil P, 2014, DIVERS DISTRIB, V20, P797, DOI 10.1111/ddi.12199; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Kraan C, 2010, ECOLOGY, V91, P1583, DOI 10.1890/09-2040.1; Kraan C, 2009, MAR ECOL PROG SER, V383, P211, DOI 10.3354/meps07994; Legendre P, 1997, J EXP MAR BIOL ECOL, V216, P99, DOI 10.1016/S0022-0981(97)00092-0; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Legendre P, 2013, NUMERICAL ECOLOGY; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Lohrer AM, 2015, SCI REP-UK, V5, DOI 10.1038/srep10349; McGill BJ, 2010, SCIENCE, V328, P575, DOI 10.1126/science.1188528; Murphy RJ, 2008, MAR ECOL PROG SER, V365, P45, DOI 10.3354/meps07456; Needham HR, 2011, ECOSYSTEMS, V14, P1096, DOI 10.1007/s10021-011-9468-0; Peres-Neto PR, 2010, GLOBAL ECOL BIOGEOGR, V19, P174, DOI 10.1111/j.1466-8238.2009.00506.x; R Development Core Team, 2012, R LANG ENV STAT COMP; Rietkerk M, 2008, TRENDS ECOL EVOL, V23, P169, DOI 10.1016/j.tree.2007.10.013; Schneider DC, 2001, BIOSCIENCE, V51, P545, DOI 10.1641/0006-3568(2001)051[0545:TROTCO]2.0.CO;2; Sharma S, 2011, ECOGRAPHY, V34, P762, DOI 10.1111/j.1600-0587.2010.06811.x; Thrush SF, 2012, ECOL APPL, V22, P1213, DOI 10.1890/11-1403.1; THRUSH SF, 1989, MAR BIOL, V102, P529, DOI 10.1007/BF00438355; Thrush SF, 2003, MAR ECOL PROG SER, V263, P101, DOI 10.3354/meps263101; THRUSH SF, 1991, TRENDS ECOL EVOL, V6, P75, DOI 10.1016/0169-5347(91)90178-Z; Thrush SF, 2009, P ROY SOC B-BIOL SCI, V276, P3209, DOI 10.1098/rspb.2009.0661; Underwood AJ, 1998, OECOLOGIA, V117, P570, DOI 10.1007/s004420050694; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; Wisz MS, 2013, BIOL REV, V88, P15, DOI 10.1111/j.1469-185X.2012.00235.x	44	15	15	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142411	10.1371/journal.pone.0142411	http://dx.doi.org/10.1371/journal.pone.0142411			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555237	Green Published, Green Submitted, gold			2022-12-27	WOS:000364430700101
J	Liao, CX; Gao, WJ; Cao, WH; Lv, J; Yu, CQ; Wang, SF; Zhou, B; Pang, ZC; Cong, LM; Wang, H; Wu, XP; Li, LM				Liao, Chunxiao; Gao, Wenjing; Cao, Weihua; Lv, Jun; Yu, Canqing; Wang, Shengfeng; Zhou, Bin; Pang, Zengchang; Cong, Liming; Wang, Hua; Wu, Xianping; Li, Liming			Associations of Body Composition Measurements with Serum Lipid, Glucose and Insulin Profile: A Chinese Twin Study	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; MASS INDEX; METABOLIC SYNDROME; WAIST CIRCUMFERENCE; VISCERAL OBESITY; RESISTANCE; ADIPOSITY; WOMEN; FAT; UPDATE	Objectives To quantitate and compare the associations of various body composition measurements with serum metabolites and to what degree genetic or environmental factors affect obesity-metabolite relation. Methods Body mass index (BMI), waist circumference (WC), lean body mass (LBM), percent body fat (PBF), fasting serum high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C), triglycerides (TG), total cholesterol (TC), glucose, insulin and lifestyle factors were assessed in 903 twins from Chinese National Twin Registry (CNTR). Homeostasis model assessment of insulin resistance (HOMA-IR) was calculated from fasting serum glucose and insulin. Linear regression models and bivariate structural equation models were used to examine the relation of various body composition measurements with serum metabolite levels and genetic/environmental influences on these associations, respectively. Results At individual level, adiposity measurements (BMI, WC and PBF) showed significant associations with serum metabolite concentrations in both sexes and the associations still existed in male twins when using within-MZ twin pair comparison analyses. Associations of BMI with TG, insulin and HOMA-IR were significantly stronger in male twins compared to female twins (BMI-by-sex interaction p = 0.043, 0.020 and 0.019, respectively). Comparison of various adiposity measurements with levels of serum metabolites revealed that WC explained the largest fraction of variance in serum LDL-C, TG, TC and glucose concentrations while BMI performed best in explaining variance in serum HDL-C, insulin and HOMA-IR levels. Of these phenotypic correlations, 64-81% were attributed to genetic factors, whereas 19-36% were attributed to unique environmental factors. Conclusions We observed different associations between adiposity and serum metabolite profile and demonstrated that WC and BMI explained the largest fraction of variance in serum lipid profile and insulin resistance, respectively. To a large degree, shared genetic factors contributed to these associations with the remaining explained by twin-specific environmental factors.	[Liao, Chunxiao; Gao, Wenjing; Cao, Weihua; Lv, Jun; Yu, Canqing; Wang, Shengfeng; Zhou, Bin; Li, Liming] Peking Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Beijing 100871, Peoples R China; [Pang, Zengchang] Qingdao Ctr Dis Control & Prevent, Qingdao, Peoples R China; [Cong, Liming] Zhejiang Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Wang, Hua] Jiangsu Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Wu, Xianping] Sichuan Ctr Dis Control & Prevent, Chengdu, Peoples R China	Peking University; Jiangsu Provincial Center for Disease Control & Prevention	Gao, WJ (corresponding author), Peking Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Beijing 100871, Peoples R China.	gaowenjing1979@gmail.com; lmlee@vip.163.com	Lv, Jun/O-4746-2019	Lv, Jun/0000-0001-7916-3870	Key Project of Chinese Ministry of Education [310006]; National Natural Science Foundation of China [81202264]; Specific Research Project of Health Public Service, Ministry of Health, China [201002007]	Key Project of Chinese Ministry of Education(Ministry of Education, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specific Research Project of Health Public Service, Ministry of Health, China	This study was supported Key Project of Chinese Ministry of Education (310006), National Natural Science Foundation of China (81202264) and the Specific Research Project of Health Public Service, Ministry of Health, China (201002007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; [Anonymous], 2000, WHO TECH REP SER, V894, P1; Benyamin B, 2007, DIABETOLOGIA, V50, P1880, DOI 10.1007/s00125-007-0758-1; Beydoun MA, 2011, PUBLIC HEALTH NUTR, V14, P77, DOI 10.1017/S1368980010002648; Brochu M, 2008, OBESITY, V16, P1085, DOI 10.1038/oby.2008.23; Carlin JB, 2005, INT J EPIDEMIOL, V34, P1089, DOI 10.1093/ije/dyi153; Chien KL, 2011, NUTR METAB CARDIOVAS, V21, P643, DOI 10.1016/j.numecd.2010.01.007; De Moor MHM, 2008, ARCH GEN PSYCHIAT, V65, P897, DOI 10.1001/archpsyc.65.8.897; Dervaux N, 2008, ATHEROSCLEROSIS, V201, P413, DOI 10.1016/j.atherosclerosis.2007.11.032; Duan HP, 2011, OBESITY FACTS, V4, P99, DOI 10.1159/000327735; Edwards KL, 1997, GENET EPIDEMIOL, V14, P241, DOI 10.1002/(SICI)1098-2272(1997)14:3<241::AID-GEPI3>3.0.CO;2-8; Farb MG, 2015, HORM MOL BIOL CLIN I, V21, P125, DOI 10.1515/hmbci-2014-0047; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Gonzalez AS, 2007, NUTRITION, V23, P36, DOI 10.1016/j.nut.2006.08.019; Gravholt CH, 2001, DIABETES CARE, V24, P1668, DOI 10.2337/diacare.24.9.1668; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Hjelmborg JVB, 2008, OBESITY, V16, P847, DOI 10.1038/oby.2007.135; Janssen I, 2004, AM J CLIN NUTR, V79, P379; Katz EG, 2011, METAB SYNDR RELAT D, V9, P55, DOI 10.1089/met.2010.0045; Kaye SM, 2013, OBESITY, V21, P1815, DOI 10.1002/oby.20228; Kettunen J, 2012, NAT GENET, V44, P269, DOI 10.1038/ng.1073; Klop B, 2013, NUTRIENTS, V5, P1218, DOI 10.3390/nu5041218; Lahmann PH, 2002, OBES RES, V10, P361, DOI 10.1038/oby.2002.50; Lee K, 2008, NUTRITION, V24, P625, DOI 10.1016/j.nut.2008.03.004; Li LM, 2013, TWIN RES HUM GENET, V16, P86, DOI 10.1017/thg.2012.148; Martyn JAJ, 2008, ANESTHESIOLOGY, V109, P137, DOI 10.1097/ALN.0b013e3181799d45; Marucci A, 2015, ACTA DIABETOL; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Morris C, 2012, P NUTR SOC, V71, P634, DOI 10.1017/S0029665112000699; Muller MJ, 2012, OBES REV, V13, P6, DOI 10.1111/j.1467-789X.2012.01033.x; Nagaya T, 1999, INT J OBESITY, V23, P771, DOI 10.1038/sj.ijo.0800961; Ng M, 2014, LANCET, DOI [10.1016/S2352-3018(14)00037-X, DOI 10.1016/S2352-3018(14)00037-X]; Ouyang FX, 2010, AM J CLIN NUTR, V91, P662, DOI 10.3945/ajcn.2009.28750; Ouyang FX, 2009, EUR J NUTR, V48, P323, DOI 10.1007/s00394-009-0016-z; Poulsen P, 2001, DIABETOLOGIA, V44, P537, DOI 10.1007/s001250051659; Ronnemaa T, 1998, J CLIN ENDOCR METAB, V83, P2792, DOI 10.1210/jc.83.8.2792; Samaras K, 1999, Twin Res, V2, P218, DOI 10.1375/twin.2.3.218; Schousboe K, 2003, TWIN RES, V6, P409, DOI 10.1375/twin.6.5.409; Shalev-Goldman E, 2014, APPL PHYSIOL NUTR ME, V39, P358, DOI 10.1139/apnm-2013-0160; Shi YG, 2004, NAT REV DRUG DISCOV, V3, P695, DOI 10.1038/nrd1469; Taylor AE, 2010, AM J CLIN NUTR, V91, P547, DOI 10.3945/ajcn.2009.28757; Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011; Wang B, 2015, PLOS ONE, V10; Wang BY, 2007, PREV MED, V45, P358, DOI 10.1016/j.ypmed.2007.07.014; Zhang SC, 2009, J CLIN ENDOCR METAB, V94, P3497, DOI 10.1210/jc.2009-1060; Zhang ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104361	46	20	22	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0140595	10.1371/journal.pone.0140595	http://dx.doi.org/10.1371/journal.pone.0140595			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556598	Green Published, gold, Green Submitted			2022-12-27	WOS:000364430700011
J	Iranpour, J; Morrot, G; Claise, B; Jean, B; Bonny, JM				Iranpour, Juliana; Morrot, Gil; Claise, Beatrice; Jean, Betty; Bonny, Jean-Marie			Using High Spatial Resolution to Improve BOLD fMRI Detection at 3T	PLOS ONE			English	Article							MODULATES BRAIN ACTIVITY; LOW-CALORIE FOODS; FUNCTIONAL MRI; PHYSIOLOGICAL NOISE; OBESE INDIVIDUALS; NEURONAL RESPONSE; FIELD GRADIENTS; HUMAN AMYGDALA; TIME-SERIES; VOXEL SIZE	For different functional magnetic resonance imaging experiments using blood oxygenation level-dependent (BOLD) contrast, the acquisition of T2*-weighted scans at a high spatial resolution may be advantageous in terms of time-course signal-to-noise ratio and of BOLD sensitivity when the regions are prone to susceptibility artifacts. In this study, we explore this solution by examining how spatial resolution influences activations elicited when appetizing food pictures are viewed. Twenty subjects were imaged at 3 T with two different voxel volumes, 3.4 mu l and 27 mu l. Despite the diminution of brain coverage, we found that high-resolution acquisition led to a better detection of activations. Though known to suffer to different degrees from susceptibility artifacts, the activations detected by high spatial resolution were notably consistent with those reported in published activation likelihood estimation meta-analyses, corresponding to taste-responsive regions. Furthermore, these regions were found activated bilaterally, in contrast with previous findings. Both the reduction of partial volume effect, which improves BOLD contrast, and the mitigation of susceptibility artifact, which boosts the signal to noise ratio in certain regions, explained the better detection noted with high resolution. The present study provides further evidences that high spatial resolution is a valuable solution for human BOLD fMRI, especially for studying food-related stimuli.	[Iranpour, Juliana; Bonny, Jean-Marie] INRA, QuaRA IR370, F-63122 St Genes Champanelle, France; [Morrot, Gil] Univ Sci & Tech Montpellier 2, CNRS, UMR 5221, Lab Charles Coulomb, F-34090 Montpellier, France; [Claise, Beatrice; Jean, Betty] CHU Gabriel Montpied, Plateforme Rech IRM, Neuroradiol A, F-63000 Clermont Ferrand, France	INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Montpellier; CHU Clermont Ferrand	Bonny, JM (corresponding author), INRA, QuaRA IR370, F-63122 St Genes Champanelle, France.	jean-marie.bonny@clermont.inra.fr			Conseil regional d'Auvergne [AIB 23000400]; European Funds for Regional Development; AIC AromaSalt, Science and Process Engineering of Agricultural Products	Conseil regional d'Auvergne(Region Auvergne-Rhone-Alpes); European Funds for Regional Development(European Commission); AIC AromaSalt, Science and Process Engineering of Agricultural Products	Funding: This work was supported by Contrat AIB 23000400, Conseil regional d'Auvergne (http//www.auvergne.fr) and European Funds for Regional Development (http://en.europe-en-france.gouv.fr/), to JI; and AIC AromaSalt, Science and Process Engineering of Agricultural Products (http://www.cepia.inra.fr/en), to JMB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Beaver JD, 2006, J NEUROSCI, V26, P5160, DOI 10.1523/JNEUROSCI.0350-06.2006; Beraha E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046931; Bodurka J, 2007, NEUROIMAGE, V34, P542, DOI 10.1016/j.neuroimage.2006.09.039; Chen NK, 2003, NEUROIMAGE, V19, P817, DOI 10.1016/S1053-8119(03)00091-0; Cornier MA, 2007, AM J CLIN NUTR, V86, P965, DOI 10.1093/ajcn/86.4.965; Cornier MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006310; Cunningham WA, 2011, SOC COGN AFFECT NEUR, V6, P286, DOI 10.1093/scan/nsq038; Davids S, 2010, INT J OBESITY, V34, P94, DOI 10.1038/ijo.2009.193; de Araujo IE, 2012, CHEMOSENS PERCEPT, V5, P64, DOI 10.1007/s12078-012-9117-9; Devlin JT, 2000, NEUROIMAGE, V11, P589, DOI 10.1006/nimg.2000.0595; FRAHM J, 1993, MAGNET RESON MED, V29, P139, DOI 10.1002/mrm.1910290126; Frank S, 2010, BRAIN RES, V1350, P159, DOI 10.1016/j.brainres.2010.04.030; Fransson P, 2002, NEUROIMAGE, V16, P977, DOI 10.1006/nimg.2002.1079; Fuehrer D, 2008, OBESITY, V16, P945, DOI 10.1038/oby.2008.33; Grabenhorst F, 2011, TRENDS COGN SCI, V15, P56, DOI 10.1016/j.tics.2010.12.004; Heller R, 2006, NEUROIMAGE, V33, P599, DOI 10.1016/j.neuroimage.2006.04.233; Holsen LM, 2005, NEUROIMAGE, V27, P669, DOI 10.1016/j.neuroimage.2005.04.043; Hyde JS, 2001, MAGN RESON MED, V46, P114, DOI 10.1002/mrm.1166; Killgore WDS, 2005, DEV PSYCHOBIOL, V47, P377, DOI 10.1002/dev.20099; Killgore WDS, 2003, NEUROIMAGE, V19, P1381, DOI 10.1016/S1053-8119(03)00191-5; Kruger G, 2001, MAGNET RESON MED, V46, P631, DOI 10.1002/mrm.1240; Kuhn S, 2012, NEUROIMAGE, V61, P289, DOI 10.1016/j.neuroimage.2012.02.065; LaBar KS, 2001, BEHAV NEUROSCI, V115, P493, DOI 10.1037//0735-7044.115.2.493; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Malik S, 2008, CELL METAB, V7, P400, DOI 10.1016/j.cmet.2008.03.007; Mathiak KA, 2012, MAGN RESON MATER PHY, V25, P177, DOI 10.1007/s10334-011-0285-4; Merboldt KD, 2000, J MAGN RESON, V145, P184, DOI 10.1006/jmre.2000.2105; Merboldt KD, 2001, NEUROIMAGE, V14, P253, DOI 10.1006/nimg.2001.0802; Miller JL, 2007, J NEUROL NEUROSUR PS, V78, P615, DOI 10.1136/jnnp.2006.099044; Moeller S, 2010, MAGN RESON MED, V63, P1144, DOI 10.1002/mrm.22361; Morawetz C, 2008, MAGN RESON IMAGING, V26, P45, DOI 10.1016/j.mri.2007.04.014; Morgan JF, 1999, BRIT MED J, V319, P1467, DOI 10.1136/bmj.319.7223.1467; Newton AT, 2012, NEUROIMAGE, V59, P2511, DOI 10.1016/j.neuroimage.2011.08.096; Ojemann JG, 1997, NEUROIMAGE, V6, P156, DOI 10.1006/nimg.1997.0289; Olman Cheryl A, 2011, Open Neuroimag J, V5, P74, DOI 10.2174/1874440001105010074; Porubska K, 2006, NEUROIMAGE, V32, P1273, DOI 10.1016/j.neuroimage.2006.04.216; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; Robinson SD, 2008, MAGN RESON MATER PHY, V21, P279, DOI 10.1007/s10334-008-0128-0; Rolls ET, 2008, ACTA PHYSIOL HUNG, V95, P131, DOI 10.1556/APhysiol.95.2008.2.1; Rolls ET, 2015, PROG NEUROBIOL, V127, P64, DOI 10.1016/j.pneurobio.2015.03.002; Rothemund Y, 2007, NEUROIMAGE, V37, P410, DOI 10.1016/j.neuroimage.2007.05.008; Santel S, 2006, BRAIN RES, V1114, P138, DOI 10.1016/j.brainres.2006.07.045; Schienle A, 2009, BIOL PSYCHIAT, V65, P654, DOI 10.1016/j.biopsych.2008.09.028; Schur EA, 2009, INT J OBESITY, V33, P653, DOI 10.1038/ijo.2009.56; Simmons WK, 2005, CEREB CORTEX, V15, P1602, DOI 10.1093/cercor/bhi038; Small DM, 2010, BRAIN STRUCT FUNCT, V214, P551, DOI 10.1007/s00429-010-0266-9; Soltysik DA, 2008, NEUROIMAGE, V41, P389, DOI 10.1016/j.neuroimage.2008.01.054; Soltysik DA, 2011, NEUROIMAGE, V56, P1329, DOI 10.1016/j.neuroimage.2011.03.023; St-Onge MP, 2005, J NUTR, V135, P1014, DOI 10.1093/jn/135.5.1014; Stevens JS, 2012, NEUROPSYCHOLOGIA, V50, P1578, DOI 10.1016/j.neuropsychologia.2012.03.011; Stoeckel LE, 2008, NEUROIMAGE, V41, P636, DOI 10.1016/j.neuroimage.2008.02.031; Tang DW, 2012, PHYSIOL BEHAV, V106, P317, DOI 10.1016/j.physbeh.2012.03.009; Tomasi DG, 2007, J MAGN RESON IMAGING, V26, P1340, DOI 10.1002/jmri.21143; Triantafyllou C, 2005, NEUROIMAGE, V26, P243, DOI 10.1016/j.neuroimage.2005.01.007; Triantafyllou C, 2006, NEUROIMAGE, V32, P551, DOI 10.1016/j.neuroimage.2006.04.182; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Uher R, 2006, BEHAV BRAIN RES, V169, P111, DOI 10.1016/j.bbr.2005.12.008; van der Laan LN, 2011, NEUROIMAGE, V55, P296, DOI 10.1016/j.neuroimage.2010.11.055; Veldhuizen MG, 2011, HUM BRAIN MAPP, V32, P2256, DOI 10.1002/hbm.21188; Wager TD, 2003, NEUROIMAGE, V19, P513, DOI 10.1016/S1053-8119(03)00078-8; Weibull A, 2008, NEUROIMAGE, V41, P346, DOI 10.1016/j.neuroimage.2008.02.015; Wildenberg JC, 2011, NEUROIMAGE, V56, P2129, DOI 10.1016/j.neuroimage.2011.03.074; Woo CW, 2014, NEUROIMAGE, V91, P412, DOI 10.1016/j.neuroimage.2013.12.058; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023; YOUNG IR, 1988, MAGN RESON IMAGING, V6, P585, DOI 10.1016/0730-725X(88)90133-6	66	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2015	10	11							e0141358	10.1371/journal.pone.0141358	http://dx.doi.org/10.1371/journal.pone.0141358			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7AC	26550990	Green Published, Green Submitted, gold			2022-12-27	WOS:000364422800003
J	Anthony, WE; Palmer-Young, EC; Leonard, AS; Irwin, RE; Adler, LS				Anthony, Winston E.; Palmer-Young, Evan C.; Leonard, Anne S.; Irwin, Rebecca E.; Adler, Lynn S.			Testing Dose-Dependent Effects of the Nectar Alkaloid Anabasine on Trypanosome Parasite Loads in Adult Bumble Bees	PLOS ONE			English	Article							INSECT HERBIVORES; PLANT DEFENSES; PREVALENCE; NICOTINE; ABILITY; MACROEVOLUTION; HONEYBEES; VIRULENCE; PATHOGEN; BOMBI	The impact of consuming biologically active compounds is often dose-dependent, where small quantities can be medicinal while larger doses are toxic. The consumption of plant secondary compounds can be toxic to herbivores in large doses, but can also improve survival in parasitized herbivores. In addition, recent studies have found that consuming nectar secondary compounds may decrease parasite loads in pollinators. However, the effect of compound dose on bee survival and parasite loads has not been assessed. To determine how secondary compound consumption affects survival and pathogen load in Bombus impatiens, we manipulated the presence of a common gut parasite, Crithidia bombi, and dietary concentration of anabasine, a nectar alkaloid produced by Nicotiana spp. using four concentrations naturally observed in floral nectar. We hypothesized that increased consumption of secondary compounds at concentrations found in nature would decrease survival of uninfected bees, but improve survival and ameliorate parasite loads in infected bees. We found medicinal effects of anabasine in infected bees; the high-anabasine diet decreased parasite loads and increased the probability of clearing the infection entirely. However, survival time was not affected by any level of anabasine concentration, or by interactive effects of anabasine concentration and infection. Crithidia infection reduced survival time by more than two days, but this effect was not significant. Our results support a medicinal role for anabasine at the highest concentration; moreover, we found no evidence for a survival-related cost of anabasine consumption across the concentration range found in nectar. Our results suggest that consuming anabasine at the higher levels of the natural range could reduce or clear pathogen loads without incurring costs for healthy bees.	[Anthony, Winston E.; Palmer-Young, Evan C.; Leonard, Anne S.; Adler, Lynn S.] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA; [Irwin, Rebecca E.] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; [Irwin, Rebecca E.] N Carolina State Univ, Dept Appl Ecol, Raleigh, NC 27695 USA	University of Massachusetts System; University of Massachusetts Amherst; Dartmouth College; University of North Carolina; North Carolina State University	Adler, LS (corresponding author), Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA.	lsadler@bio.umass.edu	Palmer-Young, Evan/AFL-1225-2022	Palmer-Young, Evan/0000-0002-9258-2073; Anthony, Winston E./0000-0001-6165-4700	National Science Foundation Division of Environmental Biology [NSF-DEB-1258096, NSF-DEB-0742923]; AFRI [USDA NRI 2008-02346]; National Science Foundation Graduate Research Fellowship; Darwin Fellowship; Graduate Program in Organismic and Evolutionary Biology; Direct For Biological Sciences [1501907] Funding Source: National Science Foundation; Division Of Environmental Biology [1258096] Funding Source: National Science Foundation	National Science Foundation Division of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); AFRI; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Darwin Fellowship; Graduate Program in Organismic and Evolutionary Biology; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The work was supported by the following: National Science Foundation Division of Environmental Biology, NSF-DEB-1258096: LSA & REI, NSF-DEB-0742923: LSA & REI, http://www.nsf.gov/div/index.jsp?div=DEB; United States Department of Agriculture, National Research Institute (now AFRI), USDA NRI 2008-02346: LSA, http://nifa.usda.gov/program/agriculture-and-foodresearch-initiative; National Science Foundation Graduate Research Fellowship: ECPY, https://www.nsfgrfp.org/; and Darwin Fellowship, Graduate Program in Organismic and Evolutionary Biology: ASL, https://www.bio.umass.edu/oeb/darwin-fellows. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler LS, 2000, OIKOS, V91, P409, DOI 10.1034/j.1600-0706.2000.910301.x; Adler LS, 2006, ECOL LETT, V9, P960, DOI 10.1111/j.1461-0248.2006.00944.x; Adler LS, 2012, ECOL LETT, V15, P1140, DOI 10.1111/j.1461-0248.2012.01838.x; Agrawal AA, 2007, TRENDS ECOL EVOL, V22, P103, DOI 10.1016/j.tree.2006.10.012; Agrawal AA, 2012, SCIENCE, V338, P113, DOI 10.1126/science.1225977; [Anonymous], 2014, R LANG ENV STAT COMP; Baracchi David, 2015, F1000Res, V4, P73, DOI 10.12688/f1000research.6262.2; BOWERS MD, 1992, J CHEM ECOL, V18, P985, DOI 10.1007/BF00980057; Brown MJF, 2003, J ANIM ECOL, V72, P994, DOI 10.1046/j.1365-2656.2003.00770.x; Brown MJF, 2000, OIKOS, V91, P421, DOI 10.1034/j.1600-0706.2000.910302.x; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Campbell FL, 1933, J ECON ENTOMOL, V26, P500, DOI 10.1093/jee/26.2.500; Cordes N, 2012, J INVERTEBR PATHOL, V109, P209, DOI 10.1016/j.jip.2011.11.005; Costa C, 2010, APIDOLOGIE, V41, P141, DOI 10.1051/apido/2009070; Detzel Andreas, 1993, Chemoecology, V4, P8, DOI 10.1007/BF01245891; DURRER S, 1994, P ROY SOC B-BIOL SCI, V258, P299, DOI 10.1098/rspb.1994.0176; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; Fokt H., 2010, CURR RES TECHNOL ED, P481; Gegear RJ, 2005, ANIM BEHAV, V70, P209, DOI 10.1016/j.anbehav.2004.09.025; Gegear RJ, 2006, P ROY SOC B-BIOL SCI, V273, P1073, DOI 10.1098/rspb.2005.3423; Gherman BI, 2014, BEHAV ECOL SOCIOBIOL, V68, P1777, DOI 10.1007/s00265-014-1786-8; Gillespie S, 2010, ECOL ENTOMOL, V35, P737, DOI 10.1111/j.1365-2311.2010.01234.x; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Hare J. Daniel, 2002, P8, DOI 10.1017/CBO9780511542190.002; Heil M, 2011, TRENDS PLANT SCI, V16, P191, DOI 10.1016/j.tplants.2011.01.003; Heinrich B., 2004, BUMBLEBEE EC REVISED; Imdorf A, 1999, APIDOLOGIE, V30, P209, DOI 10.1051/apido:19990210; Johnson MTJ, 2014, NEW PHYTOL, V203, P267, DOI 10.1111/nph.12763; Kaczorowski RL, 2014, J CHEM ECOL, V40, P325, DOI 10.1007/s10886-014-0411-7; Kaplan I, 2010, OIKOS, V119, P1105, DOI 10.1111/j.1600-0706.2009.18311.x; Kessler SC, 2015, NATURE, V521, P74, DOI 10.1038/nature14414; Koch H, 2011, P NATL ACAD SCI USA, V108, P19288, DOI 10.1073/pnas.1110474108; Lesnoff M, 2012, R PACKAGE AOD ANAL O; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Liersch S, 1998, P ROY SOC B-BIOL SCI, V265, P221, DOI 10.1098/rspb.1998.0285; Losey JE, 2006, BIOSCIENCE, V56, P311, DOI 10.1641/0006-3568(2006)56[311:TEVOES]2.0.CO;2; Manson JS, 2012, FUNCT ECOL, V26, P1100, DOI 10.1111/j.1365-2435.2012.02039.x; Manson JS, 2010, OECOLOGIA, V162, P81, DOI 10.1007/s00442-009-1431-9; Muller CB, 1996, INSECT SOC, V43, P227, DOI 10.1007/BF01242924; Otterstatter MC, 2006, PARASITOLOGY, V133, P749, DOI 10.1017/S003118200600120X; Pavia CS, 2000, J MED MICROBIOL, V49, P675, DOI 10.1099/0022-1317-49-7-675; Popp M, 2012, MICROBIOLOGYOPEN, V1, P362, DOI 10.1002/mbo3.35; PRICE PW, 1980, ANNU REV ECOL SYST, V11, P41, DOI 10.1146/annurev.es.11.110180.000353; Richardson LL, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2471; Sadd BM, 2011, EVOLUTION, V65, P2995, DOI 10.1111/j.1558-5646.2011.01345.x; Salathe RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022054; Santolamazza-Carbone S, 2014, OECOLOGIA, V174, P893, DOI 10.1007/s00442-013-2817-2; Schmid-Hempel P, 2001, NATURWISSENSCHAFTEN, V88, P147, DOI 10.1007/s001140100222; SHYKOFF JA, 1991, APIDOLOGIE, V22, P117, DOI 10.1051/apido:19910204; Singaravelan N, 2005, J CHEM ECOL, V31, P2791, DOI 10.1007/s10886-005-8394-z; Tadmor-Melamed H, 2004, FUNCT ECOL, V18, P844, DOI 10.1111/j.0269-8463.2004.00929.x; Thaler JS, 1999, NATURE, V399, P686, DOI 10.1038/21420; Therneau T.M., 2015, R PACKAGE COXME MIXE; Thomson JD, 2015, ARTHROPOD-PLANT INTE, V9, P1, DOI 10.1007/s11829-014-9350-z; Tiedeken EJ, 2014, J EXP BIOL, V217, P1620, DOI 10.1242/jeb.097543; Whitehorn PR, 2011, P ROY SOC B-BIOL SCI, V278, P1195, DOI 10.1098/rspb.2010.1550; Williams PH, 2014, BUMBLE BEES N AM; Wink M, 2000, STUD NAT PROD CHEM, V21, P3; Wright GA, 2013, SCIENCE, V339, P1202, DOI 10.1126/science.1228806; Yothers MA, 1940, J ECON ENTOMOL, V33, P800, DOI 10.1093/jee/33.5.800	60	20	20	4	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142496	10.1371/journal.pone.0142496	http://dx.doi.org/10.1371/journal.pone.0142496			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26545106	Green Published, gold, Green Submitted			2022-12-27	WOS:000364398700147
J	Chen, X; Jin, YT; Hou, XM; Liu, FQ; Wang, YL				Chen, Xing; Jin, Yuting; Hou, Xiaoming; Liu, Fengqin; Wang, Yulin			Sonic Hedgehog Signaling: Evidence for Its Protective Role in Endotoxin Induced Acute Lung Injury in Mouse Model	PLOS ONE			English	Article							DIFFERENTIATION; PATHOGENESIS; PATHWAY; HUMANS; SHH	Objective To investigate the protective role of the sonic hedgehog (SHH) signaling associated with a lipopolysaccharide (LPS)-induced acute lung injury (ALI) in a mouse model. Methods Male BALB/c mice were randomly divided into four groups: control, LPS, LPS-cyclopamine group and cyclopamine group. ALI was induced by LPS ip injection (5 mg/kg). The sonic hedgehog inhibitor cyclopamine (50 mg/kg) was given to the LPS-cyclopamine group at 30 min after LPS injection as well as normal mice as control. Lung injury was observed histologically in hematoxylin and eosin (HE) stained tissue sections, semi-quantified by lung tissue injury score, and the lung tissue mass alteration was measured by wet to dry weight ratio (W/D). mRNA expression levels of TNF-alpha, SHH, Patched (PTC) and GLI1 in lung tissue were studied with real time quantitative PCR (RT-PCR), while the protein expression of SHH and GLI1 was determined by western blot analysis. Results Lung tissue injury score, thickness of alveolar septa, W/D, and TNF-alpha mRNA expression levels were significantly higher in the ALI mice than the normal mice (P<0.05). The mRNA expression levels of SHH, PTC, and GLI1 in the ALI mice were significantly higher at 12h and 24h after LPS injection, but not at the 6h time point. Protein production of SHH and GLI1 at 6h, 12h, and 24h in the lungs of ALI mice significantly increased, in a time-dependent manner, compared with that in normal mice. Cyclopamine alone has no effect on pathological changes in normal mice. Intervention with cyclopamine in ALI mice led to a reduction in mRNA levels of SHH, PTC, and GLI1 as well as SHH and GLI1 protein levels; meanwhile, the pathological injury scores of lung tissues, thickness of alveolar septa, W/D, and mRNA expression levels of TNF-alpha increased compared with mice receiving LPS only. Conclusion The SHH signaling pathway was activated in response to LPS-induced ALI, and up-regulation of SHH expression could alleviate lung injury and be involved in the repair of injured lung tissue.	[Chen, Xing; Hou, Xiaoming; Liu, Fengqin; Wang, Yulin] Shandong Univ, Shandong Prov Hosp, Dept Pediat, Jinan 250100, Shandong, Peoples R China; [Jin, Yuting] Shandong Prov Qianfoshan Hosp, Dept Pediat, Jinan, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences	Wang, YL (corresponding author), Shandong Univ, Shandong Prov Hosp, Dept Pediat, Jinan 250100, Shandong, Peoples R China.	sdmed_pediatrics@163.com	hou, xiaoming/AAE-4532-2020		Science and Technology research project - Shandong Provincial Population and Family Planning Commission [201110]; Shandong Provincial Medical Technology Development Program [2011HZ066]	Science and Technology research project - Shandong Provincial Population and Family Planning Commission; Shandong Provincial Medical Technology Development Program	This study was sponsored by the funding from Science and Technology research project (201110) awarded by Shandong Provincial Population and Family Planning Commission and Shandong Provincial Medical Technology Development Program (2011HZ066).	Aggarwal NR, 2014, AM J PHYSIOL-LUNG C, V306, pL709, DOI 10.1152/ajplung.00341.2013; Ahlfeld SK, 2012, BIRTH DEFECTS RES A, V94, P3, DOI 10.1002/bdra.22869; Apelqvist A, 1997, CURR BIOL, V7, P801, DOI 10.1016/S0960-9822(06)00340-X; Blank R, 2011, CRIT CARE CLIN, V27, P439, DOI 10.1016/j.ccc.2011.05.005; Cigna N, 2012, AM J PATHOL, V181, P2126, DOI 10.1016/j.ajpath.2012.08.019; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; Dang HX, 2012, MOL MED REP, V6, P297, DOI 10.3892/mmr.2012.929; Fernandez IE, 2012, LANCET, V380, P680, DOI 10.1016/S0140-6736(12)61144-1; Franchitto Antonio, 2013, Hepatobiliary Surg Nutr, V2, P68, DOI 10.3978/j.issn.2304-3881.2012.10.11; Hojo H, 2012, J BIOL CHEM, V287, P17860, DOI 10.1074/jbc.M112.347716; Ihrie RA, 2011, NEURON, V71, P250, DOI 10.1016/j.neuron.2011.05.018; Jacob L, 2007, SCIENCE, V318, P66, DOI 10.1126/science.1147314; King Randall W, 2002, J Biol, V1, P8, DOI 10.1186/1475-4924-1-8; Kugler MC, 2015, AM J RESP CELL MOL, V52, P1, DOI 10.1165/rcmb.2014-0132TR; Kusano KF, 2005, NAT MED, V11, P1197, DOI 10.1038/nm1313; Li XN, 2011, J ALLERGY CLIN IMMUN, V127, P1457, DOI 10.1016/j.jaci.2011.01.056; Liu L, 2013, AM J RESP CELL MOL, V48, P703, DOI 10.1165/rcmb.2012-0347OC; Bolanos AL, 2012, AM J PHYSIOL-LUNG C, V303, pL978, DOI 10.1152/ajplung.00184.2012; Madurga A, 2013, AM J PHYSIOL-LUNG C, V305, pL893, DOI 10.1152/ajplung.00267.2013; Maeda Y, 2007, PHYSIOL REV, V87, P219, DOI 10.1152/physrev.00028.2006; MARTICH GD, 1991, J EXP MED, V173, P1021, DOI 10.1084/jem.173.4.1021; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; Michelotti GA, 2013, J CLIN INVEST, V123, P2380, DOI 10.1172/JCI66904; Paulis L, 2015, SCI REP-UK, V5, DOI 10.1038/srep07983; Peng YC, 2015, DEV BIOL, V400, P94, DOI 10.1016/j.ydbio.2015.01.019; Pola R, 2001, NAT MED, V7, P706, DOI 10.1038/89083; Renault MA, 2013, CIRC RES, V113, P1148, DOI 10.1161/CIRCRESAHA.113.301546; Renault MA, 2013, CIRC RES, V112, P762, DOI 10.1161/CIRCRESAHA.113.300871; Rominger CM, 2009, J PHARMACOL EXP THER, V329, P995, DOI 10.1124/jpet.109.152090; Smith KM, 1997, CRIT CARE MED, V25, P1888, DOI 10.1097/00003246-199711000-00030; Spirli Carlo, 2013, Hepatobiliary Surg Nutr, V2, P65, DOI 10.3978/j.issn.2304-3881.2012.12.05; Suh HN, 2015, BRIT J PHARMACOL, V172, P815, DOI 10.1111/bph.12947; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Watkins DN, 2003, NATURE, V422, P313, DOI 10.1038/nature01493; Watson S, 2010, B CANCER, V97, P1477, DOI 10.1684/bdc.2010.1231; Zhou XB, 2012, HUM MOL GENET, V21, P1325, DOI 10.1093/hmg/ddr569	36	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0140886	10.1371/journal.pone.0140886	http://dx.doi.org/10.1371/journal.pone.0140886			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26545089	Green Published, Green Submitted, gold			2022-12-27	WOS:000364398700011
J	Sloan, L; Morgan, J				Sloan, Luke; Morgan, Jeffrey			Who Tweets with Their Location? Understanding the Relationship between Demographic Characteristics and the Use of Geoservices and Geotagging on Twitter	PLOS ONE			English	Article								In this paper we take advantage of recent developments in identifying the demographic characteristics of Twitter users to explore the demographic differences between those who do and do not enable location services and those who do and do not geotag their tweets. We discuss the collation and processing of two datasets-one focusing on enabling geoservices and the other on tweet geotagging. We then investigate how opting in to either of these behaviours is associated with gender, age, class, the language in which tweets are written and the language in which users interact with the Twitter user interface. We find statistically significant differences for both behaviours for all demographic characteristics, although the magnitude of association differs substantially by factor. We conclude that there are significant demographic variations between those who opt in to geoservices and those who geotag their tweets. Not withstanding the limitations of the data, we suggest that Twitter users who publish geographical information are not representative of the wider Twitter population.	[Sloan, Luke] Cardiff Univ, Sch Social Sci, Cardiff CF10 3AX, S Glam, Wales; [Morgan, Jeffrey] Cardiff Univ, Sch Comp Sci & Informat, Cardiff CF10 3AX, S Glam, Wales	Cardiff University; Cardiff University	Sloan, L (corresponding author), Cardiff Univ, Sch Social Sci, Cardiff CF10 3AX, S Glam, Wales.	SloanLS@cardiff.ac.uk			Jisc; Economic and Social Research Council [ES/J009903/1, ES/K008013/1, ES/M003329/1]; National Centre Research for Methods [512589112]; High Performance Computing Wales; ESRC [ES/K008013/1, ES/J009903/1, ES/M003329/1, ES/F035098/1] Funding Source: UKRI; Economic and Social Research Council [ES/F035098/1] Funding Source: researchfish	Jisc; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); National Centre Research for Methods; High Performance Computing Wales; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The Collaborative Online Social Media Observatory (COSMOS) has received funding for platform development from Jisc (http://www.jisc.ac.uk/whatwedo/programmes/di_research/researchtools/COSMOS.aspx), the Economic and Social Research Council (ES/J009903/1, ES/K008013/1, ES/M003329/1), the National Centre Research for Methods (512589112 - http://www.ncrm.ac.uk/research/MIP/prediction.php) and High Performance Computing Wales (Scaling the Computational Analysis of "Big Social Data" & Massive Temporal Social Media Datasets). Details of all other awards associated with the project can be found on the COSMOS website (http://www.cosmosproject.net/). However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIS, 2013, SEIZ DAT OPP STRAT U; Botta F, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150162; Burnap P, 2015, ARXIV150501511V1; Burnap P, 2015, BRIT J CRIMINOLOGY; Burnap P, 2014, SOC NETW ANAL MIN, V4, DOI 10.1007/s13278-014-0206-4; Burnap P, 2015, INT J PARALLEL EMERG, V30, P80, DOI 10.1080/17445760.2014.902057; Burnap P, 2013, INT J SOC RES METHOD, V16, P215, DOI 10.1080/13645579.2013.774174; DiGrazia J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079449; Edwards A, 2013, INT J SOC RES METHOD, V16, P245, DOI 10.1080/13645579.2013.774185; Gayo-Avello D., 2012, I WANTED PREDICT ELE; Graham M, 2013, ARXIV13080683V1; Housley W, 2014, BIG DATA SOC, V1, DOI 10.1177/2053951714545135; Metaxas P., 2011, 2011 IEEE 3 INT C PR, P165, DOI [10.1109/PASSAT/SocialCom.2011.98, DOI 10.1109/PASSAT/SOCIALCOM.2011.98]; Moat HS, 2014, BEHAV BRAIN SCI, V37, P92, DOI 10.1017/S0140525X13001817; Morstatter F, 2014, WWW'14 COMPANION: PROCEEDINGS OF THE 23RD INTERNATIONAL CONFERENCE ON WORLD WIDE WEB, P555, DOI 10.1145/2567948.2576952; Noguchi T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095209; Preis T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01684; Preotiuc-~Pietro D., 2015, ANAL USER OCCUPATION; Rosenquist J., 2021, P INT AAAI C WEB SOC, V5, P554; Savage M, 2007, SOCIOLOGY, V41, P885, DOI 10.1177/0038038507080443; Schwartz HA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073791; Sloan L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115545; Sloan L, 2013, SOCIOL RES ONLINE, V18, DOI 10.5153/sro.3001; Tumasjan A., 2010, P INT AAAI C WEB SOC, V4	24	103	103	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142209	10.1371/journal.pone.0142209	http://dx.doi.org/10.1371/journal.pone.0142209			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544601	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000364398700095
J	Valera, P; Zavattari, P; Sanna, A; Pretti, S; Marcello, A; Mannu, C; Targhetta, C; Bruno, G; Songini, M				Valera, Paolo; Zavattari, Patrizia; Sanna, Alessandro; Pretti, Salvatore; Marcello, Alberto; Mannu, Carla; Targhetta, Clara; Bruno, Graziella; Songini, Marco			Zinc and Other Metals Deficiencies and Risk of Type 1 Diabetes: An Ecological Study in the High Risk Sardinia Island	PLOS ONE			English	Article							SUPPLEMENTATION; CHROMIUM; CHILDREN; COPPER; MELLITUS	Background Type 1 diabetes incidence presents a decreasing gradient in Europe from the Nordic countries to the Mediterranean ones. Exception to this gradient is represented by Sardinia, the second largest Mediterranean island whose population shows the highest incidence in Europe, after Finland. The genetic features of this population have created a fertile ground for the epidemic of the disease, however, as well as being strikingly high, the incidence rate has suddenly presented a continuous increase from the '50s, not explainable by accumulation of new genetic variants. Several environmental factors have been taken into account, possibly interacting with the genetic/epigenetic scenario, but there are no strong evidences to date. Methods The present study investigated the hypothesis that geochemical elements could create permissive environmental conditions for autoimmune diabetes. An ecological analysis was performed to test possible correlations between the values of eight elements in stream sediments and type 1 diabetes incidence rate in Sardinia. Results Analyses revealed negative associations between elements, such as Co, Cr, Cu, Mn, Ni, Zn, and type 1 diabetes incidence. Conclusions The results suggest a possible protective role of some elements against the onset of the disease.	[Valera, Paolo; Sanna, Alessandro; Pretti, Salvatore; Marcello, Alberto] Univ Cagliari, Dept Civil Environm Engn & Architecture, Cagliari, Italy; [Zavattari, Patrizia] Univ Cagliari, Dept Biomed Sci, Cagliari, Italy; [Mannu, Carla; Targhetta, Clara; Songini, Marco] St Michele Hosp, Ctr Study Diabet Complicat & Metab Dis, Cagliari, Italy; [Bruno, Graziella] Univ Turin, Dept Med Sci, Turin, Italy	University of Cagliari; University of Cagliari; University of Turin	Valera, P (corresponding author), Univ Cagliari, Dept Civil Environm Engn & Architecture, Cagliari, Italy.	pvalera@unica.it; pzavattari@unica.it	Valera, Paolo/E-5082-2010	Valera, Paolo/0000-0002-6812-5921; Mannu, Carla/0000-0002-5421-9193; BRUNO, Graziella/0000-0002-3011-8304; Songini, Marco/0000-0003-3524-645X; Sanna, Alessandro/0000-0001-5663-4254				Adewumi M. T., 2007, Asian Journal of Biochemistry, V2, P284; Anderson RA, 1997, DIABETES, V46, P1786, DOI 10.2337/diabetes.46.11.1786; Besser L, 2009, J NEUROSCI, V29, P2890, DOI 10.1523/JNEUROSCI.5093-08.2009; Bruno G, 2013, DIABETES, V62, P3542, DOI 10.2337/db12-1771; Casu A, 2000, DIABETES CARE, V23, P1043, DOI 10.2337/diacare.23.7.1043; Casu A, 2004, DIABETES CARE, V27, P1623, DOI 10.2337/diacare.27.7.1623; Chora AA, 2007, J CLIN INVEST, V117, P438, DOI 10.1172/JCI28844; Cunningham JJ, 1998, J AM COLL NUTR, V17, P7, DOI 10.1080/07315724.1998.10718729; Ekin S, 2003, BIOL TRACE ELEM RES, V94, P193, DOI 10.1385/BTER:94:3:193; Flem B, 2015, APPL GEOCHEM, V59, P211, DOI 10.1016/j.apgeochem.2015.01.016; Forte G, 2013, BIOL TRACE ELEM RES, V156, P79, DOI 10.1007/s12011-013-9858-6; Fraker PJ, 2004, ANNU REV NUTR, V24, P277, DOI 10.1146/annurev.nutr.24.012003.132454; Fukada T, 2011, J BIOL INORG CHEM, V16, P1123, DOI 10.1007/s00775-011-0797-4; Gilbert ER, 2012, EPIGENETICS-US, V7, P841, DOI 10.4161/epi.21238; GREEN A, 1992, LANCET, V339, P905, DOI 10.1016/0140-6736(92)90938-Y; Green A, 2001, DIABETOLOGIA, V44, pB3, DOI 10.1007/PL00002950; Haase H, 2014, METALLOMICS, V6, P1175, DOI 10.1039/c3mt00353a; Hellerstein MK, 1998, NUTR REV, V56, P302, DOI 10.1111/j.1753-4887.1998.tb01664.x; Jakovac Hrvoje, 2013, Curr Aging Sci, V6, P37; Kabu K, 2006, J IMMUNOL, V177, P1296, DOI 10.4049/jimmunol.177.2.1296; Kazi TG, 2008, BIOL TRACE ELEM RES, V122, P1, DOI 10.1007/s12011-007-8062-y; Kitabayashi C, 2010, INT IMMUNOL, V22, P375, DOI 10.1093/intimm/dxq017; KORC M, 1983, AM J PHYSIOL, V245, pG628, DOI 10.1152/ajpgi.1983.245.5.G628; Majithia AR, 2011, DIABETOLOGIA, V54, P2570, DOI 10.1007/s00125-011-2234-1; Marcello A, 1978, B SERV GEOL ITAL, V99, P277; Marcello A, 2008, GEOBASI 2 FOGLIO IGM; Marcello A, 2003, GEOCHEMICAL BASELINE; Maruthur NM, 2015, DIABETOLOGIA, V58, P295, DOI 10.1007/s00125-014-3419-1; Masala S, 2014, ACTA DIABETOL, V51, P577, DOI 10.1007/s00592-014-0558-2; Massilamany C, 2013, J NEUROIMMUNOL, V256, P19, DOI 10.1016/j.jneuroim.2012.12.004; Palmas C, 2003, J HELMINTHOL, V77, P147, DOI 10.1079/JOH2003176; Prasad AS, 1998, MOL CELL BIOCHEM, V188, P63, DOI 10.1023/A:1006868305749; Reimann C., 2010, GEOCHEMISTRY EUROPEA; Rink L, 2007, TRENDS IMMUNOL, V28, P1, DOI 10.1016/j.it.2006.11.005; Flores CR, 2011, DIABETES RES CLIN PR, V91, P333, DOI 10.1016/j.diabres.2010.12.014; Samuelsson U, 2011, PEDIATR DIABETES, V12, P156, DOI 10.1111/j.1399-5448.2010.00678.x; Shankar AH, 1998, AM J CLIN NUTR, V68, p447S, DOI 10.1093/ajcn/68.2.447S; Simmons Rebecca A, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P13, DOI 10.1097/MED.0b013e328013da5b; Sitasawad S, 2001, DIABETES RES CLIN PR, V52, P77, DOI 10.1016/S0168-8227(00)00249-7; Songini M, 1998, DIABETOLOGIA, V41, P221, DOI 10.1007/s001250050893; Songini Marco, 2010, J Diabetes Sci Technol, V4, P1248; Sun Q, 2009, DIABETES CARE, V32, P629, DOI 10.2337/dc08-1913; Temple Victor J., 2004, Papua New Guinea Medical Journal, V47, P146; Valera P, 2014, ENVIRON GEOCHEM HLTH, V36, P79, DOI 10.1007/s10653-013-9520-4; Valera RG, 2002, ANFANGE METALLURGIE; Yamasaki S, 2007, J CELL BIOL, V177, P637, DOI 10.1083/jcb.200702081; Zavattari P, 2000, HUM MOL GENET, V9, P2947, DOI 10.1093/hmg/9.20.2947	47	18	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0141262	10.1371/journal.pone.0141262	http://dx.doi.org/10.1371/journal.pone.0141262			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559814	Green Published, gold, Green Submitted			2022-12-27	WOS:000364433100027
J	Abdul-Kreem, LI; Neumann, H				Abdul-Kreem, Luma Issa; Neumann, Heiko			Neural Mechanisms of Cortical Motion Computation Based on a Neuromorphic Sensory System	PLOS ONE			English	Article							TEMPORAL VISUAL AREA; FIGURE-GROUND SEGREGATION; DIRECTION SELECTIVITY; MACAQUE MONKEY; IMAGE VELOCITY; MODEL; MT; SPEED; DYNAMICS; NEURONS	The visual cortex analyzes motion information along hierarchically arranged visual areas that interact through bidirectional interconnections. This work suggests a bio-inspired visual model focusing on the interactions of the cortical areas in which a new mechanism of feed-forward and feedback processing are introduced. The model uses a neuromorphic vision sensor (silicon retina) that simulates the spike-generation functionality of the biological retina. Our model takes into account two main model visual areas, namely V1 and MT, with different feature selectivities. The initial motion is estimated in model area V1 using spatiotemporal filters to locally detect the direction of motion. Here, we adapt the filtering scheme originally suggested by Adelson and Bergen to make it consistent with the spike representation of the DVS. The responses of area V1 are weighted and pooled by area MT cells which are selective to different velocities, i.e. direction and speed. Such feature selectivity is here derived from compositions of activities in the spatio-temporal domain and integrating over larger space-time regions (receptive fields). In order to account for the bidirectional coupling of cortical areas we match properties of the feature selectivity in both areas for feedback processing. For such linkage we integrate the responses over different speeds along a particular preferred direction. Normalization of activities is carried out over the spatial as well as the feature domains to balance the activities of individual neurons in model areas V1 and MT. Our model was tested using different stimuli that moved in different directions. The results reveal that the error margin between the estimated motion and synthetic ground truth is decreased in area MT comparing with the initial estimation of area V1. In addition, the modulated V1 cell activations shows an enhancement of the initial motion estimation that is steered by feedback signals from MT cells.	[Abdul-Kreem, Luma Issa; Neumann, Heiko] Univ Ulm, Inst Neural Informat Proc, D-89069 Ulm, Germany; [Abdul-Kreem, Luma Issa] Univ Technol Baghdad, Control & Syst Engn Dept, Baghdad, Iraq	Ulm University; University of Technology- Iraq	Abdul-Kreem, LI (corresponding author), Univ Ulm, Inst Neural Informat Proc, D-89069 Ulm, Germany.	luma.issa@uni-ulm.de	Abdul-Kreem, luma Issa/AAW-9283-2020	Abdul-Kreem, luma Issa/0000-0002-6161-2428	Ministry of Higher Education and Scientific Research (MoHESR) Iraq; German Academic Exchange Service (DAAD); DFG in the Collaborative Research Center [SFB/TR-62]	Ministry of Higher Education and Scientific Research (MoHESR) Iraq; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); DFG in the Collaborative Research Center(German Research Foundation (DFG))	Funding: LIAK has been supported by grants from the Ministry of Higher Education and Scientific Research (MoHESR) Iraq and from the German Academic Exchange Service (DAAD). HN acknowledges support from DFG in the Collaborative Research Center SFB/TR-62 (A companion technology for cognitive technical systems).	Abdul-Kreem LI, 2015, 10 INT C COMP VIS TH; Adelson E, 1985, J OPT SOC AM, V2, P90; ALBRIGHT TD, 1984, J NEUROPHYSIOL, V52, P1106, DOI 10.1152/jn.1984.52.6.1106; ALBRIGHT TD, 1987, EXP BRAIN RES, V65, P582; Bastos AM, VISUAL AREAS EXERT F; Bastos AM, 2012, NEURON, V76, P695, DOI 10.1016/j.neuron.2012.10.038; Bayerl P, 2004, NEURAL COMPUT, V16, P2041, DOI 10.1162/0899766041732404; Benosman R, 2012, NEURAL NETWORKS, V27, P32, DOI 10.1016/j.neunet.2011.11.001; Born RT, 2000, J NEUROPHYSIOL, V84, P2658, DOI 10.1152/jn.2000.84.5.2658; Born RT, 2005, ANNU REV NEUROSCI, V28, P157, DOI 10.1146/annurev.neuro.26.041002.131052; Bouecke JD, 2011, EURASIP J ADV SIG PR, DOI 10.1155/2011/781561; Brosch T, 2015, FRONTIERS NEUROSCIEN, V137; Brosch T, 2014, NEURAL COMPUT, V26, P2735, DOI 10.1162/NECO_a_00675; Brox T, 2004, LECT NOTES COMPUT SC, V2034, P25, DOI 10.1007/978-3-540-24673-2_3; CARANDINI M, 1994, SCIENCE, V264, P1333, DOI 10.1126/science.8191289; Carandini M., 1999, CEREB CORTEX, V13, P401, DOI DOI 10.1007/978-1-4615-4903-1_7; Carandini M, 2012, NAT REV NEUROSCI, V13, P51, DOI 10.1038/nrn3136; Chalupa L.M., 2004, VISUAL NEUROSCIENCES; Chey J, 1997, J OPT SOC AM A, V14, P2570, DOI 10.1364/JOSAA.14.002570; Chey J, 1998, VISION RES, V38, P2769, DOI 10.1016/S0042-6989(97)00372-6; Churchland MM, 2005, J NEUROPHYSIOL, V93, P1235, DOI 10.1152/jn.00767.2004; Crick F, 1998, NATURE, V391, P245, DOI 10.1038/34584; Crouzet SM, 2011, J NEUROSCI, V31, P8706, DOI 10.1523/JNEUROSCI.1878-11.2011; Davis J., 1994, LARGE SCALE NEURONAL; De Valois RL, 2000, VISION RES, V40, P3685, DOI 10.1016/S0042-6989(00)00210-8; Delbruck T, 2007, IEEE INT SYMP CIRC S, P845, DOI 10.1109/ISCAS.2007.378038; Delbruck T, 2010, IEEE INT SYMP CIRC S, P2426, DOI 10.1109/ISCAS.2010.5537149; Desimone R, 1998, PHILOS T R SOC B, V353, P1245, DOI 10.1098/rstb.1998.0280; Drulea M, 2013, IEEE T IMAGE PROCESS, V22, P3260, DOI 10.1109/TIP.2013.2263149; EDELMAN GM, 1993, NEURON, V10, P115, DOI 10.1016/0896-6273(93)90304-A; Escobar MJ, 2012, COMPUT VIS IMAGE UND, V116, P593, DOI 10.1016/j.cviu.2012.01.002; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; FELLEMAN DJ, 1984, J NEUROPHYSIOL, V52, P488, DOI 10.1152/jn.1984.52.3.488; FLEET DJ, 1990, INT J COMPUT VISION, V5, P77, DOI 10.1007/BF00056772; Foldiak P, 1991, NEURAL COMPUT, V3, P194, DOI 10.1162/neco.1991.3.2.194; Friston KJ, 2000, P NATL ACAD SCI USA, V97, P7591, DOI 10.1073/pnas.97.13.7591; GIRARD P, 1989, J NEUROPHYSIOL, V62, P1287, DOI 10.1152/jn.1989.62.6.1287; GROSSBERG S, 1988, NEURAL NETWORKS, V1, P17, DOI 10.1016/0893-6080(88)90021-4; GROSSBERG S, 1994, PERCEPT PSYCHOPHYS, V55, P48, DOI 10.3758/BF03206880; GROSSBERG S, 1980, PSYCHOL REV, V87, P1, DOI 10.1037/0033-295X.87.1.1; Grossberg S, 2001, VISION RES, V41, P2521, DOI 10.1016/S0042-6989(01)00131-6; GRZYWACZ NM, 1990, PROC R SOC SER B-BIO, V239, P129, DOI 10.1098/rspb.1990.0012; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; HILDRETH EC, 1987, ANNU REV NEUROSCI, V10, P477, DOI 10.1146/annurev.ne.10.030187.002401; HORN BKP, 1981, ARTIF INTELL, V17, P185, DOI 10.1016/0004-3702(81)90024-2; Johnson RR, 1997, J NEUROSCI, V17, P7129; Koivisto M, 2011, J NEUROSCI, V31, P2488, DOI 10.1523/JNEUROSCI.3074-10.2011; Konig P, 1998, Z NATURFORSCH C, V53, P542; Kouh M, 2008, NEURAL COMPUT, V20, P1427, DOI 10.1162/neco.2008.02-07-466; LAGAE L, 1993, J NEUROPHYSIOL, V69, P19, DOI 10.1152/jn.1993.69.1.19; Lamme VAF, 1998, CURR OPIN NEUROBIOL, V8, P529, DOI 10.1016/S0959-4388(98)80042-1; Larkum M, 2013, TRENDS NEUROSCI, V36, P141, DOI 10.1016/j.tins.2012.11.006; Layher G, 2013, P 35 ANN C COGN SCI, P870; Layher G, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01287; Lichtsteiner P, 2008, IEEE J SOLID-ST CIRC, V43, P566, DOI 10.1109/JSSC.2007.914337; Liu SC, 2010, CURR OPIN NEUROBIOL, V20, P288, DOI 10.1016/j.conb.2010.03.007; Lucas B, 1981, P IM UND WORKSH, P121, DOI DOI 10.5334/JORS.BL; Markov NT, 2014, J COMP NEUROL, V522, P225, DOI 10.1002/cne.23458; MAUNSELL JHR, 1987, J COMP NEUROL, V266, P535, DOI 10.1002/cne.902660407; MUMFORD D, 1991, BIOL CYBERN, V65, P135, DOI 10.1007/BF00202389; Neumann H, 1999, BIOL CYBERN, V81, P425, DOI 10.1007/s004220050573; Perrone JA, 2004, VISION RES, V44, P1733, DOI 10.1016/j.visres.2004.03.003; Perrone JA, 2001, NAT NEUROSCI, V4, P526, DOI 10.1038/87480; Perrone JA, 2002, J VISION, V2, P38, DOI [10.1167/2.7.38, DOI 10.1167/2.7.38]; Poort J, 2012, NEURON, V75, P143, DOI 10.1016/j.neuron.2012.04.032; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; ROCKLAND KS, 1989, J COMP NEUROL, V285, P54, DOI 10.1002/cne.902850106; Roelfsema PR, 2002, J COGNITIVE NEUROSCI, V14, P525, DOI 10.1162/08989290260045756; Rolls ET, 2007, NEURAL COMPUT, V19, P139, DOI 10.1162/neco.2007.19.1.139; SCHWARTZ EL, 1990, COMPUTATIONAL NEUROS; Self MW, 2012, P NATL ACAD SCI USA, V109, P11031, DOI 10.1073/pnas.1119527109; Simoncelli EP, 1998, VISION RES, V38, P743, DOI 10.1016/S0042-6989(97)00183-1; Sullivan TJ, 2004, NEUROCOMPUTING, V58, P827, DOI 10.1016/j.neucom.2004.01.134; Tschechne S., 2014, P 8 INT C BIOINSP IN, P298; Tschechne S, 2014, SPRINGER LNAI, V8774, P171, DOI DOI 10.1007/978-3-319-11656-3_16; ULLMAN S, 1995, CEREB CORTEX, V5, P1, DOI 10.1093/cercor/5.1.1; Ungerleider Leslie G., 1994, Current Opinion in Neurobiology, V4, P157, DOI 10.1016/0959-4388(94)90066-3; Wallach H., 1976, ON PERCEPTION; Watson A, 1983, NASA TECH MEMO, P84352; WATSON AB, 1985, J OPT SOC AM A, V2, P322, DOI 10.1364/JOSAA.2.000322	81	5	5	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142488	10.1371/journal.pone.0142488	http://dx.doi.org/10.1371/journal.pone.0142488			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26554589	gold, Green Published, Green Submitted			2022-12-27	WOS:000364430700115
J	Daci, A; Beretta, G; Vilasaliu, D; Shala, A; Govori, V; Norata, GD; Krasniqi, S				Daci, Armond; Beretta, Giangiacomo; Vilasaliu, Driton; Shala, Aida; Govori, Valbona; Norata, Giuseppe Danilo; Krasniqi, Shaip			Polymorphic Variants of SCN1A and EPHX1 Influence Plasma Carbamazepine Concentration, Metabolism and Pharmacoresistance in a Population of Kosovar Albanian Epileptic Patients	PLOS ONE			English	Article							MICROSOMAL EPOXIDE HYDROLASE; ANTIEPILEPTIC DRUGS; GENE POLYMORPHISMS; STEADY-STATE; CHINESE PATIENTS; MULTIDRUG-RESISTANCE; ABCB1 POLYMORPHISMS; JAPANESE PATIENTS; ILAE-COMMISSION; P-GLYCOPROTEIN	Aim The present study aimed to evaluate the effects of gene variants in key genes influencing pharmacokinetic and pharmacodynamic of carbamazepine (CBZ) on the response in patients with epilepsy. Materials & Methods Five SNPs in two candidate genes influencing CBZ transport and metabolism, namely ABCB1 or EPHX1, and CBZ response SCN1A (sodium channel) were genotyped in 145 epileptic patients treated with CBZ as monotherapy and 100 age and sex matched healthy controls. Plasma concentrations of CBZ, carbamazepine-10,11-epoxide (CBZE) and carbamazepine-10,11-trans dihydrodiol (CBZD) were determined by HPLC-UV-DAD and adjusted for CBZ dosage/kg of body weight. Results The presence of the SCN1A IVS5-91G> A variant allele is associated with increased epilepsy susceptibility. Furthermore, carriers of the SCN1A IVS5-91G> A variant or of EPHX1 c.337T>C variant presented significantly lower levels of plasma CBZ compared to carriers of the common alleles (0.71 +/- 0.28 vs 1.11 +/- 0.69 mu g/mL per mg/Kg for SCN1A IVS5-91 AA vs GG and 0.76 +/- 0.16 vs 0.94 +/- 0.49 mu g/mL per mg/Kg for EPHX1 c.337 CC vs TT; P<0.05 for both). Carriers of the EPHX1 c.416A>G showed a reduced microsomal epoxide hydrolase activity as reflected by a significantly decreased ratio of CBZD to CBZ (0.13 +/- 0.08 to 0.26 +/- 0.17, p<0.05) also of CBZD to CBZE (1.74 +/- 1.06 to 3.08 +/- 2.90; P<0.05) and CDRCBZD (0.13 +/- 0.08 vs 0.24 +/- 0.19 mu g/mL per mg/Kg; P<0.05). ABCB1 3455C>T SNP and SCN1A 3148A>G variants were not associated with significant changes in CBZ pharmacokinetic. Patients resistant to CBZ treatment showed increased dosage of CBZ (657 +/- 285 vs 489 +/- 231 mg/day; P< 0.001) but also increased plasma levels of CBZ (9.84 +/- 4.37 vs 7.41 +/- 3.43 mu g/mL; P< 0.001) compared to patients responsive to CBZ treatment. CBZ resistance was not related to any of the SNPs investigated. Conclusions The SCN1A IVS5-91G> A SNP is associated with susceptibility to epilepsy. SNPs in EPHX1 gene are influencing CBZ metabolism and disposition. CBZ plasma levels are not an indicator of resistance to the therapy.	[Daci, Armond; Shala, Aida] Univ Prishtina, Dept Pharm, Fac Med, Prishtina, Kosovo; [Daci, Armond; Krasniqi, Shaip] Univ Prishtina, Inst Pharmacol & Toxicol & Clin Pharmacol, Fac Med, Prishtina, Kosovo; [Beretta, Giangiacomo] Univ Milan, Dept Pharmaceut Sci, Milan, Italy; [Vilasaliu, Driton] Lincoln Univ, Sch Pharm, Joseph Banks Labs, Lincoln LN6 7DL, England; [Govori, Valbona] Univ Clin Ctr Kosova, Neurol Clin, Prishtina, Kosovo; [Norata, Giuseppe Danilo] Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy; [Norata, Giuseppe Danilo] Osped Bassini, Ctr Study Atherosclerosis, Cinisello Balsamo, Italy	University of Milan; University of Lincoln; Universiteti i Prishtines; University of Milan	Krasniqi, S (corresponding author), Univ Prishtina, Inst Pharmacol & Toxicol & Clin Pharmacol, Fac Med, Prishtina, Kosovo.	shaip.krasniqi@uni-pr.edu	Krasniqi, Shaip/C-2623-2019; Vllasaliu, Driton/AAV-3848-2020; Daci, Armond/J-8529-2019; Norata, Giuseppe Danilo/AAC-2863-2019	Krasniqi, Shaip/0000-0003-0312-5258; Daci, Armond/0000-0003-1276-4561; Vllasaliu, Driton/0000-0002-4379-6171; Norata, Giuseppe Danilo/0000-0002-6081-1257	Ministry of Education, Science and Technology of Kosovo [4409]; SIGMA Project for academic exchange program [SIGM1200261, SIGM1200277]	Ministry of Education, Science and Technology of Kosovo; SIGMA Project for academic exchange program	Funding: This project was supported by a grant from the Ministry of Education, Science and Technology of Kosovo (No 4409). AD and GB received two scholarships from SIGMA Project for academic exchange program founded by the European Commission (Critical Skills Learning for Innovation, Sustainable Growth Mobility and Employ Ability in the Multicultural Environment of the Western Balkans; contract numbers: SIGM1200261, SIGM1200277). Facilities and infrastructure were provided by Kosovo Interdisciplinary Knowledge Triangle Center (KIKTC, Tempus IV Grant). The authors have no other relevant affiliations or financial in-volvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2008, BRIT J CLIN PHARMACO, V66, P304, DOI 10.1111/j.1365-2125.2008.03203.x; Abou-Khalil B, 2001, NEUROLOGY, V57, P2265, DOI 10.1212/WNL.57.12.2265; Alexopoulos AV., 2013, EPILEPTOLOGY, V1, P38, DOI [10.1016/j.epilep.2013.01.001, DOI 10.1016/J.EPILEP.2013.01.001]; Arroyo S, 2002, EPILEPSIA, V43, P437, DOI 10.1046/j.1528-1157.2002.38501.x; Balan S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089253; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; BERTILSSON L, 1986, CLIN PHARMACOKINET, V11, P177, DOI 10.2165/00003088-198611030-00001; BOURGEOIS BFD, 1984, THER DRUG MONIT, V6, P259, DOI 10.1097/00007691-198409000-00001; Caruso A, 2014, PHARMACOGN PERS MED, V7, P117, DOI 10.2147/PGPM.S55548; Du J, 2006, PHARMACOGENOMICS, V7, P831, DOI 10.2217/14622416.7.6.831; Eiselt R, 2001, PHARMACOGENETICS, V11, P447, DOI 10.1097/00008571-200107000-00008; Fendri-Kriaa N, 2011, BIOCHEM BIOPH RES CO, V408, P654, DOI 10.1016/j.bbrc.2011.04.079; Ferraro TN, 2005, EPILEPSY BEHAV, V7, P18, DOI 10.1016/j.yebeh.2005.04.010; Fisher RS, 2005, EPILEPSIA, V46, P470, DOI 10.1111/j.0013-9580.2005.66104.x; Fox J, 2005, J STAT SOFTW, V14; Ghosh C, 2012, NEUROBIOL DIS, V46, P692, DOI 10.1016/j.nbd.2012.03.010; Haerian BS, 2010, SEIZURE-EUR J EPILEP, V19, P339, DOI 10.1016/j.seizure.2010.05.004; Haerian BS, 2013, PHARMACOGENOMICS, V14, P1153, DOI [10.2217/PGS.13.104, 10.2217/pgs.13.104]; Hashi S, 2015, EUR J CLIN PHARMACOL, V71, P51, DOI 10.1007/s00228-014-1773-z; Hassett C, 1997, ARCH BIOCHEM BIOPHYS, V337, P275, DOI 10.1006/abbi.1996.9794; HASSETT C, 1994, HUM MOL GENET, V3, P421, DOI 10.1093/hmg/3.3.421; Hoffmeyer S, 2000, P NATL ACAD SCI USA, V97, P3473, DOI 10.1073/pnas.050585397; Hung CC, 2012, PHARMACOGENOMICS, V13, P159, DOI [10.2217/PGS.11.141, 10.2217/pgs.11.141]; Jandova K, 2006, BRAIN, V129, P3290, DOI 10.1093/brain/awl218; KERR BM, 1994, BIOCHEM PHARMACOL, V47, P1969, DOI 10.1016/0006-2952(94)90071-X; Kim DW, 2009, EPILEPSY RES, V84, P86, DOI 10.1016/j.eplepsyres.2008.12.001; Kitteringham NR, 1996, J PHARMACOL EXP THER, V278, P1018; Krasniqi Shaip, 2010, Med Arh, V64, P80; KUDRIAKOVA TB, 1992, BRIT J CLIN PHARMACO, V33, P611, DOI 10.1111/j.1365-2125.1992.tb04089.x; Kumari R, 2013, BIOCHIMIE, V95, P1350, DOI 10.1016/j.biochi.2013.02.006; Kwan P, 2001, EPILEPSIA, V42, P1255, DOI 10.1046/j.1528-1157.2001.04501.x; Lakhan R, 2009, BRIT J CLIN PHARMACO, V68, P214, DOI 10.1111/j.1365-2125.2009.03437.x; Luna-Tortos C, 2008, NEUROPHARMACOLOGY, V55, P1364, DOI 10.1016/j.neuropharm.2008.08.032; Ma CL, 2015, PHARMACOGENOMICS, V16, P1499, DOI [10.2217/PGS.15.94, 10.2217/pgs.15.94]; Ma CL, 2014, PHARMACOGENOMICS, V15, P1323, DOI [10.2217/pgs.14.89, 10.2217/PGS.14.89]; Maekawa K, 2003, XENOBIOTICA, V33, P277, DOI 10.1080/0049825021000061615; Makmor-Bakry M, 2009, CLIN NEUROPHARMACOL, V32, P205, DOI 10.1097/WNF.0b013e318187972a; Manna I, 2011, EPILEPSIA, V52, pE40, DOI 10.1111/j.1528-1167.2011.03097.x; Marino SE, 2012, CLIN PHARMACOL THER, V91, P483, DOI 10.1038/clpt.2011.251; Meng HM, 2011, EPILEPSY BEHAV, V21, P27, DOI 10.1016/j.yebeh.2011.02.015; Menzler K, 2014, EPILEPSIA, V55, P362, DOI 10.1111/epi.12515; Milovanovic D. D., 2015, Serbian Journal of Experimental and Clinical Research, V16, P93; Nakajima Y, 2005, EUR J CLIN PHARMACOL, V61, P25, DOI 10.1007/s00228-004-0878-1; Oby E, 2006, BRAIN RES, V1086, P201, DOI 10.1016/j.brainres.2006.02.068; Ozgon GO, 2008, EUR NEUROL, V59, P67, DOI 10.1159/000109264; Panomvana D, 2013, J PHARM PHARM SCI, V16, P502, DOI 10.18433/J3Q888; Park PW, 2009, J CLIN PHARM THER, V34, P569, DOI 10.1111/j.1365-2710.2009.01057.x; Patsalos PN, 2008, EPILEPSIA, V49, P1239, DOI 10.1111/j.1528-1167.2008.01561.x; Patsalos PN, 2000, THER DRUG MONIT, V22, P127, DOI 10.1097/00007691-200002000-00027; Puranik YG, 2013, PHARMACOGENOMICS, V14, P35, DOI [10.2217/pgs.12.180, 10.2217/PGS.12.180]; Remy S, 2003, ANN NEUROL, V53, P469, DOI 10.1002/ana.10473; Sachse C, 2002, CARCINOGENESIS, V23, P1839, DOI 10.1093/carcin/23.11.1839; Seo T, 2006, CLIN PHARMACOL THER, V79, P509, DOI 10.1016/j.clpt.2006.02.009; Seo T, 2006, PHARMACOGENOMICS, V7, P551, DOI 10.2217/14622416.7.4.551; Seven M, 2014, MOL BIOL REP, V41, P331, DOI 10.1007/s11033-013-2866-y; Shaheen U, 2014, EPILEPSY RES, V108, P251, DOI 10.1016/j.eplepsyres.2013.11.009; Shorvon S, 2010, HANDBOOK OF EPILEPSY TREATMENT, 3RD EDITION, P1; Siddiqui A, 2003, NEW ENGL J MED, V348, P1442, DOI 10.1056/NEJMoa021986; Sisodiya SM, 2005, EPILEPSIA, V46, P33, DOI 10.1111/j.1528-1167.2005.00356.x; Smith CAD, 1997, LANCET, V350, P630, DOI 10.1016/S0140-6736(96)08061-0; Sterjev Z, 2012, BALK J MED GENET, V15, P19, DOI 10.2478/v10034-012-0003-1; Sterjev Z, 2012, NEUROPSYCH DIS TREAT, V8, P191, DOI 10.2147/NDT.S28285; Subenthiran S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064827; Szoeke CEI, 2006, LANCET NEUROL, V5, P189, DOI 10.1016/S1474-4422(06)70352-0; Tan NCK, 2004, NEUROLOGY, V63, P1090, DOI 10.1212/01.WNL.0000137051.33486.C7; Tate SK, 2005, P NATL ACAD SCI USA, V102, P5507, DOI 10.1073/pnas.0407346102; Taur SR, 2014, J POSTGRAD MED, V60, P265, DOI 10.4103/0022-3859.138739; Thompson CH, 2011, EPILEPSIA, V52, P1000, DOI 10.1111/j.1528-1167.2011.03040.x; Touw DJ, 2005, THER DRUG MONIT, V27, P10, DOI 10.1097/00007691-200502000-00004; Yu FH, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-207; Yun WT, 2013, EPILEPSY RES, V107, P231, DOI 10.1016/j.eplepsyres.2013.09.011; Zhang CB, 2012, ADV DRUG DELIVER REV, V64, P930, DOI 10.1016/j.addr.2011.12.003; Zhu X, 2014, PHARMACOGENOMICS, V15, P1867, DOI [10.2217/PGS.14.142, 10.2217/pgs.14.142]; Zimprich F, 2008, EPILEPSIA, V49, P1108, DOI 10.1111/j.1528-1167.2008.01549_4.x	74	26	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142408	10.1371/journal.pone.0142408	http://dx.doi.org/10.1371/journal.pone.0142408			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555147	Green Published, Green Accepted, gold			2022-12-27	WOS:000364430700100
J	Murata, H; Takamatsu, H; Lie, SL; Kataoka, K; Huh, NH; Sakaguchi, M				Murata, Hitoshi; Takamatsu, Hitoshi; Lie, Sulai; Kataoka, Ken; Huh, Nam-ho; Sakaguchi, Masakiyo			NRF2 Regulates PINK1 Expression under Oxidative Stress Conditions	PLOS ONE			English	Article							TRANSCRIPTION FACTOR NRF2; GENE; MUTATIONS; PROMOTES; PROTEIN; NEUROPROTECTION; DETOXIFICATION; PARKINSONISM; MITOCHONDRIA; PROTECTION	Mutations of the PTEN-induced putative kinase 1 (PINK1) gene are a cause of autosomal recessive forms of Parkinson's disease. Recent studies have revealed that PINK1 is an essential factor for controlling mitochondrial quality, and that it protects cells from oxidative stresses. Although there has been considerable progress in the elucidation of various aspects of PINK1 protein regulation such as activation, stability and degradation, the transcriptional regulation of PINK1 mRNA under stress conditions remains unclear. In this study, we found that nuclear factor (erythroid-derived 2)-like 2 (NRF2), an antioxidant transcription factor, regulates PINK1 expression under oxidative stress conditions. Damaged mitochondria arising from stress conditions induced NRF2-dependent transcription of the PINK1 gene through production of reactive oxygen species (ROS). Either an ROS scavenger or forced expression of KEAP1, a potent inhibitory partner to NRF2, restricted PINK1 expression induced by activated NRF2. Transcriptionally up-regulated PINK1 diminished oxidative stress-associated cell death. The results indicate that PINK1 expression is positively regulated by NRF2 and that the NRF2-PINK1 signaling axis is deeply involved in cell survival.	[Murata, Hitoshi; Takamatsu, Hitoshi; Lie, Sulai; Huh, Nam-ho; Sakaguchi, Masakiyo] Okayama Univ, Dept Cell Biol, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, Okayama 7008558, Japan; [Kataoka, Ken] Okayama Univ Sci, Fac Sci, Dept Life Sci, Kita Ku, Okayama 7000005, Japan	Okayama University; Okayama University of Science	Sakaguchi, M (corresponding author), Okayama Univ, Dept Cell Biol, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	masa-s@md.okayama-u.ac.jp	Sakaguchi, Masakiyo/B-2280-2011; MURATA, Hitoshi/B-2327-2011	Liu, Sulai/0000-0002-5257-3922	Ministry of Education, Culture, Sports, Science, and Technology of Japan [25860216]; Okayama Medical Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Okayama Medical Foundation	Funding: Funding was provided by The Ministry of Education, Culture, Sports, Science, and Technology of Japan (25860216); The Okayama Medical Foundation.	Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071; Arena G, 2013, CELL DEATH DIFFER; Balogun E, 2003, BIOCHEM J, V371, P887, DOI 10.1042/BJ20021619; Beilina A, 2005, P NATL ACAD SCI USA, V102, P5703, DOI 10.1073/pnas.0500617102; Bonifati V, 2005, NEUROLOGY, V65, P87, DOI 10.1212/01.wnl.0000167546.39375.82; Chen PC, 2009, P NATL ACAD SCI USA, V106, P2933, DOI 10.1073/pnas.0813361106; Cho HY, 2002, AM J RESP CELL MOL, V26, P175, DOI 10.1165/ajrcmb.26.2.4501; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Dinkova-Kostova AT, 2008, PLANTA MED, V74, P1548, DOI 10.1055/s-2008-1081296; Gomez-Sanchez R, 2014, NEUROBIOL DIS, V62, P426, DOI 10.1016/j.nbd.2013.10.021; Imhoff BR, 2010, CELL BIOL TOXICOL, V26, P541, DOI 10.1007/s10565-010-9162-6; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Jaramillo MC, 2013, GENE DEV, V27, P2179, DOI 10.1101/gad.225680.113; Jin Y, 2012, ONCOL REP, V27, P695, DOI 10.3892/or.2011.1543; Katoh Y, 2001, GENES CELLS, V6, P857, DOI 10.1046/j.1365-2443.2001.00469.x; Kensler T W, 2000, Drug Metabol Drug Interact, V17, P3; Klinkenberg M, 2012, NEUROGENETICS, V13, P9, DOI 10.1007/s10048-011-0303-8; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Lee JM, 2004, P NATL ACAD SCI USA, V101, P9751, DOI 10.1073/pnas.0403620101; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Li J, 2005, TOXICOL SCI, V83, P313, DOI 10.1093/toxsci/kfi027; Lou HY, 2014, NEUROPHARMACOLOGY, V79, P380, DOI 10.1016/j.neuropharm.2013.11.026; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; McMahon M, 2001, CANCER RES, V61, P3299; Mei Y, 2009, P NATL ACAD SCI USA, V106, P5153, DOI 10.1073/pnas.0901104106; Meissner C, 2011, J NEUROCHEM, V117, P856, DOI 10.1111/j.1471-4159.2011.07253.x; Murata H, 2013, MOL BIOL CELL, V24, P2772, DOI 10.1091/mbc.E13-01-0016; Murata H, 2011, J BIOL CHEM, V286, P7182, DOI 10.1074/jbc.M110.179390; Nakajima A, 2003, CANCER LETT, V201, P195, DOI 10.1016/S0304-3835(03)00443-9; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Nioi P, 2003, BIOCHEM J, V374, P337, DOI 10.1042/BJ20030754; Priyadarshini M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081851; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; Ryu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071178; Sekhar KR, 2010, TOXICOL APPL PHARM, V244, P21, DOI 10.1016/j.taap.2009.06.016; Siebert A, 2009, J NEUROSCI RES, V87, P1659, DOI 10.1002/jnr.21975; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Wild AC, 1999, J BIOL CHEM, V274, P33627, DOI 10.1074/jbc.274.47.33627; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Wu ZH, 2013, GENE DEV, V27, P157, DOI 10.1101/gad.203406.112	42	92	95	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142438	10.1371/journal.pone.0142438	http://dx.doi.org/10.1371/journal.pone.0142438			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555609	Green Published, gold, Green Submitted			2022-12-27	WOS:000364430700104
J	Budd, WT; Seashols-Williams, SJ; Clark, GC; Weaver, D; Calvert, V; Petricoin, E; Dragoescu, EA; O'Hanlon, K; Zehner, ZE				Budd, William T.; Seashols-Williams, Sarah J.; Clark, Gene C.; Weaver, Danielle; Calvert, Valerie; Petricoin, Emanuel; Dragoescu, Ema A.; O'Hanlon, Katherine; Zehner, Zendra E.			Dual Action of miR-125b As a Tumor Suppressor and OncomiR-22 Promotes Prostate Cancer Tumorigenesis	PLOS ONE			English	Article							LASER-CAPTURE MICRODISSECTION; MICRORNA EXPRESSION; GENE-EXPRESSION; PROGNOSTIC IMPLICATIONS; GROWTH; CELLS; ADENOCARCINOMA; DYSREGULATION; PROGRESSION; PREDICTION	MicroRNAs (miRs) are a novel class of small RNA molecules, the dysregulation of which can contribute to cancer. A combinatorial approach was used to identify miRs that promote prostate cancer progression in a unique set of prostate cancer cell lines, which originate from the parental p69 cell line and extend to a highly tumorigenic/metastatic M12 subline. Together, these cell lines are thought to mimic prostate cancer progression in vivo. Previous network analysis and miR arrays suggested that the loss of hsa-miR-125b together with the overexpression of hsa-miR-22 could contribute to prostate tumorigenesis. The dysregulation of these two miRs was confirmed in human prostate tumor samples as compared to adjacent benign glandular epithelium collected through laser capture microdissection from radical prostatectomies. In fact, alterations in hsa-miR-125b expression appeared to be an early event in tumorigenesis. Reverse phase microarray proteomic analysis revealed ErbB2/3 and downstream members of the PI3K/AKT and MAPK/ERK pathways as well as PTEN to be protein targets differentially expressed in the M12 tumor cell compared to its parental p69 cell. Relevant luciferase+3'-UTR expression studies confirmed a direct interaction between hsa-miR-125b and ErbB2 and between hsa-miR-22 and PTEN. Restoration of hsa-miR-125b or inhibition of hsa-miR-22 expression via an antagomiR resulted in an alteration of M12 tumor cell behavior in vitro. Thus, the dual action of hsa-miR-125b as a tumor suppressor and hsa-miR-22 as an oncomiR contributed to prostate tumorigenesis by modulations in PI3K/AKT and MAPK/ERK signaling pathways, key pathways known to influence prostate cancer progression.	[Budd, William T.; Seashols-Williams, Sarah J.; Clark, Gene C.; Zehner, Zendra E.] Virginia Commonwealth Univ, Massey Canc Ctr, Dept Biochem & Mol Biol, Richmond, VA 23284 USA; [Seashols-Williams, Sarah J.] Virginia Commonwealth Univ, Dept Forens Sci, Richmond, VA USA; [Weaver, Danielle] Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA USA; [Calvert, Valerie; Petricoin, Emanuel] George Mason Univ, Ctr Appl Prote & Mol Med, Manassas, VA USA; [Dragoescu, Ema A.] Virginia Commonwealth Univ, Dept Pathol, VCU Med Ctr, Richmond, VA USA; [O'Hanlon, Katherine] Amer Int Biotechnol, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; George Mason University; Virginia Commonwealth University	Zehner, ZE (corresponding author), Virginia Commonwealth Univ, Massey Canc Ctr, Dept Biochem & Mol Biol, Richmond, VA 23284 USA.	zendra.zehner@vcuhealth.org	Seashols-Williams, Sarah J/K-7455-2016	Seashols-Williams, Sarah J/0000-0003-0093-8261	National Cancer Institute [R21CA152349]; NATIONAL CANCER INSTITUTE [R21CA152349] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Cancer Institute, Grant Number R21CA152349 to ZEZ. The funder provided support in the form of salaries for KOH, but did not have any additional role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. The specific roles of this author is articulated in the "author contributions" section.	Astbury C, 2001, GENE CHROMOSOME CANC, V31, P143, DOI 10.1002/gcc.1128; BAE VL, 1994, INT J CANCER, V58, P721, DOI 10.1002/ijc.2910580517; Bae VL, 1998, PROSTATE, V34, P275, DOI 10.1002/(SICI)1097-0045(19980301)34:4<275::AID-PROS5>3.0.CO;2-G; Baffa R, 2009, J PATHOL, V219, P214, DOI 10.1002/path.2586; Bar N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010859; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Boehm M, 2006, CELL CYCLE, V5, P837, DOI 10.4161/cc.5.8.2688; Bostwick David G, 2004, Rev Urol, V6, P171; Budd WT, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-S5-S3; Budd WT, 2012, CHEM BIODIVERS, V9, P857, DOI 10.1002/cbdv.201100386; Budd WT, 2012, THESIS; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chen Dan, 2013, J Oral Maxillofac Res, V4, pe2, DOI 10.5037/jomr.2013.4102; Dubovenko A, 2015, J CANCER, V6, P490, DOI 10.7150/jca.8213; Espina V, 2006, NAT PROTOC, V1, P586, DOI 10.1038/nprot.2006.85; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; GLEASON DF, 1974, J UROLOGY, V111, P58, DOI 10.1016/S0022-5347(17)59889-4; Grubb RL, 2003, PROTEOMICS, V3, P2142, DOI 10.1002/pmic.200300598; Hammond SM, 2006, CURR OPIN GENET DEV, V16, P4, DOI 10.1016/j.gde.2005.12.005; He J, 2012, EMBO REP, V13, P1116, DOI 10.1038/embor.2012.162; Holbro T, 2003, P NATL ACAD SCI USA, V100, P8933, DOI 10.1073/pnas.1537685100; ISAACS JT, 1989, PROSTATE, P33; Joseph A, 2011, METHODS MOL BIOL, V755, P291, DOI 10.1007/978-1-61779-163-5_24; Kent OA, 2006, ONCOGENE, V25, P6188, DOI 10.1038/sj.onc.1209913; Klink JC, 2012, KOREAN J UROL, V53, P297, DOI 10.4111/kju.2012.53.5.297; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Li WX, 2008, INT J CANCER, V123, P1616, DOI 10.1002/ijc.23693; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu X, 2010, BRIT J CANCER, V102, P457, DOI 10.1038/sj.bjc.6605490; Nonn L, 2010, EXP MOL PATHOL, V88, P45, DOI 10.1016/j.yexmp.2009.10.005; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Paweletz CP, 2001, UROLOGY, V57, P160, DOI 10.1016/S0090-4295(00)00964-X; Paweletz CP, 2001, ONCOGENE, V20, P1981, DOI 10.1038/sj.onc.1204265; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Priolo C, 2014, CANCER RES, V74, P7198, DOI 10.1158/0008-5472.CAN-14-1490; Schaefer A, 2010, INT J CANCER, V126, P1166, DOI 10.1002/ijc.24827; Scott GK, 2007, J BIOL CHEM, P282; Seashols S, 2013, THESIS; Shi XB, 2007, P NATL ACAD SCI USA, V104, P19983, DOI 10.1073/pnas.0706641104; Shi XB, 2011, PROSTATE, V71, P538, DOI 10.1002/pros.21270; Shukla CJ, 2008, BJU INT, V101, P765, DOI 10.1111/j.1464-410X.2007.07372.x; Sorrentino A, 2008, GYNECOL ONCOL, V111, P478, DOI 10.1016/j.ygyno.2008.08.017; Srivastava A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076994; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; Veerla S, 2009, INT J CANCER, V124, P2236, DOI 10.1002/ijc.24183; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; White RWD, 2009, UROL ONCOL-SEMIN ORI, V27, P307, DOI 10.1016/j.urolonc.2009.01.004; Wu YZ, 2003, ONCOGENE, V22, P8891, DOI 10.1038/sj.onc.1206898; Yee Jie Yin, 2014, BMC Res Notes, V7, P62, DOI 10.1186/1756-0500-7-62; Zhang XP, 2009, CLIN EXP METASTAS, V26, P965, DOI 10.1007/s10585-009-9287-2; Zhang XP, 2009, MOL CANCER THER, V8, P499, DOI 10.1158/1535-7163.MCT-08-0544; Zhang Y, 2011, CANCER RES, V71, P3552, DOI 10.1158/0008-5472.CAN-10-2435; Zhao Y, 2007, TRENDS BIOCHEM SCI, V32, P189, DOI 10.1016/j.tibs.2007.02.006	56	42	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142373	10.1371/journal.pone.0142373	http://dx.doi.org/10.1371/journal.pone.0142373			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544868	Green Published, Green Submitted, gold			2022-12-27	WOS:000364398700121
J	Corgnet, B; Gonzalez, RH; Mateo, R				Corgnet, Brice; Gonzalez, Roberto Hernan; Mateo, Ricardo			Cognitive Reflection and the Diligent Worker: An Experimental Study of Millennials	PLOS ONE			English	Article							JOB-PERFORMANCE; RANGE RESTRICTION; WORKING-MEMORY; INDIVIDUAL-DIFFERENCES; 5-FACTOR MODEL; MENTAL-ABILITY; PERSONALITY; CONSCIENTIOUSNESS; VALIDITIES; SELECTION	Recent studies have shown that despite crucially needing the creative talent of millennials (people born after 1980) organizations have been reluctant to hire young workers because of their supposed lack of diligence. We propose to help resolve this dilemma by studying the determinants of task performance and shirking behaviors of millennials in a laboratory work environment. We find that cognitive ability is a good predictor of task performance in line with previous literature. In contrast with previous research, personality traits do not consistently predict either task performance or shirking behaviors. Shirking behaviors, as measured by the time participants spent browsing the internet for non-work purposes (Cyberloafing), were only explained by the performance on the Cognitive Reflection Test (CRT). This finding echoes recent research in cognitive psychology according to which conventional measures of cognitive ability only assess a narrow concept of rational thinking (the algorithmic mind) that fails to capture individuals' capacity to reflect and control their impulses. Our findings suggest that hiring diligent millennials relies on the use of novel cognitive measures such as CRT in lieu of standard personality and intelligence tests.	[Corgnet, Brice] Chapman Univ, George L Argyros Sch Business & Econ, Orange, CA USA; [Gonzalez, Roberto Hernan] Univ Nottingham, Sch Business, Div Ind Econ & Finance, Nottingham NG7 2RD, Notts, England; [Mateo, Ricardo] Univ Navarra, Business Dept, Navarra, Spain	Chapman University System; Chapman University; University of Nottingham; University of Navarra	Gonzalez, RH (corresponding author), Univ Nottingham, Sch Business, Div Ind Econ & Finance, Nottingham NG7 2RD, Notts, England.	roberto.hernangonzalez@gmail.com	Corgnet, Brice/G-7917-2017; Mateo, Ricardo/H-3556-2017	Corgnet, Brice/0000-0003-0086-8523; Mateo, Ricardo/0000-0001-6772-8002	International Foundation for Research in Experimental Economics; Argyros School of Business and Economics at Chapman University; Volkswagen Catedra of Navarra; Spanish Ministry of Education [2012/00103/001]; Spanish Plan Nacional I+D MCI [ECO2013-44879-R]; Proyectos de Excelencia de la Junta Andalucia [P12. SEJ.1436]	International Foundation for Research in Experimental Economics; Argyros School of Business and Economics at Chapman University; Volkswagen Catedra of Navarra; Spanish Ministry of Education(Spanish Government); Spanish Plan Nacional I+D MCI; Proyectos de Excelencia de la Junta Andalucia	The authors acknowledge financial support from the International Foundation for Research in Experimental Economics, the Argyros School of Business and Economics at Chapman University, the Volkswagen Catedra of Navarra, the Spanish Ministry of Education [Grant 2012/00103/001], Spanish Plan Nacional I+D MCI [ECO2013-44879-R], 2014-17, and Proyectos de Excelencia de la Junta Andalucia [P12. SEJ.1436], 2014-18. All these funders contributed in the study design, data collection, and analysis.	Alder GS, 2006, INFORM MANAGE-AMSTER, V43, P894, DOI 10.1016/j.im.2006.08.008; ARELLANO M, 1987, OXFORD B ECON STAT, V49, P431; Barrick M.R., 2009, HDB PRINCIPLES ORG B, P19, DOI 10.1002/9781119206422.ch2; BARRICK MR, 1991, PERS PSYCHOL, V44, P1, DOI 10.1111/j.1744-6570.1991.tb00688.x; Barrick MR, 2001, INT J SELECT ASSESS, V9, P9, DOI 10.1111/1468-2389.00160; Behling O., 1998, ACAD MANAGEMENT EXEC, P77, DOI 10.5465/ame.1998.254980; Berry CM, 2007, J APPL PSYCHOL, V92, P410, DOI 10.1037/0021-9010.92.2.410; Burks SV, 2015, J ECON BEHAV ORGAN, V115, P30, DOI 10.1016/j.jebo.2015.01.007; Conway ARA, 2003, TRENDS COGN SCI, V7, P547, DOI 10.1016/j.tics.2003.10.005; Corgnet B, REV BEHAV E IN PRESS; Corgnet B, 2015, EXP ECON, V18, P284, DOI 10.1007/s10683-014-9401-4; COSTA PT, 1991, PERS INDIV DIFFER, V12, P887, DOI 10.1016/0191-8869(91)90177-D; Costa PT, 2007, REVISED NEO PERSONAL; Deary IJ, 2000, INTELLIGENCE, V28, P49, DOI 10.1016/S0160-2896(99)00031-8; DIGMAN JM, 1990, ANNU REV PSYCHOL, V41, P417, DOI 10.1146/annurev.psych.41.1.417; Dilchert S, 2007, J APPL PSYCHOL, V92, P616, DOI 10.1037/0021-9010.92.3.616; Dohmen T, 2011, AM ECON REV, V101, P556, DOI 10.1257/aer.101.2.556; Eriksson T, 2009, LABOUR ECON, V16, P679, DOI 10.1016/j.labeco.2009.08.006; Frederick S, 2005, J ECON PERSPECT, V19, P25, DOI 10.1257/089533005775196732; Gneezy U, 2010, J ECON BEHAV ORGAN, V75, P144, DOI 10.1016/j.jebo.2010.04.005; GOLDBERG LR, 1990, J PERS SOC PSYCHOL, V59, P1216, DOI 10.1037/0022-3514.59.6.1216; Hern?n-Gonz?lez, 2014, ACAD MANAGEMENT BEST, V1, P13761, DOI [10.5465/AMBPP.2014.40, DOI 10.5465/AMBPP.2014.40, 10.5465/ambpp.2014.40]; HOUGH LM, 1990, J APPL PSYCHOL, V75, P581, DOI 10.1037/0021-9010.75.5.581; HUNTER JE, 1984, PSYCHOL BULL, V96, P72, DOI 10.1037/0033-2909.96.1.72; Hunter JE, 2006, J APPL PSYCHOL, V91, P594, DOI 10.1037/0021-9010.91.3.594; Hurtz GM, 2000, J APPL PSYCHOL, V85, P869, DOI 10.1037/0021-9010.85.6.869; Jensen A.R., 1998, G FACTOR SCI MENTAL; John O, 1991, BIG 5 INVENTORY VERS; John O. P., 2008, HDB PERSONALITY THEO, P114, DOI DOI 10.1016/S0191-8869(97)81000-8; John O.P., 1989, PERSONALITY PSYCHOL, P261, DOI DOI 10.1007/978-1-4684-0634-4_20; John OP, 2001, HDB PERSONALITY THEO, P102; Kahneman D., 2011, THINKING FAST SLOW; Lim VKG, 2002, J ORGAN BEHAV, V23, P675, DOI 10.1002/job.161; LOGIE RH, 1994, MEM COGNITION, V22, P395, DOI 10.3758/BF03200866; Marcus B, 2002, INT J SELECT ASSESS, V10, P18, DOI 10.1111/1468-2389.00191; Marcus B, 2009, EUR J PERSONALITY, V23, P489, DOI 10.1002/per.728; MCCRAE RR, 1987, J PERS SOC PSYCHOL, V52, P81, DOI 10.1037/0022-3514.52.1.81; MCHENRY JJ, 1990, PERS PSYCHOL, V43, P335, DOI 10.1111/j.1744-6570.1990.tb01562.x; Mount MK, 1998, HUM PERFORM, V11, P145, DOI 10.1207/s15327043hup1102&3_3; Mount MK, 1999, J MANAGE, V25, P707, DOI 10.1177/014920639902500505; OLEA MM, 1994, J APPL PSYCHOL, V79, P845, DOI 10.1037/0021-9010.79.6.845; Ones DS, 2007, PERS PSYCHOL, V60, P995, DOI 10.1111/j.1744-6570.2007.00099.x; ONES DS, 1993, J APPL PSYCHOL, V78, P679, DOI 10.1037/0021-9010.78.4.679; Rainer T. S., 2011, MILLENNIALS; Roberts BW, 2007, J APPL PSYCHOL, V92, P1427, DOI 10.1037/0021-9010.92.5.1427; Rotundo M, 2002, J APPL PSYCHOL, V87, P66, DOI 10.1037//0021-9010.87.1.66; Rotundo M, 2008, INT J HUM RESOUR MAN, V19, P856, DOI 10.1080/09585190801991400; Salgado JF, 1997, J APPL PSYCHOL, V82, P30, DOI 10.1037/0021-9010.82.1.30; Schmidt FL, 2006, PERS PSYCHOL, V59, P281, DOI 10.1111/j.1744-6570.2006.00065.x; Schmidt FL, 1998, PSYCHOL BULL, V124, P262, DOI 10.1037/0033-2909.124.2.262; Schmidt FL., 2009, HDB PRINCIPLES ORG B, P3, DOI DOI 10.1002/9781119206422.CH1; Schmidt FL, 2008, PERS PSYCHOL, V61, P827, DOI 10.1111/j.1744-6570.2008.00132.x; Shamosh NA, 2008, PSYCHOL SCI, V19, P904, DOI 10.1111/j.1467-9280.2008.02175.x; Shamosh NA, 2008, INTELLIGENCE, V36, P289, DOI 10.1016/j.intell.2007.09.004; Stanovich K. E., 2009, WHAT INTELLIGENCE TE; Stanovich K E., 2010, RATIONALITY REFLECTI; TETT RP, 1991, PERS PSYCHOL, V44, P703; Toplak ME, 2011, MEM COGNITION, V39, P1275, DOI 10.3758/s13421-011-0104-1; Witt LA, 2002, J MANAGE, V28, P835, DOI 10.1177/014920630202800607; Witt LA, 2002, J APPL PSYCHOL, V87, P164, DOI 10.1037//0021-9010.87.1.164	60	21	21	4	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141243	10.1371/journal.pone.0141243	http://dx.doi.org/10.1371/journal.pone.0141243			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV6RT	26545244	Green Published, Green Submitted, gold			2022-12-27	WOS:000364398700020
J	Horowitz, BB; Ospina-Giraldo, MD				Horowitz, Brent B.; Ospina-Giraldo, Manuel D.			The Pectin Methylesterase Gene Complement of Phytophthora sojae: Structural and Functional Analyses, and the Evolutionary Relationships with Its Oomycete Homologs	PLOS ONE			English	Article							PLANT; INFESTANS; PATHOGEN; EXPRESSION; FUNGI; AVR3A	Phytophthora sojae is an oomycete pathogen that causes the disease known as root and stem rot in soybean plants, frequently leading to massive economic damage. Additionally, P. sojae is increasingly being utilized as a model for phytopathogenic oomycete research. Despite the economic and scientific importance of P. sojae, the mechanism by which it penetrates the host roots is not yet fully understood. It has been found that oomycetes are not capable of penetrating the cell wall solely through mechanical force, suggesting that alternative factors facilitate breakdown of the host cell wall. Pectin methylesterases have been suggested to be important for Phytophthora pathogenicity, but no data exist on their role in the P. sojae infection process. We have scanned the newly revised version of the annotated P. sojae genome for the presence of putative pectin methylesterases genes and conducted a sequence analysis of all gene models found. We also searched for potential regulatory motifs in the promoter region of the proposed P. sojae models, and investigated the gene expression levels throughout the early course of infection on soybean plants. We found that P. sojae contains a large repertoire of pectin methylesterase-coding genes and that most of these genes display similar motifs in the promoter region, indicating the possibility of a shared regulatory mechanism. Phylogenetic analyses confirmed the evolutionary relatedness of the pectin methylesterase-coding genes within and across Phytophthora spp. In addition, the gene duplication events that led to the emergence of this gene family appear to have occurred prior to many speciation events in the genus Phytophthora. Our results also indicate that the highest levels of expression occurred in the first 24 hours post inoculation, with expression falling after this time. Our study provides evidence that pectin methylesterases may be important for the early action of the P. sojae infection process.	[Horowitz, Brent B.; Ospina-Giraldo, Manuel D.] Lafayette Coll, Dept Biol, Easton, PA 18042 USA	Lafayette College	Ospina-Giraldo, MD (corresponding author), Lafayette Coll, Dept Biol, Easton, PA 18042 USA.	elsgenomics@gmail.com		Horowitz, Brent/0000-0002-5744-7562	Lafayette College; Agriculture and Food Research Initiative competitive grant of the United States Department of Agriculture's National Institute of Food and Agriculture [2011-68004-30104]	Lafayette College; Agriculture and Food Research Initiative competitive grant of the United States Department of Agriculture's National Institute of Food and Agriculture	Funding was provided by Lafayette College and the Agriculture and Food Research Initiative competitive grant 2011-68004-30104 of the United States Department of Agriculture's National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avrova AO, 2008, CELL MICROBIOL, V10, P2271, DOI 10.1111/j.1462-5822.2008.01206.x; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Boudjeko T, 2005, J PHYTOPATHOL, V153, P409, DOI 10.1111/j.1439-0434.2005.00993.x; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; CATEN CE, 1968, CAN J BOTANY, V46, P329, DOI 10.1139/b68-055; Costanzo S, 2006, PHYTOPATHOLOGY, V96, pS26; Costanzo S, 2007, CURR GENET, V52, P115, DOI 10.1007/s00294-007-0144-z; Csuros M, 2008, MOL BIOL EVOL, V25, P903, DOI 10.1093/molbev/msn039; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Hardham AR, 2001, AUSTRALAS PLANT PATH, V30, P91, DOI 10.1071/AP01006; Jia YJ, 2009, J PHYTOPATHOL, V157, P585, DOI 10.1111/j.1439-0434.2008.01533.x; Jiang RHY, 2012, ANNU REV PHYTOPATHOL, V50, P295, DOI 10.1146/annurev-phyto-081211-172912; Kale SD, 2010, CELL, V142, P284, DOI 10.1016/j.cell.2010.06.008; Kemen E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001094; Kupfer DM, 2004, EUKARYOT CELL, V3, P1088, DOI 10.1128/EC.3.5.1088-1100.2004; Li PQ, 2011, J BASIC MICROB, V51, P61, DOI 10.1002/jobm.201000317; Li WH, 2007, MOL EVOLUTION; Lionetti V, 2007, PLANT PHYSIOL, V143, P1871, DOI 10.1104/pp.106.090803; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McLeod A, 2003, FUNGAL GENET BIOL, V38, P250, DOI 10.1016/S1087-1845(02)00523-6; McLeod A, 2004, EUKARYOT CELL, V3, P91, DOI 10.1128/EC.3.1.91-99.2004; MILLER PM, 1955, PHYTOPATHOLOGY, V45, P461; Mingora C, 2014, GENE, V538, P74, DOI 10.1016/j.gene.2014.01.016; Money NP, 2004, FUNGAL GENET BIOL, V41, P872, DOI 10.1016/j.fgb.2004.06.001; Ospina-Giraldo MD, 2010, CURR GENET, V56, P495, DOI 10.1007/s00294-010-0317-z; Ospina-Giraldo MD, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-525; Park BH, 2010, GLYCOBIOLOGY, V20, P1574, DOI 10.1093/glycob/cwq106; Pelloux J, 2007, TRENDS PLANT SCI, V12, P267, DOI 10.1016/j.tplants.2007.04.001; Perkins HR, 1968, CELL WALLS MEMBRANES; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Petre B, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001801; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Shen DY, 2011, CAN J MICROBIOL, V57, P84, DOI [10.1139/W10-103, 10.1139/w10-103]; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tyler BM, 2007, MOL PLANT PATHOL, V8, P1, DOI 10.1111/j.1364-3703.2006.00373.x; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; van West P, 2008, MICROBIOL-SGM, V154, P1482, DOI 10.1099/mic.0.2007/015545-0; Wawra S, 2013, MOL PLANT MICROBE IN, V26, P528, DOI 10.1094/MPMI-08-12-0200-R; Win J, 2006, FUNGAL GENET BIOL, V43, P20, DOI 10.1016/j.fgb.2005.10.003; Yaeno T, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.23865; Yaeno T, 2011, P NATL ACAD SCI USA, V108, P14682, DOI 10.1073/pnas.1106002108; Yang XB, 2001, PHYTOPATHOLOGY, V91, P769, DOI 10.1094/PHYTO.2001.91.8.769; Zerillo MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072572	43	7	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142096	10.1371/journal.pone.0142096	http://dx.doi.org/10.1371/journal.pone.0142096			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544849	Green Submitted, gold, Green Published			2022-12-27	WOS:000364398700081
J	Juarez-Ramirez, C; Theodore, FL; Villalobos, A; Jimenez-Corona, A; Lerin, S; Nigenda, G; Lewis, S				Juarez-Ramirez, Clara; Theodore, Florence L.; Villalobos, Aremis; Jimenez-Corona, Aida; Lerin, Sergio; Nigenda, Gustavo; Lewis, Sarah			Social Support of Patients with Type 2 Diabetes in Marginalized Contexts in Mexico and Its Relation to Compliance with Treatment: A Sociocultural Approach	PLOS ONE			English	Article							MORTALITY; DISEASES; BURDEN; STYLE	Objective This study aimed to describe the ways social support works in the daily life of patients with type 2 diabetes living in conditions of social and economic marginality, in order to understand how that support relates to treatment compliance. Methods Sequential mixed methods research was used. The sample of patients was obtained from primary health care units and selected considering regional representativeness, and levels of morbidity and mortality for type 2 diabetes. Results Results point to the nuclear family as the main source of support. Regardless of the area of residence, four main dimensions of support were identified: economic support, help with treatment compliance, emotional support, and material aid. Conclusions We conclude that the support network assists the patient in different ways and helps cope with the disease, but in conditions of social and economic marginality, does not guarantee the quality of attention nor enable the self-management of treatment.	[Juarez-Ramirez, Clara] Natl Inst Publ Hlth, Ctr Hlth Syst Res, Cuernavaca, Morelos, Mexico; [Theodore, Florence L.] Natl Inst Publ Hlth, Ctr Nutr Res, Cuernavaca, Morelos, Mexico; [Villalobos, Aremis] Natl Inst Publ Hlth, Ctr Populat Hlth Res, Cuernavaca, Morelos, Mexico; [Jimenez-Corona, Aida] Inst Ophthalmol Conde Valenciana IAP, Dept Ocular Epidemiol & Visual Hlth, Mexico City, DF, Mexico; [Jimenez-Corona, Aida] Minist Hlth, Directorate Epidemiol, Mexico City, DF, Mexico; [Lerin, Sergio] Ctr Res & Studies Social Anthropol, Dept Med Anthropol, Mexico City, DF, Mexico; [Nigenda, Gustavo] Morelos State Autonomous Univ, Sch Med, Cuernavaca, Morelos, Mexico; [Lewis, Sarah] Univ Calif Berkeley, Hlth Serv & Policy Anal, Berkeley, CA 94720 USA	Instituto Nacional de Salud Publica; Instituto Nacional de Salud Publica; Instituto Nacional de Salud Publica; Universidad Autonoma del Estado de Morelos; University of California System; University of California Berkeley	Juarez-Ramirez, C (corresponding author), Natl Inst Publ Hlth, Ctr Hlth Syst Res, Cuernavaca, Morelos, Mexico.	clara.juarez@insp.mx		JUAREZ-RAMIREZ, CLARA/0000-0002-1844-772X; Theodore, Florence L./0000-0002-8111-0871	National Council of Science and Technology of Mexico [FOSSIS-87041]	National Council of Science and Technology of Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The National Council of Science and Technology of Mexico (www.conacyt.mx) provided the funding for this research. Grant number: FOSSIS-87041. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Hospital Association, 2012, ENG HLTH CAR US FRAM; Barquera S, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-3; Bauman Z, 2011, SOCIAL INEQUALITIES; Berkman L. F., 2000, SOCIAL EPIDEMIOLOGY, V1, P137, DOI DOI 10.4135/9781412952576.N192]; Bonita R, 2013, LANCET, V381, P575, DOI 10.1016/S0140-6736(12)61993-X; Bourdieu P., 1979, DISTINCTION CRITIQUE; Bury M, 1982, Sociol Health Illn, V4, P167, DOI 10.1111/1467-9566.ep11339939; CASSEL J, 1976, AM J EPIDEMIOL, V104, P107, DOI 10.1093/oxfordjournals.aje.a112281; Ciechanowski P, 2004, PSYCHOSOM MED, V66, P720, DOI 10.1097/01.psy.0000138125.59122.23; COBB S, 1976, PSYCHOSOM MED, V38, P300, DOI 10.1097/00006842-197609000-00003; Coffey A, 1996, MAKING SENSE QUALITA; Daly M, 2008, THEOR SOC, V37, P537, DOI 10.1007/s11186-008-9062-4; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Di Cesare M, 2013, LANCET, V381, P585, DOI 10.1016/S0140-6736(12)61851-0; Dressler WW, 2000, AM ANTHROPOL, V102, P244, DOI 10.1525/aa.2000.102.2.244; Epple C, 2003, DIABETES CARE, V26, P2829, DOI 10.2337/diacare.26.10.2829; Garner P, 2013, LANCET, V381, P27; Geneau R, 2010, LANCET, V376, P1689, DOI 10.1016/S0140-6736(10)61414-6; GERHARDT U, 1990, SOC SCI MED, V30, P1149, DOI 10.1016/0277-9536(90)90255-Q; Hann D, 2002, J PSYCHOSOM RES, V52, P279, DOI 10.1016/S0022-3999(01)00235-5; Jimenez-Corona A, 2013, SALUD PUBLICA MEXICO, V55, pS137, DOI 10.21149/spm.v55s2.5109; Johnson N, 2008, CITIZENSHIP COHESION; Johnson RB, 2007, J MIX METHOD RES, V1, P112, DOI 10.1177/1558689806298224; Kawachi I., 2000, SOCIAL EPIDEMIOLOGY, V174, P290; King DK, 2010, DIABETES CARE, V33, P751, DOI 10.2337/dc09-1746; LOMNITZ L., 2004, REV SOCIOLOGY HUNGAR, V10, P5, DOI DOI 10.1556/REVSOC.10.2004.1.1; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mauss M, 1991, ENSAYO DONES RAZON F; Mayberry LS, 2012, DIABETES CARE, V35, P1239, DOI 10.2337/dc11-2103; Meisinger C, 2009, PSYCHOSOM MED, V71, P784, DOI 10.1097/PSY.0b013e3181ae5770; Michael YL, 2002, J PSYCHOSOM RES, V52, P285, DOI 10.1016/S0022-3999(01)00270-7; Morrish NJ, 2001, DIABETOLOGIA, V44, pS14, DOI 10.1007/PL00002934; Morse J. M., 2009, MIXED METHOD DESIGN; Oliver TR, 2006, ANNU REV PUBL HEALTH, V27, P195, DOI 10.1146/annurev.publhealth.25.101802.123126; Pan American Health Organization (PAHO), 2013, INN CAR CHRON COND O; Paulus D, 2012, KCE REPORTS; Potter J, 1987, DISCOURSE SOCIAL PSY; Putnam RD., 2000, BOWLING ALONE COLLAP; Rintala TM, 2013, J FAM NURS, V19, P3, DOI 10.1177/1074840712471899; Roglic G, 2005, DIABETES CARE, V28, P2130, DOI 10.2337/diacare.28.9.2130; Sapag JC, 2007, REV SAUDE PUBL, V41, P139, DOI 10.1590/S0034-89102007000100019; SCHLENK EA, 1984, DIABETES CARE, V7, P566, DOI 10.2337/diacare.7.6.566; Schutz A., 1995, PROBLEMA REALIDAD SO; Schutz Alfred, 1977, ESTRUCTURAS MUNDO VI; Sluzki C, 1996, RED SOCIAL FRONTERAD; THOITS PA, 1982, J COMMUNITY PSYCHOL, V10, P341, DOI 10.1002/1520-6629(198210)10:4<341::AID-JCOP2290100406>3.0.CO;2-J; Vyncke V, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-65; Weller SC, 2012, SOC SCI MED, V75, P1088, DOI 10.1016/j.socscimed.2012.05.003; Wetherell M, 1998, DISCOURSE SOC, V9, P387, DOI 10.1177/0957926598009003005; WHO, 2011, REPORT ON THE GLOBAL; Wilkinson R., 2003, THE SOLID FACTS; World Health Organisation, 1999, DEFINITION DIAGNOSIS	52	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141766	10.1371/journal.pone.0141766	http://dx.doi.org/10.1371/journal.pone.0141766			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV6RT	26545122	Green Submitted, gold, Green Published			2022-12-27	WOS:000364398700043
J	Kumari, R; Astafurov, K; Genis, A; Danias, J				Kumari, Ruma; Astafurov, Konstantin; Genis, Alina; Danias, John			Differential Effects of C1qa Ablation on Glaucomatous Damage in Two Sexes in DBA/2NNia Mice	PLOS ONE			English	Article							BRAIN MICROGLIA; MOUSE MODEL; COMPLEMENT; ACTIVATION; INDUCTION; PRESSURE; ESTROGEN; RETINA	Purpose To determine the sex and age-related effects of C1qa ablation on retinal ganglion cell (RGC) and optic nerve (ON) axonal loss in a mouse model of glaucomatous neurodegeneration. Methods Congenic C1qa mice were generated in the DBA/2NNia background. Female and male knockout (-/-), heterozygous (+/-), and wild type (+/+) mice were aged up to 14 months and IOPs were recorded in a subset of animals. Retinas of mice from all three groups at 5-6, 9-10 and 11-13 months of age were flat-mounted after retrograde labeling with Fluorogold. Imaged retinas were scored (RGC score) semi-quantitatively on a 10 point scale by two independent observers. A subset of retinas and optic nerves were also used for measurement of total number of RGCs. Semi-thin sections of ON were imaged and graded (ON score) for the amount of axonal damage semi-quantitatively, by two masked observers. Analysis of covariance (ANCOVA) was used for statistical comparisons. Microglial cells in flat-mounted retinas of 5-6 month old C1qa -/- and C1qa +/+ mice were used for assessment of microglial activation utilizing morphological criteria. Results Female C1qa -/- mice had significantly higher IOP (p<0.000001, ANOVA) between 8 and 13 months of age compared to C1qa +/+ animals. No differences in IOPs between animals of the three genotypes were observed in males. At 5-6 months of age, there was no difference in RGC or ON scores between the three genotypes in animals of either sex. At 9-10 months of age, female mice didn't show significant differences in RGC or ON scores between the three genotypes. However, male C1qa -/-and C1qa +/- mice of the same age had better RGC and ON scores (p<0.003 and p<0.05, ANCOVA, for RGC and ON scores, respectively) compared with C1qa +/+ mice. At 11-13 months of age, female C1qa -/- mice had better RGC scores (p<0.006, ANCOVA) compared to C1qa +/+ and C1qa +/-animals. Accordingly, C1qa -/- mice had higher RGC counts (p<0.03, t-test) compared to C1qa +/+ animals. In male mice, there was a tendency for 12 month old C1qa -/- animals to have better RGC scores and higher RGC counts, but this didn't reach statistical significance. ON scores in 11-13 month old animals of either sex were not different between all three genotype. Microglial activation in male 5-6 month old C1qa -/- mice was decreased compared to C1qa +/+ animals; no such effect was seen in females. Conclusions Absence of C1qa ameliorates RGC and ON loss in the DBA/2NNia strain, but this effect differs between the two sexes. C1q-mediated RGC damage seems to be more potent than IOP-mediated RGC loss. In contrast, C1qa absence provides axonal protection early on, but this protection cannot overcome the effects of significant IOP elevation.	[Kumari, Ruma; Astafurov, Konstantin; Danias, John] Suny Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA; [Genis, Alina; Danias, John] Suny Downstate Med Ctr, Dept Ophthalmol, Brooklyn, NY 11203 USA; [Kumari, Ruma; Astafurov, Konstantin; Genis, Alina; Danias, John] SUNY, Inst Eye, Brooklyn, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; SUNY Maritime College	Kumari, R (corresponding author), Suny Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA.	rumagrover23@gmail.com; John.Danias@downstate.edu		Astafurov, Konstantin/0000-0002-7264-4265	National Eye Institute [5R01EY015224]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY015224] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work received financial support from the following sources: grant # 5R01EY015224 from National Eye Institute to JD; Unrestricted challenge grant to the Dept. of Ophthalmology of SUNY Downstate from the Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MG, 2002, NAT GENET, V30, P81, DOI 10.1038/ng794; Astafurov K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104416; Astafurov K, 2014, MOL VIS, V20, P140; Bosco A, 2015, DIS MODEL MECH, V8, P443, DOI 10.1242/dmm.018788; Bosco A, 2011, J COMP NEUROL, V519, P599, DOI 10.1002/cne.22516; Botto M, 1998, EXP CLIN IMMUNOGENET, V15, P231, DOI 10.1159/000019076; Bourne RRA, 2013, LANCET GLOB HEALTH, V1, pE339, DOI 10.1016/S2214-109X(13)70113-X; Chang B, 1999, NAT GENET, V21, P405, DOI 10.1038/7741; Cribbs DH, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-179; Danias J, 2003, INVEST OPHTH VIS SCI, V44, P5151, DOI 10.1167/iovs.02-1101; Danias J, 2003, INVEST OPHTH VIS SCI, V44, P1138, DOI 10.1167/iovs.02-0553; Depboylu C, 2005, NEUROBIOL DIS, V20, P12, DOI 10.1016/j.nbd.2005.01.030; Filippopoulos T, 2006, INVEST OPHTH VIS SCI, V47, P1968, DOI 10.1167/iovs.05-0955; Griffiths MR, 2010, INT J INFLAMM, V2010, DOI 10.4061/2010/151097; Howell GR, 2011, J CLIN INVEST, V121, P1429, DOI 10.1172/JCI44646; Jakobs TC, 2005, J CELL BIOL, V171, P313, DOI 10.1083/jcb.200506099; Klegeris A, 2001, EXP GERONTOL, V36, P1179, DOI 10.1016/S0531-5565(00)00265-5; Krizaj D, 2014, CURR EYE RES, V39, P105, DOI 10.3109/02713683.2013.836541; Kuehn MH, 2006, EXP EYE RES, V83, P620, DOI 10.1016/j.exer.2006.03.002; Lei DL, 2003, NEUROSCIENCE, V121, P659, DOI 10.1016/S0306-4522(03)00245-8; Libby RT, 2005, VISUAL NEUROSCI, V22, P637, DOI 10.1017/S0952523805225130; Marina N, 2010, NAT PROTOC, V5, P1642, DOI 10.1038/nprot.2010.128; McGeer EG, 2003, PROG NEURO-PSYCHOPH, V27, P741, DOI 10.1016/S0278-5846(03)00124-6; McGeer PL, 2002, MUSCLE NERVE, V26, P459, DOI 10.1002/mus.10191; Mevorach D, 2010, APOPTOSIS, V15, P1114, DOI 10.1007/s10495-010-0530-8; MONDINO BJ, 1984, INVEST OPHTH VIS SCI, V25, P871; MONDINO BJ, 1986, INVEST OPHTH VIS SCI, V27, P1288; Reichstein D, 2007, EXP EYE RES, V84, P13, DOI 10.1016/j.exer.2006.08.009; Ren LZ, 2010, ADV EXP MED BIOL, V703, P95, DOI 10.1007/978-1-4419-5635-4_7; Sarvari M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088540; Schafer MKH, 2000, J IMMUNOL, V164, P5446, DOI 10.4049/jimmunol.164.10.5446; Seitz R, 2013, CELL TISSUE RES, V353, P339, DOI 10.1007/s00441-013-1666-y; SHELDON WG, 1995, LAB ANIM SCI, V45, P508; Sohn JH, 2000, INVEST OPHTH VIS SCI, V41, P3492; Sohn JH, 2000, INVEST OPHTH VIS SCI, V41, P4195; Stasi K, 2006, INVEST OPHTH VIS SCI, V47, P1024, DOI 10.1167/iovs.05-0830; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Takano Y, 2012, AM J OPHTHALMOL, V154, P825, DOI 10.1016/j.ajo.2012.03.050; Tezel G, 2013, CURR OPIN PHARMACOL, V13, P23, DOI 10.1016/j.coph.2012.09.013; Vegeto E, 2003, P NATL ACAD SCI USA, V100, P9614, DOI 10.1073/pnas.1531957100; Wang JW, 2016, J GLAUCOMA, V25, P459, DOI 10.1097/IJG.0000000000000200; ZHENG XB, 1994, OPHTHALMIC RES, V26, P200, DOI 10.1159/000267468	42	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142199	10.1371/journal.pone.0142199	http://dx.doi.org/10.1371/journal.pone.0142199			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544197	Green Published, Green Submitted, gold			2022-12-27	WOS:000364398700094
J	Upadhyay, M; Vivekanandan, P				Upadhyay, Mohita; Vivekanandan, Perumal			Depletion of CpG Dinucleotides in Papillomaviruses and Polyomaviruses: A Role for Divergent Evolutionary Pressures	PLOS ONE			English	Article							SYNONYMOUS CODON USAGE; DNA METHYLATION; VIRAL-DNA; SELECTION; TYPE-16; GENOME; VIRUS; LEVEL; COEVOLUTION; INTEGRATION	Background Papillomaviruses and polyomaviruses are small ds-DNA viruses infecting a wide-range of vertebrate hosts. Evidence supporting co-evolution of the virus with the host does not fully explain the evolutionary path of papillomaviruses and polyomaviruses. Studies analyzing CpG dinucleotide frequencies in virus genomes have provided interesting insights on virus evolution. CpG dinucleotide depletion has not been extensively studied among papillomaviruses and polyomaviruses. We sought to analyze the relative abundance of dinucleotides and the relative roles of evolutionary pressures in papillomaviruses and polyomaviruses. Methods We studied 127 full-length sequences from papillomaviruses and 56 full-length sequences from polyomaviruses. We analyzed the relative abundance of dinucleotides, effective codon number (ENC), differences in synonymous codon usage. We examined the association, if any, between the extent of CpG dinucleotide depletion and the evolutionary lineage of the infected host. We also investigated the contribution of mutational pressure and translational selection to the evolution of papillomaviruses and polyomaviruses. Results All papillomaviruses and polyomaviruses are CpG depleted. Interestingly, the evolutionary lineage of the infected host determines the extent of CpG depletion among papillomaviruses and polyomaviruses. CpG dinucleotide depletion was more pronounced among papillomaviruses and polyomaviruses infecting human and other mammals as compared to those infecting birds. Our findings demonstrate that CpG depletion among papillomaviruses is linked to mutational pressure; while CpG depletion among polyomaviruses is linked to translational selection. We also present evidence that suggests methylation of CpG dinucleotides may explain, at least in part, the depletion of CpG dinucleotides among papillomaviruses but not polyomaviruses. Conclusions The extent of CpG depletion among papillomaviruses and polyomaviruses is linked to the evolutionary lineage of the infected host. Our results highlight the existence of divergent evolutionary pressures leading to CpG dinucleotide depletion among small ds-DNA viruses infecting vertebrate hosts.	[Upadhyay, Mohita; Vivekanandan, Perumal] Indian Inst Technol Delhi, Kusuma Sch Biol Sci, New Delhi 006, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi	Vivekanandan, P (corresponding author), Indian Inst Technol Delhi, Kusuma Sch Biol Sci, New Delhi 006, India.	vperumal@bioschool.iitd.ac.in			Kusuma Trust	Kusuma Trust	This work was funded by Kusuma Trust.	Badal V, 2003, J VIROL, V77, P6227, DOI 10.1128/JVI.77.11.6227-6234.2003; Belalov IS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056642; Bernard Hans-Ulrich, 1994, Trends in Microbiology, V2, P140, DOI 10.1016/0966-842X(94)90602-5; BEUTLER E, 1989, P NATL ACAD SCI USA, V86, P192, DOI 10.1073/pnas.86.1.192; BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1499, DOI 10.1093/nar/8.7.1499; Bonvicini F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033316; BURGE C, 1992, P NATL ACAD SCI USA, V89, P1358, DOI 10.1073/pnas.89.4.1358; Chaiwongkot A, 2013, INT J CANCER, V132, P2087, DOI 10.1002/ijc.27906; Chang CF, 2011, VIRUS GENES, V43, P201, DOI 10.1007/s11262-011-0627-3; Cheng XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074109; Chinnery HR, 2012, AM J PATHOL, V180, P209, DOI 10.1016/j.ajpath.2011.09.041; Cooper David N, 2010, Hum Genomics, V4, P406; Duret L, 2000, MOL BIOL EVOL, V17, P1620, DOI 10.1093/oxfordjournals.molbev.a026261; FREUND R, 1991, J VIROL, V65, P350, DOI 10.1128/JVI.65.1.350-355.1991; Gorelik L, 2011, J INFECT DIS, V204, P103, DOI 10.1093/infdis/jir198; Graham SV, 2010, FUTURE MICROBIOL, V5, P1493, DOI 10.2217/FMB.10.107; HYDEDERUYSCHER R, 1988, P NATL ACAD SCI USA, V85, P8993, DOI 10.1073/pnas.85.23.8993; JEON S, 1995, J VIROL, V69, P2989, DOI 10.1128/JVI.69.5.2989-2997.1995; Johne R, 2007, J VIROL, V81, P11554, DOI 10.1128/JVI.01178-07; Johne R, 2011, ARCH VIROL, V156, P1627, DOI 10.1007/s00705-011-1008-x; Liu QG, 2000, J GEN VIROL, V81, P359, DOI 10.1099/0022-1317-81-2-359; MAZUR S, 1995, J VIROL, V69, P3059, DOI 10.1128/JVI.69.5.3059-3066.1995; Musto H, 2003, MICROBIOL-SGM, V149, P855, DOI 10.1099/mic.0.26063-0; Nair RR, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-492; Narechania A, 2005, J GEN VIROL, V86, P1307, DOI 10.1099/vir.0.80747-0; ONG CK, 1993, J VIROL, V67, P6424, DOI 10.1128/JVI.67.11.6424-6431.1993; Park IS, 2011, CANCER PREV RES, V4, P207, DOI 10.1158/1940-6207.CAPR-10-0147; Rector A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r57; Shackelton LA, 2006, J MOL EVOL, V62, P551, DOI 10.1007/s00239-005-0221-1; Shah SD, 2010, MOL BIOL EVOL, V27, P1301, DOI 10.1093/molbev/msq015; Sunyaev SR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000368; Tweedie S, 1997, MOL CELL BIOL, V17, P1469, DOI 10.1128/MCB.17.3.1469; Upadhyay M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111793; Upadhyay M, 2013, J VIROL, V87, P13816, DOI 10.1128/JVI.02515-13; Van Doorslaer K, 2013, VIROLOGY, V445, P11, DOI 10.1016/j.virol.2013.05.012; Vivekanandan P, 2008, J VIRAL HEPATITIS, V15, P103, DOI 10.1111/j.1365-2893.2007.00905.x; Warden C. D., 2012, J BIOINFORMATICS RES, V1, P46; Wollebo HS, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-264; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9; Xu Q, 2007, ANIM BIOTECHNOL, V18, P231, DOI 10.1080/10495390701574838; Xu Qing, 2011, Yichuan, V33, P620, DOI 10.3724/SP.J.1005.2011.00620; Zhao KN, 2003, VIRUS RES, V98, P95, DOI 10.1016/j.virusres.2003.08.019; Zhao KN, 2011, REV MED VIROL, V21, P397, DOI 10.1002/rmv.707; Zhou J, 1999, J VIROL, V73, P4972, DOI 10.1128/JVI.73.6.4972-4982.1999	44	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142368	10.1371/journal.pone.0142368	http://dx.doi.org/10.1371/journal.pone.0142368			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544572	gold, Green Submitted, Green Published			2022-12-27	WOS:000364398700119
J	Wong, MTY; Lambeck, AJA; van der Burg, M; la Bastide-van Gemert, S; Hogendorf, LA; van Ravenswaaij-Arts, CMA; Scholvinck, EH				Wong, Monica T. Y.; Lambeck, Annechien J. A.; van der Burg, Mirjam; la Bastide-van Gemert, Sacha; Hogendorf, Lianne A.; van Ravenswaaij-Arts, Conny M. A.; Scholvinck, Elisabeth H.			Immune Dysfunction in Children with CHARGE Syndrome: A Cross-Sectional Study	PLOS ONE			English	Article							22Q11.2 DELETION SYNDROME; CONJUGATE-VACCINE; PRIMARY IMMUNODEFICIENCY; MULTIPLEX IMMUNOASSAY; PHENOTYPIC SPECTRUM; NON-IMMUNOLOGISTS; CHD7 GENE; DIPHTHERIA; IMMUNIZATION; UPDATE	CHARGE syndrome is a variable, multiple congenital malformation syndrome. Patients with CHARGE syndrome have frequent infections that are presumed to be due to anatomical anomalies of the craniofacial region and upper airway, and cranial nerve problems resulting in swallowing difficulties and aspiration. The possible contribution of immunological abnormalities to these infections has not been systematically studied even though immune deficiencies have been described in patients with 22q11.2 deletion syndrome, a condition which shares remarkable clinical overlap with CHARGE syndrome. We assessed the frequency and nature of immune dysfunction in 24 children with genetically proven CHARGE syndrome. All patients, or their parents, completed a questionnaire on infectious history. Their immune system was extensively assessed through full blood counts, immunoglobulin levels, lymphocyte subpopulations, peripheral B- and T-cell differentiation, T-receptor excision circle (TREC) analysis, T-cell function, and vaccination responses. All CHARGE patients had a history of infections (often frequent), mainly otitis media and pneumonia, leading to frequent use of antibiotics and to hospital admissions. Decreased T-cell numbers were found in 12 (50%) patients, presumably caused by insufficient thymic output since TREC amounts were also diminished in CHARGE patients. Despite normal peripheral B-cell differentiation and immunoglobulin production in all patients, 83% of patients had insufficient antibody titers to one or more early childhood vaccinations. Based on our results, we recommend immunological evaluation of CHARGE patients with recurrent infections.	[Wong, Monica T. Y.; van Ravenswaaij-Arts, Conny M. A.] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Lambeck, Annechien J. A.; Hogendorf, Lianne A.] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Med Immunol, Groningen, Netherlands; [van der Burg, Mirjam] Erasmus MC, Univ Med Ctr Rotterdam, Dept Immunol, Rotterdam, Netherlands; [la Bastide-van Gemert, Sacha] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Scholvinck, Elisabeth H.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Paediat,Infect Dis & Immunol Sect, Groningen, Netherlands	University of Groningen; University of Groningen; Erasmus University Rotterdam; Erasmus MC; University of Groningen; University of Groningen	Scholvinck, EH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Paediat,Infect Dis & Immunol Sect, Groningen, Netherlands.	e.h.scholvinck@umcg.nl	la Bastide-van Gemert, Sacha/C-5151-2013	la Bastide-van Gemert, Sacha/0000-0003-0666-6690	Fonds NutsOhra [1202-023]	Fonds NutsOhra	The study is supported by Fonds NutsOhra (http://www.fondsnutsohra.nl/) with a grant (1202-023) to MTYW. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergman JEH, 2011, J MED GENET, V48, P334, DOI 10.1136/jmg.2010.087106; Bergman JEH, 2012, HUM MUTAT, V33, P1251, DOI 10.1002/humu.22106; Blake KD, 1998, CLIN PEDIATR, V37, P159, DOI 10.1177/000992289803700302; Chan K, 2005, J ALLERGY CLIN IMMUN, V115, P391, DOI 10.1016/j.jaci.2004.10.012; Chopra C, 2009, ACTA PAEDIATR, V98, P408, DOI 10.1111/j.1651-2227.2008.01077.x; ComansBitter WM, 1997, J PEDIATR-US, V130, P388, DOI 10.1016/S0022-3476(97)70200-2; de Melker HE, 2003, VACCINE, V21, P716, DOI 10.1016/S0264-410X(02)00587-X; de Melker HE, 1999, EMERG INFECT DIS, V5, P694, DOI 10.3201/eid0505.990511; de Vries E, 2006, CLIN EXP IMMUNOL, V145, P204, DOI 10.1111/j.1365-2249.2006.03138.x; de Vries E, 2012, CLIN EXP IMMUNOL, V167, P108, DOI 10.1111/j.1365-2249.2011.04461.x; Driessen GJ, 2011, BLOOD, V118, P6814, DOI 10.1182/blood-2011-06-361881; Elberse KEM, 2010, CLIN VACCINE IMMUNOL, V17, P674, DOI 10.1128/CVI.00408-09; Hazenberg MD, 2001, J MOL MED, V79, P631, DOI 10.1007/s001090100271; Hollander G, 2006, IMMUNOL REV, V209, P28, DOI 10.1111/j.0105-2896.2006.00357.x; Janssen N, 2012, HUM MUTAT, V33, P1149, DOI 10.1002/humu.22086; JOLLIFF CR, 1982, CLIN CHEM, V28, P126; Jongmans MCJ, 2006, J MED GENET, V43, P306, DOI 10.1136/jmg.2005.036061; Jyonouchi S, 2009, PEDIATRICS, V123, pE871, DOI 10.1542/peds.2008-3400; McLean-Tooke A, 2011, SCAND J IMMUNOL, V73, P577, DOI 10.1111/j.1365-3083.2011.02527.x; PAGON RA, 1981, J PEDIATR-US, V99, P223, DOI 10.1016/S0022-3476(81)80454-4; Patel K, 2012, J PEDIATR-US, V161, P950, DOI 10.1016/j.jpeds.2012.06.018; Poliani PL, 2009, BLOOD, V114, P105, DOI 10.1182/blood-2009-03-211029; Randall V, 2009, J CLIN INVEST, V119, P3301, DOI 10.1172/JCI37561; Sanlaville D, 2006, J MED GENET, V43, P211, DOI 10.1136/jmg.2005.036160; Saule P, 2006, MECH AGEING DEV, V127, P274, DOI 10.1016/j.mad.2005.11.001; Spijkerman J, 2013, JAMA-J AM MED ASSOC, V310, P930, DOI 10.1001/jama.2013.228052; Stam J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025690; Theodoropoulos Demetrios S, 2003, Clin Med Res, V1, P43; van Dongen TMA, 2015, PEDIATR INFECT DIS J, V34, P355, DOI 10.1097/INF.0000000000000595; van Gageldonk PGM, 2008, J IMMUNOL METHODS, V335, P79, DOI 10.1016/j.jim.2008.02.018; van Gageldonk PGM, 2011, CLIN VACCINE IMMUNOL, V18, P1183, DOI 10.1128/CVI.05081-11; van Zelm MC, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00012; Verloes A, 2005, AM J MED GENET A, V133A, P306, DOI 10.1002/ajmg.a.30559; Wong MT, 2015, EUR J HUM GENET; Zemble R, 2010, CLIN IMMUNOL, V136, P409, DOI 10.1016/j.clim.2010.04.011	35	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142350	10.1371/journal.pone.0142350	http://dx.doi.org/10.1371/journal.pone.0142350			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544072	gold, Green Submitted, Green Published			2022-12-27	WOS:000364398700117
J	Woo, T; Okudela, K; Mitsui, H; Tajiri, M; Rino, Y; Ohashi, K; Masuda, M				Woo, Tetsukan; Okudela, Koji; Mitsui, Hideaki; Tajiri, Michihiko; Rino, Yasushi; Ohashi, Kenichi; Masuda, Munetaka			Up-Regulation of S100A11 in Lung Adenocarcinoma - Its Potential Relationship with Cancer Progression	PLoS One			English	Article							METASTASIS-ASSOCIATED PROTEINS; PROTEOMIC ANALYSIS; DOWN-REGULATION; HUMAN TISSUES; EXPRESSION; CARCINOGENESIS; CLASSIFICATION; MUTATIONS; CARCINOMA	We previously reported that patients with lung adenocarcinomas with KRAS gene mutations and strong proliferating activity had poorer outcomes, even in the early stage of the disease. The aim of the present study was to elucidate the potential molecular basis of these highly malignant lung tumors by focusing on S100 proteins (S100A2, S100A7, and S100A11), which are downstream targets of oncogenic KRAS and promoters of tumor progression. The immunohistochemical expression of S100 proteins was examined in 179 primary lung adenocarcinomas, and the potential relationships between their levels and clinicopathologic factors were analyzed. Among the three subtypes, S100A11 levels were significantly higher in adenocarcinomas with KRAS mutations and strong proliferating activity. They were also higher in adenocarcinomas with poorly differentiated tumors. Furthermore, higher levels of S100A11 were associated with shorter disease-free survival. These results suggest that the up-regulation of S100A11 plays a role in tumor progression, particularly in KRAS-mutated lung adenocarcinomas.	[Woo, Tetsukan; Rino, Yasushi; Masuda, Munetaka] Yokohama City Univ, Grad Sch Med, Dept Surg, Yokohama, Kanagawa 232, Japan; [Woo, Tetsukan] Saiseikai Yokohama City South Hosp, Dept Thorac Surg, Yokohama, Kanagawa, Japan; [Okudela, Koji; Mitsui, Hideaki; Ohashi, Kenichi] Yokohama City Univ, Grad Sch Med, Dept Pathol, Yokohama, Kanagawa 232, Japan; [Tajiri, Michihiko] Kanagawa Cardiovasc & Resp Ctr, Dept Thorac Surg, Yokohama, Kanagawa, Japan	Yokohama City University; Yokohama City University; Kanagawa Cardiovascular & Respiratory Center	Woo, T (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Surg, Yokohama, Kanagawa 232, Japan.	tetsu.n.u@cotton.ocn.ne.jp			Ministry of Education, Culture, Sports, and Science of Japan (Tokyo Japan); Yokohama Medical Facility (Yokohama, Japan)	Ministry of Education, Culture, Sports, and Science of Japan (Tokyo Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Yokohama Medical Facility (Yokohama, Japan)	This work was funded by the Ministry of Education, Culture, Sports, and Science of Japan (Tokyo Japan), and Yokohama Medical Facility (Yokohama, Japan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asamura H, 2008, J THORAC ONCOL, V3, P46, DOI 10.1097/JTO.0b013e31815e8577; Cross SS, 2005, HISTOPATHOLOGY, V46, P256, DOI 10.1111/j.1365-2559.2005.02097.x; Goldstraw Peter, 2007, J Thorac Oncol, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Hao JT, 2012, MOL CELL BIOCHEM, V359, P323, DOI 10.1007/s11010-011-1026-8; Hoffman PC, 2000, LANCET, V355, P479, DOI 10.1016/S0140-6736(00)82038-3; Kondo A, 2002, ACTA MED OKAYAMA, V56, P31; Matsubara D, 2005, CANCER SCI, V96, P844, DOI 10.1111/j.1349-7006.2005.00121.x; Memon AA, 2005, CLIN CANCER RES, V11, P606; Mori M, 2004, ONCOL REP, V11, P1287; Okudela K, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0087193, 10.1371/journal.pone.0093359]; Okudela K, 2010, PATHOL INT, V60, P651, DOI 10.1111/j.1440-1827.2010.02580.x; Okudela K, 2009, AM J PATHOL, V175, P867, DOI 10.2353/ajpath.2009.080489; Rehman I, 2004, HUM PATHOL, V35, P1385, DOI 10.1016/j.humpath.2004.07.015; Roberts AB, 2003, P NATL ACAD SCI USA, V100, P8621, DOI 10.1073/pnas.1633291100; Salama I, 2008, EJSO-EUR J SURG ONC, V34, P357, DOI 10.1016/j.ejso.2007.04.009; Song HY, 2006, J CANCER RES CLIN, V132, P92, DOI 10.1007/s00432-005-0044-x; Spira A, 2004, NEW ENGL J MED, V350, P379, DOI 10.1056/NEJMra035536; Tian T, 2007, CANCER SCI, V98, P1265, DOI 10.1111/j.1349-7006.2007.00514.x; TODOROKI H, 1991, J BIOL CHEM, V266, P18668; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Wang CY, 2013, INT J MED SCI, V10, P1552, DOI 10.7150/ijms.5986; Wang GY, 2008, INT J COLORECTAL DIS, V23, P675, DOI 10.1007/s00384-008-0464-6; Woo T, 2009, LUNG CANCER, V65, P355, DOI 10.1016/j.lungcan.2008.11.020; Xiao MB, 2012, MED ONCOL, V29, P1886, DOI 10.1007/s12032-011-0058-y; Yang P, 2005, CHEST, V128, P452, DOI 10.1378/chest.128.1.452	25	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142642	10.1371/journal.pone.0142642	http://dx.doi.org/10.1371/journal.pone.0142642			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544866	gold, Green Published, Green Submitted			2022-12-27	WOS:000364398700161
J	Ye, F; Xin, ZS; Han, W; Fan, JJ; Yin, B; Wu, SZ; Yang, W; Yuan, JG; Qiang, BQ; Sun, W; Peng, XZ				Ye, Fei; Xin, Zhongshuai; Han, Wei; Fan, Jingjing; Yin, Bin; Wu, Shuzhen; Yang, Wei; Yuan, Jiangang; Qiang, Boqin; Sun, Wei; Peng, Xiaozhong			Quantitative Proteomics Analysis of the Hepatitis C Virus Replicon High-Permissive and Low-Permissive Cell Lines	PLOS ONE			English	Article							EFFICIENT REPLICATION; CATHEPSIN-B; PROTEIN; LIVER; EXPRESSION; VIMENTIN; IDENTIFICATION; INTERFERON; INDUCTION; APOPTOSIS	Chronic hepatitis C virus (HCV) infection is one of the leading causes of severe hepatitis. The molecular mechanisms underlying HCV replication and pathogenesis remain unclear. The development of the subgenome replicon model system significantly enhanced study of HCV. However, the permissiveness of the HCV subgenome replicon greatly differs among different hepatoma cell lines. Proteomic analysis of different permissive cell lines might provide new clues in understanding HCV replication. In this study, to detect potential candidates that might account for the differences in HCV replication. Label-free and iTRAQ labeling were used to analyze the differentially expressed protein profiles between Huh7.5.1 wt and HepG2 cells. A total of 4919 proteins were quantified in which 114 proteins were commonly identified as differentially expressed by both quantitative methods. A total of 37 differential proteins were validated by qRT-PCR. The differential expression of Glutathione S-transferase P (GSTP1), Ubiquitin carboxyl-terminal hydrolase isozyme L1 (UCHL1), carboxylesterase 1 (CES1), vimentin, Proteasome activator complex subunit1 (PSME1), and Cathepsin B (CTSB) were verified by western blot. And over-expression of CTSB or knock-down of vimentin induced significant changes to HCV RNA levels. Additionally, we demonstrated that CTSB was able to inhibit HCV replication and viral protein translation. These results highlight the potential role of CTSB and vimentin in virus replication.	[Ye, Fei; Han, Wei; Yin, Bin; Yuan, Jiangang; Qiang, Boqin; Peng, Xiaozhong] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Mol Biol & Biochem, State Key Lab Med Mol Biol, Beijing 100730, Peoples R China; [Ye, Fei; Han, Wei; Fan, Jingjing; Yin, Bin; Wu, Shuzhen; Yang, Wei; Yuan, Jiangang; Qiang, Boqin; Sun, Wei; Peng, Xiaozhong] Peking Union Med Coll, Beijing 100021, Peoples R China; [Xin, Zhongshuai] Natl Inst Food & Drug Control, Div Hormone, Beijing, Peoples R China; [Wu, Shuzhen; Sun, Wei] Chinese Acad Med Sci, Inst Basic Med Sci, Core Facil Instrument, Beijing 100730, Peoples R China; [Fan, Jingjing; Yang, Wei] Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; National Institute of Food & Drug Control - China; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS	Sun, W (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Core Facil Instrument, Beijing 100730, Peoples R China.	sunwei1018@hotmail.com; pengxiaozhong@pumc.edu.cn			National Basic Research Program of China (973 Program) [2011CB504902]; Major infectious diseases project [20132X10004601-002]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Major infectious diseases project	This study was supported by National Basic Research Program of China (973 Program) Grant No. 2011CB504902 and Major infectious diseases project, Grant No. 20132X10004601-002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2004, J VIROL, V78, P491, DOI 10.1128/JVI.78.1.491-501.2004; Aly HH, 2007, J HEPATOL, V46, P26, DOI 10.1016/j.jhep.2006.08.018; Bartenschlager R, 2000, J GEN VIROL, V81, P1631, DOI 10.1099/0022-1317-81-7-1631; Bartenschlager R, 2007, VIRUS RES, V127, P195, DOI 10.1016/j.virusres.2007.02.022; Bheda A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006764; Blais DR, 2010, J BIOL CHEM, V285, P25602, DOI 10.1074/jbc.M110.135483; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Blight KJ, 2003, J VIROL, V77, P3181, DOI 10.1128/JVI.77.5.3181-3190.2003; Bouchal P, 2009, J PROTEOME RES, V8, P362, DOI 10.1021/pr800622b; Casado-Vela J, 2010, PROTEOMICS, V10, P343, DOI 10.1002/pmic.200900509; Chang JH, 2008, J VIROL, V82, P8215, DOI 10.1128/JVI.02575-07; Cheng M, 2013, J VIROL, V87, P9707, DOI 10.1128/JVI.00802-13; Date T, 2004, J BIOL CHEM, V279, P22371, DOI 10.1074/jbc.M311120200; Diao S, 2010, PROTEOMICS, V10, P3723, DOI 10.1002/pmic.201000050; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Ghosh S, 2011, J VIRAL HEPATITIS, V18, pE568, DOI 10.1111/j.1365-2893.2011.01487.x; Gilar M, 2005, ANAL CHEM, V77, P6426, DOI 10.1021/ac050923i; Gottwein JM, 2008, ADV VIRUS RES, V71, P51, DOI 10.1016/S0065-3527(08)00002-X; Gu BH, 2003, J VIROL, V77, P5352, DOI 10.1128/JVI.77.9.5352-5359.2003; Guicciardi ME, 2000, J CLIN INVEST, V106, P1127, DOI 10.1172/JCI9914; Harris D, 2006, MOL CELL PROTEOMICS, V5, P1006, DOI 10.1074/mcp.M500429-MCP200; Hussain SP, 2007, ONCOGENE, V26, P2166, DOI 10.1038/sj.onc.1210279; Ishii T, 2004, CANCER LETT, V216, P89, DOI 10.1016/j.canlet.2004.05.018; Jacobs JM, 2005, J VIROL, V79, P7558, DOI 10.1128/JVI.79.12.7558-7569.2005; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kambara H, 2012, J VIROL, V86, P1382, DOI 10.1128/JVI.06242-11; Kato N, 2009, VIRUS RES, V146, P41, DOI 10.1016/j.virusres.2009.08.006; Kato T, 2003, GASTROENTEROLOGY, V125, P1808, DOI 10.1053/j.gastro.2003.09.023; Kato T, 2005, J VIROL, V79, P592, DOI 10.1128/JVI.79.1.592-596.2005; Kato T, 2001, J MED VIROL, V64, P334, DOI 10.1002/jmv.1055; Kim W, 2003, CLIN CANCER RES, V9, P5493; Kwon J, 2004, AM J PATHOL, V165, P1367, DOI 10.1016/S0002-9440(10)63394-9; Lambert MP, 2011, J HEPATOL, V54, P705, DOI 10.1016/j.jhep.2010.07.027; Lan KH, 2002, ONCOGENE, V21, P4801, DOI 10.1038/sj.onc.1205589; Lee CF, 2008, WORLD J GASTROENTERO, V14, P6072, DOI 10.3748/wjg.14.6072; Li QS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004163; Lin LT, 2010, J VIROL, V84, P9170, DOI 10.1128/JVI.00559-10; Liu S, 2012, HEPATOLOGY, V56, P57, DOI 10.1002/hep.25642; Liu SF, 2012, HEPATOLOGY, V56, P484, DOI 10.1002/hep.25665; Liu XY, 2013, J VIROL, V87, P1649, DOI 10.1128/JVI.02201-12; Lohmann V, 2003, J VIROL, V77, P3007, DOI 10.1128/JVI.77.5.3007-3019.2003; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Majumder M, 2002, VIROLOGY, V294, P94, DOI 10.1006/viro.2001.1309; Mak TN, 2012, CELL MICROBIOL, V14, P1720, DOI 10.1111/j.1462-5822.2012.01833.x; Maqbool MA, 2013, J VIROL, V87, P5523, DOI 10.1128/JVI.00585-12; Miao RD, 2008, J BIOSCIENCES, V33, P723, DOI 10.1007/s12038-008-0092-x; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Morchang A, 2013, BIOCHEM BIOPH RES CO, V438, P20, DOI 10.1016/j.bbrc.2013.07.009; Narbus CM, 2011, J VIROL, V85, P12087, DOI 10.1128/JVI.05843-11; Nitahara-Kasahara Y, 2009, VIROLOGY, V383, P319, DOI 10.1016/j.virol.2008.10.009; Pan TT, 2006, BIOCHEM BIOPH RES CO, V347, P683, DOI 10.1016/j.bbrc.2006.06.144; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Ripoli M, 2011, VIRUS RES, V160, P74, DOI 10.1016/j.virusres.2011.05.014; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Song CX, 2010, ANAL CHEM, V82, P53, DOI 10.1021/ac9023044; Teo CSH, 2014, J VIROL, V88, P1897, DOI 10.1128/JVI.01249-13; Waggoner SA, 2009, J BIOL CHEM, V284, P9039, DOI 10.1074/jbc.M806986200; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wang HX, 2012, J PROTEOME RES, V11, P487, DOI 10.1021/pr2008225; Wang YX, 2011, PROTEOMICS, V11, P2019, DOI 10.1002/pmic.201000722; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Wu Jin-ming, 2005, Zhonghua Gan Zang Bing Za Zhi, V13, P702; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107; Xin ZS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025419; Xun M, 2008, ACTA PHARMACOL SIN, V29, P720, DOI 10.1111/j.1745-7254.2008.00789.x; Yin LM, 2000, BIOCHEMISTRY-US, V39, P10001, DOI 10.1021/bi0007019; Zhao Y, 2013, TUMOR BIOL, V34, P2121, DOI 10.1007/s13277-013-0695-1; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102; Zhu MM, 2009, MOL CELL PROTEOMICS, V8, P752, DOI 10.1074/mcp.M800343-MCP200; Zhu WH, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/840518	71	10	10	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142082	10.1371/journal.pone.0142082	http://dx.doi.org/10.1371/journal.pone.0142082			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544179	Green Published, Green Submitted, gold			2022-12-27	WOS:000364398700078
J	Zou, CB; Caterina, GL; Will, RE; Stebler, E; Turton, D				Zou, Chris B.; Caterina, Giulia L.; Will, Rodney E.; Stebler, Elaine; Turton, Donald			Canopy Interception for a Tallgrass Prairie under Juniper Encroachment	PLOS ONE			English	Article							WATER STORAGE CAPACITY; RAINFALL INTERCEPTION; FOREST; STEMFLOW; THROUGHFALL; VEGETATION; DYNAMICS; MODEL; PRECIPITATION; CONSEQUENCES	Rainfall partitioning and redistribution by canopies are important ecohydrological processes underlying ecosystem dynamics. We quantified and contrasted spatial and temporal variations of rainfall redistribution for a juniper (Juniperus virginiana, redcedar) woodland and a tallgrass prairie in the south-central Great Plains, USA. Our results showed that redcedar trees had high canopy storage capacity (S) ranging from 2.14 mm for open stands to 3.44 mm for closed stands. The canopy funneling ratios (F) of redcedar trees varied substantially among stand type and tree size. The open stands and smaller trees usually had higher F values and were more efficient in partitioning rainfall into stemflow. Larger trees were more effective in partitioning rainfall into throughfall and no significant changes in the total interception ratios among canopy types and tree size were found. The S values were highly variable for tallgrass prairie, ranging from 0.27 mm at early growing season to 3.86 mm at senescence. As a result, the rainfall interception by tallgrass prairie was characterized by high temporal instability. On an annual basis, our results showed no significant difference in total rainfall loss to canopy interception between redcedar trees and tallgrass prairie. Increasing structural complexity associated with redcedar encroachment into tallgrass prairie changes the rainfall redistribution and partitioning pattern at both the temporal and spatial scales, but does not change the overall canopy interception ratios compared with unburned and ungrazed tallgrass prairie. Our findings support the idea of convergence in interception ratio for different canopy structures under the same precipitation regime. The temporal change in rainfall interception loss from redcedar encroachment is important to understand how juniper encroachment will interact with changing rainfall regime and potentially alter regional streamflow under climate change.	[Zou, Chris B.; Caterina, Giulia L.; Will, Rodney E.; Stebler, Elaine; Turton, Donald] Oklahoma State Univ, Dept Nat Resource Ecol & Management, Stillwater, OK 74078 USA; [Caterina, Giulia L.] Univ Estadual Paulista, Botucatu, SP, Brazil	Oklahoma State University System; Oklahoma State University - Stillwater; Universidade Estadual Paulista	Zou, CB (corresponding author), Oklahoma State Univ, Dept Nat Resource Ecol & Management, Stillwater, OK 74078 USA.	chris.zou@okstate.edu	Will, Rodney/G-8111-2011; Zou, Chris/A-5039-2010	Zou, Chris/0000-0003-0080-2866	U. S. Geological Survey/National Institutes for Water Research [USGS104G (G09AP00146)]; USGS OWRRI grants; National Science Foundation/Experimental Program to Stimulate Competitive Research (EPSCoR) [NSF-1301789]; NSF Dynamics of Coupled Natural and Human Systems (CNH) program [DEB-1413900]; United States Department of Agriculture/National Institute of Food and Agriculture [2014-67010-21653]; Division Of Environmental Biology [1413900] Funding Source: National Science Foundation; Office Of The Director [1301789] Funding Source: National Science Foundation	U. S. Geological Survey/National Institutes for Water Research; USGS OWRRI grants; National Science Foundation/Experimental Program to Stimulate Competitive Research (EPSCoR); NSF Dynamics of Coupled Natural and Human Systems (CNH) program(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); United States Department of Agriculture/National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	The field equipment installation, data collection were completed with support from the U. S. Geological Survey/National Institutes for Water Research USGS104G (G09AP00146 https://niwr.net/public/Migration/niwr.net) and USGS OWRRI grants. The data analysis, re-analysis, and paper writing were partially supported with funding from National Science Foundation/Experimental Program to Stimulate Competitive Research (EPSCoR http://www.nsf.gov/od/iia/programs/epscor/nsf_oiia_epscor_index.jsp) via grant NSF-1301789, NSF Dynamics of Coupled Natural and Human Systems (CNH) program (DEB-1413900 http://www.nsf.gov/div/index.jsp?div=DEB), and United States Department of Agriculture/National Institute of Food and Agriculture (2014-67010-21653 http://nifa.usda.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre F, 2008, HYDROL PROCESS, V22, P4130, DOI 10.1002/hyp.7013; [Anonymous], 1996, INVASION OKLAHOMA RA; ARCHER S, 1995, ECOSCIENCE, V2, P83, DOI 10.1080/11956860.1995.11682272; Barker W. T., 1988, Rangelands, V10, P266; Breshears DD, 2008, ECOLOGY, V89, P41, DOI 10.1890/07-0437.1; Briggs JM, 2005, BIOSCIENCE, V55, P243, DOI 10.1641/0006-3568(2005)055[0243:AEITCA]2.0.CO;2; Briggs JM, 2002, ECOSYSTEMS, V5, P578, DOI 10.1007/s10021-002-0187-4; Carlyle-Moses D., 2002, MEASUREMENT MODELLIN; Carlyle-Moses DE, 2006, HYDROL PROCESS, V20, P3651, DOI 10.1002/hyp.6380; Carlyle-Moses DE, 2011, ECOL STUD-ANAL SYNTH, V216, P407, DOI 10.1007/978-94-007-1363-5_20; Carlyle-Moses DE, 2004, J ARID ENVIRON, V58, P181, DOI 10.1016/S0140-1963(03)00125-3; CLARK ORIN RAY, 1940, ECOL MONOGR, V10, P243, DOI 10.2307/1948607; Corbett ES, 1966, HYDROLOG SCI J, V11, P110; Crockford RH, 2000, HYDROL PROCESS, V14, P2903, DOI [10.1002/1099-1085(200011/12)14:16/17<2903::AID-HYP126>3.0.CO;2-6, 10.1002/1099-1085(200011/12)14:16/17&lt;2903::AID-HYP126&gt;3.0.CO;2-6]; Duesterhaus JL, 2008, THESIS KANSAS STATE; Dunkerley D, 2000, HYDROL PROCESS, V14, P669, DOI 10.1002/(SICI)1099-1085(200003)14:4&lt;669::AID-HYP965&gt;3.0.CO;2-I; Dunkerley DL, 1999, WATER RESOUR RES, V35, P1581, DOI 10.1029/1999WR900003; Engle D. M., 2008, ECOL STUD-ANAL SYNTH, P253; Ferguson ER, 1968, SO37 USDA FOR SERV S, P14; Fuhlendorf SD, 2004, J APPL ECOL, V41, P604, DOI 10.1111/j.0021-8901.2004.00937.x; Garcia-Estringana P, 2010, J HYDROL, V389, P363, DOI 10.1016/j.jhydrol.2010.06.017; GASH JHC, 1979, Q J ROY METEOR SOC, V105, P43, DOI 10.1002/qj.49710544304; GASH JHC, 1978, J HYDROL, V38, P49, DOI 10.1016/0022-1694(78)90131-2; GILLIAM FS, 1987, SOUTHWEST NAT, V32, P267, DOI 10.2307/3671570; HERWITZ SR, 1986, EARTH SURF PROCESSES, V11, P401, DOI 10.1002/esp.3290110406; Klaassen W, 1998, J HYDROL, V212, P36, DOI 10.1016/S0022-1694(98)00200-5; Kramer I, 2009, ECOHYDROLOGY, V2, P102, DOI 10.1002/eco.44; Levia DF, 2005, CATENA, V64, P117, DOI 10.1016/j.catena.2005.08.001; Leyton L, 1967, P INT S FOR HYDR, P163; Li XY, 2009, HYDROL EARTH SYST SC, V13, P1133; Link TE, 2004, AGR FOREST METEOROL, V124, P171, DOI 10.1016/j.agrformet.2004.01.010; Liu SG, 1998, J HYDROL, V207, P32, DOI 10.1016/S0022-1694(98)00115-2; Llorens P, 2000, J HYDROL, V240, P131, DOI 10.1016/S0022-1694(00)00339-5; Llorens P, 2007, J HYDROL, V335, P37, DOI 10.1016/j.jhydrol.2006.10.032; Murakami S., 2009, HYDROLOGICAL RES LET, V3, P32, DOI [10.3178/HRL.3.32, DOI 10.3178/HRL.3.32, 10.3178/hrl.3.32]; Naito AT, 2011, PROG PHYS GEOG, V35, P423, DOI 10.1177/0309133311403538; Owens MK, 2006, HYDROL PROCESS, V20, P3179, DOI 10.1002/hyp.6326; Pypker TG, 2005, AGR FOREST METEOROL, V130, P113, DOI 10.1016/j.agrformet.2005.03.003; Qiao L, 2015, J HYDROL, V523, P231, DOI 10.1016/j.jhydrol.2015.01.056; Rodriguez-Iturbe I, 2000, WATER RESOUR RES, V36, P3, DOI 10.1029/1999WR900210; Scholes RJ, 1997, ANNU REV ECOL SYST, V28, P517, DOI 10.1146/annurev.ecolsys.28.1.517; SEASTEDT TR, 1985, OECOLOGIA, V66, P88, DOI 10.1007/BF00378557; Staelens J, 2008, HYDROL PROCESS, V22, P33, DOI 10.1002/hyp.6610; THUROW TL, 1987, J RANGE MANAGE, V40, P455, DOI 10.2307/3899611; Van Auken OW, 2000, ANNU REV ECOL SYST, V31, P197, DOI 10.1146/annurev.ecolsys.31.1.197; Yu KL, 2012, HYDROL PROCESS, V26, P3114, DOI 10.1002/hyp.8377; Zou CB, 2014, HYDROL PROCESS, V28, P6173, DOI 10.1002/hyp.10102	47	47	49	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141422	10.1371/journal.pone.0141422	http://dx.doi.org/10.1371/journal.pone.0141422			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544182	Green Published, gold, Green Submitted			2022-12-27	WOS:000364398700022
J	Fehlbaum, S; Chassard, C; Haug, MC; Fourmestraux, C; Derrien, M; Lacroix, C				Fehlbaum, Sophie; Chassard, Christophe; Haug, Martina C.; Fourmestraux, Candice; Derrien, Muriel; Lacroix, Christophe			Design and Investigation of PolyFermS In Vitro Continuous Fermentation Models Inoculated with Immobilized Fecal Microbiota Mimicking the Elderly Colon	PLOS ONE			English	Article							HUMAN GUT MODEL; INTESTINAL MICROBIOTA; CHILD GUT; TOXIN PRODUCTION; BOWEL-DISEASE; HEALTH; PH; COMMUNITIES; POPULATIONS; PREBIOTICS	In vitro gut modeling is a useful approach to investigate some factors and mechanisms of the gut microbiota independent of the effects of the host. This study tested the use of immobilized fecal microbiota to develop different designs of continuous colonic fermentation models mimicking elderly gut fermentation. Model 1 was a three-stage fermentation mimicking the proximal, transverse and distal colon. Models 2 and 3 were based on the new PolyFermS platform composed of an inoculum reactor seeded with immobilized fecal microbiota and used to continuously inoculate with the same microbiota different second-stage reactors mounted in parallel. The main gut bacterial groups, microbial diversity and metabolite production were monitored in effluents of all reactors using quantitative PCR, 16S rRNA gene 454-pyrosequencing, and HPLC, respectively. In all models, a diverse microbiota resembling the one tested in donor's fecal sample was established. Metabolic stability in inoculum reactors seeded with immobilized fecal microbiota was shown for operation times of up to 80 days. A high microbial and metabolic reproducibility was demonstrated for downstream control and experimental reactors of a PolyFermS model. The PolyFermS models tested here are particularly suited to investigate the effects of environmental factors, such as diet and drugs, in a controlled setting with the same microbiota source.	[Fehlbaum, Sophie; Chassard, Christophe; Haug, Martina C.; Lacroix, Christophe] ETH, Inst Food Nutr & Hlth, Lab Food Biotechnol, Zurich, Switzerland; [Fourmestraux, Candice; Derrien, Muriel] Danone Nutr Res, Palaiseau, France	Swiss Federal Institutes of Technology Domain; ETH Zurich; Danone Nutricia	Lacroix, C (corresponding author), ETH, Inst Food Nutr & Hlth, Lab Food Biotechnol, Zurich, Switzerland.	christophe.lacroix@hest.ethz.ch	Derrien, Muriel/AAS-6845-2021; Lacroix, Christophe/B-5139-2016	Derrien, Muriel/0000-0001-8841-9153; Lacroix, Christophe/0000-0003-4360-2020; Haug, Martina/0000-0002-4801-3236	Danone Research (Palaiseau, France)	Danone Research (Palaiseau, France)	Funding for this study was provided by Danone Research (Palaiseau, France). The funder supported the salary for SF. The authors MD and CF are employees of Danone Research. The specific roles of these authors are articulated in the 'author contributions' section.	Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Baines SD, 2005, J ANTIMICROB CHEMOTH, V55, P974, DOI 10.1093/jac/dki120; Baines SD, 2009, J ANTIMICROB CHEMOTH, V63, P520, DOI 10.1093/jac/dkn502; Belenguer A, 2006, APPL ENVIRON MICROB, V72, P3593, DOI 10.1128/AEM.72.5.3593-3599.2006; Berner AZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077772; Biagi E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010667; Biagi E, 2013, PHARMACOL RES, V69, P11, DOI 10.1016/j.phrs.2012.10.005; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chassard C, 2013, CURR OPIN CLIN NUTR, V16, P453, DOI 10.1097/MCO.0b013e3283619e63; Cinquin C, 2004, MICROB ECOL, V48, P128, DOI 10.1007/s00248-003-2022-7; Cinquin C, 2006, FEMS MICROBIOL ECOL, V57, P324, DOI 10.1111/j.1574-6941.2006.00117.x; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; Cleusix V, 2008, FEMS MICROBIOL ECOL, V63, P56, DOI 10.1111/j.1574-6941.2007.00412.x; Crowther GS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088396; CUMMINGS JH, 1991, J APPL BACTERIOL, V70, P443, DOI 10.1111/j.1365-2672.1991.tb02739.x; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012; Dostal A, 2013, FEMS MICROBIOL ECOL, V83, P161, DOI 10.1111/j.1574-6941.2012.01461.x; Duncan SH, 2002, APPL ENVIRON MICROB, V68, P5186, DOI 10.1128/AEM.68.10.5186-5190.2002; Duncan SH, 2013, MATURITAS, V75, P44, DOI 10.1016/j.maturitas.2013.02.004; Duncan SH, 2009, ENVIRON MICROBIOL, V11, P2112, DOI 10.1111/j.1462-2920.2009.01931.x; Evans JM, 1998, J AM GERIATR SOC, V46, P83, DOI 10.1111/j.1532-5415.1998.tb01018.x; Freeman J, 2007, J ANTIMICROB CHEMOTH, V60, P83, DOI 10.1093/jac/dkm113; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Lacroix C, 2015, CURR OPIN BIOTECH, V32, P149, DOI 10.1016/j.copbio.2014.12.009; Lahti L, 2013, PEERJ, V1, DOI 10.7717/peerj.32; Lawley TD, 2013, IMMUNOLOGY, V138, P1, DOI 10.1111/j.1365-2567.2012.03616.x; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Likotrafiti E, 2014, ANAEROBE, V27, P50, DOI 10.1016/j.anaerobe.2014.03.009; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Macfarlane GT, 1998, MICROB ECOL, V35, P180, DOI 10.1007/s002489900072; Madsen JL, 2004, AGE AGEING, V33, P154, DOI 10.1093/ageing/afh040; MADSEN JL, 1992, DIGEST DIS SCI, V37, P1548, DOI 10.1007/BF01296501; MERKEL IS, 1993, AM J GASTROENTEROL, V88, P1854; Michel C, 1998, ANAEROBE, V4, P257, DOI 10.1006/anae.1998.0178; Montassier E, 2014, MICROB ECOL, V67, P690, DOI 10.1007/s00248-013-0355-4; NAGENGAST FM, 1988, DIGEST DIS SCI, V33, P673, DOI 10.1007/BF01540429; Nugent SG, 2001, GUT, V48, P571, DOI 10.1136/gut.48.4.571; Nyangale EP, 2012, J PROTEOME RES, V11, P5573, DOI 10.1021/pr300637d; O'Toole PW, 2010, INT DAIRY J, V20, P281, DOI 10.1016/j.idairyj.2009.11.010; Ottman N, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00104; Payne AN, 2012, FEMS MICROBIOL ECOL, V80, P608, DOI 10.1111/j.1574-6941.2012.01330.x; Payne AN, 2012, TRENDS BIOTECHNOL, V30, P17, DOI 10.1016/j.tibtech.2011.06.011; Power SE, 2014, BRIT J NUTR, V111, P387, DOI 10.1017/S0007114513002560; Alonso VR, 2013, BRIT J NUTR, V109, pS21, DOI 10.1017/S0007114512005235; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Sun DL, 2013, APPL ENVIRON MICROB, V79, P5962, DOI 10.1128/AEM.01282-13; Tanner SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094123; Tanner SA, 2014, GUT PATHOG, V6, DOI 10.1186/s13099-014-0044-y; Tiihonen K, 2008, BRIT J NUTR, V100, P130, DOI 10.1017/S000711450888871X; Van den Abbeele P, 2010, APPL ENVIRON MICROB, V76, P5237, DOI 10.1128/AEM.00759-10; Walker AW, 2005, APPL ENVIRON MICROB, V71, P3692, DOI 10.1128/AEM.71.7.3692-3700.2005; Woodmansey EJ, 2007, J APPL MICROBIOL, V102, P1178, DOI 10.1111/j.1365-2672.2007.03400.x; Zhang J, 2015, ISME J, V9, P1979, DOI 10.1038/ismej.2015.11; Zihler A, 2010, MICROBIOL-SGM, V156, P3342, DOI 10.1099/mic.0.042036-0	56	40	40	6	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142793	10.1371/journal.pone.0142793	http://dx.doi.org/10.1371/journal.pone.0142793			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559530	Green Published, gold, Green Submitted			2022-12-27	WOS:000364433100125
J	Segev, E; Tellez, A; Vlamakis, H; Kolter, R				Segev, Einat; Tellez, Adele; Vlamakis, Hera; Kolter, Roberto			Morphological Heterogeneity and Attachment of Phaeobacter inhibens	PLOS ONE			English	Article							BIOFILM FORMATION; ROSEOBACTER CLADE; MARINE; HOLDFAST; MOTILITY; CELLS; GENE; COLONIZATION; CHEMOTAXIS; GENOMICS	The Roseobacter clade is a key group of bacteria in the ocean exhibiting diverse metabolic repertoires and a wide range of symbiotic life-styles. Many Roseobacters possess remarkable capabilities of attachment to both biotic and abiotic surfaces. When attached to each other, these bacteria form multi-cellular structures called rosettes. Phaeobacter inhibens, a well-studied Roseobacter, exhibits various cell sizes and morphologies that are either associated with rosettes or occur as single cells. Here we describe the distribution of P. inhibens morphologies and rosettes within a population. We detect an N-acetylglucosamine-containing polysaccharide on the poles of some cells and at the center of all rosettes. We demonstrate that rosettes are formed by the attachment of individual cells at the polysaccharide-containing pole rather than by cell division. Finally, we show that P. inhibens attachment to abiotic surfaces is hindered by the presence of DNA from itself, but not from other bacteria. Taken together, our findings demonstrate that cell adhesiveness is likely to play a significant role in the life cycle of P. inhibens as well as other Roseobacters.	[Segev, Einat; Tellez, Adele; Vlamakis, Hera; Kolter, Roberto] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Segev, E (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA.	Einat_Segev@hms.harvard.edu; roberto_kolter@hms.harvard.edu			European Molecular Biology Organization; Human Frontier Science Program; NIH [GM58213, GM82137]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058213, R01GM082137] Funding Source: NIH RePORTER	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Human Frontier Science Program(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by fellowships from the European Molecular Biology Organization and from the Human Frontier Science Program granted to E.S. and NIH grants GM58213 and GM82137 to R.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110; Amin SA, 2015, NATURE, V522, P98, DOI 10.1038/nature14488; Avery SV, 2006, NAT REV MICROBIOL, V4, P577, DOI 10.1038/nrmicro1460; Babic A, 2011, MBIO, V2, DOI 10.1128/mBio.00027-11; Berne C, 2013, J PHYS CHEM B, V117, P10492, DOI 10.1021/jp405802e; Berne C, 2010, MOL MICROBIOL, V77, P815, DOI 10.1111/j.1365-2958.2010.07267.x; Brinkhoff T, 2004, APPL ENVIRON MICROB, V70, P2560, DOI 10.1128/AEM.70.4.2560-2565.2003; Brinkhoff T, 2008, ARCH MICROBIOL, V189, P531, DOI 10.1007/s00203-008-0353-y; Bruhn JB, 2006, APPL ENVIRON MICROB, V72, P3011, DOI 10.1128/AEM.72.4.3011-3015.2006; Bruhn JB, 2005, APPL ENVIRON MICROB, V71, P7263, DOI 10.1128/AEM.71.11.7263-7270.2005; Bruhn JB, 2007, APPL ENVIRON MICROB, V73, P442, DOI 10.1128/AEM.02238-06; Curtis PD, 2010, MICROBIOL MOL BIOL R, V74, P13, DOI 10.1128/MMBR.00040-09; Dang HY, 2000, APPL ENVIRON MICROB, V66, P467, DOI 10.1128/AEM.66.2.467-475.2000; Frank O, 2015, SYST APPL MICROBIOL, V38, P120, DOI 10.1016/j.syapm.2014.12.001; Heindl JE, 2014, FRONT PLANT SCI, V5; Janakiraman RS, 1999, J BACTERIOL, V181, P1118, DOI 10.1128/JB.181.4.1118-1125.1999; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257; Levi A, 2006, J BACTERIOL, V188, P5315, DOI 10.1128/JB.01725-05; Li GL, 2012, MOL MICROBIOL, V83, P41, DOI 10.1111/j.1365-2958.2011.07909.x; Luo HW, 2014, MICROBIOL MOL BIOL R, V78, P573, DOI 10.1128/MMBR.00020-14; MERKER RI, 1988, APPL ENVIRON MICROB, V54, P2078, DOI 10.1128/AEM.54.8.2078-2085.1988; Miller TR, 2006, ENVIRON MICROBIOL, V8, P1648, DOI 10.1111/j.1462-2920.2006.01071.x; Miller TR, 2004, APPL ENVIRON MICROB, V70, P4692, DOI 10.1128/AEM.70.8.4692-4701.2004; Moran MA, 2007, APPL ENVIRON MICROB, V73, P4559, DOI 10.1128/AEM.02580-06; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Patzelt D, 2013, ISME J, V7, P2274, DOI 10.1038/ismej.2013.107; RUGER HJ, 1992, INT J SYST BACTERIOL, V42, P133, DOI 10.1099/00207713-42-1-133; Seyedsayamdost MR, 2011, NAT CHEM, V3, P331, DOI [10.1038/nchem.1002, 10.1038/NCHEM.1002]; Smits WK, 2006, NAT REV MICROBIOL, V4, P259, DOI 10.1038/nrmicro1381; Sonnenschein EC, 2012, APPL ENVIRON MICROB, V78, P6900, DOI 10.1128/AEM.01790-12; Sule P, 2013, J BACTERIOL, V195, P637, DOI 10.1128/JB.01777-12; Team RDC, 2010, R LANG ENV STAT COMP; Tsang PH, 2006, P NATL ACAD SCI USA, V103, P5764, DOI 10.1073/pnas.0601705103; Verstrepen KJ, 2006, MOL MICROBIOL, V60, P5, DOI 10.1111/j.1365-2958.2006.05072.x; Wagner-Dobler I, 2006, ANNU REV MICROBIOL, V60, P255, DOI 10.1146/annurev.micro.60.080805.142115; Xu J, 2012, RES MICROBIOL, V163, P674, DOI 10.1016/j.resmic.2012.10.013	37	16	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0141300	10.1371/journal.pone.0141300	http://dx.doi.org/10.1371/journal.pone.0141300			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26560130	Green Published, gold, Green Submitted			2022-12-27	WOS:000364433100030
J	Zhang, WP; Schmelzeisen, S; Parthier, D; Frings, S; Mohrlen, F				Zhang, Weiping; Schmelzeisen, Steffen; Parthier, Daniel; Frings, Stephan; Moehrlen, Frank			Anoctamin Calcium-Activated Chloride Channels May Modulate Inhibitory Transmission in the Cerebellar Cortex	PLOS ONE			English	Article							CA2+-ACTIVATED CL-CURRENTS; PURKINJE-CELLS; CLIMBING FIBER; REBOUND POTENTIATION; EXPRESSION PATTERNS; SYNAPTIC INHIBITION; MESSENGER-RNAS; TMEM16A; PLASTICITY; SIGNALS	Calcium-activated chloride channels of the anoctamin (alias TMEM16) protein family fulfill critical functions in epithelial fluid transport, smooth muscle contraction and sensory signal processing. Little is known, however, about their contribution to information processing in the central nervous system. Here we examined the recent finding that a calcium-dependent chloride conductance impacts on GABAergic synaptic inhibition in Purkinje cells of the cerebellum. We asked whether anoctamin channels may underlie this chloride conductance. We identified two anoctamin channel proteins, ANO1 and ANO2, in the cerebellar cortex. ANO1 was expressed in inhibitory interneurons of the molecular layer and the granule cell layer. Both channels were expressed in Purkinje cells but, while ANO1 appeared to be retained in the cell body, ANO2 was targeted to the dendritic tree. Functional studies confirmed that ANO2 was involved in a calcium-dependent mode of ionic plasticity that reduces the efficacy of GABAergic synapses. ANO2 channels attenuated GABAergic transmission by increasing the postsynaptic chloride concentration, hence reducing the driving force for chloride influx. Our data suggest that ANO2 channels are involved in a Ca2+-dependent regulation of synaptic weight in GABAergic inhibition. Thus, in balance with the chloride extrusion mechanism via the co-transporter KCC2, ANO2 appears to regulate ionic plasticity in the cerebellum.	[Zhang, Weiping; Schmelzeisen, Steffen; Parthier, Daniel; Frings, Stephan; Moehrlen, Frank] Heidelberg Univ, Dept Anim Mol Physiol, Ctr Organismal Studies, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Mohrlen, F (corresponding author), Heidelberg Univ, Dept Anim Mol Physiol, Ctr Organismal Studies, Neuenheimer Feld 504, Heidelberg, Germany.	moehrlen@uni-hd.de		Parthier, Daniel/0000-0001-8775-024X	China Scholarship Council	China Scholarship Council(China Scholarship Council)	This project was funded by a grant of the China Scholarship Council to WZ.	ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; Almaca J, 2009, J BIOL CHEM, V284, P28571, DOI 10.1074/jbc.M109.010074; Amjad A, 2015, J GEN PHYSL; Berglund K, 2008, BRAIN CELL BIOL, V36, P101, DOI 10.1007/s11068-008-9031-x; Bill A, 2015, J BIOL CHEM, V290, P889, DOI 10.1074/jbc.M114.618140; Billig GM, 2011, NAT NEUROSCI, V14, P763, DOI 10.1038/nn.2821; Blaesse P, 2009, NEURON, V61, P820, DOI 10.1016/j.neuron.2009.03.003; Bradley E, 2014, CHANNELS, V8, P308, DOI 10.4161/chan.28065; Bregestovski P, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.015.2009; Brenowitz SD, 2005, NEURON, V45, P419, DOI 10.1016/j.neuron.2004.12.045; Brunner JD, 2014, NATURE, V516, P207, DOI 10.1038/nature13984; Bunger S, 2009, CYTOTECHNOLOGY, V61, P153, DOI 10.1007/s10616-009-9249-1; Bulley S, 2012, CIRC RES, V111, P1027, DOI 10.1161/CIRCRESAHA.112.277145; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Cho H, 2012, NAT NEUROSCI, V15, P1015, DOI 10.1038/nn.3111; Cho SJ, 2014, CELL TISSUE RES, V357, P563, DOI 10.1007/s00441-014-1897-6; Dauner K, 2013, INVEST OPHTH VIS SCI, V54, P3126, DOI 10.1167/iovs.13-11711; Dauner K, 2012, CELL TISSUE RES, V347, P327, DOI 10.1007/s00441-012-1324-9; De Zeeuw CI, 2011, NAT REV NEUROSCI, V12, P327, DOI 10.1038/nrn3011; Diana MA, 2002, J NEUROSCI, V22, P200, DOI 10.1523/JNEUROSCI.22-01-00200.2002; Dibattista M, 2012, J GEN PHYSIOL, V140, P3, DOI 10.1085/jgp.201210780; Duguid IC, 2007, J NEUROSCI, V27, P12464, DOI 10.1523/JNEUROSCI.0178-07.2007; Duguid IC, 2004, NAT NEUROSCI, V7, P525, DOI 10.1038/nn1227; ECCLES JC, 1967, P NATL ACAD SCI USA, V58, P336, DOI 10.1073/pnas.58.1.336; Eilers J, 1996, CELL CALCIUM, V20, P215, DOI 10.1016/S0143-4160(96)90108-6; Ferrera L, 2009, J BIOL CHEM, V284, P33360, DOI 10.1074/jbc.M109.046607; Finch EA, 2012, CEREBELLUM, V11, P706, DOI 10.1007/s12311-011-0314-x; Garcia G, 2014, BRAIN RES, V1579, P35, DOI 10.1016/j.brainres.2014.07.011; Hartmann J, 2005, CELL CALCIUM, V37, P459, DOI 10.1016/j.ceca.2005.01.014; Hashimoto T, 1996, J PHYSIOL-LONDON, V497, P611, DOI 10.1113/jphysiol.1996.sp021794; Hengl T, 2010, P NATL ACAD SCI USA, V107, P6052, DOI 10.1073/pnas.0909032107; Huang SW, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00048; Huang WC, 2012, NEURON, V74, P179, DOI 10.1016/j.neuron.2012.01.033; Huang Y, 2012, EXP NEUROL, V233, P791, DOI 10.1016/j.expneurol.2011.11.043; Isomura Y, 2003, J NEUROPHYSIOL, V90, P2752, DOI 10.1152/jn.00142.2003; ITO M, 1970, INT J NEUROL, V7, P162; Jedlicka P, 2011, HIPPOCAMPUS, V21, P885, DOI 10.1002/hipo.20804; Jeon JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067989; Jeon JH, 2011, CELL TISSUE RES, V345, P223, DOI 10.1007/s00441-011-1206-6; Jin X, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004184; Kaila K, 2014, NAT REV NEUROSCI, V15, P637, DOI 10.1038/nrn3819; Kaila K, 2014, CURR OPIN NEUROBIOL, V26, P34, DOI 10.1016/j.conb.2013.11.004; Kanaka C, 2001, NEUROSCIENCE, V104, P933, DOI 10.1016/S0306-4522(01)00149-X; Kanazawa T, 2014, BRAIN RES BULL, V106, P17, DOI 10.1016/j.brainresbull.2014.04.015; KANO M, 1992, NATURE, V356, P601, DOI 10.1038/356601a0; Kano M, 1996, P NATL ACAD SCI USA, V93, P13351, DOI 10.1073/pnas.93.23.13351; Kawaguchi S, 2002, J NEUROSCI, V22, P3969, DOI 10.1523/JNEUROSCI.22-10-03969.2002; Kawakita I, 2013, EUR J NEUROSCI, V37, P532, DOI 10.1111/ejn.12076; Kellendonk C, 1999, J MOL BIOL, V285, P175, DOI 10.1006/jmbi.1998.2307; Kitamura K, 2013, NEURAL NETWORKS, V47, P11, DOI 10.1016/j.neunet.2012.08.001; Kitamura K, 2011, J NEUROSCI, V31, P10847, DOI 10.1523/JNEUROSCI.2525-10.2011; KONNERTH A, 1992, P NATL ACAD SCI USA, V89, P7051, DOI 10.1073/pnas.89.15.7051; KONNERTH A, 1990, P NATL ACAD SCI USA, V87, P2662, DOI 10.1073/pnas.87.7.2662; Kreitzer AC, 2002, CURR OPIN NEUROBIOL, V12, P324, DOI 10.1016/S0959-4388(02)00328-8; Kullmann DM, 2012, NEURON, V75, P951, DOI 10.1016/j.neuron.2012.07.030; Kuner T, 2000, NEURON, V27, P447, DOI 10.1016/S0896-6273(00)00056-8; Lee B, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-5; Liu BY, 2010, J CLIN INVEST, V120, P1240, DOI 10.1172/JCI41084; Liu YN, 2015, PFLUG ARCH EUR J PHY, V467, P1417, DOI 10.1007/s00424-014-1572-5; LLANO I, 1991, NEURON, V6, P565, DOI 10.1016/0896-6273(91)90059-9; Marandi N, 2002, PFLUG ARCH EUR J PHY, V445, P357, DOI 10.1007/s00424-002-0933-7; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Mercer AJ, 2011, J NEUROPHYSIOL, V105, P321, DOI 10.1152/jn.00332.2010; Mikawa S, 2002, DEV BRAIN RES, V136, P93, DOI 10.1016/S0165-3806(02)00345-0; MIYAKAWA H, 1992, J NEUROPHYSIOL, V68, P1178, DOI 10.1152/jn.1992.68.4.1178; Namkung W, 2011, J BIOL CHEM, V286, P2365, DOI 10.1074/jbc.M110.175109; Pedemonte N, 2014, PHYSIOL REV, V94, P419, DOI 10.1152/physrev.00039.2011; Peters CJ, 2015, P NATL ACAD SCI USA, V112, P3547, DOI 10.1073/pnas.1502291112; Pifferi S, 2009, PFLUG ARCH EUR J PHY, V458, P1023, DOI 10.1007/s00424-009-0684-9; Qian Z, 2012, NEUROSCIENCE, V201, P34, DOI 10.1016/j.neuroscience.2011.11.021; Raimondo Joseph V, 2012, Front Synaptic Neurosci, V4, P5, DOI 10.3389/fnsyn.2012.00005; Rasche S, 2010, CHEM SENSES, V35, P239, DOI 10.1093/chemse/bjq007; Reisert J, 2003, J GEN PHYSIOL, V122, P349, DOI 10.1085/jgp.200308888; Rivera C, 2005, J PHYSIOL-LONDON, V562, P27, DOI 10.1113/jphysiol.2004.077495; Roth A, 2001, J PHYSIOL-LONDON, V535, P445, DOI 10.1111/j.1469-7793.2001.00445.x; Saidu SP, 2013, J GEN PHYSIOL, V141, P691, DOI 10.1085/jgp.201210937; Satoh H, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.61; Schmolesky MT, 2002, ANN NY ACAD SCI, V978, P359, DOI 10.1111/j.1749-6632.2002.tb07581.x; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Seja P, 2012, EMBO J, V31, P1217, DOI 10.1038/emboj.2011.488; Sinkkonen ST, 2003, MOL PHARMACOL, V64, P753, DOI 10.1124/mol.64.3.753; STALEY KJ, 1995, SCIENCE, V269, P977, DOI 10.1126/science.7638623; Stephan AB, 2009, P NATL ACAD SCI USA, V106, P11776, DOI 10.1073/pnas.0903304106; Stohr H, 2009, J NEUROSCI, V29, P6809, DOI 10.1523/JNEUROSCI.5546-08.2009; Takayama Y, 2014, FASEB J, V28, P2238, DOI 10.1096/fj.13-243436; Thomas-Gatewood C, 2011, AM J PHYSIOL-HEART C, V301, pH1819, DOI 10.1152/ajpheart.00404.2011; Tien J, 2014, ELIFE, V3, DOI 10.7554/eLife.02772; Tolu S, 2010, FASEB J, V24, P723, DOI 10.1096/fj.09-139790; Vocke K, 2013, J GEN PHYSIOL, V142, P381, DOI 10.1085/jgp.201311015; Xiao QH, 2011, P NATL ACAD SCI USA, V108, P8891, DOI 10.1073/pnas.1102147108; Yang TT, 2014, P NATL ACAD SCI USA, V111, P18213, DOI 10.1073/pnas.1420984111; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Yoshida T, 2002, J NEUROSCI, V22, P1690, DOI 10.1523/JNEUROSCI.22-05-01690.2002; Yu K, 2012, CIRC RES, V110, P990, DOI 10.1161/CIRCRESAHA.112.264440; Zhang XD, 2015, P NATL ACAD SCI USA, V112, P2575, DOI 10.1073/pnas.1414741112	95	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142160	10.1371/journal.pone.0142160	http://dx.doi.org/10.1371/journal.pone.0142160			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26558388	Green Submitted, gold, Green Published			2022-12-27	WOS:000364433100058
J	Antwi-Agyei, P; Cairncross, S; Peasey, A; Price, V; Bruce, J; Baker, K; Moe, C; Ampofo, J; Armah, G; Ensink, J				Antwi-Agyei, Prince; Cairncross, Sandy; Peasey, Anne; Price, Vivien; Bruce, Jane; Baker, Kelly; Moe, Christine; Ampofo, Joseph; Armah, George; Ensink, Jeroen			A Farm to Fork Risk Assessment for the Use of Wastewater in Agriculture in Accra, Ghana	PLoS One			English	Article							URBAN VEGETABLE PRODUCTION; NORWALK VIRUS; CONTAMINATION; QUALITY; FOOD; REDUCTION; INFECTION; LETTUCE; PRODUCE	The need to minimise consumer risk, especially for food that can be consumed uncooked, is a continuing public health concern, particularly in places where safe sanitation and hygienic practices are absent. The use of wastewater in agriculture has been associated with disease risks, though its relative significance in disease transmission remains unclear. This study aimed at identifying key risk factors for produce contamination at different entry points of the food chain. Over 500 produce and ready-to-eat salad samples were collected from fields, markets, and kitchens during the dry and wet seasons in Accra, Ghana, and over 300 soil and irrigation water samples were collected. All samples were analysed for E. coli, human adenovirus and norovirus using standard microbiological procedures, and real time RT-PCR. Finally, critical exposures associated with microbial quality of produce were assessed through observations and interviews. The study found that over 80% of produce samples were contaminated with E. coli, with median concentrations ranging from 0.64 to 3.84 Log E. coli/g produce. Prepared salad from street food vendors was found to be the most contaminated (4.23 Log E. coli/g), and that consumption of salad exceeded acceptable health limits. Key risk factors identified for produce contamination were irrigation water and soil at the farm level. Storage duration and temperature of produce had a significant influence on the quality of produce sold at markets, while observations revealed that the washed water used to rinse produce before sale was dirty. The source of produce and operating with a hygiene permit were found to influence salad microbial quality at kitchens. This study argues for a need to manage produce risk factors at all domains along the food chain, though it would be more effective to prioritise at markets and kitchens due to cost, ease of implementation and public health significance.	[Antwi-Agyei, Prince; Cairncross, Sandy; Ensink, Jeroen] Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Environm Hlth Grp, Dept Dis Control, London WC1E 7HT, England; [Peasey, Anne] UCL, Dept Epidemiol & Publ Hlth, London, England; [Price, Vivien] London Sch Hyg & Trop Med, London WC1, England; [Bruce, Jane] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England; [Baker, Kelly; Moe, Christine] Emory Univ, Ctr Global Safe Water, Atlanta, GA 30322 USA; [Ampofo, Joseph] Council Sci & Ind Res CSIR, Water Res Inst WRI, Accra, Ghana; [Armah, George] Univ Ghana Legon, Noguchi Mem Inst Med Res, Coll Hlth Sci, Accra, Ghana	University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Emory University; University of Ghana	Antwi-Agyei, P (corresponding author), Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Environm Hlth Grp, Dept Dis Control, Keppel St, London WC1E 7HT, England.	Prince.AntwiAgyei@lshtm.ac.uk		Price, Vivien/0000-0003-3573-5106; Antwi-Agyei, Prince/0000-0001-6940-2428; Peasey, Anne/0000-0001-7434-2079; Baker, Kelly/0000-0002-3774-2628	Sanitation and Hygiene Applied Research for Equity (SHARE) Research consortium through a UK aid from the Department for International Development (DFID)	Sanitation and Hygiene Applied Research for Equity (SHARE) Research consortium through a UK aid from the Department for International Development (DFID)	The study was funded by the Sanitation and Hygiene Applied Research for Equity (SHARE) Research consortium (www.shareresearch.org) through a UK aid from the Department for International Development (DFID). PM received this funding for this study as part of his PhD scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo K. K., 2007, AFRICAN J FOOD AGR N, V7, P1; Adu-Gyamfi A, 2008, GHANA J SCI, V47, P3; Ali M, 2012, BANGLADESH J SCI RES, V24, P127; Allende A, 2008, POSTHARVEST BIOL TEC, V49, P155, DOI 10.1016/j.postharvbio.2007.12.010; AMA, 2007, MED TERM DEV PLAN 20; Ameko E., 2012, African Journal of Biotechnology, V11, P11078; Amoah P, 2007, TROP MED INT HEALTH, V12, P40, DOI 10.1111/j.1365-3156.2007.01940.x; Amoah P, 2007, J WATER HEALTH, V5, P455, DOI 10.2166/wh.2007.041; Amoah P, 2005, IRRIG DRAIN, V54, pS49, DOI 10.1002/ird.185; Amoah P, 2008, THESIS K NKRUMAH U S; Annor GA, 2011, FOOD NUTR SCI, V2; [Anonymous], 1989, HLTH GUID US WAST AG; [Anonymous], 2005, ESSENTIAL MED STAT; Antwi-Agyei P, QUANTITATIV IN PRESS; Antwi-Agyei P, RISK PERCEP IN PRESS; Barbarosa-Canovas GV, 2003, HANDLING PRESERVATIO; Bosch A, 2006, FOOD MICROBIOL FOOD, P151; Brackett RE, 1999, POSTHARVEST BIOL TEC, V15, P305, DOI 10.1016/S0925-5214(98)00096-9; Camelo A.F.L., 2004, MANUAL PREPARATION S; Carter MJ, 2005, J APPL MICROBIOL, V98, P1354, DOI 10.1111/j.1365-2672.2005.02635.x; Drechsel P., 2014, IRRIGATED URBAN VEGE, DOI [10.5337/2014.219, DOI 10.5337/2014.219]; Drechsel P, 2000, URBAN AGR MAG, V2, P25; Ensink JHJ, 2007, TROP MED INT HEALTH, V12, P2, DOI 10.1111/j.1365-3156.2007.01935.x; [FAO WHO], 2009, WHO MICR RISK ASS SE, V17; Fegloi P, 2012, J MED BIOMED SCI, V1, P1; Fung J., 2011, International Journal of Food Safety, Nutrition and Public Health, V4, P152, DOI 10.1504/IJFSNPH.2011.044544; Garbutt J., 1997, ESSENTIALS FOOD MICR; Ghana Standard Board (Authority) G, 2009, GHAN STAND BOARD GS; Ghana Statistical Service, 2012, 2010 POP HOUS CENS F; Gil MI, 2009, INT J FOOD MICROBIOL, V134, P37, DOI 10.1016/j.ijfoodmicro.2009.05.021; Gilbert R J, 2000, Commun Dis Public Health, V3, P163; Hamilton L.C., 2012, STAT STATA VERSION 1; Harris L.J., 2003, COMPR REV FOOD SCI F, V2, P78, DOI [10.1111/j.1541-4337.2003.tb00031, DOI 10.1111/J.1541-4337.2003.TB00031]; ICMSF. International Commission on Microbiological Specification for Food, 1974, INT COMM MICR SPEC F; Karavarsamis N, 2010, J WATER HEALTH, V8, P365, DOI 10.2166/wh.2010.045; Keraita B, 2008, THESIS U COPENHAGEN; Keraita B, 2008, WATER SCI TECHNOLOGY, V57; Keraita B, 2008, J RISK RES, V11, P1047, DOI 10.1080/13669870802380825; Keraita B, 2008, J ENVIRON SCI HEAL A, V43, P749, DOI 10.1080/10934520801959948; Keraita B, 2007, TROP MED INT HEALTH, V12, P15, DOI 10.1111/j.1365-3156.2007.01937.x; Liu PB, 2010, J MED VIROL, V82, P1612, DOI 10.1002/jmv.21851; Mara D., 2010, DISCUSSION PAPER OPT; Mara D., 2010, QUANTITATIVE MICROBI; Mensah P, 2002, B WORLD HEALTH ORGAN, V80, P546; Minhas PS, 2006, BIORESOURCE TECHNOL, V97, P1174, DOI 10.1016/j.biortech.2005.05.006; Muinde O, 2005, HYGIENIC SANITARY PR; Newell DG, 2010, INT J FOOD MICROBIOL, V139, pS3, DOI 10.1016/j.ijfoodmicro.2010.01.021; Olmez H, 2009, LWT-FOOD SCI TECHNOL, V42, P686, DOI 10.1016/j.lwt.2008.08.001; Olaimat AN, 2012, FOOD MICROBIOL, V32, P1, DOI 10.1016/j.fm.2012.04.016; Oshiro, 2002, 1604 US EPA; Parish M. E., 2003, COMPR REV FOOD SCI F, V2, P161, DOI DOI 10.1111/J.1541-4337.2003.TB00033.X; Pepper I.L., 2015, ENVIRON MICROBIOL, V3rd, P509; Rodriguez-Lazaro D, 2012, FEMS MICROBIOL REV, V36, P786, DOI 10.1111/j.1574-6976.2011.00306.x; Scallan E., 2011, EMERGING INFECT DIS, V17; Shuval H, 1997, WATER SCI TECHNOL, V35, P15, DOI 10.1016/S0273-1223(97)00228-X; Silverman AI, 2013, J WATER HLTH, V11; Stevens M., 2003, REV COLIFORMS MICROB; Teunis PFM, 2008, J MED VIROL, V80, P1468, DOI 10.1002/jmv.21237; Vaz da Costa Vargas S, 1996, TROPICAL PUBLIC HLTH, V8; WHO, 2006, WHO GUID SAF US WAST; World Health Organization, 2006, FOOD SAF RISK ANAL G; World Health Organization, 2006, GUID SAF US WAST EXC, V2; Yeboah-Manu D, 2010, RES J MICROBIOLOGY, V5	63	27	27	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142346	10.1371/journal.pone.0142346	http://dx.doi.org/10.1371/journal.pone.0142346			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556044	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000364430700088
J	Ghaffari-Nazari, H; Tavakkol-Afshari, J; Jaafari, MR; Tahaghoghi-Hajghorbani, S; Masoumi, E; Jalali, SA				Ghaffari-Nazari, Haniyeh; Tavakkol-Afshari, Jalil; Jaafari, Mahmoud Reza; Tahaghoghi-Hajghorbani, Sahar; Masoumi, Elham; Jalali, Seyed Amir			Improving Multi-Epitope Long Peptide Vaccine Potency by Using a Strategy that Enhances CD4+T Help in BALB/c Mice	PLOS ONE			English	Article							B-CELL EPITOPE; INCOMPLETE FREUNDS-ADJUVANT; CANCER-PATIENTS; ANTITUMOR IMMUNITY; CTL RESPONSE; CPG; DNA; INDUCTION; LYMPHOCYTE; ANTIGEN	Peptide-based vaccines are attractive approaches for cancer immunotherapy; but the success of these vaccines in clinical trials have been limited. Our goal is to improve immune responses and anti-tumor effects against a synthetic, multi-epitope, long peptide from rat Her2/neu (rHer2/neu) using the help of CD4+ T cells and appropriate adjuvant in a mouse tumor model. Female BALB/c mice were vaccinated with P5+435 multi-epitope long peptide that presents epitopes for cytotoxic T lymphocytes (CTL) in combination with a universal Pan DR epitope (PADRE) or CpG-oligodeoxynucleotides (CpG-ODNs) as a Toll-like receptor agonist adjuvant. The results show that vaccination with the multi-epitope long peptide in combination with the PADRE peptide and CpG-ODN induced expansion of subpopulations of CD4+ and CD8+ cells producing IFN-gamma, the average tumor size in the vaccinated mice was less than that of the other groups, and tumor growth was inhibited in 40% of the mice in the vaccinated group. The mean survival time was 82.6 +/- 1.25 days in mice vaccinated with P5+435 + CpG+ PADRE. Our results demonstrate that inclusion of PADRE and CpG with the peptide vaccine enhanced significant tumor specific-immune responses in vaccinated mice.	[Ghaffari-Nazari, Haniyeh; Tavakkol-Afshari, Jalil; Tahaghoghi-Hajghorbani, Sahar; Masoumi, Elham] Mashhad Univ Med Sci, Immunol Res Ctr, Sch Med, Immunogenet & Cell Culture Dept, Mashhad, Iran; [Jaafari, Mahmoud Reza] Mashhad Univ Med Sci, Biotechnol Res Ctr, Nanotechnol Res Ctr, Sch Pharm, Mashhad, Iran; [Jalali, Seyed Amir] Shahid Beheshti Univ Med Sci, Sch Med, Dept Immunol, Tehran, Iran	Mashhad University Medical Science; Mashhad University Medical Science; Shahid Beheshti University Medical Sciences	Jalali, SA (corresponding author), Shahid Beheshti Univ Med Sci, Sch Med, Dept Immunol, Tehran, Iran.	Jalalia@sbmu.ac.ir	Masoumi, Elham/AAP-8427-2020; Afshari, Jalil Tavakol/AAH-7891-2021; Ghaffari-nazari, Haniyeh/X-7035-2018	Ghaffari-nazari, Haniyeh/0000-0002-4129-6018; Masoumi, Elham/0000-0002-8312-955X; jalali, seyed amir/0000-0003-1174-4905	research council of Mashhad University of Medical Sciences in Iran [910444]	research council of Mashhad University of Medical Sciences in Iran	This research was financially supported by a grant (No. 910444) of the research council of Mashhad University of Medical Sciences in Iran.	Adamsson J, 2006, J IMMUNOL, V176, P4902, DOI 10.4049/jimmunol.176.8.4902; Agadjanyan MG, 2005, J IMMUNOL, V174, P1580, DOI 10.4049/jimmunol.174.3.1580; Alexander J, 1998, IMMUNOL RES, V18, P79, DOI 10.1007/BF02788751; Alexander J, 2004, VACCINE, V22, P2362, DOI 10.1016/j.vaccine.2003.11.061; Alexander J, 2000, J IMMUNOL, V164, P1625, DOI 10.4049/jimmunol.164.3.1625; BARR PJ, 1991, CELL, V66, P1, DOI 10.1016/0092-8674(91)90129-M; Baxevanis CN, 2006, CANCER IMMUNOL IMMUN, V55, P85, DOI 10.1007/s00262-005-0692-3; Bijker MS, 2007, J IMMUNOL, V179, P5033, DOI 10.4049/jimmunol.179.8.5033; Bode C, 2011, EXPERT REV VACCINES, V10, P499, DOI [10.1586/erv.10.174, 10.1586/ERV.10.174]; Dakappagari NK, 2000, CANCER RES, V60, P3782; Ghochikyan A, 2009, CNS NEUROL DISORD-DR, V8, P128, DOI 10.2174/187152709787847298; Gritzapis AD, 2006, CANCER RES, V66, P5452, DOI 10.1158/0008-5472.CAN-05-4018; Hung CF, 2007, MOL THER, V15, P1211, DOI 10.1038/sj.mt.6300121; Jager E, 2000, P NATL ACAD SCI USA, V97, P12198, DOI 10.1073/pnas.220413497; Jalali SA, 2012, NANOMED-NANOTECHNOL, V8, P692, DOI 10.1016/j.nano.2011.09.010; Jalali Seyed Amir, 2011, Recent Pat Biotechnol, V5, P108; Kenter GG, 2008, CLIN CANCER RES, V14, P169, DOI 10.1158/1078-0432.CCR-07-1881; Klinman DM, 2004, NAT REV IMMUNOL, V4, P248, DOI 10.1038/nri1329; Kochenderfer JN, 2007, CLIN IMMUNOL, V124, P119, DOI 10.1016/j.clim.2007.04.003; Lai YP, 2011, ISRN IMMUNOLOGY, V2011; Mansourian M, 2014, IMMUNOL LETT, V162, P87, DOI 10.1016/j.imlet.2014.07.008; Meng WJ, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-88; Miconnet I, 2002, J IMMUNOL, V168, P1212, DOI 10.4049/jimmunol.168.3.1212; Morse MA, 2010, INT J CANCER, V126, P2893, DOI 10.1002/ijc.24995; Muranski P, 2009, CURR OPIN IMMUNOL, V21, P200, DOI 10.1016/j.coi.2009.02.004; Nava-Parada P, 2007, CANCER RES, V67, P1326, DOI 10.1158/0008-5472.CAN-06-3290; Pakravan N, 2010, CELL STRESS CHAPERON, V15, P977, DOI 10.1007/s12192-010-0208-8; Park JM, 2005, J IMMUNOL, V174, P4228, DOI 10.4049/jimmunol.174.7.4228; Peoples GE, 2008, CLIN CANCER RES, V14, P797, DOI 10.1158/1078-0432.CCR-07-1448; Perez SA, 2010, CANCER-AM CANCER SOC, V116, P2071, DOI 10.1002/cncr.24988; Renard V, 2003, J IMMUNOL, V171, P1588, DOI 10.4049/jimmunol.171.3.1588; Riemer AB, 2004, J IMMUNOL, V173, P394, DOI 10.4049/jimmunol.173.1.394; Rosa DS, 2004, IMMUNOL LETT, V92, P259, DOI 10.1016/j.imlet.2004.01.006; Rovero S, 2000, J IMMUNOL, V165, P5133, DOI 10.4049/jimmunol.165.9.5133; Salazar LG, 2003, CLIN CANCER RES, V9, P5559; Shargh VH, 2012, VACCINE, V30, P3957, DOI 10.1016/j.vaccine.2012.03.040; Shariat S, 2014, CANCER LETT, V355, P54, DOI 10.1016/j.canlet.2014.09.016; Sotiriadou NN, 2007, CANCER IMMUNOL IMMUN, V56, P601, DOI 10.1007/s00262-006-0213-z; Sundaram R, 2003, VACCINE, V21, P2767, DOI 10.1016/S0264-410X(03)00179-8; Tsang RY, 2012, BRIT J CANCER, V106, P6, DOI 10.1038/bjc.2011.516; Ulrich JT, 2000, J IMMUNOL, V164, P5492, DOI 10.4049/jimmunol.164.10.5492; Vambutas A, 2005, VACCINE, V23, P5271, DOI 10.1016/j.vaccine.2005.04.049; van der Bruggen P, 2002, IMMUNOL REV, V188, P51, DOI 10.1034/j.1600-065X.2002.18806.x; van der Burg SH, 2006, ADV DRUG DELIVER REV, V58, P916, DOI 10.1016/j.addr.2005.11.003; van Poelgeest MIE, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-88; Velders MP, 2001, J IMMUNOL, V166, P5366, DOI 10.4049/jimmunol.166.9.5366; Weber JS, 1999, J IMMUNOTHER, V22, P431, DOI 10.1097/00002371-199909000-00007; Weiner GJ, 1997, P NATL ACAD SCI USA, V94, P10833, DOI 10.1073/pnas.94.20.10833; Wu CY, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-88; Yang B, 1996, J EXP MED, V183, P1545, DOI 10.1084/jem.183.4.1545; Zaks TZ, 1998, CANCER RES, V58, P4902; Zwaveling S, 2002, J IMMUNOL, V169, P350, DOI 10.4049/jimmunol.169.1.350	52	66	68	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142563	10.1371/journal.pone.0142563	http://dx.doi.org/10.1371/journal.pone.0142563			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556756	gold, Green Published, Green Submitted			2022-12-27	WOS:000364430700132
J	Zhang, JW; Huang, Y; Wang, XL; Lin, K; Wu, KS				Zhang, Jingwen; Huang, Yue; Wang, Xiaoling; Lin, Kun; Wu, Kusheng			Environmental Polychlorinated Biphenyl Exposure and Breast Cancer Risk: A Meta-Analysis of Observational Studies	PLOS ONE			English	Article							ADIPOSE-TISSUE CONCENTRATIONS; ORGANOCHLORINE PESTICIDES; SERUM ORGANOCHLORINES; AFRICAN-AMERICAN; TEMPORAL TRENDS; LONG-ISLAND; POLLUTANTS; PCBS; WOMEN; MILK	Background Association between polychlorinated biphenyl (PCB) exposure and breast cancer risk has been widely studied, but the results remain controversial. We performed a meta-analysis to evaluate the evidences from observational studies on PCB exposure and breast cancer risk. Methods Relevant studies with data on internal PCB dose were identified from PubMed, EMBASE, CBM and CNKI databases through November 2014. Multivariable-adjusted odds ratio (OR) with 95% confidence intervals (CIs) were applied to assess the association between PCB exposure and breast cancer risk. Heterogeneity test, sensitivity analysis, subgroup analysis and publication bias test were also performed. To further explore the association between specific groups of PCB congeners and breast cancer, we examined the PCB congeners classified, according to their structural, biological and pharmacokinetics properties, as group I (potentially estrogenic), group II (potentially anti-estrogenic and immunotoxic, dioxin-like), and group III (phenobarbital, CYP1A and CYP2B inducers, biologically persistent). Results Of 660 studies screened, 25 studies which met criteria were selected, involving a total of 12866 participants (6088 cases and 6778 controls) from eight countries. The results showed that the risk of breast cancer was associated with group II (OR = 1.23, 95% CI: 1.08-1.40) and group III (OR = 1.25, 95% CI: 1.09-1.43) PCBs, but not with group I (OR = 1.10, 95% CI: 0.97-1.24) PCBs or total PCB exposure (OR = 1.09, 95% CI: 0.97-1.22). Conclusions Our meta-analysis based on the selected studies found group II and group III PCB exposure might contribute to the risk of breast cancer. More studies in developing countries with higher PCB levels are needed, as well as studies to explore the relationships between mixtures of organochlorine compounds and breast cancer risk.	[Zhang, Jingwen; Huang, Yue; Wang, Xiaoling; Lin, Kun; Wu, Kusheng] Shantou Univ, Dept Prevent Med, Coll Med, Shantou, Guangdong, Peoples R China	Shantou University	Wu, KS (corresponding author), Shantou Univ, Dept Prevent Med, Coll Med, Shantou, Guangdong, Peoples R China.	kswu@stu.edu.cn	Wu, Kusheng/O-5141-2019; Zhang, Jing/GWZ-7332-2022	Wu, Kusheng/0000-0001-5163-2524; 	National Natural Science Foundation of China [81470152]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding: This work was supported by the National Natural Science Foundation of China (no.: 81470152). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annamalai J, 2015, ENVIRON INT, V76, P78, DOI 10.1016/j.envint.2014.12.006; Aronson KJ, 2000, CANCER EPIDEM BIOMAR, V9, P55; Aube M, 2011, ENVIRON RES, V111, P337, DOI 10.1016/j.envres.2011.01.010; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bonefeld-Jorgensen EC, 2001, TOXICOLOGY, V158, P141, DOI 10.1016/S0300-483X(00)00368-1; Bonefeld-Jorgensen Eva C, 2006, Environ Health, V5, P12, DOI 10.1186/1476-069X-5-12; Bonefeld-Jorgensen EC, 2014, BASIC CLIN PHARMACOL, V115, P118, DOI 10.1111/bcpt.12263; Bonefeld-Jorgensen EC, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-88; Brody JG, 2003, ENVIRON HEALTH PERSP, V111, P1007, DOI 10.1289/ehp.6310; Brody JG, 2007, CANCER-AM CANCER SOC, V109, P2667, DOI 10.1002/cncr.22655; Brouwer A, 1999, ENVIRON HEALTH PERSP, V107, P639, DOI 10.2307/3434557; Charlier CJ, 2004, CLIN CHIM ACTA, V347, P177, DOI 10.1016/j.cccn.2004.04.025; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; Cohn BA, 2012, BREAST CANCER RES TR, V136, P267, DOI 10.1007/s10549-012-2257-4; Demers A, 2002, AM J EPIDEMIOL, V155, P629, DOI 10.1093/aje/155.7.629; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dorgan JF, 1999, CANCER CAUSE CONTROL, V10, P1, DOI 10.1023/A:1008824131727; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fang J, 2015, ENVIRON SCI POLLUT R, V22, P8989, DOI 10.1007/s11356-015-4080-z; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; FINKLEA J, 1972, AM J PUBLIC HEALTH N, V62, P645, DOI 10.2105/AJPH.62.5.645; Fredslund SO, 2012, INT J CIRCUMPOL HEAL, V71, DOI 10.3402/ijch.v71i0.19155; FURST P, 1994, ENVIRON HEALTH PERSP, V102, P187, DOI 10.1289/ehp.102-1566908; Gammon MD, 2002, CANCER EPIDEM BIOMAR, V11, P686; Gatto NM, 2007, CANCER CAUSE CONTROL, V18, P29, DOI 10.1007/s10552-006-0070-2; Ghisari M, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-19; Ghisari M, 2013, INT J CIRCUMPOL HEAL, V72, DOI 10.3402/ijch.v72i0.21113; Helzlsouer KJ, 1999, CANCER EPIDEM BIOMAR, V8, P525; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hoyer AP, 1998, LANCET, V352, P1816, DOI 10.1016/S0140-6736(98)04504-8; HSU ST, 1985, ENVIRON HEALTH PERSP, V59, P5, DOI 10.2307/3429867; Itoh H, 2009, CANCER CAUSE CONTROL, V20, P567, DOI 10.1007/s10552-008-9265-z; Konishi Y, 2015, ENV SCI POLLUT RES I; KRIEGER N, 1994, JNCI-J NATL CANCER I, V86, P589, DOI 10.1093/jnci/86.8.589; Kuratsune M, 1972, Environ Health Perspect, V1, P119, DOI 10.2307/3428163; Laden F, 2001, INT J CANCER, V91, P568, DOI 10.1002/1097-0215(200002)9999:9999&lt;::AID-IJC1081&gt;3.0.CO;2-W; Lauby-Secretan B, 2013, LANCET ONCOL, V14, P287, DOI 10.1016/S1470-2045(13)70104-9; Liehr JG, 2000, ENDOCR REV, V21, P40, DOI 10.1210/er.21.1.40; Liljegren G, 1998, EUR J CANCER PREV, V7, P135; Lopez-Carrillo L, 2002, EUR J CANCER PREV, V11, P129, DOI 10.1097/00008469-200204000-00004; Malisch R, 2014, SCI TOTAL ENVIRON, V491, P2, DOI 10.1016/j.scitotenv.2014.03.022; MARTUCCI CP, 1993, PHARMACOL THERAPEUT, V57, P237, DOI 10.1016/0163-7258(93)90057-K; MCKINNEY JD, 1994, ENVIRON HEALTH PERSP, V102, P290, DOI 10.1289/ehp.94102290; Millikan R, 2000, CANCER EPIDEM BIOMAR, V9, P1233; Moysich KB, 1998, CANCER EPIDEM BIOMAR, V7, P181; Muto T, 2002, TOXICOLOGY, V177, P197, DOI 10.1016/S0300-483X(02)00224-X; NIP Korea DPR, 2008, DEM PEOPL REP KOR NA; OConnell D, 2019, NEWCASTLE OTTAWA SCA; Olsen JH, 1997, APMIS, V105, P141; Parkin DM, 2001, EUR J CANCER, V37, pS4, DOI 10.1016/S0959-8049(01)00267-2; Pavuk M, 2003, J EXPO ANAL ENV EPID, V13, P267, DOI 10.1038/sj.jea.7500277; Pelekanou V, 2011, INT J DEV BIOL, V55, P869, DOI 10.1387/ijdb.113369vp; Polder A, 2008, CHEMOSPHERE, V73, P14, DOI 10.1016/j.chemosphere.2008.06.002; Raaschou-Nielsen O, 2005, CANCER EPIDEM BIOMAR, V14, P67; Recio-Vega R, 2011, J APPL TOXICOL, V31, P270, DOI 10.1002/jat.1672; Rogan WJ, 1996, ARCH PEDIAT ADOL MED, V150, P981, DOI 10.1001/archpedi.1996.02170340095018; Rubin CH, 2006, INT J CIRCUMPOLAR HL, V65; SAFE SH, 1994, CRIT REV TOXICOL, V24, P87, DOI 10.3109/10408449409049308; Salehi F, 2008, J TOXICOL ENV HEAL B, V11, P276, DOI 10.1080/10937400701875923; Shakeel MK, 2010, ASIAN PAC J CANCER P, V11, P173; SOONTORNCHAT S, 1994, ENVIRON HEALTH PERSP, V102, P568, DOI 10.1289/ehp.94102568; Stellman SD, 2000, CANCER EPIDEM BIOMAR, V9, P1241; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Ward EM, 2000, CANCER EPIDEM BIOMAR, V9, P1357; Wolff MS, 2000, ENVIRON RES, V84, P151, DOI 10.1006/enrs.2000.4075; Wolff MS, 2000, CANCER EPIDEM BIOMAR, V9, P271; WOLFF MS, 1995, ENVIRON HEALTH PERSP, V103, P141, DOI 10.2307/3432524; Wolff MS, 1997, ENVIRON HEALTH PERSP, V105, P13, DOI 10.2307/3433043; Ye H.Z., 2009, CASE CONTROL STUDY R; Zani C, 2013, J ENVIRON SCI HEAL C, V31, P99, DOI 10.1080/10590501.2013.782174; Zhang Hong, 2013, Wei Sheng Yan Jiu, V42, P44; Zheng TZ, 2000, CANCER EPIDEM BIOMAR, V9, P167	73	28	30	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142513	10.1371/journal.pone.0142513	http://dx.doi.org/10.1371/journal.pone.0142513			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555153	gold, Green Published, Green Submitted			2022-12-27	WOS:000364430700120
J	Asamizu, S; Ozaki, T; Teramoto, K; Satoh, K; Onaka, H				Asamizu, Shumpei; Ozaki, Taro; Teramoto, Kanae; Satoh, Katsuya; Onaka, Hiroyasu			Killing of Mycolic Acid-Containing Bacteria Aborted Induction of Antibiotic Production by Streptomyces in Combined-Culture	PLOS ONE			English	Article							PROMOTES SECONDARY METABOLISM; CHEMICAL COMMUNICATION; A-FACTOR; BIOSYNTHESIS; CHROMATOGRAPHY; MORPHOGENESIS; GOADSPORIN; DIVERSITY; SUBSTANCE; RADIATION	Co-culture of Streptomyces with mycolic acid-containing bacteria (MACB), which we termed "combined-culture," alters the secondary metabolism pattern in Streptomyces and has been a useful method for the discovery of bioactive natural products. In the course of our investigation to identify the inducing factor(s) of MACB, we previously observed that production of pigments in Streptomyces lividans was not induced by factors such as culture extracts or mycolic acids. Although dynamic changes occurred in culture conditions because of MACB, the activation of pigment production by S. lividans was observed in a limited area where both colonies were in direct contact. This suggested that direct attachment of cells is a requirement and that components on the MACB cell membrane may play an important role in the response by S. lividans. Here we examined whether this response was influenced by dead MACB that possess intact mycolic acids assembled on the outer cell membrane. Formaldehyde fixation and.-irradiation were used to prepare dead cells that retain their shape and mycolic acids of three MACB species: Tsukamurella pulmonis, Rhodococcus erythropolis, and Rhodococcus opacus. Culturing tests verified that S. lividans does not respond to the intact dead cells of three MACB. Observation of combined-culture by scanning electron microscopy (SEM) indicated that adhesion of live MACB to S. lividans mycelia were a significant interaction that resulted in formation of co-aggregation. In contrast, in the SEM analysis, dead cells were not observed to adhere. Therefore, direct attachment by live MACB cells is proposed as one of the possible factors that causes Streptomyces to alter its specialized metabolism in combined-culture.	[Asamizu, Shumpei; Ozaki, Taro; Onaka, Hiroyasu] Univ Tokyo, Dept Biotechnol, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo, Japan; [Teramoto, Kanae] JEOL Ltd, Adv Technol Dept, Tokyo, Japan; [Satoh, Katsuya] Japan Atom Energy Agcy, Ion Beam Mutagenesis Res Grp, Biotechnol & Med Applicat Div, Quantum Beam Sci Ctr, Takasaki, Gunma, Japan	University of Tokyo; Jeol Ltd; JEOL Japan; Japan Atomic Energy Agency	Asamizu, S (corresponding author), Univ Tokyo, Dept Biotechnol, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo, Japan.	asamizu@mail.ecc.u-tokyo.ac.jp; aonaka@mail.ecc.u-tokyo.ac.jp	OZAKI, Taro/F-1614-2016; Asamizu, Shumpei/GOJ-8839-2022	OZAKI, Taro/0000-0002-4673-4478; Asamizu, Shumpei/0000-0002-7178-5410; Onaka, Hiroyasu/0000-0003-4536-1881	Institution for Fermentation, Osaka; Charitable Trust Araki Medical and Biochemical Research Memorial Fund; KAKENHI [26850044, 25292046]; Advanced Technology Department, JEOL Ltd.	Institution for Fermentation, Osaka; Charitable Trust Araki Medical and Biochemical Research Memorial Fund; KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Advanced Technology Department, JEOL Ltd.	This work was funded by the Institution for Fermentation, Osaka (http://www.ifo.or.jp/) (to SA, TO, and HO); the Charitable Trust Araki Medical and Biochemical Research Memorial Fund (to SA); KAKENHI Grant-in-Aid for Young Scientists B (No. 26850044) (https://www.jsps.go.jp/english/index.html) (to SA); and KAKENHI Grant-in-Aid for Scientific Research B (No. 25292046) (https://www.jsps.go.jp/english/index.html) (to HO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Advanced Technology Department, JEOL Ltd. provided support in the form of a salary for KT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.; We thank Prof. Yasuo Ohnishi at The University of Tokyo for fruitful discussion. We thank Dr. Kohsuke Honda at Osaka University for the kind gift of Rhodococcus opacus B4. The project was supported by Grants-in-Aid from the Institution for Fermentation, Osaka (to SA, TO, and HO), by the Charitable Trust Araki Medical and Biochemical Research Memorial Fund (to SA), and in part by a KAKENHI Grant-in-Aid for Young Scientists B (No. 26850044) (to SA) and for Scientific Research B (No. 25292046) (to HO).	Ahmed S, 2013, CHEMBIOCHEM, V14, P83, DOI 10.1002/cbic.201200619; ANDRES N, 1990, Z NATURFORSCH C, V45, P850; Antunes CA, 2015, MICROBIOL-SGM, V161, P639, DOI 10.1099/mic.0.000020; Bansal-Mutalik R, 2014, P NATL ACAD SCI USA, V111, P4958, DOI 10.1073/pnas.1403078111; BENDINGER B, 1993, APPL ENVIRON MICROB, V59, P3973, DOI 10.1128/AEM.59.11.3973-3977.1993; Berdy J, 2005, J ANTIBIOT, V58, P1, DOI 10.1038/ja.2005.1; Bertrand S, 2014, BIOTECHNOL ADV, V32, P1180, DOI 10.1016/j.biotechadv.2014.03.001; Butler WR, 2001, CLIN MICROBIOL REV, V14, P704, DOI 10.1128/CMR.14.4.704-726.2001; Chao YQ, 2011, APPL MICROBIOL BIOT, V92, P381, DOI 10.1007/s00253-011-3551-5; Craney A, 2012, CHEM BIOL, V19, P1020, DOI 10.1016/j.chembiol.2012.06.013; Derewacz DK, 2015, ACS CHEM BIOL; Elias S, 2012, FEMS MICROBIOL REV, V36, P990, DOI 10.1111/j.1574-6976.2012.00325.x; Horinouchi S, 2007, P JPN ACAD B-PHYS, V83, P277, DOI [10.2183/pjab.83.277, 10.2183/pjab/83.277]; Hoshino S, 2014, J ANTIBIOT TOKYO; Hoshino S, 2015, ORG LETT; Igarashi Y, 2001, J ANTIBIOT, V54, P1045, DOI 10.7164/antibiotics.54.1045; Igarashi Y, 2010, ORG LETT, V12, P3402, DOI 10.1021/ol1012982; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kimura Eiichiro, 2003, Adv Biochem Eng Biotechnol, V79, P37; Kolenbrander PE, 2010, NAT REV MICROBIOL, V8, P471, DOI 10.1038/nrmicro2381; Kolter R, 2015, NAT PROD REP; Krisko A, 2010, P NATL ACAD SCI USA, V107, P14373, DOI 10.1073/pnas.1009312107; Liu G, 2013, MICROBIOL MOL BIOL R, V77, P112, DOI 10.1128/MMBR.00054-12; Luti KJK, 2011, APPL MICROBIOL BIOT, V90, P461, DOI 10.1007/s00253-010-3032-2; Luti KJK, 2011, BIOTECHNOL LETT, V33, P113, DOI 10.1007/s10529-010-0401-y; Marmann A, 2014, MAR DRUGS, V12, P1043, DOI 10.3390/md12021043; Marrakchi H, 2014, CHEM BIOL, V21, P67, DOI 10.1016/j.chembiol.2013.11.011; Martin JF, 2004, J BACTERIOL, V186, P5197, DOI 10.1128/JB.186.16.5197-5201.2004; Martinkova L, 2009, ENVIRON INT, V35, P162, DOI 10.1016/j.envint.2008.07.018; Min JH, 2003, RADIAT ENVIRON BIOPH, V42, P189, DOI 10.1007/s00411-003-0205-8; Na KS, 2005, J BIOSCI BIOENG, V99, P378, DOI 10.1263/jbb.99.378; Nett M, 2009, NAT PROD REP, V26, P1362, DOI 10.1039/b817069j; Netzker T, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00299; Nutzmann HW, 2011, P NATL ACAD SCI USA, V108, P14282, DOI 10.1073/pnas.1103523108; Ohno M, 1999, BIOSCI BIOTECH BIOCH, V63, P1083, DOI 10.1271/bbb.63.1083; Onaka H, 2001, J ANTIBIOT, V54, P1036, DOI 10.7164/antibiotics.54.1036; Onaka H, 2011, APPL ENVIRON MICROB, V77, P400, DOI 10.1128/AEM.01337-10; PUCHTLER H, 1985, HISTOCHEMISTRY, V82, P201, DOI 10.1007/BF00501395; Recio E, 2004, J BIOL CHEM, V279, P41586, DOI 10.1074/jbc.M402340200; Rigali S, 2008, EMBO REP, V9, P670, DOI 10.1038/embor.2008.83; Schroeckh V, 2009, P NATL ACAD SCI USA, V106, P14558, DOI 10.1073/pnas.0901870106; Smith I, 2003, CLIN MICROBIOL REV, V16, P463, DOI 10.1128/CMR.16.3.463-496.2003; Straight PD, 2009, ANNU REV MICROBIOL, V63, P99, DOI 10.1146/annurev.micro.091208.073248; Sugiyama R, 2015, ORG LETT; Taga ME, 2003, P NATL ACAD SCI USA, V100, P14549, DOI 10.1073/pnas.1934514100; Teramoto Kanae, 2015, Mass Spectrom (Tokyo), V4, pA0035, DOI 10.5702/massspectrometry.A0035; Teramoto K, 2013, J ANTIBIOT, V66, P713, DOI 10.1038/ja.2013.79; Traxler MF, 2013, MBIO, V4, DOI 10.1128/mBio.00459-13; Vargas-Bautista C, 2014, J BACTERIOL, V196, P717, DOI 10.1128/JB.01022-13; Winn M, 2014, FEMS MICROBIOL LETT, V352, P157, DOI 10.1111/1574-6968.12378; Wu CS, 2015, SCI REP-UK, V5, DOI 10.1038/srep10868; Yamazaki H, 2003, J BACTERIOL, V185, P1273, DOI 10.1128/JB.185.4.1273-1283.2003; YANO I, 1972, FEBS LETT, V21, P215, DOI 10.1016/0014-5793(72)80140-6; Yoon V, 2014, J IND MICROBIOL BIOT, V41, P415, DOI 10.1007/s10295-013-1387-y; Zhang ZY, 2010, BBA-BIOMEMBRANES, V1798, P1829, DOI 10.1016/j.bbamem.2010.05.024	55	13	13	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142372	10.1371/journal.pone.0142372	http://dx.doi.org/10.1371/journal.pone.0142372			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544713	Green Submitted, gold, Green Published			2022-12-27	WOS:000364398700120
J	Llopis-Belenguer, C; Balbuena, JA; Galvan-Femenia, I; Rodriguez-Gonzalez, A				Llopis-Belenguer, Cristina; Antonio Balbuena, Juan; Galvan-Femenia, Ivan; Rodriguez-Gonzalez, Abril			Phenotypic Buffering in a Monogenean: Canalization and Developmental Stability in Shape and Size of the Haptoral Anchors of Ligophorus cephali (Monogenea: Dactylogyridae)	PLOS ONE			English	Article							FLUCTUATING ASYMMETRY; GEOMETRIC MORPHOMETRICS; MORPHOLOGICAL INTEGRATION; DROSOPHILA-MELANOGASTER; SEXUAL SELECTION; MUGIL-CEPHALUS; PLATYHELMINTHES; VARIABILITY; INSTABILITY; ANCYROCEPHALIDAE	Phenotypic variation results from the balance between sources of variation and counteracting regulatory mechanisms. Canalization and developmental stability are two such mechanisms, acting at two different levels of regulation. The issue of whether or not they act concurrently as a common developmental buffering capacity has been subject to debate. We used geometric morphometrics to quantify the mechanisms that guarantee phenotypic constancy in the haptoral anchors of Ligophorus cephali. Canalization and developmental stability were appraised by estimating inter- and intra-individual variation, respectively, in size and shape of dorsal and ventral anchors. The latter variation was estimated as fluctuating asymmetry (FA) between anchor pairs. The general-buffering-capacity hypothesis was tested by two different methods based on correlations and Principal Components Analyses of the different components of size and shape variation. Evidence for FA in the dorsal and ventral anchors in both shape and size was found. Our analyses supported the hypothesis of a general developmental buffering capacity. The evidence was more compelling for shape than for size and, particularly, for the ventral anchors than for the dorsal ones. These results are in line with previous studies of dactylogyrids suggesting that ventral anchors secure a firmer, more permanent attachment, whereas dorsal anchors are more mobile. Because fixation to the host is crucial for survival in ectoparasites, we suggest that homeostatic development of the ventral anchors has been promoted to ensure the morphological constancy required for efficient attachment. Geometric morphometrics can be readily applied to other host-monogenean models, affording not only to disentangle the effects of canalization and developmental stability, as shown herein, but to further partition the environmental and genetic components of the former.	[Llopis-Belenguer, Cristina; Antonio Balbuena, Juan; Rodriguez-Gonzalez, Abril] Univ Valencia, Marine Zool Unit, Cavanilles Inst Biodivers & Evolutionary Biol, Valencia, Spain; [Galvan-Femenia, Ivan] Univ Girona, Dept Comp Sci Appl Math & Stat, Girona, Spain	University of Valencia; Universitat de Girona	Llopis-Belenguer, C (corresponding author), Univ Valencia, Marine Zool Unit, Cavanilles Inst Biodivers & Evolutionary Biol, Valencia, Spain.	cristina.llopis.belenguer@gmail.com	Balbuena, Juan Antonio/O-6404-2014; Llopis-Belenguer, Cristina/Z-6264-2019; Femenía, Iván Galván/AAU-2847-2021; Llopis-Belenguer, Cristina/AAV-2175-2020	Balbuena, Juan Antonio/0000-0003-4006-1353; Llopis-Belenguer, Cristina/0000-0001-7672-0088; Femenía, Iván Galván/0000-0002-6124-3730; Llopis-Belenguer, Cristina/0000-0001-7672-0088; Rodriguez Gonzalez, Abril/0000-0002-9940-5299	Consejo Nacional de Ciencia y Tecnologia of the Mexican Government; Yucatan State, Mexico [204397]; National Plan for Scientific Research, Development and Technological Innovation of Spain [CGL2008-02701]; Generalitat Valenciana [II/2015/018]	Consejo Nacional de Ciencia y Tecnologia of the Mexican Government; Yucatan State, Mexico; National Plan for Scientific Research, Development and Technological Innovation of Spain; Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission)	ARG benefited from a PhD student grant from the Consejo Nacional de Ciencia y Tecnologia of the Mexican Government and Yucatan State, Mexico (Scholarship No. 204397), www.conacyt.mx. This study was funded by the National Plan for Scientific Research, Development and Technological Innovation of Spain (CGL2008-02701), www.idi.mineco.gob.es. This study was funded by the Generalitat Valenciana (Prometeo Project II/2015/018), www.gva.es.	Anderson M.J., 2005, PERMANOVA A FORTRAN; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Arya Priya Vrat, 2015, Journal of Parasitic Diseases, V39, P94, DOI 10.1007/s12639-013-0289-2; Breuker CJ, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000007; De Coster G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057966; Debat V, 2000, P ROY SOC B-BIOL SCI, V267, P423, DOI 10.1098/rspb.2000.1017; Debat V, 2001, TRENDS ECOL EVOL, V16, P555, DOI 10.1016/S0169-5347(01)02266-2; Debat V, 2006, EVOLUTION, V60, P2529, DOI 10.1554/06-045.1; Dworkin I, 2005, EVOLUTION, V59, P1500; Dworkin I, 2005, VARIATION CENTRAL CO, P131, DOI DOI 10.1016/B978-012088777-4/50010-7; Hallgrimsson B, 2002, YEARB PHYS ANTHROPOL, V45, P131, DOI 10.1002/ajpa.10182; Karvonen E, 2003, OIKOS, V100, P507, DOI 10.1034/j.1600-0706.2003.11851.x; Kearn G.C., 2014, OCEANOGRAPHY, V2, P1, DOI [10.4172/2332-2632.1000117, DOI 10.4172/2332-2632.1000117]; Kearn GC, 1999, PARASITOLOGY, V119, pS57, DOI 10.1017/S003118200008464X; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Klingenberg CP, 2010, NAT REV GENET, V11, P623, DOI 10.1038/nrg2829; Klingenberg CP, 2005, SYST BIOL, V54, P678, DOI 10.1080/10635150590947258; Klingenberg CP, 2003, EVOL DEV, V5, P522, DOI 10.1046/j.1525-142X.2003.03057.x; Klingenberg CP, 1998, EVOLUTION, V52, P1363, DOI 10.1111/j.1558-5646.1998.tb02018.x; Klingenberg CP, 2001, AM NAT, V157, P11, DOI 10.1086/317002; Mendlova M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037268; Milton CC, 2003, P NATL ACAD SCI USA, V100, P13396, DOI 10.1073/pnas.1835613100; Milton CC, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000075; Mitteroecker P, 2009, EVOL BIOL, V36, P235, DOI 10.1007/s11692-009-9055-x; Moller AP, 2002, ETHOLOGY, V108, P193; Oksanen J., **DATA OBJECT**; Olstad K, 2009, PARASITOLOGY, V136, P1305, DOI 10.1017/S0031182009990680; Ozener B, 2010, AM J PHYS ANTHROPOL, V143, P112, DOI 10.1002/ajpa.21300; Palmer, 1994, DEV INSTABILITY ITS, P335, DOI DOI 10.1007/978-94-011-0830-0_; Palmer M, 2010, MAR ECOL PROG SER, V399, P261, DOI 10.3354/meps08347; Pecinkova M, 2007, J ZOOL, V272, P406, DOI 10.1111/j.1469-7998.2006.00284.x; Petrov A. A., 2015, Trudy Zoologicheskogo Instituta, V319, P244; Polak M, 2008, EVOL BIOL, V35, P208, DOI 10.1007/s11692-008-9032-9; Radwan J, 2003, BIOL J LINN SOC, V80, P499, DOI 10.1046/j.1095-8312.2003.00249.x; Rao GY, 2002, HEREDITY, V88, P197, DOI 10.1038/sj.hdy.6800027; Rodriguez-Gonzalez A, 2015, INT J PARASITOL, V45, P295, DOI 10.1016/j.ijpara.2015.01.005; Rohlf FJ, TPS SERIES; Rubtsova NY, 2006, J PARASITOL, V92, P486, DOI 10.1645/GE-747R.1; Sanchez-Garcia N, 2011, AQUACULTURE, V318, P290, DOI 10.1016/j.aquaculture.2011.05.021; Santos M, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-7; Sarabeev V., 2013, Vestnik Zoologii Supplement, V28, P1; Slice DE, 2007, ANNU REV ANTHROPOL, V36, P261, DOI 10.1146/annurev.anthro.34.081804.120613; Soria Garcia J.M., 2006, Limnetica, V25, P135; Soria J.M., 2000, VERH INT VER LIMNOL, V27, P2232, DOI DOI 10.1080/03680770.1998.11901635; Vignon M, 2011, ZOOL SCR, V40, P306, DOI 10.1111/j.1463-6409.2011.00470.x; Vignon M, 2011, BIOL J LINN SOC, V102, P694, DOI 10.1111/j.1095-8312.2010.01607.x; Vignon M, 2010, PARASITOL INT, V59, P183, DOI 10.1016/j.parint.2010.01.006; Viscosi V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025630; Weisberg S, COMPANION TO APPLIED; Willmore KE, 2007, EVOL BIOL, V34, P99, DOI 10.1007/s11692-007-9008-1; Wong WL, 2013, J EXP BIOL, V216, P3008, DOI 10.1242/jeb.076190; Yonehara Y, 2011, THE SECOND INTERNATI, P1; Zelditch ML, 2012, GEOMETRIC MORPHOMETRICS FOR BIOLOGISTS: A PRIMER, 2ND EDITION, P353, DOI 10.1016/B978-0-12-386903-6.00012-5	53	5	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142365	10.1371/journal.pone.0142365	http://dx.doi.org/10.1371/journal.pone.0142365			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544190	Green Published, Green Submitted, gold			2022-12-27	WOS:000364398700118
J	Schauperl, M; Fuchs, JE; Waldner, BJ; Huber, RG; Kramer, C; Liedl, KR				Schauperl, Michael; Fuchs, Julian E.; Waldner, Birgit J.; Huber, Roland G.; Kramer, Christian; Liedl, Klaus R.			Characterizing Protease Specificity: How Many Substrates Do We Need?	PLOS ONE			English	Article							RECOGNIZE BETA-STRANDS; ENTROPY; ESTIMATORS; MECHANISM; LIBRARIES; DATABASE; EVENTS; SITES	Calculation of cleavage entropies allows to quantify, map and compare protease substrate specificity by an information entropy based approach. The metric intrinsically depends on the number of experimentally determined substrates (data points). Thus a statistical analysis of its numerical stability is crucial to estimate the systematic error made by estimating specificity based on a limited number of substrates. In this contribution, we show the mathematical basis for estimating the uncertainty in cleavage entropies. Sets of cleavage entropies are calculated using experimental cleavage data and modeled extreme cases. By analyzing the underlying mathematics and applying statistical tools, a linear dependence of the metric in respect to 1/n was found. This allows us to extrapolate the values to an infinite number of samples and to estimate the errors. Analyzing the errors, a minimum number of 30 substrates was found to be necessary to characterize substrate specificity, in terms of amino acid variability, for a protease (S4-S4') with an uncertainty of 5 percent. Therefore, we encourage experimental researchers in the protease field to record specificity profiles of novel proteases aiming to identify at least 30 peptide substrates of maximum sequence diversity. We expect a full characterization of protease specificity helpful to rationalize biological functions of proteases and to assist rational drug design.	[Fuchs, Julian E.] Univ Innsbruck, Inst Gen Inorgan & Theoret Chem, A-6020 Innsbruck, Tyrol, Austria; Univ Innsbruck, Ctr Mol Biosci Innsbruck, A-6020 Innsbruck, Tyrol, Austria	University of Innsbruck; University of Innsbruck	Fuchs, JE (corresponding author), Univ Innsbruck, Inst Gen Inorgan & Theoret Chem, Innrain 80-82, A-6020 Innsbruck, Tyrol, Austria.	Julian.Fuchs@uibk.ac.at	Liedl, Klaus R/F-3099-2015; Huber, Roland G/AAG-6353-2019; Liedl, Klaus/ABB-4725-2021; Schauperl, Michael/D-7104-2018	Liedl, Klaus R/0000-0002-0985-2299; Huber, Roland G/0000-0001-5093-5988; Liedl, Klaus/0000-0002-0985-2299; Schauperl, Michael/0000-0001-5648-8170	Austrian Science Fund FWF [P23051, P26997]; Austrian Academy of Sciences (OEAW); Austrian Science Fund (FWF) [P 23051] Funding Source: researchfish	Austrian Science Fund FWF(Austrian Science Fund (FWF)); Austrian Academy of Sciences (OEAW); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported in part by the Austrian Science Fund FWF via the grants P23051 "Targeting Influenza Neuraminidase" and P26997 "Influence of Protein Folding on Allergenicity and Immunogenicity". BJW is thankful to the Austrian Academy of Sciences (OEAW) for being a recipient of the DOC-grant for the project "Molecular Determinants of Serine Protease Specificity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonachela JA, 2008, J PHYS A, V41, P9; Boulware KT, 2006, P NATL ACAD SCI USA, V103, P7583, DOI 10.1073/pnas.0511108103; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; Diamond SL, 2007, CURR OPIN CHEM BIOL, V11, P46, DOI 10.1016/j.cbpa.2006.11.021; Drag M, 2010, NAT REV DRUG DISCOV, V9, P690, DOI 10.1038/nrd3053; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Fortelny N, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001869; Fuchs JE, 2014, PROTEINS, V82, P546, DOI 10.1002/prot.24417; Fuchs JE, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003353; Fuchs JE, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003007; GRASSBERGER P, 1988, PHYS LETT A, V128, P369, DOI 10.1016/0375-9601(88)90193-4; Grassberger P., 2003, ARXIV; Griffin MA, 2013, BIOCHEMISTRY-US, V52, P8633, DOI 10.1021/bi401325c; GYORFI L, 1987, COMPUT STAT DATA AN, V5, P425, DOI 10.1016/0167-9473(87)90065-X; Gyorfi L., 1997, INT J MATH STAT SCI, V6, P17; Harris JL, 2000, P NATL ACAD SCI USA, V97, P7754, DOI 10.1073/pnas.140132697; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Hedstrom L, 2002, CHEM REV, V102, P4429, DOI 10.1021/cr0101712; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; HERZEL H, 1995, PHYSICA A, V216, P518, DOI 10.1016/0378-4371(95)00104-F; Holste D, 1998, J PHYS A-MATH GEN, V31, P2551, DOI 10.1088/0305-4470/31/11/007; Igarashi Y, 2007, NUCLEIC ACIDS RES, V35, pD546, DOI 10.1093/nar/gkl813; Igarashi Y, 2009, NUCLEIC ACIDS RES, V37, pD611, DOI 10.1093/nar/gkn683; Ilya Nemenman FS, 2002, ADV NEURAL INFORM PR, P14; Ji HK, 2010, NAT BIOTECHNOL, V28, P337, DOI 10.1038/nbt.1619; Kielbasa SM, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-237; KOLMOGOROV AN, 1983, LECT NOTES MATH, V1021, P1; Madala PK, 2010, CHEM REV, V110, pPR1, DOI 10.1021/cr900368a; Mahrus S, 2008, CELL, V134, P866, DOI 10.1016/j.cell.2008.08.012; MATTHEWS DJ, 1993, SCIENCE, V260, P1113, DOI 10.1126/science.8493554; MCCALDON P, 1988, PROTEINS, V4, P99, DOI 10.1002/prot.340040204; Meissner F, 2014, NAT IMMUNOL, V15, P112, DOI 10.1038/ni.2781; Miller GA., 1955, NOTE BIAS INFORM EST, P95; MULLEREBERHARD HJ, 1988, ANNU REV BIOCHEM, V57, P321, DOI 10.1146/annurev.biochem.57.1.321; Nar H, 2001, STRUCTURE, V9, P29, DOI 10.1016/S0969-2126(00)00551-7; Nemenman I, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.056111; O'Donoghue AJ, 2012, NAT METHODS, V9, P1095, DOI [10.1038/NMETH.2182, 10.1038/nmeth.2182]; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Poreba M, 2010, CURR MED CHEM, V17, P3968, DOI 10.2174/092986710793205381; Poschel T, 2003, EUR PHYS J E, V12, P531, DOI 10.1140/epje/e2004-00025-4; Puente XS, 2005, BIOCHEM SOC T, V33, P331, DOI 10.1042/BST0330331; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Rawlings ND, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap015; Richter C, 1998, BIOCHEM J, V335, P481, DOI 10.1042/bj3350481; Roulston MS, 1999, PHYSICA D, V125, P285, DOI 10.1016/S0167-2789(98)00269-3; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Schilling O, 2008, NAT BIOTECHNOL, V26, P685, DOI 10.1038/nbt1408; SCHMITT AO, 1993, EUROPHYS LETT, V23, P303, DOI 10.1209/0295-5075/23/5/001; Schmitt AO, 1997, J THEOR BIOL, V188, P369, DOI 10.1006/jtbi.1997.0493; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Schurmann T, 1996, CHAOS, V6, P414, DOI 10.1063/1.166191; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; TARASENKO FP, 1968, PR INST ELECTR ELECT, V56, P2052, DOI 10.1109/PROC.1968.6784; Turk BE, 2001, NAT BIOTECHNOL, V19, P661, DOI 10.1038/90273; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Tyndall JDA, 2005, CHEM REV, V105, P973, DOI 10.1021/cr040669e; Wagner AB, 2011, IEEE T INFORM THEORY, V57, P3207, DOI 10.1109/TIT.2011.2137210; Wolfram Research Inc, 2015, MATH VERS 10 1	58	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142658	10.1371/journal.pone.0142658	http://dx.doi.org/10.1371/journal.pone.0142658			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559682	Green Submitted, Green Published, gold			2022-12-27	WOS:000364433100106
J	Alonso, N; Julian, MT; Carrascal, J; Colobran, R; Pujol-Autonell, I; Rodriguez-Fernandez, S; Tenlente, A; Fernandez, MA; Minarro, A; de Villa, MCR; Vives-Pi, M; Puig-Domingo, M				Alonso, Nuria; Julian, Maria Teresa; Carrascal, Jorge; Colobran, Roger; Pujol-Autonell, Irma; Rodriguez-Fernandez, Silvia; Tenlente, Aina; Fernandez, Marco Antonio; Minarro, Antoni; Ruiz de Villa, Maria Carmen; Vives-Pi, Marta; Puig-Domingo, Manel			Type 1 Diabetes Prevention in NOD Mice by Targeting DPPIV/CD26 Is Associated with Changes in CD8(+)T Effector Memory Subset	PLOS ONE			English	Article							DIPEPTIDYL PEPTIDASE-IV; ANTIGEN-PRESENTING CELLS; ISLET GRAFT-SURVIVAL; REGULATORY T-CELLS; CD26 EXPRESSION; CD8+T CELLS; MOUSE MODEL; INHIBITORS; LYMPHOCYTES; MECHANISMS	CD26 is a T cell activation marker consisting in a type II transmembrane glycoprotein with dipeptidyl peptidase IV (DPPIV) activity in its extracellular domain. It has been described that DPPIV inhibition delays the onset of type 1 diabetes and reverses the disease in nonobese diabetic (NOD) mice. The aim of the present study was to assess the effect of MK626, a DPPIV inhibitor, in type 1 diabetes incidence and in T lymphocyte subsets at central and peripheral compartments. Pre-diabetic NOD mice were treated with MK626. Diabetes incidence, insulitis score, and phenotyping of T lymphocytes in the thymus, spleen and pancreatic lymph nodes were determined after 4 and 6 weeks of treatment, as well as alterations in the expression of genes encoding beta-cell autoantigens in the islets. The effect of MK626 was also assessed in two in vitro assays to determine proliferative and immunosuppressive effects. Results show that MK626 treatment reduces type 1 diabetes incidence and after 6 weeks of treatment reduces insulitis. No differences were observed in the percentage of T lymphocyte subsets from central and peripheral compartments between treated and control mice. MK626 increased the expression of CD26 in CD8(+) T effector memory (TEM) from spleen and pancreatic lymph nodes and in CD8(+) T cells from islet infiltration. CD8(+) TEM cells showed an increased proliferation rate and cytokine secretion in the presence of MK626. Moreover, the combination of CD8(+) TEM cells and MK626 induces an immunosuppressive response. In conclusion, treatment with the DPPIV inhibitor MK626 prevents experimental type 1 diabetes in association to increase expression of CD26 in the CD8(+) TEM lymphocyte subset. In vitro assays suggest an immunoregulatory role of CD8(+) TEM cells that may be involved in the protection against autoimmunity to beta pancreatic islets associated to DPPIV inhibitor treatment.	[Alonso, Nuria; Julian, Maria Teresa; Puig-Domingo, Manel] Hosp Badalona Germans Trias & Pujol, Dept Endocrinol & Nutr, Badalona, Spain; [Alonso, Nuria; Julian, Maria Teresa; Puig-Domingo, Manel] Autonomous Univ Barcelona, Dept Med, Barcelona, Spain; [Carrascal, Jorge; Pujol-Autonell, Irma; Rodriguez-Fernandez, Silvia; Tenlente, Aina; Vives-Pi, Marta] Autonomous Univ Barcelona, Germans Trias & Pujol Res Inst, Dept Immunol, Badalona, Spain; [Colobran, Roger] Vall dHebron Univ Hosp, Vall dHebron Res Inst, Serv Immunol, Barcelona, Spain; [Fernandez, Marco Antonio] Germans Trias & Pujol Res Inst, Cytometry Unit, Badalona, Spain; [Minarro, Antoni; Ruiz de Villa, Maria Carmen] Univ Barcelona, Fac Biol, Dept Stat, Barcelona, Spain; [Alonso, Nuria; Vives-Pi, Marta; Puig-Domingo, Manel] Inst Salud Carlos III ISCIII, GIBER Diabet & Associated Metab Dis CIBERDEM, Madrid, Spain	Hospital Germans Trias i Pujol; Autonomous University of Barcelona; Autonomous University of Barcelona; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM	Alonso, N (corresponding author), Hosp Badalona Germans Trias & Pujol, Dept Endocrinol & Nutr, Badalona, Spain.	naionso32416@yahoo.es	Vives-Pi, Marta/AAM-8158-2020; Julian, Maria Teresa/AAD-7906-2020; Fernandez, Marco/R-3964-2019; Miñarro, Antonio/G-1740-2015; Pedrol, Nuria Alonso/AAA-8987-2021; Julián, María Teresa/AAY-4138-2020; Colobran, Roger/HGB-6371-2022; Puig-Domingo, Manel/S-2169-2019	Vives-Pi, Marta/0000-0003-3735-0779; Fernandez, Marco/0000-0002-3921-2209; Miñarro, Antonio/0000-0001-7747-5299; Pedrol, Nuria Alonso/0000-0001-9687-8050; Julián, María Teresa/0000-0003-2524-1823; Puig-Domingo, Manel/0000-0002-6744-7195; Teniente Serra, Aina/0000-0003-3440-804X; Alonso, Nuria/0000-0001-5844-2221; Rodriguez-Fernandez, Silvia/0000-0001-8429-4293; Colobran, Roger/0000-0002-5964-536X	European Foundation for the Study of Diabetes; Fondo de Investigaciones Sanitarias of the Carlos III Institute of Health [PI 1102621]; Spanish Society of Endocrinology; Carlos III Institute of Health [PI 1102621]	European Foundation for the Study of Diabetes; Fondo de Investigaciones Sanitarias of the Carlos III Institute of Health; Spanish Society of Endocrinology; Carlos III Institute of Health(Instituto de Salud Carlos III)	This work was supported by grants from European Foundation for the Study of Diabetes, the Fondo de Investigaciones Sanitarias (PI 1102621) of the Carlos III Institute of Health as well as the Spanish Society of Endocrinology. JC was supported by a grant from Carlos III Institute of Health (PI 1102621). The funders had no role in study design, data collection and analysis, decision to publish, or preparation the manuscript.	Atkinson MA, 1999, NAT MED, V5, P601, DOI 10.1038/9442; ATKINSON MA, 1994, NEW ENGL J MED, V331, P1428; Biton A, 2011, IMMUNOBIOLOGY, V216, P1295, DOI 10.1016/j.imbio.2011.07.001; Boonacker E, 2003, EUR J CELL BIOL, V82, P53, DOI 10.1078/0171-9335-00302; Boonacker EP, 2002, J HISTOCHEM CYTOCHEM, V50, P1169, DOI 10.1177/002215540205000903; BREZINSCHEK RI, 1995, J IMMUNOL, V154, P3062; Cabrera SM, 2013, CLIN EXP IMMUNOL, V172, P375, DOI 10.1111/cei.12068; Cho JM, 2011, DIABETES RES CLIN PR, V91, P72, DOI 10.1016/j.diabres.2010.10.012; Ding L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107935; Endharti AT, 2005, J IMMUNOL, V175, P7093, DOI 10.4049/jimmunol.175.11.7093; Guleria I, 2007, CLIN IMMUNOL, V125, P16, DOI 10.1016/j.clim.2007.05.013; Hatano R, 2013, IMMUNOLOGY, V138, P165, DOI 10.1111/imm.12028; Ibegbu CC, 2009, IMMUNOLOGY, V126, P346, DOI 10.1111/j.1365-2567.2008.02899.x; Jelsing J, 2012, J ENDOCRINOL, V214, P381, DOI 10.1530/JOE-11-0479; Jurczyk A, 2013, DIABETES METAB SYNDR, V6, P493, DOI 10.2147/DMSO.S53154; Kim SC, 2015, ANN RHEUM DIS, V74, P1968, DOI 10.1136/annrheumdis-2014-205216; Kim SJ, 2008, DIABETES, V57, P1331, DOI 10.2337/db07-1639; Kim SJ, 2010, DIABETES, V59, P1739, DOI 10.2337/db09-1618; Kim SJ, 2009, DIABETES, V58, P641, DOI 10.2337/db08-1101; Klemann C, 2009, CLIN EXP IMMUNOL, V155, P357, DOI 10.1111/j.1365-2249.2008.03839.x; Lee SA, 2013, J CLIN ENDOCR METAB, V98, P2553, DOI 10.1210/jc.2012-4288; Li DS, 2009, NAT PROTOC, V4, P1649, DOI 10.1038/nprot.2009.150; Li SS, 2014, CELL MOL IMMUNOL, V11, P326, DOI 10.1038/cmi.2014.25; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Makdissi A, 2012, J CLIN ENDOCR METAB, V97, P3333, DOI 10.1210/jc.2012-1544; Matteucci E, 2010, SCAND J IMMUNOL, V71, P123, DOI 10.1111/j.1365-3083.2009.02357.x; Matteucci E, 2011, J CLIN IMMUNOL, V31, P977, DOI 10.1007/s10875-011-9573-z; Ohnuma K, 2004, P NATL ACAD SCI USA, V101, P14186, DOI 10.1073/pnas.0405266101; Ohnuma K, 2008, TRENDS IMMUNOL, V29, P295, DOI 10.1016/j.it.2008.02.010; Petrelli A, 2011, DIABETES, V60, P3223, DOI 10.2337/db11-0880; Pospisilik JA, 2003, DIABETES, V52, P741, DOI 10.2337/diabetes.52.3.741; Pujol-Autonell I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063296; Reinhold D, 1998, J NEUROIMMUNOL, V87, P203, DOI 10.1016/S0165-5728(98)00100-3; Ruiz P, 1996, CYTOMETRY, V23, P322, DOI 10.1002/(SICI)1097-0320(19960401)23:4<322::AID-CYTO8>3.0.CO;2-I; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Serreze DV, 1998, J IMMUNOL, V161, P3912; Shameli A, 2011, J IMMUNOL, V187, P2859, DOI 10.4049/jimmunol.1101117; Simeoni L, 2002, HUM IMMUNOL, V63, P719, DOI 10.1016/S0198-8859(02)00433-0; Steinbrecher A, 2001, J IMMUNOL, V166, P2041, DOI 10.4049/jimmunol.166.3.2041; Suzuki H, 2008, HUM IMMUNOL, V69, P751, DOI 10.1016/j.humimm.2008.08.285; Suzuki M, 2008, HUM IMMUNOL, V69, P781, DOI 10.1016/j.humimm.2008.08.283; TANAKA T, 1993, P NATL ACAD SCI USA, V90, P4586, DOI 10.1073/pnas.90.10.4586; TANAKA T, 1992, J IMMUNOL, V149, P481; Tian L, 2010, ENDOCRINOLOGY, V151, P3049, DOI 10.1210/en.2010-0068; Tsai S, 2008, ADV IMMUNOL, V100, P79, DOI 10.1016/S0065-2776(08)00804-3; Varga T, 2011, PATHOL ONCOL RES, V17, P925, DOI 10.1007/s12253-011-9404-9; Vergani A, 2010, DIABETES, V59, P2253, DOI 10.2337/db09-1264; Yamazaki H, 2012, BIOCHEM BIOPH RES CO, V138, P165; Yin H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065777; Zhang X, 2011, DIABETES OBES METAB, V13, P337, DOI 10.1111/j.1463-1326.2010.01354.x; Zhao YJ, 2014, DIABETES-METAB RES, V30, P646, DOI 10.1002/dmrr.2530; Zhao YJ, 2014, J CLIN ENDOCR METAB, V99, pE876, DOI 10.1210/jc.2013-3633	52	9	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142186	10.1371/journal.pone.0142186	http://dx.doi.org/10.1371/journal.pone.0142186			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555789	Green Published, Green Submitted, gold			2022-12-27	WOS:000364430700066
J	Botwe, PK; Barmuta, LA; Magierowski, R; McEvoy, P; Goonan, P; Carver, S				Botwe, Paul K.; Barmuta, Leon A.; Magierowski, Regina; McEvoy, Paul; Goonan, Peter; Carver, Scott			Temporal Patterns and Environmental Correlates of Macroinvertebrate Communities in Temporary Streams	PLOS ONE			English	Article							LAND-USE; WESTERN-AUSTRALIA; WHEAT-BELT; ASSEMBLAGES; RIVER; CONNECTIVITY; DIVERSITY; IMPACTS; BIOASSESSMENT; COLONIZATION	Temporary streams are characterised by short periods of seasonal or annual stream flow after which streams contract into waterholes or pools of varying hydrological connectivity and permanence. Although these streams are widespread globally, temporal variability of their ecology is understudied, and understanding the processes that structure community composition in these systems is vital for predicting and managing the consequences of anthropogenic impacts. We used multivariate and univariate approaches to investigate temporal variability in macroinvertebrate compositional data from 13 years of sampling across multiple sites from autumn and spring, in South Australia, the driest state in the driest inhabited continent in the world. We examined the potential of land-use, geographic and environmental variables to predict the temporal variability in macroinvertebrate assemblages, and also identified indicator taxa, that is, those highly correlated with the most significantly associated physical variables. Temporal trajectories of macroinvertebrate communities varied within site in both seasons and across years. A combination of land-use, geographic and environmental variables accounted for 24% of the variation in community structure in autumn and 27% in spring. In autumn, community composition among sites were more closely clustered together relative to spring suggesting that communities were more similar in autumn than in spring. In both seasons, community structure was most strongly correlated with conductivity and latitude, and community structure was more associated with cover by agriculture than urban land-use. Maintaining temporary streams will require improved catchment management aimed at sustaining seasonal flows and critical refuge habitats, while also limiting the damaging effects from increased agriculture and urban developments.	[Botwe, Paul K.; Barmuta, Leon A.; Magierowski, Regina; Carver, Scott] Univ Tasmania, Sch Biol Sci, Hobart, Tas, Australia; [Magierowski, Regina] La Trobe Univ, Dept Ecol Environm & Evolut, Melbourne, Vic, Australia; [McEvoy, Paul] Dept Environm Water & Nat Resources, Adelaide, SA, Australia; [Goonan, Peter] South Australia Environm Protect Author, Dept Environm, Adelaide, SA, Australia	University of Tasmania; La Trobe University	Botwe, PK (corresponding author), Univ Tasmania, Sch Biol Sci, Hobart, Tas, Australia.	Paul.Botwe@utas.edu.au	Carver, Scott/J-7654-2014; Barmuta, Leon/J-2413-2013; Botwe, Paul/R-5709-2019; Magierowski, Regina/B-4588-2013	Carver, Scott/0000-0002-3579-7588; Barmuta, Leon/0000-0002-8946-3727; Magierowski, Regina/0000-0002-7547-8549; Botwe, Paul K./0000-0002-0300-2736	Holsworth Wildlife Research Endowment	Holsworth Wildlife Research Endowment	Funding: Holsworth Wildlife Research Endowment (http://www.eqt.com.au/not-for-profit-organisations/confirmed-2015-programs/holsworth-grants.aspx) funded this research. PKB received this funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan JD, 2004, ANNU REV ECOL EVOL S, V35, P257, DOI 10.1146/annurev.ecolsys.35.120202.110122; Amoros C, 2002, FRESHWATER BIOL, V47, P761, DOI 10.1046/j.1365-2427.2002.00905.x; BELBIN L, 1991, J VEG SCI, V2, P491, DOI 10.2307/3236031; Berk RA, 2003, ADVANCED QUANTITATIV, V11; Blanchette ML, 2013, FRESHWATER BIOL, V58, P742, DOI 10.1111/fwb.12080; Blanchette ML, 2012, FRESHW SCI, V31, P865, DOI 10.1899/11-068.1; Boulton AJ, 2003, FRESHWATER BIOL, V48, P1173, DOI 10.1046/j.1365-2427.2003.01084.x; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Carver S, 2009, ENVIRON ENTOMOL, V38, P1585, DOI 10.1603/022.038.0609; Chessman BC, 2004, J N AM BENTHOL SOC, V23, P599, DOI 10.1899/0887-3593(2004)023&lt;0599:BWRSUO&gt;2.0.CO;2; Chessman BC, 2010, FRESHWATER BIOL, V55, P1780, DOI 10.1111/j.1365-2427.2010.02403.x; Clarke K.R., 2001, CHANGE IN MARINE COM; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; Collier KJ, 2008, FRESHWATER BIOL, V53, P603, DOI 10.1111/j.1365-2427.2007.01923.x; Davies PE, 2000, DEVELOPMENT OF A NAT; Eng K, 2016, RIVER RES APPL, V32, P885, DOI 10.1002/rra.2939; Gorley C.K., 2006, GETTING STARTED PRIM; Heino J, 2007, FRESHWATER BIOL, V52, P1846, DOI 10.1111/j.1365-2427.2007.01801.x; Johnson LB, 2010, J N AM BENTHOL SOC, V29, P41, DOI 10.1899/09-030.1; Kefford BJ, 2011, ENVIRON POLLUT, V159, P302, DOI 10.1016/j.envpol.2010.08.025; Lake PS, 2007, FRESHWATER BIOL, V52, P597, DOI 10.1111/j.1365-2427.2006.01709.x; Larned ST, 2010, FRESHWATER BIOL, V55, P717, DOI 10.1111/j.1365-2427.2009.02322.x; Laut P, 1977, COMMONWEALTH SCIENTI; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Leigh C, 2009, FRESHWATER BIOL, V54, P549, DOI 10.1111/j.1365-2427.2008.02130.x; Leigh C, 2016, FRESHWATER BIOL, V61, P1181, DOI 10.1111/fwb.12646; Magierowski RH, 2012, MAR FRESHWATER RES, V63, P762, DOI 10.1071/MF11267; Magurran A. E, 2013, MEASURING BIOLOGICAL; MALMQVIST B, 1994, ECOGRAPHY, V17, P9, DOI 10.1111/j.1600-0587.1994.tb00072.x; MARGALEF R, 1958, SCIENTIA, V93, P41; Marshall JC, 2006, MAR FRESHWATER RES, V57, P61, DOI 10.1071/MF05021; Mason NWH, 2013, J VEG SCI, V24, P777, DOI 10.1111/jvs.12097; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; McRae SE, 2004, FRESHWATER BIOL, V49, P127, DOI 10.1046/j.1365-2426.2003.01165.x; Norris RH, 2007, FRESHWATER BIOL, V52, P959, DOI 10.1111/j.1365-2427.2006.01701.x; Oksanen J., 2017, COMMUNITY ECOLOGY PA; PIELOU EC, 1966, J THEOR BIOL, V13, P131, DOI 10.1016/0022-5193(66)90013-0; Pinder AM, 2005, HYDROBIOLOGIA, V543, P1, DOI 10.1007/s10750-004-5712-3; R Core Team, 2013, R LANG ENV STAT COMP; Raupach MR, 2012, AUSTRALIAN WATER AVA; Raupach MR, 2009, CAWCR TECHNICAL REPO; Reid DJ, 2013, AQUAT SCI, V75, P285, DOI 10.1007/s00027-012-0273-4; Rose P, 2008, FRESHWATER BIOL, V53, P2626, DOI 10.1111/j.1365-2427.2008.02074.x; Sheldon F, 2006, RIVER RES APPL, V22, P219, DOI 10.1002/rra.907; Sheldon F, 2005, HYDROBIOLOGIA, V552, P45, DOI 10.1007/s10750-005-1504-7; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Simpson JC, 2000, BIOLOGICAL ASSESSMEN; Somerfield PJ, 2000, MAR BIOL, V136, P1133, DOI 10.1007/s002270000311; Steel E. A., 2010, Living Reviews in Landscape Research, V4; Tooth S, 2000, EARTH-SCI REV, V51, P67, DOI 10.1016/S0012-8252(00)00014-3; UNDERWOOD AJ, 1988, MAR ECOL PROG SER, V46, P227, DOI 10.3354/meps046227; Warfe DM, 2013, FRESHWATER BIOL, V58, P292, DOI 10.1111/fwb.12058	52	11	11	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142370	10.1371/journal.pone.0142370	http://dx.doi.org/10.1371/journal.pone.0142370			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556711	Green Submitted, Green Published, gold			2022-12-27	WOS:000364430700092
J	Clark, PJ; Amat, J; McConnell, SO; Ghasem, PR; Greenwood, BN; Maier, SF; Fleshner, M				Clark, Peter J.; Amat, Jose; McConnell, Sara O.; Ghasem, Parsa R.; Greenwood, Benjamin N.; Maier, Steven F.; Fleshner, Monika			Running Reduces Uncontrollable Stress-Evoked Serotonin and Potentiates Stress-Evoked Dopamine Concentrations in the Rat Dorsal Striatum	PLOS ONE			English	Article							ALTER EXTRACELLULAR LEVELS; RAPHE NUCLEUS; LEARNED HELPLESSNESS; DORSOMEDIAL STRIATUM; AEROBIC FITNESS; HABIT FORMATION; EXERCISE; BRAIN; DEPRESSION; RECEPTORS	Accumulating evidence from both the human and animal literature indicates that exercise reduces the negative consequences of stress. The neurobiological etiology for this stress protection, however, is not completely understood. Our lab reported that voluntary wheel running protects rats from expressing depression-like instrumental learning deficits on the shuttle box escape task after exposure to unpredictable and inescapable tail shocks (uncontrollable stress). Impaired escape behavior is a result of stress-sensitized serotonin (5-HT) neuron activity in the dorsal raphe (DRN) and subsequent excessive release of 5-HT into the dorsal striatum following exposure to a comparatively mild stressor. However, the possible mechanisms by which exercise prevents stress-induced escape deficits are not well characterized. The purpose of this experiment was to test the hypothesis that exercise blunts the stress-evoked release of 5-HT in the dorsal striatum. Changes to dopamine (DA) levels were also examined, since striatal DA signaling is critical for instrumental learning and can be influenced by changes to 5-HT activity. Adult male F344 rats, housed with or without running wheels for 6 weeks, were either exposed to tail shock or remained undisturbed in laboratory cages. Twenty-four hours later, microdialysis was performed in the medial (DMS) and lateral (DLS) dorsal striatum to collect extracellular 5-HT and DA before, during, and following 2 mild foot shocks. We report wheel running prevents foot shock-induced elevation of extracellular 5-HT and potentiates DA concentrations in both the DMS and DLS approximately 24 h following exposure to uncontrollable stress. These data may provide a possible mechanism by which exercise prevents depression-like instrumental learning deficits following exposure to acute stress.	[Clark, Peter J.; McConnell, Sara O.; Ghasem, Parsa R.; Fleshner, Monika] Univ Colorado, Integrat Physiol, Boulder, CO 80309 USA; [Amat, Jose; Maier, Steven F.] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA; [Greenwood, Benjamin N.] Univ Colorado, Dept Psychol, Denver, CO 80217 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Denver	Clark, PJ (corresponding author), Univ Colorado, Integrat Physiol, 354 UCB, Boulder, CO 80309 USA.	peter.clark@nih.gov		Fleshner, Monika/0000-0002-0470-0827	NIH [RO1MH068283]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH068283] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Experiments completed in this manuscript were funded by NIH RO1MH068283.	Alex KD, 2005, SYNAPSE, V55, P242, DOI 10.1002/syn.20109; Amat J, 1998, BRAIN RES, V797, P12, DOI 10.1016/S0006-8993(98)00368-0; Amat J, 1998, BRAIN RES, V812, P113, DOI 10.1016/S0006-8993(98)00960-3; AZMITIA EC, 1978, J COMP NEUROL, V179, P641, DOI 10.1002/cne.901790311; Balleine BW, 2009, BEHAV BRAIN RES, V199, P43, DOI 10.1016/j.bbr.2008.10.034; BLOMSTRAND E, 1989, ACTA PHYSIOL SCAND, V136, P473, DOI 10.1111/j.1748-1716.1989.tb08689.x; CHAOULOFF F, 1987, NEUROPHARMACOLOGY, V26, P1099, DOI 10.1016/0028-3908(87)90254-1; CHAOULOFF F, 1989, ACTA PHYSIOL SCAND, V137, P1, DOI 10.1111/j.1748-1716.1989.tb08715.x; Christianson JP, 2008, BEHAV BRAIN RES, V193, P87, DOI 10.1016/j.bbr.2008.04.024; Christianson JP, 2010, BIOL PSYCHIAT, V67, P339, DOI 10.1016/j.biopsych.2009.09.011; CREWS DJ, 1987, MED SCI SPORT EXER, V19, pS114; Davis JM, 2000, AM J CLIN NUTR, V72, p573S, DOI 10.1093/ajcn/72.2.573S; De Deurwaerdere P, 1998, J NEUROSCI, V18, P6528; Di Giovanni G, 2010, CNS NEUROSCI THER, V16, P179, DOI 10.1111/j.1755-5949.2010.00135.x; Di Giovanni G, 2008, PROG BRAIN RES, V172, P45, DOI 10.1016/S0079-6123(08)00903-5; Dias-Ferreira E, 2009, SCIENCE, V325, P621, DOI 10.1126/science.1171203; Dishman RK, 1998, PHYSIOL BEHAV, V63, P911, DOI 10.1016/S0031-9384(98)00017-1; Dishman RK, 2006, OBESITY, V14, P345, DOI 10.1038/oby.2006.46; Faure A, 2005, J NEUROSCI, V25, P2771, DOI 10.1523/JNEUROSCI.3894-04.2005; Foley TE, 2008, NEUROMOL MED, V10, P67, DOI 10.1007/s12017-008-8032-3; Gervais J, 2000, SYNAPSE, V35, P281, DOI 10.1002/(SICI)1098-2396(20000315)35:4<281::AID-SYN6>3.0.CO;2-A; Goekint M, 2012, J APPL PHYSIOL, V112, P535, DOI 10.1152/japplphysiol.00306.2011; Grahn RE, 1999, BRAIN RES, V826, P35, DOI 10.1016/S0006-8993(99)01208-1; Greenwood BN, 2008, NEUROMOL MED, V10, P81, DOI 10.1007/s12017-008-8029-y; Greenwood BN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046118; Greenwood BN, 2012, BEHAV BRAIN RES, V233, P314, DOI 10.1016/j.bbr.2012.05.017; Greenwood BN, 2011, EXERC SPORT SCI REV, V39, P140, DOI 10.1097/JES.0b013e31821f7e45; Greenwood BN, 2011, BEHAV BRAIN RES, V217, P354, DOI 10.1016/j.bbr.2010.11.005; Greenwood BN, 2005, BIOL PSYCHIAT, V57, P559, DOI 10.1016/j.biopsych.2004.11.025; Greenwood BN, 2005, BRAIN RES, V1033, P164, DOI 10.1016/j.brainres.2004.11.037; Greenwood BN, 2003, J NEUROSCI, V23, P2889; Heninger GR, 1996, PHARMACOPSYCHIATRY, V29, P2, DOI 10.1055/s-2007-979535; Lacasse JR, 2005, PLOS MED, V2, P1211, DOI 10.1371/journal.pmed.0020392; Lex B, 2010, CEREB CORTEX, V20, P873, DOI 10.1093/cercor/bhp151; Maier SF, 2005, NEUROSCI BIOBEHAV R, V29, P829, DOI 10.1016/j.neubiorev.2005.03.021; MAIER SF, 1995, BEHAV NEUROSCI, V109, P404, DOI 10.1037/0735-7044.109.3.404; Maroteaux M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081868; Maswood S, 1998, BRAIN RES, V783, P115, DOI 10.1016/S0006-8993(97)01313-9; Nutt DJ, 2006, J CLIN PSYCHIAT, V67, P3; Nutt DJ, 2005, CNS SPECTRUMS, V10, P49, DOI 10.1017/S1092852900009901; Olvera-Cortes ME, 2008, PROGRESS IN BRAIN RE, V172, P567, DOI [10.1016/S0079-6123(08)00927-8, DOI 10.1016/S0079-6123(08)00927-8]; Rimmele U, 2007, PSYCHONEUROENDOCRINO, V32, P627, DOI 10.1016/j.psyneuen.2007.04.005; Rozeske RR, 2011, J NEUROSCI, V31, P14107, DOI 10.1523/JNEUROSCI.3095-11.2011; Rozeske RR, 2011, BEHAV BRAIN RES, V219, P378, DOI 10.1016/j.bbr.2011.01.030; Schwabe L, 2011, BEHAV BRAIN RES, V219, P321, DOI 10.1016/j.bbr.2010.12.038; Shiflett MW, 2010, J NEUROSCI, V30, P2951, DOI 10.1523/JNEUROSCI.1778-09.2010; SINYOR D, 1983, PSYCHOSOM MED, V45, P205, DOI 10.1097/00006842-198306000-00003; Strong PV, 2011, NEUROSCIENCE, V197, P132, DOI 10.1016/j.neuroscience.2011.09.041; van Praag H, 2014, J NEUROSCI, V34, P15139, DOI 10.1523/JNEUROSCI.2814-14.2014; Wickens JR, 2007, J NEUROSCI, V27, P8181, DOI 10.1523/JNEUROSCI.1671-07.2007; Yin HH, 2005, EUR J NEUROSCI, V22, P513, DOI 10.1111/j.1460-9568.2005.04218.x; Yin HH, 2004, EUR J NEUROSCI, V19, P181, DOI 10.1111/j.1460-9568.2004.03095.x	52	28	29	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0141898	10.1371/journal.pone.0141898	http://dx.doi.org/10.1371/journal.pone.0141898			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555633	Green Published, Green Submitted, gold			2022-12-27	WOS:000364430700044
J	Groen, BBL; Horstman, AM; Hamer, HM; de Haan, M; van Kranenburg, J; Bierau, J; Poeze, M; Wodzig, WKWH; Rasmussen, BB; van Loon, LJC				Groen, Bart B. L.; Horstman, Astrid M.; Hamer, Henrike M.; de Haan, Michiel; van Kranenburg, Janneau; Bierau, Jorgen; Poeze, Martijn; Wodzig, Will K. W. H.; Rasmussen, Blake B.; van Loon, Luc J. C.			Post-Prandial Protein Handling: You Are What You Just Ate	PLOS ONE			English	Article							INTRINSICALLY LABELED MILK; AMINO-ACID-METABOLISM; RATES IN-VIVO; SKELETAL-MUSCLE; PHENYLALANINE KINETICS; BLOOD-FLOW; YOUNG; DIGESTION; INGESTION; LEUCINE	Background Protein turnover in skeletal muscle tissue is highly responsive to nutrient intake in healthy adults. Objective To provide a comprehensive overview of post-prandial protein handling, ranging from dietary protein digestion and amino acid absorption, the uptake of dietary protein derived amino acids over the leg, the post-prandial stimulation of muscle protein synthesis rates, to the incorporation of dietary protein derived amino acids in de novo muscle protein. Design 12 healthy young males ingested 20 g intrinsically [1-C-13]-phenylalanine labeled protein. In addition, primed continuous L-[ring-H-2(5)]-phenylalanine, L-[ring-H-2(2)]-tyrosine, and L-[1-C-13]-leucine infusions were applied, with frequent collection of arterial and venous blood samples, and muscle biopsies throughout a 5 h post-prandial period. Dietary protein digestion, amino acid absorption, splanchnic amino acid extraction, amino acid uptake over the leg, and subsequent muscle protein synthesis were measured within a single in vivo human experiment. Results 55.3 +/- 2.7% of the protein-derived phenylalanine was released in the circulation during the 5 h post-prandial period. The post-prandial rise in plasma essential amino acid availability improved leg muscle protein balance (from -291 +/- 72 to 103 +/- 66 mu M.min(-1).100 mL leg volume(-1); P<0.001). Muscle protein synthesis rates increased significantly following protein ingestion (0.029 +/- 0.002 vs 0.044 +/- 0.004%.h(-1) based upon the muscle protein bound L[ring-H-2(5)]-phenylalanine enrichments (P<0.01)), with substantial incorporation of dietary protein derived L-[1-C-13]-phenylalanine into de novo muscle protein (from 0 to 0.0201 +/- 0.0025 MPE). Conclusion Ingestion of a single meal-like amount of protein allows similar to 55% of the protein derived amino acids to become available in the circulation, thereby improving whole-body and leg protein balance. About 20% of the dietary protein derived amino acids released in the circulation are taken up in skeletal muscle tissue following protein ingestion, thereby stimulating muscle protein synthesis rates and providing precursors for de novo muscle protein synthesis.	[Groen, Bart B. L.; Horstman, Astrid M.; Hamer, Henrike M.; van Loon, Luc J. C.] Top Inst Food & Nutr, Wageningen, Netherlands; [Groen, Bart B. L.; Horstman, Astrid M.; Hamer, Henrike M.; van Kranenburg, Janneau; van Loon, Luc J. C.] Maastricht Univ, Dept Human Movement Sci, Med Ctr, NL-6200 MD Maastricht, Netherlands; [de Haan, Michiel] Maastricht Univ, Dept Radiol, Med Ctr, NL-6200 MD Maastricht, Netherlands; [Bierau, Jorgen] Maastricht Univ, Lab Biochem Genet, Med Ctr, Dept Clin Genet, NL-6200 MD Maastricht, Netherlands; [Poeze, Martijn] Maastricht Univ, Dept Surg, Med Ctr, NL-6200 MD Maastricht, Netherlands; [Wodzig, Will K. W. H.] Maastricht Univ, Cent Diagnost Lab, Med Ctr, NL-6200 MD Maastricht, Netherlands; [Rasmussen, Blake B.] Univ Texas Med Branch, Dept Nutr & Metab, Galveston, TX 77555 USA	Top Institute Food & Nutrition; Maastricht University; Maastricht University; Maastricht University; Maastricht University; Maastricht University; University of Texas System; University of Texas Medical Branch Galveston	van Loon, LJC (corresponding author), Top Inst Food & Nutr, Wageningen, Netherlands.	L.vanLoon@maastrichtuniversity.nl	van Loon, Luc J C/G-5920-2010; van Loon, Luc J.C./ABG-9158-2020	van Loon, Luc J C/0000-0002-6768-9231; van Loon, Luc J.C./0000-0002-6768-9231; Rasmussen, Blake/0000-0001-7854-5375	TI Food and Nutrition; Danone; FrieslandCampina; Kellogs	TI Food and Nutrition; Danone(Danone Nutricia); FrieslandCampina; Kellogs	This work was funded by TI Food and Nutrition, a public-private partnership on precompetitive research in food and nutrition. The researchers are responsible for the study design, data collection and analysis, decision to publish, and preparation of the manuscript. The industrial partners have contributed to the project through regular discussion. Funding was realized by TI Food and Nutrition: (http://www.tifn.nl/). The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript. The sponsors Danone, FrieslandCampina and Kellogs did have a role in the study design. More specifically: the choice of stimuli, which were produced by these sponsors.	Amer Diabet Assoc, 2006, DIABETES CARE, V29, pS43; BANOS G, 1973, J PHYSIOL-LONDON, V235, P459, DOI 10.1113/jphysiol.1973.sp010397; BERGSTROM J, 1975, SCAND J CLIN LAB INV, V35, P606, DOI 10.3109/00365517509095787; BIOLO G, 1992, AM J PHYSIOL, V262, pE455, DOI 10.1152/ajpendo.1992.262.4.E455; BIOLO G, 1995, AM J PHYSIOL-ENDOC M, V268, pE75, DOI 10.1152/ajpendo.1995.268.1.E75; Boirie Y, 1997, AM J CLIN NUTR, V65, P489; Boirie Y, 1997, P NATL ACAD SCI USA, V94, P14930, DOI 10.1073/pnas.94.26.14930; Boirie Y, 1996, AM J PHYSIOL-ENDOC M, V271, pE1083, DOI 10.1152/ajpendo.1996.271.6.E1083; BOIRIE Y, 1995, J NUTR, V125, P92; Breen L, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-68; Burd NA, 2014, J APPL PHYSIOL, V117, P1363, DOI 10.1152/japplphysiol.00411.2014; Burd NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068109; Burd NA, 2012, J APPL PHYSIOL, V113, P896, DOI 10.1152/japplphysiol.00513.2012; Coppack SW, 1996, J CLIN INVEST, V98, P692, DOI 10.1172/JCI118840; Cuthbertson D, 2004, FASEB J, V18, P422, DOI 10.1096/fj.04-2640fje; Dangin M, 2002, J NUTR, V132, p3228S, DOI 10.1093/jn/131.10.3228S; Deutz NEP, 1998, J NUTR, V128, P2435, DOI 10.1093/jn/128.12.2435; English KL, 2010, CURR OPIN CLIN NUTR, V13, P34, DOI 10.1097/MCO.0b013e328333aa66; FELIG P, 1975, ANNU REV BIOCHEM, V44, P933, DOI 10.1146/annurev.bi.44.070175.004441; Fry CS, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-11; Fujita S, 2006, AM J PHYSIOL-ENDOC M, V291, pE745, DOI 10.1152/ajpendo.00271.2005; Gorissen SHM, 2014, J CLIN ENDOCR METAB, V99, P2250, DOI 10.1210/jc.2013-3970; Groen BBL, 2014, J APPL PHYSIOL, V116, P998, DOI 10.1152/japplphysiol.00919.2013; Groen BB, 2011, AM J PHYSL ENDOCRINO; HEYS SD, 1990, BIOMED ENVIRON MASS, V19, P176, DOI 10.1002/bms.1200190314; JONES PRM, 1969, J PHYSIOL-LONDON, V204, pP63; JORFELDT L, 1971, CLIN SCI, V41, P459, DOI 10.1042/cs0410459; Koopman R, 2005, AM J PHYSIOL-ENDOC M, V288, pE645, DOI 10.1152/ajpendo.00413.2004; Koopman R, 2005, AM J PHYSIOL-ENDOC M, V288, P53; Koopman R, 2007, AM J PHYSIOL-ENDOC M, V293, pE833, DOI 10.1152/ajpendo.00135.2007; Koopman R, 2009, J NUTR, V139, P1707, DOI 10.3945/jn.109.109173; Koopman R, 2009, AM J CLIN NUTR, V90, P106, DOI 10.3945/ajcn.2009.27474; LANDSMAN MLJ, 1976, J APPL PHYSIOL, V40, P575, DOI 10.1152/jappl.1976.40.4.575; Mari A, 2001, DIABETES CARE, V24, P539, DOI 10.2337/diacare.24.3.539; Matthews DE, 2007, J NUTR, V137, p1549S, DOI 10.1093/jn/137.6.1549S; Paddon-Jones D, 2004, AM J PHYSIOL-ENDOC M, V286, pE321, DOI 10.1152/ajpendo.00368.2003; Pennings B, 2011, J DAIRY SCI, V94, P4366, DOI 10.3168/jds.2011-4451; Pennings B, 2012, AM J PHYSL ENDOCRINO; Pennings B, 2013, AM J CLIN NUTR, V98, P121, DOI 10.3945/ajcn.112.051201; Pennings B, 2012, AM J PHYSIOL-ENDOC M, V302, pE992, DOI 10.1152/ajpendo.00517.2011; Pennings B, 2011, AM J CLIN NUTR, V93, P997, DOI 10.3945/ajcn.110.008102; Pennings B, 2011, AM J CLIN NUTR, V93, P322, DOI 10.3945/ajcn.2010.29649; Rasmussen BB, 2006, FASEB J, V20, P768, DOI 10.1096/fj.05-4607fje; Reitelseder S, 2010, AM J PHYSL ENDOCRINO; Res PT, 2012, MED SCI SPORTS EXERC; Rodriguez PO, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.04.010; Schnitzer JE, 1998, WHOLE ORGAN APPROACHES TO CELLULAR METABOLISM, P31; SILK DBA, 1985, P NUTR SOC, V44, P63, DOI 10.1079/PNS19850011; SKELTON DA, 1994, AGE AGEING, V23, P371, DOI 10.1093/ageing/23.5.371; Smith GI, 2010, J APPL PHYSIOL, V108, P363, DOI 10.1152/japplphysiol.00957.2009; van Hall G, 1999, P NUTR SOC, V58, P899, DOI 10.1017/S0029665199001202; van Loon LJC, 2009, J DAIRY SCI, V92, P4812, DOI 10.3168/jds.2009-2317; Volpi E, 1998, J CLIN INVEST, V101, P2000, DOI 10.1172/JCI939; Volpi E, 2001, JAMA-J AM MED ASSOC, V286, P1206, DOI 10.1001/jama.286.10.1206; Volpi E, 1999, AM J PHYSIOL-ENDOC M, V277, pE513, DOI 10.1152/ajpendo.1999.277.3.E513; Wagenmakers AJM, 1999, P NUTR SOC, V58, P987, DOI 10.1017/S0029665199001305; Wall BT, 2012, CLIN NUTR; Waterval WAH, 2009, CLIN CHIM ACTA, V407, P36, DOI 10.1016/j.cca.2009.06.023; Wolfe R R, 1984, Lab Res Methods Biol Med, V9, P1; Wolfe RR, 1992, RADIOACTIVE STABLE I; Zhang HR, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-011-0237-1	61	65	65	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0141582	10.1371/journal.pone.0141582	http://dx.doi.org/10.1371/journal.pone.0141582			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556791	Green Submitted, Green Published, gold			2022-12-27	WOS:000364430700033
J	Hortells, L; Sosa, C; Millan, A; Sorribas, V				Hortells, Luis; Sosa, Cecilia; Millan, Angel; Sorribas, Victor			Critical Parameters of the In Vitro Method of Vascular Smooth Muscle Cell Calcification	PLOS ONE			English	Article							CALCIUM-PHOSPHATE DEPOSITION; CHRONIC KIDNEY-DISEASE; POTENTIAL MECHANISM; PYROPHOSPHATE; OSTEOPONTIN; EXPRESSION; PROTEINS; RISK; NMR	Background Vascular calcification (VC) is primarily studied using cultures of vascular smooth muscle cells. However, the use of very different protocols and extreme conditions can provide findings unrelated to VC. In this work we aimed to determine the critical experimental parameters that affect calcification in vitro and to determine the relevance to calcification in vivo. Experimental Procedures and Results Rat VSMC calcification in vitro was studied using different concentrations of fetal calf serum, calcium, and phosphate, in different types of culture media, and using various volumes and rates of change. The bicarbonate content of the media critically affected pH and resulted in supersaturation, depending on the concentration of Ca2+ and Pi. Such supersaturation is a consequence of the high dependence of bicarbonate buffers on CO2 vapor pressure and bicarbonate concentration at pHs above 7.40. Such buffer systems cause considerable pH variations as a result of minor experimental changes. The variations are more critical for DMEM and are negligible when the bicarbonate concentration is reduced to 1/4. Particle nucleation and growth were observed by dynamic light scattering and electronmicroscopy. Using 2mM Pi, particles of similar to 200nm were observed at 24 hours in MEM and at 1 hour in DMEM. These nuclei grew over time, were deposited in the cells, and caused osteogene expression or cell death, depending on the precipitation rate. TEM observations showed that the initial precipitate was amorphous calcium phosphate (ACP), which converts into hydroxyapatite over time. In blood, the scenario is different, because supersaturation is avoided by a tightly controlled pH of 7.4, which prevents the formation of PO43--containing ACP. Conclusions The precipitation of ACP in vitro is unrelated to VC in vivo. The model needs to be refined through controlled pH and the use of additional procalcifying agents other than Pi in order to reproduce calcium phosphate deposition in vivo.	[Hortells, Luis; Sosa, Cecilia; Sorribas, Victor] Univ Zaragoza, Dept Toxicol, Fac Vet, Zaragoza, Spain; [Millan, Angel] Univ Zaragoza, Inst Mat Sci Aragon, CSIC, Zaragoza, Spain	University of Zaragoza; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Quimica y Materiales de Aragon (CEQMA); CSIC - Instituto de Ciencia de Materiales de Aragon (ICMA); University of Zaragoza	Millan, A (corresponding author), Univ Zaragoza, Inst Mat Sci Aragon, CSIC, Zaragoza, Spain.	amillan@unizar.es; sorribas@unizar.es	Millan, Angel/N-6157-2016; Sosa, Cecilia/B-8374-2013	Sosa, Cecilia/0000-0003-2907-0427; Millan Escolano, Angel/0000-0003-0828-3212; Hortells Garcia, Luis/0000-0003-1923-4918; Sorribas, Victor/0000-0003-3457-323X	Spanish Ministry of Economy and Competitiveness [SAF2012-33898, MAT2014-54975-R]	Spanish Ministry of Economy and Competitiveness(Spanish Government)	Funding was provided by a research grant SAF2012-33898 to VS, http://www.mineco.gob.es/portal/site/mineco/idi, Spanish Ministry of Economy and Competitiveness; research grant MAT2014-54975-R to AM, http://www.mineco.gob.es/portal/site/mineco/idi, Spanish Ministry of Economy and Competitiveness. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balica M, 1997, CIRCULATION, V95, P1954; Betts F., 1974, T AM CRYST ASS, V10, P73; CHAMLEY JH, 1977, CELL TISSUE RES, V177, P503; Chen NX, 2006, KIDNEY INT, V70, P1046, DOI 10.1038/sj.ki.5001663; Coto B, 2012, FLUID PHASE EQUILIBR, V324, P1, DOI 10.1016/j.fluid.2012.03.020; Davies C.W., 1962, ION ASS; Demer LL, 2008, CIRCULATION, V117, P2938, DOI 10.1161/CIRCULATIONAHA.107.743161; Hruska K, 2011, KIDNEY INT, V79, pS9, DOI 10.1038/ki.2011.24; Jaeger C, 2006, KEY ENG MATER, V309-311, P69, DOI 10.4028/www.scientific.net/KEM.309-311.69; Jono S, 2000, CIRC RES, V87, pE10, DOI 10.1161/01.RES.87.7.e10; Kestenbaum B, 2005, J AM SOC NEPHROL, V16, P520, DOI 10.1681/ASN.2004070602; Kiffer-Moreira T, 2013, J BONE MINER RES, V28, P81, DOI 10.1002/jbmr.1733; Kovesdy CP, 2012, NEPHROL DIAL TRANSPL, V27, P3056, DOI 10.1093/ndt/gfs291; Lanzer P, 2014, EUR HEART J, V35, P1515, DOI 10.1093/eurheartj/ehu163; Lomashvili KA, 2008, KIDNEY INT, V73, P1024, DOI 10.1038/ki.2008.26; Lomashvili KA, 2004, J AM SOC NEPHROL, V15, P1392, DOI 10.1097/01.ASN.0000128955.83129.9C; Martin-Pardillos A, 2014, TOXICOLOGY, V318, P40, DOI 10.1016/j.tox.2014.01.012; Martin-Pardillos A, 2013, TOXICOL SCI, V131, P641, DOI 10.1093/toxsci/kfs313; Niederhoffer N, 1997, HYPERTENSION, V29, P999, DOI 10.1161/01.HYP.29.4.999; O'Neill WC, 2007, KIDNEY INT, V72, P792, DOI 10.1038/sj.ki.5002412; Reynolds JL, 2004, J AM SOC NEPHROL, V15, P2857, DOI 10.1097/01.ASN.0000141960.01035.28; Sage AP, 2011, KIDNEY INT, V79, P414, DOI 10.1038/ki.2010.390; Shanahan CM, 1999, CIRCULATION, V100, P2168, DOI 10.1161/01.CIR.100.21.2168; SHANAHAN CM, 1993, CIRC RES, V73, P193, DOI 10.1161/01.RES.73.1.193; Shroff RC, 2010, J AM SOC NEPHROL, V21, P103, DOI 10.1681/ASN.2009060640; Sonou T, 2015, J ATHEROSCLER THROMB; TROPP J, 1983, J AM CHEM SOC, V105, P22, DOI 10.1021/ja00339a006; Villa-Bellosta R, 2011, AM J PHYSIOL-CELL PH, V300, pC210, DOI 10.1152/ajpcell.00229.2010; Villa-Bellosta R, 2009, ARTERIOSCL THROM VAS, V29, P761, DOI 10.1161/ATVBAHA.108.183384; Wang LJ, 2008, CHEM REV, V108, P4628, DOI 10.1021/cr0782574	30	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0141751	10.1371/journal.pone.0141751	http://dx.doi.org/10.1371/journal.pone.0141751			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26554928	Green Submitted, Green Published, gold			2022-12-27	WOS:000364430700038
J	Hou, DX; Su, M; Li, XW; Li, ZY; Yun, T; Zhao, YH; Zhang, L; Zhao, LH; Li, RF; Yu, HQ; Li, XL				Hou, Dongxia; Su, Min; Li, Xiawei; Li, Zhiying; Yun, Ting; Zhao, Yuhang; Zhang, Ling; Zhao, Lihua; Li, Rongfeng; Yu, Haiquan; Li, Xueling			The Efficient Derivation of Trophoblast Cells from Porcine In Vitro Fertilized and Parthenogenetic Blastocysts and Culture with ROCK Inhibitor Y-27632	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; DEVELOPMENTAL COMPETENCE; TROPHECTODERM LINEAGES; EXPRESSION PATTERNS; BOVINE; OOCYTES; GENES; DIFFERENTIATION; KINASE; INSTABILITY	Trophoblasts (TR) are specialized cells of the placenta and play an important role in embryo implantation. The in vitro culture of trophoblasts provided an important tool to investigate the mechanisms of implantation. In the present study, porcine trophoblast cells were derived from pig in vitro fertilized (IVF) and parthenogenetically activated (PA) blastocysts via culturing in medium supplemented with KnockOut serum replacement (KOSR) and basic fibroblast growth factor (bFGF) on STO feeder layers, and the effect of ROCK (Rho-associated coiled-coil protein kinases) inhibiter Y-27632 on the cell lines culture was tested. 5 PA blastocyst derived cell lines and 2 IVF blastocyst derived cell lines have been cultured more than 20 passages; one PA cell lines reached 110 passages without obvious morphological alteration. The derived trophoblast cells exhibited epithelium-like morphology, rich in lipid droplets, and had obvious defined boundaries with the feeder cells. The cells were histochemically stained positive for alkaline phosphatase. The expression of TR lineage markers, such as CDX2, KRT7, KRT18, TEAD4, ELF5 and HAND1, imprinted genes such as IGF2, PEG1 and PEG10, and telomerase activity related genes TERC and TERF2 were detected by immunofluorescence staining, reverse transcription PCR and quantitative real-time PCR analyses. Both PA and IVF blastocysts derived trophoblast cells possessed the ability to differentiate into mature trophoblast cells in vitro. The addition of Y-27632 improved the growth of both PA and IVF blastocyst derived cell lines and increased the expression of trophoblast genes. This study has provided an alternative highly efficient method to establish trophoblast for research focused on peri-implantation and placenta development in IVF and PA embryos.	[Hou, Dongxia; Su, Min; Li, Xiawei; Li, Zhiying; Yun, Ting; Zhao, Yuhang; Yu, Haiquan; Li, Xueling] Inner Mongolia Univ, Key Lab Natl Educ, Minist Mammalian Reprod Biol & Biotechnol, Hohhot, Inner Mongolia, Peoples R China; [Zhang, Ling; Zhao, Lihua; Li, Rongfeng] Nanjing Med Univ, State Key Labs Reprod Med, Nanjing, Jiangsu, Peoples R China; [Zhang, Ling; Zhao, Lihua; Li, Rongfeng] Nanjing Med Univ, Jiangsu Key Lab Xenotransplantat, Nanjing, Jiangsu, Peoples R China	Inner Mongolia University; Nanjing Medical University; Nanjing Medical University	Li, RF (corresponding author), Nanjing Med Univ, State Key Labs Reprod Med, Nanjing, Jiangsu, Peoples R China.	lirongfeng@njmu.edu.cn; haiquan_yu@163.com; lixueling@hotmail.com		Li, Xiawei/0000-0002-6775-4099	National Transgenic Project of China [2013ZX08010-001, 2014ZX08010-001]; National Natural Science Foundation of China [31460309, 81471001, 30871408, 31371487]	National Transgenic Project of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding: This work was supported by National Transgenic Project of China (2013ZX08010-001 and 2014ZX08010-001) and National Natural Science Foundation of China (31460309, 81471001, 30871408 and 31371487). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjaye J, 2007, PHYSIOL GENOMICS, V31, P315, DOI 10.1152/physiolgenomics.00041.2007; Bai H, 2011, J REPROD DEVELOP, V57, P518, DOI 10.1262/jrd.10-186K; Berg DK, 2011, DEV CELL, V20, P244, DOI 10.1016/j.devcel.2011.01.003; Blaschitz A, 2000, PLACENTA, V21, P733, DOI 10.1053/plac.2000.0559; Brevini TAL, 2012, STEM CELL REV REP, V8, P1076, DOI 10.1007/s12015-012-9379-2; Carey TS, 2015, MOL CELL BIOL, V35, P4158, DOI 10.1128/MCB.00546-15; Clayton L, 1999, DEV BIOL, V205, P322, DOI 10.1006/dbio.1998.9117; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Donnison M, 2005, DEVELOPMENT, V132, P2299, DOI 10.1242/dev.01819; Elling U, 2011, CELL STEM CELL, V9, P563, DOI 10.1016/j.stem.2011.10.012; Ezashi T, 2011, BIOL REPROD, V85, P779, DOI 10.1095/biolreprod.111.092809; Finan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068528; FLECHON JE, 1995, PLACENTA, V16, P643, DOI 10.1016/0143-4004(95)90033-0; FRASER LR, 1979, ENVIRON HEALTH PERSP, V31, P141, DOI 10.2307/3429152; Fujii T, 2013, J REPROD DEVELOP, V59, P151, DOI 10.1262/jrd.2012-122; Fujii T, 2010, CELL REPROGRAM, V12, P617, DOI 10.1089/cell.2010.0017; Gauthaman K, 2010, STEM CELL REV REP, V6, P86, DOI [10.1007/s12015-010-9166-x, 10.1007/s12015-009-9107-8]; Goossens K, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-64; Goossens K, 2010, REPROD FERT DEVELOP, V22, P395, DOI 10.1071/RD09080; Haigh T, 1999, PLACENTA, V20, P615, DOI 10.1053/plac.1999.0441; Hao YH, 2006, MOL REPROD DEV, V73, P77, DOI 10.1002/mrd.20358; Hao YH, 2004, BIOL REPROD, V70, P1644, DOI 10.1095/biolreprod.103.026005; Hardy K, 1996, MOL REPROD DEV, V43, P313, DOI 10.1002/(SICI)1098-2795(199603)43:3&lt;313::AID-MRD5&gt;3.0.CO;2-T; Huang XH, 2014, STEM CELLS DEV, V23, P1501, DOI 10.1089/scd.2013.0329; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; Kaibuchi K, 1999, CURR OPIN CELL BIOL, V11, P591, DOI 10.1016/S0955-0674(99)00014-9; Kaufman MH, 1983, METHODOLOGY IN VITRO; Kidder BL, 2009, STEM CELLS, V27, P317, DOI 10.1634/stemcells.2008-0710; Kure-Bayashi S, 2000, THERIOGENOLOGY, V53, P1105, DOI 10.1016/S0093-691X(00)00256-9; La Bonnardiere C, 2002, PLACENTA, V23, P716, DOI 10.1053/plac.2002.0848; Lathi RB, 2011, SEMIN REPROD MED, V29, P463, DOI 10.1055/s-0031-1293200; Leeb M, 2011, NATURE, V479, P131, DOI 10.1038/nature10448; Li W, 2014, CELL STEM CELL, V14, P404, DOI 10.1016/j.stem.2013.11.016; Li W, 2012, NATURE, V490, P407, DOI 10.1038/nature11435; Liu Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097974; McCauley TC, 2003, THERIOGENOLOGY, V60, P1569, DOI 10.1016/S0093-691X(03)00172-9; Meyer-Ter-Vehn T, 2006, INVEST OPHTH VIS SCI, V47, P4895, DOI 10.1167/iovs.06-0118; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niemann H, 2001, THERIOGENOLOGY, V56, P1291, DOI 10.1016/S0093-691X(01)00630-6; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Odiatis C, 2010, PLACENTA, V31, P630, DOI 10.1016/j.placenta.2010.05.001; Pearton DJ, 2014, DEV BIOL, V392, P344, DOI 10.1016/j.ydbio.2014.05.012; Pearton DJ, 2011, DEV BIOL, V360, P343, DOI 10.1016/j.ydbio.2011.10.007; PEDERSEN RA, 1986, EXPT APPROACHES MAMM; Petr J, 1996, THERIOGENOLOGY, V45, P1473, DOI 10.1016/0093-691X(96)00115-X; Pfeffer PL, 2012, REPRODUCTION, V143, P231, DOI 10.1530/REP-11-0374; Polydorou C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2646; PRATHER RS, 1991, MOL REPROD DEV, V28, P405, DOI 10.1002/mrd.1080280413; Ralston A, 2010, DEVELOPMENT, V137, P395, DOI 10.1242/dev.038828; RAMSOONDAR J, 1993, BIOL REPROD, V49, P681, DOI 10.1095/biolreprod49.4.681; Ray S, 2009, J BIOL CHEM, V284, P4978, DOI 10.1074/jbc.M807329200; REIMA I, 1993, DIFFERENTIATION, V54, P35; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Roberts R Michael, 2003, J Reprod Dev, V52, pS87; Saadeldin IM, 2014, PLACENTA, V35, P286, DOI 10.1016/j.placenta.2014.02.003; Shi JJ, 2013, CELL CYCLE, V12, P1492, DOI 10.4161/cc.24699; Shiokawa S, 2002, J CLIN ENDOCR METAB, V87, P5808, DOI 10.1210/jc.2002-020376; Sivasubramaiyan K, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-88; SOLTER D, 1978, P NATL ACAD SCI USA, V75, P5565, DOI 10.1073/pnas.75.11.5565; Sritanaudomchai H, 2009, DEV BIOL, V335, P179, DOI 10.1016/j.ydbio.2009.08.025; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; TAYLOR AS, 1994, HUM REPROD, V9, P2389, DOI 10.1093/oxfordjournals.humrep.a138457; Vanneste E, 2009, NAT MED, V15, P577, DOI 10.1038/nm.1924; Wang K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010622; Wen F, 2007, DEV BIOL, V312, P284, DOI 10.1016/j.ydbio.2007.09.024; Zhao HB, 2010, BIOL REPROD, V83, P370, DOI 10.1095/biolreprod.110.083402; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267; Zhou C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091728; Zhu J, 2003, CLONING STEM CELLS, V5, P355, DOI 10.1089/153623003772032853	69	13	14	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142442	10.1371/journal.pone.0142442	http://dx.doi.org/10.1371/journal.pone.0142442			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555939	Green Published, gold, Green Submitted			2022-12-27	WOS:000364430700107
J	Hu, X; Li, TT; Zheng, J; Su, NX; Liu, ZM; Luo, L				Hu, Xiao; Li, Tongtong; Zheng, Jun; Su, Ningxin; Liu, Zhaomin; Luo, Liang			How Much Do Metamemory Beliefs Contribute to the Font-Size Effect in Judgments of Learning?	PLoS One			English	Article							STABILITY BIAS; FLUENCY; MEMORY; PREDICTIONS; RETRIEVAL; ILLUSIONS; PEOPLE; JOLS; CUE	Evidence shows that the font size of study items significantly influences judgments of learning (JOLs) and that people's JOLs are generally higher for larger words than for smaller words. Previous studies have suggested that font size influences JOLs in a belief-based way. However, few studies have directly examined how much people's beliefs contribute to the font-size effect in JOLs. This study investigated the degree to which font size influenced JOLs in a belief-based way. In Experiment 1, one group of participants (learners) studied words with different font sizes and made JOLs, whereas another group of participants (observers) viewed the learners' study phase and made JOLs for the learners. In Experiment 2, participants made both JOLs and belief-based recall predictions for large and small words. Our results suggest that metamemory beliefs play an important role in the font-size effect in JOLs.	[Hu, Xiao; Li, Tongtong; Zheng, Jun; Su, Ningxin; Luo, Liang] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Liu, Zhaomin] China Univ Polit Sci & Law, Sch Sociol, Beijing, Peoples R China; [Luo, Liang] Beijing Normal Univ, Collaborat Innovat Ctr Assessment Basic Educ Qual, Beijing 100875, Peoples R China	Beijing Normal University; China University of Political Science & Law; Beijing Normal University	Liu, ZM (corresponding author), China Univ Polit Sci & Law, Sch Sociol, Beijing, Peoples R China.	zhaominl@cupl.edu.cn; luoliang@bnu.edu.cn	Liu, Zhaomin/L-8685-2019	Hu, Xiao/0000-0002-8899-6273	National Natural Science Foundation of China [31100817, 31000506]; Beijing Higher Education Young Elite Teacher Project; project for young people who are devoted to the researches of humanities and social sciences of the Ministry of Education of People's Republic of China [10YJCXLX032]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Higher Education Young Elite Teacher Project; project for young people who are devoted to the researches of humanities and social sciences of the Ministry of Education of People's Republic of China	This study was supported by the National Natural Science Foundation of China (31100817, 31000506), Beijing Higher Education Young Elite Teacher Project and the project for young people who are devoted to the researches of humanities and social sciences (10YJCXLX032) of the Ministry of Education of People's Republic of China. LL received the funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter AL, 2009, PERS SOC PSYCHOL REV, V13, P219, DOI 10.1177/1088868309341564; Ariel R, 2014, J MEM LANG, V75, P181, DOI 10.1016/j.jml.2014.06.003; Bjork RA, 2013, ANNU REV PSYCHOL, V64, P417, DOI 10.1146/annurev-psych-113011-143823; Cai Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010729; Dunlosky J, 2014, REMEMBERING ATTRIBUT; Dunlosky J., 2009, METACOGNITION; Dunlosky J., 2008, HDB METAMEMORY MEMOR; Emanuel RA, 2006, AGING NEUROPSYCHOL C, V13, P458; Hu X.L, 2015, MEMORY, P1; Karpicke JD, 2009, J EXP PSYCHOL GEN, V138, P469, DOI 10.1037/a0017341; Koriat A, 1997, J EXP PSYCHOL GEN, V126, P349, DOI 10.1037/0096-3445.126.4.349; Koriat A, 2004, J EXP PSYCHOL GEN, V133, P643, DOI 10.1037/0096-3445.133.4.643; Kornell N, 2011, PSYCHOL SCI, V22, P787, DOI 10.1177/0956797611407929; Kornell N, 2009, J EXP PSYCHOL GEN, V138, P449, DOI 10.1037/a0017350; Matvey G, 2001, MEM COGNITION, V29, P222, DOI 10.3758/BF03194916; Metcalfe J, 2005, J MEM LANG, V52, P463, DOI 10.1016/j.jml.2004.12.001; Metcalfe J, 2008, PSYCHON B REV, V15, P174, DOI 10.3758/PBR.15.1.174; Mueller ML, 2016, Q J EXP PSYCHOL, V69, P781, DOI 10.1080/17470218.2015.1058404; Mueller ML, 2014, J MEM LANG, V70, P1, DOI 10.1016/j.jml.2013.09.007; Mueller ML, 2013, PSYCHON B REV, V20, P378, DOI 10.3758/s13423-012-0343-6; Nelson T.O., 1990, PSYCHOL LEARNING MOT, V26, P125, DOI [10.1016/S0079-7421(08)60053-5, DOI 10.1016/S0079-7421(08)60053-5, 10.1016/s0079-7421(08)60053-5]; NELSON TO, 1984, PSYCHOL BULL, V95, P109, DOI 10.1037/0033-2909.95.1.109; Rhodes MG, 2008, J EXP PSYCHOL GEN, V137, P615, DOI 10.1037/a0013684; Serra MJ, 2014, MEM COGNITION, V42, P1260, DOI 10.3758/s13421-014-0431-0; Susser JA, 2013, MEM COGNITION, V41, P1000, DOI 10.3758/s13421-013-0323-8	25	29	31	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142351	10.1371/journal.pone.0142351	http://dx.doi.org/10.1371/journal.pone.0142351			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7CT	26556478	Green Published, gold, Green Submitted			2022-12-27	WOS:000364430700090
J	Lee, DM; Rodrigues, FF; Yu, CG; Swan, M; Harris, TJC				Lee, Donghoon M.; Rodrigues, Francisco F.; Yu, Cao Guo; Swan, Michael; Harris, Tony J. C.			PH Domain-Arf G Protein Interactions Localize the Arf-GEF Steppke for Cleavage Furrow Regulation in Drosophila	PLoS One			English	Article							PLECKSTRIN-HOMOLOGY DOMAINS; EXCHANGE FACTORS; NUCLEOTIDE EXCHANGE; PLASMA-MEMBRANE; FAMILY; ACTIVATION; CYTOSKELETON; ENDOCYTOSIS; BINDING; EMBRYO	The recruitment of GDP/GTP exchange factors (GEFs) to specific subcellular sites dictates where they activate small G proteins for the regulation of various cellular processes. Cytohesins are a conserved family of plasma membrane GEFs for Arf small G proteins that regulate endocytosis. Analyses of mammalian cytohesins have identified a number of recruitment mechanisms for these multi-domain proteins, but the conservation and developmental roles for these mechanisms are unclear. Here, we report how the pleckstrin homology (PH) domain of the Drosophila cytohesin Steppke affects its localization and activity at cleavage furrows of the early embryo. We found that the PH domain is necessary for Steppke furrow localization, and for it to regulate furrow structure. However, the PH domain was not sufficient for the localization. Next, we examined the role of conserved PH domain amino acid residues that are required for mammalian cytohesins to bind PIP3 or GTP-bound Arf G proteins. We confirmed that the Steppke PH domain preferentially binds PIP3 in vitro through a conserved mechanism. However, disruption of residues for PIP3 binding had no apparent effect on GFP-Steppke localization and effects. Rather, residues for binding to GTP-bound Arf G proteins made major contributions to this Steppke localization and activity. By analyzing GFP-tagged Arf and Arf-like small G proteins, we found that Arf1-GFP, Arf6-GFP and Arl4-GFP, but not Arf4-GFP, localized to furrows. However, analyses of embryos depleted of Arf1, Arf6 or Arl4 revealed either earlier defects than occur in embryos depleted of Steppke, or no detectable furrow defects, possibly because of redundancies, and thus it was difficult to assess how individual Arf small G proteins affect Steppke. Nonetheless, our data show that the Steppke PH domain and its conserved residues for binding to GTP-bound Arf G proteins have substantial effects on Steppke localization and activity in early Drosophila embryos.	[Lee, Donghoon M.; Rodrigues, Francisco F.; Yu, Cao Guo; Swan, Michael; Harris, Tony J. C.] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada	University of Toronto	Harris, TJC (corresponding author), Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada.	tony.harris@utoronto.ca		Lee, Donghoon/0000-0002-1078-6655	Canadian Institutes of Health Research (CIHR) [MOP82829]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	The work was supported by a Canadian Institutes of Health Research (CIHR) operating grant to TJCH (MOP82829) (http://www.cihr-irsc.gc.ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizel K, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001652; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Cherfils J, 2013, PHYSIOL REV, V93, P269, DOI 10.1152/physrev.00003.2012; Cohen LA, 2007, MOL BIOL CELL, V18, P2244, DOI 10.1091/mbc.E06-11-0998; Cronin TC, 2004, EMBO J, V23, P3711, DOI 10.1038/sj.emboj.7600388; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; DiNitto JP, 2007, MOL CELL, V28, P569, DOI 10.1016/j.molcel.2007.09.017; DiNitto JP, 2010, BIOCHEMISTRY-US, V49, P6083, DOI 10.1021/bi1000454; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Dyer N, 2007, DEVELOPMENT, V134, P4437, DOI 10.1242/dev.010983; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Hahn I, 2013, J CELL SCI, V126, P2470, DOI 10.1242/jcs.120964; Hiester KG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082084; Hofmann I, 2007, CURR BIOL, V17, P711, DOI 10.1016/j.cub.2007.03.007; Huang J, 2009, P NATL ACAD SCI USA, V106, P8284, DOI 10.1073/pnas.0900641106; Hunter MV, 2015, J CELL BIOL, V210, P801, DOI 10.1083/jcb.201501076; Ikenouchi J, 2010, P NATL ACAD SCI USA, V107, P748, DOI 10.1073/pnas.0908423107; Jackson CL, 2014, J CELL SCI, V127, P4103, DOI 10.1242/jcs.144899; Jacobs S, 1999, FEBS LETT, V456, P384, DOI 10.1016/S0014-5793(99)00759-0; Kitano J, 2002, J NEUROSCI, V22, P1280, DOI 10.1523/JNEUROSCI.22-04-01280.2002; Klarlund JK, 2000, J BIOL CHEM, V275, P32816, DOI 10.1074/jbc.M002435200; Krahn MP, 2010, CURR BIOL, V20, P636, DOI 10.1016/j.cub.2010.01.065; Lecuit T, 2004, J CELL SCI, V117, P3427, DOI 10.1242/jcs.01312; Lee DM, 2015, GENETICS, V200, P863, DOI 10.1534/genetics.115.176867; Lee Donghoon M, 2014, Bioarchitecture, V4, P68, DOI 10.4161/bioa.28949; Lee DM, 2013, CURR BIOL, V23, P2110, DOI 10.1016/j.cub.2013.08.058; Lim J, 2010, GENE DEV, V24, P1496, DOI 10.1101/gad.1904610; Liu JS, 2015, MOL BIOL CELL, V26, P711, DOI 10.1091/mbc.E14-11-1554; Mazumdar A, 2002, BIOESSAYS, V24, P1012, DOI 10.1002/bies.10184; Moravec R, 2012, J BIOL CHEM, V287, P31138, DOI 10.1074/jbc.M112.383117; Myers KR, 2008, TRENDS CELL BIOL, V18, P184, DOI 10.1016/j.tcb.2008.02.002; Nevrivy DJ, 2000, J BIOL CHEM, V275, P16827, DOI 10.1074/jbc.275.22.16827; Padovani D, 2014, P NATL ACAD SCI USA, V111, P12378, DOI 10.1073/pnas.1409832111; Reversi A, 2014, J CELL BIOL, V205, P395, DOI 10.1083/jcb.201309079; Sarantis H, 2012, METHOD CELL BIOL, V108, P429, DOI 10.1016/B978-0-12-386487-1.00019-5; Shao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009938; Stalder D, 2011, J BIOL CHEM, V286, P3873, DOI 10.1074/jbc.M110.145532; Teuliere J, 2014, GENETICS, V198, P229, DOI 10.1534/genetics.114.167189; Torii T, 2010, J BIOL CHEM, V285, P24270, DOI 10.1074/jbc.M110.125658; Varnai P, 2005, J CELL SCI, V118, P4879, DOI 10.1242/jcs.02606; Vert JP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-520; Yu CG, 2012, MOL BIOL CELL, V23, P3743, DOI 10.1091/mbc.E12-03-0196; Zhu WQ, 2012, NATURE, V492, P252, DOI 10.1038/nature11603	44	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142562	10.1371/journal.pone.0142562	http://dx.doi.org/10.1371/journal.pone.0142562			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556630	Green Published, Green Submitted, gold			2022-12-27	WOS:000364430700131
J	Liu, TJ; Yu, HF; Ding, L; Wu, Z; De Los Santos, FG; Liu, JH; Ullenbruch, M; Hu, B; Martins, V; Phan, SH				Liu, Tianju; Yu, Hongfeng; Ding, Lin; Wu, Zhe; De Los Santos, Francina Gonzalez; Liu, Jianhua; Ullenbruch, Matthew; Hu, Biao; Martins, Vanessa; Phan, Sem H.			Conditional Knockout of Telomerase Reverse Transcriptase in Mesenchymal Cells Impairs Mouse Pulmonary Fibrosis	PLOS ONE			English	Article							LUNG INJURY; DUAL ROLES; STEM-CELLS; CANCER; MYOFIBROBLAST; MUTATIONS; PROLIFERATION; DYSFUNCTION; EXPRESSION; INDUCTION	Telomerase is typically expressed in cellular populations capable of extended replication, such as germ cells, tumor cells, and stem cells, but is also induced in tissue injury, repair and fibrosis. Its catalytic component, telomerase reverse transcriptase (TERT) is induced in lung fibroblasts from patients with fibrotic interstitial lung disease and in rodents with bleomycin- induced pulmonary fibrosis. To evaluate the fibroblast specific role of TERT in pulmonary fibrosis, transgenic mice bearing a floxed TERT allele were generated, and then crossed with an inducible collagen alpha 2(I)-Cre mouse line to generate fibroblast specific TERT conditional knockout mice. TERT-specific deficiency in mesenchymal cells caused attenuation of pulmonary fibrosis as manifested by reduced lung hydroxyproline content, type I collagen and a-smooth muscle actin mRNA levels. The TERT-deficient mouse lung fibroblasts displayed decreased cell proliferative capacity and higher susceptibility to induced apoptosis compared with control cells. Additionally TERT deficiency was associated with heightened a-smooth muscle actin expression indicative of myofibroblast differentiation. However the impairment of cell proliferation and increased susceptibility to apoptosis would cause a reduction in the myofibroblast progenitor population necessary to mount a successful myofibroblast-dependent fibrotic response. These findings identified a key role for TERT in fibroblast proliferation and survival essential for pulmonary fibrosis.	[Liu, Tianju; Yu, Hongfeng; Ding, Lin; Wu, Zhe; De Los Santos, Francina Gonzalez; Liu, Jianhua; Ullenbruch, Matthew; Hu, Biao; Phan, Sem H.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Martins, Vanessa] Univ Sao Paulo, Fac Med, Sao Paulo, Brazil	University of Michigan System; University of Michigan; Universidade de Sao Paulo	Phan, SH (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.	shphan@umich.edu	Phan, Sem H/A-7033-2009	Phan, Sem H/0000-0002-3711-2159	NIH [HL052285, HL091775, HL112880]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112880, R01HL052285, P01HL091775] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding: This study is supported by NIH grants HL052285, HL091775 and HL112880. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder JK, 2008, P NATL ACAD SCI USA, V105, P13051, DOI 10.1073/pnas.0804280105; Alder JK, 2015, CHEST, V147, P1361, DOI 10.1378/chest.14-1947; Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; Bauer Y, 2015, AM J RESP CELL MOL, V52, P217, DOI 10.1165/rcmb.2013-0310OC; de Jesus BB, 2013, TRENDS GENET, V29, P513, DOI 10.1016/j.tig.2013.06.007; Buseman CM, 2012, MUTAT RES-FUND MOL M, V730, P90, DOI 10.1016/j.mrfmmm.2011.07.006; Cao K, 2011, J CLIN INVEST, V121, P2833, DOI 10.1172/JCI43578; Choi JK, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040010; Cogan JD, 2015, AM J RESP CRIT CARE, V191, P646, DOI 10.1164/rccm.201408-1510OC; Cronkhite JT, 2008, AM J RESP CRIT CARE, V178, P729, DOI 10.1164/rccm.200804-550OC; Driscoll B, 2000, AM J PHYSIOL-LUNG C, V279, pL1191, DOI 10.1152/ajplung.2000.279.6.L1191; Fridlender ZG, 2007, EUR RESPIR J, V30, P205, DOI 10.1183/09031936.00009407; Gazzaniga FS, 2014, BLOOD, V124, P3675, DOI 10.1182/blood-2014-06-582254; Gonzalez-Suarez E, 2001, EMBO J, V20, P2619, DOI 10.1093/emboj/20.11.2619; Gordon DM, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/390791; Greider CW, 1996, ANNU REV BIOCHEM, V65, P337, DOI 10.1146/annurev.bi.65.070196.002005; Hackett JA, 2002, ONCOGENE, V21, P619, DOI 10.1038/sj.onc.1205061; Hoffmeyer K, 2012, SCIENCE, V336, P1549, DOI 10.1126/science.1218370; Hu BA, 2012, AM J PATHOL, V180, P2257, DOI 10.1016/j.ajpath.2012.02.010; Huaux F, 2003, J IMMUNOL, V170, P2083, DOI 10.4049/jimmunol.170.4.2083; Kim JK, 2000, TOXICOL LETT, V111, P263, DOI 10.1016/S0378-4274(99)00195-2; Kropski JA, 2014, CHEST, V146, pE1, DOI 10.1378/chest.13-2224; Liu T, 2006, AM J RESP CELL MOL, V34, P625, DOI 10.1165/rcmb.2005-0252OC; Liu TJ, 2007, J CLIN INVEST, V117, P3800, DOI 10.1172/JCI32369; Liu TJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088362; Liu TJ, 2013, AM J RESP CELL MOL, V49, P260, DOI 10.1165/rcmb.2012-0514OC; Morrison SJ, 1996, IMMUNITY, V5, P207, DOI 10.1016/S1074-7613(00)80316-7; Mouraret N, 2015, CIRCULATION, V131, P742, DOI 10.1161/CIRCULATIONAHA.114.013258; Nozaki Y, 2000, AM J RESP CELL MOL, V23, P460, DOI 10.1165/ajrcmb.23.4.3958; Park JI, 2009, NATURE, V460, P66, DOI 10.1038/nature08137; Peng RQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059348; Phan Sem H, 2012, Proc Am Thorac Soc, V9, P148, DOI 10.1513/pats.201201-011AW; Richardson GD, 2012, FASEB J, V26, P4832, DOI 10.1096/fj.12-208843; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Santos JH, 2004, AGING CELL, V3, P399, DOI 10.1111/j.1474-9728.2004.00124.x; Saretzki G, 2014, CURR PHARM DESIGN, V20, P6386, DOI 10.2174/1381612820666140630095606; Sarin KY, 2005, NATURE, V436, P1048, DOI 10.1038/nature03836; Seimiya H, 2000, EMBO J, V19, P2652, DOI 10.1093/emboj/19.11.2652; Shang Y, 2015, CELL BIOCHEM BIOPHYS, V72, P405, DOI 10.1007/s12013-014-0476-5; Simonicova L, 2015, CURR GENET, V61, P517, DOI 10.1007/s00294-014-0472-8; Sirma H, 2011, GASTROENTEROLOGY, V141, P326, DOI 10.1053/j.gastro.2011.03.047; Stuart BD, 2015, NAT GENET, V47, P512, DOI 10.1038/ng.3278; Thannickal Victor J, 2006, Proc Am Thorac Soc, V3, P350, DOI 10.1513/pats.200601-001TK; Tsakiri KD, 2007, P NATL ACAD SCI USA, V104, P7552, DOI 10.1073/pnas.0701009104; Ujike-Asai A, 2007, J LEUKOCYTE BIOL, V82, P429, DOI 10.1189/jlb.1006638; Waisberg DR, 2012, CLINICS, V67, P1039, DOI 10.6061/clinics/2012(09)10; Westin ER, 2007, AGING CELL, V6, P383, DOI 10.1111/j.1474-9726.2007.00288.x; Wong JMY, 2006, GENE DEV, V20, P2848, DOI 10.1101/gad.1476206; Yang J, 2013, AM J PATHOL, V183, P1559, DOI 10.1016/j.ajpath.2013.07.016; Yui J, 1998, BLOOD, V91, P3255, DOI 10.1182/blood.V91.9.3255.3255_3255_3262	50	19	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142547	10.1371/journal.pone.0142547	http://dx.doi.org/10.1371/journal.pone.0142547			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555817	Green Published, Green Submitted, gold			2022-12-27	WOS:000364430700126
J	Nakagawa, T; Ikehara, T; Dolguchi, M; Imamura, Y; Higashi, M; Yoneda, M; Ito, T				Nakagawa, Takeya; Ikehara, Tsuyoshi; Dolguchi, Masamichi; Imamura, Yuko; Higashi, Miki; Yoneda, Mitsuhiro; Ito, Takashi			Enhancer of Acetyltransferase Chameau (EAChm) Is a Novel Transcriptional Co-Activator	PLOS ONE			English	Article							HISTONE ACETYLATION; CHROMATIN; ACTIVATION; COMPLEXES; CHAPERONE	Acetylation of nucleosomal histones by diverse histone acetyltransferases (HAT) plays pivotal roles in many cellular events. Discoveries of novel HATs and HAT related factors have provided new insights to understand the roles and mechanisms of histone acetylation. In this study, we identified prominent Histone H3 acetylation activity in vitro and purified its activity, showing that it is composed of the MYST acetyltransferase Chameau and Enhancer of the Acetyltransferase Chameau (EAChm) family. EAChm is a negatively charged acidic protein retaining aspartate and glutamate. Furthermore, we identified that Chameau and EAChm stimulate transcription in vitro together with purified general transcription factors. In addition, RNA-seq analysis of Chameu KD and EAChm KD S2 cells suggest that Chameau and EAChm regulate transcription of common genes in vivo. Our results suggest that EAChm regulates gene transcription in Drosophila embryos by enhancing Acetyltransferase Chameau activity.	[Nakagawa, Takeya; Ikehara, Tsuyoshi; Dolguchi, Masamichi; Imamura, Yuko; Higashi, Miki; Yoneda, Mitsuhiro; Ito, Takashi] Nagasaki Univ, Sch Med, Dept Biochem, Nagasaki 8528523, Japan	Nagasaki University	Ito, T (corresponding author), Nagasaki Univ, Sch Med, Dept Biochem, Nagasaki 8528523, Japan.	tito@nagasaki-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [24118003]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (T.I.). Grant number is 24118003. The URL is: https://www.jsps.go.jp/english/e-grants/ .	Asahara H, 2002, MOL CELL BIOL, V22, P2974, DOI 10.1128/MCB.22.9.2974-2983.2002; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Brownell JE, 1996, CURR OPIN GENET DEV, V6, P176, DOI 10.1016/S0959-437X(96)80048-7; Carrozza MJ, 2003, TRENDS GENET, V19, P321, DOI 10.1016/S0168-9525(03)00115-X; Chen SD, 2010, SCIENCE, V330, P1682, DOI 10.1126/science.1196380; DINGWALL C, 1987, EMBO J, V6, P69, DOI 10.1002/j.1460-2075.1987.tb04720.x; Grienenberger A, 2002, CURR BIOL, V12, P762, DOI 10.1016/S0960-9822(02)00814-X; Hong T, 2004, BIOCHEM BIOPH RES CO, V317, P259, DOI 10.1016/j.bbrc.2004.03.041; Ito T, 2000, GENE DEV, V14, P1899; Ito T, 1996, MOL CELL BIOL, V16, P3112; KAMAKAKA RT, 1994, METHOD CELL BIOL, V44, P225, DOI 10.1016/S0091-679X(08)60916-4; Kimura A, 2005, J BIOCHEM, V138, P647, DOI 10.1093/jb/mvi184; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kueh AJ, 2011, MOL CELL BIOL, V31, P845, DOI 10.1128/MCB.00159-10; Lee JS, 2010, CELL, V142, P682, DOI 10.1016/j.cell.2010.08.011; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Miotto B, 2006, GENE DEV, V20, P101, DOI 10.1101/gad.359506; Mizuguchi G, 2001, J BIOL CHEM, V276, P14773, DOI 10.1074/jbc.M100125200; Mousson F, 2005, P NATL ACAD SCI USA, V102, P5975, DOI 10.1073/pnas.0500149102; Pillus L, 2008, CURR OPIN CELL BIOL, V20, P326, DOI 10.1016/j.ceb.2008.04.009; Ruiz-Garcia AB, 1998, J BIOL CHEM, V273, P12599, DOI 10.1074/jbc.273.20.12599; STUDITSKY VM, 1995, CELL, V83, P19, DOI 10.1016/0092-8674(95)90230-9; van Holde KE., 1989, SPRINGER SERIES MOL; Voss AK, 2009, BIOESSAYS, V31, P1050, DOI 10.1002/bies.200900051; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	26	1	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142305	10.1371/journal.pone.0142305	http://dx.doi.org/10.1371/journal.pone.0142305			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555228	Green Published, Green Submitted, gold			2022-12-27	WOS:000364430700081
J	Varughese, EA; Kasper, S; Anneken, EM; Yadav, JS				Varughese, Eunice A.; Kasper, Susan; Anneken, Emily M.; Yadav, Jagjit S.			SHP-2 Mediates Cryptosporidium parvum Infectivity in Human Intestinal Epithelial Cells	PLOS ONE			English	Article							TYROSINE-PHOSPHATASE SHP-2; FOCAL ADHESION KINASE; IN-VITRO; INCREASED EXPRESSION; CELLULAR INVASION; PROTEIN; PAXILLIN; SRC; PHOSPHORYLATION; ACTIVATION	The parasite, Cryptosporidium parvum, induces human gastroenteritis through infection of host epithelial cells in the small intestine. During the initial stage of infection, C. parvum is reported to engage host mechanisms at the host cell-parasite interface to form a parasitophorous vacuole. We determined that upon infection, the larger molecular weight proteins in human small intestinal epithelial host cells (FHs 74 Int) appeared to globally undergo tyrosine dephosphorylation. In parallel, expression of the cytoplasmic protein tyrosine phosphatase Src homology-2 domain-containing phosphatase 2 (SHP-2) increased in a time-dependent manner. SHP-2 co-localized with the C. parvum sporozoite and this interaction increased the rate of C. parvum infectivity through SH2-mediated SHP-2 activity. Furthermore, we show that one potential target that SHP-2 acts upon is the focal adhesion protein, paxillin, which undergoes moderate dephosphorylation following infection, with inhibition of SHP-2 rescuing paxillin phosphorylation. Importantly, treatment with an inhibitor to SHP-2 and with an inhibitor to paxillin and Src family kinases, effectively decreased the multiplicity of C. parvum infection in a dose-dependent manner. Thus, our study reveals an important role for SHP-2 in the pathogenesis of C. parvum. Furthermore, while host proteins can be recruited to participate in the development of the electron dense band at the host cell-parasite interface, our study implies for the first time that SHP-2 appears to be recruited by the C. parvum sporozoite to regulate infectivity. Taken together, these findings suggest that SHP-2 and its down-stream target paxillin could serve as targets for intervention.	[Varughese, Eunice A.; Kasper, Susan; Yadav, Jagjit S.] Univ Cincinnati, Coll Med, Dept Environm Hlth, Div Environm Genet & Mol Toxicol, Cincinnati, OH 45267 USA; [Varughese, Eunice A.; Anneken, Emily M.] US EPA, Natl Exposure Res Lab, Cincinnati, OH 45268 USA	University of Cincinnati; United States Environmental Protection Agency	Varughese, EA (corresponding author), Univ Cincinnati, Coll Med, Dept Environm Hlth, Div Environm Genet & Mol Toxicol, Cincinnati, OH 45267 USA.	varughese.eunice@epa.gov; Jagjit.yadav@uc.edu	Yadav, Jagjit S./AAN-8805-2020	Yadav, Jagjit S./0000-0001-5036-3609	U.S. Environmental Protection Agency, through its Office of Research and Development; University of Cincinnati	U.S. Environmental Protection Agency, through its Office of Research and Development(United States Environmental Protection Agency); University of Cincinnati	The research was supported by the U.S. Environmental Protection Agency, through its Office of Research and Development, and in part by the University of Cincinnati. Commercial entities had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakken T, 2010, VIROLOGY, V397, P379, DOI 10.1016/j.virol.2009.11.030; Bauer B, 2012, CELL HOST MICROBE, V11, P576, DOI 10.1016/j.chom.2012.04.013; Bhat N, 2007, J BIOL CHEM, V282, P34877, DOI 10.1074/jbc.M706950200; Bohmer F, 2013, FEBS J, V280, P413, DOI 10.1111/j.1742-4658.2012.08655.x; Brown MC, 2005, MOL BIOL CELL, V16, P4316, DOI 10.1091/mbc.E05-02-0131; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; Carruthers Vern B., 2008, V47, P33; Chalmers RM, 2013, TRENDS PARASITOL, V29, P237, DOI 10.1016/j.pt.2013.03.001; Chang YM, 2008, ONCOGENE, V27, P6365, DOI 10.1038/onc.2008.250; Chen XM, 2004, J BIOL CHEM, V279, P31671, DOI 10.1074/jbc.M401592200; Chen XM, 2004, INFECT IMMUN, V72, P3011, DOI 10.1128/IAI.72.5.3011-3021.2004; Chen XM, 2003, GASTROENTEROLOGY, V125, P216, DOI 10.1016/S0016-5085(03)00662-0; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; Elliott DA, 2000, INFECT IMMUN, V68, P2315, DOI 10.1128/IAI.68.4.2315-2322.2000; Feng GS, 1999, EXP CELL RES, V253, P47, DOI 10.1006/excr.1999.4668; Feng M, 2008, J CHILD NEUROL, V23, P287, DOI 10.1177/0883073807309247; Forney JR, 1999, INFECT IMMUN, V67, P844, DOI 10.1128/IAI.67.2.844-852.1999; Gandji LY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123472; Gut J, 1999, J EUKARYOT MICROBIOL, V46, p56S; Higashi H, 2004, J BIOL CHEM, V279, P17205, DOI 10.1074/jbc.M309964200; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Inagaki K, 2000, ONCOGENE, V19, P75, DOI 10.1038/sj.onc.1203204; Jacot D, 2012, INT J MED MICROBIOL, V302, P195, DOI 10.1016/j.ijmm.2012.07.012; Jiang J, 2013, WORLD J GASTROENTERO, V19, P575, DOI 10.3748/wjg.v19.i4.575; Kim M, 2010, VIRULENCE, V1, P52, DOI 10.4161/viru.1.1.10486; Li J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102847; Manes S, 1999, MOL CELL BIOL, V19, P3125; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Philpott N, 2011, J VIROL, V85, P1140, DOI 10.1128/JVI.01362-10; Ren Y, 2004, J BIOL CHEM, V279, P8497, DOI 10.1074/jbc.M312575200; Schaller MD, 2001, ONCOGENE, V20, P6459, DOI 10.1038/sj.onc.1204786; Smith HV, 2005, TRENDS PARASITOL, V21, P133, DOI 10.1016/j.pt.2005.01.007; Tsubouchi A, 2002, J CELL BIOL, V159, P673, DOI 10.1083/jcb.200202117; Tsuda M, 1998, J BIOL CHEM, V273, P13223, DOI 10.1074/jbc.273.21.13223; Valigurova A, 2008, INT J PARASITOL, V38, P913, DOI 10.1016/j.ijpara.2007.11.003; Varughese EA, 2014, J MICROBIOL METH, V106, P47, DOI 10.1016/j.mimet.2014.07.017; von Wichert G, 2003, EMBO J, V22, P5023, DOI 10.1093/emboj/cdg492; Walter AO, 1999, ONCOGENE, V18, P1911, DOI 10.1038/sj.onc.1202513; Ware MW, 2010, VET PARASITOL, V168, P329, DOI 10.1016/j.vetpar.2009.11.019; WHO, 2012, RES PRIOR ZOON MARG; Wilhelm CL, 2014, PARASITE IMMUNOL, V36, P409, DOI 10.1111/pim.12115; Yan DP, 2013, CELL SIGNAL, V25, P1887, DOI 10.1016/j.cellsig.2013.05.020; Zhang HL, 2012, INFECT IMMUN, V80, P1753, DOI 10.1128/IAI.05862-11; Zhang J, 2015, J CELL MOL MED, V19, P2075, DOI 10.1111/jcmm.12618	45	4	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142219	10.1371/journal.pone.0142219	http://dx.doi.org/10.1371/journal.pone.0142219			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556238	gold, Green Submitted, Green Published			2022-12-27	WOS:000364430700069
J	Wah, W; Earnest, A; Sabanayagam, C; Cheng, CY; Ong, MEH; Wong, TY; Lamoureux, EL				Wah, Win; Earnest, Arul; Sabanayagam, Charumathi; Cheng, Ching-Yu; Ong, Marcus Eng Hock; Wong, Tien Y.; Lamoureux, Ecosse L.			Composite Measures of Individual and Area-Level Socio-Economic Status Are Associated with Visual Impairment in Singapore	PLOS ONE			English	Article							URBAN ASIAN POPULATION; RISK-FACTORS; MACULAR DEGENERATION; SOCIAL INEQUALITIES; VISION IMPAIRMENT; EYE DISEASES; MALAY-EYE; PREVALENCE; DEPRIVATION; NEIGHBORHOOD	Purpose To investigate the independent relationship of individual-and area-level socio-economic status (SES) with the presence and severity of visual impairment (VI) in an Asian population. Methods Cross-sectional data from 9993 Chinese, Malay and Indian adults aged 40-80 years who participated in the Singapore Epidemiology of eye Diseases (2004-2011) in Singapore. Based on the presenting visual acuity (PVA) in the better-seeing eye, VI was categorized into normal vision (logMAR <= 0.30), low vision (logMAR>0.30<1.00), and blindness (logMAR >= 1.00). Any VI was defined as low vision/blindness in the PVA of better-seeing eye. Individual-level low-SES was defined as a composite of primary-level education, monthly income<2000 SGD and residing in 1 or 2-room public apartment. An area-level SES was assessed using a socio-economic disadvantage index (SEDI), created using 12 variables from the 2010 Singapore census. A high SEDI score indicates a relatively poor SES. Associations between SES measures and presence and severity of VI were examined using multi-level, mixed-effects logistic and multinomial regression models. Results The age-adjusted prevalence of any VI was 19.62% (low vision = 19%, blindness = 0.62%). Both individual-and area-level SES were positively associated with any VI and low vision after adjusting for confounders. The odds ratio (95% confidence interval) of any VI was 2.11 (1.88-2.37) for low-SES and 1.07(1.02-1.13) per 1 standard deviation increase in SEDI. When stratified by unilateral/bilateral categories, while low SES showed significant associations with all categories, SEDI showed a significant association with bilateral low vision only. The association between low SES and any VI remained significant among all age, gender and ethnic sub-groups. Although a consistent positive association was observed between area-level SEDI and any VI, the associations were significant among participants aged 40-65 years and male. Conclusion In this community-based sample of Asian adults, both individual-and area-level SES were independently associated with the presence and severity of VI.	[Wah, Win] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Ctr Infect Dis Epidemiol & Res, Singapore 117548, Singapore; [Earnest, Arul; Sabanayagam, Charumathi; Cheng, Ching-Yu; Ong, Marcus Eng Hock; Wong, Tien Y.; Lamoureux, Ecosse L.] Duke NUS Grad Med Sch, Singapore, Singapore; [Earnest, Arul] Monash Univ, Dept Epidemiol & Prevent Med, Sch Publ Hlth & Prevent Med, Melbourne, Vic 3004, Australia; [Sabanayagam, Charumathi; Cheng, Ching-Yu; Wong, Tien Y.; Lamoureux, Ecosse L.] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore; [Cheng, Ching-Yu] Natl Univ Singapore, Dept Ophthalmol, Singapore 117548, Singapore; [Cheng, Ching-Yu] Natl Univ Hlth Syst, Singapore, Singapore; [Ong, Marcus Eng Hock] Singapore Gen Hosp, Dept Emergency Med, Singapore, Singapore; [Lamoureux, Ecosse L.] Univ Melbourne, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic, Australia	National University of Singapore; National University of Singapore; Monash University; National University of Singapore; Singapore National Eye Center; National University of Singapore; National University of Singapore; Singapore General Hospital; Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne	Lamoureux, EL (corresponding author), Duke NUS Grad Med Sch, Singapore, Singapore.	ecosse.lamoureux@duke-nus.edu.sg	Lamoureux, Ecosse/Z-5482-2019; Sabanayagam, Charumathi/C-1294-2011; Wong, Tien Yin/AAC-9724-2020; Cheng, Ching-Yu/Y-2229-2019	Sabanayagam, Charumathi/0000-0002-4042-4719; Wong, Tien Yin/0000-0002-8448-1264; Cheng, Ching-Yu/0000-0003-0655-885X; Wah, Win/0000-0002-4242-5651	Biomedical Research Council (BMRC) [08/1/35/19/550]; National Medical Research Council (NMRC), Singapore [STaR/0003/2008]	Biomedical Research Council (BMRC)(Agency for Science Technology & Research (A*STAR)); National Medical Research Council (NMRC), Singapore(National Medical Research Council, Singapore)	This study was funded by Biomedical Research Council (BMRC), 08/1/35/19/550 and National Medical Research Council (NMRC), STaR/0003/2008, Singapore. The funding agencies had no role in the research presented in the paper, and the researchers were fully independent in pursuing this research.	Abou-Gareeb I, 2001, Ophthalmic Epidemiol, V8, P39, DOI 10.1076/opep.8.1.39.1540; Acharya N, 2009, BRIT J OPHTHALMOL, V93, P627, DOI 10.1136/bjo.2008.147231; Anderson CJ, 2010, APPL GEN LINEAR MIXE; BAILEY IL, 1976, AM J OPTOM PHYS OPT, V53, P740; Cheung CMG, 2013, AM J OPHTHALMOL, V155, P764, DOI 10.1016/j.ajo.2012.10.013; Cheung N, 2013, BRIT J OPHTHALMOL, V97, P785, DOI 10.1136/bjophthalmol-2012-302253; Chiang PPC, 2013, DIABETIC MED, V30, pE32, DOI 10.1111/dme.12053; Chong EW, 2009, ARCH OPHTHALMOL-CHIC, V127, P1640, DOI 10.1001/archophthalmol.2009.298; Cockburn N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030718; Crampton P SC, 1997, SOC POLICY J N Z, V9, P186; Department of Statistics, 2015, LIF EXP BIRTH 2015; Diez-Roux AV, 1998, AM J PUBLIC HEALTH, V88, P216, DOI 10.2105/AJPH.88.2.216; DiezRoux AV, 1997, AM J EPIDEMIOL, V146, P48, DOI 10.1093/oxfordjournals.aje.a009191; Earnest A, PREVENTIVE MED REPOR; Evans JMM, 2000, DIABETIC MED, V17, P478, DOI 10.1046/j.1464-5491.2000.00309.x; Foong AWP, 2007, OPHTHAL EPIDEMIOL, V14, P25, DOI 10.1080/09286580600878844; Fraser S, 2001, BMJ-BRIT MED J, V322, P639, DOI 10.1136/bmj.322.7287.639; Galster GC, 2012, NEIGHBOURHOOD EFFECT, DOI [DOI 10.1007/978-94-007-2309-2_2, 10.1007/978-94-007-2309-2_2]; Grilli L., 2006, REV RANDOM EFFECTS M; Halonen JI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032937; Jollife I. T., 1986, PRINCIPAL COMPONENT; Kelaher M, 2012, BMC OPHTHALMOL, V12, DOI 10.1186/1471-2415-12-51; Lamoreux EL, 2008, INVEST OPHTH VIS SCI, V49, P528, DOI 10.1167/iovs.07-1036; Lavanya R, 2009, BRIT J OPHTHALMOL, V93, P299, DOI 10.1136/bjo.2008.148650; Lavanya R, 2009, OPHTHAL EPIDEMIOL, V16, P325, DOI 10.3109/09286580903144738; Leow BG, 2001, CENSUS POPULATION 20; Li YJ, 2013, JAMA OPHTHALMOL, V131, P499, DOI 10.1001/jamaophthalmol.2013.1165; Malik ANJ, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001496; Marmamula S, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005125; McCarty CA, 2006, BRIT J OPHTHALMOL, V90, P521, DOI 10.1136/bjo.2006.090233; Ministry Of Education, 2014, ED STAT DIG 2014 MOU; Ministry Of Health, 2013, COSTS FIN 2013; Ministry Of Health, 2014, POP VIT STAT 2014; Ministry Of Health, 2014, HOSP BILL SIZ 2014; Morenoff JD, 2007, SOC SCI MED, V65, P1853, DOI 10.1016/j.socscimed.2007.05.038; MORRIS R, 1991, J PUBLIC HEALTH MED, V13, P318; Ng WS, 2010, BRIT J OPHTHALMOL, V94, P85, DOI 10.1136/bjo.2008.153312; Ostler K, 2001, BRIT J PSYCHIAT, V178, P12, DOI 10.1192/bjp.178.1.12; Pampalon R, 2009, HEALTH REP, V20, P85; Pujades-Rodriguez M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104671; Ulldemolins AR, 2012, INDIAN J OPHTHALMOL, V60, P368, DOI 10.4103/0301-4738.100529; Roux AVD, 2001, NEW ENGL J MED, V345, P99, DOI 10.1056/NEJM200107123450205; Singapore Department of Statistics, 2010, SING CENS POP 2010; Stata Corp L, STAT MULT MIX EFF RE; Su DHW, 2008, OPHTHALMOLOGY, V115, P964, DOI 10.1016/j.ophtha.2007.08.021; Thiagalingam S, 2002, BRIT J OPHTHALMOL, V86, P1041, DOI 10.1136/bjo.86.9.1041; TIELSCH JM, 1990, ARCH OPHTHALMOL-CHIC, V108, P286, DOI 10.1001/archopht.1990.01070040138048; TIELSCH JM, 1991, ARCH OPHTHALMOL-CHIC, V109, P637, DOI 10.1001/archopht.1991.01080050051027; Turrell G, 2001, INT J EPIDEMIOL, V30, P231, DOI 10.1093/ije/30.2.231; WHO, 2014, SOC ASP BLINDN VIS I; Wong TY, 2008, ARCH OPHTHALMOL-CHIC, V126, P1091, DOI 10.1001/archopht.126.8.1091; Wong TY, 2001, ARCH OPHTHALMOL-CHIC, V119, P727, DOI 10.1001/archopht.119.5.727; Wu RY, 2010, ARCH OPHTHALMOL-CHIC, V128, P1029, DOI 10.1001/archophthalmol.2010.147; Yip JL, 2013, J EPIDEMIOL COMMUNIT; Yip W, 2013, J HYPERTENS, V31, P1539, DOI 10.1097/HJH.0b013e328361d52b; Zheng Y, 2011, INVEST OPHTHALMOL, V52, P612; Zheng YF, 2011, INVEST OPHTH VIS SCI, V52, P8799, DOI 10.1167/iovs.11-7700; Zheng YF, 2011, INVEST OPHTH VIS SCI, V52, P7634, DOI 10.1167/iovs.11-7725; Zhuang J, 2014, E ASIAN BUREAU EC RE	59	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142302	10.1371/journal.pone.0142302	http://dx.doi.org/10.1371/journal.pone.0142302			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7CT	26555141	gold, Green Published			2022-12-27	WOS:000364430700080
J	Xu, H; Bao, JD; Dai, JS; Li, YQ; Zhu, Y				Xu, Heng; Bao, Jian-Dong; Dai, Ji-Song; Li, Yongqing; Zhu, Ying			Genome-Wide Identification of New Reference Genes for qRT-PCR Normalization under High Temperature Stress in Rice Endosperm	PLoS One			English	Article							REAL-TIME PCR; DEFINING REFERENCE GENES; ALPHA-AMYLASE GENES; HOUSEKEEPING GENES; RT-PCR; INTERNAL CONTROL; EXPRESSION; VALIDATION; SELECTION; QUALITY	qRT-PCR is one of the most popular approaches to analyze specific gene expression level, and stably expressed reference genes are essential to obtain reliable results. However, many reference genes are only stable under certain circumstances and different reference genes might be required in different experiments. High temperature is a common stress that affects rice endosperm development and it has become a hot topic recently. Although study about reference genes at different developmental stages in rice has been reported, these genes may not be suitable to study high temperature mediated responses especially in endosperm. In our quest for proper reference genes to quantify gene expression in rice endosperm under high temperature, we studied 6 candidate genes selected from the transcriptome data and 11 housekeeping genes. All genes were analyzed with qRT-PCR and the expression stability was assessed with software geNorm and NormFinder. Fb15 and eIF-4a were identified as the two most stable genes in endosperm at different developmental stages, while high temperature treatment has a least effect on expression of Fb15 and UBQ5 in rice endosperm. Our results provide some good candidate reference genes for qRT-PCR normalization in rice endosperm under different temperatures.	[Xu, Heng; Dai, Ji-Song; Zhu, Ying] Zhejiang Acad Agr Sci, State Key Lab Breeding Base Zhejiang Sustainable, Hangzhou 310021, Zhejiang, Peoples R China; [Bao, Jian-Dong] Fujian Agr & Forestry Univ, Coll Life Sci, Fujian Taiwan Joint Ctr Ecol Control Crop Pests, Fuzhou 350002, Peoples R China; [Li, Yongqing] Chinese Acad Sci, Key Lab South China Agr Plant Mol Anal & Genet Im, South China Bot Garden, Guangzhou 510650, Guangdong, Peoples R China	Zhejiang Academy of Agricultural Sciences; Fujian Agriculture & Forestry University; Chinese Academy of Sciences; South China Botanical Garden, CAS	Zhu, Y (corresponding author), Zhejiang Acad Agr Sci, State Key Lab Breeding Base Zhejiang Sustainable, Hangzhou 310021, Zhejiang, Peoples R China.	yzhuzaas@163.com	Bao, Jiandong/AAG-7303-2020	Bao, Jiandong/0000-0003-3423-5118	Ministry of Science and Technology [2012CB944803, 2012AA10A302]; Zhejiang Province Natural Science Foundation [LQ13C020002]; Zhejiang Natural Science Funds for Distinguished Young Scientists [LR14C020001]; National Natural Science Foundation of China [31400230]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Zhejiang Province Natural Science Foundation(Natural Science Foundation of Zhejiang Province); Zhejiang Natural Science Funds for Distinguished Young Scientists; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the grants from Ministry of Science and Technology (2012CB944803 and 2012AA10A302) to YZ, Zhejiang Province Natural Science Foundation (LQ13C020002) to HX, Zhejiang Natural Science Funds for Distinguished Young Scientists (LR14C020001) to YZ and National Natural Science Foundation of China (31400230) to HX.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen PW, 2006, PLANT CELL, V18, P2326, DOI 10.1105/tpc.105.038844; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Hakata M, 2012, PLANT BIOTECHNOL J, V10, P1110, DOI 10.1111/j.1467-7652.2012.00741.x; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Jain M, 2009, PLANT SCI, V176, P702, DOI 10.1016/j.plantsci.2009.02.001; Ji YX, 2014, ACTA BIOCH BIOPH SIN, V46, P305, DOI 10.1093/abbs/gmu002; Kim BR, 2003, BIOTECHNOL LETT, V25, P1869, DOI 10.1023/A:1026298032009; Lee PD, 2002, GENOME RES, V12, P292, DOI 10.1101/gr.217802; Li HX, 2011, PLANT CELL REP, V30, P1641, DOI 10.1007/s00299-011-1074-2; Li QF, 2010, PLANT MOL BIOL REP, V28, P49, DOI 10.1007/s11105-009-0124-1; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Narsai R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-56; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; She KC, 2010, PLANT CELL, V22, P3280, DOI 10.1105/tpc.109.070821; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang JC, 2013, J EXP BOT, V64, P3453, DOI 10.1093/jxb/ert187; Xue LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031081; Yamakawa H, 2007, PLANT PHYSIOL, V144, P258, DOI 10.1104/pp.107.098665	25	19	22	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142015	10.1371/journal.pone.0142015	http://dx.doi.org/10.1371/journal.pone.0142015			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555942	Green Published, gold, Green Submitted			2022-12-27	WOS:000364430700047
J	Yv, FL; Hai, XX; Wang, ZG; Yan, AH; Liu, BX; Bi, YG				Yv, Fei L.; Hai, Xiaoxia; Wang, Zhigang; Yan, Aihua; Liu, Bingxiang; Bi, Yongguo			Integration of Visual and Olfactory Cues in Host Plant Identification by the Asian Longhorned Beetle, Anoplophora glabripennis (Motschulsky) (Coleoptera: Cerambycidae)	PLOS ONE			English	Article							SPOTTED LONGICORN BEETLE; MALE-PRODUCED PHEROMONE; MALASIACA THOMSON COLEOPTERA; ORIENTATION BEHAVIOR; RECOGNITION; POPULATIONS; ATTRACTION; VOLATILES; FECUNDITY; TRAP	Some insects use host and mate cues, including odor, color, and shape, to locate and recognize their preferred hosts and mates. Previous research has shown that the Asian longicorn beetle, Anoplophora glabripennis (Motschulsky), uses olfactory cues to locate host plants and differentiate them from non-host plants. However, whether A. glabripennis adults use visual cues or a combination of visual and olfactory cues remains unclear. In this study, we tested the host location and recognition behavior in A. glabripennis, which infests a number of hardwood species and causes considerable economic losses in North America, Europe and Asia. We determined the relative importance of visual and olfactory cues from Acer negundo in host plant location and recognition, as well as in the discrimination of non-host plants (Sabina chinensis and Pinus bungeana), by female and male A. glabripennis. Visual and olfactory cues from the host plants (A. negundo), alone and combined, attracted significantly more females and males than equivalent cues from non-host plants (S. chinensis and P. bungeana). Furthermore, the combination of visual and olfactory cues of host plants attracted more adults than either cue alone, and visual cues alone attracted significantly more adults than olfactory cues alone. This finding suggests that adult A. glabripennis has an innate preference for the visual and/or olfactory cues of its host plants (A. negundo) over those of the non-host plant and visual cues are initially more important than olfactory cues for orientation; furthermore, this finding also suggests that adults integrate visual and olfactory cues to find their host plants. Our results indicate that different modalities of host plant cues should be considered together to understand fully the communication between host plants and Asian longhorned beetles.	[Yv, Fei L.; Hai, Xiaoxia; Wang, Zhigang; Yan, Aihua; Liu, Bingxiang; Bi, Yongguo] Univ Agr, Coll Forestry, Baoding 071000, Hebei, Peoples R China; [Yv, Fei L.; Hai, Xiaoxia; Wang, Zhigang; Yan, Aihua; Liu, Bingxiang; Bi, Yongguo] Key Labs Germplasm Resources Forest Trees & Fores, Baoding 071000, Peoples R China		Wang, ZG (corresponding author), Univ Agr, Coll Forestry, Baoding 071000, Hebei, Peoples R China.	wzhg432@163.com			Program of National Natural Science of China [C30571501]	Program of National Natural Science of China(National Natural Science Foundation of China (NSFC))	This project was supported by the Program of National Natural Science of China (No. C30571501).	Andersson P, 2011, ARTHROPOD-PLANT INTE, V5, P269, DOI 10.1007/s11829-011-9148-1; [Anonymous], 2012, IBM SPSS STAT VERS 2; Bahlai CA, 2008, ENVIRON ENTOMOL, V37, P973, DOI 10.1603/0046-225X(2008)37[973:ROVAOC]2.0.CO;2; Benelli G, 2013, BIOL CONTROL, V64, P116, DOI 10.1016/j.biocontrol.2012.10.010; Burger H, 2010, FUNCT ECOL, V24, P1234, DOI 10.1111/j.1365-2435.2010.01744.x; Campbell SA, 2009, OIKOS, V118, P553, DOI 10.1111/j.1600-0706.2009.16761.x; Crook DJ, 2014, J CHEM ECOL, V40, P1241, DOI 10.1007/s10886-014-0520-3; Dotterl S, 2011, J COMP PHYSIOL A, V197, P1119, DOI 10.1007/s00359-011-0673-2; Fischer S, 2001, J COMP PHYSIOL A, V187, P785, DOI 10.1007/s00359-001-0249-7; Fukaya M, 2005, APPL ENTOMOL ZOOL, V40, P63, DOI 10.1303/aez.2005.63; Fukaya M, 2004, ENTOMOL EXP APPL, V111, P111, DOI 10.1111/j.0013-8703.2004.00147.x; Ginzel MD, 2003, J INSECT BEHAV, V16, P181, DOI 10.1023/A:1023911701159; Guo FZ, 2005, SCIENCE, V309, P307, DOI 10.1126/science.1111280; Haack RA, 2010, ANNU REV ENTOMOL, V55, P521, DOI 10.1146/annurev-ento-112408-085427; Hanks LM, 1999, ANNU REV ENTOMOL, V44, P483, DOI 10.1146/annurev.ento.44.1.483; He Ping, 1993, Acta Entomologica Sinica, V36, P51; Henneman ML, 2002, J CHEM ECOL, V28, P2221, DOI 10.1023/A:1021097215572; Hu JF, 2009, AGR FOREST ENTOMOL, V11, P359, DOI 10.1111/j.1461-9563.2009.00443.x; Jin Youju, 2004, Scientia Silvae Sinicae, V40, P99; Keena MA, 2002, ENVIRON ENTOMOL, V31, P490, DOI 10.1603/0046-225X-31.3.490; Kerr JL, 2010, THESIS U CANTERBURY, P57; Li Dejia, 1999, Journal of Beijing Forestry University, V21, P33; Li HX, 2008, J HEILONGJIANG VOCAT, V21, P23; Liu Bo, 2012, Zhejiang Nonglin Daxue Xuebao, V29, P617; Lu W, 2007, ENVIRON ENTOMOL, V36, P864, DOI 10.1603/0046-225X(2007)36[864:MLARIG]2.0.CO;2; McIntosh RL, 2001, AGR FOREST ENTOMOL, V3, P113, DOI 10.1046/j.1461-9563.2001.00095.x; McQuate GT, 2014, SCI REP-UK, V4, DOI 10.1038/srep04499; Meng PS, 2014, ENVIRON ENTOMOL, V43, P1379, DOI 10.1603/EN14129; Milet-Pinheiro P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128577; Milet-Pinheiro P, 2012, BEHAV ECOL, V23, P531, DOI 10.1093/beheco/arr219; Nehme ME, 2010, ENVIRON ENTOMOL, V39, P169, DOI 10.1603/EN09177; Nehme ME, 2009, ENVIRON ENTOMOL, V38, P1745, DOI 10.1603/022.038.0628; Otalora-Luna F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053120; Raguso RA, 2002, ANIM BEHAV, V64, P685, DOI 10.1006/anbe.2002.4010; Schaefer HM, 2004, TRENDS ECOL EVOL, V19, P577, DOI 10.1016/j.tree.2004.08.003; Smith MT, 2002, ENVIRON ENTOMOL, V31, P76, DOI 10.1603/0046-225X-31.1.76; Song B, 2015, J PLANT ECOL, V8, P173, DOI 10.1093/jpe/rtv012; van der Gaag D. J., 2014, Bulletin OEPP, V44, P518, DOI 10.1111/epp.12151; Wang PY, 2015, ENTOMOL EXP APPL, V155, P162, DOI 10.1111/eea.12295; Wang T, 2004, FOREST PEST DIS, V5, P42; Wang Z.G., 2004, STUDY OCCURRENCE DYN; Webster B, 2010, ANIM BEHAV, V79, P451, DOI 10.1016/j.anbehav.2009.11.028; Wickham JD, 2012, INSECT SCI, V19, P355, DOI 10.1111/j.1744-7917.2012.01504.x; Yasui H, 2008, CHEMOECOLOGY, V18, P233, DOI 10.1007/s00049-008-0410-7; Yasui H, 2011, CHEMOECOLOGY, V21, P51, DOI 10.1007/s00049-010-0065-z; Zhang AJ, 2003, NATURWISSENSCHAFTEN, V90, P410, DOI 10.1007/s00114-003-0452-1; Zhang AJ, 2002, Z NATURFORSCH C, V57, P553; [张风娟 ZHANG FengJuan], 2006, [生态学报, Acta Ecologica Sinica], V26, P870; Zhou ZhongShi, 2011, Entomologia Experimentalis et Applicata, V138, P48, DOI 10.1111/j.1570-7458.2010.01074.x	49	6	6	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142752	10.1371/journal.pone.0142752	http://dx.doi.org/10.1371/journal.pone.0142752			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556100	Green Submitted, gold, Green Published			2022-12-27	WOS:000364430700168
J	Song, KD; Wang, R; Liu, Y; Qian, DP; Zhang, H; Cai, JH				Song, Kaida; Wang, Rui; Liu, Yi; Qian, Depei; Zhang, Han; Cai, Jihong			Game Theoretical Analysis on Cooperation Stability and Incentive Effectiveness in Community Networks	PLOS ONE			English	Article							EVOLUTION	Community networks, the distinguishing feature of which is membership admittance, appear on P2P networks, social networks, and conventional Web networks. Joining the network costs money, time or network bandwidth, but the individuals get access to special resources owned by the community in return. The prosperity and stability of the community are determined by both the policy of admittance and the attraction of the privileges gained by joining. However, some misbehaving users can get the dedicated resources with some illicit and low-cost approaches, which introduce instability into the community, a phenomenon that will destroy the membership policy. In this paper, we analyze on the stability using game theory on such a phenomenon. We propose a game-theoretical model of stability analysis in community networks and provide conditions for a stable community. We then extend the model to analyze the effectiveness of different incentive policies, which could be used when the community cannot maintain its members in certain situations. Then we verify those models through a simulation. Finally, we discuss several ways to promote community network's stability by adjusting the network's properties and give some proposal on the designs of these types of networks from the points of game theory and stability.	[Song, Kaida; Wang, Rui] Beihang Univ, State Key Lab Software Dev Environm, Beijing 100191, Peoples R China; [Song, Kaida; Wang, Rui; Liu, Yi; Qian, Depei] Beihang Univ, Sch Comp Sci & Engn, Beijing 100191, Peoples R China; [Zhang, Han; Cai, Jihong] Beijing Simulat Ctr, Sci & Technol Special Syst Simulat Lab, Beijing, Peoples R China	Beihang University; Beihang University	Wang, R (corresponding author), Beihang Univ, State Key Lab Software Dev Environm, Beijing 100191, Peoples R China.	wangrui@buaa.edu.cn						Acres J., 2001, U.S. Patent, Patent No. [6,244,958, 6244958]; Aggarwal V., 2008, PAR DISTR NETW BAS P; Andrade N., 2005, P 2005 ACM IGCOMM WO; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Ballester C, 2006, ECONOMETRICA, V74, P1403, DOI 10.1111/j.1468-0262.2006.00709.x; Bharambe A R, 2008, BITTORRENT IS AUCTIO; Challet D, 1997, PHYSICA A, V246, P407, DOI 10.1016/S0378-4371(97)00419-6; Chen B. B., 2010, NEUR NETW IJCNN 2010, P1; Chen X, 2012, IET COMMUN, V6, P1640, DOI 10.1049/iet-com.2011.0196; Cohen B., 2003, WORKSH EC PEER TO PE, V6, P68; Cohill A M, 1997, COMMUNITY NETWORKS L; DASPREMONT C, 1983, CAN J ECON, V16, P17, DOI 10.2307/134972; FRIEDMAN JW, 1971, REV ECON STUD, V38, P1, DOI 10.2307/2296617; Goyal S, 2001, RAND J ECON, V32, P686, DOI 10.2307/2696388; Habib A, 2004, INT WORKSH QUAL SERV, P171; Huang K., 2015, PLOS ONE, V10; Huang KK, 2015, APPL MATH COMPUT, V266, P501, DOI 10.1016/j.amc.2015.05.065; Lian Q., 2006, 5 INT WORKSH PEER TO; Ma R. T. B., 2003, Performance Evaluation Review, V31, P23, DOI 10.1145/959143.959157; Mougi A, 2014, J THEOR BIOL, V360, P54, DOI 10.1016/j.jtbi.2014.06.030; NOE R, 1990, ANIM BEHAV, V39, P78, DOI 10.1016/S0003-3472(05)80728-6; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Peng Z., 2007, DIG SOC 2007 ICDS 07; Perc M, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011904; Perc M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015117; Rand DG, 2011, P NATL ACAD SCI USA, V108, P19193, DOI 10.1073/pnas.1108243108; Rapoport A., 1965, PRISONERS DILEMMA ST; Roos Patrick, 2009, EVOLUTIONARY GAME TH; Rozario Fabian, 2011, WIR COMM NETW C WCNC; Schlessinger D, 1993, MECH MICROBIAL DIS, P162; Tan G, 2006, INT WORKSH QUAL SERV, P41, DOI 10.1109/IWQOS.2006.250450; Wang T. M., 2012, ADV INF NETW APPL WO; Wang Z, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.021115; Weibull J W, 1997, EVOLUTIONARY GAME TH; Wu TY, 2014, J NETW COMPUT APPL, V41, P47, DOI 10.1016/j.jnca.2013.10.006; Wu WJ, 2012, IEEE T PARALL DISTR, V23, P1492, DOI 10.1109/TPDS.2011.295; Yao L., 2011, EL COMM CONTR ICECC; Zhang C, 2011, IEEE T PARALL DISTR, V22, P1164, DOI 10.1109/TPDS.2010.123	38	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2015	10	11							e0141755	10.1371/journal.pone.0141755	http://dx.doi.org/10.1371/journal.pone.0141755			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7AC	26551649	Green Published, Green Submitted, gold			2022-12-27	WOS:000364422800009
J	Gallio, E; Rampado, O; Gianaria, E; Bianchi, SD; Ropolo, R				Gallio, Elena; Rampado, Osvaldo; Gianaria, Elena; Bianchi, Silvio Diego; Ropolo, Roberto			A GPU Simulation Tool for Training and Optimisation in 2D Digital X-Ray Imaging	PLOS ONE			English	Article							DISTRIBUTIONS; RADIATION; ACCURATE; PHANTOMS; SPECTRA	Conventional radiology is performed by means of digital detectors, with various types of technology and different performance in terms of efficiency and image quality. Following the arrival of a new digital detector in a radiology department, all the staff involved should adapt the procedure parameters to the properties of the detector, in order to achieve an optimal result in terms of correct diagnostic information and minimum radiation risks for the patient. The aim of this study was to develop and validate a software capable of simulating a digital Xray imaging system, using graphics processing unit computing. All radiological image components were implemented in this application: an X-ray tube with primary beam, a virtual patient, noise, scatter radiation, a grid and a digital detector. Three different digital detectors (two digital radiography and a computed radiography systems) were implemented. In order to validate the software, we carried out a quantitative comparison of geometrical and anthropomorphic phantom simulated images with those acquired. In terms of average pixel values, the maximum differences were below 15%, while the noise values were in agreement with a maximum difference of 20%. The relative trends of contrast to noise ratio versus beamenergy and intensity were well simulated. Total calculation times were below 3 seconds for clinical images with pixel size of actual dimensions less than 0.2 mm. The application proved to be efficient and realistic. Short calculation times and the accuracy of the results obtained make this software a useful tool for training operators and dose optimisation studies.	[Gallio, Elena; Rampado, Osvaldo; Ropolo, Roberto] AOU Citta Salute & Sci, SC Fis Sanit, Turin, Italy; [Gianaria, Elena] Univ Turin, Dept Comp Sci, Turin, Italy; [Bianchi, Silvio Diego] Univ Turin, Dept Surg Sci, Turin, Italy	A.O.U. Citta della Salute e della Scienza di Torino; University of Turin; University of Turin	Gallio, E (corresponding author), AOU Citta Salute & Sci, SC Fis Sanit, Turin, Italy.	orampado@cittadellasalute.to.it; egallio@cittadellasalute.to.it		Gallio, Elena/0000-0003-1388-061X				Al Tahli S, P SPIE MED IMAGING 2, DOI [10.1117/12.812255, DOI 10.1117/12.812255]; Associazione Italianadi Fisica Medica, 2009, 6 ASS IT FIS MED; Bath M, 2005, RADIAT PROT DOSIM, V114, P253, DOI 10.1093/rpd/nch540; BIRCH R, 1979, PHYS MED BIOL, V24, P505, DOI 10.1088/0031-9155/24/3/002; Bontempi M, 2012, MED PHYS, V39, P7677, DOI 10.1118/1.4767768; Boone JM, 1997, MED PHYS, V24, P1661, DOI 10.1118/1.597953; BOX GEP, 1958, ANN MATH STAT, V29, P610, DOI 10.1214/aoms/1177706645; Duvauchelle P, 2000, NUCL INSTRUM METH B, V170, P245, DOI 10.1016/S0168-583X(00)00185-3; Fanti V, 2005, MED ENG PHYS, V27, P555, DOI 10.1016/j.medengphy.2004.11.010; Freud N, 2004, NUCL INSTRUM METH B, V222, P285, DOI 10.1016/j.nimb.2004.01.001; Gianaria E, 2015, 23RD EUROMICRO INTERNATIONAL CONFERENCE ON PARALLEL, DISTRIBUTED, AND NETWORK-BASED PROCESSING (PDP 2015), P669, DOI 10.1109/PDP.2015.55; International Commission of Radiation Protection, 1989, TISS SUBST RAD DOS M, V44; Jia X, 2012, MED PHYS, V39, P7368, DOI 10.1118/1.4766436; Kohler T, 2000, NUCL SCI S 2000 IEEE; Lazos D, 2003, COMPUT METH PROG BIO, V70, P241, DOI 10.1016/S0169-2607(02)00015-9; Mohanty S, 2012, J PHYS CONF SER, V368, DOI 10.1088/1742-6596/368/1/012024; Moore CS, 2011, BRIT J RADIOL, V84, P890, DOI 10.1259/bjr/30125639; Na YH, 2010, PHYS MED BIOL, V55, P3789, DOI 10.1088/0031-9155/55/13/015; Nickolls John, 2008, ACM Queue, V6, DOI 10.1145/1365490.1365500; nstitute of Physics and Engineering in Medicine, 2010, 32 IPEM 7; PARK SK, 1988, COMMUN ACM, V31, P1192, DOI 10.1145/63039.63042; Pratx G, 2011, MED PHYS, V38, P2685, DOI 10.1118/1.3578605; Rivetti S, 2010, MED PHYS, V37, P440, DOI 10.1118/1.3284539; Samei E, 2003, MED PHYS, V30, P608, DOI 10.1118/1.1561285; Son IY, 2006, PHYS MED BIOL, V51, P4289, DOI 10.1088/0031-9155/51/17/011; TAUSWORTHE RC, 1965, MATH COMPUT, V19, P201, DOI 10.2307/2003345; Ullman G, 2005, RADIAT PROT DOSIM, V114, P355, DOI 10.1093/rpd/nch530; Winslow M, 2005, COMPUT METH PROG BIO, V78, P179, DOI 10.1016/j.cmpb.2005.02.004; YAFFE MJ, 1983, J APPL PHOTOGR ENG, V9, P184	29	5	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141497	10.1371/journal.pone.0141497	http://dx.doi.org/10.1371/journal.pone.0141497			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26545097	Green Submitted, Green Published, gold			2022-12-27	WOS:000364398700027
J	Kartika, T; Shimizu, N; Yoshimura, T				Kartika, Titik; Shimizu, Nobuhiro; Yoshimura, Tsuyoshi			Identification of Esters as Novel Aggregation Pheromone Components Produced by the Male Powder-Post Beetle, Lyctus africanus Lesne (Coleoptera: Lyctinae)	PLoS One			English	Article							TRUNCATUS HORN COLEOPTERA; LARGER GRAIN BORER; PROSTEPHANUS-TRUNCATUS; RHYZOPERTHA-DOMINICA; BEHAVIORAL-RESPONSES; BOSTRICHIDAE; LYCTIDAE	Lyctus africanus is a cosmopolitan powder-post beetle that is considered one of the major pests threatening timber and timber products. Because infestations of this beetle are inconspicuous, damage is difficult to detect and identification is often delayed. We identified the chemical compounds involved in the aggregation behavior of L. africanus using preparations of crude hexanic extracts from male and female beetles (ME and FE, respectively). Both male and female beetles showed significant preferences for ME, which was found to contain three esters. FE was ignored by both the sexes. Further bioassay confirmed the role of esters in the aggregation behavior of L. africanus. Three esters were identified as 2-propyl dodecanoate, 3-pentyl dodecanoate, and 3-pentyl tetradecanoate. Further behavioral bioassays revealed 3-pentyl dodecanoate to play the main role in the aggregation behavior of female L. africanus beetles. However, significantly more beetles aggregated on a paper disk treated with a blend of the three esters than on a paper disk treated with a single ester. This is the first report on pheromone identification in L. africanus; in addition, the study for the first time presents 3-pentyl dodecanoate as an insect pheromone.	[Kartika, Titik] Indonesian Inst Sci, Res Ctr Biomat, Java, Indonesia; [Yoshimura, Tsuyoshi] Kyoto Univ, Res Inst Sustainable Humanosphere, Uji, Kyoto, Japan; [Shimizu, Nobuhiro] Kyoto Gakuen Univ, Fac Bioenvironm Sci, Kameoka, Japan	Indonesian Institute of Sciences; Kyoto University	Kartika, T (corresponding author), Kyoto Univ, Res Inst Sustainable Humanosphere, Uji, Kyoto, Japan.	titikkartika@biomaterial.lipi.go.id		Shimizu, Nobuhiro/0000-0002-8658-6887; Kartika, Titik/0000-0002-9185-0400				Abood F, 2006, J TROP FOR SCI, V18, P250; Altson A. M., 1923, Journal of the Linnean Society London Zoology, V35, P217; BURKHOLDER WE, 1985, ANNU REV ENTOMOL, V30, P257, DOI 10.1146/annurev.en.30.010185.001353; CORK A, 1991, J CHEM ECOL, V17, P789, DOI 10.1007/BF00994201; CRUZLOPEZ L, 1993, MEM I OSWALDO CRUZ, V88, P535, DOI 10.1590/S0074-02761993000400006; Ebeling W., 1978, URBAN ENTOMOLOGY, P167; Edde PA, 2006, ENTOMOL EXP APPL, V119, P255, DOI 10.1111/j.1570-7458.2006.00417.x; Fadamiro HY, 1996, J STORED PROD RES, V32, P163, DOI 10.1016/0022-474X(96)00003-3; FAUSTINI DL, 1982, J CHEM ECOL, V8, P679, DOI 10.1007/BF00988309; FRANCKE W, 1979, ANGEW CHEM INT EDIT, V18, P796, DOI 10.1002/anie.197907961; Furstenau B, 2013, CHEMBIOCHEM, V14, P1450, DOI 10.1002/cbic.201300247; Furukawa N., 2009, WOOD PRESERV, V35, P260, DOI DOI 10.5990/JWPA.35.260; Gerberg E.J, 1957, REVISION NEW WORLD S; Halperin J, 1999, PHYTOPARASITICA, V27, P257, DOI 10.1007/BF02981481; IMAI T, 1990, APPL ENTOMOL ZOOL, V25, P113, DOI 10.1303/aez.25.113; Iwata R, 1982, KOKU GAICHU HOUSE HO, P60; Iwata R, 1988, ACTA COLEOPTEROLOGIC, V1, P68; KHORRAMSHAHI A, 1981, J CHEM ECOL, V7, P33, DOI 10.1007/BF00988633; Korada RR, 2009, CHEMOECOLOGY, V19, P177, DOI 10.1007/s00049-009-0020-z; LEVINSON HZ, 1978, NATURWISSENSCHAFTEN, V65, P543, DOI 10.1007/BF00439806; Mito Toshikazu, 2004, Global Environmental Research, V8, P171; Peters B. C., 2002, Australian Forestry, V65, P107; Scholz D, 1998, PHYSIOL ENTOMOL, V23, P265, DOI 10.1046/j.1365-3032.1998.233089.x; Scholz D, 1997, ENTOMOL EXP APPL, V83, P53, DOI 10.1023/A:1002919705200; Schulz S, 2004, CHEMBIOCHEM, V5, P1500, DOI 10.1002/cbic.200400110; Shimizu N, 2012, J CHEM ECOL, V38, P23, DOI 10.1007/s10886-012-0063-4; TORTO B, 1994, J CHEM ECOL, V20, P1749, DOI 10.1007/BF02059896; YINON U., 1967, J STORED PROD RES, V3, P251, DOI 10.1016/0022-474X(67)90051-3	28	9	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141799	10.1371/journal.pone.0141799	http://dx.doi.org/10.1371/journal.pone.0141799			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544984	Green Published, gold, Green Submitted			2022-12-27	WOS:000364398700050
J	Kropp, J; Roti, ECR; Ringelstetter, A; Khatib, H; Abbott, DH; Salih, SM				Kropp, Jenna; Roti, Elon C. Roti; Ringelstetter, Ashley; Khatib, Hasan; Abbott, David H.; Salih, Sana M.			Dexrazoxane Diminishes Doxorubicin-Induced Acute Ovarian Damage and Preserves Ovarian Function and Fecundity in Mice	PLOS ONE			English	Article							DOSE DENSE CHEMOTHERAPY; ADVANCED BREAST-CANCER; PROVIDES CARDIOPROTECTION; FERTILITY PRESERVATION; CLINICAL-TRIAL; FEMALE MICE; PHASE-III; EPIRUBICIN; PACLITAXEL; WOMEN	Advances in cancer treatment utilizing multiple chemotherapies have dramatically increased cancer survivorship. Female cancer survivors treated with doxorubicin (DXR) chemotherapy often suffer from an acute impairment of ovarian function, which can persist as long-term, permanent ovarian insufficiency. Dexrazoxane (Dexra) pretreatment reduces DXR-induced insult in the heart, and protects in vitro cultured murine and non-human primate ovaries, demonstrating a drug-based shield to prevent DXR insult. The present study tested the ability of Dexra pretreatment to mitigate acute DXR chemotherapy ovarian toxicity in mice through the first 24 hours post-treatment, and improve subsequent long-term fertility throughout the reproductive lifespan. Adolescent CD-1 mice were treated with Dexra 1 hour prior to DXR treatment in a 1:1 mg or 10:1 mg Dexra:DXR ratio. During the acute injury period (2-24 hours post-injection), Dexra pretreatment at a 1:1 mg ratio decreased the extent of double strand DNA breaks, diminished.H2FAX activation, and reduced subsequent follicular cellular demise caused by DXR. In fertility and fecundity studies, dams pre-treated with either Dexra:DXR dose ratio exhibited litter sizes larger than DXR-treated dams, and mice treated with a 1:1 mg Dexra:DXR ratio delivered pups with birth weights greater than DXR-treated females. While DXR significantly increased the "infertility index" (quantifying the percentage of dams failing to achieve pregnancy) through 6 gestations following treatment, Dexra pretreatment significantly reduced the infertility index following DXR treatment, improving fecundity. Low dose Dexra not only protected the ovaries, but also bestowed a considerable survival advantage following exposure to DXR chemotherapy. Mouse survivorship increased from 25% post-DXR treatment to over 80% with Dexra pretreatment. These data demonstrate that Dexra provides acute ovarian protection from DXR toxicity, improving reproductive health in a mouse model, suggesting this clinically available drug may provide ovarian protection for cancer patients.	[Kropp, Jenna; Khatib, Hasan] Univ Wisconsin, Dept Anim Sci, Madison, WI USA; [Kropp, Jenna; Roti, Elon C. Roti; Ringelstetter, Ashley; Abbott, David H.; Salih, Sana M.] Univ Wisconsin, Dept Obstet & Gynecol, Madison, WI 53706 USA; [Roti, Elon C. Roti] Univ Wisconsin, Dept Med, Madison, WI USA; [Abbott, David H.] Wisconsin Natl Primate Res Ctr, Madison, WI 53715 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Salih, SM (corresponding author), Univ Wisconsin, Dept Obstet & Gynecol, Madison, WI 53706 USA.	sanasalih5@gmail.com	Khatib, Hasan/AAA-2693-2021		University of Wisconsin start up and Research and Development funds [MSN132883]; Wisconsin Alumni Research Foundation [MSN162253]; NIH training grant [K12 HD0558941]; University of Wisconsin Cancer Center Support Grant [P30CA014520]; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER	University of Wisconsin start up and Research and Development funds; Wisconsin Alumni Research Foundation; NIH training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Wisconsin Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the University of Wisconsin start up and Research and Development funds (MSN132883), Wisconsin Alumni Research Foundation (MSN162253), and NIH training grant K12 HD0558941 to SMS; and by University of Wisconsin Cancer Center Support Grant P30CA014520.	American Cancer Society, 2014, CANC FACTS FIG; ATAYA K, 1995, BIOL REPROD, V52, P365, DOI 10.1095/biolreprod52.2.365; Aubert N, 2008, NEUROBIOL DIS, V32, P66, DOI 10.1016/j.nbd.2008.06.014; Bar J, 2003, AM J OBSTET GYNECOL, V189, P853, DOI 10.1067/S0002-9378(03)00837-8; Bar-Joseph H, 2010, REPROD TOXICOL, V30, P566, DOI 10.1016/j.reprotox.2010.07.003; Bates M, 1997, CLIN THER, V19, P167, DOI 10.1016/S0149-2918(97)80084-7; Behringer K, 2010, ANN ONCOL, V21, P2052, DOI 10.1093/annonc/mdq066; Ben-Aharon I, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-20; Beretta GL, 2008, EXPERT OPIN THER TAR, V12, P1243, DOI [10.1517/14728222.12.10.1243, 10.1517/14728222.12.10.1243 ]; Calve A, 2012, CAN J PHYSIOL PHARM, V90, P1527, DOI 10.1139/y2012-126; Davis VL, 2006, CANCER-AM CANCER SOC, V107, P1690, DOI 10.1002/cncr.22105; De Giorgi U, 2005, BONE MARROW TRANSPL, V35, pS256; De Giorgi U, 2003, BONE MARROW TRANSPL, V32, P251, DOI 10.1038/sj.bmt.1704125; De Giorgi U, 2006, INT J RADIAT ONCOL, V65, P1165, DOI 10.1016/j.ijrobp.2006.02.018; De Vos M, 2014, LANCET, V384, P1302, DOI 10.1016/S0140-6736(14)60834-5; Deng SW, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-842; Doroshow JH, 2012, CURR PHARM BIOTECHNO, V13, P1949; FDA, 2011, FDA STAT DEXR; Flaws JA, 1997, BIOL REPROD, V57, P1233, DOI 10.1095/biolreprod57.5.1233; Fowden AL, 2006, PHYSIOLOGY, V21, P29, DOI 10.1152/physiol.00050.2005; Frassineti GL, 2005, J CLIN ONCOL, V23, p102S; Gewirtz DA, 1999, BIOCHEM PHARMACOL, V57, P727, DOI 10.1016/S0006-2952(98)00307-4; Gonfloni S, 2009, NAT MED, V15, P1179, DOI 10.1038/nm.2033; Green DN, 2002, AM J OBSTET GYNECOL, V187, P1070, DOI 10.1067/mob.2002.126643; HOCHSTER H, 1992, J NATL CANCER I, V84, P1725, DOI 10.1093/jnci/84.22.1725; Howlader N, 2013, SEER CANC STAT REV 1; Jurisicova A, 2006, CELL DEATH DIFFER, V13, P1466, DOI 10.1038/sj.cdd.4401819; Kiyomiya K, 2001, CANCER RES, V61, P2467; Kujjo LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017877; Lemez P, 1997, J CLIN ONCOL, V15, P3293, DOI 10.1200/JCO.1997.15.10.3293; Li XH, 2013, J GYNECOL ONCOL, V24, P177, DOI 10.3802/jgo.2013.24.2.177; Lopez M, 1998, J CLIN ONCOL, V16, P86, DOI 10.1200/JCO.1998.16.1.86; Loren AW, 2013, J CLIN ONCOL, V31, P2500, DOI 10.1200/JCO.2013.49.2678; Mah LJ, 2010, LEUKEMIA, V24, P679, DOI 10.1038/leu.2010.6; Marty M, 2004, BREAST CANCER RES TR, V88, pS201; Marty M, 2006, ANN ONCOL, V17, P614, DOI 10.1093/annonc/mdj134; Meirow D, 2010, CLIN OBSTET GYNECOL, V53, P727, DOI 10.1097/GRF.0b013e3181f96b54; Meistrich ML, 2008, REPRODUCTION, V136, P691, DOI 10.1530/REP-08-0096; Minotti G, 2004, METHOD ENZYMOL, V378, P340; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Monnier A, 2005, J CLIN ONCOL, V23, p38S; Morgan S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070117; Morita Y, 2000, NAT MED, V6, P1109, DOI 10.1038/80442; Mouridsen H, 2008, EJC SUPPL, V6, P197, DOI 10.1016/S1359-6349(08)70811-5; Paris F, 2002, NAT MED, V8, P901, DOI 10.1038/nm0902-901; Perez GI, 1997, NAT MED, V3, P1228, DOI 10.1038/nm1197-1228; Pfeifer S, 2014, FERTIL STERIL, V101, P1237, DOI 10.1016/j.fertnstert.2014.02.052; Ringelstetter AK, 2014, PLOS ONE US; Roness H, 2013, HUM REPROD, V28, P46; Rosing H, 1999, EUR J DRUG METAB PH, V24, P69, DOI 10.1007/BF03190013; Roti ECR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108174; Roti ECR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042293; Roti ECR, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097030; Salih SM, 2015, J PEDIATR ADOL GYNEC, V28, P95, DOI 10.1016/j.jpag.2014.05.012; Salih SM, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.119495; Sargent JM, 2001, BRIT J CANCER, V84, P959, DOI 10.1054/bjoc.2001.1697; Schnirer II, 2009, J CLIN ONCOL, V27; SEIFERT CF, 1994, ANN PHARMACOTHER, V28, P1063, DOI 10.1177/106002809402800912; Skaznik-Wikiel ME, 2013, FERTIL STERIL, V99, P2045, DOI 10.1016/j.fertnstert.2013.01.135; Smith MA, 1999, J NATL CANCER I, V91, P973; Sparano JA, 1999, J CLIN ONCOL, V17, P880, DOI 10.1200/JCO.1999.17.3.880; SPETH PAJ, 1988, CLIN PHARMACOKINET, V15, P15, DOI 10.2165/00003088-198815010-00002; Sterba M, 2013, ANTIOXID REDOX SIGN, V18, P899, DOI 10.1089/ars.2012.4795; Swain SM, 1997, J CLIN ONCOL, V15, P1333, DOI 10.1200/JCO.1997.15.4.1333; Swain SM, 1997, J CLIN ONCOL, V15, P1318, DOI 10.1200/JCO.1997.15.4.1318; Swain SM, 1997, J CLIN ONCOL, V15, P3294; Sydsjo G, 2011, AM J REPROD IMMUNOL, V66, P81, DOI 10.1111/j.1600-0897.2011.01035.x; TAN C, 1967, CANCER-AM CANCER SOC, V20, P333, DOI 10.1002/1097-0142(1967)20:3<333::AID-CNCR2820200302>3.0.CO;2-K; Tebbi CK, 2007, J CLIN ONCOL, V25, P493, DOI 10.1200/JCO.2005.02.3879; Testore F, 2008, AM J CARDIOVASC DRUG, V8, P257, DOI 10.2165/00129784-200808040-00005; Ting AY, 2010, J ASSIST REPROD GEN, V27, P591, DOI 10.1007/s10815-010-9463-y; Ullman-Cullere MH, 1999, LAB ANIM SCI, V49, P319; Urruticoechea A, 2008, BREAST CANCER RES TR, V110, P411, DOI 10.1007/s10549-007-9745-y; van Dalen EC, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003917.pub4; Vavrova A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076676; Venturini M, 1996, J CLIN ONCOL, V14, P3112, DOI 10.1200/JCO.1996.14.12.3112; Vrooman LM, 2011, EUR J CANCER, V47, P1373, DOI 10.1016/j.ejca.2011.03.022; Wang Pei, 2013, Zhonghua Zhong Liu Za Zhi, V35, P135, DOI 10.3760/cma.j.issn.0253-3766.2013.02.013; Zelinski MB, 2011, FERTIL STERIL, V95, P1440, DOI 10.1016/j.fertnstert.2011.01.012	79	24	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142588	10.1371/journal.pone.0142588	http://dx.doi.org/10.1371/journal.pone.0142588			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544188	Green Submitted, Green Published, gold			2022-12-27	WOS:000364398700158
J	Lluch, J; Servant, F; Paisse, S; Valle, C; Valiere, S; Kuchly, C; Vilchez, G; Donnadieu, C; Courtney, M; Burcelin, R; Amar, J; Bouchez, O; Lelouvier, B				Lluch, Jerome; Servant, Florence; Paisse, Sandrine; Valle, Carine; Valiere, Sophie; Kuchly, Claire; Vilchez, Gaelle; Donnadieu, Cecile; Courtney, Michael; Burcelin, Remy; Amar, Jacques; Bouchez, Olivier; Lelouvier, Benjamin			The Characterization of Novel Tissue Microbiota Using an Optimized 16S Metagenomic Sequencing Pipeline	PLOS ONE			English	Article							GUT MICROBIOTA; BACTERIAL; PCR; DNA; IDENTIFICATION; INHIBITION; MECHANISMS; PRIMERS; SYSTEM; BLOOD	Background Substantial progress in high-throughput metagenomic sequencing methodologies has enabled the characterisation of bacteria from various origins (for example gut and skin). However, the recently-discovered bacterial microbiota present within animal internal tissues has remained unexplored due to technical difficulties associated with these challenging samples. Results We have optimized a specific 16S rDNA-targeted metagenomics sequencing (16S meta-barcoding) pipeline based on the Illumina MiSeq technology for the analysis of bacterial DNA in human and animal tissues. This was successfully achieved in various mouse tissues despite the high abundance of eukaryotic DNA and PCR inhibitors in these samples. We extensively tested this pipeline on mock communities, negative controls, positive controls and tissues and demonstrated the presence of novel tissue specific bacterial DNA profiles in a variety of organs (including brain, muscle, adipose tissue, liver and heart). Conclusion The high throughput and excellent reproducibility of the method ensured exhaustive and precise coverage of the 16S rDNA bacterial variants present in mouse tissues. This optimized 16S metagenomic sequencing pipeline will allow the scientific community to catalogue the bacterial DNA profiles of different tissues and will provide a database to analyse host/bacterial interactions in relation to homeostasis and disease.	[Lluch, Jerome; Servant, Florence; Paisse, Sandrine; Valle, Carine; Courtney, Michael; Lelouvier, Benjamin] Vaiomer SAS, Labege, France; [Lluch, Jerome; Valiere, Sophie; Kuchly, Claire; Vilchez, Gaelle; Donnadieu, Cecile; Bouchez, Olivier] INRA, GeT PlaGe, F-31326 Castanet Tolosan, France; [Valiere, Sophie; Kuchly, Claire; Vilchez, Gaelle] INRA, UAR1209, F-31326 Castanet Tolosan, France; [Donnadieu, Cecile; Bouchez, Olivier] INRA, UMR1388, F-31326 Castanet Tolosan, France; [Burcelin, Remy; Amar, Jacques] Fac Med Toulouse, INSERM, U1048, I2MC, F-31073 Toulouse, France; [Amar, Jacques] Hop Rangueil, Dept Therapeut, Toulouse, France	INRAE; INRAE; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse	Lelouvier, B (corresponding author), Vaiomer SAS, Labege, France.	benjamin.lelouvier@vaiomer.com	Valle, Carine/X-6039-2019; burcelin, remy/M-6013-2014	kuchly, claire/0000-0001-8994-550X; Servant, Florence/0000-0003-1063-6531	DAEI (Direction de l'Action Economique et de l'Innovation) of the Midi-Pyrenees Region, France; Vaiomer SAS	DAEI (Direction de l'Action Economique et de l'Innovation) of the Midi-Pyrenees Region, France(Region Occitanie); Vaiomer SAS	This work was carried out with the financial support from the DAEI (Direction de l'Action Economique et de l'Innovation) of the Midi-Pyrenees Region, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Vaiomer SAS provided support in the form of salaries for authors [JL, FS, SP, CV, MC, BL], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "Author contributions" section.	Amar J, 2011, DIABETOLOGIA, V54, P3055, DOI 10.1007/s00125-011-2329-8; Amar J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054461; Bentley SD, 2004, ANNU REV GENET, V38, P771, DOI 10.1146/annurev.genet.38.072902.094318; Bleau C, 2015, DIABETES-METAB RES, V31, P545, DOI 10.1002/dmrr.2617; Branton WG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054673; Brekke OL, 2011, MOL IMMUNOL, V48, P2159, DOI 10.1016/j.molimm.2011.07.011; Burcelin R, 2013, DIABETES OBES METAB, V15, P61, DOI 10.1111/dom.12157; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Catanzaro R, 2015, PANMINERVA MED, V57, P127; Chen J, 2012, BIOINFORMATICS, V28, P2106, DOI 10.1093/bioinformatics/bts342; Cohan FM, 2002, ANNU REV MICROBIOL, V56, P457, DOI 10.1146/annurev.micro.56.012302.160634; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Damgaard C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120826; de Punder K, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00223; Ding T, 2014, NATURE, V509, P357, DOI 10.1038/nature13178; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Engelbrektson A, 2010, ISME J, V4, P642, DOI 10.1038/ismej.2009.153; Epstein SS, 2013, CURR OPIN MICROBIOL, V16, P636, DOI 10.1016/j.mib.2013.08.003; Eren AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066643; Erny D, 2015, NAT NEUROSCI, V18, P965, DOI 10.1038/nn.4030; Everard A, 2014, ISME J, V8, P2116, DOI 10.1038/ismej.2014.45; Frey KG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-96; Friedland RP, 2015, J ALZHEIMERS DIS, V45, P349, DOI 10.3233/JAD-142841; Ge Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099414; Goodrich JK, 2014, CELL, V158, P250, DOI 10.1016/j.cell.2014.06.037; Guido S, 2015, J FUNCT FOODS, V14, P407, DOI 10.1016/j.jff.2015.02.014; Hacker G, 2002, IMMUNOLOGY, V105, P245; Holmes E, 2012, CELL METAB, V16, P559, DOI 10.1016/j.cmet.2012.10.007; Horzempa J, 2011, J INFECT DIS, V204, P51, DOI 10.1093/infdis/jir221; Hugenholtz P, 2002, GENOME BIOL, V3; Itzhaki RE, 2004, NEUROBIOL AGING, V25, P619, DOI 10.1016/j.neurobiolaging.2003.12.021; Janda JM, 2007, J CLIN MICROBIOL, V45, P2761, DOI 10.1128/JCM.01228-07; Kim M, 2014, J MICROBIOL, V52, P355, DOI 10.1007/s12275-014-3443-3; Kim M, 2011, J MICROBIOL METH, V84, P81, DOI 10.1016/j.mimet.2010.10.020; Koren O, 2011, P NATL ACAD SCI USA, V108, P4592, DOI 10.1073/pnas.1011383107; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Kruis T, 2014, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00510; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Laurence M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097876; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Lipford GB, 1998, TRENDS MICROBIOL, V6, P496, DOI 10.1016/S0966-842X(98)01408-5; Logares R, 2014, ENVIRON MICROBIOL, V16, P2659, DOI 10.1111/1462-2920.12250; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Luche E, 2013, MOL METAB, V2, P281, DOI 10.1016/j.molmet.2013.06.005; Makarova KS, 2001, MICROBIOL MOL BIOL R, V65, P44, DOI 10.1128/MMBR.65.1.44-79.2001; Mariette J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-462; Miyazaki M, 2012, INT J SYST EVOL MICR, V62, P1075, DOI 10.1099/ijs.0.032326-0; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Navas-Molina JA, 2013, METHOD ENZYMOL, V531, P371, DOI 10.1016/B978-0-12-407863-5.00019-8; Nelson MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094249; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Nishida H, 2013, CURR ISSUES MOL BIOL, V15, P19; Ono S, 2005, WORLD J SURG, V29, P535, DOI 10.1007/s00268-004-7618-7; Opel KL, 2010, J FORENSIC SCI, V55, P25, DOI 10.1111/j.1556-4029.2009.01245.x; Pinto AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043093; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; Potgieter M, 2015, FEMS MICROBIOL REV, V39, P567, DOI 10.1093/femsre/fuv013; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Sanmiguel C, 2015, CURR OBES REP, V4, P250, DOI 10.1007/s13679-015-0152-0; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Segal Leopoldo N, 2014, Ann Am Thorac Soc, V11 Suppl 1, pS21, DOI 10.1513/AnnalsATS.201306-189MG; Soergel DAW, 2012, ISME J, V6, P1440, DOI 10.1038/ismej.2011.208; Spangler R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007010; TEDESCHI GG, 1978, EXPERIENTIA, V34, P458, DOI 10.1007/BF01935925; Tichopad A, 2004, MOL CELL PROBE, V18, P45, DOI 10.1016/j.mcp.2003.09.001; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Unno T, 2015, J MICROBIOL BIOTECHN; Vetrovsky T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057923; Wang LR, 2015, J IMMUNOL METHODS, V421, P44, DOI 10.1016/j.jim.2014.12.015; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang Y, 2014, BRAIN BEHAV IMMUN, V38, P1, DOI 10.1016/j.bbi.2013.12.015; Wang ZW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050314; Ward DM, 2008, HEREDITY, V100, P207, DOI 10.1038/sj.hdy.6801011; Ward DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039315; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Xiao L, 2015, NAT BIOTECHNOL, V33, P1103, DOI 10.1038/nbt.3353; Yamaguchi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077282; Yan AW, 2012, WORLD J HEPATOL, V4, P110, DOI 10.4254/wjh.v4.i4.110; Zhan AB, 2014, METHODS ECOL EVOL, V5, P881, DOI 10.1111/2041-210X.12230	81	94	95	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142334	10.1371/journal.pone.0142334	http://dx.doi.org/10.1371/journal.pone.0142334			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544955	Green Submitted, Green Published, gold			2022-12-27	WOS:000364398700114
J	Manesi, Z; Van Lange, PAM; Pollet, TV				Manesi, Zoi; Van Lange, Paul A. M.; Pollet, Thomas V.			Butterfly Eyespots: Their Potential Influence on Aesthetic Preferences and Conservation Attitudes	PLOS ONE			English	Article							FACE-LIKE STIMULI; NEWBORNS PREFERENCE; WATCHING EYES; CUES; COOPERATION; RELEVANT; CHOICE; ACTIVATION; PUNISHMENT; PARADIGM	Research has shown that the mere presence of stimuli that resemble eyes is sufficient to attract attention, elicit aesthetic responses, and can even enhance prosocial behavior. However, it is less clear whether eye-like stimuli could also be used as a tool for nature conservation. Several animal species, including butterflies, develop eye-like markings that are known as eyespots. In the present research, we explored whether the mere display of eyespots on butterfly wings can enhance: (a) liking for a butterfly species, and (b) attitudes and behaviors towards conservation of a butterfly species. Four online experimental studies, involving 613 participants, demonstrated that eyespots significantly increased liking for a butterfly species. Furthermore, eyespots significantly increased positive attitudes towards conservation of a butterfly species (Studies 1, 2 and 4), whereas liking mediated the eyespot effect on conservation attitudes (Study 2). However, we also found some mixed evidence for an association between eyespots and actual conservation behavior (Studies 3 and 4). Overall, these findings suggest that eyespots may increase liking for an animal and sensitize humans to conservation. We discuss possible implications for biodiversity conservation and future research directions.	[Manesi, Zoi; Van Lange, Paul A. M.; Pollet, Thomas V.] Vrije Univ Amsterdam, Fac Behav & Movement Sci, Dept Expt & Appl Psychol, Social & Org Psychol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Manesi, Z (corresponding author), Vrije Univ Amsterdam, Fac Behav & Movement Sci, Dept Expt & Appl Psychol, Social & Org Psychol, Amsterdam, Netherlands.	z.manesi@vu.nl	Pollet, Thomas/M-6346-2019; Pollet, Thomas V/H-3397-2012	Pollet, Thomas/0000-0002-4210-935X; Pollet, Thomas V/0000-0002-4210-935X; Van Lange, Paul/0000-0001-7774-6984	John Templeton Grant [43919]; Netherlands Organisation for Scientific Research (Veni, Grant) [451.10.032]	John Templeton Grant; Netherlands Organisation for Scientific Research (Veni, Grant)	Support was provided by: 1) John Templeton Grant, Grant ID: 43919 [http://www.templeton.org/what-we-fund/grants/altruism-eye-cues-and-social-value-orientation-under-what-conditions-does-a-sens]. Authors who received the funding: PAMVL TVP ZM]; 2) The Netherlands Organisation for Scientific Research (Veni, Grant ID: 451.10.032) [http://www.nwo.nl/en/research-and-results/research-projects/08/2300161108.html]. Author who received the funding: TVP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HK, 2014, PSYCHOL SCI, V25, P224, DOI 10.1177/0956797613496823; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Baillon A, 2013, EVOL HUM BEHAV, V34, P146, DOI 10.1016/j.evolhumbehav.2012.12.001; Baron-Cohen S., 1995, MINDBLINDNESS ESSAY; Bateson M, 2006, BIOL LETTERS, V2, P412, DOI 10.1098/rsbl.2006.0509; Bourrat P, 2011, EVOL PSYCHOL-US, V9, P193, DOI 10.1177/147470491100900206; Boyd R, 2010, SCIENCE, V328, P617, DOI 10.1126/science.1183665; Brakefield Paul M, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.emo122; BRAKEFIELD PM, 1984, BIOL J LINN SOC, V22, P1, DOI 10.1111/j.1095-8312.1984.tb00795.x; Breuker CJ, 2002, P ROY SOC B-BIOL SCI, V269, P1233, DOI 10.1098/rspb.2002.2005; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Burnham K. P., 2002, MODEL SELECTION AND; Burnham TC, 2007, HUM NATURE-INT BIOS, V18, P88, DOI 10.1007/s12110-007-9012-2; Butterfield ME, 2012, J EXP SOC PSYCHOL, V48, P957, DOI 10.1016/j.jesp.2012.02.010; Cai W, 2015, EVOL HUM BEHAV, V36, P110, DOI 10.1016/j.evolhumbehav.2014.09.007; Caldara R, 2006, NEUROIMAGE, V31, P313, DOI 10.1016/j.neuroimage.2005.12.011; Carbon CC, 2011, SWISS J PSYCHOL, V70, P203, DOI 10.1024/1421-0185/a000058; Cassia VM, 2004, PSYCHOL SCI, V15, P379, DOI 10.1111/j.0956-7976.2004.00688.x; Dakin R, 2011, ANIM BEHAV, V82, P21, DOI 10.1016/j.anbehav.2011.03.016; de Pinho JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088842; Dunlap RE, 2000, J SOC ISSUES, V56, P425, DOI 10.1111/0022-4537.00176; EFRON B, 1987, J AM STAT ASSOC, V82, P171, DOI 10.2307/2289144; Ekstrom M, 2012, EXP ECON, V15, P530, DOI 10.1007/s10683-011-9312-6; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; Ernest-Jones M, 2011, EVOL HUM BEHAV, V32, P172, DOI 10.1016/j.evolhumbehav.2010.10.006; Farroni T, 2005, P NATL ACAD SCI USA, V102, P17245, DOI 10.1073/pnas.0502205102; Fathi M, 2014, EVOL PSYCHOL-US, V12, P878, DOI 10.1177/147470491401200502; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fehr E, 2010, P ROY SOC B-BIOL SCI, V277, P1315, DOI 10.1098/rspb.2009.1900; GARDNER W, 1995, PSYCHOL BULL, V118, P392, DOI 10.1037/0033-2909.118.3.392; Hadjikhani N, 2009, NEUROREPORT, V20, P403, DOI 10.1097/WNR.0b013e328325a8e1; Haley KJ, 2005, EVOL HUM BEHAV, V26, P245, DOI 10.1016/j.evolhumbehav.2005.01.002; Hardin JW, 2007, GENERALIZED LINEAR M; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Hinkley DV, 1997, BOOTSTRAP METHODS AN, DOI 10.2307/1271471; Huxley J., 1957, NEW BOTTLES NEW WINE; IBM SPSS Statistics, 2011, IBM SPSS STATISTICS; Itier RJ, 2007, J COGNITIVE NEUROSCI, V19, P1815, DOI 10.1162/jocn.2007.19.11.1815; Izuma K, 2010, SOC NEUROSCI-UK, V5, P133, DOI 10.1080/17470910903202559; Johnson MH, 2005, NAT REV NEUROSCI, V6, P766, DOI 10.1038/nrn1766; JOHNSON MH, 1991, COGNITION, V40, P1, DOI 10.1016/0010-0277(91)90045-6; Keaveney SM, 2012, PSYCHOL MARKET, V29, P36, DOI 10.1002/mar.20501; Keller J, 2011, EUR J PERSONALITY, V25, P363, DOI 10.1002/per.797; Kellert S.R., 1996, VALUE LIFE BIOL DIVE; Kurzban R, 2001, J NONVERBAL BEHAV, V25, P241, DOI 10.1023/A:1012563421824; Landwehr JR, 2011, J MARKETING, V75, P132, DOI 10.1509/jmkg.75.3.132; Langton SRH, 2000, TRENDS COGN SCI, V4, P50, DOI 10.1016/S1364-6613(99)01436-9; Liu JG, 2014, CORTEX, V53, P60, DOI 10.1016/j.cortex.2014.01.013; Martin JW, 1993, TERRA, V31, P30; McCullagh P., 1989, GENERALIZED LINEAR M, DOI DOI 10.1007/978-1-4899-3242-6; Miesler L, 2011, INT J DES, V5, P17; Nettle D, 2013, EVOL HUM BEHAV, V34, P35, DOI 10.1016/j.evolhumbehav.2012.08.004; Nettle D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051738; Oda R, 2015, EVOL PSYCHOL-US, V13, DOI 10.1177/1474704915594959; Oda R, 2011, EVOL HUM BEHAV, V32, P166, DOI 10.1016/j.evolhumbehav.2010.11.002; Panagopoulos C, 2014, EVOL HUM BEHAV, V35, P279, DOI 10.1016/j.evolhumbehav.2014.02.008; Powell KL, 2012, ETHOLOGY, V118, P1096, DOI 10.1111/eth.12011; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Raihani NJ, 2012, P ROY SOC B-BIOL SCI, V279, P3556, DOI 10.1098/rspb.2012.0758; Rigdon M, 2009, J ECON PSYCHOL, V30, P358, DOI 10.1016/j.joep.2009.02.002; Robertson KA, 2005, P ROY SOC B-BIOL SCI, V272, P1541, DOI 10.1098/rspb.2005.3142; Root-Bernstein M, 2013, BIODIVERS CONSERV, V22, P1577, DOI 10.1007/s10531-013-0494-4; Sagan C., 1981, COSMOS; Simion F, 2002, DEVELOPMENTAL SCI, V5, P427, DOI 10.1111/1467-7687.00237; Sourakov A, 2013, J NAT HIST, V47, P1047, DOI 10.1080/00222933.2012.759288; Sparks A, 2013, EVOL HUM BEHAV, V34, P317, DOI 10.1016/j.evolhumbehav.2013.05.001; Spearman C, 1904, AM J PSYCHOL, V15, P72, DOI 10.2307/1412159; Stein T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029361; Stevens M, 2005, BIOL REV, V80, P573, DOI 10.1017/S1464793105006810; Stokes DL, 2007, HUM ECOL, V35, P361, DOI 10.1007/s10745-006-9056-7; Sylwester K, 2010, BIOL LETTERS, V6, P659, DOI 10.1098/rsbl.2010.0209; Takezawa M., 2011, LETT EVOLUTIONARY BE, V2, P24, DOI [DOI 10.5178/LEBS.2011.15, 10.5178/lebs.2011.15]; Tam KP, 2015, BRIT J SOC PSYCHOL, V54, P187, DOI 10.1111/bjso.12076; Tam KP, 2013, J EXP SOC PSYCHOL, V49, P514, DOI 10.1016/j.jesp.2013.02.001; Tomalski P, 2009, PERCEPTION, V38, P569, DOI 10.1068/p6137; Tomasello M, 2007, J HUM EVOL, V52, P314, DOI 10.1016/j.jhevol.2006.10.001; Turati C, 2002, DEV PSYCHOL, V38, P875, DOI 10.1037//0012-1649.38.6.875; Vallin A, 2005, P ROY SOC B-BIOL SCI, V272, P1203, DOI 10.1098/rspb.2004.3034; Van Vugt M., 2007, HDB EVOLUTIONARY PSY, P531; VanLange PAM, 1997, J PERS SOC PSYCHOL, V73, P733, DOI 10.1037/0022-3514.73.4.733; Verissimo D, 2009, ANIM CONSERV, V12, P549, DOI 10.1111/j.1469-1795.2009.00282.x; Vogt S, 2015, EVOL HUM BEHAV, V36, P224, DOI 10.1016/j.evolhumbehav.2014.11.007; Voss JL, 2012, CEREB CORTEX, V22, P2354, DOI 10.1093/cercor/bhr315; Wedekind C, 2000, SCIENCE, V288, P850, DOI 10.1126/science.288.5467.850	85	15	16	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141433	10.1371/journal.pone.0141433	http://dx.doi.org/10.1371/journal.pone.0141433			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV6RT	26544692	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000364398700024
J	Nagypal, T; Gombkoto, P; Barkoczi, B; Benedek, G; Nagy, A				Nagypal, Tamas; Gombkoeto, Peter; Barkoczi, Balazs; Benedek, Gyoergy; Nagy, Attila			Activity of Caudate Nucleus Neurons in a Visual Fixation Paradigm in Behaving Cats	PLOS ONE			English	Article							FAST-SPIKING INTERNEURONS; LATERAL SUPRASYLVIAN CORTEX; RECEPTIVE-FIELD PROPERTIES; STRIATAL NEURONS; RAT NEOSTRIATUM; SENSORIMOTOR STRIATUM; CHOLINERGIC NEURONS; CORRELATED LIGHT; FIRING PATTERNS; BASAL GANGLIA	Beside its motor functions, the caudate nucleus (CN), the main input structure of the basal ganglia, is also sensitive to various sensory modalities. The goal of the present study was to investigate the effects of visual stimulation on the CN by using a behaving, head-restrained, eye movement-controlled feline model developed recently for this purpose. Extracellular multielectrode recordings were made from the CN of two cats in a visual fixation paradigm applying static and dynamic stimuli. The recorded neurons were classified in three groups according to their electrophysiological properties: phasically active (PAN), tonically active (TAN) and high-firing (HFN) neurons. The response characteristics were investigated according to this classification. The PAN and TAN neurons were sensitive primarily to static stimuli, while the HFN neurons responded primarily to changes in the visual environment i.e. to optic flow and the offset of the stimuli. The HFNs were the most sensitive to visual stimulation; their responses were stronger than those of the PANs and TANs. The majority of the recorded units were insensitive to the direction of the optic flow, regardless of group, but a small number of direction-sensitive neurons were also found. Our results demonstrate that both the static and the dynamic components of the visual information are represented in the CN. Furthermore, these results provide the first piece of evidence on optic flow processing in the CN, which, in more general terms, indicates the possible role of this structure in dynamic visual information processing.	[Nagypal, Tamas; Barkoczi, Balazs; Benedek, Gyoergy; Nagy, Attila] Univ Szeged, Fac Med, Dept Physiol, Szeged, Hungary; [Gombkoeto, Peter] Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA	Szeged University; Rutgers State University Newark; Rutgers State University New Brunswick	Nagy, A (corresponding author), Univ Szeged, Fac Med, Dept Physiol, Szeged, Hungary.	nagy.attila.1@med.u-szeged.hu		Gombkoto, Peter/0000-0001-8393-173X	Hungarian Brain Research Program Grant [KTIA_13_NAP-A-I/15]; OTKA/Hungary Grant [83810]	Hungarian Brain Research Program Grant; OTKA/Hungary Grant(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	Funded by Hungarian Brain Research Program Grant KTIA_13_NAP-A-I/15 (AN) (http://www.agykutatas.com/); OTKA/Hungary Grant 83810. (http://www.otka.hu/) (GB). T. Nagypal was a fellow of Talentum Foundation of the Gedeon Richter Plc. (https://www.richter.hu/hu-HU/felelossegvallalas/alapitvanyok/Pages/Richter-Gedeon-TalentumAlapitvany. aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS CE, 1990, J COMP NEUROL, V292, P563, DOI 10.1002/cne.902920406; Apicella P, 2002, EUR J NEUROSCI, V16, P2017, DOI 10.1046/j.1460-9568.2002.02262.x; Averkin R, 2009, 12TH MEETING OF THE; Barnes TD, 2005, NATURE, V437, P1158, DOI 10.1038/nature04053; Barnes TD, 2011, J NEUROPHYSIOL, V105, P1861, DOI 10.1152/jn.00871.2010; Berke JD, 2004, NEURON, V43, P883, DOI 10.1016/j.neuron.2004.08.035; Berke JD, 2008, J NEUROSCI, V28, P10075, DOI 10.1523/JNEUROSCI.2192-08.2008; Brosseau-Lachaine O, 2001, CEREB CORTEX, V11, P989, DOI 10.1093/cercor/11.10.989; CHUDLER EH, 1995, BRAIN RES, V674, P33, DOI 10.1016/0006-8993(94)01427-J; DUBACH M, 1987, NEUROSCI LETT, V75, P205, DOI 10.1016/0304-3940(87)90298-9; Fino E, 2011, NEUROPHARMACOLOGY, V60, P780, DOI 10.1016/j.neuropharm.2011.01.023; Gage GJ, 2010, NEURON, V67, P466, DOI 10.1016/j.neuron.2010.06.034; Galvan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050808; Gombkoto P, 2011, NEUROSCIENCE, V182, P225, DOI 10.1016/j.neuroscience.2011.02.048; GRAVELAND GA, 1985, J COMP NEUROL, V234, P317, DOI 10.1002/cne.902340304; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Hazan L, 2006, J NEUROSCI METH, V155, P207, DOI 10.1016/j.jneumeth.2006.01.017; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P799, DOI 10.1152/jn.1989.61.4.799; Hokfelt T, 1988, J Chem Neuroanat, V1, P11; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; KAWAGUCHI Y, 1995, TRENDS NEUROSCI, V18, P527, DOI 10.1016/0166-2236(95)98374-8; KAWAGUCHI Y, 1993, J NEUROSCI, V13, P4908; KEMP JM, 1971, PHILOS T R SOC B, V262, P383, DOI 10.1098/rstb.1971.0102; Kubota Y, 2009, J NEUROPHYSIOL, V102, P2142, DOI 10.1152/jn.00522.2009; Lau B, 2007, J NEUROSCI, V27, P14502, DOI 10.1523/JNEUROSCI.3060-07.2007; Luk KC, 2001, NEUROSCIENCE, V104, P93, DOI 10.1016/S0306-4522(01)00038-0; Mallet N, 2005, J NEUROSCI, V25, P3857, DOI 10.1523/JNEUROSCI.5027-04.2005; McHaffie JG, 2005, TRENDS NEUROSCI, V28, P401, DOI 10.1016/j.tins.2005.06.006; McKown MD, 2006, J NEUROSCI METH, V153, P239, DOI 10.1016/j.jneumeth.2005.10.020; MORRONE MC, 1986, J NEUROPHYSIOL, V56, P969, DOI 10.1152/jn.1986.56.4.969; Nagy A, 2003, EUR J NEUROSCI, V18, P449, DOI 10.1046/j.1460-9568.2003.02764.x; Nagy A, 2008, EUR J NEUROSCI, V27, P1801, DOI 10.1111/j.1460-9568.2008.06137.x; Nagy A, 2010, NEUROSCI LETT, V480, P148, DOI 10.1016/j.neulet.2010.06.030; Nagypal T, 2014, J NEUROSCI METH, V221, P1, DOI 10.1016/j.jneumeth.2013.09.004; PHELPS PE, 1985, J COMP NEUROL, V238, P286, DOI 10.1002/cne.902380305; Plenz D, 1998, J NEUROSCI, V18, P266; POUDEROUX G, 1979, NEUROSCI LETT, V11, P53, DOI 10.1016/0304-3940(79)90055-7; Rokszin A, 2011, BRAIN RES, V1418, P52, DOI 10.1016/j.brainres.2011.08.015; ROLLS ET, 1983, BEHAV BRAIN RES, V7, P179, DOI 10.1016/0166-4328(83)90191-2; Rymar VV, 2004, J COMP NEUROL, V469, P325, DOI 10.1002/cne.11008; Schmitzer-Torbert N, 2004, J NEUROPHYSIOL, V91, P2259, DOI 10.1152/jn.00687.2003; Schmitzer-Torbert NC, 2008, NEUROSCIENCE, V153, P349, DOI 10.1016/j.neuroscience.2008.01.081; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; SMITH Y, 1986, BRAIN RES, V372, P241, DOI 10.1016/0006-8993(86)91131-5; Stalnaker TA, 2012, J NEUROSCI, V32, P10296, DOI 10.1523/JNEUROSCI.0832-12.2012; STRECKER RE, 1985, BRAIN RES, V329, P350, DOI 10.1016/0006-8993(85)90548-7; TAKAGI H, 1984, J NEUROCYTOL, V13, P239, DOI 10.1007/BF01148118; Tepper JM, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00150; THERIAULT E, 1987, J COMP NEUROL, V256, P1, DOI 10.1002/cne.902560102; Thorn CA, 2010, NEURON, V66, P781, DOI 10.1016/j.neuron.2010.04.036; Tseng K.Y., 2010, HDB BASAL GANGLIA ST; Vicente AF, 2012, BRAIN RES, V1466, P70, DOI 10.1016/j.brainres.2012.05.037; Villeneuve MY, 2003, J NEUROSCI METH, V129, P19, DOI 10.1016/S0165-0270(03)00198-5; VINCENT SR, 1983, NEUROSCI LETT, V35, P111, DOI 10.1016/0304-3940(83)90536-0; WILSON CJ, 1993, PROG BRAIN RES, V99, P277; WILSON CJ, 1990, J NEUROSCI, V10, P508; Wise SP, 1996, CRIT REV NEUROBIOL, V10, P317, DOI 10.1615/CritRevNeurobiol.v10.i3-4.30; Yarom O, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00036	58	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142526	10.1371/journal.pone.0142526	http://dx.doi.org/10.1371/journal.pone.0142526			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544604	Green Published, Green Submitted, gold			2022-12-27	WOS:000364398700151
J	da Silva, MG; Vinaud, MC; de Castro, AM				da Silva, Marcos Gontijo; Vinaud, Marina Clare; de Castro, Ana Maria			Prevalence of toxoplasmosis in pregnant women and vertical transmission of Toxoplasma gondii in patients from basic units of health from Gurupi, Tocantins, Brazil, from 2012 to 2014	PLOS ONE			English	Article							CONGENITAL TOXOPLASMOSIS; RISK-FACTORS; SEROLOGIC PROFILE; CHILDBEARING AGE; GLOBAL BURDEN; STATE; DIAGNOSIS; PREVENTION; INFECTION; PROGRAM	Introduction Toxoplasmosis is a parasitary disease that presents high rates of gestational and congenital infection worldwide being therefore considered a public health problem and a neglected disease. Objective To determine the prevalence of toxoplasmosis amongst pregnant women and vertical transmission of Toxoplasma gondii in their newborns attended in the Basic Units of Health (BUH) from the city of Gurupi, state of Tocantins, Brazil. Methods A prevalence study was performed, including 487 pregnant women and their newborns attended in the BUH of the urban zone of the city of Gurupi, state of Tocantins, Brazil, during the period from February 2012 to February 2014. The selection of the pregnant women occurred by convenience. In the antenatal admission they were invited to participate in this study. Three samples of peripheral blood were collected for the detection of specific anti-T. gondii IgG, IgM and IgA through ELISA, for the polimerase chain reaction (PCR) and IgG avidity during pregnancy. When IgM antibodies were detected the fetal and newborn infection investigation took place. The newborn was investigated right after birth and after one year of age through serology and PCR to confirm/exclude the vertical transmission. The analyses were performed in the Studies of the Host-Parasite Relationship Laboratory (LAERPH, IPTSP-UFG), Goiania, state of Goias, Brazil. The results were inserted in a data bank in Epi-Info 3.3.2 statistic software in which the analysis was performed with p <= 5%. Results The toxoplasmosis infection was detected in 68.37% (333/487, CI95%: 64.62-72.86). The toxoplasmosis chronic infection prevalence was of 63.03% (307/487, CI95%: 58.74-67.32). The prevalence of maternal acute infection was of 5.33% (26/487; CI95%: 3.3-7.3) suspected by IgM antibodies detection in the peripheral blood. The prevalence of confirmed vertical transmission was of 28% (7/25; CI95%: 10.4-45.6). Conclusions These results show an elevated prevalence of toxoplasmosis in pregnant women and vertical transmission of T. gondii in the city of Gurupi, state of Tocantins, Brazil.	[da Silva, Marcos Gontijo] Univ Ctr UNIRG, Parasitol Lab, Gurupi, TO, Brazil; [Vinaud, Marina Clare; de Castro, Ana Maria] Univ Fed Goias, Trop Med & Publ Hlth Inst IPTSP, Trop Med & Publ Hlth Postgrad Programme, Studies Host Parasite Relationship Lab LAERPH, BR-74605050 Goiania, Go, Brazil	Universidade Federal de Goias	da Silva, MG (corresponding author), Univ Ctr UNIRG, Parasitol Lab, Ave Rio de Janeiro Entre Ruas 9 & 10, Gurupi, TO, Brazil.	gontijobio@yahoo.com.br	Gontijo da Silva, Marcos/AGZ-3178-2022; Vinaud, Marina Clare/X-3380-2019	Gontijo da Silva, Marcos/0000-0002-6474-6640; 	financimento the Research Foundation of the State of Goias (FAPEG) [001/2012, 201200141120254]	financimento the Research Foundation of the State of Goias (FAPEG)	This work received financimento the Research Foundation of the State of Goias (FAPEG) Call No. 001/2012, Case No. 201200141120254. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali-Heydari S, 2013, PARASITE, V20, DOI 10.1051/parasite/2013017; Andrade ALSS, 1998, MET INV EP DOENC TRA; Andreucci CB, 2011, CAD SAUDE PUBLICA, V27, P1053, DOI 10.1590/S0102-311X2011000600003; Araujo AFV, 2012, BOLETIM CONJUNTURA T; Dantas SBA, 2013, CIENC RURAL, V43, P2042, DOI 10.1590/S0103-84782013001100020; Areal K. R., 2008, NEWS LAB, V87, P122; Avelino M. M., 2009, Revista de Ciencias Medicas e Biologicas, V8, P325; Avelino MM, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-33; Avelino Mariza Martins, 2004, Braz J Infect Dis, V8, P164, DOI 10.1590/S1413-86702004000200007; Barbosa IR, 2009, T ROY SOC TROP MED H, V103, P377, DOI 10.1016/j.trstmh.2008.11.025; Bollani L, 2014, J Pediat Neonatal Individualized Medicine, V3; Brasil. Ministerio da Saude Secretaria de Atencao a Saude Departamento de Acoes Programaticas Estrategicas, 2010, GEST ALT RISC MAN TE, V5; Brasil. Ministerio da Saude. Secretaria de Atencao a Saxde. Departamento de Acoes Programaticas Estrategicas, 2012, GEST RISC MAN TECN; Campos FA, 2014, BRAZ J INFECT DIS, V18, P609, DOI 10.1016/j.bjid.2014.05.008; Bichara CNC, 2012, REV SOC BRAS MED TRO, V45, P122, DOI 10.1590/S0037-86822012000100024; Carral L, 2008, MEDICINA-BUENOS AIRE, V68, P417; Carvalheiro CG, 2005, EPIDEMIOL INFECT, V133, P485, DOI 10.1017/S095026880400353X; Costa CSC, 2013, REV ELETR ENF, V15, P516, DOI [10.5216/ree.v15i2.15635, DOI 10.5216/REE.V15I2.15635]; da Silva MG, 2014, REV SOC BRAS MED TRO, V47, P469, DOI 10.1590/0037-8682-0127-2014; de Figueiredo H. R., 2010, SCI MED, V20, P71; de Jong EP, 2013, ARCH DIS CHILDHOOD-E, V98, P93, DOI 10.1136/archdischild-2012-303327; Inagaki ADD, 2012, TROP MED INT HEALTH, V17, P1349, DOI 10.1111/j.1365-3156.2012.03079.x; de Moura FL, 2013, REV SOC BRAS MED TRO, V46, P200, DOI 10.1590/0037-8682-1613-2013; De Paschale M, 2014, TROP MED INT HEALTH, V19, P743, DOI 10.1111/tmi.12296; Diaz-Suarez O, 2009, REV INST MED TROP SP, V51, P13, DOI 10.1590/S0036-46652009000100003; Elmore SA, 2010, TRENDS PARASITOL, V26, P190, DOI 10.1016/j.pt.2010.01.009; Elsheikha HM, 2008, PUBLIC HEALTH, V122, P335, DOI 10.1016/j.puhe.2007.08.009; Porto AMF, 2008, REV ASSOC MED BRAS, V54, P242, DOI 10.1590/S0104-42302008000300018; Fialho CG, 2009, ACTA SCI VET, V37, P1; Figueiro EA, 2005, REV BRAS GINECOL OBS, V27, P442, DOI 10.1590/S0100-72032005000800002; Foulon W, 2000, J PERINAT MED, V28, P337, DOI 10.1515/JPM.2000.043; Bittencourt LHFD, 2012, REV BRAS GINECOL OBS, V34, P63, DOI 10.1590/S0100-72032012000200004; Jones JL, 2009, CLIN INFECT DIS, V49, P878, DOI 10.1086/605433; Kaye A, 2011, J PEDIATR HEALTH CAR, V25, P355, DOI 10.1016/j.pedhc.2010.04.008; Khalil Mohamed, 2013, African Journal of Microbiology Research, V7, P5227; Kompalic-Cristo A, 2004, T ROY SOC TROP MED H, V98, P92, DOI 10.1016/S0035-9203(03)00012-9; Lago EG, 2014, J PEDIAT-BRAZIL, V90, P363, DOI [10.1016/j.jped.2013.12.006, 10.1016/j.jpedp.2013.12.005]; Lago EG, 2007, PAEDIATR PERINAT EP, V21, P525, DOI 10.1111/j.1365-3016.2007.00869.x; Lopes AP, 2014, PARASITOLOGY, V141, P1699, DOI 10.1017/S0031182014001413; Carellos EV, 2008, CAD SAUDE PUBLICA, V24, P391, DOI 10.1590/S0102-311X2008000200018; Carellos EVM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088588; Maggi P, 2009, NEW MICROBIOL, V32, P89; Margonato Fabiana Burdini, 2007, Rev. Bras. Saude Mater. Infant., V7, P381, DOI 10.1590/S1519-38292007000400005; Monsalve-Castillo FM, 2012, BIOMEDICA, V32, P519, DOI [10.1590/S0120-41572012000400007, 10.7705/biomedica.v32i4.749]; Ministerio da Saude (MS), 2012, AT PREN BAIX RISC; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Mussi-Pinhata M, 1999, J PEDIAT RIO J, V75, P15; Neto Eurico Camargo, 2004, Emerg Infect Dis, V10, P1068; Nicolle MC, 2009, MEM I O CRUZ, V104, P1; Oz HS, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00385; Paquet C, 2013, J OBSTET GYNAECOL CA, V35, P78, DOI 10.1016/S1701-2163(15)31053-7; Rahbari AH, 2012, KOREAN J PARASITOL, V50, P99, DOI 10.3347/kjp.2012.50.2.99; Reis MM, 2006, REV BRAS GINECOL OBS, V28, P158, DOI 10.1590/S0100-72032006000300004; Remington JS., 1995, INFECT DIS FETUS NEW, V4, P140; Robert-Gangneux F, 2012, CLIN MICROBIOL REV, V25, P264, DOI 10.1128/CMR.05013-11; Rodrigues IMX, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-349; Sartori AL, 2011, REV BRAS GINECOL OBS, V33, P93, DOI 10.1590/S0100-72032011000200007; Silva MG, 2013, U CI SAUDE, V11, P1, DOI [10.5102/ucs.v11i2.2564, DOI 10.5102/UCS.V11I2.2564]; SINIBALDI J, 1992, EUR J EPIDEMIOL, V8, P516, DOI 10.1007/BF00146369; Spalding Silvia Maria, 2002, J. Bras. Patol. Med. Lab., V38, P105, DOI 10.1590/S1676-24442002000200006; Splendore A, 2009, MEM I O CRUZ, V104, P1; Stein C, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000161; Torgerson PR, 2013, B WORLD HEALTH ORGAN, V91, P501, DOI 10.2471/BLT.12.111732; Uttah E, 2013, IJSRP, V3, P1; Varella IS, 2009, MEM I OSWALDO CRUZ, V104, P383, DOI 10.1590/S0074-02762009000200037; Vasconcelos-Santos DV, 2009, OPHTHALMOLOGY, V116, P2199, DOI 10.1016/j.ophtha.2009.04.042; Vaz RS, 2011, FACTS REPORTS, V3, P1	67	42	44	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0141700	10.1371/journal.pone.0141700	http://dx.doi.org/10.1371/journal.pone.0141700			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26558622	Green Published, gold			2022-12-27	WOS:000364433100039
J	Ram, MR; Goh, KL; Leow, AHR; Poh, BH; Loke, MF; Harrison, R; Shankar, EM; Vadivelu, J				Ram, M. Ravishankar; Goh, Khean Lee; Leow, Alex Hwong Ruey; Poh, Bee Hoon; Loke, Mun Fai; Harrison, Richard; Shankar, Esaki M.; Vadivelu, Jamuna			Polymorphisms at Locus 4p14 of Toll-Like Receptors TLR-1 and TLR-10 Confer Susceptibility to Gastric Carcinoma in Helicobacter pylori Infection	PLOS ONE			English	Article							GHRELIN EXPRESSION; CANCER; LEPTIN; DISEASE; INFLAMMATION; PATHOGENESIS; RECOGNITION; ASSOCIATION; OBESITY; CELLS	Helicobacter pylori (H. pylori) -induced gastric inflammation impacts the functions of leptin-and ghrelin-producing cells in the gastroduodenum. Inflammation resulting from H. pylori sensing via Toll-like receptors (TLRs) and the associated downstream signaling largely remain ambiguous. Here, we investigated the role of gut hormones, pro-inflammatory cytokines and single nucleotide polymorphisms (SNPs) associated with TLR 4p14 in H. pylori disease in 30 subjects with non-ulcer dyspepsia (NUD), 40 with peptic ulcer disease (PUD) and 15 with gastric cancer (GC) subjects positive and negative for H. pylori infection. The level of pro-inflammatory cytokines was directly proportional to the severity of gastritis, and disease status influenced the levels of gut hormones and pro-inflammatory cytokines. TLR-1 SNPs rs4833095 and TLR-10 SNPs rs10004195 and were directly associated with H. pylori disease, and were up-regulated in the presence of H. pylori in a genotype-independent manner. We concluded that TLR-1 rs4833095 and TLR10 rs10004195 confer susceptibility to development of gastroduodenal disease, especially GC in H. pylori disease.	[Ram, M. Ravishankar; Loke, Mun Fai; Vadivelu, Jamuna] Univ Malaya, Dept Med Microbiol, Fac Med, Kuala Lumpur 50603, Malaysia; [Goh, Khean Lee; Leow, Alex Hwong Ruey] Univ Malaya, Dept Med, Fac Med, Kuala Lumpur 50603, Malaysia; [Poh, Bee Hoon] BP Diagnost Ctr Sdn Bhd, Dept Pathol, Ipoh 30250, Perak, Malaysia; [Harrison, Richard] Biorad Labs Pty Ltd, Life Sci Res Div, Gladesville, NSW 2111, Australia; [Shankar, Esaki M.] Univ Malaya, Fac Med, Dept Med Microbiol, TIDREC, Kuala Lumpur 50603, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya	Vadivelu, J (corresponding author), Univ Malaya, Dept Med Microbiol, Fac Med, Kuala Lumpur 50603, Malaysia.	jamuna@ummc.edu.my	Loke, Mun Fai/B-1060-2011; VADIVELU, JAMUNARANI S/B-8696-2010; Goh, Khean-Lee/B-6404-2009; Leow, Alex HR/B-1626-2017; Mani, Ravishankar Ram/N-7456-2019; Muthu, Shankar Esaki/B-3132-2019; Shankar, EM/G-6444-2011	Loke, Mun Fai/0000-0002-3554-5313; VADIVELU, JAMUNARANI S/0000-0001-7322-3676; Goh, Khean-Lee/0000-0002-9965-1561; Leow, Alex HR/0000-0003-1752-0435; Mani, Ravishankar Ram/0000-0003-4229-5778; Muthu, Shankar Esaki/0000-0002-7866-9818; 	University of Malaya - Ministry of Education (UM-MOE) High Impact Research (HIR) [UM.C/625/1/HIR/MOE/CHAN-13/4, H-50001-A000029]	University of Malaya - Ministry of Education (UM-MOE) High Impact Research (HIR)	This work was supported by a grant from the University of Malaya - Ministry of Education (UM-MOE) High Impact Research (HIR) (Grant. No. UM.C/625/1/HIR/MOE/CHAN-13/4; Account No. H-50001-A000029). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Azuma T, 2001, GUT, V49, P324, DOI 10.1136/gut.49.3.324; Carabotti M, 2014, WORLD J GASTROENTERO, V20, P647, DOI 10.3748/wjg.v20.i3.647; Castano-Rodriguez N, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00336; Castano-Rodriguez N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060327; Chen MY, 2013, WORLD J GASTROENTERO, V19, P4242, DOI 10.3748/wjg.v19.i26.4242; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Devaux M, 2011, EC STUDIES, V1; Fernandez-Riejos P, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/568343; Fock K. M., 1997, Annals Academy of Medicine Singapore, V26, P637; Franceschi F, 2014, WORLD J GASTROENTERO, V20, P12809, DOI 10.3748/wjg.v20.i36.12809; Garcia JM, 2008, ENDOCRINOLOGY, V149, P455, DOI 10.1210/en.2007-0828; Isomoto H, 2004, AM J MED, V117, P429, DOI 10.1016/j.amjmed.2004.01.030; Jun DW, 2007, DIGEST DIS SCI, V52, P2866, DOI 10.1007/s10620-006-9651-x; Jung UJ, 2014, INT J MOL SCI, V15, P6184, DOI 10.3390/ijms15046184; Jurinke Christian, 2002, Adv Biochem Eng Biotechnol, V77, P57; Konturek PC, 2006, J PHYSIOL PHARMACOL, V57, P67; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; Le Beyec J, 2014, INT J OBESITY, V38, P1357, DOI 10.1038/ijo.2014.14; Lina TT, 2014, WORLD J GASTROENTERO, V20, P12753, DOI 10.3748/wjg.v20.i36.12753; Mayerle J, 2013, JAMA-J AM MED ASSOC, V309, P1912, DOI 10.1001/jama.2013.4350; Michaud M, 2013, J AM MED DIR ASSOC, V14, P877, DOI 10.1016/j.jamda.2013.05.009; Mitchell H, 2008, ALIMENT PHARM THER, V28, P903, DOI 10.1111/j.1365-2036.2008.03792.x; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Nwokolo CU, 2003, GUT, V52, P637, DOI 10.1136/gut.52.5.637; Pacifico L, 2014, WORLD J GASTROENTERO, V20, P1379, DOI 10.3748/wjg.v20.i6.1379; Paoluzi OA, 2014, WORLD J GASTROENTERO, V20, P639, DOI 10.3748/wjg.v20.i3.639; Paz-Filho G, 2012, ARQ BRAS ENDOCRINOL, V56, P9; Pilotto A, 2014, WORLD J GASTROENTERO, V20, P6364, DOI 10.3748/wjg.v20.i21.6364; Salles N, 2006, J GERONTOL A-BIOL, V61, P1144, DOI 10.1093/gerona/61.11.1144; Sanchez-Margalet V, 2003, CLIN EXP IMMUNOL, V133, P11, DOI 10.1046/j.1365-2249.2003.02190.x; Santini D, 2008, CLIN EXP IMMUNOL, V154, P360, DOI 10.1111/j.1365-2249.2008.03776.x; Schmidt HMA, 2011, J GASTROEN HEPATOL, V26, P1725, DOI 10.1111/j.1440-1746.2011.06799.x; Shiotani A, 2005, HELICOBACTER, V10, P373, DOI 10.1111/j.1523-5378.2005.00343.x; Slomiany BL, 2010, MEDIAT INFLAMM, V2010, P7, DOI DOI 10.1155/2010/280464; Suresh R, 2013, ADV PHYSIOL EDUC, V37, P284, DOI 10.1152/advan.00058.2013; Wroblewski LE, 2010, CLIN MICROBIOL REV, V23, P713, DOI 10.1128/CMR.00011-10; Xu J, 2014, SCI WORLD J, V2014, P926; Yang CA, 2013, HELICOBACTER, V18, P13, DOI 10.1111/hel.12001; Zeng Hong-Mei, 2011, Zhonghua Yu Fang Yi Xue Za Zhi, V45, P588	40	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0141865	10.1371/journal.pone.0141865	http://dx.doi.org/10.1371/journal.pone.0141865			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559190	Green Published, gold, Green Submitted			2022-12-27	WOS:000364433100043
J	Rowbottom, R; Carver, S; Barmuta, LA; Weinstein, P; Foo, D; Allen, GR				Rowbottom, Raylea; Carver, Scott; Barmuta, Leon A.; Weinstein, Philip; Foo, Dahlia; Allen, Geoff R.			Resource Limitation, Controphic Ostracod Density and Larval Mosquito Development	PLOS ONE			English	Article							ROSS-RIVER-VIRUS; EPHEMERAL WATER BODIES; AEDES-AEGYPTI DIPTERA; SALT-MARSH MOSQUITO; ADULT SIZE; WHEAT-BELT; COMPETITION; CULICIDAE; FOOD; CAMPTORHYNCHUS	Aquatic environments can be restricted with the amount of available food resources especially with changes to both abiotic and biotic conditions. Mosquito larvae, in particular, are sensitive to changes in food resources. Resource limitation through inter-, and intra-specific competition among mosquitoes are known to affect both their development and survival. However, much less is understood about the effects of non-culicid controphic competitors (species that share the same trophic level). To address this knowledge gap, we investigated and compared mosquito larval development, survival and adult size in two experiments, one with different densities of non-culicid controphic conditions and the other with altered resource conditions. We used Aedes camptorhynchus, a salt marsh breeding mosquito and a prominent vector for Ross River virus in Australia. Aedes camptorhynchus usually has few competitors due to its halo-tolerance and distribution in salt marshes. However, sympatric ostracod micro-crustaceans often co-occur within these salt marshes and can be found in dense populations, with field evidence suggesting exploitative competition for resources. Our experiments demonstrate resource limiting conditions caused significant increases in mosquito developmental times, decreased adult survival and decreased adult size. Overall, non-culicid exploitation experiments showed little effect on larval development and survival, but similar effects on adult size. We suggest that the alterations of adult traits owing to nonculicid controphic competition has potential to extend to vector-borne disease transmission.	[Rowbottom, Raylea; Allen, Geoff R.] Univ Tasmania, Sch Land & Food, TIA, Hobart, Tas, Australia; [Carver, Scott; Barmuta, Leon A.; Foo, Dahlia] Univ Tasmania, Sch Biol Sci, Hobart, Tas, Australia; [Weinstein, Philip] Univ S Australia, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia	University of Tasmania; University of Tasmania; University of South Australia	Rowbottom, R (corresponding author), Univ Tasmania, Sch Land & Food, TIA, Hobart, Tas, Australia.	raylea.rowbottom@utas.edu.au	Carver, Scott/J-7654-2014; Barmuta, Leon/J-2413-2013	Carver, Scott/0000-0002-3579-7588; Barmuta, Leon/0000-0002-8946-3727; Rowbottom, Raylea/0000-0002-3162-9368; Weinstein, Philip/0000-0001-9860-7166	Holsworth Wildlife Research Fund, ANZ Trustees Foundation; Joan Woodberry Postgraduate Fellowship, University of Tasmania	Holsworth Wildlife Research Fund, ANZ Trustees Foundation; Joan Woodberry Postgraduate Fellowship, University of Tasmania	This work was supported by The Holsworth Wildlife Research Fund, ANZ Trustees Foundation http://www.eqt.com.au/not-for-profit-organisations/confirmed-2015-programs/holsworth-grants.aspx (RR), The Joan Woodberry Postgraduate Fellowship, University of Tasmania http://www.utas.edu.au/research/graduate-research/future-students/scholarships-and-fees (RR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaskov J, 2012, FUTURE VIROL, V7, P173, DOI 10.2217/FVL.11.139; Amarasekare P, 2003, ECOL LETT, V6, P1109, DOI 10.1046/j.1461-0248.2003.00530.x; Bader CA, 2011, MED VET ENTOMOL, V25, P70, DOI 10.1111/j.1365-2915.2010.00908.x; BALLARD JWO, 1986, AUST J EXP BIOL MED, V64, P197, DOI 10.1038/icb.1986.21; Barrera R, 1996, ECOL ENTOMOL, V21, P117, DOI 10.1111/j.1365-2311.1996.tb01178.x; Barton PS, 2005, P LINN SOC N S W, V126, P261; Beketov MA, 2007, ECOL ENTOMOL, V32, P405, DOI 10.1111/j.1365-2311.2007.00889.x; Bevins SN, 2007, J VECTOR ECOL, V32, P252, DOI 10.3376/1081-1710(2007)32[252:TORIAL]2.0.CO;2; Blackmore MS, 2000, J VECTOR ECOL, V25, P212; Blaustein L, 2007, ANNU REV ENTOMOL, V52, P489, DOI 10.1146/annurev.ento.52.110405.091431; Campos RE, 2006, MEMORIAS I O CRUZ, V101, P47; Carver S, 2011, AUST J ENTOMOL, V50, P344, DOI 10.1111/j.1440-6055.2011.00825.x; Carver S, 2010, ENVIRON ENTOMOL, V39, P798, DOI 10.1603/EN09235; Carver S, 2009, ENVIRON ENTOMOL, V38, P1585, DOI 10.1603/022.038.0609; Chapman HF, 1999, MED VET ENTOMOL, V13, P423, DOI 10.1046/j.1365-2915.1999.00195.x; Chase JM, 2003, ECOL LETT, V6, P1017, DOI 10.1046/j.1461-0248.2003.00533.x; Clements A. N., 1992, BIOL MOSQUITOES, V1; Costanzo KS, 2005, ECOLOGY, V86, P3289, DOI 10.1890/05-0583; Daugherty MP, 2003, AM MIDL NAT, V150, P181, DOI 10.1674/0003-0031(2003)150[0181:LSBFAA]2.0.CO;2; Duquesne S, 2011, J MED ENTOMOL, V48, P554, DOI 10.1603/ME09282; Eitam A, 2004, PHYSIOL ENTOMOL, V29, P188, DOI 10.1111/j.0307-6962.2004.0372.x; Farjana T, 2012, MED VET ENTOMOL, V26, P210, DOI 10.1111/j.1365-2915.2011.00971.x; Gelman A., 2006, DATA ANAL USING REGR, DOI DOI 10.1017/CBO9780511790942.005; Gilles JRL, 2011, J MED ENTOMOL, V48, P296, DOI 10.1603/ME09209; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Jennings CD, 1999, MED VET ENTOMOL, V13, P431, DOI 10.1046/j.1365-2915.1999.00196.x; Juliano SA, 1998, ECOLOGY, V79, P255, DOI 10.1890/0012-9658(1998)079[0255:SIARAM]2.0.CO;2; Juliano SA, 2007, J AM MOSQUITO CONTR, V23, P265, DOI 10.2987/8756-971X(2007)23[265:PD]2.0.CO;2; Juliano SA, 2009, ANNU REV ENTOMOL, V54, P37, DOI 10.1146/annurev.ento.54.110807.090611; Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575; Khatchikian CE, 2010, EVOL ECOL, V24, P1159, DOI 10.1007/s10682-010-9359-4; Knight JM, 2011, ECOSYSTEMS, V14, P1382, DOI 10.1007/s10021-011-9487-x; Knight TM, 2004, J VECTOR ECOL, V29, P277; LOUNIBOS LP, 1994, ECOL ENTOMOL, V19, P138, DOI 10.1111/j.1365-2311.1994.tb00403.x; MERRITT RW, 1992, ANNU REV ENTOMOL, V37, P349, DOI 10.1146/annurev.en.37.010192.002025; Mitchell-Foster K, 2012, J VECTOR ECOL, V37, P221, DOI 10.1111/j.1948-7134.2012.00220.x; Mogi M, 1996, J MED ENTOMOL, V33, P53, DOI 10.1093/jmedent/33.1.53; Mokany A, 2003, AUSTRAL ECOL, V28, P33, DOI 10.1046/j.1442-9993.2003.01239.x; Mokany A, 2003, OECOLOGIA, V135, P615, DOI 10.1007/s00442-003-1215-6; Mokany A, 2002, AUST J ZOOL, V50, P549, DOI 10.1071/ZO01082; Morin P., 1999, COMMUNITY ECOL; Muturi EJ, 2011, TROP MED INT HEALTH, V16, P955, DOI 10.1111/j.1365-3156.2011.02796.x; NASCI RS, 1994, J MED ENTOMOL, V31, P123, DOI 10.1093/jmedent/31.1.123; PACKER MJ, 1989, ECOL ENTOMOL, V14, P297, DOI 10.1111/j.1365-2311.1989.tb00960.x; Padmanabha H, 2011, J MED ENTOMOL, V48, P974, DOI 10.1603/ME11020; Reiskind MH, 2009, MED VET ENTOMOL, V23, P62, DOI 10.1111/j.1365-2915.2008.00782.x; Rossi V, 2011, J LIMNOL, V70, P102, DOI 10.4081/jlimnol.2011.102; Rowbottom R, THESIS; Russell RC, 2002, ANNU REV ENTOMOL, V47, P1, DOI 10.1146/annurev.ento.47.091201.145100; Schneider JR, 2011, INFECT GENET EVOL, V11, P11, DOI 10.1016/j.meegid.2010.10.019; Silberbush A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088650; Stav G, 2005, ECOL APPL, V15, P587, DOI 10.1890/03-5191; Telang A, 2006, J EXP BIOL, V209, P645, DOI 10.1242/jeb.02026; Tilman D., 1982, Monographs in Population Biology, pi; Tun-Lin W, 2000, MED VET ENTOMOL, V14, P31, DOI 10.1046/j.1365-2915.2000.00207.x; van Schie C, 2009, AUST J ENTOMOL, V48, P293, DOI 10.1111/j.1440-6055.2009.00719.x; Walsh R, 2015, AQUATIC MICROINVERTE; Werner AK, 2012, EPIDEMIOL INFECT, V140, P359, DOI 10.1017/S0950268811000446; Williams DD, 1997, AQUAT CONSERV, V7, P105	59	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142472	10.1371/journal.pone.0142472	http://dx.doi.org/10.1371/journal.pone.0142472			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26558896	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000364433100081
J	Stagg, HR; Brown, J; Ibraim, E; Riekstina, V; Viiklepp, P; Cirule, A; Cocei, H; Danilovits, M; Dravniece, G; Jackson, C; White, PJ				Stagg, Helen R.; Brown, James; Ibraim, Elmira; Riekstina, Vija; Viiklepp, Piret; Cirule, Andra; Cocei, Horia; Danilovits, Manfred; Dravniece, Gunta; Jackson, Charlotte; White, Peter J.			Drug Susceptibility Patterns in MDR-TB Patients: Challenges for Future Regimen Design. A Cross-Sectional Study	PLOS ONE			English	Article							MULTIDRUG-RESISTANT TUBERCULOSIS; COUNTRIES	Globally, there is substantial concern regarding the challenges of treating complex drug resistance patterns in multidrug resistant tuberculosis cases. Utilising data from three different settings (Estonia, Latvia, Romania) we sought to contrast drug susceptibility profiles for multidrug resistant tuberculosis cases, highlight the difficulties in designing universal regimen, and inform future regimen selection. Demographic and microbiological surveillance data for multidrug resistant tuberculosis cases from 2004-13 were analysed. High levels of additional resistance to currently recommended second line drugs were seen in all settings, with extensive variability between countries. Accurate drug susceptibility testing and drug susceptibility testing data are vital to inform the development of comprehensive, flexible, multidrug resistant tuberculosis guidance.	[Stagg, Helen R.; Jackson, Charlotte] UCL, Res Dept Infect & Populat Hlth, London, England; [Brown, James] Royal Free London NHS Fdn Trust, Ctr Resp Med, London, England; [Brown, James] UCL, Div Med, London, England; [Ibraim, Elmira] Marius Nasta Inst Pulmonol, Bucharest, Romania; [Riekstina, Vija; Cirule, Andra] Riga East Univ Hosp, Ctr TB & Lung Dis, Riga, Latvia; [Riekstina, Vija] Univ Latvia, Riga, Latvia; [Viiklepp, Piret] Natl Inst Hlth Dev, Estonian TB Registry, Tallinn, Estonia; [Danilovits, Manfred] Tartu Univ Hosp, Lung Clin, Tartu, Estonia; [Dravniece, Gunta] KNCV TB Fdn, The Hague, Netherlands; [White, Peter J.] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Infect Dis Epidemiol, MRC,Ctr Outbreak Anal & Modelling, London, England; [White, Peter J.] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Infect Dis Epidemiol, NIHR Hlth Protect Res Unit Modelling Methodol, London, England; [White, Peter J.] Publ Hlth England, Ctr Infect Dis Surveillance & Control, Modelling & Econ Unit, London, England	University of London; University College London; University of London; University College London; Royal Free London NHS Foundation Trust; University of London; University College London; "Marius Nasta" Pneumophtisiology Institute; Riga East University Hospital; University of Latvia; National Institute for Health Development - Estonia; KNCV Tuberculosis Foundation; Imperial College London; Imperial College London; Public Health England	Stagg, HR (corresponding author), UCL, Res Dept Infect & Populat Hlth, London, England.	h.stagg@ucl.ac.uk		Stagg, Helen/0000-0003-4022-3447	Otsuka SA; MRC [MR/K010174/1] Funding Source: UKRI; Medical Research Council [MR/K010174/1, MR/K010174/1B] Funding Source: researchfish; National Institute for Health Research [HPRU-2012-10080] Funding Source: researchfish	Otsuka SA; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The collation of data for this paper and its compilation was sponsored by Otsuka SA. In her previous role as an employee of Otsuka SA, GD played a role in the study design, analysis, decision to publish, and manuscript preparation.	Chedore P, 2010, J CLIN MICROBIOL, V48, P300, DOI 10.1128/JCM.01775-09; Dalton T, 2012, LANCET, V380, P1406, DOI 10.1016/S0140-6736(12)60734-X; Kurbatova EV, 2015, EMERG INFECT DIS, V21, P977, DOI 10.3201/eid2106.141329; WHO, 2014, GLOB TUB REP 2014; World Health Organization, 2011, GUID PROGR MAN DRUG; World Health organization, 2008, POL GUID DRUG SUSC T; Zignol M, 2013, DRUG RESIST UPDATE, V16, P108, DOI 10.1016/j.drup.2014.02.003; Zumla A, 2013, NAT REV DRUG DISCOV, V12, P388, DOI 10.1038/nrd4001	8	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142425	10.1371/journal.pone.0142425	http://dx.doi.org/10.1371/journal.pone.0142425			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26558611	Green Published, gold, Green Submitted			2022-12-27	WOS:000364433100079
J	Zaton, M; Broda, K				Zaton, Michal; Broda, Krzysztof			First Record of Soft Tissue Preservation in the Upper Devonian of Poland	PLOS ONE			English	Article							HOLY CROSS MOUNTAINS; MUSCLE-TISSUE; REMARKABLE PRESERVATION; UPPER ORDOVICIAN; HUNSRUCK SLATE; MINERALIZATION; LAGERSTATTE; FOSSILIZATION; ANIMALS; FOSSILS	Soft tissue preservation is reported from Upper Devonian deposits of the Holy Cross Mountains, central Poland, for the first time. The preserved soft tissues are muscles associated with arthropod cuticle fragments. The muscles are phosphatized with variable states of preservation. Well-preserved specimens display the typical banding of striated muscles. Other muscle fragments are highly degraded and/or recrystallized such that their micro-structure is barely visible. The phosphatized muscles and associated cuticle are fragmented, occur in patches and some are scattered on the bedding plane. Due to the state of preservation and the lack of diagnostic features, the cuticle identification is problematic; however, it may have belonged to a phyllocarid crustacean. Taphonomic features of the remains indicate that they do not represent fossilized fecal matter (coprolite) but may represent a regurgitate, but the hypothesis is difficult to test. Most probably they represent the leftover remains after arthropod or fish scavenging. The present study shows that soft tissues, which even earlier were manipulated by scavenger, may be preserved if only special microenvironmental conditions within and around the animal remains are established.	[Zaton, Michal; Broda, Krzysztof] Silesian Univ, Fac Earth Sci, Sosnowiec, Poland	University of Silesia in Katowice	Zaton, M (corresponding author), Silesian Univ, Fac Earth Sci, Bedzinska 60, Sosnowiec, Poland.	mzaton@wnoz.us.edu.pl		Zaton, Michal/0000-0001-5136-5286				Aldridge RJ, 2006, PALAEONTOLOGY, V49, P857, DOI 10.1111/j.1475-4983.2006.00570.x; ALLISON PA, 1993, GEOLOGY, V21, P527, DOI 10.1130/0091-7613(1993)021<0527:EFRDOS>2.3.CO;2; ALLISON PA, 1988, PALEOBIOLOGY, V14, P331, DOI 10.1017/S0094837300012082; Bond Dave, 2003, Acta Geologica Polonica, V53, P93; Briggs DEG, 2005, P ROY SOC B-BIOL SCI, V272, P627, DOI 10.1098/rspb.2004.3006; BRIGGS DEG, 1994, PALAIOS, V9, P431, DOI 10.2307/3515135; Briggs DEG, 1996, NATURE, V382, P248, DOI 10.1038/382248a0; Briggs DEG, 1996, J GEOL SOC LONDON, V153, P665, DOI 10.1144/gsjgs.153.5.0665; Briggs DEG, 1996, AM J SCI, V296, P633, DOI 10.2475/ajs.296.6.633; Broda K, 2015, P GEOLOGIST ASSOC, V126, P589, DOI 10.1016/j.pgeola.2015.05.005; Chin K, 2003, PALAIOS, V18, P286, DOI 10.1669/0883-1351(2003)018<0286:RPOUMT>2.0.CO;2; Crowther P.R, 2001, PALAEOBIOLOGY, P328; Cunningham JA, 2012, P ROY SOC B-BIOL SCI, V279, P1857, DOI 10.1098/rspb.2011.2064; Feldmann RM, 2010, J CRUSTACEAN BIOL, V30, P629, DOI 10.1651/09-3268.1; Filipiak P, 2009, REV PALAEOBOT PALYNO, V157, P326, DOI 10.1016/j.revpalbo.2009.06.006; GABBOTT SE, 1995, NATURE, V374, P800, DOI 10.1038/374800a0; Gabbott SE, 2004, GEOLOGY, V32, P901, DOI 10.1130/G20640.1; Ginter M, 2002, ACTA PALAEONTOL POL, V47, P329; Hattin DE, 1996, CRETACEOUS RES, V17, P443, DOI 10.1006/cres.1996.0027; Kellner AWA, 1996, NATURE, V379, P32, DOI 10.1038/379032a0; Maas Andreas, 2006, Palaeoworld, V15, P266, DOI 10.1016/j.palwor.2006.10.005; Martill D.M., 1989, Geology Today, V5, P201, DOI 10.1111/j.1365-2451.1989.tb00671.x; MARTILL DM, 1990, NATURE, V346, P171, DOI 10.1038/346171a0; MARTILL DM, 1988, PALAEONTOLOGY, V31, P1; MARTILL DM, 1989, NATURE, V340, P138, DOI 10.1038/340138a0; Martill DM, 1995, PALAEONTOLOGY, V38, P897; Martill DM, 2003, PALAEOBIOLOGY, P351; Martin D, 2003, GEOLOGY, V31, P39, DOI 10.1130/0091-7613(2003)031<0039:EMOIEA>2.0.CO;2; Marynowski L, 2011, PALAEOGEOGR PALAEOCL, V306, P1, DOI 10.1016/j.palaeo.2011.03.018; Montalvo CI, 2016, LETHAIA, V49, P219, DOI 10.1111/let.12140; Moore RA, 2011, J PALEONTOL, V85, P83, DOI 10.1666/10-057.1; Myhrvold NP, 2012, HIST BIOL, V24, P505, DOI 10.1080/08912963.2011.631703; Orr PJ, 1998, SCIENCE, V281, P1173, DOI 10.1126/science.281.5380.1173; Racheboeuf Patrick R., 1994, Revue de Paleobiologie, V13, P281; RACKI G, 1996, 6 EUR CON S ECOS 6 E, P27; Raff EC, 2008, P NATL ACAD SCI USA, V105, P19360, DOI 10.1073/pnas.0810106105; Raiswell R, 2008, AM J SCI, V308, P105, DOI 10.2475/02.2008.01; Sagemann J, 1999, GEOCHIM COSMOCHIM AC, V63, P1083, DOI 10.1016/S0016-7037(99)00087-3; Schiffbauer JD, 2012, PALAIOS, V27, P275, DOI 10.2110/palo.2012.SO3; Schultze H.-P., 1989, Revista Geologica de Chile, V16, P183; Seilacher A., 1970, NEUES JAHRB GEOL P-M, V1970, P34, DOI DOI 10.1080/17451000500456262; Trinajstic K, 2007, BIOL LETTERS, V3, P197, DOI 10.1098/rsbl.2006.0604; Trinajstic K, 2013, SCIENCE, V341, P160, DOI 10.1126/science.1237275; Vannier J, 2005, PALAIOS, V20, P3, DOI 10.2110/palo.2003.p03-40; Wilby P.R., 1992, Historical Biology, V6, P25; Wilby Philip R., 1997, Geobios Memoire Special (Villeurbanne), V20, P493; Wilby PR, 1996, GEOLOGY, V24, P787, DOI 10.1130/0091-7613(1996)024<0787:ROMMIT>2.3.CO;2; Xiao SH, 1999, LETHAIA, V32, P219, DOI 10.1111/j.1502-3931.1999.tb00541.x; Xiao SH, 1998, NATURE, V391, P553, DOI 10.1038/35318; Zaton M, 2007, LETHAIA, V40, P139, DOI 10.1111/j.1502-3931.2007.00017.x; Zaton M, 2014, LETHAIA, V47, P352, DOI 10.1111/let.12062; Zaton M, 2014, PALAEOGEOGR PALAEOCL, V394, P1, DOI 10.1016/j.palaeo.2013.11.019	52	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142619	10.1371/journal.pone.0142619	http://dx.doi.org/10.1371/journal.pone.0142619			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559060	gold, Green Published, Green Submitted			2022-12-27	WOS:000364433100102
J	Bastin, JF; Fayolle, A; Tarelkin, Y; Van den Buicke, J; de Haulleville, T; Mortier, F; Beeckman, H; Van Acker, J; Serckx, A; Bogaert, J; De Canniere, C				Bastin, Jean-Francois; Fayolle, Adeline; Tarelkin, Yegor; Van den Buicke, Jan; de Haulleville, Tholes; Mortier, Frederic; Beeckman, Hans; Van Acker, Joris; Serckx, Adeline; Bogaert, Jan; De Canniere, Charles			Wood Specific Gravity Variations and Biomass of Central African Tree Species: The Simple Choice of the Outer Wood	PLOS ONE			English	Article							ABOVEGROUND BIOMASS; ERROR PROPAGATION; RADIAL VARIATION; RAIN-FOREST; DENSITY; GROWTH; MORTALITY; HYPERDOMINANCE; BIOMECHANICS; PATTERNS	Wood specific gravity is a key element in tropical forest ecology. It integrates many aspects of tree mechanical properties and functioning and is an important predictor of tree biomass. Wood specific gravity varies widely among and within species and also within individual trees. Notably, contrasted patterns of radial variation of wood specific gravity have been demonstrated and related to regeneration guilds (light demanding vs. shade-bearing). However, although being repeatedly invoked as a potential source of error when estimating the biomass of trees, both intraspecific and radial variations remain little studied. In this study we characterized detailed pith-to-bark wood specific gravity profiles among contrasted species prominently contributing to the biomass of the forest, i.e., the dominant species, and we quantified the consequences of such variations on the biomass.	[Bastin, Jean-Francois; Tarelkin, Yegor; De Canniere, Charles] Univ Libre Bruxelles, Landscape Ecol & Plant Prod Syst Unit, B-1050 Brussels, Belgium; [Bastin, Jean-Francois; Fayolle, Adeline; de Haulleville, Tholes; Bogaert, Jan] Univ Liege, BIOSE Dept, Gembloux Agrobio Tech, B-5030 Gembloux, Belgium; [Bastin, Jean-Francois; Serckx, Adeline] Ecole Reg Postuniv Amenagement & Gest Integres Fo, Kinshasa, DEM REP CONGO; [Van den Buicke, Jan; Van Acker, Joris] Univ Ghent Ctr Xray Tomog, UGCT, B-9000 Ghent, Belgium; [de Haulleville, Tholes; Beeckman, Hans] Royal Museum Cent Africa, Lab Wood Biol & Xylarium, Tervuren, Belgium; [Mortier, Frederic] CIRAD, UPR BSEF, F-34398 Montpellier, France; [Serckx, Adeline] Univ Liege, Behav Biol Unit, Liege, Belgium; [Serckx, Adeline] Royal Belgian Inst Nat Sci, Conservat Biol Unit, Brussels, Belgium	Universite Libre de Bruxelles; University of Liege; Ghent University; Royal Museum for Central Africa; CIRAD; University of Liege; Royal Belgian Institute of Natural Sciences	Bastin, JF (corresponding author), Univ Libre Bruxelles, Landscape Ecol & Plant Prod Syst Unit, CP264-2, B-1050 Brussels, Belgium.	bastin.jf@gmail.com	Beeckman, Hans/I-7653-2019; Van Acker, Joris/AAS-6030-2020	Beeckman, Hans/0000-0001-8954-6277; Van Acker, Joris/0000-0002-8961-0176; Mortier, Frederic/0000-0001-5473-709X; FAYOLLE, Adeline/0000-0002-6770-0031; Van den Bulcke, Jan/0000-0003-2939-5408	FNRS (Fonds National pour la Recherche Scientifique) [FC-89142]; ERAIFT (Ecole Regionale post-universitaire d'Amenagement et de gestion Integres des Forets et Territoires tropicaux) [ER/JPM/BM/281/Not./2012]; FRIA (FNRS); ERAIFT	FNRS (Fonds National pour la Recherche Scientifique)(Fonds de la Recherche Scientifique - FNRS); ERAIFT (Ecole Regionale post-universitaire d'Amenagement et de gestion Integres des Forets et Territoires tropicaux); FRIA (FNRS)(Fonds de la Recherche Scientifique - FNRS); ERAIFT	The authors are supported by the FNRS (Fonds National pour la Recherche Scientifique; FC-89142; www.fnrs.be). Additional funds for field support were provided by the ERAIFT (Ecole Regionale post-universitaire d'Amenagement et de gestion Integres des Forets et Territoires tropicaux; ER/JPM/BM/281/Not./2012; http://www.eraift-rdc.org). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the FRIA (FNRS) and the ERAIFT for support and funding, to the WWF Belgium and DRC, to MbouMonTour NGOs for logistical support. We also would like to thank J.Lejoly, L.Pauwels, J-.L.Doucet and J-.F.Gillet (ULg-Gembloux, Belgium) for advice and aid in botanical identifications, to J.Hebert and P.Thibaut (ULg-Gembloux, Belgium) for general advice and water displacement analysis on the samples and to Nicholas Rowe (CNRS, AMAP, France), Olivier Hardy and Marius Gilbert (ULB, Belgium) for their insightful comments. Finally, we are very grateful to the local community chiefs from Nkala and Mpelu villages, and particularly, to P.Eyiano, N.Mongama, Leboncoeur and Bovik for fieldwork assistance.	Agrawal A, 2011, ANNU REV ENV RESOUR, V36, P373, DOI 10.1146/annurev-environ-042009-094508; Bastin JF, 2015, SCI REP-UK, V5, DOI 10.1038/srep13156; Bastin JF, 2014, ECOL APPL, V24, P1984, DOI 10.1890/13-1574.1; Bates D, 2005, R NEWS, V5, P27, DOI DOI 10.1111/J.1523-1739.2005.00280.X; Brienen RJW, 2006, J ECOL, V94, P481, DOI 10.1111/j.1365-2745.2005.01080.x; Chao KJ, 2008, J ECOL, V96, P281, DOI 10.1111/j.1365-2745.2007.01343.x; Chave J, 2004, PHILOS T R SOC B, V359, P409, DOI 10.1098/rstb.2003.1425; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Chave J, 2001, J TROP ECOL, V17, P79, DOI 10.1017/S0266467401001055; Chave J, 2006, ECOL APPL, V16, P2356, DOI 10.1890/1051-0761(2006)016[2356:RAPVOW]2.0.CO;2; Chave J, 2014, GLOBAL CHANGE BIOL, V20, P3177, DOI 10.1111/gcb.12629; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; De Ridder M, 2011, ANN BOT-LONDON, V107, P293, DOI 10.1093/aob/mcq224; Detienne P., 1996, Bois et Forets des Tropiques, P19; Fauset S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7857; Fayolle A, 2014, J BIOGEOGR, V41, P2320, DOI 10.1111/jbi.12382; Fayolle A, 2014, FOREST ECOL MANAG, V329, P195, DOI 10.1016/j.foreco.2014.06.014; Fournier M, 2013, J EXP BOT, V64, P4793, DOI 10.1093/jxb/ert279; Gourlet-Fleury S, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0302; Gourlet-Fleury S, 2011, J ECOL, V99, P981, DOI 10.1111/j.1365-2745.2011.01829.x; Hawthorne W.D., 1995, ECOLOGICAL PROFILES; King DA, 2006, J ECOL, V94, P670, DOI 10.1111/j.1365-2745.2006.01112.x; King DA, 2005, FUNCT ECOL, V19, P445, DOI 10.1111/j.1365-2435.2005.00982.x; Maniatis D, 2011, IFOREST, V4, P150, DOI 10.3832/ifor0575-004; McCulloh KA, 2011, OECOLOGIA, V167, P27, DOI 10.1007/s00442-011-1973-5; Molto Q, 2013, METHODS ECOL EVOL, V4, P175, DOI 10.1111/j.2041-210x.2012.00266.x; MORSE DR, 1985, NATURE, V314, P731, DOI 10.1038/314731a0; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Nock CA, 2009, ANN BOT-LONDON, V104, P297, DOI 10.1093/aob/mcp118; Nogueira EM, 2008, FOREST ECOL MANAG, V256, P990, DOI 10.1016/j.foreco.2008.06.001; Onoda Y, 2010, NEW PHYTOL, V185, P493, DOI 10.1111/j.1469-8137.2009.03088.x; Osazuwa-Peters OL, 2014, AM J BOT, V101, P803, DOI 10.3732/ajb.1400040; Panshin A.J., 1980, TXB WOOD TECHNOLOGY; Pinheiro J, 2001, MIXED EFFECTS MODELS; Plourde BT, 2015, FUNCT ECOL, V29, P111, DOI 10.1111/1365-2435.12305; Ramananantoandro T, 2015, J FORESTRY RES, V26, P47, DOI 10.1007/s11676-015-0029-9; Reich PB, 2014, J ECOL, V102, P275, DOI 10.1111/1365-2745.12211; Sallenave, 1955, PROPRIETES PHYS MECA; Sallenave P., 1964, PROPRIETES PHYS MECA; SALLENAVE P, 1971, PROPRIETES PHYS MECA; Serckx A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093742; Slik JWF, 2006, J TROP ECOL, V22, P481, DOI 10.1017/S0266467406003324; Slik JWF, 2010, GLOBAL ECOL BIOGEOGR, V19, P50, DOI 10.1111/j.1466-8238.2009.00489.x; Slik JWF, 2013, GLOBAL ECOL BIOGEOGR, V22, P1261, DOI 10.1111/geb.12092; Stephenson NL, 2014, NATURE, V507, P90, DOI 10.1038/nature12914; Swenson NG, 2007, AM J BOT, V94, P451, DOI 10.3732/ajb.94.3.451; ter Steege H, 2013, SCIENCE, V342, P325, DOI 10.1126/science.1243092; Turner I.M., 2001, CAM TROP B, DOI 10.1017/CBO9780511542206; Urquiza-Haas T, 2007, FOREST ECOL MANAG, V247, P80, DOI 10.1016/j.foreco.2007.04.015; Van den Bulcke J, 2014, DENDROCHRONOLOGIA, V32, P39, DOI 10.1016/j.dendro.2013.07.001; Vancutsem C, 2006, REPUBLIQUE DEMOCRATI; Vieilledent G, 2012, ECOL APPL, V22, P572, DOI 10.1890/11-0039.1; Wassenberg M, 2015, TREES-STRUCT FUNCT, V29, P551, DOI 10.1007/s00468-014-1134-7; WIEMANN MC, 1988, WOOD FIBER SCI, V20, P344; Williamson GB, 2010, AM J BOT, V97, P519, DOI 10.3732/ajb.0900243; Woodcock DW, 2002, TREES-STRUCT FUNCT, V16, P437, DOI 10.1007/s00468-002-0173-7; Zanne A.E., 2009, GLOBAL WOOD DENSITY, DOI [DOI 10.5061/DRYAD.234, 10.5061/dryad.234]; Zuur Alain F., 2009, P1	58	34	34	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142146	10.1371/journal.pone.0142146	http://dx.doi.org/10.1371/journal.pone.0142146			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555144	Green Published, Green Submitted, gold			2022-12-27	WOS:000364430700060
J	Daniels, JF; Khogali, M; Mohr, E; Cox, V; Moyo, S; Edginton, M; Hinderaker, SG; Meintjes, G; Hughes, J; De Azevedo, V; van Cutsem, G; Cox, HS				Daniels, Johnny Flippie; Khogali, Mohammed; Mohr, Erika; Cox, Vivian; Moyo, Sizulu; Edginton, Mary; Hinderaker, Sven Gudmund; Meintjes, Graeme; Hughes, Jennifer; De Azevedo, Virginia; van Cutsem, Gilles; Cox, Helen Suzanne			Time to ART Initiation among Patients Treated for Rifampicin-Resistant Tuberculosis in Khayelitsha, South Africa: Impact on Mortality and Treatment Success	PLOS ONE			English	Article							HIV-INFECTED ADULTS; ANTIRETROVIRAL THERAPY; TREATMENT OUTCOMES	Setting Khayelitsha, South Africa, with high burdens of rifampicin-resistant tuberculosis (RR-TB) and HIV co-infection. Objective To describe time to antiretroviral treatment (ART) initiation among HIV-infected RR-TB patients initiating RR-TB treatment and to assess the association between time to ART initiation and treatment outcomes. Design A retrospective cohort study of patients with RR-TB and HIV co-infection not on ART at RR-TB treatment initiation. Results Of the 696 RR-TB and HIV-infected patients initiated on RR-TB treatment between 2009 and 2013, 303 (44%) were not on ART when RR-TB treatment was initiated. The median CD4 cell count was 126 cells/mm(3). Overall 257 (85%) patients started ART during RR-TB treatment, 33 (11%) within 2 weeks, 152 (50%) between 2-8 weeks and 72 (24%) after 8 weeks. Of the 46 (15%) who never started ART, 10 (21%) died or stopped RR-TB treatment within 4 weeks and 16 (37%) had at least 4 months of RR-TB treatment. Treatment success and mortality during treatment did not vary by time to ART initiation: treatment success was 41%, 43%, and 50% among patients who started ART within 2 weeks, between 2-8 weeks, and after 8 weeks (p = 0.62), while mortality was 21%, 13% and 15% respectively (p = 0.57). Mortality was associated with never receiving ART (adjusted hazard ratio (aHR) 6.0, CI 2.1-18.1), CD4 count <= 100 (aHR 2.1, CI 1.0-4.5), and multidrug-resistant tuberculosis (MDR-TB) with second-line resistance (aHR 2.5, CI 1.1-5.4). Conclusions Despite wide variation in time to ART initiation among RR-TB patients, no differences in mortality or treatment success were observed. However, a significant proportion of patients did not initiate ART despite receiving >4 months of RR-TB treatment. Programmatic priorities should focus on ensuring all patients with RR-TB/HIV co-infection initiate ART regardless of CD4 count, with special attention for patients with CD4 counts <= 100 to initiate ART as soon as possible after RR-TB treatment initiation.	[Daniels, Johnny Flippie; Mohr, Erika; Cox, Vivian; Moyo, Sizulu; Hughes, Jennifer; van Cutsem, Gilles] Med Sans Frontieres, Cape Town, South Africa; [Khogali, Mohammed] Med Sans Frontieres, Luxembourg, Luxembourg; [Moyo, Sizulu] Human Sci Res Council, HIV AIDS STIs & TB Programme, Cape Town, South Africa; [Edginton, Mary] Int Union TB & Lung Dis, Paris, France; [Edginton, Mary] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa; [Hinderaker, Sven Gudmund] Univ Bergen, Bergen, Norway; [Meintjes, Graeme; Cox, Helen Suzanne] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Meintjes, Graeme] Univ Cape Town, Dept Med, ZA-7925 Cape Town, South Africa; [De Azevedo, Virginia] City Cape Town Dept Hlth, Cape Town, South Africa; [van Cutsem, Gilles] Univ Cape Town, Ctr Infect Dis Epidemiol & Res, ZA-7925 Cape Town, South Africa; [Cox, Helen Suzanne] Univ Cape Town, Div Med Microbiol, ZA-7925 Cape Town, South Africa	Doctors Without Borders; Human Sciences Research Council-South Africa; University of Witwatersrand; University of Bergen; University of Cape Town; University of Cape Town; University of Cape Town; University of Cape Town	Daniels, JF (corresponding author), Med Sans Frontieres, Cape Town, South Africa.	msfocb-khayelitsha-tbdata@brussels.msf.org	Van Cutsem, Gilles/ABB-1171-2021	Van Cutsem, Gilles/0000-0002-8972-4480; Hughes, Jennifer/0000-0002-5349-9509; Cox, Helen/0000-0002-6538-7192; Meintjes, Graeme/0000-0003-1196-4414	Union; MSF; Department for International Development (DFID); WHO; Wellcome Trust	Union; MSF; Department for International Development (DFID); WHO(World Health Organization); Wellcome Trust(Wellcome Trust)	The research for this study was unfunded. The SORT IT programme was funded by The Union, MSF, the Department for International Development (DFID) and WHO. HC is supported by the Wellcome Trust.	[Anonymous], 2011, ACT REP 10 YEARS HIV; Blanc FX, 2011, NEW ENGL J MED, V365, P1471, DOI 10.1056/NEJMoa1013911; Boulle A, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001718; Cox H, 2014, INT J TUBERC LUNG D, V18, P441, DOI 10.5588/ijtld.13.0742; Dheda K, 2010, LANCET, V375, P1798, DOI 10.1016/S0140-6736(10)60492-8; Farley JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020436; Gandhi NR, 2010, AM J RESP CRIT CARE, V181, P80, DOI 10.1164/rccm.200907-0989OC; Havlir DV, 2011, NEW ENGL J MED, V365, P1482, DOI 10.1056/NEJMoa1013607; Howard AA, 2010, CLIN INFECT DIS, V50, pS238, DOI 10.1086/651497; Isaakidis P, 2015, INT J TUBERC LUNG D, V19, P969, DOI 10.5588/ijtld.15.0123; Isaakidis P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040781; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; Kerschberger B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046988; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Meintjes G, 2014, S AFR J HIV MED, V15, P121, DOI [10.7196/sajhivmed.1130, 10.7196/SAJHIVMED.1130]; Meintjes G, 2011, CONTIN MED ED, V29, P410; Meintjes G, 2008, LANCET INFECT DIS, V8, P516, DOI 10.1016/S1473-3099(08)70184-1; Meintjes G, 2012, S AFR J HIV MED, DOI 10.7196/SAJHIVMED.862; Mohr E, 2015, T ROY SOC TROP MED H, V109, P425, DOI 10.1093/trstmh/trv037; Nathanson E, 2004, INT J TUBERC LUNG D, V8, P1382; National Department of Health South Africa, 2011, MAN DRUG RES TUB POL; National Department of Health South Africa, 2013, MAN DRUG RES TUB POL; National Department of Health South Africa, 2009, MAN DRUG RES TB S AF; National Department of Health South Africa, 2009, NAT TUB MAN GUID 200; National Department of Health South Africa, 2010, S AFR ANT TREATM GUI; National Department of Health South Africa, 2014, NAT TUB MAN GUID 201; National Department of Health South Africa, 2013, S AFR ANT TREATM GUI; O'Donnell MR, 2013, EMERG INFECT DIS, V19, P416, DOI 10.3201/eid1903.120998; Padayatchi N, 2014, INT J TUBERC LUNG D, V18, P147, DOI 10.5588/ijtld.13.0627; Satti H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046943; Shisana O, 2014, COMMUNICATION; Southern African HIV Clinicians Society, 2008, S AFR J HIV MED; Southern African HIV Clinicians Society, 2012, S AFR J HIV MED, V13, P144; Strategic Development Information and GIS Department CoCT, 2013, CIT CAP TOWN 2011 CE; Uthman OA, 2015, ANN INTERN MED, V163, P32, DOI 10.7326/M14-2979; von Elm E, 2007, B WORLD HEALTH ORGAN, V85, P867, DOI 10.2471/BLT.07.045120; Western Cape Department of Health, 2010, W CAP ANT HIV SURV 2; World Health Organization, 2014, COMP HDB WHO GUID PR; World Health Organization, 2014, WHOHTMTB201402; World Health Organization, 2011, GUID PROGR MAN DRUG	40	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142873	10.1371/journal.pone.0142873	http://dx.doi.org/10.1371/journal.pone.0142873			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555134	Green Submitted, Green Published, gold			2022-12-27	WOS:000364430700180
J	Thi, HN; Khanh, DKT; Thu, HLT; Thomas, EG; Lee, KJ; Russell, FM				Hai Nguyen Thi; Dung Khu Thi Khanh; Ha Le Thi Thu; Thomas, Emma G.; Lee, Katherine J.; Russell, Fiona M.			Foot Length, Chest Circumference, and Mid Upper Arm Circumference Are Good Predictors of Low Birth Weight and Prematurity in Ethnic Minority Newborns in Vietnam: A Hospital-Based Observational Study	PLOS ONE			English	Article							IDENTIFY SMALL BABIES; BORN TOO SOON; ANTHROPOMETRIC SURROGATES; EXTRA CARE; SURVIVAL; HEALTH; NEED	Background The evaluation of tools to accurately identify low birth weight (LBW) and/or premature newborns in resource-limited countries is a research priority. We explored the use of foot length, chest circumference, and mid-upper arm circumference (MUAC) measured within 24 h as diagnostic tools for identifying newborns who are LBW, premature, or both; and compared measurements taken at birth with those taken at five days of age. Materials and Methods An observational study was undertaken in Hoa Binh Province General Hospital, Vietnam, in ethnic minority newborns. Birth weight, foot length, chest circumference, and MUAC were measured within 24 h of birth and in a subset of 200, were repeated on day five of life. Gestational age was estimated using the New Ballard Score. Receiver Operating Characteristic curves and optimal cut-points (the point with the highest sensitivity and specificity where the sensitivity was at least 0.8) were calculated, for predicting prematurity, LBW, and both. Measurements within 24 h and at five days of life were compared. Results 485 newborns were recruited. Chest circumference and MUAC measured within 24 h of birth were found to be highly predictive of LBW (both yielding area under the curve [AUC] of 0.98, 95% confidence interval [CI] 0.96-0.99), and performed marginally better than foot length (AUC 0.94, 95% CI 0.92-0.96). The optimal cut-points for measurements within 24 h of birth were <= 7.4cm for foot length; <= 30.4cm for chest circumference; and <= 9.0cm for MUAC. There was statistical evidence that anthropometric measurements taken within 24 h of birth were higher than measurements on day five (p<0.02 for all anthropometric measurements) but the magnitude of these differences was small (at most 2mm). Conclusions All measurements taken within 24 h of birth were good predictors of LBW, prematurity and both. Differences in measurements taken within 24 h and on day five were not clinically relevant. Further research will ensure that the application of these measures is reliable in community settings.	[Hai Nguyen Thi] Hoa Binh Gen Hosp, Dept Pediat, Hoa Binh, Vietnam; [Dung Khu Thi Khanh; Ha Le Thi Thu] Natl Hosp Pediat, Neonatal Dept, Hanoi, Vietnam; [Thomas, Emma G.; Lee, Katherine J.; Russell, Fiona M.] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Lee, Katherine J.] Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia; [Russell, Fiona M.] Univ Melbourne, Dept Paediat, Ctr Int Child Hlth, Parkville, Vic 3052, Australia	Murdoch Children's Research Institute; University of Melbourne; University of Melbourne	Russell, FM (corresponding author), Univ Melbourne, Dept Paediat, Ctr Int Child Hlth, Parkville, Vic 3052, Australia.	fmruss@unimelb.edu.au	Lee, Katherine J/A-2519-2016					[Anonymous], 1993, Bull World Health Organ, V71, P157; [Anonymous], 2008, REPR HLTH HMONG PEOP; BALLARD JL, 1991, J PEDIATR-US, V119, P417, DOI 10.1016/S0022-3476(05)82056-6; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; DAGA SR, 1988, J TROP PEDIATRICS, V34, P16, DOI 10.1093/tropej/34.1.16; Das S, 2012, J TROP PEDIATRICS, V58, P307, DOI 10.1093/tropej/fmr080; Duong DV, 2004, SOC SCI MED, V59, P2585, DOI 10.1016/j.socscimed.2004.04.007; Ezeaka V C, 2003, Niger Postgrad Med J, V10, P168; Ghosh M, 2011, J TROP PEDIATRICS, V57, P464, DOI 10.1093/tropej/fmr004; Goto E, 2011, J EPIDEMIOL, V21, P354, DOI 10.2188/jea.JE20100182; Graner S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-608; Hirve S S, 1993, Indian Pediatr, V30, P25; JAMES DK, 1979, ARCH DIS CHILD, V54, P226, DOI 10.1136/adc.54.3.226; Lawn JE, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.aaa2563; Lawn JE, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S5; Lawn JE, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S6; Malqvist M, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.19803; Malqvist M, 2011, ACTA PAEDIATR, V100, P340, DOI 10.1111/j.1651-2227.2010.02065.x; Marchant T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-859; Marchant T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001292; Marchant T, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-624; MATHUR A, 1984, J TROP PEDIATRICS, V30, P333, DOI 10.1093/tropej/30.6.333; Mukherjee S, 2013, IRAN J PEDIATR, V23, P508; Mullany LC, 2007, EUR J CLIN NUTR, V61, P40, DOI 10.1038/sj.ejcn.1602504; Nabiwemba E, 2013, CHILD CARE HLTH DEV, V39, P20, DOI 10.1111/j.1365-2214.2012.01383.x; Oestergaard MZ, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001080; Otupiri E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106712; Rustagi N, 2012, ASIA-PAC J PUBLIC HE, V24, P343, DOI 10.1177/1010539510384717; Shrestha PS, 2014, CLIN INFECT DIS, V59, pS300, DOI 10.1093/cid/ciu459; Sreeramareddy CT, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-16; UNFPA-Vietnam, 2007, FACT SHEET HOA BINH; UNICEF/WHO, 2011, STAT WORLDS CHILDR; Wardlaw T, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-82	33	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142420	10.1371/journal.pone.0142420	http://dx.doi.org/10.1371/journal.pone.0142420			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555356	gold, Green Published			2022-12-27	WOS:000364430700102
J	Arteaga, O; Revuelta, M; Uriguen, L; Alvarez, A; Montalvo, H; Hilario, E				Arteaga, Olatz; Revuelta, Miren; Urigueen, Leyre; Alvarez, Antonia; Montalvo, Haizea; Hilario, Enrique			Pretreatment with Resveratrol Prevents Neuronal Injury and Cognitive Deficits Induced by Perinatal Hypoxia-Ischemia in Rats	PLOS ONE			English	Article							BRAIN-INJURY; ISCHEMIA/REPERFUSION INJURY; CEREBRAL-ISCHEMIA; OXIDATIVE STRESS; NEONATAL BRAIN; FRENCH PARADOX; MEMORY; IMPAIRMENT; MODEL; DAMAGE	Despite advances in neonatal care, hypoxic-ischemic brain injury is still a serious clinical problem, which is responsible for many cases of perinatal mortality, cerebral palsy, motor impairment and cognitive deficits. Resveratrol, a natural polyphenol with important anti-oxidant and anti-inflammatory properties, is present in grapevines, peanuts and pomegranates. The aim of the present work was to evaluate the possible neuroprotective effect of resveratrol when administered before or immediately after a hypoxic-ischemic brain event in neonatal rats by analyzing brain damage, the mitochondrial status and long-term cognitive impairment. Our results indicate that pretreatment with resveratrol protects against brain damage, reducing infarct volume, preserving myelination and minimizing the astroglial reactive response. Moreover its neuroprotective effect was found to be long lasting, as behavioral outcomes were significantly improved at adulthood. We speculate that one of the mechanisms for this neuroprotection may be related to the maintenance of the mitochondrial inner membrane integrity and potential, and to the reduction of reactive oxygen species. Curiously, none of these protective features was observed when resveratrol was administered immediately after hypoxia-ischemia.	[Arteaga, Olatz; Revuelta, Miren; Alvarez, Antonia; Montalvo, Haizea; Hilario, Enrique] Univ Basque Country UPV EHU, Dept Cell Biol & Histol, Sch Med & Dent, Leioa, Bizkaia, Spain; [Urigueen, Leyre] Univ Basque Country UPV EHU, Dept Pharmacol, Sch Med & Dent, Leioa, Bizkaia, Spain; [Urigueen, Leyre] Ctr Invest Biomed Red Mental CIBERSAM, Madrid, Spain	University of Basque Country; University of Basque Country; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM	Arteaga, O (corresponding author), Univ Basque Country UPV EHU, Dept Cell Biol & Histol, Sch Med & Dent, Leioa, Bizkaia, Spain.	olatz.arteaga@ehu.eus	Revuelta, Miren/AAH-2410-2019; Urigüen, Leyre/Z-6217-2019	Revuelta, Miren/0000-0001-8126-2050; Urigüen, Leyre/0000-0002-1296-6895; arteaga, olatz/0000-0002-4328-4408; ALVAREZ DIAZ, ANTONIA ANGELES/0000-0002-1730-7565; Hilario, Enrique/0000-0002-8876-8131	Basque Government [IT 773/13, BFI-2011-129]	Basque Government(Basque Government)	Funding was provided by Basque Government IT 773/13 and BFI-2011-129. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albani D, 2010, BIOFACTORS, V36, P370, DOI 10.1002/biof.118; Alonso-Alconada D, 2012, HISTOL HISTOPATHOL, V27, P771, DOI 10.14670/HH-27.771; Alvarez-Diaz A, 2007, NEONATOLOGY, V92, P227, DOI 10.1159/000103741; Aridas JDS, 2014, EXP NEUROL, V261, P281, DOI 10.1016/j.expneurol.2014.07.009; Arteni NS, 2003, BRAIN RES, V973, P171, DOI 10.1016/S0006-8993(03)02436-3; Arteni NS, 2010, BEHAV BRAIN RES, V1301, P100; Azra Haider Batool, 2006, Curr Probl Pediatr Adolesc Health Care, V36, P178; Baba Lisa, 2008, Adv Neonatal Care, V8, P256, DOI 10.1097/01.ANC.0000338015.25911.8a; Balduini W, 2000, BRAIN RES, V859, P318, DOI 10.1016/S0006-8993(00)01997-1; Bastianetto S, 2014, BIOCH BIOPHYS ACTA; Broadbent NJ, 2010, LEARN MEMORY, V17, P794, DOI 10.1101/lm.1650110; Butt AM, 2014, GLIA, V62, P1762, DOI 10.1002/glia.22674; Catalgol B, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00141; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Damodaran T, 2014, BEHAV BRAIN RES, V275, P252, DOI 10.1016/j.bbr.2014.09.014; DARZYNKIEWICZ Z, 1981, P NATL ACAD SCI-BIOL, V78, P2383, DOI 10.1073/pnas.78.4.2383; Dere E, 2007, NEUROSCI BIOBEHAV R, V31, P673, DOI 10.1016/j.neubiorev.2007.01.005; Dong WP, 2007, MED HYPOTHESES, V69, P700, DOI 10.1016/j.mehy.2007.01.017; du Plessis AJ, 2002, CURR OPIN NEUROL, V15, P151, DOI 10.1097/00019052-200204000-00005; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Ferretta A, 2014, BBA-MOL BASIS DIS, V1842, P902, DOI 10.1016/j.bbadis.2014.02.010; Ferriero DM, 2004, NEW ENGL J MED, V351, P1985, DOI 10.1056/NEJMra041996; Ferriero DM, 2001, DEV NEUROSCI-BASEL, V23, P198, DOI 10.1159/000046143; Girbovan C, 2015, NUTR NEUROSCI; de Cerio FG, 2013, BRAIN SCI, V3, P191, DOI 10.3390/brainsci3010191; Gulcin I, 2010, INNOV FOOD SCI EMERG, V11, P210, DOI 10.1016/j.ifset.2009.07.002; Hagberg H, 1997, ACTA PAEDIATR, V86, P85; Hagberg H, 2014, LANCET NEUROL, V13, P217, DOI 10.1016/S1474-4422(13)70261-8; Hedtjarn M, 2002, J NEUROSCI, V22, P5910; Hilario E, 2005, ACTA PAEDIATR, V94, P903, DOI 10.1080/08035250510031151; Huang ZH, 2009, BRAIN RES, V1301, P100, DOI 10.1016/j.brainres.2009.09.006; Ikeda T, 2001, BEHAV BRAIN RES, V118, P17, DOI 10.1016/S0166-4328(00)00287-4; Jiang H, 2014, ASIAN PAC J TROP MED, V7, P496, DOI 10.1016/S1995-7645(14)60082-1; Juul SE, 2014, CLIN PERINATOL, V41, P119, DOI 10.1016/j.clp.2013.09.004; Karalis F, 2011, BRAIN RES, V1425, P98, DOI 10.1016/j.brainres.2011.09.044; Kesherwani V, 2013, NEUROSCIENCE, V241, P80, DOI 10.1016/j.neuroscience.2013.03.015; Lai MC, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/609813; Lee B, 2014, KOREAN J PHYSIOL PHA, V18, P191, DOI 10.4196/kjpp.2014.18.3.191; LEVENE ML, 1985, EARLY HUM DEV, V11, P21, DOI 10.1016/0378-3782(85)90115-X; Li XJ, 2014, EXP THER MED, V8, P1241, DOI 10.3892/etm.2014.1858; Liu BL, 2007, CANCER BIOL THER, V6, P1833, DOI 10.4161/cbt.6.12.5161; Liu CJ, 2011, BRAIN RES, V1374, P100, DOI 10.1016/j.brainres.2010.11.061; Low JA, 2004, J OBSTET GYNAECOL RE, V30, P276, DOI 10.1111/j.1447-0756.2004.00194.x; Lubics A, 2005, BEHAV BRAIN RES, V157, P157, DOI 10.1016/j.bbr.2004.06.019; Meng XJ, 2014, INDIAN J PHARM SCI, V76, P125; Mokni M, 2013, IRAN J PHARM RES, V12, P867; Morin C, 2003, DRUG EXP CLIN RES, V29, P227; Morrow BA, 2002, BEHAV BRAIN RES, V129, P217, DOI 10.1016/S0166-4328(01)00338-2; Northington FJ, 2001, NEUROBIOL DIS, V8, P207, DOI 10.1006/nbdi.2000.0371; Northington FJ, 2011, ANN NEUROL, V69, P743, DOI 10.1002/ana.22419; Pereira LO, 2007, NEUROBIOL LEARN MEM, V87, P101, DOI 10.1016/j.nlm.2006.07.003; Pallas M, 2013, CURR PHARM DESIGN, V19, P6726, DOI 10.2174/1381612811319380005; Pazos MR, 2012, NEUROPHARMACOLOGY, V63, P776, DOI 10.1016/j.neuropharm.2012.05.034; Rege SD, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00218; Revuelta M, 2015, BRAIN PATHOLOGY; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Rothstein RP, 2005, DEV NEUROSCI-BASEL, V27, P149, DOI 10.1159/000085987; Sab IM, 2013, PHARMACOL BIOCHEM BE, V107, P24, DOI 10.1016/j.pbb.2013.04.004; Sahu SS, 2013, PHARMACOL BIOCHEM BE, V103, P520, DOI 10.1016/j.pbb.2012.09.012; Sanches EF, 2013, NEUROSCIENCE, V237, P208, DOI 10.1016/j.neuroscience.2013.01.066; Simola N, 2008, EXP BRAIN RES, V185, P595, DOI 10.1007/s00221-007-1186-7; Sinha K, 2002, LIFE SCI, V71, P655, DOI 10.1016/S0024-3205(02)01691-0; Sizonenko SV, 2008, INT J DEV NEUROSCI, V26, P37, DOI 10.1016/j.ijdevneu.2007.08.014; Smoliga JM, 2011, MOL NUTR FOOD RES, V55, P1129, DOI 10.1002/mnfr.201100143; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Thornton C, 2015, CLIN CHIM ACTA, V451, P35, DOI 10.1016/j.cca.2015.01.026; Vannucci SJ, 2004, J EXP BIOL, V207, P3149, DOI 10.1242/jeb.01064; Venturini CD, 2010, OXID MED CELL LONGEV, V3, P434, DOI 10.4161/oxim.3.6.14741; Vingtdeux V, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S2-S6; Volpe J J, 1998, Semin Pediatr Neurol, V5, P135, DOI 10.1016/S1071-9091(98)80030-2; Volpe JJ, 2001, MENT RETARD DEV D R, V7, P56, DOI 10.1002/1098-2779(200102)7:1<56::AID-MRDD1008>3.0.CO;2-A; Wang HD, 2013, BRIT J PHARMACOL, V170, P796, DOI 10.1111/bph.12301; Wang R, 2014, CELL PHYSIOL BIOCHEM, V34, P854, DOI 10.1159/000366304; Warner DS, 2004, J EXP BIOL, V207, P3221, DOI 10.1242/jeb.01022; West T, 2007, DEV NEUROSCI-BASEL, V29, P363, DOI 10.1159/000105477; Witte AV, 2014, J NEUROSCI, V34, P7862, DOI 10.1523/JNEUROSCI.0385-14.2014; Wong RHX, 2013, ANN NY ACAD SCI, V1290, P52, DOI 10.1111/nyas.12155; Xie CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107192; Yousuf S, 2009, BRAIN RES, V1250, P242, DOI 10.1016/j.brainres.2008.10.068; Zhao J, 2009, J HEART LUNG TRANSPL, V28, P936, DOI 10.1016/j.healun.2009.05.014	82	60	61	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142424	10.1371/journal.pone.0142424	http://dx.doi.org/10.1371/journal.pone.0142424			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544861	Green Published, Green Submitted, gold			2022-12-27	WOS:000364398700137
J	Huang, Y; Xing, N; Wang, ZG; Zhang, XJ; Zhao, XM; Du, Q; Chang, LL; Tong, DW				Huang, Yong; Xing, Na; Wang, Zengguo; Zhang, Xiujuan; Zhao, Xiaomin; Du, Qian; Chang, Lingling; Tong, Dewen			Ultrasensitive Detection of RNA and DNA Viruses Simultaneously Using Duplex UNDP-PCR Assay	PLOS ONE			English	Article							EPIDEMIC DIARRHEA VIRUS; TRANSMISSIBLE GASTROENTERITIS VIRUS; LINKED-IMMUNOSORBENT-ASSAY; PORCINE CIRCOVIRUS TYPE-2; CLASSICAL SWINE-FEVER; MOLECULAR EPIDEMIOLOGY; MULTIPLEX PCR; STRAINS; SAMPLES; CHINA	Mixed infection of multiple viruses is common in modern intensive pig rearing. However, there are no methods available to detect DNA and RNA viruses in the same reaction system in preclinical level. In this study, we aimed to develop a duplex ultrasensitive nanoparticle DNA probe-based PCR assay (duplex UNDP-PCR) that was able to simultaneously detect DNA and RNA viruses in the same reaction system. PCV2 and TGEV are selected as representatives of the two different types of viruses. PCV2 DNA and TGEV RNA were simultaneously released from the serum sample by boiling with lysis buffer, then magnetic beads and gold nanoparticles coated with single and/or duplex specific probes for TGEV and PCV2 were added to form a sandwich-like complex with nucleic acids released from viruses. After magnetic separation, DNA barcodes specific for PCV2 and TGEV were eluted using DTT and characterized by specific PCR assay for specific DNA barcodes subsequently. The duplex UNDP-PCR showed similar sensitivity as that of single UNDP-PCR and was able to detect 20 copies each of PCV2 and TGEV in the serum, showing approximately 250-fold more sensitivity than conventional duplex PCR/RT-PCR assays. No crossreaction was observed with other viruses. The positive detection rate of single MMPs-and duplex MMPs-based duplex UNDP-PCR was identical, with 29.6% for PCV2, 9.3% for TGEV and 3.7% for PCV2 and TGEV mixed infection. This duplex UNDP-PCR assay could detect TGEV (RNA virus) and PCV2 (DNA virus) from large-scale serum samples simultaneously without the need for DNA/RNA extraction, purification and reverse transcription of RNA, and showed a significantly increased positive detection rate for PCV2 (29%) and TGEV (11.7%) preclinical infection than conventional duplex PCR/RT-PCR. Therefore, the established duplex UNDP-PCR is a rapid and economical detection method, exhibiting high sensitivity, specificity and reproducibility.	[Huang, Yong; Xing, Na; Wang, Zengguo; Zhang, Xiujuan; Zhao, Xiaomin; Du, Qian; Chang, Lingling; Tong, Dewen] Northwest A&F Univ, Coll Vet Med, Yangling 712100, Shaanxi, Peoples R China	Northwest A&F University - China	Tong, DW (corresponding author), Northwest A&F Univ, Coll Vet Med, Yangling 712100, Shaanxi, Peoples R China.	dwtong@nwsuaf.edu.cn	du, qian/GYJ-7090-2022; Huang, Yong/G-9365-2011		scientific and technological project in Shaanxi province [2015NY155]; Key project of Shaanxi province science and technology innovation team [2013KCT-28]; international science and technology cooperation fund of Northwest AF University [A213021310]; scientific research program of Northwest AF University [ZD2013009, Z111021103]	scientific and technological project in Shaanxi province; Key project of Shaanxi province science and technology innovation team; international science and technology cooperation fund of Northwest AF University; scientific research program of Northwest AF University	This study was funded by grants from the scientific and technological project in Shaanxi province (Grant No. 2015NY155), Key project of Shaanxi province science and technology innovation team (2013KCT-28), international science and technology cooperation fund of Northwest A&F University (Grant No. A213021310), and the scientific research program of Northwest A&F University (No. ZD2013009 & Z111021103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan GM, 2000, J VET DIAGN INVEST, V12, P3, DOI 10.1177/104063870001200102; Brian DA, 2005, CURR TOP MICROBIOL, V287, P1, DOI 10.1007/3-540-26765-4_1; CALLEBAUT P, 1982, VET MICROBIOL, V7, P295, DOI 10.1016/0378-1135(82)90009-8; Chen JF, 2010, ARCH VIROL, V155, P1471, DOI 10.1007/s00705-010-0720-2; Chen R, 2004, J VIROL METHODS, V122, P57, DOI 10.1016/j.jviromet.2004.08.003; Ding L., 2011, CHIN J VET MED, V47, P9; DOYLE LP, 1946, J AM VET MED ASSOC, V108, P257; Dufour D, 2011, J VIROL, V85, P4963, DOI 10.1128/JVI.02317-10; Gou HC, 2015, MOL CELL PROBE, V29, P48, DOI 10.1016/j.mcp.2014.11.004; Huang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097869; Huang Y, 2013, VIRUS RES, V175, P78, DOI 10.1016/j.virusres.2013.03.014; Kim O, 2002, CAN J VET RES, V66, P112; Kim O, 2000, VET REC, V146, P637, DOI 10.1136/vr.146.22.637; Li PC, 2011, CURR MICROBIOL, V62, P1074, DOI 10.1007/s00284-010-9825-9; Luo YZ, 2014, VET MICROBIOL, V172, P1, DOI 10.1016/j.vetmic.2014.04.004; Nam JM, 2003, SCIENCE, V301, P1884, DOI 10.1126/science.1088755; Patterson AR, 2011, J VET DIAGN INVEST, V23, P206, DOI 10.1177/104063871102300203; Ramos N, 2013, INFECT GENET EVOL, V19, P23, DOI 10.1016/j.meegid.2013.06.017; SEHGAL D, 1994, ANAL BIOCHEM, V218, P87, DOI 10.1006/abio.1994.1144; [时乐 Shi Le], 2012, [西北农业学报, Acat Agriculturae Boreali-Occidentalis Sinica], V21, P6; Sun JH, 2015, ARCH VIROL, V160, P1339, DOI 10.1007/s00705-015-2373-7; Vemulapalli R, 2009, J VIROL METHODS, V162, P231, DOI 10.1016/j.jviromet.2009.08.016; Wang J, 2016, TRANSBOUND EMERG DIS, V63, pE369, DOI 10.1111/tbed.12312; Wang LT, 2013, TROP ANIM HEALTH PRO, V45, P1087, DOI 10.1007/s11250-012-0329-4; Wang YB, 2015, VIRUS GENES, V50, P401, DOI 10.1007/s11262-015-1190-0; Wang Z. S., 2010, ANXIETY STRESS COPIN, V19, P1; Xu XG, 2012, J VIROL METHODS, V183, P69, DOI 10.1016/j.jviromet.2012.03.034; Xu XG, 2013, VET MICROBIOL, V164, P212, DOI 10.1016/j.vetmic.2013.01.034; Xu XR, 2008, ANTIVIR RES, V78, P188, DOI 10.1016/j.antiviral.2007.12.012; Yang D, 2015, VIRUS RES, V206, P120, DOI 10.1016/j.virusres.2015.02.025; Zeng ZY, 2014, J VIROL METHODS, V208, P102, DOI 10.1016/j.jviromet.2014.08.001; Zhang Q, 2013, ARCH VIROL, V158, P1631, DOI 10.1007/s00705-013-1659-x; Zhao J, 2013, J VIROL METHODS, V194, P107, DOI 10.1016/j.jviromet.2013.08.008	33	11	11	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141545	10.1371/journal.pone.0141545	http://dx.doi.org/10.1371/journal.pone.0141545			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544710	Green Published, Green Submitted, gold			2022-12-27	WOS:000364398700032
J	Ouyang, L; Xu, XX; Freed, SF; Gao, YF; Yu, J; Wang, S; Ju, WY; Zhang, YQ; Jin, FL				Ouyang, Lina; Xu, Xiaoxia; Freed, Shoaib; Gao, Yanfu; Yu, Jing; Wang, Shuang; Ju, Wenyan; Zhang, Yuqing; Jin, Fengliang			Cecropins from Plutella xylostella and Their Interaction with Metarhizium anisopliae	PLOS ONE			English	Article							ANTIBACTERIAL PEPTIDE; DIAMONDBACK MOTH; HOST-DEFENSE; ANTIMICROBIAL PEPTIDES; GENE-EXPRESSION; CDNA CLONING; DROSOPHILA; SILKWORM; PURIFICATION; RESISTANCE	Cecropins are the most potent induced peptides to resist invading microorganisms. In the present study, two full length cDNA encoding cecropin2 (Px-cec2) and cecropin3 (Px-cec3) were obtained from P. xylostella by integrated analysis of genome and transcriptome data. qRT-PCR analysis revealed the high levels of transcripts of Px-cecs (Px-cec1, Px-cec2 and Px-cec3) in epidermis, fat body and hemocytes after 24, 30 and 36 h induction of Metarhizium anisopliae, respectively. Silencing of Spatzle and Dorsal separately caused the low expression of cecropins in the fat body, epidermis and hemocytes, and made the P. xylostella larvae more susceptible to M. anisopliae. Antimicrobial assays demonstrated that the purified recombinant cecropins, i.e., Px-cec1, Px-cec2 and Px-cec3, exerted a broad spectrum of antimicrobial activity against fungi, as well as Gram-positive and Gram-negative bacteria. Especially, Px-cecs showed higher activity against M. anisopliae than another selected fungi isolates. Scanning electron microscopy (SEM) and transmission electron microscopy (TEM) revealed that cecropins exerted the vital morphological alterations to the spores of M. anisopliae. Based on our results, cecropins played an imperative role in resisting infection of M. anisopliae, which will provide the foundation of biological control of insect pests by using cecorpins as a target in the future.	[Ouyang, Lina; Xu, Xiaoxia; Gao, Yanfu; Yu, Jing; Wang, Shuang; Ju, Wenyan; Zhang, Yuqing; Jin, Fengliang] South China Agr Univ, Coll Agr, Guangzhou 510642, Guangdong, Peoples R China; [Freed, Shoaib] Bahauddin Zakariya Univ, Fac Agr Sci & Technol, Dept Entomol, Multan 60800, Pakistan	South China Agricultural University; Bahauddin Zakariya University	Jin, FL (corresponding author), South China Agr Univ, Coll Agr, Guangzhou 510642, Guangdong, Peoples R China.	jflbang@scau.edu.cn			National Natural Science Foundation of China [31371989, 31071734]; National High Technology Research and Development Program ('863' Program) of China [2012AA101505]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program ('863' Program) of China(National High Technology Research and Development Program of China)	This work was supported by grants from the National Natural Science Foundation of China (31371989, 31071734) and the National High Technology Research and Development Program ('863' Program) of China (2012AA101505).	Basukriadi A, 2014, J INSECT SCI, V14, DOI 10.1093/jisesa/ieu106; Castelo Branco M., 1997, Anais da Sociedade Entomologica do Brasil, V26, P75, DOI 10.1590/S0301-80591997000100010; Charroux B, 2010, FLY, V4, P40, DOI 10.4161/fly.4.1.10810; Chen HM, 1997, BBA-GEN SUBJECTS, V1336, P171, DOI 10.1016/S0304-4165(97)00024-X; CHRISTENSEN B, 1988, P NATL ACAD SCI USA, V85, P5072, DOI 10.1073/pnas.85.14.5072; Engel E, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/s12964-014-0041-2; Epand RF, 2008, J MOL BIOL, V379, P38, DOI 10.1016/j.jmb.2008.03.047; Ferreira AG, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004507; Forde E, 2015, MOLECULES, V20, P1210, DOI 10.3390/molecules20011210; Han PF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060771; Hong SM, 2008, BIOSCI BIOTECH BIOCH, V72, P1992, DOI 10.1271/bbb.80082; Hultmark D, 2003, CURR OPIN IMMUNOL, V15, P12, DOI 10.1016/S0952-7915(02)00005-5; Imler JL, 2000, CURR OPIN MICROBIOL, V3, P16, DOI 10.1016/S1369-5274(99)00045-4; Jan PS, 2010, APPL ENVIRON MICROB, V76, P769, DOI 10.1128/AEM.00698-09; JAYNES J M, 1989, Peptide Research, V2, P157; Jin FL, 2006, PROTEIN EXPRES PURIF, V49, P39, DOI 10.1016/j.pep.2006.03.008; Jin FL, 2012, PROTEIN EXPRES PURIF, V85, P230, DOI 10.1016/j.pep.2012.08.006; KAAYA GP, 1987, INSECT BIOCHEM, V17, P309, DOI 10.1016/0020-1790(87)90073-4; Kang D L G, 1996, INSECT BIOCHEM MOLEC, V263, P19424; Kang DW, 1996, INSECT BIOCHEM MOLEC, V26, P177, DOI 10.1016/0965-1748(95)00080-1; KYLSTEN P, 1990, EMBO J, V9, P217, DOI 10.1002/j.1460-2075.1990.tb08098.x; LEE JY, 1989, P NATL ACAD SCI USA, V86, P9159, DOI 10.1073/pnas.86.23.9159; LEMAITRE B, 1995, P NATL ACAD SCI USA, V92, P9465, DOI 10.1073/pnas.92.21.9465; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Liu ZY, 2008, SPECTROSC SPECT ANAL, V28, P612; Maltseva AL, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00497; MORISATO D, 1994, CELL, V76, P677, DOI 10.1016/0092-8674(94)90507-X; Nicolas E, 1996, DEV COMP IMMUNOL, V20, P175, DOI 10.1016/0145-305X(96)00017-1; Park SC, 2011, INT J MOL SCI, V12, P5971, DOI 10.3390/ijms12095971; Ponnuvel KM, 2010, BIOINFORMATION, V5, P97, DOI 10.6026/97320630005097; Raymond B, 2011, HEREDITY, V106, P281, DOI 10.1038/hdy.2010.65; Reddy KVR, 2004, INT J ANTIMICROB AG, V24, P536, DOI 10.1016/j.ijantimicag.2004.09.005; ROSETTO M, 1993, GENE, V134, P241, DOI 10.1016/0378-1119(93)90100-H; Santos VC, 2011, NEOTROP ENTOMOL, V40, P264, DOI 10.1590/S1519-566X2011000200017; STEINER H, 1981, NATURE, V292, P246, DOI 10.1038/292246a0; STEINER H, 1988, BIOCHIM BIOPHYS ACTA, V939, P260, DOI 10.1016/0005-2736(88)90069-7; Sung WS, 2008, BIOCHEM BIOPH RES CO, V371, P551, DOI 10.1016/j.bbrc.2008.04.107; Tang WQ, 2014, DATABASE-OXFORD, DOI 10.1093/database/bat087; TRYSELIUS Y, 1992, EUR J BIOCHEM, V204, P395, DOI 10.1111/j.1432-1033.1992.tb16648.x; Xia LJ, 2013, PROTEIN EXPRES PURIF, V90, P47, DOI 10.1016/j.pep.2013.02.013; Xia XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068852; Xu XX, 2015, WORLD J MICROB BIOT, V31, P1529, DOI 10.1007/s11274-015-1901-7; Xu XX, 2007, PROTEIN EXPRES PURIF, V53, P293, DOI 10.1016/j.pep.2006.12.020; YAMANO Y, 1994, BIOSCI BIOTECH BIOCH, V58, P1476, DOI 10.1271/bbb.58.1476; Yang J, 1999, COMP BIOCHEM PHYS B, V122, P409, DOI 10.1016/S0305-0491(99)00015-2; Zhong X, 2012, INSECT BIOCHEM MOLEC, V42, P514, DOI 10.1016/j.ibmb.2012.03.009	46	21	21	6	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142451	10.1371/journal.pone.0142451	http://dx.doi.org/10.1371/journal.pone.0142451			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544076	gold, Green Submitted, Green Published			2022-12-27	WOS:000364398700141
J	Park, SJ; Yang, JH; Park, HJ; In, YW; Lee, YM; Cho, YH; Chung, CR; Park, CM; Jeon, K; Suh, GY				Park, So Jin; Yang, Jeong Hoon; Park, Hyo Jung; In, Yong Won; Lee, Young Mi; Cho, Yang Hyun; Chung, Chi Ryang; Park, Chi-Min; Jeon, Kyeongman; Suh, Gee Young			Trough Concentrations of Vancomycin in Patients Undergoing Extracorporeal Membrane Oxygenation	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; CONTINUOUS-INFUSION; PHARMACOKINETICS; PNEUMONIA	To investigate the appropriateness of the current vancomycin dosing strategy in adult patients with extracorporeal membrane oxygenation (ECMO), between March 2013 and November 2013, patients who were treated with vancomycin while on ECMO were enrolled. Control group consisted of 60 patients on vancomycin without ECMO, stayed in medical intensive care unit during the same study period and with the same exclusion criteria. Early trough levels were obtained within the fourth dosing, and maintenance levels were measured at steady state. A total of 20 patients were included in the analysis in ECMO group. Sixteen patients received an initial intravenous dose of 1.0 g vancomycin followed by 1.0 g every 12 hours. The non-steady state trough level of vancomycin after starting administration was subtherapeutic in 19 patients (95.00%) in ECMO group as compared with 40 patients (66.67%) in the control group (p = 0.013). Vancomycin clearance was 1.27 +/- 0.51 mL/min/kg, vancomycin clearance/creatinine clearance ratio was 0.90 +/- 0.37, and elimination rate constant was 0.12 +/- 0.04 h(-1). Vancomycin dosingfrequency and total daily dose were significantly increased after clinical pharmacokinetic services of the pharmacist based on calculated pharmacokinetic parameters (from 2.10 +/- 0.72 to 2.90 +/- 0.97times/day, p = 0.002 and from 32.54 +/- 8.43 to 42.24 +/- 14.62mg/kg, p = 0.014) in ECMO group in contrast with those (from 2.11 +/- 0.69 to 2.37 +/- 0.86 times/day, p = 0.071 and from 33.91 +/- 11.85 to 31.61 +/- 17.50 mg/kg, p = 0.350) in the control group. Although the elimination rate for vancomycin was similar with population parameter of non ECMO patients, the current dosing strategy of our institution for vancomycinin our ICU was not sufficient to achieve the target trough in the initial period in most patients receiving ECMO.	[Park, So Jin; Park, Hyo Jung; In, Yong Won; Lee, Young Mi] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Crit Care Med, Seoul, South Korea; [Yang, Jeong Hoon; Chung, Chi Ryang; Park, Chi-Min; Jeon, Kyeongman; Suh, Gee Young] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Crit Care Med, Seoul, South Korea; [Yang, Jeong Hoon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Cardiol, Seoul, South Korea; [Cho, Yang Hyun] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Thorac & Cardiovasc Surg, Seoul, South Korea; [Jeon, Kyeongman; Suh, Gee Young] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Pulm & Crit Care Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Yang, JH (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Crit Care Med, Seoul, South Korea.	jhysmc@gmail.com	Jeon, Kyeongman/F-5963-2019; Suh, Gee Young/O-3676-2019	Jeon, Kyeongman/0000-0002-4822-1772; Suh, Gee Young/0000-0001-5473-1712				Amaker RD, 1996, ANTIMICROB AGENTS CH, V40, P1139, DOI 10.1128/AAC.40.5.1139; Barriere SL, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-183; Chung J, 2011, ANAESTH INTENS CARE, V39, P1030, DOI 10.1177/0310057X1103900608; Covajes C, 2013, INT J ANTIMICROB AG, V41, P261, DOI 10.1016/j.ijantimicag.2012.10.018; De Waele JJ, 2013, INT J ANTIMICROB AG, V41, P434, DOI 10.1016/j.ijantimicag.2012.12.015; Kim Dae Il, 2010, Korean J Pediatr, V53, P1000, DOI 10.3345/kjp.2010.53.12.1000; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Mulla H, 2005, BRIT J CLIN PHARMACO, V60, P265, DOI 10.1111/j.1365-2125.2005.02432.x; Nunn MO, 2011, ANN PHARMACOTHER, V45, P757, DOI 10.1345/aph.1P634; Ocampos-Martinez E, 2012, INT J ANTIMICROB AG, V39, P332, DOI 10.1016/j.ijantimicag.2011.12.008; Parekh T, 2012, CRIT CARE MED S1, V40, P1; Rybak Michael, 2009, Am J Health Syst Pharm, V66, P82, DOI 10.2146/ajhp080434; Shekar K, 2012, BMC ANESTHESIOL, V12, DOI 10.1186/1471-2253-12-29; Shekar K, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2012.02.013; Winter, 2010, BASIC CLIN PHARMACOK, P2	15	18	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141016	10.1371/journal.pone.0141016	http://dx.doi.org/10.1371/journal.pone.0141016			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544074	Green Submitted, Green Published, gold			2022-12-27	WOS:000364398700013
J	Giroux, MA; Valiquette, E; Tremblay, JP; Cote, SD				Giroux, Marie-Andree; Valiquette, Eliane; Tremblay, Jean-Pierre; Cote, Steeve D.			Isotopic Differences between Forage Consumed by a Large Herbivore in Open, Closed, and Coastal Habitats: New Evidence from a Boreal Study System	PLOS ONE			English	Article							TEMPORAL VARIATION; STABLE-ISOTOPES; NUTRITIONAL QUALITY; MARINE SUBSIDIES; DEER BROWSE; TRADE-OFFS; DELTA-C-13; CARBON; RESPONSES; SELECTION	Documenting habitat-related patterns in foraging behaviour at the individual level and over large temporal scales remains challenging for large herbivores. Stable isotope analysis could represent a valuable tool to quantify habitat-related foraging behaviour at the scale of individuals and over large temporal scales in forest dwelling large herbivores living in coastal environments, because the carbon (delta C-13) or nitrogen (delta N-15) isotopic signatures of forage can differ between open and closed habitats or between terrestrial and littoral forage, respectively. Here, we examined if we could detect isotopic differences between the different assemblages of forage taxa consumed by white-tailed deer that can be found in open, closed, supralittoral, and littoral habitats. We showed that delta C-13 of assemblages of forage taxa were 3.0 parts per thousand lower in closed than in open habitats, while delta N-15 were 2.0 parts per thousand and 7.4 parts per thousand higher in supralittoral and littoral habitats, respectively, than in terrestrial habitats. Stable isotope analysis may represent an additional technique for ecologists interested in quantifiying the consumption of terrestrial vs. marine autotrophs. Yet, given the relative isotopic proximity and the overlap between forage from open, closed, and supralittoral habitats, the next step would be to determine the potential to estimate their contribution to herbivore diet.	[Giroux, Marie-Andree; Valiquette, Eliane; Tremblay, Jean-Pierre; Cote, Steeve D.] Univ Laval, Dept Biol, NSERC Ind Res Chair Integrated Management Resourc, Quebec City, PQ G1K 7P4, Canada; [Giroux, Marie-Andree; Valiquette, Eliane; Tremblay, Jean-Pierre; Cote, Steeve D.] Univ Laval, Ctr Etud Nordiques, NSERC Ind Res Chair Integrated Management Resourc, Quebec City, PQ, Canada; [Tremblay, Jean-Pierre] Univ Laval, Ctr Forest Res, Quebec City, PQ, Canada	Laval University; Laval University; Laval University	Giroux, MA (corresponding author), Univ Quebec, Dept Biol, Rimouski, PQ G5L 3A1, Canada.	marie.a.giroux@gmail.com; steeve.cote@bio.ulaval.ca		Tremblay, Jean-Pierre/0000-0003-0978-529X	Natural Sciences and Engineering Research Council of Canada (NSERC); Produits forestiers Anticosti Inc.; Natural Sciences and Engineering Research Council of Canada (NSERC)-Produits forestiers Anticosti Industrial Research Chair; Universite Laval; NSERC	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Produits forestiers Anticosti Inc.; Natural Sciences and Engineering Research Council of Canada (NSERC)-Produits forestiers Anticosti Industrial Research Chair(Natural Sciences and Engineering Research Council of Canada (NSERC)); Universite Laval; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was funded by the Natural Sciences and Engineering Research Council of Canada (NSERC, www.nserc-crsng.gc.ca; scholarships to MAG [Alexander Graham Bell, Michael Smith, and EnviroNorth scholarships] and grants to SDC) and by Produits forestiers Anticosti Inc. that provided matching funds for the NSERC grants to SDC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC)-Produits forestiers Anticosti Industrial Research Chair (to S.D.C), Universite Laval. MAG received scholarships from NSERC (Alexander Graham Bell, Michael Smith, and EnviroNorth scholarships). We thank J.-F. Adam, J. Arsenault-Hetu, C. Bajzak, C. Hins, A. Hemery, F. Lebel, S. Menard, G. Reuchet, M. Sicilia, and M. Veilleux-Nolin for their valuable assistance in the field. We are grateful to S. De Bellefeuille and C. Hins for logistical support, as well as to D. Gallant, E. Sotka, A. Stien, M.-A. Villard, and two anonymous reviewers for insightful comments on earlier versions of the manuscript. MAG is grateful to N.G. Yoccoz and R.A. Ims for hosting her during her research stay in Tromso (Norway).	Anderson WB, 1998, OIKOS, V81, P75, DOI 10.2307/3546469; Balasse M, 2006, J ZOOL, V270, P170, DOI 10.1111/j.1469-7998.2006.00104.x; Bessa F, 2014, ECOL INDIC, V36, P694, DOI 10.1016/j.ecolind.2013.09.026; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carlton JT, 2003, MAR ECOL PROG SER, V256, P271, DOI 10.3354/meps256271; Conradt L, 2000, J ZOOL, V250, P541, DOI 10.1111/j.1469-7998.2000.tb00795.x; Croll DA, 2005, SCIENCE, V307, P1959, DOI 10.1126/science.1108485; Dalerum F, 2005, OECOLOGIA, V144, P647, DOI 10.1007/s00442-005-0118-0; Darling AF, 2010, ECOSCIENCE, V17, P73, DOI 10.2980/17-1-3287; Dussault C, 2005, ECOGRAPHY, V28, P619, DOI 10.1111/j.2005.0906-7590.04263.x; Environment Canada, 1982, CAN CLIM NORM TEMP P; Environment Canada, 2006, CLIM NORM AV DAIL DA; FARQUHAR GD, 1982, AUST J PLANT PHYSIOL, V9, P121, DOI 10.1071/PP9820121; FORD WM, 1994, FOREST ECOL MANAG, V67, P149, DOI 10.1016/0378-1127(94)90013-2; France R, 1996, ENVIRON MANAGE, V20, P249, DOI 10.1007/BF01204009; Gannes LZ, 1998, COMP BIOCHEM PHYS A, V119, P725, DOI 10.1016/S1095-6433(98)01016-2; Godvik IMR, 2009, ECOLOGY, V90, P699, DOI 10.1890/08-0576.1; Hansen BB, 2012, POLAR RES, V31, DOI 10.3402/polar.v31i0.17258; HAPPE PJ, 1990, J WILDLIFE MANAGE, V54, P557, DOI 10.2307/3809349; HEATON THE, 1987, OECOLOGIA, V74, P236, DOI 10.1007/BF00379365; Hebblewhite M, 2008, ECOL MONOGR, V78, P141, DOI 10.1890/06-1708.1; Hidding B, 2013, ECOLOGY, V94, P2852, DOI 10.1890/12-2015.1; HUOT J, 1982, BODY CONDITION FOOD; JOHNSON AS, 1995, AM MIDL NAT, V133, P18, DOI 10.2307/2426344; Ladin ZS, 2014, J WILDLIFE MANAGE, V78, P1206, DOI 10.1002/jwmg.761; Lastra M, 2014, J SEA RES, V88, P1, DOI 10.1016/j.seares.2013.12.011; LEAVITT SW, 1993, CAN J FOREST RES, V23, P210, DOI 10.1139/x93-028; Li SG, 2007, TREES-STRUCT FUNCT, V21, P479, DOI 10.1007/s00468-007-0142-2; Litvaitis JA, 2000, RES TECHNIQUES ANIMA; Masse A, 2009, J MAMMAL, V90, P961, DOI 10.1644/08-MAMM-A-148.1; Mcloughlin PD, 2007, ECOLOGY, V88, P3192, DOI 10.1890/06-1974.1; MEDINA E, 1986, Journal of Tropical Ecology, V2, P207; Montoya JP., 2008, NATURAL ABUNDANCE 15, P176; Mysterud A, 1999, WILDLIFE SOC B, V27, P385; OLEARY MH, 1988, BIOSCIENCE, V38, P328, DOI 10.2307/1310735; Owen-Smith N, 2010, PHILOS T R SOC B, V365, P2267, DOI 10.1098/rstb.2010.0095; Parnell AC, SIAR STABLE ISOTOPE; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Pellerin S, 2006, BIOL CONSERV, V128, P316, DOI 10.1016/j.biocon.2005.09.039; Phillips DL, 2001, OECOLOGIA, V127, P171, DOI 10.1007/s004420000578; Phillips DL, 2003, OECOLOGIA, V136, P261, DOI 10.1007/s00442-003-1218-3; R Development Core Team, 2012, R LANG ENV STAT COMP; Saucier J.P., 2009, ORDRE INGENIEURS FOR, V2, P165; Simard A, 2014, WILDLIFE MONOGR, V187, P1, DOI 10.1002/wmon.1010; Smith BN, 1971, PLANT PHYSIOL, P47; Spiller DA, 2010, ECOLOGY, V91, P1424, DOI 10.1890/09-0715.1; Tremblay JP, 2006, OECOLOGIA, V150, P78, DOI 10.1007/s00442-006-0504-2; Tremblay JP, 2005, CAN J ZOOL, V83, P1087, DOI [10.1139/Z05-090, 10.1139/z05-090]; VANDERMERWE NJ, 1989, GEOCHIM COSMOCHIM AC, V53, P1091, DOI 10.1016/0016-7037(89)90213-5; Verdolin JL, 2006, BEHAV ECOL SOCIOBIOL, V60, P457, DOI 10.1007/s00265-006-0172-6; VIRGINIA RA, 1982, OECOLOGIA, V54, P317, DOI 10.1007/BF00380000; West AG, 2001, FOREST ECOL MANAG, V147, P139, DOI 10.1016/S0378-1127(00)00474-6; Winnie J, 2007, ANIM BEHAV, V73, P215, DOI 10.1016/j.anbehav.2006.07.007; Zuur Alain F., 2009, P1	54	2	2	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142781	10.1371/journal.pone.0142781	http://dx.doi.org/10.1371/journal.pone.0142781			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559186	Green Submitted, Green Published, gold			2022-12-27	WOS:000364433100123
J	Kim, HT; Kim, JS; Moore, MJ; Neubig, KM; Williams, NH; Whitten, WM; Kim, JH				Kim, Hyoung Tae; Kim, Jung Sung; Moore, Michael J.; Neubig, Kurt M.; Williams, Norris H.; Whitten, W. Mark; Kim, Joo-Hwan			Seven New Complete Plastome Sequences Reveal Rampant Independent Loss of the ndh Gene Family across Orchids and Associated Instability of the Inverted Repeat/Small Single-Copy Region Boundaries	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; CHLOROPLAST GENOME; MIXOTROPHIC PLANTS; EVOLUTION; CYPRIPEDIOIDEAE; ORGANIZATION; INDIVIDUALS; ANNOTATION; INSIGHTS; GREEN	Earlier research has revealed that the ndh loci have been pseudogenized, truncated, or deleted from most orchid plastomes sequenced to date, including in all available plastomes of the two most species-rich subfamilies, Orchidoideae and Epidendroideae. This study sought to resolve deeper-level phylogenetic relationships among major orchid groups and to refine the history of gene loss in the ndh loci across orchids. The complete plastomes of seven orchids, Oncidium sphacelatum (Epidendroideae), Masdevallia coccinea (Epidendroideae), Sobralia callosa (Epidendroideae), Sobralia aff. bouchei (Epidendroideae), Elleanthus sodiroi (Epidendroideae), Paphiopedilum armeniacum (Cypripedioideae), and Phragmipedium longifolium (Cypripedioideae) were sequenced and analyzed in conjunction with all other available orchid and monocot plastomes. Most ndh loci were found to be pseudogenized or lost in Oncidium, Paphiopedilum and Phragmipedium, but surprisingly, all ndh loci were found to retain full, intact reading frames in Sobralia, Elleanthus and Masdevallia. Character mapping suggests that the ndh genes were present in the common ancestor of orchids but have experienced independent, significant losses at least eight times across four subfamilies. In addition, ndhF gene loss was correlated with shifts in the position of the junction of the inverted repeat (IR) and small single-copy (SSC) regions. The Orchidaceae have unprecedented levels of homoplasy in ndh gene presence/absence, which may be correlated in part with the unusual life history of orchids. These results also suggest that ndhF plays a role in IR/SSC junction stability.	[Kim, Hyoung Tae; Kim, Jung Sung; Kim, Joo-Hwan] Gachon Univ, Dept Life Sci, Songnam, Gyeonggi Do, South Korea; [Moore, Michael J.] Oberlin Coll, Dept Biol, Oberlin, OH 44074 USA; [Neubig, Kurt M.; Williams, Norris H.; Whitten, W. Mark] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA	Gachon University; Oberlin College; State University System of Florida; University of Florida	Moore, MJ (corresponding author), Oberlin Coll, Dept Biol, Oberlin, OH 44074 USA.	mmoore@oberlin.edu; kimjh2009@gachon.ac.kr		HyoungTae, Kim/0000-0002-2482-6064; Moore, Michael/0000-0003-2222-8332	American Orchid Society; National Research Foundation of Korea [MEST 2012-044048, MEST 2010-0029131]	American Orchid Society; National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by a grant from the American Orchid Society (http://www.aos.org/default.aspx?id= 1) and grants MEST 2012-044048 and MEST 2010-0029131 from the National Research Foundation of Korea (http://www.nrf.re.kr/nrf_eng_cms/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert Victor A., 1994, Lindleyana, V9, P115; Barrett CF, 2014, MOL BIOL EVOL, V31, P3095, DOI 10.1093/molbev/msu252; Barrett CF, 2013, CLADISTICS, V29, P65, DOI 10.1111/j.1096-0031.2012.00418.x; Barrett CF, 2012, AM J BOT, V99, P1513, DOI 10.3732/ajb.1200256; Bellino A, 2014, OECOLOGIA, V175, P875, DOI 10.1007/s00442-014-2940-8; Braukmann T, 2012, PLANT MOL BIOL, V79, P5, DOI 10.1007/s11103-012-9884-3; Braukmann TWA, 2009, CURR GENET, V55, P323, DOI 10.1007/s00294-009-0249-7; Burrows PA, 1998, EMBO J, V17, P868, DOI 10.1093/emboj/17.4.868; Cai J, 2015, NAT GENET, V47, P65, DOI 10.1038/ng.3149; Cai ZQ, 2008, J MOL EVOL, V67, P696, DOI 10.1007/s00239-008-9180-7; Cameron KM, 1999, AM J BOT, V86, P208, DOI 10.2307/2656938; Chang CC, 2006, MOL BIOL EVOL, V23, P279, DOI 10.1093/molbev/msj029; Chase MW, 2015, BOT J LINN SOC, V177, P151, DOI 10.1111/boj.12234; Blazier J, 2011, PLANT MOL BIOL, V76, P263, DOI 10.1007/s11103-011-9753-5; Chumley TW, 2006, MOL BIOL EVOL, V23, P2175, DOI 10.1093/molbev/msl089; Cox AV, 1998, AM J BOT, V85, P681, DOI 10.2307/2446538; da Rocha Perini V., 2015, MITOCHONDR DNA, DOI [10.3109/19401736.2014.1003850, DOI 10.3109/19401736.2014.1003850]; De las Rivas J, 2002, GENOME RES, V12, P567, DOI 10.1101/gr.209402; Delannoy E, 2011, MOL BIOL EVOL, V28, P2077, DOI 10.1093/molbev/msr028; Freudenstein JV, 2015, ANN BOT-LONDON, V115, P665, DOI 10.1093/aob/mcu253; Funk HT, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-45; Givnish TJ, 2010, ANN MO BOT GARD, V97, P584, DOI 10.3417/2010023; Gonneau C, 2014, J ECOL, V102, P1183, DOI 10.1111/1365-2745.12274; Govaerts R., WORLD CHECKLIST ORCH; HABERHAUSEN G, 1994, PLANT MOL BIOL, V24, P217, DOI 10.1007/BF00040588; Heath TA, 2008, J SYST EVOL, V46, P239, DOI 10.3724/SP.J.1002.2008.08016; Henriquez CL, 2014, MOL PHYLOGENET EVOL, V75, P91, DOI 10.1016/j.ympev.2014.02.017; Jheng CF, 2012, PLANT SCI, V190, P62, DOI 10.1016/j.plantsci.2012.04.001; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kim GB, 2016, MITOCHONDRIAL DNA A, V27, P1300, DOI 10.3109/19401736.2014.945566; Kim HT, 2014, MOL CELLS, V37, P372, DOI 10.14348/molcells.2014.2296; Kim JS, 2015, PLANT MOL BIOL REP, V33, P1210, DOI 10.1007/s11105-014-0833-y; Kocyan A, 2004, PLANT SYST EVOL, V247, P203, DOI 10.1007/s00606-004-0133-3; Kores Paul J., 1997, Lindleyana, V12, P1; Lanfear R, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-82; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lin CS, 2015, SCI REP-UK, V5, DOI 10.1038/srep09040; Logacheva MD, 2014, GENOME BIOL EVOL, V6, P238, DOI 10.1093/gbe/evu001; Logacheva MD, 2011, GENOME BIOL EVOL, V3, P1296, DOI 10.1093/gbe/evr102; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Luo J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099016; Maddison W.P., MESQUITE MODULAR SYS; Martin M, 2010, PLANT PHYSIOL BIOCH, V48, P636, DOI 10.1016/j.plaphy.2010.04.009; Mccoy SR, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-130; McNeal JR, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-57; Miller M.A., 2010, P GAT COMP ENV WORKS; Moore MJ, 2007, P NATL ACAD SCI USA, V104, P19363, DOI 10.1073/pnas.0708072104; Moore MJ, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-17; Moore MJ, 2010, P NATL ACAD SCI USA, V107, P4623, DOI 10.1073/pnas.0907801107; Motomura H, 2010, ANN BOT-LONDON, V106, P573, DOI 10.1093/aob/mcq156; Neyland R, 1996, AM J BOT, V83, P1195, DOI 10.2307/2446204; Neyland Ray, 1996, Lindleyana, V11, P47; Pan IC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034738; Pemberton Robert W., 2013, Lankesteriana, V13, P65; Peredo EL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068591; Rokas A, 2005, MOL BIOL EVOL, V22, P1337, DOI 10.1093/molbev/msi121; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Roy M, 2013, ECOL MONOGR, V83, P95, DOI 10.1890/11-2120.1; Ruhlman TA, 2014, METHODS MOL BIOL, V1132, P3, DOI 10.1007/978-1-62703-995-6_1; Schelkunov MI, 2015, GENOME BIOL EVOL, V7, P1179, DOI 10.1093/gbe/evv019; Selosse MA, 2014, NEW PHYTOL, V202, P337, DOI 10.1111/nph.12769; Smith SE, 2008, MYCORRHIZAL SYMBIOSIS, 3RD EDITION, P419, DOI 10.1016/B978-012370526-6.50014-3; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Steele PR, 2012, AM J BOT, V99, P330, DOI 10.3732/ajb.1100491; Stockel M, 2011, NEW PHYTOL, V189, P790, DOI 10.1111/j.1469-8137.2010.03510.x; Straub SCK, 2012, AM J BOT, V99, P349, DOI 10.3732/ajb.1100335; WAKASUGI T, 1994, P NATL ACAD SCI USA, V91, P9794, DOI 10.1073/pnas.91.21.9794; WOLFE KH, 1992, P NATL ACAD SCI USA, V89, P10648, DOI 10.1073/pnas.89.22.10648; Wu FH, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-68; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yang JB, 2014, MOL ECOL RESOUR, V14, P1024, DOI 10.1111/1755-0998.12251; Yang JB, 2013, BMC EVOL BIOL, V13, DOI [10.1186/1471-2148-13-84, 10.1186/1471-244X-13-150]; Yukawa T, 1996, J PLANT RES, V109, P169, DOI 10.1007/BF02344542	75	72	74	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142215	10.1371/journal.pone.0142215	http://dx.doi.org/10.1371/journal.pone.0142215			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26558895	Green Published, gold, Green Submitted			2022-12-27	WOS:000364433100061
J	Piple, J; Gora, R; Purbiya, P; Puliyel, A; Chugh, P; Bahl, P; Puliyel, J				Piple, Jitendra; Gora, Ranjeet; Purbiya, Pragati; Puliyel, Ashish; Chugh, Parul; Bahl, Pinky; Puliyel, Jacob			Food Choices and Consequences for the Nutritional Status: Insights into Nutrition Transition in an Hospital Community	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; OBESITY	Introduction Although economic development is generally accompanied by improvements in the overall nutritional status of the country's population the 'nutritional transition' often involves a shift to high energy diets and less exercise with negative consequences. This pilot study was done to examine if education of parents operates at the household level to influence dietary choices and the nutritional status of children in a small community of hospital workers. Material and Methods 3 groups of persons with varying skill and education levels participated. Weighed food logs were used in all households to calculate 'adult equivalent' per-capita-consumption. Nutrients were calculated using nutrients calculator software. BMI was used to classify children as underweight, normal weight and overweight. Results 128 individuals participated from 30 families included 47 children. 10 children (21%) were underweight, 29 (62%) were normal and 8 (17%) were overweight. Energy consumption was highest in families with overweight children 2692 +/-502 compared to 2259 +/-359 in families with normal weight and 2031+/-354 in the family of underweight children. These differences were statistically significant. 42% underweight children belonged to Class 1 at the lowest skill level and there were no overweight children in this group. Most of the overweight children belonged to Class 2. In Class 3 there were no underweight children and the majority was normal weight children. Conclusion Underweight children came from the poorer households. Per capita intake of the family as a whole correlated well with BMI in the children. There was increased obesity in middle income families belonging to Class 2-probably in families who move up the scale from deprivation. Nutritional status in children correlated mostly with maternal education status.	[Piple, Jitendra; Gora, Ranjeet; Purbiya, Pragati; Bahl, Pinky; Puliyel, Jacob] St Stephens Hosp, Dept Pediat, Delhi 110054, India; [Puliyel, Ashish] The Franklin, DocuBuzz Comp Solut 02 12 25, Singapore 118223, Singapore; [Chugh, Parul] Sir Ganga Ram Hosp, Statistician Dept Res, Delhi, India	St. Stephen's Hospital	Puliyel, J (corresponding author), St Stephens Hosp, Dept Pediat, Delhi 110054, India.	Puliyel@gmail.com						Abuya BA, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-80; [Anonymous], 2014, GLOBAL EPIDEMIC OBES, DOI DOI 10.7243/2052-5966-2-2; Claro RM, 2010, CAD SAUDE PUBLICA, V26, P2188, DOI 10.1590/S0102-311X2010001100020; de Onis M, LEVELS TRENDS CHILD; Drewnowski A, 1997, NUTR REV, V55, P31, DOI 10.1111/j.1753-4887.1997.tb01593.x; FerroLuzzi A, 1996, CIBA F SYMP, V201, P207; Gaiha Raghav, 2012, J Asian Afr Stud, V47, P3; Gopalan C, 1989, NUTR VALUE INDIAN FO; Griffiths C, 2014, INT J OBESITY, V38, P161, DOI 10.1038/ijo.2013.66; Gupta N, 2012, ENDOCR REV, V33, P48, DOI 10.1210/er.2010-0028; Guruswamy M, POVERTY LINE IS STAR; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Ravishankar AK, 2012, J HEALTH MANAG, V14, P313, DOI 10.1177/0972063412457513; Sathyamala C, 2014, J CLIN DIAGN RES, V8, pPC6, DOI 10.7860/JCDR/2014/7369.4389; Singh MK, 2014, TNN             0707; Venkatesan J, 2011, THE HINDU       0515	16	1	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0140807	10.1371/journal.pone.0140807	http://dx.doi.org/10.1371/journal.pone.0140807			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559817	Green Published, Green Submitted, gold			2022-12-27	WOS:000364433100008
J	Shao, XX; Yang, WY; Wu, M				Shao, Xuexin; Yang, Wenying; Wu, Ming			Seasonal Dynamics of Soil Labile Organic Carbon and Enzyme Activities in Relation to Vegetation Types in Hangzhou Bay Tidal Flat Wetland	PLOS ONE			English	Article							FRESH-WATER MARSH; MICROBIAL BIOMASS; SANJIANG PLAIN; NITROGEN; MATTER; MINERALIZATION; DECOMPOSITION; SPECIATION; RELEASE; QUALITY	Soil labile organic carbon and soil enzymes play important roles in the carbon cycle of coastal wetlands that have high organic carbon accumulation rates. Soils under three vegetations (Phragmites australis, Spartina alterniflora, and Scirpusm mariqueter) as well as bare mudflat in Hangzhou Bay wetland of China were collected seasonally. Seasonal dynamics and correlations of soil labile organic carbon fractions and soil enzyme activities were analyzed. The results showed that there were significant differences among vegetation types in the contents of soil organic carbon (SOC) and dissolved organic carbon (DOC), excepting for that of microbial biomass carbon (MBC). The P. australis soil was with the highest content of both SOC (7.86 g kg(-1)) and DOC (306 mg kg(-1)), while the S. mariqueter soil was with the lowest content of SOC (6.83 g kg(-1)), and the bare mudflat was with the lowest content of DOC (270mg kg(-1)). Soil enzyme activities were significantly different among vegetation types except for urease. The P. australis had the highest annual average activity of alkaline phosphomonoesterase (21.4 mg kg-1 h(-1)), and the S. alterniflora had the highest annual average activities of beta-glycosidase (4.10 mg kg(-1) h(-1)) and invertase (9.81mg g(-1) 24 h(-1)); however, the bare mudflat had the lowest activities of alkaline phosphomonoesterase (16.2 mg kg(-1) h(-1)), beta-glycosidase (2.87 mg kg(-1) h(-1)), and invertase (8.02mg g(-1) 24 h(-1)). Analysis also showed that the soil labile organic carbon fractions and soil enzyme activities had distinct seasonal dynamics. In addition, the soil MBC content was significantly correlated with the activities of urease and beta-glucosidase. The DOC content was significantly correlated with the activities of urease, alkaline phosphomonoesterase, and invertase. The results indicated that vegetation type is an important factor influencing the spatial-temporal variation of soil enzyme activities and labile organic carbon in coastal wetlands.	[Shao, Xuexin; Yang, Wenying; Wu, Ming] Chinese Acad Forestry, Res Inst Subtrop Forestry, Wetland Ecosyst Res Stn Hangzhou Bay, Fuyang, Zhejiang, Peoples R China	Chinese Academy of Forestry; Research Institute of Subtropical Forestry, CAF	Wu, M (corresponding author), Chinese Acad Forestry, Res Inst Subtrop Forestry, Wetland Ecosyst Res Stn Hangzhou Bay, Fuyang, Zhejiang, Peoples R China.	hangzhoubay@126.com			Fundamental Research Funds for the Central Nonprofit Research Institution [CAFYBB2014MA002, RISFCAF61256]; Special Fund for Forest Scientific Research in the Public Welfare [201404210]	Fundamental Research Funds for the Central Nonprofit Research Institution; Special Fund for Forest Scientific Research in the Public Welfare	This study was supported by the Fundamental Research Funds for the Central Nonprofit Research Institution (CAFYBB2014MA002, RISFCAF61256) and Special Fund for Forest Scientific Research in the Public Welfare (201404210). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkorta Itziar, 2003, Rev Environ Health, V18, P65; An S, 2008, CATENA, V75, P248, DOI 10.1016/j.catena.2008.07.003; Bonnett SAF, 2006, SCI TOTAL ENVIRON, V370, P561, DOI 10.1016/j.scitotenv.2006.08.032; Caravaca F, 2005, GEODERMA, V124, P375, DOI 10.1016/j.geoderma.2004.05.010; Chen CR, 2004, SOIL SCI SOC AM J, V68, P282, DOI 10.2136/sssaj2004.2820; Chen QF, 2013, INT BIODETER BIODEGR, V85, P646, DOI 10.1016/j.ibiod.2013.04.009; COLEMAN DC, 1983, ADV ECOL RES, V13, P1, DOI 10.1016/S0065-2504(08)60107-5; Fenner N, 2005, SOIL BIOL BIOCHEM, V37, P1814, DOI 10.1016/j.soilbio.2005.02.032; Guan YS, 1986, SOIL ENZYME RES METH, P309; Haynes RJ, 2005, ADV AGRON, V85, P221, DOI 10.1016/S0065-2113(04)85005-3; Huang JY, 2010, ACTA AGR SCAND B-S P, V60, P182, DOI 10.1080/09064710802680387; INSAM H, 1990, SOIL BIOL BIOCHEM, V22, P525, DOI 10.1016/0038-0717(90)90189-7; Jones DL, 2006, SOIL BIOL BIOCHEM, V38, P991, DOI 10.1016/j.soilbio.2005.08.012; Kalbitz K, 2000, SOIL SCI, V165, P277, DOI 10.1097/00010694-200004000-00001; Keuskamp JA, 2013, SOIL BIOL BIOCHEM, V57, P822, DOI 10.1016/j.soilbio.2012.08.007; Khalid M, 2007, SOIL BIOL BIOCHEM, V39, P378, DOI 10.1016/j.soilbio.2006.07.007; Kramer S, 2000, SOIL BIOL BIOCHEM, V32, P179, DOI 10.1016/S0038-0717(99)00140-6; Li XF, 2015, APPL MICROBIOL BIOT, V99, P2895, DOI 10.1007/s00253-014-6187-4; Liang BC, 1998, BIOL FERT SOILS, V26, P88, DOI 10.1007/s003740050348; Lu L. K, 1999, SOIL AGRO CHEM ANALY; Mavi M. S., 2010, Proceedings of the 19th World Congress of Soil Science: Soil solutions for a changing world, Brisbane, Australia, 1-6 August 2010. Working Group 3.4 Global change and soil salination, P43; McLatchey GP, 1998, J ENVIRON QUAL, V27, P1268, DOI 10.2134/jeq1998.00472425002700050036x; Neff JC, 2002, GLOBAL CHANGE BIOL, V8, P872, DOI 10.1046/j.1365-2486.2002.00517.x; Nie XB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081084; Niemi RM, 2005, APPL SOIL ECOL, V30, P113, DOI 10.1016/j.apsoil.2005.02.003; Phang VXH, 2015, EARTH SURF PROC LAND, V40, P1387, DOI 10.1002/esp.3745; Rietz DN, 2003, SOIL BIOL BIOCHEM, V35, P845, DOI 10.1016/S0038-0717(03)00125-1; Ros GH, 2010, SOIL SCI, V175, P15, DOI 10.1097/SS.0b013e3181c8ef3c; ROSS DJ, 1995, SOIL BIOL BIOCHEM, V27, P1431, DOI 10.1016/0038-0717(95)00069-Q; Sanaullah M, 2011, APPL SOIL ECOL, V48, P38, DOI 10.1016/j.apsoil.2011.02.004; Shao XX, 2013, ENVIRON SCI POLLUT R, V20, P6382, DOI 10.1007/s11356-013-1698-6; Singh DK, 2008, CHEMOSPHERE, V71, P412, DOI 10.1016/j.chemosphere.2007.11.005; Sinsabaugh RL, 2008, ECOL LETT, V11, P1252, DOI 10.1111/j.1461-0248.2008.01245.x; Solomon D, 2007, GLOBAL CHANGE BIOL, V13, P511, DOI 10.1111/j.1365-2486.2006.01304.x; Song YY, 2014, EUR J SOIL BIOL, V61, P72, DOI 10.1016/j.ejsobi.2014.02.001; Song YY, 2013, CATENA, V104, P265, DOI 10.1016/j.catena.2012.12.008; Song YY, 2012, ENVIRON MANAGE, V50, P418, DOI 10.1007/s00267-012-9890-x; Tian L, 2010, APPL SOIL ECOL, V46, P426, DOI 10.1016/j.apsoil.2010.09.007; Tripathi S, 2006, BIOL FERT SOILS, V42, P273, DOI 10.1007/s00374-005-0037-6; Tripathi S, 2007, SOIL BIOL BIOCHEM, V39, P2840, DOI 10.1016/j.soilbio.2007.05.027; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; [万忠梅 WAN ZhongMei], 2008, [生态学报, Acta Ecologica Sinica], V28, P5980; WANDER MM, 1994, SOIL SCI SOC AM J, V58, P1130, DOI 10.2136/sssaj1994.03615995005800040018x; Wang JY, 2012, CATENA, V96, P83, DOI 10.1016/j.catena.2012.03.009; Wang QK, 2013, ANN FOREST SCI, V70, P579, DOI 10.1007/s13595-013-0294-8; Wang QK, 2011, APPL SOIL ECOL, V47, P210, DOI 10.1016/j.apsoil.2010.12.004; Yao XH, 2006, EUR J SOIL BIOL, V42, P120, DOI 10.1016/j.ejsobi.2005.12.001; Yin R, 2014, CATENA, V115, P96, DOI 10.1016/j.catena.2013.11.015; Zhang C, 2011, GEODERMA, V161, P115, DOI 10.1016/j.geoderma.2010.12.003; Zhou GM, 2006, PEDOSPHERE, V16, P525, DOI 10.1016/S1002-0160(06)60084-2; Zhou XJ, 2004, CHINESE SCI BULL, V49, P2503, DOI 10.1360/03wd0538	51	45	55	7	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142677	10.1371/journal.pone.0142677	http://dx.doi.org/10.1371/journal.pone.0142677			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26560310	Green Published, Green Submitted, gold			2022-12-27	WOS:000364433100111
J	Bunyasi, EW; Tameris, M; Geldenhuys, H; Schmidt, BM; Luabeya, AKK; Mulenga, H; Scriba, TJ; Hanekom, WA; Mahomed, H; McShane, H; Hatherill, M				Bunyasi, Erick Wekesa; Tameris, Michele; Geldenhuys, Hennie; Schmidt, Bey-Marrie; Luabeya, Angelique Kany Kany; Mulenga, Humphrey; Scriba, Thomas J.; Hanekom, Willem A.; Mahomed, Hassan; McShane, Helen; Hatherill, Mark			Evaluation of Xpert (R) MTB/RIF Assay in Induced Sputum and Gastric Lavage Samples from Young Children with Suspected Tuberculosis from the MVA85A TB Vaccine Trial	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; DIAGNOSIS; RESISTANCE; AFRICA; ACCURACY	Objective Diagnosis of childhood tuberculosis is limited by the paucibacillary respiratory samples obtained from young children with pulmonary disease. We aimed to compare accuracy of the Xpert (R) MTB/RIF assay, an automated nucleic acid amplification test, between induced sputum and gastric lavage samples from young children in a tuberculosis endemic setting. Methods We analyzed standardized diagnostic data from HIV negative children younger than four years of age who were investigated for tuberculosis disease near Cape Town, South Africa [2009-2012]. Two paired, consecutive induced sputa and early morning gastric lavage samples were obtained from children with suspected tuberculosis. Samples underwent Mycobacterial Growth Indicator Tube [MGIT] culture and Xpert MTB/RIF assay. We compared diagnostic yield across samples using the two-sample test of proportions and McNemar's chi(2) test; and Wilson's score method to calculate sensitivity and specificity. Results 1,020 children were evaluated for tuberculosis during 1,214 admission episodes. Not all children had 4 samples collected. 57 of 4,463[1.3%] and 26 of 4,606[0.6%] samples tested positive for Mycobacterium tuberculosis on MGIT culture and Xpert MTB/RIF assay respectively. 27 of 2,198[1.2%] and 40 of 2,183[1.8%] samples tested positive [on either Xpert MTB/RIF assay or MGIT culture] on induced sputum and gastric lavage samples, respectively. 19/1,028[1.8%] and 33/1,017[3.2%] admission episodes yielded a positive MGIT culture or Xpert MTB/RIF assay from induced sputum and gastric lavage, respectively. Sensitivity of Xpert MTB/RIF assay was 8/30[26.7%; 95% CI: 14.2-44.4] for two induced sputum samples and 7/31[22.6%; 11.4-39.8] [p = 0.711] for two gastric lavage samples. Corresponding specificity was 893/893[100%; 99.6-100] and 885/890[99.4%; 98.7-99.8] respectively [p = 0.025]. Conclusion Sensitivity of Xpert MTB/RIF assay was low, compared to MGIT culture, but diagnostic performance of Xpert MTB/RIF did not differ sufficiently between induced sputum and gastric lavage to justify selection of one sampling method over the other, in young children with suspected pulmonary TB.	[Bunyasi, Erick Wekesa; Tameris, Michele; Geldenhuys, Hennie; Schmidt, Bey-Marrie; Luabeya, Angelique Kany Kany; Mulenga, Humphrey; Scriba, Thomas J.; Hanekom, Willem A.; Hatherill, Mark] Univ Cape Town, South African TB Vaccine Initiat, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Bunyasi, Erick Wekesa; Tameris, Michele; Geldenhuys, Hennie; Schmidt, Bey-Marrie; Luabeya, Angelique Kany Kany; Mulenga, Humphrey; Scriba, Thomas J.; Hanekom, Willem A.; Hatherill, Mark] Univ Cape Town, Dept Pediat & Child Hlth, ZA-7925 Cape Town, South Africa; [Mahomed, Hassan] Univ Stellenbosch, Dept Hlth, Western Cape Prov, ZA-7600 Stellenbosch, South Africa; [Mahomed, Hassan] Univ Stellenbosch, Div Community Hlth, ZA-7600 Stellenbosch, South Africa; [McShane, Helen] Univ Oxford, Nuffield Dept Clin Med, Jenner Inst, Oxford, England	University of Cape Town; University of Cape Town; Stellenbosch University; Stellenbosch University; University of Oxford; Jenner Institute	Bunyasi, EW (corresponding author), Univ Cape Town, South African TB Vaccine Initiat, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa.	ebunyasi@gmail.com	Scriba, Thomas/GPX-2573-2022; Tameris, Michele/AAR-6663-2021; Luabeya, Angelique Kany Kany/K-2769-2019; Scriba, Thomas/AAH-9413-2020; Bunyasi, Erick/O-5159-2016	Scriba, Thomas/0000-0002-0641-1359; Tameris, Michele/0000-0002-7983-7203; Luabeya, Angelique Kany Kany/0000-0001-7379-2836; Bunyasi, Erick/0000-0001-7265-1089; McShane, Helen/0000-0002-2126-5142; Hanekom, Willem/0000-0003-3070-6154	Wellcome Trust [095780] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bates M, 2013, LANCET INFECT DIS, V13, P36, DOI 10.1016/S1473-3099(12)70245-1; Blakemore R, 2010, J CLIN MICROBIOL, V48, P2495, DOI 10.1128/JCM.00128-10; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Chang K, 2012, J INFECTION, V64, P580, DOI 10.1016/j.jinf.2012.02.012; CONNOR RJ, 1987, BIOMETRICS, V43, P207, DOI 10.2307/2531961; Detjen AK, 2015, LANCET RESP MED, V3, P451, DOI 10.1016/S2213-2600(15)00095-8; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; Engelbrecht B., 2014, H1572014 W CAP PROV, P1; Hawkridge A, 2008, BMJ-BRIT MED J, P1275; Helb D, 2010, J CLIN MICROBIOL, V48, P229, DOI 10.1128/JCM.01463-09; HOBBY GL, 1973, ANTIMICROB AGENTS CH, V4, P94, DOI 10.1128/AAC.4.2.94; Mudenda V, 2012, J INFECT DIS, V205, pS340, DOI 10.1093/infdis/jir859; Nicol MP, 2011, LANCET INFECT DIS, V11, P819, DOI 10.1016/S1473-3099(11)70167-0; O'Grady J, 2012, CLIN INFECT DIS, V55, P1171, DOI 10.1093/cid/cis631; Patel VB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001536; Rachow A, 2012, CLIN INFECT DIS, V54, P1388, DOI 10.1093/cid/cis190; StataCorp LP, 2015, STATA 13 1 SE; Tameris M, 2013, TUBERCULOSIS, V93, P143, DOI 10.1016/j.tube.2013.01.003; Tameris MD, 2013, LANCET, V381, P1021, DOI 10.1016/S0140-6736(13)60177-4; WHO, 2014, GLOB TUB REP 2014; WHO U, 2014, XPERT MTB RIF IMPL M; YEAGER H, 1967, AM REV RESPIR DIS, V95, P998; Zar HJ, 2010, EXPERT REV ANTI-INFE, V8, P277, DOI [10.1586/eri.10.9, 10.1586/ERI.10.9]	24	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0141623	10.1371/journal.pone.0141623	http://dx.doi.org/10.1371/journal.pone.0141623			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26554383	Green Published, Green Submitted, gold			2022-12-27	WOS:000364430700034
J	Cleland, V; Hughes, C; Thornton, L; Venn, A; Squibb, K; Ball, K				Cleland, Verity; Hughes, Clarissa; Thornton, Lukar; Venn, Alison; Squibb, Kathryn; Ball, Kylie			A Qualitative Study of Environmental Factors Important for Physical Activity in Rural Adults	PLOS ONE			English	Article							AFRICAN-AMERICAN; URBAN; WOMEN; WALKING; OLDER	Purpose Despite increasing evidence that the physical environment impacts on physical activity among urban-dwellers, little attention has been devoted to understanding this relationship in rural populations. Work in this area is further hindered by a lack of environmental measures specifically designed for rural settings. This qualitative study aimed to explore the salience of urban physical activity environment constructs among rural adults. Methods In 2011, 49 rural men and women from three distinct areas (coastal, animal-based farming, forestry/plant-based farming) of rural Tasmania, Australia, were purposively recruited to participate in semi-structured interviews. Interviews explored features of the built and social environment commonly examined in studies of urban adults, including functional characteristics (eg, lighting, footpaths, roads/verges), road and personal safety, availability and accessibility of places to be active, destinations, and aesthetics. Interviews were recorded, transcribed verbatim and analysed using a content-thematic approach using QSR NVivo software. Findings While some urban environmental constructs were salient to these rural adults, such as availability of and accessibility to places to be active, some constructs were operationalised differently, such as road safety (where large trucks and winding roads rather than traffic density was of concern), or were not considered relevant (eg, personal safety related to crime, availability of walkable destinations, aesthetics). Conclusions The measurement of the physical environment in rural populations may require reconsideration and/or modification to ensure salience and appropriate quantification of associations with physical activity in future studies.	[Cleland, Verity; Venn, Alison; Squibb, Kathryn] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia; [Hughes, Clarissa] Univ Tasmania, Ctr Rural Hlth, Hobart, Tas, Australia; [Thornton, Lukar; Ball, Kylie] Deakin Univ, Ctr Phys Act & Nutr Res, Sch Exercise & Nutr, Sci, Burwood, Vic, Australia	University of Tasmania; Menzies Institute for Medical Research; University of Tasmania; Deakin University	Cleland, V (corresponding author), Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia.	verity.cleland@utas.edu.au	Thornton, Lukar E/C-9554-2014; Venn, Alison J/J-2803-2013; Ball, Kylie/B-5866-2015; Cleland, Verity/J-7677-2014	Ball, Kylie/0000-0003-2893-8415; Cleland, Verity/0000-0001-8358-3237; Hughes, Clarissa/0000-0002-6469-4027; Thornton, Lukar/0000-0001-8759-8671	University of Tasmania; National Health and Medical Research Council (NHMRC) [1008299, 1042442]	University of Tasmania; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	The University of Tasmania provided funding for this study. VC was supported by a National Health and Medical Research Council (NHMRC) Postdoctoral Training (Public Health) Fellowship, AV was supported by a NHMRC Fellowship (1008299), and KB was supported by a NHMRC Principal Research Fellowship (1042442).	Addy CL, 2004, AM J PUBLIC HEALTH, V94, P440, DOI 10.2105/AJPH.94.3.440; [Anonymous], 2009, GLOBAL HEALTH RISKS: MORTALITY AND BURDEN OF DISEASE ATTRIBUTABLE TO SELECTED MAJOR RISKS, P1; [Anonymous], 2010, 2010 CENS URB RUR CL; Aronson RE, 2004, J RURAL HEALTH, V20, P76, DOI 10.1111/j.1748-0361.2004.tb00010.x; Australian Bureau of Statistics, 2011, AUSTR STAT GEOGR STA, V5; Australian Bureau of Statistics, 2006, CRIM SAF AUSTR; Australian Institute of Health and Welfare, 2011, CARD DIS AUSTR FACTS; Australian Institute of Health and Welfare, 2008, RUR REG REM HLTH IND; Badland H, 2006, HEALTH PLACE, V12, P538, DOI 10.1016/j.healthplace.2005.08.007; Bauman A.E., 2007, ENV CORRELATES PHYS; Boehmer TK, 2006, AM J HEALTH PROMOT, V20, P411, DOI 10.4278/0890-1171-20.6.411; Brownson RC, 2005, PREV MED, V41, P837, DOI 10.1016/j.ypmed.2005.09.004; Centers for Disease Control and Prevention, 2012, DEATHS PREL DAT 2011; Centers for Disease Control and Prevention (CDC), 1998, MMWR Morb Mortal Wkly Rep, V47, P1097; Chrisman M, 2015, HEALTH PROMOT PRACT, V16, P142, DOI 10.1177/1524839914524958; De Marco A, 2010, J COMMUNITY PSYCHOL, V38, P99, DOI 10.1002/jcop.20354; Deshpande AD, 2005, DIABETES CARE, V28, P1012, DOI 10.2337/diacare.28.5.1012; Dobson A, 2010, AUST NZ J PUBL HEAL, V34, P624, DOI 10.1111/j.1753-6405.2010.00623.x; Eurostat, 2014, DEM STAT URB RUR TYP; Eyler AA, 2003, AM J PREV MED, V25, P86, DOI 10.1016/S0749-3797(03)00169-7; Frost SS, 2010, AM J HEALTH PROMOT, V24, P267, DOI 10.4278/ajhp.08040532; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Kirby AM, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-63; Martin SL, 2005, J RURAL HEALTH, V21, P239, DOI 10.1111/j.1748-0361.2005.tb00089.x; Osuji T, 2006, WOMEN HEALTH, V44, P41, DOI 10.1300/J013v44n01_03; Parks SE, 2003, J EPIDEMIOL COMMUN H, V57, P29, DOI 10.1136/jech.57.1.29; Pikora T, 2003, SOC SCI MED, V56, P1693, DOI 10.1016/S0277-9536(02)00163-6; Reed Julian A, 2006, J Phys Act Health, V3, P243, DOI 10.1123/jpah.3.2.243; Sallis J.F., 2002, HLTH BEHAV HLTH ED T, V3rd ed., P462; Sanderson BK, 2003, AM J PREV MED, V25, P30, DOI 10.1016/S0749-3797(03)00162-4; Singh GK, 2014, AM J PREV MED, V46, pE19, DOI 10.1016/j.amepre.2013.10.017; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Van Dyck D, 2011, J URBAN HEALTH, V88, P154, DOI 10.1007/s11524-010-9536-3; Wilcox S, 2000, J EPIDEMIOL COMMUN H, V54, P667, DOI 10.1136/jech.54.9.667; Wilcox S, 2003, J GERONTOL B-PSYCHOL, V58, pP329, DOI 10.1093/geronb/58.6.P329; Wilson DK, 2004, ANN BEHAV MED, V28, P20, DOI 10.1207/s15324796abm2801_4	36	19	19	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0140659	10.1371/journal.pone.0140659	http://dx.doi.org/10.1371/journal.pone.0140659			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7CT	26554376	Green Published, Green Submitted, gold			2022-12-27	WOS:000364430700014
J	Masic, A; Hernandez, AMV; Hazra, S; Glaser, J; Holzgrabe, U; Hazra, B; Schurigt, U				Masic, Anita; Hernandez, Ana Maria Valencia; Hazra, Sudipta; Glaser, Jan; Holzgrabe, Ulrike; Hazra, Banasri; Schurigt, Uta			Cinnamic Acid Bornyl Ester Derivatives from Valeriana wallichii Exhibit Antileishmanial In Vivo Activity in Leishmania major-Infected BALB/c Mice	PLOS ONE			English	Article							APOPTOTIC CELL-DEATH; DRUG DISCOVERY; CUTANEOUS LEISHMANIASIS; CHALCONES; VITRO; PROLIFERATION; AMAZONENSIS; RESISTANCE; INHIBITORS; DONOVANI	Human leishmaniasis covers a broad spectrum of clinical manifestations ranging from self-healing cutaneous leishmaniasis to severe and lethal visceral leishmaniasis caused among other species by Leishmania major or Leishmania donovani, respectively. Some drug candidates are in clinical trials to substitute current therapies, which are facing emerging drug-resistance accompanied with serious side effects. Here, two cinnamic acid bornyl ester derivatives (1 and 2) were assessed for their antileishmanial activity. Good selectivity and antileishmanial activity of bornyl 3-phenylpropanoate (2) in vitro prompted the antileishmanial assessment in vivo. For this purpose, BALB/c mice were infected with Leishmania major promastigotes and treated with three doses of 50 mg/kg/day of compound 2. The treatment prevented the characteristic swelling at the site of infection and correlated with reduced parasite burden. Transmitted light microscopy and transmission electron microscopy of Leishmania major promastigotes revealed that compounds 1 and 2 induce mitochondrial swelling. Subsequent studies on Leishmania major promastigotes showed the loss of mitochondrial transmembrane potential (Delta psi(m)) as a putative mode of action. As the cinnamic acid bornyl ester derivatives 1 and 2 had exhibited antileishmanial activity in vitro, and compound 2 in Leishmania major-infected BALB/c mice in vivo, they can be regarded as possible lead structures for the development of new antileishmanial therapeutic approaches.	[Masic, Anita; Hernandez, Ana Maria Valencia; Schurigt, Uta] Univ Wurzburg, Inst Mol Infect Biol, Wurzburg, Germany; [Hazra, Sudipta; Hazra, Banasri] Jadavpur Univ, Dept Pharmaceut Technol, Kolkata, India; [Glaser, Jan; Holzgrabe, Ulrike] Univ Wurzburg, Inst Pharm & Food Chem, Wurzburg, Germany	University of Wurzburg; Jadavpur University; University of Wurzburg	Glaser, J (corresponding author), Univ Wurzburg, Inst Pharm & Food Chem, Wurzburg, Germany.	jan.glaser@uni-wuerzburg.de; uta.schurigt@uni-wuerzburg.de		Holzgrabe, Ulrike/0000-0002-0364-7278	Deutsche Forschungsgemeinschaft (DFG), Collaborative Research Center [630 (SFB 630)]; Indian Council of Medical Research, New Delhi, India [3/1/3/WL/JRF-2008/MPD]; Deutsche Forschungsgemeinschaft (DFG); University of Wuerzburg	Deutsche Forschungsgemeinschaft (DFG), Collaborative Research Center(German Research Foundation (DFG)); Indian Council of Medical Research, New Delhi, India(Indian Council of Medical Research (ICMR)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); University of Wuerzburg	Funding: This work was supported by a grant of the Deutsche Forschungsgemeinschaft (DFG), Collaborative Research Center 630 (SFB 630), "Recognition, Preparation and Functional Analysis of Agents against Infectious Diseases" (projects A1 and B3; www.sfb630.uni-wuerzburg.de). SH was awarded a fellowship from the Indian Council of Medical Research, New Delhi, India (3/1/3/WL/JRF-2008/MPD). This publication was funded by the Deutsche Forschungsgemeinschaft (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Aponte JC, 2010, BIOORG MED CHEM LETT, V20, P100, DOI 10.1016/j.bmcl.2009.11.033; Baell J, 2014, NATURE, V513, P481, DOI 10.1038/513481a; BOGDAN C, 1990, EUR J IMMUNOL, V20, P1131, DOI 10.1002/eji.1830200528; Bozic DD, 2014, INDIAN J MED RES, V140, P130; Bringmann G, 2013, ANTIMICROB AGENTS CH, V57, P3003, DOI 10.1128/AAC.02201-12; Britta EA, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0236-0; Castanys-Munoz E, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.113; CHRISTENSEN SB, 1994, PLANTA MED, V60, P121, DOI 10.1055/s-2006-959431; Corware K, 2011, BIOMATERIALS, V32, P8029, DOI 10.1016/j.biomaterials.2011.07.021; Croft SL, 2006, INDIAN J MED RES, V123, P399; Croft SL, 2006, CLIN MICROBIOL REV, V19, P111, DOI 10.1128/CMR.19.1.111-126.2006; CROFT SL, 1993, T ROY SOC TROP MED H, V87, P217, DOI 10.1016/0035-9203(93)90499-G; Cruz AK, 2009, CURR DRUG TARGETS, V10, P178, DOI 10.2174/138945009787581177; Dao TTH, 2011, PHYTOCHEM REV, V10, P397, DOI 10.1007/s11101-011-9211-7; de Mello TFP, 2014, EXP PARASITOL, V136, P27, DOI 10.1016/j.exppara.2013.11.003; de Souza W, 2009, INT J BIOCHEM CELL B, V41, P2069, DOI 10.1016/j.biocel.2009.04.007; Rodrigues JCF, 2008, CURR PHARM DESIGN, V14, P925, DOI 10.2174/138161208784041033; Ferreira ME, 2002, J ETHNOPHARMACOL, V80, P199, DOI 10.1016/S0378-8741(02)00025-9; FOURNET A, 1992, J ETHNOPHARMACOL, V37, P159, DOI 10.1016/0378-8741(92)90074-2; Garcia M, 2011, ASIAN PAC J TROP MED, V4, P836, DOI 10.1016/S1995-7645(11)60204-6; Ghosh S, 2011, PARASITOL RES, V108, P861, DOI 10.1007/s00436-010-2127-0; Glaser J, 2015, MOLECULES, V20, P5740, DOI 10.3390/molecules20045740; Glaser J, 2014, MOLECULES, V19, P1394, DOI 10.3390/molecules19021394; Gumy A, 2004, INT J PARASITOL, V34, P433, DOI 10.1016/j.ijpara.2003.11.021; Gupta S, 2014, EUR J MED CHEM, V81, P359, DOI 10.1016/j.ejmech.2014.05.034; GUY RA, 1995, CLIN EXP IMMUNOL, V100, P440; Hacker G, 2000, CELL TISSUE RES, V301, P5, DOI 10.1007/s004410000193; Hazra S, 2013, EXP PARASITOL, V135, P407, DOI 10.1016/j.exppara.2013.07.021; Hazra S, 2012, PARASITOL RES, V111, P195, DOI 10.1007/s00436-012-2818-9; Inacio JDF, 2012, EXP PARASITOL, V132, P151, DOI 10.1016/j.exppara.2012.06.008; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Khademvatan S, 2011, KOREAN J PARASITOL, V49, P17, DOI 10.3347/kjp.2011.49.1.17; Khuda F, 2012, PAK J PHARM SCI, V25, P715; Kingston DGI, 2005, IDRUGS, V8, P990; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Lima HC, 1997, PARASITOL TODAY, V13, P80, DOI 10.1016/S0169-4758(96)40010-2; Masic A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001721; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nakayama H, 2007, BIOMED PHARMACOTHER, V61, P186, DOI 10.1016/j.biopha.2007.02.001; Narender T, 2005, BIOORG MED CHEM LETT, V15, P2453, DOI 10.1016/j.bmcl.2005.03.081; Narender T, 2004, BIOORG MED CHEM LETT, V14, P3913, DOI 10.1016/j.bmcl.2004.05.071; Ponte-Sucre A, 2006, ANTIMICROB AGENTS CH, V50, P2439, DOI 10.1128/AAC.01430-05; Proto WR, 2013, NAT REV MICROBIOL, V11, P58, DOI 10.1038/nrmicro2929; Rodrigues IA, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-249; Rosa MDS, 2003, ANTIMICROB AGENTS CH, V47, P1895, DOI 10.1128/AAC.47.6.1895-1901.2003; Sati S. C., 2011, Research Journal of Microbiology, V6, P289, DOI 10.3923/jm.2011.289.296; Schurigt U, 2010, ANTIMICROB AGENTS CH, V54, P5028, DOI 10.1128/AAC.00327-10; Simpson L, 1997, MOL BIOCHEM PARASIT, V87, P71, DOI 10.1016/S0166-6851(97)00044-3; Singh Sarman, 2004, Journal of Infection and Chemotherapy, V10, P307, DOI 10.1007/s10156-004-0348-9; Sogin ML, 1991, CURR OPIN GENET DEV, V1, P457, DOI 10.1016/S0959-437X(05)80192-3; SOLBACH W, 1986, INFECT IMMUN, V54, P909, DOI 10.1128/IAI.54.3.909-912.1986; Sundar S, 2008, EXPERT OPIN INV DRUG, V17, P787, DOI [10.1517/13543784.17.5.787, 10.1517/13543784.17.5.787 ]; Vermes I, 2000, J IMMUNOL METHODS, V243, P167, DOI 10.1016/S0022-1759(00)00233-7; Weingartner A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042070; ZHAI L, 1995, ANTIMICROB AGENTS CH, V39, P2742, DOI 10.1128/AAC.39.12.2742; Zhang GH, 1997, BIOTECHNIQUES, V23, P525, DOI 10.2144/97233pf01	57	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142386	10.1371/journal.pone.0142386	http://dx.doi.org/10.1371/journal.pone.0142386			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26554591	gold, Green Submitted, Green Published			2022-12-27	WOS:000364430700095
J	Zhang, ZZ; Lou, YG; Deng, DJ; Rahman, MM; Wu, QS				Zhang, Ze-Zhi; Lou, You-Gen; Deng, Dao-Juan; Rahman, Mohammed Mahabubur; Wu, Qiang-Sheng			Effects of Common Mycorrhizal Network on Plant Carbohydrates and Soil Properties in Trifoliate Orange-White Clover Association	PLOS ONE			English	Article							CARBON; FUNGI; RHIZOSPHERE; GLOMALIN	Common mycorrhizal network (CMN) allows nutrients and signals to pass between two or more plants. In this study, trifoliate orange (Poncirus trifoliata) and white clover (Trifolium repens) were planted in a two-compartmented rootbox, separated by a 37-mu m nylon mesh and then inoculated with an arbuscular mycorrhizal fungus (AMF), Diversispora spurca. Inoculation with D. spurca resulted in formation of a CMN between trifoliate orange and white clover, whilst the best AM colonization occurred in the donor trifoliate orange-receptor white clover association. In the trifoliate orange-white clover association, the mycorrhizal colonization of receptor plant by extraradical hyphae originated from the donor plant significantly increased shoot and root fresh weight and chlorophyll concentration of the receptor plant. Enzymatic activity of soil beta-glucoside hydrolase, protease, acid and neutral phosphatase, water-stable aggregate percentage at 2-4 and 0.5-1 mm size, and mean weight diameter in the rhizosphere of the receptor plant also increased. The hyphae of CMN released more easily-extractable glomalin-related soil protein and total glomalin-related soil protein into the receptor rhizosphere, which represented a significantly positive correlation with aggregate stability. AMF inoculation exhibited diverse changes in leaf and root sucrose concentration in the donor plant, and AM colonization by CMN conferred a significant increase of root glucose in the receptor plant. These results suggested that CMN formed in the trifoliate orange-white clover association, and root AM colonization by CMN promoted plant growth, root glucose accumulation, and rhizospheric soil properties in the receptor plant.	[Zhang, Ze-Zhi; Deng, Dao-Juan; Wu, Qiang-Sheng] Yangtze Univ, Coll Hort & Gardening, Jingzhou, Hubei, Peoples R China; [Zhang, Ze-Zhi; Wu, Qiang-Sheng] Yangtze Univ, Inst Root Biol, Jingzhou, Hubei, Peoples R China; [Lou, You-Gen] Yangtze Univ, Sch Foreign Studies, Jingzhou, Hubei, Peoples R China; [Rahman, Mohammed Mahabubur] Brix N Berries, Leduc, AB, Canada	Yangtze University; Yangtze University; Yangtze University	Wu, QS (corresponding author), Yangtze Univ, Coll Hort & Gardening, Jingzhou, Hubei, Peoples R China.	wuqiangsh@163.com	Wu, Qiang-Sheng/A-1956-2012	Wu, Qiang-Sheng/0000-0002-3405-8409	Institute of Root Biology, Yangtze University [R201401]; Yangtze University Foundation for Young Scholars [cyq201324]; Brix N' Berries	Institute of Root Biology, Yangtze University; Yangtze University Foundation for Young Scholars; Brix N' Berries	Funding: This study was supported by the Open Fund of Institute of Root Biology, Yangtze University (R201401) and the Yangtze University Foundation for Young Scholars (cyq201324). The Brix N' Berries provided support in the form of salaries for authors (MM Rahman), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Asai M, 1992, WEED RES, V37, P152; Babikova Z, 2013, ECOL LETT, V16, P835, DOI 10.1111/ele.12115; Barto EK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027195; Bedini S, 2009, SOIL BIOL BIOCHEM, V41, P1491, DOI 10.1016/j.soilbio.2009.04.005; Cao CJ, 1982, CHIN J SOIL SCI, V13, P39; Graves JD, 1997, PLANT SOIL, V192, P153, DOI 10.1023/A:1004257812555; Gyuricza V, 2010, ENVIRON MICROBIOL, V12, P2180, DOI 10.1111/j.1462-2920.2009.02118.x; Ishii T, 2010, ROOT RES, V19, P5; Johnson D, 2015, NEW PHYTOL, V205, P1448, DOI 10.1111/nph.13115; Kemper W. D., 1986, Methods of soil analysis. Part 1. Physical and mineralogical methods, P425; Lichtenthaler H., 1983, BIOCHEM SOC T, V11, P591, DOI [10.1042/bst0110591, 10.1042/BST0110591, DOI 10.1042/BST0110591]; Meding SM, 2008, SOIL BIOL BIOCHEM, V40, P126, DOI 10.1016/j.soilbio.2007.07.019; Nakano-Hylander A, 2007, SOIL BIOL BIOCHEM, V39, P1450, DOI 10.1016/j.soilbio.2006.12.031; Rillig MC, 2006, NEW PHYTOL, V171, P41, DOI 10.1111/j.1469-8137.2006.01750.x; Sato T, 2015, SOIL SCI PLANT NUTR, V61, P269, DOI 10.1080/00380768.2014.993298; Selosse MA, 2006, TRENDS ECOL EVOL, V21, P621, DOI 10.1016/j.tree.2006.07.003; Siddiky MRK, 2012, SOIL BIOL BIOCHEM, V50, P33, DOI 10.1016/j.soilbio.2012.03.001; Simard SW, 2004, CAN J BOT, V82, P1140, DOI [10.1139/b04-116, 10.1139/B04-116]; Song YY, 2014, SCI REP-UK, V4, DOI 10.1038/srep03915; Stott DE, 2010, SOIL SCI SOC AM J, V74, P107, DOI 10.2136/sssaj2009.0029; Walder F, 2012, PLANT PHYSIOL, V159, P789, DOI 10.1104/pp.112.195727; Wang S, 2014, SCI HORTIC-AMSTERDAM, V170, P137, DOI 10.1016/j.scienta.2014.03.003; Wu QS, 2015, J PLANT GROWTH REGUL, V34, P499, DOI 10.1007/s00344-015-9485-x; Wu QS, 2014, SCI REP-UK, V4, DOI 10.1038/srep05823; Wu QS, 2013, SCI HORTIC-AMSTERDAM, V160, P320, DOI 10.1016/j.scienta.2013.06.015; Zhao DiKun, 2012, Acta Pedologica Sinica, V49, P339; Zhao LP, 1986, CHIN J SOIL SCI, V17, P138; Zhu YG, 2000, AGR ECOSYST ENVIRON, V77, P211, DOI 10.1016/S0167-8809(99)00087-0	28	11	11	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142371	10.1371/journal.pone.0142371	http://dx.doi.org/10.1371/journal.pone.0142371			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556792	Green Submitted, gold, Green Published			2022-12-27	WOS:000364430700093
J	Chen, C; Sun, XL; Duanmu, HZ; Zhu, D; Yu, Y; Cao, L; Liu, AL; Jia, BW; Xiao, JL; Zhu, YM				Chen, Chao; Sun, Xiaoli; Duanmu, Huizi; Zhu, Dan; Yu, Yang; Cao, Lei; Liu, Ailin; Jia, Bowei; Xiao, Jialei; Zhu, Yanming			GsCML27, a Gene Encoding a Calcium-Binding Ef-Hand Protein from Glycine soja, Plays Differential Roles in Plant Responses to Bicarbonate, Salt and Osmotic Stresses	PLOS ONE			English	Article							CALMODULIN-LIKE PROTEIN; ABIOTIC STRESS; ARABIDOPSIS-THALIANA; ABSCISIC-ACID; SIGNAL-TRANSDUCTION; CONFORMATIONAL TRANSITION; SALINITY TOLERANCE; NA+/H+ ANTIPORTER; DROUGHT STRESSES; ALKALI-STRESS	Calcium, as the most widely accepted messenger, plays an important role in plant stress responses through calcium-dependent signaling pathways. The calmodulin-like family genes (CMLs) encode Ca2+ sensors and function in signaling transduction in response to environmental stimuli. However, until now, the function of plant CML proteins, especially soybean CMLs, is largely unknown. Here, we isolated a Glycine soja CML protein GsCML27, with four conserved EF-hands domains, and identified it as a calcium-binding protein through far-UV CD spectroscopy. We further found that expression of GsCML27 was induced by bicarbonate, salt and osmotic stresses. Interestingly, ectopic expression of GsCML27 in Arabidopsis enhanced plant tolerance to bicarbonate stress, but decreased the salt and osmotic tolerance during the seed germination and early growth stages. Furthermore, we found that ectopic expression of GsCML27 decreases salt tolerance through modifying both the cellular ionic (Na+, K+) content and the osmotic stress regulation. GsCML27 ectopic expression also decreased the expression levels of osmotic stress-responsive genes. Moreover, we also showed that GsCML27 localized in the whole cell, including cytoplasm, plasma membrane and nucleus in Arabidopsis protoplasts and onion epidermal cells, and displayed high expression in roots and embryos. Together, these data present evidence that GsCML27 as a Ca2+-binding EF-hand protein plays a role in plant responses to bicarbonate, salt and osmotic stresses.	[Chen, Chao; Duanmu, Huizi; Yu, Yang; Cao, Lei; Liu, Ailin; Jia, Bowei; Xiao, Jialei; Zhu, Yanming] Northeast Agr Univ, Key Lab Agr Biol Funct Genes, Harbin, Peoples R China; [Sun, Xiaoli] Heilongjiang Bayi Agr Univ, Agron Coll, Daqing, Peoples R China; [Zhu, Dan] Qingdao Agr Univ, Coll Life Sci, Qingdao, Peoples R China	Northeast Agricultural University - China; Heilongjiang Bayi Agricultural University; Qingdao Agricultural University	Zhu, YM (corresponding author), Northeast Agr Univ, Key Lab Agr Biol Funct Genes, Harbin, Peoples R China.	ymzhu2001@neau.edu.cn		, chenchao/0000-0002-1865-7751; Sun, Xiaoli/0000-0003-1134-3976	National Natural Science Foundation of China [31171578]; Heilongjiang Provincial Higher School Science and Technology Innovation Team Building Program [2011TD005]; National basic scientific talent training fund projects [J1210069]; Ministry of Agriculture transgenic major projects [2011ZX08004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Heilongjiang Provincial Higher School Science and Technology Innovation Team Building Program; National basic scientific talent training fund projects; Ministry of Agriculture transgenic major projects	Funding: This work was supported by the National Natural Science Foundation of China (31171578), Heilongjiang Provincial Higher School Science and Technology Innovation Team Building Program (2011TD005), National basic scientific talent training fund projects (J1210069), and Ministry of Agriculture transgenic major projects (2011ZX08004).	Alhendawi RA, 1997, J PLANT NUTR, V20, P1731, DOI 10.1080/01904169709365371; Chen S, 2010, PLANT BIOLOGY, V12, P317, DOI 10.1111/j.1438-8677.2009.00301.x; Cheong YH, 2003, PLANT CELL, V15, P1833, DOI 10.1105/tpc.012393; Chinnusamy V, 2004, J EXP BOT, V55, P225, DOI 10.1093/jxb/erh005; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Correia M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116737; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Day IS, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-10-research0056; DeFalco TA, 2010, BIOCHEM J, V425, P27, DOI 10.1042/BJ20091147; Delk NA, 2005, PLANT PHYSIOL, V139, P240, DOI 10.1104/pp.105.062612; Dobney S, 2009, J BIOL CHEM, V284, P31647, DOI 10.1074/jbc.M109.056770; Gao DJ, 2004, PLANT PHYSIOL, V134, P898, DOI 10.1104/pp.103.032508; Ge Y, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-153; Ge Ying, 2009, Pratacultural Science, V26, P47; Gong B, 2014, BIOCHEM BIOPH RES CO, V446, P417, DOI 10.1016/j.bbrc.2014.03.005; Gong DM, 2004, PLANT PHYSIOL, V134, P919, DOI 10.1104/pp.103.037440; Grabarek Z, 2006, J MOL BIOL, V359, P509, DOI 10.1016/j.jmb.2006.03.066; Harshavardhan VT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110065; Hashimoto K, 2011, BIOCHIMIE, V93, P2054, DOI 10.1016/j.biochi.2011.05.019; HERZBERG O, 1986, J BIOL CHEM, V261, P2638; Huang GT, 2012, MOL BIOL REP, V39, P969, DOI 10.1007/s11033-011-0823-1; Huis R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-71; Ishitani M, 2000, PLANT CELL, V12, P1667, DOI 10.1105/tpc.12.9.1667; Jiang YQ, 2009, PLANT MOL BIOL, V69, P91, DOI 10.1007/s11103-008-9408-3; Jiang ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076130; Jin H, 2008, PLANT SCI, V175, P784, DOI 10.1016/j.plantsci.2008.07.016; Jung C, 2008, PLANT PHYSIOL, V146, P623, DOI 10.1104/pp.107.110981; Kim KN, 2000, PLANT PHYSIOL, V124, P1844, DOI 10.1104/pp.124.4.1844; Knight H, 2001, TRENDS PLANT SCI, V6, P262, DOI 10.1016/S1360-1385(01)01946-X; Kolukisaoglu U, 2004, PLANT PHYSIOL, V134, P43, DOI 10.1104/pp.103.033068; KRETSINGER RH, 1973, J BIOL CHEM, V248, P3313; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Liu JP, 2000, P NATL ACAD SCI USA, V97, P3730, DOI 10.1073/pnas.060034197; Liu L, 2011, J INTEGR PLANT BIOL, V53, P731, DOI 10.1111/j.1744-7909.2011.01066.x; Liu X, 2015, PROTOPLASMA; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Magnan F, 2008, PLANT J, V56, P575, DOI 10.1111/j.1365-313X.2008.03622.x; Mahajan S, 2005, ARCH BIOCHEM BIOPHYS, V444, P139, DOI 10.1016/j.abb.2005.10.018; McCormack E, 2005, TRENDS PLANT SCI, V10, P383, DOI 10.1016/j.tplants.2005.07.001; McCormack E, 2003, NEW PHYTOL, V159, P585, DOI 10.1046/j.1469-8137.2003.00845.x; Niki I, 1996, J BIOCHEM, V120, P685; Nour-Eldin HH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl635; Park HC, 2010, PLANT CELL REP, V29, P1297, DOI 10.1007/s00299-010-0916-7; Perochon A, 2011, BIOCHIMIE, V93, P2048, DOI 10.1016/j.biochi.2011.07.012; Perruc E, 2004, PLANT J, V38, P410, DOI 10.1111/j.1365-313X.2004.02062.x; Reddy ASN, 2001, PLANT SCI, V160, P381, DOI 10.1016/S0168-9452(00)00386-1; Scarpeci TE, 2013, PLANT MOL BIOL, V83, P265, DOI 10.1007/s11103-013-0090-8; Shi DC, 2005, ENVIRON EXP BOT, V54, P8, DOI 10.1016/j.envexpbot.2004.05.003; Shi HZ, 2000, P NATL ACAD SCI USA, V97, P6896, DOI 10.1073/pnas.120170197; Singh R., 2015, PLOS ONE, V10; Soyka S, 1999, FEBS LETT, V458, P219, DOI 10.1016/S0014-5793(99)01125-4; Sun XL, 2013, PLANT CELL TISS ORG, V113, P199, DOI 10.1007/s11240-012-0260-4; Takahashi S, 2000, PLANT CELL PHYSIOL, V41, P898, DOI 10.1093/pcp/pcd010; Takahashi S, 2001, PLANT CELL PHYSIOL, V42, P214, DOI 10.1093/pcp/pce028; TANG CX, 1993, PLANT SOIL, V152, P269, DOI 10.1007/BF00029097; Tuteja N, 2007, METHOD ENZYMOL, V428, P419, DOI 10.1016/S0076-6879(07)28024-3; Vadassery J, 2012, PLANT PHYSIOL, V159, P1159, DOI 10.1104/pp.112.198150; WANG ZY, 1992, P NATL ACAD SCI USA, V89, P11814, DOI 10.1073/pnas.89.24.11814; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Xiong LM, 2001, PHYSIOL PLANTARUM, V112, P152, DOI 10.1034/j.1399-3054.2001.1120202.x; Yamaguchi T, 2005, P NATL ACAD SCI USA, V102, P16107, DOI 10.1073/pnas.0504437102; Yan A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085208; Yang CW, 2009, PHOTOSYNTHETICA, V47, P79, DOI 10.1007/s11099-009-0013-8; Yang Chuan-Ping, 2005, Sheng Wu Gong Cheng Xue Bao, V21, P220; Yang CW, 2008, PLANT GROWTH REGUL, V56, P179, DOI 10.1007/s10725-008-9299-y; Yang CW, 2007, PLANT SOIL, V294, P263, DOI 10.1007/s11104-007-9251-3; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095642; Zhao Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098098; Zhu D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111984; Zhu D, 2012, BIOCHEM BIOPH RES CO, V426, P273, DOI 10.1016/j.bbrc.2012.08.086; Zhu D, 2011, PLANT MOL BIOL, V77, P285, DOI 10.1007/s11103-011-9810-0; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zhu JK, 1997, CRIT REV PLANT SCI, V16, P253, DOI 10.1080/713608147; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	75	28	33	5	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2015	10	11							e0141888	10.1371/journal.pone.0141888	http://dx.doi.org/10.1371/journal.pone.0141888			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7AC	26550992	Green Submitted, Green Published, gold			2022-12-27	WOS:000364422800012
J	Wang, M; Li, CC; Lin, CY				Wang, Min; Li, Chuchu; Lin, Candise Y.			The Contributions of Segmental and Suprasegmental Information in Reading Chinese Characters Aloud	PLOS ONE			English	Article							VISUAL WORD RECOGNITION; TIME-COURSE; SEMANTIC ACTIVATION; LANGUAGE PRODUCTION; MANDARIN CHINESE; LEXICAL ACCESS; EYE-MOVEMENTS; DUAL-ROUTE; TONE; IDENTIFICATION	The Chinese writing system provides an excellent case for testing the contribution of segmental and suprasegmental information in reading words aloud within the same language. In logographic Chinese characters, neither segmental nor tonal information is explicitly represented, whereas in Pinyin, an alphabetic transcription of the character, both are explicitly represented. Two primed naming experiments were conducted in which the targets were always written characters. When logographic characters served as the primes (Experiment 1), syllable segmental and tonal information appeared to be represented and encoded as an integral unit which in turn facilitated target character naming. When Pinyin served as the primes (Experiment 2), the explicit phonetic representation facilitated encoding of both segmental and suprasegmental information, but with later access to suprasegmental information. In addition, Chinese speakers were faster to name characters than Pinyin in a simple naming task (Experiment 3), suggesting that Pinyin may be read via a phonological assembly route, whereas characters may be read via a lexical route. Taken together, our findings point to the need to consider the contributions of both segmental and suprasegmental information and the time course in the well-established models for reading aloud, as well as the cognitive mechanisms underlying the reading aloud of logographic characters versus alphabetic Pinyin script.	[Wang, Min; Li, Chuchu] Univ Maryland, Dept Human Dev & Quantitat Methodol, College Pk, MD 20742 USA; [Lin, Candise Y.] Univ So Calif, Dept Psychol, Los Angeles, CA 90089 USA; [Lin, Candise Y.] Univ So Calif, Program Hearing & Commun Neurosci, Los Angeles, CA USA	University System of Maryland; University of Maryland College Park; University of Southern California; University of Southern California	Wang, M (corresponding author), Univ Maryland, Dept Human Dev & Quantitat Methodol, College Pk, MD 20742 USA.	minwang@umd.edu	Li, Chuchu/AAZ-8662-2021	Li, Chuchu/0000-0001-6614-8989	University of Maryland; UMD Libraries Open Access Publishing Fund; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC009975] Funding Source: NIH RePORTER	University of Maryland; UMD Libraries Open Access Publishing Fund; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Funding: This study was supported by an International Travel Award from the University of Maryland to MW and a University of Maryland Graduate Fellowship to CCL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding for Open Access was provided by the UMD Libraries Open Access Publishing Fund.	Abramowitz LK, 2012, CURR OPIN GENET DEV, V22, P72, DOI 10.1016/j.gde.2011.12.001; Ashby J, 2005, COGNITION, V96, pB89, DOI 10.1016/j.cognition.2004.12.006; Bates D., 2015, LME4 LINEAR MIXED EF; Bauer RS., 1997, GRUYTER, DOI [10.1515/9783110823707, DOI 10.1515/9783110823707]; Bowey JA, 2005, J EXP CHILD PSYCHOL, V92, P203, DOI 10.1016/j.jecp.2005.06.005; Caramazza A, 1997, COGNITIVE NEUROPSYCH, V14, P177, DOI 10.1080/026432997381664; Chen HC, 2001, PSYCHON B REV, V8, P511, DOI 10.3758/BF03196186; Chen JY, 2002, J MEM LANG, V46, P751, DOI 10.1006/jmla.2001.2825; Chen TM, 2013, PSYCHON B REV, V20, P154, DOI 10.3758/s13423-012-0326-7; Chen YP, 2002, J COGNITIVE NEUROSCI, V14, P1088, DOI 10.1162/089892902320474535; Coltheart M, 2001, PSYCHOL REV, V108, P204, DOI 10.1037//0033-295X.108.1.204; COLTHEART M, 1993, PSYCHOL REV, V100, P589, DOI 10.1037/0033-295X.100.4.589; Coltheart M, 2005, BL HBK DEV PSYCHOL, P6, DOI 10.1002/9780470757642.ch1; Crystal D., 2011, DICT LINGUISTICS PHO; de Jong PF, 2009, J EXP CHILD PSYCHOL, V104, P267, DOI 10.1016/j.jecp.2009.06.002; DELL GS, 1986, PSYCHOL REV, V93, P283, DOI 10.1037/0033-295X.93.3.283; Feldman LB, 1999, J MEM LANG, V40, P559, DOI 10.1006/jmla.1998.2629; Fu D, 2014, NAT CHEM, V6, P615, DOI [10.1038/nchem.1961, 10.1038/NCHEM.1961]; GRAINGER J, 1994, J MEM LANG, V33, P218, DOI 10.1006/jmla.1994.1011; Hanley JR, 2005, SCI READING, P296; Harm MW, 2001, COGNITIVE NEUROPSYCH, V18, P71, DOI 10.1080/02643290125986; Lee CY, 2007, LANG SPEECH, V50, P101, DOI 10.1177/00238309070500010501; Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; Li C., 1989, MANDARIN CHINESE FUN; Li CC, 2013, PSYCHON B REV, V20, P773, DOI 10.3758/s13423-013-0395-2; Lin CY, 2013, J CHILD LANG, V40, P885, DOI 10.1017/S0305000912000281; Lin D, 2010, PSYCHOL SCI, V21, P1117, DOI 10.1177/0956797610375447; McBride-Chang C, 2008, SCI STUD READ, V12, P171, DOI 10.1080/10888430801917290; MEYER AS, 1991, J MEM LANG, V30, P69, DOI 10.1016/0749-596X(91)90011-8; MEYER AS, 1990, J MEM LANG, V29, P524, DOI 10.1016/0749-596X(90)90050-A; Nixon J, 2014, LANG COGN NEUROSCI, V30, P1; O'Seaghdha PG, 2015, JPN PSYCHOL RES, V57, P4, DOI 10.1111/jpr.12074; O'Seaghdha PG, 2010, COGNITION, V115, P282, DOI 10.1016/j.cognition.2010.01.001; Perfetti CA, 2005, PSYCHOL REV, V112, P43, DOI 10.1037/0033-295X.112.1.43; Perfetti CA, 1998, J EXP PSYCHOL LEARN, V24, P101, DOI 10.1037/0278-7393.24.1.101; PERFETTI CA, 1991, J EXP PSYCHOL LEARN, V17, P633, DOI 10.1037/0278-7393.17.4.633; PERFETTI CA, 1988, J MEM LANG, V27, P59, DOI 10.1016/0749-596X(88)90048-4; Pollatsek A, 2000, J EXP PSYCHOL HUMAN, V26, P607, DOI 10.1037/0096-1523.26.2.607; Protopapas A, 2007, BEHAV RES METHODS, V39, P859, DOI 10.3758/BF03192979; Roelofs A, 2015, JPN PSYCHOL RES, V57, P22, DOI 10.1111/jpr.12050; Schiller NO, 2007, PSYCHON B REV, V14, P460, DOI 10.3758/BF03194089; Scliffler NO, 2006, BRAIN RES, V1112, P201, DOI 10.1016/j.brainres.2006.07.027; SEIDENBERG MS, 1985, COGNITION, V19, P1, DOI 10.1016/0010-0277(85)90029-0; Shu H, 2003, CHILD DEV, V74, P27, DOI 10.1111/1467-8624.00519; Shu H, 2008, DEVELOPMENTAL SCI, V11, P171, DOI 10.1111/j.1467-7687.2007.00654.x; Spinks JA, 2000, COGNITION, V76, pB1, DOI 10.1016/S0010-0277(00)00072-X; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Tong YX, 2008, LANG COGNITIVE PROC, V23, P689, DOI 10.1080/01690960701728261; Verdonschot RG, 2015, JPN PSYCHOL RES, V57, P61, DOI 10.1111/jpr.12064; Wang M, 2011, CONTEMP EDUC PSYCHOL, V36, P142, DOI 10.1016/j.cedpsych.2011.02.001; Wong AWK, 2008, J EXP PSYCHOL LEARN, V34, P1172, DOI 10.1037/a0013000; Ye Y, 1999, LANG COGNITIVE PROC, V14, P609, DOI 10.1080/016909699386202; You WP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046595; Zhang Q, 2009, NEUROSCIENCE, V163, P252, DOI 10.1016/j.neuroscience.2009.06.015; Zhou XL, 2009, LANG COGNITIVE PROC, V24, P1009, DOI 10.1080/01690960802174514; Zhou XL, 1999, J MEM LANG, V41, P579, DOI 10.1006/jmla.1999.2663; Zovo K, 2010, ANAL CHEM, V82, P8558, DOI 10.1021/ac101583q	57	5	6	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2015	10	11							e0142060	10.1371/journal.pone.0142060	http://dx.doi.org/10.1371/journal.pone.0142060			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7AC	26551251	Green Submitted, Green Published, gold			2022-12-27	WOS:000364422800015
J	Dolan, GF; Akoopie, A; Muller, UF				Dolan, Gregory F.; Akoopie, Arvin; Mueller, Ulrich F.			A Faster Triphosphorylation Ribozyme	PLoS One			English	Article							RNA WORLD; CHEMISTRY; EVOLUTION; ACCURATE; REAGENT; LIGANDS; ORIGIN; OCEAN	In support of the RNA world hypothesis, previous studies identified trimetaphosphate (Tmp) as a plausible energy source for RNA world organisms. In one of these studies, catalytic RNAs (ribozymes) that catalyze the triphosphorylation of RNA 5'-hydroxyl groups using Tmp were obtained by in vitro selection. One ribozyme (TPR1) was analyzed in more detail. TPR1 catalyzes the triphosphorylation reaction to a rate of 0.013 min(-1) under selection conditions (50 mM Tmp, 100 mM MgCl2, 22 degrees C). To identify a triphosphorylation ribozyme that catalyzes faster triphosphorylation, and possibly learn about its secondary structure TPR1 was subjected to a doped selection. The resulting ribozyme, TPR1e, contains seven mutations relative to TPR1, displays a previously unidentified duplex that constrains the ribozyme's structure, and reacts at a 24-fold faster rate than the parent ribozyme. Under optimal conditions (150 mM Tmp, 650 mM MgCl2, 40 degrees C), the triphosphorylation rate of TRP1e reaches 6.8 min(-1).	[Dolan, Gregory F.; Akoopie, Arvin; Mueller, Ulrich F.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Muller, UF (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	ufmuller@ucsd.edu			National Aeronautics and Space Administration [NNX13AJ09G]	National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA))	This work was supported by the National Aeronautics and Space Administration under Grant No. NNX13AJ09G issued through the Science Mission Directorate (ROSES-2011), in Astrobiology/Exobiology to UFM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTEL DP, 1993, SCIENCE, V261, P1411, DOI 10.1126/science.7690155; CRICK FHC, 1968, J MOL BIOL, V38, P367, DOI 10.1016/0022-2836(68)90392-6; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; ETAIX E, 1978, J CARB-NUCLEOS-NUCL, V5, P91; Hay WW, 2006, PALAEOGEOGR PALAEOCL, V240, P3, DOI 10.1016/j.palaeo.2006.03.044; Johnston WK, 2001, SCIENCE, V292, P1319, DOI 10.1126/science.1060786; KRUGER K, 1982, CELL, V31, P147, DOI 10.1016/0092-8674(82)90414-7; Martin Lyssa L., 2015, Life-Basel, V5, P247, DOI 10.3390/life5010247; Moretti JE, 2014, NUCLEIC ACIDS RES, V42, P4767, DOI 10.1093/nar/gkt1405; Mortimer SA, 2007, J AM CHEM SOC, V129, P4144, DOI 10.1021/ja0704028; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; Orgel LE, 2004, CRIT REV BIOCHEM MOL, V39, P99, DOI 10.1080/10409230490460765; ORGEL LE, 1968, J MOL BIOL, V38, P381, DOI 10.1016/0022-2836(68)90393-8; Pasek MA, 2008, ANGEW CHEM INT EDIT, V47, P7918, DOI 10.1002/anie.200802145; Pasek MA, 2013, P NATL ACAD SCI USA, V110, P10089, DOI 10.1073/pnas.1303904110; SPRENGEL G, 1981, FEBS LETT, V132, P207, DOI 10.1016/0014-5793(81)81161-1; STEWART PB, 1970, J CHEM ENG DATA, V15, P67, DOI 10.1021/je60044a001; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Turner R, 2013, RNA, V19, P1857, DOI 10.1261/rna.042374.113; WEINER MP, 1994, PCR METH APPL, V4, pS131; Woese C.R., 1967, GENETIC CODE MOL BAS	21	17	17	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142559	10.1371/journal.pone.0142559	http://dx.doi.org/10.1371/journal.pone.0142559			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26545116	Green Published, gold, Green Submitted			2022-12-27	WOS:000364398700155
J	Kelbert, P; Droege, G; Barker, K; Braak, K; Cawsey, EM; Coddington, J; Robertson, T; Whitacre, J; Guntsch, A				Kelbert, Patricia; Droege, Gabriele; Barker, Katharine; Braak, Kyle; Cawsey, E. Margaret; Coddington, Jonathan; Robertson, Tim; Whitacre, Jamie; Guentsch, Anton			B-HIT - A Tool for Harvesting and Indexing Biodiversity Data	PLOS ONE			English	Article								With the rapidly growing number of data publishers, the process of harvesting and indexing information to offer advanced search and discovery becomes a critical bottleneck in globally distributed primary biodiversity data infrastructures. The Global Biodiversity Information Facility (GBIF) implemented a Harvesting and Indexing Toolkit (HIT), which largely automates data harvesting activities for hundreds of collection and observational data providers. The team of the Botanic Garden and Botanical Museum Berlin-Dahlem has extended this well-established system with a range of additional functions, including improved processing of multiple taxon identifications, the ability to represent associations between specimen and observation units, new data quality control and new reporting capabilities. The open source software B-HIT can be freely installed and used for setting up thematic networks serving the demands of particular user groups.	[Kelbert, Patricia; Droege, Gabriele; Guentsch, Anton] Free Univ Berlin, Bot Garden, Berlin, Germany; [Kelbert, Patricia; Droege, Gabriele; Guentsch, Anton] Free Univ Berlin, Bot Museum Berlin Dahlem, Berlin, Germany; [Barker, Katharine; Coddington, Jonathan; Whitacre, Jamie] Smithsonian Inst, Natl Museum Nat Hist, Washington, DC 20560 USA; [Braak, Kyle; Robertson, Tim] Global Biodivers Informat Facil, Copenhagen, Denmark; [Cawsey, E. Margaret] CSIRO Natl Res Collect Australia, Australian Natl Wildlife Collect, Canberra, ACT, Australia	Free University of Berlin; Free University of Berlin; Smithsonian Institution; Smithsonian National Museum of Natural History; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Kelbert, P (corresponding author), Free Univ Berlin, Bot Garden, Berlin, Germany.	p.kelbert@bgbm.org	Cawsey, Edith M/C-9594-2011	Guntsch, Anton/0000-0002-4325-4030; Braak, Kyle/0000-0002-3696-3496; Barker, Katharine/0000-0002-4788-0223; Coddington, Jonathan A./0000-0001-6004-7730	German Research Foundation (DFG) [BE 2283/8-1]; DFG project GGBN [GU 1109/5-1]; National Science Foundation [NSF DEB 0956426]	German Research Foundation (DFG)(German Research Foundation (DFG)); DFG project GGBN(German Research Foundation (DFG)); National Science Foundation(National Science Foundation (NSF))	The design and implementation of the B-HIT was funded by the German Research Foundation (DFG, http://www.dfg.de) project BiNHum (BE 2283/8-1). The analysis of data for GGBN was funded by the DFG project GGBN (GU 1109/5-1) as well as the National Science Foundation (http://www.nsf.gov, NSF DEB 0956426). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berendsohn WG, 2011, ZOOKEYS, P71, DOI 10.3897/zookeys.150.2166; Berendsohn WG, 2012, ZOOKEYS, P47, DOI 10.3897/zookeys.209.3179; Buck M., 2011, REV EUR COMP INT ENV, V20, P47, DOI [10.1111/j.1467-9388.2011.00703.x, DOI 10.1111/J.1467-9388.2011.00703.X]; Canhos VP, 2004, BIODIVERSITY INFORM, V1; Droege G, 2014, NUCLEIC ACIDS RES, V42, pD607, DOI 10.1093/nar/gkt928; Guentsch Anton, 2007, Ferrantia, V51, P103; Holetschek J, 2012, PLANT BIOSYST, V146, P771, DOI 10.1080/11263504.2012.740085; Holetschek J, 2009, LECT NOTES INFORM, V26, P552; Mathew Cherian, 2014, Biodivers Data J, pe4221, DOI 10.3897/BDJ.2.e4221; Miller JS, 2014, TAXON, V63, P959, DOI 10.12705/634.35; Robertson T., 2009, DARWIN CORE TEXT GUI; Robertson T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102623; Scoble Malcolm J., 2003, ENHSIN EUROPEAN NATU; Vieglas D., 1999, INTEGRATING DISPARAT; Wieczorek J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029715	15	4	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142240	10.1371/journal.pone.0142240	http://dx.doi.org/10.1371/journal.pone.0142240			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544980	Green Published, gold, Green Submitted			2022-12-27	WOS:000364398700098
J	Min, HK; Kim, SM; Baek, SY; Woo, JW; Park, JS; Cho, ML; Lee, J; Kwok, SK; Kim, SW; Park, SH				Min, Hong Ki; Kim, Sung-Min; Baek, Seung-Ye; Woo, Jung-Won; Park, Jin-Sil; Cho, Mi-La; Lee, Jennifer; Kwok, Seung-Ki; Kim, Sae Woong; Park, Sung-Hwan			Anthocyanin Extracted from Black Soybean Seed Coats Prevents Autoimmune Arthritis by Suppressing the Development of Th17 Cells and Synthesis of Proinflammatory Cytokines by Such Cells, via Inhibition of NF-kappa B	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; OXIDATIVE STRESS; DOUBLE-BLIND; METHOTREXATE; INFLAMMATION; MULTICENTER; COMBINATION; ACTIVATION; MECHANISM; DISTINCT	Introduction Oxidative stress plays a role in the pathogenesis of rheumatoid arthritis (RA). Anthocyanin is a plant antioxidant. We investigated the therapeutic effects of anthocyanin extracted from black soybean seed coats (AEBS) in a murine model of collagen-induced arthritis (CIA) and human peripheral blood mononuclear cells (PBMCs) and explored possible mechanisms by which AEBS might exert anti-arthritic effects. Material and Methods CIA was induced in DBA/1J mice. Cytokine levels were measured via enzyme-linked immuno-sorbent assays. Joints were assessed in terms of arthritis incidence, clinical arthritis scores, and histological features. The extent of oxidative stress in affected joints was determined by measuring the levels of nitrotyrosine and inducible nitric oxide synthase. NF-kappa B activity was assayed by measuring the ratio of phosphorylated I kappa B to total I kappa B via Western blotting. Th17 cells were stained with antibodies against CD4, IL-17, and STAT3. Osteoclast formation was assessed via TRAP staining and measurement of osteoclast-specific mRNA levels. Results In the CIA model, AEBS decreased the incidence of arthritis, histological inflammation, cartilage scores, and oxidative stress. AEBS reduced the levels of proinflammatory cytokines in affected joints of CIA mice and suppressed NF-kappa B signaling. AEBS decreased Th17 cell numbers in spleen of CIA mice. Additionally, AEBS repressed differentiation of Th17 cells and expression of Th17-associated genes in vitro, in both splenocytes of naive DBA/1J mice and human PBMCs. In vitro, the numbers of both human and mouse tartrate-resistant acid phosphatase(+) (TRAP) multinucleated cells fell, in a dose-dependent manner, upon addition of AEBS. Conclusions The anti-arthritic effects of AEBS were associated with decreases in Th17 cell numbers, and the levels of proinflammatory cytokines synthesized by such cells, mediated via suppression of NF-kappa B signaling. Additionally, AEBS suppressed osteoclastogenesis and reduced oxidative stress levels.	[Min, Hong Ki; Kim, Sung-Min; Baek, Seung-Ye; Park, Jin-Sil; Cho, Mi-La; Lee, Jennifer; Kwok, Seung-Ki; Park, Sung-Hwan] Catholic Univ Korea, Catholic Res Inst Med Sci, Rheumatism Res Ctr, Seoul, South Korea; [Min, Hong Ki; Lee, Jennifer; Kwok, Seung-Ki; Park, Sung-Hwan] Catholic Univ Korea, Sch Med, Dept Internal Med, Div Rheumatol, Seoul, South Korea; [Woo, Jung-Won] Genexine Inc, Off Clin Dev, Songnam, Gyeonggi Do, South Korea; [Kim, Sae Woong] Catholic Univ Korea, Coll Med, Catholic Integrat Med Res Inst, Seoul, South Korea; [Kim, Sae Woong] Catholic Univ Korea, Coll Med, Dept Urol, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Catholic University of Korea	Park, SH (corresponding author), Catholic Univ Korea, Catholic Res Inst Med Sci, Rheumatism Res Ctr, Seoul, South Korea.	rapark@catholic.ac.kr	Min, Hong Ki/AHE-4068-2022	Min, Hong Ki/0000-0003-1147-1046	Ministry of Health & Welfare, Republic of Korea (Korean Health Technology RD Project) [HI13C0016]; Ministry of Education, Science and Technology, Republic of Korea (Basic Science Research Program through National Research Foundation of Korea [NRF]) [NRF-2013R1A2A2A01007720]; Genexine Inc.	Ministry of Health & Welfare, Republic of Korea (Korean Health Technology RD Project); Ministry of Education, Science and Technology, Republic of Korea (Basic Science Research Program through National Research Foundation of Korea [NRF]); Genexine Inc.	This study was supported by the Ministry of Health & Welfare, Republic of Korea (Korean Health Technology R&D Project grant HI13C0016), and by the Ministry of Education, Science and Technology, Republic of Korea (Basic Science Research Program through the National Research Foundation of Korea [NRF], NRF-2013R1A2A2A01007720). Genexine Inc. provided support in the form of salaries for author JWW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Breedveld FC, 2006, ARTHRITIS RHEUM-US, V54, P26, DOI 10.1002/art.21519; Chandel NS, 2000, J IMMUNOL, V165, P1013, DOI 10.4049/jimmunol.165.2.1013; Choung MG, 2001, J AGR FOOD CHEM, V49, P5848, DOI 10.1021/jf010550w; Cohen SB, 2006, ARTHRITIS RHEUM-US, V54, P2793, DOI 10.1002/art.22025; Decendit A, 2013, BIOCHEM PHARMACOL, V86, P1461, DOI 10.1016/j.bcp.2013.06.010; Finckh A, 2006, ARTHRIT RHEUM-ARTHR, V55, P864, DOI 10.1002/art.22353; Genovese MC, 2005, NEW ENGL J MED, V353, P1114, DOI 10.1056/NEJMoa050524; Gravallese EM, 2002, ANN RHEUM DIS, V61, P84, DOI 10.1136/ard.61.suppl_2.ii84; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hayes MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106955; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jacobs MD, 1998, CELL, V95, P749, DOI 10.1016/S0092-8674(00)81698-0; Klareskog L, 2004, LANCET, V363, P675, DOI 10.1016/S0140-6736(04)15640-7; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Noack M, 2014, AUTOIMMUN REV, V13, P668, DOI 10.1016/j.autrev.2013.12.004; O'Gradaigh D, 2004, ANN RHEUM DIS, V63, P354, DOI 10.1136/ard.2003.008458; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Peck A, 2009, CLIN IMMUNOL, V132, P295, DOI 10.1016/j.clim.2009.03.522; Ruan QG, 2012, ADV EXP MED BIOL, V946, P207, DOI 10.1007/978-1-4614-0106-3_12; Singh S, 2010, FREE RADICAL RES, V44, P1267, DOI 10.3109/10715762.2010.507670; Sohn DW, 2014, UROLOGY, DOI [10.1016/j.urology.2014.06.026, DOI 10.1016/J.UR0L0GY.2014.06.026]; SPECTOR TD, 1990, RHEUM DIS CLIN N AM, V16, P513; Sun SC, 2013, TRENDS IMMUNOL, V34, P282, DOI 10.1016/j.it.2013.01.004; Taverniti V, 2014, J AGR FOOD CHEM, V62, P8346, DOI 10.1021/jf502180j; van den Berg WB, 2009, NAT REV RHEUMATOL, V5, P549, DOI 10.1038/nrrheum.2009.179; Vasanthi P, 2009, INT J RHEUM DIS, V12, P29, DOI 10.1111/j.1756-185X.2009.01375.x; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; WINYARD PG, 1987, LANCET, V1, P69; Wruck CJ, 2011, ANN RHEUM DIS, V70, P844, DOI 10.1136/ard.2010.132720; Yoon BI, 2018, CHIN J INTEGR MED, V24, P621, DOI 10.1007/s11655-013-1547-y	35	35	37	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0138201	10.1371/journal.pone.0138201	http://dx.doi.org/10.1371/journal.pone.0138201			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544846	Green Submitted, gold, Green Published			2022-12-27	WOS:000364398700001
J	Pan, CW; Liu, H; Sun, HP; Xu, Y				Pan, Chen-Wei; Liu, Hu; Sun, Hong-Peng; Xu, Yong			Increased Difficulties in Managing Stairs in Visually Impaired Older Adults: A Community-Based Survey	PLOS ONE			English	Article							EYE DISEASES; INDIAN POPULATION; VISION IMPAIRMENT; BLINDNESS; PREVALENCE; CATARACT; FALLS; EPIDEMIOLOGY; FRACTURES; PEOPLE	Purpose Managing stairs is a challenging aspect of daily activities of living for older people. We assessed whether older adults with visual impairment (VI) have greater difficulties of managing stairs in daily lives. Methods The study was designed as a community-based cross-sectional study based on a Chinese cohort aged 60 years and older in rural China. Visual acuity (VA) was measured in both eyes using a retro-illuminated Snellen chart with tumbling-E optotypes. VI (including blindness) was defined as presenting VA of worse than 20/60 in either eye. Having any difficulties in managing stairs was self-reported based on a question drawn from the Barthel Index. Information on participants' socioeconomic status, lifestyle-related factors, diseases histories and medication intake was collected using a questionnaire. Results The Barthel Index, Activities of Daily Living questionnaire was completed by 4597 (99.7%) participants including 2218 men and 2379 women. The age of the participants ranged from 60 to 93 years with a mean of 67.6 +/- 6.3 years. In age and gender adjusted models, adults with VI had a higher likelihood of having difficulties in managing stairs (odds ratio [OR] = 2.7; 95% confidence interval [CI] 2.0, 3.7) compared with those without. The association of VI with the likelihood of having difficulties in managing stairs was stronger in older adults who lived alone (OR = 3.2; 95% CI 1.8, 4.5) compared with those who lived with other family members (OR = 2.0; 95% CI 1.3, 4.3). Compared with hypertension, diabetes, obesity and cognitive dysfunction, VI had the greatest impact on people's abilities of managing stairs. VI was associated with an increased likelihood of having difficulties in managing stairs, especially in those who lived alone. However, whether the finding could be extrapolated to other populations warrants further studies as different environmental exposures such as illumination and types of stairs may alter the association observed in this study. Conclusion VI was associated with an increased likelihood of having difficulties in managing stairs, especially in those who lived alone. However, whether the finding could be extrapolated to other populations warrants further studies as different environmental exposures such as illumination and types of stairs may alter the association observed in this study.	[Pan, Chen-Wei; Sun, Hong-Peng; Xu, Yong] Soochow Univ, Coll Med, Sch Publ Hlth, Jiangsu Key Lab Prevent & Translat Med Geriatr Di, Suzhou, Peoples R China; [Liu, Hu] Nanjing Med Univ, Affiliated Hosp 1, Dept Ophthalmol, Nanjing, Jiangsu, Peoples R China	Soochow University - China; Nanjing Medical University	Xu, Y (corresponding author), Soochow Univ, Coll Med, Sch Publ Hlth, Jiangsu Key Lab Prevent & Translat Med Geriatr Di, Suzhou, Peoples R China.	childhealth@suda.edu.cn	Pan, Chen-Wei/L-7174-2019	Pan, Chen-Wei/0000-0003-3362-4613; Liu, Hu/0000-0002-3952-4165				Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Bourne R, 2012, ARCH OPHTHALMOL-CHIC, V130, P645, DOI 10.1001/archophthalmol.2012.1032; Brundle C, 2015, HEALTH EXPECT, V18, P2021, DOI 10.1111/hex.12355; Cheng JW, 2013, OPHTHALMIC RES, V49, P1, DOI 10.1159/000327144; Collin C, 1988, Int Disabil Stud, V10, P61; Cugati S, 2007, ARCH OPHTHALMOL-CHIC, V125, P917, DOI 10.1001/archopht.125.7.917; Duerksen R, 2003, OPHTHAL EPIDEMIOL, V10, P349, DOI 10.1076/opep.10.5.349.17326; Dunzhu S, 2003, BRIT J OPHTHALMOL, V87, P1443, DOI 10.1136/bjo.87.12.1443; Frick KD, 2003, AM J OPHTHALMOL, V135, P471, DOI 10.1016/S0002-9394(02)02110-4; Hairi NN, 2013, PREV MED, V56, P8, DOI 10.1016/j.ypmed.2012.10.016; Hong T, 2014, INVEST OPHTH VIS SCI, V55, P7589, DOI 10.1167/iovs.14-14262; Hyman L, 2001, OPHTHALMOLOGY, V108, P1751, DOI 10.1016/S0161-6420(01)00590-5; Kramer H, 2004, AM J HYPERTENS, V17, P963, DOI 10.1016/j.amjhyper.2004.06.001; Kuang TM, 2008, J CHIN MED ASSOC, V71, P467, DOI 10.1016/S1726-4901(08)70150-3; Lamoreux EL, 2008, INVEST OPHTH VIS SCI, V49, P528, DOI 10.1167/iovs.07-1036; Loriaut P, 2014, OPHTHALMIC RES, V52, P212, DOI 10.1159/000362881; McLaughlin D, 2011, J AM GERIATR SOC, V59, P1560, DOI 10.1111/j.1532-5415.2011.03530.x; Murthy GVS, 2001, OPHTHALMOLOGY, V108, P679, DOI 10.1016/S0161-6420(00)00579-0; Oh-Park M, 2011, ARCH PHYS MED REHAB, V92, P2006, DOI 10.1016/j.apmr.2011.07.193; Ong SY, 2012, ARCH OPHTHALMOL-CHIC, V130, P895, DOI 10.1001/archophthalmol.2012.152; Ong SY, 2013, INVEST OPHTH VIS SCI, V54, P799, DOI 10.1167/iovs.12-10460; Song E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112054; Swenor BK, 2015, J AM GERIATR SOC, V63, P46, DOI 10.1111/jgs.13183; Thulasiraj RD, 2003, OPHTHALMOLOGY, V110, P1491, DOI 10.1016/S0161-6420(03)00565-7; Varma R, 2004, OPHTHALMOLOGY, V111, P1132, DOI 10.1016/j.ophtha.2004.02.002; Wade D T, 1988, Int Disabil Stud, V10, P64; Wang XZ, 2014, OPHTHALMOLOGY, V121, P1837, DOI 10.1016/j.ophtha.2014.03.017; Wong TY, 2006, BRIT J OPHTHALMOL, V90, P506, DOI 10.1136/bjo.2005.083733; Wong TY, 2006, AM J OPHTHALMOL, V141, P446, DOI 10.1016/j.ajo.2005.08.063; Zhao JL, 2010, OPHTHALMOLOGY, V117, P409, DOI 10.1016/j.ophtha.2009.11.023; Zheng DD, 2016, AGING MENT HEALTH, V20, P295, DOI 10.1080/13607863.2015.1008985; Zheng YF, 2011, OPHTHALMOLOGY, V118, P1798, DOI 10.1016/j.ophtha.2011.02.014; Zou Y, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008417	33	7	7	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142516	10.1371/journal.pone.0142516	http://dx.doi.org/10.1371/journal.pone.0142516			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26545238	Green Submitted, Green Published, gold			2022-12-27	WOS:000364398700148
J	Meier, SM; Petersen, L; Schendel, DE; Mattheisen, M; Mortensen, PB; Mors, O				Meier, Sandra M.; Petersen, Liselotte; Schendel, Diana E.; Mattheisen, Manuel; Mortensen, Preben B.; Mors, Ole			Obsessive-Compulsive Disorder and Autism Spectrum Disorders: Longitudinal and Offspring Risk	PLOS ONE			English	Article							ANXIETY DISORDERS; NEUROPSYCHIATRIC DISORDERS; PSYCHIATRIC MORBIDITY; REPETITIVE BEHAVIORS; SYMPTOM DIMENSIONS; PATERNAL-AGE; DE-NOVO; ADOLESCENTS; CHILDREN; POPULATION	Background Despite substantial similarities and overlaps in the pathophysiology of obsessive-compulsive disorders (OCD) and autism spectrum disorders, little is known about the clinical and etiologic cohesion of these two disorders. We therefore aimed to determine the patterns of comorbidity, longitudinal risks, and shared familial risks between these disorders. Methods In a prospective study design we explored the effect of a prior diagnosis of OCD in patients and parents on the susceptibility to autism spectrum disorders and vice versa. Analyses were adjusted for sex, age, calendar year, parental age and place at residence at time of birth. As measures of relative risk incidence rate ratios (IRR) and accompanying 95% confidence intervals (CIs) were employed. Results The risk of a comorbid diagnosis of OCD in individuals with autism spectrum disorder and aggregation of autism spectrum disorders in offspring of parents with OCD were increased. Individuals first diagnosed with autism spectrum disorders had a 2-fold higher risk of a later diagnosis of OCD (IRR = 2.18, 95% CI = 1.91-2.48), whereas individuals diagnosed with OCD displayed a nearly 4-fold higher risk to be diagnosed with autism spectrum disorders (IRR = 3.91, 95% CI = 3.46-4.40) later in life. The observed associations were somewhat stronger for less severe types of autism spectrum disorders without a comorbid diagnosis of mental disabilities. Conclusions The high comorbidity, sequential risk, and shared familial risks between OCD and autism spectrum disorders are suggestive of partially shared etiological mechanisms. The results have implications for current gene-searching efforts and for clinical practice.	[Meier, Sandra M.; Petersen, Liselotte; Schendel, Diana E.; Mortensen, Preben B.] Aarhus Univ, Natl Ctr Register Based Res, DK-8000 Aarhus C, Denmark; [Schendel, Diana E.] Aarhus Univ, Dept Publ Hlth, Epidemiol Sect, DK-8000 Aarhus C, Denmark; [Mattheisen, Manuel] Aarhus Univ, Dept Biomed, DK-8000 Aarhus C, Denmark; [Mors, Ole] Aarhus Univ Hosp, Res Dept P, Risskov, Denmark; [Meier, Sandra M.; Petersen, Liselotte; Schendel, Diana E.; Mattheisen, Manuel; Mortensen, Preben B.; Mors, Ole] iPSYCH, Lundbeck Fdn Initiat Integrat Psychiat Res, Copenhagen, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH)	Meier, SM (corresponding author), Aarhus Univ, Natl Ctr Register Based Res, DK-8000 Aarhus C, Denmark.	smeier@ncrr.au.dk	Meier, Sandra/AAB-1242-2021; Mattheisen, Manuel/B-4949-2012; Mortensen, Preben B/D-2358-2015; Mattheisen, Manuel/S-3725-2019	Mattheisen, Manuel/0000-0002-8442-493X; Mortensen, Preben B/0000-0002-5230-9865; Mattheisen, Manuel/0000-0002-8442-493X; Schendel, Diana/0000-0002-8588-1227; Petersen, Liselotte Vogdrup/0000-0002-0479-5379; Mors, Ole/0000-0002-5660-0393	Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); Stanley Medical Research Institute; Lundbeck Foundation [R155-2014-1724] Funding Source: researchfish; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH105500] Funding Source: NIH RePORTER	Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); Stanley Medical Research Institute; Lundbeck Foundation(Lundbeckfonden); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by the Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH). Dr Mortensen received further funding from the Stanley Medical Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen TF, 1999, DAN MED BULL, V46, P263; Anholt GE, 2010, J AUTISM DEV DISORD, V40, P580, DOI 10.1007/s10803-009-0922-1; [Anonymous], 2012, MORBIDITY MORTALITY, V61, P1; Atladottir HO, 2010, ARCH PEDIAT ADOL MED, V164, P470, DOI 10.1001/archpediatrics.2010.9; Bolton PF, 1998, PSYCHOL MED, V28, P385, DOI 10.1017/S0033291797006004; Brimacombe M, 2007, J CHILD NEUROL, V22, P593, DOI 10.1177/0883073807302609; Cadman T., 2015, AUTISM RES; Cadman T, 2012, J AM ACAD CHILD PSY, V51, P879, DOI 10.1016/j.jaac.2012.06.017; Carrasco M, 2012, PEDIATRICS, V129, pE1301, DOI 10.1542/peds.2011-3285; de Bruin EI, 2007, J AUTISM DEV DISORD, V37, P877, DOI 10.1007/s10803-006-0215-x; Dove D, 2012, PEDIATRICS, V130, P717, DOI 10.1542/peds.2012-0683; Fineberg NA, 2012, INT J NEUROPSYCHOPH, V15, P1173, DOI 10.1017/S1461145711001829; Frans EM, 2013, JAMA PSYCHIAT, V70, P516, DOI 10.1001/jamapsychiatry.2013.1180; Glasson EJ, 2004, ARCH GEN PSYCHIAT, V61, P618, DOI 10.1001/archpsyc.61.6.618; Gothelf D, 2008, J NEURAL TRANSM, V115, P929, DOI 10.1007/s00702-008-0037-4; Gross-Isseroff R, 2001, World J Biol Psychiatry, V2, P193; Hallmayer J, 2011, ARCH GEN PSYCHIAT, V68, P1095, DOI 10.1001/archgenpsychiatry.2011.76; Haznedar MM, 2006, AM J PSYCHIAT, V163, P1252, DOI 10.1176/appi.ajp.163.7.1252; Hollander E, 2012, AM J PSYCHIAT, V169, P292, DOI 10.1176/appi.ajp.2011.10050764; Huerta M, 2012, AM J PSYCHIAT, V169, P1056, DOI 10.1176/appi.ajp.2012.12020276; Hultman CM, 2011, MOL PSYCHIATR, V16, P1203, DOI 10.1038/mp.2010.121; Hurwitz R, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008372.pub2; Iervolino AC, 2011, ARCH GEN PSYCHIAT, V68, P637, DOI 10.1001/archgenpsychiatry.2011.54; Ivarsson T, 2008, J ANXIETY DISORD, V22, P969, DOI 10.1016/j.janxdis.2007.10.003; Knapp M, 2009, AUTISM, V13, P317, DOI 10.1177/1362361309104246; Koo MS, 2010, EXPERT REV NEUROTHER, V10, P275, DOI [10.1586/ern.09.148, 10.1586/ERN.09.148]; Langen M, 2007, BIOL PSYCHIAT, V62, P262, DOI 10.1016/j.biopsych.2006.09.040; Lauritsen MB, 2010, J AUTISM DEV DISORD, V40, P139, DOI 10.1007/s10803-009-0818-0; Leslie DL, 2008, J AM ACAD CHILD PSY, V47, P1166, DOI 10.1097/CHI.0b013e3181825a3d; Li XH, 2012, BRAIN RES BULL, V88, P543, DOI 10.1016/j.brainresbull.2012.05.017; Lichtenstein P, 2010, AM J PSYCHIAT, V167, P1357, DOI 10.1176/appi.ajp.2010.10020223; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; MacNeil BM, 2009, RES AUTISM SPECT DIS, V3, P1, DOI 10.1016/j.rasd.2008.06.001; Mataix-Cols D, 2013, JAMA PSYCHIAT, V70, P709, DOI 10.1001/jamapsychiatry.2013.3; MCDOUGLE CJ, 1995, AM J PSYCHIAT, V152, P772; Miman O, 2010, PSYCHIAT RES, V177, P263, DOI 10.1016/j.psychres.2009.12.013; Mors O, 2011, SCAND J PUBLIC HEALT, V39, P54, DOI 10.1177/1403494810395825; Neuhaus E, 2010, CLIN PSYCHOL REV, V30, P733, DOI 10.1016/j.cpr.2010.05.007; Nikolaus S, 2010, REV NEUROSCIENCE, V21, P119; Pedersen CB, 2006, DAN MED BULL, V53, P441; Pedersen CB, 2014, JAMA PSYCHIAT, V71, P573, DOI 10.1001/jamapsychiatry.2014.16; Pedersen CB, 2001, BRIT J PSYCHIAT, V179, P46, DOI 10.1192/bjp.179.1.46; Radua J, 2010, ARCH GEN PSYCHIAT, V67, P701, DOI 10.1001/archgenpsychiatry.2010.70; Robinson EB, 2014, P NATL ACAD SCI USA, V111, P15161, DOI 10.1073/pnas.1409204111; Ruscio AM, 2010, MOL PSYCHIATR, V15, P53, DOI 10.1038/mp.2008.94; Russell AJ, 2005, BRIT J PSYCHIAT, V186, P525, DOI 10.1192/bjp.186.6.525; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Simonoff E, 2008, J AM ACAD CHILD PSY, V47, P921, DOI 10.1097/CHI.0b013e318179964f; Srivastava AK, 2014, NEUROSCI BIOBEHAV R, V46, P161, DOI 10.1016/j.neubiorev.2014.02.015; Tolin DF, 2008, PSYCHIAT RES, V160, P200, DOI 10.1016/j.psychres.2007.08.008; Torres AR, 2006, AM J PSYCHIAT, V163, P1978, DOI 10.1176/appi.ajp.163.11.1978; van Steensel FJA, 2011, CLIN CHILD FAM PSYCH, V14, P302, DOI 10.1007/s10567-011-0097-0; Vasconcelos MS, 2007, BIOL PSYCHIAT, V61, P301, DOI 10.1016/j.biopsych.2006.07.014; White SW, 2009, CLIN PSYCHOL REV, V29, P216, DOI 10.1016/j.cpr.2009.01.003; Wu M, 2012, PHARMACOL BIOCHEM BE, V100, P726, DOI 10.1016/j.pbb.2011.10.007; Wu YJ, 2012, PSYCHIAT RES, V198, P353, DOI 10.1016/j.psychres.2012.01.020; Zarei M, 2011, BIOL PSYCHIAT, V70, P1083, DOI 10.1016/j.biopsych.2011.06.032	57	38	40	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0141703	10.1371/journal.pone.0141703	http://dx.doi.org/10.1371/journal.pone.0141703			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7DR	26558765	Green Published, gold, Green Submitted			2022-12-27	WOS:000364433100040
J	Pappa, KI; Polyzos, A; Jacob-Hirsch, J; Amariglio, N; Vlachos, GD; Loutradis, D; Anagnou, NP				Pappa, Kalliopi I.; Polyzos, Alexander; Jacob-Hirsch, Jasmine; Amariglio, Ninette; Vlachos, George D.; Loutradis, Dimitrios; Anagnou, Nicholas P.			Profiling of Discrete Gynecological Cancers Reveals Novel Transcriptional Modules and Common Features Shared by Other Cancer Types and Embryonic Stem Cells	PLOS ONE			English	Article							CERVICAL SQUAMOCOLUMNAR JUNCTION; ONCOSTATIN-M-RECEPTOR; EXPRESSION PATTERNS; GENES; CYCLE; CARCINOMA; OVEREXPRESSION; IDENTIFICATION; MICROARRAY; SIGNATURES	Studies on individual types of gynecological cancers (GCs), utilizing novel expression technologies, have revealed specific pathogenetic patterns and gene markers for cervical (CC), endometrial (EC) and vulvar cancer (VC). Although the clinical phenotypes of the three types of gynecological cancers are discrete, the fact they originate from a common embryological origin, has led to the hypothesis that they might share common features reflecting regression to early embryogenesis. To address this question, we performed a comprehensive comparative analysis of their profiles. Our data identified both common features (pathways and networks) and novel distinct modules controlling the same deregulated biological processes in all three types. Specifically, four novel transcriptional modules were discovered regulating cell cycle and apoptosis. Integration and comparison of our data with other databases, led to the identification of common features among cancer types, embryonic stem (ES) cells and the newly discovered cell population of squamocolumnar (SC) junction of the cervix, considered to host the early cancer events. Conclusively, these data lead us to propose the presence of common features among gynecological cancers, other types of cancers, ES cells and the pre-malignant SC junction cells, where the novel E2F/NFY and MAX/CEBP modules play an important role for the pathogenesis of gynecological carcinomas.	[Pappa, Kalliopi I.; Vlachos, George D.; Loutradis, Dimitrios] Univ Athens, Sch Med, Dept Obstet & Gynecol 1, Alexandra Hosp, GR-11527 Athens, Greece; [Pappa, Kalliopi I.; Anagnou, Nicholas P.] Acad Athens, Lab Cell & Gene Therapy, Biomed Res Fdn, Athens, Greece; [Polyzos, Alexander] Acad Athens, Basic Res Ctr, Biomed Res Fdn, Athens, Greece; [Jacob-Hirsch, Jasmine; Amariglio, Ninette] Tel Aviv Univ, Canc Res Ctr, Chaim Sheba Med Ctr, Tel Hashomer & Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Anagnou, Nicholas P.] Univ Athens, Sch Med, Biol Lab, GR-11527 Athens, Greece	Alexandra Hospital; Athens Medical School; National & Kapodistrian University of Athens; Academy of Athens; Academy of Athens; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Athens Medical School; National & Kapodistrian University of Athens	Anagnou, NP (corresponding author), Acad Athens, Lab Cell & Gene Therapy, Biomed Res Fdn, Athens, Greece.	anagnou@med.uoa.gr	Anagnou, Nicholas/GLR-3609-2022; PAPPA, KALLIOPI/K-9345-2018	PAPPA, KALLIOPI/0000-0002-1061-7405	Oncology Program of the Central Council of Health of the Ministry of Health [70-3-9209]; Empirikion Foundation [70-3-7345]; European Union's European Social Fund (ESF); Greek National Funds through the Program THALIS; Operational Program Education and Lifelong Learning of the National Strategic Reference Framework (NSRF) [70-3-11830]	Oncology Program of the Central Council of Health of the Ministry of Health; Empirikion Foundation; European Union's European Social Fund (ESF); Greek National Funds through the Program THALIS; Operational Program Education and Lifelong Learning of the National Strategic Reference Framework (NSRF)	This work was supported by the Oncology Program of the Central Council of Health of the Ministry of Health, Grant No. 70-3-9209 (www.moh.gov.gr); by the Empirikion Foundation, Grant No. 70-3-7345 to NPA (www.empirikion.gr); and by the European Union's European Social Fund (ESF) and Greek National Funds through the Program THALIS, under the Operational Program Education and Lifelong Learning of the National Strategic Reference Framework (NSRF), Grant No. 70-3-11830 to KIP (http://excellence.minedu.gov.gr/thales/en/).	Abu-Rustum NR, 2011, INT J GYNECOL CANCER, V21, P511, DOI 10.1097/IGC.0b013e31820cc305; Alisoltani A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096320; Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bosse T, 2013, MODERN PATHOL, V26, P1525, DOI 10.1038/modpathol.2013.96; Bublil EM, 2007, CURR OPIN CELL BIOL, V19, P124, DOI 10.1016/j.ceb.2007.02.008; Choschzick M, 2012, HUM PATHOL, V43, P1386, DOI 10.1016/j.humpath.2011.11.014; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Culhane AC, 2012, NUCLEIC ACIDS RES, V40, pD1060, DOI 10.1093/nar/gkr901; Elkon R, 2003, GENOME RES, V13, P773, DOI 10.1101/gr.947203; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Fruzangohar M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125537; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Gorski JJ, 2011, NUCLEIC ACIDS RES, V39, P9536, DOI 10.1093/nar/gkr679; Herfs M, 2015, INT J CANCER, V136, P1043, DOI 10.1002/ijc.28978; Herfs M, 2013, AM J SURG PATHOL, V37, P1311, DOI 10.1097/PAS.0b013e3182989ee2; Herfs M, 2013, J PATHOL, V229, P460, DOI 10.1002/path.4110; Herfs M, 2012, P NATL ACAD SCI USA, V109, P10516, DOI 10.1073/pnas.1202684109; Hoadley KA, 2014, CELL, V158, P929, DOI 10.1016/j.cell.2014.06.049; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hubert P, 2014, J PATHOL, V234, P464, DOI 10.1002/path.4435; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kowalewska M, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-223; Landry JJM, 2013, G3-GENES GENOM GENET, V3, P1213, DOI 10.1534/g3.113.005777; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Martinez E, 2015, ONCOGENE, V34, P2732, DOI 10.1038/onc.2014.216; Mine KL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2693; Ng G, 2007, J PATHOL, V212, P325, DOI 10.1002/path.2184; Ng VY, 2010, STEM CELLS, V28, P29, DOI 10.1002/stem.221; NUSSE R, 1992, CELL, V69, P1073, DOI 10.1016/0092-8674(92)90630-U; Ojesina AI, 2014, NATURE, V506, P371, DOI 10.1038/nature12881; Orchel J, 2012, INT J GYNECOL CANCER, V22, P937, DOI 10.1097/IGC.0b013e318259d8da; Pappa KI, 2011, TRANSL ONCOL, V4, P301, DOI 10.1593/tlo.11148; Peng L, 2015, SCI REP-UK, V5, DOI 10.1038/srep13413; Pereira PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011780; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ravi R, 2000, GENE DEV, V14, P34; Santegoets LAM, 2007, INT J CANCER, V121, P759, DOI 10.1002/ijc.22769; Santegoets LAM, 2012, INT J CANCER, V130, P2874, DOI 10.1002/ijc.26345; Scotto L, 2008, GENE CHROMOSOME CANC, V47, P755, DOI 10.1002/gcc.20577; Shamir R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-232; SLACK JMW, 2006, ESSENTIAL DEV BIOL; Soncin F, 2011, GENES-BASEL, V2, P229, DOI 10.3390/genes2010229; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thomas A, 2013, CANCER MED-US, V2, P836, DOI 10.1002/cam4.152; U.S. Cancer Statistics Working Group, 2014, US CANC STAT 1999 20; Ulitsky I, 2010, NAT PROTOC, V5, P303, DOI 10.1038/nprot.2009.230; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Winder DM, 2011, J PATHOL, V225, P448, DOI 10.1002/path.2968; Yang Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4231; Yuan RH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065501; Zhai Y, 2007, CANCER RES, V67, P10163, DOI 10.1158/0008-5472.CAN-07-2056	58	43	43	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142229	10.1371/journal.pone.0142229	http://dx.doi.org/10.1371/journal.pone.0142229			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559525	Green Published, gold, Green Submitted			2022-12-27	WOS:000364433100065
J	Giridharan, VV; Thandavarayan, RA; Arumugam, S; Mizuno, M; Nawa, H; Suzuki, K; Ko, KM; Krishnamurthy, P; Watanabe, K; Konishi, T				Giridharan, Vijayasree V.; Thandavarayan, Rajarajan A.; Arumugam, Somasundaram; Mizuno, Makoto; Nawa, Hiroyuki; Suzuki, Kenji; Ko, Kam M.; Krishnamurthy, Prasanna; Watanabe, Kenichi; Konishi, Tetsuya			Schisandrin B Ameliorates ICV-Infused Amyloid beta Induced Oxidative Stress and Neuronal Dysfunction through Inhibiting RAGE/NF-kappa B/MAPK and Up-Regulating HSP/Beclin Expression	PLOS ONE			English	Article							GLYCATION-END-PRODUCTS; ABSORBENCY CAPACITY ORAC; ALZHEIMERS-DISEASE; ANIMAL-MODEL; NITRIC-OXIDE; IN-VITRO; PROTEIN; RECEPTOR; MICE; RAT	Amyloid beta (A beta)-induced neurotoxicity is a major pathological mechanism of Alzheimer's disease (AD). Our previous studies have demonstrated that schisandrin B (Sch B), an antioxidant lignan from Schisandra chinensis, could protect mouse brain against scopolamine-and cisplatin-induced neuronal dysfunction. In the present study, we examined the protective effect of Sch B against intracerebroventricular (ICV)-infused A beta-induced neuronal dysfunction in rat cortex and explored the potential mechanism of its action. Our results showed that 26 days co-administration of Sch B significantly improved the behavioral performance of A beta (1-40)-infused rats in step-through test. At the same time, Sch B attenuated A beta-induced increases in oxidative and nitrosative stresses, inflammatory markers such as inducible nitric oxide syntheses, cyclooxygenase-2, interleukin-1 beta (IL-1 beta), IL-6, and tumor necrosis factor-alpha, and DNA damage. Several proteins such as receptor for advanced glycation end products (RAGE), nuclear factor-kappa B, mitogen-activated protein kinases, and apoptosis markers were over expressed in A beta-infused rats but were significantly inhibited by Sch B treatment. Furthermore, Sch B negatively modulated the A beta level with simultaneous up-regulation of HSP70 and beclin, autophagy markers in A beta-infused rats. The aforementioned effects of Sch B suggest its protective role against A beta-induced neurotoxicity through intervention in the negative cycle of RAGE-mediated A beta accumulation during AD patho-physiology.	[Giridharan, Vijayasree V.] JKK Nattraja Coll Pharm, Komarapalayam, Tamil Nadu, India; [Thandavarayan, Rajarajan A.; Krishnamurthy, Prasanna] Houston Methodist Res Inst, Dept Cardiovasc Sci, Houston, TX 77030 USA; [Arumugam, Somasundaram; Watanabe, Kenichi] Niigata Univ Pharm & Appl Life Sci NUPALS, Dept Clin Pharmacol, Niigata, Japan; [Mizuno, Makoto; Nawa, Hiroyuki] Niigata Univ, Div Neurobiol, Brain Res Inst, Niigata, Japan; [Suzuki, Kenji] Niigata Univ, Grad Sch Med & Dent Sci, Dept Gastroenterol & Hepatol, Niigata, Japan; [Ko, Kam M.] Hong Kong Univ Sci & Technol, Sect Biochem & Cell Biol, Hong Kong, Hong Kong, Peoples R China; [Konishi, Tetsuya] NUPALS, NUPALS Liaison RD Promot Div, Basic Studies Generat Funct Foods 2, Niigata, Japan; [Konishi, Tetsuya] Changchun Univ Chinese Med, Changchun, Peoples R China	The Methodist Hospital System; The Methodist Hospital - Houston; Niigata University; Niigata University; Niigata University; Hong Kong University of Science & Technology; Changchun University of Chinese Medicine	Thandavarayan, RA (corresponding author), Houston Methodist Res Inst, Dept Cardiovasc Sci, Houston, TX 77030 USA.	atrajarajan@gmail.com; konishi@nupals.ac.jp	Arumugam, S./AAT-7570-2020	KRISHNAMURTHY, PRASANNA/0000-0002-4842-6364; Arumugam, Somasundaram/0000-0002-2096-2552	Promotion and Mutual Aid Corporation for Private Schools, Japan; National Institutes of Health (NIH) [1R01HL116729]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116729] Funding Source: NIH RePORTER	Promotion and Mutual Aid Corporation for Private Schools, Japan(Promotion and Mutual Aid Corporation for Private Schools of Japan); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding: T.K. was supported by The Promotion and Mutual Aid Corporation for Private Schools, Japan; P. K. was supported by National Institutes of Health (NIH) grant 1R01HL116729.	Abdul HM, 2007, FREE RADICAL BIO MED, V42, P371, DOI 10.1016/j.freeradbiomed.2006.11.006; Baiguera S, 2009, INT J MOL MED, V24, P9, DOI 10.3892/ijmm_00000199; Caceres DD, 1999, PHYTOMEDICINE, V6, P217, DOI 10.1016/S0944-7113(99)80012-9; Cerpa W, 2008, CURR ALZHEIMER RES, V5, P233, DOI 10.2174/156720508784533321; Chang PC, 2004, KIDNEY INT, V65, P1664, DOI 10.1111/j.1523-1755.2004.00602.x; Chaubey RC, 2001, MUTAT RES-GEN TOX EN, V490, P187, DOI 10.1016/S1383-5718(00)00166-2; Chiu PY, 2004, MOL CELL BIOCHEM, V266, P139, DOI 10.1023/B:MCBI.0000049151.79238.30; Chiu PY, 2003, FREE RADICAL BIO MED, V35, P368, DOI 10.1016/S0891-5849(03)00274-0; Craft JM, 2006, GLIA, V53, P484, DOI 10.1002/glia.20306; Darvesh S, 2004, CLIN BIOCHEM, V37, P42, DOI 10.1016/j.clinbiochem.2003.09.004; Degaspari S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125271; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Fan Lin-Hua, 2011, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V29, P255; Gegg ME, 2003, J NEUROCHEM, V86, P228, DOI 10.1046/j.1471-4159.2003.01821.x; Giridharan VV, 2011, FREE RADICAL RES, V45, P950, DOI 10.3109/10715762.2011.571682; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Grutzendler J, 2001, DRUGS, V61, P41, DOI 10.2165/00003495-200161010-00005; Hashimoto M, 2005, BBA-MOL CELL BIOL L, V1738, P91, DOI 10.1016/j.bbalip.2005.11.011; JOACHIM CL, 1992, ALZ DIS ASSOC DIS, V6, P7, DOI 10.1097/00002093-199205000-00003; Kim SR, 1999, PLANTA MED, V65, P218, DOI 10.1055/s-1999-13983; Kim TI, 2009, FREE RADICAL BIO MED, V47, P1601, DOI 10.1016/j.freeradbiomed.2009.09.008; Kurihara H, 2004, BIOL PHARM BULL, V27, P1093, DOI 10.1248/bpb.27.1093; Kwon SH, 2009, EUR J PHARMACOL, V619, P44, DOI 10.1016/j.ejphar.2009.06.062; Lecanu L, 2004, STEROIDS, V69, P1, DOI 10.1016/j.steroids.2003.09.007; Lee CL, 2007, J NEUROSCI RES, V85, P3171, DOI 10.1002/jnr.21428; Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105; Li Shu-Fang, 2010, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V28, P329; LIU GT, 1989, CHINESE MED J-PEKING, V102, P740; Lue LF, 2001, EXP NEUROL, V171, P29, DOI 10.1006/exnr.2001.7732; Maccioni RB, 2001, ARCH MED RES, V32, P367, DOI 10.1016/S0188-4409(01)00316-2; Mallidis C, 2007, HUM REPROD, V22, P2169, DOI 10.1093/humrep/dem156; Moreira PI, 2006, BIOL RES, V39, P7, DOI 10.4067/S0716-97602006000100002; NITTA A, 1994, NEUROSCI LETT, V170, P63, DOI 10.1016/0304-3940(94)90239-9; Nitta A, 1997, JPN J PHARMACOL, V73, P51, DOI 10.1254/jjp.73.51; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Olariu A, 2002, BRAIN RES, V957, P278, DOI 10.1016/S0006-8993(02)03608-9; Ou BX, 2002, J AGR FOOD CHEM, V50, P3122, DOI 10.1021/jf0116606; Paxinos G., 2004, J CHEM INF MODEL, V5th; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; Ranaivo HR, 2006, J NEUROSCI, V26, P662, DOI 10.1523/JNEUROSCI.4652-05.2006; Reddy PH, 2006, J NEUROCHEM, V96, P1, DOI 10.1111/j.1471-4159.2005.03530.x; Schieven GL, 2005, CURR TOP MED CHEM, V5, P921, DOI 10.2174/1568026054985902; Schmidt AM, 2000, BBA-MOL CELL RES, V1498, P99, DOI 10.1016/S0167-4889(00)00087-2; SCHUBERT D, 1995, P NATL ACAD SCI USA, V92, P1989, DOI 10.1073/pnas.92.6.1989; Song JX, 2011, PHYTOTHER RES, V25, P435, DOI 10.1002/ptr.3269; Srikanth V, 2011, NEUROBIOL AGING, V32, P763, DOI 10.1016/j.neurobiolaging.2009.04.016; Stephan A, 2005, GENES BRAIN BEHAV, V4, P157, DOI 10.1111/j.1601-183X.2004.00113.x; Takaya T, 2006, ATHEROSCLEROSIS, V186, P402, DOI 10.1016/j.atherosclerosis.2005.08.009; Takeda A, 1998, ACTA NEUROPATHOL, V95, P555, DOI 10.1007/s004010050839; Thandavarayan RA, 2010, FREE RADICAL BIO MED, V49, P1422, DOI 10.1016/j.freeradbiomed.2010.08.005; Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J; VINCENT D, 1958, Ann Pharm Fr, V16, P179; Wakisaka Y, 2010, J CEREBR BLOOD F MET, V30, P56, DOI 10.1038/jcbfm.2009.183; Wang R, 2001, EUR J PHARMACOL, V421, P149, DOI 10.1016/S0014-2999(01)01030-5; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Yan Shirley ShiDu, 2012, Front Biosci (Schol Ed), V4, P240; Zhou QB, 2014, INFLAMMATION, V37, P107, DOI 10.1007/s10753-013-9717-9; ZLOKOVIC BV, 1993, BIOCHEM BIOPH RES CO, V197, P1034, DOI 10.1006/bbrc.1993.2582	59	54	60	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142483	10.1371/journal.pone.0142483	http://dx.doi.org/10.1371/journal.pone.0142483			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556721	Green Submitted, gold, Green Published			2022-12-27	WOS:000364430700112
J	Wang, J; Wang, SW; Li, ML; Wu, DD; Liu, F; Yang, RS; Ji, SP; Ji, AL; Li, YZ				Wang, Jun; Wang, Shuaiwei; Li, Mengling; Wu, Dongdong; Liu, Fang; Yang, Ruisheng; Ji, Shaoping; Ji, Ailing; Li, Yanzhang			The Neuropilin-1 Inhibitor, ATWLPPR Peptide, Prevents Experimental Diabetes-Induced Retinal Injury by Preserving Vascular Integrity and Decreasing Oxidative Stress	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; ADHESION MOLECULE-1 ICAM-1; BLOOD-BRAIN-BARRIER; RETINOPATHY; CELLS; VEGF; EXPRESSION; PERMEABILITY; RECEPTOR; BINDING	Neuropilin-1 (NRP-1) is a transmembrane glycoprotein. As a VEGF co-receptor, NRP1 significantly enhances VEGFR2 signaling and promotes vascular permeability and migration. The purpose of this study was to evaluate the effects of an NRP-1 inhibitor, ATWLPPR peptide, on the early stages of diabetic retinopathy. Eight-week-old male C57BL/6 mice were divided into three groups: a Normal group, a Diabetes (DB) ATWLPPR treatment group and a DB saline group. Electroretinography (ERG), fundus fluorescence angiography (FFA) and leukostasis were examined to evaluate the retinal injury induced by diabetes at the end of the fifth week after STZ injection. Occludin expression and extravasation of albumin were measured to determine the extent of vascular injury. The oxidative stress level and the levels of inflammation-associated proteins were also assayed. The results indicated that treatment with ATWLPPR prevents the abnormal condition of ERG (amplitudes of b-wave decreased and implicit time increased) and vascular injury (occludin degradation and increase in extravasated albumin). These effects were associated with a reduction in the oxidase stress level and the expression of VEGF, GFAP, and ICAM-1. We conclude that ATWLPPR, an NRP-1 inhibitor, may reduce the early retinal damage induced by diabetes by preserving vascular integrity and decreasing the oxidative stress level. Blockade of NRP-1 may be a new therapeutic strategy for the early stages of DR.	[Wang, Jun; Wang, Shuaiwei; Li, Mengling; Wu, Dongdong; Ji, Shaoping; Ji, Ailing; Li, Yanzhang] Henan Univ, Coll Med, Kaifeng 475004, Peoples R China; [Liu, Fang; Yang, Ruisheng] Henan Univ, Affiliated Hosp 1, Kaifeng 475004, Peoples R China	Henan University; Henan University	Wang, J (corresponding author), Henan Univ, Coll Med, Kaifeng 475004, Peoples R China.	whb21c@henu.edu.cn; ailingji@163.com; yanzhang206@163.com	Wu, dongdong/F-6086-2012; Wu, Dongdong/GQP-4472-2022; Wu, Dongdong/GPX-6051-2022; Wu, Dongdong/K-5194-2019	Wu, Dongdong/0000-0001-6739-8437; Wu, Dongdong/0000-0001-6739-8437; 	National Natural Science Foundation of China (NSFC) [31300884]; Science and Technology Development Project of Henan Province [132300410012]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Science and Technology Development Project of Henan Province	This work was supported by the National Natural Science Foundation of China (NSFC: 31300884) and Science and Technology Development Project of Henan Province (no. 132300410012). The funders participated in the study design, data collection and analysis, decision to publish and preparation of the manuscript.	Adamis AP, 2008, SEMIN IMMUNOPATHOL, V30, P65, DOI 10.1007/s00281-008-0111-x; Al-Shabrawey M, 2008, INVEST OPHTH VIS SCI, V49, P3239, DOI 10.1167/iovs.08-1755; Alex L, 1997, CELL, V90, P753; Antal B, 2012, IEEE T BIO-MED ENG, V59, P1720, DOI 10.1109/TBME.2012.2193126; Antonetti DA, 1998, DIABETES, V47, P1953, DOI 10.2337/diabetes.47.12.1953; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Banumathi E, 2010, EXP EYE RES, V90, P89, DOI 10.1016/j.exer.2009.09.014; Barber AJ, 2000, INVEST OPHTH VIS SCI, V41, P3561; Binetruy-Tournaire R, 2000, EMBO J, V19, P1525, DOI 10.1093/emboj/19.7.1525; Cerani A, 2013, CELL METAB, V18, P505, DOI 10.1016/j.cmet.2013.09.003; Cheema HR, 2014, INT J OPHTHALMOL-CHI, V7, P251, DOI 10.3980/j.issn.2222-3959.2014.02.11; Cunha-Vaz J, 2011, EUR J OPHTHALMOL, V21, pS3, DOI 10.5301/EJO.2010.6049; Deissler HL, 2014, EXP EYE RES, V122, P20, DOI 10.1016/j.exer.2014.02.024; Delibegovic M, 2007, MOL CELL BIOL, V27, P7727, DOI 10.1128/MCB.00959-07; Dohgu Shinya, 2015, Folia Pharmacologica Japonica, V146, P63, DOI 10.1254/fpj.146.63; Fantin A, 2014, DEVELOPMENT, V141, P556, DOI 10.1242/dev.103028; Gelfand MV, 2014, ELIFE, V3, DOI 10.7554/eLife.03720; Hammes HP, 2005, HORM METAB RES, V37, pS39, DOI 10.1055/s-2005-861361; Hartnett ME, 2000, DIABETES CARE, V23, P234, DOI 10.2337/diacare.23.2.234; Hernandez C, 2013, DIABETES, V62, P2569, DOI 10.2337/db12-0926; Herre DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126866; Herzog B, 2011, MOL BIOL CELL, V22, P2766, DOI 10.1091/mbc.E09-12-1061; Hosoya K, 2013, ADV EXP MED BIOL, V763, P85; Huang XQ, 2011, DIABETES RES CLIN PR, V91, P371, DOI 10.1016/j.diabres.2010.12.026; Joussen AM, 2001, AM J PATHOL, V158, P147, DOI 10.1016/S0002-9440(10)63952-1; Kim I, 2001, J BIOL CHEM, V276, P7614, DOI 10.1074/jbc.M009705200; Koleva-Georgieva Desislava N, 2011, Folia Med (Plovdiv), V53, P44; Kowluru RA, 2006, INVEST OPHTH VIS SCI, V47, P1594, DOI 10.1167/iovs.05-1276; Kubo Y, 2007, DIABETIC RETINOPATHY, P92; Kumawat Manjulata, 2014, J Indian Med Assoc, V112, P29; Li GY, 2012, DIABETES, V61, P3294, DOI 10.2337/db11-1249; Li Q, 2002, EXP EYE RES, V74, P615, DOI 10.1006/exer.2002.1170; Miyamoto K, 2000, AM J PATHOL, V156, P1733, DOI 10.1016/S0002-9440(10)65044-4; Moran E, 2014, INVEST OPHTH VIS SCI, V55, P4568, DOI 10.1167/iovs.13-13127; Naruse R, 2013, SAUDI MED J, V34, P135; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Rojas M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084357; Rungger-Brandle E, 2000, INVEST OPHTH VIS SCI, V41, P1971; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Spoerri PE, 2006, MOL VIS, V12, P32; Starzec A, 2006, LIFE SCI, V79, P2370, DOI 10.1016/j.lfs.2006.08.005; Suidan GL, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-218; Wang JJ, 2010, DIABETES, V59, P2297, DOI 10.2337/db09-1420; Wu DD, 2010, PEPTIDES, V31, P850, DOI 10.1016/j.peptides.2010.01.007; Wuensch T, 2010, DIABETES, V59, P844, DOI 10.2337/db09-1100; Xie Ping QLXY, 2004, ACTA U MED NANJING, V24, P123; Yang WJ, 2015, EMBO MOL MED; Yee CS, 2015, BONE; Yuan DQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099219; Zhang B, 2012, INFORM SCIENCES, V200, P78, DOI 10.1016/j.ins.2012.03.003	50	9	10	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142571	10.1371/journal.pone.0142571	http://dx.doi.org/10.1371/journal.pone.0142571			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26554379	Green Published, gold, Green Submitted			2022-12-27	WOS:000364430700134
J	Liu, GY; Zhou, YH; Liu, D; Wang, QQ; Ruan, ZL; He, Q; Zhang, LM				Liu, Guoyan; Zhou, Yonghong; Liu, Dan; Wang, Qianqian; Ruan, Zengliang; He, Qian; Zhang, Liming			Global Transcriptome Analysis of the Tentacle of the Jellyfish Cyanea capillata Using Deep Sequencing and Expressed Sequence Tags: Insight into the Toxin- and Degenerative Disease-Related Transcripts	PLOS ONE			English	Article								Background Jellyfish contain diverse toxins and other bioactive components. However, large-scale identification of novel toxins and bioactive components from jellyfish has been hampered by the low efficiency of traditional isolation and purification methods. Results We performed de novo transcriptome sequencing of the tentacle tissue of the jellyfish Cyanea capillata. A total of 51,304,108 reads were obtained and assembled into 50,536 unigenes. Of these, 21,357 unigenes had homologues in public databases, but the remaining unigenes had no significant matches due to the limited sequence information available and species-specific novel sequences. Functional annotation of the unigenes also revealed general gene expression profile characteristics in the tentacle of C. capillata. A primary goal of this study was to identify putative toxin transcripts. As expected, we screened many transcripts encoding proteins similar to several well-known toxin families including phospholipases, metalloproteases, serine proteases and serine protease inhibitors. In addition, some transcripts also resembled molecules with potential toxic activities, including cnidarian CfTX-like toxins with hemolytic activity, plancitoxin-1, venom toxin-like peptide-6, histamine- releasing factor, neprilysin, dipeptidyl peptidase 4, vascular endothelial growth factor A, angiotensin-converting enzyme-like and endothelin-converting enzyme 1-like proteins. Most of these molecules have not been previously reported in jellyfish. Interestingly, we also characterized a number of transcripts with similarities to proteins relevant to several degenerative diseases, including Huntington's, Alzheimer's and Parkinson's diseases. This is the first description of degenerative disease-associated genes in jellyfish. Conclusion We obtained a well-categorized and annotated transcriptome of C. capillata tentacle that will be an important and valuable resource for further understanding of jellyfish at the molecular level and information on the underlying molecular mechanisms of jellyfish stinging. The findings of this study may also be used in comparative studies of gene expression profiling among different jellyfish species.	[Liu, Guoyan; Zhou, Yonghong; Liu, Dan; Wang, Qianqian; Ruan, Zengliang; Zhang, Liming] Second Mil Med Univ, Marine Biopharmaceut Inst, Shanghai 200433, Peoples R China; [Liu, Guoyan; Zhou, Yonghong; Liu, Dan; Wang, Qianqian; Ruan, Zengliang; Zhang, Liming] Second Mil Med Univ, Fac Naval Med, Dept Marine Biotechnol, Shanghai 200433, Peoples R China; [He, Qian] Second Mil Med Univ, Affiliated Hosp 3, Dept Gynecol, Shanghai 200433, Peoples R China	Naval Medical University; Naval Medical University; Naval Medical University	He, Q (corresponding author), Second Mil Med Univ, Affiliated Hosp 3, Dept Gynecol, Shanghai 200433, Peoples R China.	heqian@smmu.edu.cn; lmzhang@smmu.edu.cn	Ruan, Zengliang/CAG-5992-2022; Ruan, Zengliang/AAD-3032-2022	Ruan, Zengliang/0000-0002-9468-0232; Ruan, Zengliang/0000-0002-9468-0232; Zhou, Yonghong/0000-0002-1242-1764	National Natural Science Foundation of China [41306136]; Natural Science Foundation of Shanghai Municipal Government [12ZR1437000]; National High Technology Research and Development Program of China (863 Program) [2013M092904]; National Natural Science Foundation of China [41306136]; Natural Science Foundation of Shanghai Municipal Government [12ZR1437000]; National High Technology Research and Development Program of China (863 Program) [2013M092904]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai Municipal Government; National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai Municipal Government; National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	Funding: This work was supported by the Young Scientists Fund of National Natural Science Foundation of China (41306136), the Natural Science Foundation of Shanghai Municipal Government (12ZR1437000) and the National High Technology Research and Development Program of China (863 Program) (2013M092904). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird SD, 2008, COMP BIOCH PHYSL B, V150; Aird SD, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-790; Almeida DD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-362; Almeida FM, 2002, TOXICON, V40, P1041, DOI 10.1016/S0041-0101(02)00084-3; Armstrong RA, 2013, FOLIA NEUROPATHOL, V51; Arni RK, 1996, TOXICON, V34, P827, DOI 10.1016/0041-0101(96)00036-0; Bailey PM, 2005, TOXICON, V45, P233, DOI 10.1016/j.toxicon.2004.10.013; Beilei W, 2012, J CARDIOVASC PHARM, V59; Benraiss A, 2011, NEUROTHERAPEUTICS, V8, P577, DOI 10.1007/s13311-011-0075-8; Brekhman V, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1320-z; Brinkman D, 2007, TOXICON, V50, P850, DOI 10.1016/j.toxicon.2007.06.016; Brinkman DL, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1568-3; Brinkman DL, 2014, J BIOL CHEM, V289, P4798, DOI 10.1074/jbc.M113.534149; Burke WA, 2002, DERMATOLOGIC THERAPY, V15; Casewell NR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-564; Cegolon L, 2013, MAR DRUGS, V11, P523, DOI 10.3390/md11020523; Chaim OM, 2011, TOXINS BASEL, V3; Chapman JA, 2010, NATURE, V464, P592, DOI 10.1038/nature08830; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Fox JW., 2013, TOXICON, V62; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gutierrez JM, 2000, BIOCHIMIE, V82, P841, DOI 10.1016/S0300-9084(00)01163-9; Hao DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021220; Harada K, 2011, MOL MED REP, V4, P919, DOI 10.3892/mmr.2011.506; Huang Q, 2012, PLOS ONE, V7; Iseli C, 1999, P INT C INTELL SYST; Kang C, 2014, TOXICON, V86, P116, DOI 10.1016/j.toxicon.2014.04.005; Kim E, 2006, TOXICOL LETT, V167, P205, DOI 10.1016/j.toxlet.2006.09.009; Kini RM., 2005, TOXICON, V45; Learmont SA, 2006, AUSTRALASIAN EMERGEN, V9; Lee H, 2011, TOXICON, V58, P277, DOI 10.1016/j.toxicon.2011.06.007; Lee VS, 2007, INSECT MOL BIOL, V16; Li R, 2014, J PROTEOMICS, P106; Liang XX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033861; Ma Y, 2009, BMC GENOMICS, V10; Marino A, 2008, COMP BIOCH PHYSL A, V151; Mulenga A, 2005, EXP APPL ACAROL, V37, P215, DOI 10.1007/s10493-005-3261-8; Nagai H, 2002, BIOSCI BIOTECHNOL BI, V66; Nagai H, 2000, BIOCH BIOPHYS RES CO, V275; Nevalainen TJ, 2004, COMP BIOCH PHYSL B, V139; Ogawa Y, 2008, TOXICON, V51, P984, DOI 10.1016/j.toxicon.2008.02.003; Ota E, 2006, TOXICON, V48, P1002, DOI 10.1016/j.toxicon.2006.08.005; Rokyta DR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-312; Ruan Z, 2014, MAR DRUGS, V12; Ruan Z, 2014, PLOS ONE, V9; Sade YB, 2012, INT J BIOCH CELL BIO, V44; Safavi-Hemami H, 2013, J PROTEOMICS, V91, P97, DOI 10.1016/j.jprot.2013.07.007; Santoro ML, 2009, TOXICON, V54, P499, DOI 10.1016/j.toxicon.2009.05.016; Schwartz EF, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-119; Serrano SM, 2005, TOXICON, V45; Shen GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029127; Shiomi K, 2004, TOXICON, V44; Siang AS, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-24; Sugahara T, 2006, BIOSCI BIOTECHNOL BI, V70; Tao X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036234; Tibballs J, 2006, TOXICON, V48; Toom PM, 1972, COMP BIOCH PHYSL B, V43; Torres AFC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087556; Trevisan-Silva D, 2010, BIOCHIMIE, V92, P21, DOI 10.1016/j.biochi.2009.10.003; Turk T, 2009, TOXICON, V54; Turner AJ, 2001, BIOESSAYS, V23; Undheim EA, 2013, TOXINS BASEL, V5; Uri S, 2005, CONTACT DERMATITIS, V52; Vincent B, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-693; Whelan NV, 2014, GENOME BIOL EVOL, V6; Wu PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028000; Xiao L, 2010, TOXICOL IN VITRO, V24; Xiao L, 2009, TOXICON, V53, P146, DOI 10.1016/j.toxicon.2008.10.023; Yang DY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032283; Yang R, 2005, J CARDIOVASC PHARMAC, V129; Ye J., 2006, NUCL ACIDS RES, V34; Yu H, 2007, FOOD CHEM TOXICOL, V45	72	61	64	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2015	10	11							e0142680	10.1371/journal.pone.0142680	http://dx.doi.org/10.1371/journal.pone.0142680			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7AC	26551022	Green Submitted, gold, Green Published			2022-12-27	WOS:000364422800031
J	Bhattacharya, T; Ghosh, TS; Mande, SS				Bhattacharya, Tanudeep; Ghosh, Tarini Shankar; Mande, Sharmila S.			Global Profiling of Carbohydrate Active Enzymes in Human Gut Microbiome	PLOS ONE			English	Article							SYMBIOSIS; OBESITY; SIZE	Motivation Carbohydrate Active enzyme (CAZyme) families, encoded by human gut microflora, play a crucial role in breakdown of complex dietary carbohydrates into components that can be absorbed by our intestinal epithelium. Since nutritional wellbeing of an individual is dependent on the nutrient harvesting capability of the gut microbiome, it is important to understand how CAZyme repertoire in the gut is influenced by factors like age, geography and food habits. Results This study reports a comprehensive in-silico analysis of CAZyme profiles in the gut microbiomes of 448 individuals belonging to different geographies, using similarity searches of the corresponding gut metagenomic contigs against the carbohydrate active enzymes database. The study identifies a core group of 89 CAZyme families that are present across 85% of the gut microbiomes. The study detects several geography/age-specific trends in gut CAZyme repertoires of the individuals. Notably, a group of CAZymes having a positive correlation with BMI has been identified. Further this group of BMI-associated CAZymes is observed to be specifically abundant in the Firmicutes phyla. One of the major findings from this study is identification of three distinct groups of individuals, referred to as 'CAZotypes', having similar CAZyme profiles. Distinct taxonomic drivers for these CAZotypes as well as the probable dietary basis for such trends have also been elucidated. The results of this study provide a global view of CAZyme profiles across individuals of various geographies and age-groups. These results re-iterate the need of a more precise understanding of the role of carbohydrate active enzymes in human nutrition.	[Bhattacharya, Tanudeep] Teach India, Pune, Maharashtra, India; [Ghosh, Tarini Shankar; Mande, Sharmila S.] Tata Consultancy Serv Ltd, TCS Innovat Labs, Pune, Maharashtra, India	Tata Sons; Tata Consultancy Services Limited (TCS)	Mande, SS (corresponding author), Tata Consultancy Serv Ltd, TCS Innovat Labs, 54-B Hadapsar Ind Estate, Pune, Maharashtra, India.	sharmila.mande@tcs.com	Ghosh, Tarini/AAW-5456-2020	Ghosh, Tarini/0000-0001-9570-0365				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Barker M, 2003, J CHEMOMETR, V17, P166, DOI 10.1002/cem.785; BRANDLEY BK, 1986, J LEUKOCYTE BIOL, V40, P97, DOI 10.1002/jlb.40.1.97; Cantarel BL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028742; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Damgaard C, 2000, ECOLOGY, V81, P1139, DOI 10.1890/0012-9658(2000)081[1139:DIIPSO]2.0.CO;2; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; El Kaoutari A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084033; El Kaoutari A, 2013, NAT REV MICROBIOL, V11, P497, DOI 10.1038/nrmicro3050; Flint HJ, 2012, GUT MICROBES, V3, P289, DOI 10.4161/gmic.19897; Ghosh TS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095547; Ghosh TS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083823; Gini C., 1936, GEN SERIES, V208, P73; Holeman A, 2004, CURR OPIN BIOTECH, V15, P615, DOI 10.1016/j.copbio.2004.10.001; Hooper LV, 2001, GLYCOBIOLOGY, V11, p1R, DOI 10.1093/glycob/11.2.1R; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Li WZ, 2001, BIOINFORMATICS, V17, P282, DOI 10.1093/bioinformatics/17.3.282; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Sen Gupta S, 2011, GUT PATHOG, V3, DOI 10.1186/1757-4749-3-7; Sharma AR, 2010, INT J SOCIAL FORESTR, V3, P17; Tsai Franklin, 2009, Curr Gastroenterol Rep, V11, P307, DOI 10.1007/s11894-009-0045-z; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, J PHYSIOL-LONDON, V587, P4153, DOI 10.1113/jphysiol.2009.174136; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Williams LJ, 2010, WILEY INTERDISCIPLIN, V2; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	30	55	56	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142038	10.1371/journal.pone.0142038	http://dx.doi.org/10.1371/journal.pone.0142038			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544883	gold, Green Published, Green Submitted			2022-12-27	WOS:000364398700073
J	Jiang, X; Luo, X; Zhou, NY				Jiang, Xuan; Luo, Xi; Zhou, Ning-Yi			Two Polyhydroxyalkanoate Synthases from Distinct Classes from the Aromatic Degrader Cupriavidus pinatubonensis JMP134 Exhibit the Same Substrate Preference	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; IN-VIVO; DEGRADATION; CATABOLISM; PLASMIDS; BIOSYNTHESIS; CONSTRUCTION; SPECIFICITY; CLONING; GENOME	Cupriavidus pinatubonensis JMP134 utilizes a variety of aromatic substrates as sole carbon sources, including meta-nitrophenol (MNP). Two polyhydroxyalkanoate (PHA) synthase genes, phaC1 and phaC2, were annotated and categorized as class I and class II PHA synthase genes, respectively. In this study, both His-tagged purified PhaC1 and PhaC2 were shown to exhibit typical class I PHA synthase substrate specificity to make short-chain-length (SCL) PHA from 3-hydroxybutyryl-CoA and failed to make medium-chain-length (MCL) PHA from 3-hydroxyoctanoyl-CoA. The phaC1 or phaC2 deletion strain could also produce SCL PHA when grown in fructose or octanoate, but the double mutant of phaC1 and phaC2 lost this ability. The PhaC2 also exhibited substrate preference towards SCL substrates when expressed in Pseudomonas aeruginosa PAO1 phaC mutant strain. On the other hand, the transcriptional level of phaC1 was 70-fold higher than that of phaC2 in MNP-grown cells, but 240-fold lower in octanoate-grown cells. Further study demonstrated that only phaC1 was involved in PHA synthesis in MNP-grown cells. These findings suggested that phaC1 and phaC2 genes were differentially regulated under different growth conditions in this strain. Within the phaC2-containing gene cluster, a single copy of PHA synthase gene was present clustering with genes encoding enzymes in the biosynthesis of PHA precursors. This is markedly different from the genetic organization of all other previously reported class II PHA synthase gene clusters and this cluster likely comes from a distinct evolutionary path.	[Jiang, Xuan; Luo, Xi; Zhou, Ning-Yi] Chinese Acad Sci, Wuhan Inst Virol, Key Lab Agr & Environm Microbiol, Wuhan 430071, Peoples R China; [Zhou, Ning-Yi] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200240, Peoples R China; [Zhou, Ning-Yi] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200240, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhou, NY (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, Key Lab Agr & Environm Microbiol, Wuhan 430071, Peoples R China.	n.zhou@pentium.whiov.ac.cn		Jiang, Xuan/0000-0003-2749-7304	National Key Basic Research Program of China (973 Program) [2012CB725202]; National Natural Science Foundation of China [31300123]	National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by the following: 973 Program, grant no. 2012CB725202 from the National Key Basic Research Program of China (http://www.973.gov.cn/English/Index.aspx); and grant no. 31300123 from the National Natural Science Foundation of China (http://www.nsfc.gov.cn/publish/portal1/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON AJ, 1990, INT J BIOL MACROMOL, V12, P102, DOI 10.1016/0141-8130(90)90060-N; BRANDL H, 1988, APPL ENVIRON MICROB, V54, P1977, DOI 10.1128/AEM.54.8.1977-1982.1988; Chen JY, 2004, FEMS MICROBIOL LETT, V234, P231, DOI 10.1016/j.femsle.2004.03.029; Chen YF, 2014, APPL MICROBIOL BIOT, V98, P1349, DOI 10.1007/s00253-013-5001-z; Chen YJ, 2014, ENZYME MICROB TECH, V56, P60, DOI 10.1016/j.enzmictec.2014.01.005; Chuah JA, 2013, APPL ENVIRON MICROB, V79, P3813, DOI 10.1128/AEM.00564-13; Dehio C, 1997, J BACTERIOL, V179, P538, DOI 10.1128/jb.179.2.538-540.1997; DON RH, 1981, J BACTERIOL, V145, P681, DOI 10.1128/JB.145.2.681-686.1981; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; HOLLOWAY BW, 1979, MICROBIOL REV, V43, P73, DOI 10.1128/MMBR.43.1.73-102.1979; Hu F, 2014, APPL MICROBIOL BIOT, V98, P4749, DOI 10.1007/s00253-014-5567-0; HUISMAN GW, 1989, APPL ENVIRON MICROB, V55, P1949, DOI 10.1128/AEM.55.8.1949-1954.1989; Quelas JI, 2013, J BACTERIOL, V195, P3145, DOI 10.1128/JB.02203-12; KEEN NT, 1988, GENE, V70, P191, DOI 10.1016/0378-1119(88)90117-5; Kessler B, 2000, INT J SYST EVOL MICR, V50, P711, DOI 10.1099/00207713-50-2-711; Lee SY, 1996, ANN NY ACAD SCI, V782, P133, DOI 10.1111/j.1749-6632.1996.tb40555.x; Li MZ, 2005, NAT GENET, V37, P311, DOI 10.1038/ng1505; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Louie TM, 2002, J BACTERIOL, V184, P3492, DOI 10.1128/JB.184.13.3492-3500.2002; Lykidis A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009729; Matsusaki H, 1998, J BACTERIOL, V180, P6459, DOI 10.1128/JB.180.24.6459-6467.1998; Min J, 2014, APPL ENVIRON MICROB, V80, P6212, DOI 10.1128/AEM.02093-14; PEMBERTON JM, 1977, NATURE, V268, P732, DOI 10.1038/268732a0; Perez-Pantoja D, 2008, FEMS MICROBIOL REV, V32, P736, DOI 10.1111/j.1574-6976.2008.00122.x; Recinos DA, 2012, P NATL ACAD SCI USA, V109, P19420, DOI 10.1073/pnas.1213901109; Rehm BHA, 1999, INT J BIOL MACROMOL, V25, P3, DOI 10.1016/S0141-8130(99)00010-0; Rehm BHA, 2003, BIOCHEM J, V376, P15, DOI 10.1042/BJ20031254; Schenzle A, 1997, APPL ENVIRON MICROB, V63, P1421, DOI 10.1128/AEM.63.4.1421-1427.1997; Sheu DS, 2004, J BACTERIOL, V186, P4177, DOI 10.1128/JB.186.13.4177-4184.2004; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TIMM A, 1990, APPL ENVIRON MICROB, V56, P3360, DOI 10.1128/AEM.56.11.3360-3367.1990; VALENTIN HE, 1994, APPL MICROBIOL BIOT, V40, P699; Xu Y, 2013, APPL ENVIRON MICROB, V79, P6362, DOI 10.1128/AEM.02110-13; Yin Y, 2010, CURR MICROBIOL, V61, P471, DOI 10.1007/s00284-010-9640-3; Yin Y, 2010, APPL MICROBIOL BIOT, V87, P2077, DOI 10.1007/s00253-010-2666-4; ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875	36	4	4	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142332	10.1371/journal.pone.0142332	http://dx.doi.org/10.1371/journal.pone.0142332			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544851	Green Published, gold, Green Submitted			2022-12-27	WOS:000364398700113
J	Gilligan, TM; Tembrock, LR; Farris, RE; Barr, NB; van der Straten, MJ; van de Vossenberg, BTLH; Metz-Verschure, E				Gilligan, Todd M.; Tembrock, Luke R.; Farris, Roxanne E.; Barr, Norman B.; van der Straten, Marja J.; van de Vossenberg, Bart T. L. H.; Metz-Verschure, Eveline			A Multiplex Real-Time PCR Assay to Diagnose and Separate Helicoverpa armigera and H-zea (Lepidoptera: Noctuidae) in the New World	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; MOLECULAR-IDENTIFICATION; HUBNER LEPIDOPTERA; DNA; NORTH; DIFFERENTIATION; SEQUENCE; RECORD	The Old World bollworm, Helicoverpa armigera (Hubner), and the corn earworm, H. zea (Boddie), are two of the most important agricultural pests in the world. Diagnosing these two species is difficult-adults can only be separated with a complex dissection, and larvae cannot be identified to species using morphology, necessitating the use of geographic origin for identification in most instances. With the discovery of H. armigera in the New World, identification of immature Helicoverpa based on origin is no longer possible because H. zea also occurs in all of the geographic regions where H. armigera has been discovered. DNA barcoding and restriction fragment length polymorphism (RFLP) analyses have been reported in publications to distinguish these species, but these methods both require post-PCR processing (i.e., DNA sequencing or restriction digestion) to complete. We report the first real-time PCR assay to distinguish these pests based on two hydrolysis probes that bind to a segment of the internal transcribed spacer region 2 (ITS2) amplified using a single primer pair. One probe targets H. armigera, the second probe targets H. zea, and a third probe that targets a conserved segment of 18S rDNA is used as a control of DNA quality. The assay can be completed in 50 minutes when using isolated DNA and is successfully tested on larvae intercepted at ports of entry and adults captured during domestic surveys. We demonstrate that the assay can be run in triplex with no negative effects on sensitivity, can be run using alternative real-time PCR reagents and instruments, and does not cross react with other New World Heliothinae.	[Gilligan, Todd M.] USDA APHIS PPQ Sci & Technol, Identificat Technol Program, Ft Collins, CO 80526 USA; [Tembrock, Luke R.] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; [Farris, Roxanne E.; Barr, Norman B.] USDA APHIS PPQ Sci & Technol, Mission Lab, Edinburg, TX USA; [van der Straten, Marja J.; van de Vossenberg, Bart T. L. H.; Metz-Verschure, Eveline] Minist Econ Affairs, Natl Plant Protect Org, Netherlands Food & Consumers Prod Safety Author, Wageningen, Netherlands	Colorado State University	Gilligan, TM (corresponding author), USDA APHIS PPQ Sci & Technol, Identificat Technol Program, Ft Collins, CO 80526 USA.	todd.m.gilligan@aphis.usda.gov		van de Vossenberg, Bart T.L.H./0000-0003-1205-6119	U.S. Department of Agriculture Farm [3.0248]	U.S. Department of Agriculture Farm	This work was funded by U.S. Department of Agriculture Farm Bill Section 10007 for FY2014 suggestion number 3.0248 to TMG and NBB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; Amornsak W, 1998, AUST J ENTOMOL, V37, P174, DOI 10.1111/j.1440-6055.1998.tb01567.x; Barr NB, 2011, J ECON ENTOMOL, V104, P1706, DOI 10.1603/EC11093; Barr NB, 2009, J ECON ENTOMOL, V102, P2333, DOI 10.1603/029.102.0640; Behere GT, 2008, B ENTOMOL RES, V98, P599, DOI 10.1017/S0007485308005956; Behere GT, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-117; Braasch DA, 2001, CHEM BIOL, V8, P1, DOI 10.1016/S1074-5521(00)00058-2; Brambila J., 2009, INSTRUCTIONS DISSECT; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cunningham JP, 2014, J ECON ENTOMOL, V107, P881, DOI 10.1603/EC14036; Czepak Cecília, 2013, Pesqui. Agropecu. Trop., V43, P110, DOI 10.1590/S1983-40632013000100015; El-Lissy O, 2015, DETECTION OLD WORLD; Murua MG, 2014, FLA ENTOMOL, V97, P854, DOI 10.1653/024.097.0279; Gilligan TM, 2014, LEPINTERCEPT IDENTIF; HARDWICK D. F., 1965, Memoirs of the Entomology Society of Canada; Harris DJ, 2000, MOL BIOL EVOL, V17, P284, DOI 10.1093/oxfordjournals.molbev.a026308; Hayden J., 2015, PEST ALERT HELICOVER; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Keller I, 2006, GENETICS, V174, P863, DOI 10.1534/genetics.106.061341; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; Kranthi S, 2005, CURR SCI INDIA, V89, P1322; Kriticos DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119618; LASTER ML, 1995, J ECON ENTOMOL, V88, P1288, DOI 10.1093/jee/88.5.1288; LASTER ML, 1995, J ECON ENTOMOL, V88, P77, DOI 10.1093/jee/88.1.77; Leite NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113286; Logan J. M. J., 2004, REAL TIME PCR ESSENT, P13; Magnacca KN, 2010, MOL ECOL RESOUR, V10, P60, DOI 10.1111/j.1755-0998.2009.02724.x; Mastrangelo T, 2014, J ECON ENTOMOL, V107, P970, DOI 10.1603/EC13403; Matthews M., 1999, Heliothine moths of Australia. A guide to pest bollworms and related noctuid groups.; Ming Qing-Lei, 2006, Insect Science, V13, P437, DOI 10.1111/j.1744-7917.2006.00113.x; Bueno RCOD, 2014, REV BRAS FRUTIC, V36, P520, DOI 10.1590/0100-2945-357/13; Owczarzy R, 2011, BIOCHEMISTRY-US, V50, P9352, DOI 10.1021/bi200904e; Pogue MG, 2004, ANN ENTOMOL SOC AM, V97, P1222, DOI 10.1603/0013-8746(2004)097[1222:ANSOHZ]2.0.CO;2; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Smith E., 2014, PHYTOSANITARY ALERT; Specht A, 2013, PESQUI AGROPECU BRAS, V48, P689, DOI 10.1590/S0100-204X2013000600015; Tay WT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080134; Taylor S, 2010, METHODS, V50, pS1, DOI 10.1016/j.ymeth.2010.01.005; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596	42	22	23	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142912	10.1371/journal.pone.0142912	http://dx.doi.org/10.1371/journal.pone.0142912			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26558366	gold, Green Published, Green Submitted			2022-12-27	WOS:000364433100138
J	Lam, WWT; Liao, QY; Wong, JHF; Lai, CL; Yuen, MF; Tsang, JWH; Fielding, R				Lam, Wendy Wing Tak; Liao, Qiuyan; Wong, Jennifer Hiu Fai; Lai, Ching Lung; Yuen, Man Fung; Tsang, Janice Wing Hang; Fielding, Richard			Measuring and Validating a General Cancer Predisposition Perception Scale: An Adaptation of the Revised-IPQ-Genetic Predisposition Scale	PLOS ONE			English	Article							CHINESE-HEALTH-QUESTIONNAIRE; RHEUMATOID-ARTHRITIS; ILLNESS PERCEPTIONS; FUNCTIONAL STATUS; BREAST-CANCER; WOMEN; ADJUSTMENT; BELIEFS; VERSION; RISK	Background Illness perceptions are linked to individual help-seeking and preventive behaviors. Previous illness perception studies have identified five dimensions of illness-related experience and behaviour. The Revised Illness Perception Questionnaire (IPQ-R) for genetic predisposition (IPQ-R-GP) was developed to measure illness perceptions in those genetically-predisposed to blood disease. We adapted the IPQ-R-GP to measure perceptions of generalized cancer predisposition. This paper describes the development and validation of the Cancer Predisposition Perception Scale (CPPS). Methods The draft CPPS scale was first administered to 167 well Hepatitis B carriers and 123 other healthy individuals and the factor structure was examined using Exploratory Factor Analysis. Then the factor structure was confirmed in a second sample comprising 148 healthy controls, 150 smokers and 152 passive smokers using Confirmatory Factor Analysis (CFA). Results Six-factors comprising 26 items provided optimal fit by eigen and scree-plot methods, accounting for 58.9% of the total variance. CFA indicated good fit of the six-factor model after further excluding three items. The six factors, Emotional representation (5 items), Illness coherence (4 items), Treatment control (3 items), Consequences (5 items), Internal locus of control (2 items) and External locus of control (4 items) demonstrated adequate-togood subscale internal consistency (Cronbach's a = 0.63-0.90). Divergent validity was suggested by low correlations with optimism, self-efficacy, and scales for measuring physical and psychological health symptoms. Conclusion The CPPS appears to be a valid measure of perceived predisposition to generic cancer risks and can be used to examine cancer-risk-related cognitions in individuals at higher and lower cancer risk.	[Lam, Wendy Wing Tak; Liao, Qiuyan; Wong, Jennifer Hiu Fai; Fielding, Richard] Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Lai, Ching Lung; Yuen, Man Fung] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Tsang, Janice Wing Hang] Univ Hong Kong, Dept Med Oncol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Fielding, R (corresponding author), Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China.	fielding@hku.hk	; Lam, Wendy Wing Tak/C-4319-2009	Lai, Ching-Lung/0000-0002-5927-2436; Liao, Qiuyan/0000-0002-1105-6857; Lam, Wendy Wing Tak/0000-0003-2383-0149	Hong Kong Government's Research fund for Health and Health Service Research [08090791]	Hong Kong Government's Research fund for Health and Health Service Research	This work was funded by a grant from the Hong Kong Government's Research fund for Health and Health Service Research (grant no: 08090791), http://rfs2.fhb.gov.hk/english/funds/funds_hmrf/funds_hmrf_abt/funds_hmrf_abt.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowling A, 2005, J EPIDEMIOL COMMUN H, V59, P342, DOI 10.1136/jech.2004.021204; Chen SL, 2008, J ADV NURS, V64, P524, DOI 10.1111/j.1365-2648.2008.04808.x; CHENG TA, 1990, ACTA PSYCHIAT SCAND, V82, P304, DOI 10.1111/j.1600-0447.1990.tb01389.x; Cheung SK, 1999, PSYCHOL REP, V85, P1221, DOI 10.2466/pr0.1999.85.3f.1221; CHONG MY, 1989, PSYCHOL MED, V19, P495, DOI 10.1017/S0033291700012526; Dhanasekaran R, 2012, HEPATIC MED-EVID RES, V4, P19, DOI 10.2147/HMER.S16316; Griva K, 2000, PSYCHOL HEALTH, V15, P733, DOI 10.1080/08870440008405578; Groarke AM, 2005, PSYCHOL HEALTH, V20, P597, DOI 10.1080/14768320500094177; Hagger MS, 2005, PSYCHOL HEALTH, V20, P161, DOI 10.1080/0887044042000334724; Heijmans MJWM, 1998, J PSYCHOSOM RES, V45, P39, DOI 10.1016/S0022-3999(97)00265-1; Hong Kong Office of the Telecommunications Authority, 2014, KEY TEL STAT HONG KO; IDLER EL, 1995, J GERONTOL B-PSYCHOL, V50, pS344, DOI 10.1093/geronb/50B.6.S344; Kaptein AA, 2007, HEALTH PSYCHOL, V26, P807, DOI 10.1037/0278-6133.26.6.807; Kline R.B., 2011, PRINCIPLES PRACTICE; Lai JCL, 2000, PERS INDIV DIFFER, V28, P781, DOI 10.1016/S0191-8869(99)00138-5; Lam WWT, 2010, PSYCHO-ONCOLOGY, V19, P1044, DOI 10.1002/pon.1658; Leventhal H, 1998, PSYCHOL HEALTH, V13, P717, DOI 10.1080/08870449808407425; Leventhal H., 1984, HDB PSYCHOL HLTH, V4, P219; Li WWY, 2012, PSYCHO-ONCOLOGY, V21, P1316, DOI 10.1002/pon.2038; McCaul KD, 1996, HEALTH PSYCHOL, V15, P423, DOI 10.1037/0278-6133.15.6.423; Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494; Pesch B, 2012, INT J CANCER, V131, P1210, DOI 10.1002/ijc.27339; Scharloo M, 1999, J RHEUMATOL, V26, P1686; Scharloo M, 2000, BRIT J DERMATOL, V142, P899, DOI 10.1046/j.1365-2133.2000.03469.x; Schwarzer R., 1995, MEASURES HLTH PSYCHO, P35, DOI DOI 10.1037/T00393-000; Takagi H, 2006, LUNG CANCER, V51, P245, DOI 10.1016/j.lungcan.2005.11.004; Thun MJ, 2002, ONCOGENE, V21, P7307, DOI 10.1038/sj.onc.1205807; WALLSTON KA, 1978, HEALTH EDUC QUART, V6, P160, DOI 10.1177/109019817800600107; Yuen MF, 2009, J GASTROEN HEPATOL, V24, P346, DOI 10.1111/j.1440-1746.2009.05784.x	29	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142620	10.1371/journal.pone.0142620	http://dx.doi.org/10.1371/journal.pone.0142620			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7DR	26559191	gold, Green Published, Green Submitted			2022-12-27	WOS:000364433100103
J	Tseng, CH				Tseng, Chin-Hsiao			Type 2 Diabetes Mellitus and Kidney Cancer Risk: A Retrospective Cohort Analysis of the National Health Insurance	PLOS ONE			English	Article							POPULATION-BASED COHORT; BLADDER-CANCER; MORTALITY; EPIDEMIOLOGY; BIAS; MEN	Purpose To evaluate the association between incidence of any kidney cancer and type 2 diabetes mellitus. Methods A random sample of 1,000,000 subjects covered by the National Health Insurance was recruited. A total of 998728 people (115655 diabetes and 883073 non-diabetes) without kidney cancer at recruitment were followed from 2003 to 2005. The cumulative incidence of kidney cancer from 2003 to 2005 in diabetic patients and non-diabetic people in all ages and in age <40, 40-64, 65-74 and >= 75 years were calculated in the diabetic patients and the non-diabetic people, respectively. Logistic regression was used to estimate the odds ratios comparing diabetic patients to non-diabetic people in the respective age groups. Multivariable-adjusted odds ratios for kidney cancer with regards to diabetes status and diabetes duration (as a continuous variable or categorized into subgroups of non-diabetes, diabetes duration <1 year, 1-2.9 years, 3-4.9 years and >= 5 years) were estimated after multivariable adjustment. The multivariable-adjusted odds ratios for all baseline variables were also estimated for diabetic patients and non-diabetic people, respectively. Results The 3-year cumulative incidence of kidney cancer in the diabetic patients and the non-diabetic people was 166.9 and 33.1 per 100,000 person-years, respectively. The incidence increased with regards to increasing age in both the diabetic patients and the non-diabetic people, but a higher risk of kidney cancer for the diabetic patients compared to the non-diabetic people was consistently observed in different age groups. After multivariable adjustment, the odds ratio for diabetic patients versus non-diabetic people was 1.7 (95% confidence interval: 1.3-2.1, P<0.01). While compared to the non-diabetic people, the odds ratio (95% confidence interval) for diabetes duration <1, 1-2.9 years, 3-4.9 years and >= 5 years was 1.5 (0.8-2.7), 1.6 (1.0-2.4), 1.6 (1.1-2.4) and 1.7 (1.3-2.3), respectively (P-trend <0.01). Analyses conducted in the diabetic patients and the non-diabetic people, respectively, consistently showed age, nephropathy and end-stage renal disease as significant risk factors of kidney cancer. Additionally, living in metropolitan Taipei region might also be associated with a higher risk of kidney cancer in the non-diabetic people, indicating a potential link between kidney cancer and some factors related to urbanization. Conclusions Patients with type 2 diabetes mellitus have a significantly higher risk of kidney cancer.	[Tseng, Chin-Hsiao] Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei, Taiwan; [Tseng, Chin-Hsiao] Natl Taiwan Univ Hosp, Dept Internal Med, Div Endocrinol & Metab, Taipei 100, Taiwan; [Tseng, Chin-Hsiao] Natl Hlth Res Inst, Div Environm Hlth & Occupat Med, Zhunan, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Health Research Institutes - Taiwan	Tseng, CH (corresponding author), Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei, Taiwan.	ccktsh@ms6.hinet.net			Ministry of Science and Technology of Taiwan [MOST 103-2314-B-002-187-MY3]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	The study was supported by the Ministry of Science and Technology (MOST 103-2314-B-002-187-MY3) of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcidiacono B, 2012, EXP DIABETES RES, DOI 10.1155/2012/789174; Bao CP, 2013, J DIABETES COMPLICAT, V27, P357, DOI 10.1016/j.jdiacomp.2013.01.004; BIDOLI E, 1993, REV EPIDEMIOL SANTE, V41, P374; BLOT WJ, 1979, J NATL CANCER I, V63, P363; Chen HF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067420; Chiang CJ, 2010, JPN J CLIN ONCOL, V40, P897, DOI 10.1093/jjco/hyq057; Cho E, 2011, HEMATOL ONCOL CLIN N, V25, P651, DOI 10.1016/j.hoc.2011.04.002; Chow WH, 2010, NAT REV UROL, V7, P245, DOI 10.1038/nrurol.2010.46; Connell L, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001711; Cumberbatch MG, 2016, EUR UROL, V70, P458, DOI 10.1016/j.eururo.2015.06.042; Harding JL, 2015, DIABETES CARE, V38, P264, DOI 10.2337/dc14-1996; Health Promotion Administration Ministry of Health and Welfare, 2012, CANC REG ANN REP; Hsieh MC, 2012, EXP DIABETES RES, DOI 10.1155/2012/413782; Inoue M, 2006, ARCH INTERN MED, V166, P1871, DOI 10.1001/archinte.166.17.1871; Jee SH, 2005, JAMA-J AM MED ASSOC, V293, P194, DOI 10.1001/jama.293.2.194; Jiang Y., 2009, Plant Biology (Rockville), V2009, P111; Khan Mmh, 2006, Asian Pac J Cancer Prev, V7, P253; Kuriki K, 2007, EUR J CANCER PREV, V16, P83, DOI 10.1097/01.cej.0000228404.37858.40; Lai SW, 2013, ANN ACAD MED SINGAP, V42, P120; Larsson SC, 2011, DIABETOLOGIA, V54, P1013, DOI 10.1007/s00125-011-2051-6; Lin CC, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-381; Lin CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125421; Lindblad P, 1999, DIABETOLOGIA, V42, P107, DOI 10.1007/s001250051122; Liu XD, 2015, INT J CANCER, V137, P903, DOI 10.1002/ijc.29440; Ljungberg B, 2011, EUR UROL, V60, P615, DOI 10.1016/j.eururo.2011.06.049; Oberaigner W, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1058; Pearce N, 2007, OCCUP ENVIRON MED, V64, P562, DOI 10.1136/oem.2006.026690; Setiawan VW, 2007, AM J EPIDEMIOL, V166, P932, DOI 10.1093/aje/kwm170; Song SS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134321; STROBE, 2007, STROBE CHECKL VERS 4; Szablewski L, 2014, DIABETES-METAB RES, V30, P543, DOI 10.1002/dmrr.2573; Tseng CH, 2006, DIABETOLOGIA, V49, P1755, DOI 10.1007/s00125-006-0314-4; Tseng CH, 2012, ANN ONCOL, V23, P153, DOI 10.1093/annonc/mdr334; Tseng CH, 2008, ACTA PAEDIATR, V97, P392, DOI 10.1111/j.1651-2227.2008.00684.x; Tseng CH, 2014, J ENVIRON SCI HEAL C, V32, P1, DOI 10.1080/10590501.2014.877645; Tseng CH, 2013, ACTA DIABETOL, V50, P879, DOI 10.1007/s00592-013-0471-0; Tseng CH, 2012, DIABETES CARE, V35, P278, DOI 10.2337/dc11-1449; Tseng CH, 2011, ANN MED, V43, P142, DOI 10.3109/07853890.2010.530683; Tseng CH, 2011, DIABETES CARE, V34, P616, DOI 10.2337/dc10-1640; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; Wang GP, 2012, CANCER EPIDEMIOL, V36, P177, DOI 10.1016/j.canep.2011.09.006; Wang M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11503; Wideroff L, 1997, J NATL CANCER I, V89, P1360, DOI 10.1093/jnci/89.18.1360; Xu X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058079; Yang CY, 1998, JPN J CANCER RES, V89, P355, DOI 10.1111/j.1349-7006.1998.tb00571.x; Yang WS, 2015, EUR J CANC PREV; Zendehdel K, 2003, JNCI-J NATL CANCER I, V95, P1797, DOI 10.1093/jnci/djg105; Zhu ZW, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056662, 10.1371/journal.pone.0080028]; Zucchetto A, 2007, ANN ONCOL, V18, P596, DOI 10.1093/annonc/mdl438	49	11	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142480	10.1371/journal.pone.0142480	http://dx.doi.org/10.1371/journal.pone.0142480			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559055	gold, Green Published, Green Submitted			2022-12-27	WOS:000364433100082
J	Carreira, VS; Fan, YX; Kurita, H; Wang, Q; Ko, CI; Naticchioni, M; Jiang, M; Koch, S; Zhang, X; Biesiada, J; Medvedovic, M; Xia, Y; Rubinstein, J; Puga, A				Carreira, Vinicius S.; Fan, Yunxia; Kurita, Hisaka; Wang, Qin; Ko, Chia-I; Naticchioni, Midi; Jiang, Min; Koch, Sheryl; Zhang, Xiang; Biesiada, Jacek; Medvedovic, Mario; Xia, Ying; Rubinstein, Jack; Puga, Alvaro			Disruption of Ah Receptor Signaling during Mouse Development Leads to Abnormal Cardiac Structure and Function in the Adult	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; CONGENITAL HEART-DISEASE; METABOLIC SYNDROME; GENE-EXPRESSION; BLOOD-PRESSURE; TCDD; MUTATIONS; FETAL; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN; PHOSPHOLAMBAN	The Developmental Origins of Health and Disease (DOHaD) Theory proposes that the environment encountered during fetal life and infancy permanently shapes tissue physiology and homeostasis such that damage resulting from maternal stress, poor nutrition or exposure to environmental agents may be at the heart of adult onset disease. Interference with endogenous developmental functions of the aryl hydrocarbon receptor (AHR), either by gene ablation or by exposure in utero to 2,3,7,8-tetrachlorodibenzo- p-dioxin (TCDD), a potent AHR ligand, causes structural, molecular and functional cardiac abnormalities and altered heart physiology in mouse embryos. To test if embryonic effects progress into an adult phenotype, we investigated whether Ahr ablation or TCDD exposure in utero resulted in cardiac abnormalities in adult mice long after removal of the agent. Ten-months old adult Ahr(-/-) and in utero TCDD-exposed Ahr(+/+) mice showed sexually dimorphic abnormal cardiovascular phenotypes characterized by echocardiographic findings of hypertrophy, ventricular dilation and increased heart weight, resting heart rate and systolic and mean blood pressure, and decreased exercise tolerance. Underlying these effects, genes in signaling networks related to cardiac hypertrophy and mitochondrial function were differentially expressed. Cardiac dysfunction in mouse embryos resulting from AHR signaling disruption seems to progress into abnormal cardiac structure and function that predispose adults to cardiac disease, but while embryonic dysfunction is equally robust in males and females, the adult abnormalities are more prevalent in females, with the highest severity in Ahr(-/-) females. The findings reported here underscore the conclusion that AHR signaling in the developing heart is one potential target of environmental factors associated with cardiovascular disease.	[Carreira, Vinicius S.; Fan, Yunxia; Kurita, Hisaka; Wang, Qin; Ko, Chia-I; Zhang, Xiang; Biesiada, Jacek; Medvedovic, Mario; Xia, Ying; Puga, Alvaro] Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA; [Carreira, Vinicius S.; Fan, Yunxia; Kurita, Hisaka; Wang, Qin; Ko, Chia-I; Zhang, Xiang; Biesiada, Jacek; Medvedovic, Mario; Xia, Ying; Puga, Alvaro] Univ Cincinnati, Coll Med, Ctr Environm Genet, Cincinnati, OH 45267 USA; [Naticchioni, Midi; Jiang, Min; Koch, Sheryl; Rubinstein, Jack] Univ Cincinnati, Coll Med, Dept Internal Med, Div Cardiovasc Hlth & Dis, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Puga, A (corresponding author), Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA.	Alvaro.Puga@uc.edu	Biesiada, Jacek/I-2844-2018; Kurita, Hisaka/ABA-3983-2020	Biesiada, Jacek/0000-0003-0435-2225; Rubinstein, Jack/0000-0002-8811-1551; Carreira, Vinicius/0000-0003-4524-0510	National Institute of Environmental Health Sciences (NIEHS) [R01 ES06273, R01 ES024744, R01 ES10807]; NIEHS Center for Environmental Genetics [P30 ES06096]; NIEHS Gene Environment Interactions Training Grant [T32 ES016646]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES006273, R01ES024744, T32ES016646, R01ES010807, P30ES006096] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS Center for Environmental Genetics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS Gene Environment Interactions Training Grant; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding: This research was supported by National Institute of Environmental Health Sciences (NIEHS) grants R01 ES06273, R01 ES024744, and R01 ES10807, and by the NIEHS Center for Environmental Genetics grant P30 ES06096. V.S.C. was supported by NIEHS Gene Environment Interactions Training Grant T32 ES016646. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott BD, 1999, TOXICOL APPL PHARM, V155, P62, DOI 10.1006/taap.1998.8601; Akazawa H, 2005, PHARMACOL THERAPEUT, V107, P252, DOI 10.1016/j.pharmthera.2005.03.005; Antkiewicz DS, 2005, TOXICOL SCI, V84, P368, DOI 10.1093/toxsci/kfi073; Aragon AC, 2008, TOXICOL SCI, V101, P321, DOI 10.1093/toxsci/kfm272; Armstrong EJ, 2004, CIRC RES, V95, P459, DOI 10.1161/01.RES.0000141146.95728.da; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Carreira VS, 2015, TOXICOL SCI, V147, P425, DOI 10.1093/toxsci/kfv138; Carro T, 2013, ENVIRON TOXICOL CHEM, V32, P1325, DOI 10.1002/etc.2178; Dabir P, 2008, CIRC RES, V102, P1558, DOI 10.1161/CIRCRESAHA.108.176990; Dalton T P, 2001, Cardiovasc Toxicol, V1, P285, DOI 10.1385/CT:1:4:285; Davarinos NA, 1999, J BIOL CHEM, V274, P28708, DOI 10.1074/jbc.274.40.28708; Derda AA, 2015, INT J CARDIOL, V196, P115, DOI 10.1016/j.ijcard.2015.05.185; DEVITO MJ, 1995, ENVIRON HEALTH PERSP, V103, P820, DOI 10.2307/3432395; Elliott DA, 2003, J AM COLL CARDIOL, V41, P2072, DOI 10.1016/S0735-1097(03)00420-0; Forgacs AL, 2010, TOXICOL APPL PHARM, V246, P58, DOI 10.1016/j.taap.2010.04.006; Furness SGB, 2007, FEBS LETT, V581, P3616, DOI 10.1016/j.febslet.2007.04.011; Furness SGB, 2009, PHARMACOL THERAPEUT, V124, P336, DOI 10.1016/j.pharmthera.2009.09.004; Gelb B, 2013, CIRC RES, V112, P698, DOI 10.1161/CIRCRESAHA.111.300297; Giannone JV, 1998, BIOCHEM PHARMACOL, V55, P489, DOI 10.1016/S0006-2952(97)00493-0; Hofsteen P, 2013, TOXICOL SCI, V132, P211, DOI 10.1093/toxsci/kfs329; Houtkooper RH, 2013, NATURE, V497, P451, DOI 10.1038/nature12188; Jay PY, 2004, J CLIN INVEST, V113, P1130, DOI 10.1172/JCI200419846; Jones SP, 2009, TOXICOL SCI, V109, P66, DOI 10.1093/toxsci/kfp039; Kannel WB, 1996, JAMA-J AM MED ASSOC, V276, P1269, DOI 10.1001/jama.276.15.1269; Kennedy LH, 2013, TOXICOL SCI, V132, P235, DOI 10.1093/toxsci/kfs325; Kewley RJ, 2004, INT J BIOCHEM CELL B, V36, P189, DOI 10.1016/S1357-2725(03)00211-5; Kim JT, 2014, REV ENDOCR METAB DIS, V15, P253, DOI 10.1007/s11154-014-9297-5; Kornfeld OS, 2015, CIRC RES, V116, P1783, DOI 10.1161/CIRCRESAHA.116.305432; Lee HK, 2011, DIABETES METAB J, V35, P207, DOI 10.4093/dmj.2011.35.3.207; Lesnefsky EJ, 2001, J MOL CELL CARDIOL, V33, P1065, DOI 10.1006/jmcc.2001.1378; Li L, 1998, AM J PHYSIOL-HEART C, V274, pH1335, DOI 10.1152/ajpheart.1998.274.4.H1335; Long QQ, 2015, AM J CARDIOVASC DIS, V5, P19; Lund AK, 2008, HYPERTENSION, V51, P803, DOI 10.1161/HYPERTENSIONAHA.107.100586; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Marcaletti Stefan, 2011, Curr Protoc Mouse Biol, V1, P141, DOI 10.1002/9780470942390.mo100160; Mason PJ, 2004, CIRCULATION, V109, P1623, DOI 10.1161/01.CIR.0000124488.06377.77; McElhinney DB, 2003, J AM COLL CARDIOL, V42, P1650, DOI 10.1016/j.jacc.2003.05.004; Mone SM, 2004, PEDIATRICS, V113, P1058; Myburgh KH, 2003, COMP BIOCHEM PHYS A, V136, P171, DOI 10.1016/S1095-6433(03)00220-4; Nembhard WN, 2010, J PEDIATR-US, V156, P259, DOI 10.1016/j.jpeds.2009.07.058; Park WH, 2013, BIOFACTORS, V39, P494, DOI 10.1002/biof.1092; Pashmforoush M, 2004, CELL, V117, P373, DOI 10.1016/S0092-8674(04)00405-2; Puga A, 2011, TOXICOL SCI, V120, P256, DOI 10.1093/toxsci/kfq393; Puga A, 2009, BIOCHEM PHARMACOL, V77, P713, DOI 10.1016/j.bcp.2008.08.031; Quintana FJ, 2013, PHARMACOL REV, V65, P1148, DOI 10.1124/pr.113.007823; Razeghi P, 2001, CIRCULATION, V104, P2923, DOI 10.1161/hc4901.100526; Rubinstein J, 2014, AM J PHYSIOL-HEART C, V306, pH574, DOI 10.1152/ajpheart.00854.2013; Sauzeau V, 2011, J BIOL CHEM, V286, P2896, DOI 10.1074/jbc.M110.187534; Schmidt JV, 1996, ANNU REV CELL DEV BI, V12, P55, DOI 10.1146/annurev.cellbio.12.1.55; Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108; Shertzer HG, 2006, TOXICOL APPL PHARM, V217, P363, DOI 10.1016/j.taap.2006.09.014; Sipido KR, 2002, CARDIOVASC RES, V53, P782, DOI 10.1016/S0008-6363(01)00470-9; Srivastava D, 1999, CURR OPIN CARDIOL, V14, P263, DOI 10.1097/00001573-199905000-00011; Srivastava D, 2000, NATURE, V407, P221, DOI 10.1038/35025190; Stites T, 2006, J NUTR, V136, P390, DOI 10.1093/jn/136.2.390; Tanaka M, 1999, DEVELOPMENT, V126, P1269; Tanner K, 2005, PEDIATRICS, V116, pE833, DOI 10.1542/peds.2005-0397; Tappenden DM, 2013, J TOXICOL-US, V2013, DOI 10.1155/2013/279829; Tennstedt C, 1999, HEART, V82, P34, DOI 10.1136/hrt.82.1.34; Thackaberry EA, 2005, TOXICOL SCI, V88, P242, DOI 10.1093/toxsci/kfi302; van der Bom T, 2011, NAT REV CARDIOL, V8, P50, DOI 10.1038/nrcardio.2010.166; Vecoli C, 2014, CURR GENOMICS, V15, P390, DOI 10.2174/1389202915666140716175634; Vijay V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117047; Wang Q, 2013, ENVIRON HEALTH PERSP, V121, P1334, DOI 10.1289/ehp.1307297; WEBER H, 1985, ARCH TOXICOL, V57, P159, DOI 10.1007/BF00290880; Weraarpachai W, 2012, AM J HUM GENET, V90, P142, DOI 10.1016/j.ajhg.2011.11.027; Wijnen WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096290; Winans B, 2015, J IMMUNOL, V194, P4446, DOI 10.4049/jimmunol.1402044; Yeung Edwina H, 2014, Curr Epidemiol Rep, V1, P9; Yoshioka W, 2011, J STEROID BIOCHEM, V127, P96, DOI 10.1016/j.jsbmb.2010.12.005; Zhang Nan, 2011, J Cardiovasc Dis Res, V2, P91, DOI 10.4103/0975-3583.83033	71	33	35	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142440	10.1371/journal.pone.0142440	http://dx.doi.org/10.1371/journal.pone.0142440			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555816	Green Published, Green Submitted, gold			2022-12-27	WOS:000364430700106
J	Doellinger, J; Schaade, L; Nitsche, A				Doellinger, Joerg; Schaade, Lars; Nitsche, Andreas			Comparison of the Cowpox Virus and Vaccinia Virus Mature Virion Proteome: Analysis of the Species- and Strain-Specific Proteome	PLOS ONE			English	Article							KAPPA-B ACTIVATION; INTRACELLULAR MATURE; POXVIRUS; IDENTIFICATION; ALPHA; GENE	Cowpox virus (CPXV) causes most zoonotic orthopoxvirus (OPV) infections in Europe and Northern as well as Central Asia. The virus has the broadest host range of OPV and is transmitted to humans from rodents and other wild or domestic animals. Increasing numbers of human CPXV infections in a population with declining immunity have raised concerns about the virus' zoonotic potential. While there have been reports on the proteome of other human-pathogenic OPV, namely vaccinia virus (VACV) and monkeypox virus (MPXV), the protein composition of the CPXV mature virion (MV) is unknown. This study focused on the comparative analysis of the VACV and CPXV MV proteome by label-free single-run proteomics using nano liquid chromatography and high-resolution tandem mass spectrometry (nLC-MS/MS). The presented data reveal that the common VACV and CPXV MV proteome contains most of the known conserved and essential OPV proteins and is associated with cellular proteins known to be essential for viral replication. While the species-specific proteome could be linked mainly to less genetically-conserved gene products, the strain-specific protein abundance was found to be of high variance in proteins associated with entry, host-virus interaction and protein processing.	[Doellinger, Joerg; Schaade, Lars; Nitsche, Andreas] Robert Koch Inst, Ctr Biol Threats & Special Pathogens, Highly Pathogen Viruses ZBS1, Berlin, Germany	Robert Koch Institute	Doellinger, J (corresponding author), Robert Koch Inst, Ctr Biol Threats & Special Pathogens, Highly Pathogen Viruses ZBS1, Berlin, Germany.	doellingerj@rki.de		Doellinger, Joerg/0000-0001-8309-082X; Nitsche, Andreas/0000-0001-8185-3176				BAXBY D, 1994, BRIT J DERMATOL, V131, P598, DOI 10.1111/j.1365-2133.1994.tb04969.x; BREMAN JG, 1980, NEW ENGL J MED, V303, P1263, DOI 10.1056/NEJM198011273032204; Chang SJ, 2009, J VIROL, V83, P4140, DOI 10.1128/JVI.01835-08; Chung CS, 2006, J VIROL, V80, P2127, DOI 10.1128/JVI.80.5.2127-2140.2006; Cox J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S16-S12; Cox J, 2011, J AM SOC MASS SPECTR, V22, P1373, DOI 10.1007/s13361-011-0142-8; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; CZERNY CP, 1991, J VET MED B, V38, P421, DOI 10.1111/j.1439-0450.1991.tb00891.x; Dabrowski PW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079953; Earl P L, 2001, Curr Protoc Mol Biol, VChapter 16, DOI 10.1002/0471142727.mb1617s43; Essbauer S, 2010, VET MICROBIOL, V140, P229, DOI 10.1016/j.vetmic.2009.08.026; Geiger T, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014050; Humphries AC, 2012, CELL HOST MICROBE, V12, P346, DOI 10.1016/j.chom.2012.08.002; Ishihama Y, 2006, J PROTEOME RES, V5, P988, DOI 10.1021/pr050385q; Katsafanas GC, 2007, CELL HOST MICROBE, V2, P221, DOI 10.1016/j.chom.2007.08.005; Leite JA, 2011, ARCH VIROL, V156, P617, DOI 10.1007/s00705-010-0900-0; Lewis-Jones S, 2004, CURR OPIN INFECT DIS, V17, P81, DOI 10.1097/00001432-200404000-00003; Manes NP, 2008, J PROTEOME RES, V7, P960, DOI 10.1021/pr070432+; McKelvey TA, 2002, J VIROL, V76, P11216, DOI 10.1128/JVI.76.22.11216-11225.2002; Nishiyama A, 2011, GENE DEV, V25, P165, DOI 10.1101/gad.614411; Pelkonen PM, 2003, EMERG INFECT DIS, V9, P1458, DOI 10.3201/eid0911.020814; PERKUS ME, 1990, VIROLOGY, V179, P276, DOI 10.1016/0042-6822(90)90296-4; Resch W, 2007, VIROLOGY, V358, P233, DOI 10.1016/j.virol.2006.08.025; Schroeder K, 2010, MOL CELL PROBE, V24, P110, DOI 10.1016/j.mcp.2009.10.008; Shchelkunov SN, 2012, ADV VIROL, V2012, DOI 10.1155/2012/524743; Shchelkunov SN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003756; Shisler JL, 2004, J VIROL, V78, P3553, DOI 10.1128/JVI.78.7.3553-3560.2004; Smith CA, 1997, VIROLOGY, V236, P316, DOI 10.1006/viro.1997.8730; Teale A, 2009, J VIROL, V83, P2099, DOI 10.1128/JVI.01753-08; Upton C, 2003, J VIROL, V77, P7590, DOI 10.1128/JVI.77.13.7590-7600.2003; Vorou RM, 2008, CURR OPIN INFECT DIS, V21, P153, DOI 10.1097/QCO.0b013e3282f44c74; Wiebusch L, 2003, EMBO REP, V4, P42, DOI 10.1038/sj.embor.embor707; Wisniewski JR, 2015, ANAL CHEM, V87, P4110, DOI 10.1021/ac504689z; Wisniewski JR, 2014, J PROTEOMICS, V109, P322, DOI 10.1016/j.jprot.2014.07.012; Wisniewski JR, 2014, MOL CELL PROTEOMICS, V13, P3497, DOI 10.1074/mcp.M113.037309; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Wunschel D, 2013, ANALYST, V138, P6385, DOI 10.1039/c3an00711a; Xu ZY, 2014, J VIROL, V88, P490, DOI 10.1128/JVI.02385-13; Yoder JD, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-10	39	18	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0141527	10.1371/journal.pone.0141527	http://dx.doi.org/10.1371/journal.pone.0141527			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556597	Green Published, gold, Green Submitted			2022-12-27	WOS:000364430700031
J	Ellis, K; Friedman, C; Yedvobnick, B				Ellis, Kaitlyn; Friedman, Chloe; Yedvobnick, Barry			Drosophila domino Exhibits Genetic Interactions with a Wide Spectrum of Chromatin Protein-Encoding Loci	PLOS ONE			English	Article							NOTCH PATHWAY FUNCTION; CELL SELF-RENEWAL; TRANSCRIPTION FACTOR; REMODELING COMPLEX; WING DEVELOPMENT; MELANOGASTER; EXPRESSION; SCREEN; TIP60; POLYCOMB	The Drosophila domino gene encodes protein of the SWI2/SNF2 family that has widespread roles in transcription, replication, recombination and DNA repair. Here, the potential relationship of Domino protein to other chromatin-associated proteins has been investigated through a genetic interaction analysis. We scored for genetic modification of a domino wing margin phenotype through coexpression of RNAi directed against a set of previously characterized and more newly characterized chromatin-encoding loci. A set of other SWI2/SNF2 loci were also assayed for interaction with domino. Our results show that the majority of tested loci exhibit synergistic enhancement or suppression of the domino wing phenotype. Therefore, depression in domino function sensitizes the wing margin to alterations in the activity of numerous chromatin components. In several cases the genetic interactions are associated with changes in the level of cell death measured across the dorsal-ventral margin of the wing imaginal disc. These results highlight the broad realms of action of many chromatin proteins and suggest significant overlap with Domino function in fundamental cell processes, including cell proliferation, cell death and cell signaling.	[Ellis, Kaitlyn; Friedman, Chloe; Yedvobnick, Barry] Emory Univ, Dept Biol, Atlanta, GA 30322 USA	Emory University	Yedvobnick, B (corresponding author), Emory Univ, Dept Biol, Atlanta, GA 30322 USA.	Barry.Yedvobnick@Emory.Edu			Ammerman Foundation [D2641000]	Ammerman Foundation	This research was funded by a gift to BY lab from the Ammerman Foundation #D2641000, (http://nccsweb.urban.org/orgs/profile.php/521320467?popup=1#overview). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AE, 2011, DEVELOPMENT, V138, P1957, DOI 10.1242/dev.058461; Armstrong JA, 2005, GENETICS, V170, P1761, DOI 10.1534/genetics.105.041327; Asha H, 2003, GENETICS, V163, P203; Badenhorst P, 2002, GENE DEV, V16, P3186, DOI 10.1101/gad.1032202; Bararia D, 2008, LEUKEMIA, V22, P800, DOI 10.1038/sj.leu.2405101; Bhatia S, 2010, GENES CELLS, V15, P725, DOI 10.1111/j.1365-2443.2010.01416.x; BRAND AH, 1993, DEVELOPMENT, V118, P401; Braun A, 1997, GENETICS, V147, P623; Carre C, 2005, MOL CELL BIOL, V25, P8228, DOI 10.1128/MCB.25.18.8228-8238.2005; Carrera P, 2003, GENE DEV, V17, P2578, DOI 10.1101/gad.276703; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Collins H, 2013, G3-GENES GENOM GENET, V3, P1639, DOI 10.1534/g3.113.007419; Cronin SJF, 2009, SCIENCE, V325, P340, DOI 10.1126/science.1173164; Dekanty A, 2015, ONCOGENE, V34, P978, DOI 10.1038/onc.2014.42; Eissenberg JC, 2005, MOL CELL BIOL, V25, P6559, DOI 10.1128/MCB.25.15.6559-6569.2005; Fan Y, 2010, CELL DEATH DIFFER, V17, P534, DOI 10.1038/cdd.2009.185; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Gause M, 2006, MOL CELL BIOL, V26, P2347, DOI 10.1128/MCB.26.6.2347-2359.2006; Giraldez AJ, 2003, DEVELOPMENT, V130, P6533, DOI 10.1242/dev.00904; Gonzalez I, 2008, GENETICS, V179, P1373, DOI 10.1534/genetics.107.082966; Gordy C, 2012, PROTEIN CELL, V3, P17, DOI 10.1007/s13238-011-1127-x; Hall LE, 2004, GENET RES, V83, P71, DOI 10.1017/S0016672304006731; Helms W, 1999, DEV BIOL, V215, P358, DOI 10.1006/dbio.1999.9477; Kassavetis GA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098173; Kehle J, 1998, SCIENCE, V282, P1897, DOI 10.1126/science.282.5395.1897; KENNISON JA, 1988, P NATL ACAD SCI USA, V85, P8136, DOI 10.1073/pnas.85.21.8136; Kolesnikova TD, 2013, CHROMOSOMA, V122, P55, DOI 10.1007/s00412-012-0390-9; Kusch T, 2004, SCIENCE, V306, P2084, DOI 10.1126/science.1103455; Kwon MH, 2013, G3-GENES GENOM GENET, V3, P815, DOI 10.1534/g3.112.005496; Kwon SH, 2011, CELL CYCLE, V10, P625, DOI 10.4161/cc.10.4.14796; Li J, 2013, EMBO J, V32, P1829, DOI 10.1038/emboj.2013.111; Lu JR, 2007, P NATL ACAD SCI USA, V104, P9381, DOI 10.1073/pnas.0610279104; McDaniel IE, 2008, GENETICS, V178, P583, DOI 10.1534/genetics.107.079038; Moberg KH, 2005, DEV CELL, V9, P699, DOI 10.1016/j.devcel.2005.09.018; Mondal BC, 2014, ELIFE, V3, DOI 10.7554/eLife.03626; Moshkin YM, 2009, MOL CELL, V35, P782, DOI 10.1016/j.molcel.2009.07.020; Nagy P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003664; Qi D, 2006, GENETICS, V174, P241, DOI 10.1534/genetics.106.059980; Ruhf ML, 2001, DEVELOPMENT, V128, P1429; Schneiderman JI, 2009, P NATL ACAD SCI USA, V106, P14472, DOI 10.1073/pnas.0905816106; Schulz LL, 2006, FASEB J, V20, P488, DOI 10.1096/fj.05-5020fje; Sebald J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043144; Shukla V, 2014, GENETICS, V196, P481, DOI 10.1534/genetics.113.160531; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Tennessen JM, 2011, CELL METAB, V13, P139, DOI 10.1016/j.cmet.2011.01.005; van Bemmel JG, 2013, MOL CELL, V49, P759, DOI 10.1016/j.molcel.2013.01.040; Verheyen EM, 1996, GENETICS, V144, P1127; Walker J, 2011, GENETICS, V187, P1067, DOI 10.1534/genetics.110.123893; Xi RW, 2005, SCIENCE, V310, P1487, DOI 10.1126/science.1120140; Yagi Y, 2005, EMBO REP, V6, P1088, DOI 10.1038/sj.embor.7400542; Yan D, 2014, DEV CELL, V28, P459, DOI 10.1016/j.devcel.2014.01.020; Ye YH, 1999, J CELL BIOL, V146, P1351, DOI 10.1083/jcb.146.6.1351; Yu ZS, 2013, DEVELOPMENT, V140, P3635, DOI 10.1242/dev.094599; Zaytseva O, 2014, GENETICS, V196, P443, DOI 10.1534/genetics.113.159541; Zhang CX, 2000, DEV BIOL, V222, P27, DOI 10.1006/dbio.2000.9704	55	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142635	10.1371/journal.pone.0142635	http://dx.doi.org/10.1371/journal.pone.0142635			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555684	Green Submitted, Green Published, gold			2022-12-27	WOS:000364430700145
J	Kojima, KK; Jurka, J				Kojima, Kenji K.; Jurka, Jerzy			Ancient Origin of the U2 Small Nuclear RNA Gene-Targeting Non-LTR Retrotransposons Utopia	PLOS ONE			English	Article							SEQUENCE; FAMILY; SITE; PERFORMANCE; PHYLOGENIES; MECHANISM; ELEMENTS; DOMAIN; BLAST	Most non-long terminal repeat (non-LTR) retrotransposons encoding a restriction-like endonuclease show target-specific integration into repetitive sequences such as ribosomal RNA genes and microsatellites. However, only a few target-specific lineages of non-LTR retrotransposons are distributed widely and no lineage is found across the eukaryotic kingdoms. Here we report the most widely distributed lineage of target sequence-specific non-LTR retrotransposons, designated Utopia. Utopia is found in three supergroups of eukaryotes: Amoebozoa, SAR, and Opisthokonta. Utopia is inserted into a specific site of U2 small nuclear RNA genes with different strength of specificity for each family. Utopia families from oomycetes and wasps show strong target specificity while only a small number of Utopia copies from reptiles are flanked with U2 snRNA genes. Oomycete Utopia families contain an "archaeal" RNase H domain upstream of reverse transcriptase (RT), which likely originated from a plant RNase H gene. Analysis of Utopia from oomycetes indicates that multiple lineages of Utopia have been maintained inside of U2 genes with few copy numbers. Phylogenetic analysis of RT suggests the monophyly of Utopia, and it likely dates back to the early evolution of eukaryotes.	[Kojima, Kenji K.; Jurka, Jerzy] Genet Informat Res Inst, Los Altos, CA USA; [Kojima, Kenji K.] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol & Med Sci, Minato Ku, Tokyo, Japan; [Kojima, Kenji K.] Univ Tokyo, Inst Med Sci, Minato Ku, Tokyo, Japan	University of Tokyo; University of Tokyo	Kojima, KK (corresponding author), Genet Informat Res Inst, Los Altos, CA USA.	kojima@girinst.org	Kojima, Kenji/AAO-2213-2021		National Library Of Medicine of the National Institutes of Health [P41LM006252]; NATIONAL LIBRARY OF MEDICINE [P41LM006252] Funding Source: NIH RePORTER	National Library Of Medicine of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Research reported in this publication was supported by the National Library Of Medicine of the National Institutes of Health (http://www.nlm.nih.gov) under Award Number P41LM006252. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Adl SM, 2012, J EUKARYOT MICROBIOL, V59, P429, DOI 10.1111/j.1550-7408.2012.00644.x; AKSOY S, 1990, NUCLEIC ACIDS RES, V18, P785, DOI 10.1093/nar/18.4.785; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bao WD, 2015, MOBILE DNA-UK, V6, DOI 10.1186/s13100-015-0041-9; Belancio VP, 2008, GENOME RES, V18, P343, DOI 10.1101/gr.5558208; Belfort M, 1997, NUCLEIC ACIDS RES, V25, P3379, DOI 10.1093/nar/25.17.3379; BURKE WD, 1987, MOL CELL BIOL, V7, P2221, DOI 10.1128/MCB.7.6.2221; Burke WD, 2003, MOL BIOL EVOL, V20, P1260, DOI 10.1093/molbev/msg141; Burke WD, 2002, MOL BIOL EVOL, V19, P619, DOI 10.1093/oxfordjournals.molbev.a004121; Burke WD, 1999, MOL BIOL EVOL, V16, P502, DOI 10.1093/oxfordjournals.molbev.a026132; Eickbush T.H., 2002, MOBILE DNA-UK, V2, P1111, DOI [10.1128/9781555817954.ch49, DOI 10.1128/9781555817954.CH49]; Feng QH, 1996, CELL, V87, P905, DOI 10.1016/S0092-8674(00)81997-2; GABRIEL A, 1990, MOL CELL BIOL, V10, P615, DOI 10.1128/MCB.10.2.615; Gladyshev EA, 2010, MOBILE DNA-UK, V1, DOI 10.1186/1759-8753-1-12; Green RE, 2014, SCIENCE, V346, P1335, DOI 10.1126/science.1254449; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Jiang RHY, 2006, J MOL EVOL, V63, P458, DOI 10.1007/s00239-005-0211-3; Kapitonov VV, 2008, NAT REV GENET, V9, DOI 10.1038/nrg2165-c1; Kapitonov VV, 2009, GENE, V448, P207, DOI 10.1016/j.gene.2009.07.019; Kapitonov VV, 2009, REPBASE REPORTS, V9, P1524; Kapitonov VV, 2009, REPBASE REPORTS, V9, P1150; Kapitonov VV, 2009, REPBASE REPORTS, V9, P1143; Kapitonov VV, 2014, REPBASE REPORTS, V14, P311; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Kojima KK, 2006, MOL BIOL EVOL, V23, P1984, DOI 10.1093/molbev/msl067; Kojima KK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068260; Kojima KK, 2005, MOL BIOL EVOL, V22, P2157, DOI 10.1093/molbev/msi210; Kojima KK, 2005, GENOME RES, V15, P1106, DOI 10.1101/gr.3271405; Kojima KK, 2004, MOL BIOL EVOL, V21, P207, DOI 10.1093/molbev/msg235; Kojima KK, 2015, GENOME BIOL EVOL; Kojima KK, 2012, REPBASE REPORTS, V2012, P1906; LUAN DD, 1993, CELL, V72, P595, DOI 10.1016/0092-8674(93)90078-5; Malik HS, 1999, MOL BIOL EVOL, V16, P793, DOI 10.1093/oxfordjournals.molbev.a026164; Malik HS, 2000, GENETICS, V154, P193; OKAZAKI S, 1995, MOL CELL BIOL, V15, P4545; Smyshlyaev G, 2013, P NATL ACAD SCI USA, V110, P20140, DOI 10.1073/pnas.1310958110; St John JA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-415; Starnes JH, 2012, GENETICS, V191, P389, DOI 10.1534/genetics.111.137950; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; XIONG Y, 1993, NUCLEIC ACIDS RES, V21, P1318, DOI 10.1093/nar/21.5.1318; Yahara K, 2009, P NATL ACAD SCI USA, V106, P18861, DOI 10.1073/pnas.0908404106; ZIMMERLY S, 1995, CELL, V82, P545, DOI 10.1016/0092-8674(95)90027-6	46	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0140084	10.1371/journal.pone.0140084	http://dx.doi.org/10.1371/journal.pone.0140084			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556480	Green Published, gold, Green Submitted			2022-12-27	WOS:000364430700010
J	Liu, F; Wang, XW; Wu, G; Chen, L; Hu, P; Ren, H; Hu, HD				Liu, Fen; Wang, Xiwei; Wu, Gang; Chen, Ling; Hu, Peng; Ren, Hong; Hu, Huaidong			Coffee Consumption Decreases Risks for Hepatic Fibrosis and Cirrhosis: A Meta-Analysis	PLOS ONE			English	Article							GAMMA-GLUTAMYL-TRANSFERASE; LIVER FIBROSIS; HEPATOCELLULAR-CARCINOMA; CAFFEINE CONSUMPTION; ALCOHOL-CONSUMPTION; DRINKING; DIETARY; REPRODUCIBILITY; MECHANISMS; NAFLD	Background and Aim Previous studies have demonstrated that coffee consumption may be inversely correlated with hepatic fibrosis and cirrhosis. However, the reported results have been inconsistent. To summarize previous evidences quantitatively, a meta-analysis was performed. Methods The Medline, Web of Science, and Embase databases (from inception to June 2015) were searched to identify relevant trials that evaluated the effects of coffee consumption on hepatic fibrosis or cirrhosis. Odds ratios (ORs) of advanced hepatic fibrosis or cirrhosis for low or moderate, high, and any coffee consumption versus no consumption were pooled. Two cups per day was used as the cut-off level between low or moderate and high consumption. Results Sixteen studies were included, involving 3034 coffee consumers and 132076 people who do not consume coffee. The pooled results of the meta-analysis indicated that coffee consumers were less likely to develop cirrhosis compared with those who do not consume coffee, with a summary OR of 0.61 (95% CI: 0.45-0.84). For low or moderate coffee consumption versus no consumption, the pooled OR of hepatic cirrhosis was 0.66 (95% CI: 0.47-0.92). High coffee consumption could also significantly reduce the risk for hepatic cirrhosis when compared with no coffee consumption (OR = 0.53, 95% CI: 0.42-0.68). The effect of coffee consumption on hepatic fibrosis was summarized as well. The pooled OR of advanced hepatic fibrosis for coffee consumption versus no consumption was 0.73 (95% CI: 0.58-0.92). The protective effect of coffee on hepatic fibrosis and cirrhosis was also identified in subgroup meta-analyses of patients with alcoholic liver disease and chronic hepatitis C virus (HCV) infection. Conclusion Coffee consumption can significantly reduce the risk for hepatic fibrosis and cirrhosis.	[Liu, Fen; Wang, Xiwei; Chen, Ling; Hu, Peng; Ren, Hong; Hu, Huaidong] Chongqing Med Univ, Dept Clin Nutr, Affiliated Hosp 2, Chongqing, Peoples R China; [Liu, Fen; Wang, Xiwei; Chen, Ling; Hu, Huaidong] Chongqing Med Univ, Key Lab Mol Biol Infect Dis, Affiliated Hosp 2, Dept Infect Dis,Inst Viral Hepatitis, Chongqing, Peoples R China; [Wu, Gang] Luzhou Med Coll, Dept Infect Dis, Affiliated Hosp, Luzhou, Peoples R China	Chongqing Medical University; Chongqing Medical University; Southwest Medical University	Hu, HD (corresponding author), Chongqing Med Univ, Dept Clin Nutr, Affiliated Hosp 2, Chongqing, Peoples R China.	huaidong.hu@gmail.com			National Natural Science Foundation of China [81171560]; National Key Technology Support Program [2012BAI35B03]; "Par-Eu Scholars Program" of Chongqing city; National Science and Technology Major Project of China [2008ZX10002-006, 2012ZX10002007001, 2011ZX09302005, 2012ZX09303001-001, 2012ZX10002003]; Key Project of Chongqing Science and Technology [cstc2012gg-yyjsB10007]; Chongqing Natural Science Commission Foundation [cstc2011jjA10025]; Medical Research Fund by Chongqing Municipal Health Bureau [2009-1-71]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology Support Program(National Key Technology R&D Program); "Par-Eu Scholars Program" of Chongqing city; National Science and Technology Major Project of China; Key Project of Chongqing Science and Technology; Chongqing Natural Science Commission Foundation; Medical Research Fund by Chongqing Municipal Health Bureau	Funding: Funding was provided by the National Natural Science Foundation of China (81171560), National Key Technology Support Program (2012BAI35B03), and the "Par-Eu Scholars Program" of Chongqing city. This study was also supported by the National Science and Technology Major Project of China (2008ZX10002-006, 2012ZX10002007001, 2011ZX09302005, 2012ZX09303001-001, 2012ZX10002003), the Key Project of Chongqing Science and Technology (cstc2012gg-yyjsB10007), the Chongqing Natural Science Commission Foundation (cstc2011jjA10025), the Medical Research Fund by Chongqing Municipal Health Bureau (2009-1-71), and the "Par-Eu Scholars Program" of Chongqing city. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anty R, 2012, J HEPATOL, V57, P1090, DOI 10.1016/j.jhep.2012.07.014; Bambha K, 2014, LIVER INT, V34, P1250, DOI 10.1111/liv.12379; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bravi F, 2007, HEPATOLOGY, V46, P430, DOI 10.1002/hep.21708; Bravi F, 2013, CLIN GASTROENTEROL H, V11, P1413, DOI 10.1016/j.cgh.2013.04.039; CASIGLIA E, 1993, EUR J EPIDEMIOL, V9, P293, DOI 10.1007/BF00146266; Chu CM, 2006, SEMIN LIVER DIS, V26, P142, DOI 10.1055/s-2006-939752; Corrao G, 2001, ANN EPIDEMIOL, V11, P458, DOI 10.1016/S1047-2797(01)00223-X; CORRAO G, 1994, EUR J EPIDEMIOL, V10, P657, DOI 10.1007/BF01719277; Costentin CE, 2011, J HEPATOL, V54, P1123, DOI 10.1016/j.jhep.2010.08.027; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dranoff JA, 2014, HEPATOLOGY, V60, P464, DOI 10.1002/hep.27032; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; El-Serag H, 2014, GASTROENTEROLOGY, V146, pS129; Esposito F, 2003, ALIMENT PHARM THER, V17, P595, DOI 10.1046/j.1365-2036.2003.01429.x; Fattovich G, 2004, GASTROENTEROLOGY, V127, pS35, DOI 10.1053/j.gastro.2004.09.014; Freedman ND, 2009, HEPATOLOGY, V50, P1360, DOI 10.1002/hep.23162; FRIEDMAN SL, 1993, NEW ENGL J MED, V328, P1828; GALBRAITH RF, 1988, STAT MED, V7, P889, DOI 10.1002/sim.4780070807; Gallus S, 2002, ANN EPIDEMIOL, V12, P202, DOI 10.1016/S1047-2797(01)00304-0; HASEGAWA M, 1989, HEPATOLOGY, V10, P973, DOI 10.1002/hep.1840100614; Hedges LV, 2001, PSYCHOL METHODS, V6, P203, DOI 10.1037/1082-989X.6.3.203; Heidelbaugh JJ, 2006, AM FAM PHYSICIAN, V74, P756; Higgins JP GS, 2011, COCHRANE COLLABORATI, V5. 1. 0; Honjo S, 2001, J CLIN EPIDEMIOL, V54, P823, DOI 10.1016/S0895-4356(01)00344-4; Hu FB, 1999, AM J CLIN NUTR, V69, P243; Hui Alex Y., 2003, Expert Reviews in Molecular Medicine, V5, P1, DOI 10.1017/S1462399403005684; Imbert-Bismut F, 2001, LANCET, V357, P1069, DOI 10.1016/S0140-6736(00)04258-6; Khalaf N, 2015, CLIN GASTROENTEROL H, V13, P1521, DOI 10.1016/j.cgh.2015.01.030; Klatsky AL, 2006, ARCH INTERN MED, V166, P1190, DOI 10.1001/archinte.166.11.1190; KONO S, 1994, AM J EPIDEMIOL, V139, P723, DOI 10.1093/oxfordjournals.aje.a117062; Larsson SC, 2007, GASTROENTEROLOGY, V132, P1740, DOI 10.1053/j.gastro.2007.03.044; Larter CZ, 2013, OBESITY, V21, P1189, DOI 10.1002/oby.20123; Machado SR, 2014, BRAZ J INFECT DIS, V18, P170, DOI 10.1016/j.bjid.2013.09.001; MANTEL N, 1959, J NATL CANCER I, V22, P719; Modi AA, 2010, HEPATOLOGY, V51, P201, DOI 10.1002/hep.23279; Moreno MG, 2011, HEPATOL INT, V5, P857, DOI 10.1007/s12072-010-9247-6; Ong A, 2011, LIVER INT, V31, P1047, DOI 10.1111/j.1478-3231.2011.02555.x; Ruhl CE, 2005, GASTROENTEROLOGY, V128, P24, DOI 10.1053/j.gastro.2004.09.075; Shim SG, 2013, J GASTROEN HEPATOL, V28, P1877, DOI 10.1111/jgh.12317; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Stroffolini T, 2010, LIVER INT, V30, P867, DOI 10.1111/j.1478-3231.2010.02261.x; Tanaka K, 1998, INT J EPIDEMIOL, V27, P438, DOI 10.1093/ije/27.3.438; TOKUNAGA S, 1994, ENVIRON HEALTH PERSP, V102, P5, DOI 10.1289/ehp.94102s85; Triantos C, 2013, GASTROENTEROLOGY, V144, pS1008; Vitaglione P, 2010, HEPATOLOGY, V52, P1652, DOI 10.1002/hep.23902; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Walton HB, 2013, SCOT MED J, V58, P217, DOI 10.1177/0036933013507869; Wang XW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100128; White DL, 2011, DIGEST DIS SCI, V56, P1835, DOI 10.1007/s10620-010-1505-x	50	41	42	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142457	10.1371/journal.pone.0142457	http://dx.doi.org/10.1371/journal.pone.0142457			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556483	gold, Green Published, Green Submitted			2022-12-27	WOS:000364430700110
J	Ranganath, S; Bhandari, A; Avitahl-Curtis, N; McMahon, J; Wachtel, D; Zhang, JN; Leitheiser, C; Bernier, SG; Liu, G; Tran, TT; Celino, H; Tobin, J; Jung, J; Zhao, H; Glen, KE; Graul, C; Griffin, A; Schairer, WC; Higgins, C; Reza, TL; Mowe, E; Rivers, S; Scott, S; Monreal, A; Shea, C; Bourne, G; Coons, C; Smith, A; Tang, K; Mandyam, RA; Masferrer, J; Liu, D; Patel, DV; Fretzen, A; Murphy, CA; Milne, GT; Smythe, ML; Carlson, KE				Ranganath, Sheila; Bhandari, Ashok; Avitahl-Curtis, Nicole; McMahon, Jaimee; Wachtel, Derek; Zhang, Jenny; Leitheiser, Christopher; Bernier, Sylvie G.; Liu, Guang; Tran, Tran T.; Celino, Herodion; Tobin, Jenny; Jung, Joon; Zhao, Hong; Glen, Katie E.; Graul, Chris; Griffin, Aliesha; Schairer, Wayne C.; Higgins, Carolyn; Reza, Tammi L.; Mowe, Eva; Rivers, Sam; Scott, Sonya; Monreal, Alex; Shea, Courtney; Bourne, Greg; Coons, Casey; Smith, Adaline; Tang, Kim; Mandyam, Ramya A.; Masferrer, Jaime; Liu, David; Patel, Dinesh V.; Fretzen, Angelika; Murphy, Craig A.; Milne, G. Todd; Smythe, Mark L.; Carlson, Kenneth E.			Discovery and Characterization of a Potent Interleukin-6 Binding Peptide with Neutralizing Activity In Vivo	PLOS ONE			English	Article							CLASSIFICATION	Interleukin-6 (IL-6) is an important member of the cytokine superfamily, exerting pleiotropic actions on many physiological processes. Over-production of IL-6 is a hallmark of immune-mediated inflammatory diseases such as Castleman's Disease (CD) and rheumatoid arthritis (RA). Antagonism of the interleukin IL-6/IL-6 receptor (IL-6R)/gp130 signaling complex continues to show promise as a therapeutic target. Monoclonal antibodies (mAbs) directed against components of this complex have been approved as therapeutics for both CD and RA. To potentially provide an additional modality to antagonize IL-6 induced pathophysiology, a peptide-based antagonist approach was undertaken. Using a combination of molecular design, phage-display, and medicinal chemistry, disulfide-rich peptides (DRPs) directed against IL-6 were developed with low nanomolar potency in inhibiting IL-6-induced pSTAT3 in U937 monocytic cells. Targeted PEGylation of IL-6 binding peptides resulted in molecules that retained their potency against IL-6 and had a prolongation of their pharmacokinetic (PK) profiles in rodents and monkeys. One such peptide, PN-2921, contained a 40 kDa polyethylene glycol (PEG) moiety and inhibited IL-6-induced pSTAT3 in U937 cells with sub-nM potency and possessed 23, 36, and 59 h PK half-life values in mice, rats, and cynomolgus monkeys, respectively. Parenteral administration of PN-2921 to mice and cynomolgus monkeys potently inhibited IL-6-induced biomarker responses, with significant reductions in the acute inflammatory phase proteins, serum amyloid A (SAA) and C-reactive protein (CRP). This potent, PEGylated IL-6 binding peptide offers a new approach to antagonize IL-6-induced signaling and associated pathophysiology.	[Ranganath, Sheila; Bernier, Sylvie G.; Liu, Guang; Monreal, Alex; Milne, G. Todd; Carlson, Kenneth E.] Ironwood Pharmaceut, Discovery Biol, Cambridge, MA USA; [Bhandari, Ashok; Celino, Herodion; Patel, Dinesh V.] Protagonist Therapeut, Chem, Milpitas, CA USA; [Avitahl-Curtis, Nicole; Tobin, Jenny; Graul, Chris; Rivers, Sam; Shea, Courtney; Tang, Kim; Masferrer, Jaime] Ironwood Pharmaceut, Discovery Pharmacol, Cambridge, MA USA; [McMahon, Jaimee; Zhang, Jenny; Glen, Katie E.; Griffin, Aliesha; Mowe, Eva; Scott, Sonya; Bourne, Greg; Mandyam, Ramya A.; Murphy, Craig A.; Smythe, Mark L.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Wachtel, Derek; Higgins, Carolyn] Ironwood Pharmaceut, DMPK, Cambridge, MA USA; [Leitheiser, Christopher; Zhao, Hong; Schairer, Wayne C.; Coons, Casey; Fretzen, Angelika] Ironwood Pharmaceut, Pharmaceut Dev, Cambridge, MA USA; [Tran, Tran T.; Bourne, Greg; Murphy, Craig A.; Smythe, Mark L.] Therapeutics Pty Ltd, Protagonist Pty Ltd, Brisbane, Qld, Australia; [Jung, Joon] Ironwood Pharmaceut, Chem, Cambridge, MA USA; [Reza, Tammi L.; Smith, Adaline] Ironwood Pharmaceut, Discovery Toxicol, Cambridge, MA USA; [Liu, David] Protagonist Therapeut, Biol, Milpitas, CA USA	Ironwood Pharmaceuticals, Inc.; Ironwood Pharmaceuticals, Inc.; University of Queensland; Ironwood Pharmaceuticals, Inc.; Ironwood Pharmaceuticals, Inc.; Ironwood Pharmaceuticals, Inc.; Ironwood Pharmaceuticals, Inc.	Carlson, KE (corresponding author), Ironwood Pharmaceut, Discovery Biol, Cambridge, MA USA.	kcarlson@ironwoodpharma.com	Bourne, Greg/C-7290-2017	Bourne, Greg/0000-0002-2792-2895; Griffin, Aliesha/0000-0001-6105-6962; Smythe, Mark/0000-0001-7840-1021	Ironwood Pharmaceuticals, Inc.	Ironwood Pharmaceuticals, Inc.	This research was funded by Ironwood Pharmaceuticals, Inc. The funding source was involved in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; Braddock M, 2007, EXPERT OPIN INV DRUG, V16, P251, DOI 10.1517/13543784.16.2.251; Cohan P, 2014, ENDOCR PRACT, V20, P84, DOI 10.4158/EP13127.RA; Harris JM, 2001, CLIN PHARMACOKINET, V40, P539, DOI 10.2165/00003088-200140070-00005; Heinrich PC, 2003, BIOCHEM J, V374, P42024; HIRANO T, 1986, NATURE, V324, P73, DOI 10.1038/324073a0; KING DS, 1990, INT J PEPT PROT RES, V36, P255; Love BL, 2014, AM J HEALTH-SYST PH, V71, P1081, DOI 10.2146/ajhp130575; Manfredini R, DEV IL 6 ANTAGONIST, V24, P1207; Moutabarrik A, 1994, Transpl Int, V7 Suppl 1, pS552; Mudter J, 2007, INFLAMM BOWEL DIS, V13, P1016, DOI 10.1002/ibd.20148; Nishimoto N, 2006, NAT CLIN PRACT RHEUM, V2, P619, DOI 10.1038/ncprheum0338; Northfield SE, 2014, EUR J MED CHEM, V77, P248, DOI 10.1016/j.ejmech.2014.03.011; Oberg F, 1992, GROWTH FACTORS, V7, P85, DOI 10.3109/08977199209023940; Scheller J, 2014, SEMIN IMMUNOL, V26, P2, DOI 10.1016/j.smim.2013.11.002; Silverman J, 2005, NAT BIOTECHNOL, V23, P1556, DOI 10.1038/nbt1166; Smythe ML, 1999, [No title captured], Patent No. [WO/2000/023474 A1, 2000023474]; Starovasnik MA, 1997, P NATL ACAD SCI USA, V94, P10080, DOI 10.1073/pnas.94.19.10080; Tanaka T, 2012, INT J BIOL SCI, V8, P1227, DOI 10.7150/ijbs.4666; Tonikian R, 2007, NAT PROTOC, V2, P1368, DOI 10.1038/nprot.2007.151; Tran TT, 2010, J COMPUT AID MOL DES, V24, P917, DOI 10.1007/s10822-010-9384-y; Tran TT, 2005, J COMPUT AID MOL DES, V19, P551, DOI 10.1007/s10822-005-9006-2; van Rhee F, 2010, J CLIN ONCOL, V28, P3701, DOI 10.1200/JCO.2009.27.2377; Vardanyan M, 2010, PAIN, V151, P257, DOI 10.1016/j.pain.2010.05.022; Zaki MH, CNTO 328 MONOCLONAL, V111, P592, DOI [10.1002/ijc.20270, DOI 10.1002/IJC.20270]; Zoller F, 2011, MOLECULES, V16, P2467, DOI 10.3390/molecules16032467	28	17	17	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0141330	10.1371/journal.pone.0141330	http://dx.doi.org/10.1371/journal.pone.0141330			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555695	Green Published, Green Submitted, gold			2022-12-27	WOS:000364430700025
J	Banerjee, M; Duan, QM; Xie, ZJ				Banerjee, Moumita; Duan, Qiming; Xie, Zijian			SH2 Ligand-Like Effects of Second Cytosolic Domain of Na/K-ATPase alpha 1 Subunit on Src Kinase	PLOS ONE			English	Article							FOCAL ADHESION KINASE; PROTEIN-TYROSINE KINASES; SIGNAL-TRANSDUCTION; FAMILY KINASES; BINDING-SITE; C-SRC; PHOSPHORYLATION SITES; CELL-MIGRATION; CANCER-CELLS; V-SRC	Our previous studies have suggested that the alpha 1 Na/K-ATPase interacts with Src to form a receptor complex. In vitro binding assays indicate an interaction between second cytosolic domain (CD2) of Na/K-ATPase alpha 1 subunit and Src SH2 domain. Since SH2 domain targets Src to specific signaling complexes, we expressed CD2 as a cytosolic protein and studied whether it could act as a Src SH2 ligand in LLC-PK1 cells. Co-immunoprecipitation analyses indicated a direct binding of CD2 to Src, consistent with the in vitro binding data. Functionally, CD2 expression increased basal Src activity, suggesting a Src SH2 ligand-like property of CD2. Consistently, we found that CD2 expression attenuated several signaling pathways where Src plays an important role. For instance, although it increased surface expression of Na/K-ATPase, it decreased ouabain-induced activation of Src and ERK by blocking the formation of Na/K-ATPase/Src complex. Moreover, it also attenuated cell attachment-induced activation of Src/FAK. Consequently, CD2 delayed cell spreading, and inhibited cell proliferation. Furthermore, these effects appear to be Src-specific because CD2 expression had no effect on EGF-induced activation of EGF receptor and ERK. Hence, the new findings indicate the importance of Na/K-ATPase/Src interaction in ouabain-induced signal transduction, and support the proposition that the CD2 peptide may be utilized as a Src SH2 ligand capable of blocking Src-dependent signaling pathways via a different mechanism from a general Src kinase inhibitor.	[Banerjee, Moumita; Xie, Zijian] Marshall Univ, Marshall Inst Interdisciplinary Res, Huntington, WV 25755 USA; [Duan, Qiming] Case Western Reserve Univ, Sch Med, Dept Med, Case Cardiovasc Res Inst, Cleveland, OH 44106 USA; [Duan, Qiming] Harrington Heart & Vasc Inst, Cleveland, OH USA	Marshall University; Case Western Reserve University	Xie, ZJ (corresponding author), Marshall Univ, Marshall Inst Interdisciplinary Res, Huntington, WV 25755 USA.	xiez@marshall.edu	Banerjee, Moumita/Y-7651-2019; Duan, Qiming/I-1822-2019	Duan, Qiming/0000-0002-6204-3028; Banerjee, Moumita/0000-0002-4463-7914	NHLBI [HL109015]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109015] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding: This work was supported by NHLBI grant HL109015.	Al-Obeidi FA, 2000, ONCOGENE, V19, P5690, DOI 10.1038/sj.onc.1203926; ALONSO G, 1995, J BIOL CHEM, V270, P9840, DOI 10.1074/jbc.270.17.9840; Basu N, 2009, MOL CELL BIOL, V29, P5277, DOI 10.1128/MCB.00001-09; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; Bradshaw JM, 1999, BIOCHEMISTRY-US, V38, P5147, DOI 10.1021/bi982974y; Brunton VG, 2005, CANCER RES, V65, P1335, DOI 10.1158/0008-5472.CAN-04-1949; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Cary LA, 2002, MOL CELL BIOL, V22, P2427, DOI 10.1128/MCB.22.8.2427-2440.2002; Cary LA, 1998, J CELL BIOL, V140, P211, DOI 10.1083/jcb.140.1.211; DEVARAJAN P, 1994, P NATL ACAD SCI USA, V91, P2965, DOI 10.1073/pnas.91.8.2965; Dvela M, 2012, AM J PHYSIOL-CELL PH, V302, pC442, DOI 10.1152/ajpcell.00336.2011; EIDE BL, 1995, MOL CELL BIOL, V15, P2819; Hanks SK, 2003, FRONT BIOSCI-LANDMRK, V8, pD982, DOI 10.2741/1114; HULL RN, 1976, IN VITRO CELL DEV B, V12, P670, DOI 10.1007/BF02797469; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Izawa T, 2012, MOL CELL BIOL, V32, P2943, DOI 10.1128/MCB.00077-12; Kaneko T, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003021; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Kraskouskaya D, 2013, CHEM SOC REV, V42, P3337, DOI 10.1039/c3cs35449k; Lai FF, 2013, J BIOL CHEM, V288, P13295, DOI 10.1074/jbc.M113.467381; Li ZC, 2011, J BIOL CHEM, V286, P32394, DOI 10.1074/jbc.M110.207597; Li ZC, 2009, J BIOL CHEM, V284, P21066, DOI 10.1074/jbc.M109.013821; Li ZC, 2009, PFLUG ARCH EUR J PHY, V457, P635, DOI 10.1007/s00424-008-0470-0; Liang M, 2007, J BIOL CHEM, V282, P10585, DOI 10.1074/jbc.M609181200; Lindfors HE, 2012, IUBMB LIFE, V64, P538, DOI 10.1002/iub.1038; Lingrel JB, 2010, ANNU REV PHYSIOL, V72, P395, DOI 10.1146/annurev-physiol-021909-135725; Liu BA, 2012, PHILOS T R SOC B, V367, P2556, DOI 10.1098/rstb.2012.0107; Liu JA, 2005, KIDNEY INT, V67, P1844, DOI 10.1111/j.1523-1755.2005.00283.x; Liu LJ, 2007, AM J PHYSIOL-CELL PH, V293, pC1489, DOI 10.1152/ajpcell.00158.2007; Lombardo CR, 1995, BIOCHEMISTRY-US, V34, P16456, DOI 10.1021/bi00050a029; Mandine E, 2002, BIOCHEM BIOPH RES CO, V298, P185, DOI 10.1016/S0006-291X(02)02424-5; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Owen JD, 1999, MOL CELL BIOL, V19, P4806; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Pawson T, 2009, CURR OPIN CELL BIOL, V21, P147, DOI 10.1016/j.ceb.2009.02.005; Playford MP, 2004, ONCOGENE, V23, P7928, DOI 10.1038/sj.onc.1208080; Pugacheva EN, 2006, CURR OPIN CELL BIOL, V18, P507, DOI 10.1016/j.ceb.2006.08.014; Richardson A, 1997, MOL CELL BIOL, V17, P6906, DOI 10.1128/MCB.17.12.6906; Roskoski R, 2004, BIOCHEM BIOPH RES CO, V324, P1155, DOI 10.1016/j.bbrc.2004.09.171; Sawyer TK, 2002, MINI-REV MED CHEM, V2, P475, DOI 10.2174/1389557023405765; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Schlaepfer DD, 1998, MOL CELL BIOL, V18, P2571, DOI 10.1128/MCB.18.5.2571; Schlaepfer DD, 1996, MOL CELL BIOL, V16, P5623; Sen Banibrata, 2011, J Signal Transduct, V2011, P865819, DOI 10.1155/2011/865819; Shakespeare W, 2000, P NATL ACAD SCI USA, V97, P9373, DOI 10.1073/pnas.97.17.9373; Shvartsman DE, 2007, J CELL BIOL, V178, P675, DOI 10.1083/jcb.200701133; Stabach PR, 2008, AM J PHYSIOL-CELL PH, V295, pC1202, DOI 10.1152/ajpcell.00273.2008; Stover DR, 1996, J BIOL CHEM, V271, P12481, DOI 10.1074/jbc.271.21.12481; Taylor JD, 2008, PROTEINS, V73, P929, DOI 10.1002/prot.22119; Tian J, 2006, MOL BIOL CELL, V17, P317, DOI 10.1091/mbc.E05-08-0735; Tian J, 2009, J BIOL CHEM, V284, P14921, DOI 10.1074/jbc.M808355200; Violette SM, 2001, BONE, V28, P54, DOI 10.1016/S8756-3282(00)00427-0; WAKSMAN G, 1993, CELL, V72, P779, DOI 10.1016/0092-8674(93)90405-F; Waksman Gabriel, 2004, Expert Reviews in Molecular Medicine, V6, P1, DOI 10.1017/S1462399404007331; Xie Zijian, 2003, Mol Interv, V3, P157, DOI 10.1124/mi.3.3.157; XING Z, 1994, MOL BIOL CELL, V5, P413, DOI 10.1091/mbc.5.4.413; Yadav SS, 2007, CANCER LETT, V257, P116, DOI 10.1016/j.canlet.2007.07.012; Ye GF, 2009, BIOORG CHEM, V37, P133, DOI 10.1016/j.bioorg.2009.05.003; Ye QQ, 2013, J BIOL CHEM, V288, P5803, DOI 10.1074/jbc.M112.442608; Ye QQ, 2011, J BIOL CHEM, V286, P6225, DOI 10.1074/jbc.M110.202051; Yeo MG, 2006, MOL CELL BIOL, V26, P4399, DOI 10.1128/MCB.01147-05; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	65	22	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2015	10	11							e0142119	10.1371/journal.pone.0142119	http://dx.doi.org/10.1371/journal.pone.0142119			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7AC	26551526	gold, Green Submitted, Green Published			2022-12-27	WOS:000364422800017
J	Silhavy, R; Silhavy, P; Prokopova, Z				Silhavy, Radek; Silhavy, Petr; Prokopova, Zdenka			Algorithmic Optimisation Method for Improving Use Case Points Estimation	PLOS ONE			English	Article								This paper presents a new size estimation method that can be used to estimate size level for software engineering projects. The Algorithmic Optimisation Method is based on Use Case Points and on Multiple Least Square Regression. The method is derived into three phases. The first phase deals with calculation Use Case Points and correction coefficients values. Correction coefficients are obtained by using Multiple Least Square Regression. New project is estimated in the second and third phase. In the second phase Use Case Points parameters for new estimation are set up and in the third phase project estimation is performed. Final estimation is obtained by using newly developed estimation equation, which used two correction coefficients. The Algorithmic Optimisation Method performs approximately 43% better than the Use Case Points method, based on their magnitude of relative error score. All results were evaluated by standard approach: visual inspection, goodness of fit measure and statistical significance.	[Silhavy, Radek; Silhavy, Petr; Prokopova, Zdenka] Tomas Bata Univ Zlin, Fac Appl Informat, Zlin, Czech Republic	Tomas Bata University Zlin	Silhavy, R (corresponding author), Tomas Bata Univ Zlin, Fac Appl Informat, Zlin, Czech Republic.	rsilhavy@fai.utb.cz	Silhavy, Petr/H-6414-2012; Silhavy, Radek/H-6422-2012; Prokopová, Zdenka/H-6371-2012	Silhavy, Petr/0000-0002-3724-7854; Silhavy, Radek/0000-0002-5637-8796; Prokopová, Zdenka/0000-0002-0762-7100	Department of Computers and Communication System of the Faculty of Applied Informatics (Tomas Bata University in Zlin)	Department of Computers and Communication System of the Faculty of Applied Informatics (Tomas Bata University in Zlin)	Funding: This study was funded by the Department of Computers and Communication System of the Faculty of Applied Informatics (Tomas Bata University in Zlin).	Azevedo S, 2012, INNOV SYST SOFTW ENG, V8, P51, DOI 10.1007/s11334-011-0177-9; Braz MR, 2006, COMP SOFTW APPL C 20; Diev S., 2006, ACM SIGSOFT SOFTWARE, V31, P1, DOI [10.1145/1218776.1218780, DOI 10.1145/1218776.1218780]; Karner G., 1993, LITHIDAEX9344 U LINK, V21; Mohagheghi P, 2005, PROC INT CONF SOFTW, P303; Ochodek M, 2011, INFORM SOFTWARE TECH, V53, P885, DOI 10.1016/j.infsof.2011.02.004; Ochodek M, 2011, INFORM SOFTWARE TECH, V53, P200, DOI 10.1016/j.infsof.2010.10.005; Pindyck R.S., 2013, ECONOMETRIC MODELS E; Robiolo G, 2009, T PATHS 2 USE CASE B, P422, DOI [10.1109/esem.2009.5316021, DOI 10.1109/ESEM.2009.5316021]; Robiolo G, 2008, INNOV SYST SOFTW ENG, V4, P31, DOI 10.1007/s11334-007-0043-y; Subriadi Apol Pribadi, 2014, Journal of Theoretical and Applied Information Technology, V59, P735; Wang F., 2009, EXTENDED USE CASE PO, P1, DOI [10.1109/cise.2009.5364706, 10.1109/CISE.2009.5364706, DOI 10.1109/CISE.2009.5364706]	12	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2015	10	11							e0141887	10.1371/journal.pone.0141887	http://dx.doi.org/10.1371/journal.pone.0141887			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7AC	26550835	Green Published, gold, Green Submitted			2022-12-27	WOS:000364422800011
J	Xie, BD; Zhang, CF; Kang, K; Jiang, SL				Xie, Baodong; Zhang, Chunfeng; Kang, Kai; Jiang, Shulin			miR-599 Inhibits Vascular Smooth Muscle Cells Proliferation and Migration by Targeting TGFB2	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; EPITHELIAL-MESENCHYMAL TRANSITION; GASTRIC-CANCER; NEOINTIMAL FORMATION; GALLBLADDER CANCER; PHENOTYPIC SWITCH; DOWN-REGULATION; EXPRESSION; MICRORNA; ATHEROSCLEROSIS	Aberrant proliferation and migration of vascular smooth muscle cells (VSMCs) play a crucial role in the pathogenesis of cardiovascular diseases including coronary heart disease, restenosis and atherosclerosis. MicroRNAs are a class of small, non-coding and endogenous RNAs that play critical roles in VSMCs function. In this study, we showed that PDGF-bb, as a stimulant, promoted VSMCs proliferation and suppressed the expression of miR-599. Moreover, overexpression of miR-599 inhibited VSMCs proliferation and also suppressed the PCNA and ki-67 expression. In addition, we demonstrated that ectopic expression of miR-599 repressed the VSMCs migration. We also showed that miR-599 inhibited type I collagen, type V collagen and proteoglycan expression. Furthermore, we identified TGFb2 as a direct target gene of miR-599 in VSMCs. Overexpression of TGFb2 reversed miR-599-induced inhibition of VSMCs proliferation and type I collagen, type V collagen and proteoglycan expression. In conclusion, our findings suggest miR-599 plays a crucial role in controlling VSMCs proliferation and matrix gene expression by regulating TGFb2 expression.	[Xie, Baodong; Zhang, Chunfeng; Kang, Kai; Jiang, Shulin] Harbin Med Univ, Affiliated Hosp 2, Dept Cardiovasc Surg, Harbin, Heilongjiang, Peoples R China	Harbin Medical University	Kang, K (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Dept Cardiovasc Surg, Harbin, Heilongjiang, Peoples R China.	kai1kang@sina.com; jiangshulin@aliyun.com			Science and Technology Research Project of Department of Education of Heilongjiang Province [12541434]; Heilongjiang Provincial Science and Technology Research Project [LC2012C03]; National Science Foundation of China [81471805]; Chinese Postdoctoral Science Foundation [2014 M551272]; Scienctific Research Project of Educational Department of Heilongjiang Province [11531109]	Science and Technology Research Project of Department of Education of Heilongjiang Province; Heilongjiang Provincial Science and Technology Research Project; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Scienctific Research Project of Educational Department of Heilongjiang Province	Funding: This research was funded by a grant from the Science and Technology Research Project of Department of Education of Heilongjiang Province (12541434), Heilongjiang Provincial Science and Technology Research Project (LC2012C03), National Science Foundation of China (81471805), Chinese Postdoctoral Science Foundation (2014 M551272), and Scienctific Research Project of Educational Department of Heilongjiang Province (11531109) to KK. URL is http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cesi V, 2011, CELL CYCLE, V10, P4149, DOI 10.4161/cc.10.23.18346; Chen J, 2014, J CELL PHYSIOL, V229, P1647, DOI 10.1002/jcp.24610; Choe N, 2013, ATHEROSCLEROSIS, V229, P348, DOI 10.1016/j.atherosclerosis.2013.05.009; Han M, 2011, CURR OPIN CARDIOL, V26, P181, DOI 10.1097/HCO.0b013e328345983d; Hou N, 2011, CLIN EXP PHARMACOL P, V38, P905, DOI 10.1111/j.1440-1681.2011.05619.x; Karnuth B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093067; Kitamura K, 2014, MOL CANCER THER, V13, P444, DOI 10.1158/1535-7163.MCT-13-0448; Li P, 2013, CIRC RES, V113, P1117, DOI 10.1161/CIRCRESAHA.113.301306; Li P, 2013, CARDIOVASC RES, V99, P185, DOI 10.1093/cvr/cvt082; Li Z, 2015, ONCOTARGET; Li Z, 2015, ONCOTARGET, V6, P17559, DOI 10.18632/oncotarget.2755; Li Z, 2015, ONCOTARGET, V6, P13914, DOI 10.18632/oncotarget.4227; Li Z, 2015, CELL PROLIFERAT, V48, P278, DOI 10.1111/cpr.12180; Li Z, 2015, CELL PROLIFERAT, V48, P1, DOI 10.1111/cpr.12160; Li Z, 2015, GASTRIC CANCER, V18, P43, DOI 10.1007/s10120-014-0340-8; Lyu XM, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-51; Ma S, 2011, CYTOKINE GROWTH F R, V22, P167, DOI 10.1016/j.cytogfr.2011.05.004; Mallat Z, 2002, CURR OPIN LIPIDOL, V13, P523, DOI 10.1097/00041433-200210000-00008; Murakami Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106314; Otaegui D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006309; Piepoli A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033663; Qiu YH, 2014, MOL BIOSYST, V10, P679, DOI 10.1039/c3mb70479c; Sabarinathan R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082699; Singh NN, 2006, CYTOKINE GROWTH F R, V17, P487, DOI 10.1016/j.cytogfr.2006.09.002; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Song L, 2012, ARCH BIOCHEM BIOPHYS, V528, P204, DOI 10.1016/j.abb.2012.08.015; Stein JJ, 2014, SURGERY, V155, P228, DOI 10.1016/j.surg.2013.08.003; Torella D, 2011, CIRC RES, V109, P880, DOI 10.1161/CIRCRESAHA.111.240150; Vrba L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054398; Wang J, 2013, EXP CELL RES, V319, P1165, DOI 10.1016/j.yexcr.2013.03.010; Wang J, 2014, TUMOR BIOL, V35, P4859, DOI 10.1007/s13277-014-1637-2; Wang YS, 2012, CARDIOVASC RES, V95, P517, DOI 10.1093/cvr/cvs223; Wojcicka A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097624; Xu XY, 2015, FEBS LETT, V589, P407, DOI 10.1016/j.febslet.2014.12.027; Yu X, 2015, ONCOTARGET; Yu X, 2015, CELL PROLIFERAT, V48, P271, DOI 10.1111/cpr.12179; Yu X, 2014, INT J MOL MED, V34, P923, DOI 10.3892/ijmm.2014.1853; Yu X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083080; Zhang H, 2013, MOL CELL BIOCHEM, V375, P11, DOI 10.1007/s11010-012-1512-7; Zhang Y, 2011, J HYPERTENS, V29, P1560, DOI 10.1097/HJH.0b013e328348ef8e; Zhang ZP, 2011, CANCER GENET-NY, V204, P486, DOI 10.1016/j.cancergen.2011.07.004; Zhao J, 2013, ARTERIOSCL THROM VAS, V33, P257, DOI 10.1161/ATVBAHA.112.300200	42	46	52	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2015	10	11							e0141512	10.1371/journal.pone.0141512	http://dx.doi.org/10.1371/journal.pone.0141512			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7AC	26551255	Green Published, Green Submitted, gold			2022-12-27	WOS:000364422800006
J	Bradley, SJ; Suarez-Fueyo, A; Moss, DR; Kyttaris, VC; Tsokos, GC				Bradley, Sean J.; Suarez-Fueyo, Abel; Moss, David R.; Kyttaris, Vasileios C.; Tsokos, George C.			T Cell Transcriptomes Describe Patient Subtypes in Systemic Lupus Erythematosus	PLOS ONE			English	Article							GENE-EXPRESSION; DISEASE-ACTIVITY; RHEUMATOID-ARTHRITIS; INTERFERON; ACTIVATION; DIFFERENTIATION; AUTOIMMUNITY; PROGRESSION; HOMEOSTASIS; COMPLEXES	Background T cells regulate the adaptive immune response and have altered function in autoimmunity. Systemic Lupus Erythematosus (SLE) has great diversity of presentation and treatment response. Peripheral blood component gene expression affords an efficient platform to investigate SLE immune dysfunction and help guide diagnostic biomarker development for patient stratification. Methods Gene expression in peripheral blood T cell samples for 14 SLE patients and 4 controls was analyzed by high depth sequencing. Unbiased clustering of genes and samples revealed novel patterns related to disease etiology. Functional annotation of these genes highlights pathways and protein domains involved in SLE manifestation. Results We found transcripts for hundreds of genes consistently altered in SLE T cell samples, for which DAVID analysis highlights induction of pathways related to mitochondria, nucleotide metabolism and DNA replication. Fewer genes had reduced mRNA expression, and these were linked to signaling, splicing and transcriptional activity. Gene signatures associated with the presence of dsDNA antibodies, low complement levels and nephritis were detected. T cell gene expression also indicates the presence of several patient subtypes, such as having only a minimal expression phenotype, male type, or severe with or without induction of genes related to membrane protein production. Conclusions Unbiased transcriptome analysis of a peripheral blood component provides insight on autoimmune pathophysiology and patient variability. We present an open source workflow and richly annotated dataset to support investigation of T cell biology, develop biomarkers for patient stratification and perhaps help indicate a source of SLE immune dysfunction.	[Bradley, Sean J.; Suarez-Fueyo, Abel; Kyttaris, Vasileios C.; Tsokos, George C.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med,Div Rheumatol, Boston, MA 02215 USA; [Moss, David R.] Tufts Med Ctr, Dept Anesthesiol, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Tufts Medical Center	Bradley, SJ (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med,Div Rheumatol, Boston, MA 02215 USA.	sjbradle@bidmc.harvard.edu; gtsokos@bidmc.harvard.edu	Kyttaris, Vasileios/AAR-4507-2020; Suarez Fueyo, Abel/E-5746-2017; tsokos, george C/O-3360-2013; Suarez-Fueyo, Abel/D-1691-2013	Kyttaris, Vasileios/0000-0001-7652-3826; tsokos, george C/0000-0001-9589-2360; Suarez-Fueyo, Abel/0000-0002-8696-0197	United States National Institutes for Health [R01AI042269, R01AR060849];  [T32 AI074549]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI074549, R01AI042269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060849] Funding Source: NIH RePORTER	United States National Institutes for Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was funded by the United States National Institutes for Health (http://www.nih.gov/), with grant number R01AI042269 to GCT (Lymphocyte Signaling Defects in Patients with Lupus), R01AR060849 to VCK (The role of interleukin 23 in lupus), and SJB is funded under training grant T32 AI074549. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absher DM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003678; Anderson AE, 2016, ANN RHEUM DIS, V75, P466, DOI 10.1136/annrheumdis-2014-205850; Becker AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067003; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Bindea G, 2013, IMMUNITY, V39, P782, DOI 10.1016/j.immuni.2013.10.003; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Cheng Q, 2016, CLIN RESPIR J, V10, P469, DOI 10.1111/crj.12247; Chiche L, 2014, ARTHRITIS RHEUMATOL, V66, P1583, DOI 10.1002/art.38628; Clemenceau B, 2008, J IMMUNOL, V180, P5327, DOI 10.4049/jimmunol.180.8.5327; Coit P, 2015, J AUTOIMMUN, V61, P29, DOI 10.1016/j.jaut.2015.05.003; Crosetto N, 2008, J BIOL CHEM, V283, P35173, DOI 10.1074/jbc.M803219200; Cruvinel E, 2014, HUM MOL GENET, V23, P4674, DOI 10.1093/hmg/ddu187; Dai C, 2014, CURR OPIN IMMUNOL, V31, P87, DOI 10.1016/j.coi.2014.10.004; Derre L, 2010, J CLIN INVEST, V120, P157, DOI 10.1172/JCI40070; Dopico XC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8000; Egawa T, 2007, J EXP MED, V204, P1945, DOI 10.1084/jem.20070133; Feng XB, 2006, ARTHRITIS RHEUM, V54, P2951, DOI 10.1002/art.22044; Grammatikos AP, 2014, CLIN IMMUNOL, V150, P192, DOI 10.1016/j.clim.2013.12.002; Hedrich CM, 2014, P NATL ACAD SCI USA, V111, P13457, DOI 10.1073/pnas.1408023111; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI [10.1002/529-0131(199709)40:9&It;1725::AID-ART29>3.0.CO;2-Y, DOI 10.1002/1529-0131(199709)40:9&]; Hoofd C, 2012, CELL SIGNAL, V24, P1461, DOI 10.1016/j.cellsig.2012.03.006; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Hwang SS, 2013, P NATL ACAD SCI USA, V110, P276, DOI 10.1073/pnas.1214682110; Jin YL, 2014, DIABETES, V63, P2506, DOI 10.2337/db13-1716; Kariuki SN, 2015, GENES IMMUN, V16, P15, DOI 10.1038/gene.2014.57; Kennedy WP, 2015, LUPUS SCI MED, V2, DOI 10.1136/lupus-2014-000080; Kis-Toth K, 2014, J IMMUNOL, V192, P4436, DOI 10.4049/jimmunol.1302909; Koga T, 2014, J CLIN INVEST, V124, P2234, DOI 10.1172/JCI73411; Ladd AC, 2014, NEUROMOL MED, V16, P714, DOI 10.1007/s12017-014-8321-y; Li HR, 2012, BIOCHEMISTRY-US, V51, P1687, DOI 10.1021/bi2019089; Li QZ, 2010, CLIN EXP IMMUNOL, V159, P281, DOI 10.1111/j.1365-2249.2009.04057.x; Liong ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045802; Liu XS, 2014, GENE DEV, V28, P1917, DOI 10.1101/gad.245910.114; Maciejak A, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0149-z; McKinney EF, 2015, NATURE, V523, P612, DOI 10.1038/nature14468; Mizui M, 2014, J IMMUNOL, V193, P2168, DOI 10.4049/jimmunol.1400977; Moulton VR, 2015, J CLIN INVEST, V125, P2220, DOI 10.1172/JCI78087; Ramakrishnan R, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-90; Roedder S, 2015, J AM SOC NEPHROL, V26, P2042, DOI 10.1681/ASN.2013111239; Shi LH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093846; Shi M, 2014, EUR J CANCER, V50, P928, DOI 10.1016/j.ejca.2013.11.026; Siegemund S, 2015, BLOOD, V125, P2786, DOI 10.1182/blood-2014-06-583187; Siggens L, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/1756-8935-8-4; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Tsalik EL, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0111-5; Whitney AR, 2003, P NATL ACAD SCI USA, V100, P1896, DOI 10.1073/pnas.252784499; Yan ZJ, 2012, MOL CELL, V47, P61, DOI 10.1016/j.molcel.2012.05.026; Yang PT, 2004, CLIN EXP IMMUNOL, V138, P342, DOI 10.1111/j.1365-2249.2004.02617.x; Yang S, 2004, IMMUNOLOGY, V112, P274, DOI 10.1111/j.1365-2567.2004.01862.x; Yoshida Y, 2015, ARTHRITIS RHEUMATOL, V67, P1481, DOI 10.1002/art.39086	52	36	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141171	10.1371/journal.pone.0141171	http://dx.doi.org/10.1371/journal.pone.0141171			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544975	Green Submitted, Green Published, gold			2022-12-27	WOS:000364398700018
J	Cheng, YF; Young, GH; Lin, JT; Jang, HH; Chen, CC; Nong, JY; Chen, PK; Kuo, CY; Kao, SH; Liang, YJ; Chen, HM				Cheng, Yi-Fang; Young, Guang-Huar; Lin, Jiun-Tsai; Jang, Hyun-Hwa; Chen, Chin-Chen; Nong, Jing-Yi; Chen, Po-Ku; Kuo, Cheng-Yi; Kao, Shao-Hsuan; Liang, Yao-Jen; Chen, Han-Min			Activation of AMP-Activated Protein Kinase by Adenine Alleviates TNF-Alpha-Induced Inflammation in Human Umbilical Vein Endothelial Cells	PLOS ONE			English	Article							NF-KAPPA-B; NITRIC-OXIDE SYNTHESIS; LEUKOCYTE ADHESION MOLECULES; ACUTE KIDNEY INJURY; E-SELECTIN; IN-VIVO; VASCULAR INFLAMMATION; EXPRESSION; ICAM-1; MODULATION	The AMP-activated protein kinase (AMPK) signaling system plays a key role in cellular stress by repressing the inflammatory responses induced by the nuclear factor-kappa B (NF-kappa B) system. Previous studies suggest that the anti-inflammatory role of AMPK involves activation by adenine, but the mechanism that allows adenine to produce these effects has not yet been elucidated. In human umbilical vein endothelial cells (HUVECs), adenine was observed to induce the phosphorylation of AMPK in both a time-and dose-dependent manner as well as its downstream target acetyl Co-A carboxylase (ACC). Adenine also attenuated NF-kappa B targeting of gene expression in a dose-dependent manner and decreased monocyte adhesion to HUVECs following tumor necrosis factor (TNF-alpha) treatment. The short hairpin RNA (shRNA) against AMPK alpha 1 in HUVECs attenuated the adenine-induced inhibition of NF-kappa B activation in response to TNF-a, thereby suggesting that the anti-inflammatory role of adenine is mediated by AMPK. Following the knockdown of adenosyl phosphoribosyl transferase (APRT) in HUVECs, adenine supplementation failed to induce the phosphorylation of AMPK and ACC. Similarly, the expression of a shRNA against APRT nullified the anti-inflammatory effects of adenine in HUVECs. These results suggested that the role of adenine as an AMPK activator is related to catabolism by APRT, which increases the cellular AMP levels to activate AMPK.	[Cheng, Yi-Fang; Young, Guang-Huar; Lin, Jiun-Tsai; Jang, Hyun-Hwa; Chen, Po-Ku; Kuo, Cheng-Yi] Energenesis Biomed Co Ltd, New Taipei, Taiwan; [Chen, Chin-Chen; Liang, Yao-Jen; Chen, Han-Min] Catholic Fu Jen Univ, Dept Life Sci, Inst Appl Sci & Engn, New Taipei, Taiwan; [Nong, Jing-Yi] Natl Taiwan Univ, Collage Med, Dept Internal Med, Taipei 10764, Taiwan; [Kao, Shao-Hsuan] Chung Shan Med Univ, Inst Biochem & Biotechnol, Taichung, Taiwan	Fu Jen Catholic University; National Taiwan University; Chung Shan Medical University	Chen, HM (corresponding author), Catholic Fu Jen Univ, Dept Life Sci, Inst Appl Sci & Engn, New Taipei, Taiwan.	056489@mail.fju.edu.tw	Kao, Shao-Hsuan/I-3875-2019		Energenesis Biomedical Co. Ltd	Energenesis Biomedical Co. Ltd	Energenesis Biomedical Co. Ltd provided support in the form of salaries for authors Y.F. Cheng, H.H. Jang, J.T. Lin, G.H. Young, P.K. Chen and C.Y. Kuo, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Abbott MJ, 2009, AM J PHYSIOL-REG I, V297, pR1724, DOI 10.1152/ajpregu.00179.2009; Alexander A, 2011, FEBS LETT, V585, P952, DOI 10.1016/j.febslet.2011.03.010; BEVILACQUA MP, 1994, ANNU REV MED, V45, P361, DOI 10.1146/annurev.med.45.1.361; Boyle JG, 2008, J BIOL CHEM, V283, P11210, DOI 10.1074/jbc.M710048200; Brasier AR, 2010, CARDIOVASC RES, V86, P211, DOI 10.1093/cvr/cvq076; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Chen C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034181; Chen CC, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/692061; Chu SC, 2014, MOL PHARMACOL, V86, P609, DOI 10.1124/mol.114.094037; Collins T, 2001, J CLIN INVEST, V107, P255, DOI 10.1172/JCI10373; COLLINS T, 1995, FASEB J, V9, P899, DOI 10.1096/fasebj.9.10.7542214; Davis BJ, 2006, DIABETES, V55, P496, DOI 10.2337/diabetes.55.02.06.db05-1064; Fisslthaler B, 2009, CIRC RES, V105, P114, DOI 10.1161/CIRCRESAHA.109.201590; FRIES JWU, 1993, AM J PATHOL, V143, P725; Giri S, 2004, J NEUROSCI, V24, P479, DOI 10.1523/JNEUROSCI.4288-03.2004; Haraldsen G, 1996, J IMMUNOL, V156, P2558; Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982; Hattori Y, 2006, HYPERTENSION, V47, P1183, DOI 10.1161/01.HYP.0000221429.94591.72; HOCHSTADTOZER J, 1971, J BIOL CHEM, V246, P5304; HOUSSET P, 1977, EUR J BIOCHEM, V73, P99, DOI 10.1111/j.1432-1033.1977.tb11295.x; Huang NL, 2009, INT J CARDIOL, V134, P169, DOI 10.1016/j.ijcard.2008.04.010; Krasner NM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097554; Kuo CL, 2008, J CELL BIOCHEM, V103, P931, DOI 10.1002/jcb.21466; Lee S, 2007, INT IMMUNOL, V19, P1349, DOI 10.1093/intimm/dxm104; Lin YM, 2013, CANCER LETT, V328, P135, DOI 10.1016/j.canlet.2012.08.029; LO SK, 1993, AM J PHYSIOL, V264, pL406; Marino M, 2008, J NEUROIMMUNOL, V196, P41, DOI 10.1016/j.jneuroim.2008.02.005; Mishra J, 2006, PEDIATR NEPHROL, V21, P856, DOI 10.1007/s00467-006-0055-0; Morrow VA, 2003, J BIOL CHEM, V278, P31629, DOI 10.1074/jbc.M212831200; MURRAY AW, 1971, ANNU REV BIOCHEM, V40, P811, DOI 10.1146/annurev.bi.40.070171.004115; Prasad R, 2006, J NEUROSCI RES, V84, P614, DOI 10.1002/jnr.20953; Savoia C, 2007, CLIN SCI, V112, P375, DOI 10.1042/CS20060247; SLUITER W, 1993, J CARDIOVASC PHARM, V22, pS37, DOI 10.1097/00005344-199322004-00006; Wagnerova J, 2002, J NEUROL SCI, V195, P51, DOI 10.1016/S0022-510X(01)00685-2; Wu VC, 2013, ANGIOGENESIS, V16, P609, DOI 10.1007/s10456-013-9339-8; Wung BS, 2005, J BIOMED SCI, V12, P91, DOI 10.1007/s11373-004-8170-z; Yang XD, 2010, MOL CELL BIOL, V30, P2170, DOI 10.1128/MCB.01343-09; Yang YY, 2004, ATHEROSCLEROSIS, V174, P207, DOI 10.1016/j.atherosclerosis.2004.01.024; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Young GH, 2006, PLANTA, V223, P468, DOI 10.1007/s00425-005-0103-1; Young GH, 2015, J PROTEOMICS, V120, P204, DOI 10.1016/j.jprot.2015.03.012; Young GH, 2014, ANTIOXID REDOX SIGN, V20, P1181, DOI 10.1089/ars.2013.5366; Young GH, 2012, KIDNEY INT, V81, P611, DOI 10.1038/ki.2011.461; Zhang Y, 2011, ARTERIOSCL THROM VAS, V31, P2897, DOI 10.1161/ATVBAHA.111.237453; Zhao X, 2008, AM J PHYSIOL-LUNG C, V295, pL497, DOI 10.1152/ajplung.90210.2008; Zou MH, 2004, J BIOL CHEM, V279, P43940, DOI 10.1074/jbc.M404421200	46	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142283	10.1371/journal.pone.0142283	http://dx.doi.org/10.1371/journal.pone.0142283			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544976	Green Submitted, Green Published, gold			2022-12-27	WOS:000364398700106
J	Lieske, NV; Tonby, K; Kvale, D; Dyrhol-Riise, AM; Tasken, K				Lieske, Nora V.; Tonby, Kristian; Kvale, Dag; Dyrhol-Riise, Anne M.; Tasken, Kjetil			Targeting Tuberculosis and HIV Infection-Specific Regulatory T Cells with MEK/ERK Signaling Pathway Inhibitors	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; IMMUNE-RESPONSES; MEK INHIBITORS; TNF-ALPHA; ACTIVATION; BLOOD; DISEASE; IL-2; INTERLEUKIN-2; HOMEOSTASIS	Human regulatory T cells (Tregs) are essential in maintaining immunological tolerance and suppress effector T cells. Tregs are commonly up-regulated in chronic infectious diseases such as tuberculosis (TB) and human immunodeficiency virus (HIV) infection and thereby hamper disease-specific immune responses and eradication of pathogens. The MEK/ERK signaling pathway is involved in regulation of the FoxP3 transcription factor, which directs a lineage-specific transcriptional program to define Tregs and control their suppressive function. Here, we aimed to target activation of disease-specific Tregs by inhibition of the MEK/ERK signaling pathway based on the hypothesis that this would improve anti-HIV and anti-TB immunity. Stimulation of T cells from untreated TB (n = 12) and HIV (n = 8) patients with disease-specific antigens in vitro in the presence of the MEK inhibitor (MEKI) trametinib (GSK1120212) resulted in significant down-regulation of both FoxP3 levels (MFI) and fractions of resting (CD45RA(+)FoxP3(+)) and activated (CD45RA(-)FoxP3(++)) Tregs. MEKI also reduced the levels of specific T effector cells expressing the pro-inflammatory cytokines (IFN-gamma, TNF-alpha and IL-2) in both HIV and TB patients. In conclusion, MEKIs modulate disease antigen-specific Treg activation and may have potential application in new treatment strategies in chronic infectious diseases where reduction of Treg activity would be favorable. Whether MEKIs can be used in current HIV or TB therapy regimens needs to be further investigated.	[Lieske, Nora V.; Tasken, Kjetil] Univ Oslo, Nord EMBL Partnership, Ctr Mol Med Norway, Oslo, Norway; [Tonby, Kristian; Kvale, Dag; Dyrhol-Riise, Anne M.] Univ Oslo, Inst Clin Med, Oslo, Norway; [Tonby, Kristian; Kvale, Dag; Dyrhol-Riise, Anne M.; Tasken, Kjetil] Oslo Univ Hosp, Dept Infect Dis, Oslo, Norway; [Kvale, Dag; Dyrhol-Riise, Anne M.; Tasken, Kjetil] Univ Oslo, Kristian Gerhard Jebsen Inflammat Res Ctr, Oslo, Norway; [Tasken, Kjetil] Univ Oslo, Ctr Biotechnol, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Tasken, K (corresponding author), Univ Oslo, Nord EMBL Partnership, Ctr Mol Med Norway, Oslo, Norway.	kjetil.tasken@ncmm.uio.no		Tasken, Kjetil/0000-0003-2841-4697; Kvale, Dag/0000-0001-6410-2530	Research Council of Norway [RCN204784, RCN187615]; South Eastern Norway Regional Health Authority [11/01137-144, 2013074]; Kristian Gerhard Jebsen Inflammation Research Centre [2012/23]	Research Council of Norway(Research Council of Norway); South Eastern Norway Regional Health Authority; Kristian Gerhard Jebsen Inflammation Research Centre	This work was supported by the Research Council of Norway (RCN204784 and RCN187615, http://www.forskningsradet.no/en/Home_page/1177315753906, N.L., Kj.T.), the South Eastern Norway Regional Health Authority (11/01137-144 and 2013074, http://www.helse-sorost.no/omoss_/english_/, Kr.T and Kj.T respectively) and the Kristian Gerhard Jebsen Inflammation Research Centre (2012/23, http://www.stiftkgj.no/?lang = en, K.T.).	Abrams D, 2009, NEW ENGL J MED, V361, P1548, DOI 10.1056/NEJMoa0903175; Appay V, 2008, J PATHOL, V214, P231, DOI 10.1002/path.2276; Arruvito L, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057336, DOI 10.1371/J0URNAL.P0NE.0052580]; Aukrust P, 1999, J INFECT DIS, V179, P74, DOI 10.1086/314572; Barnes PF, 2003, AM J RESP CRIT CARE, V168, P142, DOI 10.1164/rccm.2305001; Beiranvand E, 2014, INFLAMMATION ALLERGY; Belkaid Y, 2009, ANNU REV IMMUNOL, V27, P551, DOI 10.1146/annurev.immunol.021908.132723; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Bi X, 2009, EUR J IMMUNOL, V39, P301, DOI 10.1002/eji.200838667; Boaz MJ, 2003, CLIN EXP IMMUNOL, V134, P454, DOI 10.1111/j.1365-2249.2003.02307.x; Brazille P, 2003, CLIN EXP IMMUNOL, V131, P304, DOI 10.1046/j.1365-2249.2003.02064.x; Caccamo N, 2010, EUR J IMMUNOL, V40, P2211, DOI 10.1002/eji.201040455; Chatt JA, 2002, AIDS RES HUM RETROV, V18, P1367, DOI 10.1089/088922202320935447; Chen XC, 2007, CLIN IMMUNOL, V123, P50, DOI 10.1016/j.clim.2006.11.009; Chevalier MF, 2013, BLOOD, V121, P29, DOI 10.1182/blood-2012-07-409755; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Day CL, 2011, J IMMUNOL, V187, P2222, DOI 10.4049/jimmunol.1101122; Feruglio SL, 2015, CLIN EXP IMMUNOL, V179, P454, DOI 10.1111/cei.12468; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Giovannetti A, 2001, CLIN EXP IMMUNOL, V124, P21, DOI 10.1046/j.1365-2249.2001.01502.x; Gonzalez-Juarrereo M, 2012, IMMUNOTHERAPY-UK, V4, P187, DOI [10.2217/IMT.11.168, 10.2217/imt.11.168]; Guyot-Revol V, 2006, AM J RESP CRIT CARE, V173, P803, DOI 10.1164/rccm.200508-1294OC; Haraguchi Soichi, 2006, AIDS Res Ther, V3, P8, DOI 10.1186/1742-6405-3-8; Harari A, 2011, NAT MED, V17, P372, DOI 10.1038/nm.2299; HOBER D, 1992, CLIN IMMUNOL IMMUNOP, V62, P168, DOI 10.1016/0090-1229(92)90069-Z; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Horta A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057336; Hougardy JM, 2007, AM J RESP CRIT CARE, V176, P409, DOI 10.1164/rccm.200701-084OC; Hunt PW, 2003, J INFECT DIS, V187, P1534, DOI 10.1086/374786; JOHNSON BJ, 1995, CYTOKINES MOL THER, V1, P185; Johnson JL, 2003, AM J RESP CRIT CARE, V168, P185, DOI 10.1164/rccm.200211-1359OC; Kalland ME, 2011, J IMMUNOL, V187, P5233, DOI 10.4049/jimmunol.1101804; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Kim JM, 2011, IMMUNOTHERAPY-UK, V3, P247, DOI 10.2217/IMT.10.91; Kursar M, 2007, J IMMUNOL, V178, P2661, DOI 10.4049/jimmunol.178.5.2661; Lintermans LL, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00504; Marin ND, 2010, TUBERCULOSIS, V90, P252, DOI 10.1016/j.tube.2010.05.003; Marriott JB, 1997, AIDS RES HUM RETROV, V13, P1625, DOI 10.1089/aid.1997.13.1625; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Mills KHG, 2004, NAT REV IMMUNOL, V4, P841, DOI 10.1038/nri1485; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Moreno-Fernandez ME, 2012, J VIROL, V86, P10262, DOI 10.1128/JVI.00993-12; Pastrana Jahaira Lopez, 2012, J Clin Exp Cardiolog, V2012, P2; Popik W, 2000, J VIROL, V74, P2558, DOI 10.1128/JVI.74.6.2558-2566.2000; Prezzemolo T, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00180; Ribeiro-Rodrigues R, 2006, CLIN EXP IMMUNOL, V144, P25, DOI 10.1111/j.1365-2249.2006.03027.x; Robbs BK, 2013, BBA-MOL CELL RES, V1833, P2016, DOI 10.1016/j.bbamcr.2013.04.003; Roberts L, 2010, AIDS, V24, P819, DOI 10.1097/QAD.0b013e3283367836; Roca FJ, 2013, CELL, V153, P521, DOI 10.1016/j.cell.2013.03.022; Rolf J, 2010, J IMMUNOL, V184, P6563, DOI 10.4049/jimmunol.1000202; Rouse BT, 2006, IMMUNOL REV, V212, P272, DOI 10.1111/j.0105-2896.2006.00412.x; Sakaguchi S, 2001, IMMUNOL REV, V182, P18, DOI 10.1034/j.1600-065X.2001.1820102.x; Shafiani S, 2010, J EXP MED, V207, P1409, DOI 10.1084/jem.20091885; Shevach EM, 2000, ANNU REV IMMUNOL, V18, P423, DOI 10.1146/annurev.immunol.18.1.423; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Shindo T, 2013, BLOOD, V121, P4617, DOI 10.1182/blood-2012-12-476218; Simonetta F, 2012, J INFECT DIS, V205, P1510, DOI 10.1093/infdis/jis235; Trujillo JI, 2011, EXPERT OPIN THER PAT, V21, P1045, DOI 10.1517/13543776.2011.577068; Uhlin M, 2012, J INFECT DIS, V205, pS325, DOI 10.1093/infdis/jis197; Vella LJ, 2014, CANCER IMMUNOL RES, V2, P351, DOI 10.1158/2326-6066.CIR-13-0181; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; VONSYDOW M, 1991, AIDS RES HUM RETROV, V7, P375, DOI 10.1089/aid.1991.7.375; Wallis RS, 1996, J INFECT DIS, V174, P727, DOI 10.1093/infdis/174.4.727; Wallis RS, 2004, CLIN INFECT DIS, V39, P1254, DOI 10.1086/424455; Wang D, 2007, BBA-MOL CELL RES, V1773, P1248, DOI 10.1016/j.bbamcr.2006.11.009; Weiss L, 2004, BLOOD, V104, P3249, DOI 10.1182/blood-2004-01-0365; Wergeland I, 2011, SCAND J IMMUNOL, V73, P234, DOI 10.1111/j.1365-3083.2010.02496.x; Westby M, 1998, CLIN EXP IMMUNOL, V111, P257; World Health Organization, 2014, GLOB TUB REP; Yamane H, 2013, IMMUNOL REV, V252, P12, DOI 10.1111/imr.12032; Zhao YJ, 2014, NAT REV CLIN ONCOL, V11, P385, DOI 10.1038/nrclinonc.2014.83; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563	72	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141903	10.1371/journal.pone.0141903	http://dx.doi.org/10.1371/journal.pone.0141903			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544592	Green Submitted, gold, Green Published			2022-12-27	WOS:000364398700063
J	Matse, JH; Yoshizawa, J; Wang, XY; Elashoff, D; Bolscher, JGM; Veerman, ECI; Leemans, CR; Pegtel, MD; Wong, DTW; Bloemena, E				Matse, Johannes H.; Yoshizawa, Janice; Wang, Xiaoyan; Elashoff, David; Bolscher, Jan G. M.; Veerman, Enno C. I.; Leemans, C. Rene; Pegtel, Michiel D.; Wong, David T. W.; Bloemena, Elisabeth			Human Salivary Micro-RNA in Patients with Parotid Salivary Gland Neoplasms	PLOS ONE			English	Article							BIOMARKERS; CLASSIFICATION; DISCOVERY; ACCURACY	Background Currently, clinical examination, ultrasound scanning (with or without fine needle aspiration cytology), preoperative CT-scan and MRI are available for the differential diagnosis of parotid gland swelling. A preliminary non-invasive salivary diagnostic tool may be helpful in the clinical decision making process. Altered salivary micro-RNA (miRNA) expression levels have been observed in saliva from patients with various cancers. Therefore, we investigated miRNA expression levels in saliva samples from patients with a parotid gland neoplasm using Human miRNA cards in comparison to controls. Results In the discovery phase, eight miRNAs were identified having different expression levels in patients compared to controls. In the validation phase, the differences in miRNA expression levels between patients and controls were confirmed for seven out of eight discovered miRNAs (p < 0.001). A combination of two miRNAs yielded a receiver-operator-characteristics curve with an AUC of 0.94 (95% CI: 0.87-1.00; sensitivity 91%; specificity 86%). Validation of discovered miRNAs in segregated collected parotid saliva revealed that expression of these miRNAs differ between whole saliva and parotid saliva. Conclusions A two miRNA combination can predict the presence of a parotid gland neoplasm. Furthermore, this study suggested that the identified, patient-specific, salivary miRNAs were not derived from the parotid gland itself.	[Matse, Johannes H.; Bloemena, Elisabeth] Vrije Univ Amsterdam Med Ctr, Acad Ctr Dent Amsterdam ACTA, Dept Oral & Maxillofacial Surg & Oral Pathol, Amsterdam, Netherlands; [Matse, Johannes H.; Bolscher, Jan G. M.; Veerman, Enno C. I.] Univ Amsterdam, ACTA, Dept Oral Biochem, Amsterdam, Netherlands; [Matse, Johannes H.; Bolscher, Jan G. M.; Veerman, Enno C. I.] Vrije Univ Amsterdam, Amsterdam, Netherlands; [Yoshizawa, Janice; Wong, David T. W.] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90024 USA; [Yoshizawa, Janice; Wong, David T. W.] Univ Calif Los Angeles, Dent Res Inst, Los Angeles, CA 90024 USA; [Wang, Xiaoyan; Elashoff, David] Univ Calif Los Angeles, David Geffen Sch Med, Stat Core, Div Gen Internal Med & Hlth Serv Res, Los Angeles, CA 90095 USA; [Leemans, C. Rene] Vrije Univ Amsterdam Med Ctr, Dept Otolaryngol, Amsterdam, Netherlands; [Pegtel, Michiel D.; Bloemena, Elisabeth] Vrije Univ Amsterdam Med Ctr, Dept Pathol, Amsterdam, Netherlands	Academic Center for Dentistry Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Bloemena, E (corresponding author), Vrije Univ Amsterdam Med Ctr, Acad Ctr Dent Amsterdam ACTA, Dept Oral & Maxillofacial Surg & Oral Pathol, Amsterdam, Netherlands.	e.bloemena@vumc.nl	Pegtel, Dirk m/M-8393-2015; Matse, Johannes/AAS-7760-2021; Bolscher, Jan/ABF-6102-2021; Pegtel, Dirk Michiel/ABD-5481-2021; Bloemena, Elisabeth/V-1095-2018; Bloemena, Elisabeth/AAZ-1247-2021	Pegtel, Dirk m/0000-0002-7357-4406; Bolscher, Jan/0000-0001-5669-6164; Pegtel, Dirk Michiel/0000-0002-7357-4406; Bloemena, Elisabeth/0000-0002-0221-9538; Leemans, C. Rene/0000-0001-7887-083X	NCATS NIH HHS [UL1 TR000124] Funding Source: Medline	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Brinkmann O, 2011, ADV CLIN CHEM, V55, P21, DOI 10.1016/B978-0-12-387042-1.00002-2; Cai CX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029750; Chang KW, 2008, J DENT RES, V87, P1063, DOI 10.1177/154405910808701116; Chen PS, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-90; Chiosea SI, 2008, VIRCHOWS ARCH, V452, P629, DOI 10.1007/s00428-007-0574-5; Heneghan HM, 2010, J CLIN ONCOL, V28, pE573, DOI 10.1200/JCO.2010.29.8901; Hu S, 2008, CLIN CANCER RES, V14, P6246, DOI 10.1158/1078-0432.CCR-07-5037; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Matse JH, 2013, CLIN CANCER RES, V19, P3032, DOI 10.1158/1078-0432.CCR-12-3505; Matthaei H, 2012, CLIN CANCER RES, V18, P4713, DOI 10.1158/1078-0432.CCR-12-0035; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Nugent M, 2011, EJSO-EUR J SURG ONC, V37, P649, DOI 10.1016/j.ejso.2011.05.005; Park NJ, 2009, CLIN CANCER RES, V15, P5473, DOI 10.1158/1078-0432.CCR-09-0736; Pepe MS, 2008, J NATL CANCER I, V100, P1432, DOI 10.1093/jnci/djn326; Sapre N, 2013, PROSTATE CANCER, V2013, DOI 10.1155/2013/539680; Schmidt RL, 2011, AM J CLIN PATHOL, V136, P45, DOI 10.1309/AJCPOIE0CZNAT6SQ; SEIFERT G, 1990, PATHOL RES PRACT, V186, P555, DOI 10.1016/S0344-0338(11)80220-7; Streckfus CF, 2007, EXPERT REV PROTEOMIC, V4, P329, DOI 10.1586/14789450.4.3.329; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Thomadaki K, 2011, J DENT RES, V90, P1325, DOI 10.1177/0022034511420721; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Yoshizawa Janice M, 2013, Methods Mol Biol, V936, P313; Zen K, 2012, MED RES REV, V32, P326, DOI 10.1002/med.20215; Zhang L, 2010, GASTROENTEROLOGY, V138, P949, DOI 10.1053/j.gastro.2009.11.010	27	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142264	10.1371/journal.pone.0142264	http://dx.doi.org/10.1371/journal.pone.0142264			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544193	Green Published, gold			2022-12-27	WOS:000364398700102
J	Potamitis, I; Rigakis, I; Fysarakis, K				Potamitis, Ilyas; Rigakis, Iraklis; Fysarakis, Konstantinos			Insect Biometrics: Optoacoustic Signal Processing and Its Applications to Remote Monitoring of McPhail Type Traps	PLOS ONE			English	Article							FRUIT-FLY; DIPTERA	Monitoring traps are important components of integrated pest management applied against important fruit fly pests, including Bactrocera oleae (Gmelin) and Ceratitis capitata (Wide-mann), Diptera of the Tephritidae family, which effect a crop-loss/per year calculated in billions of euros worldwide. Pests can be controlled with ground pesticide sprays, the efficiency of which depends on knowing the time, location and extent of infestations as early as possible. Trap inspection is currently carried out manually, using the McPhail trap, and the mass spraying is decided based on a decision protocol. We introduce the term 'insect biometrics' in the context of entomology as a measure of a characteristic of the insect (in our case, the spectrum of its wingbeat) that allows us to identify its species and make devices to help face old enemies with modern means. We modify a McPhail type trap into becoming electronic by installing an array of photoreceptors coupled to an infrared emitter, guarding the entrance of the trap. The beating wings of insects flying in the trap intercept the light and the light fluctuation is turned to a recording. Custom-made electronics are developed that are placed as an external add-on kit, without altering the internal space of the trap. Counts from the trap are transmitted using a mobile communication network. This trap introduces a new automated remote-monitoring method different to audio and vision-based systems. We evaluate our trap in large number of insects in the laboratory by enclosing the electronic trap in insectary cages. Our experiments assess the potential of delivering reliable data that can be used to initialize reliably the spraying process at large scales but to also monitor the impact of the spraying process as it eliminates the time-lag between acquiring and delivering insect counts to a central agency.	[Potamitis, Ilyas] Technol Educ Inst Crete, Dept Music Technol & Acoust, GR-74100 Rethymno Crete, Greece; [Rigakis, Iraklis] Technol Educ Inst Crete, Dept Elect, GR-73133 Khania, Greece; [Fysarakis, Konstantinos] Tech Univ Crete, Dept Elect & Comp Engn, GR-73100 Kounoupidiana, Chania, Greece	Hellenic Mediterranean University; Hellenic Mediterranean University; Technical University of Crete	Potamitis, I (corresponding author), Technol Educ Inst Crete, Dept Music Technol & Acoust, GR-74100 Rethymno Crete, Greece.	potamitis@staff.teicrete.gr	Fysarakis, Konstantinos/I-4412-2019	Fysarakis, Konstantinos/0000-0002-6871-8102; Potamitis, Ilyas/0000-0002-7111-3331	NVIDIA Corporation; TITAN-X GPU; European Union's Seventh Framework Program by REA-Research Executive Agency [605073]	NVIDIA Corporation; TITAN-X GPU; European Union's Seventh Framework Program by REA-Research Executive Agency	We gratefully acknowledge the support of NVIDIA Corporation with the donation of a TITAN-X GPU partly used for this research. The research leading to these results has received funding from the European Union's Seventh Framework Program managed by REA-Research Executive Agency (http://ec.europa.eu/research/rea) (FP7/2007-2013) under grant agreement n degrees 605073 project ENTOMATIC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARROS MD, 1991, FLA ENTOMOL, V74, P467, DOI 10.2307/3494843; Daane KM, 2010, ANNU REV ENTOMOL, V55, P151, DOI 10.1146/annurev.ento.54.110807.090553; Ellington CP, 1999, J EXP BIOL, V202, P3439; Elson-Harris M, 1992, FRUIT FLIES EC IMPOR; Engel JE, 2001, FLA ENTOMOL, V84, P336, DOI 10.2307/3496490; Fletcher B, 1983, ENTOMOLOGICA HELLENI, V1, P16; Jiang JA, 2008, COMPUT ELECTRON AGR, V62, P243, DOI 10.1016/j.compag.2008.01.005; Kirsch P, 2006, 80 ANN W ORCH PEST D; Michelakis S. E., 1983, Fruit flies of economic importance. Proceedings of the CEC/IOBC International Symposium, Athens, Greece, 16-19 November 1982, P603; MOORE A, 1986, J ECON ENTOMOL, V79, P1703, DOI 10.1093/jee/79.6.1703; MOORE A, 1991, J INSECT BEHAV, V4, P391, DOI 10.1007/BF01048285; Nardi F, 2005, MOL ECOL, V14, P2729, DOI 10.1111/j.1365-294X.2005.02610.x; NEUENSCHWANDER P, 1981, Z ANGEW ENTOMOL, V91, P193; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Plant Health Australia, 2011, AUSTR HDB ID FRUIT F; Potamitis I., 2015, 22 INT C SOUND VIBR; Potamitis I, 2015, IEEE SENS J, V15, P4621, DOI 10.1109/JSEN.2015.2424924; Potamitis I, 2014, SENSORS-BASEL, V14, P22285, DOI 10.3390/s141222285; Potamitis I, 2014, ECOL INFORM, V21, P40, DOI 10.1016/j.ecoinf.2013.11.005; Schafer P, 2014, CLASSIFYING INSECTS	20	28	28	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0140474	10.1371/journal.pone.0140474	http://dx.doi.org/10.1371/journal.pone.0140474			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544845	Green Published, gold, Green Submitted			2022-12-27	WOS:000364398700009
J	Uwatoko, T; Yoshizumi, M; Miyata, J; Ubukata, S; Fujiwara, H; Kawada, R; Kubota, M; Sasamoto, A; Sugihara, G; Aso, T; Urayama, S; Fukuyama, H; Murai, T; Takahashi, H				Uwatoko, Teruhisa; Yoshizumi, Miho; Miyata, Jun; Ubukata, Shiho; Fujiwara, Hironobu; Kawada, Ryosaku; Kubota, Manabu; Sasamoto, Akihiko; Sugihara, Genichi; Aso, Toshihiko; Urayama, Shinichi; Fukuyama, Hidenao; Murai, Toshiya; Takahashi, Hidehiko			Insular Gray Matter Volume and Objective Quality of Life in Schizophrenia	PLOS ONE			English	Article							CORTEX ABNORMALITIES; SYMPTOMS; PREDICTORS; METAANALYSIS; OUTPATIENTS; SCALE; 1ST-EPISODE; DEFICITS	Improving quality of life has been recognized as an important outcome for schizophrenia treatment, although the fundamental determinants are not well understood. In this study, we investigated the association between brain structural abnormalities and objective quality of life in schizophrenia patients. Thirty-three schizophrenia patients and 42 age-, sex-, and education-matched healthy participants underwent magnetic resonance imaging. The Quality of Life Scale was used to measure objective quality of life in schizophrenia patients. Voxel-based morphometry was performed to identify regional brain alterations that correlate with Quality of Life Scale score in the patient group. Schizophrenia patients showed gray matter reductions in the frontal, temporal, limbic, and subcortical regions. We then performed voxel-based multiple regression analysis in these regions to identify any correlations between regional gray matter volume and Quality of Life Scale scores. We found that among four subcategories of the scale, the Instrumental Role category score correlated with gray matter volume in the right anterior insula in schizophrenia patients. In addition, this correlation was shown to be mediated by negative symptoms. Our findings suggest that the neural basis of objective quality of life might differ topographically from that of subjective QOL in schizophrenia.	[Uwatoko, Teruhisa; Yoshizumi, Miho; Miyata, Jun; Ubukata, Shiho; Fujiwara, Hironobu; Kawada, Ryosaku; Kubota, Manabu; Sasamoto, Akihiko; Sugihara, Genichi; Murai, Toshiya; Takahashi, Hidehiko] Kyoto Univ, Grad Sch Med, Dept Psychiat, Kyoto, Japan; [Uwatoko, Teruhisa] Kyoto Univ Hlth Serv, Kyoto, Japan; [Aso, Toshihiko; Urayama, Shinichi; Fukuyama, Hidenao] Kyoto Univ, Grad Sch Med, Human Brain Res Ctr, Kyoto, Japan; [Fujiwara, Hironobu] Kyoto Univ Hosp, Integrated Clin Educ Ctr, Kyoto 606, Japan; [Kubota, Manabu] Natl Inst Radiol Sci, Mol Imaging Ctr, Mol Neuroimaging Program, Chiba 260, Japan	Kyoto University; Kyoto University; Kyoto University; Kyoto University; National Institutes for Quantum Science & Technology	Takahashi, H (corresponding author), Kyoto Univ, Grad Sch Med, Dept Psychiat, Kyoto, Japan.	hidehiko@kuhp.kyoto-u.ac.jp	Aso, Toshihiko/C-2798-2018; Fukuyama, Hidenao/AAI-7118-2020; Miyata, Jun/S-2978-2016	Aso, Toshihiko/0000-0003-4814-089X; Miyata, Jun/0000-0003-1803-1975; Takahashi, Hidehiko/0000-0002-5102-1982; Uwatoko, Teruhisa/0000-0002-7917-9060	Japan Society for the Promotion of Science [15H01690, 26461767, 15H04893, 23680045, 23118004, 23120009, 15K09825, 15K09864, 26350831]; Takeda Science Foundation; Uehara Memorial Foundation; Senshin Medical Research Foundation; Astellas Pharma Inc.; Ministry of Education, Culture, Sports, Science and Technology of Japan; Schizophrenia Research Group; Research Program for Brain Sciences; Grants-in-Aid for Scientific Research [15H04893] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Senshin Medical Research Foundation(SENSHIN Medical Research Foundation); Astellas Pharma Inc.(Astellas Pharmaceuticals); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Schizophrenia Research Group; Research Program for Brain Sciences; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research B 15H01690), TM; the Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research C (26461767), JM; the Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research A (15H04893), TM; the Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research for Young Scientist A (23680045), HT; the Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research on Innovative Area (23118004), TM; the Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research on Innovative Area (23120009), HT; the Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research C (15K09825), GS; the Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research C (15K09864), TU; the Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research C (26350831), TU; the Takeda Science Foundation, TA; The Uehara Memorial Foundation, TM; the Senshin Medical Research Foundation, AS; the Schizophrenia Research Group, Astellas Pharma Inc., AS; and the Ministry of Education, Culture, Sports, Science and Technology of Japan, Research Program for Brain Sciences, HT. None of the funding sources had a role in study design; in the collection, analysis, and interpretation of data; in the writing of the report or in the decision to submit the manuscript for publication.	Addington J, 2008, BRIT J PSYCHIAT, V192, P67, DOI 10.1192/bjp.bp.107.039784; Aki H, 2008, PSYCHIAT RES, V158, P19, DOI 10.1016/j.psychres.2006.05.017; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Awad AG, 1997, QUAL LIFE RES, V6, P21; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bernhardt BC, 2012, ANNU REV NEUROSCI, V35, P1, DOI 10.1146/annurev-neuro-062111-150536; Bora E, 2011, SCHIZOPHR RES, V127, P46, DOI 10.1016/j.schres.2010.12.020; BREIER A, 1991, ARCH GEN PSYCHIAT, V48, P239; Browne S, 1996, ACTA PSYCHIAT SCAND, V94, P118, DOI 10.1111/j.1600-0447.1996.tb09835.x; Caron J, 2005, PSYCHIAT RES, V137, P203, DOI 10.1016/j.psychres.2005.07.002; Crespo-Facorro B, 2000, SCHIZOPHR RES, V46, P35, DOI 10.1016/S0920-9964(00)00028-1; Dickerson FB, 1998, ACTA PSYCHIAT SCAND, V98, P124, DOI 10.1111/j.1600-0447.1998.tb10053.x; Eack SM, 2007, SCHIZOPHRENIA BULL, V33, P1225, DOI 10.1093/schbul/sbl071; Ellison-Wright I, 2008, AM J PSYCHIAT, V165, P1015, DOI 10.1176/appi.ajp.2008.07101562; First M. B., 2005, STRUCTURED CLIN INTE; Fitzgerald PB, 2001, ACTA PSYCHIAT SCAND, V103, P387, DOI 10.1034/j.1600-0447.2001.00254.x; Fitzgerald PB, 2003, PSYCHIAT RES, V119, P55, DOI 10.1016/S0165-1781(03)00099-4; Fusar-Poli P, 2012, SCHIZOPHRENIA BULL, V38, P1297, DOI 10.1093/schbul/sbr134; Green MF, 1996, AM J PSYCHIAT, V153, P321; Haijma SV, 2013, SCHIZOPHRENIA BULL, V39, P1129, DOI 10.1093/schbul/sbs118; Hatton SN, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-45; HEINRICHS DW, 1984, SCHIZOPHRENIA BULL, V10, P388, DOI 10.1093/schbul/10.3.388; Ho BC, 1998, AM J PSYCHIAT, V155, P1196, DOI 10.1176/ajp.155.9.1196; Inagaki A., 2008, JPN J CLIN PSYCHOPHA, V11, P887; Kaneda Y, 2002, PSYCHIAT RES, V113, P107, DOI 10.1016/S0165-1781(02)00240-8; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Koutsouleris N, 2008, NEUROIMAGE, V39, P1600, DOI 10.1016/j.neuroimage.2007.10.029; Kurtz MM, 2012, PSYCHIAT RES, V200, P102, DOI 10.1016/j.psychres.2012.06.025; Lambert M, 2004, CNS DRUGS, V18, P5, DOI 10.2165/00023210-200418002-00002; Lamm C, 2010, BRAIN STRUCT FUNCT, V214, P579, DOI 10.1007/s00429-010-0251-3; Lehman AF, 2010, PRACTICE GUIDELINE T, V161, P1, DOI [10.1037/0003-066x.57.12.1052, DOI 10.1037/0003-066X.57.12.1052]; Lovero KL, 2009, NEUROIMAGE, V45, P976, DOI 10.1016/j.neuroimage.2008.12.070; Manoliu A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00216; Milian MJ, 2014, EUR NEUROPSYCHOPHARM, V24, P645, DOI 10.1016/j.euroneuro.2014.03.008; Miyata R, 2001, QUALITY LIFE SCALE G; Narvaez JM, 2008, SCHIZOPHR RES, V98, P201, DOI 10.1016/j.schres.2007.09.001; Norman RMG, 2000, ACTA PSYCHIAT SCAND, V102, P303, DOI 10.1034/j.1600-0447.2000.102004303.x; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Pressler M, 2005, BIOL PSYCHIAT, V57, P394, DOI 10.1016/j.biopsych.2004.11.010; Rabinowitz J, 2012, SCHIZOPHR RES, V137, P147, DOI 10.1016/j.schres.2012.01.015; Ritsner M, 2005, QUAL LIFE RES, V14, P1693, DOI 10.1007/s11136-005-2816-9; Ritsner M, 2003, J NERV MENT DIS, V191, P287, DOI 10.1097/00005053-200305000-00003; Ruesch P, 2004, SOC PSYCH PSYCH EPID, V39, P686, DOI 10.1007/s00127-004-0812-y; Shepherd AM, 2012, BIOL PSYCHIAT, V72, P775, DOI 10.1016/j.biopsych.2012.04.020; Sim K, 2004, PSYCHIAT RES, V129, P141, DOI 10.1016/j.psychres.2004.07.007; Smith MJ, 2012, SCHIZOPHR RES, V137, P196, DOI 10.1016/j.schres.2012.01.012; Smith TE, 2001, J NERV MENT DIS, V189; Tolman AW, 2012, SCHIZOPHRENIA BULL, V38, P304, DOI 10.1093/schbul/sbq077; Tomotake M, 2011, PSYCHOL REP, V99, P477; Ubukata S, 2013, J PSYCHIATR RES, V47, P548, DOI 10.1016/j.jpsychires.2013.01.002; Wang Y, 2013, PSYCHIAT RES, V210, P62, DOI 10.1016/j.psychres.2013.03.015; Wechsler D., 1981, WAIS R MANUAL WECHSL; Wilkinson G, 2000, BRIT J PSYCHIAT, V177, P42, DOI 10.1192/bjp.177.1.42; Woon PS, 2010, PROG NEURO-PSYCHOPH, V34, P463, DOI 10.1016/j.pnpbp.2010.01.014; Wylie KP, 2010, SCHIZOPHR RES, V123, P93, DOI 10.1016/j.schres.2010.08.027; Yamauchi K, 2008, PSYCHIAT CLIN NEUROS, V62, P404, DOI 10.1111/j.1440-1819.2008.01818.x	56	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142018	10.1371/journal.pone.0142018	http://dx.doi.org/10.1371/journal.pone.0142018			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV6RT	26544607	Green Published, Green Submitted, gold			2022-12-27	WOS:000364398700071
J	Schaefer-Klein, JL; Murphy, SJ; Johnson, SH; Vasmatzis, G; Kovtun, IV				Schaefer-Klein, J. L.; Murphy, Stephen J.; Johnson, Sarah H.; Vasmatzis, George; Kovtun, Irina V.			Topoisomerase 2 Alpha Cooperates with Androgen Receptor to Contribute to Prostate Cancer Progression	PLOS ONE			English	Article							EARLY MITOTIC INHIBITOR-1; II-ALPHA; CARCINOMA CORRELATION; SYSTEMIC PROGRESSION; GLEASON SCORE; BREAST-CANCER; HIGH-RISK; EXPRESSION; GENE; PHOSPHORYLATION	Overexpression of TOP2A is associated with risk of systemic progression in prostate cancer patients, and higher levels of TOP2A were found in hormone-resistant cases. To elucidate the mechanism by which high levels of TOP2A contribute to tumor progression we generated TOP2A overexpressing prostate cancer cell lines. We show that TOP2A promotes tumor aggressiveness by inducing chromosomal rearrangements of genes that contribute to a more invasive phenotype. Anti-androgen treatment alone was ineffective in killing TOP2A overexpressing cells due to activation of an androgen receptor network. TOP2A poisons killed tumor cells more efficiently early in the progression course, while at later stages they provided greater benefit when combined with anti-androgen therapy. Mechanistically, we find that TOP2A enhances androgen signaling by facilitating transcription of androgen responsive genes, thereby promoting tumor cell growth. These studies revealed a relationship between TOP2A and androgen receptor signaling pathway that contributes to prostate cancer progression and confers sensitivity to treatments.	[Schaefer-Klein, J. L.; Murphy, Stephen J.; Vasmatzis, George] Mayo Clin, Dept Mol Med, Rochester, MN USA; [Kovtun, Irina V.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA; [Schaefer-Klein, J. L.; Murphy, Stephen J.; Johnson, Sarah H.; Vasmatzis, George; Kovtun, Irina V.] Mayo Clin, Ctr Individualized Med, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Kovtun, IV (corresponding author), Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA.	Kovtun.Irina@mayo.edu	Kovtun, Irina/ABA-8484-2020		Waterman Biomarker Discovery grant; Center of Individualized Medicine at Mayo Clinic	Waterman Biomarker Discovery grant; Center of Individualized Medicine at Mayo Clinic	This work was supported by a Waterman Biomarker Discovery grant and the Center of Individualized Medicine at Mayo Clinic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arndt S, 2015, INT J CANCER, V119, P2812; Azuma Y, 2003, J CELL BIOL, V163, P477, DOI 10.1083/jcb.200304088; Bastus NC, 2010, CANCER RES, V70, P9544, DOI 10.1158/0008-5472.CAN-10-1638; Beer TM, 2014, NEW ENGL J MED, V371, P424, DOI 10.1056/NEJMoa1405095; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Bishr M, 2013, NAT REV UROL, V10, P522, DOI 10.1038/nrurol.2013.137; Boisgerault N, 2013, MOL THER, V21, P1507, DOI 10.1038/mt.2013.116; Bower JJ, 2010, ONCOGENE, V29, P4787, DOI 10.1038/onc.2010.232; Brinkmann AO, 1999, J STEROID BIOCHEM, V69, P307, DOI 10.1016/S0960-0760(99)00049-7; Chen T, 2014, ONCOGENE; Chen W, 2012, DRUG DISCOV THER, V6, P230, DOI 10.5582/ddt.2012.v6.5.230; Chen XY, 2005, NAT CELL BIOL, V7, P262, DOI 10.1038/ncb1226; Cheville JC, 2008, J CLIN ONCOL, V26, P3930, DOI 10.1200/JCO.2007.15.6752; Chikamori K, 2003, J BIOL CHEM, V278, P12696, DOI 10.1074/jbc.M300837200; Deming PB, 2001, P NATL ACAD SCI USA, V98, P12044, DOI 10.1073/pnas.221430898; Denmeade SR, 2004, PROSTATE, V58, P211, DOI 10.1002/pros.10360; Depowski PL, 2000, MODERN PATHOL, V13, P542, DOI 10.1038/modpathol.3880094; DOWNES CS, 1994, NATURE, V372, P467, DOI 10.1038/372467a0; Drucker TM, 2014, BIOINFORMATICS, V30, P1627, DOI 10.1093/bioinformatics/btu078; Ellis Leigh, 2014, Oncoscience, V1, P609; Engel R, 2004, EXP CELL RES, V295, P421, DOI 10.1016/j.yexcr.2004.01.012; Faggad A, 2009, MODERN PATHOL, V22, P579, DOI 10.1038/modpathol.2009.14; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; FROELICHAMMON SJ, 1995, J BIOL CHEM, V270, P21429, DOI 10.1074/jbc.270.37.21429; FRY AM, 1991, CANCER RES, V51, P6592; Garner E, 2007, CANCER RES, V67, P7631, DOI 10.1158/0008-5472.CAN-07-0334; Haffner MC, 2010, NAT GENET, V42, P668, DOI 10.1038/ng.613; Hande KR, 2008, UPDATE CANC THERAPEU, V3, P13, DOI DOI 10.1016/J.UCT.2008.02.001; HECK MMS, 1986, J CELL BIOL, V103, P2569, DOI 10.1083/jcb.103.6.2569; Horie-Inoue K, 2004, BIOCHEM BIOPH RES CO, V325, P1312, DOI 10.1016/j.bbrc.2004.10.174; Hughes C, 2006, J CLIN PATHOL, V59, P721, DOI 10.1136/jcp.2005.029975; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Karnes RJ, 2010, CANCER RES, V70, P8994, DOI 10.1158/0008-5472.CAN-10-1358; Kennedy RD, 2005, CANCER RES, V65, P10265, DOI 10.1158/0008-5472.CAN-05-1841; Kovtun IV, 2013, CANCER RES, V73, P3275, DOI 10.1158/0008-5472.CAN-12-2803; Kovtun IV, 2004, HUM MOL GENET, V13, P3057, DOI 10.1093/hmg/ddh325; Lan YS, 2008, INT J CANCER, V123, P543, DOI 10.1002/ijc.23548; Li H, 2008, J BIOL CHEM, V283, P6209, DOI 10.1074/jbc.M709007200; Liu XB, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0735-0; Lorente D, 2015, NAT REV UROL, V12, P37, DOI 10.1038/nrurol.2014.345; Lou ZK, 2005, NAT STRUCT MOL BIOL, V12, P589, DOI 10.1038/nsmb953; McPherson JP, 1998, CANCER RES, V58, P4519; Murphy SJ, 2012, DNA RES, V19, P395, DOI 10.1093/dnares/dss021; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Nitiss JL, 2009, NAT REV CANCER, V9, P327, DOI 10.1038/nrc2608; PEDERSENBJERGAARD J, 1991, LANCET, V338, P359, DOI 10.1016/0140-6736(91)90490-G; Petrylak DP., 2013, CHALLENGES TREATIN S, V19, ps366; Qi XM, 2011, J BIOL CHEM, V286, P35883, DOI 10.1074/jbc.M111.229260; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Rudolph P, 1999, BREAST CANCER RES TR, V55, P61, DOI 10.1023/A:1006159016703; Seth A, 2005, EUR J CANCER, V41, P2462, DOI 10.1016/j.ejca.2005.08.013; Shimizu N, 2013, J BIOL CHEM, V288, P17238, DOI 10.1074/jbc.M112.446351; Tomida S, 2007, ONCOGENE, V26, P4600, DOI 10.1038/sj.onc.1210242; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024; Trinh BQ, 2013, CANCER RES, V73, P1000, DOI 10.1158/0008-5472.CAN-12-3538; Tsai SC, 2000, NAT GENET, V26, P349, DOI 10.1038/81671; Vasmatzis G, 2012, BLOOD, V120, P2280, DOI 10.1182/blood-2012-03-419937; VISAKORPI T, 1995, NAT GENET, V9, P401, DOI 10.1038/ng0495-401; Wan JC, 2002, NAT REV MOL CELL BIO; Wang LHC, 2008, CHROMOSOMA, V117, P123, DOI 10.1007/s00412-007-0131-7; Williamson LM, 2011, CARCINOGENESIS, V32, P279, DOI 10.1093/carcin/bgq255; Willman JH, 2000, PROSTATE, V42, P280; Winter RN, 2011, CANCER RES, V61, P1227; Zhao YH, 2013, HUM PATHOL, V44, P365, DOI 10.1016/j.humpath.2012.03.030; ZINI N, 1994, EXP CELL RES, V210, P336, DOI 10.1006/excr.1994.1046	65	29	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142327	10.1371/journal.pone.0142327	http://dx.doi.org/10.1371/journal.pone.0142327			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26560244	Green Submitted, Green Published, gold			2022-12-27	WOS:000364433100071
J	Krueger, JG; Suarez-Farinas, M; Cueto, I; Khacherian, A; Matheson, R; Parish, LC; Leonardi, C; Shortino, D; Gupta, A; Haddad, J; Vlasuk, GP; Jacobson, EW				Krueger, James G.; Suarez-Farinas, Mayte; Cueto, Inna; Khacherian, Artemis; Matheson, Robert; Parish, Lawrence C.; Leonardi, Craig; Shortino, Denise; Gupta, Akanksha; Haddad, Jonathan; Vlasuk, George P.; Jacobson, Eric W.			A Randomized, Placebo-Controlled Study of SRT2104, a SIRT1 Activator, in Patients with Moderate to Severe Psoriasis	PLoS One			English	Article							FAMILY; SIRTUINS; INDEX; AREA	Activation of Sirtuin (silent mating type information regulation 2 homolog) 1, or SIRT1, is an unexplored therapeutic approach for treatment of inflammatory diseases. We randomized 40 patients with moderate-to-severe psoriasis (4:1) to three escalating doses of SRT2104, a selective activator of SIRT1, or placebo. Across all SRT2104 groups, 35% of patients (p<0.0001) achieved good to excellent histological improvement based on skin biopsies taken at baseline and day 84 but was not consistently in agreement with PASI. Improvement in histology was associated with modulation of IL-17 and TNF-alpha signaling pathways and keratinocyte differentiation target genes. 27 subjects (69%) across all treatment groups, including placebo, experienced at least one treatment emergent adverse event. The majority of AEs were either mild or moderate. Most common were headache (8%), dizziness (8%), upper respiratory tract infection (8%), and psoriatic arthropathy (8%). Average drug exposure increased in a dose-dependent manner for escalating doses of SRT2104 and had high intra-subject variability in exposure (AUC %CV: 51-89%). Given the interesting signals of clinical activity, impact on gene expression and the generally favorable safety profile seen in this study, further investigation of SIRT1 activators for the treatment of psoriasis is warranted.	[Krueger, James G.; Suarez-Farinas, Mayte; Cueto, Inna; Khacherian, Artemis] Rockefeller Univ, Invest Dermatol Lab, New York, NY 10021 USA; [Suarez-Farinas, Mayte] Rockefeller Univ, Ctr Clin & Translat Sci, New York, NY 10021 USA; [Matheson, Robert] Oregon Med Res Ctr PC, Portland, OR USA; [Parish, Lawrence C.] Paddington Testing Co Inc, Philadelphia, PA USA; [Leonardi, Craig] Cent Dermatol, St Louis, MO USA; [Shortino, Denise; Haddad, Jonathan] GlaxoSmithKline, Clin Stat, Res Triangle Pk, NC USA; [Gupta, Akanksha; Vlasuk, George P.; Jacobson, Eric W.] Sirtris, Cambridge, MA USA	Rockefeller University; Rockefeller University; GlaxoSmithKline	Gupta, A (corresponding author), Sirtris, Cambridge, MA USA.	akanksha.x.gupta@gsk.com			Sirtris, a GSK company [NCT01154101]; GSK; Paddington Testing Co, Inc., Central Dermatology and Oregon Medical Research Center	Sirtris, a GSK company; GSK(GlaxoSmithKline); Paddington Testing Co, Inc., Central Dermatology and Oregon Medical Research Center	The study was funded by Sirtris, a GSK company (NCT01154101). JH, DS, AG, GPV, EWJ are employees of GSK. GSK provided support in the form of salaries for authors (JH, DS, AG, GPV, EWJ) and design, collection of data, study analysis and preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions section. LCP is employed by Paddington Testing Co, Inc.. CL is employed by Central Dermatology. RM is employed by Oregon Medical Research Center. Paddington Testing Co, Inc., Central Dermatology and Oregon Medical Research Center provided support in the form of salaries for authors LCP, CL and RM respectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions section.	Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Carlin CS, 2004, J AM ACAD DERMATOL, V50, P859, DOI 10.1016/j.jaad.2003.09.014; Chiricozzi A, 2011, J INVEST DERMATOL, V131, P677, DOI 10.1038/jid.2010.340; Daubener W, 1999, ADV EXP MED BIOL, V467, P517; GIBBS S, 1993, GENOMICS, V16, P630, DOI 10.1006/geno.1993.1240; Hoffmann E, 2013, BRIT J CLIN PHARMACO, V75, P186, DOI 10.1111/j.1365-2125.2012.04340.x; Jackson B, 2005, J INVEST DERMATOL, V124, P1062, DOI 10.1111/j.0022-202X.2005.23699.x; Langley RG, 2004, J AM ACAD DERMATOL, V51, P563, DOI 10.1016/j.jaad.2004.04.012; Lavu S, 2008, NAT REV DRUG DISCOV, V7, P841, DOI 10.1038/nrd2665; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Nograles KE, 2008, BRIT J DERMATOL, V159, P1092, DOI 10.1111/j.1365-2133.2008.08769.x; Ng PY, 2013, LETT DRUG DES DISCOV, V10, P793; Suarez-Farinas M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-294; Suarez-Farinas M, 2012, J INVEST DERMATOL, V132, P2552, DOI 10.1038/jid.2012.184; Tian SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044274; Wu ZJ, 2004, NAT BIOTECHNOL, V22, P656, DOI 10.1038/nbt0604-656b; Zaba LC, 2010, J ALLERGY CLIN IMMUN, V125, P1261, DOI 10.1016/j.jaci.2010.03.018	18	53	55	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142081	10.1371/journal.pone.0142081	http://dx.doi.org/10.1371/journal.pone.0142081			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556603	gold, Green Published, Green Submitted			2022-12-27	WOS:000364430700051
J	Lee, JS; Bin Jang, H; Kim, KS; Kim, TH; Im, SP; Kim, SW; Lazarte, JMS; Kim, JS; Jung, TS				Lee, Jung Seok; Bin Jang, Ho; Kim, Ki Sei; Kim, Tae Hwan; Im, Se Pyeong; Kim, Si Won; Lazarte, Jassy Mary S.; Kim, Jae Sung; Jung, Tae Sung			Complete Genomic and Lysis-Cassette Characterization of the Novel Phage, KBNP1315, which Infects Avian Pathogenic Escherichia coli (APEC)	PLOS ONE			English	Article							BACTERIOPHAGES; PROTEIN; HOST; SEQUENCE; COLIBACILLOSIS; CLASSIFICATION; EVOLUTIONARY; PREVALENCE; ELEMENTS; STRAINS	Avian pathogenic Escherichia coli (APEC) is a major pathogen that causes avian colibacillosis and is associated with severe economic losses in the chicken-farming industry. Here, bacteriophage KBNP1315, infecting APEC strain KBP1315, was genomically and functionally characterized. The evolutionary relationships of KBNP1315 were analyzed at the genomic level using gene (protein)-sharing networks, the Markov clustering (MCL) algorithm, and comparative genomics. Our network analysis showed that KBNP1315 was connected to 30 members of the Autographivirinae subfamily, which comprises the SP6-, T7-, P60-, phiKMV-, GAP227- and KP34-related groups. Network decomposition suggested that KBNP1315 belongs to the SP6-like phages, but our comparison of putative encoded proteins revealed that key proteins of KBNP1315, including the tail spike protein and endolysin, had relative low levels of amino acid sequence similarity with other members of the SP6-like phages. Thus KBNP1315 may only be distantly related to the SP6-like phages, and (based on the difference in endolysin) its lysis mechanism may differ from theirs. To characterize the lytic functions of the holin and endolysin proteins from KBNP1315, we expressed these proteins individually or simultaneously in E. coli BL21 (DE3) competent cell. Interestingly, the expressed endolysin was secreted into the periplasm and caused a high degree of host cell lysis that was dose-dependently delayed/blocked by NaN3-mediated inhibition of the SecA pathway. The expressed holin triggered only a moderate inhibition of cell growth, whereas coexpression of holin and endolysin enhanced the lytic effect of endolysin. Together, these results revealed that KBNP1315 appears to use a pin-holin/signal-arrest-release (SAR) endolysin pathway to trigger host cell lysis.	[Lee, Jung Seok; Im, Se Pyeong; Kim, Si Won; Lazarte, Jassy Mary S.; Kim, Jae Sung; Jung, Tae Sung] Gyeongsang Natl Univ, Inst Anim Med, Coll Vet Med, Lab Aquat Anim Dis, Jinju 660701, South Korea; [Bin Jang, Ho] Katholieke Univ Leuven, Lab Gene Technol, B-3001 Leuven, Belgium; [Kim, Ki Sei; Kim, Tae Hwan] KBNP Inc, KBNP Technol Inst, Yesan, Choongcheongnam, South Korea	Gyeongsang National University; KU Leuven	Jung, TS (corresponding author), Gyeongsang Natl Univ, Inst Anim Med, Coll Vet Med, Lab Aquat Anim Dis, Jinju 660701, South Korea.	jungts@gsnu.ac.kr	Jung, Tae Sung/G-8245-2017	Jung, Tae Sung/0000-0001-6028-0946; Jang, Ho Bin/0000-0003-1316-316X	Ministry of Science, ICT and Future Planning of South Korea [NRF- 2013R1A1A1059608]; KBNP Technology Institute, KBNP, Inc.	Ministry of Science, ICT and Future Planning of South Korea; KBNP Technology Institute, KBNP, Inc.	Funding: This work was made possible by a Korea Research Foundation grant funded by the Ministry of Science, ICT and Future Planning of South Korea (NRF- 2013R1A1A1059608). KBNP Technology Institute, KBNP, Inc., provided support in the form of salaries for authors KHK and THK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ackermann HW, 2001, ARCH VIROL, V146, P843, DOI 10.1007/s007050170120; Adams MH, 1959, BACTERIOPHAGES; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Barnes H.J., 2003, DIS POULT, V12, P691; Bass L, 1999, ANTIMICROB AGENTS CH, V43, P2925, DOI 10.1128/AAC.43.12.2925; Briers Yves, 2011, Bacteriophage, V1, P25, DOI 10.4161/bact.1.1.14868; Brohee S, 2008, NUCLEIC ACIDS RES, V36, pW444, DOI 10.1093/nar/gkn336; Brussow H, 2002, CELL, V108, P13, DOI 10.1016/S0092-8674(01)00637-7; BUTLER ET, 1982, J BIOL CHEM, V257, P5772; Catalao MJ, 2011, J BACTERIOL, V193, P2793, DOI 10.1128/JB.01519-10; Clokie M.R.J., 2009, BACTERIOPHAGES; CLOUD SS, 1985, AVIAN DIS, V29, P1084, DOI 10.2307/1590463; Dagan T, 2011, TRENDS MICROBIOL, V19, P483, DOI 10.1016/j.tim.2011.07.001; Dobbins AT, 2004, J BACTERIOL, V186, P1933, DOI 10.1128/JB.186.7.1933-1944.2004; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Francki R.I.B., 2012, CLASSIFICATION NOMEN, VVol. 2; Green MR, 2012, MOL CLONING LAB MANU, V1; Grose JH, 2014, VIROLOGY, V468, P421, DOI 10.1016/j.virol.2014.08.024; Hatfull GF, 2008, CURR OPIN MICROBIOL, V11, P447, DOI 10.1016/j.mib.2008.09.004; Hendrix RW, 1999, P NATL ACAD SCI USA, V96, P2192, DOI 10.1073/pnas.96.5.2192; Jang HB, 2013, J VIROL, V87, P12866, DOI 10.1128/JVI.02656-13; Janssen T, 2001, INT J MED MICROBIOL, V291, P371, DOI 10.1078/1438-4221-00143; Johnson TJ, 2008, APPL ENVIRON MICROB, V74, P7043, DOI 10.1128/AEM.01395-08; Johnson TJ, 2006, J BACTERIOL, V188, P745, DOI 10.1128/JB.188.2.745-758.2006; Kabir SML, 2010, INT J ENV RES PUB HE, V7, P89, DOI 10.3390/ijerph7010089; Kim TE, 2007, J CLIN MICROBIOL, V45, P3309, DOI 10.1128/JCM.01922-06; Kuty GF, 2010, J BACTERIOL, V192, P5682, DOI 10.1128/JB.00674-10; Lavigne R, 2004, BIOINFORMATICS, V20, P629, DOI 10.1093/bioinformatics/btg456; Lavigne R, 2008, RES MICROBIOL, V159, P406, DOI 10.1016/j.resmic.2008.03.005; Leiman PG, 2007, J MOL BIOL, V371, P836, DOI 10.1016/j.jmb.2007.05.083; Leplae R, 2004, NUCLEIC ACIDS RES, V32, pD45, DOI 10.1093/nar/gkh084; Lima-Mendez G, 2008, MOL BIOL EVOL, V25, P762, DOI 10.1093/molbev/msn023; Lima-Mendez G, 2011, RES MICROBIOL, V162, P737, DOI 10.1016/j.resmic.2011.06.006; Lynch KH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-574; Murray PR, 1995, TRENDS MICROBIOL, V3, P449, DOI DOI 10.1016/S0966-842X(00)89003-4; Naville M, 2011, RNA BIOL, V8, P11, DOI 10.4161/rna.8.1.13346; Oliveira A, 2010, VET MICROBIOL, V146, P303, DOI 10.1016/j.vetmic.2010.05.015; Oliveira H, 2013, J VIROL, V87, P4558, DOI 10.1128/JVI.03277-12; Park T, 2007, J BACTERIOL, V189, P9135, DOI 10.1128/JB.00847-07; Rahman M. A., 2004, Bangladesh Journal of Veterinary Medicine, V2, P99; Rodriguez-Siek KE, 2005, MICROBIOL-SGM, V151, P2097, DOI 10.1099/mic.0.27499-0; Sao-Jose C, 2000, J BACTERIOL, V182, P5823, DOI 10.1128/JB.182.20.5823-5831.2000; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Scholl D, 2004, J MOL BIOL, V335, P1151, DOI 10.1016/j.jmb.2003.11.035; Scholl D, 2002, J BACTERIOL, V184, P2833, DOI 10.1128/JB.184.10.2833-2836.2002; Schubert S, 1998, INFECT IMMUN, V66, P480, DOI 10.1128/IAI.66.2.480-485.1998; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shin H, 2014, APPL ENVIRON MICROB, V80, P374, DOI 10.1128/AEM.02279-13; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Stummeyer K, 2006, MOL MICROBIOL, V60, P1123, DOI 10.1111/j.1365-2958.2006.05173.x; Sun QG, 2009, NAT STRUCT MOL BIOL, V16, P1192, DOI 10.1038/nsmb.1681; Van Dongen SM., 2001, THESIS; Wang IN, 2000, ANNU REV MICROBIOL, V54, P799, DOI 10.1146/annurev.micro.54.1.799; Xu M, 2004, P NATL ACAD SCI USA, V101, P6415, DOI 10.1073/pnas.0400957101; Young R, 2000, TRENDS MICROBIOL, V8, P120, DOI 10.1016/S0966-842X(00)01705-4; Young R, 2013, CURR OPIN MICROBIOL, V16, P790, DOI 10.1016/j.mib.2013.08.008	57	5	5	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142504	10.1371/journal.pone.0142504	http://dx.doi.org/10.1371/journal.pone.0142504			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555076	Green Published, Green Submitted, gold			2022-12-27	WOS:000364430700119
J	Lin, SF; Chen, YJ; Tu, HP; Lee, CL; Hsieh, CL; Wu, WL; Chen, CH				Lin, Shih-Feng; Chen, Yi-Jen; Tu, Hung-Pin; Lee, Chia-Ling; Hsieh, Ching-Lin; Wu, Wen-Lan; Chen, Chia-Hsin			The Effects of Extracorporeal Shock Wave Therapy in Patients with Coccydynia: A Randomized Controlled Trial	PLOS ONE			English	Article							LOW-BACK-PAIN; COCCYGODYNIA; MANAGEMENT; RABBITS; METAANALYSIS; ETIOLOGY; INDEX	Coccydynia is pain in the coccygeal region, and usually treated conservatively. Extracorporeal shock wave therapy (ESWT) was incorporated as non-invasive treatment of many musculoskeletal conditions. However, the effects of ESWT on coccydynia are less discussed. The purpose of this study is to evaluate the effects of ESWT on the outcomes of coccydynia. Patients were allocated to ESWT (n = 20) or physical modality (SIT) group (n = 21) randomly, and received total treatment duration of 4 weeks. The visual analog scale (VAS), Oswestry disability index (ODI), and self-reported satisfaction score were used to assess treatment effects. The VAS and ODI scores were significantly decreased after treatment in both groups, and the decrease in the VAS score was significantly greater in the ESWT group. The mean proportional changes in the ODI scores were greater in the ESWT group than in the SIT group, but the between-group difference was not statistically significant. The patients in the ESWT group had significantly higher subjective satisfaction scores than SIT group. We concluded that ESWT is more effective and satisfactory in reducing discomfort and disability caused by coccydynia than the use of physical modalities. Thus, ESWT is recommended as an alternative treatment option for patients with coccydynia.	[Lin, Shih-Feng; Chen, Yi-Jen; Lee, Chia-Ling; Chen, Chia-Hsin] Kaohsiung Municipal Tatung Hosp, Dept Phys Med & Rehabil, Kaohsiung, Taiwan; [Chen, Yi-Jen; Lee, Chia-Ling; Chen, Chia-Hsin] Kaohsiung Med Univ Hosp, Dept Phys Med & Rehabil, Kaohsiung, Taiwan; [Chen, Yi-Jen] Kaohsiung Med Univ, Grad Inst Clin Med, Coll Med, Kaohsiung, Taiwan; [Tu, Hung-Pin] Kaohsiung Med Univ, Sch Med, Coll Med, Dept Publ Hlth & Environm Med, Kaohsiung, Taiwan; [Lee, Chia-Ling] Kaohsiung Municipal Hsiaokang Hosp, Dept Phys Med & Rehabil, Kaohsiung, Taiwan; [Hsieh, Ching-Lin] Natl Taiwan Univ, Sch Occupat Therapy, Coll Med, Taipei 10764, Taiwan; [Wu, Wen-Lan] Kaohsiung Med Univ, Dept Sports Med, Coll Med, Kaohsiung, Taiwan; [Chen, Chia-Hsin] Kaohsiung Med Univ, Sch Med, Dept Phys Med & Rehabil, Coll Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; National Taiwan University; Kaohsiung Medical University; Kaohsiung Medical University	Chen, CH (corresponding author), Kaohsiung Municipal Tatung Hosp, Dept Phys Med & Rehabil, Kaohsiung, Taiwan.	chchen@kmu.edu.tw	Hsieh, Ching-Lin/G-6057-2011	Hsieh, Ching-Lin/0000-0001-9468-9969; Wu, Wenlan/0000-0003-2199-4553; Chen, Chia-Hsin/0000-0002-6557-9848; Chen, Yi-Jen/0000-0002-5178-2335; Tu, Hung-Pin/0000-0003-1044-2673	Kaohsiung Municipal Ta-Tung Hospital [KMTTH-101-012, KMTTH-101-023, KMTTH 102-010]; National Science Council, Taiwan [NSC 101-2314-B-037-002 -MY3]	Kaohsiung Municipal Ta-Tung Hospital; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	Funding: This work was supported by grants from Kaohsiung Municipal Ta-Tung Hospital (Grant numbers: KMTTH-101-012, KMTTH-101-023 and KMTTH 102-010) and the National Science Council (Grant number: NSC 101-2314-B-037-002 -MY3), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsson SO, 1997, J ORTHOPAED RES, V15, P256, DOI 10.1002/jor.1100150215; Balain B, 2006, SPINE, V31, pE414, DOI 10.1097/01.brs.0000219867.07683.7a; Lara-Palomo IC, 2013, CLIN REHABIL, V27, P439, DOI 10.1177/0269215512460780; CHAUSSY C, 1980, LANCET, V2, P1265; Childress MA, 2013, AM FAM PHYSICIAN, V87, P486; De Andres J, 2003, J PAIN, V4, P257, DOI 10.1016/S1526-5900(03)00620-5; Dizon JNC, 2013, AM J PHYS MED REHAB, V92, P606, DOI 10.1097/PHM.0b013e31828cd42b; Fairbank JCT, 2000, SPINE, V25, P2940, DOI 10.1097/00007632-200011150-00017; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fogel GR, 2004, J AM ACAD ORTHOP SUR, V12, P49, DOI 10.5435/00124635-200401000-00007; Fritz JM, 2009, SPINE, V34, P2803, DOI 10.1097/BRS.0b013e3181ae2bd4; Fuentes JP, 2010, PHYS THER, V90, P1219, DOI 10.2522/ptj.20090335; Goats G C, 1989, Br J Sports Med, V23, P123; Hausdor J, 2008, BRAIN RES, V1207, P96, DOI 10.1016/j.brainres.2008.02.013; Hodges Scott D, 2004, Spine J, V4, P138, DOI 10.1016/j.spinee.2003.07.011; Hurley DA, 2001, ARCH PHYS MED REHAB, V82, P485, DOI 10.1053/apmr.2001.21934; Khan KM, 2009, BRIT J SPORT MED, V43, P247, DOI 10.1136/bjsm.2008.054239; Kuo YR, 2009, WOUND REPAIR REGEN, V17, P522, DOI 10.1111/j.1524-475X.2009.00504.x; Lee S, 2014, J PHYS THER SCI, V26, P7, DOI 10.1589/jpts.26.7; Maigne J Y, 2001, Spine (Phila Pa 1976), V26, pE479, DOI 10.1097/00007632-200110150-00024; Maigne JY, 2006, SPINE, V31, pE621, DOI 10.1097/01.brs.0000231895.72380.64; Maigne JY, 2000, SPINE, V25, P3072, DOI 10.1097/00007632-200012010-00015; Maigne JY, 2001, SPINE, V26, pE484; Marwan Y, 2014, SPINE J, V14, pE1, DOI 10.1016/j.spinee.2013.07.438; Mazza L, 2004, Tech Coloproctol, V8, P77; Melzack R, 1979, Int Rehabil Med, V1, P111; Nathan ST, 2010, J BONE JOINT SURG BR, V92B, P1622, DOI 10.1302/0301-620X.92B12.25486; Nijs J, 2011, EXPERT OPIN PHARMACO, V12, P1087, DOI 10.1517/14656566.2011.547475; Notarnicola Angela, 2012, Muscles Ligaments Tendons J, V2, P33; Ostelo RWJG, 2008, SPINE, V33, P90, DOI 10.1097/BRS.0b013e31815e3a10; Patel R, 2008, CURR REV MUSCULOSKE, V1, P223, DOI 10.1007/s12178-008-9028-1; Peters J, 2004, SKELETAL RADIOL, V33, P712, DOI 10.1007/s00256-004-0849-8; POSTACCHINI F, 1983, J BONE JOINT SURG AM, V65, P1116, DOI 10.2106/00004623-198365080-00011; Rush J., 1996, CURR ORTHOPAED, V10, P128; RUSH PJ, 1994, BRIT J RHEUMATOL, V33, P566; Schwind J, 2013, J MAN MANIP THER, V21, P71, DOI 10.1179/2042618613Y.0000000028; Seil R, 2006, EXPERT REV MED DEVIC, V3, P463, DOI 10.1586/17434440.3.4.463; Shields Nora, 2002, Physiother Res Int, V7, P191, DOI 10.1002/pri.259; Wang CJ, 2003, J ORTHOP RES, V21, P984, DOI 10.1016/S0736-0266(03)00104-9; WEWERS ME, 1990, RES NURS HEALTH, V13, P227, DOI 10.1002/nur.4770130405; WRAY CC, 1991, J BONE JOINT SURG BR, V73, P335, DOI 10.1302/0301-620X.73B2.2005168; Wright A, 2012, J MAN MANIP THER, V20, P160, DOI 10.1179/2042618612Y.0000000001; Wu CL, 2009, J MANIP PHYSIOL THER, V32, P287, DOI 10.1016/j.jmpt.2009.03.002	43	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142475	10.1371/journal.pone.0142475	http://dx.doi.org/10.1371/journal.pone.0142475			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556601	Green Submitted, gold, Green Published			2022-12-27	WOS:000364430700111
J	Noli, B; Brancia, C; Pilleri, R; D'Amato, F; Messana, I; Manconi, B; Ebling, FJP; Ferri, GL; Cocco, C				Noli, Barbara; Brancia, Carla; Pilleri, Roberta; D'Amato, Filomena; Messana, Irene; Manconi, Barbara; Ebling, Francis J. P.; Ferri, Gian-Luca; Cocco, Cristina			Photoperiod Regulates vgf-Derived Peptide Processing in Siberian Hamsters	PLOS ONE			English	Article							GENE-EXPRESSION; FOOD-INTAKE; ARCUATE NUCLEUS; BODY-WEIGHT; TLQP-21; PRODUCT; IDENTIFICATION; RECEPTOR; PROTEIN	VGF mRNA is induced in specific hypothalamic areas of the Siberian hamster upon exposure to short photoperiods, which is associated with a seasonal decrease in appetite and weight loss. Processing of VGF generates multiple bioactive peptides, so the objective of this study was to determine the profile of the VGF-derived peptides in the brain, pituitary and plasma from Siberian hamsters, and to establish whether differential processing might occur in the short day lean state versus long day fat. Antisera against short sequences at the C-or N-termini of proVGF, as well as against NERP-1, TPGH and TLQP peptides, were used for analyses of tissues, and both immunohistochemistry and enzyme linked immunosorbent assay (ELISA) coupled with high-performance liquid (HPLC) or gel chromatography were carried out. VGF peptide immunoreactivity was found within cortex cholinergic perikarya, in multiple hypothalamic nuclei, including those containing vasopressin, and in pituitary gonadotrophs. ELISA revealed that exposure to short day photoperiod led to a down-regulation of VGF immunoreactivity in the cortex, and a less pronounced decrease in the hypothalamus and pituitary, while the plasma VGF levels were not affected by the photoperiod. HPLC and gel chromatography both confirmed the presence of multiple VGF-derived peptides in these tissues, while gel chromatography showed the presence of the VGF precursor in all tissues tested except for the cortex. These observations are consistent with the view that VGF-derived peptides have pleiotropic actions related to changing photoperiod, possibly by regulating cholinergic systems in the cortex, vasopressin hypothalamic pathways, and the reproductive axis.	[Noli, Barbara; Brancia, Carla; Pilleri, Roberta; D'Amato, Filomena; Ferri, Gian-Luca; Cocco, Cristina] Univ Cagliari, NEF Lab, Dept Biomed Sci, Monserrato, CA, Italy; [Messana, Irene; Manconi, Barbara] Univ Cagliari, Dept Life & Environm Sci, Monserrato, CA, Italy; [Ebling, Francis J. P.] Univ Nottingham, Sch Med, Sch Life Sci, Nottingham, England	University of Cagliari; University of Cagliari; University of Nottingham	Cocco, C (corresponding author), Univ Cagliari, NEF Lab, Dept Biomed Sci, Monserrato, CA, Italy.	cristina.cocco@unica.it	Ebling, Francis/Q-6193-2019; Ferri, Luca Angelo/AAC-5890-2022; Messana, Irene/L-2478-2019	Ebling, Francis/0000-0002-7316-9582; Ferri, Luca Angelo/0000-0001-9031-6284; Messana, Irene/0000-0002-1436-6105; BRANCIA, CARLA/0000-0002-0716-3983; FERRI, Gian-Luca/0000-0003-2768-349X	ARS (Autonomous Region of Sardinia) through the "Sardinia PO" funds [L.R. 7/2007]	ARS (Autonomous Region of Sardinia) through the "Sardinia PO" funds	This study was sponsored by the ARS (Autonomous Region of Sardinia) through the "Sardinia PO FSE 2007-1013" funds (the L.R. 7/2007 for the "Promotion of the Scientific Research and of the Technological Innovation in Sardinia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar E, 2013, NEUROENDOCRINOLOGY, V98, P38, DOI 10.1159/000350323; Alder J, 2003, J NEUROSCI, V23, P10800; Barrett P, 2005, ENDOCRINOLOGY, V146, P1930, DOI 10.1210/en.2004-1452; BARTNESS TJ, 1995, PHYSIOL BEHAV, V58, P539, DOI 10.1016/0031-9384(95)00082-T; BARTNESS TJ, 1989, AM J PHYSIOL, V257, pR1533, DOI 10.1152/ajpregu.1989.257.6.R1533; Bartolomucci A, 2006, P NATL ACAD SCI USA, V103, P14584, DOI 10.1073/pnas.0606102103; BERGER P, 1990, J ENDOCRINOL, V125, P301, DOI 10.1677/joe.0.1250301; Bozdagi O, 2008, J NEUROSCI, V28, P9857, DOI 10.1523/JNEUROSCI.3145-08.2008; Brancia C, 2005, J ENDOCRINOL, V186, P97, DOI 10.1677/joe.1.05992; Cocco C, 2003, APPL IMMUNOHISTO M M, V11, P274; Cocco C, 2007, J HISTOCHEM CYTOCHEM, V55, P619, DOI 10.1369/jhc.6A7040.2007; Cocco C, 2010, J ANAT, V217, P683, DOI 10.1111/j.1469-7580.2010.01309.x; D'Amato F, 2012, J CHEM NEUROANAT, V44, P57, DOI 10.1016/j.jchemneu.2012.05.001; EBLING FJP, 1994, GEN COMP ENDOCR, V95, P475, DOI 10.1006/gcen.1994.1147; Ebling FJP, 2014, HORM BEHAV, V66, P56, DOI 10.1016/j.yhbeh.2014.03.009; Ferri GL, 2011, J CHEM NEUROANAT, V42, P249, DOI 10.1016/j.jchemneu.2011.05.007; Ferri GL, 2002, APPL IMMUNOHISTO M M, V10, P381, DOI 10.1097/00022744-200212000-00016; FERRI GL, 1992, MOL BRAIN RES, V13, P139, DOI 10.1016/0169-328X(92)90053-E; Hannedouche S, 2013, J BIOL CHEM, V288, P27434, DOI 10.1074/jbc.M113.497214; Herwig A, 2012, J NEUROENDOCRINOL, V24, P991, DOI 10.1111/j.1365-2826.2012.02324.x; Jethwa PH, 2007, ENDOCRINOLOGY, V148, P4044, DOI 10.1210/en.2007-0038; Mintz EM, 2001, J CHEM NEUROANAT, V21, P225, DOI 10.1016/S0891-0618(01)00111-9; Morin LP, 2001, STEREOTAXIC ATLAS GO; Nilaweera KN, 2009, J NEUROENDOCRINOL, V21, P123, DOI 10.1111/j.1365-2826.2008.01810.x; Noli B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108456; Oda Y, 1999, PATHOL INT, V49, P921, DOI 10.1046/j.1440-1827.1999.00977.x; Reddy AB, 1999, EUR J NEUROSCI, V11, P3255, DOI 10.1046/j.1460-9568.1999.00746.x; Ross AW, 2005, ENDOCRINOLOGY, V146, P1940, DOI 10.1210/en.2004-1538; Rozek W, 2013, TUMOR BIOL, V34, P1773, DOI 10.1007/s13277-013-0716-0; Thakker-Varia S, 2007, J NEUROSCI, V27, P12156, DOI 10.1523/JNEUROSCI.1898-07.2007; Toshinai K, 2010, AM J PHYSIOL-ENDOC M, V299, pE394, DOI 10.1152/ajpendo.00768.2009; TRANI E, 1995, J NEUROCHEM, V65, P2441; Tsujino N, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00028; VANDENPOL AN, 1989, J NEUROSCI, V9, P4122; Wisor JP, 1997, J COMP NEUROL, V378, P229; Yamaguchi H, 2007, J BIOL CHEM, V282, P26354, DOI 10.1074/jbc.M701665200	36	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0141193	10.1371/journal.pone.0141193	http://dx.doi.org/10.1371/journal.pone.0141193			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555143	gold, Green Submitted, Green Published			2022-12-27	WOS:000364430700020
J	Sebastiao, E; Chodzko-Zajko, W; Schwingel, A				Sebastiao, Emerson; Chodzko-Zajko, Wojtek; Schwingel, Andiara			An In-Depth Examination of Perceptions of Physical Activity in Regularly Active and Insufficiently Active Older African American Women: A Participatory Approach	PLOS ONE			English	Article							RACIAL DISPARITIES; HEALTH; BARRIERS; EXERCISE; ADULTS; DISCRIMINATION; ENABLERS	Despite considerable research and programmatic efforts to alleviate racial/ethnic disparities in physical activity (PA), disparities in PA among older minorities and major racial ethnic groups persist. This study explored perceptions of PA among regularly active (RA) and insufficiently active (IA) older African American women (AAW) and the factors that influence (positively and negatively) their physical participation in their socio-cultural environment. A total of 20 AAW aged 60 to 80 years participated in a cross-sectional mixed-methods study (i.e., qualitative and quantitative) employing participatory research approaches (i.e., photoelicitation) along with an objective assessment of PA. Nine women were considered RA and 11 IA according to current PA recommendations. RA and IA women held two major beliefs about the nature of PA (i.e., PA as a broadly defined construct that goes beyond traditional exercise routines; and PA and exercise are synonymous and can be used interchangeably) and had a good understanding of its benefits. Participants in both groups did not know about the importance of PA intensity for health benefits. Barriers and facilitator of PA were found to be similar among RA and IA participants. Special attention should be paid to providing access to no or low cost opportunities for PA participation in safe environments.	[Sebastiao, Emerson; Chodzko-Zajko, Wojtek; Schwingel, Andiara] Univ Illinois, Dept Kinesiol & Community Hlth, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign	Sebastiao, E (corresponding author), Univ Illinois, Dept Kinesiol & Community Hlth, Urbana, IL USA.	esbast2@illinois.edu	Sebastiao, Emerson/ABF-7353-2020		Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [BEX 5718/10-4]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The authors thank Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) for the scholarship provided to ES to pursue his PhD (process number BEX 5718/10-4).	[Anonymous], 2013, STAT AG HLTH AM 2013; Belza Basia, 2004, Prev Chronic Dis, V1, pA09; Booth ML, 1997, PREV MED, V26, P131, DOI 10.1006/pmed.1996.9982; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; BRFSS, 2011, PREV TRENDS DAT PART; CASPERSEN CJ, 1985, PUBLIC HEALTH REP, V100, P126; Centers for Disease Control and Prevention, 2014, 2014 STAT IND REP PH; Chodzko-Zajko WJ, 2008, MED SCI SPORT EXER, V41, P1510, DOI DOI 10.1249/MSS.0b013e3181a0c95c; DHHS, 2008, PHYS ACT GUID AM CHA; DHHS, 2008, PHYS ACT GUID AM; *DHHS, 2008, PHYS ACT GUID ADV CO; Edwards MB, 2013, J PHYS ACT HEALTH, V10, P932, DOI 10.1123/jpah.10.7.932; Evenson KR, PREV CHRONIC DIS, V9, pE26; Fielding JE, 2002, AM J PREV MED, V22, P67; Fleury J, 2009, QUAL HEALTH RES, V19, P677, DOI 10.1177/1049732309334471; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Gobbi Sebastiao, 2012, J Aging Res, V2012, P685190, DOI 10.1155/2012/685190; Harley AE, 2009, HEALTH EDUC BEHAV, V36, P97, DOI 10.1177/1090198107306434; Harper D., 2002, VISUAL STUDIES, V17, P14; Johnson CM, 2010, BMC WOMENS HEALTH, V10, DOI 10.1186/1472-6874-10-21; Karlsen S, 2002, AM J PUBLIC HEALTH, V92, P624, DOI 10.2105/AJPH.92.4.624; Kawachi I, 2005, HEALTH AFFAIR, V24, P343, DOI 10.1377/hlthaff.24.2.343; KING AC, 1988, AM J CARDIOL, V61, P628, DOI 10.1016/0002-9149(88)90778-3; Lavizzo-Mourey R, 2001, J NATL MED ASSOC, V93, P475; Leavy B, 2002, J AGING PHYS ACTIV, V18, P219; Lincoln Y.S., 1985, NATURALISTIC ENQUIRY; Macera Caroline A, 2005, Prev Chronic Dis, V2, pA17; Marshall AL, 2010, MED SCI SPORT EXER, V42, P1094, DOI 10.1249/MSS.0b013e3181c5ec18; Mathews AE, 2010, J AGING PHYS ACTIV, V18, P119, DOI 10.1123/japa.18.2.119; Price AE, 2013, J AGING PHYS ACTIV, V21, P348, DOI 10.1123/japa.21.3.348; QSR International, 2013, NVIVO 10 RES SOFTW A; Rasinaho M, 2007, J AGING PHYS ACTIV, V15, P90, DOI 10.1123/japa.15.1.90; Schutzer KA, 2004, PREV MED, V39, P1056, DOI 10.1016/j.ypmed.2004.04.003; Sebastiao Emerson, 2014, J Aging Res, V2014, P941019, DOI 10.1155/2014/941019; Shih VC, 2005, ARCH PHYS MED REHAB, V86, P1521, DOI 10.1016/j.apmr.2005.02.009; Siddiqi Z, 2011, HEALTH EDUC RES, V26, P1010, DOI 10.1093/her/cyr068; Stathi A, 2012, J AGING PHYS ACTIV, V20, P148, DOI 10.1123/japa.20.2.148; Stokols D, 1996, AM J HEALTH PROMOT, V10, P247, DOI 10.4278/0890-1171-10.4.247; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Wang C, 1997, HEALTH EDUC BEHAV, V24, P369, DOI 10.1177/109019819702400309; Wilcox S, 2005, J WOMEN AGING, V17, P37, DOI 10.1300/J074v17n01_04; Wilcox Sara, 2002, Ethnicity and Disease, V12, P353; Williams DR, 2009, J BEHAV MED, V32, P20, DOI 10.1007/s10865-008-9185-0; Williams DR, 2003, AM J PUBLIC HEALTH, V93, P200, DOI 10.2105/AJPH.93.2.200; Williams DR, 2005, HEALTH AFFAIR, V24, P325, DOI 10.1377/hlthaff.24.2.325	45	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142703	10.1371/journal.pone.0142703	http://dx.doi.org/10.1371/journal.pone.0142703			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7CT	26554842	Green Submitted, Green Published, gold			2022-12-27	WOS:000364430700157
J	Skerget, S; Rosenow, MA; Petritis, K; Karr, TL				Skerget, Sheri; Rosenow, Matthew A.; Petritis, Konstantinos; Karr, Timothy L.			Sperm Proteome Maturation in the Mouse Epididymis	PLOS ONE			English	Article							IPG STRIP PREFRACTIONATION; SEGMENTAL GENE-EXPRESSION; LC-MS/MS IDENTIFICATION; INTRALUMINAL COMPARTMENT; MAMMALIAN SPERMATOZOA; CAUDA EPIDIDYMIDIS; STATISTICAL-MODEL; 20S PROTEASOMES; BETA-DEFENSIN; PROTEINS	In mammals, transit through the epididymis, which involves the acquisition, loss and modification of proteins, is required to confer motility and fertilization competency to sperm. The overall dynamics of maturation is poorly understood, and a systems level understanding of the complex maturation process will provide valuable new information about changes occurring during epididymal transport. We report the proteomes of sperm collected from the caput, corpus and cauda segments of the mouse epididymis, identifying 1536, 1720 and 1234 proteins respectively. This study identified 765 proteins that are present in sperm obtained from all three segments. We identified 1766 proteins that are potentially added (732) or removed (1034) from sperm during epididymal transit. Phenotypic analyses of the caput, corpus and cauda sperm proteomes identified 60 proteins that have known sperm phenotypes when mutated, or absent from sperm. Our analysis indicates that as much as one-third of proteins with known sperm phenotypes are added to sperm during epididymal transit. GO analyses revealed that cauda sperm are enriched for specific functions including sperm-egg recognition and motility, consistent with the observation that sperm acquire motility and fertilization competency during transit through the epididymis. In addition, GO analyses revealed that the immunity protein profile of sperm changes during sperm maturation. Finally, we identified components of the 26S proteasome, the immunoproteasome, and a proteasome activator in mature sperm.	[Skerget, Sheri; Karr, Timothy L.] Arizona State Univ, Biodesign Inst, Ctr Infect Dis & Vaccinol, Tempe, AZ USA; [Rosenow, Matthew A.; Petritis, Konstantinos] Translat Genom Res Inst, Ctr Prote, Phoenix, AZ USA	Arizona State University; Arizona State University-Tempe; Translational Genomics Research Institute	Karr, TL (corresponding author), Kyoto Inst Technol, Drosophila Genom & Genet Resources, Ukyo Ku, Saga Ippongi Cho, Kyoto 606, Japan.	timkarr@kit.ac.jp	Petritis, Konstantinos/AAP-4353-2021	Petritis, Konstantinos/0000-0001-8660-8532; Skerget, Sheri/0000-0001-5153-0835				Aitken RJ, 2007, ASIAN J ANDROL, V9, P554, DOI 10.1111/j.1745-7262.2007.00280.x; AITKEN RJ, 1987, J REPROD FERTIL, V81, P459; Baker MA, 2008, PROTEOMICS, V8, P1720, DOI 10.1002/pmic.200701020; Baker MA, 2008, PROTEOMICS, V8, P2312, DOI 10.1002/pmic.200700876; Baker MA, 2007, PROTEOM CLIN APPL, V1, P524, DOI 10.1002/prca.200601013; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Cao WL, 2006, MOL CELL PROTEOMICS, V5, P801, DOI 10.1074/mcp.M500322-MCP200; Chauvin T, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.104208; Cordoba M, 2006, THERIOGENOLOGY, V65, P882, DOI 10.1016/j.theriogenology.2005.06.015; Dacheux JL, 2009, MOL CELL ENDOCRINOL, V306, P45, DOI 10.1016/j.mce.2009.03.007; Danchin E, 2004, IMMUNOL REV, V198, P216, DOI 10.1111/j.0105-2896.2004.00132.x; de Mateo S, 2011, PROTEOMICS, V11, P2714, DOI 10.1002/pmic.201000799; Dorus S, 2012, SYST BIOL REPROD MED, V58, P218, DOI 10.3109/19396368.2012.700442; Dorus S, 2010, MOL BIOL EVOL, V27, P1235, DOI 10.1093/molbev/msq007; Frenette G, 2010, BIOL REPROD, V83, P473, DOI 10.1095/biolreprod.109.082438; Frolich O, 2001, BIOL REPROD, V64, P1072, DOI 10.1095/biolreprod64.4.1072; Gerner M, 2012, BIOINFORMATICS, V28, P2154, DOI 10.1093/bioinformatics/bts332; Girouard J, 2011, INT J ANDROL, V34, pE475, DOI 10.1111/j.1365-2605.2011.01203.x; Guo XJ, 2010, J PROTEOME RES, V9, P1246, DOI 10.1021/pr900735k; Harris CL, 2006, MOL IMMUNOL, V43, P57, DOI 10.1016/j.molimm.2005.06.026; Hirano Y, 2005, NATURE, V437, P1381, DOI 10.1038/nature04106; Jelinsky SA, 2007, BIOL REPROD, V76, P561, DOI 10.1095/biolreprod.106.057323; Johnston DS, 2005, BIOL REPROD, V73, P404, DOI 10.1095/biolreprod.105.039719; Johnston DS, 2005, ANN NY ACAD SCI, V1061, P190, DOI 10.1196/annals.1336.021; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Khor B, 2006, MOL CELL BIOL, V26, P2999, DOI 10.1128/MCB.26.8.2999-3007.2006; Kierszenbaum Abraham L, 2007, Soc Reprod Fertil Suppl, V65, P33; Liu Q, 2001, ENDOCRINOLOGY, V142, P4529, DOI 10.1210/en.142.10.4529; Lundgren DH, 2010, EXPERT REV PROTEOMIC, V7, P39, DOI 10.1586/EPR.09.69; Magin TM, 2007, EXP CELL RES, V313, P2021, DOI 10.1016/j.yexcr.2007.03.005; Murata S, 2009, NAT REV MOL CELL BIO, V10, P104, DOI 10.1038/nrm2630; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nie L, 2007, CRIT REV BIOTECHNOL, V27, P63, DOI 10.1080/07388550701334212; Oh JS, 2009, MOL CELLS, V28, P441, DOI 10.1007/s10059-009-0140-x; Ostermeier GC, 2004, NATURE, V429, P154, DOI 10.1038/429154a; Peddinti D, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-19; Rechsteiner M, 2005, TRENDS CELL BIOL, V15, P27, DOI 10.1016/j.tcb.2004.11.003; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Reimand J, 2011, NUCLEIC ACIDS RES, V39, pW307, DOI 10.1093/nar/gkr378; Rejraji H, 2002, MOL REPROD DEV, V63, P96, DOI 10.1002/mrd.10136; Rejraji H, 2006, BIOL REPROD, V74, P1104, DOI 10.1095/biolreprod.105.049304; Roberts KP, 2008, BIOL REPROD, V79, P1046, DOI 10.1095/biolreprod.108.070664; Semple F, 2012, J INNATE IMMUN, V4, P337, DOI 10.1159/000336619; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Skerget S, 2013, MOL CELL PROTEOMICS, V12, P3052, DOI 10.1074/mcp.M112.026476; Sostaric E, 2008, ANIM REPROD SCI, V107, P237, DOI 10.1016/j.anireprosci.2008.04.011; Stein KK, 2006, PROTEOMICS, V6, P3533, DOI 10.1002/pmic.200500845; Sullivan R, 2005, BLOOD CELL MOL DIS, V35, P1, DOI 10.1016/j.bcmd.2005.03.005; Sullivan R, 2007, ASIAN J ANDROL, V9, P483, DOI 10.1111/j.1745-7262.2007.00281.x; Suryawanshi AR, 2012, J ANDROL, V33, P963, DOI 10.2164/jandrol.111.014753; Tanaka K, 2009, P JPN ACAD B-PHYS, V85, P12, DOI [10.2183/pjab.85.12, 10.2183/pjab/85.12]; Thimon V, 2008, HUM REPROD, V23, P1698, DOI 10.1093/humrep/den181; Tollner TL, 2008, HUM REPROD, V23, P2523, DOI 10.1093/humrep/den276; Ustrell V, 2002, EMBO J, V21, P3516, DOI 10.1093/emboj/cdf333; Whitby FG, 2000, NATURE, V408, P115, DOI 10.1038/35040607; Yudin AI, 2008, REPRODUCTION, V136, P753, DOI 10.1530/REP-08-0164; Zhang H, 2004, MATRIX BIOL, V22, P653, DOI 10.1016/j.matbio.2003.11.010; Zhang JS, 2006, MOL CELL ENDOCRINOL, V250, P169, DOI 10.1016/j.mce.2005.12.041; Zhou CX, 2004, NAT CELL BIOL, V6, P458, DOI 10.1038/ncb1127; Zimmerman S, 2009, J REPROD IMMUNOL, V83, P19, DOI 10.1016/j.jri.2009.07.006; Zimmerman SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017256	61	68	69	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0140650	10.1371/journal.pone.0140650	http://dx.doi.org/10.1371/journal.pone.0140650			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556802	gold, Green Submitted, Green Published			2022-12-27	WOS:000364430700013
J	Thorn, KA; Cox, LG				Thorn, Kevin A.; Cox, Larry G.			Probing the Carbonyl Functionality of a Petroleum Resin and Asphaltene through Oximation and Schiff Base Formation in Conjunction with N-15 NMR	PLOS ONE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; CRUDE-OIL; STRUCTURAL-CHARACTERIZATION; BIODEGRADATION; NITROGEN; SPECTROSCOPY; METHYLATION; IRRADIATION; BEMIDJI; AQUIFER	Despite recent advances in spectroscopic techniques, there is uncertainty regarding the nature of the carbonyl groups in the asphaltene and resin fractions of crude oil, information necessary for an understanding of the physical properties and environmental fate of these materials. Carbonyl and hydroxyl group functionalities are not observed in natural abundance C-13 nuclear magnetic resonance (NMR) spectra of asphaltenes and resins and therefore require spin labeling techniques for detection. In this study, the carbonyl functionalities of the resin and asphaltene fractions from a light aliphatic crude oil that is the source of groundwater contamination at the long term USGS study site near Bemidji, Minnesota, have been examined through reaction with N-15-labeled hydroxylamine and aniline in conjunction with analysis by solid and liquid state N-15 NMR. Ketone groups were revealed through N-15 NMR detection of their oxime and Schiff base derivatives, and esters through their hydroxamic acid derivatives. Anilinohydroquinone adducts provided evidence for quinones. Some possible configurations of the ketone groups in the resin and asphaltene fractions can be inferred from a consideration of the likely reactions that lead to heterocyclic condensation products with aniline and to the Beckmann reaction products from the initially formed oximes. These include aromatic ketones and ketones adjacent to quaternary carbon centers, beta-hydroxyketones, beta-diketones, and beta-ketoesters. In a solid state cross polarization/magic angle spinning (CP/MAS) N-15 NMR spectrum recorded on the underivatized asphaltene as a control, carbazole and pyrrole-like nitrogens were the major naturally abundant nitrogens detected.	[Thorn, Kevin A.; Cox, Larry G.] US Geol Survey, Denver Fed Ctr, Denver, CO 80225 USA	United States Department of the Interior; United States Geological Survey	Thorn, KA (corresponding author), US Geol Survey, Denver Fed Ctr, MS 408, Denver, CO 80225 USA.	kathorn@usgs.gov			United States Geological Survey Toxics Substances Hydrology Program; Toxics Substances Hydrology Program of the U.S. Geological Survey	United States Geological Survey Toxics Substances Hydrology Program; Toxics Substances Hydrology Program of the U.S. Geological Survey	Funding: This work was funded by the United States Geological Survey Toxics Substances Hydrology Program.; This work was supported by the Toxics Substances Hydrology Program of the U.S. Geological Survey.	Altgelt KH, 1994, COMPOSITION ANAL HEA; Andersen SI, 2001, PETROL SCI TECHNOL, V19, P1; Andrews AB, 2011, ENERG FUEL, V25, P3068, DOI 10.1021/ef2003443; Apperley DC, 2012, SOLID STATE NMR BASI, DOI 10.5643/9781606503522; Arnaud CH, 2009, CHEM ENG NEWS, V87, P12; Baltisberger RJ, 1983, CHEM LIGNITE LIQUEFA; Deanhardt ML, 1990, FUEL SCI TECHN INT, V8, P135; Dutriez T, 2012, FUEL, V96, P108, DOI 10.1016/j.fuel.2011.11.070; EGANHOUSE RP, 1993, APPL GEOCHEM, V8, P551, DOI 10.1016/0883-2927(93)90013-7; Essaid HI, 2011, GROUND WATER, V49, P706, DOI 10.1111/j.1745-6584.2009.00654.x; Ghollami M, 2013, J PET ENV BIOTECHNOL, V4, P1; GREEN TK, 1994, ENERG FUEL, V8, P244, DOI 10.1021/ef00043a038; Griffiths MT, 2014, ANAL CHEM, V86, P527, DOI 10.1021/ac4025335; Helms JR, 2012, ORG GEOCHEM, V44, P21, DOI 10.1016/j.orggeochem.2011.12.001; Hult MF, 1984, 844188 WAT RES INV; Jahromi H, 2014, FUEL, V117, P230, DOI 10.1016/j.fuel.2013.09.085; Jennings PW, 1993, BINDER CHARACTERIZAT; Joule J. A., 1995, HETEROCYCLIC CHEM; Kelemen SR, 2002, ENERG FUEL, V16, P1507, DOI 10.1021/ef0200828; Kim S, 2005, ORG GEOCHEM, V36, P1117, DOI 10.1016/j.orggeochem.2005.03.010; Kiruri LW, 2013, ENVIRON SCI TECHNOL, V47, P4220, DOI 10.1021/es305157w; Lavania M, 2012, BIODEGRADATION, V23, P15, DOI 10.1007/s10532-011-9482-0; Lewan MD, 2014, ORG GEOCHEM, V75, P54, DOI 10.1016/j.orggeochem.2014.06.004; Majumdar RD, 2013, ENERG FUEL, V27, P6528, DOI 10.1021/ef401412w; McKenna AM, 2013, ENERG FUEL, V27, P1257, DOI 10.1021/ef301747d; MEIER BH, 1986, J AM CHEM SOC, V108, P6072, DOI 10.1021/ja00279a084; MITRAKIRTLEY S, 1993, J AM CHEM SOC, V115, P252, DOI 10.1021/ja00054a036; Mullins O. C., 2007, ASPHALTENES HEAVY OI, DOI [10.1007/0-387-68903-6, DOI 10.1007/0-387-68903-6]; Mullins OC, 2011, ANNU REV ANAL CHEM, V4, P393, DOI 10.1146/annurev-anchem-061010-113849; Ng GHC, 2014, J CONTAM HYDROL, V164, P1, DOI 10.1016/j.jconhyd.2014.04.006; Pesarini PF, 2010, J PHOTOCH PHOTOBIO A, V214, P48, DOI 10.1016/j.jphotochem.2010.06.005; Pineda-Flores G, 2004, BIODEGRADATION, V15, P145, DOI 10.1023/B:BIOD.0000026476.03744.bb; Podgorski DC, 2013, ENERG FUEL, V27, P1268, DOI 10.1021/ef301737f; RONTANI JF, 1985, CHEMOSPHERE, V14, P1413, DOI 10.1016/0045-6535(85)90161-4; ROSE KD, 1987, ENERG FUEL, V1, P233, DOI 10.1021/ef00003a001; Schnitzer M., 1972, HUMIC SUBSTANCES ENV; Schuler B, 2015, J AM CHEM SOC, V137, P9870, DOI 10.1021/jacs.5b04056; Shekar SC, 2002, J MAGN RESON, V157, P223, DOI 10.1006/jmre.2002.2587; Smernik RJ, 2005, BIOGEOCHEMISTRY, V75, P507, DOI 10.1007/s10533-005-2857-8; Solum MS, 1997, ENERG FUEL, V11, P491, DOI 10.1021/ef960169r; SORENSEN OW, 1983, J MAGN RESON, V55, P347, DOI 10.1016/0022-2364(83)90248-2; Speight J.G., 2014, CHEM TECHNOLOGY PETR, DOI [DOI 10.1201/B16559_3-174, 10.1201/b16559_3-174]; Speight J.G., 2012, BIOREMEDIATION PETRO; Tavassoli T, 2012, FUEL, V93, P142, DOI 10.1016/j.fuel.2011.10.021; THORN KA, 1992, ENVIRON SCI TECHNOL, V26, P107, DOI 10.1021/es00025a011; Thorn KA, 1996, ENVIRON SCI TECHNOL, V30, P2764, DOI 10.1021/es9509339; Thorn KA, 1998, ORG GEOCHEM, V29, P909, DOI 10.1016/S0146-6380(98)00167-3; Thorn KA, 2012, J ENVIRON QUAL, V41, P865, DOI 10.2134/jeq2011.0335; Thorn KA, 2010, J ENVIRON QUAL, V39, P1416, DOI 10.2134/jeq2009.0408; Thorn KA, 2009, ORG GEOCHEM, V40, P484, DOI 10.1016/j.orggeochem.2009.01.007; Uribe-Alvarez C, 2011, MICROB BIOTECHNOL, V4, P663, DOI 10.1111/j.1751-7915.2011.00269.x; VENKATESWARAN K, 1995, CAN J MICROBIOL, V41, P418, DOI 10.1139/m95-055	53	4	5	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142452	10.1371/journal.pone.0142452	http://dx.doi.org/10.1371/journal.pone.0142452			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556054	Green Published, Green Submitted, gold			2022-12-27	WOS:000364430700108
J	Zaccagnini, G; Palmisano, A; Canu, T; Maimone, B; Lo Russo, FM; Ambrogi, F; Gaetano, C; Cobelli, F; Del Maschio, A; Esposito, A; Martelli, F				Zaccagnini, Germana; Palmisano, Anna; Canu, Tamara; Maimone, Biagina; Lo Russo, Francesco M.; Ambrogi, Federico; Gaetano, Carlo; De Cobelli, Francesco; Del Maschio, Alessandro; Esposito, Antonio; Martelli, Fabio			Magnetic Resonance Imaging Allows the Evaluation of Tissue Damage and Regeneration in a Mouse Model of Critical Limb Ischemia	PLoS One			English	Article							MUSCLE-FIBER TRACKING; SKELETAL-MUSCLE; MRI ANALYSIS; ANGIOGENESIS; INJURY; P66(SHCA); LIGATION; DISEASE; ONSET; MICE	Magnetic resonance imaging (MRI) provides non-invasive, repetitive measures in the same individual, allowing the study of a physio-pathological event over time. In this study, we tested the performance of 7 Tesla multi-parametric MRI to monitor the dynamic changes of mouse skeletal muscle injury and regeneration upon acute ischemia induced by femoral artery dissection. T2-mapping (T2 relaxation time), diffusion-tensor imaging (Fractional Anisotropy) and perfusion by Dynamic Contrast-Enhanced MRI (K-trans) were measured and imaging results were correlated with histological morphometric analysis in both Gastrocnemius and Tibialis anterior muscles. We found that tissue damage positively correlated with T2-relaxation time, while myofiber regeneration and capillary density positively correlated with Fractional Anisotropy. Interestingly, K-trans positively correlated with capillary density. Accordingly, repeated MRI measurements between day 1 and day 28 after surgery in ischemic muscles showed that: 1) T2-relaxation time rapidly increased upon ischemia and then gradually declined, returning almost to basal level in the last phases of the regeneration process; 2) Fractional Anisotropy dropped upon ischemic damage induction and then recovered along with muscle regeneration and neoangiogenesis; 3) K-trans reached a minimum upon ischemia, then progressively recovered. Overall, Gastrocnemius and Tibialis anterior muscles displayed similar patterns of MRI parameters dynamic, with more marked responses and less variability in Tibialis anterior. We conclude that MRI provides quantitative information about both tissue damage after ischemia and the subsequent vascular and muscle regeneration, accounting for the differences between subjects and, within the same individual, between different muscles.	[Zaccagnini, Germana; Maimone, Biagina; Martelli, Fabio] IRCCS Policlin San Donato, Mol Cardiol Lab, Milan, Italy; [Palmisano, Anna; Canu, Tamara; Lo Russo, Francesco M.; De Cobelli, Francesco; Del Maschio, Alessandro; Esposito, Antonio] Ist Sci San Raffaele, Expt Imaging Ctr, Preclin Imaging Facil, I-20132 Milan, Italy; [Palmisano, Anna; Lo Russo, Francesco M.; De Cobelli, Francesco; Del Maschio, Alessandro; Esposito, Antonio] Univ Vita Salute San Raffaele, Milan, Italy; [Ambrogi, Federico] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy; [Gaetano, Carlo] Goethe Univ Frankfurt, Internal Med Clin 3, Dept Cardiol, Div Cardiovasc Epigenet, D-60054 Frankfurt, Germany	IRCCS Policlinico San Donato; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; University of Milan; Goethe University Frankfurt	Esposito, A (corresponding author), Ist Sci San Raffaele, Expt Imaging Ctr, Preclin Imaging Facil, I-20132 Milan, Italy.	esposito.antonio@unisr.it; fabio.martelli@grupposandonato.it	Zaccagnini, Germana/J-7722-2016; Martelli, Fabio/AAL-3788-2020; Esposito, Antonio/K-5088-2018; Tamara, Canu/ABG-8524-2020; Palmisano, Anna/AAN-3242-2020; Gaetano, Carlo/P-9997-2019; DE COBELLI, Francesco/AAC-6488-2022; Esposito, Antonio/AAZ-7967-2020	Zaccagnini, Germana/0000-0002-9441-4735; Martelli, Fabio/0000-0002-8624-7738; Esposito, Antonio/0000-0002-1170-6266; Tamara, Canu/0000-0002-4589-9377; Palmisano, Anna/0000-0002-1564-2060; Gaetano, Carlo/0000-0002-5238-1832; DE COBELLI, Francesco/0000-0003-4014-3711; Esposito, Antonio/0000-0002-1170-6266	Ministero della Salute; Cariplo Foundation [2013-0887]	Ministero della Salute(Ministry of Health, Italy); Cariplo Foundation(Fondazione Cariplo)	This study was supported by Ministero della Salute and Cariplo Foundation (grant n. 2013-0887). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao WK, 2004, CARDIOVASC RES, V61, P548, DOI 10.1016/j.cardiores.2003.12.004; Berthet C, 2014, J CEREBR BLOOD F MET, V34, P1848, DOI 10.1038/jcbfm.2014.155; Chen YF, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-40; Comi AM, 2009, INT J DEV NEUROSCI, V27, P271, DOI 10.1016/j.ijdevneu.2008.12.006; Couffinhal T, 1998, AM J PATHOL, V152, P1667; Couffinhal T, 2009, FRONT BIOSCI-LANDMRK, V14, P3310, DOI 10.2741/3454; Curiel RV, 2009, ANN NY ACAD SCI, V1154, P101, DOI 10.1111/j.1749-6632.2009.04386.x; Damon BM, 2002, MAGN RESON MED, V48, P97, DOI 10.1002/mrm.10198; Delli Pizzi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044752; Diehm N, 2009, J CARDIOVASC SURG, V50, P647; Emanueli C, 2002, CIRCULATION, V106, P2257, DOI 10.1161/01.CIR.0000033971.56802.C5; Esposito A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059308; Feng S, 2014, J MAGN RESON IMAGING, V40, P779, DOI 10.1002/jmri.24417; Fitzmaurice G, 2011, APPL LONGITUDINAL AN, V2nd; Gianella A, 2010, CARDIOVASC RES, V85, P503, DOI 10.1093/cvr/cvp325; Heemskerk AM, 2005, MAGNET RESON MED, V53, P1333, DOI 10.1002/mrm.20476; Heemskerk AM, 2007, RADIOLOGY, V243, P413, DOI 10.1148/radiol.2432060491; Heemskerk AM, 2009, MAGN RESON MED, V61, P467, DOI 10.1002/mrm.21819; Helisch A, 2006, ARTERIOSCL THROM VAS, V26, P520, DOI 10.1161/01.ATV.0000202677.55012.a0; Jones WS, 2014, AM HEART J, V167, P489, DOI 10.1016/j.ahj.2013.12.012; Katare R, 2013, ARTERIOSCL THROM VAS, V33, P1872, DOI 10.1161/ATVBAHA.113.301217; Loerakker S, 2011, MAGN RESON MED, V66, P528, DOI 10.1002/mrm.22801; Lotfi S, 2013, ATHEROSCLEROSIS, V227, P1, DOI 10.1016/j.atherosclerosis.2012.10.060; Mac Gabhann F, 2010, MICROCIRCULATION, V17, P333, DOI 10.1111/j.1549-8719.2010.00034.x; Madonna R, 2014, MOL BIOTECHNOL, V56, P438, DOI 10.1007/s12033-014-9735-3; Madonna R, 2012, CIRC J, V76, P1517, DOI 10.1253/circj.CJ-11-1215; Marqueste T, 2008, J APPL PHYSIOL, V105, P299, DOI 10.1152/japplphysiol.00738.2007; Mathur S, 2011, MUSCLE NERVE, V43, P878, DOI 10.1002/mus.21986; Ortuno JE, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-316; R Foundation for Statistical Computing V Austria., R LANG ENV STAT COMP; Saab G, 1999, MAGNET RESON MED, V42, P150, DOI 10.1002/(SICI)1522-2594(199907)42:1<150::AID-MRM20>3.0.CO;2-5; Sciorati C, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/879703; Stekelenburg A, 2007, J APPL PHYSIOL, V102, P2002, DOI 10.1152/japplphysiol.01115.2006; STUSS DT, 1987, J CLIN EXP NEUROPSYC, V9, P131, DOI 10.1080/01688638708405353; Toldo S, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.002360; Wang J, 2011, DIABETIC MED, V28, P618, DOI 10.1111/j.1464-5491.2011.03244.x; Waters RE, 2004, J APPL PHYSIOL, V97, P773, DOI 10.1152/japplphysiol.00107.2004; Wishnia A, 2001, NEUROMUSCULAR DISORD, V11, P50, DOI 10.1016/S0960-8966(00)00164-4; Zaccagnini G, 2004, CIRCULATION, V109, P2917, DOI 10.1161/01.CIR.0000129309.58874.0F; Zaccagnini G, 2007, J BIOL CHEM, V282, P31453, DOI 10.1074/jbc.M702511200; Zaccagnini G, 2014, ANTIOXID REDOX SIGN, V21, P1177, DOI 10.1089/ars.2013.5206; Zhang H, 2013, BRIT J RADIOL, V86, DOI 10.1259/bjr.20120042; Zhang JY, 2008, EXP NEUROL, V212, P448, DOI 10.1016/j.expneurol.2008.04.033	43	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142111	10.1371/journal.pone.0142111	http://dx.doi.org/10.1371/journal.pone.0142111			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26554362	Green Submitted, Green Published, gold			2022-12-27	WOS:000364430700054
J	Kwon, DH; Kang, TJ; Kim, YH; Lee, SH				Kwon, Deok Ho; Kang, Taek-Jun; Kim, Young Ho; Lee, Si Hyeock			Phenotypic- and Genotypic-Resistance Detection for Adaptive Resistance Management in Tetranychus urticae Koch	PLOS ONE			English	Article							2-SPOTTED SPIDER-MITE; IN-FIELD POPULATIONS; INSECTICIDE RESISTANCE; ALLELE-FREQUENCY; PYRETHROID RESISTANCE; ACARICIDE RESISTANCE; POINT MUTATIONS; PHYLOGENETIC ANALYSIS; SODIUM-CHANNEL; TARGET-SITE	Rapid resistance detection is necessary for the adaptive management of acaricide-resistant populations of Tetranychus urticae. Detection of phenotypic and genotypic resistance was conducted by employing residual contact vial bioassay (RCV) and quantitative sequencing (QS) methods, respectively. RCV was useful for detecting the acaricide resistance levels of T. urticae, particularly for on-site resistance detection; however, it was only applicable for rapid-acting acaricides (12 out of 19 tested acaricides). QS was effective for determining the frequencies of resistance alleles on a population basis, which corresponded to 12 nonsynonymous point mutations associated with target-site resistance to five types of acaricides [organophosphates (monocrotophos, pirimiphos-methyl, dimethoate and chlorpyrifos), pyrethroids (fenpropathrin and bifenthrin), abamectin, bifenazate and etoxazole]. Most field-collected mites exhibited high levels of multiple resistance, as determined by RCV and QS data, suggesting the seriousness of their current acaricide resistance status in rose cultivation areas in Korea. The correlation analyses revealed moderate to high levels of positive relationships between the resistance allele frequencies and the actual resistance levels in only five of the acaricides evaluated, which limits the general application of allele frequency as a direct indicator for estimating actual resistance levels. Nevertheless, the resistance allele frequency data alone allowed for the evaluation of the genetic resistance potential and background of test mite populations. The combined use of RCV and QS provides basic information on resistance levels, which is essential for choosing appropriate acaricides for the management of resistant T. urticae.	[Kwon, Deok Ho; Kim, Young Ho; Lee, Si Hyeock] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul 151921, South Korea; [Kang, Taek-Jun] RDA, Natl Inst Hort & Herbal Sci, Dept Hort Crop Res, Jeonju 565852, South Korea; [Lee, Si Hyeock] Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151921, South Korea	Seoul National University (SNU); National Institute of Horticultural & Herbal Science (NIHHS), Republic of Korea; Rural Development Administration (RDA), Republic of Korea; Seoul National University (SNU)	Kwon, DH (corresponding author), Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul 151921, South Korea.	jota486@snu.ac.kr; shlee22@snu.ac.kr			Rural Development Administration [PJ009365]	Rural Development Administration(Rural Development Administration (RDA), Republic of Korea)	This work was supported by a grant from the Rural Development Administration (grant no. PJ009365) (http://www.rda.go.kr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alstad DN, 1996, AGBIOTECH NEWS INFOR, V8, P177; Anazawa Y, 2003, INSECT BIOCHEM MOLEC, V33, P509, DOI 10.1016/S0965-1748(03)00025-0; Andow DA, 1998, J ECON ENTOMOL, V91, P579, DOI 10.1093/jee/91.3.579; [Anonymous], 1998, WHOCDCMAL98; Auguie B, 2017, GRIDEXTRA MISCELLANE; BROGDON WG, 1989, PARASITOL TODAY, V5, P56, DOI 10.1016/0169-4758(89)90192-0; BROWN TM, 1987, ANNU REV ENTOMOL, V32, P145, DOI 10.1146/annurev.en.32.010187.001045; Clark J. Marshall, 2009, Journal of Asia-Pacific Entomology, V12, P1, DOI 10.1016/j.aspen.2008.10.007; Clark JM, 2001, PEST MANAG SCI, V57, P968, DOI 10.1002/ps.369; CROFT BA, 1988, EXP APPL ACAROL, V4, P277, DOI 10.1007/BF01196191; de Mendonca RS, 2011, EXP APPL ACAROL, V55, P1, DOI 10.1007/s10493-011-9453-5; Demaeght P, 2014, INSECT BIOCHEM MOLEC, V51, P52, DOI 10.1016/j.ibmb.2014.05.004; DENNEHY TJ, 1983, J ECON ENTOMOL, V76, P1225, DOI 10.1093/jee/76.6.1225; DENNEHY TJ, 1987, J ECON ENTOMOL, V80, P998, DOI 10.1093/jee/80.5.998; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dermauw W, 2012, INSECT BIOCHEM MOLEC, V42, P455, DOI 10.1016/j.ibmb.2012.03.002; DEVONSHIRE AL, 1992, B ENTOMOL RES, V82, P459, DOI 10.1017/S0007485300042516; DITTRICH V, 1962, J ECON ENTOMOL, V55, P644, DOI 10.1093/jee/55.5.644; Feyereisen R, 2015, PESTIC BIOCHEM PHYS, V121, P61, DOI 10.1016/j.pestbp.2015.01.004; Germer S, 2000, GENOME RES, V10, P258, DOI 10.1101/gr.10.2.258; Grbic M, 2011, NATURE, V479, P487, DOI 10.1038/nature10640; Hinomoto N, 2001, APPL ENTOMOL ZOOL, V36, P459, DOI 10.1303/aez.2001.459; Ilias A, 2014, INSECT BIOCHEM MOLEC, V48, P17, DOI 10.1016/j.ibmb.2014.02.006; Jamroz RC, 1998, INSECT BIOCHEM MOLEC, V28, P1031, DOI 10.1016/S0965-1748(98)00094-0; KCPA, 2014, AGR US GUID BOOK YEA; Khajehali J, 2011, PEST MANAG SCI, V67, P1424, DOI 10.1002/ps.2191; Khajehali J, 2010, PEST MANAG SCI, V66, P220, DOI 10.1002/ps.1884; Koh Sang-Hyun, 2009, Journal of Asia-Pacific Entomology, V12, P15, DOI 10.1016/j.aspen.2008.10.004; Kwon DH, 2010, INSECT MOL BIOL, V19, P583, DOI 10.1111/j.1365-2583.2010.01017.x; Kwon DH, 2008, J MED ENTOMOL, V45, P912, DOI 10.1603/0022-2585(2008)45[912:DOPRAF]2.0.CO;2; Kwon DH, 2014, J ASIA-PAC ENTOMOL, V17, P99, DOI 10.1016/j.aspen.2013.11.001; Kwon DH, 2012, INSECT BIOCHEM MOLEC, V42, P212, DOI 10.1016/j.ibmb.2011.12.003; Kwon DH, 2011, J ASIA-PAC ENTOMOL, V14, P379, DOI 10.1016/j.aspen.2011.05.001; Kwon DH, 2010, J ASIA-PAC ENTOMOL, V13, P333, DOI 10.1016/j.aspen.2010.05.005; Kwon DH, 2010, J ASIA-PAC ENTOMOL, V13, P229, DOI 10.1016/j.aspen.2010.02.002; Kwon DH, 2010, PESTIC BIOCHEM PHYS, V97, P93, DOI 10.1016/j.pestbp.2009.07.009; Kwon DH, 2010, PESTIC BIOCHEM PHYS, V96, P36, DOI 10.1016/j.pestbp.2009.08.013; Kwon DH, 2004, PESTIC BIOCHEM PHYS, V80, P21, DOI 10.1016/j.pestbp.2004.06.001; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee So-Young, 2004, Korean Journal of Applied Entomology, V43, P43; Liu NN, 2015, ANNU REV ENTOMOL, V60, P537, DOI 10.1146/annurev-ento-010814-020828; Liu Q, 1997, GENOME RES, V7, P389, DOI 10.1101/gr.7.4.389; Livak KJ, 1999, GENET ANAL-BIOMOL E, V14, P143, DOI 10.1016/S1050-3862(98)00019-9; Riga M, 2014, INSECT BIOCHEM MOLEC, V46, P43, DOI 10.1016/j.ibmb.2014.01.006; Seong KM, 2010, J MED ENTOMOL, V47, P592, DOI 10.1603/ME09274; SOMMER SS, 1989, MAYO CLIN PROC, V64, P1361, DOI 10.1016/S0025-6196(12)65378-6; Tabashnik BE, 2014, J ECON ENTOMOL, V107, P496, DOI 10.1603/EC13458; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tsagkarakou A, 2009, INSECT MOL BIOL, V18, P583, DOI 10.1111/j.1365-2583.2009.00900.x; Van Leeuwen T, 2008, P NATL ACAD SCI USA, V105, P5980, DOI 10.1073/pnas.0802224105; Van Leeuwen T, 2007, PEST MANAG SCI, V63, P150, DOI 10.1002/ps.1314; Van Leeuwen T, 2015, PESTIC BIOCHEM PHYS, V121, P12, DOI 10.1016/j.pestbp.2014.12.009; Van Leeuwen T, 2013, PEST MANAG SCI, V69, P156, DOI 10.1002/ps.3335; Van Leeuwen T, 2012, P NATL ACAD SCI USA, V109, P4407, DOI 10.1073/pnas.1200068109; Van Nieuwenhuyse P, 2009, PEST MANAG SCI, V65, P404, DOI 10.1002/ps.1705; Wilkening S, 2005, BIOTECHNIQUES, V39, P853, DOI 10.2144/000112027	57	16	16	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0139934	10.1371/journal.pone.0139934	http://dx.doi.org/10.1371/journal.pone.0139934			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26545209	gold, Green Published			2022-12-27	WOS:000364398700004
J	Mazzeo, MF; Lippolis, R; Sorrentino, A; Liberti, S; Fragnito, F; Siciliano, RA				Mazzeo, Maria Fiorella; Lippolis, Rosa; Sorrentino, Alida; Liberti, Sarah; Fragnito, Federica; Siciliano, Rosa Anna			Lactobacillus acidophilus-Rutin Interplay Investigated by Proteomics	PLOS ONE			English	Article							TANNIC-ACID; STRESS RESPONSES; POLYPHENOLS; PLANTARUM; PROTEINS; IMPACT; METABOLISM; STARVATION; PH	Dietary polyphenols are bioactive molecules that beneficially affect human health, due to their anti-oxidant, anti-inflammatory, cardio-protective and chemopreventive properties. They are absorbed in a very low percentage in the small intestine and reach intact the colon, where they are metabolized by the gut microbiota. Although it is well documented a key role of microbial metabolism in the absorption of polyphenols and modulation of their biological activity, molecular mechanisms at the basis of the bacteria-polyphenols interplay are still poorly understood. In this context, differential proteomics was applied to reveal adaptive response mechanisms that enabled a potential probiotic Lactobacillus acidophilus strain to survive in the presence of the dietary polyphenol rutin. The response to rutin mainly modulated the expression level of proteins involved in general stress response mechanisms and, in particular, induced the activation of protein quality control systems, and affected carbohydrate and amino acid metabolism, protein synthesis and cell wall integrity. Moreover, rutin triggered the expression of proteins involved in oxidation-reduction processes. This study provides a first general view of the impact of dietary polyphenols on metabolic and biological processes of L. acidophilus.	[Mazzeo, Maria Fiorella; Sorrentino, Alida; Liberti, Sarah; Fragnito, Federica; Siciliano, Rosa Anna] CNR, Inst Food Sci, Avellino, Italy; [Lippolis, Rosa] CNR, Inst Biomembranes & Bioenerget, I-70126 Bari, Italy; [Liberti, Sarah] Univ Naples Federico II, Dept Chem Sci, Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell' Alimentazione (ISA-CNR); Consiglio Nazionale delle Ricerche (CNR); University of Naples Federico II	Mazzeo, MF (corresponding author), CNR, Inst Food Sci, Avellino, Italy.	fmazzeo@isa.cnr.it	ALIDA, SORRENTINO/AAL-1737-2021; Siciliano, Rosa Anna/G-9822-2013; Mazzeo, Maria Fiorella/AAX-7262-2020	Mazzeo, Maria Fiorella/0000-0003-1542-0027; SICILIANO, ROSAANNA/0000-0002-1042-3424; LIPPOLIS, ROSA/0000-0001-9894-1957	Italian Ministry of Economy and Finance; ENEA [191/2009]; internal resources of CNR	Italian Ministry of Economy and Finance; ENEA(ENEA, Italy); internal resources of CNR	This work was partially supported by funds from the Italian Ministry of Economy and Finance to CNR and ENEA for the project "Innovazione e sviluppo del Mezzogiorno - Conoscenze Integrate per Sostenibilita ed Innovazione del Made in Italy Agroalimentare"-Legge n. 191/2009. All additional funding was from internal resources of CNR.	Abou Hachem M, 2013, BIOCATAL BIOTRANSFOR, V31, P226, DOI 10.3109/10242422.2013.828048; Almajano MP, 2008, FOOD CHEM, V108, P55, DOI 10.1016/j.foodchem.2007.10.040; Curiel JA, 2011, MOL NUTR FOOD RES, V55, P1454, DOI 10.1002/mnfr.201000621; Appel RD, 1999, METH MOL B, V112, P363; Ashida N, 2011, J BIOSCI BIOENG, V112, P333, DOI 10.1016/j.jbiosc.2011.06.001; Barreteau H, 2008, FEMS MICROBIOL REV, V32, P168, DOI 10.1111/j.1574-6976.2008.00104.x; Beekwilder J, 2009, APPL ENVIRON MICROB, V75, P3447, DOI 10.1128/AEM.02675-08; Bossi A, 2007, J APPL MICROBIOL, V102, P787, DOI 10.1111/j.1365-2672.2006.03118.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cecconi D, 2009, ELECTROPHORESIS, V30, P957, DOI 10.1002/elps.200800310; China R, 2012, MICROBIOL RES, V167, P500, DOI 10.1016/j.micres.2012.04.003; Crozier A, 2009, NAT PROD REP, V26, P1001, DOI 10.1039/b802662a; De Angelis M, 2004, PROTEOMICS, V4, P106, DOI 10.1002/pmic.200300497; Duda-Chodak A, 2012, J PHYSIOL PHARMACOL, V63, P497; Etxeberria U, 2013, J AGR FOOD CHEM, V61, P9517, DOI 10.1021/jf402506c; Ferain T, 1996, J BACTERIOL, V178, P5431, DOI 10.1128/JB.178.18.5431-5437.1996; GORG A, 1988, ELECTROPHORESIS, V9, P531, DOI 10.1002/elps.1150090913; Heunis T, 2014, J PROTEOME RES, V13, P4028, DOI 10.1021/pr500353x; HOCHSTRASSER DF, 1988, ANAL BIOCHEM, V173, P424, DOI 10.1016/0003-2697(88)90209-6; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Johnson B, 2013, MICROBIOL-SGM, V159, P2269, DOI 10.1099/mic.0.070755-0; Kuwana R, 2012, J BIOSCI BIOENG, V114, P9, DOI 10.1016/j.jbiosc.2012.02.010; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee J, 2010, APPL ENVIRON MICROB, V76, P4829, DOI 10.1128/AEM.02892-09; Len MCL, 2004, MICROBIOL-SGM, V150, P1353, DOI 10.1099/mic.0.26888-0; Lippolis R, 2011, J PROTEOMICS, V74, P2846, DOI 10.1016/j.jprot.2011.06.032; Majumder A, 2011, PROTEOMICS, V11, P3470, DOI 10.1002/pmic.201100115; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; Nandakumar R, 2014, J DAIRY SCI, V97, P1999, DOI 10.3168/jds.2013-7470; Peil L, 2013, P NATL ACAD SCI USA, V110, P15265, DOI 10.1073/pnas.1310642110; Rechner AR, 2004, FREE RADICAL BIO MED, V36, P212, DOI 10.1016/j.freeradbiomed.2003.09.022; Rivas-Sendra A, 2011, J APPL MICROBIOL, V111, P1473, DOI 10.1111/j.1365-2672.2011.05160.x; Rodriguez-Diaz J, 2012, BIOTECHNOL BIOENG, V109, P1704, DOI 10.1002/bit.24475; Rossi M, 2013, J AGR FOOD CHEM, V61, P9551, DOI 10.1021/jf402722m; Russo M, 2012, BIOCHEM PHARMACOL, V83, P6, DOI 10.1016/j.bcp.2011.08.010; Santiago B, 2012, J BACTERIOL, V194, P2010, DOI 10.1128/JB.06737-11; Selma MV, 2009, J AGR FOOD CHEM, V57, P6485, DOI 10.1021/jf902107d; Sharma S, 2013, EXPERT OPIN INV DRUG, V22, P1063, DOI 10.1517/13543784.2013.805744; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shi LC, 2014, P NATL ACAD SCI USA, V111, P2140, DOI 10.1073/pnas.1318476111; Siciliano RA, 2012, CURR OPIN MICROBIOL, V15, P390, DOI 10.1016/j.mib.2012.03.006; Ude S, 2013, SCIENCE, V339, P82, DOI 10.1126/science.1228985; van de Guchte M, 2002, ANTON LEEUW INT J G, V82, P187, DOI 10.1023/A:1020631532202; van Duynhoven J, 2011, P NATL ACAD SCI USA, V108, P4531, DOI 10.1073/pnas.1000098107; Vasanthi HR, 2012, CURR MED CHEM, V19, P2242; Wang Y, 2005, CRYOBIOLOGY, V50, P294, DOI 10.1016/j.cryobiol.2005.03.001; Wang Y, 2011, BIOTECHNOL PROGR, V27, P342, DOI 10.1002/btpr.566; Zou SB, 2012, J BACTERIOL, V194, P413, DOI 10.1128/JB.05864-11	48	13	14	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142376	10.1371/journal.pone.0142376	http://dx.doi.org/10.1371/journal.pone.0142376			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544973	gold, Green Submitted, Green Published			2022-12-27	WOS:000364398700122
J	Morita, K; Naruto, T; Tanimoto, K; Yasukawa, C; Oikawa, Y; Masuda, K; Imoto, I; Inazawa, J; Omura, K; Harada, H				Morita, Kei-ichi; Naruto, Takuya; Tanimoto, Kousuke; Yasukawa, Chisato; Oikawa, Yu; Masuda, Kiyoshi; Imoto, Issei; Inazawa, Johji; Omura, Ken; Harada, Hiroyuki			Simultaneous Detection of Both Single Nucleotide Variations and Copy Number Alterations by Next-Generation Sequencing in Gorlin Syndrome	PLOS ONE			English	Article							CELL CARCINOMA SYNDROME; GERMLINE MUTATIONS; PTCH1 MUTATIONS; NEVUS SYNDROME; HUMAN HOMOLOG; GENE; DELETIONS; PROTEIN; FRENCH	Gorlin syndrome (GS) is an autosomal dominant disorder that predisposes affected individuals to developmental defects and tumorigenesis, and caused mainly by heterozygous germline PTCH1 mutations. Despite exhaustive analysis, PTCH1 mutations are often unidentifiable in some patients; the failure to detect mutations is presumably because of mutations occurred in other causative genes or outside of analyzed regions of PTCH1, or copy number alterations (CNAs). In this study, we subjected a cohort of GS-affected individuals from six unrelated families to next-generation sequencing (NGS) analysis for the combined screening of causative alterations in Hedgehog signaling pathway-related genes. Specific single nucleotide variations (SNVs) of PTCH1 causing inferred amino acid changes were identified in four families (seven affected individuals), whereas CNAs within or around PTCH1 were found in two families in whom possible causative SNVs were not detected. Through a targeted resequencing of all coding exons, as well as simultaneous evaluation of copy number status using the alignment map files obtained via NGS, we found that GS phenotypes could be explained by PTCH1 mutations or deletions in all affected patients. Because it is advisable to evaluate CNAs of candidate causative genes in point mutation-negative cases, NGS methodology appears to be useful for improving molecular diagnosis through the simultaneous detection of both SNVs and CNAs in the targeted genes/regions.	[Morita, Kei-ichi; Yasukawa, Chisato; Oikawa, Yu; Omura, Ken; Harada, Hiroyuki] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Oral & Maxillofacial Surg, Tokyo, Japan; [Morita, Kei-ichi; Tanimoto, Kousuke; Inazawa, Johji] Tokyo Med & Dent Univ, Bioresource Res Ctr, Tokyo, Japan; [Morita, Kei-ichi; Inazawa, Johji; Omura, Ken] Tokyo Med & Dent Univ, Hard Tissue Genome Res Ctr, Tokyo, Japan; [Naruto, Takuya] Univ Tokushima, Grad Sch, Inst Biomed Sci, Dept Stress Sci, Tokushima, Japan; [Tanimoto, Kousuke] Tokyo Med & Dent Univ, Med Res Inst, Genome Lab, Tokyo, Japan; [Tanimoto, Kousuke; Inazawa, Johji] Med Res Inst, Dept Mol Cytogenet, Tokyo, Japan; [Tanimoto, Kousuke; Inazawa, Johji] Tokyo Med & Dent Univ, Sch Biomed Sci, Grad Sch Med, Tokyo, Japan; [Masuda, Kiyoshi] Univ Tokushima, Grad Sch, Inst Biomed Sci, Dept Human Genet, Tokushima, Japan; [Omura, Ken] Tokyo Gen Hosp, Oral Canc Ctr, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokushima University; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokushima University	Morita, K (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Oral & Maxillofacial Surg, Tokyo, Japan.	keiichi.m.osur@tmd.ac.jp	Imoto, Issei/AAD-5799-2020		JSPS KAKENHI from Ministry of Education, Culture, Sports, Science and Technology, Japan [26293304]	JSPS KAKENHI from Ministry of Education, Culture, Sports, Science and Technology, Japan	This work was supported by JSPS KAKENHI Grant Number 26293304 (I.I.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	BALE AE, 1995, P ASSOC AM PHYSICIAN, V107, P253; Boutet N, 2003, J INVEST DERMATOL, V121, P478, DOI 10.1046/j.1523-1747.2003.12423.x; Fan Z, 2008, J MED GENET, V45, P303, DOI 10.1136/jmg.2007.055343; Fujii K, 2007, HUM GENET, V122, P459, DOI 10.1007/s00439-007-0419-y; Fujii K, 2014, PEDIATR INT, V56, P667, DOI 10.1111/ped.12461; Fujii K, 2013, FAM CANCER, V12, P611, DOI 10.1007/s10689-013-9623-1; Gao Wenming, 2015, Hum Genome Var, V2, P15004, DOI 10.1038/hgv.2015.4; Goncalves KD, 2011, FEBS LETT, V585, P2556, DOI 10.1016/j.febslet.2011.07.010; GORLIN RJ, 1960, NEW ENGL J MED, V262, P908, DOI 10.1056/NEJM196005052621803; GORLIN RJ, 1995, DERMATOL CLIN, V13, P113, DOI 10.1016/S0733-8635(18)30114-1; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Lindstrom E, 2006, HUM MUTAT, V27, P215, DOI 10.1002/humu.20296; Nagao K, 2011, CLIN GENET, V79, P196, DOI 10.1111/j.1399-0004.2010.01527.x; Okamoto Nana, 2014, Hum Genome Var, V1, P14022, DOI 10.1038/hgv.2014.22; RAYNER CRW, 1977, BRIT J PLAST SURG, V30, P62, DOI 10.1016/S0007-1226(77)90037-6; Reifenberger J, 2001, J INVEST DERMATOL, V116, P472, DOI 10.1046/j.1523-1747.2001.01279-2.x; Shimada Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070995; Shimada Y, 2013, J ORAL PATHOL MED, V42, P275, DOI 10.1111/j.1600-0714.2012.01202.x; Smith MJ, 2014, J CLIN ONCOL, V32, P4155, DOI 10.1200/JCO.2014.58.2569; Soufir N, 2006, BRIT J CANCER, V95, P548, DOI 10.1038/sj.bjc.6603303; Wicking C, 1997, AM J HUM GENET, V60, P21	22	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0140480	10.1371/journal.pone.0140480	http://dx.doi.org/10.1371/journal.pone.0140480			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544948	Green Submitted, gold, Green Published			2022-12-27	WOS:000364398700010
J	Rollin, HB; Kootbodien, T; Channa, K; Odland, JO				Roellin, Halina B.; Kootbodien, Tahira; Channa, Kalavati; Odland, Jon O.			Prenatal Exposure to Cadmium, Placental Permeability and Birth Outcomes in Coastal Populations of South Africa	PLOS ONE			English	Article							ENVIRONMENTAL CONTAMINANTS; ESSENTIAL ELEMENTS; RISK-ASSESSMENT; BLOOD; MICRONUTRIENTS; TRANSPORT; INTERACTS; LEAD; FOOD	Background The impact of prenatal exposure to cadmium (Cd) on birth outcomes is an area of concern. This study aimed to assess an impact of prenatal Cd exposure on birth outcomes in distinct coastal populations of South Africa. Methods Cadmium was measured in maternal blood (CdB) (n = 641), cord blood and in maternal urine (n = 317). This investigation assessed the associations between CdB (non-transformed) and birth outcomes across the 25th, 50th, and 75th percentile for birth weight, birth length and head circumference, to test for a linear trend. Associations between natural log-transformed maternal CdB, size at birth and other factors were further evaluated using linear mixed-effects modelling with random intercepts. Results The average gestational age in the total sample was 38 weeks; 47% of neonates were female, average birth weight was 3065 g and 11% were of low birth weight (< 2500 g). The geometric mean (GM) of the maternal CdB level was 0.25 mu g/L (n = 641; 95% CI, 0.230.27). The cord blood Cd level was 0.27 mu g/L (n = 317; 95% CI, 0.26-0.29) and urine (creatinine-corrected) Cd level was 0.27 mu g/L (n = 318; 95% CI, 0.24-0.29). The CdB cord: maternal ratio in the sub-cohort was 1, suggesting that the placenta offers no protective mechanism to the foetus. An inverse association was found between CdB and the lower birth weight percentile in female neonates only (beta = -0.13, p = 0.047). Mothers who reported eating vine vegetables daily had lower levels of CdB (beta = -0.55, p = 0.025). Maternal smoking was associated with an elevation in natural log-transformed CdB levels in both male and female cohorts. Discussion Significant inverse associations between prenatal Cd exposure and birth anthropometry were found in female neonates but not in male neonates, suggesting potential sex differences in the toxico-kinetics and toxico-dynamics of Cd.	[Roellin, Halina B.; Odland, Jon O.] Univ Pretoria, Fac Hlth Sci, Sch Hlth Syst & Publ Hlth, ZA-0002 Pretoria, South Africa; [Roellin, Halina B.; Kootbodien, Tahira] MRC, Environm & Hlth Res Unit, Johannesburg, South Africa; [Channa, Kalavati] Lancet Labs, Dept Analyt Chem, Johannesburg, South Africa; [Odland, Jon O.] Univ Tromso, Inst Community Med, Tromso, Norway	University of Pretoria; UiT The Arctic University of Tromso	Rollin, HB (corresponding author), Univ Pretoria, Fac Hlth Sci, Sch Hlth Syst & Publ Hlth, ZA-0002 Pretoria, South Africa.	Halina.Rollin@up.ac.za	Odland, Jon Oyvind/L-5096-2017	Odland, Jon Oyvind/0000-0002-2756-0732; Rollin, Halina/0000-0001-5247-6519	National Research Foundation (NRF), South Africa [64528]; Arctic Monitoring and Assessment Programme (AMAP), Norway	National Research Foundation (NRF), South Africa(National Research Foundation - South Africa); Arctic Monitoring and Assessment Programme (AMAP), Norway	This research was funded in part by the National Research Foundation (NRF), South Africa (Grant 64528) and the Arctic Monitoring and Assessment Programme (AMAP), Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernethy DR, 2010, PHARM RES-DORDR, V27, P750, DOI 10.1007/s11095-010-0080-3; Akesson AA, 2005, ENVIRON HEALTH PERSP, V113, P1627, DOI 10.1289/ehp.8033; Akesson A, 2014, ENVIRON HEALTH PERSP, V122, P431, DOI 10.1289/ehp.1307110; Al-Saleh I, 2014, INT J HYG ENVIR HEAL, V217, P205, DOI 10.1016/j.ijheh.2013.04.009; Authority EFS, 2009, SCI OP CADM FOOD SCI; BARANOWSKA I, 1995, OCCUP ENVIRON MED, V52, P229, DOI 10.1136/oem.52.4.229; CDC,, 2013, 4 CDCP; Chan HM, 2001, FOOD ADDIT CONTAM, V18, P607, DOI 10.1080/02652030110035660; Charania NA, 2014, ENVIRON SCI-PROC IMP, V16, P1422, DOI 10.1039/c4em00064a; Fontaine J, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-25; FRIBERG L, 1983, ANNU REV PUBL HEALTH, V4, P367, DOI 10.1146/annurev.pu.04.050183.002055; Hansen S, 2011, J ENVIRON MONITOR, V13, P2143, DOI 10.1039/c1em10051c; Hanson ML, 2012, TOXICOL APPL PHARM, V261, P196, DOI 10.1016/j.taap.2012.04.002; Hlimi T, 2012, INT J CIRCUMPOL HEAL, V71, DOI 10.3402/ijch.v71i0.17344; Hubal EAC, 2014, REGUL TOXICOL PHARM, V69, P113, DOI 10.1016/j.yrtph.2013.09.008; Johnson MD, 2003, NAT MED, V9, P1081, DOI 10.1038/nm902; Kido Shinsuke, 2012, Nihon Eiseigaku Zasshi, V67, P464; Kim C, 1998, FOOD ADDIT CONTAM A, V15, P307; Kippler M, 2013, EPIGENETICS-US, V8, P494, DOI 10.4161/epi.24401; Kippler M, 2012, ENVIRON HEALTH PERSP, V120, P284, DOI 10.1289/ehp.1103711; Kippler M, 2010, TOXICOL LETT, V192, P162, DOI 10.1016/j.toxlet.2009.10.018; Kippler M, 2009, TOXICOLOGY, V257, P64, DOI 10.1016/j.tox.2008.12.009; Kjellstrom T, 1992, IARC Sci Publ, P301; Nawrot TS, 2010, BIOMETALS, V23, P769, DOI 10.1007/s10534-010-9343-z; Needham LL, 2011, ENVIRON SCI TECHNOL, V45, P1121, DOI 10.1021/es1019614; Nordberg GF, 2007, HANDBOOK ON THE TOXICOLOGY OF METALS, 3RD EDITION, P445, DOI 10.1016/B978-012369413-3/50078-1; Nordberg M., 2002, HEAVY METALS ENV; Osman K, 2000, CLIN BIOCHEM, V33, P131, DOI 10.1016/S0009-9120(00)00052-7; Rudge CV, 2009, J ENVIRON MONITOR, V11, P1322, DOI 10.1039/b903805a; Sakamoto M, 2013, ENVIRON INT, V60, P106, DOI 10.1016/j.envint.2013.08.007; Sanders AP, 2014, EPIGENETICS-US, V9, P212, DOI 10.4161/epi.26798; Sun H, 2014, CHEMOSPHERE, V108, P33, DOI 10.1016/j.chemosphere.2014.02.080; Thompson J, 2008, REPROD TOXICOL, V25, P304, DOI 10.1016/j.reprotox.2008.02.001; Vahter M, 2002, ENVIRON RES, V88, P145, DOI 10.1006/enrs.2002.4338; Veyhe AS, 2015, INT J HYG ENVIR HEAL, V218, P254, DOI 10.1016/j.ijheh.2014.12.001; WHO, 2011, WHO TECH REP SER, V966, P1; World Health O, 2009, CADMIUM	37	36	36	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142455	10.1371/journal.pone.0142455	http://dx.doi.org/10.1371/journal.pone.0142455			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544567	gold, Green Submitted, Green Published			2022-12-27	WOS:000364398700143
J	Shin, HJ; Park, ER; Yun, SH; Kim, SH; Jung, WH; Woo, SR; Joo, HY; Jang, SH; Chung, HY; Hong, SH; Cho, MH; Park, JJ; Yun, M; Lee, KH				Shin, Hyun-Jin; Park, Eun-Ran; Yun, Sun-Hee; Kim, Su-Hyeon; Jung, Won-Hee; Woo, Seon Rang; Joo, Hyun-Yoo; Jang, Su Hwa; Chung, Hee Yong; Hong, Sung Hee; Cho, Myung-Haing; Park, Joong-Jean; Yun, Miyong; Lee, Kee-Ho			p31(comet)-Induced Cell Death Is Mediated by Binding and Inactivation of Mad2	PLoS One			English	Article							SPINDLE ASSEMBLY CHECKPOINT; ANAPHASE-PROMOTING COMPLEX; MITOTIC CHECKPOINT; CHROMOSOMAL INSTABILITY; LUNG-CANCER; P53 GENE; HEPATOCELLULAR-CARCINOMA; GENOMIC INSTABILITY; PROTEIN MAD2; EXPRESSION	Mad2, a key component of the spindle checkpoint, is closely associated with chromosomal instability and poor prognosis in cancer. p31(comet) is a Mad2-interacting protein that serves as a spindle checkpoint silencer at mitosis. In this study, we showed that p31(comet)-induced apoptosis and senescence occur via counteraction of Mad2 activity. Upon retroviral transduction of p31(comet), the majority of human cancer cell lines tested lost the ability to form colonies in a low-density seeding assay. Cancer cells with p31(comet) overexpression underwent distinct apoptosis and/or senescence, irrespective of p53 status, confirming the cytotoxicity of p31(comet). Interestingly, both cytotoxic and Mad2 binding activities were eliminated upon deletion of the C-terminal 30 amino acids of p31(comet). Point mutation or deletion of the region affecting Mad2 binding additionally abolished cytotoxic activity. Consistently, wildtype Mad2 interacting with p31(comet), but not its non-binding mutant, inhibited cell death, indicating that the mechanism of p31(comet)-induced cell death involves Mad2 inactivation. Our results clearly suggest that the regions of p31(comet) affecting interactions with Mad2, including the C-terminus, are essential for induction of cell death. The finding that p31(comet)-induced cell death is mediated by interactions with Mad2 that lead to its inactivation is potentially applicable in anticancer therapy.	[Shin, Hyun-Jin; Park, Eun-Ran; Yun, Sun-Hee; Kim, Su-Hyeon; Jung, Won-Hee; Woo, Seon Rang; Joo, Hyun-Yoo; Hong, Sung Hee; Yun, Miyong; Lee, Kee-Ho] Korea Inst Radiol & Med Sci, Div Radiat Canc Res, Seoul 139706, South Korea; [Jang, Su Hwa; Chung, Hee Yong] Hanyang Univ, Grad Sch Biomed Sci & Engn, Seoul 133791, South Korea; [Cho, Myung-Haing] Seoul Natl Univ, Coll Vet Med, Toxicol Lab, Seoul 151742, South Korea; [Park, Joong-Jean] Korea Univ, Coll Med, Dept Physiol, Seoul 136705, South Korea; [Yun, Miyong] Kyung Hee Univ, Coll Oriental Med, Seoul 130701, South Korea; [Park, Eun-Ran] Yonsei Univ, Dept Pathol, Coll Med, Seoul 120749, South Korea; [Park, Eun-Ran] Yonsei Univ, BK PLUS Project Med Sci 21, Coll Med, Seoul 120749, South Korea	Korea Institute of Radiological & Medical Sciences; Hanyang University; Seoul National University (SNU); Korea University; Korea University Medicine (KU Medicine); Kyung Hee University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Yun, M (corresponding author), Korea Inst Radiol & Med Sci, Div Radiat Canc Res, Seoul 139706, South Korea.	myyun91@khu.ac.kr; khlee@kirams.re.kr	Cho, Myung-Haing/B-7362-2014; YUN, MIYONG/S-9433-2019	Cho, Myung-Haing/0000-0002-3993-2011; Chung, Hee Yong/0000-0001-7580-0537; Jang, Su Hwa/0000-0002-3022-6612; Park, Joong-Jean/0000-0002-4534-3002	National Research Foundation of Korea [2012M3A9B6055346]; nuclear R&D program of Korea Ministry of Sciences and Technology	National Research Foundation of Korea(National Research Foundation of Korea); nuclear R&D program of Korea Ministry of Sciences and Technology	This study was supported by grants from National Research Foundation of Korea (2012M3A9B6055346), and nuclear R&D program of Korea Ministry of Sciences and Technology.	BRESSAC B, 1990, P NATL ACAD SCI USA, V87, P1973, DOI 10.1073/pnas.87.5.1973; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Date DA, 2014, J BIOL CHEM, V289, P11367, DOI 10.1074/jbc.M113.520841; Date DA, 2013, CELL CYCLE, V12, P3824, DOI 10.4161/cc.26811; DILLER L, 1990, MOL CELL BIOL, V10, P5772, DOI 10.1128/MCB.10.11.5772; Dobles M, 2000, CELL, V101, P635, DOI 10.1016/S0092-8674(00)80875-2; Fang GW, 1998, GENE DEV, V12, P1871, DOI 10.1101/gad.12.12.1871; Frio TR, 2010, NEW ENGL J MED, V363, P2628, DOI 10.1056/NEJMoa1006565; Gao N, 2001, J CANCER RES CLIN, V127, P359, DOI 10.1007/s004320000184; Grabsch H, 2003, J PATHOL, V200, P16, DOI 10.1002/path.1324; Habu T, 2002, EMBO J, V21, P6419, DOI 10.1093/emboj/cdf659; Habu T, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-562; He M, 2011, ONCOGENE, V30, P1947, DOI 10.1038/onc.2010.567; Hernando E, 2004, NATURE, V430, P797, DOI 10.1038/nature02820; Hisaoka M, 2008, PATHOL INT, V58, P329, DOI 10.1111/j.1440-1827.2008.02232.x; Jaffrey RG, 2000, CANCER RES, V60, P4349; Kato T, 2011, LUNG CANCER, V74, P124, DOI 10.1016/j.lungcan.2011.01.025; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Lin Y., 1996, Annals Academy of Medicine Singapore, V25, P22; LOWE SW, 1994, P NATL ACAD SCI USA, V91, P2026, DOI 10.1073/pnas.91.6.2026; Ma HT, 2012, J BIOL CHEM, V287, P21561, DOI 10.1074/jbc.M112.364356; Mapelli M, 2006, EMBO J, V25, P1273, DOI 10.1038/sj.emboj.7601033; MASUDA H, 1987, P NATL ACAD SCI USA, V84, P7716, DOI 10.1073/pnas.84.21.7716; Michel L, 2004, P NATL ACAD SCI USA, V101, P4459, DOI 10.1073/pnas.0306069101; Michel LS, 2001, NATURE, V409, P355, DOI 10.1038/35053094; MITSUDOMI T, 1992, ONCOGENE, V7, P171; Nowak MA, 2002, P NATL ACAD SCI USA, V99, P16226, DOI 10.1073/pnas.202617399; Prencipe M, 2009, BRIT J CANCER, V101, P1900, DOI 10.1038/sj.bjc.6605419; Salmela AL, 2013, CHROMOSOMA, V122, P431, DOI 10.1007/s00412-013-0419-8; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Shin HJ, 2003, CANCER CELL, V4, P483, DOI 10.1016/S1535-6108(03)00302-7; Sironi L, 2001, EMBO J, V20, P6371, DOI 10.1093/emboj/20.22.6371; Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019; Sotillo R, 2010, NATURE, V464, P436, DOI 10.1038/nature08803; Sudo T, 2004, CANCER RES, V64, P2502, DOI 10.1158/0008-5472.CAN-03-2013; Teichner A, 2011, P NATL ACAD SCI USA, V108, P3187, DOI 10.1073/pnas.1100023108; Westhorpe FG, 2011, J CELL SCI, V124, P3905, DOI 10.1242/jcs.093286; Xia GH, 2004, EMBO J, V23, P3133, DOI 10.1038/sj.emboj.7600322; Yang MJ, 2007, CELL, V131, P744, DOI 10.1016/j.cell.2007.08.048; Yun M, 2009, MOL CANCER RES, V7, P371, DOI 10.1158/1541-7786.MCR-08-0056; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039; Zhang SH, 2008, HUM PATHOL, V39, P1827, DOI 10.1016/j.humpath.2008.06.003	43	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141523	10.1371/journal.pone.0141523	http://dx.doi.org/10.1371/journal.pone.0141523			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544187	Green Published, Green Submitted, gold			2022-12-27	WOS:000364398700030
J	Dugrand-Judek, A; Olry, A; Hehn, A; Costantino, G; Ollitrault, P; Froelicher, Y; Bourgaud, F				Dugrand-Judek, Audray; Olry, Alexandre; Hehn, Alain; Costantino, Gilles; Ollitrault, Patrick; Froelicher, Yann; Bourgaud, Frederic			The Distribution of Coumarins and Furanocoumarins in Citrus Species Closely Matches Citrus Phylogeny and Reflects the Organization of Biosynthetic Pathways	PLOS ONE			English	Article							MOLECULAR-CLONING; CYP3A4 INHIBITOR; PRENYLTRANSFERASE; PHOTOTOXICITY; DIVERSITY; RUTACEAE; FRUIT; IDENTIFICATION; FUROCOUMARINS; QUANTITATION	Citrus plants are able to produce defense compounds such as coumarins and furanocoumarins to cope with herbivorous insects and pathogens. In humans, these chemical compounds are strong photosensitizers and can interact with medications, leading to the "grapefruit juice effect". Removing coumarins and furanocoumarins from food and cosmetics imply additional costs and might alter product quality. Thus, the selection of Citrus cultivars displaying low coumarin and furanocoumarin contents constitutes a valuable alternative. In this study, we performed ultra-performance liquid chromatography coupled with mass spectrometry analyses to determine the contents of these compounds within the peel and the pulp of 61 Citrus species representative of the genetic diversity all Citrus. Generally, Citrus peel contains larger diversity and higher concentrations of coumarin/furanocoumarin than the pulp of the same fruits. According to the chemotypes found in the peel, Citrus species can be separated into 4 groups that correspond to the 4 ancestral taxa (pummelos, mandarins, citrons and papedas) and extended with their respective secondary species descendants. Three of the 4 ancestral taxa (pummelos, citrons and papedas) synthesize high amounts of these compounds, whereas mandarins appear practically devoid of them. Additionally, all ancestral taxa and their hybrids are logically organized according to the coumarin and furanocoumarin pathways described in the literature. This organization allows hypotheses to be drawn regarding the biosynthetic origin of compounds for which the biogenesis remains unresolved. Determining coumarin and furanocoumarin contents is also helpful for hypothesizing the origin of Citrus species for which the phylogeny is presently not firmly established. Finally, this work also notes favorable hybridization schemes that will lead to low coumarin and furanocoumarin contents, and we propose to select mandarins and Ichang papeda as Citrus varieties for use in creating species devoid of these toxic compounds in future breeding programs.	[Dugrand-Judek, Audray; Olry, Alexandre; Hehn, Alain; Bourgaud, Frederic] Univ Lorraine, UMR 1121, Lab Agron & Environm Nancy Colmar, 2 Ave Foret de Haye,TSA 40602, F-54518 Vandoeuvre Les Nancy, France; [Dugrand-Judek, Audray; Olry, Alexandre; Hehn, Alain; Bourgaud, Frederic] Univ Lorraine, INRA, UMR 1121, Lab Agron & Environm Nancy Colmar, F-54518 Vandoeuvre Les Nancy, France; [Costantino, Gilles] INRA, UMR AGAP, Stn INRA, F-20230 San Giuliano, France; [Ollitrault, Patrick] Inst Valenciano Invest Agr, Ctr Protecc Vegetal & Biotecnol, Valencia 46113, Spain; [Ollitrault, Patrick] CIRAD, UMR AGAP, Stn Roujol, F-97170 Petit Bourg, Guadeloupe, France; [Froelicher, Yann] CIRAD, UMR AGAP, Stn INRA, F-20230 San Giuliano, France	Universite de Lorraine; INRAE; Universite de Lorraine; INRAE; Instituto Valenciano de Investigaciones Agrarias (IVIA); CIRAD; CIRAD; INRAE	Bourgaud, F (corresponding author), Univ Lorraine, UMR 1121, Lab Agron & Environm Nancy Colmar, 2 Ave Foret de Haye,TSA 40602, F-54518 Vandoeuvre Les Nancy, France.	froelicher@cirad.fr; frederic.bourgaud@univ-lorraine.fr		Bourgaud, Frederic/0000-0002-9898-2625; Hehn, Alain/0000-0003-4507-8031; Dugrand-Judek, Audray/0000-0001-6951-8244; Ollitrault, Patrick/0000-0002-9456-5517				Bailey DG, 2013, CAN MED ASSOC J, V185, P309, DOI 10.1503/cmaj.120951; BAILEY DG, 1991, LANCET, V337, P268, DOI 10.1016/0140-6736(91)90872-M; Barkley NA, 2006, THEOR APPL GENET, V112, P1519, DOI 10.1007/s00122-006-0255-9; BERENBAUM MR, 1991, J CHEM ECOL, V17, P207, DOI 10.1007/BF00994434; Bourgaud F., 2006, Phytochemistry Reviews, V5, P293, DOI 10.1007/s11101-006-9040-2; Bourgaud F, 1992, EUR J AGRON, V1, P37; Buscemi S, 2012, AM J CLIN NUTR, V95, P1089, DOI 10.3945/ajcn.111.031088; Calka O, 2005, CONTACT DERMATITIS, V53, P58, DOI 10.1111/j.0105-1873.2005.0456e.x; Carbonell-Caballero J, 2015, MOL BIOL EVOL, V32, P2015, DOI 10.1093/molbev/msv082; Colombain M, 2001, PLANTA MED, V67, P644, DOI 10.1055/s-2001-17364; Curk F, 2014, CITRUS GENE POOL ORG; Curk F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125628; Dugrand A, 2013, J AGR FOOD CHEM, V61, P10677, DOI 10.1021/jf402763t; Durand-Hulak M, 2015, ANN BOT-LONDON, V115, P861, DOI 10.1093/aob/mcv012; Federici CT, 1998, THEOR APPL GENET, V96, P812, DOI 10.1007/s001220050807; Froelicher Y, 2011, TREE GENET GENOMES, V7, P49, DOI 10.1007/s11295-010-0314-x; Fujita T, 2008, BIOL PHARM BULL, V31, P925, DOI 10.1248/bpb.31.925; Garcia-Lor A, 2013, ANN BOT-LONDON, V111, P1, DOI 10.1093/aob/mcs227; Gmitter F. G. Jr., 2007, Fruits and nuts, P265; Gravot A, 2004, ARCH BIOCHEM BIOPHYS, V422, P71, DOI 10.1016/j.abb.2003.12.013; Groppo M, 2008, AM J BOT, V95, P985, DOI 10.3732/ajb.2007313; Hwang SL, 2012, J AGR FOOD CHEM, V60, P877, DOI 10.1021/jf204452y; Karamat F, 2014, PLANT J, V77, P627, DOI 10.1111/tpj.12409; Larbat R, 2007, J BIOL CHEM, V282, P542, DOI 10.1074/jbc.M604762200; Larbat R, 2009, J BIOL CHEM, V284, P4776, DOI 10.1074/jbc.M807351200; Li HX, 2015, PLANT PHYSIOL, V167, P650, DOI 10.1104/pp.114.253682; Lin HL, 2012, DRUG METAB DISPOS, V40, P998, DOI 10.1124/dmd.112.044560; Liu YQ, 2012, COMPR REV FOOD SCI F, V11, P530, DOI 10.1111/j.1541-4337.2012.00201.x; Messer A, 2012, FOOD CHEM TOXICOL, V50, P756, DOI 10.1016/j.fct.2011.11.023; Munakata R, 2014, PLANT PHYSIOL, V166, P80, DOI 10.1104/pp.114.246892; Myung K, 2008, J AGR FOOD CHEM, V56, P12064, DOI 10.1021/jf802713g; Nicolosi E, 2000, THEOR APPL GENET, V100, P1155, DOI 10.1007/s001220051419; Ohta T, 2002, TETRAHEDRON, V58, P6631, DOI 10.1016/S0040-4020(02)00739-1; Ollitrault P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-13; Paine MF, 2005, J PHARMACOL EXP THER, V312, P1151, DOI 10.1124/jpet.104.076836; PATHAK MA, 1960, J INVEST DERMATOL, V35, P165, DOI 10.1038/jid.1960.101; Praloran J-C, 1971, CITRUS; Raquet N, 2014, FOOD CHEM TOXICOL, V68, P257, DOI 10.1016/j.fct.2014.03.014; Robl M, 2013, ARCH DIS CHILD, V98, P915, DOI 10.1136/archdischild-2013-304407; Sasaki K, 2008, PLANT PHYSIOL, V146, P1075, DOI 10.1104/pp.107.110544; Sasaki K, 2011, J BIOL CHEM, V286, P24125, DOI 10.1074/jbc.M111.244426; Swingle W T, 1967, CITRUS IND, P190; Tanaka T., 1977, STUD CITROG, V14, P1; UNCTAD, 2011, CITR CONS; VanderMolen KM, 2013, PHYTOCHEM ANALYSIS, V24, P654, DOI 10.1002/pca.2449; Vialart Guilhem, 2012, Plant J, V70, P460, DOI 10.1111/j.1365-313X.2011.04879.x; Voo SS, 2012, PLANT PHYSIOL, V159, P81, DOI 10.1104/pp.112.194233; Wangensteen H, 2003, EUR J CLIN PHARMACOL, V58, P663, DOI 10.1007/s00228-002-0537-3; Wilkinson GR, 2005, NEW ENGL J MED, V352, P2211, DOI 10.1056/NEJMra032424; Wu GA, 2014, NAT BIOTECHNOL, V32, P656, DOI 10.1038/nbt.2906; Xu J, 2015, FOOD CHEM, V187, P75, DOI 10.1016/j.foodchem.2015.04.007	53	69	72	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142757	10.1371/journal.pone.0142757	http://dx.doi.org/10.1371/journal.pone.0142757			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26558757	Green Published, gold			2022-12-27	WOS:000364433100120
J	Gorges, M; Muller, HP; Lule, D; Del Tredici, K; Brettschneider, J; Keller, J; Pfandl, K; Ludolph, AC; Kassubek, J; Pinkhardt, EH				Gorges, Martin; Mueller, Hans-Peter; Lule, Dorothee; Del Tredici, Kelly; Brettschneider, Johannes; Keller, Juergen; Pfandl, Katharina; Ludolph, Albert C.; Kassubek, Jan; Pinkhardt, Elmar H.			Eye Movement Deficits Are Consistent with a Staging Model of pTDP-43 Pathology in Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; OCULOMOTOR FUNCTION; PARKINSONS-DISEASE; ABNORMALITIES; SACCADES; IMPAIRMENTS; CRITERIA; ALS	Background The neuropathological process underlying amyotrophic lateral sclerosis (ALS) can be traced as a four-stage progression scheme of sequential corticofugal axonal spread. The examination of eye movement control gains deep insights into brain network pathology and provides the opportunity to detect both disturbance of the brainstem oculomotor circuitry as well as executive deficits of oculomotor function associated with higher brain networks. Objective To study systematically oculomotor characteristics in ALS and its underlying network pathology in order to determine whether eye movement deterioration can be categorized within a staging system of oculomotor decline that corresponds to the neuropathological model. Methods Sixty-eight ALS patients and 31 controls underwent video-oculographic, clinical and neuropsychological assessments. Results Oculomotor examinations revealed increased anti-and delayed saccades' errors, gazepalsy and a cerebellary type of smooth pursuit disturbance. The oculomotor disturbances occurred in a sequential manner: Stage 1, only executive control of eye movements was affected. Stage 2 indicates disturbed executive control plus 'genuine' oculomotor dysfunctions such as gaze-paly. We found high correlations (p<0.001) between the oculomotor stages and both, the clinical presentation as assessed by the ALS Functional Rating Scale (ALSFRS) score, and cognitive scores from the Edinburgh Cognitive and Behavioral ALS Screen (ECAS). Conclusions Dysfunction of eye movement control in ALS can be characterized by a two-staged sequential pattern comprising executive deficits in Stage 1 and additional impaired infratentorial oculomotor control pathways in Stage 2. This pattern parallels the neuropathological staging of ALS and may serve as a technical marker of the neuropathological spreading.	[Gorges, Martin; Mueller, Hans-Peter; Lule, Dorothee; Keller, Juergen; Pfandl, Katharina; Ludolph, Albert C.; Kassubek, Jan; Pinkhardt, Elmar H.] Univ Ulm, Dept Neurol, D-89069 Ulm, Germany; [Del Tredici, Kelly] Univ Ulm, Dept Neurol, Sect Clin Neuroanat, D-89069 Ulm, Germany; [Brettschneider, Johannes] Univ Penn, Sch Med, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA	Ulm University; Ulm University; University of Pennsylvania; Pennsylvania Medicine	Pinkhardt, EH (corresponding author), Univ Ulm, Dept Neurol, D-89069 Ulm, Germany.	elmar.pinkhardt@uni-ulm.de	Del Tredici, Kelly/AAT-1286-2020; Kassubek, Jan/O-1740-2019; Kassubek, Jan/F-2774-2015; Kassubek, Jan/GPX-0910-2022	Del Tredici, Kelly/0000-0002-9130-7838; Kassubek, Jan/0000-0002-7106-9270; Kassubek, Jan/0000-0002-7106-9270; Kassubek, Jan/0000-0002-7106-9270	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) [LU 336/15-1]; German Network for Motor Neuron Diseases [BMBF 01GM1103A]	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG)); German Network for Motor Neuron Diseases	This study was supported by the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG Grant Number LU 336/15-1) and the German Network for Motor Neuron Diseases (BMBF 01GM1103A).	Anderson TJ, 2013, NAT REV NEUROL, V9, P74, DOI 10.1038/nrneurol.2012.273; Boxer AL, 2012, ARCH NEUROL-CHICAGO, V69, P509, DOI 10.1001/archneurol.2011.1021; Braak H, 2013, NAT REV NEUROL, V9, P708, DOI 10.1038/nrneurol.2013.221; Brettschneider J, 2013, ANN NEUROL, V74, P20, DOI 10.1002/ana.23937; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Burrell JR, 2013, AMYOTROPH LAT SCL FR, V14, P294, DOI 10.3109/21678421.2013.783077; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Chen Athena L, 2010, Front Neurol, V1, P147, DOI 10.3389/fneur.2010.00147; Donaghy C, 2011, J NEUROL NEUROSUR PS, V82, P110, DOI 10.1136/jnnp.2010.212407; Donaghy C, 2010, J NEUROL, V257, P1134, DOI 10.1007/s00415-010-5478-7; Douaud G, 2011, BRAIN, V134, P3467, DOI 10.1093/brain/awr279; Fukushima K, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00004; Garbutt S, 2008, BRAIN, V131, P1268, DOI 10.1093/brain/awn047; Gorges M, 2015, BRAIN IMAGI IN PRESS; Gorges M, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/658243; Gorges M, 2013, BRAIN CONNECT, V3, P265, DOI 10.1089/brain.2013.0146; JACOBS L, 1981, NEUROLOGY, V31, P1282, DOI 10.1212/WNL.31.10.1282; Kassubek J, 2011, UNCOMMON CAUSES MOVE, P306; Kassubek J, 2014, BRAIN, V137, P1733, DOI 10.1093/brain/awu090; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; Koval MJ, 2011, J NEUROSCI, V31, P8659, DOI 10.1523/JNEUROSCI.1258-11.2011; Krauzlis RJ, 2004, J NEUROPHYSIOL, V91, P591, DOI 10.1152/jn.00801.2003; Lule D, 2015, AMYOTROPH LAT SCL FR, V16, P16, DOI 10.3109/21678421.2014.959451; MARTIFABREGAS J, 1993, J NEUROL, V240, P475, DOI 10.1007/BF00874116; Menke RAL, 2014, BRAIN, V137, P2546, DOI 10.1093/brain/awu162; Meyniel C, 2005, J NEUROL NEUROSUR PS, V76, P1581, DOI 10.1136/jnnp.2004.060392; Moss HE, 2012, J NEUROL SCI, V314, P97, DOI 10.1016/j.jns.2011.10.016; Peltsch A, 2011, NEUROBIOL AGING, V32, P669, DOI 10.1016/j.neurobiolaging.2009.04.001; Pierrot-Deseilligny C, 2004, CURR OPIN NEUROL, V17, P17, DOI 10.1097/00019052-200402000-00005; Pinkhardt EH, 2014, J NEUROL, V261, P791, DOI 10.1007/s00415-014-7275-1; Pinkhardt EH, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-5; Pinkhardt EH, 2011, PARKINSONISM RELAT D, V17, P223, DOI 10.1016/j.parkreldis.2010.08.004; Pinkhardt EH, 2009, J NEUROL, V256, P1438, DOI 10.1007/s00415-009-5131-5; Pinkhardt EH, 2008, J NEUROL, V255, P1916, DOI 10.1007/s00415-009-0027-y; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Rub U, 2001, VISION RES, V41, P2149, DOI 10.1016/S0042-6989(01)00090-6; Schneider E, 2009, ANN NY ACAD SCI, V1164, P461, DOI 10.1111/j.1749-6632.2009.03858.x; Sharika KM, 2013, P NATL ACAD SCI USA, V110, pE1311, DOI 10.1073/pnas.1210492110; Sharma R, 2011, ARCH NEUROL-CHICAGO, V68, P857, DOI 10.1001/archneurol.2011.130; SHAUNAK S, 1995, ANN NEUROL, V38, P38, DOI 10.1002/ana.410380109; Sparks DL, 2002, NAT REV NEUROSCI, V3, P952, DOI 10.1038/nrn986; Stuphorn V, 2006, NAT NEUROSCI, V9, P925, DOI 10.1038/nn1714; Terao Y, 2011, NEUROPSYCHOLOGIA, V49, P1794, DOI 10.1016/j.neuropsychologia.2011.03.002; Thakkar KN, 2014, J NEUROSCI, V34, P8918, DOI 10.1523/JNEUROSCI.0732-14.2014; Turner MR, 2005, BRAIN, V128, P1323, DOI 10.1093/brain/awh509; Van der Hulst E-J, 2014, J NEUROL NEUROSURG P	46	33	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142546	10.1371/journal.pone.0142546	http://dx.doi.org/10.1371/journal.pone.0142546			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559944	Green Published, Green Submitted, gold			2022-12-27	WOS:000364433100088
J	Kotonska-Feiga, J; Dobicki, W; Pokorny, P; Nowacki, W				Kotonska-Feiga, Julia; Dobicki, Wojciech; Pokorny, Przemyslaw; Nowacki, Wojciech			The Activity of Neutral alpha-Glucosidase and Selected Biochemical Parameters in the Annual Cycle of Breeding Carp (Cyprinus carpio L.)	PLOS ONE			English	Article							COMMON CARP; EPIDIDYMIS; ENZYMES; MUSCLE; SEMEN; SERUM; MEN; DNA	The aim of the study was to demonstrate seasonal changes in the hydrolytic and transferase activity of neutral alpha-glucosidase, the level of glucose, cholesterol, triglycerides and total protein in the annual breeding cycle of the carp. The study was conducted on fish from a fish farm in Lower Silesia (Poland). Blood serum was collected from the heart in: June, September and December of two consecutive years. The results of the study show that the hydrolytic and transferase activity of neutral alpha-glucosidase, as well as the results of basic biochemical parameters are highest in summer, when the fish seek and intake food intensively. The lowest values were observed in spring, when carp have the lowest metabolism after the wintering period.	[Kotonska-Feiga, Julia; Dobicki, Wojciech; Pokorny, Przemyslaw] Wroclaw Univ Environm & Life Sci, Dept Hydrobiol & Aquaculture, Inst Biol, Wroclaw, Poland; [Nowacki, Wojciech] Wroclaw Univ Environm & Life Sci, Dept Immunol Pathophysiol & Vet Prevent Med, Wroclaw, Poland	Wroclaw University of Environmental & Life Sciences; Wroclaw University of Environmental & Life Sciences	Kotonska-Feiga, J (corresponding author), Wroclaw Univ Environm & Life Sci, Dept Internal Med, Wroclaw, Poland.	julia.kotonska-feiga@up.wroc.pl	Dobicki, Wojciech/S-8193-2016; Dobicki, Wojciech/T-3374-2019; Pokorny, Przemysław/A-1833-2017	Pokorny, Przemyslaw/0000-0002-3816-7848; Dobicki, Wojciech/0000-0003-4081-0537; Nowacki, Wojciech/0000-0002-8304-0686	Wroclaw Centre of Biotechnology; programme the Leading National Research Centre (KNOW)	Wroclaw Centre of Biotechnology; programme the Leading National Research Centre (KNOW)	Publication was supported by Wroclaw Centre of Biotechnology, programme the Leading National Research Centre (KNOW) for years 2014-2018. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayir Abdulkadir, 2007, Comparative Clinical Pathology, V16, P119, DOI 10.1007/s00580-006-0663-x; Chiba S, 1997, BIOSCI BIOTECH BIOCH, V61, P1233, DOI 10.1271/bbb.61.1233; Chiba S, 1988, HDB AMYLASES RELATED, P104; Elzanaty S, 2002, HUM REPROD, V17, P2904, DOI 10.1093/humrep/17.11.2904; Henkel R, 2006, J ANDROL, V27, P34, DOI 10.2164/jandrol.05064; Jan U, 2012, REP OPINION, V4, P1; KARPIAK S, 1977, ARCH IMMUNOL THER EX, V25, P199; KOTONSKI B, 1982, Polskie Archiwum Weterynaryjne, V23, P65; KOTONSKI B, 1986, FOLIA HISTOCHEM CYTO, V24, P15; KOTONSKI B, 1984, Polskie Archiwum Weterynaryjne, V24, P79; Levrant S, 2009, SYST BIOL REPROD MED, V55, P116, DOI 10.1080/19396360902801935; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MADEJ J M, 1991, Archivum Immunologiae et Therapiae Experimentalis, V39, P309; Mahmoud AM, 1998, HUM REPROD, V13, P591, DOI 10.1093/humrep/13.3.591; MARTINIUK F, 1981, BIOCHIM BIOPHYS ACTA, V658, P248, DOI 10.1016/0005-2744(81)90295-3; MELOTTI P, 1989, J APPL ICHTHYOL, V5, P74, DOI 10.1111/j.1439-0426.1989.tb00476.x; Nomenclature Committee of the International Union of Biochemistry and Molecular Biology (NC IUBMB), ENZ NOM REC NOM COMM; Patriche T., 2011, AACL Bioflux, V4, P137; Pena P, 2004, ANDROLOGIA, V36, P315, DOI 10.1111/j.1439-0272.2004.00625.x; Shimeno S, 1997, AQUACULTURE, V151, P371, DOI 10.1016/S0044-8486(96)01492-5; SOBIECH K A, 1986, Polskie Archiwum Weterynaryjne, V26, P49; Vivas-Acevedo G, 2014, BJU INT, V113, P642, DOI 10.1111/bju.12523; Watanabe M, 2009, ANDROLOGIA, V41, P316, DOI 10.1111/j.1439-0272.2009.00950.x; YEUNG CH, 1990, BIOL REPROD, V42, P669, DOI 10.1095/biolreprod42.4.669; Zopfgen A, 2000, HUM REPROD, V15, P840, DOI 10.1093/humrep/15.4.840	25	3	3	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142227	10.1371/journal.pone.0142227	http://dx.doi.org/10.1371/journal.pone.0142227			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559406	Green Submitted, gold, Green Published			2022-12-27	WOS:000364433100064
J	Ryan, EB; Fraser, D; Weary, DM				Ryan, E. B.; Fraser, D.; Weary, D. M.			Public Attitudes to Housing Systems for Pregnant Pigs	PLOS ONE			English	Article							MEAT QUALITY; MOTIVATION; BEHAVIOR; WELFARE; PERFORMANCE; INFORMATION; RESPONSES; ANIMALS	Understanding concerns about the welfare of farm animals is important for the development of socially sustainable production practices. This study used an online survey to test how views on group versus stall housing for pregnant sows varied when Canadian and US participants were provided information about these systems, including access to scientific papers, YouTube videos, Google images, and a frequently-asked-questions page (S1 Appendix). Initial responses and changes in responses after accessing the information were analyzed from Likert scores of 242 participants and from their written comments. Participants were less willing to accept the use of gestation stalls after viewing information on sow housing. For example, initially 30.4% of respondents indicated that they supported the use of gestation stalls; this declined to 17.8% after participants were provided additional information. Qualitative analysis of comments showed that supporters of gestation stalls expressed concern about the spread of disease and aggression between animals in less confined systems, whereas supporters of group housing placed more emphasis on the sow's ability to interact socially and perform natural behaviors. These results point to public opposition to the use of gestation stalls, and indicate that the more that the public learns about gestation stalls the less willing they will be to accept their use.	[Ryan, E. B.; Fraser, D.; Weary, D. M.] Univ British Columbia, Fac Land & Food Syst, Anim Welf Program, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Weary, DM (corresponding author), Univ British Columbia, Fac Land & Food Syst, Anim Welf Program, Vancouver, BC V5Z 1M9, Canada.	danweary@mail.ubc.ca	Weary, Daniel M/A-8868-2010	Weary, Daniel M/0000-0002-0917-3982	Mary and David Macaree Graduate Fellowship	Mary and David Macaree Graduate Fellowship	This project was funded by the Mary and David Macaree Graduate Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguinaldo JP, 2004, RETHINKING VALIDITY, V9, P127; Ahmad R., 2006, INTEGRATED ASSESSMEN, V6, P9; Appleby Mike., 1999, WHAT SHOULD WE DO AN; Boissy A, 2007, PHYSIOL BEHAV, V92, P375, DOI 10.1016/j.physbeh.2007.02.003; Boogaard BK, 2011, ANIMAL, V5, P1458, DOI 10.1017/S1751731111000371; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Coffey A, 1996, MAKING SENSE QUALITA; Croney CC, 2010, J ANIM SCI, V88, pE75, DOI 10.2527/jas.2009-2353; Danielson P, 2010, ETHICS INF TECHNOL, V12, P251, DOI 10.1007/s10676-009-9214-x; Elmore MRP, 2011, APPL ANIM BEHAV SCI, V133, P154, DOI 10.1016/j.applanim.2011.05.017; Frewer L., 2002, SCI PUBLIC POLICY, V29, P137, DOI DOI 10.3152/147154302781781092; Gonyou HW, 2005, JAVMA-J AM VET MED A, V226, P1336, DOI 10.2460/javma.2005.226.1336; Jonas E, 2001, J PERS SOC PSYCHOL, V80, P557, DOI 10.1037/0022-3514.80.4.557; Kanis E, 2003, J AGR ENVIRON ETHIC, V16, P137, DOI 10.1023/A:1022985913847; Kirkden RD, 2006, ANIM WELFARE, V15, P119; Kirkden RD, 2006, APPL ANIM BEHAV SCI, V100, P29, DOI 10.1016/j.applanim.2006.04.009; Krystallis A, 2009, LIVEST SCI, V126, P46, DOI 10.1016/j.livsci.2009.05.016; Lassen J, 2006, LIVEST SCI, V103, P221, DOI 10.1016/j.livsci.2006.05.008; Lemire M, 2008, INT J MED INFORM, V77, P723, DOI 10.1016/j.ijmedinf.2008.03.002; Millet S, 2005, J SCI FOOD AGR, V85, P709, DOI 10.1002/jsfa.2033; Moon A, 2012, INT J SOC ROBOT, V4, P77, DOI 10.1007/s12369-011-0120-0; Morrison RS, 2007, APPL ANIM BEHAV SCI, V103, P12, DOI 10.1016/j.applanim.2006.04.002; Noy C, 2008, INT J SOC RES METHOD, V11, P327, DOI 10.1080/13645570701401305; Onwuegbuzie A.J., 2009, INT J QUALITATIVE ME, V8, P1, DOI [10.1177/160940690900800301, DOI 10.1177/160940690900800301]; Pajor EA, 2005, JAVMA-J AM VET MED A, V226, P1340, DOI 10.2460/javma.2005.226.1340; Rhodes RT, 2005, JAVMA-J AM VET MED A, V227, P1580, DOI 10.2460/javma.2005.227.1580; Schuppli CA, 2014, J ANIM SCI, V92, P5185, DOI 10.2527/jas.2014-7725; Sorensen JT, 2010, LIVEST SCI, V131, P1, DOI 10.1016/j.livsci.2010.02.025; Tashakkori A, 2003, J MARKETING RES JMR; Tonsor G. T., 2009, Journal of Agricultural and Applied Economics, V41, P713; Tonsor GT, 2012, AM J AGR ECON, V94, P503, DOI 10.1093/ajae/aar078; Tversky B, 2002, INT J HUM-COMPUT ST, V57, P247, DOI 10.1006/ijhc.1017; Vanhonacker F, 2009, LIVEST SCI, V123, P16, DOI 10.1016/j.livsci.2008.09.023; Ventura BA, 2013, J DAIRY SCI, V96, P6105, DOI 10.3168/jds.2012-6040; Verbeke W, 1999, FOOD QUAL PREFER, V10, P437, DOI 10.1016/S0950-3293(99)00031-2; Weary DM, 2011, J ANIM SCI, V89, P3831, DOI 10.2527/jas.2011-3858	36	34	34	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0141878	10.1371/journal.pone.0141878	http://dx.doi.org/10.1371/journal.pone.0141878			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7DR	26559417	Green Published, Green Submitted, gold			2022-12-27	WOS:000364433100044
J	Deosarkar, SP; Prabhakarpandian, B; Wang, B; Sheffield, JB; Krynska, B; Kiani, MF				Deosarkar, Sudhir P.; Prabhakarpandian, Balabhaskar; Wang, Bin; Sheffield, Joel B.; Krynska, Barbara; Kiani, Mohammad F.			A Novel Dynamic Neonatal Blood-Brain Barrier on a Chip	PLOS ONE			English	Article							IN-VITRO MODEL; ENDOTHELIAL-CELLS; SHEAR-STRESS; ASTROCYTES INDUCE; PERMEABILITY; RAT; BBB; ADULT; PENETRATION; DISRUPTION	Studies of neonatal neural pathologies and development of appropriate therapeutics are hampered by a lack of relevant in vitro models of neonatal blood-brain barrier (BBB). To establish such a model, we have developed a novel blood-brain barrier on a chip ((BC)-C-3) that comprises a tissue compartment and vascular channels placed side-by-side mimicking the three-dimensional morphology, size and flow characteristics of microvessels in vivo. Rat brain endothelial cells (RBEC) isolated from neonatal rats were seeded in the vascular channels of (BC)-C-3 and maintained under shear flow conditions, while neonatal rat astrocytes were cultured under static conditions in the tissue compartment of the (BC)-C-3. RBEC formed continuous endothelial lining with a central lumen along the length of the vascular channels of (BC)-C-3 and exhibited tight junction formation, as measured by the expression of zonula occludens-1 (ZO-1). ZO-1 expression significantly increased with shear flow in the vascular channels and with the presence of astrocyte conditioned medium (ACM) or astrocytes cultured in the tissue compartment. Consistent with in vivo BBB, (BC)-C-3 allowed endfeet-like astrocyte-endothelial cell interactions through a porous interface that separates the tissue compartment containing cultured astrocytes from the cultured RBEC in the vascular channels. The permeability of fluorescent 40 kDa dextran from vascular channel to the tissue compartment significantly decreased when RBEC were cultured in the presence of astrocytes or ACM (from 41.0 +/- 0.9 x 10(-6) cm/s to 2.9 +/- 1.0 x 10(-6) cm/s or 1.1 +/- 0.4 x 10(-6) cm/s, respectively). Measurement of electrical resistance in (BC)-C-3 further supports that the addition of ACM significantly improves the barrier function in neonatal RBEC. Moreover, (BC)-C-3 exhibits significantly improved barrier characteristics compared to the transwell model and (BC)-C-3 permeability was not significantly different from the in vivo BBB permeability in neonatal rats. In summary, we developed a first dynamic in vitro neonatal BBB on a chip ((BC)-C-3) that closely mimics the in vivo microenvironment, offers the flexibility of real time analysis, and is suitable for studies of BBB function as well as screening of novel therapeutics.	[Deosarkar, Sudhir P.; Wang, Bin; Kiani, Mohammad F.] Temple Univ, Dept Mech Engn, Philadelphia, PA 19122 USA; [Prabhakarpandian, Balabhaskar] CFD Res Corp, Biomed Technol, Huntsville, AL 35806 USA; [Wang, Bin] Widener Univ, Dept Biomed Engn, Chester, PA 19013 USA; [Sheffield, Joel B.] Temple Univ, Dept Biol, Philadelphia, PA 19122 USA; [Krynska, Barbara; Kiani, Mohammad F.] Temple Univ, Shriners Hosp Pediat Res Ctr, Sch Med, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; CFD Research Corporation; Widener University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Shriners Hospitals Children Philadelphia	Kiani, MF (corresponding author), Temple Univ, Dept Mech Engn, Philadelphia, PA 19122 USA.	mkiani@temple.edu			Oak Ridge National Laboratory by the Scientific User Facilities Division, Office of Basic Energy Sciences, U.S. Department of Energy	Oak Ridge National Laboratory by the Scientific User Facilities Division, Office of Basic Energy Sciences, U.S. Department of Energy(United States Department of Energy (DOE))	A portion of this research was conducted at the Center for Nanophase Materials Sciences, which is sponsored at Oak Ridge National Laboratory by the Scientific User Facilities Division, Office of Basic Energy Sciences, U.S. Department of Energy.	Abbott NJ, 2012, METHODS MOL BIOL, V814, P415, DOI 10.1007/978-1-61779-452-0_28; Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Arya V, 2006, DRUG METAB DISPOS, V34, P939, DOI 10.1124/dmd.105.007419; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Booth R, 2012, LAB CHIP, V12, P1784, DOI 10.1039/c2lc40094d; Bueter W, 2010, INT J DEV NEUROSCI, V28, P411, DOI 10.1016/j.ijdevneu.2010.04.006; Cecchelli R, 2007, NAT REV DRUG DISCOV, V6, P650, DOI 10.1038/nrd2368; COOMBER BL, 1985, MICROVASC RES, V30, P99, DOI 10.1016/0026-2862(85)90042-1; Cucullo L, 2005, CURR OPIN DRUG DISC, V8, P89; Cucullo L, 2002, BRAIN RES, V951, P243, DOI 10.1016/S0006-8993(02)03167-0; Cucullo L, 2007, EPILEPSIA, V48, P505, DOI 10.1111/j.1528-1167.2006.00960.x; Cucullo L, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-40; Cucullo L, 2011, J CEREBR BLOOD F MET, V31, P767, DOI 10.1038/jcbfm.2010.162; Deli MA, 2005, CELL MOL NEUROBIOL, V25, P59, DOI 10.1007/s10571-004-1377-8; Fernandez-Lopez D, 2012, J NEUROSCI, V32, P9588, DOI 10.1523/JNEUROSCI.5977-11.2012; Griep LM, 2013, BIOMED MICRODEVICES, V15, P145, DOI 10.1007/s10544-012-9699-7; He YR, 2014, STROKE, V45, P2514, DOI 10.1161/STROKEAHA.114.005427; Hellinger E, 2012, EUR J PHARM BIOPHARM, V82, P340, DOI 10.1016/j.ejpb.2012.07.020; Helms HC, 2014, METHODS MOL BIOL, V1135, P365, DOI 10.1007/978-1-4939-0320-7_30; JANZER RC, 1987, NATURE, V325, P253, DOI 10.1038/325253a0; Kniesel U, 2000, CELL MOL NEUROBIOL, V20, P57, DOI 10.1023/A:1006995910836; Kuchler-Bopp S, 1999, NEUROREPORT, V10, P1347, DOI 10.1097/00001756-199904260-00035; Lamberti G, 2014, ANAL CHEM, V86, P8344, DOI 10.1021/ac5018716; Liu WY, 2015, CNS NEUROSCI THER, V21, P568, DOI 10.1111/cns.12405; MAYHAN WG, 1985, AM J PHYSIOL, V248, pH712, DOI 10.1152/ajpheart.1985.248.5.H712; Mooradian AD, 2003, MECH AGEING DEV, V124, P143, DOI 10.1016/S0047-6374(02)00041-6; Muramatsu K, 1997, STROKE, V28, P2281, DOI 10.1161/01.STR.28.11.2281; Nakagawa S, 2009, NEUROCHEM INT, V54, P253, DOI 10.1016/j.neuint.2008.12.002; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Pardridge William M, 2005, NeuroRx, V2, P3; Pardridge WM, 2005, MOL BIOTECHNOL, V30, P57, DOI 10.1385/MB:30:1:057; Perriere N, 2005, J NEUROCHEM, V93, P279, DOI 10.1111/j.1471-4159.2004.03020.x; Persidsky Y, 2006, J NEUROIMMUNE PHARM, V1, P223, DOI 10.1007/s11481-006-9025-3; Prabhakarpandian B, 2013, LAB CHIP, V13, P1093, DOI 10.1039/c2lc41208j; Redzic Z, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-3; Rosas-Hernandez H, 2015, NEUROSCIENCE, V301, P61, DOI 10.1016/j.neuroscience.2015.05.066; Santaguida S, 2006, BRAIN RES, V1109, P1, DOI 10.1016/j.brainres.2006.06.027; Saunders NR, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00046; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Siddharthan V, 2007, BRAIN RES, V1147, P39, DOI 10.1016/j.brainres.2007.02.029; Stewart PA, 2000, CELL MOL NEUROBIOL, V20, P149, DOI 10.1023/A:1007026504843; Takata F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055166; Takeshita Y, 2014, J NEUROSCI METH, V232, P165, DOI 10.1016/j.jneumeth.2014.05.013; Watson PMD, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-59; Weiss N, 2009, BBA-BIOMEMBRANES, V1788, P842, DOI 10.1016/j.bbamem.2008.10.022; Wuest DM, 2013, J NEUROSCI METH, V212, P211, DOI 10.1016/j.jneumeth.2012.10.016; Yoon BH, 2000, AM J OBSTET GYNECOL, V182, P675, DOI 10.1067/mob.2000.104207; Yuan H, 2003, BRAIN RES, V969, P59, DOI 10.1016/S0006-8993(03)02278-9	48	116	119	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142725	10.1371/journal.pone.0142725	http://dx.doi.org/10.1371/journal.pone.0142725			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555149	Green Published, gold, Green Submitted			2022-12-27	WOS:000364430700160
J	Huang, YK; Yu, JC; Kang, WM; Ma, ZQ; Ye, X; Tian, SB; Yan, C				Huang, Ya-kai; Yu, Jian-chun; Kang, Wei-ming; Ma, Zhi-qiang; Ye, Xin; Tian, Shu-bo; Yan, Chao			Significance of Serum Pepsinogens as a Biomarker for Gastric Cancer and Atrophic Gastritis Screening: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							HELICOBACTER-PYLORI; TURBIDIMETRIC IMMUNOASSAY; I/II RATIO; FOLLOW-UP; HIGH-RISK; DIAGNOSIS; ACCURACY; MARKERS; TESTS; ADENOCARCINOMA	Background Human pepsinogens are considered promising serological biomarkers for the screening of atrophic gastritis (AG) and gastric cancer (GC). However, there has been controversy in the literature with respect to the validity of serum pepsinogen (SPG) for the detection of GC and AG. Consequently, we conducted a systematic review and meta-analysis to assess the diagnostic accuracy of SPG in GC and AG detection. Methods We searched PubMed, Embase, and the Chinese National Knowledge Infrastructure (CNKI) for correlative original studies published up to September 30, 2014. The summary sensitivity, specificity, positive diagnostic likelihood ratio (DLR+), negative diagnostic likelihood ratio (DLR-), area under the summary receiver operating characteristic curve (AUC) and diagnostic odds ratio (DOR) were used to evaluate SPG in GC and AG screening based on bivariate random effects models. The inter-study heterogeneity was evaluated by the I-2 statistics and publication bias was assessed using Begg and Mazumdar's test. Meta-regression and subgroup analyses were performed to explore study heterogeneity. Results In total, 31 studies involving 1,520 GC patients and 2,265 AG patients were included in the meta-analysis. The summary sensitivity, specificity, DLR+, DLR-, AUC and DOR for GC screening using SPG were 0.69 (95% CI: 0.60-0.76), 0.73 (95% CI: 0.62-0.82), 2.57 (95% CI: 1.82-3.62), and 0.43 (95% CI: 0.34-0.54), 0.76 (95% CI: 0.72-0.80) and 6.01 (95% CI: 3.69-9.79), respectively. For AG screening, the summary sensitivity, specificity, DLR+, DLR-, AUC and DOR were 0.69 (95% CI: 0.55-0.80), 0.88 (95% CI: 0.77-0.94), 5.80 (95% CI: 3.06-10.99), and 0.35 (95% CI: 0.24-0.51), 0.85 (95% CI: 0.82-0.88) and 16.50 (95% CI: 8.18-33.28), respectively. In subgroup analysis, the use of combination of concentration of PGI and the ratio of PGI:PGII as measurement of SPG for GC screening yielded sensitivity of 0.70 (95% CI: 0.66-0.75), specificity of 0.79 (95% CI: 0.79-0.80), DOR of 6.92 (95% CI: 4.36-11.00), and AUC of 0.78 (95% CI: 0.72-0.81), while the use of concentration of PGI yielded sensitivity of 0.55 (95% CI: 0.51-0.60), specificity of 0.79 (95% CI: 0.76-0.82), DOR of 6.88 (95% CI: 2.30-20.60), and AUC of 0.77 (95% CI: 0.73-0.92). For AG screening, the use of ratio of PGI:PGII as measurement of SPG yielded sensitivity of 0.69 (95% CI: 0.52-0.83), specificity of 0.84 (95% CI: 0.68-0.93), DOR of 11.51 (95% CI: 6.14-21.56), and AUC of 0.83 (95% CI: 0.80-0.86), the use of combination of concentration of PGI and the ratio of PGI:PGII yield sensitivity of 0.79 (95% CI: 0.72-0.85), specificity of 0.89 (95% CI: 0.85-0.93), DOR of 24.64 (95% CI: 6.95-87.37), and AUC of 0.87 (95% CI: 0.81-0.92), concurrently, the use of concentration of PGI yield sensitivity of 0.46 (95% CI: 0.38-0.54), specificity of 0.93 (95% CI: 0.91-0.95), DOR of 19.86 (95% CI: 0.86-456.91), and AUC of 0.86 (95% CI: 0.52-1.00). Conclusion SPG has great potential as a noninvasive, population-based screening tool in GC and AG screening. In addition, given the potential publication bias and high heterogeneity of the included studies, further high quality studies are required in the future.	[Yu, Jian-chun] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Gen Surg, Beijing 100730, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Yu, JC (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Gen Surg, Beijing 100730, Peoples R China.	yjcpumch@126.com		Kang, Weiming/0000-0002-6736-4728	Beijing Municipal Natural Science Foundation of China [7132209]	Beijing Municipal Natural Science Foundation of China	The present study was financially supported by Beijing Municipal Natural Science Foundation of China (No. 7132209; http://www.bjnsf.org/nsf_xmsq/nsf_zzxm/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agkoc M, 2010, EURASIAN J MED, V42, P15, DOI 10.5152/eajm.2010.05; Aikou S, 2011, GASTROENTEROLOGY, V141, P837, DOI 10.1053/j.gastro.2011.05.040; Aoki K, 1997, J Epidemiol, V7, P143; Aulia Diana, 2009, Acta Med Indones, V41, P107; Bowden J, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-41; Broutet N, 2003, BRIT J CANCER, V88, P1239, DOI 10.1038/sj.bjc.6600877; Chae H, 2008, KOREAN J LAB MED, V28, P201, DOI 10.3343/kjlm.2008.28.3.201; CHANG FY, 1992, SCAND J GASTROENTERO, V27, P884, DOI 10.3109/00365529209000158; Choi IJ, 2014, CLIN ENDOSC, V47, P497, DOI 10.5946/ce.2014.47.6.497; CORREA P, 1992, CANCER RES, V52, P6735; Correa Pelayo, 2004, Gastric Cancer, V7, P9, DOI 10.1007/s10120-003-0265-0; de Vries AC, 2007, HELICOBACTER, V12, P1, DOI 10.1111/j.1523-5378.2007.00541.x; Dinis-Ribeiro M, 2004, NEOPLASIA, V6, P449, DOI 10.1593/neo.03505; Du Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104936; Graham DY, 2006, CLIN GASTROENTEROL H, V4, P306, DOI 10.1016/j.cgh.2005.11.003; Haneda M, 2013, J GASTROEN HEPATOL, V28, P78, DOI 10.1111/j.1440-1746.2012.07285.x; He CY, 2011, J GASTROEN HEPATOL, V26, P1039, DOI 10.1111/j.1440-1746.2011.06692.x; Huang M, 2014, J CLIN PATHOL, V67, P350, DOI 10.1136/jclinpath-2013-201942; Huang YK, 2015, WORLD J GASTROENTERO, V21, P9863, DOI 10.3748/wjg.v21.i34.9863; Huang ZG, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-74; Iijima K, 2009, WORLD J GASTROENTERO, V15, P853, DOI 10.3748/wjg.15.853; Inoue H, 1998, CANCER EPIDEM BIOMAR, V7, P261; Kang JM, 2008, HELICOBACTER, V13, P146, DOI 10.1111/j.1523-5378.2008.00592.x; KEKKI M, 1991, SCAND J GASTROENTERO, V26, P109, DOI 10.3109/00365529109103997; Kikuchi R, 2011, TOHOKU J EXP MED, V223, P35, DOI 10.1620/tjem.223.35; Kitahara F, 1999, GUT, V44, P693, DOI 10.1136/gut.44.5.693; Leeflang MMG, 2014, CLIN MICROBIOL INFEC, V20, P105, DOI 10.1111/1469-0691.12474; Ley C, 2001, CANCER EPIDEM BIOMAR, V10, P107; Lin F, 2014, EXPERT REV PROTEOMIC, V11, P515, DOI 10.1586/14789450.2014.904751; Liu DN, 2013, GASTRIC CANCER, V16, P498, DOI 10.1007/s10120-013-0232-3; Lomba-Viana R, 2012, EUR J GASTROEN HEPAT, V24, P37, DOI 10.1097/MEG.0b013e32834d0a0a; McNicholl AG, 2014, EUR J GASTROEN HEPAT, V26, P941, DOI 10.1097/MEG.0000000000000132; Miki K, 2007, J DIGEST DIS, V8, P8, DOI 10.1111/j.1443-9573.2007.00278.x; Mizuno S, 2009, GASTRIC CANCER, V12, P158, DOI 10.1007/s10120-009-0522-y; Mukoubayashi C, 2007, INTERNAL MED, V46, P261, DOI 10.2169/internalmedicine.46.6181; Nardone G, 2005, ALIMENT PHARM THER, V22, P1139, DOI 10.1111/j.1365-2036.2005.02734.x; Nashimoto A, 2003, J CLIN ONCOL, V21, P2282, DOI 10.1200/JCO.2003.06.103; Nasrollahzadeh D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026957; Nomura AMY, 2005, J INFECT DIS, V191, P2075, DOI 10.1086/430353; Oksanen A, 2000, SCAND J GASTROENTERO, V35, P791; PALS G, 1987, SCAND J CLIN LAB INV, V47, P29; Park CH, 2016, GASTRIC CANCER, V19, P128, DOI 10.1007/s10120-015-0473-4; Pasechnikov V, 2014, WORLD J GASTROENTERO, V20, P13842, DOI 10.3748/wjg.v20.i38.13842; Penno MAS, 2012, J PROTEOMICS, V77, P40, DOI 10.1016/j.jprot.2012.07.002; Sadjadi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074440; SAMLOFF IM, 1971, J IMMUNOL, V106, P962; SAMLOFF IM, 1982, GASTROENTEROLOGY, V83, P204; Shikata K, 2012, SCAND J GASTROENTERO, V47, P669, DOI 10.3109/00365521.2012.658855; Shin Hai-Rim, 2005, Cancer Res Treat, V37, P325, DOI 10.4143/crt.2005.37.6.325; Sierra R, 2006, CLIN EXP MED, V6, P72, DOI 10.1007/s10238-006-0098-3; SITAS F, 1993, CANCER EPIDEM BIOMAR, V2, P119; Suzuki H, 2004, HEPATO-GASTROENTEROL, V51, P1249; Syrjanen KJ, 2015, EUR J GASTROEN HEPAT, V27, P102, DOI 10.1097/MEG.0000000000000215; THAKKAR H, 1991, CLIN CHEM, V37, P1248; Tian SB, 2014, ASIAN PAC J CANCER P, V15, P6295, DOI 10.7314/APJCP.2014.15.15.6295; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Wang KN, 2016, GUT, V65, P1619, DOI 10.1136/gutjnl-2015-309276; Wu Kai Chun, 2004, Chin J Dig Dis, V5, P22; Yang SK, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-452; Yeh JM, 2016, GUT, V65, P563, DOI 10.1136/gutjnl-2014-308588; Yoshihara M, 1998, AM J GASTROENTEROL, V93, P1090; Yu ZL, 2008, CHINESE J DIGESTIVE, V25, P512, DOI [10.3760/cma.j.issn.1007-5232.2008.10.003, DOI 10.3760/CMA.J.ISSN.1007-5232.2008.10.003]; Zamora Javier, 2006, BMC Med Res Methodol, V6, P31, DOI 10.1186/1471-2288-6-31; Zeng ZY, 2014, CLIN EXP MED, V14, P337, DOI 10.1007/s10238-013-0246-5; Zhang XM, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-3; Zoalfaghari Abbas, 2014, Med J Islam Repub Iran, V28, P150; 黄语嫣, 2013, [中华内科杂志, Chinese Journal of Internal Medicine], V52, P332	67	115	133	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142080	10.1371/journal.pone.0142080	http://dx.doi.org/10.1371/journal.pone.0142080			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556485	Green Published, Green Submitted, gold			2022-12-27	WOS:000364430700050
J	Li, FF; Han, Y; Shi, SA; Li, X; Zhu, XD; Zhou, J; Shao, QL; Li, XQ; Liu, SL				Li, Fei-Feng; Han, Ying; Shi, Shuai; Li, Xia; Zhu, Xi-Dong; Zhou, Jing; Shao, Qing-Liang; Li, Xue-Qi; Liu, Shu-Lin			Characterization of Transcriptional Repressor Gene MSX1 Variations for Possible Associations with Congenital Heart Diseases	PLOS ONE			English	Article							CARDIAC NEURAL CREST; OUTFLOW TRACT; CELL-DIFFERENTIATION; SURVIVAL; DEFECTS; MICROENVIRONMENT; OSTEOARTHRITIS; PROLIFERATION; POLYMORPHISM; POPULATION	Background The human heart consists of several cell types with distinct lineage origins. Interactions between these cardiac progenitors are very important for heart formation. The muscle segment homeobox gene family plays a key role in the cell morphogenesis and growth, controlled cellular proliferation, differentiation, and apoptosis, but the relationships between the genetic abnormalities and CHD phenotypes still remain largely unknown. The aim of this work was to evaluate variations in MSX1 and MSX2 for their possible associations with CHD. Methods We sequenced the MSX1 and MSX2 genes for 300 Chinese Han CHD patients and 400 normal controls and identified the variations. The statistical analyses were conducted using Chi-Square Tests as implemented in SPSS (version 19.0). The Hardy-Weinberg equilibrium test of the population was carried out using the online software OEGE. Results Six variations rs4647952, rs2048152, rs4242182, rs61739543, rs111542301 and rs3087539 were identified in the MSX2 gene, but the genetic heterozygosity of those SNPs was very low. In contrast, the genetic heterozygosity of two variations rs3821949 near the 5'UTR and rs12532 within 3'UTR of the MSX1 gene was considerably high. Statistical analyses showed that rs3821949 and rs12532 were associated with the risk of CHD (specifically VSD). Conclusions The SNPs rs3821949 and rs12532 in the MSX1 gene were associated with CHD in Chinese Han populations.	[Li, Fei-Feng; Li, Xia; Liu, Shu-Lin] Harbin Med Univ, Genom Res Ctr, State Prov Key Lab Biopharmaceut Engn, Harbin, Peoples R China; [Li, Fei-Feng; Liu, Shu-Lin] Heilongjiang Acad Med Sci, Translat Med Res & Cooperat Ctr Northern China, Wuchang, Heilongjiang, Peoples R China; [Han, Ying; Shi, Shuai; Li, Xue-Qi] Harbin Med Univ, Affiliated Hosp 4, Dept Cardiol, Harbin, Peoples R China; [Zhu, Xi-Dong] Harbin Med Univ, Affiliated Hosp 2, Dept Neurol, Harbin, Peoples R China; [Zhou, Jing] Harbin Med Univ, Affiliated Hosp 2, Intens Care Unit, Harbin, Peoples R China; [Shao, Qing-Liang] Harbin Med Univ, Affiliated Hosp 2, Dept Neonatal, Harbin, Peoples R China; [Liu, Shu-Lin] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada	Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University; University of Calgary	Li, XQ (corresponding author), Harbin Med Univ, Affiliated Hosp 4, Dept Cardiol, Harbin, Peoples R China.	Lixueqi@medmail.com.cn; slliu@ucalgary.ca			Heilongjiang Innovation Research Foundation for Graduate Studies [YJSCX2014-10HYD]; National Natural Science Foundation of China [NSFC81271786, 81110378, 30970119, 81030029]	Heilongjiang Innovation Research Foundation for Graduate Studies; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from Heilongjiang Innovation Research Foundation for Graduate Studies (YJSCX2014-10HYD), and grants of National Natural Science Foundation of China (NSFC81271786, 81110378, 30970119, 81030029) to SLL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbosky L, 2006, DEV DYNAM, V235, P2592, DOI 10.1002/dvdy.20885; Belinsky GS, 2013, STEM CELLS DEV, V22, P1522, DOI 10.1089/scd.2012.0150; Bruneau BG, 2008, NATURE, V451, P943, DOI 10.1038/nature06801; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Chan AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056831; CHANTHOMAS PS, 1993, DEV DYNAM, V197, P203, DOI 10.1002/aja.1001970305; Chen SG, 2010, BIOCHEM BIOPH RES CO, V391, P552, DOI 10.1016/j.bbrc.2009.11.096; Chen YH, 2007, DEV BIOL, V308, P421, DOI 10.1016/j.ydbio.2007.05.037; Cheng G, 1999, DEVELOPMENT, V126, P5041; Cheong HS, 2010, BMB REP, V43, P830, DOI 10.5483/BMBRep.2010.43.12.830; Christensen BC, 2009, CARCINOGENESIS, V30, P1003, DOI 10.1093/carcin/bgp099; Costa FF, 2009, EPIGENOMICS-UK, V1, P387, DOI 10.2217/EPI.09.25; Deng X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104535; Dvash T, 2007, STEM CELLS, V25, P465, DOI 10.1634/stemcells.2006-0179; Fujimuro T, 2014, SCI REP-UK, V4, DOI 10.1038/srep06462; Han J, 2007, MECH DEVELOP, V124, P729, DOI 10.1016/j.mod.2007.06.006; Hoffman JIE, 2004, AM HEART J, V147, P425, DOI 10.1016/j.ahj.2003.05.003; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Ishii M, 2005, DEVELOPMENT, V132, P4937, DOI 10.1242/dev.02072; Jiang LY, 2013, RHEUMATOL INT, V33, P1763, DOI 10.1007/s00296-012-2593-z; Kebed KY, 2014, MAYO CLIN PROC, V89, P1143, DOI 10.1016/j.mayocp.2014.04.024; Kimura M, 2014, EUR J ORAL SCI, V122, P15, DOI 10.1111/eos.12105; Li FF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131542; Lo CW, 1999, TRENDS CARDIOVAS MED, V9, P63, DOI 10.1016/S1050-1738(99)00015-8; Lou F, 2014, EUR REV MED PHARMACO, V18, P2444; Malchenko S, 2010, J CELL PHYSIOL, V225, P390, DOI 10.1002/jcp.22280; Miller KA, 2008, DEV BIOL, V317, P686, DOI 10.1016/j.ydbio.2008.02.016; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; Pierpont ME, 2007, CIRCULATION, V115, P3015, DOI 10.1161/CIRCULATIONAHA.106.183056; Postovit LM, 2008, P NATL ACAD SCI USA, V105, P4329, DOI 10.1073/pnas.0800467105; Richards AA, 2010, CURR CARDIOL REV, V6, P91, DOI 10.2174/157340310791162703; SATOKATA I, 1994, NAT GENET, V6, P348, DOI 10.1038/ng0494-348; Satokata I, 2000, NAT GENET, V24, P391, DOI 10.1038/74231; Schuldiner M, 2003, METHOD ENZYMOL, V365, P446; Souza LT, 2013, BRAZ J MED BIOL RES, V46, P555, DOI 10.1590/1414-431X20133054; Tabibzadeh S, 2006, STEM CELLS, V24, P1998, DOI 10.1634/stemcells.2006-0075; Tan ZX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036590; Tosetto E, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-41; van de Laar IMBH, 2011, NAT GENET, V43, P121, DOI 10.1038/ng.744; van der Bom T, 2011, NAT REV CARDIOL, V8, P50, DOI 10.1038/nrcardio.2010.166; van der Linde D, 2012, J AM COLL CARDIOL, V60, P397, DOI 10.1016/j.jacc.2011.12.052; van Driel LMJW, 2008, EUR HEART J, V29, P1424, DOI 10.1093/eurheartj/ehn170; van Weerd JH, 2011, CARDIOVASC RES, V91, P203, DOI 10.1093/cvr/cvr138; Vorotnikova E, 2010, MATRIX BIOL, V29, P690, DOI 10.1016/j.matbio.2010.08.007; Ward C, 2005, DEV BIOL, V284, P72, DOI 10.1016/j.ydbio.2005.05.003; Yelbuz TM, 2002, CIRCULATION, V106, P504, DOI 10.1161/01.CIR.0000023044.44974.8A	46	5	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142666	10.1371/journal.pone.0142666	http://dx.doi.org/10.1371/journal.pone.0142666			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556783	gold, Green Published, Green Submitted			2022-12-27	WOS:000364430700153
J	Lim, JU; Yeo, CD; Rhee, CK; Kim, YH; Park, CK; Kim, JS; Kim, JW; Lee, SH; Kim, SJ; Yoon, HK; Kim, TJ; Lee, KY				Lim, Jeong Uk; Yeo, Chang Dong; Rhee, Chin Kook; Kim, Yong Hyun; Park, Chan Kwon; Kim, Ju Sang; Kim, Jin Woo; Lee, Sang Haak; Kim, Seung Joon; Yoon, Hyoung Kyu; Kim, Tae-Jung; Lee, Kyo Young			Chronic Obstructive Pulmonary Disease-Related Non-Small-Cell Lung Cancer Exhibits a Low Prevalence of EGFR and ALK Driver Mutations	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; TYROSINE KINASE INHIBITORS; COPD; GEFITINIB; ADENOCARCINOMA; IMPACT; NSCLC; GENE; IDENTIFICATION; ASSOCIATION	Lung cancer and chronic obstructive pulmonary disease (COPD) are two major lung diseases. Epidermal growth factor receptor (EGFR) mutations, v-Ki-ras2 Kirsten rat sarcoma (KRAS) mutations and anaplastic lymphoma kinase (ALK) gene rearrangements represent driver mutations that are frequently assessed on initial evaluation of non-small-cell lung cancer (NSCLC). The present study focused on the expression of driver mutations in NSCLC patients presenting with COPD and further evaluated the association between NSCLC and COPD. Data from 501 consecutive patients with histologically proven recurrent or metastatic NSCLC were analyzed retrospectively. The patients underwent spirometry and geno-typing of EGFR, ALK, and KRAS in tissue samples. Patient characteristics and expression of driver mutations were compared between the COPD and non-COPD groups. Among 350 patients with spirometric results, 106 (30.3%) were diagnosed with COPD, 108 (30.9%) had EGFR mutations, 31 (8.9%) had KRAS mutations, and 34 (9.7%) showed ALK rearrangements. COPD was independently associated with lower prevalences of EGFR mutations (95% confidence interval [CI], 0.254-0.931, p = 0.029) and ALK rearrangements (95% CI, 0.065-0.600, p = 0.004). The proportions of EGFR mutations and ALK rearrangements decreased as the severity of airflow obstruction increased (p = 0.001). In never smokers, the prevalence of EGFR mutations was significantly lower in the COPD group than in the non-COPD group (12.7% vs. 49.0%, p = 0.002). COPD-related NSCLC patients exhibited low prevalences of EGFR mutations and ALK rearrangements compared with the non-COPD group. Further studies are required regarding the molecular mechanisms underlying lung cancer associated with COPD.	[Lim, Jeong Uk; Yeo, Chang Dong; Rhee, Chin Kook; Kim, Yong Hyun; Park, Chan Kwon; Kim, Ju Sang; Kim, Jin Woo; Lee, Sang Haak; Kim, Seung Joon; Yoon, Hyoung Kyu] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Pulmonol, Seoul, South Korea; [Kim, Tae-Jung; Lee, Kyo Young] Catholic Univ Korea, Coll Med, Dept Hosp Pathol, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea	Kim, JW (corresponding author), Catholic Univ Korea, Coll Med, Dept Internal Med, Div Pulmonol, Seoul, South Korea.	medkjw@catholikc.ac.kr	Rhee, Chin Kook/P-8885-2018; Lim, Jeong Uk/AAI-7281-2020; KIM, JUSANG/AAB-3748-2019	Rhee, Chin Kook/0000-0003-4533-7937; Lim, Jeong Uk/0000-0001-8364-2380; KIM, JUSANG/0000-0002-4433-231X				Adcock IM, 2011, RESPIRATION, V81, P265, DOI 10.1159/000324601; Arteaga CL, 2002, SEMIN ONCOL, V29, P3, DOI 10.1053/sonc.2002.35642; Cerda S, 1997, MUTAT RES-REV MUTAT, V386, P141, DOI 10.1016/S1383-5742(96)00050-6; de Torres JP, 2011, AM J RESP CRIT CARE, V184, P913, DOI 10.1164/rccm.201103-0430OC; De-Torres JP, 2015, AM J RESP CRIT CARE, V191, P285, DOI 10.1164/rccm.201407-1210OC; Dialyna IA, 2003, ONCOL REP, V10, P1829; Fukuchi Y, 2004, RESPIROLOGY, V9, P458, DOI 10.1111/j.1440-1843.2004.00637.x; Gazdar AF, 2004, TRENDS MOL MED, V10, P481, DOI 10.1016/j.molmed.2004.08.008; Gridelli C, 2014, CANCER TREAT REV, V40, P300, DOI 10.1016/j.ctrv.2013.07.002; Hashimoto N, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-14; Hohberger LA, 2014, J THORAC ONCOL, V9, P639, DOI 10.1097/JTO.0000000000000144; Houghton AM, 2008, NAT MED, V14, P1023, DOI 10.1038/nm1008-1023; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kim HR, 2014, LUNG CANCER, V83, P374, DOI 10.1016/j.lungcan.2013.12.011; Kim TJ, 2014, J SURG ONCOL, V110, P245, DOI 10.1002/jso.23646; Lapperre TS, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-85; Leighl NB, 2014, J CLIN ONCOL, V32, P3673, DOI 10.1200/JCO.2014.57.3055; Li Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052093; Loganathan RS, 2006, CHEST, V129, P1305, DOI 10.1378/chest.129.5.1305; Lopez-Encuentra A, 2005, EUR J CARDIO-THORAC, V27, P8, DOI 10.1016/j.ejcts.2004.09.010; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maeda R, 2011, J THORAC ONCOL, V6, P735, DOI 10.1097/JTO.0b013e318208e963; Maki-Nevala S, 2014, J THORAC ONCOL, V9, P886, DOI 10.1097/JTO.0000000000000132; Miller VA, 2004, J CLIN ONCOL, V22, P1103, DOI 10.1200/JCO.2004.08.158; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Roberts PJ, 2013, J CLIN ONCOL, V31, P1112, DOI 10.1200/JCO.2012.43.0454; Scagliotti GV, 2004, CLIN CANCER RES, V10, p4227S, DOI 10.1158/1078-0432.CCR-040007; Schiavon M, 2014, LUNG CANCER, V86, P311, DOI 10.1016/j.lungcan.2014.10.004; Sekine Y, 2002, LUNG CANCER-J IASLC, V37, P95, DOI 10.1016/S0169-5002(02)00014-4; Sekine Y, 2012, EUR RESPIR J, V39, P1230, DOI 10.1183/09031936.00126011; Shigematsu H, 2005, JNCI-J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; SKILLRUD DM, 1986, ANN INTERN MED, V105, P503, DOI 10.7326/0003-4819-105-4-503; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Suzuki M, 2010, ANN SURG ONCOL, V17, P878, DOI 10.1245/s10434-009-0739-3; Takiguchi Y, 2014, WORLD J CLIN ONCOL, V5, P660, DOI 10.5306/wjco.v5.i4.660; Tsao AS, 2006, J THORAC ONCOL, V1, P231, DOI 10.1016/S1556-0864(15)31573-2; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Wilson DO, 2008, AM J RESP CRIT CARE, V178, P738, DOI 10.1164/rccm.200803-435OC; Yeo CD, 2013, LUNG CANCER, V81, P207, DOI 10.1016/j.lungcan.2013.04.023	41	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142306	10.1371/journal.pone.0142306	http://dx.doi.org/10.1371/journal.pone.0142306			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555338	gold, Green Published, Green Submitted			2022-12-27	WOS:000364430700082
J	Park, GT; Sundaramoorthy, J; Lee, JD; Kim, JH; Seo, HS; Song, JT				Park, Gyu Tae; Sundaramoorthy, Jagadeesh; Lee, Jeong-Dong; Kim, Jeong Hoe; Seo, Hak Soo; Song, Jong Tae			Elucidation of Molecular Identity of the W3 Locus and Its Implication in Determination of Flower Colors in Soybean	PLoS One			English	Article							MYB TRANSCRIPTION FACTOR; CIS-REGULATORY ELEMENTS; PURPLE-BLUE FLOWER; GENE-EXPRESSION; SYNTHASE; PIGMENTATION; EVOLUTION; PROMOTER; MUTATION; SEED	The wide range of flower colors in soybean is controlled by six independent loci (W1, W2, W3, W4, Wm, and Wp). Among these loci, mutations in the W3 locus under the w4 allelic background (i.e., w3w4) produce near-white flowers, while the W3w4 genotype produces purple throat flowers. Although a gene encoding dihydroflavonol 4-reductase, DFR1, has been known to be closely associated with the W3 locus, its molecular identity has not yet been characterized. In the present study, we aimed to determine whether DFR1 is responsible for allelic variations in the W3 locus. On the basis of the sequence of a DFR probe, Glyma. 14G072700 was identified as a candidate gene for DFR1, and nucleotide sequences of Glyma. 14G072700 from cultivars with previously validated genotypes for the W3 locus were determined. As a result, a number of nucleotide polymorphisms, mainly single-base substitutions, between both coding and 50-upstream region sequences of the W3 and w3 alleles were identified. Among them, an indel of 311-bp in the 50-upstream region was noteworthy, since the Glyma. 14G072700 in all the w3 alleles examined contained the indel, whereas that in all the W3 alleles did not; the former was barely expressed, but the latter was well expressed. These results suggest that Glyma. 14G072700 is likely to correspond to DFR1 for the W3 locus and that its expression patterns may lead to allelic color phenotypes of W3 and w3 alleles under the w4 allelic background.	[Park, Gyu Tae; Sundaramoorthy, Jagadeesh; Lee, Jeong-Dong; Song, Jong Tae] Kyungpook Natl Univ, Sch Appl Biosci, Daegu, South Korea; [Kim, Jeong Hoe] Kyungpook Natl Univ, Dept Biol, Daegu, South Korea; [Seo, Hak Soo] Seoul Natl Univ, Dept Plant Biosci, Seoul, South Korea	Kyungpook National University; Kyungpook National University; Seoul National University (SNU)	Song, JT (corresponding author), Kyungpook Natl Univ, Sch Appl Biosci, Daegu, South Korea.	jtsong68@knu.ac.kr	Sundaramoorthy, Jagadeesh/O-4027-2017	Sundaramoorthy, Jagadeesh/0000-0002-0748-5800; Song, Jong Tae/0000-0002-2052-6582	"Cooperative Research Program for Agriculture Science & Technology Development" Rural Development Administration, Republic of Korea [PJ01108702]	"Cooperative Research Program for Agriculture Science & Technology Development" Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This work was carried out with the support of "Cooperative Research Program for Agriculture Science & Technology Development (Project No. PJ01108702)" Rural Development Administration, Republic of Korea.	Baudry A, 2004, PLANT J, V39, P366, DOI 10.1111/j.1365-313X.2004.02138.x; BUZZELL RI, 1987, J HERED, V78, P53, DOI 10.1093/oxfordjournals.jhered.a110309; Buzzell RI, 1982, SOYBEAN GENET NEWSL, V9, P26; Doyle J. J., 1987, PHYTOCHEM B, P11; FASOULA DA, 1995, CROP SCI, V35, P1028, DOI 10.2135/cropsci1995.0011183X003500040017x; Gompel N, 2005, NATURE, V433, P481, DOI 10.1038/nature03235; Gowik U, 2004, PLANT CELL, V16, P1077, DOI 10.1105/tpc.019729; HARTWIG EDGAR E., 1962, CROP SCI, V2, P152, DOI 10.2135/cropsci1962.0011183X000200020021x; Iwashina T, 2007, J HERED, V98, P250, DOI 10.1093/jhered/esm012; Kazama Y, 2013, PLANT CELL REP, V32, P11, DOI 10.1007/s00299-012-1336-7; Libault M, 2010, PLANT GENOME, V1, P44; Ma HM, 2009, J AM SOC HORTIC SCI, V134, P88, DOI 10.21273/JASHS.134.1.88; McCarty DR, 1986, MAIZE GENET COOP NEW, V60, P61; Palmer RG., 2004, SOYBEANS IMPROVEMENT, P137, DOI DOI 10.2134/AGRONMONOGR16.3ED.C5; Piluk P., 2012, P 1 MAE FAH LUANG U, P1; Sakai H, 2000, PLANT J, V24, P703, DOI 10.1046/j.1365-313x.2000.00909.x; Shapiro MD, 2004, NATURE, V428, P717, DOI 10.1038/nature02415; Shimada S, 2005, PLANT J, V44, P950, DOI 10.1111/j.1365-313X.2005.02574.x; SHIRSAT A, 1989, MOL GEN GENET, V215, P326, DOI 10.1007/BF00339737; Sundaramoorthy J, 2015, J KOREAN SOC APPL BI, V58, P555, DOI 10.1007/s13765-015-0077-z; Takahashi R, 2008, J HERED, V99, P593, DOI 10.1093/jhered/esn041; Takahashi R, 2007, PLANT MOL BIOL, V63, P125, DOI 10.1007/s11103-006-9077-z; Takahashi R, 2013, J HERED, V104, P149, DOI 10.1093/jhered/ess081; Takahashi R, 2011, J HERED, V102, P458, DOI 10.1093/jhered/esr028; WANG CS, 1994, PLANT PHYSIOL, V105, P739, DOI 10.1104/pp.105.2.739; Wessinger CA, 2012, J EXP BOT, V63, P5741, DOI 10.1093/jxb/ers267; Wittkopp PJ, 2012, NAT REV GENET, V13, P59, DOI 10.1038/nrg3095; Xu M, 2005, GENOME, V48, P334, DOI [10.1139/g04-105, 10.1139/G04-105]; Xu M, 2010, GENETICS, V184, P53, DOI 10.1534/genetics.109.107904; Yan F, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-58; Zabala G, 2005, PLANT CELL, V17, P2619, DOI 10.1105/tpc.105.033506; Zabala G, 2007, PLANT GENOME, V47, P113	32	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142643	10.1371/journal.pone.0142643	http://dx.doi.org/10.1371/journal.pone.0142643			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555888	Green Submitted, gold, Green Published			2022-12-27	WOS:000364430700147
J	Schofield, TP; Butterworth, P				Schofield, Timothy P.; Butterworth, Peter			Patterns of Welfare Attitudes in the Australian Population	PLoS One			English	Article							MENTAL-HEALTH; PUBLIC-OPINION; STIGMA; REFORM; INEQUALITIES; PSYCHOLOGY; INCOME; ISSUE; WOMEN	The study of community attitudes toward welfare and welfare recipients is an area of increasing interest. This is not only because negative attitudes can lead to stigmatization and discrimination, but because of the relevance of social attitudes to policy decisions. We quantify the attitudes toward welfare in the Australian population using attitude data from a nationally representative survey (N = 3243). Although there was broad support for the social welfare system, negative attitudes are held toward those who receive welfare benefits. Using canonical correlation analysis we identify multivariate associations between welfare attitudes and respondent demographic characteristics. A primary attitudinal dimension of welfare positivity was found amongst those with higher levels of education, life instability, and personal exposure to the welfare system. Other patterns of negative welfare attitudes appeared to be motivated by beliefs that the respondent's personal circumstances indicate their deservingness. Moreover, a previously unidentified and unconsidered subset of respondents was identified. This group had positive attitudes toward receiving government benefits despite having no recent experience of welfare. They did, however, possess many of the characteristics that frequently lead to welfare receipt. These results provide insights into not only how attitudinal patterns segment across the population, but are of relevance to policy makers considering how to align welfare reform with community attitudes.	[Schofield, Timothy P.; Butterworth, Peter] Australian Natl Univ, Ctr Res Ageing Hlth & Wellbeing, Res Sch Populat Hlth, Canberra, ACT, Australia	Australian National University	Schofield, TP (corresponding author), Australian Natl Univ, Ctr Res Ageing Hlth & Wellbeing, Res Sch Populat Hlth, Canberra, ACT, Australia.	timothy.schofield@anu.edu.au	Butterworth, Peter/AFK-2636-2022; Schofield, Tee/D-3801-2015	Schofield, Tee/0000-0002-0357-9607; Butterworth, Peter/0000-0002-1531-3881	Australian Research Council [DP120101887]	Australian Research Council(Australian Research Council)	PB received funding from the Australian Research Council (http://arc.gov.au; DP120101887). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer V, 2009, LABOUR HIST-AUST, P177; Bamfield L, 2009, J ROWNTREE FDN PUBLI, V6, P1; Baumberg B, 2012, BENEFITS STIGMA BRIT; Baumberg B, 2012, J POVERTY SOC JUSTIC, V20, P149, DOI 10.1332/175982712X652050; Butterworth P, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-44; Butterworth P, 2003, AUST NZ J PUBL HEAL, V27, P441, DOI 10.1111/j.1467-842X.2003.tb00424.x; Coiro MJ, 2001, WOMEN HEALTH, V32, P1, DOI 10.1300/J013v32n01_01; Commonwealth of Australia, 220142015 COMM AUSTR; Corrigan PW, 2009, WORLD PSYCHIATRY, V8, P75; Daniels D, 2008, TRENDS RECEIPT INCOM; Dooley D, 2002, AM J COMMUN PSYCHOL, V30, P787, DOI 10.1023/A:1020253002468; Evans A, 2009, AUSTR SURVEY SOCIAL; Ford E, 2010, PUBLIC HEALTH, V124, P675, DOI 10.1016/j.puhe.2010.08.019; Goffman E. M., 1963, BEHAV PUBLIC PLACES; Hamilton C., 2002, OVERCONSUMPTION AUST; Harmer J, 2008, PENSION REV BACKGROU; Harmer J., 2009, PENSION REV REPORT; Hatzenbuehler ML, 2014, SOC SCI MED, V103, P1, DOI 10.1016/j.socscimed.2013.12.017; Hatzenbuehler ML, 2013, AM J PUBLIC HEALTH, V103, P813, DOI 10.2105/AJPH.2012.301069; Humpage L., 2011, POLICY Q, V7, P8; Jayakody R, 2000, J HEALTH POLIT POLIC, V25, P623, DOI 10.1215/03616878-25-4-623; Juon HS, 2010, J URBAN HEALTH, V87, P76, DOI 10.1007/s11524-009-9413-0; Kiely KM, 2013, AUST NZ J PSYCHIAT, V47, P654, DOI 10.1177/0004867413484094; Link BG, 2006, LANCET, V367, P528, DOI 10.1016/S0140-6736(06)68184-1; Major B, 2005, ANNU REV PSYCHOL, V56, P393, DOI 10.1146/annurev.psych.56.091103.070137; McClure P., 2014, NEW SYSTEM BETTER EM; McKay S, 2014, J POVERTY SOC JUSTIC, V22, P3, DOI 10.1332/175982714X13910760153802; Meers D., 2014, DAILY TELEGRAPH; Mood C, 2006, EUR SOCIOL REV, V22, P443, DOI 10.1093/esr/jcl007; Pearce N, 2013, 30 NROT SPC ATT NATC; Petersen MB, 2012, POLIT PSYCHOL, V33, P395, DOI 10.1111/j.1467-9221.2012.00883.x; Petersen MB, 2011, EUR J POLIT RES, V50, P24, DOI 10.1111/j.1475-6765.2010.01923.x; Roosma F, 2013, SOC INDIC RES, V113, P235, DOI 10.1007/s11205-012-0099-4; Saunders P, 2002, J SOC POLICY, V31, P21, DOI 10.1017/S0047279402006499; Sherry A, 2005, J PERS ASSESS, V84, P37, DOI 10.1207/s15327752jpa8401_09; Stuber J, 2006, SOC SCI MED, V63, P933, DOI 10.1016/j.socscimed.2006.01.012; Sundberg T, 2013, SOC POLICY ADMIN, V47, P416, DOI 10.1111/spol.12027; Yates J, 2008, AUST ECON REV, V41, P200, DOI 10.1111/j.1467-8462.2008.00502.x	38	20	20	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142792	10.1371/journal.pone.0142792	http://dx.doi.org/10.1371/journal.pone.0142792			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7CT	26554361	Green Published, gold			2022-12-27	WOS:000364430700174
J	Nessler, JA; Silvas, M; Carpenter, S; Newcomer, SC				Nessler, J. A.; Silvas, M.; Carpenter, S.; Newcomer, S. C.			Wearing a Wetsuit Alters Upper Extremity Motion during Simulated Surfboard Paddling	PLOS ONE			English	Article							SPACE RECONSTRUCTION PARAMETERS; JOINT POSITION SENSE; TIME-SERIES; STRIDE-INTERVAL; COMPLEX NETWORK; EMBEDDING DIMENSION; NONLINEAR DYNAMICS; BODY-TEMPERATURE; THERMAL SWIMSUIT; PRACTICAL METHOD	Surfers often wear wetsuits while paddling in the ocean. This neoprene covering may be beneficial to upper extremity movement by helping to improve proprioceptive acuity, or it may be detrimental by providing increased resistance. The purpose of this study was to evaluate the effects of wearing a wetsuit on muscle activation, upper extremity motion, heart rate, and oxygen consumption during simulated surfboard paddling in the laboratory. Twelve male, recreational surfers performed two paddling trials at a constant workload on a swim bench ergometer both with and without a wetsuit. Kinematic data and EMG were acquired from the right arm via motion capture, and oxygen consumption and heart rate were recorded with a metabolic cart and heart rate monitor. Wearing a wetsuit had no significant effect on oxygen consumption or heart rate. A significant increase in EMG activation was observed for the middle deltoid but not for any of the other shoulder muscle evaluated. Finally, approximate entropy and estimates of the maximum Lyapunov exponent increased significantly for vertical trajectory of the right wrist (i.e. stroke height) when a wetsuit was worn. These results suggest that a 2mm wetsuit has little effect on the energy cost of paddling at lower workloads but does affect arm motion. These changes may be the result of enhanced proprioceptive acuity due to mechanical compression from the wetsuit.	[Carpenter, S.] Waters Edge Phys Therapy & Wellness, Oceanside, CA USA			jnessler@csusm.edu						Abarbanel H.D.I., 1996, ANAL OBSERVED CHAOTI; Aziz W, 2006, EUR J APPL PHYSIOL, V98, P30, DOI 10.1007/s00421-006-0226-5; Bernstein N, 1967, COORDINATION REGULAT; Birmingham TB, 1998, AM J SPORT MED, V26, P562, DOI 10.1177/03635465980260041601; Buzzi UH, 2003, CLIN BIOMECH, V18, P435, DOI 10.1016/S0268-0033(03)00029-9; Cai WD, 2008, KYBERNETIKA, V44, P557; Cao LY, 1997, PHYSICA D, V110, P43, DOI 10.1016/S0167-2789(97)00118-8; Castagna O, 2013, INT J SPORTS MED, V34, P1043, DOI 10.1055/s-0033-1345136; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Cignetti F, 2009, J BIOMECH, V42, P1452, DOI 10.1016/j.jbiomech.2009.04.012; CORDIER P, 1994, HUM MOVEMENT SCI, V13, P745, DOI 10.1016/0167-9457(94)90016-7; Costa M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021906; Costa M, 2003, PHYSICA A, V330, P53, DOI 10.1016/j.physa.2003.08.022; Damouras S, 2010, GAIT POSTURE, V31, P336, DOI 10.1016/j.gaitpost.2009.12.002; Deutsch KM, 2004, J EXP CHILD PSYCHOL, V88, P319, DOI 10.1016/j.jecp.2004.04.003; Dingwell JB, 2000, CHAOS, V10, P848, DOI 10.1063/1.1324008; Dorman LE, 2009, EUR J APPL PHYSIOL, V105, P463, DOI 10.1007/s00421-008-0924-2; DUGGAN A, 1988, ERGONOMICS, V31, P3, DOI 10.1080/00140138808966645; FRASER AM, 1986, PHYS REV A, V33, P1134, DOI 10.1103/PhysRevA.33.1134; Gao ZK, 2015, EPL-EUROPHYS LETT, V109, DOI 10.1209/0295-5075/109/30005; Gao ZK, 2015, EXP THERM FLUID SCI, V60, P157, DOI 10.1016/j.expthermflusci.2014.09.008; Gao ZK, 2012, NONLINEAR ANAL-REAL, V13, P947, DOI 10.1016/j.nonrwa.2011.08.029; Gates DH, 2008, EXP BRAIN RES, V187, P573, DOI 10.1007/s00221-008-1326-8; Georgoulis Anastasios D, 2006, J Clin Monit Comput, V20, P11, DOI 10.1007/s10877-006-1032-7; Harbourne RT, 2003, DEV PSYCHOBIOL, V42, P368, DOI 10.1002/dev.10110; Hausdorff JM, 1997, J APPL PHYSIOL, V82, P262; HAUSDORFF JM, 1995, J APPL PHYSIOL, V78, P349, DOI 10.1152/jappl.1995.78.1.349; Hegger R, 1999, CHAOS, V9, P413, DOI 10.1063/1.166424; Herrington Lee, 2005, Res Sports Med, V13, P37, DOI 10.1080/15438620590922077; Kaipust JP, 2012, MOTOR CONTROL, V16, P229, DOI 10.1123/mcj.16.2.229; KENNEL MB, 1992, PHYS REV A, V45, P3403, DOI 10.1103/PhysRevA.45.3403; Kim HS, 1999, PHYSICA D, V127, P48, DOI 10.1016/S0167-2789(98)00240-1; Kugiumtzis D, 1996, PHYSICA D, V95, P13, DOI 10.1016/0167-2789(96)00054-1; Kurz MJ, 2010, NONLIN DYNAM PSYCHOL, V14, P151; Lacasa L, 2008, P NATL ACAD SCI USA, V105, P4972, DOI 10.1073/pnas.0709247105; Madansingh S, 2015, J APPL BIOMECH, V31, P95, DOI [10.1123/JAB.2014-0056, 10.1123/jab.2014-0056]; Magee D., 2008, ORTHOPAEDIC PHYS ASS, V5th ed.; Moraiti C, 2007, KNEE SURG SPORT TR A, V15, P1406, DOI 10.1007/s00167-007-0373-1; Nessler JA, 2015, WEARING WETSUIT ALTE; Nessler JA, 2013, ANN BIOMED ENG, V41, P1680, DOI 10.1007/s10439-012-0657-6; Nessler JA, 2011, MOTOR CONTROL, V15, P390, DOI 10.1123/mcj.15.3.390; Nessler JA, 2009, CHAOS, V19, DOI 10.1063/1.3125762; Newell KM, 2001, HUM MOVEMENT SCI, V20, P695, DOI 10.1016/S0167-9457(01)00073-2; Newell KM, 2000, J EXPT PSYCHOL HUMAN, V29, P379; Niessen MHM, 2009, AM J PHYS MED REHAB, V88, P979, DOI 10.1097/PHM.0b013e3181c1eac1; Norkin CC, 2009, MEASUREMENT JOINT MO; Nuber G W, 1986, Am J Sports Med, V14, P7, DOI 10.1177/036354658601400102; Perc M, 2005, EUR J PHYS, V26, P525, DOI 10.1088/0143-0807/26/3/017; Pincus S.M., 1994, AM J PSYCHOL, V266, P1643; Pincus SM, 1991, CHAOS, V5, P110; Prado A, 2014, WETSUIT EFFECT PHYSL; RICHARDSON AB, 1980, AM J SPORT MED, V8, P159, DOI 10.1177/036354658000800303; Riera F, 2014, AVIAT SPACE ENVIR MD, V85, P509, DOI 10.3357/ASEM.3077.2014; Riley MA, 1999, GAIT POSTURE, V9, P65, DOI 10.1016/S0966-6362(98)00044-7; ROSENSTEIN MT, 1993, PHYSICA D, V65, P117, DOI 10.1016/0167-2789(93)90009-P; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Stergiou N., 2004, INNOVATIVE ANAL HUMA; Stergiou Nicholas, 2006, J Neurol Phys Ther, V30, P120; Tomikawa M, 2008, J SCI MED SPORT, V11, P417, DOI 10.1016/j.jsams.2007.02.005; Tomikawa M, 2009, J SCI MED SPORT, V12, P317, DOI 10.1016/j.jsams.2007.10.009; Turvey MT, 1993, VARIABILITY MOTOR CO; Ulkar B, 2004, BRIT J SPORT MED, V38, P549, DOI 10.1136/bjsm.2002.004275; Van Tiggelen D, 2008, SCAND J MED SCI SPOR, V18, P62, DOI 10.1111/j.1600-0838.2007.00649.x; Wakabayashi Hitoshi, 2007, Journal of Physiological Anthropology, V26, P179, DOI 10.2114/jpa2.26.179; Wakabayashi Hitoshi, 2006, Journal of Physiological Anthropology, V25, P331, DOI 10.2114/jpa2.25.331; Yang Y, 2008, PHYSICA A, V387, P1381, DOI 10.1016/j.physa.2007.10.055; Zhang J, 2008, PHYSICA D, V237, P2856, DOI 10.1016/j.physd.2008.05.008; Zhang J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001033	68	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2015	10	11							e0142325	10.1371/journal.pone.0142325	http://dx.doi.org/10.1371/journal.pone.0142325			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7AC	26551321	Green Published, Green Submitted, gold			2022-12-27	WOS:000364422800024
J	Chen, P; Han, Y; Pan, JX				Chen, Ping; Han, Yan; Pan, Jinxiao			High-Dynamic-Range CT Reconstruction Based on Varying Tube-Voltage Imaging	PLOS ONE			English	Article							EXPOSURE	For complicated structural components characterized by wide X-ray attenuation ranges, the conventional computed tomography (CT) imaging using a single tube-voltage at each rotation angle cannot obtain all structural information. This limitation results in a shortage of CT information, because the effective thickness of the components along the direction of X-ray penetration exceeds the limitation of the dynamic range of the X-ray imaging system. To address this problem, high-dynamic-range CT (HDR-CT) reconstruction is proposed. For this new method, the tube's voltage is adjusted several times to match the corresponding effective thickness about the local information from an object. Then, HDR fusion and HDRCT are applied to obtain the full reconstruction information. An accompanying experiment demonstrates that this new technology can extend the dynamic range of X-ray imaging systems and provide the complete internal structures of complicated structural components.	[Chen, Ping; Han, Yan; Pan, Jinxiao] North Univ China, Natl Key Lab Elect Measurement Technol, Taiyuan 030051, Peoples R China; [Chen, Ping; Han, Yan; Pan, Jinxiao] North Univ China, Key Lab Instrumentat Sci & Dynam Measurement, Taiyuan 030051, Peoples R China	North University of China; North University of China	Chen, P (corresponding author), North Univ China, Natl Key Lab Elect Measurement Technol, Taiyuan 030051, Peoples R China.	pc0912@163.com			National Natural Science Foundation of China [61227003, 61301259, 61571404]; Science Foundation of Shanxi Province [2015021099]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of Shanxi Province	This work is partially supported by grants from the National Natural Science Foundation of China (Nos. 61227003, 61301259, 61571404). This work is also supported by the Science Foundation of Shanxi Province (No. 2015021099).	Fei P, 2012, OPT EXPRESS, V20, P8824, DOI 10.1364/OE.20.008824; FELDKAMP LA, 1984, J OPT SOC AM A, V1, P612, DOI 10.1364/JOSAA.1.000612; Hausleiter J, 2010, JACC-CARDIOVASC IMAG, V3, P1113, DOI 10.1016/j.jcmg.2010.08.016; Kalender WA, 2006, PHYS MED BIOL, V51, pR29, DOI 10.1088/0031-9155/51/13/R03; Kalra MK, 2004, RADIOLOGY, V233, P649, DOI 10.1148/radiol.2333031150; Kramer P, 2010, MEAS SCI TECHNOL, V21, DOI 10.1088/0957-0233/21/4/045105; Liu B, 2014, J X-RAY SCI TECHNOL, V22, P241, DOI 10.3233/XST-140422; MANN S, 1995, IS&T'S 48TH ANNUAL CONFERENCE - IMAGING ON THE INFORMATION SUPERHIGHWAY, FINAL PROGRAM AND PROCEEDINGS, P442; Mueller K, 1999, IEEE T MED IMAGING, V18, P538, DOI 10.1109/42.781018; Sisniega A, 2014, PHYS MED BIOL, V59, P421, DOI 10.1088/0031-9155/59/2/421; Sun GQ, 2012, NONLINEAR DYNAM, V69, P1097, DOI 10.1007/s11071-012-0330-5; Sun GQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11246; Sun GQ, 2014, COMMUN NONLINEAR SCI, V19, P1507, DOI 10.1016/j.cnsns.2013.09.016; Sun GQ, 2012, APPL MATH COMPUT, V218, P11151, DOI 10.1016/j.amc.2012.04.071; YAN XH, 1991, IEEE T MED IMAGING, V10, P462, DOI 10.1109/42.97597	15	12	12	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141789	10.1371/journal.pone.0141789	http://dx.doi.org/10.1371/journal.pone.0141789			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544723	Green Published, Green Submitted, gold			2022-12-27	WOS:000364398700048
J	Jonas, RA; Wang, YX; Yang, H; Li, JJ; Xu, L; Panda-Jonas, S; Jonas, JB				Jonas, Rahul A.; Wang, Ya Xing; Yang, Hua; Li, Jian Jun; Xu, Liang; Panda-Jonas, Songhomitra; Jonas, Jost B.			Optic Disc - Fovea Angle: The Beijing Eye Study 2011	PLoS One			English	Article							NERVE-FIBER LAYER; SUBFOVEAL CHOROIDAL THICKNESS; VISUAL-FIELD; COMPUTATIONAL MODEL; TEMPORAL RAPHE; OCULAR TORSION; GLAUCOMA; VARIABILITY; FUNDUS; SIZE	Purpose To determine the optic disc-fovea angle (defined as angle between the horizontal and the line between the optic disc center and the fovea) and to assess its relationships with ocular and systemic parameters. Methods The population-based cross-sectional Beijing Eye Study 2011 included 3468 individuals. A detailed ophthalmic examination was carried out. Using fundus photographs, we measured the disc-fovea angle. Results Readable fundus photographs were available for 6043 eyes of 3052 (88.0%) individuals with a mean age of 63.6 +/- 9.3 years (range: 50-91 years) and a mean axial length of 23.2 +/- 1.0 mm (range: 18.96-28.87 mm). Mean disc-fovea angle was 7.76 +/- 3.63 degrees (median: 7.65 degrees; range: -6.3 +/- to 28.9 degrees). The mean inter-eye difference was 4.01 +/- 2.94 degrees (median: 3.49 degrees; range: 0.00-22.3 degrees). In multivariate analysis, larger disc-fovea angle was associated (regression coefficient r(2): 0.08) with older age (P = 0.009; standardized regression coefficient beta: 0.05), thinner RNFL in the nasal superior sector (P < 0.001; beta: -0.17), superior sector (P < 0.001; beta: -0.10) and temporal superior sector (P < 0.001; beta: -0.11) and thicker RNFL in the inferior sector (P < 001; beta: 0.13), nasal inferior sector (P < 001; beta: 0.13) and nasal sector (P = 0.007; beta: 0.06), higher prevalence of retinal vein occlusion (P = 0.02; beta: 0.04), and with larger cylindrical refractive error (P = 0.04; beta: 0.04). Conclusions The optic disc-fovea angle markedly influences the regional distribution of the RNFL thickness pattern. The disc-fovea angle may routinely be taken into account in the morphological glaucoma diagnosis and in the assessment of structure-function relationship in optic nerve diseases. Future studies may address potential associations between a larger disc-fovea angle and retinal vein occlusions and between the disc-fovea angle and the neuroretinal rim shape.	[Jonas, Rahul A.; Wang, Ya Xing; Yang, Hua; Li, Jian Jun; Xu, Liang; Jonas, Jost B.] Capital Med Univ, Beijing Tongren Hosp, Beijing Ophthalmol & Visual Sci Key Lab, Beijing Inst Ophthalmol,Beijing Tongren Eye Ctr, Beijing, Peoples R China; [Jonas, Rahul A.; Panda-Jonas, Songhomitra; Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Mannheim, Germany	Capital Medical University; Ruprecht Karls University Heidelberg	Wang, YX (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Beijing Ophthalmol & Visual Sci Key Lab, Beijing Inst Ophthalmol,Beijing Tongren Eye Ctr, Beijing, Peoples R China.	yaxingw@gmail.com	wang, YA XING/K-9671-2016; Jonas, Rahul A/N-9304-2017	wang, YA XING/0000-0003-2749-7793; Jonas, Rahul/0000-0002-5389-3047	State Natural Sciences Fund [81041018]; Natural Sciences Fund of Beijing government [7092021, 7112031]	State Natural Sciences Fund(National Natural Science Foundation of China (NSFC)); Natural Sciences Fund of Beijing government	This work was supported by State Natural Sciences Fund (81041018) and the Natural Sciences Fund of Beijing government (7092021; 7112031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amini N, 2014, INVEST OPHTH VIS SCI, V55, P7332, DOI 10.1167/iovs.14-14962; Asaoka R, 2012, INVEST OPHTH VIS SCI, V53, P8396, DOI 10.1167/iovs.12-9794; Chauhan BC, 2014, OPHTHALMOLOGY, V121, P2287, DOI 10.1016/j.ophtha.2014.06.023; Choi JA, 2014, INVEST OPHTH VIS SCI, V55, P1419, DOI 10.1167/iovs.13-13604; Denniss J, 2014, INVEST OPHTH VIS SCI, V55, P1985, DOI 10.1167/iovs.13-13758; Denniss J, 2014, INVEST OPHTH VIS SCI, V55, P728, DOI 10.1167/iovs.13-13142; Denniss J, 2012, INVEST OPHTH VIS SCI, V53, P6981, DOI 10.1167/iovs.12-9657; Ganeshrao SB, 2015, OPHTHALMOLOGY, V122, P1695, DOI 10.1016/j.ophtha.2015.04.021; Garway-Heath DF, 2000, OPHTHALMOLOGY, V107, P1809, DOI 10.1016/S0161-6420(00)00284-0; Huang G, 2014, INVEST OPHTH VIS SCI, V55, P5952, DOI 10.1167/iovs.14-14893; Hwang YH, 2012, J GLAUCOMA, V21, P260, DOI 10.1097/IJG.0b013e31820719e1; Jansonius NM, 2012, EXP EYE RES, V105, P70, DOI 10.1016/j.exer.2012.10.008; Jethani J, 2010, INDIAN J OPHTHALMOL, V58, P417, DOI 10.4103/0301-4738.67060; JONAS JB, 1989, OPHTHALMOLOGY, V96, P627; JONAS JB, 1988, INVEST OPHTH VIS SCI, V29, P1151; Jonas JB, 1997, OPHTHALMOLOGY, V104, P1934, DOI 10.1016/S0161-6420(97)30004-9; JONAS JB, 1988, GRAEF ARCH CLIN EXP, V226, P531, DOI 10.1007/BF02169200; Jonas JB, 1997, AM J OPHTHALMOL, V124, P488, DOI 10.1016/S0002-9394(14)70864-5; Jonas JB, 2013, INVEST OPHTH VIS SCI, V54, P1295, DOI 10.1167/iovs.12-11352; Kim KE, 2015, OPHTHALMOLOGY, V122, P502, DOI 10.1016/j.ophtha.2014.09.031; Lamparter J, 2013, INVEST OPHTH VIS SCI, V54, P6074, DOI 10.1167/iovs.13-11902; LITTMANN H, 1982, KLIN MONATSBL AUGENH, V180, P286, DOI 10.1055/s-2008-1055068; Medeiros FA, 2012, INVEST OPHTH VIS SCI, V53, P6939, DOI 10.1167/iovs.12-10345; Pekel G, 2014, KAOHSIUNG J MED SCI, V30, P531, DOI 10.1016/j.kjms.2014.08.003; Piedrahita-Alonso E, 2014, BRIT J OPHTHALMOL, V98, P115, DOI 10.1136/bjophthalmol-2013-303680; Rohrschneider K, 2004, INVEST OPHTH VIS SCI, V45, P3257, DOI 10.1167/iovs.03-1157; Shao L, 2015, INVEST OPHTH VIS SCI, V56, P810, DOI 10.1167/iovs.14-15736; Shin KH, 2013, AM J OPHTHALMOL, V155, P177, DOI 10.1016/j.ajo.2012.07.011; Vurgese S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029692; Wang YX, 2010, AM J OPHTHALMOL, V150, P917, DOI 10.1016/j.ajo.2010.06.037; Wei WB, 2013, OPHTHALMOLOGY, V120, P175, DOI 10.1016/j.ophtha.2012.07.048; Xu J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111320; Xu L, 2007, OPHTHALMOLOGY, V114, P121, DOI 10.1016/j.ophtha.2006.05.071	33	40	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141771	10.1371/journal.pone.0141771	http://dx.doi.org/10.1371/journal.pone.0141771			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26545259	gold, Green Submitted, Green Published			2022-12-27	WOS:000364398700044
J	Lopez-Campos, JL; Arranz, MA; Acuna, CC; Valero, FR; Garcia, RA; Molina, AH; Perez-Grovas, RIA; Gil, FG; Maldonado, FC; Ballesteros, LC; Palop, MS; Perez-Tejero, D; Segado, A; Bonachera, JC; Sierra, BH; Domenech, A; Varela, MA; Vargas, FG; Rueda, JJC				Luis Lopez-Campos, Jose; Abad Arranz, Maria; Calero Acuna, Carmen; Romero Valero, Fernando; Ayerbe Garcia, Ruth; Hidalgo Molina, Antonio; Aguilar Perez-Grovas, Ricardo Ismael; Garcia Gil, Francisco; Casas Maldonado, Francisco; Caballero Ballesteros, Laura; Sanchez Palop, Maria; Perez-Tejero, Dolores; Segado, Alejandro; Calvo Bonachera, Jose; Hernandez Sierra, Barbara; Domenech, Adolfo; Arroyo Varela, Macarena; Gonzalez Vargas, Francisco; Cruz Rueda, Juan Jose			Clinical Audits in Outpatient Clinics for Chronic Obstructive Pulmonary Disease: Methodological Considerations and Workflow	PLOS ONE			English	Article							EUROPEAN COPD AUDIT; QUALITY-OF-CARE; HEALTH-CARE; EXACERBATIONS; ORGANIZATION; MANAGEMENT; VARIABILITY; PERFORMANCE; GUIDELINES; ADMISSIONS	Objectives Previous clinical audits for chronic obstructive pulmonary disease (COPD) have provided valuable information on the clinical care delivered to patients admitted to medical wards because of COPD exacerbations. However, clinical audits of COPD in an outpatient setting are scarce and no methodological guidelines are currently available. Based on our previous experience, herein we describe a clinical audit for COPD patients in specialized outpatient clinics with the overall goal of establishing a potential methodological workflow. Methods A pilot clinical audit of COPD patients referred to respiratory outpatient clinics in the region of Andalusia, Spain (over 8 million inhabitants), was performed. The audit took place between October 2013 and September 2014, and 10 centers (20% of all public hospitals) were invited to participate. Cases with an established diagnosis of COPD based on risk factors, clinical symptoms, and a post-bronchodilator FEV1/FVC ratio of less than 0.70 were deemed eligible. The usefulness of formally scheduled regular follow-up visits was assessed. Two different databases (resources and clinical database) were constructed. Assessments were planned over a year divided by 4 three-month periods, with the goal of determining seasonal-related changes. Exacerbations and survival served as the main endpoints. Conclusions This paper describes a methodological framework for conducting a clinical audit of COPD patients in an outpatient setting. Results from such audits can guide health information systems development and implementation in real-world settings.	[Luis Lopez-Campos, Jose; Abad Arranz, Maria; Calero Acuna, Carmen] Univ Seville, Hosp Univ Virgen del Rocio, Inst Biomed Sevilla IBiS, Unidad Med Quirurg Enfermedades Resp, Seville, Spain; [Luis Lopez-Campos, Jose; Calero Acuna, Carmen] Inst Salud Carlos III, CIBER Enfermedades Resp CIBERES, Madrid, Spain; [Romero Valero, Fernando; Hidalgo Molina, Antonio] Hosp Puerta Mar, Cadiz, Spain; [Ayerbe Garcia, Ruth; Aguilar Perez-Grovas, Ricardo Ismael] Hosp Juan Ramon Jimenez, Huelva, Spain; [Casas Maldonado, Francisco; Sanchez Palop, Maria] Hosp Univ Reina Sofia, Cordoba, Spain; [Casas Maldonado, Francisco; Sanchez Palop, Maria] Hosp Univ San Cecilio, Granada, Spain; [Perez-Tejero, Dolores; Segado, Alejandro] Hosp Infanta Margarita, Cordoba, Spain; [Calvo Bonachera, Jose; Hernandez Sierra, Barbara] Hosp Torrecardenas, Almeria, Spain; [Domenech, Adolfo; Arroyo Varela, Macarena] Hosp Reg Univ Malaga, Malaga, Spain; [Gonzalez Vargas, Francisco; Cruz Rueda, Juan Jose] Hosp Univ Virgen Nieves, Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; Universidad de Cadiz; Hospital Universitario Puerta del Mar; Hospital Juan Ramon Jimenez; Hospital Universitario Reina Sofia - Cordoba; Hospital Universitario San Cecilio; Hospital Torrecardenas; Hospital Universitario Virgen de las Nieves	Lopez-Campos, JL (corresponding author), Univ Seville, Hosp Univ Virgen del Rocio, Inst Biomed Sevilla IBiS, Unidad Med Quirurg Enfermedades Resp, Seville, Spain.	lcampos@separ.es	Bodineau, José Luis López-Campos/AAG-5203-2019	Bodineau, José Luis López-Campos/0000-0003-1703-1367; Domenech del Rio, Adolfo/0000-0002-3127-9150	Laboratorios Menarini, SA (Barcelona, Spain)	Laboratorios Menarini, SA (Barcelona, Spain)	This study was financially supported by an unrestricted grant from Laboratorios Menarini, SA (Barcelona, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agabiti N, 2010, EUR RESPIR J, V35, P1031, DOI 10.1183/09031936.00056209; Asch SM, 2006, NEW ENGL J MED, V354, P1147, DOI 10.1056/NEJMsa044464; Berwick DM, 2003, MEDICAL CARE SUPPL, V41, pl30; Blumenthal D, 2010, NEW ENGL J MED, V363, P501, DOI 10.1056/NEJMp1006114; Esposito Pasquale, 2014, World J Nephrol, V3, P249, DOI 10.5527/wjn.v3.i4.249; Flottorp SA, 2010, USING AUDIT FEEDBACK, VIX; Gerber JS, 2014, JAMA-J AM MED ASSOC, V312, P2569, DOI 10.1001/jama.2014.14042; Heffner JE, 2010, CHEST, V137, P1181, DOI 10.1378/chest.09-2306; Hosker H, 2007, RESP MED, V101, P754, DOI 10.1016/j.rmed.2006.08.016; Hunter MG, 2012, SEX HEALTH, V9, P495, DOI 10.1071/SH11192; Soler-Cataluna JJ, 2009, ARCH BRONCONEUMOL, V45, P196, DOI 10.1016/j.arbres.2008.05.008; Joynt KE, 2011, JAMA-J AM MED ASSOC, V306, P45, DOI 10.1001/jama.2011.902; Kim C, 2014, INT J TUBERC LUNG D, V18, P737, DOI 10.5588/ijtld.13.0634; Liaaen ED, 2010, RESP MED, V104, P1304, DOI 10.1016/j.rmed.2010.03.007; Lopez-Campos JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110394; Lopez-Campos JL, 2014, EUR RESPIR J, V43, P754, DOI 10.1183/09031936.00074413; Lopez-Campos JL, 2014, LANCET RESP MED, V2, P54, DOI 10.1016/S2213-2600(13)70232-7; Lopez-Campos JL, 2013, EUR RESPIR J, V41, P270, DOI 10.1183/09031936.00021812; McIntyre N, 1995, J Eval Clin Pract, V1, P5; Merlo J, 2003, J EPIDEMIOL COMMUN H, V57, P550, DOI 10.1136/jech.57.8.550; Miravitlles M, 2014, ARCH BRONCONEUMOL, V50, P1, DOI 10.1016/S0300-2896(14)70070-5; Miravitlles M, 2012, ARCH BRONCONEUMOL, V48, P247, DOI 10.1016/j.arbres.2012.04.001; Nardini S, 2014, MULTIDISCIP RESP MED, V9, DOI 10.1186/2049-6958-9-40; Nonato NL, 2015, ARCH BRONCONEUMOL, V51, P315, DOI 10.1016/j.arbres.2014.02.017; Pozo-Rodriguez F, 2015, INT J CLIN PRACT, V69, P938, DOI 10.1111/ijcp.12601; Pozo-Rodriguez F, 2010, ARCH BRONCONEUMOL, V46, P349, DOI 10.1016/j.arbres.2010.04.004; Pretto JJ, 2012, INTERN MED J, V42, P380, DOI 10.1111/j.1445-5994.2011.02475.x; Roberts CM, 2013, THORAX, V68, P1169, DOI 10.1136/thoraxjnl-2013-203465; Roberts CM, 2001, EUR RESPIR J, V17, P343, DOI 10.1183/09031936.01.17303430; SIMPSON FG, 1987, BRIT J DIS CHEST, V81, P150, DOI 10.1016/0007-0971(87)90133-1; Stewart I C, 1984, Health Bull (Edinb), V42, P45; Trevest Katie, 2014, Clin Diabetes, V32, P158, DOI 10.2337/diaclin.32.4.158; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP	33	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141856	10.1371/journal.pone.0141856	http://dx.doi.org/10.1371/journal.pone.0141856			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544556	Green Published, gold, Green Submitted			2022-12-27	WOS:000364398700055
J	Sosa-Hernandez, E; Ballesteros-Rodea, G; Arias-Del-Angel, JA; Devora-Canales, D; Manning-Cela, RG; Santana-Solano, J; Santillan, M				Sosa-Hernandez, Eduardo; Ballesteros-Rodea, Gilberto; Arias-del-Angel, Jorge A.; Devora-Canales, Diego; Manning-Cela, Rebeca G.; Santana-Solano, Jesus; Santillan, Moises			Experimental and Mathematical-Modeling Characterization of Trypanosoma cruzi Epimastigote Motility	PLOS ONE			English	Article							FLAGELLUM; INFECTION	The present work is aimed at characterizing the motility of parasite T. cruzi in its epimastigote form. To that end, we recorded the trajectories of two strains of this parasite (a wildtype strain and a stable transfected strain, which contains an ectopic copy of LYT1 gene and whose motility is known to be affected). We further extracted parasite trajectories from the recorded videos, and statistically analysed the following trajectory-step features: step length, angular change of direction, longitudinal and transverse displacements with respect to the previous step, and mean square displacement. Based on the resulting observations, we developed a mathematical model to simulate parasite trajectories. The fact that the model predictions closely match most of the experimentally observed parasite-trajectory characteristics, allows us to conclude that the model is an accurate description of T. cruzi motility.	[Sosa-Hernandez, Eduardo; Arias-del-Angel, Jorge A.; Devora-Canales, Diego; Santana-Solano, Jesus; Santillan, Moises] Ctr Invest & Estudios Avanzados IPN, Unidad Monterrey, Apodaca Nl, Mexico; [Ballesteros-Rodea, Gilberto] Univ Autonoma San Luis Potosi, Fac Agron & Vet, SLP, San Luis Potosi, Mexico; [Manning-Cela, Rebeca G.] Ctr Invest & Estudios Avanzados IPN, Dept Biomed Mol, Mexico City, DF, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Universidad Autonoma de San Luis Potosi; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Santillan, M (corresponding author), Ctr Invest & Estudios Avanzados IPN, Unidad Monterrey, Apodaca Nl, Mexico.	msantillan@cinvestav.mx	Sosa-Hernández, Juan Eduardo/C-3436-2017; Santillan, Moises/A-2942-2008	Sosa-Hernández, Juan Eduardo/0000-0001-5441-4768; Santillan, Moises/0000-0001-8605-7451; Ballesteros-Rodea, Gilberto/0000-0001-5283-6975	Consejo Nacional de Ciencia y Tecnologia [60152]	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by Consejo Nacional de Ciencia y Tecnologia, http://www.conacyt.mx, Grant 60152, awarded to R M-C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballesteros-Rodea G, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/520380; Ballesteros-Rodea G, 2012, VET MEXICO, V43, P29; Berg, 2018, RANDOM WALKS BIOL; Berg H C, 2003, E COLI MOTION; Bern C, 2015, NEW ENGL J MED, V373, P1882, DOI [10.1056/NEJMra1410150, 10.1056/NEJMc1510996]; BRENER Z, 1963, Rev Inst Med Trop Sao Paulo, V5, P220; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217; de Souza W, 2010, MICROBIOL MONOGR, V17, P27, DOI 10.1007/978-3-642-12863-9_2; Finkelsztein EJ, 2015, EXP PARASITOL, V150, P36, DOI 10.1016/j.exppara.2015.01.007; Freire-de-Lima L, 2015, GLYCOBIOLOGY, V25, P1142, DOI 10.1093/glycob/cwv057; Hernandez-Ortiz JP, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.204501; Johnson CA, 2013, INFECT IMMUN, V81, P4139, DOI 10.1128/IAI.01459-12; Kohl L, 2003, EMBO J, V22, P5336, DOI 10.1093/emboj/cdg518; Langousis G, 2014, NAT REV MICROBIOL, V12, P505, DOI 10.1038/nrmicro3274; Lugo-Caballero C, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/493525; Pereira PCM, 2013, J VENOM ANIM TOXINS, V19, DOI 10.1186/1678-9199-19-34; Nardy AF, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/178947; OTHMER HG, 1988, J MATH BIOL, V26, P263, DOI 10.1007/BF00277392; Rodriguez A, 1997, J CELL BIOL, V137, P93, DOI 10.1083/jcb.137.1.93; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Sibley LD, 2000, TRAFFIC, V1, P100, DOI 10.1034/j.1600-0854.2000.010202.x; Theves M, 2013, BIOPHYS J, V105, P1915, DOI 10.1016/j.bpj.2013.08.047; Uppaluri S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002058; Weisse S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037296; Wu XL, 2000, PHYS REV LETT, V84, P3017, DOI 10.1103/PhysRevLett.84.3017	25	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142478	10.1371/journal.pone.0142478	http://dx.doi.org/10.1371/journal.pone.0142478			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544863	Green Published, Green Submitted, gold			2022-12-27	WOS:000364398700145
J	Wagy, MD; Bongard, JC				Wagy, Mark D.; Bongard, Josh C.			Combining Computational and Social Effort for Collaborative Problem Solving	PLOS ONE			English	Article							LOCOMOTION; SYSTEMS	Rather than replacing human labor, there is growing evidence that networked computers create opportunities for collaborations of people and algorithms to solve problems beyond either of them. In this study, we demonstrate the conditions under which such synergy can arise. We show that, for a design task, three elements are sufficient: humans apply intuitions to the problem, algorithms automatically determine and report back on the quality of designs, and humans observe and innovate on others' designs to focus creative and computational effort on good designs. This study suggests how such collaborations should be composed for other domains, as well as how social and computational dynamics mutually influence one another during collaborative problem solving.	[Wagy, Mark D.; Bongard, Josh C.] Univ Vermont, Dept Comp Sci, Burlington, VT 05405 USA	University of Vermont	Wagy, MD (corresponding author), Univ Vermont, Dept Comp Sci, Burlington, VT 05405 USA.	mwagy@uvm.edu			National Science Foundation [DGE-1144388, PECASE-0953837]; Defense Advanced Research Projects Agency [FA8650-11-1-7155]	National Science Foundation(National Science Foundation (NSF)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	This work was supported by the National Science Foundation (www.nsf.gov) under project DGE-1144388. This work was also supported by the National Science Foundation under grant PECASE-0953837, and by the Defense Advanced Research Projects Agency (www.darpa.mil) under grant FA8650-11-1-7155. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auerbach J.E., 2010, P 12 ANN C GEN EV CO; Auerbach JE, 2011, GECCO-2011: PROCEEDINGS OF THE 13TH ANNUAL GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P1475; BOOKER LB, 1989, ARTIF INTELL, V40, P235, DOI 10.1016/0004-3702(89)90050-7; Breazeal C, 2013, J HUM-ROBOT INTERACT, V2, P82, DOI 10.5898/JHRI.2.1.Breazeal; Chernova Sonia, 2011, RO MAN 2011 IEEE, P21, DOI DOI 10.1109/ROMAN.2011.6005284; Clune J, 2009, IEEE C EVOL COMPUTAT, P2764, DOI 10.1109/CEC.2009.4983289; D'Andrea R, 2014, IEEE T AUTOM SCI ENG, V11, P647, DOI 10.1109/TASE.2014.2326952; Duggan M, 2013, 6 ONLINE ADULTS ARE, P3; Edan Y, 2009, SPRINGER HANDBOOK OF AUTOMATION, P1095, DOI 10.1007/978-3-540-78831-7_63; Finnerty JR, 2005, BIOESSAYS, V27, P1174, DOI 10.1002/bies.20299; Ghosh S, 2011, NAT REV GENET, V12, P821, DOI 10.1038/nrg3096; Haasdijk E, 2010, LECT NOTES COMPUT SC, V6274, P169, DOI 10.1007/978-3-642-15323-5_15; Hinton GE, 2006, SCIENCE, V313, P504, DOI 10.1126/science.1127647; Janis IL, 1972, VICTIMS GROUPTHINK P; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Khatib F, 2011, P NATL ACAD SCI USA, V108, P18949, DOI 10.1073/pnas.1115898108; Kim JS, 2014, NATURE, V509, P331, DOI 10.1038/nature13240; Klug M, 2014, ARXIV14072893; Lintott CJ, 2008, MON NOT R ASTRON SOC, V389, P1179, DOI 10.1111/j.1365-2966.2008.13689.x; Lipson H., 2013, FABRICATED NEW WORLD; MATHER G, 1993, PERCEPTION, V22, P759, DOI 10.1068/p220759; Neri P, 1998, NATURE, V395, P894, DOI 10.1038/27661; Pentland A, 2012, HARVARD BUS REV, V90, P61; Risi S, 2013, GECCO'13: PROCEEDINGS OF THE 2013 GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P263; Schmidt M, 2009, SCIENCE, V324, P81, DOI 10.1126/science.1165893; Secretan J, 2008, CHI 2008: 26TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS VOLS 1 AND 2, CONFERENCE PROCEEDINGS, P1759; Sorokin A, 2010, IEEE INT C INT ROBOT, P2117, DOI 10.1109/IROS.2010.5650464; Stanley KO, 2007, GENET PROGRAM EVOL M, V8, P131, DOI 10.1007/s10710-007-9028-8; Stanley KO, 2009, ARTIF LIFE, V15, P185, DOI 10.1162/artl.2009.15.2.15202; Tanenbaum J.G., 2013, P SIGCHI C HUMAN FAC, P2603, DOI DOI 10.1145/2470654.2481360; Turner ME, 1998, ORGAN BEHAV HUM DEC, V73, P105, DOI 10.1006/obhd.1998.2756; Wagy M, ALIFE 14 14 C SYNTH, V14, P138; Werfel J, 2014, SCIENCE, V343, P754, DOI 10.1126/science.1245842; Woolley AW, 2010, SCIENCE, V330, P686, DOI 10.1126/science.1193147; Woolley BG, 2014, GECCO'14: PROCEEDINGS OF THE 2014 GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P233, DOI 10.1145/2576768.2598353	37	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142524	10.1371/journal.pone.0142524	http://dx.doi.org/10.1371/journal.pone.0142524			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV6RT	26544199	Green Submitted, Green Published, gold			2022-12-27	WOS:000364398700150
J	Zhang, YF; Jin, M; Du, B; Lin, H; Xu, CY; Jiang, WJ; Jia, JP				Zhang, Yunfeng; Jin, Min; Du, Bin; Lin, Hao; Xu, Chengyong; Jiang, Weijian; Jia, Jianping			A Novel Canine Model of Acute Vertebral Artery Occlusion	PLOS ONE			English	Article							ISCHEMIC-STROKE; MECHANICAL THROMBECTOMY; THROMBOEMBOLIC STROKE; ANIMAL-MODEL; SWINE MODEL; RECANALIZATION; DEVICE; REVASCULARIZATION; EFFICACY; SAFETY	Background The extended time window and theoretic reduction in hemorrhage make mechanical strategies an attractive approach for the treatment of patients with ischemic stroke. However, a limited availability of suitable animal models of cerebrovascular thrombosis has hampered the study of novel endovascular interventions. The aim of the present study was to develop a new technique for site-specific placement of a thrombus in a canine model that would allow for the evaluation of mechanical thrombectomy and clot retrieval methods and the visualization of thrombus dislocation or fragmentation during angiographic manipulation. Methods Angiography and embolization with a preformed thrombus were performed in 12 canines. Under fluoroscopic guidance, an embolism protection device (EPD) was anchored to the middle segment of the left vertebral artery (VA) via the left femoral arterial sheath. A preformed radiopaque clot was injected through the guide catheter into the left VA, via the contralateral femoral artery, proximal to the EPD. After 15 min of occlusion, the EPD was removed and persistent occlusion of the VA was documented angiographically. Results Angiography performed during the observation period confirmed the persistence of VA occlusion in each case, and displacement of the radiopaque clots did not occur during the 3-hour observation period. The technique allowed selective embolization of targeted vessels without thrombus fragmentation. Conclusion This study demonstrates, for the first time, a canine model of post-circulation embolism induced by autologous blood clot placement. This model can be rapidly formed and easily operated, and the site of thrombosis can be readily controlled.	[Zhang, Yunfeng; Jia, Jianping] Capital Med Univ, Xuan Wu Hosp, Dept Neurol, Beijing, Peoples R China; [Jin, Min; Du, Bin; Lin, Hao; Xu, Chengyong; Jiang, Weijian] Chinese Peoples Liberat Army, Artillery Gen Hosp 2, Beijing, Peoples R China; [Zhang, Yunfeng] Nantong Univ, Affiliated Hosp, Dept Neurol, Nantong, Peoples R China	Capital Medical University; Nantong University	Jia, JP (corresponding author), Capital Med Univ, Xuan Wu Hosp, Dept Neurol, Beijing, Peoples R China.	jiajp@vip.126.com		Jia, Jianping/0000-0003-4624-0336				Amiridze N, 2009, J STROKE CEREBROVASC, V18, P281, DOI 10.1016/j.jstrokecerebrovasdis.2008.11.013; Boltze J, 2008, J CEREBR BLOOD F MET, V28, P1951, DOI 10.1038/jcbfm.2008.89; Boulos AS, 2011, J NEUROSURG, V114, P1117, DOI 10.3171/2010.8.JNS09352; Busch E, 1997, BRAIN RES, V778, P16, DOI 10.1016/S0006-8993(97)01008-1; Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792; Castano C, 2010, STROKE, V41, P1836, DOI 10.1161/STROKEAHA.110.584904; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Feng L, 2013, EXP THER MED, V6, P947, DOI 10.3892/etm.2013.1248; Gory B, 2013, INTERV NEURORADIOL, V19, P147, DOI 10.1177/159101991301900201; Gounis MJ, 2013, STROKE, V44, pS7, DOI 10.1161/STROKEAHA.111.000692; Gounis MJ, 2013, J NEUROINTERV SURG, V5, P85, DOI 10.1136/neurintsurg-2012-010435; Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905; Gralla J, 2006, AM J NEURORADIOL, V27, P1357; Gravanis I, 2008, EXPERT OPIN THER TAR, V12, P159, DOI 10.1517/14728222.12.2.159 ; Jahan R, 2010, AM J NEURORADIOL, V31, P1938, DOI 10.3174/ajnr.A2169; Jovin TG, 2015, NEW ENGL J MED, V372, P2296, DOI 10.1056/NEJMoa1503780; Khatri P, 2009, NEUROLOGY, V73, P1066, DOI 10.1212/WNL.0b013e3181b9c847; Levy EI, 2006, AM J NEURORADIOL, V27, P2069; Levy EI, 2011, NEUROSURGERY, V69, P915, DOI 10.1227/NEU.0b013e318222afd1; Levy EI, 2009, STROKE, V40, P3552, DOI 10.1161/STROKEAHA.109.561274; Mehra M, 2012, J NEUROINTERV SURG, V4, P307, DOI 10.1136/neurintsurg-2011-010101; Nogueira RG, 2012, J NEUROINTERV SURG, V4, P295, DOI 10.1136/neurintsurg-2011-010053; Orset C, 2007, STROKE, V38, P2771, DOI 10.1161/STROKEAHA.107.487520; PASSAMANI E, 1985, NEW ENGL J MED, V312, P932; Pereira VM, 2015, J NEURORADIOLOGY, V42, P12, DOI 10.1016/j.neurad.2014.11.002; Przybylowski CJ, 2014, WORLD J CLIN CASES, V2, P614, DOI 10.12998/wjcc.v2.i11.614; Ren M, 2012, J NEUROSCI METH, V211, P296, DOI 10.1016/j.jneumeth.2012.09.006; Rha JH, 2007, STROKE, V38, P967, DOI 10.1161/01.STR.0000258112.14918.24; Saver JL, 2015, NEW ENGL J MED, V372, P2285, DOI 10.1056/NEJMoa1415061; Suh SH, 2010, AM J NEURORADIOL, V31, P459, DOI 10.3174/ajnr.A1865; Sun L, 2011, BRAIN RES, V1368, P346, DOI 10.1016/j.brainres.2010.10.067; Wardlaw JM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000213.pub3; Yuki I, 2013, AM J NEURORADIOL, V34, pE87, DOI 10.3174/ajnr.A3221	33	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142251	10.1371/journal.pone.0142251	http://dx.doi.org/10.1371/journal.pone.0142251			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26545253	Green Published, gold, Green Submitted			2022-12-27	WOS:000364398700100
J	Cowan, J; Gaudet, L; Mulpuru, S; Corrales-Medina, V; Hawken, S; Cameron, C; Aaron, SD; Cameron, DW				Cowan, Juthaporn; Gaudet, Logan; Mulpuru, Sunita; Corrales-Medina, Vicente; Hawken, Steven; Cameron, Chris; Aaron, Shawn D.; Cameron, D. William			A Retrospective Longitudinal Within-Subject Risk Interval Analysis of Immunoglobulin Treatment for Recurrent Acute Exacerbation of Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							INTRAVENOUS IMMUNOGLOBULIN; COPD EXACERBATIONS; DOUBLE-BLIND; AUTOIMMUNE; MODERATE; AZITHROMYCIN; INFLAMMATION; MECHANISMS; INFLIXIMAB; MORTALITY	Background Recurrent acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are common, debilitating, costly and often difficult to prevent. Methods We reviewed records of patients who had COPD and immunoglobulin (Ig) treatment as adjunctive preventative treatment for AECOPD, and documented all AECOPD episodes for one year before and after initiation of Ig treatment. We graded AECOPD episodes as moderate for prescription of antibiotics and/or corticosteroids or for visit to the Emergency Department, and as severe for hospital admission. We conducted a retrospective withinsubject self-controlled risk interval analysis to compare the outcome of annual AECOPD rate before and after treatment. Results We identified 22 cases of certain COPD, of which three had early discontinuation of Ig treatment due to rash and local swelling to subcutaneous Ig, and five had incomplete records leaving 14 cases for analyses. The median baseline IgG level was 5.9 g/L (interquartile range 4.1-7.4). Eight had CT radiographic bronchiectasis. Overall, the incidence of AECOPD was consistently and significantly reduced in frequency from mean 4.7 (+/- 3.1) per patient-year before, to 0.6 (+/- 1.0) after the Ig treatment (p = 0.0001). There were twelve episodes of severe AECOPD (in seven cases) in the year prior, and one in the year after Ig treatment initiation (p = 0.016). Conclusions Ig treatment appears to decrease the frequency of moderate and severe recurrent AECOPD. A prospective, controlled evaluation of adjunctive Ig treatment to standard therapy of recurrent AECOPD is warranted.	[Cowan, Juthaporn; Corrales-Medina, Vicente; Cameron, D. William] Univ Ottawa, Div Infect Dis, Dept Med, Ottawa, ON, Canada; [Mulpuru, Sunita; Aaron, Shawn D.] Univ Ottawa, Div Respirol, Dept Med, Ottawa, ON, Canada; [Gaudet, Logan; Mulpuru, Sunita; Corrales-Medina, Vicente; Hawken, Steven; Cameron, Chris; Aaron, Shawn D.; Cameron, D. William] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute	Cowan, J (corresponding author), Univ Ottawa, Div Infect Dis, Dept Med, Ottawa, ON, Canada.	jcowan@toh.on.ca	Cameron, Bill/E-9180-2010	Cameron, Bill/0000-0002-0090-3539; Aaron, Shawn/0000-0002-4762-3542; Corrales-Medina, Vicente/0000-0002-9691-491X	University of Ottawa Department of Medicine at The Ottawa Hospital	University of Ottawa Department of Medicine at The Ottawa Hospital	This study was unfunded by any sponsor. DWC, SDA, SM, JC and VCM are recipients of research salary support from the University of Ottawa Department of Medicine at The Ottawa Hospital.	Aaron SD, 2013, THORAX, V68, P142, DOI 10.1136/thoraxjnl-2012-202432; Albert RK, 2011, NEW ENGL J MED, V365, P689, DOI 10.1056/NEJMoa1104623; Anthony RM, 2008, SCIENCE, V320, P373, DOI 10.1126/science.1154315; Anthony RM, 2011, NATURE, V475, P110, DOI 10.1038/nature10134; Arram EO, 2012, EGYPT J CHEST DIS TU, V61, P307, DOI 10.1016/j.ejcdt.2012.07.001; Bayry J, 2003, NEUROL SCI, V24, pS217, DOI 10.1007/s10072-003-0081-7; Bayry Jagadeesh, 2005, Expert Rev Clin Immunol, V1, P213, DOI 10.1586/1744666X.1.2.213; Bayry J, 2009, P NATL ACAD SCI USA, V106, pE24, DOI 10.1073/pnas.0900016106; Brightling CE, 2014, LANCET RESP MED, V2, P891, DOI 10.1016/S2213-2600(14)70187-0; Brusselle G, 2014, LANCET RESP MED, V2, P681, DOI 10.1016/S2213-2600(14)70163-8; Cameron EJ, 2012, CLIN EXP ALLERGY, V42, P1302, DOI 10.1111/j.1365-2222.2012.03979.x; Celik P, 2005, RESP MED, V99, P444, DOI 10.1016/j.rmed.2004.09.008; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Daele J, 2000, Acta Otorhinolaryngol Belg, V54, P373; Dentener MA, 2008, RESPIRATION, V76, P275, DOI 10.1159/000117386; Farrington CP, 2004, VACCINE, V22, P2064, DOI 10.1016/j.vaccine.2004.01.017; Fedor ME, 2006, ANN ALLERG ASTHMA IM, V97, P113, DOI 10.1016/S1081-1206(10)61380-4; Gelfand EW, 2012, NEW ENGL J MED, V367, P2015, DOI 10.1056/NEJMra1009433; Gershon AS, 2013, AM J RESP CRIT CARE, V187, P596, DOI 10.1164/rccm.201211-2044OC; Gilardin L, 2015, CAN MED ASSOC J, V187, P257, DOI 10.1503/cmaj.130375; Gompertz S, 2002, CHEST, V122, P289, DOI 10.1378/chest.122.1.289; Han Meilan K, 2011, Proc Am Thorac Soc, V8, P356, DOI 10.1513/pats.201102-016RM; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Hoyert Donna L, 2012, Natl Vital Stat Rep, V61, P1; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Kawano T, 2002, INT ARCH ALLERGY IMM, V128, P240, DOI 10.1159/000064258; Kazatchkine MD, 2001, NEW ENGL J MED, V345, P747, DOI 10.1056/NEJMra993360; Kherad Omar, 2010, Praxis (Bern 1994), V99, P235, DOI 10.1024/1661-8157/a000034; McCullers JA, 2014, NAT REV MICROBIOL, V12, P252, DOI 10.1038/nrmicro3231; Mittmann N, 2008, RESP MED, V102, P413, DOI 10.1016/j.rmed.2007.10.010; Morozumi M, 2010, J INFECT CHEMOTHER, V16, P78, DOI 10.1007/s10156-009-0021-4; Ochsenbein AF, 1999, SCIENCE, V286, P2156, DOI 10.1126/science.286.5447.2156; Paquin-Proulx D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075199; Phaff SJ, 2006, J ANTIMICROB CHEMOTH, V57, P741, DOI 10.1093/jac/dkl014; Qian JH, 2014, IMMUNOPHARM IMMUNOT, V36, P33, DOI 10.3109/08923973.2013.864668; Ray WA, 2004, NEW ENGL J MED, V351, P1089, DOI 10.1056/NEJMoa040582; Rennard SI, 2007, AM J RESP CRIT CARE, V175, P926, DOI 10.1164/rccm.200607-995OC; Sabroe I, 2013, THORAX, V68, P1085, DOI 10.1136/thoraxjnl-2013-203773; Salemi S, 2014, INT REV IMMUNOL; Seemungal TAR, 1998, AM J RESP CRIT CARE, V157, P1418, DOI 10.1164/ajrccm.157.5.9709032; Siedlar M, 2011, CLIN IMMUNOL, V139, P122, DOI 10.1016/j.clim.2011.01.002; Singanayagam Aran, 2013, Ann Am Thorac Soc, V10, P81, DOI 10.1513/AnnalsATS.201208-043OC; Soler-Cataluna JJ, 2005, THORAX, V60, P925, DOI 10.1136/thx.2005.040527; Toy EL, 2010, COPD, V7, P214, DOI 10.3109/15412555.2010.481697; Wedzicha JA, 2007, LANCET, V370, P786, DOI 10.1016/S0140-6736(07)61382-8; Yip NH, 2006, AM J RESP CRIT CARE, V173, P917, DOI 10.1164/rccm.200510-1609OC; Zhu JR, 2014, CHIN INFECT CONTROL, V13, P281	47	30	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142205	10.1371/journal.pone.0142205	http://dx.doi.org/10.1371/journal.pone.0142205			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26558756	Green Published, gold, Green Submitted			2022-12-27	WOS:000364433100060
J	Diez-Cirarda, M; Ojeda, N; Pena, J; Cabrera-Zubizarreta, A; Gomez-Beldarrain, MA; Gomez-Esteban, JC; Ibarretxe-Bilbao, N				Diez-Cirarda, Maria; Ojeda, Natalia; Pena, Javier; Cabrera-Zubizarreta, Alberto; Angeles Gomez-Beldarrain, Maria; Carlos Gomez-Esteban, Juan; Ibarretxe-Bilbao, Naroa			Neuroanatomical Correlates of Theory of Mind Deficit in Parkinson's Disease: A Multimodal Imaging Study	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; WHITE-MATTER; EMOTION RECOGNITION; DIFFUSION; BRAIN; DEMENTIA; ABNORMALITIES; DISORDERS; ONSET; GREY	Background Parkinson's disease (PD) patients show theory of mind (ToM) deficit since the early stages of the disease, and this deficit has been associated with working memory, executive functions and quality of life impairment. To date, neuroanatomical correlates of ToM have not been assessed with magnetic resonance imaging in PD. The main objective of this study was to assess cerebral correlates of ToM deficit in PD. The second objective was to explore the relationships between ToM, working memory and executive functions, and to analyse the neural correlates of ToM, controlling for both working memory and executive functions. Methods Thirty-seven PD patients (Hoehn and Yahr median = 2.0) and 15 healthy controls underwent a neuropsychological assessment and magnetic resonance images in a 3T-scanner were acquired. T1-weighted images were analysed with voxel-based morphometry, and white matter integrity and diffusivity measures were obtained from diffusion weighted images and analysed using tract-based spatial statistics. Results PD patients showed impairments in ToM, working memory and executive functions; grey matter loss and white matter reduction compared to healthy controls. Grey matter volume decrease in the precentral and postcentral gyrus, middle and inferior frontal gyrus correlated with ToM deficit in PD. White matter in the superior longitudinal fasciculus (adjacent to the parietal lobe) and white matter adjacent to the frontal lobe correlated with ToM impairment in PD. After controlling for executive functions, the relationship between ToM deficit and white matter remained significant for white matter areas adjacent to the precuneus and the parietal lobe. Conclusions Findings reinforce the existence of ToM impairment from the early Hoehn and Yahr stages in PD, and the findings suggest associations with white matter and grey matter volume decrease. This study contributes to better understand ToM deficit and its neural correlates in PD, which is a basic skill for development of healthy social relationships.	[Diez-Cirarda, Maria; Ojeda, Natalia; Pena, Javier; Ibarretxe-Bilbao, Naroa] Univ Deusto, Fac Psychol & Educ, Dept Methods & Expt Psychol, Bilbao, Basque Country, Spain; [Cabrera-Zubizarreta, Alberto] Hosp Galdakao, MR Unit, OSATEK, Galdakao, Basque Country, Spain; [Angeles Gomez-Beldarrain, Maria] Hosp Galdakao, Neurol Serv, Galdakao, Basque Country, Spain; [Carlos Gomez-Esteban, Juan] Biocruces Res Inst, Neurodegenerat Unit, Baracaldo, Biscay, Spain; [Carlos Gomez-Esteban, Juan] Cruces Univ Hosp, Neurol Serv, Baracaldo, Biscay, Spain	University of Deusto; Galdakao Hospital; Galdakao Hospital; Hospital Universitario Cruces	Ibarretxe-Bilbao, N (corresponding author), Univ Deusto, Fac Psychol & Educ, Dept Methods & Expt Psychol, Bilbao, Basque Country, Spain.	naroa.ibarretxe@deusto.es	Esteban, Juan Carlos Gomez/AAH-5755-2019; Cirarda, Maria Diez/AAS-9951-2020; Ibarretxe-Bilbao, Naroa/C-5575-2011; OJEDA, NATALIA/U-8897-2019	Esteban, Juan Carlos Gomez/0000-0002-4697-3890; Cirarda, Maria Diez/0000-0001-6768-189X; Ibarretxe-Bilbao, Naroa/0000-0002-2434-5252; OJEDA, NATALIA/0000-0002-0952-0649; Pena, Javier/0000-0002-0041-7020	Department of Health of the Basque Government [2011111117]; Spanish Ministry of Economy and Competitiveness [PSI2012-32441]	Department of Health of the Basque Government; Spanish Ministry of Economy and Competitiveness(Spanish Government)	This study was supported by the Department of Health of the Basque Government [2011111117 to NIB] and the Spanish Ministry of Economy and Competitiveness [PSI2012-32441 to NIB]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AL, 2011, CHARACTERIZATION CER, V1, P423, DOI [10.1089/brain.2011.0071, DOI 10.1089/BRAIN.2011.0071]; Barnea-Goraly N, 2004, BIOL PSYCHIAT, V55, P323, DOI 10.1016/j.biopsych.2003.10.022; Barnes J, 2010, NEUROIMAGE, V53, P1244, DOI 10.1016/j.neuroimage.2010.06.025; Beyer MK, 2007, J NEUROL NEUROSUR PS, V78, P254, DOI 10.1136/jnnp.2006.093849; Bodden ME, 2010, PARKINSONISM RELAT D, V16, P466, DOI 10.1016/j.parkreldis.2010.04.014; Bodden ME, 2010, MOVEMENT DISORD, V25, P13, DOI 10.1002/mds.22818; Carrington SJ, 2009, HUM BRAIN MAPP, V30, P2313, DOI 10.1002/hbm.20671; Charlton RA, 2009, PSYCHOL AGING, V24, P338, DOI 10.1037/a0015225; Cooper H, 2009, HDB RES SYNTHESIS ME; Costa A, 2013, BEHAV NEUROL, V27, P523, DOI [10.3233/BEN-129018, 10.1155/2013/903127]; Douaud G, 2007, BRAIN, V130, P2375, DOI 10.1093/brain/awm184; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; FLETCHER PC, 1995, COGNITION, V57, P109, DOI 10.1016/0010-0277(95)00692-R; GALLAGHER C, 2013, WHITE MATTER MICROST, V19, P349, DOI DOI 10.1017/S1355617712001373; Gallagher HL, 2000, NEUROPSYCHOLOGIA, V38, P11, DOI 10.1016/S0028-3932(99)00053-6; Ghosh BCP, 2012, BRAIN, V135, P2089, DOI 10.1093/brain/aws128; Goldman JG, 2011, MINERVA MED, V102, P441; Hilti LM, 2013, BRAIN, V136, P318, DOI 10.1093/brain/aws316; Hoehn MM, 1998, NEUROLOGY, V50, P318, DOI 10.1212/WNL.50.2.318; Hojat M, 2004, ADV HEALTH SCI EDUC, V9, P241, DOI 10.1023/B:AHSE.0000038173.00909.f6; Ibarretxe-Bilbao N, 2009, EUR J NEUROSCI, V30, P1162, DOI 10.1111/j.1460-9568.2009.06892.x; Jones DK, 2010, NMR BIOMED, V23, P803, DOI 10.1002/nbm.1543; Kaufer DI, 2000, J NEUROPSYCH CLIN N, V12, P233, DOI 10.1176/appi.neuropsych.12.2.233; Kawamura M, 2007, J NEUROL, V254, P49, DOI 10.1007/s00415-007-4008-8; Keller TA, 2007, NEUROREPORT, V18, P23, DOI 10.1097/01.wnr.0000239965.21685.99; Kendi ATK, 2008, AM J NEURORADIOL, V29, P501, DOI 10.3174/ajnr.A0850; Kumfor F, 2014, BRAIN, V137, P3061, DOI 10.1093/brain/awu246; Lee EY, 2013, PARKINSONISM RELAT D, V19, P1088, DOI 10.1016/j.parkreldis.2013.07.018; Litvan I, 2012, MOVEMENT DISORD, V27, P349, DOI 10.1002/mds.24893; Lobo A., 2001, REVALIDACION NORMALI; Makris N, 2005, CEREB CORTEX, V15, P854, DOI 10.1093/cercor/bhh186; MARTINEZMARTIN P, 1994, MOVEMENT DISORD, V9, P76, DOI 10.1002/mds.870090112; Matsui H, 2007, ACTA NEUROL SCAND, V116, P177, DOI 10.1111/j.1600-0404.2007.00838.x; Melzer TR, 2013, NEUROLOGY, V80, P1841, DOI 10.1212/WNL.0b013e3182929f62; Melzer TR, 2012, J NEUROL NEUROSUR PS, V83, P188, DOI 10.1136/jnnp-2011-300828; Monetta L, 2009, CORTEX, V45, P972, DOI 10.1016/j.cortex.2009.02.021; Pena J, 2014, NEUROLOGY, V83, P2167, DOI 10.1212/WNL.0000000000001043; Pena-Casanova J, 2009, ARCH CLIN NEUROPSYCH, V24, P321, DOI 10.1093/arclin/acp038; Poletti M, 2012, NEUROSCI BIOBEHAV R, V36, P2147, DOI 10.1016/j.neubiorev.2012.07.004; Poletti M, 2011, BEHAV BRAIN RES, V219, P342, DOI 10.1016/j.bbr.2011.01.010; Pousa E, 1999, MEASUREMENT THEORY M; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Santangelo G, 2012, MOVEMENT DISORD, V27, P98, DOI 10.1002/mds.23949; Schurz M, 2014, FRACTIONATING THEORY, DOI [10.1016/j.neubiorev.2014.01.009, DOI 10.1016/J.NEUBIOREV.2014.01.009]; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Shulman KI, 2000, INT J GERIATR PSYCH, V15, P548, DOI 10.1002/1099-1166(200006)15:6<548::AID-GPS242>3.0.CO;2-U; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Sugranyes G, 2011, AUTISM SPECTRUM DISO, V6, DOI [10.1371/journal.pone.0025322, DOI 10.1371/JOURNAL.PONE.0025322]; Theilmann RJ, 2013, WHITE MATTER CHANGES, V4, DOI [10.3389/fneur.2013.00037, DOI 10.3389/FNEUR.2013.00037]; TOMLINSON CL, 2010, SYSTEMATIC REV LEVOD, V25, P2649, DOI DOI 10.1002/MDS.23429; Von Der Heide RJ, 2013, BRAIN, V136, P1692, DOI 10.1093/brain/awt094; Wechsler D., 2012, WAIS 4 KASIKIRJA; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Yip JTH, 2003, MOVEMENT DISORD, V18, P1115, DOI 10.1002/mds.10497; Yu RL, 2013, TRANSL NEURODEGENER, V2, DOI 10.1186/2047-9158-2-7; Zheng Z, 2013, HUM BRAIN MAPP	58	19	20	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142234	10.1371/journal.pone.0142234	http://dx.doi.org/10.1371/journal.pone.0142234			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559669	Green Submitted, Green Published, gold			2022-12-27	WOS:000364433100066
J	Fowler, EAF; Horner, JR				Fowler, Elizabeth A. Freedman; Horner, John R.			A New Brachylophosaurin Hadrosaur (Dinosauria: Ornithischia) with an Intermediate Nasal Crest from the Campanian Judith River Formation of Northcentral Montana	PLOS ONE			English	Article							2 MEDICINE FORMATION; LONG-BONE HISTOLOGY; MAIASAURA-PEEBLESORUM; KAIPAROWITS FORMATION; WESTERN INTERIOR; CRANIAL ANATOMY; SOUTHERN UTAH; 40AR/39AR AGE; GROWTH; REVISION	Background Brachylophosaurini is a clade of hadrosaurine dinosaurs currently known from the Campanian (Late Cretaceous) of North America. Its members include: Acristavus gagslarsoni, which lacks a nasal crest; Brachylophosaurus canadensis, which possesses a flat paddleshaped nasal crest projecting posteriorly over the dorsal skull roof; and Maiasaura peeblesorum, which possesses a dorsally-projecting nasofrontal crest. Acristavus, from the lower Two Medicine Formation of Montana (similar to 81-80 Ma), is hypothesized to be the ancestral member of the clade. Brachylophosaurus specimens are from the middle Oldman Formation of Alberta and equivalent beds in the Judith River Formation of Montana; the upper Oldman Formation is dated 77.8 Ma. Methodology/Principal Findings A new brachylophosaurin hadrosaur, Probrachylophosaurus bergei (gen. et sp. nov.) is described and phylogenetically analyzed based on the skull and postcranium of a large individual from the Judith River Formation of northcentral Montana (79.8-79.5 Ma); the horizon is equivalent to the lower Oldman Formation of Alberta. Cranial morphology of Probrachylophosaurus, most notably the nasal crest, is intermediate between Acristavus and Brachylophosaurus. In Brachylophosaurus, the nasal crest lengthens and flattens ontogenetically, covering the supratemporal fenestrae in large adults. The smaller nasal crest of Probrachylophosaurus is strongly triangular in cross section and only minimally overhangs the supratemporal fenestrae, similar to an ontogenetically earlier stage of Brachylophosaurus. Sutural fusion and tibial osteohistology reveal that the holotype of Probrachylophosaurus was relatively more mature than a similarly large Brachylophosaurus specimen; thus, Probrachylophosaurus is not simply an immature Brachylophosaurus. Conclusions/Significance The small triangular posteriorly oriented nasal crest of Probrachylophosaurus is proposed to represent a transitional nasal morphology between that of a non-crested ancestor such as Acristavus and the large flat posteriorly oriented nasal crest of adult Brachylophosaurus. Because Probrachylophosaurus is stratigraphically and morphologically intermediate between these taxa, Probrachylophosaurus is hypothesized to be an intermediate member of the Acristavus-Brachylophosaurus evolutionary lineage. Background Brachylophosaurini is a clade of hadrosaurine dinosaurs currently known from the Campanian (Late Cretaceous) of North America. Its members include: Acristavus gagslarsoni, which lacks a nasal crest; Brachylophosaurus canadensis, which possesses a flat paddleshaped nasal crest projecting posteriorly over the dorsal skull roof; and Maiasaura peeblesorum, which possesses a dorsally-projecting nasofrontal crest. Acristavus, from the lower Two Medicine Formation of Montana (similar to 81-80 Ma), is hypothesized to be the ancestral member of the clade. Brachylophosaurus specimens are from the middle Oldman Formation of Alberta and equivalent beds in the Judith River Formation of Montana; the upper Oldman Formation is dated 77.8 Ma. Methodology/Principal Findings A new brachylophosaurin hadrosaur, Probrachylophosaurus bergei (gen. et sp. nov.) is described and phylogenetically analyzed based on the skull and postcranium of a large individual from the Judith River Formation of northcentral Montana (79.8-79.5 Ma); the horizon is equivalent to the lower Oldman Formation of Alberta. Cranial morphology of Probrachylophosaurus, most notably the nasal crest, is intermediate between Acristavus and Brachylophosaurus. In Brachylophosaurus, the nasal crest lengthens and flattens ontogenetically, covering the supratemporal fenestrae in large adults. The smaller nasal crest of Probrachylophosaurus is strongly triangular in cross section and only minimally overhangs the supratemporal fenestrae, similar to an ontogenetically earlier stage of Brachylophosaurus. Sutural fusion and tibial osteohistology reveal that the holotype of Probrachylophosaurus was relatively more mature than a similarly large Brachylophosaurus specimen; thus, Probrachylophosaurus is not simply an immature Brachylophosaurus. Conclusions/Significance The small triangular posteriorly oriented nasal crest of Probrachylophosaurus is proposed to represent a transitional nasal morphology between that of a non-crested ancestor such as Acristavus and the large flat posteriorly oriented nasal crest of adult Brachylophosaurus. Because Probrachylophosaurus is stratigraphically and morphologically intermediate between these taxa, Probrachylophosaurus is hypothesized to be an intermediate member of the Acristavus-Brachylophosaurus evolutionary lineage. Background Brachylophosaurini is a clade of hadrosaurine dinosaurs currently known from the Campanian (Late Cretaceous) of North America. Its members include: Acristavus gagslarsoni, which lacks a nasal crest; Brachylophosaurus canadensis, which possesses a flat paddleshaped nasal crest projecting posteriorly over the dorsal skull roof; and Maiasaura peeblesorum, which possesses a dorsally-projecting nasofrontal crest. Acristavus, from the lower Two Medicine Formation of Montana (similar to 81-80 Ma), is hypothesized to be the ancestral member of the clade. Brachylophosaurus specimens are from the middle Oldman Formation of Alberta and equivalent beds in the Judith River Formation of Montana; the upper Oldman Formation is dated 77.8 Ma. Methodology/Principal Findings A new brachylophosaurin hadrosaur, Probrachylophosaurus bergei (gen. et sp. nov.) is described and phylogenetically analyzed based on the skull and postcranium of a large individual from the Judith River Formation of northcentral Montana (79.8-79.5 Ma); the horizon is equivalent to the lower Oldman Formation of Alberta. Cranial morphology of Probrachylophosaurus, most notably the nasal crest, is intermediate between Acristavus and Brachylophosaurus. In Brachylophosaurus, the nasal crest lengthens and flattens ontogenetically, covering the supratemporal fenestrae in large adults. The smaller nasal crest of Probrachylophosaurus is strongly triangular in cross section and only minimally overhangs the supratemporal fenestrae, similar to an ontogenetically earlier stage of Brachylophosaurus. Sutural fusion and tibial osteohistology reveal that the holotype of Probrachylophosaurus was relatively more mature than a similarly large Brachylophosaurus specimen; thus, Probrachylophosaurus is not simply an immature Brachylophosaurus. Conclusions/Significance The small triangular posteriorly oriented nasal crest of Probrachylophosaurus is proposed to represent a transitional nasal morphology between that of a non-crested ancestor such as Acristavus and the large flat posteriorly oriented nasal crest of adult Brachylophosaurus. Because Probrachylophosaurus is stratigraphically and morphologically intermediate between these taxa, Probrachylophosaurus is hypothesized to be an intermediate member of the Acristavus-Brachylophosaurus evolutionary lineage. Background Brachylophosaurini is a clade of hadrosaurine dinosaurs currently known from the Campanian (Late Cretaceous) of North America. Its members include: Acristavus gagslarsoni, which lacks a nasal crest; Brachylophosaurus canadensis, which possesses a flat paddleshaped nasal crest projecting posteriorly over the dorsal skull roof; and Maiasaura peeblesorum, which possesses a dorsally-projecting nasofrontal crest. Acristavus, from the lower Two Medicine Formation of Montana (similar to 81-80 Ma), is hypothesized to be the ancestral member of the clade. Brachylophosaurus specimens are from the middle Oldman Formation of Alberta and equivalent beds in the Judith River Formation of Montana; the upper Oldman Formation is dated 77.8 Ma. Methodology/Principal Findings A new brachylophosaurin hadrosaur, Probrachylophosaurus bergei (gen. et sp. nov.) is described and phylogenetically analyzed based on the skull and postcranium of a large individual from the Judith River Formation of northcentral Montana (79.8-79.5 Ma); the horizon is equivalent to the lower Oldman Formation of Alberta. Cranial morphology of Probrachylophosaurus, most notably the nasal crest, is intermediate between Acristavus and Brachylophosaurus. In Brachylophosaurus, the nasal crest lengthens and flattens ontogenetically, covering the supratemporal fenestrae in large adults. The smaller nasal crest of Probrachylophosaurus is strongly triangular in cross section and only minimally overhangs the supratemporal fenestrae, similar to an ontogenetically earlier stage of Brachylophosaurus. Sutural fusion and tibial osteohistology reveal that the holotype of Probrachylophosaurus was relatively more mature than a similarly large Brachylophosaurus specimen; thus, Probrachylophosaurus is not simply an immature Brachylophosaurus. Conclusions/Significance The small triangular posteriorly oriented nasal crest of Probrachylophosaurus is proposed to represent a transitional nasal morphology between that of a non-crested ancestor such as Acristavus and the large flat posteriorly oriented nasal crest of adult Brachylophosaurus. Because Probrachylophosaurus is stratigraphically and morphologically intermediate between these taxa, Probrachylophosaurus is hypothesized to be an intermediate member of the Acristavus-Brachylophosaurus evolutionary lineage. Background Brachylophosaurini is a clade of hadrosaurine dinosaurs currently known from the Campanian (Late Cretaceous) of North America. Its members include: Acristavus gagslarsoni, which lacks a nasal crest; Brachylophosaurus canadensis, which possesses a flat paddleshaped nasal crest projecting posteriorly over the dorsal skull roof; and Maiasaura peeblesorum, which possesses a dorsally-projecting nasofrontal crest. Acristavus, from the lower Two Medicine Formation of Montana (similar to 81-80 Ma), is hypothesized to be the ancestral member of the clade. Brachylophosaurus specimens are from the middle Oldman Formation of Alberta and equivalent beds in the Judith River Formation of Montana; the upper Oldman Formation is dated 77.8 Ma. Methodology/Principal Findings A new brachylophosaurin hadrosaur, Probrachylophosaurus bergei (gen. et sp. nov.) is described and phylogenetically analyzed based on the skull and postcranium of a large individual from the Judith River Formation of northcentral Montana (79.8-79.5 Ma); the horizon is equivalent to the lower Oldman Formation of Alberta. Cranial morphology of Probrachylophosaurus, most notably the nasal crest, is intermediate between Acristavus and Brachylophosaurus. In Brachylophosaurus, the nasal crest lengthens and flattens ontogenetically, covering the supratemporal fenestrae in large adults. The smaller nasal crest of Probrachylophosaurus is strongly triangular in cross section and only minimally overhangs the supratemporal fenestrae, similar to an ontogenetically earlier stage of Brachylophosaurus. Sutural fusion and tibial osteohistology reveal that the holotype of Probrachylophosaurus was relatively more mature than a similarly large Brachylophosaurus specimen; thus, Probrachylophosaurus is not simply an immature Brachylophosaurus. Conclusions/Significance The small triangular posteriorly oriented nasal crest of Probrachylophosaurus is proposed to represent a transitional nasal morphology between that of a non-crested ancestor such as Acristavus and the large flat posteriorly oriented nasal crest of adult Brachylophosaurus. Because Probrachylophosaurus is stratigraphically and morphologically intermediate between these taxa, Probrachylophosaurus is hypothesized to be an intermediate member of the Acristavus-Brachylophosaurus evolutionary lineage. Background Brachylophosaurini is a clade of hadrosaurine dinosaurs currently known from the Campanian (Late Cretaceous) of North America. Its members include: Acristavus gagslarsoni, which lacks a nasal crest; Brachylophosaurus canadensis, which possesses a flat paddleshaped nasal crest projecting posteriorly over the dorsal skull roof; and Maiasaura peeblesorum, which possesses a dorsally-projecting nasofrontal crest. Acristavus, from the lower Two Medicine Formation of Montana (similar to 81-80 Ma), is hypothesized to be the ancestral member of the clade. Brachylophosaurus specimens are from the middle Oldman Formation of Alberta and equivalent beds in the Judith River Formation of Montana; the upper Oldman Formation is dated 77.8 Ma. Methodology/Principal Findings A new brachylophosaurin hadrosaur, Probrachylophosaurus bergei (gen. et sp. nov.) is described and phylogenetically analyzed based on the skull and postcranium of a large individual from the Judith River Formation of northcentral Montana (79.8-79.5 Ma); the horizon is equivalent to the lower Oldman Formation of Alberta. Cranial morphology of Probrachylophosaurus, most notably the nasal crest, is intermediate between Acristavus and Brachylophosaurus. In Brachylophosaurus, the nasal crest lengthens and flattens ontogenetically, covering the supratemporal fenestrae in large adults. The smaller nasal crest of Probrachylophosaurus is strongly triangular in cross section and only minimally overhangs the supratemporal fenestrae, similar to an ontogenetically earlier stage of Brachylophosaurus. Sutural fusion and tibial osteohistology reveal that the holotype of Probrachylophosaurus was relatively more mature than a similarly large Brachylophosaurus specimen; thus, Probrachylophosaurus is not simply an immature Brachylophosaurus. Conclusions/Significance The small triangular posteriorly oriented nasal crest of Probrachylophosaurus is proposed to represent a transitional nasal morphology between that of a non-crested ancestor such as Acristavus and the large flat posteriorly oriented nasal crest of adult Brachylophosaurus. Because Probrachylophosaurus is stratigraphically and morphologically intermediate between these taxa, Probrachylophosaurus is hypothesized to be an intermediate member of the Acristavus-Brachylophosaurus evolutionary lineage.	[Fowler, Elizabeth A. Freedman; Horner, John R.] Montana State Univ, Museum Rockies, Bozeman, MT 59717 USA; [Fowler, Elizabeth A. Freedman; Horner, John R.] Montana State Univ, Dept Earth Sci, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman	Fowler, EAF (corresponding author), Montana State Univ, Museum Rockies, Bozeman, MT 59717 USA.	eafreedman@gmail.com	Freedman, Elizabeth/J-1752-2012	Freedman, Elizabeth/0000-0002-5763-5272	Doris O. and Samuel P. Welles Research Fund (University of California Museum of Paleontology); M.A. Fritz Travel Grant for the Advancement of Studies in Palaeontology (Royal Ontario Museum); Jackson School of Geosciences Student Member Travel Grant (Society of Vertebrate Paleontology); College of Letters and Science Student Research Travel Grant (Montana State University)	Doris O. and Samuel P. Welles Research Fund (University of California Museum of Paleontology); M.A. Fritz Travel Grant for the Advancement of Studies in Palaeontology (Royal Ontario Museum); Jackson School of Geosciences Student Member Travel Grant (Society of Vertebrate Paleontology); College of Letters and Science Student Research Travel Grant (Montana State University)	Fieldwork and research funding was generously provided to JRH by the Ameya Preserve, Damaris Wagoner, David Sands, and other generous donors to the Museum of the Rockies Student Fund and Horner Fund; and to EAFF by the Tampa Bay Fossil Club and the Montana State University Department of Cell Biology and Neuroscience. Travel funding was generously provided to EAFF by the Doris O. and Samuel P. Welles Research Fund (University of California Museum of Paleontology), the M.A. Fritz Travel Grant for the Advancement of Studies in Palaeontology (Royal Ontario Museum), the Jackson School of Geosciences Student Member Travel Grant (Society of Vertebrate Paleontology), and the College of Letters and Science Student Research Travel Grant (Montana State University). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell PR, 2011, ACTA PALAEONTOL POL, V56, P703, DOI 10.4202/app.2010.0061; Bell PR, 2011, CRETACEOUS RES, V32, P30, DOI 10.1016/j.cretres.2010.10.002; Brinkman DB, 2004, PALAEOGEOGR PALAEOCL, V213, P295, DOI 10.1016/j.palaeo.2004.07.016; Campione NE, 2013, PALAEOBIO PALAEOENV, V93, P65, DOI 10.1007/s12549-012-0097-1; Campione NE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025186; Cuthbertson RS, 2010, ZOOL J LINN SOC-LOND, V159, P373, DOI 10.1111/j.1096-3642.2009.00612.x; Dilkes DW, 2000, T ROY SOC EDIN-EARTH, V90, P87, DOI 10.1017/S0263593300007185; Dilkes DW, 1993, THESIS, P447; DODSON P, 1975, SYST ZOOL, V24, P37, DOI 10.2307/2412696; EBERTH DA, 1993, CAN J EARTH SCI, V30, P174, DOI 10.1139/e93-016; Eberth DA, 2011, INT HADR S DRUMH ALB, P54; Eberth DA, 2005, LIFE O PAST, P54; Evans DC, 2007, J VERTEBR PALEONTOL, V27, P373, DOI 10.1671/0272-4634(2007)27[373:AAROLM]2.0.CO;2; Evans DC, 2010, ZOOL J LINN SOC-LOND, V159, P398, DOI 10.1111/j.1096-3642.2009.00611.x; Gallagher WB, 1996, J VERTEBRATE PALE S3, V16, p36A; Gates TA, 2007, ZOOL J LINN SOC-LOND, V151, P351, DOI 10.1111/j.1096-3642.2007.00349.x; Gates TA, 2011, J VERTEBR PALEONTOL, V31, P798, DOI 10.1080/02724634.2011.577854; GOODWIN MB, 1989, CAN J EARTH SCI, V26, P1384, DOI 10.1139/e89-118; Haeckel E, 1901, RIDDLE UNIVERSE CLOS; Haeckel Ernst, 1866, GENERELLE MORPHOLOGI; Horner J.R., 1988, Journal of Vertebrate Paleontology, V8, P314; Horner J.R., 1983, J VERTEBR PALEONTOL, V3, P29, DOI [DOI 10.1080/02724634.1983.10011954, 10.1080/02724634.1983.10011954]; Horner JR, 2004, DINOSAURIA, 2ND EDITION, P438; Horner JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016574; Horner JR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007626; Horner JR, 2009, J VERTEBR PALEONTOL, V29, P734, DOI 10.1671/039.029.0312; Horner John R., 1994, P312; Horner JR, 2000, J VERTEBR PALEONTOL, V20, P115, DOI 10.1671/0272-4634(2000)020[0115:LBHOTH]2.0.CO;2; HORNER JR, 1979, NATURE, V282, P296, DOI 10.1038/282296a0; Horner JR, 1989, J VERTEBR PALEONTOL, V9, p25A; Horner JR, 1984, FIELD C GUIDEBOOK, P299; Horner JR, 1992, MUSEUM ROCKIES OCCAS, V2, P1; Hubner TR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029958; Jinnah ZA, 2009, CRETACEOUS RES, V30, P287, DOI 10.1016/j.cretres.2008.07.012; Kirkland James I., 2013, P153; Kohler M, 2012, NATURE, V487, P358, DOI 10.1038/nature11264; Lambe L., 1914, Ottawa Naturalist, V27; Lamm ET, 2013, BONE HISTOLOGY OF FOSSIL TETRAPODS: ADVANCING METHODS, ANALYSIS, AND INTERPRETATION, P55; Langston Jr W, 1960, FIELDIANA GEOLOGY ME, V3, P314; LaRock JW, 2001, THESIS, P61; Leiggi Patrick, 1994, P59; Mcgarrity CT, 2013, ZOOL J LINN SOC-LOND, V167, P531, DOI 10.1111/zoj.12009; Peng J-H, 2001, PROV MUS ALBERTA NAT, V25, P1, DOI DOI 10.5962/BHL.TITLE.115853; Prieto-Marquez A, 2005, J VERTEBR PALEONTOL, V25, P144, DOI 10.1671/0272-4634(2005)025[0144:NIOTCO]2.0.CO;2; Prieto-Marquez Albert, 2007, P91; Prieto-Marquez A, 2014, J SYST PALAEONTOL, V12, P133, DOI 10.1080/14772019.2013.770417; Prieto-Marquez A, 2011, PALAEONTOLOGY, V54, P773, DOI 10.1111/j.1475-4983.2011.01053.x; Prieto-Marquez A, 2010, ZOOL J LINN SOC-LOND, V159, P435, DOI 10.1111/j.1096-3642.2009.00617.x; Prieto-Marquez A, 2010, J VERTEBR PALEONTOL, V30, P813, DOI 10.1080/02724631003763508; Prieto-Marquez A, 2010, J VERTEBR PALEONTOL, V30, P838, DOI 10.1080/02724631003762971; Renne PR, 2010, GEOCHIM COSMOCHIM AC, V74, P5349, DOI 10.1016/j.gca.2010.06.017; Renne PR, 1998, CHEM GEOL, V145, P117, DOI 10.1016/S0009-2541(97)00159-9; Roberts EM, 2005, CRETACEOUS RES, V26, P307, DOI 10.1016/j.cretres.2005.01.002; ROGERS RR, 1993, CAN J EARTH SCI, V30, P1066, DOI 10.1139/e93-090; Rozhdestvensky AK, 1965, PALEONTOL ZH, V3, P95; Ryan MJ, 2007, J VERTEBR PALEONTOL, V27, P944, DOI 10.1671/0272-4634(2007)27[944:AROTLC]2.0.CO;2; Ryan Michael J., 2010, P181; Ryan MJ, 2005, LIFE O PAST, P312; Sampson SD, 1997, ZOOL J LINN SOC-LOND, V121, P293, DOI 10.1111/j.1096-3642.1997.tb00340.x; Scannella JB, 2014, P NATL ACAD SCI USA, V111, P10245, DOI 10.1073/pnas.1313334111; Schott R, 2010, J VERTEBR PALEONTOL, p159A; Sternberg C. M., 1953, Bulletin National Museum of Canada, VNo. 128, P275; Sues HD, 2009, P R SOC B, V276, P2549, DOI 10.1098/rspb.2009.0229; Swofford DL, 2002, PAUP 4 0B10 PHYLOGEN; THOMAS R G, 1990, Cretaceous Research, V11, P125, DOI 10.1016/S0195-6671(05)80030-8; Trexler DL, 1995, THESIS, P235; Tsuihiji T, 2011, J VERTEBR PALEONTOL, V31, P497, DOI 10.1080/02724634.2011.557116; Van Itterbeeck J, 2005, CRETACEOUS RES, V26, P699, DOI 10.1016/j.cretres.2005.03.004; Varricchio DJ, 2010, GEOL SOC AM SPEC PAP, V465, P269, DOI 10.1130/2010.2465(17); VARRICCHIO DJ, 1993, CAN J EARTH SCI, V30, P997, DOI 10.1139/e93-083; Woodward HN, 2015, PALEOBIOLOGY; Xing Hai, 2012, Vertebrata Palasiatica, V50, P160	72	44	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0141304	10.1371/journal.pone.0141304	http://dx.doi.org/10.1371/journal.pone.0141304			55	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26560175	gold, Green Published, Green Submitted			2022-12-27	WOS:000364433100031
J	Hirata, K; Wake, M; Takahashi, T; Nakazato, J; Yagi, N; Miyagi, T; Shimotakahara, J; Mototake, H; Tengan, T; Takara, TR; Yamaguchi, Y				Hirata, Kazuhito; Wake, Minoru; Takahashi, Takanori; Nakazato, Jun; Yagi, Nobuhito; Miyagi, Tadayoshi; Shimotakahara, Junichi; Mototake, Hidemitsu; Tengan, Toshiho; Takara, Tsuyoshi R.; Yamaguchi, Yutaka			Clinical Predictors for Delayed or Inappropriate Initial Diagnosis of Type A Acute Aortic Dissection in the Emergency Room	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; CORONARY-ARTERY OCCLUSION; TRANSTHORACIC ECHOCARDIOGRAPHY; MANAGEMENT; FEATURES	Background Initial diagnosis of acute aortic dissection (AAD) in the emergency room (ER) is sometimes difficult or delayed. The aim of this study is to define clinical predictors related to inappropriate or delayed diagnosis of Stanford type A AAD. Methods We conducted a retrospective analysis of 127 consecutive patients with type A AAD who presented to the ER within 12 h of symptom onset (age: 69.0 +/- 15.4 years, male/female = 49/78). An inappropriate initial diagnosis (IID) was considered if AAD was not included in the differential diagnosis or if chest computed tomography or echocardiography was not performed as initial imaging tests. Clinical variables were compared between IID and appropriate diagnosis group. The time to final diagnosis (TFD) was also evaluated. Delayed diagnosis (DD) was defined as TFD > third quartile. Clinical factors predicting DD were evaluated in comparison with early diagnosis (defined as TFD within the third quartile). In addition, TFD was compared with respect to each clinical variable using a rank sum test. Results An IID was determined for 37% of patients. Walk-in (WI) visit to the ER [odds ratio (OR) 2.6, 95% confidence interval (CI) = 1.01-6.72, P = 0.048] and coronary malperfusion (CM, OR = 6.48, 95% CI = 1.14-36.82, P = 0.035) were predictors for IID. Overall, the median TFD was 1.5 h (first/third quartiles = 0.5/4.0 h). DD (> 4.5 h) was observed in 27 cases (21.3%). TFD was significantly longer in WI patients (median and first/third quartiles = 1.0 and 0.5/2.85 h for the ambulance group vs. 3.0 and 1.0/8.0 h for the WI group, respectively; P = 0.003). Multivariate analysis revealed that WI visit was the only predictor for DD (OR = 3.72, 95% CI = 1.39-9.9, P = 0.009). TFD was significantly shorter for appropriate diagnoses than for IIDs (1.0 vs. 6.0 h, respectively; P < 0.0001). Conclusions WI visit to the ER and CM were predictors for IID, and WI was the only predictor for DD in acute type A AAD in the community hospital.	[Hirata, Kazuhito; Wake, Minoru; Takahashi, Takanori; Nakazato, Jun; Yagi, Nobuhito; Miyagi, Tadayoshi; Shimotakahara, Junichi] Okinawa Chubu Hosp, Div Cardiol, Uruma, Okinawa, Japan; [Mototake, Hidemitsu; Tengan, Toshiho] Okinawa Chubu Hosp, Div Cardiovasc Surg, Uruma, Okinawa, Japan; [Takara, Tsuyoshi R.; Yamaguchi, Yutaka] Okinawa Chubu Hosp, Div Emergency Dept, Uruma, Okinawa, Japan	Okinawa Chubu Central Hospital; Okinawa Chubu Central Hospital; Okinawa Chubu Central Hospital	Hirata, K (corresponding author), Okinawa Chubu Hosp, Div Cardiol, 281 Miyasato, Uruma, Okinawa, Japan.	kheart911@yahoo.co.jp						Ashida K, 2000, JPN CIRC J, V64, P130, DOI 10.1253/jcj.64.130; Barabas M, 2000, CATHETER CARDIO INTE, V51, P74, DOI 10.1002/1522-726X(200009)51:1<74::AID-CCD17>3.0.CO;2-F; Blankenship J, 1989, J AM COLL CARDIOL, V15, P1579; Cecconi M, 2012, AM HEART J, V163, P112, DOI 10.1016/j.ahj.2011.09.022; ERIKSEN UH, 1992, EUR HEART J, V13, P840, DOI 10.1093/oxfordjournals.eurheartj.a060266; Hagan PG, JAMA, V283, P897; Harris KM, 2011, CIRCULATION, V124, P1911, DOI 10.1161/CIRCULATIONAHA.110.006320; Hirata K, 2012, ACUTE CORONARY SYNDR, P99; Hirata K, 2010, J CARDIOL, V56, P147, DOI 10.1016/j.jjcc.2010.03.007; HIRST AE, 1958, MEDICINE, V37, P217, DOI 10.1097/00005792-195809000-00003; Klompas M, 2002, JAMA-J AM MED ASSOC, V287, P2261; Kosuge M, 2013, AM J CARDIOL, V112, P424, DOI 10.1016/j.amjcard.2013.03.050; Kurabayashi M, 2011, J CARDIOL, V58, P287, DOI 10.1016/j.jjcc.2011.07.008; Kurisu S, 2004, HEART, V90, P1059, DOI 10.1136/hrt.2003.026799; MELCHIOR T, 1993, INT J CARDIOL, V42, P1, DOI 10.1016/0167-5273(93)90095-X; Nallamothu BK, 2002, AM J MED, V113, P468, DOI 10.1016/S0002-9343(02)01254-8; Nienaber CA, 2003, CIRCULATION, V108, P628, DOI 10.1161/01.CIR.0000087009.16755.E4; Nikus KC, 2008, J ELECTROCARDIOL, V41, P626, DOI 10.1016/j.jelectrocard.2008.06.020; Rapezzi C, 2008, AM J CARDIOL, V102, P1399, DOI 10.1016/j.amjcard.2008.07.013; Shirakabe A, 2008, CIRC J, V72, P986, DOI 10.1253/circj.72.986; Sobczyk D, 2015, CARDIOVASC ULTRASOUN, V13, DOI 10.1186/s12947-015-0008-5; SPITTELL PC, 1993, MAYO CLIN PROC, V68, P642, DOI 10.1016/S0025-6196(12)60599-0; Tsai TT, 2005, CIRCULATION, V112, P3802, DOI 10.1161/CIRCULATIONAHA.105.534198; Woolev CF, 1988, PROG CARDIOVASC DIS, V40, P56; Zhan S, 2012, J CLIN HYPERTENS GRE, V14, P256	25	15	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0141929	10.1371/journal.pone.0141929	http://dx.doi.org/10.1371/journal.pone.0141929			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559676	Green Submitted, gold, Green Published			2022-12-27	WOS:000364433100046
J	Holgado, B; Vecchia, FM; Fortuny, J; Bernardini, F; Tuniz, C				Holgado, Borja; Marco Dalla Vecchia, Fabio; Fortuny, Josep; Bernardini, Federico; Tuniz, Claudio			A Reappraisal of the Purported Gastric Pellet with Pterosaurian Bones from the Upper Triassic of Italy	PLOS ONE			English	Article							DIAPSIDA; ARCHOSAURS; REVISION; REPTILIA; ONTOGENY; ANATOMY; ORIGIN; SKULL	A small accumulation of bones from the Norian (Upper Triassic) of the Seazza Brook Valley (Carnic Prealps, Northern Italy) was originally (1989) identified as a gastric pellet made of pterosaur skeletal elements. The specimen has been reported in literature as one of the very few cases of gastric ejecta containing pterosaur bones since then. However, the detailed analysis of the bones preserved in the pellet, their study by X-ray microCT, and the comparison with those of basal pterosaurs do not support a referral to the Pterosauria. Comparison with the osteology of a large sample of Middle-Late Triassic reptiles shows some affinity with the protorosaurians, mainly with Langobardisaurus pandolfii that was found in the same formation as the pellet. However, differences with this species suggest that the bones belong to a similar but distinct taxon. The interpretation as a gastric pellet is confirmed.	[Holgado, Borja; Marco Dalla Vecchia, Fabio; Fortuny, Josep] Inst Catala Paleont Miquel Crusafont ICP, Mesozo Res Grp, E-08201 Sabadell, Catalonia, Spain; [Holgado, Borja] Univ Valencia, Dept Geol, E-46100 Valencia, Spain; [Bernardini, Federico; Tuniz, Claudio] Museo Stor Fis, Ctr Fermi, I-00184 Rome, Italy; [Bernardini, Federico; Tuniz, Claudio] Ctr Studi & Ric Enrico Fermi, I-00184 Rome, Italy; [Bernardini, Federico; Tuniz, Claudio] Abdus Salam Int Ctr Theoret Phys ICTP, Multidisciplinary Lab, I-34014 Trieste, Italy; [Tuniz, Claudio] Univ Wollongong, Sch Earth & Environm Sci, Ctr Archaeol Sci, Wollongong, NSW 2522, Australia	Institut Catala de Paleontologia Miquel Crusafont (ICP); University of Valencia; Abdus Salam International Centre for Theoretical Physics (ICTP); University of Wollongong	Holgado, B (corresponding author), Inst Catala Paleont Miquel Crusafont ICP, Mesozo Res Grp, C Escola Ind 23, E-08201 Sabadell, Catalonia, Spain.	bortx.holgado@gmail.com	Holgado, Borja/AAA-8113-2021; Fortuny, Josep/L-2523-2014	Holgado, Borja/0000-0001-8968-0775; Fortuny, Josep/0000-0003-4282-1619; Bernardini, Federico/0000-0002-3282-8799				Abel RL, 2012, PALAEONTOL ELECTRON, V15; Barrett Paul M., 2008, Zitteliana Reihe B, V28, P61; Barthel KW., 1994, STUDY MESOZOIC PALAE; Behrensmeyer A.K., 1991, Topics in Geobiology, V9, P291; Von Baczko MB, 2013, GEOL SOC SPEC PUBL, V379, P187, DOI 10.1144/SP379.4; BENNETT SC, 1993, PALEOBIOLOGY, V19, P92, DOI 10.1017/S0094837300012331; Cope ED, 1870, T AM PHILOS SOC, V14; CURRIE PJ, 1995, CAN J EARTH SCI, V32, P922, DOI 10.1139/e95-077; DALLA VECCHIA F.M., 2008, VERTEBRATI FOSSILI F; Dalla Vecchia F. M., 2004, GORTANIA, V25, P47; Dalla Vecchia F.M., 2014, MEMORIE MUSEO FRIULA, V54; Dalla Vecchia F. M., 1998, B SOC PALEONTOLOGICA, V36, P355; Dalla Vecchia F. M., 1989, GORTANIA, V10, P121; Dalla Vecchia Fabio M., 2003, Geological Society Special Publication, V217, P23, DOI 10.1144/GSL.SP.2003.217.01.03; Dalla Vecchia FM, 2013, GEOL SOC SPEC PUBL, V379, P119, DOI 10.1144/SP379.14; Dalla Vecchia FM, 2013, ACTA PALAEONTOL POL, V58, P325, DOI 10.4202/app.2011.0132; Dalla Vecchia Fabio M., 2006, Bulletin of the New Mexico Museum of Natural History and Science, V37, P432; Dalla Vecchia FM, 2009, RIV ITAL PALEONTOL S, V115, P159, DOI 10.13130/2039-4942/6377; Dalla Vecchia Fabio Marco, 2000, Bollettino della Societa Paleontologica Italiana, V39, P225; Dalla Vecchia FM, 2012, FRIULI 215 MILIONI A; DALLAVECCHIA FM, 2002, GORTANIA, V23, P5; Davis PG, 1998, PALAIOS, V13, P3, DOI 10.2307/3515277; EWER RF, 1965, PHILOS T ROY SOC B, V248, P379, DOI 10.1098/rstb.1965.0003; Ezcurra MD, 2013, GEOL SOC SPEC PUBL, V379, P9, DOI 10.1144/SP379.11; Fraser NC, 2007, J VERTEBR PALEONTOL, V27, P261, DOI 10.1671/0272-4634(2007)27[261:ANGTDA]2.0.CO;2; Frey E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031945; GANS C, 1987, PALEOBIOLOGY, V13, P415; Hone DWE, 2008, PALAEONTOLOGY, V51, P95, DOI 10.1111/j.1475-4983.2007.00739.x; Hone DWE, 2014, PALAEOGEOGR PALAEOCL, V394, P89, DOI 10.1016/j.palaeo.2013.11.022; Irmis RB, 2013, GEOL SOC SPEC PUBL, V379, P275, DOI 10.1144/SP379.24; Janicke V, 1970, Neues Jb. Geol. Palaont. Mh., V1970, P452; Jenkins Farish A. Jr., 2001, Bulletin of the Museum of Comparative Zoology, V156, P151; Jiang DY, 2011, J VERTEBR PALEONTOL, V31, P1230, DOI 10.1080/02724634.2011.610853; Trotteyn MJ, 2011, AMEGHINIANA, V48, P424, DOI 10.5710/AMGH.v48i4(351); Kellner AWA, 2015, AN ACAD BRAS CIENC, V87, P669, DOI 10.1590/0001-3765201520150307; Langer MC, 2013, GEOL SOC SPEC PUBL, V379, P157, DOI 10.1144/SP379.9; Langer MC, 2004, DINOSAURIA, 2ND EDITION, P25; Dalla Vecchia FM, 2015, HIST BIOL, V27, P683, DOI 10.1080/08912963.2014.933826; Martill David M., 2008, Zitteliana Reihe B, V28, P175; Myhrvold NP, 2012, HIST BIOL, V24, P505, DOI 10.1080/08912963.2011.631703; Nesbitt SJ, 2013, GEOL SOC SPEC PUBL, V379, P241, DOI 10.1144/SP379.1; Nesbitt SJ, 2011, B AM MUS NAT HIST, P1, DOI 10.1206/352.1; Nesbitt SJ, 2009, ZOOL J LINN SOC-LOND, V157, P814, DOI 10.1111/j.1096-3642.2009.00530.x; Nosotti Stefania, 2007, Memorie della Societa Italiana di Scienze Naturali e del Museo Civico di Storia Naturale di Milano, V35, P1; Olsen P.E., 1979, Postilla, P1; Osi A, 2010, ANAT REC, V293, P243, DOI 10.1002/ar.21053; Padian K, 2008, SPEC PAP PALAEONTOL, P5; Padian K, 2008, SPEC PAP PALAEONTOL, P69, DOI 10.1111/j.1475-4983.2008.00795.x; Premru E., 1991, BESCHEREIBUNG UNPUB; Renesto S, 2005, RIV ITAL PALEONTOL S, V111, P247, DOI 10.13130/2039-4942/6310; Renesto S, 2003, J VERTEBR PALEONTOL, V23, P703, DOI 10.1671/A1101; Renesto S, 2000, J VERTEBR PALEONTOL, V20, P622, DOI 10.1671/0272-4634(2000)020[0622:TUDAFH]2.0.CO;2; Renesto S., 2010, NEW MEXICO MUSEUM NA, V46, P1; Renesto Silvio, 1994, Rivista Italiana di Paleontologia e Stratigrafia, V100, P285; Renesto S, 2007, RIV ITAL PALEONTOL S, V113, P191, DOI 10.13130/2039-4942/5870; Renesto Silvio, 2002, Senckenbergiana Lethaea, V82, P95; Romer A, 1956, OSTEOLOGY REPTILES; Saller F, 2013, NEUES JAHRB GEOL P-A, V268, P83, DOI 10.1127/0077-7749/2013/0319; Sangster S, 2003, ANATOMY FUNCTIONAL M; Schafer W., 1972, ECOLOGY PALAEOECOLOG; Schweigert G., 2001, JAHRBERICHTE MITT OB, V83, P357, DOI 10.1127/jmogv/83/2001/357; Serpagli E, 1990, INTRO PALEONTOLOGIA; SHAROV A G, 1971, Trudy Paleontologicheskogo Instituta Akademiya Nauk SSSR, V130, P104; Spielmann J.A., 2008, NEW MEXICO MUSEUM NA, V43, P1; Tannenbaum Kaye Fran, 1994, P171; Thies D, 2013, NEUES JAHRB GEOL P-A, V267, P117, DOI 10.1127/0077-7749/2012/0301; Tuniz C, 2013, NUCL INSTRUM METH A, V711, P106, DOI 10.1016/j.nima.2013.01.046; Unwin DM., 2006, PTEROSAURS DEEP TIME; Veldmeijer Andre J., 2007, P295, DOI 10.1007/978-3-540-46046-6_13; Welinhofer P., 1975, Palaeontographica Abt A, V148, P1; WELLNHOFER P, 1978, HDB PALAEOHERPETOLOG; Wellnhofer P, 1991, ILLUSTRATED ENCY PTE; WILD R, 1978, Bollettino della Societa Paleontologica Italiana, V17, P176; Wild R., 1984, GORTANIA, V5, P45; Wild R., 1973, ABHANDLUNGEN SCHWEIZ, V95, P1; Witton M.P., 2013, PTEROSAURS NATURAL H, DOI DOI 10.1515/9781400847655	76	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0141275	10.1371/journal.pone.0141275	http://dx.doi.org/10.1371/journal.pone.0141275			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26560101	gold, Green Published, Green Submitted			2022-12-27	WOS:000364433100029
J	Musinguzi, G; Bastiaens, H; Wanyenze, RK; Mukose, A; Van Geertruyden, JP; Nuwaha, F				Musinguzi, Geofrey; Bastiaens, Hilde; Wanyenze, Rhoda K.; Mukose, Aggrey; Van Geertruyden, Jean-Pierre; Nuwaha, Fred			Capacity of Health Facilities to Manage Hypertension in Mukono and Buikwe Districts in Uganda: Challenges and Recommendations	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; NONCOMMUNICABLE DISEASES; CARDIOVASCULAR RISK; CARE; PREVENTION; PRIORITY; BURDEN	Background The burden of chronic diseases is increasing in both low-and middle-income countries. However, healthcare systems in low-income countries are inadequately equipped to deal with the growing disease burden, which requires chronic care for patients. The aim of this study was to assess the capacity of health facilities to manage hypertension in two districts in Uganda. Methods In a cross-sectional study conducted between June and October 2012, we surveyed 126 health facilities (6 hospitals, 4 Health Center IV (HCIV), 23 Health Center III (HCIII), 41 Health Center II (HCII) and 52 private clinics/dispensaries) in Mukono and Buikwe districts in Uganda. We assessed records, conducted structured interviews with heads of facilities, and administered questionnaires to 271 health workers. The study assessed service provision for hypertension, availability of supplies such as medicines, guidelines and equipment, in-service training for hypertension, knowledge of hypertension management, challenges and recommendations. Results Of the 126 health facilities, 92.9% reported managing (diagnosing/treating) patients with hypertension, and most (80.2%) were run by non-medical doctors or non-physician health workers (NPHW). Less than half (46%) of the facilities had guidelines for managing hypertension. A 10th of the facilities lacked functioning blood pressure devices and 28% did not have stethoscopes. No facilities ever calibrated their BP devices except one. About a half of the facilities had anti-hypertensive medicines in stock; mainly thiazide diuretics (46%), beta blockers (56%) and calcium channel blockers (48.4%). Alpha blockers, mixed alpha & beta blockers and angiotensin II receptor antagonists were only stocked by private clinics/dispensaries. Most HCIIs lacked anti-hypertensive medicines, including the first line thiazide diuretics. Significant knowledge gaps in classification of patients as hypertensive were noted among respondents. All health workers (except 5, 1.9%) indicated that they needed additional training in hypertension management. Several provider and patient related challenges were also observed in this study. Conclusions Health facilities in this setting are inadequately equipped to provide services for management of hypertension. Diagnostic equipment, anti-hypertensive drugs and personnel present great challenges. To address the increasing burden of hypertension and other chronic diseases, measures are needed to substantially strengthen the healthcare facilities, including training of personnel in management of hypertension and other chronic diseases, and improving diagnostic and treatment supplies.	[Musinguzi, Geofrey; Wanyenze, Rhoda K.; Nuwaha, Fred] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Dis Control & Environm Hlth, Kampala, Uganda; [Bastiaens, Hilde] Univ Antwerp, Primary & Interdisciplinary Care, B-2020 Antwerp, Belgium; [Mukose, Aggrey] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Kampala, Uganda; [Musinguzi, Geofrey; Mukose, Aggrey; Van Geertruyden, Jean-Pierre] Univ Antwerp, Dept Epidemiol & Biostat, Int Hlth, B-2020 Antwerp, Belgium	Makerere University; University of Antwerp; Makerere University; University of Antwerp	Musinguzi, G (corresponding author), Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Dis Control & Environm Hlth, Kampala, Uganda.	mgeof@musph.ac.ug	Van geertruyden, Jean-Pierre/K-6425-2014	Van geertruyden, Jean-Pierre/0000-0001-5006-6364; Bastiaens, Hilde/0000-0002-5509-3406	Makerere University Infectious Diseases Institute TARGETS II Project; Flemish Inter-University Council (VLIR-UOS) via the HEFS Platform Harvest Call [ZIUS2013VOA0902]	Makerere University Infectious Diseases Institute TARGETS II Project; Flemish Inter-University Council (VLIR-UOS) via the HEFS Platform Harvest Call	The Study was funded by Makerere University Infectious Diseases Institute TARGETS II Project. The Flemish Inter-University Council (VLIR-UOS) via the HEFS Platform Harvest Call (ZIUS2013VOA0902) supported GM for a short research stay at the University of Antwerp to draft the manuscript.	Abegunde DO, 2007, B WORLD HEALTH ORGAN, V85, P432, DOI 10.2471/BLT.06.032177; Ali MK, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005121; [Anonymous], 2010, PACK ESS NONC DIS IN, P66; [Anonymous], 2007, AFR HEALTH SCI, V7, P38; Beaglehole R, 2008, LANCET, V372, P940, DOI 10.1016/S0140-6736(08)61404-X; Bischoff A, 2009, INT J ENV RES PUB HE, V6, P2258, DOI 10.3390/ijerph6082258; Boutayeb A, 2006, T ROY SOC TROP MED H, V100, P191, DOI 10.1016/j.trstmh.2005.07.021; Bovet P, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-407; Dass SK, 2004, CHANGING TRENDS HLTH; David L, 2007, ECOLOGICAL ENV ANTHR, V3, P2007; Hyder A. A., 2006, APPL BURDEN DIS ANAL; Kengne AP, 2009, J CLIN HYPERTENS, V11, P564, DOI 10.1111/j.1751-7176.2009.00165.x; Mendis S, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/584041; Mendis S, 2007, J HYPERTENS, V25, P1578, DOI 10.1097/HJH.0b013e3282861fd3; Mendis S, 2013, INT J HYPERTENS, V2013, DOI 10.1155/2013/878460; Miranda JJ, 2008, TROP MED INT HEALTH, V13, P1225, DOI 10.1111/j.1365-3156.2008.02116.x; Musinguzi G, 2015, J CLIN HYPERTENS, V17, P63, DOI 10.1111/jch.12371; Musinguzi G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062236; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; O'Neill K, 2013, B WORLD HEALTH ORGAN, V91, P923, DOI 10.2471/BLT.12.116798; Peck R, 2014, LANCET GLOB HEALTH, V2, pE285, DOI 10.1016/S2214-109X(14)70033-6; Perkovic V, 2007, HYPERTENSION, V50, P991, DOI 10.1161/HYPERTENSIONAHA.107.095497; Republic of Uganda, 2010, HLTH SECT STRAT INV; Sekokotla D, 2003, HYPERTENSION MANAGEM; Strong K, 2005, LANCET, V366, P1578, DOI 10.1016/S0140-6736(05)67341-2; Thorogood M, 2007, SCAND J PUBLIC HEALT, V35, P52, DOI 10.1080/14034950701355411; Whyte SR, 2014, 7 SPP	27	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142312	10.1371/journal.pone.0142312	http://dx.doi.org/10.1371/journal.pone.0142312			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26560131	Green Published, gold, Green Submitted			2022-12-27	WOS:000364433100070
J	O'Shea-Wheller, TA; Sendova-Franks, AB; Franks, NR				O'Shea-Wheller, Thomas A.; Sendova-Franks, Ana B.; Franks, Nigel R.			Differentiated Anti-Predation Responses in a Superorganism	PLOS ONE			English	Article							ALARM PHEROMONES; NEST; HYMENOPTERA; COLONIES	Insect societies are complex systems, displaying emergent properties much greater than the sum of their individual parts. As such, the concept of these societies as single 'superorganisms' is widely applied to describe their organisation and biology. Here, we test the applicability of this concept to the response of social insect colonies to predation during a vulnerable period of their life history. We used the model system of house-hunting behaviour in the ant Temnothorax albipennis. We show that removing individuals from directly within the nest causes an evacuation response, while removing ants at the periphery of scouting activity causes the colony to withdraw back into the nest. This suggests that colonies react differentially, but in a coordinated fashion, to these differing types of predation. Our findings lend support to the superorganism concept, as the whole society reacts much like a single organism would in response to attacks on different parts of its body. The implication of this is that a collective reaction to the location of worker loss within insect colonies is key to avoiding further harm, much in the same way that the nervous systems of individuals facilitate the avoidance of localised damage.	[O'Shea-Wheller, Thomas A.; Franks, Nigel R.] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Sendova-Franks, Ana B.] UWE Bristol, Dept Engn Design & Math, Bristol, Avon, England	University of Bristol; University of West England	O'Shea-Wheller, TA (corresponding author), Univ Bristol, Sch Biol Sci, Life Sci Bldg,24 Tyndall Ave, Bristol, Avon, England.	to13870@bristol.ac.uk	Franks, Nigel/AAG-8207-2019	Franks, Nigel/0000-0001-8139-9604; O'Shea-Wheller, Thomas/0000-0002-5537-2659				Backen SJ, 2000, BEHAV ECOL SOCIOBIOL, V48, P125, DOI 10.1007/s002650000219; BRADSHAW JWS, 1975, NATURE, V258, P230, DOI 10.1038/258230a0; BUSCHINGER A, 1988, INSECT SOC, V35, P61, DOI 10.1007/BF02224138; Chadab R., 1979, Psyche (Cambridge), V86, P115, DOI 10.1155/1979/38164; Dornhaus A, 2004, ANIM BEHAV, V67, P959, DOI 10.1016/j.anbehav.2003.09.004; DOWMAN R, 1992, PAIN, V49, P187, DOI 10.1016/0304-3959(92)90142-X; DUFFIELD RM, 1976, COMP BIOCHEM PHYS B, V54, P439, DOI 10.1016/0305-0491(76)90116-4; Eaton RC, 2001, PROG NEUROBIOL, V63, P467, DOI 10.1016/S0301-0082(00)00047-2; EHRLICH D, 1981, J COMP NEUROL, V195, P643, DOI 10.1002/cne.901950408; Franks NR, 2013, ANIM BEHAV, V85, P1233, DOI 10.1016/j.anbehav.2013.03.010; Franks NR, 2008, ANIM BEHAV, V76, P323, DOI 10.1016/j.anbehav.2008.02.009; Franks NR, 2006, P ROY SOC B-BIOL SCI, V273, P165, DOI 10.1098/rspb.2005.3312; Franks NR, 2000, BEHAV ECOL, V11, P315, DOI 10.1093/beheco/11.3.315; Franks NR, 2002, PHILOS T R SOC B, V357, P1567, DOI 10.1098/rstb.2002.1066; Franks NR, 2002, ANIM BEHAV, V65, P215; Gardner A, 2009, J EVOLUTION BIOL, V22, P659, DOI 10.1111/j.1420-9101.2008.01681.x; Holldobler B., 1990, pi; Holldobler B., 2009, SUPERORGANISM, P522; Lin N, 1963, BEHAVIOUR, V20, P115; Oster G. F., 1979, CASTE ECOLOGY SOCIAL, DOI DOI 10.1007/BF00046355; Pamminger T, 2011, BEHAV ECOL, V22, P255, DOI 10.1093/beheco/arq191; Pinter-Wollman N, 2012, BEHAV ECOL SOCIOBIOL, V66, P1407, DOI 10.1007/s00265-012-1396-2; REEVE HK, 1987, BEHAVIOUR, V102, P147, DOI 10.1163/156853986X00090; Richardson TO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009621; Roberts A, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00016; Robinson EJH, 2009, P ROY SOC B-BIOL SCI, V276, P4373, DOI 10.1098/rspb.2009.1244; Sasaki T, 2014, J EXP BIOL, V217, P3229, DOI 10.1242/jeb.106849; SENDOVAFRANKS AB, 1995, ANIM BEHAV, V50, P121, DOI 10.1006/anbe.1995.0226; WILKENS LA, 1981, PROC R SOC SER B-BIO, V211, P341, DOI 10.1098/rspb.1981.0011; WILSON EO, 1953, Q REV BIOL, V28, P136, DOI 10.1086/399512	30	7	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0141012	10.1371/journal.pone.0141012	http://dx.doi.org/10.1371/journal.pone.0141012			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26558385	Green Published, Green Submitted, gold			2022-12-27	WOS:000364433100018
J	Weihmann, T; Reinhardt, L; Weissing, K; Siebert, T; Wipfler, B				Weihmann, Tom; Reinhardt, Lars; Weissing, Kevin; Siebert, Tobias; Wipfler, Benjamin			Fast and Powerful: Biomechanics and Bite Forces of the Mandibles in the American Cockroach Periplaneta americana	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; TWITCH MUSCLES; SLOW-TWITCH; BLUE CRABS; PERFORMANCE; INSECT; MORPHOLOGY; SKELETONS; SUPPORT; JOINT	Knowing the functionality and capabilities of masticatory apparatuses is essential for the ecological classification of jawed organisms. Nevertheless insects, especially with their outstanding high species number providing an overwhelming morphological diversity, are notoriously underexplored with respect to maximum bite forces and their dependency on the mandible opening angles. Aiming for a general understanding of insect biting, we examined the generalist feeding cockroach Periplaneta americana, characterized by its primitive chewing mouth parts. We measured active isometric bite forces and passive forces caused by joint resistance over the entire mandibular range with a custom-built 2D force transducer. The opening angle of the mandibles was quantified by using a video system. With respect to the effective mechanical advantage of the mandibles and the cross-section areas, we calculated the forces exerted by the mandible closer muscles and the corresponding muscle stress values. Comparisons with the scarce data available revealed close similarities of the cockroaches' mandible closer stress values (58 N/cm2) to that of smaller specialist carnivorous ground beetles, but strikingly higher values than in larger stag beetles. In contrast to available datasets our results imply the activity of faster and slower muscle fibres, with the latter becoming active only when the animals chew on tough material which requires repetitive, hard biting. Under such circumstances the coactivity of fast and slow fibres provides a force boost which is not available during short-term activities, since long latencies prevent a specific effective employment of the slow fibres in this case.	[Weihmann, Tom] Univ Cambridge, Dept Zool, Cambridge, England; [Reinhardt, Lars] Univ Jena, Sci Mot, Jena, Germany; [Weissing, Kevin] Univ Jena, Inst Spezielle Zool & Evolutionsbiol, Phyletischem Museum, Entomol Grp, Jena, Germany; [Siebert, Tobias] Univ Stuttgart, Inst Sport & Mot Sci, D-70174 Stuttgart, Germany	University of Cambridge; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; University of Stuttgart	Weihmann, T (corresponding author), Univ Cambridge, Dept Zool, Cambridge, England.	tw424@cam.ac.uk; benjamin.wipfler@uni-jena.de	Siebert, Tobias/C-9626-2012; Weihmann, Tom/GYJ-8011-2022	Siebert, Tobias/0000-0003-4090-5480; Weihmann, Tom/0000-0002-6628-1816	German Research Foundation (DFG) [We 4664/2-1]; Daimler und Benz Stiftung [32-10/12]; German Research Foundation [WI 4324/1-1]	German Research Foundation (DFG)(German Research Foundation (DFG)); Daimler und Benz Stiftung; German Research Foundation(German Research Foundation (DFG))	This work was financially supported by the German Research Foundation (DFG, We 4664/2-1) to TW and by a PostDoc stipend of the Daimler und Benz Stiftung (32-10/12) and the German Research Foundation (WI 4324/1-1) to BW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ache JM, 2012, J NEUROPHYSIOL, V107, P2756, DOI 10.1152/jn.01072.2011; Ahn AN, 2002, J EXP BIOL, V205, P379; ALEXANDER RM, 1985, J EXP BIOL, V115, P231; Anderson RA, 2008, BIOL J LINN SOC, V93, P709, DOI 10.1111/j.1095-8312.2007.00905.x; Bell W. J., 2007, COCKROACHES ECOLOGY; Blanke A, 2012, CLADISTICS, V28, P560, DOI 10.1111/j.1096-0031.2012.00405.x; Blumel M, 2012, BIOL CYBERN, V106, P559, DOI 10.1007/s00422-012-0530-6; Chapman RF, 2013, J CHEM INF MODEL, V5th; Chapman RF., 1995, REGULATORY MECH INSE, Vvol. 1995; CHESLER M, 1981, J NEUROBIOL, V12, P391, DOI 10.1002/neu.480120408; Claussen DL, 2008, J COMP PHYSIOL B, V178, P333, DOI 10.1007/s00360-007-0226-8; Clissold FJ, 2007, ADV INSECT PHYSIOL, V34, P317, DOI 10.1016/S0065-2806(07)34006-X; CROW MT, 1982, J GEN PHYSIOL, V79, P147, DOI 10.1085/jgp.79.1.147; Dai ZD, 2002, J EXP BIOL, V205, P2479; ELNER RW, 1978, OECOLOGIA, V36, P333, DOI 10.1007/BF00348059; Full RJ, 1998, J EXP BIOL, V201, P997; Gorb S, 2000, J MORPHOL, V244, P1, DOI 10.1002/(SICI)1097-4687(200004)244:1<1::AID-JMOR1>3.0.CO;2-E; GOVIND CK, 1985, BIOL BULL, V168, P321, DOI 10.2307/1541244; Goyens J, 2015, FUNCT ECOL, V29, P35, DOI 10.1111/1365-2435.12294; Goyens J, 2014, J EXP BIOL, V217, P1065, DOI 10.1242/jeb.091744; Gronenberg W, 1997, CELL TISSUE RES, V289, P347, DOI 10.1007/s004410050882; Guschlbauer C, 2007, J EXP BIOL, V210, P1092, DOI 10.1242/jeb.02729; Herrel A, 2006, PHYSIOL BIOCHEM ZOOL, V79, P1, DOI 10.1086/498196; HOYLE G, 1978, J EXP BIOL, V73, P205; Lappin AK, 2014, J EXP BIOL, V217, P4303, DOI 10.1242/jeb.106385; McMeeking RM, 2012, J THEOR BIOL, V297, P17, DOI 10.1016/j.jtbi.2011.12.003; Paul J, 1999, J EXP BIOL, V202, P797; Petie R, 2007, J THEOR BIOL, V244, P565, DOI 10.1016/j.jtbi.2006.09.004; PRUIM GJ, 1980, J BIOMECH, V13, P755, DOI 10.1016/0021-9290(80)90237-7; Rast GF, 2001, NEUROSCIENCE, V108, P167, DOI 10.1016/S0306-4522(01)00406-7; Reinhardt L, 2014, J EXP BIOL, V217, P704, DOI 10.1242/jeb.094177; Roces F, 1996, NATURE, P373; Rode C, 2009, J MECH MED BIOL, V9, P105, DOI 10.1142/S0219519409002870; SAVAGE R J G, 1977, Palaeontology (Oxford), V20, P237; SCHMIDTNIELSEN K, 1975, J EXP ZOOL, V194, P287, DOI 10.1002/jez.1401940120; Schmitt C, 2014, J EXP BIOL, V217, P3095, DOI 10.1242/jeb.092742; Siebert T, 2014, COMPUTATIONAL MODELI, P173, DOI DOI 10.1533/9780857096739.2.173; Siebert T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130985; Siebert T, 2010, J COMP PHYSIOL B, V180, P199, DOI 10.1007/s00360-009-0401-1; Snodgrass R.E, 1944, FEEDING APPARATUS BI; Taylor GM, 2000, P ROY SOC B-BIOL SCI, V267, P1475, DOI 10.1098/rspb.2000.1167; Taylor JRA, 2007, J EXP BIOL, V210, P4272, DOI 10.1242/jeb.007054; Taylor JRA, 2003, SCIENCE, V301, P209, DOI 10.1126/science.1085987; van der Meijden A, 2012, J EXP BIOL, V215, P3411, DOI 10.1242/jeb.072926; Weihmann T, ARTHROPOD S IN PRESS; Weihmann T, 2009, J COMP PHYSIOL A, V195, P1011, DOI 10.1007/s00359-009-0475-y; Weihmann T, 2009, COMP BIOCHEM PHYS A, V153A, pS124, DOI 10.1016/j.cbpa.2009.04.207; Weissing K, ARTHROPOD SYST UNPUB; WENDT IR, 1974, AM J PHYSIOL, V226, P642, DOI 10.1152/ajplegacy.1974.226.3.642; WHEATER CP, 1989, J INSECT PHYSIOL, V35, P815, DOI 10.1016/0022-1910(89)90096-6; Wipfler B, 2012, ARTHROPOD STRUCT DEV, V41, P87, DOI 10.1016/j.asd.2011.06.005; Wipfler B, 2015, CLADISTICS, V31, P50, DOI 10.1111/cla.12068; Wipfler B, 2011, SYST ENTOMOL, V36, P241, DOI 10.1111/j.1365-3113.2010.00556.x	53	21	22	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0141226	10.1371/journal.pone.0141226	http://dx.doi.org/10.1371/journal.pone.0141226			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559671	Green Submitted, Green Published, gold			2022-12-27	WOS:000364433100026
J	Chapman, JR; Waldenstrom, J				Chapman, Joanne R.; Waldenstrom, Jonas			With Reference to Reference Genes: A Systematic Review of Endogenous Controls in Gene Expression Studies	PLOS ONE			English	Review							REAL-TIME PCR; SUITABLE REFERENCE GENES; POLYMERASE-CHAIN-REACTION; RELIABLE REFERENCE GENES; STABLE REFERENCE GENES; RT-QPCR ANALYSIS; HOUSEKEEPING GENES; QUANTITATIVE PCR; BETA-ACTIN; RELATIVE QUANTIFICATION	The choice of reference genes that are stably expressed amongst treatment groups is a crucial step in real-time quantitative PCR gene expression studies. Recent guidelines have specified that a minimum of two validated reference genes should be used for normalisation. However, a quantitative review of the literature showed that the average number of reference genes used across all studies was 1.2. Thus, the vast majority of studies continue to use a single gene, with beta-actin (ACTB) and/or glyceraldehyde 3-phosphate dehydrogenase (GAPDH) being commonly selected in studies of vertebrate gene expression. Few studies (15%) tested a panel of potential reference genes for stability of expression before using them to normalise data. Amongst studies specifically testing reference gene stability, few found ACTB or GAPDH to be optimal, whereby these genes were significantly less likely to be chosen when larger panels of potential reference genes were screened. Fewer reference genes were tested for stability in non-model organisms, presumably owing to a dearth of available primers in less well characterised species. Furthermore, the experimental conditions under which real-time quantitative PCR analyses were conducted had a large influence on the choice of reference genes, whereby different studies of rat brain tissue showed different reference genes to be the most stable. These results highlight the importance of validating the choice of normalising reference genes before conducting gene expression studies.	[Chapman, Joanne R.; Waldenstrom, Jonas] Linnaeus Univ, Ctr Ecol & Evolut Microbial Model Syst, Kalmar, Sweden	Linnaeus University	Chapman, JR (corresponding author), Linnaeus Univ, Ctr Ecol & Evolut Microbial Model Syst, Kalmar, Sweden.	joanne.chapman@lnu.se	Chapman, Joanne/B-9783-2011; Waldenström, Jonas/E-4460-2013	Chapman, Joanne/0000-0003-2849-1094; Waldenström, Jonas/0000-0002-1152-4235				Altmann S, 2015, FISH PHYSIOL BIOCHEM, V41, P397, DOI 10.1007/s10695-014-9991-y; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Anderson Kelli C, 2012, BMC Res Notes, V5, P21, DOI 10.1186/1756-0500-5-21; Ballester M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080385; Barber RD, 2005, PHYSIOL GENOMICS, V21, P389, DOI 10.1152/physiolgenomics.00025.2005; Marques TEBS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071892; Bonefeld BE, 2008, SYNAPSE, V62, P302, DOI 10.1002/syn.20496; Bonnet M, 2013, ANIMAL, V7, P1344, DOI 10.1017/S1751731113000475; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin Stephen A, 2004, J Biomol Tech, V15, P155; Bustin SA, 2010, METHODS, V50, P217, DOI 10.1016/j.ymeth.2009.12.006; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cabiati M, 2012, J MOL ENDOCRINOL, V48, P251, DOI 10.1530/JME-12-0024; Chang Z, 2010, ANAL BIOCHEM, V406, P214, DOI 10.1016/j.ab.2010.07.021; Chen J, 2009, ACTA OTO-LARYNGOL, V129, P644, DOI 10.1080/00016480802311015; Cicinnati VR, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-350; Cook NL, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-7; Das RK, 2013, ENDOCR RES, V38, P105, DOI 10.3109/07435800.2012.723294; de Moura AC, 2014, EINSTEIN-SAO PAULO, V12, P336, DOI [10.1590/S1679-45082014AO3042, 10.1590/s1679-45082014ao3042]; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Ersahin T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093341; Fernandes JMO, 2008, COMP BIOCHEM PHYS B, V150, P23, DOI 10.1016/j.cbpb.2008.01.003; Feuer R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135852; Fox BC, 2010, TOXICOL IN VITRO, V24, P1962, DOI 10.1016/j.tiv.2010.08.007; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Goidin D, 2001, ANAL BIOCHEM, V295, P17, DOI 10.1006/abio.2001.5171; Gonzalez-Herrera L, 2013, FORENSIC SCI INT, V232, P218, DOI 10.1016/j.forsciint.2013.08.001; Gubern Carme, 2009, BMC Mol Biol, V10, P57, DOI 10.1186/1471-2199-10-57; Guo Y, 2010, ACTA PHARMACOL SIN, V31, P1487, DOI 10.1038/aps.2010.115; Hashemi A, 2012, BIOCHEM BIOPH RES CO, V426, P649, DOI 10.1016/j.bbrc.2012.09.009; He Y, 2013, NEUROTOXICOLOGY, V39, P138, DOI 10.1016/j.neuro.2013.08.009; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hruz T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-156; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Jacobsen AV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115592; Ji H, 2013, ASIAN AUSTRAL J ANIM, V26, P423, DOI 10.5713/ajas.2012.12417; Ju XH, 2011, VET IMMUNOL IMMUNOP, V144, P160, DOI 10.1016/j.vetimm.2011.07.004; Julian GS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109902; Kadegowda AKG, 2009, J DAIRY SCI, V92, P2007, DOI 10.3168/jds.2008-1655; Kosir R, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-60; Langnaese K, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-53; Lee KC, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-4; Li B, 2014, INT J OBESITY, V38, P192, DOI 10.1038/ijo.2013.86; Ling DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029788; Liu LL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117058; Liu MC, 2014, GENES GENOM, V36, P573, DOI 10.1007/s13258-014-0193-x; Liu Yuen-Jong, 2009, BMC Genomics, V10, P480, DOI 10.1186/1471-2164-10-480; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mar JC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-110; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; Matz MV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071448; Mitter K, 2009, COMP BIOCHEM PHYS B, V153, P340, DOI 10.1016/j.cbpb.2009.04.009; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Nestorov J, 2013, J MED BIOCHEM, V32, P325, DOI 10.2478/jomb-2014-0001; NG SY, 1985, MOL CELL BIOL, V5, P2720, DOI 10.1128/MCB.5.10.2720; Noriega NC, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-47; Nygard AB, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-67; Olias P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099678; Pabinger Stephan, 2014, Biomol Detect Quantif, V1, P23; Park SJ, 2015, GENE, V558, P152, DOI 10.1016/j.gene.2014.12.052; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; R Core Team, 2021, R LANGUAGE ENV STAT; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Ribeiro MA, 2014, MOL BIOL REP, V41, P7063, DOI 10.1007/s11033-014-3637-0; Robledo D, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-648; Rocha-Martins M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043028; Ruan WJ, 2007, CLIN CHIM ACTA, V385, P1, DOI 10.1016/j.cca.2007.07.003; Saremi B, 2012, J DAIRY SCI, V95, P3131, DOI 10.3168/jds.2011-4803; Schildberg T, 2013, STEM CELL RES, V11, P1288, DOI 10.1016/j.scr.2013.08.015; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Selvey S, 2001, MOL CELL PROBE, V15, P307, DOI 10.1006/mcpr.2001.0376; Shimamoto Y, 2013, MOL BIOL REP, V40, P6747, DOI 10.1007/s11033-013-2791-0; Solanas M, 2001, ANAL BIOCHEM, V288, P99, DOI 10.1006/abio.2000.4889; Steibel JP, 2009, GENOMICS, V94, P146, DOI 10.1016/j.ygeno.2009.04.008; Stephens Alexandre S, 2011, BMC Res Notes, V4, P410, DOI 10.1186/1756-0500-4-410; Sun Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041659; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; Swijsen Ann, 2012, BMC Res Notes, V5, P685, DOI 10.1186/1756-0500-5-685; Taki FA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094311; Tanic N, 2007, J MOL NEUROSCI, V32, P38, DOI 10.1007/s12031-007-0006-7; Tucker JD, 2012, RADIAT RES, V177, P209, DOI 10.1667/RR2749.1; Uddin Muhammad Jasim, 2011, BMC Res Notes, V4, P441, DOI 10.1186/1756-0500-4-441; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Zhang JL, 1999, BIOCHEM J, V337, P231, DOI 10.1042/0264-6021:3370231	87	146	147	11	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0141853	10.1371/journal.pone.0141853	http://dx.doi.org/10.1371/journal.pone.0141853			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555275	Green Published, Green Submitted, gold			2022-12-27	WOS:000364430700041
J	Clarke, N; Biscocho, J; Kwei, KA; Davidson, JM; Sridhar, S; Gong, X; Pollack, JR				Clarke, Nicole; Biscocho, Jewison; Kwei, Kevin A.; Davidson, Jean M.; Sridhar, Sushmita; Gong, Xue; Pollack, Jonathan R.			Integrative Genomics Implicates EGFR as a Downstream Mediator in NKX2-1 Amplified Non-Small Cell Lung Cancer	PLOS ONE			English	Article							SET ENRICHMENT ANALYSIS; TRANSCRIPTION FACTOR-I; ADENOCARCINOMA; GENE; LINES; EXPRESSION; ONCOGENE; SURVIVAL; MUTATION; PROGRESSION	NKX2-1, encoding a homeobox transcription factor, is amplified in approximately 15% of non-small cell lung cancers (NSCLC), where it is thought to drive cancer cell proliferation and survival. However, its mechanism of action remains largely unknown. To identify relevant downstream transcriptional targets, here we carried out a combined NKX2-1 transcriptome (NKX2-1 knockdown followed by RNAseq) and cistrome (NKX2-1 binding sites by ChIPseq) analysis in four NKX2-1-amplified human NSCLC cell lines. While NKX2-1 regulated genes differed among the four cell lines assayed, cell proliferation emerged as a common theme. Moreover, in 3 of the 4 cell lines, epidermal growth factor receptor (EGFR) was among the top NKX2-1 upregulated targets, which we confirmed at the protein level by western blot. Interestingly, EGFR knockdown led to upregulation of NKX2-1, suggesting a negative feedback loop. Consistent with this finding, combined knockdown of NKX2-1 and EGFR in NCI-H1819 lung cancer cells reduced cell proliferation (as well as MAP-kinase and PI3-kinase signaling) more than knockdown of either alone. Likewise, NKX2-1 knockdown enhanced the growth-inhibitory effect of the EGFR-inhibitor erlotinib. Taken together, our findings implicate EGFR as a downstream effector of NKX2-1 in NKX2-1 amplified NSCLC, with possible clinical implications, and provide a rich dataset for investigating additional mediators of NKX2-1 driven oncogenesis.	[Clarke, Nicole; Biscocho, Jewison; Kwei, Kevin A.; Davidson, Jean M.; Sridhar, Sushmita; Gong, Xue; Pollack, Jonathan R.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA	Stanford University	Pollack, JR (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.	pollack1@stanford.edu			Tobacco-Related Disease Research Program [21XT-0054]; Gates Millennium Foundation; Stanford Cancer Biology Program; Stanford Tumor Biology Training Program	Tobacco-Related Disease Research Program(University of California System); Gates Millennium Foundation; Stanford Cancer Biology Program; Stanford Tumor Biology Training Program	This research was supported by a grant from the Tobacco-Related Disease Research Program (21XT-0054). NC was supported by fellowships from the Gates Millennium Foundation and Stanford Cancer Biology Program, and JMD from the Stanford Tumor Biology Training Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann J, 2005, CANCER RES, V65, P226; American Cancer Society, 2014, FORMALDEHYDE; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; BANKSSCHLEGEL SP, 1985, CANCER RES, V45, P1187; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Boggaram V, 2009, CLIN SCI, V116, P27, DOI 10.1042/CS20080068; Cao YX, 2010, J BIOL CHEM, V285, P2152, DOI 10.1074/jbc.M109.039172; Chen FF, 2015, CANCER GENE THER, V22, P431, DOI 10.1038/cgt.2015.38; Chen G, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-28; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Conde E, 2006, CLIN CANCER RES, V12, P710, DOI 10.1158/1078-0432.CCR-05-1362; Cooper WA, 2013, J THORAC DIS, V5, pS479, DOI 10.3978/j.issn.2072-1439.2013.08.03; Finberg KE, 2007, J MOL DIAGN, V9, P320, DOI 10.2353/jmoldx.2007.060182; Garraway LA, 2006, NAT REV CANCER, V6, P593, DOI 10.1038/nrc1947; Gazdar AF, 2010, JNCI-J NATL CANCER I, V102, P1310, DOI 10.1093/jnci/djq279; Gazdar AF, 1996, J CELL BIOCHEM, P1; Haura Eric B, 2004, Clin Lung Cancer, V6, P113, DOI 10.3816/CLC.2004.n.025; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Kendall J, 2007, P NATL ACAD SCI USA, V104, P16663, DOI 10.1073/pnas.0708286104; Kubo T, 2009, INT J CANCER, V124, P1778, DOI 10.1002/ijc.24150; Kwei KA, 2008, ONCOGENE, V27, P3635, DOI 10.1038/sj.onc.1211012; Maeda Y, 2012, J CLIN INVEST, V122, P4388, DOI 10.1172/JCI64048; Minoo P, 2007, MOL CELL BIOL, V27, P2155, DOI 10.1128/MCB.01133-06; Mu D, 2013, J BIOL CHEM, V288, P24992, DOI 10.1074/jbc.R113.491647; Ordonez NG, 2000, ADV ANAT PATHOL, V7, P123, DOI 10.1097/00125480-200007020-00007; Pao W, 2010, NAT REV CANCER, V10, P760, DOI 10.1038/nrc2947; Phelps RM, 1996, J CELL BIOCHEM, P32; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Tagne JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029907; Tanaka H, 2007, CANCER RES, V67, P6007, DOI 10.1158/0008-5472.CAN-06-4774; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Tsai HY, 2013, ONCOGENE, V32, P4921, DOI 10.1038/onc.2012.514; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Watanabe H, 2013, GENE DEV, V27, P197, DOI 10.1101/gad.203208.112; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Winslow MM, 2011, NATURE, V473, P101, DOI 10.1038/nature09881; Wistuba II, 1999, CLIN CANCER RES, V5, P991; Yamaguchi T, 2013, CANCER CELL, V23, P718, DOI 10.1016/j.ccr.2013.04.002; Yamaguchi T, 2012, CANCER CELL, V21, P348, DOI 10.1016/j.ccr.2012.02.008; Yeh JE, 2013, CURR OPIN ONCOL, V25, P652, DOI 10.1097/01.cco.0000432528.88101.1a	42	9	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142061	10.1371/journal.pone.0142061	http://dx.doi.org/10.1371/journal.pone.0142061			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556242	Green Published, gold, Green Submitted			2022-12-27	WOS:000364430700049
J	Li, FG; Chen, J; Jiang, XY; Zou, SM				Li, Fu-Gui; Chen, Jie; Jiang, Xia-Yun; Zou, Shu-Ming			Transcriptome Analysis of Blunt Snout Bream (Megalobrama amblycephala) Reveals Putative Differential Expression Genes Related to Growth and Hypoxia	PLOS ONE			English	Article							MOLECULAR-CLONING; RNA-SEQ; HIF-1-ALPHA; DUPLICATION; ANNOTATION; TELEOST; VISUALIZATION; CONSERVATION; HIF-2-ALPHA; INCREASES	The blunt snout bream (Megalobrama amblycephala) is an important freshwater aquaculture species, but it is sensitive to hypoxia. No transcriptome data related to growth and hypoxia response are available for this species. In this study, we performed de novo transcriptome sequencing for the liver and gills of the fast-growth family and slow-growth family derived from 'Pujiang No. 1'F10 blunt snout bream that were under hypoxic stress and normoxia, respectively. The fish were divided into the following 4 groups: fast-growth family under hypoxic stress, FH; slow-growth family under hypoxic stress, SH; fast-growth family under normoxia, FN; and slow-growth family under normoxia, SN. A total of 185 million high-quality reads were obtained from the normalized cDNA of the pooled samples, which were assembled into 465,582 contigs and 237,172 transcripts. A total of 31,338 transcripts from the same locus (unigenes) were annotated and assigned to 104 functional groups, and 23,103 unigenes were classified into seven main categories, including 45 secondary KEGG pathways. A total of 22,255 (71%) known putative unigenes were found to be shared across the genomes of five model fish species and mammals, and a substantial number (9.4%) of potentially novel genes were identified. When 6,639 unigenes were used in the analysis of differential expression (DE) genes, the number of putative DE genes related to growth pathways in FH, SH, SN and FN was 159, 118, 92 and 65 in both the liver and gills, respectively, and the number of DE genes related to hypoxic response was 57, 33, 23 and 21 in FH, FN, SH and SN, respectively. Our results suggest that growth performance of the fast-growth family should be due to complex mutual gene regulatory mechanisms of these putative DE genes between growth and hypoxia.	[Li, Fu-Gui; Chen, Jie; Jiang, Xia-Yun; Zou, Shu-Ming] Shanghai Ocean Univ, Key Lab Freshwater Aquat Genet Resources, Shanghai 201306, Peoples R China	Shanghai Ocean University	Jiang, XY (corresponding author), Shanghai Ocean Univ, Key Lab Freshwater Aquat Genet Resources, Huchenghuan Rd 999, Shanghai 201306, Peoples R China.	jiangxy@shou.edu.cn; smzou@shou.edu.cn			Key Technologies Research and Development Program of China [2012BAD26B02]; National Science Foundation of China [31272633, 31201760]; Shanghai University Knowledge Service Platform [ZF1206]	Key Technologies Research and Development Program of China(National Key Technology R&D Program); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai University Knowledge Service Platform	This work was supported by grants from the Key Technologies Research and Development Program of China (2012BAD26B02), the National Science Foundation of China (31272633; 31201760), and the Shanghai University Knowledge Service Platform (ZF1206). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Cui XQ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-210; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fan HK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059997; Gao JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088804; Gao ZX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042637; Ge XP, 2011, CHINESE FISHERY QUAL, V1, P22; Glenn TC, 2011, MOL ECOL RESOUR, V11, P759, DOI 10.1111/j.1755-0998.2011.03024.x; Gotz S, 2011, BIOINFORMATICS, V27, P919, DOI 10.1093/bioinformatics/btr059; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Greer SN, 2012, EMBO J, V31, P2448, DOI 10.1038/emboj.2012.125; Thanh HN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109656; He L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053915; He XP, 2012, ANIM GENET, V43, P233, DOI 10.1111/j.1365-2052.2011.02230.x; Howe EA, 2011, BIOINFORMATICS, V27, P3209, DOI 10.1093/bioinformatics/btr490; Ji PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035152; Jiang HC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105122; Jin W, 2001, NAT GENET, V29, P389, DOI 10.1038/ng766; Kamei H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003091; Ke H W, 1965, ACTA HYDROBIOL SIN, V5, P282; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Li DJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-192; LI SF, 1993, AQUACULTURE, V111, P117, DOI 10.1016/0044-8486(93)90030-3; Li SF, 2003, NAGA, V26, P19; Li WT, 2014, COMPUT BIOL CHEM, V48, P77, DOI 10.1016/j.compbiolchem.2013.02.003; Li WT, 2012, J BIOINF COMPUT BIOL, V10, DOI 10.1142/S0219720012310038; Liao XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062308; Liu SC, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.453; Liu SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063895; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Ming JH, 2010, FISH SHELLFISH IMMUN, V28, P407, DOI 10.1016/j.fsi.2009.11.018; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Niu DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067456; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Qing DJ, 2009, PLANT CELL PHYSIOL, V50, P889, DOI 10.1093/pcp/pcp038; Rahman MS, 2007, GENE, V396, P273, DOI 10.1016/j.gene.2007.03.009; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rojas DA, 2007, GENE EXPR PATTERNS, V7, P339, DOI 10.1016/j.modgep.2006.08.002; Russell SJ, 2007, NAT REV MOL CELL BIO, V8, P681, DOI 10.1038/nrm2234; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Shen RJ, 2010, COMP BIOCHEM PHYS B, V157, P273, DOI 10.1016/j.cbpb.2010.06.013; Sun CF, 2011, GEN COMP ENDOCR, V172, P409, DOI 10.1016/j.ygcen.2011.04.005; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tian Yu-Mei, 2014, Zoological Research, V35, P300, DOI 10.13918/j.issn.2095-8137.2014.4.300; Wang CM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-139; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Xiao WH, 2015, SCI CHINA LIFE SCI, V58, P148, DOI 10.1007/s11427-015-4801-z; Xu W, 2008, J HYDROECOL, V1, P7; Yue G, 2001, MAR BIOTECHNOL, V3, P1, DOI 10.1007/s101260000043; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; ZHANG D, 2001, J CHINA 3 GORGES U, V3, P282; Zhang EY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103440; Zhang W, 2010, COMP BIOCHEM PHYS A, V157, P212, DOI 10.1016/j.cbpa.2010.06.184; Zhang XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042082; Zhao YH, 2011, FISH SHELLFISH IMMUN, V31, P462, DOI 10.1016/j.fsi.2011.06.024; Zhou JF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003926; Zou SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007026	62	31	35	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142801	10.1371/journal.pone.0142801	http://dx.doi.org/10.1371/journal.pone.0142801			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26554582	Green Submitted, Green Published, gold			2022-12-27	WOS:000364430700175
J	Li, XM; Xu, M; Wang, F; Ji, Y; Davidson, WS; Li, ZF; Tso, P				Li, Xiaoming; Xu, Min; Wang, Fei; Ji, Yong; Davidson, W. Sean; Li, Zongfang; Tso, Patrick			Interaction of ApoA-IV with NR4A1 and NR1D1 Represses G6Pase and PEPCK Transcription: Nuclear Receptor-Mediated Downregulation of Hepatic Gluconeogenesis in Mice and a Human Hepatocyte Cell Line	PLoS One			English	Article							APOLIPOPROTEIN-A-IV; HUMAN SKELETAL-MUSCLE; CHOLESTEROL EFFLUX; GENE-EXPRESSION; METABOLISM; NOR-1; INSULIN; NUR77; NURR1; RAT	We have previously shown that the nuclear receptor, NR1D1, is a cofactor in ApoA-IV-mediated downregulation of gluconeogenesis. Nuclear receptor, NR4A1, is involved in the transcriptional regulation of various genes involved in inflammation, apoptosis, and glucose metabolism. We investigated whether NR4A1 influences the effect of ApoA-IV on hepatic glucose metabolism. Our in situ proximity ligation assays and coimmunoprecipitation experiments indicated that ApoA-IV colocalized with NR4A1 in human liver (HepG2) and kidney (HEK-293) cell lines. The chromatin immunoprecipitation experiments and luciferase reporter assays indicated that the ApoA-IV and NR4A1 colocalized at the ROR alpha response element of the human G6Pase promoter, reducing its transcriptional activity. Our RNA interference experiments showed that knocking down the expression of NR4A1 in primary mouse hepatocytes treated with ApoA-IV increased the expression of NR1D1, G6Pase, and PEPCK, and that knocking down NR1D1 expression increased the level of NR4A1. We also found that ApoA-IV induced the expression of endogenous NR4A1 in both cultured primary mouse hepatocytes and in the mouse liver, and decreased glucose production in primary mouse hepatocytes. Our findings showed that ApoA-IV colocalizes with NR4A1, which suppresses G6Pase and PEPCK gene expression at the transcriptional level, reducing hepatic glucose output and lowering blood glucose. The ApoA-IV-induced increase in NR4A1 expression in hepatocytes mediates further repression of gluconeogenesis. Our findings suggest that NR1D1 and NR4A1 serve similar or complementary functions in the ApoA-IV-mediated regulation of gluconeogenesis.	[Li, Xiaoming; Li, Zongfang] Xi An Jiao Tong Univ, Natl Local Joint Engn Res Ctr Biodiagnost & Bioth, Affiliated Hosp 2, Coll Med, Xian 710004, Shaanxi, Peoples R China; [Li, Xiaoming; Xu, Min; Wang, Fei; Ji, Yong; Davidson, W. Sean; Tso, Patrick] Univ Cincinnati, Metab Dis Inst, Dept Pathol & Lab Med, Cincinnati, OH 45237 USA	Xi'an Jiaotong University; University System of Ohio; University of Cincinnati	Li, ZF (corresponding author), Xi An Jiao Tong Univ, Natl Local Joint Engn Res Ctr Biodiagnost & Bioth, Affiliated Hosp 2, Coll Med, 157 W 5th Rd, Xian 710004, Shaanxi, Peoples R China.	lizhongfangbm@163.com; Patrick_Tso@yeah.net		Davidson, William/0000-0003-2756-2989	National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health [DK 59630, DK 92138, DK 76928]; Cincinnati MMPC [U24 DK059630]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076928, R01DK092138, U24DK059630] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Cincinnati MMPC; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by grants from the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health awarded to Dr. Tso (grant nos. DK 59630, DK 92138, and DK 76928) and The Cincinnati MMPC (grant no. U24 DK059630). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandoh S, 1997, LEUKEMIA, V11, P1453, DOI 10.1038/sj.leu.2400800; Chao LC, 2009, DIABETES, V58, P2788, DOI 10.2337/db09-0763; Duez H, 2008, DIABETES VASC DIS RE, V5, P82, DOI 10.3132/dvdr.2008.0014; DVORIN E, 1986, J BIOL CHEM, V261, P5714; Fernandez PM, 2000, ENDOCRINOLOGY, V141, P2392, DOI 10.1210/en.141.7.2392; Fournier N, 2000, ARTERIOSCL THROM VAS, V20, P1283, DOI 10.1161/01.ATV.20.5.1283; Fu YC, 2007, J BIOL CHEM, V282, P31525, DOI 10.1074/jbc.M701132200; GHISELLI G, 1989, BIOCHIM BIOPHYS ACTA, V1006, P26, DOI 10.1016/0005-2760(89)90319-6; LAU LF, 1985, EMBO J, V4, P3145, DOI 10.1002/j.1460-2075.1985.tb04057.x; Li XM, 2014, J BIOL CHEM, V289, P2396, DOI 10.1074/jbc.M113.511766; LIU ZG, 1994, NATURE, V367, P281, DOI 10.1038/367281a0; Lu S, 2006, J BIOL CHEM, V281, P3473, DOI 10.1074/jbc.M502501200; Mahoney DJ, 2005, FASEB J, V19, P1498, DOI 10.1096/fj.04-3149fje; MARUYAMA K, 1995, CANCER LETT, V96, P117, DOI 10.1016/0304-3835(95)03921-I; Murphy EP, 2001, ARTHRITIS RHEUM-US, V44, P782, DOI 10.1002/1529-0131(200104)44:4<782::AID-ANR134>3.3.CO;2-8; Pearen MA, 2008, ENDOCRINOLOGY, V149, P2853, DOI 10.1210/en.2007-1202; Pei LM, 2006, NAT MED, V12, P1048, DOI 10.1038/nm1471; Pires NMM, 2007, CIRCULATION, V115, P493, DOI 10.1161/CIRCULATIONAHA.106.626838; Qin XF, 1998, AM J PHYSIOL-HEART C, V274, pH1836, DOI 10.1152/ajpheart.1998.274.5.H1836; Rius J, 2006, ATHEROSCLEROSIS, V184, P276, DOI 10.1016/j.atherosclerosis.2005.04.008; Saucedo-Cardenas O, 1998, P NATL ACAD SCI USA, V95, P4013, DOI 10.1073/pnas.95.7.4013; Spiegelman BM, 2004, CELL, V119, P157, DOI 10.1016/j.cell.2004.09.037; STEINMETZ A, 1990, J BIOL CHEM, V265, P7859; Thorngate FE, 2003, J LIPID RES, V44, P2331, DOI 10.1194/jlr.M300224-JLR200; Tubb MR, 2007, J BIOL CHEM, V282, P28385, DOI 10.1074/jbc.M704070200; Wang F, 2012, P NATL ACAD SCI USA, V109, P9641, DOI 10.1073/pnas.1201433109; Wang ZL, 2003, NATURE, V423, P555, DOI 10.1038/nature01645; Weinberg RB, 2002, CURR OPIN LIPIDOL, V13, P125, DOI 10.1097/00041433-200204000-00003; Weyrich P, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-77; WILSON TE, 1993, MOL CELL BIOL, V13, P861, DOI 10.1128/MCB.13.2.861; WORONICZ JD, 1994, NATURE, V367, P277, DOI 10.1038/367277a0; WU AL, 1979, J BIOL CHEM, V254, P7316; Wu XX, 2007, ENDOCRINE, V31, P5, DOI 10.1007/s12020-007-0007-x; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248	35	13	14	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142098	10.1371/journal.pone.0142098	http://dx.doi.org/10.1371/journal.pone.0142098			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556724	Green Published, Green Submitted, gold			2022-12-27	WOS:000364430700052
J	Maria, NSS; Barnes, SR; Weist, MR; Colcher, D; Raubitschek, AA; Jacobs, RE				Maria, Naomi S. Sta; Barnes, Samuel R.; Weist, Michael R.; Colcher, David; Raubitschek, Andrew A.; Jacobs, Russell E.			Low Dose Focused Ultrasound Induces Enhanced Tumor Accumulation of Natural Killer Cells	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; IN-VIVO; NK CELLS; DRUG-DELIVERY; IMMUNOTHERAPY; MICROBUBBLES; PERMEABILITY; MOUSE; DOXORUBICIN; DISRUPTION	Natural killer (NK) cells play a vital antitumor role as part of the innate immune system. Efficacy of adoptive transfer of NK cells depends on their ability to recognize and target tumors. We investigated whether low dose focused ultrasound with microbubbles (ldbFUS) could facilitate the targeting and accumulation of NK cells in a mouse xenograft of human colorectal adenocarcinoma (carcinoembryonic antigen (CEA)-expressing LS-174T implanted in NOD. Cg-Prkdc(scid)II2rg(tm1Wjl/SzJ) (NSG) mice) in the presence of an anti-CEA immunocytokine (ICK), hT84.66/M5A-IL-2 (M5A-IL-2). Human NK cells were labeled with an FDA-approved ultra-small superparamagnetic iron oxide particle, ferumoxytol. Simultaneous with the intravenous injection of microbubbles, focused ultrasound was applied to the tumor. In vivo longitudinal magnetic resonance imaging (MRI) identified enhanced accumulation of NK cells in the ensonified tumor, which was validated by endpoint histology. Significant accumulation of NK cells was observed up to 24 hrs at the tumor site when ensonified with 0.50 MPa peak acoustic pressure ldbFUS, whereas tumors treated with at 0.25 MPa showed no detectable NK cell accumulation. These clinically translatable results show that ldbFUS of the tumor mass can potentiate tumor homing of NK cells that can be evaluated non-invasively using MRI.	[Maria, Naomi S. Sta; Barnes, Samuel R.; Jacobs, Russell E.] CALTECH, Beckman Inst, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Weist, Michael R.; Colcher, David; Raubitschek, Andrew A.] Beckman Inst, Dept Canc Immunotherapeut & Tumor Immunol, Duarte, CA USA	California Institute of Technology; City of Hope; Beckman Research Institute of City of Hope	Jacobs, RE (corresponding author), CALTECH, Beckman Inst, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	rjacobs@caltech.edu	; Jacobs, Russell/H-1087-2011	Sta Maria, Naomi/0000-0001-9710-2908; Jacobs, Russell/0000-0002-1382-8486	National Institutes of Health [EB000993, CA43904]; Beckman Institute at Caltech; Beckman Institute at the City of Hope; NATIONAL CANCER INSTITUTE [P01CA043904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000993] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beckman Institute at Caltech; Beckman Institute at the City of Hope; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the National Institutes of Health (EB000993) (http://www.nibib.nih.gov/) and the Beckman Institute at Caltech (http://www.beckmaninstitute.caltech.edu/) to REJ; and National Institutes of Health (CA43904) (http://www.cancer.gov/) and the Beckman Institute at the City of Hope (http://www.cityofhope.org/beckman-research-institute) to DC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Bataineh O, 2012, CANCER TREAT REV, V38, P346, DOI 10.1016/j.ctrv.2011.08.004; Alderson KL, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/379123; Alkins R, 2013, CANCER RES, V73, P1892, DOI 10.1158/0008-5472.CAN-12-2609; Ames E, 2014, CANCER IMMUNOL IMMUN, V63, P21, DOI 10.1007/s00262-013-1469-8; Arct J, 2008, CLIN DERMATOL, V26, P347, DOI 10.1016/j.clindermatol.2008.01.004; Barnes SR, 2015, BMC MED IMAGING, V15, DOI 10.1186/s12880-015-0062-3; Chen PY, 2010, NEURO-ONCOLOGY, V12, P1050, DOI 10.1093/neuonc/noq054; Chenevert Thomas L, 2002, Mol Imaging, V1, P336, DOI 10.1162/153535002321093945; Cheng M, 2013, CELL MOL IMMUNOL, V10, P230, DOI 10.1038/cmi.2013.10; Cheng Min, 2012, Front Med, V6, P56, DOI 10.1007/s11684-012-0177-7; Chopra R, 2010, ACS CHEM NEUROSCI, V1, P391, DOI 10.1021/cn9000445; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Daldrup-Link HE, 2005, EUR RADIOL, V15, P4, DOI 10.1007/s00330-004-2526-7; Dall'Ozzo S, 2004, CANCER RES, V64, P4664, DOI 10.1158/0008-5472.CAN-03-2862; Figueiredo C, 2009, J MOL MED, V87, P199, DOI 10.1007/s00109-008-0417-0; Galli F, 2014, Q J NUCL MED MOL IM, V58, P276; Gillies SD, 2005, BLOOD, V105, P3972, DOI 10.1182/blood-2004-09-3533; Hamstra DA, 2005, P NATL ACAD SCI USA, V102, P16759, DOI 10.1073/pnas.0508347102; Jha P, 2010, CANCER RES, V70, P6109, DOI 10.1158/0008-5472.CAN-09-3774; Jolesz FA, 2009, ANNU REV MED, V60, P417, DOI 10.1146/annurev.med.60.041707.170303; Khurana A, 2013, NANOMEDICINE-UK, V8, P1969, DOI 10.2217/nnm.12.198; Kiessling F, 2012, J NUCL MED, V53, P345, DOI 10.2967/jnumed.111.099754; KIESSLING R, 1975, EUR J IMMUNOL, V5, P117, DOI 10.1002/eji.1830050209; Kinoshita M, 2006, P NATL ACAD SCI USA, V103, P11719, DOI 10.1073/pnas.0604318103; Konofagou EE, 2012, THERANOSTICS, V2, P1223, DOI 10.7150/thno.5576; Kuo TT, 2011, MABS-AUSTIN, V3, P422, DOI 10.4161/mabs.3.5.16983; Lazovic J, 2008, CLIN CANCER RES, V14, P3832, DOI 10.1158/1078-0432.CCR-07-5067; Liu HL, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-221; Lode HN, 1998, PHARMACOL THERAPEUT, V80, P277, DOI 10.1016/S0163-7258(98)00033-3; Lu P, 2009, SURGERY, V145, P286, DOI 10.1016/j.surg.2008.10.010; Maria ASS, 2014, MAGN RESON INSIGHTS, V7, P15, DOI 10.4137/MRI.S13145; McDannold N, 2012, CANCER RES, V72, P3652, DOI 10.1158/0008-5472.CAN-12-0128; Miller JS, 2013, HEMATOL-AM SOC HEMAT, P247, DOI 10.1182/asheducation-2013.1.247; Miller JS, 2005, BLOOD, V105, P3051, DOI 10.1182/blood-2004-07-2974; Muller T, 2008, CANCER IMMUNOL IMMUN, V57, P411, DOI 10.1007/s00262-007-0383-3; O'Reilly MA, 2012, JOVE-J VIS EXP, DOI 10.3791/3555; Orsi F, 2010, J CANCER RES THER, V6, P414, DOI 10.4103/0973-1482.77064; Park J, 2012, J CONTROL RELEASE, V162, P134, DOI 10.1016/j.jconrel.2012.06.012; Ruggeri L, 2005, CURR OPIN IMMUNOL, V17, P211, DOI 10.1016/j.coi.2005.01.007; Samiotaki G, 2012, MAGN RESON MED, V67, P769, DOI 10.1002/mrm.23063; Sheu AY, 2013, INVEST RADIOL, V48, P492, DOI 10.1097/RLI.0b013e31827994e5; Somanchi Srinivas S, 2011, J Vis Exp, DOI 10.3791/2540; Talebian L, 2014, TRANSFUSION, V54, P1515, DOI 10.1111/trf.12517; Nhan T, 2013, J CONTROL RELEASE, V172, P274, DOI 10.1016/j.jconrel.2013.08.029; Tao Sun, 2013, Journal of the Acoustical Society of America, V134, DOI 10.1121/1.4831336; Treat LH, 2007, INT J CANCER, V121, P901, DOI 10.1002/ijc.22732; Vestweber D, 2012, ANN NY ACAD SCI, V1257, P184, DOI 10.1111/j.1749-6632.2012.06558.x; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Vlachos F, 2011, MAGN RESON MED, V66, P821, DOI 10.1002/mrm.22848; Wang ST, 2014, ULTRASOUND MED BIOL, V40, P130, DOI 10.1016/j.ultrasmedbio.2013.09.015; Watson KD, 2012, CANCER RES, V72, P1485, DOI 10.1158/0008-5472.CAN-11-3232; Yazaki PJ, 2004, PROTEIN ENG DES SEL, V17, P481, DOI 10.1093/protein/gzh056	53	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142767	10.1371/journal.pone.0142767	http://dx.doi.org/10.1371/journal.pone.0142767			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556731	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000364430700172
J	Okamoto, A; Higo, M; Shiiba, M; Nakashima, D; Koyama, T; Miyamoto, I; Kasama, H; Kasamatsu, A; Ogawara, K; Yokoe, H; Tanzawa, H; Uzawa, K				Okamoto, Atsushi; Higo, Morihiro; Shiiba, Masashi; Nakashima, Dai; Koyama, Tomoyoshi; Miyamoto, Isao; Kasama, Hiroki; Kasamatsu, Atsushi; Ogawara, Katsunori; Yokoe, Hidetaka; Tanzawa, Hideki; Uzawa, Katsuhiro			Down-Regulation of Nucleolar and Spindle-Associated Protein 1 (NUSAP1) Expression Suppresses Tumor and Cell Proliferation and Enhances Anti-Tumor Effect of Paclitaxel in Oral Squamous Cell Carcinoma	PLOS ONE			English	Article							CANCER; THERAPY; ALCOHOL; TOBACCO; TAXOL	Background Nucleolar and spindle-associated protein 1 (NUSAP1) is an important mitotic regulator. In addition to its crucial function in mitosis, NUSAP1 has recently received attention due to the interesting roles in carcinogenesis. The aim of this study was to reveal functional mechanisms of NUSAP1 in oral squamous cell carcinoma (OSCC). Methods mRNA and protein expression levels of NUSAP1 in 9 OSCC-derived cells were analyzed by quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR) and immuno-blotting analyses. The correlation between the NUSAP1 expression profile and the clinicopathological factors was evaluated by immunohistochemistry (IHC) in clinical OSCC samples (n = 70). The NUSAP1 knockdown cells were established with short hairpin RNA (shRNA) in OSCC cells, and functional assays were performed using these cells. In addition to the evaluation of cellular proliferation and cell cycle, we also investigated the potential role of NUSAP1 in paclitaxel (PTX)-induced cellular responses. Results mRNA and protein expression of NUSAP1 were significantly up-regulated in OSCC-derived cells compared with human normal oral keratinocytes (P < 0.05). IHC revealed that NUSAP-1 expression is closely associated with primary advanced T stage (P<0.05). Suppression of NUSAP1 expression levels led to significant (P<0.05) inhibition of cellular proliferation. Furthermore, apoptosis induced by PTX was enhanced in NUSAP1 knockdown OSCC cells. Conclusions NUSAP1 may be a crucial biomarker for OSCC. Moreover, down-regulated NUSAP1 expression suppresses tumor proliferation and also enhances anti-tumor effect of PTX by activating apoptotic pathways. Thus, the present study strongly suggests that regulating NUSAP1 expression should contribute to the therapy for OSCC.	[Okamoto, Atsushi; Shiiba, Masashi; Koyama, Tomoyoshi; Miyamoto, Isao; Kasama, Hiroki; Tanzawa, Hideki; Uzawa, Katsuhiro] Chiba Univ, Grad Sch Med, Dept Oral Sci, Chuo Ku, Chiba, Japan; [Higo, Morihiro; Nakashima, Dai; Kasamatsu, Atsushi; Ogawara, Katsunori; Tanzawa, Hideki; Uzawa, Katsuhiro] Chiba Univ Hosp, Dept Dent & Oral Maxillofacial Surg, Chuo Ku, Chiba, Japan; [Shiiba, Masashi] Chiba Univ, Grad Sch Med, Dept Med Oncol, Chuo Ku, Chiba, Japan; [Yokoe, Hidetaka] Natl Def Med Coll Hosp, Dept Oral & Maxillofacial Surg, Res Inst, Tokorozawa, Saitama, Japan	Chiba University; Chiba University; National Defense Medical College - Japan	Shiiba, M (corresponding author), Chiba Univ, Grad Sch Med, Dept Oral Sci, Chuo Ku, Chiba, Japan.	m.shiiba@faculty.chiba-u.jp		Uzawa, Katsuhiro/0000-0002-7036-0859				Baba T, 2013, MOL CARCINOGENESIS; Chen DT, 2010, BREAST CANCER RES TR, V119, P335, DOI 10.1007/s10549-009-0344-y; Diaz-Rodriguez E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027583; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Ferrero M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028602; Iyer J, 2011, CELL SIGNAL, V23, P991, DOI 10.1016/j.cellsig.2010.11.006; Iyoda M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014082; Koike H, 2005, CONNECT TISSUE RES, V46, P117, DOI 10.1080/03008200591008437; Kokkinakis DM, 2005, MOL CANCER THER, V4, P1338, DOI 10.1158/1535-7163.MCT-05-0141; MACFARLANE GJ, 1995, ORAL ONCOL, V31B, P181; MARSHALL CJ, 1991, CELL, V64, P313, DOI 10.1016/0092-8674(91)90641-B; MASHBERG A, 1993, CANCER-AM CANCER SOC, V72, P1369, DOI 10.1002/1097-0142(19930815)72:4<1369::AID-CNCR2820720436>3.0.CO;2-L; MCGUIRE WP, 1989, ANN INTERN MED, V111, P273, DOI 10.7326/0003-4819-111-4-273; PINDBORG JJ, 1997, WHO CLASSIFICATION T; Raemaekers T, 2003, J CELL BIOL, V162, P1017, DOI 10.1083/jcb.200302129; Satow R, 2010, CLIN CANCER RES, V16, P2518, DOI 10.1158/1078-0432.CCR-09-2214; SCHIFF PB, 1980, P NATL ACAD SCI-BIOL, V77, P1561, DOI 10.1073/pnas.77.3.1561; Shimizu F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083187; Shimizu T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045510; Sobin L, 2009, TNM CLASSIFICATION M; Sudbo J, 2005, INT J CANCER, V115, P339, DOI 10.1002/ijc.20896; Verburg FA, 2010, HORM METAB RES, V42, P736, DOI 10.1055/s-0030-1254132; Yamano Y, 2008, INT J ONCOL, V32, P1001	23	35	41	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142252	10.1371/journal.pone.0142252	http://dx.doi.org/10.1371/journal.pone.0142252			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26554377	Green Published, gold, Green Submitted			2022-12-27	WOS:000364430700074
J	Pytka, K; Partyka, A; Jastrzebska-Wiesek, M; Siwek, A; Gluch-Lutwin, M; Mordyl, B; Kazek, G; Rapacz, A; Olczyk, A; Galuszka, A; Blachuta, M; Waszkielewicz, A; Marona, H; Sepa, J; Filipek, B; Wesolowska, A				Pytka, Karolina; Partyka, Anna; Jastrzebska-Wiesek, Magdalena; Siwek, Agata; Gluch-Lutwin, Monika; Mordyl, Barbara; Kazek, Grzegorz; Rapacz, Anna; Olczyk, Adrian; Galuszka, Adam; Blachuta, Marian; Waszkielewicz, Anna; Marona, Henryk; Sepa, Jacek; Filipek, Barbara; Wesolowska, Anna			Antidepressant- and Anxiolytic-Like Effects of New Dual 5-HT1A and 5-HT7 Antagonists in Animal Models	PLOS ONE			English	Article							TARGETING SEROTONIN 5-HT2A; MAJOR DEPRESSIVE DISORDER; FORCED SWIMMING TEST; PHARMACOLOGICAL EVALUATION; POTENTIAL ANTIDEPRESSANT; P-CHLOROPHENYLALANINE; RECEPTOR ANTAGONISTS; DERIVATIVES; BINDING; MICE	The aim of this study was to further characterize pharmacological properties of two phenylpiperazine derivatives: 1-{2-[2-(2,6-dimethlphenoxy)ethoxy]ethyl}-4-(2-methoxyphenyl) piperazynine hydrochloride (HBK-14) and 2-[2-(2-chloro-6-methylphenoxy) ethoxy] ethyl-4-(2-methoxyphenyl) piperazynine dihydrochloride (HBK-15) in radioligand binding and functional in vitro assays as well as in vivo models. Antidepressant-like properties were investigated in the forced swim test (FST) in mice and rats. Anxiolytic-like activity was evaluated in the four-plate test in mice and elevated plus maze test (EPM) in rats. Imipramine and escitalopram were used as reference drugs in the FST, and diazepam was used as a standard anxiolytic drug in animal models of anxiety. Our results indicate that HBK-14 and HBK-15 possess high or moderate affinity for serotonergic 5-HT2, adrenergic alpha(1), and dopaminergic D-2 receptors as well as being full 5-HT1A and 5-HT7 receptor antagonists. We also present their potent antidepressant-like activity (HBK-14-FST mice: 2.5 and 5 mg/kg; FST rats: 5 mg/kg) and (HBK-15-FST mice: 1.25, 2.5 and 5 mg/kg; FST rats: 1.25 and 2.5 mg/kg). We show that HBK-14 (four-plate test: 2.5 and 5 mg/kg; EPM: 2.5 mg/kg) and HBK-15 (four-plate test: 2.5 and 5 mg/kg; EPM: 5 mg/kg) possess anxiolytic-like properties. Among the two, HBK-15 has stronger antidepressant-like properties, and HBK-14 displays greater anxiolytic-like activity. Lastly, we demonstrate the involvement of serotonergic system, particularly 5-HT1A receptor, in the antidepressant-and anxiolytic-like actions of investigated compounds.	[Pytka, Karolina; Kazek, Grzegorz; Rapacz, Anna; Sepa, Jacek; Filipek, Barbara] Jagiellonian Univ, Dept Pharmacodynam, Fac Pharm, Med Coll,Med 9, PL-30688 Krakow, Poland; [Partyka, Anna; Jastrzebska-Wiesek, Magdalena; Wesolowska, Anna] Jagiellonian Univ, Dept Clin Pharm, Fac Pharm, Med Coll,Med 9, PL-30688 Krakow, Poland; [Siwek, Agata; Gluch-Lutwin, Monika; Mordyl, Barbara] Jagiellonian Univ, Dept Pharmacobiol, Fac Pharm, Med Coll,Med 9, PL-30688 Krakow, Poland; [Olczyk, Adrian; Galuszka, Adam; Blachuta, Marian] Silesian Tech Univ, Inst Automat Control, Akad 16, PL-44100 Gliwice, Poland; [Waszkielewicz, Anna; Marona, Henryk] Jagiellonian Univ, Dept Bioorgan Chem, Fac Pharm, Chair Organ Chem,Med Coll,Med 9, PL-30688 Krakow, Poland	Jagiellonian University; Collegium Medicum Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University; Silesian University of Technology; Jagiellonian University; Collegium Medicum Jagiellonian University	Pytka, K (corresponding author), Jagiellonian Univ, Dept Pharmacodynam, Fac Pharm, Med Coll,Med 9, PL-30688 Krakow, Poland.	karolina.pytka@ut.edu.pl	Partyka, Anna/AAZ-8648-2020; Galuszka, Adam/ABB-2203-2021; Głuch-Lutwin, Monika/AAE-2702-2019; Pytka, Karolina/Z-5491-2019; Siwek, Agata/AAE-2742-2019; Mordyl, Barbara/AAD-8247-2019; Blachuta, Marian/V-2022-2018	Galuszka, Adam/0000-0002-6176-0500; Głuch-Lutwin, Monika/0000-0003-1632-6569; Pytka, Karolina/0000-0001-7134-9515; Siwek, Agata/0000-0001-5321-9266; Mordyl, Barbara/0000-0001-7906-0353; Marona, Henryk/0000-0002-3815-4174; Filipek, Barbara/0000-0001-8487-9945; Waszkielewicz, Anna/0000-0002-2871-9418; SAPA, JACEK/0000-0003-4670-1665; Jastrzebska-Wiesek, Magdalena/0000-0002-5388-1214; Wesolowska, Anna/0000-0003-2383-3278; Rapacz, Anna/0000-0002-0190-1682; Blachuta, Marian/0000-0001-6468-7962	Jagiellonian University [K/DSC/001955]; Silesian University of Technology [BK 227/RAu1/2015/1]; GeCONil-Upper Silesian Center for Computational Science and Engineering [POIG.02.03.01-24-099/13]	Jagiellonian University; Silesian University of Technology; GeCONil-Upper Silesian Center for Computational Science and Engineering	Funding: This study was supported by Jagiellonian University grant number K/DSC/001955 and Silesian University of Technology grant number BK 227/RAu1/2015/1. The research was partially performed on the infrastructure supported by POIG.02.03.01-24-099/13 grant: "GeCONil-Upper Silesian Center for Computational Science and Engineering". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agai-Csongor E, 2012, BIOORG MED CHEM LETT, V22, P3437, DOI 10.1016/j.bmcl.2012.03.104; Albert PR, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00199; Boldrini M, 2008, J PSYCHIATR RES, V42, P433, DOI 10.1016/j.jpsychires.2007.05.004; Chae E, 2012, BIOORG MED CHEM LETT, V22, P2434, DOI 10.1016/j.bmcl.2012.02.023; CHEETHAM SC, 1990, PSYCHOPHARMACOLOGY, V102, P544, DOI 10.1007/BF02247138; Cheng HC, 2001, J PHARMACOL TOX MET, V46, P61, DOI 10.1016/S1056-8719(02)00166-1; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Dawson LA, 2009, CNS NEUROSCI THER, V15, P107, DOI 10.1111/j.1755-5949.2008.00067.x; DETKE MJ, 1995, PSYCHOPHARMACOLOGY, V121, P66, DOI 10.1007/BF02245592; Garcia-Garcia AL, 2014, PSYCHOPHARMACOLOGY, V231, P623, DOI 10.1007/s00213-013-3389-x; Griebel G, 2000, NEUROPHARMACOLOGY, V39, P1848, DOI 10.1016/S0028-3908(00)00074-5; Guscott M, 2005, NEUROPHARMACOLOGY, V48, P492, DOI 10.1016/j.neuropharm.2004.11.015; Hedlund PB, 2005, BIOL PSYCHIAT, V58, P831, DOI 10.1016/j.biopsych.2005.05.012; Hedlund PB, 2009, PSYCHOPHARMACOLOGY, V206, P345, DOI 10.1007/s00213-009-1626-0; Hsiung S, 2003, J NEUROCHEM, V87, P182, DOI 10.1046/j.1471-4159.2003.01987.x; Imaizumi M, 1996, METHOD FIND EXP CLIN, V18, P513; Jastrzebska-Wiesek M, 2014, NEUROPHARMACOLOGY, V85, P253, DOI 10.1016/j.neuropharm.2014.05.036; Jindal A, 2012, EUR J PHARMACOL, V689, P125, DOI 10.1016/j.ejphar.2012.05.051; Johnson DS, 2011, BIOORG MED CHEM LETT, V21, P2621, DOI 10.1016/j.bmcl.2011.01.059; Kang SY, 2010, BIOORG MED CHEM LETT, V20, P1705, DOI 10.1016/j.bmcl.2010.01.093; Kim JY, 2010, BIOORG MED CHEM LETT, V20, P6439, DOI 10.1016/j.bmcl.2010.09.081; KOE BK, 1966, J PHARMACOL EXP THER, V154, P499; Kolaczkowski M, 2014, J MED CHEM, V57, P4543, DOI 10.1021/jm401895u; Lanzenberger RR, 2007, BIOL PSYCHIAT, V61, P1081, DOI 10.1016/j.biopsych.2006.05.022; Le Francois B, 2008, NEUROPHARMACOLOGY, V55, P977, DOI 10.1016/j.neuropharm.2008.06.046; Li YC, 2009, PROG NEURO-PSYCHOPH, V33, P435, DOI 10.1016/j.pnpbp.2009.01.006; LUCKI I, 1994, NEUROSCI BIOBEHAV R, V18, P85, DOI 10.1016/0149-7634(94)90039-6; MAJ J, 1985, EUR J PHARMACOL, V119, P113, DOI 10.1016/0014-2999(85)90328-0; Manosso LM, 2013, PROG NEURO-PSYCHOPH, V46, P48, DOI 10.1016/j.pnpbp.2013.06.012; McCorvy JD, 2015, PHARMACOL THERAPEUT, V150, P129, DOI 10.1016/j.pharmthera.2015.01.009; Mnie-Filali O, 2007, DRUG NEWS PERSPECT, V20, P613, DOI 10.1358/dnp.2007.20.10.1181354; Mork A, 2012, J PHARMACOL EXP THER, V340, P666, DOI 10.1124/jpet.111.189068; Mullins UL, 1999, NEUROPSYCHOPHARMACOL, V21, P352, DOI 10.1016/S0893-133X(99)00041-X; Naumenko VS, 2014, CNS NEUROSCI THER, V20, P582, DOI 10.1111/cns.12247; Nikiforuk A, 2011, PSYCHOPHARMACOLOGY, V217, P411, DOI 10.1007/s00213-011-2297-1; Owens MJ, 1997, J PHARMACOL EXP THER, V283, P1305; Petit-Demouliere B, 2005, PSYCHOPHARMACOLOGY, V177, P245, DOI 10.1007/s00213-004-2048-7; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Prakash C, 1997, DRUG METAB DISPOS, V25, P1288; Pytka K, 2016, PHARMACOL REP, V68, P263, DOI 10.1016/j.pharep.2015.08.007; Pytka K, 2015, EUR J PHARMACOL, V764, P537, DOI 10.1016/j.ejphar.2015.07.041; Pytka K, 2015, PHARMACOL REP, V67, P160, DOI 10.1016/j.pharep.2014.08.016; Scorza MC, 2012, BRIT J PHARMACOL, V167, P1021, DOI 10.1111/j.1476-5381.2011.01770.x; Szewczyk B, 2009, INT J NEUROPSYCHOPH, V12, P155, DOI 10.1017/S1461145708009012; Waszkielewicz AM, 2013, BIOORG MED CHEM LETT, V23, P4419, DOI 10.1016/j.bmcl.2013.05.062; Waszkielewicz AM, 2015, CHEM BIOL DRUG DES, V85, P326, DOI 10.1111/cbdd.12394; Wesolowska A, 2008, PHARMACOL REP, V60, P464; Whale R, 2010, J PSYCHOPHARMACOL, V24, P513, DOI 10.1177/0269881108097714; Zeni ALB, 2012, EUR J PHARMACOL, V679, P68, DOI 10.1016/j.ejphar.2011.12.041	50	34	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142499	10.1371/journal.pone.0142499	http://dx.doi.org/10.1371/journal.pone.0142499			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26554929	Green Published, gold, Green Submitted			2022-12-27	WOS:000364430700118
J	Shao, Y; Li, P; Zhu, ST; Yue, JP; Ji, XJ; He, Z; Ma, D; Wang, L; Wang, YJ; Zong, Y; Wu, YD; Zhang, ST				Shao, Ying; Li, Peng; Zhu, Sheng-tao; Yue, Ji-ping; Ji, Xiao-jun; He, Zhen; Ma, Dan; Wang, Li; Wang, Yong-jun; Zong, Ye; Wu, Yong-dong; Zhang, Shu-tian			Cyclooxygenase-2, a Potential Therapeutic Target, Is Regulated by miR-101 in Esophageal Squamous Cell Carcinoma	PLOS ONE			English	Article							DOWN-REGULATION; TUMOR-SUPPRESSOR; CERVICAL-CANCER; GASTRIC-CANCER; EXPRESSION; GROWTH; COX-2; PROLIFERATION; INVASION; MIGRATION	Background & Aims Cyclooxygenase-2 (COX-2) is known to promote the carcinogenesis of esophageal squamous cell carcinoma (ESCC). There are no reports on whether microRNAs (miRNAs) regulate COX-2 expression in ESCC. This study investigated the effect of miR-101 on ESCC through modulating COX-2 expression in ESCC. Methods Real-time quantitative reverse transcription-polymerase chain reaction (RT-PCR) was used to quantify miR-101 expression in ESCC clinical tissues and cell lines. The effects of miR-101 on ESCC progression were evaluated by cell counting kit-8 (CCK8), transwell migration and invasion assays, as well as by flow cytometry. The COX-2 and PEG2 levels were determined by western blot and enzyme-linked immunosorbent assays (ELISA). The luciferase reporter assay was used to verify COX-2 as a direct target of miR-101. The antitumor activity of miR-101 in vivo was investigated in a xenograft nude mouse model of ESCC. Results Downregulation of miR-101 was confirmed through comparison of 30 pairs of ESCC tumor and adjacent normal tissues (P < 0.001), as well as in 11 ESCC cell lines and a human immortalized esophageal cell line (P < 0.001). Transfection of miR-101 in ESCC cell lines significantly suppressed cell proliferation, migration, and invasion (all P < 0.001). The antitumor effect of miR-101 was verified in a xenograft model. Furthermore, COX-2 was shown to be a target of miR-101. Conclusions Overexpression of miR-101 in ESCC inhibits proliferation and metastasis. Therefore, the miR-101/COX-2 pathway might be a therapeutic target in ESCC.	[Shao, Ying; Li, Peng; Zhu, Sheng-tao; Yue, Ji-ping; He, Zhen; Ma, Dan; Wang, Li; Wang, Yong-jun; Zong, Ye; Wu, Yong-dong; Zhang, Shu-tian] Capital Med Univ, Beijing Friendship Hosp, Natl Clin Res Ctr Digest Dis, Dept Gastroenterol,Beijing Key Lab Precancerous L, Beijing, Peoples R China; [Ji, Xiao-jun] Capital Med Univ, Intens Care Unit, Beijing Friendship Hosp, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Zhang, ST (corresponding author), Capital Med Univ, Beijing Friendship Hosp, Natl Clin Res Ctr Digest Dis, Dept Gastroenterol,Beijing Key Lab Precancerous L, Beijing, Peoples R China.	zhangshutian@ccmu.edu.cn	He, Zhen/D-1275-2009	He, Zhen/0000-0001-6302-6556; , Jiping/0000-0003-0717-8613	national 973 Plan of China [2012CB526600]; National Natural Science Foundation of China [81341061]	national 973 Plan of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by national 973 Plan of China (approval number: 2012CB526600) to STZ (http://www.973.gov.cn/), and the National Natural Science Foundation of China (approval number: 81341061) to YS (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhim Z, 2011, BRIT J CANCER, V105, P393, DOI 10.1038/bjc.2011.262; Akanuma N, 2014, BRIT J CANCER, V110, P189, DOI 10.1038/bjc.2013.676; Akhtar N, 2012, ANN RHEUM DIS, V71, P1073, DOI 10.1136/annrheumdis-2011-200519; Barnas C, 1997, INT J CANCER, V71, P79, DOI 10.1002/(SICI)1097-0215(19970328)71:1<79::AID-IJC14>3.0.CO;2-4; Bertagnolli MM, 2007, LANCET ONCOL, V8, P439, DOI 10.1016/S1470-2045(07)70139-0; Chen LC, 2012, EUR J CANCER, V48, P3104, DOI 10.1016/j.ejca.2012.02.007; Chen MB, 2015, BIOCH BIOPHYS RES CO; Corley DA, 2003, GASTROENTEROLOGY, V124, P47, DOI 10.1053/gast.2003.50008; Ding DP, 2011, CARCINOGENESIS, V32, P1025, DOI 10.1093/carcin/bgr078; Elmets CA, 2014, J INVEST DERMATOL, V134, P2497, DOI 10.1038/jid.2014.192; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fosslien E, 2000, ANN CLIN LAB SCI, V30, P3; Fu MG, 2013, FEBS LETT, V587, P3471, DOI 10.1016/j.febslet.2013.08.036; FUNKHOUSER EM, 1995, CANCER-AM CANCER SOC, V76, P1116, DOI 10.1002/1097-0142(19951001)76:7<1116::AID-CNCR2820760703>3.0.CO;2-I; Gong H, 2013, CLIN CANCER RES, V19, P1083, DOI 10.1158/1078-0432.CCR-12-3169; Hao YB, 2011, CANCER PREV RES, V4, P1073, DOI 10.1158/1940-6207.CAPR-10-0333; He XP, 2012, FEBS J, V279, P4201, DOI 10.1111/febs.12013; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Ji Junfang, 2010, Front Med China, V4, P412, DOI 10.1007/s11684-010-0260-x; Ji YH, 2010, FEBS LETT, V584, P961, DOI 10.1016/j.febslet.2010.01.036; Jiang W, 2015, ANTICANCER AGENTS ME; Jiang YZ, 2015, ONCOL LETT, V9, P471, DOI 10.3892/ol.2014.2701; Kase S, 2004, PATHOBIOLOGY, V71, P84, DOI 10.1159/000074421; Kim BM, 2011, CANCER LETT, V300, P134, DOI 10.1016/j.canlet.2010.09.014; Kim HS, 2012, BIOCHEM PHARMACOL, V83, P385, DOI 10.1016/j.bcp.2011.11.008; Kim JI, 2010, MOL CANCER RES, V8, P569, DOI 10.1158/1541-7786.MCR-09-0511; Kong KL, 2012, GUT, V61, P33, DOI 10.1136/gutjnl-2011-300178; Konno Y, 2014, ONCOTARGET; Konno Y, 2014, ONCOTARGET, V5, P6049, DOI 10.18632/oncotarget.2157; Kumagai Y, 2015, INT SURG, V100, P733, DOI 10.9738/INTSURG-D-14-00234.1; Kurashige J, 2012, BRIT J CANCER, V106, P182, DOI 10.1038/bjc.2011.509; Lei Q, 2014, ONCOL REP, V32, P261, DOI 10.3892/or.2014.3167; Li P, 2009, DIS ESOPHAGUS, V22, P21, DOI 10.1111/j.1442-2050.2008.00836.x; Li W, 2014, GASTROENTEROLOGY, V146, P1714, DOI 10.1053/j.gastro.2014.03.002; Liang XL, 2014, INT J GYNECOL CANCER, V24, P1165, DOI 10.1097/IGC.0000000000000187; Lin C, 2011, CARCINOGENESIS, V32, P19, DOI 10.1093/carcin/bgq212; Lin C, 2014, INT J CLIN EXP PATHO, V7, P6543; Lin C, 2014, ASIAN PAC J CANCER P, V15, P45, DOI 10.7314/APJCP.2014.15.1.45; Liu JF, 2009, ANN SURG ONCOL, V16, P1397, DOI 10.1245/s10434-009-0382-z; Liu L, 2014, TUMOR BIOL, V35, P12619, DOI 10.1007/s13277-014-2585-6; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Meng XY, 2011, DIS ESOPHAGUS, V24, P444, DOI 10.1111/j.1442-2050.2010.01159.x; Meng XY, 2012, J DIGEST DIS, V13, P208, DOI 10.1111/j.1751-2980.2012.00578.x; Park SJ, 2013, OSTEOARTHR CARTILAGE, V21, P981, DOI 10.1016/j.joca.2013.04.012; Psaty BM, 2006, NEW ENGL J MED, V355, P950, DOI 10.1056/NEJMe068158; Shamma A, 2000, CLIN CANCER RES, V6, P1229; Shen Q, 2014, CANCER LETT, V344, P204, DOI 10.1016/j.canlet.2013.10.030; Shi HY, 2011, CANCER LETT, V309, P19, DOI 10.1016/j.canlet.2011.05.010; Song T, 2011, ASIAN PAC J CANCER P, V12, P929; Song Y, 2014, ONCOTARGET, V5, P11669, DOI 10.18632/oncotarget.2581; Strillacci A, 2009, EXP CELL RES, V315, P1439, DOI 10.1016/j.yexcr.2008.12.010; Tanaka Y, 2013, CANCER-AM CANCER SOC, V119, P1159, DOI 10.1002/cncr.27895; Wang CH, 2014, ONCOL LETT, V8, P1815, DOI 10.3892/ol.2014.2361; Wang L, 2014, CELL PHYSIOL BIOCHEM, V34, P413, DOI 10.1159/000363010; Wang R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046173; Wang ZQ, 2014, FEBS LETT, V588, P915, DOI 10.1016/j.febslet.2014.01.035; Yang C, 2014, CANCER CELL INT, V14, DOI 10.1186/s12935-014-0138-0; Yao YL, 2015, CNS NEUROSCI THER, V21, P40, DOI 10.1111/cns.12321; Yu HP, 2003, CANCER LETT, V198, P193, DOI 10.1016/S0304-3835(03)00340-9; Zang WQ, 2014, TUMOR BIOL, V35, P12583, DOI 10.1007/s13277-014-2579-4; Zhang F, 2014, CANCER LETT, V342, P121, DOI 10.1016/j.canlet.2013.08.037; Zhang HF, 2014, CARCINOGENESIS, V35, P292, DOI 10.1093/carcin/bgt320; Zhang JQ, 2013, AM J PATHOL, V182, P1629, DOI 10.1016/j.ajpath.2013.01.045; Zhang KL, 2014, ONCOL REP, V32, P2143, DOI 10.3892/or.2014.3459; Zhang L, 2011, WORLD J GASTROENTERO, V17, P4572, DOI 10.3748/wjg.v17.i41.4572; Zhang L, 2010, PATHOL ONCOL RES, V16, P39, DOI 10.1007/s12253-009-9185-6; Zhang W, 2003, CANCER DETECT PREV, V27, P243, DOI 10.1016/S0361-090X(03)00072-2; Zhi HY, 2003, INT J CANCER, V106, P327, DOI 10.1002/ijc.11225; Zhou XY, 2015, CANCER BIOL THER, V16, P160, DOI 10.4161/15384047.2014.987523; Zong Y, 2009, WORLD J GASTROENTERO, V15, P2500, DOI 10.3748/wjg.15.2500	70	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0140642	10.1371/journal.pone.0140642	http://dx.doi.org/10.1371/journal.pone.0140642			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556718	gold, Green Published, Green Submitted			2022-12-27	WOS:000364430700012
J	Yu, SH; Wang, X; Zhang, T; Stressler, T; Fischer, L; Jiang, B; Mu, WM				Yu, Shuhuai; Wang, Xiao; Zhang, Tao; Stressler, Timo; Fischer, Lutz; Jiang, Bo; Mu, Wanmeng			Identification of a Novel Di-D-Fructofuranose 1,2 ': 2,3 ' Dianhydride (DFA III) Hydrolysis Enzyme from Arthrobacter aurescens SK8.001	PLOS ONE			English	Article							DIFRUCTOSE-ANHYDRIDE-III; INULIN FRUCTOTRANSFERASE; SWISS-MODEL; SP H65-7; SK 8.001; ULTRAFILTRATION MEMBRANE; CALCIUM-ABSORPTION; CLONING; GENE; PURIFICATION	Previously, a di-D-fructofuranose 1,2': 2,3' dianhydride (DFA III)-producing strain, Arthrobacter aurescens SK8.001, was isolated from soil, and the gene cloning and characterization of the DFA III-forming enzyme was studied. In this study, a DFA III hydrolysis enzyme (DFA IIIase)-encoding gene was obtained from the same strain, and the DFA IIIase gene was cloned and expressed in Escherichia coli. The SDS-PAGE and gel filtration results indicated that the purified enzyme was a homotrimer holoenzyme of 145 kDa composed of subunits of 49 kDa. The enzyme displayed the highest catalytic activity for DFA III at pH 5.5 and 55 degrees C, with specific activity of 232 U mg(-1). Km and Vmax for DFA III were 30.7 +/- 4.3 mM and 1.2 +/- 0.1 mM min(-1), respectively. Interestingly, DFA III-forming enzymes and DFA IIIases are highly homologous in amino acid sequence. The molecular modeling and docking of DFA IIIase were first studied, using DFA III-forming enzyme from Bacillus sp. snu-7 as a template. It was suggested that A. aurescens DFA IIIase shared a similar three-dimensional structure with the reported DFA III-forming enzyme from Bacillus sp. snu-7. Furthermore, their catalytic sites may occupy the same position on the proteins. Based on molecular docking analysis and site-directed mutagenesis, it was shown that D207 and E218 were two potential critical residues for the catalysis of A. aurescens DFA IIIase.	[Yu, Shuhuai; Wang, Xiao; Zhang, Tao; Jiang, Bo; Mu, Wanmeng] Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi 214122, Jiangsu, Peoples R China; [Zhang, Tao; Jiang, Bo; Mu, Wanmeng] Jiangnan Univ, Synerget Innovat Ctr Food Safety & Nutr, Wuxi 214122, Jiangsu, Peoples R China; [Stressler, Timo; Fischer, Lutz] Univ Hohenheim, Inst Food Sci & Biotechnol, Dept Biotechnol & Enzyme Sci, D-70599 Stuttgart, Germany	Jiangnan University; Jiangnan University; University Hohenheim	Mu, WM (corresponding author), Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi 214122, Jiangsu, Peoples R China.	wmmu@jiangnan.edu.cn			NSFC Project [21276001, 31371788]; Fundamental Research Funds for the Central Universities [JUSRP51304A]; Support Project of Jiangsu Province [BK20130001]	NSFC Project(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Support Project of Jiangsu Province	This work was supported by the NSFC Project (Nos. 21276001 and 31371788), the Fundamental Research Funds for the Central Universities (No. JUSRP51304A), and the Support Project of Jiangsu Province (BK20130001).	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Beg QK, 2001, APPL MICROBIOL BIOT, V56, P326, DOI 10.1007/s002530100704; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cho CM, 1997, J MICROBIOL BIOTECHN, V7, P121; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Hang H, 2013, CARBOHYD POLYM, V95, P654, DOI 10.1016/j.carbpol.2013.02.058; Hang H, 2013, CARBOHYD POLYM, V92, P1608, DOI 10.1016/j.carbpol.2012.09.052; Hang H, 2012, DESALINATION, V284, P309, DOI 10.1016/j.desal.2011.09.016; Hang H, 2012, J BIOSCI BIOENG, V113, P55, DOI 10.1016/j.jbiosc.2011.08.026; Hang H, 2011, APPL MICROBIOL BIOT, V92, P457, DOI 10.1007/s00253-011-3553-3; Hara H, 2010, NUTRITION, V26, P120, DOI 10.1016/j.nut.2009.05.024; Haraguchi K, 2000, J BIOSCI BIOENG, V89, P590, DOI 10.1016/S1389-1723(00)80062-6; HARAGUCHI K, 1995, BIOSCI BIOTECH BIOCH, V59, P1809, DOI 10.1271/bbb.59.1809; Haraguchi K, 2013, CARBOHYD POLYM, V93, P473, DOI 10.1016/j.carbpol.2012.12.045; Jung WS, 2007, J BIOL CHEM, V282, P8414, DOI 10.1074/jbc.M607143200; Kawaguchi K, 2014, ARCH MICROBIOL, V196, P17, DOI 10.1007/s00203-013-0938-y; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kikuchi H., 2004, J APPL GLYCOSCI, V51, P291, DOI [10.5458/jag.51.291, DOI 10.5458/JAG.51.291]; Kim CS, 2007, J MICROBIOL BIOTECHN, V17, P37; Kim HY, 2000, J MICROBIOL BIOTECHN, V10, P275; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Matsumoto M, 2007, J AGR FOOD CHEM, V55, P4202, DOI 10.1021/jf070049p; MATSUYAMA T, 1982, J BIOCHEM-TOKYO, V92, P1325, DOI 10.1093/oxfordjournals.jbchem.a134051; Minamida K, 2006, BIOSCI BIOTECH BIOCH, V70, P332, DOI 10.1271/bbb.70.332; Minamida K, 2005, J BIOSCI BIOENG, V99, P230, DOI 10.1263/jbb.99.230; Mitamura R, 2006, EUR J NUTR, V45, P242, DOI 10.1007/s00394-006-0592-0; Mongodin EF, 2006, PLOS GENET, V2, P2094, DOI 10.1371/journal.pgen.0020214; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Mutanda T, 2009, APPL BIOCHEM BIOTECH, V159, P65, DOI 10.1007/s12010-008-8479-6; Nakamori M, 2010, J NUTR SCI VITAMINOL, V56, P191, DOI 10.3177/jnsv.56.191; Neubauer A, 2000, BIOCATAL BIOTRANSFOR, V18, P443, DOI 10.3109/10242420009015262; Offen W, 2006, EMBO J, V25, P1396, DOI 10.1038/sj.emboj.7600970; Park J, 2012, J BIOL CHEM, V287, P31233, DOI 10.1074/jbc.M112.389270; Pudjiraharti S, 2014, J ANTIBIOT, V67, P137, DOI 10.1038/ja.2013.95; Saito K, 2000, BIOSCI BIOTECH BIOCH, V64, P1321, DOI 10.1271/bbb.64.1321; Saito K, 2003, J BIOSCI BIOENG, V95, P538, DOI 10.1016/S1389-1723(03)80058-0; Sakurai H, 1997, BIOSCI BIOTECH BIOCH, V61, P989, DOI 10.1271/bbb.61.989; Sato T, 2012, J DAIRY SCI, V95, P5336, DOI 10.3168/jds.2011-4989; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shao H, 2005, PLANT CELL, V17, P3141, DOI 10.1105/tpc.105.035055; Shigematsu N, 2004, BIOSCI BIOTECH BIOCH, V68, P1011, DOI 10.1271/bbb.68.1011; Singh RS, 2013, BIOLOGIA, V68, P1028, DOI 10.2478/s11756-013-0259-2; TANAKA T, 1975, J BIOCHEM-TOKYO, V78, P1201, DOI 10.1093/oxfordjournals.jbchem.a131017; Tuncay H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074763; Wang X, 2015, J AGR FOOD CHEM, V63, P3509, DOI 10.1021/jf506165n; Wang X, 2015, APPL MICROBIOL BIOT, V99, P175, DOI 10.1007/s00253-014-6238-x; Yang F, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0243-3; YOKOTA A, 1991, J FERMENT BIOENG, V72, P258, DOI 10.1016/0922-338X(91)90159-E; YOKOTA A, 1991, J FERMENT BIOENG, V72, P262, DOI 10.1016/0922-338X(91)90160-I; Yu SH, 2015, J MOL CATAL B-ENZYM, V120, P16, DOI 10.1016/j.molcatb.2015.06.012; Zhao M, 2013, EUR FOOD RES TECHNOL, V236, P991, DOI 10.1007/s00217-013-1962-5; Zhao M, 2011, J SCI FOOD AGR, V91, P2715, DOI 10.1002/jsfa.4582; Zhao M, 2011, BIORESOURCE TECHNOL, V102, P1757, DOI 10.1016/j.biortech.2010.08.093	55	4	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142640	10.1371/journal.pone.0142640	http://dx.doi.org/10.1371/journal.pone.0142640			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555784	gold, Green Published, Green Submitted			2022-12-27	WOS:000364430700146
J	Nahar, N; Paul, RC; Sultana, R; Gurley, ES; Garcia, F; Abedin, J; Sumon, SA; Banik, KC; Asaduzzaman, M; Rimi, NA; Rahman, M; Luby, SP				Nahar, Nazmun; Paul, Repon C.; Sultana, Rebeca; Gurley, Emily S.; Garcia, Fernando; Abedin, Jaynal; Sumon, Shariful Amin; Banik, Kajal Chandra; Asaduzzaman, Mohammad; Rimi, Nadia Ali; Rahman, Mahmudur; Luby, Stephen P.			Raw Sap Consumption Habits and Its Association with Knowledge of Nipah Virus in Two Endemic Districts in Bangladesh	PLOS ONE			English	Article							DATE PALM SAP; TO-PERSON TRANSMISSION; UNPASTEURIZED MILK; RESERVOIR HOSTS; PTEROPID BATS; OUTBREAK; INFECTIONS; WEIGHT; HUMANS; ACCESS	Human Nipah virus (NiV) infection in Bangladesh is a fatal disease that can be transmitted from bats to humans who drink contaminated raw date palm sap collected overnight during the cold season. Our study aimed to understand date palm sap consumption habits of rural residents and factors associated with consumption. In November-December 2012 the field team interviewed adult respondents from randomly selected villages from Rajbari and Kushtia Districts in Bangladesh. We calculated the proportion of people who consumed raw sap and had heard about a disease from raw sap consumption. We assessed the factors associated with raw sap consumption by calculating prevalence ratios (PR) adjusted for village level clustering effects. Among the 1,777 respondents interviewed, half (50%) reported drinking raw sap during the previous sap collection season and 37% consumed raw sap at least once per month. Few respondents (5%) heard about NiV. Thirty-seven percent of respondents reported hearing about a disease transmitted through raw sap consumption, inclusive of a 10% who related it with milder illness like diarrhea, vomiting or indigestion rather than NiV. Respondents who harvested date palm trees in their household were more likely to drink sap than those who did not own date palm trees (79% vs. 65% PR 1.2, 95% CI 1.1-1.3, p<0.001). When sap was available, respondents who heard about a disease from raw sap consumption were just as likely to drink it as those who did not hear about a disease (69% vs. 67%, PR 1.0, 95% CI 0.9-1.1, p = 0.512). Respondents' knowledge of NiV was low. They might not have properly understood the risk of NiV, and were likely to drink sap when it was available. Implementing strategies to increase awareness about the risks of NiV and protect sap from bats might reduce the risk of NiV transmission.	[Nahar, Nazmun; Paul, Repon C.; Sultana, Rebeca; Gurley, Emily S.; Abedin, Jaynal; Sumon, Shariful Amin; Banik, Kajal Chandra; Asaduzzaman, Mohammad; Rimi, Nadia Ali] ICDDRB, Dhaka, Bangladesh; [Nahar, Nazmun] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Garcia, Fernando] FHI360, Washington DC Off, Washington, DC USA; [Rahman, Mahmudur] IEDCR, Dhaka, Bangladesh; [Luby, Stephen P.] Stanford Univ, Infect Dis & Geog Med, Stanford, CA 94305 USA	International Centre for Diarrhoeal Disease Research (ICDDR); University of Basel; Swiss Tropical & Public Health Institute; Stanford University	Nahar, N (corresponding author), ICDDRB, Dhaka, Bangladesh.	nahar.nazmun@yahoo.com	Abedin, Jaynal/AAB-4089-2020; Gurley, Emily S/B-7903-2010	Abedin, Jaynal/0000-0002-4830-4092; Gurley, Emily S/0000-0002-8648-9403; Sultana, Rebeca/0000-0002-4180-5679; Sumon, Shariful Amin/0000-0001-5770-1527; Nahar, Nazmun/0000-0002-4530-6009; Rimi, Nadia/0000-0002-5566-8812; Luby, Stephen/0000-0001-5385-899X	FHI 360 [GHN-A-00-09-000002-00]	FHI 360	Funding: This study was funded by FHI 360, grant number GHN-A-00-09-000002-00.	Afrin S, 2013, ASARENESS CAMPAIGN N; Antia R, 2003, NATURE, V426, P658, DOI 10.1038/nature02104; Arankalle VA, 2011, EMERG INFECT DIS, V17, P907, DOI 10.3201/eid1705.100968; BBS (Bangladesh Bureau of Statistics), 2015, POPULATION HOUSING C; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Contento I., 1995, Journal of Nutrition Education, V27, P277; Correspondent S, 2013, NIPAH KILLS 5 MORE; Davidson R, 1993, ESTIMATION INFERENCE; de Wit E, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004001; DUCLOS PJ, 1990, INT J EPIDEMIOL, V19, P673, DOI 10.1093/ije/19.3.673; Editor N, 2011, NIPAH SPREADING NO R; Gase LN, 2014, HEALTH EDUC BEHAV, V41, P431, DOI 10.1177/1090198114529128; Gurley ES, 2007, EMERG INFECT DIS, V13, P1031, DOI 10.3201/eid1307.061128; Halpin K, 2011, AM J TROP MED HYG, V85, P946, DOI 10.4269/ajtmh.2011.10-0567; Hattersley LA, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-61; Homaira N, 2010, EPIDEMIOL INFECT, V138, P1630, DOI 10.1017/S0950268810000695; ICDDRB, 2010, HLTH SCI B, V8, P6; Islam A, 2013, ECOHEALTH; Islam MS, 2012, HLTH SCI B, V10, P16; Jayarao BM, 2006, J DAIRY SCI, V89, P2451, DOI 10.3168/jds.S0022-0302(06)72318-9; Kabeer N, 2001, WORLD DEV, V29, P63, DOI 10.1016/S0305-750X(00)00081-4; Keene WE, 1997, J INFECT DIS, V176, P815, DOI 10.1086/517310; Khan MSU, 2010, ECOHEALTH, V7, P517, DOI 10.1007/s10393-010-0366-2; Khan SU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042689; LeJeune JT, 2009, CLIN INFECT DIS, V48, P93, DOI 10.1086/595007; Li F, 2009, AM J EPIDEMIOL, V169, P401, DOI 10.1093/aje/kwn398; Longenberger AH, 2013, CLIN INFECT DIS, V57, P263, DOI 10.1093/cid/cit231; Luby SP, 2006, EMERG INFECT DIS, V12, P1888; Luby SP, 2013, ANTIVIR RES, V100, P38, DOI 10.1016/j.antiviral.2013.07.011; Luby SP, 2009, CLIN INFECT DIS, V49, P1743, DOI 10.1086/647951; Luby SP, 2009, EMERG INFECT DIS, V15, P1229, DOI 10.3201/eid1508.081237; Mehta NK, 2008, AM J PREV MED, V34, P127, DOI 10.1016/j.amepre.2007.09.031; Middleton DJ, 2007, J COMP PATHOL, V136, P266, DOI 10.1016/j.jcpa.2007.03.002; Nahar N, 2014, GLOB HEALTH PROMOT, V21, P7, DOI 10.1177/1757975914528249; Nahar N, 2013, HEALTH PROMOT INT, V28, P378, DOI 10.1093/heapro/das020; Nahar N, 2010, ECOHEALTH, V7, P196, DOI 10.1007/s10393-010-0320-3; Nestle M, 1998, NUTR REV, V56, pS50, DOI 10.1111/j.1753-4887.1998.tb01732.x; Oliver SP, 2009, FOODBORNE PATHOG DIS, V6, P793, DOI 10.1089/fpd.2009.0302; Olstad DL, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-376; Rahman MA, 2012, VECTOR-BORNE ZOONOT, V12, P65, DOI 10.1089/vbz.2011.0656; Reynes JM, 2005, EMERG INFECT DIS, V11, P1042, DOI 10.3201/eid1107.041350; Sazzad HMS, 2013, EMERG INFECT DIS, V19, P210, DOI 10.3201/eid1902.120971; Tamers SL, 2014, DOES MOTIVATE BEHAV; Wacharapluesadee S, 2005, EMERG INFECT DIS, V11, P1949, DOI 10.3201/eid1112.050613; Wong S, 2007, REV MED VIROL, V17, P67, DOI 10.1002/rmv.520; Zoellner J, 2012, J NUTR EDUC BEHAV, V44, P172, DOI 10.1016/j.jneb.2011.06.010	46	18	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2015	10	11							e0142292	10.1371/journal.pone.0142292	http://dx.doi.org/10.1371/journal.pone.0142292			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7AC	26551202	Green Published, gold, Green Accepted			2022-12-27	WOS:000364422800023
J	Park, JSY; Lee, MK; Kang, S; Jin, Y; Fu, SB; Rosales, JL; Lee, KY				Park, John S. Y.; Lee, Marie-Katrina; Kang, SungMyung; Jin, Yan; Fu, Songbin; Rosales, Jesusa L.; Lee, Ki-Young			Species-Specific Expression of Full-Length and Alternatively Spliced Variant Forms of CDK5RAP2	PLoS One			English	Article							PROTEINS; COMPLEX	CDK5RAP2 is one of the primary microcephaly genes that are associated with reduced brain size and mental retardation. We have previously shown that human CDK5RAP2 exists as a full-length form (hCDK5RAP2) or an alternatively spliced variant form (hCDK5RAP2-V1) that is lacking exon 32. The equivalent of hCDK5RAP2-V1 has been reported in rat and mouse but the presence of full-length equivalent hCDK5RAP2 in rat and mouse has not been examined. Here, we demonstrate that rat expresses both a full length and an alternatively spliced variant form of CDK5RAP2 that are equivalent to our previously reported hCDK5RAP2 and hCDK5RAP2-V1, repectively. However, mouse expresses only one form of CDK5RAP2 that is equivalent to the human and rat alternatively spliced variant forms. Knowledge of this expression of different forms of CDK5RAP2 in human, rat and mouse is essential in selecting the appropriate model for studies of CDK5RAP2 and primary microcephaly but our findings further indicate the evolutionary divergence of mouse from the human and rat species.	[Park, John S. Y.; Lee, Marie-Katrina; Kang, SungMyung; Lee, Ki-Young] Univ Calgary, Dept Cell Biol & Anat, Southern Alberta Canc Res, Calgary, AB, Canada; [Park, John S. Y.; Lee, Marie-Katrina; Kang, SungMyung; Rosales, Jesusa L.; Lee, Ki-Young] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Jin, Yan; Fu, Songbin] Harbin Med Univ, Med Genet Lab, Harbin, Peoples R China; [Rosales, Jesusa L.] Univ Calgary, Dept Biochem & Mol Biol, Southern Alberta Canc Res, Calgary, AB, Canada	University of Calgary; University of Calgary; Harbin Medical University; University of Calgary	Lee, KY (corresponding author), Univ Calgary, Dept Cell Biol & Anat, Southern Alberta Canc Res, Calgary, AB, Canada.	kylee@ucalgary.ca		Rosales, Jesusa/0000-0002-2543-3801	Canadian Institutes of Health Research [MOP-123400]; NSERC [RGPIN/312985-2011, RGPIN1356448-2008]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding: This work was supported in part by grants from the Canadian Institutes of Health Research (MOP-123400) and NSERC (RGPIN/312985-2011) to KYL and NSERC (RGPIN1356448-2008) to JLR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Buchman JJ, 2010, NEURON, V66, P386, DOI 10.1016/j.neuron.2010.03.036; Ching YP, 2000, GENE, V242, P285, DOI 10.1016/S0378-1119(99)00499-0; Cox J, 2006, TRENDS MOL MED, V12, P358, DOI 10.1016/j.molmed.2006.06.006; Faheem M, 2015, BMC MED GENOMICS, V8, DOI 10.1186/1755-8794-8-S1-S4; Fong KW, 2008, MOL BIOL CELL, V19, P115, DOI 10.1091/mbc.E07-04-0371; Fong KW, 2009, MOL BIOL CELL, V20, P3660, DOI 10.1091/mbc.E09-01-0009; Hall JG, 2013, GENE, V528, P55, DOI 10.1016/j.gene.2013.03.081; Hussain MS, 2013, CLIN GENET, V83, P446, DOI 10.1111/j.1399-0004.2012.01932.x; Issa L, 2013, CEREB CORTEX, V23, P2245, DOI 10.1093/cercor/bhs212; Issa L, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-59; Kim T, 2011, CELL CYCLE, V10, P1010, DOI 10.4161/cc.10.6.15121; Kraemer N, 2011, CELL MOL LIFE SCI, V68, P1719, DOI 10.1007/s00018-011-0635-4; Lee KY, 1997, INT J BIOCHEM CELL B, V29, P951, DOI 10.1016/S1357-2725(97)00048-4; Pagnamenta AT, 2012, AM J MED GENET A, V158A, P2577, DOI 10.1002/ajmg.a.35558; Park JSY, 2011, CELL CYCLE, V10, P1331, DOI 10.4161/cc.10.8.15358; Rosales JL, 2006, BIOESSAYS, V28, P1023, DOI 10.1002/bies.20473; Rosales JL, 2010, CELL CYCLE, V9, P618, DOI 10.4161/cc.9.3.10597; Salman-Dilgimen A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003841; Wang Z, 2010, J BIOL CHEM, V285, P22658, DOI 10.1074/jbc.M110.105965; Woods CG, 2005, AM J HUM GENET, V76, P717, DOI 10.1086/429930	21	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2015	10	11							e0142577	10.1371/journal.pone.0142577	http://dx.doi.org/10.1371/journal.pone.0142577			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7AC	26550838	gold, Green Published, Green Submitted			2022-12-27	WOS:000364422800029
J	Hirata, Y; Li, HW; Takahashi, K; Ishii, H; Sykes, M; Fujisaki, J				Hirata, Yuichi; Li, Hao-Wei; Takahashi, Kazuko; Ishii, Hiroshi; Sykes, Megan; Fujisaki, Joji			MHC Class I Expression by Donor Hematopoietic Stem Cells Is Required to Prevent NK Cell Attack in Allogeneic, but Not Syngeneic Recipient Mice	PLOS ONE			English	Article							MARROW GRAFT-REJECTION; NATURAL-KILLER; LONG-TERM; ENGRAFTMENT	NK cells resist engraftment of syngeneic and allogeneic bone marrow (BM) cells lacking major histocompatibility (MHC) class I molecules, suggesting a critical role for donor MHC class I molecules in preventing NK cell attack against donor hematopoietic stem and progenitor cells (HSPCs), and their derivatives. However, using high-resolution in vivo imaging, we demonstrated here that syngeneic MHC class I knockout (KO) donor HSPCs persist with the same survival frequencies as wild-type donor HSPCs. In contrast, syngeneic MHC class I KO differentiated hematopoietic cells and allogeneic MHC class I KO HSPCs were rejected in a manner that was significantly inhibited by NK cell depletion. In vivo time-lapse imaging demonstrated that mice receiving allogeneic MHC class I KO HSPCs showed a significant increase in NK cell motility and proliferation as well as frequencies of NK cell contact with and killing of HSPCs as compared to mice receiving wild-type HSPCs. The data indicate that donor MHC class I molecules are required to prevent NK cell-mediated rejection of syngeneic differentiated cells and allogeneic HSPCs, but not of syngeneic HSPCs.	[Hirata, Yuichi; Li, Hao-Wei; Takahashi, Kazuko; Ishii, Hiroshi; Sykes, Megan; Fujisaki, Joji] Columbia Univ, Coll Physicians & Surgeons, Dept Med Surg & Microbiol Immunol, Columbia Ctr Translat Immunol, New York, NY 10027 USA; [Takahashi, Kazuko] Juntendo Univ, Sch Med, Dept Pathol, Tokyo 113, Japan	Columbia University; Juntendo University	Fujisaki, J (corresponding author), Columbia Univ, Coll Physicians & Surgeons, Dept Med Surg & Microbiol Immunol, Columbia Ctr Translat Immunol, New York, NY 10027 USA.	jf2819@cumc.columbia.edu			Schaefer Research Scholar Award; Uehara Memorial Foundation Research Fellowship Award; Office of the Director, National Institutes of Health [S10OD020056]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD020056] Funding Source: NIH RePORTER	Schaefer Research Scholar Award; Uehara Memorial Foundation Research Fellowship Award(Uehara Memorial Foundation); Office of the Director, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Schaefer Research Scholar Award (J.F.) and Uehara Memorial Foundation Research Fellowship Award (Y.H.). Research reported in this publication was performed in the CCTI Flow Cytometry Core, supported in part by the Office of the Director, National Institutes of Health under award S10OD020056.	BIX M, 1991, NATURE, V349, P329, DOI 10.1038/349329a0; Champsaur M, 2010, IMMUNOL REV, V235, P267, DOI 10.1111/j.0105-2896.2010.00893.x; Deguine J, 2010, IMMUNITY, V33, P632, DOI 10.1016/j.immuni.2010.09.016; Fujisaki J, 2011, NATURE, V474, P216, DOI 10.1038/nature10160; Geldhof AB, 1998, BLOOD, V91, P196, DOI 10.1182/blood.V91.1.196.196_196_206; Huang YM, 2004, BLOOD, V104, P873, DOI 10.1182/blood-2003-11-3910; Lee LA, 1996, TRANSPLANTATION, V61, P125, DOI 10.1097/00007890-199601150-00024; Li N, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00152; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Niederkorn JY, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00148; Niederkorn JY, 2006, NAT IMMUNOL, V7, P354, DOI 10.1038/ni1328; Oberbarnscheidt MH, 2014, J CLIN INVEST, V124, P3579, DOI 10.1172/JCI74370; OHLEN C, 1995, EUR J IMMUNOL, V25, P1286, DOI 10.1002/eji.1830250523; OHLEN C, 1989, SCIENCE, V246, P666, DOI 10.1126/science.2814488; Park D, 2012, CELL STEM CELL, V10, P259, DOI 10.1016/j.stem.2012.02.003; Shizuru J A, 1996, Biol Blood Marrow Transplant, V2, P3; Zecher D, 2009, J IMMUNOL, V183, P7810, DOI 10.4049/jimmunol.0902194	17	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141785	10.1371/journal.pone.0141785	http://dx.doi.org/10.1371/journal.pone.0141785			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544200	Green Published, gold, Green Submitted			2022-12-27	WOS:000364398700046
J	Peatfield, N; Caulfield, J; Parkinson, J; Intriligator, J				Peatfield, Nicholas; Caulfield, Joanne; Parkinson, John; Intriligator, James			Brands and Inhibition: A Go/No-Go Task Reveals the Power of Brand Influence	PLOS ONE			English	Article							COMPETITIVE INTERFERENCE; CONSUMER MEMORY; CONTEXT; BIAS	Whether selecting a candy in a shop or picking a digital camera online, there are usually many options from which consumers may choose. With such abundance, consumers must use a variety of cognitive, emotional, and heuristic means to filter out and inhibit some of their responses. Here we use brand logos within a Go/No-Go task to probe inhibitory control during the presentation of familiar and unfamiliar logos. The results showed no differences in response times or in commission errors (CE) between familiar and unfamiliar logos. However, participants demonstrated a generally more cautious attitude of responding to the familiar brands: they were significantly slower and less accurate at responding to these brands in the Go trials. These findings suggest that inhibitory control can be exercised quite effectively for familiar brands, but that when such inhibition fails, the potent appetitive nature of brands is revealed.	[Peatfield, Nicholas; Caulfield, Joanne; Parkinson, John; Intriligator, James] Bangor Univ, Sch Psychol, Bangor LL57 2AS, Gwynedd, Wales; [Peatfield, Nicholas] Univ Trento, Ctr Mind Brain Sci, Rovereto, TN, Italy	Bangor University; University of Trento	Peatfield, N (corresponding author), Bangor Univ, Sch Psychol, Bangor LL57 2AS, Gwynedd, Wales.	nick.peatfield@gmail.com			Student Stipend from my old university Bangor University	Student Stipend from my old university Bangor University	This work was supported by a Student Stipend from my old university Bangor University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBA JW, 1985, J MARKETING RES, V22, P340, DOI 10.2307/3151430; ALBA JW, 1986, J MARKETING RES, V23, P363, DOI 10.2307/3151812; Albert J, 2010, NEUROIMAGE, V49, P914, DOI 10.1016/j.neuroimage.2009.08.045; Anderson MC, 2001, NATURE, V410, P366, DOI 10.1038/35066572; Bassett JF, 2005, BEHAV RES METHODS, V37, P506, DOI 10.3758/BF03192721; BURKE RR, 1988, J CONSUM RES, V15, P55, DOI 10.1086/209145; Cacioppo JT, 1999, ANNU REV PSYCHOL, V50, P191, DOI 10.1146/annurev.psych.50.1.191; Chen M, 1999, PERS SOC PSYCHOL B, V25, P215, DOI 10.1177/0146167299025002007; Cowan W, 1984, PSYCHOL REV; Dimofte CV, 2010, PSYCHOL MARKET, V27, P921, DOI 10.1002/mar.20366; Dittmar H, 2005, BRIT J PSYCHOL, V96, P467, DOI 10.1348/000712605X53533; Erickson K, 2005, AM J PSYCHIAT, V162, P2171, DOI 10.1176/appi.ajp.162.11.2171; Erk S, 2002, NEUROREPORT, V13, P2499, DOI 10.1097/00001756-200212200-00024; Fadardi JS, 2009, DRUG ALCOHOL DEPEN, V101, P137, DOI 10.1016/j.drugalcdep.2008.11.015; Friese M, 2006, PSYCHOL MARKET, V23, P727, DOI 10.1002/mar.20126; Garavan H, 1999, P NATL ACAD SCI USA, V96, P8301, DOI 10.1073/pnas.96.14.8301; Hare TA, 2005, BIOL PSYCHIAT, V57, P624, DOI 10.1016/j.biopsych.2004.12.038; Inman J, 1998, MARKETING LETT; JACOBY LL, 1989, J EXP PSYCHOL GEN, V118, P126, DOI 10.1037/0096-3445.118.2.126; KENT RJ, 1994, J MARKETING, V58, P97, DOI 10.2307/1252313; Likert R., 1932, ARCH PSYCHOL, V22, P55, DOI DOI 10.1037/H0053694; Lindsey CD, 2007, J CONSUM RES, V33, P470, DOI 10.1086/510220; Macmillan NA, 2005, DETECTION THEORY USE; Miniard P, 1991, MARKETING LETT; Murphy FC, 1999, PSYCHOL MED, V29, P1307, DOI 10.1017/S0033291799001233; Nosek BA, 2001, SOC COGNITION, V19, P625, DOI 10.1521/soco.19.6.625.20886; Pavlov IP, 2003, CONDITIONED REFLEXES; PERFECT TJ, 1994, APPL COGNITIVE PSYCH, V8, P693, DOI 10.1002/acp.2350080707; Raymond JE, 2005, J EXP PSYCHOL HUMAN, V31, P1404, DOI 10.1037/0096-1523.31.6.1404; Reber R, 2004, PERS SOC PSYCHOL REV, V8, P364, DOI 10.1207/s15327957pspr0804_3; Roberts GMP, 2008, BRAIN RES, V1224, P79, DOI 10.1016/j.brainres.2008.05.061; Rutherford HJV, 2011, EMOT REV, V3, P333, DOI 10.1177/1754073911402392; Schaefer M, 2007, NEUROREPORT, V18, P141, DOI 10.1097/WNR.0b013e328010ac84; Schaefer M, 2006, NEUROIMAGE, V31, P861, DOI 10.1016/j.neuroimage.2005.12.047; Schmeichel BJ, 2010, J PERS SOC PSYCHOL, V99, P162, DOI 10.1037/a0019797; Schulz KP, 2007, ARCH CLIN NEUROPSYCH, V22, P151, DOI 10.1016/j.acn.2006.12.001; Schulz KP, 2009, HUM BRAIN MAPP, V30, P2821, DOI 10.1002/hbm.20706; Thomas A, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-149; WHITTLESEA BWA, 1993, J EXP PSYCHOL LEARN, V19, P1235, DOI 10.1037/0278-7393.19.6.1235	39	3	3	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141787	10.1371/journal.pone.0141787	http://dx.doi.org/10.1371/journal.pone.0141787			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV6RT	26544606	gold, Green Published, Green Submitted			2022-12-27	WOS:000364398700047
J	Agrafioti, P; Athanassiou, CG; Vassilakos, TN; Vlontzos, G; Arthur, FH				Agrafioti, Paraskevi; Athanassiou, Christos G.; Vassilakos, Thomas N.; Vlontzos, George; Arthur, Frank H.			Using a Lethality Index to Assess Susceptibility of Tribolium confusum and Oryzaephilus surinamensis to Insecticides	PLOS ONE			English	Article							STORED-PRODUCT PSOCIDS; RESIDUAL EFFICACY; DIFFERENT SURFACES; BETA-CYFLUTHRIN; SHORT EXPOSURES; FOOD SOURCE; CONCRETE; CHLORFENAPYR; COLEOPTERA; CASTANEUM	We evaluated knockdown caused by four insecticides: alpha-cypermethrin, chlorfenapyr, pirimiphos-methyl and fipronil against adults of Tribolium confusum Jacquelin Duval, the confused flour beetle and Oryzaephilus surinamensis (L.), the sawtoothed grain beetle. Bioassays were conducted on concrete and metal surfaces. Adults of the tested species were exposed on both surfaces treated with the above insecticides at two doses (low and high). Knockdown assessment was done after 15, 30 and 60 min of adult exposure in the treated surfaces. Also, after 1, 3, 5, 7 and 14 d of exposure, a lethality index was calculated with an equation resulting to values from 0 to 100, where 100 indicated complete mortality and 0 complete survival. We also developed a lethality index by ranking each adult on each surface from 0 to 4, 0: adults moved normally, 1: adults were knocked down, but were able to walk for short intervals, 2: adults were knocked down and unable to walk, but with visible movement of antennae etc., 3: adults were knocked down, with very minimal movement of the tarsi and the antennae and 4: adults were dead (no movement). Knockdown of adults immediately after exposure (15-60 min) was higher for pirimiphos-methyl followed by alpha-cypermethrin, for both dose rates tested and species, but only on the metal surface. The lethality index was nearly 100 for all insecticides after 5d of exposure for O. surinamensis, while for T. confusum the adult lethality index was considerably lower for alpha-cypermethrin, suggesting that that recovery from knockdown occurred. Chlorfenapyr was the only insecticide that was more effective on concrete than on metal, while the reverse was noted for the other three insecticides. These results show that knockdown has different levels, which can be used as indicators of insect mortality or recovery.	[Agrafioti, Paraskevi; Athanassiou, Christos G.; Vassilakos, Thomas N.; Vlontzos, George] Univ Thessaly, Dept Agr Crop Prod & Rural Environm, Volos, Greece; [Arthur, Frank H.] USDA ARS, Ctr Grain & Anim Hlth Res, Manhattan, KS USA	University of Thessaly; United States Department of Agriculture (USDA)	Athanassiou, CG (corresponding author), Univ Thessaly, Dept Agr Crop Prod & Rural Environm, Lab Entomol & Agr Zool, Volos, Greece.	athanassiou@agr.uth.gr	Athanassiou, Christos/ABE-8867-2020	Vlontzos, George/0000-0002-0735-2274				Arthur FH, 1997, J STORED PROD RES, V33, P167, DOI 10.1016/S0022-474X(96)00041-0; Arthur FH, 1998, J ECON ENTOMOL, V91, P773, DOI 10.1093/jee/91.3.773; Arthur FH, 2012, J INSECT SCI, V12, P1; Arthur FH, 2008, J STORED PROD RES, V44, P145, DOI 10.1016/j.jspr.2007.08.005; Arthur FH, 2012, J PEST SCI, V85, P323, DOI 10.1007/s10340-012-0439-9; Arthur FH, 2012, J PEST SCI, V85, P261, DOI 10.1007/s10340-011-0396-8; Arthur FH, 2009, PEST MANAG SCI, V65, P791, DOI 10.1002/ps.1756; Arthur FH, 2009, INSECT SCI, V16, P157, DOI 10.1111/j.1744-7917.2009.00267.x; Athanassiou CG, 2014, J ECON ENTOMOL, V107, P854, DOI 10.1603/EC13376; Athanassiou CG, 2013, J ECON ENTOMOL, V106, P1064, DOI 10.1603/EC12406; Athanassiou CG, 2010, J ECON ENTOMOL, V103, P197, DOI 10.1603/EC09115; Campbell JF, 2007, ECOLOGICALLY BASED INTEGRATED PEST MANAGEMENT, P406, DOI 10.1079/9781845930646.0406; Campbell JF, 2014, J ECON ENTOMOL, V107, P440, DOI 10.1603/EC13423; CHADWICK PR, 1985, PESTIC SCI, V16, P383, DOI 10.1002/ps.2780160413; Creighton L, 2001, JMP START STAT GUIDE; GEORGHIOU G. P., 1962, MOSQUITO NEWS, V22, P260; Guedes NMP, 2009, B ENTOMOL RES, V99, P393, DOI 10.1017/S0007485309006610; Guedes RNC, 2008, PEST MANAG SCI, V64, P1314, DOI 10.1002/ps.1634; Jankov D, 2013, J PEST SCI, V86, P211, DOI 10.1007/s10340-012-0469-3; Kavallieratos NG, 2010, PEST MANAG SCI, V66, P640, DOI 10.1002/ps.1923; Leskey TC, 2012, J ECON ENTOMOL, V105, P1726, DOI 10.1603/EC12096; Likert R., 1932, J ARCH PSYCHOL, V22, P5, DOI DOI 10.1097/AUD.0000000000000341; Michaud JP, 2002, J ENTOMOL SCI, V37, P83, DOI 10.18474/0749-8004-37.1.83; Nayak MK, 2003, J STORED PROD RES, V39, P343, DOI 10.1016/S0022-474X(02)00029-2; OBRIEN PC, 1984, BIOMETRICS, V40, P1079, DOI 10.2307/2531158; Sehgal B, 2014, PEST MANAG SCI, V70, P576, DOI 10.1002/ps.3580; Sokal RR, 1995, BIOMETRY; Tsaganou FC, 2014, J ECON ENTOMOL, V107, P2222, DOI 10.1603/EC14210; Vassilakos TN, 2014, J PEST SCI, V87, P485, DOI 10.1007/s10340-014-0574-6; Wijayaratne LKW, 2012, J ECON ENTOMOL, V105, P718, DOI 10.1603/EC11375	30	25	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142044	10.1371/journal.pone.0142044	http://dx.doi.org/10.1371/journal.pone.0142044			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26560316	gold, Green Submitted, Green Published			2022-12-27	WOS:000364433100051
J	Bicker, A; Brahmer, AM; Meller, S; Kristiansen, G; Gorr, TA; Hankeln, T				Bicker, Anne; Brahmer, Alexandra M.; Meller, Sebastian; Kristiansen, Glen; Gorr, Thomas A.; Hankeln, Thomas			The Distinct Gene Regulatory Network of Myoglobin in Prostate and Breast Cancer	PLOS ONE			English	Article							ENDOGENOUS MYOGLOBIN; RECEPTOR EXPRESSION; HYPOXIA; CELLS; DIFFERENTIATION; TRANSCRIPTION; NEUROGLOBIN; PREVENTION; MECHANISM; BETA	Myoglobin (MB) is not only strongly expressed in myocytes, but also at much lower levels in different cancer entities. 40% of breast tumors are MB-positive, with the globin being coexpressed with markers of tumor hypoxia in a proportion of cases. In breast cancer, MB expression is associated with a positive hormone receptor status and patient prognosis. In prostate cancer, another hormone-dependent cancer type, 53% of tumors were recently shown to express MB. Especially in more aggressive prostate cancer specimen MB expression also correlates with increased patient survival rates. Both findings might be due to tumor-suppressing properties of MB in cancer cells. In contrast to muscle, MB transcription in breast and prostate cancer mainly depends on a novel, alternative promoter site. We show here that its associated transcripts can be upregulated by hypoxia and downregulated by estrogens and androgens in MCF7 breast and LNCaP prostate cancer cells, respectively. Bioinformatic data mining of epigenetic histone marks and experimental verification reveal a hitherto uncharacterized transcriptional network that drives the regulation of the MB gene in cancer cells. We identified candidate hormone-receptor binding elements that may interact with the cancer-associated MB promoter to decrease its activity in breast and prostate cancer cells. Additionally, a regulatory element, 250 kb downstream of the promoter, acts as a hypoxia-inducible site within the transcriptional machinery. Understanding the distinct regulation of MB in tumors will improve unraveling the respiratory protein's function in the cancer context and may provide new starting points for developing therapeutic strategies.	[Bicker, Anne; Brahmer, Alexandra M.; Hankeln, Thomas] Johannes Gutenberg Univ Mainz, Inst Mol Genet, D-55122 Mainz, Germany; [Meller, Sebastian; Kristiansen, Glen] Univ Hosp Bonn, Inst Pathol, Bonn, Germany; [Gorr, Thomas A.] Univ Zurich, Inst Vet Physiol, Vetsuisse Fac, Zurich, Switzerland; [Gorr, Thomas A.] Univ Zurich, Regenerat Med Program, Zurich, Switzerland; [Gorr, Thomas A.] Univ Zurich Hosp, CH-8091 Zurich, Switzerland	Johannes Gutenberg University of Mainz; University of Bonn; University of Zurich; University of Zurich; University of Zurich; University Zurich Hospital	Hankeln, T (corresponding author), Johannes Gutenberg Univ Mainz, Inst Mol Genet, D-55122 Mainz, Germany.	hankeln@uni-mainz.de	Brahmer, Alexandra/ABI-6051-2020	Brahmer, Alexandra/0000-0001-5963-4209; Gorr, Thomas/0000-0002-6023-4234; Bicker, Anne/0000-0003-4364-9777	Center for Computational Sciences Mainz (CSM); Johannes Gutenberg University Mainz	Center for Computational Sciences Mainz (CSM); Johannes Gutenberg University Mainz	This work was supported by the Center for Computational Sciences Mainz (CSM) 2013 and an intramural grant (Stufe 1) of Johannes Gutenberg University Mainz.	Burmester T, 2014, ACTA PHYSIOL, V211, P501, DOI 10.1111/apha.12312; Chen RY, 2015, J IMMUNOL, V194, P4019, DOI 10.4049/jimmunol.1400806; D'Aprile A, 2014, STEM CELLS, V32, P1267, DOI 10.1002/stem.1646; Davis RW, 2014, J COMP PHYSIOL B, V184, P23, DOI 10.1007/s00360-013-0782-z; Flogel U, 2001, P NATL ACAD SCI USA, V98, P735, DOI 10.1073/pnas.011460298; Flogel U, 2004, FASEB J, V18, P1156, DOI 10.1096/fj.03-1382fje; Flonta SE, 2009, AM J PATHOL, V175, P201, DOI 10.2353/ajpath.2009.081124; Fullwood Melissa J, 2010, Curr Protoc Mol Biol, VChapter 21, DOI 10.1002/0471142727.mb2115s89; Galluzzo M, 2009, J CLIN INVEST, V119, P865, DOI 10.1172/JCI36579; Glass CK, 2000, GENE DEV, V14, P121; Godecke A, 1999, P NATL ACAD SCI USA, V96, P10495, DOI 10.1073/pnas.96.18.10495; Guertin MJ, 2014, MOL ENDOCRINOL, V28, P1522, DOI 10.1210/me.2014-1130; Guo MMWC, 2014, AM J CLIN EXP UROL, V2, P169; Hendgen-Cotta UB, 2014, TRENDS CARDIOVAS MED, V24, P69, DOI 10.1016/j.tcm.2013.06.006; Holliday DL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2889; KALKHOVEN E, 1995, CELL GROWTH DIFFER, V6, P1151; Kanatous SB, 2010, J EXP BIOL, V213, P2741, DOI 10.1242/jeb.041442; Kristiansen G, 2010, BRIT J CANCER, V102, P1736, DOI 10.1038/sj.bjc.6605702; Kristiansen G, 2011, J BIOL CHEM, V286, P43417, DOI 10.1074/jbc.M111.227553; MacMunn CA., 1886, J PHYSL, V5, P24; Malik S, 2010, MOL CELL BIOL, V30, P399, DOI 10.1128/MCB.00907-09; Meller S, 2014, VIRCHOWS ARCH, V465, P419, DOI 10.1007/s00428-014-1646-y; Merx Marc W., 2001, FASEB Journal, V15, P1077; Qiu Y, 1998, J BIOL CHEM, V273, P23426, DOI 10.1074/jbc.273.36.23426; RUCK P, 1995, HEMATOL PATHOL, V9, P49; Schlater AE, 2014, J APPL PHYSIOL, V117, P307, DOI 10.1152/japplphysiol.00973.2013; Shiva S, 2007, CIRC RES, V100, P654, DOI 10.1161/01.RES.0000260171.52224.6b; Steinmetz R, 1996, CANCER RES, V56, P5403; WITTENBERG BA, 1989, ANNU REV PHYSIOL, V51, P857, DOI 10.1146/annurev.physiol.51.1.857; Wittenberg BA, 2009, AM J PHYSIOL-CELL PH, V296, pC390, DOI 10.1152/ajpcell.00002.2009; Wittenberg JB, 2003, J EXP BIOL, V206, P2011, DOI 10.1242/jeb.00243; Zhang PJ, 2003, MODERN PATHOL, V16, P229, DOI 10.1097/01.MP.0000056630.76035.F3	35	20	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142662	10.1371/journal.pone.0142662	http://dx.doi.org/10.1371/journal.pone.0142662			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559958	gold, Green Published, Green Submitted			2022-12-27	WOS:000364433100108
J	Tsuda, S; Jaffery, H; Doran, D; Hezwani, M; Robbins, PJ; Yoshida, M; Cronin, L				Tsuda, Soichiro; Jaffery, Hussain; Doran, David; Hezwani, Mohammad; Robbins, Phillip J.; Yoshida, Mari; Cronin, Leroy			Customizable 3D Printed 'Plug and Play' Millifluidic Devices for Programmable Fluidics	PLOS ONE			English	Article							MICROFLUIDIC DEVICES; CHEMICAL-SYNTHESIS; REACTIONWARE; GROWTH	Three dimensional (3D) printing is actively sought after in recent years as a promising novel technology to construct complex objects, which scope spans from nano-to over millimeter scale. Previously we utilized Fused deposition modeling (FDM)-based 3D printer to construct complex 3D chemical fluidic systems, and here we demonstrate the construction of 3D milli-fluidic structures for programmable liquid handling and control of biological samples. Basic fluidic operation devices, such as water-in-oil (W/O) droplet generators for producing compartmentalized mono-disperse droplets, sensor-integrated chamber for online monitoring of cellular growth, are presented. In addition, chemical surface treatment techniques are used to construct valve-based flow selector for liquid flow control and inter-connectable modular devices for networking fluidic parts. As such this work paves the way for complex operations, such as mixing, flow control, and monitoring of reaction / cell culture progress can be carried out by constructing both passive and active components in 3D printed structures, which designs can be shared online so that anyone with 3D printers can reproduce them by themselves.	[Tsuda, Soichiro; Jaffery, Hussain; Doran, David; Hezwani, Mohammad; Robbins, Phillip J.; Yoshida, Mari; Cronin, Leroy] Univ Glasgow, Sch Chem, WestCHEM, Glasgow, Lanark, Scotland; [Tsuda, Soichiro] Univ Glasgow, Inst Mol Cell & Syst Biol, Glasgow, Lanark, Scotland	University of Glasgow; University of Glasgow	Cronin, L (corresponding author), Univ Glasgow, Sch Chem, WestCHEM, Glasgow, Lanark, Scotland.	Lee.Cronin@glasgow.ac.uk	Robbins, Philip/E-8260-2018; Cronin, Leroy/AAW-8067-2020; Cronin, Leroy/B-7752-2008; Jaffery, Hussain/AGV-9241-2022; Jaffery, Hussain/M-8300-2014	Cronin, Leroy/0000-0001-8035-5757; Cronin, Leroy/0000-0001-8035-5757; Yoshida (Robbins), Mari/0000-0003-1380-967X; Jaffery, Hussain/0000-0002-1408-3260	EPSRC [EP/I033459/1, EP/J015156/1, EP/K021966/1, EP/K023004/1, EP/K038885/1, EP/L015668/1, EP/L023652/1]; BBSRC [BB/M011267/1]; EC [610730 EVOPROG, 611640 EVOBLISS, 318671 MICREAGENTS]; Biotechnology and Biological Sciences Research Council [BB/I024437/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/L015668/1, EP/L023652/1, 1164940, EP/I033459/1, EP/K021966/1, EP/K023004/1, EP/K038885/1] Funding Source: researchfish; BBSRC [BB/I024437/1] Funding Source: UKRI	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EC(European CommissionEuropean Commission Joint Research Centre); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by EPSRC grants EP/I033459/1, EP/J015156/1, EP/K021966/1, EP/K023004/1, EP/K038885/1, EP/L015668/1, and EP/L023652/1; BBSRC grant BB/M011267/1; and EC projects 610730 EVOPROG, 611640 EVOBLISS, and 318671 MICREAGENTS.	Agresti JJ, 2010, P NATL ACAD SCI USA, V107, P4004, DOI 10.1073/pnas.0910781107; Ahn BY, 2009, SCIENCE, V323, P1590, DOI 10.1126/science.1168375; Anderson KB, 2013, ANAL CHEM, V85, P5622, DOI 10.1021/ac4009594; Au AK, 2015, LAB CHIP, V15, P1934, DOI 10.1039/c5lc00126a; Baraban L, 2011, LAB CHIP, V11, P4057, DOI 10.1039/c1lc20545e; Chang DE, 2002, MOL MICROBIOL, V45, P289, DOI 10.1046/j.1365-2958.2002.03001.x; Chisholm G, 2014, ENERG ENVIRON SCI, V7, P3026, DOI 10.1039/c4ee01426j; Cronin Group, 3D PRINT REACT DES R; Erkal JL, 2014, LAB CHIP, V14, P2023, DOI 10.1039/c4lc00171k; Gibson I., 2021, POWDER BED FUSION AD, P125, DOI [10.1016/j.addma.2020.101465, DOI 10.1016/J.ADDMA.2020.101465]; Gross BC, 2014, ANAL CHEM, V86, P3240, DOI 10.1021/ac403397r; Jakiela S, 2013, ANGEW CHEM INT EDIT, V52, P8908, DOI 10.1002/anie.201301524; Kitson PJ, 2014, ANGEW CHEM INT EDIT, V53, P12723, DOI 10.1002/anie.201402654; Kitson PJ, 2013, CHEM SCI, V4, P3099, DOI 10.1039/c3sc51253c; Kitson PJ, 2012, LAB CHIP, V12, P3267, DOI 10.1039/c2lc40761b; Kolesky DB, 2014, ADV MATER, V26, P3124, DOI 10.1002/adma.201305506; Lee KS, 2009, LAB CHIP, V9, P1618, DOI 10.1039/b820924c; Lee KG, 2014, RSC ADV, V4, P32876, DOI 10.1039/c4ra05072j; Mathieson JS, 2013, BEILSTEIN J NANOTECH, V4, P285, DOI 10.3762/bjnano.4.31; Ogilvie IRG, 2011, LAB CHIP, V11, P2455, DOI 10.1039/c1lc20069k; Ogilvie IRG, 2010, J MICROMECH MICROENG, V20, DOI 10.1088/0960-1317/20/6/065016; Paz VF, 2012, J LASER APPL, V24, DOI 10.2351/1.4712151; Scanlon TC, 2014, BIOTECHNOL BIOENG, V111, P232, DOI 10.1002/bit.25019; Sezonov G, 2007, J BACTERIOL, V189, P8746, DOI 10.1128/JB.01368-07; Shepherd JNH, 2011, ADV FUNCT MATER, V21, P47, DOI 10.1002/adfm.201001746; Stampfl J, 2005, MACROMOL CHEM PHYS, V206, P1253, DOI 10.1002/macp.200500199; Symes MD, 2012, NAT CHEM, V4, P349, DOI [10.1038/NCHEM.1313, 10.1038/nchem.1313]; Therriault D, 2003, NAT MATER, V2, P265, DOI 10.1038/nmat863; Waldbaur A, 2011, ANAL METHODS-UK, V3, P2681, DOI 10.1039/c1ay05253e; Wijnen B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107216	30	46	47	9	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0141640	10.1371/journal.pone.0141640	http://dx.doi.org/10.1371/journal.pone.0141640			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26558389	gold, Green Accepted, Green Published			2022-12-27	WOS:000364433100038
J	Burrough, ER; Arruda, BL; Patience, JF; Plummer, PJ				Burrough, Eric R.; Arruda, Bailey L.; Patience, John F.; Plummer, Paul J.			Alterations in the Colonic Microbiota of Pigs Associated with Feeding Distillers Dried Grains with Solubles	PLOS ONE			English	Article							DIETARY FIBER; GROWING PIGS; LARGE-INTESTINE; DIGESTIBILITY; FERMENTATION; COMMUNITIES; ENERGY; AGE	In an effort to reduce feed costs, many pork producers have increased their use of coproducts of biofuel production in commercial pig diets, including increased feeding of distiller's dried grains with solubles (DDGS). The inclusion of DDGS increases the insoluble fiber content in the ration, which has the potential to impact the colonic microbiota considerably as the large intestine contains a dynamic microenvironment with tremendous interplay between microorganisms. Any alteration to the physical or chemical properties of the colonic contents has the potential to impact the resident bacterial population and potentially favor or inhibit the establishment of pathogenic species. In the present study, colonic contents collected at necropsy from pigs fed either 30% or no DDGS were analyzed to examine the relative abundance of bacterial taxa associated with feeding this ingredient. No difference in alpha diversity (richness) was detected between diet groups. However, the beta diversity was significantly different between groups with feeding of DDGS being associated with a decreased Firmicutes: Bacteriodetes ratio (P = .004) and a significantly lower abundance of Lactobacillus spp. (P = .016). Predictive functional profiling of the microbiota revealed more predicted genes associated with carbohydrate metabolism, protein digestion, and degradation of glycans in the microbiota of pigs fed DDGS. Taken together, these findings confirm that alterations in dietary insoluble fiber significantly alter the colonic microbial profile of pigs and suggest the resultant microbiome may predispose to the development of colitis.	[Burrough, Eric R.; Arruda, Bailey L.; Plummer, Paul J.] Iowa State Univ, Dept Vet Diagnost & Prod Anim Med, Coll Vet Med, Ames, IA 50011 USA; [Patience, John F.] Iowa State Univ, Dept Anim Sci, Ames, IA USA; [Plummer, Paul J.] Iowa State Univ, Dept Vet Microbiol & Preventat Med, Coll Vet Med, Ames, IA USA	Iowa State University; Iowa State University; Iowa State University	Burrough, ER (corresponding author), Iowa State Univ, Dept Vet Diagnost & Prod Anim Med, Coll Vet Med, Ames, IA 50011 USA.	burrough@iastate.edu	Patience, john F./A-2935-2009	Burrough, Eric/0000-0003-4747-9189	Iowa Pork Producers Association; National Pork Board (NPB) [13-212]	Iowa Pork Producers Association; National Pork Board (NPB)	This work was supported by a grant from the Iowa Pork Producers Association and the National Pork Board (NPB #13-212). The funders had no involvement in study design, data collection, analysis and interpretation of data, writing the manuscript, or decision to submit the article for publication.	Bellgard MI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004641; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chaban B, 2012, MICROB ECOL, V63, P348, DOI 10.1007/s00248-011-9931-7; Costa MO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106399; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; FILIPE MI, 1979, INVEST CELL PATHOL, V2, P195; Gutierrez NA, 2014, J ANIM SCI, V92, P4505, DOI 10.2527/jas.2013-7265; Hashizume K, 2003, J NUTR, V133, P3187, DOI 10.1093/jn/133.10.3187; Heo JM, 2015, BETWEEN EXPT ANAL RE, V86; Hou CL, 2015, J ANIM SCI BIOTECHNO, V6, DOI 10.1186/s40104-015-0014-3; Kim HB, 2011, VET MICROBIOL, V153, P124, DOI 10.1016/j.vetmic.2011.05.021; Knudsen KEB, 1997, ANIM FEED SCI TECH, V67, P319, DOI 10.1016/S0377-8401(97)00009-6; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Leonel AJ, 2012, CURR OPIN CLIN NUTR, V15, P474, DOI 10.1097/MCO.0b013e32835665fa; Lu XM, 2014, APPL MICROBIOL BIOT, V98, P2657, DOI 10.1007/s00253-013-5211-4; Niu Q, 2015, SCI REP-UK, V5, DOI 10.1038/srep09938; ROBERTON AM, 1993, BIOCHEM J, V293, P683, DOI 10.1042/bj2930683; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Stein HH, 2009, J ANIM SCI, V87, P1292, DOI 10.2527/jas.2008-1290; Urriola PE, 2010, J ANIM SCI, V88, P2373, DOI 10.2527/jas.2009-2227; Urriola PE, 2010, J ANIM SCI, V88, P1454, DOI 10.2527/jas.2009-2162; Wilberts BL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114741; Williams BA, 2005, ANIM RES, V54, P191, DOI 10.1051/animres:2005011; Williams BA, 2001, FERMENTATION LARGE I, V14, P2007; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Youmans BP, 2015, GUT MICROBES, V6, P110, DOI 10.1080/19490976.2015.1019693; Zhao WJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117441	29	16	17	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0141337	10.1371/journal.pone.0141337	http://dx.doi.org/10.1371/journal.pone.0141337			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555787	Green Published, Green Submitted, gold			2022-12-27	WOS:000364430700026
J	Chang, SN; Juang, JJM; Tsai, CT; Ko, JT; Lien, WP				Chang, Sheng-Nan; Juang, Jimmy Jyh-Ming; Tsai, Chia-Ti; Ko, Jiing-Tang; Lien, Wen-Pin			A Novel Integrated Score Index of Echocardiographic Indices for the Evaluation of Left Ventricular Diastolic Function	PLOS ONE			English	Article							PRESERVED EJECTION FRACTION; MITRAL ANNULUS VELOCITY; CHRONIC HEART-FAILURE; DOPPLER-ECHOCARDIOGRAPHY; EUROPEAN-SOCIETY; CATHETERIZATION; EPIDEMIOLOGY; DYSFUNCTION; PREVALENCE; PRESSURES	Background We propose a novel integrated score index, which could be used to quantify and grade left ventricular (LV) diastolic function. Methods We enrolled 629 participants [393 healthy subjects, 145 with hypertension (HTN), 24 with hypertrophic cardiomyopathy (HCM), and 67 with coronary artery disease (CAD)]. This score index was with a score of 1 for an E/A ratio < 1, a score of 1 for a septal e'/a' ratio <= 0.8, a score of 2 for a lateral e'/a' ratio <= 1, a score of 2 for a septal E/e' ratio >= 10-15, a score of 3 for a lateral E/e' ratio >= 8-15, and a score of 1 for a deceleration time > 240 ms. The sum of each score was considered as the final value in this scoring method (either a septal or a lateral E/e' ratio > 15 was given a total score of 10, regardless of the other measurements). Results After analysis, the AUROC of this integrated score index for predicting any diastolic dysfunction (discriminated by the American Society of Echocardiography guidelines) was 0.962, and the AUROC of the method from the logistic regression was 0.970. The mean values of the score index for the groups were 3.81 +/- 0.12 in healthy, 6.48 +/- 0.19 in HTN, 7.35 +/- 0.46 in HCM, and 6.62 +/- 0.29 in CAD. Using the score index, the healthy subjects obtained lower scores compared with those of HTN (p = 0.00), HCM (p = 0.00), and CAD (p = 0.00). Therefore, this score index could discriminate patients with diseases with impaired diastolic function from the healthy subjects when the total sum of the score was equal to or greater than 4. Conclusions If the presently used methods cannot allow the clear diagnosis of LV diastolic dysfunction, this integrated score index might be helpful for discriminating diseases with impaired diastolic function.	[Chang, Sheng-Nan; Tsai, Chia-Ti] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Chang, Sheng-Nan] Natl Taiwan Univ Hosp, Yun Lin Branch, Dept Internal Med, Div Cardiol, Dou Liu City, Taiwan; [Juang, Jimmy Jyh-Ming; Tsai, Chia-Ti; Lien, Wen-Pin] Natl Taiwan Univ Hosp, Dept Internal Med, Ctr Cardiovasc, Taipei 100, Taiwan; [Ko, Jiing-Tang] Nuliv Wellness Clin, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Lien, WP (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Ctr Cardiovasc, Taipei 100, Taiwan.	lienwp@ntuh.gov.tw		TSAI, CHIA-TI/0000-0002-4853-8665; CHANG, SHENG NAN/0000-0002-2663-5042; Juang, Jyh-Ming Jimmy/0000-0003-4767-7636	New Century Health Care Promotion Foundation of Taiwan; Nuliv Wellness Clinic; New Century Health Care Promotion Foundation	New Century Health Care Promotion Foundation of Taiwan; Nuliv Wellness Clinic; New Century Health Care Promotion Foundation	This study was supported by grants from the New Century Health Care Promotion Foundation of Taiwan. The foundation had no role in the study design, data collection, analysis, decision to publish, or preparation of the manuscript. Author Jiing-Tang Ko is employed by Nuliv Wellness Clinic. Nuliv Wellness Clinic provided support in the form of salary for author Jiing-Tang Ko, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.; This study was supported by a grant from the New Century Health Care Promotion Foundation. We gratefully acknowledge Jou-Wei Lin M.D., PhD for the consultation and statistical analysis. We also appreciate the technical assistance of Ms. Hsiung-Yin Lin and Ms. Chiung-Fang Yeh in the recording of echocardiograms. We are also grateful for the secretarial assistance of Ms. Hui-Yen Chang and Ms Hwei-Ming Kuo during the preparation of this manuscript.	Bhatia RS, 2006, NEW ENGL J MED, V355, P260, DOI 10.1056/NEJMoa051530; Cohen GI, 1996, J AM COLL CARDIOL, V27, P1753, DOI 10.1016/0735-1097(96)00088-5; Daneshvar D, 2010, AM HEART J, V160, P394, DOI 10.1016/j.ahj.2010.06.040; Hogg K, 2004, J AM COLL CARDIOL, V43, P317, DOI 10.1016/j.jacc.2003.07.046; Kasner M, 2007, CIRCULATION, V116, P637, DOI 10.1161/CIRCULATIONAHA.106.661983; Khouri SJ, 2004, J AM SOC ECHOCARDIOG, V17, P290, DOI 10.1016/j.echo.2003.08.012; Kim YJ, 2000, J AM SOC ECHOCARDIOG, V13, P980, DOI 10.1067/mje.2000.107156; Kitzman Dalane W., 2000, Cardiology Clinics, V18, P597, DOI 10.1016/S0733-8651(05)70164-8; Leischik R, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/765921; Martos R, 2007, CIRCULATION, V115, P888, DOI 10.1161/CIRCULATIONAHA.106.638569; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Miura Y, 2010, CIRC J, V74, P2612, DOI 10.1253/circj.CJ-10-0677; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Nishimura RA, 1997, J AM COLL CARDIOL, V30, P8, DOI 10.1016/S0735-1097(97)00144-7; Oh JK, 2006, J AM COLL CARDIOL, V47, P500, DOI 10.1016/j.jacc.2005.09.032; Okura H, 2009, CIRC-CARDIOVASC IMAG, V2, P41, DOI 10.1161/CIRCIMAGING.108.809087; Ommen SR, 2000, CIRCULATION, V102, P1788; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; Sakata Y, 2013, CIRC J, V77, P2209, DOI 10.1253/circj.CJ-13-0971; Shiba N, 2011, EPMA J, V2, P425, DOI 10.1007/s13167-011-0097-7; Sohn DW, 1997, J AM COLL CARDIOL, V30, P474, DOI 10.1016/S0735-1097(97)88335-0; Tschope C, 2009, CIRCULATION, V120, P810, DOI 10.1161/CIRCULATIONAHA.109.869628; Yamada H, 1999, J AM SOC ECHOCARDIOG, V12, P574, DOI 10.1016/S0894-7317(99)70005-2	24	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142175	10.1371/journal.pone.0142175	http://dx.doi.org/10.1371/journal.pone.0142175			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555598	Green Submitted, gold, Green Published			2022-12-27	WOS:000364430700064
J	Coid, JW; Kallis, C; Doyle, M; Shaw, J; Ullrich, S				Coid, Jeremy W.; Kallis, Constantinos; Doyle, Mike; Shaw, Jenny; Ullrich, Simone			Identifying Causal Risk Factors for Violence among Discharged Patients	PLOS ONE			English	Article							PSYCHIATRIC MORBIDITY; ANTISOCIAL-BEHAVIOR; CRIMINAL RECIDIVISM; DYNAMIC PREDICTION; MENTAL-DISORDER; OFFENDERS; DELUSIONS; ILLNESS; HCR-20; NEEDS	Background Structured Professional Judgement (SPJ) is routinely administered in mental health and criminal justice settings but cannot identify violence risk above moderate accuracy. There is no current evidence that violence can be prevented using SPJ. This may be explained by routine application of predictive instead of causal statistical models when standardising SPJ instruments. Methods We carried out a prospective cohort study of 409 male and female patients discharged from medium secure services in England and Wales to the community. Measures were taken at baseline (pre-discharge), 6 and 12 months post-discharge using the Historical, Clinical and Risk-20 items version 3 (HCR-20v3) and Structural Assessment of Protective Factors (SAPROF). Information on violence was obtained via the McArthur community violence instrument and the Police National Computer. Results In a lagged model, HCR-20v3 and SAPROF items were poor predictors of violence. Eight items of the HCR-20v3 and 4 SAPROF items did not predict violent behaviour better than chance. In re-analyses considering temporal proximity of risk/protective factors (exposure) on violence (outcome), risk was elevated due to violent ideation (OR 6.98, 95% CI 13.85-12.65, P<0.001), instability (OR 5.41, 95% CI 3.44-8.50, P<0.001), and poor coping/stress (OR 8.35, 95% CI 4.21-16.57, P<0.001). All 3 risk factors were explanatory variables which drove the association with violent outcome. Self-control (OR 0.13, 95% CI 0.08-0.24, P< 0.001) conveyed protective effects and explained the association of other protective factors with violence. Conclusions Using two standardised SPJ instruments, predictive (lagged) methods could not identify risk and protective factors which must be targeted in interventions for discharged patients with severe mental illness. Predictive methods should be abandoned if the aim is to progress from risk assessment to effective risk management and replaced by methods which identify factors causally associated with violence.	[Coid, Jeremy W.; Kallis, Constantinos; Ullrich, Simone] Queen Mary Univ London, Violence Prevent Res Unit, Wolfson Inst Prevent Med, London E1 2AD, England; [Doyle, Mike; Shaw, Jenny] Univ Manchester, Inst Brain Behav & Mental Hlth, Manchester M13 9PL, Lancs, England	University of London; Queen Mary University London; University of Manchester	Ullrich, S (corresponding author), Queen Mary Univ London, Violence Prevent Res Unit, Wolfson Inst Prevent Med, Garrod Bldg,Turner St, London E1 2AD, England.	s.ullrich@qmul.ac.uk		Kallis, Constantinos/0000-0003-0866-5421; Kallis, Constantinos/0000-0002-4584-8844	UK National Institute for Health Research (NIHR) [RP-PG-0407-10500]; National Institute for Health Research [RP-PG-0407-10500] Funding Source: researchfish	UK National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	Funding: This study was funded by the UK National Institute for Health Research (NIHR) under its Programme Grants for Applied Research funding scheme (RP-PG-0407-10500). The views expressed in this manuscript are those of the authors and not necessarily those of the UK National Health Service (NHS), the NIHR or the UK Department of Health. There was no editorial direction or censorship from the funders.	Appelbaum PS, 2000, AM J PSYCHIAT, V157, P566, DOI 10.1176/appi.ajp.157.4.566; Bonta J, 1998, PSYCHOL BULL, V123, P123, DOI 10.1037/0033-2909.123.2.123; Borum R, 2010, INT PERSP FOREN MENT, P63; Brown SL, 2009, LAW HUMAN BEHAV, V33, P25, DOI 10.1007/s10979-008-9139-7; Coid J, 2006, AM J EPIDEMIOL, V164, P1199, DOI 10.1093/aje/kwj339; Coid JW, 2013, AM J PSYCHIAT, V170, P985, DOI 10.1176/appi.ajp.2013.12091188; Coid JW, 2011, J FORENSIC PSYCHI PS, V22, P3, DOI 10.1080/14789949.2010.495990; Cooke D, 2014, J THREAT ASSESSMENT, V1, P42, DOI DOI 10.1037/tam0000004; Douglas KS, 2010, INT PERSP FOREN MENT, P147; Doyle M, 2014, BRIT J PSYCHIAT, V205, P177, DOI 10.1192/bjp.bp.113.136622; Elbogen EB, 2009, ARCH GEN PSYCHIAT, V66, P152, DOI 10.1001/archgenpsychiatry.2008.537; Falzer PR, 2013, BEHAV SCI LAW, V31, P40, DOI 10.1002/bsl.2043; Fazel S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4692; Fazel S, 2009, J CLIN PSYCHIAT, V70, P362, DOI 10.4088/JCP.08m04274; Gueorguieva R, 2004, ARCH GEN PSYCHIAT, V61, P310, DOI 10.1001/archpsyc.61.3.310; Hart SD, 2013, BEHAV SCI LAW, V31, P81, DOI 10.1002/bsl.2049; Hart SD, 2010, INT PERSP FOREN MENT, P269; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Howard PD, 2013, LAW HUMAN BEHAV, V37, P163, DOI 10.1037/lhb0000012; Jones NJ, 2010, CRIM JUSTICE BEHAV, V37, P860, DOI 10.1177/0093854810368924; Kroner DG, 2005, INT J LAW PSYCHIAT, V28, P360, DOI 10.1016/j.ijlp.2004.01.011; Kropp PR, 2010, INT PERSP FOREN MENT, P227; Large MM, 2015, AUST NZ J PSYCHIAT, V49, P91, DOI 10.1177/0004867414539570; Large MM, 2011, PSYCHIATR BULL, V35, P413, DOI 10.1192/pb.bp.110.033910; Monahan J, 2005, PSYCHIAT SERV, V56, P810, DOI 10.1176/appi.ps.56.7.810; O'Shea LE, 2015, COMPR PSYCHIAT, V62, P132, DOI 10.1016/j.comppsych.2015.07.009; Peterson JK, 2014, LAW HUMAN BEHAV, V38, P439, DOI 10.1037/lhb0000075; Prins SJ, 2014, LAW HUM BEHAV; Quinsey VL, 2006, J INTERPERS VIOLENCE, V21, P1539, DOI 10.1177/0886260506294238; Schlager MD, 2011, CRIM JUSTICE BEHAV, V38, P541, DOI 10.1177/0093854811402300; Skeem JL, 2014, LAW HUMAN BEHAV, V38, P212, DOI 10.1037/lhb0000054; Troquete NAC, 2013, BRIT J PSYCHIAT, V202, P365, DOI 10.1192/bjp.bp.112.113043; Ullrich S, 2014, SCHIZOPHRENIA BULL, V40, P1174, DOI 10.1093/schbul/sbt126; Van Dorn R, 2012, SOC PSYCH PSYCH EPID, V47, P487, DOI 10.1007/s00127-011-0356-x; Webster C, 2013, VIOLENCE RISK ASSESS; Whitwell JL, 2008, CURR OPIN NEUROL, V21, P410, DOI 10.1097/WCO.0b013e32830719d4; Yang M, 2010, PSYCHOL BULL, V136, P740, DOI 10.1037/a0020473	37	25	25	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142493	10.1371/journal.pone.0142493	http://dx.doi.org/10.1371/journal.pone.0142493			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7CT	26554711	Green Submitted, Green Published, gold			2022-12-27	WOS:000364430700116
J	Jansen, K; Thamm, M; Bock, CT; Scheufele, R; Kucherer, C; Muenstermann, D; Hagedorn, HJ; Jessen, H; Dupke, S; Hamouda, O; Gunsenheimer-Bartmeyer, B; Meixenberger, K				Jansen, Klaus; Thamm, Michael; Bock, Claus-Thomas; Scheufele, Ramona; Kuecherer, Claudia; Muenstermann, Dieter; Hagedorn, Hans-Jochen; Jessen, Heiko; Dupke, Stephan; Hamouda, Osamah; Gunsenheimer-Bartmeyer, Barbara; Meixenberger, Karolin		HIV Seroconverter Study Grp	High Prevalence and High Incidence of Coinfection with Hepatitis B, Hepatitis C, and Syphilis and Low Rate of Effective Vaccination against Hepatitis B in HIV-Positive Men Who Have Sex with Men with Known Date of HIV Seroconversion in Germany	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; VIRUS-INFECTION; RISK-FACTORS; HCV INFECTION; ISOLATED ANTIBODY; VIRAL-HEPATITIS; CORE ANTIGEN; TRENDS; COHORT; MSM	Objectives Men who have sex with men (MSM) are at higher risk for coinfection with hepatitis B virus (HBV), hepatitis C virus (HCV), and syphilis than the general population. HIV infection and these coinfections accelerate disease progression reciprocally. This study evaluated the prevalence and incidence of these coinfections in HIV1-positive MSM in Germany. Materials and Methods As part of a nationwide, multicenter, prospective cohort study of HIV-infected MSM, plasma samples collected yearly were screened for HBsAg and antibodies to HBc, HBs, HCV, and syphilis. Samples with indications of active HBV or HCV infection were confirmed by polymerase chain reaction. Prevalence and incidence of each infection and incidence rates per study participant were calculated, and incidences over 4-year time intervals compared. Results This study screened 5,445 samples from 1,843 MSM. Median age at HIV seroconversion was 33 years. Prevalences of active, cleared, and occult HBV, and of active/cleared HCV were 1.7%, 27.1%, 0.2%, and 8.2%, respectively, and 47.5% had been effectively vaccinated against HBV. Prevalence of antibodies to Treponema pallidum and of triple or quadruple sexually transmitted infections (STIs) were 39.6% and 18.9%, respectively. Prevalence of STI, cleared HBV, HBV vaccination, and history of syphilis differed significantly among age groups. Incidences of HBV, HCV, and syphilis were 2.51, 1.54, and 4.06 per 100 person-years, respectively. Incidences of HCV and syphilis increased over time. HCV incidence was significantly higher in MSM coinfected with syphilis and living in Berlin, and syphilis incidence was significantly higher for MSM living in Berlin. Discussion Despite extensive HBV vaccination campaigns, fewer than 50% of screened MSM were effectively vaccinated, with a high proportion of HIV-positive MSM coinfected with HBV. High rates of STI coinfections in HIV-positive MSM and increasing incidences emphasize the need for better tailored campaigns for HBV vaccination and STI prevention.	[Jansen, Klaus; Thamm, Michael; Bock, Claus-Thomas; Scheufele, Ramona; Kuecherer, Claudia; Hamouda, Osamah; Gunsenheimer-Bartmeyer, Barbara; Meixenberger, Karolin] Robert Koch Inst, Berlin, Germany; [Muenstermann, Dieter; Hagedorn, Hans-Jochen] Lab Krone, Bad Salzuflen, Germany; [Jessen, Heiko] Med Care Ctr Jessen, Berlin, Germany; [Dupke, Stephan] Med Care Ctr Driesener Str, Berlin, Germany	Robert Koch Institute	Jansen, K (corresponding author), Robert Koch Inst, Berlin, Germany.	JansenK@rki.de	Jessen, Heiko/P-2192-2019; Bock, C.-Thomas/A-3518-2012	Bock, C.-Thomas/0000-0002-2773-486X	Federal Ministry of Health [IIA5-2013-2514AUK375]; Federal Ministry of Education and Research [01KI1206]; Robert Koch Institute	Federal Ministry of Health; Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Robert Koch Institute	Funding: The study was supported by grants from the Federal Ministry of Health (grant IIA5-2013-2514AUK375; www.bmg.bund.de), the Federal Ministry of Education and Research (grant 01KI1206; www.bmbf.de), and by internal grants of the Robert Koch Institute (www.rki.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter MJ, 2006, J HEPATOL, V44, pS6, DOI 10.1016/j.jhep.2005.11.004; Anderson AM, 2010, WORLD J GASTROENTERO, V16, P4107, DOI 10.3748/wjg.v16.i32.4107; Apers L, 2015, JAIDS-J ACQ IMM DEF, V68, P585, DOI 10.1097/QAI.0000000000000528; Attar BM, 2015, GASTROENT RES PRACT, V2015, DOI 10.1155/2015/579147; Bartmeyer B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012718; Bernstein KT, 2010, JAIDS-J ACQ IMM DEF, V53, P537, DOI 10.1097/QAI.0b013e3181c3ef29; Van der Meer JTM, 2009, SEX TRANSM DIS, V36, P84, DOI 10.1097/OLQ.0b013e318186debb; Bremer V, 2005, SEX TRANSM INFECT, V81, P173, DOI 10.1136/sti.2004.009878; Buchacz K, 2004, AIDS, V18, P2075, DOI 10.1097/00002030-200410210-00012; Chadwick D, 2014, HIV MED, V15, P189, DOI 10.1111/hiv.12093; Chamie G, 2007, CLIN INFECT DIS, V44, P577, DOI 10.1086/511038; Cruciani M, 2009, VACCINE, V27, P17, DOI 10.1016/j.vaccine.2008.10.040; Danta M, 2007, AIDS, V21, P983, DOI 10.1097/QAD.0b013e3281053a0c; de Coul ELMO, 2014, INT J STD AIDS, V25, P40, DOI 10.1177/0956462413491736; de Ledinghen V, 2008, J VIRAL HEPATITIS, V15, P427, DOI 10.1111/j.1365-2893.2007.00962.x; de Vries-Sluijs TEMS, 2011, J INFECT DIS, V203, P984, DOI 10.1093/infdis/jiq137; Dougan S, 2007, SEX TRANSM DIS, V34, P783, DOI 10.1097/01.olq.0000260919.34598.5b; Dudareva-Vizule S, 2014, SEX TRANSM INFECT, V90, P46, DOI 10.1136/sextrans-2012-050929; European AIDS clinical society, 2014, EACS GUID 7 02; European Centre for Disease Prevention and Control/WHO Regional Office for Europe, 2014, HIV AIDS SURV EUR 20; Fenton KA, 2004, SEX TRANSM INFECT, V80, P255, DOI 10.1136/sti.2004.009415; Filippini P, 2012, J INFECTION, V64, P436, DOI 10.1016/j.jinf.2011.12.018; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Gamage DG, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-39; Gatserelia L, 2014, Georgian Med News, P37; Hagedorn H-J, 2010, ABBOTT TIMES, V20, P11; Hamouda O, 2013, BUNDESGESUNDHEITSBLA, V56, P1600, DOI 10.1007/s00103-013-1866-3; Heiligenberg M, 2012, SEX TRANSM DIS, V39, P8, DOI 10.1097/OLQ.0b013e3182354e81; Impfkommission Standige, 1983, BUNDESGESUNDHEITSBLA, V26, P130; Ingiliz P, 2014, HIV MED, V15, P355, DOI 10.1111/hiv.12127; Jin FY, 2007, SEX TRANSM INFECT, V83, P397, DOI 10.1136/sti.2007.025684; Jin FY, 2010, JAIDS-J ACQ IMM DEF, V53, P144, DOI 10.1097/QAI.0b013e3181b48f33; Joshi D, 2011, LANCET, V377, P1198, DOI 10.1016/S0140-6736(10)62001-6; Khamduang W, 2013, CLIN INFECT DIS, V56, P1704, DOI 10.1093/cid/cit166; Kim JH, 2012, J KOREAN MED SCI, V27, P830, DOI 10.3346/jkms.2012.27.7.830; Knyphausen FZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095956; Konopnicki D, 2005, AIDS, V19, P593, DOI 10.1097/01.aids.0000163936.99401.fe; Laboratories Abbott, 2014, PACK ARCH SYST ANT H; Lacombe K, 2012, GUT, V61, P47, DOI 10.1136/gutjnl-2012-302062; Landrum ML, 2009, VACCINE, V27, P4731, DOI 10.1016/j.vaccine.2009.04.016; Liang SH, 2010, JAIDS-J ACQ IMM DEF, V54, P122, DOI 10.1097/QAI.0b013e3181daafd5; Linas BP, 2012, CLIN INFECT DIS, V55, P279, DOI 10.1093/cid/cis382; Lopes VB, 2013, VACCINE, V31, P1040, DOI 10.1016/j.vaccine.2012.12.047; Maldonado-Rodriguez A, 2015, WORLD J HEPATOL, V7, P253, DOI 10.4254/wjh.v7.i2.253; Marcus U, 2005, SEX TRANSM INFECT, V81, P456, DOI 10.1136/sti.2005.014555; Marcus U, 2006, SEX TRANSM DIS, V33, P11, DOI 10.1097/01.olq.0000187224.10428.31; Morsica G, 2009, INFECTION, V37, P445, DOI 10.1007/s15010-008-8194-9; Nastouli E, 2009, J CLIN VIROL, V44, P78, DOI 10.1016/j.jcv.2008.09.008; Nicoll A, 2002, BMJ-BRIT MED J, V324, P1324, DOI 10.1136/bmj.324.7349.1324; O'Bryan TA, 2015, HIV MED, V16, P161, DOI 10.1111/hiv.12189; Obermeier M, 2011, EUR J MED RES, V16, P237, DOI 10.1186/2047-783X-16-5-237; Peterman TA, 2007, CURR OPIN INFECT DIS, V20, P54, DOI 10.1097/QCO.0b013e32801158cc; Poethko-Muller C, 2013, BUNDESGESUNDHEITSBLA, V56, P707, DOI 10.1007/s00103-013-1673-x; Poggensee G, 2007, HIV MED, V8, P511, DOI 10.1111/j.1468-1293.2007.00504.x; Rauch A, 2005, CLIN INFECT DIS, V41, P395, DOI 10.1086/431486; Rey D, 2000, VACCINE, V18, P1161, DOI 10.1016/S0264-410X(99)00389-8; Rieg G, 2008, AIDS PATIENT CARE ST, V22, P947, DOI 10.1089/apc.2007.0240; Robert Koch-Institut, 2014, EPID B, V2014, P429; Robert Koch-Institut, 2014, EPIDEMIOLOGISCHES B, V2014, P485; Rockstroh JK, 2005, J INFECT DIS, V192, P992, DOI 10.1086/432762; Rockstroh JK, 2015, LIVER INT, V35, P51, DOI 10.1111/liv.12721; Sanchez C, 2013, LIVER INT, V33, P1357, DOI 10.1111/liv.12212; Schmidt AJ, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-132; Schmidt AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017781; Shire NJ, 2007, JAIDS-J ACQ IMM DEF, V44, P309, DOI 10.1097/QAI.0b013e31802e29a9; Smith CJ, 2014, LANCET, V384, P241, DOI 10.1016/S0140-6736(14)60604-8; Soriano V, 2010, J ANTIMICROB CHEMOTH, V65, P548, DOI 10.1093/jac/dkp479; Spielmann N, 2010, SEX TRANSM INFECT, V86, P331, DOI 10.1136/sti.2009.040857; Spornraft-Ragaller P, 2014, J DTSCH DERMATOL GES, V12, P707, DOI 10.1111/ddg.12382; Sulkowski MS, 2014, J HEPATOL, V61, pS108, DOI 10.1016/j.jhep.2014.08.006; Sulkowski MS, 2013, J INFECT DIS, V207, pS26, DOI 10.1093/infdis/jis764; Sulkowski MS, 2013, LIVER INT, V33, P63, DOI 10.1111/liv.12082; Taylor LE, 2013, CLIN INFECT DIS, V57, pS118, DOI 10.1093/cid/cit326; The EMIS Network, 2013, EMIS 2010 EUR MEN WH; Thomson EC, 2009, AIDS, V23, P89, DOI 10.1097/QAD.0b013e32831940a3; Thurnheer MC, 2010, AIDS, V24, P1907, DOI 10.1097/QAD.0b013e32833bfe21; Tohme RA, 2010, HEPATOLOGY, V52, P1497, DOI 10.1002/hep.23808; Torrone EA, 2011, JAIDS-J ACQ IMM DEF, V58, P328, DOI 10.1097/QAI.0b013e31822e1075; Urbanus AT, 2014, AIDS, V28, P781, DOI 10.1097/QAD.0000000000000126; Urbanus AT, 2009, AIDS, V23, pF1, DOI 10.1097/QAD.0b013e32832e5631; van de Laar T, 2009, GASTROENTEROLOGY, V136, P1609, DOI 10.1053/j.gastro.2009.02.006; van de Laar TJW, 2007, J INFECT DIS, V196, P230, DOI 10.1086/518796; van de Laar TJW, 2010, AIDS, V24, P1799, DOI 10.1097/QAD.0b013e32833c11a5; van den Berg R, 2009, AIDS REV, V11, P157; van der Helm JJ, 2011, AIDS, V25, P1083, DOI 10.1097/QAD.0b013e3283471cce; Vogel M, 2009, CLIN INFECT DIS, V49, DOI 10.1086/600058; Walsh N, 2012, CURR OPIN HIV AIDS, V7, P339, DOI 10.1097/COH.0b013e328354131e; Wandeler G, 2012, CLIN INFECT DIS, V55, P1408, DOI 10.1093/cid/cis694; Weber R, 2013, HIV MED, V14, P195, DOI 10.1111/j.1468-1293.2012.01051.x; Wong J, 2015, SEX TRANSM INFECT; Wong W, 2005, SEX TRANSM DIS, V32, P458, DOI 10.1097/01.olq.0000168280.34424.58; Yao ZQ, 2013, ARCH IMMUNOL THER EX, V61, P193, DOI 10.1007/s00005-013-0219-0; Zetola NM, 2007, CLIN INFECT DIS, V44, P1222, DOI 10.1086/513427	93	62	63	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142515	10.1371/journal.pone.0142515	http://dx.doi.org/10.1371/journal.pone.0142515			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555244	Green Submitted, Green Published, gold			2022-12-27	WOS:000364430700121
J	Peng, Y; Xiong, X; Adhikari, K; Knadel, M; Grunwald, S; Greve, MH				Peng, Yi; Xiong, Xiong; Adhikari, Kabindra; Knadel, Maria; Grunwald, Sabine; Greve, Mogens Humlekrog			Modeling Soil Organic Carbon at Regional Scale by Combining Multi-Spectral Images with Laboratory Spectra	PLOS ONE			English	Article							INFRARED REFLECTANCE SPECTROSCOPY; VEGETATION INDEXES; REGRESSION; PHOSPHORUS; PREDICTION; FLORIDA; OPTIMIZATION; QUALITY; NIR	There is a great challenge in combining soil proximal spectra and remote sensing spectra to improve the accuracy of soil organic carbon (SOC) models. This is primarily because mixing of spectral data from different sources and technologies to improve soil models is still in its infancy. The first objective of this study was to integrate information of SOC derived from visible near-infrared reflectance (Vis-NIR) spectra in the laboratory with remote sensing (RS) images to improve predictions of topsoil SOC in the Skjern river catchment, Denmark. The second objective was to improve SOC prediction results by separately modeling uplands and wetlands. A total of 328 topsoil samples were collected and analyzed for SOC. Satellite Pour l'Observation de la Terre (SPOT5), Landsat Data Continuity Mission (Landsat 8) images, laboratory Vis-NIR and other ancillary environmental data including terrain parameters and soil maps were compiled to predict topsoil SOC using Cubist regression and Bayesian kriging. The results showed that the model developed from RS data, ancillary environmental data and laboratory spectral data yielded a lower root mean square error (RMSE) (2.8%) and higher R-2 (0.59) than the model developed from only RS data and ancillary environmental data (RMSE: 3.6%, R-2: 0.46). Plant-available water (PAW) was the most important predictor for all the models because of its close relationship with soil organic matter content. Moreover, vegetation indices, such as the Normalized Difference Vegetation Index (NDVI) and Enhanced Vegetation Index (EVI), were very important predictors in SOC spatial models. Furthermore, the 'upland model' was able to more accurately predict SOC compared with the 'upland & wetland model'. However, the separately calibrated 'upland and wetland model' did not improve the prediction accuracy for wetland sites, since it was not possible to adequately discriminate the vegetation in the RS summer images. We conclude that laboratory Vis-NIR spectroscopy adds critical information that significantly improves the prediction accuracy of SOC compared to using RS data alone. We recommend the incorporation of laboratory spectra with RS data and other environmental data to improve soil spatial modeling and digital soil mapping (DSM).	[Peng, Yi; Knadel, Maria; Greve, Mogens Humlekrog] Aarhus Univ, Fac Sci & Technol, Dept Agroecol, DK-8830 Tjele, Denmark; [Xiong, Xiong; Grunwald, Sabine] Univ Florida, Dept Soil & Water Sci, Gainesville, FL 32611 USA; [Adhikari, Kabindra] Univ Wisconsin Madison, Dept Soil Sci, FD Hole Soils Lab, Madison, WI 53706 USA	Aarhus University; State University System of Florida; University of Florida; University of Wisconsin System; University of Wisconsin Madison	Peng, Y (corresponding author), Aarhus Univ, Fac Sci & Technol, Dept Agroecol, Blichers Alle 20,POB 50, DK-8830 Tjele, Denmark.	yi.peng@agro.au.dk	Knadel, Maria/O-9886-2015; Knadel, Maria/I-9190-2019; Adhikari, Kabindra/H-3273-2019; Xiong, Xiong/A-6693-2013	Knadel, Maria/0000-0001-7539-6191; Knadel, Maria/0000-0001-7539-6191; Adhikari, Kabindra/0000-0002-1365-7015; PENG, YI/0000-0002-7836-8089; Xiong, Xiong/0000-0001-6978-1624	HOBE project; GUDP; Villum Fonden [00007163] Funding Source: researchfish	HOBE project; GUDP; Villum Fonden(Villum Fonden)	This work was supported by HOBE project, website: http://www.hobecenter.dk/; and GUDP, website: http://naturerhverv.dk/tilskud-selvbeljening/tilskudsguide/groent-udviklings-og-demonstrationsprogram-gudp/.	Adhikari K, 2014, GEODERMA, V214, P101, DOI 10.1016/j.geoderma.2013.09.023; Adhikari K, 2013, SOIL SCI SOC AM J, V77, P860, DOI 10.2136/sssaj2012.0275; Arrouays D, 2014, ADV AGRON, V125, P93, DOI 10.1016/B978-0-12-800137-0.00003-0; Bellon-Maurel V, 2011, SOIL BIOL BIOCHEM, V43, P1398, DOI 10.1016/j.soilbio.2011.02.019; Bellon-Maurel V, 2010, TRAC-TREND ANAL CHEM, V29, P1073, DOI 10.1016/j.trac.2010.05.006; Ben-Dor E, 2008, ADV AGRON, V97, P321, DOI 10.1016/S0065-2113(07)00008-9; Bivand R, 2013, RGDAL BINDINGS GEOSP; Brown DJ, 2007, GEODERMA, V140, P444, DOI 10.1016/j.geoderma.2007.04.021; Brown DJ, 2006, GEODERMA, V132, P273, DOI 10.1016/j.geoderma.2005.04.025; Brown L, 2000, REMOTE SENS ENVIRON, V71, P16, DOI 10.1016/S0034-4257(99)00035-8; Chang CW, 2001, SOIL SCI SOC AM J, V65, P480, DOI 10.2136/sssaj2001.652480x; Chang CW, 2002, SOIL SCI, V167, P110, DOI 10.1097/00010694-200202000-00003; COHEN WB, 1991, PHOTOGRAMM ENG REM S, V57, P195; Coll C, 2010, IEEE T GEOSCI REMOTE, V48, P547, DOI 10.1109/TGRS.2009.2024934; Du CW, 2009, ENVIRON CHEM LETT, V7, P97, DOI 10.1007/s10311-008-0166-x; Fernandez-Buces N, 2006, J ARID ENVIRON, V65, P644, DOI 10.1016/j.jaridenv.2005.08.005; Gao F, 2012, J APPL REMOTE SENS, V6, DOI 10.1117/1.JRS.6.063554; Gao X, 2000, REMOTE SENS ENVIRON, V74, P609, DOI 10.1016/S0034-4257(00)00150-4; Gholizadeh A, 2013, APPL SPECTROSC, V67, P1349, DOI 10.1366/13-07288; Gitelson AA, 1996, REMOTE SENS ENVIRON, V58, P289, DOI 10.1016/S0034-4257(96)00072-7; Goge F, 2012, CHEMOMETR INTELL LAB, V110, P168, DOI 10.1016/j.chemolab.2011.11.003; Govender M, 2007, WATER SA, V33, P145; Greve MH, 2007, GEOGR TIDSSKR-DEN, V107, P1; Grunwald S, 2011, SOIL SCI SOC AM J, V75, P1201, DOI 10.2136/sssaj2011.0025; GRUNWALD S, 2005, ENV SOIL LANDSCAPE M; Grunwald S, 2015, ADV AGRON, V131, P1, DOI 10.1016/bs.agron.2014.12.004; Guzinski R, 2014, BIOGEOSCIENCES, V11, P5021, DOI 10.5194/bg-11-5021-2014; Hijmans RJ, 2012, RASTER GEOGRAPHIC AN; Huete A, 2002, REMOTE SENS ENVIRON, V83, P195, DOI 10.1016/S0034-4257(02)00096-2; Huete AR, 1997, REMOTE SENS ENVIRON, V59, P440, DOI 10.1016/S0034-4257(96)00112-5; Jensen KH, 2011, VADOSE ZONE J, V10, P1, DOI 10.2136/vzj2011.0006; Kienast-Brown, 2010, DIGITAL SOIL MAPPING; Kim JS, 2014, IEEE T GEOSCI REMOTE, V52, P6724, DOI 10.1109/TGRS.2014.2301443; Knadel M, 2011, SOIL SCI SOC AM J, V75, P1799, DOI 10.2136/sssaj2010.0452; Knox NM, 2015, GEODERMA, V239, P229, DOI 10.1016/j.geoderma.2014.10.019; Krogh L, 2003, AGR ECOSYST ENVIRON, V96, P19, DOI 10.1016/S0167-8809(03)00016-1; Kuhn M., 2012, THE CARET PACKAGE; Kuhn M, 2014, PACKAGE CUBIST; Madsen H. B., 1992, DANISH SOIL CLASSIFI, VI; McBratney AB, 2003, GEODERMA, V117, P3, DOI 10.1016/S0016-7061(03)00223-4; McDowell M.L., 2012, APPL ENVIRON SOIL SC, DOI [10.1155/2012/294121, DOI 10.1155/2012/294121]; McDowell ML, 2012, GEODERMA, V189, P312, DOI 10.1016/j.geoderma.2012.06.009; McKenzie NJ, 1999, GEODERMA, V89, P67, DOI 10.1016/S0016-7061(98)00137-2; Minasny B, 2008, CHEMOMETR INTELL LAB, V94, P72, DOI 10.1016/j.chemolab.2008.06.003; Mulder VL, 2011, GEODERMA, V162, P1, DOI 10.1016/j.geoderma.2010.12.018; Nellis MD, 1903, T KANSAS ACAD SCI, V1992, P93; Pedersen ML, 2007, ECOL ENG, V30, P131, DOI 10.1016/j.ecoleng.2006.06.009; Peng Y, 2014, SOIL SCI, V179, P325, DOI 10.1097/SS.0000000000000074; Peng Y, 2013, J NEAR INFRARED SPEC, V21, P213, DOI 10.1255/jnirs.1053; Pilz J, 2008, STOCH ENV RES RISK A, V22, P621, DOI 10.1007/s00477-007-0165-7; Quinlan J. R., 1992, Proceedings of the 5th Australian Joint Conference on Artificial Intelligence. AI '92, P343; Quinlan J.R., 1993, C4 5 PROGRAMS MACHIN; Reeves JB, 1999, J NEAR INFRARED SPEC, V7, P179, DOI 10.1255/jnirs.248; Rivero RG, 2007, GEODERMA, V140, P428, DOI 10.1016/j.geoderma.2007.04.026; Rivero RG, 2009, REMOTE SENS ENVIRON, V113, P2389, DOI 10.1016/j.rse.2009.07.015; ROCK BN, 1986, BIOSCIENCE, V36, P439, DOI 10.2307/1310339; Rondeaux G, 1996, REMOTE SENS ENVIRON, V55, P95, DOI 10.1016/0034-4257(95)00186-7; Rossel RAV, 2010, GEODERMA, V158, P46, DOI 10.1016/j.geoderma.2009.12.025; Rossel RAV, 2006, GEODERMA, V131, P59, DOI 10.1016/j.geoderma.2005.03.007; Rouse Haas, 1973, MONITORING VERNAL AD, DOI DOI 10.1002/MRM.26868; Sarkhot DV, 2011, GEODERMA, V164, P22, DOI 10.1016/j.geoderma.2011.05.006; Shepherd KD, 2002, SOIL SCI SOC AM J, V66, P988, DOI 10.2136/sssaj2002.0988; Sorensen LK, 2002, J NEAR INFRARED SPEC, V10, P15, DOI 10.1255/jnirs.317; Stenberg B, 2010, ADV AGRON, V107, P163, DOI 10.1016/S0065-2113(10)07005-7; Stisen S, 2007, REMOTE SENS ENVIRON, V110, P262, DOI 10.1016/j.rse.2007.02.025; Stjernholm M, 2004, CORINE LANDCOVER UPD; Sumfleth K, 2008, ECOL INDIC, V8, P485, DOI 10.1016/j.ecolind.2007.05.005; Vasques GM, 2012, LANDSCAPE ECOL, V27, P355, DOI 10.1007/s10980-011-9702-3; Vasques GM, 2010, J ENVIRON QUAL, V39, P923, DOI 10.2134/jeq2009.0314; Vasques GM, 2009, SOIL SCI SOC AM J, V73, P176, DOI 10.2136/sssaj2008.0015; Weng QH, 2004, REMOTE SENS ENVIRON, V89, P467, DOI 10.1016/j.rse.2003.11.005; Williams P., 2001, NEAR INFRARED TECHNO; Xiong X, 2014, ENVIRON MODELL SOFTW, V57, P202, DOI 10.1016/j.envsoft.2014.03.004; Yang CM, 2004, CROP SCI, V44, P1283, DOI 10.2135/cropsci2004.1283; Zhang GN, 2014, J ARID LAND, V6, P156, DOI 10.1007/s40333-013-0241-4; Zhou Y, 2014, RANGELAND ECOL MANAG, V67, P9, DOI 10.2111/REM-D-13-00059.1	76	42	43	8	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142295	10.1371/journal.pone.0142295	http://dx.doi.org/10.1371/journal.pone.0142295			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555071	Green Submitted, Green Published, gold			2022-12-27	WOS:000364430700079
J	Qasim, N; Mahmood, R				Qasim, Neha; Mahmood, Riaz			Diminution of Oxidative Damage to Human Erythrocytes and Lymphocytes by Creatine: Possible Role of Creatine in Blood	PLOS ONE			English	Article							DNA-DAMAGE; LIPID-PEROXIDATION; SUPPLEMENTATION; STRESS; CELLS; EXERCISE; DISEASE; ASSAY; SURVIVAL; LIVER	Creatine (Cr) is naturally produced in the body and stored in muscles where it is involved in energy generation. It is widely used, especially by athletes, as a staple supplement for improving physical performance. Recent reports have shown that Cr displays antioxidant activity which could explain its beneficial cellular effects. We have evaluated the ability of Cr to protect human erythrocytes and lymphocytes against oxidative damage. Erythrocytes were challenged with model oxidants, 2, 2'-azobis(2-amidinopropane) dihydrochloride (AAPH) and hydrogen peroxide (H2O2) in the presence and absence of Cr. Incubation of erythrocytes with oxidant alone increased hemolysis, methemoglobin levels, lipid peroxidation and protein carbonyl content. This was accompanied by decrease in glutathione levels. Antioxidant enzymes and antioxidant power of the cell were compromised while the activity of membrane bound enzyme was lowered. This suggests induction of oxidative stress in erythrocytes by AAPH and H2O2. However, Cr protected the erythrocytes by ameliorating the AAPH and H2O2 induced changes in these parameters. This protective effect was confirmed by electron microscopic analysis which showed that oxidant-induced cell damage was attenuated by Cr. No cellular alterations were induced by Cr alone even at 20 mM, the highest concentration used. Creatinine, a by-product of Cr metabolism, was also shown to exert protective effects, although it was slightly less effective than Cr. Human lymphocytes were similarly treated with H2O2 in absence and presence of different concentrations of Cr. Lymphocytes incubated with oxidant alone had alterations in various biochemical and antioxidant parameters including decrease in cell viability and induction of DNA damage. The presence of Cr attenuated all these H2O2-induced changes in lymphocytes. Thus, Cr can function as a blood antioxidant, protecting cells from oxidative damage, genotoxicity and can potentially increase their lifespan.	[Qasim, Neha; Mahmood, Riaz] Aligarh Muslim Univ, Dept Biochem, Fac Life Sci, Aligarh, Uttar Pradesh, India	Aligarh Muslim University	Mahmood, R (corresponding author), Aligarh Muslim Univ, Dept Biochem, Fac Life Sci, Aligarh, Uttar Pradesh, India.	riazmahmood2002@yahoo.co.in						Aksentijevic D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109021; Alcaide P, 2011, HUM MUTAT, V32, P282, DOI 10.1002/humu.21421; Araujo MB, 2013, J INT SOC SPORT NUTR, V10, DOI 10.1186/1550-2783-10-54; BALSOM PD, 1994, SPORTS MED, V18, P268, DOI 10.2165/00007256-199418040-00005; Battisti V, 2009, CLIN CHIM ACTA, V402, P114, DOI 10.1016/j.cca.2008.12.030; Bemben MG, 2005, SPORTS MED, V35, P107, DOI 10.2165/00007256-200535020-00002; Bender A, 2008, NEUROBIOL AGING, V29, P1404, DOI 10.1016/j.neurobiolaging.2007.03.001; BENESCH RE, 1973, ANAL BIOCHEM, V55, P245, DOI 10.1016/0003-2697(73)90309-6; BENNETT SE, 1994, CELL BIOCHEM FUNCT, V12, P99, DOI 10.1002/cbf.290120204; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; Beutler E., 1984, GLUTATHIONE RED CELL; Bonting S. L., 1970, MEMBRANE ION TRANSPO, P257; Buege J A, 1978, Methods Enzymol, V52, P302; BUYSSE AM, 1990, CLIN CHIM ACTA, V187, P155, DOI 10.1016/0009-8981(90)90342-P; Ceddia RB, 2004, J PHYSIOL-LONDON, V555, P409, DOI 10.1113/jphysiol.2003.056291; Cimen MYB, 2008, CLIN CHIM ACTA, V390, P1, DOI 10.1016/j.cca.2007.12.025; Clark JF, 1997, J ATHL TRAINING, V32, P45; CLEMENS MR, 1988, DEUT MED WOCHENSCHR, V113, P91, DOI 10.1055/s-2008-1067599; Da Ros R, 2004, DIABETIC MED, V21, P1249, DOI 10.1111/j.1464-5491.2004.01312.x; Dalle-Donne I, 2003, CLIN CHIM ACTA, V329, P23, DOI 10.1016/S0009-8981(03)00003-2; Demant TW, 1999, SPORTS MED, V28, P49, DOI 10.2165/00007256-199928010-00005; Deminice R, 2012, AMINO ACIDS, V43, P709, DOI 10.1007/s00726-011-1121-x; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Erslev AF, 1995, WILLIAMS HEMATOLOGY, P441; FALCIERI E, 1988, J SUBMICR CYTOL PATH, V20, P623; FEHR J, 1979, BLOOD, V53, P966; FLOHE L, 1984, METHOD ENZYMOL, V105, P114; Genc G, 2014, RENAL FAILURE, V36, P1108, DOI 10.3109/0886022X.2014.917576; Genius J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030554; GIUGLIANO D, 1995, METABOLISM, V44, P363, DOI 10.1016/0026-0495(95)90167-1; Glader B E, 1979, Prog Clin Biol Res, V30, P503; GRIFFITHS WJ, 1967, BRIT J HAEMATOL, V13, P175, DOI 10.1111/j.1365-2141.1967.tb08728.x; Gualano B, 2012, AMINO ACIDS, V43, P519, DOI 10.1007/s00726-011-1132-7; Guidi C, 2008, BBA-GEN SUBJECTS, V1780, P16, DOI 10.1016/j.bbagen.2007.09.018; Guimaraes-Ferreira L, 2012, EUR J APPL PHYSIOL, V112, P3905, DOI 10.1007/s00421-012-2378-9; HALLIWELL B, 1991, FEBS LETT, V281, P9, DOI 10.1016/0014-5793(91)80347-6; Halliwell B., 2007, FREE RADICALS BIOL M; Hasler CR, 1998, NEPHROL DIAL TRANSPL, V13, P3132, DOI 10.1093/ndt/13.12.3132; Hattangadi SM, 2007, J CLIN INVEST, V117, P2075, DOI 10.1172/JCI32559; Horvat A, 2006, PHYSIOL RES, V55, P325, DOI 10.33549/physiolres.930696; Igisu Hideki, 1994, Journal of UOEH, V16, P253; Inal M, 1999, FREE RADICAL RES, V31, P211, DOI 10.1080/10715769900300771; Jiao YF, 1998, CLIN BIOCHEM, V31, P59, DOI 10.1016/S0009-9120(97)00164-1; Johnson RM, 2005, FREE RADICAL BIO MED, V39, P1407, DOI 10.1016/j.freeradbiomed.2005.07.002; Juravleva E, 2005, J NEUROSCI RES, V79, P224, DOI 10.1002/jnr.20291; Kim HJ, 2011, AMINO ACIDS, V40, P1409, DOI 10.1007/s00726-011-0878-2; Kim YW, 2014, BLOOD, V123, P625, DOI 10.1182/blood-2013-09-512749; Knight JA, 2000, ANN CLIN LAB SCI, V30, P145; Larbi A, 2007, EXP GERONTOL, V42, P852, DOI 10.1016/j.exger.2007.05.004; Lawler JM, 2002, BIOCHEM BIOPH RES CO, V290, P47, DOI 10.1006/bbrc.2001.6164; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MacCormick VM, 2004, CAN J APPL PHYSIOL, V29, P704, DOI 10.1139/h04-045; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; Mishra K, 2012, FOOD CHEM, V130, P1036, DOI 10.1016/j.foodchem.2011.07.127; Nisha M, 2011, INT J PHARM SCI, V3, P28; Persky AM, 2003, CLIN PHARMACOKINET, V42, P557, DOI 10.2165/00003088-200342060-00005; POOLZOBEL BL, 1993, FOOD CHEM TOXICOL, V31, P271, DOI 10.1016/0278-6915(93)90077-C; Power LW, 1989, DIAGNOSTIC HEMATOLOG, P198; Preen DB, 2005, INT J SPORT NUTR EXE, V15, P84, DOI 10.1123/ijsnem.15.1.84; Rahimi R, 2011, J STRENGTH COND RES, V25, P3448, DOI 10.1519/JSC.0b013e3182162f2b; Ramalingam M, 2012, J NEURAL TRANSM, V119, P891, DOI 10.1007/s00702-011-0758-7; SATO Y, 1995, BIOCHEMISTRY-US, V34, P8940, DOI 10.1021/bi00028a002; Schedel JM, 1999, LIFE SCI, V65, P2463, DOI 10.1016/S0024-3205(99)00512-3; Schrag M, 2013, NEUROBIOL DIS, V59, P100, DOI 10.1016/j.nbd.2013.07.005; SEGEL GB, 1979, J CLIN INVEST, V64, P834, DOI 10.1172/JCI109531; Sestili P, 2006, FREE RADICAL BIO MED, V40, P837, DOI 10.1016/j.freeradbiomed.2005.10.035; Sestili P, 2011, AMINO ACIDS, V40, P1385, DOI 10.1007/s00726-011-0875-5; SHEETZ MP, 1974, P NATL ACAD SCI USA, V71, P4457, DOI 10.1073/pnas.71.11.4457; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Snow RJ, 2001, MOL CELL BIOCHEM, V224, P169, DOI 10.1023/A:1011908606819; STUART J, 1985, J CLIN PATHOL, V38, P965, DOI 10.1136/jcp.38.9.965; Takashimizu S, 2000, ALCOHOL CLIN EXP RES, V24, p81S, DOI 10.1111/j.1530-0277.2000.tb00018.x; Tarnopolsky MA, 2011, AMINO ACIDS, V40, P1397, DOI 10.1007/s00726-011-0876-4; Wallimann T, 2011, AMINO ACIDS, V40, P1271, DOI 10.1007/s00726-011-0877-3; Wintrobe M M, 2009, WINTROBES CLIN HEMAT, V1; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107	79	32	34	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0141975	10.1371/journal.pone.0141975	http://dx.doi.org/10.1371/journal.pone.0141975			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555819	Green Published, Green Submitted, gold			2022-12-27	WOS:000364430700046
J	Bloodhart, B; Maibach, E; Myers, T; Zhao, XQ				Bloodhart, Brittany; Maibach, Edward; Myers, Teresa; Zhao, Xiaoquan			Local Climate Experts: The Influence of Local TV Weather Information on Climate Change Perceptions	PLOS ONE			English	Article							PERSONAL-EXPERIENCE; RISK PERCEPTIONS; BELIEF; CONSEQUENCES; POLARIZATION; TEMPERATURE; VARIABILITY; KNOWLEDGE; IDENTITY; OPINION	Individuals who identify changes in their local climate are also more likely to report that they have personally experienced global climate change. One way that people may come to recognize that their local climate is changing is through information provided by local TV weather forecasters. Using random digit dialing, 2,000 adult local TV news viewers in Virginia were surveyed to determine whether routine exposure to local TV weather forecasts influences their perceptions of extreme weather in Virginia, and their perceptions about climate change more generally. Results indicate that paying attention to TV weather forecasts is associated with beliefs that extreme weather is becoming more frequent in Virginia, which in turn is associated with stronger beliefs and concerns about climate change. These associations were strongest for individuals who trust their local TV weathercaster as a source of information about climate change, and for those who identify as politically conservative or moderate. The findings add support to the literature suggesting that TV weathercasters can play an important role in educating the public about climate change.	[Bloodhart, Brittany] Colorado State Univ, Dept Psychol, Ft Collins, CO 80523 USA; [Maibach, Edward; Myers, Teresa; Zhao, Xiaoquan] George Mason Univ, Ctr Climate Change Commun, Fairfax, VA 22030 USA	Colorado State University; George Mason University	Bloodhart, B (corresponding author), Colorado State Univ, Dept Psychol, Ft Collins, CO 80523 USA.	brittany.bloodhart@rams.colostate.edu	Maibach, Edward/A-7102-2009	Maibach, Edward/0000-0003-3409-9187	National Science Foundation [DUE-1043235]	National Science Foundation(National Science Foundation (NSF))	Funding: This project was funded by the National Science Foundation (Award # DUE-1043235) and through anonymous donations to the George Mason University Foundation. BB and EM received funding to work on this project. The funders had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Akerlof K, 2013, GLOBAL ENVIRON CHANG, V23, P81, DOI 10.1016/j.gloenvcha.2012.07.006; American Press Institute, 2014, PERS NEWS CYCL; Anderson AA, 2013, WEATHER CLIM SOC, V5, P367, DOI 10.1175/WCAS-D-12-00051.1; Borick CP, 2014, WEATHER CLIM SOC, V6, P413, DOI 10.1175/WCAS-D-13-00042.1; Borick CP, 2010, SOC SCI QUART, V91, P777, DOI 10.1111/j.1540-6237.2010.00719.x; Brulle RJ, 2012, CLIMATIC CHANGE, V114, P169, DOI 10.1007/s10584-012-0403-y; Chestnut, 2002, EC VALUE CURRENT IMP; Corso R. A., 2007, LOCAL TELEVISION NEW; Demuth JL, 2011, WEATHER CLIM SOC, V3, P177, DOI 10.1175/2011WCAS1061.1; Demuth JL, 2009, B AM METEOROL SOC, V90, P1614, DOI 10.1175/2009BAMS2787.1; Egan PJ, 2012, J POLIT, V74, P796, DOI 10.1017/S0022381612000448; Goebbert K, 2012, WEATHER CLIM SOC, V4, P132, DOI 10.1175/WCAS-D-11-00044.1; Hamilton LC, 2013, WEATHER CLIM SOC, V5, P112, DOI 10.1175/WCAS-D-12-00048.1; Hart PS, 2012, COMMUN RES, V39, P701, DOI 10.1177/0093650211416646; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Herrnstadt E., 2013, 201348 HARV ENV EC P; Hovland C.I., 1953, COMMUN PERSUATION; Howe PD, 2013, GLOBAL ENVIRON CHANG, V23, P1488, DOI 10.1016/j.gloenvcha.2013.09.014; Joireman J, 2010, J ENVIRON PSYCHOL, V30, P358, DOI 10.1016/j.jenvp.2010.03.004; Kahan DM, 2013, JUDGM DECIS MAK, V8, P407; Krosnick JA, 2006, CLIMATIC CHANGE, V77, P7, DOI 10.1007/s10584-006-9068-8; KUNDA Z, 1990, PSYCHOL BULL, V108, P480, DOI 10.1037/0033-2909.108.3.480; Lang C, 2014, CLIMATIC CHANGE, V125, P291, DOI 10.1007/s10584-014-1180-6; Leiserowitz, 2009, GLOBAL WARMINGS 6 AM; Leiserowitz A., 2012, CLIMATE CHANGE AM MI; Leiserowitz A., 2008, FLORIDA PUBLIC OPINI; Leiserowitz A., 2014, POLITICS GLOBAL WARM; Leiserowitz AA, 2005, RISK ANAL, V25, P1433, DOI 10.1111/j.1540-6261.2005.00690.x; Li Y, 2011, PSYCHOL SCI, V22, P454, DOI 10.1177/0956797611400913; LIN CA, 1992, JOURNALISM QUART, V69, P373, DOI 10.1177/107769909206900211; Malka A, 2009, RISK ANAL, V29, P633, DOI 10.1111/j.1539-6924.2009.01220.x; McCright AM, 2011, SOCIOL QUART, V52, P155, DOI 10.1111/j.1533-8525.2011.01198.x; McCright AM, 2008, PUBLIC OPIN QUART, V72, P651, DOI 10.1093/poq/nfn051; Melillo JM, 2014, CLIMATE CHANGE IMPAC, V841, DOI DOI 10.7930/J0Z31WJ2; Meyer William B, 2000, AM THEIR WEATHER; Meze-Hausken E, 2004, CLIM RES, V27, P19, DOI 10.3354/cr027019; Morss RE, 2010, METEOROL APPL, V17, P149, DOI 10.1002/met.196; Myers TA, 2013, NAT CLIM CHANGE, V3, P343, DOI [10.1038/nclimate1754, 10.1038/NCLIMATE1754]; Myers TA, 2011, COMMUN METHODS MEAS, V5, P297, DOI 10.1080/19312458.2011.624490; National Weather Service, 2005, CUST SAT SURV GEN PU; Osbahr H, 2011, EXP AGR, V47, P293, DOI 10.1017/S0014479710000785; Petty R. E., 1986, COMMUN PERSUATION, P1; Risen JL, 2011, J PERS SOC PSYCHOL, V100, P777, DOI 10.1037/a0022460; Roncoli C, 2002, SOC NATUR RESOUR, V15, P409, DOI 10.1080/08941920252866774; Rosenstiel T., 2011, PEOPLE LEARN THEIR L; Scannell L., 2013, ENVIRON BEHAV, V45, P60, DOI [https://doi.org/10.1177/0013916511421196, DOI 10.1177/0013916511421196]; Sherman-Morris K., 2005, ENV HAZARDS, V6, P201, DOI [10.1016/j.hazards.2006.10.002, DOI 10.1016/j.hazards.2006.10.002]; Slovic P, 2004, RISK ANAL, V24, P311, DOI 10.1111/j.0272-4332.2004.00433.x; Spence A, 2012, RISK ANAL, V32, P957, DOI 10.1111/j.1539-6924.2011.01695.x; Strauss S, 2003, WEATHER CLIMATE CULT; Trope Y, 2010, PSYCHOL REV, V117, P440, DOI 10.1037/a0018963; Tschakert P, 2010, CLIMATIC CHANGE, V103, P471, DOI 10.1007/s10584-009-9776-y; Weber E. U., 1997, PSYCHOL PERSPECTIVES, P314; Weber EU, 2006, CLIMATIC CHANGE, V77, P103, DOI 10.1007/s10584-006-9060-3; Weber EU, 2002, J BEHAV DECIS MAKING, V15, P263, DOI 10.1002/bdm.414; West CT, 2008, LAND DEGRAD DEV, V19, P289, DOI 10.1002/ldr.842; Zahran S, 2006, SOC NATUR RESOUR, V19, P771, DOI 10.1080/08941920600835528; Zhao X., 2013, B AM METEOROLOGICAL, V95, P117, DOI DOI 10.1175/BAMS-D-12-00144.1	58	37	37	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2015	10	11							e0141526	10.1371/journal.pone.0141526	http://dx.doi.org/10.1371/journal.pone.0141526			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7AC	26551357	Green Submitted, gold, Green Published			2022-12-27	WOS:000364422800007
J	Kobayashi, T; Suzuki, E; Noguchi, M; Kawachi, I; Takao, S				Kobayashi, Tomoko; Suzuki, Etsuji; Noguchi, Masayuki; Kawachi, Ichiro; Takao, Soshi			Community-Level Social Capital and Psychological Distress among the Elderly in Japan: A Population-Based Study	PLOS ONE			English	Article							MENTAL-HEALTH; DEPRESSIVE SYMPTOMS; POLITICAL-ECONOMY; OLDER-ADULTS; ASSOCIATION; TRUST; PERFORMANCE; CARPIANO	Despite accumulating evidence, previous studies have not clearly separated the contribution of community-level social capital on mental health from that of individual-level social support. We examined the association between community-level social capital and psychological distress in a sample of older Japanese individuals, taking into account the effects of individual-level social capital and social support. We collected data via a cross-sectional survey among all residents aged >= 65 in three rural municipalities in Okayama Prefecture. We measured two components of social capital in the questionnaire: perceptions of trust and reciprocity in the community. Community-level social capital was obtained by aggregating individual responses and calculating the proportion of subjects reporting mistrust and lack of reciprocity. Psychological distress was assessed by the Kessler Psychological Distress scale. We calculated risk ratios (RRs) and 95% confidence intervals (CIs) for psychological distress using two-level Poisson regression models (9,761 individuals nested within 35 communities). The prevalence of psychological distress was 39.8%. Low community-level social capital was associated with psychological distress, even after controlling for individual-level social support, age, sex, educational attainment, frequency of alcohol consumption, smoking status, body mass index, marital status, socioeconomic status, and number of cohabiters. The adjusted RRs per 10% increase of the proportion of mistrust and lack of reciprocity in the communities were 1.23 (95% CI: 1.01-1.51) and 1.12 (95% CI: 1.02-1.24), respectively. Lower levels of community-level social capital are associated with psychological distress among the Japanese elderly population, even after adjusting for individual- level perceptions of social capital and social support.	[Kobayashi, Tomoko] Osaka Univ, Grad Sch Med, Dept Social Med, Publ Hlth, Osaka, Japan; [Suzuki, Etsuji; Takao, Soshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Epidemiol, Okayama, Japan; [Noguchi, Masayuki] Okayama Prefectural Mental Hlth & Welf Ctr, Okayama, Japan; [Kawachi, Ichiro] Harvard Univ, TH Chan Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA	Osaka University; Okayama University; Harvard University; Harvard T.H. Chan School of Public Health	Kobayashi, T (corresponding author), Osaka Univ, Grad Sch Med, Dept Social Med, Publ Hlth, Osaka, Japan.	t.kobayashi@pbhel.med.osaka-u.ac.jp	Suzuki, Etsuji/B-2342-2011; Noguchi, Masayuki/P-1053-2019	Suzuki, Etsuji/0000-0002-1290-5793; 				Almedom AM, 2005, SOC SCI MED, V61, P943, DOI 10.1016/j.socscimed.2004.12.025; Araya R, 2006, SOC SCI MED, V62, P3072, DOI 10.1016/j.socscimed.2005.11.037; Bassett E., 2013, CURRENT TOPICS PUBLI, DOI DOI 10.5772/53501; Bassett E, 2013, SOC SCI MED, V86, P96, DOI 10.1016/j.socscimed.2013.03.005; Bojorquez-Chapela I, 2012, AGING MENT HEALTH, V16, P462, DOI 10.1080/13607863.2011.651432; Carpiano RM, 2014, SOC SCI MED, V116, P225, DOI 10.1016/j.socscimed.2014.03.017; De Silva MJ, 2005, J EPIDEMIOL COMMUN H, V59, P619, DOI 10.1136/jech.2004.029678; Ferrari AJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001547; Forsman AK, 2012, AGING MENT HEALTH, V16, P771, DOI 10.1080/13607863.2012.667784; Forsman AK, 2011, SCAND J PUBLIC HEALT, V39, P757, DOI 10.1177/1403494811418281; Fujisawa Y, 2009, SOC SCI MED, V69, P500, DOI 10.1016/j.socscimed.2009.05.046; Furukawa TA, 2008, INT J METH PSYCH RES, V17, P152, DOI 10.1002/mpr.257; Hamano T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013214; Hamano T, 2011, STRESS HEALTH, V27, P163, DOI 10.1002/smi.1324; Harpham T., 2008, SOCIAL CAPITAL HLTH, P51, DOI DOI 10.1007/978-0-387-71311-3_3; Kasai Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077918; Kawachi I, 2004, INT J EPIDEMIOL, V33, P682, DOI 10.1093/ije/dyh177; Kawachi I., 2000, SOCIAL EPIDEMIOLOGY, V174, P290; Kawachi I, 2013, GLOBAL PERSPECTIVES, DOI [10.1007/978-1-4614-7464-7, DOI 10.1007/978-1-4614-7464-7_1]; Kawachi I, 2008, SOCIAL CAPITAL HLTH, DOI [10.1007/978-0-387-71311-3_1, DOI 10.1007/978-0-387-71311-3_1]; Kishimoto Y, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1189; Lindstrom M, 2014, SOC SCI MED, V116, P235, DOI 10.1016/j.socscimed.2014.04.028; Ministry of Health, 2015, ANN HLTH LAB WELF RE, V6, P20; Ministry of Health Labour and Welfare, PAT SURV 2011; Muramatsu N, 2011, GERONTOLOGIST, V51, P425, DOI 10.1093/geront/gnr067; Noguchi M, 2015, INT J GERIATR PSYCH, V30, P1156, DOI 10.1002/gps.4268; Noguchi M, 2014, SOC PSYCH PSYCH EPID, V49, P619, DOI 10.1007/s00127-013-0752-5; Phongsavan P, 2006, SOC SCI MED, V63, P2546, DOI 10.1016/j.socscimed.2006.06.021; Pollack CE, 2004, HEALTH PLACE, V10, P383, DOI 10.1016/j.healthplace.2004.08.008; Prince MJ, 2015, LANCET, V385, P549, DOI 10.1016/S0140-6736(14)61347-7; Sakihara M, 2000, REVISION VALIDITY ME, P1; Sakurai K, 2011, PSYCHIAT CLIN NEUROS, V65, P434, DOI 10.1111/j.1440-1819.2011.02236.x; Sawada Y, 2014, SOC SCI MED, V116, P237, DOI 10.1016/j.socscimed.2014.06.001; Scheffler RM, 2007, SOC SCI MED, V65, P842, DOI 10.1016/j.socscimed.2007.03.042; Szreter S, 2004, INT J EPIDEMIOL, V33, P650, DOI 10.1093/ije/dyh013; Takagi D., 2013, GLOBAL PERSPECTIVES, P143, DOI DOI 10.1007/978-1-4614-7464-7_6; Yip W, 2007, SOC SCI MED, V64, P35, DOI 10.1016/j.socscimed.2006.08.027	37	15	15	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2015	10	11							e0142629	10.1371/journal.pone.0142629	http://dx.doi.org/10.1371/journal.pone.0142629			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7AC	26550997	Green Published, gold, Green Submitted			2022-12-27	WOS:000364422800030
J	Huang, G; Wu, LW; Yang, SC; Fei, JG; Deng, SX; Li, J; Chen, GD; Fu, Q; Deng, RH; Qiu, J; Wang, CX; Chen, LZ				Huang, Gang; Wu, Lin-wei; Yang, Shi-Cong; Fei, Ji-guang; Deng, Su-xiong; Li, Jun; Chen, Guo-dong; Fu, Qian; Deng, Rong-hai; Qiu, Jiang; Wang, Chang-xi; Chen, Li-zhong			Factors Influencing Graft Outcomes Following Diagnosis of Polyomavirus - Associated Nephropathy after Renal Transplantation	PLoS One			English	Article							BK VIRUS-INFECTION; PREEMPTIVE IMMUNOSUPPRESSION REDUCTION; SINGLE-CENTER ANALYSIS; RECIPIENTS; REPLICATION; IMPACT; STRATEGIES; ALLOGRAFTS; CLEARANCE; UTILITY	Background Polyomavirus associated nephropathy (PVAN) is a significant cause of early allograft loss and the course is difficult to predict. The aim of this study is to identify factors influencing outcome for PVAN. Methods Between 2006 and 2014, we diagnosed PVAN in 48 (7.8%) of 615 patients monitored for BK virus every 1-4 weeks after modification of maintenance immunosuppression. Logistic or Cox regression analysis were performed to determine which risk factors independently affected clinical outcome and graft loss respectively. Results After 32.1 +/- 26.4 months follow-up, the frequencies of any graft functional decline at 1 year post-diagnosis, graft loss and any graft functional decline at the last available follow-up were 27.1% (13/48), 25.0%(12/48), and 33.3% (16/48), respectively. The 1, 3, 5 year graft survival rates were 100%, 80.5% and 69.1%, respectively. The mean level of serum creatinine at 1 year post-diagnosis and long-term graft survival rates were the worst in class C (p<0.05). Thirty-eight of 46 (82.6%) BKV DNAuria patients reduced viral load by 90% with a median time of 2.75 months (range, 0.25-34.0 months) and showed better graft survival rates than the 8 patients (17.4%) without viral load reduction (p<0.001). Multivariate logistic regression analysis showed that extensive interstitial inflammation (OR 20.2, p = 0.042) and delayed fall in urinary viral load (>2.75 months for >90% decrease) in urine (OR 16.7, = 0.055) correlated with worse creatinine at 1 year post-diagnosis. Multivariate Cox regression analysis showed that extensive interstitial inflammation (HR 46988, p = 0.032) at diagnosis, and high PVAN stage (HR 162.2, p = 0.021) were associated with worse long-term graft survival rates. Conclusions The extent of interstitial inflammation influences short and long-term graft outcomes in patients with PVAN. The degree of PVAN, rate of reduction in viral load, and viral clearance also can be used as prognostic markers in PVAN.	[Huang, Gang; Wu, Lin-wei; Fei, Ji-guang; Deng, Su-xiong; Li, Jun; Chen, Guo-dong; Fu, Qian; Deng, Rong-hai; Qiu, Jiang; Wang, Chang-xi; Chen, Li-zhong] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Organ Transplantat, Guangzhou 510275, Guangdong, Peoples R China; [Yang, Shi-Cong] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Pathol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Qiu, J (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Organ Transplantat, Guangzhou 510275, Guangdong, Peoples R China.	guhuil@mail.sysu.edu.cn; wangchangxi1963@126.com			National Natural Science Foundation of China [81400754]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from National Natural Science Foundation of China (No. 81400754) to G.H., http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeras C, 2008, TRANSPLANTATION, V85, P1099, DOI 10.1097/TP.0b013e31816a33d4; Brennan DC, 2005, AM J TRANSPLANT, V5, P582, DOI 10.1111/j.1600-6143.2005.00742.x; Bueghrig CK, 2003, KIDNEY INT, V64, P665; Chung BH, 2012, TRANSPL INT, V25, P687, DOI 10.1111/j.1432-2277.2012.01480.x; Drachenberg CB, 2004, AM J TRANSPLANT, V4, P2082, DOI 10.1046/j.1600-6143.2004.00603.x; Drachenberg CB, 2006, CLIN J AM SOC NEPHRO, V1, P374, DOI 10.2215/CJN.02021205; Drachenberg RC, 2001, AM J TRANSPLANT, V1, P373, DOI 10.1034/j.1600-6143.2001.10414.x; Funk GA, 2008, AM J TRANSPLANT, V8, P2368, DOI 10.1111/j.1600-6143.2008.02402.x; Gaber LW, 2006, TRANSPLANTATION, V82, P196, DOI 10.1097/01.tp.0000226176.87700.a4; Ginevri F, 2007, AM J TRANSPLANT, V7, P2727, DOI 10.1111/j.1600-6143.2007.01984.x; Helantera I, 2010, INFECT DIS CLIN N AM, V24, P339, DOI 10.1016/j.idc.2010.02.003; Hirsch HH, 2013, AM J TRANSPLANT, V13, P179, DOI 10.1111/ajt.12110; Hirsch HH, 2005, TRANSPLANTATION, V79, P1277, DOI 10.1097/01.TP.0000156165.83160.09; Huang G, 2015, DIAGN MICR INFEC DIS, V81, P21, DOI 10.1016/j.diagmicrobio.2014.09.024; Huang G, 2013, DIAGN MICR INFEC DIS, V75, P292, DOI 10.1016/j.diagmicrobio.2012.11.012; Huang G, 2010, CLIN TRANSPLANT, V24, P599, DOI 10.1111/j.1399-0012.2009.01141.x; Kuten SA, 2014, TRANSPL INFECT DIS, V16, P975, DOI 10.1111/tid.12313; Masutani K, 2012, AM J TRANSPLANT, V12, P907, DOI 10.1111/j.1600-6143.2012.03993.x; Pappo O, 1996, MODERN PATHOL, V9, P105; Pham PT, 2014, CURR OPIN ORGAN TRAN, V19, P401, DOI 10.1097/MOT.0000000000000101; PURIGHALLA R, 1995, AM J KIDNEY DIS, V26, P671, DOI 10.1016/0272-6386(95)90608-8; Racusen LC, 1999, KIDNEY INT, V55, P713, DOI 10.1046/j.1523-1755.1999.00299.x; Schwarz A, 2012, TRANSPLANTATION, V94, P396, DOI 10.1097/TP.0b013e31825a505d; Sellares J, 2011, AM J TRANSPLANT, V11, P489, DOI 10.1111/j.1600-6143.2010.03415.x; Wadei HM, 2006, AM J TRANSPLANT, V6, P1025, DOI 10.1111/j.1600-6143.2006.01296.x; Weiss AS, 2008, CLIN J AM SOC NEPHRO, V3, P1812, DOI 10.2215/CJN.05691207	26	17	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0142460	10.1371/journal.pone.0142460	http://dx.doi.org/10.1371/journal.pone.0142460			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26544696	Green Published, Green Submitted, gold			2022-12-27	WOS:000364398700144
J	Song, XP; Zhou, SQ; Zhang, Y; Liu, YJ; Zhu, HQ; Gao, JH				Song, Xiaopeng; Zhou, Shuqin; Zhang, Yi; Liu, Yijun; Zhu, Huaiqiu; Gao, Jia-Hong			Frequency-Dependent Modulation of Regional Synchrony in the Human Brain by Eyes Open and Eyes Closed Resting-States	PLOS ONE			English	Article								The eyes-open (EO) and eyes-closed (EC) states have differential effects on BOLD-fMRI signal dynamics, affecting both the BOLD oscillation frequency of a single voxel and the regional homogeneity (ReHo) of several neighboring voxels. To explore how the two resting- states modulate the local synchrony through different frequency bands, we decomposed the time series of each voxel into several components that fell into distinct frequency bands. The ReHo in each of the bands was calculated and compared between the EO and EC conditions. The cross-voxel correlations between the mean frequency and the overall ReHo of each voxel's original BOLD series in different brain areas were also calculated and compared between the two states. Compared with the EC state, ReHo decreased with EO in a wide frequency band of 0.01-0.25 Hz in the bilateral thalamus, sensorimotor network, and superior temporal gyrus, while ReHo increased significantly in the band of 0-0.01 Hz in the primary visual cortex, and in a higher frequency band of 0.02-0.1 Hz in the higher order visual areas. The cross-voxel correlations between the frequency and overall ReHo were negative in all the brain areas but varied from region to region. These correlations were stronger with EO in the visual network and the default mode network. Our results suggested that different frequency bands of ReHo showed different sensitivity to the modulation of EO-EC states. The better spatial consistency between the frequency and overall ReHo maps indicated that the brain might adopt a stricter frequency-dependent configuration with EO than with EC.	[Song, Xiaopeng; Zhou, Shuqin; Liu, Yijun; Zhu, Huaiqiu] Peking Univ, Coll Engn, Dept Biomed Engn, Beijing 100871, Peoples R China; [Zhang, Yi] Xidian Univ, Sch Life Sci & Technol, Xian 710071, Shanxi, Peoples R China; [Gao, Jia-Hong] Peking Univ, Ctr MRI Res, Beijing 100871, Peoples R China; [Gao, Jia-Hong] Peking Univ, Beijing City Key Lab Med Phys & Engn, Beijing 100871, Peoples R China	Peking University; Xidian University; Peking University; Peking University	Gao, JH (corresponding author), Peking Univ, Ctr MRI Res, Beijing 100871, Peoples R China.	jgao@pku.edu.cn	Zhu, Huaiqiu/C-3617-2012; Zhang, Yi/J-7496-2017	Zhu, Huaiqiu/0000-0002-6376-218X; Zhang, Yi/0000-0003-0859-9735	National Natural Science Foundation of China [61131003, 81271549, 61431013, 81470816, 81430037, 31421003, 81227003]; China's National Strategic Basic Research Program (973) [2012CB720700]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China's National Strategic Basic Research Program (973)	This work was supported by the National Natural Science Foundation of China (61131003, 81271549, 61431013, 81470816, 81430037, 31421003 and 81227003) and China's National Strategic Basic Research Program (973) (2012CB720700).	Baria AT, 2011, J NEUROSCI, V31, P7910, DOI 10.1523/JNEUROSCI.1296-11.2011; Baria AT, 2013, NEUROIMAGE; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Deco G, 2013, CEREB CORTEX, pt176; Fukunaga M, 2006, MAGN RESON IMAGING, V24, P979, DOI 10.1016/j.mri.2006.04.018; He BJ, 2013, J NEUROSCI, V33, P4672, DOI 10.1523/JNEUROSCI.2922-12.2013; Hipp JF, 2012, NAT NEUROSCI, V15, P884, DOI 10.1038/nn.3101; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Jao T, 2013, NEUROIMAGE, V69, P21, DOI 10.1016/j.neuroimage.2012.12.007; Laufs H, 2006, NEUROIMAGE, V31, P1408, DOI 10.1016/j.neuroimage.2006.02.002; Li Z, 2012, PLOS ONE, V9; Liang X, 2013, P NATL ACAD SCI USA, V110, P1929, DOI 10.1073/pnas.1214900110; Liu DQ, 2013, NEUROINFORMATICS, V11, P469, DOI 10.1007/s12021-013-9187-0; Lv Y, 2013, PLOS ONE, V5; Marx E, 2004, NEUROIMAGE, V21, P1818, DOI 10.1016/j.neuroimage.2003.12.026; Marx E, 2003, NEUROIMAGE, V19, P924, DOI 10.1016/S1053-8119(03)00150-2; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Michels L, 2013, NEUROIMAGE, V81, P231, DOI 10.1016/j.neuroimage.2013.04.030; Mo J, 2013, NEUROIMAGE, V68, P112, DOI 10.1016/j.neuroimage.2012.11.058; Niazy RK, 2011, PROG BRAIN RES, V193, P259, DOI 10.1016/B978-0-444-53839-0.00017-X; Patriat R, 2013, NEUROIMAGE, V78, P463, DOI 10.1016/j.neuroimage.2013.04.013; Peng TY, 2013, MAGN RESON IMAGING, V31, P336, DOI 10.1016/j.mri.2012.06.013; Siegel M, 2012, NAT REV NEUROSCI; Song X, 2014, PLOS ONE, V1; Wu CWW, 2008, NEUROIMAGE, V42, P1047, DOI 10.1016/j.neuroimage.2008.05.035; Xie HB, 2006, COMPUT METH PROG BIO, V82, P114, DOI 10.1016/j.cmpb.2006.02.009; Yang H, 2007, NEUROIMAGE, V36, P144, DOI 10.1016/j.neuroimage.2007.01.054; Yuan BK, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00503; Yuan H, 2013, NEUROIMAGE, V79, P81, DOI 10.1016/j.neuroimage.2013.04.068; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zou O, 2015, NEUROIMAGE; Zou Q, 2015, PLOS ONE, V3; Zou QH, 2009, HUM BRAIN MAPP, V30, P3066, DOI 10.1002/hbm.20728	33	13	13	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2015	10	11							e0141507	10.1371/journal.pone.0141507	http://dx.doi.org/10.1371/journal.pone.0141507			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV6RT	26545233	Green Published, Green Submitted, gold			2022-12-27	WOS:000364398700028
J	Zhang, Y; Xiao, RR; Yin, TL; Zou, W; Tang, Y; Ding, JL; Yang, J				Zhang, Yi; Xiao, Rong-Rong; Yin, Tailang; Zou, Wei; Tang, Yun; Ding, Jinli; Yang, Jing			Generation of Gradients on a Microfluidic Device: Toward a High-Throughput Investigation of Spermatozoa Chemotaxis	PLOS ONE			English	Article							SPERM CHEMOTAXIS; MAMMALIAN SPERM; PROGESTERONE; CHEMOATTRACTANT; CAPACITATION; MECHANISMS; MIGRATION; AXON	Various research tools have been used for in vitro detection of sperm chemotaxis. However, they are typically poor in maintenance of gradient stability, not to mention their low efficiency. Microfluidic device offers a new experimental platform for better control over chemical concentration gradient than traditional ones. In the present study, an easy-handle diffusion-based microfluidic chip was established. This device allowed for conduction of three parallel experiments on the same chip, and improved the performance of sperm chemotaxis research. In such a chip, there were six channels surrounding a hexagonal pool. The channels are connected to the hexagon by microchannels. Firstly, the fluid flow in the system was characterized; secondly, fluorescein solution was used to calibrate gradient profiles formed in the central hexagon; thirdly, sperm behavior was observed under two concentration gradients of progesterone (100 pM and 1 mM, respectively) as a validation of the device. Significant differences in chemotactic parameters were recognized between experimental and control groups (p < 0.05). Compared with control group, sperm motility was greatly enhanced in 1 mM group (p < 0.05), but no significant difference was found in 100 pM group. In conclusion, we proposed a microfluidic device for the study of sperm chemotaxis that was capable of generating multi-channel gradients on a chip and would help reduce experimental errors and save time in experiment.	[Zhang, Yi; Yin, Tailang; Ding, Jinli; Yang, Jing] Wuhan Univ, Renmin Hosp, Reprod Med Ctr, Wuhan 430072, Hubei Province, Peoples R China; [Xiao, Rong-Rong; Zou, Wei; Tang, Yun] Wuhan Univ, Key Lab Analyt Chem Biol & Med, Minist Educ, Coll Chem & Mol Sci, Wuhan 430072, Peoples R China	Wuhan University; Wuhan University	Yang, J (corresponding author), Wuhan Univ, Renmin Hosp, Reprod Med Ctr, Wuhan 430072, Hubei Province, Peoples R China.	dryangjing607@gmail.com			National Natural Science Foundation of China [81370767]; Health and Family Planning Commission of Hubei Province [JS-2011001]; Public Welfare of Hubei Province [2013BCB005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Health and Family Planning Commission of Hubei Province; Public Welfare of Hubei Province	Funding: This research was supported by National Natural Science Foundation of China (81370767, grant recipient JY), Health and Family Planning Commission of Hubei Province (JS-2011001, grant recipient JY) and Public Welfare of Hubei Province (2013BCB005, grant recipient JY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldi E, 2009, MOL CELL ENDOCRINOL, V308, P39, DOI 10.1016/j.mce.2009.02.006; Calogero AE, 2000, HUM REPROD, V15, P28, DOI 10.1093/humrep/15.suppl_1.28; Chang HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060587; Cheng SY, 2007, LAB CHIP, V7, P763, DOI 10.1039/b618463d; COHENDAYAG A, 1995, P NATL ACAD SCI USA, V92, P11039, DOI 10.1073/pnas.92.24.11039; Eisenbach M, 2006, NAT REV MOL CELL BIO, V7, P276, DOI 10.1038/nrm1893; Eisenbach M, 1999, REV REPROD, V4, P56, DOI 10.1530/revreprod/4.1.56; Eisenbach M, 1999, DEV GENET, V25, P87, DOI 10.1002/(SICI)1520-6408(1999)25:2&lt;87::AID-DVG2&gt;3.0.CO;2-4; Fabro G, 2002, BIOL REPROD, V67, P1565, DOI 10.1095/biolreprod.102.006395; Gakamsky A, 2009, HUM REPROD, V24, P1152, DOI 10.1093/humrep/den409; Gatica LV, 2013, MOL HUM REPROD, V19, P559, DOI 10.1093/molehr/gat037; Henkel Ralf R, 2003, Reprod Biol Endocrinol, V1, P108, DOI 10.1186/1477-7827-1-108; Kaupp UB, 2012, J GEN PHYSIOL, V140, P583, DOI 10.1085/jgp.201210902; Kaupp UB, 2008, ANNU REV PHYSIOL, V70, P93, DOI 10.1146/annurev.physiol.70.113006.100654; Kim BJ, 2012, ANN BIOMED ENG, V40, P1316, DOI 10.1007/s10439-011-0489-9; Li J, 2011, TRENDS CELL BIOL, V21, P489, DOI 10.1016/j.tcb.2011.05.002; Lopez-Garcia MDC, 2008, BIOMED MICRODEVICES, V10, P709, DOI 10.1007/s10544-008-9182-7; Miki K, 2013, CURR BIOL, V23, P443, DOI 10.1016/j.cub.2013.02.007; Oren-Benaroya R, 2008, HUM REPROD, V23, P2339, DOI 10.1093/humrep/den265; Park JW, 2006, NAT PROTOC, V1, P2128, DOI 10.1038/nprot.2006.316; Sagare-Patil V, 2012, INT J ANDROL, V35, P633, DOI 10.1111/j.1365-2605.2012.01291.x; Srinivasan P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099640; Suarez SS, 2006, HUM REPROD UPDATE, V12, P23, DOI 10.1093/humupd/dmi047; Sugiyama Hitoshi, 2004, Methods Mol Biol, V253, P27; Teves ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008211; Teves ME, 2006, FERTIL STERIL, V86, P745, DOI 10.1016/j.fertnstert.2006.02.080; Tung CK, 2014, LAB CHIP, V14, P1348, DOI 10.1039/c3lc51297e; WHO, 2001, ANN I SUPER SANITA, V37, pI; WILLIAMS M, 1993, HUM REPROD, V8, P2019, DOI 10.1093/oxfordjournals.humrep.a137975; Xiao RR, 2014, ANAL CHEM, V86, P11649, DOI 10.1021/ac504159g; Xiao RR, 2013, ANAL CHEM, V85, P7842, DOI 10.1021/ac4022055; Zou YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061593	32	149	154	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142555	10.1371/journal.pone.0142555	http://dx.doi.org/10.1371/journal.pone.0142555			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26171860	Green Published, gold, Green Submitted			2022-12-27	WOS:000364430700127
